PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FP	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	DL	D2	EA	PG	WC	WE	SC	GA	PM	OA	HC	HP	DA	UT
J	Harms, R; Morsey, B; Boyer, CW; Fox, HS; Sarvetnick, N				Harms, Robert; Morsey, Brenda; Boyer, Craig W.; Fox, Howard S.; Sarvetnick, Nora			Methamphetamine Administration Targets Multiple Immune Subsets and Induces Phenotypic Alterations Suggestive of Immunosuppression	PLOS ONE			English	Article							NATURAL-KILLER-CELLS; MOUSE NK CELLS; T-CELLS; VIRUS-INFECTION; ACTIVATION; MONOCYTES; RISK; AMPHETAMINE; MOLECULE; HIV	Methamphetamine (Meth) is a widely abused stimulant and its users are at increased risk for multiple infectious diseases. To determine the impact of meth on the immune system, we utilized a murine model that simulates the process of meth consumption in a typical addict. Our phenotypic analysis of leukocytes from this dose escalation model revealed that meth affected key immune subsets. Meth administration led to a decrease in abundance of natural killer (NK) cells and the remaining NK cells possessed a phenotype suggesting reduced responsiveness. Dendritic cells (DCs) and Gr-1(high) monocytes/macrophages were also decreased in abundance while Gr-1(low) monocytes/macrophages appear to show signs of perturbation. CD4 and CD8 T cell subsets were affected by methamphetamine, both showing a reduction in antigen-experienced subsets. CD4 T cells also exhibited signs of activation, with increased expression of CD150 on CD226-expressing cells and an expansion of KLRG1(+), FoxP3(-) cells. These results exhibit that meth has the ability to disrupt immune homeostasis and impact key subsets of leukocytes which may leave users more vulnerable to pathogens.	[Harms, Robert; Boyer, Craig W.; Sarvetnick, Nora] Univ Nebraska Med Ctr, Dept Surgery Transplant, Omaha, NE USA; [Morsey, Brenda; Fox, Howard S.] Univ Nebraska Med Ctr, Dept Pharmacol & Expt Neurosci, Omaha, NE USA; [Sarvetnick, Nora] Univ Nebraska Med Ctr, Regenerat Med Project, Omaha, NE USA	University of Nebraska System; University of Nebraska Medical Center; University of Nebraska System; University of Nebraska Medical Center; University of Nebraska System; University of Nebraska Medical Center	Harms, R (corresponding author), Univ Nebraska Med Ctr, Dept Surgery Transplant, Omaha, NE USA.	rharms@unmc.edu		Fox, Howard/0000-0003-2032-374X	NIH from the National Institute on Drug Abuse [RO1:345160-2058101]; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA032513] Funding Source: NIH RePORTER	NIH from the National Institute on Drug Abuse; NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This work was funded by NIH RO1:345160-2058101 from the National Institute on Drug Abuse. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Beyersdorf N, 2007, EUR J IMMUNOL, V37, P3445, DOI 10.1002/eji.200737126; Bonell CP, 2010, INT J DRUG POLICY, V21, P244, DOI 10.1016/j.drugpo.2009.07.002; Bromley SK, 2001, NAT IMMUNOL, V2, P1159, DOI 10.1038/ni737; Brouwer KC, 2006, SUBST USE MISUSE, V41, P707, DOI 10.1080/10826080500411478; Butte MJ, 2008, MOL IMMUNOL, V45, P3567, DOI 10.1016/j.molimm.2008.05.014; Butte MJ, 2007, IMMUNITY, V27, P111, DOI 10.1016/j.immuni.2007.05.016; Chiossone L, 2009, BLOOD, V113, P5488, DOI 10.1182/blood-2008-10-187179; Cohen AL, 2007, EMERG INFECT DIS, V13, P1707, DOI 10.3201/eid1311.070148; Corsi Karen F, 2008, Curr Drug Abuse Rev, V1, P292; Cruickshank CC, 2009, ADDICTION, V104, P1085, DOI 10.1111/j.1360-0443.2009.02564.x; Daley JM, 2008, J LEUKOCYTE BIOL, V83, P64, DOI 10.1189/jlb.0407247; Dardalhon V, 2005, J IMMUNOL, V175, P1558, DOI 10.4049/jimmunol.175.3.1558; Degenhardt L, 2008, DRUG ALCOHOL REV, V27, P217, DOI 10.1080/09595230801956538; Denoeud J, 2011, J LEUKOCYTE BIOL, V89, P195, DOI 10.1189/jlb.0610351; Ellis RJ, 2003, J INFECT DIS, V188, P1820, DOI 10.1086/379894; Forrest DW, 2010, J URBAN HEALTH, V87, P480, DOI 10.1007/s11524-009-9422-z; Freeman P, 2011, ARCH PEDIAT ADOL MED, V165, P736, DOI 10.1001/archpediatrics.2011.118; GAGNON L, 1992, TOXICOL LETT, V63, P313, DOI 10.1016/0378-4274(92)90093-Y; Geissmann F, 2003, IMMUNITY, V19, P71, DOI 10.1016/S1074-7613(03)00174-2; Gonzales R, 2006, J SUBST ABUSE TREAT, V31, P195, DOI 10.1016/j.jsat.2006.04.006; Gonzales R, 2010, ANNU REV PUBL HEALTH, V31, P385, DOI 10.1146/annurev.publhealth.012809.103600; Hayakawa Y, 2006, J IMMUNOL, V176, P1517, DOI 10.4049/jimmunol.176.3.1517; Henning G, 2001, EUR J IMMUNOL, V31, P2741, DOI 10.1002/1521-4141(200109)31:9<2741::AID-IMMU2741>3.0.CO;2-6; Hermiston ML, 2003, ANNU REV IMMUNOL, V21, P107, DOI 10.1146/annurev.immunol.21.120601.140946; HOUSE RV, 1994, IMMUNOPHARM IMMUNOT, V16, P1, DOI 10.3109/08923979409029897; Howie D, 2002, BLOOD, V100, P2899, DOI 10.1182/blood-2002-02-0445; Huntington ND, 2007, J IMMUNOL, V178, P4764, DOI 10.4049/jimmunol.178.8.4764; Hutin YJF, 2000, AM J EPIDEMIOL, V152, P186, DOI 10.1093/aje/152.2.186; In SW, 2005, J TOXICOL ENV HEAL A, V68, P2133, DOI 10.1080/15287390500177156; In SW, 2004, J TOXICOL ENV HEAL A, V67, P1923, DOI 10.1080/15287390490514589; Ito M, 2006, J EXP MED, V203, P289, DOI 10.1084/jem.20051986; Iwasa M, 1996, INT J LEGAL MED, V109, P23, DOI 10.1007/BF01369597; Kirkos WC, 2008, CAN MED ASSOC J, V178, P1655, DOI 10.1503/cmaj.071299; KOJIMA T, 1986, FORENSIC SCI INT, V31, P93, DOI 10.1016/0379-0738(86)90193-3; Krasnova IN, 2009, BRAIN RES REV, V60, P379, DOI 10.1016/j.brainresrev.2009.03.002; Li YL, 2009, IMMUNITY, V31, P35, DOI 10.1016/j.immuni.2009.04.019; Liang H, 2008, AM J PATHOL, V172, P1617, DOI 10.2353/ajpath.2008.070971; Marcenaro E, 2011, IMMUNOTHERAPY-UK, V3, P1075, DOI [10.2217/IMT.11.99, 10.2217/imt.11.99]; Marcondes MCG, 2010, AM J PATHOL, V177, P355, DOI 10.2353/ajpath.2010.090953; Marshall BDL, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-20; Martinez LR, 2009, J INFECT DIS, V200, P131, DOI 10.1086/599328; Mau MK, 2009, VASC HEALTH RISK MAN, V5, P45; Mcketin R, 2008, DRUG ALCOHOL REV, V27, P220, DOI 10.1080/09595230801923710; NAGATA T, 1990, FORENSIC SCI INT, V48, P39, DOI 10.1016/0379-0738(90)90270-9; Nahrendorf M, 2007, J EXP MED, V204, P3037, DOI 10.1084/jem.20070885; Nicosia N, 2009, THE ECONOMIC COST OF; Nordahl TE, 2003, J NEUROPSYCH CLIN N, V15, P317, DOI 10.1176/appi.neuropsych.15.3.317; Park JJ, 2010, BLOOD, V116, P1291, DOI 10.1182/blood-2010-01-265975; Peltzer K, 2010, SUBST USE MISUSE, V45, P2221, DOI 10.3109/10826084.2010.481594; Peng YF, 2009, J IMMUNOL, V182, P2777, DOI 10.4049/jimmunol.0803172; Potula R, 2010, J IMMUNOL, V185, P2867, DOI 10.4049/jimmunol.0903691; Reiley WW, 2010, P NATL ACAD SCI USA, V107, P19408, DOI 10.1073/pnas.1006298107; Riviere GJ, 2000, J PHARMACOL EXP THER, V292, P1042; Robbins SH, 2002, J IMMUNOL, V168, P2585, DOI 10.4049/jimmunol.168.6.2585; Saito M, 2005, EXPERIMENTAL ANIMALS, V55, P477; Saito M, 2008, EXP ANIM TOKYO, V57, P35, DOI 10.1538/expanim.57.35; Sarkar S, 2008, J EXP MED, V205, P625, DOI 10.1084/jem.20071641; Sato Y, 2000, Nihon Hoigaku Zasshi, V54, P420; Schif-Zuck S, 2011, EUR J IMMUNOL, V41, P366, DOI 10.1002/eji.201040801; Sharpe AH, 2002, NAT REV IMMUNOL, V2, P116, DOI 10.1038/nri727; Sheridan J, 2009, J PSYCHOACTIVE DRUGS, V41, P11, DOI 10.1080/02791072.2009.10400670; Strauss-Ayali D, 2007, J LEUKOCYTE BIOL, V82, P244, DOI 10.1189/jlb.0307191; Swirski FK, 2009, SCIENCE, V325, P612, DOI 10.1126/science.1175202; Tacke F, 2006, J EXP MED, V203, P583, DOI 10.1084/jem.20052119; Talloczy Z, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.0040028; Thomas DM, 2004, J PHARMACOL EXP THER, V311, P1, DOI 10.1124/jpet.104.070961; Tsujimura K, 2006, IMMUNOL LETT, V106, P48, DOI 10.1016/j.imlet.2006.04.006; Vogt TM, 2006, ADDICTION, V101, P726, DOI 10.1111/j.1360-0443.2006.01407.x; Volkow ND, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015269; Waggoner SN, 2012, NATURE, V481, P394, DOI 10.1038/nature10624; Waldhauer I, 2008, ONCOGENE, V27, P5932, DOI 10.1038/onc.2008.267; Walzer T, 2007, P NATL ACAD SCI USA, V104, P3384, DOI 10.1073/pnas.0609692104; Wey SP, 2008, TOXICOL LETT, V181, P157, DOI 10.1016/j.toxlet.2008.07.015; Wiede F, 2009, J LEUKOCYTE BIOL, V85, P108, DOI 10.1189/jlb.0107018; Wing K, 2010, NAT IMMUNOL, V11, P7, DOI 10.1038/ni.1818; Ye L, 2008, J VIRAL HEPATITIS, V15, P261, DOI 10.1111/j.1365-2893.2007.00940.x; Yu QL, 2002, INT IMMUNOPHARMACOL, V2, P951, DOI 10.1016/S1567-5769(02)00047-4	77	45	45	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 5	2012	7	12							e49897	10.1371/journal.pone.0049897	http://dx.doi.org/10.1371/journal.pone.0049897			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	057TZ	23227154	Green Published, Green Submitted, gold			2022-12-27	WOS:000312588200016
J	Legon, W; Rowlands, A; Opitz, A; Sato, TF; Tyler, WJ				Legon, Wynn; Rowlands, Abby; Opitz, Alexander; Sato, Tomokazu F.; Tyler, William J.			Pulsed Ultrasound Differentially Stimulates Somatosensory Circuits in Humans as Indicated by EEG and fMRI	PLOS ONE			English	Article							POSITRON-EMISSION-TOMOGRAPHY; EVOKED-POTENTIALS; FOCUSED ULTRASOUND; CYTOARCHITECTONIC AREAS; TRANSIENT CAVITATION; CEREBRAL-CORTEX; HUMAN BRAIN; HAIRY SKIN; PAIN; RESPONSES	Peripheral somatosensory circuits are known to respond to diverse stimulus modalities. The energy modalities capable of eliciting somatosensory responses traditionally belong to mechanical, thermal, electromagnetic, and photonic domains. Ultrasound (US) applied to the periphery has also been reported to evoke diverse somatosensations. These observations however have been based primarily on subjective reports and lack neurophysiological descriptions. To investigate the effects of peripherally applied US on human somatosensory brain circuit activity we recorded evoked potentials using electroencephalography and conducted functional magnetic resonance imaging of blood oxygen level-dependent (BOLD) responses to fingertip stimulation with pulsed US. We found a pulsed US waveform designed to elicit a mild vibration sensation reliably triggered evoked potentials having distinct waveform morphologies including a large double-peaked vertex potential. Fingertip stimulation with this pulsed US waveform also led to the appearance of BOLD signals in brain regions responsible for somatosensory discrimination including the primary somatosensory cortex and parietal operculum, as well as brain regions involved in hierarchical somatosensory processing, such as the insula, anterior middle cingulate cortex, and supramarginal gyrus. By changing the energy profile of the pulsed US stimulus waveform we observed pulsed US can differentially activate somatosensory circuits and alter subjective reports that are concomitant with changes in evoked potential morphology and BOLD response patterns. Based on these observations we conclude pulsed US can functionally stimulate different somatosensory fibers and receptors, which may permit new approaches to the study and diagnosis of peripheral nerve injury, dysfunction, and disease.	[Tyler, William J.] Virginia Tech, Carilion Res Inst, Roanoke, VA USA; Virginia Tech, Sch Biomed Engn & Sci, Roanoke, VA USA	Virginia Polytechnic Institute & State University; Virginia Polytechnic Institute & State University	Tyler, WJ (corresponding author), Virginia Tech, Carilion Res Inst, Roanoke, VA USA.	wtyler@vt.edu		Tyler, William/0000-0002-7758-5022	Virginia Tech and the Virginia Tech Carilion Research Institute	Virginia Tech and the Virginia Tech Carilion Research Institute	All authors on the manuscript are inventors on a patent application disclosing the use of ultrasound for peripheral stimulation. The authors' filing of this patent did not affect their objectivity or resolve in conducting the research. In addition, WJT and TFS have other patents pending on brain stimulation methods and devices and hold equity in a neuromodulation device company not related to this study. The authors' activities as consultants to this company did not affect their objectivity and again are not related to the present study. These activities do not alter their adherence to all the PLOS ONE policies on sharing data and materials. Funding for this study was provided by start-up funds to WJT from Virginia Tech and the Virginia Tech Carilion Research Institute. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALLISON T, 1992, ELECTROEN CLIN NEURO, V84, P301, DOI 10.1016/0168-5597(92)90082-M; ALLISON T, 1989, J NEUROPHYSIOL, V62, P694, DOI 10.1152/jn.1989.62.3.694; Arnadottir J, 2010, ANNU REV BIOPHYS, V39, P111, DOI 10.1146/annurev.biophys.37.032807.125836; Bodegard A, 2001, NEURON, V31, P317, DOI 10.1016/S0896-6273(01)00362-2; Brotchie A, 2009, PHYS REV LETT, V102, DOI 10.1103/PhysRevLett.102.084302; Buchel C, 2002, J NEUROSCI, V22, P970, DOI 10.1523/JNEUROSCI.22-03-00970.2002; Burton H, 2000, SOMATOSENS MOT RES, V17, P213; Burton H, 1997, CEREB CORTEX, V7, P3, DOI 10.1093/cercor/7.1.3; Chen ACN, 2001, NEUROSCI LETT, V316, P79, DOI 10.1016/S0304-3940(01)02374-6; Christensen AP, 2007, NAT REV NEUROSCI, V8, P510, DOI 10.1038/nrn2149; Craig AD, 2009, NAT REV NEUROSCI, V10, P59, DOI 10.1038/nrn2555; Cruccu G, 2008, CLIN NEUROPHYSIOL, V119, P1705, DOI 10.1016/j.clinph.2008.03.016; Cruccu G, 2004, EUR J NEUROL, V11, P153, DOI 10.1111/j.1468-1331.2004.00791.x; Dalecki D, 2004, ANNU REV BIOMED ENG, V6, P229, DOI 10.1146/annurev.bioeng.6.040803.140126; Delmas P, 2011, NAT REV NEUROSCI, V12, P139, DOI 10.1038/nrn2993; Delorme A, 2004, J NEUROSCI METH, V134, P9, DOI 10.1016/j.jneumeth.2003.10.009; Dickey TC, 2012, ULTRASOUND MED BIOL, V38, P85, DOI 10.1016/j.ultrasmedbio.2011.09.020; Eickhoff S, 2005, HUM BRAIN MAPP, V24, P206, DOI 10.1002/hbm.20082; Eickhoff SB, 2007, CEREB CORTEX, V17, P1800, DOI 10.1093/cercor/bhl090; Frot M, 2001, PAIN, V94, P65, DOI 10.1016/S0304-3959(01)00342-6; Galkin VE, 2012, CURR BIOL, V22, pR96, DOI 10.1016/j.cub.2011.12.010; Gavrilov L R, 1976, Prog Brain Res, V43, P279; GAVRILOV LR, 1977, BRAIN RES, V135, P265, DOI 10.1016/0006-8993(77)91030-7; Gavrilov LR, 1996, ULTRASOUND MED BIOL, V22, P179, DOI 10.1016/0301-5629(96)83782-3; Gelnar PA, 1998, NEUROIMAGE, V7, P261, DOI 10.1006/nimg.1998.0341; GEVINS A, 1994, ELECTROEN CLIN NEURO, V90, P337, DOI 10.1016/0013-4694(94)90050-7; Granovsky Y, 2005, PAIN, V115, P238, DOI 10.1016/j.pain.2005.02.017; Hameroff S, 2012, BRAIN STIMUL; Hamill OP, 2006, PFLUG ARCH EUR J PHY, V453, P333, DOI 10.1007/s00424-006-0131-0; Hegner YL, 2010, J NEUROPHYSIOL, V103, P3115, DOI 10.1152/jn.00940.2009; HOLLAND CK, 1990, J ACOUST SOC AM, V88, P2059, DOI 10.1121/1.400102; HYNYNEN K, 1991, ULTRASOUND MED BIOL, V17, P157, DOI 10.1016/0301-5629(91)90123-E; Iannetti GD, 2006, J PHYSIOL-LONDON, V577, P235, DOI 10.1113/jphysiol.2006.115675; Iannetti GD, 2003, J NEUROPHYSIOL, V89, P562, DOI 10.1152/jn.00393.2002; Lumpkin EA, 2007, NATURE, V445, P858, DOI 10.1038/nature05662; Meng FJ, 2011, CELL MOL BIOENG, V4, P148, DOI 10.1007/s12195-010-0140-0; O'Brien WD, 2007, PROG BIOPHYS MOL BIO, V93, P212, DOI 10.1016/j.pbiomolbio.2006.07.010; Oertel BG, 2012, HUM BRAIN MAPP, V33, P883, DOI 10.1002/hbm.21256; OLDFIELD RC, 1971, NEUROPSYCHOLOGIA, V9, P97, DOI 10.1016/0028-3932(71)90067-4; Peltz E, 2011, NEUROIMAGE, V54, P1324, DOI 10.1016/j.neuroimage.2010.09.012; PERRIN F, 1987, IEEE T BIO-MED ENG, V34, P283, DOI 10.1109/TBME.1987.326089; PERRIN F, 1989, ELECTROEN CLIN NEURO, V72, P184, DOI 10.1016/0013-4694(89)90180-6; Peyron R, 2000, NEUROPHYSIOL CLIN, V30, P263, DOI 10.1016/S0987-7053(00)00227-6; Qin Z, 2010, J BIOMECH, V43, P15, DOI 10.1016/j.jbiomech.2009.09.004; Ringler R, 2003, PAIN, V105, P445, DOI 10.1016/S0304-3959(03)00258-6; Rolke R, 2006, EUR J PAIN, V10, P77, DOI 10.1016/j.ejpain.2005.02.003; SOMMER FG, 1982, MED PHYS, V9, P1, DOI 10.1118/1.595065; Tolle TR, 1999, ANN NEUROL, V45, P40, DOI 10.1002/1531-8249(199901)45:1<40::AID-ART8>3.0.CO;2-L; Tommerdahl M, 2010, NEUROSCI BIOBEHAV R, V34, P160, DOI 10.1016/j.neubiorev.2009.08.009; Treede RD, 2003, J NEUROL, V250, P1152, DOI 10.1007/s00415-003-0237-7; TREEDE RD, 1988, ELECTROEN CLIN NEURO, V70, P429, DOI 10.1016/0013-4694(88)90020-X; Tsunozaki M, 2009, CURR OPIN NEUROBIOL, V19, P362, DOI 10.1016/j.conb.2009.07.008; Tufail Y, 2011, NAT PROTOC, V6, P1453, DOI 10.1038/nprot.2011.371; Tufail Y, 2010, NEURON, V66, P681, DOI 10.1016/j.neuron.2010.05.008; Tyler WJ, 2011, NEUROSCIENTIST, V17, P25, DOI 10.1177/1073858409348066; Tyler WJ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003511; Valentini E, 2012, NEUROIMAGE, V59, P1571, DOI 10.1016/j.neuroimage.2011.08.069; Van de Winckel A, 2005, NEUROIMAGE, V26, P441, DOI 10.1016/j.neuroimage.2005.01.058; WRIGHT A, 1989, NEUROSCI LETT, V97, P145, DOI 10.1016/0304-3940(89)90154-7; WRIGHT A, 1993, PAIN, V52, P149, DOI 10.1016/0304-3959(93)90126-A	60	61	79	0	40	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 4	2012	7	12							e51177	10.1371/journal.pone.0051177	http://dx.doi.org/10.1371/journal.pone.0051177			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	051EQ	23226567	Green Submitted, Green Published, gold			2022-12-27	WOS:000312108500049
J	Mann, CD; Bastianpillai, C; Neal, CP; Masood, MM; Jones, DJL; Teichert, F; Singh, R; Karpova, E; Berry, DP; Manson, MM				Mann, Christopher D.; Bastianpillai, Christopher; Neal, Christopher P.; Masood, Muhammad M.; Jones, Donald J. L.; Teichert, Friederike; Singh, Rajinder; Karpova, Elena; Berry, David P.; Manson, Margaret M.			Notch3 and Hey-1 as Prognostic Biomarkers in Pancreatic Adenocarcinoma	PLOS ONE			English	Article							EPITHELIAL-MESENCHYMAL TRANSITION; ENDOTHELIAL GROWTH-FACTOR; SMOOTH-MUSCLE-CELLS; HUMAN LUNG CANCERS; SIGNALING PATHWAY; OVARIAN-CANCER; JAGGED1 EXPRESSION; DOWN-REGULATION; APOPTOSIS; TRANSFORMATION	In order to achieve a better outcome for pancreatic cancer patients, reliable biomarkers are required which allow for improved diagnosis. These may emanate from a more detailed molecular understanding of the aggressive nature of this disease. Having previously reported that Notch3 activation appeared to be associated with more aggressive disease, we have now examined components of this pathway (Notch1, Notch3, Notch4, HES-1, HEY-1) in more detail in resectable (n = 42) and non-resectable (n = 50) tumours compared to uninvolved pancreas. All three Notch family members were significantly elevated in tumour tissue, compared to uninvolved pancreas, with expression maintained within matched lymph node metastases. Furthermore, significantly higher nuclear expression of Notch1, -3 and -4, HES-1, and HEY-1 (all p <= 0.001) was noted in locally advanced and metastatic tumours compared to resectable cancers. In survival analyses, nuclear Notch3 and HEY-1 expression were significantly associated with reduced overall and disease-free survival following tumour resection with curative intent, with nuclear HEY-1 maintaining independent prognostic significance for both outcomes on multivariate analysis. These data further support a central role for Notch signalling in pancreatic cancer and suggest that nuclear expression of Notch3 and its target gene, HEY-1, merit validation in biomarker panels for diagnosis, prognosis and treatment efficacy. A peptide fragment of Notch3 was detected in plasma from patients with inoperable pancreatic cancer, but due to wide inter-individual variation, mean levels were not significantly different compared to age-matched controls.	[Mann, Christopher D.; Bastianpillai, Christopher; Neal, Christopher P.; Masood, Muhammad M.; Jones, Donald J. L.; Teichert, Friederike; Singh, Rajinder; Karpova, Elena; Berry, David P.; Manson, Margaret M.] Univ Leicester, Dept Canc Studies & Mol Med, Leicester, Leics, England	University of Leicester	Manson, MM (corresponding author), Univ Leicester, Dept Canc Studies & Mol Med, Leicester, Leics, England.	mmm2@le.ac.uk	Singh, Raj/HDN-1244-2022; Jones, Donald/Y-6803-2019; Singh, Raj/A-5398-2011	Jones, Donald/0000-0001-6583-870X; 	Royal College of Surgeons, England; Pathological Society; CR-UK/DoH Leicester Experimental Cancer Medicine Centre; Hope Against Cancer; Cancer Prevention Research Trust	Royal College of Surgeons, England; Pathological Society; CR-UK/DoH Leicester Experimental Cancer Medicine Centre; Hope Against Cancer; Cancer Prevention Research Trust	This study was funded by a Royal College of Surgeons, England, fellowship to CDM, the Pathological Society (sponsored student CB), CR-UK/DoH Leicester Experimental Cancer Medicine Centre (FT, EK, M. Manson), Hope Against Cancer (M. Manson) and the Cancer Prevention Research Trust (M. Manson). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Apelqvist A, 1999, NATURE, V400, P877, DOI 10.1038/23716; Beatus P, 1999, DEVELOPMENT, V126, P3925; Buchler P, 2005, ANN SURG, V242, P791, DOI 10.1097/01.sla.0000189115.94847.f1; Campos AH, 2002, CIRC RES, V91, P999, DOI 10.1161/01.RES.0000044944.99984.25; Donnem T, 2010, CANCER-AM CANCER SOC, V116, P5676, DOI 10.1002/cncr.25551; Doucas H, 2008, J SURG ONCOL, V97, P63, DOI 10.1002/jso.20894; Garcea G, 2005, EUR J CANCER, V41, P2213, DOI 10.1016/j.ejca.2005.04.044; Gungor C, 2011, CANCER RES, V71, P5009, DOI 10.1158/0008-5472.CAN-11-0036; Hanlon L, 2010, CANCER RES, V70, P4280, DOI 10.1158/0008-5472.CAN-09-4645; Haruki N, 2005, CANCER RES, V65, P3555, DOI 10.1158/0008-5472.CAN-04-3132; Hingorani SR, 2003, CANCER CELL, V4, P437, DOI 10.1016/S1535-6108(03)00309-X; Jensen J, 2000, NAT GENET, V24, P36, DOI 10.1038/71657; Joutel A, 1996, NATURE, V383, P707, DOI 10.1038/383707a0; Jubb AM, 2010, AM J PATHOL, V176, P2019, DOI 10.2353/ajpath.2010.090908; Jung SG, 2010, CANCER SCI, V101, P1977, DOI 10.1111/j.1349-7006.2010.01641.x; Kawai-Kowase K, 2007, AM J PHYSIOL-CELL PH, V292, pC59, DOI 10.1152/ajpcell.00394.2006; Kim JW, 2005, P NATL ACAD SCI USA, V102, P14308, DOI 10.1073/pnas.0501600102; Konishi J, 2010, ONCOGENE, V29, P589, DOI 10.1038/onc.2009.366; Konishi J, 2007, CANCER RES, V67, P8051, DOI 10.1158/0008-5472.CAN-07-1022; Lin JT, 2010, ANN SURG ONCOL, V17, P2976, DOI 10.1245/s10434-010-1118-9; MacKenzie F, 2004, J BIOL CHEM, V279, P11657, DOI 10.1074/jbc.M312102200; Mazur PK, 2010, P NATL ACAD SCI USA, V107, P13438, DOI 10.1073/pnas.1002423107; Miyamoto Y, 2003, CANCER CELL, V3, P565, DOI 10.1016/S1535-6108(03)00140-5; Nair P, 2003, J VIROL, V77, P7106, DOI 10.1128/JVI.77.12.7106-7112.2003; Okochi M, 2006, J BIOL CHEM, V281, P7890, DOI 10.1074/jbc.M513250200; Park JT, 2008, CANCER RES, V68, P8852, DOI 10.1158/0008-5472.CAN-08-0517; Park JT, 2006, CANCER RES, V66, P6312, DOI 10.1158/0008-5472.CAN-05-3610; Park JT, 2010, AM J PATHOL, V177, P1087, DOI 10.2353/ajpath.2010.100316; Radtke F, 1999, IMMUNITY, V10, P547, DOI 10.1016/S1074-7613(00)80054-0; Ronchini C, 2001, MOL CELL BIOL, V21, P5925, DOI 10.1128/MCB.21.17.5925-5934.2001; Santagata S, 2004, CANCER RES, V64, P6854, DOI 10.1158/0008-5472.CAN-04-2500; Sarmento LM, 2005, J EXP MED, V202, P157, DOI 10.1084/jem.20050559; Shi TP, 2008, J UROLOGY, V180, P361, DOI 10.1016/j.juro.2008.02.037; Sweeney C, 2004, FASEB J, V18, P1421, DOI 10.1096/fj.04-1700fje; Talora C, 2002, GENE DEV, V16, P2252, DOI 10.1101/gad.988902; Wang WL, 2003, BIOCHEM BIOPH RES CO, V308, P596, DOI 10.1016/S0006-291X(03)01453-0; Wang ZW, 2009, CANCER RES, V69, P2400, DOI 10.1158/0008-5472.CAN-08-4312; Wang ZW, 2006, CANCER RES, V66, P2778, DOI 10.1158/0008-5472.CAN-05-4281; Wang ZW, 2006, MOL CANCER THER, V5, P483, DOI 10.1158/1535-7163.MCT-05-0299; Wu KR, 2011, JPN J CLIN ONCOL, V41, P411, DOI 10.1093/jjco/hyq205; Yamaguchi N, 2008, CANCER RES, V68, P1881, DOI 10.1158/0008-5472.CAN-07-1597; Yang YN, 2011, J CLIN INVEST, V121, P1373, DOI 10.1172/JCI42579	42	51	55	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 4	2012	7	12							e51119	10.1371/journal.pone.0051119	http://dx.doi.org/10.1371/journal.pone.0051119			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	051EQ	23226563	Green Submitted, gold, Green Published			2022-12-27	WOS:000312108500046
J	Morrison, NI; Simmons, GS; Fu, GL; O'Connell, S; Walker, AS; Dafa'alla, T; Walters, M; Claus, J; Tang, GL; Jin, L; Marubbi, T; Epton, MJ; Harris, CL; Staten, RT; Miller, E; Miller, TA; Alphey, L				Morrison, Neil I.; Simmons, Gregory S.; Fu, Guoliang; O'Connell, Sinead; Walker, Adam S.; Dafa'alla, Tarig; Walters, Michelle; Claus, John; Tang, Guolei; Jin, Li; Marubbi, Thea; Epton, Matthew J.; Harris, Claire L.; Staten, Robert T.; Miller, Ernest; Miller, Thomas A.; Alphey, Luke			Engineered Repressible Lethality for Controlling the Pink Bollworm, a Lepidopteran Pest of Cotton	PLOS ONE			English	Article							INHERITED STERILITY; MATING COMPETITIVENESS; MEDFLY DIPTERA; RESISTANCE; FLY; ERADICATION; RADIATION; DOMINANT; TRANSFORMATION; GELECHIIDAE	The sterile insect technique (SIT) is an environmentally friendly method of pest control in which insects are mass-produced, irradiated and released to mate with wild counterparts. SIT has been used to control major pest insects including the pink bollworm (Pectinophora gossypiella Saunders), a global pest of cotton. Transgenic technology has the potential to overcome disadvantages associated with the SIT, such as the damaging effects of radiation on released insects. A method called RIDL (Release of Insects carrying a Dominant Lethal) is designed to circumvent the need to irradiate insects before release. Premature death of insects' progeny can be engineered to provide an equivalent to sterilisation. Moreover, this trait can be suppressed by the provision of a dietary antidote. In the pink bollworm, we generated transformed strains using different DNA constructs, which showed moderate-to-100% engineered mortality. In permissive conditions, this effect was largely suppressed. Survival data on cotton in field cages indicated that field conditions increase the lethal effect. One strain, called OX3402C, showed highly penetrant and highly repressible lethality, and was tested on host plants where its larvae caused minimal damage before death. These results highlight a potentially valuable insecticide-free tool against pink bollworm, and indicate its potential for development in other lepidopteran pests.	[Morrison, Neil I.; Fu, Guoliang; O'Connell, Sinead; Walker, Adam S.; Dafa'alla, Tarig; Jin, Li; Marubbi, Thea; Harris, Claire L.; Alphey, Luke] Oxitec Ltd, Oxford, England; [Morrison, Neil I.; Fu, Guoliang; Jin, Li; Epton, Matthew J.; Alphey, Luke] Univ Oxford, Dept Zool, Oxford OX1 3PS, England; [Simmons, Gregory S.; Walters, Michelle; Claus, John; Tang, Guolei; Staten, Robert T.; Miller, Ernest] Anim Plant Hlth & Inspect Serv, Ctr Plant Hlth Sci & Technol, USDA, Phoenix, AZ USA; [Simmons, Gregory S.] Anim Plant Hlth & Inspect Serv, Ctr Plant Hlth Sci & Technol, USDA, Salinas, CA USA; [Miller, Thomas A.] Univ Calif Riverside, Dept Entomol, Riverside, CA 92521 USA	University of Oxford; United States Department of Agriculture (USDA); United States Department of Agriculture (USDA); University of California System; University of California Riverside	Alphey, L (corresponding author), Oxitec Ltd, Oxford, England.	luke.alphey@oxitec.com		Harris, Claire/0000-0002-8695-7537; Alphey, Luke/0000-0002-2916-3802	Oxitec Limited	Oxitec Limited	Those authors affiliated to Oxitec Limited (as noted in the author list) are or were employees of this company, which therefore provided salary and other support for the research program; these authors also have shares or share options in Oxitec Ltd. This does not alter the authors' adherence to all the PLOS ONE policies on sharing data and materials.	Alphey L, 2010, VECTOR-BORNE ZOONOT, V10, P295, DOI 10.1089/vbz.2009.0014; Alphey N, 2007, J ECON ENTOMOL, V100, P1642, DOI 10.1603/0022-0493(2007)100[1642:MIRBMR]2.0.CO;2; Alphey N, 2011, J THEOR BIOL, V270, P42, DOI 10.1016/j.jtbi.2010.11.016; Alphey N, 2009, J ECON ENTOMOL, V102, P717, DOI 10.1603/029.102.0233; Benson DA, 2005, NUCLEIC ACIDS RES, V33, pD34, DOI 10.1093/nar/gki063; Blake C, 2010, PBW NEARS DESERT COT; Bloem S, 2001, FLA ENTOMOL, V84, P165, DOI 10.2307/3496163; Blomefield TL, 2010, J APPL ENTOMOL, V134, P216, DOI 10.1111/j.1439-0418.2008.01377.x; Caceres C, 2002, GENETICA, V116, P107, DOI 10.1023/A:1020967810703; Carpenter JE, 2009, FLA ENTOMOL, V92, P80, DOI 10.1653/024.092.0113; Cayol JP, 1999, J ECON ENTOMOL, V92, P140, DOI 10.1093/jee/92.1.140; Dever G. E. A., 1984, EPIDEMIOLOGY HLTH SE; Dhurua S, 2011, PEST MANAG SCI, V67, P898, DOI 10.1002/ps.2127; Dyck V.A., 2006, STERILE INSECT TECHN; Fu GL, 2007, NAT BIOTECHNOL, V25, P353, DOI 10.1038/nbt1283; Fu GL, 2010, P NATL ACAD SCI USA, V107, P4550, DOI 10.1073/pnas.1000251107; Gloor G. B., 1992, DROSOPHILA INFORMATI, V71, P148; Gong P, 2005, NAT BIOTECHNOL, V23, P453, DOI 10.1038/nbt1071; GOSSEN M, 1992, P NATL ACAD SCI USA, V89, P5547, DOI 10.1073/pnas.89.12.5547; GRAHAM HM, 1972, J ECON ENTOMOL, V65, P645, DOI 10.1093/jee/65.3.645; Grimaldi David, 2005, pi; Handler AM, 2000, INSECT TRANSGENESIS, P3; Harris AF, 2012, NATURE BIOT IN PRESS; Harris AF, 2011, NAT BIOTECHNOL, V29, P1034, DOI 10.1038/nbt.2019; HOLBROOK FR, 1970, J ECON ENTOMOL, V63, P1175, DOI 10.1093/jee/63.4.1175; HOOPER GHS, 1971, J ECON ENTOMOL, V64, P1068, DOI 10.1093/jee/64.5.1068; KNIPLING EF, 1955, J ECON ENTOMOL, V48, P459, DOI 10.1093/jee/48.4.459; Koudelova J, 2001, FLA ENTOMOL, V84, P172, DOI 10.2307/3496164; Koyama J, 2004, ANNU REV ENTOMOL, V49, P331, DOI 10.1146/annurev.ento.49.061802.123224; Labbe GMC, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001724; Lacroix R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042771; Lukyanov KA, 2000, J BIOL CHEM, V275, P25879, DOI 10.1074/jbc.C000338200; Lux SA, 2002, FLA ENTOMOL, V85, P102, DOI 10.1653/0015-4040(2002)085[0102:EOIOTC]2.0.CO;2; Martins S, 2012, INSECT MOL BIOL, V21, P414, DOI 10.1111/j.1365-2583.2012.01146.x; Matz MV, 1999, NAT BIOTECHNOL, V17, P969, DOI 10.1038/13657; Mayer DG, 1998, PREV VET MED, V36, P1, DOI 10.1016/S0167-5877(98)00078-6; Morrison N. I., 2011, ASIA PAC J MOL BIOL, V18, P275; NORTH DT, 1975, ANNU REV ENTOMOL, V20, P167, DOI 10.1146/annurev.en.20.010175.001123; Papathanos PA, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-S2-S5; Peloquin JJ, 2000, INSECT MOL BIOL, V9, P323, DOI 10.1046/j.1365-2583.2000.00194.x; Phuc HK, 2007, BMC BIOL, V5, DOI 10.1186/1741-7007-5-11; Rendon P, 2004, J ECON ENTOMOL, V97, P1547, DOI 10.1603/0022-0493-97.5.1547; Sambrook J., 2001, MOL CLONING LAB MANU; Seth RK, 2001, FLA ENTOMOL, V84, P183, DOI 10.2307/3496165; Simmons GS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024110; Stewart FD, 1984, HDB INSECT REARING, P176; Suckling D. M., 2007, P603, DOI 10.1007/978-1-4020-6059-5_56; Tabashnik BE, 2010, NAT BIOTECHNOL, V28, P1304, DOI 10.1038/nbt.1704; Thomas DD, 2000, SCIENCE, V287, P2474, DOI 10.1126/science.287.5462.2474; Wakelyn P, 2010, COTTON TECHNOLOGY 21; Walters M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038547	51	19	27	0	38	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 4	2012	7	12							e50922	10.1371/journal.pone.0050922	http://dx.doi.org/10.1371/journal.pone.0050922			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	051EQ	23226548	Green Submitted, Green Published, gold			2022-12-27	WOS:000312108500035
J	Viel, JF; Studer, JM; Ottignon, Y; Hirsch, JP				Viel, Jean-Francois; Studer, Jean-Marie; Ottignon, Yves; Hirsch, Jean-Pierre		Franche-Comte Polyp Surveillance S	Predictors of Colorectal Polyp Recurrence after the First Polypectomy in Private Practice Settings: A Cohort Study	PLOS ONE			English	Article							SURVEILLANCE COLONOSCOPY; SCREENING COLONOSCOPY; COMMUNITY PRACTICE; NATIONAL-SURVEY; GUIDELINES; ADENOMAS; CANCER; RISK; PHYSICIANS; NEOPLASMS	Background: Supplementary observational data in the community setting are required to better assess the predictors of colorectal polyp recurrence and the effectiveness of colonoscopy surveillance under real circumstances. Aim: The goal of this study was to identify patient characteristics and polyp features at baseline colonoscopy that are associated with the recurrence of colorectal polyps (including hyperplastic polyps) among patients consulting private practice physicians. Patients and Methods: This cohort study was conducted from March 2004 to December 2010 in 26 private gastroenterology practices (France). It included 1023 patients with a first-time diagnosis of histologically confirmed polyp removed during a diagnostic or screening colonoscopy. At enrollment, interviews were conducted to obtain data on socio-demographic variables and risk factors. Pathology reports were reviewed to abstract data on polyp features at baseline colonoscopy. Colorectal polyps diagnosed at the surveillance colonoscopy were considered as end points. The time to event was analyzed with an accelerated failure time model assuming a Weibull distribution. Results: Among the 1023 patients with colorectal polyp at baseline, 553 underwent a surveillance colonoscopy. The mean time interval from baseline colonoscopy to first surveillance examination was 3.42 (standard deviation, 1.45) years. The recurrence rates were 50.5% and 32.9% for all polyps and adenomas, respectively. In multivariate models, the number of polyps at baseline was the only significant predictor for both polyp recurrence (hazard ratio [HR] 1.19, 95% CI 1.06 to 1.33), and adenoma recurrence (HR 1.17, 95% CI 1.03 to 1.34). Conclusion: The efficacy of surveillance colonoscopy in community gastroenterology practice compared favorably with academic settings. This study provides further evidence that the number of initial colorectal polyps is useful for predicting the risk of polyp recurrence, even in the community setting. Citation: Viel J-F, Studer J-M, Ottignon Y, Hirsch J-P, Franche-Comte Polyp Surveillance Study Group (2012) Predictors of Colorectal Polyp Recurrence after the First Polypectomy in Private Practice Settings: A Cohort Study. PLoS ONE 7(12): e50990. doi: 10.1371/journal.pone.0050990	[Viel, Jean-Francois] Univ Hosp, Dept Epidemiol & Publ Hlth, Rennes, France	CHU Rennes	Viel, JF (corresponding author), Univ Hosp, Dept Epidemiol & Publ Hlth, Rennes, France.	jean-francois.viel@univ-rennes1.fr	Viel, Jean-Francois/K-2224-2015	Viel, Jean-Francois/0000-0002-6716-7468	French Ministry of Health; National League Against Cancer; 4 Departmental Leagues against Cancer (Montbeliard, Vesoul, Lons le Saulnier, Besancon); French National Cancer Institute	French Ministry of Health; National League Against Cancer(Ligue nationale contre le cancer); 4 Departmental Leagues against Cancer (Montbeliard, Vesoul, Lons le Saulnier, Besancon); French National Cancer Institute(Institut National du Cancer (INCA) France)	This work was supported by grants from the French Ministry of Health, the National League Against Cancer, 4 Departmental Leagues against Cancer (Montbeliard, Vesoul, Lons le Saulnier, Besancon) and the French National Cancer Institute. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arditi C, 2009, ENDOSCOPY, V41, P209, DOI 10.1055/s-0028-1119646; Avidan B, 2002, AM J GASTROENTEROL, V97, P1524, DOI 10.1016/S0002-9270(02)04157-6; Bonithon-Kopp C, 2004, DIS COLON RECTUM, V47, P323, DOI 10.1007/s10350-003-0054-1; Boolchand V, 2006, ANN INTERN MED, V145, P654, DOI 10.7326/0003-4819-145-9-200611070-00007; Brenner H, 2010, J NATL CANCER I, V102, P89, DOI 10.1093/jnci/djp436; Brueckl WM, 2006, WORLD J GASTROENTERO, V12, P7313, DOI 10.3748/wjg.v12.i45.7313; Chung SJ, 2011, GUT, V60, P1537, DOI 10.1136/gut.2010.232876; Gao F, 2009, COLORECTAL DIS, V11, P893, DOI 10.1111/j.1463-1318.2008.01746.x; Huang YL, 2010, J GASTROENTEROL, V45, P838, DOI 10.1007/s00535-010-0227-3; Jacobs ET, 2009, AM J EPIDEMIOL, V169, P657, DOI 10.1093/aje/kwn401; Laiyemo AO, 2008, ANN INTERN MED, V148, P419, DOI 10.7326/0003-4819-148-6-200803180-00004; Laiyemo AO, 2009, CLIN GASTROENTEROL H, V7, P562, DOI 10.1016/j.cgh.2008.12.009; Lieberman DA, 2007, GASTROENTEROLOGY, V133, P1077, DOI 10.1053/j.gastro.2007.07.006; Martinez ME, 2009, GASTROENTEROLOGY, V136, P832, DOI 10.1053/j.gastro.2008.12.007; Mysliwiec PA, 2004, ANN INTERN MED, V141, P264, DOI 10.7326/0003-4819-141-4-200408170-00006; Nusko G, 2008, INT J COLORECTAL DIS, V23, P1065, DOI 10.1007/s00384-008-0508-y; Paskett ED, 2005, CANCER CAUSE CONTROL, V16, P1021, DOI 10.1007/s10552-005-0298-2; Pinsky PF, 2009, CLIN GASTROENTEROL H, V7, P86, DOI 10.1016/j.cgh.2008.07.014; Ransohoff DF, 2011, DIGEST DIS SCI, V56, P2623, DOI 10.1007/s10620-011-1791-y; Reid ME, 2003, CANCER EPIDEM BIOMAR, V12, P1006; Saini SD, 2006, GASTROINTEST ENDOSC, V64, P614, DOI 10.1016/j.gie.2006.06.057; Schoen RE, 2003, AM J GASTROENTEROL, V98, P1237, DOI 10.1016/S0002-9270(03)00271-5; Schoen RE, 2010, GASTROENTEROLOGY, V138, P73, DOI 10.1053/j.gastro.2009.09.062; van Rijn JC, 2006, AM J GASTROENTEROL, V101, P343, DOI 10.1111/j.1572-0241.2006.00390.x; Winawer S, 2003, GASTROENTEROLOGY, V124, P544, DOI 10.1053/gast.2003.50044; Winawer SJ, 2006, GASTROENTEROLOGY, V130, P1872, DOI 10.1053/j.gastro.2006.03.012; WINAWER SJ, 1993, NEW ENGL J MED, V328, P901, DOI 10.1056/NEJM199304013281301	27	12	16	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 3	2012	7	12							e50990	10.1371/journal.pone.0050990	http://dx.doi.org/10.1371/journal.pone.0050990			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	051DH	23226555	Green Submitted, gold, Green Published			2022-12-27	WOS:000312104700030
J	Bisson, N; Ruston, J; Jeansson, M; Vanderlaan, R; Hardy, WR; Du, JM; Hussein, SM; Coward, RJ; Quaggin, SE; Pawson, T				Bisson, Nicolas; Ruston, Julie; Jeansson, Marie; Vanderlaan, Rachel; Hardy, W. Rod; Du, Jianmei; Hussein, Samer M.; Coward, Richard J.; Quaggin, Susan E.; Pawson, Tony			The Adaptor Protein Grb2 Is Not Essential for the Establishment of the Glomerular Filtration Barrier	PLOS ONE			English	Article							ACTIN-BASED MOTILITY; ALDRICH-SYNDROME PROTEIN; KIDNEY SLIT DIAPHRAGM; TYROSINE KINASE; VACCINIA VIRUS; NEPHRIN; POLYMERIZATION; CYTOSKELETON; PODOCYTES; COMPONENT	The kidney filtration barrier is formed by the combination of endothelial cells, basement membrane and epithelial cells called podocytes. These specialized actin-rich cells form long and dynamic protrusions, the foot processes, which surround glomerular capillaries and are connected by specialized intercellular junctions, the slit diaphragms. Failure to maintain the filtration barrier leads to massive proteinuria and nephrosis. A number of proteins reside in the slit diaphragm, notably the transmembrane proteins Nephrin and Neph1, which are both able to act as tyrosine phosphorylated scaffolds that recruit cytoplasmic effectors to initiate downstream signaling. While association between tyrosine-phosphorylated Neph1 and the SH2/SH3 adaptor Grb2 was shown in vitro to be sufficient to induce actin polymerization, in vivo evidence supporting this finding is still lacking. To test this hypothesis, we generated two independent mouse lines bearing a podocyte-specific constitutive inactivation of the Grb2 locus. Surprisingly, we show that mice lacking Grb2 in podocytes display normal renal ultra-structure and function, thus demonstrating that Grb2 is not required for the establishment of the glomerular filtration barrier in vivo. Moreover, our data indicate that Grb2 is not required to restore podocyte function following kidney injury. Therefore, although in vitro experiments suggested that Grb2 is important for the regulation of actin dynamics, our data clearly shows that its function is not essential in podocytes in vivo, thus suggesting that Grb2 rather plays a secondary role in this process.	[Bisson, Nicolas; Ruston, Julie; Jeansson, Marie; Vanderlaan, Rachel; Hardy, W. Rod; Du, Jianmei; Hussein, Samer M.; Coward, Richard J.; Quaggin, Susan E.; Pawson, Tony] Mt Sinai Hosp, Samuel Lunenfeld Res Inst, Toronto, ON, Canada; [Vanderlaan, Rachel; Pawson, Tony] Univ Toronto, Dept Mol Genet, Toronto, ON, Canada; [Quaggin, Susan E.] Univ Toronto, Dept Med, Univ Hlth Network, Toronto, ON, Canada; [Quaggin, Susan E.] Univ Toronto, St Michaels Hosp, Div Nephrol, Toronto, ON M5B 1W8, Canada	University of Toronto; University Toronto Affiliates; Sinai Health System Toronto; Lunenfeld Tanenbaum Research Institute; University of Toronto; University of Toronto; University Toronto Affiliates; University Health Network Toronto; University of Toronto; University Toronto Affiliates; Saint Michaels Hospital Toronto	Pawson, T (corresponding author), Mt Sinai Hosp, Samuel Lunenfeld Res Inst, Joseph & Wolf Lebov Hlth Complex, Toronto, ON, Canada.	pawson@lunenfeld.ca	Pawson, Tony J/E-4578-2013	Bisson, Nicolas/0000-0001-7752-9517; Coward, Richard/0000-0001-6183-2546; Jeansson, Marie/0000-0003-1075-8563	Canadian Institutes of Health Research (CIHR) [77756, 62931]; Banting and Best Diabetes Centre; Wenner-Gren Foundation	Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); Banting and Best Diabetes Centre; Wenner-Gren Foundation	This project is supported through grants from the Canadian Institutes of Health Research (CIHR) (#77756, #62931) to SEQ and TP. NB held a research fellowship from the CIHR. MJ was funded by fellowships from Banting and Best Diabetes Centre and the Wenner-Gren Foundation. SEQ holds the Gabor-Zellerman Chair in Renal Research and a Tier II Canada Research Chair. TP holds the Apotex Chair in Molecular Oncology and is a Distinguished Investigator of the CIHR. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bisson N, 2011, NAT BIOTECHNOL, V29, P653, DOI 10.1038/nbt.1905; Blasutig IM, 2008, MOL CELL BIOL, V28, P2035, DOI 10.1128/MCB.01770-07; Cheng AM, 1998, CELL, V95, P793, DOI 10.1016/S0092-8674(00)81702-X; Cory GOC, 1996, J IMMUNOL, V157, P3791; Donoviel DB, 2001, MOL CELL BIOL, V21, P4829, DOI 10.1128/MCB.21.14.4829-4836.2001; Faul C, 2007, TRENDS CELL BIOL, V17, P428, DOI 10.1016/j.tcb.2007.06.006; Feng GS, 1996, J BIOL CHEM, V271, P12129, DOI 10.1074/jbc.271.21.12129; Frischknecht F, 1999, NATURE, V401, P926, DOI 10.1038/44860; Garg P, 2007, MOL CELL BIOL, V27, P8698, DOI 10.1128/MCB.00948-07; George B, 2012, J CLIN INVEST, V122, P674, DOI 10.1172/JCI60070; Hardy WR, 2007, SCIENCE, V317, P251, DOI 10.1126/science.1140114; Harita Y, 2008, J BIOL CHEM, V283, P9177, DOI 10.1074/jbc.M707247200; Harita Y, 2009, J BIOL CHEM, V284, P8951, DOI 10.1074/jbc.M806851200; Hattori S, 2011, J SIGNAL TRANSDUCT, V2011; Huber TB, 2003, MOL CELL BIOL, V23, P4917, DOI 10.1128/MCB.23.14.4917-4928.2003; Jones N, 2006, NATURE, V440, P818, DOI 10.1038/nature04662; Jones N, 2009, J AM SOC NEPHROL, V20, P1533, DOI 10.1681/ASN.2009010056; Kestila M, 1998, MOL CELL, V1, P575, DOI 10.1016/S1097-2765(00)80057-X; Liu SK, 1998, ONCOGENE, V17, P3073, DOI 10.1038/sj.onc.1202337; MCCORMICK F, 1993, NATURE, V363, P15, DOI 10.1038/363015a0; Obenauer JC, 2003, NUCLEIC ACIDS RES, V31, P3635, DOI 10.1093/nar/gkg584; Patrakka J, 2007, TRENDS MOL MED, V13, P396, DOI 10.1016/j.molmed.2007.06.006; Quaggin SE, 2008, DEVELOPMENT, V135, P609, DOI 10.1242/dev.001081; Scaplehorn N, 2002, CURR BIOL, V12, P740, DOI 10.1016/S0960-9822(02)00812-6; Sellin L, 2002, FASEB J, V16, P115, DOI 10.1096/fj.02-0242fje; Sison K, 2010, J AM SOC NEPHROL, V21, P1691, DOI 10.1681/ASN.2010030295; Tang DD, 2005, J BIOL CHEM, V280, P23380, DOI 10.1074/jbc.M413390200; Tossidou I, 2007, J BIOL CHEM, V282, P7457, DOI 10.1074/jbc.M608519200; Verma R, 2003, J BIOL CHEM, V278, P20716, DOI 10.1074/jbc.M301689200; Wang Y, 2000, KIDNEY INT, V58, P1797, DOI 10.1046/j.1523-1755.2000.00342.x; Weisswange I, 2009, NATURE, V458, P87, DOI 10.1038/nature07773	31	8	8	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 30	2012	7	11							e50996	10.1371/journal.pone.0050996	http://dx.doi.org/10.1371/journal.pone.0050996			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	054WM	23226445	Green Submitted, gold, Green Published			2022-12-27	WOS:000312376100256
J	Churbanov, A; Milligan, B				Churbanov, Alexander; Milligan, Brook			Accurate Diagnostics for Bovine tuberculosis Based on High-Throughput Sequencing	PLOS ONE			English	Article							GAMMA-INTERFERON ASSAY; MESSENGER-RNA; TRANSCRIPTOME; IMMUNOASSAY; EXPRESSION; INFECTION; CATTLE; TESTS; SEQ	Background: Bovine tuberculosis (bTB) is an enduring contagious disease of cattle that has caused substantial losses to the global livestock industry. Despite large-scale eradication efforts, bTB continues to persist. Current bTB tests rely on the measurement of immune responses in vivo (skin tests), and in vitro (bovine interferon-c release assay). Recent developments are characterized by interrogating the expression of an increasing number of genes that participate in the immune response. Currently used assays have the disadvantages of limited sensitivity and specificity, which may lead to incomplete eradication of bTB. Moreover, bTB that reemerges from wild disease reservoirs requires early and reliable diagnostics to prevent further spread. In this work, we use high-throughput sequencing of the peripheral blood mononuclear cells (PBMCs) transcriptome to identify an extensive panel of genes that participate in the immune response. We also investigate the possibility of developing a reliable bTB classification framework based on RNA-Seq reads. Methodology/Principal Findings: Pooled PBMC mRNA samples from unaffected calves as well as from those with disease progression of 1 and 2 months were sequenced using the Illumina Genome Analyzer II. More than 90 million reads were splice-aligned against the reference genome, and deposited to the database for further expression analysis and visualization. Using this database, we identified 2,312 genes that were differentially expressed in response to bTB infection (p, 10 28). We achieved a bTB infected status classification accuracy of more than 99% with split-sample validation on newly designed and learned mixtures of expression profiles. Conclusions/Significance: We demonstrated that bTB can be accurately diagnosed at the early stages of disease progression based on RNA-Seq high-throughput sequencing. The inclusion of multiple genes in the diagnostic panel, combined with the superior sensitivity and broader dynamic range of RNA-Seq, has the potential to improve the accuracy of bTB diagnostics. The computational pipeline used for the project is available from http://code.google.com/p/bovine-tb-prediction.	[Churbanov, Alexander] Chinese Acad Sci, BIG, Beijing, Peoples R China; [Milligan, Brook] New Mexico State Univ, Dept Biol, Las Cruces, NM 88003 USA	Chinese Academy of Sciences; New Mexico State University	Churbanov, A (corresponding author), Chinese Acad Sci, BIG, Beijing, Peoples R China.	alexander@big.ac.cn			Chinese Academy of Sciences Fellowship for Young International Scientists [2011Y1SA09]; National Natural Science Foundation of China (NSFC) [31150110466]; NSF [DBI-0821806]	Chinese Academy of Sciences Fellowship for Young International Scientists; National Natural Science Foundation of China (NSFC)(National Natural Science Foundation of China (NSFC)); NSF(National Science Foundation (NSF))	This study was supported by grant 2011Y1SA09 from the Chinese Academy of Sciences Fellowship for Young International Scientists, by grant 31150110466 from the National Natural Science Foundation of China (NSFC), and in part by NSF award DBI-0821806. No additional external funding received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ameni G, 2000, TROP ANIM HEALTH PRO, V32, P267, DOI 10.1023/A:1005271421976; Antognoli MC, 2011, PREV VET MED, V101, P35, DOI 10.1016/j.prevetmed.2011.05.012; Aranday-Cortes E, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030626; Bilmes J., 2002, TECHNICAL REPORT; Bradford JR, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-282; Cloonan N, 2008, NAT METHODS, V5, P613, DOI 10.1038/nmeth.1223; de la Rua-Domenech R, 2006, RES VET SCI, V81, P190, DOI 10.1016/j.rvsc.2005.11.005; Durbin R., 1998, BIOL SEQUENCE ANAL P; ESSEY MA, 1994, VET MICROBIOL, V40, P15, DOI 10.1016/0378-1135(94)90043-4; FRANCIS J, 1978, VET REC, V103, P420, DOI 10.1136/vr.103.19.420; Grant GR, 2011, BIOINFORMATICS, V27, P2518, DOI 10.1093/bioinformatics/btr427; Holland RCG, 2008, BIOINFORMATICS, V24, P2096, DOI 10.1093/bioinformatics/btn397; Lacroix V, 2008, WABI 08 P 8 INT WORK; Marassi CD, 2010, ACTA TROP, V113, P199, DOI 10.1016/j.actatropica.2009.10.002; Meade KG, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-400; Meade KG, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-447; Medeiros L, 2010, BRAZILIAN J MICROBIO; Mortazavi A, 2008, NAT METHODS, V5, P621, DOI 10.1038/nmeth.1226; Nagalakshmi U, 2008, SCIENCE, V320, P1344, DOI 10.1126/science.1158441; ONuallain EM, 1997, VET IMMUNOL IMMUNOP, V56, P65, DOI 10.1016/S0165-2427(96)05734-0; Ozsolak F, 2011, NAT REV GENET, V12, P87, DOI 10.1038/nrg2934; Palmer MV, 2006, VET MICROBIOL, V112, P181, DOI 10.1016/j.vetmic.2005.11.028; Pan Q, 2008, NAT GENET, V40, P1413, DOI 10.1038/ng.259; Rabiner L., 1993, FUNDAMENTALS SPEECH; RABINER LR, 1989, P IEEE, V77, P257, DOI 10.1109/5.18626; ROTHEL JS, 1990, AUST VET J, V67, P134, DOI 10.1111/j.1751-0813.1990.tb07730.x; Thacker TC, 2007, VET IMMUNOL IMMUNOP, V119, P204, DOI 10.1016/j.vetimm.2007.05.009; Thacker TC, 2009, CLIN VACCINE IMMUNOL, V16, P1139, DOI 10.1128/CVI.00424-08; Wang Z, 2009, NAT REV GENET, V10, P57, DOI 10.1038/nrg2484; Waters WR, 2003, CLIN DIAGN LAB IMMUN, V10, P960, DOI 10.1128/CDLI.10.5.960-966.2003; Wood PR, 2001, TUBERCULOSIS, V81, P147, DOI 10.1054/tube.2000.0272; WOOD PR, 1990, RES VET SCI, V49, P46, DOI 10.1016/S0034-5288(18)31044-0; WOOD PR, 1991, AUST VET J, V68, P286, DOI 10.1111/j.1751-0813.1991.tb03254.x; Wu TD, 2005, BIOINFORMATICS, V21, P1859, DOI 10.1093/bioinformatics/bti310; Wu TD, 2010, BIOINFORMATICS, V26, P873, DOI 10.1093/bioinformatics/btq057	35	12	12	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 30	2012	7	11							e50147	10.1371/journal.pone.0050147	http://dx.doi.org/10.1371/journal.pone.0050147			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	054WM	23226242	gold, Green Published, Green Submitted			2022-12-27	WOS:000312376100051
J	D'Alonzo, M; Cipriani, C				D'Alonzo, Marco; Cipriani, Christian			Vibrotactile Sensory Substitution Elicits Feeling of Ownership of an Alien Hand	PLOS ONE			English	Article							RUBBER HAND; PERCEPTION; ILLUSION; TOUCH; BODY; SKIN; SENSATION; AMPUTEES	Tactile feedback plays a key role in the attribution of a limb to the self and in the motor control of grasping and manipulation. However, due to technological limits, current prosthetic hands do not provide amputees with cutaneous touch feedback. Recent findings showed that amputees can be tricked into experiencing an alien rubber hand as part of their own body, by applying synchronous touches to the stump which is out of view, and to the rubber hand in full view. It was suggested that similar effects could be achieved by using a prosthesis with touch sensors that provides synchronous cutaneous feedback through an array of tactile stimulators on the stump. Such a prosthesis holds the potential to be easily incorporated within one's body scheme, because it would reproduce the perceptual illusion in everyday usage. We propose to use sensory substitution - specifically vibrotactile - to address this issue, as current haptic technology is still too bulky and inefficient. In this basic study we addressed the fundamental question of whether visuo-tactile modality mismatch promotes self-attribution of a limb, and to what extent compared to a modality-matched paradigm, on normally-limbed subjects. We manipulated visuo-tactile stimulations, comprising combinations of modality matched, modality mismatched, synchronous and asynchronous stimulations, in a set of experiments fashioned after the Rubber Hand Illusion. Modality mismatched stimulation was provided using a keypad-controlled vibrotactile display. Results from three independent measures of embodiment (questionnaires, pointing tests and skin conductance responses) indicate that vibrotactile sensory substitution can be used to induce self-attribution of a rubber hand when synchronous but modality-conflicting visuo-tactile stimulation is delivered to the biological finger pads and to the equivalent rubber hand phalanges.	[D'Alonzo, Marco; Cipriani, Christian] Scuola Super Sant Anna, BioRobot Inst, Pontedera, Italy	Scuola Superiore Sant'Anna	Cipriani, C (corresponding author), Scuola Super Sant Anna, BioRobot Inst, Pontedera, Italy.	ch.cipriani@sssup.it		D'Alonzo, Marco/0000-0002-6815-6242	Italian Ministry of Education University and Research [RBFR10VCLD]; European Commission [FP7-ICT-228844]	Italian Ministry of Education University and Research(Ministry of Education, Universities and Research (MIUR)); European Commission(European CommissionEuropean Commission Joint Research Centre)	This work was supported by the Italian Ministry of Education University and Research, under the FIRB-2010 MY-HAND Project [RBFR10VCLD] and by the European Commission under the WAY project (FP7-ICT-228844). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Armel KC, 2003, P ROY SOC B-BIOL SCI, V270, P1499, DOI 10.1098/rspb.2003.2364; Bertelson P, 1998, PSYCHON B REV, V5, P482, DOI 10.3758/BF03208826; Botvinick M, 1998, NATURE, V391, P756, DOI 10.1038/35784; CHILDRESS DS, 1973, IEEE T BIO-MED ENG, VBE20, P200, DOI 10.1109/TBME.1973.324273; Cipriani C, 2012, IEEE T BIO-MED ENG, V59, P400, DOI 10.1109/TBME.2011.2173342; Constantini M, 2007, CONSCIOUS COGN, V12, P229; Ehrsson HH, 2008, BRAIN, V131, P3443, DOI 10.1093/brain/awn297; Ehrsson HH, 2004, SCIENCE, V305, P875, DOI 10.1126/science.1097011; ESSICK GK, 1990, ARCH ORAL BIOL, V35, P785, DOI 10.1016/0003-9969(90)90002-R; Essick GK, 1995, J NEUROSCI, V15, P949; Farne A, 2000, BRAIN, V123, P2350, DOI 10.1093/brain/123.11.2350; Johansson RS, 2009, NAT REV NEUROSCI, V10, P345, DOI 10.1038/nrn2621; Kim K, 2010, IEEE-ASME T MECH, V15, P27, DOI 10.1109/TMECH.2009.2013944; Kuiken TA, 2007, P NATL ACAD SCI USA, V104, P20061, DOI 10.1073/pnas.0706525104; Marasco PD, 2011, BRAIN, V134, P747, DOI 10.1093/brain/awq361; Padilla MA, 2010, LECT NOTES COMPUT SC, V6192, P194, DOI 10.1007/978-3-642-14075-4_28; Pavani F, 2000, PSYCHOL SCI, V11, P353, DOI 10.1111/1467-9280.00270; RAMACHANDRAN VS, 1993, P NATL ACAD SCI USA, V90, P10413, DOI 10.1073/pnas.90.22.10413; Rochat P, 1998, EXP BRAIN RES, V123, P102, DOI 10.1007/s002210050550; Rosen B, 2009, SCAND J PLAST RECONS, V43, P260, DOI 10.3109/02844310903113107; Schutz-Bosbach S, 2009, BRAIN COGNITION, V70, P136, DOI 10.1016/j.bandc.2009.01.006; Sears H., 2008, P MYOEL CONTR POW PR, P175; Shimada S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006185; Slater M, 2008, FRONT HUM NEUROSCI, V2, DOI 10.3389/neuro.09.006.2008; Tsakiris M, 2005, J EXP PSYCHOL HUMAN, V31, P80, DOI 10.1037/0096-1523.31.1.80; Tsakiris M, 2010, EXP BRAIN RES, V204, P343, DOI 10.1007/s00221-009-2039-3; VALLBO AB, 1984, HUM NEUROBIOL, V3, P3; van den Bos E, 2002, COGNITION, V85, P177, DOI 10.1016/S0010-0277(02)00100-2; WESTLING G, 1987, EXP BRAIN RES, V66, P128	29	38	38	1	37	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 30	2012	7	11							e50756	10.1371/journal.pone.0050756	http://dx.doi.org/10.1371/journal.pone.0050756			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	054WM	23226375	Green Published, gold, Green Submitted			2022-12-27	WOS:000312376100186
J	Kanamori, S; Kai, Y; Kondo, K; Hirai, H; Ichida, Y; Suzuki, K; Kawachi, I				Kanamori, Satoru; Kai, Yuko; Kondo, Katsunori; Hirai, Hiroshi; Ichida, Yukinobu; Suzuki, Kayo; Kawachi, Ichiro			Participation in Sports Organizations and the Prevention of Functional Disability in Older Japanese: The AGES Cohort Study	PLOS ONE			English	Article							INCIDENT DISABILITY; ADULTS	Background: We sought to examine prospectively the difference in the association between incident functional disability and exercise with or without sports organization participation. Methods: The study was based on the Aichi Gerontological Evaluation Study (AGES) Cohort Study data. In October 2003, self-reported questionnaires were mailed to 29,374 non-disabled Japanese individuals aged 65 years or older. Of these, 13,310 individuals were introduced to the Study, and they were followed for 4 years. Analysis was carried out on 11,581 subjects who provided all necessary information for the analysis. Results: Analysis was carried out on incident functional disability by 4 groups of different combinations of performance of exercise and participation in a sports organization Active Participant (AP), Exercise Alone (EA), Passive Participant (PP) and Sedentary (S). Compared to the AP group, the EA group had a hazard ratio (HR) of 1.29 (1.02-1.64) for incident functional disability. No significant difference was seen with the PP group, with an HR of 1.16 (0.76-1.77). When a measure of social networks was added to the covariates, the HR of the EA group dropped to 1.27 (1.00-1.61), and significant differences disappeared. In contrast, it showed hardly any change when social support was added. Conclusion: The results suggested that, even with a regular exercise habit, incident functional disability may be better prevented when a person participates in a sports organization than when he/she does not. In addition, participation in a sports organization correlates positively with social networks, which may lead to a small decrease in incident functional disability.	[Kanamori, Satoru] Juntendo Univ, Fac Hlth & Care & Nursing, Tokyo, Japan; [Kai, Yuko] Meiji Yasuda Fdn Hlth & Welf, Phys Fitness Res Inst, Hachioji, Tokyo, Japan; [Kondo, Katsunori; Ichida, Yukinobu; Suzuki, Kayo] Nihon Fukushi Univ, Ctr Well Being & Soc, Nagoya, Aichi, Japan; [Hirai, Hiroshi] Iwate Univ, Fac Engn, Dept Civil & Environm Engn, Morioka, Iwate 020, Japan; [Kawachi, Ichiro] Harvard Univ, Sch Publ Hlth, Dept Soc Human Dev & Hlth, Boston, MA 02115 USA	Juntendo University; Iwate University; Harvard University; Harvard T.H. Chan School of Public Health	Kanamori, S (corresponding author), Juntendo Univ, Fac Hlth & Care & Nursing, Tokyo, Japan.	skanamo@juntendo.ac.jp	Kondo, Katsunori/AAI-6373-2020	Kai, Yuko/0000-0002-7176-0352	MEXT [23243070]	MEXT(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This study was supported in part by MEXT-Supported Program for the Strategic Research Foundation at Private Universities, 2009-2013 and Grant-in-Aid for Scientific Research (23243070). 2The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Boyle PA, 2007, J AM GERIATR SOC, V55, P195, DOI 10.1111/j.1532-5415.2007.01038.x; Colcombe S, 2003, PSYCHOL SCI, V14, P125, DOI 10.1111/1467-9280.t01-1-01430; de Leon CFM, 2001, J GERONTOL B-PSYCHOL, V56, pS179, DOI 10.1093/geronb/56.3.S179; de Leon CFM, 1999, J GERONTOL B-PSYCHOL, V54, pS162, DOI 10.1093/geronb/54B.3.S162; Gillespie LD, 2001, INTERVENTIONS FOR PR, P4; Hirai Hiroshi, 2009, Nihon Koshu Eisei Zasshi, V56, P501; Holt-Lunstad J, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000316; HOUSE JS, 1988, SCIENCE, V241, P540, DOI 10.1037/0003-066X.59.8.676; James BD, 2011, J GERONTOL A-BIOL, V66, P467, DOI 10.1093/gerona/gly231; Kondo K, 2010, HEALTH INEQUALITIES; Liao WC, 2011, J AM GERIATR SOC, V59, P200, DOI 10.1111/j.1532-5415.2010.03272.x; Ministry of health labor and welfare, PREVENTIVE LONG TERM; Nishi A, 2011, J EPIDEMIOL, V21, P151, DOI 10.2188/jea.JE20100135; Paterson DH, 2010, INT J BEHAV NUTR PHY, V7, DOI 10.1186/1479-5868-7-38; Schempf AH, 2011, J EPIDEMIOL COMMUN H, V65, P190, DOI 10.1136/jech.2010.118190; Sheikh JI, 1986, CLINICAL GERONTOLOGY; Street Gillian, 2007, Health Promot J Austr, V18, P236; Stuck AE, 1999, SOC SCI MED, V48, P445, DOI 10.1016/S0277-9536(98)00370-0; Takeda T, 2010, JAPANESE J PUBLIC HL, V57, P1054; Tsutsui T, 2005, J AM GERIATR SOC, V53, P522, DOI 10.1111/j.1532-5415.2005.53175.x; United Nations Department of Economic and Social Affairs Population Division, 2011, WORLD POPULATION PRO; Wolff I, 1999, OSTEOPOROSIS INT, V9, P1, DOI 10.1007/s001980050109	22	38	38	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 30	2012	7	11							e51061	10.1371/journal.pone.0051061	http://dx.doi.org/10.1371/journal.pone.0051061			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	054WM	23226458	Green Published, Green Submitted, gold			2022-12-27	WOS:000312376100269
J	Mairer, K; Gobel, M; Defrancesco, M; Wille, M; Messner, H; Loizides, A; Schocke, M; Burtscher, M				Mairer, Klemens; Goebel, Markus; Defrancesco, Michaela; Wille, Maria; Messner, Hubert; Loizides, Alexander; Schocke, Michael; Burtscher, Martin			MRI Evidence: Acute Mountain Sickness Is Not Associated with Cerebral Edema Formation during Simulated High Altitude	PLOS ONE			English	Article							BLOOD-BRAIN-BARRIER; FLOW; EXERCISE; AUTOREGULATION; PERMEABILITY; METABOLISM; PREVALENCE; DIFFUSION; EASTERN	Acute mountain sickness (AMS) is a common condition among non-acclimatized individuals ascending to high altitude. However, the underlying mechanisms causing the symptoms of AMS are still unknown. It has been suggested that AMS is a mild form of high-altitude cerebral edema both sharing a common pathophysiological mechanism. We hypothesized that brain swelling and consequently AMS development is more pronounced when subjects exercise in hypoxia compared to resting conditions. Twenty males were studied before and after an eight hour passive (PHE) and active (plus exercise) hypoxic exposure (AHE) (FiO2 = 11.0%, PiO2 similar to 80 mmHg). Cerebral edema formation was investigated with a 1.5 Tesla magnetic resonance scanner and analyzed by voxel based morphometry (VBM), AMS was assessed using the Lake Louise Score. During PHE and AHE AMS was diagnosed in 50% and 70% of participants, respectively (p>0.05). While PHE slightly increased gray and white matter volume and the apparent diffusion coefficient, these changes were clearly more pronounced during AHE but were unrelated to AMS. In conclusion, our findings indicate that rest and especially exercise in normobaric hypoxia are associated with accumulation of water in the extracellular space, however independent of AMS development. Thus, it is suggested that AMS and HACE do not share a common pathophysiological mechanism.	[Mairer, Klemens; Goebel, Markus; Wille, Maria; Burtscher, Martin] Univ Innsbruck, Dept Sports Sci, Med Sect, A-6020 Innsbruck, Austria; [Defrancesco, Michaela] Med Univ Innsbruck, Univ Hosp, Dept Psychiat & Psychotherapy, Innsbruck, Austria; [Messner, Hubert; Loizides, Alexander; Schocke, Michael] Med Univ Innsbruck, Univ Clin Radiol 1, Dept Radiol, Innsbruck, Austria	University of Innsbruck; Medical University of Innsbruck; Medical University of Innsbruck	Mairer, K (corresponding author), Univ Innsbruck, Dept Sports Sci, Med Sect, A-6020 Innsbruck, Austria.	Klemens.mairer@gmail.com	Schocke, Michael/AAC-3666-2020; Burtscher, Martin/M-7015-2019	Defrancesco, Michaela/0000-0001-9613-9485; Burtscher, Martin/0000-0002-5232-3632	Tyrolean Science Fund (TWF) [UNI-0407/29]; Leopold-Franzens University of Innsbruck	Tyrolean Science Fund (TWF); Leopold-Franzens University of Innsbruck	This study was supported by funds of the Tyrolean Science Fund (TWF) (grant number UNI-0407/29). KM received a scholarship and a promotion for research of the Leopold-Franzens University of Innsbruck. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ashburner J, 2000, NEUROIMAGE, V11, P805, DOI 10.1006/nimg.2000.0582; Ashburner J, 2007, NEUROIMAGE, V38, P95, DOI 10.1016/j.neuroimage.2007.07.007; Bailey DM, 2009, J PHYSIOL-LONDON, V587, P73, DOI 10.1113/jphysiol.2008.159855; Bailey DM, 2009, AM J PHYSIOL-REG I, V297, pR1283, DOI 10.1152/ajpregu.00366.2009; Bailey DM, 2009, CELL MOL LIFE SCI, V66, P3583, DOI 10.1007/s00018-009-0145-9; BAUMGARTNER RW, 1994, AVIAT SPACE ENVIR MD, V65, P726; Brugniaux JV, 2007, RESP PHYSIOL NEUROBI, V158, P212, DOI 10.1016/j.resp.2007.04.008; BURTSCHER M, 1995, LANCET, V346, P254, DOI 10.1016/S0140-6736(95)91303-3; Burtscher M, 2001, HEADACHE, V41, P542, DOI 10.1046/j.1526-4610.2001.041006542.x; Burtscher M, 2009, LANCET NEUROL, V8, P604, DOI 10.1016/S1474-4422(09)70160-7; Guadagno JV, 2006, STROKE, V37, P1741, DOI 10.1161/01.STR.0000232437.00621.86; Gupta AK, 1997, ANESTH ANALG, V85, P817, DOI 10.1097/00000539-199710000-00018; Ito J, 1996, J NEUROSURG, V84, P97, DOI 10.3171/jns.1996.84.1.0097; JENSEN JB, 1990, J APPL PHYSIOL, V69, P430, DOI 10.1152/jappl.1990.69.2.430; Jiang BH, 1996, AM J PHYSIOL-CELL PH, V271, pC1172, DOI 10.1152/ajpcell.1996.271.4.C1172; Julian CG, 2011, J APPL PHYSIOL, V111, P392, DOI 10.1152/japplphysiol.00391.2011; Kallenberg K, 2007, J CEREBR BLOOD F MET, V27, P1064, DOI 10.1038/sj.jcbfm.9600404; Kaur C, 2008, CURR NEUROVASC RES, V5, P71, DOI 10.2174/156720208783565645; Kaur C, 2006, GLIA, V54, P826, DOI 10.1002/glia.20420; LASSEN NA, 1992, INT J SPORTS MED, V13, pS47, DOI 10.1055/s-2007-1024591; Levine BD, 1999, ADV EXP MED BIOL, V474, P319; Maggiorini M, 1998, AVIAT SPACE ENVIR MD, V69, P1186; Mairer K, 2010, HIGH ALT MED BIOL, V11, P343, DOI 10.1089/ham.2010.1039; Mairer K, 2009, HIGH ALT MED BIOL, V10, P239, DOI 10.1089/ham.2008.1091; Mayhan WG, 1999, AM J PHYSIOL-CELL PH, V276, pC1148, DOI 10.1152/ajpcell.1999.276.5.C1148; MAYHAN WG, 1986, CIRC RES, V59, P216, DOI 10.1161/01.RES.59.2.216; Moller K, 2002, J CEREBR BLOOD F MET, V22, P118, DOI 10.1097/00004647-200201000-00014; Patel N, 2004, METAB BRAIN DIS, V19, P431, DOI 10.1023/B:MEBR.0000043987.09022.e3; POWELL RR, 1982, PERCEPT MOTOR SKILL, V54, P923, DOI 10.2466/pms.1982.54.3.923; Roach RC, 2001, J EXP BIOL, V204, P3161; Roach RC, 1996, J APPL PHYSIOL, V81, P1908, DOI 10.1152/jappl.1996.81.5.1908; Roach RC, 2000, J APPL PHYSIOL, V88, P581, DOI 10.1152/jappl.2000.88.2.581; ROACH RC, 1993, HYPOXIA AND MOLECULAR MEDICINE, P272; Saito S, 1999, ARCH ENVIRON HEALTH, V54, P271, DOI 10.1080/00039899909602485; Schneider M, 2002, MED SCI SPORT EXER, V34, P1886, DOI 10.1097/00005768-200212000-00005; Schoch HJ, 2002, BRAIN, V125, P2549, DOI 10.1093/brain/awf257; Schoonman GG, 2008, J CEREBR BLOOD F MET, V28, P198, DOI 10.1038/sj.jcbfm.9600513; SORENSEN SC, 1974, J APPL PHYSIOL, V37, P305, DOI 10.1152/jappl.1974.37.3.305; Subudhi AW, 2011, J APPL PHYSIOL, V110, P1219, DOI 10.1152/japplphysiol.01393.2010; Subudhi AW, 2010, STROKE, V41, P641, DOI 10.1161/STROKEAHA.109.574749; Subudhi AW, 2009, J APPL PHYSIOL, V107, P1165, DOI 10.1152/japplphysiol.00498.2009; Subudhi AW, 2007, AM J PHYSIOL-HEART C, V294, P164; Vogiatzis I, 2011, J PHYSIOL-LONDON, V589, P4027, DOI 10.1113/jphysiol.2011.210880; WARD MP, 2000, HIGH ALTITUDE MED PH	44	21	21	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 30	2012	7	11							e50334	10.1371/journal.pone.0050334	http://dx.doi.org/10.1371/journal.pone.0050334			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	054WM	23226263	Green Submitted, gold, Green Published			2022-12-27	WOS:000312376100073
J	Schaffner, N; Folkers, G; Kappeli, S; Musholt, M; Hofbauer, GFL; Candia, V				Schaffner, Nils; Folkers, Gerd; Kaeppeli, Silvia; Musholt, Markus; Hofbauer, Guenther F. L.; Candia, Victor			A New Tool for Real-Time Pain Assessment in Experimental and Clinical Environments	PLOS ONE			English	Article							SCALES; RATINGS; SESSION; WOUNDS	Pain measurement largely depends on the ability to rate personal subjective pain. Nevertheless, pain scales can be difficult to use during medical procedures. We hypothesized that pain can be expressed intuitively and in real-time by squeezing a pressure sensitive device. We developed such a device called "Painmouse (R)" and tested it on healthy volunteers and patients in two separate studies: Sixteen male participants rated different painful heat stimuli via Painmouse (R) and a Visual Analog Scale (VAS). Retest was done one week later. Participants clearly distinguished four distinct pain levels using both methods. Values from the first and second sessions were comparable. Thereafter, we tested the Painmouse (R) by asking twelve female and male leg-ulcer patients to continuously squeeze it during the whole length of their wound-dressing change. Patients rated each step of dressing change on an 11-point numeric rating scale. Painmouse (R) ratings were highest for the wound cleaning and debridement step. Application of the new dressing was not evaluated as very painful. On the other hand, numeric scale ratings did not differentiate between dressing change steps. We conclude that the Painmouse (R) enables pain assessment even under difficult clinical circumstances, such as during a medical treatment in elderly patients.	[Schaffner, Nils; Folkers, Gerd; Candia, Victor] Univ Zurich, Coll Helveticum, Zurich, Switzerland; [Schaffner, Nils; Folkers, Gerd; Candia, Victor] ETH, Zurich, Switzerland; [Kaeppeli, Silvia] Univ Zurich Hosp, Ctr Nursing Res & Dev, CH-8091 Zurich, Switzerland; [Musholt, Markus; Hofbauer, Guenther F. L.] Univ Zurich Hosp, Dept Dermatol, CH-8091 Zurich, Switzerland	University of Zurich; Swiss Federal Institutes of Technology Domain; ETH Zurich; University of Zurich; University Zurich Hospital; University of Zurich; University Zurich Hospital	Candia, V (corresponding author), Univ Zurich, Coll Helveticum, Zurich, Switzerland.	candia@collegium.ethz.ch	Hofbauer, Gunther/B-2671-2010	Hofbauer, Gunther/0000-0003-0542-7989; Folkers, Gerd/0000-0002-3620-705X	OPO Stiftung; Collegium Helveticum	OPO Stiftung; Collegium Helveticum	The study was supported by the OPO Stiftung http://www.opo-stiftung.ch/and the Collegium Helveticum http://www.collegium.ethz.ch/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ARMSTRONG D, 1953, J PHYSIOL-LONDON, V120, P326, DOI 10.1113/jphysiol.1953.sp004898; Austin EJ, 2006, PERS INDIV DIFFER, V40, P1235, DOI 10.1016/j.paid.2005.10.018; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Boormans EM, 2009, PAIN PRACT, V9, P100, DOI 10.1111/j.1533-2500.2009.00260.x; Briggs M, 2003, Ostomy Wound Manage, V49, P10; Briggs M., 2002, PAIN WOUND DRESSING, P12; Ebbeskog B, 2005, J CLIN NURS, V14, P1223, DOI 10.1111/j.1365-2702.2005.01194.x; EP Bureau, 2011, PATENTSCOPE; Flaherty E, 2008, AM J NURS, V108, P40, DOI 10.1097/01.NAJ.0000324375.02027.9f; Gibson M C, 2004, J Wound Care, V13, P187; Granot M, 2003, EUR J PAIN, V7, P139, DOI 10.1016/S1090-3801(02)00087-3; Herr KA, 2004, CLIN J PAIN, V20, P207, DOI 10.1097/00002508-200407000-00002; Hollinworth H, 2000, J Wound Care, V9, P369; Jamison RN, 2002, PAIN, V99, P341, DOI 10.1016/S0304-3959(02)00178-1; Jensen MP, 1998, CLIN J PAIN, V14, P343, DOI 10.1097/00002508-199812000-00012; Kammerlander G, 2002, J Wound Care, V11, P76; Lorimer Karen R, 2003, J Wound Ostomy Continence Nurs, V30, P132, DOI 10.1067/mjw.2003.122; Machata AM, 2009, ANAESTHESIA, V64, P392, DOI 10.1111/j.1365-2044.2008.05798.x; Moffatt CJ, 2002, UNDERSTANDING WOUND, P2; Nemeth Kathleen A, 2003, Adv Skin Wound Care, V16, P260, DOI 10.1097/00129334-200309000-00017; OLDFIELD RC, 1971, NEUROPSYCHOLOGIA, V9, P97, DOI 10.1016/0028-3932(71)90067-4; PRICE DD, 1983, PAIN, V17, P45, DOI 10.1016/0304-3959(83)90126-4; Price PE, 2008, INT WOUND J, V5, P159, DOI 10.1111/j.1742-481X.2008.00471.x; Quiton RL, 2008, PAIN, V137, P245, DOI 10.1016/j.pain.2007.08.034; Schaffner N, 2010, PAIN PERCEPTION ITS; Thomas S, 2008, INT WOUND J, V5, P602, DOI 10.1111/j.1742-481X.2008.00541.x; Woo KY, 2008, INT WOUND J, V5, P144, DOI 10.1111/j.1742-481X.2008.00486.x; Yarnitsky D, 1996, PAIN, V67, P327, DOI 10.1016/0304-3959(96)03110-7	28	1	1	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 30	2012	7	11							e51014	10.1371/journal.pone.0051014	http://dx.doi.org/10.1371/journal.pone.0051014			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	054WM	23226449	Green Accepted, Green Submitted, Green Published, gold			2022-12-27	WOS:000312376100260
J	Shettigar, M; Pearce, S; Pandey, R; Khan, F; Dorrian, SJ; Balotra, S; Russell, RJ; Oakeshott, JG; Pandey, G				Shettigar, Madhura; Pearce, Stephen; Pandey, Rinku; Khan, Fazlurrahman; Dorrian, Susan J.; Balotra, Sahil; Russell, Robyn J.; Oakeshott, John G.; Pandey, Gunjan			Cloning of a Novel 6-Chloronicotinic Acid Chlorohydrolase from the Newly Isolated 6-Chloronicotinic Acid Mineralizing Bradyrhizobiaceae Strain SG-6C	PLOS ONE			English	Article							NICOTINIC-ACID; NEONICOTINOID INSECTICIDES; SYMBIOSIS ISLAND; GENE-TRANSFER; METABOLISM; CATABOLISM; OXIDATION; SEQUENCE	A 6-chloronicotinic acid mineralizing bacterium was isolated from enrichment cultures originating from imidacloprid-contaminated soil samples. This Bradyrhizobiaceae, designated strain SG-6C, hydrolytically dechlorinated 6-chloronicotinic acid to 6-hydroxynicotinic acid, which was then further metabolised via the nicotinic acid pathway. This metabolic pathway was confirmed by growth and resting cell assays using HPLC and LC-MS studies. A candidate for the gene encoding the initial dechlorination step, named cch2 (for 6-chloronicotinic acid chlorohydrolase), was identified using genome sequencing and its function was confirmed using resting cell assays on E. coli heterologously expressing this gene. The 464 amino acid enzyme was found to be a member of the metal dependent hydrolase superfamily with similarities to the TRZ/ATZ family of chlorohydrolases. We also provide evidence that cch2 was mobilized into this bacterium by an Integrative and Conjugative Element (ICE) that feeds 6-hydroxynicotinic acid into the existing nicotinic acid mineralization pathway.	[Shettigar, Madhura; Pearce, Stephen; Pandey, Rinku; Khan, Fazlurrahman; Dorrian, Susan J.; Balotra, Sahil; Russell, Robyn J.; Oakeshott, John G.; Pandey, Gunjan] CSIRO Ecosyst Sci, Canberra, ACT, Australia; [Khan, Fazlurrahman] Inst Microbial Technol, Chandigarh, India	Commonwealth Scientific & Industrial Research Organisation (CSIRO); Council of Scientific & Industrial Research (CSIR) - India; CSIR - Institute of Microbial Technology (IMTECH)	Pandey, G (corresponding author), CSIRO Ecosyst Sci, Canberra, ACT, Australia.	gunjan.pandey@csiro.au	Khan, Fazlurrahman/GNP-4177-2022; Oakeshott, John G/B-5365-2009; Dorrian, Susan/G-9629-2011; Pandey, Gunjan/B-8133-2009; Pearce, Stephen/T-2681-2019; Pandey, Gunjan/I-6993-2019; Russell, Robyn/C-5449-2008	Oakeshott, John G/0000-0001-8324-7874; Pandey, Gunjan/0000-0002-3514-4624; Pearce, Stephen/0000-0002-9400-8091; Russell, Robyn/0000-0001-5600-3305; Khan, Fazlurrahman/0000-0002-4902-3188	CSIRO, Australia	CSIRO, Australia(Commonwealth Scientific & Industrial Research Organisation (CSIRO))	This work was supported by CSIRO, Australia. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alhapel A, 2006, P NATL ACAD SCI USA, V103, P12341, DOI 10.1073/pnas.0601635103; Casida JE, 2011, J AGR FOOD CHEM, V59, P2923, DOI 10.1021/jf102438c; Decourtye A, 2010, ADV EXP MED BIOL, V683, P85; Devers M, 2005, PEST MANAG SCI, V61, P870, DOI 10.1002/ps.1098; Devers M, 2007, GENE, V392, P1, DOI 10.1016/j.gene.2006.09.015; Dimopoulou ID, 1997, J ANTIMICROB CHEMOTH, V39, P303, DOI 10.1093/jac/39.3.303; Elbert A, 2008, PEST MANAG SCI, V64, P1099, DOI 10.1002/ps.1616; ENSIGN JC, 1964, J BIOL CHEM, V239, P2285; Guglielmini J, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002222; Halm MP, 2006, ENVIRON SCI TECHNOL, V40, P2448, DOI 10.1021/es051392i; He JX, 2004, P NATL ACAD SCI USA, V101, P2530, DOI 10.1073/pnas.0304622101; HIRSCHBERG R, 1972, J BACTERIOL, V112, P392, DOI 10.1128/JB.112.1.392-397.1972; Horne I, 2003, FEMS MICROBIOL LETT, V222, P1, DOI 10.1016/S0378-1097(03)00211-8; Jeschke P, 2008, PEST MANAG SCI, V64, P1084, DOI 10.1002/ps.1631; Jimenez JI, 2008, P NATL ACAD SCI USA, V105, P11329, DOI 10.1073/pnas.0802273105; Kaiser JP, 1996, MICROBIOL REV, V60, P483, DOI 10.1128/MMBR.60.3.483-498.1996; KITTS CL, 1989, J BACTERIOL, V171, P3406, DOI 10.1128/jb.171.6.3406-3411.1989; KITTS CL, 1992, J BACTERIOL, V174, P7791, DOI 10.1128/JB.174.23.7791-7797.1992; Lal R, 2006, TRENDS BIOTECHNOL, V24, P121, DOI 10.1016/j.tibtech.2006.01.005; Nagata Y, 2011, ENZYME MICROB TECH, V49, P499, DOI 10.1016/j.enzmictec.2011.10.005; Nakano H, 1999, EUR J BIOCHEM, V260, P120, DOI 10.1046/j.1432-1327.1999.00124.x; Pandey G, 2009, BIOCHEM BIOPH RES CO, V380, P710, DOI 10.1016/j.bbrc.2009.01.156; Pandey G, 2010, APPL ENVIRON MICROB, V76, P2940, DOI 10.1128/AEM.02990-09; Pearce SL, 2011, J BACTERIOL, V193, P5057, DOI 10.1128/JB.05647-11; Ramsay JP, 2006, MOL MICROBIOL, V62, P723, DOI 10.1111/j.1365-2958.2006.05396.x; Rouchaud J, 1996, B ENVIRON CONTAM TOX, V56, P29, DOI 10.1007/s001289900005; Schattner P, 2005, NUCLEIC ACIDS RES, V33, pW686, DOI 10.1093/nar/gki366; Schmuck R, 2001, PEST MANAG SCI, V57, P225, DOI 10.1002/ps.270; STADTMAN ER, 1972, J BACTERIOL, V110, P758, DOI 10.1128/JB.110.2.758-760.1972; Sullivan JT, 2002, J BACTERIOL, V184, P3086, DOI 10.1128/JB.184.11.3086-3095.2002; SULLIVAN JT, 1995, P NATL ACAD SCI USA, V92, P8985, DOI 10.1073/pnas.92.19.8985; Tomizawa M, 2005, INSECT BIOCHEM MOLEC, V35, P1347, DOI 10.1016/j.ibmb.2005.08.006; Tomizawa M, 2005, ANNU REV PHARMACOL, V45, P247, DOI 10.1146/annurev.pharmtox.45.120403.095930; Tomizawa M, 2003, ANNU REV ENTOMOL, V48, P339, DOI 10.1146/annurev.ento.48.091801.112731; Tomizawa M, 2011, J AGR FOOD CHEM, V59, P2883, DOI 10.1021/jf103856c; Tomizawa M, 2009, ACCOUNTS CHEM RES, V42, P260, DOI 10.1021/ar800131p; Wozniak RAF, 2010, NAT REV MICROBIOL, V8, P552, DOI 10.1038/nrmicro2382	37	12	12	5	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 30	2012	7	11							e51162	10.1371/journal.pone.0051162	http://dx.doi.org/10.1371/journal.pone.0051162			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	054WM	23226482	Green Published, Green Submitted			2022-12-27	WOS:000312376100293
J	Wang, Y; Yu, JM; Gao, Q; Hu, LW; Gao, N; Gong, HZ; Liu, Y				Wang, Yang; Yu, Jiaming; Gao, Qian; Hu, Liwen; Gao, Na; Gong, Huizhi; Liu, Yang			The Relationship between the Disability Prevalence of Cataracts and Ambient Erythemal Ultraviolet Radiation in China	PLOS ONE			English	Article							VISUAL IMPAIRMENT; OZONE DEPLETION; EXPOSURE; POPULATION; EYE; PERSPECTIVE; ADULTS; INDIA; RISK	In Western countries, ultraviolet (UV)-induced skin cancer has been studied extensively regarding the high incidence of skin cancers in the white population; however, for people of color, cataracts are the main public health issue in relation to increased ambient ultraviolet radiation (UVR). To our knowledge, few studies have been conducted examining the relationship between cataracts and ambient UVR in China. In this study, we aimed to explore the relationship between and the factors influencing the disability prevalence of cataracts and annual ambient erythemal UVR exposure in 31 regions of China. The data used to determine the disability prevalence of cataracts was obtained from the Second China National Sample Survey on Disability. The regional annual erythemal UVR was calculated using Geographic Information System (GIS) methods based on data from the National Aeronautics and Space Administration (NASA) database. The relationship between the disability prevalence of cataracts and the annual ambient erythemal UVR was examined by using logistic regression. Both the age-standardized disability prevalence of cataracts (OR = 3.97, 95%CI 1.30-12.13, per 100KJ/m(2) increase in annual ambient erythemal UVR) and the disability prevalence of cataracts among a population >= 65 years old (OR = 3.97, 95% CI 1.30-12.13, per 100KJ/m(2) increase in annual ambient erythemal UVR) were higher in association with higher ambient erythemal UVR. Regions with higher urbanization and educational levels had lower disability prevalence of cataracts. We found positive associations of the age-standardized disability prevalence of cataracts and the disability prevalence of cataracts among a population >= 65 years old with ambient erythemal UVR in 31 regions of China.	[Wang, Yang; Gao, Qian; Hu, Liwen; Gao, Na; Gong, Huizhi; Liu, Yang] China Med Univ, Sch Publ Hlth, Shenyang, Peoples R China; [Yu, Jiaming] China Med Univ, Dept Ophthalmol, Affiliated Hosp 4, Shenyang, Peoples R China	China Medical University; China Medical University	Liu, Y (corresponding author), China Med Univ, Sch Publ Hlth, Shenyang, Peoples R China.	cmuliuyang@yahoo.com	Hu, Liwen/AAQ-2735-2020		Chinese National Natural Science Foundation [81273034, 30800895, 30700652]	Chinese National Natural Science Foundation(National Natural Science Foundation of China (NSFC))	The Chinese National Natural Science Foundation supported this study (No.81273034, No. 30800895 and No.30700652). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], NIMB 7 DAT; Blumthaler M, 1997, J PHOTOCH PHOTOBIO B, V39, P130, DOI 10.1016/S1011-1344(96)00018-8; Cullen AP, 2011, EYE CONTACT LENS, V37, P185, DOI 10.1097/ICL.0b013e318223392e; Dandona L, 1999, OPHTHALMOLOGY, V106, P497, DOI 10.1016/S0161-6420(99)90107-0; De Gruijl FR, 2002, HLTH EFFECTS STRATOS, P25; Earth Probe data, EARTH PROB DAT; Elwood JM, 1997, INT J CANCER, V73, P198, DOI 10.1002/(SICI)1097-0215(19971009)73:2<198::AID-IJC6>3.0.CO;2-R; FARMAN JC, 1985, NATURE, V315, P207, DOI 10.1038/315207a0; Huang SS, 2009, ARCH OPHTHALMOL-CHIC, V127, P1362, DOI 10.1001/archophthalmol.2009.138; JAVITT JC, 1994, DOC OPHTHALMOL, V88, P307, DOI 10.1007/BF01203684; Lucas RM, 2011, EYE CONTACT LENS, V37, P168, DOI 10.1097/ICL.0b013e31821cb0cf; National Bureau of Statistics of China, 2005, STAT COMM REG CENS 2; Office of the Second China National Sample Survey on Disability, 2007, DOC 2 CHIN NAT SAMPL; Rosmini Francesco, 1994, Annals of Epidemiology, V4, P266; Sasaki K, 1999, J Epidemiol, V9, pS33; Sasaki K., 1995, J JPN OPHTHALMOL SOC, V99, P204; Vajpayee RB, 1999, OPHTHALMIC RES, V31, P86, DOI 10.1159/000055518; West SK, 2005, AM J EPIDEMIOL, V162, P1080, DOI 10.1093/aje/kwi329; West SK, 1998, JAMA-J AM MED ASSOC, V280, P714, DOI 10.1001/jama.280.8.714; Xu L, 2006, AM J OPHTHALMOL, V141, P591, DOI 10.1016/j.ajo.2005.10.018	20	5	5	0	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 30	2012	7	11							e51137	10.1371/journal.pone.0051137	http://dx.doi.org/10.1371/journal.pone.0051137			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	054WM	23226480	Green Published, gold, Green Submitted			2022-12-27	WOS:000312376100291
J	Xia, Q; Chen, ZX; Wang, YC; Ma, YS; Zhang, F; Che, W; Fu, D; Wang, XF				Xia, Qing; Chen, Zi-Xian; Wang, Yi-Chao; Ma, Yu-Shui; Zhang, Feng; Che, Wu; Fu, Da; Wang, Xiao-Feng			Association between the Melatonin Receptor 1B Gene Polymorphism on the Risk of Type 2 Diabetes, Impaired Glucose Regulation: A Meta-Analysis	PLOS ONE			English	Article							FASTING PLASMA-GLUCOSE; HAN CHINESE INDIVIDUALS; BETA-CELL FUNCTION; INSULIN-SECRETION; COMMON VARIANT; MTNR1B; RS10830963; HOMEOSTASIS; MELLITUS; SLEEP	Background: Melatonin receptor 1B (MTNR1B) belongs to the seven-transmembrane G protein-coupled receptor superfamily involved in insulin secretion, which has attracted considerable attention as a candidate gene for type 2 diabetes (T2D) since it was first identified as a loci associated with fasting plasma glucose level through genome wide association approach. The relationship between MTNR1B and T2D has been reported in various ethnic groups. The aim of this study was to consolidate and summarize published data on the potential of MTNR1B polymorphisms in T2D risk prediction. Methods: PubMed, EMBASE, ISI web of science and the CNKI databases were systematically searched to identify relevant studies. Odds ratios (ORs) and 95% confidence intervals (95% CIs) were calculated. Heterogeneity and publication bias were also tested. Results: A total of 23 studies involving 172,963 subjects for two common polymorphisms (rs10830963, rs1387153) on MTNR1B were included. An overall random effects per-allele OR of 1.05 (95% CI: 1.02-1.08; P<10(-4)) and 1.04 (95% CI: 0.98-1.10; P = 0.20) were found for the two variants respectively. Similar results were also observed using dominant or recessive genetic model. There was strong evidence of heterogeneity, which largely disappeared after stratification by ethnicity. Significant results were found in Caucasians when stratified by ethnicity; while no significant associations were observed in East Asians and South Asians. Besides, we found that the rs10830963 polymorphism is a risk factor associated with increased impaired glucose regulation susceptibility. Conclusions: This meta-analysis demonstrated that the rs10830963 polymorphism is a risk factor for developing impaired glucose regulation and T2D.	[Xia, Qing; Chen, Zi-Xian; Wang, Yi-Chao; Ma, Yu-Shui; Zhang, Feng; Che, Wu; Fu, Da; Wang, Xiao-Feng] Fudan Univ, Zhongshan Hosp, Dept Orthoped Surg, Shanghai 200433, Peoples R China	Fudan University	Fu, D (corresponding author), Fudan Univ, Zhongshan Hosp, Dept Orthoped Surg, Shanghai 200433, Peoples R China.	superdafu@hotmail.com; superwangxf@hotmail.com	Fu, Da/GXF-2656-2022; Fu, Da/F-1763-2013; ma, yushui/HGC-6206-2022		China Postdoctoral Science Foundation [20100480542, 201104227]; Nature Science Foundation of Shanghai [12ZR1436000]; Youth Innovation Promotion Association, Chinese Academy of Sciences	China Postdoctoral Science Foundation(China Postdoctoral Science Foundation); Nature Science Foundation of Shanghai(Natural Science Foundation of Shanghai); Youth Innovation Promotion Association, Chinese Academy of Sciences	This work was supported by China Postdoctoral Science Foundation Funded Project (20100480542, 201104227), Nature Science Foundation of Shanghai (12ZR1436000) and Youth Innovation Promotion Association, Chinese Academy of Sciences. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Been LF, 2012, NUTR METAB CARDIOVAS, V22, P944, DOI 10.1016/j.numecd.2011.01.006; BEGG CB, 1994, BIOMETRICS, V50, P1088, DOI 10.2307/2533446; Bonnefond A, 2012, NAT GENET, V44, P297, DOI 10.1038/ng.1053; Bouatia-Naji N, 2008, SCIENCE, V320, P1085, DOI 10.1126/science.1156849; Bouatia-Naji N, 2009, NAT GENET, V41, P89, DOI 10.1038/ng.277; COCHRAN WG, 1954, BIOMETRICS, V10, P101, DOI 10.2307/3001666; DERSIMONIAN R, 1986, CONTROL CLIN TRIALS, V7, P177, DOI 10.1016/0197-2456(86)90046-2; Dietrich K, 2011, DIABETIC MED, V28, P1373, DOI 10.1111/j.1464-5491.2011.03374.x; Dupuis J, 2010, NAT GENET, V42, P105, DOI 10.1038/ng.520; Egger M, 1997, BMJ-BRIT MED J, V315, P629, DOI 10.1136/bmj.315.7109.629; Gerstein HC, 2007, DIABETES RES CLIN PR, V78, P305, DOI 10.1016/j.diabres.2007.05.004; Hu C, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011761; Jaworek J, 2007, J PHYSIOL PHARMACOL, V58, P65; Kan MY, 2010, DIABETIC MED, V27, P598, DOI 10.1111/j.1464-5491.2010.02975.x; Knutson KL, 2007, SLEEP MED REV, V11, P163, DOI 10.1016/j.smrv.2007.01.002; Konturek SJ, 2007, J PHYSIOL PHARMACOL, V58, P23; Laposky AD, 2008, FEBS LETT, V582, P142, DOI 10.1016/j.febslet.2007.06.079; Ling Y, 2011, CARDIOVASC DIABETOL, V10, DOI 10.1186/1475-2840-10-27; Liu C, 2010, BMC MED GENET, V11, DOI 10.1186/1471-2350-11-59; LIU Y, 2012, ZHONGGUO LAO NIAN XU, V6, P111; Lyssenko V, 2009, NAT GENET, V41, P82, DOI 10.1038/ng.288; Mulder H, 2009, DIABETOLOGIA, V52, P1240, DOI 10.1007/s00125-009-1359-y; Ohshige T, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026911; Olsson L, 2011, DIABETOLOGIA, V54, P1375, DOI 10.1007/s00125-011-2106-8; Peschke E, 2006, J PINEAL RES, V40, P184, DOI 10.1111/j.1600-079X.2005.00297.x; Peschke E, 2008, J PINEAL RES, V44, P26, DOI 10.1111/j.1600-079X.2007.00519.x; Peschke E, 2007, J PINEAL RES, V42, P350, DOI 10.1111/j.1600-079X.2007.00426.x; Prokopenko I, 2009, NAT GENET, V41, P77, DOI 10.1038/ng.290; Ramraeheya RD, 2008, J PINEAL RES, V44, P273, DOI 10.1111/j.1600-079X.2007.00523.x; Rees SD, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024710; Reiling E, 2009, DIABETOLOGIA, V52, P1866, DOI 10.1007/s00125-009-1413-9; Renstrom F, 2011, DIABETES, V60, P345, DOI 10.2337/db10-0933; Ronn T, 2009, DIABETOLOGIA, V52, P830, DOI 10.1007/s00125-009-1297-8; SAAD MF, 1988, NEW ENGL J MED, V319, P1500, DOI 10.1056/NEJM198812083192302; Saxena R, 2010, NAT GENET, V42, P142, DOI 10.1038/ng.521; Simonis-Bik AM, 2010, DIABETES, V59, P293, DOI 10.2337/db09-1048; Song JY, 2011, OBESITY FACTS, V4, P197, DOI 10.1159/000329306; Sparso T, 2009, DIABETES, V58, P1450, DOI 10.2337/db08-1660; Staiger H, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003962; Tabara Y, 2011, METABOLISM, V60, P1634, DOI 10.1016/j.metabol.2011.03.014; Tam CHT, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011428; Thompson SG, 1999, STAT MED, V18, P2693, DOI 10.1002/(SICI)1097-0258(19991030)18:20<2693::AID-SIM235>3.0.CO;2-V; Walford GA, 2012, DIABETOLOGIA, V55, P331, DOI 10.1007/s00125-011-2353-8; Wang J, 2007, DIABETOLOGIA, V50, P1192, DOI 10.1007/s00125-007-0656-6; Wang Y, 2007, DIABETOLOGIA, V50, P774, DOI 10.1007/s00125-006-0564-1; Watanabe RM, 1999, HUM HERED, V49, P159, DOI 10.1159/000022865; WOOLF B, 1955, ANN HUM GENET, V19, P251, DOI 10.1111/j.1469-1809.1955.tb01348.x; Wuehlbauer E, 2009, EUR J PHARMACOL, V606, P61, DOI 10.1016/j.ejphar.2009.01.029; Xu M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014022	49	30	30	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 30	2012	7	11							e50107	10.1371/journal.pone.0050107	http://dx.doi.org/10.1371/journal.pone.0050107			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	054WM	23226241	Green Submitted, Green Published, gold			2022-12-27	WOS:000312376100050
J	Xu, R; Han, QF; Zhu, TY; Ren, YP; Chen, JH; Zhao, HP; Chen, MH; Dong, J; Wang, Y; Hao, CM; Zhang, R; Zhang, XH; Wang, M; Tian, N; Wang, HY				Xu, Rong; Han, Qing-Feng; Zhu, Tong-Ying; Ren, Ye-Ping; Chen, Jiang-Hua; Zhao, Hui-Ping; Chen, Meng-Hua; Dong, Jie; Wang, Yue; Hao, Chuan-Ming; Zhang, Rui; Zhang, Xiao-Hui; Wang, Mei; Tian, Na; Wang, Hai-Yan			Impact of Individual and Environmental Socioeconomic Status on Peritoneal Dialysis Outcomes: A Retrospective Multicenter Cohort Study	PLOS ONE			English	Article							CHRONIC KIDNEY-DISEASE; TECHNIQUE FAILURE; SURVIVAL; HEMODIALYSIS; PATIENT; RISK; POPULATION; PREDICTORS; MORTALITY; CARE	Objectives: We aimed to explore the impacts of individual and environmental socioeconomic status (SES) on the outcome of peritoneal dialysis (PD) in regions with significant SES disparity, through a retrospective multicenter cohort in China. Methods: Overall, 2,171 incident patients from seven PD centers were included. Individual SES was evaluated from yearly household income per person and education level. Environmental SES was represented by regional gross domestic product (GDP) per capita and medical resources. Undeveloped regions were defined as those with regional GDP lower than the median. All-cause and cardiovascular death and initial peritonitis were recorded as outcome events. Results: Poorer PD patients or those who lived in undeveloped areas were younger and less-educated and bore a heavier burden of medical expenses. They had lower hemoglobin and serum albumin at baseline. Low income independently predicted the highest risks for all-cause or cardiovascular death and initial peritonitis compared with medium and high income. The interaction effect between individual education and regional GDP was determined. In undeveloped regions, patients with an elementary school education or lower were at significantly higher risk for all-cause death but not cardiovascular death or initial peritonitis compared with those who attended high school or had a higher diploma. Regional GDP was not associated with any outcome events. Conclusion: Low personal income independently influenced all-cause and cardiovascular death, and initial peritonitis in PD patients. Education level predicted all-cause death only for patients in undeveloped regions. For PD patients in these high risk situations, integrated care before dialysis and well-constructed PD training programs might be helpful.	[Xu, Rong; Dong, Jie; Wang, Hai-Yan] Peking Univ, Key Lab Renal Dis, Minist Educ,Hosp 1, Renal Div,Dept Med,Inst Nephrol,Minist Hlth, Beijing 100871, Peoples R China; [Han, Qing-Feng; Wang, Yue] Peking Univ, Dept Nephrol, Hosp 3, Beijing 100871, Peoples R China; [Zhu, Tong-Ying; Hao, Chuan-Ming] Fudan Univ, Dept Nephrol, Huashan Hosp, Shanghai 200433, Peoples R China; [Ren, Ye-Ping; Zhang, Rui] Harbin Med Univ, Affiliated Hosp 2, Dept Nephrol, Harbin, Heilongjiang, Peoples R China; [Chen, Jiang-Hua; Zhang, Xiao-Hui] Zhejiang Univ, Coll Med, Affiliated Hosp 1, Kidney Dis Ctr, Hangzhou 310003, Zhejiang, Peoples R China; [Zhao, Hui-Ping; Wang, Mei] Peking Univ, Dept Nephrol, Peoples Hosp, Beijing 100871, Peoples R China; [Chen, Meng-Hua; Tian, Na] Ningxia Med Univ, Gen Hosp, Dept Nephrol, Ningxia, Peoples R China	Peking University; Peking University; Fudan University; Harbin Medical University; Zhejiang University; Peking University; Ningxia Medical University	Dong, J (corresponding author), Peking Univ, Key Lab Renal Dis, Minist Educ,Hosp 1, Renal Div,Dept Med,Inst Nephrol,Minist Hlth, Beijing 100871, Peoples R China.	dongjie@medmail.com.cn	Dong, Jie/AFM-0048-2022; tian, na/GVR-9226-2022		Baxter Corp, China; ISN GO RP Committee; Baxter Corp	Baxter Corp, China; ISN GO RP Committee; Baxter Corp	This study is supported by Baxer Clinical Research Award from Baxter Corp, China and ISN Research Award from ISN GO R&P Committee. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors have the following interests. This work was supported in part by the Baxer Clinical Research Award of Baxter Corp. There are no patents, products in development or marketed products to declare. This does not alter authors' adherence to all the PLOS ONE policies on sharing data and materials, as detailed online in the guide for authors.	Adams AS, 2003, BMC HEALTH SERV RES, V3, DOI 10.1186/1472-6963-3-6; Afolalu B, 2009, PERITON DIALYSIS INT, V29, P292; ANZDATA website, 2007, 30 ANZDATA; AVRAM MM, 1994, AM J KIDNEY DIS, V23, P91, DOI 10.1016/S0272-6386(12)80817-1; Bastos KD, 2011, CLIN J AM SOC NEPHRO, V6, P1676, DOI 10.2215/CJN.09041010; Batlle D, 2006, KIDNEY INT, V70, pS40, DOI 10.1038/sj.ki.5001976; BLAKE PG, 1993, J AM SOC NEPHROL, V3, P1501; Blake PG, 2000, AM J KIDNEY DIS, V35, P506, DOI 10.1016/S0272-6386(00)70205-8; Brown EA, 2010, NEPHROL DIAL TRANSPL, V25, P3755, DOI 10.1093/ndt/gfq212; Carruthers D M, 1996, Perit Dial Int, V16 Suppl 1, pS452; Carruthers Dale, 2004, Nephrology (Carlton), V9 Suppl 4, pS129, DOI 10.1111/j.1440-1797.2004.00348.x; Caskey FJ, 2006, KIDNEY INT, V70, P2134, DOI 10.1038/sj.ki.5001999; Chichlowska KL, 2008, PSYCHOSOM MED, V70, P986, DOI 10.1097/PSY.0b013e318183a491; Chidambaram M, 2011, PERITON DIALYSIS INT, V31, P565, DOI 10.3747/pdi.2010.00096; FARIAS MG, 1994, KIDNEY INT, V46, P1392, DOI 10.1038/ki.1994.410; Goldfarb-Rumyantzev AS, 2010, NEPHROL DIAL TRANSPL, V25, P3672, DOI 10.1093/ndt/gfq177; Goldman DP, 2002, P NATL ACAD SCI USA, V99, P10929, DOI 10.1073/pnas.162086599; Jager KJ, 2004, AM J KIDNEY DIS, V43, P891, DOI 10.1053/j.ajkd.2003.12.051; Juergensen E, 2006, CLIN J AM SOC NEPHRO, V1, P1191, DOI 10.2215/CJN.01220406; Kennedy BP, 1998, BRIT MED J, V317, P917; Klarenbach S, 2009, SEMIN NEPHROL, V29, P524, DOI 10.1016/j.semnephrol.2009.06.009; Leinig CE, 2011, J RENAL NUTR, V21, P176, DOI 10.1053/j.jrn.2010.06.026; Li PKT, 2010, PERITON DIALYSIS INT, V30, P393, DOI 10.3747/pdi.2010.00049; Lim WH, 2011, NEPHROL DIAL TRANSPL, V26, P3366, DOI 10.1093/ndt/gfr070; Martin LC, 2011, CLIN J AM SOC NEPHRO, V6, P1944, DOI 10.2215/CJN.11431210; Mehrotra R, 2011, PERIT DIAL INT; Merkin SS, 2007, SOC SCI MED, V65, P809, DOI 10.1016/j.socscimed.2007.04.011; Mujais S, 2006, KIDNEY INT, V70, pS21, DOI 10.1038/sj.ki.5001912; Oliver MJ, 2007, KIDNEY INT, V71, P673, DOI 10.1038/sj.ki.5002107; Oliver MJ, 2010, NEPHROL DIAL TRANSPL, V25, P2737, DOI 10.1093/ndt/gfq085; Pereira BJG, 2000, KIDNEY INT, V57, P351, DOI 10.1046/j.1523-1755.2000.00840.x; Raaijmakers R, 2010, PEDIATR NEPHROL, V25, P2149, DOI 10.1007/s00467-010-1592-0; RUBIN J, 1985, ARCH INTERN MED, V145, P1041, DOI 10.1001/archinte.145.6.1041; RUBIN J, 1983, AM J KIDNEY DIS, V2, P602, DOI 10.1016/S0272-6386(83)80039-0; Sanabria M, 2008, KIDNEY INT, V73, pS165, DOI 10.1038/sj.ki.5002619; Schaubel DE, 2001, KIDNEY INT, V60, P1517, DOI 10.1046/j.1523-1755.2001.00969.x; Smith SC, 2004, CIRCULATION, V109, P3112, DOI 10.1161/01.CIR.0000133427.35111.67; Taira DA, 2007, ETHNIC HEALTH, V12, P265, DOI 10.1080/13557850701234955; Tonelli M, 2007, KIDNEY INT, V72, P1023, DOI 10.1038/sj.ki.5002443; Volkova N, 2008, J AM SOC NEPHROL, V19, P356, DOI 10.1681/ASN.2006080934; Wee LE, 2012, HYPERTENS RES, V35, P295, DOI 10.1038/hr.2011.187; Weinhandl ED, 2010, J AM SOC NEPHROL, V21, P499, DOI 10.1681/ASN.2009060635; Xu R, 2012, PERITON DIALYSIS INT, V32, P94, DOI 10.3747/pdi.2010.00213; Yang X, 2011, CHINESE MED J-PEKING, V124, P2696, DOI 10.3760/cma.j.issn.0366-6999.2011.17.024; Zhang LX, 2012, LANCET, V379, P815, DOI 10.1016/S0140-6736(12)60033-6; Zuo L, 2006, ETHNIC DIS, V16	46	41	44	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 30	2012	7	11							e50766	10.1371/journal.pone.0050766	http://dx.doi.org/10.1371/journal.pone.0050766			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	054WM	23226378	gold, Green Published, Green Submitted			2022-12-27	WOS:000312376100189
J	Yin, XT; Zhao, L; Xu, JH; Evans, AC; Fan, LZ; Ge, HT; Tang, YC; Khundrakpam, B; Wang, J; Liu, SW				Yin, Xuntao; Zhao, Lu; Xu, Junhai; Evans, Alan C.; Fan, Lingzhong; Ge, Haitao; Tang, Yuchun; Khundrakpam, Budhachandra; Wang, Jian; Liu, Shuwei			Anatomical Substrates of the Alerting, Orienting and Executive Control Components of Attention: Focus on the Posterior Parietal Lobe	PLOS ONE			English	Article							LATERAL INTRAPARIETAL AREA; CORTICAL SURFACE-AREA; HUMAN CEREBRAL-CORTEX; EVENT-RELATED FMRI; SPATIAL ATTENTION; TOP-DOWN; VISUAL-ATTENTION; TARGET DETECTION; VISUOSPATIAL ATTENTION; FRONTOPARIETAL NETWORK	Both neuropsychological and functional neuroimaging studies have identified that the posterior parietal lobe (PPL) is critical for the attention function. However, the unique role of distinct parietal cortical subregions and their underlying white matter (WM) remains in question. In this study, we collected both magnetic resonance imaging and diffusion tensor imaging (DTI) data in normal participants, and evaluated their attention performance using attention network test (ANT), which could isolate three different attention components: alerting, orienting and executive control. Cortical thickness, surface area and DTI parameters were extracted from predefined PPL subregions and correlated with behavioural performance. Tract-based spatial statistics (TBSS) was used for the voxel-wise statistical analysis. Results indicated structure-behaviour relationships on multiple levels. First, a link between the cortical thickness and WM integrity of the right inferior parietal regions and orienting performance was observed. Specifically, probabilistic tractography demonstrated that the integrity of WM connectivity between the bilateral inferior parietal lobules mediated the orienting performance. Second, the scores of executive control were significantly associated with the WM diffusion metrics of the right supramarginal gyrus. Finally, TBSS analysis revealed that alerting performance was significant correlated with the fractional anisotropy of local WM connecting the right thalamus and supplementary motor area. We conclude that distinct areas and features within PPL are associated with different components of attention. These findings could yield a more complete understanding of the nature of the PPL contribution to visuospatial attention.	[Yin, Xuntao; Xu, Junhai; Ge, Haitao; Tang, Yuchun; Liu, Shuwei] Shandong Univ, Res Ctr Sect & Imaging Anat, Sch Med, Jinan 250100, Shandong, Peoples R China; [Yin, Xuntao; Zhao, Lu; Evans, Alan C.; Khundrakpam, Budhachandra] McGill Univ, Montreal Neurol Inst, McConnell Brain Imaging Ctr, Montreal, PQ, Canada; [Yin, Xuntao; Wang, Jian] Third Mil Med Univ, Dept Radiol, Southwest Hosp, Chongqing, Peoples R China; [Fan, Lingzhong] Chinese Acad Sci, Natl Lab Pattern Recognit, Inst Automat, Beijing, Peoples R China	Shandong University; McGill University; Army Medical University; Chinese Academy of Sciences; Institute of Automation, CAS	Liu, SW (corresponding author), Shandong Univ, Res Ctr Sect & Imaging Anat, Sch Med, Jinan 250100, Shandong, Peoples R China.	liusw@sdu.edu.cn	Evans, Alan C/B-2373-2013; Khundrakpam, Budhachandra/AAC-9037-2019	Evans, Alan C/0000-0003-3841-6098; Khundrakpam, Budhachandra/0000-0001-8095-5656; Xu, Junhai/0000-0002-4289-647X; Yin, Xuntao/0000-0002-8228-6908	National Natural Science Foundation of China [30871305]; China Postdoctoral Science Foundation [20110491577]; Promotive Research Fund for Excellent Young and Middle-aged Scientists of Shandong Province [BS2011YY035]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); China Postdoctoral Science Foundation(China Postdoctoral Science Foundation); Promotive Research Fund for Excellent Young and Middle-aged Scientists of Shandong Province	This study was supported by National Natural Science Foundation of China (no. 30871305), China Postdoctoral Science Foundation (no. 20110491577) and Promotive Research Fund for Excellent Young and Middle-aged Scientists of Shandong Province (no. BS2011YY035). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akkal D, 2007, J NEUROSCI, V27, P10659, DOI 10.1523/JNEUROSCI.3134-07.2007; Arcizet F, 2011, CEREB CORTEX, V21, P2498, DOI 10.1093/cercor/bhr035; Badre D, 2004, NEURON, V41, P473, DOI 10.1016/S0896-6273(03)00851-1; Balslev D, 2005, CEREB CORTEX, V15, P166, DOI 10.1093/cercor/bhh119; Behrens TEJ, 2007, NEUROIMAGE, V34, P144, DOI 10.1016/j.neuroimage.2006.09.018; Behrmann M, 2004, CURR OPIN NEUROBIOL, V14, P212, DOI 10.1016/j.conb.2004.03.012; Bisley JW, 2011, EUR J NEUROSCI, V33, P1982, DOI 10.1111/j.1460-9568.2011.07700.x; Bisley JW, 2003, SCIENCE, V299, P81, DOI 10.1126/science.1077395; Blankenburg F, 2010, CEREB CORTEX, V20, P2702, DOI 10.1093/cercor/bhq015; BOURGEOIS JP, 1993, J NEUROSCI, V13, P2801; Buschman TJ, 2007, SCIENCE, V315, P1860, DOI 10.1126/science.1138071; Bush G, 2011, BIOL PSYCHIAT, V69, P1160, DOI 10.1016/j.biopsych.2011.01.022; Chambers CD, 2004, NAT NEUROSCI, V7, P217, DOI 10.1038/nn1203; Chen ZJ, 2011, NEUROIMAGE, V56, P235, DOI 10.1016/j.neuroimage.2011.01.010; Cieslik EC, 2010, J NEUROPHYSIOL, V104, P1472, DOI 10.1152/jn.00261.2010; COLLINS DL, 1994, J COMPUT ASSIST TOMO, V18, P192, DOI 10.1097/00004728-199403000-00005; Corbetta M, 2000, NAT NEUROSCI, V3, P292, DOI 10.1038/73009; Corbetta M, 2002, NAT REV NEUROSCI, V3, P201, DOI 10.1038/nrn755; Corbetta M, 2008, NEURON, V58, P306, DOI 10.1016/j.neuron.2008.04.017; Coull JT, 1996, NEUROPSYCHOLOGIA, V34, P1085, DOI 10.1016/0028-3932(96)00029-2; Crespo-Facorro B, 2011, PSYCHOL MED, V41, P1449, DOI 10.1017/S003329171000200X; ERIKSEN BA, 1974, PERCEPT PSYCHOPHYS, V16, P143, DOI 10.3758/BF03203267; Fan J, 2003, P NATL ACAD SCI USA, V100, P7406, DOI 10.1073/pnas.0732088100; Fan J, 2002, J COGNITIVE NEUROSCI, V14, P340, DOI 10.1162/089892902317361886; Fan J, 2005, NEUROIMAGE, V26, P471, DOI 10.1016/j.neuroimage.2005.02.004; Fan J, 2007, J NEUROSCI, V27, P2272, DOI 10.1523/JNEUROSCI.3470-06.2007; Fimm B, 2001, J NEUROL NEUROSUR PS, V71, P652, DOI 10.1136/jnnp.71.5.652; Friedman-Hill SR, 2003, P NATL ACAD SCI USA, V100, P4263, DOI 10.1073/pnas.0730772100; Gillebert CR, 2011, BRAIN, V134, P1694, DOI 10.1093/brain/awr085; Gong GL, 2009, CEREB CORTEX, V19, P524, DOI 10.1093/cercor/bhn102; Green AE, 2008, NAT REV NEUROSCI; Han SH, 2004, BRAIN, V127, P650, DOI 10.1093/brain/awh071; Hartwigsen G, 2010, P NATL ACAD SCI USA, V107, P16494, DOI 10.1073/pnas.1008121107; Hillis AE, 2005, J NEUROSCI, V25, P3161, DOI 10.1523/JNEUROSCI.4468-04.2005; Hogstrom LJ, 2012, CEREB CORTEX; Kanai R, 2011, J NEUROSCI, V31, P6620, DOI 10.1523/JNEUROSCI.5864-10.2011; Kim JS, 2005, NEUROIMAGE, V27, P210, DOI 10.1016/j.neuroimage.2005.03.036; Kinomura S, 1996, SCIENCE, V271, P512, DOI 10.1126/science.271.5248.512; Kinsbourne M, 1977, Adv Neurol, V18, P41; Koch G, 2011, J NEUROSCI, V31, P8967, DOI 10.1523/JNEUROSCI.6567-10.2011; Kochunov P, 2010, NEUROIMAGE, V49, P1190, DOI 10.1016/j.neuroimage.2009.09.052; Lane AR, 2011, J COGNITIVE NEUROSCI, V23, P1964, DOI 10.1162/jocn.2010.21576; Lerch JP, 2005, NEUROIMAGE, V24, P163, DOI 10.1016/j.neuroimage.2004.07.045; Lyttelton O, 2007, NEUROIMAGE, V34, P1535, DOI 10.1016/j.neuroimage.2006.10.041; Mainero C, 2004, NEUROIMAGE, V21, P858, DOI 10.1016/j.neuroimage.2003.10.004; Malhotra P, 2009, BRAIN, V132, P645, DOI 10.1093/brain/awn350; Mayo JP, 2009, J NEUROPHYSIOL, V101, P1123, DOI 10.1152/jn.91369.2008; McAlonan K, 2008, NATURE, V456, P391, DOI 10.1038/nature07382; Michelon P, 2006, J NEUROPHYSIOL, V95, P811, DOI 10.1152/jn.00488.2005; Mort DJ, 2003, BRAIN, V126, P1986, DOI 10.1093/brain/awg200; Nagai Y, 2004, NEUROIMAGE, V21, P1232, DOI 10.1016/j.neuroimage.2003.10.036; Neuhaus AH, 2007, J PSYCHIATR RES, V41, P635, DOI 10.1016/j.jpsychires.2006.06.012; Niogi S, 2010, FRONT NEUROANAT, V4, DOI [10.3389/neuro.05.002.2010, 10.3389/fneur.2010.00149]; OLDFIELD RC, 1971, NEUROPSYCHOLOGIA, V9, P97, DOI 10.1016/0028-3932(71)90067-4; Panizzon MS, 2009, CEREB CORTEX, V19, P2728, DOI 10.1093/cercor/bhp026; Papeo L, 2010, EXP BRAIN RES, V206, P129, DOI 10.1007/s00221-010-2198-2; PARDO JV, 1991, NATURE, V349, P61, DOI 10.1038/349061a0; Picard N, 1996, CEREB CORTEX, V6, P342, DOI 10.1093/cercor/6.3.342; POSNER MI, 1990, ANNU REV NEUROSCI, V13, P25, DOI 10.1146/annurev.ne.13.030190.000325; Posner MI, 2008, ANN NY ACAD SCI, V1129, P193, DOI 10.1196/annals.1417.011; Raz A, 2006, NAT REV NEUROSCI, V7, P367, DOI 10.1038/nrn1903; Rizzolatti G, 2003, EXP BRAIN RES, V153, P146, DOI 10.1007/s00221-003-1588-0; Rushworth MFS, 2006, CEREB CORTEX, V16, P1418, DOI 10.1093/cercor/bhj079; Saalmann YB, 2007, SCIENCE, V316, P1612, DOI 10.1126/science.1139140; Schiff S, 2011, J COGNITIVE NEUROSCI, V23, P3998, DOI 10.1162/jocn_a_00080; Shaw P, 2008, J NEUROSCI, V28, P3586, DOI 10.1523/JNEUROSCI.5309-07.2008; Shulman GL, 2010, J NEUROSCI, V30, P3640, DOI 10.1523/JNEUROSCI.4085-09.2010; Silvanto J, 2009, CEREB CORTEX, V19, P327, DOI 10.1093/cercor/bhn091; Simpson GV, 2011, J NEUROSCI, V31, P13880, DOI 10.1523/JNEUROSCI.1519-10.2011; Sled JG, 1998, IEEE T MED IMAGING, V17, P87, DOI 10.1109/42.668698; Smith SM, 2002, HUM BRAIN MAPP, V17, P143, DOI 10.1002/hbm.10062; Smith SM, 2004, NEUROIMAGE, V23, pS208, DOI 10.1016/j.neuroimage.2004.07.051; Smith SM, 2006, NEUROIMAGE, V31, P1487, DOI 10.1016/j.neuroimage.2006.02.024; Song SK, 2005, NEUROIMAGE, V26, P132, DOI 10.1016/j.neuroimage.2005.01.028; Sowell ER, 2004, J NEUROSCI, V24, P8223, DOI 10.1523/JNEUROSCI.1798-04.2004; Sturm W, 2001, NEUROIMAGE, V14, pS76, DOI 10.1006/nimg.2001.0839; Szczepanski SM, 2010, J NEUROSCI, V30, P148, DOI 10.1523/JNEUROSCI.3862-09.2010; Tamm L, 2006, AM J PSYCHIAT, V163, P1033, DOI 10.1176/appi.ajp.163.6.1033; Tamnes CK, 2010, NEUROPSYCHOLOGIA, V48, P2496, DOI 10.1016/j.neuropsychologia.2010.04.024; Tamnes CK, 2010, CEREB CORTEX, V20, P534, DOI 10.1093/cercor/bhp118; Thiel CM, 2004, NEUROIMAGE, V21, P318, DOI 10.1016/j.neuroimage.2003.08.044; Thimm M, 2010, PSYCHOL MED, P1; Tzourio-Mazoyer N, 2002, NEUROIMAGE, V15, P273, DOI 10.1006/nimg.2001.0978; Urbanek C, 2009, BIOL PSYCHIAT, V65, p161S; Walsh BJ, 2011, J COGNITIVE NEUROSCI, V23, P2211, DOI 10.1162/jocn.2010.21595; Wang K, 2005, SCHIZOPHR RES, V78, P235, DOI 10.1016/j.schres.2005.01.019; Westlye LT, 2011, CEREB CORTEX, V21, P345, DOI 10.1093/cercor/bhq101; Winkler AM, 2012, NEUROIMAGE, V61, P1428, DOI 10.1016/j.neuroimage.2012.03.026; Yanaka HT, 2010, NEUROSCI RES, V68, P51, DOI 10.1016/j.neures.2010.05.005; Yin X, 2011, HUM BRAIN MAPP; Zijdenbos AP, 2002, IEEE T MED IMAGING, V21, P1280, DOI 10.1109/TMI.2002.806283	91	39	41	0	38	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 30	2012	7	11							e50590	10.1371/journal.pone.0050590	http://dx.doi.org/10.1371/journal.pone.0050590			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	054WM	23226322	Green Published, gold, Green Submitted			2022-12-27	WOS:000312376100134
J	Colombi, CE; Fernandez, E; Currie, BS; Alcober, OA; Martinez, R; Correa, G				Colombi, Carina E.; Fernandez, Eliana; Currie, Brian S.; Alcober, Oscar A.; Martinez, Ricardo; Correa, Gustavo			Large-Diameter Burrows of the Triassic Ischigualasto Basin, NW Argentina: Paleoecological and Paleoenvironmental Implications	PLOS ONE			English	Article							BEAUFORT-GROUP; TETRAPOD BURROWS; EARLY EVOLUTION; KAROO BASIN; DINOSAUR; CYNODONT; ORIGIN; RECORD; SAUROPODOMORPHA; EUCYNODONTIA	Large-diameter ichnofossils comprising three morphotypes have been identified in the Upper Triassic Ischigualasto and Los Colorados formations of northwestern Argentina. These burrows add to the global record of the early appearance of fossorial behavior during early Mesozoic time. Morphotypes 1 and 2 are characterized by a network of tunnels and shafts that can be assigned to tetrapod burrows given similarities with previously described forms. However, differences in diameter, overall morphology, and stratigraphic occurrence allow their independent classification. Morphotype 3 forms a complex network of straight branches that intersect at oblique angles. Their calcareous composition and surface morphology indicate these structures have a composite biogenic origin likely developed due to combined plant/animal interactions. The association of Morphotypes 1 and 2 with fluvial overbank lithologies deposited under an extremely seasonal arid climate confirms interpretations that the early appearance of burrowing behavior was employed by vertebrates in response to both temperature and moisture-stress associated with seasonally or perpetually dry Pangean paleoclimates. Comparisons of burrow morphology and biomechanical attributes of the abundant paleovertebrate fauna preserved in both formations permit interpretations regarding the possible burrow architects for Morphotypes 1 and 2. In the case of the Morphotype 1, the burrow constructor could be one of the small carnivorous cynodonts, Ecteninion or Probelesodon. Assigning an architect for Morphotype 2 is more problematic due to mismatches between the observed burrow morphology and the size of the known Los Colorados vertebrates. Citation: Colombi CE, Fernandez E, Currie BS, Alcober OA, Martinez R, et al. (2012) Large-Diameter Burrows of the Triassic Ischigualasto Basin, NW Argentina: Paleoecological and Paleoenvironmental Implications. PLoS ONE 7(12): e50662. doi:10.1371/journal.pone.0050662	[Colombi, Carina E.; Correa, Gustavo] Consejo Nacl Invest Cient & Tecn, San Juan, Argentina; [Colombi, Carina E.; Fernandez, Eliana; Alcober, Oscar A.; Martinez, Ricardo; Correa, Gustavo] Univ Nacl San Juan, Inst & Museo Ciencias Nat, Dept Paleontol Vertebrados, San Juan, Argentina; [Currie, Brian S.] Miami Univ, Dept Geol, Oxford, OH 45056 USA	Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); Universidad Nacional de San Juan; University System of Ohio; Miami University	Colombi, CE (corresponding author), Consejo Nacl Invest Cient & Tecn, San Juan, Argentina.	ccolombi@unsj.edu.ar		Colombi, Carina/0000-0003-0192-9455; Correa, Gustavo Alejandro/0000-0002-9799-9644; Currie, Brian/0000-0002-5759-3914	Instituto y Museo de Ciencias Naturales	Instituto y Museo de Ciencias Naturales	We thank the Instituto y Museo de Ciencias Naturales for their support at all stages of research. We also thank the field crews of the 2005 and 2006 Ischigualasto Basin fieldwork. We are indebted to Kay Behrensmeyer for her significant field discussion. We thank Ameghiniana for the permission to reproduce original figures under a Creative Commons Attribution Licence.	Abdala F, 2006, ZOOL J LINN SOC-LOND, V147, P383, DOI 10.1111/j.1096-3642.2006.00224.x; Alcober O, 1997, J VERTEBR PALEONTOL, V17, P548, DOI 10.1080/02724634.1997.10011001; Alcober OA, 2010, ZOOKEYS, P55, DOI 10.3897/zookeys.63.550; ANDERSEN DC, 1982, AM NAT, V119, P18, DOI 10.1086/283887; Arcucci AB, 2004, GEOBIOS-LYON, V37, P557, DOI 10.1016/j.geobios.2003.04.008; Arcucci AB, 2003, AMEGHINIANA, V40, P217; Bonaparte, 1971, P 2 IUGS GONDW S, P665; BONAPARTE J F, 1982, Journal of Vertebrate Paleontology, V2, P362; Bonaparte J.F., 1994, Revista del Museo Argentino de Ciencias Naturales "Bernardino Rivadavia" e Instituto Nacional de Investigacion de las Ciencias Naturales Paleontologia, V5, P1; BONAPARTE J F, 1978, Ameghiniana, V15, P327; Bonaparte J. F., 1963, Acta Geologica Lilloana, V4, P111; Bonaparte J. F., 1962, Publ Mus Cienc nat Mar del Plata, V1, P135; Bonaparte J.F., 1981, Revista del Museo Argentino de Ciencias Naturales "Bernardino Rivadavia" y Instituto Nacional de Investigacion de las Ciencias Naturales Palaeontologia, V3, P55; Bonaparte J.F, 1970, P PAP 2 GONDW S S AF, P665; Bonaparte J.F, 1980, ACT 2 C ARG PAL, V1, P123; Bonaparte JF, 1999, AMEGHINIANA, V36, P115; Bonaparte JF, 1978, OPERA LILLOANAO, V26, P596; Bonaparte JF, 1997, TRIASICO SL RIOJA; Bonaparte JF, 1969, IUGS C MAR PLATA MAR, V1967, P283; BONAPARTE JF, 1971, OPERA LILLOANA, V22, P87; Bordy EM, 2011, LETHAIA, V44, P33, DOI 10.1111/j.1502-3931.2010.00223.x; Desojo JB, 2009, PALAEONTOL Z, V83, P499, DOI 10.1007/s12542-009-0032-6; Casamiquela R. M., 1960, Rev Asoc pal argent, V2, P3; Casamiquela R. M., 1967, Ameghiniana, V5, P47; Casselli A, 2001, REV ASOC GEOL ARGENT, V56, P173; Colombi CE, 2011, REV BRAS PALEONTOLOG, V14, P39, DOI 10.4072/rbp.2011.1.04; Colombi CE, 2008, AMEGHINIANA, V45, P795; Colombi CE, 2008, PALAIOS, V23, P778, DOI 10.2110/palo.2007.p07-101r; Colombi GE, 2011, 4 C LAT PAL VERT AM; COX CB, 1965, PHILOS T ROY SOC B, V248, P457, DOI 10.1098/rstb.1965.0005; Currie BS, 2009, J S AM EARTH SCI, V27, P74, DOI 10.1016/j.jsames.2008.10.004; Damiani R, 2003, P ROY SOC B-BIOL SCI, V270, P1747, DOI 10.1098/rspb.2003.2427; Davenport J., 1992, ANIMAL LIFE LOW TEMP; Delany M.J., 1979, ECOLOGY AFRICAN MAMM; Dentzien-Dias Paula C., 2007, Arquivos do Museu Nacional (Rio de Janeiro), V65, P585; Desojo JB, 2003, REV GEOL CHILE, V30, P53; Ezcurra MD, 2010, J SYST PALAEONTOL, V8, P371, DOI 10.1080/14772019.2010.484650; Groenewald GH, 2001, PALAIOS, V16, P148, DOI 10.2307/3515526; Hasiotis Stephen T., 2007, P196, DOI 10.1016/B978-044452949-7/50138-8; Hasiotis Stephen T., 2004, Ichnos, V11, P103, DOI 10.1080/10420940490428760; Hasiotis Stephen T., 1993, Ichnos, V2, P291; Krapovickas V, 2012, LETHAIA; KUTZBACH JE, 1989, J GEOPHYS RES-ATMOS, V94, P3341, DOI 10.1029/JD094iD03p03341; Laundre J.W., 1989, Northwestern Naturalist, V70, P18, DOI 10.2307/3536924; Lopez Gamundi O.R., 1994, GEOL S AMER, V1984, P281, DOI DOI 10.1130/MEM184-P281; Martin AJ, 2009, CRETACEOUS RES, V30, P1223, DOI 10.1016/j.cretres.2009.06.003; Martinelli AG, 2005, AMEGHINIANA, V42, P191; Martinelli AG, 2007, J VERTEBR PALEONTOL, V27, P442, DOI 10.1671/0272-4634(2007)27[442:OCMETF]2.0.CO;2; Martinez RN, 2011, SCIENCE, V331, P206, DOI 10.1126/science.1198467; Martinez RN, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004397; Martinez RN, 1996, J VERTEBR PALEONTOL, V16, P271, DOI 10.1080/02724634.1996.10011314; Martinez RN, 1996, J VERTEBR PALEONTOL, V16, P285, DOI 10.1080/02724634.1996.10011315; Milana J.P., 1994, REV ASOC GEOL ARGENT, V49, P217; Miller MF, 2001, PALAIOS, V16, P218, DOI 10.2307/3515601; Modesto SP, 2010, PALAIOS, V25, P274, DOI 10.2110/palo.2009.p09-077r; PARRISH JT, 1993, J GEOL, V101, P215, DOI 10.1086/648217; Pol D, 2007, SPEC PAP PALAEONTOL, P223; Reichman O.J., 1990, Current Mammalogy, V2, P197; Reig O. A., 1963, Ameghiniana, V3, P3; Reig OA., 1959, REV ASOC GEOL ARGENT, V13, P257; ROGERS RR, 1993, SCIENCE, V260, P794, DOI 10.1126/science.260.5109.794; ROMER A. S., 1954, BREVIORA MUS COMP ZOOL [HARVARD], V30, P1; ROUGIER GW, 1995, SCIENCE, V268, P855, DOI 10.1126/science.268.5212.855; Santi-Malnis P, 2011, LATINMAG LETT, V1, P1; Sereno Paul C., 1993, Journal of Vertebrate Paleontology, V13, P451; SERENO PC, 1993, NATURE, V361, P64, DOI 10.1038/361064a0; Sidor CA, 2008, J VERTEBR PALEONTOL, V28, P277, DOI 10.1671/0272-4634(2008)28[277:TBFTTO]2.0.CO;2; SILL W D, 1970, Ameghiniana, V7, P341; SILL W D, 1974, Bulletin of the Museum of Comparative Zoology, V146, P317; SIMMS MJ, 1990, J GEOL SOC LONDON, V147, P321, DOI 10.1144/gsjgs.147.2.0321; SIMMS MJ, 1989, GEOLOGY, V17, P265, DOI 10.1130/0091-7613(1989)017<0265:SOCCAE>2.3.CO;2; Small BJ, 2002, ZOOL J LINN SOC-LOND, V136, P97, DOI 10.1046/j.1096-3642.2002.00028.x; Smith RMH, 1996, PALAEONTOLOGY, V39, P289; SMITH RMH, 1987, PALAEOGEOGR PALAEOCL, V60, P155, DOI 10.1016/0031-0182(87)90030-7; Smith Roger M. H., 1995, Palaeontologia Africana, V32, P45; Stipanicic PN, 1979, GEOLOGIA REGIONAL AR, P503; Tabor NJ, 2006, GEOL SOC AM SPEC PAP, P17, DOI 10.1130/2006.2416(02); Talanda M, 2011, PALAIOS, V26, P99, DOI 10.2110/palo.2010.p10-024r; Tanner LH, 2004, EARTH-SCI REV, V65, P103, DOI 10.1016/S0012-8252(03)00082-5; Tanner LH, 2009, VOLUMINA JURASSICA, V6, P99; Trotteyn MJ, 2012, J VERTEBR PALEONTOL, V32, P485, DOI 10.1080/02724634.2012.645975; Varricchio DJ, 2007, P ROY SOC B-BIOL SCI, V274, P1361, DOI 10.1098/rspb.2006.0443; Voigt S, 2011, PALAIOS, V26, P555, DOI 10.2110/palo.2011.p11-014r; Walker J. D., 2009, GSA TODAY, V19, P60, DOI DOI 10.1130/2009.CTS004R2C; Willmer P., 2000, ENV PHYSL ANIMALS	85	19	19	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 5	2012	7	12							e50662	10.1371/journal.pone.0050662	http://dx.doi.org/10.1371/journal.pone.0050662			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	057TZ	23227195	Green Published, Green Submitted, gold			2022-12-27	WOS:000312588200055
J	Wang, HY; Fan, LS; Wei, JC; Weng, YJ; Zhou, L; Shi, Y; Zhou, WJ; Ma, D; Wang, CY				Wang, Hongyan; Fan, Liangsheng; Wei, Juncheng; Weng, Yanjie; Zhou, Li; Shi, Ying; Zhou, Wenjuan; Ma, Ding; Wang, Changyu			Akt Mediates Metastasis-Associated Gene 1 (MTA1) Regulating the Expression of E-cadherin and Promoting the Invasiveness of Prostate Cancer Cells (Publication with Expression of Concern. See vol. 17, 2022)	PLOS ONE			English	Article; Publication with Expression of Concern							EPITHELIAL-MESENCHYMAL TRANSITION; PI3K-AKT PATHWAY; MESSENGER-RNA; PROTEIN; REPRESSION; ADHESION; LINES; EMT; ACTIVATION; MIGRATION	Human metastasis-associated gene 1 (MTA1) is highly associated with the metastasis of prostate cancer; however, the molecular functions of MTA1 that facilitate metastasis remain unclear. In this study, we demonstrate that the silencing of MTA1 by siRNA treatment results in the upregulation of E-cadherin expression by the phosphorylation of AKT (p-AKT) and decreases the invasiveness of prostate cancer cells. We show that MTA1 is expressed in over 90% of prostate cancer tissues, especially metastatic prostate cancer tissue, comparing to non-expression in normal prostate tissue. RT-PCR analysis and Western blot assay showed that MTA1 expression is significantly higher in highly metastatic prostate cancer PC-3M-1E8 cells (1E8) than in poorly metastatic prostate cancer PC-3M-2B4 cells (2B4). Silencing MTA1 expression by siRNA treatment in 1E8 cells increased the cellular malignant characters, including the cellular adhesive ability, decreased the cellular invasive ability and changed the polarity of cellular cytoskeleton. 1E8 cells over-expressing MTA1 had a reduced expression of E-cadherin, while 1E8 cells treated with MTA1 siRNA had a higher expression of E-cadherin. The expression of phosphorylated AKT (p-AKT) or the inhibition of p-AKT by wortmannin treatment (100 nM) significantly altered the function of MTA1 in the regulation of E-cadherin expression. Alterations in E-cadherin expression changed the role of p-AKT in cellular malignant characters. All of these results demonstrate that MTA1 plays an important role in controlling the malignant transformation of prostate cancer cells through the p-AKT/E-cadherin pathway. This study also provides a new mechanistic role for MTA1 in the regulation of prostate cancer metastasis.	[Wang, Hongyan; Fan, Liangsheng; Weng, Yanjie; Shi, Ying; Zhou, Wenjuan; Ma, Ding; Wang, Changyu] Huazhong Univ Sci & Technol, Canc Biol Res Ctr, Tongji Hosp, Wuhan 430074, Hubei, Peoples R China; [Wei, Juncheng; Ma, Ding; Wang, Changyu] Huazhong Univ Sci & Technol, Dept Gynecol Oncol, Tongji Hosp, Wuhan 430074, Hubei, Peoples R China; [Wang, Hongyan] Shandong Univ, Qilu Hosp, Dept Obstet & Gynecol, Jinan 250100, Shandong, Peoples R China; [Zhou, Li] Tianjin Cent Hosp Obstet & Gynecol, Tianjin, Peoples R China; [Fan, Liangsheng] Guangzhou Med Univ, Dept Obstet & Gynecol, Affiliated Hosp 1, Guangzhou, Guangdong, Peoples R China	Huazhong University of Science & Technology; Huazhong University of Science & Technology; Shandong University; Guangzhou Medical University	Wang, CY (corresponding author), Huazhong Univ Sci & Technol, Canc Biol Res Ctr, Tongji Hosp, Wuhan 430074, Hubei, Peoples R China.	dma@tjh.tjmu.edu.cn; tjwcy@yahoo.com.cn	shi, zhensheng/GXN-3967-2022		National Natural Science Foundation of China [30973184]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by a grant from the National Natural Science Foundation of China (30973184)(www.nsfc.gov.cn). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arzumanyan A, 2012, ONCOGENE, V31, P563, DOI 10.1038/onc.2011.255; Cano A, 2000, NAT CELL BIOL, V2, P76, DOI 10.1038/35000025; Christofori G, 1999, TRENDS BIOCHEM SCI, V24, P73, DOI 10.1016/S0968-0004(98)01343-7; Cox AD, 2002, CANCER BIOL THER, V1, P599, DOI 10.4161/cbt.306; Dannenmann C, 2008, CANCER BIOL THER, V7, P1462, DOI 10.4161/cbt.7.9.6427; De Santis G, 2009, ONCOGENE, V28, P1206, DOI 10.1038/onc.2008.470; Desai RA, 2009, J CELL SCI, V122, P905, DOI 10.1242/jcs.028183; Dhanasekaran SM, 2001, NATURE, V412, P822, DOI 10.1038/35090585; Fang J, 2007, CELL SIGNAL, V19, P2487, DOI 10.1016/j.cellsig.2007.07.025; Federico A, 2009, CANCER RES, V69, P7079, DOI 10.1158/0008-5472.CAN-09-1542; Geng Li, 2008, Open Biochem J, V2, P100, DOI 10.2174/1874091X00802010100; Gravdal K, 2007, CLIN CANCER RES, V13, P7003, DOI 10.1158/1078-0432.CCR-07-1263; Grille SJ, 2003, CANCER RES, V63, P2172; Hazan RB, 2004, ANN NY ACAD SCI, V1014, P155, DOI 10.1196/annals.1294.016; Hofer MD, 2004, CANCER RES, V64, P825, DOI 10.1158/0008-5472.CAN-03-2755; Jemal A, 2011, CA-CANCER J CLIN, V61, P133, DOI [10.3322/caac.20105, 10.3322/caac.20073]; Julien S, 2007, ONCOGENE, V26, P7445, DOI 10.1038/sj.onc.1210546; Katsamba P, 2009, P NATL ACAD SCI USA, V106, P11594, DOI 10.1073/pnas.0905349106; Kumar R, 2003, CELL, V113, P142, DOI 10.1016/S0092-8674(03)00274-5; Larue L, 2005, ONCOGENE, V24, P7443, DOI 10.1038/sj.onc.1209091; Liu YN, 2008, MOL CELL BIOL, V28, P7096, DOI 10.1128/MCB.00449-08; Luo J, 2003, CANCER CELL, V4, P257, DOI 10.1016/S1535-6108(03)00248-4; Manavathi B, 2007, P NATL ACAD SCI USA, V104, P13128, DOI 10.1073/pnas.0705878104; Martin KC, 2009, CELL, V136, P719, DOI 10.1016/j.cell.2009.01.044; Molli PR, 2008, ONCOGENE, V27, P1971, DOI 10.1038/sj.onc.1210839; Moreno-Bueno G, 2008, ONCOGENE, V27, P6958, DOI 10.1038/onc.2008.346; Nicolson GL, 2003, CLIN EXP METASTAS, V20, P19, DOI 10.1023/A:1022534217769; Onder TT, 2008, CANCER RES, V68, P3645, DOI 10.1158/0008-5472.CAN-07-2938; Osaki M, 2004, APOPTOSIS, V9, P667, DOI 10.1023/B:APPT.0000045801.15585.dd; Pakala SB, 2011, ONCOGENE, V30, P2230, DOI 10.1038/onc.2010.608; Peinado H, 2004, MOL CELL BIOL, V24, P306, DOI 10.1128/MCB.24.1.306-319.2004; Peyton SR, 2007, CELL BIOCHEM BIOPHYS, V47, P300, DOI 10.1007/s12013-007-0004-y; Qian HL, 2005, CLIN EXP METASTAS, V22, P653, DOI 10.1007/s10585-006-9005-2; Radaelli E, 2009, FUTURE ONCOL, V5, P1113, DOI [10.2217/fon.09.93, 10.2217/FON.09.93]; Rao YM, 2011, J HUAZHONG U SCI-MED, V31, P1, DOI 10.1007/s11596-011-0141-9; Sasaki H, 2001, CANCER LETT, V174, P159, DOI 10.1016/S0304-3835(01)00704-2; Shimul S, 2010, J CANC SCI THER, V2, P114; Simpson A, 2001, GENE, V273, P29, DOI 10.1016/S0378-1119(01)00563-7; Singh A, 2010, ONCOGENE, V29, P4741, DOI 10.1038/onc.2010.215; Toh Y, 2004, INT J CANCER, V110, P362, DOI 10.1002/ijc.20154; TOH Y, 1994, J BIOL CHEM, V269, P22958; Toh Y, 2009, CLIN EXP METASTAS, V26, P215, DOI 10.1007/s10585-008-9233-8; Tong D, 2007, ONCOL RES, V16, P465, DOI 10.3727/096504007783338322; Wu MFF, 2007, PROTEOMICS, V7, P1973, DOI 10.1002/pmic.200600643; Yan W, 2009, BIOCHEM BIOPH RES CO, V382, P631, DOI 10.1016/j.bbrc.2009.03.088; Yang WH, 2008, CLIN CANCER RES, V14, P5494, DOI 10.1158/1078-0432.CCR-08-0233; Yao YL, 2003, J BIOL CHEM, V278, P42560, DOI 10.1074/jbc.M302955200; Yilmaz M, 2009, CANCER METAST REV, V28, P15, DOI 10.1007/s10555-008-9169-0; Zhang Y, 1999, GENE DEV, V13, P1924, DOI 10.1101/gad.13.15.1924	49	30	33	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 5	2012	7	12							e46888	10.1371/journal.pone.0046888	http://dx.doi.org/10.1371/journal.pone.0046888			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	057TZ	23227138	Green Submitted, gold, Green Published			2022-12-27	WOS:000312588200001
J	Bass, D; Yabuki, A; Santini, S; Romac, S; Berney, C				Bass, David; Yabuki, Akinori; Santini, Sebastien; Romac, Sarah; Berney, Cedric			Reticulamoeba Is a Long-Branched Granofilosean (Cercozoa) That Is Missing from Sequence Databases	PLOS ONE			English	Article							N-SP; PHYLOGENY; COMMUNITY; SUPERGROUP; DIVERSITY; REVEALS; CAMERA; MODEL	We sequenced the 18S ribosomal RNA gene of seven isolates of the enigmatic marine amoeboflagellate Reticulamoeba Grell, which resolved into four genetically distinct Reticulamoeba lineages, two of which correspond to R. gemmipara Grell and R. minor Grell, another with a relatively large cell body forming lacunae, and another that has similarities to both R. minor and R. gemmipara but with a greater propensity to form cell clusters. These lineages together form a long-branched clade that branches within the cercozoan class Granofilosea (phylum Cercozoa), showing phylogenetic affinities with the genus Mesofila. The basic morphology of Reticulamoeba is a roundish or ovoid cell with a more or less irregular outline. Long and branched reticulopodia radiate from the cell. The reticulopodia bear granules that are bidirectionally motile. There is also a biflagellate dispersal stage. Reticulamoeba is frequently observed in coastal marine environmental samples. PCR primers specific to the Reticulamoeba clade confirm that it is a frequent member of benthic marine microbial communities, and is also found in brackish water sediments and freshwater biofilm. However, so far it has not been found in large molecular datasets such as the nucleotide database in NCBI GenBank, metagenomic datasets in Camera, and the marine microbial eukaryote sampling and sequencing consortium BioMarKs, although closely related lineages can be found in some of these datasets using a highly targeted approach. Therefore, although such datasets are very powerful tools in microbial ecology, they may, for several methodological reasons, fail to detect ecologically and evolutionary key lineages.	[Bass, David; Berney, Cedric] Nat Hist Museum, Dept Life Sci, London SW7 5BD, England; [Yabuki, Akinori] Univ Oxford, Dept Zool, Oxford OX1 3PS, England; [Santini, Sebastien] Aix Marseille Univ, Mediterranean Inst Microbiol, UMR 7256, CNRS,Struct & Genom Informat Lab, Marseille, France; [Romac, Sarah] Equipe Evolut Plancton & Paleooceans, UMR 7144, CNRS, Roscoff, France	Natural History Museum London; University of Oxford; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Aix-Marseille Universite; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); UDICE-French Research Universities; Sorbonne Universite	Bass, D (corresponding author), Nat Hist Museum, Dept Life Sci, Cromwell Rd, London SW7 5BD, England.	d.bass@nhm.ac.uk		Yabuki, Akinori/0000-0002-4070-0226; Santini, Sebastien/0000-0001-7087-1950; Berney, Cedric/0000-0001-8689-9907	NERC [NE/H009426/1, NE/H000887/1]; Natural Environment Research Council [NE/H000887/1, NE/H009426/1] Funding Source: researchfish	NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	DB and CB are funded by NERC (www.nerc.ac.uk) research grants NE/H009426/1 and NE/H000887/1. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altekar G, 2004, BIOINFORMATICS, V20, P407, DOI 10.1093/bioinformatics/btg427; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Bass D, 2004, INT J SYST EVOL MICR, V54, P2393, DOI 10.1099/ijs.0.63229-0; Bass D, 2009, PROTIST, V160, P75, DOI 10.1016/j.protis.2008.07.002; Brate J, 2010, ISME J, V4, P1144, DOI 10.1038/ismej.2010.39; Brown MW, 2012, CURR BIOL, V22, P1123, DOI 10.1016/j.cub.2012.04.021; Cavalier-Smith T, 2008, PROTIST, V159, P591, DOI 10.1016/j.protis.2008.04.002; Cavalier-Smith T, 2009, PROTIST, V160, P452, DOI 10.1016/j.protis.2009.03.003; FELSENSTEIN J, 1981, J MOL EVOL, V17, P368, DOI 10.1007/BF01734359; FELSENSTEIN J, 1985, EVOLUTION, V39, P783, DOI 10.1111/j.1558-5646.1985.tb00420.x; Gomez F, 2011, ENVIRON MICROBIOL, V13, P193, DOI 10.1111/j.1462-2920.2010.02320.x; GRELL KG, 1994, ARCH PROTISTENKD, V144, P55, DOI 10.1016/S0003-9365(11)80223-X; GRELL KG, 1995, ARCH PROTISTENKD, V145, P3, DOI 10.1016/S0003-9365(11)80296-4; Hawkins RJ, 2007, FEMS MICROBIOL ECOL, V62, P187, DOI 10.1111/j.1574-6941.2007.00376.x; Koid A, 2012, APPL ENVIRON MICROB, V78, P3958, DOI 10.1128/AEM.06941-11; LANAVE C, 1984, J MOL EVOL, V20, P86, DOI 10.1007/BF02101990; Logares R, 2012, ISME J, V6, P1823, DOI 10.1038/ismej.2012.36; Miller M.A., 2010, P GAT COMP ENV WORKS; Myl'nikov AP, 2011, INLAND WATER BIOL, V4, P440, DOI 10.1134/S1995082911040146; Nikolaev SI, 2004, P NATL ACAD SCI USA, V101, P8066, DOI 10.1073/pnas.0308602101; Not F, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007143; Pawlowski J, 2009, J EUKARYOT MICROBIOL, V56, P16, DOI 10.1111/j.1550-7408.2008.00379.x; Richards TA, 2005, CURR OPIN MICROBIOL, V8, P240, DOI 10.1016/j.mib.2005.04.010; RODRIGUEZ F, 1990, J THEOR BIOL, V142, P485, DOI 10.1016/S0022-5193(05)80104-3; Rogerson A, 1996, EUR J PROTISTOL, V32, P271, DOI 10.1016/S0932-4739(96)80026-5; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; Seshadri R, 2007, PLOS BIOL, V5, P394, DOI 10.1371/journal.pbio.0050075; Stamatakis A, 2006, BIOINFORMATICS, V22, P2688, DOI 10.1093/bioinformatics/btl446; Stoeck T, 2010, MOL ECOL, V19, P21, DOI 10.1111/j.1365-294X.2009.04480.x; Stoeck T, 2007, MICROB ECOL, V53, P328, DOI 10.1007/s00248-006-9166-1; Sun SL, 2011, NUCLEIC ACIDS RES, V39, pD546, DOI 10.1093/nar/gkq1102	31	16	16	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 4	2012	7	12							e49090	10.1371/journal.pone.0049090	http://dx.doi.org/10.1371/journal.pone.0049090			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	051EQ	23226495	Green Published, gold			2022-12-27	WOS:000312108500003
J	Pelosi, E; Castelli, G; Martin-Padura, I; Bordoni, V; Santoro, S; Conigliaro, A; Cerio, AM; De Santis Puzzonia, M; Marighetti, P; Biffoni, M; Alonzi, T; Amicone, L; Alcalay, M; Bertolini, F; Testa, U; Tripodi, M				Pelosi, Elvira; Castelli, Germana; Martin-Padura, Ines; Bordoni, Veronica; Santoro, Simona; Conigliaro, Alice; Cerio, Anna Maria; De Santis Puzzonia, Marco; Marighetti, Paola; Biffoni, Mauro; Alonzi, Tonino; Amicone, Laura; Alcalay, Myriam; Bertolini, Francesco; Testa, Ugo; Tripodi, Marco			Human Haemato-Endothelial Precursors: Cord Blood CD34+ Cells Produce Haemogenic Endothelium	PLOS ONE			English	Article							HEMATOPOIETIC STEM-CELLS; AORTIC ENDOTHELIUM; PROGENITOR CELLS; MESODERMAL CELLS; HEMANGIOBLAST; GENERATION; DIFFERENTIATION; LINEAGES; IDENTIFICATION; TRANSITION	Embryologic and genetic evidence suggest a common origin of haematopoietic and endothelial lineages. In the murine embryo, recent studies indicate the presence of haemogenic endothelium and of a common haemato-endothelial precursor, the haemangioblast. Conversely, so far, little evidence supports the presence of haemogenic endothelium and haemangioblasts in later stages of development. Our studies indicate that human cord blood haematopoietic progenitors (CD34+45+144-), triggered by murine hepatocyte conditioned medium, differentiate into adherent proliferating endothelial precursors (CD144+CD105+CD146+CD31+CD45-) capable of functioning as haemogenic endothelium. These cells, proven to give rise to functional vasculature in vivo, if further instructed by haematopoietic growth factors, first switch to transitional CD144+45+ cells and then to haematopoietic cells. These results highlight the plasticity of haemato-endhothelial precursors in human post-natal life. Furthermore, these studies may provide highly enriched populations of human post-fetal haemogenic endothelium, paving the way for innovative projects at a basic and possibly clinical level.	[Pelosi, Elvira; Castelli, Germana; Santoro, Simona; Cerio, Anna Maria; Biffoni, Mauro; Testa, Ugo] Ist Super Sanita, Dept Haematol Oncol & Mol Med, I-00161 Rome, Italy; [Bordoni, Veronica; Alonzi, Tonino; Tripodi, Marco] IRCCS, L Spallanzani Natl Inst Infect Dis, Rome, Italy; [Conigliaro, Alice; De Santis Puzzonia, Marco; Amicone, Laura; Tripodi, Marco] Univ Roma La Sapienza, Ist Pasteur Cenci Bolognetti, Dipartimento Biotecnol Cellulari & Ematol, Rome, Italy; [Martin-Padura, Ines; Marighetti, Paola; Bertolini, Francesco] European Inst Oncol, Dept Med, Lab Haematol Oncol, Milan, Italy; [Alcalay, Myriam] Ist Europeo Oncol, Dept Expt Oncol, Milan, Italy; [Alcalay, Myriam] Univ Milan, Dipartimento Med Chirurg & Odontoiatria, Milan, Italy	Istituto Superiore di Sanita (ISS); IRCCS Lazzaro Spallanzani; Fondazione Cenci Bolognetti; Sapienza University Rome; IRCCS European Institute of Oncology (IEO); IRCCS European Institute of Oncology (IEO); University of Milan	Pelosi, E (corresponding author), Ist Super Sanita, Dept Haematol Oncol & Mol Med, Viale Regina Elena 299, I-00161 Rome, Italy.	elvira.pelosi@iss.it; tripodi@bce.uniroma1.it	pelosi, elvira/J-7298-2016; Alcalay, Myriam/AAB-4300-2019; De Santis Puzzonia, Marco/J-3611-2016; bordoni, veronica/K-8614-2016; Tripodi, Marco/ABO-1160-2022; Testa, Ugo/J-6472-2016; Conigliaro, Alice/J-8717-2016; Biffoni, Mauro/J-8318-2016; Tripodi, Marco/F-1143-2011; bertolini, francesco/AAC-9780-2019; Conigliaro, Alice/L-5590-2019; Alcalay, Myriam/B-3182-2016; castelli, germana/J-7244-2016	pelosi, elvira/0000-0002-3043-6249; Alcalay, Myriam/0000-0002-5558-4272; bordoni, veronica/0000-0002-1747-2245; Tripodi, Marco/0000-0001-6135-971X; Testa, Ugo/0000-0001-7900-8942; Conigliaro, Alice/0000-0002-3037-835X; Biffoni, Mauro/0000-0002-1304-9060; Tripodi, Marco/0000-0001-6135-971X; bertolini, francesco/0000-0001-5660-3255; Conigliaro, Alice/0000-0002-3037-835X; Alcalay, Myriam/0000-0002-5558-4272; Amicone, Laura/0000-0002-3487-5740; De Santis Puzzonia, Marco/0000-0001-5691-1733; castelli, germana/0000-0002-3593-1230	Ministero della Salute (The Italian Ministry of Health), Rome, Italy [RF2006-411189]; Associazione Italiana per la Ricerca sul Cancro (AIRC) (The Italian Association for Cancer Research), Milan, Italy; MIUR, Ministero Universita e Ricerca Scientifica (The Ministry of Education, University and Research), Tavola Valdese OPM	Ministero della Salute (The Italian Ministry of Health), Rome, Italy; Associazione Italiana per la Ricerca sul Cancro (AIRC) (The Italian Association for Cancer Research), Milan, Italy(Fondazione AIRC per la ricerca sul cancro); MIUR, Ministero Universita e Ricerca Scientifica (The Ministry of Education, University and Research), Tavola Valdese OPM(Ministry of Education, Universities and Research (MIUR))	Funding: Ministero della Salute (The Italian Ministry of Health), Rome, Italy (RF2006-411189); Associazione Italiana per la Ricerca sul Cancro (AIRC) (The Italian Association for Cancer Research), Milan, Italy; MIUR, Ministero Universita e Ricerca Scientifica (The Ministry of Education, University and Research), Tavola Valdese OPM., Regione Lazio Italy. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aiuti A, 1998, HEPATOLOGY, V28, P1645, DOI 10.1002/hep.510280626; Baker CD, 2009, AM J RESP CRIT CARE, V180, P454, DOI 10.1164/rccm.200901-0115OC; Bertrand JY, 2010, NATURE, V464, P108, DOI 10.1038/nature08738; Boisset JC, 2010, NATURE, V464, P116, DOI 10.1038/nature08764; Bordoni V, 2004, HEPATOLOGY, V39, P1508, DOI 10.1002/hep.20234; Bordoni V, 2007, HEPATOLOGY, V45, P1218, DOI 10.1002/hep.21568; Chen MJ, 2009, NATURE, V457, P887, DOI 10.1038/nature07619; Choi JH, 2009, LIFE SCI, V85, P39, DOI 10.1016/j.lfs.2009.04.008; Choi K, 1998, DEVELOPMENT, V125, P725; Cumano A, 2007, ANNU REV IMMUNOL, V25, P745, DOI 10.1146/annurev.immunol.25.022106.141538; Dieterlen-Lievre F, 2009, CELL STEM CELL, V4, P189, DOI 10.1016/j.stem.2009.02.006; Eichmann A, 1997, P NATL ACAD SCI USA, V94, P5141, DOI 10.1073/pnas.94.10.5141; Eilken HM, 2009, NATURE, V457, P896, DOI 10.1038/nature07760; Fehling HJ, 2003, DEVELOPMENT, V130, P4217, DOI 10.1242/dev.00589; Haase A, 2009, CELL STEM CELL, V5, P434, DOI 10.1016/j.stem.2009.08.021; Ingram DA, 2004, BLOOD, V104, P2752, DOI 10.1182/blood-2004-04-1396; Kinder SJ, 1999, DEVELOPMENT, V126, P4691; Kissa K, 2010, NATURE, V464, P112, DOI 10.1038/nature08761; Lancrin C, 2009, NATURE, V457, P892, DOI 10.1038/nature07679; Liu ZJ, 2011, BLOOD, V117, P4106, DOI 10.1182/blood-2010-07-293092; MAHESHWARI RK, 1991, J CELL PHYSIOL, V146, P164, DOI 10.1002/jcp.1041460121; Nishikawa S, 1998, DEVELOPMENT, V125, P1747; Nishikawa S, 1998, IMMUNITY, V8, P761, DOI 10.1016/S1074-7613(00)80581-6; Pelosi E, 2002, BLOOD, V100, P3203, DOI 10.1182/blood-2002-05-1511; Rhodes KE, 2008, CELL STEM CELL, V2, P252, DOI 10.1016/j.stem.2008.01.001; Robb L, 1998, BIOESSAYS, V20, P611, DOI 10.1002/(SICI)1521-1878(199808)20:8<611::AID-BIES3>3.0.CO;2-L; Vogeli KM, 2006, NATURE, V443, P337, DOI 10.1038/nature05045; Wu X, 2007, STEM CELLS, V25, P2770, DOI 10.1634/stemcells.2006-0783; Xiong JW, 2008, DEV DYNAM, V237, P1218, DOI 10.1002/dvdy.21542; Yoder MC, 2009, J THROMB HAEMOST, V7, P49, DOI 10.1111/j.1538-7836.2009.03407.x; Yokomizo T, 2001, GENES CELLS, V6, P13, DOI 10.1046/j.1365-2443.2001.00393.x; Zovein AC, 2008, CELL STEM CELL, V3, P625, DOI 10.1016/j.stem.2008.09.018	32	17	19	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 4	2012	7	12							e51109	10.1371/journal.pone.0051109	http://dx.doi.org/10.1371/journal.pone.0051109			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	051EQ	23226561	gold, Green Published, Green Submitted			2022-12-27	WOS:000312108500044
J	Puga-Freitas, R; Barot, S; Taconnat, L; Renou, JP; Blouin, M				Puga-Freitas, Ruben; Barot, Sebastien; Taconnat, Ludivine; Renou, Jean-Pierre; Blouin, Manuel			Signal Molecules Mediate the Impact of the Earthworm Aporrectodea caliginosa on Growth, Development and Defence of the Plant Arabidopsis thaliana	PLOS ONE			English	Article							SYSTEMIC ACQUIRED-RESISTANCE; PROMOTING RHIZOBACTERIA; AUXIN; EXPRESSION; ETHYLENE; TRANSCRIPTOME; EMERGENCE; PATHOGEN; MUTANTS; BIOMASS	Earthworms have generally a positive impact on plant growth, which is often attributed to a trophic mechanism: namely, earthworms increase the release of mineral nutrients from soil litter and organic matter. An alternative hypothesis has been proposed since the discovery of a signal molecule (Indole Acetic Acid) in earthworm faeces. In this study, we used methodologies developed in plant science to gain information on ecological mechanisms involved in plant-earthworm interaction, by looking at plant response to earthworm presence at a molecular level. First, we looked at plant overall response to earthworm faeces in an in vitro device where only signal molecules could have an effect on plant growth; we observed that earthworms were inducing positive or negative effects on different plant species. Then, using an Arabidopsis thaliana mutant with an impaired auxin transport, we demonstrated the potential of earthworms to stimulate root growth and to revert the dwarf mutant phenotype. Finally, we performed a comparative transcriptomic analysis of Arabidopsis thaliana in the presence and absence of earthworms; we found that genes modulated in the presence of earthworms are known to respond to biotic and abiotic stresses, or to the application of exogenous hormones. A comparison of our results with other studies found in databases revealed strong analogies with systemic resistance, induced by signal molecules emitted by Plant Growth Promoting Rhizobacteria and/or elicitors emitted by non-virulent pathogens. Signal molecules such as auxin and ethylene, which are considered as major in plant-microorganisms interactions, can also be of prior importance to explain plant-macroinvertebrates interactions. This could imply revisiting ecological theories which generally stress on the role of trophic relationships.	[Puga-Freitas, Ruben; Blouin, Manuel] Univ Paris Est Creteil, UMR Biogeochim & Ecol Milieux Continentaux, Creteil, France; [Barot, Sebastien] Ecole Normale Super, Inst Rech Dev, UMR Biogeochim & Ecol Milieux Continentaux, F-75231 Paris, France; [Taconnat, Ludivine; Renou, Jean-Pierre] CNRS, INRA, Unite Rech Genom Vegetale, Evry, France	UDICE-French Research Universities; Sorbonne Universite; Universite Paris-Est-Creteil-Val-de-Marne (UPEC); Institut de Recherche pour le Developpement (IRD); UDICE-French Research Universities; PSL Research University Paris; Ecole Normale Superieure (ENS); Sorbonne Universite; Centre National de la Recherche Scientifique (CNRS); INRAE; UDICE-French Research Universities; Universite Paris Saclay	Blouin, M (corresponding author), Univ Paris Est Creteil, UMR Biogeochim & Ecol Milieux Continentaux, Creteil, France.	blouin@u-pec.fr	Blouin, Manuel/K-6013-2019; barot, sébastien/A-8447-2012	Blouin, Manuel/0000-0002-3928-9070; barot, sébastien/0000-0002-5910-538X	Faculte des Sciences et Technologies of Paris-Est Creteil university	Faculte des Sciences et Technologies of Paris-Est Creteil university	The authors thank the Faculte des Sciences et Technologies of Paris-Est Creteil university for financial support. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2010, PLANT PHYSL 5 EDITIO; Arancon NQ, 2003, PEDOBIOLOGIA, V47, P731; Barazani O, 1999, J CHEM ECOL, V25, P2397, DOI 10.1023/A:1020890311499; BARTEL B, 1994, P NATL ACAD SCI USA, V91, P6649, DOI 10.1073/pnas.91.14.6649; Bashan Y, 1998, SOIL BIOL BIOCHEM, V30, P1225, DOI 10.1016/S0038-0717(97)00187-9; Benjamins R, 2003, PLANT PHYSIOL, V132, P1623, DOI 10.1104/pp.103.019943; Blouin M, 2006, SOIL BIOL BIOCHEM, V38, P2063, DOI 10.1016/j.soilbio.2005.12.023; Blouin M, 2005, ECOL LETT, V8, P202, DOI 10.1111/j.1461-0248.2004.00711.x; Bonkowski M, 2004, NEW PHYTOL, V162, P617, DOI 10.1111/j.1469-8137.2004.01066.x; Boyes DC, 2001, PLANT CELL, V13, P1499, DOI 10.1105/tpc.13.7.1499; BROEKAERT WF, 1989, SCIENCE, V245, P1100, DOI 10.1126/science.245.4922.1100; Brown George G., 2004, P13; Brown GG, 1999, EARTHWORM MANAGEMENT IN TROPICAL AGROECOSYSTEMS, P87; Busam G, 1997, PLANT PHYSIOL, V115, P1039, DOI 10.1104/pp.115.3.1039; Canellas LP, 2002, PLANT PHYSIOL, V130, P1951, DOI 10.1104/pp.007088; Cartieaux F, 2003, PLANT J, V36, P177, DOI 10.1046/j.1365-313X.2003.01867.x; Crowe ML, 2003, NUCLEIC ACIDS RES, V31, P156, DOI 10.1093/nar/gkg071; Dharmasiri S, 2006, SCIENCE, V312, P1218, DOI 10.1126/science.1122847; Elmer WH, 2009, PLANT DIS, V93, P175, DOI 10.1094/PDIS-93-2-0175; Endlweber K, 2011, SOIL BIOL BIOCHEM, V43, P1130, DOI 10.1016/j.soilbio.2010.11.013; Frankenberger W. T., 1995, PHYTOHORMONES SOILS; Heil M, 1999, J ECOL, V87, P341, DOI 10.1046/j.1365-2745.1999.00359.x; Himmelbauer ML, 2004, PLANT SOIL, V260, P111, DOI 10.1023/B:PLSO.0000030171.28821.55; HOBBIE L, 1995, PLANT J, V7, P211, DOI 10.1046/j.1365-313X.1995.7020211.x; Hobbie LJ, 2006, TRENDS PLANT SCI, V11, P517, DOI 10.1016/j.tplants.2006.09.003; Jana U, 2010, SOIL BIOL BIOCHEM, V42, P244, DOI 10.1016/j.soilbio.2009.10.022; Laossi KR, 2010, PLANT SOIL, V328, P109, DOI 10.1007/s11104-009-0086-y; Lavelle P., 2001, SOIL ECOLOGY; Muday GK, 2012, TRENDS PLANT SCI, V17, P181, DOI 10.1016/j.tplants.2012.02.001; MURASHIGE T, 1962, PHYSIOL PLANTARUM, V15, P473, DOI 10.1111/j.1399-3054.1962.tb08052.x; Muscolo A, 1999, SOIL BIOL BIOCHEM, V31, P1303, DOI 10.1016/S0038-0717(99)00049-8; Muscolo A, 1998, SOIL BIOL BIOCHEM, V30, P1199, DOI 10.1016/S0038-0717(98)00005-4; Nardi S, 2002, SOIL BIOL BIOCHEM, V34, P1527, DOI 10.1016/S0038-0717(02)00174-8; Nehl DB, 1997, APPL SOIL ECOL, V5, P1, DOI 10.1016/S0929-1393(96)00124-2; Noguera D, 2011, ECOL APPL, V21, P2349, DOI 10.1890/10-2204.1; Peng XJ, 2003, BMC BIOINFORMATICS, V4, DOI 10.1186/1471-2105-4-26; Persello-Cartieaux F, 2003, PLANT CELL ENVIRON, V26, P189, DOI 10.1046/j.1365-3040.2003.00956.x; PICKETT FB, 1990, PLANT PHYSIOL, V94, P1462, DOI 10.1104/pp.94.3.1462; Ping LY, 2004, TRENDS PLANT SCI, V9, P263, DOI 10.1016/j.tplants.2004.04.008; Puga-Freitas R, 2012, APPL ENV SOIL SCI, V2012, P4; Scheu S, 2003, PEDOBIOLOGIA, V47, P846, DOI 10.1016/s0031-4056(04)70279-6; Segarra S, 2010, PLANT CELL ENVIRON, V33, P11, DOI 10.1111/j.1365-3040.2009.02045.x; Sels J, 2008, PLANT PHYSIOL BIOCH, V46, P941, DOI 10.1016/j.plaphy.2008.06.011; Stepanova AN, 2007, PLANT CELL, V19, P2169, DOI 10.1105/tpc.107.052068; Swarup R, 2004, PLANT CELL, V16, P3069, DOI 10.1105/tpc.104.024737; Truman WM, 2010, PLANT PHYSIOL, V152, P1562, DOI 10.1104/pp.109.152173; Varet A, 2003, PLANT PHYSIOL, V132, P2023, DOI 10.1104/pp.103.020438; Verhagen BWM, 2004, MOL PLANT MICROBE IN, V17, P895, DOI 10.1094/MPMI.2004.17.8.895; Wang YQ, 2005, MOL PLANT MICROBE IN, V18, P385, DOI 10.1094/MPMI-18-0385; Wurst S, 2010, APPL SOIL ECOL, V45, P123, DOI 10.1016/j.apsoil.2010.04.005; Xu XP, 2006, PLANT CELL, V18, P1310, DOI 10.1105/tpc.105.037523; Zaller JG, 2007, EUR J SOIL BIOL, V43, pS332, DOI 10.1016/j.ejsobi.2007.08.020; Zheng ZY, 2006, PLANT J, V48, P592, DOI 10.1111/j.1365-313X.2006.02901.x	53	43	47	4	82	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 3	2012	7	12							e49504	10.1371/journal.pone.0049504	http://dx.doi.org/10.1371/journal.pone.0049504			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	051DH	23226498	Green Published, gold			2022-12-27	WOS:000312104700007
J	Bornsen, L; Christensen, JR; Ratzer, R; Oturai, AB; Sorensen, PS; Sondergaard, HB; Sellebjerg, F				Bornsen, Lars; Christensen, Jeppe Romme; Ratzer, Rikke; Oturai, Annette Bang; Sorensen, Per Soelberg; Sondergaard, Helle Bach; Sellebjerg, Finn			Effect of Natalizumab on Circulating CD4(+) T-Cells in Multiple Sclerosis	PLOS ONE			English	Article							DISEASE-ACTIVITY; TYROSINE PHOSPHORYLATION; FINGOLIMOD FTY720; REGULATORY CELLS; GENE-EXPRESSION; B-CELLS; VLA-4; ACTIVATION; COSTIMULATION; FIBRONECTIN	In multiple sclerosis (MS), treatment with the monoclonal antibody natalizumab effectively reduces the formation of acute lesions in the central nervous system (CNS). Natalizumab binds the integrin very late antigen (VLA)-4, expressed on the surface of immune cells, and inhibits VLA-4 dependent transmigration of circulating immune-cells across the vascular endothelium into the CNS. Recent studies suggested that natalizumab treated MS patients have an increased T-cell pool in the blood compartment which may be selectively enriched in activated T-cells. Proposed causes are sequestration of activated T-cells due to reduced extravasation of activated and pro-inflammatory T-cells or due to induction of VLA-4 mediated co-stimulatory signals by natalizumab. In this study we examined how natalizumab treatment altered the distribution of effector and memory T-cell subsets in the blood compartment and if T-cells in general or myelin-reactive T-cells in particular showed signs of increased immune activation. Furthermore we examined the effects of natalizumab on CD4(+) T-cell responses to myelin in vitro. Natalizumab-treated MS patients had significantly increased numbers of effector-memory T-cells in the blood. In T-cells from natalizumab-treated MS patients, the expression of TNF-alpha mRNA was increased whereas the expression of fourteen other effector cytokines or transcription factors was unchanged. Natalizumab-treated MS patients had significantly decreased expression of the co-stimulatory molecule CD134 on CD4(+) CD26(HIGH) T-cells, in blood, and natalizumab decreased the expression of CD134 on MBP-reactive CD26(HIGH) CD4(+) T-cells in vitro. Otherwise CD4(+) T-cells from natalizumab-treated and untreated MS patients showed similar responses to MBP. In conclusion natalizumab treatment selectively increased the effector memory T-cell pool but not the activation state of T-cells in the blood compartment. Myelin-reactive T-cells were not selectively increased in natalizumab treated MS.	[Bornsen, Lars; Christensen, Jeppe Romme; Ratzer, Rikke; Oturai, Annette Bang; Sorensen, Per Soelberg; Sondergaard, Helle Bach; Sellebjerg, Finn] Rigshosp, Dept Neurol, Copenhagen Univ Hosp, Danish Multiple Sclerosis Ctr, DK-2100 Copenhagen, Denmark	Rigshospitalet; University of Copenhagen	Bornsen, L (corresponding author), Rigshosp, Dept Neurol, Copenhagen Univ Hosp, Danish Multiple Sclerosis Ctr, DK-2100 Copenhagen, Denmark.	boernsen@gmail.com		Romme Christensen, Jeppe/0000-0002-7727-3467; Sondergaard, Helle Bach/0000-0001-9435-0658; Sellebjerg, Finn/0000-0002-1333-9623; Sorensen, Per Soelberg/0000-0002-2818-3780	Danish Multiple Sclerosis Society; Warwara Larsen Foundation; Johnsen Foundation; Danish Council for Independent Research [271-06-0246]; Danish Council for Strategic Research [2142-08-0039]; Biogen Idec; Merck Serono; Novartis; Genmab; TEVA; Elan; Bayer Schering; Baxter; Sanofi-Aventis; BioMS; Bayer; RoFAR; Roche; Genzyme; Danish Medical Research Council [271-06-0246]; European Union Sixth Framework Programme: Life sciences, Genomics and Biotechnology for Health; Danish Strategic Research Council [2142-08-0039]; Lounkaer Foundation; Danish MS Society	Danish Multiple Sclerosis Society; Warwara Larsen Foundation; Johnsen Foundation; Danish Council for Independent Research(Det Frie Forskningsrad (DFF)); Danish Council for Strategic Research(Danske Strategiske Forskningsrad (DSF)); Biogen Idec(Biogen); Merck Serono(Merck & Company); Novartis(Novartis); Genmab(Genmab); TEVA(Teva Pharmaceutical Industries); Elan; Bayer Schering(Bayer AG); Baxter; Sanofi-Aventis(Sanofi-Aventis); BioMS; Bayer(Bayer AG); RoFAR; Roche(Roche Holding); Genzyme(Sanofi-AventisGenzyme Corporation); Danish Medical Research Council(Danish Medical Research CouncilUK Research & Innovation (UKRI)Medical Research Council UK (MRC)); European Union Sixth Framework Programme: Life sciences, Genomics and Biotechnology for Health; Danish Strategic Research Council(Danske Strategiske Forskningsrad (DSF)); Lounkaer Foundation; Danish MS Society	This study was supported by grants from the Danish Multiple Sclerosis Society, the Warwara Larsen Foundation, the Johnsen Foundation, the Danish Council for Independent Research (grant 271-06-0246) and the Danish Council for Strategic Research (grant 2142-08-0039). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors have read the journal's policy and report the following conflicts: Lars Bornsen reports no disclosures. Jeppe Romme Christensen has received honoraria for lecturing from Biogen-Idec. Rikke Ratzer reports no disclosures. Helle B. Sondergaard reports no disclosures. Annette Bang Oturai has served on scientific advisory boards for Novartis, has received speaker honoraria from Biogen Idec, Merck Serono, and Novartis; and has received research support from the Danish Multiple Sclerosis Society, the Warwara Larsen Foundation and the Johnsen Foundation. Per Soelberg Sorensen has served on scientific advisory boards for and received funding of travel for these activities from Biogen Idec, Merck Serono, Novartis, Genmab, TEVA, Elan; has served as Editor-in-Chief of the European Journal of Neurology, and as an editorial board member for Therapeutic Advances in Neurological Disorders and Multiple Sclerosis; receives speaker honoraria from Biogen Idec, Merck Serono, TEVA, Bayer Schering, Sanofi-aventis, and Novartis; and has received research support from Biogen Idec, Bayer Schering, Merck Serono, TEVA, Baxter, Sanofi-Aventis, BioMS, Novartis, Bayer, RoFAR, Roche, Genzyme, and from the Danish Multiple Sclerosis Society, the Danish Medical Research Council, and the European Union Sixth Framework Programme: Life sciences, Genomics and Biotechnology for Health. Finn Sellebjerg has served on scientific advisory boards for Biogen Idec, Merck Serono, Novartis, Sanofi-Aventis and Teva; has received funding for travel from Sanofi-Aventis and Teva; has served as a consultant for Novo Nordisk; has received speaker honoraria from Bayer-Schering, Biogen Idec, Merck-Serono, Sanofi-Aventis, Schering-Ploug; and has received research support from Biogen Idec and Sanofi-Aventis, from the Danish Medical Research Council (#271-06-0246), the Danish Strategic Research Council (#2142-08-0039); the Lounkaer Foundation, the Danish MS Society, the Johnsen Foundation, and the Warwara Larsen Foundation. This does not alter the authors' adherence to all the PLOS ONE policies on sharing data and materials.	Amyes E, 2003, J EXP MED, V198, P903, DOI 10.1084/jem.20022058; Annibali V, 2011, BRAIN, V134, P542, DOI 10.1093/brain/awq354; Brinkmann V, 2010, NAT REV DRUG DISCOV, V9, P883, DOI 10.1038/nrd3248; Croft M, 2010, ANNU REV IMMUNOL, V28, P57, DOI 10.1146/annurev-immunol-030409-101243; DAVIS LS, 1990, J IMMUNOL, V145, P785; ENNIS E, 1993, J EXP MED, V177, P207, DOI 10.1084/jem.177.1.207; Frisullo G, 2011, MULT SCLER J, V17, P556, DOI 10.1177/1352458510392263; Hafler DA, 2007, NEW ENGL J MED, V357, P851, DOI 10.1056/NEJMoa073493; Ibegbu CC, 2009, IMMUNOLOGY, V126, P346, DOI 10.1111/j.1365-2567.2008.02899.x; Jensen J, 2006, J NEUROIMMUNOL, V179, P163, DOI 10.1016/j.jneuroim.2006.06.024; Jensen J, 2004, J NEUROIMMUNOL, V149, P202, DOI 10.1016/j.jneuroim.2003.12.019; Khademi M, 2008, EUR J NEUROL, V15, P309, DOI 10.1111/j.1468-1331.2007.02037.x; Khademi M, 2009, EUR J NEUROL, V16, P528, DOI 10.1111/j.1468-1331.2009.02532.x; Khoury SJ, 2000, ARCH NEUROL-CHICAGO, V57, P1183, DOI 10.1001/archneur.57.8.1183; Kivisakk P, 2004, ANN NEUROL, V55, P627, DOI 10.1002/ana.20049; Kivisakk P, 2009, NEUROLOGY, V72, P1922, DOI 10.1212/WNL.0b013e3181a8266f; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Maggi L, 2010, EUR J IMMUNOL, V40, P2174, DOI 10.1002/eji.200940257; Mehling M, 2011, NEUROLOGY, V76, pS20, DOI 10.1212/WNL.0b013e31820db341; Mehling M, 2010, NEUROLOGY, V75, P403, DOI 10.1212/WNL.0b013e3181ebdd64; Morimoto C, 1998, IMMUNOL REV, V161, P55, DOI 10.1111/j.1600-065X.1998.tb01571.x; Niino M, 2006, ANN NEUROL, V59, P748, DOI 10.1002/ana.20859; NOJIMA Y, 1992, J EXP MED, V175, P1045, DOI 10.1084/jem.175.4.1045; NOJIMA Y, 1990, J EXP MED, V172, P1185, DOI 10.1084/jem.172.4.1185; Polman CH, 2006, NEW ENGL J MED, V354, P899, DOI 10.1056/NEJMoa044397; Putzki N, 2010, EUR NEUROL, V63, P311, DOI 10.1159/000302687; Ramos-Cejudo J, 2011, J CLIN IMMUNOL, V31, P623, DOI 10.1007/s10875-011-9522-x; Reinhold D, 1998, J NEUROIMMUNOL, V87, P203, DOI 10.1016/S0165-5728(98)00100-3; Roederer M, 2001, CYTOMETRY, V45, P194, DOI 10.1002/1097-0320(20011101)45:3<194::AID-CYTO1163>3.0.CO;2-C; Rogers PR, 2001, IMMUNITY, V15, P445, DOI 10.1016/S1074-7613(01)00191-1; Rosen DB, 2008, J IMMUNOL, V180, P6508, DOI 10.4049/jimmunol.180.10.6508; Rufer N, 2003, BLOOD, V102, P1779, DOI 10.1182/blood-2003-02-0420; SATO T, 1995, J IMMUNOL, V155, P2938; Sellebjerg F, 2005, MULT SCLER J, V11, P641, DOI 10.1191/1352458505ms1217oa; Sellebjerg F, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035927; SHIMIZU Y, 1990, IMMUNOL REV, V114, P109, DOI 10.1111/j.1600-065X.1990.tb00563.x; Skarica M, 2011, J NEUROIMMUNOL, V235, P70, DOI 10.1016/j.jneuroim.2011.02.010; Sondergaard HB, 2011, EUR J HUM GENET, V19, P1100, DOI 10.1038/ejhg.2011.88; Stenner MP, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003319; Stuve O, 2007, CNS DRUG REV, V13, P79, DOI 10.1111/j.1527-3458.2007.00003.x; Stuve O, 2006, ANN NEUROL, V59, P743, DOI 10.1002/ana.20858	41	46	48	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 30	2012	7	11							e47578	10.1371/journal.pone.0047578	http://dx.doi.org/10.1371/journal.pone.0047578			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	054WM	23226199	Green Submitted, Green Published, gold			2022-12-27	WOS:000312376100007
J	Brymora, A; Duggin, IG; Berven, LA; van Dam, EM; Roufogalis, BD; Robinson, PJ				Brymora, Adam; Duggin, Iain G.; Berven, Leise A.; van Dam, Ellen M.; Roufogalis, Basil D.; Robinson, Phillip J.			Identification and Characterisation of the RalA-ERp57 Interaction: Evidence for GDI Activity of ERp57	PLOS ONE			English	Article							DISSOCIATION INHIBITOR GDI; NUCLEOTIDE EXCHANGE FACTOR; GTPASE-ACTIVATING PROTEIN; RAB ESCORT PROTEIN; CRYSTAL-STRUCTURE; FILOPODIA FORMATION; MULTIPLE FUNCTIONS; MAMMALIAN-CELLS; BINDING PROTEIN; PC12 CELLS	RalA is a membrane-associated small GTPase that regulates vesicle trafficking. Here we identify a specific interaction between RalA and ERp57, an oxidoreductase and signalling protein. ERp57 bound specifically to the GDP-bound form of RalA, but not the GTP-bound form, and inhibited the dissociation of GDP from RalA in vitro. These activities were inhibited by reducing agents, but no disulphide bonds were detected between RalA and ERp57. Mutation of all four of ERp57's active site cysteine residues blocked sensitivity to reducing agents, suggesting that redox-dependent conformational changes in ERp57 affect binding to RalA. Mutations in the switch II region of the GTPase domain of RalA specifically reduced or abolished binding to ERp57, but did not block GTP-specific binding to known RalA effectors, the exocyst and RalBP1. Oxidative treatment of A431 cells with H2O2 inhibited cellular RalA activity, and the effect was exacerbated by expression of recombinant ERp57. The oxidative treatment significantly increased the amount of RalA localised to the cytosol. These findings suggest that ERp57 regulates RalA signalling by acting as a redox-sensitive guanine-nucleotide dissociation inhibitor (RalGDI).	[Brymora, Adam; Berven, Leise A.; van Dam, Ellen M.; Robinson, Phillip J.] Univ Sydney, Childrens Med Res Inst, Cell Signalling Unit, Sydney, NSW 2006, Australia; [Duggin, Iain G.; Roufogalis, Basil D.] Univ Sydney, Fac Pharm, Sydney, NSW 2006, Australia	Children's Medical Research Institute - Australia; University of Sydney; University of Sydney	Robinson, PJ (corresponding author), Univ Sydney, Childrens Med Res Inst, Cell Signalling Unit, Sydney, NSW 2006, Australia.	probinson@cmri.org.au	Robinson, Phillip J/G-4008-2011; Duggin, Iain/B-3904-2011	Robinson, Phillip J/0000-0002-7878-0313; Duggin, Iain/0000-0003-4868-7350; Roufogalis, Basil/0000-0001-9123-5478	Australian National Health and Medical Research Council (NHMRC)	Australian National Health and Medical Research Council (NHMRC)(National Health and Medical Research Council (NHMRC) of Australia)	This work was supported by grants from the Australian National Health and Medical Research Council (NHMRC). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adra CN, 1997, P NATL ACAD SCI USA, V94, P4279, DOI 10.1073/pnas.94.9.4279; Apperizeller-Herzog C, 2008, BBA-MOL CELL RES, V1783, P535, DOI 10.1016/j.bbamcr.2007.11.010; Bae YS, 1997, J BIOL CHEM, V272, P217, DOI 10.1074/jbc.272.1.217; Bhullar RP, 1996, BBA-MOL CELL RES, V1311, P181, DOI 10.1016/0167-4889(96)00002-X; Bodemann BO, 2008, NAT REV CANCER, V8, P133, DOI 10.1038/nrc2296; Bodemann BO, 2011, CELL, V144, P253, DOI 10.1016/j.cell.2010.12.018; Bos JL, 2007, CELL, V129, P865, DOI 10.1016/j.cell.2007.05.018; Boulter Etienne, 2010, Small GTPases, V1, P65; Brymora A, 2001, J BIOL CHEM, V276, P29792, DOI 10.1074/jbc.C100320200; Brymora A, 2001, ANAL BIOCHEM, V295, P119, DOI 10.1006/abio.2001.5215; Cascone I, 2008, EMBO J, V27, P2375, DOI 10.1038/emboj.2008.166; Ceriani M, 2007, EXP CELL RES, V313, P2293, DOI 10.1016/j.yexcr.2007.03.016; Chandra A, 2012, NAT CELL BIOL, V14, P148, DOI 10.1038/ncb2394; Chinni SR, 1998, EXP CELL RES, V242, P373, DOI 10.1006/excr.1998.4105; Coe H, 2010, INT J BIOCHEM CELL B, V42, P796, DOI 10.1016/j.biocel.2010.01.009; Csepanyi-Komi R, 2011, MOL CELL ENDOCRINOL; Cuddihy SL, 2011, ANTIOXID REDOX SIGN, V15, P167, DOI 10.1089/ars.2010.3843; Dong G, 2009, IMMUNITY, V30, P21, DOI 10.1016/j.immuni.2008.10.018; Dovas A, 2005, BIOCHEM J, V390, P1, DOI 10.1042/BJ20050104; Ellerman DA, 2006, DEV CELL, V10, P831, DOI 10.1016/j.devcel.2006.03.011; EMKEY R, 1991, J BIOL CHEM, V266, P9703; FABRICANT RN, 1977, P NATL ACAD SCI USA, V74, P565, DOI 10.1073/pnas.74.2.565; Feig LA, 2003, TRENDS CELL BIOL, V13, P419, DOI 10.1016/S0962-8924(03)00152-1; Ferro E, 2010, CELL SIGNAL, V22, P1804, DOI 10.1016/j.cellsig.2010.05.010; Forman HJ, 2002, MOL CELL BIOCHEM, V234, P49, DOI 10.1023/A:1015913229650; Fukai S, 2003, EMBO J, V22, P3267, DOI 10.1093/emboj/cdg329; Gandhi PN, 2004, BIOCHEM J, V378, P409, DOI 10.1042/BJ20030979; Gibson RM, 2001, BIOCHEM J, V359, P285, DOI 10.1042/0264-6021:3590285; Goi T, 1999, MOL CELL BIOL, V19, P1731; Goody RS, 2005, CELL MOL LIFE SCI, V62, P1657, DOI 10.1007/s00018-005-4486-8; Grillo C, 2007, J BIOL CHEM, V282, P10299, DOI 10.1074/jbc.M700966200; Grizot S, 2001, BIOCHEMISTRY-US, V40, P10007, DOI 10.1021/bi010288k; Hoffman GR, 2000, CELL, V100, P345, DOI 10.1016/S0092-8674(00)80670-4; Ismail SA, 2011, NAT CHEM BIOL, V7, P942, DOI [10.1038/nchembio.686, 10.1038/NCHEMBIO.686]; Johnson JL, 2009, J BIOL CHEM, V284, P23860, DOI 10.1074/jbc.M109.031815; Kashatus DF, 2011, NAT CELL BIOL, V13, P1108, DOI 10.1038/ncb2310; Khanal RC, 2007, CURR MED CHEM, V14, P1087, DOI 10.2174/092986707780362871; Kim JR, 2002, ARCH BIOCHEM BIOPHYS, V397, P414, DOI 10.1006/abbi.2001.2691; Kozlov G, 2006, STRUCTURE, V14, P1331, DOI 10.1016/j.str.2006.06.019; LEONARD D, 1992, J BIOL CHEM, V267, P22860; Lind C, 2002, ARCH BIOCHEM BIOPHYS, V406, P229, DOI 10.1016/S0003-9861(02)00468-X; Liu J, 2011, PROTOPLASMA; MALORNI W, 1995, CHEM-BIOL INTERACT, V96, P113, DOI 10.1016/0009-2797(94)03576-T; Moskalenko S, 2002, NAT CELL BIOL, V4, P66, DOI 10.1038/ncb728; Nicely NI, 2004, STRUCTURE, V12, P2025, DOI 10.1016/j.str.2004.08.011; Overmeyer JH, 1998, MOL BIOL CELL, V9, P223, DOI 10.1091/mbc.9.1.223; Overmeyer JH, 2001, J BIOL CHEM, V276, P20379, DOI 10.1074/jbc.M101511200; Pautsch A, 2005, EMBO J, V24, P3670, DOI 10.1038/sj.emboj.7600813; Peaper DR, 2005, EMBO J, V24, P3613, DOI 10.1038/sj.emboj.7600814; Ramirez-Rangel I, 2011, MOL CELL BIOL, V31, P1657, DOI 10.1128/MCB.00824-10; Rebhun JF, 2000, J BIOL CHEM, V275, P13406, DOI 10.1074/jbc.C000085200; Sugihara K, 2002, NAT CELL BIOL, V4, P73, DOI 10.1038/ncb720; Takai Y, 2001, PHYSIOL REV, V81, P153, DOI 10.1152/physrev.2001.81.1.153; Turano C, 2011, CELL MOL BIOL LETT, V16, P539, DOI 10.2478/s11658-011-0022-z; van Dam EM, 2006, INT J BIOCHEM CELL B, V38, P1841, DOI 10.1016/j.biocel.2006.04.006; Vetter IR, 2001, SCIENCE, V294, P1299, DOI 10.1126/science.1062023; Wang L, 2004, J BIOL CHEM, V279, P19875, DOI 10.1074/jbc.M400522200; Wang ZX, 2010, J BIOL CHEM, V285, P6186, DOI 10.1074/jbc.M109.072421; Wu YW, 2010, NAT CHEM BIOL, V6, P534, DOI [10.1038/NCHEMBIO.386, 10.1038/nchembio.386]; Wu YH, 2011, BLOOD; Yamashita T, 2003, NAT NEUROSCI, V6, P461, DOI 10.1038/nn1045	61	5	5	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 30	2012	7	11							e50879	10.1371/journal.pone.0050879	http://dx.doi.org/10.1371/journal.pone.0050879			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	054WM	23226417	Green Published, gold, Green Submitted			2022-12-27	WOS:000312376100228
J	Chan, RWY; Leung, CYH; Nicholls, JM; Peiris, JSM; Chan, MCW				Chan, Renee W. Y.; Leung, Connie Y. H.; Nicholls, John M.; Peiris, J. S. Malik; Chan, Michael C. W.			Proinflammatory Cytokine Response and Viral Replication in Mouse Bone Marrow Derived Macrophages Infected with Influenza H1N1 and H5N1 Viruses	PLOS ONE			English	Article							ALVEOLAR EPITHELIAL-CELLS; A VIRUS; CHEMOKINE PRODUCTION; ENDOTHELIAL-CELLS; MICE; GENE; PATHOGENESIS; INDUCTION; HUMANS; EXPRESSION	The pathogenesis of human influenza H5N1 virus infection remains poorly understood and controversial. Cytokine dysregulation in human infection has been hypothesized to contribute to disease severity. We developed in vitro cultures of mouse bone marrow derived macrophages (BMDM Phi) from C57BL/6N mouse to compare influenza A (H5N1 and H1N1) virus replication and pro-inflammatory cytokine and chemokine responses. While both H1N1 and H5N1 viruses infected the mouse bone marrow derived macrophages, only the H1N1 virus had showed evidence of productive viral replication from the infected cells. In comparison with human seasonal influenza H1N1 (A/HK/54/98) and mouse adapted influenza H1N1 (A/WSN/33) viruses, the highly pathogenic influenza H5N1 virus (A/HK/483/97) was a more potent inducer of the chemokine, CXCL 10 (IP-10), while there was not a clear differential TNF-alpha protein expression pattern. Although human influenza viruses rarely cause infection in mice without prior adaption, the use of in vitro cell cultures of primary mouse cells is of interest, especially given the availability of gene-defective (knock-out) mice for specific genes.	[Chan, Renee W. Y.; Leung, Connie Y. H.; Peiris, J. S. Malik; Chan, Michael C. W.] Univ Hong Kong, LKS Fac Med, Influenza Res Ctr, Pokfulam, Hong Kong, Peoples R China; [Chan, Renee W. Y.; Leung, Connie Y. H.; Peiris, J. S. Malik; Chan, Michael C. W.] Univ Hong Kong, LKS Fac Med, Sch Publ Hlth, Pokfulam, Hong Kong, Peoples R China; [Chan, Renee W. Y.; Nicholls, John M.] Univ Hong Kong, Queen Mary Hosp, Dept Pathol, Pokfulam, Hong Kong, Peoples R China; [Peiris, J. S. Malik] HKU Pasteur Res Ctr, Hong Kong, Hong Kong, Peoples R China	University of Hong Kong; University of Hong Kong; University of Hong Kong; University of Hong Kong	Peiris, JSM (corresponding author), Univ Hong Kong, LKS Fac Med, Influenza Res Ctr, Pokfulam, Hong Kong, Peoples R China.	malik@hku.hk; mchan@hkucc.hku.hk	Chan, Renee Wan Yi/AAA-6598-2020; Nicholls, John Malcolm/C-4375-2009	Chan, Renee Wan Yi/0000-0001-6485-0926; Nicholls, John Malcolm/0000-0001-7217-7444; Leung, Connie YH/0000-0003-1102-4684	AoE from the Area of Excellence Scheme of the University Grants Committee, Hong Kong SAR Government [AoE/M-12/06]	AoE from the Area of Excellence Scheme of the University Grants Committee, Hong Kong SAR Government	This work was supported by the AoE Funding (AoE/M-12/06) from the Area of Excellence Scheme of the University Grants Committee, Hong Kong SAR Government. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdel-Ghafar AN, 2008, NEW ENGL J MED, V358, P261, DOI 10.1056/NEJMra0707279; Akira S, 2000, BIOCHEM SOC T, V28, P551, DOI 10.1042/bst0280551; [Anonymous], WHO CUM NUMB CONF HU; Bussfeld D, 1998, CELL IMMUNOL, V186, P1, DOI 10.1006/cimm.1998.1295; Chan MCW, 2005, RESP RES, V6, DOI 10.1186/1465-9921-6-135; Chan MCW, 2009, RESP RES, V10, DOI 10.1186/1465-9921-10-102; Chan RWY, 2009, ANTIMICROB AGENTS CH, V53, P3935, DOI 10.1128/AAC.00389-09; Cheung CY, 2002, LANCET, V360, P1831, DOI 10.1016/S0140-6736(02)11772-7; Giulietti A, 2001, METHODS, V25, P386, DOI 10.1006/meth.2001.1261; HALLER O, 1980, NATURE, V283, P660, DOI 10.1038/283660a0; Hofmann P, 1997, J LEUKOCYTE BIOL, V61, P408, DOI 10.1002/jlb.61.4.408; HORISBERGER MA, 1983, P NATL ACAD SCI-BIOL, V80, P1910, DOI 10.1073/pnas.80.7.1910; HORISBERGER MA, 1980, J GEN VIROL, V50, P205, DOI 10.1099/0022-1317-50-1-205; Hui KPY, 2009, J IMMUNOL, V182, P1088, DOI 10.4049/jimmunol.182.2.1088; Karber G., 1931, ARCH EXP PATHOL PH, V162, P480, DOI DOI 10.1007/BF01863914; Kawakami K, 1999, CELL IMMUNOL, V193, P9, DOI 10.1006/cimm.1999.1460; Lee SMY, 2012, J LEUKOCYTE BIOL, V92, P1, DOI 10.1189/jlb.0312130; Lipatov AS, 2005, J GEN VIROL, V86, P1121, DOI 10.1099/vir.0.80663-0; Lu XH, 1999, J VIROL, V73, P5903, DOI 10.1128/JVI.73.7.5903-5911.1999; Mancardi S, 2003, IMMUNOLOGY, V108, P523, DOI 10.1046/j.1365-2567.2003.01613.x; Mok KP, 2009, J INFECT DIS, V200, P1104, DOI 10.1086/605606; NAIN M, 1990, J IMMUNOL, V145, P1921; OCHIAI H, 1992, J MED VIROL, V36, P217, DOI 10.1002/jmv.1890360312; Peiris JSM, 2007, CLIN MICROBIOL REV, V20, P243, DOI 10.1128/CMR.00037-06; SHAYEGANI M, 1974, INFECT IMMUN, V9, P991, DOI 10.1128/IAI.9.6.991-998.1974; Srivastava B, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004857; Szretter KJ, 2007, J VIROL, V81, P2736, DOI 10.1128/JVI.02336-06; Tumpey TM, 2000, J VIROL, V74, P6105, DOI 10.1128/JVI.74.13.6105-6116.2000; Wareing MD, 2004, J LEUKOCYTE BIOL, V76, P886, DOI 10.1189/jlb.1203644; Yu WCL, 2011, J VIROL, V85, P6844, DOI 10.1128/JVI.02200-10	31	14	14	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 30	2012	7	11							e51057	10.1371/journal.pone.0051057	http://dx.doi.org/10.1371/journal.pone.0051057			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	054WM	23226456	gold, Green Published, Green Submitted			2022-12-27	WOS:000312376100267
J	Dong, W; Yang, ZL; Yang, F; Wang, JL; Zhuang, Y; Xu, CR; Zhang, B; Tian, XL; Liu, D				Dong, Wei; Yang, Zhenglin; Yang, Fan; Wang, Jialiang; Zhuang, Yan; Xu, Chongren; Zhang, Bo; Tian, Xiao-Li; Liu, Dong			Suppression of Rap1 Impairs Cardiac Myofibrils and Conduction System in Zebrafish	PLOS ONE			English	Article							MEDIATED CELL-ADHESION; JUNCTION FORMATION; C-EPSILON; EPAC; PROTEIN; CAMP; ACTIVATION; MYOCYTES; HEART; RECEPTOR	Numerous studies have revealed that Rap1 (Ras-proximate-1 or Ras-related protein 1), a small GTPase protein, plays a crucial role in mediating cAMP signaling in isolated cardiac tissues and cell lines. However, the involvement of Rap1 in the cardiac development in vivo is largely unknown. By injecting anti-sense morpholino oligonucleotides to knock down Rap1a and Rap1b in zebrafish embryos, and in combination with time-lapsed imaging, in situ hybridization, immunohistochemistry and transmission electron microscope techniques, we seek to understand the role of Rap1 in cardiac development and functions. At an optimized low dose of mixed rap1a and rap1b morpholino oligonucleotides, the heart developed essentially normally until cardiac contraction occurred. Morphant hearts showed the myocardium defect phenotypes, most likely due to disrupted myofibril assembly and alignment. In vivo heart electrocardiography revealed prolonged P-R interval and QRS duration, consistent with an adherens junction defect and reduced Connexons in cardiac myocytes of morphants. We conclude that a proper level of Rap1 is crucial for heart morphogenesis and function, and suggest that Rap1 and/or their downstream factor genes are potential candidates for genetic screening for human heart diseases.	[Yang, Fan; Tian, Xiao-Li] Peking Univ, Inst Mol Med, Beijing 100871, Peoples R China; [Dong, Wei; Yang, Zhenglin; Wang, Jialiang; Xu, Chongren; Liu, Dong] Peking Univ, Sch Life Sci, Beijing 100871, Peoples R China; [Dong, Wei; Yang, Zhenglin; Wang, Jialiang; Zhuang, Yan; Zhang, Bo; Liu, Dong] Peking Univ, State Key Lab Biomembrane & Membrane Biotechnol, Beijing 100871, Peoples R China	Peking University; Peking University; Peking University	Tian, XL (corresponding author), Peking Univ, Inst Mol Med, Beijing 100871, Peoples R China.	tianxiaoli@pku.edu.cn; doliu@pku.edu.cn	Yang, Zhenglin/ABP-2541-2022	Yang, Zhenglin/0000-0003-2743-5779	Chinese Ministry of Science and Technology [2012CB944503, 2007CB512100, 2012CB945101]	Chinese Ministry of Science and Technology(Ministry of Science and Technology, China)	This study was supported by grants from the National Basic Research Program of the Chinese Ministry of Science and Technology [973 Grant 2012CB944503 (to DL), 2007CB512100 (to XT) and 2012CB945101 (to BZ)]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexander J, 1998, DEV GENET, V22, P288, DOI 10.1002/(SICI)1520-6408(1998)22:3<288::AID-DVG10>3.3.CO;2-T; Bakkers J, 2011, CARDIOVASC RES, V91, P279, DOI 10.1093/cvr/cvr098; Bos JL, 2003, BIOCHEM SOC T, V31, P83, DOI 10.1042/bst0310083; Bos JL, 2001, NAT REV MOL CELL BIO, V2, P369, DOI 10.1038/35073073; Carmona G, 2008, BLOOD, V111, P2640, DOI 10.1182/blood-2007-04-086231; Cazorla O, 2009, P NATL ACAD SCI USA, V106, P14144, DOI 10.1073/pnas.0812536106; Darrow BJ, 1996, CIRC RES, V79, P174, DOI 10.1161/01.RES.79.2.174; Dodge-Kafka KL, 2005, NATURE, V437, P574, DOI 10.1038/nature03966; Duchniewicz M, 2006, MOL CELL BIOL, V26, P643, DOI 10.1128/MCB.26.2.643-653.2006; Duquesnes N, 2010, PFLUG ARCH EUR J PHY, V460, P731, DOI 10.1007/s00424-010-0854-9; Durand CA, 2006, EUR J IMMUNOL, V36, P2235, DOI 10.1002/eji.200535004; Gore AV, 2008, DIS MODEL MECH, V1, P275, DOI 10.1242/dmm.000513; Guerrero PA, 1997, J CLIN INVEST, V99, P1991, DOI 10.1172/JCI119367; Hagendorff A, 2001, Z KARDIOL, V90, P898, DOI 10.1007/s003920170060; Hothi SS, 2008, PFLUG ARCH EUR J PHY, V457, P253, DOI 10.1007/s00424-008-0508-3; Jeyaraj SC, 2011, LIFE SCI, V88, P645, DOI 10.1016/j.lfs.2011.01.023; Kawahara A, 2009, SCIENCE, V323, P524, DOI 10.1126/science.1167449; Knox AL, 2002, SCIENCE, V295, P1285, DOI 10.1126/science.1067549; Kooistra MRH, 2007, J CELL SCI, V120, P17, DOI 10.1242/jcs.03306; Laurent AC, 2012, BIOCHEM SOC T, V40, P51, DOI 10.1042/BST20110642; Matsui Takaaki, 2007, Nat Clin Pract Cardiovasc Med, V4 Suppl 1, pS77, DOI 10.1038/ncpcardio0764; Metrich M, 2009, PHARMACOL REP, V61, P146, DOI 10.1016/S1734-1140(09)70017-9; Noda K, 2010, MOL BIOL CELL, V21, P584, DOI 10.1091/mbc.E09-07-0580; Oestreich EA, 2007, J BIOL CHEM, V282, P5488, DOI 10.1074/jbc.M608495200; Oestreich EA, 2009, J BIOL CHEM, V284, P1514, DOI 10.1074/jbc.M806994200; Osborne N, 2008, CURR BIOL, V18, P1882, DOI 10.1016/j.cub.2008.10.061; Pannekoek WJ, 2009, BBA-BIOMEMBRANES, V1788, P790, DOI 10.1016/j.bbamem.2008.12.010; Price LS, 2004, J BIOL CHEM, V279, P35127, DOI 10.1074/jbc.M404917200; Raaijmakers JH, 2009, J BIOL CHEM, V284, P10995, DOI 10.1074/jbc.R800061200; Rangarajan S, 2003, J CELL BIOL, V160, P487, DOI 10.1083/jcb.200209105; Somekawa S, 2005, CIRC RES, V97, P655, DOI 10.1161/01.RES.0000183880.49270.f9; Tsai IC, 2007, DEV CELL, V12, P335, DOI 10.1016/j.devcel.2007.02.009; Westerfield M, 2000, ZEBRAFISH BOOK GUIDE, P12	33	11	12	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 30	2012	7	11							e50960	10.1371/journal.pone.0050960	http://dx.doi.org/10.1371/journal.pone.0050960			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	054WM	23226434	Green Submitted, gold, Green Published			2022-12-27	WOS:000312376100245
J	Jin, S; Yao, HT; Weber, JL; Melkoumian, ZK; Ye, KM				Jin, Sha; Yao, Huantong; Weber, Jennifer L.; Melkoumian, Zara K.; Ye, Kaiming			A Synthetic, Xeno-Free Peptide Surface for Expansion and Directed Differentiation of Human Induced Pluripotent Stem Cells	PLOS ONE			English	Article							SELF-RENEWAL; SIGNAL-TRANSDUCTION; ADHESION; FORCE; PROLIFERATION; CULTURE; GROWTH; IDENTIFICATION; TOPOGRAPHY; MECHANISMS	Human induced pluripotent stem cells have the potential to become an unlimited cell source for cell replacement therapy. The realization of this potential, however, depends on the availability of culture methods that are robust, scalable, and use chemically defined materials. Despite significant advances in hiPSC technologies, the expansion of hiPSCs relies upon the use of animal-derived extracellular matrix extracts, such as Matrigel, which raises safety concerns over the use of these products. In this work, we investigated the feasibility of expanding and differentiating hiPSCs on a chemically defined, xeno-free synthetic peptide substrate, i.e. Corning Synthemax (R) Surface. We demonstrated that the Synthemax Surface supports the attachment, spreading, and proliferation of hiPSCs, as well as hiPSCs' lineage-specific differentiation. hiPSCs colonies grown on Synthemax Surfaces exhibit less spread and more compact morphology compared to cells grown on Matrigel (TM). The cytoskeleton characterization of hiPSCs grown on the Synthemax Surface revealed formation of denser actin filaments in the cell-cell interface. The down-regulation of vinculin and up-regulation of zyxin expression were also observed in hiPSCs grown on the Synthemax Surface. Further examination of cell-ECM interaction revealed that hiPSCs grown on the Synthemax Surface primarily utilize alpha(v)beta(5) integrins to mediate attachment to the substrate, whereas multiple integrins are involved in cell attachment to Matrigel. Finally, hiPSCs can be maintained undifferentiated on the Synthemax Surface for more than ten passages. These studies provide a novel approach for expansion of hiPSCs using synthetic peptide engineered surface as a substrate to avoid a potential risk of contamination and lot-to-lot variability with animal derived materials.	[Jin, Sha; Yao, Huantong; Ye, Kaiming] Univ Arkansas, Coll Engn, Dept Biomed Engn, Fayetteville, AR 72701 USA; [Weber, Jennifer L.; Melkoumian, Zara K.] Corning Inc, Life Sci, Corning, NY 14831 USA	University of Arkansas System; University of Arkansas Fayetteville; Corning Inc; State University of New York (SUNY) System; SUNY Community College	Jin, S (corresponding author), Univ Arkansas, Coll Engn, Dept Biomed Engn, Fayetteville, AR 72701 USA.	sjin@uark.edu			National Science Foundation (NSF) [CBET 0756455]; Arkansas Biosciences Institute [0402-27504-211108, 0402-27504-210012]; National Institutes of Health (NIH) from the National Center for Research Resources (NCRR) [1P30RR031154]; NATIONAL CENTER FOR RESEARCH RESOURCES [P30RR031154] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P30GM103450] Funding Source: NIH RePORTER	National Science Foundation (NSF)(National Science Foundation (NSF)); Arkansas Biosciences Institute; National Institutes of Health (NIH) from the National Center for Research Resources (NCRR)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This research was partially supported by National Science Foundation (NSF) grant CBET 0756455, Arkansas Biosciences Institute grant 0402-27504-211108, 0402-27504-210012, and National Institutes of Health (NIH) funding 1P30RR031154 from the National Center for Research Resources (NCRR), a component of the National Institutes of Health. Its contents are solely the responsibility of the authors and do not necessarily represent the official view of NCRR or NIH. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amit M, 2004, BIOL REPROD, V70, P837, DOI 10.1095/biolreprod.103.021147; [Anonymous], 2007, HUM CELL CULT; Balaban NQ, 2001, NAT CELL BIOL, V3, P466, DOI 10.1038/35074532; Bendall SC, 2008, REGEN MED, V3, P365, DOI 10.2217/17460751.3.3.365; Berry CC, 2004, BIOMATERIALS, V25, P5781, DOI 10.1016/j.biomaterials.2004.01.029; Bershadsky AD, 2003, ANNU REV CELL DEV BI, V19, P677, DOI 10.1146/annurev.cellbio.19.111301.153011; Besser D, 2004, J BIOL CHEM, V279, P45076, DOI 10.1074/jbc.M404979200; Braam SR, 2008, STEM CELLS, V26, P2257, DOI 10.1634/stemcells.2008-0291; Bresnick AR, 1999, CURR OPIN CELL BIOL, V11, P26, DOI 10.1016/S0955-0674(99)80004-0; BURGESON RE, 1994, MATRIX BIOL, V14, P209, DOI 10.1016/0945-053X(94)90184-8; Chin MH, 2009, CELL STEM CELL, V5, P111, DOI 10.1016/j.stem.2009.06.008; D'Amour KA, 2006, NAT BIOTECHNOL, V24, P1392, DOI 10.1038/nbt1259; Dalby MJ, 2002, BIOMATERIALS, V23, P2945, DOI 10.1016/S0142-9612(01)00424-0; Derda R, 2007, ACS CHEM BIOL, V2, P347, DOI 10.1021/cb700032u; Derda R, 2010, J AM CHEM SOC, V132, P1289, DOI 10.1021/ja906089g; Evseenko D, 2009, STEM CELLS DEV, V18, P919, DOI 10.1089/scd.2008.0293; Fu X, 2011, TISSUE ENG PART C-ME, V17, P927, DOI [10.1089/ten.tec.2010.0735, 10.1089/ten.TEC.2010.0735]; Galbraith CG, 2002, J CELL BIOL, V159, P695, DOI 10.1083/jcb.200204153; Geiger B, 2001, NAT REV MOL CELL BIO, V2, P793, DOI 10.1038/35099066; Geiger B, 2001, CURR OPIN CELL BIOL, V13, P584, DOI 10.1016/S0955-0674(00)00255-6; Gerecht S, 2007, P NATL ACAD SCI USA, V104, P11298, DOI 10.1073/pnas.0703723104; Grashoff C, 2010, NATURE, V466, P263, DOI 10.1038/nature09198; Hannoun Z, 2010, CELL REPROGRAM, V12, P133, DOI 10.1089/cell.2009.0099; ITO Y, 1991, J BIOMED MATER RES, V25, P1325, DOI 10.1002/jbm.820251102; James D, 2005, DEVELOPMENT, V132, P1273, DOI 10.1242/dev.01706; Jin S, 2005, J VIROL, V79, P8793, DOI 10.1128/JVI.79.14.8793-8801.2005; Jin S, 2004, CLIN DIAGN LAB IMMUN, V11, P1120, DOI 10.1128/CDLI.11.6.1120-1129.2004; Jin S, 2011, BIOTECHNOL PROG; Jin S, 2012, TISSUE ENG A; Jin S, 2011, P ISSCR ANN M, P175; Kantawong F, 2010, ACTA BIOMATER, V6, P3694, DOI 10.1016/j.actbio.2010.02.038; Katsumi A, 2004, J BIOL CHEM, V279, P12001, DOI 10.1074/jbc.R300038200; Klim JR, 2010, NAT METHODS, V7, P989, DOI 10.1038/NMETH.1532; Kroon E, 2008, NAT BIOTECHNOL, V26, P443, DOI 10.1038/nbt1393; Liu MY, 1999, AM J PHYSIOL-LUNG C, V277, pL667, DOI 10.1152/ajplung.1999.277.4.L667; Ludwig TE, 2006, NAT BIOTECHNOL, V24, P185, DOI 10.1038/nbt1177; Mahlstedt MM, 2010, BIOTECHNOL BIOENG, V105, P130, DOI 10.1002/bit.22520; Markert LD, 2009, STEM CELLS DEV, V18, P1331, DOI 10.1089/scd.2009.0114; McNamara LE, 2010, J TISSUE ENG, V1, DOI 10.4061/2010/120623; Melkoumian Z, 2010, NAT BIOTECHNOL, V28, P606, DOI 10.1038/nbt.1629; Meng Y, 2010, FASEB J, V24, P1056, DOI 10.1096/fj.08-126821; Murata T, 2001, J HEPATOL, V35, P474, DOI 10.1016/S0168-8278(01)00169-6; Nakajima M, 2003, EUR J PHARMACOL, V459, P113, DOI 10.1016/S0014-2999(02)02869-8; NOMIZU M, 1995, J BIOL CHEM, V270, P20583, DOI 10.1074/jbc.270.35.20583; Peerani R, 2007, EMBO J, V26, P4744, DOI 10.1038/sj.emboj.7601896; Pfannkuche K, 2010, CELL PHYSIOL BIOCHEM, V26, P105, DOI 10.1159/000320514; PIERSCHBACHER MD, 1984, NATURE, V309, P30, DOI 10.1038/309030a0; Rao BM, 2005, CURR OPIN BIOTECH, V16, P568, DOI 10.1016/j.copbio.2005.08.001; Riveline D, 2001, J CELL BIOL, V153, P1175, DOI 10.1083/jcb.153.6.1175; Rowland TJ, 2010, STEM CELLS DEV, V19, P1231, DOI 10.1089/scd.2009.0328; Ruoslahti E, 1996, ANNU REV CELL DEV BI, V12, P697, DOI 10.1146/annurev.cellbio.12.1.697; Shi YG, 2003, CELL, V113, P685, DOI 10.1016/S0092-8674(03)00432-X; SOLOMON F, 1981, J CELL BIOL, V89, P157, DOI 10.1083/jcb.89.1.157; Somlyo AP, 2000, J PHYSIOL-LONDON, V522, P177, DOI 10.1111/j.1469-7793.2000.t01-2-00177.x; Stewart MH, 2008, J MOL MED, V86, P875, DOI 10.1007/s00109-008-0356-9; Stupack Dwayne G, 2007, Oncology (Williston Park), V21, P6; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Thomson JA, 1998, SCIENCE, V282, P1145, DOI 10.1126/science.282.5391.1145; van der Gaag EJ, 2002, J INVEST DERMATOL, V118, P246, DOI 10.1046/j.0022-202x.2001.01657.x; Van Hoof D, 2009, STEM CELL RES, V3, P73, DOI 10.1016/j.scr.2009.08.003; Vuoristo S, 2009, J CELL MOL MED, V13, P2622, DOI 10.1111/j.1582-4934.2008.00643.x; Weber JL, 2010, NATURE METHODS, pan6; Xu RH, 2005, NAT METHODS, V2, P185, DOI 10.1038/NMETH744; Ye K, 2011, HUMAN EMBRYONIC INDU; Yeung T, 2005, CELL MOTIL CYTOSKEL, V60, P24, DOI 10.1002/cm.20041; Yu JY, 2009, SCIENCE, V324, P797, DOI 10.1126/science.1172482	67	67	69	1	53	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 30	2012	7	11							e50880	10.1371/journal.pone.0050880	http://dx.doi.org/10.1371/journal.pone.0050880			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	054WM	23226418	Green Published, gold, Green Submitted			2022-12-27	WOS:000312376100229
J	Medina-Franco, JL; Martinez-Mayorga, K; Peppard, TL; Del Rio, A				Medina-Franco, Jose L.; Martinez-Mayorga, Karina; Peppard, Terry L.; Del Rio, Alberto			Chemoinformatic Analysis of GRAS (Generally Recognized as Safe) Flavor Chemicals and Natural Products	PLOS ONE			English	Article							DRUG DISCOVERY; SPACE; DATABASES; FOOD; INHIBITORS; DIVERSITY; MOLECULES	Food materials designated as "Generally Recognized as Safe'' (GRAS) are attracting the attention of researchers in their attempts to systematically identify compounds with putative health-related benefits. In particular, there is currently a great deal of interest in exploring possible secondary benefits of flavor ingredients, such as those relating to health and wellness. One step in this direction is the comprehensive characterization of the chemical structures contained in databases of flavoring substances. Herein, we report a comprehensive analysis of the recently updated FEMA GRAS list of flavoring substances (discrete chemical entities only). Databases of natural products, approved drugs and a large set of commercial molecules were used as references. Remarkably, natural products continue to be an important source of bioactive compounds for drug discovery and nutraceutical purposes. The comparison of five collections of compounds of interest was performed using molecular properties, rings, atom counts and structural fingerprints. It was found that the molecular size of the GRAS flavoring substances is, in general, smaller cf. members of the other databases analyzed. The lipophilicity profile of the GRAS database, a key property to predict human bioavailability, is similar to approved drugs. Several GRAS chemicals overlap to a broad region of the property space occupied by drugs. The GRAS list analyzed in this work has high structural diversity, comparable to approved drugs, natural products and libraries of screening compounds. This study represents one step towards the use of the distinctive features of the flavoring chemicals contained in the GRAS list and natural products to systematically search for compounds with potential health-related benefits.	[Medina-Franco, Jose L.; Martinez-Mayorga, Karina] Torrey Pines Inst Mol Studies, Port St Lucie, FL USA; [Peppard, Terry L.] Robertet Flavors Inc, Piscataway, NJ USA; [Del Rio, Alberto] Univ Bologna, Dept Expt Diagnost & Specialty Med, Bologna, Italy	Torrey Pines Institute for Molecular Studies, Florida; University of Bologna	Medina-Franco, JL (corresponding author), Torrey Pines Inst Mol Studies, Port St Lucie, FL USA.	jmedina@tpims.org	Medina-Franco, Jose/AAJ-1633-2020; Del Rio, Alberto/F-5230-2010	Medina-Franco, Jose/0000-0003-4940-1107; Del Rio, Alberto/0000-0002-1890-6797	State of Florida, Executive Office of the Governor's Office of Tourism, Trade, and Economic Development	State of Florida, Executive Office of the Governor's Office of Tourism, Trade, and Economic Development	This work was supported by the State of Florida, Executive Office of the Governor's Office of Tourism, Trade, and Economic Development. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agrafiotis DK, 2001, J CHEM INF COMP SCI, V41, P159, DOI 10.1021/ci000091j; Andreoli F, 2013, CURR PHARM IN PRESS; [Anonymous], 2011, MOL OP ENV MOE VERS; [Anonymous], 2012, CANV VERS 1 5; Barbosa AJM, 2012, CURR TOP MED CHEM, V12, P866; Bickerton GR, 2012, NAT CHEM, V4, P90, DOI [10.1038/nchem.1243, 10.1038/NCHEM.1243]; Bonachera F, 2012, BIOORGAN MED CHEM, V20, P5396, DOI 10.1016/j.bmc.2012.04.024; Burdock GA, 2006, TOXICOLOGY, V221, P17, DOI 10.1016/j.tox.2006.01.012; Burdock GA, 2004, TOXICOL LETT, V150, P3, DOI 10.1016/j.toxlet.2003.07.004; Burdock GA, 2003, FOOD TECHNOL-CHICAGO, V57, P17; Caporuscio F, 2011, J MED CHEM, V54, P4006, DOI 10.1021/jm2000689; Clemons PA, 2011, P NATL ACAD SCI USA, V108, P6817, DOI 10.1073/pnas.1015024108; Dandapani S, 2010, NAT CHEM BIOL, V6, P861, DOI 10.1038/nchembio.479; Del Rio A, 2010, MOL BIOSYST, V6, P2122, DOI 10.1039/c0mb00039f; Duan JX, 2010, J MOL GRAPH MODEL, V29, P157, DOI 10.1016/j.jmgm.2010.05.008; Ertl P, 2008, J CHEM INF MODEL, V48, P68, DOI 10.1021/ci700286x; Feher M, 2003, J CHEM INF COMP SCI, V43, P218, DOI 10.1021/ci0200467; Ganesan A, 2008, CURR OPIN CHEM BIOL, V12, P306, DOI 10.1016/j.cbpa.2008.03.016; Harvey AL, 2008, DRUG DISCOV TODAY, V13, P894, DOI 10.1016/j.drudis.2008.07.004; Harvey AL, 2010, EXPERT OPIN DRUG DIS, V5, P559, DOI 10.1517/17460441.2010.488263; Henkel T, 1999, ANGEW CHEM INT EDIT, V38, P643, DOI 10.1002/(SICI)1521-3773(19990301)38:5<643::AID-ANIE643>3.0.CO;2-G; Jaccard P., 1901, B SOC VAUD SCI N, V37, P241, DOI DOI 10.5169/SEALS-266450; Lachance H, 2012, J MED CHEM, V55, P5989, DOI 10.1021/jm300288g; Lipinski CA, 1997, ADV DRUG DELIVER REV, V23, P3, DOI 10.1016/S0169-409X(96)00423-1; Lopez-Vallejo F, 2012, DRUG DISCOV TODAY, V17, P718, DOI 10.1016/j.drudis.2012.04.001; Lopez-Vallejo F, 2011, EXPERT OPIN DRUG DIS, V6, P1227, DOI 10.1517/17460441.2011.637106; Lopez-Vallejo F, 2011, COMB CHEM HIGH T SCR, V14, P475, DOI 10.2174/138620711795767866; Lopez-Vallejo F, 2011, CHEM BIOL DRUG DES, V77, P328, DOI 10.1111/j.1747-0285.2011.01100.x; Martinez-Mayorga K, 2013, 245 ACS NAT M NEW OR; Martinez-Mayorga K, 2011, J CHEMOMETR, V25, P550, DOI 10.1002/cem.1399; Medina-Franco JL, 2012, DRUG DEVELOP RES, V73, P430, DOI 10.1002/ddr.21034; Medina-Franco JL, 2011, MOL DIVERS, V15, P293, DOI 10.1007/s11030-010-9262-5; Medina-Franco JL, 2008, CURR COMPUT-AID DRUG, V4, P322, DOI 10.2174/157340908786786010; Peppard TL, 2008, PREDICTION TOOL MODE, P374; Perez-Villanueva J, 2010, BIOORGAN MED CHEM, V18, P7380, DOI 10.1016/j.bmc.2010.09.019; Ritchie TJ, 2011, DRUG DISCOV TODAY, V16, P164, DOI 10.1016/j.drudis.2010.11.014; Ritchie TJ, 2009, DRUG DISCOV TODAY, V14, P1011, DOI 10.1016/j.drudis.2009.07.014; Rogers D, 2010, J CHEM INF MODEL, V50, P742, DOI 10.1021/ci100050t; Rognan D, 2010, MOL INFORM, V29, P176, DOI 10.1002/minf.200900081; Sanders MPA, 2012, J CHEM INF MODEL, V52, P1607, DOI 10.1021/ci2005274; Scalbert A, 2011, J AGR FOOD CHEM, V59, P4331, DOI 10.1021/jf200591d; Singh N, 2009, J CHEM INF MODEL, V49, P1010, DOI 10.1021/ci800426u; Smith RL, 2011, FOOD TECHNOL-CHICAGO, V65, P44; Sprous DG, 2007, FOOD CHEM TOXICOL, V45, P1419, DOI 10.1016/j.fct.2007.02.004; Willett P, 1998, J CHEM INF COMP SCI, V38, P983, DOI 10.1021/ci9800211; Wishart DS, 2008, NUCLEIC ACIDS RES, V36, pD901, DOI 10.1093/nar/gkm958; Yongye AB, 2012, CHEM BIOL DRUG DES, V80, P717, DOI 10.1111/cbdd.12011; Yongye AB, 2011, J CHEM INF MODEL, V51, P1259, DOI 10.1021/ci200081k; Yoo J, 2011, COMPUT MOL BIOSCI, V1, P7	49	27	27	0	41	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 30	2012	7	11							e50798	10.1371/journal.pone.0050798	http://dx.doi.org/10.1371/journal.pone.0050798			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	054WM	23226386	Green Published, gold, Green Submitted			2022-12-27	WOS:000312376100197
J	Menezes, V; Mathew, Y; Takayama, K; Kanno, A; Hosseini, H				Menezes, Viren; Mathew, Yohan; Takayama, Kazuyoshi; Kanno, Akira; Hosseini, Hamid			Laser Plasma Jet Driven Microparticles for DNA/Drug Delivery	PLOS ONE			English	Article							DRUG-DELIVERY; DNA; DEVICE	This paper describes a microparticle delivery device that generates a plasma jet through laser ablation of a thin metal foil and uses the jet to accomplish particle delivery into soft living targets for transferring biological agents. Pure gold microparticles of 1 mm size were coated with a plasmid DNA, pIG121Hm, and were deposited as a thin layer on one surface of an aluminum foil. The laser (Nd:YAG, 1064 nm wavelength) ablation of the foil generated a plasma jet that carried the DNA coated particles into the living onion cells. The particles could effectively penetrate the target cells and disseminate the DNA, effecting the transfection of the cells. Generation of the plasma jet on laser ablation of the foil and its role as a carrier of microparticles was visualized using a high-speed video camera, Shimadzu HPV-1, at a frame rate of 500 kfps (2 mu s interframe interval) in a shadowgraph optical set-up. The particle speed could be measured from the visualized images, which was about 770 m/s initially, increased to a magnitude of 1320 m/s, and after a quasi-steady state over a distance of 10 mm with an average magnitude of 1100 m/s, started declining, which typically is the trend of a high-speed, pulsed, compressible jet. Aluminum launch pad (for the particles) was used in the present study to make the procedure cost-effective, whereas the guided, biocompatible launch pads made of gold, silver or titanium can be used in the device during the actual clinical operations. The particle delivery device has a potential to have a miniature form and can be an effective, hand-held drug/DNA delivery device for biological applications.	[Hosseini, Hamid] Kumamoto Univ, Bioelect Res Ctr, Kumamoto, Japan; [Menezes, Viren; Mathew, Yohan] Indian Inst Technol, Dept Aerosp Engn, Bombay 400076, Maharashtra, India; [Takayama, Kazuyoshi] Tohoku Univ, Inst Fluid Sci, Sendai, Miyagi 980, Japan; [Kanno, Akira] Tohoku Univ, Grad Sch Life Sci, Sendai, Miyagi 980, Japan	Kumamoto University; Indian Institute of Technology System (IIT System); Indian Institute of Technology (IIT) - Bombay; Tohoku University; Tohoku University	Hosseini, H (corresponding author), Kumamoto Univ, Bioelect Res Ctr, Kumamoto, Japan.	hosseini@kumamoto-u.ac.jp	Kanno, Akira/H-2782-2013	Kanno, Akira/0000-0002-9762-4842	Global COE program (Global Initiative Center for Pulsed Power Engineering); Ministry of Education, Culture, Sports, Science and Technology of Japan [24540539]	Global COE program (Global Initiative Center for Pulsed Power Engineering); Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported in part by Global COE program (Global Initiative Center for Pulsed Power Engineering) and Grant-in-Aid for Scientific Research from the Ministry of Education, Culture, Sports, Science and Technology of Japan (24540539). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Chen DX, 2000, NAT MED, V6, P1187, DOI 10.1038/80538; FYNAN EF, 1993, P NATL ACAD SCI USA, V90, P11478, DOI 10.1073/pnas.90.24.11478; Kendall M, 2006, J ALLERGY CLIN IMMUN, V117, P275, DOI 10.1016/j.jaci.2005.09.049; KIKKERT JR, 1993, PLANT CELL TISS ORG, V33, P221, DOI 10.1007/BF02319005; KLEIN TM, 1987, NATURE, V327, P70, DOI 10.1038/327070a0; Menezes V, 2008, SHOCK WAVES, V18, P393, DOI 10.1007/s00193-008-0163-9; Menezes V, 2005, APPL PHYS LETT, V87, DOI 10.1063/1.2093930; Nakada M, 2008, JPN J APPL PHYS, V47, P1522, DOI 10.1143/JJAP.47.1522; Shangguan HQ, 1996, APPL OPTICS, V35, P3347, DOI 10.1364/AO.35.003347; Uchida M, 2009, BBA-GEN SUBJECTS, V1790, P754, DOI 10.1016/j.bbagen.2009.05.013; Zhang GX, 2001, EXP NEUROL, V167, P304, DOI 10.1006/exnr.2000.7584	11	12	12	3	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 30	2012	7	11							e50823	10.1371/journal.pone.0050823	http://dx.doi.org/10.1371/journal.pone.0050823			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	054WM	23226394	Green Submitted, Green Published, gold			2022-12-27	WOS:000312376100205
J	Smith, G; Raghunandan, R; Wu, YY; Liu, Y; Massare, M; Nathan, M; Zhou, B; Lu, HX; Boddapati, S; Li, JN; Flyer, D; Glenn, G				Smith, Gale; Raghunandan, Rama; Wu, Yingyun; Liu, Ye; Massare, Michael; Nathan, Margret; Zhou, Bin; Lu, Hanxin; Boddapati, Sarathi; Li, Jingning; Flyer, David; Glenn, Gregory			Respiratory Syncytial Virus Fusion Glycoprotein Expressed in Insect Cells Form Protein Nanoparticles That Induce Protective Immunity in Cotton Rats	PLOS ONE			English	Article							VACCINE DEVELOPMENT; STRUCTURAL BASIS; F-GLYCOPROTEIN; RSV F; DISEASE; ANTIBODY; INFECTION; NEUTRALIZATION; IMMUNIZATION; MOTAVIZUMAB	Respiratory Syncytial Virus (RSV) is an important viral agent causing severe respiratory tract disease in infants and children as well as in the elderly and immunocompromised individuals. The lack of a safe and effective RSV vaccine represents a major unmet medical need. RSV fusion (F) surface glycoprotein was modified and cloned into a baculovirus vector for efficient expression in Sf9 insect cells. Recombinant RSV F was glycosylated and cleaved into covalently linked F2 and F1 polypeptides that formed homotrimers. RSV F extracted and purified from insect cell membranes assembled into 40 nm protein nanoparticles composed of multiple RSV F oligomers arranged in the form of rosettes. The immunogenicity and protective efficacy of purified RSV F nanoparticles was compared to live and formalin inactivated RSV in cotton rats. Immunized animals induced neutralizing serum antibodies, inhibited virus replication in the lungs, and had no signs of disease enhancement in the respiratory track of challenged animals. RSV F nanoparticles also induced IgG competitive for binding of palivizumab neutralizing monoclonal antibody to RSV F antigenic site II. Antibodies to this epitope are known to protect against RSV when passively administered in high risk infants. Together these data provide a rational for continued development a recombinant RSV F nanoparticle vaccine candidate.	[Smith, Gale; Raghunandan, Rama; Wu, Yingyun; Liu, Ye; Massare, Michael; Zhou, Bin; Lu, Hanxin; Flyer, David] Novavax Inc, Discovery, Rockville, MD USA; [Nathan, Margret] Novavax Inc, Proc Dev, Rockville, MD USA; [Boddapati, Sarathi] Novavax Inc, Formulat Dev, Rockville, MD USA; [Li, Jingning] Novavax Inc, Analyt Dev, Rockville, MD USA; [Glenn, Gregory] Novavax Inc, Clin Dev, Rockville, MD USA		Smith, G (corresponding author), Novavax Inc, Discovery, Rockville, MD USA.	gsmith@novavax.com						BEELER JA, 1989, J VIROL, V63, P2941, DOI 10.1128/JVI.63.7.2941-2950.1989; Blanco JCG, 2010, HUM VACCINES, V6, P482, DOI 10.4161/hv.6.6.11562; Calder LJ, 2000, VIROLOGY, V271, P122, DOI 10.1006/viro.2000.0279; Carbonell-Estrany X, 2010, PEDIATRICS, V125, pE35, DOI 10.1542/peds.2008-1036; Chaiwatpongsakorn S, 2011, J VIROL, V85, P3968, DOI 10.1128/JVI.01813-10; CHIN J, 1969, AM J EPIDEMIOL, V89, P449, DOI 10.1093/oxfordjournals.aje.a120957; Collins PL, 2007, FIELDS VIROLOGY, P1601; CONNORS M, 1991, J VIROL, V65, P1634, DOI 10.1128/JVI.65.3.1634-1637.1991; Crowe James E Jr, 2003, Paediatr Respir Rev, V4, P112, DOI 10.1016/S1526-0542(03)00033-2; Dudas RA, 1998, CLIN MICROBIOL REV, V11, P430, DOI 10.1128/CMR.11.3.430; Delgado MF, 2009, NAT MED, V15, P34, DOI 10.1038/nm.1894; Graham BS, 2011, IMMUNOL REV, V239, P149, DOI 10.1111/j.1600-065X.2010.00972.x; Johnson S, 1997, J INFECT DIS, V176, P1215, DOI 10.1086/514115; KAPIKIAN AZ, 1969, AM J EPIDEMIOL, V89, P405, DOI 10.1093/oxfordjournals.aje.a120954; KIM HW, 1969, AM J EPIDEMIOL, V89, P422, DOI 10.1093/oxfordjournals.aje.a120955; McLellan JS, 2011, J VIROL, V85, P7788, DOI 10.1128/JVI.00555-11; McLellan JS, 2010, NAT STRUCT MOL BIOL, V17, P248, DOI 10.1038/nsmb.1723; Moghaddam A, 2006, NAT MED, V12, P905, DOI 10.1038/nm1456; Murata Y, 2009, CLIN LAB MED, V29, P725, DOI 10.1016/j.cll.2009.07.004; MURPHY BR, 1988, J CLIN MICROBIOL, V26, P1595, DOI 10.1128/JCM.26.8.1595-1597.1988; MURPHY BR, 1991, VACCINE, V9, P185, DOI 10.1016/0264-410X(91)90151-U; Openshaw PJM, 2001, VACCINE, V20, pS27, DOI 10.1016/S0264-410X(01)00301-2; Polack FP, 2002, J EXP MED, V196, P859, DOI 10.1084/jem.20020781; Prince GA, 1999, LAB INVEST, V79, P1385; PRINCE GA, 1986, J VIROL, V57, P721, DOI 10.1128/JVI.57.3.721-728.1986; PRINCE GA, 1978, AM J PATHOL, V93, P771; Prince GA, 2001, J GEN VIROL, V82, P2881, DOI 10.1099/0022-1317-82-12-2881; Pushko P, 2007, VACCINE, V25, P4283, DOI 10.1016/j.vaccine.2007.02.059; Ruiz-Arguello MB, 2004, J GEN VIROL, V85, P3677, DOI 10.1099/vir.0.80318-0; Ruiz-Arguello MB, 2002, VIROLOGY, V298, P317, DOI 10.1006/viro.2002.1497; Sandritter T, 1999, J Pediatr Health Care, V13, P191, DOI 10.1016/S0891-5245(99)90039-1; Sandritter T, 1999, J PEDIATR HEALTH CAR, V13, P196; Swanson KA, 2011, P NATL ACAD SCI USA, V108, P9619, DOI 10.1073/pnas.1106536108	33	110	116	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 30	2012	7	11							e50852	10.1371/journal.pone.0050852	http://dx.doi.org/10.1371/journal.pone.0050852			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	054WM	23226404	gold, Green Submitted, Green Published			2022-12-27	WOS:000312376100215
J	Ueki, A; Shimizu, T; Masuda, K; Yamaguchi, SI; Ishikawa, T; Sugihara, E; Onishi, N; Kuninaka, S; Miyoshi, K; Muto, A; Toyama, Y; Banno, K; Aoki, D; Saya, H				Ueki, Arisa; Shimizu, Takatsune; Masuda, Kenta; Yamaguchi, Sayaka I.; Ishikawa, Tomoki; Sugihara, Eiji; Onishi, Nobuyuki; Kuninaka, Shinji; Miyoshi, Keita; Muto, Akihiro; Toyama, Yoshiaki; Banno, Kouji; Aoki, Daisuke; Saya, Hideyuki			Up-Regulation of Imp3 Confers In Vivo Tumorigenicity on Murine Osteosarcoma Cells	PLOS ONE			English	Article							RNA-BINDING-PROTEIN; K562 LEUKEMIA-CELLS; MESSENGER-RNA; GROWTH FACTOR-2; EXPRESSION; CANCER; PROGNOSIS; GENE; PROLIFERATION; METASTASIS	Osteosarcoma is a high-grade malignant bone tumor that manifests ingravescent clinical behavior. The intrinsic events that confer malignant properties on osteosarcoma cells have remained unclear, however. We previously established two lines of mouse osteosarcoma cells: AX cells, which are able to form tumors in syngeneic mice, and AXT cells, which were derived from such tumors and acquired an increased tumorigenic capacity during tumor development. We have now identified Igf2 mRNA-binding protein3 (Imp3) as a key molecule responsible for this increased tumorigenicity of AXT cells in vivo. Imp3 is consistently up-regulated in tumors formed by AX cells, and its expression in these cells was found to confer malignant properties such as anchorage-independent growth, loss of contact inhibition, and escape from anoikis in vitro. The expression level of Imp3 also appeared directly related to tumorigenic ability in vivo which is the critical determination for tumor-initiating cells. The effect of Imp3 on tumorigenicity of osteosarcoma cells did not appear to be mediated through Igf2-dependent mechanism. Our results implicate Imp3 as a key regulator of stem-like tumorigenic characteristics in osteosarcoma cells and as a potential therapeutic target for this malignancy.	[Ueki, Arisa; Shimizu, Takatsune; Masuda, Kenta; Yamaguchi, Sayaka I.; Ishikawa, Tomoki; Sugihara, Eiji; Onishi, Nobuyuki; Kuninaka, Shinji; Saya, Hideyuki] Keio Univ, Sch Med, Div Gene Regulat, Inst Adv Med Res, Tokyo, Japan; [Ueki, Arisa; Masuda, Kenta; Banno, Kouji; Aoki, Daisuke] Keio Univ, Sch Med, Dept Obstet & Gynecol, Tokyo 160, Japan; [Shimizu, Takatsune; Muto, Akihiro] Hoshi Univ, Sch Pharm & Pharmaceut Sci, Dept Pathophysiol, Tokyo 142, Japan; [Yamaguchi, Sayaka I.; Toyama, Yoshiaki] Keio Univ, Sch Med, Dept Orthoped Surg, Tokyo, Japan; [Ishikawa, Tomoki] Daiichi Sankyo Co Ltd, Kasai R&D Ctr, Tokyo, Japan; [Miyoshi, Keita] Keio Univ, Sch Med, Dept Mol Biol, Tokyo, Japan; [Shimizu, Takatsune; Sugihara, Eiji; Saya, Hideyuki] Japan Sci & Technol Agcy, Core Res Evolut Sci & Technol CREST, Tokyo, Japan	Keio University; Keio University; Hoshi University; Keio University; Daiichi Sankyo Company Limited; Keio University; Japan Science & Technology Agency (JST)	Shimizu, T (corresponding author), Keio Univ, Sch Med, Div Gene Regulat, Inst Adv Med Res, Tokyo, Japan.	t-shimizu@hoshi.ac.jp	ONISHI, Nobuyuki/L-6296-2013; Aoki, Daisuke/E-6650-2014; Saya, Hideyuki/J-4325-2013; Banno, Kouji/C-9638-2014; Kuninaka, Shinji/J-7158-2013; Sugihara, Eiji/J-8058-2013; Toyama, Yoshiaki/K-5743-2013	Sugihara, Eiji/0000-0002-3233-1045; Saya, Hideyuki/0000-0001-6610-1902	Ministry of Education, Culture, Sports, Science, and Technology of Japan; CREST, JST, Japan [2401320, 22130007]	Ministry of Education, Culture, Sports, Science, and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); CREST, JST, Japan(Japan Science & Technology Agency (JST)Core Research for Evolutional Science and Technology (CREST))	This work was supported by grants from the Ministry of Education, Culture, Sports, Science, and Technology of Japan and CREST, JST, Japan (TS #2401320) http://kaken.nii.ac.jp/d/r/40407101.en.html, (HS #22130007) http://www.cancer-stem-cell.com/, CREST: http://www.jst.go.jp/kisoken/crest/en/research_area/ongoing/area03-1.html. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Berdasco M, 2010, DEV CELL, V19, P698, DOI 10.1016/j.devcel.2010.10.005; Chen P, 2012, J MOL HISTOL, V43, P63, DOI 10.1007/s10735-011-9370-2; Chen ST, 2011, CANCER SCI, V102, P2191, DOI 10.1111/j.1349-7006.2011.02100.x; Do SI, 2008, ONCOL RES, V17, P269, DOI 10.3727/096504008786991639; Fujino RS, 2006, MOL ENDOCRINOL, V20, P904, DOI 10.1210/me.2005-0423; Hafner M, 2010, CELL, V141, P129, DOI 10.1016/j.cell.2010.03.009; Hanahan D, 2000, CELL, V100, P57, DOI 10.1016/S0092-8674(00)81683-9; Hock J, 2007, EMBO REP, V8, P1052, DOI 10.1038/sj.embor.7401088; Jeng YM, 2008, HEPATOLOGY, V48, P1118, DOI 10.1002/hep.22459; Jiang Z, 2006, LANCET ONCOL, V7, P556, DOI 10.1016/S1470-2045(06)70732-X; Kabbarah O, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010770; Kitamura T, 2003, EXP HEMATOL, V31, P1007, DOI 10.1016/j.exphem.2003.07.005; Liao BS, 2011, J BIOL CHEM, V286, P31145, DOI 10.1074/jbc.M111.263913; Liao BS, 2005, J BIOL CHEM, V280, P18517, DOI 10.1074/jbc.M500270200; Liao BS, 2004, J BIOL CHEM, V279, P48716, DOI 10.1074/jbc.M405853200; Magee JA, 2012, CANCER CELL, V21, P283, DOI 10.1016/j.ccr.2012.03.003; Mori H, 2001, J NEUROSCI RES, V64, P132, DOI 10.1002/jnr.1060; Mueller F, 2003, BRIT J CANCER, V88, P699, DOI 10.1038/sj.bjc.6600790; MuellerPillasch F, 1997, ONCOGENE, V14, P2729, DOI 10.1038/sj.onc.1201110; Nielsen FC, 2002, J CELL SCI, V115, P2087; Nielsen FC, 2001, SCAND J CLIN LAB INV, V61, P93; Nielsen J, 1999, MOL CELL BIOL, V19, P1262; Samanta S, 2012, ONCOGENE; Shimizu T, 2010, ONCOGENE, V29, P5687, DOI 10.1038/onc.2010.312; Shimizu T, 2012, MOL CANCER RES, V10, P454, DOI 10.1158/1541-7786.MCR-11-0347; Simpson CD, 2008, CANCER LETT, V272, P177, DOI 10.1016/j.canlet.2008.05.029; Suvasini R, 2011, J BIOL CHEM, V286, P25882, DOI 10.1074/jbc.M110.178012; Thullberg M, 2008, CELL CYCLE, V7, P984, DOI 10.4161/cc.7.8.5674; Toledano H, 2012, NATURE, V485, P605, DOI 10.1038/nature11061; Vikesaa J, 2006, EMBO J, V25, P1456, DOI 10.1038/sj.emboj.7601039; Visvader JE, 2011, NATURE, V469, P314, DOI 10.1038/nature09781; Wang JB, 2010, CANCER CELL, V18, P207, DOI 10.1016/j.ccr.2010.08.009; Yaniv K, 2002, GENE, V287, P49, DOI 10.1016/S0378-1119(01)00866-6	33	17	20	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 30	2012	7	11							e50621	10.1371/journal.pone.0050621	http://dx.doi.org/10.1371/journal.pone.0050621			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	054WM	23226335	Green Published, Green Submitted, gold			2022-12-27	WOS:000312376100146
J	Wade, VA; Karnon, J; Eliott, JA; Hiller, JE				Wade, Victoria A.; Karnon, Jonathan; Eliott, Jaklin A.; Hiller, Janet E.			Home Videophones Improve Direct Observation in Tuberculosis Treatment: A Mixed Methods Evaluation	PLOS ONE			English	Article							DIRECTLY OBSERVED THERAPY; RANDOMIZED CONTROLLED-TRIAL; COST-EFFECTIVENESS; STRATEGIES; MANAGEMENT; ADHERENCE; PROGRAM; WORKERS; URBAN; DOTS	Background: The use of direct observation to monitor tuberculosis treatment is controversial: cost, practical difficulties, and lack of patient acceptability limit effectiveness. Telehealth is a promising alternative delivery method for improving implementation. This study aimed to evaluate the clinical and cost-effectiveness of a telehealth service delivering direct observation, compared to an in-person drive-around service. Methodology/Principal Findings: The study was conducted within a community nursing service in South Australia. Telehealth patients received daily video calls at home on a desktop videophone provided by the nursing call center. A retrospective cohort study assessed the effectiveness of the telehealth and traditional forms of observation, defined by the proportion of missed observations recorded in case notes. This data was inputted to a model, estimating the incremental cost-effectiveness ratio (ICER) of telehealth. Semi-structured interviews were conducted with current patients, community nursing and Chest Clinic staff, concerning service acceptability, usability and sustainability. The percentage of missed observations for the telehealth service was 12.1 (n = 58), compared to 31.1 for the in-person service (n = 70). Most of the difference of 18.9% (95% CI: 12.2 - 25.4) was due to fewer pre-arranged absences. The economic analysis calculated the ICER to be AUD$1.32 (95% CI: $0.51 - $2.26) per extra day of successful observation. The video service used less staff time, and became dominant if implemented on a larger scale and/or with decreased technology costs. Qualitative analysis found enabling factors of flexible timing, high patient acceptance, staff efficiency, and Chest Clinic support. Substantial technical problems were manageable, and improved liaison between the nursing service and Chest Clinic was an unexpected side-benefit. Conclusions/Significance: Home video observation is a patient-centered, resource efficient way of delivering direct observation for TB, and is cost-effective when compared with a drive-around service. Future research is recommended to determine applicability and effectiveness in other settings.	[Wade, Victoria A.; Karnon, Jonathan; Hiller, Janet E.] Univ Adelaide, Discipline Publ Hlth, Adelaide, SA, Australia; [Eliott, Jaklin A.] Univ Adelaide, Discipline Gen Practice, Adelaide, SA, Australia; [Hiller, Janet E.] Australian Catholic Univ, Melbourne, Vic, Australia	University of Adelaide; University of Adelaide; Australian Catholic University	Wade, VA (corresponding author), Univ Adelaide, Discipline Publ Hlth, Adelaide, SA, Australia.	victoria.wade@adelaide.edu.au	Hiller, Janet E./A-5633-2008	Hiller, Janet E./0000-0002-8532-4033; Karnon, Jonathan/0000-0003-3220-2099	RDNS SA (Royal District Nursing Service of SA Limited); Australian Postgraduate Award	RDNS SA (Royal District Nursing Service of SA Limited); Australian Postgraduate Award(Australian Government)	Victoria Wade was paid by RDNS SA (Royal District Nursing Service of SA Limited) in 2008 for conducting an evaluation of the pilot study of the videophone service and was supported to conduct this work by the Australian Government, through an Australian Postgraduate Award. These funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding was received for this study.	Australian Taxation Office, 2011, CLAIM DED EXP US CEN; Braun V., 2006, QUAL RES PSYCHOL, V3, P77, DOI [DOI 10.1191/1478088706QP063OA, 10.1191/1478088706qp063oa]; Creswell J.W., 2007, DESIGNING CONDUCTING; DeMaio J, 2001, CLIN INFECT DIS, V33, P2082, DOI 10.1086/324506; Diamond A, 2006, GENETIC MATCHING EST; Donald PR, 2009, NEW ENGL J MED, V360, P2393, DOI 10.1056/NEJMp0903806; Fair Work Australia, 2011, NURS S AUSTR AW; Frieden TR, 2007, B WORLD HEALTH ORGAN, V85, P407, DOI 10.2471/BLT.06.038927; Garner P, 2006, PLOS MED, V3, P1467, DOI 10.1371/journal.pmed.0030350; Grigsby B, 2007, TELEMED J E-HEALTH, V13, P645, DOI 10.1089/tmj.2007.0090; Harper Ian, 2010, Anthropol Med, V17, P201, DOI 10.1080/13648470.2010.493606; Hirsch-Moverman Y, 2008, INT J TUBERC LUNG D, V12, P1235; Hoffman JA, 2010, AM J PREV MED, V39, P78, DOI 10.1016/j.amepre.2010.02.018; International Telecommunication Union, 2011, MEAS INF SOC; Karnon J, 2011, PHARMACOECONOMICS, V29, P51, DOI 10.2165/11584610-000000000-00000; Khan MA, 2002, HEALTH POLICY PLANN, V17, P178, DOI 10.1093/heapol/17.2.178; Krueger K, 2010, INT J TUBERC LUNG D, V14, P779; Lawn SD, 2011, LANCET, V378, P57, DOI 10.1016/S0140-6736(10)62173-3; Lienhardt C, 2004, TROP MED INT HEALTH, V9, P833, DOI 10.1111/j.1365-3156.2004.01273.x; MacIntyre CR, 2003, INT J TUBERC LUNG D, V7, P848; Macq J, 2007, TROP MED INT HEALTH, V12, P873, DOI 10.1111/j.1365-3156.2007.01858.x; Malotte CK, 2001, AM J PREV MED, V20, P103, DOI 10.1016/S0749-3797(00)00283-X; Microsoft Corporation, 2004, EXC 2004 MAC; Mohan CI, 2007, INT J TUBERC LUNG D, V11, P27; Moonan PK, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-19; Munro SA, 2007, PLOS MED, V4, P1230, DOI 10.1371/journal.pmed.0040238; NHMRC, 2018, NAT STAT ETH COND HU; Noyes J, 2007, J ADV NURS, V57, P227, DOI 10.1111/j.1365-2648.2006.04092.x; Obstfelder A, 2007, IMPLEMENT SCI, V2, DOI 10.1186/1748-5908-2-25; Organisation for Economic Co-operation and Development, 2012, MONTHL COMP PRIC LEV; QSR International, 2009, NVIVO; Rusen ID, 2007, INT J TUBERC LUNG D, V11, P120; Schermer M, 2009, J MED ETHICS, V35, P688, DOI 10.1136/jme.2009.030973; Snell N J, 1999, Expert Opin Pharmacother, V1, P31, DOI 10.1517/14656566.1.1.31; StataCorp, 2009, STAT 11 BAS REF MAN, V1; Tracy J, 2008, TELEMED J E-HEALTH, V14, P990, DOI 10.1089/tmj.2008.0125; Tranter P, 2007, STAT AUSTR CIT 2007; VOLMINK J, 2007, COCHRANE DATABASE SY; Wade V, 2011, HDB DIGITAL HOMECARE; Wade V, 2009, ELECTRON J HEALTH IN, V4; Walley JD, 2001, LANCET, V357, P664, DOI 10.1016/S0140-6736(00)04129-5; Weis SE, 1999, INT J TUBERC LUNG D, V3, P976; World Health Organization, 2009, GLOB TUB CONTR EP ST; Xu WG, 2009, BMC HEALTH SERV RES, V9, DOI 10.1186/1472-6963-9-169; Zwarenstein M, 2000, INT J TUBERC LUNG D, V4, P550; Zwarenstein M, 1998, LANCET, V352, P1340, DOI 10.1016/S0140-6736(98)04022-7	46	44	48	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 30	2012	7	11							e50155	10.1371/journal.pone.0050155	http://dx.doi.org/10.1371/journal.pone.0050155			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	054WM	23226243	Green Published, gold, Green Submitted			2022-12-27	WOS:000312376100052
J	Zhang, XY; Cui, XD; Cheng, LX; Guan, XM; Li, H; Li, X; Cheng, M				Zhang, Xiaoyun; Cui, Xiaodong; Cheng, Lixia; Guan, Xiumei; Li, Hong; Li, Xin; Cheng, Min			Actin Stabilization by Jasplakinolide Affects the Function of Bone Marrow-Derived Late Endothelial Progenitor Cells	PLOS ONE			English	Article							NITRIC-OXIDE SYNTHASE; IN-VITRO; F-ACTIN; DEPENDENT PATHWAY; STEM-CELLS; KAPPA-B; CYTOSKELETON; APOPTOSIS; POLYMERIZATION; ACTIVATION	Background: Bone marrow-derived endothelial progenitor cells (EPCs), especially late EPCs, play a critical role in endothelial maintenance and repair, and postnatal vasculogenesis. Although the actin cytoskeleton has been considered as a modulator that controls the function and modulation of stem cells, its role in the function of EPCs, and in particular late EPCs, remains poorly understood. Methodology/Principal Finding: Bone marrow-derived late EPCs were treated with jasplakinolide, a compound that stabilizes actin filaments. Cell apoptosis, proliferation, adhesion, migration, tube formation, nitric oxide (NO) production and endothelial NO synthase (eNOS) phosphorylation were subsequently assayed in vitro. Moreover, EPCs were locally infused into freshly balloon-injured carotid arteries, and the reendothelialization capacity was evaluated after 14 days. Jasplakinolide affected the actin distribution of late EPCs in a concentration and time dependent manner, and a moderate concentration of (100 nmol/l) jasplakinolide directly stabilized the actin filament of late EPCs. Actin stabilization by jasplakinolide enhanced the late EPC apoptosis induced by VEGF deprivation, and significantly impaired late EPC proliferation, adhesion, migration and tube formation. Furthermore, jasplakinolide attenuated the reendothelialization capacity of transplanted EPCs in the injured arterial segment in vivo. However, eNOS phosphorylation and NO production were increased in late EPCs treated with jasplakinolide. NO donor sodium nitroprusside (SNP) rescued the functional activities of jasplakinolide-stressed late EPCs while the endothelial NO synthase inhibitor L-NAME led to a further dysfunction induced by jasplakinolide in late EPCs. Conclusions/Significance: A moderate concentration of jasplakinolide results in an accumulation of actin filaments, enhancing the apoptosis induced by cytokine deprivation, and impairing the proliferation and function of late EPCs both in vitro and in vivo. NO donor reverses these impairments, suggesting the role of NO-related mechanisms in jasplakinolide-induced EPC downregulation. Actin cytoskeleton may thus play a pivotal role in regulating late EPC function.	[Zhang, Xiaoyun; Cui, Xiaodong; Guan, Xiumei; Li, Hong; Li, Xin; Cheng, Min] Weifang Med Coll, Med Res Ctr, Weifang, Shandong, Peoples R China; [Cheng, Lixia] Peoples Hosp, Dept Endocrinol, Weifang, Shandong, Peoples R China	Weifang Medical University	Cheng, M (corresponding author), Weifang Med Coll, Med Res Ctr, Weifang, Shandong, Peoples R China.	chengmin1976@wfmc.edu.cn			National Natural Science Foundation of China [30900290]; Natural Science Foundation of Shandong Province [ZR2009CQ027]; Program for New Century Excellent Talents in University [NCET-10-0922]; Foundation of Shandong Educational Committee [J09LF06]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Shandong Province(Natural Science Foundation of Shandong Province); Program for New Century Excellent Talents in University(Program for New Century Excellent Talents in University (NCET)); Foundation of Shandong Educational Committee	This work was supported by the National Natural Science Foundation of China (NO. 30900290), the Natural Science Foundation of Shandong Province (NO. ZR2009CQ027), Program for New Century Excellent Talents in University (NO. NCET-10-0922) and Foundation of Shandong Educational Committee (NO. J09LF06). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abid MR, 2004, J BIOL CHEM, V279, P44030, DOI 10.1074/jbc.M408285200; Aicher A, 2003, NAT MED, V9, P1370, DOI 10.1038/nm948; Angelos MG, 2010, BIOPHYS J, V99, P3545, DOI 10.1016/j.bpj.2010.10.004; Barbier S, 2009, HAEMATOL-HEMATOL J, V94, P507, DOI 10.3324/haematol.13690; Brixius K, 2006, EUR J CARDIOV PREV R, V13, P705, DOI 10.1097/01.hjr.0000221862.34662.31; Brown MA, 2009, TISSUE ENG PT A, V15, P3575, DOI 10.1089/ten.TEA.2008.0444; Bubb MR, 2000, J BIOL CHEM, V275, P5163, DOI 10.1074/jbc.275.7.5163; BUBB MR, 1994, J BIOL CHEM, V269, P14869; Bugyi B, 2010, ANNU REV BIOPHYS, V39, P449, DOI 10.1146/annurev-biophys-051309-103849; Carlier MF, 2007, J BIOL CHEM, V282, P23005, DOI 10.1074/jbc.R700020200; Chen C, 2009, NEPHRON EXP NEPHROL, V113, pE26, DOI 10.1159/000228080; Chen JF, 2010, MOL CELL BIOCHEM, V335, P137, DOI 10.1007/s11010-009-0250-y; Chen YH, 2007, DIABETES, V56, P1559, DOI 10.2337/db06-1103; Connelly JT, 2010, NAT CELL BIOL, V12, P711, DOI 10.1038/ncb2074; Du J, 2010, CELL PHYSIOL BIOCHEM, V25, P501, DOI 10.1159/000303055; Funcke F, 2008, EUR J CELL BIOL, V87, P81, DOI 10.1016/j.ejcb.2007.08.002; Furtak V, 2001, BIOCHEM BIOPH RES CO, V289, P845, DOI 10.1006/bbrc.2001.6064; Genesca M, 2006, APOPTOSIS, V11, P563, DOI 10.1007/s10495-006-4937-1; Griese DP, 2003, CARDIOVASC RES, V58, P469, DOI 10.1016/S0008-6363(03)00266-9; Groleau J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023308; Hur J, 2004, ARTERIOSCL THROM VAS, V24, P288, DOI 10.1161/01.ATV.0000114236.77009.06; Kawabe-Yako R, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024646; Kihara T, 2011, BIOCHEM BIOPH RES CO, V409, P1, DOI 10.1016/j.bbrc.2011.04.022; Kirfel G, 2004, EUR J CELL BIOL, V83, P717, DOI 10.1078/0171-9335-00421; Knecht DA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014039; Kolluru GK, 2008, EUR J CELL BIOL, V87, P147, DOI 10.1016/j.ejcb.2007.10.001; Kosmidou I, 2007, ARTERIOSCL THROM VAS, V27, P2642, DOI 10.1161/ATVBAHA.107.154492; Kustermans G, 2005, BIOCHEM J, V387, P531, DOI 10.1042/BJ20041318; Ladhoff J, 2010, CARDIOVASC RES, V88, P121, DOI 10.1093/cvr/cvq109; Landmesser U, 2005, CURR OPIN CARDIOL, V20, P547, DOI 10.1097/01.hco.0000179821.11071.79; Laufs U, 2000, J CLIN INVEST, V106, P15, DOI 10.1172/JCI9639; Medina RJ, 2010, BMC MED GENOMICS, V3, DOI 10.1186/1755-8794-3-18; Odaka C, 2000, CLIN DIAGN LAB IMMUN, V7, P947, DOI 10.1128/CDLI.7.6.947-952.2000; Ozuyaman B, 2005, THROMB HAEMOSTASIS, V94, P770, DOI 10.1160/TH05-01-0038; Papakonstanti EA, 2008, FEBS LETT, V582, P2120, DOI 10.1016/j.febslet.2008.02.064; Posey SC, 1999, J BIOL CHEM, V274, P4259, DOI 10.1074/jbc.274.7.4259; Rao JY, 1999, J CELL BIOCHEM, V75, P686, DOI 10.1002/(SICI)1097-4644(19991215)75:4<686::AID-JCB14>3.0.CO;2-F; Rohde E, 2006, STEM CELLS, V24, P357, DOI 10.1634/stemcells.2005-0072; Schober JM, 2003, J THROMB HAEMOST, V1, P2404, DOI 10.1046/j.1538-7836.2003.00417.x; Searles CD, 2004, CIRC RES, V95, P488, DOI 10.1161/01.RES.0000138953.21377.80; Sharma DK, 2005, CANCER RES, V65, P8233, DOI 10.1158/0008-5472.CAN-05-0803; Shirota T, 2003, TISSUE ENG, V9, P127, DOI 10.1089/107632703762687609; Smadja DM, 2005, ARTERIOSCL THROM VAS, V25, P2321, DOI 10.1161/01.ATV.0000184762.63888.bd; Spector I, 1999, MICROSC RES TECHNIQ, V47, P18, DOI 10.1002/(SICI)1097-0029(19991001)47:1<18::AID-JEMT3>3.0.CO;2-E; Urbich C, 2005, J MOL CELL CARDIOL, V39, P733, DOI 10.1016/j.yjmcc.2005.07.003; Vita JA, 2011, CIRCULATION, V124, pE906, DOI 10.1161/CIRCULATIONAHA.111.078824; Vogel S, 2010, J BIOL CHEM, V285, P33756, DOI 10.1074/jbc.M110.132985; Yoder MC, 2007, BLOOD, V109, P1801, DOI 10.1182/blood-2006-08-043471; Zhang F, 2009, P NATL ACAD SCI USA, V106, P6152, DOI 10.1073/pnas.0813061106	49	24	27	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 30	2012	7	11							e50899	10.1371/journal.pone.0050899	http://dx.doi.org/10.1371/journal.pone.0050899			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	054WM	23226422	Green Published, Green Submitted, gold			2022-12-27	WOS:000312376100233
J	Kapczynski, A; Park, C; Sampat, B				Kapczynski, Amy; Park, Chan; Sampat, Bhaven			Polymorphs and Prodrugs and Salts (Oh My!): An Empirical Analysis of "Secondary'' Pharmaceutical Patents	PLOS ONE			English	Article							LIFE	Background: While there has been much discussion by policymakers and stakeholders about the effects of "secondary patents'' on the pharmaceutical industry, there is no empirical evidence on their prevalence or determinants. Characterizing the landscape of secondary patents is important in light of recent court decisions in the U.S. that may make them more difficult to obtain, and for developing countries considering restrictions on secondary patents. Methodology/Principal Findings: We read the claims of the 1304 Orange Book listed patents on all new molecular entities approved in the U.S. between 1988 and 2005, and coded the patents as including chemical compound claims (claims covering the active molecule itself) and/or one of several types of secondary claims. We distinguish between patents with any secondary claims, and those with only secondary claims and no chemical compound claims ("independent'' secondary patents). We find that secondary claims are common in the pharmaceutical industry. We also show that independent secondary patents tend to be filed and issued later than chemical compound patents, and are also more likely to be filed after the drug is approved. When present, independent formulation patents add an average of 6.5 years of patent life (95% C.I.: 5.9 to 7.3 years), independent method of use patents add 7.4 years (95% C.I.: 6.4 to 8.4 years), and independent patents on polymorphs, isomers, prodrug, ester, and/or salt claims add 6.3 years (95% C.I.: 5.3 to 7.3 years). We also provide evidence that late-filed independent secondary patents are more common for higher sales drugs. Conclusions/Significance: Policies and court decisions affecting secondary patenting are likely to have a significant impact on the pharmaceutical industry. Secondary patents provide substantial additional patent life in the pharmaceutical industry, at least nominally. Evidence that they are also more common for best-selling drugs is consistent with accounts of active "life cycle management'' or "evergreening'' of patent portfolios in the industry.	[Sampat, Bhaven] Columbia Univ, Mailman Sch Publ Hlth, Dept Hlth Policy & Management, New York, NY 10027 USA; [Kapczynski, Amy] Yale Univ, Yale Law Sch, New Haven, CT USA; [Park, Chan] Med Patent Pool, Geneva, Switzerland	Columbia University; Yale University	Sampat, B (corresponding author), Columbia Univ, Mailman Sch Publ Hlth, Dept Hlth Policy & Management, New York, NY 10027 USA.	bns3@columbia.edu						Agency for Healthcare Research and Quality, 1996, MEDICAL EXPENDITURE; Amin T, 2012, HEALTH AFFAIR, V31, P2286, DOI 10.1377/hlthaff.2012.0107; Burdon M., 2003, J MED MARK, V3, P226, DOI DOI 10.1057/PALGRAVE.JMM.5040125; CAVES RE, 1991, BROOKINGS PAP ECO AC, P1; Cheng J, 2008, COLUMBIA LAW REV, V108, P1471; Cohen Wesley M., 2000, WORKING PAPER NO 755; Correa C. M., 2007, GUIDELINES FOR THE E; Eisenberg Rebecca S., 2008, LEWIS CLARK L REV, V12, P375; European Commission, 2009, PHARMACEUTICAL SECTO; Federal Trade Commission, 2002, GENERIC DRUG ENTRY P; Furrow ME, 2008, FOOD DRUG LAW J, V63, P275; Gorlin DL, 2008, FOOD DRUG LAW J, V63, P823; Grabowski HG, 2000, INT J TECHNOL MANAGE, V19, P98, DOI 10.1504/IJTM.2000.002803; Grubb PW, 2010, PATENTS FOR CHEMICAL; Hemphill CS, 2012, J HEALTH ECON, V31, P327, DOI 10.1016/j.jhealeco.2012.01.004; Hemphill CS, 2011, J EMPIR LEGAL STUD, V8, P613, DOI 10.1111/j.1740-1461.2011.01235.x; Jaffe A, 2006, INNOVATION AND ITS D; Kapczynski A, 2009, CALIF LAW REV, V97, P1571; LEVIN RC, 1987, BROOKINGS PAP ECO AC, P783; MANSFIELD E, 1986, MANAGE SCI, V32, P173, DOI 10.1287/mnsc.32.2.173; OECD, 2004, PATENTS INNOVATION A; Pammolli F, 2011, NAT REV DRUG DISCOV, V10, P428, DOI 10.1038/nrd3405; Park C, 2008, DEFINING THE CONCEPT; Park C, 2010, THE IMPLEMENTATION O; Rathod S, 2010, EVER GREENING A STAT, V7, P227; Scherer F.M., 2009, J TELECOMM HIGH TECH, V7, P167; US Food and Drug Administration, ORANGE BOOK APPROVED; USPTO, CASSIS BIB DVD	28	66	68	2	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 5	2012	7	12							e49470	10.1371/journal.pone.0049470	http://dx.doi.org/10.1371/journal.pone.0049470			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	057TZ	23227141	Green Published, gold, Green Submitted			2022-12-27	WOS:000312588200004
J	Kong, SW; Collins, CD; Shimizu-Motohashi, Y; Holm, IA; Campbell, MG; Lee, IH; Brewster, SJ; Hanson, E; Harris, HK; Lowe, KR; Saada, A; Mora, A; Madison, K; Hundley, R; Egan, J; McCarthy, J; Eran, A; Galdzicki, M; Rappaport, L; Kunkel, LM; Kohane, IS				Kong, Sek Won; Collins, Christin D.; Shimizu-Motohashi, Yuko; Holm, Ingrid A.; Campbell, Malcolm G.; Lee, In-Hee; Brewster, Stephanie J.; Hanson, Ellen; Harris, Heather K.; Lowe, Kathryn R.; Saada, Adrianna; Mora, Andrea; Madison, Kimberly; Hundley, Rachel; Egan, Jessica; McCarthy, Jillian; Eran, Ally; Galdzicki, Michal; Rappaport, Leonard; Kunkel, Louis M.; Kohane, Isaac S.			Characteristics and Predictive Value of Blood Transcriptome Signature in Males with Autism Spectrum Disorders	PLOS ONE			English	Article							LYMPHOBLASTOID CELL-LINES; GENE-EXPRESSION; PERIPHERAL-BLOOD; MENTAL-RETARDATION; BIPOLAR DISORDER; CHILDREN; BRAIN; IDENTIFICATION; MUTATIONS; PATHWAYS	Autism Spectrum Disorders (ASD) is a spectrum of highly heritable neurodevelopmental disorders in which known mutations contribute to disease risk in 20% of cases. Here, we report the results of the largest blood transcriptome study to date that aims to identify differences in 170 ASD cases and 115 age/sex-matched controls and to evaluate the utility of gene expression profiling as a tool to aid in the diagnosis of ASD. The differentially expressed genes were enriched for the neurotrophin signaling, long-term potentiation/depression, and notch signaling pathways. We developed a 55-gene prediction model, using a cross-validation strategy, on a sample cohort of 66 male ASD cases and 33 age-matched male controls (P1). Subsequently, 104 ASD cases and 82 controls were recruited and used as a validation set (P2). This 55-gene expression signature achieved 68% classification accuracy with the validation cohort (area under the receiver operating characteristic curve (AUC): 0.70 [95% confidence interval [CI]: 0.62-0.77]). Not surprisingly, our prediction model that was built and trained with male samples performed well for males (AUC 0.73, 95% CI 0.65-0.82), but not for female samples (AUC 0.51, 95% CI 0.36-0.67). The 55-gene signature also performed robustly when the prediction model was trained with P2 male samples to classify P1 samples (AUC 0.69, 95% CI 0.58-0.80). Our result suggests that the use of blood expression profiling for ASD detection may be feasible. Further study is required to determine the age at which such a test should be deployed, and what genetic characteristics of ASD can be identified. Citation: Kong SW, Collins CD, Shimizu-Motohashi Y, Holm IA, Campbell MG, et al. (2012) Characteristics and Predictive Value of Blood Transcriptome Signature in Males with Autism Spectrum Disorders. PLoS ONE 7(12): e49475. doi:10.1371/journal.pone.0049475	[Collins, Christin D.; Shimizu-Motohashi, Yuko; Holm, Ingrid A.; Brewster, Stephanie J.; Hanson, Ellen; Harris, Heather K.; Lowe, Kathryn R.; Egan, Jessica; McCarthy, Jillian; Kunkel, Louis M.] Boston Childrens Hosp, Program Genom, Div Genet, Boston, MA USA; [Kong, Sek Won; Campbell, Malcolm G.; Lee, In-Hee; Eran, Ally; Galdzicki, Michal; Kohane, Isaac S.] Boston Childrens Hosp, Informat Program, Harvard Massachusetts Inst Technol, Div Hlth Sci & Technol, Boston, MA USA; [Holm, Ingrid A.; Kunkel, Louis M.; Kohane, Isaac S.] Boston Childrens Hosp, Manton Ctr Orphan Dis Res, Boston, MA USA; [Hanson, Ellen; Saada, Adrianna; Mora, Andrea; Madison, Kimberly; Hundley, Rachel; Rappaport, Leonard] Boston Childrens Hosp, Div Dev Med, Boston, MA USA; [Hanson, Ellen; Hundley, Rachel] Boston Childrens Hosp, Dept Psychiat, Boston, MA USA; [Kong, Sek Won] Boston Childrens Hosp, Dept Cardiol, Boston, MA USA; [Kong, Sek Won; Collins, Christin D.; Shimizu-Motohashi, Yuko; Holm, Ingrid A.; Rappaport, Leonard; Kunkel, Louis M.; Kohane, Isaac S.] Harvard Univ, Sch Med, Dept Pediat, Boston, MA 02115 USA; [Kunkel, Louis M.] Harvard Univ, Sch Med, Howard Hughes Med Inst, Boston, MA 02115 USA; [Kunkel, Louis M.] Harvard Univ, Sch Med, Dept Genet, Boston, MA USA; [Kohane, Isaac S.] Harvard Univ, Sch Med, Ctr Biomed Informat, Boston, MA USA; [Holm, Ingrid A.; Brewster, Stephanie J.; Harris, Heather K.; Lowe, Kathryn R.; Kohane, Isaac S.] Autism Consortium, Boston, MA USA	Harvard University; Boston Children's Hospital; Harvard University; Boston Children's Hospital; Harvard University; Boston Children's Hospital; Harvard University; Boston Children's Hospital; Harvard University; Boston Children's Hospital; Harvard University; Boston Children's Hospital; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Howard Hughes Medical Institute; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School	Kunkel, LM (corresponding author), Boston Childrens Hosp, Program Genom, Div Genet, Boston, MA USA.	kunkel@enders.tch.harvard.edu; isaac_kohane@harvard.edu	Rappaport, Leonard/HGD-6175-2022; Galdzicki, Michal/F-5682-2010	Kong, Sek Won/0000-0003-4877-7567; Lee, In-Hee/0000-0002-8857-1355; Holm, Ingrid/0000-0003-4712-8821; Galdzicki, Michal/0000-0002-8392-8183; Eran, Alal/0000-0001-6784-7597	Simons Foundation [95117]; Nancy Lurie Marks Family Foundation; Autism Speaks [1968, 4828]; Howard Hughes Medical Institute; Autism Consortium; National Institute of Mental Health [R01MH085143]; National Institute of Child Health and Human Development [P30HD018655]; Charles H. Hood Foundation; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [P30HD018655] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH085143] Funding Source: NIH RePORTER	Simons Foundation; Nancy Lurie Marks Family Foundation; Autism Speaks; Howard Hughes Medical Institute(Howard Hughes Medical Institute); Autism Consortium; National Institute of Mental Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); National Institute of Child Health and Human Development(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); Charles H. Hood Foundation; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This work was supported by grants from Simons Foundation (95117, to LMK and ISK), Nancy Lurie Marks Family Foundation (to LMK and ISK), Autism Speaks (1968 to LMK and 4828 to CDC), Howard Hughes Medical Institute (LMK), Autism Consortium, National Institute of Mental Health (R01MH085143, to LMK), Molecular Genetics Core laboratory supported by National Institute of Child Health and Human Development (P30HD018655, to LMK), and Charles H. Hood Foundation (SWK). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abrahams BS, 2008, NAT REV GENET, V9, P341, DOI 10.1038/nrg2346; Abu-Elneel K, 2008, NEUROGENETICS, V9, P153, DOI 10.1007/s10048-008-0133-5; Affymetrix, 2005, GUID PROB LOG INT ER; American Psychiatric Association, 2000, DIAGN STAT MAN MENT; Anney R, 2010, HUM MOL GENET, V19, P4072, DOI 10.1093/hmg/ddq307; Asymetrix, 2005, AFF US GUID PROD COM; Badens C, 2006, CLIN GENET, V70, P57, DOI 10.1111/j.1399-0004.2006.00641.x; Baio Jon, 2012, Morbidity and Mortality Weekly Report, V61, P1; Baron CA, 2006, J AUTISM DEV DISORD, V36, P973, DOI 10.1007/s10803-006-0134-x; Basu SN, 2009, NUCLEIC ACIDS RES, V37, pD832, DOI 10.1093/nar/gkn835; Bienvenu T, 2002, HUM MOL GENET, V11, P981, DOI 10.1093/hmg/11.8.981; Brodersen KH, 2010, BALANCED ACCURACY IT, P3121; Castensson A, 2003, BIOL PSYCHIAT, V54, P1212, DOI 10.1016/S0006-3223(03)00526-2; Castermans D, 2007, EUR J HUM GENET, V15, P422, DOI 10.1038/sj.ejhg.5201785; Chao MV, 2003, NAT REV NEUROSCI, V4, P299, DOI 10.1038/nrn1078; Chow ML, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002592; Coppola G, 2008, ANN NEUROL, V64, P92, DOI 10.1002/ana.21397; Corbett BA, 2007, MOL PSYCHIATR, V12, P292, DOI 10.1038/sj.mp.4001943; Dai JJ, 2006, STAT APPL GENET MOL, V5; Dennis G, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-9-r60; Enstrom AM, 2009, BRAIN BEHAV IMMUN, V23, P124, DOI 10.1016/j.bbi.2008.08.001; Filzmoser P., 2009, MULTIVARIATE STAT AN, V66, P112; Fury Wen, 2006, Conf Proc IEEE Eng Med Biol Soc, V2006, P5531; Garbett K, 2008, NEUROBIOL DIS, V30, P303, DOI 10.1016/j.nbd.2008.01.012; Glatt SJ, 2012, J AM ACAD CHILD ADOL, V51, P934; Gregg JP, 2008, GENOMICS, V91, P22, DOI 10.1016/j.ygeno.2007.09.003; Griggs BL, 2008, GENOMICS, V91, P195, DOI 10.1016/j.ygeno.2007.10.011; Happe F, 2008, NEUROPSYCHOL REV, V18, P287, DOI 10.1007/s11065-008-9076-8; Harris SL, 2000, J AUTISM DEV DISORD, V30, P137, DOI 10.1023/A:1005459606120; Hennekam RCM, 2006, EUR J HUM GENET, V14, P981, DOI 10.1038/sj.ejhg.5201594; Hosack DA, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-10-r70; HOWLAND A, 1975, DEV MED CHILD NEUROL, V17, P325; Hu VW, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-118; Hu VW, 2009, AUTISM RES, V2, P78, DOI 10.1002/aur.73; Hu VW, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005775; Huang DW, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-9-r183; Ihaka R., 1996, J COMPUT GRAPH STAT, V5, P299, DOI [DOI 10.1080/10618600.1996.10474713, 10.2307/1390807]; Jacquemont ML, 2006, J MED GENET, V43, P843, DOI 10.1136/jmg.2006.043166; Jasinska AJ, 2009, HUM MOL GENET, V18, P4415, DOI 10.1093/hmg/ddp397; Johnson WE, 2007, BIOSTATISTICS, V8, P118, DOI 10.1093/biostatistics/kxj037; Kanehisa M, 2010, NUCLEIC ACIDS RES, V38, pD355, DOI 10.1093/nar/gkp896; Kesler SR, 2007, NEUROGENETICS, V8, P143, DOI 10.1007/s10048-007-0080-6; Kuhn M, 2008, J STAT SOFTW, V28, P1, DOI 10.18637/jss.v028.i05; Leek JT, 2007, PLOS GENET, V3, P1724, DOI 10.1371/journal.pgen.0030161; Levitt P, 2009, J CLIN INVEST, V119, P747, DOI 10.1172/JCI37934; Lord C, 2006, ARCH GEN PSYCHIAT, V63, P694, DOI 10.1001/archpsyc.63.6.694; Marshall CR, 2008, AM J HUM GENET, V82, P477, DOI 10.1016/j.ajhg.2007.12.009; McKusick V.A., 1998, MENDELIAN INHERITANC; Mondal K, 2012, HUM MOL GENET; Nguyen DV, 2002, BIOINFORMATICS, V18, P39, DOI 10.1093/bioinformatics/18.1.39; Nishimura Y, 2007, HUM MOL GENET, V16, P1682, DOI 10.1093/hmg/ddm116; Padmos RC, 2008, ARCH GEN PSYCHIAT, V65, P395, DOI 10.1001/archpsyc.65.4.395; Pinto D, 2010, NATURE, V466, P368, DOI 10.1038/nature09146; Piton A, 2011, MOL PSYCHIATR, V16, P867, DOI 10.1038/mp.2010.54; Purcell AE, 2001, NEUROLOGY, V57, P1618, DOI 10.1212/WNL.57.9.1618; Ramoz N, 2008, AM J MED GENET B, V147B, P1152, DOI 10.1002/ajmg.b.30739; Rohatgi S, 2010, AM J MED GENET A, V152A, P1641, DOI 10.1002/ajmg.a.33441; Ruggieri Martino, 2010, Front Biosci (Elite Ed), V2, P701, DOI 10.2741/e130; Sarachana T, 2010, GENOME MED, V2, DOI 10.1186/gm144; Scherzer CR, 2007, P NATL ACAD SCI USA, V104, P955, DOI 10.1073/pnas.0610204104; Seno MMG, 2011, BRAIN RES, V1380, P85, DOI 10.1016/j.brainres.2010.09.046; Shattuck PT, 2009, J AM ACAD CHILD PSY, V48, P474, DOI 10.1097/CHI.0b013e31819b3848; Shen YP, 2010, PEDIATRICS, V125, pE727, DOI 10.1542/peds.2009-1684; Shi LM, 2010, NAT BIOTECHNOL, V28, P827, DOI 10.1038/nbt.1665; Stenson P. D., 2012, CURR PROTOC BIOINFOR; Stettner GM, 2011, AM J MED GENET A, V155A, P2003, DOI 10.1002/ajmg.a.34122; Storey JD, 2003, P NATL ACAD SCI USA, V100, P9440, DOI 10.1073/pnas.1530509100; Sullivan PF, 2006, AM J MED GENET B, V141B, P261, DOI 10.1002/ajmg.b.30272; Talebizadeh Z, 2008, AUTISM RES, V1, P240, DOI 10.1002/aur.33; van't Veer LJ, 2002, NATURE, V415, P530, DOI 10.1038/415530a; Vargas DL, 2005, ANN NEUROL, V57, P67, DOI 10.1002/ana.20315; Voineagu I, 2011, NATURE, V474, P380, DOI 10.1038/nature10110; Washizuka S, 2009, NEUROSCI RES, V63, P199, DOI 10.1016/j.neures.2008.12.004; Wiggins LD, 2006, J DEV BEHAV PEDIATR, V27, pS79, DOI 10.1097/00004703-200604002-00005; Witten I. H., 2005, DATA MINING PRACTICA	75	107	109	1	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 5	2012	7	12							e49475	10.1371/journal.pone.0049475	http://dx.doi.org/10.1371/journal.pone.0049475			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	057TZ	23227143	Green Published, gold, Green Submitted			2022-12-27	WOS:000312588200006
J	Krivokharchenko, A; Karmenyan, A; Sarkisov, O; Bader, M; Chiou, A; Shakhbazyan, A				Krivokharchenko, Alexander; Karmenyan, Artashes; Sarkisov, Oleg; Bader, Michael; Chiou, Arthur; Shakhbazyan, Avetik			Laser Fusion of Mouse Embryonic Cells and Intra-Embryonic Fusion of Blastomeres without Affecting the Embryo Integrity	PLOS ONE			English	Article							ELECTRIC-FIELD; IN-VITRO; POLYETHYLENE-GLYCOL; BLASTOCYSTS; ELECTROFUSION	Manipulation with early mammalian embryos is the one of the most important approach to study preimplantation development. Artificial cell fusion is a research tool for various biotechnological experiments. However, the existing methods have various disadvantages, first of them impossibility to fuse selected cells within multicellular structures like mammalian preimplantation embryos. In our experiments we have successfully used high repetition rate picosecond near infrared laser beam for fusion of pairs of oocytes and oocytes with blastomeres. Fused cells looked morphologically normal and keep their ability for further divisions in vitro. We also fused two or three blastomeres inside four-cell mouse embryos. The presence of one, two or three nuclei in different blastomeres of the same early preimplantation mouse embryo was confirmed under UV-light after staining of DNA with the vital dye Hoechst-33342. The most of established embryos demonstrated high viability and developed in vitro to the blastocyst stage. We demonstrated for the first time the use of laser beam for the fusion of various embryonic cells of different size and of two or three blastomeres inside of four-cell mouse embryos without affecting the embryo's integrity and viability. These embryos with blastomeres of various ploidy maybe unique model for numerous purposes. Thus, we propose laser optical manipulation as a new tool for investigation of fundamental mechanisms of mammalian development.	[Karmenyan, Artashes; Chiou, Arthur] Natl Yang Ming Univ, Biophoton & Mol Imaging Res Ctr, Taipei 112, Taiwan; [Krivokharchenko, Alexander; Bader, Michael] Max Delbruck Ctr Mol Med, Berlin, Germany; [Sarkisov, Oleg; Shakhbazyan, Avetik] Russian Acad Sci, NN Semenov Chem Phys Inst, Moscow, Russia; [Chiou, Arthur] Natl Yang Ming Univ, Inst Biophoton, Taipei 112, Taiwan; [Shakhbazyan, Avetik] Russian Acad Sci, Inst Theoret & Expt Biophys, Pushchino 142292, Moscow Region, Russia	National Yang Ming Chiao Tung University; Helmholtz Association; Max Delbruck Center for Molecular Medicine; Russian Academy of Sciences; N.N. Semenov Federal Research Centre for Chemical Physics, Russian Academy of Sciences; National Yang Ming Chiao Tung University; Russian Academy of Sciences; Institute of Theoretical & Experimental Biophysics	Karmenyan, A (corresponding author), Natl Yang Ming Univ, Biophoton & Mol Imaging Res Ctr, Taipei 112, Taiwan.	artashes@ym.edu.tw	Bader, Michael/K-2124-2013; Karmenyan, Artashes/U-3697-2019	Bader, Michael/0000-0003-4780-4164	DFG [KR 3719/1-1, KR 3719/2-1]; Russian Foundation for Basic Research; Taiwan National Science Consulate [NSC 99-2923-B-010-003-MY2, NSC 10-04-92001-NNC_a]	DFG(German Research Foundation (DFG)); Russian Foundation for Basic Research(Russian Foundation for Basic Research (RFBR)); Taiwan National Science Consulate	A Krivokharchenko was supported by the grant of DFG(KR 3719/1-1 & KR 3719/2-1). This work was supported by a joint grant between the Russian Foundation for Basic Research and Taiwan National Science Consulate NSC 99-2923-B-010-003-MY2 and NSC 10-04-92001-NNC_a. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BERG H, 1982, BIOELECTROCH BIOENER, V9, P223, DOI 10.1016/0302-4598(82)80178-5; Curnow EC, 2000, MOL REPROD DEV, V56, P372, DOI 10.1002/1098-2795(200007)56:3&lt;372::AID-MRD7&gt;3.0.CO;2-W; EGLITIS MA, 1980, J EXP ZOOL, V213, P309, DOI 10.1002/jez.1402130222; Karmenyan AV, 2009, MOL REPROD DEV, V76, P975, DOI 10.1002/mrd.21045; Kohli V, 2009, WIRES NANOMED NANOBI, V1, P11, DOI 10.1002/wnan.29; Krivokharchenko A, 2003, BIOL REPROD, V68, P829, DOI 10.1095/biolreprod.102.006494; Krivokharchenko A, 2002, MOL REPROD DEV, V61, P460, DOI 10.1002/mrd.90001; KUBIAK JZ, 1985, EXP CELL RES, V157, P561, DOI 10.1016/0014-4827(85)90143-0; Kuetemeyer K, 2011, J BIOMED OPT, V16, DOI 10.1117/1.3609818; Kuetemeyer K, 2010, J BIOMED OPT, V15, DOI 10.1117/1.3463012; NAGY A, 1990, DEVELOPMENT, V110, P815; ONEILL GT, 1990, CYTOGENET CELL GENET, V53, P191, DOI 10.1159/000132928; OZIL JP, 1986, J EMBRYOL EXP MORPH, V96, P211; Popova E, 2011, HUM REPROD, V26, P662, DOI 10.1093/humrep/deq379; Prather RS, 1996, MOL REPROD DEV, V45, P38, DOI 10.1002/(SICI)1098-2795(199609)45:1&lt;38::AID-MRD5&gt;3.0.CO;2-T; Shakhbazyan A K, 2009, Dokl Biol Sci, V429, P587; SPINDLE A, 1981, EXP CELL RES, V131, P465, DOI 10.1016/0014-4827(81)90259-7; STEUBING RW, 1991, CYTOMETRY, V12, P505, DOI 10.1002/cyto.990120607; WIEGAND R, 1987, J CELL SCI, V88, P145	19	8	8	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 5	2012	7	12							e50029	10.1371/journal.pone.0050029	http://dx.doi.org/10.1371/journal.pone.0050029			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	057TZ	23227157	Green Published, Green Accepted, gold			2022-12-27	WOS:000312588200019
J	Liniger, M; Summerfield, A; Ruggli, N				Liniger, Matthias; Summerfield, Artur; Ruggli, Nicolas			MDA5 Can Be Exploited as Efficacious Genetic Adjuvant for DNA Vaccination against Lethal H5N1 Influenza Virus Infection in Chickens	PLOS ONE			English	Article							RIG-I; INNATE IMMUNITY; ADAPTER PROTEIN; IFN-BETA; VACCINES; RESPONSES; CELLS; RECEPTORS; RECOGNITION; STRATEGIES	Chickens lack the retinoic acid-inducible gene I (RIG-I) and sense avian influenza virus (AIV) infections by means of the melanoma differentiation-associated gene 5 product (chMDA5). Plasmid-driven expression of the N-terminal half of chMDA5 containing the caspase activation and recruitment domains [chMDA5(1-483)] triggers interferon-beta responses in chicken cells. We hypothesized that mimicking virus infection by chMDA5(1-483) expression may enhance vaccine-induced adaptive immunity. In order to test this, the potential genetic adjuvant properties of chMDA5(1-483) were evaluated in vivo in combination with a suboptimal quantity of a plasmid DNA vaccine expressing haemagglutinin (HA) of H5N1 AIV. Co-administration of the HA plasmid with plasmid DNA for chMDA5(1-483) expression resulted in approximately 10-fold higher HA-specific antibody responses than injection of the HA plasmid mixed with empty vector DNA as control. Accordingly, compared with HA DNA vaccination alone, the chMDA5(1-483)-adjuvanted HA DNA vaccine mediated enhanced protection against a lethal H5N1 challenge infection in chickens, with reduced clinical signs and cloacal virus shedding. These data demonstrate that innate immune activation by expression of signaling domains of RIG-I-like receptors can be exploited to enhance vaccine efficacy.	[Liniger, Matthias; Summerfield, Artur; Ruggli, Nicolas] Inst Virol & Immunoprophylaxis, Res Dept, Mittelhausern, Switzerland		Ruggli, N (corresponding author), Inst Virol & Immunoprophylaxis, Res Dept, Mittelhausern, Switzerland.	nicolas.ruggli@ivi.admin.ch	Summerfield, Artur/K-2105-2016; Summerfield, Artur/H-6025-2019	Summerfield, Artur/0000-0001-8292-4634; Summerfield, Artur/0000-0001-8292-4634; Ruggli, Nicolas/0000-0002-7679-6290	Swiss Federal Veterinary Office [1.07.09]; EU [044220]	Swiss Federal Veterinary Office; EU(European Commission)	This work was funded by the Swiss Federal Veterinary Office (grant number 1.07.09; www.bvet.admin.ch) and by the EU FP6 project FUPATH (grant number 044220; cordis.europa.eu). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barber MRW, 2010, P NATL ACAD SCI USA, V107, P5913, DOI 10.1073/pnas.1001755107; Coffman RL, 2010, IMMUNITY, V33, P492, DOI 10.1016/j.immuni.2010.10.002; Didierlaurent AM, 2009, J IMMUNOL, V183, P6186, DOI 10.4049/jimmunol.0901474; Gack MU, 2008, P NATL ACAD SCI USA, V105, P16743, DOI 10.1073/pnas.0804947105; Gao YL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041332; Gasparini R, 2012, EXPERT REV VACCINES, V11, P145, DOI [10.1586/erv.11.170, 10.1586/ERV.11.170]; Heegaard PMH, 2011, ARCH VIROL, V156, P183, DOI 10.1007/s00705-010-0863-1; Hessel A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016247; Horimoto T, 2006, TRENDS MOL MED, V12, P506, DOI 10.1016/j.molmed.2006.09.003; Ireton RC, 2011, VIRUSES-BASEL, V3, P906, DOI 10.3390/v3060906; Johnston D, 2007, CANCER IMMUNOL IMMUN, V56, P1133, DOI 10.1007/s00262-006-0262-3; Karpala AJ, 2011, J IMMUNOL, V186, P5397, DOI 10.4049/jimmunol.1003712; Kasturi SP, 2011, NATURE, V470, P543, DOI 10.1038/nature09737; Kawai T, 2005, NAT IMMUNOL, V6, P981, DOI 10.1038/ni1243; Kobiyama K, 2009, J IMMUNOL, V182, P1593, DOI 10.4049/jimmunol.182.3.1593; Kool M, 2008, J IMMUNOL, V181, P3755, DOI 10.4049/jimmunol.181.6.3755; Krenn BM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018577; Kumagai Yutaro, 2008, Journal of Infection and Chemotherapy, V14, P86, DOI 10.1007/s10156-008-0596-1; Kumar H, 2008, J IMMUNOL, V180, P683, DOI 10.4049/jimmunol.180.2.683; Kumar H, 2009, BIOCHEM BIOPH RES CO, V388, P621, DOI 10.1016/j.bbrc.2009.08.062; Kumar Sachin, 2010, Recent Pat Biotechnol, V4, P235, DOI 10.2174/187220810793611473; Laddy DJ, 2006, INT REV IMMUNOL, V25, P99, DOI 10.1080/08830180600785827; Lambrecht BN, 2009, CURR OPIN IMMUNOL, V21, P23, DOI 10.1016/j.coi.2009.01.004; Leroux-Roels G, 2010, VACCINE, V28, pC25, DOI 10.1016/j.vaccine.2010.07.021; Levitz SM, 2012, CELL, V148, P1284, DOI 10.1016/j.cell.2012.02.012; Liniger M, 2007, EXPERT REV VACCINES, V6, P255, DOI 10.1586/14760584.6.2.255; Liniger M, 2012, VIROL J, V9, DOI 10.1186/1743-422X-9-7; Liniger M, 2012, J VIROL, V86, P705, DOI 10.1128/JVI.00742-11; Lladser A, 2011, MOL THER, V19, P594, DOI 10.1038/mt.2010.268; Luke JM, 2011, J VIROL, V85, P1370, DOI 10.1128/JVI.01250-10; Luo MC, 2011, VACCINE, V29, P2561, DOI 10.1016/j.vaccine.2011.01.060; Manicassamy S, 2009, SEMIN IMMUNOL, V21, P185, DOI 10.1016/j.smim.2009.05.005; Manzoor R, 2009, J VIROL, V83, P1572, DOI 10.1128/JVI.01879-08; Meylan E, 2005, NATURE, V437, P1167, DOI 10.1038/nature04193; Moser M, 2010, VACCINE, V28, pC2, DOI 10.1016/j.vaccine.2010.07.022; Moulin HR, 2011, VET RES, V42, DOI 10.1186/1297-9716-42-6; Mueller M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009097; Olive C, 2012, EXPERT REV VACCINES, V11, P237, DOI [10.1586/erv.11.189, 10.1586/ERV.11.189]; Plotkin SA, 2005, NAT MED, V11, pS5, DOI 10.1038/nm1209; Rao SS, 2009, POULTRY SCI, V88, P860, DOI 10.3382/ps.2008-00360; Rao S, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002432; Sarkar D, 2008, P NATL ACAD SCI USA, V105, P17040, DOI 10.1073/pnas.0804956105; Schwartz JA, 2011, J VIROL, V85, P4602, DOI 10.1128/JVI.02491-10; Schwarz H, 2004, J INTERF CYTOK RES, V24, P179, DOI 10.1089/107999004322917025; Seth RB, 2005, CELL, V122, P669, DOI 10.1016/j.cell.2005.08.012; Soda K, 2008, JPN J VET RES, V55, P93; Spackman E, 2002, J CLIN MICROBIOL, V40, P3256, DOI 10.1128/JCM.40.9.3256-3260.2002; Steel J, 2011, BIODRUGS, V25, P285, DOI 10.2165/11593870-000000000-00000; Steel J, 2009, J VIROL, V83, P1742, DOI 10.1128/JVI.01920-08; Stevceva L, 2000, GENES IMMUN, V1, P308, DOI 10.1038/sj.gene.6363680; Tovey MG, 2010, METHODS MOL BIOL, V626, P287, DOI 10.1007/978-1-60761-585-9_19; Tritto E, 2009, VACCINE, V27, P3331, DOI 10.1016/j.vaccine.2009.01.084; Veits J, 2008, VACCINE, V26, P1688, DOI 10.1016/j.vaccine.2008.01.016; Vemula SV, 2010, EXPERT OPIN BIOL TH, V10, P1469, DOI 10.1517/14712598.2010.519332; Xu LG, 2005, MOL CELL, V19, P727, DOI 10.1016/j.molcel.2005.08.014; Xu R, 2008, VACCINE, V26, P4819, DOI 10.1016/j.vaccine.2008.06.103; Yang SG, 2009, VACCINE, V27, P7451, DOI 10.1016/j.vaccine.2009.05.014; Yoneyama M, 2004, NAT IMMUNOL, V5, P730, DOI 10.1038/ni1087; Zou J, 2009, BMC EVOL BIOL, V9, DOI 10.1186/1471-2148-9-85	60	27	30	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 5	2012	7	12							e49952	10.1371/journal.pone.0049952	http://dx.doi.org/10.1371/journal.pone.0049952			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	057TZ	23227156	Green Published, gold			2022-12-27	WOS:000312588200018
J	Mullineaux, LS; Le Bris, N; Mills, SW; Henri, P; Bayer, SR; Secrist, RG; Siu, N				Mullineaux, Lauren S.; Le Bris, Nadine; Mills, Susan W.; Henri, Pauline; Bayer, Skylar R.; Secrist, Richard G.; Siu, Nam			Detecting the Influence of Initial Pioneers on Succession at Deep-Sea Vents	PLOS ONE			English	Article							EAST PACIFIC RISE; HYDROTHERMAL VENTS; COMMUNITY STRUCTURE; 9-DEGREES-50'N; COLONIZATION; PATTERNS; LARVAE	Deep-sea hydrothermal vents are subject to major disturbances that alter the physical and chemical environment and eradicate the resident faunal communities. Vent fields are isolated by uninhabitable deep seafloor, so recolonization via dispersal of planktonic larvae is critical for persistence of populations. We monitored colonization near 9 degrees 50'N on the East Pacific Rise following a catastrophic eruption in order to address questions of the relative contributions of pioneer colonists and environmental change to variation in species composition, and the role of pioneers at the disturbed site in altering community structure elsewhere in the region. Pioneer colonists included two gastropod species: Ctenopelta porifera, which was new to the vent field, and Lepetodrilus tevnianus, which had been rare before the eruption but persisted in high abundance afterward, delaying and possibly out-competing the ubiquitous pre-eruption congener L. elevatus. A decrease in abundance of C. porifera over time, and the arrival of later species, corresponded to a decrease in vent fluid flow and in the sulfide to temperature ratio. For some species these successional changes were likely due to habitat requirements, but other species persisted (L. tevnianus) or arrived (L. elevatus) in patterns unrelated to their habitat preferences. After two years, disturbed communities had started to resemble pre-eruption ones, but were lower in diversity. When compared to a prior (1991) eruption, the succession of foundation species (tubeworms and mussels) appeared to be delayed, even though habitat chemistry became similar to the pre-eruption state more quickly. Surprisingly, a nearby community that had not been disturbed by the eruption was invaded by the pioneers, possibly after they became established in the disturbed vents. These results indicate that the post-eruption arrival of species from remote locales had a strong and persistent effect on communities at both disturbed and undisturbed vents. Citation: Mullineaux LS, Le Bris N, Mills SW, Henri P, Bayer SR, et al. (2012) Detecting the Influence of Initial Pioneers on Succession at Deep-Sea Vents. PLoS ONE 7(12): e50015. doi:10.1371/journal.pone.0050015	[Mullineaux, Lauren S.; Mills, Susan W.; Bayer, Skylar R.] Woods Hole Oceanog Inst, Dept Biol, Woods Hole, MA 02543 USA; [Le Bris, Nadine; Henri, Pauline] Univ Paris 06, CNRS, Banyuls Sur Mer, France; [Secrist, Richard G.] Virginia Inst Marine Sci, Dept Biol Sci, Gloucester Point, VA 23062 USA; [Siu, Nam] Western Washington Univ, Dept Biol, Bellingham, WA 98225 USA	Woods Hole Oceanographic Institution; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Sorbonne Universite; William & Mary; Virginia Institute of Marine Science; Western Washington University	Mullineaux, LS (corresponding author), Woods Hole Oceanog Inst, Dept Biol, Woods Hole, MA 02543 USA.	lmullineaux@whoi.edu	Bayer, Skylar/K-7300-2019; Le Bris, Nadine/E-1381-2014	Bayer, Skylar/0000-0003-4128-9536; Le Bris, Nadine/0000-0002-0142-4847; Mullineaux, Lauren/0000-0002-8932-2625	National Science Foundation grant [OCE-0424953]; WHOI Deep Ocean Exploration Institute; WHOI Summer Student Fellow program; Woods Hole Partnership in Education Program; IFREMER; CNRS; Fondation TOTAL Chair Extreme Marine Environment, Biodiversity and Global change	National Science Foundation grant(National Science Foundation (NSF)); WHOI Deep Ocean Exploration Institute; WHOI Summer Student Fellow program; Woods Hole Partnership in Education Program; IFREMER; CNRS(Centre National de la Recherche Scientifique (CNRS)); Fondation TOTAL Chair Extreme Marine Environment, Biodiversity and Global change	The authors received funding from National Science Foundation grant OCE-0424953, WHOI Deep Ocean Exploration Institute, WHOI Summer Student Fellow program, Woods Hole Partnership in Education Program, IFREMER and CNRS, Fondation TOTAL Chair Extreme Marine Environment, Biodiversity and Global change. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams DK, 2008, LIMNOL OCEANOGR, V53, P1945, DOI 10.4319/lo.2008.53.5.1945; Bayer SR, 2011, MAR BIOL, V158, P181, DOI 10.1007/s00227-010-1550-1; Berlow EL, 1997, ECOL MONOGR, V67, P435, DOI 10.1890/0012-9615(1997)067[0435:FCTCHE]2.0.CO;2; Desbruyeres D., 2006, HDB DEEP SEA HYDROTH, V18; Govenar B, 2005, MAR ECOL PROG SER, V305, P67, DOI 10.3354/meps305067; Govenar B, 2010, TOP GEOBIOL, V33, P403, DOI 10.1007/978-90-481-9572-5_13; Hunt HL, 2004, DEEP-SEA RES PT I, V51, P225, DOI 10.1016/j.dsr.2003.10.008; Jollivet D, 1999, EVOLUTION, V53, P1128, DOI 10.1111/j.1558-5646.1999.tb04527.x; Le Bris N, 2006, MAR CHEM, V98, P167, DOI 10.1016/j.marchem.2005.08.008; Le Bris N, 2003, DEEP-SEA RES PT I, V50, P737, DOI 10.1016/S0967-0637(03)00051-7; Lenihan HS, 2008, DEEP-SEA RES PT I, V55, P1707, DOI 10.1016/j.dsr.2008.07.007; Luther GW, 2001, NATURE, V410, P813, DOI 10.1038/35071069; LUTZ RA, 1994, NATURE, V371, P663, DOI 10.1038/371663a0; Marcus J, 2009, DEEP-SEA RES PT II, V56, P1586, DOI 10.1016/j.dsr2.2009.05.004; MCCOOK LJ, 1994, VEGETATIO, V110, P115, DOI 10.1007/BF00033394; Metaxas A, 2004, LIMNOL OCEANOGR, V49, P1949, DOI 10.4319/lo.2004.49.6.1949; Micheli F, 2002, ECOL MONOGR, V72, P365, DOI 10.1890/0012-9615(2002)072[0365:PSCADS]2.0.CO;2; Mills SW, 2007, BIOL BULL-US, V212, P185, DOI 10.2307/25066601; Mouquet N., 2005, METACOMMUNITIES SPAT, P237; Mullineaux LS, 2010, P NATL ACAD SCI USA, V107, P7829, DOI 10.1073/pnas.0913187107; Mullineaux LS, 2000, OECOLOGIA, V123, P275, DOI 10.1007/s004420051014; Mullineaux LS, 2005, MAR ECOL PROG SER, V293, P1, DOI 10.3354/meps293001; Mullineaux LS, 2003, ECOL MONOGR, V73, P523, DOI 10.1890/02-0674; Nees HA, 2008, J SHELLFISH RES, V27, P169, DOI 10.2983/0730-8000(2008)27[169:HVMHCP]2.0.CO;2; Nees HA, 2009, DEEP-SEA RES PT II, V56, P1607, DOI 10.1016/j.dsr2.2009.05.007; Neubert Michael G., 2006, P321, DOI 10.1016/B978-012088781-1/50012-1; Shank TM, 1998, DEEP-SEA RES PT II, V45, P465, DOI 10.1016/S0967-0645(97)00089-1; SHMIDA A, 1985, J BIOGEOGR, V12, P1, DOI 10.2307/2845026; Sousa WP, 2001, MARINE COMMUNITY ECOLOGY, P85; Tunnicliffe V, 1997, DEEP-SEA RES PT I, V44, P1627, DOI 10.1016/S0967-0637(97)00041-1; Van Dover CL, 2003, MAR ECOL PROG SER, V253, P55, DOI 10.3354/meps253055; WHITTAKER R H, 1972, Taxon, V21, P213, DOI 10.2307/1218190	32	31	31	1	57	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 4	2012	7	12							e50015	10.1371/journal.pone.0050015	http://dx.doi.org/10.1371/journal.pone.0050015			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	051EQ	23226507	Green Published, gold			2022-12-27	WOS:000312108500008
J	Romero-Ramirez, L; Garcia-Alvarez, I; Campos-Olivas, R; Gilbert, M; Goneau, MF; Fernandez-Mayoralas, A; Nieto-Sampedro, M				Romero-Ramirez, Lorenzo; Garcia-Alvarez, Isabel; Campos-Olivas, Ramon; Gilbert, Michel; Goneau, Marie-France; Fernandez-Mayoralas, Alfonso; Nieto-Sampedro, Manuel			Specific Synthesis of Neurostatin and Gangliosides O-Acetylated in the Outer Sialic Acids Using a Sialate Transferase	PLOS ONE			English	Article							PURIFICATION; GLYCOSPHINGOLIPIDS; ACETYLTRANSFERASE; IDENTIFICATION; INHIBITOR; NMR	Gangliosides are sialic acid containing glycosphingolipids, commonly found on the outer leaflet of the plasma membrane. O-acetylation of sialic acid hydroxyl groups is one of the most common modifications in gangliosides. Studies on the biological activity of O-acetylated gangliosides have been limited by their scarcity in nature. This comparatively small change in ganglioside structure causes major changes in their physiological properties. When the ganglioside GD1b was O-acetylated in the outer sialic acid, it became the potent inhibitor of astroblast and astrocytoma proliferation called Neurostatin. Although various chemical and enzymatic methods to O-acetylate commercial gangliosides have been described, O-acetylation was nonspecific and produced many side-products that reduced the yield. An enzyme with O-acetyltransferase activity (SOAT) has been previously cloned from the bacteria Campylobacter jejuni. This enzyme catalyzed the acetylation of oligosaccharide-bound sialic acid, with high specificity for terminal alpha-2,8-linked residues. Using this enzyme and commercial gangliosides as starting material, we have specifically O-acetylated the gangliosides' outer sialic acids, to produce the corresponding gangliosides specifically O-acetylated in the sialic acid bound in alpha-2,3 and alpha-2,8 residues. We demonstrate here that O-acetylation occurred specifically in the C-9 position of the sialic acid. In summary, we present a new method of specific O-acetylation of ganglioside sialic acids that permits the large scale preparation of these modified glycosphingolipids, facilitating both, the study of their mechanism of antitumoral action and their use as therapeutic drugs for treating glioblastoma multiform (GBM) patients. Citation: Romero-Ramirez L, Garcia-Alvarez I, Campos-Olivas R, Gilbert M, Goneau M-F, et al. (2012) Specific Synthesis of Neurostatin and Gangliosides O-Acetylated in the Outer Sialic Acids Using a Sialate Transferase. PLoS ONE 7(12): e49983. doi:10.1371/journal.pone.0049983	[Romero-Ramirez, Lorenzo; Garcia-Alvarez, Isabel; Nieto-Sampedro, Manuel] Hosp Nacl Paraplej, Unidad Neurol Expt, Toledo, Spain; [Romero-Ramirez, Lorenzo; Nieto-Sampedro, Manuel] CSIC, Inst Cajal Neurobiol, Madrid, Spain; [Garcia-Alvarez, Isabel; Fernandez-Mayoralas, Alfonso] CSIC, Inst Quim Organ Gen, E-28006 Madrid, Spain; [Campos-Olivas, Ramon] Spanish Natl Canc Ctr CNIO, Spect & NMR Unit, Struct Biol & Biocomp Programme, Madrid, Spain; [Gilbert, Michel; Goneau, Marie-France] Natl Res Council Canada, Ottawa, ON, Canada	Hospital Nacional de Paraplejicos; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto Cajal (IC); Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Quimica Organica General (IQOG); Centro Nacional de Investigaciones Oncologicas (CNIO); National Research Council Canada	Romero-Ramirez, L (corresponding author), Hosp Nacl Paraplej, Unidad Neurol Expt, Toledo, Spain.	Hlromero@cajal.csic.es	García-Álvarez, Isabel/J-8022-2014; Alvarez, Isabel Garcia/J-7347-2017; Alvarez, Isabel Garcia/ABH-2430-2020; Fernández-Mayoralas, Alfonso/K-2929-2014; Campos-Olivas, Ramón/L-9173-2014	García-Álvarez, Isabel/0000-0002-2273-5046; Alvarez, Isabel Garcia/0000-0002-2273-5046; Fernández-Mayoralas, Alfonso/0000-0002-1241-7538; Campos-Olivas, Ramón/0000-0002-5743-2221; Gilbert, Michel/0000-0002-0204-4408	Comunidad Autonoma de Madrid [BIPEDD2 (S2010/BMD-2457)]; FISCAM Comunidad de Castilla-La Mancha [PI2008/19, PI2009/51]; Plan Nacional from Spanish Ministry of Science and Innovation [SAF-2009-11245]; FIS from Spanish Ministry of Science and Innovation [FIS-PI11/01436]	Comunidad Autonoma de Madrid(Comunidad de Madrid); FISCAM Comunidad de Castilla-La Mancha; Plan Nacional from Spanish Ministry of Science and Innovation(Ministry of Science and Innovation, Spain (MICINN)); FIS from Spanish Ministry of Science and Innovation(Ministry of Science and Innovation, Spain (MICINN))	This work was supported in part by the grant BIPEDD2 (S2010/BMD-2457) from Comunidad Autonoma de Madrid (to RCO); PI2008/19 (to MNS) and PI2009/51 (to LRR) from FISCAM Comunidad de Castilla-La Mancha; the Plan Nacional from Spanish Ministry of Science and Innovation SAF-2009-11245 (to MNS); and FIS from Spanish Ministry of Science and Innovation FIS-PI11/01436 (to AFM). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abad-Rodriguez J, 1998, GLIA, V23, P156, DOI 10.1002/(SICI)1098-1136(199806)23:2<156::AID-GLIA7>3.0.CO;2-4; Abad-Rodriguez J, 2000, J NEUROCHEM, V74, P2547, DOI 10.1046/j.1471-4159.2000.0742547.x; ACQUOTTI D, 1991, CHEM PHYS LIPIDS, V59, P107, DOI 10.1016/0009-3084(91)90001-R; BLUM AS, 1987, P NATL ACAD SCI USA, V84, P8716, DOI 10.1073/pnas.84.23.8716; CAVANAGH J, 1992, J MAGN RESON, V96, P670, DOI 10.1016/0022-2364(92)90357-D; Claus H, 2004, MOL MICROBIOL, V51, P227, DOI 10.1046/j.1365-2958.2003.03819.x; DEROME AE, 1990, J MAGN RESON, V88, P177, DOI 10.1016/0022-2364(90)90123-Q; GASA S, 1983, J BIOL CHEM, V258, P876; GAZZOTTI G, 1985, J CHROMATOGR, V348, P371, DOI 10.1016/S0021-9673(01)92475-6; Hakomori S, 1998, GLYCOBIOLOGY, V8, pXI; HAKOMORI SI, 1990, J BIOL CHEM, V265, P18713; HIGA HH, 1989, J BIOL CHEM, V264, P19427; Houliston RS, 2006, J BIOL CHEM, V281, P11480, DOI 10.1074/jbc.M512183200; Hubl U, 2000, J BIOCHEM, V127, P1021, DOI 10.1093/oxfordjournals.jbchem.a022693; Iwersen M, 2003, BIOL CHEM, V384, P1035, DOI 10.1515/BC.2003.116; KLENK E, 1960, H-S Z PHYSIOL CHEM, V319, P283, DOI 10.1515/bchm2.1960.319.1.283; Kohla G, 2002, NEUROCHEM RES, V27, P583, DOI 10.1023/A:1020211714104; KUBO H, 1985, J LIPID RES, V26, P638; LEDEEN ROBERT, 1965, BIOCHEMISTRY, V4, P2225, DOI 10.1021/bi00886a040; Lewis AL, 2004, P NATL ACAD SCI USA, V101, P11123, DOI 10.1073/pnas.0403010101; Lrhorfi LA, 2007, BIOL CHEM, V388, P297, DOI 10.1515/BC.2007.033; MANZI AE, 1990, J BIOL CHEM, V265, P13091; RAUVALA H, 1979, EUR J BIOCHEM, V97, P555, DOI 10.1111/j.1432-1033.1979.tb13144.x; Romero-Ramirez L, 2004, J MED CHEM, V47, P4983, DOI 10.1021/jm049816r; SAITO M, 1979, J BIOL CHEM, V254, P7845; SCHLEUCHER J, 1994, J BIOMOL NMR, V4, P301; Shi WX, 1998, GLYCOBIOLOGY, V8, P199, DOI 10.1093/glycob/8.2.199; Steenbergen SM, 2006, J BACTERIOL, V188, P6195, DOI 10.1128/JB.00466-06; Takayama S, 1996, TETRAHEDRON LETT, V37, P9271, DOI 10.1016/S0040-4039(97)82939-5; Taki T, 1979, Tanpakushitsu Kakusan Koso, V24, P985; THURIN J, 1985, J BIOL CHEM, V260, P4556; Valle-Argos B, 2010, EUR J MED CHEM, V45, P2034, DOI 10.1016/j.ejmech.2010.01.015; VARKI A, 1992, GLYCOBIOLOGY, V2, P25, DOI 10.1093/glycob/2.1.25; Venerando B, 1997, BLOOD, V90, P2047, DOI 10.1182/blood.V90.5.2047; WILLIAMS MA, 1980, J NEUROCHEM, V35, P266, DOI 10.1111/j.1471-4159.1980.tb12515.x; WILLKER W, 1993, MAGN RESON CHEM, V31, P287, DOI 10.1002/mrc.1260310315	36	9	9	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 3	2012	7	12							e49983	10.1371/journal.pone.0049983	http://dx.doi.org/10.1371/journal.pone.0049983			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	051DH	23226505	Green Published, Green Submitted, gold			2022-12-27	WOS:000312104700012
J	Dong, FC; Wang, B; Zhang, LL; Tang, HR; Li, JS; Wang, YL				Dong, Fangcong; Wang, Bin; Zhang, Lulu; Tang, Huiru; Li, Jieshou; Wang, Yulan			Metabolic Response to Klebsiella pneumoniae Infection in an Experimental Rat Model	PLOS ONE			English	Article							POLYUNSATURATED FATTY-ACIDS; INFLAMMATION; PLASMA; MICE; BACTEREMIA; LIPOPROTEINS; METABONOMICS; ENDOTOXIN; CHILDREN; SYSTEMS	Bacteremia, the presence of viable bacteria in the blood stream, is often associated with several clinical conditions. Bacteremia can lead to multiple organ failure if managed incorrectly, which makes providing suitable nutritional support vital for reducing bacteremia-associated mortality. In order to provide such information, we investigated the metabolic consequences of a Klebsiella pneumoniae (K. pneumoniae) infection in vivo by employing a combination of 1 H nuclear magnetic resonance spectroscopy and multivariate data analysis. K. pneumoniae was intravenously infused in rats; urine and plasma samples were collected at different time intervals. We found that K. pneumoniae-induced bacteremia stimulated glycolysis and the tricarboxylic acid cycle and also promoted oxidation of fatty acids and creatine phosphate to facilitate the energy-demanding host response. In addition, K. pneumoniae bacteremia also induced anti-endotoxin, anti-inflammatory and anti-oxidization responses in the host. Furthermore, bacteremia could cause a disturbance in the gut microbiotal functions as suggested by alterations in a range of amines and bacteria-host co-metabolites. Our results suggest that supplementation with glucose and a high-fat and choline-rich diet could ameliorate the burdens associated with bacteremia. Our research provides underlying pathological processes of bacteremia and a better understanding of the clinical and biochemical manifestations of bacteremia.	[Dong, Fangcong; Zhang, Lulu; Tang, Huiru; Wang, Yulan] Chinese Acad Sci, Key Lab Magnet Resonance Biol Syst, State Key Lab Magnet Resonance & Atom & Mol Phys, Wuhan Ctr Magnet Resonance,Wuhan Inst Phys & Math, Wuhan, Peoples R China; [Wang, Bin; Li, Jieshou] Jinling Hosp, Res Inst Gen Surg, Nanjing, Jiangsu, Peoples R China; [Dong, Fangcong; Zhang, Lulu] Chinese Acad Sci, Grad Sch, Beijing, Peoples R China	Chinese Academy of Sciences; Wuhan Institute of Physics & Mathematics, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS	Wang, YL (corresponding author), Chinese Acad Sci, Key Lab Magnet Resonance Biol Syst, State Key Lab Magnet Resonance & Atom & Mol Phys, Wuhan Ctr Magnet Resonance,Wuhan Inst Phys & Math, Wuhan, Peoples R China.	yulan.wang@wipm.ac.cn	Li, jie/GXG-4583-2022; DONG, FANGCONG/P-3857-2019; Wang, Yulan/A-8864-2012; Tang, Huiru/F-9849-2011; DONG, FANGCONG/AAJ-3833-2021	DONG, FANGCONG/0000-0002-6423-5816; Wang, Yulan/0000-0002-2831-8737; Tang, Huiru/0000-0002-7139-2756; 	Ministry of Science and Technology of China [2007CB513005, 2009CB118804]; National Nature Science Foundation of China [30830098, 20825520, 20921004]	Ministry of Science and Technology of China(Ministry of Science and Technology, China); National Nature Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was funded by the Ministry of Science and Technology of China (2007CB513005, 2009CB118804) and the National Nature Science Foundation of China (30830098, 20825520, 20921004). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BACH BA, 1977, IMMUNOCHEMISTRY, V14, P215, DOI 10.1016/0019-2791(77)90197-5; BANERJEE S, 1959, P SOC EXP BIOL MED, V101, P340, DOI 10.3181/00379727-101-24931; Barcia AM, 2005, CLIN INFECT DIS, V41, pS498, DOI 10.1086/432005; BONE RC, 1995, J ENDOTOXIN RES, V2, P151, DOI 10.1177/096805199500200302; Calder PC, 2008, MOL NUTR FOOD RES, V52, P885, DOI 10.1002/mnfr.200700289; Calder PC, 2006, AM J CLIN NUTR, V83, p1505S, DOI 10.1093/ajcn/83.6.1505S; CATES KL, 1983, AM J MED, V75, P19, DOI 10.1016/0002-9343(83)90068-2; Cloarec O, 2005, ANAL CHEM, V77, P517, DOI 10.1021/ac048803i; Das U N, 2006, J Assoc Physicians India, V54, P309; Dieterle F, 2006, ANAL CHEM, V78, P4281, DOI 10.1021/ac051632c; Eriksson L, 2008, J CHEMOMETR, V22, P594, DOI 10.1002/cem.1187; Fecteau G, 2009, VET CLIN N AM-FOOD A, V25, P195, DOI 10.1016/j.cvfa.2008.10.004; GALLIN JI, 1969, NEW ENGL J MED, V281, P1081, DOI 10.1056/NEJM196911132812001; Glasser JS, 2010, BURNS, V36, P528, DOI 10.1016/j.burns.2009.07.006; GROOTVELD M, 1993, FEBS LETT, V322, P266, DOI 10.1016/0014-5793(93)81584-M; Harris HW, 2002, CRIT CARE MED, V30, P23, DOI 10.1097/00003246-200201000-00004; Holmes E, 2006, PLANTA MED, V72, P771, DOI 10.1055/s-2006-946682; Innis SM, 2007, AM J CLIN NUTR, V85, P702, DOI 10.1093/ajcn/85.3.702; Jabs CM, 1998, SURGERY, V124, P65, DOI 10.1067/msy.1998.87894; JACOBSEN JG, 1968, PHYSIOL REV, V48, P424, DOI 10.1152/physrev.1968.48.2.424; Khovidhunkit W, 2004, J LIPID RES, V45, P1169, DOI 10.1194/jlr.R300019-JLR200; Khovidhunkit W, 2000, J INFECT DIS, V181, pS462, DOI 10.1086/315611; Kitchens RL, 2003, J LIPID RES, V44, P2339, DOI 10.1194/jlr.M300228-JLR200; Kure I, 2010, J PHARMACOL EXP THER, V332, P541, DOI 10.1124/jpet.109.159046; Li JV, 2008, J PROTEOME RES, V7, P3948, DOI 10.1021/pr800209d; Lin WH, 2010, INFECTION, V38, P459, DOI 10.1007/s15010-010-0049-5; Liu CX, 2010, J PROTEOME RES, V9, P6774, DOI 10.1021/pr100970q; Luyer MDP, 2004, ANN SURG, V239, P257, DOI 10.1097/01.sla.0000108695.60059.80; MARTIN FPJ, 2008, MOL SYST BIOL, V4; Meatherall BL, 2009, AM J MED, V122, P866, DOI 10.1016/j.amjmed.2009.03.034; Nicholson JK, 1999, XENOBIOTICA, V29, P1181, DOI 10.1080/004982599238047; Nimri LF, 2001, J TROP PEDIATRICS, V47, P356, DOI 10.1093/tropej/47.6.356; Olofsson P, 2002, ARTHRITIS RHEUM, V46, P259, DOI 10.1002/1529-0131(200201)46:1<259::AID-ART10035>3.0.CO;2-2; POSTEL J, 1977, ANN SURG, V185, P475, DOI 10.1097/00000658-197704000-00018; Redmond HP, 1998, NUTRITION, V14, P599, DOI 10.1016/S0899-9007(98)00097-5; Rivera CA, 1998, AM J PHYSIOL-GASTR L, V275, pG862, DOI 10.1152/ajpgi.1998.275.4.G862; SCHULTZ DR, 1990, SEMIN ARTHRITIS RHEU, V20, P129, DOI 10.1016/0049-0172(90)90055-K; Skogberg K, 2008, EPIDEMIOL INFECT, V136, P108, DOI 10.1017/S0950268807008138; Swann JR, 2011, J PROTEOME RES, V10, P3590, DOI 10.1021/pr200243t; Tang HR, 2006, PROG BIOCHEM BIOPHYS, V33, P401; Trygg J, 2002, J CHEMOMETR, V16, P119, DOI 10.1002/cem.695; Uslan DZ, 2007, ARCH INTERN MED, V167, P834, DOI 10.1001/archinte.167.8.834; Wall R, 2010, NUTR REV, V68, P280, DOI 10.1111/j.1753-4887.2010.00287.x; Wang YL, 2004, P NATL ACAD SCI USA, V101, P12676, DOI 10.1073/pnas.0404878101; Wang YL, 2008, P NATL ACAD SCI USA, V105, P6127, DOI 10.1073/pnas.0801777105; Wischmeyer PE, 2001, CRIT CARE MED, V29, P2075, DOI 10.1097/00003246-200111000-00006; Wu JF, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000807; Wyss M, 2000, PHYSIOL REV, V80, P1107, DOI 10.1152/physrev.2000.80.3.1107; Xiao CN, 2009, ANALYST, V134, P916, DOI 10.1039/b818802e; Xu PB, 2008, J INFECTION, V56, P474, DOI 10.1016/j.jinf.2008.03.011; Yinnon AM, 1996, QJM-MON J ASSOC PHYS, V89, P933; Zamaria N, 2004, REPROD NUTR DEV, V44, P273, DOI 10.1051/rnd:2004034; Zhang JT, 2011, J PROTEOME RES, V10, P1904, DOI 10.1021/pr101140n; Zhang LM, 2011, J PROTEOME RES, V10, P614, DOI 10.1021/pr100792q; Zhao XJ, 2011, J PROTEOME RES, V10, P5183, DOI 10.1021/pr2006457	55	24	25	2	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 30	2012	7	11							e51060	10.1371/journal.pone.0051060	http://dx.doi.org/10.1371/journal.pone.0051060			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	054WM	23226457	gold, Green Published, Green Submitted			2022-12-27	WOS:000312376100268
J	Fasih, N; Rafiq, Y; Jabeen, K; Hasan, R				Fasih, Naima; Rafiq, Yasraba; Jabeen, Kausar; Hasan, Rumina			High Isoniazid Resistance Rates in Rifampicin Susceptible Mycobacterium tuberculosis Pulmonary Isolates from Pakistan	PLOS ONE			English	Article							WESTERN CAPE PROVINCE; DRUG-RESISTANCE; OUTCOMES; MUTATIONS	Background: Rapid new diagnostic methods (including Xpert MTB/RIF assay) use rifampicin resistance as a surrogate marker for multidrug resistant tuberculosis. Patients infected with rifampicin susceptible strains are prescribed first line anti-tuberculosis therapy. The roll out of such methods raises a concern that strains with resistance to other first line anti-tuberculosis drugs including isoniazid will be missed and inappropriate treatment given. To evaluate implications of using such methods review of resistance data from high burden settings such as ours is essential. Objective: To determine resistance to first line anti-tuberculosis drugs amongst rifampicin susceptible pulmonary Mycobacterium tuberculosis (MTB) isolates from Pakistan. Materials and Methods: Data of pulmonary Mycobacterium tuberculosis strains isolated in Aga Khan University Hospital (AKUH) laboratory (2009-2011) was retrospectively analyzed. Antimicrobial susceptibility profile of rifampicin susceptible isolates was evaluated for resistance to isoniazid, pyrazinamide, ethambutol, and streptomycin. Results: Pulmonary specimens submitted to AKUH from 2009 to 2011 yielded 7738 strains of Mycobacterium tuberculosis. These included 54% (n 4183) rifampicin susceptible and 46% (n: 3555) rifampicin resistant strains. Analysis of rifampicin susceptible strains showed resistance to at least one of the first line drugs in 27% (n: 1133) of isolates. Overall isoniazid resistance was 15.5% (n: 649), with an isoniazid mono-resistance rate of 4% (n: 174). Combined resistance to isoniazid, pyrazinamide, and ethambutol was noted in 1% (n: 40), while resistance to isoniazid, pyrazinamide, ethambutol, and streptomycin was observed in 1.7% (n: 70) of strains. Conclusions: Our data suggests that techniques (including Xpert MTB/RIF assay) relying on rifampicin susceptibility as an indicator for initiating first line therapy will not detect patients infected with MTB strains resistant to other first line drugs (including isoniazid). The roll out of these techniques must therefore be accompanied by strict monitoring ensuring early resistance detection to increase chances of improved patient outcomes.	[Fasih, Naima; Rafiq, Yasraba; Jabeen, Kausar; Hasan, Rumina] Aga Khan Univ Hosp, Dept Pathol & Microbiol, Karachi, Pakistan	Aga Khan University	Hasan, R (corresponding author), Aga Khan Univ Hosp, Dept Pathol & Microbiol, Karachi, Pakistan.	rumina.hasan@aku.edu	Jabeen, Kauser/I-8018-2015; Hasan, Rumina/F-4420-2015	Jabeen, Kauser/0000-0003-2497-7847				Ali A, 2011, ANTIMICROB AGENTS CH, V55, P5654, DOI 10.1128/AAC.05101-11; Ali A, 2009, SCAND J INFECT DIS, V41, P37, DOI 10.1080/00365540802570519; [Anonymous], 2008, 4 WHO; Ayaz A, 2012, INT J INFECT DIS, V16, pE303, DOI 10.1016/j.ijid.2011.12.015; Farooqi JQ, 2012, J PAK MED ASSOC, V62, P767; Gegia M, 2012, INT J TUBERC LUNG D, V16, P812, DOI 10.5588/ijtld.11.0637; Hoopes AJ, 2008, ARCH INTERN MED, V168, P1984, DOI 10.1001/archinte.168.18.1984; Jacobson KR, 2011, CLIN INFECT DIS, V53, P369, DOI 10.1093/cid/cir406; Menzies D, 2009, PLOS MED, V6, DOI [10.1371/journal.pmed.1000150, 10.1371/journal.pmed.1000146]; Smith SE, 2012, INT J TUBERC LUNG D, V16, P203, DOI 10.5588/ijtld.11.0445; Streicher EM, 2004, J CLIN MICROBIOL, V42, P891, DOI 10.1128/JCM.42.2.891-894.2004; Vadwai V, 2012, SCAND J INFECT DIS, V44, P48, DOI 10.3109/00365548.2011.611169; World Health Organization, 2011, RAP IMPL XPERT MTB R; Yee DP, 2012, INT J TUBERC LUNG D, V16, P604, DOI 10.5588/ijtld.11.0376	14	8	8	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 30	2012	7	11							e50551	10.1371/journal.pone.0050551	http://dx.doi.org/10.1371/journal.pone.0050551			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	054WM	23226311	Green Published, Green Submitted, gold			2022-12-27	WOS:000312376100123
J	Galvan, A; Hu, X; Smith, Y; Wichmann, T				Galvan, Adriana; Hu, Xing; Smith, Yoland; Wichmann, Thomas			In Vivo Optogenetic Control of Striatal and Thalamic Neurons in Non-Human Primates	PLOS ONE			English	Article							BASAL GANGLIA; GLOBUS-PALLIDUS; MILLISECOND-TIMESCALE; RAT NEOSTRIATUM; NEURAL CIRCUITS; OPTICAL CONTROL; GABA RECEPTORS; BRAIN; CHANNELRHODOPSIN-2; INTERNEURONS	Electrical and pharmacological stimulation methods are commonly used to study neuronal brain circuits in vivo, but are problematic, because electrical stimulation has limited specificity, while pharmacological activation has low temporal resolution. A recently developed alternative to these methods is the use of optogenetic techniques, based on the expression of light sensitive channel proteins in neurons. While optogenetics have been applied in in vitro preparations and in in vivo studies in rodents, their use to study brain function in nonhuman primates has been limited to the cerebral cortex. Here, we characterize the effects of channelrhodopsin-2 (ChR2) transfection in subcortical areas, i.e., the putamen, the external globus pallidus (GPe) and the ventrolateral thalamus (VL) of rhesus monkeys. Lentiviral vectors containing the ChR2 sequence under control of the elongation factor 1 alpha promoter (pLenti-EF1 alpha-hChR2(H134R)-eYFP-WPRE, titer 10(9) particles/ml) were deposited in GPe, putamen and VL. Four weeks later, a probe combining a conventional electrode and an optic fiber was introduced in the previously injected brain areas. We found light-evoked responses in 31.5% and 32.7% of all recorded neurons in the striatum and thalamus, respectively, but only in 2.5% of recorded GPe neurons. As expected, most responses were time-locked increases in firing, but decreases or mixed responses were also seen, presumably via ChR2-mediated activation of local inhibitory connections. Light and electron microscopic analyses revealed robust expression of ChR2 on the plasma membrane of cell somas, dendrites, spines and terminals in the striatum and VL. This study demonstrates that optogenetic experiments targeting the striatum and basal ganglia-related thalamic nuclei can be successfully achieved in monkeys. Our results indicate important differences of the type and magnitude of responses in each structure. Experimental conditions such as the vector used, the number and rate of injections, or the light stimulation conditions have to be optimized for each structure studied.	[Galvan, Adriana; Hu, Xing; Smith, Yoland; Wichmann, Thomas] Emory Univ, Yerkes Natl Primate Res Ctr, Atlanta, GA 30322 USA; [Galvan, Adriana; Hu, Xing; Smith, Yoland; Wichmann, Thomas] Emory Univ, Morris K Udall Ctr Excellence Parkinsons Dis Res, Atlanta, GA 30322 USA; [Galvan, Adriana; Smith, Yoland; Wichmann, Thomas] Emory Univ, Sch Med, Dept Neurol, Atlanta, GA 30322 USA	Emory University; Emory University; Emory University	Galvan, A (corresponding author), Emory Univ, Yerkes Natl Primate Res Ctr, Atlanta, GA 30322 USA.	agalvan@emory.edu			National Institutes of Health [R01NS042937, R01NS062876, P50-NS071669]; National Center for Research Resources [P51RR000165]; Office of Research Infrastructure Programs [OD P51OD011132]; NATIONAL CENTER FOR RESEARCH RESOURCES [P51RR000165] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS042937, P50NS071669, R01NS062876] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [P51OD011132] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); Office of Research Infrastructure Programs; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported by National Institutes of Health grants R01NS042937, R01NS062876, P50-NS071669, and by the National Center for Research Resources P51RR000165 and is currently supported by the Office of Research Infrastructure Programs/OD P51OD011132. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmed MR, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3000664; AOSAKI T, 1994, J NEUROSCI, V14, P3969; Bass CE, 2010, J NEUROCHEM, V114, P1344, DOI 10.1111/j.1471-4159.2010.06850.x; Bernstein JG, 2011, TRENDS COGN SCI, V15, P592, DOI 10.1016/j.tics.2011.10.003; Bogenpohl J, 2012, NEUROPHARMACOLOGY; BOLAM JP, 1984, NEUROSCIENCE, V12, P711, DOI 10.1016/0306-4522(84)90165-9; Boyden ES, 2005, NAT NEUROSCI, V8, P1263, DOI 10.1038/nn1525; Cardin JA, 2010, NAT PROTOC, V5, P247, DOI 10.1038/nprot.2009.228; Charara A, 2004, J COMP NEUROL, V476, P65, DOI 10.1002/cne.20210; Chuhma N, 2011, J NEUROSCI, V31, P1183, DOI 10.1523/JNEUROSCI.3833-10.2011; CRUTCHER MD, 1984, EXP BRAIN RES, V53, P244, DOI 10.1007/BF00238154; Deisseroth K, 2011, NAT METHODS, V8, P26, DOI 10.1038/NMETH.F.324; DELONG MR, 1971, J NEUROPHYSIOL, V34, P414, DOI 10.1152/jn.1971.34.3.414; DELONG MR, 1973, SCIENCE, V179, P1240, DOI 10.1126/science.179.4079.1240; Diester I, 2011, NAT NEUROSCI; Elias S, 2007, J NEUROSCI, V27, P2525, DOI 10.1523/JNEUROSCI.4156-06.2007; English DF, 2012, NAT NEUROSCI, V15, P123, DOI 10.1038/nn.2984; Galvan A, 2006, NEUROSCIENCE, V143, P351, DOI 10.1016/j.neuroscience.2006.09.019; Galvan A, 2005, J NEUROPHYSIOL, V94, P990, DOI 10.1152/jn.00068.2005; Galvan A, 2010, ENCYCLOPEDIA OF MOVEMENT DISORDERS, VOL 1: A-G, P113; Galvan A, 2011, SOC NEUROSCIENCE, P8003; Galvan A, 2011, EXP NEUROL, V229, P429, DOI 10.1016/j.expneurol.2011.03.010; Garber JC, 2011, GUIDE CARE USE LAB A; Gradinaru V, 2009, SCIENCE; Gradinaru V, 2007, J NEUROSCI, V27, P14231, DOI 10.1523/JNEUROSCI.3578-07.2007; Graybiel AM, 2008, ANNU REV NEUROSCI, V31, P359, DOI 10.1146/annurev.neuro.29.051605.112851; Gunaydin LA, 2010, NAT NEUROSCI, V13, P387, DOI 10.1038/nn.2495; Han X, 2008, SOC NEUROSCIENCE; Han X, 2009, NEURON, V62, P191, DOI 10.1016/j.neuron.2009.03.011; Hardman CD, 2002, J COMP NEUROL, V445, P238, DOI 10.1002/cne.10165; Higley MJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019155; Jakobsson J, 2003, J NEUROSCI RES, V73, P876, DOI 10.1002/jnr.10719; Jones E.G., 2007, THALAMUS, VVolume 1, P575; Kafri Tal, 2004, Methods Mol Biol, V246, P367; KIMURA M, 1986, Neuroscience Research, V3, P436, DOI 10.1016/0168-0102(86)90035-0; Kliem MA, 2004, J NEUROSCI METH, V138, P45, DOI 10.1016/j.jneumeth.2004.03.015; Kordower JH, 2000, SCIENCE, V290, P767, DOI 10.1126/science.290.5492.767; Kravitz AV, 2010, NATURE, V466, P622, DOI 10.1038/nature09159; Kravitz AV, 2010, IBAGS, VX, pP; Mattis J, 2011, NAT METH; McMillan JL, 2010, J AM ASSOC LAB ANIM, V49, P705; MIZUSHIMA S, 1990, NUCLEIC ACIDS RES, V18, P5322, DOI 10.1093/nar/18.17.5322; Nagel G, 2003, P NATL ACAD SCI USA, V100, P13940, DOI 10.1073/pnas.1936192100; Nagel G, 2005, CURR BIOL, V15, P2279, DOI 10.1016/j.cub.2005.11.032; Nanda B, 2009, EUR J NEUROSCI, V29, P588, DOI 10.1111/j.1460-9568.2008.06598.x; Ohara S, 2007, EXP BRAIN RES, V180, P281, DOI 10.1007/s00221-007-0856-9; Parent A, 1986, COMP NEUROBIOLOGY BA; Paxinos G., 2000, RHESUS MONKEY BRAIN; Peters A., 1991, FINE STRUCTURE NERVO; Rasband W., 2006, IMAGEJ; Reiner A, 1998, BRAIN RES REV, V28, P235, DOI 10.1016/S0165-0173(98)00016-2; Sidibe M, 1997, J COMP NEUROL, V382, P323; Sztainberg Y, 2011, J NEUROSCI, V31, P17416, DOI 10.1523/JNEUROSCI.3087-11.2011; Tepper JM, 2004, CURR OPIN NEUROBIOL, V14, P685, DOI 10.1016/j.conb.2004.10.003; Turner RS, 2010, CURR OPIN NEUROBIOL, V20, P704, DOI 10.1016/j.conb.2010.08.022; Wichmann T, 1998, NEUROSURG CLIN N AM, V9, P223; Wilson CJ, 2007, PROG BRAIN RES, V160, P91, DOI 10.1016/S0079-6123(06)60006-X; WILSON CJ, 1990, J NEUROSCI, V10, P508; Yin DL, 2011, NEUROIMAGE, V54, pS196, DOI 10.1016/j.neuroimage.2009.08.069; Yizhar O, 2011, NEURON, V71, P9, DOI 10.1016/j.neuron.2011.06.004; Zhang F, 2007, NAT REV NEUROSCI, V8, P577, DOI 10.1038/nrn2192; Zhang F, 2010, NAT PROTOC, V5, P439, DOI 10.1038/nprot.2009.226	62	35	35	0	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 30	2012	7	11							e50808	10.1371/journal.pone.0050808	http://dx.doi.org/10.1371/journal.pone.0050808			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	054WM	23226390	Green Published, Green Submitted, gold			2022-12-27	WOS:000312376100201
J	Guasch, L; Sala, E; Castell-Auvi, A; Cedo, L; Liedl, KR; Wolber, G; Muehlbacher, M; Mulero, M; Pinent, M; Ardevol, A; Valls, C; Pujadas, G; Garcia-Vallve, S				Guasch, Laura; Sala, Esther; Castell-Auvi, Anna; Cedo, Lidia; Liedl, Klaus R.; Wolber, Gerhard; Muehlbacher, Markus; Mulero, Miquel; Pinent, Montserrat; Ardevol, Anna; Valls, Cristina; Pujadas, Gerard; Garcia-Vallve, Santiago			Identification of PPARgamma Partial Agonists of Natural Origin (I): Development of a Virtual Screening Procedure and In Vitro Validation	PLOS ONE			English	Article							PPAR-GAMMA; NUCLEAR RECEPTORS; NEXT-GENERATION; DRUG DISCOVERY; MODULATORS; INSIGHTS; DATABASE; LIGANDS; DESIGN; PROCYANIDINS	Background: Although there are successful examples of the discovery of new PPAR gamma agonists, it has recently been of great interest to identify new PPAR gamma partial agonists that do not present the adverse side effects caused by PPAR gamma full agonists. Consequently, the goal of this work was to design, apply and validate a virtual screening workflow to identify novel PPAR gamma partial agonists among natural products. Methodology/Principal Findings: We have developed a virtual screening procedure based on structure-based pharmacophore construction, protein-ligand docking and electrostatic/shape similarity to discover novel scaffolds of PPAR gamma partial agonists. From an initial set of 89,165 natural products and natural product derivatives, 135 compounds were identified as potential PPAR gamma partial agonists with good ADME properties. Ten compounds that represent ten new chemical scaffolds for PPAR gamma partial agonists were selected for in vitro biological testing, but two of them were not assayed due to solubility problems. Five out of the remaining eight compounds were confirmed as PPAR gamma partial agonists: they bind to PPAR gamma do not or only moderately stimulate the transactivation activity of PPAR gamma do not induce adipogenesis of preadipocyte cells and stimulate the insulin-induced glucose uptake of adipocytes. Conclusions/Significance: We have demonstrated that our virtual screening protocol was successful in identifying novel scaffolds for PPAR gamma partial agonists.	[Guasch, Laura; Sala, Esther; Castell-Auvi, Anna; Cedo, Lidia; Mulero, Miquel; Pinent, Montserrat; Ardevol, Anna; Valls, Cristina; Pujadas, Gerard; Garcia-Vallve, Santiago] Univ Rovira & Virgili, Dept Bioquim & Biotecnol, Grp Recerca Nutrigen, Tarragona, Catalonia, Spain; [Liedl, Klaus R.; Muehlbacher, Markus] Leopold Franzens Univ Innsbruck, Ctr Mol Biosci, Fac Chem & Pharm, Dept Theoret Chem, Innsbruck, Austria; [Wolber, Gerhard] Free Univ Berlin, Inst Pharm, Berlin, Germany; [Muehlbacher, Markus] Univ Erlangen Nurnberg, Dept Psychiat & Psychotherapy, D-91054 Erlangen, Germany; [Pujadas, Gerard; Garcia-Vallve, Santiago] CEICS, TECNIO, CTNS, Reus, Catalonia, Spain	Universitat Rovira i Virgili; University of Innsbruck; Free University of Berlin; University of Erlangen Nuremberg	Garcia-Vallve, S (corresponding author), Univ Rovira & Virgili, Dept Bioquim & Biotecnol, Grp Recerca Nutrigen, Tarragona, Catalonia, Spain.	santi.garcia-vallve@urv.cat	Pujadas, Gerard/B-1457-2010; Cedó, Lídia/ABG-1998-2020; PUJADAS, GERARD/W-9348-2019; Sala, Esther/AAB-4997-2022; Pinent, Montserrat/ABE-6178-2021; Wolber, Gerhard/ABD-4955-2020; Liedl, Klaus/ABB-4725-2021; Garcia-Vallve, Santi/A-4226-2008; Wolber, Gerhard/C-7133-2008; Pinent, Montserrat/C-7109-2011; Valls-Bautista, Cristina/K-8769-2014; Liedl, Klaus R/F-3099-2015; Ardévol, Anna/AAO-6194-2021; Mulero, Miquel/L-4672-2014	Pujadas, Gerard/0000-0003-2598-8089; Cedó, Lídia/0000-0003-4354-3411; PUJADAS, GERARD/0000-0003-2598-8089; Pinent, Montserrat/0000-0003-3550-5378; Wolber, Gerhard/0000-0002-5344-0048; Liedl, Klaus/0000-0002-0985-2299; Garcia-Vallve, Santi/0000-0002-0348-7497; Wolber, Gerhard/0000-0002-5344-0048; Pinent, Montserrat/0000-0003-3550-5378; Valls-Bautista, Cristina/0000-0001-5583-5695; Liedl, Klaus R/0000-0002-0985-2299; Ardévol, Anna/0000-0003-0156-7538; Mulero, Miquel/0000-0003-2545-2065; Sala, Esther/0000-0002-5149-1992; Guasch, Laura/0000-0003-4990-7765	"Ministerio de Educacion y Ciencia" of the Spanish Government [AGL2008-01310, AGL2011-25831]; Generalitat de Catalunya [ACC1O (TECCT10-1-0008)]	"Ministerio de Educacion y Ciencia" of the Spanish Government(Spanish Government); Generalitat de Catalunya(Generalitat de Catalunya)	This study was supported by grants AGL2008-01310 and AGL2011-25831 from the "Ministerio de Educacion y Ciencia" of the Spanish Government and the ACC1O (TECCT10-1-0008) program (Generalitat de Catalunya). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ardevol A, 2000, INT J OBESITY, V24, P319, DOI 10.1038/sj.ijo.0801130; Berger J, 2002, ANNU REV MED, V53, P409, DOI 10.1146/annurev.med.53.082901.104018; Berman HM, 2000, NUCLEIC ACIDS RES, V28, P235, DOI 10.1093/nar/28.1.235; BORENFREUND E, 1985, TOXICOL LETT, V24, P119, DOI 10.1016/0378-4274(85)90046-3; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Bruning JB, 2007, STRUCTURE, V15, P1258, DOI 10.1016/j.str.2007.07.014; Choi JH, 2010, NATURE, V466, P451, DOI 10.1038/nature09291; Choi J, 2010, BIOORGAN MED CHEM, V18, P8315, DOI 10.1016/j.bmc.2010.09.068; Dixon SL, 2006, J COMPUT AID MOL DES, V20, P647, DOI 10.1007/s10822-006-9087-6; Duan JX, 2010, J MOL GRAPH MODEL, V29, P157, DOI 10.1016/j.jmgm.2010.05.008; Fakhrudin N, 2010, MOL PHARMACOL, V77, P559, DOI 10.1124/mol.109.062141; Farce A, 2009, CURR MED CHEM, V16, P1768, DOI 10.2174/092986709788186165; Feldman PL, 2008, CURR TOP MED CHEM, V8, P728, DOI 10.2174/156802608784535084; Francis GA, 2003, ANNU REV PHYSIOL, V65, P261, DOI 10.1146/annurev.physiol.65.092101.142528; Garcia-Vallve S, 1998, MOL BIOL EVOL, V15, P665, DOI 10.1093/oxfordjournals.molbev.a025970; Gelman L, 2007, BBA-MOL CELL BIOL L, V1771, P1094, DOI 10.1016/j.bbalip.2007.03.004; Guasch L, 2011, J COMPUT AID MOL DES, V25, P717, DOI 10.1007/s10822-011-9446-9; Guex N, 1997, ELECTROPHORESIS, V18, P2714, DOI 10.1002/elps.1150181505; Hopkins CR, 2006, BIOORG MED CHEM LETT, V16, P5659, DOI 10.1016/j.bmcl.2006.08.003; Huang N, 2006, J MED CHEM, V49, P6789, DOI 10.1021/jm0608356; Huang THW, 2005, BASIC CLIN PHARMACOL, V96, P3, DOI 10.1111/j.1742-7843.2005.pto960102.x; Irwin JJ, 2005, J CHEM INF MODEL, V45, P177, DOI 10.1021/ci049714+; Jones D, 2010, NAT REV DRUG DISCOV, V9, P668, DOI 10.1038/nrd3271; Kelley LA, 1996, PROTEIN ENG, V9, P1063, DOI 10.1093/protein/9.11.1063; Kleywegt GJ, 2004, ACTA CRYSTALLOGR D, V60, P2240, DOI 10.1107/S0907444904013253; Lagorce D, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-396; Lewis SN, 2010, PPAR RES, V2010, DOI 10.1155/2010/861238; Lipinski CA, 2001, ADV DRUG DELIVER REV, V46, P3, DOI 10.1016/S0169-409X(00)00129-0; Lu IL, 2006, J MED CHEM, V49, P2703, DOI 10.1021/jm051129s; Markt P, 2008, J MED CHEM, V51, P6303, DOI 10.1021/jm800128k; Mills N, 2006, J AM CHEM SOC, V128, P13649, DOI 10.1021/ja0697875; Petersen RK, 2011, J COMPUT AID MOL DES, V25, P107, DOI 10.1007/s10822-010-9398-5; Pinent M, 2004, ENDOCRINOLOGY, V145, P4985, DOI 10.1210/en.2004-0764; Pochetti G, 2007, J BIOL CHEM, V282, P17314, DOI 10.1074/jbc.M702316200; Pourcet Benoit, 2006, Expert Opin Emerg Drugs, V11, P379, DOI 10.1517/14728214.11.3.379; Rau O, 2006, PHARMAZIE, V61, P952; Salam NK, 2008, CHEM BIOL DRUG DES, V71, P57, DOI 10.1111/j.1747-0285.2007.00606.x; Schuster D, 2010, CURR PHARM DESIGN, V16, P1666, DOI 10.2174/138161210791164072; Shearer BG, 2007, BBA-MOL CELL BIOL L, V1771, P1082, DOI 10.1016/j.bbalip.2007.05.005; Tanrikulu Y, 2009, CHEMBIOCHEM, V10, P75, DOI 10.1002/cbic.200800520; Vidovic D, 2011, CHEMMEDCHEM, V6, P94, DOI 10.1002/cmdc.201000428; Willson TM, 2000, J MED CHEM, V43, P527, DOI 10.1021/jm990554g; Wolber G, 2005, J CHEM INF MODEL, V45, P160, DOI 10.1021/ci049885e; Wolber G, 2006, J COMPUT AID MOL DES, V20, P773, DOI 10.1007/s10822-006-9078-7; Vincent ZA, 2007, BBA-MOL CELL BIOL L, V1771, P915, DOI 10.1016/j.bbalip.2007.01.007; Zsoldos Z, 2007, J MOL GRAPH MODEL, V26, P198, DOI 10.1016/j.jmgm.2006.06.002	46	38	41	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 30	2012	7	11							e50816	10.1371/journal.pone.0050816	http://dx.doi.org/10.1371/journal.pone.0050816			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	054WM	23226391	Green Published, gold, Green Submitted			2022-12-27	WOS:000312376100202
J	Hamed, M; Ismael, S; Paulsen, M; Helms, V				Hamed, Mohamed; Ismael, Siba; Paulsen, Martina; Helms, Volkhard			Cellular Functions of Genetically Imprinted Genes in Human and Mouse as Annotated in the Gene Ontology	PLOS ONE			English	Article							EXPRESSION; GRB10; MICE	By analyzing the cellular functions of genetically imprinted genes as annotated in the Gene Ontology for human and mouse, we found that imprinted genes are often involved in developmental, transport and regulatory processes. In the human, paternally expressed genes are enriched in GO terms related to the development of organs and of anatomical structures. In the mouse, maternally expressed genes regulate cation transport as well as G-protein signaling processes. Furthermore, we investigated if imprinted genes are regulated by common transcription factors. We identified 25 TF families that showed an enrichment of binding sites in the set of imprinted genes in human and 40 TF families in mouse. In general, maternally and paternally expressed genes are not regulated by different transcription factors. The genes Nnat, Klf14, Blcap, Gnas and Ube3a contribute most to the enrichment of TF families. In the mouse, genes that are maternally expressed in placenta are enriched for AP1 binding sites. In the human, we found that these genes possessed binding sites for both, AP1 and SP1.	[Hamed, Mohamed; Ismael, Siba; Helms, Volkhard] Univ Saarland, Ctr Bioinformat, D-6600 Saarbrucken, Germany; [Paulsen, Martina] Univ Saarland, Dept Genet, D-6600 Saarbrucken, Germany	Saarland University; Saarland University	Helms, V (corresponding author), Univ Saarland, Ctr Bioinformat, D-6600 Saarbrucken, Germany.	volkhard.helms@bioinformatik.uni-saarland.de		Helms, Volkhard/0000-0002-2180-9154	German Academic Exchange Service (DAAD); Deutsche Forschungsgemeinschaft [PA 750/3-1]	German Academic Exchange Service (DAAD)(Deutscher Akademischer Austausch Dienst (DAAD)); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was supported was supported by scholarships to MH and SI via the German Academic Exchange Service (DAAD) and by a grant by the Deutsche Forschungsgemeinschaft (PA 750/3-1). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bain G, 1997, IMMUNITY, V6, P145, DOI 10.1016/S1074-7613(00)80421-5; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Berg JS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026410; Brown KW, 1996, HUM MOL GENET, V5, P2027, DOI 10.1093/hmg/5.12.2027; Fitzpatrick GV, 2002, NAT GENET, V32, P426, DOI 10.1038/ng988; HAIG D, 1989, BIOL J LINN SOC, V38, P215, DOI 10.1111/j.1095-8312.1989.tb01576.x; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Hutter B, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-649; Ihaka R., 1996, J COMPUT GRAPH STAT, V5, P299, DOI [DOI 10.1080/10618600.1996.10474713, 10.2307/1390807]; Jerome CA, 1997, GENOMICS, V40, P215, DOI 10.1006/geno.1996.4535; Kent L, 2008, AM J MED GENET B, V147B, P1295, DOI 10.1002/ajmg.b.30729; Kruger I, 2007, DEV DYNAM, V236, P2235, DOI 10.1002/dvdy.21222; LAU MMH, 1994, GENE DEV, V8, P2953, DOI 10.1101/gad.8.24.2953; Lefebvre L, 1998, NAT GENET, V20, P163, DOI 10.1038/2464; Liu J, 2000, J CLIN INVEST, V106, P1167, DOI 10.1172/JCI10431; MOORE T, 1991, TRENDS GENET, V7, P45, DOI 10.1016/0168-9525(91)90230-N; Mori K, 2005, MOL CELL ENDOCRINOL, V230, P39, DOI 10.1016/j.mce.2004.11.004; Morison IM, 2005, TRENDS GENET, V21, P457, DOI 10.1016/j.tig.2005.06.008; Morison IM, 2001, NUCLEIC ACIDS RES, V29, P275, DOI 10.1093/nar/29.1.275; Okae H, 2012, HUM MOL GENET, V21, P548, DOI 10.1093/hmg/ddr488; Reik W, 2001, NAT REV GENET, V2, P21, DOI 10.1038/35047554; Smoot ME, 2011, BIOINFORMATICS, V27, P431, DOI 10.1093/bioinformatics/btq675; Steinhoff C, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-144; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Thomas K, 2007, MOL CELL ENDOCRINOL, V270, P1, DOI 10.1016/j.mce.2007.03.001; Tycko B, 2002, J CELL PHYSIOL, V192, P245, DOI 10.1002/jcp.10129; Varrault A, 2006, DEV CELL, V11, P711, DOI 10.1016/j.devcel.2006.09.003; Wingender E, 2008, BRIEF BIOINFORM, V9, P326, DOI 10.1093/bib/bbn016; Zhang B, 2005, NUCLEIC ACIDS RES, V33, pW741, DOI 10.1093/nar/gki475	29	8	8	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 30	2012	7	11							e50285	10.1371/journal.pone.0050285	http://dx.doi.org/10.1371/journal.pone.0050285			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	054WM	23226257	Green Published, Green Submitted, gold			2022-12-27	WOS:000312376100067
J	Kahn, HS; Bullard, KM; Barker, LE; Imperatore, G				Kahn, Henry S.; Bullard, Kai McKeever; Barker, Lawrence E.; Imperatore, Giuseppina			Differences between Adiposity Indicators for Predicting All-Cause Mortality in a Representative Sample of United States Non-Elderly Adults	PLOS ONE			English	Article							LIPID-ACCUMULATION PRODUCT; BODY-MASS INDEX; INSULIN-RESISTANCE; ABDOMINAL ADIPOSITY; AFRICAN-AMERICAN; HEART-DISEASE; OBESITY; RISK; POPULATION; WAIST	Background: Adiposity predicts health outcomes, but this relationship could depend on population characteristics and adiposity indicator employed. In a representative sample of 11,437 US adults (National Health and Nutrition Examination Survey, 1988-1994, ages 18-64) we estimated associations with all-cause mortality for body mass index (BMI) and four abdominal adiposity indicators (waist circumference [WC], waist-to-height ratio [WHtR], waist-to-hip ratio [WHR], and waist-to-thigh ratio [WTR]). In a fasting subsample we considered the lipid accumulation product (LAP; [WC enlargement* triglycerides]). Methods and Findings: For each adiposity indicator we estimated linear and categorical mortality risks using sex-specific, proportional-hazards models adjusted for age, black ancestry, tobacco exposure, and socioeconomic position. There were 1,081 deaths through 2006. Using linear models we found little difference among indicators (adjusted hazard ratios [aHRs] per SD increase 1.2-1.4 for men, 1.3-1.5 for women). Using categorical models, men in adiposity midrange (quartiles 2+3; compared to quartile 1) were not at significantly increased risk (aHRs<1.1) unless assessed by WTR (aHR 1.4 [95% CI 1.0-1.9]). Women in adiposity midrange, however, tended toward elevated risk (aHRs 1.2-1.5), except for black women assessed by BMI, WC or WHtR (aHRs 0.7-0.8). Men or women in adiposity quartile 4 (compared to midrange) were generally at risk (aHRs>1.1), especially black men assessed by WTR (aHR 1.9 [1.4-2.6]) and black women by LAP (aHR 2.2 [1.4-3.5]). Quartile 4 of WC or WHtR carried no significant risk for diabetic persons (aHRs 0.7-1.1), but elevated risks for those without diabetes (aHRs>1.5). For both sexes, quartile 4 of LAP carried increased risks for tobacco-exposed persons (aHRs>1.6) but not for non-exposed (aHRs<1.0). Conclusions: Predictions of mortality risk associated with top-quartile adiposity vary with the indicator used, sex, ancestry, and other characteristics. Interpretations of adiposity should consider how variation in the physiology and expandability of regional adipose-tissue depots impacts health.	[Kahn, Henry S.; Bullard, Kai McKeever; Barker, Lawrence E.; Imperatore, Giuseppina] US Ctr Dis Control & Prevent, Div Diabet Translat, Atlanta, GA USA	Centers for Disease Control & Prevention - USA	Kahn, HS (corresponding author), US Ctr Dis Control & Prevent, Div Diabet Translat, Atlanta, GA USA.	hkahn@cdc.gov	Kahn, Henry S/A-6946-2009	Kahn, Henry S/0000-0003-2533-1562				Amer Diabet Assoc, 2012, DIABETES CARE, V35, pS64, DOI [10.2337/dc12-S064, 10.2337/dc09-S062, 10.2337/dc11-S011]; Chavez JA, 2010, BBA-MOL CELL BIOL L, V1801, P252, DOI 10.1016/j.bbalip.2009.09.015; Arsenault BJ, 2010, CAN MED ASSOC J, V182, P1427, DOI 10.1503/cmaj.091276; Ashwell M., 2011, OPEN OBESITY J, V3, P78, DOI [10.2174/1876823701103010078, DOI 10.2174/1876823701103010078]; Bedogni G, 2010, BMC GASTROENTEROL, V10, DOI 10.1186/1471-230X-10-98; Bigaard J, 2004, INT J OBESITY, V28, P741, DOI 10.1038/sj.ijo.0802635; Boorsma W, 2008, OBESITY, V16, P2696, DOI 10.1038/oby.2008.433; Bozorgmanesh M, 2010, LIPIDS HEALTH DIS, V9, DOI 10.1186/1476-511X-9-100; Bozorgmanesh M, 2010, LIPIDS HEALTH DIS, V9, DOI 10.1186/1476-511X-9-45; Calle EE, 1999, NEW ENGL J MED, V341, P1097, DOI 10.1056/NEJM199910073411501; Cameron AJ, 2012, INT J EPIDEMIOL, V41, P484, DOI 10.1093/ije/dyr198; Chen ZM, 2012, INT J EPIDEMIOL, V41, P472, DOI 10.1093/ije/dyr208; Cornier MA, 2011, CIRCULATION, V124, P1996, DOI 10.1161/CIR.0b013e318233bc6a; CRAIG WY, 1989, BMJ-BRIT MED J, V298, P784, DOI 10.1136/bmj.298.6676.784; Dowd JB, 2011, INT J EPIDEMIOL, V40, P183, DOI 10.1093/ije/dyq189; Dulloo AG, 2010, INT J OBESITY, V34, pS4, DOI 10.1038/ijo.2010.234; Flegal KM, 2005, JAMA-J AM MED ASSOC, V293, P1861, DOI 10.1001/jama.293.15.1861; Galea S, 2011, AM J PUBLIC HEALTH, V101, P1456, DOI 10.2105/AJPH.2010.300086; Hahn RA, 1996, EPIDEMIOLOGY, V7, P75, DOI 10.1097/00001648-199601000-00013; Heitmann BL, 2009, BMJ-BRIT MED J, V339, DOI 10.1136/bmj.b3292; Hunter GR, 2010, OBESITY, V18, P274, DOI 10.1038/oby.2009.229; Ingram KH, 2011, OBESITY, V19, P1469, DOI 10.1038/oby.2011.45; Ioachimescu AG, 2010, OBESITY, V18, P1836, DOI 10.1038/oby.2009.453; Jerant A, 2012, J AM BOARD FAM MED, V25, P422, DOI 10.3122/jabfm.2012.04.110289; Kahn Henry S, 2005, BMC Cardiovasc Disord, V5, P26, DOI 10.1186/1471-2261-5-26; Kahn HS, 2006, DIABETES CARE, V29, P151, DOI 10.2337/diacare.29.1.151; Kahn HS, 2003, AM J CLIN NUTR, V78, P928, DOI 10.1093/ajcn/78.5.928; Karastergiou K, 2012, BIOL SEX DIFFER, V3, DOI 10.1186/2042-6410-3-13; Katzmarzyk PT, 2011, OBESITY, V19, P1272, DOI 10.1038/oby.2010.319; Kokkinos P, 2012, DIABETES CARE, V35, P1021, DOI 10.2337/dc11-2407; Lahti-Koski M, 2012, CLIN OBES, V2, P57, DOI 10.1111/j.1758-8111.2012.00035.x; Lakoski SG, 2011, J CLIN ENDOCR METAB, V96, P1805, DOI 10.1210/jc.2010-3055; Lazo M, 2011, BMJ, P343; Manolopoulos KN, 2010, INT J OBESITY, V34, P949, DOI 10.1038/ijo.2009.286; Mason C, 2008, OBESITY, V16, P2690, DOI 10.1038/oby.2008.438; McEwen LN, 2012, DIABETES CARE, V35, P1301, DOI 10.2337/dc11-2281; MOHADJER L, 1996, NATL HLTH NUTR EXAMI; Muennig P, 2010, AM J PUBLIC HEALTH, V100, P1758, DOI 10.2105/AJPH.2009.165019; Muoio DM, 2010, BBA-MOL CELL BIOL L, V1801, P281, DOI 10.1016/j.bbalip.2009.11.007; National Center for Health Statistics, 2001, 3 NAT HLTH NUTR EX S; National Center for Health Statistics, 1988, NAT HLTH NUTR EX 3 B; National Center for Health Statistics, 1994, PLAN OP 3 NAT HLTH N; National Center for Health Statistics. Office of Analysis and Epidemiology, 2009, 3 NAT HLTH NUTR EX S; Petursson H, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026621; Pirkle JL, 1996, JAMA-J AM MED ASSOC, V275, P1233, DOI 10.1001/jama.275.16.1233; Pischon T, 2008, NEW ENGL J MED, V359, P2105, DOI 10.1056/NEJMoa0801891; Reis JP, 2009, ANN EPIDEMIOL, V19, P134, DOI 10.1016/j.annepidem.2008.10.008; Schneider HJ, 2010, J CLIN ENDOCR METAB, V95, P1777, DOI 10.1210/jc.2009-1584; Simpson JA, 2007, OBESITY, V15, P994, DOI 10.1038/oby.2007.622; Singh P, 2012, AM J CLIN NUTR, V96, P229, DOI 10.3945/ajcn.111.033829; Sorensen TIA, 2011, OBESITY FACTS, V4, P91, DOI 10.1159/000328198; Taylor AE, 2010, AM J CLIN NUTR, V91, P547, DOI 10.3945/ajcn.2009.28757; Trauner M, 2010, BBA-MOL CELL BIOL L, V1801, P299, DOI 10.1016/j.bbalip.2009.10.007; Valderrama Amy L., 2011, Morbidity and Mortality Weekly Report, V60, P1248; Virtue S, 2010, BBA-MOL CELL BIOL L, V1801, P338, DOI 10.1016/j.bbalip.2009.12.006; Wehr E, 2011, OBESITY, V19, P1873, DOI 10.1038/oby.2011.42; Welborn TA, 2007, EUR J CLIN NUTR, V61, P1373, DOI 10.1038/sj.ejcn.1602656; Whitlock G, 2009, LANCET, V373, P1083, DOI 10.1016/S0140-6736(09)60318-4; World Health Organization Expert Committee on Physical Status, 1995, WHO TECHN REP SER, V854; Xia C, 2012, EUR J CLIN NUTR, V66, P1035, DOI 10.1038/ejcn.2012.83; Yang Chen, 2010, Zhonghua Liu Xing Bing Xue Za Zhi, V31, P5; Zaratin ACM, 2004, METABOLISM, V53, P858, DOI 10.1016/j.metabol.2004.02.005; Zhang XL, 2007, ARCH INTERN MED, V167, P886, DOI 10.1001/archinte.167.9.886	63	38	40	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 30	2012	7	11							e50428	10.1371/journal.pone.0050428	http://dx.doi.org/10.1371/journal.pone.0050428			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	054WM	23226283	Green Published, gold, Green Submitted			2022-12-27	WOS:000312376100095
J	Khan, S; Rammeloo, AW; Heikkila, JJ				Khan, Saad; Rammeloo, Ashley W.; Heikkila, John J.			Withaferin A Induces Proteasome Inhibition, Endoplasmic Reticulum Stress, the Heat Shock Response and Acquisition of Thermotolerance	PLOS ONE			English	Article							IMMUNOGLOBULIN-BINDING-PROTEIN; HSP70 GENE-EXPRESSION; INTRACELLULAR-LOCALIZATION; TRANSCRIPTION FACTOR; HSP30; CHAPERONE; FAMILY; CELLS; CRYSTALLIN; DISEASE	In the present study, withaferin A (WA), a steroidal lactone with anti-inflammatory and anti-tumor properties, inhibited proteasome activity and induced endoplasmic reticulum (ER) and cytoplasmic HSP accumulation in Xenopus laevis A6 kidney epithelial cells. Proteasomal inhibition by WA was indicated by an accumulation of ubiquitinated protein and a decrease in chymotrypsin-like activity. Additionally, immunoblot analysis revealed that treatment of cells with WA induced the accumulation of HSPs including ER chaperones, BiP and GRP94, as well as cytoplasmic/nuclear HSPs, HSP70 and HSP30. Furthermore, WA-induced an increase in the relative levels of the protein kinase, Akt, while the levels of actin were unchanged compared to control. Northern blot experiments determined that WA induced an accumulation in bip, hsp70 and hsp30 mRNA but not eIF-1 alpha mRNA. Interestingly, WA acted synergistically with mild heat shock to enhance HSP70 and HSP30 accumulation to a greater extent than the sum of both stressors individually. This latter phenomenon was not observed with BiP or GRP94. Immunocytochemical analysis indicated that WA-induced BiP accumulation occurred mainly in the perinuclear region in a punctate pattern, while HSP30 accumulation occurred primarily in a granular pattern in the cytoplasm with some staining in the nucleus. Prolonged exposure to WA resulted in disorganization of the F-actin cytoskeleton as well as the production of relatively large HSP30 staining structures that co-localized with F-actin. Finally, prior exposure of cells to WA treatment, which induced the accumulation of HSPs conferred a state of thermal protection since it protected the F-actin cytoskeleton against a subsequent cytotoxic thermal challenge.	[Khan, Saad; Rammeloo, Ashley W.; Heikkila, John J.] Univ Waterloo, Dept Biol, Waterloo, ON N2L 3G1, Canada	University of Waterloo	Heikkila, JJ (corresponding author), Univ Waterloo, Dept Biol, Waterloo, ON N2L 3G1, Canada.	heikkila@sciborg.uwaterloo.ca			Natural Science and Engineering Research Council (NSERC); Canada Research Chair in Stress Protein Gene Research; NSERC graduate scholarship	Natural Science and Engineering Research Council (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC)); Canada Research Chair in Stress Protein Gene Research; NSERC graduate scholarship(Natural Sciences and Engineering Research Council of Canada (NSERC))	This research was supported by Natural Science and Engineering Research Council (NSERC) grants to J.J.H. who is also the recipient of a Canada Research Chair in Stress Protein Gene Research. S. K. is the recipient of an NSERC graduate scholarship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdulle R, 2002, CELL STRESS CHAPERON, V7, P6, DOI 10.1379/1466-1268(2002)007<0006:XSHSPH>2.0.CO;2; Arrigo AP, 1998, BIOL CHEM, V379, P19; Arrigo AP, 1994, BIOL HEAT SHOCK PROT, P335; Balch WE, 2008, SCIENCE, V319, P916, DOI 10.1126/science.1141448; Bargagna-Mohan P, 2010, J BIOL CHEM, V285, P7657, DOI 10.1074/jbc.M109.093765; Bonelli MA, 2004, EXP GERONTOL, V39, P423, DOI 10.1016/j.exger.2003.12.004; Borm B, 2005, EXP CELL RES, V302, P83, DOI 10.1016/j.yexcr.2004.08.034; Bova MP, 1999, P NATL ACAD SCI USA, V96, P6137, DOI 10.1073/pnas.96.11.6137; Buchner J, 1998, METHOD ENZYMOL, V290, P339, DOI 10.1016/S0076-6879(98)90030-1; Bush KT, 1997, J BIOL CHEM, V272, P9086; Choi MJ, 2011, TOXICOL IN VITRO, V25, P692, DOI 10.1016/j.tiv.2011.01.010; DEVI PU, 1995, CANCER LETT, V95, P189, DOI 10.1016/0304-3835(95)03892-Z; Doshi BM, 2009, CELL STRESS CHAPERON, V14, P445, DOI 10.1007/s12192-008-0098-1; Feige U., 1996, STRESS INDUCIBLE CEL; Fernando P, 2000, CELL STRESS CHAPERON, V5, P148, DOI 10.1379/1466-1268(2000)005<0148:FCOXSH>2.0.CO;2; Fernando P, 2003, EXP CELL RES, V286, P175, DOI 10.1016/S0014-4827(03)00067-3; Fernando P, 2002, COMP BIOCHEM PHYS B, V133, P95, DOI 10.1016/S1096-4959(02)00110-0; Garcia-Mata R, 1999, J CELL BIOL, V146, P1239, DOI 10.1083/jcb.146.6.1239; Gauley J, 2008, COMP BIOCHEM PHYS A, V151, P133, DOI 10.1016/j.cbpa.2008.06.010; Gellalchew M, 2005, CELL BIOL INT, V29, P221, DOI 10.1016/j.cellbi.2004.12.006; Haas KF, 2007, BIOL CELL, V99, P615, DOI 10.1042/BC20070019; Heikkila JJ, 2010, COMP BIOCHEM PHYS A, V156, P19, DOI 10.1016/j.cbpa.2010.01.024; Irobi J, 2004, NAT GENET, V36, P597, DOI 10.1038/ng1328; Johnston JA, 1998, J CELL BIOL, V143, P1883, DOI 10.1083/jcb.143.7.1883; Kawazoe Y, 1998, EUR J BIOCHEM, V255, P356, DOI 10.1046/j.1432-1327.1998.2550356.x; Khan S, 2011, COMP BIOCHEM PHYS A, V158, P566, DOI 10.1016/j.cbpa.2011.01.008; Kim D, 1999, BIOCHEM BIOPH RES CO, V254, P264, DOI 10.1006/bbrc.1998.9840; Kitiphongspattana K, 2005, J BIOL CHEM, V280, P15727, DOI 10.1074/jbc.M410876200; KRONE PH, 1992, GENE, V110, P159, DOI 10.1016/0378-1119(92)90643-4; Lang L, 1999, DEV GENET, V25, P365, DOI 10.1002/(SICI)1520-6408(1999)25:4<365::AID-DVG10>3.0.CO;2-2; Lang L, 2000, CELL STRESS CHAPERON, V5, P36, DOI 10.1379/1466-1268(2000)005<0036:SITSEO>2.0.CO;2; Lee DH, 1998, MOL CELL BIOL, V18, P30, DOI 10.1128/MCB.18.1.30; Lehman NL, 2009, ACTA NEUROPATHOL, V118, P329, DOI 10.1007/s00401-009-0560-x; Liao W, 2006, J CELL BIOCHEM, V99, P1085, DOI 10.1002/jcb.20996; Lundgren J, 2005, MOL CELL BIOL, V25, P4662, DOI 10.1128/MCB.25.11.4662-4675.2005; Luss H, 2002, CARDIOVASC RES, V54, P140, DOI 10.1016/S0008-6363(02)00232-8; MacRae TH, 2000, CELL MOL LIFE SCI, V57, P899, DOI 10.1007/PL00000733; Maitra R, 2009, J INFLAMM-LOND, V6, DOI 10.1186/1476-9255-6-15; Malhi H, 2011, J HEPATOL, V54, P795, DOI 10.1016/j.jhep.2010.11.005; Mandal C, 2008, APOPTOSIS, V13, P1450, DOI 10.1007/s10495-008-0271-0; Manning BD, 2007, CELL, V129, P1261, DOI 10.1016/j.cell.2007.06.009; Manwell LA, 2007, COMP BIOCHEM PHYS A, V148, P521, DOI 10.1016/j.cbpa.2007.06.422; Mishra L C, 2000, Altern Med Rev, V5, P334; Miskovic D, 1999, DEV GENET, V25, P31, DOI 10.1002/(SICI)1520-6408(1999)25:1<31::AID-DVG4>3.0.CO;2-M; Miskovic D, 1997, COMP BIOCHEM PHYS B, V116, P227, DOI 10.1016/S0305-0491(96)00219-2; Mohan Royce, 2004, Angiogenesis, V7, P115, DOI 10.1007/s10456-004-1026-3; Morimoto RI, 1998, GENE DEV, V12, P3788, DOI 10.1101/gad.12.24.3788; Morimoto RI, 2008, GENE DEV, V22, P1427, DOI 10.1101/gad.1657108; Noonan EJ, 2008, CELL STRESS CHAPERON, V13, P105, DOI 10.1007/s12192-007-0003-3; OHTSUKA K, 1993, INT J HYPERTHER, V9, P115, DOI 10.3109/02656739309061484; OVSENEK N, 1990, DEVELOPMENT, V110, P427; Quinlan R, 1999, NAT MED, V5, P25, DOI 10.1038/4704; Ross CA, 2004, TRENDS CELL BIOL, V14, P703, DOI 10.1016/j.tcb.2004.10.006; Santagata S, 2012, ACS CHEM BIOL, V7, P339, DOI 10.1021/cb200353m; Sun FC, 2006, BIOCHEM J, V396, P31, DOI 10.1042/BJ20051916; Taylor JP, 2002, SCIENCE, V296, P1991, DOI 10.1126/science.1067122; Tonkiss J, 2005, INT J HYPERTHER, V21, P433, DOI 10.1080/02656730500165514; Van Montfort R, 2002, ADV PROTEIN CHEM, V59, P105; Voellmy R, 2004, CELL STRESS CHAPERON, V9, P122, DOI 10.1379/CSC-14R.1; Voyer J, 2008, COMP BIOCHEM PHYS A, V151, P253, DOI 10.1016/j.cbpa.2008.07.004; Walcott SE, 2010, COMP BIOCHEM PHYS A, V156, P285, DOI 10.1016/j.cbpa.2010.02.015; Westerheide SD, 2005, J BIOL CHEM, V280, P33097, DOI 10.1074/jbc.R500010200; WIEGANT FAC, 1987, CANCER RES, V47, P1674; Woolfson JP, 2009, COMP BIOCHEM PHYS A, V152, P91, DOI 10.1016/j.cbpa.2008.09.006; Wu YT, 2011, J BIOL CHEM, V286, P14190, DOI 10.1074/jbc.M111.219923; Xu YM, 2009, BIOORGAN MED CHEM, V17, P2210, DOI 10.1016/j.bmc.2008.10.091; Yang H, 2008, CURR PROTEIN PEPT SC, V9, P227, DOI 10.2174/138920308784533998; Yang HJ, 2007, MOL PHARMACOL, V71, P426, DOI 10.1124/mol.106.030015; Young JTF, 2010, CELL STRESS CHAPERON, V15, P323, DOI 10.1007/s12192-009-0147-4; Young JTF, 2009, COMP BIOCHEM PHYS A, V153, P417, DOI 10.1016/j.cbpa.2009.03.024; Yu YK, 2010, BIOCHEM PHARMACOL, V79, P542, DOI 10.1016/j.bcp.2009.09.017	71	24	24	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 30	2012	7	11							e50547	10.1371/journal.pone.0050547	http://dx.doi.org/10.1371/journal.pone.0050547			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	054WM	23226310	Green Published, Green Submitted, gold			2022-12-27	WOS:000312376100122
J	Kirby, AE				Kirby, Amy E.			Synergistic Action of Gentamicin and Bacteriophage in a Continuous Culture Population of Staphylococcus aureus	PLOS ONE			English	Article							KLEBSIELLA-PNEUMONIAE B5055; ESCHERICHIA-COLI; LISTERIA-MONOCYTOGENES; TEICHOIC-ACIDS; PHAGE THERAPY; PSEUDOMONAS-AERUGINOSA; ANTIMICROBIAL AGENTS; ANTIBIOTIC-TREATMENT; N-ACETYLGLUCOSAMINE; CELL-AGGREGATION	With the increasing frequency of antibiotic resistance and the decreasing frequency of new antibiotics entering the market, interest has returned to developing bacteriophage as a therapeutic agent. Acceptance of phage therapy, however, is limited by the unknown pharmacodynamics of a replicating agent, as well as the potential for the evolution of resistant bacteria. One way to overcome some of these limitations is to incorporate phage and antibiotics into a dual therapy regimen; however, this increases the complexity of the pharmacodynamics. The aim of this study is to develop an experimental system to evaluate the pharmacodynamics of dual phage-drug therapy. A continuous culture system for Staphylococcus aureus is used to simulate the pharmacokinetics of periodic antibiotic dosing alone and in combination with lytic phage. A computer model representation of the system allows further evaluation of the conditions governing the observed pharmacodynamics. The results of this experimental/modeling approach suggest that dual therapy can be more efficacious than single therapies, particularly if there is an overlap in the physiological pathways targeted by the individual agents. In this case, treatment with gentamicin induces a population of cells with a strong aggregation phenotype. These aggregators also have an increased ability to form biofilm, which is a well-known, non-genetic mechanism of drug resistance. However, the aggregators are also more susceptible than the parental strain to the action of the phage. Thus, dual treatment with gentamicin and phage resulted in lower final cell densities than either treatment alone. Unlike in the phage-only treatment, phage-resistant isolates were not detected in the dual treatment.	Emory Univ, Dept Biol, Atlanta, GA 30322 USA	Emory University	Kirby, AE (corresponding author), Emory Univ, Dept Biol, Atlanta, GA 30322 USA.	aekirby@emory.edu		Kirby, Amy/0000-0002-6928-668X	Proctor Gamble; National Institutes of Health [GM091875]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM091875] Funding Source: NIH RePORTER	Proctor Gamble(Procter & Gamble); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This research was supported by a grant from Proctor & Gamble and National Institutes of Health (GM091875) awarded to Bruce Levin. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abuladze T, 2008, APPL ENVIRON MICROB, V74, P6230, DOI 10.1128/AEM.01465-08; Alhede M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027943; Andersen MT, 2005, MICROBIOL-SGM, V151, P905, DOI 10.1099/mic.0.27513-0; [Anonymous], 2005, PERF STAND ANT SUS S; Atterbury RJ, 2009, MICROB BIOTECHNOL, V2, P601, DOI 10.1111/j.1751-7915.2009.00089.x; Bjarnsholt T, 2009, PEDIATR PULM, V44, P547, DOI 10.1002/ppul.21011; Bohannan BJM, 2000, ECOL LETT, V3, P362, DOI 10.1046/j.1461-0248.2000.00161.x; Bohannan BJM, 2002, ANTON LEEUW INT J G, V81, P107, DOI 10.1023/A:1020585711378; Burrowes B, 2011, EXPERT REV ANTI-INFE, V9, P775, DOI [10.1586/ERI.11.90, 10.1586/eri.11.90]; CHAO L, 1977, ECOLOGY, V58, P369, DOI 10.2307/1935611; Coffey B, 2010, ANNU REV FOOD SCI T, V1, P449, DOI 10.1146/annurev.food.102308.124046; Comeau AM, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000799; Cushnie TPT, 2007, J APPL MICROBIOL, V103, P1562, DOI 10.1111/j.1365-2672.2007.03393.x; Edgar R, 2012, APPL ENVIRON MICROB, V78, P744, DOI 10.1128/AEM.05741-11; Fedtke I, 2007, MOL MICROBIOL, V65, P1078, DOI 10.1111/j.1365-2958.2007.05854.x; Frick IM, 2000, MOL MICROBIOL, V37, P1232, DOI 10.1046/j.1365-2958.2000.02084.x; Galvez A, 2010, CURR OPIN BIOTECH, V21, P142, DOI 10.1016/j.copbio.2010.01.005; Gu JM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031698; Guenther S, 2009, APPL ENVIRON MICROB, V75, P93, DOI 10.1128/AEM.01711-08; Haaber J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041075; HABERER K, 1982, J VIROL, V41, P501, DOI 10.1128/JVI.41.2.501-507.1982; HELLER K, 1979, J BACTERIOL, V139, P32, DOI 10.1128/JB.139.1.32-38.1979; Holland LM, 2011, MICROBIOL-SGM, V157, P408, DOI 10.1099/mic.0.042234-0; Huff WE, 2010, POULTRY SCI, V89, P895, DOI 10.3382/ps.2009-00528; Hyman Paul, 2009, V501, P175, DOI 10.1007/978-1-60327-164-6_18; INCARDONA NL, 1973, J VIROL, V11, P775, DOI 10.1128/JVI.11.5.775-782.1973; Jalasvuori M, 2011, BIOL LETTERS, V7, P902, DOI 10.1098/rsbl.2011.0384; KORONA R, 1993, EVOLUTION, V47, P556, DOI 10.1111/j.1558-5646.1993.tb02113.x; KROPINSKI AM, 1970, J GEN VIROL, V6, P85, DOI 10.1099/0022-1317-6-1-85; Kropinski Andrew M., 2009, V501, P151, DOI 10.1007/978-1-60327-164-6_15; Kumari S, 2011, J MED MICROBIOL, V60, P205, DOI 10.1099/jmm.0.018580-0; KUSSER W, 1985, EUR J BIOCHEM, V151, P601, DOI 10.1111/j.1432-1033.1985.tb09146.x; LENSKI RE, 1985, AM NAT, V125, P585, DOI 10.1086/284364; Letkiewicz S, 2010, FEMS IMMUNOL MED MIC, V60, P99, DOI 10.1111/j.1574-695X.2010.00723.x; Levin BR, 2004, NAT REV MICROBIOL, V2, P166, DOI 10.1038/nrmicro822; Levin BR, 2010, ANTIMICROB AGENTS CH, V54, P3414, DOI 10.1128/AAC.00381-10; Lin KC, 2012, APPL MICROBIOL BIOT, V94, P755, DOI 10.1007/s00253-011-3857-3; LJUNGH A, 1985, INFECT IMMUN, V47, P522, DOI 10.1128/IAI.47.2.522-526.1985; Loc-Carrillo Catherine, 2011, Bacteriophage, V1, P111; Lu TK, 2007, P NATL ACAD SCI USA, V104, P11197, DOI 10.1073/pnas.0704624104; Lu TK, 2011, CURR OPIN MICROBIOL, V14, P524, DOI 10.1016/j.mib.2011.07.028; Lu TK, 2009, P NATL ACAD SCI USA, V106, P4629, DOI 10.1073/pnas.0800442106; Meader E, 2010, ANAEROBE, V16, P549, DOI 10.1016/j.anaerobe.2010.08.006; Merabishvili M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004944; Moradpour Z, 2011, BIOTECHNOL ADV, V29, P732, DOI 10.1016/j.biotechadv.2011.06.003; Morello E, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016963; O'Toole GA, 1998, MOL MICROBIOL, V28, P449, DOI 10.1046/j.1365-2958.1998.00797.x; Partridge SR, 2011, FEMS MICROBIOL REV, V35, P820, DOI 10.1111/j.1574-6976.2011.00277.x; Rahman M, 2011, BIOFOULING, V27, P1087, DOI 10.1080/08927014.2011.631169; Regoes RR, 2004, ANTIMICROB AGENTS CH, V48, P3670, DOI 10.1128/AAC.48.10.3670-3676.2004; ROY B, 1993, APPL ENVIRON MICROB, V59, P2914, DOI 10.1128/AEM.59.9.2914-2917.1993; Schroeder K, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007567; Sillankorva S, 2011, CURR MICROBIOL, V62, P1128, DOI 10.1007/s00284-010-9834-8; Sulakvelidze A, 2001, ANTIMICROB AGENTS CH, V45, P649, DOI 10.1128/AAC.45.3.649-659.2001; Tothova L, 2011, MED SCI MONITOR, V17, pBR173, DOI 10.12659/MSM.881844; Udekwu KI, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038866; Vaks L, 2011, J NANOBIOTECHNOL, V9, DOI 10.1186/1477-3155-9-58; Vandersteegen K, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024418; Verma V, 2010, BIOFOULING, V26, P729, DOI 10.1080/08927014.2010.511196; Verma V, 2009, J ANTIMICROB CHEMOTH, V64, P1212, DOI 10.1093/jac/dkp360; Wagstaff JL, 2008, MOL BIOSYST, V4, P170, DOI 10.1039/b715242f; Wendlinger G, 1996, MICROBIOL-UK, V142, P985, DOI 10.1099/00221287-142-4-985; Wright A, 2009, CLIN OTOLARYNGOL, V34, P349, DOI 10.1111/j.1749-4486.2009.01973.x; Xia GQ, 2010, J BIOL CHEM, V285, P13405, DOI 10.1074/jbc.M109.096172	64	63	64	0	47	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 30	2012	7	11							e51017	10.1371/journal.pone.0051017	http://dx.doi.org/10.1371/journal.pone.0051017			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	054WM	23226451	Green Published, gold			2022-12-27	WOS:000312376100262
J	Pan, ZW; Sun, XL; Ren, JS; Li, X; Gao, X; Lu, CY; Zhang, Y; Sun, H; Wang, Y; Wang, HM; Wang, JH; Xie, LJ; Lu, YJ; Yang, BF				Pan, Zhenwei; Sun, Xuelin; Ren, Jinshuai; Li, Xin; Gao, Xu; Lu, Chunying; Zhang, Yang; Sun, Hui; Wang, Ying; Wang, Huimin; Wang, Jinghao; Xie, Liangjun; Lu, Yanjie; Yang, Baofeng			miR-1 Exacerbates Cardiac Ischemia-Reperfusion Injury in Mouse Models	PLOS ONE			English	Article							MUSCLE-SPECIFIC MICRORNA; MYOCARDIAL-INFARCTION; HEAT-SHOCK; IN-VIVO; HSP60; CARDIOMYOCYTES; EXPRESSION; PROTECTION; APOPTOSIS; EPSILON	Recent studies have revealed the critical role of microRNAs (miRNAs) in regulating cardiac injury. Among them, the cardiac enriched microRNA-1(miR-1) has been extensively investigated and proven to be detrimental to cardiac myocytes. However, solid in vivo evidence for the role of miR-1 in cardiac injury is still missing and the potential therapeutic advantages of systemic knockdown of miR-1 expression remained unexplored. In this study, miR-1 transgenic (miR-1 Tg) mice and locked nucleic acid modified oligonucleotide against miR-1 (LNA-antimiR-1) were used to explore the effects of miR-1 on cardiac ischemia/reperfusion injury (30 min ischemia followed by 24 h reperfusion). The cardiac miR-1 level was significantly increased in miR-1 Tg mice, and suppressed in LNA-antimiR-1 treated mice. When subjected to ischemia/reperfusion injury, miR-1 overexpression exacerbated cardiac injury, manifested by increased LDH, CK levels, caspase-3 expression, apoptosis and cardiac infarct area. On the contrary, LNA-antimiR-1 treatment significantly attenuated cardiac ischemia/reperfusion injury. The expression of PKC epsilon and HSP60 was significantly repressed by miR-1 and enhanced by miR-1 knockdown, which may be a molecular mechanism for the role miR-1 in cardiac injury. Moreover, luciferase assay confirmed the direct regulation of miR-1 on protein kinase C epsilon (PKC epsilon) and heat shock protein 60 (HSP60). In summary, this study demonstrated that miR-1 is a causal factor for cardiac injury and systemic LNA-antimiR-1 therapy is effective in ameliorating the problem.	[Pan, Zhenwei; Sun, Xuelin; Ren, Jinshuai; Li, Xin; Lu, Chunying; Zhang, Yang; Sun, Hui; Wang, Ying; Wang, Huimin; Wang, Jinghao; Xie, Liangjun; Lu, Yanjie; Yang, Baofeng] Harbin Med Univ, Dept Pharmacol, Key Lab Cardiovasc Med Res, Minist Educ,State Prov Key Labs Biomed Pharmaceut, Harbin, Heilongjiang, Peoples R China; [Gao, Xu] Harbin Med Univ, Dept Biochem, Harbin, Heilongjiang, Peoples R China	Harbin Medical University; Harbin Medical University	Pan, ZW (corresponding author), Harbin Med Univ, Dept Pharmacol, Key Lab Cardiovasc Med Res, Minist Educ,State Prov Key Labs Biomed Pharmaceut, Harbin, Heilongjiang, Peoples R China.	panzw@ems.hrbmu.edu.cn; yjlu86@yahoo.com	wang, huimin/HDM-8421-2022; gao, xu/U-4765-2019		National Natural Science Foundation of China [81130088, 30971252, 81000100, 81170219]; Funds for Creative Research Groups of The National Natural Science Foundation of China [81121003]; China Postdoctoral Science Foundation [20080440915]; Heilongjiang Province Science Foundation for Youths [QC07C69]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Funds for Creative Research Groups of The National Natural Science Foundation of China; China Postdoctoral Science Foundation(China Postdoctoral Science Foundation); Heilongjiang Province Science Foundation for Youths	This work was supported by National Natural Science Foundation of China (81130088, 30971252, 81000100, 81170219), the Funds for Creative Research Groups of The National Natural Science Foundation of China (81121003), China Postdoctoral Science Foundation (20080440915), and Heilongjiang Province Science Foundation for Youths(QC07C69). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ai J, 2012, CARDIOVASC RES, V95, P385, DOI 10.1093/cvr/cvs196; Ai J, 2010, BIOCHEM BIOPH RES CO, V391, P73, DOI 10.1016/j.bbrc.2009.11.005; Chen CH, 2008, SCIENCE, V321, P1493, DOI 10.1126/science.1158554; Cheng YH, 2010, CLIN SCI, V119, P87, DOI 10.1042/CS20090645; Dorn GW, 1999, P NATL ACAD SCI USA, V96, P12798, DOI 10.1073/pnas.96.22.12798; Elmen J, 2008, NUCLEIC ACIDS RES, V36, P1153, DOI 10.1093/nar/gkm1113; Hollander JM, 2003, FREE RADICAL BIO MED, V35, P742, DOI 10.1016/S0891-5849(03)00400-3; Hullinger TG, 2011, CIRCULATION RES; Kaufman BA, 2003, J CELL BIOL, V163, P457, DOI 10.1083/jcb.200306132; KOLL H, 1992, CELL, V68, P1163, DOI 10.1016/0092-8674(92)90086-R; Krutzfeldt J, 2005, NATURE, V438, P685, DOI 10.1038/nature04303; Kukreja RC, 2011, MOL PHARMACOL, V80, P558, DOI 10.1124/mol.111.073528; Lewis BP, 2005, CELL, V120, P15, DOI 10.1016/j.cell.2004.12.035; Lin KM, 2001, CIRCULATION, V103, P1787, DOI 10.1161/01.CIR.103.13.1787; Liu GS, 1999, J MOL CELL CARDIOL, V31, P1937, DOI 10.1006/jmcc.1999.1026; Ogbi M, 2004, BIOCHEM J, V382, P923, DOI 10.1042/BJ20040468; Ono K, 2011, FEBS J, V278, P1619, DOI 10.1111/j.1742-4658.2011.08090.x; Ping PP, 1997, CIRC RES, V81, P404, DOI 10.1161/01.RES.81.3.404; Ren XP, 2009, CIRCULATION, V119, P2357, DOI 10.1161/CIRCULATIONAHA.108.814145; Sayed D, 2007, CIRC RES, V100, P416, DOI 10.1161/01.RES.0000257913.42552.23; Shan ZX, 2010, FEBS LETT, V584, P3592, DOI 10.1016/j.febslet.2010.07.027; Shan ZX, 2009, BIOCHEM BIOPH RES CO, V381, P597, DOI 10.1016/j.bbrc.2009.02.097; Tang YH, 2009, INT HEART J, V50, P377, DOI 10.1536/ihj.50.377; Vargas-Parada L, 2001, PARASITOLOGY, V122, P583, DOI 10.1017/S0031182001007764; Yang BF, 2007, NAT MED, V13, P486, DOI 10.1038/nm1569; Ye YM, 2011, PHYSIOL GENOMICS, V43, P534, DOI 10.1152/physiolgenomics.00130.2010; Yu XY, 2008, BIOCHEM BIOPH RES CO, V376, P548, DOI 10.1016/j.bbrc.2008.09.025; Zhao Y, 2005, NATURE, V436, P214, DOI 10.1038/nature03817; Zhao Y, 2007, CELL, V129, P303, DOI 10.1016/j.cell.2007.03.030	29	85	95	3	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 30	2012	7	11							e50515	10.1371/journal.pone.0050515	http://dx.doi.org/10.1371/journal.pone.0050515			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	054WM	23226300	Green Submitted, Green Published, gold			2022-12-27	WOS:000312376100112
J	Pastor-Palacios, G; Lopez-Ramirez, V; Cardona-Felix, CS; Brieba, LG				Pastor-Palacios, Guillermo; Lopez-Ramirez, Varinia; Cardona-Felix, Cesar S.; Brieba, Luis G.			A Transposon-Derived DNA Polymerase from Entamoeba histolytica Displays Intrinsic Strand Displacement, Processivity and Lesion Bypass	PLOS ONE			English	Article							TRANSLESION SYNTHESIS; ACTIVE-SITE; NUCLEOTIDE INCORPORATION; UNIQUE SEQUENCE; ABASIC SITE; B-FAMILY; FIDELITY; REPLICATION; MECHANISM; PROTEIN	Entamoeba histolytica encodes four family B2 DNA polymerases that vary in amino acid length from 813 to 1279. These DNA polymerases contain a N-terminal domain with no homology to other proteins and a C-terminal domain with high amino acid identity to archetypical family B2 DNA polymerases. A phylogenetic analysis indicates that these family B2 DNA polymerases are grouped with DNA polymerases from transposable elements dubbed Polintons or Mavericks. In this work, we report the cloning and biochemical characterization of the smallest family B2 DNA polymerase from E. histolytica. To facilitate its characterization we subcloned its 660 amino acids C-terminal region that comprises the complete exonuclease and DNA polymerization domains, dubbed throughout this work as EhDNApolB2. We found that EhDNApolB2 displays remarkable strand displacement, processivity and efficiently bypasses the DNA lesions: 8-oxo guanosine and abasic site. Family B2 DNA polymerases from T. vaginalis, G. lambia and E. histolytica contain a Terminal Region Protein 2 (TPR2) motif twice the length of the TPR2 from phi 29 DNA polymerase. Deletion studies demonstrate that as in phi 29 DNA polymerase, the TPR2 motif of EhDNApolB2 is solely responsible of strand displacement and processivity. Interestingly the TPR2 of EhDNApolB2 is also responsible for efficient abasic site bypass. These data suggests that the 21 extra amino acids of the TPR2 motif may shape the active site of EhDNApolB2 to efficiently incorporate and extended opposite an abasic site. Herein we demonstrate that an open reading frame derived from Politons-Mavericks in parasitic protozoa encode a functional enzyme and our findings support the notion that the introduction of novel motifs in DNA polymerases can confer specialized properties to a conserved scaffold.	[Pastor-Palacios, Guillermo; Cardona-Felix, Cesar S.; Brieba, Luis G.] Inst Politecn Nacl, Ctr Invest & Estudios Avanzados, Lab Nacl Genom Biodiversidad, Guanajuato, Mexico; [Lopez-Ramirez, Varinia] Inst Politecn Nacl, Ctr Invest & Estudios Avanzados, Dept Ingn Genet, Guanajuato, Mexico	CINVESTAV - Centro de Investigacion y de Estudios Avanzados del Instituto Politecnico Nacional; Instituto Politecnico Nacional - Mexico; CINVESTAV - Centro de Investigacion y de Estudios Avanzados del Instituto Politecnico Nacional; Instituto Politecnico Nacional - Mexico	Brieba, LG (corresponding author), Inst Politecn Nacl, Ctr Invest & Estudios Avanzados, Lab Nacl Genom Biodiversidad, Guanajuato, Mexico.	lgbrieba@langebio.cinvestav.mx	Lopez, Varinia/T-6107-2019; Brieba, Luis/I-8447-2016	Brieba, Luis/0000-0002-6073-5207; Pastor-Palacios, Guillermo/0000-0003-4273-2851	CONACYT [128647]; Howard Hughes Medical Institute	CONACYT(Consejo Nacional de Ciencia y Tecnologia (CONACyT)); Howard Hughes Medical Institute(Howard Hughes Medical Institute)	This work was supported by CONACYT basic science grant number 128647 and a grant from the Howard Hughes Medical Institute to LGB. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aller P, 2007, P NATL ACAD SCI USA, V104, P814, DOI 10.1073/pnas.0606648104; Andraos N, 2004, J BIOL CHEM, V279, P50609, DOI 10.1074/jbc.M408428200; Arana ME, 2008, NUCLEIC ACIDS RES, V36, P3847, DOI 10.1093/nar/gkn310; Arana ME, 2007, DNA REPAIR, V6, P213, DOI 10.1016/j.dnarep.2006.09.012; Berman AJ, 2007, EMBO J, V26, P3494, DOI 10.1038/sj.emboj.7601780; BERNAD A, 1987, EMBO J, V6, P4219, DOI 10.1002/j.1460-2075.1987.tb02770.x; BERNAD A, 1989, CELL, V59, P219, DOI 10.1016/0092-8674(89)90883-0; Bhattacharya S, 2002, J GENET, V81, P73, DOI 10.1007/BF02715903; BLANCO L, 1989, J BIOL CHEM, V264, P8935; BLANCO L, 1986, VIROLOGY, V153, P179, DOI 10.1016/0042-6822(86)90021-8; Blanco L, 1996, J BIOL CHEM, V271, P8509, DOI 10.1074/jbc.271.15.8509; BLASCO MA, 1995, J BIOL CHEM, V270, P2735, DOI 10.1074/jbc.270.6.2735; Brieba LG, 2005, STRUCTURE, V13, P1653, DOI 10.1016/j.str.2005.07.020; Brieba LG, 2004, EMBO J, V23, P3452, DOI 10.1038/sj.emboj.7600354; Bruck I, 2001, GENOME BIOL, V2; Cann IKO, 1999, J BACTERIOL, V181, P5984, DOI 10.1128/JB.181.19.5984-5992.1999; Cardona-Felix CS, 2011, ACTA CRYSTALLOGR D, V67, P497, DOI 10.1107/S0907444911010547; Cheetham GMT, 1999, SCIENCE, V286, P2305, DOI 10.1126/science.286.5448.2305; Choi JY, 2010, J MOL BIOL, V404, P34, DOI 10.1016/j.jmb.2010.09.015; CLARK JM, 1987, BIOCHEMISTRY-US, V26, P5398, DOI 10.1021/bi00391a027; de Vega M, 2007, NUCLEIC ACIDS RES, V35, P5096, DOI 10.1093/nar/gkm545; de Vega M, 2010, P NATL ACAD SCI USA, V107, P16506, DOI 10.1073/pnas.1011428107; Efrati E, 1997, J BIOL CHEM, V272, P2559; EGER BT, 1991, BIOCHEMISTRY-US, V30, P1441, DOI 10.1021/bi00219a039; Herrera-Aguirre ME, 2010, J BIOMED BIOTECHNOL, DOI 10.1155/2010/734898; Fischer MG, 2011, SCIENCE, V332, P231, DOI 10.1126/science.1199412; GARMENDIA C, 1992, J BIOL CHEM, V267, P2594; Guindon S, 2010, SYST BIOL, V59, P307, DOI 10.1093/sysbio/syq010; Haracska L, 2001, J BIOL CHEM, V276, P6861, DOI 10.1074/jbc.M008021200; Hogg M, 2011, J MOL BIOL, V405, P642, DOI 10.1016/j.jmb.2010.10.041; Hsu GW, 2004, NATURE, V431, P217, DOI 10.1038/nature02908; JOHNSON KA, 1993, ANNU REV BIOCHEM, V62, P685, DOI 10.1146/annurev.bi.62.070193.003345; Kamtekar S, 2004, MOL CELL, V16, P609, DOI 10.1016/j.molcel.2004.10.019; Kapitonov VV, 2006, P NATL ACAD SCI USA, V103, P4540, DOI 10.1073/pnas.0600833103; Kayal E, 2012, GENOME BIOL EVOLUTIO; Kirouac KN, 2011, P NATL ACAD SCI USA, V108, P3210, DOI 10.1073/pnas.1013909108; Klassen Roland, 2007, V7, P187, DOI 10.1007/7171_2007_095; Komazin-Meredith G, 2008, STRUCTURE, V16, P1214, DOI 10.1016/j.str.2008.05.008; Kunkel TA, 2000, ANNU REV BIOCHEM, V69, P497, DOI 10.1146/annurev.biochem.69.1.497; Lee YS, 2009, CELL, V139, P312, DOI 10.1016/j.cell.2009.07.050; Loftus B, 2005, NATURE, V433, P865, DOI 10.1038/nature03291; Lorenzi HA, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000716; Makioka A, 1998, J PARASITOL, V84, P857, DOI 10.2307/3284604; McCulloch SD, 2008, CELL RES, V18, P148, DOI 10.1038/cr.2008.4; Pastor-Palacios G, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000786; Prakash S, 2005, ANNU REV BIOCHEM, V74, P317, DOI 10.1146/annurev.biochem.74.082803.133250; Pritham EJ, 2007, GENE, V390, P3, DOI 10.1016/j.gene.2006.08.008; Rodriguez I, 2005, P NATL ACAD SCI USA, V102, P6407, DOI 10.1073/pnas.0500597102; Rodriguez I, 2009, NUCLEIC ACIDS RES, V37, P193, DOI 10.1093/nar/gkn928; Seki M, 2004, EMBO J, V23, P4484, DOI 10.1038/sj.emboj.7600424; SHEAFF R, 1991, BIOCHEMISTRY-US, V30, P8590, DOI 10.1021/bi00099a014; Shibutani S, 1997, J BIOL CHEM, V272, P13916, DOI 10.1074/jbc.272.21.13916; Stanley SL, 2003, LANCET, V361, P1025, DOI 10.1016/S0140-6736(03)12830-9; Steitz TA, 1999, J BIOL CHEM, V274, P17395, DOI 10.1074/jbc.274.25.17395; TABOR S, 1987, J BIOL CHEM, V262, P16212; Takata K, 2006, J BIOL CHEM, V281, P23445, DOI 10.1074/jbc.M604317200; Thompson EHZ, 2002, BIOCHEMISTRY-US, V41, P713, DOI 10.1021/bi0114271; Truniger V, 1999, J MOL BIOL, V286, P57, DOI 10.1006/jmbi.1998.2477; Vicente JB, 2009, CELL MICROBIOL, V11, P51, DOI 10.1111/j.1462-5822.2008.01236.x; Wang Y, 2004, NUCLEIC ACIDS RES, V32, P1197, DOI 10.1093/nar/gkh271; Washington MT, 2003, P NATL ACAD SCI USA, V100, P12093, DOI 10.1073/pnas.2134223100; Yang XM, 1997, J BIOL CHEM, V272, P6599, DOI 10.1074/jbc.272.10.6599; Yoon JH, 2010, GENE DEV, V24, P123, DOI 10.1101/gad.1872810	63	9	9	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 30	2012	7	11							e49964	10.1371/journal.pone.0049964	http://dx.doi.org/10.1371/journal.pone.0049964			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	054WM	23226232	Green Published, gold, Green Submitted			2022-12-27	WOS:000312376100040
J	Robert, KA; Braun, S				Robert, Kylie A.; Braun, Shannon			Milk Composition during Lactation Suggests a Mechanism for Male Biased Allocation of Maternal Resources in the Tammar Wallaby (Macropus eugenii)	PLOS ONE			English	Article							CERVUS-ELAPHUS-HISPANICUS; RED DEER; POUCH YOUNG; SEX-RATIO; AGE-DETERMINATION; LIFE-HISTORY; CALF GROWTH; HIND MILK; REPRODUCTION; CONSUMPTION	Recent research has found empirical evidence in support of the Trivers-Willard Hypothesis that offspring sex allocation is correlated with maternal investment. Tammar wallabies birthing sons have higher investment ability; however a mechanism for sex specific differential allocation of maternal resources in wallabies remains elusive. In metatherians the majority of maternal investment is during lactation. To examine if differential allocation occurs during lactation, we measured total milk protein, lipid and carbohydrates, from mothers with male and female pouch young, during phase 2B (100-215 days post partum) and phase 3 (215-360 days post partum) of lactation. Mothers of sons allocated significantly higher levels of protein than mothers of daughters during phase 2B of lactation, however no sex specific difference in maternal allocation was found for lipids, carbohydrates, or any milk component during phase 3 of lactation. We were unable to measure milk production to establish any differences in the amount of milk allocated. However, with the production of more milk comes a dilution effect on milk components. Given that we find no apparent dilution of milk components may suggest equality in milk production. Offspring body weight at 14 months of age was related to protein allocation during phase 2B of lactation, providing a maternal mechanism for differential allocation with fitness consequences. We believe collection of earlier phase 2A (0-100 days post partum) milk may yield important results given that differential investment in metatherians may be most apparent early in lactation, prior to any significant maternal investment, when a decision on termination of investment can be made with very little energetic loss to the mother. Interestingly, small mothers did not birth sons and better maternal condition was associated with raising sons. These data are in support of TWH and demonstrate a potential mechanism through which condition dependent and sex specific maternal investment may occur.	[Robert, Kylie A.; Braun, Shannon] La Trobe Univ, Dept Zool, Bundoora, Vic 3083, Australia	La Trobe University	Robert, KA (corresponding author), La Trobe Univ, Dept Zool, Bundoora, Vic 3083, Australia.	K.Robert@latrobe.edu.au	Robert, Kylie/C-5181-2009	Robert, Kylie/0000-0002-8554-8440	La Trobe University FSTE research grant	La Trobe University FSTE research grant	The research was funded by a La Trobe University FSTE research grant (K. A. R.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ATWOOD CS, 1992, J DAIRY RES, V59, P287, DOI 10.1017/S0022029900030569; Cameron EZ, 2004, P ROY SOC B-BIOL SCI, V271, P1723, DOI 10.1098/rspb.2004.2773; Chambers BK, 2008, THESIS U W AUSTR PER; Clutton-Brock T.H., 1991, EVOLUTION PARENTAL C; CLUTTONBROCK TH, 1984, NATURE, V308, P358, DOI 10.1038/308358a0; Cockburn A, 2002, SEX RATIOS: CONCEPTS AND RESEARCH METHODS, P266, DOI 10.1017/CBO9780511542053.014; COCKBURN A, 1990, AUST J ZOOL, V37, P467; Daly KA, 2007, VET IMMUNOL IMMUNOP, V120, P187, DOI 10.1016/j.vetimm.2007.07.008; DOVE H, 1989, J ZOOL, V219, P385, DOI 10.1111/j.1469-7998.1989.tb02587.x; Fujita M, 2012, AM J PHYS ANTHROPOL, V149, P52, DOI 10.1002/ajpa.22092; Gallego L, 2009, REPRODUCTION, V138, P859, DOI 10.1530/REP-09-0017; GITTLEMAN JL, 1988, AM ZOOL, V28, P863, DOI 10.1093/icb/28.3.863; GOPALAN C, 1962, B WORLD HEALTH ORGAN, V26, P203; GREEN B, 1988, AUST J ZOOL, V36, P217, DOI 10.1071/ZO9880217; GREEN SW, 1982, AUST J BIOL SCI, V35, P145; Hinde K, 2009, AM J PHYS ANTHROPOL, V138, P148, DOI 10.1002/ajpa.20911; Hinde K, 2007, CURR BIOL, V17, pR958, DOI 10.1016/j.cub.2007.09.029; Hinde K, 2009, AM J HUM BIOL, V21, P512, DOI 10.1002/ajhb.20917; Inns R.W, 1980, ECOLOGY KANGAROO ISL; INNS RW, 1982, AUST WILDLIFE RES, V9, P213, DOI 10.1071/WR9820213; JOHNSON KA, 1989, KANGAROOS WALLABIES, V2, P641; Landete-Castillejos T, 2009, THERIOGENOLOGY, V71, P400, DOI 10.1016/j.theriogenology.2008.08.006; Landete-Castillejos T, 2005, BEHAV ECOL SOCIOBIOL, V57, P267, DOI 10.1007/s00265-004-0848-8; Landete-Castillejos T, 2002, BIOL REPROD, V67, P1613, DOI 10.1095/biolreprod.102.004507; Landete-Castillejos T, 2001, J ANIM SCI, V79, P1085; Landete-Castillejos TS, 2003, PHYSIOL BIOCHEM ZOOL, V76, P594, DOI 10.1086/375660; Leimar O, 1996, BEHAV ECOL, V7, P316, DOI 10.1093/beheco/7.3.316; Lindstrom J, 1999, TRENDS ECOL EVOL, V14, P343, DOI 10.1016/S0169-5347(99)01639-0; Martin R.D., 1984, Symposia of the Zoological Society of London, P87; MERCHANT J. C., 1966, AUSTRALIAN J ZOOL, V14, P593, DOI 10.1071/ZO9660593; MESSER M, 1988, COMP BIOCHEM PHYS B, V90, P367, DOI 10.1016/0305-0491(88)90088-0; Metges CC, 2001, J NUTR, V131, P2062, DOI 10.1093/jn/131.7.2062; Oftedal O.T., 1984, Symposia of the Zoological Society of London, P33; POOLE WE, 1985, AUST WILDLIFE RES, V12, P127; Poole WE, 1991, 21 CSIRO DIV WILDFL; Powe CE, 2010, AM J HUM BIOL, V22, P50, DOI 10.1002/ajhb.20941; RASMUSSEN KM, 1992, ANNU REV NUTR, V12, P103, DOI 10.1146/annurev.nu.12.070192.000535; Robert KA, 2011, MAMMAL REV, V41, P1, DOI 10.1111/j.1365-2907.2010.00168.x; Robert KA, 2010, BIOL LETTERS, V6, P242, DOI 10.1098/rsbl.2009.0774; Rose RW, 2005, AUST J ZOOL, V53, P241, DOI 10.1071/ZO05009; RUDD CD, 1994, J ZOOL, V232, P151, DOI 10.1111/j.1469-7998.1994.tb01565.x; Rutkowska J, 2011, P ROY SOC B-BIOL SCI, V278, P2962, DOI 10.1098/rspb.2010.2654; Schwanz L, 2012, AUST J ZOOL IN PRESS; Stearns S.C., 1992, pi; Sunnucks P, 1997, AUST J ZOOL, V45, P573, DOI 10.1071/ZO97038; SUTTON JD, 1989, J DAIRY SCI, V72, P2801, DOI 10.3168/jds.S0022-0302(89)79426-1; Taggart DA, 2002, ANIM CONSERV, V5, P275, DOI 10.1017/S136794300200402X; TRIVERS RL, 1973, SCIENCE, V179, P90, DOI 10.1126/science.179.4068.90; Trott JF, 2003, BIOL REPROD, V68, P929, DOI 10.1095/biolreprod.102.005934; Tyndale-Biscoe H., 1987, REPROD PHYSL MARSUPI; TYNDALEBISCOE CH, 1990, PROG CLIN BIOL RES, V342, P659; Wang JH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024030	52	26	26	0	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 30	2012	7	11							e51099	10.1371/journal.pone.0051099	http://dx.doi.org/10.1371/journal.pone.0051099			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	054WM	23226470	Green Published, gold, Green Submitted			2022-12-27	WOS:000312376100281
J	Zhou, SW; Huang, YY; Wei, Y; Jiang, ZM; Zhang, YD; Yang, Q; Xie, DR				Zhou, Si-wei; Huang, Yuan-yuan; Wei, Ying; Jiang, Zhi-min; Zhang, Yuan-dong; Yang, Qiong; Xie, De-rong			No Survival Benefit from Adding Cetuximab or Panitumumab to Oxaliplatin-Based Chemotherapy in the First-Line Treatment of Metastatic Colorectal Cancer in KRAS Wild Type Patients: A Meta-Analysis	PLOS ONE			English	Article							FLUOROURACIL; BEVACIZUMAB; LEUCOVORIN; EFFICACY; TRIAL	Background: The efficacy of combined therapies of oxaliplatin-based chemotherapy and anti-epidermal growth factor receptor (anti-EGFR) monoclonal antibodies (MAbs) remains controversial in colorectal cancer (CRC). The aim of this study is to estimate the efficacy and safety of adding cetuximab or panitumumab to oxaliplatin-based chemotherapy in the first line treatment in KRAS wild type patients with metastatic colorectal cancer (mCRC) through meta-analysis. Methods: Medline, EMBASE, and Cochrane library, American Society of Clinical Oncology (ASCO) and European Society for Medical Oncology (ESMO) were searched. Eligible studies were randomized controlled trials (RCTs) which evaluated oxaliplatin-based chemotherapy with or without anti-EGFR drugs (cetuximab or panitumumab) in untreated KRAS wild type patients with mCRC. The outcomes included overall survival (OS), progression-free survival (PFS), overall response rate (ORR) and toxicities. Hazard ratios (HR) and risk ratio (RR) were used for the meta-analysis and were expressed with 95% confidence intervals. Results: This meta-analysis included four RCTs with 1270 patients, and all of the patients were administered oxaliplatin-based chemotherapy regimens with or without anti-EGFR MAbs. The result of heterogeneity of OS was not significant. Compared with chemotherapy alone, the addition of cetuximab or panitumumab didn't result in significant improvement in OS (HR = 1.00, 95% CI [0.88, 1.13], P = 0.95) or PFS (HR = 0.86, 95% CI [0.71, 1.04], P = 0.13). The subgroup analysis of cetuximab also revealed no significant benefit in OS (HR = 1.02, 95% CI [0.89, 1.18], P = 0.75) or in PFS (HR = 0.87, 95% CI [0.65, 1.17], P = 0.36). Patients who received combined therapy didn't have a higher ORR (Risk Ratio = 1.08, 95% CI [0.86, 1.36]). Toxicities slightly increased in anti-EGFR drugs group. Conclusions: The addition of cetuximab or panitumumab to oxaliplatin-based chemotherapy in first-line treatment of mCRC in wild type KRAS population did not improve efficacy in survival benefit and response rate. More RCTs are warranted to evaluate the combination of chemotherapy and targeted therapy.	[Zhou, Si-wei; Wei, Ying; Jiang, Zhi-min; Yang, Qiong; Xie, De-rong] Sun Yat Sen Univ, Sun Yat Sen Mem Hosp, Key Lab Malignant Tumor Gene Regulat & Target The, Guangdong Higher Educ Inst,Dept Oncol, Guangzhou 510275, Guangdong, Peoples R China; [Huang, Yuan-yuan] Sun Yat Sen Univ, Ctr Canc, State Key Lab Oncol S China, Guangzhou 510275, Guangdong, Peoples R China; [Zhang, Yuan-dong] Guangdong Acad Med Sci, Guangdong Gen Hosp, Ctr Canc, Guangzhou, Guangdong, Peoples R China	Sun Yat Sen University; Sun Yat Sen University; Guangdong Academy of Medical Sciences & Guangdong General Hospital	Xie, DR (corresponding author), Sun Yat Sen Univ, Sun Yat Sen Mem Hosp, Key Lab Malignant Tumor Gene Regulat & Target The, Guangdong Higher Educ Inst,Dept Oncol, Guangzhou 510275, Guangdong, Peoples R China.	xiederong@21cn.com						Adelstein BA, 2011, EUR J CANCER, V47, P1343, DOI 10.1016/j.ejca.2011.03.031; Amado RG, 2008, J CLIN ONCOL, V26, P1626, DOI 10.1200/JCO.2007.14.7116; Bokemeyer C, 2011, ANN ONCOL, V22, P1535, DOI 10.1093/annonc/mdq632; Bokemeyer C, 2009, J CLIN ONCOL, V27, P663, DOI 10.1200/JCO.2008.20.8397; Bria E GR, 2007, J CLIN ONCOL, V25; Cunningham D, 2004, NEW ENGL J MED, V351, P337, DOI 10.1056/NEJMoa033025; Douillard JY, 2010, J CLIN ONCOL, V28, P4697, DOI 10.1200/JCO.2009.27.4860; Hecht JR, 2009, J CLIN ONCOL, V27, P672, DOI 10.1200/JCO.2008.19.8135; Ibrahim EM, 2010, INT J COLORECTAL DIS, V25, P713, DOI 10.1007/s00384-010-0927-4; Jadad AR, 1996, CONTROL CLIN TRIALS, V17, P1, DOI 10.1016/0197-2456(95)00134-4; JEMAL A, 2011, CA CANCER J CLIN, V61, P134; Karapetis CS, 2008, NEW ENGL J MED, V359, P1757, DOI 10.1056/NEJMoa0804385; Kopetz S, 2009, CANCER RES, V69, P3842, DOI 10.1158/0008-5472.CAN-08-2246; Lara PN, 2011, J CLIN ONCOL, V29, P2965, DOI 10.1200/JCO.2011.35.0660; Lu Y, 2007, CANCER RES, V67, P8240, DOI 10.1158/0008-5472.CAN-07-0589; Maughan TS, 2011, LANCET, V377, P2103, DOI 10.1016/S0140-6736(11)60613-2; O'Neil BH, 2008, ONCOLOGIST, V13, P1074, DOI 10.1634/theoncologist.2008-0083; Sterne JAC, 2001, BMJ-BRIT MED J, V323, P101, DOI 10.1136/bmj.323.7304.101; Tol J, 2009, NEW ENGL J MED, V360, P563, DOI 10.1056/NEJMoa0808268; Tveit K. M., 2012, J CLIN ONCOL, P4; US Department of Health and Human Services, GUID IND CLIN TRIAL; Van Cutsem E, 2009, NEW ENGL J MED, V360, P1408, DOI 10.1056/NEJMoa0805019; Wolpin BM, 2008, GASTROENTEROLOGY, V134, P1296, DOI 10.1053/j.gastro.2008.02.098; Wong SL, 2010, J CLIN ONCOL, V28, P493, DOI 10.1200/JCO.2009.23.4450	24	26	27	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 30	2012	7	11							e50925	10.1371/journal.pone.0050925	http://dx.doi.org/10.1371/journal.pone.0050925			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	054WM	23226426	gold, Green Published, Green Submitted			2022-12-27	WOS:000312376100237
J	Pelzer, ES; Allan, JA; Theodoropoulos, C; Ross, T; Beagley, KW; Knox, CL				Pelzer, Elise S.; Allan, John A.; Theodoropoulos, Christina; Ross, Tara; Beagley, Kenneth W.; Knox, Christine L.			Hormone-Dependent Bacterial Growth, Persistence and Biofilm Formation - A Pilot Study Investigating Human Follicular Fluid Collected during IVF Cycles	PLOS ONE			English	Article							CELLS; WOMEN; FOLLICLES	Human follicular fluid, considered sterile, is aspirated as part of an in vitro fertilization (IVF) cycle. However, it is easily contaminated by the trans-vaginal collection route and little information exists in its potential to support the growth of microorganisms. The objectives of this study were to determine whether human follicular fluid can support bacterial growth over time, whether the steroid hormones estradiol and progesterone (present at high levels within follicular fluid) contribute to the in vitro growth of bacterial species, and whether species isolated from follicular fluid form biofilms. We found that bacteria in follicular fluid could persist for at least 28 weeks in vitro and that the steroid hormones stimulated the growth of some bacterial species, specifically Lactobacillus spp., Bifidobacterium spp. Streptococcus spp. and E. coli. Several species, Lactobacillus spp., Propionibacterium spp., and Streptococcus spp., formed biofilms when incubated in native follicular fluids in vitro (18/24, 75%). We conclude that bacteria aspirated along with follicular fluid during IVF cycles demonstrate a persistent pattern of growth. This discovery is important since it can offer a new avenue for investigation in infertile couples. Citation: Pelzer ES, Allan JA, Theodoropoulos C, Ross T, Beagley KW, et al. (2012) Hormone-Dependent Bacterial Growth, Persistence and Biofilm Formation - A Pilot Study Investigating Human Follicular Fluid Collected during IVF Cycles. PLoS ONE 7(12): e49965. doi: 10.1371/journal.pone.0049965	[Pelzer, Elise S.; Theodoropoulos, Christina; Beagley, Kenneth W.; Knox, Christine L.] Queensland Univ Technol, Inst Hlth & Biomed Innovat, Fac Sci & Technol, Brisbane, Qld 4001, Australia; [Pelzer, Elise S.] Wesley Hosp, Wesley Res Inst, Womens Hlth Lab, Auchenflower, Qld, Australia; [Allan, John A.; Ross, Tara] Wesley Hosp, Wesley Reprod Med Unit, Auchenflower, Qld, Australia	Queensland University of Technology (QUT); Wesley Hospital; Wesley Hospital	Pelzer, ES (corresponding author), Queensland Univ Technol, Inst Hlth & Biomed Innovat, Fac Sci & Technol, Brisbane, Qld 4001, Australia.	epelzer@wesleyresearch.com.au	Beagley, Kenneth/J-1129-2012	Beagley, Kenneth/0000-0003-3112-6557; Theodoropoulos, Christina/0000-0002-1140-7813; Knox, Christine/0000-0003-3997-6812; Pelzer, Elise/0000-0002-9825-7968	Wesley Research Institute Grant	Wesley Research Institute Grant	This work was supported by a Wesley Research Institute Grant. Laboratory work was performed in the John and Wendy Thorsen Women's Health Laboratory at the Wesley Research Institute. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALLISON DG, 1984, J MICROBIOL METH, V2, P93, DOI 10.1016/0167-7012(84)90034-4; Brabin L, 2005, SEX TRANSM INFECT, V81, P483, DOI 10.1136/sti.2005.014621; Brabin L, 2005, SEX TRANSM INFECT, V81, P128, DOI 10.1136/sti.2004.010223; Cottell E, 1996, FERTIL STERIL, V66, P776, DOI 10.1016/S0015-0282(16)58635-X; de Mola JRL, 1999, GYNECOL ENDOCRINOL, V13, P155, DOI 10.3109/09513599909167549; EDWARDS RG, 1974, J REPROD FERTIL, V37, P189, DOI 10.1530/jrf.0.0370189; Fey PD, 2010, CURR OPIN MICROBIOL, V13, P610, DOI 10.1016/j.mib.2010.09.007; Fey PD, 2010, FUTURE MICROBIOL, V5, P917, DOI 10.2217/FMB.10.56; Fux CA, 2005, TRENDS MICROBIOL, V13, P34, DOI 10.1016/j.tim.2004.11.010; GURGAN T, 1993, HUM REPROD, V8, P508; HILL GA, 1989, J IN VITRO FERTIL EM, V6, P201, DOI 10.1007/BF01132865; Hyman RW, 2005, P NATL ACAD SCI USA, V102, P7952, DOI 10.1073/pnas.0503236102; Jakobsson Tell, 2008, Ann Clin Microbiol Antimicrob, V7, P14, DOI 10.1186/1476-0711-7-14; Jakubovics NS, 2010, ORAL DIS, V16, P729, DOI 10.1111/j.1601-0825.2010.01701.x; Jakubovics NS, 2010, MOL ORAL MICROBIOL, V25, P4, DOI 10.1111/j.2041-1014.2009.00563.x; Klausen M, 2003, MOL MICROBIOL, V50, P61, DOI 10.1046/j.1365-2958.2003.03677.x; Klausen M, 2003, MOL MICROBIOL, V48, P1511, DOI 10.1046/j.1365-2958.2003.03525.x; Kreth J, 2009, J BACTERIOL, V191, P6281, DOI 10.1128/JB.00906-09; Kushnir MM, 2009, CLIN CHEM, V55, P519, DOI 10.1373/clinchem.2008.110262; Li Y, 2005, J DENT RES, V84, P559, DOI 10.1177/154405910508400614; Makrigiannakis A, 2000, ANN NY ACAD SCI, V900, P46; Nijland R, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015668; Patterson JL, 2009, MICROBIOLOGY; Pelzer ES, 2011, HUM REPROD, V26, P1799, DOI 10.1093/humrep/der108; Periasamy S, 2009, J BACTERIOL, V191, P6804, DOI 10.1128/JB.01006-09; Pruthi V, 2003, Indian J Med Microbiol, V21, P161; Quirk SM, 2006, J ENDOCRINOL, V189, P441, DOI 10.1677/joe.1.06549; RAZ R, 1993, NEW ENGL J MED, V329, P753, DOI 10.1056/NEJM199309093291102; Romero R, 2008, AM J OBSTET GYNECOL, V198; Sanchez MC, 2011, J PERIODONTAL RES, V46, P252, DOI 10.1111/j.1600-0765.2010.01341.x; Shimada H, 2001, BIOL REPROD, V64, P1739, DOI 10.1095/biolreprod64.6.1739; Simmons WL, 2007, J BACTERIOL, V189, P1905, DOI 10.1128/JB.01512-06; Speroff L, 2005, SPEROFFS CLIN GYNECO, P573; Spurbeck RR, 2008, INFECT IMMUN, V76, P3124, DOI 10.1128/IAI.00101-08; Stepanovic S, 2003, GYNECOL OBSTET INVES, V56, P173, DOI 10.1159/000074103; Swidsinski A, 2010, ANAEROBE, V16, P478, DOI 10.1016/j.anaerobe.2010.06.011; Verhelst R, 2005, BMC MICROBIOL, V5, DOI 10.1186/1471-2180-5-61; Vielfort K, 2008, MICROBES INFECT, V10, P1325, DOI 10.1016/j.micinf.2008.07.032	38	31	35	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 4	2012	7	12							e49965	10.1371/journal.pone.0049965	http://dx.doi.org/10.1371/journal.pone.0049965			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	051EQ	23226503	Green Submitted, gold, Green Published			2022-12-27	WOS:000312108500006
J	Dessalle, K; Euthine, V; Chanon, S; Delarichaudy, J; Fujii, I; Rome, S; Vidal, H; Nemoz, G; Simon, C; Lefai, E				Dessalle, Kevin; Euthine, Vanessa; Chanon, Stephanie; Delarichaudy, Joffrey; Fujii, Isao; Rome, Sophie; Vidal, Hubert; Nemoz, Georges; Simon, Chantal; Lefai, Etienne			SREBP-1 Transcription Factors Regulate Skeletal Muscle Cell Size by Controlling Protein Synthesis through Myogenic Regulatory Factors	PLOS ONE			English	Article							ELEMENT-BINDING PROTEINS; EXPRESSION; INSULIN; MYOD; GENE; ATROPHY; VIVO; LOCALIZATION; ACCUMULATION; ACTIVATION	SREBP-1 are ubiquitously expressed transcription factors, strongly expressed in lipogenic tissues where they regulate several metabolic processes like fatty acid synthesis. In skeletal muscle, SREBP-1 proteins regulate the expression of hundreds of genes, and we previously showed that their overexpression induced muscle atrophy together with a combined lack of expression of myogenic regulatory factors. Here we present evidences that SREBP-1 regulate muscle protein synthesis through the downregulation of the expression of MYOD1, MYOG and MEF2C factors. In myotubes overexpressing SREBP-1, restoring the expression of myogenic factors prevented atrophy and rescued protein synthesis, without affecting SREBP-1 action on atrogenes and proteolysis. Our results point out the roles of MRFs in the maintenance of the protein content and cell size in adult muscle fibre, and contribute to decipher the mechanisms by which SREBP-1 regulate muscle mass.	[Dessalle, Kevin; Euthine, Vanessa; Chanon, Stephanie; Delarichaudy, Joffrey; Rome, Sophie; Vidal, Hubert; Nemoz, Georges; Simon, Chantal; Lefai, Etienne] Univ Lyon 1, INRA 1235, INSERM U1060, CarMeN Lab, Oullins, France; [Fujii, Isao] Sojo Univ, Fac Pharmaceut Sci, Lab Clin Pharmacol & Therapeut, Kumamoto, Japan	INRAE; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Claude Bernard Lyon 1; Sojo University	Lefai, E (corresponding author), Univ Lyon 1, INRA 1235, INSERM U1060, CarMeN Lab, Oullins, France.	lefai@univ-lyon1.fr	Lefai, Etienne/L-7961-2019; Lefai, Etienne/E-9615-2019; , simon/B-2895-2011; Vidal, Hubert/M-6674-2017	Lefai, Etienne/0000-0002-3042-7801; Lefai, Etienne/0000-0002-3042-7801; , simon/0000-0002-7820-3233; Vidal, Hubert/0000-0002-9467-0317; ROME, SOPHIE/0000-0003-3986-5936; Chanon, Stephanie/0000-0001-6930-6671	INSERM; INRA; Canceropole Lyon Rhone-Alpes; French Ministry of Higher Education	INSERM(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission); INRA; Canceropole Lyon Rhone-Alpes; French Ministry of Higher Education	This work was supported by INSERM, INRA, and a grant from the Canceropole Lyon Rhone-Alpes (Procan Axe III 2010). KD and JDL are recipients of PhD fellowships from the French Ministry of Higher Education. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abiola M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008509; Amemiya-Kudo M, 2002, J LIPID RES, V43, P1220, DOI 10.1194/jlr.M100417-JLR200; Boonsong T, 2007, BIOCHEM SOC T, V35, P1310, DOI 10.1042/BST0351310; Bruusgaard JC, 2012, J APPL PHYSIOL, V113, P290, DOI 10.1152/japplphysiol.00436.2012; Charge SB, 2008, BMC DEV BIOL, V8, DOI 10.1186/1471-213X-8-5; Commerford SR, 2004, AM J PHYSIOL-REG I, V287, pR218, DOI 10.1152/ajpregu.00377.2003; Cozzone D, 2006, DIABETOLOGIA, V49, P990, DOI 10.1007/s00125-006-0140-8; De Larichaudy J, 2012, SKELET MUSCLE, V2, DOI 10.1186/2044-5040-2-2; Dif N, 2006, BIOCHEM J, V400, P179, DOI 10.1042/BJ20060499; Ducluzeau PH, 2001, DIABETES, V50, P1134, DOI 10.2337/diabetes.50.5.1134; EDMONDSON DG, 1993, J BIOL CHEM, V268, P755; Evans WJ, 2010, AM J CLIN NUTR, V91, p1123S, DOI 10.3945/ajcn.2010.28608A; Fujii I, 2006, BRAIN DEV-JPN, V28, P420, DOI 10.1016/j.braindev.2005.12.007; Guillet-Deniau I, 2002, DIABETES, V51, P1722, DOI 10.2337/diabetes.51.6.1722; GULVE EA, 1989, BIOCHEM J, V260, P377, DOI 10.1042/bj2600377; Horton JD, 2002, BIOCHEM SOC T, V30, P1091, DOI 10.1042/bst0301091; Horton JD, 2003, P NATL ACAD SCI USA, V100, P12027, DOI 10.1073/pnas.1534923100; Hughes SM, 1997, MECH DEVELOP, V61, P151, DOI 10.1016/S0925-4773(96)00631-4; HUGHES SM, 1993, DEVELOPMENT, V118, P1137; Im SS, 2009, MOL CELL BIOL, V29, P4864, DOI 10.1128/MCB.00553-09; Ishido M, 2004, ACTA PHYSIOL SCAND, V180, P281, DOI 10.1046/j.0001-6772.2003.01238.x; Ishido M, 2004, AM J PHYSIOL-CELL PH, V287, pC484, DOI 10.1152/ajpcell.00080.2004; Kallin A, 2007, J LIPID RES, V48, P1628, DOI 10.1194/jlr.M700136-JLR200; Kitzmann M, 1998, J CELL BIOL, V142, P1447, DOI 10.1083/jcb.142.6.1447; Kotzka J, 2000, J LIPID RES, V41, P99; Lagirand-Cantaloube J, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004973; Lecomte V, 2010, MOL CELL BIOL, V30, P1182, DOI 10.1128/MCB.00690-09; LI H, 1993, NUCLEIC ACIDS RES, V21, P335, DOI 10.1093/nar/21.2.335; Li Y, 2011, CELL METAB, V13, P376, DOI 10.1016/j.cmet.2011.03.009; Macpherson PCD, 2011, J CELL BIOCHEM, V112, P2149, DOI 10.1002/jcb.23136; Maxwell KN, 2003, J LIPID RES, V44, P2109, DOI 10.1194/jlr.M300203-JLR200; MERLIE JP, 1994, J BIOL CHEM, V269, P2461; Moresi V, 2010, CELL, V143, P35, DOI 10.1016/j.cell.2010.09.004; Nadeau KJ, 2004, J BIOL CHEM, V279, P34380, DOI 10.1074/jbc.M403596200; Peterson TR, 2011, CELL, V146, P408, DOI 10.1016/j.cell.2011.06.034; Ponugoti B, 2010, J BIOL CHEM, V285, P33959, DOI 10.1074/jbc.M110.122978; Porstmann T, 2008, CELL METAB, V8, P224, DOI 10.1016/j.cmet.2008.07.007; Raghow R, 2008, TRENDS ENDOCRIN MET, V19, P65, DOI 10.1016/j.tem.2007.10.009; Rome S, 2008, PHYSIOL GENOMICS, V34, P327, DOI 10.1152/physiolgenomics.90211.2008; Sewter C, 2002, DIABETES, V51, P1035, DOI 10.2337/diabetes.51.4.1035; Walker AK, 2010, GENE DEV, V24, P1403, DOI 10.1101/gad.1901210; Walters EH, 2000, J MUSCLE RES CELL M, V21, P647, DOI 10.1023/A:1005683825960	42	26	26	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 30	2012	7	11							e50878	10.1371/journal.pone.0050878	http://dx.doi.org/10.1371/journal.pone.0050878			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	054WM	23226416	Green Published, gold			2022-12-27	WOS:000312376100227
J	Frazier, WJ; Xue, JJ; Luce, WA; Liu, YS				Frazier, W. Joshua; Xue, Jianjing; Luce, Wendy A.; Liu, Yusen			MAPK Signaling Drives Inflammation in LPS-Stimulated Cardiomyocytes: The Route of Crosstalk to G-Protein-Coupled Receptors	PLOS ONE			English	Article							NECROSIS-FACTOR-ALPHA; KAPPA-B ACTIVATION; KINASE PHOSPHATASE-1; SEPTIC SHOCK; SEVERE SEPSIS; PROSTAGLANDIN RECEPTORS; MYOCARDIAL DYSFUNCTION; CHEMOTAXIS; EXPRESSION; PATHWAYS	Profound cardiovascular dysfunction is an important cause of mortality from septic shock. The molecular underpinnings of cardiac dysfunction during the inflammatory surge of early sepsis are not fully understood. MAPKs are important signal transducers mediating inflammation whereas G-protein signaling pathways modulate the cardiac response to stress. Using H9c2 cardiomyocytes, we investigated the interaction of MAPK and G-protein signaling in a sepsis model to test the hypothesis that the cardiomyocyte inflammatory response is controlled by MAPKs via G-protein-mediated events. We found that LPS stimulated proinflammatory cytokine production was markedly exacerbated by siRNA knockdown of the MAPK negative regulator Mkp-1. Cytokine production was blunted when cells were treated with p38 inhibitor. Two important cellular signaling molecules typically regulated by G-protein-coupled receptors, cAMP and PKC activity, were also stimulated by LPS and inflammatory cytokines TNF-alpha and IL-6, through a process regulated by Mkp-1 and p38. Interestingly, neutralizing antibodies against Gas and G alpha(q) blocked the increase in cellular cAMP and PKC activation, respectively, in response to inflammatory stimuli, indicating a critical role of G-protein coupled receptors in this process. LPS stimulation increased COX-2 in H9c2 cells, which also express prostaglandin receptors. Blockade of G-protein-coupled EP4 prostaglandin receptor by AH 23848 prevented LPS-induced cAMP increase. These data implicate MAPKs and G-proteins in the cardiomyocyte inflammatory response to LPS as well as crosstalk via COX-2-generated PGE(2). These data add to our understanding of the pathogenesis of septic shock and have the potential to guide the selection of future therapeutics.	[Frazier, W. Joshua; Luce, Wendy A.; Liu, Yusen] Ohio State Univ, Coll Med, Dept Pediat, Columbus, OH 43210 USA; [Frazier, W. Joshua; Xue, Jianjing; Liu, Yusen] Nationwide Childrens Hosp, Res Inst, Ctr Perinatal Res, Columbus, OH USA; [Luce, Wendy A.] Nationwide Childrens Hosp, Res Inst, Ctr Cardiovasc & Pulm Res, Columbus, OH USA	University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; Nationwide Childrens Hospital; Research Institute at Nationwide Children's Hospital; University System of Ohio; Ohio State University; Nationwide Childrens Hospital; Research Institute at Nationwide Children's Hospital	Frazier, WJ (corresponding author), Ohio State Univ, Coll Med, Dept Pediat, Columbus, OH 43210 USA.	warren.frazier@nationwidechildrens.org	Frazier, W. Joshua/C-8651-2013; Liu, Yusen/E-3527-2011	Liu, Yusen/0000-0002-0994-0109	National Institute of Allergy Immunology and Infectious Disease [R01 AI68956, AI57798]; Eunice Kennedy Shriver National Institute of Child Health and Human Development [K12 HD043372]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI068956, R21AI057798, R01AI057798] Funding Source: NIH RePORTER	National Institute of Allergy Immunology and Infectious Disease; Eunice Kennedy Shriver National Institute of Child Health and Human Development(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by grants from the National Institute of Allergy Immunology and Infectious Disease (www.niaid.nih.gov R01 AI68956 and AI57798 to YL) and the Eunice Kennedy Shriver National Institute of Child Health and Human Development (www.nichd.nih.gov K12 HD043372 to WJF). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Angus D C, 2001, Crit Care Med, V29, P1303, DOI 10.1097/00003246-200107000-00002; Aronoff DM, 2012, MEDIAT INFLAMM, V2012, DOI 10.1155/2012/696897; Ashton AW, 2003, J BIOL CHEM, V278, P11858, DOI 10.1074/jbc.M210766200; Belcheva MM, 2002, NEUROSIGNALS, V11, P34, DOI 10.1159/000057320; Birkenmeier K, 2008, EUR J CLIN INVEST, V38, P902, DOI 10.1111/j.1365-2362.2008.02052.x; Booz GW, 2002, MOL CELL BIOCHEM, V240, P39, DOI 10.1023/A:1020648425895; Braz JC, 2003, J CLIN INVEST, V111, P1475, DOI 10.1172/JCI200317295; Brierley J, 2009, CRIT CARE MED, V37, P666, DOI 10.1097/CCM.0b013e31819323c6; Chalupka AN, 2012, CRIT CARE CLIN, V28, P57, DOI 10.1016/j.ccc.2011.09.003; Chen FP, 2009, J APPL PHYSIOL, V106, P1132, DOI 10.1152/japplphysiol.90542.2008; Clause KC, 2009, TISSUE ENG PT A, V15, P1373, DOI 10.1089/ten.tea.2008.0169; Cohen J, 2002, NATURE, V420, P885, DOI 10.1038/nature01326; Dellinger RP, 2008, CRIT CARE MED, V36, P296, DOI 10.1097/01.CCM.0000298158.12101.41; Engel FB, 2006, P NATL ACAD SCI USA, V103, P15546, DOI 10.1073/pnas.0607382103; Esberg Lucy B, 2004, Cardiovasc Toxicol, V4, P375, DOI 10.1385/CT:4:4:375; Frazier WJ, 2008, PEDIATR CLIN N AM, V55, P647, DOI 10.1016/j.pcl.2008.02.009; Frazier WJ, 2009, J IMMUNOL, V183, P7411, DOI 10.4049/jimmunol.0804343; Gouwy M, 2009, J LEUKOCYTE BIOL, V86, P671, DOI 10.1189/jlb.1008638; Halpert MM, 2011, J IMMUNOL, V187, P2346, DOI 10.4049/jimmunol.1100534; Hamm HE, 1998, J BIOL CHEM, V273, P669, DOI 10.1074/jbc.273.2.669; Hata AN, 2004, PHARMACOL THERAPEUT, V103, P147, DOI 10.1016/j.pharmthera.2004.06.003; Hochstadt A, 2011, J CARDIOTHOR VASC AN, V25, P526, DOI 10.1053/j.jvca.2010.11.026; Hotchkiss RS, 2003, NEW ENGL J MED, V348, P138, DOI 10.1056/NEJMra021333; Kacimi R, 2003, HYPERTENSION, V41, P968, DOI 10.1161/01.HYP.0000062465.60601.CC; Kumar A, 2006, J INFECT DIS, V193, P251, DOI 10.1086/498909; Liu YS, 2007, NAT REV IMMUNOL, V7, P202, DOI 10.1038/nri2035; Lopez-Ilasaca M, 1998, BIOCHEM PHARMACOL, V56, P269, DOI 10.1016/S0006-2952(98)00059-8; Nagamatsu Y, 2006, J PHARMACOL SCI, V101, P144, DOI 10.1254/jphs.FP0051036; Ngai J, 2009, BMC IMMUNOL, V10, DOI 10.1186/1471-2172-10-27; Ottosen ER, 2003, J MED CHEM, V46, P5651, DOI 10.1021/jm030851s; Patial S, 2011, J CELL PHYSIOL, V226, P1323, DOI 10.1002/jcp.22460; Patten M, 2002, CARDIOVASC RES, V53, P156, DOI 10.1016/S0008-6363(01)00443-6; Peng TQ, 2009, CARDIOVASC RES, V81, P733, DOI 10.1093/cvr/cvn336; Peter PS, 2007, J CLIN INVEST, V117, P1335, DOI 10.1172/JCI29576; Rapuano BE, 1997, J CELL BIOCHEM, V65, P198, DOI 10.1002/(SICI)1097-4644(199705)65:2<198::AID-JCB6>3.0.CO;2-P; Shepherd EG, 2004, J BIOL CHEM, V279, P54023, DOI 10.1074/jbc.M408444200; Sugden PH, 1997, CELL SIGNAL, V9, P337, DOI 10.1016/S0898-6568(96)00191-X; Sun L, 2012, ACTA PHARMACOL SIN, V33, P342, DOI 10.1038/aps.2011.200; Tang EHC, 2012, J CARDIOVASC PHARM, V59, P116, DOI 10.1097/FJC.0b013e3182244a12; Wang XX, 2008, LIFE SCI, V83, P671, DOI 10.1016/j.lfs.2008.09.003; Wang XX, 2007, J IMMUNOL, V178, P5312, DOI 10.4049/jimmunol.178.8.5312; Wu LL, 2003, SHOCK, V19, P533, DOI 10.1097/01.shk.0000055816.40894.cd; Zhang T, 2012, CARDIOVASC RES, V93, P471, DOI 10.1093/cvr/cvr346; Zhao Q, 2006, J EXP MED, V203, P131, DOI 10.1084/jem.20051794; Zhao Q, 2005, J BIOL CHEM, V280, P8101, DOI 10.1074/jbc.M411760200	45	44	52	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 30	2012	7	11							e50071	10.1371/journal.pone.0050071	http://dx.doi.org/10.1371/journal.pone.0050071			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	054WM	23226236	gold, Green Published, Green Submitted			2022-12-27	WOS:000312376100045
J	Perdomo, J; Jiang, XM; Carter, DR; Khachigian, LM; Chong, BH				Perdomo, Jose; Jiang, Xing-Mai; Carter, Daniel R.; Khachigian, Levon M.; Chong, Beng H.			SUMOylation Regulates the Transcriptional Repression Activity of FOG-2 and Its Association with GATA-4	PLOS ONE			English	Article							ZINC-FINGER; HEART MORPHOGENESIS; SUMO MODIFICATION; GENE ACTIVITY; CO-REPRESSOR; IN-VITRO; PROTEIN; UBIQUITIN; ACTIVATION; COFACTOR	Friend of GATA 2 (FOG-2), a co-factor of several GATA transcription factors (GATA-4, -5 and 6), is a critical regulator of coronary vessel formation and heart morphogenesis. Here we demonstrate that FOG-2 is SUMOylated and that this modification modulates its transcriptional activity. FOG-2 SUMOylation occurs at four lysine residues (K312, 471, 915, 955). Three of these residues are part of the characteristic SUMO consensus site (psi KXE), while K955 is found in the less frequent TKXE motif. Absence of SUMOylation did not affect FOG-29s nuclear localization. However, mutation of the FOG-2 SUMOylation sites, or de-SUMOylation, with SENP-1 or SENP-8 resulted in stronger transcriptional repression activity in both heterologous cells and cardiomyocytes. Conversely, increased FOG-2 SUMOylation by overexpression of SUMO-1 or expression of a SUMO-1-FOG-2 fusion protein rendered FOG-2 incapable of repressing GATA-4-mediated activation of the B-type natriuretic peptide (BNP) promoter. Moreover, we demonstrate both increased interaction between a FOG-2 SUMO mutant and GATA-4 and enhanced SUMOylation of wild-type FOG-2 by co-expression of GATA-4. These data suggest a new dynamics in which GATA-4 may alter the activity of FOG-2 by influencing its SUMOylation status.	[Perdomo, Jose; Jiang, Xing-Mai] Univ New S Wales, Dept Med, St George Clin Sch, Sydney, NSW, Australia; [Perdomo, Jose; Khachigian, Levon M.; Chong, Beng H.] Univ New S Wales, Ctr Vasc Res, Sydney, NSW, Australia; [Carter, Daniel R.] Univ New S Wales, Childrens Canc Inst Australia, Lowy Canc Res Ctr, Sydney, NSW, Australia; [Chong, Beng H.] Univ New S Wales, Dept Haematol, St George Hosp, Sydney, NSW, Australia; [Chong, Beng H.] Univ New S Wales, Dept Haematol, Sutherland Hosp, Sydney, NSW, Australia	University of New South Wales Sydney; University of New South Wales Sydney; Children's Cancer Institute; University of New South Wales Sydney; St George Hospital; University of New South Wales Sydney; University of New South Wales Sydney	Perdomo, J (corresponding author), Univ New S Wales, Dept Med, St George Clin Sch, Sydney, NSW, Australia.	j.perdomo@unsw.edu.au	Chong, Beng/AAM-9010-2021; Khachigian, Levon/AAZ-7458-2020; Chong, Beng/AAE-2617-2019; Perdomo, Jose/H-8871-2019	Perdomo, Jose/0000-0002-1554-708X; Khachigian, Levon/0000-0003-3446-0323; Carter, Daniel/0000-0002-8464-238X	NHMRC, Australia [455395]; Australian Postgraduate Award	NHMRC, Australia(National Health and Medical Research Council (NHMRC) of Australia); Australian Postgraduate Award(Australian Government)	This work was supported by a Program Grant from NHMRC, Australia to LMK and BHC (455395). DRC was supported by an Australian Postgraduate Award. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arco PGD, 2005, MOL CELL BIOL, V25, P2688, DOI 10.1128/MCB.25.7.2688-2697.2005; Belaguli NS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035717; Cheng J, 2007, CELL, V131, P584, DOI 10.1016/j.cell.2007.08.045; Costa MW, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024812; Crispino JD, 2001, GENE DEV, V15, P839, DOI 10.1101/gad.875201; Deconinck AE, 2000, DEVELOPMENT, V127, P2031; Fox AH, 1999, EMBO J, V18, P2812, DOI 10.1093/emboj/18.10.2812; Gao F, 2006, NAT CELL BIOL, V8, P1171, DOI 10.1038/ncb1483; Gill G, 2004, GENE DEV, V18, P2046, DOI 10.1101/gad.1214604; Gill G, 2005, CURR OPIN GENET DEV, V15, P536, DOI 10.1016/j.gde.2005.07.004; Girdwood D, 2003, MOL CELL, V11, P1043, DOI 10.1016/S1097-2765(03)00141-2; GREPIN C, 1995, MOL CELL BIOL, V15, P4095; Hirai M, 2004, J BIOL CHEM, V279, P37640, DOI 10.1074/jbc.M401737200; Holmes M, 1999, J BIOL CHEM, V274, P23491, DOI 10.1074/jbc.274.33.23491; Hong W, 2005, EMBO J, V24, P2367, DOI 10.1038/sj.emboj.7600703; Jakobs A, 2007, NAT METHODS, V4, P245, DOI 10.1038/NMETH1006; Kamitani T, 1998, J BIOL CHEM, V273, P26675, DOI 10.1074/jbc.273.41.26675; Kim EY, 2012, J MOL CELL CARDIOL, V52, P638, DOI 10.1016/j.yjmcc.2011.11.011; Kotaja N, 2002, J BIOL CHEM, V277, P30283, DOI 10.1074/jbc.M204768200; Liang QR, 2001, J BIOL CHEM, V276, P30245, DOI 10.1074/jbc.M102174200; Lu JR, 1999, MOL CELL BIOL, V19, P4495; Mascle XH, 2007, J BIOL CHEM, V282, P10190, DOI 10.1074/jbc.M611429200; Melchior F, 2000, ANNU REV CELL DEV BI, V16, P591, DOI 10.1146/annurev.cellbio.16.1.591; Melchior F, 2003, TRENDS BIOCHEM SCI, V28, P612, DOI 10.1016/j.tibs.2003.09.002; Molkentin JD, 1997, GENE DEV, V11, P1061, DOI 10.1101/gad.11.8.1061; Oka T, 2006, CIRC RES, V98, P837, DOI 10.1161/01.RES.0000215985.18538.c4; Perdomo J, 2005, MOL CELL BIOL, V25, P1549, DOI 10.1128/MCB.25.4.1549-1559.2005; Philips AS, 2007, J BIOL CHEM, V282, P24915, DOI 10.1074/jbc.M701789200; Pichler A, 2002, TRAFFIC, V3, P381, DOI 10.1034/j.1600-0854.2002.30601.x; Pikkarainen S, 2004, CARDIOVASC RES, V63, P196, DOI 10.1016/j.cardiores.2004.03.025; Roche AE, 2008, J MOL CELL CARDIOL, V44, P352, DOI 10.1016/j.yjmcc.2007.10.023; Ross S, 2002, MOL CELL, V10, P831, DOI 10.1016/S1097-2765(02)00682-2; Saitoh H, 2000, J BIOL CHEM, V275, P6252, DOI 10.1074/jbc.275.9.6252; Salinas S, 2004, J CELL BIOL, V165, P767, DOI 10.1083/jcb.200310136; Shyu YC, 2005, MOL CELL BIOL, V25, P10365, DOI 10.1128/MCB.25.23.10365-10378.2005; Snow JW, 2010, J BIOL CHEM, V285, P28064, DOI 10.1074/jbc.M109.096909; Svensson EC, 2000, J BIOL CHEM, V275, P20762, DOI 10.1074/jbc.M001522200; Svensson EC, 1999, P NATL ACAD SCI USA, V96, P956, DOI 10.1073/pnas.96.3.956; Tevosian SG, 2000, CELL, V101, P729, DOI 10.1016/S0092-8674(00)80885-5; Tevosian SG, 1999, P NATL ACAD SCI USA, V96, P950, DOI 10.1073/pnas.96.3.950; Verger A, 2003, EMBO REP, V4, P137, DOI 10.1038/sj.embor.embor738; Wang J, 2004, J BIOL CHEM, V279, P49091, DOI 10.1074/jbc.M407494200; Wang J, 2008, J BIOL CHEM, V283, P23235, DOI 10.1074/jbc.M709748200; Wang J, 2010, CIRC RES, V107, P19, DOI 10.1161/CIRCRESAHA.110.220491; Xue Y, 2006, NUCL ACIDS RES, P34; Zhou FF, 2005, FEBS LETT, V579, P3369, DOI 10.1016/j.febslet.2005.04.076	46	9	11	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 30	2012	7	11							e50637	10.1371/journal.pone.0050637	http://dx.doi.org/10.1371/journal.pone.0050637			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	054WM	23226341	Green Submitted, Green Published, gold			2022-12-27	WOS:000312376100152
J	Tan, SW; Lai, SW				Tan, Shih-Wei; Lai, Shih-Wen			Characterization and Modeling Analysis for Metal-Semiconductor-Metal GaAs Diodes with Pd/SiO2 Mixture Electrode	PLOS ONE			English	Article							HYDROGEN SENSING CHARACTERISTICS; SCHOTTKY DIODES; PD; SENSOR; SENSITIVITY; TRANSISTOR; INTERFACE; DIPOLES; CHANNEL; PD/GAN	Characterization and modeling of metal-semiconductor-metal (MSM) GaAs diodes using to evaporate SiO2 and Pd simultaneously as a mixture electrode (called M-MSM diodes) compared with similar to evaporate Pd as the electrode (called Pd-MSM diodes) were reported. The barrier height (phi(b)) and the Richardson constant (A*) were carried out for the thermionic-emission process to describe well the current transport for Pd-MSM diodes in the consideration of the carrier over the metal-semiconductor barrier. In addition, in the consideration of the carrier over both the metal-semiconductor barrier and the insulator-semiconductor barrier simultaneously, thus the thermionic-emission process can be used to describe well the current transport for M-MSM diodes. Furthermore, in the higher applied voltage, the carrier recombination will be taken into discussion. Besides, a composite-current (CC) model is developed to evidence the concepts. Our calculated results are in good agreement with the experimental ones.	[Tan, Shih-Wei; Lai, Shih-Wen] Natl Taiwan Ocean Univ, Dept Elect Engn, Keelung, Taiwan	National Taiwan Ocean University	Tan, SW (corresponding author), Natl Taiwan Ocean Univ, Dept Elect Engn, Keelung, Taiwan.	tanshwei@mail.ntou.edu.tw			National Taiwan Ocean University of the Republic of China [NTOU-100-014, 101B290031]	National Taiwan Ocean University of the Republic of China	This work is financially supported by the National Taiwan Ocean University of the Republic of China under the contract No. NTOU-100-014 and 101B290031. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ali M, 2006, IEEE SENS J, V6, P1115, DOI 10.1109/JSEN.2006.881346; Chen LY, 2008, IEEE T ELECTRON DEV, V55, P3310, DOI 10.1109/TED.2008.2005126; Chiu SY, 2009, ELECTRON LETT, V45, P231, DOI 10.1049/el:20092158; Chiu SY, 2009, IEEE ELECTR DEVICE L, V30, P898, DOI 10.1109/LED.2009.2025894; Chiu SY, 2009, JPN J APPL PHYS, V48, DOI 10.1143/JJAP.48.041002; Chiu SY, 2008, IEEE ELECTR DEVICE L, V29, P1328, DOI 10.1109/LED.2008.2006994; Filippov VI, 2006, IEEE SENS J, V6, P1250, DOI 10.1109/JSEN.2006.881088; FOGELBERG J, 1995, J APPL PHYS, V78, P988, DOI 10.1063/1.360293; Hsu WC, 2010, ELECTROCHEM SOLID ST, V13, pH234, DOI 10.1149/1.3407624; Huang JR, 2007, SENSOR ACTUAT B-CHEM, V123, P1040, DOI 10.1016/j.snb.2006.11.008; Huang JR, 2006, SENSOR ACTUAT B-CHEM, V117, P151, DOI 10.1016/j.snb.2005.11.020; Hung CW, 2006, IEEE ELECTR DEVICE L, V27, P951, DOI 10.1109/LED.2006.886313; KANG WP, 1994, J APPL PHYS, V75, P8175, DOI 10.1063/1.356517; Lee CS, 2011, IEEE T ELECTRON DEV, V58, P2981, DOI 10.1109/TED.2011.2158650; Lin KW, 2004, IEEE SENS J, V4, P72, DOI 10.1109/JSEN.2003.820320; Lu CT, 2003, IEEE ELECTR DEVICE L, V24, P390, DOI 10.1109/LED.2003.813354; LUNDSTROM KI, 1975, J APPL PHYS, V46, P3876, DOI 10.1063/1.322185; RIDEOUT VL, 1970, SOLID STATE ELECTRON, V13, P993, DOI 10.1016/0038-1101(70)90097-3; Schalwig J, 2002, APPL PHYS LETT, V80, P1222, DOI 10.1063/1.1450044; Song JH, 2008, IEEE SENS J, V8, P903, DOI 10.1109/JSEN.2008.923938; Sze S. M., 2007, PHYS SEMICONDUCTOR D, V3rd, P134; Tsai JH, 2007, ELECTRON LETT, V43, P732, DOI 10.1049/el:20070621; Tsai TH, 2008, APPL PHYS EXPRESS, V1, DOI 10.1143/APEX.1.041102; Tsai YY, 2007, SENSOR ACTUAT B-CHEM, V120, P687, DOI 10.1016/j.snb.2006.03.035	24	2	2	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 30	2012	7	11							e50681	10.1371/journal.pone.0050681	http://dx.doi.org/10.1371/journal.pone.0050681			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	054WM	23226352	Green Published, gold, Green Submitted			2022-12-27	WOS:000312376100163
J	Visser, JC; Bellstedt, DU; Pirie, MD				Visser, Johan Christiaan; Bellstedt, Dirk Uwe; Pirie, Michael David			The Recent Recombinant Evolution of a Major Crop Pathogen, Potato virus Y	PLOS ONE			English	Article							VENOUS NECROSIS; NUCLEOTIDE-SEQUENCE; STRAIN; PATTERNS; ISOLATE; PVYN; DNA; IDENTIFICATION; POTYVIRUSES; DIVERSITY	Potato virus Y (PVY) is a major agricultural disease that reduces crop yields worldwide. Different strains of PVY are associated with differing degrees of pathogenicity, of which the most common and economically important are known to be recombinant. We need to know the evolutionary origins of pathogens to prevent further escalations of diseases, but putatively reticulate genealogies are challenging to reconstruct with standard phylogenetic approaches. Currently available phylogenetic hypotheses for PVY are either limited to non-recombinant strains, represent only parts of the genome, and/or incorrectly assume a strictly bifurcating phylogenetic tree. Despite attempts to date potyviruses in general, no attempt has been made to date the origins of pathogenic PVY. We test whether diversification of the major strains of PVY and recombination between them occurred within the time frame of the domestication and modern cultivation of potatoes. In so doing, we demonstrate a novel extension of a phylogenetic approach for reconstructing reticulate evolutionary scenarios. We infer a well resolved phylogeny of 44 whole genome sequences of PVY viruses, representative of all known strains, using recombination detection and phylogenetic inference techniques. Using Bayesian molecular dating we show that the parental strains of PVY diverged around the time potatoes were first introduced to Europe, that recombination between them only occurred in the last century, and that the multiple recombination events that led to highly pathogenic PVY NTN occurred within the last 50 years. Disease causing agents are often transported across the globe by humans, with disastrous effects for us, our livestock and crops. Our analytical approach is particularly pertinent for the often small recombinant genomes involved (e.g. HIV/influenza A). In the case of PVY, increased transport of diseased material is likely to blame for uniting the parents of recombinant pathogenic strains: this process needs to be minimised to prevent further such occurrences.	[Visser, Johan Christiaan; Bellstedt, Dirk Uwe; Pirie, Michael David] Univ Stellenbosch, Dept Biochem, ZA-7600 Stellenbosch, South Africa	Stellenbosch University	Pirie, MD (corresponding author), Univ Stellenbosch, Dept Biochem, ZA-7600 Stellenbosch, South Africa.	mpirie@sun.ac.za	; Pirie, Michael/A-3067-2008	Bellstedt, Dirk/0000-0002-6376-4855; Pirie, Michael/0000-0003-0403-4470	Potatoes South Africa; Claude Leon Foundation Postdoctoral Fellowship	Potatoes South Africa; Claude Leon Foundation Postdoctoral Fellowship	This research was supported in part by funding granted to DUB from Potatoes South Africa, and by a Claude Leon Foundation Postdoctoral Fellowship to MDP. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Antonelli A, 2010, P ROYAL SOC B, V278, P675; Barker H, 2009, AM J POTATO RES, V86, P227, DOI 10.1007/s12230-009-9076-0; BECZNER L, 1984, POTATO RES, V27, P339, DOI 10.1007/BF02357646; Bellstedt DU, 2010, AM J BOT, V97, pE65, DOI 10.3732/ajb.1000181; Blanchard A, 2008, POTATO 2 FRUIT VEGET, V3, P6; Boonham N, 2002, PLANT PATHOL, V51, P117, DOI 10.1046/j.1365-3059.2002.00681.x; Brucher H., 1975, Kulturpflanze, V23, P11; Castro-Nallar E, 2012, MOL PHYLOGENET EVOL, V62, P777, DOI 10.1016/j.ympev.2011.11.019; CHRZANOWSKA M, 1991, POTATO RES, V34, P179, DOI DOI 10.1007/BF02358039; Crosslin JM, 2005, AM J POTATO RES, V82, P263, DOI 10.1007/BF02871955; Cuevas JM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037853; DRAKE JW, 1993, P NATL ACAD SCI USA, V90, P4171, DOI 10.1073/pnas.90.9.4171; Drummond AJ, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-214; Drummond AJ, 2006, PLOS BIOL, V4, P699, DOI 10.1371/journal.pbio.0040088; Fanigliulo A, 2005, ARCH VIROL, V150, P709, DOI 10.1007/s00705-004-0449-x; Fellers JP, 2002, MOL PLANT PATHOL, V3, P145, DOI 10.1046/j.1364-3703.2002.00106.x; Galvino-Costa SBF, 2011, PLANT PATHOL, P1; Gibbs AJ, 2010, J GEN VIROL, V91, P13, DOI 10.1099/vir.0.015925-0; Gibbs AJ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002523; Gibbs MJ, 2000, BIOINFORMATICS, V16, P573, DOI 10.1093/bioinformatics/16.7.573; Hall T.A., 1999, NUCL ACIDS S SER, V41, P95; Heath L, 2006, J VIROL, V80, P11827, DOI 10.1128/JVI.01100-06; Ho SYW, 2011, SYST BIOL, V60, P366, DOI 10.1093/sysbio/syq099; Holland BR, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-202; Hu XJ, 2009, VIRUS RES, V143, P68, DOI 10.1016/j.virusres.2009.03.008; Hu XX, 2009, ARCH VIROL, V154, P1303, DOI 10.1007/s00705-009-0448-z; Humphreys AM, 2011, EVOLUTION, V65, P1163, DOI 10.1111/j.1558-5646.2010.01184.x; Huson DH, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-460; Huson DH, 2007, LECT NOTES COMPUT SC, V4453, P211; Huson DH, 2006, MOL BIOL EVOL, V23, P254, DOI 10.1093/molbev/msj030; Jakab G, 1997, J GEN VIROL, V78, P3141, DOI 10.1099/0022-1317-78-12-3141; Karasev AV, 2011, PHYTOPATHOLOGY, V101, P778, DOI 10.1094/PHYTO-10-10-0284; Lefeuvre P, 2007, J GEN VIROL, V88, P3458, DOI 10.1099/vir.0.83252-0; Lefeuvre P, 2009, J VIROL, V83, P2697, DOI 10.1128/JVI.02152-08; Lemey P, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000520; LEROMANCER M, 1994, PLANT PATHOL, V43, P138, DOI 10.1111/j.1365-3059.1994.tb00563.x; Lole KS, 1999, J VIROL, V73, P152, DOI 10.1128/JVI.73.1.152-160.1999; Lorenzen JH, 2006, PLANT DIS, V90, P935, DOI 10.1094/PD-90-0935; Lorenzen J, 2008, ARCH VIROL, V153, P517, DOI 10.1007/s00705-007-0030-5; Blanco-Pastor JL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039089; Marcussen T, 2012, SYST BIOL, V61, P107, DOI 10.1093/sysbio/syr096; Martin D, 2000, BIOINFORMATICS, V16, P562, DOI 10.1093/bioinformatics/16.6.562; Martin DP, 2010, BIOINFORMATICS, V26, P2462, DOI 10.1093/bioinformatics/btq467; Martin DP, 2005, AIDS RES HUM RETROV, V21, P98, DOI 10.1089/aid.2005.21.98; McDonald JG, 1996, AM POTATO J, V73, P309, DOI 10.1007/BF02855210; Miller M.A., 2010, P GAT COMP ENV WORKS; Moury B, 2002, J GEN VIROL, V83, P2563, DOI 10.1099/0022-1317-83-10-2563; Moury B, 2010, MOL PLANT PATHOL, V11, P161, DOI [10.1111/j.1364-3703.2009.00573.x, 10.1111/j.1364-3703.2009.00573.X]; Nie XZ, 2004, CAN J PLANT PATHOL, V26, P573; Ogawa T, 2008, VIRUS RES, V131, P199, DOI 10.1016/j.virusres.2007.09.010; Orlando A, 1945, ARQUIVOS I BIOL, V6, P133; Padidam M, 1999, VIROLOGY, V265, P218, DOI 10.1006/viro.1999.0056; Pelser PB, 2010, AM J BOT, V97, P856, DOI 10.3732/ajb.0900287; Pirie MD, 2008, MOL PHYLOGENET EVOL, V48, P1106, DOI 10.1016/j.ympev.2008.05.030; Pirie MD, 2009, SYST BIOL, V58, P612, DOI 10.1093/sysbio/syp068; Posada D, 2001, MOL BIOL EVOL, V18, P1976, DOI 10.1093/oxfordjournals.molbev.a003738; Rahman MS, 2009, BANGLASESH J AGR RES, V4, P609; RAMBAUT A., 2003, TRACER V 1 5; ROBAGLIA C, 1989, J GEN VIROL, V70, P935, DOI 10.1099/0022-1317-70-4-935; Salaman RN, 1930, NATURE, V126, P241, DOI 10.1038/126241a0; SALMINEN MO, 1995, AIDS RES HUM RETROV, V11, P1423, DOI 10.1089/aid.1995.11.1423; SAWYER S, 1989, MOL BIOL EVOL, V6, P526; Schubert J, 2007, J VIROLOGICAL METHOD, P140; Singh M, 1996, CAN J PLANT PATHOL, V18, P209, DOI 10.1080/07060669609500615; Singh RP, 2008, ARCH VIROL, V153, P1, DOI 10.1007/s00705-007-1059-1; SMITH JM, 1992, J MOL EVOL, V34, P126; Smith KM, 1931, NATURE, V127, P702, DOI 10.1038/127702a0; Spooner DM, 2005, P NATL ACAD SCI USA, V102, P14694, DOI 10.1073/pnas.0507400102; Stamatakis A, 2008, SYST BIOL, V57, P758, DOI 10.1080/10635150802429642; Stamatakis A, 2006, BIOINFORMATICS, V22, P2688, DOI 10.1093/bioinformatics/btl446; Swofford D, 2002, PAUP PHYLOGENETIC AN, DOI 10.1111/J.0014-3820.2002.TB00191.X; Tan ZY, 2004, J GEN VIROL, V85, P2683, DOI 10.1099/vir.0.80124-0; THOLE V, 1993, GENE, V123, P149, DOI 10.1016/0378-1119(93)90118-M; Towle M.A., 1961, ETHNOBOTANY PRECOLUM; Valkonen Jari P. T., 2007, P619; Visser JC, 2009, ARCH VIROL, V154, P1891, DOI 10.1007/s00705-009-0525-3; WARD CW, 1991, INTERVIROLOGY, V32, P269, DOI 10.1159/000150211; Warren M., 2005, POTATO VIRUS Y PVY P; Wiens JJ, 2006, J BIOMED INFORM, V39, P34, DOI 10.1016/j.jbi.2005.04.001; WILGENBUSCH JC, 2004, AWTY SYSTEM GRAPHICA	80	39	43	0	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 30	2012	7	11							e50631	10.1371/journal.pone.0050631	http://dx.doi.org/10.1371/journal.pone.0050631			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	054WM	23226339	Green Published, gold, Green Submitted			2022-12-27	WOS:000312376100150
J	Waters, PS; McDermott, AM; Wall, D; Heneghan, HM; Miller, N; Newell, J; Kerin, MJ; Dwyer, RM				Waters, Peadar S.; McDermott, Ailbhe M.; Wall, Deirdre; Heneghan, Helen M.; Miller, Nicola; Newell, John; Kerin, Michael J.; Dwyer, Roisin M.			Relationship between Circulating and Tissue microRNAs in a Murine Model of Breast Cancer	PLOS ONE			English	Article							CARCINOMA-CELL-LINES; SERUM TUMOR-MARKERS; EXPRESSION SIGNATURE; MIR-221; METASTASIS; BIOMARKER; PROMOTES; SURVIVAL; INVASION; GENES	MiRNAs are key regulators of tumorigenesis that are aberrantly expressed in the circulation and tissue of patients with cancer. The aim of this study was to determine whether miRNA dysregulation in the circulation reflected similar changes in tumour tissue. Athymic nude mice (n = 20) received either a mammary fat pad (n = 8, MFP), or subcutaneous (n = 7, SC) injection of MDA-MB-231 cells. Controls received no tumour cells (n = 5). Tumour volume was monitored weekly and blood sampling performed at weeks 1, 3 and 6 following tumour induction (total n = 60). Animals were sacrificed at week 6 and tumour tissue (n = 15), lungs (n = 20) and enlarged lymph nodes (n = 3) harvested. MicroRNAs were extracted from all samples (n = 98) and relative expression quantified using RQ-PCR. MiR-221 expression was significantly increased in tumour compared to healthy tissue (p<0.001). MiR-10b expression was significantly higher in MFP compared to SC tumours (p<0.05), with the highest levels detected in diseased lymph nodes (p<0.05). MiR-10b was undetectable in the circulation, with no significant change in circulating miR-221 expression detected during disease progression. MiR-195 and miR-497 were significantly decreased in tumour tissue (p<0.05), and also in the circulation of animals 3 weeks following tumour induction (p<0.05). At both tissue and circulating level, a positive correlation was observed between miR-497 and miR-195 (r = 0.61, p<0.001; r = 0.41, p<0.01 respectively). This study highlights the distinct roles of miRNAs in circulation and tissue. It also implicates miRNAs in disease dissemination and progression, which may be important in systemic therapy and biomarker development.	[Waters, Peadar S.; McDermott, Ailbhe M.; Heneghan, Helen M.; Miller, Nicola; Kerin, Michael J.; Dwyer, Roisin M.] Natl Univ Ireland, Discipline Surg, Sch Med, Galway, Ireland; [Wall, Deirdre; Newell, John] Natl Univ Ireland, HRB Clin Res Facil, Galway, Ireland; [Wall, Deirdre; Newell, John] Natl Univ Ireland, Sch Math Stat & Appl Math, Galway, Ireland	Ollscoil na Gaillimhe-University of Galway; Health Research Board - Ireland; Ollscoil na Gaillimhe-University of Galway; Ollscoil na Gaillimhe-University of Galway	Dwyer, RM (corresponding author), Natl Univ Ireland, Discipline Surg, Sch Med, Galway, Ireland.	roisin.dwyer@nuigalway.ie	Miller, Nicola/F-4009-2018; Kerin, Michael J/D-6748-2013; Dwyer, Roisin M/C-6654-2013	Miller, Nicola/0000-0002-5416-7047; Dwyer, Roisin M/0000-0002-5854-0339; Heneghan, Helen/0000-0002-2009-3406; Kerin, Michael/0000-0003-4164-5561; Newell, John/0000-0001-7685-6655; Wall, Deirdre/0000-0001-6510-6082	National Breast Cancer Research Institute (NBCRI)	National Breast Cancer Research Institute (NBCRI)	This work was supported by funding received from the National Breast Cancer Research Institute (NBCRI, www.nbcri.ie). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agaoglu FY, 2011, TUMOR BIOL, V32, P583, DOI 10.1007/s13277-011-0154-9; Calin GA, 2002, P NATL ACAD SCI USA, V99, P15524, DOI 10.1073/pnas.242606799; Calin GA, 2004, P NATL ACAD SCI USA, V101, P11755, DOI 10.1073/pnas.0404432101; Carney PA, 2003, ANN INTERN MED, V138, P168, DOI 10.7326/0003-4819-138-3-200302040-00008; Christensen M, 2009, NEUROSCI LETT, V466, P55, DOI 10.1016/j.neulet.2009.04.043; Cocucci E, 2009, TRENDS CELL BIOL, V19, P43, DOI 10.1016/j.tcb.2008.11.003; Davoren PA, 2008, BMC MOL BIOL, V9, DOI 10.1186/1471-2199-9-76; Duffy MJ, 2006, CLIN CHEM, V52, P345, DOI 10.1373/clinchem.2005.059832; Esquela-Kerscher A, 2006, NAT REV CANCER, V6, P259, DOI 10.1038/nrc1840; Galardi S, 2007, J BIOL CHEM, V282, P23716, DOI 10.1074/jbc.M701805200; Gee HE, 2008, NATURE, V455, DOI 10.1038/nature07362; Ghosh AK, 2009, BLOOD, V115, P1755; Harris L, 2007, J CLIN ONCOL, V25, P5287, DOI 10.1200/JCO.2007.14.2364; Hedeker D, 2007, ADDICTION, V102, P1564, DOI 10.1111/j.1360-0443.2007.01946.x; Heneghan HM, 2010, ONCOLOGIST, V15, P673, DOI 10.1634/theoncologist.2010-0103; Heneghan HM, 2010, ANN SURG, V251, P499, DOI 10.1097/SLA.0b013e3181cc939f; Iorio MV, 2005, CANCER RES, V65, P7065, DOI 10.1158/0008-5472.CAN-05-1783; Jemal A, 2009, CA-CANCER J CLIN, V59, P225, DOI 10.3322/caac.20006; Kaplan HG, 2006, CLIN BREAST CANCER, V7, P133, DOI 10.3816/CBC.2006.n.022; Lawrie CH, 2009, BRIT J HAEMATOL, V147, P398, DOI 10.1111/j.1365-2141.2009.07857.x; Lehmann U, 2008, J PATHOL, V214, P17, DOI 10.1002/path.2251; Li D, 2011, CLIN CANCER RES, V17, P1722, DOI 10.1158/1078-0432.CCR-10-1800; Li XH, 2010, GUT, V59, P579, DOI 10.1136/gut.2008.175497; Lima LG, 2009, CANCER LETT, V283, P168, DOI 10.1016/j.canlet.2009.03.041; Liu Z, 2012, INT J ONCOL, V40, P1553, DOI 10.3892/ijo.2012.1342; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lowery AJ, 2008, CLIN CANCER RES, V14, P360, DOI 10.1158/1078-0432.CCR-07-0992; Ma L, 2007, NATURE, V449, P682, DOI 10.1038/nature06174; Ma L, 2010, NAT BIOTECHNOL, V28, P341, DOI 10.1038/nbt.1618; Miller TE, 2008, J BIOL CHEM, V283, P29897, DOI 10.1074/jbc.M804612200; Mitchell PS, 2008, P NATL ACAD SCI USA, V105, P10513, DOI 10.1073/pnas.0804549105; Nakata K, 2011, SURGERY, V150, P916, DOI 10.1016/j.surg.2011.06.017; Negrini M, 2008, BREAST CANCER RES, V10, DOI 10.1186/bcr1867; Nishida N, 2012, ANN SURG ONCOL; Perou CM, 2000, NATURE, V406, P747, DOI 10.1038/35021093; Pineau P, 2010, P NATL ACAD SCI USA, V107, P264, DOI 10.1073/pnas.0907904107; PRICE JE, 1990, CANCER RES, V50, P717; Saito Y, 2009, J GASTROENTEROL, V44, P18, DOI 10.1007/s00535-008-2285-3; Shafi G, 2010, CAN J NEUROL SCI, V37, P177, DOI 10.1017/S0317167100009902; Shah MY, 2011, GENOME MED, V3, DOI 10.1186/gm272; Soci UPR, 2011, PHYSIOL GENOMICS, V43, P665, DOI 10.1152/physiolgenomics.00145.2010; Sturgeon CM, 2009, BMJ-BRIT MED J, V339, DOI 10.1136/bmj.b3527; Visone R, 2007, ENDOCR-RELAT CANCER, V14, P791, DOI 10.1677/ERC-07-0129; Volinia S, 2006, P NATL ACAD SCI USA, V103, P2257, DOI 10.1073/pnas.0510565103; Wu F, 2011, INFLAMM BOWEL DIS, V17, P241, DOI 10.1002/ibd.21450; Wurz K, 2010, GENE CHROMOSOME CANC, V49, P577, DOI 10.1002/gcc.20768; Xiao JJ, 2011, PHYSIOL GENOMICS, V43, P655, DOI 10.1152/physiolgenomics.00139.2010; Zhao RH, 2011, ONKOLOGIE, V34, P675, DOI 10.1159/000334552; Zheng C., 2011, MED ONCOL; Zhu Weizhu, 2009, BMC Res Notes, V2, P89, DOI 10.1186/1756-0500-2-89	50	39	42	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 30	2012	7	11							e50459	10.1371/journal.pone.0050459	http://dx.doi.org/10.1371/journal.pone.0050459			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	054WM	23226290	Green Published, Green Submitted, gold			2022-12-27	WOS:000312376100102
J	Winther-Janson, M; Wueringer, BE; Seymour, JE				Winther-Janson, Marit; Wueringer, Barbara E.; Seymour, Jamie E.			Electroreceptive and Mechanoreceptive Anatomical Specialisations in the Epaulette Shark (Hemiscyllium ocellatum)	PLOS ONE			English	Article							LATERAL-LINE SYSTEM; ELECTROSENSORY PORE DISTRIBUTION; MECHANOTACTILE HYPOTHESIS; AMPULLARY SYSTEMS; SENSORY SYSTEMS; ELASMOBRANCHS; MORPHOLOGY; LORENZINI; STINGRAY; STIMULATION	The arrangement of the electroreceptive ampullary system and closely related mechanoreceptive lateral line canal system was investigated in the epaulette shark, Hemiscyllium ocellatum. The lateral line canals form an elaborate network across the head and are continuously punctuated by pores. Ampullary pores are distributed in eleven distinct pore fields, and associated ampullary bulbs are aggregated in five independent ampullary clusters on either side of the head. Pores are primarily concentrated around the mouth and across the snout of the animal. We provide the anatomical basis for future behavioural studies on electroreception and mechanoreception in epaulette sharks, as well as supporting evidence that the electroreceptive ampullary system is specialised to provide behaviourally relevant stimuli. In addition, we describe ampullary pores distributed as far posteriorly as the dorsal fin and thus reject the assumption that ampullary pores are restricted to the cephalic region in sharks. Citation: Winther-Janson M, Wueringer BE, Seymour JE (2012) Electroreceptive and Mechanoreceptive Anatomical Specialisations in the Epaulette Shark (Hemiscyllium ocellatum). PLoS ONE 7(11): e49857. doi:10.1371/journal.pone.0049857	[Winther-Janson, Marit; Wueringer, Barbara E.] James Cook Univ, Sch Marine & Trop Biol, Cairns, Qld, Australia; [Seymour, Jamie E.] James Cook Univ, Ctr Biodiscovery & Mol Dev Therapeut, Cairns, Qld, Australia	James Cook University; James Cook University	Winther-Janson, M (corresponding author), James Cook Univ, Sch Marine & Trop Biol, Cairns, Qld, Australia.	Winther.Janson@gmail.com	Seymour, Jamie E/C-9748-2013	Seymour, Jamie E/0000-0002-4805-3289; Wueringer, Barbara Elisabeth/0000-0003-3202-0068	James Cook University	James Cook University	Funding was provided by James Cook University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Atkinson CJL, 2006, J MAR BIOL ASSOC UK, V86, P447, DOI 10.1017/S0025315406013336; BERNAYS EA, 1994, Q REV BIOL, V69, P187, DOI 10.1086/418539; Bodznick D., 1986, P225; BOORD RL, 1977, AM ZOOL, V17, P431; BROUN G R, 1979, Neurophysiology, V11, P118, DOI 10.1007/BF01064519; Camperi M, 2007, PLOS COMPUT BIOL, V3, P1083, DOI 10.1371/journal.pcbi.0030113; Chu Y. T., 1979, MONOGRAPH FISHES CHI; Collin SP, 2004, ANIM BIOL, V54, P1, DOI 10.1163/157075604323010024; Ewart JC, 1892, T R SOC EDINB, V37, P59; Garman S., 1888, B MUS COMP ZOOL HARV, V17, P57; GRUBER SH, 1967, SHARKS SKATES RAYS, P479; Heupel MR, 1998, MAR FRESHWATER RES, V49, P753, DOI 10.1071/MF97026; HOBSON EDMUND S., 1963, PACIFIC SCI, V17, P171; Hueter RE, 2004, CRC MAR BIOL SER, P325; JOHNSEN PB, 1985, MAR BEHAV PHYSIOL, V11, P283, DOI 10.1080/10236248509387053; Jordan LK, 2008, J MORPHOL, V269, P1325, DOI 10.1002/jmor.10660; Jordan LK, 2009, J EXP BIOL, V212, P3037, DOI 10.1242/jeb.028712; Jorgensen JM, 2005, SPR HDB AUD, V21, P47; Kajiura SM, 2001, ENVIRON BIOL FISH, V61, P125, DOI 10.1023/A:1011028312787; Kajiura SM, 2010, CRC MAR BIOL SER, P393; KALMIJN AJ, 1971, J EXP BIOL, V55, P371; KALMIJN AJ, 1966, NATURE, V212, P1232, DOI 10.1038/2121232b0; Kasumyan A.O., 2003, J ICHTHYOL, V43, P175; Kempster RM, 2012, J FISH BIOL, V80, P2055, DOI 10.1111/j.1095-8649.2011.03214.x; Kempster RM, 2011, AQUAT BIOL, V11, P225, DOI 10.3354/ab00311; Last PR, 1994, SHARKS RAYS AUSTR, P146; Litherland L, 2008, VISUAL NEUROSCI, V25, P549, DOI 10.1017/S0952523808080693; LU J, 1994, BIOPHYS J, V67, P1525, DOI 10.1016/S0006-3495(94)80626-5; Maruska KP, 1998, J MORPHOL, V238, P1, DOI 10.1002/(SICI)1097-4687(199810)238:1<1::AID-JMOR1>3.0.CO;2-D; Maruska KP, 2001, ENVIRON BIOL FISH, V60, P47, DOI 10.1023/A:1007647924559; Maruska KR, 2004, J EXP BIOL, V207, P3463, DOI 10.1242/jeb.01140; Marzullo TA, 2011, MAR FRESHWATER RES, V62, P771, DOI 10.1071/MF10156; MURRAY RW, 1962, J EXP BIOL, V39, P119; MURRAY RW, 1965, J PHYSIOL-LONDON, V180, P592, DOI 10.1113/jphysiol.1965.sp007719; MURRAY RW, 1960, NATURE, V187, P957, DOI 10.1038/187957a0; Nauwelaerts S, 2007, J R SOC INTERFACE, V4, P341, DOI 10.1098/rsif.2006.0180; RASCHI W, 1988, COPEIA, P116; RASCHI W, 1986, J MORPHOL, V189, P225, DOI 10.1002/jmor.1051890303; Raschi WG, 2001, SENSORY BIOLOGY OF JAWED FISHES: NEW INSIGHTS, P297; Roberts B.L., 1978, P331; Safi K, 2010, EVOL ECOL, V24, P703, DOI 10.1007/s10682-009-9326-0; Sisneros JA, 1998, J COMP PHYSIOL A, V183, P87, DOI 10.1007/s003590050237; Springer S., 1960, Fishery Bulletin United States, V61, P1; SZABO T, 1974, ELECTRORECEPTORS OTH, P13; Theiss SM, 2011, MAR BIOL, V158, P723, DOI 10.1007/s00227-010-1595-1; Wilga CD, 2007, INTEGR COMP BIOL, V47, P55, DOI 10.1093/icb/icm029; Wueringer BE, 2011, BRAIN BEHAV EVOLUT, V78, P139, DOI 10.1159/000329515; Wueringer BE, 2011, BRAIN BEHAV EVOLUT, V78, P150, DOI 10.1159/000329518; Wueringer BE, 2008, REV FISH BIOL FISHER, V18, P47, DOI 10.1007/s11160-007-9063-9	49	10	10	1	69	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 30	2012	7	11							e49857	10.1371/journal.pone.0049857	http://dx.doi.org/10.1371/journal.pone.0049857			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	054WM	23226226	Green Submitted, Green Accepted, Green Published, gold			2022-12-27	WOS:000312376100034
J	Yan, MY; Hall, JW; Yang, JS; Ji, YD				Yan, Meiying; Hall, Jeffrey W.; Yang, Junshu; Ji, Yinduo			The Essential yhcSR Two-Component Signal Transduction System Directly Regulates the lac and opuCABCD Operons of Staphylococcus aureus	PLOS ONE			English	Article							DNA MICROARRAY ANALYSIS; CELL-WALL METABOLISM; BACILLUS-SUBTILIS; STREPTOCOCCUS-PNEUMONIAE; MODULATES EXPRESSION; RESPONSE REGULATOR; BIOFILM FORMATION; GENE-EXPRESSION; GLYCINE BETAINE; IDENTIFICATION	Our previous studies suggested that the essential two-component signal transduction system, YhcSR, regulates the opuCABCD operon at the transcriptional level, and the Pspac-driven opuCABCD partially complements the lethal effects of yhcS antisense RNA expression in Staphylococcus aureus. However, the reason why yhcSR regulon is required for growth is still unclear. In this report, we present that the lac and opuC operons are directly transcriptionally regulated by YhcSR. Using real-time RT-PCR we showed that the down-regulation of yhcSR expression affected the transcription of lacA encoding galactose-6-phosphotase isomerase subunit LacA, and opuCA encoding a subunit of a glycine betaine/carnitine/choline ABC transporter. Promoter-lux reporter fusion studies further confirmed the transcriptional regulation of lac by YhcSR. Gel shift assays revealed that YhcR binds to the promoter regions of the lac and opuC operons. Moreover, the Pspac-driven lacABC expression in trans was able to partially complement the lethal effect of induced yhcS antisense RNA. Likewise, the Pspac-driven opuCABCD expression in trans complemented the growth defect of S. aureus in a high osmotic strength medium during the depletion of YhcSR. Taken together, the above data indicate that the yhcSR system directly regulates the expression of lac and opuC operons, which, in turn, may be partially associated with the essentiality of yhcSR in S. aureus. These results provide a new insight into the biological functions of the yhcSR, a global regulator.	[Yan, Meiying; Hall, Jeffrey W.; Yang, Junshu; Ji, Yinduo] Univ Minnesota, Coll Vet Med, Dept Vet & Biomed Sci, St Paul, MN 55108 USA	University of Minnesota System; University of Minnesota Twin Cities	Ji, YD (corresponding author), Univ Minnesota, Coll Vet Med, Dept Vet & Biomed Sci, St Paul, MN 55108 USA.	jixxx002@umn.edu		Hall, Jeffrey/0000-0002-0214-4062	National Institutes of Health [AI057451]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI057451] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by a grant from the National Institutes of Health (AI057451). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barrett JF, 1998, ANTIMICROB AGENTS CH, V42, P1529, DOI 10.1128/AAC.42.7.1529; Bisicchia P, 2007, MOL MICROBIOL, V65, P180, DOI 10.1111/j.1365-2958.2007.05782.x; Chen CL, 2007, J BACTERIOL, V189, P6901, DOI 10.1128/JB.00763-07; Dubrac S, 2004, J BACTERIOL, V186, P1175, DOI 10.1128/JB.186.4.1175-1181.2004; Dubrac S, 2007, J BACTERIOL, V189, P8257, DOI 10.1128/JB.00645-07; Dunman PM, 2001, J BACTERIOL, V183, P7341, DOI 10.1128/JB.183.24.7341-7353.2001; Fabret C, 1998, J BACTERIOL, V180, P6375; Forsyth RA, 2002, MOL MICROBIOL, V43, P1387, DOI 10.1046/j.1365-2958.2002.02832.x; Fukuchi K, 2000, MICROBIOL-UK, V146, P1573, DOI 10.1099/00221287-146-7-1573; GROSS R, 1993, FEMS MICROBIOL LETT, V104, P301, DOI 10.1016/0378-1097(93)90602-X; Grundmann H, 2006, LANCET, V368, P874, DOI 10.1016/S0140-6736(06)68853-3; Head CG, 1998, J MOL BIOL, V281, P857, DOI 10.1006/jmbi.1998.1985; Howell A, 2003, MOL MICROBIOL, V49, P1639, DOI 10.1046/j.1365-2958.2003.03661.x; Huang KJ, 1997, P NATL ACAD SCI USA, V94, P2828, DOI 10.1073/pnas.94.7.2828; Ji YD, 2001, SCIENCE, V293, P2266, DOI 10.1126/science.1063566; Ji YD, 2007, METHOD ENZYMOL, V423, P502, DOI 10.1016/S0076-6879(07)23024-1; Kappes RM, 1999, MOL MICROBIOL, V32, P203, DOI 10.1046/j.1365-2958.1999.01354.x; Kazakova SV, 2005, NEW ENGL J MED, V352, P468, DOI 10.1056/NEJMoa042859; Kiran MD, 2009, INT J ARTIF ORGANS, V32, P592, DOI 10.1177/039139880903200908; Kiran MD, 2009, INT J ARTIF ORGANS, V32, P600, DOI 10.1177/039139880903200909; Kobayashi K, 2001, J BACTERIOL, V183, P7365, DOI 10.1128/JB.183.24.7365-7370.2001; KREISWIRTH BN, 1983, NATURE, V305, P709, DOI 10.1038/305709a0; Kuroda M, 2003, MOL MICROBIOL, V49, P807, DOI 10.1046/j.1365-2958.2003.03599.x; Li YH, 2002, J BACTERIOL, V184, P6333, DOI 10.1128/JB.184.22.6333-6342.2002; Liang XD, 2005, J BACTERIOL, V187, P5486, DOI 10.1128/JB.187.15.5486-5492.2005; Liang XD, 2006, INFECT IMMUN, V74, P4655, DOI 10.1128/IAI.00322-06; Luong TT, 2006, J BACTERIOL, V188, P1899, DOI 10.1128/JB.188.5.1899-1910.2006; Manna AC, 2004, J BACTERIOL, V186, P5267, DOI 10.1128/JB.186.16.5267-5280.2004; Manna AC, 2006, MOL MICROBIOL, V60, P1289, DOI 10.1111/j.1365-2958.2006.05171.x; Martin PK, 1999, J BACTERIOL, V181, P3666, DOI 10.1128/JB.181.12.3666-3673.1999; Miller AA, 2001, MOL MICROBIOL, V40, P976, DOI 10.1046/j.1365-2958.2001.02441.x; Mohedano ML, 2005, J BACTERIOL, V187, P2357, DOI 10.1128/JB.187.7.2357-2367.2005; Ng WL, 2004, MOL MICROBIOL, V53, P1161, DOI 10.1111/j.1365-2958.2004.04196.x; Ng WL, 2003, MOL MICROBIOL, V50, P1647, DOI 10.1046/j.1365-2958.2003.03806.x; Novick RA, 2006, STAPHYLOCOCCAL PATHO; Ogura M, 2001, NUCLEIC ACIDS RES, V29, P3804, DOI 10.1093/nar/29.18.3804; OSKOUIAN B, 1990, J BACTERIOL, V172, P3804, DOI 10.1128/jb.172.7.3804-3812.1990; Pragman AA, 2004, J BACTERIOL, V186, P2430, DOI 10.1128/JB.186.8.2430-2438.2004; Rice LB, 2006, AM J MED, V119, pS11, DOI 10.1016/j.amjmed.2006.03.012; Stock AM, 2000, ANNU REV BIOCHEM, V69, P183, DOI 10.1146/annurev.biochem.69.1.183; Sun F, 2012, J AM CHEM SOC, V134, P305, DOI 10.1021/ja2071835; Sun JS, 2005, J BACTERIOL, V187, P7876, DOI 10.1128/JB.187.22.7876-7880.2005; Throup JP, 2000, MOL MICROBIOL, V35, P566, DOI 10.1046/j.1365-2958.2000.01725.x; Verheul A, 1997, J BACTERIOL, V179, P6979, DOI 10.1128/jb.179.22.6979-6985.1997; Vijaranakul U, 1997, APPL ENVIRON MICROB, V63, P1889, DOI 10.1128/AEM.63.5.1889-1897.1997; Vilhelmsson O, 2002, J FOOD PROTECT, V65, P1008, DOI 10.4315/0362-028X-65.6.1008; Yan MY, 2011, J BACTERIOL, V193, P1799, DOI 10.1128/JB.01511-10; Yan MY, 2009, PLASMID, V61, P188, DOI 10.1016/j.plasmid.2009.02.001; Yin DZ, 2004, PHARMACOGENOMICS, V5, P101, DOI 10.1517/phgs.5.1.101.25679	49	18	19	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 30	2012	7	11							e50608	10.1371/journal.pone.0050608	http://dx.doi.org/10.1371/journal.pone.0050608			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	054WM	23226327	Green Submitted, gold, Green Published			2022-12-27	WOS:000312376100139
J	Golbuu, Y; Wolanski, E; Idechong, JW; Victor, S; Isechal, AL; Oldiais, NW; Idip, D; Richmond, RH; van Woesik, R				Golbuu, Yimnang; Wolanski, Eric; Idechong, Jacques Wasai; Victor, Steven; Isechal, Adelle Lukes; Oldiais, Noelle Wenty; Idip, David, Jr.; Richmond, Robert H.; van Woesik, Robert			Predicting Coral Recruitment in Palau's Complex Reef Archipelago	PLOS ONE			English	Article							FISH LARVAE; GENE FLOW; SCLERACTINIAN CORALS; PLANULA LARVAE; CONNECTIVITY; POPULATIONS; RETENTION; DISPERSAL; DIVERSITY; DIFFUSION	Reproduction and recruitment are key processes that replenish marine populations. Here we use the Palau archipelago, in the western Pacific Ocean, as a case study to examine scales of connectivity and to determine whether an oceanographic model, incorporating the complex reef architecture, is a useful predictor of coral recruitment. We tested the hypothesis that the reefs with the highest retention also had the highest densities of juvenile coral density from 80 field sites. Field comparisons showed a significant correlation between the densities of juvenile Acropora colonies and total larval recruitment derived from the model (i.e., calculated as the sum of the densities of larvae that self-seeded and recruited from the other reefs in the archipelago). Long-distance larval imports may be too infrequent to sustain coral populations, but are critical for recovery in times of extreme local stress.	[Golbuu, Yimnang; Idechong, Jacques Wasai; Isechal, Adelle Lukes; Oldiais, Noelle Wenty; Idip, David, Jr.] Palau Int Coral Reef Ctr, Koror, Palau; [Wolanski, Eric; van Woesik, Robert] James Cook Univ, Sch Marine & Trop Biol, Townsville, Qld 4811, Australia; [Wolanski, Eric] Australian Inst Marine Sci, Townsville, Qld 4810, Australia; [Victor, Steven] Palau Field Off, Nat Conservancy, Koror, Palau; [Richmond, Robert H.] Univ Hawaii Manoa, Kewalo Marine Lab, Honolulu, HI 96822 USA; [van Woesik, Robert] Florida Inst Technol, Dept Biol Sci, Melbourne, FL 32901 USA	James Cook University; Australian Institute of Marine Science; University of Hawaii System; University of Hawaii Manoa; Florida Institute of Technology	Golbuu, Y (corresponding author), Palau Int Coral Reef Ctr, Koror, Palau.	ygolbuu@picrc.org	Richmond, Robert/G-1385-2014		NOAA; David and Lucile Packard Foundation; Palau International Coral Reef Center	NOAA(National Oceanic Atmospheric Admin (NOAA) - USA); David and Lucile Packard Foundation(The David & Lucile Packard Foundation); Palau International Coral Reef Center	This work was supported by NOAA Coastal Oceans Program, NOAA Coral Reef Conservation Program, The David and Lucile Packard Foundation, and The Palau International Coral Reef Center. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Almany GR, 2007, SCIENCE, V316, P742, DOI 10.1126/science.1140597; Andutta FP, 2012, ESTUAR COAST SHELF S, V101, P54, DOI 10.1016/j.ecss.2012.02.013; Ayre DJ, 2000, EVOLUTION, V54, P1590; Barber PH, 2000, NATURE, V406, P692, DOI 10.1038/35021135; Battista T. A., 2007, 59 NOAA NOS NCCOS BI; BLACK KP, 1987, J GEOPHYS RES-OCEANS, V92, P9514, DOI 10.1029/JC092iC09p09514; Burgess SC, 2007, MAR ECOL PROG SER, V341, P233, DOI 10.3354/meps341233; Christie MR, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015715; Christie MR, 2010, MOL ECOL, V19, P1042, DOI 10.1111/j.1365-294X.2010.04524.x; Cowen RK, 2006, SCIENCE, V311, P522, DOI 10.1126/science.1122039; DOHERTY P, 1994, SCIENCE, V263, P935, DOI 10.1126/science.263.5149.935; Fischer H.B., 1979, MIXING INLAND COASTA, DOI 10.1016/C2009-0-22051-4; Golbuu Y, 2007, CORAL REEFS, V26, P319, DOI 10.1007/s00338-007-0200-7; Golbuu Y, 2003, ESTUAR COAST SHELF S, V57, P941, DOI 10.1016/S0272-7714(02)00424-9; GOLBUU Y, 2011, J MAR BIOL, V2011, DOI DOI 10.1155/2011/981273; Golbuu Y, 2011, THESIS SO CROSS U LI; Golbuu Y, 2007, MAR BIOL, V152, P639, DOI 10.1007/s00227-007-0717-x; Golbuu Y, 2011, MAR POLLUT BULL, V62, P824, DOI 10.1016/j.marpolbul.2010.12.015; Graham EM, 2008, CORAL REEFS, V27, P529, DOI 10.1007/s00338-008-0361-z; Hamann M, 2011, ECOL MODEL, V222, P1515, DOI 10.1016/j.ecolmodel.2011.02.003; Harrington L, 2004, ECOLOGY, V85, P3428, DOI 10.1890/04-0298; Houk P, 2006, PAC SCI, V60, P177, DOI 10.1353/psc.2006.0005; Jones GP, 2009, CORAL REEFS, V28, P307, DOI 10.1007/s00338-009-0469-9; Jones GP, 2005, CURR BIOL, V15, P1314, DOI 10.1016/j.cub.2005.06.061; Kohler KE, 2006, COMPUT GEOSCI-UK, V32, P1259, DOI 10.1016/j.cageo.2005.11.009; LEE TN, 1992, CONT SHELF RES, V12, P971, DOI 10.1016/0278-4343(92)90055-O; LOBEL PS, 1986, DEEP-SEA RES, V33, P483, DOI 10.1016/0198-0149(86)90127-5; Munday PL, 2009, CORAL REEFS, V28, P379, DOI 10.1007/s00338-008-0461-9; Nakajima Y, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011149; Nishikawa A, 2008, PAC SCI, V62, P413, DOI 10.2984/1534-6188(2008)62[413:DAPOGF]2.0.CO;2; OKUBO A, 1971, DEEP-SEA RES, V18, P789, DOI 10.1016/0011-7471(71)90046-5; OLIVER JK, 1992, CONT SHELF RES, V12, P873, DOI 10.1016/0278-4343(92)90049-P; Paris CB, 2007, MAR ECOL PROG SER, V347, P285, DOI 10.3354/meps06985; Penland L, 2004, CORAL REEFS, V23, P133, DOI 10.1007/s00338-003-0362-x; Planes S, 2009, P NATL ACAD SCI USA, V106, P5693, DOI 10.1073/pnas.0808007106; RICHMOND RH, 1987, MAR BIOL, V93, P527, DOI 10.1007/BF00392790; SALE PF, 1977, AM NAT, V111, P337, DOI 10.1086/283164; Spagnol S, 2002, MAR ECOL PROG SER, V235, P299, DOI 10.3354/meps235299; Spagnol S., 2001, OCEANOGRAPHIC PROCES, p[145, 356]; Swearer SE, 1999, NATURE, V402, P799, DOI 10.1038/45533; Wagner D, 2008, B MAR SCI, V83, P553; Wolanski E, 1997, NATURWISSENSCHAFTEN, V84, P262, DOI 10.1007/s001140050394; WOLANSKI E, 1990, ESTUAR COAST SHELF S, V31, P789, DOI 10.1016/0272-7714(90)90083-4; Wolanski E, 2000, ESTUAR COAST SHELF S, V50, P27, DOI 10.1006/ecss.1999.0528; Wolanski E., 2007, CORAL REEFS PALAU, P238	45	29	29	2	67	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 28	2012	7	11							e50998	10.1371/journal.pone.0050998	http://dx.doi.org/10.1371/journal.pone.0050998			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	057YW	23209842	Green Published, Green Accepted, gold			2022-12-27	WOS:000312601700098
J	Hamacher, K				Hamacher, Kay			Resilience to Leaking - Dynamic Systems Modeling of Information Security	PLOS ONE			English	Article							INSIDERS; CHAOS	Leaking of confidential material is a major threat to information security within organizations and to society as a whole. This insight has gained traction in the political realm since the activities of Wikileaks, which hopes to attack 'unjust' systems or 'conspiracies'. Eventually, such threats to information security rely on a biologistic argument on the benefits and drawbacks that uncontrolled leaking might pose for 'just' and 'unjust' entities. Such biological metaphors are almost exclusively based on the economic advantage of participants. Here, I introduce a mathematical model of the complex dynamics implied by leaking. The complex interactions of adversaries are modeled by coupled logistic equations including network effects of econo-communication networks. The modeling shows, that there might arise situations where the leaking envisioned and encouraged by Wikileaks and the like can strengthen the defending entity (the 'conspiracy'). In particular, the only severe impact leaking can have on an organization seems to originate in the exploitation of leaks by another entity the organization competes with. Therefore, the model suggests that leaks can be used as a 'tactical mean' in direct adversary relations, but do not necessarily increase public benefit and societal immunization to 'conspiracies'. Furthermore, within the model the exploitation of the (open) competition between entities seems to be a more promising approach to control malicious organizations : divide-et-impera policies triumph here.	[Hamacher, Kay] Tech Univ Darmstadt, Dept Phys, Dept Comp Sci, Darmstadt, Germany; [Hamacher, Kay] Tech Univ Darmstadt, Dept Biol, Darmstadt, Germany	Technical University of Darmstadt; Technical University of Darmstadt	Hamacher, K (corresponding author), Tech Univ Darmstadt, Dept Phys, Dept Comp Sci, Darmstadt, Germany.	hamacher@bio.tu-darmstadt.de		Hamacher, Kay/0000-0002-6921-8345				[Anonymous], ROD BECKSTROMS LECTU; Apte C, 2011, PROCEEDINGS OF THE 1; Arsac W, 2011, SACMAT, P143; BAUMOL WJ, 1989, J ECON PERSPECT, V3, P77, DOI 10.1257/jep.3.1.77; Bertino E., 2011, P 6 ACM S INF COMP C, P10, DOI DOI 10.1145/1966913; Bonabeau E, 2002, P NATL ACAD SCI USA, V99, P7280, DOI 10.1073/pnas.082080899; Bonabeau E, 2000, APPLICATIONS OF SIMULATION TO SOCIAL SCIENCES, P451, DOI 10.1142/S0219525900000315; Deiseroth B, 2010, FINANCIAL CRYPTOGRAP; DUNBAR RIM, 1992, J HUM EVOL, V22, P469, DOI 10.1016/0047-2484(92)90081-J; ECKMANN JP, 1985, REV MOD PHYS, V57, P617, DOI 10.1103/RevModPhys.57.617; Ferguson N., 2010, CRYPTOGRAPHY ENGINEE; Ford A., 1999, MODELING THE ENVIRON; Frank M, 2010, IMETI 2010: 3RD INTERNATIONAL MULTI-CONFERENCE ON ENGINEERING AND TECHNOLOGICAL INNOVATION, VOL II (POST-CONFERENCE EDITION), P1, DOI 10.1097/IPC.0b013e3181e978c0; Gandolfo G, 1997, ECONOMIC DYNAMICS; Gehrmann E, 2011, PHYS REV E, V84, DOI 10.1103/PhysRevE.84.021913; Green D, 2009, AMCIS, P54; Hamacher K, 2011, PROCEEDINGS OF THE 2011 NEW SECURITY PARADIGMS WORKSHOP (NSPW'11), P115; Hao D, 2010, INTRUST, P237; JEFFRIES C, 1982, PHYS REV A, V26, P2117, DOI 10.1103/PhysRevA.26.2117; Maloof MA, 2007, LECT NOTES COMPUT SC, V4637, P146; Marwan N, 2007, PHYS REP, V438, P237, DOI 10.1016/j.physrep.2006.11.001; McDonald D., 2004, PRACTICAL HAZOPS TRI; Pfleeger SL, 2010, IEEE T INF FOREN SEC, V5, P169, DOI 10.1109/TIFS.2009.2039591; Posey C, 2011, COMPUT SECUR, V30, P486, DOI 10.1016/j.cose.2011.05.002; Predd J, 2008, IEEE SECUR PRIV, V6, P66, DOI 10.1109/MSP.2008.87; Reed DP, 2001, HARVARD BUS REV, V79, P23; Shapiro C, 1993, INFORM RULES; Shropshire Jordan, 2009, Information Management & Computer Security, V17, P296, DOI 10.1108/09685220910993962; Soetaert K, 2010, J STAT SOFTW, V33, P1, DOI 10.18637/jss.v033.i09; WALL-NER J, 1998, P 1998 WORKSH NEW SE, P2, DOI DOI 10.1145/310889.310900; Willison R, 2009, COMMUN ACM, V52, P133, DOI 10.1145/1562164.1562198; WRIGHT DH, 1989, AM NAT, V134, P664, DOI 10.1086/285003; Zimm A. D., 2005, Computational & Mathematical Organization Theory, V11, P37, DOI 10.1007/s10588-005-1726-2	33	1	1	1	48	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 5	2012	7	12							e49804	10.1371/journal.pone.0049804	http://dx.doi.org/10.1371/journal.pone.0049804			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	057TZ	23227151	Green Submitted, gold, Green Published			2022-12-27	WOS:000312588200013
J	Maddin, HC; Jenkins, FA; Anderson, JS				Maddin, Hillary C.; Jenkins, Farish A., Jr.; Anderson, Jason S.			The Braincase of Eocaecilia micropodia (Lissamphibia, Gymnophiona) and the Origin of Caecilians	PLOS ONE			English	Article							DERMOPHIS-MEXICANUS AMPHIBIA; PALEOZOIC ANCESTRY; LIVING AMPHIBIANS; FOSSIL RECORD; SALAMANDERS; PHYLOGENY; EVOLUTION; DISSOROPHOIDEA; TEMNOSPONDYLI; SKULL	The scant fossil record of caecilians has obscured the origin and evolution of this lissamphibian group. Eocaecilia micropodia from the Lower Jurassic of North America remains the only stem-group caecilian with an almost complete skull preserved. However, this taxon has been controversial, engendering re-evaluation of traits considered to be plesiomorphic for extant caecilians. Both the validity of the placement of E. micropodia as a stem caecilian and estimates of the plesiomorphic condition of extant caecilians have been questioned. In order to address these issues, the braincase of E. micropodia was examined via micro-computed tomography. The braincase is considered to be a more reliable phylogenetic indicator than peripheral regions of the skull. These data reveal significant new information, including the possession of an ossified nasal septum, ossified anterior wall of the sphenethmoid, long anterolateral processes on the sphenethmoid, and paired olfactory nerve foramina, which are known only to occur in extant caecilians; the latter are possibly related to the evolution of the tentacle, a caecilian autapomorphy. A phylogenetic analysis that included 64 non-amniote taxa and 308 characters represents the first extensive test of the phylogenetic affinities of E. micropodia. The results place E. micropodia securely on the stem of extant caecilians, representing a clade within Temnospondyli that is the sister taxon to batrachians plus Gerobatrachus. Ancestral character state reconstruction confirms the braincase of E. micropodia to be largely representative of the plesiomorphic condition of extant caecilians. Additionally, the results refine the context within which the evolution of the caecilian form can be evaluated. The robust construction and pattern of the dermal skull of E. micropodia is interpreted as symplesiomorphic with advanced dissorophoid temnospondyls, rather than being autapomorphic in its robust construction. Together these data increase confidence in incorporating E. micropodia into discussions of caecilian evolution.	[Maddin, Hillary C.; Jenkins, Farish A., Jr.] Harvard Univ, Dept Organism & Evolutionary Biol, Cambridge, MA 02138 USA; [Maddin, Hillary C.; Jenkins, Farish A., Jr.] Harvard Univ, Museum Comparat Zool, Cambridge, MA 02138 USA; [Maddin, Hillary C.; Anderson, Jason S.] Univ Calgary, Dept Comparat Biol & Expt Med, Calgary, AB, Canada	Harvard University; Harvard University; University of Calgary	Maddin, HC (corresponding author), Harvard Univ, Dept Organism & Evolutionary Biol, Cambridge, MA 02138 USA.	hmaddin@fas.harvard.edu			Natural Sciences and Engineering Research Council of Canada Postdoctoral Fellowship; Natural Sciences and Engineering Research Council of Canada [327756-2011]; Directorate For Geosciences [0948842] Funding Source: National Science Foundation	Natural Sciences and Engineering Research Council of Canada Postdoctoral Fellowship(Natural Sciences and Engineering Research Council of Canada (NSERC)); Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); Directorate For Geosciences(National Science Foundation (NSF)NSF - Directorate for Geosciences (GEO))	Funding was provided by Natural Sciences and Engineering Research Council of Canada Postdoctoral Fellowship to HCM and Natural Sciences and Engineering Research Council of Canada Discovery Grant to JSA (327756-2011). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson JS, 2008, NATURE, V453, P515, DOI 10.1038/nature06865; Anderson JS, 2002, J PALEONTOL, V76, P1029, DOI 10.1666/0022-3360(2002)076<1029:ROTAGP>2.0.CO;2; [Anonymous], 2020, BIOL AMPHIBIANS, V28, P32; BADENHORST A, 1978, Annale Universiteit van Stellenbosch Serie A II (Soologie), V1, P1; BILLO R, 1987, J MORPHOL, V192, P101, DOI 10.1002/jmor.1051920203; BOLT JR, 1969, SCIENCE, V166, P888, DOI 10.1126/science.166.3907.888; Boy Juergen A., 1995, Palaeontologische Zeitschrift, V69, P429; Cannatella DC, 2009, TIMETREE LIFE, P351; Cardini A, 2008, BIOL J LINN SOC, V93, P813, DOI 10.1111/j.1095-8312.2008.01011.x; Carroll RL, 2007, ZOOL J LINN SOC-LOND, V150, P1, DOI 10.1111/j.1096-3642.2007.00246.x; CARROLL ROBERT L., 1964, BULL MUS COMP ZOOL HARVARD UNIV, V131, P161; ESTES R, 1972, NATURE, V239, P228, DOI 10.1038/239228b0; Evans SE, 2001, PALAEONTOLOGY, V44, P259, DOI 10.1111/1475-4983.00179; Evans SE, 1996, PALAEONTOLOGY, V39, P77; Frobisch NB, 2008, J VERTEBR PALEONTOL, V28, P1015, DOI 10.1671/0272-4634-28.4.1015; Goswami Anjali, 2010, P141; Gower DJ, 2009, TIMETREE LIFE; Haas A, 2001, J MORPHOL, V247, P1, DOI 10.1002/1097-4687(200101)247:1<1::AID-JMOR1000>3.0.CO;2-3; Hecht Max K., 1997, P95; IVAKHNENKO M F, 1978, Paleontologicheskii Zhurnal, P84; JENKINS FA, 1993, NATURE, V365, P246; Jenkins Farish A. Jr., 2007, Bulletin of the Museum of Comparative Zoology, V158, P285, DOI 10.3099/0027-4100(2007)158[285:AOEMAL]2.0.CO;2; Kleinteich T, 2012, J EXP BIOL, V215, P833, DOI 10.1242/jeb.065979; Lee MSY, 2006, MOL PHYLOGENET EVOL, V40, P635, DOI 10.1016/j.ympev.2006.03.013; Lieberman DE, 2000, YEARB PHYS ANTHROPOL, V43, P117; Maddin Hillary C., 2012, Fieldiana-Life and Earth Sciences, V5, P59; Maddin HC, 2012, ZOOL J LINN SOC-LOND, V166, P160, DOI 10.1111/j.1096-3642.2012.00838.x; Maddin HC, 2011, J MORPHOL, V272, P850, DOI 10.1002/jmor.10953; Maddin HC, 2010, EVOL DEV, V12, P393, DOI 10.1111/j.1525-142X.2010.00426.x; Maddison W., 2018, MESQUITE MODULAR SYS; Maisano JA, 2006, J MORPHOL, V267, P70, DOI 10.1002/jmor.10388; Muller H, 2006, J MORPHOL, V267, P968, DOI 10.1002/jmor.10454; Norris HW, 1918, J MORPHOL, V31, P487; Nussbaum R.A., 1977, Occasional Papers of the Museum of Zoology University of Michigan, VNo. 682, P1; NUSSBAUM RA, 1983, J ZOOL, V199, P545; Pagel M, 2006, AM NAT, V167, P808, DOI 10.1086/503444; Pyron RA, 2011, MOL PHYLOGENET EVOL, V61, P543, DOI 10.1016/j.ympev.2011.06.012; RAGE J-C, 1989, Palaeontographica Abteilung A Palaeozoologie-Stratigraphie, V206, P1; Rage J-C, 2011, GEO PAL UGANDA, V4, P1; Reiss J, 1996, J HERPETOL, V30, P27, DOI 10.2307/1564703; San Mauro D, 2005, AM NAT, V165, P590, DOI 10.1086/429523; SCHMIDT A, 1990, J MORPHOL, V205, P255, DOI 10.1002/jmor.1052050303; Schoch RR, 2005, J VERTEBR PALEONTOL, V25, P502, DOI 10.1671/0272-4634(2005)025[0502:TAMFTL]2.0.CO;2; Schoch RR, 2003, EVOL DEV, V5, P314, DOI 10.1046/j.1525-142X.2003.03038.x; Sigurdsen T, 2010, J VERTEBR PALEONTOL, V30, P1360, DOI 10.1080/02724634.2010.501445; Swofford DL, 2002, PAUP PHYLOGENETIC AN; Wake DB, 2011, SCIENCE, V331, P1032, DOI 10.1126/science.1188545; WAKE MH, 1982, J MORPHOL, V173, P203, DOI 10.1002/jmor.1051730208; Wake MH, 2003, AMPHIBIAN BIOL, P1911; Wake TA, 1999, QUATERNARY RES, V52, P138, DOI 10.1006/qres.1999.2046; Werner Christa, 1994, Neues Jahrbuch fuer Geologie und Palaeontologie Monatshefte, V10, P633; Wilkinson M, 1997, BIOL REV, V72, P423, DOI 10.1017/S0006323197005069; Wilkinson M, 2006, REPROD BIOL PHYLOGEN, V5, P39; Zhang P, 2005, SYST BIOL, V54, P391, DOI 10.1080/10635150590945278; ZILLES K, 1981, Z MIKROSK ANAT FORSC, V95, P943	55	50	50	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 5	2012	7	12							e50743	10.1371/journal.pone.0050743	http://dx.doi.org/10.1371/journal.pone.0050743			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	057TZ	23227204	Green Published, Green Submitted, gold			2022-12-27	WOS:000312588200063
J	Bongiorni, S; Mancini, G; Chillemi, G; Pariset, L; Valentini, A				Bongiorni, Silvia; Mancini, Giordano; Chillemi, Giovanni; Pariset, Lorraine; Valentini, Alessio			Identification of a Short Region on Chromosome 6 Affecting Direct Calving Ease in Piedmontese Cattle Breed	PLOS ONE			English	Article							QUANTITATIVE TRAIT LOCI; GENOME-WIDE ASSOCIATION; AFFECTING FEMALE FERTILITY; DANISH; GROWTH; REGRESSION; MUTATIONS; TESTS; MODEL; SCAN	Calving in cattle is affected by calf morphology and by dam characteristics. It is described by two different traits: maternal calving ease, which is the ability to generate dams with good physiological predisposition to calving, and direct calving ease, which is the ability to generate calves that are easily born. The aim of this study was to identify regions of cattle genome harboring genes possibly affecting direct calving ease in the Piedmontese cattle breed. A population of 323 bulls scored for direct calving ease (EBV) was analyzed by a medium-density SNP marker panel (54,001 SNPs) to perform a genome-wide scan. The strongest signal was detected on chromosome 6 between 37.8 and 38.7 Mb where 13 SNPs associated to direct calving ease were found. Three genes are located in this region: LAP3, encoding for a leucine aminopeptidase involved in the oxytocin hydrolysis; NCAPG, encoding for a non-SMC condensin I complex, which has been associated in cattle with fetal growth and carcass size; and LCORL, which has been associated to height in humans and cattle. To further confirm the results of the genome-wide scan we genotyped additional SNPs within these genes and analyzed their association with direct calving ease. The results of this additional analysis fully confirmed the findings of the GWAS and particularly indicated LAP3 as the most probable gene involved. Linkage Disequilibrium (LD) analysis showed high correlation between SNPs located within LAP3 and LCORL indicating a possible selection signature due either to increased fitness or breeders' selection for the trait. Citation: Bongiorni S, Mancini G, Chillemi G, Pariset L, Valentini A (2012) Identification of a Short Region on Chromosome 6 Affecting Direct Calving Ease in Piedmontese Cattle Breed. PLoS ONE 7(12): e50137. doi: 10.1371/journal.pone.0050137	[Mancini, Giordano; Chillemi, Giovanni] CASPUR, Interuniv Consortium Applicat Super Comp Univ & R, Rome, Italy; [Bongiorni, Silvia; Pariset, Lorraine; Valentini, Alessio] Univ Tuscia, Dept Innovat Biol Agrofood & Forest Syst, Viterbo, Italy	CINECA, Italy; Tuscia University	Mancini, G (corresponding author), CASPUR, Interuniv Consortium Applicat Super Comp Univ & R, Rome, Italy.	g.mancini@caspur.it	Chillemi, Giovanni/O-2825-2019; Chillemi, Giovanni/E-5201-2010; valentini, alessio/L-3970-2013	Chillemi, Giovanni/0000-0003-3901-6926; Chillemi, Giovanni/0000-0003-3901-6926; valentini, alessio/0000-0003-4733-7519; Bongiorni, Silvia/0000-0001-5111-0566	SelMol project; Ministero delle politiche agricole alimentari e forestali; CASPUR standard HPC grant "Utilizzo di panel da 54 k SNPs per identificare regioni cromosomiche ad alta differenziazione intraspecifica o sotto selezione per la scoperta di geni implicati nella variazione fenotipica"; CASPUR	SelMol project; Ministero delle politiche agricole alimentari e forestali; CASPUR standard HPC grant "Utilizzo di panel da 54 k SNPs per identificare regioni cromosomiche ad alta differenziazione intraspecifica o sotto selezione per la scoperta di geni implicati nella variazione fenotipica"; CASPUR	This work has been supported by the SelMol project (http://www.selmol.eu/) financed by Ministero delle politiche agricole alimentari e forestali and by the CASPUR standard HPC grant 2010 "Utilizzo di panel da 54 k SNPs per identificare regioni cromosomiche ad alta differenziazione intraspecifica o sotto selezione per la scoperta di geni implicati nella variazione fenotipica." GM PhD fellowship was granted by CASPUR. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albera A, 2004, J ANIM SCI, V82, P3440; Amin N, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001274; Astle W, 2009, STAT SCI, V24, P451, DOI 10.1214/09-STS307; Aulchenko YS, 2007, GENETICS, V177, P577, DOI 10.1534/genetics.107.075614; Balding DJ, 2006, NAT REV GENET, V7, P781, DOI 10.1038/nrg1916; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Brand B, 2010, J DAIRY SCI, V93, P1205, DOI 10.3168/jds.2009-2553; Carnier P, 2000, J ANIM SCI, V78, P2532; Chen WM, 2007, AM J HUM GENET, V81, P913, DOI 10.1086/521580; Devlin B, 1999, BIOMETRICS, V55, P997, DOI 10.1111/j.0006-341X.1999.00997.x; Druet T, 2008, GENETICS, V178, P2227, DOI 10.1534/genetics.107.085035; Eberlein A, 2009, GENETICS, V183, P951, DOI 10.1534/genetics.109.106476; Freer B, 2008, HEREFORD BREED J, P176; Grobet L, 1998, MAMM GENOME, V9, P210, DOI 10.1007/s003359900727; Gudbjartsson DF, 2008, NAT GENET, V40, P609, DOI 10.1038/ng.122; Gutierrez-Gil B, 2009, J ANIM SCI, V87, P24, DOI 10.2527/jas.2008-0922; Hao K, 2007, BIOINFORMATICS, V23, P252, DOI 10.1093/bioinformatics/btl574; Hoglund JK, 2009, J DAIRY SCI, V92, P2136, DOI 10.3168/jds.2008-1104; Holmberg M, 2006, J DAIRY SCI, V89, P3664, DOI 10.3168/jds.S0022-0302(06)72406-7; Kneeland J, 2004, J ANIM SCI, V82, P3405; Lindholm-Perry AK, 2012, ANIMAL GENE IN PRESS; Lindholm-Perry AK, 2011, BMC GENET, V12, DOI 10.1186/1471-2156-12-103; Liu Y, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-180; Makvandi-Nejad S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039929; Marchitelli C, 2003, MAMM GENOME, V14, P392, DOI 10.1007/s00335-002-2176-5; McPherron AC, 1997, P NATL ACAD SCI USA, V94, P12457, DOI 10.1073/pnas.94.23.12457; MEIJERING A, 1984, LIVEST PROD SCI, V11, P143, DOI 10.1016/0301-6226(84)90057-5; Mevik BH, 2007, J STAT SOFTW, V18, P1, DOI 10.18637/jss.v018.i02; Olsen HG, 2005, GENETICS, V169, P275, DOI 10.1534/genetics.104.031559; Paternoster L, 2011, HUM MOL GENET, V20, P4069, DOI 10.1093/hmg/ddr309; Pausch H, 2011, GENETICS, V187, P289, DOI 10.1534/genetics.110.124057; Pearson TA, 2008, JAMA-J AM MED ASSOC, V299, P1335, DOI 10.1001/jama.299.11.1335; Pryce JE, 2011, GENETICS, V187, P981, DOI 10.1534/genetics.110.123943; Sahana G, 2011, J DAIRY SCI, V94, P479, DOI 10.3168/jds.2010-3381; Schrooten C, 2004, J DAIRY SCI, V87, P3550, DOI 10.3168/jds.S0022-0302(04)73492-X; Setoguchi K, 2011, ANIM GENET, V42, P650, DOI 10.1111/j.1365-2052.2011.02196.x; Setoguchi K, 2009, BMC GENET, V10, DOI 10.1186/1471-2156-10-43; Signer-Hasler H, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037282; Snelling WM, 2011, J ANIM SCI, V89, P1731, DOI 10.2527/jas.2010-3526; Snelling WM, 2010, J ANIM SCI, V88, P837, DOI 10.2527/jas.2009-2257; Thomasen JR, 2008, J DAIRY SCI, V91, P2098, DOI 10.3168/jds.2007-0602; Thompson PB, 1999, LIVEST PROD SCI, V61, P111, DOI 10.1016/S0301-6226(99)00061-5; Van Tassell CP, 2003, J DAIRY SCI, V86, P3366, DOI 10.3168/jds.S0022-0302(03)73940-X; Weedon MN, 2008, NAT GENET, V40, P575, DOI 10.1038/ng.121; Wiener P, 2002, GENET SEL EVOL, V34, P221, DOI [10.1186/1297-9686-34-2-221, 10.1051/gse:2002005]; Wigginton JE, 2005, AM J HUM GENET, V76, P887, DOI 10.1086/429864; Zheng X, 2011, MOL BIOL REP, V38, P4053, DOI 10.1007/s11033-010-0524-1	47	37	38	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 4	2012	7	12							e50137	10.1371/journal.pone.0050137	http://dx.doi.org/10.1371/journal.pone.0050137			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	051EQ	23226511	Green Submitted, gold, Green Published			2022-12-27	WOS:000312108500010
J	Chang, MJ; Xiao, JH; Wang, Y; Yan, YL; Yang, J; Wang, JL				Chang, Mu-Jun; Xiao, Jun-Hua; Wang, Yong; Yan, Yong-Li; Yang, Jun; Wang, Jia-Ling			2, 3, 5, 4 '-Tetrahydroxystilbene-2-O-Beta-D-Glucoside Improves Gastrointestinal Motility Disorders in STZ-Induced Diabetic Mice	PLOS ONE			English	Article							NITRIC-OXIDE SYNTHASE; GLYCATION END-PRODUCTS; OXIDATIVE STRESS; MYENTERIC NEURONS; PPAR-GAMMA; EXPERIMENTAL COLITIS; LONGITUDINAL MUSCLE; ADULT RATS; SIRT1; NEUROPATHY	Oxidative stress has recently been considered as a pivotal player in the pathogenesis of diabetic gastrointestinal dysfunction. We therefore investigated the role of 2, 3, 5, 4'-tetrahydroxystilbene-2-O-beta-D-glucoside (THSG) that has a strong anti-oxidant property, in diabetic gastrointestinal dysmotility as well as the underlying protective mechanisms. THSG restored the delayed gastric emptying and the increased intestinal transit in streptozotocin (STZ)-induced diabetic mice. Loss of neuronal nitric oxide synthase (nNOS) expression and impaired nonadrenergic, noncholinergic (NANC) relaxations in diabetic mice were relieved by long-term preventive treatment with THSG. Meanwhile, THSG (10(-7),10(-4) mol/L) enhanced concentration-dependently NANC relaxations of isolated colons in diabetic mice. Diabetic mice displayed a significant increase in Malondialdehyde (MDA) level and decrease in the activity of glutathione peroxidase (GSH-Px), which were ameliorated by THSG. Inhibition of caspase-3 and activation of ERK phosphorylation related MAPK pathway were involved in prevention of enhanced apoptosis in diabetes afforded by THSG. Moreover, THSG prevented the significant decrease in PPAR-gamma and SIRT1 expression in diabetic ileum. Our study indicates that THSG improves diabetic gastrointestinal disorders through activation of MAPK pathway and upregulation of PPAR-gamma and SIRT1. Citation: Chang M-J, Xiao J-H, Wang Y, Yan Y-L, Yang J, et al. (2012) 2, 3, 5, 4'-Tetrahydroxystilbene-2-O-Beta-D-Glucoside Improves Gastrointestinal Motility Disorders in STZ-Induced Diabetic Mice. PLoS ONE 7(12): e50291. doi:10.1371/journal.pone.0050291	[Chang, Mu-Jun; Xiao, Jun-Hua; Wang, Yong; Yan, Yong-Li; Yang, Jun; Wang, Jia-Ling] Huazhong Univ Sci & Technol, Tongji Med Coll, Dept Pharmacol, Wuhan 430074, Peoples R China	Huazhong University of Science & Technology	Wang, JL (corresponding author), Huazhong Univ Sci & Technol, Tongji Med Coll, Dept Pharmacol, Wuhan 430074, Peoples R China.	wangtjmu@hotmail.com	xiao, junhua/D-1169-2017		National Science Fund for Young Scholar of China [30801418]	National Science Fund for Young Scholar of China	This work was supported by grants from the National Science Fund for Young Scholar of China (NO. 30801418 and http://www.nsfc.gov.cn/Portal0/default152.htm). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anitha M, 2006, J CLIN INVEST, V116, P344, DOI 10.1172/JCI26295; Bhor VM, 2004, INT J BIOCHEM CELL B, V36, P89, DOI 10.1016/S1357-2725(03)00142-0; BULT H, 1990, NATURE, V345, P346, DOI 10.1038/345346a0; Bytzer P, 2001, ARCH INTERN MED, V161, P1989, DOI 10.1001/archinte.161.16.1989; Cellek S, 2003, DIABETES, V52, P2353, DOI 10.2337/diabetes.52.9.2353; Chandrasekharan B, 2007, NEUROGASTROENT MOTIL, V19, P951, DOI 10.1111/j.1365-2982.2007.01023.x; Chandrasekharan B, 2011, NEUROGASTROENT MOTIL, V23, DOI 10.1111/j.1365-2982.2010.01611.x; Chaudhary N, 2009, CURR OPIN CLIN NUTR, V12, P431, DOI 10.1097/MCO.0b013e32832cdaae; Choi KM, 2008, GASTROENTEROLOGY, V135, P2055, DOI 10.1053/j.gastro.2008.09.003; Chung SS, 2009, MOL CELL BIOL, V29, P20, DOI 10.1128/MCB.00544-08; Curtin JF, 2002, J IMMUNOL METHODS, V265, P49, DOI 10.1016/S0022-1759(02)00070-4; Dali-Youcef N, 2007, ANN MED, V39, P335, DOI 10.1080/07853890701408194; De Winter BY, 2002, SHOCK, V18, P125, DOI 10.1097/00024382-200208000-00006; Pereira RVF, 2008, J MOL HISTOL, V39, P595, DOI 10.1007/s10735-008-9200-3; Furlan MMDP, 1999, ARQ NEURO-PSIQUIAT, V57, P740, DOI 10.1590/S0004-282X1999000500003; Furlan MMDP, 2002, ARQ NEURO-PSIQUIAT, V60, P576, DOI 10.1590/S0004-282X2002000400012; Giannakou ME, 2004, TRENDS CELL BIOL, V14, P408, DOI 10.1016/j.tcb.2004.07.006; Guarente L, 2006, NATURE, V444, P868, DOI 10.1038/nature05486; Guo C, 2004, NEUROGASTROENT MOTIL, V16, P335, DOI 10.1111/j.1365-2982.2004.00524.x; JENKINSON KM, 1995, BRIT J PHARMACOL, V116, P1551, DOI 10.1111/j.1476-5381.1995.tb16372.x; Jeyabal PVS, 2008, NEUROGASTROENT MOTIL, V20, P253, DOI 10.1111/j.1365-2982.2007.01018.x; Kashyap P, 2011, NEUROGASTROENT MOTIL, V23, P111, DOI 10.1111/j.1365-2982.2010.01659.x; Kobayashi Y, 2005, INT J MOL MED, V16, P237; Korenaga K, 2006, NEUROGASTROENT MOTIL, V18, P392, DOI 10.1111/j.1365-2982.2006.00774.x; Kruszewski M, 2005, DNA REPAIR, V4, P1306, DOI 10.1016/j.dnarep.2005.06.013; Kubota S, 2009, INVEST OPHTH VIS SCI, V50, P3512, DOI 10.1167/iovs.08-2666; Lee TI, 2009, EUR J CLIN INVEST, V39, P23, DOI 10.1111/j.1365-2362.2008.02062.x; Liang FX, 2009, NAT REV ENDOCRINOL, V5, P367, DOI 10.1038/nrendo.2009.101; MARTINEZCUESTA MA, 1995, BRIT J PHARMACOL, V114, P919, DOI 10.1111/j.1476-5381.1995.tb13291.x; Matsuda NM, 2010, FUND CLIN PHARMACOL, V24, P261, DOI 10.1111/j.1472-8206.2009.00761.x; Mersmann J, 2008, SHOCK, V30, P64, DOI 10.1097/SHK.0b013e31815dbdc3; Milne JC, 2007, NATURE, V450, P712, DOI 10.1038/nature06261; Owuor ED, 2002, BIOCHEM PHARMACOL, V64, P765, DOI 10.1016/S0006-2952(02)01137-1; Picard F, 2004, NATURE, V429, P771, DOI 10.1038/nature02583; Saini A, 2011, EXP PHYSL; Schmeichel AM, 2003, DIABETES, V52, P165, DOI 10.2337/diabetes.52.1.165; Shotton HR, 2004, AUTON NEUROSCI-BASIC, V111, P57, DOI 10.1016/j.autneu.2004.02.004; Srinivasan S, 2000, DIABETES, V49, P1932, DOI 10.2337/diabetes.49.11.1932; Sulaiman M, 2010, AM J PHYSIOL-HEART C, V298, pH833, DOI 10.1152/ajpheart.00418.2009; Surendran S, 2005, BIOCHEM BIOPH RES CO, V338, P919, DOI 10.1016/j.bbrc.2005.10.039; Tang BL, 2006, NEUROBIOL AGING, V27, P501, DOI 10.1016/j.neurobiolaging.2005.02.001; Tonelli J, 2004, DIABETES, V53, P1621, DOI 10.2337/diabetes.53.6.1621; Vaziri H, 2001, CELL, V107, P149, DOI 10.1016/S0092-8674(01)00527-X; Verne GN, 1998, GASTROENTEROL CLIN N, V27, P861, DOI 10.1016/S0889-8553(05)70035-2; Vincent AM, 2004, ENDOCR REV, V25, P612, DOI 10.1210/er.2003-0019; Vincent AM, 2007, ENDOCRINOLOGY, V148, P548, DOI 10.1210/en.2006-0073; Voukali E, 2011, NEUROGASTROENT MOTIL, V23, P964, DOI 10.1111/j.1365-2982.2011.01778.x; Wang T, 2009, FREE RADICAL BIO MED, V47, P229, DOI 10.1016/j.freeradbiomed.2009.02.027; Wang XM, 2008, EUR J PHARMACOL, V578, P339, DOI 10.1016/j.ejphar.2007.09.013; Wang Y, 2012, AM J PHYSIOL-GASTR L, V302, pG207, DOI 10.1152/ajpgi.00302.2011; Watkins CC, 2000, J CLIN INVEST, V106, P373, DOI 10.1172/JCI8273; Yamamori T, 2010, NUCLEIC ACIDS RES, V38, P832, DOI 10.1093/nar/gkp1039; Yi JH, 2008, BRAIN RES, V1244, P164, DOI 10.1016/j.brainres.2008.09.074; Zeng C, 2011, MOLECULES, V16, P8552, DOI 10.3390/molecules16108552; Zhang SH, 2009, ACTA PHARMACOL SIN, V30, P1479, DOI 10.1038/aps.2009.144	55	26	27	1	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 3	2012	7	12							e50291	10.1371/journal.pone.0050291	http://dx.doi.org/10.1371/journal.pone.0050291			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	051DH	23226517	Green Published, Green Submitted, gold			2022-12-27	WOS:000312104700016
J	Kim, WD; Lee, YH; Kim, MH; Jung, SY; Son, WC; Yoon, SJ; Lee, BW				Kim, Wook-Dong; Lee, Yong-ho; Kim, Min-Hee; Jung, Sun-Young; Son, Woo-Chan; Yoon, Seon-Joo; Lee, Byung-Wan			Human Monoclonal Antibodies against Glucagon Receptor Improve Glucose Homeostasis by Suppression of Hepatic Glucose Output in Diet-Induced Obese Mice	PLOS ONE			English	Article							INSULIN-RESISTANCE; KNOCKOUT MICE; ANTAGONIST; HYPERGLUCAGONEMIA; HYPERGLYCEMIA; PEPTIDE-1	Aim: Glucagon is an essential regulator of hepatic glucose production (HGP), which provides an alternative therapeutic target for managing type 2 diabetes with glucagon antagonists. We studied the effect of a novel human monoclonal antibody against glucagon receptor (GCGR), NPB112, on glucose homeostasis in diet-induced obese (DIO) mice. Methods: The glucose-lowering efficacy and safety of NPB112 were investigated in DIO mice with human GCGR for 11 weeks, and a hyperinsulinemic-euglycemic clamp study was conducted to measure HGP. Results: Single intraperitoneal injection of NPB112 with 5 mg/kg effectively decreased blood glucose levels in DIO mice for 5 days. A significant reduction in blood glucose was observed in DIO mice treated with NPB112 at a dose >= 5 mg/kg for 6 weeks, and its glucose-lowering effect was dose-dependent. Long-term administration of NPB112 also caused a mild 29% elevation in glucagon level, which was returned to the normal range after discontinuation of treatment. The clamp study showed that DIO mice injected with NPB112 at 5 mg/kg were more insulin sensitive than control mice, indicating amelioration of insulin resistance by treatment with NPB112. DIO mice treated with NPB112 showed a significant improvement in the ability of insulin to suppress HGP, showing a 33% suppression (from 8.3 mg/kg/min to 5.6 mg/kg/min) compared to the 2% suppression (from 9.8 mg/kg/min to 9.6 mg/kg/min) in control mice. In addition, no hypoglycemia or adverse effect was observed during the treatment. Conclusions: A novel human monoclonal GCGR antibody, NPB112, effectively lowered the glucose level in diabetic animal models with mild and reversible hyperglucagonemia. Suppression of excess HGP with NPB112 may be a promising therapeutic modality for the treatment of type 2 diabetes. Citation: Kim W-D, Lee Y-h, Kim M-H, Jung S-Y, Son W-C, et al. (2012) Human Monoclonal Antibodies against Glucagon Receptor Improve Glucose Homeostasis by Suppression of Hepatic Glucose Output in Diet-Induced Obese Mice. PLoS ONE 7(12): e50954. doi: 10.1371/journal.pone.0050954	[Kim, Wook-Dong; Kim, Min-Hee; Yoon, Seon-Joo] Neopharm Co Ltd, Dept New Drug Discovery, Taejon, South Korea; [Lee, Yong-ho; Lee, Byung-Wan] Yonsei Univ, Coll Med, Dept Internal Med, Seoul 120749, South Korea; [Lee, Yong-ho; Lee, Byung-Wan] Yonsei Univ, Grad Sch, Dept Med, Seoul 120749, South Korea; [Jung, Sun-Young; Son, Woo-Chan] Univ Ulsan, Coll Med, Asan Med Ctr, Dept Pathol, Seoul, South Korea	Yonsei University; Yonsei University Health System; Yonsei University; University of Ulsan; Asan Medical Center	Yoon, SJ (corresponding author), Neopharm Co Ltd, Dept New Drug Discovery, Taejon, South Korea.	yoonsj@neopharmus.com; bwanlee@yuhs.ac	Lee, Yong-ho/AAT-4106-2020; Wan, Lee Byung/K-2649-2019	Lee, Yong-ho/0000-0002-6219-4942; Lee, Byung-Wan/0000-0002-9899-4992	Medicine & Bio Project for "New Drug Development through Fostering of Med-Bio Hub" of the Chungcheong Leading Industry Office (CCLIO); Ministry of Knowledge Economy (MKE)	Medicine & Bio Project for "New Drug Development through Fostering of Med-Bio Hub" of the Chungcheong Leading Industry Office (CCLIO); Ministry of Knowledge Economy (MKE)(Ministry of Trade, Industry & Energy (MOTIE), Republic of Korea)	This work was supported by the Medicine & Bio Project for "New Drug Development through Fostering of Med-Bio Hub" of the Chungcheong Leading Industry Office (CCLIO) and Ministry of Knowledge Economy (MKE). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahren B, 2005, DIABETES OBES METAB, V7, P2, DOI 10.1111/j.1463-1326.2004.00361.x; Conarello SL, 2007, DIABETOLOGIA, V50, P142, DOI 10.1007/s00125-006-0481-3; D'Alessio D, 2011, DIABETES OBES METAB, V13, P126, DOI 10.1111/j.1463-1326.2011.01449.x; Dunning BE, 2005, DIABETOLOGIA, V48, P1700, DOI 10.1007/s00125-005-1878-0; Dunning BE, 2007, ENDOCR REV, V28, P253, DOI 10.1210/er.2006-0026; Gelling RW, 2003, P NATL ACAD SCI USA, V100, P1438, DOI 10.1073/pnas.0237106100; Gu W, 2011, J PHARMACOL EXP THER, V338, P70, DOI 10.1124/jpet.111.179986; Gu W, 2010, AM J PHYSIOL-ENDOC M, V299, pE624, DOI 10.1152/ajpendo.00102.2010; Gu W, 2009, J PHARMACOL EXP THER, V331, P871, DOI 10.1124/jpet.109.157685; Lau J, 2007, J MED CHEM, V50, P113, DOI 10.1021/jm058026u; Mang Y, 2004, DIABETES, V53, P410; Meeran K, 1999, ENDOCRINOLOGY, V140, P244, DOI 10.1210/en.140.1.244; Mu J, 2011, DIABETOLOGIA, V54, P2381, DOI 10.1007/s00125-011-2217-2; O'Brien PM, 2002, METHOD MOL BIOL, P133; Petersen KF, 2001, DIABETOLOGIA, V44, P2018, DOI 10.1007/s001250100006; Qureshi SA, 2004, DIABETES, V53, P3267, DOI 10.2337/diabetes.53.12.3267; REAVEN GM, 1987, J CLIN ENDOCR METAB, V64, P106, DOI 10.1210/jcem-64-1-106; Rhee SY, 2011, DIABETES METAB J, V35, P107, DOI 10.4093/dmj.2011.35.2.107; Rivera N, 2007, J PHARMACOL EXP THER, V321, P743, DOI 10.1124/jpet.106.115717; Shankar G, 2008, J PHARMACEUT BIOMED, V48, P1267, DOI 10.1016/j.jpba.2008.09.020; Sloop KW, 2004, J CLIN INVEST, V113, P1571, DOI 10.1172/JCI200420911; UNGER RH, 1985, DIABETOLOGIA, V28, P574, DOI 10.1007/BF00281991; Winzell MS, 2007, DIABETOLOGIA, V50, P1453, DOI 10.1007/s00125-007-0675-3; Yan H, 2009, J PHARMACOL EXP THER, V329, P102, DOI 10.1124/jpet.108.147009; Yoon KH, 2011, DIABETES METAB J, V35, P26, DOI [10.4093/dmj.2011.35.1.26, 10.4093/dmj.2011.35.5.444]	25	13	15	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 3	2012	7	12							e50954	10.1371/journal.pone.0050954	http://dx.doi.org/10.1371/journal.pone.0050954			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	051DH	23226550	Green Published, Green Submitted, gold			2022-12-27	WOS:000312104700027
J	Anantharaman, S; Craft, JA				Anantharaman, Sandhya; Craft, John A.			Annual Variation in the Levels of Transcripts of Sex-Specific Genes in the Mantle of the Common Mussel, Mytilus edulis	PLOS ONE			English	Article							POLYCYCLIC AROMATIC-HYDROCARBONS; ABALONE HALIOTIS-ASININA; DREISSENA-POLYMORPHA; PATINOPECTEN-YESSOENSIS; OCEAN ACIDIFICATION; MARINE MUSSELS; WATCH PROGRAM; M-TROSSULUS; EXPRESSION; METABOLISM	Mytilus species are used as sentinels for the assessment of environmental health but sex or stage in the reproduction cycle is rarely considered even though both parameters are likely to influence responses to pollution. We have validated the use of a qPCR assay for sex identification and related the levels of transcripts to the reproductive cycle. A temporal study of mantle of Mytilus edulis found transcripts of male-specific vitelline coat lysin (VCL) and female-specific vitelline envelope receptor for lysin (VERL) could identify sex over a complete year. The levels of VCL/VERL were proportional to the numbers of sperm/ova and are indicative of the stage of the reproductive cycle. Maximal levels of VCL and VERL were found in February 2009 declining to minima between July - August before increasing and re-attaining a peak in February 2010. Water temperature may influence these transitions since they coincide with minimal water temperature in February and maximal temperature in August. An identical pattern of variation was found for a cryptic female-specific transcript (H5) but a very different pattern was observed for oestrogen receptor 2 (ER2). ER2 varied in a sex-specific way with male > female for most of the cycle, with a female maxima in July and a male maxima in December. Using artificially spawned animals, the transcripts for VCL, VERL and H5 were shown to be present in gametes and thus their disappearance from mantle is indicative of spawning. VCL and VERL are present at equivalent levels in February and July-August but during gametogenesis (August to January) and spawning (March to June) VCL is present at lower relative amounts than VERL. This may indicate sex-specific control mechanisms for these processes and highlight a potential pressure point leading to reduced reproductive output if environmental factors cause asynchrony to gamete maturation or release.	[Anantharaman, Sandhya; Craft, John A.] Glasgow Caledonian Univ, Dept Life Sci, Glasgow G4 0BA, Lanark, Scotland	Glasgow Caledonian University	Anantharaman, S (corresponding author), Glasgow Caledonian Univ, Dept Life Sci, Glasgow G4 0BA, Lanark, Scotland.	sandhya.anantharaman@gcu.ac.uk			Glasgow Caledonian University	Glasgow Caledonian University	Funding provided by Glasgow Caledonian University for the award of a Doctoral Training Grant for SA. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Banni M, 2007, BIOMARKERS, V12, P369, DOI 10.1080/13547500701217061; Banni M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018904; Barra R, 2007, REV ENVIRON CONTAM T, V191, P1, DOI 10.1007/978-0-387-69163-3_1; Boyle SP, 2000, CHEM-BIOL INTERACT, V125, P209, DOI 10.1016/S0009-2797(00)00147-2; Brown M, 2006, MAR ENVIRON RES, V62, pS128, DOI 10.1016/j.marenvres.2006.04.057; Burger J, 2006, SCI TOTAL ENVIRON, V368, P937, DOI 10.1016/j.scitotenv.2006.04.022; Carreau S, 2012, ADV MED SCI, P1; Carreau Serge, 2012, Front Biosci (Elite Ed), V4, P1; Choi HG, 2010, ENVIRON MONIT ASSESS, V169, P473, DOI 10.1007/s10661-009-1190-4; Ciocan CM, 2004, ENVIRON SCI TECHNOL, V38, P1073, DOI 10.1021/es030110g; Ciocan CM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022326; Ciocan CM, 2010, ENVIRON POLLUT, V158, P2977, DOI 10.1016/j.envpol.2010.05.025; Counihan RT, 2001, MAR ECOL PROG SER, V213, P193, DOI 10.3354/meps213193; Cubero-Leon E, 2012, ENV SCI POLLUT RES I; Cummins SF, 2011, J COMP NEUROL, V519, P2043, DOI 10.1002/cne.22621; deBruyn AMH, 2009, ENVIRON SCI TECHNOL, V43, P3700, DOI 10.1021/es900472k; DELONGCAMP D, 1974, GEN COMP ENDOCR, V22, P116, DOI 10.1016/0016-6480(74)90093-8; Devier MH, 2010, ANAL CHIM ACTA, V657, P28, DOI 10.1016/j.aca.2009.10.023; Eick GN, 2011, MOL CELL ENDOCRINOL, V334, P31, DOI 10.1016/j.mce.2010.09.003; Fasulo S, 2008, AQUAT TOXICOL, V88, P62, DOI 10.1016/j.aquatox.2008.03.009; Fernandes D, 2011, J STEROID BIOCHEM, V127, P189, DOI 10.1016/j.jsbmb.2010.12.009; FONG PP, 1994, EXPERIENTIA, V50, P506, DOI 10.1007/BF01920759; FONG PP, 1995, J EXP ZOOL, V272, P163, DOI 10.1002/jez.1402720211; Galindo BE, 2002, GENE, V288, P111, DOI 10.1016/S0378-1119(02)00459-6; Gaylord B, 2011, J EXP BIOL, V214, P2586, DOI 10.1242/jeb.055939; Gazeau F, 2010, BIOGEOSCIENCES, V7, P2051, DOI 10.5194/bg-7-2051-2010; Goldberg ED, 2000, SCI TOTAL ENVIRON, V247, P165, DOI 10.1016/S0048-9697(99)00488-X; Gorbman A, 2003, GEN COMP ENDOCR, V131, P62, DOI 10.1016/S0016-6480(02)00647-0; Hines A, 2007, ANAL BIOCHEM, V369, P175, DOI 10.1016/j.ab.2007.06.008; Hines A, 2010, TOXICOL SCI, V115, P369, DOI 10.1093/toxsci/kfq004; Inoue K, 1995, BIOL BULL, V189, P370, DOI 10.2307/1542155; Lauenstein GG, 2007, MAR POLLUT BULL, V54, P284, DOI 10.1016/j.marpolbul.2006.10.006; Lazzara R, 2012, AQUAT TOXICOL, V106, P123, DOI 10.1016/j.aquatox.2011.11.003; LEGUELLEC D, 1987, GEN COMP ENDOCR, V66, P425, DOI 10.1016/0016-6480(87)90253-X; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; LIVINGSTONE DR, 1984, SCI TOTAL ENVIRON, V39, P209, DOI 10.1016/0048-9697(84)90080-9; Martinez MF, 2000, CAN VET J, V41, P786; MATSUTANI T, 1987, GEN COMP ENDOCR, V67, P111, DOI 10.1016/0016-6480(87)90210-3; MORSE DE, 1977, SCIENCE, V196, P298, DOI 10.1126/science.403609; Narbonne JF, 2005, BIOMARKERS, V10, P58, DOI 10.1080/13547500500071339; Onitsuka T, 2007, MAR ECOL PROG SER, V351, P129, DOI 10.3354/meps07150; Ortiz-Zarragoitia M, 2010, ECOTOX ENVIRON SAFE, V73, P693, DOI 10.1016/j.ecoenv.2010.04.002; OSADA M, 1990, PROSTAGLANDINS, V40, P229, DOI 10.1016/0090-6980(90)90011-J; Ramu K, 2007, ENVIRON SCI TECHNOL, V41, P4580, DOI 10.1021/es070380p; Scarpato A, 2010, J ENVIRON MONITOR, V12, P924, DOI 10.1039/b920455e; Sedik WF, 2010, MAR BIOL, V157, P639, DOI 10.1007/s00227-009-1349-0; Seed R., 1976, MARINE MUSSELS THEIR, P13; Shoji M, 2006, LIFE SCI, V78, P2012, DOI 10.1016/j.lfs.2005.09.019; SRIVASTAVA KC, 1985, MOL PHYSIOL, V8, P101; Suarez P., 2012, CHEMOSPHERE; TAKAGI T, 1994, J BIOCHEM-TOKYO, V116, P598, DOI 10.1093/oxfordjournals.jbchem.a124566; Tanabe T, 2010, GEN COMP ENDOCR, V166, P620, DOI 10.1016/j.ygcen.2010.01.014; Tanguy A, 2008, GENE, V408, P27, DOI 10.1016/j.gene.2007.10.021; Toro JE, 2002, MAR BIOL, V141, P897, DOI 10.1007/s00227-002-0897-3; Torrado M, 2003, J EXP BIOL, V206, P313, DOI 10.1242/jeb.00087; Vacquier VD, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a002931; VIARENGO A, 1991, COMP BIOCHEM PHYS C, V100, P187, DOI 10.1016/0742-8413(91)90151-I; Wacker A, 2003, OECOLOGIA, V135, P332, DOI 10.1007/s00442-003-1208-5; Waxman DJ, 2006, MOL ENDOCRINOL, V20, P2613, DOI 10.1210/me.2006-0007; York PS, 2012, FRONT ZOOL, V9, DOI 10.1186/1742-9994-9-9; Zorita I, 2007, ENVIRON POLLUT, V148, P236, DOI 10.1016/j.envpol.2006.10.022	61	14	14	0	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 30	2012	7	11							e50861	10.1371/journal.pone.0050861	http://dx.doi.org/10.1371/journal.pone.0050861			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	054WM	23226407	gold, Green Published, Green Submitted			2022-12-27	WOS:000312376100218
J	Asgari, S; Gonzalez, N; Subudhi, AW; Hamilton, R; Vespa, P; Bergsneider, M; Roach, RC; Hu, X				Asgari, Shadnaz; Gonzalez, Nestor; Subudhi, Andrew W.; Hamilton, Robert; Vespa, Paul; Bergsneider, Marvin; Roach, Robert C.; Hu, Xiao			Continuous Detection of Cerebral Vasodilatation and Vasoconstriction Using Intracranial Pulse Morphological Template Matching	PLOS ONE			English	Article							CRITICAL CLOSING PRESSURE; BLOOD-FLOW; SUBARACHNOID HEMORRHAGE; CARBON-DIOXIDE; WAVE; ALGORITHM; VELOCITY; SIGNALS; INDEX; CARE	Although accurate and continuous assessment of cerebral vasculature status is highly desirable for managing cerebral vascular diseases, no such method exists for current clinical practice. The present work introduces a novel method for real-time detection of cerebral vasodilatation and vasoconstriction using pulse morphological template matching. Templates consisting of morphological metrics of cerebral blood flow velocity (CBFV) pulse, measured at middle cerebral artery using Transcranial Doppler, are obtained by applying a morphological clustering and analysis of intracranial pulse algorithm to the data collected during induced vasodilatation and vasoconstriction in a controlled setting. These templates were then employed to define a vasodilatation index (VDI) and a vasoconstriction index (VCI) for any inquiry data segment as the percentage of the metrics demonstrating a trend consistent with those obtained from the training dataset. The validation of the proposed method on a dataset of CBFV signals of 27 healthy subjects, collected with a similar protocol as that of training dataset, during hyperventilation (and CO2 rebreathing tests) shows a sensitivity of 92% (and 82%) for detection of vasodilatation (and vasoconstriction) and the specificity of 90% (and 92%), respectively. Moreover, the proposed method of detection of vasodilatation (vasoconstriction) is capable of rejecting all the cases associated with vasoconstriction (vasodilatation) and outperforms other two conventional techniques by at least 7% for vasodilatation and 19% for vasoconstriction.	[Asgari, Shadnaz; Gonzalez, Nestor; Hamilton, Robert; Vespa, Paul; Bergsneider, Marvin; Hu, Xiao] Univ Calif Los Angeles, Dept Neurosurg, Los Angeles, CA 90024 USA; [Asgari, Shadnaz] Calif State Univ Long Beach, Dept Comp Sci & Comp Engn, Long Beach, CA 90840 USA; [Hamilton, Robert; Bergsneider, Marvin; Hu, Xiao] Univ Calif Los Angeles, Dept Bioengn, Los Angeles, CA USA; [Subudhi, Andrew W.] Univ Colorado, Dept Biol, Colorado Springs, CO 80907 USA; [Subudhi, Andrew W.; Roach, Robert C.] Univ Colorado Anschutz Med Campus, Dept Emergency Med, Denver, CO 80202 USA	University of California System; University of California Los Angeles; California State University System; California State University Long Beach; University of California System; University of California Los Angeles; University of Colorado System; University of Colorado at Colorado Springs; Denver Health Medical Center; University of Colorado System; University of Colorado Anschutz Medical Campus	Hu, X (corresponding author), Univ Calif Los Angeles, Dept Neurosurg, Los Angeles, CA 90024 USA.	xhu@mednet.ucla.edu	; Roach, Robert/F-4729-2011	Subudhi, Andrew/0000-0001-9719-7660; Gonzalez, Nestor/0000-0002-8277-6317; Roach, Robert/0000-0002-7998-8976	National Heart, Lung, and Blood Institute [HL-070362];  [NS059797];  [NS066008]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL070362] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS076738, R21NS059797, R01NS066008] Funding Source: NIH RePORTER	National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); ; ; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	The present work is partially supported by NS059797 and R01 awards NS066008 and National Heart, Lung, and Blood Institute grant HL-070362. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ARBEILLE P, 1987, ULTRASOUND MED BIOL, V13, P329, DOI 10.1016/0301-5629(87)90166-9; Asgari S, 2011, PHYSIOL MEAS, V32, P1639, DOI 10.1088/0967-3334/32/10/011; Asgari S, 2011, NEUROCRIT CARE, V15, P55, DOI 10.1007/s12028-010-9463-x; Asgari S, 2011, J NEUROSCI METH, V197, P171, DOI 10.1016/j.jneumeth.2011.01.032; Asgari S, 2010, IEEE T INF TECHNOL B, V14, P166, DOI 10.1109/TITB.2009.2034845; Asgari S, 2009, PHYSIOL MEAS, V30, P1211, DOI 10.1088/0967-3334/30/11/006; Battisti-Charbonney A, 2011, J PHYSIOL-LONDON, V589, P3039, DOI 10.1113/jphysiol.2011.206052; BEASLEY MG, 1979, STROKE, V10, P331, DOI 10.1161/01.STR.10.3.331; Bloor B M, 1972, Bull Soc Int Chir, V31, P311; Carey BJ, 2001, CLIN SCI, V101, P351, DOI 10.1042/CS20010021; Diedler J, 2010, NEUROCRIT CARE, V12, P313, DOI 10.1007/s12028-010-9350-5; EVANS DH, 1988, ULTRASOUND MED BIOL, V14, P103, DOI 10.1016/0301-5629(88)90176-7; Hu X, 2008, PHYSIOL MEAS, V29, P459, DOI 10.1088/0967-3334/29/4/004; Hu X, 2010, PHYSIOL MEAS, V31, P679, DOI 10.1088/0967-3334/31/5/006; Hu X, 2009, IEEE T BIO-MED ENG, V56, P696, DOI 10.1109/TBME.2008.2008636; Hu X, 2009, J CEREBR BLOOD F MET, V29, P688, DOI 10.1038/jcbfm.2008.160; Kaufman L., 2005, FINDING GROUPS DATA; Klingelhofer J, 1996, J NEUROL SCI, V143, P72, DOI 10.1016/S0022-510X(96)00138-4; MAYBERG MR, 1994, CIRCULATION, V90, P2592, DOI 10.1161/01.CIR.90.5.2592; Panerai RB, 2011, PHYSIOL MEAS, V32, P467, DOI 10.1088/0967-3334/32/4/007; Panerai RB, 2003, MED ENG PHYS, V25, P621, DOI 10.1016/S1350-4533(03)00027-4; Satoh T, 2003, AM J NEURORADIOL, V24, P1436; Scalzo F, 2011, ARTIFICIAL INTELLIGE; Scalzo F, 2010, BIOMED ENG ONLINE, V9, DOI 10.1186/1475-925X-9-61; Scalzo F, 2009, MED BIOL ENG COMPUT, V47, P967, DOI 10.1007/s11517-009-0505-5; Subudhi AW, 2010, STROKE, V41, P641, DOI 10.1161/STROKEAHA.109.574749; Thiele RH, 2011, ANESTH ANALG, V113, P766, DOI 10.1213/ANE.0b013e31822773ec; Tisdall MM, 2007, BRIT J ANAESTH, V99, P61, DOI 10.1093/bja/aem143; Wartenberg KE, 2007, CRIT CARE CLIN, V23, P507, DOI 10.1016/j.ccc.2007.06.002; Wilkinson IB, 1998, J HYPERTENS, V16, P2079, DOI 10.1097/00004872-199816121-00033	30	14	14	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 30	2012	7	11							e50795	10.1371/journal.pone.0050795	http://dx.doi.org/10.1371/journal.pone.0050795			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	054WM	23226385	Green Published, Green Submitted, gold			2022-12-27	WOS:000312376100196
J	Bauer, M; Kang, LF; Qiu, YL; Wu, JH; Peng, M; Chen, HH; Camci-Unal, G; Bayomy, AF; Sosnovik, DE; Khademhosseini, A; Liao, R				Bauer, Michael; Kang, Lifeng; Qiu, Yiling; Wu, Jinhui; Peng, Michelle; Chen, Howard H.; Camci-Unal, Gulden; Bayomy, Ahmad F.; Sosnovik, David E.; Khademhosseini, Ali; Liao, Ronglih			Adult Cardiac Progenitor Cell Aggregates Exhibit Survival Benefit Both In Vitro and In Vivo	PLOS ONE			English	Article							SIDE POPULATION CELLS; RANDOMIZED PHASE-1 TRIAL; STEM-CELLS; MYOCARDIAL REGENERATION; ISCHEMIC-HEART; MICROWELL ARRAY; THERAPY; TRANSPLANTATION; ENGRAFTMENT; DIFFERENTIATION	Background: A major hurdle in the use of exogenous stems cells for therapeutic regeneration of injured myocardium remains the poor survival of implanted cells. To date, the delivery of stem cells into myocardium has largely focused on implantation of cell suspensions. Methodology and Principal Findings: We hypothesize that delivering progenitor cells in an aggregate form would serve to mimic the endogenous state with proper cell-cell contact, and may aid the survival of implanted cells. Microwell methodologies allow for the culture of homogenous 3D cell aggregates, thereby allowing cell-cell contact. In this study, we find that the culture of cardiac progenitor cells in a 3D cell aggregate augments cell survival and protects against cellular toxins and stressors, including hydrogen peroxide and anoxia/reoxygenation induced cell death. Moreover, using a murine model of cardiac ischemia-reperfusion injury, we find that delivery of cardiac progenitor cells in the form of 3D aggregates improved in vivo survival of implanted cells. Conclusion: Collectively, our data support the notion that growth in 3D cellular systems and maintenance of cell-cell contact improves exogenous cell survival following delivery into myocardium. These approaches may serve as a strategy to improve cardiovascular cell-based therapies.	[Kang, Lifeng; Wu, Jinhui; Peng, Michelle; Camci-Unal, Gulden; Khademhosseini, Ali] Harvard Univ, Sch Med, Brigham & Womens Hosp, Ctr Biomed Engn,Dept Med, Cambridge, MA 02138 USA; [Bauer, Michael; Qiu, Yiling; Bayomy, Ahmad F.; Liao, Ronglih] Harvard Univ, Brigham & Womens Hosp, Sch Med, Div Cardiol, Boston, MA 02115 USA; [Bauer, Michael; Qiu, Yiling; Bayomy, Ahmad F.; Liao, Ronglih] Harvard Univ, Brigham & Womens Hosp, Sch Med, Div Genet,Dept Med, Boston, MA 02115 USA; [Kang, Lifeng; Wu, Jinhui; Peng, Michelle; Camci-Unal, Gulden; Sosnovik, David E.; Khademhosseini, Ali] MIT, Harvard Mit Div Hlth Sci & Technol, Cambridge, MA 02139 USA; [Kang, Lifeng] Natl Univ Singapore, Dept Pharm, Singapore 117548, Singapore; [Wu, Jinhui] Nanjing Univ, Sch Life Sci, Nanjing, Jiangsu, Peoples R China; [Chen, Howard H.; Sosnovik, David E.] Harvard Univ, Sch Med, Dept Radiol, Martinos Ctr Biomed Imaging,Massachusetts Gen Hos, Boston, MA 02115 USA; [Bayomy, Ahmad F.] Univ Washington, Dept Orthopaed & Sports Med, Seattle, WA 98195 USA; [Khademhosseini, Ali] Harvard Univ, Wyss Inst Biol Inspired Engn, Boston, MA 02115 USA; [Liao, Ronglih] Harvard Univ, Harvard Stem Cell Inst, Cambridge, MA 02138 USA	Harvard University; Brigham & Women's Hospital; Harvard University; Brigham & Women's Hospital; Harvard Medical School; Harvard University; Brigham & Women's Hospital; Harvard Medical School; Harvard University; Massachusetts Institute of Technology (MIT); National University of Singapore; Nanjing University; Harvard University; Harvard Medical School; University of Washington; University of Washington Seattle; Harvard University; Harvard University	Khademhosseini, A (corresponding author), Harvard Univ, Sch Med, Brigham & Womens Hosp, Ctr Biomed Engn,Dept Med, Cambridge, MA 02138 USA.	alik@rics.bwh.harvard.edu; rliao@rics.bwh.harvard.edu	Kang, Lifeng/AAE-5217-2020; Wu, Jinhui/J-9476-2012; Khademhosseini, Ali/A-9435-2010; Bayomy, Ahmad F./AAC-3888-2020; Qiu, Yiling/C-7138-2013; Wu, Jinhui/N-8386-2019	Kang, Lifeng/0000-0002-1676-7607; Wu, Jinhui/0000-0001-8809-1290; Khademhosseini, Ali/0000-0002-2692-1524; Bayomy, Ahmad F./0000-0003-0963-9399; Wu, Jinhui/0000-0001-8809-1290; Chen, Howard H./0000-0002-5145-0584; Khademhosseini, Ali/0000-0001-6322-8852; Liao, Ronglih/0000-0002-9598-9020	National Institutes of Health [HL099073, HL086967, HL093147, EB012597, DE019024, HL093038]; National Science Foundation CAREER award; American Heart Association; NUS overseas postdoctoral fellowship; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL099073, R01HL093038, R01HL086967] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [R01EB012597] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [RL1DE019024] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation CAREER award(National Science Foundation (NSF)); American Heart Association(American Heart Association); NUS overseas postdoctoral fellowship; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	This work was supported, in part, by National Institutes of Health research grants HL099073 (RL, AK, DES), HL086967 and HL093147 (RL), EB012597, and DE019024 (AK) and HL093038 (DES) grants. AK was supported, in part, by the National Science Foundation CAREER award. MB was supported by a postdoctoral fellowship from American Heart Association. LK was supported by a NUS overseas postdoctoral fellowship. The funders played no role in study design, data collection, analysis, preparation and publication of manuscript.	Akins RE, 1999, TISSUE ENG, V5, P103, DOI 10.1089/ten.1999.5.103; Bartosh TJ, 2008, J CELL BIOCHEM, V105, P612, DOI 10.1002/jcb.21862; Bauwens CL, 2008, STEM CELLS, V26, P2300, DOI 10.1634/stemcells.2008-0183; Bearzi C, 2007, P NATL ACAD SCI USA, V104, P14068, DOI 10.1073/pnas.0706760104; Beltrami AP, 2003, CELL, V114, P763, DOI 10.1016/S0092-8674(03)00687-1; Bernstein HS, 2012, PEDIATR RES, V71, P491, DOI 10.1038/pr.2011.61; Birks EJ, 2006, NEW ENGL J MED, V355, P1873, DOI 10.1056/NEJMoa053063; Bolli R, 2011, LANCET, V378, P1847, DOI 10.1016/S0140-6736(11)61590-0; Chen Chi-Shuo, 2008, J Vis Exp, DOI 10.3791/692; Chiu RCJ, 2003, HEART FAIL REV, V8, P247, DOI 10.1023/A:1024769617018; Gnecchi M, 2012, VASC PHARMACOL, V57, P48, DOI 10.1016/j.vph.2012.04.002; Haider HK, 2008, J MOL CELL CARDIOL, V45, P554, DOI 10.1016/j.yjmcc.2008.05.004; Hu SJ, 2011, CIRCULATION, V124, pS27, DOI 10.1161/CIRCULATIONAHA.111.017954; Hwang YS, 2009, P NATL ACAD SCI USA, V106, P16978, DOI 10.1073/pnas.0905550106; Jain M, 2001, CIRCULATION, V103, P1920; Kang LF, 2010, J BIOMED MATER RES A, V93A, P547, DOI 10.1002/jbm.a.32557; Kofidis T, 2005, CIRCULATION, V111, P2486, DOI 10.1161/01.CIR.0000165063.09283.A8; Lu G, 2009, CIRCULATION, V119, P2587, DOI 10.1161/CIRCULATIONAHA.108.827691; Makkar RR, 2012, LANCET, V379, P895, DOI 10.1016/S0140-6736(12)60195-0; Moeller HC, 2008, BIOMATERIALS, V29, P752, DOI 10.1016/j.biomaterials.2007.10.030; Narula J, 1996, NEW ENGL J MED, V335, P1182, DOI 10.1056/NEJM199610173351603; Oikonomopoulos A, 2011, CIRC RES, V109, P1363, DOI 10.1161/CIRCRESAHA.111.250282; Olivetti G, 1997, NEW ENGL J MED, V336, P1131, DOI 10.1056/NEJM199704173361603; Oyama T, 2007, J CELL BIOL, V176, P329, DOI 10.1083/jcb.200603014; Passier R, 2008, NATURE, V453, P322, DOI 10.1038/nature07040; Penicka M, 2005, CIRCULATION, V112, pE63, DOI 10.1161/CIRCULATIONAHA.104.496133; Penn MS, 2008, CIRC RES, V102, P1471, DOI 10.1161/CIRCRESAHA.108.175174; Pfister O, 2005, CIRC RES, V97, P52, DOI 10.1161/01.RES.0000173297.53793.fa; Pfister O, 2008, CIRC RES, V103, P825, DOI 10.1161/CIRCRESAHA.108.174615; Pfister O, 2010, METHODS MOL BIOL, V660, P53, DOI 10.1007/978-1-60761-705-1_4; Ptaszek LM, 2012, LANCET, V379, P933, DOI 10.1016/S0140-6736(12)60075-0; Sanz-Ruiz R, 2008, J CARDIOVASC TRANSL, V1, P55, DOI 10.1007/s12265-007-9006-9; Swijnenburg RJ, 2008, STEM CELLS DEV, V17, P1023, DOI 10.1089/scd.2008.0091; Tang YL, 2005, J AM COLL CARDIOL, V46, P1339, DOI 10.1016/j.jacc.2005.05.079; Uggeri J, 2004, HISTOCHEM CELL BIOL, V122, P499, DOI 10.1007/s00418-004-0712-y; Urbanek K, 2005, P NATL ACAD SCI USA, V102, P8692, DOI 10.1073/pnas.0500169102; Urbanek K, 2006, P NATL ACAD SCI USA, V103, P9226, DOI 10.1073/pnas.0600635103; Wang XH, 2006, STEM CELLS, V24, P1779, DOI 10.1634/stemcells.2005-0386; Wu KH, 2011, ANN THORAC SURG, V92, P1917, DOI 10.1016/j.athoracsur.2011.07.012; Ye ZY, 2011, ADV DRUG DELIVER REV, V63, P688, DOI 10.1016/j.addr.2011.02.007; Zhang H, 2010, J CELL MOL MED, V14, P1078, DOI 10.1111/j.1582-4934.2010.01076.x; Zhang M, 2001, J MOL CELL CARDIOL, V33, P907, DOI 10.1006/jmcc.2001.1367	42	29	29	1	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 30	2012	7	11							e50491	10.1371/journal.pone.0050491	http://dx.doi.org/10.1371/journal.pone.0050491			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	054WM	23226295	Green Submitted, Green Published, gold			2022-12-27	WOS:000312376100107
J	Cirit, M; Grant, KG; Haugh, JM				Cirit, Murat; Grant, Kyle G.; Haugh, Jason M.			Systemic Perturbation of the ERK Signaling Pathway by the Proteasome Inhibitor, MG132	PLOS ONE			English	Article							REGULATED KINASE; CELLS; PHOSPHORYLATION; SPECIFICITY; CASCADE; CANCER; PHOSPHATASE-1; ACTIVATION	Inhibition of the ubiquitin-proteasome protein degradation pathway has been identified as a viable strategy for anti-tumor therapy based on its broad effects on cell proliferation. By the same token, the variety of elicited effects confounds the interpretation of cell-based experiments using proteasome inhibitors such as MG132. It has been proposed that MG132 treatment reduces growth factor-stimulated phosphorylation of extracellular signal-regulated kinases (ERKs), at least in part through upregulation of dual specificity phosphatases (DUSPs). Here, we show that the effects of MG132 treatment on ERK signaling are more widespread, leading to a reduction in activation of the upstream kinase MEK. This suggests that MG132 systemically perturbs the intracellular phosphoproteome, impacting ERK signaling by reducing phosphorylation status at multiple levels of the kinase cascade.	[Cirit, Murat; Grant, Kyle G.; Haugh, Jason M.] N Carolina State Univ, Dept Chem & Biomol Engn, Raleigh, NC 27695 USA	University of North Carolina; North Carolina State University	Haugh, JM (corresponding author), N Carolina State Univ, Dept Chem & Biomol Engn, Raleigh, NC 27695 USA.	jason_haugh@ncsu.edu		Haugh, Jason/0000-0002-2476-4027	National Institutes of Health [GM088987]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM088987] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This study was supported by the National Institutes of Health (GM088987). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams J, 2004, NAT REV CANCER, V4, P349, DOI 10.1038/nrc1361; Brondello JM, 1997, J BIOL CHEM, V272, P1368, DOI 10.1074/jbc.272.2.1368; Chan DW, 2008, CARCINOGENESIS, V29, P1742, DOI 10.1093/carcin/bgn167; Chiarugi P, 2002, J CELL SCI, V115, P2219; Cirit M, 2012, BIOCHEM J, V441, P77, DOI 10.1042/BJ20110833; Cirit Murat, 2011, Commun Integr Biol, V4, P353, DOI 10.4161/cib.4.3.15149; Cirit M, 2010, J BIOL CHEM, V285, P36736, DOI 10.1074/jbc.M110.148759; Dhillon AS, 2007, ONCOGENE, V26, P3279, DOI 10.1038/sj.onc.1210421; Glickman MH, 2002, PHYSIOL REV, V82, P373, DOI 10.1152/physrev.00027.2001; HALL A, 1983, NATURE, V303, P396, DOI 10.1038/303396a0; Hall AB, 2003, CURR BIOL, V13, P308, DOI 10.1016/S0960-9822(03)00086-1; Jurek A, 2009, J BIOL CHEM, V284, P4626, DOI 10.1074/jbc.M808490200; KAZLAUSKAS A, 1990, EMBO J, V9, P3279, DOI 10.1002/j.1460-2075.1990.tb07527.x; Kucharska A, 2009, CELL SIGNAL, V21, P1794, DOI 10.1016/j.cellsig.2009.07.015; Lin YW, 2003, J BIOL CHEM, V278, P21534, DOI 10.1074/jbc.M301854200; Lock P, 2006, BIOCHEM BIOPH RES CO, V351, P1018, DOI 10.1016/j.bbrc.2006.10.150; Lonne GK, 2009, J BIOL CHEM, V284, P33456, DOI 10.1074/jbc.M109.036186; Lornejad-Schafer MR, 2005, CELL PHYSIOL BIOCHEM, V16, P193, DOI 10.1159/000089845; Miyake S, 1999, J BIOL CHEM, V274, P16619, DOI 10.1074/jbc.274.23.16619; Muratani M, 2003, NAT REV MOL CELL BIO, V4, P192, DOI 10.1038/nrm1049; Owens DM, 2007, ONCOGENE, V26, P3203, DOI 10.1038/sj.onc.1210412; Pera MF, 2003, METHOD ENZYMOL, V365, P429; Roberts PJ, 2007, ONCOGENE, V26, P3291, DOI 10.1038/sj.onc.1210422; Shaul YD, 2007, BBA-MOL CELL RES, V1773, P1213, DOI 10.1016/j.bbamcr.2006.10.005; Wang CC, 2009, MOL SYST BIOL, V5, DOI 10.1038/msb.2009.4; Wei Q, 2006, J BIOL CHEM, V281, P21652, DOI 10.1074/jbc.M602105200; Yoon S, 2006, GROWTH FACTORS, V24, P21, DOI 10.1080/02699050500284218; Yu CR, 2004, EXP CELL RES, V295, P555, DOI 10.1016/j.yexcr.2004.02.001	28	18	18	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 30	2012	7	11							e50975	10.1371/journal.pone.0050975	http://dx.doi.org/10.1371/journal.pone.0050975			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	054WM	23226437	Green Submitted, Green Published, gold			2022-12-27	WOS:000312376100248
J	Gong, JS; Li, H; Zhu, XY; Lu, ZM; Wu, Y; Shi, JS; Xu, ZH				Gong, Jin-Song; Li, Heng; Zhu, Xiao-Yan; Lu, Zhen-Ming; Wu, Yan; Shi, Jing-Song; Xu, Zheng-Hong			Fungal His-Tagged Nitrilase from Gibberella intermedia: Gene Cloning, Heterologous Expression and Biochemical Properties	PLOS ONE			English	Article							PURIFICATION; BIOCATALYSIS; PROTEIN; ACID	Background: Nitrilase is an important member of the nitrilase superfamiliy. It has attracted substantial interest from academia and industry for its function of converting nitriles directly into the corresponding carboxylic acids in recent years. Thus nitrilase has played a crucial role in production of commercial carboxylic acids in chemical industry and detoxification of nitrile-contaminated wastes. However, conventional studies mainly focused on the bacterial nitrilase and the potential of fungal nitrilase has been far from being fully explored. Research on fungal nitrilase gene expression will advance our understanding for its biological function of fungal nitrilase in nitrile hydrolysis. Methodology/Principal Findings: A fungal nitrilase gene from Gibberella intermedia was cloned through reverse transcription-PCR. The open reading frame consisted of 963 bp and potentially encoded a protein of 320 amino acid residues with a theoretical molecular mass of 35.94 kDa. Furthermore, the catalytic triad (Glu-45, Lys-127, and Cys-162) was proposed and confirmed by site-directed mutagenesis. The encoding gene was expressed in Escherichia coli Rosetta-gami (DE3) and the recombinant protein with His6-tag was purified to electrophoretic homogeneity. The purified enzyme exhibited optimal activity at 45 degrees C and pH 7.8. This nitrilase was specific towards aliphatic and aromatic nitriles. The kinetic parameters V-max and K-m for 3-cyanopyridine were determined to be 0.81 mu mol/min.mg and 12.11 mM through Hanes-Woolf plot, respectively. 3-Cyanopyridine (100 mM) could be thoroughly hydrolyzed into nicotinic acid within 10 min using the recombinant strain with the release of about 3% nicotinamide and no substrate was detected. Conclusions/Significance: In the present study, a fungal nitrilase was cloned from the cDNA sequence of G. intermedia and successfully expressed in E. coli Rosetta-gami (DE3). The recombinant strain displayed good 3-cyanopyridine degradation efficiency and wide substrate spectrum. This fungal nitrilase might be a potential candidate for industrial applications in carboxylic acids production.	[Gong, Jin-Song; Lu, Zhen-Ming; Xu, Zheng-Hong] Jiangnan Univ, Sch Med & Pharmaceut, Lab Pharmaceut Engn, Wuxi, Peoples R China; [Gong, Jin-Song; Zhu, Xiao-Yan; Wu, Yan; Xu, Zheng-Hong] Jiangnan Univ, Key Lab Ind Biotechnol, Minist Educ, Wuxi, Peoples R China; [Li, Heng; Shi, Jing-Song] Jiangnan Univ, Sch Med & Pharmaceut, Lab Bioact Prod Proc Engn, Wuxi, Peoples R China	Jiangnan University; Jiangnan University; Jiangnan University	Xu, ZH (corresponding author), Jiangnan Univ, Sch Med & Pharmaceut, Lab Pharmaceut Engn, Wuxi, Peoples R China.	zhenghxu@jiangnan.edu.cn			National High-Tech RD Program [2011AA02A211]; Fundamental Research Funds for the Central Universities [JUSRP111A51]	National High-Tech RD Program(National High Technology Research and Development Program of China); Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities)	This work was supported by a grant from the National High-Tech R&D Program (No. 2011AA02A211) and the Fundamental Research Funds for the Central Universities (No. JUSRP111A51). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Banerjee A, 2002, APPL MICROBIOL BIOT, V60, P33, DOI 10.1007/s00253-002-1062-0; Banerjee A, 2009, MOL BIOTECHNOL, V41, P35, DOI 10.1007/s12033-008-9094-z; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Chen J, 2009, ADV BIOCHEM ENG BIOT, V113, P33, DOI 10.1007/10_2008_25; GOLDLUST A, 1989, BIOTECHNOL APPL BIOC, V11, P581; Gong JS, 2011, APPL BIOCHEM BIOTECH, V165, P963, DOI 10.1007/s12010-011-9312-1; He YC, 2012, BIORESOURCE TECHNOL, V115, P88, DOI 10.1016/j.biortech.2011.09.084; Hoyle AJ, 1998, ENZYME MICROB TECH, V23, P475, DOI 10.1016/S0141-0229(98)00076-3; Kaplan O, 2006, APPL MICROBIOL BIOT, V73, P567, DOI 10.1007/s00253-006-0503-6; Kaplan O, 2011, BIOTECHNOL LETT, V33, P309, DOI 10.1007/s10529-010-0421-7; Kaplan O, 2011, BMC BIOTECHNOL, V11, DOI 10.1186/1472-6750-11-2; KOBAYASHI M, 1989, EUR J BIOCHEM, V182, P349, DOI 10.1111/j.1432-1033.1989.tb14837.x; Liu ZQ, 2011, J AGR FOOD CHEM, V59, P11560, DOI 10.1021/jf202746a; Luo H, 2010, APPL BIOCHEM BIOTECH, V160, P393, DOI 10.1007/s12010-008-8324-y; Martinkova L, 2010, CURR OPIN CHEM BIOL, V14, P130, DOI 10.1016/j.cbpa.2009.11.018; Mueller P, 2006, PROTEIN EXPRES PURIF, V47, P672, DOI 10.1016/j.pep.2006.01.006; NAGASAWA T, 1990, EUR J BIOCHEM, V194, P765, DOI 10.1111/j.1432-1033.1990.tb19467.x; Pace HC, 2001, GENOME BIOL, V2; Petrickova A, 2012, APPL MICROBIOL BIOT, V93, P1553, DOI 10.1007/s00253-011-3525-7; Schreiner U, 2010, CHEMCATCHEM, V2, P263, DOI 10.1002/cctc.200900212; Semba S, 2006, J BIOL CHEM, V281, P28244, DOI 10.1074/jbc.M603590200; Singh R, 2006, CHEM BIODIVERS, V3, P1279, DOI 10.1002/cbdv.200690131; Snajdrova R, 2004, J MOL CATAL B-ENZYM, V29, P227, DOI 10.1016/j.molcatb.2003.12.012; STALKER DM, 1988, J BIOL CHEM, V263, P6310; THIMANN KV, 1964, ARCH BIOCHEM BIOPHYS, V105, P133, DOI 10.1016/0003-9861(64)90244-9; Thomas SM, 2002, TRENDS BIOTECHNOL, V20, P238, DOI 10.1016/S0167-7799(02)01935-2; Vejvoda V, 2008, J MOL CATAL B-ENZYM, V50, P99, DOI 10.1016/j.molcatb.2007.09.006; Vejvoda V, 2006, BIOCATAL BIOTRANSFOR, V24, P414, DOI 10.1080/10242420601033910; Vejvoda V, 2010, PROCESS BIOCHEM, V45, P1115, DOI 10.1016/j.procbio.2010.03.033; Wohlgemuth R, 2010, CURR OPIN BIOTECH, V21, P713, DOI 10.1016/j.copbio.2010.09.016; Zhang ZJ, 2011, BIOPROC BIOSYST ENG, V34, P315, DOI 10.1007/s00449-010-0473-z; Zheng GW, 2011, CURR OPIN BIOTECH, V22, P784, DOI 10.1016/j.copbio.2011.07.002; Zhu DM, 2008, J BIOTECHNOL, V133, P327, DOI 10.1016/j.jbiotec.2007.10.001	33	19	21	4	53	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 30	2012	7	11							e50622	10.1371/journal.pone.0050622	http://dx.doi.org/10.1371/journal.pone.0050622			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	054WM	23226336	Green Submitted, Green Published, gold			2022-12-27	WOS:000312376100147
J	Hag, AMF; Pedersen, SF; Christoffersen, C; Binderup, T; Jensen, MM; Jorgensen, JT; Skovgaard, D; Ripa, RS; Kjaer, A				Hag, Anne Mette Fisker; Pedersen, Sune Folke; Christoffersen, Christina; Binderup, Tina; Jensen, Mette Munk; Jorgensen, Jesper Tranekjaer; Skovgaard, Dorthe; Ripa, Rasmus Sejersten; Kjaer, Andreas			F-18-FDG PET Imaging of Murine Atherosclerosis: Association with Gene Expression of Key Molecular Markers	PLOS ONE			English	Article							TISSUE FACTOR; PLAQUE INFLAMMATION; ACCUMULATION; MICE; CHEMOATTRACTANT; OSTEOPONTIN; ATHEROGENESIS; DEFICIENCY; DELETION; THERAPY	Aim: To study whether F-18-FDG can be used for in vivo imaging of atherogenesis by examining the correlation between F-18-FDG uptake and gene expression of key molecular markers of atherosclerosis in apoE(-/-) mice. Methods: Nine groups of apoE(-/-) mice were given normal chow or high-fat diet. At different time-points, F-18-FDG PET/contrast-enhanced CT scans were performed on dedicated animal scanners. After scans, animals were euthanized, aortas removed, gamma counted, RNA extracted from the tissue, and gene expression of chemo (C-X-C motif) ligand 1 (CXCL-1), monocyte chemoattractant protein (MCP)-1, vascular cell adhesion molecule (VCAM)-1, cluster of differentiation molecule (CD)-68, osteopontin (OPN), lectin-like oxidized LDL-receptor (LOX)-1, hypoxia-inducible factor (HIF)-1 alpha, HIF-2 alpha, vascular endothelial growth factor A (VEGF), and tissue factor (TF) was measured by means of qPCR. Results: The uptake of F-18-FDG increased over time in the groups of mice receiving high-fat diet measured by PET and ex vivo gamma counting. The gene expression of all examined markers of atherosclerosis correlated significantly with F-18-FDG uptake. The strongest correlation was seen with TF and CD68 (p < 0.001). A multivariate analysis showed CD68, OPN, TF, and VCAM-1 to be the most important contributors to the uptake of F-18-FDG. Together they could explain 60% of the F-18-FDG uptake. Conclusion: We have demonstrated that F-18-FDG can be used to follow the progression of atherosclerosis in apoE(-/-) mice. The gene expression of ten molecular markers representing different molecular processes important for atherosclerosis was shown to correlate with the uptake of F-18-FDG. Especially, the gene expressions of CD68, OPN, TF, and VCAM-1 were strong predictors for the uptake.	[Hag, Anne Mette Fisker; Pedersen, Sune Folke; Binderup, Tina; Jensen, Mette Munk; Jorgensen, Jesper Tranekjaer; Skovgaard, Dorthe; Ripa, Rasmus Sejersten; Kjaer, Andreas] Univ Copenhagen, Rigshosp, Fac Hlth & Med Sci, DK-2100 Copenhagen, Denmark; [Hag, Anne Mette Fisker; Pedersen, Sune Folke; Binderup, Tina; Jensen, Mette Munk; Jorgensen, Jesper Tranekjaer; Skovgaard, Dorthe; Ripa, Rasmus Sejersten; Kjaer, Andreas] Univ Copenhagen, Rigshosp, Dept Clin Physiol Nucl Med & PET, DK-2100 Copenhagen, Denmark; [Christoffersen, Christina] Rigshosp, Dept Clin Biochem, DK-2100 Copenhagen, Denmark	Rigshospitalet; University of Copenhagen; Rigshospitalet; University of Copenhagen; Rigshospitalet; University of Copenhagen	Hag, AMF (corresponding author), Univ Copenhagen, Rigshosp, Fac Hlth & Med Sci, DK-2100 Copenhagen, Denmark.	annemf@sund.ku.dk	Jørgensen, Jesper Tranekjær/AAY-3085-2020; , Rasmus Ripa/GSN-2844-2022; Kjaer, Andreas/E-8932-2015	Jørgensen, Jesper Tranekjær/0000-0001-7573-9596; , Rasmus Ripa/0000-0003-2035-2321; Christoffersen, Christina/0000-0003-3751-5203; Kjaer, Andreas/0000-0002-2706-5547; Hag, Anne Mette F/0000-0001-9492-3663	Danish National Advanced Technology Foundation; John and Birthe Meyer Foundation; Novo Nordisk Foundation; Svend Andersen Fonden; Lundbeck Foundation; A.P. Moller Foundation; Danish Medical Research Council	Danish National Advanced Technology Foundation; John and Birthe Meyer Foundation; Novo Nordisk Foundation(Novo Nordisk FoundationNovocure Limited); Svend Andersen Fonden; Lundbeck Foundation(Lundbeckfonden); A.P. Moller Foundation; Danish Medical Research Council(Danish Medical Research CouncilUK Research & Innovation (UKRI)Medical Research Council UK (MRC))	The financial support from Danish National Advanced Technology Foundation, The John and Birthe Meyer Foundation, Novo Nordisk Foundation, Svend Andersen Fonden, Lundbeck Foundation, A.P. Moller Foundation, and Danish Medical Research Council is greatfully acknowledged. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Boisvert WA, 2006, AM J PATHOL, V168, P1385, DOI 10.2353/ajpath.2006.040748; Camera M, 2012, THROMB RES, V129, P279, DOI 10.1016/j.thromres.2011.11.028; Cho HJ, 2009, CURR ATHEROSCLER REP, V11, P206, DOI 10.1007/s11883-009-0032-8; Cook-Mills JM, 2011, ANTIOXID REDOX SIGN, V15, P1607, DOI 10.1089/ars.2010.3522; Fleige Simone, 2006, Molecular Aspects of Medicine, V27, P126, DOI 10.1016/j.mam.2005.12.003; Fueger BJ, 2006, J NUCL MED, V47, P999; Gao LG, 2012, J CLIN PATHOL, V65, P872, DOI 10.1136/jclinpath-2012-200828; Gu L, 1998, MOL CELL, V2, P275, DOI 10.1016/S1097-2765(00)80139-2; Hatakeyama K, 1997, ATHEROSCLEROSIS, V133, P213, DOI 10.1016/S0021-9150(97)00132-9; Hellemans J, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-2-r19; Hiari Nadine, 2011, Curr Cardiol Rep, V13, P43, DOI 10.1007/s11886-010-0150-5; Hu CP, 2008, CARDIOVASC RES, V79, P287, DOI 10.1093/cvr/cvn110; Hyafil F, 2009, J NUCL MED, V50, P959, DOI 10.2967/jnumed.108.060749; Kataoka H, 1999, CIRCULATION, V99, P3110, DOI 10.1161/01.CIR.99.24.3110; Libby P, 2002, CIRCULATION, V105, P1135, DOI 10.1161/hc0902.104353; Libby P, 2011, CIRC RES, V109, P1100, DOI 10.1161/RES.0b013e31823bdb84; Loboda A, 2010, MOL CELLS, V29, P435, DOI 10.1007/s10059-010-0067-2; Maier T, 2009, FEBS LETT, V583, P3966, DOI 10.1016/j.febslet.2009.10.036; Matsui Y, 2003, ARTERIOSCL THROM VAS, V23, P1029, DOI 10.1161/01.ATV.0000074878.29805.D0; Mehta JL, 2007, CIRC RES, V100, P1634, DOI 10.1161/CIRCRESAHA.107.149724; Nakashima Y, 1998, ARTERIOSCL THROM VAS, V18, P842, DOI 10.1161/01.ATV.18.5.842; OBRIEN KD, 1993, J CLIN INVEST, V92, P945, DOI 10.1172/JCI116670; Ogawa M, 2004, J NUCL MED, V45, P1245; Owens AP, 2012, J CLIN INVEST, V122, P558, DOI 10.1172/JCI58969; Pauwels EKJ, 1998, NUCL MED BIOL, V25, P317, DOI 10.1016/S0969-8051(97)00226-6; Pedersen SF, 2010, NUCL MED COMMUN, V31, P423, DOI 10.1097/MNM.0b013e32833767e0; Qi JY, 1998, PHYS MED BIOL, V43, P1001, DOI 10.1088/0031-9155/43/4/027; Ramprasad MP, 1996, P NATL ACAD SCI USA, V93, P14833, DOI 10.1073/pnas.93.25.14833; Ross R, 1999, NEW ENGL J MED, V340, P115, DOI 10.1056/NEJM199901143400207; Rudd JHF, 2007, J AM COLL CARDIOL, V50, P892, DOI 10.1016/j.jacc.2007.05.024; Rudd JHF, 2009, ARTERIOSCL THROM VAS, V29, P1009, DOI 10.1161/ATVBAHA.108.165563; Rudd JHF, 2002, CIRCULATION, V105, P2708, DOI 10.1161/01.CIR.0000020548.60110.76; Sheikine Y, 2010, ATHEROSCLEROSIS, V211, P371, DOI 10.1016/j.atherosclerosis.2010.01.002; Silvola JMU, 2011, JACC-CARDIOVASC IMAG, V4, P1294, DOI 10.1016/j.jcmg.2011.07.009; Sluimer JC, 2008, J AM COLL CARDIOL, V51, P1258, DOI 10.1016/j.jacc.2007.12.025; Stephen SL, 2010, INT J HYPERTENS, V2010, DOI 10.4061/2010/646929; Strom A, 2004, J VASC RES, V41, P314, DOI 10.1159/000079205; Tawakol A, 2005, J NUCL CARDIOL, V12, P294, DOI 10.1016/j.nuclcard.2005.03.002; Tawakol A, 2006, J AM COLL CARDIOL, V48, P1818, DOI 10.1016/j.jacc.2006.05.076; Tilley RE, 2006, ARTERIOSCL THROM VAS, V26, P555, DOI 10.1161/01.ATV.0000202028.62414.3c; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; Vuorio T, 2012, EXPERT OPIN BIOL TH, V12, P79, DOI 10.1517/14712598.2012.641011; Westrick RJ, 2001, CIRCULATION, V103, P3044, DOI 10.1161/hc2501.092492; Yadav A, 2010, CLIN CHIM ACTA, V411, P1570, DOI 10.1016/j.cca.2010.07.006; Zernecke A, 2008, ARTERIOSCL THROM VAS, V28, P1897, DOI 10.1161/ATVBAHA.107.161174; Zhang S, 2011, J ATHEROSCLER THROMB, V18, P846, DOI 10.5551/jat.7211	46	34	35	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 30	2012	7	11							e50908	10.1371/journal.pone.0050908	http://dx.doi.org/10.1371/journal.pone.0050908			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	054WM	23226424	Green Published, gold, Green Submitted			2022-12-27	WOS:000312376100235
J	Meng, YJ; Shao, CG; Ma, XX; Wang, HZ; Chen, M				Meng, Yijun; Shao, Chaogang; Ma, Xiaoxia; Wang, Huizhong; Chen, Ming			Expression-Based Functional Investigation of the Organ-Specific MicroRNAs in Arabidopsis	PLOS ONE			English	Article							BINDING-PROTEIN HYL1; MESSENGER-RNA; REGULATORY NETWORKS; TRANSCRIPTION FACTORS; PARALLEL ANALYSIS; PROCESSING CENTER; PLANT DEVELOPMENT; LEAF DEVELOPMENT; FLOWERING TIME; MIRNA TARGETS	MicroRNAs (miRNAs) play a pivotal role in plant development. The expression patterns of the miRNA genes significantly influence their regulatory activities. By utilizing small RNA (sRNA) high-throughput sequencing (HTS) data, the miRNA expression patterns were investigated in four organs (flowers, leaves, roots and seedlings) of Arabidopsis. Based on a set of criteria, dozens of organ-specific miRNAs were discovered. A dominant portion of the organ-specific miRNAs identified from the ARGONAUTE 4-enriched sRNA HTS libraries were highly expressed in flowers. Additionally, the expression of the precursors of the organ-specific miRNAs was analyzed. Degradome sequencing data-based approach was employed to identify the targets of the organ-specific miRNAs. The miRNA-target interactions were used for network construction. Subnetwork analysis unraveled some novel regulatory cascades, such as the feedback regulation mediated by miR161, the potential self-regulation of the genes miR172, miR396, miR398 and miR860, and the miR863-guided cleavage of the SERRATE transcript. Our bioinformatics survey expanded the organ-specific miRNA-target list in Arabidopsis, and could deepen the biological view of the miRNA expression and their regulatory roles.	[Meng, Yijun; Ma, Xiaoxia; Wang, Huizhong] Hangzhou Normal Univ, Coll Life & Environm Sci, Hangzhou, Zhejiang, Peoples R China; [Shao, Chaogang] Huzhou Teachers Coll, Coll Life Sci, Huzhou, Peoples R China; [Chen, Ming] Zhejiang Univ, Coll Life Sci, Dept Bioinformat, Hangzhou 310003, Zhejiang, Peoples R China	Hangzhou Normal University; Huzhou University; Zhejiang University	Meng, YJ (corresponding author), Hangzhou Normal Univ, Coll Life & Environm Sci, Hangzhou, Zhejiang, Peoples R China.	mengyijun@zju.edu.cn; whz62@163.com; mchen@zju.edu.cn	Chen, Ming/AAV-3682-2020	Chen, Ming/0000-0002-9677-1699	National Natural Sciences Foundation of China [31100937, 30971743]; Hangzhou Normal University [2011QDL60]; Fundamental Research Funds for the Central Universities; National High Technology Research and Development Program of China ('863' Program) [2008AA10Z125]	National Natural Sciences Foundation of China(National Natural Science Foundation of China (NSFC)); Hangzhou Normal University; Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities); National High Technology Research and Development Program of China ('863' Program)(National High Technology Research and Development Program of China)	This work was funded by the National Natural Sciences Foundation of China [31100937] and [30971743], the Starting Grant funded by Hangzhou Normal University to Yijun Meng [2011QDL60], the Fundamental Research Funds for the Central Universities and the National High Technology Research and Development Program of China ('863' Program) (2008AA10Z125). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdel-Ghany SE, 2008, J BIOL CHEM, V283, P15932, DOI 10.1074/jbc.M801406200; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Aukerman MJ, 2003, PLANT CELL, V15, P2730, DOI 10.1105/tpc.016238; Barrett T, 2009, NUCLEIC ACIDS RES, V37, pD885, DOI 10.1093/nar/gkn764; Bielewicz D, 2012, NUCLEIC ACIDS RES, V40, pD191, DOI 10.1093/nar/gkr878; Borges F, 2008, PLANT PHYSIOL, V148, P1168, DOI 10.1104/pp.108.125229; Chen XM, 2004, SCIENCE, V303, P2022, DOI 10.1126/science.1088060; Chen XM, 2009, ANNU REV CELL DEV BI, V25, P21, DOI 10.1146/annurev.cellbio.042308.113417; Chenu K, 2007, NEW PHYTOL, V175, P472, DOI 10.1111/j.1469-8137.2007.02123.x; Clarke JH, 1999, PLANT J, V20, P493, DOI 10.1046/j.1365-313x.1999.00623.x; Crooks GE, 2004, GENOME RES, V14, P1188, DOI 10.1101/gr.849004; Cui X, 2009, GENE, V431, P61, DOI 10.1016/j.gene.2008.11.016; Dai XB, 2011, NUCLEIC ACIDS RES, V39, pW155, DOI 10.1093/nar/gkr319; Du Z, 2010, NUCLEIC ACIDS RES, V38, pW64, DOI 10.1093/nar/gkq310; Dunoyer P, 2004, PLANT CELL, V16, P1235, DOI 10.1105/tpc.020719; Gandikota M, 2007, PLANT J, V49, P683, DOI 10.1111/j.1365-313X.2006.02983.x; German MA, 2008, NAT BIOTECHNOL, V26, P941, DOI 10.1038/nbt1417; German MA, 2009, NAT PROTOC, V4, P356, DOI 10.1038/nprot.2009.8; Grant-Downton R, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-643; Griffiths-Jones S, 2008, NUCLEIC ACIDS RES, V36, pD154, DOI 10.1093/nar/gkm952; Grigg SP, 2005, NATURE, V437, P1022, DOI 10.1038/nature04052; Gu M, 2010, PHYSIOL PLANTARUM, V138, P226, DOI 10.1111/j.1399-3054.2009.01320.x; Guddeti S, 2005, CELL RES, V15, P631, DOI 10.1038/sj.cr.7290333; Han MH, 2004, P NATL ACAD SCI USA, V101, P1093, DOI 10.1073/pnas.0307969100; Huala E, 2001, NUCLEIC ACIDS RES, V29, P102, DOI 10.1093/nar/29.1.102; Jerzmanowski A, 2007, BBA-GENE STRUCT EXPR, V1769, P330, DOI 10.1016/j.bbaexp.2006.12.003; Johnson C, 2009, GENOME RES, V19, P1429, DOI 10.1101/gr.089854.108; Jones-Rhoades MW, 2006, ANNU REV PLANT BIOL, V57, P19, DOI 10.1146/annurev.arplant.57.032905.105218; Jung JH, 2007, PLANT CELL, V19, P2736, DOI 10.1105/tpc.107.054528; Jung J, 2007, PLANTA, V225, P575, DOI 10.1007/s00425-006-0373-2; Kim HJ, 2008, NATURE, V455, P1134, DOI 10.1038/nature07289; Laubinger S, 2008, P NATL ACAD SCI USA, V105, P8795, DOI 10.1073/pnas.0802493105; Lee Y, 2004, EMBO J, V23, P4051, DOI 10.1038/sj.emboj.7600385; Li CF, 2006, CELL, V126, P93, DOI 10.1016/j.cell.2006.05.032; Llave C, 2002, SCIENCE, V297, P2053, DOI 10.1126/science.1076311; Lobbes D, 2006, EMBO REP, V7, P1052, DOI 10.1038/sj.embor.7400806; Lu SF, 2011, J INTEGR PLANT BIOL, V53, P879, DOI 10.1111/j.1744-7909.2011.01080.x; Machida S, 2011, NUCLEIC ACIDS RES, V39, P7828, DOI 10.1093/nar/gkr428; Matzke M, 2009, CURR OPIN CELL BIOL, V21, P367, DOI 10.1016/j.ceb.2009.01.025; McCaig BC, 2005, PLANTA, V221, P619, DOI 10.1007/s00425-004-1472-6; Meng YJ, 2011, RNA BIOL, V8, P1124, DOI 10.4161/rna.8.6.17743; Meng YJ, 2011, PLANT PHYSIOL, V157, P1583, DOI 10.1104/pp.111.187088; Meng YJ, 2011, BRIEF BIOINFORM, V12, P645, DOI 10.1093/bib/bbq091; Meng YJ, 2010, J EXP BOT, V61, P3833, DOI 10.1093/jxb/erq209; Meng YJ, 2009, PLANTA, V230, P883, DOI 10.1007/s00425-009-0994-3; Mi SJ, 2008, CELL, V133, P116, DOI 10.1016/j.cell.2008.02.034; Nakano M, 2006, NUCLEIC ACIDS RES, V34, pD731, DOI 10.1093/nar/gkj077; Nodine MD, 2010, GENE DEV, V24, P2678, DOI 10.1101/gad.1986710; Palatnik JF, 2007, DEV CELL, V13, P115, DOI 10.1016/j.devcel.2007.04.012; Palatnik JF, 2003, NATURE, V425, P257, DOI 10.1038/nature01958; Pontes O, 2006, CELL, V126, P79, DOI 10.1016/j.cell.2006.05.031; Pontier D, 2005, GENE DEV, V19, P2030, DOI 10.1101/gad.348405; Prigge MJ, 2001, PLANT CELL, V13, P1263, DOI 10.1105/tpc.13.6.1263; Qi YJ, 2006, NATURE, V443, P1008, DOI 10.1038/nature05198; Rodriguez RE, 2010, DEVELOPMENT, V137, P103, DOI 10.1242/dev.043067; Shannon P, 2003, GENOME RES, V13, P2498, DOI 10.1101/gr.1239303; Souret FF, 2004, MOL CELL, V15, P173, DOI 10.1016/j.molcel.2004.06.006; Tsuji H, 2006, PLANT J, V47, P427, DOI 10.1111/j.1365-313X.2006.02795.x; Vaucheret H, 2008, TRENDS PLANT SCI, V13, P350, DOI 10.1016/j.tplants.2008.04.007; Vazquez F, 2004, CURR BIOL, V14, P346, DOI 10.1016/j.cub.2004.01.035; Voinnet O, 2009, CELL, V136, P669, DOI 10.1016/j.cell.2009.01.046; Wang H, 2011, PLANT J, V67, P292, DOI 10.1111/j.1365-313X.2011.04594.x; Wang L, 2011, J EXP BOT, V62, P761, DOI 10.1093/jxb/erq307; Wu G, 2009, CELL, V138, P750, DOI 10.1016/j.cell.2009.06.031; Xie ZX, 2005, PLANT PHYSIOL, V138, P2145, DOI 10.1104/pp.105.062943; Xing SP, 2010, PLANT CELL, V22, P3935, DOI 10.1105/tpc.110.079343; Yamasaki H, 2009, PLANT CELL, V21, P347, DOI 10.1105/tpc.108.060137; Yang L, 2006, PLANT J, V47, P841, DOI 10.1111/j.1365-313X.2006.02835.x; Zhang YJ, 2005, NUCLEIC ACIDS RES, V33, pW701, DOI 10.1093/nar/gki383; Zhao L, 2007, PLANT J, V51, P840, DOI 10.1111/j.1365-313X.2007.03181.x; Zhou M, 2011, FEBS J, V278, P929, DOI 10.1111/j.1742-4658.2011.08008.x; Zhu QH, 2011, J EXP BOT, V62, P487, DOI 10.1093/jxb/erq295; Zhu QH, 2009, BMC PLANT BIOL, V9, DOI 10.1186/1471-2229-9-149	73	12	17	1	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 30	2012	7	11							e50870	10.1371/journal.pone.0050870	http://dx.doi.org/10.1371/journal.pone.0050870			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	054WM	23226412	gold, Green Published, Green Submitted			2022-12-27	WOS:000312376100223
J	Nagata, N; Shimbo, T; Yazaki, H; Asayama, N; Akiyama, J; Teruya, K; Igari, T; Ohmagari, N; Oka, S; Uemura, N				Nagata, Naoyoshi; Shimbo, Takuro; Yazaki, Hirohisa; Asayama, Naoki; Akiyama, Junichi; Teruya, Katsuji; Igari, Toru; Ohmagari, Norio; Oka, Shinichi; Uemura, Naomi			Predictive Clinical Factors in the Diagnosis of Gastrointestinal Kaposi's Sarcoma and Its Endoscopic Severity	PLOS ONE			English	Article							ACQUIRED-IMMUNODEFICIENCY-SYNDROME; ACTIVE ANTIRETROVIRAL THERAPY; AIDS; HIV; ERA; PERFORATION; ANTIBODY; DISEASE; COHORT; TRACT	Background: The diagnosis of gastrointestinal (GI) involvement in Kaposi's sarcoma (KS) is important to make because the need for treatment depends on the extent of the disease. Moreover, severe GI lesions can cause serious complications. Endoscopy with biopsy is an extremely useful method to diagnose GI-KS. However, determining the indications for endoscopy is difficult because KS can occur without GI symptoms or cutaneous KS. This study sought to clarify predictive clinical factors for GI-KS and its severity on endoscopy. Methodology/Principal Findings: A total of 1,027 HIV-infected patients who underwent endoscopy were analyzed. Sexual behavior, CD4 count, HIV RNA, history of highly active antiretroviral therapy (HAART), GI symptoms, and cutaneous KS were assessed. Endoscopic severity including bulky tumor, ulceration, and number of lesions were evaluated. Thirty-three patients had GI-KS and 46 patients cutaneous KS. Among the GI-KS patients, 78.8% (26/33) had no GI symptoms and 24.2% (8/33) had no cutaneous KS. Univariate analysis identified men who have sex with men (MSM), CD4 <100 cells/mu L, HIV RNA >= 10,000 copies/mu L, no history of HAART, and cutaneous KS were significantly associated with GI-KS. Among these factors, cutaneous KS was closely related to GI-KS on multivariable analysis. Among patients without cutaneous KS, MSM and CD4 count <100 cells/mu L were the only independent clinical factors related to GI-KS. Bulky tumor was significantly associated with CD4 <100 cells/mu L and large number of lesions was significantly associated with HIV-RNA >= 10,000 copies/mu L. Conclusions: To diagnose GI-KS, clinical factors need to be considered before endoscopy. The presence of GI symptoms is not useful in predicting GI-KS. MSM and CD4 count <100 cells/mu L are predictive factors among patients without cutaneous KS. Caution should be exercised especially in patients with low CD4 counts or high HIV viral loads as they are more likely to develop severe GI-KS lesions.	[Nagata, Naoyoshi; Asayama, Naoki; Akiyama, Junichi] Natl Ctr Global Hlth & Med, Dept Gastroenterol & Hepatol, Tokyo, Japan; [Shimbo, Takuro] Natl Ctr Global Hlth & Med, Int Clin Res Ctr, Res Inst, Tokyo, Japan; [Yazaki, Hirohisa; Teruya, Katsuji; Oka, Shinichi] Natl Ctr Global Hlth & Med, Div AIDS Clin Ctr, Tokyo, Japan; [Igari, Toru] Natl Ctr Global Hlth & Med, Dept Clin Pathol, Tokyo, Japan; [Ohmagari, Norio] Natl Ctr Global Hlth & Med, Dept Infect Dis, Tokyo, Japan; [Uemura, Naomi] Kohnodai Hosp, Natl Ctr Global Hlth & Med, Dept Gastroenterol & Hepatol, Chiba, Japan	National Center for Global Health & Medicine - Japan; National Center for Global Health & Medicine - Japan; National Center for Global Health & Medicine - Japan; National Center for Global Health & Medicine - Japan; National Center for Global Health & Medicine - Japan; National Center for Global Health & Medicine - Japan	Nagata, N (corresponding author), Natl Ctr Global Hlth & Med, Dept Gastroenterol & Hepatol, Tokyo, Japan.	nnagata_ncgm@yahoo.co.jp	Ohmagari, Norio/GLN-5290-2022	Ohmagari, Norio/0000-0002-4622-8970; Oka, Shinichi/0000-0002-9283-2167	Medicine for Ministry of Health, Labour and Welfare; Health and Labour Sciences Research Grants; Research on Clinical Trials' Infrastructure Development	Medicine for Ministry of Health, Labour and Welfare; Health and Labour Sciences Research Grants(Ministry of Health, Labour and Welfare, Japan); Research on Clinical Trials' Infrastructure Development	This study was partly supported by Medicine for Ministry of Health, Labour and Welfare, Health and Labour Sciences Research Grants, Research on Clinical Trials' Infrastructure Development and grants for research and development in National Center for Global Health and Medicine. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BARRISON IG, 1988, BRIT MED J, V296, P92, DOI 10.1136/bmj.296.6615.92; BERAL V, 1990, LANCET, V335, P123, DOI 10.1016/0140-6736(90)90001-L; BERAL V, 1992, LANCET, V339, P632, DOI 10.1016/0140-6736(92)90793-3; Biggar RJ, 1996, HEMATOL ONCOL CLIN N, V10, P997, DOI 10.1016/S0889-8588(05)70380-4; Braun M, 1982, CA Cancer J Clin, V32, P340, DOI 10.3322/canjclin.32.6.340; Buchacz K, 2010, AIDS, V24, P1549, DOI 10.1097/QAD.0b013e32833a3967; CARRATALA J, 1992, AIDS, V6, P241; CHANG Y, 1994, SCIENCE, V266, P1865, DOI 10.1126/science.7997879; DANZIG JB, 1991, AM J GASTROENTEROL, V86, P715; Dezube BJ, 1996, HEMATOL ONCOL CLIN N, V10, P1023, DOI 10.1016/S0889-8588(05)70382-8; Engels EA, 2006, AIDS, V20, P1645, DOI 10.1097/01.aids.0000238411.75324.59; FRIEDMAN SL, 1985, GASTROENTEROLOGY, V89, P102, DOI 10.1016/0016-5085(85)90750-4; Gallafent JH, 2005, J CLIN ONCOL, V23, P1253, DOI 10.1200/JCO.2005.04.156; IOACHIM HL, 1995, CANCER-AM CANCER SOC, V75, P1376, DOI 10.1002/1097-0142(19950315)75:6<1376::AID-CNCR2820750621>3.0.CO;2-Y; Kahl P, 2007, PATHOL RES PRACT, V203, P227, DOI 10.1016/j.prp.2007.01.007; Kahn HJ, 2002, MODERN PATHOL, V15, P434, DOI 10.1038/modpathol.3880543; Krown SE, 1997, J CLIN ONCOL, V15, P3085, DOI 10.1200/JCO.1997.15.9.3085; LAINE L, 1990, AM J GASTROENTEROL, V85, P959; LINGENFELSER T, 1994, Z GASTROENTEROL, V32, P688; Lodi S, 2010, JNCI-J NATL CANCER I, V102, P784, DOI 10.1093/jnci/djq134; Mocroft A, 2004, CANCER-AM CANCER SOC, V100, P2644, DOI 10.1002/cncr.20309; Nagata N, 2011, CLIN GASTROENTEROL H, V9, pXXII, DOI 10.1016/j.cgh.2010.12.017; Nasti G, 2003, J CLIN ONCOL, V21, P2876, DOI 10.1200/JCO.2003.10.162; NGENDAHAYO P, 1989, B CANCER, V76, P383; RAVALLI S, 1990, AM J GASTROENTEROL, V85, P772; Rosado FGN, 2012, ARCH PATHOL LAB MED, V136, P301, DOI 10.5858/arpa.2011-0213-OA; Stebbing J, 2006, LANCET, V367, P1495, DOI 10.1016/S0140-6736(06)68649-2; WEPRIN L, 1982, J CLIN GASTROENTEROL, V4, P357, DOI 10.1097/00004836-198208000-00013; Yoshida EM, 1997, CAN J GASTROENTEROL, V11, P38, DOI 10.1155/1997/425861	29	24	28	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 30	2012	7	11							e46967	10.1371/journal.pone.0046967	http://dx.doi.org/10.1371/journal.pone.0046967			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	054WM	23226197	Green Published, Green Submitted, gold			2022-12-27	WOS:000312376100005
J	Pozzi, B; Amodio, S; Lucano, C; Sciullo, A; Ronzoni, S; Castelletti, D; Adler, T; Treise, I; Betsholtz, IH; Rathkolb, B; Busch, DH; Wolf, E; Fuchs, H; Gailus-Durner, V; de Angelis, MH; Betsholtz, C; Casola, S; Di Fiore, PP; Offenhauser, N				Pozzi, Benedetta; Amodio, Stefania; Lucano, Caterina; Sciullo, Anna; Ronzoni, Simona; Castelletti, Daniela; Adler, Thure; Treise, Irina; Betsholtz, Ingrid Holmberg; Rathkolb, Birgit; Busch, Dirk H.; Wolf, Eckhard; Fuchs, Helmut; Gailus-Durner, Valerie; de Angelis, Martin Hrabe; Betsholtz, Christer; Casola, Stefano; Di Fiore, Pier Paolo; Offenhaeuser, Nina			The Endocytic Adaptor Eps15 Controls Marginal Zone B Cell Numbers	PLOS ONE			English	Article							TYROSINE KINASE SUBSTRATE; POSITIVE SELECTION; PLASMA-MEMBRANE; LIPID RAFTS; EH-DOMAIN; PROTEIN; EPSIN; COMPONENTS; EXPRESSION; GROWTH	Eps15 is an endocytic adaptor protein involved in clathrin and non-clathrin mediated endocytosis. In Caenorhabditis elegans and Drosophila melanogaster lack of Eps15 leads to defects in synaptic vesicle recycling and synapse formation. We generated Eps15-KO mice to investigate its function in mammals. Eps15-KO mice are born at the expected Mendelian ratio and are fertile. Using a large-scale phenotype screen covering more than 300 parameters correlated to human disease, we found that Eps15-KO mice did not show any sign of disease or neural deficits. Instead, altered blood parameters pointed to an immunological defect. By competitive bone marrow transplantation we demonstrated that Eps15-KO hematopoietic precursor cells were more efficient than the WT counterparts in repopulating B220(+) bone marrow cells, CD19(-) thymocytes and splenic marginal zone (MZ) B cells. Eps15-KO mice showed a 2-fold increase in MZ B cell numbers when compared with controls. Using reverse bone marrow transplantation, we found that Eps15 regulates MZ B cell numbers in a cell autonomous manner. FACS analysis showed that although MZ B cells were increased in Eps15-KO mice, transitional and pre-MZ B cell numbers were unaffected. The increase in MZ B cell numbers in Eps15 KO mice was not dependent on altered BCR signaling or Notch activity. In conclusion, in mammals, the endocytic adaptor protein Eps15 is a regulator of B-cell lymphopoiesis.	[Pozzi, Benedetta; Amodio, Stefania; Lucano, Caterina; Sciullo, Anna; Castelletti, Daniela; Casola, Stefano; Di Fiore, Pier Paolo; Offenhaeuser, Nina] IFOM Fdn Ist FIRC Oncol Mol, Milan, Italy; [Ronzoni, Simona; Di Fiore, Pier Paolo] IEO Ist Europeo Oncol, Milan, Italy; [Adler, Thure; Treise, Irina; Rathkolb, Birgit; Fuchs, Helmut; Gailus-Durner, Valerie; de Angelis, Martin Hrabe] Helmholtz Ctr, Inst Expt Genet, German Mouse Clin, Munich, Germany; [Adler, Thure; Treise, Irina; Busch, Dirk H.] Tech Univ Munich, Inst Med Microbiol Immunol & Hyg, Munich, Germany; [Betsholtz, Ingrid Holmberg; Betsholtz, Christer] Karolinska Inst, Dept Med Biochem & Biophys, Stockholm, Sweden; [Rathkolb, Birgit; Wolf, Eckhard] Univ Munich, Gene Ctr, Munich, Germany; [de Angelis, Martin Hrabe] Tech Univ Munich, Chair Expt Genet, Freising Weihenstephan, Germany; [Di Fiore, Pier Paolo] Univ Milan, Milan, Italy	IFOM - FIRC Institute of Molecular Oncology; IRCCS European Institute of Oncology (IEO); Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Technical University of Munich; Karolinska Institutet; University of Munich; Technical University of Munich; University of Milan	Offenhauser, N (corresponding author), IFOM Fdn Ist FIRC Oncol Mol, Milan, Italy.	nina.offenhauser@ifom.eu	Rathkolb, Birgit/F-7041-2013; Ronzoni, Simona/AAQ-1669-2020; Gailus-Durner, Valerie/M-7337-2014; Casola, Stefano/O-3922-2014; de Angelis, Martin Hrabe/F-5531-2012; Casola, Stefano/AAN-8319-2021; Di Fiore, Pier Paolo/K-2130-2012; Fuchs, Helmut/M-7347-2014	de Angelis, Martin Hrabe/0000-0002-7898-2353; Casola, Stefano/0000-0001-5580-0986; Di Fiore, Pier Paolo/0000-0002-2252-0950; Fuchs, Helmut/0000-0002-5143-2677; Wolf, Eckhard/0000-0002-0430-9510; Offenhauser, Nina/0000-0002-3316-3047	AIRC (Associazione Italiana per la Ricerca sul Cancro); Fondazione Monzino; Fondazione Ferrari; German Federal Ministry of Education and Research, NGFN-Plus grant [01GS0850, 01GS0851, 01GS0852]; Infrafrontier [01KX1012, 211404]; European Union [EUMODIC LSHG-2006-037188]; Italian Foundation for Cancer Research (FIRC)	AIRC (Associazione Italiana per la Ricerca sul Cancro)(Fondazione AIRC per la ricerca sul cancro); Fondazione Monzino; Fondazione Ferrari; German Federal Ministry of Education and Research, NGFN-Plus grant; Infrafrontier; European Union(European Commission); Italian Foundation for Cancer Research (FIRC)(Fondazione AIRC per la ricerca sul cancro)	This work was funded by grants from AIRC (Associazione Italiana per la Ricerca sul Cancro), Fondazione Monzino and Fondazione Ferrari to PPDF, and by grants from the German Federal Ministry of Education and Research, NGFN-Plus grant numbers 01GS0850 to MHdA, 01GS0851 to EW and 01GS0852 to DB. The German Mouse clinic received funding from Infrafrontier (01KX1012 and 211404) and the European Union (EUMODIC LSHG-2006-037188). SC is supported by the Italian Foundation for Cancer Research (FIRC). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akbergenova Y, 2010, NEUROSCIENCE, V170, P441, DOI 10.1016/j.neuroscience.2010.07.021; Allman D, 2004, IMMUNOL REV, V197, P147, DOI 10.1111/j.0105-2896.2004.0108.x; Bao H, 2008, TRAFFIC, V9, P2190, DOI 10.1111/j.1600-0854.2008.00832.x; Becker-Herman S, 2002, J IMMUNOL, V168, P5507, DOI 10.4049/jimmunol.168.11.5507; Benmerah A, 1999, J CELL SCI, V112, P1303; Benmerah A, 1995, J CELL BIOL, V131, P1831, DOI 10.1083/jcb.131.6.1831; Carbone R, 1997, CANCER RES, V57, P5498; Carey JB, 2008, J EXP MED, V205, P2043, DOI 10.1084/jem.20080559; Cariappa A, 2001, IMMUNITY, V14, P603, DOI 10.1016/S1074-7613(01)00135-2; Casola S, 2004, NAT IMMUNOL, V5, P317, DOI 10.1038/ni1036; Casola S, 2007, CURR OPIN IMMUNOL, V19, P143, DOI 10.1016/j.coi.2007.02.010; Chen H, 1998, NATURE, V394, P793, DOI 10.1038/29555; Chen H, 1999, J BIOL CHEM, V274, P3257, DOI 10.1074/jbc.274.6.3257; Cinamon G, 2004, NAT IMMUNOL, V5, P713, DOI 10.1038/ni1083; Clark MR, 2011, MOL IMMUNOL, V48, P1281, DOI 10.1016/j.molimm.2010.10.024; Coda L, 1998, J BIOL CHEM, V273, P3003, DOI 10.1074/jbc.273.5.3003; Di Paolo G, 2002, NEURON, V33, P789, DOI 10.1016/S0896-6273(02)00601-3; Edeling MA, 2006, DEV CELL, V10, P329, DOI 10.1016/j.devcel.2006.01.016; Ellinghaus U, 2008, EUR J IMMUNOL, V38, P2096, DOI 10.1002/eji.200838254; FAZIOLI F, 1993, MOL CELL BIOL, V13, P5814, DOI 10.1128/MCB.13.9.5814; Ferguson SM, 2007, SCIENCE, V316, P570, DOI 10.1126/science.1140621; Fulton RJ, 1997, CLIN CHEM, V43, P1749; Gibb DR, 2010, J EXP MED, V207, P623, DOI 10.1084/jem.20091990; Guo F, 2007, BLOOD, V110, P2381, DOI 10.1182/blood-2007-02-075143; Gururajan M, 2008, J IMMUNOL, V181, P4590, DOI 10.4049/jimmunol.181.7.4590; Haglund K, 2003, NAT CELL BIOL, V5, P461, DOI 10.1038/ncb983; Heltemes LM, 2002, J IMMUNOL, V169, P1283, DOI 10.4049/jimmunol.169.3.1283; Iannolo G, 1997, CANCER RES, V57, P240; Karnell FG, 2005, J BIOL CHEM, V280, P25621, DOI 10.1074/jbc.M503162200; Kasprowicz J, 2008, J CELL BIOL, V182, P1007, DOI 10.1083/jcb.200804162; Kitaura Y, 2007, IMMUNITY, V26, P567, DOI 10.1016/j.immuni.2007.03.015; Koh TW, 2007, J CELL BIOL, V178, P309, DOI 10.1083/jcb.200701030; Kuroda K, 2003, IMMUNITY, V18, P301, DOI 10.1016/S1074-7613(03)00029-3; Lo CG, 2003, J EXP MED, V197, P353, DOI 10.1084/jem.20021569; Lopes-Carvalho T, 2004, IMMUNOL REV, V197, P192, DOI 10.1111/j.0105-2896.2004.0112.x; Lopes-Carvalho Thiago, 2005, V8, P91; Maillard I, 2004, BLOOD, V104, P1696, DOI 10.1182/blood-2004-02-0514; Majumdar A, 2006, EXP CELL RES, V312, P2288, DOI 10.1016/j.yexcr.2006.03.030; Marie B, 2004, NEURON, V43, P207, DOI 10.1016/j.neuron.2004.07.001; Martin F, 2002, NAT REV IMMUNOL, V2, P323, DOI 10.1038/nri799; Martina JA, 2001, J CELL BIOL, V153, P1111, DOI 10.1083/jcb.153.5.1111; Offenhauser N, 2000, MECH DEVELOP, V95, P309, DOI 10.1016/S0925-4773(00)00363-4; Offenhauser N, 2006, CELL, V127, P213, DOI 10.1016/j.cell.2006.09.011; Otero DC, 2003, J IMMUNOL, V170, P73, DOI 10.4049/jimmunol.170.1.73; Overstreet E, 2004, DEVELOPMENT, V131, P5355, DOI 10.1242/dev.01434; Pece S, 2011, BBA-REV CANCER, V1815, P26, DOI 10.1016/j.bbcan.2010.10.001; Pierce SK, 2002, NAT REV IMMUNOL, V2, P96, DOI 10.1038/nri726; Pillai S, 2005, ANNU REV IMMUNOL, V23, P161, DOI 10.1146/annurev.immunol.23.021704.115728; Pillai S, 2004, IMMUNOL REV, V197, P206, DOI 10.1111/j.0105-2896.2003.097.x; Pillai S, 2009, NAT REV IMMUNOL, V9, P767, DOI 10.1038/nri2656; Polo S, 2002, NATURE, V416, P451, DOI 10.1038/416451a; Quong MW, 2004, J EXP MED, V199, P1101, DOI 10.1084/jem.20031180; Regan-Klapisz E, 2005, J CELL SCI, V118, P4437, DOI 10.1242/jcs.02571; Saito T, 2003, IMMUNITY, V18, P675, DOI 10.1016/S1074-7613(03)00111-0; Salcini AE, 1997, GENE DEV, V11, P2239, DOI 10.1101/gad.11.17.2239; Salcini AE, 2001, NAT CELL BIOL, V3, P755, DOI 10.1038/35087075; Sheng Y, 2008, IMMUNOL LETT, V121, P33, DOI 10.1016/j.imlet.2008.08.001; Sigismund S, 2005, P NATL ACAD SCI USA, V102, P2760, DOI 10.1073/pnas.0409817102; Song R, 2008, J EXP MED, V205, P2525, DOI 10.1084/jem.20081344; Sproul TW, 2000, J IMMUNOL, V165, P6020, DOI 10.4049/jimmunol.165.11.6020; Tanigakik K, 2002, NAT IMMUNOL, V3, P443, DOI 10.1038/ni793; Tocchetti A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009468; Torrisi MR, 1999, MOL BIOL CELL, V10, P417, DOI 10.1091/mbc.10.2.417; Tortola L, 2010, BLOOD, V116, P5200, DOI 10.1182/blood-2010-05-284547; von Zastrow M, 2007, CURR OPIN CELL BIOL, V19, P436, DOI 10.1016/j.ceb.2007.04.021; Wang WD, 2004, DEVELOPMENT, V131, P5367, DOI 10.1242/dev.01413; Wang W, 2008, TRAFFIC, V9, P742, DOI 10.1111/j.1600-0854.2008.00712.x; Wen LJ, 2005, IMMUNITY, V23, P297, DOI 10.1016/j.immuni.2005.08.007; Wither JE, 2005, J IMMUNOL, V175, P4309, DOI 10.4049/jimmunol.175.7.4309; Wu L, 2007, BLOOD, V110, P3618, DOI 10.1182/blood-2007-06-097030; Xing Y, 2009, MOL IMMUNOL, V46, P1120, DOI 10.1016/j.molimm.2008.10.031; Yu Y, 2008, HUM MOL GENET, V17, P3281, DOI 10.1093/hmg/ddn224; Yuseff MI, 2009, TRAFFIC, V10, P629, DOI 10.1111/j.1600-0854.2009.00913.x; Zhang XK, 2008, J IMMUNOL, V181, P1644, DOI 10.4049/jimmunol.181.3.1644	74	12	12	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 30	2012	7	11							e50818	10.1371/journal.pone.0050818	http://dx.doi.org/10.1371/journal.pone.0050818			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	054WM	23226392	Green Published, Green Submitted, gold			2022-12-27	WOS:000312376100203
J	Stanton, JB; Schneider, DA; Dinkel, KD; Balmer, BF; Baszler, TV; Mathison, BA; Boykin, DW; Kumar, A				Stanton, James B.; Schneider, David A.; Dinkel, Kelcey D.; Balmer, Bethany F.; Baszler, Timothy V.; Mathison, Bruce A.; Boykin, David W.; Kumar, Arvind			Discovery of a Novel, Monocationic, Small-Molecule Inhibitor of Scrapie Prion Accumulation in Cultured Sheep Microglia and Rov Cells	PLOS ONE			English	Article							VIRAL DIARRHEA VIRUS; TRANSMISSIBLE SPONGIFORM ENCEPHALOPATHIES; INCUBATION PERIOD; CONGO RED; INFECTED HAMSTERS; PROTEIN-FORMATION; AMPHOTERICIN-B; PHOSPHOROTHIOATE OLIGONUCLEOTIDES; BRANCHED POLYAMINES; PRPSC ACCUMULATION	Prion diseases, including sheep scrapie, are neurodegenerative diseases with the fundamental pathogenesis involving conversion of normal cellular prion protein (PrPC) to disease-associated prion protein (PrPSc). Chemical inhibition of prion accumulation is widely investigated, often using rodent-adapted prion cell culture models. Using a PrPSc-specific ELISA we discovered a monocationic phenyl-furan-benzimidazole (DB772), which has previously demonstrated anti-pestiviral activity and represents a chemical category previously untested for anti-prion activity, that inhibited PrPSc accumulation and prion infectivity in primary sheep microglial cell cultures (PRNP 136VV/154RR/171QQ) and Rov9 cultures (VRQ-ovinized RK13 cells). We investigated potential mechanisms of this anti-prion activity by evaluating PrPC expression with quantitative RT-PCR and PrP ELISA, comparing the concentration-dependent anti-prion and anti-pestiviral effects of DB772, and determining the selectivity index. Results demonstrate at least an approximate two-log inhibition of PrPSc accumulation in the two cell systems and confirmed that the inhibition of PrPSc accumulation correlates with inhibition of prion infectivity. PRNP transcripts and total PrP protein concentrations within cell lysates were not decreased; thus, decreased PrPC expression is not the mechanism of PrPSc inhibition. PrPSc accumulation was multiple logs more resistant than pestivirus to DB772, suggesting that the anti-PrPSc activity was independent of anti-pestivirus activity. The anti-PrPSc selectivity index in cell culture was approximately 4.6 in microglia and 5.5 in Rov9 cells. The results describe a new chemical category that inhibits ovine PrPSc accumulation in primary sheep microglia and Rov9 cells, and can be used for future studies into the treatment and mechanism of prion diseases.	[Stanton, James B.; Dinkel, Kelcey D.; Balmer, Bethany F.; Baszler, Timothy V.; Mathison, Bruce A.] Washington State Univ, Dept Vet Microbiol & Pathol, Pullman, WA 99164 USA; [Schneider, David A.] ARS, USDA, Anim Dis Res Unit, Pullman, WA USA; [Boykin, David W.; Kumar, Arvind] Georgia State Univ, Dept Chem, Atlanta, GA 30303 USA	Washington State University; United States Department of Agriculture (USDA); University System of Georgia; Georgia State University	Stanton, JB (corresponding author), Washington State Univ, Dept Vet Microbiol & Pathol, Pullman, WA 99164 USA.	jstanton@vetmed.wsu.edu	Stanton, James/A-5277-2011; Schneider, David/A-2833-2010	Stanton, James/0000-0002-7661-2631; Schneider, David/0000-0001-9659-6731	United States Department of Agriculture/Agricultural Research Service [58-5348-7-577]; Washington State University New Faculty Seed Grant; National Institutes of Health [AI064200]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI064200] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008336] Funding Source: NIH RePORTER	United States Department of Agriculture/Agricultural Research Service(United States Department of Agriculture (USDA)USDA Agricultural Research Service); Washington State University New Faculty Seed Grant; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by United States Department of Agriculture/Agricultural Research Service Specific Cooperative Agreement No. 58-5348-7-577, the Washington State University New Faculty Seed Grant, and National Institutes of Health AI064200. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adjou KT, 2000, J COMP PATHOL, V122, P3, DOI 10.1053/jcpa.1999.0338; Alverson J, 2006, J GEN VIROL, V87, P1035, DOI 10.1099/vir.0.81418-0; Ammari M, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-S6-S9; Baker CA, 2002, J VIROL, V76, P10905, DOI 10.1128/JVI.76.21.10905-10913.2002; Barret A, 2003, J VIROL, V77, P8462, DOI 10.1128/JVI.77.15.8462-8469.2003; BASLER K, 1986, CELL, V46, P417, DOI 10.1016/0092-8674(86)90662-8; BOLIN SR, 1994, J VIROL METHODS, V48, P211, DOI 10.1016/0166-0934(94)90120-1; BORCHELT DR, 1990, J CELL BIOL, V110, P743, DOI 10.1083/jcb.110.3.743; Budhia S, 2006, J IMMUNOL METHODS, V309, P160, DOI 10.1016/j.jim.2005.12.006; BUELER H, 1993, CELL, V73, P1339, DOI 10.1016/0092-8674(93)90360-3; CAUGHEY B, 1991, J BIOL CHEM, V266, P18217; Caughey B, 2006, ACCOUNTS CHEM RES, V39, P646, DOI 10.1021/ar050068p; CAUGHEY B, 1993, J VIROL, V67, P6270, DOI 10.1128/JVI.67.10.6270-6272.1993; CAUGHEY B, 1992, J NEUROCHEM, V59, P768, DOI 10.1111/j.1471-4159.1992.tb09437.x; CAUGHEY B, 1993, J VIROL, V67, P643, DOI 10.1128/JVI.67.2.643-650.1993; Caughey WS, 1998, P NATL ACAD SCI USA, V95, P12117, DOI 10.1073/pnas.95.21.12117; Demaimay R, 1997, J VIROL, V71, P9685, DOI 10.1128/JVI.71.12.9685-9689.1997; DEMAIMAY R, 1994, J GEN VIROL, V75, P2499, DOI 10.1099/0022-1317-75-9-2499; Doh-Ura K, 2000, J VIROL, V74, P4894, DOI 10.1128/JVI.74.10.4894-4897.2000; Dormont D, 2003, BRIT MED BULL, V66, P281, DOI 10.1093/bmb/66.1.281; EHLERS B, 1984, J GEN VIROL, V65, P1325, DOI 10.1099/0022-1317-65-8-1325; FARQUHAR CF, 1986, J GEN VIROL, V67, P463, DOI 10.1099/0022-1317-67-3-463; Fischer M, 1996, EMBO J, V15, P1255, DOI 10.1002/j.1460-2075.1996.tb00467.x; GABIZON R, 1993, J CELL PHYSIOL, V157, P319, DOI 10.1002/jcp.1041570215; Ghaemmaghami S, 2010, J VIROL, V84, P3408, DOI 10.1128/JVI.02145-09; Gilch S, 2007, FEBS J, V274, P5834, DOI 10.1111/j.1742-4658.2007.06105.x; Givens MD, 2004, ANTIVIR RES, V64, P113, DOI 10.1016/j.antiviral.2004.07.004; Givens MD, 2003, ANTIMICROB AGENTS CH, V47, P2223, DOI 10.1128/AAC.47.7.2223-2230.2003; Herrmann LM, 2001, HAEMATOLOGICA, V86, P146; Huang FP, 2002, J GEN VIROL, V83, P267, DOI 10.1099/0022-1317-83-1-267; INGROSSO L, 1995, J VIROL, V69, P506, DOI 10.1128/JVI.69.1.506-508.1995; Iwamaru Y, 2007, J VIROL, V81, P1524, DOI 10.1128/JVI.01379-06; Karpuj MV, 2007, MOL MED, V13, P190, DOI 10.2119/2006-00073.Karpuj; KIMBERLIN RH, 1986, ANTIMICROB AGENTS CH, V30, P409, DOI 10.1128/AAC.30.3.409; KLATZO I, 1959, LAB INVEST, V8, P799; Kocisko DA, 2006, ANTIMICROB AGENTS CH, V50, P1034, DOI 10.1128/AAC.50.3.1034-1044.2006; Kocisko DA, 2006, ANTIMICROB AGENTS CH, V50, P759, DOI 10.1128/AAC.50.2.759-761.2006; Kocisko DA, 2006, J VIROL, V80, P1044, DOI 10.1128/JVI.80.2.1044-1046.2006; Kocisko DA, 2005, NEUROSCI LETT, V388, P106, DOI 10.1016/j.neulet.2005.06.053; Kocisko DA, 2003, J VIROL, V77, P10288, DOI 10.1128/JVI.77.19.10288-10294.2003; Korth C, 2001, P NATL ACAD SCI USA, V98, P9836, DOI 10.1073/pnas.161274798; Lacroux C, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000238; LADOGANA A, 1992, J GEN VIROL, V73, P661, DOI 10.1099/0022-1317-73-3-661; Lansiaux A, 2002, J MED CHEM, V45, P1994, DOI 10.1021/jm010539n; Laskus T, 2000, J INFECT DIS, V181, P442, DOI 10.1086/315283; Lasmezas CI, 2003, REV SCI TECH OIE, V22, P23, DOI 10.20506/rst.22.1.1390; Ligios C, 2011, J VIROL, V85, P1136, DOI 10.1128/JVI.02022-10; Marella M, 2002, J BIOL CHEM, V277, P25457, DOI 10.1074/jbc.M203248200; Murakami-Kubo I, 2004, J VIROL, V78, P1281, DOI 10.1128/JVI.78.3.1281-1288.2004; Newcomer Benjamin W., 2012, Antiviral Chemistry & Chemotherapy, V22, P171, DOI 10.3851/IMP1903; Pani A, 2007, ANTIMICROB AGENTS CH, V51, P4141, DOI 10.1128/AAC.00524-07; Peixoto P, 2008, NUCLEIC ACIDS RES, V36, P3341, DOI 10.1093/nar/gkn208; POCCHIARI M, 1987, J GEN VIROL, V68, P219, DOI 10.1099/0022-1317-68-1-219; Prinz M, 2002, P NATL ACAD SCI USA, V99, P919, DOI 10.1073/pnas.022626399; Priola SA, 2003, J INFECT DIS, V188, P699, DOI 10.1086/377310; Priola SA, 2000, SCIENCE, V287, P1503, DOI 10.1126/science.287.5457.1503; PRUSINER SB, 1982, SCIENCE, V216, P136, DOI 10.1126/science.6801762; PRUSINER SB, 1990, CELL, V63, P673, DOI 10.1016/0092-8674(90)90134-Z; Raymond GJ, 2006, J VIROL, V80, P596, DOI 10.1128/JVI.80.2.596-604.2006; Rudyk H, 2000, J GEN VIROL, V81, P1155, DOI 10.1099/0022-1317-81-4-1155; Sethi S, 2002, LANCET, V360, P229, DOI 10.1016/S0140-6736(02)09513-2; Stanton JB, 2008, J VIROL, V82, P9839, DOI 10.1128/JVI.01137-08; Supattapone S, 1999, P NATL ACAD SCI USA, V96, P14529, DOI 10.1073/pnas.96.25.14529; Supattapone S, 2001, J VIROL, V75, P3453, DOI 10.1128/JVI.75.7.3453-3461.2001; Thompson MJ, 2010, CHEMMEDCHEM, V5, P1476, DOI 10.1002/cmdc.201000217; Trevitt CR, 2006, BRAIN, V129, P2241, DOI 10.1093/brain/awl150; VILCEK S, 1994, ARCH VIROL, V136, P309, DOI 10.1007/BF01321060; Vilette D, 2001, P NATL ACAD SCI USA, V98, P4055, DOI 10.1073/pnas.061337998; Wilkinson J, 2009, J VIROL, V83, P1312, DOI 10.1128/JVI.01890-08	69	12	12	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 30	2012	7	11							e51173	10.1371/journal.pone.0051173	http://dx.doi.org/10.1371/journal.pone.0051173			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	054WM	23226483	Green Submitted, Green Published, gold			2022-12-27	WOS:000312376100294
J	Stebbings, R; Fevrier, M; Li, B; Lorin, C; Koutsoukos, M; Mee, E; Rose, N; Hall, J; Page, M; Almond, N; Voss, G; Tangy, F				Stebbings, Richard; Fevrier, Michele; Li, Bo; Lorin, Clarisse; Koutsoukos, Marguerite; Mee, Edward; Rose, Nicola; Hall, Joanna; Page, Mark; Almond, Neil; Voss, Gerald; Tangy, Frederic			Immunogenicity of a Recombinant Measles-HIV-1 Clade B Candidate Vaccine	PLOS ONE			English	Article							IMMUNODEFICIENCY-VIRUS HIV; HUMORAL IMMUNE-RESPONSES; T-CELL RESPONSES; NEUTRALIZING ANTIBODIES; CYNOMOLGUS MACAQUES; POTENTIAL IMPACT; RHESUS MACAQUES; VECTOR; ADENOVIRUS; INFECTION	Live attenuated measles virus is one of the most efficient and safest vaccines available, making it an attractive candidate vector for a HIV/AIDS vaccine aimed at eliciting cell-mediated immune responses (CMI). Here we have characterized the potency of CMI responses generated in mice and non-human primates after intramuscular immunisation with a candidate recombinant measles vaccine carrying an HIV-1 insert encoding Clade B Gag, RT and Nef (MV1-F4). Eight Mauritian derived, MHC-typed cynomolgus macaques were immunised with 10(5) TCID50 of MV1-F4, four of which were boosted 28 days later with the same vaccine. F4 and measles virus (MV)-specific cytokine producing T cell responses were detected in 6 and 7 out of 8 vaccinees, respectively. Vaccinees with either M6 or recombinant MHC haplotypes demonstrated the strongest cytokine responses to F4 peptides. Polyfunctional analysis revealed a pattern of TNF alpha and IL-2 responses by CD4+ T cells and TNF alpha and IFN gamma responses by CD8+ T cells to F4 peptides. HIV-specific CD4+ and CD8+ T cells expressing cytokines waned in peripheral blood lymphocytes by day 84, but CD8+ T cell responses to F4 peptides could still be detected in lymphoid tissues more than 3 months after vaccination. Anti-F4 and anti-MV antibody responses were detected in 6 and 8 out of 8 vaccinees, respectively. Titres of anti-F4 and MV antibodies were boosted in vaccinees that received a second immunisation. MV1-F4 carrying HIV-1 Clade B inserts induces robust boostable immunity in non-human primates. These results support further exploration of the MV1-F4 vector modality in vaccination strategies that may limit HIV-1 infectivity.	[Stebbings, Richard; Li, Bo] Natl Inst Biol Stand & Controls, Div Biotherapeut, Potters Bar, Herts, England; [Fevrier, Michele; Tangy, Frederic] Inst Pasteur, Unite Genom Virale & Vaccinat, Paris, France; [Lorin, Clarisse; Koutsoukos, Marguerite; Voss, Gerald] GlaxoSmithKline Vaccines, Rixensart, Belgium; [Mee, Edward; Rose, Nicola; Hall, Joanna; Page, Mark; Almond, Neil] Natl Inst Biol Stand & Controls, Div Virol, Potters Bar, Herts, England	National Institute for Biological Standards & Control; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; GlaxoSmithKline; National Institute for Biological Standards & Control	Stebbings, R (corresponding author), Natl Inst Biol Stand & Controls, Div Biotherapeut, Potters Bar, Herts, England.	rstebbings@nibsc.ac.uk	Stebbings, Richard/E-2117-2013; Rose, Nicola/E-9366-2013	Stebbings, Richard/0000-0001-9628-2708; Almond, Neil/0000-0001-6105-0616; Rose, Nicola/0000-0003-1102-5062; Mee, Edward/0000-0003-3514-8067	European Union through the Sixth European Research Framework Programme [2005-019043 RMV-HIV]; EUROPRISE Network of Excellence on HIV vaccines and Microbicides (EC FP6) [037611]; NIHR Centre for Research in Health Protection at the Health Protection Agency; GlaxoSmithKline Biologicals	European Union through the Sixth European Research Framework Programme; EUROPRISE Network of Excellence on HIV vaccines and Microbicides (EC FP6); NIHR Centre for Research in Health Protection at the Health Protection Agency; GlaxoSmithKline Biologicals(GlaxoSmithKline)	This work was supported by the European Union through the Sixth European Research Framework Programme (project number 2005-019043 RMV-HIV). The funding was granted to the RMV HIV consortium, including The National Institute for Biological Standards and Control (NIBSC; Potters Bar, Hertfordshire, UK), the Centre Cochin-Pasteur d'Essais Vaccinaux, Hopital Cochin (Paris, France), Ghent University, Centre for Vaccinology (Ghent, Belgium), St. George's University of London (London, UK), GlaxoSmithKline Biologicals (Rixensart, Belgium) and the Institut Pasteur (Paris, France). Funding to attend meetings was provided by EUROPRISE Network of Excellence on HIV vaccines and Microbicides (EC FP6 grant 037611). RS, NA, NR and MP were funded in part by the NIHR Centre for Research in Health Protection at the Health Protection Agency. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; CL, MK and GV are employees of GlaxoSmithKline Vaccines. GlaxoSmithKline Biologicals partly funded this study. RS, MF, BL, EM, NR, JH MP and NA declare no competing interest. FT and CL are listed as "Inventor" of patents related to the measles vector vaccine, the rights of which have been assigned to the Institut Pasteur. Both authors do not hold a patent for the measles vector vaccine described in the present study. MK and GV own shares and/or options to shares in GSK. There are no further patents, products in development or marketed products to declare. This does not alter the authors' adherence to all the PLOS ONE policies on sharing data and materials, as detailed online in the guide for authors.	Aarnink A, 2011, IMMUNOGENETICS, V63, P267, DOI 10.1007/s00251-010-0504-6; Abbas AK, 1996, NATURE, V383, P787, DOI 10.1038/383787a0; Andersson KM, 2011, VACCINE, V29, P6092, DOI 10.1016/j.vaccine.2011.06.060; ANDERSSON L, 1995, IMMUNOL REV, V143, P5, DOI 10.1111/j.1600-065X.1995.tb00667.x; Bolton DL, 2012, VACCINE, V30, P5991, DOI 10.1016/j.vaccine.2012.06.029; Brandler S, 2007, PLOS NEGLECT TROP D, V1, DOI 10.1371/journal.pntd.0000096; Brandler S, 2010, VACCINE, V28, P6730, DOI 10.1016/j.vaccine.2010.07.073; Campbell JJ, 2001, J IMMUNOL, V166, P877, DOI 10.4049/jimmunol.166.2.877; Cho BK, 1999, P NATL ACAD SCI USA, V96, P2976, DOI 10.1073/pnas.96.6.2976; Choi YK, 1999, VET PATHOL, V36, P594, DOI 10.1354/vp.36-6-594; Combredet C, 2003, J VIROL, V77, P11546, DOI 10.1128/JVI.77.21.11546-11554.2003; Despres P, 2005, J INFECT DIS, V191, P207, DOI 10.1086/426824; Dilraj A, 2000, LANCET, V355, P798, DOI 10.1016/S0140-6736(99)95140-1; Draper SJ, 2010, J IMMUNOL, V185, P7583, DOI 10.4049/jimmunol.1001760; Dudareva M, 2009, VACCINE, V27, P3501, DOI 10.1016/j.vaccine.2009.03.080; El Mubarak HS, 2007, J GEN VIROL, V88, P2028, DOI 10.1099/vir.0.82804-0; Flynn MN, 2005, J INFECT DIS, V191, P654, DOI 10.1086/428404; Gamble LJ, 2010, DRUG DES DEV THER, V5, P9, DOI 10.2147/DDDT.S6959; Girard MP, 2011, VACCINE, V29, P6191, DOI [10.1016/j.vaccine.2011.08.031, 10.1016/j.vaccine.2011.06.085]; Griffin J. P., 2001, Adverse Drug Reactions and Toxicological Reviews, V20, P1; Guerbois M, 2009, VIROLOGY, V388, P191, DOI 10.1016/j.virol.2009.02.047; Hilleman MR, 2001, VACCINE, V20, P651, DOI 10.1016/S0264-410X(01)00384-X; Howe RC, 2005, CLIN EXP IMMUNOL, V140, P333, DOI 10.1111/j.1365-2249.2005.02766.x; Huang XL, 2008, J LEUKOCYTE BIOL, V83, P1530, DOI 10.1189/jlb.1107795; Joint United Nations Programme on HIV/AIDS, 2010, GLOB REP UNAIDS REP; Kahl CA, 2010, VACCINE, V28, P5691, DOI 10.1016/j.vaccine.2010.06.050; Lee MS, 2000, J MED VIROL, V62, P511, DOI 10.1002/1096-9071(200012)62:4&lt;511::AID-JMV17&gt;3.0.CO;2-Z; Leslie A, 2005, J EXP MED, V201, P891, DOI 10.1084/jem.20041455; Lin JP, 2008, HUM GENE THER, V19, P663, DOI 10.1089/hum.2008.033; Liniger M, 2009, VACCINE, V27, P3299, DOI 10.1016/j.vaccine.2009.01.057; Long EF, 2011, VACCINE, V29, P6113, DOI 10.1016/j.vaccine.2011.04.013; Lorin C, 2005, VACCINE, V23, P4463, DOI 10.1016/j.vaccine.2005.04.024; Lorin C, 2004, J VIROL, V78, P146, DOI 10.1128/JVI.78.1.146-157.2004; McMichael AJ, 2010, NAT REV IMMUNOL, V10, P11, DOI 10.1038/nri2674; Mee ET, 2009, IMMUNOGENETICS, V61, P327, DOI 10.1007/s00251-009-0369-8; Mee ET, 2009, J MED PRIMATOL, V38, P1, DOI 10.1111/j.1600-0684.2008.00299.x; Moore CB, 2002, SCIENCE, V296, P1439, DOI 10.1126/science.1069660; Mrkic B, 1998, J VIROL, V72, P7420, DOI 10.1128/JVI.72.9.7420-7427.1998; Nagelkerke NJD, 2011, VACCINE, V29, P6079, DOI 10.1016/j.vaccine.2011.06.048; Naniche D, 2004, J INFECT DIS, V190, P1387, DOI 10.1086/424571; O'Connor SL, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3000524; Ovsyannikova IG, 2003, CLIN DIAGN LAB IMMUN, V10, P411, DOI 10.1128/CDLI.10.3.411-416.2003; Pathan AA, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001052; Penn DJ, 2002, P NATL ACAD SCI USA, V99, P11260, DOI 10.1073/pnas.162006499; Pichla-Gollon SL, 2009, J VIROL, V83, P5567, DOI 10.1128/JVI.00405-09; Picker LJ, 2006, CURR OPIN IMMUNOL, V18, P399, DOI 10.1016/j.coi.2006.05.001; RADECKE F, 1995, EMBO J, V14, P5773, DOI 10.1002/j.1460-2075.1995.tb00266.x; Radecke F, 1997, REV MED VIROL, V7, P49, DOI 10.1002/(SICI)1099-1654(199704)7:1<49::AID-RMV181>3.0.CO;2-N; Rager-Zisman B, 2003, VACCINE, V21, P2580, DOI 10.1016/S0264-410X(03)00053-7; Rerks-Ngarm S, 2009, NEW ENGL J MED, V361, P2209, DOI 10.1056/NEJMoa0908492; Sallusto F, 1999, NATURE, V401, P708, DOI 10.1038/44385; Singh M, 1999, J GEN VIROL, V80, P101, DOI 10.1099/0022-1317-80-1-101; Singh M, 1999, J VIROL, V73, P4823, DOI 10.1128/JVI.73.6.4823-4828.1999; Stebbings R, 2005, J VIROL, V79, P12264, DOI 10.1128/JVI.79.19.12264-12272.2005; Takada A, 2008, J IMMUNOL, V180, P1678, DOI 10.4049/jimmunol.180.3.1678; Tangy F, 2005, VIRAL IMMUNOL, V18, P317, DOI 10.1089/vim.2005.18.317; Thacker EE, 2009, EXPERT REV VACCINES, V8, P761, DOI [10.1586/erv.09.29, 10.1586/ERV.09.29]; Tung J, 2012, P NATL ACAD SCI USA, V109, P6490, DOI 10.1073/pnas.1202734109; Van Braeckel E, 2011, CLIN INFECT DIS, V52, P522, DOI 10.1093/cid/ciq160; Voronin Y, 2010, CURR OPIN HIV AIDS, V5, P414, DOI 10.1097/COH.0b013e32833cfe32; Wang Z, 2001, VACCINE, V19, P2329, DOI 10.1016/S0264-410X(00)00523-5; Wiseman RW, 2007, J VIROL, V81, P349, DOI 10.1128/JVI.01841-06; Wong-Chew RM, 2003, J MED VIROL, V70, P276, DOI 10.1002/jmv.10390	63	35	35	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 30	2012	7	11							e50397	10.1371/journal.pone.0050397	http://dx.doi.org/10.1371/journal.pone.0050397			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	054WM	23226275	Green Published, Green Submitted, gold			2022-12-27	WOS:000312376100085
J	Straube, B; Green, A; Weis, S; Kircher, T				Straube, Benjamin; Green, Antonia; Weis, Susanne; Kircher, Tilo			A Supramodal Neural Network for Speech and Gesture Semantics: An fMRI Study	PLOS ONE			English	Article							SUPERIOR TEMPORAL CORTEX; SENTENCE COMPREHENSION; FUNCTIONAL-ANATOMY; ICONIC GESTURES; CORTICAL ORGANIZATION; PREFRONTAL CORTEX; MIRROR NEURONS; BRAIN ACTIVITY; HAND ACTIONS; LANGUAGE	In a natural setting, speech is often accompanied by gestures. As language, speech-accompanying iconic gestures to some extent convey semantic information. However, if comprehension of the information contained in both the auditory and visual modality depends on same or different brain-networks is quite unknown. In this fMRI study, we aimed at identifying the cortical areas engaged in supramodal processing of semantic information. BOLD changes were recorded in 18 healthy right-handed male subjects watching video clips showing an actor who either performed speech (S, acoustic) or gestures (G, visual) in more (+) or less (-) meaningful varieties. In the experimental conditions familiar speech or isolated iconic gestures were presented; during the visual control condition the volunteers watched meaningless gestures (G-), while during the acoustic control condition a foreign language was presented (S-). The conjunction of the visual and acoustic semantic processing revealed activations extending from the left inferior frontal gyrus to the precentral gyrus, and included bilateral posterior temporal regions. We conclude that proclaiming this frontotemporal network the brain's core language system is to take too narrow a view. Our results rather indicate that these regions constitute a supramodal semantic processing network.	[Straube, Benjamin; Green, Antonia; Kircher, Tilo] Univ Marburg, Dept Psychiat & Psychotherapy, Marburg, Germany; [Green, Antonia] Rhein Westfal TH Aachen, Dept Psychiat & Psychotherapy, Aachen, Germany; [Weis, Susanne] Rhein Westfal TH Aachen, Dept Neurol, Aachen, Germany; [Weis, Susanne] Univ Durham, Dept Psychol, Durham DH1 3LE, England	Philipps University Marburg; RWTH Aachen University; RWTH Aachen University; Durham University	Straube, B (corresponding author), Univ Marburg, Dept Psychiat & Psychotherapy, Marburg, Germany.	straubeb@med.uni-marburg.de	Straube, Benjamin/ABR-2656-2022; Kircher, Tilo/AAT-6480-2020; Straube, Benjamin/M-6500-2019; Straube, Benjamin/K-3126-2012	Kircher, Tilo/0000-0002-2514-2625; Straube, Benjamin/0000-0002-9837-0944; Straube, Benjamin/0000-0002-9837-0944	IZKF Aachen (Interdisciplinary Centre for Clinical Research within the faculty of Medicine at RWTH Aachen University) [VV N68-e]; DFG (Deutsche Forschungsgemeinschaft) [IRTG 1328, Ki 588/6-1]; German Federal Ministry of Education and Research (BMBF) [01GV0615]	IZKF Aachen (Interdisciplinary Centre for Clinical Research within the faculty of Medicine at RWTH Aachen University); DFG (Deutsche Forschungsgemeinschaft)(German Research Foundation (DFG)); German Federal Ministry of Education and Research (BMBF)(Federal Ministry of Education & Research (BMBF))	This research was supported by a grant from the IZKF Aachen (Interdisciplinary Centre for Clinical Research within the faculty of Medicine at RWTH Aachen University; VV N68-e) and by the DFG (Deutsche Forschungsgemeinschaft; IRTG 1328 and Ki 588/6-1). BS is supported by the German Federal Ministry of Education and Research (BMBF; project no. 01GV0615). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Beattie G, 2000, BRIT J PSYCHOL, V91, P473, DOI 10.1348/000712600161943; Biagi L, 2010, BRAIN RES BULL, V81, P434, DOI 10.1016/j.brainresbull.2009.12.002; Binder JR, 2009, CEREB CORTEX, V19, P2767, DOI 10.1093/cercor/bhp055; Bookheimer S, 2002, ANNU REV NEUROSCI, V25, P151, DOI 10.1146/annurev.neuro.25.112701.142946; Buccino G, 2001, EUR J NEUROSCI, V13, P400, DOI 10.1046/j.1460-9568.2001.01385.x; Buccino G, 2004, NEURON, V42, P323, DOI 10.1016/S0896-6273(04)00181-3; Buckner RL, 2000, BRAIN, V123, P620, DOI 10.1093/brain/123.3.620; Buxbaum LJ, 2005, COGNITIVE BRAIN RES, V25, P226, DOI 10.1016/j.cogbrainres.2005.05.014; Cabeza R, 2000, J COGNITIVE NEUROSCI, V12, P1, DOI 10.1162/08989290051137585; Chaminade T, 2005, NEUROPSYCHOLOGIA, V43, P115, DOI 10.1016/j.neuropsychologia.2004.04.026; Chong TTJ, 2008, NEUROIMAGE, V40, P298, DOI 10.1016/j.neuroimage.2007.11.030; Constable RT, 2004, NEUROIMAGE, V22, P11, DOI 10.1016/j.neuroimage.2004.01.001; Corballis MC, 2003, BEHAV BRAIN SCI, V26, P199, DOI 10.1017/S0140525X03000062; Corballis MC, 2010, BRAIN LANG, V112, P25, DOI 10.1016/j.bandl.2009.02.002; Culham JC, 2006, CURR OPIN NEUROBIOL, V16, P205, DOI 10.1016/j.conb.2006.03.005; Damasio H, 2004, COGNITION, V92, P179, DOI 10.1016/j.cognition.2002.07.001; Davare M, 2010, CURR BIOL, V20, P176, DOI 10.1016/j.cub.2009.11.063; Decety J, 1997, BRAIN, V120, P1763, DOI 10.1093/brain/120.10.1763; Decety J, 1999, TRENDS COGN SCI, V3, P172, DOI 10.1016/S1364-6613(99)01312-1; Dick AS, 2009, HUM BRAIN MAPP, V30, P3509, DOI 10.1002/hbm.20774; Eickhoff SB, 2005, NEUROIMAGE, V25, P1325, DOI 10.1016/j.neuroimage.2004.12.034; Emmorey K, 2011, BRAIN LANG, V117, P34, DOI 10.1016/j.bandl.2010.10.003; Emmorey K, 2010, NEUROIMAGE, V49, P994, DOI 10.1016/j.neuroimage.2009.08.001; Fadiga L, 2006, CORTEX, V42, P486, DOI 10.1016/S0010-9452(08)70383-6; Faillenot I, 1997, CEREB CORTEX, V7, P77, DOI 10.1093/cercor/7.1.77; FEYEREISEN P, 1988, CAH PSYCHOL COGN, V8, P3; Fiebach CJ, 2007, J COGNITIVE NEUROSCI, V19, P2035, DOI 10.1162/jocn.2007.19.12.2035; Filimon F, 2007, NEUROIMAGE, V37, P1315, DOI 10.1016/j.neuroimage.2007.06.008; Friederici AD, 2003, CEREB CORTEX, V13, P170, DOI 10.1093/cercor/13.2.170; Friston KJ, 1996, NEUROIMAGE, V4, P97, DOI 10.1006/nimg.1996.0033; Gaillard WD, 2004, NEUROLOGY, V63, P1403, DOI 10.1212/01.wnl.0000141852.65175.a7; Gentilucci M, 2006, NEUROSCI BIOBEHAV R, V30, P949, DOI 10.1016/j.neubiorev.2006.02.004; Green A, 2009, HUM BRAIN MAPP, V30, P3309, DOI 10.1002/hbm.20753; Grezes J, 2001, HUM BRAIN MAPP, V12, P1, DOI 10.1002/1097-0193(200101)12:1<1::AID-HBM10>3.0.CO;2-V; Hagoort P, 2005, TRENDS COGN SCI, V9, P416, DOI 10.1016/j.tics.2005.07.004; Hickok G, 2000, TRENDS COGN SCI, V4, P131, DOI 10.1016/S1364-6613(00)01463-7; Hickok G, 2004, COGNITION, V92, P67, DOI 10.1016/j.cognition.2003.10.011; Hickok G, 2007, NAT REV NEUROSCI, V8, P393, DOI 10.1038/nrn2113; Holle H, 2008, NEUROIMAGE, V39, P2010, DOI 10.1016/j.neuroimage.2007.10.055; Holle H, 2007, J COGNITIVE NEUROSCI, V19, P1175, DOI 10.1162/jocn.2007.19.7.1175; Holle H, 2012, FRONT PSYCHOL, V3, DOI 10.3389/fpsyg.2012.00074; Holle H, 2010, NEUROIMAGE, V49, P875, DOI 10.1016/j.neuroimage.2009.08.058; Hubbard AL, 2009, HUM BRAIN MAPP, V30, P1028, DOI 10.1002/hbm.20565; Husain FT, 2009, BRAIN RES, V1276, P140, DOI 10.1016/j.brainres.2009.04.034; Jastorff J, 2010, J NEUROPHYSIOL, V104, P128, DOI 10.1152/jn.00254.2010; Johnson-Frey SH, 2004, TRENDS COGN SCI, V8, P71, DOI 10.1016/j.tics.2003.12.002; Kelly SD, 2004, BRAIN LANG, V89, P253, DOI 10.1016/S0093-934X(03)00335-3; Kircher T, 2009, HUM BRAIN MAPP, V30, P4116, DOI 10.1002/hbm.20833; Kircher T, 2009, NEUROPSYCHOLOGIA, V47, P169, DOI 10.1016/j.neuropsychologia.2008.08.009; Kircher TTJ, 2001, ARCH GEN PSYCHIAT, V58, P769, DOI 10.1001/archpsyc.58.8.769; Kircher TTJ, 2001, NEUROPSYCHOLOGIA, V39, P798, DOI 10.1016/S0028-3932(01)00014-8; Kuperberg GR, 2008, NEUROIMAGE, V40, P367, DOI 10.1016/j.neuroimage.2007.10.009; Lindenberg R, 2007, NEUROPSYCHOLOGIA, V45, P2407, DOI 10.1016/j.neuropsychologia.2007.02.008; Lotze M, 2006, NEUROPSYCHOLOGIA, V44, P1787, DOI 10.1016/j.neuropsychologia.2006.03.016; MacSweeney M, 2002, BRAIN, V125, P1583, DOI 10.1093/brain/awf153; MacSweeney M, 2008, TRENDS COGN SCI, V12, P432, DOI 10.1016/j.tics.2008.07.010; McNeill D., 1992, HAND MIND WHAT GESTU; McNeill D, 2005, GESTURE THOUGHT, pxii; Molnar-Szakacs I, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000626; Nakamura A, 2004, NEUROIMAGE, V23, P25, DOI 10.1016/j.neuroimage.2004.04.034; Ni W, 2000, J COGNITIVE NEUROSCI, V12, P120, DOI 10.1162/08989290051137648; Nichols T, 2005, NEUROIMAGE, V25, P653, DOI 10.1016/j.neuroimage.2004.12.005; Novick JM, 2005, COGN AFFECT BEHAV NE, V5, P263, DOI 10.3758/CABN.5.3.263; Obermeier C, 2011, CORTEX; Obermeier C, 2011, THESIS M PLANCK I HU; Obermeier C, 2011, J COGNITIVE NEUROSCI, V23, P1648, DOI 10.1162/jocn.2010.21498; Obleser J, 2011, NEUROIMAGE, V56, P2310, DOI 10.1016/j.neuroimage.2011.03.035; Ozyurek A, 2007, BRAIN LANG, V101, P181, DOI 10.1016/j.bandl.2007.03.006; Ozyurek A, 2007, J COGNITIVE NEUROSCI, V19, P605, DOI 10.1162/jocn.2007.19.4.605; OLDFIELD RC, 1971, NEUROPSYCHOLOGIA, V9, P97, DOI 10.1016/0028-3932(71)90067-4; Pallier C, 2003, CEREB CORTEX, V13, P155, DOI 10.1093/cercor/13.2.155; Patterson K, 2007, NAT REV NEUROSCI, V8, P976, DOI 10.1038/nrn2277; Perani D, 1996, NEUROREPORT, V7, P2439, DOI 10.1097/00001756-199611040-00007; Pierno AC, 2009, CEREB CORTEX, V19, P367, DOI 10.1093/cercor/bhn089; Price CJ, 2010, ANN NY ACAD SCI, V1191, P62, DOI 10.1111/j.1749-6632.2010.05444.x; Sachs O, 2008, BRAIN RES, V1218, P194, DOI 10.1016/j.brainres.2008.03.045; Sachs O, 2008, NEUROPSYCHOLOGIA, V46, P409, DOI 10.1016/j.neuropsychologia.2007.08.015; Sachs O, 2011, J COGNITIVE NEUROSCI, V23, P1263, DOI 10.1162/jocn.2010.21483; Sass K, 2009, BRAIN RES, V1270, P78, DOI 10.1016/j.brainres.2009.03.013; Sass K, 2009, NEUROIMAGE, V45, P224, DOI 10.1016/j.neuroimage.2008.10.014; Schlosser MJ, 1998, HUM BRAIN MAPP, V6, P1, DOI 10.1002/(SICI)1097-0193(1998)6:1<1::AID-HBM1>3.0.CO;2-7; Slotnick SD, 2004, NAT NEUROSCI, V7, P664, DOI 10.1038/nn1252; Straube B, 2012, HUM BRAIN MAPP; Straube B, 2011, J COGNITIVE NEUROSCI, V23, P306, DOI 10.1162/jocn.2010.21505; Straube B, 2011, HUM BRAIN MAPP, V32, P520, DOI 10.1002/hbm.21041; Straube B, 2010, NEUROPSYCHOLOGIA, V48, P382, DOI 10.1016/j.neuropsychologia.2009.09.025; Straube B, 2009, J COGNITIVE NEUROSCI, V21, P821, DOI 10.1162/jocn.2009.21053; Thompson-Schill SL, 1997, P NATL ACAD SCI USA, V94, P14792, DOI 10.1073/pnas.94.26.14792; Tivarus ME, 2006, COGN BEHAV NEUROL, V19, P194; Valyear KF, 2012, J NEUROSCI, V32, P4247, DOI 10.1523/JNEUROSCI.5270-11.2012; Vandenberghe R, 2002, J COGNITIVE NEUROSCI, V14, P550, DOI 10.1162/08989290260045800; Vigneau M, 2006, NEUROIMAGE, V30, P1414, DOI 10.1016/j.neuroimage.2005.11.002; Vigneau M, 2011, NEUROIMAGE, V54, P577, DOI 10.1016/j.neuroimage.2010.07.036; Wagner AD, 2001, NEURON, V31, P329, DOI 10.1016/S0896-6273(01)00359-2; Wiggs CL, 1999, NEUROPSYCHOLOGIA, V37, P103; Willems RM, 2007, CEREB CORTEX, V17, P2322, DOI 10.1093/cercor/bhl141; Willems RM, 2009, NEUROIMAGE, V47, P1992, DOI 10.1016/j.neuroimage.2009.05.066; Wu YC, 2005, PSYCHOPHYSIOLOGY, V42, P654, DOI 10.1111/j.1469-8986.2005.00356.x; Wu YC, 2007, BRAIN LANG, V101, P234, DOI 10.1016/j.bandl.2006.12.003; Wu YC, 2007, PSYCHON B REV, V14, P57, DOI 10.3758/BF03194028; Xu J, 2009, P NATL ACAD SCI USA, V106, P20664, DOI 10.1073/pnas.0909197106	101	53	54	1	43	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 30	2012	7	11							e51207	10.1371/journal.pone.0051207	http://dx.doi.org/10.1371/journal.pone.0051207			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	054WM	23226488	Green Accepted, Green Published, Green Submitted, gold			2022-12-27	WOS:000312376100300
J	Sun, XC; Ma, P; Mumm, RH				Sun, Xiaochun; Ma, Ping; Mumm, Rita H.			Nonparametric Method for Genomics-Based Prediction of Performance of Quantitative Traits Involving Epistasis in Plant Breeding	PLOS ONE			English	Article							MARKER-ASSISTED SELECTION; GENETIC VALUES; CLASSIFICATION; MORTALITY	Genomic selection (GS) procedures have proven useful in estimating breeding value and predicting phenotype with genome-wide molecular marker information. However, issues of high dimensionality, multicollinearity, and the inability to deal effectively with epistasis can jeopardize accuracy and predictive ability. We, therefore, propose a new nonparametric method, pRKHS, which combines the features of supervised principal component analysis (SPCA) and reproducing kernel Hilbert spaces (RKHS) regression, with versions for traits with no/low epistasis, pRKHS-NE, to high epistasis, pRKHS-E. Instead of assigning a specific relationship to represent the underlying epistasis, the method maps genotype to phenotype in a nonparametric way, thus requiring fewer genetic assumptions. SPCA decreases the number of markers needed for prediction by filtering out low-signal markers with the optimal marker set determined by cross-validation. Principal components are computed from reduced marker matrix (called supervised principal components, SPC) and included in the smoothing spline ANOVA model as independent variables to fit the data. The new method was evaluated in comparison with current popular methods for practicing GS, specifically RR-BLUP, BayesA, BayesB, as well as a newer method by Crossa et al., RKHS-M, using both simulated and real data. Results demonstrate that pRKHS generally delivers greater predictive ability, particularly when epistasis impacts trait expression. Beyond prediction, the new method also facilitates inferences about the extent to which epistasis influences trait expression.	[Ma, Ping] Univ Illinois, Dept Stat, Urbana, IL 61801 USA; [Sun, Xiaochun; Mumm, Rita H.] Univ Illinois, Dept Crop Sci, Urbana, IL USA; [Sun, Xiaochun; Mumm, Rita H.] Univ Illinois, Illinois Plant Breeding Ctr, Urbana, IL USA	University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign	Ma, P (corresponding author), Univ Illinois, Dept Stat, Urbana, IL 61801 USA.	pingma@illinois.edu; ritamumm@illinois.edu	Sun, Xiaochun/J-8596-2014; Ma, Ping/M-7746-2015	Sun, Xiaochun/0000-0001-5395-2580; Ma, Ping/0000-0002-5728-3596	National Science Foundation [DMS 0800631, DMS 1055815]; Office of Science (BER), U.S. Department of Energy; Agriculture and Food Research Initiative Competitive from the USDA National Institute of Food and Agriculture [2010-85117-20532]; Hatch award [ILLU-802-354]; Monsanto Company; Direct For Mathematical & Physical Scien [0800631] Funding Source: National Science Foundation	National Science Foundation(National Science Foundation (NSF)); Office of Science (BER), U.S. Department of Energy(United States Department of Energy (DOE)); Agriculture and Food Research Initiative Competitive from the USDA National Institute of Food and Agriculture; Hatch award; Monsanto Company; Direct For Mathematical & Physical Scien(National Science Foundation (NSF)NSF - Directorate for Mathematical & Physical Sciences (MPS))	X. Sun was supported in his graduate studies as a Monsanto Fellow in Plant Breeding through a gift from Monsanto Company to the University of Illinois. P. Ma was supported by the National Science Foundation grant DMS 0800631, CAREER award DMS 1055815, and the Office of Science (BER), U.S. Department of Energy. R. H. Mumm was supported in part by the Agriculture and Food Research Initiative Competitive from the USDA National Institute of Food and Agriculture, grant award 2010-85117-20532, with additional funding from Hatch, award ILLU-802-354. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; Monsanto Company provided funding, which was used to support a fellowship (including annual stipend) for graduate student and first author XS. However, this funding was provided as a gift to the University of Illinois at Urbana-Champaign and Monsanto did not have any part in selection of XS as a fellowship awardee. Monsanto did/does not have any involvement in the conduct of this study or ownership in the data or results that were produced in the work outlined in this paper. This does not alter the authors' adherence to all the PLOS ONE policies on sharing data and materials.	Akey J, 2001, EUR J HUM GENET, V9, P291, DOI 10.1038/sj.ejhg.5200619; Bair E, 2006, J AM STAT ASSOC, V101, P119, DOI 10.1198/016214505000000628; Bennewitz J, 2009, GENET SEL EVOL, V41, DOI 10.1186/1297-9686-41-20; Bernardo R, 2007, CROP SCI, V47, P1082, DOI 10.2135/cropsci2006.11.0690; Buckler ES, 2009, SCIENCE, V325, P714, DOI 10.1126/science.1174276; Calus M P L, 2008, Genetics, V178, P553, DOI 10.1534/genetics.107.080838; COCKERHAM CC, 1954, GENETICS, V39, P859; Crossa J, 2010, GENETICS, V186, P713, DOI 10.1534/genetics.110.118521; de los Campos G, 2010, GENET RES, V92, P295, DOI 10.1017/S0016672310000285; de los Campos G, 2009, GENETICS, V182, P375, DOI 10.1534/genetics.109.101501; Dudley JW, 2009, CROP SCI, V49, P1533, DOI 10.2135/cropsci2008.08.0491er; Falconer D. S., 1996, Introduction to quantitative genetics.; Fan J., 1996, LOCAL POLYNOMIAL MOD; FERNANDO RL, 1989, GENET SEL EVOL, V21, P467, DOI 10.1051/gse:19890407; Fu Y, 2006, GENETICS, V174, P1671, DOI 10.1534/genetics.106.060376; Gianola D, 2008, GENETICS, V178, P2289, DOI 10.1534/genetics.107.084285; Gianola D, 2006, GENETICS, V173, P1761, DOI 10.1534/genetics.105.049510; Gonzalez-Recio O, 2008, GENETICS, V178, P2305, DOI 10.1534/genetics.107.084293; Gruber MHJ., 1998, IMPROVING EFFICIENCY; Gu C, 2005, ANN STAT, V33, P1357, DOI 10.1214/009053605000000110; Gu C, 2011, GSS GEN SMOOTH SPLIN; Gu C., 2002, SPR S STAT, DOI 10.1007/978-1-4757-3683-0; Habier D, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-186; Hastie T., 2009, ELEMENTS STAT LEARNI, V2nd ed.; Kosambi D. D., 1944, ANN EUGENICS, V12, P172; LANDE R, 1990, GENETICS, V124, P743; Li JH, 2011, BIOINFORMATICS, V27, P516, DOI 10.1093/bioinformatics/btq688; Long N, 2007, J ANIM BREED GENET, V124, P377, DOI 10.1111/j.1439-0388.2007.00694.x; Luan T, 2009, GENETICS, V183, P1119, DOI 10.1534/genetics.109.107391; Ma P, 2009, STAT BIOSCI, V1, P144, DOI 10.1007/s12561-009-9014-1; Macciotta NPP, 2010, J DAIRY SCI, V93, P2765, DOI 10.3168/jds.2009-3029; Macciotta Nicolo P P, 2009, BMC Proc, V3 Suppl 1, pS14; Mallick BK, 2005, J R STAT SOC B, V67, P219, DOI 10.1111/j.1467-9868.2005.00498.x; Meuwissen THE, 2001, GENETICS, V157, P1819; Nadaraya E.A., 1964, THEOR PROBAB APPL+, V9, P141, DOI [10.1137/1110024, DOI 10.1137/1109020]; Plummer M., 2006, R NEWS, V6, P7, DOI DOI 10.1159/000323281; Schulz-Streeck Torben, 2011, BMC Proc, V5 Suppl 3, pS12, DOI 10.1186/1753-6561-5-S3-S12; VanRaden PM, 2009, J DAIRY SCI, V92, P16, DOI 10.3168/jds.2008-1514; von Korff M, 2010, THEOR APPL GENET, V121, P1455, DOI 10.1007/s00122-010-1401-y; Wahba G, 1990, SOC IND APPL MATH, DOI [10.1137/1.9781611970128, DOI 10.1137/1.9781611970128]; Wang Y, 2019, SMOOTHING SPLINES ME, DOI DOI 10.1201/B10954; Watson G.S, 1964, SANKHYA A, P359, DOI DOI 10.2307/25049340; Xu SZ, 2007, GENETICS, V175, P1955, DOI 10.1534/genetics.106.066571; Xu SZ, 2003, GENETICS, V163, P789; Zeng ZB, 2005, GENETICS, V169, P1711, DOI 10.1534/genetics.104.035857	45	13	13	0	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 30	2012	7	11							e50604	10.1371/journal.pone.0050604	http://dx.doi.org/10.1371/journal.pone.0050604			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	054WM	23226325	Green Published, gold, Green Submitted			2022-12-27	WOS:000312376100137
J	Yang, CH; Wang, CY; Huang, KS; Yeh, CS; Wang, AHJ; Wang, WT; Lin, MY				Yang, Chih-Hui; Wang, Chih-Yu; Huang, Keng-Shiang; Yeh, Chen-Sheng; Wang, Andrew H. -J.; Wang, Wei-Ting; Lin, Ming-Yu			Facile Synthesis of Radial-Like Macroporous Superparamagnetic Chitosan Spheres with In-Situ Co-Precipitation and Gelation of Ferro-Gels	PLOS ONE			English	Article							BIODEGRADABLE POLYMERIC MICROSPHERES; DRUG-DELIVERY SYSTEM; PULMONARY DELIVERY; POROUS STRUCTURES; SILICA-GEL; METAL IONS; NANOPARTICLES; SCAFFOLDS; TISSUE; MICROPARTICLES	Macroporous chitosan spheres encapsulating superparamagnetic iron oxide nanoparticles were synthesized by a facile and effective one-step fabrication process. Ferro-gels containing ferrous cations, ferric cations and chitosan were dropped into a sodium hydroxide solution through a syringe pump. In addition, a sodium hydroxide solution was employed for both gelation (chitosan) and co-precipitation (ferrous cations and ferric cations) of the ferro-gels. The results showed that the in-situ co-precipitation of ferro-ions gave rise to a radial morphology with non-spheroid macro pores (large cavities) inside the chitosan spheres. The particle size of iron oxide can be adjusted from 2.5 nm to 5.4 nm by tuning the concentration of the sodium hydroxide solution. Using Fourier Transform Infrared Spectroscopy and X-ray diffraction spectra, the synthesized nanoparticles were illustrated as Fe3O4 nanoparticles. In addition, the prepared macroporous chitosan spheres presented a super-paramagnetic behaviour at room temperature with a saturation magnetization value as high as ca. 18 emu/g. The cytotoxicity was estimated using cell viability by incubating doses (0 similar to 1000 mu g/mL) of the macroporous chitosan spheres. The result showed good viability (above 80%) with alginate chitosan particles below 1000 mu g/mL, indicating that macroporous chitosan spheres were potentially useful for biomedical applications in the future.	[Yang, Chih-Hui; Wang, Wei-Ting] I Shou Univ, Dept Biol Sci Technol, Kaohsiung, Taiwan; [Wang, Chih-Yu] I Shou Univ, Dept Biomed Engn, Kaohsiung, Taiwan; [Huang, Keng-Shiang] I Shou Univ, Sch Chinese Med Postbaccalaureate, Kaohsiung, Taiwan; [Yeh, Chen-Sheng] Natl Cheng Kung Univ, Dept Chem, Tainan 70101, Taiwan; [Wang, Andrew H. -J.] Acad Sinica, Inst Biol Chem, Taipei, Taiwan; [Lin, Ming-Yu] Natl Appl Res Labs, Instrument Technol Res Ctr, Taipei, Taiwan; [Lin, Ming-Yu] Natl Chiao Tung Univ, Inst Mol Med & Bioengn, Hsinchu, Taiwan	I Shou University; I Shou University; I Shou University; National Cheng Kung University; Academia Sinica - Taiwan; National Applied Research Laboratories - Taiwan; National Yang Ming Chiao Tung University	Yang, CH (corresponding author), I Shou Univ, Dept Biol Sci Technol, Kaohsiung, Taiwan.	chyang@isu.edu.tw	HUANG, KENG-SHIANG/X-9893-2019; Yeh, Chen-Sheng/H-4347-2011	Huang, Keng-Shiang/0000-0002-7751-0223	National Science Council of Taiwan, R.O.C.	National Science Council of Taiwan, R.O.C.(Ministry of Science and Technology, Taiwan)	This work was financially supported by a grant from the National Science Council of Taiwan, R.O.C. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arami H, 2011, ADV POLYM SCI, V243, P163, DOI 10.1007/12_2011_121; Cai X, 2011, J MATER CHEM, V21, P12015, DOI 10.1039/c1jm11503k; California A, 2011, EUR POLYM J, V47, P2442, DOI 10.1016/j.eurpolymj.2011.10.005; Carn F, 2005, CHEM MATER, V17, P644, DOI 10.1021/cm048554e; Chang YC, 2006, GOLD BULL, V39, P98, DOI 10.1007/BF03215536; Costa-Pinto AR, 2011, TISSUE ENG PART B-RE, V17, P331, DOI 10.1089/ten.teb.2010.0704; Davis ME, 2002, NATURE, V417, P813, DOI 10.1038/nature00785; Deng M, 2010, ADV FUNCT MATER, V20, P2794, DOI 10.1002/adfm.201000968; Deville S, 2006, SCIENCE, V311, P515, DOI 10.1126/science.1120937; Edwards DA, 1997, SCIENCE, V276, P1868, DOI 10.1126/science.276.5320.1868; Fullana SG, 2010, ACTA BIOMATER, V6, P2294, DOI 10.1016/j.actbio.2009.11.019; Guven S, 2011, BIOMATERIALS, V32, P5801, DOI 10.1016/j.biomaterials.2011.04.064; Hortiguela MJ, 2011, BIOMACROMOLECULES, V12, P179, DOI 10.1021/bm1010883; Huang KS, 2011, SOFT MATTER, V7, P6713, DOI 10.1039/c0sm01361g; Huang KS, 2009, J CONTROL RELEASE, V137, P15, DOI 10.1016/j.jconrel.2009.02.019; Hwang JR, 1997, J CONTROL RELEASE, V49, P217; Kanai Y, 2008, IND ENG CHEM RES, V47, P3114, DOI 10.1021/ie070235k; Kievit FM, 2011, ACCOUNTS CHEM RES, V44, P853, DOI 10.1021/ar2000277; Kim HK, 2006, J CONTROL RELEASE, V112, P167, DOI 10.1016/j.jconrel.2006.02.004; Kim H, 2011, BIOMATERIALS, V32, P1685, DOI 10.1016/j.biomaterials.2010.10.045; Kim TK, 2006, BIOMATERIALS, V27, P152, DOI 10.1016/j.biomaterials.2005.05.081; Lahooti S, 2000, BIOMATERIALS, V21, P987, DOI 10.1016/S0142-9612(99)00251-3; Lee J, 2010, J CONTROL RELEASE, V146, P61, DOI 10.1016/j.jconrel.2010.05.026; Levenberg S, 2005, NAT BIOTECHNOL, V23, P879, DOI 10.1038/nbt1109; Li XL, 2011, CHEM ENG J, V178, P60, DOI 10.1016/j.cej.2011.10.012; Liu XW, 2009, LANGMUIR, V25, P3, DOI 10.1021/la802754t; Lu LC, 2011, CARBOHYD POLYM, V83, P1984, DOI 10.1016/j.carbpol.2010.11.003; NAIKWADE S, 2009, SCI PHARM, V77, P419, DOI DOI 10.3797/scipharm.0901-11; Nakanishi K, 2007, ACCOUNTS CHEM RES, V40, P863, DOI 10.1021/ar600034p; Ngah WSW, 2011, CARBOHYD POLYM, V83, P1446, DOI 10.1016/j.carbpol.2010.11.004; Odedra D, 2011, ACTA BIOMATER, V7, P3027, DOI 10.1016/j.actbio.2011.05.002; Park J, 2004, NAT MATER, V3, P891, DOI 10.1038/nmat1251; Patel MP, 2010, J PHARM PHARM SCI, V13, P536, DOI 10.18433/J3JC7C; Piao Y, 2008, ADV FUNCT MATER, V18, P3745, DOI 10.1002/adfm.200800731; Son JS, 2011, J CONTROL RELEASE, V153, P133, DOI 10.1016/j.jconrel.2011.03.010; Song WL, 2010, SOFT MATTER, V6, P5868, DOI 10.1039/c0sm00901f; Svec F, 1996, SCIENCE, V273, P205, DOI 10.1126/science.273.5272.205; Tokuyama H, 2007, LANGMUIR, V23, P11246, DOI 10.1021/la701492u; Tsapis N, 2002, P NATL ACAD SCI USA, V99, P12001, DOI 10.1073/pnas.182233999; Wang CY, 2012, BIOMATERIALS, V33, P1547, DOI 10.1016/j.biomaterials.2011.10.047; Wang ZJ, 2009, NANOTECHNOLOGY, V20, DOI 10.1088/0957-4484/20/46/465606; Wu JM, 2006, INT J BIOL MACROMOL, V39, P185, DOI 10.1016/j.ijbiomac.2006.03.017; Xi FN, 2004, J CHROMATOGR A, V1057, P41, DOI 10.1016/j.chroma.2004.09.059; Yang CH, 2009, LAB CHIP, V9, P961, DOI 10.1039/b814952f; Yang CH, 2009, LAB CHIP, V9, P145, DOI 10.1039/b807454b; Yu HT, 2010, ANGEW CHEM INT EDIT, V49, P5106, DOI 10.1002/anie.200907173; Zhang HF, 2005, NAT MATER, V4, P787, DOI 10.1038/nmat1487; Zhang L, 2001, J PHYS CHEM B, V105, P7414, DOI 10.1021/jp010174i; Zhao LL, 2011, SOFT MATTER, V7, P6144, DOI 10.1039/c1sm05305a; Zhou ZH, 2001, J MATER CHEM, V11, P1704, DOI 10.1039/b100758k	50	17	17	1	70	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 30	2012	7	11							e49329	10.1371/journal.pone.0049329	http://dx.doi.org/10.1371/journal.pone.0049329			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	054WM	23226207	Green Published, Green Submitted, gold			2022-12-27	WOS:000312376100016
J	Yu, CX; Fan, D; Lopez, A; Yin, HH				Yu, Chunxiu; Fan, David; Lopez, Alberto; Yin, Henry H.			Dynamic Changes in Single Unit Activity and Gamma Oscillations in a Thalamocortical Circuit during Rapid Instrumental Learning	PLOS ONE			English	Article							MEDIAL PREFRONTAL CORTEX; MEDIODORSAL THALAMIC NUCLEUS; BASAL GANGLIA; NEUROTOXIC LESIONS; THETA OSCILLATIONS; FRONTAL-CORTEX; RAT; ORGANIZATION; REWARD; ACQUISITION	The medial prefrontal cortex (mPFC) and mediodorsal thalamus (MD) together form a thalamocortical circuit that has been implicated in the learning and production of goal-directed actions. In this study we measured neural activity in both regions simultaneously, as rats learned to press a lever to earn food rewards. In both MD and mPFC, instrumental learning was accompanied by dramatic changes in the firing patterns of the neurons, in particular the rapid emergence of single-unit neural activity reflecting the completion of the action and reward delivery. In addition, we observed distinct patterns of changes in the oscillatory LFP response in MD and mPFC. With learning, there was a significant increase in theta band oscillations (6-10 Hz) in the MD, but not in the mPFC. By contrast, gamma band oscillations (40-55 Hz) increased in the mPFC, but not in the MD. Coherence between these two regions also changed with learning: gamma coherence in relation to reward delivery increased, whereas theta coherence did not. Together these results suggest that, as rats learned the instrumental contingency between action and outcome, the emergence of task related neural activity is accompanied by enhanced functional interaction between MD and mPFC in response to the reward feedback.	[Yu, Chunxiu; Fan, David; Lopez, Alberto; Yin, Henry H.] Duke Univ, Dept Psychol & Neurosci, Durham, NC 27708 USA; [Yin, Henry H.] Duke Univ, Dept Neurobiol, Durham, NC USA; [Yin, Henry H.] Duke Univ, Ctr Cognit Neurosci, Durham, NC USA	Duke University; Duke University; Duke University	Yin, HH (corresponding author), Duke Univ, Dept Psychol & Neurosci, Durham, NC 27708 USA.	hy43@duke.edu			Duke University	Duke University	This research was supported by Duke University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADAMS CD, 1981, Q J EXP PSYCHOL-B, V33, P109, DOI 10.1080/14640748108400816; Balleine BW, 1998, NEUROPHARMACOLOGY, V37, P407, DOI 10.1016/S0028-3908(98)00033-1; Basar E, 2000, INT J PSYCHOPHYSIOL, V35, P95, DOI 10.1016/S0167-8760(99)00047-1; Benchenane K, 2011, CURR OPIN NEUROBIOL, V21, P475, DOI 10.1016/j.conb.2011.01.004; Benchenane K, 2010, NEURON, V66, P921, DOI 10.1016/j.neuron.2010.05.013; Berke JD, 2004, NEURON, V43, P883, DOI 10.1016/j.neuron.2004.08.035; Buzsaki G, 2012, ANN REV NEUROSCI; Buzsaki G, 2012, NAT REV NEUROSCI, V13, P407, DOI 10.1038/nrn3241; Cashdollar N, 2009, P NATL ACAD SCI USA, V106, P20493, DOI 10.1073/pnas.0904823106; Corbit LH, 2003, BEHAV BRAIN RES, V146, P145, DOI 10.1016/j.bbr.2003.09.023; Corbit LH, 2003, EUR J NEUROSCI, V18, P1286, DOI 10.1046/j.1460-9568.2003.02833.x; DeCoteau WE, 2007, P NATL ACAD SCI USA, V104, P5644, DOI 10.1073/pnas.0700818104; DICKINSON A, 1985, PHILOS T ROY SOC B, V308, P67, DOI 10.1098/rstb.1985.0010; Fan D, 2012, J NEUROSCI, V32, P5534, DOI 10.1523/JNEUROSCI.5924-11.2012; Fan D, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022033; FERRON A, 1984, BRAIN RES, V302, P257, DOI 10.1016/0006-8993(84)90238-5; Floresco SB, 2003, J NEUROSCI, V23, P3930; Fries P, 2001, SCIENCE, V291, P1560, DOI 10.1126/science.1055465; GAFFAN D, 1990, J NEUROSCI, V10, P3479; GIGUERE M, 1988, J COMP NEUROL, V277, P195, DOI 10.1002/cne.902770204; GOLDMANRAKIC PS, 1985, J COMP NEUROL, V242, P535, DOI 10.1002/cne.902420406; GRILLNER S, 2005, TRENDS NEUROSCI; GROENEWEGEN HJ, 1988, NEUROSCIENCE, V24, P379, DOI 10.1016/0306-4522(88)90339-9; Haber SN, 2009, BRAIN RES BULL, V78, P69, DOI 10.1016/j.brainresbull.2008.09.013; Haddon JE, 2006, J NEUROSCI, V26, P2933, DOI 10.1523/JNEUROSCI.3243-05.2006; Hadland KA, 2003, J NEUROPHYSIOL, V89, P1161, DOI 10.1152/jn.00634.2002; Hasselmo ME, 2005, HIPPOCAMPUS, V15, P936, DOI 10.1002/hipo.20116; Herry C, 1999, J NEUROPHYSIOL, V82, P2827, DOI 10.1152/jn.1999.82.5.2827; Hunt PR, 1998, J NEUROSCI, V18, P10045; Jones MW, 2005, PLOS BIOL, V3, P2187, DOI 10.1371/journal.pbio.0030402; Killcross S, 2003, CEREB CORTEX, V13, P400, DOI 10.1093/cercor/13.4.400; Kuroda M, 1998, PROG NEUROBIOL, V54, P417, DOI 10.1016/S0301-0082(97)00070-1; Lee H, 2005, NEURON, V45, P147, DOI 10.1016/j.neuron.2004.12.025; Luk CH, 2009, J NEUROSCI, V29, P7526, DOI 10.1523/JNEUROSCI.0386-09.2009; Matsumoto K, 2003, SCIENCE, V301, P229, DOI 10.1126/science.1084204; Maurice N, 1998, J NEUROSCI, V18, P9539; Maurice N, 1998, SYNAPSE, V29, P363, DOI 10.1002/(SICI)1098-2396(199808)29:4<363::AID-SYN8>3.0.CO;2-3; MCDONALD AJ, 1991, NEUROSCIENCE, V44, P1, DOI 10.1016/0306-4522(91)90247-L; Miller EK, 2000, NAT REV NEUROSCI, V1, P59, DOI 10.1038/35036228; Mitchell AS, 2007, J NEUROSCI, V27, P11888, DOI 10.1523/JNEUROSCI.1835-07.2007; Mitchell AS, 2007, J NEUROSCI, V27, P11289, DOI 10.1523/JNEUROSCI.1914-07.2007; Ostlund SB, 2005, J NEUROSCI, V25, P7763, DOI 10.1523/JNEUROSCI.1921-05.2005; Ostlund SB, 2008, J NEUROSCI, V28, P4398, DOI 10.1523/JNEUROSCI.5472-07.2008; Paxinos G, 1998, RAT BRAIN STEROTAXIC; Pereda E, 2005, PROG NEUROBIOL, V77, P1, DOI 10.1016/j.pneurobio.2005.10.003; PIROT S, 1994, EUR J NEUROSCI, V6, P1225, DOI 10.1111/j.1460-9568.1994.tb00621.x; RAY JP, 1993, J COMP NEUROL, V337, P1, DOI 10.1002/cne.903370102; RAY JP, 1992, J COMP NEUROL, V323, P167, DOI 10.1002/cne.903230204; Ridderinkhof KR, 2004, SCIENCE, V306, P443, DOI 10.1126/science.1100301; Rushworth MFS, 2011, NEURON, V70, P1054, DOI 10.1016/j.neuron.2011.05.014; Sakkalis V, 2009, IEEE T INF TECHNOL B, V13, P433, DOI 10.1109/TITB.2008.923141; Singer W, 1999, NEURON, V24, P49, DOI 10.1016/S0896-6273(00)80821-1; van der Meer MAA, 2009, FRONT INTEGR NEUROSC, V3, DOI [10.3389/neuro.07.009.2009, 10.3389/neuro.07.001.2009]; Varela F, 2001, NAT REV NEUROSCI, V2, P229, DOI 10.1038/35067550; Yin HH, 2006, NAT REV NEUROSCI, V7, P464, DOI 10.1038/nrn1919; Yin HH, 2005, EUR J NEUROSCI, V22, P513, DOI 10.1111/j.1460-9568.2005.04218.x; Yu CX, 2010, FRONT INTEGR NEUROSC, V4, DOI 10.3389/fnint.2010.00014	57	10	11	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 30	2012	7	11							e50578	10.1371/journal.pone.0050578	http://dx.doi.org/10.1371/journal.pone.0050578			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	054WM	23226318	Green Published, Green Submitted, gold			2022-12-27	WOS:000312376100130
J	Angeletti, D; Albrecht, L; Blomqvist, K; Quintana, MD; Akhter, T; Bachle, SM; Sawyer, A; Sandalova, T; Achour, A; Wahlgren, M; Moll, K				Angeletti, Davide; Albrecht, Letusa; Blomqvist, Karin; del Pilar Quintana, Maria; Akhter, Tahmina; Bachle, Susanna M.; Sawyer, Alan; Sandalova, Tatyana; Achour, Adnane; Wahlgren, Mats; Moll, Kirsten			Plasmodium falciparum Rosetting Epitopes Converge in the SD3-Loop of PfEMP1-DBL1 alpha	PLOS ONE			English	Article							VAR GENE-TRANSCRIPTION; STRUCTURAL BASIS; INFECTED ERYTHROCYTES; ANTIGENIC VARIATION; RECEPTOR-BINDING; VARIANT ANTIGEN; IN-VIVO; MALARIA; PROTEIN; PFEMP1	The ability of Plasmodium falciparum parasitized RBC (pRBC) to form rosettes with normal RBC is linked to the virulence of the parasite and RBC polymorphisms that weaken rosetting confer protection against severe malaria. The adhesin PfEMP1 mediates the binding and specific antibodies prevent sequestration in the micro-vasculature, as seen in animal models. Here we demonstrate that epitopes targeted by rosette disrupting antibodies converge in the loop of subdomain 3 (SD3) which connects the h6 and h7 alpha-helices of PfEMP1-DBL1 alpha. Both monoclonal antibodies and polyclonal IgG, that bound to epitopes in the SD3-loop, stained the surface of pRBC, disrupted rosettes and blocked direct binding of recombinant NTS-DBL1 alpha to RBC. Depletion of polyclonal IgG raised to NTS-DBL1 alpha on a SD3 loop-peptide removed the anti-rosetting activity. Immunizations with recombinant subdomain 1 (SD1), subdomain 2 (SD2) or SD3 all generated antibodies reacting with the pRBC-surface but only the sera of animals immunized with SD3 disrupted rosettes. SD3-sequences were found to segregate phylogenetically into two groups (A/B). Group A included rosetting sequences that were associated with two cysteine-residues present in the SD2-domain while group B included those with three or more cysteines. Our results suggest that the SD3 loop of PfEMP1-DBL1 alpha is an important target of anti-rosetting activity, clarifying the molecular basis of the development of variant-specific rosette disrupting antibodies.	[Angeletti, Davide; Albrecht, Letusa; Blomqvist, Karin; del Pilar Quintana, Maria; Akhter, Tahmina; Wahlgren, Mats; Moll, Kirsten] Karolinska Inst, Dept Microbiol Tumor & Cellbiol MTC, Stockholm, Sweden; [del Pilar Quintana, Maria] Univ Rosario, Fac Ciencias Nat & Matemat, Escuela Med & Ciencias Salud, Bogota, Colombia; [Bachle, Susanna M.; Sandalova, Tatyana; Achour, Adnane] Karolinska Inst, Huddinge Hosp, Dept Med, Ctr Infect Med, S-10401 Stockholm, Sweden; [Sawyer, Alan] EMBL Monoclonal Antibodies Core Facil, Monterotondo, RM, Italy	Karolinska Institutet; Universidad del Rosario; Karolinska Institutet; European Molecular Biology Laboratory (EMBL)	Wahlgren, M (corresponding author), Karolinska Inst, Dept Microbiol Tumor & Cellbiol MTC, Stockholm, Sweden.	mats.wahlgren@ki.se; kirsten.moll@ki.se	Angeletti, Davide/H-7350-2019; Albrecht, Letusa/I-1837-2012	Angeletti, Davide/0000-0002-5256-1972; Albrecht, Letusa/0000-0001-6406-2057; Sandalova, Tatyana/0000-0002-7694-6420; Sawyer, Alan/0000-0001-5942-4498; Bachle, Susanna M/0000-0002-4237-0638; Achour, Adnane/0000-0003-0432-710X; Quintana, Maria del Pilar/0000-0001-6190-3324	Swedish Research Council (VR) [VR/2012-2014/521-2011-3377]; Swedish Academy of Sciences (KVA, Soderberg foundation); Karolinska Institutet-DPA; EU Network of Excellence EviMalar	Swedish Research Council (VR)(Swedish Research Council); Swedish Academy of Sciences (KVA, Soderberg foundation); Karolinska Institutet-DPA(Karolinska Institutet); EU Network of Excellence EviMalar	This work was supported by Swedish Research Council (VR) (grant number VR/2012-2014/521-2011-3377), The Swedish Academy of Sciences (KVA, Soderberg foundation), Karolinska Institutet-DPA and the EU Network of Excellence EviMalar. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albrecht L, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-17; Andersen P, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.0040042; [Anonymous], 2008, METHODS MALARIA RES; Barfod L, 2011, P NATL ACAD SCI USA, V108, P12485, DOI 10.1073/pnas.1103708108; Barragan A, 2000, INFECT IMMUN, V68, P2971, DOI 10.1128/IAI.68.5.2971-2975.2000; Baruch DI, 2002, P NATL ACAD SCI USA, V99, P3860, DOI 10.1073/pnas.022018399; BARUCH DI, 1995, CELL, V82, P77, DOI 10.1016/0092-8674(95)90054-3; Batchelor JD, 2011, NAT STRUCT MOL BIOL, V18, P908, DOI 10.1038/nsmb.2088; Benson Dennis A, 2005, Nucleic Acids Res, V33, pD34; Blomqvist K, 2010, MOL BIOCHEM PARASIT, V170, P74, DOI 10.1016/j.molbiopara.2009.12.002; Bull PC, 2008, MOL MICROBIOL, V68, P1519, DOI 10.1111/j.1365-2958.2008.06248.x; CARLSON J, 1992, J EXP MED, V176, P1311, DOI 10.1084/jem.176.5.1311; CARLSON J, 1994, BLOOD, V84, P3909, DOI 10.1182/blood.V84.11.3909.bloodjournal84113909; CARLSON J, 1990, LANCET, V336, P1457, DOI 10.1016/0140-6736(90)93174-N; Chen QJ, 2000, J EXP MED, V192, P1, DOI 10.1084/jem.192.1.1; Coley AM, 2007, PLOS PATHOG, V3, P1308, DOI 10.1371/journal.ppat.0030138; Dahlback M, 2006, PLOS PATHOG, V2, P1069, DOI 10.1371/journal.ppat.0020124; De Masi F, 2005, PROTEOMICS, V5, P4070, DOI 10.1002/pmic.200401279; Dondorp AM, 2008, J INFECT DIS, V197, P79, DOI 10.1086/523762; Doumbo OK, 2009, AM J TROP MED HYG, V81, P987, DOI 10.4269/ajtmh.2009.09-0406; Fairhurst RM, 2005, NATURE, V435, P1117, DOI 10.1038/nature03631; FANDEUR T, 1995, J EXP MED, V181, P283, DOI 10.1084/jem.181.1.283; Gardner MJ, 2002, NATURE, V419, P498, DOI 10.1038/nature01097; Ghumra A, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002665; Hayes CN, 2008, BIOINFORMATICS, V24, P2564, DOI 10.1093/bioinformatics/btn477; Heddini A, 2001, INFECT IMMUN, V69, P5849, DOI 10.1128/IAI.69.9.5849-5856.2001; Huson DH, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-460; Juillerat A, 2011, P NATL ACAD SCI USA, V108, P5243, DOI 10.1073/pnas.1018692108; KAUL DK, 1991, BLOOD, V78, P812; Kelley LA, 2009, NAT PROTOC, V4, P363, DOI 10.1038/nprot.2009.2; Kirchgatter K, 2002, MOL MED, V8, P16, DOI 10.1007/BF03401999; Kraemer SM, 2006, CURR OPIN MICROBIOL, V9, P374, DOI 10.1016/j.mib.2006.06.006; Mayor A, 2005, BLOOD, V105, P2557, DOI 10.1182/blood-2004-05-1722; Miller LH, 2002, NATURE, V415, P673, DOI 10.1038/415673a; Normark J, 2007, P NATL ACAD SCI USA, V104, P15835, DOI 10.1073/pnas.0610485104; Pinto VV, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017942; Rask TS, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000933; ROWE A, 1995, INFECT IMMUN, V63, P2323, DOI 10.1128/IAI.63.6.2323-2326.1995; Rowe JA, 2007, P NATL ACAD SCI USA, V104, P17471, DOI 10.1073/pnas.0705390104; Rowe JA, 2002, AM J TROP MED HYG, V66, P692, DOI 10.4269/ajtmh.2002.66.692; Rowe JA, 1997, NATURE, V388, P292, DOI 10.1038/40888; Scherf A, 2008, ANNU REV MICROBIOL, V62, P445, DOI 10.1146/annurev.micro.61.080706.093134; Scholander C, 1996, NAT MED, V2, P204, DOI 10.1038/nm0296-204; Siddiqui AA, 2012, INFECT IMMUN, V80, P2920, DOI 10.1128/IAI.00206-12; Singh K, 2010, J BIOL CHEM, V285, P24855, DOI 10.1074/jbc.M110.118612; Singh SK, 2006, NATURE, V439, P741, DOI 10.1038/nature04443; Smith J D, 1995, Cell, V82, P101; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Taylor HM, 2000, MOL BIOCHEM PARASIT, V105, P13, DOI 10.1016/S0166-6851(99)00159-0; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Tolia NH, 2005, CELL, V122, P183, DOI 10.1016/j.cell.2005.05.033; Treutiger CJ, 1999, EXP PARASITOL, V93, P215, DOI 10.1006/expr.1999.4454; TREUTIGER CJ, 1992, AM J TROP MED HYG, V46, P503, DOI 10.4269/ajtmh.1992.46.503; Vigan-Womas I, 2008, INFECT IMMUN, V76, P5565, DOI 10.1128/IAI.00901-08; Vigan-Womas I, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016544; Vogt AM, 2003, BLOOD, V101, P2405, DOI 10.1182/blood-2002-07-2016; Vogt AM, 2006, PLOS PATHOG, V2, P853, DOI 10.1371/journal.ppat.0020100; WILSON IA, 1990, ANNU REV IMMUNOL, V8, P737, DOI 10.1146/annurev.iy.08.040190.003513; Wyatt R, 1998, NATURE, V393, P705, DOI 10.1038/31514	59	15	15	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 5	2012	7	12							e50758	10.1371/journal.pone.0050758	http://dx.doi.org/10.1371/journal.pone.0050758			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	057TZ	23227205	Green Published, gold, Green Accepted			2022-12-27	WOS:000312588200064
J	Maneshi, M; Moeller, F; Fahoum, F; Gotman, J; Grova, C				Maneshi, Mona; Moeller, Friederike; Fahoum, Firas; Gotman, Jean; Grova, Christophe			Resting-State Connectivity of the Sustained Attention Network Correlates with Disease Duration in Idiopathic Generalized Epilepsy	PLOS ONE			English	Article							JUVENILE MYOCLONIC EPILEPSY; FUNCTIONAL CONNECTIVITY; GLOBAL SIGNAL; COGNITIVE DYSFUNCTION; COMPONENT ANALYSIS; SIMULTANEOUS EEG; WAVE DISCHARGES; HUMAN BRAIN; FMRI; PERFORMANCE	Introduction: In idiopathic generalized epilepsy (IGE), a normal electroencephalogram between generalized spike and wave (GSW) discharges is believed to reflect normal brain function. However, some studies indicate that even excluding GSW-related errors, IGE patients perform poorly on sustained attention task, the deficit being worse as a function of disease duration. We hypothesized that at least in a subset of structures which are normally involved in sustained attention, resting-state functional connectivity (FC) is different in IGE patients compared to controls and that some of the changes are related to disease duration. Method: Seeds were selected based on a sustained attention study in controls. Resting-state functional magnetic resonance imaging (fMRI) data was obtained from 14 IGE patients and 14 matched controls. After physiological noise removal, the mean time-series of each seed was used as a regressor in a general linear model to detect regions that showed correlation with the seed. In patients, duration factor was defined based on epilepsy duration. Between-group differences weighted by the duration factor were evaluated with mixed-effects model. Correlation was then evaluated in IGE patients between the FC, averaged over each significant cluster, and the duration factor. Results: Eight of 18 seeds showed significant difference in FC across groups. However, only for seeds in the medial superior frontal and precentral gyri and in the medial prefrontal area, average FC taken over significant clusters showed high correlation with the duration factor. These 3 seeds showed changes in FC respectively with the premotor and superior frontal gyrus, the dorsal premotor, and the supplementary motor area plus precentral gyrus. Conclusion: Alterations of FC in IGE patients are not limited to the frontal areas. However, as indicated by specificity analysis, patients with long history of disease show changes in FC mainly within the frontal areas. Citation: Maneshi M, Moeller F, Fahoum F, Gotman J, Grova C (2012) Resting-State Connectivity of the Sustained Attention Network Correlates with Disease Duration in Idiopathic Generalized Epilepsy. PLoS ONE 7(12): e50359. doi:10.1371/journal.pone.0050359	[Maneshi, Mona; Moeller, Friederike; Fahoum, Firas; Gotman, Jean; Grova, Christophe] McGill Univ, Montreal Neurol Inst & Hosp, Montreal, PQ, Canada; [Grova, Christophe] McGill Univ, Dept Biomed Engn, Montreal, PQ, Canada; [Moeller, Friederike] Univ Kiel, Dept Neuropediat, Kiel, Germany	McGill University; McGill University; University of Kiel	Maneshi, M (corresponding author), McGill Univ, Montreal Neurol Inst & Hosp, Montreal, PQ, Canada.	mona.maneshi@mail.mcgill.ca	Fahoum, Firas/AFJ-8624-2022	Fahoum, Firas/0000-0003-2262-5530; Grova, Christophe/0000-0003-2775-9968; Moeller, Friederike/0000-0003-2434-2825	Canadian Institutes of Health Research [MOP-38079]; Fonds de Recherche en Sante du Quebec (FRSQ)	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Fonds de Recherche en Sante du Quebec (FRSQ)(Fonds de la Recherche en Sante du Quebec)	This work was supported by grant MOP-38079 from the Canadian Institutes of Health Research (http://www.cihr-irsc.gc.ca/). Dr. C. Grova was supported by a salary award from Fonds de Recherche en Sante du Quebec (FRSQ). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adler CM, 2001, SYNAPSE, V42, P266, DOI 10.1002/syn.1112; Allen PJ, 2000, NEUROIMAGE, V12, P230, DOI 10.1006/nimg.2000.0599; Archer JS, 2006, EPILEPSIA, V47, P1487, DOI 10.1111/j.1528-1167.2006.00620.x; Ballard JC, 2001, J CLIN EXP NEUROPSYC, V23, P331, DOI 10.1076/jcen.23.3.331.1188; Beckmann CF, 2003, NEUROIMAGE, V20, P1052, DOI 10.1016/S1053-8119(03)00435-X; Bellec P, 2010, NEUROIMAGE, V51, P1126, DOI 10.1016/j.neuroimage.2010.02.082; Benar CG, 2003, CLIN NEUROPHYSIOL, V114, P569, DOI 10.1016/S1388-2457(02)00383-8; Berman R, 2010, EPILEPSIA, V51, P2011, DOI 10.1111/j.1528-1167.2010.02652.x; BISWAL B, 1995, MAGNET RESON MED, V34, P537, DOI 10.1002/mrm.1910340409; Blumenfeld H, 2003, EPILEPSIA, V44, P7, DOI 10.1046/j.1528-1157.44.s.2.2.x; COLLINS DL, 1994, J COMPUT ASSIST TOMO, V18, P192, DOI 10.1097/00004728-199403000-00005; CONNERS CK, 1985, PSYCHOPHARMACOL BULL, V21, P891; Damoiseaux JS, 2006, P NATL ACAD SCI USA, V103, P13848, DOI 10.1073/pnas.0601417103; Desikan RS, 2006, NEUROIMAGE, V31, P968, DOI 10.1016/j.neuroimage.2006.01.021; Desjardins AE, 2001, NEUROIMAGE, V13, P751, DOI 10.1006/nimg.2000.0719; Eickhoff SB, 2005, NEUROIMAGE, V25, P1325, DOI 10.1016/j.neuroimage.2004.12.034; Fox MD, 2005, P NATL ACAD SCI USA, V102, P9673, DOI 10.1073/pnas.0504136102; Fox MD, 2010, FRONT SYST NEUROSCI, V4, DOI [10.3389/fnsys.2010.00019, 10.3389/fnsys.2010.0001]; Fox MD, 2009, J NEUROPHYSIOL, V101, P3270, DOI 10.1152/jn.90777.2008; Pascalicchio TF, 2007, EPILEPSY BEHAV, V10, P263, DOI 10.1016/j.yebeh.2006.11.012; FRISTON KJ, 1993, J CEREBR BLOOD F MET, V13, P5, DOI 10.1038/jcbfm.1993.4; Gotman J, 2005, P NATL ACAD SCI USA, V102, P15236, DOI 10.1073/pnas.0504935102; Hamandi K, 2006, NEUROIMAGE, V31, P1700, DOI 10.1016/j.neuroimage.2006.02.016; Jenkinson M, 2002, NEUROIMAGE, V17, P825, DOI 10.1006/nimg.2002.1132; Killory BD, 2011, NEUROIMAGE, V56, P2209, DOI 10.1016/j.neuroimage.2011.03.036; Kim J, 2006, NEUROIMAGE, V31, P376, DOI 10.1016/j.neuroimage.2005.11.035; KOSTOPOULOS G, 1983, BRAIN RES, V278, P207, DOI 10.1016/0006-8993(83)90239-1; Kruger G, 2001, MAGNET RESON MED, V46, P631, DOI 10.1002/mrm.1240; LANSDELL H, 1964, EXP NEUROL, V9, P463, DOI 10.1016/0014-4886(64)90054-8; Laufs H, 2006, EPILEPSIA, V47, P444, DOI 10.1111/j.1528-1167.2006.00443.x; Lund TE, 2001, MAGNET RESON MED, V46, P628, DOI 10.1002/mrm.1238; Lund TE, 2006, NEUROIMAGE, V29, P54, DOI 10.1016/j.neuroimage.2005.07.005; Luo C, 2011, HUM BRAIN MAPP, V32, P438, DOI 10.1002/hbm.21034; Macey PM, 2004, NEUROIMAGE, V22, P360, DOI 10.1016/j.neuroimage.2003.12.042; Mattson RH, 2003, EPILEPSIA, V44, P2, DOI 10.1046/j.1528-1157.44.s.2.3.x; Maxwell SE, 2003, DESIGNING EXPT ANAL, DOI DOI 10.1158/2159-8290.CD-16-0040; McKeown MJ, 1998, HUM BRAIN MAPP, V6, P160, DOI 10.1002/(SICI)1097-0193(1998)6:3<160::AID-HBM5>3.0.CO;2-1; MIRSKY AF, 1965, ELECTROEN CLIN NEURO, V18, P334, DOI 10.1016/0013-4694(65)90053-2; MIRSKY AF, 1960, EXP NEUROL, V2, P75, DOI 10.1016/0014-4886(60)90049-2; Mirsky AF, 2002, NEUROPSYCHOLOGY CHIL, P141; Moeller F, 2011, EPILEPSIA, V52, P515, DOI 10.1111/j.1528-1167.2010.02938.x; Murphy K, 2009, NEUROIMAGE, V44, P893, DOI 10.1016/j.neuroimage.2008.09.036; O'Muircheartaigh J, 2011, NEUROLOGY, V76, P34, DOI 10.1212/WNL.0b013e318203e93d; Ogg RJ, 2008, MAGN RESON IMAGING, V26, P504, DOI 10.1016/j.mri.2007.09.004; Perlbarg V, 2008, INT J BIOMED IMAGING, V2008, DOI 10.1155/2008/218519; Piazzini A, 2008, EPILEPSIA, V49, P657, DOI 10.1111/j.1528-1167.2007.01482.x; Savic I, 2000, EPILEPSIA, V41, P290, DOI 10.1111/j.1528-1157.2000.tb00158.x; Shehzad Z, 2009, CEREB CORTEX, V19, P2209, DOI 10.1093/cercor/bhn256; Smith SM, 2002, HUM BRAIN MAPP, V17, P143, DOI 10.1002/hbm.10062; Smith SM, 2004, BRIT J RADIOL, V77, pS167, DOI 10.1259/bjr/33553595; Smith SM, 2004, NEUROIMAGE, V23, pS208, DOI 10.1016/j.neuroimage.2004.07.051; Song M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017294; Srivastava G, 2005, NEUROIMAGE, V24, P50, DOI 10.1016/j.neuroimage.2004.09.041; Tae WS, 2006, KOREAN J RADIOL, V7, P162, DOI 10.3348/kjr.2006.7.3.162; Tana M G, 2010, Comput Intell Neurosci, P329213, DOI 10.1155/2010/329213; Uddin LQ, 2009, HUM BRAIN MAPP, V30, P625, DOI 10.1002/hbm.20531; Vahdat S, 2011, J NEUROSCI, V31, P16907, DOI 10.1523/JNEUROSCI.2737-11.2011; van de Ven VG, 2004, HUM BRAIN MAPP, V22, P165, DOI 10.1002/hbm.20022; Vlooswijk MCG, 2010, LANCET NEUROL, V9, P1018, DOI 10.1016/S1474-4422(10)70180-0; Vollmar C, 2011, BRAIN, V134, P1710, DOI 10.1093/brain/awr098; Wandschneider B, 2010, NEUROLOGY, V75, P2161, DOI 10.1212/WNL.0b013e318202010a; Wang ZG, 2011, BRAIN RES, V1374, P134, DOI 10.1016/j.brainres.2010.12.034; Weissenbacher A, 2009, NEUROIMAGE, V47, P1408, DOI 10.1016/j.neuroimage.2009.05.005; Woermann FG, 1999, BRAIN, V122, P2101, DOI 10.1093/brain/122.11.2101; Woodward ND, 2011, SCHIZOPHR RES, V130, P86, DOI 10.1016/j.schres.2011.03.010; Woolrich MW, 2009, NEUROIMAGE, V45, pS173, DOI 10.1016/j.neuroimage.2008.10.055; Zhang YY, 2001, IEEE T MED IMAGING, V20, P45, DOI 10.1109/42.906424	67	20	20	2	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 5	2012	7	12							e50359	10.1371/journal.pone.0050359	http://dx.doi.org/10.1371/journal.pone.0050359			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	057TZ	23227168	gold, Green Published, Green Submitted			2022-12-27	WOS:000312588200029
J	Polachini, GM; Sobral, LM; Mercante, AMC; Paes-Leme, AF; Xavier, FCA; Henrique, T; Guimaraes, DM; Vidotto, A; Fukuyama, EE; Gois, JF; Cury, PM; Curioni, OA; Michaluart, P; Silva, AMA; Wunsch, V; Nunes, FD; Leopoldino, AM; Tajara, EH				Polachini, Giovana M.; Sobral, Lays M.; Mercante, Ana M. C.; Paes-Leme, Adriana F.; Xavier, Flavia C. A.; Henrique, Tiago; Guimaraes, Douglas M.; Vidotto, Alessandra; Fukuyama, Erica E.; Gois-Filho, Jose F.; Cury, Patricia M.; Curioni, Otavio A.; Michaluart, Pedro, Jr.; Silva, Adriana M. A.; Wuensch-Filho, Victor; Nunes, Fabio D.; Leopoldino, Andreia M.; Tajara, Eloiza H.			Proteomic Approaches Identify Members of Cofilin Pathway Involved in Oral Tumorigenesis	PLOS ONE			English	Article							SQUAMOUS-CELL CARCINOMA; MOLECULAR-BIOLOGY; HEAD; ACTIN; EXPRESSION; PROTEINS; TISSUE; INVASION; COMPLEX; CAVITY	The prediction of tumor behavior for patients with oral carcinomas remains a challenge for clinicians. The presence of lymph node metastasis is the most important prognostic factor but it is limited in predicting local relapse or survival. This highlights the need for identifying biomarkers that may effectively contribute to prediction of recurrence and tumor spread. In this study, we used one-and two-dimensional gel electrophoresis, mass spectrometry and immunodetection methods to analyze protein expression in oral squamous cell carcinomas. Using a refinement for classifying oral carcinomas in regard to prognosis, we analyzed small but lymph node metastasis-positive versus large, lymph node metastasis-negative tumors in order to contribute to the molecular characterization of subgroups with risk of dissemination. Specific protein patterns favoring metastasis were observed in the "more-aggressive'' group defined by the present study. This group displayed upregulation of proteins involved in migration, adhesion, angiogenesis, cell cycle regulation, anti-apoptosis and epithelial to mesenchymal transition, whereas the "less-aggressive'' group was engaged in keratinocyte differentiation, epidermis development, inflammation and immune response. Besides the identification of several proteins not yet described as deregulated in oral carcinomas, the present study demonstrated for the first time the role of cofilin-1 in modulating cell invasion in oral carcinomas.	[Polachini, Giovana M.; Henrique, Tiago; Vidotto, Alessandra; Tajara, Eloiza H.] Fac Med FAMERP, Dept Biol Mol, Sao Jose Do Rio Preto, SP, Brazil; [Sobral, Lays M.; Leopoldino, Andreia M.] Univ Sao Paulo, Fac Ciencias Farmaceut, Dept Anal Clin Toxicol & Bromatol, BR-14049 Ribeirao Preto, SP, Brazil; [Mercante, Ana M. C.] Hosp Heliopolis, Lab Patol, Sao Paulo, Brazil; [Paes-Leme, Adriana F.] Ctr Nacl Pesquisa Energia & Mat, Lab Nacl Biociencias LNBio, Campinas, SP, Brazil; [Xavier, Flavia C. A.] Univ Fed Bahia, Fac Odontol, Dept Propedeut, Salvador, BA, Brazil; [Xavier, Flavia C. A.] Univ Fed Bahia, Fac Odontol, Clin Integrada, Salvador, BA, Brazil; [Guimaraes, Douglas M.; Nunes, Fabio D.] Univ Sao Paulo, Fac Odontol, Dept Estomatol, Sao Paulo, Brazil; [Fukuyama, Erica E.; Gois-Filho, Jose F.] Inst Canc Arnaldo Vieira de Carvalho, Serv Cirurgia Cabeca & Pescoc, Sao Paulo, Brazil; [Cury, Patricia M.] Fac Med FAMERP, Dept Patol & Med Legal, Sao Jose Do Rio Preto, SP, Brazil; [Curioni, Otavio A.] Hosp Heliopolis, Dept Cirurgia Cabeca & Pescoc & Otorrinolaringol, Sao Paulo, Brazil; [Michaluart, Pedro, Jr.] Univ Sao Paulo, Fac Med, Dept Cirurgia, Div Cirurgia Cabeca & Pescoc, Sao Paulo, Brazil; [Silva, Adriana M. A.] Univ Fed Espirito Santo, Dept Prod Vegetal, Vitoria, ES, Brazil; [Wuensch-Filho, Victor] Univ Sao Paulo, Fac Saude Publ, Dept Epidemiol, BR-01255 Sao Paulo, Brazil; [Tajara, Eloiza H.] Univ Sao Paulo, Inst Biociencias, Dept Genet & Biol Evolut, Sao Paulo, Brazil	Universidade de Sao Paulo; Faculdade de Medicina de Sao Jose do Rio Preto (FAMERP); Universidade de Sao Paulo; Universidade Federal da Bahia; Universidade Federal da Bahia; Universidade de Sao Paulo; Universidade de Sao Paulo; Faculdade de Medicina de Sao Jose do Rio Preto (FAMERP); Universidade de Sao Paulo; Universidade Federal do Espirito Santo; Universidade de Sao Paulo; Universidade de Sao Paulo	Tajara, EH (corresponding author), Fac Med FAMERP, Dept Biol Mol, Sao Jose Do Rio Preto, SP, Brazil.	tajara@famerp.br	Filho, Victor Wunsch/C-4475-2012; Leopoldino, Andreia M/E-9926-2012; Guimaraes, Douglas/AAP-8971-2021; Henrique, Tiago/B-7512-2013; Nunes, Fabio Daumas/B-4543-2011; Tajara, Eloiza H/G-7586-2012; Cury, Patricia/GRX-5489-2022; Álvares-da-Silva, Adriana M/J-2912-2018; Leme, Adriana F Paes/C-9679-2012; Henrique, Tiago/B-4160-2014; Xavier, Flávia C/G-1501-2012; Xavier, Flávia/ABB-4632-2020; Henrique, Tiago/O-1969-2019; Guimaraes, Douglas/GXZ-9821-2022; Sobral, Lays M/G-4831-2012	Leopoldino, Andreia M/0000-0002-8313-4754; Guimaraes, Douglas/0000-0001-7856-1324; Nunes, Fabio Daumas/0000-0002-7785-6785; Tajara, Eloiza H/0000-0002-2603-2057; Álvares-da-Silva, Adriana M/0000-0002-8078-0304; Leme, Adriana F Paes/0000-0001-7959-147X; Xavier, Flávia/0000-0002-0199-6503; Henrique, Tiago/0000-0001-9100-539X; Sobral, Lays M/0000-0002-8731-850X	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo/FAPESP; Rede Proteoma do Estado de Sao Paulo; Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior/CAPES; Conselho Nacional de Pesquisas/CNPq	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo/FAPESP(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); Rede Proteoma do Estado de Sao Paulo; Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior/CAPES(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); Conselho Nacional de Pesquisas/CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	Funding was provided by Fundacao de Amparo a Pesquisa do Estado de Sao Paulo/FAPESP, Rede Proteoma do Estado de Sao Paulo, Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior/CAPES and Conselho Nacional de Pesquisas/CNPq, through financial support and fellowships. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANNEROTH G, 1987, SCAND J DENT RES, V95, P229; Argiris A, 2008, LANCET, V371, P1695, DOI 10.1016/S0140-6736(08)60728-X; Bello IO, 2010, ORAL ONCOL, V46, P636, DOI 10.1016/j.oraloncology.2010.06.008; Bentz BG, 2000, LARYNGOSCOPE, V110, P1642, DOI 10.1097/00005537-200010000-00013; Bockmuhl U, 2002, GENE CHROMOSOME CANC, V33, P29, DOI 10.1002/gcc.1209.abs; Bragulla HH, 2009, J ANAT, V214, P516, DOI 10.1111/j.1469-7580.2009.01066.x; Bryce NS, 2003, MOL BIOL CELL, V14, P1002, DOI 10.1091/mbc.E02-04-0244; Bueno PR, 1998, HEAD NECK-J SCI SPEC, V20, P232, DOI 10.1002/(SICI)1097-0347(199805)20:3<232::AID-HED8>3.0.CO;2-1; Chan C, 2009, CURR BIOL, V19, P537, DOI 10.1016/j.cub.2009.02.060; Chaudhry F, 2010, CYTOSKELETON, V67, P120, DOI 10.1002/cm.20429; Chhabra D, 2005, BIOPHYS J, V89, P1902, DOI 10.1529/biophysj.105.062083; Chung CH, 2006, CANCER RES, V66, P8210, DOI 10.1158/0008-5472.CAN-06-1213; Cutillas PR, 2005, MOL CELL PROTEOMICS, V4, P1038, DOI 10.1074/mcp.M500078-MCP200; de Lanerolle P, 2011, NAT CELL BIOL, V13, P1282, DOI 10.1038/ncb2364; de Marqui ABT, 2006, J BIOCHEM MOL BIOL, V39, P216; De Wever O, 2003, J PATHOL, V200, P429, DOI 10.1002/path.1398; Eming SA, 2010, J PROTEOME RES, V9, P4758, DOI 10.1021/pr100456d; Escalante T, 2009, J PROTEOME RES, V8, P5120, DOI 10.1021/pr900489m; Freeman SN, 2011, J IMMUNOL, V187, P5887, DOI 10.4049/jimmunol.1102233; Gimona M, 2008, SEMIN CANCER BIOL, V18, P23, DOI 10.1016/j.semcancer.2007.08.005; Goley ED, 2006, NAT REV MOL CELL BIO, V7, P713, DOI 10.1038/nrm2026; Hadler-Olsen E, 2010, VIRCHOWS ARCH, V457, P677, DOI 10.1007/s00428-010-0980-y; Hanahan D, 2000, CELL, V100, P57, DOI 10.1016/S0092-8674(00)81683-9; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; He YL, 2005, CANCER RES, V65, P4739, DOI 10.1158/0008-5472.CAN-04-4576; Huang Q, 2002, GENE CHROMOSOME CANC, V34, P224, DOI 10.1002/gcc.10062; Huang SH, 2009, CANCER-AM CANCER SOC, V115, P1489, DOI 10.1002/cncr.24161; Kainuma K, 2006, ACTA OTO-LARYNGOL, V126, P967, DOI 10.1080/00016480500546367; Kawashiri S, 2009, HEAD NECK-J SCI SPEC, V31, P1346, DOI 10.1002/hed.21097; Kelley LC, 2008, CLIN EXP METASTAS, V25, P289, DOI 10.1007/s10585-008-9154-6; Kligys K, 2007, J BIOL CHEM, V282, P32520, DOI 10.1074/jbc.M707041200; Koehn J, 2008, J PROTEOME RES, V7, P3818, DOI 10.1021/pr800077a; Kremer BE, 2007, CELL, V130, P837, DOI 10.1016/j.cell.2007.06.053; Kurtz KA, 2005, ARCH PATHOL LAB MED, V129, P354; Leemans CR, 2011, NAT REV CANCER, V11, P9, DOI 10.1038/nrc2982; Li R, 2006, FASEB J, V20, P1218, DOI 10.1096/fj.05-5258fje; Linder S, 2011, ANNU REV CELL DEV BI, V27, P185, DOI 10.1146/annurev-cellbio-092910-154216; Mayland MK, 2005, LARYNGOSCOPE, V115, P629, DOI 10.1097/01.mlg.0000161338.54515.b1; Naresh KN, 2001, CANCER, V91, P578, DOI 10.1002/1097-0142(20010201)91:3<578::AID-CNCR1037>3.3.CO;2-N; Oser M, 2009, J CELL BIOCHEM, V108, P1252, DOI 10.1002/jcb.22372; Leme AFP, 2012, J PROTEOME RES, V11, P279, DOI 10.1021/pr2006439; Patel V, 2008, CLIN CANCER RES, V14, P1002, DOI 10.1158/1078-0432.CCR-07-1497; Peng XC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027309; Pollard TD, 2009, SCIENCE, V326, P1208, DOI 10.1126/science.1175862; Poukkula M, 2011, CYTOSKELETON, V68, P471, DOI 10.1002/cm.20530; Riedel F, 2001, ONCOL REP, V8, P471; Roepman P, 2005, NAT GENET, V37, P182, DOI 10.1038/ng1502; Schaaij-Visser TBM, 2009, CLIN CANCER RES, V15, P7666, DOI 10.1158/1078-0432.CCR-09-2134; Sedivy R, 2003, J ORAL PATHOL MED, V32, P455, DOI 10.1034/j.1600-0714.2003.00168.x; Sobin, 2009, UICC TNM CLASSIFICAT; Stadler ME, 2008, HEMATOL ONCOL CLIN N, V22, P1099, DOI 10.1016/j.hoc.2008.08.007; Thiery JP, 2002, NAT REV CANCER, V2, P442, DOI 10.1038/nrc822; Turhani D, 2006, ELECTROPHORESIS, V27, P1417, DOI 10.1002/elps.200500510; Van Troys M, 2008, EUR J CELL BIOL, V87, P649, DOI 10.1016/j.ejcb.2008.04.001; Wang WG, 2007, NAT REV CANCER, V7, P429, DOI 10.1038/nrc2148; Wang YF, 2011, ONCOL REP, V26, P1595, DOI 10.3892/or.2011.1447; Wang Z, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-383; Wong YK, 2003, J ORAL MAXIL SURG, V61, P1257, DOI 10.1016/S0278-2391(03)00725-0; Woolgar JA, 2009, ORAL ONCOL, V45, P361, DOI 10.1016/j.oraloncology.2008.07.016; Yamaguchi H, 2005, J CELL BIOL, V168, P441, DOI 10.1083/jcb.200407076; Zhang Y, 2010, J INT MED RES, V38, P1042, DOI 10.1177/147323001003800331	61	23	25	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 5	2012	7	12							e50517	10.1371/journal.pone.0050517	http://dx.doi.org/10.1371/journal.pone.0050517			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	057TZ	23227181	Green Published, Green Submitted, gold			2022-12-27	WOS:000312588200041
J	Song, J; Desphande, AS; Meier, TB; Tudorascu, DL; Vergun, S; Nair, VA; Biswal, BB; Meyerand, ME; Birn, RM; Bellec, P; Prabhakaran, V				Song, Jie; Desphande, Alok S.; Meier, Timothy B.; Tudorascu, Dana L.; Vergun, Svyatoslav; Nair, Veena A.; Biswal, Bharat B.; Meyerand, Mary E.; Birn, Rasmus M.; Bellec, Pierre; Prabhakaran, Vivek			Age-Related Differences in Test-Retest Reliability in Resting-State Brain Functional Connectivity	PLOS ONE			English	Article							INDEPENDENT COMPONENT ANALYSIS; GLOBAL SIGNAL REGRESSION; FMRI DATA; DEFAULT NETWORK; IMAGES; MRI; ANTICORRELATIONS; SCHIZOPHRENIA; FLUCTUATIONS; OPTIMIZATION	Resting-state functional MRI (rs-fMRI) has emerged as a powerful tool for investigating brain functional connectivity (FC). Research in recent years has focused on assessing the reliability of FC across younger subjects within and between scan-sessions. Test-retest reliability in resting-state functional connectivity (RSFC) has not yet been examined in older adults. In this study, we investigated age-related differences in reliability and stability of RSFC across scans. In addition, we examined how global signal regression (GSR) affects RSFC reliability and stability. Three separate resting-state scans from 29 younger adults (18-35 yrs) and 26 older adults (55-85 yrs) were obtained from the International Consortium for Brain Mapping (ICBM) dataset made publically available as part of the 1000 Functional Connectomes project www.nitrc.org/projects/fcon_1000.92 regions of interest (ROIs) with 5 cubic mm radius, derived from the default, cingulo-opercular, fronto-parietal and sensorimotor networks, were previously defined based on a recent study. Mean time series were extracted from each of the 92 ROIs from each scan and three matrices of z-transformed correlation coefficients were created for each subject, which were then used for evaluation of multi-scan reliability and stability. The young group showed higher reliability of RSFC than the old group with GSR (p-value = 0.028) and without GSR (p-value < 0.001). Both groups showed a high degree of multi-scan stability of RSFC and no significant differences were found between groups. By comparing the test-retest reliability of RSFC with and without GSR across scans, we found significantly higher proportion of reliable connections in both groups without GSR, but decreased stability. Our results suggest that aging is associated with reduced reliability of RSFC which itself is highly stable within-subject across scans for both groups, and that GSR reduces the overall reliability but increases the stability in both age groups and could potentially alter group differences of RSFC.	[Song, Jie; Meyerand, Mary E.] Univ Wisconsin Madison, Dept Biomed Engn, Madison, WI USA; [Desphande, Alok S.] Univ Wisconsin Madison, Dept Elec & Comp Engn, Madison, WI USA; [Meier, Timothy B.; Prabhakaran, Vivek] Univ Wisconsin Madison, Neurosci Training Program, Madison, WI USA; [Tudorascu, Dana L.] Univ Pittsburgh, Dept Med, Pittsburgh, PA USA; [Vergun, Svyatoslav; Meyerand, Mary E.] Univ Wisconsin Madison, Dept Med Phys, Madison, WI USA; [Nair, Veena A.; Prabhakaran, Vivek] Univ Wisconsin Madison, Dept Radiol, Madison, WI USA; [Biswal, Bharat B.] Univ Med & Dent New Jersey, Dept Radiol, Newark, NJ 07103 USA; [Birn, Rasmus M.] Univ Wisconsin Madison, Dept Psychiat, Madison, WI USA; [Bellec, Pierre] Univ Montreal, Geriatr Inst, Res Ctr, Montreal, PQ, Canada	University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; Rutgers State University New Brunswick; Rutgers State University Medical Center; University of Wisconsin System; University of Wisconsin Madison; Universite de Montreal	Song, J (corresponding author), Univ Wisconsin Madison, Dept Biomed Engn, Madison, WI USA.	jsong46@wisc.edu	Nair, Veena A/E-4037-2013	prabhakaran, vivek/0000-0002-1974-3125; NAIR, VEENA/0000-0002-5666-3239; Bellec, Pierre/0000-0002-9111-0699	NIH-NIMH ARRA Challenge Grant [RC1MH090912]; Pilot Grant from the Clinical and Translational Science Award (CTSA) program of the National Center for Research Resources (NCRR) [UW ICTR NIH/UL1RR025011]; KL2 Scholar Award; NIH [5R01AG032088]; National Research Service [T32EB011434]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000427] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR025011] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [T32EB011434] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [RC1MH090912] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG032088] Funding Source: NIH RePORTER	NIH-NIMH ARRA Challenge Grant; Pilot Grant from the Clinical and Translational Science Award (CTSA) program of the National Center for Research Resources (NCRR); KL2 Scholar Award; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Research Service; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	Supported by grants RC1MH090912 NIH-NIMH ARRA Challenge Grant to MEM, UW ICTR NIH/UL1RR025011 Pilot Grant from the Clinical and Translational Science Award (CTSA) program of the National Center for Research Resources (NCRR) and KL2 Scholar Award to VP, NIH 5R01AG032088 to BBB, and National Research Service Award T32EB011434 to SV. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Achard S, 2007, PLOS COMPUT BIOL, V3, P174, DOI 10.1371/journal.pcbi.0030017; Andrews-Hanna JR, 2007, NEURON, V56, P924, DOI 10.1016/j.neuron.2007.10.038; Baumgartner R, 1999, MAGN RESON IMAGING, V17, P1525, DOI 10.1016/S0730-725X(99)00101-0; Birn RM, 2006, NEUROIMAGE, V31, P1536, DOI 10.1016/j.neuroimage.2006.02.048; BISWAL B, 1995, MAGNET RESON MED, V34, P537, DOI 10.1002/mrm.1910340409; Biswal BB, 2010, P NATL ACAD SCI USA, V107, P4734, DOI 10.1073/pnas.0911855107; Bluhm RL, 2007, SCHIZOPHRENIA BULL, V33, P1004, DOI 10.1093/schbul/sbm052; Caceres A, 2009, NEUROIMAGE, V45, P758, DOI 10.1016/j.neuroimage.2008.12.035; Carbonell F, 2011, BRAIN CONNECT, V1, P496, DOI 10.1089/brain.2011.0065; Chai XQJ, 2012, NEUROIMAGE, V59, P1420, DOI 10.1016/j.neuroimage.2011.08.048; Chen S, 2008, BRAIN RES, V1239, P141, DOI 10.1016/j.brainres.2008.08.028; Cherkassky VL, 2006, NEUROREPORT, V17, P1687, DOI 10.1097/01.wnr.0000239956.45448.4c; Damoiseaux JS, 2008, CEREB CORTEX, V18, P1856, DOI 10.1093/cercor/bhm207; Damoiseaux JS, 2006, P NATL ACAD SCI USA, V103, P13848, DOI 10.1073/pnas.0601417103; Davis SW, 2008, CEREB CORTEX, V18, P1201, DOI 10.1093/cercor/bhm155; Della-Maggiore V, 2002, NEUROIMAGE, V17, P19, DOI 10.1006/nimg.2002.1113; Di Martino A, 2009, AM J PSYCHIAT, V166, P891, DOI 10.1176/appi.ajp.2009.08121894; Dosenbach NUF, 2007, P NATL ACAD SCI USA, V104, P11073, DOI 10.1073/pnas.0704320104; Dosenbach NUF, 2010, SCIENCE, V329, P1358, DOI 10.1126/science.1194144; Fox MD, 2005, P NATL ACAD SCI USA, V102, P9673, DOI 10.1073/pnas.0504136102; Good CD, 2001, NEUROIMAGE, V14, P685, DOI 10.1006/nimg.2001.0857; Greicius MD, 2003, P NATL ACAD SCI USA, V100, P253, DOI 10.1073/pnas.0135058100; Hampson M, 2002, HUM BRAIN MAPP, V15, P247, DOI 10.1002/hbm.10022; Jafri MJ, 2008, NEUROIMAGE, V39, P1666, DOI 10.1016/j.neuroimage.2007.11.001; Jenkinson M, 2002, NEUROIMAGE, V17, P825, DOI 10.1006/nimg.2002.1132; Jenkinson M, 2001, MED IMAGE ANAL, V5, P143, DOI 10.1016/S1361-8415(01)00036-6; Kennedy DP, 2008, NEUROIMAGE, V39, P1877, DOI 10.1016/j.neuroimage.2007.10.052; Koch W, 2010, NEUROIMAGE, V51, P280, DOI 10.1016/j.neuroimage.2009.12.008; Lui S, 2011, AM J PSYCHIAT, V168, P642, DOI 10.1176/appi.ajp.2010.10101419; Meier TB, 2012, NEUROIMAGE, V60, P601, DOI 10.1016/j.neuroimage.2011.12.052; Meltzer JA, 2009, NEUROIMAGE, V47, P745, DOI 10.1016/j.neuroimage.2009.04.089; Meunier D, 2009, NEUROIMAGE, V44, P715, DOI 10.1016/j.neuroimage.2008.09.062; MULLER R, 1994, STAT MED, V13, P2465, DOI 10.1002/sim.4780132310; Murphy K, 2009, NEUROIMAGE, V44, P893, DOI 10.1016/j.neuroimage.2008.09.036; Saad ZS, 2012, BRAIN CONNECT, V2, P25, DOI 10.1089/brain.2012.0080; Sampat M P, 2006, Br J Radiol, V79 Spec No 2, pS134, DOI 10.1259/bjr/96723280; Seeley WW, 2009, NEURON, V62, P42, DOI 10.1016/j.neuron.2009.03.024; Shehzad Z, 2009, CEREB CORTEX, V19, P2209, DOI 10.1093/cercor/bhn256; SHROUT PE, 1979, PSYCHOL BULL, V86, P420, DOI 10.1037/0033-2909.86.2.420; Thomason ME, 2011, NEUROIMAGE, V55, P165, DOI 10.1016/j.neuroimage.2010.11.080; Tomasi D, 2012, MOL PSYCHIATR, V17, P549, DOI 10.1038/mp.2011.81; Toro R, 2008, CEREB CORTEX, V18, P2553, DOI 10.1093/cercor/bhn014; van de Ven VG, 2004, HUM BRAIN MAPP, V22, P165, DOI 10.1002/hbm.20022; van den Heuvel M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002001; Van Dijk KRA, 2012, NEUROIMAGE, V59, P431, DOI 10.1016/j.neuroimage.2011.07.044; Veer IM, 2010, FRONT SYST NEUROSCI, V4, DOI 10.3389/fnsys.2010.00041; Weissenbacher A, 2009, NEUROIMAGE, V47, P1408, DOI 10.1016/j.neuroimage.2009.05.005; Wu K, 2012, HUM BRAIN MAPP, V33, P552, DOI 10.1002/hbm.21232; Zang YF, 2004, NEUROIMAGE, V22, P394, DOI 10.1016/j.neuroimage.2003.12.030; Zhou Y, 2007, SCHIZOPHR RES, V97, P194, DOI 10.1016/j.schres.2007.05.029	50	61	62	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 5	2012	7	12							e49847	10.1371/journal.pone.0049847	http://dx.doi.org/10.1371/journal.pone.0049847			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	057TZ	23227153	Green Submitted, Green Published, gold			2022-12-27	WOS:000312588200015
J	Chakrapani, V; Newman, PA; Singhal, N; Jerajani, J; Shunmugam, M				Chakrapani, Venkatesan; Newman, Peter A.; Singhal, Neeti; Jerajani, Jhalak; Shunmugam, Murali			Willingness to Participate in HIV Vaccine Trials among Men Who Have Sex with Men in Chennai and Mumbai, India: A Social Ecological Approach	PLOS ONE			English	Article							RISK; BARRIERS; PERCEPTIONS; PREVENTION; MOTIVATORS; ENROLLMENT; HIV/AIDS	Background: Recruitment of low-and middle-income country volunteers from most-at-risk populations in HIV vaccine trials is essential to vaccine development. In India, men who have sex with men (MSM) are at disproportionately high risk for HIV infection and an important population for trial recruitment. Investigations of willingness to participate (WTP) in HIV vaccine trials have focused predominantly on individual-level determinants. We explored multi-level factors associated with WTP among MSM in India. Methods: We conducted 12 focus groups (n = 68) with low socioeconomic MSM in Chennai and Mumbai, and 14 key informant interviews with MSM community leaders and service providers. Focus groups/interviews were recorded, transcribed and translated into English. Two bilingual investigators conducted thematic analysis using line-by-line coding and a constant comparative method, with member-checking by community representatives. Results: Factors associated with WTP were evidenced across the social ecology of MSM-social-structural: poverty, HIV-, sexual-and gender non-conformity stigma, institutionalized discrimination and government sponsorship of trials; community-level: endorsement by MSM community leaders and organizations, and fear of within-group discrimination; interpersonal: anticipated family discord, partner rejection, having financially-dependent family members and disclosure of same-sex sexuality; and individual-level: HIV vaccine trial knowledge and misconceptions, safety concerns, altruism and preventive misconception. Conclusion: Pervasive familial, community and social-structural factors characteristic of the Indian sociocultural context may complicate individual-focused approaches to WTP and thereby constrain the effectiveness of interventions to support recruitment and retention in HIV vaccine trials. Interventions to reduce stigma and discrimination against MSM and people living with HIV, capacity-building of MSM community organizations and transparent communications tailored to the knowledge and educational level of local communities may support meaningful engagement of MSM in HIV vaccine trials. Vigilance in providing fair but not excessive compensation and healthcare benefits and in mitigating preventive misconception are warranted to support ethical conduct of trials among MSM in India.	[Newman, Peter A.] Univ Toronto, Factor Inwentash Fac Social Work, Toronto, ON, Canada; [Chakrapani, Venkatesan; Shunmugam, Murali] Ctr Sexual & Hlth Res & Policy, Chennai, Tamil Nadu, India; [Chakrapani, Venkatesan; Singhal, Neeti; Jerajani, Jhalak; Shunmugam, Murali] Humsafar Trust, Mumbai, Maharashtra, India	University of Toronto	Newman, PA (corresponding author), Univ Toronto, Factor Inwentash Fac Social Work, Toronto, ON, Canada.	p.newman@utoronto.ca	Newman, Peter A/P-7056-2019; Swaibu, Ramadhani A/H-3164-2011; Chakrapani, Venkatesan/P-8056-2014	Newman, Peter A/0000-0003-0444-5915; Chakrapani, Venkatesan/0000-0001-9998-9135	Canadian Institutes of Health Research; Social Sciences and Humanities Research Council; Canada Research Chairs program	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Social Sciences and Humanities Research Council(Social Sciences and Humanities Research Council of Canada (SSHRC)); Canada Research Chairs program(Canada Research Chairs)	This study was funded by the Canadian Institutes of Health Research, the Social Sciences and Humanities Research Council, and the Canada Research Chairs program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ashforth A, 2005, SOC DYNAMICS, V31, P285, DOI 10.1080/02533950508628716; Burt RS, 2005, BROKERAGE CLOSURE IN; Chakrapani V, 2008, CULT HEALTH SEX, V10, P313, DOI 10.1080/13691050701816714; Chakrapani V, 2007, AIDS EDUC PREV, V19, P346, DOI 10.1521/aeap.2007.19.4.346; Dhalla S, 2011, AIDS CARE, V23, P1430, DOI 10.1080/09540121.2011.555750; Dhalla S, 2011, VACCINE, V29, P5850, DOI 10.1016/j.vaccine.2011.06.055; Downs JS, 2008, VACCINE, V26, P1595, DOI 10.1016/j.vaccine.2008.01.011; Excler JL, 2008, INDIAN J MED RES, V127, P531; Fisher CB, 2010, J EMPIR RES HUM RES, V5, P65, DOI 10.1525/jer.2010.5.2.65; Guest G, 2012, APPL THEMATIC ANAL, DOI 10.4135/9781483384436; Horowitz CR, 2009, CIRCULATION, V119, P2633, DOI 10.1161/CIRCULATIONAHA.107.729863; IMF-International Monetary Fund, 2009, WORLD EC OUTL DAT; Joint United Nations Programme on HIV/AIDS (UNAIDS), 2011, GOOD PART PRACT GUID; Joint United Nations Programme on HIV/AIDS (UNAIDS), 2010, GLOB REP UNAIDS REP; Kumta S, 2010, JAIDS-J ACQ IMM DEF, V53, P227, DOI 10.1097/QAI.0b013e3181c354d8; Lincoln Y.S., 1985, NATURALISTIC ENQUIRY; Mamotte N, 2010, BMC MED ETHICS, V11, DOI 10.1186/1472-6939-11-3; Mills E, 2004, AIDS, V18, P2235, DOI 10.1097/00002030-200411190-00003; Moodley K, 2002, SAMJ S AFR MED J, V92, P904; National AIDS Control Organization (NACO) Department of AIDS Control Ministry of Health and Family Welfare Government of India, ANN CMIS B 2008 09; Newman PA, 2008, SEX TRANSM INFECT, V84, P434, DOI 10.1136/sti.2008.031484; Newman PA, 2011, VACCINE, V29, P451, DOI 10.1016/j.vaccine.2010.10.076; Newman PA, 2006, JAIDS-J ACQ IMM DEF, V41, P210, DOI 10.1097/01.qai.0000179454.93443.60; Newman PA, 2006, LANCET, V367, P302, DOI 10.1016/S0140-6736(06)68067-7; Newman PA, 2008, VACCINE, V26, P1091, DOI 10.1016/j.vaccine.2007.12.016; Newman PA, 2009, HEALTH EDUC BEHAV, V36, P321, DOI 10.1177/1090198107305078; Nyamathi AM, 2007, AIDS BEHAV, V11, P619, DOI 10.1007/s10461-006-9173-8; Nzioka C, 1996, AIDS CARE, V8, P565, DOI 10.1080/09540129650125524; Patton M. Q., 2002, QUALITATIVE RES EVAL, V3rd; Sahay S, 2005, VACCINE, V23, P1351, DOI 10.1016/j.vaccine.2004.09.032; Stadler J, 2003, AIDS EDUC PREV, V15, P357, DOI 10.1521/aeap.15.5.357.23823; Streefland PH, 2003, VACCINE, V21, P1304, DOI 10.1016/S0264-410X(02)00685-0; Suhadev M, 2006, INDIAN J MED RES, V124, P631; Suhadev M, 2009, AIDS RES HUM RETROV, V25, P217, DOI 10.1089/aid.2007.0312	34	32	32	2	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 4	2012	7	12							e51080	10.1371/journal.pone.0051080	http://dx.doi.org/10.1371/journal.pone.0051080			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	051EQ	23226560	Green Published, gold, Green Submitted			2022-12-27	WOS:000312108500043
J	Yang, W; Tan, J; Liu, RK; Cui, XX; Ma, QL; Geng, YQ; Qiao, WT				Yang, Wei; Tan, Juan; Liu, Ruikang; Cui, Xiaoxu; Ma, Qinglin; Geng, Yunqi; Qiao, Wentao			Interferon-gamma Upregulates Expression of IFP35 Gene in HeLa Cells via Interferon Regulatory Factor-1	PLOS ONE			English	Article							PROTEASOME-MEDIATED DEGRADATION; STIMULATED RESPONSE ELEMENT; IFN-GAMMA; TRANSCRIPTION FACTORS; FACTOR FAMILY; BINDING PROTEIN; ACTIVATION; PROMOTER; IRF-1; VIRUS	Background: Interferon-induced 35-kDa protein (IFP35) plays important roles in antiviral defense and the progression of some skin cancer diseases. It can be induced by interferon-c (IFN-gamma) in multiple human cells. However, the mechanisms by which IFN-gamma contributes to IFP35 induction remain to be elucidated. Methods/Principal Findings: We identified the transcription start sites of IFP35 by 59 rapid amplification of cDNA ends (RACE) and cloned the promoter of IFP35. Sequence analysis and luciferase assays revealed two GC boxes and an IFN-stimulated response element (ISRE) in the 59 upstream region of the transcription start sites, which were important for the basal transcription of IFP35 gene. Furthermore, we found that interferon regulatory factor 1 (IRF-1) and IRF-2 could bind to IFP35 promoter and upregulate endogenous IFP35 protein level. Depletion of endogenous IRF-1 by interfering RNA reduced the constitutive and IFN-gamma-dependent expression of IFP35, whereas depletion of IRF-2 had little effect on IFN-gamma-inducible IFP35 expression. Moreover, IRF-1 was recruited to the ISRE site in IFP35 promoter in IFN-gamma treated HeLa cells, as demonstrated by electrophoretic mobility shift and chromatin immunoprecipitation assays. Conclusions/Significance: These findings provide the first evidence that IRF-1 and IRF-2 are involved in constitutive IFP35 expression in HeLa cells, while IRF-1 also activates IFP35 expression in an IFN-gamma-inducible manner. Our data therefore identified a new IRF-1 and IRF-2 target gene, which may expand our current understanding of the versatile functions of IRF1 and IRF-2. Citation: Yang W, Tan J, Liu R, Cui X, Ma Q, et al. (2012) Interferon-gamma Upregulates Expression of IFP35 Gene in HeLa Cells via Interferon Regulatory Factor-1. PLoS ONE 7(12): e50932. doi: 10.1371/journal.pone.0050932	[Qiao, Wentao] Nankai Univ, Key Lab Mol Microbiol & Biotechnol, Minist Educ, Tianjin 300071, Peoples R China; Nankai Univ, Key Lab Microbial Funct Genom Tianjin, Coll Life Sci, Tianjin 300071, Peoples R China	Nankai University; Nankai University	Qiao, WT (corresponding author), Nankai Univ, Key Lab Mol Microbiol & Biotechnol, Minist Educ, Tianjin 300071, Peoples R China.	wentaoqiao@nankai.edu.cn			National Natural Science Foundation of China [30900068, 81071343]; 973 Project [2010CB534907]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); 973 Project(National Basic Research Program of China)	This work was supported by grants from the National Natural Science Foundation of China (30900068, 81071343) and the 973 Project (2010CB534907). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arons E, 2001, J IMMUNOL, V166, P3942, DOI 10.4049/jimmunol.166.6.3942; Au WC, 1998, J BIOL CHEM, V273, P29210, DOI 10.1074/jbc.273.44.29210; AU WC, 1995, P NATL ACAD SCI USA, V92, P11657, DOI 10.1073/pnas.92.25.11657; BANGE FC, 1994, J BIOL CHEM, V269, P1091; Barnes BJ, 2001, J BIOL CHEM, V276, P23382, DOI 10.1074/jbc.M101216200; Beretta L, 1996, ONCOGENE, V12, P1593; Chen J, 2000, J BIOL CHEM, V275, P36278, DOI 10.1074/jbc.M006975200; DARNELL JE, 1994, SCIENCE, V264, P1415, DOI 10.1126/science.8197455; De Ambrosis A, 2007, INT J CANCER, V120, P39, DOI 10.1002/ijc.22173; DECKER T, 1989, EMBO J, V8, P2009, DOI 10.1002/j.1460-2075.1989.tb03608.x; DECKER T, 1991, EMBO J, V10, P927, DOI 10.1002/j.1460-2075.1991.tb08026.x; Durocher Y, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.2.e9; Gongora C, 2000, NUCLEIC ACIDS RES, V28, P2333, DOI 10.1093/nar/28.12.2333; Grotzinger T, 1996, J BIOL CHEM, V271, P25253, DOI 10.1074/jbc.271.41.25253; HARADA H, 1989, CELL, V58, P729, DOI 10.1016/0092-8674(89)90107-4; HELMS C, 1985, DNA-J MOLEC CELL BIO, V4, P39, DOI 10.1089/dna.1985.4.39; Lin RT, 2005, J BIOL CHEM, V280, P3088, DOI 10.1074/jbc.M408452200; Lin RT, 1998, MOL CELL BIOL, V18, P2986, DOI 10.1128/MCB.18.5.2986; Liu JG, 2005, J BIOL CHEM, V280, P24347, DOI 10.1074/jbc.M500973200; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Luo W, 1996, J BIOL CHEM, V271, P23445, DOI 10.1074/jbc.271.38.23445; MIYAMOTO M, 1988, CELL, V54, P903, DOI 10.1016/S0092-8674(88)91307-4; Namiki S, 2005, FEBS LETT, V579, P2781, DOI 10.1016/j.febslet.2005.04.012; Ning S, 2011, GENES IMMUN, V12, P399, DOI 10.1038/gene.2011.21; Oshima S, 2004, MOL CELL BIOL, V24, P6298, DOI 10.1128/MCB.24.14.6298-6310.2004; Osterlund PI, 2007, J IMMUNOL, V179, P3434, DOI 10.4049/jimmunol.179.6.3434; PINE R, 1994, EMBO J, V13, P158, DOI 10.1002/j.1460-2075.1994.tb06245.x; Pomerantz RG, 2010, BRIT J DERMATOL, V163, P1090, DOI 10.1111/j.1365-2133.2010.09973.x; Rebane A, 2012, J ALLERGY CLIN IMMUN, V129, P1297, DOI 10.1016/j.jaci.2012.02.020; REID LE, 1989, P NATL ACAD SCI USA, V86, P840, DOI 10.1073/pnas.86.3.840; Ruiz-Ruiz C, 2004, J BIOL CHEM, V279, P19712, DOI 10.1074/jbc.M313023200; Samuel CE, 2001, CLIN MICROBIOL REV, V14, P778, DOI 10.1128/CMR.14.4.778-809.2001; Savitsky D, 2010, CANCER IMMUNOL IMMUN, V59, P489, DOI 10.1007/s00262-009-0804-6; SHUAI K, 1993, SCIENCE, V261, P1744, DOI 10.1126/science.7690989; Smale ST, 2003, ANNU REV BIOCHEM, V72, P449, DOI 10.1146/annurev.biochem.72.121801.161520; Stark GR, 2012, IMMUNITY, V36, P503, DOI 10.1016/j.immuni.2012.03.013; Su Y, 2010, CELL MICROBIOL, V12, P1098, DOI 10.1111/j.1462-5822.2010.01453.x; Takaoka A, 2008, CANCER SCI, V99, P467, DOI 10.1111/j.1349-7006.2007.00720.x; Tan J, 2008, J VIROL, V82, P4275, DOI 10.1128/JVI.02249-07; Taniguchi T, 2001, ANNU REV IMMUNOL, V19, P623, DOI 10.1146/annurev.immunol.19.1.623; TRACY S, 1981, PREP BIOCHEM, V11, P251, DOI 10.1080/00327488108061767; VAUGHAN PS, 1995, NATURE, V377, P362, DOI 10.1038/377362a0; Wang XY, 1996, BIOCHEM BIOPH RES CO, V229, P316, DOI 10.1006/bbrc.1996.1799; Zhang LQ, 2007, CELL SIGNAL, V19, P932, DOI 10.1016/j.cellsig.2006.11.002; Zhang LW, 2002, J INTERF CYTOK RES, V22, P95, DOI 10.1089/107999002753452700	46	10	11	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 4	2012	7	12							e50932	10.1371/journal.pone.0050932	http://dx.doi.org/10.1371/journal.pone.0050932			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	051EQ	23226549	gold, Green Published, Green Submitted			2022-12-27	WOS:000312108500036
J	Siyanova-Chanturia, A; Pesciarelli, F; Cacciari, C				Siyanova-Chanturia, Anna; Pesciarelli, Francesca; Cacciari, Cristina			The Electrophysiological Underpinnings of Processing Gender Stereotypes in Language	PLOS ONE			English	Article							EVENT-RELATED POTENTIALS; BRAIN POTENTIALS; PRESIDENTIAL-ADDRESS; LEXICAL DECISION; INFORMATION; FREQUENCY; CONTEXT; WORDS; COMPREHENSION; INTEGRATION	Despite the widely documented influence of gender stereotypes on social behaviour, little is known about the electrophysiological substrates engaged in the processing of such information when conveyed by language. Using event-related brain potentials (ERPs), we examined the brain response to third-person pronouns (lei "she" and lui "he") that were implicitly primed by definitional (passeggera(FEM) "passenger", pensionato(MASC) "pensioner"), or stereotypical antecedents (insegnante "teacher", conducente "driver"). An N400-like effect on the pronoun emerged when it was preceded by a definitionally incongruent prime (passeggera(FEM) - lui; pensionato(MASC) - lei), and a stereotypically incongruent prime for masculine pronouns only (insegnante - lui). In addition, a P300-like effect was found when the pronoun was preceded by definitionally incongruent primes. However, this effect was observed for female, but not male participants. Overall, these results provide further evidence for on-line effects of stereotypical gender in language comprehension. Importantly, our results also suggest a gender stereotype asymmetry in that male and female stereotypes affected the processing of pronouns differently.	[Siyanova-Chanturia, Anna; Pesciarelli, Francesca; Cacciari, Cristina] Univ Modena & Reggio Emilia, Dept Biomed Sci, Modena, Italy; [Siyanova-Chanturia, Anna] Victoria Univ Wellington, Sch Linguist & Appl Language Studies, Wellington, New Zealand	Universita di Modena e Reggio Emilia; Victoria University Wellington	Siyanova-Chanturia, A (corresponding author), Univ Modena & Reggio Emilia, Dept Biomed Sci, Modena, Italy.	anna.siyanova@vuw.ac.nz	Cacciari, Cristina/H-2463-2013; Pesciarelli, Francesca/H-5518-2013; PESCIARELLI, Francesca/ABE-9870-2021; Pesciarelli, Francesca/AAK-1692-2020	Cacciari, Cristina/0000-0002-5506-244X; Pesciarelli, Francesca/0000-0003-3007-4775; Pesciarelli, Francesca/0000-0003-3007-4775; Siyanova-Chanturia, Anna/0000-0002-8336-8569	European Community [237907]	European Community(European Commission)	The research leading to these results has received funding from the European Community's Seventh Framework Program (FP7/2007-2013) under grant agreement no 237907. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aprile M, 2005, DALLE PAROLE AI DIZI; BANAJI MR, 1995, J PERS SOC PSYCHOL, V68, P181, DOI 10.1037/0022-3514.68.2.181; Banaji MR, 1996, PSYCHOL SCI, V7, P136, DOI 10.1111/j.1467-9280.1996.tb00346.x; Barber H, 2003, CORTEX, V39, P465, DOI 10.1016/S0010-9452(08)70259-4; Barber H, 2005, J COGNITIVE NEUROSCI, V17, P137, DOI 10.1162/0898929052880101; Baroni Marco, 2004, LREC; Bartholow BD, 2001, PSYCHOL SCI, V12, P197, DOI 10.1111/1467-9280.00336; Bartholow BD, 2010, PSYCHOPHYSIOLOGY, V47, P201, DOI 10.1111/j.1469-8986.2009.00955.x; Bem S.L., 1993, LENSES GENDER; BEM SL, 1974, J CONSULT CLIN PSYCH, V42, P155, DOI 10.1037/h0036215; BENTIN S, 1985, ELECTROEN CLIN NEURO, V60, P343, DOI 10.1016/0013-4694(85)90008-2; Blair IV, 1996, J PERS SOC PSYCHOL, V70, P1142, DOI 10.1037/0022-3514.70.6.1142; Borgida E, 2005, J LAW POLICY, V13, P613; Bornkessel-Schlesewsky I, 2008, BRAIN RES REV, V59, P55, DOI 10.1016/j.brainresrev.2008.05.003; Brown CM, 1999, J COGNITIVE NEUROSCI, V11, P261, DOI 10.1162/089892999563382; Cacciari C, 2007, APPL PSYCHOLINGUIST, V28, P277, DOI 10.1017/S0142716407070142; Carreiras M, 2004, COGNITIVE BRAIN RES, V20, P98, DOI 10.1016/j.cogbrainres.2004.01.009; Carreiras M, 1996, Q J EXP PSYCHOL-A, V49, P639, DOI 10.1080/027249896392531; Chwilla DJ, 2000, J MEM LANG, V42, P314, DOI 10.1006/jmla.1999.2680; COHEN J, 1992, PSYCHOL BULL, V112, P155, DOI 10.1037/0033-2909.112.1.155; Cohen J.E., 1988, STAT POWER ANAL BEHA; Contreras JM, 2011, SOCIAL COGNITIVE AFF; Coulson S, 1998, LANG COGNITIVE PROC, V13, P21, DOI 10.1080/016909698386582; Coulson S, 1998, LANG COGNITIVE PROC, V13, P653, DOI 10.1080/016909698386410; DONCHIN E, 1981, PSYCHOPHYSIOLOGY, V18, P493, DOI 10.1111/j.1469-8986.1981.tb01815.x; DONCHIN E, 1988, BEHAV BRAIN SCI, V11, P357, DOI 10.1017/S0140525X00058027; Duffy SA, 2004, MEM COGNITION, V32, P551, DOI 10.3758/BF03195846; EAGLY AH, 1987, J PERS SOC PSYCHOL, V53, P451, DOI 10.1037/0022-3514.53.3.451; Fiske S. T, 1998, HDB SOCIAL PSYCHOL, P357, DOI DOI 10.1002/9780470561119; FISKE ST, 1990, ADV EXP SOC PSYCHOL, V23, P1, DOI 10.1016/S0065-2601(08)60317-2; Garnham A, 2002, MEM COGNITION, V30, P439, DOI 10.3758/BF03194944; Glick P, 1996, J PERS SOC PSYCHOL, V70, P491, DOI 10.1037/0022-3514.70.3.491; Greenwald AG, 2000, FEELING THINKING ROL, P308; Gunter TC, 1997, PSYCHOPHYSIOLOGY, V34, P660, DOI 10.1111/j.1469-8986.1997.tb02142.x; Hagoort P, 2004, SCIENCE, V304, P438, DOI 10.1126/science.1095455; Hammer A, 2005, J COGNITIVE NEUROSCI, V17, P227, DOI 10.1162/0898929053124947; Hegarty P, 2001, J PERS SOC PSYCHOL, V80, P723, DOI 10.1037//0022-3514.80.5.723; Irmen L, 2004, J LANG SOC PSYCHOL, V23, P272, DOI 10.1177/0261927x04266810; Irmen L, 2010, BRAIN RES, V1353, P133, DOI 10.1016/j.brainres.2010.07.018; Kaan E, 2003, J COGNITIVE NEUROSCI, V15, P98, DOI 10.1162/089892903321107855; Kennison SM, 2003, J PSYCHOLINGUIST RES, V32, P355, DOI 10.1023/A:1023599719948; Kim A, 2005, J MEM LANG, V52, P205, DOI 10.1016/j.jml.2004.10.002; King JW, 1998, NEUROSCI LETT, V244, P61, DOI 10.1016/S0304-3940(98)00140-2; Kok A, 2001, PSYCHOPHYSIOLOGY, V38, P557, DOI 10.1017/S0048577201990559; Kreiner H, 2008, J MEM LANG, V58, P239, DOI 10.1016/j.jml.2007.09.003; Kuperberg GR, 2007, BRAIN RES, V1146, P23, DOI 10.1016/j.brainres.2006.12.063; Kuperberg GR, 2003, COGNITIVE BRAIN RES, V17, P117, DOI 10.1016/S0926-6410(03)00086-7; KUTAS M, 1980, SCIENCE, V207, P203, DOI 10.1126/science.7350657; Kutas M, 1997, PSYCHOPHYSIOLOGY, V34, P383, DOI 10.1111/j.1469-8986.1997.tb02382.x; KUTAS M, 1977, SCIENCE, V197, P792, DOI 10.1126/science.887923; Kutas M, 2000, TRENDS COGN SCI, V4, P463, DOI 10.1016/S1364-6613(00)01560-6; KUTAS M, 1984, NATURE, V307, P161, DOI 10.1038/307161a0; Kutas M, 2011, ANNU REV PSYCHOL, V62, P621, DOI 10.1146/annurev.psych.093008.131123; Lamers MJ, 2006, BMC NEUROSCI, V7, DOI 10.1186/1471-2202-7-23; Lattner S, 2003, NEUROSCI LETT, V339, P191, DOI 10.1016/S0304-3940(03)00027-2; MILLER DT, 1991, J PERS SOC PSYCHOL, V61, P5, DOI 10.1037/0022-3514.61.1.5; Molinaro N, 2011, CORTEX, V47, P908, DOI 10.1016/j.cortex.2011.02.019; Munte TF, 2001, NEUROPSYCHOLOGIA, V39, P91, DOI 10.1016/S0028-3932(00)00095-6; NEVILLE HJ, 1992, CEREB CORTEX, V2, P244, DOI 10.1093/cercor/2.3.244; Oakhill J, 2005, MEM COGNITION, V33, P972, DOI 10.3758/BF03193206; OLDFIELD RC, 1971, NEUROPSYCHOLOGIA, V9, P97, DOI 10.1016/0028-3932(71)90067-4; Osterhout L, 1997, BIOL PSYCHOL, V46, P143, DOI 10.1016/S0301-0511(97)05250-2; Osterhout L, 2002, J NEUROLINGUIST, V15, P171, DOI 10.1016/S0911-6044(01)00036-7; Osterhout L, 1999, LANG COGNITIVE PROC, V14, P1, DOI 10.1080/016909699386356; Osterhout L, 1997, MEM COGNITION, V25, P273, DOI 10.3758/BF03211283; OSTERHOUT L, 1992, J MEM LANG, V31, P785, DOI 10.1016/0749-596X(92)90039-Z; Osterhout L, 1995, J MEM LANG, V34, P739, DOI 10.1006/jmla.1995.1033; Osterhout L, 1995, ELECTROPHYSIOLOGY MI; Pyykkonen P, 2010, EXP PSYCHOL, V57, P126, DOI 10.1027/1618-3169/a000016; Roehm D, 2007, J COGNITIVE NEUROSCI, V19, P1259, DOI 10.1162/jocn.2007.19.8.1259; ROSENBERG BG, 1969, DEV PSYCHOL, V1, P661, DOI 10.1037/h0028273; Schmitt BM, 2002, COGNITIVE BRAIN RES, V14, P333, DOI 10.1016/S0926-6410(02)00136-2; Siegel DJ., 2001, DEV MIND RELATIONSHI; Sturt P, 2003, J MEM LANG, V48, P542, DOI 10.1016/S0749-596X(02)00536-3; Van Berkum JJA, 2012, CAMBRIDGE HDB PSYCHO; Van Berkum JJA, 2008, J COGNITIVE NEUROSCI, V20, P580, DOI 10.1162/jocn.2008.20054; de Meerendonk N, 2009, LANG LINGUIST COMPAS, V3, DOI 10.1111/j.1749-818x.2009.00163.x; VANPETTEN C, 1990, MEM COGNITION, V18, P380, DOI 10.3758/BF03197127; VANRIJN ACM, 1990, MED BIOL ENG COMPUT, V28, P389, DOI 10.1007/BF02441961; VERLEGER R, 1988, BEHAV BRAIN SCI, V11, P343, DOI 10.1017/S0140525X00058015; White KR, 2009, SOC COGN AFFECT NEUR, V4, P191, DOI 10.1093/scan/nsp004	81	27	28	0	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 3	2012	7	12							e48712	10.1371/journal.pone.0048712	http://dx.doi.org/10.1371/journal.pone.0048712			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	051DH	23226494	Green Published, Green Submitted, gold			2022-12-27	WOS:000312104700004
J	Beaver, LM; Klichko, VI; Chow, ES; Kotwica-Rolinska, J; Williamson, M; Orr, WC; Radyuk, SN; Giebultowicz, JM				Beaver, Laura M.; Klichko, Vladimir I.; Chow, Eileen S.; Kotwica-Rolinska, Joanna; Williamson, Marisa; Orr, William C.; Radyuk, Svetlana N.; Giebultowicz, Jadwiga M.			Circadian Regulation of Glutathione Levels and Biosynthesis in Drosophila melanogaster	PLOS ONE			English	Article							GLUTAMATE-CYSTEINE LIGASE; GENE-EXPRESSION; OXIDATIVE STRESS; MODIFIER SUBUNIT; MOLECULAR EVOLUTION; S-TRANSFERASES; LIFE-SPAN; CLOCK; METABOLISM; PHYSIOLOGY	Circadian clocks generate daily rhythms in neuronal, physiological, and metabolic functions. Previous studies in mammals reported daily fluctuations in levels of the major endogenous antioxidant, glutathione (GSH), but the molecular mechanisms that govern such fluctuations remained unknown. To address this question, we used the model species Drosophila, which has a rich arsenal of genetic tools. Previously, we showed that loss of the circadian clock increased oxidative damage and caused neurodegenerative changes in the brain, while enhanced GSH production in neuronal tissue conferred beneficial effects on fly survivorship under normal and stress conditions. In the current study we report that the GSH concentrations in fly heads fluctuate in a circadian clock-dependent manner. We further demonstrate a rhythm in activity of glutamate cysteine ligase (GCL), the rate-limiting enzyme in glutathione biosynthesis. Significant rhythms were also observed for mRNA levels of genes encoding the catalytic (Gclc) and modulatory (Gclm) subunits comprising the GCL holoenzyme. Furthermore, we found that the expression of a glutathione S-transferase, GstD1, which utilizes GSH in cellular detoxification, significantly fluctuated during the circadian day. To directly address the role of the clock in regulating GSH-related rhythms, the expression levels of the GCL subunits and GstD1, as well as GCL activity and GSH production were evaluated in flies with a null mutation in the clock genes cycle and period. The rhythms observed in control flies were not evident in the clock mutants, thus linking glutathione production and utilization to the circadian system. Together, these data suggest that the circadian system modulates pathways involved in production and utilization of glutathione.	[Klichko, Vladimir I.; Orr, William C.; Radyuk, Svetlana N.] So Methodist Univ, Dept Biol Sci, Dallas, TX 75275 USA; [Beaver, Laura M.; Chow, Eileen S.; Kotwica-Rolinska, Joanna; Williamson, Marisa; Giebultowicz, Jadwiga M.] Oregon State Univ, Dept Zool, Corvallis, OR 97331 USA; [Kotwica-Rolinska, Joanna] Univ Warsaw, Inst Zool, Dept Anim Physiol, Warsaw, Poland	Southern Methodist University; Oregon State University; University of Warsaw	Radyuk, SN (corresponding author), So Methodist Univ, Dept Biol Sci, Dallas, TX 75275 USA.	snradyuk@smu.edu; giebultj@science.oregonstate.edu	Kotwica-Rolinska, Joanna/AAC-2866-2021; Kotwica-Rolinska, Joanna/K-2941-2014	Kotwica-Rolinska, Joanna/0000-0001-5984-4126; Kotwica-Rolinska, Joanna/0000-0001-5984-4126; Radyuk, Svetlana/0000-0002-3467-5255	National Institutes of Health (NIH) [R21: NIH R21 NS075500, R21AG038989]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R21NS075500] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R21AG038989] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This research was supported by National Institutes of Health (NIH) R21: NIH R21 NS075500 to JMG and SNR, and in part by NIH R21AG038989 grant to JMG. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abruzzi KC, 2011, GENE DEV, V25, P2374, DOI [10.1101/gad.178079.111, 10.1101/gad.174110.111]; Albrecht U, 2006, J PHYSIOL-PARIS, V100, P243, DOI 10.1016/j.jphysparis.2007.05.004; Allada R, 2010, ANNU REV PHYSIOL, V72, P605, DOI 10.1146/annurev-physiol-021909-135815; Beaver LM, 2010, TOXICOL SCI, V115, P513, DOI 10.1093/toxsci/kfq083; Ceriani MF, 2002, J NEUROSCI, V22, P9305, DOI 10.1523/jneurosci.22-21-09305.2002; Chen Y, 2005, J BIOL CHEM, V280, P33766, DOI 10.1074/jbc.M504604200; Chintapalli VR, 2007, NAT GENET, V39, P715, DOI 10.1038/ng2049; Claridge-Chang A, 2001, NEURON, V32, P657, DOI 10.1016/S0896-6273(01)00515-3; Claudel T, 2007, FEBS LETT, V581, P3626, DOI 10.1016/j.febslet.2007.04.009; Daines B, 2011, GENOME RES, V21, P315, DOI 10.1101/gr.107854.110; Dickinson DA, 2004, FREE RADICAL BIO MED, V37, P1152, DOI 10.1016/j.freeradbiomed.2004.06.011; Dickinson DA, 2002, ANN NY ACAD SCI, V973, P488, DOI 10.1111/j.1749-6632.2002.tb04690.x; Dringen R, 2003, BIOL CHEM, V384, P505, DOI 10.1515/BC.2003.059; Eckel-Mahan KL, 2012, P NATL ACAD SCI USA, V109, P5541, DOI 10.1073/pnas.1118726109; Edgar RS, 2012, NATURE, V485, P459, DOI 10.1038/nature11088; Forman HJ, 2009, MOL ASPECTS MED, V30, P1, DOI 10.1016/j.mam.2008.08.006; Fraser JA, 2003, J BIOL CHEM, V278, P46369, DOI 10.1074/jbc.M308035200; Fraser JA, 2002, J BIOL CHEM, V277, P1158, DOI 10.1074/jbc.M106683200; Gachon F, 2011, EXPERT OPIN DRUG MET, V7, P147, DOI 10.1517/17425255.2011.544251; Green CB, 2008, CELL, V134, P728, DOI 10.1016/j.cell.2008.08.022; Hardeland R, 2003, CHRONOBIOL INT, V20, P921, DOI 10.1081/CBI-120025245; Hardin PE, 2011, ADV GENET, V74, P141, DOI 10.1016/B978-0-12-387690-4.00005-2; Hochmuth CE, 2011, CELL STEM CELL, V8, P188, DOI 10.1016/j.stem.2010.12.006; Hooven LA, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006469; Hughes ME, 2012, GENOME RES, V22, P1266, DOI 10.1101/gr.128876.111; Jackson FR, 2011, GLIA, V59, P1341, DOI 10.1002/glia.21097; Kang TH, 2009, P NATL ACAD SCI USA, V106, P2864, DOI 10.1073/pnas.0812638106; Keegan KP, 2007, PLOS COMPUT BIOL, V3, P2087, DOI 10.1371/journal.pcbi.0030208; Kondratov RV, 2006, GENE DEV, V20, P1868, DOI 10.1101/gad.1432206; KONOPKA RJ, 1971, P NATL ACAD SCI USA, V68, P2112, DOI 10.1073/pnas.68.9.2112; Krishnan N, 2008, BIOCHEM BIOPH RES CO, V374, P299, DOI 10.1016/j.bbrc.2008.07.011; Krishnan N, 2012, NEUROBIOL DIS, V45, P1129, DOI 10.1016/j.nbd.2011.12.034; Krishnan N, 2009, AGING-US, V1, P937, DOI 10.18632/aging.100103; Kula-Eversole E, 2010, P NATL ACAD SCI USA, V107, P13497, DOI 10.1073/pnas.1002081107; Lee JI, 2006, BIOCHEM J, V393, P181, DOI 10.1042/BJ20051111; Limon-Pacheco Jorge H., 2010, Central Nervous System Agents in Medicinal Chemistry, V10, P287; Lin Y, 2002, P NATL ACAD SCI USA, V99, P9562, DOI 10.1073/pnas.132269699; Ling DJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017762; Low WY, 2007, GENETICS, V177, P1363, DOI 10.1534/genetics.107.075838; Lu SC, 2009, MOL ASPECTS MED, V30, P42, DOI 10.1016/j.mam.2008.05.005; Luchak JM, 2007, ANN NY ACAD SCI, V1119, P260, DOI 10.1196/annals.1404.000; Maher P, 2006, ANTIOXID REDOX SIGN, V8, P1941, DOI 10.1089/ars.2006.8.1941; Matzkin LM, 2008, GENETICS, V178, P1073, DOI 10.1534/genetics.107.083287; McDonald MJ, 2001, CELL, V107, P567, DOI 10.1016/S0092-8674(01)00545-1; Orr WC, 2005, J BIOL CHEM, V280, P37331, DOI 10.1074/jbc.M508272200; Radyuk SN, 2012, MECH AGEING DEV, V133, P401, DOI 10.1016/j.mad.2012.04.006; Radyuk SN, 2009, J BIOL CHEM, V284, P2266, DOI 10.1074/jbc.M805913200; Rebrin I, 2004, BIOCHEM J, V382, P131, DOI 10.1042/BJ20040506; Reddy AB, 2010, TRENDS CELL BIOL, V20, P36, DOI 10.1016/j.tcb.2009.10.005; Reppert SM, 2000, J BIOL RHYTHM, V15, P357, DOI 10.1177/074873000129001459; Rutila JE, 1998, CELL, V93, P805, DOI 10.1016/S0092-8674(00)81441-5; Sahar S, 2012, TRENDS ENDOCRIN MET, V23, P1, DOI 10.1016/j.tem.2011.10.005; Sawicki R, 2003, BIOCHEM J, V370, P661, DOI 10.1042/BJ20021287; Stanewsky R, 2003, J NEUROBIOL, V54, P111, DOI 10.1002/neu.10164; Suh JH, 2004, P NATL ACAD SCI USA, V101, P3381, DOI 10.1073/pnas.0400282101; Sykiotis GP, 2008, DEV CELL, V14, P76, DOI 10.1016/j.devcel.2007.12.002; Taghert PH, 2006, J BIOL RHYTHM, V21, P445, DOI 10.1177/0748730406293910; Toroser D, 2005, BIOCHEM BIOPH RES CO, V326, P586, DOI 10.1016/j.bbrc.2004.11.066; Valko M, 2007, INT J BIOCHEM CELL B, V39, P44, DOI 10.1016/j.biocel.2006.07.001; Wijnen H, 2006, PLOS GENET, V2, P326, DOI 10.1371/journal.pgen.0020039; Wijnen H, 2006, ANNU REV GENET, V40, P409, DOI 10.1146/annurev.genet.40.110405.090603; Xu KY, 2008, CELL METAB, V8, P289, DOI 10.1016/j.cmet.2008.09.006; Xu KY, 2011, CELL METAB, V13, P639, DOI 10.1016/j.cmet.2011.05.001	63	59	59	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 30	2012	7	11							e50454	10.1371/journal.pone.0050454	http://dx.doi.org/10.1371/journal.pone.0050454			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	054WM	23226288	gold, Green Submitted, Green Published			2022-12-27	WOS:000312376100100
J	Beleza, S; Campos, J; Lopes, J; Araujo, II; Almada, AH; Silva, ACE; Parra, EJ; Rocha, J				Beleza, Sandra; Campos, Joana; Lopes, Jailson; Araujo, Isabel Ines; Almada, Ana Hoppfer; Correia e Silva, Antonio; Parra, Esteban J.; Rocha, Jorge			The Admixture Structure and Genetic Variation of the Archipelago of Cape Verde and Its Implications for Admixture Mapping Studies	PLOS ONE			English	Article							Y-CHROMOSOME; SKIN PIGMENTATION; BLOOD-PRESSURE; SOCIAL CLASSIFICATION; ANCESTRAL PROPORTIONS; GENOMIC ANCESTRY; POPULATION; COLOR; LEGACY; PHYLOGEOGRAPHY	Recently admixed populations offer unique opportunities for studying human history and for elucidating the genetic basis of complex traits that differ in prevalence between human populations. Historical records, classical protein markers, and preliminary genetic data indicate that the Cape Verde islands in West Africa are highly admixed and primarily descended from European males and African females. However, little is known about the variation in admixture levels, admixture dynamics and genetic diversity across the islands, or about the potential of Cape Verde for admixture mapping studies. We have performed a detailed analysis of phenotypic and genetic variation in Cape Verde based on objective skin color measurements, socio-economic status (SES) evaluations and data for 50 autosomal, 34 X-chromosome, and 21 nonrecombinant Y-chromosome (NRY) markers in 845 individuals from six islands of the archipelago. We find extensive genetic admixture between European and African ancestral populations (mean West African ancestry = 0.57, sd = 0.08), with individual African ancestry proportions varying considerably among the islands. African ancestry proportions calculated with X and Y-chromosome markers confirm that the pattern of admixture has been sex-biased. The high-resolution NRY-STRs reveal additional patterns of variation among the islands that are most consistent with differentiation after admixture. The differences in the autosomal admixture proportions are clearly evident in the skin color distribution across the islands (Pearson r = 0.54, P-value<2e-16). Despite this strong correlation, there are significant interactions between SES and skin color that are independent of the relationship between skin color and genetic ancestry. The observed distributions of admixture, genetic variation and skin color and the relationship of skin color with SES relate to historical and social events taking place during the settlement history of Cape Verde, and have implications for the design of association studies using this population.	[Beleza, Sandra; Campos, Joana; Rocha, Jorge] Univ Porto, Inst Patol & Imunol Mol, IPATIMUP, P-4100 Oporto, Portugal; [Lopes, Jailson; Rocha, Jorge] Ctr Invest Biodiversidade & Recursos Genet, CIBIO, Vairao, Portugal; [Lopes, Jailson; Araujo, Isabel Ines; Almada, Ana Hoppfer; Correia e Silva, Antonio] Univ Cabo Verde, Cabo Verde, Portugal; [Parra, Esteban J.] Univ Toronto, Dept Anthropol, Mississauga, ON L5L 1C6, Canada; [Rocha, Jorge] Univ Porto, Dept Biol, Fac Ciencias, P-4100 Oporto, Portugal	Universidade do Porto; Universidade do Porto; University of Toronto; University Toronto Mississauga; Universidade do Porto	Beleza, S (corresponding author), Stanford Univ, Sch Med, Dept Genet, Palo Alto, CA 94304 USA.	sbeleza@stanford.edu		rocha, jorge/0000-0001-5460-7615; parra, esteban J/0000-0002-2057-8577; Monteiro de Pina Araujo, Isabel Ines/0000-0001-7766-1059; Beleza, Sandra/0000-0002-7004-3431	Portuguese Institution "Fundacao para a Ciencia e a Tecnologia" (FCT) [PTDC/BIA-BDE/64044/2006]; FCT [SFRH/BPD/21887/2005]; Calouste Gulbenkian Foundation	Portuguese Institution "Fundacao para a Ciencia e a Tecnologia" (FCT); FCT(Portuguese Foundation for Science and TechnologyEuropean Commission); Calouste Gulbenkian Foundation	This work was supported by the Portuguese Institution "Fundacao para a Ciencia e a Tecnologia" (FCT; PTDC/BIA-BDE/64044/2006). SB was supported by FCT (SFRH/BPD/21887/2005). JL was supported by a Calouste Gulbenkian Foundation fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams SM, 2008, AM J HUM GENET, V83, P725, DOI 10.1016/j.ajhg.2008.11.007; [Anonymous], 2000, FIELD METHOD, DOI DOI 10.1177/1525822X0001200104; Balaresque P, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000285; Baleno IC., 2001, HIST GERAL CABO VERD, P125; BANDELT HJ, 1995, GENETICS, V141, P743; Bandelt HJ, 1999, MOL BIOL EVOL, V16, P37, DOI 10.1093/oxfordjournals.molbev.a026036; Basu A, 2009, OBESITY, V17, P1226, DOI 10.1038/oby.2009.24; Beleza S, 2006, ANN HUM GENET, V70, P181, DOI 10.1111/j.1529-8817.2005.00221.x; Beleza S, 2005, HUM GENET, V117, P366, DOI 10.1007/s00439-005-1290-3; Bonilla C, 2004, HUM GENET, V115, P57, DOI 10.1007/s00439-004-1125-7; Brehm A, 2002, ANN HUM GENET, V66, P49, DOI 10.1017/S0003480001001002; Bryc K, 2010, P NATL ACAD SCI USA, V107, P786, DOI 10.1073/pnas.0909559107; Carreira, 1983, CABO VERDE FORMACAO; Carvalho-Silva DR, 2001, AM J HUM GENET, V68, P281, DOI 10.1086/316931; Coelho M, 2009, BMC EVOL BIOL, V9, DOI 10.1186/1471-2148-9-80; Correia e Silva A, 2001, HIST GERAL CABO VERD; Correia e Silva A, 2000, NOS TEMPOS PORTO GRA; Correia e Silva AL., 2002, HIST GERAL CABO VERD, P1; Cruciani F, 2002, AM J HUM GENET, V70, P1197, DOI 10.1086/340257; Curtin Philip D., 1998, RISE FALL PLANTATION; Dupanloup I, 2001, MOL BIOL EVOL, V18, P672, DOI 10.1093/oxfordjournals.molbev.a003847; Ellis N, 2002, GENOME RES, V12, P339; Excoffier L, 2005, EVOL BIOINFORM, V1, P47, DOI 10.1177/117693430500100003; Fernandes AT, 2003, ANN HUM GENET, V67, P340, DOI 10.1046/j.1469-1809.2003.00029.x; Florez JC, 2009, DIABETOLOGIA, V52, P1528, DOI 10.1007/s00125-009-1412-x; Freedman ML, 2006, P NATL ACAD SCI USA, V103, P14068, DOI 10.1073/pnas.0605832103; Giolo SR, 2012, EUR J HUM GENET, V20, P111, DOI 10.1038/ejhg.2011.144; Goncalves R, 2003, HUM GENET, V113, P467, DOI 10.1007/s00439-003-1007-4; Gravlee CC, 2005, AM J PUBLIC HEALTH, V95, P2191, DOI 10.2105/AJPH.2005.065615; Gravlee CC, 2005, AM J HUM BIOL, V17, P195, DOI 10.1002/ajhb.20111; Gravlee CC, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006821; Heyer E, 2005, TRENDS GENET, V21, P234, DOI 10.1016/j.tig.2005.02.007; Hoggart CJ, 2004, AM J HUM GENET, V74, P965, DOI 10.1086/420855; Hoggart CJ, 2003, AM J HUM GENET, V72, P1492, DOI 10.1086/375613; Kao WHL, 2008, NAT GENET, V40, P1185, DOI 10.1038/ng.232; Montrond AA, 2008, FRANCOIS LOUIS ARMAN; Myakishev MV, 2001, GENOME RES, V11, P163, DOI 10.1101/gr.157901; Nalls MA, 2008, AM J HUM GENET, V82, P81, DOI 10.1016/j.ajhg.2007.09.003; Parra EJ, 2001, AM J PHYS ANTHROPOL, V114, P18, DOI 10.1002/1096-8644(200101)114:1<18::AID-AJPA1002>3.0.CO;2-2; Parra EJ, 2004, NAT GENET, V36, pS54, DOI 10.1038/ng1440; Parra EJ, 1998, AM J HUM GENET, V63, P1839, DOI 10.1086/302148; PARRA EJ, 1995, AM J PHYS ANTHROPOL, V97, P381, DOI 10.1002/ajpa.1330970405; Parra FC, 2003, P NATL ACAD SCI USA, V100, P177, DOI 10.1073/pnas.0126614100; Pena SDJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017063; Quillen EE, 2011, AM J HUM BIOL, V23, P567, DOI 10.1002/ajhb.21183; Reich D, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000360; Rosa A, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-124; Russell-Wood A. J. R., 1998, PORTUGUESE EMPIRE 14; Santos RV, 2009, CURR ANTHROPOL, V50, P787, DOI 10.1086/644532; Semino O, 2002, AM J HUM GENET, V70, P265, DOI 10.1086/338306; Shriver MD, 2003, HUM GENET, V112, P387, DOI 10.1007/s00439-002-0896-y; Shriver MD, 2000, AM J PHYS ANTHROPOL, V112, P17, DOI 10.1002/(SICI)1096-8644(200005)112:1<17::AID-AJPA3>3.0.CO;2-D; Smith MW, 2004, AM J HUM GENET, V74, P1001, DOI 10.1086/420856; Tishkoff SA, 2009, SCIENCE, V324, P1035, DOI 10.1126/science.1172257; Tomas G, 2002, HUM BIOL, V74, P397, DOI 10.1353/hub.2002.0036; Trovoada MJ, 2004, ANN HUM GENET, V68, P40, DOI 10.1046/j.1529-8817.2003.00070.x; Underhill PA, 2001, ANN HUM GENET, V65, P43, DOI 10.1046/j.1469-1809.2001.6510043.x; Winkler CA, 2010, ANNU REV GENOM HUM G, V11, P65, DOI 10.1146/annurev-genom-082509-141523; Zakharia F, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-12-r141; Zerjal T, 2003, AM J HUM GENET, V72, P717, DOI 10.1086/367774	60	18	18	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 30	2012	7	11							e51103	10.1371/journal.pone.0051103	http://dx.doi.org/10.1371/journal.pone.0051103			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	054WM	23226471	Green Published, gold, Green Submitted			2022-12-27	WOS:000312376100282
J	Chan, M; Johansson, MA				Chan, Miranda; Johansson, Michael A.			The Incubation Periods of Dengue Viruses	PLOS ONE			English	Article							YELLOW-FEVER VIRUS; AEDES-AEGYPTI; HEMORRHAGIC-FEVER; UNITED-STATES; INFECTION; SUSCEPTIBILITY; TRANSMISSION; TEMPERATURE; SEROTYPE-2; TRAVELER	Dengue viruses are major contributors to illness and death globally. Here we analyze the extrinsic and intrinsic incubation periods (EIP and IIP), in the mosquito and human, respectively. We identified 146 EIP observations from 8 studies and 204 IIP observations from 35 studies. These data were fitted with censored Bayesian time-to-event models. The best-fitting temperature-dependent EIP model estimated that 95% of EIPs are between 5 and 33 days at 25 degrees C, and 2 and 15 days at 30 degrees C, with means of 15 and 6.5 days, respectively. The mean IIP estimate was 5.9 days, with 95% expected between days 3 and 10. Differences between serotypes were not identified for either incubation period. These incubation period models should be useful in clinical diagnosis, outbreak investigation, prevention and control efforts, and mathematical modeling of dengue virus transmission.	[Johansson, Michael A.] Ctr Dis Control & Prevent, Dengue Branch, Div Vector Borne Dis, San Juan, PR USA; [Chan, Miranda] Emory Univ, Rollins Sch Publ Hlth, Dept Epidemiol, Atlanta, GA 30322 USA	Centers for Disease Control & Prevention - USA; Emory University; Rollins School Public Health	Johansson, MA (corresponding author), Ctr Dis Control & Prevent, Dengue Branch, Div Vector Borne Dis, San Juan, PR USA.	mjohansson@cdc.gov		Johansson, Michael/0000-0002-5090-7722				Amendola G., 1996, Mediterranean Journal of Infectious and Parasitic Diseases, V11, P61; Anderson Teresa, 2011, Morbidity and Mortality Weekly Report, V60, P914; Armstrong PM, 2001, VECTOR-BORNE ZOONOT, V1, P159, DOI 10.1089/153036601316977769; Armstrong PM, 2003, AM J TROP MED HYG, V68, P539, DOI 10.4269/ajtmh.2003.68.539; Bancroft T.L., 1906, AUST MED GAZ, V25, P17; BLACKBURN NK, 1987, S AFR MED J, V71, P386; BLANC GEORGES, 1930, ANN INST PASTEUR [PARIS], V44, P367; Brooks SP, 1998, J COMPUT GRAPH STAT, V7, P434, DOI 10.2307/1390675; Cardosa J, 2009, PLOS NEGLECT TROP D, V3, DOI 10.1371/journal.pntd.0000423; Carpenter DN, 1905, J AMER MED ASSOC, V44, P214; Centers for Disease Control and Prevention, 1982, MMWR-MORBID MORTAL W, V30, P622; CHANDLER A. C., 1923, American Journal of Tropical Medicine, V3, P233; Chaturvedi UC, 2006, FEMS IMMUNOL MED MIC, V47, P155, DOI 10.1111/j.1574-695X.2006.00058.x; Christophers, 1960, AEDES AEGYPTI L YELL; CLELAND J. B., 1916, Medical Journal of Australia, V2, P179; Coffey LL, 2009, MICROBES INFECT, V11, P143, DOI 10.1016/j.micinf.2008.12.006; Courtney M, 2009, PEDIATR EMERG CARE, V25, P769, DOI 10.1097/PEC.0b013e3181bec8c7; Davis NC, 1932, AM J HYG, V16, P163, DOI 10.1093/oxfordjournals.aje.a117853; Durand JP, 2000, EMERG INFECT DIS, V6, P83, DOI 10.3201/eid0601.000116; FOCKS DA, 1995, AM J TROP MED HYG, V53, P489, DOI 10.4269/ajtmh.1995.53.489; Gasperino J, 2007, LIVER INT, V27, P1148, DOI 10.1111/j.1478-3231.2007.01543.x; GUBLER DJ, 1979, AM J TROP MED HYG, V28, P1045, DOI 10.4269/ajtmh.1979.28.1045; Guzman MG, 2010, NAT REV MICROBIOL, pS7, DOI 10.1038/nrmicro2460; Halstead SB, 2008, ANNU REV ENTOMOL, V53, P273, DOI 10.1146/annurev.ento.53.103106.093326; HARDY JL, 1983, ANNU REV ENTOMOL, V28, P229, DOI 10.1146/annurev.en.28.010183.001305; Harris G., 1903, J TROP MED-US, V6, P209; Helbok R, 2004, WIEN KLIN WOCHENSCHR, V116, P58; IWAMOTO I, 1973, Tropical Medicine, V15, P225; JACOBS MG, 1991, BRIT MED J, V302, P828, DOI 10.1136/bmj.302.6780.828; Jensenius M, 2007, SCAND J INFECT DIS, V39, P272, DOI 10.1080/00365540600891307; Johansson MA, 2010, AM J TROP MED HYG, V83, P183, DOI 10.4269/ajtmh.2010.09-0782; Lambrechts L, 2011, P NATL ACAD SCI USA, V108, P7460, DOI 10.1073/pnas.1101377108; Lessler J, 2009, LANCET INFECT DIS, V9, P291, DOI 10.1016/S1473-3099(09)70069-6; Lunn D, 2009, STAT MED, V28, P3049, DOI 10.1002/sim.3680; MALISON MD, 1983, JAMA-J AM MED ASSOC, V249, P496, DOI 10.1001/jama.249.4.496; McCarthy M A, 1995, Can Commun Dis Rep, V21, P185; MCLEAN DM, 1974, CAN J MICROBIOL, V20, P255, DOI 10.1139/m74-040; MELISSANT CF, 1992, NETH J MED, V41, P272; Morita Y, 2008, JPN J INFECT DIS, V61, P90; New M, 2002, CLIMATE RES, V21, P1, DOI 10.3354/cr021001; Nilsson J, 2005, SCAND J INFECT DIS, V37, P776, DOI 10.1080/00365540410020992; Ninove L, 2009, EMERG INFECT DIS, V15, P1871, DOI 10.3201/eid1511.081736; Nishiura H, 2007, J INFECT DIS, V195, P1007, DOI 10.1086/511825; Ooi EE, 2009, FUTURE VIROL, V4, P571, DOI 10.2217/FVL.09.55; PATEY O, 1993, AM J TROP MED HYG, V48, P793, DOI 10.4269/ajtmh.1993.48.793; Rico-Hesse R, 2010, CURR TOP MICROBIOL, V338, P45, DOI 10.1007/978-3-642-02215-9_4; Rohani A, 2009, SE ASIAN J TROP MED, V40, P942; San Juan Laboratories, 1986, DENGUE SURVEILLANCE, V29, P1; SARTWELL PE, 1950, AM J HYG, V51, P310, DOI 10.1093/oxfordjournals.aje.a119397; SCHLEUPNER CJ, 1977, WESTERN J MED, V127, P145; SCHULE P. A., 1928, American Journal of Tropical Medicine, V8, P203; SILER J. F., 1926, PHILIPPINE JOUR SCI, V29, P1; SIMMONS JAMES STEVENS, 1931, PHILIPPINE JOUR SCI, V44, P1; SNIJDERS E. P., 1931, American Journal of Tropical Medicine, V11, P171; Spiegelhalter DJ, 2002, J R STAT SOC B, V64, P583, DOI 10.1111/1467-9868.00353; Sturtz S, 2005, J STAT SOFTW, V12, P1, DOI 10.18637/jss.v012.i03; Takasaki T, 2008, J TRAVEL MED, V15, P46, DOI 10.1111/j.1708-8305.2007.00165.x; Tavakoli NP, 2007, J CLIN MICROBIOL, V45, P1523, DOI 10.1128/JCM.00209-07; Teichmam D, 1999, EUR J CLIN MICROBIOL, V18, P310, DOI 10.1007/s100960050285; Thai KTD, 2011, EXP BIOL MED, V236, P944, DOI 10.1258/ebm.2011.010402; Tomashek KM, 2011, CDC HLTH INFORM INT, P156; Trout A., 2010, Morbidity and Mortality Weekly Report, V59, P577; VAINIO K, 2010, EURO SURVEILL, V15; Waagsbo B, 2010, J CLIN VIROL, V47, P303, DOI 10.1016/j.jcv.2009.11.005; WATTS DM, 1987, AM J TROP MED HYG, V36, P143, DOI 10.4269/ajtmh.1987.36.143; Weaver SC, 2009, INFECT GENET EVOL, V9, P523, DOI 10.1016/j.meegid.2009.02.003; World Health Organization, 2009, DENGUE GUIDELINES DI	68	284	293	6	75	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 30	2012	7	11							e50972	10.1371/journal.pone.0050972	http://dx.doi.org/10.1371/journal.pone.0050972			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	054WM	23226436	Green Submitted, Green Published, gold			2022-12-27	WOS:000312376100247
J	Cortese, M; Calo, S; D'Aurizio, R; Lilja, A; Pacchiani, N; Merola, M				Cortese, Mirko; Calo, Stefano; D'Aurizio, Romina; Lilja, Anders; Pacchiani, Nicola; Merola, Marcello			Recombinant Human Cytomegalovirus (HCMV) RL13 Binds Human Immunoglobulin G Fc	PLOS ONE			English	Article							SIMPLEX-VIRUS TYPE-1; GLYCOPROTEIN-E; RECEPTOR; PROTEIN; IDENTIFICATION; PREDICTION; GENOME; IGG; INTERNALIZATION; EXPRESSION	The human cytomegalovirus (HCMV) protein RL13 has recently been described to be present in all primary isolates but rapidly mutated in culture adapted viruses. Although these data suggest a crucial role for this gene product in HCMV primary infection, no function has so far been assigned to this protein. Working with RL13 expressed in isolation in transfected human epithelial cells, we demonstrated that recombinant RL13 from the clinical HCMV isolates TR and Merlin have selective human immunoglobulin (Ig)-binding properties towards IgG1 and IgG2 subtypes. An additional Fc binding protein, RL12, was also identified as an IgG1 and IgG2 binding protein but not further characterized. The glycoprotein RL13 trafficked to the plasma membrane where it bound and internalized exogenous IgG or its constant fragment (Fcc). Analysis of RL13 ectodomain mutants suggested that the RL13 Ig-like domain is responsible for the Fc binding activity. Ligand-dependent internalization relied on a YxxL endocytic motif located in the C-terminal tail of RL13. Additionally, we showed that the tyrosine residue could be replaced by phenylalanine but not by alanine, indicating that the internalization signal was independent from phosphorylation events. In sum, RL13 binds human IgG and may contribute to HCMV immune evasion in the infected host, but this function does not readily explain the instability of the RL13 gene during viral propagation in cultured cells.	[Cortese, Mirko; Calo, Stefano; D'Aurizio, Romina; Pacchiani, Nicola; Merola, Marcello] Novartis Vaccines & Diagnost, Siena, Italy; [Lilja, Anders] Novartis Vaccines & Diagnost, Cambridge, MA USA; [Merola, Marcello] Univ Naples Federico II, Dept Struct & Funct Biol, Naples, Italy	Novartis; Novartis; University of Naples Federico II	Merola, M (corresponding author), Novartis Vaccines & Diagnost, Siena, Italy.	marcello.merola@novartis.com	Cortese, Mirko/T-4742-2019; D'Aurizio, Romina/J-8762-2016	Cortese, Mirko/0000-0003-1786-4211; D'Aurizio, Romina/0000-0002-1728-6397	Novartis; Ministero dell'Istruzione dell'Universita e della Ricerca [PON01_00117]; Novartis Vaccines Diagnostics; Novartis fellowship from the PhD program in Cellular, Molecular and Industrial Biology of the University of Bologna; Novartis from PhD program in Cellular Biology of the University of Padua	Novartis(Novartis); Ministero dell'Istruzione dell'Universita e della Ricerca(Ministry of Education, Universities and Research (MIUR)); Novartis Vaccines Diagnostics; Novartis fellowship from the PhD program in Cellular, Molecular and Industrial Biology of the University of Bologna; Novartis from PhD program in Cellular Biology of the University of Padua	This study was supported by Novartis and Ministero dell'Istruzione dell'Universita e della Ricerca PON01_00117. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding was received for this study.; This study was funded by Novartis Vaccines Diagnostics and partially by "Ministero dell'Istruzione dell'Universita e della Ricerca, grant number PON01_00117". This does not alter the authors' adherence to all the PLOS ONE policies on sharing data and materials, as detailed online in the guide for authors. Commercial funder does not alter authors' adherence to all the PLOS ONE policies on sharing data and materials. MC and SC are the recipients of a Novartis fellowship from the PhD program in Cellular, Molecular and Industrial Biology of the University of Bologna, and from the PhD program in Cellular Biology of the University of Padua, respectively. RD, AL and NP are full-time employees of Novartis Vaccines and Diagnostics. MM is employee of the University of Naples "Federico II" and Novartis external collaborator.	Akter P, 2003, J GEN VIROL, V84, P1117, DOI 10.1099/vir.0.18952-0; Atalay R, 2002, J VIROL, V76, P8596, DOI 10.1128/JVI.76.17.8596-8608.2002; Bonifacino JS, 2003, ANNU REV BIOCHEM, V72, P395, DOI 10.1146/annurev.biochem.72.121801.161800; Britt W, 2008, CURR TOP MICROBIOL, V325, P417; Chan JFW, 2011, CLIN VACCINE IMMUNOL, V18, P305, DOI 10.1128/CVI.00363-10; Dargan DJ, 2010, J GEN VIROL, V91, P1535, DOI 10.1099/vir.0.018994-0; Davison AJ, 2003, J GEN VIROL, V84, P17, DOI 10.1099/vir.0.18606-0; Dolan A, 2004, J GEN VIROL, V85, P1301, DOI 10.1099/vir.0.79888-0; DUBIN G, 1990, J VIROL, V64, P2725, DOI 10.1128/JVI.64.6.2725-2731.1990; FRANK I, 1989, J VIROL, V63, P4479, DOI 10.1128/JVI.63.11.4479-4488.1989; Gordon CL, 2010, CLIN INFECT DIS, V50, P672, DOI 10.1086/650462; Hook LM, 2007, HUMAN HERPESVIRUSES: BIOLOGY, THERAPY, AND IMMUNOPROPHYLAXIS, P1137; Jones DT, 1999, J MOL BIOL, V292, P195, DOI 10.1006/jmbi.1999.3091; Julenius K, 2005, GLYCOBIOLOGY, V15, P153, DOI 10.1093/glycob/cwh151; Kall L, 2004, J MOL BIOL, V338, P1027, DOI 10.1016/j.jmb.2004.03.016; Letunic I, 2009, NUCLEIC ACIDS RES, V37, pD229, DOI 10.1093/nar/gkn808; Lichtenstein DL, 2002, J VIROL, V76, P11329, DOI 10.1128/JVI.76.22.11329-11342.2002; Lilley BN, 2001, J VIROL, V75, P11218, DOI 10.1128/JVI.75.22.11218-11221.2001; LIPMAN DJ, 1985, SCIENCE, V227, P1435, DOI 10.1126/science.2983426; LITWIN V, 1992, J VIROL, V66, P3643, DOI 10.1128/JVI.66.6.3643-3651.1992; Mocarski ES., 2007, FIELDS VIROLOGY, P2702; Moorman NJ, 2010, MOL CELL PROTEOMICS, V9, P851, DOI 10.1074/mcp.M900485-MCP200; Mulder Nicola, 2007, V396, P59; Murphy E, 2008, CURR TOP MICROBIOL, V325, P1; Murphy E, 2003, P NATL ACAD SCI USA, V100, P14976, DOI 10.1073/pnas.2136652100; Pan Q, 2000, IMMUNOL REV, V178, P99, DOI 10.1034/j.1600-065X.2000.17815.x; PARA MF, 1982, J VIROL, V41, P137, DOI 10.1128/JVI.41.1.137-144.1982; Powers C, 2008, CURR TOP MICROBIOL, V325, P333; Reeves M, 2008, CURR TOP MICROBIOL, V325, P297; Rice P, 2000, TRENDS GENET, V16, P276, DOI 10.1016/S0168-9525(00)02024-2; Schneider-Merck T, 2010, J IMMUNOL, V184, P512, DOI 10.4049/jimmunol.0900847; Sekulin K, 2007, VIRUS GENES, V35, P577, DOI 10.1007/s11262-007-0158-0; Sprague ER, 2008, J VIROL, V82, P3490, DOI 10.1128/JVI.01476-07; Sprague ER, 2006, PLOS BIOL, V4, P975, DOI 10.1371/journal.pbio.0040148; Stanton RJ, 2010, J CLIN INVEST, V120, P3191, DOI 10.1172/JCI42955; Taly JF, 2011, NAT PROTOC, V6, P1669, DOI 10.1038/nprot.2011.393; THALE R, 1994, J VIROL, V68, P7757; Tortorella D, 2000, ANNU REV IMMUNOL, V18, P861, DOI 10.1146/annurev.immunol.18.1.861; Van de Walle GR, 2003, J GEN VIROL, V84, P939, DOI 10.1099/vir.0.18663-0; Varnum SM, 2004, J VIROL, V78, P10960, DOI 10.1128/JVI.78.20.10960-10966.2004; Wang FS, 2005, J VIROL, V79, P13362, DOI 10.1128/JVI.79.21.13362-13372.2005; Weeks BS, 1997, BIOCHEM BIOPH RES CO, V235, P31, DOI 10.1006/bbrc.1997.6720	43	36	36	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 30	2012	7	11							e50166	10.1371/journal.pone.0050166	http://dx.doi.org/10.1371/journal.pone.0050166			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	054WM	23226246	Green Submitted, Green Published, gold			2022-12-27	WOS:000312376100055
J	Dutra, RL; de Carvalho, MB; dos Santos, M; Mercante, AMD; Gazito, D; de Cicco, R; Tajara, EH; Louro, ID; da Silva, AMA				Dutra, Roberta Lelis; de Carvalho, Marcos Brasilino; dos Santos, Marcelo; da Cunha Mercante, Ana Maria; Gazito, Diana; de Cicco, Rafael; Tajara, Eloiza Helena; Louro, Iuri Drumond; Alvares da Silva, Adriana Madeira		GENCAPO Grp	FGFR4 Profile as a Prognostic Marker in Squamous Cell Carcinoma of the Mouth and Oropharynx	PLOS ONE			English	Article							FACTOR RECEPTOR 4; BREAST-CANCER; GLY388ARG POLYMORPHISM; ARG(388) ALLELE; ARG388 ALLELE; TISSUE MICROARRAYS; UBIQUITIN-BINDING; NECK-CANCER; GENE; HEAD	Background: Fibroblast growth factor receptor 4 (FGFR4) is a member of a receptor tyrosine kinase family of enzymes involved in cell cycle control and proliferation. A common single nucleotide polymorphism (SNP) Gly388Arg variant has been associated with increased tumor cell motility and progression of breast cancer, head and neck cancer and soft tissue sarcomas. The present study evaluated the prognostic significance of FGFR4 in oral and oropharynx carcinomas, finding an association of FGFR4 expression and Gly388Arg genotype with tumor onset and prognosis. Patients and Methods: DNA from peripheral blood of 122 patients with oral and oropharyngeal squamous cell carcinomas was used to determine FGFR4 genotype by PCR-RFLP. Protein expression was assessed by immunohistochemistry (IHC) on paraffin-embedded tissue microarrays. Results: Presence of allele Arg388 was associated with lymphatic embolization and with disease related premature death. In addition, FGFR4 low expression was related with lymph node positivity and premature relapse of disease, as well as disease related death. Conclusion: Our results propose FGFR4 profile, measured by the Gly388Arg genotype and expression, as a novel marker of prognosis in squamous cell carcinoma of the mouth and oropharynx.	[Alvares da Silva, Adriana Madeira] Univ Fed Espirito Santo, Dept Biol, Alegre, ES, Brazil; [Dutra, Roberta Lelis] Univ Sao Paulo, Fac Med, Sao Paulo, Brazil; [de Carvalho, Marcos Brasilino] Hosp Heliopolis, Mol Biol Lab, Sao Paulo, Brazil; [de Carvalho, Marcos Brasilino] Hosp Heliopolis, Serv Cirurgia Cabeca & Pescoco, Sao Paulo, Brazil; [dos Santos, Marcelo] Univ Fed Espirito Santo, Programa Pos Grad Biotecnol, Vitoria, ES, Brazil; [da Cunha Mercante, Ana Maria] Hosp Heliopolis, Dept Anat Patol, Sao Paulo, Brazil; [Gazito, Diana] Assoc Beneficente Coleta Sangue, Lab Sequenciamento, Sao Paulo, Brazil; [de Cicco, Rafael] Inst Canc Res, Sao Paulo, Brazil; [GENCAPO Grp] GENCAPO, Head & Neck Genome Project, Sao Paulo, Brazil; [Tajara, Eloiza Helena] Fac Med Sao Jose Rio Preto, Dept Biol Mol, Sao Paulo, Brazil; [Louro, Iuri Drumond] Univ Fed Espirito Santo, Dept Ciencias Biol, Vitoria, ES, Brazil	Universidade Federal do Espirito Santo; Universidade de Sao Paulo; Universidade Federal do Espirito Santo; Universidade de Sao Paulo; Universidade Federal do Espirito Santo	da Silva, AMA (corresponding author), Univ Fed Espirito Santo, Dept Biol, Alegre, ES, Brazil.	adriana.biomol@gmail.com	Álvares-da-Silva, Adriana M/J-2912-2018; Tajara, Eloiza H/G-7586-2012; Figueiredo, David Livingstone Alves/J-8474-2016; dos Santos, Marcelo/K-2582-2012; Rodrigues-Lisoni, Flavia Cristina/P-2447-2015; Dutra, Roberta/D-4421-2012; De Cicco, Rafael/AAM-8926-2020; Louro, Iuri D/I-8641-2012; Brasilino de Carvalho, Marcos/C-1869-2014; Guimaraes, Pedro/A-9715-2008	Álvares-da-Silva, Adriana M/0000-0002-8078-0304; Tajara, Eloiza H/0000-0002-2603-2057; dos Santos, Marcelo/0000-0001-7321-7479; Rodrigues-Lisoni, Flavia Cristina/0000-0002-8855-9049; Louro, Iuri/0000-0001-5160-9615; Figueiredo, David Livingstone Alves/0000-0002-5446-296X; De Cicco, Rafael/0000-0003-2505-0461; Brasilino de Carvalho, Marcos/0000-0001-6854-2680; Guimaraes, Pedro/0000-0002-7530-600X	FAPESP [04/15022-0, 04/12054-9]	FAPESP(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP))	This work was supported by FAPESP grants no 04/15022-0 and no 04/12054-9 (Fundacao de Apoio a Pesquisa de Sao Paulo, http://www.fapesp.br/). FAPESP is a Research support institution with the sole role of financing peer reviewed projects of the Sao Paulo State. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andrade VCD, 2007, EXP MOL PATHOL, V82, P53, DOI 10.1016/j.yexmp.2006.05.003; Ansell A, 2009, ORAL ONCOL, V45, P23, DOI 10.1016/j.oraloncology.2008.03.007; Bange J, 2002, CANCER RES, V62, P840; Becker N, 2003, CANCER EPIDEM BIOMAR, V12, P582; Burke D, 1998, TRENDS BIOCHEM SCI, V23, P59, DOI 10.1016/S0968-0004(97)01170-5; Campos AHJFM, 2009, MOL CELL BIOCHEM, V321, P95, DOI 10.1007/s11010-008-9923-1; Cappellen D, 1999, NAT GENET, V23, P18, DOI 10.1038/12615; Cavallaro U, 2001, NAT CELL BIOL, V3, P650, DOI 10.1038/35083041; Chandarlapaty S, 2011, CANCER CELL, V19, P58, DOI 10.1016/j.ccr.2010.10.031; Dailey L, 2005, CYTOKINE GROWTH F R, V16, P233, DOI 10.1016/j.cytogfr.2005.01.007; Ezzat S, 2002, J CLIN INVEST, V109, P69, DOI 10.1172/JCI200214036; Frullanti E, 2011, EUR J CANCER PREV, V20, P340, DOI 10.1097/CEJ.0b013e3283457274; Hedvat CV, 2002, HUM PATHOL, V33, P968, DOI 10.1053/hupa.2002.127438; Hsu FD, 2002, MODERN PATHOL, V15, P1374, DOI 10.1097/01.MP.0000039571.02827.CE; Hurley JH, 2006, BIOCHEM J, V399, P361, DOI 10.1042/BJ20061138; Jebar AH, 2005, ONCOGENE, V24, P5218, DOI 10.1038/sj.onc.1208705; Jeffers Michael, 2002, Expert Opin Ther Targets, V6, P469, DOI 10.1517/14728222.6.4.469; Jezequel P, 2004, BRIT J CANCER, V90, P189, DOI 10.1038/sj.bjc.6601450; Kirkin V, 2007, CURR OPIN CELL BIOL, V19, P199, DOI 10.1016/j.ceb.2007.02.002; Lemmon MA, 2010, CELL, V141, P1117, DOI 10.1016/j.cell.2010.06.011; Liu LW, 2011, UROL INT, V87, P159, DOI 10.1159/000329069; Lopez-Knowles E, 2006, CANCER RES, V66, P7401, DOI 10.1158/0008-5472.CAN-06-1182; Marme F, 2012, INT J CANCER, V131, pE586, DOI 10.1002/ijc.27329; Mayland MK, 2005, LARYNGOSCOPE, V115, P629, DOI 10.1097/01.mlg.0000161338.54515.b1; MILLER SA, 1988, NUCLEIC ACIDS RES, V16, P1215, DOI 10.1093/nar/16.3.1215; Morimoto Y, 2003, CANCER, V98, P2245, DOI 10.1002/cncr.11778; Olson DC, 1998, CELL GROWTH DIFFER, V9, P557; Powers CJ, 2000, ENDOCR-RELAT CANCER, V7, P165, DOI 10.1677/erc.0.0070165; Ragin CCR, 2007, J DENT RES, V86, P104, DOI 10.1177/154405910708600202; Rimm DL, 2001, EXP MOL PATHOL, V70, P255, DOI 10.1006/exmp.2001.2363; Seitzer N, 2010, CANCER RES, V70, P802, DOI 10.1158/0008-5472.CAN-09-3239; Shah RNH, 2002, ONCOGENE, V21, P8251, DOI 10.1038/sj.onc.1206020; Sobin, 2009, UICC TNM CLASSIFICAT; Soini Y, 2000, BRIT J CANCER, V83, P880, DOI 10.1054/bjoc.2000.1384; Spinola M, 2005, ONCOL REP, V14, P415; Spinola M, 2005, J CLIN ONCOL, V23, P7307, DOI 10.1200/JCO.2005.17.350; Streit S, 2006, BRIT J CANCER, V94, P1879, DOI 10.1038/sj.bjc.6603181; Streit S, 2004, INT J CANCER, V111, P213, DOI 10.1002/ijc.20204; Tanuma JI, 2010, ONCOL REP, V23, P739, DOI 10.3892/or_00000692; Tateno T, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002400; Thussbas C, 2006, J CLIN ONCOL, V24, P3747, DOI 10.1200/JCO.2005.04.8587; Triantis V, 2010, HEPATOLOGY, V52, P656, DOI 10.1002/hep.23708; Turke AB, 2012, CANCER RES, V72, P3228, DOI 10.1158/0008-5472.CAN-11-3747; Xu B, 2011, BMC CANCER, V11, DOI 10.1186/1471-2407-11-84	44	25	26	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 30	2012	7	11							e50747	10.1371/journal.pone.0050747	http://dx.doi.org/10.1371/journal.pone.0050747			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	054WM	23226373	Green Published, Green Submitted, gold			2022-12-27	WOS:000312376100184
J	Feldacker, C; Johnson, D; Hosseinipour, M; Phiri, S; Tweya, H				Feldacker, Caryl; Johnson, Derek; Hosseinipour, Mina; Phiri, Sam; Tweya, Hannock			Who Starts? Factors Associated with Starting Antiretroviral Therapy among Eligible Patients in Two, Public HIV Clinics in Lilongwe, Malawi	PLOS ONE			English	Article							SUB-SAHARAN AFRICA; FOLLOW-UP; TREATMENT PROGRAMS; EARLY MORTALITY; PATIENTS LOST; PRE-ART; CARE; RETENTION; INITIATION; OUTCOMES	Background: Lighthouse Trust operates two, public, integrated HIV clinics, Lighthouse (LH) and Martin Preuss Center (MPC), in Lilongwe, Malawi. Approximately 20% of patients eligible for antiretroviral therapy (ART) do not start ART. We explore individual and geographic factors that influence whether ART-eligible patients initiate ART. Methods: Adult patients eligible for ART between 2008-2011 were included. Analysis was stratified by clinic. Using logistic regression, we evaluated factors associated with initiating ART including gender, age, body mass index (BMI), employment, tuberculosis (TB), eligible at initial registration, WHO stage, CD4, months in pre-ART care (from initial registration to eligibility date), and patient neighborhood distance to clinic. Results: Of 14,216 study patients, 4841 were from LH; 9285 were from MPC. At LH and MPC, respectively, median age was 34.2 and 33.8 years; median BMI was 22.0 and 20.6; and median distance was 5.6 and 4.9 Km. In multivariate models, odds of starting ART was highest among those older than 35 years and those eligible for ART based on WHO stages 3-4 vs. those in WHO stages 1-2 with CD4<250. Patients with 1-12 months in pre-ART were at least 11 times more likely to start ART than peers with less pre-ART time. At LH, living 2.5-5 Km from the clinic increased the likelihood of starting ART over patients living closer. Conclusions: Length of the pre-ART period is the most significant predictor of starting ART among eligible patients. Better understanding of motivation for retention in pre-ART care may reduce attrition along the treatment cascade.	[Feldacker, Caryl; Phiri, Sam; Tweya, Hannock] Lighthouse Trust, Lilongwe, Malawi; [Feldacker, Caryl] Univ Washington, I TECH, Seattle, WA 98195 USA; [Johnson, Derek; Hosseinipour, Mina] Univ N Carolina Project, Lilongwe, Malawi; [Hosseinipour, Mina] Univ N Carolina, Sch Med, Chapel Hill, NC USA	University of Washington; University of Washington Seattle; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine	Feldacker, C (corresponding author), Lighthouse Trust, Lilongwe, Malawi.	cfeldacker@gmail.com		Feldacker, Caryl/0000-0002-8152-6754	National Institutes of Health; University of Washington; I-TECH; U.S. Department of Health and Human Services, Health Resources and Services Administration (HRSA) [U91HA06801]	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of Washington(University of Washington); I-TECH; U.S. Department of Health and Human Services, Health Resources and Services Administration (HRSA)(United States Department of Health & Human ServicesUnited States Health Resources & Service Administration (HRSA))	Derek Johnson was funded by a Fogarty Fellowship of the National Institutes of Health and worked on this project in partial fulfillment of the requirements of the funding (http://www.fic.nih.gov/Programs/Pages/fulbright-fellowships.aspx). Funding for other authors was not associated with any grants. The development of this paper was supported by the University of Washington and I-TECH with funding from Cooperative Agreement U91HA06801 from the U.S. Department of Health and Human Services, Health Resources and Services Administration (HRSA). The funders played no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amuron B, 2009, BMC PUBLIC HEALTH, V9, DOI 10.1186/1471-2458-9-290; Bassett IV, 2009, JAIDS-J ACQ IMM DEF, V51, P135, DOI 10.1097/QAI.0b013e3181a44ef2; Brinkhof MWG, 2008, B WORLD HEALTH ORGAN, V86, P559, DOI 10.2471/BLT.07.044248; Brinkhof MWG, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005790; Douglas GP, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000319; Faal M, 2011, JAIDS-J ACQ IMM DEF, V58, pE54, DOI 10.1097/QAI.0b013e3182303921; Fox MP, 2010, TROP MED INT HEALTH, V15, P1, DOI 10.1111/j.1365-3156.2010.02508.x; Geng Elvin H, 2010, Curr HIV/AIDS Rep, V7, P234, DOI 10.1007/s11904-010-0061-5; Geng EH, 2010, JAIDS-J ACQ IMM DEF, V53, P405, DOI 10.1097/QAI.0b013e3181b843f0; Google Inc, 2011, GOOGL EARTH SOFTW; Government of Malawi Ministry of Health, 2011, Q HIV PROGR REP; Harries AD, 2010, TROP MED INT HEALTH, V15, P70, DOI 10.1111/j.1365-3156.2010.02506.x; Jani IV, 2011, LANCET, V378, P1572, DOI 10.1016/S0140-6736(11)61052-0; Jarvis JN, 2010, AIDS, V24, P1233, DOI 10.1097/QAD.0b013e3283383aeb; Katz IT, 2011, AIDS, V25, P2177, DOI 10.1097/QAD.0b013e32834b6464; Keiser O, 2008, TROP MED INT HEALTH, V13, P870, DOI 10.1111/j.1365-3156.2008.02078.x; Kitahata MM, 2009, NEW ENGL J MED, V360, P1815, DOI 10.1056/NEJMoa0807252; Kohler PK, 2011, AIDS, V25, P1657, DOI 10.1097/QAD.0b013e32834957fd; Kranzer K, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013801; Lahuerta M, 2011, JAIDS-J ACQ IMM DEF, V58, pE75, DOI 10.1097/QAI.0b013e31822ac0a9; Larson BA, 2010, TROP MED INT HEALTH, V15, P43, DOI 10.1111/j.1365-3156.2010.02511.x; Lawn SD, 2008, AIDS, V22, P1897, DOI 10.1097/QAD.0b013e32830007cd; Lessells RJ, 2011, JAIDS-J ACQ IMM DEF, V56, pE79, DOI 10.1097/QAI.0b013e3182075ae2; Losina E, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009538; Maskew M, 2007, SAMJ S AFR MED J, V97, P853; McGrath N, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/1471-2458-10-601; McGuire M, 2010, TROP MED INT HEALTH, V15, P55, DOI 10.1111/j.1365-3156.2010.02504.x; Ministry of Health and National AIDS Commission, 2011, MAL INT GUID CLIN MA; Ministry of Health Malawi, 2008, TREATM AIDS GUID US; Pepper DJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019484; Phiri S, 2011, TROP MED INT HEALTH, V16, P1397, DOI 10.1111/j.1365-3156.2011.02848.x; Rosen S, 2007, PLOS MED, V4, P1691, DOI 10.1371/journal.pmed.0040298; Rosen S, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1001056; Scott V, 2011, TROP MED INT HEALTH, V16, P1384, DOI 10.1111/j.1365-3156.2011.02842.x; STATA, 2010, STATA 11 0 STAT STAT; Tayler-Smith K, 2010, T ROY SOC TROP MED H, V104, P313, DOI 10.1016/j.trstmh.2010.01.007; Tweya H, 2010, TROP MED INT HEALTH, V15, P82, DOI 10.1111/j.1365-3156.2010.02509.x; Weigel R, 2012, TROP MED INT HEALTH, V17, P751, DOI 10.1111/j.1365-3156.2012.02980.x; World Health Organization, 2004, PERSP PRACT ANT TREA; Yu JKL, 2007, B WORLD HEALTH ORGAN, V85, P550, DOI 10.2471/BLT.06.037739; Zachariah R, 2011, T ROY SOC TROP MED H, V105, P421, DOI 10.1016/j.trstmh.2011.04.014; Zachariah R, 2009, TROP MED INT HEALTH, V14, P713, DOI 10.1111/j.1365-3156.2009.02291.x	42	16	17	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 30	2012	7	11							e50871	10.1371/journal.pone.0050871	http://dx.doi.org/10.1371/journal.pone.0050871			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	054WM	23226413	Green Published, Green Submitted, gold			2022-12-27	WOS:000312376100224
J	Hassan, F; Nuovo, GJ; Crawford, M; Boyaka, PN; Kirkby, S; Nana-Sinkam, SP; Cormet-Boyaka, E				Hassan, Fatemat; Nuovo, Gerard J.; Crawford, Melissa; Boyaka, Prosper N.; Kirkby, Stephen; Nana-Sinkam, Serge P.; Cormet-Boyaka, Estelle			MiR-101 and miR-144 Regulate the Expression of the CFTR Chloride Channel in the Lung	PLOS ONE			English	Article							BRONCHIAL EPITHELIAL-CELLS; FORMALIN-FIXED TISSUES; IN-SITU DETECTION; CYSTIC-FIBROSIS; CIGARETTE-SMOKE; MICRORNAS; TARGETS; GENE; DEHYDRATION; SIGNATURES	The Cystic Fibrosis Transmembrane conductance Regulator (CFTR) is a chloride channel that plays a critical role in the lung by maintaining fluid homeostasis. Absence or malfunction of CFTR leads to Cystic Fibrosis, a disease characterized by chronic infection and inflammation. We recently reported that air pollutants such as cigarette smoke and cadmium negatively regulate the expression of CFTR by affecting several steps in the biogenesis of CFTR protein. MicroRNAs (miRNAs) have recently received a great deal of attention as both biomarkers and therapeutics due to their ability to regulate multiple genes. Here, we show that cigarette smoke and cadmium up-regulate the expression of two miRNAs (miR-101 and miR-144) that are predicted to target CFTR in human bronchial epithelial cells. When premature miR-101 and miR-144 were transfected in human airway epithelial cells, they directly targeted the CFTR 3'UTR and suppressed the expression of the CFTR protein. Since miR-101 was highly up-regulated by cigarette smoke in vitro, we investigated whether such increase also occurred in vivo. Mice exposed to cigarette smoke for 4 weeks demonstrated an up-regulation of miR-101 and suppression of CFTR protein in their lungs. Finally, we show that miR-101 is highly expressed in lung samples from patients with severe chronic obstructive pulmonary disease (COPD) when compared to control patients. Taken together, these results suggest that chronic cigarette smoking up-regulates miR-101 and that this miRNA could contribute to suppression of CFTR in the lungs of COPD patients. Citation: Hassan F, Nuovo GJ, Crawford M, Boyaka PN, Kirkby S, et al. (2012) MiR-101 and miR-144 Regulate the Expression of the CFTR Chloride Channel in the Lung. PLoS ONE 7(11): e50837. doi: 10.1371/journal.pone.0050837	[Hassan, Fatemat; Crawford, Melissa; Kirkby, Stephen; Nana-Sinkam, Serge P.; Cormet-Boyaka, Estelle] Ohio State Univ, Dept Internal Med, Div Pulm Allergy Crit Care & Sleep Med, Columbus, OH 43210 USA; [Nuovo, Gerard J.] Ohio State Univ, Ohio State Comprehens Canc Ctr, Columbus, OH 43210 USA; [Boyaka, Prosper N.] Ohio State Univ, Dept Vet Biosci, Columbus, OH 43210 USA	University System of Ohio; Ohio State University; James Cancer Hospital & Solove Research Institute; University System of Ohio; Ohio State University; University System of Ohio; Ohio State University	Cormet-Boyaka, E (corresponding author), Ohio State Univ, Dept Internal Med, Div Pulm Allergy Crit Care & Sleep Med, Columbus, OH 43210 USA.	boyaka.2@osu.edu	Cormet-Boyaka, Estelle/H-5624-2011	Boyaka, Prosper/0000-0001-6857-9088	National Institutes of Health [RO3 HL095442]; American Lung Association [GRT00019086]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R03HL095442] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Lung Association; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by National Institutes of Health Grants RO3 HL095442, and the American Lung Association GRT00019086. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bodas M, 2011, AM J PHYSIOL-LUNG C, V300, pL811, DOI 10.1152/ajplung.00408.2010; Boucher RC, 2007, J INTERN MED, V261, P5, DOI 10.1111/j.1365-2796.2006.01744.x; Boucher RC, 2004, EUR RESPIR J, V23, P146, DOI 10.1183/09031936.03.00057003; Cantin AM, 2006, AM J RESP CRIT CARE, V173, P1139, DOI 10.1164/rccm.200508-1330OC; Clunes LA, 2012, FASEB J, V26, P533, DOI 10.1096/fj.11-192377; COZENS AL, 1994, AM J RESP CELL MOL, V10, P38, DOI 10.1165/ajrcmb.10.1.7507342; Crawford M, 2009, BIOCHEM BIOPH RES CO, V388, P483, DOI 10.1016/j.bbrc.2009.07.143; Di Leva Gianpiero, 2006, Birth Defects Research, V78, P180, DOI 10.1002/bdrc.20073; Ezzie M. E., 2011, THORAX; Fabbri M, 2008, CANCER J, V14, P1, DOI 10.1097/PPO.0b013e318164145e; Gaedcke J, 2012, CLIN CANC RES; Gillen AE, 2011, BIOCHEM J, V438, P25, DOI 10.1042/BJ20110672; Hassan Jr F, 2011, CIGARETTE SMOKE REGU; Jing Y, 2012, TOXICOL SCI, V125, P10, DOI 10.1093/toxsci/kfr256; Megiorni F, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026601; Mercer BA, 2004, J BIOL CHEM, V279, P17690, DOI 10.1074/jbc.M313842200; Nana-Sinkam Serge Patrick, 2009, Expert Rev Respir Med, V3, P373, DOI 10.1586/ers.09.30; Nuovo GJ, 2008, METHODS, V44, P39, DOI 10.1016/j.ymeth.2007.10.008; Nuovo GJ, 2010, METHODS, V52, P307, DOI 10.1016/j.ymeth.2010.08.009; Rennolds J, 2010, TOXICOL SCI, V116, P349, DOI 10.1093/toxsci/kfq101; Shih RH, 2011, J NEUROINFLAMM, V8, DOI 10.1186/1742-2094-8-104; TRAPNELL BC, 1991, P NATL ACAD SCI USA, V88, P6565, DOI 10.1073/pnas.88.15.6565; Valente AJ, 2012, CELL SIGNAL, V24, P560, DOI 10.1016/j.cellsig.2011.10.010; Wang WZ, 2011, INT J CANCER, V129, P1624, DOI 10.1002/ijc.25818; Wang XD, 2006, CELL, V127, P803, DOI 10.1016/j.cell.2006.09.043; Whitman SP, 2010, BLOOD, V116, P3622, DOI 10.1182/blood-2010-05-283648; Xu XL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033846; Zhu QY, 2010, J IMMUNOL, V185, P7435, DOI 10.4049/jimmunol.1000798	28	113	122	3	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 30	2012	7	11							e50837	10.1371/journal.pone.0050837	http://dx.doi.org/10.1371/journal.pone.0050837			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	054WM	23226399	Green Submitted, Green Published, gold			2022-12-27	WOS:000312376100210
J	Hirotsu, C; Rydlewski, M; Araujo, MS; Tufik, S; Andersen, ML				Hirotsu, Camila; Rydlewski, Mariana; Araujo, Mariana Silva; Tufik, Sergio; Andersen, Monica Levy			Sleep Loss and Cytokines Levels in an Experimental Model of Psoriasis	PLOS ONE			English	Article							HUMAN-LEUKOCYTE ELASTASE; EXPRESS HIGH-LEVELS; QUALITY-OF-LIFE; TRANSGENIC MICE; SERUM-LEVELS; T-CELLS; SKIN; DEPRIVATION; RESPONSES; STRESS	Up to 80% of people develop a cutaneous condition closely connected to their exposure to stressful life events. Psoriasis is a chronic recurrent inflammatory skin disorder with multifactorial etiology, including genetic background, environmental factors, and immune system disturbances with a strong cytokine component. Moreover, psoriasis is variably associated with sleep disturbance and sleep deprivation. This study evaluated the influence of sleep loss in the context of an animal model of psoriasis by measuring cytokine and stress-related hormone levels. Male adult Balb/C mice with or without psoriasis were subjected to 48 h of selective paradoxical sleep deprivation (PSD). Sleep deprivation potentiated the activities of kallikrein-5 and kallikrein-7 in the skin of psoriatic groups. Also, mice with psoriasis had significant increases in specific proinflammatory cytokines (IL-1 beta, IL-6 and IL-12) and decreases in the anti-inflammatory cytokine (IL-10) after PSD, which were normalized after 48 h of sleep rebound. Linear regression showed that IL-2, IL-6 and IL-12 levels predicted 66% of corticosterone levels, which were selectively increased in psoriasis mice subject to PSD. Kallikrein-5 was also correlated with pro-inflammatory cytokines, explaining 58% of IL-6 and IL-12 variability. These data suggest that sleep deprivation plays an important role in the exacerbation of psoriasis through modulation of the immune system in the epidermal barrier. Thus, sleep loss should be considered a risk factor for the development of psoriasis.	[Hirotsu, Camila; Tufik, Sergio; Andersen, Monica Levy] Univ Fed Sao Paulo, Dept Psicobiol, Sao Paulo, Brazil; [Rydlewski, Mariana; Araujo, Mariana Silva] Univ Fed Sao Paulo, Dept Bioquim, Sao Paulo, Brazil	Universidade Federal de Sao Paulo (UNIFESP); Universidade Federal de Sao Paulo (UNIFESP)	Andersen, ML (corresponding author), Univ Fed Sao Paulo, Dept Psicobiol, Sao Paulo, Brazil.	ml.andersen12@gmail.com	Andersen, Monica L/C-7616-2012; Sono, Cepid/I-5371-2013; Araujo, Mariana/E-5434-2014	Andersen, Monica L/0000-0002-1894-6748; Araujo, Mariana/0000-0001-5312-5075; Hirotsu, Camila/0000-0002-6760-0663	AFIP; FAPESP [CEPID 98/14303-3, 10/50129-1]; CNPq	AFIP; FAPESP(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	This work was supported by grants from AFIP and FAPESP (CEPID 98/14303-3 to ST and 10/50129-1 to CH). MLA, MSA and ST are recipients of CNPq fellowships. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersen ML, 2004, BRAZ J MED BIOL RES, V37, P791, DOI 10.1590/S0100-879X2004000600003; Araujo P, 2011, HORM BEHAV, V59, P174, DOI 10.1016/j.yhbeh.2010.11.003; Arjona A, 2005, J IMMUNOL, V174, P7618, DOI 10.4049/jimmunol.174.12.7618; Arjona A, 2006, J INTERF CYTOK RES, V26, P645, DOI 10.1089/jir.2006.26.645; Asadullah K, 1999, DRUG TODAY, V35, P913; Asadullah K, 2001, J INVEST DERMATOL, V116, P975, DOI 10.1046/j.1523-1747.2001.01350.x; Asadullah K, 2001, J INVEST DERMATOL, V116, P721, DOI 10.1046/j.0022-202x.2001.01317.x; Asadullah K, 1999, ARCH DERMATOL, V135, P187, DOI 10.1001/archderm.135.2.187; Asadullah Khusru, 2004, Current Drug Targets - Inflammation and Allergy, V3, P185, DOI 10.2174/1568010043343886; Baran W, 2008, ACTA DERM-VENEREOL, V88, P113, DOI 10.2340/00015555-0427; Barker JNWN, 2001, CLIN EXP DERMATOL, V26, P321, DOI 10.1046/j.1365-2230.2001.00830.x; Benedict C, 2007, BRAIN BEHAV IMMUN, V21, P1058, DOI 10.1016/j.bbi.2007.04.004; Besedovsky L, 2012, PFLUG ARCH EUR J PHY, V463, P121, DOI 10.1007/s00424-011-1044-0; Blessing M, 1996, J CELL BIOL, V135, P227, DOI 10.1083/jcb.135.1.227; Canete JD, 2000, ANN RHEUM DIS, V59, P263, DOI 10.1136/ard.59.4.263; Carroll JM, 1997, J INVEST DERMATOL, V108, P412, DOI 10.1111/1523-1747.ep12289702; Castanon-Cervantes O, 2010, J IMMUNOL, V185, P5796, DOI 10.4049/jimmunol.1001026; de Korte J, 2004, J INVEST DERM SYMP P, V9, P140, DOI 10.1046/j.1087-0024.2003.09110.x; Dimitrov S, 2004, BRAIN BEHAV IMMUN, V18, P341, DOI 10.1016/j.bbi.2003.08.004; Dimitrov S, 2007, SLEEP, V30, P401, DOI 10.1093/sleep/30.4.401; Ekholm E, 1999, ARCH DERMATOL RES, V291, P195, DOI 10.1007/s004030050393; Elkayam O, 2000, RHEUMATOL INT, V19, P101, DOI 10.1007/s002960050111; Esquifino AI, 1996, BRAIN BEHAV IMMUN, V10, P92, DOI 10.1006/brbi.1996.0010; GATES AH, 1965, SCIENCE, V148, P1471, DOI 10.1126/science.148.3676.1471; Gibson TLB, 1999, GROWTH HORM IGF RES, V9, P241, DOI 10.1054/ghir.1999.0115; GLINSKI W, 1991, ACTA DERM-VENEREOL, V71, P277; Gowda S, 2010, J AM ACAD DERMATOL, V63, P114, DOI 10.1016/j.jaad.2009.07.003; Griffiths CEM, 2001, CLIN EXP DERMATOL, V26, P338, DOI 10.1046/j.1365-2230.2001.00834.x; GROSSMAN RM, 1989, P NATL ACAD SCI USA, V86, P6367, DOI 10.1073/pnas.86.16.6367; GROVES RW, 1995, P NATL ACAD SCI USA, V92, P11874, DOI 10.1073/pnas.92.25.11874; GUPTA MA, 1989, GEN HOSP PSYCHIAT, V11, P166, DOI 10.1016/0163-8343(89)90036-4; HALBERG F, 1960, P SOC EXP BIOL MED, V103, P142; Kawada A, 1997, ARCH DERMATOL RES, V289, P87, DOI 10.1007/s004030050160; Kitka T, 2009, BEHAV BRAIN RES, V205, P482, DOI 10.1016/j.bbr.2009.08.004; Kono M, 2001, FASEB J, V15, P2297, DOI 10.1096/fj.01-0254fje; Krueger G, 2001, ARCH DERMATOL, V137, P280; Langley RGB, 2005, ANN RHEUM DIS, V64, P18, DOI 10.1136/ard.2004.033217; MOLDOFSKY H, 1989, FASEB J, V3, P1972, DOI 10.1096/fasebj.3.8.2785942; Morizane S, 2012, J ALLERGY CLIN IMMUN, V130, P259, DOI 10.1016/j.jaci.2012.03.006; MORRISSEY PJ, 1993, J EXP MED, V178, P237, DOI 10.1084/jem.178.1.237; Moynihan J, 2010, GIORN ITAL DERMAT V, V145, P221; MOZZANICA N, 1988, ACTA DERM-VENEREOL, V68, P312; MUSSI A, 1994, J BIOL REG HOMEOS AG, V8, P117; NEUNER P, 1991, J INVEST DERMATOL, V97, P27, DOI 10.1111/1523-1747.ep12477880; NICKOLOFF BJ, 1991, ARCH DERMATOL, V127, P871, DOI 10.1001/archderm.127.6.871; Ovaere P, 2009, TRENDS BIOCHEM SCI, V34, P453, DOI 10.1016/j.tibs.2009.08.001; Ozawa Maki, 2004, Current Drug Targets - Inflammation and Allergy, V3, P137, DOI 10.2174/1568010043343868; Pandey AK, 2011, BIOCHEM BIOPH RES CO, V410, P242, DOI 10.1016/j.bbrc.2011.05.123; Park E, 2005, AM J PHYSIOL-REG I, V289, pR1360, DOI 10.1152/ajpregu.00103.2005; Perry MG, 2009, ANN RHEUM DIS, V68, P63, DOI 10.1136/ard.2007.086561; POWRIE F, 1993, INT IMMUNOL, V5, P1461, DOI 10.1093/intimm/5.11.1461; RADAELLI A, 1982, CHRONOBIOLOGIA, V9, P203; Reis ES, 2011, BRAIN BEHAV IMMUN, V25, P1416, DOI 10.1016/j.bbi.2011.04.011; Richards HL, 2005, BRIT J DERMATOL, V153, P1114, DOI 10.1111/j.1365-2133.2005.06817.x; Rogalski C, 2002, J INVEST DERMATOL, V118, P49, DOI 10.1046/j.0022-202x.2001.01650.x; Rogozinski R, 1986, Ginekol Pol, V57, P30; Roussaki-Schulze AV, 2005, INT J CLIN PHARM RES, V25, P169; Ruiz FS, 2012, INNATE IMMUN-LONDON, V18, P44, DOI 10.1177/1753425910385962; Schafer T, 2006, DERMATOLOGY, V212, P327, DOI 10.1159/000092283; Scheff JD, 2010, J THEOR BIOL, V264, P1068, DOI 10.1016/j.jtbi.2010.03.026; Schon MP, 1997, NAT MED, V3, P183, DOI 10.1038/nm0297-183; Seifert M, 2000, ARCH DERMATOL RES, V292, P164, DOI 10.1007/s004030050473; Silva RH, 2004, NEUROPHARMACOLOGY, V46, P895, DOI 10.1016/j.neuropharm.2003.11.032; Silver AC, 2012, IMMUNITY, V36, P251, DOI 10.1016/j.immuni.2011.12.017; Skov L, 2000, CLIN EXP DERMATOL, V25, P57; SUNDBERG JP, 1990, J INVEST DERMATOL, V95, pS62, DOI 10.1111/1523-1747.ep12505816; Takahashi H, 2010, CLIN EXP DERMATOL, V35, P645, DOI 10.1111/j.1365-2230.2009.03704.x; TURKSEN K, 1992, P NATL ACAD SCI USA, V89, P5068, DOI 10.1073/pnas.89.11.5068; van Leeuwen WMA, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004589; VASSAR R, 1991, GENE DEV, V5, P714, DOI 10.1101/gad.5.5.714; WIEDOW O, 1995, ARCH DERMATOL RES, V287, P632, DOI 10.1007/BF00371734; Yehuda S, 2009, J INTERF CYTOK RES, V29, P393, DOI 10.1089/jir.2008.0080; Zager A, 2007, AM J PHYSIOL-REG I, V293, pR504, DOI 10.1152/ajpregu.00105.2007; Zager A, 2012, NEUROIMMUNOMODULAT, V19, P79, DOI 10.1159/000329484; Zager A, 2009, EUR NEUROPSYCHOPHARM, V19, P589, DOI 10.1016/j.euroneuro.2009.03.005	75	61	65	1	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 30	2012	7	11							e51183	10.1371/journal.pone.0051183	http://dx.doi.org/10.1371/journal.pone.0051183			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	054WM	23226485	Green Submitted, Green Published, gold			2022-12-27	WOS:000312376100296
J	Jenkins, PA; Song, YS; Brem, RB				Jenkins, Paul A.; Song, Yun S.; Brem, Rachel B.			Genealogy-Based Methods for Inference of Historical Recombination and Gene Flow and Their Application in Saccharomyces cerevisiae	PLOS ONE			English	Article							DNA-SEQUENCE DATA; YEAST; EVOLUTIONARY; SELECTION; INTROGRESSION; HYBRIDIZATION; SIMULATION; EVENTS; MODEL; RATES	Genetic exchange between isolated populations, or introgression between species, serves as a key source of novel genetic material on which natural selection can act. While detecting historical gene flow from DNA sequence data is of much interest, many existing methods can be limited by requirements for deep population genomic sampling. In this paper, we develop a scalable genealogy-based method to detect candidate signatures of gene flow into a given population when the source of the alleles is unknown. Our method does not require sequenced samples from the source population, provided that the alleles have not reached fixation in the sampled recipient population. The method utilizes recent advances in algorithms for the efficient reconstruction of ancestral recombination graphs, which encode genealogical histories of DNA sequence data at each site, and is capable of detecting the signatures of gene flow whose footprints are of length up to single genes. Further, we employ a theoretical framework based on coalescent theory to test for statistical significance of certain recombination patterns consistent with gene flow from divergent sources. Implementing these methods for application to whole-genome sequences of environmental yeast isolates, we illustrate the power of our approach to highlight loci with unusual recombination histories. By developing innovative theory and methods to analyze signatures of gene flow from population sequence data, our work establishes a foundation for the continued study of introgression and its evolutionary relevance.	[Brem, Rachel B.] Univ Calif Berkeley, Dept Mol & Cell Biol, Berkeley, CA 94720 USA; [Jenkins, Paul A.; Song, Yun S.] Univ Calif Berkeley, Div Comp Sci, Berkeley, CA 94720 USA; [Song, Yun S.] Univ Calif Berkeley, Dept Stat, Berkeley, CA 94720 USA	University of California System; University of California Berkeley; University of California System; University of California Berkeley; University of California System; University of California Berkeley	Brem, RB (corresponding author), Univ Calif Berkeley, Dept Mol & Cell Biol, 229 Stanley Hall, Berkeley, CA 94720 USA.	rbrem@berkeley.edu		Jenkins, Paul/0000-0001-7603-4205	National Science Foundation CAREER Grant [DBI-0846015]; Packard Fellowship for Science and Engineering; Ellison Medical Foundation New Scholar Award in Aging	National Science Foundation CAREER Grant(National Science Foundation (NSF)); Packard Fellowship for Science and Engineering; Ellison Medical Foundation New Scholar Award in Aging	This work was supported in part by a National Science Foundation CAREER Grant (DBI-0846015; http://www.nsf.gov/) and a Packard Fellowship for Science and Engineering (http://www.packard.org/) to Y.S.S., and an Ellison Medical Foundation New Scholar Award in Aging (http://www.ellisonfoundation.org/) to R. B. B. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson TM, 2009, SCIENCE, V323, P1339, DOI 10.1126/science.1165448; Baroni M, 2006, SYST BIOL, V55, P46, DOI 10.1080/10635150500431197; Beerli P, 2004, MOL ECOL, V13, P827, DOI 10.1111/j.1365-294X.2004.02101.x; Doniger SW, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000183; Elyashiv E, 2010, GENOME RES, V20, P1558, DOI 10.1101/gr.108993.110; Evans PD, 2006, P NATL ACAD SCI USA, V103, P18178, DOI 10.1073/pnas.0606966103; Fay JC, 2005, PLOS GENET, V1, P66, DOI 10.1371/journal.pgen.0010005; Gansner ER, 2000, SOFTWARE PRACT EXPER, V30, P1203, DOI 10.1002/1097-024X(200009)30:11<1203::AID-SPE338>3.0.CO;2-N; Hudson RR, 2002, BIOINFORMATICS, V18, P337, DOI 10.1093/bioinformatics/18.2.337; HUDSON RR, 1992, GENETICS, V132, P583; Huson DH, 2006, MOL BIOL EVOL, V23, P254, DOI 10.1093/molbev/msj030; Kim M, 2008, SCIENCE, V322, P1116, DOI 10.1126/science.1164371; Le SQ, 2011, GENOME RES, V21, P952, DOI 10.1101/gr.113084.110; Liti G, 2006, GENETICS, V174, P839, DOI 10.1534/genetics.106.062166; Liti G, 2009, NATURE, V458, P337, DOI 10.1038/nature07743; Lopes Miguel de Barros, 2002, FEMS Yeast Research, V1, P323; Lyngso RB, 2005, LECT NOTES COMPUT SC, V3692, P239; Machado CA, 2002, MOL BIOL EVOL, V19, P472, DOI 10.1093/oxfordjournals.molbev.a004103; MacLeod D, 2005, BMC EVOL BIOL, V5, DOI 10.1186/1471-2148-5-27; Magwene PM, 2011, P NATL ACAD SCI USA, V108, P1987, DOI 10.1073/pnas.1012544108; Minichiello MJ, 2006, AM J HUM GENET, V79, P910, DOI 10.1086/508901; Muller LAH, 2009, FEMS YEAST RES, V9, P143, DOI 10.1111/j.1567-1364.2008.00464.x; Nakhleh L, 2004, P 8 ANN INT C RESAER, P337; Naumova ES, 2005, YEAST, V22, P1099, DOI 10.1002/yea.1298; Neafsey DE, 2010, GENOME RES, V20, P938, DOI 10.1101/gr.103911.109; Nosil P, 2009, MOL ECOL, V18, P375, DOI 10.1111/j.1365-294X.2008.03946.x; Novo M, 2009, P NATL ACAD SCI USA, V106, P16333, DOI 10.1073/pnas.0904673106; Ronald J, 2006, GENETICS, V174, P541, DOI 10.1534/genetics.106.060863; Ruderfer DM, 2006, NAT GENET, V38, P1077, DOI 10.1038/ng1859; SANDHU DK, 1985, MICROB ECOL, V11, P51, DOI 10.1007/BF02015108; Schacherer J, 2009, NATURE, V458, P342, DOI 10.1038/nature07670; SLATKIN M, 1989, GENETICS, V123, P603; Strasburg JL, 2010, MOL BIOL EVOL, V27, P297, DOI 10.1093/molbev/msp233; Vishnoi A, 2011, MOL BIOL EVOL, V28, P2615, DOI 10.1093/molbev/msr085; Wakeley J., 2008, COALESCENT THEORY IN; Wei W, 2007, P NATL ACAD SCI USA, V104, P12825, DOI 10.1073/pnas.0701291104; Wiuf C, 2001, MOL BIOL EVOL, V18, P1929, DOI 10.1093/oxfordjournals.molbev.a003733	37	6	6	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 30	2012	7	11							e46947	10.1371/journal.pone.0046947	http://dx.doi.org/10.1371/journal.pone.0046947			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	054WM	23226196	Green Published, Green Submitted, gold			2022-12-27	WOS:000312376100004
J	Lian, L; Qu, LJ; Chen, YM; Lamont, SJ; Yang, N				Lian, Ling; Qu, Lujiang; Chen, Yanmei; Lamont, Susan J.; Yang, Ning			A Systematic Analysis of miRNA Transcriptome in Marek's Disease Virus-Induced Lymphoma Reveals Novel and Differentially Expressed miRNAs	PLOS ONE			English	Article							CHRONIC LYMPHOCYTIC-LEUKEMIA; PAPILLARY THYROID-CARCINOMA; DEEP SEQUENCING APPROACH; CELL LINE MSB-1; MICRORNA EXPRESSION; HEPATOCELLULAR-CARCINOMA; ENCODED MICRORNAS; PROSTATE-CANCER; BREAST-CANCER; LUNG CANCERS	Marek's disease is a lymphoproliferative neoplastic disease of the chicken, which poses a serious threat to poultry health. Marek's disease virus (MDV)-induced T-cell lymphoma is also an excellent biomedical model for neoplasia research. Recently, miRNAs have been demonstrated to play crucial roles in mediating neoplastic transformation. To investigate host miRNA expression profiles in the tumor transformation phase of MDV infection, we performed deep sequencing in two MDV-infected samples (tumorous spleen and MD lymphoma from liver), and two non-infected controls (non-infected spleen and lymphocytes). In total, 187 and 16 known miRNAs were identified in chicken and MDV, respectively, and 17 novel chicken miRNAs were further confirmed by qPCR. We identified 28 down-regulated miRNAs and 11 up-regulated miRNAs in MDV-infected samples by bioinformatic analysis. Of nine further tested by qPCR, seven were verified. The gga-miR-181a, gga-miR-26a, gga-miR-221, gga-miR-222, gga-miR-199*, and gga-miR-140* were down-regulated, and gga-miR-146c was up-regulated in MDV-infected tumorous spleens and MD lymphomas. In addition, 189 putative target genes for seven differentially expressed miRNAs were predicted. The luciferase reporter gene assay showed interactions of gga-miR-181a with MYBL1, gga-miR-181a with IGF2BP3, and gga-miR-26a with EIF3A. Differential expression of miRNAs and the predicted targets strongly suggest that they contribute to MDV-induced lymphomagenesis.	[Lian, Ling; Qu, Lujiang; Chen, Yanmei; Yang, Ning] China Agr Univ, Dept Anim Genet & Breeding, Natl Engn Lab Anim Breeding, MOA Lab Anim Genet & Breeding,Coll Anim Sci & Tec, Beijing 100094, Peoples R China; [Lamont, Susan J.] Iowa State Univ, Dept Anim Sci, Ames, IA USA	China Agricultural University; Iowa State University	Yang, N (corresponding author), China Agr Univ, Dept Anim Genet & Breeding, Natl Engn Lab Anim Breeding, MOA Lab Anim Genet & Breeding,Coll Anim Sci & Tec, Beijing 100094, Peoples R China.	nyang@cau.edu.cn		Yang, Ning/0000-0001-5772-3320	China Agriculture Research Systems [CARS-41]; National Scientific Supporting Projects of China [2011BAD28B03]	China Agriculture Research Systems; National Scientific Supporting Projects of China	This work was supported in part by funds from the China Agriculture Research Systems (CARS-41) and the National Scientific Supporting Projects of China (2011BAD28B03). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ambs S, 2008, CANCER RES, V68, P6162, DOI 10.1158/0008-5472.CAN-08-0144; Bachmann F, 1997, CANCER RES, V57, P988; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Bockmeyer CL, 2011, BREAST CANCER RES TR, V130, P735, DOI 10.1007/s10549-010-1303-3; Bottoni A, 2007, J CELL PHYSIOL, V210, P370, DOI 10.1002/jcp.20832; Burgess SC, 2004, P NATL ACAD SCI USA, V101, P13879, DOI 10.1073/pnas.0305789101; Burnside J, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-185; Burnside J, 2006, J VIROL, V80, P8778, DOI 10.1128/JVI.00831-06; Calin GA, 2002, P NATL ACAD SCI USA, V99, P15524, DOI 10.1073/pnas.242606799; Calin GA, 2005, NEW ENGL J MED, V353, P1793, DOI 10.1056/NEJMoa050995; Calin GA, 2004, P NATL ACAD SCI USA, V101, P11755, DOI 10.1073/pnas.0404432101; Calin GA, 2007, BEST PRACT RES CL HA, V20, P425, DOI 10.1016/j.beha.2007.02.003; CALNEK BW, 1986, CRC CR REV MICROBIOL, V12, P293; Chang TC, 2008, NAT GENET, V40, P43, DOI 10.1038/ng.2007.30; Chen GP, 1999, INT J CANCER, V84, P95, DOI 10.1002/(SICI)1097-0215(19990420)84:2<95::AID-IJC1>3.0.CO;2-N; Chen HC, 2009, BRIT J CANCER, V100, P1002, DOI 10.1038/sj.bjc.6604948; Chen YT, 2008, MODERN PATHOL, V21, P1139, DOI 10.1038/modpathol.2008.105; Chen YX, 2006, BIOCHEM BIOPH RES CO, V340, P758, DOI 10.1016/j.bbrc.2005.12.068; Cheng AM, 2005, NUCLEIC ACIDS RES, V33, P1290, DOI 10.1093/nar/gki200; Ciafre SA, 2005, BIOCHEM BIOPH RES CO, V334, P1351, DOI 10.1016/j.bbrc.2005.07.030; Croonquist PA, 2005, ONCOGENE, V24, P6269, DOI 10.1038/sj.onc.1208771; Dalmay T, 2008, J INTERN MED, V263, P366, DOI 10.1111/j.1365-2796.2008.01926.x; Dellas A, 1998, CANCER, V83, P1376, DOI 10.1002/(SICI)1097-0142(19981001)83:7<1376::AID-CNCR15>3.0.CO;2-1; Facchinetti V, 2000, ONCOGENE, V19, P3931, DOI 10.1038/sj.onc.1203730; Fu HJ, 2005, FEBS LETT, V579, P3849, DOI 10.1016/j.febslet.2005.05.064; Gartel AL, 2001, P NATL ACAD SCI USA, V98, P4510, DOI 10.1073/pnas.081074898; Gartel AL, 2008, SEMIN CANCER BIOL, V18, P103, DOI 10.1016/j.semcancer.2008.01.008; Glazov EA, 2008, GENOME RES, V18, P957, DOI 10.1101/gr.074740.107; He HL, 2005, P NATL ACAD SCI USA, V102, P19075, DOI 10.1073/pnas.0509603102; He L, 2004, NAT REV GENET, V5, P522, DOI 10.1038/nrg1379; Huang JC, 2007, NAT METHODS, V4, P1045, DOI 10.1038/nmeth1130; Iorio MV, 2005, CANCER RES, V65, P7065, DOI 10.1158/0008-5472.CAN-05-1783; Kaiser P, 2003, J VIROL, V77, P762, DOI 10.1128/JVI.77.1.762-768.2003; Kobel M, 2009, MODERN PATHOL, V22, P469, DOI 10.1038/modpathol.2008.206; Kota J, 2009, CELL, V137, P1005, DOI 10.1016/j.cell.2009.04.021; Kuchenbauer F, 2008, GENOME RES, V18, P1787, DOI 10.1101/gr.077578.108; Lambeth LS, 2009, J GEN VIROL, V90, P1164, DOI 10.1099/vir.0.007831-0; Lee EJ, 2007, INT J CANCER, V120, P1046, DOI 10.1002/ijc.22394; Lewis BP, 2005, CELL, V120, P15, DOI 10.1016/j.cell.2004.12.035; Li CZ, 2007, MODERN PATHOL, V20, P242, DOI 10.1038/modpathol.3800735; Li MZ, 2011, INT J BIOL SCI, V7, P1045, DOI 10.7150/ijbs.7.1045; Li MZ, 2010, PLOS ONE, V5, DOI [10.1371/journal.pone.0015168, 10.1371/journal.pone.0011541]; Li TT, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-186; Lian L, 2012, POULTRY SCI, V91, P2130, DOI 10.3382/ps.2012-02226; Lian L, 2010, POULTRY SCI, V89, P2123, DOI 10.3382/ps.2010-00919; Liu PT, 2003, NAT IMMUNOL, V4, P525, DOI 10.1038/ni925; Lorimer IAJ, 2009, CELL CYCLE, V8, P2685; Lowery AJ, 2008, CLIN CANCER RES, V14, P360, DOI 10.1158/1078-0432.CCR-07-0992; Mao WH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033040; Martinez I, 2008, ONCOGENE, V27, P2575, DOI 10.1038/sj.onc.1210919; Morgan R, 2008, J VIROL, V82, P12213, DOI 10.1128/JVI.01722-08; Murakami Y, 2006, ONCOGENE, V25, P2537, DOI 10.1038/sj.onc.1209283; Nikiforova MN, 2008, J CLIN ENDOCR METAB, V93, P1600, DOI 10.1210/jc.2007-2696; Oshiro A, 2006, BLOOD, V107, P4500, DOI 10.1182/blood-2005-09-3801; Ou JT, 2012, FISH SHELLFISH IMMUN, V32, P345, DOI 10.1016/j.fsi.2011.11.027; Pincheira R, 2001, BRIT J CANCER, V84, P1520, DOI 10.1054/bjoc.2001.1828; Porkka KP, 2007, CANCER RES, V67, P6130, DOI 10.1158/0008-5472.CAN-07-0533; Raaphorst FM, 2003, NEOPLASIA, V5, P481, DOI 10.1016/S1476-5586(03)80032-5; Romualdi C, 2003, PHYSIOL GENOMICS, V12, P159, DOI 10.1152/physiolgenomics.00096.2002; Sander S, 2008, BLOOD, V112, P4202, DOI 10.1182/blood-2008-03-147645; Schaeffer DF, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-59; Shi L, 2008, BRAIN RES, V1236, P185, DOI 10.1016/j.brainres.2008.07.085; Takamizawa J, 2004, CANCER RES, V64, P3753, DOI 10.1158/0008-5472.CAN-04-0637; Valencia-Sanchez MA, 2006, GENE DEV, V20, P515, DOI 10.1101/gad.1399806; Visone R, 2007, ONCOGENE, V26, P7590, DOI 10.1038/sj.onc.1210564; Visone R, 2009, BLOOD, V114, P3872, DOI 10.1182/blood-2009-06-229211; Wang Y, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-512; WITTER RL, 2003, DIS POULTRY, P407; Xu HT, 2008, J VIROL METHODS, V149, P201, DOI 10.1016/j.jviromet.2008.02.005; Xu HT, 2010, CANCER CELL INT, V10, DOI 10.1186/1475-2867-10-15; Xu J, 2012, LIVER INT, V32, P752, DOI 10.1111/j.1478-3231.2011.02750.x; Yao YX, 2008, J VIROL, V82, P4007, DOI 10.1128/JVI.02659-07; Yao YX, 2007, J VIROL, V81, P7164, DOI 10.1128/JVI.00112-07; Yao YX, 2009, J GEN VIROL, V90, P1551, DOI 10.1099/vir.0.009902-0; Yeung ML, 2008, CANCER RES, V68, P8976, DOI 10.1158/0008-5472.CAN-08-0769; Zamore PD, 2005, SCIENCE, V309, P1519, DOI 10.1126/science.1111444; Zhang J, 2012, PLANTA IN PRESS; Zhang LL, 2007, J BIOL CHEM, V282, P5790, DOI 10.1074/jbc.M606284200	78	45	49	0	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 30	2012	7	11							e51003	10.1371/journal.pone.0051003	http://dx.doi.org/10.1371/journal.pone.0051003			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	054WM	23226446	gold, Green Submitted, Green Published			2022-12-27	WOS:000312376100257
J	Lohia, M; Qin, Y; Macara, IG				Lohia, Madhura; Qin, Yi; Macara, Ian G.			The Scribble Polarity Protein Stabilizes E-Cadherin/p120-Catenin Binding and Blocks Retrieval of E-Cadherin to the Golgi	PLOS ONE			English	Article							EPITHELIAL-CELL ADHESION; BETA-CATENIN; DROSOPHILA; LOCALIZATION; ENDOCYTOSIS; TRAFFICKING; DOMAINS; COMPLEX; P120-CATENIN; INTERACTS	Several polarity proteins, including Scribble (Scrb) have been implicated in control of vesicle traffic, and in particular the endocytosis of E-cadherin, but through unknown mechanisms. We now show that depletion of Scrb enhances endocytosis of E-cadherin by weakening the E-cadherin-p120-catenin interaction. Unexpectedly, however, the internalized E-cadherin is not degraded but accumulates in the Golgi apparatus. Silencing p120-catenin causes degradation of E-cadherin in lysosomes, but degradation is blocked by the co-depletion of Scrb, which diverts the internalized E-cadherin to the Golgi. Loss of Scrb also enhances E-cadherin binding to retromer components, and retromer is required for Golgi accumulation of Scrb, and E-cadherin stability. These data identify a novel and unanticipated function for Scrb in blocking retromer-mediated diversion of E-cadherin to the Golgi. They provide evidence that polarity proteins can modify the intracellular itinerary for endocytosed membrane proteins.	[Macara, Ian G.] Vanderbilt Univ, Med Ctr, Dept Cell & Dev Biol, Nashville, TN 37212 USA; [Lohia, Madhura; Qin, Yi] Univ Virginia, Dept Microbiol, Ctr Cell Signaling, Sch Med Charlottesville, Charlottesville, VA 22903 USA	Vanderbilt University; University of Virginia	Macara, IG (corresponding author), Vanderbilt Univ, Med Ctr, Dept Cell & Dev Biol, Nashville, TN 37212 USA.	iang.g.macara@vanderbilt.edu			National Institutes of Health, Department of Health and Human Services [GM070902]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM070902] Funding Source: NIH RePORTER	National Institutes of Health, Department of Health and Human Services(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by grant GM070902 from the National Institutes of Health, Department of Health and Human Services(www.nih.gov). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams CL, 1998, J CELL BIOL, V142, P1105, DOI 10.1083/jcb.142.4.1105; Albertson R, 2004, J CELL SCI, V117, P6061, DOI 10.1242/jcs.01525; Asuri S, 2008, J CELL BIOCHEM, V105, P1027, DOI 10.1002/jcb.21902; Audebert S, 2004, CURR BIOL, V14, P987, DOI 10.1016/j.cub.2004.05.051; Balklava Z, 2007, NAT CELL BIOL, V9, P1066, DOI 10.1038/ncb1627; Bilder D, 2000, NATURE, V403, P676, DOI 10.1038/35001108; Bonifacino JS, 2008, CURR OPIN CELL BIOL, V20, P427, DOI 10.1016/j.ceb.2008.03.009; Brieher WM, 1996, J CELL BIOL, V135, P487, DOI 10.1083/jcb.135.2.487; Bryant DM, 2007, J CELL SCI, V120, P1818, DOI 10.1242/jcs.000653; Bryant DM, 2010, NAT CELL BIOL, V12, P1035, DOI 10.1038/ncb2106; Carlton J, 2005, TRAFFIC, V6, P75, DOI 10.1111/j.1600-0854.2005.00260.x; Chen XY, 2006, METHOD ENZYMOL, V406, P362, DOI 10.1016/S0076-6879(06)06026-5; Davis MA, 2006, DEV CELL, V10, P21, DOI 10.1016/j.devcel.2005.12.004; Davis MA, 2003, J CELL BIOL, V163, P525, DOI 10.1083/jcb.200307111; Dorfman J, 2008, MOL BIOL CELL, V19, P1614, DOI 10.1091/mbc.E07-05-0454; Georgiou M, 2008, CURR BIOL, V18, P1631, DOI 10.1016/j.cub.2008.09.029; Harris KP, 2008, J CELL BIOL, V183, P1129, DOI 10.1083/jcb.200807020; Huber AH, 2001, CELL, V105, P391, DOI 10.1016/S0092-8674(01)00330-0; Kallay LM, 2006, J CELL BIOCHEM, V99, P647, DOI 10.1002/jcb.20992; Lahuna O, 2005, EMBO J, V24, P1364, DOI 10.1038/sj.emboj.7600616; Lalli G, 2009, J CELL SCI, V122, P1499, DOI 10.1242/jcs.044339; Leibfried A, 2008, CURR BIOL, V18, P1639, DOI 10.1016/j.cub.2008.09.063; Lin SX, 2004, MOL BIOL CELL, V15, P721, DOI 10.1091/mbc.E03-07-0497; MANDERS EMM, 1993, J MICROSC-OXFORD, V169, P375, DOI 10.1111/j.1365-2818.1993.tb03313.x; Moreau MM, 2010, J NEUROSCI, V30, P9738, DOI 10.1523/JNEUROSCI.6007-09.2010; Murdoch JN, 2003, HUM MOL GENET, V12, P87, DOI 10.1093/hmg/ddg014; Musch A, 2002, MOL BIOL CELL, V13, P158, DOI 10.1091/mbc.01-10-0496; NAVARRO C, 2005, ONCOGENE; O'Brien LE, 2001, NAT CELL BIOL, V3, P831, DOI 10.1038/ncb0901-831; Pagliarini RA, 2003, SCIENCE, V302, P1227, DOI 10.1126/science.1088474; Pocha SM, 2011, CURR BIOL, V21, P1111, DOI 10.1016/j.cub.2011.05.007; Qin Y, 2005, J CELL BIOL, V171, P1061, DOI 10.1083/jcb.200506094; REYNOLDS AB, 1994, MOL CELL BIOL, V14, P8333, DOI 10.1128/MCB.14.12.8333; Sun Y, 2009, MOL BIOL CELL, V20, P3390, DOI 10.1091/mbc.E08-12-1172; Thoreson MA, 2000, J CELL BIOL, V148, P189, DOI 10.1083/jcb.148.1.189; Wang Q, 2007, MOL BIOL CELL, V18, P874, DOI 10.1091/mbc.E06-07-0651; Wang ZZ, 2009, EMBO J, V28, P2360, DOI 10.1038/emboj.2009.190; Yap AS, 1998, J CELL BIOL, V141, P779, DOI 10.1083/jcb.141.3.779; Zeitler J, 2004, J CELL BIOL, V167, P1137, DOI 10.1083/jcb.200407158	39	43	43	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 30	2012	7	11							e51130	10.1371/journal.pone.0051130	http://dx.doi.org/10.1371/journal.pone.0051130			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	054WM	23226478	Green Published, Green Submitted, gold			2022-12-27	WOS:000312376100289
J	Ota, K; Omori, T; Miyakawa, H; Okada, M; Aonishi, T				Ota, Keisuke; Omori, Toshiaki; Miyakawa, Hiroyoshi; Okada, Masato; Aonishi, Toru			Higher-Order Spike Triggered Analysis of Neural Oscillators	PLOS ONE			English	Article							PHASE-RESPONSE CURVES; CHOLINERGIC NEUROMODULATION; SINGLE NEURON; COMPUTATION; NETWORKS; RHYTHMS; AVERAGE; MODELS; DRIVEN	For the purpose of elucidating the neural coding process based on the neural excitability mechanism, researchers have recently investigated the relationship between neural dynamics and the spike triggered stimulus ensemble (STE). Ermentrout et al. analytically derived the relational equation between the phase response curve (PRC) and the spike triggered average (STA). The STA is the first cumulant of the STE. However, in order to understand the neural function as the encoder more explicitly, it is necessary to elucidate the relationship between the PRC and higher-order cumulants of the STE. In this paper, we give a general formulation to relate the PRC and the nth moment of the STE. By using this formulation, we derive a relational equation between the PRC and the spike triggered covariance (STC), which is the covariance of the STE. We show the effectiveness of the relational equation through numerical simulations and use the equation to identify the feature space of the rat hippocampal CA1 pyramidal neurons from their PRCs. Our result suggests that the hippocampal CA1 pyramidal neurons oscillating in the theta frequency range are commonly sensitive to inputs composed of theta and gamma frequency components.	[Aonishi, Toru] Tokyo Inst Technol, Dept Computat Intelligence & Syst Sci, Yokohama, Kanagawa 227, Japan; [Ota, Keisuke; Okada, Masato] RIKEN, Brain Sci Inst, Wako, Saitama, Japan; [Omori, Toshiaki] Kobe Univ, Dept Elect & Elect Engn, Kobe, Hyogo 657, Japan; [Miyakawa, Hiroyoshi] Tokyo Univ Pharm & Life Sci, Sch Life Sci, Hachioji, Tokyo 19203, Japan; [Okada, Masato] Univ Tokyo, Dept Complex Sci & Engn, Kashiwa, Chiba, Japan	Tokyo Institute of Technology; RIKEN; Kobe University; Tokyo University of Pharmacy & Life Sciences; University of Tokyo	Aonishi, T (corresponding author), Tokyo Inst Technol, Dept Computat Intelligence & Syst Sci, Midori Ku, Yokohama, Kanagawa 227, Japan.	aonishi@dis.titech.ac.jp	Omori, Toshiaki/P-4952-2016		MEXT of Japan [22120506, 23119708, 20240020, 23500375, 24654118]; Okawa Foundation for Information and Telecommunications, Japan [11-09]	MEXT of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Okawa Foundation for Information and Telecommunications, Japan	This work was partially supported by Grants-in-Aid for Scientific Research on Innovative Areas [Nos. 22120506 (TO) and 23119708 (MO)], Grant-in-Aid for Scientific Research (A) [No. 20240020 (MO)], Grant-in-Aid for Scientific Research (C) [No. 23500375 (TA)] and Grant-in-Aid for Challenging Exploratory Research [No. 24654118(MO)] from the MEXT of Japan. TO was partially supported by Research Grant [No. 11-09] from the Okawa Foundation for Information and Telecommunications, Japan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aoyagi T, 2003, NEURAL COMPUT, V15, P1035, DOI 10.1162/089976603765202659; Arcas BAY, 2003, NEURAL COMPUT, V15, P1715, DOI 10.1162/08997660360675017; Arcas BAY, 2003, NEURAL COMPUT, V15, P1789, DOI 10.1162/08997660360675044; Buzsaki G, 2002, NEURON, V33, P325, DOI 10.1016/S0896-6273(02)00586-X; DAYAN P, 2001, THEORETICAL NEUROSCI, pCH1; DeCoteau WE, 2007, P NATL ACAD SCI USA, V104, P5644, DOI 10.1073/pnas.0700818104; Draguhn A, 1998, NATURE, V394, P189, DOI 10.1038/28184; Ermentrout B, 1996, NEURAL COMPUT, V8, P979, DOI 10.1162/neco.1996.8.5.979; Ermentrout GB, 2007, PHYS REV LETT, V99, DOI 10.1103/PhysRevLett.99.248103; Ermentrout GB, 2011, J COMPUT NEUROSCI, V31, P185, DOI 10.1007/s10827-010-0305-9; Fellous JM, 2000, HIPPOCAMPUS, V10, P187, DOI 10.1002/(SICI)1098-1063(2000)10:2<187::AID-HIPO8>3.3.CO;2-D; Fink CG, 2012, SPR SER COMPUT NEURO, V6, P475, DOI 10.1007/978-1-4614-0739-3_19; Frank T, 1996, FOKKER PLANCK EQUATI; Galan RF, 2005, PHYS REV LETT, V94, DOI 10.1103/PhysRevLett.94.158101; Hong S, 2007, NEURAL COMPUT, V19, P3133, DOI 10.1162/neco.2007.19.12.3133; Klausberger T, 2008, SCIENCE, V321, P53, DOI 10.1126/science.1149381; Lengyel M, 2005, NAT NEUROSCI, V8, P1677, DOI 10.1038/nn1561; Lisman J, 2005, HIPPOCAMPUS, V15, P913, DOI 10.1002/hipo.20121; MARMARELIS PZ, 1972, SCIENCE, V175, P1276, DOI 10.1126/science.175.4027.1276; Mato G, 2008, NEURAL COMPUT, V20, P2418, DOI 10.1162/neco.2008.10-07-632; MORRIS C, 1981, BIOPHYS J, V35, P193, DOI 10.1016/S0006-3495(81)84782-0; Nakao H, 2007, PHYS REV LETT, V98, DOI 10.1103/PhysRevLett.98.184101; Netoff TI, 2005, J NEUROPHYSIOL, V93, P1197, DOI 10.1152/jn.00982.2004; Ohzawa I, 1997, NEUROREPORT, V8, pR3; Omori T, 2010, PHYS REV E, V81, DOI 10.1103/PhysRevE.81.021901; Ota K, 2012, SPR SER COMPUT NEURO, V6, P179, DOI 10.1007/978-1-4614-0739-3_8; Ota K, 2011, PHYS REV E, V84, DOI 10.1103/PhysRevE.84.041902; Ota K, 2009, J PHYS CONF SER, V197, DOI 10.1088/1742-6596/197/1/012016; Ota K, 2009, J COMPUT NEUROSCI, V26, P185, DOI 10.1007/s10827-008-0104-8; Paninski L, 2006, NEURAL COMPUT, V18, P2592, DOI 10.1162/neco.2006.18.11.2592; Pillow JW, 2006, J VISION, V6, P414, DOI 10.1167/6.4.9; Polhamus DG, 2012, SPR SER COMPUT NEURO, V6, P163, DOI 10.1007/978-1-4614-0739-3_7; Rinzel J., 1998, METHODS NEURONAL MOD, V2, P251; Rust NC, 2005, NEURON, V46, P945, DOI 10.1016/j.neuron.2005.05.021; Rust NC, 2004, NEUROCOMPUTING, V58, P793, DOI 10.1016/j.neucom.2004.01.128; Schwartz O, 2006, J VISION, V6, P484, DOI 10.1167/6.4.13; Sherwood WE, 2010, SIAM J APPL DYN SYST, V9, P659, DOI 10.1137/090773519; Simoncelli EP, 2004, COGNITIVE NEUROSCIENCES III, THIRD EDITION, P327; Stiefel KM, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003947; Stiefel KM, 2009, J COMPUT NEUROSCI, V26, P289, DOI 10.1007/s10827-008-0111-9; Takekawa T, 2007, J COMPUT NEUROSCI, V23, P189, DOI 10.1007/s10827-007-0027-9; Teramae JN, 2008, PHYS REV LETT, V101, DOI 10.1103/PhysRevLett.101.248105; Traub RD, 1996, J PHYSIOL-LONDON, V493, P471, DOI 10.1113/jphysiol.1996.sp021397; Tsubo Y, 2007, PHYS REV LETT, V99, DOI 10.1103/PhysRevLett.99.228101; Tsubo Y, 2007, EUR J NEUROSCI, V25, P3429, DOI 10.1111/j.1460-9568.2007.05579.x	49	3	3	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 30	2012	7	11							e50232	10.1371/journal.pone.0050232	http://dx.doi.org/10.1371/journal.pone.0050232			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	054WM	23226249	Green Published, Green Submitted, gold			2022-12-27	WOS:000312376100059
J	Steffes, G; Lorente-Canovas, B; Pearson, S; Brooker, RH; Spiden, S; Kiernan, AE; Guenet, JL; Steel, KP				Steffes, Georg; Lorente-Canovas, Beatriz; Pearson, Selina; Brooker, Rachael H.; Spiden, Sarah; Kiernan, Amy E.; Guenet, Jean-Louis; Steel, Karen P.			Mutanlallemand (mtl) and Belly Spot and Deafness (bsd) Are Two New Mutations of Lmx1a Causing Severe Cochlear and Vestibular Defects	PLOS ONE			English	Article							MOUSE INNER-EAR; SEMICIRCULAR CANAL FORMATION; NAIL-PATELLA SYNDROME; SHAKER SHORT-TAIL; HOMEOBOX GENE; HIPPOCAMPAL-FORMATION; DREHER GENE; DIFFERENTIATION; EXPRESSION; MICE	Mutanlallemand (mtl) and Belly Spot and Deafness (bsd) are two new spontaneous alleles of the Lmx1a gene in mice. Homozygous mutants show head tossing and circling behaviour, indicative of vestibular defects, and they have short tails and white belly patches of variable size. The analysis of auditory brainstem responses (ABR) showed that mtl and bsd homozygotes are deaf, whereas heterozygous and wildtype littermates have normal hearing. Paint-filled inner ears at E16.5 revealed that mtl and bsd homozygotes lack endolymphatic ducts and semicircular canals and have short cochlear ducts. These new alleles show similarities with dreher (Lmx1a) mutants. Complementation tests between mtl and dreher and between mtl and bsd suggest that mtl and bsd are new mutant alleles of the Lmx1a gene. To determine the Lmx1a mutation in mtl and bsd mutant mice we performed PCR followed by sequencing of genomic DNA and cDNA. The mtl mutation is a single point mutation in the 39 splice site of exon 4 leading to an exon extension and the activation of a cryptic splice site 44 base pairs downstream, whereas the bsd mutation is a genomic deletion that includes exon 3. Both mutations lead to a truncated LMX1A protein affecting the homeodomain (mtl) or LIM2-domain (bsd), which is critical for LMX1A protein function. Moreover, the levels of Lmx1a transcript in mtl and bsd mutants are significantly down-regulated. Hmx2/3 and Pax2 expression are also down-regulated in mtl and bsd mutants, suggesting a role of Lmx1a upstream of these transcription factors in early inner ear morphogenesis. We have found that these mutants develop sensory patches although they are misshapen. The characterization of these two new Lmx1a alleles highlights the critical role of this gene in the development of the cochlea and vestibular system.	[Steffes, Georg; Lorente-Canovas, Beatriz; Pearson, Selina; Brooker, Rachael H.; Spiden, Sarah; Steel, Karen P.] Wellcome Trust Sanger Inst, Hinxton, England; [Lorente-Canovas, Beatriz; Steel, Karen P.] Kings Coll London, Wolfson Ctr Age Related Dis, London, England; [Spiden, Sarah; Kiernan, Amy E.; Steel, Karen P.] MRC, Inst Hearing Res, Nottingham, England; [Kiernan, Amy E.] Univ Rochester, Med Ctr, Rochester, NY 14642 USA; [Guenet, Jean-Louis] Inst Pasteur, Paris, France	Wellcome Trust Sanger Institute; University of London; King's College London; University of Rochester; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris	Steel, KP (corresponding author), Wellcome Trust Sanger Inst, Hinxton, England.	Karen.Steel@kcl.ac.uk			Wellcome Trust [098051]; Medical research Council (MRC); MRC [G0300212, MC_qA137918] Funding Source: UKRI; Medical Research Council [MC_qA137918, G0300212] Funding Source: researchfish	Wellcome Trust(Wellcome TrustEuropean Commission); Medical research Council (MRC)(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work was funded by the Wellcome Trust (grant 098051) and the Medical research Council (MRC). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bergstrom DE, 1999, GENOMICS, V59, P291, DOI 10.1006/geno.1999.5873; Bissonnette JP, 1996, J COMP NEUROL, V368, P620, DOI 10.1002/(SICI)1096-9861(19960513)368:4<620::AID-CNE12>3.0.CO;2-L; BOBER E, 1994, DEV BIOL, V162, P288, DOI 10.1006/dbio.1994.1086; Bongers EMHF, 2008, EUR J HUM GENET, V16, P1240, DOI 10.1038/ejhg.2008.83; BONNEVIE K., 1936, GENETICA, V18, P105, DOI 10.1007/BF01507189; Burton Q, 2004, DEV BIOL, V272, P161, DOI 10.1016/j.ydbio.2004.04.024; Chang WI, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000050; Chizhikov V, 2006, MAMM GENOME, V17, P1025, DOI 10.1007/s00335-006-0033-7; Chung S, 2009, CELL STEM CELL, V5, P646, DOI 10.1016/j.stem.2009.09.015; Dai JX, 2009, DEV GROWTH DIFFER, V51, P241, DOI 10.1111/j.1440-169X.2008.01083.x; DEOL M. S., 1964, J EMBRYOL EXP MORPHOL, V12, P727; DEOL MS, 1966, NATURE, V209, P219, DOI 10.1038/209219a0; Dunn LC, 1934, P NATL ACAD SCI USA, V20, P230, DOI 10.1073/pnas.20.4.230; Dunston JA, 2004, GENOMICS, V84, P565, DOI 10.1016/j.ygeno.2004.06.002; Failli V, 2002, MECH DEVELOP, V118, P225, DOI 10.1016/S0925-4773(02)00254-X; FALCONER DS, 1951, Z INDUKT ABSTAMM VER, V84, P71, DOI 10.1007/BF00309744; Fischer H., 1956, Zeitschrift fuer Mikroskopisch-Anatomische Forschung, V62, P348; FISCHER H, 1957, Arch Ohren Nasen Kehlkopfheilkd, V170, P411, DOI 10.1007/BF02137549; Fischer H, 1958, Z MIKR ANAT FORSCH, V64; Hadrys T, 1998, DEVELOPMENT, V125, P33; Hilton JM, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-9-r90; Hulander M, 2003, DEVELOPMENT, V130, P2013, DOI 10.1242/dev.00376; Ingham Neil J, 2011, Curr Protoc Mouse Biol, V1, P279, DOI 10.1002/9780470942390.mo110059; Kaufman M.H., 1992, ATLAS MOUSE DEV; Keane TM, 2012, NATURE, V5; Kiernan AE, 2006, BRAIN RES, V1091, P270, DOI 10.1016/j.brainres.2006.02.037; Kim HM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017949; Kim HM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014041; Kondo T, 2008, P NATL ACAD SCI USA, V105, P5780, DOI 10.1073/pnas.0708704105; Kondo T, 2011, STEM CELLS, V29, P836, DOI 10.1002/stem.624; Koo SK, 2009, DEV BIOL, V333, P14, DOI 10.1016/j.ydbio.2009.06.016; Kuwamura M, 2005, DEV BRAIN RES, V155, P99, DOI 10.1016/j.devbrainres.2004.12.009; Lawoko-Kerali G, 2002, J COMP NEUROL, V442, P378, DOI 10.1002/cne.10088; LEMOUELLIC H, 1990, P NATL ACAD SCI USA, V87, P4712, DOI 10.1073/pnas.87.12.4712; LEMOUELLIC H, 1992, CELL, V69, P251, DOI 10.1016/0092-8674(92)90406-3; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; LYONS JP, 1988, BEHAV GENET, V18, P35, DOI 10.1007/BF01067074; Matilainen T, 2007, INT J DEV BIOL, V51, P409, DOI 10.1387/ijdb.072273tm; Millonig JH, 2000, NATURE, V403, P764, DOI 10.1038/35001573; Miyama K, 1999, DEV BIOL, V208, P123, DOI 10.1006/dbio.1998.9197; Murakami A, 2004, J BIOL CHEM, V279, P28564, DOI 10.1074/jbc.M313814200; Nichols DH, 2008, CELL TISSUE RES, V334, P339, DOI 10.1007/s00441-008-0709-2; Pirvola U, 2004, DEV BIOL, V273, P350, DOI 10.1016/j.ydbio.2004.06.010; Prosser HM, 2008, MOL CELL BIOL, V28, P1702, DOI 10.1128/MCB.01282-07; Salminen M, 2000, DEVELOPMENT, V127, P13; SEKIGUCHI M, 1992, DEV BRAIN RES, V67, P105, DOI 10.1016/0165-3806(92)90030-Z; Sekiguchi M, 1996, DEV BRAIN RES, V92, P31, DOI 10.1016/0165-3806(95)00195-6; STEEL KP, 1992, NAT GENET, V2, P75, DOI 10.1038/ng0992-75; Theiler K, 1989, HOUSE MOUSE ATLAS EM, DOI 10.1007/978-3-642-88418-4; Torres MA, 1996, DEVELOPMENT, V122, P3381; WAHLSTEN D, 1983, J HERED, V74, P421, DOI 10.1093/oxfordjournals.jhered.a109829; Wang WD, 2004, DEV CELL, V7, P439, DOI 10.1016/j.devcel.2004.06.016; Wang WD, 2001, DEVELOPMENT, V128, P5017; Wang WD, 1998, DEVELOPMENT, V125, P621; Washburn L, 1986, MOUSE NEWS LETT, V2; Yan CH, 2011, J NEUROSCI, V31, P12413, DOI 10.1523/JNEUROSCI.1077-11.2011	56	18	19	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 30	2012	7	11							e51065	10.1371/journal.pone.0051065	http://dx.doi.org/10.1371/journal.pone.0051065			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	054WM	23226461	Green Published, gold, Green Submitted			2022-12-27	WOS:000312376100272
J	Wells, EM; Dearborn, DG; Jackson, LW				Wells, Ellen M.; Dearborn, Dorr G.; Jackson, Leila W.			Activity Change in Response to Bad Air Quality, National Health and Nutrition Examination Survey, 2007-2010	PLOS ONE			English	Article							POLLUTION; MORTALITY; OZONE; EXPOSURE	Air pollution contributes to poor respiratory and cardiovascular health. Susceptible individuals may be advised to mitigate effects of air pollution through actions such as reducing outdoor physical activity on days with high pollution. Our analysis identifies the extent to which susceptible individuals changed activities due to bad air quality. This cross-sectional study included 10,898 adults from the National Health and Nutrition Examination Survey (NHANES) 2007-2010. Participants reported if they did something differently when air quality was bad. Susceptible categories included respiratory conditions, cardiovascular conditions and older age (>= 65 years). Analyses accounted for complex survey design; logistic regression models controlled for gender, race, education, smoking, and body mass index. 1305 individuals reported doing something differently (12.0%, 95% confidence interval (CI): 10.9, 13.1). This percentage was 14.2% (95% CI: 11.6, 16.8), 25.1% (95% CI: 21.7, 28.6), and 15.5% (95% CI: 12.2, 18.9) among older adults, those with a respiratory condition, and those with a cardiovascular condition, respectively. In adjusted regression models the following were significantly more likely to have changed activity compared to those who did not belong to any susceptible group: respiratory conditions (adjusted odds ratio (aOR): 2.61, 95% CI: 2.03, 3.35); respiratory and cardiovascular conditions (aOR: 4.36, 95% CI: 2.47, 7.69); respiratory conditions and older age (aOR: 3.83; 95% CI: 2.47, 5.96); or all three groups (aOR: 3.52; 95% CI: (2.33, 5.32). Having cardiovascular conditions alone was not statistically significant. Some individuals, especially those with a respiratory condition, reported changing activities due to poor air quality. However, efforts should continue to educate the public about air quality and health.	[Wells, Ellen M.; Dearborn, Dorr G.] Case Western Reserve Univ, Sch Med, Dept Environm Hlth Sci, Cleveland, OH 44106 USA; [Wells, Ellen M.; Jackson, Leila W.] Case Western Reserve Univ, Dept Epidemiol & Biostat, Sch Med, Cleveland, OH 44106 USA	Case Western Reserve University; Case Western Reserve University	Wells, EM (corresponding author), Case Western Reserve Univ, Sch Med, Dept Environm Hlth Sci, Cleveland, OH 44106 USA.	ellen.wells@case.edu		Wells, Ellen/0000-0002-7293-1395	Swetland Center for Environmental Health	Swetland Center for Environmental Health	EMW and DGD were supported by the Swetland Center for Environmental Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abelsohn A, 2011, CAN FAM PHYSICIAN, V57, P881; Bateson TF, 2004, EPIDEMIOLOGY, V15, P143, DOI 10.1097/01.ede.0000112210.68754.fa; Bell ML, 2004, JAMA-J AM MED ASSOC, V292, P2372, DOI 10.1001/jama.292.19.2372; Centers for Disease Control and Prevention, 2007, NAT HLTH NUTR EX SUR; Department of Health and Human Services. National Heart Lung and Blood Institute, 1998, CLIN GUID ID EV TREA; Dominici F, 2006, JAMA-J AM MED ASSOC, V295, P1127, DOI 10.1001/jama.295.10.1127; Fann N, 2012, RISK ANAL, V32, P81, DOI 10.1111/j.1539-6924.2011.01630.x; Friedman MS, 2001, JAMA-J AM MED ASSOC, V285, P897, DOI 10.1001/jama.285.7.897; Howel D, 2003, ENVIRON RES, V91, P163, DOI 10.1016/S0013-9351(02)00037-3; Hukkanen J, 2005, PHARMACOL REV, V57, P79, DOI 10.1124/pr.57.1.3; Kelly FJ, 2012, RESPIROLOGY, V17, P7, DOI 10.1111/j.1440-1843.2011.02065.x; Laden F, 2006, AM J RESP CRIT CARE, V173, P667, DOI 10.1164/rccm.200503-443OC; Langrish JP, 2012, ENVIRON HEALTH PERSP, V120, P367, DOI 10.1289/ehp.1103898; Laumbach RJ, 2010, AM FAM PHYSICIAN, V81, P175; Medina-Ramon M, 2008, EPIDEMIOLOGY, V19, P672, DOI 10.1097/EDE.0b013e3181773476; Nowka MR, 2011, PROG CARDIOVASC DIS, V53, P379, DOI 10.1016/j.pcad.2010.12.003; Peel JL, 2005, EPIDEMIOLOGY, V16, P164, DOI 10.1097/01.ede.0000152905.42113.db; Pope C. Arden III, 2000, Environmental Health Perspectives, V108, P713, DOI 10.2307/3454408; Sacks JD, 2011, ENVIRON HEALTH PERSP, V119, P446, DOI 10.1289/ehp.1002255; Semenza JC, 2008, ENVIRON RES, V107, P401, DOI 10.1016/j.envres.2008.03.005; Shofer S, 2007, AM J MED SCI, V333, P257, DOI 10.1097/MAJ.0b013e31803b913c; Stafoggia M, 2010, AM J RESP CRIT CARE, V182, P376, DOI 10.1164/rccm.200908-1269OC; US Environmental Protection Agency National Oceanic and Atmospheric Adminsistration National Aeronautics and Space Administration National Park Service National Association of Clean Air Agencies, 2011, AIRNOW; Wen XJ, 2009, J COMMUN HEALTH, V34, P40, DOI 10.1007/s10900-008-9126-4	24	32	33	1	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 30	2012	7	11							e50526	10.1371/journal.pone.0050526	http://dx.doi.org/10.1371/journal.pone.0050526			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	054WM	23226304	Green Submitted, gold, Green Published			2022-12-27	WOS:000312376100116
J	Masi, S; Chauffour, S; Bain, O; Todd, A; Guillot, J; Krief, S				Masi, Shelly; Chauffour, Sophie; Bain, Odile; Todd, Angelique; Guillot, Jacques; Krief, Sabrina			Seasonal Effects on Great Ape Health: A Case Study of Wild Chimpanzees and Western Gorillas	PLOS ONE			English	Article							PAN-TROGLODYTES-SCHWEINFURTHII; KIBALE NATIONAL-PARK; INTESTINAL PARASITES; MOUNTAIN GORILLAS; LOWLAND GORILLAS; PREGNANT-WOMEN; GASTROINTESTINAL PARASITES; BIOACTIVE PROPERTIES; POPULATION DECLINES; DIETARY-RESPONSE	Among factors affecting animal health, environmental influences may directly or indirectly impact host nutritional condition, fecundity, and their degree of parasitism. Our closest relatives, the great apes, are all endangered and particularly sensitive to infectious diseases. Both chimpanzees and western gorillas experience large seasonal variations in fruit availability but only western gorillas accordingly show large changes in their degree of frugivory. The aim of this study is to investigate and compare factors affecting health (through records of clinical signs, urine, and faecal samples) of habituated wild ape populations: a community (N = 46 individuals) of chimpanzees (Pan troglodytes) in Kanyawara, Kibale National Park (Uganda), and a western gorilla (G. gorilla) group (N = 13) in Bai Hokou in the Dzanga-Ndoki National Park (Central African Republic). Ape health monitoring was carried out in the wet and dry seasons (chimpanzees: July-December 2006; gorillas: April-July 2008 and December 2008-February 2009). Compared to chimpanzees, western gorillas were shown to have marginally greater parasite diversity, higher prevalence and intensity of both parasite and urine infections, and lower occurrence of diarrhea and wounds. Parasite infections (prevalence and load), but not abnormal urine parameters, were significantly higher during the dry season of the study period for western gorillas, who thus appeared more affected by the large temporal changes in the environment in comparison to chimpanzees. Infant gorillas were the most susceptible among all the age/sex classes (of both apes) having much more intense infections and urine blood concentrations, again during the dry season. Long term studies are needed to confirm the influence of seasonal factors on health and parasitism of these great apes. However, this study suggest climate change and forest fragmentation leading to potentially larger seasonal fluctuations of the environment may affect patterns of ape parasitism and further exacerbate health impacts on great ape populations that live in highly seasonal habitats.	[Masi, Shelly; Krief, Sabrina] Museum Natl Hist Nat, Dept Hommes, Soc UMR Ecoanthropol & Ethnobiol 7206, F-75231 Paris, France; [Chauffour, Sophie; Guillot, Jacques] Ecole Natl Vet Alfort, UMR Anses, Upec BIPAR, Maisons Alfort, France; [Bain, Odile] CNRS, UMR OSEB 7205, Paris, France; [Todd, Angelique] WWF, Dzanga Sangha Protected Areas, Bangui, Cent Afr Republ; [Krief, Sabrina] Projet Conservat Grands Singes, Paris, France	Museum National d'Histoire Naturelle (MNHN); Ecole Nationale Veterinaire d'Alfort (ENVA); Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Sorbonne Universite; World Wildlife Fund	Masi, S (corresponding author), Museum Natl Hist Nat, Dept Hommes, Soc UMR Ecoanthropol & Ethnobiol 7206, F-75231 Paris, France.	masi@mnhn.fr	Todd, Angelique/AAR-3087-2021; Guillot, Jacques/J-9428-2016	Guillot, Jacques/0000-0003-3577-6979; Todd, Angelique/0000-0002-9207-4925	ATM 16 (Action Transversale du Museum national d'histoire naturelle); project "JC SAFAPE" of the ANR (Agence nationale de la recherche); Cleveland Metroparks Zoo; Cleveland Zoological Society	ATM 16 (Action Transversale du Museum national d'histoire naturelle); project "JC SAFAPE" of the ANR (Agence nationale de la recherche)(French National Research Agency (ANR)); Cleveland Metroparks Zoo; Cleveland Zoological Society	Funding: The authors thank the ATM 16 (Action Transversale du Museum national d'histoire naturelle), the project "JC SAFAPE" of the ANR (Agence nationale de la recherche), the Cleveland Metroparks Zoo, and the Cleveland Zoological Society, for funding this research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALTMANN J, 1974, BEHAVIOUR, V49, P227, DOI 10.1163/156853974X00534; Ashford RW, 2000, ANN TROP MED PARASIT, V94, P173, DOI 10.1080/00034980057518; Ashford RW, 1996, J ZOOL, V239, P507, DOI 10.1111/j.1469-7998.1996.tb05939.x; Bermejo M, 2006, SCIENCE, V314, P1564, DOI 10.1126/science.1133105; Blake, 2005, LONG TERM SYSTEM MON; Boesch Christophe, 1996, P101, DOI 10.1017/CBO9780511752414.010; Bowman D.D., 1995, GEORGIS PARASITOLOGY, Vsixth; Breuer T, 2009, AM J PRIMATOL, V71, P106, DOI 10.1002/ajp.20628; Brockman DK, 2005, CAM S BIO EVOL ANTHR, V44, P1, DOI 10.1017/CBO9780511542343; Carter JL, 2006, NEPHROL DIAL TRANSPL, V21, P3031, DOI 10.1093/ndt/gfl373; Chapman CA, 2005, EVOL ANTHROPOL, V14, P134, DOI 10.1002/evan.20068; Chapman CA, 2007, AM J PHYS ANTHROPOL, V134, P240, DOI 10.1002/ajpa.20664; CHIVERS DJ, 1980, J MORPHOL, V166, P337, DOI 10.1002/jmor.1051660306; Christensen CM, 1995, INT J PARASITOL, V25, P1491, DOI 10.1016/0020-7519(95)00085-2; COHEN S, 1992, PSYCHOL SCI, V3, P301, DOI 10.1111/j.1467-9280.1992.tb00677.x; Conklin-Brittain N. L., 2006, FEEDING ECOLOGY APES; Conklin-Brittain NL, 1998, INT J PRIMATOL, V19, P971, DOI 10.1023/A:1020370119096; Coop RL, 2001, TRENDS PARASITOL, V17, P325, DOI 10.1016/S1471-4922(01)01900-6; COTE IM, 1995, BEHAV ECOL, V6, P159, DOI 10.1093/beheco/6.2.159; Craigie ID, 2010, BIOL CONSERV, V143, P2221, DOI 10.1016/j.biocon.2010.06.007; Crestian J., 1975, Recueil de Medecine Veterinaire de l'Ecole d'Alfort, V151, P13; DOLLFUS R. P., 1955, Archives de Museum d'Histoire Naturelle., V3, P27; DORAN DM, 2001, MOUNTAIN GORILLAS 3, P123, DOI DOI 10.1017/CBO9780511661631.006; Doran-Sheehy D, 2009, AM J PHYS ANTHROPOL, V140, P727, DOI 10.1002/ajpa.21118; Dupain J, 2002, INT J PRIMATOL, V23, P1053, DOI 10.1023/A:1019697915897; DURETTEDESSET MC, 1992, SYST PARASITOL, V23, P159, DOI 10.1007/BF00010868; Freeland WJ, 1977, THESIS U MICHIGAN AR; Freeman AS, 2004, J WILDLIFE DIS, V40, P775, DOI 10.7589/0090-3558-40.4.775; Fujita S, 2011, PRIMATOL MONOGR, P353, DOI 10.1007/978-4-431-53921-6_37; Genton C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037106; Gillespie TR, 2006, CONSERV BIOL, V20, P441, DOI 10.1111/j.1523-1739.2006.00290.x; Gillespie TR, 2005, J PARASITOL, V91, P569, DOI 10.1645/GE-434R; GOODALL J, 1983, Z TIERPSYCHOL, V61, P1; Goodall J., 1986, CHIMPANZEES GOMBE PA; GULLAND FMD, 1992, PARASITOLOGY, V105, P493, DOI 10.1017/S0031182000074679; Hahn BH, 2000, SCIENCE, V287, P607, DOI 10.1126/science.287.5453.607; Hartert TV, 2003, AM J OBSTET GYNECOL, V189, P1705, DOI 10.1016/S0002-9378(03)00857-3; Hartter J.N., 2007, THESIS U FLORIDA GAI; Hartter J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032408; Hartter J, 2009, LANDSCAPE ECOL, V24, P643, DOI 10.1007/s10980-009-9339-7; Hastings Barkley E., 1992, American Association of Zoo Veterinarians Annual Proceedings, V1992, P301; HAUSFATER G, 1982, Primates, V23, P287, DOI 10.1007/BF02381167; Head JS, 2011, INT J PRIMATOL, V32, P755, DOI 10.1007/s10764-011-9499-6; HERCBERG S, 1986, HUM NUTR-CLIN NUTR, V40C, P371; Huffman MA, 1997, PRIMATES, V38, P111, DOI 10.1007/BF02382002; HUFFMAN MA, 1989, PRIMATES, V30, P51, DOI 10.1007/BF02381210; Huffman MA, 1996, INT J PRIMATOL, V17, P475, DOI 10.1007/BF02735188; Huffman Michael A., 1994, P129; International Union for Conservation of Nature, 2012, IUCN RED LIST THREAT; Janson C. H., 1999, PRIMATE COMMUNITIES; Kamiss Ami, 2006, RECENSEMENT POPULATI; Knott CD, 1998, INT J PRIMATOL, V19, P1061, DOI 10.1023/A:1020330404983; Koski KG, 2001, ANNU REV NUTR, V21, P297, DOI 10.1146/annurev.nutr.21.1.297; Krief S, 2006, AM J PRIMATOL, V68, P51, DOI 10.1002/ajp.20206; Krief S, 2005, J ETHNOPHARMACOL, V101, P1, DOI 10.1016/j.jep.2005.03.024; Krief S, 2005, J NAT PROD, V68, P897, DOI 10.1021/np049576i; Krief S, 2005, INT J PRIMATOL, V26, P467, DOI 10.1007/s10764-005-2934-9; Krief S, 2004, ANTIMICROB AGENTS CH, V48, P3196, DOI 10.1128/AAC.48.8.3196-3199.2004; Krief S, 2008, J MED PRIMATOL, V37, P188, DOI 10.1111/j.1600-0684.2008.00285.x; Krief S, 2012, MALARIA J, V11, DOI 10.1186/1475-2875-11-116; Krief S, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000630; Krief S, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000765; Lambert JE, 1998, EVOL ANTHROPOL, V7, P8, DOI 10.1002/(SICI)1520-6505(1998)7:1<8::AID-EVAN3>3.0.CO;2-C; LANDSOUDSOUKATE J, 1995, ANN TROP MED PARASIT, V89, P73, DOI 10.1080/00034983.1995.11812931; Leendertz FH, 2006, BIOL CONSERV, V131, P325, DOI 10.1016/j.biocon.2006.05.002; Leendertz FH, 2004, NATURE, V430, P451, DOI 10.1038/nature02722; Leendertz SAJ, 2010, AM J PRIMATOL, V72, P689, DOI 10.1002/ajp.20825; Leroy EM, 2004, SCIENCE, V303, P387, DOI 10.1126/science.1092528; Levine N.D., 1968, NEMATODE PARASITES D; Lilly AA, 1999, AM J PRIMATOL, V48, P197, DOI 10.1002/(SICI)1098-2345(1999)48:3&lt;197::AID-AJP3&gt;3.0.CO;2-Y; Lilly AA, 2002, INT J PRIMATOL, V23, P555, DOI 10.1023/A:1014969617036; Liu WM, 2010, NATURE, V467, P420, DOI 10.1038/nature09442; Marquerdt WC, 1985, PARASITOLOGY, P349; Masi S, 2012, INFLUENCE FRUGIVORY; Masi S, 2008, SEASONAL INFLUENCE F; Masi S, 2012, PHYSIOL BEHAV, V105, P337, DOI 10.1016/j.physbeh.2011.08.012; Masi S, 2009, AM J PRIMATOL, V71, P91, DOI 10.1002/ajp.20629; Mehlman PT, 2002, INT J PRIMATOL, V23, P1257, DOI 10.1023/A:1021126920753; Milton K, 1996, J ZOOL, V239, P39, DOI 10.1111/j.1469-7998.1996.tb05435.x; Morel P. C., 1959, Revue Rev Elev, V12, P153; Muehlenbein MP, 2010, BIOPSYCHOSOC MED, V4, DOI 10.1186/1751-0759-4-21; MULLOOLY JP, 1986, PUBLIC HEALTH REP, V101, P205; Murray DL, 1998, ECOLOGY, V79, P1209, DOI 10.1890/0012-9658(1998)079[1209:DPANSI]2.0.CO;2; Neuzil KM, 1998, AM J EPIDEMIOL, V148, P1094, DOI 10.1093/oxfordjournals.aje.a009587; Pontzer H, 2006, INT J PRIMATOL, V27, P295, DOI 10.1007/s10764-005-9011-2; Profousova I, 2011, FOLIA MICROBIOL, V56, P339, DOI 10.1007/s12223-011-0053-x; Remis MJ, 2004, INT J PRIMATOL, V25, P825, DOI 10.1023/B:IJOP.0000029124.04610.c7; Rogers ME, 2004, AM J PRIMATOL, V64, P173, DOI 10.1002/ajp.20071; Rothman JM, 2009, CAM S BIO EVOL ANTHR, V57, P441; Ryan SJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0029030; Sleeman JM, 2000, J ZOO WILDLIFE MED, V31, P322, DOI 10.1638/1042-7260(2000)031[0322:GPOMGG]2.0.CO;2; Sleeman JM, 1998, J ZOO WILDLIFE MED, V29, P432; Soll SJ, 2010, P NATL ACAD SCI USA, V107, P19496, DOI 10.1073/pnas.1012344107; Stear MJ, 1995, PARASITE IMMUNOL, V17, P643, DOI 10.1111/j.1365-3024.1995.tb01010.x; STRUHSAKER T. T., 1997, ECOLOGY AFRICAN RAIN; STUART MD, 1993, J HELMINTHOL SOC W, V60, P111; TUTIN CEG, 1993, AM J PRIMATOL, V30, P195, DOI 10.1002/ajp.1350300305; Walsh PD, 2003, NATURE, V422, P611, DOI 10.1038/nature01566; Walsh PD, 2007, AM NAT, V169, P684, DOI 10.1086/513494; Waterman P.G., 1984, P177; Wolfe ND, 1998, EMERG INFECT DIS, V4, P149, DOI 10.3201/eid0402.980202; WRANGHAM R W, 1983, Primates, V24, P276, DOI 10.1007/BF02381090; Wrangham RW, 1998, INT J PRIMATOL, V19, P949, DOI 10.1023/A:1020318102257; WRANGHAM RW, 1995, AM J PRIMATOL, V37, P297, DOI 10.1002/ajp.1350370404	104	36	36	0	95	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 5	2012	7	12							e49805	10.1371/journal.pone.0049805	http://dx.doi.org/10.1371/journal.pone.0049805			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	057TZ	23227152	gold, Green Published, Green Submitted			2022-12-27	WOS:000312588200014
J	Prilipko, O; Huynh, N; Schwartz, S; Tantrakul, V; Kushida, C; Paiva, T; Guilleminault, C				Prilipko, Olga; Huynh, Nelly; Schwartz, Sophie; Tantrakul, Visasiri; Kushida, Clete; Paiva, Teresa; Guilleminault, Christian			The Effects of CPAP Treatment on Task Positive and Default Mode Networks in Obstructive Sleep Apnea Patients: An fMRI Study	PLOS ONE			English	Article							MAGNETIC-RESONANCE-SPECTROSCOPY; BODY-MASS INDEX; WORKING-MEMORY; COGNITIVE FUNCTION; BRAIN ACTIVATION; ATTENTIONAL NETWORKS; SUSTAINED ATTENTION; AIRWAY PRESSURE; DYSFUNCTION; DEPRIVATION	Introduction: Functional magnetic resonance imaging studies enable the investigation of neural correlates underlying behavioral performance. We investigate the effect of active and sham Continuous Positive Airway Pressure (CPAP) treatment on working memory function of patients with Obstructive Sleep Apnea Syndrome (OSAS) considering Task Positive and Default Mode networks (TPN and DMN). Methods: An experiment with 4 levels of visuospatial n-back task was used to investigate the pattern of cortical activation in 17 men with moderate or severe OSAS before and after 2 months of therapeutic (active) or sub-therapeutic (sham) CPAP treatment. Results: Patients with untreated OSAS had significantly less deactivation in the temporal regions of the DMN as compared to healthy controls, but activation within TPN regions was comparatively relatively preserved. After 2 months of treatment, active and sham CPAP groups exhibited opposite trends of cerebral activation and deactivation. After treatment, the active CPAP group demonstrated an increase of cerebral activation in the TPN at all task levels and of task-related cerebral deactivation in the anterior midline and medial temporal regions of the DMN at the 3-back level, associated with a significant improvement of behavioral performance, whereas the sham CPAP group exhibited less deactivation in the temporal regions of Default Mode Network and less Task Positive Network activation associated to longer response times at the 3-back. Conclusion: OSAS has a significant negative impact primarily on task-related DMN deactivation, particularly in the medial temporal regions, possibly due to nocturnal hypoxemia, as well as TPN activation, particularly in the right ventral frontoparietal network. After 2 months of active nasal CPAP treatment a positive response was noted in both TPN and DMN but without compete recovery of existing behavioral and neuronal deficits. Initiation of CPAP treatment early in the course of the disease may prevent or slow down the occurrence of irreversible impairment.	[Prilipko, Olga; Huynh, Nelly; Tantrakul, Visasiri; Kushida, Clete; Guilleminault, Christian] Stanford Univ, Sleep Clin, Redwood City, CA USA; [Prilipko, Olga; Huynh, Nelly; Tantrakul, Visasiri; Kushida, Clete; Guilleminault, Christian] Stanford Univ, Ctr Human Sleep Res, Redwood City, CA USA; [Schwartz, Sophie] Univ Geneva, Med Ctr, CH-1211 Geneva, Switzerland; [Paiva, Teresa] CENC, Dept Neurol, Lisbon, Portugal	Stanford University; Stanford University; University of Geneva	Guilleminault, C (corresponding author), Stanford Univ, Sleep Clin, Redwood City, CA USA.	cguil@stanford.edu		Paiva, Maria Teresa Aguiar dos Santos/0000-0002-7937-7841	Swiss National Foundation for Scientific Research; Swiss Foundation for Grants in Medicine and Biology (FSBMB)	Swiss National Foundation for Scientific Research(Swiss National Science Foundation (SNSF)); Swiss Foundation for Grants in Medicine and Biology (FSBMB)	This study was supported by research grants from Swiss National Foundation for Scientific Research and Swiss Foundation for Grants in Medicine and Biology (FSBMB), as well as Respironics, Resmed, and Covidien. The publication is supported by an unrestrictive educational grant from Kai sensor Inc. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aloia MS, 2004, J INT NEUROPSYCH SOC, V10, P772, DOI 10.1017/S1355617704105134; Archbold KH, 2009, J CLIN SLEEP MED, V5, P21; Ayalon L, 2009, J SLEEP RES; Ayalon L, 2006, NEUROIMAGE, V31, P1817, DOI 10.1016/j.neuroimage.2006.02.042; Ayalon L, 2009, SLEEP, V32, P373, DOI 10.1093/sleep/32.3.373; Bartlett DJ, 2004, SLEEP MED, V5, P593, DOI 10.1016/j.sleep.2004.08.004; Beebe DW, 2002, J SLEEP RES, V11, P1, DOI 10.1046/j.1365-2869.2002.00289.x; Buckner RL, 2008, ANN NY ACAD SCI, V1124, P1, DOI 10.1196/annals.1440.011; Canessa N, 2011, AM J RESP CRIT CARE, V183, P1419, DOI 10.1164/rccm.201005-0693OC; Castellanos FX, 2008, BIOL PSYCHIAT, V63, P332, DOI 10.1016/j.biopsych.2007.06.025; Castronovo V, 2009, SLEEP, V32, P1161, DOI 10.1093/sleep/32.9.1161; Chee MWL, 2008, CURR OPIN NEUROL, V21, P417, DOI 10.1097/WCO.0b013e3283052cf7; Choo WC, 2005, NEUROIMAGE, V25, P579, DOI 10.1016/j.neuroimage.2004.11.029; Corbetta M, 2002, NAT REV NEUROSCI, V3, P201, DOI 10.1038/nrn755; Cournot M, 2006, NEUROLOGY, V67, P1208, DOI 10.1212/01.wnl.0000238082.13860.50; Demeter E, 2011, NEUROIMAGE, V54, P1518, DOI 10.1016/j.neuroimage.2010.09.026; Drummond SPA, 2005, SLEEP, V28, P1059; Fan J, 2005, NEUROIMAGE, V26, P471, DOI 10.1016/j.neuroimage.2005.02.004; Farre R, 1999, LANCET, V353, P1154, DOI 10.1016/S0140-6736(99)01056-9; Felver-Gant JC, 2007, J CLIN SLEEP MED, V3, P589; Ferini-Strambi L, 2003, BRAIN RES BULL, V61, P87, DOI 10.1016/S0361-9230(03)00068-6; Fox MD, 2005, P NATL ACAD SCI USA, V102, P9673, DOI 10.1073/pnas.0504136102; Garrity AG, 2007, AM J PSYCHIAT, V164, P450, DOI 10.1176/appi.ajp.164.3.450; Gazdzinski S, 2010, OBESITY, V18, P743, DOI 10.1038/oby.2009.325; Glover GH, 2001, MAGNET RESON MED, V46, P515, DOI 10.1002/mrm.1222; Goel N, 2009, SEMIN NEUROL, V29, P320, DOI 10.1055/s-0029-1237117; Grady CL, 2009, CEREB CORTEX; Gujar N, 2009, J COGN NEUROSCI; Gunstad J, 2007, COMPR PSYCHIAT, V48, P57, DOI 10.1016/j.comppsych.2006.05.001; Gusnard DA, 2001, NAT REV NEUROSCI, V2, P685, DOI 10.1038/35094500; Kim DH, 2002, MAGNET RESON MED, V48, P715, DOI 10.1002/mrm.10267; Lau EYY, 2010, J INT NEUROPSYCH SOC, V16, P1077, DOI 10.1017/S1355617710000901; Ledberg A, 1998, NEUROIMAGE, V8, P113, DOI 10.1006/nimg.1998.0336; Morrell MJ, 2003, SLEEP MED, V4, P451, DOI 10.1016/S1389-9457(03)00159-X; O'Donoghue FJ, 2012, SLEEP, V35, P41, DOI 10.5665/sleep.1582; Prilipko O, 2011, SLEEP, V34, P293, DOI 10.1093/sleep/34.3.293; Quan SF, 2011, SLEEP, V34, P303, DOI 10.1093/sleep/34.3.303; Raichle ME, 2001, P NATL ACAD SCI USA, V98, P676, DOI 10.1073/pnas.98.2.676; Saunamaki T, 2007, ACTA NEUROL SCAND, V115, P1, DOI 10.1111/j.1600-0404.2006.00744.x; Song XW, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025031; Thomas RJ, 2005, J APPL PHYSIOL, V98, P2226, DOI 10.1152/japplphysiol.01225.2004; Tomasi D, 2009, CEREB CORTEX, V19, P233, DOI 10.1093/cercor/bhn073; Torelli F, 2011, NEUROIMAGE, V54, P787, DOI 10.1016/j.neuroimage.2010.09.065; Toro R, 2008, CEREB CORTEX, V18, P2553, DOI 10.1093/cercor/bhn014; van Eimeren T, 2009, ARCH NEUROL-CHICAGO, V66, P877, DOI 10.1001/archneurol.2009.97; Wolf PA, 2007, CURR ALZHEIMER RES, V4, P111, DOI 10.2174/156720507780362263; Worsley KJ, 2002, NEUROIMAGE, V15, P1, DOI 10.1006/nimg.2001.0933	47	23	24	2	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 5	2012	7	12							e47433	10.1371/journal.pone.0047433	http://dx.doi.org/10.1371/journal.pone.0047433			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	057TZ	23227139	Green Published, gold, Green Submitted			2022-12-27	WOS:000312588200002
J	Sibley, CG; Bulbulia, J				Sibley, Chris G.; Bulbulia, Joseph			Faith after an Earthquake: A Longitudinal Study of Religion and Perceived Health before and after the 2011 Christchurch New Zealand Earthquake	PLOS ONE			English	Article							SIGNALING THEORY; EVOLUTION; BELIEF; SPIRITUALITY; ADJUSTMENT; RESPONSES; DISPLAYS; PSALMS; MODEL; GOODS	On 22 February 2011, Christchurch New Zealand (population 367,700) experienced a devastating earthquake, causing extensive damage and killing one hundred and eighty-five people. The earthquake and aftershocks occurred between the 2009 and 2011 waves of a longitudinal probability sample conducted in New Zealand, enabling us to examine how a natural disaster of this magnitude affected deeply held commitments and global ratings of personal health, depending on earthquake exposure. We first investigated whether the earthquake-affected were more likely to believe in God. Consistent with the Religious Comfort Hypothesis, religious faith increased among the earthquake-affected, despite an overall decline in religious faith elsewhere. This result offers the first population-level demonstration that secular people turn to religion at times of natural crisis. We then examined whether religious affiliation was associated with differences in subjective ratings of personal health. We found no evidence for superior buffering from having religious faith. Among those affected by the earthquake, however, a loss of faith was associated with significant subjective health declines. Those who lost faith elsewhere in the country did not experience similar health declines. Our findings suggest that religious conversion after a natural disaster is unlikely to improve subjective well-being, yet upholding faith might be an important step on the road to recovery. Citation: Sibley CG, Bulbulia J (2012) Faith after an Earthquake: A Longitudinal Study of Religion and Perceived Health before and after the 2011 Christchurch New Zealand Earthquake. PLoS ONE 7(12): e49648. doi:10.1371/journal.pone.0049648	[Bulbulia, Joseph] Univ New Zealand, Wellington, New Zealand; [Sibley, Chris G.] Univ Auckland, Auckland 1, New Zealand	University of Auckland	Bulbulia, J (corresponding author), Univ New Zealand, Wellington, New Zealand.	Joseph.Bulbulia@vuw.ac.nz	Sibley, Chris G/D-2974-2009	Sibley, Chris G/0000-0002-4064-8800; Bulbulia, Joseph/0000-0002-5861-2056	University of Auckland FRDF [3624435/9853]; ECREA [3626075]; The Interacting Minds Project; Religion Cognition and Culture Unit at Aarhus University; Victoria University URF Grant [8-3046-108855]	University of Auckland FRDF; ECREA; The Interacting Minds Project; Religion Cognition and Culture Unit at Aarhus University; Victoria University URF Grant	Collection of the New Zealand Attitudes and Values Study 2009 (NZAVS-09) data analyzed in this paper was funded by University of Auckland FRDF (#3624435/9853) and ECREA (#3626075) grants awarded to Chris Sibley. The Interacting Minds Project and Religion Cognition and Culture Unit at Aarhus University, and Victoria University URF Grant (8-3046-108855) supported Joseph Bulbulia. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alcorta CS, 2005, HUM NATURE-INT BIOS, V16, P323, DOI 10.1007/s12110-005-1014-3; [Anonymous], 2004, MODES RELIG COGNITIV; Atkinson QD, 2011, EVOL HUM BEHAV, V32, P41, DOI 10.1016/j.evolhumbehav.2010.07.008; Atran S, 2004, BEHAV BRAIN SCI, V27, P713, DOI 10.1017/S0140525X04000172; Atran Scott, 2010, Biology Theory, V5, P18, DOI 10.1162/BIOT_a_00018; Atran Scott, 2002, GODS WE TRUST EVOLUT; Barrett HC, 2005, EVOL HUM BEHAV, V26, P313, DOI 10.1016/j.evolhumbehav.2004.08.015; Boyer P, 2006, BEHAV BRAIN SCI, V29, P595, DOI 10.1017/S0140525X06009332; Brewer MB, 1999, J SOC ISSUES, V55, P429, DOI 10.1111/0022-4537.00126; Bulbulia J., 2008, EVOLUTION RELIG STUD, P153; Bulbulia J, 2013, CONT TOP COGN NEUROS, P169; Bulbulia J, 2012, NUMEN-INT REV HIST R, V59, P564, DOI 10.1163/15685276-12341240; Bulbulia J, 2011, RELIGION, V41, P363, DOI 10.1080/0048721X.2011.604508; Bulbulia J, 2012, BIOL PHILOS, V27, P1, DOI 10.1007/s10539-011-9295-x; Calhoun LG, 2000, J TRAUMA STRESS, V13, P521, DOI 10.1023/A:1007745627077; Cambell David, 2003, RELIG SOCIAL CAPITAL, P87; Chen DL, 2010, J POLIT ECON, V118, P300, DOI 10.1086/652462; Cummins RA, 2003, SOC INDIC RES, V64, P159, DOI 10.1023/A:1024704320683; Dennett D. C., 2006, BREAKING SPELL RELIG; Festinger L, 1956, PROPHECY FAILS, DOI 10.1037/10030-000; Feuerbach Ludwig, 1957, ESSENCE CHRISTIANITY; Frazier W, 2009, THESIS MISSISSIPPI S; Freud Sigmund, 1927, FUTURE ILLUSION; Geertz AW, 2010, METH THEORY STUD REL, V22, P304, DOI 10.1163/157006810X531094; Geertz AW, 1999, HIST REFLECTIONS, V25, P445; Gervais W, 2011, RELIGION, P41; Graham J, 2009, J PERS SOC PSYCHOL, V96, P1029, DOI 10.1037/a0015141; Gray K, 2010, PERS SOC PSYCHOL REV, V14, P7, DOI 10.1177/1088868309350299; Haidt J, 2009, SOCIAL PSYCHOL BASES, P371, DOI [10.1093/acprof:oso/9780195320916.003.015, DOI 10.1093/ACPROF:OSO/9780195320916.003.015]; Haidt J, 2007, SCIENCE, V316, P998, DOI 10.1126/science.1137651; Henrich J, 2009, EVOL HUM BEHAV, V30, P244, DOI 10.1016/j.evolhumbehav.2009.03.005; Hick J, 1966, EVIL GOD LOVE; Houkamau CA, 2011, SOC INDIC RES, V103, P379, DOI 10.1007/s11205-010-9705-5; Hoverd W, 2008, NZ SOCIOLOGY, V23, P41; Hoverd W. J., 2010, NZ SOCIOLOGY, V25, P59; Hoverd WJ, 2012, J SCI STUD RELIG, V51, P286, DOI 10.1111/j.1468-5906.2012.01643.x; Inzlicht M, 2011, RELIG BRAIN BEHAV, V1, P192, DOI 10.1080/2153599X.2011.647849; Inzlicht M, 2010, PSYCHOL SCI, V21, P1184, DOI 10.1177/0956797610375451; Irons W., 2001, EVOLUTION CAPACITY C, P292; Johnson DDP, 2005, HUM NATURE-INT BIOS, V16, P410, DOI 10.1007/s12110-005-1017-0; Johnson Dominic., 2006, EVOLUTIONARY PSYCHOL, P4, DOI [10.1177/147470490600400119, DOI 10.1177/147470490600400119]; Johnson DDP, 2011, NATURE, V477, P317, DOI 10.1038/nature10384; Johnston-Monje D, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020396; Kay AC, 2010, J PERS SOC PSYCHOL, V99, P725, DOI 10.1037/a0021140; Kay AC, 2010, PSYCHOL SCI, V21, P216, DOI 10.1177/0956797609357750; Koenig H. G, 2001, HDB RELIG HLTH; Lanman JA, 2012, J CONTEMP RELIG, V27, P49, DOI 10.1080/13537903.2012.642726; Leibniz GW., 1710, THEODICY ESSAYS GOOD; Lewis D., 1993, PHILOS PAP, V22, P149; Lienard P, 2006, AM ANTHROPOL, V108, P814, DOI 10.1525/aa.2006.108.4.814; Luhrmann Tanya M., 2012, GOD TALKS BACK UNDER; Malinowski Bronislaw, 1948, MAGIC SCI RELIG OTHE; Marx K, 1867, CAPTIAL CRITIQUE POL; McClenon James., 2002, WONDROUS HEALING SHA; MCINTOSH DN, 1993, J PERS SOC PSYCHOL, V65, P812, DOI 10.1037/0022-3514.65.4.812; McKay RT, 2009, BEHAV BRAIN SCI, V32, P493, DOI 10.1017/S0140525X09990975; Miller WR, 2003, AM PSYCHOL, V58, P24, DOI 10.1037/0003-066X.58.1.24; Morris P, 2002, SPIRIT STRANGE LAND; Norenzayan A, 2006, PERS SOC PSYCHOL B, V32, P174, DOI 10.1177/0146167205280251; Norenzayan A, CULTURAL EV IN PRESS; Norenzayan A, MAKING BIG IN PRESS; Norenzayan A, 2008, SCIENCE, V322, P58, DOI 10.1126/science.1158757; Norris Pippa, 2004, SACRED SECULAR RELIG; Paldam M, 2012, RELIG TRANSITION LON; PALOUTZIAN RF, 1978, J PSYCHOL THEOL, V6, P266, DOI 10.1177/009164717800600403; Pargament K.I., 1997, PSYCHOL RELIG COPING; Putnam R., 2000, BOWLING ALONE COLLAP; Richerson PJ, 2013, STRUNGMANN FORUM REP, P1; Richman K, 2012, STUD RELIG-SCI RELIG, V41, P148, DOI 10.1177/0008429812441314; Salsman JM, 2005, PERS SOC PSYCHOL B, V31, P522, DOI 10.1177/0146167204271563; Schjodt U, 2007, J COGN CULT, V7, P313, DOI 10.1163/156853707X208530; Schjoedt U, RELIG BRAIN IN PRESS; Schjoedt U, 2009, SOC COGN AFFECT NEUR, V4, P199, DOI 10.1093/scan/nsn050; Schloss J, 2008, EVOLUTION RELIG STUD, P197; Seirmarco G, 2012, PSYCHOL RELIG SPIRIT, V4, P10, DOI 10.1037/a0023479; Shariff AF, 2010, EVOLUTION, CULTURE, AND THE HUMAN MIND, P119; Sibley C. G., 2012, J COGNITIVE SCI RELI, V1, P29, DOI DOI 10.1558/JCSR.V1I1.29; Sibley CG, 2011, SOC INDIC RES, V104, P103, DOI 10.1007/s11205-010-9729-x; Sosis R, 2007, CURR ANTHROPOL, V48, P903, DOI 10.1086/523015; Sosis Richard, 2003, Hum Nat, V14, P91, DOI 10.1007/s12110-003-1000-6; Sosis R, 2011, AM ANTHROPOL, V113, P40, DOI 10.1111/j.1548-1433.2010.01305.x; Sterelny Kim, 2007, Biology Theory, V2, P317, DOI 10.1162/biot.2007.2.3.317; Trevino KM, 2007, SOUTH MED J, V100, P946, DOI 10.1097/SMJ.0b013e3181454660; Turchin P., 2006, WAR PEACE WAR; Vazquez C, 2005, J ANXIETY DISORD, V19, P313, DOI 10.1016/j.janxdis.2004.03.002; Wilson DS, 2009, EVOL HUM BEHAV, V30, P190, DOI 10.1016/j.evolhumbehav.2008.12.002; Wilson DS, 2005, HUM NATURE-INT BIOS, V16, P382, DOI 10.1007/s12110-005-1016-1; Wilson DS, 2002, DRAWINS CATHEDRAL EV; Xygalatas Dimitris, 2008, EVOLUTION RELIG STUD, P189; Zuckerman P, 2009, SOCIOL COMPASS, V3, P949, DOI 10.1111/j.1751-9020.2009.00247.x; Zuckerman Phil., 2008, SOC GOD WHAT LEAST R	91	97	98	0	43	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 5	2012	7	12							e49648	10.1371/journal.pone.0049648	http://dx.doi.org/10.1371/journal.pone.0049648			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	057TZ	23227147	Green Published, gold			2022-12-27	WOS:000312588200010
J	Chen, L; Wang, ZX; Li, SR; Zhao, GJ; Tian, MS; Sun, ZC				Chen, Liang; Wang, Zhenxiang; Li, Shirong; Zhao, Guangjian; Tian, Maosheng; Sun, Zhicheng			SFRP2 and Slug Contribute to Cellular Resistance to Apoptosis in Hypertrophic Scars	PLOS ONE			English	Article							FRIZZLED-RELATED PROTEIN-2; KELOIDS; CELLS; EXPRESSION; FIBROSIS; INVASION; GROWTH; TISSUE; BCL-2; SKIN	Hypertrophic scars (HS) are skin disorders which occur after wounding and thermal injury. Our previous studies have suggested that secreted frizzled-related protein 2 (SFRP2) is involved in HS formation and that the suppression of SFRP2 promotes apoptosis of hypertrophic scar fibroblasts (HSFBs). However, the mechanisms have not been clarified. Previous studies revealed that Slug expression inhibits cell apoptosis, in vitro and in vivo, and SFRP2 regulates the expression of Slug in cervical cancer cells. In the present study, we quantified differential expression levels of expression of SFRP2 and Slug in HS and normal skin tissues by immunohistochemistry, both of which have important anti-apoptosis roles. Furthermore, a short hairpin RNA approach was adopted to investigate the potential function of SFRP2 and Slug in HSFB apoptosis. Cell apoptosis was detected using fluorescence-activated cell sorting and Caspase-3 activity was assayed by spectrophotometry. This study demonstrates that SFRP2 expression, as well as Slug, is dramatically up-regulated in HS relative to normal skin tissues, and the Slug expression is positively correlated with SFRP2. Slug expression was down-regulated in SFRP2-deficient cells, and the down-regulation of Slug expression increased sensitivity to apoptosis which was induced through a caspase-3-dependent pathway. The infected cells with reduced levels of Slug were tested for the expression of apoptosis-related genes (Bcl-2, Bax and PUMA) which were previously identified as Slug targets. Bcl-2 expression was down-regulated in Slug-deficient cells. In conclusion, SFRP2 appears to interact with Slug to affect the apoptosis of hypertrophic scar fibroblasts. Citation: Chen L, Wang Z, Li S, Zhao G, Tian M, et al. (2012) SFRP2 and Slug Contribute to Cellular Resistance to Apoptosis in Hypertrophic Scars. PLoS ONE 7(12): e50229. doi:10.1371/journal.pone.0050229	[Zhao, Guangjian; Tian, Maosheng; Sun, Zhicheng] Chinese Peoples Armed Police Force, Dept Plast Surg, Affiliated Hosp, Pingjin Hosp,Logist Coll, Tianjin, Peoples R China; [Chen, Liang; Wang, Zhenxiang; Li, Shirong] Third Mil Med Univ, Dept Plast Surg, Southwest Hosp, Chongqing, Peoples R China	Army Medical University	Sun, ZC (corresponding author), Chinese Peoples Armed Police Force, Dept Plast Surg, Affiliated Hosp, Pingjin Hosp,Logist Coll, Tianjin, Peoples R China.	ymzxmr@126.com			National Natural Science Foundation of China [81000841, 81272102]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	Experiments done for the manuscript revisions were supported by National Natural Science Foundation of China (No. 81000841 and 81272102). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aarabi S, 2007, FASEB J, V21, P3250, DOI 10.1096/fj.07-8218com; Baygi ME, 2010, TUMOR BIOL, V31, P297, DOI 10.1007/s13277-010-0037-5; Bermejo-Rodriguez C, 2006, GENOMICS, V87, P113, DOI 10.1016/j.ygeno.2005.09.014; Cao B, 2008, J ASIAN NAT PROD RES, V10, P147, DOI 10.1080/10286020701394308; Cha HS, 2010, EXP MOL MED, V42, P428, DOI 10.3858/emm.2010.42.6.044; Chen W, 2003, J SURG RES, V113, P208, DOI 10.1016/S0022-4804(03)00188-4; Chung MT, 2009, GYNECOL ONCOL, V112, P646, DOI 10.1016/j.ygyno.2008.10.026; De Felice B, 2009, MOL CELL BIOCHEM, V327, P191, DOI 10.1007/s11010-009-0057-x; DEITCH EA, 1983, J TRAUMA, V23, P895, DOI 10.1097/00005373-198310000-00009; DESMOULIERE A, 1995, AM J PATHOL, V146, P56; He W, 2010, P NATL ACAD SCI USA, V107, P21110, DOI 10.1073/pnas.1004708107; Hou XH, 2009, J ASIAN NAT PROD RES, V11, P663, DOI 10.1080/10286020902975772; Inoue A, 2002, CANCER CELL, V2, P279, DOI 10.1016/S1535-6108(02)00155-1; Kobayashi K, 2009, NAT CELL BIOL, V11, P46, DOI 10.1038/ncb1811; Linge C, 2005, J INVEST DERMATOL, V125, P72, DOI 10.1111/j.0022-202X.2005.23771.x; Martin P, 1997, SCIENCE, V276, P75, DOI 10.1126/science.276.5309.75; Nedelec B, 2001, SURGERY, V130, P798, DOI 10.1067/msy.2001.116453; Newkirk KM, 2008, J INVEST DERMATOL, V128, P361, DOI 10.1038/sj.jid.5700990; Oliveira GV, 2009, INT WOUND J, V6, P445, DOI 10.1111/j.1742-481X.2009.00638.x; Russell SB, 2010, J INVEST DERMATOL, V130, P2489, DOI 10.1038/jid.2010.162; Sathi GA, 2009, ORAL ONCOL, V45, P856, DOI 10.1016/j.oraloncology.2009.02.001; Satoh W, 2008, GENESIS, V46, P92, DOI 10.1002/dvg.20369; Sun ZC, 2011, MOL CELL BIOCHEM, V352, P25, DOI 10.1007/s11010-011-0736-2; Suzuki K, 1999, JPN J CLIN ONCOL, V29, P323, DOI 10.1093/jjco/29.7.323; Teofoli P, 1999, J DERMATOL SCI, V22, P31, DOI 10.1016/S0923-1811(99)00040-7; Tribulo C, 2004, DEV BIOL, V275, P325, DOI 10.1016/j.ydbio.2004.07.041; Vitali R, 2008, CLIN CANCER RES, V14, P4622, DOI 10.1158/1078-0432.CCR-07-5210; Wolfram D, 2009, DERMATOL SURG, V35, P171, DOI 10.1111/j.1524-4725.2008.34406.x; Wu WS, 2005, CELL, V123, P641, DOI 10.1016/j.cell.2005.09.029; Yang HW, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-301; Zhang KJ, 2011, MED ONCOL, V28, pS301, DOI 10.1007/s12032-010-9759-x; Zhang KJ, 2011, MED ONCOL, V28, P1089, DOI 10.1007/s12032-010-9652-7; Zhou W, 2011, J CLIN ENDOCR METAB, V96, pE1237, DOI 10.1210/jc.2010-3040	33	7	7	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 4	2012	7	12							e50229	10.1371/journal.pone.0050229	http://dx.doi.org/10.1371/journal.pone.0050229			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	051EQ	23226515	Green Submitted, Green Published, gold			2022-12-27	WOS:000312108500013
J	Ruger, JP; Chawarski, M; Mazlan, M; Ng, N; Schottenfeld, R				Ruger, Jennifer Prah; Chawarski, Marek; Mazlan, Mahmud; Ng, Nora; Schottenfeld, Richard			Cost-Effectiveness of Buprenorphine and Naltrexone Treatments for Heroin Dependence in Malaysia	PLOS ONE			English	Article							OPIOID DEPENDENCE; SUBSTANCE-ABUSE; MAINTENANCE TREATMENT; ST-PETERSBURG; ADDICTION; METHADONE; DRUG; ABSTINENCE; THERAPY	Aims: To aid public health policymaking, we studied the cost-effectiveness of buprenorphine, naltrexone, and placebo interventions for heroin dependence in Malaysia. Design: We estimated the cost-effectiveness ratios of three treatments for heroin dependence. We used a microcosting methodology to determine fixed, variable, and societal costs of each intervention. Cost data were collected from investigators, staff, and project records on the number and type of resources used and unit costs; societal costs for participants' time were estimated using Malaysia's minimum wage. Costs were estimated from a provider and societal perspective and reported in 2004 US dollars. Setting: Muar, Malaysia. Participants: 126 patients enrolled in a randomized, double-blind, placebo-controlled clinical trial in Malaysia (2003-2005) receiving counseling and buprenorphine, naltrexone, or placebo for treatment of heroin dependence. Measurements: Primary outcome measures included days in treatment, maximum consecutive days of heroin abstinence, days to first heroin use, and days to heroin relapse. Secondary outcome measures included treatment retention, injection drug use, illicit opiate use, AIDS Risk Inventory total score, and drug risk and sex risk subscores. Findings: Buprenorphine was more effective and more costly than naltrexone for all primary and most secondary outcomes. Incremental cost-effectiveness ratios were below $50 for primary outcomes, mostly below $350 for secondary outcomes. Naltrexone was dominated by placebo for all secondary outcomes at almost all endpoints. Incremental treatment costs were driven mainly by medication costs, especially the price of buprenorphine. Conclusions: Buprenorphine appears to be a cost-effective alternative to naltrexone that might enhance economic productivity and reduce drug use over a longer term. Citation: Ruger JP, Chawarski M, Mazlan M, Ng N, Schottenfeld R (2012) Cost-Effectiveness of Buprenorphine and Naltrexone Treatments for Heroin Dependence in Malaysia. PLoS ONE 7(12): e50673. doi:10.1371/journal.pone.0050673	[Ruger, Jennifer Prah; Ng, Nora] Yale Univ, Sch Med, Dept Publ Hlth, New Haven, CT 06510 USA; [Chawarski, Marek; Schottenfeld, Richard] Yale Univ, Sch Med, Dept Psychiat, New Haven, CT USA; [Mazlan, Mahmud] Subst Abuse Ctr, Muar Johor, Malaysia	Yale University; Yale University	Ruger, JP (corresponding author), Yale Univ, Sch Med, Dept Publ Hlth, New Haven, CT 06510 USA.	jennifer.ruger@yale.edu			Patrick and Catherine Weldon Donaghue Medical Research Foundation; National Institute on Drug Abuse [R01 DA14718, K24 DA000445, K01 DA01635810]; State of Connecticut Department of Mental Health and Addiction Services; Whitney and Betty MacMillan Center for International and Area Studies at Yale University; NATIONAL INSTITUTE ON DRUG ABUSE [K24DA000445, R01DA014718] Funding Source: NIH RePORTER	Patrick and Catherine Weldon Donaghue Medical Research Foundation; National Institute on Drug Abuse(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission); State of Connecticut Department of Mental Health and Addiction Services; Whitney and Betty MacMillan Center for International and Area Studies at Yale University; NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This study was funded in part by the National Institute on Drug Abuse (grant numbers R01 DA14718 and K24 DA000445 and K01 DA01635810). Two of the Investigators (RS and MC) received support from the State of Connecticut Department of Mental Health and Addiction Services; JPR was also supported by the Patrick and Catherine Weldon Donaghue Medical Research Foundation and the Whitney and Betty MacMillan Center for International and Area Studies at Yale University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors thank Poh Hong Wa and Jody Sindelar for helpful comments and participation in the study. JPR had full access to all of the data in the study and takes responsibility for the integrity of the data and the accuracy of the data analysis. Dr. Ruger would like to thank The Patrick and Catherine Weldon Donaghue Medical Research Foundation for their funding support.	Barnett PG, 2001, ADDICTION, V96, P1267, DOI 10.1046/j.1360-0443.2001.96912676.x; Basu A, 2008, HEALTH ECON, V17, P927, DOI 10.1002/hec.1305; Chawarski MC, 2008, DRUG ALCOHOL DEPEN, V94, P281, DOI 10.1016/j.drugalcdep.2007.11.008; Chawarski MC, 1996, NIDA RES MONOGR, P188; Connock M, 2007, HEALTH TECHNOL ASSES, V11, P1; Gold MR, 1996, COST EFFECTIVENESS H; Harris AH, 2005, PHARMACOECONOMICS, V23, P77, DOI 10.2165/00019053-200523010-00007; Johansson BA, 2006, ADDICTION, V101, P491, DOI 10.1111/j.1360-0443.2006.01369.x; Johnson RE, 2000, NEW ENGL J MED, V343, P1290, DOI 10.1056/NEJM200011023431802; Krupitsky EM, 2004, J SUBST ABUSE TREAT, V26, P285, DOI 10.1016/j.jsat.2004.02.002; Krupitsky EM, 2006, J SUBST ABUSE TREAT, V31, P319, DOI 10.1016/j.jsat.2006.05.005; Mattick R.P., 2003, COCHRANE DB SYST REV, V2, DOI DOI 10.1002/14651858.CD002207.PUB2; Mazlan M, 2006, DRUG ALCOHOL REV, V25, P473, DOI 10.1080/09595230600883354; MCLELLAN AT, 1980, J NERV MENT DIS, V168, P26, DOI 10.1097/00005053-198001000-00006; Metzger DS, 2010, JAIDS-J ACQ IMM DEF, V55, pS32, DOI 10.1097/QAI.0b013e3181f9c10b; Metzger David S, 2010, Curr HIV/AIDS Rep, V7, P220, DOI 10.1007/s11904-010-0059-z; Milby JB, 2010, AM J PUBLIC HEALTH, V100, P913, DOI 10.2105/AJPH.2008.152975; Ministry of Health Malaysia/World Health Organization, CONS REP HIV AIDS EP; Minozzi S, 2006, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001333.pub2; Olmstead TA, 2009, DRUG ALCOHOL DEPEN, V102, P108, DOI 10.1016/j.drugalcdep.2009.02.005; Pattanaphesaj J, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/1471-2458-10-401; Reece AS, 2009, J SUBST ABUSE TREAT, V37, P256, DOI 10.1016/j.jsat.2009.03.008; Ruger JP, 2012, HEALTH SERV RES, V47, P865, DOI 10.1111/j.1475-6773.2011.01335.x; Schaub M, 2010, INT J DRUG POLICY, V21, P229, DOI 10.1016/j.drugpo.2009.10.005; Schottenfeld RS, 2008, LANCET, V371, P2192, DOI 10.1016/S0140-6736(08)60954-X; Shanahan MD, 2006, ADDICT BEHAV, V31, P371, DOI 10.1016/j.addbeh.2005.05.016; Stotts AL, 2009, EXPERT OPIN PHARMACO, V10, P1727, DOI 10.1517/14656560903037168; United Nations Office on Drugs and Crime, 2010, WORLD DRUG REP 2010; Vucinovic M, 2008, YONSEI MED J, V49, P705, DOI 10.3349/ymj.2008.49.5.705; Xie HY, 2010, J SUBST ABUSE TREAT, V39, P132, DOI 10.1016/j.jsat.2010.05.011; Xing Y, 2012, AIDS CARE, V24, P756, DOI 10.1080/09540121.2011.630359	31	10	10	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 4	2012	7	12							e50673	10.1371/journal.pone.0050673	http://dx.doi.org/10.1371/journal.pone.0050673			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	051EQ	23226534	Green Published, gold			2022-12-27	WOS:000312108500027
J	Jankovic, D; Winhofer, Y; Promintzer-Schifferl, M; Wohlschlager-Krenn, E; Anderwald, CH; Wolf, P; Scherer, T; Reiter, G; Trattnig, S; Luger, A; Krebs, M; Krssak, M				Jankovic, Drazenka; Winhofer, Yvonne; Promintzer-Schifferl, Miriam; Wohlschlaeger-Krenn, Evelyne; Anderwald, Christian Heinz; Wolf, Peter; Scherer, Thomas; Reiter, Gert; Trattnig, Siegfried; Luger, Anton; Krebs, Michael; Krssak, Martin			Effects of Insulin Therapy on Myocardial Lipid Content and Cardiac Geometry in Patients with Type-2 Diabetes Mellitus	PLOS ONE			English	Article							TRIGLYCERIDE CONTENT; DIASTOLIC FUNCTION; DEPENDENT CHANGES; IN-VIVO; SPECTROSCOPY; METABOLISM; STEATOSIS; HYPERINSULINEMIA; REPRODUCIBILITY; SENSITIVITY	Aims/Hypothesis: Recent evidence suggests a link between myocardial steatosis and diabetic cardiomyopathy. Insulin, as a lipogenic and growth-promoting hormone, might stimulate intramyocardial lipid (MYCL) deposition and hypertrophy. Therefore, the aim of the present study was to investigate the short-term effects of insulin therapy (IT) on myocardial lipid content and morphology in patients with T2DM. Methods: Eighteen patients with T2DM were recruited (age 5662 years; HbA1c: 10.5=0.4%). In 10 patients with insufficient glucose control under oral medication IT was initiated due to secondary failure of oral glucose lowering therapy (IT-group), while 8 individuals did not require additional insulin substitution (OT-group). In order to assess MYCL and intrahepatic lipid (IHLC) content as well as cardiac geometry and function magnetic resonance spectroscopy (MRS) and imaging (MRI) examinations were performed at baseline (IT and OT) and 10 days after initiation of IT. Follow up measurements took place 181649 days after IT. Results: Interestingly, basal MYCLs were 50% lower in IT-compared to OT-group (0.41 +/- 0.12 vs. 0.80 +/- 0.11% of water signal; p = 0.034). After 10 days of IT, an acute 80%-rise in MYCL (p = 0.008) was observed, while IHLC did not change. Likewise, myocardial mass (+13%; p = 0.004), wall thickness in end-diastole (+13%; p = 0.030) and concentricity, an index of cardiac remodeling, increased (+28%; p = 0.026). In the long-term MYCL returned to baseline, while IHCL significantly decreased (-31%; p = 0.000). No acute changes in systolic left ventricular function were observed. Conclusions/Interpretation: The initiation of IT in patients with T2DM was followed by an acute rise in MYCL concentration and myocardial mass. Citation: Jankovic D, Winhofer Y, Promintzer-Schifferl M, Wohlschlager-Krenn E, Anderwald CH, et al. (2012) Effects of Insulin Therapy on Myocardial Lipid Content and Cardiac Geometry in Patients with Type-2 Diabetes Mellitus. PLoS ONE 7(12): e50077. doi:10.1371/journal.pone.0050077	[Jankovic, Drazenka; Winhofer, Yvonne; Promintzer-Schifferl, Miriam; Wohlschlaeger-Krenn, Evelyne; Anderwald, Christian Heinz; Wolf, Peter; Scherer, Thomas; Luger, Anton; Krebs, Michael; Krssak, Martin] Med Univ Vienna, Div Endocrinol & Metab, Dept Internal Med 3, Vienna, Austria; [Anderwald, Christian Heinz] CNR, Metab Unit, ISIB, Padua, Italy; [Anderwald, Christian Heinz] Specialized Hosp Metab Dis, Micheldorf, Austria; [Reiter, Gert] Siemens Healthcare, Graz, Austria; [Trattnig, Siegfried; Krssak, Martin] Med Univ Vienna, Ctr Excellence High Field MR, Dept Radiodiagnost, Vienna, Austria	Medical University of Vienna; Consiglio Nazionale delle Ricerche (CNR); Siemens AG; Medical University of Vienna	Krebs, M (corresponding author), Med Univ Vienna, Div Endocrinol & Metab, Dept Internal Med 3, Vienna, Austria.	michael.krebs@meduniwien.ac.at	Anderwald, Christian Heinz/AAG-2271-2021; Krssak, Martin/AAU-8183-2020	Anderwald, Christian Heinz/0000-0001-7485-0815; Krssak, Martin/0000-0001-9717-803X; Scherer, Thomas/0000-0003-4980-706X; Krebs, Michael/0000-0002-9265-7274; Wolf, Peter/0000-0001-6779-734X; Winhofer, Yvonne/0000-0002-0555-9044	Austrian Heart Fund; Scientific Fund of the Mayor of the City of Vienna [12023]; "Jubilaumsfond'' of the Austrian National Bank [13249]; Oesterreichische Nationalbank (Anniversary Fund) [13249]	Austrian Heart Fund; Scientific Fund of the Mayor of the City of Vienna; "Jubilaumsfond'' of the Austrian National Bank; Oesterreichische Nationalbank (Anniversary Fund)	This study was supported by the Austrian Heart Fund and the Scientific Fund of the Mayor of the City of Vienna (project number 12023) granted to M. Krebs as well as by the "Jubilaumsfond'' of the Austrian National Bank (project number 13249) to M. Krebs. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This study was partly supported by funds of the Oesterreichische Nationalbank (Anniversary Fund, project number 13249, granted to M. Krssak), by the Austrian Heart Fund and the Scientific Fund of the Mayor of the City of Vienna (project number 12023, both granted to M. Krebs). Gert Reiter is employed by Siemens Healthcare. The following Siemens products were used in this study: 3.0-T Tim Trio System, ARGUS software, and a Spectroscopy Processing tool within Syngo VB15 and VB17 user interface. There are no further patents, products in development or marketed products to declare. This does not alter the authors' adherence to all the PLOS ONE policies on sharing data and materials.	Aasum E, 2003, DIABETES, V52, P434, DOI 10.2337/diabetes.52.2.434; Anderwald C, 2002, DIABETES, V51, P3025, DOI 10.2337/diabetes.51.10.3025; Bilet L, 2011, BASIC RES CARDIOL, V106, P307, DOI 10.1007/s00395-010-0144-x; Bucci M, 2011, CARDIOVASC THER; BURMEISTER W, 1966, KLIN WOCHENSCHR, V44, P901, DOI 10.1007/BF01711970; Condorelli G, 2002, P NATL ACAD SCI USA, V99, P12333, DOI 10.1073/pnas.172376399; Coort SLM, 2007, MOL CELL BIOCHEM, V299, P5, DOI 10.1007/s11010-005-9030-5; DeFronzo RA, 1997, DIABETES REV, V5, P177; Dyck DJ, 2001, AM J PHYSIOL-ENDOC M, V281, pE600, DOI 10.1152/ajpendo.2001.281.3.E600; Fang ZY, 2004, ENDOCR REV, V25, P543, DOI 10.1210/er.2003-0012; Gerstein HC, 2008, NEW ENGL J MED, V358, P2545, DOI 10.1056/NEJMoa0802743; Hammer S, 2008, AM J PHYSIOL-ENDOC M, V295, pE714, DOI 10.1152/ajpendo.90413.2008; Hammer S, 2008, J CLIN ENDOCR METAB, V93, P497, DOI 10.1210/jc.2007-2015; Hue L, 2009, AM J PHYSIOL-ENDOC M, V297, pE578, DOI 10.1152/ajpendo.00093.2009; Iozzo P, 2009, J CLIN ENDOCR METAB, V94, P4472, DOI 10.1210/jc.2009-0436; Krssak M, 2004, MAGN RESON MATER PHY, V16, P155, DOI 10.1007/s10334-003-0029-1; Krssak M, 2011, DIABETOLOGIA, V54, P1871, DOI 10.1007/s00125-011-2146-0; Krssak M, 2010, EUR J RADIOL, V74, pE61, DOI 10.1016/j.ejrad.2009.03.062; Listenberger LL, 2001, J BIOL CHEM, V276, P14890, DOI 10.1074/jbc.M010286200; McGavock JM, 2007, CIRCULATION, V116, P1170, DOI 10.1161/CIRCULATIONAHA.106.645614; Nakayama H, 2001, JPN CIRC J, V65, P783, DOI 10.1253/jcj.65.783; Nickenig G, 1998, CIRCULATION, V98, P2453, DOI 10.1161/01.CIR.98.22.2453; NUNODA S-I, 1985, Heart and Vessels, V1, P43, DOI 10.1007/BF02066486; RANDLE PJ, 1963, LANCET, V1, P785; REGAN TJ, 1977, J CLIN INVEST, V60, P885, DOI 10.1172/JCI108843; Reingold JS, 2005, AM J PHYSIOL-ENDOC M, V289, pE935, DOI 10.1152/ajpendo.00095.2005; Rijzewijk LJ, 2008, J AM COLL CARDIOL, V52, P1793, DOI 10.1016/j.jacc.2008.07.062; Rodrigues B, 1998, MOL CELL BIOCHEM, V180, P53, DOI 10.1023/A:1006882805197; Samuelsson AM, 2006, AM J PHYSIOL-HEART C, V291, pH787, DOI 10.1152/ajpheart.00974.2005; Sharma N, 2007, CARDIOVASC RES, V73, P257, DOI 10.1016/j.cardiores.2006.11.007; Sharma S, 2004, FASEB J, V18, P1692, DOI 10.1096/fj.04-2263com; Shiojima I, 2006, GENE DEV, V20, P3347, DOI 10.1101/gad.1492806; Stanley WC, 1997, CARDIOVASC RES, V34, P25, DOI 10.1016/S0008-6363(97)00047-3; Szczepaniak LS, 2003, MAGN RESON MED, V49, P417, DOI 10.1002/mrm.10372; van der Meer RW, 2007, RADIOLOGY, V245, P251, DOI 10.1148/radiol.2451061904; Velagaleti RS, 2010, CIRC-CARDIOVASC IMAG, V3, P257, DOI 10.1161/CIRCIMAGING.109.911438; Velloso LA, 1996, P NATL ACAD SCI USA, V93, P12490, DOI 10.1073/pnas.93.22.12490; Waiter GD, 1999, MAGN RESON IMAGING, V17, P99, DOI 10.1016/S0730-725X(98)00158-1; WENDE AR, 2009, BIOCH BIOPHYS ACTA; Winhofer Y, 2012, DIABETES, V61, P1210, DOI 10.2337/db11-1275; WITTERS LA, 1992, J BIOL CHEM, V267, P2864; Zammit VA, 1999, PROG LIPID RES, V38, P199, DOI 10.1016/S0163-7827(99)00002-8; Zhou YT, 2000, P NATL ACAD SCI USA, V97, P1784, DOI 10.1073/pnas.97.4.1784; Zib I, 2007, J INVEST MED, V55, P230, DOI 10.2310/6650.2007.00003	44	24	25	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 3	2012	7	12							e50077	10.1371/journal.pone.0050077	http://dx.doi.org/10.1371/journal.pone.0050077			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	051DH	23226508	Green Published, gold, Green Submitted			2022-12-27	WOS:000312104700013
J	Carr, M; Bensasson, D; Bergman, CM				Carr, Martin; Bensasson, Douda; Bergman, Casey M.			Evolutionary Genomics of Transposable Elements in Saccharomyces cerevisiae	PLOS ONE			English	Article							HORIZONTAL TRANSFER; TY ELEMENTS; DROSOPHILA-MELANOGASTER; INTERELEMENT SELECTION; LTR-RETROTRANSPOSONS; SEQUENCE ALIGNMENT; YEAST CENTROMERES; DNA POLYMORPHISM; POPULATION; RECOMBINATION	Saccharomyces cerevisiae is one of the premier model systems for studying the genomics and evolution of transposable elements. The availability of the S. cerevisiae genome led to unprecedented insights into its five known transposable element families (the LTR retrotransposons Ty1-Ty5) in the years shortly after its completion. However, subsequent advances in bioinformatics tools for analysing transposable elements and the recent availability of genome sequences for multiple strains and species of yeast motivates new investigations into Ty evolution in S. cerevisiae. Here we provide a comprehensive phylogenetic and population genetic analysis of all Ty families in S. cerevisiae based on a systematic re-annotation of Ty elements in the S288c reference genome. We show that previous annotation efforts have underestimated the total copy number of Ty elements for all known families. In addition, we identify a new family of Ty3-like elements related to the S. paradoxus Ty3p which is composed entirely of degenerate solo LTRs. Phylogenetic analyses of LTR sequences identified three families with short-branch, recently active clades nested among long branch, inactive insertions (Ty1, Ty3, Ty4), one family with essentially all recently active elements (Ty2) and two families with only inactive elements (Ty3p and Ty5). Population genomic data from 38 additional strains of S. cerevisiae show that the majority of Ty insertions in the S288c reference genome are fixed in the species, with insertions in active clades being predominantly polymorphic and insertions in inactive clades being predominantly fixed. Finally, we use comparative genomic data to provide evidence that the Ty2 and Ty3p families have arisen in the S. cerevisiae genome by horizontal transfer. Our results demonstrate that the genome of a single individual contains important information about the state of TE population dynamics within a species and suggest that horizontal transfer may play an important role in shaping the genomic diversity of transposable elements in unicellular eukaryotes.	[Carr, Martin] Univ Huddersfield, Sch Appl Sci, Huddersfield HD1 3DH, W Yorkshire, England; [Bensasson, Douda; Bergman, Casey M.] Univ Manchester, Fac Life Sci, Manchester, Lancs, England	University of Huddersfield; University of Manchester	Carr, M (corresponding author), Univ Huddersfield, Sch Appl Sci, Huddersfield HD1 3DH, W Yorkshire, England.	MartCarr74@gmail.com	Bergman, Casey/F-7854-2010	Bergman, Casey/0000-0002-5462-9854; Carr, Martin/0000-0003-2108-2052; Bensasson, Douda/0000-0002-9015-2707	NERC [NE/D008824/1]; Natural Environment Research Council [NE/D008824/1] Funding Source: researchfish	NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	This work was partly supported by a NERC Fellowship to Douda Bensasson [grant number NE/D008824/1] (http://www.nerc.ac.uk). No additional external funding was received for this study. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aminetzach YT, 2005, SCIENCE, V309, P764, DOI 10.1126/science.1112699; Baller JA, 2012, GENOME RES; Baller JA, 2011, P NATL ACAD SCI USA, V108, P20351, DOI 10.1073/pnas.1103665108; Bartolome C, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-2-r22; Bensasson D, 2008, GENETICS, V178, P2161, DOI 10.1534/genetics.107.083980; Bensasson D, 2011, BMC EVOL BIOL, V11, DOI 10.1186/1471-2148-11-211; Bergman CM, 2007, BRIEF BIOINFORM, V8, P382, DOI 10.1093/bib/bbm048; Bergman CM, 2007, P NATL ACAD SCI USA, V104, P11340, DOI 10.1073/pnas.0702552104; Biemont C, 1997, GENETICS, V147, P1997; Blanc VM, 2004, FEMS YEAST RES, V4, P487, DOI 10.1016/S1567-1356(03)00199-5; BOEKE JD, 1991, MOL CELLULAR BIOL YE, P193; BROOKFIELD JFY, 1986, GENETICS, V112, P393; CAMERON JR, 1979, CELL, V16, P739, DOI 10.1016/0092-8674(79)90090-4; Carr M, 2008, PROTIST, V159, P579, DOI 10.1016/j.protis.2008.05.001; Carreto L, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-524; Charlesworth B, 1997, GENETICS, V147, P1993; CHARLESWORTH B, 1989, ANNU REV GENET, V23, P251, DOI 10.1146/annurev.ge.23.120189.001343; Cliften P, 2003, SCIENCE, V301, P71, DOI 10.1126/science.1084337; CURCIO MJ, 1988, MOL CELL BIOL, V8, P3571, DOI 10.1128/MCB.8.9.3571; Daborn PJ, 2002, SCIENCE, V297, P2253, DOI 10.1126/science.1074170; Darboux I, 2007, CELL MICROBIOL, V9, P2022, DOI 10.1111/j.1462-5822.2007.00934.x; Doniger SW, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000183; Dymond JS, 2011, NATURE, V477, P471, DOI 10.1038/nature10403; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Esberg A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025211; Fingerman EG, 2003, YEAST, V20, P761, DOI 10.1002/yea.1005; FINK GR, 1986, TRENDS GENET, V2, P118, DOI 10.1016/0168-9525(86)90200-3; Fraser HB, 2010, P NATL ACAD SCI USA, V107, P2977, DOI 10.1073/pnas.0912245107; Gabriel A, 2006, PLOS GENET, V2, P2026, DOI 10.1371/journal.pgen.0020212; Gaisne M, 1999, CURR GENET, V36, P195, DOI 10.1007/s002940050490; Galtier N, 1996, COMPUT APPL BIOSCI, V12, P543; Gilbert C, 2010, NATURE, V464, P1347, DOI 10.1038/nature08939; Goffeau A, 1996, SCIENCE, V274, P546, DOI 10.1126/science.274.5287.546; Gonzalez J, 2008, PLOS BIOL, V6, P2109, DOI 10.1371/journal.pbio.0060251; Greig D, 2002, SCIENCE, V298, P1773, DOI 10.1126/science.1076374; Hani J, 1998, NUCLEIC ACIDS RES, V26, P689, DOI 10.1093/nar/26.3.689; HANSEN LJ, 1990, J VIROL, V64, P2599, DOI 10.1128/JVI.64.6.2599-2607.1990; Hollister JD, 2007, MOL BIOL EVOL, V24, P2515, DOI 10.1093/molbev/msm197; HUDSON RR, 1985, GENETICS, V111, P147; Hug AM, 1996, NUCLEIC ACIDS RES, V24, P2338, DOI 10.1093/nar/24.12.2338; JANETZKY B, 1992, J BIOL CHEM, V267, P19798; Jordan IK, 1999, J MOL EVOL, V49, P352, DOI 10.1007/PL00006558; Jordan IK, 1998, J MOL EVOL, V47, P14, DOI 10.1007/PL00006358; Jordan IK, 1999, GENETICA, V107, P3, DOI 10.1023/A:1004022704701; Jordan IK, 1999, GENETICS, V151, P1341; Jordan IK, 1998, J MOL EVOL, V47, P670, DOI 10.1007/PL00006425; Kellis M, 2003, NATURE, V423, P241, DOI 10.1038/nature01644; Kim JM, 1998, GENOME RES, V8, P464, DOI 10.1101/gr.8.5.464; KINGSMAN AJ, 1981, J MOL BIOL, V145, P619, DOI 10.1016/0022-2836(81)90306-5; Knight SAB, 1996, GENE DEV, V10, P1917, DOI 10.1101/gad.10.15.1917; KUPIEC M, 1988, MOL CELL BIOL, V8, P2942, DOI 10.1128/MCB.8.7.2942; Lerat E, 2011, GENE, V473, P100, DOI 10.1016/j.gene.2010.11.009; Librado P, 2009, BIOINFORMATICS, V25, P1451, DOI 10.1093/bioinformatics/btp187; Liti G, 2005, YEAST, V22, P177, DOI 10.1002/yea.1200; Liti G, 2006, GENETICS, V174, P839, DOI 10.1534/genetics.106.062166; Liti G, 2009, NATURE, V458, P337, DOI 10.1038/nature07743; Marinoni G, 1999, J BACTERIOL, V181, P6488, DOI 10.1128/JB.181.20.6488-6496.1999; Maside X, 2003, MOL BIOL EVOL, V20, P1183, DOI 10.1093/molbev/msg120; MONTGOMERY E, 1987, GENET RES, V49, P31, DOI 10.1017/S0016672300026707; Moore SP, 2004, YEAST, V21, P649, DOI 10.1002/yea.1129; Mularoni L, 2012, GENOME RES; NAUMOV G, 1992, YEAST, V8, P599, DOI 10.1002/yea.320080804; NEI M, 1979, P NATL ACAD SCI USA, V76, P5269, DOI 10.1073/pnas.76.10.5269; Neuveglise C, 2002, GENOME RES, V12, P930, DOI 10.1101/gr.219202; Pereira Vini, 2008, BMC Genomics, V9, P614, DOI 10.1186/1471-2164-9-614; Pritham EJ, 2009, J HERED, V100, P648, DOI 10.1093/jhered/esp065; Qi X, 2012, GENOME RES; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; Sanchez-Gracia A, 2005, TRENDS GENET, V21, P200, DOI 10.1016/j.tig.2005.02.001; Schlenke TA, 2004, P NATL ACAD SCI USA, V101, P1626, DOI 10.1073/pnas.0303793101; Sebastiani F, 2002, RES MICROBIOL, V153, P53, DOI 10.1016/S0923-2508(01)01286-4; Servant G, 2008, MOL CELL BIOL, V28, P5543, DOI 10.1128/MCB.00416-08; Shibata Y, 2009, NUCLEIC ACIDS RES, V37, P6454, DOI 10.1093/nar/gkp650; Sipiczki M, 2008, FEMS YEAST RES, V8, P996, DOI 10.1111/j.1567-1364.2008.00369.x; Song MZ, 2007, GENE, V390, P206, DOI 10.1016/j.gene.2006.09.033; Stamatakis A, 2008, SYST BIOL, V57, P758, DOI 10.1080/10635150802429642; TAJIMA F, 1989, GENETICS, V123, P585; Thomas J, 2010, GENOME BIOL EVOL, V2, P656, DOI 10.1093/gbe/evq050; VOYTAS DF, 1992, NATURE, V358, P717, DOI 10.1038/358717a0; WATTERSON GA, 1975, THEOR POPUL BIOL, V7, P256, DOI 10.1016/0040-5809(75)90020-9; Wei W, 2007, P NATL ACAD SCI USA, V104, P12825, DOI 10.1073/pnas.0701291104; Wheelan SJ, 2006, P NATL ACAD SCI USA, V103, P17632, DOI 10.1073/pnas.0605450103; WILKE CM, 1992, GENETICA, V86, P155, DOI 10.1007/BF00133718; ZOU S, 1995, P NATL ACAD SCI USA, V92, P920, DOI 10.1073/pnas.92.3.920	84	61	62	0	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 30	2012	7	11							e50978	10.1371/journal.pone.0050978	http://dx.doi.org/10.1371/journal.pone.0050978			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	054WM	23226439	Green Accepted, gold, Green Published, Green Submitted			2022-12-27	WOS:000312376100250
J	Coylewright, M; Shepel, K; LeBlanc, A; Pencille, L; Hess, E; Shah, N; Montori, VM; Ting, HH				Coylewright, Megan; Shepel, Kathy; LeBlanc, Annie; Pencille, Laurie; Hess, Erik; Shah, Nilay; Montori, Victor M.; Ting, Henry H.			Shared Decision Making in Patients with Stable Coronary Artery Disease: PCI Choice	PLOS ONE			English	Article							TYPE-2 DIABETES-MELLITUS; PILOT RANDOMIZED-TRIAL; MEDICAL THERAPY; CARDIOVASCULAR ANGIOGRAPHY; HEART-ASSOCIATION; INFORMED-CONSENT; TASK-FORCE; AD HOC; AID; INTERVENTIONS	Background: Percutaneous coronary intervention (PCI) and optimal medical therapy (OMT) are comparable, alternative therapies for many patients with stable angina; however, patients may have misconceptions regarding the impact of PCI on risk of death and myocardial infarction (MI) in stable coronary artery disease (CAD). Methods and Results: We designed and developed a patient-centered decision aid (PCI Choice) to promote shared decision making for patients with stable CAD. The estimated benefits and risks of PCI+OMT as compared to OMT were displayed in a decision aid using pictographs with natural frequencies and text. We engaged patients, clinicians, health service researchers, and designers with over 20 successive iterations of the decision aid, which were field tested during real-world clinical encounters involving clinicians and patients. The decision aid is intended to facilitate knowledge transfer, deliberation based on patient values and preferences, and shared decision making. Conclusions: We describe the methods and outcomes of the design and development of a decision aid (PCI Choice) to promote shared decision making between clinicians and patients regarding the choice of PCI+OMT vs. OMT for treatment of stable CAD. We will evaluate the impact of PCI Choice on patient knowledge, decisional conflict, participation in decision-making, and treatment choice in an upcoming randomized trial. Citation: Coylewright M, Shepel K, LeBlanc A, Pencille L, Hess E, et al. (2012) Shared Decision Making in Patients with Stable Coronary Artery Disease: PCI Choice. PLoS ONE 7(11): e49827. doi:10.1371/journal.pone.0049827	[Coylewright, Megan; Ting, Henry H.] Mayo Clin, Dept Med, Div Cardiovasc Dis, Rochester, MN 55905 USA; [Coylewright, Megan; LeBlanc, Annie; Pencille, Laurie; Hess, Erik; Shah, Nilay; Montori, Victor M.; Ting, Henry H.] Mayo Clin, Knowledge & Evaluat Res Unit, Rochester, MN USA; [Shepel, Kathy] Mayo Clin, Sect Creat Media, Rochester, MN USA; [Hess, Erik] Mayo Clin, Dept Emergency Med, Div Emergency Med Res, Rochester, MN USA; [Shah, Nilay; Montori, Victor M.] Mayo Clin, Dept Hlth Sci Res, Div Hlth Care Policy & Res, Rochester, MN USA; [Montori, Victor M.] Mayo Clin, Dept Med, Div Endocrinol Diabet Metab & Nutr, Rochester, MN USA	Mayo Clinic; Mayo Clinic; Mayo Clinic; Mayo Clinic; Mayo Clinic; Mayo Clinic	Ting, HH (corresponding author), Mayo Clin, Dept Med, Div Cardiovasc Dis, Rochester, MN 55905 USA.	ting.henry@mayo.edu	LeBlanc, Annie/AAZ-1381-2020	Montori, Victor/0000-0003-0595-2898	Program Development Grant from the Jeanne Sullivan Development fund	Program Development Grant from the Jeanne Sullivan Development fund	Dr. Ting was awarded a Program Development Grant from the Jeanne Sullivan Development fund to study shared decision making in coronary artery disease. This funding source had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.	Arnold SV, 2008, CIRC-CARDIOVASC QUAL, V1, P21, DOI 10.1161/CIRCOUTCOMES.108.791863; Astley CM, 2008, HEART LUNG CIRC, V17, P25, DOI 10.1016/j.hlc.2007.04.008; Blankenship JC, 2012, JACC-CARDIOVASC INTE, V5, P236, DOI 10.1016/j.jcin.2012.01.004; Boden WE, 2007, NEW ENGL J MED, V356, P1503, DOI 10.1056/NEJMoa070829; Borden WB, 2011, JAMA-J AM MED ASSOC, V305, P1882, DOI 10.1001/jama.2011.601; Breslin M, 2008, PATIENT EDUC COUNS, V73, P465, DOI 10.1016/j.pec.2008.07.024; Brooks MM, 2010, CIRCULATION, V122, P1690, DOI 10.1161/CIRCULATIONAHA.109.912642; Chan PS, 2011, JAMA-J AM MED ASSOC, V306, P53, DOI 10.1001/jama.2011.916; Chandrasekharan DP, 2011, EUR J CARDIO-THORAC, V39, P912, DOI 10.1016/j.ejcts.2010.08.033; Coylewright MBM, 2012, SHARED DECISION MAKI; Coylewright M, 2008, MAYO CLIN PROC, V83, P799, DOI 10.4065/83.7.799; Coylewright MGK, 2012, AM HEART ASS QUAL CA; Dontje K, 2012, J CARDIOVASCULAR NUR; Fleming LM, 2011, CATHETERIZATION 1122; Hannan EL, 2009, JACC-CARDIOVASC INTE, V2, P350, DOI 10.1016/j.jcin.2009.01.006; Hansen ML, 2010, ARCH INTERN MED, V170, P1433, DOI 10.1001/archinternmed.2010.271; Hawley ST, 2008, PATIENT EDUC COUNS, V73, P448, DOI 10.1016/j.pec.2008.07.023; Kandzari DE, 2011, JACC-CARDIOVASC INTE, V4, P543, DOI 10.1016/j.jcin.2010.12.014; Kent DM, 2011, CIRC-CARDIOVASC QUAL, V4, P260, DOI 10.1161/CIRCOUTCOMES.111.961136; Korenstein D, 2012, ARCH INTERN MED, V172, P171, DOI 10.1001/archinternmed.2011.772; Kurz-Milcke E, 2008, ANN NY ACAD SCI, V1128, P18, DOI 10.1196/annals.1399.004; Levine GN, 2011, J AM COLL CARDIOL, V58, pE44, DOI 10.1016/j.jacc.2011.08.007; Mahoney EM, 2010, CIRCULATION, V121, P71, DOI 10.1161/CIRCULATIONAHA.109.900704; Montori VM, 2011, AM J MED, V124, P549, DOI 10.1016/j.amjmed.2011.01.013; Montori VM, 2007, PLOS MED, V4, P1303, DOI 10.1371/journal.pmed.0040233; Mullan RJ, 2009, ARCH INTERN MED, V169, P1560, DOI 10.1001/archinternmed.2009.293; Nallamothu BK, 2010, JAMA-J AM MED ASSOC, V304, P2059, DOI 10.1001/jama.2010.1509; O'Connor A, 2004, HLTH AFFAIRS; O'Connor A., 2005, IPDAS COLLABORATION, P54; Patel MR, 2012, J AM COLL CARDIOL, V59, P1995, DOI [10.1016/j.jacc.2012.03.003, 10.1002/ccd.24467]; Patel MR, 2009, CATHETER CARDIO INTE, V73, pE1, DOI 10.1002/ccd.21964; Pencille LJ, 2009, TRIALS, V10, DOI 10.1186/1745-6215-10-113; Pierce MA, 2010, TRIALS, V11, DOI 10.1186/1745-6215-11-57; Roger VL, 2011, CIRCULATION, V123, pE18, DOI 10.1161/CIR.0b013e3182009701; Rothberg MB, 2010, ANN INTERN MED, V153, P307, DOI 10.7326/0003-4819-153-5-201009070-00005; Spertus JA, 2006, CIRCULATION, V113, P2803, DOI 10.1161/CIRCULATIONAHA.106.618066; Stergiopoulos K, 2012, ARCH INTERN MED, V172, P312, DOI 10.1001/archinternmed.2011.1484; Weintraub WS, 2008, NEW ENGL J MED, V359, P677, DOI 10.1056/NEJMoa072771; Weymiller AJ, 2007, ARCH INTERN MED, V167, P1076, DOI 10.1001/archinte.167.10.1076	39	37	38	3	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 30	2012	7	11							e49827	10.1371/journal.pone.0049827	http://dx.doi.org/10.1371/journal.pone.0049827			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	054WM	23226223	Green Submitted, Green Published, gold			2022-12-27	WOS:000312376100031
J	Hirata, H; Ueno, K; Shahryari, V; Tanaka, Y; Tabatabai, ZL; Hinoda, Y; Dahiya, R				Hirata, Hiroshi; Ueno, Koji; Shahryari, Varahram; Tanaka, Yuichiro; Tabatabai, Z. Laura; Hinoda, Yuji; Dahiya, Rajvir			Oncogenic miRNA-182-5p Targets Smad4 and RECK in Human Bladder Cancer	PLOS ONE			English	Article							BETA-CATENIN ACTIVATION; TUMOR-SUPPRESSOR; SIGNALING ACTIVITY; EXPRESSION; METASTASIS; MIR-182; RESTORATION; BIOMARKERS; MICRORNAS; CELLS	Onco-miR-182-5p has been reported to be over-expressed in bladder cancer (BC) tissues however a detailed functional analysis of miR-182-5p has not been carried out in BC. Therefore the purpose of this study was to: 1. conduct a functional analysis of miR-182-5p in bladder cancer, 2. assess its usefulness as a tumor marker, 3. identify miR-182-5p target genes in BC. Initially we found that miR-182-5p expression was significantly higher in bladder cancer compared to normal tissues and high miR-182-5p expression was associated with shorter overall survival in BC patients. To study the functional significance of miR-182-5p, we over-expressed miR-182-5p with miR-182-5p precursor and observed that cell proliferation, migration and invasion abilities were increased in BC cells. However cell apoptosis was inhibited by miR-182-5p. We also identified Smad4 and RECK as potential target genes of miR-182-5p using several algorithms. 3'UTR luciferase activity of these target genes was significantly decreased and protein expression of these target genes was significantly up-regulated in miR-182-5p inhibitor transfected bladder cancer cells. MiR-182-5p also increased nuclear beta-catenin expression and while Smad4 repressed nuclear beta-catenin expression. In conclusion, our data suggests that miR-182-5p plays an important role as an oncogene by knocking down RECK and Smad4, resulting in activation of the Wnt-beta-catenin signaling pathway in bladder cancer.	[Hirata, Hiroshi; Ueno, Koji; Shahryari, Varahram; Tanaka, Yuichiro; Dahiya, Rajvir] San Francisco VA Med Ctr, Dept Urol, San Francisco, CA USA; [Hirata, Hiroshi; Ueno, Koji; Shahryari, Varahram; Tanaka, Yuichiro; Tabatabai, Z. Laura; Dahiya, Rajvir] Univ Calif San Francisco, San Francisco, CA 94143 USA; [Tabatabai, Z. Laura] San Francisco VA Med Ctr, Dept Pathol, San Francisco, CA USA; [Hinoda, Yuji] Yamaguchi Univ, Grad Sch Med, Dept Oncol & Lab Med, Yamaguchi, Japan	US Department of Veterans Affairs; Veterans Health Administration (VHA); San Francisco VA Medical Center; University of California System; University of California San Francisco; US Department of Veterans Affairs; Veterans Health Administration (VHA); San Francisco VA Medical Center; Yamaguchi University	Dahiya, R (corresponding author), San Francisco VA Med Ctr, Dept Urol, San Francisco, CA USA.	rdahiya@urology.ucsf.edu			National Center for Research Resources of the United States National Institutes of Health [RO1CA138642, RO1CA130860, RO1CA160079]; VA Merit Review grants; VA Program Project; NATIONAL CANCER INSTITUTE [R01CA160079, R01CA138642, R01CA130860] Funding Source: NIH RePORTER	National Center for Research Resources of the United States National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); VA Merit Review grants(US Department of Veterans Affairs); VA Program Project; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This study was supported by National Center for Research Resources of the United States National Institutes of Health through Grant Number RO1CA138642, RO1CA130860, RO1CA160079, VA Merit Review grants, and VA Program Project. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adam L, 2009, CLIN CANCER RES, V15, P5060, DOI 10.1158/1078-0432.CCR-08-2245; Ahmad I, 2011, CELL DEATH DIS, V2, DOI 10.1038/cddis.2011.7; Ahmad I, 2011, ONCOGENE, V30, P178, DOI 10.1038/onc.2010.399; Black PC, 2007, CANCER METAST REV, V26, P623, DOI 10.1007/s10555-007-9084-9; Bo JJ, 2011, FEBS J, V278, P786, DOI 10.1111/j.1742-4658.2010.07997.x; Chang HC, 2006, CANCER RES, V66, P8413, DOI 10.1158/0008-5472.CAN-06-0685; Chen H, 2012, CANCER LETT, V320, P40, DOI 10.1016/j.canlet.2012.01.027; Chiyomaru T, 2010, BRIT J CANCER, V102, P883, DOI 10.1038/sj.bjc.6605570; Dyrskjot L, 2009, CANCER RES, V69, P4851, DOI 10.1158/0008-5472.CAN-08-4043; Fabbri M, 2008, CANCER J, V14, P1, DOI 10.1097/PPO.0b013e318164145e; Freeman TJ, 2012, GASTROENTEROLOGY, V142, P562, DOI 10.1053/j.gastro.2011.11.026; Gontero P, 2004, EUR UROL, V46, P296, DOI 10.1016/j.eururo.2004.04.001; Guo X, 2009, CELL RES, V19, P71, DOI 10.1038/cr.2008.302; Guttilla IK, 2009, J BIOL CHEM, V284, P23204, DOI 10.1074/jbc.M109.031427; Han YH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018286; Huang L, 2011, INT J CANCER, V128, P1758, DOI 10.1002/ijc.25509; Inui M, 2010, NAT REV MOL CELL BIO, V11, P252, DOI 10.1038/nrm2868; Jiang LL, 2010, AM J PATHOL, V177, P29, DOI 10.2353/ajpath.2010.090812; Jung HM, 2012, J BIOL CHEM, V287, P29261, DOI 10.1074/jbc.M112.366518; Liebert M, 1996, Semin Urol Oncol, V14, P62; Liu ZJ, 2012, J PATHOL, V228, P204, DOI 10.1002/path.4000; Mihelich BL, 2011, J BIOL CHEM, V286, P44503, DOI 10.1074/jbc.M111.262915; Moon RT, 2004, NAT REV GENET, V5, P689, DOI 10.1038/nrg1427; Myatt SS, 2010, CANCER RES, V70, P367, DOI 10.1158/0008-5472.CAN-09-1891; Netto GJ, 2010, PATHOLOGY, V42, P384, DOI 10.3109/00313021003779145; Noda M, 2003, CANCER METAST REV, V22, P167, DOI 10.1023/A:1023043315031; Noguchi S, 2011, CANCER LETT, V307, P211, DOI 10.1016/j.canlet.2011.04.005; Noordhuis MG, 2011, CLIN CANCER RES, V17, P1317, DOI 10.1158/1078-0432.CCR-10-2320; Pasin Erik, 2008, Rev Urol, V10, P31; Pollard C, 2010, EXPERT REV MOL MED, V12, DOI 10.1017/S1462399410001407; Proctor I, 2010, HISTOPATHOLOGY, V57, P1, DOI 10.1111/j.1365-2559.2010.03592.x; Reis ST, 2012, BMC UROL, V12, DOI 10.1186/1471-2490-12-18; Romero D, 2008, CARCINOGENESIS, V29, P1070, DOI 10.1093/carcin/bgn054; Segura MF, 2009, P NATL ACAD SCI USA, V106, P1814, DOI 10.1073/pnas.0808263106; Stenzl A, 2011, EUR UROL, V59, P1009, DOI 10.1016/j.eururo.2011.03.023; Tao J, 2011, ONCOL REP, V25, P1721, DOI 10.3892/or.2011.1245; Tatarano S, 2011, INT J ONCOL, V39, P13, DOI 10.3892/ijo.2011.1012; Tian XX, 2009, BIOCHEM BIOPH RES CO, V380, P478, DOI 10.1016/j.bbrc.2009.01.124; Trang P, 2008, Oncogene, V27 Suppl 2, pS52, DOI 10.1038/onc.2009.353; Ueno K, 2012, MOL CANCER THER, V11, P244, DOI 10.1158/1535-7163.MCT-11-0592; Wallerand H, 2008, CURR OPIN UROL, V18, P524, DOI 10.1097/MOU.0b013e3283097889; Yang G, 2010, INT J BIOL SCI, V6, P1; Yoshida Y, 2012, ONCOGENE, V31, P4128, DOI 10.1038/onc.2011.570; Yoshitomi T, 2011, ONCOL REP, V25, P1661, DOI 10.3892/or.2011.1253	44	102	108	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 30	2012	7	11							e51056	10.1371/journal.pone.0051056	http://dx.doi.org/10.1371/journal.pone.0051056			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	054WM	23226455	Green Submitted, Green Published, gold			2022-12-27	WOS:000312376100266
J	Mitsos, A; Melas, IN; Morris, MK; Saez-Rodriguez, J; Lauffenburger, DA; Alexopoulos, LG				Mitsos, Alexander; Melas, Ioannis N.; Morris, Melody K.; Saez-Rodriguez, Julio; Lauffenburger, Douglas A.; Alexopoulos, Leonidas G.			Non Linear Programming (NLP) Formulation for Quantitative Modeling of Protein Signal Transduction Pathways	PLOS ONE			English	Article							SYSTEMS BIOLOGY; FUNCTIONAL-ANALYSIS; NETWORKS; CELL; PROTEOMICS; RECEPTOR; GENES; MAP	Modeling of signal transduction pathways plays a major role in understanding cells' function and predicting cellular response. Mathematical formalisms based on a logic formalism are relatively simple but can describe how signals propagate from one protein to the next and have led to the construction of models that simulate the cells response to environmental or other perturbations. Constrained fuzzy logic was recently introduced to train models to cell specific data to result in quantitative pathway models of the specific cellular behavior. There are two major issues in this pathway optimization: i) excessive CPU time requirements and ii) loosely constrained optimization problem due to lack of data with respect to large signaling pathways. Herein, we address both issues: the former by reformulating the pathway optimization as a regular nonlinear optimization problem; and the latter by enhanced algorithms to pre/post-process the signaling network to remove parts that cannot be identified given the experimental conditions. As a case study, we tackle the construction of cell type specific pathways in normal and transformed hepatocytes using medium and large-scale functional phosphoproteomic datasets. The proposed Non Linear Programming (NLP) formulation allows for fast optimization of signaling topologies by combining the versatile nature of logic modeling with state of the art optimization algorithms.	[Melas, Ioannis N.; Alexopoulos, Leonidas G.] Natl Tech Univ Athens, Dept Mech Engn, Zografos, Greece; [Mitsos, Alexander] MIT, Dept Mech Engn, Cambridge, MA 02139 USA; [Morris, Melody K.; Lauffenburger, Douglas A.] MIT, Dept Biol Engn, Cambridge, MA 02139 USA; [Morris, Melody K.; Lauffenburger, Douglas A.] MIT, Ctr Cell Decis Proc, Boston, MA USA; [Morris, Melody K.; Lauffenburger, Douglas A.] Harvard Univ, Sch Med, Boston, MA USA; [Saez-Rodriguez, Julio] European Bioinformat Inst EMBL EBI, Cambridge, England	National Technical University of Athens; Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT); Harvard University; Harvard Medical School; European Molecular Biology Laboratory (EMBL)	Alexopoulos, LG (corresponding author), Natl Tech Univ Athens, Dept Mech Engn, Zografos, Greece.	leoalexopoulos@gmail.com	Alexopoulos, Leonidas/AAN-1148-2021; Mitsos, Alexander/D-5873-2011; Saez-Rodriguez, Julio/H-7114-2019	Mitsos, Alexander/0000-0003-0335-6566; Saez-Rodriguez, Julio/0000-0002-8552-8976; Melas, Ioannis/0000-0002-3338-5838; Alexopoulos, Leonidas G/0000-0003-0425-166X	European Union (European Social Fund - ESF); Greek national funds through the Operational Program "Education and Lifelong Learning" of the National Strategic Reference Framework (NSRF) - Research Funding Program: Thalis; Rockwell International; NIH [P50-GM068762, R24-DK090963]; Institute for Collaborative Biotechnologies from the US Army Research Office [W911NF-09-0001]; Deutsche Forschungsgemeinschaft (German Research Association) [GSC 111]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R24DK090963] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P50GM068762] Funding Source: NIH RePORTER	European Union (European Social Fund - ESF)(European Social Fund (ESF)); Greek national funds through the Operational Program "Education and Lifelong Learning" of the National Strategic Reference Framework (NSRF) - Research Funding Program: Thalis; Rockwell International; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Institute for Collaborative Biotechnologies from the US Army Research Office; Deutsche Forschungsgemeinschaft (German Research Association)(German Research Foundation (DFG)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	Leonidas G. Alexopoulos and Loannis N. Melas were funded via European Union (European Social Fund - ESF) and Greek national funds through the Operational Program "Education and Lifelong Learning" of the National Strategic Reference Framework (NSRF) - Research Funding Program: Thalis. Investing in knowledge society through the European Social Fund. Alexander Mitsos was funded by Rockwell International Career Development Professorship. Douglas Lauffenburger and Melody Morris received funding from NIH grants P50-GM068762 and R24-DK090963, and the Institute for Collaborative Biotechnologies through grant W911NF-09-0001 from the US Army Research Office. Financial support from Deutsche Forschungsgemeinschaft (German Research Association) through grant GSC 111 is gratefully acknowledged. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aldridge BB, 2006, NAT CELL BIOL, V8, P1195, DOI 10.1038/ncb1497; Aldridge BB, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000340; Alexopoulos LG, 2010, MOL CELL PROTEOMICS, V9, P1849, DOI 10.1074/mcp.M110.000406; Barabasi AL, 2004, NAT REV GENET, V5, P101, DOI 10.1038/nrg1272; Beck J.V, 1977, PARAMETER ESTIMATION; Boccaletti S, 2006, PHYS REP, V424, P175, DOI 10.1016/j.physrep.2005.10.009; Bornholdt S, 2008, J R SOC INTERFACE, V5, pS85, DOI 10.1098/rsif.2008.0132.focus; Bosl WJ, 2007, BMC SYST BIOL, V1, DOI 10.1186/1752-0509-1-13; Calzone L, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000702; Cerami EG, 2011, NUCLEIC ACIDS RES, V39, pD685, DOI 10.1093/nar/gkq1039; Chaouiya C, 2012, METHODS MOL BIOL, V804, P463, DOI 10.1007/978-1-61779-361-5_23; Chou IC, 2009, MATH BIOSCI, V219, P57, DOI 10.1016/j.mbs.2009.03.002; Chu Y, 2007, IET SYST BIOL, V1, P342, DOI 10.1049/iet-syb:20060053; de Hoog CL, 2004, ANNU REV GENOM HUM G, V5, P267, DOI 10.1146/annurev.genom.4.070802.110305; Downward J, 2001, NATURE, V411, P759, DOI 10.1038/35081138; Eduati F, 2012, BIOINFORMATICS, V28, P2311, DOI 10.1093/bioinformatics/bts363; Ewing RM, 2007, MOL SYST BIOL, V3, DOI 10.1038/msb4100134; Helikar T, 2008, P NATL ACAD SCI USA, V105, P1913, DOI 10.1073/pnas.0705088105; Hinze T, 2007, 8 WORKSH MEMBR COMP, P363, DOI [10.1007/978-3-540-77312-2_20, DOI 10.1007/978-3-540-77312-2_20]; Hoops S, 2006, BIOINFORMATICS, V22, P3067, DOI 10.1093/bioinformatics/btl485; Hughey JJ, 2010, WIRES SYST BIOL MED, V2, P194, DOI 10.1002/wsbm.52; Joshi-Tope G, 2005, NUCLEIC ACIDS RES, V33, pD428, DOI 10.1093/nar/gki072; Kanehisa M, 2000, NUCLEIC ACIDS RES, V28, P27, DOI 10.1093/nar/28.1.27; KAUFFMAN SA, 1969, J THEOR BIOL, V22, P437, DOI 10.1016/0022-5193(69)90015-0; Kholodenko BN, 1999, J BIOL CHEM, V274, P30169, DOI 10.1074/jbc.274.42.30169; Klamt S, 2007, BMC SYST BIOL, V1, DOI 10.1186/1752-0509-1-2; Lipniacki T, 2004, J THEOR BIOL, V228, P195, DOI 10.1016/j.jtbi.2004.01.001; MacNamara A, 2012, PHYS BIOL, V9, DOI 10.1088/1478-3975/9/4/045003; Mahdavi A, 2007, PLOS COMPUT BIOL, V3, P1257, DOI 10.1371/journal.pcbi.0030130; Melas IN, 2012, MOL BIOSYST, V8, P1571, DOI 10.1039/c2mb05482e; Melas IN, 2011, BMC SYST BIOL, V5, DOI 10.1186/1752-0509-5-107; Mendoza L, 2006, THEOR BIOL MED MODEL, V3, DOI 10.1186/1742-4682-3-13; Mitsos A, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000591; Morris MK, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1001099; Morris MK, 2010, BIOCHEMISTRY-US, V49, P3216, DOI 10.1021/bi902202q; Orton RJ, 2005, BIOCHEM J, V392, P249, DOI 10.1042/BJ20050908; Pandey A, 2000, NATURE, V405, P837, DOI 10.1038/35015709; Qiu P, 2011, IEEE T BIO-MED ENG, V58, P3518, DOI 10.1109/TBME.2011.2163188; Quach M, 2007, BIOINFORMATICS, V23, P3209, DOI 10.1093/bioinformatics/btm510; Rual JF, 2005, NATURE, V437, P1173, DOI 10.1038/nature04209; Saez-Rodriguez J, 2008, BIOINFORMATICS, V24, P840, DOI 10.1093/bioinformatics/btn018; Saez-Rodriguez J, 2009, MOL SYST BIOL, V5, DOI 10.1038/msb.2009.87; Salwinski L, 2004, NAT BIOTECHNOL, V22, P1017, DOI 10.1038/nbt991; Samaga R, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000438; Schoeberl B, 2002, NAT BIOTECHNOL, V20, P370, DOI 10.1038/nbt0402-370; Souchelnytskyi S, 2005, PROTEOMICS, V5, P4123, DOI 10.1002/pmic.200500135; Stelling J, 2002, NATURE, V420, P190, DOI 10.1038/nature01166; Thakar J, 2007, PLOS COMPUT BIOL, V3, P1022, DOI 10.1371/journal.pcbi.0030109; Tomita M, 1999, BIOINFORMATICS, V15, P72, DOI 10.1093/bioinformatics/15.1.72; Wachter A, 2006, MATH PROGRAM, V106, P25, DOI 10.1007/s10107-004-0559-y; Watterson S, 2008, DRUG DISCOV TODAY, V13, P447, DOI 10.1016/j.drudis.2008.03.019; Yue H, 2006, MOL BIOSYST, V2, P640, DOI 10.1039/b609442b; Zheng Y, 2006, IEE P SYST BIOL, V153, P201, DOI 10.1049/ip-syb:20050088	53	11	11	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 30	2012	7	11							e50085	10.1371/journal.pone.0050085	http://dx.doi.org/10.1371/journal.pone.0050085			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	054WM	23226239	gold, Green Published, Green Submitted			2022-12-27	WOS:000312376100048
J	Peter, KH; Sommer, U				Peter, Kalista Higini; Sommer, Ulrich			Phytoplankton Cell Size: Intra- and Interspecific Effects of Warming and Grazing	PLOS ONE			English	Article							CLIMATE-CHANGE; FRESH-WATER; METABOLIC BALANCE; MARINE; TEMPERATURE; ZOOPLANKTON; CLADOCERANS; KINETICS; COPEPODS; ALTERS	Decreasing body size has been suggested as the third universal biological response to global warming after latitudinal/altitudinal range shifts and shifts in phenology. Size shifts in a community can be the composite result of intraspecific size shifts and of shifts between differently sized species. Metabolic explanations for the size shifts dominate in the literature but top down effects, i.e. intensified size-selective consumption at higher temperatures, have been proposed as alternative explanation. Therefore, we performed phytoplankton experiments with a factorial combination of warming and consumer type (protist feeding mainly on small algae vs. copepods mainly feeding on large algae). Natural phytoplankton was exposed to 3 (1st experiment) or 4 (2nd experiment) temperature levels and 3 (1st experiment: nano-, microzooplankton, copepods) or 2 (2nd experiment: microzooplankton, copepods) types of consumers. Size shifts of individual phytoplankton species and community mean size were analyzed. Both, mean cell size of most of the individual species and mean community cell size decreased with temperature under all grazing regimes. Grazing by copepods caused an additional reduction in cell size. Our results reject the hypothesis, that intensified size selective consumption at higher temperature would be the dominant explanation of decreasing body size. In this case, the size reduction would have taken place only in the copepod treatments but not in the treatments with protist grazing (nano-and microzooplankton).	[Peter, Kalista Higini; Sommer, Ulrich] Helmholtz Ctr Ocean Res Kiel GEOMAR, Kiel, Germany	Helmholtz Association; GEOMAR Helmholtz Center for Ocean Research Kiel	Sommer, U (corresponding author), Helmholtz Ctr Ocean Res Kiel GEOMAR, Kiel, Germany.	usommer@geomar.de			DAAD (German Academic Exchange Service) [A/10/90415]; institutional budget of Ulrich Sommer (Helmholtz Centre for Ocean Resarch/GEOMAR)	DAAD (German Academic Exchange Service)(Deutscher Akademischer Austausch Dienst (DAAD)); institutional budget of Ulrich Sommer (Helmholtz Centre for Ocean Resarch/GEOMAR)	The research has been supported by a DAAD (German Academic Exchange Service) fellowship for Kalista Higini Peter (code number A/10/90415. The consumables have been financed from the institutional budget of Ulrich Sommer (Helmholtz Centre for Ocean Resarch/GEOMAR). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen AP, 2005, FUNCT ECOL, V19, P202, DOI 10.1111/j.1365-2435.2005.00952.x; Allen AP, 2002, SCIENCE, V297, P1545, DOI 10.1126/science.1072380; [Anonymous], 1847, GOTTINGERSTUDIEN, V1, P595; ATKINSON D, 1994, ADV ECOL RES, V25, P1, DOI 10.1016/s0065-2504(08)60212-3; Atkinson D, 2003, INT J ART DES EDUC, V22, P2, DOI 10.1111/1468-5949.00303; Brown JH, 2004, ECOLOGY, V85, P1771, DOI 10.1890/03-9000; Daufresne M, 2009, P NATL ACAD SCI USA, V106, P12788, DOI 10.1073/pnas.0902080106; DROOP MR, 1983, BOT MAR, V26, P99, DOI 10.1515/botm.1983.26.3.99; DROOP MR, 1973, J PHYCOL, V9, P264; Finkel ZV, 2007, P NATL ACAD SCI USA, V104, P20416, DOI 10.1073/pnas.0709381104; Finkel ZV, 2010, J PLANKTON RES, V32, P119, DOI 10.1093/plankt/fbp098; Finkel ZV, 2005, P NATL ACAD SCI USA, V102, P8927, DOI 10.1073/pnas.0409907102; Forster J, 2011, FUNCT ECOL, V25, P1024, DOI 10.1111/j.1365-2435.2011.01852.x; Gardner JL, 2011, TRENDS ECOL EVOL, V26, P285, DOI 10.1016/j.tree.2011.03.005; GOLDMAN JC, 1979, NATURE, V279, P210, DOI 10.1038/279210a0; Hillebrand H, 1999, J PHYCOL, V35, P403, DOI 10.1046/j.1529-8817.1999.3520403.x; Irwin AJ, 2006, J PLANKTON RES, V28, P459, DOI 10.1093/plankt/fbi148; JAMES FC, 1970, ECOLOGY, V51, P365, DOI 10.2307/1935374; Litchman E, 2009, P NATL ACAD SCI USA, V106, P2665, DOI 10.1073/pnas.0810891106; Lopez-Urrutia A, 2006, P NATL ACAD SCI USA, V103, P8739, DOI 10.1073/pnas.0601137103; Maranon E, 2012, LIMNOL OCEANOGR, V57, P1266, DOI 10.4319/lo.2012.57.5.1266; Muren U, 2005, HYDROBIOLOGIA, V545, P153, DOI 10.1007/s10750-005-2742-4; O'Connor MI, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000178; O'Connor MI, 2009, ECOLOGY, V90, P388, DOI 10.1890/08-0034.1; Parmesan C, 2003, NATURE, V421, P37, DOI 10.1038/nature01286; Root TL, 2003, NATURE, V421, P57, DOI 10.1038/nature01333; Ruger T, 2012, AQUAT BOT, V97, P64, DOI 10.1016/j.aquabot.2011.12.001; Sommer U, 2006, OECOLOGIA, V147, P183, DOI 10.1007/s00442-005-0320-0; Sommer U, 2005, OECOLOGIA, V142, P274, DOI 10.1007/s00442-004-1708-y; Sommer U, 2001, ECOL LETT, V4, P545, DOI 10.1046/j.1461-0248.2001.00263.x; SOMMER U, 1991, FUNCT ECOL, V5, P535, DOI 10.2307/2389636; Sommer U, 2008, GLOBAL CHANGE BIOL, V14, P1199, DOI 10.1111/j.1365-2486.2008.01571.x; Sommer U, 2007, OECOLOGIA, V150, P655, DOI 10.1007/s00442-006-0539-4; Sommer U, 2012, MAR BIOL, V159, P2479, DOI [10.1007/s00227-012-2085-4, 10.1007/s00227-012-1897-6]; Sommer U, 2011, GLOBAL CHANGE BIOL, V17, P154, DOI 10.1111/j.1365-2486.2010.02182.x; Utermohl H., 1958, MITT INT VER THEOR, V9, P263; Walther GR, 2002, NATURE, V416, P389, DOI 10.1038/416389a; Winder M, 2009, P ROY SOC B-BIOL SCI, V276, P427, DOI 10.1098/rspb.2008.1200; Yvon-Durocher G, 2011, GLOBAL CHANGE BIOL, V17, P1681, DOI 10.1111/j.1365-2486.2010.02321.x; Yvon-Durocher G, 2010, PHILOS T R SOC B, V365, P2117, DOI 10.1098/rstb.2010.0038	40	64	68	5	136	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 30	2012	7	11							e49632	10.1371/journal.pone.0049632	http://dx.doi.org/10.1371/journal.pone.0049632			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	054WM	23226215	Green Accepted, gold, Green Published			2022-12-27	WOS:000312376100023
J	Romanovskaya, A; Paavilainen, H; Nygardas, M; Bamford, DH; Hukkanen, V; Poranen, MM				Romanovskaya, Alesia; Paavilainen, Henrik; Nygardas, Michaela; Bamford, Dennis H.; Hukkanen, Veijo; Poranen, Minna M.			Enzymatically Produced Pools of Canonical and Dicer-Substrate siRNA Molecules Display Comparable Gene Silencing and Antiviral Activities against Herpes Simplex Virus	PLOS ONE			English	Article							RNA INTERFERENCE; IN-VITRO; TYPE-1; INHIBITION; DSRNAS; REPLICATION; EXPRESSION; INDUCTION; RESPONSES; DUPLEXES	RNA interference (RNAi)-based sequence-specific gene silencing is applied to identify gene function and also possesses great potential for inhibiting virus replication both in animals and plants. Small interfering RNA (siRNA) molecules are the inducers of gene silencing in the RNAi pathway but may also display immunostimulatory activities and promote apoptosis. Canonical siRNAs are 21 nucleotides (nt) in length and are loaded to the RNA Induced Silencing Complex when introduced into the cells, while longer siRNA molecules are first processed by endogenous Dicer and thus termed Dicer-substrate siRNA (DsiRNA). We have applied RNA polymerases from bacteriophages T7 and phi6 to make high-quality double-stranded RNA molecules that are specific for the UL29 gene of herpes simplex virus (HSV). The 653 nt long double-stranded RNA molecules were converted to siRNA and DsiRNA pools using Dicer enzymes originating from human or Giardia intestinalis, producing siRNAs of approximately 21 and 27 nt in length, respectively. Chemically synthesised 21 and 27 nt single-site siRNA targeting the UL29 were used as references. The impact of these siRNAs on cell viability, inflammatory responses, gene silencing, and anti-HSV activity were assayed in cells derived from human nervous system and skin. Both pools and the canonical single-site siRNAs displayed substantial antiviral activity resulting in four orders of magnitude reduction in virus titer. Notably, the pool of DsiRNAs caused lower immunostimulation than the pool of canonical siRNAs, whereas the immunostimulation effect was in relation to the length with the single-site siRNAs. Our results also propose differences in the processivity of the two Dicers.	[Romanovskaya, Alesia; Bamford, Dennis H.; Poranen, Minna M.] Univ Helsinki, Dept Biosci, Helsinki, Finland; [Bamford, Dennis H.] Univ Helsinki, Inst Biotechnol, Helsinki, Finland; [Paavilainen, Henrik; Nygardas, Michaela; Hukkanen, Veijo] Univ Turku, Dept Virol, Turku, Finland	University of Helsinki; University of Helsinki; University of Turku	Poranen, MM (corresponding author), Univ Helsinki, Dept Biosci, Helsinki, Finland.	minna.poranen@helsinki.fi		Poranen, Minna/0000-0002-4775-3670; Bamford, Dennis/0000-0002-6438-8118; Tripp, Ralph/0000-0002-2924-9956; Romanovskaya, Alesia/0000-0002-3070-0177; Levanova, Alesia/0000-0003-4231-2275	Academy of Finland [250113, 256069, 256197, 255342, 256518, 128915]; Sigrid Juselius Foundation; Alfred Kordelin foundation; Instrumentarium foundation; FinPharma Doctoral program - Drug Discovery section	Academy of Finland(Academy of Finland); Sigrid Juselius Foundation(Sigrid Juselius Foundation); Alfred Kordelin foundation; Instrumentarium foundation; FinPharma Doctoral program - Drug Discovery section	This study was supported by grants from the Academy of Finland (grant number 250113 and 256069 to MMP, 256197, 255342 and 256518 to DHB and 128915 to VH; www.aka.fi) and Sigrid Juselius Foundation (to MMP and DHB; www.sigridjuselius.fi). AR has been a fellow of the Centre for International Mobility (CIMO, http://www.cimo.fi). HP has been funded by Alfred Kordelin foundation (http://www.kordelin.fi), Instrumentarium foundation (http://www.instrufoundation.fi) and FinPharma Doctoral program - Drug Discovery section (http://fpdp.fi). MN is a fellow in Turku Doctoral Programme of Biomedical Sciences (http://www.tubs.utu.fi). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aalto AP, 2007, RNA, V13, P422, DOI 10.1261/rna.348307; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Beaucage SL, 2008, CURR OPIN DRUG DISC, V11, P203; Bernstein E, 2001, RNA, V7, P1509; Betancur JG, 2012, RNA, V18, P24, DOI 10.1261/rna.029785.111; Bhuyan PK, 2004, J VIROL, V78, P10276, DOI 10.1128/JVI.78.19.10276-10281.2004; Bohula EA, 2003, J BIOL CHEM, V278, P15991, DOI 10.1074/jbc.M300714200; BOUKAMP P, 1988, J CELL BIOL, V106, P761, DOI 10.1083/jcb.106.3.761; Buchholz F, 2006, NAT METHODS, V3, P696, DOI 10.1038/NMETH912; Caplen NJ, 2001, P NATL ACAD SCI USA, V98, P9742, DOI 10.1073/pnas.171251798; Cerutti H, 2006, CURR GENET, V50, P81, DOI 10.1007/s00294-006-0078-x; Donze O, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.10.e46; Duan F, 2012, CLIN EXP OPHTHALMOL, V40, P195, DOI 10.1111/j.1442-9071.2011.02668.x; Elbashir SM, 2001, NATURE, V411, P494, DOI 10.1038/35078107; Fedorov Y, 2006, RNA, V12, P1188, DOI 10.1261/rna.28106; Foster DJ, 2012, RNA, V18, P557, DOI 10.1261/rna.031120.111; Geisbert TW, 2006, J INFECT DIS, V193, P1650, DOI 10.1086/504267; Gitlin L, 2005, J VIROL, V79, P1027, DOI 10.1128/JVI.79.2.1027-1035.2005; GOTTLIEB P, 1992, J VIROL, V66, P2611, DOI 10.1128/JVI.66.5.2611-2616.1992; Griffiths-Jones S, 2004, NUCLEIC ACIDS RES, V32, pD109, DOI 10.1093/nar/gkh023; Guiley KZ, 2012, NUCLEIC ACIDS RES, V40, DOI 10.1093/nar/gkr1174; Jagla B, 2005, RNA, V11, P864, DOI 10.1261/rna.7275905; Jiang M, 2011, J IMMUNOL, V187, P1713, DOI 10.4049/jimmunol.1100361; Judge AD, 2005, NAT BIOTECHNOL, V23, P457, DOI 10.1038/nbt1081; Kim DH, 2004, NAT BIOTECHNOL, V22, P321, DOI 10.1038/nbt940; Kim DH, 2005, NAT BIOTECHNOL, V23, P222, DOI 10.1038/nbt1051; MacRae IJ, 2006, COLD SPRING HARB SYM, V71, P73, DOI 10.1101/sqb.2006.71.042; MacRae IJ, 2006, SCIENCE, V311, P195, DOI 10.1126/science.1121638; Myers JW, 2003, NAT BIOTECHNOL, V21, P324, DOI 10.1038/nbt792; Nygardas M, 2011, GENE THER, V18, P646, DOI 10.1038/gt.2011.4; Nygardas M, 2009, J GEN VIROL, V90, P2468, DOI 10.1099/vir.0.011338-0; Palliser D, 2006, NATURE, V439, P89, DOI 10.1038/nature04263; Peek AS, 2007, CURR OPIN MOL THER, V9, P110; Peri P, 2008, VIROL J, V5, DOI 10.1186/1743-422X-5-140; Provost P, 2002, EMBO J, V21, P5864, DOI 10.1093/emboj/cdf578; Rand TA, 2004, P NATL ACAD SCI USA, V101, P14385, DOI 10.1073/pnas.0405913101; Reynolds A, 2004, NAT BIOTECHNOL, V22, P326, DOI 10.1038/nbt936; Reynolds A, 2006, RNA, V12, P988, DOI 10.1261/rna.2340906; Rose SD, 2005, NUCLEIC ACIDS RES, V33, P4140, DOI 10.1093/nar/gki732; Salomon W, 2010, NUCLEIC ACIDS RES, V38, P3771, DOI 10.1093/nar/gkq055; Shah PS, 2011, PHARM RES-DORDR, V28, P2966, DOI 10.1007/s11095-011-0549-8; Wang QQ, 2004, MICROBIOL MOL BIOL R, V68, P432, DOI 10.1128/MMBR.68.3.432-452.2004; Wilson JA, 2005, J VIROL, V79, P7050, DOI 10.1128/JVI.79.11.7050-7058.2005; Yang D, 2002, P NATL ACAD SCI USA, V99, P9942, DOI 10.1073/pnas.152327299; Zhang HD, 2002, EMBO J, V21, P5875, DOI 10.1093/emboj/cdf582; Zhang YQ, 2008, CLIN EXP DERMATOL, V33, P56, DOI 10.1111/j.1365-2230.2007.02543.x	46	22	22	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 30	2012	7	11							e51019	10.1371/journal.pone.0051019	http://dx.doi.org/10.1371/journal.pone.0051019			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	054WM	23226452	Green Published, gold, Green Submitted			2022-12-27	WOS:000312376100263
J	Whitby, PW; Morton, DJ; VanWagoner, TM; Seale, TW; Cole, BK; Mussa, HJ; McGhee, PA; Bauer, CYS; Springer, JM; Stull, TL				Whitby, Paul W.; Morton, Daniel J.; VanWagoner, Timothy M.; Seale, Thomas W.; Cole, Brett K.; Mussa, Huda J.; McGhee, Phillip A.; Bauer, Chee Yoon S.; Springer, Jennifer M.; Stull, Terrence L.			Haemophilus influenzae OxyR: Characterization of Its Regulation, Regulon and Role in Fitness	PLOS ONE			English	Article							HAPTOGLOBIN-BINDING-PROTEINS; OXIDATIVE STRESS RESISTANCE; HYDROGEN-PEROXIDE; CHINCHILLA MODEL; TRANSCRIPTION FACTOR; HEME-UTILIZATION; VIRULENCE; GENE; EXPRESSION; HEMOGLOBIN	To prevent damage by reactive oxygen species, many bacteria have evolved rapid detection and response systems, including the OxyR regulon. The OxyR system detects reactive oxygen and coordinates the expression of numerous defensive antioxidants. In many bacterial species the coordinated OxyR-regulated response is crucial for in vivo survival. Regulation of the OxyR regulon of Haemophilus influenzae was examined in vitro, and significant variation in the regulated genes of the OxyR regulon among strains of H. influenzae was observed. Quantitative PCR studies demonstrated a role for the OxyR-regulated peroxiredoxin/glutaredoxin as a mediator of the OxyR response, and also indicated OxyR self-regulation through a negative feedback loop. Analysis of transcript levels in H. influenzae samples derived from an animal model of otitis media demonstrated that the members of the OxyR regulon were actively upregulated within the chinchilla middle ear. H. influenzae mutants lacking the oxyR gene exhibited increased sensitivity to challenge with various peroxides. The impact of mutations in oxyR was assessed in various animal models of H. influenzae disease. In paired comparisons with the corresponding wild-type strains, the oxyR mutants were unaffected in both the chinchilla model of otitis media and an infant model of bacteremia. However, in weanling rats the oxyR mutant was significantly impaired compared to the wildtype strain. In contrast, in all three animal models when infected with a mixture of equal numbers of both wild-type and mutant strains the mutant strain was significantly out competed by the wild-type strain. These findings clearly establish a crucial role for OxyR in bacterial fitness.	[Whitby, Paul W.; Morton, Daniel J.; VanWagoner, Timothy M.; Seale, Thomas W.; Cole, Brett K.; Mussa, Huda J.; McGhee, Phillip A.; Bauer, Chee Yoon S.; Springer, Jennifer M.; Stull, Terrence L.] Univ Oklahoma, Hlth Sci Ctr, Dept Pediat, Oklahoma City, OK 73190 USA; [Stull, Terrence L.] Univ Oklahoma, Hlth Sci Ctr, Dept Microbiol & Immunol, Oklahoma City, OK 73190 USA; [VanWagoner, Timothy M.] Oklahoma Christian Univ, Dept Biol, Oklahoma City, OK USA	University of Oklahoma System; University of Oklahoma Health Sciences Center; University of Oklahoma System; University of Oklahoma Health Sciences Center	Whitby, PW (corresponding author), Univ Oklahoma, Hlth Sci Ctr, Dept Pediat, Oklahoma City, OK 73190 USA.	pwhitby@ouhsc.edu		VanWagoner, Timothy/0000-0001-6103-590X; Morton, Daniel/0000-0002-3931-5566	Public Health Service from the national Institute for Allergy and Infectious Disease [AI29611]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R56AI029611, R01AI029611] Funding Source: NIH RePORTER	Public Health Service from the national Institute for Allergy and Infectious Disease; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by Public Health Service Grant AI29611 from the national Institute for Allergy and Infectious Disease. The authors gratefully acknowledge the ongoing support of the Children's Hospital Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anjem A, 2009, MOL MICROBIOL, V72, P844, DOI 10.1111/j.1365-2958.2009.06699.x; Antelmann H, 2011, ANTIOXID REDOX SIGN, V14, P1049, DOI 10.1089/ars.2010.3400; Aslund F, 1999, P NATL ACAD SCI USA, V96, P6161, DOI 10.1073/pnas.96.11.6161; Bakaletz LO, 1997, VACCINE, V15, P955, DOI 10.1016/S0264-410X(96)00298-8; Bakaletz LO, 1999, INFECT IMMUN, V67, P2746, DOI 10.1128/IAI.67.6.2746-2762.1999; Benjamin JAM, 2010, CAN J PHYSIOL PHARM, V88, P264, DOI 10.1139/Y10-014; BISHAI WR, 1994, INFECT IMMUN, V62, P4855, DOI 10.1128/IAI.62.11.4855-4860.1994; Calhoun LN, 2011, J APPL MICROBIOL, V110, P375, DOI 10.1111/j.1365-2672.2010.04890.x; Chiang SM, 2012, ARCH BIOCHEM BIOPHYS, V525, P161, DOI 10.1016/j.abb.2012.02.007; FLEISCHMANN RD, 1995, SCIENCE, V269, P496, DOI 10.1126/science.7542800; Gawronski JD, 2009, P NATL ACAD SCI USA, V106, P16422, DOI 10.1073/pnas.0906627106; Gitiban N, 2005, J VIROL, V79, P6035, DOI 10.1128/JVI.79.10.6035-6042.2005; Harrison A, 2005, J BACTERIOL, V187, P4627, DOI 10.1128/JB.187.13.4627-4636.2005; Harrison A, 2007, J BACTERIOL, V189, P1004, DOI 10.1128/JB.01040-06; Hishinuma S, 2006, ENVIRON MICROBIOL, V8, P2115, DOI 10.1111/j.1462-2920.2006.01088.x; Hoopman TC, 2011, INFECT IMMUN, V79, P745, DOI 10.1128/IAI.01060-10; Imlay JA, 2008, ANNU REV BIOCHEM, V77, P755, DOI 10.1146/annurev.biochem.77.061606.161055; Jett BD, 1997, BIOTECHNIQUES, V23, P648, DOI 10.2144/97234bm22; Knapp GS, 2009, PROTEIN SCI, V18, P101, DOI 10.1002/pro.5; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lushchak VI, 2011, COMP BIOCHEM PHYS C, V153, P175, DOI 10.1016/j.cbpc.2010.10.004; Maciver I, 1996, INFECT IMMUN, V64, P4618, DOI 10.1128/IAI.64.11.4618-4629.1996; Morton DJ, 2007, MICROBES INFECT, V9, P932, DOI 10.1016/j.micinf.2007.03.013; Morton DJ, 2007, MICROBIOL-SGM, V153, P215, DOI 10.1099/mic.0.2006/000190-0; Morton Daniel J, 2012, BMC Res Notes, V5, P327, DOI 10.1186/1756-0500-5-327; Morton Daniel J, 2009, BMC Res Notes, V2, P166, DOI 10.1186/1756-0500-2-166; Morton DJ, 2010, BMC MICROBIOL, V10, DOI 10.1186/1471-2180-10-113; Morton DJ, 2009, INT J MED MICROBIOL, V299, P479, DOI 10.1016/j.ijmm.2009.03.004; Morton DJ, 2006, FEMS IMMUNOL MED MIC, V46, P426, DOI 10.1111/j.1574-695X.2006.00052.x; Morton DJ, 2004, IRON TRANSPORT IN BACTERIA, P273; Morton DJ, 2004, MICROBIOL-SGM, V150, P3923, DOI 10.1099/mic.0.27238-0; Morton DJ, 1999, INFECT IMMUN, V67, P2729, DOI 10.1128/IAI.67.6.2729-2739.1999; Morton DJ, 2004, MICROB PATHOGENESIS, V36, P25, DOI 10.1016/j.micpath.2003.08.007; Morton DJ, 2005, FEMS MICROBIOL LETT, V253, P193, DOI 10.1016/j.femsle.2005.09.016; Murphy TF, 2009, PEDIATR INFECT DIS J, V28, P43, DOI 10.1097/INF.0b013e318184dba2; Pauwels F, 2004, J BIOL CHEM, V279, P12163, DOI 10.1074/jbc.M312037200; Poje Grant, 2003, Methods Mol Med, V71, P57; Qu J, 2010, BMC MICROBIOL, V10, DOI 10.1186/1471-2180-10-162; Runyen-Janecky L, 2006, INFECT IMMUN, V74, P4666, DOI 10.1128/IAI.00562-06; Saeed-Kothe A, 2004, APPL ENVIRON MICROB, V70, P4136, DOI 10.1128/AEM.70.7.4136-4143.2004; Seale TW, 2006, INFECT IMMUN, V74, P6213, DOI 10.1128/IAI.00744-06; Seaver LC, 2001, J BACTERIOL, V183, P7173, DOI 10.1128/JB.183.24.7173-7181.2001; Seib KL, 2007, MOL MICROBIOL, V63, P54, DOI 10.1111/j.1365-2958.2006.05478.x; Sund CJ, 2008, MOL MICROBIOL, V67, P129, DOI 10.1111/j.1365-2958.2007.06031.x; SUZUKI K, 1994, INFECT IMMUN, V62, P1710, DOI 10.1128/IAI.62.5.1710-1718.1994; Tseng HJ, 2003, INFECT IMMUN, V71, P550, DOI 10.1128/IAI.71.1.550-556.2003; TURK DC, 1984, J MED MICROBIOL, V18, P1, DOI 10.1099/00222615-18-1-1; VanWagoner TM, 2004, J BACTERIOL, V186, P6409, DOI 10.1128/JB.186.19.6409-6421.2004; Vergauwen B, 2006, BMC MICROBIOL, V6, DOI 10.1186/1471-2180-6-3; Vergauwen B, 2003, J BACTERIOL, V185, P5555, DOI 10.1128/JB.185.18.5555-5562.2003; Whitby PW, 2006, J BACTERIOL, V188, P5640, DOI 10.1128/JB.00417-06; Whitby PW, 2010, MICROBIOL-SGM, V156, P1188, DOI 10.1099/mic.0.036400-0; Whitby PW, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-6; Whitby PW, 1998, FEMS MICROBIOL LETT, V158, P57, DOI 10.1016/S0378-1097(97)00500-4; Wong SMS, 2007, MOL MICROBIOL, V64, P1375, DOI 10.1111/j.1365-2958.2007.05747.x; Zheng M, 1998, SCIENCE, V279, P1718, DOI 10.1126/science.279.5357.1718	56	19	20	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 30	2012	7	11							e50588	10.1371/journal.pone.0050588	http://dx.doi.org/10.1371/journal.pone.0050588			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	054WM	23226321	Green Published, gold, Green Submitted			2022-12-27	WOS:000312376100133
J	Xiong, JB; He, ZL; Van Nostrand, JD; Luo, GS; Tu, SX; Zhou, JZ; Wang, GJ				Xiong, Jinbo; He, Zhili; Van Nostrand, Joy D.; Luo, Guosheng; Tu, Shuxin; Zhou, Jizhong; Wang, Gejiao			Assessing the Microbial Community and Functional Genes in a Vertical Soil Profile with Long-Term Arsenic Contamination	PLOS ONE			English	Article							ORGANIC-MATTER; REDUCING BACTERIA; MONO LAKE; DIVERSITY; CARBON; WATER; GROUNDWATER; RESISTANCE; FIXATION; DYNAMICS	Arsenic (As) contamination in soil and groundwater has become a serious problem to public health. To examine how microbial communities and functional genes respond to long-term arsenic contamination in vertical soil profile, soil samples were collected from the surface to the depth of 4 m (with an interval of 1 m) after 16-year arsenic downward infiltration. Integrating BioLog and functional gene microarray (GeoChip 3.0) technologies, we showed that microbial metabolic potential and diversity substantially decreased, and community structure was markedly distinct along the depth. Variations in microbial community functional genes, including genes responsible for As resistance, carbon and nitrogen cycling, phosphorus utilization and cytochrome c oxidases were detected. In particular, changes in community structures and activities were correlated with the biogeochemical features along the vertical soil profile when using the rbcL and nifH genes as biomarkers, evident for a gradual transition from aerobic to anaerobic lifestyles. The C/N showed marginally significant correlations with arsenic resistance (p = 0.069) and carbon cycling genes (p = 0.073), and significant correlation with nitrogen fixation genes (p = 0.024). The combination of C/N, NO3- and P showed the highest correlation (r = 0.779, p = 0.062) with the microbial community structure. Contradict to our hypotheses, a long-term arsenic downward infiltration was not the primary factor, while the spatial isolation and nutrient availability were the key forces in shaping the community structure. This study provides new insights about the heterogeneity of microbial community metabolic potential and future biodiversity preservation for arsenic bioremediation management.	[Xiong, Jinbo; Luo, Guosheng; Wang, Gejiao] Huazhong Agr Univ, State Key Lab Agr Microbiol, Coll Life Sci & Technol, Wuhan, Peoples R China; [Xiong, Jinbo; He, Zhili; Van Nostrand, Joy D.; Zhou, Jizhong] Univ Oklahoma, Dept Bot & Microbiol, Inst Environm Genom, Norman, OK 73019 USA; [Tu, Shuxin] Huazhong Agr Univ, Coll Resources & Environm, Wuhan, Peoples R China	Huazhong Agricultural University; University of Oklahoma System; University of Oklahoma - Norman; Huazhong Agricultural University	Wang, GJ (corresponding author), Huazhong Agr Univ, State Key Lab Agr Microbiol, Coll Life Sci & Technol, Wuhan, Peoples R China.	gejiaow@yahoo.com.cn	He, Zhili/C-2879-2012; Xiong, Jinbo/ADU-9249-2022; Van Nostrand, Joy D/F-1740-2016; 吴, 昊/AAB-1620-2020	He, Zhili/0000-0001-8225-7333; Van Nostrand, Joy D/0000-0001-9548-6450; Xiong, Jinbo/0000-0003-0645-8058; Tu, Shuxin/0000-0001-7180-1794	Major International Joint Research Project [31010103903]; National Natural Science Foundation of China [30970075]; Virtual Institute for Microbial Stress and Survival; U.S. Department of Energy, Office of Biological and Environmental Research, Genomics Program: GTL [DE-AC02-05CH11231]	Major International Joint Research Project(National Natural Science Foundation of China (NSFC)); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Virtual Institute for Microbial Stress and Survival; U.S. Department of Energy, Office of Biological and Environmental Research, Genomics Program: GTL(United States Department of Energy (DOE))	This work was supported by the Major International Joint Research Project (31010103903), the National Natural Science Foundation of China (30970075), the Virtual Institute for Microbial Stress and Survival (http://VIMSS.lbl.gov), which was supported by the U.S. Department of Energy, Office of Biological and Environmental Research, Genomics Program: GTL through contract DE-AC02-05CH11231 between Lawrence Berkeley National Laboratory and the U.S. Department of Energy. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adriano D.C., 2001, TRACE ELEMENTS TERRE, DOI 10.1007/978-0-387-21510-5; ALEF K, 1986, SOIL BIOL BIOCHEM, V18, P233, DOI 10.1016/0038-0717(86)90033-7; Badger MR, 2008, J EXP BOT, V59, P1525, DOI 10.1093/jxb/erm297; Barber KR, 2004, HYDROL PROCESS, V18, P329, DOI 10.1002/hyp.1378; Bryan CG, 2009, BMC MICROBIOL, V9, DOI 10.1186/1471-2180-9-127; Cai L, 2009, BMC MICROBIOL, V9, DOI 10.1186/1471-2180-9-4; Churchill GA, 2004, BIOTECHNIQUES, V37, P173, DOI 10.2144/04372TE01; Cole J, 1996, FEMS MICROBIOL LETT, V136, P1; de Lipthay JR, 2008, FEMS MICROBIOL ECOL, V65, P145, DOI 10.1111/j.1574-6941.2008.00501.x; Fan H, 2008, J APPL MICROBIOL, V105, P529, DOI 10.1111/j.1365-2672.2008.03790.x; Fierer N, 2003, SOIL BIOL BIOCHEM, V35, P167, DOI 10.1016/S0038-0717(02)00251-1; Fierer N, 2009, ECOL LETT, V12, P1238, DOI 10.1111/j.1461-0248.2009.01360.x; Ge Y, 2010, ENVIRON SCI POLLUT R, V17, P807, DOI 10.1007/s11356-009-0185-6; Haack SK, 2004, ENVIRON MICROBIOL, V6, P438, DOI 10.1111/j.1462-2920.2003.00563.x; Hansel CM, 2008, APPL ENVIRON MICROB, V74, P1620, DOI 10.1128/AEM.01787-07; He ZL, 2010, ISME J, V4, P1167, DOI 10.1038/ismej.2010.46; HILL MO, 1980, VEGETATIO, V42, P47, DOI 10.1007/BF00048870; HIRSCH AM, 1995, MOL BIOL EVOL, V12, P16, DOI 10.1093/oxfordjournals.molbev.a040184; Holden PA, 2005, VADOSE ZONE J, V4, P1, DOI 10.2113/4.1.1; HOLLAND EA, 1987, ECOLOGY, V68, P425, DOI 10.2307/1939274; Islam FS, 2004, NATURE, V430, P68, DOI 10.1038/nature02638; Kim MJ, 2002, ENVIRON POLLUT, V120, P379, DOI 10.1016/S0269-7491(02)00114-8; Kulp TR, 2008, SCIENCE, V321, P967, DOI 10.1126/science.1160799; Kusian B, 1997, FEMS MICROBIOL REV, V21, P135, DOI 10.1016/S0168-6445(97)00054-5; Liao XY, 2005, ENVIRON INT, V31, P791, DOI 10.1016/j.envint.2005.05.030; Liengen T, 1997, ARCTIC ALPINE RES, V29, P470, DOI 10.2307/1551994; Liu GH, 2012, ENVIRON MICROBIOL, V14, P1624, DOI 10.1111/j.1462-2920.2011.02672.x; Lovley DR, 2003, NAT REV MICROBIOL, V1, P35, DOI 10.1038/nrmicro731; LOVLEY DR, 1995, REV GEOPHYS, V33, P365, DOI 10.1029/95RG01305; Ludemann H, 2000, APPL ENVIRON MICROB, V66, P754, DOI 10.1128/AEM.66.2.754-762.2000; Mandal BK, 2002, TALANTA, V58, P201, DOI 10.1016/S0039-9140(02)00268-0; Mehta MP, 2003, APPL ENVIRON MICROB, V69, P960, DOI 10.1128/AEM.69.2.960-970.2003; Neumann G, 1999, PLANT SOIL, V211, P121, DOI 10.1023/A:1004380832118; Niggemyer A, 2001, APPL ENVIRON MICROB, V67, P5568, DOI 10.1128/AEM.67.12.5568-5580.2001; Oremland RS, 2003, SCIENCE, V300, P939, DOI 10.1126/science.1081903; Oremland RS, 2002, APPL ENVIRON MICROB, V68, P4795, DOI 10.1128/AEM.68.10.4795-4802.2002; Poly F, 2001, APPL ENVIRON MICROB, V67, P2255, DOI 10.1128/AEM.67.5.2255-2262.2001; Preston-Mafham J, 2002, FEMS MICROBIOL ECOL, V42, P1, DOI 10.1111/j.1574-6941.2002.tb00990.x; Qin J, 2006, P NATL ACAD SCI USA, V103, P2075, DOI 10.1073/pnas.0506836103; Redman AD, 2002, ENVIRON SCI TECHNOL, V36, P2889, DOI 10.1021/es0112801; Rosen BP, 2002, FEBS LETT, V529, P86, DOI 10.1016/S0014-5793(02)03186-1; Shively JM, 1998, ANNU REV MICROBIOL, V52, P191, DOI 10.1146/annurev.micro.52.1.191; Sun GF, 2004, TOXICOL APPL PHARM, V198, P268, DOI 10.1016/j.taap.2003.10.017; Trumbore S, 2000, ECOL APPL, V10, P399, DOI 10.1890/1051-0761(2000)010[0399:AOSOMA]2.0.CO;2; Van Nostrand JD, 2011, APPL ENVIRON MICROB, V77, P3860, DOI 10.1128/AEM.01981-10; Van Nostrand JD, 2009, ENVIRON MICROBIOL, V11, P2611, DOI 10.1111/j.1462-2920.2009.01986.x; Wang GJ, 2004, J BACTERIOL, V186, P3187, DOI 10.1128/JB.186.10.3187-3194.2004; WARDLE DA, 1992, BIOL REV, V67, P321, DOI 10.1111/j.1469-185X.1992.tb00728.x; Welch AH, 2000, GROUND WATER, V38, P589, DOI 10.1111/j.1745-6584.2000.tb00251.x; Xia YJ, 2004, TOXICOLOGY, V198, P25, DOI 10.1016/j.tox.2004.01.016; Xiong JB, 2010, APPL ENVIRON MICROB, V76, P7277, DOI 10.1128/AEM.00500-10; Xu MY, 2010, ISME J, V4, P1060, DOI 10.1038/ismej.2010.31; Zhou JZ, 2004, APPL ENVIRON MICROB, V70, P1723, DOI 10.1128/AEM.70.3.1723-1734.2004; Zhou JZ, 1996, APPL ENVIRON MICROB, V62, P316, DOI 10.1128/AEM.62.2.316-322.1996	54	28	30	6	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 30	2012	7	11							e50507	10.1371/journal.pone.0050507	http://dx.doi.org/10.1371/journal.pone.0050507			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	054WM	23226297	Green Published, Green Submitted, gold			2022-12-27	WOS:000312376100109
J	Dong, HS; Fahmy, TM; Metcalfe, SM; Morton, SL; Dong, X; Inverardi, L; Adams, DB; Gao, WD; Wang, HJ				Dong, Huansheng; Fahmy, Tarek M.; Metcalfe, Su M.; Morton, Steve L.; Dong, Xiao; Inverardi, Luca; Adams, David B.; Gao, Wenda; Wang, Hongjun			Immuno-Isolation of Pancreatic Islet Allografts Using Pegylated Nanotherapy Leads to Long-Term Normoglycemia in Full MHC Mismatch Recipient Mice	PLOS ONE			English	Article							LEUKEMIA INHIBITORY FACTOR; BETA-CELL NEOGENESIS; TRANSPLANTATION; TECHNOLOGIES; EXPRESSION; CAMOUFLAGE; SURVIVAL; DELIVERY; DEVICES; LIF	Two major hurdles need to be surmounted for cell therapy for diabetes: (i) allo-immune rejection of grafted pancreatic islets, or stem/precursor cell-derived insulin-secreting cells; and (ii) continuing auto-immunity against the diabetogenic endogenous target antigen. Nanotherapeutics offer a novel approach to overcome these problems and here we ask if creation of "stealth'' islets encapsulated within a thin cage of pegylated material of 100-200 nanometers thick provides a viable option for islet transplantation. The aims of this study were to test islet viability and functionality following encapsulation within the pegylated cage, and functional efficacy in vivo in terms of graft-derived control of normoglycemia in diabetic mice. We first demonstrated that pegylation of the islet surface, plus or minus nanoparticles, improved long-term islet viability in vitro compared to non-pegylated (naked) control islets. Moreover, pegylation of the islets with nanoparticles was compatible with glucose-stimulated insulin secretion and insulin biogenesis. We next looked for functionality of the created "stealth'' DBA/2 (H-2(d)) islets in vivo by comparing glycemic profiles across 4 groups of streptozotozin- induced diabetic C57BL/6 (H-2(b)) recipients of (i) naked islets; (ii) pegylated islets; (iii) pegylated islets with nanoparticles (empty); and (iv) pegylated islets with nanoparticles loaded with a cargo of leukemia inhibitory factor (LIF), a factor both promotes adaptive immune tolerance and regulates pancreatic beta cell mass. Without any other treatment, normoglycemia was lost after 17 d (+/27.5 d) in control group. In striking contrast, recipients in groups (ii), (iii), and (iv) showed long-term (>100 d) normoglycemia involving 30%; 43%, and 57% of the recipients in each respective group. In conclusion, construction of "stealth'' islets by pegylation-based nanotherapeutics not only supports islet structure and function, but also effectively isolates the islets from immune-mediated destruction. The added value of nanoparticles to deliver immune modulators plus growth factors such as LIF expands the potential of this novel therapeutic approach to cell therapy for diabetes. Citation: Dong H, Fahmy TM, Metcalfe SM, Morton SL, Dong X, et al. (2012) Immuno-Isolation of Pancreatic Islet Allografts Using Pegylated Nanotherapy Leads to Long-Term Normoglycemia in Full MHC Mismatch Recipient Mice. PLoS ONE 7(12): e50265. doi:10.1371/journal.pone.0050265	[Dong, Huansheng; Adams, David B.; Wang, Hongjun] Med Univ S Carolina, Dept Surg, Charleston, SC 29425 USA; [Fahmy, Tarek M.] Yale Univ, Dept Biomed Engn, New Haven, CT USA; [Metcalfe, Su M.] Univ Cambridge, Dept Neurol, Brain Repair Ctr, Cambridge, England; [Morton, Steve L.] Natl Ctr Coastal Ocean Sci, Charleston, SC USA; [Dong, Xiao] Qingdao Agr Univ, Coll Life Sci, Qingdao, Peoples R China; [Inverardi, Luca] Univ Miami, Miller Sch Med, Diabet Res Inst, Miami, FL 33136 USA; [Gao, Wenda] Antagen Inst Biomed Res, Boston, MA USA	Medical University of South Carolina; Yale University; University of Cambridge; National Oceanic Atmospheric Admin (NOAA) - USA; National Ocean Service, NOAA; National Centers for Coastal Ocean Science (NOOCS); Qingdao Agricultural University; University of Miami	Wang, HJ (corresponding author), Med Univ S Carolina, Dept Surg, Charleston, SC 29425 USA.	wangho@musc.edu	Wang, Hongjun/AAA-1319-2021		JDRF [41-2009-760, 5-2012-149]; National Institutes of Health/National Center for Research Resources Grant at South Carolina Clinical and Translational Research (SCTR) Institute [UL1RR029882]; Clinical and Translational Science Awards (CTSA)	JDRF(Juvenile Diabetes Research Foundation); National Institutes of Health/National Center for Research Resources Grant at South Carolina Clinical and Translational Research (SCTR) Institute; Clinical and Translational Science Awards (CTSA)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS))	This study was supported in part by JDRF grant 41-2009-760 (to WG, HW, TF, and SMM), the JDRF grant 5-2012-149 (to HW and DA), and the National Institutes of Health/National Center for Research Resources Grant Number UL1RR029882 at South Carolina Clinical and Translational Research (SCTR) Institute and the Clinical and Translational Science Awards (CTSA). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baeyens L, 2006, CELL DEATH DIFFER, V13, P1892, DOI 10.1038/sj.cdd.4401883; Baeyens L, 2005, DIABETOLOGIA, V48, P49, DOI 10.1007/s00125-004-1606-1; Basarkar A, 2009, PHARM RES-DORDR, V26, P72, DOI 10.1007/s11095-008-9710-4; Biancone L, 2002, CELL TRANSPLANT, V11, P309; De Breuck S, 2006, DIABETOLOGIA, V49, P108, DOI 10.1007/s00125-005-0079-1; Elcin YM, 2003, ADV EXP MED BIOL, V534, P255; Fort A, 2008, CELL TRANSPLANT, V17, P997, DOI 10.3727/096368908786991498; Gao W, 2009, CELL CYCLE, V8, P1444, DOI 10.4161/cc.8.9.8348; Giovagnoli S, 2005, J CONTROL RELEASE, V107, P65, DOI 10.1016/j.jconrel.2005.05.021; Giraldo Jaime A, 2010, J Diabetes Sci Technol, V4, P1238; Jain R, 1998, DRUG DEV IND PHARM, V24, P703, DOI 10.3109/03639049809082719; Jain RA, 2000, BIOMATERIALS, V21, P2475, DOI 10.1016/S0142-9612(00)00115-0; Kobayashi T, 2003, TRANSPLANT P, V35, P484, DOI 10.1016/S0041-1345(02)03829-0; Lee DY, 2007, TISSUE ENG, V13, P2133, DOI 10.1089/ten.2006.0009; Lee DY, 2007, BIOMATERIALS, V28, P1957, DOI 10.1016/j.biomaterials.2006.12.015; Mao GH, 2009, BIOMATERIALS, V30, P1706, DOI 10.1016/j.biomaterials.2008.12.030; Merani S, 2006, CLIN SCI, V110, P611, DOI 10.1042/CS20050342; Metcalfe SM, 2011, GENES IMMUN, V12, P157, DOI 10.1038/gene.2011.9; Metcalfe SM, 2005, TRANSPLANTATION, V79, P726, DOI 10.1097/01.TP.0000149324.42994.38; Mfopou JK, 2012, DIABETOLOGIA, V55, P1024, DOI 10.1007/s00125-011-2434-8; Murad KL, 1999, BLOOD, V94, P2135; Murad KT, 1999, BLOOD, V93, P2121, DOI 10.1182/blood.V93.6.2121.406a30_2121_2127; Orive G, 2003, NAT MED, V9, P104, DOI 10.1038/nm0103-104; Park J, 2011, MOL PHARMACEUT, V8, P143, DOI 10.1021/mp100203a; SAWHNEY AS, 1994, BIOTECHNOL BIOENG, V44, P383, DOI 10.1002/bit.260440317; Scott MD, 1998, CURR PHARM DESIGN, V4, P423; Scott MD, 1997, P NATL ACAD SCI USA, V94, P7566, DOI 10.1073/pnas.94.14.7566; Teramura Y, 2008, BIOCONJUGATE CHEM, V19, P1389, DOI 10.1021/bc800064t; Wang HJ, 2005, DIABETES, V54, P1400, DOI 10.2337/diabetes.54.5.1400; Wilson JT, 2008, ADV DRUG DELIVER REV, V60, P124, DOI 10.1016/j.addr.2007.08.034	30	41	44	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 5	2012	7	12							e50265	10.1371/journal.pone.0050265	http://dx.doi.org/10.1371/journal.pone.0050265			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	057TZ	23227162	Green Submitted, gold, Green Published			2022-12-27	WOS:000312588200023
J	Han, JZ; Townes-Anderson, E				Han, Jianzhong; Townes-Anderson, Ellen			Cell Specific Post-Translational Processing of Pikachurin, A Protein Involved in Retinal Synaptogenesis	PLOS ONE			English	Article							SYNAPSE FORMATION; DYSTROGLYCAN; ADULT; GROWTH; RETINOBLASTOMA; BINDING	Pikachurin is a recently identified, highly conserved, extracellular matrix-like protein. Murine pikachurin has 1,017 amino acids (similar to 110 kDa), can bind to alpha-dystroglycan, and has been found to localize mainly in the synaptic cleft of photoreceptor ribbon synapses. Its knockout selectively disrupts synaptogenesis between photoreceptor and bipolar cells. To further characterize this synaptic protein, we used an antibody raised against the N-terminal of murine pikachurin on Western blots of mammalian and amphibian retinas and found, unexpectedly, that a low weight similar to 60-kDa band was the predominant signal for endogenous pikachurin. This band was predicted to be an N-terminal product of post-translational cleavage of pikachurin. A similar sized protein was also detected in human Y79 retinoblastoma cells, a cell line with characteristics of photoreceptor cells. In Y79 cells, endogenous pikachurin immunofluorescence was found on the cell surface of living cells. The expression of the N-fragment was not significantly affected by dystroglycan overexpression in spite of the biochemical evidence for pikachurin-alpha-dystroglycan binding. The presence of a corresponding endogenous C-fragment was not determined because of the lack of a suitable antibody. However, a protein of similar to 65 kDa was detected in Y79 cells expressing recombinant pikachurin with a C-terminal tag. In contrast, in QBI-HEK 293A cells, whose endogenous pikachurin protein level is negligible, recombinant pikachurin did not appear to be cleaved. Instead pikachurin was found either intact or as dimers. Finally, whole and N- and C-fragments of recombinant pikachurin were present in the conditioned media of Y79 cells indicating the secretion of pikachurin. The site of cleavage, however, was not conclusively determined. Our data suggest the existence of post-translational cleavage of pikachurin protein as well as the extracellular localization of cleaved protein specifically by retinal cells. The functions of the pikachurin N- and C-fragments in the photoreceptor ribbon synapse are unknown. Citation: Han J, Townes-Anderson E (2012) Cell Specific Post-Translational Processing of Pikachurin, A Protein Involved in Retinal Synaptogenesis. PLoS ONE 7(12): e50552. doi: 10.1371/journal.pone.0050552	[Han, Jianzhong; Townes-Anderson, Ellen] Univ Med & Dent New Jersey, New Jersey Med Sch, Dept Neurol & Neurosci, Newark, NJ 07103 USA	Rutgers State University New Brunswick; Rutgers State University Medical Center	Han, JZ (corresponding author), Univ Med & Dent New Jersey, New Jersey Med Sch, Dept Neurol & Neurosci, 185 S Orange Ave, Newark, NJ 07103 USA.	hanj1@umdnj.edu			National Institutes of Health [EY012031]; F.M. Kirby Foundation; NATIONAL EYE INSTITUTE [R01EY012031] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); F.M. Kirby Foundation; NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This work was supported by National Institutes of Health grant EY012031 and the F.M. Kirby Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barresi R, 2006, J CELL SCI, V119, P199, DOI 10.1242/jcs.02814; BOGENMANN E, 1988, SCIENCE, V240, P76, DOI 10.1126/science.2451289; DIPOLO A, 1995, P NATL ACAD SCI USA, V92, P4016, DOI 10.1073/pnas.92.9.4016; Durbeej M, 1998, J HISTOCHEM CYTOCHEM, V46, P449, DOI 10.1177/002215549804600404; Fontainhas AM, 2008, INVEST OPHTH VIS SCI, V49, P4177, DOI 10.1167/iovs.07-1580; Guidry C, 1996, INVEST OPHTH VIS SCI, V37, P740; Han JZ, 2007, J CELL BIOL, V176, P101, DOI 10.1083/jcb.200607128; Hu HY, 2011, NEUROSCI LETT, V489, P10, DOI 10.1016/j.neulet.2010.11.056; Kanagawa M, 2010, J BIOL CHEM, V285, P31208, DOI 10.1074/jbc.M110.116343; Kolomeyer AM, 2011, INVEST OPHTH VIS SCI, V52, P5973, DOI 10.1167/iovs.10-6965; KUMA K, 1993, MOL BIOL EVOL, V10, P539; MACLEISH PR, 1988, NEURON, V1, P751, DOI 10.1016/0896-6273(88)90173-0; Manabe RI, 2008, P NATL ACAD SCI USA, V105, P12849, DOI 10.1073/pnas.0803640105; Megason SG, 2002, DEVELOPMENT, V129, P2087; Moukhles H, 2000, J COMP NEUROL, V420, P182, DOI 10.1002/(SICI)1096-9861(20000501)420:2<182::AID-CNE3>3.0.CO;2-2; Sato S, 2008, NAT NEUROSCI, V11, P923, DOI 10.1038/nn.2160; Tian M, 1996, EUR J NEUROSCI, V8, P2739, DOI 10.1111/j.1460-9568.1996.tb01568.x	17	9	9	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 4	2012	7	12							e50552	10.1371/journal.pone.0050552	http://dx.doi.org/10.1371/journal.pone.0050552			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	051EQ	23226524	Green Submitted, Green Published, gold			2022-12-27	WOS:000312108500017
J	Nabar, NR; Yuan, F; Lin, XY; Wang, L; Bai, G; Mayl, J; Li, YQ; Zhou, SF; Wang, JH; Cai, JF; Cao, CH				Nabar, Neel R.; Yuan, Fang; Lin, Xiaoyang; Wang, Li; Bai, Ge; Mayl, Jonathan; Li, Yaqiong; Zhou, Shu-Feng; Wang, Jinhuan; Cai, Jianfeng; Cao, Chuanhai			Cell Therapy: A Safe and Efficacious Therapeutic Treatment for Alzheimer's Disease in APP+PS1 Mice	PLOS ONE			English	Article							AMYLOID-PRECURSOR-PROTEIN; TRANSGENIC MICE; DENDRITIC CELLS; BETA-PEPTIDE; MOUSE MODEL; PRESENILIN-1 TRANSGENES; IMMUNE-RESPONSE; MEMORY DEFICITS; ANIMAL-MODEL; T-CELLS	Previously, our lab was the first to report the use of antigen-sensitized dendritic cells as a vaccine against Alzheimer's disease (AD). In preparation of this vaccine, we sensitized the isolated dendritic cells ex vivo with A beta peptide, and administered these sensitized dendritic cells as a therapeutic agent. This form of cell therapy has had success in preventing and/or slowing the rate of cognitive decline when administered prior to the appearance of A beta plaques in PDAPP mice, but has not been tested in 2 x Tg models. Herein, we test the efficacy and safety of this vaccine in halting and reversing Alzheimer's pathology in 9-month-old APP+PS1 mice. The results showed that administration of this vaccine elicits a long-lasting antibody titer, which correlated well with a reduction of A beta burden upon histological analysis. Cognitive function in transgenic responders to the vaccine was rescued to levels similar to those found in non-transgenic mice, indicating that the vaccine is capable of providing therapeutic benefit in APP+PS1 mice when administered after the onset of AD pathology. The vaccine also shows indications of circumventing past safety problems observed in AD immunotherapy, as Th1 pro-inflammatory cytokines were not elevated after long-term vaccine administration. Moreover, microhemorrhaging and T-cell infiltration into the brain are not observed in any of the treated subjects. All in all, this vaccine has many advantages over contemporary vaccines against Alzheimer's disease, and may lead to a viable treatment for the disease in the future.	[Nabar, Neel R.; Zhou, Shu-Feng; Cao, Chuanhai] Univ S Florida, Coll Pharm, Dept Pharmaceut Sci, Tampa, FL 33620 USA; [Nabar, Neel R.; Lin, Xiaoyang; Wang, Li; Mayl, Jonathan; Cao, Chuanhai] Univ S Florida, USF Hlth Byrd Alzheimers Inst, Tampa, FL USA; [Yuan, Fang] Chinese People Liberty Army Gen Hosp, Beijing, Peoples R China; [Yuan, Fang] Third Mil Med Univ, Chongqing, Peoples R China; [Bai, Ge; Li, Yaqiong; Cai, Jianfeng] Univ S Florida, Dept Chem, Tampa, FL 33620 USA; [Wang, Jinhuan] Tianjin Huanhu Hosp, Tianjin, Peoples R China	State University System of Florida; University of South Florida; State University System of Florida; University of South Florida; Chinese People's Liberation Army General Hospital; Army Medical University; State University System of Florida; University of South Florida	Cao, CH (corresponding author), Univ S Florida, Coll Pharm, Dept Pharmaceut Sci, Tampa, FL 33620 USA.	ccao@health.usf.edu	Zhou, Shu-Feng/E-3166-2013	Zhou, Shu-Feng/0000-0002-5542-6119; Cao, Chuanhai/0000-0002-5765-6401; Nabar, Neel/0000-0002-9704-3570	USF; Tianjin Municipal Science and Technology Commission [09JCZDJC20200]; Tianjin Public Health Bureau [06KG 09]; Byrd Alzheimer's Center start-up grant; University of South Florida College of Pharmacy's start up grant	USF; Tianjin Municipal Science and Technology Commission; Tianjin Public Health Bureau; Byrd Alzheimer's Center start-up grant; University of South Florida College of Pharmacy's start up grant	This research was supported by funds from startup fund of USF and key project of Tianjin Municipal Science and Technology Commission (09JCZDJC20200), as well as by the funds from key project of Tianjin Public Health Bureau (06KG 09). This study was supported by the Byrd Alzheimer's Center start-up grant and the University of South Florida College of Pharmacy's start up grant. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akiyama H, 2000, NEUROBIOL AGING, V21, P383, DOI 10.1016/S0197-4580(00)00124-X; Alcantar NA, 2010, ALZHEIMERS DEMENT, V6, pS247; Arendash GW, 2001, BRAIN RES, V891, P42, DOI 10.1016/S0006-8993(00)03186-3; Association As, 2012, ALZHEIMERS DEMENT, P131; Banchereau J, 1998, NATURE, V392, P245, DOI 10.1038/32588; Bard F, 2000, NAT MED, V6, P916, DOI 10.1038/78682; Bayer AJ, 2005, NEUROLOGY, V64, P94, DOI 10.1212/01.WNL.0000148604.77591.67; Boyd TD, 2010, J ALZHEIMERS DIS, V21, P507, DOI 10.3233/JAD-2010-091471; Brookmeyer R, 2007, ALZHEIMERS DEMENT, V3, P186, DOI 10.1016/j.jalz.2007.04.381; Bryan K.J., 2009, TRANSGENIC MOUSE MOD; Cao CH, 2008, J NEUROIMMUNOL, V200, P1, DOI 10.1016/j.jneuroim.2008.05.017; Cao CH, 2009, NEUROBIOL DIS, V34, P63, DOI 10.1016/j.nbd.2008.12.015; Cohen S, 2005, J IMMUNOTHER, V28, P461, DOI 10.1097/01.cji.0000171312.16171.77; Deane R, 2003, NAT MED, V9, P907, DOI 10.1038/nm890; DeMattos RB, 2001, P NATL ACAD SCI USA, V98, P8850, DOI 10.1073/pnas.151261398; Dodart JC, 1999, BEHAV NEUROSCI, V113, P982, DOI 10.1037/0735-7044.113.5.982; Ethell DW, 2006, NEUROBIOL DIS, V23, P351, DOI 10.1016/j.nbd.2006.03.008; Fulop T, 2003, ARTHRITIS RES THER, V5, P290, DOI 10.1186/ar1019; Gajewski TF, 2001, CLIN CANCER RES, V7, p895S; GAMES D, 1995, NATURE, V373, P523, DOI 10.1038/373523a0; Gandy S, 2011, NATURE, V475, pS15, DOI 10.1038/475S15a; Gordon MN, 2002, EXP NEUROL, V173, P183, DOI 10.1006/exnr.2001.7754; Gotz J, 2011, CELLULAR MOL LIFE SC, P1; Greter M, 2005, NAT MED, V11, P328, DOI 10.1038/nm1197; Holcomb L, 1998, NAT MED, V4, P97, DOI 10.1038/nm0198-097; Holcomb LA, 1999, BEHAV GENET, V29, P177, DOI 10.1023/A:1021691918517; Hsiao K, 1996, SCIENCE, V274, P99, DOI 10.1126/science.274.5284.99; Ja H, 1992, SCIENCE, V256, P184; Janus C, 2000, NATURE, V408, P979, DOI 10.1038/35050110; Katsel P, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007642; Kayed R, 2003, SCIENCE, V300, P486, DOI 10.1126/science.1079469; Kim HD, 2005, BIOCHEM BIOPH RES CO, V336, P84, DOI 10.1016/j.bbrc.2005.08.044; Kutzler MA, 2006, VACCINE, V24, P4630, DOI 10.1016/j.vaccine.2005.08.036; Leighty RE, 2004, BEHAV BRAIN RES, V153, P107, DOI 10.1016/j.bbr.2003.11.004; Loveland BE, 2006, CLIN CANCER RES, V12, P869, DOI 10.1158/1078-0432.CCR-05-1574; Luo Z, 2012, J NEUROIMMUNE PHARM; Maier M, 2006, J NEUROSCI, V26, P4717, DOI 10.1523/JNEUROSCI.0381-06.2006; Merck, 2007, STUD V950 PEOPL ALZH; Mittendorf EA, 2006, CANCER-AM CANCER SOC, V106, P2309, DOI 10.1002/cncr.21849; Monsonego A, 2001, P NATL ACAD SCI USA, V98, P10273, DOI 10.1073/pnas.191118298; Morgan D, 2000, NATURE, V408, P982, DOI 10.1038/35050116; Morgan D, 2003, NEUROCHEM RES, V28, P1029, DOI 10.1023/A:1023255106106; Morgan D, 2011, J INTERN MED, V269, P54, DOI 10.1111/j.1365-2796.2010.02315.x; Novartus, 2011, INV SAF TOL REP SUBC; Octave JN, 1995, REV NEUROSCIENCE, V6, P287; Orgogozo JM, 2003, NEUROLOGY, V61, P46, DOI 10.1212/01.WNL.0000073623.84147.A8; PARKER KC, 1994, J IMMUNOL, V152, P163; Pashenkov M, 2001, BRAIN, V124, P480, DOI 10.1093/brain/124.3.480; Pfizer JANSSEN Alzheimer Immunotherapy Research & Development L, 2007, STUD EV ACC 001 SUBJ; Pillay Nirvana S., 2004, Current Alzheimer Research, V1, P295, DOI 10.2174/1567205043331965; Postupna N, 2011, BRAIN PATHOL; Puolivali J, 2002, NEUROBIOL DIS, V9, P339, DOI 10.1006/nbdi.2002.0481; Reitz C, 2011, NAT REV NEUROL, V7, P137, DOI [10.1038/nrneurol.2011.2, 10.1101/cshperspect.a006239]; Satthaporn S, 2001, J ROY COLL SURG EDIN, V46, P159; Saxena Uday, 2011, Int J Physiol Pathophysiol Pharmacol, V3, P133; Schenk D, 1999, NATURE, V400, P173, DOI 10.1038/22124; Shankar GM, 2008, NAT MED, V14, P837, DOI 10.1038/nm1782; Sigurdsson EM, 2002, NEUROBIOL AGING, V23, P1001, DOI 10.1016/S0197-4580(02)00124-0; Smit WM, 1997, HUM IMMUNOL, V53, P216, DOI 10.1016/S0198-8859(96)00285-6; Solomon B, 1997, P NATL ACAD SCI USA, V94, P4109, DOI 10.1073/pnas.94.8.4109; Tabira T, 2010, TOHOKU J EXP MED, V220, P95, DOI 10.1620/tjem.220.95; Toellner KM, 1998, J EXP MED, V187, P1193, DOI 10.1084/jem.187.8.1193; Trinchese F, 2004, ANN NEUROL, V55, P801, DOI 10.1002/ana.20101; Tsai KJ, 2007, J EXP MED, V204, P1273, DOI 10.1084/jem.20062481; Tuppo EE, 2005, INT J BIOCHEM CELL B, V37, P289, DOI 10.1016/j.biocel.2004.07.009; Vellas B, 2009, CURR ALZHEIMER RES, V6, P144, DOI 10.2174/156720509787602852	66	14	15	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 3	2012	7	12							e49468	10.1371/journal.pone.0049468	http://dx.doi.org/10.1371/journal.pone.0049468			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	051DH	23226497	Green Submitted, gold, Green Published			2022-12-27	WOS:000312104700006
J	Wolf, B; Schwarzer, A; Cote, AL; Hampton, TH; Schwaab, T; Huarte, E; Tomlinson, CR; Gui, J; Fisher, JL; Fadul, CE; Hamilton, JW; Ernstoff, MS				Wolf, Benita; Schwarzer, Adrian; Cote, Anik L.; Hampton, Thomas H.; Schwaab, Thomas; Huarte, Eduardo; Tomlinson, Craig R.; Gui, Jiang; Fisher, Jan L.; Fadul, Camilo E.; Hamilton, Joshua W.; Ernstoff, Marc S.			Gene Expression Profile of Peripheral Blood Lymphocytes from Renal Cell Carcinoma Patients Treated with IL-2, Interferon-alpha and Dendritic Cell Vaccine	PLOS ONE			English	Article							MONONUCLEAR-CELLS; FLT3 LIGAND; T-CELL; CANCER STATISTICS; GROWTH; CHEMOKINES; SIGNATURES; PATTERNS; MUTATION; THERAPY	Lymphocytes are a key component of the immune system and their differentiation and function are directly influenced by cancer. We examined peripheral blood lymphocyte (PBL) gene expression as a biomarker of illness and treatment effect using the Affymetrix Human Gene ST1 platform in patients with metastatic renal cell carcinoma (mRCC) who received combined treatment with IL-2, interferon-?-2a and dendritic cell vaccine. We examined gene expression, cytokine levels in patient serum and lymphocyte subsets as determined by flow cytometry (FCM). Pre-treatment PBLs from patients with mRCC exhibit a gene expression profile and serum cytokine profile consistent with inflammation and proliferation not found in healthy donors (HD). PBL gene expression from patients with mRCC showed increased mRNA of genes involved with T-cell and T-REG-cell activation pathways, which was also reflected in lymphocyte subset distribution. Overall, PBL gene expression post-treatment (POST) was not significantly different than pre-treatment (PRE). Nevertheless, treatment related changes in gene expression (post-treatment minus pre-treatment) revealed an increased expression of T-cell and B-cell receptor signaling pathways in responding (R) patients compared to non-responding (NR) patients. In addition, we observed down-regulation of T-REG-cell pathways post-treatment in R vs. NR patients. While exploratory in nature, this study supports the hypothesis that enhanced inflammatory cytotoxic pathways coupled with blunting of the regulatory pathways is necessary for effective anti-cancer activity associated with immune therapy. This type of analysis can potentially identify additional immune therapeutic targets in patients with mRCC. Citation: Wolf B, Schwarzer A, Cote AL, Hampton TH, Schwaab T, et al. (2012) Gene Expression Profile of Peripheral Blood Lymphocytes from Renal Cell Carcinoma Patients Treated with IL-2, Interferon-alpha and Dendritic Cell Vaccine. PLoS ONE 7(12): e50221. doi:10.1371/journal.pone.0050221	[Wolf, Benita; Schwarzer, Adrian; Cote, Anik L.; Schwaab, Thomas; Fisher, Jan L.; Fadul, Camilo E.; Ernstoff, Marc S.] Dartmouth Hitchcock Med Ctr, Med Oncol Immunotherapy Grp, Sect Hematol Oncol, Lebanon, NH 03766 USA; [Wolf, Benita] Univ Hosp Tubingen, Dept Gastroenterol Hepatol & Infect Dis, Tubingen, Germany; [Schwarzer, Adrian] Hannover Biomed Res Sch, Hannover, Germany; [Schwaab, Thomas] Roswell Pk Canc Inst, Dept Urol, Buffalo, NY 14263 USA; [Tomlinson, Craig R.; Fisher, Jan L.; Fadul, Camilo E.; Ernstoff, Marc S.] Dartmouth Med Sch, Dept Med, Immunotherapy Program, Norris Cotton Canc Ctr, Lebanon, NH USA; [Hampton, Thomas H.] Dartmouth Med Sch, Dept Pharmacol Toxicol, Hanover, NH USA; [Gui, Jiang] Dartmouth Med Sch, Sect Biostat & Epidemiol, Dept Family & Community Med, Lebanon, NH USA; [Huarte, Eduardo] Montana State Univ, Bozeman, MT 59717 USA; [Hamilton, Joshua W.] Marine Biol Lab, Woods Hole, MA 02543 USA	Dartmouth College; Eberhard Karls University of Tubingen; Eberhard Karls University Hospital; Roswell Park Cancer Institute; Dartmouth College; Norris Cotton Cancer Center; Dartmouth College; Dartmouth College; Montana State University System; Montana State University Bozeman; Marine Biological Laboratory - Woods Hole	Ernstoff, MS (corresponding author), Dartmouth Hitchcock Med Ctr, Med Oncol Immunotherapy Grp, Sect Hematol Oncol, Lebanon, NH 03766 USA.	Marc.S.Ernstoff@Hitchcock.org	Tomlinson, Craig/F-1319-2017; Wolf, Benita/AAX-4507-2020; Schwarzer, Adrian/AAA-2571-2022	Wolf, Benita/0000-0001-5673-4239; Schwarzer, Adrian/0000-0001-5684-2280; Huarte, Eduardo/0000-0001-7498-7547; Tomlinson, Craig/0000-0003-0923-1449; Hampton, Thomas/0000-0003-0543-402X	National Institutes of Health [RO1 CA5648, R21CA112761, P20RR016437, P30CA023108]; NATIONAL CANCER INSTITUTE [R21CA112761, R01CA095648, P30CA023108] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR016437] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	This work was supported by grants from the National Institutes of Health (RO1 CA5648, R21CA112761, P20RR016437, and P30CA023108). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANGEVIN E, 1993, INT J CANCER, V54, P60, DOI 10.1002/ijc.2910540111; Ardavin Carlos, 2004, Immunity, V20, P17, DOI 10.1016/S1074-7613(03)00352-2; Atkins MB, 2007, CLIN CANCER RES, V13, p667S, DOI 10.1158/1078-0432.CCR-06-2231; Baehner FL, 2011, J SURG ONCOL, V103, P563, DOI 10.1002/jso.21838; Bhardwaj N, 2007, J CLIN INVEST, V117, P1130, DOI 10.1172/JCI32136; Bukowski RM, 1998, CLIN CANCER RES, V4, P2337; Burczynski ME, 2005, CLIN CANCER RES, V11, P1181; Buza-Vidas N, 2007, BLOOD, V110, P424, DOI 10.1182/blood-2006-09-047480; Cardi G, 1998, CANCER RES, V58, P2078; Cardi G, 1997, CANCER RES, V57, P3517; Chaussabel D, 2005, ANN NY ACAD SCI, V1062, P146, DOI 10.1196/annals.1358.017; Choueiri TK, 2010, BJU INT, V106, P772, DOI 10.1111/j.1464-410X.2010.09218.x; Clement JM, 2009, CLIN GENITOURIN CANC, V7, pE7, DOI 10.3816/CGC.2009.n.014; Coller HA, 2000, P NATL ACAD SCI USA, V97, P3260, DOI 10.1073/pnas.97.7.3260; Crocenzi TS, 2005, CLIN IMMUNOL, V117, P6, DOI 10.1016/j.clim.2005.06.010; Dedrick RL, 2007, J IMMUNOTOXICOL, V4, P201, DOI 10.1080/15476910701385562; Donskov F, 2006, J CLIN ONCOL, V24, P1997, DOI 10.1200/JCO.2005.03.9594; Edwards CJ, 2007, MOL MED, V13, P40, DOI 10.2119/2006-000056.Edwards; Ernstoff MS, 2007, CLIN CANCER RES, V13, p733S, DOI 10.1158/1078-0432.CCR-06-2064; Everitt B S, 1998, Stat Methods Med Res, V7, P253, DOI 10.1191/096228098670492314; Friedline RH, 2009, J EXP MED, V206, P421, DOI 10.1084/jem.20081811; Hampton TH, 2010, AM J PHYSIOL-LUNG C, V298, pL473, DOI 10.1152/ajplung.00379.2009; Harada S, 2007, INT J ONCOL, V30, P1461; Hirano S, 2007, J GASTROEN HEPATOL, V22, P690, DOI 10.1111/j.1440-1746.2006.04551.x; Hodi FS, 2010, NEW ENGL J MED, V363, P711, DOI 10.1056/NEJMoa1003466; Jaffe CC, 2006, J CLIN ONCOL, V24, P3245, DOI 10.1200/JCO.2006.06.5599; Jemal A, 2009, CA-CANCER J CLIN, V59, P225, DOI 10.3322/caac.20006; Kojima H, 2003, CURR PHARM DESIGN, V9, P1827, DOI 10.2174/1381612033454388; Kondo T, 2006, CANCER SCI, V97, P780, DOI 10.1111/j.1349-7006.2006.00231.x; Lacroix L, 2008, EXPERT REV MOL DIAGN, V8, P167, DOI 10.1586/14737159.8.2.167; Lyman SD, 1998, BLOOD, V91, P1101, DOI 10.1182/blood.V91.4.1101; Meyer MW, 2008, MANAGE ORGAN REV, V4, P3, DOI 10.1111/j.1740-8784.2008.00094.x; Motzer RJ, 2009, J CLIN ONCOL, V27, P3274, DOI 10.1200/JCO.2009.21.8461; Mutch MG, 2007, J SURG ONCOL, V96, P693, DOI 10.1002/jso.20915; Ochoa A C, 1995, Important Adv Oncol, P43; Panda A, 2009, TRENDS IMMUNOL, V30, P325, DOI 10.1016/j.it.2009.05.004; Parkin DM, 2005, CA-CANCER J CLIN, V55, P74, DOI 10.3322/canjclin.55.2.74; Quezada SA, 2006, J CLIN INVEST, V116, P1935, DOI 10.1172/JCI27745; Radich JP, 2004, GENOMICS, V83, P980, DOI 10.1016/j.ygeno.2003.12.013; Schwaab T, 2009, CLIN CANCER RES, V15, P4986, DOI 10.1158/1078-0432.CCR-08-3240; Schwarzer A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046600; Shi LM, 2006, NAT BIOTECHNOL, V24, P1151, DOI 10.1038/nbt1239; Sitkovsky M, 2005, NAT REV IMMUNOL, V5, P712, DOI 10.1038/nri1685; Soh D, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-449; Stanley AC, 2010, PHYSIOLOGY, V25, P218, DOI 10.1152/physiol.00017.2010; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Twine NC, 2003, CANCER RES, V63, P6069; Vecchiarelli-Federico LM, 2010, CANCER RES, V70, P863, DOI 10.1158/0008-5472.CAN-09-3592; Vuillaume ML, 2009, CANCER INFORM, V7, P41; Woodland DL, 2006, TRENDS IMMUNOL, V27, P303, DOI 10.1016/j.it.2006.05.002; Wu Y, 2011, J CANCER RES CLIN, V137, P887, DOI 10.1007/s00432-010-0951-3	51	14	15	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 3	2012	7	12							e50221	10.1371/journal.pone.0050221	http://dx.doi.org/10.1371/journal.pone.0050221			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	051DH	23226513	gold, Green Published, Green Submitted			2022-12-27	WOS:000312104700015
J	Casadebaig, P; Quesnel, G; Langlais, M; Faivre, R				Casadebaig, Pierre; Quesnel, Gauthier; Langlais, Michel; Faivre, Robert			A Generic Model to Simulate Air-Borne Diseases as a Function of Crop Architecture	PLOS ONE			English	Article							PLANT-DISEASE; THERMAL TIME; GROWTH; EPIDEMIC; TEMPERATURE; RESISTANCE; DYNAMICS; SYSTEMS; CANOPY; ENVIRONMENT	In a context of pesticide use reduction, alternatives to chemical-based crop protection strategies are needed to control diseases. Crop and plant architectures can be viewed as levers to control disease outbreaks by affecting microclimate within the canopy or pathogen transmission between plants. Modeling and simulation is a key approach to help analyze the behaviour of such systems where direct observations are difficult and tedious. Modeling permits the joining of concepts from ecophysiology and epidemiology to define structures and functions generic enough to describe a wide range of epidemiological dynamics. Additionally, this conception should minimize computing time by both limiting the complexity and setting an efficient software implementation. In this paper, our aim was to present a model that suited these constraints so it could first be used as a research and teaching tool to promote discussions about epidemic management in cropping systems. The system was modelled as a combination of individual hosts (population of plants or organs) and infectious agents (pathogens) whose contacts are restricted through a network of connections. The system dynamics were described at an individual scale. Additional attention was given to the identification of generic properties of host-pathogen systems to widen the model's applicability domain. Two specific pathosystems with contrasted crop architectures were considered: ascochyta blight on pea (homogeneously layered canopy) and potato late blight (lattice of individualized plants). The model behavior was assessed by simulation and sensitivity analysis and these results were discussed against the model ability to discriminate between the defined types of epidemics. Crop traits related to disease avoidance resulting in a low exposure, a slow dispersal or a de-synchronization of plant and pathogen cycles were shown to strongly impact the disease severity at the crop scale.	[Casadebaig, Pierre; Quesnel, Gauthier; Faivre, Robert] Ctr Rech Toulouse, Inst Natl Rech Agron, Unite Biometrie & Intelligence Artificielle UPR 8, Castanet Tolosan, France; [Langlais, Michel] Univ Bordeaux, Inst Math Bordeaux, Bordeaux, France	INRAE; UDICE-French Research Universities; Universite de Bordeaux	Casadebaig, P (corresponding author), Ctr Rech Toulouse, Inst Natl Rech Agron, Unite Biometrie & Intelligence Artificielle UPR 8, Castanet Tolosan, France.	pierre.casadebaig@toulouse.inra.fr	Casadebaig, Pierre/AAL-3307-2020; Casadebaig, Pierre/AAL-6998-2020	Casadebaig, Pierre/0000-0001-7225-936X	Agence Nationale de la Recherche (project ARCHIDEMIO) [ANR-08-STRA-04-07]	Agence Nationale de la Recherche (project ARCHIDEMIO)(French National Research Agency (ANR))	This work was granted by Agence Nationale de la Recherche (project ARCHIDEMIO, grant ANR-08-STRA-04-07). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Affholder F, 2012, AGRON J, V104, P735, DOI 10.2134/agronj2011.0376; Ando K, 2007, CAB REV; [Anonymous], 2009, OMG UNIFIED MODELING; Aubertot J, 2006, SUSTAINABLE STRATEGI; Bergez J.E., 2012, ENV MODELLING SOFTWA; BOOTE KJ, 1983, PHYTOPATHOLOGY, V73, P1581, DOI 10.1094/Phyto-73-1581; Burie JB, 2011, ANN BOT-LONDON, V107, P885, DOI 10.1093/aob/mcq233; CARNEGIE SF, 1982, PHYTOPATHOL Z, V104, P157; Chan K., 2000, SENSITIVITY ANAL; Chelle M, 2005, NEW PHYTOL, V166, P781, DOI 10.1111/j.1469-8137.2005.01350.x; Chenu K, 2009, GENETICS, V183, P1507, DOI 10.1534/genetics.109.105429; Develey-Riviere MP, 2007, NEW PHYTOL, V175, P405, DOI 10.1111/j.1469-8137.2007.02130.x; Deytieux V, 2010, ENDURE INT C 23 24 N; DOSTER MA, 1985, PHYTOPATHOLOGY, V75, P318, DOI 10.1094/Phyto-75-318; Duthie JA, 1997, PHYTOPATHOLOGY, V87, P1088, DOI 10.1094/PHYTO.1997.87.11.1088; Ferrandino FJ, 2008, PHYTOPATHOLOGY, V98, P492, DOI 10.1094/PHYTO-98-5-0492; Fleisher DH, 2006, AGRON J, V98, P522, DOI 10.2134/agronj2005.0136; Granier C, 1998, PLANT CELL ENVIRON, V21, P695, DOI 10.1046/j.1365-3040.1998.00319.x; Hammer G, 2006, TRENDS PLANT SCI, V11, P587, DOI 10.1016/j.tplants.2006.10.006; HAREL D, 1987, SCI COMPUT PROGRAM, V8, P231, DOI 10.1016/0167-6423(87)90035-9; HAU B, 1990, ANNU REV PHYTOPATHOL, V28, P221, DOI 10.1146/annurev.py.28.090190.001253; JEFFERIES RA, 1989, J EXP BOT, V40, P1375, DOI 10.1093/jxb/40.12.1375; JEGER MJ, 1982, PHYTOPATHOLOGY, V72, P1185, DOI 10.1094/Phyto-72-1185; JEGER MJ, 1986, PLANT DISEASE EPIDEM, V1, P255; Johnson DA, 2003, PHYTOPATHOLOGY, V93, P805, DOI 10.1094/PHYTO.2003.93.7.805; Keeling MJ, 2005, J R SOC INTERFACE, V2, P295, DOI 10.1098/rsif.2005.0051; Kleczkowski A, 1997, P ROY SOC B-BIOL SCI, V264, P979, DOI 10.1098/rspb.1997.0135; Le May C, 2005, EUR J PLANT PATHOL, V112, P1, DOI 10.1007/s10658-004-5272-4; Le May C, 2008, PLANT PATHOLOGY; Lizaso JI, 2003, FIELD CROP RES, V80, P1, DOI 10.1016/S0378-4290(02)00151-X; Madden LV, 2006, EUR J PLANT PATHOL, V115, P3, DOI 10.1007/s10658-005-1229-5; Oerke EC, 2006, J AGR SCI, V144, P31, DOI 10.1017/S0021859605005708; Pangga IB, 2011, PLANT PATHOL, V60, P70, DOI 10.1111/j.1365-3059.2010.02408.x; Quesnel G, 2009, SIMUL MODEL PRACT TH, V17, P641, DOI 10.1016/j.simpat.2008.11.003; Quilot B, 2005, J EXP BOT, V56, P3083, DOI 10.1093/jxb/eri305; R Development Core Team, 2010, R LANG ENV STAT COMP; Richard B, 2011, EUROPEAN J IN PRESS; Robert C, 2008, FUNCT PLANT BIOL, V35, P997, DOI 10.1071/FP08066; Roche R, 1998, ANN BOT-LONDON, V81, P545, DOI 10.1006/anbo.1998.0592; Saltelli A, 1999, TECHNOMETRICS, V41, P39, DOI 10.2307/1270993; Scherm H, 2006, EUR J PLANT PATHOL, V115, P61, DOI 10.1007/s10658-005-3682-6; Scherm H, 1996, ECOL MODEL, V87, P217, DOI 10.1016/0304-3800(95)00030-5; Schneider O, 2006, SOIL TILL RES, V85, P115, DOI 10.1016/j.still.2004.12.007; Tardieu F, 2010, J EXP BOT, V61, P2039, DOI 10.1093/jxb/erq135; Trudgill DL, 2005, ANN APPL BIOL, V146, P1, DOI 10.1111/j.1744-7348.2005.04088.x; Turc O, 1997, ANN BOT-LONDON, V80, P265, DOI 10.1006/anbo.1996.0431; Urban D, 2001, ECOLOGY, V82, P1205, DOI 10.1890/0012-9658(2001)082[1205:LCAGTP]2.0.CO;2; van der Plank J. E., 1982, HOST PATHOGEN INTERA; Vos J, 2010, J EXP BOT, V61, P2101, DOI 10.1093/jxb/erp345; Wickham H, 2009, WILEY INTERDISCIPLIN; Willocquet L, 2004, PHYTOPATHOLOGY, V94, P883, DOI 10.1094/PHYTO.2004.94.8.883; Wilson PA, 1998, CROP PROT, V17, P231, DOI 10.1016/S0261-2194(97)00088-4; Zeigler B., 2000, THEORY MODELING SIMU, V100	55	9	9	1	49	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 30	2012	7	11							e49406	10.1371/journal.pone.0049406	http://dx.doi.org/10.1371/journal.pone.0049406			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	054WM	23226209	Green Published, gold, Green Submitted			2022-12-27	WOS:000312376100018
J	Catoire, M; Mensink, M; Boekschoten, MV; Hangelbroek, R; Muller, M; Schrauwen, P; Kersten, S				Catoire, Milene; Mensink, Marco; Boekschoten, Mark V.; Hangelbroek, Roland; Muller, Michael; Schrauwen, Patrick; Kersten, Sander			Pronounced Effects of Acute Endurance Exercise on Gene Expression in Resting and Exercising Human Skeletal Muscle	PLOS ONE			English	Article							RESISTANCE EXERCISE; PROTEIN-SYNTHESIS; NUCLEAR RECEPTOR; METABOLISM; NUR77; CYTOSCAPE; RECOVERY; TARGET	Regular physical activity positively influences whole body energy metabolism and substrate handling in exercising muscle. While it is recognized that the effects of exercise extend beyond exercising muscle, it is unclear to what extent exercise impacts non-exercising muscles. Here we investigated the effects of an acute endurance exercise bouts on gene expression in exercising and non-exercising human muscle. To that end, 12 male subjects aged 44-56 performed one hour of one-legged cycling at 50% W-max. Muscle biopsies were taken from the exercising and non-exercising leg before and immediately after exercise and analyzed by microarray. One-legged cycling raised plasma lactate, free fatty acids, cortisol, noradrenalin, and adrenalin levels. Surprisingly, acute endurance exercise not only caused pronounced gene expression changes in exercising muscle but also in non-exercising muscle. In the exercising leg the three most highly induced genes were all part of the NR4A family. Remarkably, many genes induced in non-exercising muscle were PPAR targets or related to PPAR signalling, including PDK4, ANGPTL4 and SLC22A5. Pathway analysis confirmed this finding. In conclusion, our data indicate that acute endurance exercise elicits pronounced changes in gene expression in non-exercising muscle, which are likely mediated by changes in circulating factors such as free fatty acids. The study points to a major influence of exercise beyond the contracting muscle.	[Catoire, Milene; Mensink, Marco; Boekschoten, Mark V.; Hangelbroek, Roland; Muller, Michael; Kersten, Sander] Wageningen Univ, Div Human Nutr, Wageningen, Netherlands; [Boekschoten, Mark V.; Muller, Michael; Kersten, Sander] Netherlands Nutrigen Ctr, Top Inst Food & Nutr, Wageningen, Netherlands; [Schrauwen, Patrick] Maastricht Univ, Med Ctr, Dept Human Biol, Maastricht, Netherlands	Wageningen University & Research; Top Institute Food & Nutrition; Maastricht University	Kersten, S (corresponding author), Wageningen Univ, Div Human Nutr, Wageningen, Netherlands.	Sander.Kersten@wur.nl	Boekschoten, Mark V/A-2458-2011; Muller, Michael/B-5795-2008; Boekschoten, Mark/AAS-4597-2021; Catoire, MIlène/D-9612-2016; Muller, Michael/M-5724-2019; Kersten, Sander/A-1116-2011	Boekschoten, Mark V/0000-0002-2139-0795; Muller, Michael/0000-0002-5930-9905; Boekschoten, Mark/0000-0002-2139-0795; Muller, Michael/0000-0002-5930-9905; Kersten, Sander/0000-0003-4488-7734; schrauwen, patrick/0000-0002-0973-847X; Hangelbroek, Roland/0000-0002-0442-5378; Mensink, Marco/0000-0002-9725-5709	Dutch Diabetes Foundation [2009.60.003]; Netherlands Nutrigenomics Centre	Dutch Diabetes Foundation; Netherlands Nutrigenomics Centre	The study was funded by the Dutch Diabetes Foundation (grant # 2009.60.003; http://www.diabetesfonds.nl/) and the Netherlands Nutrigenomics Centre (http://www.netherlandsnutrigenomicscentre.nl). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bartlett JD, 2012, J APPL PHYSL; Bindea G, 2009, BIOINFORMATICS, V25, P1091, DOI 10.1093/bioinformatics/btp101; Bolstad BM, 2003, BIOINFORMATICS, V19, P185, DOI 10.1093/bioinformatics/19.2.185; Brass EP, 2009, J APPL PHYSIOL, V107, P605, DOI 10.1152/japplphysiol.91347.2008; Buford TW, 2009, EUR J APPL PHYSIOL, V107, P463, DOI 10.1007/s00421-009-1145-z; BUONO MJ, 1981, MED SCI SPORT EXER, V13, P290; Carroll TJ, 2006, J APPL PHYSIOL, V101, P1514, DOI 10.1152/japplphysiol.00531.2006; Chao LC, 2007, MOL ENDOCRINOL, V21, P2152, DOI 10.1210/me.2007-0169; CHESLEY A, 1992, J APPL PHYSIOL, V73, P1383, DOI 10.1152/jappl.1992.73.4.1383; Chin ER, 2010, EXERC SPORT SCI REV, V38, P76, DOI 10.1097/JES.0b013e3181d495d2; Cohen TJ, 2009, FASEB J, V23, P99, DOI 10.1096/fj.08-115931; Dai MH, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni179; Farid Reza, 2005, Iran J Allergy Asthma Immunol, V4, P133; Farthing JP, 2009, J APPL PHYSIOL, V106, P830, DOI 10.1152/japplphysiol.91331.2008; Friedmann-Bette B, 2012, J APPL PHYSIOL, V112, P289, DOI 10.1152/japplphysiol.00959.2011; Hoier B, 2011, J PHYSL; Jensen JH, 2012, EXPT PHYSL; Kanzleiter T, 2009, BBA-MOL BASIS DIS, V1792, P777, DOI 10.1016/j.bbadis.2009.05.002; Kawasaki E, 2011, J PHYSIOL SCI, V61, P1, DOI 10.1007/s12576-010-0114-y; Kawasaki E, 2009, J APPL PHYSIOL, V106, P1826, DOI 10.1152/japplphysiol.90923.2008; Keller C, 2005, J APPL PHYSIOL, V99, P2075, DOI 10.1152/japplphysiol.00590.2005; Keller P, 2003, BIOCHEM BIOPH RES CO, V310, P550, DOI 10.1016/j.bbrc.2003.09.048; Kim PL, 2005, J PHYSIOL-LONDON, V568, P283, DOI 10.1113/jphysiol.2005.093708; Krey G, 1997, MOL ENDOCRINOL, V11, P779, DOI 10.1210/me.11.6.779; Lin K, 2011, J INTEGR BIOINFORMAT, V8, DOI 10.2390/biecoll-jib-2011-160; Long YC, 2007, J BIOL CHEM, V282, P1607, DOI 10.1074/jbc.M609208200; Lundby C, 2005, EUR J APPL PHYSIOL, V95, P351, DOI 10.1007/s00421-005-0022-7; Magnus CRA, 2010, J APPL PHYSIOL, V109, P1887, DOI 10.1152/japplphysiol.00597.2010; Mahoney DJ, 2005, FASEB J, V19, P1498, DOI 10.1096/fj.04-3149fje; Mahoney DJ, 2004, PHYSIOL GENOMICS, V18, P226, DOI 10.1152/physiolgenomics.00067.2004; Mandard S, 2004, CELL MOL LIFE SCI, V61, P393, DOI 10.1007/s00018-003-3216-3; Maxwell MA, 2005, J BIOL CHEM, V280, P12573, DOI 10.1074/jbc.M409580200; Melendez MM, 2007, J SURG RES, V142, P301, DOI 10.1016/j.jss.2007.03.043; Myers SA, 2009, MOL CELL ENDOCRINOL, V309, P101, DOI 10.1016/j.mce.2009.05.006; Niklas P, 2010, EUR J APPL PHYSIOL, V110, P597, DOI 10.1007/s00421-010-1544-1; Pearen MA, 2008, ENDOCRINOLOGY, V149, P2853, DOI 10.1210/en.2007-1202; Pilegaard H, 2000, AM J PHYSIOL-ENDOC M, V279, pE806; Rakhshandehroo M, 2010, PPAR RES, V2010, DOI 10.1155/2010/612089; Rakhshandehroo M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006796; Richardson RS, 1999, AM J PHYSIOL-HEART C, V277, pH2247, DOI 10.1152/ajpheart.1999.277.6.H2247; Sanderson LM, 2009, MOL CELL BIOL, V29, P6257, DOI 10.1128/MCB.00370-09; Sartor MA, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-538; Schmutz S, 2006, PFLUG ARCH EUR J PHY, V451, P678, DOI 10.1007/s00424-005-1497-0; Shannon P, 2003, GENOME RES, V13, P2498, DOI 10.1101/gr.1239303; Slentz CA, 2011, AM J PHYSIOL-ENDOC M, V301, pE1033, DOI 10.1152/ajpendo.00291.2011; Sullivan S, 2012, HEPATOLOGY, V55, P1738, DOI 10.1002/hep.25548; Thompson D, 2012, PHYSIOL REV, V92, P157, DOI 10.1152/physrev.00012.2011; Valkeinen H, 2010, SCAND J MED SCI SPOR, V20, P545, DOI 10.1111/j.1600-0838.2010.01133.x; Yang YF, 2005, J APPL PHYSIOL, V98, P1745, DOI 10.1152/japplphysiol.01185.2004; Zanchi NE, 2010, CELL BIOCHEM FUNCT, V28, P232, DOI 10.1002/cbf.1665	50	81	87	0	37	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 30	2012	7	11							e51066	10.1371/journal.pone.0051066	http://dx.doi.org/10.1371/journal.pone.0051066			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	054WM	23226462	Green Published, gold, Green Submitted			2022-12-27	WOS:000312376100273
J	Chou, SH; Ko, BS; Chiou, JS; Hsu, YC; Tsai, MH; Chiu, YC; Yu, IS; Lin, SW; Hou, HA; Kuo, YY; Lin, HM; Wu, MF; Chou, WC; Tien, HF				Chou, Shiu-Huey; Ko, Bor-Sheng; Chiou, Ji-Shain; Hsu, Yueh-Chwen; Tsai, Mong-Hsun; Chiu, Yu-Chiao; Yu, I-Shing; Lin, Shu-Wha; Hou, Hsin-An; Kuo, Yi-Yi; Lin, Hsiu-Mei; Wu, Ming-Fang; Chou, Wen-Chien; Tien, Hwei-Fang			A Knock-In Npm1 Mutation in Mice Results in Myeloproliferation and Implies a Perturbation in Hematopoietic Microenvironment	PLOS ONE			English	Article							ACUTE MYELOID-LEUKEMIA; ACUTE MYELOGENOUS LEUKEMIA; SET ENRICHMENT ANALYSIS; NUCLEAR EXPORT SIGNALS; BONE-MARROW-CELLS; GENE-EXPRESSION; NORMAL KARYOTYPE; MUTANT NUCLEOPHOSMIN; FAVORABLE PROGNOSIS; PROTEIN B23	Somatic Nucleophosmin (NPM1) mutation frequently occurs in acute myeloid leukemia (AML), but its role in leukemogenesis remains unclear. This study reports the first "conventional'' knock-in mouse model of Npm1 mutation, which was achieved by inserting TCTG after nucleotide c.857 (c.854_857dupTCTG) to mimic human mutation without any "humanized'' sequence. The resultant mutant peptide differed slightly different from that in humans but exhibited cytoplasmic pulling force. Homozygous (Npm1(c+/c+)) mice showed embryonic lethality before day E8.5, wheras heterozygous (Npm1(wt/c+)) mice appeared healthy at birth and were fertile. Approximately 36% of Npm1(wt/c+) mice developed myeloproliferative disease (MPD) with extramedullary hematopoiesis. Those Npm1(wt/c+) mice that did not develop MPD nevertheless gradually developed monocytosis and showed increased numbers of marrow myeloid precursors. This second group of Npm1(wt/c+) mice also showed compromised cobblestone area formation, suggesting pathology in the hematopoietic niche. Microarray experiments and bioinformatic analysis on mice myeloid precursor cells and 227 human samples revealed the expression of CXCR4/CXCL12-related genes was significantly suppressed in mutant cells from both mice and humans. Thus, our mouse model demonstrated that Npm1 mutation can result in MPD, but is insufficient for leukemogenesis. Perturbation of hematopoietic niche in mutant hematopoietic stem cells (implied by underrepresentation of CXCR4/CXCL12-related genes) may be important in the pathogenesis of NPM1 mutations. Citation: Chou S-H, Ko B-S, Chiou J-S, Hsu Y-C, Tsai M-H, et al. (2012) A Knock-In Npm1 Mutation in Mice Results in Myeloproliferation and Implies a Perturbation in Hematopoietic Microenvironment. PLoS ONE 7(11): e49769. doi:10.1371/journal.pone.0049769	[Ko, Bor-Sheng; Hou, Hsin-An; Chou, Wen-Chien; Tien, Hwei-Fang] Natl Taiwan Univ Hosp, Dept Internal Med, Div Hematol, Taipei 100, Taiwan; [Chou, Shiu-Huey; Chiou, Ji-Shain] Fu Jen Catholic Univ, Dept Life Sci, Taipei, Taiwan; [Ko, Bor-Sheng] Natl Hlth Res Inst, Inst Cellular & Syst Med, Miaoli, Miaoli County, Taiwan; [Hsu, Yueh-Chwen] Natl Taiwan Univ, Coll Med, Grad Inst Clin Med, Taipei 10764, Taiwan; [Tsai, Mong-Hsun] Natl Taiwan Univ, Inst Biotechnol, Taipei 10764, Taiwan; [Chiu, Yu-Chiao] Natl Taiwan Univ, Grad Inst Biomed Elect & Bioinformat, Taipei 10764, Taiwan; [Yu, I-Shing; Lin, Shu-Wha] Natl Taiwan Univ, Coll Med, Transgen Mouse Models Core, Taipei 10764, Taiwan; [Kuo, Yi-Yi; Lin, Hsiu-Mei; Chou, Wen-Chien] Natl Taiwan Univ Hosp, Dept Lab Med, Taipei, Taiwan; [Wu, Ming-Fang] Natl Taiwan Univ, Coll Med, Anim Med Ctr, Taipei 10764, Taiwan	National Taiwan University; National Taiwan University Hospital; Fu Jen Catholic University; National Health Research Institutes - Taiwan; National Taiwan University; National Taiwan University; National Taiwan University; National Taiwan University; National Taiwan University; National Taiwan University Hospital; National Taiwan University	Chou, WC (corresponding author), Natl Taiwan Univ Hosp, Dept Internal Med, Div Hematol, Taipei 100, Taiwan.	wchou@ntu.edu.tw; hftien@ntu.edu.tw		Chiu, Yu-Chiao/0000-0003-1647-8634; KO, BOR-SHENG/0000-0002-7965-7579; CHOU, WEN-CHIEN/0000-0003-2967-698X; LIN, SHU-WHA/0000-0001-6748-5581; TIEN, HWEI-FANG/0000-0002-1384-5593; TSAI, MONG-HSUN/0000-0001-8777-5818; HOU, HSIN-AN/0000-0003-2780-4845	National Science Council (Taiwan) [NSC 98-2314-B-002-033-MY3, NSC 98-2314-B-030-003-MY3, NSC 100-2325-B-002-032, NSC 100-2325-B-002-033, NSC 101-2325-B-002-029]; National Health Research Institute [NHRI-EX97-9731BI]; Department of Health [DOH101-TD-C-111-001]	National Science Council (Taiwan)(Ministry of Science and Technology, Taiwan); National Health Research Institute(National Health Research Institutes - Taiwan); Department of Health	This work was supported by grants NSC 98-2314-B-002-033-MY3, NSC 98-2314-B-030-003-MY3, NSC 100-2325-B-002-032, NSC 100-2325-B-002-033, and NSC 101-2325-B-002-029 from National Science Council (Taiwan), NHRI-EX97-9731BI from National Health Research Institute, and DOH101-TD-C-111-001 from Department of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alles MC, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004710; Boissel N, 2005, BLOOD, V106, P3618, DOI 10.1182/blood-2005-05-2174; Bolli N, 2007, CANCER RES, V67, P6230, DOI 10.1158/0008-5472.CAN-07-0273; Bolli N, 2010, BLOOD, V115, P3329, DOI 10.1182/blood-2009-02-207225; Bourquin JP, 2006, P NATL ACAD SCI USA, V103, P3339, DOI 10.1073/pnas.0511150103; Cheng K, 2010, BLOOD, V115, P3341, DOI 10.1182/blood-2009-03-208587; Chou SH, 2001, TRANSPLANTATION, V72, P1768, DOI 10.1097/00007890-200112150-00010; Chou WC, 2006, CANCER RES, V66, P3310, DOI 10.1158/0008-5472.CAN-05-4316; Colombo E, 2002, NAT CELL BIOL, V4, P529, DOI 10.1038/ncb814; de Leval L, 2007, BLOOD, V109, P4952, DOI 10.1182/blood-2006-10-055145; Dohner K, 2005, BLOOD, V106, P3740, DOI 10.1182/blood-2005-05-2164; Falini B, 2005, NEW ENGL J MED, V352, P254, DOI 10.1056/NEJMoa041974; Falini B, 2007, BLOOD, V109, P874, DOI 10.1182/blood-2006-07-012252; Falini B, 2006, BLOOD, V107, P4514, DOI 10.1182/blood-2005-11-4745; Grisendi S, 2005, NATURE, V437, P147, DOI 10.1038/nature03915; Hingorani K, 2000, J BIOL CHEM, V275, P24451, DOI 10.1074/jbc.M003278200; Hoshida Y, 2008, NEW ENGL J MED, V359, P1995, DOI 10.1056/NEJMoa0804525; JOHNSON GR, 1989, EMBO J, V8, P441, DOI 10.1002/j.1460-2075.1989.tb03396.x; Kurki S, 2004, CANCER CELL, V5, P465, DOI 10.1016/S1535-6108(04)00110-2; la Cour T, 2004, PROTEIN ENG DES SEL, V17, P527, DOI 10.1093/protein/gzh062; Lataillade JJ, 2008, BLOOD, V112, P3026, DOI 10.1182/blood-2008-06-158386; Mootha VK, 2003, NAT GENET, V34, P267, DOI 10.1038/ng1180; NAKAHATA T, 1982, P NATL ACAD SCI-BIOL, V79, P3843, DOI 10.1073/pnas.79.12.3843; Nishimura Y, 2002, BIOSCI BIOTECH BIOCH, V66, P2239, DOI 10.1271/bbb.66.2239; Okuda M, 2000, CELL, V103, P127, DOI 10.1016/S0092-8674(00)00093-3; Oron AP, 2008, BIOINFORMATICS, V24, P2586, DOI 10.1093/bioinformatics/btn465; Savkur RS, 1998, NUCLEIC ACIDS RES, V26, P4508, DOI 10.1093/nar/26.19.4508; Schnittger S, 2005, BLOOD, V106, P3733, DOI 10.1182/blood-2005-06-2248; Spoo AC, 2007, BLOOD, V109, P786, DOI 10.1182/blood-2006-05-024844; Sportoletti P, 2008, BLOOD, V111, P3859, DOI 10.1182/blood-2007-06-098251; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Sugiyama T, 2006, IMMUNITY, V25, P977, DOI 10.1016/j.immuni.2006.10.016; Suzuki T, 2005, BLOOD, V106, P2854, DOI 10.1182/blood-2005-04-1733; Tefferi A, 2005, J CLIN ONCOL, V23, P8520, DOI 10.1200/JCO.2004.00.9316; Uy GL, 2012, BLOOD, V119, P3917, DOI 10.1182/blood-2011-10-383406; Vassiliou GS, 2011, NAT GENET, V43, P470, DOI 10.1038/ng.796; Verhaak RGW, 2005, BLOOD, V106, P3747, DOI 10.1182/blood-2005-05-2168	37	16	17	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 30	2012	7	11							e49769	10.1371/journal.pone.0049769	http://dx.doi.org/10.1371/journal.pone.0049769			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	054WM	23226219	Green Published, gold, Green Submitted			2022-12-27	WOS:000312376100027
J	Dezfulian, MH; Soulliere, DM; Dhaliwal, RK; Sareen, M; Crosby, WL				Dezfulian, Mohammad H.; Soulliere, Danielle M.; Dhaliwal, Rajdeep K.; Sareen, Madhulika; Crosby, William L.			The SKP1-Like Gene Family of Arabidopsis Exhibits a High Degree of Differential Gene Expression and Gene Product Interaction during Development	PLOS ONE			English	Article							F-BOX PROTEIN; SCF UBIQUITIN-LIGASE; MERISTEM IDENTITY; FLORAL-MERISTEM; CELL-DIVISION; COMPLEX; SYSTEM; ASK1; INSIGHTS; TARGETS	The Arabidopsis thaliana genome encodes several families of polypeptides that are known or predicted to participate in the formation of the SCF-class of E3-ubiquitin ligase complexes. One such gene family encodes the Skp1-like class of polypeptide subunits, where 21 genes have been identified and are known to be expressed in Arabidopsis. Phylogenetic analysis based on deduced polypeptide sequence organizes the family of ASK proteins into 7 clades. The complexity of the ASK gene family, together with the close structural similarity among its members raises the prospect of significant functional redundancy among select paralogs. We have assessed the potential for functional redundancy within the ASK gene family by analyzing an expanded set of criteria that define redundancy with higher resolution. The criteria used include quantitative expression of locus-specific transcripts using qRT-PCR, assessment of the sub-cellular localization of individual ASK:YFP auto-fluorescent fusion proteins expressed in vivo as well as the in planta assessment of individual ASK-F-Box protein interactions using bimolecular fluorescent complementation techniques in combination with confocal imagery in live cells. The results indicate significant functional divergence of steady state transcript abundance and protein-protein interaction specificity involving ASK proteins in a pattern that is poorly predicted by sequence-based phylogeny. The information emerging from this and related studies will prove important for defining the functional intersection of expression, localization and gene product interaction that better predicts the formation of discrete SCF complexes, as a prelude to investigating their molecular mode of action.	[Dezfulian, Mohammad H.; Soulliere, Danielle M.; Dhaliwal, Rajdeep K.; Sareen, Madhulika; Crosby, William L.] Univ Windsor, Dept Biol Sci, Windsor, ON N9B 3P4, Canada	University of Windsor	Crosby, WL (corresponding author), Univ Windsor, Dept Biol Sci, Windsor, ON N9B 3P4, Canada.	bcrosby@uwindsor.ca	Haj Dezfulian, Mohammad/ABF-2352-2021	Haj Dezfulian, Mohammad/0000-0001-9979-5365	Natural Sciences and Engineering Research Council of Canada (RGPIN) [171305-7]; University of Windsor	Natural Sciences and Engineering Research Council of Canada (RGPIN)(Natural Sciences and Engineering Research Council of Canada (NSERC)); University of Windsor	Financial support from the Natural Sciences and Engineering Research Council of Canada (RGPIN No. 171305-7) and the University of Windsor are gratefully acknowledged. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alonso JM, 2003, SCIENCE, V301, P653, DOI 10.1126/science.1086391; Asara JM, 2006, NAT PROTOC, V1, P46, DOI 10.1038/nprot.2006.7; Bai C, 1996, CELL, V86, P263, DOI 10.1016/S0092-8674(00)80098-7; Barbash O, 2008, CELL CYCLE, V7, P2983, DOI 10.4161/cc.7.19.6775; Barbash O, 2008, CANCER CELL, V14, P68, DOI 10.1016/j.ccr.2008.05.017; Bennett MD, 2011, ANN BOT-LONDON, V107, P467, DOI 10.1093/aob/mcq258; Cardozo T, 2004, NAT REV MOL CELL BIO, V5, P739, DOI 10.1038/nrm1471; Chae E, 2008, DEVELOPMENT, V135, P1235, DOI 10.1242/dev.015842; Chini A, 2007, NATURE, V448, P666, DOI 10.1038/nature06006; Connelly C, 1996, CELL, V86, P275, DOI 10.1016/S0092-8674(00)80099-9; del Pozo JC, 2006, PLANT CELL, V18, P2224, DOI 10.1105/tpc.105.039651; Desprez T, 2007, P NATL ACAD SCI USA, V104, P15572, DOI 10.1073/pnas.0706569104; Devoto A, 2002, PLANT J, V32, P457, DOI 10.1046/j.1365-313X.2002.01432.x; Dharmasiri N, 2005, DEV CELL, V9, P109, DOI 10.1016/j.devcel.2005.05.014; Dharmasiri N, 2005, NATURE, V435, P441, DOI 10.1038/nature03543; Diaz-Camino C, 2003, ANAL BIOCHEM, V316, P171, DOI 10.1016/S0003-2697(02)00706-6; Dieterle M, 2001, GENE DEV, V15, P939, DOI 10.1101/gad.197201; Earley KW, 2006, PLANT J, V45, P616, DOI 10.1111/j.1365-313X.2005.02617.x; Gagne JM, 2002, P NATL ACAD SCI USA, V99, P11519, DOI 10.1073/pnas.162339999; Gusti A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004780; Harmon FG, 2003, CURR BIOL, V13, P2091, DOI 10.1016/j.cub.2003.11.019; Harrison SJ, 2006, PLANT METHODS, V2, DOI 10.1186/1746-4811-2-19; Hepworth SR, 2006, PLANTA, V223, P769, DOI 10.1007/s00425-005-0138-3; Imaizumi T, 2003, NATURE, V426, P302, DOI 10.1038/nature02090; Jin JP, 2004, GENE DEV, V18, P2573, DOI 10.1101/gad.1255304; Jurado S, 2008, PLANT J, V53, P828, DOI 10.1111/j.1365-313X.2007.03378.x; Kafri R, 2009, CELL, V136, P389, DOI 10.1016/j.cell.2009.01.027; Kapushesky M, 2004, NUCLEIC ACIDS RES, V32, pW465, DOI 10.1093/nar/gkh470; Kim WY, 2007, NATURE, V449, P356, DOI 10.1038/nature06132; Kong H, 2007, PLANT J, V50, P873, DOI 10.1111/j.1365-313X.2007.03097.x; Kong HZ, 2004, MOL BIOL EVOL, V21, P117, DOI 10.1093/molbev/msh001; Lechner E, 2006, CURR OPIN PLANT BIOL, V9, P631, DOI 10.1016/j.pbi.2006.09.003; LEVIN JZ, 1995, PLANT CELL, V7, P529, DOI 10.1105/tpc.7.5.529; Li X, 2001, PLANT J, V27, P235, DOI 10.1046/j.1365-313x.2001.01084.x; Li Xin, 2002, Funct Integr Genomics, V2, P254, DOI 10.1007/s10142-002-0076-0; Li YF, 2010, J BIOL CHEM, V285, P13896, DOI 10.1074/jbc.M110.111518; Liu FQ, 2004, PLANT CELL, V16, P5, DOI 10.1105/tpc.017772; Marrocco K, 2003, PLANT MOL BIOL, V52, P715, DOI 10.1023/A:1025056008926; Moon J, 2006, PLANT PHYSL; MURASHIGE T, 1962, PHYSIOL PLANTARUM, V15, P473, DOI 10.1111/j.1399-3054.1962.tb08052.x; Murphy TD, 2003, J CELL SCI, V116, P2321, DOI 10.1242/jcs.00463; Nayak S, 2002, CURR BIOL, V12, P277, DOI 10.1016/S0960-9822(02)00682-6; Pfaffl MW, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.9.e36; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Popescu SC, 2007, P NATL ACAD SCI USA, V104, P4730, DOI 10.1073/pnas.0611615104; Rensing SA, 2008, SCIENCE, V319, P64, DOI 10.1126/science.1150646; Risseeuw EP, 2003, PLANT J, V34, P753, DOI 10.1046/j.1365-313X.2003.01768.x; Schulman BA, 2000, NATURE, V408, P381, DOI 10.1038/35042620; Schwab R, 2006, PLANT CELL, V18, P1121, DOI 10.1105/tpc.105.039834; Sheard LB, 2010, NATURE, V468, P400, DOI 10.1038/nature09430; Simon P, 2003, BIOINFORMATICS, V19, P1439, DOI 10.1093/bioinformatics/btg157; SMYTH DR, 1990, PLANT CELL, V2, P755, DOI 10.1105/tpc.2.8.755; Takahashi N, 2004, PLANT CELL PHYSIOL, V45, P83, DOI 10.1093/pcp/pch009; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Tan X, 2007, NATURE, V446, P640, DOI 10.1038/nature05731; Tang X, 2007, CELL, V129, P1165, DOI 10.1016/j.cell.2007.04.042; Thines B, 2007, NATURE, V448, P661, DOI 10.1038/nature05960; Toufighi K, 2005, PLANT J, V43, P153, DOI 10.1111/j.1365-313X.2005.02437.x; Vierstra RD, 2003, TRENDS PLANT SCI, V8, P135, DOI 10.1016/S1360-1385(03)00014-1; Vierstra RD, 2009, NAT REV MOL CELL BIO, V10, P385, DOI 10.1038/nrm2688; Voinnet O, 2003, PLANT J, V33, P949, DOI 10.1046/j.1365-313X.2003.01676.x; Wagner A, 2001, ELS; Wang YX, 2006, PLANTA, V223, P613, DOI 10.1007/s00425-005-0154-3; Weltmeier F, 2006, EMBO J, V25, P3133, DOI 10.1038/sj.emboj.7601206; WILKINSON MD, 1995, PLANT CELL, V7, P1485, DOI 10.1105/tpc.7.9.1485; Winter D, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000718; Wu G, 2003, MOL CELL, V11, P1445, DOI 10.1016/S1097-2765(03)00234-X; Zhao DZ, 2006, PLANT MOL BIOL, V62, P99, DOI 10.1007/s11103-006-9006-1; Zhao DH, 2003, PLANT MOL BIOL, V53, P163, DOI 10.1023/B:PLAN.0000009273.81702.b5; Zhao DZ, 2003, PLANT PHYSIOL, V133, P203, DOI 10.1104/pp.103.024703; Zheng N, 2002, NATURE, V416, P703, DOI 10.1038/416703a; Zimmermann P, 2004, PLANT PHYSIOL, V136, P2621, DOI 10.1104/pp.104.046367	72	25	29	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 30	2012	7	11							e50984	10.1371/journal.pone.0050984	http://dx.doi.org/10.1371/journal.pone.0050984			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	054WM	23226441	Green Published, gold, Green Submitted			2022-12-27	WOS:000312376100252
J	Hofreuter, D; Mohr, J; Wensel, O; Rademacher, S; Schreiber, K; Schomburg, D; Gao, BL; Galan, JE				Hofreuter, Dirk; Mohr, Juliane; Wensel, Olga; Rademacher, Sebastian; Schreiber, Kerstin; Schomburg, Dietmar; Gao, Beile; Galan, Jorge E.			Contribution of Amino Acid Catabolism to the Tissue Specific Persistence of Campylobacter jejuni in a Murine Colonization Model	PLOS ONE			English	Article							CYTOLETHAL DISTENDING TOXIN; L-SERINE DEHYDRATASE; GENOME SEQUENCE; INTESTINAL COLONIZATION; STAPHYLOCOCCUS-AUREUS; EPITHELIAL-CELLS; ESSENTIAL GENES; IN-VIVO; GROWTH; IDENTIFICATION	Campylobacter jejuni is a major cause of food-borne disease in industrialized countries. Carbohydrate utilization by C. jejuni is severely restricted, and knowledge about which substrates fuel C. jejuni infection and growth is limited. Some amino acids have been shown to serve as carbon sources both in vitro and in vivo. In the present study we investigated the contribution of serine and proline catabolism to the in vitro and in vivo growth of C. jejuni 81-176. We confirmed that the serine transporter SdaC and the serine ammonia-lyase SdaA are required for serine utilization, and demonstrated that a predicted proline permease PutP and a bifunctional proline/delta-1-pyrroline-5-carboxylate dehydrogenase PutA are required for proline utilization by C. jejuni 81-176. C. jejuni 81-176 mutants unable to utilize serine were shown to be severely defective for colonization of the intestine and systemic tissues in a mouse model of infection. In contrast, C. jejuni 81-176 mutants unable to utilize proline were only defective for intestinal colonization. These results further emphasize the importance of amino acid utilization in C. jejuni colonization of various tissues.	[Hofreuter, Dirk; Mohr, Juliane; Wensel, Olga; Rademacher, Sebastian] Hannover Med Sch, Inst Med Microbiol, D-3000 Hannover, Germany; [Schreiber, Kerstin; Schomburg, Dietmar] Tech Univ Carolo Wilhelmina Braunschweig, Inst Biochem Biotechnol & Bioinformat, D-38106 Braunschweig, Germany; [Gao, Beile; Galan, Jorge E.] Yale Univ, Sch Med, Sect Microbial Pathogenesis, New Haven, CT USA	Hannover Medical School; Braunschweig University of Technology; Yale University	Hofreuter, D (corresponding author), Hannover Med Sch, Inst Med Microbiol, D-3000 Hannover, Germany.	hofreuter.dirk@mh-hannover.de	Hofreuter, Dirk/O-3208-2015	Schomburg, Dietmar/0000-0002-3354-822X; Rademacher, Sebastian/0000-0002-1592-9838	Ellison Medical Foundation; Deutsche Forschungsgemeinschaft [DFG HO 4553/1-1, HO 4553/1-2, 1316]; Hannover Biomedical Research School (HBRS); Center for Infection Biology (ZIB)	Ellison Medical Foundation(Lawrence Ellison Foundation); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Hannover Biomedical Research School (HBRS); Center for Infection Biology (ZIB)	This work was supported by a grant from the Ellison Medical Foundation to JEG and by the Deutsche Forschungsgemeinschaft with the grant DFG HO 4553/1-1 and the grant HO 4553/1-2 as part of the priority program 1316 'Host Adapted Metabolism of Bacterial Pathogens' to DH. The Hannover Biomedical Research School (HBRS) and the Center for Infection Biology (ZIB) supported JM. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abu Dawud R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039896; Allos BM, 2001, CLIN INFECT DIS, V32, P1201, DOI 10.1086/319760; Bachtiar BM, 2007, FEMS IMMUNOL MED MIC, V49, P149, DOI 10.1111/j.1574-695X.2006.00182.x; Bacon DJ, 2001, MOL MICROBIOL, V40, P769, DOI 10.1046/j.1365-2958.2001.02431.x; Barnes HA, 2007, MICROB PATHOGENESIS, V43, P198, DOI 10.1016/j.micpath.2007.05.007; Bereswill S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020953; BLACK RE, 1988, J INFECT DIS, V157, P472, DOI 10.1093/infdis/157.3.472; Blaser MJ, 1997, J INFECT DIS, V176, pS103, DOI 10.1086/513780; BOOTH IR, 1990, FEMS MICROBIOL LETT, V75, P239, DOI 10.1016/0378-1097(90)90534-W; Brown SA, 2008, NAT REV MICROBIOL, V6, P657, DOI 10.1038/nrmicro1955; Butzler JP, 2004, CLIN MICROBIOL INFEC, V10, P868, DOI 10.1111/j.1469-0691.2004.00983.x; Buysse JM, 2001, CURR MED CHEM, V8, P1713, DOI 10.2174/0929867013371699; Chang C, 2006, INFECT IMMUN, V74, P5261, DOI 10.1128/IAI.01094-05; Colegio OR, 2001, J BACTERIOL, V183, P2384, DOI 10.1128/JB.183.7.2384-2388.2001; Cooper KK, 2011, J BACTERIOL, V193, P1491, DOI 10.1128/JB.01475-10; Coulter SN, 1998, MOL MICROBIOL, V30, P393, DOI 10.1046/j.1365-2958.1998.01075.x; Davis LM, 2009, J BACTERIOL, V191, P1631, DOI 10.1128/JB.01394-08; Day WA, 2000, INFECT IMMUN, V68, P6337, DOI 10.1128/IAI.68.11.6337-6345.2000; de Zoete MR, 2007, VACCINE, V25, P5548, DOI 10.1016/j.vaccine.2006.12.002; Empadinhas N, 2008, INT MICROBIOL, V11, P151, DOI 10.2436/20.1501.01.55; Fouts DE, 2005, PLOS BIOL, V3, P72, DOI 10.1371/journal.pbio.0030015; Fox JG, 2004, INFECT IMMUN, V72, P1116, DOI 10.1128/IAI.72.2.1116-1125.2004; Friis C, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012253; GRABOWSKI R, 1991, EUR J BIOCHEM, V199, P89, DOI 10.1111/j.1432-1033.1991.tb16095.x; Gripp E, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-584; Guccione E, 2008, MOL MICROBIOL, V69, P77, DOI 10.1111/j.1365-2958.2008.06263.x; Hendrixson DR, 2004, MOL MICROBIOL, V52, P471, DOI 10.1111/j.1365-2958.2004.03988.x; Hepworth PJ, 2011, ENVIRON MICROBIOL, V13, P1549, DOI 10.1111/j.1462-2920.2011.02461.x; Hickey TE, 2000, INFECT IMMUN, V68, P6535, DOI 10.1128/IAI.68.12.6535-6541.2000; Hiller K, 2009, ANAL CHEM, V81, P3429, DOI 10.1021/ac802689c; Hofreuter D, 2008, CELL HOST MICROBE, V4, P425, DOI 10.1016/j.chom.2008.10.002; Hofreuter D, 2006, INFECT IMMUN, V74, P4694, DOI 10.1128/IAI.00210-06; JimenezZurdo JI, 1997, MOL MICROBIOL, V23, P85, DOI 10.1046/j.1365-2958.1997.1861555.x; Jones MA, 2004, INFECT IMMUN, V72, P3769, DOI 10.1128/IAI.72.7.3769-3776.2004; Karlyshev AV, 2004, MICROBIOL-SGM, V150, P1957, DOI 10.1099/mic.0.26721-0; Kavermann H, 2003, J EXP MED, V197, P813, DOI 10.1084/jem.20021531; Kelly DJ, 2001, J APPL MICROBIOL, V90, p16S, DOI 10.1046/j.1365-2672.2001.01350.x; Krause-Gruszczynska M, 2007, CELL MICROBIOL, V9, P2431, DOI 10.1111/j.1462-5822.2007.00971.x; Krishnan N, 2008, INFECT IMMUN, V76, P3037, DOI 10.1128/IAI.01737-07; Leach S, 1997, J APPL MICROBIOL, V82, P631; Lee MD, 2006, AVIAN DIS, V50, P1, DOI 10.1637/7474-111605R.1; Leon-Kempis MD, 2006, MOL MICROBIOL, V60, P1262, DOI 10.1111/j.1365-2958.2006.05168.x; Lin AE, 2009, INFECT IMMUN, V77, P4912, DOI 10.1128/IAI.00571-08; Mendz GL, 1997, BBA-GEN SUBJECTS, V1334, P291, DOI 10.1016/S0304-4165(96)00107-9; Metris A, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-535; Miller WG, 2000, APPL ENVIRON MICROB, V66, P5426, DOI 10.1128/AEM.66.12.5426-5436.2000; Mohammed KAS, 2004, LETT APPL MICROBIOL, V39, P261, DOI 10.1111/j.1472-765X.2004.01574.x; MOROOKA T, 1985, J GEN MICROBIOL, V131, P1973; Muraoka WT, 2011, J BACTERIOL, V193, P1065, DOI 10.1128/JB.01252-10; Naikare H, 2006, INFECT IMMUN, V74, P5433, DOI 10.1128/IAI.00052-06; Naito M, 2010, J BACTERIOL, V192, P2182, DOI 10.1128/JB.01222-09; Nakajima K, 2008, BIOMED RES-TOKYO, V29, P9, DOI 10.2220/biomedres.29.9; Newell DG, 2003, APPL ENVIRON MICROB, V69, P4343, DOI 10.1128/AEM.69.8.4343-4351.2003; Novik V, 2010, INFECT IMMUN, V78, P3540, DOI 10.1128/IAI.00109-10; Pajaniappan M, 2008, MOL MICROBIOL, V68, P474, DOI 10.1111/j.1365-2958.2008.06161.x; Parkhill J, 2000, NATURE, V403, P665, DOI 10.1038/35001088; Pearson BM, 2007, J BACTERIOL, V189, P8402, DOI 10.1128/JB.01404-07; Pei ZH, 1998, INFECT IMMUN, V66, P938, DOI 10.1128/IAI.66.3.938-943.1998; PEI ZH, 1993, J BIOL CHEM, V268, P18717; Peng KT, 2010, INFECT IMMUN, V78, P2723, DOI 10.1128/IAI.00008-10; Plaimas K, 2010, BMC SYST BIOL, V4, DOI 10.1186/1752-0509-4-56; Poly F, 2008, INFECT IMMUN, V76, P5655, DOI 10.1128/IAI.00780-08; Poly F, 2007, INFECT IMMUN, V75, P3425, DOI 10.1128/IAI.00050-07; Ribardo DA, 2011, J BACTERIOL, V193, P6233, DOI 10.1128/JB.05473-11; ROBINSON DA, 1981, BRIT MED J, V282, P1584, DOI 10.1136/bmj.282.6276.1584; Rohmer L, 2011, TRENDS MICROBIOL, V19, P341, DOI 10.1016/j.tim.2011.04.003; Schwan WR, 1998, INFECT IMMUN, V66, P567, DOI 10.1128/IAI.66.2.567-572.1998; Servet C, 2012, FRONT BIOSCI-LANDMRK, V17, P607, DOI 10.2741/3947; Stahl M, 2011, P NATL ACAD SCI USA, V108, P7194, DOI 10.1073/pnas.1014125108; Stahl M, 2011, FUNCT INTEGR GENOMIC, V11, P241, DOI 10.1007/s10142-011-0214-7; Takamiya M, 2011, J BACTERIOL, V193, P5546, DOI 10.1128/JB.05753-11; Takamiya M, 2011, STAND GENOMIC SCI, V4, P113, DOI 10.4056/sigs.1313504; TAKATA T, 1992, INFECT IMMUN, V60, P3596, DOI 10.1128/IAI.60.9.3596-3600.1992; Thomas MT, 2011, ENVIRON MICROBIOL, V13, P48, DOI 10.1111/j.1462-2920.2010.02307.x; van Alphen LB, 2008, CELL MICROBIOL, V10, P53, DOI 10.1111/j.1462-5822.2007.01014.x; van Putten JPM, 2009, CURR TOP MICROBIOL, V337, P197, DOI 10.1007/978-3-642-01846-6_7; Velayudhan J, 2004, INFECT IMMUN, V72, P260, DOI 10.1128/IAI.72.1.260-268.2004; Velayudhan J, 2002, MICROBIOL-SGM, V148, P685, DOI 10.1099/00221287-148-3-685; Watson RO, 2007, INFECT IMMUN, V75, P1994, DOI 10.1128/IAI.01216-06; Watson RO, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.0040014; Weingarten RA, 2009, J BACTERIOL; Weingarten RA, 2008, APPL ENVIRON MICROB, V74, P1367, DOI 10.1128/AEM.02261-07; WESTFALL HN, 1986, APPL ENVIRON MICROB, V52, P700, DOI 10.1128/AEM.52.4.700-705.1986; WOOD JM, 1988, J MEMBRANE BIOL, V106, P183, DOI 10.1007/BF01872157; Wright JA, 2009, MICROBIOL-SGM, V155, P80, DOI 10.1099/mic.0.021790-0; Xu Fuzhou, 2010, J Bacteriol, V192, P4425, DOI 10.1128/JB.00478-10; Yao RJ, 1997, MOL MICROBIOL, V23, P1021, DOI 10.1046/j.1365-2958.1997.2861650.x; Young KT, 2007, NAT REV MICROBIOL, V5, P665, DOI 10.1038/nrmicro1718; Yuki N, 2001, Lancet Infect Dis, V1, P29; Zhang MJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015060	90	28	28	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 30	2012	7	11							e50699	10.1371/journal.pone.0050699	http://dx.doi.org/10.1371/journal.pone.0050699			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	054WM	23226358	Green Published, Green Submitted, gold			2022-12-27	WOS:000312376100169
J	Mackey, TK; Liang, BA				Mackey, Tim K.; Liang, Bryan A.			Patent and Exclusivity Status of Essential Medicines for Non-Communicable Disease	PLOS ONE			English	Article							LOW-INCOME; ACCESS; AVAILABILITY	Objective: The threat of non-communicable diseases ("NCDs") is increasingly becoming a global health crisis and are pervasive in high, middle, and low-income populations resulting in an estimated 36 million deaths per year. There is a need to assess intellectual property rights ("IPRs") that may impede generic production and availability and affordability to essential NCD medicines. Methods: Using the data sources listed below, the study design systematically eliminated NCD drugs that had no patent/exclusivity provisions on API, dosage, or administration route. The first step identified essential medicines that treat certain high disease burden NCDs. A second step examined the patent and exclusivity status of active ingredient, dosage and listed route of administration using exclusion criteria outlined in this study. Materials: We examined the patent and exclusivity status of medicines listed in the World Health Organization's ("WHO") Model List of Essential Drugs (Medicines) ("MLEM") and other WHO sources for drugs treating certain NCDs. i.e., cardiovascular and respiratory disease, cancers, and diabetes. We utilized the USA Food and Drug Administration Orange Book and the USA Patent and Trademark Office databases as references given the predominant number of medicines registered in the USA. Results: Of the 359 MLEM medicines identified, 22% (79/359) address targeted NCDs. Of these 79, only eight required in-depth patent or exclusivity assessment. Upon further review, no NCD MLEM medicines had study patent or exclusivity protection for reviewed criteria. Conclusions: We find that ensuring availability and affordability of potential generic formulations of NCD MLEM medicines appears to be more complex than the presence of IPRs with API, dosage, or administration patent or exclusivity protection. Hence, more sophisticated analysis of NCD barriers to generic availability and affordability should be conducted in order to ensure equitable access to global populations for these essential medicines.	[Mackey, Tim K.; Liang, Bryan A.] Calif Western Sch Law, Inst Hlth Law Studies, San Diego, CA USA; [Mackey, Tim K.] San Diego State Univ, Univ Calif San Diego, Joint Doctoral Program Global Hlth, San Diego, CA 92182 USA; [Liang, Bryan A.] Univ Calif San Diego, Sch Med, San Diego Ctr Patient Safety, San Diego, CA 92103 USA; [Liang, Bryan A.] Univ Calif San Diego, Sch Med, Dept Anesthesiol, San Diego, CA 92103 USA	California State University System; San Diego State University; University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California San Diego	Mackey, TK (corresponding author), Calif Western Sch Law, Inst Hlth Law Studies, San Diego, CA USA.	tmackey@ucsd.edu	Mackey, Tim/H-9156-2013	Mackey, Tim/0000-0002-2191-7833; Liang, Bryan/0000-0001-7801-5673				Abegunde D, 2011, BACKGROUND PAPER ESS; Alawan A, 2011, WHO NCDS NOW THE LEA; [Anonymous], 2002, PHARMACEUTICAL PRODU; [Anonymous], 2000, DEFINING AND MEASURI; [Anonymous], WHO MODEL LIST OF ES; Attaran A, 2004, HEALTH AFFAIR, V23, P155, DOI 10.1377/hlthaff.23.3.155; Beran D, 2008, B WORLD HEALTH ORGAN, V86, P648, DOI 10.2471/BLT.07.048710; Cameron A, 2009, LANCET, V373, P240, DOI 10.1016/S0140-6736(08)61762-6; Cameron A, 2011, B WORLD HEALTH ORGAN, V89, P412, DOI 10.2471/BLT.10.084327; Carrera PM, 2009, HEALTH AFFAIR, V28, P1861, DOI 10.1377/hlthaff.28.6.1861-a; Chua GN, 2010, HEALTH POLICY, V95, P229, DOI 10.1016/j.healthpol.2009.11.019; Cohen Jillian Clare, 2003, Dev World Bioeth, V3, P27, DOI 10.1111/1471-8847.00058; Connelly P, 2011, SCIENCE, V333, P156, DOI 10.1126/science.333.6039.156-b; Cruz AA, 2009, ALLERGY, V64, P319, DOI 10.1111/j.1398-9995.2009.02026.x; Daar AS, 2007, NATURE, V450, P494, DOI 10.1038/450494a; Farmer P, 2010, LANCET, V376, P1186, DOI 10.1016/S0140-6736(10)61152-X; Gill GV, 2011, DIABETOLOGIA, V54, P19, DOI 10.1007/s00125-010-1897-3; Guglietta A, 2009, NAT CLIN PRACT CARD, V6, P112, DOI 10.1038/ncpcardio1424; Harrison C, 2011, NAT REV DRUG DISCOV, V10, P12, DOI 10.1038/nrd3356; Hollis A, 2006, AN ASSESSMENT OF THE; IMS, 2010, IMS HEALTH FORECASTS; Kishore SP, 2011, J AM COLL CARDIOL, V57, P1980, DOI 10.1016/j.jacc.2010.12.029; Mackey TK, 2012, DRUG DISCOV TODAY, V17, P1254, DOI 10.1016/j.drudis.2012.06.012; Mamudu HM, 2011, GLOB PUBLIC HEALTH, V6, P347, DOI 10.1080/17441692.2011.574230; Mathers CD, 2006, PLOS MED, V3, DOI 10.1371/journal.pmed.0030442; Mendis S, 2007, B WORLD HEALTH ORGAN, V85, P279, DOI 10.2471/BLT.06.033647; Metered Dose Inhalers: The Transition to Ozone-Safe Propellants, METERED DOSE INHALER; Miano P, 2011, APPROVAL OWNERSHIP M; Miranda JJ, 2008, TROP MED INT HEALTH, V13, P1225, DOI 10.1111/j.1365-3156.2008.02116.x; Mirza Zafar, 2008, Eastern Mediterranean Health Journal, V14, pS74; Patel A, 2010, HEALTH POLICY PLANN, V25, P61, DOI 10.1093/heapol/czp039; Peters DH, 2008, ANN NY ACAD SCI, V1136, P161, DOI 10.1196/annals.1425.011; Rodgers A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019857; Steinbrook R, 2009, NEW ENGL J MED, V361, P1525, DOI 10.1056/NEJMp0906922; 't Hoen E, 2011, J INT AIDS SOC, V14, DOI 10.1186/1758-2652-14-15; US Food and Drug Administration, 2011, APPROVED DRUG PRODUC, V31st; US Food and Drug Administration, FREQUENTLY ASKED QUE; WHO, 2011, GLOBAL STATUS REPORT; World Health Organization, THE TOP 10 CAUSES OF; World Health Organization, 2008, 2008 2013 ACTION PLA; World Health Organization, 2000, THE USE OF ESSENTIAL	41	10	10	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 30	2012	7	11							e51022	10.1371/journal.pone.0051022	http://dx.doi.org/10.1371/journal.pone.0051022			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	054WM	23226453	Green Published, gold			2022-12-27	WOS:000312376100264
J	Rubelt, F; Sievert, V; Knaust, F; Diener, C; Lim, TS; Skriner, K; Klipp, E; Reinhardt, R; Lehrach, H; Konthur, Z				Rubelt, Florian; Sievert, Volker; Knaust, Florian; Diener, Christian; Lim, Theam Soon; Skriner, Karl; Klipp, Edda; Reinhardt, Richard; Lehrach, Hans; Konthur, Zoltan			Onset of Immune Senescence Defined by Unbiased Pyrosequencing of Human Immunoglobulin mRNA Repertoires	PLOS ONE			English	Article							ZEBRAFISH ANTIBODY REPERTOIRE; DIVERSITY; RESPONSES; REARRANGEMENTS; RECOMBINATION; POPULATIONS; MECHANISM; ISOTYPES; LIBRARY; BIOLOGY	The immune system protects us from foreign substances or pathogens by generating specific antibodies. The variety of immunoglobulin (Ig) paratopes for antigen recognition is a result of the V(D)J rearrangement mechanism, while a fast and efficient immune response is mediated by specific immunoglobulin isotypes obtained through class switch recombination (CSR). To get a better understanding on how antibody-based immune protection works and how it changes with age, the interdependency between these two parameters need to be addressed. Here, we have performed an in depth analysis of antibody repertoires of 14 healthy donors representing different gender and age groups. For this task, we developed a unique pyrosequencing approach, which is able to monitor the expression levels of all immunoglobulin V(D)J recombinations of all isotypes including subtypes in an unbiased and quantitative manner. Our results show that donors have individual immunoglobulin repertoires and cannot be clustered according to V(D)J recombination patterns, neither by age nor gender. However, after incorporating isotype-specific analysis and considering CSR information into hierarchical clustering the situation changes. For the first time the donors cluster according to age and separate into young adults and elderly donors (> 50). As a direct consequence, this clustering defines the onset of immune senescence at the age of fifty and beyond. The observed age-dependent reduction of CSR ability proposes a feasible explanation why reduced efficacy of vaccination is seen in the elderly and implies that novel vaccine strategies for the elderly should include the "Golden Agers''. Citation: Rubelt F, Sievert V, Knaust F, Diener C, Lim TS, et al. (2012) Onset of Immune Senescence Defined by Unbiased Pyrosequencing of Human Immunoglobulin mRNA Repertoires. PLoS ONE 7(11): e49774. doi:10.1371/journal.pone.0049774	[Rubelt, Florian; Sievert, Volker; Knaust, Florian; Diener, Christian; Lim, Theam Soon; Reinhardt, Richard; Lehrach, Hans; Konthur, Zoltan] Max Planck Inst Mol Genet, D-14195 Berlin, Germany; [Rubelt, Florian] Free Univ Berlin, Fac Biol Chem & Pharm, Berlin, Germany; [Diener, Christian; Klipp, Edda] Humboldt Univ, D-10099 Berlin, Germany; [Lim, Theam Soon] Univ Sains Malaysia, Inst Res Mol Med, George Town, Malaysia; [Skriner, Karl] Charite, Dept Rheumatol & Clin Immunol, D-13353 Berlin, Germany; [Reinhardt, Richard] Max Planck Inst Plant Breeding Res, Max Planck Genome Ctr Cologne, Cologne, Germany	Max Planck Society; Free University of Berlin; Humboldt University of Berlin; Universiti Sains Malaysia; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Max Planck Society	Konthur, Z (corresponding author), Max Planck Inst Mol Genet, Ihnestr 73, D-14195 Berlin, Germany.	konthur@molgen.mpg.de	Konthur, Zoltán/E-4575-2010; Lim, Theam Soon/A-6688-2011; Lim, Theam Soon/N-6687-2019; Diener, Christian/X-9574-2019; Lim, Theam Soon/H-8402-2016	Konthur, Zoltán/0000-0002-8767-9823; Lim, Theam Soon/0000-0002-0656-3045; Lim, Theam Soon/0000-0002-0656-3045; Diener, Christian/0000-0002-7476-0868; Lim, Theam Soon/0000-0002-0656-3045; Reinhardt, Richard/0000-0001-9376-2132; Skriner, Karl/0000-0002-5415-270X; /0000-0001-7593-5511	Max Planck Society for the Advancement of Sciences; Malaysia Ministry of Higher Education, Higher Institution Center of Excellence (HICoE) [311/CIPPM/4401005]	Max Planck Society for the Advancement of Sciences; Malaysia Ministry of Higher Education, Higher Institution Center of Excellence (HICoE)	This work was supported by Max Planck Society for the Advancement of Sciences. TSL acknowledges financial support from the Malaysia Ministry of Higher Education, Higher Institution Center of Excellence (HICoE) Grant (311/CIPPM/4401005). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aberle JH, 2012, AGE DORDR; Alamyar E., 2012, IMMUNOME RES, V8, P1, DOI [10.4172/1745-7580.1000056, DOI 10.4172/1745-7580.1000056]; Arnaout RA, 2005, BMC GENOMICS, V6, DOI 10.1186/1471-2164-6-148; Boyd SD, 2010, J IMMUNOL, V184, P6986, DOI 10.4049/jimmunol.1000445; Boyd SD, 2009, SCI TRANSL MED, V1, DOI 10.1126/scitranslmed.3000540; Briney BS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036750; Brochet X, 2008, NUCLEIC ACIDS RES, V36, pW503, DOI 10.1093/nar/gkn316; BURLINGTON DB, 1983, INFECT IMMUN, V41, P540, DOI 10.1128/IAI.41.2.540-545.1983; Chao A, 2003, ENVIRON ECOL STAT, V10, P429, DOI 10.1023/A:1026096204727; Fischer N, 2011, MABS-AUSTIN, V3, P17, DOI 10.4161/mabs.3.1.14169; Frasca D, 2012, J IMMUNOL, V188, P279, DOI 10.4049/jimmunol.1003964; Frasca D, 2011, AGEING RES REV, V10, P330, DOI 10.1016/j.arr.2010.08.004; Frasca D, 2011, J CLIN IMMUNOL, V31, P430, DOI 10.1007/s10875-010-9501-7; Gameiro CM, 2010, MATURITAS, V67, P316, DOI 10.1016/j.maturitas.2010.08.003; Gibson KL, 2009, AGING CELL, V8, P18, DOI 10.1111/j.1474-9726.2008.00443.x; Glanville J, 2011, P NATL ACAD SCI USA, V108, P20066, DOI 10.1073/pnas.1107498108; Glanville J, 2009, P NATL ACAD SCI USA, V106, P20216, DOI 10.1073/pnas.0909775106; Jackson KJL, 2012, IMMUNOGENETICS, V64, P3, DOI 10.1007/s00251-011-0559-z; Jiang N, 2011, P NATL ACAD SCI USA, V108, P5348, DOI 10.1073/pnas.1014277108; Lefranc MP, 2009, NUCLEIC ACIDS RES, V37, pD1006, DOI 10.1093/nar/gkn838; Lim TS, 2010, NEW BIOTECHNOL, V27, P108, DOI 10.1016/j.nbt.2010.01.001; Margulies M, 2005, NATURE, V437, P376, DOI 10.1038/nature03959; Maul RW, 2011, NAT IMMUNOL, V12, P70, DOI 10.1038/ni.1970; Prabakaran P, 2012, IMMUNOGENETICS, V64, P337, DOI 10.1007/s00251-011-0595-8; Rice P, 2000, TRENDS GENET, V16, P276, DOI 10.1016/S0168-9525(00)02024-2; Sasaki S, 2011, J CLIN INVEST, V121, P3109, DOI 10.1172/JCI57834; Schatz DG, 2011, NAT REV IMMUNOL, V11, P251, DOI 10.1038/nri2941; Schroeder HW, 2010, J ALLERGY CLIN IMMUN, V125, pS41, DOI 10.1016/j.jaci.2009.09.046; Schutze T, 2011, ANAL BIOCHEM, V410, P155, DOI 10.1016/j.ab.2010.11.029; Stavnezer J, 2008, ANNU REV IMMUNOL, V26, P261, DOI 10.1146/annurev.immunol.26.021607.090248; Stiasny K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034145; Wang Y, 2011, IMMUNOGENETICS, V63, P259, DOI 10.1007/s00251-010-0510-8; Weinberger B, 2008, CLIN INFECT DIS, V46, P1078, DOI 10.1086/529197; Weinberger B, 2010, VACCINE, V28, P3511, DOI 10.1016/j.vaccine.2010.03.024; Weinstein JA, 2009, SCIENCE, V324, P807, DOI 10.1126/science.1170020; Wu YC, 2010, BLOOD, V116, P1070, DOI 10.1182/blood-2010-03-275859; Zhu Zhongyu, 2009, V525, P129, DOI 10.1007/978-1-59745-554-1_6	37	22	23	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 30	2012	7	11							e49774	10.1371/journal.pone.0049774	http://dx.doi.org/10.1371/journal.pone.0049774			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	054WM	23226220	Green Published, Green Submitted, gold			2022-12-27	WOS:000312376100028
J	Shimatani, IK; Yoda, K; Katsumata, N; Sato, K				Shimatani, Ichiro Ken; Yoda, Ken; Katsumata, Nobuhiro; Sato, Katsufumi			Toward the Quantification of a Conceptual Framework for Movement Ecology Using Circular Statistical Modeling	PLOS ONE			English	Article							ANIMAL MOVEMENT; CALONECTRIS-LEUCOMELAS; ORIENTATION; BEHAVIOR; PATHS	To analyze an animal's movement trajectory, a basic model is required that satisfies the following conditions: the model must have an ecological basis and the parameters used in the model must have ecological interpretations, a broad range of movement patterns can be explained by that model, and equations and probability distributions in the model should be mathematically tractable. Random walk models used in previous studies do not necessarily satisfy these requirements, partly because movement trajectories are often more oriented or tortuous than expected from the models. By improving the modeling for turning angles, this study aims to propose a basic movement model. On the basis of the recently developed circular auto-regressive model, we introduced a new movement model and extended its applicability to capture the asymmetric effects of external factors such as wind. The model was applied to GPS trajectories of a seabird (Calonectris leucomelas) to demonstrate its applicability to various movement patterns and to explain how the model parameters are ecologically interpreted under a general conceptual framework for movement ecology. Although it is based on a simple extension of a generalized linear model to circular variables, the proposed model enables us to evaluate the effects of external factors on movement separately from the animal's internal state. For example, maximum likelihood estimates and model selection suggested that in one homing flight section, the seabird intended to fly toward the island, but misjudged its navigation and was driven off-course by strong winds, while in the subsequent flight section, the seabird reset the focal direction, navigated the flight under strong wind conditions, and succeeded in approaching the island.	[Shimatani, Ichiro Ken] Inst Stat Math, Tokyo, Japan; [Yoda, Ken] Nagoya Univ, Grad Sch Environm Studies, Chikusa Ku, Nagoya, Aichi 4648601, Japan; [Katsumata, Nobuhiro; Sato, Katsufumi] Univ Tokyo, Atmosphere & Ocean Res Inst, Int Coastal Res Ctr, Kashiwa, Chiba, Japan	Research Organization of Information & Systems (ROIS); Institute of Statistical Mathematics (ISM) - Japan; Nagoya University; University of Tokyo	Shimatani, IK (corresponding author), Inst Stat Math, Tokyo, Japan.	shimatan@ism.ac.jp			Japanese Society for the Promotion of Science [A19255001]; program Bio-Logging Science of the University of Tokyo; 'UTBLS'; ISM Cooperative Research Program [20-IMS-CRP-4404, 21-IMS-CRP-4104]	Japanese Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); program Bio-Logging Science of the University of Tokyo; 'UTBLS'; ISM Cooperative Research Program	This study was supported by funds from the Japanese Society for the Promotion of Science (A19255001), the program Bio-Logging Science of the University of Tokyo, 'UTBLS', and the ISM Cooperative Research Program (20-IMS-CRP-4404. 21-IMS-CRP-4104). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akaike H., 1973, P 2 INT S INF THEOR, VI, P610, DOI DOI 10.1007/978-1-4612-1694-0_15; Benhamou S, 2006, ECOLOGY, V87, P518, DOI 10.1890/05-0495; Brokewell PJ, 2000, INTRO TIME SERIES FO; Brooks CJ, 2008, ANIM BEHAV, V76, P277, DOI 10.1016/j.anbehav.2008.02.005; Clark JS, 2006, TRENDS ECOL EVOL, V21, P375, DOI 10.1016/j.tree.2006.03.016; Downs TD, 2002, BIOMETRIKA, V89, P683, DOI 10.1093/biomet/89.3.683; Getz WM, 2008, P NATL ACAD SCI USA, V105, P19066, DOI 10.1073/pnas.0801732105; Giuggioli L, 2010, J ANIM ECOL, V79, P906, DOI 10.1111/j.1365-2656.2010.01682.x; Gurarie E, 2011, AM NAT, V178, P113, DOI 10.1086/660285; Gurarie E, 2009, ECOL LETT, V12, P395, DOI 10.1111/j.1461-0248.2009.01293.x; Kato S, 2010, J R STAT SOC B, V72, P655, DOI 10.1111/j.1467-9868.2010.00748.x; Kato S, 2010, J AM STAT ASSOC, V105, P249, DOI 10.1198/jasa.2009.tm08313; Mardia K.V., 1999, DIRECTIONAL STAT, DOI [10.1002/9780470316979, DOI 10.1002/9780470316979]; McClintock BT, 2012, ECOL MONOGR, V82, P335, DOI 10.1890/11-0326.1; Nagy M, 2010, NATURE, V464, P890, DOI 10.1038/nature08891; Nams VO, 2006, ANIM BEHAV, V72, P1197, DOI 10.1016/j.anbehav.2006.04.005; Nathan R, 2008, P NATL ACAD SCI USA, V105, P19052, DOI 10.1073/pnas.0800375105; Patterson TA, 2008, TRENDS ECOL EVOL, V23, P87, DOI 10.1016/j.tree.2007.10.009; Sakamoto KQ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005379; Sakamoto Y., 1986, AKAIKE INFORM CRITER; Schick RS, 2008, ECOL LETT, V11, P1338, DOI 10.1111/j.1461-0248.2008.01249.x; Shiomi K, 2012, ANIM BEHAV, V83, P355, DOI 10.1016/j.anbehav.2011.11.010; Tracey JA, 2011, ENVIRON ECOL STAT, V18, P393, DOI 10.1007/s10651-010-0138-8; Yamamoto T, 2008, ANIM BEHAV, V76, P1647, DOI 10.1016/j.anbehav.2008.07.019; Yamamoto T, 2010, AUK, V127, P871, DOI 10.1525/auk.2010.10029	25	12	13	0	41	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 30	2012	7	11							e50309	10.1371/journal.pone.0050309	http://dx.doi.org/10.1371/journal.pone.0050309			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	054WM	23226261	Green Submitted, Green Published, gold			2022-12-27	WOS:000312376100071
J	Yang, P; Ma, CN; Shi, WX; Cui, SJ; Lu, GL; Peng, XM; Zhang, DT; Liu, YM; Liang, HJ; Zhang, Y; Zhang, L; Seale, H; Wang, QY				Yang, Peng; Ma, Chunna; Shi, Weixian; Cui, Shujuan; Lu, Guilan; Peng, Xiaomin; Zhang, Daitao; Liu, Yimeng; Liang, Huijie; Zhang, Yi; Zhang, Li; Seale, Holly; Wang, Quanyi			A Serological Survey of Antibodies to H5, H7 and H9 Avian Influenza Viruses amongst the Duck-Related Workers in Beijing, China	PLOS ONE			English	Article							A H5N1; RISK-FACTORS; HUMAN INFECTION; WILD BIRDS; POULTRY WORKERS; RECEPTOR SPECIFICITY; HEMAGGLUTININ GENE; DOMESTIC POULTRY; LOW-FREQUENCY; HONG-KONG	The continued spread of highly pathogenic avian influenza (HPAI) viruses of H5 and H7 subtypes and low pathogenic avian influenza (LPAI) viruses of H5, H7 and H9 subtypes in birds and the subsequent infections in humans pose an ongoing pandemic threat. It has been proposed that poultry workers are at higher risk of exposure to HPAI or LPAI viruses and subsequently infection due to their repeated exposure to chickens or domestic waterfowl. The aim of this study was to examine the seroprevalence of antibodies against H5, H7 and H9 viruses amongst duck-related workers in Beijing, China and the risk factors associated with seropositivity. In March, 2011, 1741 participants were recruited from (1) commercial duck-breeding farms; (2) private duck-breeding farms; and (3) duck-slaughtering farms. Local villagers who bred ducks in their backyards were also recruited. A survey was administered by face-to-face interview, and blood samples were collected from subjects for antibody testing against H5, H7 and H9 viruses. We found that none of the subjects were seropositive for either H5 or H7 viruses, and only 0.7% (12/1741) had antibody against H9. A statistically significant difference in H9 antibody seroprevalence existed between the various categories of workers (P = 0.005), with the highest figures recorded amongst the villagers (1.7%). Independent risk factors associated with seropositivity toinfection with H9 virus included less frequent disinfection of worksite (OR, 5.13 [95% CI, 1.07-24.58]; P = 0.041; <= twice monthly versus. twice monthly) and handling ducks with wounds on hands (OR, 4.13 [95% CI, 1.26-13.57]; P = 0.019). Whilst the risk of infection with H5, H7 and H9 viruses appears to be low among duck-related workers in Beijing, China, ongoing monitoring of infection with the H9 virus is still warranted, especially amongst villagers who breed backyard ducks to monitor for any changes. Citation: Yang P, Ma C, Shi W, Cui S, Lu G, et al. (2012) A Serological Survey of Antibodies to H5, H7 and H9 Avian Influenza Viruses amongst the Duck-Related Workers in Beijing, China. PLoS ONE 7(11): e50770. doi:10.1371/journal.pone.0050770	[Yang, Peng; Ma, Chunna; Shi, Weixian; Cui, Shujuan; Lu, Guilan; Peng, Xiaomin; Zhang, Daitao; Liu, Yimeng; Liang, Huijie; Zhang, Yi; Zhang, Li; Wang, Quanyi] Beijing Ctr Dis Prevent & Control CDC, Inst Infect Dis & Endem Dis Control, Beijing, Peoples R China; [Seale, Holly] Univ New S Wales, Sch Publ Hlth & Community Med, UNSW Med, Sydney, NSW, Australia	University of New South Wales Sydney	Wang, QY (corresponding author), Beijing Ctr Dis Prevent & Control CDC, Inst Infect Dis & Endem Dis Control, Beijing, Peoples R China.	bjcdcxm@126.com	Seale, Holly/D-4200-2011	Seale, Holly/0000-0002-1877-5395	Beijing Nova Program of Beijing Science and Technology Commission [2011047]; National Key Program for Infectious Disease of China of Chinese Ministry of Science and Technology [2012ZX10004215-003-001]	Beijing Nova Program of Beijing Science and Technology Commission; National Key Program for Infectious Disease of China of Chinese Ministry of Science and Technology	This work was supported by the Beijing Nova Program (2011047) of Beijing Science and Technology Commission (http://www.bjkw.gov.cn) and the National Key Program for Infectious Disease of China (2012ZX10004215-003-001) of Chinese Ministry of Science and Technology (http://www.most.gov.cn/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdel-Ghafar AN, 2008, NEW ENGL J MED, V358, P261, DOI 10.1056/NEJMra0707279; Alexander DJ, 2007, AVIAN DIS, V51, P161, DOI 10.1637/7602-041306R.1; Butt KM, 2005, J CLIN MICROBIOL, V43, P5760, DOI 10.1128/JCM.43.11.5760-5767.2005; Cavailler P, 2010, J CLIN VIROL, V48, P123, DOI 10.1016/j.jcv.2010.02.021; Dawood FS, 2009, NEW ENGL J MED, V360, P2605, DOI 10.1056/NEJMoa0903810; Dinh PN, 2006, EMERG INFECT DIS, V12, P1841; Fouchier RAM, 2004, P NATL ACAD SCI USA, V101, P1356, DOI 10.1073/pnas.0308352100; Gill JS, 2006, EMERG INFECT DIS, V12, P1284, DOI 10.3201/eid1708.060492; Gou Y, 2000, Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi, V14, P209; Guo Y, 1999, Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi, V13, P105; Hinjoy S, 2008, EMERG INFECT DIS, V14, P499, DOI 10.3201/eid1403.070662; Huo X, 2012, BMC INFECT DIS, V12, DOI 10.1186/1471-2334-12-93; Ito T, 1997, VIROLOGY, V227, P493, DOI 10.1006/viro.1996.8323; Ji K, 2010, J VIROL METHODS, V163, P186, DOI 10.1016/j.jviromet.2009.09.013; Jia N, 2008, J VIROL METHODS, V153, P43, DOI 10.1016/j.jviromet.2008.06.016; Jia N, 2009, J CLIN VIROL, V44, P225, DOI 10.1016/j.jcv.2008.12.014; Kayali G, 2008, J CLIN VIROL, V43, P73, DOI 10.1016/j.jcv.2008.04.013; Kim HR, 2012, EMERG INFECT DIS, V18, P480, DOI [10.3201/eid1803.111490, 10.3201/1803.111490]; Koopmans M, 2004, LANCET, V363, P587, DOI 10.1016/S0140-6736(04)15589-X; Kou Z, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006926; Kurtz J, 1996, LANCET, V348, P901, DOI 10.1016/S0140-6736(05)64783-6; Li YB, 2010, J VIROL, V84, P8389, DOI 10.1128/JVI.00413-10; Lin YP, 2000, P NATL ACAD SCI USA, V97, P9654, DOI 10.1073/pnas.160270697; Martin V, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1001308; Meijer A, 2006, J VIROL METHODS, V132, P113, DOI 10.1016/j.jviromet.2005.10.001; Mounts AW, 1999, J INFECT DIS, V180, P505, DOI 10.1086/314903; Olsen B, 2006, SCIENCE, V312, P384, DOI 10.1126/science.1122438; Pawar SD, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036374; Peiris M, 1999, LANCET, V354, P916, DOI 10.1016/S0140-6736(99)03311-5; Reid AH, 1999, P NATL ACAD SCI USA, V96, P1651, DOI 10.1073/pnas.96.4.1651; SCHAFER JR, 1993, VIROLOGY, V194, P781, DOI 10.1006/viro.1993.1319; SCHOLTISSEK C, 1978, VIROLOGY, V87, P13, DOI 10.1016/0042-6822(78)90153-8; Schultsz C, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007948; SHORTRIDGE KF, 1982, LANCET, V2, P812; Stephenson I, 2003, J MED VIROL, V70, P391, DOI 10.1002/jmv.10408; Team E., 2007, EUROSURVEILLANCE, V12, P3206, DOI DOI 10.2807/ESW.12.22.03206-EN; Van Kerkhove MD, 2008, INFLUENZA OTHER RESP, V2, P155, DOI 10.1111/j.1750-2659.2008.00052.x; Vong S, 2006, EMERG INFECT DIS, V12, P1542, DOI 10.3201/eid1210.060424; Vong S, 2009, J INFECT DIS, V199, P1744, DOI 10.1086/599208; Wang M, 2009, NEW ENGL J MED, V360, P2583, DOI 10.1056/NEJMc0900358; WHO, 2012, CUM NUMB CONF HUM CA; Woo JT, 2008, J VET SCI, V9, P161, DOI 10.4142/jvs.2008.9.2.161; Zhang Y, 2012, VET MICROBIOL, V156, P285, DOI 10.1016/j.vetmic.2011.11.014; Zhou L, 2009, J INFECT DIS, V199, P1726, DOI 10.1086/599206	44	32	35	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 30	2012	7	11							e50770	10.1371/journal.pone.0050770	http://dx.doi.org/10.1371/journal.pone.0050770			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	054WM	23226380	Green Published, Green Submitted, gold			2022-12-27	WOS:000312376100191
J	Zong, ZW; Li, N; Ran, XZ; Su, YP; Shen, Y; Shi, CM; Cheng, TM				Zong, Zhaowen; Li, Nan; Ran, Xinze; Su, Yongping; Shen, Yue; Shi, Chun-meng; Cheng, Tian-min			Isolation and Characterization of Two Kinds of Stem Cells from the Same Human Skin Back Sample with Therapeutic Potential in Spinal Cord Injury	PLOS ONE			English	Article							SUBLETHALLY IRRADIATED RATS; MYELINATING SCHWANN-CELLS; MULTILINEAGE DIFFERENTIATION; NERVOUS-SYSTEM; BONE-MARROW; ADULT SKIN; PRECURSORS; PROLIFERATION; FIBROBLASTS; PLASTICITY	Backgrounds and Objective: Spinal cord injury remains to be a challenge to clinicians and it is attractive to employ autologous adult stem cell transplantation in its treatment, however, how to harvest cells with therapeutic potential easily and how to get enough number of cells for transplantation are challenging issues. In the present study, we aimed to isolate skin-derived precursors (SKPs) and dermal multipotent stem cells (dMSCs) simultaneously from single human skin samples from patients with paraplegia. Methods: Dissociated cells were initially generated from the dermal layer of skin samples from patients with paraplegia and cultured in SKPs proliferation medium. Four hours later, many cells adhered to the base of the flask. The suspended cells were then transferred to another flask for further culture as SKPs, while the adherent cells were cultured in dMSCs proliferation medium. Twenty-four hours later, the adherent cells were harvested and single-cell colonies were generated using serial dilution method. [H-3]thymidine incorporation assay, microchemotaxis Transwell chambers assay, RT-PCR and fluorescent immunocytochemistry were employed to examine the characterizations of the isolated cells. Results: SKPs and dMSCs were isolated simultaneously from a single skin sample. SKPs and dMSCs differed in several respects, including in terms of intermediate protein expression, proliferation capacities, and differentiation tendencies towards mesodermal and neural progenies. However, both SKPs and dMSCs showed high rates of differentiation into neurons and Schwann cells under appropriate inducing conditions. dMSCs isolated by this method showed no overt differences from dMSCs isolated by routine methods. Conclusions: Two kinds of stem cells, namely SKPs and dMSCs, can be isolated simultaneously from individual human skin sample from paraplegia patients. Both of them show ability to differentiate into neural cells under proper inducing conditions, indicating their potential for the treatment of spinal cord injury patients by autologous cell transplantation.	[Zong, Zhaowen; Shen, Yue] Third Mil Med Univ, Daping Hosp, Dept Trauma Surg, State Key Lab Trauma Burn & Combined Injury, Chongqing, Peoples R China; [Li, Nan; Ran, Xinze; Su, Yongping; Shi, Chun-meng; Cheng, Tian-min] Third Mil Med Univ, Sch Mil Prevent Med, Inst Combined Injury, State Key Lab Trauma Burn & Combined Injury, Chongqing, Peoples R China	Army Medical University; Army Medical University	Zong, ZW (corresponding author), Third Mil Med Univ, Daping Hosp, Dept Trauma Surg, State Key Lab Trauma Burn & Combined Injury, Chongqing, Peoples R China.	zongzhaowen@163.com		Shi, Chunmeng/0000-0002-8264-738X	Foundation of State Key Laboratory of Trauma, Burns and Combined Injury [SKLZZ 200817]; Natural Science Foundation Project of CQ CSTC (CSTC) [2009BA5017]	Foundation of State Key Laboratory of Trauma, Burns and Combined Injury; Natural Science Foundation Project of CQ CSTC (CSTC)(Natural Science Foundation Project of CQ CSTC)	This study was supported by the Foundation of State Key Laboratory of Trauma, Burns and Combined Injury (SKLZZ 200817) and Natural Science Foundation Project of CQ CSTC (CSTC, 2009BA5017). The funders' websites are http://202.202.224.96/ and http://www.ctin.ac.cn/ respectively. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bartsch G, 2005, STEM CELLS DEV, V14, P337, DOI 10.1089/scd.2005.14.337; Biernaskie J, 2007, J NEUROSCI, V27, P9545, DOI 10.1523/JNEUROSCI.1930-07.2007; Chen FG, 2007, J CELL SCI, V120, P2875, DOI 10.1242/jcs.03478; Falk A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029597; Fernandes KJL, 2008, PHILOS T R SOC B, V363, P185, DOI 10.1098/rstb.2006.2020; Fernandes KJL, 2004, NAT CELL BIOL, V6, P1082, DOI 10.1038/ncb1181; Gorio A, 2004, NEUROSCIENCE, V125, P179, DOI 10.1016/j.neuroscience.2003.10.046; Hoogduijn MJ, 2006, STEM CELLS DEV, V15, P49, DOI 10.1089/scd.2006.15.49; Joshi CV, 2002, CURR OPIN CELL BIOL, V14, P749, DOI 10.1016/S0955-0674(02)00392-7; Khoo MLM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019025; Kim SJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037036; Liu HB, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0034608, 10.1371/journal.pone.0050785]; Lorenz K, 2008, EXP DERMATOL, V17, P925, DOI 10.1111/j.1600-0625.2008.00724.x; McKenzie IA, 2006, J NEUROSCI, V26, P6651, DOI 10.1523/JNEUROSCI.1007-06.2006; Narine K, 2006, TISSUE ENG, V12, P2707, DOI 10.1089/ten.2006.12.2707; Riekstina U, 2008, CYTOTECHNOLOGY, V58, P153, DOI 10.1007/s10616-009-9183-2; Risner-Janiczek JR, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024169; Schafer KH, 2009, ANAT REC, V292, P1940, DOI 10.1002/ar.21033; Seaberg RM, 2004, NAT BIOTECHNOL, V22, P1115, DOI 10.1038/nbt1004; Shi CM, 2004, J RADIAT RES, V45, P19, DOI 10.1269/jrr.45.19; Shi CM, 2004, MED HYPOTHESES, V62, P683, DOI 10.1016/j.mehy.2003.12.022; Shih DTB, 2005, STEM CELLS, V23, P1012, DOI 10.1634/stemcells.2004-0125; Sotiropoulou PA, 2006, STEM CELLS, V24, P462, DOI 10.1634/stemcells.2004-0331; Toma JG, 2001, NAT CELL BIOL, V3, P778, DOI 10.1038/ncb0901-778; Toma JG, 2005, STEM CELLS, V23, P727, DOI 10.1634/stemcells.2004-0134; Wong CE, 2006, J CELL BIOL, V175, P1005, DOI 10.1083/jcb.200606062; Zong ZW, 2008, RADIAT RES, V170, P444, DOI 10.1667/RR0744.1; Zong ZW, 2009, J RADIAT RES, V50, P193, DOI 10.1269/jrr.08113	28	10	11	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 30	2012	7	11							e50222	10.1371/journal.pone.0050222	http://dx.doi.org/10.1371/journal.pone.0050222			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	054WM	23226248	gold, Green Submitted, Green Published			2022-12-27	WOS:000312376100057
J	Ito, Y; Ito, T; Karasawa, S; Enomoto, T; Nashimoto, A; Hase, Y; Sakamoto, S; Mimori, T; Matsumoto, Y; Yamaguchi, Y; Handa, H				Ito, Yuki; Ito, Takumi; Karasawa, Satoki; Enomoto, Teruya; Nashimoto, Akihiro; Hase, Yasuyoshi; Sakamoto, Satoshi; Mimori, Tsuneyo; Matsumoto, Yoshihisa; Yamaguchi, Yuki; Handa, Hiroshi			Identification of DNA-Dependent Protein Kinase Catalytic Subunit (DNA-PKcs) as a Novel Target of Bisphenol A	PLOS ONE			English	Article							DOUBLE-STRAND BREAKS; V(D)J RECOMBINATION; IONIZING-RADIATION; IN-VIVO; REPAIR; KU; EXPOSURE; BINDING; CANCER; RISK	Bisphenol A (BPA) forms the backbone of plastics and epoxy resins used to produce packaging for various foods and beverages. BPA is also an estrogenic disruptor, interacting with human estrogen receptors (ER) and other related nuclear receptors. Nevertheless, the effects of BPA on human health remain unclear. The present study identified DNA-dependent protein kinase catalytic subunit (DNA-PKcs) as a novel BPA-binding protein. DNA-PKcs, in association with the Ku heterodimer (Ku70/80), is a critical enzyme involved in the repair of DNA double-strand breaks. Low levels of DNA-PK activity are previously reported to be associated with an increased risk of certain types of cancer. Although the Kd for the interaction between BPA and a drug-binding mutant of DNA-PKcs was comparatively low (137 nM), high doses of BPA were required before cellular effects were observed (100-300 mu M). The results of an in vitro kinase assay showed that BPA inhibited DNA-PK kinase activity in a concentration-dependent manner. In M059K cells, BPA inhibited the phosphorylation of DNA-PKcs at Ser2056 and H2AX at Ser139 in response to ionizing radiation (IR)-irradiation. BPA also disrupted DNA-PKcs binding to Ku70/80 and increased the radiosensitivity of M059K cells, but not M059J cells (which are DNA-PKcs-deficient). Taken together, these results provide new evidence of the effects of BPA on DNA repair in mammalian cells, which are mediated via inhibition of DNA-PK activity. This study may warrant the consideration of the possible carcinogenic effects of high doses of BPA, which are mediated through its action on DNA-PK.	[Ito, Yuki; Karasawa, Satoki; Enomoto, Teruya; Nashimoto, Akihiro; Hase, Yasuyoshi; Sakamoto, Satoshi; Yamaguchi, Yuki; Handa, Hiroshi] Tokyo Inst Technol, Grad Sch Biosci & Biotechnol, Midori Ku, Yokohama, Kanagawa, Japan; [Ito, Takumi; Handa, Hiroshi] Tokyo Inst Technol, Solut Res Lab, Midori Ku, Yokohama, Kanagawa 227, Japan; [Mimori, Tsuneyo] Kyoto Univ, Grad Sch Med, Dept Rheumatol & Clin Immunol, Sakyo Ku, Kyoto, Japan; [Matsumoto, Yoshihisa] Tokyo Inst Technol, Nucl Reactors Res Lab, Meguro Ku, Tokyo 152, Japan	Tokyo Institute of Technology; Tokyo Institute of Technology; Kyoto University; Tokyo Institute of Technology	Handa, H (corresponding author), Tokyo Inst Technol, Grad Sch Biosci & Biotechnol, Midori Ku, Yokohama, Kanagawa, Japan.	handa.h.aa@m.titech.ac.jp	Yamaguchi, Yuki/B-9390-2015; Sakamoto, Satoshi/ABA-8705-2020; Matsumoto, Yoshihisa/G-3430-2017	Yamaguchi, Yuki/0000-0002-0197-614X; Sakamoto, Satoshi/0000-0002-6165-1558; Matsumoto, Yoshihisa/0000-0002-0758-290X; Ito, Takumi/0000-0002-9997-2664	Ministry of Economy, Trade and Industry; Japan Science and Technology Agency; Japan's Ministry of Education, Culture, Sports, Science and Technology; New Energy and Industrial Technology Development Organization; Grants-in-Aid for Scientific Research [23710267] Funding Source: KAKEN	Ministry of Economy, Trade and Industry; Japan Science and Technology Agency(Japan Science & Technology Agency (JST)); Japan's Ministry of Education, Culture, Sports, Science and Technology(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); New Energy and Industrial Technology Development Organization(New Energy and Industrial Technology Development Organization (NEDO)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by a Grant for Research and Development Projects of High Sensitivity Environment Sensor from Ministry of Economy, Trade and Industry, by Special Coordination Funds for Promoting Science and Technology from the Japan Science and Technology Agency, by the Global Centers of Excellence Program from Japan's Ministry of Education, Culture, Sports, Science and Technology and by a Grant for Research and Development Projects in Cooperation with Academic Institutions from the New Energy and Industrial Technology Development Organization. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alcaraz C, 1990, J Vet Diagn Invest, V2, P191; Allard P, 2010, P NATL ACAD SCI USA, V107, P20405, DOI 10.1073/pnas.1010386107; Alonso-Magdalena P, 2005, ENVIRON HEALTH PERSP, V113, P969, DOI 10.1289/ehp.8002; Auckley DH, 2001, CARCINOGENESIS, V22, P723, DOI 10.1093/carcin/22.5.723; Betancourt AM, 2010, J PROTEOMICS, V73, P1241, DOI 10.1016/j.jprot.2010.02.020; BLUNT T, 1995, CELL, V80, P813, DOI 10.1016/0092-8674(95)90360-7; Chen BPC, 2005, J BIOL CHEM, V280, P14709, DOI 10.1074/jbc.M408827200; DIGNAM JD, 1983, NUCLEIC ACIDS RES, V11, P1475, DOI 10.1093/nar/11.5.1475; FDA, 2010, UPD BISPH US FOOD CO; GOTTLIEB TM, 1993, CELL, V72, P131, DOI 10.1016/0092-8674(93)90057-W; Hammarsten O, 1998, P NATL ACAD SCI USA, V95, P525, DOI 10.1073/pnas.95.2.525; HARTLEY KO, 1995, CELL, V82, P849, DOI 10.1016/0092-8674(95)90482-4; Hickson I, 2004, CANCER RES, V64, P9152, DOI 10.1158/0008-5472.CAN-04-2727; Hiroi T, 2006, ENDOCRINOLOGY, V147, P2773, DOI 10.1210/en.2005-1235; INOMATA Y, 1992, ANAL BIOCHEM, V206, P109, DOI 10.1016/S0003-2697(05)80018-1; Ito T, 2010, SCIENCE, V327, P1345, DOI 10.1126/science.1177319; Kienker LJ, 2000, NUCLEIC ACIDS RES, V28, P2752, DOI 10.1093/nar/28.14.2752; KIRCHGESSNER CU, 1995, SCIENCE, V267, P1178, DOI 10.1126/science.7855601; Kundakovic M, 2011, BRAIN BEHAV IMMUN, V25, P1084, DOI 10.1016/j.bbi.2011.02.005; Le HH, 2008, TOXICOL LETT, V176, P149, DOI 10.1016/j.toxlet.2007.11.001; LEESMILLER SP, 1995, SCIENCE, V267, P1183, DOI 10.1126/science.7855602; Li D, 2010, HUM REPROD, V25, P519, DOI 10.1093/humrep/dep381; Maffini MV, 2006, MOL CELL ENDOCRINOL, V254, P179, DOI 10.1016/j.mce.2006.04.033; Mahaney BL, 2009, BIOCHEM J, V417, P639, DOI 10.1042/BJ20080413; Marton MJ, 1997, MOL CELL BIOL, V17, P4474, DOI 10.1128/MCB.17.8.4474; Matsumoto Y, 1997, BIOCHEM BIOPH RES CO, V234, P568, DOI 10.1006/bbrc.1997.6689; Milligan SR, 1998, ENVIRON HEALTH PERSP, V106, P23; MIMORI T, 1986, J BIOL CHEM, V261, P2274; Mori N, 2001, ONCOGENE, V20, P3609, DOI 10.1038/sj.onc.1204497; Nishio K, 2008, COLLOID SURFACE B, V64, P162, DOI 10.1016/j.colsurfb.2008.01.013; Prins Gail S, 2008, Fertil Steril, V89, pe41, DOI 10.1016/j.fertnstert.2007.12.023; Rubin BS, 2011, J STEROID BIOCHEM, V127, P27, DOI 10.1016/j.jsbmb.2011.05.002; Sakamoto S, 2009, CHEM REC, V9, P66, DOI 10.1002/tcr.20170; Someya M, 2006, CARCINOGENESIS, V27, P117, DOI 10.1093/carcin/bgi175; Stahlhut RW, 2009, ENVIRON HEALTH PERSP, V117, P784, DOI 10.1289/ehp.0800376; Stiff T, 2004, CANCER RES, V64, P2390, DOI 10.1158/0008-5472.CAN-03-3207; Veuger SJ, 2003, CANCER RES, V63, P6008; Welshons WV, 2003, ENVIRON HEALTH PERSP, V111, P994, DOI 10.1289/ehp.5494; Yu YJ, 2001, CANCER RES, V61, P1820; Zhao Y, 2006, CANCER RES, V66, P5354, DOI 10.1158/0008-5472.CAN-05-4275; Zhu HT, 2009, J PEDIATR SURG, V44, P672, DOI 10.1016/j.jpedsurg.2008.10.067	41	15	15	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 5	2012	7	12							e50481	10.1371/journal.pone.0050481	http://dx.doi.org/10.1371/journal.pone.0050481			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	057TZ	23227178	Green Submitted, Green Published, gold			2022-12-27	WOS:000312588200038
J	Kuo, KL; Hung, SC; Lin, YP; Tang, CF; Lee, TS; Lin, CP; Tarng, DC				Kuo, Ko-Lin; Hung, Szu-Chun; Lin, Yao-Ping; Tang, Ching-Fang; Lee, Tzong-Shyuan; Lin, Chih-Pei; Tarng, Der-Cherng			Intravenous Ferric Chloride Hexahydrate Supplementation Induced Endothelial Dysfunction and Increased Cardiovascular Risk among Hemodialysis Patients	PLOS ONE			English	Article							TRANSCRIPTION FACTOR ACTIVATION; ADHESION MOLECULE EXPRESSION; OXYGEN SPECIES GENERATION; MEDIATED FENTON REACTIONS; CARDIAC SYNDROME-X; BODY IRON STORES; NF-KAPPA B; MYOCARDIAL-INFARCTION; PARENTERAL IRON; NADPH OXIDASE	Background: The association between intravenous (IV) iron administration and outcomes in hemodialysis (HD) patients is still debated. Therefore, this study was aimed to assess the relationship between the IV administration of ferric chloride hexahydrate (Atofen (R)) and cardiovascular (CV) outcome and the interaction between iron-induced oxidative stress and endothelial dysfunction in chronic HD patients. Methodology/Principal Findings: A cohort of 1239 chronic HD patients was recruited. In a follow-up of 12 months, Kaplan-Meier survival curves showed that higher doses of IV Atofen associated with higher risks for CV events and deaths in HD patients. In multivariate Cox models, compared to no iron supplementation, IV Atofen administration was an independent predictor for CV events and overall mortality. However, the nature of the observational cohort study possibly bears selection bias. We further found that IV Atofen enhanced the superoxide production of mononuclear cells (MNCs), the levels of circulating soluble adhesion molecules, and the adhesion of MNCs to human aortic endothelial cells (HAECs). In vitro experiments showed that Atofen increased the expression of intracellular cell adhesion molecule-1 and vascular cell adhesion molecule-1 in HAECs and aggravated the endothelial adhesiveness in a dose-dependent manner. These iron-induced changes were significantly attenuated by the co-treatment of HAECs with N-acetylcysteine and inhibitors of NADPH oxidase, nuclear factor kappa B, and activator protein-1. Conclusion: A cumulative dose of IV Atofen > 800 mg within 6 months was associated with an adverse CV outcome and a higher mortality among chronic HD patients. The detrimental effects of IV iron supplementation were partly due to the increased oxidative stress and induction of MNC adhesion to endothelial cells, a pivotal index of early atherogenesis. Citation: Kuo K-L, Hung S-C, Lin Y-P, Tang C-F, Lee T-S, et al. (2012) Intravenous Ferric Chloride Hexahydrate Supplementation Induced Endothelial Dysfunction and Increased Cardiovascular Risk among Hemodialysis Patients. PLoS ONE 7(12): e50295. doi:10.1371/journal.pone.0050295	[Kuo, Ko-Lin; Lee, Tzong-Shyuan; Tarng, Der-Cherng] Natl Yang Ming Univ, Dept & Inst Physiol, Taipei 112, Taiwan; [Tarng, Der-Cherng] Natl Yang Ming Univ, Inst Clin Med, Taipei 112, Taiwan; [Lin, Chih-Pei] Natl Yang Ming Univ, Dept Biotechnol & Lab Sci Med, Taipei 112, Taiwan; [Lin, Chih-Pei] Natl Yang Ming Univ, Inst Biotechnol Med, Taipei 112, Taiwan; [Kuo, Ko-Lin; Hung, Szu-Chun] Tzu Chi Univ, Sch Med, Hualien, Taiwan; [Kuo, Ko-Lin; Hung, Szu-Chun] Buddhist Tzu Chi Gen Hosp, Taipei Branch, Div Nephrol, Taipei, Taiwan; [Lin, Chih-Pei] Taipei Vet Gen Hosp, Dept Pathol & Lab Med, Div Gen Lab, Taipei, Taiwan; [Lin, Yao-Ping; Tang, Ching-Fang; Tarng, Der-Cherng] Taipei Vet Gen Hosp, Dept Med, Div Nephrol, Taipei, Taiwan; [Lin, Yao-Ping; Tang, Ching-Fang; Tarng, Der-Cherng] Taipei Vet Gen Hosp, Ctr Immunol, Taipei, Taiwan	National Yang Ming Chiao Tung University; National Yang Ming Chiao Tung University; National Yang Ming Chiao Tung University; National Yang Ming Chiao Tung University; Tzu Chi University; Buddhist Tzu Chi General Hospital; Taipei Veterans General Hospital; Taipei Veterans General Hospital; Taipei Veterans General Hospital	Lin, CP (corresponding author), Natl Yang Ming Univ, Dept Biotechnol & Lab Sci Med, Taipei 112, Taiwan.	cplin@vghtpe.gov.tw; dctarng@vghtpe.gov.tw	Lee, Tzong-Shyuan/AAE-5803-2020	Lee, Tzong-Shyuan/0000-0002-9593-4062; Kuo, Ko-Lin/0000-0002-7477-0388	National Science Council [NSC 96-2628-B-010-001-MY3, NSC 99-2314-B-303-002-MY3]; Taipei Veterans General Hospital [V100C-143, V100E4-003]; Ministry of Education's Aim for the Top University Plan; Taipei Tzu Chi General Hospital [TCRD-TPE-97-15]	National Science Council(Ministry of Science and Technology, Taiwan); Taipei Veterans General Hospital(Taipei Veterans General Hospital); Ministry of Education's Aim for the Top University Plan(Ministry of Education, Taiwan); Taipei Tzu Chi General Hospital	This work was supported by grants from the National Science Council (NSC 96-2628-B-010-001-MY3 and NSC 99-2314-B-303-002-MY3), Taipei Veterans General Hospital (V100C-143 and V100E4-003), Ministry of Education's Aim for the Top University Plan, and Taipei Tzu Chi General Hospital (TCRD-TPE-97-15). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Besarab A, 2000, J AM SOC NEPHROL, V11, P530, DOI 10.1681/ASN.V113530; Carlini RG, 2006, NEPHROL DIAL TRANSPL, V21, P3055, DOI 10.1093/ndt/gfl341; Chen JW, 2004, ARTERIOSCL THROM VAS, V24, P2075, DOI 10.1161/01.ATV.0000145016.69181.fa; Chen JW, 2003, ARTERIOSCL THROM VAS, V23, P1559, DOI 10.1161/01.ATV.0000089012.73180.63; DiDonato JA, 1997, NATURE, V388, P548, DOI 10.1038/41493; Drueke T, 2002, CIRCULATION, V106, P2212, DOI 10.1161/01.CIR.0000035250.66458.67; EVANS PJ, 1995, FREE RADICAL RES, V23, P465, DOI 10.3109/10715769509065267; Feldman HI, 2004, J AM SOC NEPHROL, V15, P1623, DOI 10.1097/01.ASN.0000128009.69594.BE; Feldman HI, 2002, J AM SOC NEPHROL, V13, DOI 10.1681/ASN.V133734; Griendling KK, 2000, ARTERIOSCL THROM VAS, V20, P2175, DOI 10.1161/01.ATV.20.10.2175; Griendling KK, 2001, J CLIN INVEST, V108, P1423, DOI 10.1172/JCI200114453; HEINECKE JW, 1984, J CLIN INVEST, V74, P1890, DOI 10.1172/JCI111609; Henle ES, 1996, J BIOL CHEM, V271, P21177, DOI 10.1074/jbc.271.35.21177; Hoen B, 1998, J AM SOC NEPHROL, V9, P869; Horl WH, 2007, J AM SOC NEPHROL, V18, P382, DOI 10.1681/ASN.2006080856; Ikeda Y, 2011, ATHEROSCLEROSIS, V215, P339, DOI 10.1016/j.atherosclerosis.2011.01.009; Kalantar-Zadeh K, 2005, J AM SOC NEPHROL, V16, P3070, DOI 10.1681/ASN.2005040423; Kartikasari AER, 2004, ARTERIOSCL THROM VAS, V24, P2257, DOI 10.1161/01.ATV.0000147406.00871.b3; Kiechl S, 1997, CIRCULATION, V96, P3300; Klipstein-Grobusch K, 1999, AM J CLIN NUTR, V69, P1231; Kuo KL, 2008, J AM SOC NEPHROL, V19, P1817, DOI 10.1681/ASN.2007101084; Kurtoglu E, 2003, BIOL TRACE ELEM RES, V96, P109, DOI 10.1385/BTER:96:1-3:109; Lee TS, 1999, CIRCULATION, V99, P1222, DOI 10.1161/01.CIR.99.9.1222; Leu HB, 2006, FREE RADICAL BIO MED, V40, P983, DOI 10.1016/j.freeradbiomed.2005.10.047; Li LX, 2009, ARTERIOSCL THROM VAS, V29, P732, DOI 10.1161/ATVBAHA.108.183210; Lim CS, 2004, KIDNEY INT, V65, P1802, DOI 10.1111/j.1523-1755.2004.00580.x; Lin CP, 2008, EUR J CLIN INVEST, V38, P106, DOI 10.1111/j.1365-2362.2007.01911.x; Lin CP, 2008, J BIOMED SCI, V15, P183, DOI 10.1007/s11373-007-9212-0; Lin CP, 2003, INT J CARDIOL, V89, P53, DOI 10.1016/S0167-5273(02)00428-X; Luo YZ, 1996, J BIOL CHEM, V271, P21167, DOI 10.1074/jbc.271.35.21167; Martin T, 1997, EUR J IMMUNOL, V27, P1091, DOI 10.1002/eji.1830270508; Parfrey PS, 2005, J AM SOC NEPHROL, V16, P2180, DOI 10.1681/ASN.2004121039; Rooyakkers TM, 2002, EUR J CLIN INVEST, V32, P9, DOI 10.1046/j.1365-2362.2002.0320s1009.x; Ross R, 1999, NEW ENGL J MED, V340, P115, DOI 10.1056/NEJM199901143400207; SALONEN JT, 1992, CIRCULATION, V86, P803, DOI 10.1161/01.CIR.86.3.803; Sengoelge G, 2003, J AM SOC NEPHROL, V14, P2639, DOI 10.1097/01.ASN.0000087087.61306.4A; SMITH C, 1992, BIOCHEM J, V286, P901, DOI 10.1042/bj2860901; Stadler N, 2004, ARTERIOSCL THROM VAS, V24, P949, DOI 10.1161/01.ATV.0000124892.90999.cb; SULLIVAN JL, 1981, LANCET, V1, P1293; SUNDERPLASSMANN G, 1995, NEPHROL DIAL TRANSPL, V10, P2070; Tuomainen TP, 1998, CIRCULATION, V97, P1461; Yin WH, 2007, INT J CARDIOL, V121, P276, DOI 10.1016/j.ijcard.2006.11.012; Zager RA, 2002, AM J KIDNEY DIS, V40, P90, DOI 10.1053/ajkd.2002.33917; Zager RA, 2004, KIDNEY INT, V66, P144, DOI 10.1111/j.1523-1755.2004.00716.x; Zhu Y, 1998, ARTERIOSCL THROM VAS, V18, P473, DOI 10.1161/01.ATV.18.3.473	45	58	59	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 5	2012	7	12							e50295	10.1371/journal.pone.0050295	http://dx.doi.org/10.1371/journal.pone.0050295			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	057TZ	23227165	Green Submitted, gold, Green Published			2022-12-27	WOS:000312588200026
J	Li, YQ; Long, JY; He, L; Lu, HD; Gu, ZH; Sun, P				Li, Yuanqing; Long, Jinyi; He, Lin; Lu, Haidong; Gu, Zhenghui; Sun, Pei			A Sparse Representation-Based Algorithm for Pattern Localization in Brain Imaging Data Analysis	PLOS ONE			English	Article							SUPPORT VECTOR MACHINES; MONKEY STRIATE CORTEX; HUMAN EXTRASTRIATE CORTEX; FUNCTIONAL ARCHITECTURE; RECEPTIVE FIELDS; VISUAL-CORTEX; FMRI DATA; FACES; CLASSIFICATION; ORIENTATION	Considering the two-class classification problem in brain imaging data analysis, we propose a sparse representation-based multi-variate pattern analysis (MVPA) algorithm to localize brain activation patterns corresponding to different stimulus classes/brain states respectively. Feature selection can be modeled as a sparse representation (or sparse regression) problem. Such technique has been successfully applied to voxel selection in fMRI data analysis. However, single selection based on sparse representation or other methods is prone to obtain a subset of the most informative features rather than all. Herein, our proposed algorithm recursively eliminates informative features selected by a sparse regression method until the decoding accuracy based on the remaining features drops to a threshold close to chance level. In this way, the resultant feature set including all the identified features is expected to involve all the informative features for discrimination. According to the signs of the sparse regression weights, these selected features are separated into two sets corresponding to two stimulus classes/brain states. Next, in order to remove irrelevant/noisy features in the two selected feature sets, we perform a nonparametric permutation test at the individual subject level or the group level. In data analysis, we verified our algorithm with a toy data set and an intrinsic signal optical imaging data set. The results show that our algorithm has accurately localized two class-related patterns. As an application example, we used our algorithm on a functional magnetic resonance imaging (fMRI) data set. Two sets of informative voxels, corresponding to two semantic categories (i.e., "old people'' and "young people''), respectively, are obtained in the human brain. Citation: Li Y, Long J, He L, Lu H, Gu Z, et al. (2012) A Sparse Representation-Based Algorithm for Pattern Localization in Brain Imaging Data Analysis. PLoS ONE 7(12): e50332. doi:10.1371/journal.pone.0050332	[Li, Yuanqing; Long, Jinyi; He, Lin; Gu, Zhenghui] S China Univ Technol, Ctr Brain Comp Interfaces & Brain Informat Proc, Guangzhou, Guangdong, Peoples R China; [Lu, Haidong] Chinese Acad Sci, Shanghai Inst Biol Sci, Inst Neurosci, State Key Lab Neurosci, Shanghai, Peoples R China; [Sun, Pei] RIKEN, Brain Sci Inst, Lab Cognit Brain Mapping, Wako, Saitama, Japan; [Sun, Pei] Tsinghua Univ, Dept Psychol, Beijing 100084, Peoples R China	South China University of Technology; Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; RIKEN; Tsinghua University	Li, YQ (corresponding author), S China Univ Technol, Ctr Brain Comp Interfaces & Brain Informat Proc, Guangzhou, Guangdong, Peoples R China.	auyqli@scut.edu.cn; psun@brain.riken.jp	Sun, Pei/B-5191-2013	Sun, Pei/0000-0003-4184-1079	National High-Tech R&D Program of China (863 Program) [2012AA011601]; National Natural Science Foundation of China [91120305, 60825306, 61105121]; High Level Talent Project of Guangdong Province, People's Republic of China	National High-Tech R&D Program of China (863 Program)(National High Technology Research and Development Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); High Level Talent Project of Guangdong Province, People's Republic of China	This work was supported by National High-Tech R&D Program of China (863 Program) under grant 2012AA011601, the National Natural Science Foundation of China under grants 91120305, 60825306 and 61105121, and High Level Talent Project of Guangdong Province, People's Republic of China. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BERRY DS, 1986, PSYCHOL BULL, V100, P3, DOI 10.1037/0033-2909.100.1.3; Bishop C. M, 2006, PATTERN RECOGNITION; BLASDEL GG, 1992, J NEUROSCI, V12, P3139, DOI 10.1523/JNEUROSCI.12-08-03139.1992; Blekas K, 2010, IEEE T BIOMEDICAL EN, P1; Bruce V, 1998, EYE BEHOLDER SCI FAC, Vx; BURT DM, 1995, P ROY SOC B-BIOL SCI, V259, P137, DOI 10.1098/rspb.1995.0021; Carroll MK, 2009, NEUROIMAGE, V44, P112, DOI 10.1016/j.neuroimage.2008.08.020; Chen Y, 2011, NEUROIMAGE, V56, P582, DOI 10.1016/j.neuroimage.2010.07.035; CORBETTA M, 1991, CIBA F SYMP, V163, P165; CORBETTA M, 1991, J NEUROSCI, V11, P2383; De Martino F, 2008, NEUROIMAGE, V43, P44, DOI 10.1016/j.neuroimage.2008.06.037; Formisano E, 2008, SCIENCE, V322, P970, DOI 10.1126/science.1164318; Friston KJ, 1994, HUMAN BRAIN MAPPING, V2, P189, DOI DOI 10.1002/HBM.460020402; FROSTIG RD, 1990, P NATL ACAD SCI USA, V87, P6082, DOI 10.1073/pnas.87.16.6082; Goebel R, 2009, EXP BRAIN RES, V198, P153, DOI 10.1007/s00221-009-1881-7; Guyon I, 2002, MACH LEARN, V46, P389, DOI 10.1023/A:1012487302797; Hanson SJ, 2008, NEURAL COMPUT, V20, P486, DOI 10.1162/neco.2007.09-06-340; HAXBY JV, 1991, P NATL ACAD SCI USA, V88, P1621, DOI 10.1073/pnas.88.5.1621; Haxby JV, 2001, SCIENCE, V293, P2425, DOI 10.1126/science.1063736; HAXBY JV, 1994, J NEUROSCI, V14, P6336; Haynes JD, 2005, NAT NEUROSCI, V8, P686, DOI 10.1038/nn1445; HUBEL DH, 1968, J PHYSIOL-LONDON, V195, P215, DOI 10.1113/jphysiol.1968.sp008455; HUBEL DH, 1962, J PHYSIOL-LONDON, V160, P106, DOI 10.1113/jphysiol.1962.sp006837; Kamitani Y, 2005, NAT NEUROSCI, V8, P679, DOI 10.1038/nn1444; Kriegeskorte N, 2006, P NATL ACAD SCI USA, V103, P3863, DOI 10.1073/pnas.0600244103; LaConte S, 2005, NEUROIMAGE, V26, P317, DOI 10.1016/j.neuroimage.2005.01.048; Laird AR, 2005, HUM BRAIN MAPP, V25, P155, DOI 10.1002/hbm.20136; Langs G, 2011, NEUROIMAGE, V56, P497, DOI 10.1016/j.neuroimage.2010.07.074; Lee K, 2011, IEEE T MED IMAGING, V30, P1076, DOI 10.1109/TMI.2010.2097275; Li YQ, 2009, IEEE T BIO-MED ENG, V56, P2439, DOI 10.1109/TBME.2009.2025866; Lu HDD, 2010, NEURON, V68, P1002, DOI 10.1016/j.neuron.2010.11.020; Mitchell TM, 2008, SCIENCE, V320, P1191, DOI 10.1126/science.1152876; Miyawaki Y, 2008, NEURON, V60, P915, DOI 10.1016/j.neuron.2008.11.004; Mouao-Miranda J, 2007, NEUROIMAGE, V36, P88, DOI 10.1016/j.neuroimage.2007.02.020; Mourao-Miranda J, 2005, NEUROIMAGE, V28, P980, DOI 10.1016/j.neuroimage.2005.06.070; OBERMAYER K, 1993, J NEUROSCI, V13, P4114; Penny W., 2003, RANDOM EFFECTS ANAL; Pereira F., 2007, BRAIN BLOBS MACHINE; Pereira F, 2009, NEUROIMAGE, V45, pS199, DOI 10.1016/j.neuroimage.2008.11.007; Polyn SM, 2005, SCIENCE, V310, P1963, DOI 10.1126/science.1117645; Raizada RDS, 2010, NEUROIMAGE, V51, P462, DOI 10.1016/j.neuroimage.2010.01.080; Taylor KI, 2006, P NATL ACAD SCI USA, V103, P8239, DOI 10.1073/pnas.0509704103; Wang Z, 2007, NEUROIMAGE, V36, P1139, DOI 10.1016/j.neuroimage.2007.03.072; Yamashita O, 2008, NEUROIMAGE, V42, P1414, DOI 10.1016/j.neuroimage.2008.05.050	44	21	22	1	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 5	2012	7	12							e50332	10.1371/journal.pone.0050332	http://dx.doi.org/10.1371/journal.pone.0050332			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	057TZ	23227167	gold, Green Published			2022-12-27	WOS:000312588200028
J	van der Waart, AB; van der Velden, WJFM; van Halteren, AGS; Leenders, MJLG; Feuth, T; Blijlevens, NMA; van der Voort, R; Dolstra, H				van der Waart, Anniek B.; van der Velden, Walter J. F. M.; van Halteren, Astrid G. S.; Leenders, Marij J. L. G.; Feuth, Ton; Blijlevens, Nicole M. A.; van der Voort, Robbert; Dolstra, Harry			Decreased Levels of Circulating IL17-Producing CD161(+)CCR6(+) T Cells Are Associated with Graft-versus-Host Disease after Allogeneic Stem Cell Transplantation	PLOS ONE			English	Article							TH17 CELLS; MULTIPLE-SCLEROSIS; PERIPHERAL-BLOOD; CD161 EXPRESSION; TNF-ALPHA; LYMPHOCYTES; DIFFERENTIATION; POLYMORPHISMS; EXPANSION; LEUKEMIA	The C-type lectin-like receptor CD161 is a well-established marker for human IL17-producing T cells, which have been implicated to contribute to the development of graft-versus-host disease (GVHD) after allogeneic stem cell transplantation (allo-SCT). In this study, we analyzed CD161(+) T cell recovery, their functional properties and association with GVHD occurrence in allo-SCT recipients. While CD161(+)CD4(+) T cells steadily recovered, CD161(hi)CD8(+) T cell numbers declined during tapering of Cyclosporine A (CsA), which can be explained by their initial growth advantage over CD161(neg/low)CD8(+) T cells due to ABCB1-mediated CsA efflux. Interestingly, occurrence of acute and chronic GVHD was significantly correlated with decreased levels of circulating CD161(+)CD4(+) as well as CD161(hi)CD8(+) T cells. In addition, these subsets from transplanted patients secreted high levels of IFN gamma and IL17. Moreover, we found that CCR6 co-expression by CD161(+) T cells mediated specific migration towards CCL20, which was expressed in GVHD biopsies. Finally, we demonstrated that CCR6(+) T cells indeed were present in these CCL20(+) GVHD-affected tissues. In conclusion, we showed that functional CD161(+)CCR6(+) co-expressing T cells disappear from the circulation and home to GVHD-affected tissue sites. These findings support the hypothesis that CCR6(+)CD161-expressing T cells may be involved in the immune pathology of GVHD following their CCL20-dependent recruitment into affected tissues.	[van der Waart, Anniek B.; Leenders, Marij J. L. G.; van der Voort, Robbert; Dolstra, Harry] Radboud Univ Nijmegen, Med Ctr, Dept Lab Med, Hematol Lab, NL-6525 ED Nijmegen, Netherlands; [van der Velden, Walter J. F. M.; Blijlevens, Nicole M. A.] Radboud Univ Nijmegen, Med Ctr, Dept Hematol, NL-6525 ED Nijmegen, Netherlands; [van Halteren, Astrid G. S.] Leiden Univ, Med Ctr, Immunol Lab, Dept Pediat, Leiden, Netherlands; [Feuth, Ton] Radboud Univ Nijmegen, Med Ctr, Dept Epidemiol Biostat & Hlth Technol Assessment, NL-6525 ED Nijmegen, Netherlands	Radboud University Nijmegen; Radboud University Nijmegen; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Radboud University Nijmegen	Dolstra, H (corresponding author), Radboud Univ Nijmegen, Med Ctr, Dept Lab Med, Hematol Lab, NL-6525 ED Nijmegen, Netherlands.	H.Dolstra@labgk.umcn.nl	van der Waart, Anniek/AAD-9606-2020; Dolstra, H./L-4276-2015; Blijlevens, N.M.A./H-8012-2014; van der Velden, Walter/D-2216-2016; van der Waart, Anniek B/O-4185-2015	van der Waart, Anniek/0000-0001-5986-3060; Dolstra, H./0000-0002-3998-687X; van der Waart, Anniek B/0000-0001-5986-3060	Vanderes Foundation	Vanderes Foundation	This work was supported by a research grant from the Vanderes Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aldemir H, 2005, J IMMUNOL, V175, P7791, DOI 10.4049/jimmunol.175.12.7791; Annels NE, 2003, J EXP MED, V197, P1385, DOI 10.1084/jem.20030137; Annibali V, 2011, BRAIN, V134, P542, DOI 10.1093/brain/awq354; Billerbeck E, 2010, P NATL ACAD SCI USA, V107, P3006, DOI 10.1073/pnas.0914839107; Bossard C, 2012, LEUKEMIA; Broady R, 2010, BLOOD, V116, P5748, DOI 10.1182/blood-2010-07-295436; Broen K, 2011, BIOL BLOOD MARROW TR, V17, P1443, DOI 10.1016/j.bbmt.2011.07.004; Carlson MJ, 2009, BLOOD, V113, P1365, DOI 10.1182/blood-2008-06-162420; Choudhuri S, 2006, INT J TOXICOL, V25, P231, DOI 10.1080/10915810600746023; Cosmi L, 2008, J EXP MED, V205, P1903, DOI 10.1084/jem.20080397; Dander E, 2009, TRANSPLANTATION, V88, P1261, DOI 10.1097/TP.0b013e3181bc267e; Dusseaux M, 2011, BLOOD, V117, P1250, DOI 10.1182/blood-2010-08-303339; Eissens DN, 2010, LEUKEMIA, V24, P583, DOI 10.1038/leu.2009.269; Ersvaer E, 2011, CANCER IMMUNOL IMMUN, V60, P1669, DOI 10.1007/s00262-011-1118-z; Ferrara JLM, 2009, LANCET, V373, P1550, DOI 10.1016/S0140-6736(09)60237-3; Ferrara JLM, 2006, SEMIN HEMATOL, V43, P3, DOI 10.1053/j.seminhematol.2005.09.001; Hendriks MP, 2006, BONE MARROW TRANSPL, V38, P521, DOI 10.1038/sj.bmt.1705481; Hill GR, 1999, J CLIN INVEST, V104, P459, DOI 10.1172/JCI6896; Hirata T, 2010, ENDOCRINOLOGY, V151, P5468, DOI 10.1210/en.2010-0398; Huarte E, 2008, BLOOD, V112, P1259, DOI 10.1182/blood-2007-12-130773; Kappel LW, 2009, BLOOD, V113, P945, DOI 10.1182/blood-2008-08-172155; LANIER LL, 1994, J IMMUNOL, V153, P2417; Lee SJ, 2003, BIOL BLOOD MARROW TR, V9, P215, DOI 10.1053/bbmt.2003.50026; Maggi L, 2010, EUR J IMMUNOL, V40, P2174, DOI 10.1002/eji.200940257; Mitsuo A, 2006, RHEUMATOLOGY, V45, P1477, DOI 10.1093/rheumatology/kel119; Mohty M, 2008, CYTOKINE GROWTH F R, V19, P53, DOI 10.1016/j.cytogfr.2007.10.010; Nikolic B, 2000, J CLIN INVEST, V105, P1289, DOI 10.1172/JCI7894; Nistala K, 2010, P NATL ACAD SCI USA, V107, P14751, DOI 10.1073/pnas.1003852107; Northfield JW, 2008, HEPATOLOGY, V47, P396, DOI 10.1002/hep.22040; Overes IM, 2008, BRIT J HAEMATOL, V141, P799, DOI 10.1111/j.1365-2141.2008.07125.x; Poggi A, 1997, IMMUNOL LETT, V57, P121, DOI 10.1016/S0165-2478(97)00050-3; Poggi A, 1999, J IMMUNOL, V162, P4349; PRZEPIORKA D, 1995, BONE MARROW TRANSPL, V15, P825; Ratajczak P, 2010, BLOOD, V116, P1165, DOI 10.1182/blood-2009-12-255810; Schaap N, 2001, LEUKEMIA, V15, P1339, DOI 10.1038/sj.leu.2402203; Schmuth M, 2002, EXP DERMATOL, V11, P135, DOI 10.1034/j.1600-0625.2002.110205.x; Schutyser E, 2003, CYTOKINE GROWTH F R, V14, P409, DOI 10.1016/S1359-6101(03)00049-2; Shlomchik WD, 2007, NAT REV IMMUNOL, V7, P340, DOI 10.1038/nri2000; Socie G, 2009, BLOOD, V114, P4327, DOI 10.1182/blood-2009-06-204669; Takahashi T, 2006, J IMMUNOL, V176, P211, DOI 10.4049/jimmunol.176.1.211; Turtle CJ, 2011, BLOOD, V118, P2752, DOI 10.1182/blood-2011-02-334698; Turtle CJ, 2009, IMMUNITY, V31, P834, DOI 10.1016/j.immuni.2009.09.015; Welniak LA, 2007, ANNU REV IMMUNOL, V25, P139, DOI 10.1146/annurev.immunol.25.022106.141606; Yi TS, 2008, BLOOD, V112, P2101, DOI 10.1182/blood-2007-12-126987; Yi TS, 2009, BLOOD, V114, P3101, DOI 10.1182/blood-2009-05-219402; Zeis M, 2001, Hematol J, V2, P136, DOI 10.1038/sj.thj.6200087	46	30	32	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 4	2012	7	12							e50896	10.1371/journal.pone.0050896	http://dx.doi.org/10.1371/journal.pone.0050896			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	051EQ	23226545	Green Published, Green Submitted, gold			2022-12-27	WOS:000312108500033
J	Collins, MA; Brisset, JC; Zhang, YQ; Bednar, F; Pierre, J; Heist, KA; Galban, CJ; Galban, S; di Magliano, MP				Collins, Meredith A.; Brisset, Jean-Christophe; Zhang, Yaqing; Bednar, Filip; Pierre, Josette; Heist, Kevin A.; Galban, Craig J.; Galban, Stefanie; di Magliano, Marina Pasca			Metastatic Pancreatic Cancer Is Dependent on Oncogenic Kras in Mice	PLOS ONE			English	Article							DUCTAL ADENOCARCINOMA; MOUSE MODELS; TUMOR MAINTENANCE; ORTHOTOPIC MODEL; MYC; REGRESSION; LESIONS; RAS; TUMORIGENESIS; INACTIVATION	Pancreatic cancer is one of the deadliest human malignancies, and its prognosis has not improved over the past 40 years. Mouse models that spontaneously develop pancreatic adenocarcinoma and mimic the progression of the human disease are emerging as a new tool to investigate the basic biology of this disease and identify potential therapeutic targets. Here, we describe a new model of metastatic pancreatic adenocarcinoma based on pancreas-specific, inducible and reversible expression of an oncogenic form of Kras, together with pancreas-specific expression of a mutant form of the tumor suppressor p53. Using high-resolution magnetic resonance imaging to follow individual animals in longitudinal studies, we show that both primary and metastatic lesions depend on continuous Kras activity for their maintenance. However, reactivation of Kras* following prolonged inactivation leads to rapid tumor relapse, raising the concern that Kras*-resistance might eventually be acquired. Thus, our data identifies Kras* as a key oncogene in pancreatic cancer maintenance, but raises the possibility of acquired resistance should Kras inhibitors become available for use in pancreatic cancer.	[Collins, Meredith A.; di Magliano, Marina Pasca] Univ Michigan, Cellular & Mol Biol Program, Ann Arbor, MI 48109 USA; [Brisset, Jean-Christophe; Heist, Kevin A.; Galban, Craig J.] Univ Michigan, Dept Radiol, Ann Arbor, MI 48109 USA; [Brisset, Jean-Christophe; Heist, Kevin A.; Galban, Craig J.; Galban, Stefanie] Univ Michigan, Ctr Mol Imaging, Ann Arbor, MI 48109 USA; [Zhang, Yaqing; Bednar, Filip; Pierre, Josette; di Magliano, Marina Pasca] Univ Michigan, Dept Surg, Ann Arbor, MI 48109 USA; [Galban, Stefanie] Univ Michigan, Dept Radiat Oncol, Ann Arbor, MI 48109 USA; [Galban, Craig J.; Galban, Stefanie; di Magliano, Marina Pasca] Univ Michigan, Ctr Comprehens Canc, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan	di Magliano, MP (corresponding author), Univ Michigan, Cellular & Mol Biol Program, Ann Arbor, MI 48109 USA.	marinapa@umich.edu	Brisset, Jean-Christophe/M-1227-2014; zhang, yaqing/C-2283-2015	Brisset, Jean-Christophe/0000-0002-7947-3622; Pasca di Magliano, Marina/0000-0001-9632-9035	University of Michigan Biological Scholar Program; GI SPORE [P50CA13810]; US National Institutes of Health research [P50CA93990]; NIH [P50 CA093990, T32 HD007505]; University of Michigan Program in Cellular and Molecular Biology training grant (NIH) [T32 GM07315]; University of Michigan Center for Organogenesis Training Grant [5-T32-HD007515]; American College of Surgeons Resident Research Scholarship; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [T32HD007505] Funding Source: NIH RePORTER; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [F32HD007515] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [P50CA130810, P50CA093990, R01CA151588] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007315] Funding Source: NIH RePORTER	University of Michigan Biological Scholar Program; GI SPORE; US National Institutes of Health research; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of Michigan Program in Cellular and Molecular Biology training grant (NIH); University of Michigan Center for Organogenesis Training Grant; American College of Surgeons Resident Research Scholarship; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This project was supported by the University of Michigan Biological Scholar Program and by GI SPORE, P50CA13810 (Pilot Grant to MPdM) and by the US National Institutes of Health research grant P50CA93990. MRI conducted by the Center for Molecular Imaging is supported by NIH P50 CA093990. MAC is supported by a University of Michigan Program in Cellular and Molecular Biology training grant (NIH T32 GM07315) and by a University of Michigan Center for Organogenesis Training Grant (5-T32-HD007515). FB is supported by the American College of Surgeons Resident Research Scholarship and by NIH T32 HD007505. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abasolo I, 2009, EUR J NUCL MED MOL I, V36, P1156, DOI 10.1007/s00259-009-1083-3; Aguirre AJ, 2003, GENE DEV, V17, P3112, DOI 10.1101/gad.1158703; Bardeesy N, 2006, P NATL ACAD SCI USA, V103, P5947, DOI 10.1073/pnas.0601273103; Belteki G, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni051; Boxer RB, 2004, CANCER CELL, V6, P577, DOI 10.1016/j.ccr.2004.10.013; Caulin C, 2007, J CLIN INVEST, V117, P1893, DOI 10.1172/JCI31721; Chin L, 1999, NATURE, V400, P468, DOI 10.1038/22788; Collins MA, 2012, J CLIN INVEST, V122, P639, DOI 10.1172/JCI59227; Collisson EA, 2011, NAT MED, V17, P500, DOI 10.1038/nm.2344; D'Cruz CM, 2001, NAT MED, V7, P235, DOI 10.1038/84691; Debies MT, 2008, J CLIN INVEST, V118, P51, DOI 10.1172/JCI33320; Felsher DW, 1999, MOL CELL, V4, P199, DOI 10.1016/S1097-2765(00)80367-6; Fendrich V, 2011, NEOPLASIA, V13, P180, DOI 10.1593/neo.10956; Fisher GH, 2001, GENE DEV, V15, P3249, DOI 10.1101/gad.947701; Fukuda A, 2011, CANCER CELL, V19, P441, DOI 10.1016/j.ccr.2011.03.002; Grimm J, 2003, INT J CANCER, V106, P806, DOI 10.1002/ijc.11281; He ZQ, 2000, PANCREAS, V21, P69, DOI 10.1097/00006676-200007000-00054; Hezel AF, 2006, GENE DEV, V20, P1218, DOI 10.1101/gad.1415606; Hingorani SR, 2003, CANCER CELL, V4, P437, DOI 10.1016/S1535-6108(03)00309-X; Hingorani SR, 2005, CANCER CELL, V7, P469, DOI 10.1016/j.ccr.2005.04.023; Hruban RH, 2001, AM J SURG PATHOL, V25, P579, DOI 10.1097/00000478-200105000-00003; Jackson EL, 2005, CANCER RES, V65, P10280, DOI 10.1158/0008-5472.CAN-05-2193; Jones S, 2008, SCIENCE, V321, P1801, DOI 10.1126/science.1164368; Kanda M, 2012, GASTROENTEROLOGY; Kawaguchi Y, 2002, NAT GENET, V32, P128, DOI 10.1038/ng959; Moody SE, 2005, CANCER CELL, V8, P197, DOI 10.1016/j.ccr.2005.07.009; Morris JP, 2010, NAT REV CANCER, V10, P683, DOI 10.1038/nrc2899; Morris JP, 2010, J CLIN INVEST, V120, P508, DOI 10.1172/JCI40045; Morton JP, 2010, P NATL ACAD SCI USA, V107, P246, DOI 10.1073/pnas.0908428107; Olive KP, 2006, CLIN CANCER RES, V12, P5277, DOI 10.1158/1078-0432.CCR-06-0436; Olive KP, 2009, SCIENCE, V324, P1457, DOI 10.1126/science.1171362; Olive KP, 2004, CELL, V119, P847, DOI 10.1016/j.cell.2004.11.004; Petitjean A, 2007, HUM MUTAT, V28, P622, DOI 10.1002/humu.20495; Podsypanina K, 2008, P NATL ACAD SCI USA, V105, P5242, DOI 10.1073/pnas.0801197105; Rakhra K, 2010, CANCER CELL, V18, P485, DOI 10.1016/j.ccr.2010.10.002; Singh A, 2009, CANCER CELL, V15, P489, DOI 10.1016/j.ccr.2009.03.022; Singh M, 2010, NAT BIOTECHNOL, V28, P585, DOI 10.1038/nbt.1640; Ying HQ, 2012, CELL, V149, P656, DOI 10.1016/j.cell.2012.01.058	38	121	123	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 3	2012	7	12							e49707	10.1371/journal.pone.0049707	http://dx.doi.org/10.1371/journal.pone.0049707			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	051DH	23226501	gold, Green Submitted, Green Published			2022-12-27	WOS:000312104700010
J	Aubert, P; Suarez-Farinas, M; Mitsui, H; Johnson-Huang, LM; Harden, JL; Pierson, KC; Dolan, JG; Novitskaya, I; Coats, I; Estes, J; Cowen, EW; Plass, N; Lee, CCR; Sun, HW; Lowes, MA; Goldbach-Mansky, R				Aubert, Pamela; Suarez-Farinas, Mayte; Mitsui, Hiroshi; Johnson-Huang, Leanne M.; Harden, Jamie Lynn; Pierson, Katherine C.; Dolan, Joseph G.; Novitskaya, Inna; Coats, Israel; Estes, Jacob; Cowen, Edward W.; Plass, Nicole; Lee, Chyi-Chia Richard; Sun, Hong-Wei; Lowes, Michelle A.; Goldbach-Mansky, Raphaela			Homeostatic Tissue Responses in Skin Biopsies from NOMID Patients with Constitutive Overproduction of IL-1 beta	PLOS ONE			English	Article							ENDOTOXIN TOLERANCE; SUSTAINED RESPONSE; CIAS1 MUTATIONS; ONSET; NEUTROPHILS; CELLS; LIPOPOLYSACCHARIDE; INFLAMMATION; PROGRESSION; ACTIVATION	The autoinflammatory disorder, Neonatal-onset Multisystem Inflammatory Disease (NOMID) is the most severe phenotype of disorders caused by mutations in CIAS1 that result in increased production and secretion of active IL-1 beta. NOMID patients present with systemic and organ-specific inflammation of the skin, central nervous system and bone, and respond dramatically to treatment with IL-1 blocking agents. We compared the cellular infiltrates and transcriptome of skin biopsies from patients with NOMID (n = 14) before treatment (lesional (LS) and non-lesional (pre-NL) skin) and after treatment (post-NL) with the IL-1 blocker anakinra (recombinant IL-1 receptor antagonist, Kineret (R), Swedish Orphan Biovitrum AB, SOBI), to normal skin (n = 5) to assess tissue responses in the context of untreated and treated disease. Abundant neutrophils distinguish LS skin from pre-NL and post-NL skin. CD11c(+) dermal dendritic cells and CD163(+) macrophages expressed activated caspase-1 and are a likely source of cutaneous IL-1 production. Treatment with anakinra led to the disappearance of neutrophils, but CD3(+) T cells and HLA-DR+ cells remained elevated. Among the upregulated genes IL-6, IL-8, TNF, IL-17A, CCL20, and the neutrophil defensins DEFA1 and DEFA3 were differentially regulated in LS tissues (compared to normal skin). Important significantly downregulated pathways in LS skin included IL-1R/TLR signaling, type I and II cytokine receptor signaling, mitochondrial dysfunction, and antigen presentation. The differential expression and regulation of microRNAs and pathways involved in post-transcriptional modification were suggestive of epigenetic modification in the chronically inflamed tissue. Overall, the dysregulated genes and pathways suggest extensive "adaptive" mechanisms to control inflammation and maintain tissue homeostasis, likely triggered by chronic IL-1 release in the skin of patients with NOMID.	[Aubert, Pamela; Dolan, Joseph G.; Plass, Nicole; Goldbach-Mansky, Raphaela] NIAMS, Translat Autoinflammatory Dis Sect, NIH, Bethesda, MD 20892 USA; [Suarez-Farinas, Mayte; Mitsui, Hiroshi; Johnson-Huang, Leanne M.; Harden, Jamie Lynn; Pierson, Katherine C.; Novitskaya, Inna; Coats, Israel; Lowes, Michelle A.] Rockefeller Univ, Invest Dermatol Lab, New York, NY 10021 USA; [Suarez-Farinas, Mayte] Rockefeller Univ, Ctr Clin & Translat Sci, New York, NY 10021 USA; [Estes, Jacob] SAIC, Frederick, MD USA; [Cowen, Edward W.] NCI, NIH, Bethesda, MD 20892 USA; [Sun, Hong-Wei] NIAMS, Biodata Min & Discovery Sect, NIH, Bethesda, MD USA; [Lee, Chyi-Chia Richard] NCI, Pathol Lab, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS); Rockefeller University; Rockefeller University; Science Applications International Corporation (SAIC); SAIC-Frederick; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Goldbach-Mansky, R (corresponding author), NIAMS, Translat Autoinflammatory Dis Sect, NIH, Bethesda, MD 20892 USA.	goldbacr@arb.niams.nih.gov	Goldbach-Mansky, Raphaela/N-5917-2017; Lee, Chyi-Chia R/I-1938-2013; Suarez-Farinas, Mayte/I-3558-2012; Lee, Chyi-Chia Richard/AAO-1149-2020; Lowes, Michelle A/G-9585-2016	Lee, Chyi-Chia R/0000-0002-5306-7781; Suarez-Farinas, Mayte/0000-0001-8712-3553; Lowes, Michelle A/0000-0003-4256-478X	National Institutes of Health (NIH); Pfizer Inc; National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) Intramural Research Program (IRP); National Institutes of Health (NIH) from the National Center for Research Resources (NCRR) [UL1 RR 024143]; Dana Foundation (Human Immunology Consortium Grant); NIH [UL1 RR024143]; Milstein Program in Medical Research; Doris Duke Charitable Foundation; Regeneron; Novartis; Linda and Leonard Berkowitz Postdoctoral Fellowship;  [1 K23 AR052404];  [1 R01 AR060222]; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR024143] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [ZIEAR041176, R01AR060222, K23AR052404, ZIHAR041173, ZICAR041186, ZIAAR041138, ZIDAR041180] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Pfizer Inc(Pfizer); National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) Intramural Research Program (IRP); National Institutes of Health (NIH) from the National Center for Research Resources (NCRR)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); Dana Foundation (Human Immunology Consortium Grant); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Milstein Program in Medical Research; Doris Duke Charitable Foundation(Doris Duke Charitable Foundation (DDCF)); Regeneron(Regeneron); Novartis(Novartis); Linda and Leonard Berkowitz Postdoctoral Fellowship; ; ; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	This research was completed while PA was a fellow in the Clinical Research Training Program, a public-private partnership supported jointly by the National Institutes of Health (NIH) and Pfizer Inc (via a grant to the Foundation for NIH from Pfizer Inc). This study, including the salaries of PA, JD, NP, H-WS and RG-M was supported through the National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) Intramural Research Program (IRP). Research at Rockefeller University was supported by National Institutes of Health (NIH) grant UL1 RR 024143 from the National Center for Research Resources (NCRR), and through a Pilot Project grant 2008-2009. KCP is supported by the Dana Foundation (Human Immunology Consortium Grant); MSF is partially supported by NIH grant UL1 RR024143 and the Milstein Program in Medical Research; MAL is supported by 1 K23 AR052404 and The Doris Duke Charitable Foundation. Dr RG-M has received grant support from Regeneron and Novartis for clinical studies in patients with CAPS. MAL and JLH were supported by 1 R01 AR060222. LMJ-H was supported by the Linda and Leonard Berkowitz Postdoctoral Fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; Dr RG-M has received grant support from Regeneron and Novartis for clinical studies in patients with CAPS. This research was completed while PA was a fellow in the the Clinical Research Training Program, a public-private partnership supported jointly by the National Institutes of Health and Pfizer Inc (via a grant to the Foundation for NIH from Pfizer Inc). JE is employed by Frederick SAI. This does not alter the authors' adherence to all the PLOS ONE policies on sharing data and materials.	Aksentijevich I, 2002, ARTHRITIS RHEUM-US, V46, P3340, DOI 10.1002/art.10688; Bazzoni F, 2010, EUR J IMMUNOL, V40, P2360, DOI 10.1002/eji.200940294; BEESON PB, 1947, J EXP MED, V86, P29, DOI 10.1084/jem.86.1.29; Brydges SD, 2009, IMMUNITY, V30, P875, DOI 10.1016/j.immuni.2009.05.005; Caroli F, 2007, RHEUMATOLOGY, V46, P473, DOI 10.1093/rheumatology/kel269; Cavaillon JM, 2006, CRIT CARE, V10, DOI 10.1186/cc5055; CERRETTI DP, 1992, SCIENCE, V256, P97, DOI 10.1126/science.1373520; Chung Y, 2009, IMMUNITY, V30, P576, DOI 10.1016/j.immuni.2009.02.007; Dinarello CA, 2009, ANNU REV IMMUNOL, V27, P519, DOI 10.1146/annurev.immunol.021908.132612; Feldmann J, 2002, AM J HUM GENET, V71, P198, DOI 10.1086/341357; Foster SL, 2007, NATURE, V447, P972, DOI 10.1038/nature05836; Fuentes-Duculan J, 2010, J INVEST DERMATOL, V130, P2412, DOI 10.1038/jid.2010.165; Gasser O, 2004, BLOOD, V104, P2543, DOI 10.1182/blood-2004-01-0361; Gattorno M, 2007, ARTHRITIS RHEUM, V56, P3138, DOI 10.1002/art.22842; Ghayur T, 1997, NATURE, V386, P619, DOI 10.1038/386619a0; Goldbach-Mansky R, 2006, NEW ENGL J MED, V355, P581, DOI 10.1056/NEJMoa055137; Gulen MF, 2010, IMMUNITY, V32, P54, DOI 10.1016/j.immuni.2009.12.003; Hill SC, 2007, PEDIATR RADIOL, V37, P145, DOI 10.1007/s00247-006-0358-0; Hoffman HM, 2004, LANCET, V364, P1779, DOI 10.1016/S0140-6736(04)17401-1; Kloetzel PM, 2001, NAT REV MOL CELL BIO, V2, P179, DOI 10.1038/35056572; Kostka SL, 2009, J IMMUNOL, V182, P3039, DOI 10.4049/jimmunol.0713598; Kumar S, 2002, COMPUT SCI ENG, V4, P18, DOI 10.1109/MCISE.2002.976433; Kumar V, 2010, INT IMMUNOPHARMACOL, V10, P1325, DOI 10.1016/j.intimp.2010.08.012; Kuwata H, 2003, BLOOD, V102, P4123, DOI 10.1182/blood-2003-04-1228; Leslie KS, 2006, ARCH DERMATOL, V142, P1591, DOI 10.1001/archderm.142.12.1591; Liao F, 1999, J IMMUNOL, V162, P186; Liao YL, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012976; Mantovani A, 2004, J LEUKOCYTE BIOL, V75, P738, DOI 10.1189/jlb.1003473; Mantovani A, 2011, NAT REV IMMUNOL, V11, P519, DOI 10.1038/nri3024; Masters SL, 2009, ANNU REV IMMUNOL, V27, P621, DOI 10.1146/annurev.immunol.25.022106.141627; Meng GX, 2009, IMMUNITY, V30, P860, DOI 10.1016/j.immuni.2009.04.012; Miles K, 2009, J IMMUNOL, V183, P2122, DOI 10.4049/jimmunol.0804187; Mosser DM, 2008, NAT REV IMMUNOL, V8, P958, DOI 10.1038/nri2448; Nakamura Y, 2009, J EXP MED, V206, P1037, DOI 10.1084/jem.20082179; Natoli G, 2011, GENE DEV, V25, P101, DOI 10.1101/gad.2018811; Nograles KE, 2008, BRIT J DERMATOL, V159, P1092, DOI 10.1111/j.1365-2133.2008.08769.x; Nold MF, 2010, NAT IMMUNOL, V11, P1014, DOI 10.1038/ni.1944; Saccani S, 2002, NAT IMMUNOL, V3, P69, DOI 10.1038/ni748; Saito M, 2008, BLOOD, V111, P2132, DOI 10.1182/blood-2007-06-094201; Scapini P, 2001, EUR J IMMUNOL, V31, P1981, DOI 10.1002/1521-4141(200107)31:7<1981::AID-IMMU1981>3.0.CO;2-X; Sibley CH, 2012, ARTHRITIS RHEUM-US, V64, P2375, DOI 10.1002/art.34409; Soehnlein O, 2010, NAT REV IMMUNOL, V10, P427, DOI 10.1038/nri2779; Sonkoly E, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000610; Suarez-Farinas M, 2011, J INVEST DERMATOL, V131, P391, DOI 10.1038/jid.2010.280; Suarez-Farinas M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010247; THORNBERRY NA, 1992, NATURE, V356, P768, DOI 10.1038/356768a0; van Rooij E, 2008, P NATL ACAD SCI USA, V105, P13027, DOI 10.1073/pnas.0805038105; Vandercappellen J, 2008, CANCER LETT, V267, P226, DOI 10.1016/j.canlet.2008.04.050; Wessells J, 2004, J BIOL CHEM, V279, P49995, DOI 10.1074/jbc.M404246200; West MA, 2002, CRIT CARE MED, V30, pS64, DOI 10.1097/00003246-200201001-00009; Zaba LC, 2007, J CLIN INVEST, V117, P2517, DOI 10.1172/JCI32282	51	26	27	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 30	2012	7	11							e49408	10.1371/journal.pone.0049408	http://dx.doi.org/10.1371/journal.pone.0049408			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	054WM	23226210	gold, Green Published, Green Submitted			2022-12-27	WOS:000312376100019
J	Goodswen, SJ; Kennedy, PJ; Ellis, JT				Goodswen, Stephen J.; Kennedy, Paul J.; Ellis, John T.			Evaluating High-Throughput Ab Initio Gene Finders to Discover Proteins Encoded in Eukaryotic Pathogen Genomes Missed by Laboratory Techniques	PLOS ONE			English	Article							TOXOPLASMA-GONDII; SEQUENCE-ANALYSIS; MULTIPLE SOURCES; PREDICTION; IDENTIFICATION; MODEL; TRANSLATION; APICOMPLEXA; INTEGRATION; ALIGNMENTS	Next generation sequencing technology is advancing genome sequencing at an unprecedented level. By unravelling the code within a pathogen's genome, every possible protein (prior to post-translational modifications) can theoretically be discovered, irrespective of life cycle stages and environmental stimuli. Now more than ever there is a great need for high-throughput ab initio gene finding. Ab initio gene finders use statistical models to predict genes and their exon-intron structures from the genome sequence alone. This paper evaluates whether existing ab initio gene finders can effectively predict genes to deduce proteins that have presently missed capture by laboratory techniques. An aim here is to identify possible patterns of prediction inaccuracies for gene finders as a whole irrespective of the target pathogen. All currently available ab initio gene finders are considered in the evaluation but only four fulfil high-throughput capability: AUGUSTUS, GeneMark_hmm, GlimmerHMM, and SNAP. These gene finders require training data specific to a target pathogen and consequently the evaluation results are inextricably linked to the availability and quality of the data. The pathogen, Toxoplasma gondii, is used to illustrate the evaluation methods. The results support current opinion that predicted exons by ab initio gene finders are inaccurate in the absence of experimental evidence. However, the results reveal some patterns of inaccuracy that are common to all gene finders and these inaccuracies may provide a focus area for future gene finder developers.	[Goodswen, Stephen J.; Ellis, John T.] Univ Technol Sydney, Sch Med & Mol Sci, Sydney, NSW 2007, Australia; [Goodswen, Stephen J.; Ellis, John T.] Univ Technol Sydney, Inst I3, Sydney, NSW 2007, Australia; [Kennedy, Paul J.] Univ Technol Sydney, Fac Engn & Informat Technol, Sch Software, Sydney, NSW 2007, Australia; [Kennedy, Paul J.] Univ Technol Sydney, Ctr Quantum Computat & Intelligent Syst, Sydney, NSW 2007, Australia	University of Technology Sydney; University of Technology Sydney; University of Technology Sydney; University of Technology Sydney	Ellis, JT (corresponding author), Univ Technol Sydney, Sch Med & Mol Sci, Sydney, NSW 2007, Australia.	John.Ellis@uts.edu.au	Kennedy, Paul/M-8450-2014; Kennedy, Paul/GPC-6789-2022; Ellis, John T/L-6988-2016	Kennedy, Paul/0000-0001-7837-3171; Kennedy, Paul/0000-0001-7837-3171; Ellis, John T/0000-0001-7328-4831; Goodswen, Stephen/0000-0001-6184-3157	Pfizer Animal Health	Pfizer Animal Health	SJG gratefully acknowledges receipt of a PhD scholarship from Pfizer Animal Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript	Allen JE, 2005, BIOINFORMATICS, V21, P3596, DOI 10.1093/bioinformatics/bti609; Allen JE, 2004, GENOME RES, V14, P142, DOI 10.1101/gr.1562804; Baxevanis AD, 2002, BIOINFORMATICS, P233; Birney E, 1997, ISMB-97 - FIFTH INTERNATIONAL CONFERENCE ON INTELLIGENT SYSTEMS FOR MOLECULAR BIOLOGY, PROCEEDINGS, P56; Bork P, 2000, GENOME RES, V10, P398, DOI 10.1101/gr.10.4.398; BORODOVSKY M, 1994, NUCLEIC ACIDS RES, V22, P4756, DOI 10.1093/nar/22.22.4756; Brent MR, 2007, NAT BIOTECHNOL, V25, P883, DOI 10.1038/nbt0807-883; Burge C, 1997, J MOL BIOL, V268, P78, DOI 10.1006/jmbi.1997.0951; Burset M, 2000, NUCLEIC ACIDS RES, V28, P4364, DOI 10.1093/nar/28.21.4364; Burset M, 1996, GENOMICS, V34, P353, DOI 10.1006/geno.1996.0298; CHAMBERS I, 1987, TRENDS BIOCHEM SCI, V12, P255, DOI 10.1016/0968-0004(87)90125-3; Che F-Y, 2010, MOL CELLULAR PROTEOM; Claverie JM, 1997, COMPUT CHEM, V21, P203, DOI 10.1016/S0097-8485(96)00039-3; DeCaprio D, 2007, GENOME RES, V17, P1389, DOI 10.1101/gr.6558107; Dybas JM, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003899; Fickett JW, 1996, COMPUT CHEM, V20, P103, DOI 10.1016/S0097-8485(96)80012-X; Fickett JW, 1996, TRENDS GENET, V12, P316, DOI 10.1016/0168-9525(96)10038-X; Flower Darren R, 2010, Immunome Res, V6 Suppl 2, pS1, DOI 10.1186/1745-7580-6-S2-S1; Gelfand MS, 1996, P NATL ACAD SCI USA, V93, P9061, DOI 10.1073/pnas.93.17.9061; Gross SS, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-12-r269; Gross SS, 2006, J COMPUT BIOL, V13, P379, DOI 10.1089/cmb.2006.13.379; Guigo R, 2000, GENOME RES, V10, P1631, DOI 10.1101/gr.122800; Guigo R, 1997, COMPUT CHEM, V21, P215, DOI 10.1016/S0097-8485(97)00008-9; Guigo R, 2006, GENOME BIOL, V7; Haas BJ, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-1-r7; Harrow J, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-1-201; Howe KL, 2002, GENOME RES, V12, P1418, DOI 10.1101/gr.149502; Hubbard T, 2002, NUCLEIC ACIDS RES, V30, P38, DOI 10.1093/nar/30.1.38; Ivanov IP, 2011, NUCLEIC ACIDS RES, V39, P4220, DOI 10.1093/nar/gkr007; Kassahn KS, 2011, INTEGR BIOL-UK, V3, P522, DOI 10.1039/c0ib00062k; Kim K, 2004, INT J PARASITOL, V34, P423, DOI 10.1016/j.ijpara.2003.12.009; Kissinger JC, 2003, NUCLEIC ACIDS RES, V31, P234, DOI 10.1093/nar/gkg072; Knapp K, 2007, NUCLEIC ACIDS RES, V35, P317, DOI 10.1093/nar/gkl1026; Korf I, 2004, BMC BIOINFORMATICS, V5, DOI 10.1186/1471-2105-5-59; Krogh A, 1997, 2 METHODS IMPROVING; Kulp D, 1996, Proc Int Conf Intell Syst Mol Biol, V4, P134; Li L, 2003, GENOME RES, V13, P443, DOI 10.1101/gr.693203; LIU Q, 2008, BMC BIOINFORMATICS, V9; Liu Q, 2008, BIOINFORMATICS, V24, P597, DOI 10.1093/bioinformatics/btn004; Lomsadze A, 2005, NUCLEIC ACIDS RES, V33, P6494, DOI 10.1093/nar/gki937; Lukashin AV, 1998, NUCLEIC ACIDS RES, V26, P1107, DOI 10.1093/nar/26.4.1107; Majoros WH, 2004, BIOINFORMATICS, V20, P2878, DOI 10.1093/bioinformatics/bth315; Margulies EH, 2008, NAT REV GENET, V9, P303, DOI 10.1038/nrg2185; Mathe C, 2002, NUCLEIC ACIDS RES, V30, P4103, DOI 10.1093/nar/gkf543; Montoya JG, 2004, LANCET, V363, P1965, DOI 10.1016/S0140-6736(04)16412-X; Mora M, 2006, CURR OPIN MICROBIOL, V9, P532, DOI 10.1016/j.mib.2006.07.003; Ninaber A, 1999, RADIAT ENVIRON BIOPH, V38, P23, DOI 10.1007/s004110050134; Parra G, 2000, GENOME RES, V10, P511, DOI 10.1101/gr.10.4.511; Parra G, 2003, GENOME RES, V13, P108, DOI 10.1101/gr.871403; Patel AA, 2003, NAT REV MOL CELL BIO, V4, P960, DOI 10.1038/nrm1259; Pertea Mihaela, 2002, USING GLIMMERM FIND; Roos David S., 1999, Novartis Foundation Symposium, V226, P176; Roos DS, 2005, SCIENCE, V309, P72, DOI 10.1126/science.1115252; Salamov AA, 2000, GENOME RES, V10, P516, DOI 10.1101/gr.10.4.516; Schweikert G, 2009, NUCLEIC ACIDS RES, V37, pW312, DOI 10.1093/nar/gkp479; Serruto D, 2009, VACCINE, V27, P3245, DOI 10.1016/j.vaccine.2009.01.072; Service RF, 2000, SCIENCE, V289, P27; Sleator RD, 2010, GENE, V461, P1, DOI 10.1016/j.gene.2010.04.008; SNYDER EE, 1993, NUCLEIC ACIDS RES, V21, P607, DOI 10.1093/nar/21.3.607; Solovyev V V, 1995, Proc Int Conf Intell Syst Mol Biol, V3, P367; Stanke M, 2004, NUCLEIC ACIDS RES, V32, pW309, DOI 10.1093/nar/gkh379; Stanke M, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-s1-s11; Takahashi K, 2005, GENOMICS, V85, P360, DOI 10.1016/j.ygeno.2004.11.012; Touriol C, 2003, BIOL CELL, V95, P169, DOI 10.1016/S0248-4900(03)00033-9; van Baren MJ, 2002, CURRENT PROTOCOLS BI; Wakaguri H, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-312; Wang Z, 2009, NAT REV GENET, V10, P57, DOI 10.1038/nrg2484; Wastling JM, 2009, INT J PARASITOL, V39, P135, DOI 10.1016/j.ijpara.2008.10.003; Wei CC, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-327; Xu Y, 1996, P IEEE, V84, P1544, DOI 10.1109/5.537117; Yeh RF, 2001, GENOME RES, V11, P803, DOI 10.1101/gr.175701	71	23	23	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 30	2012	7	11							e50609	10.1371/journal.pone.0050609	http://dx.doi.org/10.1371/journal.pone.0050609			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	054WM	23226328	Green Published, Green Submitted, gold			2022-12-27	WOS:000312376100140
J	Hammerle, H; Beich-Frandsen, M; Vecerek, B; Rajkowitsch, L; Carugo, O; Djinovic-Carugo, K; Blaesi, U				Haemmerle, Hermann; Beich-Frandsen, Mads; Vecerek, Branislav; Rajkowitsch, Lukas; Carugo, Oliviero; Djinovic-Carugo, Kristina; Blaesi, Udo			Structural and Biochemical Studies on ATP Binding and Hydrolysis by the Escherichia coli RNA Chaperone Hfq	PLOS ONE			English	Article							MESSENGER-RNA; HOST FACTOR; PROTEIN; DOMAIN; ROLES; GENE; SITE; RPOS; DSRA; S1	In Escherichia coli the RNA chaperone Hfq is involved in riboregulation by assisting base-pairing between small regulatory RNAs (sRNAs) and mRNA targets. Several structural and biochemical studies revealed RNA binding sites on either surface of the donut shaped Hfq-hexamer. Whereas sRNAs are believed to contact preferentially the YKH motifs present on the proximal site, poly(A)(15) and ADP were shown to bind to tripartite binding motifs (ARE) circularly positioned on the distal site. Hfq has been reported to bind and to hydrolyze ATP. Here, we present the crystal structure of a C-terminally truncated variant of E. coli Hfq (Hfq(65)) in complex with ATP, showing that it binds to the distal R-sites. In addition, we revisited the reported ATPase activity of full length Hfq purified to homogeneity. At variance with previous reports, no ATPase activity was observed for Hfq. In addition, FRET assays neither indicated an impact of ATP on annealing of two model oligoribonucleotides nor did the presence of ATP induce strand displacement. Moreover, ATP did not lead to destabilization of binary and ternary Hfq-RNA complexes, unless a vast stoichiometric excess of ATP was used. Taken together, these studies strongly suggest that ATP is dispensable for and does not interfere with Hfq-mediated RNA transactions.	[Beich-Frandsen, Mads; Carugo, Oliviero; Djinovic-Carugo, Kristina] Univ Vienna, Max F Perutz Labs, Dept Struct & Computat Biol, Vienna, Austria; [Haemmerle, Hermann; Rajkowitsch, Lukas; Blaesi, Udo] Univ Vienna, Max F Perutz Labs, Dept Microbiol Immunobiol & Genet, Vienna, Austria; [Vecerek, Branislav] Acad Sci Czech Republ, Inst Microbiol, Prague, Czech Republic; [Djinovic-Carugo, Kristina] Univ Ljubljana, Dept Biochem, Fac Chem & Chem Technol, Ljubljana, Slovenia	Medical University of Vienna; University of Vienna; Vienna Biocenter (VBC); Max F. Perutz Laboratories (MFPL); Medical University of Vienna; University of Vienna; Vienna Biocenter (VBC); Max F. Perutz Laboratories (MFPL); Czech Academy of Sciences; Institute of Microbiology of the Czech Academy of Sciences; University of Ljubljana	Djinovic-Carugo, K (corresponding author), Univ Vienna, Max F Perutz Labs, Dept Struct & Computat Biol, Campus Vienna Bioctr 5, Vienna, Austria.	kristina.djinovic@univie.ac.at; udo.blaesi@univie.ac.at	Paul, Lukas/L-9231-2015; Vecerek, Branislav/H-2545-2014; Djinovic-Carugo, Kristina/AAW-1167-2021; Beich-Frandsen, Mads/H-7689-2014	Paul, Lukas/0000-0001-9410-4078; Vecerek, Branislav/0000-0001-9520-6324; Djinovic-Carugo, Kristina/0000-0003-0252-2972; Beich-Frandsen, Mads/0000-0002-9573-5119	Austrian Science Fund [F1722, F1720, SFB17]; doctoral program 'RNA-Biology' [W-1207]	Austrian Science Fund(Austrian Science Fund (FWF)); doctoral program 'RNA-Biology'	The work was supported by grants F1722 (KDC) and F1720 (UB), in the framework of the Special Research Program (SFB17) on "Modulators of RNA fate and function" by the Austrian Science Fund. HH was supported by the doctoral program 'RNA-Biology' (W-1207). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Achsel T, 2001, P NATL ACAD SCI USA, V98, P3685, DOI 10.1073/pnas.071033998; Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Arluison V, 2007, PROTEIN SCI, V16, P1830, DOI 10.1110/ps.072883707; Arluison V, 2007, NUCLEIC ACIDS RES, V35, P999, DOI 10.1093/nar/gkl1124; Baba T, 2006, MOL SYST BIOL, V2, DOI 10.1038/msb4100050; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Beich-Frandsen M, 2011, NUCLEIC ACIDS RES, V39, P4900, DOI 10.1093/nar/gkq1346; Davis IW, 2007, NUCLEIC ACIDS RES, V35, pW375, DOI 10.1093/nar/gkm216; DeLano W. L., 2007, MACPYMOL A PYMOL BAS; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; FRANZE MT, 1968, NATURE, V219, P588, DOI 10.1038/219588a0; Gottesman S, 2004, ANNU REV MICROBIOL, V58, P303, DOI 10.1146/annurev.micro.58.030603.123841; Hopkins JF, 2011, NUCLEIC ACIDS RES, V39, P5193, DOI 10.1093/nar/gkr062; KABSCH W, 1993, J APPL CRYSTALLOGR, V26, P795, DOI 10.1107/S0021889893005588; KAJITANI M, 1994, J BACTERIOL, V176, P531, DOI 10.1128/JB.176.2.531-534.1994; Lazar P, 2010, J MOL GRAPH MODEL, V29, P573, DOI 10.1016/j.jmgm.2010.11.003; Link TM, 2009, P NATL ACAD SCI USA, V106, P19286, DOI 10.1073/pnas.0908744106; Mayer O, 2007, NUCLEIC ACIDS RES, V35, P1257, DOI 10.1093/nar/gkl1143; Mikulecky PJ, 2004, NAT STRUCT MOL BIOL, V11, P1206, DOI 10.1038/nsmb858; Miranda G, 1997, J MOL BIOL, V267, P1089, DOI 10.1006/jmbi.1997.0939; Moll I, 2003, RNA, V9, P1308, DOI 10.1261/rna.5850703; Muffler A, 1996, GENE DEV, V10, P1143, DOI 10.1101/gad.10.9.1143; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Neuhard, 1987, ESCHERICHIA COLI SAL, V1, P445; Newman J, 2005, ACTA CRYSTALLOGR D, V61, P1426, DOI [10.1107/S0907444905024984, 10.1107/S090744905024984]; Nikulin A, 2005, ACTA CRYSTALLOGR D, V61, P141, DOI 10.1107/S0907444904030008; Panja S, 2012, J MOL BIOL, V417, P406, DOI 10.1016/j.jmb.2012.02.009; Rajkowitsch L, 2007, RNA, V13, P2053, DOI 10.1261/rna.671807; Rajkowitsch L, 2007, BIOTECHNIQUES, V43, P304, DOI 10.2144/000112530; Reynolds C, 2009, BIOINFORMATICS, V25, P413, DOI 10.1093/bioinformatics/btn584; Sauter C, 2003, NUCLEIC ACIDS RES, V31, P4091, DOI 10.1093/nar/gkg480; Schumacher MA, 2002, EMBO J, V21, P3546, DOI 10.1093/emboj/cdf322; Someya T, 2012, NUCLEIC ACIDS RES, V40, P1856, DOI 10.1093/nar/gkr892; Sonnleitner E, 2002, MICROBIOL-SGM, V148, P883, DOI 10.1099/00221287-148-3-883; Soper TJ, 2011, RNA, V17, P1544, DOI 10.1261/rna.2767211; Sukhodolets MV, 2003, BIOCHEMISTRY-US, V42, P8022, DOI 10.1021/bi020638i; TSUI HCT, 1994, MOL MICROBIOL, V13, P35, DOI 10.1111/j.1365-2958.1994.tb00400.x; Vagin A, 1997, J APPL CRYSTALLOGR, V30, P1022, DOI 10.1107/S0021889897006766; Vagin AA, 2004, ACTA CRYSTALLOGR D, V60, P2184, DOI 10.1107/S0907444904023510; Vecerek B, 2003, MOL MICROBIOL, V50, P897, DOI 10.1046/j.1365-2958.2003.03727.x; Vecerek B, 2008, NUCLEIC ACIDS RES, V36, P133, DOI 10.1093/nar/gkm985; Vogel J, 2011, NAT REV MICROBIOL, V9, P578, DOI 10.1038/nrmicro2615; WALKER JE, 1982, EMBO J, V1, P945, DOI 10.1002/j.1460-2075.1982.tb01276.x; Wang WW, 2011, GENE DEV, V25, P2106, DOI 10.1101/gad.16746011	44	16	16	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 30	2012	7	11							e50892	10.1371/journal.pone.0050892	http://dx.doi.org/10.1371/journal.pone.0050892			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	054WM	23226421	Green Submitted, gold, Green Published			2022-12-27	WOS:000312376100232
J	Heuer, A; Rubner, O				Heuer, Andreas; Rubner, Oliver			How Does the Past of a Soccer Match Influence Its Future? Concepts and Statistical Analysis	PLOS ONE			English	Article							GOAL DISTRIBUTIONS; FOOTBALL	Scoring goals in a soccer match can be interpreted as a stochastic process. In the most simple description of a soccer match one assumes that scoring goals follows from independent rate processes of both teams. This would imply simple Poissonian and Markovian behavior. Deviations from this behavior would imply that the previous course of the match has an impact on the present match behavior. Here a general framework for the identification of deviations from this behavior is presented. For this endeavor it is essential to formulate an a priori estimate of the expected number of goals per team in a specific match. This can be done based on our previous work on the estimation of team strengths. Furthermore, the well-known general increase of the number of the goals in the course of a soccer match has to be removed by appropriate normalization. In general, three different types of deviations from a simple rate process can exist. First, the goal rate may depend on the exact time of the previous goals. Second, it may be influenced by the time passed since the previous goal and, third, it may reflect the present score. We show that the Poissonian scenario is fulfilled quite well for the German Bundesliga. However, a detailed analysis reveals significant deviations for the second and third aspect. Dramatic effects are observed if the away team leads by one or two goals in the final part of the match. This analysis allows one to identify generic features about soccer matches and to learn about the hidden complexities behind scoring goals. Among others the reason for the fact that the number of draws is larger than statistically expected can be identified.	[Heuer, Andreas; Rubner, Oliver] WWU Muenster, Inst Phys Chem, Munster, Germany; [Heuer, Andreas; Rubner, Oliver] WWU Muenster, Ctr Nonlinear Sci, Munster, Germany		Heuer, A (corresponding author), WWU Muenster, Inst Phys Chem, Munster, Germany.	andheuer@uni-muenster.de						Albert J, 2007, STAT THINKING SPORTS; Ben-Naim E, 2007, EPL-EUROPHYS LETT, V77, DOI 10.1209/0295-5075/77/30005; Ben-Naim E, 2007, PHYS REV E, V76, DOI 10.1103/PhysRevE.76.026106; Bittner E, 2009, EUR PHYS J B, V67, P459, DOI 10.1140/epjb/e2008-00396-1; Bittner E, 2007, EPL-EUROPHYS LETT, V78, DOI 10.1209/0295-5075/78/58002; Dixon MJ, 1997, J R STAT SOC C-APPL, V46, P265, DOI 10.1111/1467-9876.00065; Dobson S, 2003, EUR J OPER RES, V148, P247, DOI 10.1016/S0377-2217(02)00681-1; Gabel A, 2012, ARXIV11092825; Gembris D, 2002, NATURE, V417, P506, DOI 10.1038/417506a; Heuer A, 2010, EPL-EUROPHYS LETT, V89, DOI 10.1209/0295-5075/89/38007; Heuer A, 2009, EUR PHYS J B, V67, P445, DOI 10.1140/epjb/e2009-00024-8; Heuer A, 2012, PERFEKTE TIPP STAT F; Heuer A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017664; Lee AJ., 1997, CHANCE, V10, P15, DOI [10.1080/09332480.1997.10554791, DOI 10.1080/09332480.1997.10554791]; Maher M, 1982, STAT NEERL, V36, P109, DOI [10.1111/j.1467-9574.1982.tb00782.x, DOI 10.1111/J.1467-9574.1982.TB00782.X, DOI 10.1111/j.1467-9574.1982.tb00782.x]; Radicchi F, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017249; Rue H, 2000, J ROY STAT SOC D-STA, V49, P399, DOI 10.1111/1467-9884.00243; Schmidt C., 2008, MYTHS FACTS FOOTBALL; Sire C, 2009, EUR PHYS J B, V67, P473, DOI 10.1140/epjb/e2008-00405-5; Tolan M, 2010, SO WERDEN WIR WELTME; Wesson J, 2002, SCI SOCCER	21	23	23	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 30	2012	7	11							e47678	10.1371/journal.pone.0047678	http://dx.doi.org/10.1371/journal.pone.0047678			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	054WM	23226200	Green Published, gold			2022-12-27	WOS:000312376100008
J	Hsu, JT; Chen, YJ; Tsai, MT; Lan, HHC; Cheng, FC; Chen, MYC; Wang, SP				Hsu, Jui-Ting; Chen, Ying-Ju; Tsai, Ming-Tzu; Lan, Howard Haw-Chang; Cheng, Fu-Chou; Chen, Michael Y. C.; Wang, Shun-Ping			Predicting Cortical Bone Strength from DXA and Dental Cone-Beam CT	PLOS ONE			English	Article							COMPUTED-TOMOGRAPHY; GEOMETRIC ACCURACY; PRIMARY STABILITY; MINERAL DENSITY; RAT FEMUR; PQCT; VALIDATION; INDEX	Objective: This study compared the capabilities of dual-energy X-ray absorptiometry (DXA) and dental cone-beam computed tomography (CBCT) for predicting the cortical bone strength of rat femurs and tibias. Materials and Methods: Specimens of femurs and tibias obtained from 14 rats were first scanned with DXA to obtain the areal bone mineral density (BMD) of the midshaft cortical portion of the bones. The bones were then scanned using dental CBCT to measure the volumetric cortical bone mineral density (vCtBMD) and the cross-sectional moment of inertia (CSMI) for calculating the bone strength index (BSI). A three-point bending test was conducted to measure the fracture load of each femur and tibia. Bivariate linear Pearson analysis was used to calculate the correlation coefficients (r values) among the CBCT measurements, DXA measurements, and three-point bending parameters. Results: The correlation coefficients for the associations of the fracture load with areal BMD (measured using DXA), vCtBMD (measured using CBCT), CSMI (measured using CBCT), and BSI were 0.585 (p = 0.028) and 0.532 (p = 0.050) (for the femur and tibia, respectively), 0.638 (p = 0.014) and 0.762 (p = 0.002), 0.778 (p = 0.001) and 0.792 (p, 0.001), and 0.822 (p, 0.001) and 0.842 (p < 0.001), respectively. Conclusions: CBCT was found to be superior to DXA for predicting cortical bone fracture loads in rat femurs and tibias. The BSI, which is a combined index of densitometric and geometric parameters, was especially useful. Further clinical studies are needed to validate the predictive value of BSI obtained from CBCT and should include testing on human cadaver specimens.	[Wang, Shun-Ping] Taichung Vet Gen Hosp, Dept Orthopaed, Taichung, Taiwan; [Hsu, Jui-Ting; Chen, Michael Y. C.] China Med Univ, Coll Med, Sch Dent, Taichung, Taiwan; [Chen, Ying-Ju; Cheng, Fu-Chou] Taichung Vet Gen Hosp, Dept Med Res, Stem Cell Ctr, Taichung, Taiwan; [Tsai, Ming-Tzu] Hungkuang Univ, Dept Biomed Engn, Taichung, Taiwan; [Lan, Howard Haw-Chang] Taichung Vet Gen Hosp, Dept Radiol, Taichung, Taiwan; [Lan, Howard Haw-Chang] Cent Taiwan Univ Sci & Technol, Sch Radiol Technol, Taichung, Taiwan	Taichung Veterans General Hospital; China Medical University Taiwan; Taichung Veterans General Hospital; Hungkuang University; Taichung Veterans General Hospital; Central Taiwan University Science & Technology	Wang, SP (corresponding author), Taichung Vet Gen Hosp, Dept Orthopaed, Taichung, Taiwan.	richard@ms32.url.com.tw	Hsu, Jui-Ting/I-8224-2012; Tsai, Ming-Tzu/GSM-9284-2022		China Medical University, Taiwan [CMU99-COL-43]	China Medical University, Taiwan(China Medical University)	This research was supported by China Medical University, Taiwan (Grant number: CMU99-COL-43). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baba R, 2004, DENTOMAXILLOFAC RAD, V33, P285, DOI 10.1259/dmfr/87440549; Bagi CM, 2006, BONE, V38, P136, DOI 10.1016/j.bone.2005.07.028; Benavides E, 2012, IMPLANT DENT, V21, P78, DOI 10.1097/ID.0b013e31824885b5; Bensamoun SF, 2006, BONE, V39, P1244, DOI 10.1016/j.bone.2006.05.021; Bissonnette JP, 2008, INT J RADIAT ONCOL, V71, pS57, DOI 10.1016/j.ijrobp.2007.06.086; Cawthon PM, 2012, J BONE MINER RES, V27, P2179, DOI 10.1002/jbmr.1671; Chang HW, 2012, CLIN ORAL INVEST, V16, P679, DOI 10.1007/s00784-011-0552-9; Chen WP, 2003, J CHIN INST ENG, V26, P737, DOI 10.1080/02533839.2003.9670828; Doube M, 2010, BONE, V47, P1076, DOI 10.1016/j.bone.2010.08.023; Dumas A, 2009, OSTEOPOROSIS INT, V20, P435, DOI 10.1007/s00198-008-0658-3; Fanning Brendan, 2011, J Ir Dent Assoc, V57, P256; Fei J, 2010, ANAT REC, V293, P1984, DOI 10.1002/ar.21270; FERRETTI JL, 1995, BONE, V17, pS353, DOI 10.1016/8756-3282(95)00313-3; Ferretti JL, 1996, BONE, V18, P97, DOI 10.1016/8756-3282(95)00438-6; Genant HK, 1996, J BONE MINER RES, V11, P707; Gray Crawford F, 2010, Prim Dent Care, V17, P161, DOI 10.1308/135576110792936113; Hsu JT, 2006, COMPUT METH PROG BIO, V84, P34, DOI 10.1016/j.cmpb.2006.08.002; Hsu JT, 2011, CLIN ORAL INVEST, V15, P511, DOI 10.1007/s00784-010-0410-1; Huang HL, 2010, COMPUT BIOL MED, V40, P464, DOI 10.1016/j.compbiomed.2010.02.011; Huang HL, 2010, J MED BIOL ENG, V30, P85; Huang HL, 2012, CLIN ORAL INVEST, P1; Isoda K, 2012, CLIN ORAL IMPLAN RES, V23, P832, DOI 10.1111/j.1600-0501.2011.02203.x; Iwamoto J, 2005, J BONE MINER METAB, V23, P456, DOI 10.1007/s00774-005-0628-1; Jamsa T, 1998, BONE, V23, P155, DOI 10.1016/S8756-3282(98)00076-3; Jiang GZ, 2008, J BONE MINER METAB, V26, P130, DOI 10.1007/s00774-007-0811-7; Ke HZ, 1998, BONE, V23, P249, DOI 10.1016/S8756-3282(98)00102-1; Koong B, 2010, CLIN ORAL IMPLAN RES, V21, P1201, DOI 10.1111/j.1600-0501.2010.01996.x; Leppanen O, 2006, J BONE MINER RES, V21, P1231, DOI 10.1359/JBMR.060511; Leppanen OV, 2008, J BIOMECH, V41, P1623, DOI 10.1016/j.jbiomech.2008.03.017; Link TM, 2012, RADIOLOGY, V263, P3, DOI 10.1148/radiol.12110462; Marmulla R, 2005, DENTOMAXILLOFAC RAD, V34, P28, DOI 10.1259/dmfr/31342245; Moisio K. C., 2003, Journal of Musculoskeletal & Neuronal Interactions, V3, P240; Nackaerts O, 2011, CLIN ORAL IMPLAN RES, V22, P873, DOI 10.1111/j.1600-0501.2010.02076.x; Nada RM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016520; Nomura Y, 2013, CLIN ORAL IMPLAN RES, V24, P543, DOI 10.1111/j.1600-0501.2012.02420.x; Nomura Y, 2010, CLIN ORAL IMPLAN RES, V21, P558, DOI 10.1111/j.1600-0501.2009.01896.x; Ravoori M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009854; Scibora LM, 2012, OBES SURG, P1; Siu WS, 2003, J BONE MINER METAB, V21, P316, DOI 10.1007/s00774-003-0427-5; Song YD, 2009, INT J ORAL MAX IMPL, V24, P59; Stendig-Lindberg G, 2004, J AM COLL NUTR, V23, p704S, DOI 10.1080/07315724.2004.10719413; Yamano S, 2010, CLIN ORAL IMPLAN RES, V21, P1353, DOI 10.1111/j.1600-0501.2010.01955.x	42	17	18	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 30	2012	7	11							e50008	10.1371/journal.pone.0050008	http://dx.doi.org/10.1371/journal.pone.0050008			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	054WM	23226234	Green Submitted, Green Published, gold			2022-12-27	WOS:000312376100043
J	Kumar, S; Ganji, PN; Song, HJ; von Kalm, L; Borst, DW				Kumar, Sandeep; Ganji, Purnachandra Nagaraju; Song, Hojun; von Kalm, Laurence; Borst, David W.			Exposure to Exogenous Enkephalins Disrupts Reproductive Development in the Eastern Lubber Grasshopper, Romalea microptera (Insecta: Orthoptera)	PLOS ONE			English	Article							BLOWFLY CALLIPHORA-VOMITORIA; RED SWAMP CRAYFISH; METHIONINE-ENKEPHALIN; OVARIAN MATURATION; IN-VIVO; MET-ENKEPHALIN-ARG6-GLY7-LEU8-LIKE PEPTIDES; FUNCTIONAL-SIGNIFICANCE; PROCAMBARUS-CLARKII; NEURONAL PATHWAYS; JUVENILE-HORMONE	Enkephalins play a major role in reproductive physiology in crustaceans; however their role in reproductive development in insects is largely unknown. We investigated the effect of exposure to exogenous leucine-enkephalin (Leu-Enk), methionine-enkephalin (Met-Enk), and the opioid antagonist naloxone on gonad development in the Eastern lubber grasshopper, Romalea microptera. Injection of either Leu-Enk or naloxone alone significantly increased the testicular index and testicular follicular diameter in males, and the ovarian index, oocyte length, and oocyte diameter in females. In contrast, injection of Met-Enk inhibited all measures of reproductive development in both sexes. Surprisingly, co-injection of naloxone with either enkephalin enhanced the effect associated with administration of the enkephalin alone. This study clearly demonstrates the ability of enkephalins to disrupt insect sexual development and also suggests the existence of conserved enkephaline-dependent regulatory mechanisms in insects and crustaceans.	[Kumar, Sandeep; Ganji, Purnachandra Nagaraju; Song, Hojun; von Kalm, Laurence; Borst, David W.] Univ Cent Florida, Dept Biol, Orlando, FL 32816 USA; [Ganji, Purnachandra Nagaraju] Emory Univ, Winship Canc Inst, Dept Hematol & Med Oncol, Atlanta, GA 30322 USA; [Kumar, Sandeep; von Kalm, Laurence; Borst, David W.] Univ Cent Florida, Biomol Sci Ctr, Orlando, FL 32816 USA	State University System of Florida; University of Central Florida; Emory University; State University System of Florida; University of Central Florida	Kumar, S (corresponding author), Univ Cent Florida, Dept Biol, Orlando, FL 32816 USA.	skumar@knights.ucf.edu	Nagaraju, Purnachandra/D-4193-2011	Nagaraju, Purnachandra/0000-0002-4989-5234	National Science Foundation [NSF-0611447]	National Science Foundation(National Science Foundation (NSF))	This research was supported by a grant from National Science Foundation, NSF-0611447 (DW Borst). The contents are solely the responsibility of the authors and do not necessarily represent the official views of NSF. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Borst DW, 2000, INSECT BIOCHEM MOLEC, V30, P813, DOI 10.1016/S0965-1748(00)00053-9; BRUNI JF, 1977, LIFE SCI, V21, P461, DOI 10.1016/0024-3205(77)90528-8; Cahansky AV, 2008, INVERTEBR REPROD DEV, V51, P61, DOI 10.1080/07924259.2008.9652256; CICERO TJ, 1989, ENDOCRINOLOGY, V125, P957, DOI 10.1210/endo-125-2-957; DUVE H, 1989, CELL TISSUE RES, V258, P147, DOI 10.1007/BF00223154; DUVE H, 1990, CELL TISSUE RES, V259, P147, DOI 10.1007/BF00571439; DUVE H, 1988, CELL TISSUE RES, V251, P399, DOI 10.1007/BF00215849; Froehlich JC, 1997, ALCOHOL HEALTH RES W, V21, P132; GUBLER U, 1982, NATURE, V295, P206, DOI 10.1038/295206a0; HANSEN BL, 1982, CELL TISSUE RES, V225, P319; HARRISON LM, 1994, PEPTIDES, V15, P1309, DOI 10.1016/0196-9781(94)90159-7; Hatle JD, 2000, INSECT BIOCHEM MOLEC, V30, P821, DOI 10.1016/S0965-1748(00)00054-0; HUGHES J, 1975, NATURE, V258, P577, DOI 10.1038/258577a0; Judd ET, 2010, INTEGR COMP BIOL, V50, P818, DOI 10.1093/icb/icq105; Kishori B, 2003, CRUSTACEANA, V76, P1281, DOI 10.1163/156854003323009812; KREAM RM, 1980, J BIOL CHEM, V255, P9218; Mark M, 2006, ANNU REV PHARMACOL, V46, P451, DOI 10.1146/annurev.pharmtox.46.120604.141156; MICHAELTITUS A, 1989, NEUROPHARMACOLOGY, V28, P117, DOI 10.1016/0028-3908(89)90046-4; Nagaraju GPC, 2010, COMP BIOCHEM PHYS D, V5, P317, DOI 10.1016/j.cbd.2010.09.002; Nagaraju GPC, 2011, J EXP BIOL, V214, P3, DOI 10.1242/jeb.047183; Reddy PS, 2000, NATURWISSENSCHAFTEN, V87, P535; Salzet M, 1997, BRAIN RES, V768, P224, DOI 10.1016/S0006-8993(97)00646-X; Sarojini R, 1997, COMP BIOCHEM PHYS C, V117, P207, DOI 10.1016/S0742-8413(97)00055-8; SAROJINI R, 1995, COMP BIOCHEM PHYS A, V111, P279, DOI 10.1016/0300-9629(94)00214-E; Sarojini R, 1996, COMP BIOCHEM PHYS C, V115, P149, DOI 10.1016/S0742-8413(96)00108-9; SCHOOFS L, 1988, GEN COMP ENDOCR, V69, P1, DOI 10.1016/0016-6480(88)90046-9; SCHULZ R, 1979, N-S ARCH PHARMACOL, V306, P93, DOI 10.1007/BF00515600; SIMANTOV R, 1976, P NATL ACAD SCI USA, V73, P2515, DOI 10.1073/pnas.73.7.2515; Sundberg Steven V., 2001, Journal of Orthoptera Research, V10, P39, DOI 10.1665/1082-6467(2001)010[0039:MADOOA]2.0.CO;2; TANG AH, 1978, EUR J PHARMACOL, V47, P473, DOI 10.1016/0014-2999(78)90131-0; THORPE A, 1990, PROG CLIN BIOL RES, V342, P293; UDENFRIEND S, 1983, ARCH BIOCHEM BIOPHYS, V221, P309, DOI 10.1016/0003-9861(83)90149-2	32	8	9	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 30	2012	7	11							e51126	10.1371/journal.pone.0051126	http://dx.doi.org/10.1371/journal.pone.0051126			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	054WM	23226477	Green Published, gold			2022-12-27	WOS:000312376100288
J	Langenhorst, D; Gogishvili, T; Ribechini, E; Kneitz, S; McPherson, K; Lutz, MB; Hunig, T				Langenhorst, Daniela; Gogishvili, Tea; Ribechini, Eliana; Kneitz, Susanne; McPherson, Kirsty; Lutz, Manfred B.; Huenig, Thomas			Sequential Induction of Effector Function, Tissue Migration and Cell Death during Polyclonal Activation of Mouse Regulatory T-Cells	PLOS ONE			English	Article							IN-VITRO; CYTOKINE STORM; APOPTOSIS; FOXP3(+); INTERLEUKIN-10; EXPRESSION; RESISTANCE; SUPPRESS; PROLIFERATION; EXPANSION	The ability of CD4(+)Foxp3(+) regulatory T-cells (Treg) to produce interleukin (IL)-10 is important for the limitation of inflammation at environmental interfaces like colon or lung. Under steady state conditions, however, few Tregs produce IL-10 ex vivo. To investigate the origin and fate of IL-10 producing Tregs we used a superagonistic mouse anti-mouse CD28 mAb (CD28SA) for polyclonal in vivo stimulation of Tregs, which not only led to their numeric expansion but also to a dramatic increase in IL-10 production. IL-10 secreting Tregs strongly upregulated surface receptors associated with suppressive function as compared to non-producing Tregs. Furthermore, polyclonally expanding Tregs shifted their migration receptor pattern after activation from a CCR7(+)CCR5(-) lymph node-seeking to a CCR7(-)CCR5(+) inflammation-seeking phenotype, explaining the preferential recruitment of IL-10 producers to sites of ongoing immune responses. Finally, we observed that IL-10 producing Tregs from CD28SA stimulated mice were more apoptosis-prone in vitro than their IL-10 negative counterparts. These findings support a model where prolonged activation of Tregs results in terminal differentiation towards an IL-10 producing effector phenotype associated with a limited lifespan, implicating built-in termination of immunosuppression.	[Langenhorst, Daniela; Gogishvili, Tea; Ribechini, Eliana; McPherson, Kirsty; Lutz, Manfred B.; Huenig, Thomas] Univ Wurzburg, Inst Virol & Immunobiol, D-8700 Wurzburg, Germany; [Kneitz, Susanne] Univ Wurzburg, Interdisciplinary Ctr Clin Res IZKF, Wurzburg, Germany; [McPherson, Kirsty] Univ Melbourne, Dept Microbiol & Immunol, Melbourne, Vic, Australia	University of Wurzburg; University of Wurzburg; University of Melbourne	Hunig, T (corresponding author), Univ Wurzburg, Inst Virol & Immunobiol, Versbacher Str 7, D-8700 Wurzburg, Germany.	huenig@vim.uni-wuerzburg.de	McPherson, Kirsty G/E-6331-2017	McPherson, Kirsty G/0000-0003-3083-6303; Lutz, Manfred B./0000-0001-9193-1772	German Research Foundation (DFG) [SFB-TR 52]; German Excellence Initiative; University of Wurzburg	German Research Foundation (DFG)(German Research Foundation (DFG)); German Excellence Initiative; University of Wurzburg	This work was supported by the German Research Foundation (DFG) through SFB-TR 52, by a grant of the German Excellence Initiative to the Graduate School of Life Sciences, University of Wurzburg and by the funding program Open Access Publishing of the DFG and the University of Wurzburg. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alenzi FQB, 2004, BRIT J BIOMED SCI, V61, P99, DOI 10.1080/09674845.2004.11732652; Bailey DP, 2006, J LEUKOCYTE BIOL, V80, P581, DOI 10.1189/jlb.0405201; Banz A, 2002, J IMMUNOL, V169, P750, DOI 10.4049/jimmunol.169.2.750; Barthlott T, 2005, INT IMMUNOL, V17, P279, DOI 10.1093/intimm/dxh207; Beyersdorf N, 2005, J EXP MED, V202, P445, DOI 10.1084/jem.20051060; Chen JJ, 2011, INT IMMUNOPHARMACOL, V11, P610, DOI 10.1016/j.intimp.2010.11.034; de la Rosa M, 2004, EUR J IMMUNOL, V34, P2480, DOI 10.1002/eji.200425274; Dennehy KM, 2007, J IMMUNOL, V178, P1363, DOI 10.4049/jimmunol.178.3.1363; Dennehy KM, 2006, J IMMUNOL, V176, P5725, DOI 10.4049/jimmunol.176.10.5725; Eastwood D, 2010, BRIT J PHARMACOL, V161, P512, DOI 10.1111/j.1476-5381.2010.00922.x; Fritzsching B, 2006, BLOOD, V108, P3371, DOI 10.1182/blood-2006-02-005660; Gogishvili T, 2013, EUR J IMMUNOL, V43, P188, DOI 10.1002/eji.201242824; Gogishvili T, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004643; Guilliams M, 2008, J INFECT DIS, V198, P781, DOI 10.1086/590439; Huber Wolfgang, 2002, Bioinformatics, V18 Suppl 1, pS96; Huehn J, 2004, J EXP MED, V199, P303, DOI 10.1084/jem.20031562; Huehn J, 2005, TRENDS IMMUNOL, V26, P632, DOI 10.1016/j.it.2005.10.001; Hunig T, 2007, ADV IMMUNOL, V95, P111, DOI 10.1016/S0065-2776(07)95004-X; Kang SG, 2007, GASTROENTEROLOGY, V132, P966, DOI 10.1053/j.gastro.2007.01.008; Kleinewietfeld M, 2005, BLOOD, V105, P2877, DOI 10.1182/blood-2004-07-2505; Knoechel B, 2005, J EXP MED, V202, P1375, DOI 10.1084/jem.20050855; KUHN R, 1993, CELL, V75, P263, DOI 10.1016/0092-8674(93)80068-P; Lahl K, 2007, J EXP MED, V204, P57, DOI 10.1084/jem.20061852; Lin CH, 2003, EUR J IMMUNOL, V33, P626, DOI 10.1002/eji.200323570; Maynard CL, 2007, NAT IMMUNOL, V8, P931, DOI 10.1038/ni1504; Pandiyan P, 2008, BIOL DIRECT, V3, DOI 10.1186/1745-6150-3-6; Papiernik M, 1998, INT IMMUNOL, V10, P371, DOI 10.1093/intimm/10.4.371; Qureshi OS, 2011, SCIENCE, V332, P600, DOI 10.1126/science.1202947; Romer PS, 2011, BLOOD; Rubtsov YP, 2008, IMMUNITY, V28, P546, DOI 10.1016/j.immuni.2008.02.017; Sakaguchi S, 2005, NAT IMMUNOL, V6, P345, DOI 10.1038/ni1178; Siegmund K, 2005, BLOOD, V106, P3097, DOI 10.1182/blood-2005-05-1864; Siewert C, 2007, EUR J IMMUNOL, V37, P978, DOI 10.1002/eji.200636575; Smyth GK, 2005, STAT BIOL HEALTH, P397, DOI 10.1007/0-387-29362-0_23; Suntharalingam G, 2006, NEW ENGL J MED, V355, P1018, DOI 10.1056/NEJMoa063842; Tacke M, 1997, EUR J IMMUNOL, V27, P239, DOI 10.1002/eji.1830270136; Tang QZ, 2008, NAT IMMUNOL, V9, P239, DOI 10.1038/ni1572; THIEDE K, 1988, INT J CANCER, V42, P939, DOI 10.1002/ijc.2910420625; Thornton AM, 1998, J EXP MED, V188, P287, DOI 10.1084/jem.188.2.287; Tincani A, 2001, THROMB HAEMOSTASIS, V86, P575; Wang HJ, 2005, CELL IMMUNOL, V235, P117, DOI 10.1016/j.cellimm.2005.08.031; Yamaguchi T, 2007, IMMUNITY, V27, P145, DOI 10.1016/j.immuni.2007.04.017; Zaiss MM, 2010, J IMMUNOL, V184, P7238, DOI 10.4049/jimmunol.0903841; Zhang N, 2009, IMMUNITY, V30, P458, DOI 10.1016/j.immuni.2008.12.022	44	15	16	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 30	2012	7	11							e50080	10.1371/journal.pone.0050080	http://dx.doi.org/10.1371/journal.pone.0050080			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	054WM	23226238	Green Published, gold			2022-12-27	WOS:000312376100047
J	Liu, QY; Liu, XB; Zhou, GC; Jiang, JY; Guo, YH; Ren, DS; Zheng, CJ; Wu, HX; Yang, SR; Liu, JL; Li, HS; Li, HZ; Li, Q; Yang, WZ; Chu, C				Liu, Qiyong; Liu, Xiaobo; Zhou, Guangchao; Jiang, Jingyi; Guo, Yuhong; Ren, Dongsheng; Zheng, Canjun; Wu, Haixia; Yang, Shuran; Liu, Jingli; Li, Hongsheng; Li, Huazhong; Li, Qun; Yang, Weizhong; Chu, Cordia			Dispersal Range of Anopheles sinensis in Yongcheng City, China by Mark-Release-Recapture Methods	PLOS ONE			English	Article							REPUBLIC-OF-CHINA; CLIMATE-CHANGE; MALARIA ERADICATION; POPULATION-SIZE; CENTRAL-AMERICA; CULICIDAE; DIPTERA; SURVIVAL; BEHAVIOR; GAMBIAE	Background: Studying the dispersal range of Anopheles sinensis is of major importance for understanding the transition from malaria control to elimination. However, no data are available regarding the dispersal range of An. sinensis in China. The aim of the present study was to study the dispersal range of An. sinensis and provide the scientific basis for the development of effective control measures for malaria elimination in China. Methodology/Principal Findings: Mark-Release-Recapture (MRR) experiments were conducted with 3000 adult wild An. sinensis in 2010 and 3000 newly emerged wild An. sinensis in 2011 in two villages of Yongcheng City in Henan Province. Marked An. sinensis were recaptured daily for ten successive days using light traps. The overall recapture rates were 0.83% (95% CI, 0.50%,similar to 1.16%) in 2010 and 1.33% (95% CI, 0.92%,similar to 1.74%) in 2011. There was no significant difference in the recapture rates of wild An. sinensis and newly emerged An. sinensis. The majority of An. sinensis were captured due east at study site I compared with most in the west at study site II. Eighty percent and 90% of the marked An. sinensis were recaptured within a radius of 100 m from the release point in study site I and II, respectively, with a maximum dispersal range of 400 m within the period of this study. Conclusions/Significance: Our results indicate that local An. sinensis may have limited dispersal ranges. Therefore, control efforts should target breeding and resting sites in proximity of the villages. Citation: Liu Q, Liu X, Zhou G, Jiang J, Guo Y, et al. (2012) Dispersal Range of Anopheles sinensis in Yongcheng City, China by Mark-Release-Recapture Methods. PLoS ONE 7(11): e51209. doi:10.1371/journal.pone.0051209	[Liu, Qiyong; Liu, Xiaobo; Guo, Yuhong; Ren, Dongsheng; Wu, Haixia; Yang, Shuran; Liu, Jingli] Chinese Ctr Dis Control & Prevent, Natl Inst Communicable Dis Control & Prevent, State Key Lab Infect Dis Prevent & Control, Dept Vector Biol & Control, Beijing, Peoples R China; [Liu, Qiyong; Liu, Xiaobo; Guo, Yuhong; Ren, Dongsheng; Wu, Haixia; Yang, Shuran; Liu, Jingli] WHO Collaborating Ctr Vector Surveillance & Manag, Beijing, Peoples R China; [Zhou, Guangchao; Jiang, Jingyi; Li, Hongsheng] Yongcheng Ctr Dis Control & Prevent, Yongcheng, Henan, Peoples R China; [Li, Qun] Chinese Ctr Dis Control & Prevent, Publ Hlth Emergency Ctr, Beijing, Peoples R China; [Zheng, Canjun; Li, Huazhong] Chinese Ctr Dis Control & Prevent, Dept Infect Dis Control & Prevent, Beijing, Peoples R China; [Liu, Qiyong; Liu, Xiaobo; Guo, Yuhong; Ren, Dongsheng; Wu, Haixia; Yang, Shuran; Liu, Jingli; Yang, Weizhong] Chinese Ctr Dis Control & Prevent, China CDC Key Lab Surveillance & Early Warning In, Beijing, Peoples R China; [Chu, Cordia] Griffith Univ, Ctr Environm & Populat Hlth, Nathan, Qld 4111, Australia	Chinese Center for Disease Control & Prevention; National Institute for Communicable Disease Control & Prevention, Chinese Center for Disease Control & Prevention; Chinese Center for Disease Control & Prevention; Chinese Center for Disease Control & Prevention; Chinese Center for Disease Control & Prevention; Griffith University	Liu, QY (corresponding author), Chinese Ctr Dis Control & Prevent, Natl Inst Communicable Dis Control & Prevent, State Key Lab Infect Dis Prevent & Control, Dept Vector Biol & Control, Beijing, Peoples R China.	liuqiyong@icdc.cn; c.chu@griffith.edu.au	Yang, Wei/HIA-0360-2022	Chu, Cordia/0000-0002-3683-5638	National Basic Research Program of China (973 Program) [2012CB955500, 2012CB955504]; National Science Foundation of China (NSFC) [30972563]	National Basic Research Program of China (973 Program)(National Basic Research Program of China); National Science Foundation of China (NSFC)(National Natural Science Foundation of China (NSFC))	This study was funded by the National Basic Research Program of China (973 Program) (Grant No. 2012CB955500, 2012CB955504) and the National Science Foundation of China (NSFC) (Grant No. 30972563). The funders had no role in study disign, data collection and analysis, decision to publish, or preparation of the manuscript.; Special thanks are extended to Dr. Robert J. Novak from University of South Florida for his guidance in the field of Yongcheng City. We thank Dr. Weidong Gu from EDEB/NCEZID/CDC and Dr. Abdelrafie Mohamed Makhawi Ibrahim from University of Bahri for their revision of the manuscript. We thank Xudong Zhao, Yunpu Su, Hongwei Zhang, Jiqi Liu and Zhenqiang Tang from Henan Center for Disease Control and Prevention for their guidance in the field. We thank Zhengrong Cui, Yang Shen, Yunjun Su, Mingjie Zhu, Guangxu Zhou, Haishan Wang from Yongcheng CDC for their help in organizing and conducting of field survey. We thank Peng Zhang from BEI JING KAIMEISITE TRADE CETER (http://www.kaimste.cn) for his help in donating the fluorescent powder. This study was funded by the National Basic Research Program of China (973 Program) (Grant No. 2012CB955500, 2012CB955504) and the National Science Foundation of China (NSFC) (Grant No. 30972563).	Achee NL, 2007, J AM MOSQUITO CONTR, V23, P276, DOI 10.2987/8756-971X(2007)23[276:AMSTDT]2.0.CO;2; Achee NL, 2005, J AM MOSQUITO CONTR, V21, P366, DOI 10.2987/8756-971X(2006)21[366:AMSUAN]2.0.CO;2; Aguas R, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001767; Alonso PL, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1000406; Baber I, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010270; Boni MF, 2008, PLOS MED, V5, P1542, DOI 10.1371/journal.pmed.0050231; BOUMA MJ, 1994, LANCET, V343, P1440, DOI 10.1016/S0140-6736(94)92569-0; Butler D, 2009, NATURE, V462, P19, DOI 10.1038/462017a; Campbell CC, 2009, NEW ENGL J MED, V361, P522, DOI 10.1056/NEJMe0905159; Cho Shin-Hyeong, 2002, Korean Journal of Parasitology, V40, P139, DOI 10.3347/kjp.2002.40.3.139; Chow C.-Y., 1991, Chinese Journal of Entomology Special Publication, P67; Das P, 2010, LANCET, V376, P1515, DOI 10.1016/S0140-6736(10)61551-6; EJERCTTO A, 1951, Bull World Health Organ, V3, P663; Fabian Mashauri M., 2005, Southeast Asian Journal of Tropical Medicine and Public Health, V36, P54; Feachem R, 2008, LANCET, V371, P1633, DOI 10.1016/S0140-6736(08)60424-9; Feachem RGA, 2007, JAMA-J AM MED ASSOC, V297, P2281, DOI 10.1001/jama.297.20.2281; Ferguson HM, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000303; Gething PW, 2010, NATURE, V465, P342, DOI 10.1038/nature09098; GILLIES M. T., 1961, BULL ENT RES, V52, P99, DOI 10.1017/S0007485300055309; Goklany IM, 2004, SCIENCE, V306, P55, DOI 10.1126/science.306.5693.55; Gou G.X., 1998, CHIN J VECTOR BIOL C, V9, P133; Hales S, 2005, LANCET INFECT DIS, V5, P258, DOI 10.1016/S1473-3099(05)70092-X; Hales S, 2003, LANCET, V362, P1775, DOI 10.1016/S0140-6736(03)14939-2; Haque U, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014341; Harrington LC, 2001, J MED ENTOMOL, V38, P537, DOI 10.1603/0022-2585-38.4.537; Hay SI, 2002, NATURE, V415, P905, DOI 10.1038/415905a; Hsiang MS, 2010, LANCET, V375, P1586, DOI 10.1016/S0140-6736(10)60350-9; JAAL Z, 1992, ANN TROP MED PARASIT, V86, P419, DOI 10.1080/00034983.1992.11812687; Kappe SHI, 2010, SCIENCE, V328, P862, DOI 10.1126/science.1184785; Kilama W, 2009, LANCET, V374, P1480, DOI 10.1016/S0140-6736(09)61884-5; Killeen GF, 2003, LANCET INFECT DIS, V3, P297, DOI 10.1016/S1473-3099(03)00611-X; KLIGLER I. J., 1932, Transactions of the Royal Society of Tropical Medicine and Hygiene, V26, P73, DOI 10.1016/S0035-9203(32)90091-1; Lines J, 2007, TROPICAL MED; Liu XB, 2012, PARASITE VECTOR, V5, DOI 10.1186/1756-3305-5-58; Liu XB, 2011, PARASITE VECTOR, V4, DOI 10.1186/1756-3305-4-221; Ma Y., 1998, ACAD J SEC MIL MED U, V19, P237; *MALERA CONS GROUP, 2011, PLOS MED, V0008; Midega JT, 2007, J MED ENTOMOL, V44, P923, DOI 10.1603/0022-2585(2007)44[923:EDASOA]2.0.CO;2; Mueller I, 2009, LANCET INFECT DIS, V9, P555, DOI 10.1016/S1473-3099(09)70177-X; Paaijmans KP, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001146; RAWLINGS P, 1981, ECOL ENTOMOL, V6, P307, DOI 10.1111/j.1365-2311.1981.tb00618.x; REISEN WK, 1980, T ROY SOC TROP MED H, V74, P307, DOI 10.1016/0035-9203(80)90089-9; Reisen WK, 2003, J MED ENTOMOL, V40, P820, DOI 10.1603/0022-2585-40.6.820; REISEN WK, 1979, ANN TROP MED PARASIT, V73, P251, DOI 10.1080/00034983.1979.11687255; Roberts L, 2007, SCIENCE, V318, P1544, DOI 10.1126/science.318.5856.1544; Toure YT, 1998, MED VET ENTOMOL, V12, P74, DOI 10.1046/j.1365-2915.1998.00071.x; Tsuda Y, 2000, J VECTOR ECOL, V25, P16; Tsuda Y, 1999, J MED ENTOMOL, V36, P601, DOI 10.1093/jmedent/36.5.601; Wang DQ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0028988; Yewhalaw D, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016066; Zhang HongWei, 2007, Zhongguo Meijieshengwuxue ji Kongzhi Zazhi = Chinese Journal of Vector Biology and Control, V18, P42; Zhou SS, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-337	53	8	10	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 30	2012	7	11							e51209	10.1371/journal.pone.0051209	http://dx.doi.org/10.1371/journal.pone.0051209			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	054WM	23226489	Green Published, Green Submitted, gold			2022-12-27	WOS:000312376100301
J	Paul, R; Groza, T; Hunter, J; Zankl, A				Paul, Razan; Groza, Tudor; Hunter, Jane; Zankl, Andreas			Decision Support Methods for Finding Phenotype - Disorder Associations in the Bone Dysplasia Domain	PLOS ONE			English	Article								A lack of mature domain knowledge and well established guidelines makes the medical diagnosis of skeletal dysplasias (a group of rare genetic disorders) a very complex process. Machine learning techniques can facilitate objective interpretation of medical observations for the purposes of decision support. However, building decision support models using such techniques is highly problematic in the context of rare genetic disorders, because it depends on access to mature domain knowledge. This paper describes an approach for developing a decision support model in medical domains that are underpinned by relatively sparse knowledge bases. We propose a solution that combines association rule mining with the Dempster-Shafer theory (DST) to compute probabilistic associations between sets of clinical features and disorders, which can then serve as support for medical decision making (e.g., diagnosis). We show, via experimental results, that our approach is able to provide meaningful outcomes even on small datasets with sparse distributions, in addition to outperforming other Machine Learning techniques and behaving slightly better than an initial diagnosis by a clinician.	[Paul, Razan; Groza, Tudor; Hunter, Jane] Univ Queensland, Sch ITEE, St Lucia, Qld, Australia; [Zankl, Andreas] Univ Queensland, Bone Dysplasia Res Grp, UQ Ctr Clin Res UQCCR, Herston, Qld, Australia; [Zankl, Andreas] Royal Brisbane & Womens Hosp, Genet Hlth Queensland, Herston, Qld, Australia	University of Queensland; University of Queensland; Royal Brisbane & Women's Hospital	Groza, T (corresponding author), Univ Queensland, Sch ITEE, St Lucia, Qld, Australia.	tudor.groza@uq.edu.au	Hunter, Jane/E-5213-2013	Hunter, Jane/0000-0002-7163-4137; Groza, Tudor/0000-0003-2267-8333	Australian Research Council (ARC) [SKELETOME - LP100100156]	Australian Research Council (ARC)(Australian Research Council)	Australian Research Council (ARC) under the Linkage grant SKELETOME - LP100100156. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agrawal R., 1994, P 20 INT C VERY LARG, V1215, P487; Azevedo PJ, 2007, LECT NOTES ARTIF INT, V4701, P510; Begum S, 2011, IEEE T SYST MAN CY C, V41, P421, DOI 10.1109/TSMCC.2010.2071862; Bloch I, 1996, PATTERN RECOGN LETT, V17, P905, DOI 10.1016/0167-8655(96)00039-6; Breiman L., 2001, Machine Learning, V45, P5, DOI 10.1023/A:1010933404324; Chan KY, 2011, EXPERT SYST APPL, V38, P9799, DOI 10.1016/j.eswa.2011.02.020; Cherkassky V, 1997, IEEE Trans Neural Netw, V8, P1564, DOI 10.1109/TNN.1997.641482; DEMPSTER AP, 1967, ANN MATH STAT, V38, P325, DOI 10.1214/aoms/1177698950; Ding J, 2011, BIOINFORMATICS; Gadaras I, 2009, ARTIF INTELL MED, V47, P25, DOI 10.1016/j.artmed.2009.05.003; Gan YL, 2009, BIOINFORMATICS, V25, P2006, DOI 10.1093/bioinformatics/btp359; Gordon J, 1984, MYCIN EXPT STANFORD, V3, P832; Grcar M, 2006, LECT NOTES ARTIF INT, V4198, P58; Hayward J, 2010, ARTIF INTELL MED, V49, P187, DOI 10.1016/j.artmed.2010.04.009; Hudson DL, 2006, ENCY BIOMEDICAL ENG; Jonquet Clement, 2009, Summit Transl Bioinform, V2009, P56; Khatibi V, 2010, EXPERT SYST APPL, V37, P8536, DOI 10.1016/j.eswa.2010.05.022; Kohler S, 2009, AM J HUM GENET, V85, P457, DOI 10.1016/j.ajhg.2009.09.003; Kopriva I, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-496; Li WM, 2001, 2001 IEEE INTERNATIONAL CONFERENCE ON DATA MINING, PROCEEDINGS, P369, DOI 10.1109/ICDM.2001.989541; Mabee PM, 2007, TRENDS ECOL EVOL, V22, P345, DOI 10.1016/j.tree.2007.03.013; Martin J, 2009, INT J APPROX REASON, V50, P315, DOI 10.1016/j.ijar.2008.03.017; Murai T, 2003, LECT NOTES ARTIF INT, V2843, P377; Quinlan J. R., 1986, Machine Learning, V1, P81, DOI 10.1007/BF00116251; Rish I., 2001, IJCAI 2001 WORKSH EM, V3, P41, DOI DOI 10.1039/B104835J; Robinson PN, 2008, AM J HUM GENET, V83, P610, DOI 10.1016/j.ajhg.2008.09.017; Roeder C, 2010, BIOINFORMATICS, V26, P1800, DOI 10.1093/bioinformatics/btq250; Rohitha KK, 2007, IEEE T SYST MAN CY B, V37, P1446, DOI 10.1109/TSMCB.2007.903536; Shafer G, 2021, MATH THEORY EVIDENCE, DOI 10.1515/9780691214696; Straszecka E, 2006, INFORM SCIENCES, V176, P3026, DOI 10.1016/j.ins.2005.12.006; Tan AC, 2005, BIOINFORMATICS, V21, P2643; Wickramaratna K, 2009, IEEE T KNOWL DATA EN, V21, P985, DOI 10.1109/TKDE.2008.229; Yager RR, 2008, STUD FUZZ SOFT COMP, V219, P1, DOI 10.1007/978-3-540-44792-4	33	11	12	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 30	2012	7	11							e50614	10.1371/journal.pone.0050614	http://dx.doi.org/10.1371/journal.pone.0050614			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	054WM	23226331	gold, Green Submitted, Green Published			2022-12-27	WOS:000312376100142
J	Philibert, A; Loyce, C; Makowski, D				Philibert, Aurore; Loyce, Chantal; Makowski, David			Quantifying Uncertainties in N2O Emission Due to N Fertilizer Application in Cultivated Areas	PLOS ONE			English	Article							GREENHOUSE-GAS EMISSIONS; NITROUS-OXIDE EMISSIONS; AGRICULTURAL SOILS; TEMPERATE	Nitrous oxide (N2O) is a greenhouse gas with a global warming potential approximately 298 times greater than that of CO2. In 2006, the Intergovernmental Panel on Climate Change (IPCC) estimated N2O emission due to synthetic and organic nitrogen (N) fertilization at 1% of applied N. We investigated the uncertainty on this estimated value, by fitting 13 different models to a published dataset including 985 N2O measurements. These models were characterized by (i) the presence or absence of the explanatory variable "applied N", (ii) the function relating N2O emission to applied N (exponential or linear function), (iii) fixed or random background (i.e. in the absence of N application) N2O emission and (iv) fixed or random applied N effect. We calculated ranges of uncertainty on N2O emissions from a subset of these models, and compared them with the uncertainty ranges currently used in the IPCC-Tier 1 method. The exponential models outperformed the linear models, and models including one or two random effects outperformed those including fixed effects only. The use of an exponential function rather than a linear function has an important practical consequence: the emission factor is not constant and increases as a function of applied N. Emission factors estimated using the exponential function were lower than 1% when the amount of N applied was below 160 kg N ha(-1). Our uncertainty analysis shows that the uncertainty range currently used by the IPCC-Tier 1 method could be reduced.	[Philibert, Aurore; Loyce, Chantal; Makowski, David] INRA, UMR Agron 211, F-78850 Thiverval Grignon, France; [Philibert, Aurore; Loyce, Chantal; Makowski, David] AgroParisTech, UMR Agron 211, Thiverval Grignon, France	AgroParisTech; INRAE; UDICE-French Research Universities; Universite Paris Saclay; AgroParisTech; UDICE-French Research Universities; Universite Paris Saclay	Philibert, A (corresponding author), INRA, UMR Agron 211, F-78850 Thiverval Grignon, France.	Aurore.Philibert@grignon.inra.fr	Makowski, David/V-4233-2019	Makowski, David/0000-0001-6385-3703	French Research Agency (ANR)	French Research Agency (ANR)(French National Research Agency (ANR))	This work was funded by the French Research Agency (ANR project ORACLE: Opportunities and Risks of Agrosystems & forests in response to CLimate, socio-economic and policy changEs in France (and Europe)). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AKAIKE H, 1974, IEEE T AUTOMAT CONTR, VAC19, P716, DOI 10.1109/TAC.1974.1100705; Bernadier AB, 2012, GLOBAL CHANGE BIOL, V18, P928; Bouwman AF, 1996, NUTR CYCL AGROECOSYS, V46, P53, DOI 10.1007/BF00210224; Brooks SP, 1998, J COMPUT GRAPH STAT, V7, P434, DOI 10.2307/1390675; Burnham K. P., 2002, MODEL SELECTION MULT, V2nd; Crutzen PJ, 2008, ATMOS CHEM PHYS, V8, P389, DOI 10.5194/acp-8-389-2008; Davidian M, 1995, NONLINEAR MIXED EFFE; Davidson EA, 2009, NAT GEOSCI, V2, P659, DOI 10.1038/NGEO608; Del Grosso SJ, 2010, GLOBAL BIOGEOCHEM CY, V24, DOI 10.1029/2009GB003544; Del Grosso SJ, 2009, GLOBAL PLANET CHANGE, V67, P44, DOI 10.1016/j.gloplacha.2008.12.006; Efron B, 1986, STAT SCI, V1, P54, DOI DOI 10.1214/SS/1177013815; Efron Bradley, 1993, INTRO BOOTSTRAP, V57; Food and Agricultural Organisation, 2011, FAO STAT DAT FAOSTAT; Freibauer A, 2003, BIOGEOCHEMISTRY, V63, P93, DOI 10.1023/A:1023398108860; Galloway JN, 2004, BIOGEOCHEMISTRY, V70, P153, DOI 10.1007/s10533-004-0370-0; Hoben JP, 2011, GLOBAL CHANGE BIOL, V17, P1140, DOI 10.1111/j.1365-2486.2010.02349.x; Intergovernmental Panel on Climate Change (IPCC), 2006, 2006 IPCC GUIDELINES, V4; IPCC, 2007, CLIM CHANG 2007 PHYS; IPCC, 2001, ADV CLIM CHANG RES; Leip A, 2011, ENVIRON POLLUT, V159, P3223, DOI 10.1016/j.envpol.2010.11.024; Lesschen JP, 2011, ENVIRON POLLUT, V159, P3215, DOI 10.1016/j.envpol.2011.04.001; Lokupitiya E, 2006, J ENVIRON QUAL, V35, P1413, DOI 10.2134/jeq2005.0157; Lunn DJ, 2000, STAT COMPUT, V10, P325, DOI 10.1023/A:1008929526011; McSwiney CP, 2005, GLOBAL CHANGE BIOL, V11, P1712, DOI 10.1111/j.1365-2486.2005.01040.x; Millar N, 2010, MITIG ADAPT STRAT GL, V15, P185, DOI 10.1007/s11027-010-9212-7; Mosier A, 1998, NUTR CYCL AGROECOSYS, V52, P225, DOI 10.1023/A:1009740530221; Philibert A, 2012, AGR ECOSYST ENVIRON, V148, P72, DOI 10.1016/j.agee.2011.12.003; Pinheiro J, 2001, MIXED EFFECTS MODELS; Rochette P, 2010, EUR J SOIL SCI, V61, P186, DOI 10.1111/j.1365-2389.2009.01222.x; Rochette P, 2008, CAN J SOIL SCI, V88, P641, DOI 10.4141/CJSS07025; Rochette P, 2008, SOIL TILL RES, V101, P97, DOI 10.1016/j.still.2008.07.011; Roelandt C, 2005, GLOBAL CHANGE BIOL, V11, P1701, DOI 10.1111/j.1365-2486.2005.01025.x; Skiba U., 2000, CHEMOSPHERE GLOBAL C, V2, P379, DOI DOI 10.1016/S1465-9972(00)00016-7; Smith K., 1999, BACKGROUND PAPER IPC, P361; Smith P, 2007, CLIMATE CHANGE 2007; Snyder CS, 2009, AGR ECOSYST ENVIRON, V133, P247, DOI 10.1016/j.agee.2009.04.021; Spiegelhalter DJ, 2002, J R STAT SOC B, V64, P583, DOI 10.1111/1467-9868.00353; Spiertz JHJ, 2010, AGRON SUSTAIN DEV, V30, P43, DOI 10.1051/agro:2008064; Stehfest E, 2006, NUTR CYCL AGROECOSYS, V74, P207, DOI 10.1007/s10705-006-9000-7; Tilman D, 2002, NATURE, V418, P671, DOI 10.1038/nature01014	40	66	66	1	89	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 30	2012	7	11							e50950	10.1371/journal.pone.0050950	http://dx.doi.org/10.1371/journal.pone.0050950			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	054WM	23226430	Green Published, gold, Green Submitted			2022-12-27	WOS:000312376100241
J	Ross, D; Saxena, M; Altmann, M				Ross, Daniela; Saxena, Manisha; Altmann, Michael			eIF4E Is an Important Determinant of Adhesion and Pseudohyphal Growth of the Yeast S. cerevisiae	PLOS ONE			English	Article							CAP-BINDING PROTEIN; SACCHAROMYCES-CEREVISIAE; TRANSLATION INITIATION; FILAMENTOUS GROWTH; GENE; DIFFERENTIATION; EXPRESSION; NUTRIENTS; TARGET; CANCER	eIF4E, the cytoplasmatic cap-binding protein, is required for efficient cap-dependent translation. We have studied the influence of mutations that alter the activity and/or expression level of eIF4E on haploid and diploid cells in the yeast S. cerevisiae. Temperature-sensitive eIF4E mutants with reduced levels of expression and reduced cap-binding affinity clearly show a loss in haploid adhesion and diploid pseudohyphenation upon starvation for nitrogen. Some of these mutations affect the interaction of the cap-structure of mRNAs with the cap-binding groove of eIF4E. The observed reduction in adhesive and pseudohyphenating properties is less evident for an eIF4E mutant that shows reduced interaction with p20 (an eIF4E-binding protein) or for a p20-knockout mutant. Loss of adhesive and pseudohyphenating properties was not only observed for eIF4E mutants but also for knockout mutants of components of eIF4F such as eIF4B and eIF4G1. We conclude from these experiments that mutations that affect components of the eIF4F-complex loose properties such as adhesion and pseudohyphal differentiation, most likely due to less effective translation of required mRNAs for such processes. Citation: Ross D, Saxena M, Altmann M (2012) eIF4E Is an Important Determinant of Adhesion and Pseudohyphal Growth of the Yeast S. cerevisiae. PLoS ONE 7(11): e50773. doi:10.1371/journal.pone.0050773	[Ross, Daniela; Saxena, Manisha; Altmann, Michael] Univ Bern, Inst Biochem & Mol Med, Bern, Switzerland	University of Bern	Altmann, M (corresponding author), Univ Bern, Inst Biochem & Mol Med, Bern, Switzerland.	michael.altmann@ibmm.unibe.ch		Ross-Kaschitza, Daniela/0000-0003-1367-0671	Swiss National Science Foundation [31003A-119996]	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission)	This work was supported by Swiss National Science Foundation grant 31003A-119996 to MA. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALTMANN M, 1989, NUCLEIC ACIDS RES, V17, P5923, DOI 10.1093/nar/17.15.5923; Altmann M, 1997, EMBO J, V16, P1114, DOI 10.1093/emboj/16.5.1114; ALTMANN M, 1989, MOL CELL BIOL, V9, P4467, DOI 10.1128/MCB.9.10.4467; ALTMANN M, 1987, MOL CELL BIOL, V7, P998, DOI 10.1128/MCB.7.3.998; Blagden SP, 2011, NAT REV CLIN ONCOL, V8, P280, DOI 10.1038/nrclinonc.2011.16; BOEKE JD, 1984, MOL GEN GENET, V197, P345, DOI 10.1007/BF00330984; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; BURNETTE WN, 1981, ANAL BIOCHEM, V112, P195, DOI 10.1016/0003-2697(81)90281-5; Cankorur-Cetinkaya A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038351; Cosentino GP, 2000, MOL CELL BIOL, V20, P4604, DOI 10.1128/MCB.20.13.4604-4613.2000; Cridge AG, 2010, NUCLEIC ACIDS RES, V38, P8039, DOI 10.1093/nar/gkq686; Cullen PJ, 2012, GENETICS, V190, P23, DOI 10.1534/genetics.111.127456; Cutler NS, 2001, MOL BIOL CELL, V12, P4103, DOI 10.1091/mbc.12.12.4103; Furic L, 2010, P NATL ACAD SCI USA, V107, P14134, DOI 10.1073/pnas.1005320107; Gilbert WV, 2007, SCIENCE, V317, P1224, DOI 10.1126/science.1144467; Hoyle NP, 2007, J CELL BIOL, V179, P65, DOI 10.1083/jcb.200707010; HUTCHISON CA, 1978, J BIOL CHEM, V253, P6551; Ibrahimo S, 2006, YEAST, V23, P1075, DOI 10.1002/yea.1415; Joshi B, 2005, BMC EVOL BIOL, V5, DOI 10.1186/1471-2148-5-48; Konicek BW, 2011, CANCER RES, V71, P1849, DOI 10.1158/0008-5472.CAN-10-3298; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Matsuo H, 1997, NAT STRUCT BIOL, V4, P717, DOI 10.1038/nsb0997-717; Park YU, 2006, EUKARYOT CELL, V5, P2120, DOI 10.1128/EC.00121-06; Paz I, 2001, J BACTERIOL, V183, P4477, DOI 10.1128/JB.183.15.4477-4483.2001; Ptushkina M, 1998, EMBO J, V17, P4798, DOI 10.1093/emboj/17.16.4798; Rupp S, 1999, EMBO J, V18, P1257, DOI 10.1093/emboj/18.5.1257; Saville SP, 2006, ANTIMICROB AGENTS CH, V50, P3312, DOI 10.1128/AAC.00628-06; Strittmatter AW, 2006, MOL GENET GENOMICS, V276, P113, DOI 10.1007/s00438-006-0127-7; Valerius O, 2007, MOL CELL PROTEOMICS, V6, P1968, DOI 10.1074/mcp.M700184-MCP200; Yanagiya A, 2012, MOL CELL, V46, P847, DOI 10.1016/j.molcel.2012.04.004; Zaman S, 2008, ANNU REV GENET, V42, P27, DOI 10.1146/annurev.genet.41.110306.130206; Zhou HY, 2010, CURR PROTEIN PEPT SC, V11, P409, DOI 10.2174/138920310791824093	33	3	3	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 30	2012	7	11							e50773	10.1371/journal.pone.0050773	http://dx.doi.org/10.1371/journal.pone.0050773			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	054WM	23226381	Green Submitted, Green Published, gold			2022-12-27	WOS:000312376100192
J	Whittington, AC; Nienow, TE; Whittington, CL; Fort, TJ; Grove, TJ				Whittington, A. Carl; Nienow, Tatyana E.; Whittington, Christi L.; Fort, Timothy J.; Grove, Theresa J.			Functional and Structural Characterization of a Eurytolerant Calsequestrin from the Intertidal Teleost Fundulus heteroclitus	PLOS ONE			English	Article							SKELETAL-MUSCLE; SARCOPLASMIC-RETICULUM; CALCIUM-BINDING; TROPONIN-C; CARDIAC CALSEQUESTRIN; CA2+ BINDING; SWISS-MODEL; PROTEIN; TEMPERATURE; PH	Calsequestrins (CSQ) are high capacity, medium affinity, calcium-binding proteins present in the sarcoplasmic reticulum (SR) of cardiac and skeletal muscles. CSQ sequesters Ca2+ during muscle relaxation and increases the Ca2+-storage capacity of the SR. Mammalian CSQ has been well studied as a model of human disease, but little is known about the environmental adaptation of CSQ isoforms from poikilothermic organisms. The mummichog, Fundulus heteroclitus, is an intertidal fish that experiences significant daily and seasonal environmental fluctuations and is an interesting study system for investigations of adaptation at the protein level. We determined the full-length coding sequence of a CSQ isoform from skeletal muscle of F. heteroclitus (FCSQ) and characterized the function and structure of this CSQ. The dissociation constant (K-d) of FCSQ is relatively insensitive to changes in temperature and pH, thus indicating that FCSQ is a eurytolerant protein. We identified and characterized a highly conserved salt bridge network in FCSQ that stabilizes the formation of front-to-front dimers, a process critical to CSQ function. The functional profile of FCSQ correlates with the natural history of F. heteroclitus suggesting that the eurytolerant function of FCSQ may be adaptive.	[Nienow, Tatyana E.; Fort, Timothy J.; Grove, Theresa J.] Valdosta State Univ, Dept Biol, Valdosta, GA USA; [Whittington, A. Carl] Florida State Univ, Dept Chem & Biochem, Tallahassee, FL 32306 USA; [Whittington, Christi L.] Univ S Florida, Dept Chem, Tampa, FL 33620 USA	University System of Georgia; Valdosta State University; State University System of Florida; Florida State University; State University System of Florida; University of South Florida	Grove, TJ (corresponding author), Valdosta State Univ, Dept Biol, Valdosta, GA USA.	tjgrove@valdosta.edu			Valdosta State University Faculty Seed Research grant; National Science Foundation [IOS-0817805]; Division Of Integrative Organismal Systems [0817805] Funding Source: National Science Foundation	Valdosta State University Faculty Seed Research grant; National Science Foundation(National Science Foundation (NSF)); Division Of Integrative Organismal Systems(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	This work was supported by a Valdosta State University Faculty Seed Research grant to TJG and a National Science Foundation grant (IOS-0817805) to TJG and TJF. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANDERSON DE, 1990, BIOCHEMISTRY-US, V29, P2403, DOI 10.1021/bi00461a025; [Anonymous], PYMOL MOL GRAPH SYST; Arnold K, 2006, BIOINFORMATICS, V22, P195, DOI 10.1093/bioinformatics/bti770; Bal NC, 2010, J BIOL CHEM, V285, P17188, DOI 10.1074/jbc.M109.096354; Beard NA, 2004, PROG BIOPHYS MOL BIO, V85, P33, DOI 10.1016/j.pbiomolbio.2003.07.001; Beard NA, 2002, BIOPHYS J, V82, P310, DOI 10.1016/S0006-3495(02)75396-4; Beltran M, 2006, BIOL RES, V39, P493, DOI 10.4067/S0716-97602006000300011; BLOCK BA, 1994, J CELL BIOL, V127, P1275, DOI 10.1083/jcb.127.5.1275; Blumenschein TMA, 2004, BIOCHEMISTRY-US, V43, P4955, DOI 10.1021/bi035504z; Bosshard HR, 2004, J MOL RECOGNIT, V17, P1, DOI 10.1002/jmr.657; CALA SE, 1983, J BIOL CHEM, V258, P1932; CAMPBELL KP, 1983, J BIOL CHEM, V258, P1267; Canato M, 2010, P NATL ACAD SCI USA, V107, P22326, DOI 10.1073/pnas.1009168108; COZENS B, 1984, J BIOL CHEM, V259, P6248; Detrich HW, 2000, J BIOL CHEM, V275, P37038, DOI 10.1074/jbc.M005699200; Erickson JR, 2006, COMP BIOCHEM PHYS A, V143, P228, DOI 10.1016/j.cbpa.2005.11.020; Erickson JR, 2005, COMP BIOCHEM PHYS A, V140, P179, DOI 10.1016/j.cbpb.2004.12.001; FRANZINIARMSTRONG C, 1987, J CELL BIOL, V105, P49, DOI 10.1083/jcb.105.1.49; Gillis TE, 2002, COMP BIOCHEM PHYS A, V132, P763, DOI 10.1016/S1095-6433(02)00046-6; Gillis TE, 2000, AM J PHYSIOL-REG I, V279, pR1707, DOI 10.1152/ajpregu.2000.279.5.R1707; Gillis TE, 2007, PHYSIOL GENOMICS, V32, P16, DOI 10.1152/physiolgenomics.00197.2007; Giordano A, 2005, BIOCHEM J, V388, P657, DOI 10.1042/BJ20041539; Goutelle S, 2008, FUND CLIN PHARMACOL, V22, P633, DOI 10.1111/j.1472-8206.2008.00633.x; Grove TJ, 2005, J MUSCLE RES CELL M, V26, P191, DOI 10.1007/s10974-005-9010-0; Guex N, 1997, ELECTROPHORESIS, V18, P2714, DOI 10.1002/elps.1150181505; Hasenfuss G, 1996, BASIC RES CARDIOL, V91, P17, DOI 10.1007/BF00795357; Healy TM, 2010, PHYSIOL GENOMICS, V41, P171, DOI 10.1152/physiolgenomics.00209.2009; Hidalgo C, 1996, BIOPHYS J, V71, P2130, DOI 10.1016/S0006-3495(96)79413-4; Hochachka P. W., 2002, BIOCH ADAPTATION MEC, DOI 10.1002/bmb.2002.494030030071; Houle TD, 2004, CARDIOVASC RES, V64, P227, DOI 10.1016/j.cardiores.2004.09.009; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; IKEMOTO N, 1972, J BIOL CHEM, V247, P7835; Infante C, 2011, COMP BIOCHEM PHYS B, V158, P304, DOI 10.1016/j.cbpb.2011.01.002; Jaenicke R, 2000, J BIOTECHNOL, V79, P193, DOI 10.1016/S0168-1656(00)00236-4; JORGENSEN WL, 1983, J CHEM PHYS, V79, P926, DOI 10.1063/1.445869; Kim E, 2007, J MOL BIOL, V373, P1047, DOI 10.1016/j.jmb.2007.08.055; KING LE, 1976, ANAL BIOCHEM, V71, P223, DOI 10.1016/0003-2697(76)90031-2; Knollmann BC, 2009, J PHYSIOL-LONDON, V587, P3081, DOI 10.1113/jphysiol.2009.172098; Korajoki H, 2009, J EXP BIOL, V212, P3403, DOI 10.1242/jeb.031617; Kornyeyev D, 2012, J MOL CELL CARDIOL, V52, P21, DOI 10.1016/j.yjmcc.2011.09.020; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Lewit-Bentley A, 2000, CURR OPIN STRUC BIOL, V10, P637, DOI 10.1016/S0959-440X(00)00142-1; MacKerell AD, 1998, J PHYS CHEM B, V102, P3586, DOI 10.1021/jp973084f; MACLENNAN DH, 1971, P NATL ACAD SCI USA, V68, P1231, DOI 10.1073/pnas.68.6.1231; MEHLER EL, 1984, BIOCHEMISTRY-US, V23, P3887, DOI 10.1021/bi00312a015; Moerland TS, 1998, J THERM BIOL, V23, P275, DOI 10.1016/S0306-4565(98)00016-3; Nayeem A, 2006, PROTEIN SCI, V15, P808, DOI 10.1110/ps.051892906; Paolini C, 2007, J PHYSIOL-LONDON, V583, P767, DOI 10.1113/jphysiol.2007.138024; Park HJ, 2003, J BIOL CHEM, V278, P16176, DOI 10.1074/jbc.M300120200; Park HJ, 2004, J BIOL CHEM, V279, P18026, DOI 10.1074/jbc.M311553200; POWERS DA, 1989, SCIENCE, V246, P352, DOI 10.1126/science.2678474; Powers DA, 1998, J EXP ZOOL, V282, P71; Protasi F, 2011, J MUSCLE RES CELL M, V32, P257, DOI 10.1007/s10974-011-9277-2; REEVES RB, 1972, RESP PHYSIOL, V14, P219, DOI 10.1016/0034-5687(72)90030-8; REITHMEIER RAF, 1980, J BIOL CHEM, V255, P1839; Rios E, 2006, J MUSCLE RES CELL M, V27, P337, DOI 10.1007/s10974-006-9082-5; Royer L, 2009, J PHYSIOL-LONDON, V587, P3101, DOI 10.1113/jphysiol.2009.171934; Rudolf R, 2006, J CELL BIOL, V173, P187, DOI 10.1083/jcb.200601160; Sanchez EJ, 2012, J BIOL CHEM, V287, P11592, DOI 10.1074/jbc.M111.335075; Sanchez R, 1997, CURR OPIN STRUC BIOL, V7, P206, DOI 10.1016/S0959-440X(97)80027-9; Sartoris FJ, 2003, J THERM BIOL, V28, P363, DOI 10.1016/S0306-4565(03)00012-3; Somero GN, 2004, COMP BIOCHEM PHYS B, V139, P321, DOI 10.1016/j.cbpc.2004.05.003; SOMERO GN, 1977, AM NAT, V111, P527, DOI 10.1086/283182; SOMERO GN, 1975, J EXP ZOOL, V194, P175, DOI 10.1002/jez.1401940111; SWEZEY RR, 1982, BIOCHEMISTRY-US, V21, P4496, DOI 10.1021/bi00261a047; Valle G, 2008, BIOCHEM J, V413, P291, DOI 10.1042/BJ20080163; Wang SR, 1998, NAT STRUCT BIOL, V5, P476, DOI 10.1038/nsb0698-476; Warshel A, 2006, BBA-PROTEINS PROTEOM, V1764, P1647, DOI 10.1016/j.bbapap.2006.08.007; WATABE S, 1991, COMP BIOCHEM PHYS B, V99, P545, DOI 10.1016/0305-0491(91)90336-C; Wei L, 2006, BIOPHYS J, V91, P1288, DOI 10.1529/biophysj.106.082610; Whittington AC, 2012, J EXP BIOL, V215, P3281, DOI 10.1242/jeb.070615; YANO K, 1994, MOL CELL BIOCHEM, V135, P61, DOI 10.1007/BF00925961; Zavodszky P, 1998, P NATL ACAD SCI USA, V95, P7406, DOI 10.1073/pnas.95.13.7406	73	2	2	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 30	2012	7	11							e50801	10.1371/journal.pone.0050801	http://dx.doi.org/10.1371/journal.pone.0050801			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	054WM	23226387	gold, Green Published, Green Submitted			2022-12-27	WOS:000312376100198
J	Fedina, TY; Kuo, TH; Dreisewerd, K; Dierick, HA; Yew, JY; Pletcher, SD				Fedina, Tatyana Y.; Kuo, Tsung-Han; Dreisewerd, Klaus; Dierick, Herman A.; Yew, Joanne Y.; Pletcher, Scott D.			Dietary Effects on Cuticular Hydrocarbons and Sexual Attractiveness in Drosophila	PLOS ONE			English	Article							LIFE-SPAN; S6 KINASE; FEMALE; MELANOGASTER; RESTRICTION; RECOGNITION; TEMPERATURE; MOJAVENSIS; COLEOPTERA; EVOLUTION	Dietary composition is known to have profound effects on many aspects of animal physiology, including lifespan, general health, and reproductive potential. We have previously shown that aging and insulin signaling significantly influence the composition and sexual attractiveness of Drosophila melanogaster female cuticular hydrocarbons (CHCs), some of which are known to be sex pheromones. Because diet is intimately linked to aging and to the activity of nutrient-sensing pathways, we asked how diet affects female CHCs and attractiveness. Here we report consistent and significant effects of diet composition on female CHC profiles across ages, with dietary yeast and sugar driving CHC changes in opposite directions. Surprisingly, however, we found no evidence that these changes affect female attractiveness. Multivariate comparisons among responses of CHC profiles to diet, aging, and insulin signaling suggest that diet may alter the levels of some CHCs in a way that results in profiles that are more attractive while simultaneously altering other CHCs in a way that makes them less attractive. For example, changes in short-chain CHCs induced by a high-yeast diet phenocopy changes caused by aging and by decreased insulin signaling, both of which result in less attractive females. On the other hand, changes in long-chain CHCs in response to the same diet result in levels that are comparable to those observed in attractive young females and females with increased insulin signaling. The effects of a high-sugar diet tend in the opposite direction, as levels of short-chain CHCs resemble those in attractive females with increased insulin signaling and changes in long-chain CHCs are similar to those caused by decreased insulin signaling. Together, these data suggest that diet-dependent changes in female CHCs may be sending conflicting messages to males.	[Fedina, Tatyana Y.; Pletcher, Scott D.] Univ Michigan, Dept Mol & Integrat Physiol, Ann Arbor, MI 48109 USA; [Kuo, Tsung-Han; Dierick, Herman A.; Pletcher, Scott D.] Baylor Coll Med, Dept Mol & Human Genet, Houston, TX 77030 USA; [Dreisewerd, Klaus; Yew, Joanne Y.] Univ Munster, Inst Med Phys & Biophys, Munster, Germany; [Yew, Joanne Y.] Natl Univ Singapore, Dept Biol Sci, Singapore 117548, Singapore; [Yew, Joanne Y.] Temasek Life Sci Lab, Singapore, Singapore; [Pletcher, Scott D.] Univ Michigan, Geriatr Ctr, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan; Baylor College of Medicine; University of Munster; National University of Singapore; University of Michigan System; University of Michigan	Pletcher, SD (corresponding author), Univ Michigan, Dept Mol & Integrat Physiol, Ann Arbor, MI 48109 USA.	spletch@umich.edu	Yew, Joanne/D-6562-2014; Dreisewerd, Klaus/K-3884-2015	Dreisewerd, Klaus/0000-0002-7619-808X	U.S. National Institutes of Health [R01AG030593, R01AG023166]; Glenn Foundation; American Federation for Aging Research; Ellison Medical Foundation; Alexander von Humboldt foundation; Singapore National Research Foundation [RF001-363]; National Institute of General Medical Sciences [GM074675, GM0676450]; National Science Foundation [IDS-075165]; National Institute on Aging [P30-AG-013283]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK020572] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM102279, R01GM074675] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG023166, P30AG013283, R01AG030593] Funding Source: NIH RePORTER	U.S. National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Glenn Foundation; American Federation for Aging Research; Ellison Medical Foundation(Lawrence Ellison Foundation); Alexander von Humboldt foundation(Alexander von Humboldt Foundation); Singapore National Research Foundation(National Research Foundation, Singapore); National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); National Science Foundation(National Science Foundation (NSF)); National Institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This research was supported by U.S. National Institutes of Health (R01AG030593 and R01AG023166), the Glenn Foundation, the American Federation for Aging Research, the Ellison Medical Foundation (to S.D.P.), the Alexander von Humboldt foundation, Singapore National Research Foundation (RF001-363 to J.Y.Y.), the National Institute of General Medical Sciences (GM074675 and GM0676450) and the National Science Foundation (IDS-075165 to E. A. Kravitz). This work utilized the Drosophila Aging Core of the Nathan Shock Center of Excellence in the Biology of Aging funded by the National Institute on Aging (P30-AG-013283). Deposited in PMC for release after 12 months. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ambuhl PM, 2011, INT J VITAM NUTR RES, V81, P162, DOI 10.1024/0300-9831/a000056; Andersson Malte, 1994; [Anonymous], 2003, ANIMAL SIGNALS; ANTONY C, 1985, J CHEM ECOL, V11, P1617, DOI 10.1007/BF01012116; ANTONY C, 1982, J INSECT PHYSIOL, V28, P873, DOI 10.1016/0022-1910(82)90101-9; Arienti M, 2010, INTEGR ZOOL, V5, P272, DOI 10.1111/j.1749-4877.2010.00213.x; Avruch J, 2009, AM J PHYSIOL-ENDOC M, V296, pE592, DOI 10.1152/ajpendo.90645.2008; Bass TM, 2007, J GERONTOL A-BIOL, V62, P1071, DOI 10.1093/gerona/62.10.1071; Blomquist GJ, 2010, INSECT HYDROCARBONS: BIOLOGY, BIOCHEMISTRY, AND CHEMICAL ECOLOGY, P1, DOI 10.1017/CBO9780511711909; Carvalho M, 2012, MOL SYST BIOL, V8, DOI 10.1038/msb.2012.29; Catterson JH, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012062; Clancy DJ, 2001, SCIENCE, V292, P104, DOI 10.1126/science.1057991; COOK R, 1975, ANIM BEHAV, V23, P521, DOI 10.1016/0003-3472(75)90129-3; Etges WJ, 2006, J CHEM ECOL, V32, P2629, DOI 10.1007/s10886-006-9187-8; Etges WJ, 2009, EVOLUTION, V63, P1712, DOI 10.1111/j.1558-5646.2009.00661.x; Fanson BG, 2012, AGE, V34, P1361, DOI 10.1007/s11357-011-9308-3; Fedina TY, 2007, J INSECT PHYSIOL, V53, P93, DOI 10.1016/j.jinsphys.2006.10.011; Ferveur JF, 2005, BEHAV GENET, V35, P279, DOI 10.1007/s10519-005-3220-5; Fontana L, 2010, SCIENCE, V328, P321, DOI 10.1126/science.1172539; Fricke C, 2008, EVOLUTION, V62, P3170, DOI 10.1111/j.1558-5646.2008.00515.x; GEER BW, 1977, INSECT BIOCHEM, V7, P371, DOI 10.1016/0020-1790(77)90040-3; Gosden TP, 2011, J EVOLUTION BIOL, V24, P685, DOI 10.1111/j.1420-9101.2010.02205.x; Grandison RC, 2009, NATURE, V462, P1061, DOI 10.1038/nature08619; Hietakangas V, 2009, ANNU REV GENET, V43, P389, DOI 10.1146/annurev-genet-102108-134815; Howard RW, 2005, ANNU REV ENTOMOL, V50, P371, DOI 10.1146/annurev.ento.50.071803.130359; Jolliffe I.T., 2002, SPRINGER SERIES STAT; Katewa SD, 2011, EXP GERONTOL, V46, P382, DOI 10.1016/j.exger.2010.11.036; Kent C, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000962; Kuo TH, 2012, PLOS GENET, V8, P640, DOI 10.1371/journal.pgen.1002684; Kuo TH, 2012, J EXP BIOL, V215, P814, DOI 10.1242/jeb.064980; Lewis SM, 2012, J EVOLUTION BIOL, V25, P438, DOI 10.1111/j.1420-9101.2011.02408.x; Liang D, 2000, NATURWISSENSCHAFTEN, V87, P412, DOI 10.1007/s001140050752; Lin Y, 2010, J ENDOCRINOL, V204, P1, DOI 10.1677/JOE-09-0260; Lizcano JM, 2003, BIOCHEM J, V374, P297, DOI 10.1042/BJ20030577; Magwere T, 2004, J GERONTOL A-BIOL, V59, P3; Maklakov AA, 2008, CURR BIOL, V18, P1062, DOI 10.1016/j.cub.2008.06.059; Partridge L, 2011, EXP GERONTOL, V46, P376, DOI 10.1016/j.exger.2010.09.003; Piper MDW, 2011, CELL METAB, V14, P154, DOI 10.1016/j.cmet.2011.06.013; Radimerski T, 2002, NAT CELL BIOL, V4, P251, DOI 10.1038/ncb763; Richard DS, 2005, J INSECT PHYSIOL, V51, P455, DOI 10.1016/j.jinsphys.2004.12.013; Savarit F, 2002, J EXP BIOL, V205, P3241; Simpson SJ, 2009, AGING-US, V1, P875, DOI 10.18632/aging.100098; Skorupa DA, 2008, AGING CELL, V7, P478, DOI 10.1111/j.1474-9726.2008.00400.x; Spikes AE, 2010, J CHEM ECOL, V36, P943, DOI 10.1007/s10886-010-9837-8; Tirone TA, 2001, WORLD J SURG, V25, P461, DOI 10.1007/s002680020338; Vargas MA, 2010, CURR BIOL, V20, P1006, DOI 10.1016/j.cub.2010.04.009; Vigne P, 2006, PLOS ONE, V1, DOI 10.1371/journal.pone.0000056; Yew JY, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016898; Yew JY, 2009, CURR BIOL, V19, P1245, DOI 10.1016/j.cub.2009.06.037	49	71	73	2	89	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 5	2012	7	12							e49799	10.1371/journal.pone.0049799	http://dx.doi.org/10.1371/journal.pone.0049799			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	057TZ	23227150	gold, Green Published, Green Submitted			2022-12-27	WOS:000312588200012
J	Fletcher, JM				Fletcher, Jason M.			Why Have Tobacco Control Policies Stalled? Using Genetic Moderation to Examine Policy Impacts	PLOS ONE			English	Article							NICOTINIC ACETYLCHOLINE-RECEPTORS; LUNG-CANCER; SUSCEPTIBILITY LOCUS; SUBUNIT GENES; DEPENDENCE; ASSOCIATION; SMOKING; ADDICTION; CHRNB3; TAXES	Background: Research has shown that tobacco control policies have helped produce the dramatic decline in use over the decades following the 1964 surgeon general's report. However, prevalence rates have stagnated during the past two decades in the US, even with large tobacco taxes and expansions of clean air laws. The observed differences in tobacco control policy effectiveness and why policies do not help all smokers are largely unexplained. Objective: The aim of this study was to determine the importance of genetics in explaining response to tobacco taxation policy by testing the potential of gene-policy interaction in determining adult tobacco use. Methods: A moderated regression analysis framework was used to test interactive effects between genotype and tobacco policy in predicting tobacco use. Cross sectional data of US adults from the National Health and Nutrition Examination Survey (NHANES) linked with genotype and geocodes were used to identify tobacco use phenotypes, state-level taxation rates, and variation in the nicotinic acetylcholine receptor (CHRNA6) genotype. Tobacco use phenotypes included current use, number of cigarettes smoked per day, and blood serum cotinine measurements. Results: Variation in the nicotinic acetylcholine receptor was found to moderate the influence of tobacco taxation on multiple measures of tobacco use. Individuals with the protective G/G polymorphism (51% of the sample) responded to taxation while others had no response. The estimated differences in response by genotype were C/C genotype: b = -0.016 se = 0.018; G/C genotype: b = 0.014 se = 0.017; G/G genotype: b = -0.071 se 0.029. Conclusions: This study provides novel evidence of "gene-policy'' interaction and suggests a genetic mechanism for the large differences in response to tobacco policies. The inability for these policies to reduce use for individuals with specific genotypes suggests alternative methods may be needed to further reduce use.	Yale Univ, Sch Publ Hlth, Dept Hlth Policy & Management, New Haven, CT 06520 USA	Yale University	Fletcher, JM (corresponding author), Yale Univ, Sch Publ Hlth, Dept Hlth Policy & Management, New Haven, CT 06520 USA.	jason.fletcher@yale.edu			Robert Wood Johnson Foundation Health & Society Scholars Program at Columbia University	Robert Wood Johnson Foundation Health & Society Scholars Program at Columbia University	This study was funded by a seed grant from the Robert Wood Johnson Foundation Health & Society Scholars Program at Columbia University. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adda J, 2006, AM ECON REV, V96, P1013, DOI 10.1257/aer.96.4.1013; Ai CR, 2003, ECON LETT, V80, P123, DOI 10.1016/S0165-1765(03)00032-6; Aiken L. S., 1991, MULTIPLE REGRESSION; Amos CI, 2008, NAT GENET, V40, P616, DOI 10.1038/ng.109; BECKER GS, 1988, J POLIT ECON, V96, P675, DOI 10.1086/261558; Brant-Zawadzki PB, 2007, J VASC SURG, V45, p8A, DOI 10.1016/j.jvs.2007.02.033; Centers for Disease Control and Prevention (CDC), 1999, MMWR Morb Mortal Wkly Rep, V48, P241; Centers for Disease Control and Prevention (CDC), 2009, MMWR Morb Mortal Wkly Rep, V58, P524; Chaloupka FJ, 2000, HANDB ECON, V17, P1539; Conley DC, 2009, HDB MED SOCIOLOGY; DeCicca P, 2000, J RISK UNCERTAINTY, V21, P311, DOI 10.1023/A:1007819625751; Fletcher JM, 2009, 15130 NBER; Greenbaum L, 2009, MOL PSYCHIATR, V14, P912, DOI 10.1038/mp.2009.59; Gruber Jonathan, 2001, RISKY BEHAV YOUTHS E; Healthy People, 2005, LEDING HLTH INDICATO; Hoft NR, 2009, NEUROPSYCHOPHARMACOL, V34, P698, DOI 10.1038/npp.2008.122; Hung RJ, 2008, NATURE, V452, P633, DOI 10.1038/nature06885; Inst. Med. (IOM), 2007, END TOB PROBL BLUEPR; Jaffee SR, 2007, MOL PSYCHIATR, V12, P432, DOI 10.1038/sj.mp.4001950; Maziere P, 2007, DRUG DISCOV TODAY, V12, P452, DOI 10.1016/j.drudis.2007.04.002; Meyer EL, 2008, J NEUROCHEM, V105, P1761, DOI 10.1111/j.1471-4159.2008.05266.x; Mineur YS, 2008, BIOCHEM PHARMACOL, V75, P323, DOI 10.1016/j.bcp.2007.06.010; NIDA, 2009, NIH PUBL; Saccone SF, 2007, HUM MOL GENET, V16, P36, DOI 10.1093/hmg/ddl438; Smith GD, 2007, J ROY SOC MED, V100, P432, DOI 10.1258/jrsm.100.9.432; Sullivan P F, 1999, Nicotine Tob Res, V1 Suppl 2, pS51; Thorgeirsson TE, 2008, NATURE, V452, P638, DOI 10.1038/nature06846; Zeiger JS, 2008, HUM MOL GENET, V17, P724, DOI 10.1093/hmg/ddm344	28	31	32	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 5	2012	7	12							e50576	10.1371/journal.pone.0050576	http://dx.doi.org/10.1371/journal.pone.0050576			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	057TZ	23227187	Green Published, Green Submitted, gold			2022-12-27	WOS:000312588200047
J	Nischal, L; Mohsin, M; Khan, I; Kardam, H; Wadhwa, A; Abrol, YP; Iqbal, M; Ahmad, A				Nischal, Lata; Mohsin, Mohd; Khan, Ishrat; Kardam, Hemant; Wadhwa, Asha; Abrol, Yash Pal; Iqbal, Muhammad; Ahmad, Altaf			Identification and Comparative Analysis of MicroRNAs Associated with Low-N Tolerance in Rice Genotypes	PLOS ONE			English	Article							STRESS-REGULATED MICRORNAS; EXPRESSION PATTERNS; GENE-EXPRESSION; PHOSPHATE-STARVATION; NITROGEN LIMITATION; SMALL RNAS; RT-PCR; ARABIDOPSIS; PLANT; RESPONSES	Background: Nitrogen [N] is a critical limiting nutrient for plants and has to be exogenously supplied to many crops, to achieve high yield with significant economic and environmental costs, specifically for rice. Development of low-input nitrogen sustainable crop is necessary for sustainable agriculture. Identification of regulatory elements associated with low-N tolerance is imperative for formulating innovative approaches for developing low-N tolerant crop plants, using gene manipulation. MicroRNAs (miRNAs) are known to play crucial roles in the modulation of gene expression in plants under various environmental conditions. Methodology/Principal Findings: MiRNAs associated with low-N tolerance have not been identified so far. In this study, we investigated microarray-based miRNA expression in low-N tolerant and low-N sensitive rice genotypes under low N condition. Expressions of 32 miRNAs differed significantly in the two genotypes. Of these 32 miRNAs, expressions of nine miRNAs were further validated experimentally in leaves as well as in roots. Of these differentially expressed miRNAs, six miRNAs (miR156, miR164, miR528, miR820, miR821 and miR1318) were reported in leaves and four (miR164, miR167, miR168 and miR528) in roots. Target genes of all the 32 miRNAs were predicted, which encode transcription factors, and proteins associated with metabolic processes or stress responses. Expression levels of some of the corresponding miRNA targets were analysed and found to be significantly higher in low N-tolerant genotype than low-N sensitive genotype. These findings suggested that miRNAs played an important role in low-N tolerance in rice. Conclusions/Significance: Genome-wide differences in expression of miRNA in low N-tolerant and low N-sensitive rice genotypes were reported. This provides a platform for selection as well as manipulation of genotypes for better N utilization efficiency. Citation: Nischal L, Mohsin M, Khan I, Kardam H, Wadhwa A, et al. (2012) Identification and Comparative Analysis of MicroRNAs Associated with Low-N Tolerance in Rice Genotypes. PLoS ONE 7(12): e50261. doi:10.1371/journal.pone.0050261	[Nischal, Lata; Mohsin, Mohd; Khan, Ishrat; Kardam, Hemant; Wadhwa, Asha; Abrol, Yash Pal; Iqbal, Muhammad; Ahmad, Altaf] Jamia Hamdard, Fac Sci, Dept Bot, Mol Ecol Lab, New Delhi, India	Jamia Hamdard University	Ahmad, A (corresponding author), Jamia Hamdard, Fac Sci, Dept Bot, Mol Ecol Lab, New Delhi, India.	aahmed@jamiahamdard.ac.in	AHMAD, ALTAF/AAE-9371-2020	AHMAD, ALTAF/0000-0003-4099-7338	Department of Biotechnology, Government of India	Department of Biotechnology, Government of India(Department of Biotechnology (DBT) India)	The Department of Biotechnology, Government of India has supported this work. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABROL YP, 1990, DEV PLANT SOIL SCI, V41, P773; Abrol YP, 1999, CURR SCI INDIA, V76, P1357; Ahmad A, 2007, NITROGEN IN ENVIRONM, P115; Baggs EM, 2000, SOIL USE MANAGE, V16, P82, DOI 10.1111/j.1475-2743.2000.tb00179.x; Bari R, 2006, PLANT PHYSIOL, V141, P988, DOI 10.1104/pp.106.079707; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Bouwman AF, 2002, GLOBAL BIOGEOCHEM CY, V16, DOI [10.1029/2001GB001811, 10.1029/2001GB001812]; Carrington JC, 2003, SCIENCE, V301, P336, DOI 10.1126/science.1085242; Castaings L, 2009, PLANT J, V57, P426, DOI 10.1111/j.1365-313X.2008.03695.x; Chen CF, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni178; Chiou TJ, 2006, PLANT CELL, V18, P412, DOI 10.1105/tpc.105.038943; Czechowski T, 2004, PLANT J, V38, P366, DOI 10.1111/j.1365-313X.2004.02051.x; DAVIES DB, 1995, J SCI FOOD AGR, V68, P399, DOI 10.1002/jsfa.2740680402; Diaz U, 2006, PLANT CELL PHYSIOL, V47, P74, DOI 10.1093/pcp/pci225; Franco-Zorrilla JM, 2007, NAT GENET, V39, P1033, DOI 10.1038/ng2079; Fujii H, 2005, CURR BIOL, V15, P2038, DOI 10.1016/j.cub.2005.10.016; Gifford ML, 2008, P NATL ACAD SCI USA, V105, P803, DOI 10.1073/pnas.0709559105; Gou JY, 2011, PLANT CELL, V23, P1512, DOI 10.1105/tpc.111.084525; Gutierrez RA, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-1-r7; Hakeem KR, 2012, RICE SCI, V19, P213, DOI 10.1016/S1672-6308(12)60043-2; Hammond JP, 2003, PLANT PHYSIOL, V132, P578, DOI 10.1104/pp.103.020941; Hawker NP, 2004, PLANT PHYSIOL, V135, P2261, DOI 10.1104/pp.104.040196; Henriksson E, 2005, PLANT PHYSIOL, V139, P509, DOI 10.1104/pp.105.063461; HISCOX JD, 1979, CAN J BOT, V57, P1332, DOI 10.1139/b79-163; Jiao YQ, 2010, NAT GENET, V42, P541, DOI 10.1038/ng.591; Jones-Rhoades MW, 2004, MOL CELL, V14, P787, DOI 10.1016/j.molcel.2004.05.027; Kantar M, 2011, PLANTA, V233, P471, DOI 10.1007/s00425-010-1309-4; Karan R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040203; Kawashima CG, 2009, PLANT J, V57, P313, DOI 10.1111/j.1365-313X.2008.03690.x; Kirk GJD, 2005, ANN BOT-LONDON, V96, P639, DOI 10.1093/aob/mci216; Kronzucker HJ, 2000, NEW PHYTOL, V145, P471, DOI 10.1046/j.1469-8137.2000.00606.x; Kulcheski FR, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-307; Li WX, 2008, PLANT CELL, V20, P2238, DOI 10.1105/tpc.108.059444; Li YF, 2010, PLANT J, V62, P742, DOI 10.1111/j.1365-313X.2010.04187.x; Lian XM, 2006, PLANT MOL BIOL, V60, P617, DOI 10.1007/s11103-005-5441-7; Liu HH, 2008, RNA, V14, P836, DOI 10.1261/rna.895308; Liu Q, 2009, FEBS LETT, V583, P723, DOI 10.1016/j.febslet.2009.01.020; Liu RX, 2012, PLANT MOL BIOL REP, V30, P297, DOI 10.1007/s11105-011-0346-x; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lodeiro AR, 2000, PLANT SCI, V154, P31, DOI 10.1016/S0168-9452(99)00246-0; Lu SF, 2005, PLANT CELL, V17, P2186, DOI 10.1105/tpc.105.033456; Mallory A, 2010, PLANT CELL, V22, P3879, DOI 10.1105/tpc.110.080671; Marschner H., 1995, MARSCHNERS MINERAL N, DOI DOI 10.1016/B978-0-12-473542-2.X5000-7; Meng YJ, 2009, PLANTA, V230, P883, DOI 10.1007/s00425-009-0994-3; Miura K, 2010, NAT GENET, V42, P545, DOI 10.1038/ng.592; Palenchar PM, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-11-r91; Pant BD, 2009, PLANT PHYSIOL, V150, P1541, DOI 10.1104/pp.109.139139; Pathak RR, 2008, CURR SCI INDIA, V94, P1394; Peng MS, 2008, J EXP BOT, V59, P2933, DOI 10.1093/jxb/ern148; Peng MS, 2007, PLANT MOL BIOL, V65, P775, DOI 10.1007/s11103-007-9241-0; Prigge MJ, 2005, PLANT CELL, V17, P61, DOI 10.1105/tpc.104.026161; Raghuram N., 1995, PHYSIOL MOL BIOL PLA, V1, P103; Sato T, 2011, PLANT SIGNAL BEHAV, V6, P1465, DOI 10.4161/psb.6.10.17343; Seo J, 2002, COMPUTER, V35, P80; Shen JQ, 2010, MOL GENET GENOMICS, V284, P477, DOI 10.1007/s00438-010-0581-0; Smith RD, 1996, ANNU REV PLANT PHYS, V47, P101, DOI 10.1146/annurev.arplant.47.1.101; Sunkar R, 2004, PLANT CELL, V16, P2001, DOI 10.1105/tpc.104.022830; Sunkar R, 2007, TRENDS PLANT SCI, V12, P301, DOI 10.1016/j.tplants.2007.05.001; Sylvester-Bradley R, 2009, J EXP BOT, V60, P1939, DOI 10.1093/jxb/erp116; Uauy C, 2006, SCIENCE, V314, P1298, DOI 10.1126/science.1133649; Vaucheret H, 2004, GENE DEV, V18, P1187, DOI 10.1101/gad.1201404; Wang RC, 2000, PLANT CELL, V12, P1491, DOI 10.1105/tpc.12.8.1491; Wang RC, 2003, PLANT PHYSIOL, V132, P556, DOI 10.1104/pp.103.021253; Wang RC, 2007, PLANT PHYSIOL, V145, P1735, DOI 10.1104/pp.107.108944; Wang XB, 2002, GENE, V297, P93, DOI 10.1016/S0378-1119(02)00870-3; Wu G, 2006, DEVELOPMENT, V133, P3539, DOI 10.1242/dev.02521; Wu G, 2009, CELL, V138, P750, DOI 10.1016/j.cell.2009.06.031; Wu L, 2010, MOL CELL, V38, P465, DOI 10.1016/j.molcel.2010.03.008; Xie KB, 2012, PLANT PHYSIOL, V158, P1382, DOI 10.1104/pp.111.190488; Xu ZH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028009; Zhang YJ, 2005, NUCLEIC ACIDS RES, V33, pW701, DOI 10.1093/nar/gki383; Zhao M, 2011, NEW PHYTOL, V190, P906, DOI 10.1111/j.1469-8137.2011.03647.x	72	50	56	0	48	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 5	2012	7	12							e50261	10.1371/journal.pone.0050261	http://dx.doi.org/10.1371/journal.pone.0050261			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	057TZ	23227161	Green Published, gold, Green Submitted			2022-12-27	WOS:000312588200022
J	Coskun-Ari, FF; Guldemir, D; Durmaz, R				Coskun-Ari, Fatma Filiz; Guldemir, Dilek; Durmaz, Riza			One-Step Multiplex PCR Assay for Detecting Streptococcus pneumoniae Serogroups/Types Covered by 13-Valent Pneumococcal Conjugate Vaccine (PCV13)	PLOS ONE			English	Article							DETERMINING CAPSULAR SEROTYPES; VIRULENCE FACTORS; DISEASE; EPIDEMIOLOGY; ERA; 6C	The life-threatening illnesses caused by Streptococcus pneumoniae have been declined significantly after the use of pneumococcal conjugate vaccines. Continuous monitoring of the vaccine serogroups/types is necessary to follow the changing epidemiology of invasive pneumococcal diseases. Recently, the sequential multiplex PCR approach, which uses several different sets of reactions, has been commonly adopted for determining capsular serogroups/types of S. pneumoniae isolates. In our study, we focused on development of a one-step multiplex PCR assay detecting all 1, 3, 4, 5, 6A/B, 7F, 9V, 14, 18C, 19A, 19F and 23F serogroups/types targeted by PCV13. The content of multiplex PCR mix and the cycling conditions were optimized in a manner that allowed rapid and accurate serotyping of a pneumococcal isolate by performing only a single amplification reaction. In our study of 182 clinical isolates, the one-step multiplex PCR assay exhibited 100% sensitivity and specificity, suggesting that its utilization can significantly reduce the use of traditional antiserum method requiring expensive reagents. Citation: Coskun-Ari FF, Guldemir D, Durmaz R (2012) One-Step Multiplex PCR Assay for Detecting Streptococcus pneumoniae Serogroups/Types Covered by 13-Valent Pneumococcal Conjugate Vaccine (PCV13). PLoS ONE 7(12): e50406. doi:10.1371/journal.pone.0050406	[Coskun-Ari, Fatma Filiz; Guldemir, Dilek; Durmaz, Riza] Publ Hlth Agcy Turkey, Mol Microbiol Res & Applicat Lab, Dept Microbiol Reference Labs, Ankara, Turkey; [Durmaz, Riza] Kirikkale Univ, Dept Clin Microbiol, Fac Med, Kirikkale, Turkey	Kirikkale University	Durmaz, R (corresponding author), Publ Hlth Agcy Turkey, Mol Microbiol Res & Applicat Lab, Dept Microbiol Reference Labs, Ankara, Turkey.	rizadurmaz@ymail.com	ari, filiz/M-9052-2019; Guldemir, Dilek/G-8338-2018	ari, filiz/0000-0002-8107-732X; 				ALONSODEVELASCO E, 1995, MICROBIOL REV, V59, P591, DOI 10.1128/MMBR.59.4.591-603.1995; [Anonymous], 2000, MMWR Recomm Rep, V49, P1; Anonymous, 2010, Morbidity and Mortality Weekly Report, V59, P258; Billal DS, 2008, EUR J PEDIATR, V167, P401, DOI 10.1007/s00431-007-0510-3; Brito DA, 2003, J CLIN MICROBIOL, V41, P2378, DOI 10.1128/JCM.41.6.2378-2384.2003; Calix JJ, 2010, J INFECT DIS, V202, P29, DOI 10.1086/653123; Centers for Disease Control and Prevention, 2009, SER DISTR INV PNEUM; Ceyhan M, 2010, EUR J CLIN MICROBIOL, V29, P289, DOI 10.1007/s10096-009-0853-y; Dias CA, 2007, J MED MICROBIOL, V56, P1185, DOI 10.1099/jmm.0.47347-0; Doern GV, 1999, MANUAL CLIN MICROBIO, P286; Grall N, 2011, EUR J CLIN MICROBIOL, V30, P1511, DOI 10.1007/s10096-011-1251-9; Hanquet G, 2010, EMERG INFECT DIS, V16, P1428, DOI 10.3201/eid1609.100102; Harriman Kathleen, 2011, Morbidity and Mortality Weekly Report, V60, P1477; Hausdorff WP, 2005, LANCET INFECT DIS, V5, P83, DOI 10.1016/S1473-3099(05)01280-6; HENRICHSEN J, 1995, J CLIN MICROBIOL, V33, P2759, DOI 10.1128/JCM.33.10.2759-2762.1995; Hicks LA, 2007, J INFECT DIS, V196, P1346, DOI 10.1086/521626; Jacobs MR, 2009, J CLIN MICROBIOL, V47, P64, DOI 10.1128/JCM.01524-08; Jin P, 2009, J INFECT DIS, V200, P1375, DOI 10.1086/606118; Johnson HL, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000348; Jourdain S, 2011, BMC INFECT DIS, V11, DOI 10.1186/1471-2334-11-100; Kellner JD, 2009, CLIN INFECT DIS, V49, P205, DOI 10.1086/599827; Lund E, 1978, METHOD MICROBIOL, P242; Miernyk K, 2011, J CLIN MICROBIOL, V49, P3209, DOI 10.1128/JCM.00610-11; Millar EV, 2010, CLIN INFECT DIS, V51, P1258, DOI 10.1086/657070; Morais L, 2007, J MED MICROBIOL, V56, P1181, DOI 10.1099/jmm.0.47346-0; Munoz-Almagro C, 2008, CLIN INFECT DIS, V46, P174, DOI 10.1086/524660; Pai R, 2006, J CLIN MICROBIOL, V44, P124, DOI 10.1128/JCM.44.1.124-131.2006; Park IH, 2007, J CLIN MICROBIOL, V45, P1225, DOI 10.1128/JCM.02199-06; Pilishvili T, 2010, J INFECT DIS, V201, P32, DOI 10.1086/648593; Sa-Leao R, 2009, CLIN MICROBIOL INFEC, V15, P1002, DOI 10.1111/j.1469-0691.2009.02775.x; WATSON DA, 1995, EUR J CLIN MICROBIOL, V14, P479, DOI 10.1007/BF02113425; Whitney CG, 2003, NEW ENGL J MED, V348, P1737, DOI 10.1056/NEJMoa022823; Yasin RM, 2011, VACCINE, V29, P5688, DOI 10.1016/j.vaccine.2011.06.004	33	18	18	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 4	2012	7	12							e50406	10.1371/journal.pone.0050406	http://dx.doi.org/10.1371/journal.pone.0050406			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	051EQ	23226519	Green Submitted, Green Published, gold			2022-12-27	WOS:000312108500016
J	Fan, SJ; Zhang, Y; Hu, N; Sun, QH; Ding, XB; Li, GW; Zheng, B; Gu, M; Huang, FS; Sun, YQ; Zhou, ZQ; Lu, X; Huang, C; Ji, G				Fan, Shengjie; Zhang, Yu; Hu, Na; Sun, Qinhu; Ding, Xiaobo; Li, Guowen; Zheng, Bin; Gu, Ming; Huang, Feisi; Sun, Yin-Qiang; Zhou, Zhiqin; Lu, Xiong; Huang, Cheng; Ji, Guang			Extract of Kuding Tea Prevents High-Fat Diet-Induced Metabolic Disorders in C57BL/6 Mice via Liver X Receptor (LXR) beta Antagonism	PLOS ONE			English	Article							NUCLEAR RECEPTORS; URSOLIC ACID; ADIPOCYTE DIFFERENTIATION; INSULIN-RESISTANCE; GREEN TEA; INTESTINAL-ABSORPTION; LIPID-METABOLISM; GENE-EXPRESSION; ILEX-KUDINGCHA; PPAR-GAMMA	Objective: To investigate the effects of ilex kudingcha C. J. Tseng (kuding tea), a traditional beverage in China, on the metabolic disorders in C57BL/6 mice induced by high-fat diets. Design: For the preventive experiment, the female C57BL/6 mice were fed with a standard diet (Chow), high-fat diet (HF), and high-fat diet mixed with 0.05% ethanol extract of kuding tea (EK) for 5 weeks. For the therapeutic experiment, the C57BL/6 mice were fed high-fat diet for 3 months, and then mice were split and EK was given with oral gavages for 2 weeks at 50 mg/day/kg. Body weight and daily food intake amounts were measured. At the end of treatment, the adipocyte images were assayed with a scanning electron microscope, and the fasting blood glucose, glucose tolerance test, serum lipid profile and lipids in the livers were analyzed. A reporter gene assay system was used to test the whether EK could act on nuclear receptor transcription factors, and the gene expression analysis was performed with a quantitative PCR assay. Results: In the preventive treatment, EK blocked the body weight gain, reduced the size of the adipocytes, lowered serum triglyceride, cholesterol, LDL-cholesterol, fasting blood glucose levels and glucose tolerance in high-fat diet-fed C57BL/6 mice. In the therapeutic treatment, EK reduced the size of the white adipocytes, serum TG and fasting blood glucose levels in obese mice. With the reporter assay, EK inhibited LXR beta transactivity and mRNA expression of LXRb target genes. Conclusion: We observed that EK has both preventive and therapeutic roles in metabolic disorders in mice induced with high-fat diets. The effects appear to be mediated through the antagonism of LXRb transactivity. Our data indicate that kuding tea is a useful dietary therapy and a potential source for the development of novel anti-obesity and lipid lowering drugs. Citation: Fan S, Zhang Y, Hu N, Sun Q, Ding X, et al. (2012) Extract of Kuding Tea Prevents High-Fat Diet-Induced Metabolic Disorders in C57BL/6 Mice via Liver X Receptor (LXR) beta Antagonism. PLoS ONE 7(12): e51007. doi: 10.1371/journal.pone.0051007	[Fan, Shengjie; Zhang, Yu; Ding, Xiaobo; Zheng, Bin; Gu, Ming; Huang, Feisi; Huang, Cheng] Shanghai Univ Tradit Chinese Med, Sch Pharm, Drug Discovery Lab, Shanghai, Peoples R China; [Hu, Na; Sun, Yin-Qiang; Lu, Xiong] Shanghai Univ Tradit Chinese Med, Sci Expt Ctr, Shanghai, Peoples R China; [Sun, Qinhu] Shanghai Univ Tradit Chinese Med, Inst Chinese Mat Med, Shanghai, Peoples R China; [Ding, Xiaobo; Zhou, Zhiqin; Ji, Guang] Southwest Univ, Coll Hort & Landscape Architecture, Chongqing, Peoples R China; [Ding, Xiaobo; Zhou, Zhiqin] Minist Educ, Key Lab Hort Sci So Mountainous Reg, Chongqing, Peoples R China; [Li, Guowen] Shanghai Univ Tradit Chinese Med, Longhua Hosp, Inst Digest Dis, Shanghai, Peoples R China	Shanghai University of Traditional Chinese Medicine; Shanghai University of Traditional Chinese Medicine; Shanghai University of Traditional Chinese Medicine; Southwest University - China; Shanghai University of Traditional Chinese Medicine	Huang, C (corresponding author), Shanghai Univ Tradit Chinese Med, Sch Pharm, Drug Discovery Lab, Shanghai, Peoples R China.	chuang.shutcm@gmail.com; jiliver@vip.sina.com			National Natural Science Foundation of China [30873260]; Talents Scheme from the Science and Technology Commission of Shanghai Municipality [09XD1403800]; Supporting Project for Elitists in the New Century from The Ministry of Education [NCET-07563]; Shanghai Leading Academic Discipline Project [J50305, E3008]; XinLin Scholar and Outstanding Team Training Plan of Shanghai University of Traditional Chinese Medicine	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Talents Scheme from the Science and Technology Commission of Shanghai Municipality; Supporting Project for Elitists in the New Century from The Ministry of Education; Shanghai Leading Academic Discipline Project(Shanghai Leading Academic Discipline Project); XinLin Scholar and Outstanding Team Training Plan of Shanghai University of Traditional Chinese Medicine	This work was supported by National Natural Science Foundation of China (no. 30873260), the Talents Scheme from the Science and Technology Commission of Shanghai Municipality (no. 09XD1403800), the Supporting Project for Elitists in the New Century from The Ministry of Education (no. NCET-07563), the Shanghai Leading Academic Discipline Project (no. J50305 and E3008), and the XinLin Scholar and Outstanding Team Training Plan of Shanghai University of Traditional Chinese Medicine. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alberti S, 2001, J CLIN INVEST, V107, P565, DOI 10.1172/JCI9794; Azevedo MF, 2010, PHYTOTHER RES, V24, pS220, DOI 10.1002/ptr.3118; Chinetti G, 2004, BIOCHEM BIOPH RES CO, V314, P151, DOI 10.1016/j.bbrc.2003.12.058; Chun TH, 2010, DIABETES, V59, P2484, DOI 10.2337/db10-0073; Edwards PA, 2002, VASC PHARMACOL, V38, P249, DOI 10.1016/S1537-1891(02)00175-1; Finucane MM, 2011, LANCET, V377, P557, DOI 10.1016/S0140-6736(10)62037-5; Flier JS, 2004, CELL, V116, P337, DOI 10.1016/S0092-8674(03)01081-X; FORMAN BM, 1995, CELL, V83, P803, DOI 10.1016/0092-8674(95)90193-0; Gerhold DL, 2002, ENDOCRINOLOGY, V143, P2106, DOI 10.1210/en.143.6.2106; Goldwasser J, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012399; Gong HB, 2004, EXPERT OPIN THER TAR, V8, P49, DOI 10.1517/14728222.8.1.49; Gong ZW, 2009, ENDOCRINOLOGY, V150, P104, DOI 10.1210/en.2008-0322; Gupta R, 2012, NAT PROD RES, V26, P1125, DOI 10.1080/14786419.2011.560845; Huang C, 2006, BIOCHEM BIOPH RES CO, V348, P571, DOI 10.1016/j.bbrc.2006.07.095; Huang Z, 1997, CHIN J INFOR TRADIT, V4, P25; Jia Y, 2011, BIOORG MED CHEM LETT, V21, P5876, DOI 10.1016/j.bmcl.2011.07.095; Joseph SB, 2002, P NATL ACAD SCI USA, V99, P7604, DOI 10.1073/pnas.112059299; Joseph SB, 2004, CELL, V119, P299, DOI 10.1016/j.cell.2004.09.032; Kanaya N, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026654; Kim JY, 2011, J ETHNOPHARMACOL, V133, P558, DOI 10.1016/j.jep.2010.10.037; Kim J, 2009, ARCH PHARM RES, V32, P983, DOI 10.1007/s12272-009-1702-3; Koo SI, 2007, J NUTR BIOCHEM, V18, P179, DOI 10.1016/j.jnutbio.2006.12.005; Kraegen EW, 2001, EXP CLIN ENDOCR DIAB, V109, pS516; Kratzer A, 2009, J LIPID RES, V50, P312, DOI 10.1194/jlr.M800376-JLR200; Laffitte BA, 2003, P NATL ACAD SCI USA, V100, P5419, DOI 10.1073/pnas.0830671100; Lewis GF, 2002, ENDOCR REV, V23, P201, DOI 10.1210/er.23.2.201; Liu Aihua, 2002, Zhong Yao Cai, V25, P148; Liu B, 2005, CHIN NUR RES, V19, P21; Loest HB, 2002, J NUTR, V132, P1282, DOI 10.1093/jn/132.6.1282; Lund EG, 2003, ARTERIOSCL THROM VAS, V23, P1169, DOI 10.1161/01.ATV.0000056743.42348.59; Mitro N, 2007, NATURE, V445, P219, DOI 10.1038/nature05449; Niesor EJ, 2001, CURR PHARM DESIGN, V7, P231, DOI 10.2174/1381612013398185; Ntambi JM, 2000, J NUTR, V130, p3122S, DOI 10.1093/jn/130.12.3122S; Peet DJ, 1998, CELL, V93, P693, DOI 10.1016/S0092-8674(00)81432-4; Popovich N G, 1997, J Am Pharm Assoc (Wash), VNS37, P31; Popovich NG, 1997, J AM PHARM ASSOC, VNS37, P56; Rao VS, 2011, J MED FOOD, V14, P1375, DOI 10.1089/jmf.2010.0267; Raz I, 2005, DIABETES-METAB RES, V21, P3, DOI 10.1002/dmrr.493; Reddy KP, 2009, BIOORG MED CHEM LETT, V19, P4463, DOI 10.1016/j.bmcl.2009.05.034; Saltiel AR, 2001, NATURE, V414, P799, DOI 10.1038/414799a; Sheng XY, 2011, AM J PHYSIOL-ENDOC M, V300, pE886, DOI 10.1152/ajpendo.00332.2010; Song C, 2001, STEROIDS, V66, P473, DOI 10.1016/S0039-128X(00)00239-7; Visscher TLS, 2001, ANNU REV PUBL HEALTH, V22, P355, DOI 10.1146/annurev.publhealth.22.1.355; Wang Q, 1998, CHIN J ETHNOMED ETHN, V34, P12; Wang S, 1994, CHIN J INTEGR MED, V11, P670; Wang S, 2006, J NUTR BIOCHEM, V17, P492, DOI 10.1016/j.jnutbio.2006.03.004; Wong IYF, 2001, J AGR FOOD CHEM, V49, P3113, DOI 10.1021/jf0100604; [吴弢 Wu Tao], 2005, [中国药学杂志, Chinese Pharmaceutical Journal], V40, P1460; Zheng J, 2009, PLANTA MED, V75, P1410, DOI 10.1055/s-0029-1185722; Zheng J, 2009, CLIN HEMORHEOL MICRO, V42, P29, DOI 10.3233/CH-2009-1183; Zhu F, 2009, J AGR FOOD CHEM, V57, P6082, DOI 10.1021/jf901020h	51	57	59	1	48	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 4	2012	7	12							e51007	10.1371/journal.pone.0051007	http://dx.doi.org/10.1371/journal.pone.0051007			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	051EQ	23226556	Green Published, gold, Green Submitted			2022-12-27	WOS:000312108500039
J	Jiang, TT; Chang, Q; Zhao, ZY; Yan, SM; Wang, L; Cai, JY; Xu, GZ				Jiang, Tingting; Chang, Qing; Zhao, Zhenyang; Yan, Saimei; Wang, Ling; Cai, Jiyang; Xu, Gezhi			Melatonin-Mediated Cytoprotection against Hyperglycemic Injury in Muller Cells	PLOS ONE			English	Article							ENDOTHELIAL GROWTH-FACTOR; DIABETIC-RETINOPATHY; OXIDATIVE STRESS; PATHOPHYSIOLOGICAL MECHANISMS; TREATMENT PERSPECTIVES; MITOCHONDRIAL-DNA; HUMAN RETINA; RAT RETINA; RECEPTOR; LOCALIZATION	Oxidative stress is a contributing factor to the development and progression of diabetic retinopathy, a leading cause of blindness in people at working age worldwide. Recent studies showed that Muller cells play key roles in diabetic retinopathy and produce vascular endothelial growth factor (VEGF) that regulates retinal vascular leakage and proliferation. Melatonin is a potent antioxidant capable of protecting variety of retinal cells from oxidative damage. In addition to the pineal gland, the retina produces melatonin. In the current study, we investigated whether melatonin protects against hyperglycemia-induced oxidative injury to Muller cells and explored the potential underlying mechanisms. Our results show that both melatonin membrane receptors, MT1 and MT2, are expressed in cultured primary Muller cells and are upregulated by elevated glucose levels. Both basal and high glucose-induced VEGF production was attenuated by melatonin treatment in a dose-dependent manner. Furthermore, we found that melatonin is a potent activator of Akt in Muller cells. Our findings suggest that in addition to functioning as a direct free radical scavenger, melatonin can elicit cellular signaling pathways that are protective against retinal injury during diabetic retinopathy. Citation: Jiang T, Chang Q, Zhao Z, Yan S, Wang L, et al. (2012) Melatonin-Mediated Cytoprotection against Hyperglycemic Injury in Muller Cells. PLoS ONE 7(12): e50661. doi:10.1371/journal.pone.0050661	[Jiang, Tingting; Chang, Qing; Zhao, Zhenyang; Yan, Saimei; Wang, Ling; Xu, Gezhi] Fudan Univ, Dept Ophthalmol, Eye & ENT Hosp, Shanghai 200433, Peoples R China; [Zhao, Zhenyang; Cai, Jiyang] Vanderbilt Univ, Med Ctr, Vanderbilt Eye Inst, Nashville, TN USA	Fudan University; Vanderbilt University	Chang, Q (corresponding author), Fudan Univ, Dept Ophthalmol, Eye & ENT Hosp, Shanghai 200433, Peoples R China.	qngchang@yahoo.com.cn	Zhao, Zhenyang/N-3321-2015	Zhao, Zhenyang/0000-0002-1701-3751	The Shanghai Committee of Science and Technology, China [08411963400]; Research to Prevent Blindness, Inc.	The Shanghai Committee of Science and Technology, China; Research to Prevent Blindness, Inc.(Research to Prevent Blindness (RPB))	This research was supported by The Shanghai Committee of Science and Technology, China (No.08411963400) (www.stcsm.gov.cn), and Research to Prevent Blindness, Inc. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aiello LP, 1998, DIABETES CARE, V21, P143, DOI 10.2337/diacare.21.1.143; Bai YY, 2009, J PATHOL, V219, P446, DOI 10.1002/path.2611; Bringmann A, 2006, PROG RETIN EYE RES, V25, P397, DOI 10.1016/j.preteyeres.2006.05.003; Buonfiglio DD, 2011, INVEST OPHTH VIS SCI, V52, P7416, DOI 10.1167/iovs.10-6756; Caldwelll RB, 2003, DIABETES-METAB RES, V19, P442, DOI 10.1002/dmrr.415; Contreras-Alcantara S, 2010, OBESITY, V18, P1861, DOI 10.1038/oby.2010.24; Das A, 2010, J PINEAL RES, V48, P157, DOI 10.1111/j.1600-079X.2009.00739.x; Dubocovich ML, 2005, ENDOCRINE, V27, P101, DOI 10.1385/ENDO:27:2:101; EBISAWA T, 1994, P NATL ACAD SCI USA, V91, P6133, DOI 10.1073/pnas.91.13.6133; Ferrara N, 2004, ENDOCR REV, V25, P581, DOI 10.1210/er.2003-0027; Frank RN, 2004, NEW ENGL J MED, V350, P48, DOI 10.1056/NEJMra021678; Frasson M, 1999, INVEST OPHTH VIS SCI, V40, P2724; Galano A, 2011, J PINEAL RES, V51, P1, DOI 10.1111/j.1600-079X.2011.00916.x; Hu R, 2010, ANTIOXID REDOX SIGN, V13, P1679, DOI 10.1089/ars.2010.3276; Jou MJ, 2007, J PINEAL RES, V43, P389, DOI 10.1111/j.1600-079X.2007.00490.x; Kaur C, 2007, J PATHOL, V212, P429, DOI 10.1002/path.2195; Kensler TW, 2007, ANNU REV PHARMACOL, V47, P89, DOI 10.1146/annurev.pharmtox.46.120604.141046; Kong PJ, 2008, KOREAN J PHYSIOL PHA, V12, P37, DOI 10.4196/kjpp.2008.12.2.37; Lee SH, 2006, J PINEAL RES, V40, P79, DOI 10.1111/j.1600-079X.2005.00283.x; Madsen-Bouterse SA, 2008, REV ENDOCR METAB DIS, V9, P315, DOI 10.1007/s11154-008-9090-4; Manning BD, 2007, CELL, V129, P1261, DOI 10.1016/j.cell.2007.06.009; Martin V, 2006, CANCER RES, V66, P1081, DOI 10.1158/0008-5472.CAN-05-2354; Mathes AM, 2008, CRIT CARE MED, V36, P24, DOI 10.1097/01.CCM.0000292088.33318.F0; Natesan AK, 2002, VISUAL NEUROSCI, V19, P265, DOI 10.1017/S0952523802192042; Nicholson BP, 2010, GRAEF ARCH CLIN EXP, V248, P915, DOI 10.1007/s00417-010-1315-z; Oku H, 2002, OPHTHALMIC RES, V34, P38, DOI 10.1159/000048323; Papaiahgari S, 2006, ANTIOXID REDOX SIGN, V8, P43, DOI 10.1089/ars.2006.8.43; POEGGELER B, 1993, J PINEAL RES, V14, P151, DOI 10.1111/j.1600-079X.1993.tb00498.x; Porta M, 2004, PHARMACOL THERAPEUT, V103, P167, DOI 10.1016/j.pharmthera.2004.07.001; Proietti S, 2011, J PINEAL RES, V50, P150, DOI 10.1111/j.1600-079X.2010.00824.x; Reiter RJ, 2009, CRIT REV BIOCHEM MOL, V44, P175, DOI 10.1080/10409230903044914; REPPERT SM, 1995, P NATL ACAD SCI USA, V92, P8734, DOI 10.1073/pnas.92.19.8734; RIEPE RE, 1977, NATURE, V268, P654, DOI 10.1038/268654a0; Rodriguez C, 2004, J PINEAL RES, V36, P1, DOI 10.1046/j.1600-079X.2003.00092.x; Salam A, 2011, ACTA OPHTHALMOL, V89, P405, DOI 10.1111/j.1755-3768.2010.02079.x; Scher J, 2002, INVEST OPHTH VIS SCI, V43, P889; Schutte M, 1998, NEUROSCI LETT, V246, P53, DOI 10.1016/S0304-3940(98)00229-8; Seabra WDV, 2000, J PINEAL RES, V29, P193; Stehle JH, 2011, J PINEAL RES, V51, P17, DOI 10.1111/j.1600-079X.2011.00856.x; Tosini G, 1998, BRAIN RES, V789, P221, DOI 10.1016/S0006-8993(97)01446-7; Wang JJ, 2010, DIABETES, V59, P2297, DOI 10.2337/db09-1420; Wang L, 2008, INVEST OPHTH VIS SCI, V49, P1671, DOI 10.1167/iovs.07-1099; Williams R, 2004, EYE, V18, P963, DOI 10.1038/sj.eye.6701476; Xu SC, 2011, J PINEAL RES, V51, P426, DOI 10.1111/j.1600-079X.2011.00906.x; Ye XF, 2012, INVEST OPHTH VIS SCI, V53, P3481, DOI 10.1167/iovs.11-9076; Yi CX, 2005, ANN NY ACAD SCI, V1057, P384, DOI 10.1196/annals.1356.029	46	37	37	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 4	2012	7	12							e50661	10.1371/journal.pone.0050661	http://dx.doi.org/10.1371/journal.pone.0050661			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	051EQ	23226532	Green Submitted, gold, Green Published			2022-12-27	WOS:000312108500025
J	Jungmann, O; Nikolovska, K; Stock, C; Schulz, JN; Eckes, B; Riethmuller, C; Owens, RT; Iozzo, RV; Seidler, DG				Jungmann, Oliver; Nikolovska, Katerina; Stock, Christian; Schulz, Jan-Niklas; Eckes, Beate; Riethmueller, Christoph; Owens, Rick T.; Iozzo, Renato V.; Seidler, Daniela G.			` The Dermatan Sulfate Proteoglycan Decorin Modulates alpha 2 beta 1 Integrin and the Vimentin Intermediate Filament System during Collagen Synthesis	PLOS ONE			English	Article							LEUCINE-RICH PROTEOGLYCANS; EHLERS-DANLOS-SYNDROME; GROWTH-FACTOR RECEPTOR; MICE LACKING VIMENTIN; CELL-ADHESION; PROTEIN-VIMENTIN; FACTOR-BETA; MIGRATION; FIBROBLASTS; ACTIVATION	Decorin, a small leucine-rich proteoglycan harboring a dermatan sulfate chain at its N-terminus, is involved in regulating matrix organization and cell signaling. Loss of the dermatan sulfate of decorin leads to an Ehlers-Danlos syndrome characterized by delayed wound healing. Decorin-null (Dcn(-/-)) mice display a phenotype similar to that of EDS patients. The fibrillar collagen phenotype of Dcn(-/-) mice could be rescued in vitro by decorin but not with decorin lacking the glycosaminoglycan chain. We utilized a 3D cell culture model to investigate the impact of the altered extracellular matrix on Dcn(-/-) fibroblasts. Using 2D gel electrophoresis followed by mass spectrometry, we identified vimentin as one of the proteins that was differentially upregulated by the presence of decorin. We discovered that a decorin-deficient matrix leads to abnormal nuclear morphology in the Dcn(-/-) fibroblasts. This phenotype could be rescued by the decorin proteoglycan but less efficiently by the decorin protein core. Decorin treatment led to a significant reduction of the alpha 2 beta 1 integrin at day 6 in Dcn(-/-) fibroblasts, whereas the protein core had no effect on beta 1. Interestingly, only the decorin core induced mRNA synthesis, phosphorylation and de novo synthesis of vimentin indicating that the proteoglycan decorin in the extracellular matrix stabilizes the vimentin intermediate filament system. We could support these results in vivo, because the dermis of wild-type mice have more vimentin and less beta 1 integrin compared to Dcn(-/-). Furthermore, the alpha 2 beta 1 null fibroblasts also showed a reduced amount of vimentin compared to wild-type. These data show for the first time that decorin has an impact on the biology of alpha 2 beta 1 integrin and the vimentin intermediate filament system. Moreover, our findings provide a mechanistic explanation for the reported defects in wound healing associated with the Dcn(-/-) phenotype.	[Jungmann, Oliver; Nikolovska, Katerina; Seidler, Daniela G.] Univ Hosp Munster, Insitute Physiol Chem & Pathobiochem, Munster, Germany; [Stock, Christian] Univ Hosp Munster, Inst Physiol 2, Munster, Germany; [Schulz, Jan-Niklas; Eckes, Beate] Univ Cologne, Dept Dermatol, Cologne, Germany; [Riethmueller, Christoph] Serend Ip GmbH, Ctr Nanotechnol, Munster, Germany; [Owens, Rick T.] LifeCell Corp, Branchburg, NJ USA; [Iozzo, Renato V.] Thomas Jefferson Univ, Dept Pathol Anat & Cell Biol, Philadelphia, PA 19107 USA	University of Munster; University of Munster; University of Cologne; Jefferson University	Seidler, DG (corresponding author), Univ Hosp Munster, Insitute Physiol Chem & Pathobiochem, Munster, Germany.	dgseidle@uni-muenster.de	Iozzo, Renato/AAS-1980-2020	Iozzo, Renato/0000-0002-5908-5112; Schulz, Jan-Niklas/0000-0001-9286-206X	Deutsche Forschungsgemeinschaft [SE1431/1-1, SFB829]; Molecular and Cellular GlycoSciences [GRK1549]; NATIONAL CANCER INSTITUTE [R01CA039481] Funding Source: NIH RePORTER	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Molecular and Cellular GlycoSciences; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	The study was supported by the Deutsche Forschungsgemeinschaft through SE1431/1-1 (to DGS) and SFB829 (to BE) and GRK1549 "Molecular and Cellular GlycoSciences'' (to DGS and KN). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barczyk M, 2010, CELL TISSUE RES, V339, P269, DOI 10.1007/s00441-009-0834-6; Bhide VM, 2005, J BIOL CHEM, V280, P23103, DOI 10.1074/jbc.M410060200; Brandan E, 2006, J BIOL CHEM, V281, P31562, DOI 10.1074/jbc.M602919200; COLUCCIGUYON E, 1994, CELL, V79, P679, DOI 10.1016/0092-8674(94)90553-3; Coulombe PA, 2004, NAT CELL BIOL, V6, P699, DOI 10.1038/ncb0804-699; Cukierman E, 2001, SCIENCE, V294, P1708, DOI 10.1126/science.1064829; Danielson KG, 1997, J CELL BIOL, V136, P729, DOI 10.1083/jcb.136.3.729; Eckes B, 1998, J CELL SCI, V111, P1897; Eckes B, 2000, J CELL SCI, V113, P2455; Ferdous Z, 2010, J BIOMED MATER RES A, V93A, P419, DOI 10.1002/jbm.a.32545; Fiedler LR, 2008, J BIOL CHEM, V283, P17406, DOI 10.1074/jbc.M710025200; Fisher LW, 1995, ACTA ORTHOP SCAND, V66, P61, DOI 10.3109/17453679509157649; Goldoni S, 2004, J BIOL CHEM, V279, P6606, DOI 10.1074/jbc.M310342200; Goldoni S, 2008, AM J PATHOL, V173, P844, DOI 10.2353/ajpath.2008.080275; Goldoni S, 2009, J CELL BIOL, V185, P743, DOI 10.1083/jcb.200901129; HEINO J, 1989, J BIOL CHEM, V264, P380; Helfand BT, 2004, J CELL SCI, V117, P133, DOI 10.1242/jcs.00936; Holtkotter O, 2002, J BIOL CHEM, V277, P10789, DOI 10.1074/jbc.M112307200; INAGAKI M, 1987, NATURE, V328, P649, DOI 10.1038/328649a0; Iozzo RV, 2011, J BIOL CHEM, V286, P34712, DOI 10.1074/jbc.M111.262766; Iozzo RV, 1999, J BIOL CHEM, V274, P18843, DOI 10.1074/jbc.274.27.18843; Iozzo RV, 1999, J BIOL CHEM, V274, P4489, DOI 10.1074/jbc.274.8.4489; Ivaska J, 2007, EXP CELL RES, V313, P2050, DOI 10.1016/j.yexcr.2007.03.040; Jarvelainen H, 2006, WOUND REPAIR REGEN, V14, P443, DOI 10.1111/j.1743-6109.2006.00150.x; Jokinen J, 2004, J BIOL CHEM, V279, P31956, DOI 10.1074/jbc.M401409200; Kalamajski S, 2010, MATRIX BIOL, V29, P248, DOI 10.1016/j.matbio.2010.01.001; Khatau SB, 2009, P NATL ACAD SCI USA, V106, P19017, DOI 10.1073/pnas.0908686106; Kim S, 2007, GENE DEV, V21, P1581, DOI 10.1101/gad.1552107; Kovbasnjuk ON, 2000, J MEMBRANE BIOL, V176, P19, DOI 10.1007/s002320001072; Kreis S, 2005, EXP CELL RES, V305, P110, DOI 10.1016/j.yexcr.2004.12.023; KRESSE H, 1987, AM J HUM GENET, V41, P436; Liu J, 2011, MOL CELL BIOL, V31, P3366, DOI 10.1128/MCB.01403-10; Maccarana M, 2009, MOL CELL BIOL, V29, P5517, DOI 10.1128/MCB.00430-09; Martys JL, 1999, MOL BIOL CELL, V10, P1289, DOI 10.1091/mbc.10.5.1289; Merle B, 1999, J CELL BIOCHEM, V75, P538; Merline R, 2011, SCI SIGNAL, V4, DOI 10.1126/scisignal.2001868; Miyake N, 2010, HUM MUTAT, V31, P966, DOI 10.1002/humu.21300; NEUHOFF V, 1988, ELECTROPHORESIS, V9, P255, DOI 10.1002/elps.1150090603; Nieminen M, 2006, NAT CELL BIOL, V8, P156, DOI 10.1038/ncb1355; OFARRELL PH, 1975, J BIOL CHEM, V250, P4007; Paradise RK, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0015746; Parsons-Wingerter P, 2005, AM J PATHOL, V167, P193, DOI 10.1016/S0002-9440(10)62965-3; Perlson E, 2005, NEURON, V45, P715, DOI 10.1016/j.neuron.2005.01.023; Ranta V, 1998, J CELL PHYSIOL, V176, P92, DOI 10.1002/(SICI)1097-4652(199807)176:1<92::AID-JCP11>3.0.CO;2-Q; Reed CC, 2002, GLYCOCONJUGATE J, V19, P249, DOI 10.1023/A:1025383913444; Ridger VC, 2001, J IMMUNOL, V166, P3484, DOI 10.4049/jimmunol.166.5.3484; Riethmuller C, 2008, PFLUG ARCH EUR J PHY, V456, P71, DOI 10.1007/s00424-007-0412-2; Ruehland C, 2007, FEBS J, V274, P4246, DOI 10.1111/j.1742-4658.2007.05951.x; Schaefer L, 2000, KIDNEY INT, V58, P1557, DOI 10.1046/j.1523-1755.2000.00317.x; Schaefer L, 2008, J BIOL CHEM, V283, P21305, DOI 10.1074/jbc.R800020200; Schonherr E, 2005, J BIOL CHEM, V280, P15767, DOI 10.1074/jbc.M500451200; Seidler DG, 2006, J BIOL CHEM, V281, P26408, DOI 10.1074/jbc.M602853200; Seidler DG, 2006, J MOL MED, V84, P583, DOI 10.1007/s00109-006-0046-4; Seidler DG, 2012, CURR OPIN STRUC BIOL, V22, P578, DOI 10.1016/j.sbi.2012.07.012; Seidler DG, 2011, J IMMUNOL, V187, P6108, DOI 10.4049/jimmunol.1100373; Seidler DG, 2005, BIOCHEM BIOPH RES CO, V332, P1162, DOI 10.1016/j.bbrc.2005.04.175; STEINERT PM, 1985, CELL, V42, P411, DOI 10.1016/0092-8674(85)90098-4; Stock C, 2005, J PHYSIOL-LONDON, V567, P225, DOI 10.1113/jphysiol.2005.088344; Stock C, 2011, J CELL PHYSIOL, V226, P2641, DOI 10.1002/jcp.22612; Takagi J, 2002, IMMUNOL REV, V186, P141, DOI 10.1034/j.1600-065X.2002.18613.x; Toivola DM, 2005, TRENDS CELL BIOL, V15, P608, DOI 10.1016/j.tcb.2005.09.004; Tsuruta D, 2003, J CELL SCI, V116, P4977, DOI 10.1242/jcs.00823; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; White DJ, 2004, INT J BIOCHEM CELL B, V36, P1405, DOI 10.1016/j.biocel.2003.08.016; Wolf K, 2009, SEMIN CELL DEV BIOL, V20, P931, DOI 10.1016/j.semcdb.2009.08.005; YAMAGUCHI Y, 1990, NATURE, V346, P281, DOI 10.1038/346281a0; Zamfir AD, 2009, PROTEOMICS, V9, P3435, DOI 10.1002/pmic.200800440	67	20	20	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 3	2012	7	12							e50809	10.1371/journal.pone.0050809	http://dx.doi.org/10.1371/journal.pone.0050809			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	051DH	23226541	Green Published, gold, Green Submitted			2022-12-27	WOS:000312104700023
J	Bellantuono, AJ; Granados-Cifuentes, C; Miller, DJ; Hoegh-Guldberg, O; Rodriguez-Lanetty, M				Bellantuono, Anthony J.; Granados-Cifuentes, Camila; Miller, David J.; Hoegh-Guldberg, Ove; Rodriguez-Lanetty, Mauricio			Coral Thermal Tolerance: Tuning Gene Expression to Resist Thermal Stress	PLOS ONE			English	Article							NF-KAPPA-B; REEF CORAL; HEAT-SHOCK; CLIMATE-CHANGE; TYROSINE PHOSPHORYLATION; MONTASTRAEA-FAVEOLATA; CELL-DEATH; TEMPERATURE; FERRITIN; ZOOXANTHELLAE	The acclimatization capacity of corals is a critical consideration in the persistence of coral reefs under stresses imposed by global climate change. The stress history of corals plays a role in subsequent response to heat stress, but the transcriptomic changes associated with these plastic changes have not been previously explored. In order to identify host transcriptomic changes associated with acquired thermal tolerance in the scleractinian coral Acropora millepora, corals preconditioned to a sub-lethal temperature of 3 degrees C below bleaching threshold temperature were compared to both non-preconditioned corals and untreated controls using a cDNA microarray platform. After eight days of hyperthermal challenge, conditions under which non-preconditioned corals bleached and preconditioned corals (thermal-tolerant) maintained Symbiodinium density, a clear differentiation in the transcriptional profiles was revealed among the condition examined. Among these changes, nine differentially expressed genes separated preconditioned corals from non-preconditioned corals, with 42 genes differentially expressed between control and preconditioned treatments, and 70 genes between non-preconditioned corals and controls. Differentially expressed genes included components of an apoptotic signaling cascade, which suggest the inhibition of apoptosis in preconditioned corals. Additionally, lectins and genes involved in response to oxidative stress were also detected. One dominant pattern was the apparent tuning of gene expression observed between preconditioned and non-preconditioned treatments; that is, differences in expression magnitude were more apparent than differences in the identity of genes differentially expressed. Our work revealed a transcriptomic signature underlying the tolerance associated with coral thermal history, and suggests that understanding the molecular mechanisms behind physiological acclimatization would be critical for the modeling of reefs in impending climate change scenarios.	[Bellantuono, Anthony J.; Rodriguez-Lanetty, Mauricio] Florida Int Univ, Dept Biol Sci, Miami, FL 33199 USA; [Granados-Cifuentes, Camila] Univ Louisiana, Dept Biol, Lafayette, LA USA; [Miller, David J.] James Cook Univ, Australian Res Council, Ctr Excellence Coral Reef Studies, Townsville, Qld 4811, Australia; [Miller, David J.; Hoegh-Guldberg, Ove] James Cook Univ, Comparat Genom Ctr, Townsville, Qld 4811, Australia; [Hoegh-Guldberg, Ove] Univ Queensland, Global Change Inst, St Lucia, Qld 4072, Australia	State University System of Florida; Florida International University; University of Louisiana Lafayette; James Cook University; James Cook University; University of Queensland	Rodriguez-Lanetty, M (corresponding author), Florida Int Univ, Dept Biol Sci, Miami, FL 33199 USA.		Hoegh-Guldberg, Ove/ABA-5420-2020; Hoegh-Guldberg, Ove/H-6169-2011	Hoegh-Guldberg, Ove/0000-0001-7510-6713; Hoegh-Guldberg, Ove/0000-0001-7510-6713	National Science Foundation [OCE-0851123, 0851123]; Directorate For Geosciences [1321500] Funding Source: National Science Foundation	National Science Foundation(National Science Foundation (NSF)); Directorate For Geosciences(National Science Foundation (NSF)NSF - Directorate for Geosciences (GEO))	The work was supported by National Science Foundation - OCE-0851123 http://www.nsf.gov/awardsearch/showAward.do?AwardNumber = 0851123, The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arosio P, 2002, FREE RADICAL BIO MED, V33, P457, DOI 10.1016/S0891-5849(02)00842-0; Ashkenazi A, 1998, SCIENCE, V281, P1305, DOI 10.1126/science.281.5381.1305; Baird A, 2008, SCIENCE, V320, P315, DOI 10.1126/science.320.5874.315; Baker AC, 2001, NATURE, V411, P765, DOI 10.1038/35081151; Baker AC, 2003, ANNU REV ECOL EVOL S, V34, P661, DOI 10.1146/annurev.ecolsys.34.011802.132417; Baker AC, 2004, NATURE, V430, P741, DOI 10.1038/430741a; Bellantuono AJ, 2012, P ROY SOC B-BIOL SCI, V279, P1100, DOI 10.1098/rspb.2011.1780; Berkelmans R, 2006, P ROY SOC B-BIOL SCI, V273, P2305, DOI 10.1098/rspb.2006.3567; Berlett BS, 1997, J BIOL CHEM, V272, P20313, DOI 10.1074/jbc.272.33.20313; BLACK NA, 1995, BIOL BULL, V188, P234, DOI 10.2307/1542301; Brander LM, 2007, ECOL ECON, V63, P209, DOI 10.1016/j.ecolecon.2006.11.002; Brown BE, 2002, CORAL REEFS, V21, P119, DOI 10.1007/s00338-002-0215-z; Brown BE, 2002, MAR ECOL PROG SER, V242, P119, DOI 10.3354/meps242119; Brown BE, 2000, MAR ECOL PROG SER, V195, P117, DOI 10.3354/meps195117; BUDDEMEIER RW, 1993, BIOSCIENCE, V43, P320, DOI 10.2307/1312064; Carilli J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034418; Castillo KD, 2005, MAR BIOL, V148, P261, DOI 10.1007/s00227-005-0046-x; Causton HC, 2001, MOL BIOL CELL, V12, P323, DOI 10.1091/mbc.12.2.323; Chen DR, 2003, MOL BIOL CELL, V14, P214, DOI 10.1091/mbc.E02-08-0499; Conesa A, 2005, BIOINFORMATICS, V21, P3674, DOI 10.1093/bioinformatics/bti610; Costanza R, 1997, NATURE, V387, P253, DOI 10.1038/387253a0; Cui XG, 2005, BIOSTATISTICS, V6, P59, DOI 10.1093/biostatistics/kxh018; De Croos JNA, 2004, J BIOENERG BIOMEMBR, V36, P229, DOI 10.1023/B:JOBB.0000031974.35812.c9; Desalvo MK, 2008, MOL ECOL, V17, P3952, DOI 10.1111/j.1365-294X.2008.03879.x; DeSalvo MK, 2010, MOL ECOL, V19, P1174, DOI 10.1111/j.1365-294X.2010.04534.x; DeSalvo MK, 2010, MAR ECOL PROG SER, V402, P97, DOI 10.3354/meps08372; Donner SD, 2005, GLOBAL CHANGE BIOL, V11, P2251, DOI 10.1111/j.1365-2486.2005.01073.x; Downs CA, 2005, MAR POLLUT BULL, V51, P558, DOI 10.1016/j.marpolbul.2005.04.017; Downs CA, 2000, MAR BIOTECHNOL, V2, P533, DOI 10.1007/s101260000038; Downs CA, 2009, AUTOPHAGY, V5, P211, DOI 10.4161/auto.5.2.7405; Dunn SR, 2007, P ROY SOC B-BIOL SCI, V274, P3079, DOI 10.1098/rspb.2007.0711; Dunn SR, 2004, CELL DEATH DIFFER, V11, P1213, DOI 10.1038/sj.cdd.4401484; Eakin C. M., 2009, V205, P41; Edgar R, 2002, NUCLEIC ACIDS RES, V30, P207, DOI 10.1093/nar/30.1.207; Fang LS, 1997, CORAL REEFS, V16, P127, DOI 10.1007/s003380050066; Fitt WK, 2001, CORAL REEFS, V20, P51, DOI 10.1007/s003380100146; Foret S, 2007, CORAL REEFS, V26, P475, DOI 10.1007/s00338-007-0206-1; GAMOU S, 1995, FEBS LETT, V357, P161, DOI 10.1016/0014-5793(94)01335-X; Ganot P, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002187; Gasch AP, 2000, MOL BIOL CELL, V11, P4241, DOI 10.1091/mbc.11.12.4241; Gates RD, 1999, AM ZOOL, V39, P30; GLYNN PW, 1993, CORAL REEFS, V12, P1, DOI 10.1007/BF00303779; GLYNN PW, 1984, ENVIRON CONSERV, V11, P133, DOI 10.1017/S0376892900013825; Goldstein AL, 2004, EXPERT OPIN BIOL TH, V4, P559, DOI 10.1517/eobt.4.4.559.29474; Grasso LC, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-540; Guiry A, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-211; HEFFETZ D, 1990, J BIOL CHEM, V265, P2896; Hess J, 2004, J CELL SCI, V117, P5965, DOI 10.1242/jcs.01589; Hoegh-Guldberg O, 2007, SCIENCE, V318, P1737, DOI 10.1126/science.1152509; Hoegh-Guldberg O, 1999, MAR FRESHWATER RES, V50, P839, DOI 10.1071/MF99078; Honore B, 2009, BIOESSAYS, V31, P262, DOI 10.1002/bies.200800186; Huang SP, 1998, ZOOL STUD, V37, P89; Hughes TP, 2003, SCIENCE, V301, P929, DOI 10.1126/science.1085046; Knebel A, 1996, EMBO J, V15, P5314, DOI 10.1002/j.1460-2075.1996.tb00916.x; Koike K, 2004, BIOL BULL-US, V207, P80, DOI 10.2307/1543582; Krasnov A, 2005, BMC GENOMICS, V6, DOI 10.1186/1471-2164-6-3; Kumar S., 2011, PLOS ONE, V6; Kvennefors ECE, 2008, DEV COMP IMMUNOL, V32, P1582, DOI 10.1016/j.dci.2008.05.010; Kvitt H, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028665; Lodish H., 1995, MOL CELL BIOL; Lopez-Maury L, 2009, NAT REV GENET, V10, DOI 10.1038/nrg2500; Mattson D, 2004, INT J HYPERTHER, V20, P224, DOI 10.1080/02656730310001619956; Mayfield AB, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026529; Maynard JA, 2008, MAR BIOL, V155, P173, DOI 10.1007/s00227-008-1015-y; MEINTS RH, 1980, J CELL SCI, V43, P239; Meyer E, 2011, MOL ECOL, V20, P3599, DOI 10.1111/j.1365-294X.2011.05205.x; Middlebrook R, 2008, J EXP BIOL, V211, P1050, DOI 10.1242/jeb.013284; Molinier J, 2006, NATURE, V442, P1046, DOI 10.1038/nature05022; Oliver TA, 2011, CORAL REEFS, V30, P429, DOI 10.1007/s00338-011-0721-y; Orino K, 2001, BIOCHEM J, V357, P241, DOI 10.1042/0264-6021:3570241; Orrenius S, 2003, NAT REV MOL CELL BIO, V4, P552, DOI 10.1038/nrm1150; Pandolfi JM, 2011, SCIENCE, V333, P418, DOI 10.1126/science.1204794; Pernice M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016095; Polato NR, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011221; Pritts TA, 2000, ARCH SURG-CHICAGO, V135, P860, DOI 10.1001/archsurg.135.7.860; R DEVELOPMENT CORE TEAM, 2011, R LANG ENV STAT COMP; Richier S, 2008, COMP BIOCHEM PHYS D, V3, P283, DOI 10.1016/j.cbd.2008.08.001; Rodriguez-Lanetty M, 2009, MOL ECOL, V18, P5101, DOI 10.1111/j.1365-294X.2009.04419.x; Rohwer F, 2002, MAR ECOL PROG SER, V243, P1, DOI 10.3354/meps243001; Rosenberg SM, 2003, SCIENCE, V300, P1382, DOI 10.1126/science.1085691; Rowan R, 2004, NATURE, V430, P742, DOI 10.1038/430742a; Ryan KM, 2000, NATURE, V404, P892, DOI 10.1038/35009130; Sandeman I. M, 2006, Rev. biol. trop, V54, P79; Schwarz JA, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-97; Sharp VA, 1997, J THERM BIOL, V22, P11, DOI 10.1016/S0306-4565(96)00029-0; Shaulian E, 2002, NAT CELL BIOL, V4, pE131, DOI 10.1038/ncb0502-e131; Smith DJ, 2005, GLOBAL CHANGE BIOL, V11, P1, DOI 10.1111/j.1529-8817.2003.00895.x; Smith-Keune C, 2008, MAR BIOTECHNOL, V10, P166, DOI 10.1007/s10126-007-9049-6; Sonna LA, 2002, J APPL PHYSIOL, V92, P1725, DOI 10.1152/japplphysiol.01143.2001; Sorensen JG, 2007, J EVOLUTION BIOL, V20, P1624, DOI 10.1111/j.1420-9101.2007.01326.x; STEEN RG, 1987, BIOL BULL, V172, P246, DOI 10.2307/1541797; STIMSON J, 1991, J EXP MAR BIOL ECOL, V153, P63, DOI 10.1016/S0022-0981(05)80006-1; Storey JD, 2002, J ROY STAT SOC B, V64, P479, DOI 10.1111/1467-9868.00346; Tchernov D, 2011, P NATL ACAD SCI USA, V108, P9905, DOI 10.1073/pnas.1106924108; Theil EC, 2007, BIOMETALS, V20, P513, DOI 10.1007/s10534-006-9063-6; Thompson DM, 2009, P ROY SOC B-BIOL SCI, V276, P2893, DOI 10.1098/rspb.2009.0591; Torti FM, 2002, BLOOD, V99, P3505, DOI 10.1182/blood.V99.10.3505; Vidal-Dupiol Jeremie, 2009, BMC Physiology, V9, P14, DOI 10.1186/1472-6793-9-14; Voolstra CR, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-627; Weis VM, 2008, J EXP BIOL, V211, P3059, DOI 10.1242/jeb.009597; Wilkinson C., 2004, STATUS CORAL REEFS W, V2; Williams GJ, 2010, MAR POLLUT BULL, V60, P1467, DOI 10.1016/j.marpolbul.2010.05.009; Wong HR, 1999, CELL STRESS CHAPERON, V4, P1; Wood-Charlson EM, 2006, CELL MICROBIOL, V8, P1985, DOI 10.1111/j.1462-5822.2006.00765.x; WU H, 2008, R MAANOVA EXTENSIVE	105	96	95	1	151	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 30	2012	7	11							e50685	10.1371/journal.pone.0050685	http://dx.doi.org/10.1371/journal.pone.0050685			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	054WM	23226355	gold, Green Published, Green Accepted, Green Submitted			2022-12-27	WOS:000312376100166
J	Peng, KC; Lee, SH; Hour, AL; Pan, CY; Lee, LH; Chen, JY				Peng, Kuan-Chieh; Lee, Shu-Hua; Hour, Ai-Ling; Pan, Chieh-Yu; Lee, Lin-Han; Chen, Jyh-Yih			Five Different Piscidins from Nile Tilapia, Oreochromis niloticus: Analysis of Their Expressions and Biological Functions	PLOS ONE			English	Article							HOST-DEFENSE PEPTIDES; HYBRID STRIPED BASS; ANTIMICROBIAL PEPTIDES; GENE-EXPRESSION; CANDIDA-ALBICANS; IMMUNE-RESPONSE; MAST-CELLS; FISH; EPINECIDIN-1; ALPHA	Piscidins are antimicrobial peptides (AMPs) that play important roles in helping fish resist pathogenic infections. Through comparisons of tilapia EST clones, the coding sequences of five piscidin-like AMPs (named TP1 similar to 5) of Nile tilapia, Oreochromis niloticus, were determined. The complete piscidin coding sequences of TP1, -2, -3, -4, and -5 were respectively composed of 207, 234, 231, 270, and 195 bases, and each contained a translated region of 68, 77, 76, 89, and 64 amino acids. The tissue-specific, Vibrio vulnificus stimulation-specific, and Streptococcus agalactiae stimulation-specific expressions of TP2, -3, and -4 mRNA were determined by a comparative RT-PCR. Results of the tissue distribution analysis revealed high expression levels of TP2 mRNA in the skin, head kidneys, liver, and spleen. To study bacterial stimulation, S. agalactiae (SA47) was injected, and the TP4 transcript was upregulated by >13-fold (compared to the wild-type (WT) control, without injection) and was 60-fold upregulated (compared to the WT control, without injection) 24 h after the S. agalactiae (SA47) injection in the spleen and gills. Synthesized TP3 and TP4 peptides showed antimicrobial activities against several bacteria in this study, while the synthesized TP1, -2, and -5 peptides did not. The synthesized TP2, -3, and -4 peptides showed hemolytic activities and synthesized TP3 and TP4 peptides inhibited tilapia ovary cell proliferation with a dose-dependent effect. In summary, the amphiphilic alpha-helical cationic peptides of TP3 and TP4 may represent novel and potential antimicrobial agents for further peptide drug development.	[Peng, Kuan-Chieh; Lee, Shu-Hua; Pan, Chieh-Yu; Lee, Lin-Han; Chen, Jyh-Yih] Acad Sinica, Inst Cellular & Organism Biol, Marine Res Stn, Ilan, Taiwan; [Hour, Ai-Ling] Fu Jen Catholic Univ, Dept Life Sci, Taipei, Taiwan	Academia Sinica - Taiwan; Fu Jen Catholic University	Chen, JY (corresponding author), Acad Sinica, Inst Cellular & Organism Biol, Marine Res Stn, Ilan, Taiwan.	zoocjy@gate.sinica.edu.tw	Chen, Jyh-Yih/F-3412-2014	Chen, Jyh-Yih/0000-0001-7858-8236				Afacan NJ, 2012, CURR PHARM DESIGN, V18, P807, DOI 10.2174/138161212799277617; Amiche M, 2011, CURR PHARM BIOTECHNO, V12, P1184, DOI 10.2174/138920111796117319; Browne MJ, 2011, DEV COMP IMMUNOL, V35, P399, DOI 10.1016/j.dci.2010.11.010; Chen JY, 2004, MAR BIOTECHNOL, V6, P1, DOI 10.1007/s10126-002-0115-9; Chen JY, 2010, COMP BIOCHEM PHYS B, V155, P155, DOI 10.1016/j.cbpb.2009.10.017; Chen YX, 2007, ANTIMICROB AGENTS CH, V51, P1398, DOI 10.1128/AAC.00925-06; Choi KY, 2012, J INNATE IMMUN, V4, P361, DOI 10.1159/000336630; Cole AM, 2000, ANTIMICROB AGENTS CH, V44, P2039, DOI 10.1128/AAC.44.8.2039-2045.2000; Corrales J, 2010, DEV COMP IMMUNOL, V34, P331, DOI 10.1016/j.dci.2009.11.004; Dezfuli BS, 2011, PARASITE IMMUNOL, V33, P116, DOI 10.1111/j.1365-3024.2010.01266.x; Ellis AE, 2001, DEV COMP IMMUNOL, V25, P827, DOI 10.1016/S0145-305X(01)00038-6; Feng CY, 2009, PHYSIOL GENOMICS, V37, P149, DOI 10.1152/physiolgenomics.90373.2008; Fernandes JMO, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009501; Hsu JC, 2011, PEPTIDES, V32, P900, DOI 10.1016/j.peptides.2011.02.013; Lauth X, 2002, J BIOL CHEM, V277, P5030, DOI 10.1074/jbc.M109173200; Lee SA, 2007, BIOCHEMISTRY-US, V46, P3653, DOI 10.1021/bi062233u; Lequin O, 2006, BIOCHEMISTRY-US, V45, P468, DOI 10.1021/bi051711i; Lin SB, 2009, FISH SHELLFISH IMMUN, V26, P451, DOI 10.1016/j.fsi.2009.01.008; Linde A, 2008, J VET INTERN MED, V22, P247, DOI 10.1111/j.1939-1676.2007.0038.x; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Luenser K, 2005, IMMUNOGENETICS, V57, P487, DOI 10.1007/s00251-005-0001-5; Marques R, 2011, CELL MOL LIFE SCI, V68, P3661, DOI 10.1007/s00018-011-0829-9; Menousek J, 2012, INT J ANTIMICROB AG, V39, P402, DOI 10.1016/j.ijantimicag.2012.02.003; Mulero I, 2008, DEV COMP IMMUNOL, V32, P1531, DOI 10.1016/j.dci.2008.05.015; Noga EJ, 2011, COMP BIOCHEM PHYS D, V6, P44, DOI 10.1016/j.cbd.2010.06.001; Noga EJ, 2009, COMP BIOCHEM PHYS B, V152, P299, DOI 10.1016/j.cbpb.2008.12.018; Pan CY, 2007, DNA CELL BIOL, V26, P403, DOI 10.1089/dna.2006.0564; Pan CY, 2009, PEPTIDES, V30, P1058, DOI 10.1016/j.peptides.2009.02.006; Park NG, 2011, BIOCHEMISTRY-US, V50, P3288, DOI 10.1021/bi101395j; Park Y, 2005, J BIOCHEM MOL BIOL, V38, P507; Patrzykat A, 2003, TRENDS BIOTECHNOL, V21, P362, DOI 10.1016/S0167-7799(03)00145-8; Polyansky AA, 2009, FEBS LETT, V583, P2425, DOI 10.1016/j.febslet.2009.06.044; Rajanbabu V, 2011, PEPTIDES, V32, P415, DOI 10.1016/j.peptides.2010.11.005; Rajanbabu V, 2010, J BIOL CHEM, V285, P30577, DOI 10.1074/jbc.M110.137935; Ruangsri J, 2012, FISH SHELLFISH IMMUN, V32, P396, DOI 10.1016/j.fsi.2011.11.022; Ryu JH, 2010, MOL CELLS, V30, P173, DOI 10.1007/s10059-010-0146-4; Salger SA, 2011, FISH SHELLFISH IMMUN, V30, P420, DOI 10.1016/j.fsi.2010.10.009; Silphaduang U, 2006, DIS AQUAT ORGAN, V72, P241, DOI 10.3354/dao072241; Silphaduang U, 2001, NATURE, V414, P268, DOI 10.1038/35104690; Soto E, 2011, J VET DIAGN INVEST, V23, P821, DOI 10.1177/1040638711407058; Sung WS, 2008, BIOL PHARM BULL, V31, P1906, DOI 10.1248/bpb.31.1906; Sung WS, 2008, BIOCHEM BIOPH RES CO, V371, P551, DOI 10.1016/j.bbrc.2008.04.107; Terova G, 2011, BMC IMMUNOL, V12, DOI 10.1186/1471-2172-12-69; Travis SM, 2000, INFECT IMMUN, V68, P2748, DOI 10.1128/IAI.68.5.2748-2755.2000; Wang ZP, 2012, J IMMUNOL, V188, P345, DOI 10.4049/jimmunol.1101703; Yeaman MR, 2003, PHARMACOL REV, V55, P27, DOI 10.1124/pr.55.1.2; Zahran E, 2010, J FISH DIS, V33, P995, DOI 10.1111/j.1365-2761.2010.01205.x	47	102	111	2	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 30	2012	7	11							e50263	10.1371/journal.pone.0050263	http://dx.doi.org/10.1371/journal.pone.0050263			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	054WM	23226256	gold, Green Submitted, Green Published			2022-12-27	WOS:000312376100066
J	Peng, XE; Wu, YL; Lin, SW; Lu, QQ; Hu, ZJ; Lin, X				Peng, Xian-E; Wu, Yun-Li; Lin, Shao-Wei; Lu, Qing-Qing; Hu, Zhi-Jian; Lin, Xu			Genetic Variants in PNPLA3 and Risk of Non-Alcoholic Fatty Liver Disease in a Han Chinese Population	PLOS ONE			English	Article							ADIPOSE TRIGLYCERIDE LIPASE; MESSENGER-RNA EXPRESSION; GENOME-WIDE ASSOCIATION; LIFE-STYLE; GREEN TEA; ADIPONUTRIN; SUSCEPTIBILITY; POLYMORPHISM; INDEXES; INSULIN	We investigated the possible association between genetic variants in the Patatin like phospholipase-3 (PNPLA3) gene and nonalcoholic fatty liver disease (NAFLD) in a Han Chinese population. We evaluated twelve tagging single-nucleotide polymorphisms (tSNPs) of the PNPLA3 gene in a frequency matched case-control study from Fuzhou city of China (553 cases, 553 controls). In the multivariate logistic regression analysis, the rs738409 GG or GC, and rs139051 TT genotypes were found to be associated with increased risk of NAFLD, and a significant trend of increased risk with increasing numbers of risk genotype was observed in the cumulative effect analysis of these single nucleotide polymorphisms. Furthermore, haplotype association analysis showed that, compared with the most common haplotype, the CAAGAATGCGTG and CGAAGGTGTCCG haplotypes conferred a statistically significant increased risk for NAFLD, while the CGGGAACCCGCG haplotype decreased the risk of NAFLD. Moreover, rs738409 C>G appeared to have a multiplicative joint effect with tea drinking (P<0.005) and an additive joint effect with obesity (Interaction contrast ratio (ICR) = 2.31, 95% CI: 0.7-8.86), hypertriglyceridemia (ICR = 3.07, 95% CI: 0.98-5.09) or hypertension (ICR = 1.74, 95% CI: 0.52-3.12). Our data suggests that PNPLA3 genetic polymorphisms might influence the susceptibility to NAFLD development independently or jointly in Han Chinese.	[Peng, Xian-E; Wu, Yun-Li; Lin, Xu] Fujian Med Univ, Res Ctr Mol Med, Minist Educ Gastrointestinal Canc, Key Lab, Fuzhou, Peoples R China; [Peng, Xian-E; Lin, Shao-Wei; Hu, Zhi-Jian] Fujian Med Univ, Sch Publ Hlth, Dept Epidemiol & Hlth Stat, Fuzhou, Peoples R China; [Wu, Yun-Li; Lin, Xu] Fujian Med Univ, Dept Med Microbiol, Key Lab Tumor Microbiol, Fuzhou, Peoples R China; [Lu, Qing-Qing] Fujian Med Univ, Union Hosp, Dept Gastroenterol, Fuzhou, Peoples R China	Fujian Medical University; Fujian Medical University; Fujian Medical University; Fujian Medical University	Lin, X (corresponding author), Fujian Med Univ, Res Ctr Mol Med, Minist Educ Gastrointestinal Canc, Key Lab, Fuzhou, Peoples R China.	linxu@mail.fjmu.edu.cn			National Natural Science Foundation of China [81001279]; Fujian Science and Technology Innovation Foundation for Young Scientists [2010J05067]; Science Foundation for Distinguished Young Scholars of Fujian province [2009J06016]; Key Program of Scientific Research of Fujian Medical University [09ZD004]; Foundation of Fujian Educational Committee [JA10138, JK2009014]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Fujian Science and Technology Innovation Foundation for Young Scientists; Science Foundation for Distinguished Young Scholars of Fujian province(National Natural Science Foundation of China (NSFC)National Science Fund for Distinguished Young Scholars); Key Program of Scientific Research of Fujian Medical University; Foundation of Fujian Educational Committee	This work was supported by grants from the National Natural Science Foundation of China (No. 81001279), Fujian Science and Technology Innovation Foundation for Young Scientists (No. 2010J05067), the Science Foundation for Distinguished Young Scholars of Fujian province (No. 2009J06016), the Key Program of Scientific Research of Fujian Medical University (09ZD004), and the Foundation of Fujian Educational Committee (No. JA10138 and No. JK2009014). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alberti KGMM, 2005, LANCET, V366, P1059, DOI 10.1016/S0140-6736(05)67402-8; Barrett JC, 2005, BIOINFORMATICS, V21, P263, DOI 10.1093/bioinformatics/bth457; Barshop NJ, 2008, ALIMENT PHARM THER, V28, P13, DOI 10.1111/j.1365-2036.2008.03703.x; Baulande S, 2001, J BIOL CHEM, V276, P33336, DOI 10.1074/jbc.M105193200; Calvo RM, 2009, MOL CELL ENDOCRINOL, V311, P39, DOI 10.1016/j.mce.2009.07.006; Chalasani N, 2010, GASTROENTEROLOGY, V139, P1567, DOI 10.1053/j.gastro.2010.07.057; Chen SH, 2008, J GASTROEN HEPATOL, V23, P1415, DOI 10.1111/j.1440-1746.2008.05523.x; del Giudice EM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027933; Euskirchen G, 2004, MOL CELL BIOL, V24, P3804, DOI 10.1128/MCB.24.9.3804-3814.2004; Foppa I, 1997, AM J EPIDEMIOL, V146, P596; Harrison SA, 2007, GUT, V56, P1760, DOI 10.1136/gut.2006.112094; He SQ, 2010, J BIOL CHEM, V285, P6706, DOI 10.1074/jbc.M109.064501; Hoekstra M, 2010, J HEPATOL, V52, P244, DOI 10.1016/j.jhep.2009.11.004; HOSMER DW, 1992, EPIDEMIOLOGY, V3, P452, DOI 10.1097/00001648-199209000-00012; Huang YC, 2010, P NATL ACAD SCI USA, V107, P7892, DOI 10.1073/pnas.1003585107; IMAI K, 1995, BRIT MED J, V310, P693, DOI 10.1136/bmj.310.6981.693; Jenkins CM, 2004, J BIOL CHEM, V279, P48968, DOI 10.1074/jbc.M407841200; Kantartzis K, 2009, DIABETES, V58, P2616, DOI 10.2337/db09-0279; Kershaw EE, 2006, DIABETES, V55, P148, DOI 10.2337/diabetes.55.01.06.db05-0982; Kuriyama S, 2006, JAMA-J AM MED ASSOC, V296, P1255, DOI 10.1001/jama.296.10.1255; Lake AC, 2005, J LIPID RES, V46, P2477, DOI 10.1194/jlr.M500290-JLR200; Lake SL, 2003, HUM HERED, V55, P56, DOI 10.1159/000071811; Lehman DM, 2005, DIABETES, V54, P1214, DOI 10.2337/diabetes.54.4.1214; Li XH, 2011, HEPATOLOGY, V54, P2275, DOI 10.1002/hep.24567; Li YL, 2012, HEPATOLOGY, V55, P327, DOI 10.1002/hep.24659; Liu YM, 2004, J CLIN ENDOCR METAB, V89, P2684, DOI 10.1210/jc.2003-031978; Miyoshi H, 2008, J CELL BIOCHEM, V105, P1430, DOI 10.1002/jcb.21964; Moore JH, 2002, ANN MED, V34, P88, DOI 10.1080/07853890252953473; Peng XE, 2012, GENE, V500, P54, DOI 10.1016/j.gene.2012.03.050; Polson DA, 2004, J NUTR BIOCHEM, V15, P242, DOI 10.1016/j.nutbio.2003.11.009; Purcell S, 2003, BIOINFORMATICS, V19, P149, DOI 10.1093/bioinformatics/19.1.149; Romeo S, 2010, INT J OBESITY, V34, P190, DOI 10.1038/ijo.2009.216; Romeo S, 2008, NAT GENET, V40, P1461, DOI 10.1038/ng.257; Romeo S, 2010, J HEPATOL, V53, P335, DOI 10.1016/j.jhep.2010.02.034; Rotman Y, 2010, HEPATOLOGY, V52, P894, DOI 10.1002/hep.23759; Sano M, 2005, AM J HYPERTENS, V18, P403, DOI 10.1016/j.amjhyper.2004.10.016; Santoro N, 2010, HEPATOLOGY, V52, P1281, DOI 10.1002/hep.23832; Schwimmer JB, 2009, GASTROENTEROLOGY, V136, P1585, DOI 10.1053/j.gastro.2009.01.050; Song JN, 2005, FASEB J, V19, P1266, DOI 10.1096/fj.04-3580com; Sookoian S, 2008, CYTOKINE, V44, P201, DOI 10.1016/j.cyto.2008.08.001; Sookoian S, 2009, J NUTR BIOCHEM, V20, P765, DOI 10.1016/j.jnutbio.2008.07.005; Sookoian S, 2009, J LIPID RES, V50, P2111, DOI 10.1194/jlr.P900013-JLR200; Speliotes EK, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1001324; Speliotes EK, 2010, HEPATOLOGY, V52, P904, DOI 10.1002/hep.23768; Suzuki A, 2005, J HEPATOL, V43, P1060, DOI 10.1016/j.jhep.2005.06.008; Trepo E, 2011, J HEPATOL, V55, P906, DOI 10.1016/j.jhep.2011.01.028; Wagenknecht LE, 2011, LIVER INT, V31, P412, DOI 10.1111/j.1478-3231.2010.02444.x; Yuan X, 2008, AM J HUM GENET, V83, P520, DOI 10.1016/j.ajhg.2008.09.012; Zeng MD, 2008, J DIGEST DIS, V9, P108, DOI 10.1111/j.1751-2980.2008.00331.x	49	36	38	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 30	2012	7	11							e50256	10.1371/journal.pone.0050256	http://dx.doi.org/10.1371/journal.pone.0050256			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	054WM	23226254	gold, Green Submitted, Green Published			2022-12-27	WOS:000312376100064
J	Salimath, AS; Phelps, EA; Boopathy, AV; Che, PL; Brown, M; Garcia, AJ; Davis, ME				Salimath, Apoorva S.; Phelps, Edward A.; Boopathy, Archana V.; Che, Pao-lin; Brown, Milton; Garcia, Andres J.; Davis, Michael E.			Dual Delivery of Hepatocyte and Vascular Endothelial Growth Factors via a Protease-Degradable Hydrogel Improves Cardiac Function in Rats	PLOS ONE			English	Article							ACUTE MYOCARDIAL-INFARCTION; ENGINEERED PEG HYDROGELS; PEPTIDE NANOFIBERS; CELL THERAPY; STEM-CELLS; INTRAMYOCARDIAL INJECTION; ALGINATE BIOMATERIAL; PROGENITOR CELLS; IN-VITRO; ANGIOGENESIS	Acute myocardial infarction (MI) caused by ischemia and reperfusion (IR) is the most common cause of cardiac dysfunction due to local cell death and a temporally regulated inflammatory response. Current therapeutics are limited by delivery vehicles that do not address spatial and temporal aspects of healing. The aim of this study was to engineer biotherapeutic delivery materials to harness endogenous cell repair to enhance myocardial repair and function. We have previously engineered poly(ethylene glycol) (PEG)-based hydrogels to present cell adhesive motifs and deliver VEGF to promote vascularization in vivo. In the current study, bioactive hydrogels with a protease-degradable crosslinker were loaded with hepatocyte and vascular endothelial growth factors (HGF and VEGF, respectively) and delivered to the infarcted myocardium of rats. Release of both growth factors was accelerated in the presence of collagenase due to hydrogel degradation. When delivered to the border zones following ischemia-reperfusion injury, there was no acute effect on cardiac function as measured by echocardiography. Over time there was a significant increase in angiogenesis, stem cell recruitment, and a decrease in fibrosis in the dual growth factor delivery group that was significant compared with single growth factor therapy. This led to an improvement in chronic function as measured by both invasive hemodynamics and echocardiography. These data demonstrate that dual growth factor release of HGF and VEGF from a bioactive hydrogel has the capacity to significantly improve cardiac remodeling and function following IR injury.	[Salimath, Apoorva S.; Phelps, Edward A.; Boopathy, Archana V.; Garcia, Andres J.; Davis, Michael E.] Georgia Inst Technol, Parker H Petit Inst Bioengn & Biosci, Atlanta, GA 30332 USA; [Salimath, Apoorva S.; Phelps, Edward A.; Garcia, Andres J.] Georgia Inst Technol, George W Woodruff Sch Mech Engn, Atlanta, GA 30332 USA; [Boopathy, Archana V.; Che, Pao-lin; Brown, Milton; Davis, Michael E.] Emory Univ, Wallace H Coulter Dept Biomed Engn, Atlanta, GA 30322 USA; [Boopathy, Archana V.; Che, Pao-lin; Brown, Milton; Davis, Michael E.] Emory Univ, Sch Med, Div Cardiol, Atlanta, GA USA	University System of Georgia; Georgia Institute of Technology; University System of Georgia; Georgia Institute of Technology; Emory University; Emory University	Davis, ME (corresponding author), Georgia Inst Technol, Parker H Petit Inst Bioengn & Biosci, Atlanta, GA 30332 USA.	michael.davis@bme.emory.edu	Phelps, Edward A/Q-1302-2016	Phelps, Edward A/0000-0001-8666-805X	National Heart, Lung, and Blood Institute (NHLBI) [HHSN268201000043C]; American Heart Association (AHA) fellowship; National Science Foundation (NSF) Center Grant [CBET-0939511]; Georgia Tech/Emory Center for the Engineering of Living Tissues	National Heart, Lung, and Blood Institute (NHLBI)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); American Heart Association (AHA) fellowship(American Heart Association); National Science Foundation (NSF) Center Grant(National Science Foundation (NSF)); Georgia Tech/Emory Center for the Engineering of Living Tissues	This work was supported by a contract from the National Heart, Lung, and Blood Institute (NHLBI) (HHSN268201000043C) as part of a Program of Excellence in Nanotechnology. Additionally, funding was received in the form of an American Heart Association (AHA) fellowship, National Science Foundation (NSF) Center Grant (CBET-0939511), and Georgia Tech/Emory Center for the Engineering of Living Tissues. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Almeda FQ, 2001, CRIT CARE CLIN, V17, P411, DOI 10.1016/S0749-0704(05)70175-5; Angoulvant D, 2011, J HEART LUNG TRANSPL, V30, P95, DOI 10.1016/j.healun.2010.08.023; Anversa P, 2006, J AM COLL CARDIOL, V47, P1769, DOI 10.1016/j.jacc.2006.02.003; Anversa P, 1995, Cardiologia, V40, P909; Anversa P, 2000, CIRC RES, V86, P121, DOI 10.1161/01.RES.86.2.121; Assmus B, 2006, NEW ENGL J MED, V355, P1222, DOI 10.1056/NEJMoa051779; Chen RR, 2007, PHARM RES, V24, P258, DOI 10.1007/s11095-006-9173-4; Chimenti I, 2011, BIOMATERIALS, V32, P9271, DOI 10.1016/j.biomaterials.2011.08.049; Cho KR, 2008, EUR J CARDIO-THORAC, V34, P857, DOI 10.1016/j.ejcts.2008.05.045; Danielsen CC, 1998, J MOL CELL CARDIOL, V30, P1431; Davis ME, 2006, P NATL ACAD SCI USA, V103, P8155, DOI 10.1073/pnas.0602877103; Engel FB, 2006, P NATL ACAD SCI USA, V103, P15546, DOI 10.1073/pnas.0607382103; Epstein SE, 2001, CIRCULATION, V104, P115, DOI 10.1161/01.CIR.104.1.115; Fatma S, 2010, ANTIOXID REDOX SIGN, V13, P1857, DOI 10.1089/ars.2010.3104; French KM, 2012, ACTA BIOMATER; Hsieh PCH, 2006, J CLIN INVEST, V116, P237, DOI 10.1172/JCI25878; Ifkovits JL, 2010, P NATL ACAD SCI USA, V107, P11507, DOI 10.1073/pnas.1004097107; Jacot JG, 2008, BIOPHYS J, V95, P3479, DOI 10.1529/biophysj.107.124545; Jacot JG, 2006, J BIOMED MATER RES A, V79A, P485, DOI 10.1002/jbm.a.30812; Jacot JG, 2010, ANN NY ACAD SCI, V1188, P121, DOI 10.1111/j.1749-6632.2009.05091.x; Kadner K, 2012, BIOMATERIALS, V33, P2060, DOI 10.1016/j.biomaterials.2011.11.031; Kajstura J, 1996, LAB INVEST, V74, P86; Kang HJ, 2004, LANCET, V363, P751, DOI 10.1016/S0140-6736(04)15689-4; Kloner RA, 2000, J THROMB THROMBOLYS, V10, P285, DOI 10.1023/A:1026507627097; Leri A, 2001, Ital Heart J, V2 Suppl 3, p12S; Linke A, 2005, P NATL ACAD SCI USA, V102, P8966, DOI 10.1073/pnas.0502678102; Miyagawa S, 2006, TRANSPLANTATION, V81, P902, DOI 10.1097/01.tp.0000202843.86864.10; Morishita R, 2004, CURR GENE THER, V4, P199; Nakagawa K, 2000, SEMIN THROMB HEMOST, V26, P61, DOI 10.1055/s-2000-9805; Ozawa CR, 2004, J CLIN INVEST, V113, P516, DOI 10.1172/JCI200418420; Patterson J, 2011, BIOMATERIALS, V32, P1301, DOI 10.1016/j.biomaterials.2010.10.016; Patterson J, 2010, BIOMATERIALS, V31, P7836, DOI 10.1016/j.biomaterials.2010.06.061; Perez-Ilzarbe M, 2008, EUR J HEART FAIL, V10, P1065, DOI 10.1016/j.ejheart.2008.08.002; Phelps EA, 2012, ADV MATER, V24, P64, DOI 10.1002/adma.201103574; Phelps EA, 2010, P NATL ACAD SCI USA, V107, P3323, DOI 10.1073/pnas.0905447107; Rane AA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021571; Roger VL, 2012, CIRCULATION, V125, pE2, DOI 10.1161/CIR.0b013e31823ac046; Ruvinov E, 2011, BIOMATERIALS, V32, P565, DOI 10.1016/j.biomaterials.2010.08.097; Ruvinov E, 2010, BIOMATERIALS, V31, P4573, DOI 10.1016/j.biomaterials.2010.02.026; Saif J, 2010, ARTERIOSCL THROM VAS, V30, P1897, DOI 10.1161/ATVBAHA.110.207928; Samuel SM, 2010, DIABETES, V59, P51, DOI 10.2337/db09-0336; Schwarz ER, 2000, J AM COLL CARDIOL, V35, P1323, DOI 10.1016/S0735-1097(00)00522-2; Siltanen A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019161; Sun QH, 2010, PHARM RES-DORDR, V27, P264, DOI 10.1007/s11095-009-0014-0; Sy JC, 2008, NAT MATER, V7, P863, DOI 10.1038/nmat2299; Sy JC, 2010, J CARDIOVASC TRANSL, V3, P461, DOI 10.1007/s12265-010-9210-x; Tang JM, 2009, EXP CELL RES, V315, P3521, DOI 10.1016/j.yexcr.2009.09.026; Vilahur G, 2011, J MOL CELL CARDIOL, V50, P522, DOI 10.1016/j.yjmcc.2010.12.021; Wall ST, 2010, J BIOMED MATER RES A, V95A, P1055, DOI 10.1002/jbm.a.32904; Wang YG, 2004, J MOL CELL CARDIOL, V37, P1041, DOI 10.1016/j.yjmcc.2004.09.004; Xaymardan M, 2009, STEM CELLS, V27, P1911, DOI 10.1002/stem.106; Yamaguchi T, 2005, SURG TODAY, V35, P855, DOI 10.1007/s00595-005-3042-3; Zentilin L, 2010, FASEB J, V24, P1467, DOI 10.1096/fj.09-143180; Zhu XY, 2009, BIOCHEM BIOPH RES CO, V379, P1084, DOI 10.1016/j.bbrc.2009.01.019	54	74	75	1	75	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 30	2012	7	11							e50980	10.1371/journal.pone.0050980	http://dx.doi.org/10.1371/journal.pone.0050980			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	054WM	23226440	gold, Green Published, Green Submitted			2022-12-27	WOS:000312376100251
J	Sasaki, T; Kubota-Koketsu, R; Takei, M; Hagihara, T; Iwamoto, S; Murao, T; Sawami, K; Fukae, D; Nakamura, M; Nagata, E; Kawakami, A; Mitsubayashi, Y; Ohno, M; Uehara, Y; Fukukawa, T; Kanai, Y; Kosaka, M; Ikuta, K				Sasaki, Tadahiro; Kubota-Koketsu, Ritsuko; Takei, Michihiro; Hagihara, Tatsuo; Iwamoto, Shinichi; Murao, Takuya; Sawami, Kazuo; Fukae, Daizou; Nakamura, Masahiro; Nagata, Eiichi; Kawakami, Akira; Mitsubayashi, Yuko; Ohno, Masafumi; Uehara, Yasuo; Fukukawa, Takashi; Kanai, Yuta; Kosaka, Mieko; Ikuta, Kazuyoshi			Reliability of a Newly-Developed Immunochromatography Diagnostic Kit for Pandemic Influenza A/H1N1pdm Virus: Implications for Drug Administration	PLOS ONE			English	Article							RAPID ANTIGEN TEST; PERFORMANCE	Background: For the diagnosis of seasonal influenza, clinicians rely on point-of-care testing (POCT) using commercially available kits developed against seasonal influenza viruses. However, POCT has not yet been established for the diagnosis of pandemic influenza A virus (H1N1pdm) infection due to the low sensitivity of the existing kits for H1N1pdm. Methodology/Principal Findings: An immunochromatography (IC) test kit was developed based on a monoclonal antibody against H1N1pdm, which does not cross-react with seasonal influenza A or B viruses. The efficacy of this kit (PDM-IC kit) for the diagnosis of H1N1pdm infection was compared with that of an existing kit for the detection of seasonal influenza viruses (SEA-IC kit). Nasal swabs (n = 542) were obtained from patients with flu-like syndrome at 13 clinics in Osaka, Japan during the winter of 2010/2011. Among the 542 samples, randomly selected 332 were further evaluated for viral presence by reverse transcriptase polymerase chain reaction (RT-PCR). The PDM-IC kit versus the SEA-IC kit showed higher sensitivity to and specificity for H1N1pdm, despite several inconsistencies between the two kits or between the kits and RT-PCR. Consequently, greater numbers of false-negative and false-positive cases were documented when the SEA-IC kit was employed. Significant correlation coefficients for sensitivity, specificity, and negative prediction values between the two kits were observed at individual clinics, indicating that the results could be affected by clinic-related techniques for sampling and kit handling. Importantly, many patients (especially influenza-negative cases) were prescribed anti-influenza drugs that were incongruous with their condition, largely due to physician preference for patient responses to questionnaires and patient symptomology, as opposed to actual viral presence. Conclusions/Significance: Concomitant use of SEA-IC and PDM-IC kits increased the likelihood of correct influenza diagnosis. Increasing the credibility of POCT is anticipated to decrease the inappropriate dispensing of anti-influenza drugs, thereby minimizing the emergence of drug-resistant H1N1pdm strains.	[Sasaki, Tadahiro; Kubota-Koketsu, Ritsuko; Kanai, Yuta; Ikuta, Kazuyoshi] Osaka Univ, Microbial Dis Res Inst, Dept Virol, Suita, Osaka 565, Japan; [Takei, Michihiro; Hagihara, Tatsuo; Iwamoto, Shinichi; Murao, Takuya; Sawami, Kazuo; Fukae, Daizou; Nakamura, Masahiro; Nagata, Eiichi; Kawakami, Akira; Mitsubayashi, Yuko; Ohno, Masafumi; Uehara, Yasuo; Fukukawa, Takashi] Osaka Higashinari Ku Med Assoc, Higashinari Ku, Osaka, Japan; [Kosaka, Mieko] Alfresa Pharma Corp, Osaka, Japan	Osaka University	Sasaki, T (corresponding author), Osaka Univ, Microbial Dis Res Inst, Dept Virol, Suita, Osaka 565, Japan.	sasatada@biken.osaka-u.ac.jp	Kanai, Yuta/Q-3372-2019	Kanai, Yuta/0000-0002-5102-6951	Japan Society for the Promotion of Science; Alfresa Phama Corporation; Grants-in-Aid for Scientific Research [23406017] Funding Source: KAKEN	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Alfresa Phama Corporation; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported in part by a Grant-in-Aid for Scientific Research (B) (Overseas Academic Research) from the Japan Society for the Promotion of Science to K. I. Also, this work was partly supported by funding from Alfresa Phama Corporation to Osaka University to perform a collaborative research. The funders had no role in study design, data collection or analysis, decision to publish, or preparation of the manuscript. No additional external funding was received for this study.	Choi WS, 2011, YONSEI MED J, V52, P683, DOI 10.3349/ymj.2011.52.4.683; Choi YJ, 2010, J CLIN MICROBIOL, V48, P2260, DOI 10.1128/JCM.02392-09; Chowell G, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1000436; Drexler JF, 2009, EMERG INFECT DIS, V15, P1662, DOI 10.3201/eid1510.091186; Ramirez-Gonzalez JE, 2011, EMERG INFECT DIS, V17, P283, DOI 10.3201/eid1702.100897; European Centre for Disease Prevention and Control, 2010, ECDC DAIL UPD PAND H; Faix DJ, 2009, NEW ENGL J MED, V361, P728, DOI 10.1056/NEJMc0904264; Fraser C, 2009, SCIENCE, V324, P1557, DOI 10.1126/science.1176062; Garske T, 2009, BRIT MED J, V339, DOI 10.1136/bmj.b2840; Gentile D, 1998, CLIN DIAGN LAB IMMUN, V5, P604, DOI 10.1128/CDLI.5.5.604-608.1998; Gordon A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010364; Herzum I, 2010, CLIN CHEM LAB MED, V48, P53, DOI 10.1515/CCLM.2010.022; Itoh Y, 2009, NATURE, V460, P1021, DOI 10.1038/nature08260; Kamigaki T, 2009, PLOS CURR, V1; Kawachi S, 2011, J CLIN VIROL, V51, P68, DOI 10.1016/j.jcv.2011.01.007; Kiso M, 2004, LANCET, V364, P759, DOI 10.1016/S0140-6736(04)16934-1; Kiso M, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001079; Kok J, 2010, J CLIN MICROBIOL, V48, P290, DOI 10.1128/JCM.01465-09; Louie JK, 2010, EMERG INFECT DIS, V16, P824, DOI [10.3201/eid1605.091794, 10.3201/eid1605.091797]; Miyoshi-Akiyama T, 2010, J CLIN MICROBIOL, V48, P703, DOI 10.1128/JCM.02262-09; Mizuike R, 2011, CLIN VACCINE IMMUNOL, V18, P494, DOI 10.1128/CVI.00269-10; Mustaquim D., 2010, Morbidity and Mortality Weekly Report, V59, P901; Nalluswami Kumar, 2011, Morbidity and Mortality Weekly Report, V60, P1213; Neumann G, 2009, NATURE, V459, P931, DOI 10.1038/nature08157; Presanis AM, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000207; Rungrotmongkol T, 2009, BIOCHEM BIOPH RES CO, V385, P390, DOI 10.1016/j.bbrc.2009.05.066; Sugaya N, 2011, J INFECTION, V63, P288, DOI 10.1016/j.jinf.2011.06.008; Suntarattiwong P, 2010, PEDIATR INFECT DIS J, V29, P366, DOI 10.1097/INF.0b013e3181c6f05c; Tuite AR, 2010, CAN MED ASSOC J, V182, P128, DOI 10.1503/cmaj.091807; Vaillant L, 2009, EUROSURVEILLANCE, V14, P2; Vasoo S, 2009, CLIN INFECT DIS, V49, P1090, DOI 10.1086/644743; Watcharananan S, 2010, J INFECTION, V60, P86, DOI 10.1016/j.jinf.2009.10.049; WHO, 2010, WEEKLY EPIDEMIOLOGIC, V85, P3; Zhu HC, 2011, J VIROL, V85, P10432, DOI 10.1128/JVI.05352-11	34	14	15	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 30	2012	7	11							e50670	10.1371/journal.pone.0050670	http://dx.doi.org/10.1371/journal.pone.0050670			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	054WM	23226350	Green Published, gold, Green Submitted			2022-12-27	WOS:000312376100161
J	Zhao, DM; Liang, LB; Li, YB; Jiang, YP; Liu, LL; Chen, HL				Zhao, Dongming; Liang, Libin; Li, Yanbing; Jiang, Yongping; Liu, Liling; Chen, Hualan			Phylogenetic and Pathogenic Analyses of Avian Influenza A H5N1 Viruses Isolated from Poultry in Vietnam	PLOS ONE			English	Article							HONG-KONG; MOLECULAR-BASIS; VIRULENCE; HEMAGGLUTININ; EVOLUTION; CHINA; HUMANS; TRANSMISSION; EMERGENCE; MARKETS	Despite great efforts to control the infection of poultry with H5N1 viruses, these pathogens continue to evolve and spread in nature, threatening public health. Elucidating the characteristics of H5N1 avian influenza virus will benefit disease control and pandemic preparation. Here, we sequenced the genomes of 15 H5N1 avian influenza viruses isolated in Vietnam in 2006 and 2007 and performed phylogenetic analyses to compare these sequences with those of other viruses available in the public databases. Molecular characterization of the H5N1 viruses revealed that seven genetically distinct clades of H5N1 viruses have appeared in Vietnam. Clade 2.3.4 viruses existed in Vietnam as early as 2005. Fifteen viruses isolated during 2006 and 2007 belonged to clade 1 and clade 2.3.4, and were divided into five genotypes. Reassortants between the clade 1 and clade 2.3.4 viruses were detected in both North and South Vietnam. We also assessed the replication and pathogenicity of these viruses in mice and found that these isolates replicated efficiently and exhibited distinct virulence in mice. Our results provide important information regarding the diversity of H5N1 viruses in nature.	[Zhao, Dongming; Liang, Libin; Li, Yanbing; Jiang, Yongping; Liu, Liling; Chen, Hualan] Chinese Acad Agr Sci, Harbin Vet Res Inst, State Key Lab Vet Biotechnol, Harbin, Peoples R China	Chinese Academy of Agricultural Sciences; Harbin Veterinary Research Institute, CAAS	Chen, HL (corresponding author), Chinese Acad Agr Sci, Harbin Vet Res Inst, State Key Lab Vet Biotechnol, Harbin, Peoples R China.	hlchen1@yahoo.com		Li, Yanbing/0000-0002-0676-3709	NSFC [30825032]; 973 programs [2011CB505000, 2010CB534000]	NSFC(National Natural Science Foundation of China (NSFC)); 973 programs(National Basic Research Program of China)	This work was supported by the NSFC (30825032) (H. Chen), and the 973 programs (2011CB505000 and 2010CB534000) (H. Chen). The URLs of funders' websites are :http://www.nsfc.gov.cn/Portal0/default152.htm and http://www.973.gov.cn/AreaAppl.aspx. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barnett JM, 1999, VIROLOGY, V265, P286, DOI 10.1006/viro.1999.0058; Chen H, 2004, P NATL ACAD SCI USA, V101, P10452, DOI 10.1073/pnas.0403212101; Chen Y, 2010, VIROLOGY, V405, P15, DOI 10.1016/j.virol.2010.05.024; Cheung CL, 2006, J INFECT DIS, V193, P1626, DOI 10.1086/504723; Choi YK, 2005, J VIROL, V79, P10821, DOI 10.1128/JVI.79.16.10821-10825.2005; Davis CT, 2010, AVIAN DIS, V54, P307, DOI 10.1637/8801-040109-ResNote.1; DESHPANDE KL, 1987, P NATL ACAD SCI USA, V84, P36, DOI 10.1073/pnas.84.1.36; Fan SF, 2009, VIROLOGY, V384, P28, DOI 10.1016/j.virol.2008.11.044; Furuse Y, 2009, ANTIMICROB AGENTS CH, V53, P4457, DOI 10.1128/AAC.00650-09; Guan Y, 1999, P NATL ACAD SCI USA, V96, P9363, DOI 10.1073/pnas.96.16.9363; Hatta M, 2001, SCIENCE, V293, P1840, DOI 10.1126/science.1062882; HORIMOTO T, 1994, J VIROL, V68, P3120, DOI 10.1128/JVI.68.5.3120-3128.1994; Hurt AC, 2009, ANTIMICROB AGENTS CH, V53, P4433, DOI 10.1128/AAC.00334-09; Jiao PR, 2008, J VIROL, V82, P1146, DOI 10.1128/JVI.01698-07; Kuiken T, 2004, SCIENCE, V306, P241, DOI 10.1126/science.1102287; Le QM, 2010, J GEN VIROL, V91, P2485, DOI 10.1099/vir.0.021659-0; Lee VJ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008096; Li Y, 2006, ARCH VIROL, V151, P1615, DOI 10.1007/s00705-006-0738-7; Li YB, 2010, J VIROL, V84, P8389, DOI 10.1128/JVI.00413-10; Li ZJ, 2006, J VIROL, V80, P11115, DOI 10.1128/JVI.00993-06; Li ZJ, 2005, J VIROL, V79, P12058, DOI 10.1128/JVI.79.18.12058-12064.2005; Maines TR, 2005, J VIROL, V79, P11788, DOI 10.1128/JVI.79.18.11788-11800.2005; Nguyen DC, 2005, J VIROL, V79, P4201, DOI 10.1128/JVI.79.7.4201-4212.2005; Nguyen TD, 2008, EMERG INFECT DIS, V14, P632, DOI 10.3201/eid1404.071343; Nguyen T, 2009, VIROLOGY, V387, P250, DOI 10.1016/j.virol.2009.03.006; Pfeiffer J, 2009, VIRUS RES, V142, P108, DOI 10.1016/j.virusres.2009.01.019; Ping JH, 2008, BIOCHEM BIOPH RES CO, V371, P168, DOI 10.1016/j.bbrc.2008.04.045; REED L. J., 1938, AMER JOUR HYG, V27, P493; Smith GJD, 2006, P NATL ACAD SCI USA, V103, P16936, DOI 10.1073/pnas.0608157103; Smith GJD, 2009, P NATL ACAD SCI USA, V106, P11709, DOI 10.1073/pnas.0904991106; Smith GJD, 2009, NATURE, V459, P1122, DOI 10.1038/nature08182; Stevens J, 2006, SCIENCE, V312, P404, DOI 10.1126/science.1124513; Thanawongnuwech R, 2005, EMERG INFECT DIS, V11, P699, DOI 10.3201/eid1105.050007; Viboud C, 2006, PLOS MED, V3, P468, DOI 10.1371/journal.pmed.0030089; Vijaykrishna D, 2011, NATURE, V473, P519, DOI 10.1038/nature10004; Wan XF, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003462; Webster RG, 2002, J VIROL, V76, P118, DOI 10.1128/JVI.76.1.118-126.2002; Yamada S, 2006, NATURE, V444, P378, DOI 10.1038/nature05264; Yamada T, 2008, NATURE, V454, P162, DOI 10.1038/454162a	39	7	7	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 30	2012	7	11							e50959	10.1371/journal.pone.0050959	http://dx.doi.org/10.1371/journal.pone.0050959			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	054WM	23226433	Green Published, Green Submitted, gold			2022-12-27	WOS:000312376100244
J	Severance, EG; Kannan, G; Gressitt, KL; Xiao, JC; Alaedini, A; Pletnikov, MV; Yolken, RH				Severance, Emily G.; Kannan, Geetha; Gressitt, Kristin L.; Xiao, Jianchun; Alaedini, Armin; Pletnikov, Mikhail V.; Yolken, Robert H.			Anti-Gluten Immune Response following Toxoplasma gondii Infection in Mice	PLOS ONE			English	Article							CELIAC-DISEASE; GENE-EXPRESSION; INTESTINAL PERMEABILITY; GLIADIN PEPTIDES; DIETARY ANTIGENS; GUT PERMEABILITY; ORAL INFECTION; C57BL/6 MICE; SCHIZOPHRENIA; COMPLEMENT	Gluten sensitivity may affect disease pathogenesis in a subset of individuals who have schizophrenia, bipolar disorder or autism. Exposure to Toxoplasma gondii is a known risk factor for the development of schizophrenia, presumably through a direct pathological effect of the parasite on brain and behavior. A co-association of antibodies to wheat gluten and to T. gondii in individuals with schizophrenia was recently uncovered, suggesting a coordinated gastrointestinal means by which T. gondii and dietary gluten might generate an immune response. Here, we evaluated the connection between these infectious- and food-based antigens in mouse models. BALB/c mice receiving a standard wheat-based rodent chow were infected with T. gondii via intraperitoneal, peroral and prenatal exposure methods. Significant increases in the levels of anti-gluten IgG were documented in all infected mice and in offspring from chronically infected dams compared to uninfected controls ( repetitive measures ANOVAs, two-tailed t-tests, all p <= 0.00001). Activation of the complement system accompanied this immune response (p <= 0.002-0.00001). Perorally-infected females showed higher levels of anti-gluten IgG than males (p <= 0.009) indicating that T. gondii-generated gastrointestinal infection led to a significant anti-gluten immune response in a sex-dependent manner. These findings support a gastrointestinal basis by which two risk factors for schizophrenia, T. gondii infection and sensitivity to dietary gluten, might be connected to produce the immune activation that is becoming an increasingly recognized pathology of psychiatric disorders. Citation: Severance EG, Kannan G, Gressitt KL, Xiao J, Alaedini A, et al. (2012) Anti-Gluten Immune Response following Toxoplasma gondii Infection in Mice. PLoS ONE 7(11): e50991. doi:10.1371/journal.pone.0050991	[Severance, Emily G.; Gressitt, Kristin L.; Xiao, Jianchun; Yolken, Robert H.] Johns Hopkins Univ, Sch Med, Dept Pediat, Stanley Div Dev Neurovirol, Baltimore, MD 21205 USA; [Kannan, Geetha; Pletnikov, Mikhail V.] Johns Hopkins Univ, Sch Med, Dept Psychiat, Div Neurobiol, Baltimore, MD 21205 USA; [Alaedini, Armin] Columbia Univ, Dept Med, Med Ctr, New York, NY USA	Johns Hopkins University; Johns Hopkins University; Columbia University	Severance, EG (corresponding author), Johns Hopkins Univ, Sch Med, Dept Pediat, Stanley Div Dev Neurovirol, Baltimore, MD 21205 USA.	eseverance@jhmi.edu	Pletnikov, Mikhail V/G-8709-2012; yolken, robert/AAW-2556-2021	Pletnikov, Mikhail V/0000-0002-8819-6559; 	National Institute of Mental Health (NIMH) P50 Silvio O. Conte Center at Johns Hopkins [MH-94268]; Brain and Behavior Research Foundation; Scott-Gentle Foundation Young Investigator; Stanley Medical Research Institute; NATIONAL INSTITUTE OF MENTAL HEALTH [P50MH094268] Funding Source: NIH RePORTER	National Institute of Mental Health (NIMH) P50 Silvio O. Conte Center at Johns Hopkins; Brain and Behavior Research Foundation; Scott-Gentle Foundation Young Investigator; Stanley Medical Research Institute; NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This work was supported by a National Institute of Mental Health (NIMH) P50 Silvio O. Conte Center at Johns Hopkins (grant# MH-94268; http://www.nimh.nih.gov/); by the Brain and Behavior Research Foundation where Dr. Severance is a Scott-Gentle Foundation Young Investigator (http://bbrfoundation.org/); and by the Stanley Medical Research Institute (www.stanleyresearch.org/). These funders played no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alaedini A, 2005, ANN INTERN MED, V142, P289, DOI 10.7326/0003-4819-142-4-200502150-00011; Barrington R, 2001, IMMUNOL REV, V180, P5, DOI 10.1034/j.1600-065X.2001.1800101.x; Bereswill S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015099; Boulanger LM, 2009, NEURON, V64, P93, DOI 10.1016/j.neuron.2009.09.001; Collins SM, 2009, GASTROENTEROLOGY, V136, P2003, DOI 10.1053/j.gastro.2009.01.075; Craven M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041594; Dickerson F, 2011, BIPOLAR DISORD, V13, P52, DOI 10.1111/j.1399-5618.2011.00894.x; Dickerson F, 2010, BIOL PSYCHIAT, V68, P100, DOI 10.1016/j.biopsych.2010.03.021; Dohan F C, 1980, Adv Biochem Psychopharmacol, V22, P535; DOHAN FC, 1981, BIOL PSYCHIAT, V16, P1115; DOHAN FC, 1988, SCHIZOPHRENIA BULL, V14, P489, DOI 10.1093/schbul/14.4.489; DOHAN FC, 1970, LANCET, V1, P897; DOHAN FC, 1979, LANCET, V1, P1031, DOI 10.1016/S0140-6736(79)92780-6; Drago S, 2006, SCAND J GASTROENTERO, V41, P408, DOI 10.1080/00365520500235334; Drude S, 2011, LAB ANIMAL, V40, P119, DOI 10.1038/laban0411-119; Egan CE, 2012, IMMUNOL CELL BIOL, V90, P668, DOI 10.1038/icb.2011.93; Erridge C, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009125; Flegr J, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001389; FRANK MM, 1991, IMMUNOL TODAY, V12, P322, DOI 10.1016/0167-5699(91)90009-I; Gatkowska J, 2012, PARASITOL RES, V111, P53, DOI 10.1007/s00436-011-2800-y; Goodwin D, 2012, J PARASITOL, V98, P706, DOI 10.1645/GE-3068.1; Hand TW, 2012, SCIENCE, V337, P1553, DOI 10.1126/science.1220961; Heyman M, 2012, GUT, V61, P1355, DOI 10.1136/gutjnl-2011-300327; HUMPHREY JH, 1976, LANCET, V1, P800; Kannan G, 2010, FOLIA PARASIT, V57, P151, DOI 10.14411/fp.2010.019; Karlsson H, 2012, AM J PSYCHIAT, V169, P625, DOI 10.1176/appi.ajp.2012.11081197; Lambert GP, 2009, J ANIM SCI, V87, pE101, DOI 10.2527/jas.2008-1339; Lammers KM, 2008, GASTROENTEROLOGY, V135, P194, DOI 10.1053/j.gastro.2008.03.023; Lidar M, 2009, ANN NY ACAD SCI, V1173, P649, DOI 10.1111/j.1749-6632.2009.04641.x; Liesenfeld O, 2001, J PARASITOL, V87, P1491, DOI 10.1645/0022-3395(2001)087[1491:IOGASH]2.0.CO;2; Liesenfeld O, 2002, J INFECT DIS, V185, pS96, DOI 10.1086/338006; Liesenfeld O, 1999, IMMUNOBIOLOGY, V201, P229, DOI 10.1016/S0171-2985(99)80063-1; Matysiak-Budnik T, 2003, GASTROENTEROLOGY, V125, P696, DOI 10.1016/S0016-5085(03)01049-7; Menard S, 2012, AM J PATHOL, V180, P608, DOI 10.1016/j.ajpath.2011.10.019; Munoz M, 2011, IMMUNOL REV, V240, P269, DOI 10.1111/j.1600-065X.2010.00992.x; Munoz M, 2009, J EXP MED, V206, P3047, DOI 10.1084/jem.20090900; Nejad MR, 2011, AM J GASTROENTEROL, V106, P548, DOI 10.1038/ajg.2010.425; Rallabhandi P, 2012, J AOAC INT, V95, P349, DOI 10.5740/jaoacint.SGE_Rallabhandi; Reichelt KL, 1996, PROG NEURO-PSYCHOPH, V20, P1083, DOI 10.1016/S0278-5846(96)00099-1; Reichelt KL, 1998, SCHIZOPHR RES, V34, P211; REICHELT KL, 1995, J NEUROCHEM, V65, pS43; REICHELT KL, 1994, J NEUROCHEM, V63, pS86; REICHELT KL, 1991, BIOL PSYCHIAT, V29, P515, DOI 10.1016/0006-3223(91)90283-R; ROBERTS CW, 1995, INFECT IMMUN, V63, P2549, DOI 10.1128/IAI.63.7.2549-2555.1995; Samaroo D, 2010, SCHIZOPHR RES, V118, P248, DOI 10.1016/j.schres.2009.08.009; Sander GR, 2005, FEBS LETT, V579, P4851, DOI 10.1016/j.febslet.2005.07.066; Sapone A, 2011, BMC MED, V9, DOI 10.1186/1741-7015-9-23; Schreiner M, 2009, MEM I OSWALDO CRUZ, V104, P221, DOI 10.1590/S0074-02762009000200015; Severance EG, 2012, NEUROBIOL DIS, V48, P447, DOI 10.1016/j.nbd.2012.07.005; Severance EG, 2012, SCHIZOPHR RES, V138, P48, DOI 10.1016/j.schres.2012.02.025; Severance EG, 2010, BIPOLAR DISORD, V12, P834, DOI 10.1111/j.1399-5618.2010.00879.x; Severance EG, 2010, SCHIZOPHR RES, V118, P240, DOI 10.1016/j.schres.2009.12.030; Silva IA, 2005, DEV COMP IMMUNOL, V29, P171, DOI 10.1016/j.dci.2004.05.008; Soderholm JD, 2001, AM J PHYSIOL-GASTR L, V280, pG7, DOI 10.1152/ajpgi.2001.280.1.G7; Stevens B, 2007, CELL, V131, P1164, DOI 10.1016/j.cell.2007.10.036; Torrey EF, 2007, SCHIZOPHRENIA BULL, V33, P729, DOI 10.1093/schbul/sbl050; Torrey EF, 2012, SCHIZOPHRENIA BULL, V38, P642, DOI 10.1093/schbul/sbs043; Tripathi A, 2009, P NATL ACAD SCI USA, V106, P16799, DOI 10.1073/pnas.0906773106; Walport MJ, 2001, NEW ENGL J MED, V344, P1058, DOI 10.1056/NEJM200104053441406; Walport MJ, 2001, NEW ENGL J MED, V344, P1140, DOI 10.1056/NEJM200104123441506; Webster JP, 2007, SCHIZOPHRENIA BULL, V33, P752, DOI 10.1093/schbul/sbl073; Webster JP, 2010, FOLIA PARASIT, V57, P95, DOI 10.14411/fp.2010.012; Webster JP, 2001, MICROBES INFECT, V3, P1037, DOI 10.1016/S1286-4579(01)01459-9; Weight CM, 2012, ANN NY ACAD SCI, V1258, P135, DOI 10.1111/j.1749-6632.2012.06534.x; Whiteley P, 2010, NUTR NEUROSCI, V13, P87, DOI 10.1179/147683010X12611460763922; Wynne O, 2011, STRESS, V14, P247, DOI 10.3109/10253890.2010.532576; Xiao J, 2012, NEUROSCIENCE, V206, P39, DOI 10.1016/j.neuroscience.2011.12.051; Xiao JC, 2009, MICROBES INFECT, V11, P1011, DOI 10.1016/j.micinf.2009.07.007	68	22	23	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 29	2012	7	11							e50991	10.1371/journal.pone.0050991	http://dx.doi.org/10.1371/journal.pone.0050991			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	051DI	23209841	Green Published, gold, Green Submitted			2022-12-27	WOS:000312104900093
J	Brunstrom, JM; Burn, JF; Sell, NR; Collingwood, JM; Rogers, PJ; Wilkinson, LL; Hinton, EC; Maynard, OM; Ferriday, D				Brunstrom, Jeffrey M.; Burn, Jeremy F.; Sell, Nicola R.; Collingwood, Jane M.; Rogers, Peter J.; Wilkinson, Laura L.; Hinton, Elanor C.; Maynard, Olivia M.; Ferriday, Danielle			Episodic Memory and Appetite Regulation in Humans	PLOS ONE			English	Article							INFLUENCE FOOD-INTAKE; SNACK INTAKE; CHANGES EXPECTATIONS; ENERGY REGULATION; EATING BEHAVIOR; BODY-WEIGHT; MEAL; RATS; HIPPOCAMPUS; CONSUMPTION	Psychological and neurobiological evidence implicates hippocampal-dependent memory processes in the control of hunger and food intake. In humans, these have been revealed in the hyperphagia that is associated with amnesia. However, it remains unclear whether 'memory for recent eating' plays a significant role in neurologically intact humans. In this study we isolated the extent to which memory for a recently consumed meal influences hunger and fullness over a three-hour period. Before lunch, half of our volunteers were shown 300 ml of soup and half were shown 500 ml. Orthogonal to this, half consumed 300 ml and half consumed 500 ml. This process yielded four separate groups (25 volunteers in each). Independent manipulation of the 'actual' and 'perceived' soup portion was achieved using a computer-controlled peristaltic pump. This was designed to either refill or draw soup from a soup bowl in a covert manner. Immediately after lunch, self-reported hunger was influenced by the actual and not the perceived amount of soup consumed. However, two and three hours after meal termination this pattern was reversed - hunger was predicted by the perceived amount and not the actual amount. Participants who thought they had consumed the larger 500-ml portion reported significantly less hunger. This was also associated with an increase in the 'expected satiation' of the soup 24-hours later. For the first time, this manipulation exposes the independent and important contribution of memory processes to satiety. Opportunities exist to capitalise on this finding to reduce energy intake in humans.	[Brunstrom, Jeffrey M.; Burn, Jeremy F.; Sell, Nicola R.; Collingwood, Jane M.; Rogers, Peter J.; Wilkinson, Laura L.; Hinton, Elanor C.; Maynard, Olivia M.; Ferriday, Danielle] Univ Bristol, Sch Expt Psychol, Nutr & Behav Unit, Bristol, Avon, England	University of Bristol	Brunstrom, JM (corresponding author), Univ Bristol, Sch Expt Psychol, Nutr & Behav Unit, Bristol, Avon, England.	Jeff.Brunstrom@Bristol.ac.uk	Brunstrom, Jeffrey M/C-7892-2009; Maynard, Olivia/H-9233-2019; Brunstrom, Jeff/AAS-3433-2021	Brunstrom, Jeffrey M/0000-0003-4657-7799; Maynard, Olivia/0000-0002-9048-6627; Brunstrom, Jeff/0000-0003-4657-7799; Wilkinson, Laura/0000-0002-8093-0843; Hinton, Elanor/0000-0003-2793-8552; Ferriday, Dani/0000-0003-2665-0055	Biotechnology and Biological Sciences Research Council (United Kingdom); Diet and Health Research Industry Club (BSRC-DRINC) [BB/G005443/1]; Biotechnology and Biological Sciences Research Council [BB/G005443/1] Funding Source: researchfish; BBSRC [BB/G005443/1] Funding Source: UKRI	Biotechnology and Biological Sciences Research Council (United Kingdom)(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Diet and Health Research Industry Club (BSRC-DRINC); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This research was supported by a grant from the Biotechnology and Biological Sciences Research Council (United Kingdom) and it was awarded as part of the Diet and Health Research Industry Club (BSRC-DRINC, ref: BB/G005443/1). (http://www.bbsrc.ac.uk/home/home.aspx) The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Benoit SC, 2010, BRAIN RES, V1350, P71, DOI 10.1016/j.brainres.2010.06.009; Berthoud HR, 2004, PHYSIOL BEHAV, V81, P781, DOI 10.1016/j.physbeh.2004.04.034; Blundell J. E., 1987, FOOD ACCEPTANCE NUTR; BOOTH DA, 1992, P NUTR SOC, V51, P21, DOI 10.1079/PNS19920006; Brunstrom JM, 2011, APPETITE, V56, P310, DOI 10.1016/j.appet.2011.01.002; Brunstrom JM, 2010, APPETITE, V55, P25, DOI 10.1016/j.appet.2010.03.005; Brunstrom JM, 2010, APPETITE, V54, P587, DOI 10.1016/j.appet.2010.01.015; Brunstrom JM, 2009, OBESITY, V17, P1884, DOI 10.1038/oby.2009.201; Capaldi ED, 2006, APPETITE, V46, P117, DOI 10.1016/j.appet.2005.10.008; Cassady BA, 2012, AM J CLIN NUTR, V95, P587, DOI 10.3945/ajcn.111.025437; Cecil JE, 1998, APPETITE, V31, P377, DOI 10.1006/appe.1998.0177; Clifton PG, 1998, BEHAV NEUROSCI, V112, P502, DOI 10.1037/0735-7044.112.3.502; Davidson TL, 2007, CURR OPIN PHARMACOL, V7, P613, DOI 10.1016/j.coph.2007.10.008; DAVIDSON TL, 1993, BEHAV NEURAL BIOL, V59, P167, DOI 10.1016/0163-1047(93)90925-8; Davidson TL, 2005, OBES RES, V13, P537, DOI 10.1038/oby.2005.57; Davidson TL, 2004, INT J OBESITY, V28, P933, DOI 10.1038/sj.ijo.0802660; Davidson TL, 2005, PHYSIOL BEHAV, V86, P731, DOI 10.1016/j.physbeh.2005.09.004; Eichenbaum H, 2000, NAT REV NEUROSCI, V1, P41, DOI 10.1038/35036213; Farr SA, 2006, PEPTIDES, V27, P1420, DOI 10.1016/j.peptides.2005.10.006; Ferriday D., 2011, APPETITE S, V57, pS15; GELIEBTER A, 1988, PHYSIOL BEHAV, V44, P665, DOI 10.1016/0031-9384(88)90333-2; Gibson EL, 2006, PHYSIOL BEHAV, V89, P53, DOI 10.1016/j.physbeh.2006.01.024; Godden DR, 1975, BRIT J PSYCHOL, V66, P2044; Hardman CA, 2011, AM J CLIN NUTR, V94, P1196, DOI 10.3945/ajcn.111.016873; HEBBEN N, 1985, BEHAV NEUROSCI, V99, P1031, DOI 10.1037/0735-7044.99.6.1031; Hemmer P, 2009, PSYCHON B REV, V16, P80, DOI 10.3758/PBR.16.1.80; Higgs S, 2002, APPETITE, V39, P159, DOI 10.1006/appe.2002.0500; Higgs S, 2008, PSYCHOL SCI, V19, P623, DOI 10.1111/j.1467-9280.2008.02132.x; Higgs S, 2008, PHYSIOL BEHAV, V94, P454, DOI 10.1016/j.physbeh.2008.02.011; Higgs S, 2011, APPETITE, V57, P202, DOI 10.1016/j.appet.2011.04.016; Higgs S, 2009, APPETITE, V52, P39, DOI 10.1016/j.appet.2008.07.007; HINTZMAN DL, 1986, PSYCHOL REV, V93, P411, DOI 10.1037/0033-295X.93.4.411; Hogenkamp PS, 2011, APPETITE, V57, P635, DOI 10.1016/j.appet.2011.08.008; IRVINE MA, 2008, APPETITE, V51, P761; Kanoski SE, 2011, PHYSIOL BEHAV, V103, P59, DOI 10.1016/j.physbeh.2010.12.003; Kennedy PJ, 2004, J NEUROSCI, V24, P6979, DOI 10.1523/JNEUROSCI.1388-04.2004; KISSILEFF HR, 1982, ANNU REV NUTR, V2, P371, DOI 10.1146/annurev.nu.02.070182.002103; Moran TH, 2000, NUTRITION, V16, P858, DOI 10.1016/S0899-9007(00)00419-6; Morewedge CK, 2010, SCIENCE, V330, P1530, DOI 10.1126/science.1195701; O'Sullivan HL, 2010, AM J CLIN NUTR, V91, P1584, DOI 10.3945/ajcn.2009.28863; Oldham-Cooper RE, 2011, AM J CLIN NUTR, V93, P308, DOI 10.3945/ajcn.110.004580; Oliver G, 2000, PSYCHOSOM MED, V62, P853, DOI 10.1097/00006842-200011000-00016; Pliner P, 2007, APPETITE, V48, P278, DOI 10.1016/j.appet.2006.04.009; POCOCK SJ, 1975, BIOMETRICS, V31, P103, DOI 10.2307/2529712; Power ML, 2008, APPETITE, V50, P194, DOI 10.1016/j.appet.2007.10.006; Rorden C, 2004, NAT REV NEUROSCI, V5, P813, DOI 10.1038/nrn1521; Rozin P, 1998, PSYCHOL SCI, V9, P392, DOI 10.1111/1467-9280.00073; SCHACTER DL, 1987, J EXP PSYCHOL LEARN, V13, P501, DOI 10.1037/0278-7393.13.3.501; Speekenbrink M, 2010, J EXP PSYCHOL GEN, V139, P266, DOI 10.1037/a0018620; Swithers SE, 2006, INT J OBESITY, V30, P1685, DOI 10.1038/sj.ijo.0803329; Swithers SE, 2008, BEHAV NEUROSCI, V122, P161, DOI 10.1037/0735-7044.122.1.161; Swithers SE, 2011, BEHAV NEUROSCI, V125, P512, DOI 10.1037/a0024404; Tsai AG, 2011, OBES REV, V12, P50, DOI 10.1111/j.1467-789X.2009.00708.x; Turton AJ, NEUROPSYCHOL REHABIL, V20, P180; VANSTRIEN T, 1986, INT J EAT DISORDER, V5, P295, DOI 10.1002/1098-108X(198602)5:2<295::AID-EAT2260050209>3.0.CO;2-T; Wansink B, 2005, JAMA-J AM MED ASSOC, V293, P1727, DOI 10.1001/jama.293.14.1727; Wilkinson LL, 2009, APPETITE, V52, P780, DOI 10.1016/j.appet.2009.02.009; WOODS SC, 1991, PSYCHOL REV, V98, P488, DOI 10.1037/0033-295X.98.4.488; Woods SC, 2004, AM J PHYSIOL-GASTR L, V286, pG7, DOI 10.1152/ajpgi.00448.2003; WOOLEY OW, 1972, J COMP PHYSIOL PSYCH, V80, P250, DOI 10.1037/h0033069; WOOLEY SC, 1972, PSYCHOSOM MED, V34, P62, DOI 10.1097/00006842-197201000-00007; Zhao WQ, 2004, EUR J PHARMACOL, V490, P71, DOI 10.1016/j.ejphar.2004.02.045; Zijlstra N, 2009, AM J CLIN NUTR, V90, P269, DOI 10.3945/ajcn.2009.27694	63	81	81	0	76	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 5	2012	7	12							e50707	10.1371/journal.pone.0050707	http://dx.doi.org/10.1371/journal.pone.0050707			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	057TZ	23227200	Green Submitted, Green Published, gold			2022-12-27	WOS:000312588200059
J	James, RG; Davidson, KC; Bosch, KA; Biechele, TL; Robin, NC; Taylor, RJ; Major, MB; Camp, ND; Fowler, K; Martins, TJ; Moon, RT				James, Richard G.; Davidson, Kathryn C.; Bosch, Katherine A.; Biechele, Travis L.; Robin, Nicholas C.; Taylor, Russell J.; Major, Michael B.; Camp, Nathan D.; Fowler, Kerry; Martins, Timothy J.; Moon, Randall T.			WIKI4, a Novel Inhibitor of Tankyrase and Wnt/beta-Catenin Signaling	PLOS ONE			English	Article							EMBRYONIC STEM-CELLS; BETA-CATENIN; SULFATE PROTEOGLYCAN; MOUSE DEVELOPMENT; PATHWAY; ACTIVATION; DIFFERENTIATION; REGENERATION; REQUIREMENT; GROWTH	The Wnt/beta-catenin signaling pathway controls important cellular events during development and often contributes to disease when dysregulated. Using high throughput screening we have identified a new small molecule inhibitor of Wnt/beta-catenin signaling, WIKI4. WIKI4 inhibits expression of beta-catenin target genes and cellular responses to Wnt/beta-catenin signaling in cancer cell lines as well as in human embryonic stem cells. Furthermore, we demonstrate that WIKI4 mediates its effects on Wnt/beta-catenin signaling by inhibiting the enzymatic activity of TNKS2, a regulator of AXIN ubiquitylation and degradation. While TNKS has previously been shown to be the target of small molecule inhibitors of Wnt/beta-catenin signaling, WIKI4 is structurally distinct from previously identified TNKS inhibitors.	[James, Richard G.; Davidson, Kathryn C.; Bosch, Katherine A.; Biechele, Travis L.; Robin, Nicholas C.; Taylor, Russell J.; Camp, Nathan D.; Moon, Randall T.] Univ Washington, Dept Pharmacol, Seattle, WA 98195 USA; [James, Richard G.; Davidson, Kathryn C.; Bosch, Katherine A.; Biechele, Travis L.; Robin, Nicholas C.; Taylor, Russell J.; Camp, Nathan D.; Martins, Timothy J.; Moon, Randall T.] Inst Stem Cell & Regenerat Med, Seattle, WA USA; [Davidson, Kathryn C.; Bosch, Katherine A.; Biechele, Travis L.; Robin, Nicholas C.; Camp, Nathan D.; Moon, Randall T.] Howard Hughes Med Inst, Seattle, WA USA; [Martins, Timothy J.] Quellos High Throughput Screening Core, Seattle, WA USA; [James, Richard G.; Davidson, Kathryn C.; Bosch, Katherine A.; Biechele, Travis L.; Robin, Nicholas C.; Taylor, Russell J.; Camp, Nathan D.; Martins, Timothy J.; Moon, Randall T.] Univ Washington, Sch Med, Seattle, WA USA; [Major, Michael B.] Univ North Carolina Chapel Hill, Dept Cell & Dev Biol, Chapel Hill, NC USA; [Fowler, Kerry] KWF Consulting, Seattle, WA USA	University of Washington; University of Washington Seattle; Howard Hughes Medical Institute; University of Washington; University of Washington Seattle; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine	Moon, RT (corresponding author), Univ Washington, Dept Pharmacol, Seattle, WA 98195 USA.	rtmoon@uw.edu	Moon, Randall T/B-1743-2014; Moon, Randall/M-5605-2019	Moon, Randall T/0000-0002-9352-1408; Moon, Randall/0000-0002-9352-1408; Major, Michael/0000-0002-6753-8513; james, richard/0000-0002-2302-7367	National Institutes of Health (NIH) [PO1 GM081619, U01 HL100395]; NIH/National Heart, Lung, and Blood Institute K99/R00 grant [1K99HL103768-01]; NIH/National Institute of Arthritis and Musculoskeletal and Skin Diseases Training Grant [T32AR056969]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R00HL103768, U01HL100395, K99HL103768] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [T32AR056969] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P01GM081619] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH/National Heart, Lung, and Blood Institute K99/R00 grant; NIH/National Institute of Arthritis and Musculoskeletal and Skin Diseases Training Grant; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by the National Institutes of Health (NIH) grants PO1 GM081619 and U01 HL100395. RGJ was funded by the NIH/National Heart, Lung, and Blood Institute K99/R00 grant 1K99HL103768-01. TLB was funded in part through NIH/National Institute of Arthritis and Musculoskeletal and Skin Diseases Training Grant T32AR056969. RTM is an Investigator of the Howard Hughes Medical Institute. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Biechele TL, 2012, SCI SIGNAL, V5, DOI 10.1126/scisignal.2002274; Biechele TL, 2010, CHEM BIOL, V17, P1177, DOI 10.1016/j.chembiol.2010.08.012; Bilechele Travis L., 2008, V468, P99, DOI 10.1007/978-1-59745-249-6_8; Bone HK, 2011, J CELL SCI, V124, P1992, DOI 10.1242/jcs.081679; Callow MG, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022595; Chen BZ, 2009, NAT CHEM BIOL, V5, P100, DOI 10.1038/nchembio.137; Clevers H, 2006, CELL, V127, P469, DOI 10.1016/j.cell.2006.10.018; Clevers H, 2012, CELL, V149, P1192, DOI 10.1016/j.cell.2012.05.012; COOPER S, 1992, BIOCHEM J, V286, P959, DOI 10.1042/bj2860959; Cooper S, 2002, J ANAT, V200, P259, DOI 10.1046/j.1469-7580.2002.00034.x; Davidson KC, 2012, P NATL ACAD SCI USA, V109, P4485, DOI 10.1073/pnas.1118777109; de La Coste A, 1998, P NATL ACAD SCI USA, V95, P8847; Derksen PWB, 2004, P NATL ACAD SCI USA, V101, P6122, DOI 10.1073/pnas.0305855101; Dorsky RI, 2002, DEV BIOL, V241, P229, DOI 10.1006/dbio.2001.0515; Dutta-Simmons J, 2009, BLOOD, V114, P2699, DOI 10.1182/blood-2008-12-194290; Ge XL, 2012, MOL MED REP, V5, P1433, DOI 10.3892/mmr.2012.835; Gelebart P, 2008, BLOOD, V112, P5171, DOI 10.1182/blood-2008-02-139212; HAEGEL H, 1995, DEVELOPMENT, V121, P3529; Huang SMA, 2009, NATURE, V461, P614, DOI 10.1038/nature08356; Huelsken J, 2000, J CELL BIOL, V148, P567, DOI 10.1083/jcb.148.3.567; Irwin JJ, 2005, J CHEM INF MODEL, V45, P177, DOI 10.1021/ci049714+; Jho EH, 2002, MOL CELL BIOL, V22, P1172, DOI 10.1128/MCB.22.4.1172-1183.2002; Koesters R, 2003, J PATHOL, V199, P68, DOI 10.1002/path.1248; Li FQ, 2005, CURR NEUROVASC RES, V2, P331, DOI 10.2174/156720205774322557; Lickert H, 2002, DEV CELL, V3, P171, DOI 10.1016/S1534-5807(02)00206-X; Lipinski CA, 2001, ADV DRUG DELIVER REV, V46, P3, DOI 10.1016/S0169-409X(00)00129-0; Liu PT, 1999, NAT GENET, V22, P361, DOI 10.1038/11932; Lu DS, 2004, P NATL ACAD SCI USA, V101, P3118, DOI 10.1073/pnas.0308648100; Lustig B, 2002, MOL CELL BIOL, V22, P1184, DOI 10.1128/MCB.22.4.1184-1193.2002; MacDonald BT, 2009, DEV CELL, V17, P9, DOI 10.1016/j.devcel.2009.06.016; Major MB, 2008, SCI SIGNAL, V1, pra12; Major MB, 2007, SCIENCE, V316, P1043, DOI 10.1126/science/1141515; Maretto S, 2003, P NATL ACAD SCI USA, V100, P3299, DOI 10.1073/pnas.0434590100; Martin BL, 2012, DEV CELL, V22, P223, DOI 10.1016/j.devcel.2011.11.001; Meijer L, 2003, CHEM BIOL, V10, P1255, DOI 10.1016/j.chembiol.2003.11.010; Miyoshi Y, 1998, CANCER RES, V58, P2524; Moro E, 2012, DEV BIOL, V366, P327, DOI 10.1016/j.ydbio.2012.03.023; Muller-Tidow C, 2004, MOL CELL BIOL, V24, P2890, DOI 10.1128/MCB.24.7.2890-2904.2004; PERA MF, 1988, DIFFERENTIATION, V39, P139, DOI 10.1111/j.1432-0436.1988.tb00089.x; Roh H, 2001, CANCER RES, V61, P6563; Shimizu N, 2012, DEV BIOL; Stoick-Cooper CL, 2007, GENE DEV, V21, P1292, DOI 10.1101/gad.1540507; Tanaka SS, 2011, DEV GROWTH DIFFER, V53, P843, DOI 10.1111/j.1440-169X.2011.01292.x; Tian E, 2003, NEW ENGL J MED, V349, P2483, DOI 10.1056/NEJMoa030847; Waaler J, 2012, CANCER RES, V72, P2822, DOI 10.1158/0008-5472.CAN-11-3336; White BD, 2012, GASTROENTEROLOGY, V142, P219, DOI 10.1053/j.gastro.2011.12.001; Yoshikawa Y, 1997, DEV BIOL, V183, P234, DOI 10.1006/dbio.1997.8502; Zhang JH, 1999, J BIOMOL SCREEN, V4, P67, DOI 10.1177/108705719900400206; Zhang Y, 2011, NAT CELL BIOL, V13, P623, DOI 10.1038/ncb2222	49	71	74	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 5	2012	7	12							e50457	10.1371/journal.pone.0050457	http://dx.doi.org/10.1371/journal.pone.0050457			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	201YT	23227175	Green Published, Green Submitted, gold			2022-12-27	WOS:000323179700004
J	Kapfhamer, D; King, I; Zou, ME; Lim, JP; Heberlein, U; Wolf, FW				Kapfhamer, David; King, Ian; Zou, Mimi E.; Lim, Jana P.; Heberlein, Ulrike; Wolf, Fred W.			JNK Pathway Activation Is Controlled by Tao/TAOK3 to Modulate Ethanol Sensitivity	PLOS ONE			English	Article							N-TERMINAL-KINASE; DUAL-SPECIFICITY PHOSPHATASES; JUN NH2-TERMINAL KINASE; INDUCED CELL-DEATH; OXIDATIVE STRESS; PROTEIN-KINASE; INFLAMMATORY MEDIATORS; STE20-LIKE KINASE; INDUCED APOPTOSIS; ALCOHOL	Neuronal signal transduction by the JNK MAP kinase pathway is altered by a broad array of stimuli including exposure to the widely abused drug ethanol, but the behavioral relevance and the regulation of JNK signaling is unclear. Here we demonstrate that JNK signaling functions downstream of the Sterile20 kinase family gene tao/Taok3 to regulate the behavioral effects of acute ethanol exposure in both the fruit fly Drosophila and mice. In flies tao is required in neurons to promote sensitivity to the locomotor stimulant effects of acute ethanol exposure and to establish specific brain structures. Reduced expression of key JNK pathway genes substantially rescued the structural and behavioral phenotypes of tao mutants. Decreasing and increasing JNK pathway activity resulted in increased and decreased sensitivity to the locomotor stimulant properties of acute ethanol exposure, respectively. Further, JNK expression in a limited pattern of neurons that included brain regions implicated in ethanol responses was sufficient to restore normal behavior. Mice heterozygous for a disrupted allele of the homologous Taok3 gene (Taok3Gt) were resistant to the acute sedative effects of ethanol. JNK activity was constitutively increased in brains of Taok3Gt/+ mice, and acute induction of phospho-JNK in brain tissue by ethanol was occluded in Taok3Gt/+ mice. Finally, acute administration of a JNK inhibitor conferred resistance to the sedative effects of ethanol in wild-type but not Taok3Gt/+ mice. Taken together, these data support a role of a TAO/TAOK3-JNK neuronal signaling pathway in regulating sensitivity to acute ethanol exposure in flies and in mice.	[Kapfhamer, David; Zou, Mimi E.; Lim, Jana P.; Heberlein, Ulrike; Wolf, Fred W.] Univ Calif San Francisco, Ernest Gallo Clin, Emeryville, CA USA; [Kapfhamer, David; Zou, Mimi E.; Lim, Jana P.; Heberlein, Ulrike; Wolf, Fred W.] Univ Calif San Francisco, Res Ctr, Emeryville, CA USA; [King, Ian; Heberlein, Ulrike] Univ Calif San Francisco, Dept Anat, Program Neurosci, San Francisco, CA 94143 USA	University of California System; University of California San Francisco; Ernest Gallo Clinic & Research Center; University of California System; University of California San Francisco; University of California System; University of California San Francisco	Kapfhamer, D (corresponding author), Univ Calif San Francisco, Ernest Gallo Clin, Emeryville, CA USA.	dkapfhamer@gallo.ucsf.edu; fwolf@ucmerced.edu		King, Ian/0000-0003-3405-9767	National Institutes of Health/National Institute on Alcohol Abuse and Alcoholism Grant [P50 AA017072]; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [R01AA010035, P50AA017072] Funding Source: NIH RePORTER	National Institutes of Health/National Institute on Alcohol Abuse and Alcoholism Grant; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA))	This work was supported by National Institutes of Health/National Institute on Alcohol Abuse and Alcoholism Grant P50 AA017072 (FWW, UH). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aroor AR, 2010, ALCOHOL CLIN EXP RES, V34, P1543, DOI 10.1111/j.1530-0277.2010.01239.x; Aroor AR, 2004, LIFE SCI, V74, P2339, DOI 10.1016/j.lfs.2003.11.001; Bakal C, 2008, SCIENCE, V322, P453, DOI 10.1126/science.1158739; Bennett BL, 2001, P NATL ACAD SCI USA, V98, P13681, DOI 10.1073/pnas.251194298; Biernat J, 2002, MOL BIOL CELL, V13, P4013, DOI 10.1091/mbc.02-03-0046; Blanco AM, 2005, J IMMUNOL, V175, P6893, DOI 10.4049/jimmunol.175.10.6893; Boyce-Rustay JM, 2006, ALCOHOL CLIN EXP RES, V30, P1957, DOI 10.1111/j.1530-0277.2006.00241.x; Chen Z, 2001, J BIOL CHEM, V276, P16070, DOI 10.1074/jbc.M100681200; Collins CA, 2006, NEURON, V51, P57, DOI 10.1016/j.neuron.2006.05.026; Corl AB, 2005, NAT NEUROSCI, V8, P18, DOI 10.1038/nn1363; Corl AB, 2009, CELL, V137, P949, DOI 10.1016/j.cell.2009.03.020; Crabbe JC, 1996, NAT GENET, V14, P98, DOI 10.1038/ng0996-98; Cui SZ, 2011, ACTA PHARMACOL SIN, V32, P175, DOI 10.1038/aps.2010.199; Dan I, 2001, TRENDS CELL BIOL, V11, P220, DOI 10.1016/S0962-8924(01)01980-8; Das SK, 2007, LIFE SCI, V81, P177, DOI 10.1016/j.lfs.2007.05.005; Davies DL, 2013, ALCOHOL CLIN EXP RES, V37, P8, DOI 10.1111/j.1530-0277.2012.01846.x; de la Monte SM, 2000, ALCOHOL CLIN EXP RES, V24, P716, DOI 10.1097/00000374-200005000-00017; Downing C, 2003, GENES BRAIN BEHAV, V2, P140, DOI 10.1034/j.1601-183X.2003.00022.x; Eddison M, 2011, NEURON, V70, P979, DOI 10.1016/j.neuron.2011.03.030; Faccidomo S, 2009, PSYCHOPHARMACOLOGY, V204, P135, DOI 10.1007/s00213-008-1444-9; Fadda F, 1998, PROG NEUROBIOL, V56, P385, DOI 10.1016/S0301-0082(98)00032-X; Fee JR, 2004, ALCOHOL CLIN EXP RES, V28, P1459, DOI 10.1097/01.ALC.0000141809.53115.71; French RL, 2009, P NATL ACAD SCI USA, V106, P20924, DOI 10.1073/pnas.0910813106; Gao FB, 1999, GENE DEV, V13, P2549, DOI 10.1101/gad.13.19.2549; Gao YQ, 2005, J CEREBR BLOOD F MET, V25, P694, DOI 10.1038/sj.jcbfm.9600062; Gibson GE, 2002, NEUROCHEM INT, V40, P493, DOI 10.1016/S0197-0186(01)00120-6; Glise B, 1997, GENE DEV, V11, P1738, DOI 10.1101/gad.11.13.1738; Goodrich LV, 2008, NEURON, V60, P9, DOI 10.1016/j.neuron.2008.09.003; Han JY, 2008, J NEUROSCI RES, V86, P3221, DOI 10.1002/jnr.21759; Han JY, 2006, NEUROSCI LETT, V398, P113, DOI 10.1016/j.neulet.2005.12.065; Hogan B, 1994, MANIPULATING MOUSE E; Hutchison M, 1998, J BIOL CHEM, V273, P28625, DOI 10.1074/jbc.273.44.28625; Insolera R, 2011, DEV NEUROBIOL, V71, P483, DOI 10.1002/dneu.20867; Jeffrey KL, 2007, NAT REV DRUG DISCOV, V6, P391, DOI 10.1038/nrd2289; Johne C, 2008, MOL BIOL CELL, V19, P1391, DOI 10.1091/mbc.E07-07-0730; Jung ME, 2011, NEUROBIOL AGING, V32, P2266, DOI 10.1016/j.neurobiolaging.2010.01.005; Junttila MR, 2008, FASEB J, V22, P954, DOI 10.1096/fj.06-7859rev; Kapfhamer D, 2008, GENES BRAIN BEHAV, V7, P669, DOI 10.1111/j.1601-183X.2008.00404.x; Kapfhamer D., 2012, GENES BRAIN BEHAV; King Ian, 2011, Commun Integr Biol, V4, P554, DOI 10.4161/cib.4.5.16051; King I, 2011, J NEUROSCI, V31, P1139, DOI 10.1523/JNEUROSCI.4416-10.2011; Kolch W, 2005, FEBS LETT, V579, P1891, DOI 10.1016/j.febslet.2005.02.002; Kong EC, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009954; Kong EC, 2010, ALCOHOL CLIN EXP RES, V34, P302, DOI 10.1111/j.1530-0277.2009.01093.x; Krishna M, 2008, CELL MOL LIFE SCI, V65, P3525, DOI 10.1007/s00018-008-8170-7; Ku BM, 2007, NEUROSCI LETT, V419, P64, DOI 10.1016/j.neulet.2007.03.049; Lang R, 2006, J IMMUNOL, V177, P7497, DOI 10.4049/jimmunol.177.11.7497; Martin-Blanco E, 1998, GENE DEV, V12, P557, DOI 10.1101/gad.12.4.557; McAlhany RE, 2000, DEV BRAIN RES, V119, P209, DOI 10.1016/S0165-3806(99)00171-6; Milton VJ, 2012, DEV NEUROBIOL, V72, P100, DOI 10.1002/dneu.20957; Milton VJ, 2011, P NATL ACAD SCI USA, V108, P17521, DOI 10.1073/pnas.1014511108; Mitchell JM, 2012, PSYCHOPHARM BERL; Mitsopoulos C, 2003, J BIOL CHEM, V278, P18085, DOI 10.1074/jbc.M213064200; Mitsuyama K, 2006, CLIN EXP IMMUNOL, V143, P24, DOI 10.1111/j.1365-2249.2005.02959.x; Moore TM, 2000, J BIOL CHEM, V275, P4311, DOI 10.1074/jbc.275.6.4311; Morean ME, 2010, ALCOHOL CLIN EXP RES, V34, P385, DOI 10.1111/j.1530-0277.2009.01103.x; Naassila M, 2004, NEUROPHARMACOLOGY, V46, P243, DOI 10.1016/j.neuropharm.2003.09.002; Naassila M, 2002, J NEUROSCI, V22, P10487; Nagata H, 2009, HEPATOLOGY, V49, P1944, DOI 10.1002/hep.22860; Newton PM, 2007, BEHAV NEUROSCI, V121, P439, DOI 10.1037/0735-7044.121.2.439; Ng J, 2012, DEVELOPMENT, V139, P165, DOI 10.1242/dev.068668; Nutt DJ, 2010, LANCET, V376, P1558, DOI 10.1016/S0140-6736(10)61462-6; Offenhauser N, 2006, CELL, V127, P213, DOI 10.1016/j.cell.2006.09.011; Palmer AA, 2004, PSYCHOPHARMACOLOGY, V176, P386, DOI 10.1007/s00213-004-1896-5; Pascual M, 2003, J NEUROCHEM, V87, P1535, DOI 10.1046/j.1471-4159.2003.02130.x; Patterson KI, 2009, BIOCHEM J, V418, P475, DOI 10.1042/BJ20082234; Peng JS, 2009, J NEUROSCI, V29, P8408, DOI 10.1523/JNEUROSCI.0714-09.2009; Pfeiffer BD, 2010, GENETICS, V186, P735, DOI 10.1534/genetics.110.119917; Radwanska K, 2008, NEUROPSYCHOPHARMACOL, V33, P1835, DOI 10.1038/sj.npp.1301567; Rallis A, 2010, DEV BIOL, V339, P65, DOI 10.1016/j.ydbio.2009.12.016; Ren J, 2009, TOXICOL LETT, V187, P149, DOI 10.1016/j.toxlet.2009.02.019; RiesgoEscovar JR, 1996, GENE DEV, V10, P2759, DOI 10.1101/gad.10.21.2759; Sahara N, 2008, EUR J NEUROSCI, V27, P2897, DOI 10.1111/j.1460-9568.2008.06258.x; Sanchez-Alvarez L, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002257; SCHUCKIT MA, 1994, AM J PSYCHIAT, V151, P184; SEGER R, 1995, FASEB J, V9, P726, DOI 10.1096/fasebj.9.9.7601337; Sluss HK, 1996, GENE DEV, V10, P2745, DOI 10.1101/gad.10.21.2745; Srahna M, 2006, PLOS BIOL, V4, P2076, DOI 10.1371/journal.pbio.0040348; Sun TQ, 2001, NAT CELL BIOL, V3, P628, DOI 10.1038/35083016; Takahama K, 2012, BIOCHEM BIOPH RES CO, V417, P807, DOI 10.1016/j.bbrc.2011.12.040; Takamura M, 2007, LIFE SCI, V80, P1335, DOI 10.1016/j.lfs.2006.12.034; Tao H, 2011, AM J HUM GENET, V88, P138, DOI 10.1016/j.ajhg.2010.12.012; Tassi E, 1999, J BIOL CHEM, V274, P33287, DOI 10.1074/jbc.274.47.33287; Timm T, 2003, EMBO J, V22, P5090, DOI 10.1093/emboj/cdg447; Valles SL, 2004, BRAIN PATHOL, V14, P365; Villegas SN, 2006, BRAIN RES BULL, V71, P116, DOI 10.1016/j.brainresbull.2006.08.014; Wagle M, 2011, J NEUROSCI, V31, P214, DOI 10.1523/JNEUROSCI.3339-10.2011; Wang JW, 2007, J NEUROSCI, V27, P574, DOI 10.1523/JNEUROSCI.5094-06.2007; Weber U, 2000, DEVELOPMENT, V127, P3619; Wetzel MK, 2008, NEURON, V59, P708, DOI 10.1016/j.neuron.2008.07.021; Wilkinson MB, 2011, J NEUROSCI, V31, P9084, DOI 10.1523/JNEUROSCI.0039-11.2011; Wolf FW, 2002, J NEUROSCI, V22, P11035; Xia Y, 2004, TRENDS CELL BIOL, V14, P94, DOI 10.1016/j.tcb.2003.12.005; Yasuda S, 2007, NEURON, V56, P456, DOI 10.1016/j.neuron.2007.08.020; Young CL, 2008, NEUROBIOL DIS, V31, P355, DOI 10.1016/j.nbd.2008.05.009; Yustein JT, 2003, ONCOGENE, V22, P6129, DOI 10.1038/sj.onc.1206605; Zihni C, 2006, J BIOL CHEM, V281, P7317, DOI 10.1074/jbc.M513769200	97	25	27	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 5	2012	7	12							e50594	10.1371/journal.pone.0050594	http://dx.doi.org/10.1371/journal.pone.0050594			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	057TZ	23227189	gold, Green Published, Green Submitted			2022-12-27	WOS:000312588200049
J	Wang, H; Chalovich, JM; Marriott, G				Wang, Hui; Chalovich, Joseph M.; Marriott, Gerard			Structural Dynamics of Troponin I during Ca2+-Activation of Cardiac Thin Filaments: A Multi-Site Forster Resonance Energy Transfer Study	PLOS ONE			English	Article							SKELETAL-MUSCLE; HYPERTROPHIC CARDIOMYOPATHY; TROPOMYOSIN POSITIONS; MYOSIN SUBFRAGMENT-1; COOPERATIVE BINDING; CRYSTAL-STRUCTURE; REGULATED ACTIN; C-TERMINUS; CONTRACTION; COMPLEX	A multi-site, steady-state Forster resonance energy transfer (FRET) approach was used to quantify Ca2+-induced changes in proximity between donor loci on human cardiac troponin I (cTnI), and acceptor loci on human cardiac tropomyosin (cTm) and F-actin within functional thin filaments. A fluorescent donor probe was introduced to unique and key cysteine residues on the C- and N-termini of cTnI. A FRET acceptor probe was introduced to one of three sites located on the inner or outer domain of F-actin, namely Cys-374 and the phalloidin-binding site on F-actin, and Cys-190 of cTm. Unlike earlier FRET analyses of protein dynamics within the thin filament, this study considered the effects of non-random distribution of dipoles for the donor and acceptor probes. The major conclusion drawn from this study is that Ca2+ and myosin S1-binding to the thin filament results in movement of the C-terminal domain of cTnI from the outer domain of F-actin towards the inner domain, which is associated with the myosin-binding. A hinge-linkage model is used to best-describe the finding of a Ca2+-induced movement of the C-terminus of cTnI with a stationary N-terminus. This dynamic model of the activation of the thin filament is discussed in the context of other structural and biochemical studies on normal and mutant cTnI found in hypertrophic cardiomyopathies. Citation: Wang H, Chalovich JM, Marriott G (2012) Structural Dynamics of Troponin I during Ca2+-Activation of Cardiac Thin Filaments: A Multi-Site Forster Resonance Energy Transfer Study. PLoS ONE 7(12): e50420. doi:10.1371/journal.pone.0050420	[Wang, Hui] Univ N Carolina, Sch Med, Dept Pharmacol, Chapel Hill, NC USA; [Chalovich, Joseph M.] E Carolina Univ, Brody Sch Med, Dept Biochem & Mol Biol, Greenville, NC USA; [Marriott, Gerard] Univ Calif Berkeley, Dept Bioengn, Berkeley, CA 94720 USA	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine; University of North Carolina; East Carolina University; University of California System; University of California Berkeley	Marriott, G (corresponding author), Univ Calif Berkeley, Dept Bioengn, Berkeley, CA 94720 USA.	marriott1@berkeley.edu	Wang, Hui/A-2312-2012	Chalovich, Joseph/0000-0002-1243-4055; Marriott, Gerard/0000-0003-3197-4839	National Institutes of Health [HLO69970, AR40540]; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR040540] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	This work was supported by National Institutes of Health (HLO69970 awarded to GM and AR40540 to JC). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bacchiocchi C, 2002, BIOPHYS J, V82, P1524, DOI 10.1016/S0006-3495(02)75505-7; CHALOVICH JM, 1992, PHARMACOL THERAPEUT, V55, P95, DOI 10.1016/0163-7258(92)90013-P; Craig R, 2001, J MOL BIOL, V311, P1027, DOI 10.1006/jmbi.2001.4897; DALE RE, 1974, BIOPOLYMERS, V13, P1573, DOI 10.1002/bip.1974.360130807; Dale RE, 1975, BIOCH FLUORESCENCE C, P115; Dong WJ, 2008, J BIOL CHEM, V283, P3424, DOI 10.1074/jbc.M703822200; Dong WJ, 2007, BIOCHEMISTRY-US, V46, P9752, DOI 10.1021/bi700574n; Dong WJ, 2006, ARCH BIOCHEM BIOPHYS, V456, P135, DOI 10.1016/j.abb.2006.08.007; Elliott K, 2000, J BIOL CHEM, V275, P22069, DOI 10.1074/jbc.M002502200; FARAH CS, 1995, FASEB J, V9, P755, DOI 10.1096/fasebj.9.9.7601340; Franklin AJ, 2012, BIOPHYS J, V102, P2536, DOI 10.1016/j.bpj.2012.04.037; Gafurov B, 2004, BIOCHEMISTRY-US, V43, P15276, DOI 10.1021/bi048646h; GAGNE SM, 1995, NAT STRUCT BIOL, V2, P784, DOI 10.1038/nsb0995-784; GREASER ML, 1971, J BIOL CHEM, V246, P4226; GREENE LE, 1980, P NATL ACAD SCI-BIOL, V77, P2616, DOI 10.1073/pnas.77.5.2616; HEIDECKER M, 1995, BIOCHEMISTRY-US, V34, P11017, DOI 10.1021/bi00035a007; HERZBERG O, 1985, NATURE, V313, P653, DOI 10.1038/313653a0; HERZBERG O, 1986, J BIOL CHEM, V261, P2638; Holmes KC, 2003, NATURE, V425, P423, DOI 10.1038/nature02005; Huxley H. E., 1972, COLD SPRING HARB SYM, V37, P361; Kimura A, 1997, NAT GENET, V16, P379, DOI 10.1038/ng0897-379; KODAMA T, 1986, J BIOCHEM-TOKYO, V99, P1465, DOI 10.1093/oxfordjournals.jbchem.a135616; Lakowicz J.R., 2006, PRINCIPLES FLUORESCE; LEAVIS PC, 1984, CRC CR REV BIOCH MOL, V16, P235, DOI 10.3109/10409238409108717; MARRIOTT G, 1988, BIOCHEMISTRY-US, V27, P6214, DOI 10.1021/bi00417a004; Marston SB, 2011, J CARDIOVASC TRANSL, V4, P245, DOI 10.1007/s12265-011-9266-2; MCKILLOP DFA, 1993, BIOPHYS J, V65, P693, DOI 10.1016/S0006-3495(93)81110-X; Miki M, 1998, J BIOCHEM-TOKYO, V123, P1104; Miki M, 2004, J BIOCHEM, V136, P39, DOI 10.1093/jb/mvh090; Miki M, 1998, J BIOCHEM-TOKYO, V123, P324; Miki M, 1990, EUR J BIOCH, V187, P155; Miki Masao, 2002, Results Probl Cell Differ, V36, P191; Munoz-Losa A, 2009, BIOPHYS J, V96, P4779, DOI 10.1016/j.bpj.2009.03.052; Murakami K, 2005, J MOL BIOL, V352, P178, DOI 10.1016/j.jmb.2005.06.067; Oda T, 2009, NATURE, V457, P441, DOI 10.1038/nature07685; Otterbein LR, 2001, SCIENCE, V293, P708, DOI 10.1126/science.1059700; Pirani A, 2006, J MOL BIOL, V357, P707, DOI 10.1016/j.jmb.2005.12.050; POTTER JD, 1982, METHOD ENZYMOL, V85, P241; Rarick HM, 1997, J BIOL CHEM, V272, P26887, DOI 10.1074/jbc.272.43.26887; ROBERTSON SP, 1982, J BIOL CHEM, V257, P260; She MD, 1998, J MOL BIOL, V281, P445, DOI 10.1006/jmbi.1998.1933; Solaro RJ, 2008, BIOCHEM BIOPH RES CO, V369, P82, DOI 10.1016/j.bbrc.2007.12.114; SUNDARALINGAM M, 1985, SCIENCE, V227, P945, DOI 10.1126/science.3969570; Takahashi-Yanaga F, 2001, J MOL CELL CARDIOL, V33, P2095, DOI 10.1006/jmcc.2001.1473; Takeda S, 2003, NATURE, V424, P35, DOI 10.1038/nature01780; TAO T, 1989, BIOCHEMISTRY-US, V28, P5902, DOI 10.1021/bi00440a029; TAO T, 1983, BIOCHEMISTRY-US, V22, P3059, DOI 10.1021/bi00282a006; TAO T, 1990, SCIENCE, V247, P1339, DOI 10.1126/science.2138356; VanBeek DB, 2007, BIOPHYS J, V92, P4168, DOI 10.1529/biophysj.106.092650; Vassylyev DG, 1998, P NATL ACAD SCI USA, V95, P4847, DOI 10.1073/pnas.95.9.4847; Vinogradova MV, 2005, P NATL ACAD SCI USA, V102, P5038, DOI 10.1073/pnas.0408882102; WANG CK, 1986, J MOL BIOL, V191, P509, DOI 10.1016/0022-2836(86)90145-2; Wang H, 2008, BIOPHYS J, V94, P4358, DOI 10.1529/biophysj.107.121129; WEEDS AG, 1975, NATURE, V257, P54, DOI 10.1038/257054a0; Xing J, 2009, J BIOL CHEM, V284, P16432, DOI 10.1074/jbc.M808075200; Xing J, 2008, BIOCHEMISTRY-US, V47, P13383, DOI 10.1021/bi801492x; Xu C, 1999, BIOPHYS J, V77, P985, DOI 10.1016/S0006-3495(99)76949-3; Yan YL, 2003, METHOD ENZYMOL, V360, P561; ZOT AS, 1987, ANNU REV BIOPHYS BIO, V16, P535	59	2	2	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 5	2012	7	12							e50420	10.1371/journal.pone.0050420	http://dx.doi.org/10.1371/journal.pone.0050420			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	057TZ	23227172	Green Published, gold, Green Submitted			2022-12-27	WOS:000312588200033
J	Lee, H; Kim, DK; Oh, KH; Joo, KW; Kim, YS; Chae, DW; Kim, S; Chin, HJ				Lee, Hajeong; Kim, Dong Ki; Oh, Kook-Hwan; Joo, Kwon Wook; Kim, Yon Su; Chae, Dong-Wan; Kim, Suhnggwon; Chin, Ho Jun			Mortality of IgA Nephropathy Patients: A Single Center Experience over 30 Years	PLOS ONE			English	Article							PROGNOSIS; THERAPY	Research on the prognosis of IgA nephropathy (IgAN) has focused on renal survival, with little information being available on patient survival. Hence, this investigation aimed to explore long-term patient outcome in IgAN patients. Clinical and pathological characteristics at the time of renal biopsy were reviewed in 1,364 IgAN patients from 1979 to 2008. The outcomes were patient death and end stage renal disease (ESRD) progression. Overall, 71 deaths (5.3%) and 277 cases of ESRD (20.6%) occurred during 13,916 person-years. Ten-, 20-, and 30-year patient survival rates were 96.3%, 91.8%, and 82.7%, respectively. More than 50% patient deaths occurred without ESRD progression. Overall mortality was elevated by 43% from an age/sex-matched general population (GP) (standardized mortality ratio [SMR], 1.43; 95% confidence interval [CI], 1.04-1.92). Men had comparable mortality to GP (SMR, 1.22; 95% CI, 0.82-1.75), but, in women, the mortality rate was double (SMR, 2.17; 95% CI, 1.21-3.57). Patients with renal risk factors such as initial renal dysfunction (estimated glomerular filgration rate <60 ml/min per 1.73m(2); SMR, 1.70; 95% CI, 1.13-2.46), systolic blood pressure >= 140 mmHg (SMR, 1.88; 95% CI, 1.19-2.82) or proteinuria >= 1 g/day (SMR, 1.66; 95% CI, 1.16-2.29) had an elevated mortality rate. Patients with preserved renal function, normotension, and proteinuria <1 g/day, however, had a similar mortality rate to GP. When risk stratification was performed by counting the number of major risk factors present at diagnosis, low-risk IgAN patients had a mortality rate equal to that of GP, whereas high-risk patients had a mortality rate higher than that of GP. This investigation demonstrated that overall mortality in IgAN patients was higher than that of GP. Women and patients with renal risk factors had a higher mortality than that of GP, Therefore, strategies optimized to alleviate major renal risk factors are warranted to reduce patient mortality.	[Lee, Hajeong; Kim, Suhnggwon; Chin, Ho Jun] Seoul Natl Univ, Coll Med, Dept Immunol, Seoul, South Korea; [Lee, Hajeong; Kim, Dong Ki; Oh, Kook-Hwan; Joo, Kwon Wook; Kim, Yon Su; Kim, Suhnggwon] Seoul Natl Univ Hosp, Dept Internal Med, Seoul 110744, South Korea; [Joo, Kwon Wook; Kim, Yon Su; Chae, Dong-Wan; Kim, Suhnggwon; Chin, Ho Jun] Seoul Natl Univ Hosp, Kidney Res Inst, Seoul 110744, South Korea; [Chae, Dong-Wan; Chin, Ho Jun] Seoul Natl Univ, Bundang Hosp, Dept Internal Med, Songnam, South Korea	Seoul National University (SNU); Seoul National University (SNU); Seoul National University Hospital; Seoul National University (SNU); Seoul National University Hospital; Seoul National University (SNU)	Chin, HJ (corresponding author), Seoul Natl Univ, Coll Med, Dept Immunol, Seoul, South Korea.	mednep@snubh.org	Kim, Suhnggwon/J-5407-2012; Chin, Ho Jun/J-5678-2012; Kim, Dong Ki/J-5389-2012; Joo, Kwon Wook/J-5675-2012	Kim, Dong Ki/0000-0002-5195-7852; 				ALAMARTINE E, 1991, AM J KIDNEY DIS, V18, P12, DOI 10.1016/S0272-6386(12)80284-8; Bartosik LP, 2001, AM J KIDNEY DIS, V38, P728, DOI 10.1053/ajkd.2001.27689; Berthoux F, 2011, J AM SOC NEPHROL, V22, P752, DOI 10.1681/ASN.2010040355; BEUKHOF JR, 1986, KIDNEY INT, V29, P549, DOI 10.1038/ki.1986.33; Bjorneklett R, 2012, NEPHROL DIAL TRANSPL, V27, P1485, DOI 10.1093/ndt/gfr446; Chang JH, 2009, NEPHROL DIAL TRANSPL, V24, P2406, DOI 10.1093/ndt/gfp091; Collins Allan J, 2012, Am J Kidney Dis, V59, pe1, DOI 10.1053/j.ajkd.2011.11.015; D'Amico G, 2004, SEMIN NEPHROL, V24, P179, DOI 10.1016/j.semnephrol.2004.01.001; Donadio JV, 2002, NEW ENGL J MED, V347, P738, DOI 10.1056/NEJMra020109; Frimat L, 1997, NEPHROL DIAL TRANSPL, V12, P2569; Jin Dong Chan, 2011, Korean Journal of Internal Medicine, V26, P123, DOI 10.3904/kjim.2011.26.2.123; Kang SH, 2012, NEPHROL DIAL TRANSPL, V27, P252, DOI 10.1093/ndt/gfr295; Kim JK, 2012, CLIN J AM SOC NEPHRO, V7, P427, DOI 10.2215/CJN.04820511; Kim SY, 2003, NEPHROLOGY, V8, pS2, DOI 10.1046/j.1440-1797.8.s.5.x; Le WB, 2012, NEPHROL DIAL TRANSPL, V27, P1479, DOI 10.1093/ndt/gfr527; Myllymaki JM, 2007, KIDNEY INT, V71, P343, DOI 10.1038/sj.ki.5002046; Radford MG, 1997, J AM SOC NEPHROL, V8, P199; Shi SF, 2011, CLIN J AM SOC NEPHRO, V6, P2175, DOI 10.2215/CJN.11521210; Tsuboi N, 2010, CLIN J AM SOC NEPHRO, V5, P39, DOI 10.2215/CJN.04680709; ULM K, 1990, AM J EPIDEMIOL, V131, P373, DOI 10.1093/oxfordjournals.aje.a115507; Walsh M, 2010, CLIN J AM SOC NEPHRO, V5, P425, DOI 10.2215/CJN.06530909; Xie JY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038904	22	49	51	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 4	2012	7	12							e51225	10.1371/journal.pone.0051225	http://dx.doi.org/10.1371/journal.pone.0051225			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	051EQ	23226568	gold, Green Published, Green Submitted			2022-12-27	WOS:000312108500051
J	Zhao, DH; Xie, D; Zhou, HJ; Jiang, H; An, SQ				Zhao, Dehua; Xie, Dong; Zhou, Hengjie; Jiang, Hao; An, Shuqing			Estimation of Leaf Area Index and Plant Area Index of a Submerged Macrophyte Canopy Using Digital Photography	PLOS ONE			English	Article							SEAGRASS; ANGLE; LAI; PHOSPHORUS; PARTICLES; LAI-2000; SYSTEM; CROPS; WATER	Non-destructive estimation using digital cameras is a common approach for estimating leaf area index (LAI) of terrestrial vegetation. However, no attempt has been made so far to develop non-destructive approaches to LAI estimation for aquatic vegetation. Using the submerged plant species Potamogeton malainus, the objective of this study was to determine whether the gap fraction derived from vertical photographs could be used to estimate LAI of aquatic vegetation. Our results suggested that upward-oriented photographs taken from beneath the water surface were more suitable for distinguishing vegetation from other objects than were downward-oriented photographs taken from above the water surface. Exposure settings had a substantial influence on the identification of vegetation in upward-oriented photographs. Automatic exposure performed nearly as well as the optimal trial exposure, making it a good choice for operational convenience. Similar to terrestrial vegetation, our results suggested that photographs taken for the purpose of distinguishing gap fraction in aquatic vegetation should be taken under diffuse light conditions. Significant logarithmic relationships were observed between the vertical gap fraction derived from upward-oriented photographs and plant area index (PAI) and LAI derived from destructive harvesting. The model we developed to depict the relationship between PAI and gap fraction was similar to the modified theoretical Poisson model, with coefficients of 1.82 and 1.90 for our model and the theoretical model, respectively. This suggests that vertical upward-oriented photographs taken from below the water surface are a feasible alternative to destructive harvesting for estimating PAI and LAI for the submerged aquatic plant Potamogeton malainus. Citation: Zhao D, Xie D, Zhou H, Jiang H, An S (2012) Estimation of Leaf Area Index and Plant Area Index of a Submerged Macrophyte Canopy Using Digital Photography. PLoS ONE 7(12): e51034. doi: 10.1371/journal.pone.0051034	[Zhao, Dehua; Xie, Dong; Zhou, Hengjie; Jiang, Hao; An, Shuqing] Nanjing Univ, Dept Biol Sci & Technol, Nanjing, Jiangsu, Peoples R China	Nanjing University	Zhao, DH (corresponding author), Nanjing Univ, Dept Biol Sci & Technol, Nanjing, Jiangsu, Peoples R China.	dhzhao@nju.edu.cn			National Natural Science Foundation of China [31000226]; State Key Development Program for Basic Research of China [2008CB418004]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); State Key Development Program for Basic Research of China(State Key Development Program for Basic Research of China)	This research was supported by the National Natural Science Foundation of China (31000226), and the State Key Development Program for Basic Research of China (2008CB418004). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Armitage JM, 2008, ENVIRON SCI TECHNOL, V42, P4052, DOI 10.1021/es702439u; Babin M, 2003, J GEOPHYS RES-OCEANS, V108, DOI 10.1029/2001JC000882; Baret F, 2010, AGR FOREST METEOROL, V150, P1393, DOI 10.1016/j.agrformet.2010.04.011; BLINDOW I, 1993, FRESHWATER BIOL, V30, P159, DOI 10.1111/j.1365-2427.1993.tb00796.x; Bowers DG, 2006, ESTUAR COAST SHELF S, V67, P219, DOI 10.1016/j.ecss.2005.11.010; Breda NJJ, 2003, J EXP BOT, V54, P2403, DOI 10.1093/jxb/erg263; Brisson J, 2009, SCI TOTAL ENVIRON, V407, P3923, DOI 10.1016/j.scitotenv.2008.05.047; Camargo JA, 2011, ECOL INDIC, V11, P911, DOI 10.1016/j.ecolind.2010.10.001; CHEN JM, 1992, PLANT CELL ENVIRON, V15, P421, DOI 10.1111/j.1365-3040.1992.tb00992.x; Chen JM, 1997, J GEOPHYS RES-ATMOS, V102, P29429, DOI 10.1029/97JD01107; Cheng XY, 2006, CHINESE SCI BULL, V51, P1603, DOI 10.1007/s11434-006-2005-4; Demarez V, 2008, AGR FOREST METEOROL, V148, P644, DOI 10.1016/j.agrformet.2007.11.015; Dierberg FE, 2002, WATER RES, V36, P1409, DOI 10.1016/S0043-1354(01)00354-2; Dierssen HM, 2003, LIMNOL OCEANOGR, V48, P444, DOI 10.4319/lo.2003.48.1_part_2.0444; Doxaran D, 2009, LIMNOL OCEANOGR, V54, P1257, DOI 10.4319/lo.2009.54.4.1257; Franklin P, 2008, SCI TOTAL ENVIRON, V400, P369, DOI 10.1016/j.scitotenv.2008.06.018; Garriques S, 2008, AGR FOREST METEOROL, V148, P1193, DOI 10.1016/j.agrformet.2008.02.014; Graham EA, 2009, ENVIRON EXP BOT, V65, P238, DOI 10.1016/j.envexpbot.2008.09.013; Jonckheere I, 2004, AGR FOREST METEOROL, V121, P19, DOI 10.1016/j.agrformet.2003.08.027; Knight RL, 2003, ECOL ENG, V20, P45, DOI 10.1016/S0925-8574(03)00003-X; KUUSK A, 1995, REMOTE SENS ENVIRON, V51, P342, DOI 10.1016/0034-4257(94)00059-V; La Peyre MK, 2012, ESTUAR COAST SHELF S, V98, P108, DOI 10.1016/j.ecss.2011.12.010; LANG ARG, 1986, AUST J BOT, V34, P349, DOI 10.1071/BT9860349; Liu JG, 2010, AGR FOREST METEOROL, V150, P1485, DOI 10.1016/j.agrformet.2010.08.002; [刘伟龙 Liu Weilong], 2007, [生态学报, Acta Ecologica Sinica], V27, P159; Liu ZL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032155; Livingston RJ, 1998, AQUAT BOT, V60, P135, DOI 10.1016/S0304-3770(97)00079-X; Luisa EM, 2008, AGR FOREST METEOROL, V148, P1553, DOI 10.1016/j.agrformet.2008.05.005; Macfarlane C, 2007, AGR FOREST METEOROL, V143, P176, DOI 10.1016/j.agrformet.2006.10.013; Morisette JT, 2006, IEEE T GEOSCI REMOTE, V44, P1804, DOI 10.1109/TGRS.2006.872529; Nackaerts K, 2000, AGR FOREST METEOROL, V101, P247, DOI 10.1016/S0168-1923(00)00090-3; Nfon E, 2011, SCI TOTAL ENVIRON, V409, P5416, DOI 10.1016/j.scitotenv.2011.08.070; Pope RM, 1997, APPL OPTICS, V36, P8710, DOI 10.1364/AO.36.008710; Rosqvist K, 2010, AQUAT BOT, V93, P39, DOI 10.1016/j.aquabot.2010.03.002; Sakamoto T, 2012, AGR FOREST METEOROL, V154, P113, DOI 10.1016/j.agrformet.2011.10.014; van der Heide T, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016504; Vojtech E, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000499; WANG YP, 1988, AGR FOREST METEOROL, V43, P319, DOI 10.1016/0168-1923(88)90057-3; Weiss M, 2004, AGR FOREST METEOROL, V121, P37, DOI 10.1016/j.agrformet.2003.08.001; Yang CY, 2010, INT J REMOTE SENS, V31, P4595, DOI 10.1080/01431161.2010.485138; Yang DT, 2009, SENSORS-BASEL, V9, P830, DOI 10.3390/s90200830; Zhang YQ, 2005, AGR FOREST METEOROL, V133, P166, DOI 10.1016/j.agrformet.2005.09.009	42	5	5	1	40	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 4	2012	7	12							e51034	10.1371/journal.pone.0051034	http://dx.doi.org/10.1371/journal.pone.0051034			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	051EQ	23226557	gold, Green Published, Green Submitted			2022-12-27	WOS:000312108500040
J	Agdas, D; Webster, GD; Masters, FJ				Agdas, Duzgun; Webster, Gregory D.; Masters, Forrest J.			Wind Speed Perception and Risk	PLOS ONE			English	Article							MEDIATION; CRITERIA	Background: How accurately do people perceive extreme wind speeds and how does that perception affect the perceived risk? Prior research on human-wind interaction has focused on comfort levels in urban settings or knock-down thresholds. No systematic experimental research has attempted to assess people's ability to estimate extreme wind speeds and perceptions of their associated risks. Method: We exposed 76 people to 10, 20, 30, 40, 50, and 60 mph (4.5, 8.9, 13.4, 17.9, 22.3, and 26.8 m/s) winds in randomized orders and asked them to estimate wind speed and the corresponding risk they felt. Results: Multilevel modeling showed that people were accurate at lower wind speeds but overestimated wind speeds at higher levels. Wind speed perceptions mediated the direct relationship between actual wind speeds and perceptions of risk (i.e., the greater the perceived wind speed, the greater the perceived risk). The number of tropical cyclones people had experienced moderated the strength of the actual-perceived wind speed relationship; consequently, mediation was stronger for people who had experienced fewer storms. Conclusion: These findings provide a clearer understanding of wind and risk perception, which can aid development of public policy solutions toward communicating the severity and risks associated with natural disasters.	[Webster, Gregory D.] Univ Florida, Dept Psychol, Coll Liberal Arts & Sci, Gainesville, FL 32611 USA; [Agdas, Duzgun; Masters, Forrest J.] Univ Florida, Coll Engn, Engn Sch Sustainable Infrastruct & Environm, Gainesville, FL 32611 USA	State University System of Florida; University of Florida; State University System of Florida; University of Florida	Webster, GD (corresponding author), Univ Florida, Dept Psychol, Coll Liberal Arts & Sci, Gainesville, FL 32611 USA.	gdwebs@gmail.com	Masters, Forrest James/AAS-8723-2021; Agdas, Duzgun/E-2209-2014; Masters, Forrest J/D-1287-2011	Masters, Forrest James/0000-0001-8203-9846; Agdas, Duzgun/0000-0002-3703-914X; Masters, Forrest J/0000-0001-8203-9846	Federal Alliance for Safe Homes (FLASH); University of Florida	Federal Alliance for Safe Homes (FLASH); University of Florida(University of Florida)	The authors thank the Federal Alliance for Safe Homes (FLASH; http://www.flash.org) for supporting the research. Publication of this article was funded in part by the University of Florida Open-Access Publishing Fund. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aiken L. S., 1991, MULTIPLE REGRESSION; Bauer DJ, 2006, PSYCHOL METHODS, V11, P142, DOI 10.1037/1082-989X.11.2.142; Bottema M, 2000, BUILD ENVIRON, V35, P1, DOI 10.1016/S0360-1323(98)00065-1; Dow K., 2000, ENVIRON HAZARDS-UK, V2, P143, DOI [DOI 10.1016/S1464-2867(01)00014-6, 10.1016/S1464-2867(01)00014-6]; Horney JA, 2010, RISK ANAL, V30, P501, DOI 10.1111/j.1539-6924.2009.01341.x; Hunt J. C. R., 1976, BUILD ENVIRON, V11, P15, DOI [DOI 10.1016/0360-1323(76)90015-9, 10.1016/0360-1323(76)90015-9]; JACKSON PS, 1978, BUILD ENVIRON, V13, P251, DOI 10.1016/0360-1323(78)90016-1; Jordan SC, 2008, BUILD ENVIRON, V43, P1521, DOI 10.1016/j.buildenv.2007.08.004; MELBOURNE WH, 1978, J IND AERODYNAM, V3, P241, DOI 10.1016/0167-6105(78)90013-2; Muller D, 2005, J PERS SOC PSYCHOL, V89, P852, DOI 10.1037/0022-3514.89.6.852; MURAKAMI S, 1981, J WIND ENG IND AEROD, V7, P289, DOI 10.1016/0167-6105(81)90055-6; Muthen L.K., 2010, MPLUS USERS GUIDE; Nezlek J. B., 2011, MULTILEVEL MODELING; Peacock WG, 2005, LANDSCAPE URBAN PLAN, V73, P120, DOI 10.1016/j.landurbplan.2004.11.004; Penwarden AD, 1978, BUILD ENVIRON, V13, P75, DOI [DOI 10.1016/0360-1323(78)90026-4, 10.1016/0360-1323(78)90026-4]; Preacher KJ, 2010, PSYCHOL METHODS, V15, P209, DOI 10.1037/a0020141; Raudenbush SW, 2004, SSI; Raudenbush SW, 2002, HIERARCHICAL LINEAR; SLOVIC P, 1987, SCIENCE, V236, P280, DOI 10.1126/science.3563507; Stein RM, 2011, RISK PERCEPTIONS INF; Tobin G, 1999, GLOBAL ENV CHANGE B, V1, P13, DOI DOI 10.1016/S1464-2867(99)00002-9	21	19	19	2	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 30	2012	7	11							e49944	10.1371/journal.pone.0049944	http://dx.doi.org/10.1371/journal.pone.0049944			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	054WM	23226230	Green Published, gold, Green Submitted			2022-12-27	WOS:000312376100038
J	Choi, MY; Vander Meer, RK				Choi, Man-Yeon; Vander Meer, Robert K.			Ant Trail Pheromone Biosynthesis Is Triggered by a Neuropeptide Hormone	PLOS ONE			English	Article							PROTEIN-COUPLED RECEPTOR; ACTIVATING NEUROPEPTIDE; SOLENOPSIS-INVICTA; HELICOVERPA-ZEA; FIRE ANT; PBAN RECEPTOR; BOMBYX-MORI; DROSOPHILA-MELANOGASTER; ENDOCRINE REGULATION; HELIOTHIS-VIRESCENS	Our understanding of insect chemical communication including pheromone identification, synthesis, and their role in behavior has advanced tremendously over the last half-century. However, endocrine regulation of pheromone biosynthesis has progressed slowly due to the complexity of direct and/or indirect hormonal activation of the biosynthetic cascades resulting in insect pheromones. Over 20 years ago, a neurohormone, pheromone biosynthesis activating neuropeptide (PBAN) was identified that stimulated sex pheromone biosynthesis in a lepidopteran moth. Since then, the physiological role, target site, and signal transduction of PBAN has become well understood for sex pheromone biosynthesis in moths. Despite that PBAN-like peptides (similar to 200) have been identified from various insect Orders, their role in pheromone regulation had not expanded to the other insect groups except for Lepidoptera. Here, we report that trail pheromone biosynthesis in the Dufour's gland (DG) of the fire ant, Solenopsis invicta, is regulated by PBAN. RNAi knock down of PBAN gene (in subesophageal ganglia) or PBAN receptor gene (in DG) expression inhibited trail pheromone biosynthesis. Reduced trail pheromone was documented analytically and through a behavioral bioassay. Extension of PBAN's role in pheromone biosynthesis to a new target insect, mode of action, and behavioral function will renew research efforts on the involvement of PBAN in pheromone biosynthesis in Insecta. Citation: Choi M-Y, Vander Meer RK (2012) Ant Trail Pheromone Biosynthesis Is Triggered by a Neuropeptide Hormone. PLoS ONE 7(11): e50400. doi:10.1371/journal.pone.0050400				mychoi@ars.usda.gov; bob.vandermeer@ars.usda.gov		Choi, Man-yeon/0000-0003-0769-380X				Banks W.A., 1981, AATSS21 USDA SEA; BARLIN MR, 1976, J INSECT PHYSIOL, V22, P839, DOI 10.1016/0022-1910(76)90253-5; Ben Yosef T, 2009, J INSECT PHYSIOL, V55, P825, DOI 10.1016/j.jinsphys.2009.05.006; Billen Johan, 1998, P3; Blomquist GJ, 2010, INSECT BIOCHEM MOLEC, V40, P699, DOI 10.1016/j.ibmb.2010.07.013; Bober R, 2010, P NATL ACAD SCI USA, V107, P16858, DOI 10.1073/pnas.1008812107; Cazzamali G, 2005, BIOCHEM BIOPH RES CO, V335, P14, DOI 10.1016/j.bbrc.2005.07.038; Cheng YX, 2010, ARCH INSECT BIOCHEM, V75, P13, DOI 10.1002/arch.20379; Choi MY, 2009, INSECT MOL BIOL, V18, P161, DOI 10.1111/j.1365-2583.2009.00867.x; Choi MY, 2012, J INSECT PHYSIOL, V58, P1159, DOI 10.1016/j.jinsphys.2012.06.005; Choi MY, 2011, J INSECT PHYSIOL, V57, P161, DOI 10.1016/j.jinsphys.2010.10.008; Choi MY, 2010, ARCH INSECT BIOCHEM, V74, P67, DOI 10.1002/arch.20356; Choi MY, 2009, CELL TISSUE RES, V335, P431, DOI 10.1007/s00441-008-0721-6; Choi MY, 2003, P NATL ACAD SCI USA, V100, P9721, DOI 10.1073/pnas.1632485100; Hauser F, 2008, FRONT NEUROENDOCRIN, V29, P142, DOI 10.1016/j.yfrne.2007.10.003; Hauser F, 2006, PROG NEUROBIOL, V80, P1, DOI 10.1016/j.pneurobio.2006.07.005; Hewes RS, 2001, GENOME RES, V11, P1126, DOI 10.1101/gr.169901; HOLMAN GM, 1986, COMP BIOCHEM PHYS C, V85, P219, DOI 10.1016/0742-8413(86)90077-0; Homma T, 2006, BIOCHEM BIOPH RES CO, V344, P386, DOI 10.1016/j.bbrc.2006.03.085; Hull JJ, 2004, J BIOL CHEM, V279, P51500, DOI 10.1074/jbc.M408142200; JOUVENAZ DP, 1978, FLA ENTOMOL, V61, P244, DOI 10.2307/3494217; Jurenka R, 2004, TOP CURR CHEM, V239, P97, DOI 10.1007/b95450; Jurenka R, 2011, INSECT MOL BIOL, V20, P323, DOI 10.1111/j.1365-2583.2010.01065.x; Jurenka Russell, 2011, Front Endocrinol (Lausanne), V2, P46, DOI 10.3389/fendo.2011.00046; Kim YJ, 2008, PEPTIDES, V29, P268, DOI 10.1016/j.peptides.2007.12.001; KUNIYOSHI H, 1992, BIOSCI BIOTECH BIOCH, V56, P167, DOI 10.1271/bbb.56.167; Lee DW, 2011, INSECT BIOCHEM MOLEC, V41, P236, DOI 10.1016/j.ibmb.2011.01.001; MATSUMOTO S, 1990, J INSECT PHYSIOL, V36, P427, DOI 10.1016/0022-1910(90)90060-S; Ohnishi A, 2006, P NATL ACAD SCI USA, V103, P4398, DOI 10.1073/pnas.0511270103; Olsen SS, 2007, BIOCHEM BIOPH RES CO, V362, P245, DOI 10.1016/j.bbrc.2007.06.190; Park Y, 2002, P NATL ACAD SCI USA, V99, P11423, DOI 10.1073/pnas.162276199; Percy-Cunningham J.E., 1987, P27; Predel R, 2001, J INSECT PHYSIOL, V47, P287, DOI 10.1016/S0022-1910(00)00113-X; Rafaeli A, 2007, INSECT MOL BIOL, V16, P287, DOI 10.1111/j.1365-2583.2007.00725.x; Rafaeli A, 2009, GEN COMP ENDOCR, V162, P69, DOI 10.1016/j.ygcen.2008.04.004; Raina AK, 2003, ARCH INSECT BIOCHEM, V53, P147, DOI 10.1002/arch.10094; RAINA AK, 1989, SCIENCE, V244, P796, DOI 10.1126/science.244.4906.796; RAINA AK, 1984, SCIENCE, V225, P531, DOI 10.1126/science.225.4661.531; RAINA AK, 1992, INSECT BIOCHEM MOLEC, V22, P221, DOI 10.1016/0965-1748(92)90058-M; SUWAN S, 1994, INSECT BIOCHEM MOLEC, V24, P1001, DOI 10.1016/0965-1748(94)90137-6; Tillman JA, 1998, INSECT BIOCHEM MOLEC, V28, P705, DOI 10.1016/S0965-1748(97)00117-3; Tillman JA, 1999, INSECT BIOCHEM MOLEC, V29, P481, DOI 10.1016/S0965-1748(99)00016-8; Uehara H, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024213; van der Meer R.K., 1986, P201; WILSON EDWARD O., 1962, ANIMAL BEHAVIOR, V10, P134, DOI 10.1016/0003-3472(62)90141-0; WILSON EO, 1959, SCIENCE, V129, P643, DOI 10.1126/science.129.3349.643; Xu WH, 2003, INSECT MOL BIOL, V12, P509, DOI 10.1046/j.1365-2583.2003.00437.x; Zdarek J, 1997, ANN NY ACAD SCI, V814, P67, DOI 10.1111/j.1749-6632.1997.tb46145.x; Zheng L, 2007, GENE, V393, P20, DOI 10.1016/j.gene.2006.12.025	50	17	19	0	57	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 30	2012	7	11							e50400	10.1371/journal.pone.0050400	http://dx.doi.org/10.1371/journal.pone.0050400			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	054WM	23226278	gold, Green Published			2022-12-27	WOS:000312376100088
J	Condit, R; Chisholm, RA; Hubbell, SP				Condit, Richard; Chisholm, Ryan A.; Hubbell, Stephen P.			Thirty Years of Forest Census at Barro Colorado and the Importance of Immigration in Maintaining Diversity	PLOS ONE			English	Article							RELATIVE SPECIES ABUNDANCE; NEUTRAL THEORY; TROPICAL FOREST; COMMUNITY; NICHE; BIODIVERSITY; COEXISTENCE; TREE; PATTERNS; MODELS	The neutral theory of community ecology can predict diversity and abundances of tropical trees, but only under the assumption of steady input of new species into the community. Without input, diversity of a neutral community collapses, so the theory's predictions are not relevant unless novel species evolve or immigrate. We derive analytically the species input needed to maintain a target tree diversity, and find that a rate close to 1.0 x 10(-4) per recruit would maintain the observed diversity of 291 species in the Barro Colorado 50-ha tree plot in Panama. We then measured the rate empirically by comparing species present in one complete enumeration of the plot to those present five years later. Over six census intervals, the observed rate of input was 0.6 x 10(-4) to 1.8 x 10(-4) species per recruit, suggesting that there is adequate immigration of novel species to maintain diversity. Species interactions, niche partitioning, or density-dependence, while they may be present, do not appear to enhance tree species richness at Barro Colorado. Citation: Condit R, Chisholm RA, Hubbell SP (2012) Thirty Years of Forest Census at Barro Colorado and the Importance of Immigration in Maintaining Diversity. PLoS ONE 7(11): e49826. doi:10.1371/journal.pone.0049826	[Condit, Richard; Chisholm, Ryan A.; Hubbell, Stephen P.] Smithsonian Trop Res Inst, Panama City, Panama; [Hubbell, Stephen P.] Univ Calif Los Angeles, Deparment Ecol & Evolutionary Biol, Los Angeles, CA USA	Smithsonian Institution; Smithsonian Tropical Research Institute; University of California System; University of California Los Angeles	Condit, R (corresponding author), Smithsonian Trop Res Inst, Panama City, Panama.	conditr@gmail.com	Chisholm, Ryan/H-8033-2012	Chisholm, Ryan/0000-0002-9847-1710	Smithsonian Tropical Research Institute; Smithsonian Institution Global Earth Observatories; HSBC Climate Partnership; National Science Foundation [0948585]; Division Of Environmental Biology [1046113] Funding Source: National Science Foundation	Smithsonian Tropical Research Institute(Smithsonian InstitutionSmithsonian Tropical Research Institute); Smithsonian Institution Global Earth Observatories; HSBC Climate Partnership; National Science Foundation(National Science Foundation (NSF)); Division Of Environmental Biology(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	The Smithsonian Tropical Research Institute, Smithsonian Institution Global Earth Observatories, and HSBC Climate Partnership provided logistical and financial assistance, and the authors thank S. Davies, I. Rubino, and E. Bermingham for their support. The census has been supported by numerous grants from the National Science Foundation, most recently, no. 0948585. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adler PB, 2007, ECOL LETT, V10, P95, DOI 10.1111/j.1461-0248.2006.00996.x; Alonso D, 2004, ECOL LETT, V7, P901, DOI 10.1111/j.1461-0248.2004.00640.x; Alonso D, 2006, TRENDS ECOL EVOL, V21, P451, DOI 10.1016/j.tree.2006.03.019; Amarasekare P, 2001, AM NAT, V158, P572, DOI 10.1086/323586; ANGERMEIER PL, 1989, ECOLOGY, V70, P1450, DOI 10.2307/1938204; Chave J, 2006, NATURE, V441, pE1, DOI 10.1038/nature04826; Chave J, 2002, AM NAT, V159, P1, DOI 10.1086/324112; Chesson P, 2000, ANNU REV ECOL SYST, V31, P343, DOI 10.1146/annurev.ecolsys.31.1.343; Chisholm RA, 2011, THEOR ECOL-NETH, V4, P195, DOI 10.1007/s12080-011-0113-5; Chisholm RA, 2010, P NATL ACAD SCI USA, V107, P15821, DOI 10.1073/pnas.1009387107; Chust G, 2006, J VEG SCI, V17, P83, DOI 10.1111/j.1654-1103.2006.tb02426.x; Comita LS, 2010, SCIENCE, V329, P330, DOI 10.1126/science.1190772; Condit R, 2004, J TROP ECOL, V20, P51, DOI 10.1017/S0266467403001081; Condit R., 2005, BIOL SKRIFTER, V55, P57; Condit R, 1998, TROPICAL FOREST CENS; Conlisk J, 2010, OIKOS, V119, P379, DOI 10.1111/j.1600-0706.2009.17765.x; Croat T.B., 1978, FLORA BARRO COLORADO; Doncaster CP, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007460; Etienne RS, 2011, THEOR ECOL-NETH, V4, P87, DOI 10.1007/s12080-010-0076-y; Etienne RS, 2005, ECOL LETT, V8, P253, DOI 10.1111/j.1461-0248.2004.00717.x; Haegeman B, 2008, J THEOR BIOL, V252, P288, DOI 10.1016/j.jtbi.2008.01.023; Harrison S, 2008, ECOL LETT, V11, P969, DOI 10.1111/j.1461-0248.2008.01210.x; He FL, 2012, J PLANT ECOL, V5, P72, DOI 10.1093/jpe/rtr040; He FL, 2005, ECOLOGY, V86, P360, DOI 10.1890/04-1449; Hubbell S.P., 1983, TROPICAL RAIN FOREST, P25; Hubbell SP, 1986, CONSERVATION BIOL SC, P205; Hubbell Stephen P., 2001, V32, pi; Leibold MA, 2006, ECOLOGY, V87, P1399, DOI 10.1890/0012-9658(2006)87[1399:COTNAN]2.0.CO;2; Loreau M, 1999, AM NAT, V154, P427, DOI 10.1086/303252; Mouquet N, 2003, AM NAT, V162, P544, DOI 10.1086/378857; Mouquet N, 2002, AM NAT, V159, P420, DOI 10.1086/338996; Ostling A, 2012, THEOR ECOL-NETH, V5, P181, DOI 10.1007/s12080-010-0107-8; Paciorek CJ, 2000, J ECOL, V88, P765, DOI 10.1046/j.1365-2745.2000.00494.x; Rex MA, 2005, AM NAT, V165, P163, DOI 10.1086/427226; RICKLEFS RE, 1987, SCIENCE, V235, P167, DOI 10.1126/science.235.4785.167; Ricklefs RE, 2006, ECOLOGY, V87, P1424, DOI 10.1890/0012-9658(2006)87[1424:TUNTOB]2.0.CO;2; SHMIDA A, 1984, VEGETATIO, V58, P29; Tilman D, 2004, P NATL ACAD SCI USA, V101, P10854, DOI 10.1073/pnas.0403458101; Volkov I, 2005, NATURE, V438, P658, DOI 10.1038/nature04030; Volkov I, 2003, NATURE, V424, P1035, DOI 10.1038/nature01883; Volkov I, 2007, NATURE, V450, P45, DOI 10.1038/nature06197; Zillio T, 2007, OIKOS, V116, P931, DOI 10.1111/j.2007.0030-1299.15662.x	42	43	46	1	67	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 30	2012	7	11							e49826	10.1371/journal.pone.0049826	http://dx.doi.org/10.1371/journal.pone.0049826			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	054WM	23226222	gold, Green Submitted, Green Published			2022-12-27	WOS:000312376100030
J	Damasceno, EM; Monteiro, JC; Duboc, LF; Dolder, H; Mancini, K				Damasceno, Eduardo Medeiros; Monteiro, Juliana Castro; Duboc, Luiz Fernando; Dolder, Heidi; Mancini, Karina			Morphology of the Epidermis of the Neotropical Catfish Pimelodella lateristriga (Lichtenstein, 1823) with Emphasis in Club Cells	PLOS ONE			English	Article							ALARM SUBSTANCE CELLS; GYMNOCORYMBUS-TERNETZI CHARACIDAE; CENTRAL NERVOUS EXCITATION; DORSAL LIGHT RESPONSE; FATHEAD MINNOWS; PIMEPHALES-PROMELAS; CHANNEL CATFISH; FRIGHT REACTION; PREDATION RISK; FINE-STRUCTURE	The epidermis of Ostariophysi fish is composed of 4 main cell types: epidermal cells (or filament containing cells), mucous cells, granular cells and club cells. The morphological analysis of the epidermis of the catfish Pimelodella lateristriga revealed the presence of only two types of cells: epidermal and club cells. The latter were evident in the middle layer of the epidermis, being the largest cells within the epithelium. Few organelles were located in the perinuclear region, while the rest of the cytoplasm was filled with a non-vesicular fibrillar substance. Club cells contained two irregular nuclei with evident nucleoli and high compacted peripheral chromatin. Histochemical analysis detected prevalence of protein within the cytoplasm other than carbohydrates, which were absent. These characteristics are similar to those described to most Ostariophysi studied so far. On the other hand, the epidermal cells differ from what is found in the literature. The present study described three distinct types, as follows: superficial, abundant and dense cells. Differences among them were restricted to their cytoplasm and nucleus morphology. Mucous cells were found in all Ostariophysi studied so far, although they were absent in P. lateristriga, along with granular cells, also typical of other catfish epidermis. The preset study corroborates the observations on club cells' morphology in Siluriformes specimens, and shows important differences in epidermis composition and cell structure of P. lateristriga regarding the literature data.	[Damasceno, Eduardo Medeiros; Monteiro, Juliana Castro; Duboc, Luiz Fernando; Dolder, Heidi; Mancini, Karina] Univ Fed Espirito Santo, Ctr Univ No Espirito Santo, Dept Ciencias Agr & Biol, Sao Mateus, Espirito Santo, Brazil	Universidade Federal do Espirito Santo	Mancini, K (corresponding author), Univ Fed Espirito Santo, Ctr Univ No Espirito Santo, Dept Ciencias Agr & Biol, Sao Mateus, Espirito Santo, Brazil.	karinamancini@ceunes.ufes.br	Duboc, Luiz Fernando/G-5351-2012; Pirovani, Juliana Castro Monteiro/AAI-4917-2021; Duboc, Luiz Fernando/J-9522-2019	Duboc, Luiz Fernando/0000-0002-0405-4992; Pirovani, Juliana Castro Monteiro/0000-0002-4157-6503; Duboc, Luiz Fernando/0000-0003-1299-5212				AGRAWAL N, 1992, JPN J ICHTHYOL, V39, P93, DOI 10.1007/BF02905637; Al-Banaw A, 2010, ANAT HISTOL EMBRYOL, V39, P42, DOI 10.1111/j.1439-0264.2009.00977.x; ALHASSAN JM, 1987, J TOXICOL-TOXIN REV, V6, P1, DOI 10.3109/15569548709053860; Barbosa A, 2010, ACTA ETHOL, V13, P119, DOI 10.1007/s10211-010-0081-6; Bockmann F.A., 2003, CHECK LIST FRESHWATE, P406; Lizarazo RJB, 2008, REV BIOL TROP, V56, P885; Brown GE, 2001, J FISH BIOL, V58, P1465, DOI 10.1006/jfbi.2000.1541; Burgess WE., 1989, ATLAS FRESHWATER MAR; Chapman GB, 1997, J FISH BIOL, V51, P503, DOI 10.1111/j.1095-8649.1997.tb01508.x; Chivers DP, 1998, ECOSCIENCE, V5, P338, DOI 10.1080/11956860.1998.11682471; DOWNING SW, 1971, J ULTRA MOL STRUCT R, V35, P295, DOI 10.1016/S0022-5320(71)80159-4; Guerra RR, 2006, ANAT HISTOL EMBRYOL, V35, P144, DOI 10.1111/j.1439-0264.2005.00614.x; Halbgewachs CF, 2009, BIOL J LINN SOC, V98, P891, DOI 10.1111/j.1095-8312.2009.01328.x; Henrikson RC, 1968, J ULTRASTRUCT RES, V21, P222; IGER Y, 1990, J FISH BIOL, V36, P421, DOI 10.1111/j.1095-8649.1990.tb05622.x; Jung JA, 2011, ECOL FRESHW FISH, V20, P220, DOI 10.1111/j.1600-0633.2010.00481.x; Kats LB, 1998, ECOSCIENCE, V5, P361, DOI 10.1080/11956860.1998.11682468; LAWRENCE BJ, 1989, J CHEM ECOL, V15, P209, DOI 10.1007/BF02027783; Lutfy R. G., 1964, SCH AIN SHAMS SCI B, V10, P153; Malabarba L. R., 1998, PHYLOGENY CLASSIFICA; MITTAL AK, 1994, J FISH BIOL, V44, P857, DOI 10.1111/j.1095-8649.1994.tb01260.x; Nakamura O, 2001, DEV COMP IMMUNOL, V25, P431, DOI 10.1016/S0145-305X(01)00012-X; Park JY, 2010, J APPL ICHTHYOL, V26, P64, DOI 10.1111/j.1439-0426.2009.01354.x; Park JY, 2003, ENVIRON BIOL FISH, V66, P3, DOI 10.1023/A:1023298520696; PETERS N, 1990, INT REV GES HYDROBIO, V75, P257, DOI 10.1002/iroh.19900750211; PFEIFFER W, 1977, COPEIA, P653, DOI 10.2307/1443164; PFEIFFER W, 1962, BIOL REV, V37, P495, DOI 10.1111/j.1469-185X.1962.tb01472.x; PFEIFFER W, 1978, J COMP PHYSIOL, V123, P281, DOI 10.1007/BF00656882; PFEIFFER W, 1985, J CHEM ECOL, V11, P507, DOI 10.1007/BF00989562; PFEIFFER W, 1960, Z VERGL PHYSIOL, V43, P578, DOI 10.1007/BF00298105; PFEIFFER W, 1971, Z ZELLFORSCH MIK ANA, V118, P203, DOI 10.1007/BF00341564; Pfeiffer W., 1970, Anat. Anz., V126, P113; RALPHS JR, 1992, J FISH BIOL, V40, P473, DOI 10.1111/j.1095-8649.1992.tb02594.x; Smith ME, 2000, J CHEM ECOL, V26, P1635, DOI 10.1023/A:1005586812771; Smith R.J.F., 1992, Reviews in Fish Biology and Fisheries, V2, P33, DOI 10.1007/BF00042916; Smith RJF, 1997, P ROY SOC B-BIOL SCI, V264, P445, DOI 10.1098/rspb.1997.0063; SMITH RJF, 1976, CAN J ZOOL, V54, P1172, DOI 10.1139/z76-134; SOLOMON DJ, 1977, J FISH BIOL, V11, P363, DOI 10.1111/j.1095-8649.1977.tb04130.x; Stabell OB, 2010, J COMP PHYSIOL A, V196, P639, DOI 10.1007/s00359-010-0550-4; SUZUKI Y, 1986, DEV COMP IMMUNOL, V10, P509, DOI 10.1016/0145-305X(86)90172-2; Trajano E, 2004, COPEIA, P315; WHITEAR M, 1984, Z MIKROSK ANAT FORSC, V98, P481; Wisenden BD, 1997, J FISH BIOL, V50, P799, DOI 10.1111/j.1095-8649.1997.tb01973.x; Wisenden BD, 2008, ENVIRON BIOL FISH, V81, P141, DOI 10.1007/s10641-006-9181-6; Wisenden Brian D., 2000, P365; YOAKIM EG, 1982, J FISH BIOL, V20, P213, DOI 10.1111/j.1095-8649.1982.tb03921.x; ZACCONE G, 1990, HISTOCHEMISTRY, V93, P355, DOI 10.1007/BF00315850	48	7	7	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 30	2012	7	11							e50255	10.1371/journal.pone.0050255	http://dx.doi.org/10.1371/journal.pone.0050255			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	054WM	23226253	Green Published, gold, Green Submitted			2022-12-27	WOS:000312376100063
J	Diaz-Horta, O; Duman, D; Foster, J; Sirmaci, A; Gonzalez, M; Mahdieh, N; Fotouhi, N; Bonyadi, M; Cengiz, FB; Menendez, I; Ulloa, RH; Edwards, YJK; Zuchner, S; Blanton, S; Tekin, M				Diaz-Horta, Oscar; Duman, Duygu; Foster, Joseph, II; Sirmaci, Asli; Gonzalez, Michael; Mahdieh, Nejat; Fotouhi, Nikou; Bonyadi, Mortaza; Cengiz, Filiz Basak; Menendez, Ibis; Ulloa, Rick H.; Edwards, Yvonne J. K.; Zuechner, Stephan; Blanton, Susan; Tekin, Mustafa			Whole-Exome Sequencing Efficiently Detects Rare Mutations in Autosomal Recessive Nonsyndromic Hearing Loss	PLOS ONE			English	Article							DEAFNESS; POPULATION; FRAMEWORK; CAPTURE; GENES	Identification of the pathogenic mutations underlying autosomal recessive nonsyndromic hearing loss (ARNSHL) is difficult, since causative mutations in 39 different genes have so far been reported. After excluding mutations in the most common ARNSHL gene, GJB2, via Sanger sequencing, we performed whole-exome sequencing (WES) in 30 individuals from 20 unrelated multiplex consanguineous families with ARNSHL. Agilent SureSelect Human All Exon 50 Mb kits and an Illumina Hiseq2000 instrument were used. An average of 93%, 84% and 73% of bases were covered to 1X, 10X and 20X within the ARNSHL-related coding RefSeq exons, respectively. Uncovered regions with WES included those that are not targeted by the exome capture kit and regions with high GC content. Twelve homozygous mutations in known deafness genes, of which eight are novel, were identified in 12 families: MYO15A-p. Q1425X, -p.S1481P, -p.A1551D; LOXHD1-p.R1494X, -p.E955X; GIPC3-p.H170N; ILDR1-p.Q274X; MYO7A-p.G2163S; TECTA-p.Y1737C; TMC1-p.S530X; TMPRSS3-p.F13Lfs*10; TRIOBP-p.R785Sfs*50. Each mutation was within a homozygous run documented via WES. Sanger sequencing confirmed co-segregation of the mutation with deafness in each family. Four rare heterozygous variants, predicted to be pathogenic, in known deafness genes were detected in 12 families where homozygous causative variants were already identified. Six heterozygous variants that had similar characteristics to those abovementioned variants were present in 15 ethnically-matched individuals with normal hearing. Our results show that rare causative mutations in known ARNSHL genes can be reliably identified via WES. The excess of heterozygous variants should be considered during search for causative mutations in ARNSHL genes, especially in small-sized families.	[Diaz-Horta, Oscar; Foster, Joseph, II; Sirmaci, Asli; Gonzalez, Michael; Menendez, Ibis; Ulloa, Rick H.; Edwards, Yvonne J. K.; Zuechner, Stephan; Blanton, Susan; Tekin, Mustafa] Univ Miami, Miller Sch Med, John P Hussman Inst Human Genom, Miami, FL 33136 USA; [Diaz-Horta, Oscar; Foster, Joseph, II; Sirmaci, Asli; Gonzalez, Michael; Menendez, Ibis; Ulloa, Rick H.; Edwards, Yvonne J. K.; Zuechner, Stephan; Blanton, Susan; Tekin, Mustafa] Univ Miami, Miller Sch Med, Dr John T Macdonald Dept Human Genet, Miami, FL 33136 USA; [Duman, Duygu; Cengiz, Filiz Basak] Ankara Univ, Div Pediat Genet, Sch Med, TR-06100 Ankara, Turkey; Univ Tehran Med Sci, Growth & Dev Res Ctr, Tehran, Iran; [Fotouhi, Nikou; Bonyadi, Mortaza] Univ Tabriz, Fac Nat Sci, Ctr Excellence Biodivers, Tabriz, Iran	University of Miami; University of Miami; Ankara University; Tehran University of Medical Sciences; University of Tabriz	Tekin, M (corresponding author), Univ Miami, Miller Sch Med, John P Hussman Inst Human Genom, Miami, FL 33136 USA.	mtekin@med.miami.edu	Mahdieh, Nejat/J-1258-2014; Tekin, Mustafa/ABG-7627-2020; duman, duygu/AAF-8093-2020; Duman, Duygu/AAG-7765-2019; Blanton, Susan Halloran/ABF-1323-2021	Mahdieh, Nejat/0000-0002-8614-1538; duman, duygu/0000-0001-7583-0349; Bonyadi, Mortaza/0000-0003-3216-2947; Edwards, Yvonne/0000-0001-8505-3168; Tekin, Mustafa/0000-0002-3525-7960	National Institutes of Health - National Institute on Deafness and Other Communication Disorders [R01DC009645]; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC009645] Funding Source: NIH RePORTER	National Institutes of Health - National Institute on Deafness and Other Communication Disorders(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	This study was supported by National Institutes of Health - National Institute on Deafness and Other Communication Disorders grant R01DC009645 to MT. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adzhubei IA, 2010, NAT METHODS, V7, P248, DOI 10.1038/nmeth0410-248; American National Standards Institute, 2004, METH MAN PUR TON THR; Berezin C, 2004, BIOINFORMATICS, V20, P1322, DOI 10.1093/bioinformatics/bth070; Brownstein Z, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-9-r89; Cengiz FB, 2010, GENET TEST MOL BIOMA, V14, P543, DOI 10.1089/gtmb.2010.0039; DePristo MA, 2011, NAT GENET, V43, P491, DOI 10.1038/ng.806; Duman D, 2012, FRONT BIOSCI-LANDMRK, V17, P2213, DOI 10.2741/4046; Duman D, 2011, GENET TEST MOL BIOMA, V15, P29, DOI 10.1089/gtmb.2010.0120; Friedman TB, 2003, ANNU REV GENOM HUM G, V4, P341, DOI 10.1146/annurev.genom.4.070802.110347; Hildebrand MS, 2010, ANN OTO RHINOL LARYN, V119, P830, DOI 10.1177/000348941011901207; Janecke AR, 1999, HUM MUTAT, V13, P133, DOI 10.1002/(SICI)1098-1004(1999)13:2<133::AID-HUMU5>3.0.CO;2-U; Kumar P, 2009, NAT PROTOC, V4, P1073, DOI 10.1038/nprot.2009.86; Li H, 2010, BIOINFORMATICS, V26, P589, DOI 10.1093/bioinformatics/btp698; McKenna A, 2010, GENOME RES, V20, P1297, DOI 10.1101/gr.107524.110; Morton CC, 2006, NEW ENGL J MED, V354, P2151, DOI 10.1056/NEJMra050700; Ng SB, 2009, NATURE, V461, P272, DOI 10.1038/nature08250; Shearer AE, 2010, P NATL ACAD SCI USA, V107, P21104, DOI 10.1073/pnas.1012989107; Shearer AE, 2012, GENETICS ADV GENETIC; Sirmaci A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032000; Teer JK, 2010, HUM MOL GENET, V19, pR145, DOI 10.1093/hmg/ddq333; Walsh T, 2010, AM J HUM GENET, V87, P90, DOI 10.1016/j.ajhg.2010.05.010	21	117	122	0	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 30	2012	7	11							e50628	10.1371/journal.pone.0050628	http://dx.doi.org/10.1371/journal.pone.0050628			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	054WM	23226338	Green Published, gold, Green Submitted			2022-12-27	WOS:000312376100149
J	Huang, XF; Li, Y; Gu, YH; Liu, M; Xu, Y; Yuan, Y; Sun, F; Zhang, HQ; Shi, HJ				Huang, Xue-Feng; Li, Yan; Gu, Yi-Hua; Liu, Miao; Xu, Yan; Yuan, Yao; Sun, Fei; Zhang, Hui-Qin; Shi, Hui-Juan			The Effects of Di-(2-ethylhexyl)-phthalate Exposure on Fertilization and Embryonic Development In Vitro and Testicular Genomic Mutation In Vivo	PLOS ONE			English	Article							PHTHALIC-ACID ESTERS; OXIDATIVE STRESS; RISK-ASSESSMENT; HUMAN SPERM; DNA-DAMAGE; DI(2-ETHYLHEXYL) PHTHALATE; GENE-EXPRESSION; TRANSGENIC MICE; DEHP; RATS	The present study was undertaken to determine the reproductive hazards of Di-(2-ethylhexyl)-phthalate (DEHP) on mouse spermatozoa and embryos in vitro and genomic changes in vivo. Direct low-level DEHP exposure (1 mu g/ml) on spermatozoa and embryos was investigated by in vitro fertilization (IVF) process, culture of preimplanted embryos in DEHP-supplemented medium and embryo transfer to achieve full term development. Big Blue (R) transgenic mouse model was employed to evaluate the mutagenesis of testicular genome with in vivo exposure concentration of DEHP (500 mg/kg/day). Generally, DEHP-treated spermatozoa (1 mu g/ml, 30 min) presented reduced fertilization ability (P<0.05) and the resultant embryos had decreased developmental potential compared to DMSO controls (P<0.05). Meanwhile, the transferred 2-cell stage embryos derived from treated spermatozoa also exhibited decreased birth rate than that of control (P<0.05). When fertilized oocytes or 2-cell stage embryos were recovered by in vivo fertilization (without treatment) and then exposed to DEHP, the subsequent development proceed to blastocysts was different, fertilized oocytes were significantly affected (P<0.05) whereas developmental progression of 2-cell stage embryos was similar to controls (P>0.05). Testes of the Big Blue (R) transgenic mice treated with DEHP for 4 weeks indicated an approximately 3-fold increase in genomic DNA mutation frequency compared with controls (P<0.05). These findings unveiled the hazardous effects of direct low-level exposure of DEHP on spermatozoa's fertilization ability as well as embryonic development, and proved that in vivo DEHP exposure posed mutagenic risks in the reproductive organ - at least in testes, are of great concern to human male reproductive health.	[Huang, Xue-Feng; Liu, Miao; Xu, Yan; Zhang, Hui-Qin; Shi, Hui-Juan] Fudan Univ, Shanghai Med Coll, Shanghai 200433, Peoples R China; [Huang, Xue-Feng; Li, Yan] Wenzhou Med Coll, Affiliated Hosp 1, Reprod Med Ctr, Wenzhou, Peoples R China; [Gu, Yi-Hua; Yuan, Yao; Zhang, Hui-Qin; Shi, Hui-Juan] Shanghai Inst Planned Parenthood Res, Natl Populat & Family Planning Key Lab Contracept, Shanghai, Peoples R China; [Sun, Fei] Univ Sci & Technol China, Sch Life Sci, Reprod Biol Lab, Hefei 230026, Peoples R China	Fudan University; Wenzhou Medical University; Chinese Academy of Sciences; University of Science & Technology of China, CAS	Huang, XF (corresponding author), Fudan Univ, Shanghai Med Coll, Shanghai 200433, Peoples R China.	xuefhuang@hotmail.com; shihuijuan2011@163.com	Sun, Fei/N-2850-2013; Zhang, Hui/HHN-8494-2022		Major State Basic Research Development Program of China (973 Program) [2009CB941700]; National Natural Science Foundation of China [81270744]; National Comprehensive Programs of Reproductive Health and Family Planning [C1-93]; Shanghai Leading Academic Discipline Project [S30201]	Major State Basic Research Development Program of China (973 Program)(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Comprehensive Programs of Reproductive Health and Family Planning; Shanghai Leading Academic Discipline Project(Shanghai Leading Academic Discipline Project)	The research was supported by the grants as follows: the Major State Basic Research Development Program of China (973 Program, 2009CB941700), the grants from National Natural Science Foundation of China (81270744), Three National Comprehensive Programs of Reproductive Health and Family Planning (C1-93) and Shanghai Leading Academic Discipline Project (S30201). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ambruosi B, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027452; Arcadi FA, 1998, FOOD CHEM TOXICOL, V36, P963, DOI 10.1016/S0278-6915(98)00065-9; Boerrigter Michael ETI, 2004, J Carcinog, V3, P7, DOI 10.1186/1477-3163-3-7; Buettner VL, 1996, ONCOGENE, V13, P2407; Caldwell JC, 2012, MUTAT RES-REV MUTAT, V751, P82, DOI 10.1016/j.mrrev.2012.03.001; Caperton L, 2007, P NATL ACAD SCI USA, V104, P5085, DOI 10.1073/pnas.0611642104; Carnevali O, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010201; Christiansen S, 2010, REPROD TOXICOL, V30, P313, DOI 10.1016/j.reprotox.2010.04.005; Clark K, 2003, HANDB ENVIRON CHEM, V3, P227; Duty SM, 2003, ENVIRON HEALTH PERSP, V111, P1164, DOI 10.1289/ehp.5756; Duty SM, 2005, ENVIRON HEALTH PERSP, V113, P1530, DOI 10.1289/ehp.8083; Erkekoglu P, 2012, TOXICOL MECH METHOD, V22, P415, DOI 10.3109/15376516.2012.666652; Erkekoglu P, 2010, TOXICOL APPL PHARM, V248, P52, DOI 10.1016/j.taap.2010.07.016; Feige JN, 2010, ENVIRON HEALTH PERSP, V118, P234, DOI 10.1289/ehp.0901217; Han SW, 2009, J TOXICOL ENV HEAL A, V72, P1463, DOI 10.1080/15287390903212972; Hauser R, 2007, HUM REPROD, V22, P688, DOI 10.1093/humrep/del428; Heudorf U, 2007, INT J HYG ENVIR HEAL, V210, P623, DOI 10.1016/j.ijheh.2007.07.011; Hokanson R, 2006, HUM EXP TOXICOL, V25, P687, DOI 10.1177/0960327106071977; Huang LP, 2011, FERTIL STERIL, V96, P90, DOI 10.1016/j.fertnstert.2011.04.093; Huang PC, 2009, ENVIRON INT, V35, P14, DOI 10.1016/j.envint.2008.05.012; Jonsson BAG, 2005, EPIDEMIOLOGY, V16, P487, DOI 10.1097/01.ede.0000164555.19041.01; Kang ER, 2011, EPIGENETICS-US, V6, P937, DOI 10.4161/epi.6.7.16067; Kanki K, 2005, MOL CARCINOGEN, V42, P9, DOI 10.1002/mc.20061; Kasahara E, 2002, BIOCHEM J, V365, P849, DOI 10.1042/BJ20020254; KOHLER SW, 1991, P NATL ACAD SCI USA, V88, P7958, DOI 10.1073/pnas.88.18.7958; Koo HJ, 2004, J TOXICOL ENV HEAL A, V67, P1901, DOI 10.1080/15287390490513300; Kudo C, 2004, J NEUROCHEM, V88, P1416, DOI 10.1046/j.1471-4159.2003.02270.x; Kwack SJ, 2009, J TOXICOL ENV HEAL A, V72, P1446, DOI 10.1080/15287390903212923; Lagos-Cabre R, 2012, BIOL RES, V45, P5, DOI 10.4067/S0716-97602012000100001; LAMB JC, 1987, TOXICOL APPL PHARM, V88, P255, DOI 10.1016/0041-008X(87)90011-1; Lee J, 2004, TOXICOL LETT, V152, P1, DOI 10.1016/j.toxlet.2004.03.011; Maire MA, 2005, TOXICOL LETT, V158, P237, DOI 10.1016/j.toxlet.2005.04.004; Manjanatha MG, 2000, CARCINOGENESIS, V21, P265, DOI 10.1093/carcin/21.2.265; Manojkumar V, 1998, VOX SANG, V75, P139, DOI 10.1159/000030975; Matsumoto M, 2008, REGUL TOXICOL PHARM, V50, P37, DOI 10.1016/j.yrtph.2007.09.004; Miura Y, 2007, ASIAN J ANDROL, V9, P199, DOI 10.1111/j.1745-7262.2007.00220.x; Pant N, 2011, HUM EXP TOXICOL, V30, P507, DOI 10.1177/0960327110374205; Pant N, 2008, TOXICOL APPL PHARM, V231, P112, DOI 10.1016/j.taap.2008.04.001; Piche CD, 2012, ECOTOX ENVIRON SAFE, V79, P108, DOI 10.1016/j.ecoenv.2011.12.008; Rhee GS, 2002, TOXICOL IN VITRO, V16, P443, DOI 10.1016/S0887-2333(02)00026-7; Santhosh A, 1998, INDIAN J MED RES, V108, P17; Schmidt JS, 2012, ENVIRON HEALTH PERSP, V120, P1123, DOI 10.1289/ehp.1104016; Takatori S, 2012, CHEMOSPHERE, V86, P454, DOI 10.1016/j.chemosphere.2011.09.043; Tranfo G, 2012, TOXICOL LETT, V213, P15, DOI 10.1016/j.toxlet.2011.11.033; TYL RW, 1988, FUND APPL TOXICOL, V10, P395, DOI 10.1016/0272-0590(88)90286-2; Uren-Webster TM, 2010, AQUAT TOXICOL, V99, P360, DOI 10.1016/j.aquatox.2010.05.015; vom Saal FS, 2005, ENVIRON HEALTH PERSP, V113, P926, DOI 10.1289/ehp.7713; Wakayama S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006753; Wang W, 2012, TOXICOL APPL PHARM, V258, P288, DOI 10.1016/j.taap.2011.11.008; Yauk C, 2008, P NATL ACAD SCI USA, V105, P605, DOI 10.1073/pnas.0705896105	50	21	23	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 30	2012	7	11							e50465	10.1371/journal.pone.0050465	http://dx.doi.org/10.1371/journal.pone.0050465			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	054WM	23226291	Green Submitted, gold, Green Published			2022-12-27	WOS:000312376100103
J	Kobayashi, DT; Decker, D; Zaworski, P; Klott, K; McGonigal, J; Ghazal, N; Sly, L; Chung, B; Vanderlugt, J; Chen, KS				Kobayashi, Dione T.; Decker, Douglas; Zaworski, Phillip; Klott, Karen; McGonigal, Julie; Ghazal, Nabil; Sly, Laurel; Chung, Brett; Vanderlugt, James; Chen, Karen S.			Evaluation of Peripheral Blood Mononuclear Cell Processing and Analysis for Survival Motor Neuron Protein	PLOS ONE			English	Article							SPINAL MUSCULAR-ATROPHY; SMN MESSENGER-RNA; MOUSE MODEL; NATURAL-HISTORY; GENE-EXPRESSION; SEVERITY; DELIVERY; TYPE-1; ASSAY; PBMC	Objectives: Survival Motor Neuron (SMN) protein levels may become key pharmacodynamic (PD) markers in spinal muscular atrophy (SMA) clinical trials. SMN protein in peripheral blood mononuclear cells (PBMCs) can be quantified for trials using an enzyme-linked immunosorbent assay (ELISA). We developed protocols to collect, process, store and analyze these samples in a standardized manner for SMA clinical studies, and to understand the impact of age and intraindividual variability over time on PBMC SMN signal. Methods: Several variables affecting SMN protein signal were evaluated using an ELISA. Samples were from healthy adults, adult with respiratory infections, SMA patients, and adult SMA carriers. Results: Delaying PBMCs processing by 45 min, 2 hr or 24 hr after collection or isolation allows sensitive detection of SMN levels and high cell viability (> 90%). SMN levels from PBMCs isolated by EDTA tubes/Lymphoprep gradient are stable with processing delays and have greater signal compared to CPT-collected samples. SMN signal in healthy individuals varies up to 8x when collected at intervals up to 1 month. SMN signals from individuals with respiratory infections show 3-5x changes, driven largely by the CD14 fraction. SMN signal in PBMC frozen lysates are relatively stable for up to 6 months. Cross-sectional analysis of PBMCs from SMA patients and carriers suggest SMN protein levels decline with age. Conclusions: The sources of SMN signal variability in PBMCs need to be considered in the design and of SMA clinical trials, and interpreted in light of recent medical history. Improved normalization to DNA or PBMC subcellular fractions may mitigate signal variability and should be explored in SMA patients.	[Kobayashi, Dione T.; Chung, Brett; Chen, Karen S.] Spinal Muscular Atrophy Fdn, New York, NY USA; [Decker, Douglas; Zaworski, Phillip; Sly, Laurel] PharmOptima LLC, Portage, MI USA; [Klott, Karen; McGonigal, Julie; Ghazal, Nabil; Vanderlugt, James] Jasper Clin, Kalamazoo, MI USA		Kobayashi, DT (corresponding author), Spinal Muscular Atrophy Fdn, New York, NY USA.	dkobayashi@smafoundation.org		kobayashi, dione/0000-0002-5541-7175	Spinal Muscular Atrophy Foundation	Spinal Muscular Atrophy Foundation	All work was funded by the Spinal Muscular Atrophy Foundation (http://www.smafoundation.org/), a non-profit organization. DTK, BC, and KSC are employees of the SMA Foundation and were engaged in study design, data analysis, the decision to publish and manuscript preparation.	Angelozzi C, 2008, J MED GENET, V45, P29, DOI 10.1136/jmg.2007.051177; Azzouz M, 2004, J CLIN INVEST, V114, P1726, DOI 10.1172/JCI200422922; Baechler EC, 2004, GENES IMMUN, V5, P347, DOI 10.1038/sj.gene.6364098; Barnes MG, 2010, BIOPRESERV BIOBANK, V8, P153, DOI 10.1089/bio.2010.0009; Beaulieu CL, 2012, ORPHANET J RARE DIS, V7, DOI 10.1186/1750-1172-7-39; Brahe C, 2005, EUR J HUM GENET, V13, P256, DOI 10.1038/sj.ejhg.5201320; Brichta L, 2006, ANN NEUROL, V59, P970, DOI 10.1002/ana.20836; Butchbach MER, 2010, HUM MOL GENET, V19, P454, DOI 10.1093/hmg/ddp510; Chang JG, 2001, P NATL ACAD SCI USA, V98, P9808, DOI 10.1073/pnas.171105098; Chung BHY, 2004, PEDIATRICS, V114, pE548, DOI 10.1542/peds.2004-0668; Crawford TO, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033572; Dominguez E, 2011, HUM MOL GENET, V20, P681, DOI 10.1093/hmg/ddq514; ElsasserBeile U, 1995, PEDIATR ALLERGY IMMU, V6, P170, DOI 10.1111/j.1399-3038.1995.tb00278.x; Feldkotter M, 2002, AM J HUM GENET, V70, P358, DOI 10.1086/338627; Finkel RS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035462; Foust KD, 2010, NAT BIOTECHNOL, V28, P271, DOI 10.1038/nbt.1610; Gabanella F, 2005, HUM MOL GENET, V14, P3629, DOI 10.1093/hmg/ddi390; Garcia-Pineres AJ, 2006, J IMMUNOL METHODS, V313, P209, DOI 10.1016/j.jim.2006.04.004; Hastings ML, 2009, SCI TRANSL MED, V1, DOI 10.1126/scitranslmed.3000208; Hua YM, 2010, GENE DEV, V24, P1634, DOI 10.1101/gad.1941310; JAPOUR AJ, 1993, ANTIMICROB AGENTS CH, V37, P1095, DOI 10.1128/AAC.37.5.1095; Kierstead LS, 2007, AIDS RES HUM RETROV, V23, P86, DOI 10.1089/aid.2006.0129; Kleeberger CA, 1999, CLIN DIAGN LAB IMMUN, V6, P14, DOI 10.1128/CDLI.6.1.14-19.1999; Kobayashi DT, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024269; Kolb SJ, 2006, BMC NEUROL, V6, DOI 10.1186/1471-2377-6-6; Lefebvre S, 1997, NAT GENET, V16, P265, DOI 10.1038/ng0797-265; Lunn MR, 2004, CHEM BIOL, V11, P1489, DOI 10.1016/j.chembiol.2004.08.024; Mallone R, 2011, CLIN EXP IMMUNOL, V163, P33, DOI 10.1111/j.1365-2249.2010.04272.x; Mannaa Mohannad M, 2009, J Clin Neuromuscul Dis, V10, P85, DOI 10.1097/CND.0b013e318190310f; Markowitz JA, 2012, PEDIATR NEUROL, V46, P1, DOI 10.1016/j.pediatrneurol.2011.09.001; NGUYEN T, 2008, CAN PHARM J, V141, P71; Oskoui M, 2007, NEUROLOGY, V69, P1931, DOI 10.1212/01.wnl.0000290830.40544.b9; Passini MA, 2010, J CLIN INVEST, V120, P1253, DOI 10.1172/JCI41615; Piepers S, 2011, J NEUROL NEUROSUR PS, V82, P850, DOI 10.1136/jnnp.2009.200253; Porensky PN, 2012, HUM MOL GENET, V21, P1625, DOI 10.1093/hmg/ddr600; Rose FF, 2009, HUM MOL GENET, V18, P997, DOI 10.1093/hmg/ddn426; Rosinger S, 2010, CLIN TRIALS, V7, pS65, DOI 10.1177/1740774510373493; Ruitenberg JJ, 2006, BMC IMMUNOL, V7, DOI 10.1186/1471-2172-7-11; Simard LR, 2007, NEUROLOGY, V68, P451, DOI 10.1212/01.wnl.0000252934.70676.ab; Sumner CJ, 2006, NEUROLOGY, V66, P1067, DOI 10.1212/01.wnl.0000201929.56928.13; Sumner CJ, 2003, ANN NEUROL, V54, P647, DOI 10.1002/ana.10743; Swoboda KJ, 2005, ANN NEUROL, V57, P704, DOI 10.1002/ana.20473; Tiziano FD, 2011, INT J MOL SCI, V12, P24, DOI 10.3390/ijms12010024; Tiziano FD, 2010, J MED GENET, V47, P856, DOI 10.1136/jmg.2010.080366; Tiziano FD, 2010, EUR J HUM GENET, V18, P52, DOI 10.1038/ejhg.2009.116; Torrecilla E, 2010, BRIT J NUTR, V104, P1650, DOI 10.1017/S0007114510002710; Van Meerbeke JP, 2011, DISCOV MED, V12, P291; Vezain M, 2007, EUR J HUM GENET, V15, P1054, DOI 10.1038/sj.ejhg.5201885; Wang CH, 2007, J CHILD NEUROL, V22, P1027, DOI 10.1177/0883073807305788	49	15	18	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 30	2012	7	11							e50763	10.1371/journal.pone.0050763	http://dx.doi.org/10.1371/journal.pone.0050763			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	054WM	23226377	Green Submitted, Green Published, gold			2022-12-27	WOS:000312376100188
J	Levis, HJ; Peh, GSL; Toh, KP; Poh, R; Shortt, AJ; Drake, RAL; Mehta, JS; Daniels, JT				Levis, Hannah J.; Peh, Gary S. L.; Toh, Kah-Peng; Poh, Rebekah; Shortt, Alex J.; Drake, Rosemary A. L.; Mehta, Jodhbir S.; Daniels, Julie T.			Plastic Compressed Collagen as a Novel Carrier for Expanded Human Corneal Endothelial Cells for Transplantation	PLOS ONE			English	Article							LIMBAL EPITHELIAL-CELLS; OCULAR SURFACE DISEASE; AMNIOTIC MEMBRANE; KERATOPLASTY; PRESERVATION; EXPANSION; MATRIX	Current treatments for reversible blindness caused by corneal endothelial cell failure involve replacing the failed endothelium with donor tissue using a one donor-one recipient strategy. Due to the increasing pressure of a worldwide donor cornea shortage there has been considerable interest in developing alternative strategies to treat endothelial disorders using expanded cell replacement therapy. Protocols have been developed which allow successful expansion of endothelial cells in vitro but this approach requires a supporting material that would allow easy transfer of cells to the recipient. We describe the first use of plastic compressed collagen as a highly effective, novel carrier for human corneal endothelial cells. A human corneal endothelial cell line and primary human corneal endothelial cells retained their characteristic cobblestone morphology and expression of tight junction protein ZO-1 and pump protein Na+/K+ ATPase alpha 1 after culture on collagen constructs for up to 14 days. Additionally, ultrastructural analysis suggested a well-integrated endothelial layer with tightly opposed cells and apical microvilli. Plastic compressed collagen is a superior biomaterial in terms of its speed and ease of production and its ability to be manipulated in a clinically relevant manner without breakage. This method provides expanded endothelial cells with a substrate that could be suitable for transplantation allowing one donor cornea to potentially treat multiple patients.	[Levis, Hannah J.; Shortt, Alex J.; Daniels, Julie T.] UCL Inst Ophthalmol, Dept Ocular Biol & Therapeut, London, England; [Peh, Gary S. L.; Toh, Kah-Peng; Poh, Rebekah; Mehta, Jodhbir S.] Singapore Eye Res Inst, Singapore, Singapore; [Mehta, Jodhbir S.] Singapore Natl Eye Ctr, Singapore, Singapore; [Drake, Rosemary A. L.] TAP Biosyst, Royston, Herts, England	University of London; University College London; National University of Singapore; Singapore National Eye Center; Singapore National Eye Center	Levis, HJ (corresponding author), UCL Inst Ophthalmol, Dept Ocular Biol & Therapeut, London, England.	h.levis@ucl.ac.uk	Peh, Gary/A-8327-2010; Levis, Hannah/AAH-6556-2019; Mehta, Jodhbir/O-6192-2015; Shortt, Alex/C-7782-2014	Peh, Gary/0000-0002-5387-4209; Daniels, Julie/0000-0003-2099-9360; Shortt, Alex/0000-0001-6576-3875; Levis, Hannah/0000-0002-3923-1178	Technology Strategy Board; EPSRC; National Institute for the Health Research Biomedical Research Centre for Ophthalmology, Moorfields Eye Hospital; UCL Institute of Ophthalmology; National Research Foundation Translational and Clinical Research Programme Grant, Singapore [R621/42/2008]; Biomedical Research Council, Translational Clinical Research Partnership Grant, Singapore [TCR0101673]; National Institute for Health Research [CL-2009-18-007] Funding Source: researchfish	Technology Strategy Board; EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); National Institute for the Health Research Biomedical Research Centre for Ophthalmology, Moorfields Eye Hospital; UCL Institute of Ophthalmology; National Research Foundation Translational and Clinical Research Programme Grant, Singapore; Biomedical Research Council, Translational Clinical Research Partnership Grant, Singapore(Agency for Science Technology & Research (A*STAR)); National Institute for Health Research(National Institute for Health Research (NIHR))	The study was supported by the Technology Strategy Board, the EPSRC (HL), the National Institute for the Health Research Biomedical Research Centre for Ophthalmology, Moorfields Eye Hospital and UCL Institute of Ophthalmology (JTD), the National Research Foundation Translational and Clinical Research Programme Grant, Singapore (R621/42/2008), and the Biomedical Research Council, Translational Clinical Research Partnership Grant, Singapore (TCR0101673) (GSP, RP, KPT, JSM). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Armitage WJ, 2011, TRANSFUS MED HEMOTH, V38, P143, DOI 10.1159/000326632; Bayyoud T, 2012, CURR EYE RES, V37, P179, DOI 10.3109/02713683.2011.644382; ENGELMANN K, 1989, IN VITRO CELL DEV B, V25, P1065; ENGELMANN K, 1995, CORNEA, V14, P62; Ham L, 2009, EYE, V23, P1990, DOI 10.1038/eye.2008.393; Heindl LM, 2011, OPHTHALMOLOGY, V118, P294, DOI 10.1016/j.ophtha.2010.05.025; Ishino Y, 2004, INVEST OPHTH VIS SCI, V45, P800, DOI 10.1167/iovs.03-0016; Joyce NC, 1996, INVEST OPHTH VIS SCI, V37, P645; Klintworth Gordon K, 2009, Orphanet J Rare Dis, V4, P7, DOI 10.1186/1750-1172-4-7; Levis H, 2009, CURR OPIN BIOTECH, V20, P593, DOI 10.1016/j.copbio.2009.09.002; Levis HJ, 2010, BIOMATERIALS; Li W, 2007, INVEST OPHTH VIS SCI, V48, P614, DOI 10.1167/iovs.06-1126; Madden PW, 2011, BIOMATERIALS, P1; Mau K, 2009, OPTOMETRY, V80, P513, DOI 10.1016/j.optm.2008.11.010; Mimura T, 2004, INVEST OPHTH VIS SCI, V45, P2992, DOI 10.1167/iovs.03-1174; Nakamura T, 2003, CORNEA, V22, P70, DOI 10.1097/00003226-200301000-00017; Peh GSL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028310; Peh GSL, 2011, TRANSPLANTATION, V91, P811, DOI 10.1097/TP.0b013e3182111f01; Rose L, 2009, CAN J OPHTHALMOL, V44, P401, DOI 10.3129/i09-090; Schwab IR, 2000, CORNEA, V19, P421, DOI 10.1097/00003226-200007000-00003; Senoo T, 2000, INVEST OPHTH VIS SCI, V41, P660; Shimazaki J, 2002, OPHTHALMOLOGY, V109, P1285, DOI 10.1016/S0161-6420(02)01089-8; Shortt AJ, 2009, BIOMATERIALS, V30, P1056, DOI 10.1016/j.biomaterials.2008.10.048; Tsai RJ, 2000, NEW ENGL J MED, V343, P86, DOI 10.1056/NEJM200007133430202; Watanabe R, 2011, TISSUE ENGINEERING P; Yoeruek E, 2009, CORNEA, V28, P416, DOI 10.1097/ICO.0b013e31818c2c36	26	83	84	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 30	2012	7	11							e50993	10.1371/journal.pone.0050993	http://dx.doi.org/10.1371/journal.pone.0050993			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	054WM	23226443	gold, Green Submitted, Green Published			2022-12-27	WOS:000312376100254
J	Lorenz, C; Hausner, J; Buttner, D				Lorenz, Christian; Hausner, Jens; Buettner, Daniela			HrcQ Provides a Docking Site for Early and Late Type III Secretion Substrates from Xanthomonas	PLOS ONE			English	Article							CAMPESTRIS PV. VESICATORIA; ENTEROPATHOGENIC ESCHERICHIA-COLI; GRAM-NEGATIVE BACTERIA; YEAST 2-HYBRID SYSTEM; C-RING; PROTEIN SECRETION; SHIGELLA-FLEXNERI; NEEDLE COMPLEX; FUNCTIONAL-CHARACTERIZATION; PATHOGENICITY ISLAND	Pathogenicity of many Gram-negative bacteria depends on a type III secretion (T3S) system which translocates bacterial effector proteins into eukaryotic cells. The membrane-spanning secretion apparatus is associated with a cytoplasmic ATPase complex and a predicted cytoplasmic (C) ring structure which is proposed to provide a substrate docking platform for secreted proteins. In this study, we show that the putative C ring component HrcQ from the plant pathogenic bacterium Xanthomonas campestris pv. vesicatoria is essential for bacterial pathogenicity and T3S. Fractionation studies revealed that HrcQ localizes to the cytoplasm and associates with the bacterial membranes under T3S-permissive conditions. HrcQ binds to the cytoplasmic T3S-ATPase HrcN, its predicted regulator HrcL and the cytoplasmic domains of the inner membrane proteins HrcV and HrcU. Furthermore, we observed an interaction between HrcQ and secreted proteins including early and late T3S substrates. HrcQ might therefore act as a general substrate acceptor site of the T3S system and is presumably part of a larger protein complex. Interestingly, the N-terminal export signal of the T3S substrate AvrBs3 is dispensable for the interaction with HrcQ, suggesting that binding of AvrBs3 to HrcQ occurs after its initial targeting to the T3S system.	[Lorenz, Christian; Hausner, Jens; Buettner, Daniela] Univ Halle Wittenberg, Inst Biol, Dept Genet, Halle, Saale, Germany	Martin Luther University Halle Wittenberg	Buttner, D (corresponding author), Univ Halle Wittenberg, Inst Biol, Dept Genet, Halle, Saale, Germany.	daniela.buettner@genetik.uni-halle.de			Deutsche Forschungsgemeinschaft [BU 2145/5-1, Sonderforschungsbereich SFB 648]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was supported by grants from the Deutsche Forschungsgemeinschaft (BU 2145/5-1; Sonderforschungsbereich SFB 648) to D.B. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akeda Y, 2005, NATURE, V437, P911, DOI 10.1038/nature03992; Arnold R, 2010, MICROBES INFECT, V12, P346, DOI 10.1016/j.micinf.2010.02.003; Ausubel FM., 1992, CURRENT PROTOCOLS MO, V3; Bange G, 2010, P NATL ACAD SCI USA, V107, P11295, DOI 10.1073/pnas.1001383107; Berger C, 2010, MICROBIOL-SGM, V156, P1963, DOI 10.1099/mic.0.039248-0; Biemans-Oldehinkel E, 2011, J BACTERIOL, V193, P5514, DOI 10.1128/JB.05235-11; Blocker A, 2001, MOL MICROBIOL, V39, P652, DOI 10.1046/j.1365-2958.2001.02200.x; BONAS U, 1991, MOL PLANT MICROBE IN, V4, P81, DOI 10.1094/MPMI-4-081; Boonyom R, 2010, MICROBIOL-SGM, V156, P1805, DOI 10.1099/mic.0.038117-0; Brown PN, 2005, J BACTERIOL, V187, P2890, DOI 10.1128/JB.187.8.2890-2902.2005; Buttner D, 2012, MICROBIOL MOL BIOL R, V76, P262, DOI 10.1128/MMBR.05017-11; Buttner D, 2010, FEMS MICROBIOL REV, V34, P107, DOI 10.1111/j.1574-6976.2009.00192.x; Buttner D, 2006, MOL MICROBIOL, V59, P513, DOI 10.1111/j.1365-2958.2005.04924.x; Buttner D, 2004, MOL MICROBIOL, V54, P755, DOI 10.1111/j.1365-2958.2004.04302.x; Buttner D, 2002, EMBO J, V21, P5313, DOI 10.1093/emboj/cdf536; Buttner D, 2002, J BACTERIOL, V184, P2389, DOI 10.1128/JB.184.9.2389-2398.2002; Bzymek KP, 2012, BIOCHEMISTRY-US, V51, P1669, DOI 10.1021/bi201792p; CANTEROS B, 1990, THESIS U FLORIDA; Chevance FFV, 2008, NAT REV MICROBIOL, V6, P455, DOI 10.1038/nrmicro1887; Cornelis GR, 2006, CURR OPIN MICROBIOL, V9, P201, DOI 10.1016/j.mib.2006.01.002; Creasey EA, 2003, MICROBIOL-SGM, V149, P2093, DOI 10.1099/mic.0.26355-0; DANIELS MJ, 1984, EMBO J, V3, P3323, DOI 10.1002/j.1460-2075.1984.tb02298.x; Deane JE, 2010, CELL MOL LIFE SCI, V67, P1065, DOI 10.1007/s00018-009-0230-0; DEPAMPHI.ML, 1971, J BACTERIOL, V105, P384, DOI 10.1128/JB.105.1.384-395.1971; Desvaux M, 2006, TRENDS MICROBIOL, V14, P157, DOI 10.1016/j.tim.2006.02.009; Engler C, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003647; Erhardt M, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a000299; Erhardt M, 2010, MOL MICROBIOL, V75, P376, DOI 10.1111/j.1365-2958.2009.06973.x; Escolar L, 2001, MOL PLANT PATHOL, V2, P287, DOI 10.1046/j.1464-6722.2001.00077.x; Fadouloglou VE, 2004, P NATL ACAD SCI USA, V101, P70, DOI 10.1073/pnas.0304579101; FIGURSKI DH, 1979, P NATL ACAD SCI USA, V76, P1648, DOI 10.1073/pnas.76.4.1648; FRANCIS NR, 1994, J MOL BIOL, V235, P1261, DOI 10.1006/jmbi.1994.1079; Gauthier A, 2003, J BACTERIOL, V185, P6747, DOI 10.1128/JB.185.23.6747-6755.2003; Gonzalez-Pedrajo B, 2006, MOL MICROBIOL, V60, P984, DOI 10.1111/j.1365-2958.2006.05149.x; Hartmann N, 2012, MICROBIOL-SGM, V158, P1334, DOI 10.1099/mic.0.057604-0; He SY, 2004, BBA-MOL CELL RES, V1694, P181, DOI 10.1016/j.bbamcr.2004.03.011; Huguet E, 1998, MOL MICROBIOL, V29, P1379, DOI 10.1046/j.1365-2958.1998.01019.x; Jackson MW, 2000, FEMS MICROBIOL LETT, V186, P85, DOI 10.1111/j.1574-6968.2000.tb09086.x; Johnson DL, 2008, J BACTERIOL, V190, P2972, DOI 10.1128/JB.01997-07; Johnson S, 2008, FEMS MICROBIOL LETT, V286, P274, DOI 10.1111/j.1574-6968.2008.01284.x; Jones JDG, 2006, NATURE, V444, P323, DOI 10.1038/nature05286; KANIGA K, 1991, GENE, V109, P137, DOI 10.1016/0378-1119(91)90599-7; Konishi M, 2009, J BACTERIOL, V191, P6186, DOI 10.1128/JB.00601-09; Kousik CS, 1998, PLANT DIS, V82, P181, DOI 10.1094/PDIS.1998.82.2.181; Kubori T, 1998, SCIENCE, V280, P602, DOI 10.1126/science.280.5363.602; Lara-Tejero M, 2011, SCIENCE, V331, P1188, DOI 10.1126/science.1201476; Lorenz C, 2009, THESIS M LUTHER U HA; Lorenz C, 2008, MOL MICROBIOL, V69, P344, DOI 10.1111/j.1365-2958.2008.06280.x; Lorenz C, 2011, MOL MICROBIOL, V79, P447, DOI 10.1111/j.1365-2958.2010.07461.x; Lorenz C, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000094; Lorenz C, 2009, J BACTERIOL, V191, P1414, DOI 10.1128/JB.01446-08; Marlovits TC, 2004, SCIENCE, V306, P1040, DOI 10.1126/science.1102610; Mattei PJ, 2011, FEBS J, V278, P414, DOI 10.1111/j.1742-4658.2010.07974.x; McDermott JE, 2011, INFECT IMMUN, V79, P23, DOI 10.1128/IAI.00537-10; McMurry JL, 2006, BIOCHEMISTRY-US, V45, P11790, DOI 10.1021/bi0605890; MENARD R, 1993, J BACTERIOL, V175, P5899; Minamino T, 2000, MOL MICROBIOL, V35, P1052, DOI 10.1046/j.1365-2958.2000.01771.x; Minamino T, 2012, MOL MICROBIOL, V83, P775, DOI 10.1111/j.1365-2958.2011.07964.x; MINSAVAGE GV, 1990, MOL PLANT MICROBE IN, V3, P41, DOI 10.1094/MPMI-3-041; Morita-Ishihara T, 2006, J BIOL CHEM, V281, P599, DOI 10.1074/jbc.M509644200; Mueller CA, 2008, MOL MICROBIOL, V68, P1085, DOI 10.1111/j.1365-2958.2008.06237.x; Noel L, 2002, J BACTERIOL, V184, P1340, DOI 10.1128/JB.184.5.1340-1348.2002; Noel L, 2001, MOL MICROBIOL, V41, P1271, DOI 10.1046/j.1365-2958.2001.02567.x; OOSAWA K, 1994, J BACTERIOL, V176, P3683, DOI 10.1128/JB.176.12.3683-3691.1994; Pallen MJ, 2005, TRENDS MICROBIOL, V13, P143, DOI 10.1016/j.tim.2005.02.008; Ronald P C, 1988, Mol Plant Microbe Interact, V1, P191, DOI 10.1094/MPMI-1-191; Rossier O, 1999, P NATL ACAD SCI USA, V96, P9368, DOI 10.1073/pnas.96.16.9368; Rossier O, 2000, MOL MICROBIOL, V38, P828, DOI 10.1046/j.1365-2958.2000.02173.x; Sani M, 2007, MICRON, V38, P291, DOI 10.1016/j.micron.2006.04.007; Schulz S, 2011, INFECT IMMUN, V79, P2998, DOI 10.1128/IAI.00180-11; Schulze S, 2012, NEW PHYTOL, V195, P894, DOI 10.1111/j.1469-8137.2012.04210.x; Spaeth KE, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000579; Szczesny R, 2010, NEW PHYTOL, V187, P983, DOI 10.1111/j.1469-8137.2010.03312.x; Szurek B, 2001, PLANT J, V26, P523, DOI 10.1046/j.0960-7412.2001.01046.x; Tamir-Ariel D, 2007, J BACTERIOL, V189, P6359, DOI 10.1128/JB.00320-07; Thomas J, 2004, P NATL ACAD SCI USA, V101, P3945, DOI 10.1073/pnas.0307223101; VIEIRA J, 1987, METHOD ENZYMOL, V153, P3; Wengelnik K, 1999, J BACTERIOL, V181, P6828, DOI 10.1128/JB.181.21.6828-6831.1999; Wengelnik K, 1996, MOL PLANT MICROBE IN, V9, P704, DOI 10.1094/MPMI-9-0704; Zhao RH, 1996, J MOL BIOL, V261, P195, DOI 10.1006/jmbi.1996.0452	80	23	27	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 30	2012	7	11							e51063	10.1371/journal.pone.0051063	http://dx.doi.org/10.1371/journal.pone.0051063			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	054WM	23226460	gold, Green Published, Green Submitted			2022-12-27	WOS:000312376100271
J	Skrede, S; Ferno, J; Bjorndal, B; Brede, WR; Bohov, P; Berge, RK; Steen, VM				Skrede, Silje; Ferno, Johan; Bjorndal, Bodil; Brede, Wenche Rodseth; Bohov, Pavol; Berge, Rolf Kristian; Steen, Vidar Martin			Lipid-Lowering Effects of Tetradecylthioacetic Acid in Antipsychotic-Exposed, Female Rats: Challenges with Long-Term Treatment	PLOS ONE			English	Article							INDUCED WEIGHT-GAIN; STEAROYL-COA DESATURASE; LIPOGENIC GENE-EXPRESSION; BODY-WEIGHT; FATTY-ACID; ADIPOSE-TISSUE; DRUG TREATMENT; OLANZAPINE; LIVER; METABOLISM	Background: Psychiatric patients often require chronic treatment with antipsychotic drugs, and while rats are frequently used to study antipsychotic-induced metabolic adverse effects, long-term exposure has only partially mimicked the appetite-stimulating and weight-inducing effects found in the clinical setting. Antipsychotic-induced effects on serum lipids are also inconsistent in rats, but in a recent study we demonstrated that subchronic treatment with the orexigenic antipsychotic olanzapine resulted in weight-independent increase in serum triglycerides and activation of lipogenic gene expression in female rats. In addition, a recent long-term study in male rats showed that chronic treatment with antipsychotic drugs induced dyslipidemic effects, despite the lack of weight gain. Aims: In the current study, we sought to examine long-term effects of antipsychotic drugs on weight gain, lipid levels and lipid composition after twice-daily administration of antipsychotics to female rats, and to investigate potential beneficial effects of the lipid-lowering agent tetradecylthioacetic acid (TTA), a modified fatty acid. Methods: Female rats were exposed to orexigenic antipsychotics (olanzapine or clozapine), metabolically neutral antipsychotics (aripiprazole or ziprasidone), or TTA for 8 weeks. Separate groups received a combination of clozapine and TTA or olanzapine and TTA. The effects of TTA and the combination of olanzapine and TTA after 2 weeks were also investigated. Results: The antipsychotic-induced weight gain and serum triglyceride increase observed in the subchronic setting was not present after 8 weeks of treatment with antipsychotics, while lipid-lowering effect of TTA was much more pronounced in the chronic than in the subchronic setting, with concomitant upregulation of key oxidative enzymes in the liver. Unexpectedly, TTA potentiated weight gain in rats treated with antipsychotics. Conclusion: TTA is a promising candidate for prophylactic treatment of antipsychotic-induced dyslipidemic effects, but a more valid long-term rat model for antipsychotic-induced metabolic adverse effects is required.	[Skrede, Silje; Ferno, Johan; Steen, Vidar Martin] Univ Bergen, Dept Clin Med, Dr Einar Martens Res Grp Biol Psychiat, Bergen, Hordaland, Norway; [Skrede, Silje; Ferno, Johan; Steen, Vidar Martin] Haukeland Hosp, Ctr Med Genet & Mol Med, N-5021 Bergen, Hordaland, Norway; [Bjorndal, Bodil; Bohov, Pavol; Berge, Rolf Kristian] Univ Bergen, Inst Med, Sect Med Biochem, Lipid Res Grp, Bergen, Hordaland, Norway; [Brede, Wenche Rodseth] St Olavs Hosp, Dept Clin Pharmacol, Trondheim, Sor Trondelag, Norway; [Berge, Rolf Kristian] Univ Bergen, Dept Heart Dis, Bergen, Hordaland, Norway	University of Bergen; University of Bergen; Haukeland University Hospital; University of Bergen; Norwegian University of Science & Technology (NTNU); University of Bergen	Skrede, S (corresponding author), Univ Bergen, Dept Clin Med, Dr Einar Martens Res Grp Biol Psychiat, Bergen, Hordaland, Norway.	silje.skrede@med.uib.no	Bjørndal, Bodil/HDN-4287-2022; Fernø, Johan A/D-5024-2011; Bjørndal, Bodil/H-6143-2017; Skrede, Silje/AAA-4453-2019	Fernø, Johan A/0000-0002-4598-2955; Bjørndal, Bodil/0000-0001-9718-5117; 	Research Council of Norway; Norwegian council for Mental Health; ExtraStiftelsen Helse og Rehabilitering; Helse Vest RHF; Dr. Einar Martens Fund	Research Council of Norway(Research Council of Norway); Norwegian council for Mental Health; ExtraStiftelsen Helse og Rehabilitering; Helse Vest RHF; Dr. Einar Martens Fund	The present study has been supported by grants from the Research Council of Norway (incl. the FUGE program and "PSYKISK HELSE'' program), Norwegian council for Mental Health, ExtraStiftelsen Helse og Rehabilitering, Helse Vest RHF, and Dr. Einar Martens Fund. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albaugh VL, 2006, OBESITY, V14, P36, DOI 10.1038/oby.2006.6; Albaugh VL, 2012, SCHIZOPHRENIA BULL, V38, P153, DOI 10.1093/schbul/sbq053; Allison DB, 1999, AM J PSYCHIAT, V156, P1686; Arjona AA, 2004, BEHAV BRAIN RES, V152, P121, DOI 10.1016/j.bbr.2003.09.040; ASIEDU DK, 1995, EUR J BIOCHEM, V227, P715, DOI 10.1111/j.1432-1033.1995.tb20193.x; Attie AD, 2002, J LIPID RES, V43, P1899, DOI 10.1194/jlr.M200189-JLR200; BAPTISTA T, 1993, PHARMACOL BIOCHEM BE, V45, P51, DOI 10.1016/0091-3057(93)90084-7; BERGE RK, 1994, PHARMACOL THERAPEUT, V61, P345, DOI 10.1016/0163-7258(94)90016-7; BERGE RK, 1984, EUR J BIOCHEM, V141, P637, DOI 10.1111/j.1432-1033.1984.tb08239.x; Birkenaes AB, 2008, J CLIN PSYCHOPHARM, V28, P132, DOI 10.1097/JCP.0b013e318166c4f7; Blouin M, 2008, OBESITY, V16, P1780, DOI 10.1038/oby.2008.277; BREMER J, 1981, BIOCHIM BIOPHYS ACTA, V665, P628, DOI 10.1016/0005-2760(81)90282-4; Buchanan RW, 2010, SCHIZOPHRENIA BULL, V36, P71, DOI 10.1093/schbul/sbp116; Chintoh AF, 2009, SCHIZOPHR RES, V108, P127, DOI 10.1016/j.schres.2008.12.012; Cooper GD, 2005, PSYCHOPHARMACOLOGY, V181, P80, DOI 10.1007/s00213-005-2224-4; Davoodi N, 2009, PSYCHOPHARMACOLOGY, V203, P693, DOI 10.1007/s00213-008-1415-1; Deng C, 2012, J PSYCHOPHARMACOL, V26, P1271, DOI 10.1177/0269881112449396; Fell MJ, 2007, PSYCHOPHARMACOLOGY, V194, P221, DOI 10.1007/s00213-007-0833-9; Ferno J, 2005, PHARMACOGENOMICS J, V5, P298, DOI 10.1038/sj.tpj.6500323; Ferno J, 2006, BMC NEUROSCI, V7, DOI 10.1186/1471-2202-7-69; Goudie AJ, 2002, J PSYCHOPHARMACOL, V16, P291, DOI 10.1177/026988110201600402; Gudbrandsen OA, 2009, CHEM-BIOL INTERACT, V179, P227, DOI 10.1016/j.cbi.2008.10.004; Han M, 2008, PSYCHONEUROENDOCRINO, V33, P569, DOI 10.1016/j.psyneuen.2008.01.018; Horton JD, 2002, J CLIN INVEST, V109, P1125, DOI 10.1172/JCI200215593; Jassim G, 2012, PSYCHOPHARMACOLOGY, V219, P783, DOI 10.1007/s00213-011-2397-y; Kalinichev M, 2005, PSYCHOPHARMACOLOGY, V182, P220, DOI 10.1007/s00213-005-0081-9; Kim JY, 2007, J CLIN INVEST, V117, P2621, DOI 10.1172/JCI31021; Kluge M, 2007, J CLIN PSYCHOPHARM, V27, P662, DOI 10.1097/jcp.0b013e31815a8872; Leucht S, 2009, LANCET, V373, P31, DOI 10.1016/S0140-6736(08)61764-X; Lovas K, 2009, DIABETES OBES METAB, V11, P304, DOI 10.1111/j.1463-1326.2008.00958.x; Madsen L, 1998, J LIPID RES, V39, P583; Mandard S, 2004, CELL MOL LIFE SCI, V61, P393, DOI 10.1007/s00018-003-3216-3; McNamara RK, 2012, PHARMACOL RES, V66, P283, DOI 10.1016/j.phrs.2012.06.010; McNamara RK, 2011, SCHIZOPHR RES, V129, P66, DOI 10.1016/j.schres.2011.03.016; Minet-Ringuet J, 2007, MOL PSYCHIATR, V12, P562, DOI 10.1038/sj.mp.4001948; Miyazaki M, 2001, J LIPID RES, V42, P1018; Morken T, 2011, SCAND J CLIN LAB INV, V71, P269, DOI 10.3109/00365513.2011.559552; Pouzet B, 2003, PHARMACOL BIOCHEM BE, V75, P133, DOI 10.1016/S0091-3057(03)00042-X; Procyshyn RM, 2007, J PSYCHIATR NEUROSCI, V32, P331; Raeder MB, 2006, MOL CELL BIOCHEM, V289, P167, DOI 10.1007/s11010-006-9160-4; Rozen S, 2000, Methods Mol Biol, V132, P365; Rummel-Kluge C, 2010, SCHIZOPHR RES, V123, P225, DOI 10.1016/j.schres.2010.07.012; Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73; SKORVE J, 1993, J LIPID RES, V34, P1177; Skrede S, 2012, INT J NEUROPSYCHOPH, V15, P163, DOI 10.1017/S1461145711001271; SMALL GM, 1985, BIOCHEM J, V227, P205, DOI 10.1042/bj2270205; Smith GC, 2008, DIABETOLOGIA, V51, P2309, DOI 10.1007/s00125-008-1152-3; Snigdha S, 2008, J Psychopharmacol, V22, P567, DOI 10.1177/0269881107081519; Stefanidis A, 2009, OBESITY, V17, P16, DOI 10.1038/oby.2008.468; Urichuk L, 2008, CURR DRUG METAB, V9, P410, DOI 10.2174/138920008784746373; Virtue S, 2010, BBA-MOL CELL BIOL L, V1801, P338, DOI 10.1016/j.bbalip.2009.12.006; Wensaas AJ, 2009, DIABETES OBES METAB, V11, P1034, DOI 10.1111/j.1463-1326.2009.01092.x	52	7	7	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 30	2012	7	11							e50853	10.1371/journal.pone.0050853	http://dx.doi.org/10.1371/journal.pone.0050853			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	054WM	23226405	Green Submitted, Green Published, gold			2022-12-27	WOS:000312376100216
J	Takaesu, G; Inagaki, M; Takubo, K; Mishina, Y; Hess, PR; Dean, GA; Yoshimura, A; Matsumoto, K; Suda, T; Ninomiya-Tsuji, J				Takaesu, Giichi; Inagaki, Maiko; Takubo, Keiyo; Mishina, Yuji; Hess, Paul R.; Dean, Gregg A.; Yoshimura, Akihiko; Matsumoto, Kunihiro; Suda, Toshio; Ninomiya-Tsuji, Jun			TAK1 (MAP3K7) Signaling Regulates Hematopoietic Stem Cells through TNF-Dependent and -Independent Mechanisms	PLOS ONE			English	Article							ACTIVATED KINASE 1; OXIDATIVE STRESS; SELF-RENEWAL; TAB3; HOMEOSTASIS; APOPTOSIS; SURVIVAL; PROTEIN; MICE; EPITHELIUM	A cytokine/stress signaling kinase Tak1 (Map3k7) deficiency is known to impair hematopoietic progenitor cells. However, the role of TAK1 signaling in the stem cell function of the hematopoietic system is not yet well defined. Here we characterized hematopoietic stem cells (HSCs) harboring deletion of Tak1 and its activators, Tak1 binding proteins 1 and 2 (Tab1 and Tab2) using a competitive transplantation assay in a mouse model. Tak1 single or Tab1/Tab2 double deletions completely eliminated the reconstitution activity of HSCs, whereas Tab1 or Tab2 single deletion did not cause any abnormality. Tak1 single or Tab1/Tab2 double deficient lineage-negative, Sca-1(+), c-Kit(+) (LSK) cells did not proliferate and underwent cell death. We found that Tnfr1 deficiency restored the reconstitution activity of Tak1 deficient bone marrow cells for 6-18 weeks. However, the reconstitution activity of Tak1- and Tnfr1-double deficient bone marrow cells declined over the long term, and the number of phenotypically identified long-term hematopoietic stem cells were diminished. Our results indicate that TAB1- or TAB2-dependent activation of TAK1 is required for maintenance of the hematopoietic system through two mechanisms: one is prevention of TNF-dependent cell death and the other is TNF-independent maintenance of long-term HSC.	[Takaesu, Giichi] Keio Univ, Sch Med, Ctr Integrated Med Res, Tokyo, Japan; [Inagaki, Maiko; Ninomiya-Tsuji, Jun] N Carolina State Univ, Dept Environm & Mol Toxicol, Raleigh, NC 27695 USA; [Takubo, Keiyo; Suda, Toshio] Keio Univ, Sch Med, Dept Cell Differentiat, Sakaguchi Lab Dev Biol, Tokyo, Japan; [Mishina, Yuji] Univ Michigan, Sch Dent, Dept Biol & Mat Sci, Ann Arbor, MI 48109 USA; [Hess, Paul R.; Dean, Gregg A.] N Carolina State Univ, Coll Vet Med, Dept Clin Sci, Raleigh, NC USA; [Dean, Gregg A.] N Carolina State Univ, Coll Vet Med, Ctr Comparat Med & Translat Res, Raleigh, NC USA; [Yoshimura, Akihiko] Keio Univ, Sch Med, Dept Microbiol & Immunol, Tokyo, Japan; [Matsumoto, Kunihiro] Nagoya Univ, Grad Sch Sci, Dept Mol Biol, Nagoya, Aichi 4648601, Japan	Keio University; University of North Carolina; North Carolina State University; Keio University; University of Michigan System; University of Michigan; University of North Carolina; North Carolina State University; University of North Carolina; North Carolina State University; Keio University; Nagoya University	Takaesu, G (corresponding author), Keio Univ, Sch Med, Ctr Integrated Med Res, Tokyo, Japan.	takaesug1@z7.keio.jp; Jun_Tsuji@ncsu.edu	Suda, Toshio/H-6761-2013; Takubo, Keiyo/AAX-5546-2020; Dean, Gregg A/A-5623-2012; Yoshimura, Akihiko/K-5515-2013	Suda, Toshio/0000-0001-7540-1771; Takubo, Keiyo/0000-0002-1736-7592; Dean, Gregg A/0000-0001-7025-9550; Ninomiya-Tsuji, Jun/0000-0002-5584-0176; Takaesu, Giichi/0000-0002-1581-1055	Keio Kanrinmaru Project; Promotion of Environmental Improvement for Independence of Young Researchers under the Special Coordination Funds for Promoting Science and Technology (JST, Japan); National Institutes of Health [GM068812]; Grants-in-Aid for Scientific Research [22790292] Funding Source: KAKEN; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM068812] Funding Source: NIH RePORTER	Keio Kanrinmaru Project; Promotion of Environmental Improvement for Independence of Young Researchers under the Special Coordination Funds for Promoting Science and Technology (JST, Japan); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by "Keio Kanrinmaru Project", the Promotion of Environmental Improvement for Independence of Young Researchers under the Special Coordination Funds for Promoting Science and Technology (JST, Japan) (to GT), and National Institutes of Health Grant GM068812 (to JN-T). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams GB, 2006, NAT IMMUNOL, V7, P333, DOI 10.1038/ni1331; Badea TC, 2003, J NEUROSCI, V23, P2314; Chen ZJ, 2006, CELL DEATH DIFFER, V13, P687, DOI 10.1038/sj.cdd.4401869; Cheung PCF, 2004, BIOCHEM J, V378, P27, DOI 10.1042/BJ20031794; Christensen JL, 2001, P NATL ACAD SCI USA, V98, P14541, DOI 10.1073/pnas.261562798; Gan BY, 2010, NATURE, V468, P701, DOI 10.1038/nature09595; Gurumurthy S, 2010, NATURE, V468, P659, DOI 10.1038/nature09572; Higashi AY, 2009, J IMMUNOL, V182, P5633, DOI 10.4049/jimmunol.0802413; Inagaki M, 2008, GENESIS, V46, P431, DOI 10.1002/dvg.20418; Inagaki M, 2008, J BIOL CHEM, V283, P33080, DOI 10.1074/jbc.M807574200; Ishitani T, 2003, EMBO J, V22, P6277, DOI 10.1093/emboj/cdg605; Ito K, 2004, NATURE, V431, P997, DOI 10.1038/nature02989; Jin G, 2004, P NATL ACAD SCI USA, V101, P2028, DOI 10.1073/pnas.0307314101; Kajino-Sakamoto R, 2008, J IMMUNOL, V181, P1143, DOI 10.4049/jimmunol.181.2.1143; Kajino-Sakamoto R, 2010, J IMMUNOL, V185, P4729, DOI 10.4049/jimmunol.0903587; Kanayama A, 2004, MOL CELL, V15, P535, DOI 10.1016/j.molcel.2004.08.008; Kiel MJ, 2005, CELL, V121, P1109, DOI 10.1016/j.cell.2005.05.026; Liu J, 2009, NATURE, V459, P387, DOI 10.1038/nature08040; Moore KA, 2006, SCIENCE, V311, P1880, DOI 10.1126/science.1110542; Nakada D, 2010, NATURE, V468, P653, DOI 10.1038/nature09571; Omori E, 2008, J BIOL CHEM, V283, P26161, DOI 10.1074/jbc.M804513200; Omori E, 2012, P NATL ACAD SCI USA, V109, P3365, DOI 10.1073/pnas.1116188109; Omori E, 2006, J BIOL CHEM, V281, P19610, DOI 10.1074/jbc.M603384200; Ono K, 2001, J BIOL CHEM, V276, P24396, DOI 10.1074/jbc.M102631200; Orkin SH, 2008, CELL, V132, P631, DOI 10.1016/j.cell.2008.01.025; PFEFFER K, 1993, CELL, V73, P457, DOI 10.1016/0092-8674(93)90134-C; Pronk CJH, 2011, J EXP MED, V208, P1563, DOI 10.1084/jem.20110752; Sanjo H, 2003, MOL CELL BIOL, V23, P1231, DOI 10.1128/MCB.23.4.1231-1238.2003; Sato S, 2005, NAT IMMUNOL, V6, P1087, DOI 10.1038/ni1255; Schmidt-Supprian M, 2007, NAT IMMUNOL, V8, P665, DOI 10.1038/ni0707-665; Scholz R, 2010, J BIOL CHEM, V285, P25753, DOI 10.1074/jbc.M109.093468; Suda T, 2011, CELL STEM CELL, V9, P298, DOI 10.1016/j.stem.2011.09.010; Tang MH, 2008, J EXP MED, V205, P1611, DOI 10.1084/jem.20080297; Tothova Z, 2007, CELL, V128, P325, DOI 10.1016/j.cell.2007.01.003; Wan YSY, 2006, NAT IMMUNOL, V7, P851, DOI 10.1038/ni1355; Wilson A, 2008, CELL, V135, P1118, DOI 10.1016/j.cell.2008.10.048; Xiao YC, 2011, BLOOD, V118, P6057, DOI 10.1182/blood-2011-06-359448; Zhang CC, 2006, NAT MED, V12, P240, DOI 10.1038/nm1342	38	10	10	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 30	2012	7	11							e51073	10.1371/journal.pone.0051073	http://dx.doi.org/10.1371/journal.pone.0051073			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	054WM	23226465	gold, Green Published, Green Submitted			2022-12-27	WOS:000312376100276
J	Yanicostas, C; Barbieri, E; Hibi, M; Brice, A; Stevanin, G; Soussi-Yanicostas, N				Yanicostas, Constantin; Barbieri, Elisa; Hibi, Masahiko; Brice, Alexis; Stevanin, Giovanni; Soussi-Yanicostas, Nadia			Requirement for Zebrafish Ataxin-7 in Differentiation of Photoreceptors and Cerebellar Neurons	PLOS ONE			English	Article							CONE-ROD DYSTROPHY; MACHADO-JOSEPH-DISEASE; BINDING PROTEIN GENE; CAG REPEAT; HOMEOBOX GENE; EXPANDED POLYGLUTAMINE; TRINUCLEOTIDE REPEAT; SPINOCEREBELLAR ATAXIA-7; EXPRESSION ANALYSIS; HUMAN BRAIN	The expansion of a polyglutamine (polyQ) tract in the N-terminal region of ataxin-7 (atxn7) is the causative event in spinocerebellar ataxia type 7 (SCA7), an autosomal dominant neurodegenerative disorder mainly characterized by progressive, selective loss of rod-cone photoreceptors and cerebellar Purkinje and granule cells. The molecular and cellular processes underlying this restricted neuronal vulnerability, which contrasts with the broad expression pattern of atxn7, remains one of the most enigmatic features of SCA7, and more generally of all polyQ disorders. To gain insight into this specific neuronal vulnerability and achieve a better understanding of atxn7 function, we carried out a functional analysis of this protein in the teleost fish Danio rerio. We characterized the zebrafish atxn7 gene and its transcription pattern, and by making use of morpholino-oligonucleotide-mediated gene inactivation, we analysed the phenotypes induced following mild or severe zebrafish atxn7 depletion. Severe or nearly complete zebrafish atxn7 loss-of-function markedly impaired embryonic development, leading to both early embryonic lethality and severely deformed embryos. More importantly, in relation to SCA7, moderate depletion of the protein specifically, albeit partially, prevented the differentiation of both retina photoreceptors and cerebellar Purkinje and granule cells. In addition, [1-232] human atxn7 fragment rescued these phenotypes showing strong function conservation of this protein through evolution. The specific requirement for zebrafish atxn7 in the proper differentiation of cerebellar neurons provides, to our knowledge, the first in vivo evidence of a direct functional relationship between atxn7 and the differentiation of Purkinje and granule cells, the most crucial neurons affected in SCA7 and most other polyQ-mediated SCAs. These findings further suggest that altered protein function may play a role in the pathophysiology of the disease, an important step toward the development of future therapeutic strategies.	[Yanicostas, Constantin; Barbieri, Elisa; Soussi-Yanicostas, Nadia] Hop Robert Debre, INSERM, U676, F-75019 Paris, France; [Yanicostas, Constantin; Barbieri, Elisa; Soussi-Yanicostas, Nadia] Univ Paris Diderot, Paris, France; [Barbieri, Elisa; Brice, Alexis; Stevanin, Giovanni] INSERM, U975, Paris, France; [Barbieri, Elisa; Brice, Alexis; Stevanin, Giovanni] Univ Paris 06, Ctr Rech, Inst Cerveau & Moelle Epiniere, UMR S975,GHU Pitie Salpetriere, Paris, France; [Barbieri, Elisa; Brice, Alexis; Stevanin, Giovanni] CNRS, UMR7225, Paris, France; [Hibi, Masahiko] RIKEN Ctr Dev Biol, Lab Vertebrate Axis Format, Kobe, Hyogo, Japan; [Hibi, Masahiko] Nagoya Univ, Biosci & Biotechnol Ctr, Nagoya, Aichi 4648601, Japan; [Stevanin, Giovanni] Ecole Prat Hautes Etud, Paris, France	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Robert-Debre - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite; Institut National de la Sante et de la Recherche Medicale (Inserm); Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; UDICE-French Research Universities; Sorbonne Universite; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); RIKEN; Nagoya University; UDICE-French Research Universities; PSL Research University Paris; Ecole Pratique des Hautes Etudes (EPHE)	Soussi-Yanicostas, N (corresponding author), Hop Robert Debre, INSERM, U676, F-75019 Paris, France.	nadia.soussi@inserm.fr	Stevanin, Giovanni/E-5038-2016; Brice, Alexis/A-2170-2009; Soussi-Yanicostas, Nadia/U-6339-2018; brice, alexis/AAE-8275-2019; Hibi, Masahiko/I-6215-2014; Soussi-Yanicostas, Nadia/GPF-8264-2022	Stevanin, Giovanni/0000-0001-9368-8657; brice, alexis/0000-0002-0941-3990; Hibi, Masahiko/0000-0002-9142-4444; Soussi-Yanicostas, Nadia/0000-0001-7734-9401	Institut National de la Sante et de la Recherche Medicale (Inserm) [R04190SP, R05245DS]; Association Francaise contre les Myopathies (AFM); Agence Nationale de la Recherche (ANR) [SCA7]	Institut National de la Sante et de la Recherche Medicale (Inserm)(Institut National de la Sante et de la Recherche Medicale (Inserm)); Association Francaise contre les Myopathies (AFM)(Association Francaise contre les Myopathies); Agence Nationale de la Recherche (ANR)(French National Research Agency (ANR))	This work was supported by the Institut National de la Sante et de la Recherche Medicale (Inserm), Avenir programs (Nos. R04190SP and R05245DS), the Association Francaise contre les Myopathies (AFM) and the Agence Nationale de la Recherche (ANR, Grant "SCA7"). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abou-Sleymane G, 2006, HUM MOL GENET, V15, P691, DOI 10.1093/hmg/ddi483; Aleman TS, 2002, EXP EYE RES, V74, P737, DOI 10.1006/exer.2002.1169; Ayari B, 2010, J NEUROTRAUM, V27, P959, DOI 10.1089/neu.2009.0972; Bae YK, 2009, DEV BIOL, V330, P406, DOI 10.1016/j.ydbio.2009.04.013; Benton CS, 1998, NEUROLOGY, V51, P1081, DOI 10.1212/WNL.51.4.1081; Cancel G, 2000, BRAIN, V123, P2519, DOI 10.1093/brain/123.12.2519; Chen Q, 2008, J NEUROSCI RES, V86, P1615, DOI 10.1002/jnr.21601; Chen SM, 2004, HUM MOL GENET, V13, P53, DOI 10.1093/hmg/ddh005; Crespo-Barreto J, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001021; David G, 1997, NAT GENET, V17, P65, DOI 10.1038/ng0997-65; De Strooper B, 2007, EMBO REP, V8, P141, DOI 10.1038/sj.embor.7400897; Durr A, 1996, ANN NEUROL, V39, P490, DOI 10.1002/ana.410390411; Einum DD, 2001, NEUROGENETICS, V3, P83, DOI 10.1007/s100480000100; Freund CL, 1998, NAT GENET, V18, P311, DOI 10.1038/ng0498-311; Freund CL, 1997, CELL, V91, P543, DOI 10.1016/S0092-8674(00)80440-7; Fujigasaki H, 2001, BRAIN, V124, P1939, DOI 10.1093/brain/124.10.1939; Furukawa T, 1997, CELL, V91, P531, DOI 10.1016/S0092-8674(00)80439-0; Garden GA, 2002, J NEUROSCI, V22, P4897, DOI 10.1523/JNEUROSCI.22-12-04897.2002; Garden GA, 2006, SPINOCEREBELLAR ATAX, P399; Garden GA, 2008, CEREBELLUM, V7, P138, DOI 10.1007/s12311-008-0027-y; HATTEN ME, 1978, NATURE, V276, P504, DOI 10.1038/276504a0; Helmlinger D, 2006, PLOS BIOL, V4, P432, DOI 10.1371/journal.pbio.0040067; Helmlinger D, 2004, HUM MOL GENET, V13, P1257, DOI 10.1093/hmg/ddh139; HICKS D, 1986, EXP EYE RES, V42, P55, DOI 10.1016/0014-4835(86)90017-5; Ikeda H, 1996, NAT GENET, V13, P196, DOI 10.1038/ng0696-196; Imbert G, 1996, NAT GENET, V14, P285, DOI 10.1038/ng1196-285; Johansson J, 1998, HUM MOL GENET, V7, P171, DOI 10.1093/hmg/7.2.171; Jonasson J, 2002, ACTA NEUROPATHOL, V104, P29, DOI 10.1007/s00401-001-0514-4; Jun K, 1999, P NATL ACAD SCI USA, V96, P15245, DOI 10.1073/pnas.96.26.15245; KAWAGUCHI Y, 1994, NAT GENET, V8, P221, DOI 10.1038/ng1194-221; KIMMEL CB, 1995, DEV DYNAM, V203, P253, DOI 10.1002/aja.1002030302; Koide R, 1999, HUM MOL GENET, V8, P2047, DOI 10.1093/hmg/8.11.2047; KOIDE R, 1994, NAT GENET, V6, P9, DOI 10.1038/ng0194-9; Krebs AR, 2010, EMBO REP, V11, P541, DOI 10.1038/embor.2010.75; La Spada AR, 2001, NEURON, V31, P913, DOI 10.1016/S0896-6273(01)00422-6; LANDIS DMD, 1978, J COMP NEUROL, V179, P831, DOI 10.1002/cne.901790408; LANNOO MJ, 1991, PROG NEUROBIOL, V37, P329, DOI 10.1016/0301-0082(91)90022-S; LASPADA AR, 1991, NATURE, V352, P77, DOI 10.1038/352077a0; Latouche M, 2007, J NEUROSCI, V27, P2483, DOI 10.1523/JNEUROSCI.5453-06.2007; Lebre AS, 2003, CYTOGENET GENOME RES, V100, P154, DOI 10.1159/000072850; MACDONALD ME, 1993, CELL, V72, P971, DOI 10.1016/0092-8674(93)90585-E; Marsh JL, 2000, HUM MOL GENET, V9, P13, DOI 10.1093/hmg/9.1.13; MARTIN JJ, 1994, ACTA NEUROPATHOL, V88, P277; McLeod CJ, 2005, HUM MOL GENET, V14, P1041, DOI 10.1093/hmg/ddi096; McMahon SJ, 2005, P NATL ACAD SCI USA, V102, P8478, DOI 10.1073/pnas.0503493102; Miyazaki T, 2004, J NEUROSCI, V24, P1734, DOI 10.1523/JNEUROSCI.4208-03.2004; Mueller T, 2002, MECH DEVELOP, V117, P123, DOI 10.1016/S0925-4773(02)00194-6; Nakamura K, 2001, HUM MOL GENET, V10, P1441, DOI 10.1093/hmg/10.14.1441; NASIR J, 1995, CELL, V81, P811, DOI 10.1016/0092-8674(95)90542-1; Nielsen AL, 2003, GENE, V310, P123, DOI 10.1016/S0378-1119(03)00526-2; Ordway JM, 1997, CELL, V91, P753, DOI 10.1016/S0092-8674(00)80464-X; Orr HT, 2007, ANNU REV NEUROSCI, V30, P575, DOI 10.1146/annurev.neuro.29.051605.113042; ORR HT, 1993, NAT GENET, V4, P221, DOI 10.1038/ng0793-221; Palhan VB, 2005, P NATL ACAD SCI USA, V102, P8472, DOI 10.1073/pnas.0503505102; Paulson HL, 2009, J NEURO-OPHTHALMOL, V29, P227, DOI 10.1097/WNO0b013e3181b416de; Pulst SM, 1996, NAT GENET, V14, P269, DOI 10.1038/ng1196-269; Sanpei K, 1996, NAT GENET, V14, P277, DOI 10.1038/ng1196-277; Scholefield J, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007232; Serra HG, 2006, CELL, V127, P697, DOI 10.1016/j.cell.2006.09.036; Sowa ME, 2009, CELL, V138, P389, DOI 10.1016/j.cell.2009.04.042; Stevanin G, 2000, EUR J HUM GENET, V8, P4, DOI 10.1038/sj.ejhg.5200403; Strom AL, 2002, GENE, V285, P91, DOI 10.1016/S0378-1119(02)00399-2; Swain PK, 1997, NEURON, V19, P1329, DOI 10.1016/S0896-6273(00)80423-7; Taroni F, 2004, NAT REV NEUROSCI, V5, P641, DOI 10.1038/nrn1474; Tilton F, 2008, TOXICOL SCI, V106, P103, DOI 10.1093/toxsci/kfn145; van de Warrenburg BPC, 2001, J NEUROL, V248, P911, DOI 10.1007/s004150170082; Wang HL, 2006, CELL SIGNAL, V18, P541, DOI 10.1016/j.cellsig.2005.05.024; Westerfield M, 2000, ZEBRAFISH BOOK GUIDE; Whitney A, 2007, DEV MED CHILD NEUROL, V49, P140, DOI 10.1111/j.1469-8749.2007.00140.x; Yabu T, 2001, FISHERIES SCI, V67, P333, DOI 10.1046/j.1444-2906.2001.00233.x; Yanicostas C, 2008, DEV BIOL, V320, P469, DOI 10.1016/j.ydbio.2008.06.008; Yoo SY, 2003, NEURON, V37, P383, DOI 10.1016/S0896-6273(02)01190-X; Zander C, 2001, HUM MOL GENET, V10, P2569, DOI 10.1093/hmg/10.22.2569; Zhuchenko O, 1997, NAT GENET, V15, P62, DOI 10.1038/ng0197-62	74	21	21	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 30	2012	7	11							e50705	10.1371/journal.pone.0050705	http://dx.doi.org/10.1371/journal.pone.0050705			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	054WM	23226359	gold, Green Published, Green Submitted			2022-12-27	WOS:000312376100170
J	Chan, CC; Cheng, LY; Lu, J; Huang, YH; Chiou, SH; Tsai, PH; Huo, TI; Lin, HC; Lee, FY				Chan, Che-Chang; Cheng, Ling-Yi; Lu, Jean; Huang, Yi-Hsiang; Chiou, Shih-Hwa; Tsai, Ping-Hsing; Huo, Teh-Ia; Lin, Han-Chieh; Lee, Fa-Yauh			The Role of Interferon-gamma Inducible Protein-10 in a Mouse Model of Acute Liver Injury Post Induced Pluripotent Stem Cells Transplantation	PLOS ONE			English	Article							HEPATOCYTE TRANSPLANTATION; CHRONIC HEPATITIS; CXC CHEMOKINES; DISEASE; MICE; REGENERATION; EXPRESSION; FIBROSIS; THERAPY; INHIBITION	Background: Liver injuries are important medical problems that require effective therapy. Stem cell or hepatocyte transplantation has the potential to restore function of the damaged liver and ameliorate injury. However, the regulatory factors crucial for the repair and regeneration after cell transplantation have not been fully characterized. Our study investigated the effects and the expression of the regulatory factors in mouse models of acute liver injury either transplanted with the induced pluripotent stem cells (iPS) or the hepatocytes that differentiated from iPS cells (iHL). Methods/Principal Findings: Mice received CCl4 injection and were randomized to receive vehicle, iPS, or iHL transfusions vial tail veins and were observed for 24, 48 or 72 hours. The group of mice with iPS transplantation performed better than the group of mice receiving iHL in reducing the serum alanine aminotransferase, aspartate aminotransferase, and liver necrosis areas at 24 hours after CCl4 injury. Moreover, iPS significantly increased the numbers of proliferating hepatocytes at 48 hours. Cytokine array identified that chemokine IP-10 could be the potential regulatory factor that ameliorates liver injury. Further studies revealed that iPS secreted IP-10 in vitro and transfusion of iPS increased IP-10 protein and mRNA expressions in the injured livers in vivo. The primary hepatocytes and non-parenchyma cells were isolated from normal and injured livers. Hepatocytes from injured livers that received iPS treatment expressed more IP-10 mRNA than their nonhepatocyte counter-parts. In addition, animal studies revealed that administration of recombinant IP-10 (rIP-10) effectively reduced liver injuries while IP-10-neutralizing antibody attenuated the protective effects of iPS and decreased hepatocyte proliferation. Both iPS and rIP-10 significantly reduced the 72-hour mortality rate in mice that received multiple CCl4-injuries. Conclusions/Significance: These findings suggested that IP-10 may have an important regulatory role in facilitating the repair and regeneration of injured liver after iPS transplantation.	[Chan, Che-Chang; Cheng, Ling-Yi; Huang, Yi-Hsiang; Chiou, Shih-Hwa] Natl Yang Ming Univ, Sch Med, Inst Clin Med, Taipei 112, Taiwan; [Chiou, Shih-Hwa; Tsai, Ping-Hsing; Huo, Teh-Ia] Natl Yang Ming Univ, Sch Med, Inst Pharmacol, Taipei 112, Taiwan; [Lu, Jean] Acad Sinica, Genom Res Ctr, Taipei 115, Taiwan; [Chan, Che-Chang; Cheng, Ling-Yi; Huang, Yi-Hsiang; Huo, Teh-Ia; Lin, Han-Chieh; Lee, Fa-Yauh] Taipei Vet Gen Hosp, Dept Internal Med, Div Gastroenterol, Taipei, Taiwan; [Chiou, Shih-Hwa; Tsai, Ping-Hsing] Taipei Vet Gen Hosp, Dept Med Res & Educ, Stem Cell Lab, Taipei, Taiwan	National Yang Ming Chiao Tung University; National Yang Ming Chiao Tung University; Academia Sinica - Taiwan; Taipei Veterans General Hospital; Taipei Veterans General Hospital	Huang, YH (corresponding author), Natl Yang Ming Univ, Sch Med, Inst Clin Med, Taipei 112, Taiwan.	yhhuang@vghtpe.gov.tw; shchiou@vghtpe.gov.tw		Huang, Yi-Hsiang/0000-0001-5241-5425	National Science Council [NSC97-2314-B-075-027-MY2, NSC97-3111-B-075-001-MY3, NSC98-2314- B-075-008-MY3]; Taipei Veterans General Hospital [V97B1-014, V98C1-016]; National Yang-Ming University (Ministry of Education, Aim for the Top University Plan), Taiwan	National Science Council(Ministry of Science and Technology, Taiwan); Taipei Veterans General Hospital(Taipei Veterans General Hospital); National Yang-Ming University (Ministry of Education, Aim for the Top University Plan), Taiwan(Ministry of Education, Taiwan)	This study was supported by research grants from the National Science Council (NSC97-2314-B-075-027-MY2, NSC97-3111-B-075-001-MY3, NSC98-2314- B-075-008-MY3), Taipei Veterans General Hospital (V97B1-014, V98C1-016), and National Yang-Ming University (Ministry of Education, Aim for the Top University Plan), Taiwan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Banas A, 2009, J GASTROEN HEPATOL, V24, P70, DOI 10.1111/j.1440-1746.2008.05496.x; Bone-Larson CL, 2001, J IMMUNOL, V167, P7077, DOI 10.4049/jimmunol.167.12.7077; Espejel S, 2010, J CLIN INVEST, V120, P3120, DOI 10.1172/JCI43267; Farber JM, 1997, J LEUKOCYTE BIOL, V61, P246, DOI 10.1002/jlb.61.3.246; Flohr TR, 2009, CURR OPIN ORGAN TRAN, V14, P64, DOI 10.1097/MOT.0b013e328320fd7b; Fox IJ, 2004, J HEPATOL, V40, P878, DOI 10.1016/j.jhep.2004.04.009; Heydtmann M, 2009, HEPATOLOGY, V49, P676, DOI 10.1002/hep.22763; Jiang DH, 2010, J CLIN INVEST, V120, P2049, DOI 10.1172/JCI38644; Kakinuma S, 2009, J GASTROENTEROL, V44, P167, DOI 10.1007/s00535-008-2297-z; Kao CL, 2010, STEM CELLS DEV, V19, P247, DOI 10.1089/scd.2009.0186; Kawashita Y, 2005, SURG TODAY, V35, P705, DOI 10.1007/s00595-005-3024-5; Koniaris LG, 2001, J IMMUNOL, V167, P399, DOI 10.4049/jimmunol.167.1.399; Kuo TK, 2008, GASTROENTEROLOGY, V134, P2111, DOI 10.1053/j.gastro.2008.03.015; Mach F, 1999, J CLIN INVEST, V104, P1041, DOI 10.1172/JCI6993; Nakaya I, 2007, NEPHRON EXP NEPHROL, V107, pE12, DOI 10.1159/000106505; Nanji AA, 1999, HEPATOLOGY, V30, P934, DOI 10.1002/hep.510300402; Narumi S, 1997, J IMMUNOL, V158, P5536; Navarro-Alvarez N, 2009, CURR STEM CELL RES T, V4, P141, DOI 10.2174/157488809788167418; Njoku DB, 2009, J AUTOIMMUN, V32, P52, DOI 10.1016/j.jaut.2008.11.003; Okita K, 2007, NATURE, V448, P313, DOI 10.1038/nature05934; Parekkadan B, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000941; Puppi Juliana, 2009, V481, P1, DOI 10.1007/978-1-59745-201-4_1; Si-Tayeb K, 2010, HEPATOLOGY, V51, P297, DOI 10.1002/hep.23354; Singh UP, 2008, J INTERF CYTOK RES, V28, P31, DOI 10.1089/jir.2007.0059; Song ZH, 2009, CELL RES, V19, P1233, DOI 10.1038/cr.2009.107; Tager AM, 2004, AM J RESP CELL MOL, V31, P395, DOI 10.1165/rcmb.2004-0175OC; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Taniguchi E, 2006, GASTROENTEROLOGY, V130, P521, DOI 10.1053/j.gastro.2005.10.050; Wasmuth HE, 2009, GASTROENTEROLOGY, V137, P309, DOI 10.1053/j.gastro.2009.03.053; Xu D, 2009, P NATL ACAD SCI USA, V106, P808, DOI 10.1073/pnas.0812090106; Yamanouchi K, 2009, HEPATOLOGY, V49, P258, DOI 10.1002/hep.22573; Yoneyama H, 2007, MED MOL MORPHOL, V40, P191, DOI 10.1007/s00795-007-0371-x; Yoshimi A, 2009, BIOL BLOOD MARROW TR, V15, P389, DOI 10.1016/j.bbmt.2008.11.021; Zeremski M, 2008, HEPATOLOGY, V48, P1440, DOI 10.1002/hep.22500; Zhai YA, 2008, HEPATOLOGY, V47, P207, DOI 10.1002/hep.21986	35	9	10	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 5	2012	7	12							e50577	10.1371/journal.pone.0050577	http://dx.doi.org/10.1371/journal.pone.0050577			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	057TZ	23227188	gold, Green Submitted, Green Published			2022-12-27	WOS:000312588200048
J	Sengul, A; van Elk, M; Rognini, G; Aspell, JE; Bleuler, H; Blanke, O				Senguel, Ali; van Elk, Michiel; Rognini, Giulio; Aspell, Jane Elizabeth; Bleuler, Hannes; Blanke, Olaf			Extending the Body to Virtual Tools Using a Robotic Surgical Interface: Evidence from the Crossmodal Congruency Task	PLOS ONE			English	Article							MINIMALLY INVASIVE SURGERY; PERIPERSONAL SPACE; TOUCH; REPRESENTATION; PERFORMANCE; ASSISTANCE; FEEDBACK; NEURONS; SYSTEMS; HUMANS	The effects of real-world tool use on body or space representations are relatively well established in cognitive neuroscience. Several studies have shown, for example, that active tool use results in a facilitated integration of multisensory information in peripersonal space, i.e. the space directly surrounding the body. However, it remains unknown to what extent similar mechanisms apply to the use of virtual-robotic tools, such as those used in the field of surgical robotics, in which a surgeon may use bimanual haptic interfaces to control a surgery robot at a remote location. This paper presents two experiments in which participants used a haptic handle, originally designed for a commercial surgery robot, to control a virtual tool. The integration of multisensory information related to the virtual-robotic tool was assessed by means of the crossmodal congruency task, in which subjects responded to tactile vibrations applied to their fingers while ignoring visual distractors superimposed on the tip of the virtual-robotic tool. Our results show that active virtual-robotic tool use changes the spatial modulation of the crossmodal congruency effects, comparable to changes in the representation of peripersonal space observed during real-world tool use. Moreover, when the virtual-robotic tools were held in a crossed position, the visual distractors interfered strongly with tactile stimuli that was connected with the hand via the tool, reflecting a remapping of peripersonal space. Such remapping was not only observed when the virtual-robotic tools were actively used (Experiment 1), but also when passively held the tools (Experiment 2). The present study extends earlier findings on the extension of peripersonal space from physical and pointing tools to virtual-robotic tools using techniques from haptics and virtual reality. We discuss our data with respect to learning and human factors in the field of surgical robotics and discuss the use of new technologies in the field of cognitive neuroscience.	[Senguel, Ali; van Elk, Michiel; Rognini, Giulio; Blanke, Olaf] Ecole Polytech Fed Lausanne, Sch Life Sci, Ctr Neuroprosthet, Lausanne, Switzerland; [Senguel, Ali; van Elk, Michiel; Rognini, Giulio; Aspell, Jane Elizabeth; Blanke, Olaf] Ecole Polytech Fed Lausanne, Cognit Neurosci Lab, Brain Mind Inst, Lausanne, Switzerland; [Senguel, Ali; Rognini, Giulio; Bleuler, Hannes] Ecole Polytech Fed Lausanne, Syst Robot Lab, Lausanne, Switzerland; [Blanke, Olaf] Univ Hosp Geneva HUG, Dept Neurol, Geneva, Switzerland	Swiss Federal Institutes of Technology Domain; Ecole Polytechnique Federale de Lausanne; Swiss Federal Institutes of Technology Domain; Ecole Polytechnique Federale de Lausanne; Swiss Federal Institutes of Technology Domain; Ecole Polytechnique Federale de Lausanne; University of Geneva	Sengul, A (corresponding author), Ecole Polytech Fed Lausanne, Sch Life Sci, Ctr Neuroprosthet, Lausanne, Switzerland.	ali.sengul@epfl.ch	Aspell, Jane/K-6230-2019	Aspell, Jane/0000-0002-4757-2124	European Community [FP7-ICT-2007-2, FP7-ICT-2009.5.2]; Marie Curie Grant (IEF) [252713]; European Science Foundation; Swiss National Science Foundation; Bertarelli Foundation	European Community(European Commission); Marie Curie Grant (IEF); European Science Foundation(European Science Foundation (ESF)European Commission); Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Bertarelli Foundation	A. Sengul was supported by ARAKNES project, a European Community's Seventh Framework Programme (FP7-ICT-2007-2) and SAFROS project, a European Community's Seventh Framework Programme research project (FP7-ICT-2009.5.2), M. van Elk was supported by a Marie Curie Grant (IEF grant 252713). O. Blanke is supported by the European Science Foundation, the Swiss National Science Foundation, and the Bertarelli Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aspell JE, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006488; Bassolino M, 2010, NEUROPSYCHOLOGIA, V48, P803, DOI 10.1016/j.neuropsychologia.2009.11.009; Farne A, 2005, NEUROPSYCHOLOGIA, V43, P238, DOI 10.1016/j.neuropsychologia.2004.11.010; Goldenberg G, 2009, BRAIN, V132, P1645, DOI 10.1093/brain/awp080; Holmes NP, 2007, CORTEX, V43, P469, DOI 10.1016/S0010-9452(08)70471-4; Holmes NP, 2012, EXP BRAIN RES, V218, P273, DOI 10.1007/s00221-012-3042-7; Holmes NP, 2004, NEUROSCI LETT, V372, P62, DOI 10.1016/j.neulet.2004.09.024; Holmes NP, 2006, BEYOND THE BODY VISU; Iriki A, 1996, NEUROREPORT, V7, P2325; Iriki A, 2001, NEUROSCI RES, V40, P163, DOI 10.1016/S0168-0102(01)00225-5; Iriki ATM, PHIL TRANS R SOC B I; Ishibashi H, 2000, CAN J PHYSIOL PHARM, V78, P958, DOI 10.1139/cjpp-78-11-958; Kenngott HG, 2012, LANGENBECK ARCH SURG, V397, P333, DOI 10.1007/s00423-011-0859-7; Ladavas E, 2008, COGN NEUROPSYCHOL, V25, P1099, DOI 10.1080/02643290802359113; Lee EC, 2005, SURG ENDOSC, V19, P1064, DOI 10.1007/s00464-004-8213-6; Maravita A, 2004, TRENDS COGN SCI, V8, P79, DOI 10.1016/j.tics.2003.12.008; Maravita A, 2002, COGNITION, V83, pB25, DOI 10.1016/S0010-0277(02)00003-3; Maravita A, 2006, FROM BODY IN THE BRA; Moizumi S, 2007, NEUROSCI RES, V59, P60, DOI 10.1016/j.neures.2007.05.013; Narazaki K, 2006, SURG ENDOSC, V20, P96, DOI 10.1007/s00464-005-3011-3; Octavia JR, 2011, MULTIMED TOOLS APPL, V54, P121, DOI 10.1007/s11042-010-0525-z; Okamura AM, 2009, CURR OPIN UROL, V19, P102, DOI 10.1097/MOU.0b013e32831a478c; Pavani F, 2000, PSYCHOL SCI, V11, P353, DOI 10.1111/1467-9280.00270; Peeters R, 2009, J NEUROSCI, V29, P11523, DOI 10.1523/JNEUROSCI.2040-09.2009; Prasad SM, 2002, AM J SURG, V183, P702, DOI 10.1016/S0002-9610(02)00871-1; Rassweiler J, 2005, MINIM INVASIV THER, V14, P109, DOI 10.1080/13645700510010908; Rognini G, 2012, EUR J NEUROSCI; Rosen J, 2011, SURGICAL ROBOTICS: SYSTEMS APPLICATIONS AND VISIONS, P1, DOI 10.1007/978-1-4419-1126-1; Santos-Carreras L, 2010, APPL BIONICS BIOMECH, V7, P217, DOI 10.1080/11762322.2010.503110; Santos-Carreras L, 2011, SURG INNOV; Shore DI, 2006, NEUROSCI LETT, V392, P96, DOI 10.1016/j.neulet.2005.09.001; Stone R, 2000, SPRINGER VERLAG LECT, P1; Suematsu Y, 2004, AM J SURG, V188, p98S, DOI 10.1016/j.amjsurg.2004.08.003; Tavakoli M, 2007, IEEE T SYST MAN CY B, V37, P1512, DOI 10.1109/TSMCB.2007.903700; Zopf R, 2010, NEUROPSYCHOLOGIA, V48, P713, DOI 10.1016/j.neuropsychologia.2009.10.028	35	39	39	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 5	2012	7	12							e49473	10.1371/journal.pone.0049473	http://dx.doi.org/10.1371/journal.pone.0049473			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	057TZ	23227142	Green Published, Green Submitted, gold			2022-12-27	WOS:000312588200005
J	Tekle, YI; Nielsen, KM; Liu, JZ; Pettigrew, MM; Meyers, LA; Galvani, AP; Townsend, JP				Tekle, Yonas I.; Nielsen, Kaare M.; Liu, Jingzhou; Pettigrew, Melinda M.; Meyers, Lauren A.; Galvani, Alison P.; Townsend, Jeffrey P.			Controlling Antimicrobial Resistance through Targeted, Vaccine-Induced Replacement of Strains	PLOS ONE			English	Article							PNEUMOCOCCAL CONJUGATE VACCINES; ACUTE OTITIS-MEDIA; STAPHYLOCOCCUS-AUREUS; STREPTOCOCCUS-PNEUMONIAE; HAEMOPHILUS-INFLUENZAE; SEROTYPE REPLACEMENT; MOLECULAR ANALYSIS; INVASIVE DISEASE; UNITED-STATES; COMMUNITY	Vaccination has proven effective in controlling many infectious diseases. However, differential effectiveness with regard to pathogen genotype is a frequent reason for failures in vaccine development. Often, insufficient immune response is induced to prevent infection by the diversity of existing serotypes present in pathogenic populations of bacteria. These vaccines that target a too narrow spectrum of serotypes do not offer sufficient prevention of infections, and can also lead to undesirable strain replacements. Here, we examine a novel idea to specifically exploit the narrow spectrum coverage of some vaccines to combat specific, emerging multi- and pan-resistant strains of pathogens. Application of a narrow-spectrum vaccine could serve to prevent infections by some strains that are hard to treat, rather than offer the vaccinated individual protection against infections by the pathogenic species as such. We suggest that vaccines targeted to resistant serotypes have the potential to become important public health tools, and would represent a new approach toward reducing the burden of particular multi-resistant strains occurring in hospitals. Vaccines targeting drug-resistant serotypes would also be the first clinical intervention with the potential to drive the evolution of pathogenic populations toward drug-sensitivity. We illustrate the feasibility of this approach by modeling a hypothetical vaccine that targets a subset of methicillin-resistant Staphylococcus aureus (MRSA) genotypes, in combination with drug treatment targeted at drug-sensitive genotypes. We find that a combined intervention strategy can limit nosocomial outbreaks, even when vaccine efficacy is imperfect. The broader utility of vaccine-based resistance control strategies should be further explored taking into account population structure, and the resistance and transmission patterns of the pathogen considered.	[Tekle, Yonas I.; Liu, Jingzhou; Pettigrew, Melinda M.; Galvani, Alison P.] Yale Univ, Sch Med, Dept Epidemiol & Publ Hlth, New Haven, CT 06510 USA; [Tekle, Yonas I.; Galvani, Alison P.; Townsend, Jeffrey P.] Yale Univ, Dept Ecol & Evolutionary Biol, Sch Med, New Haven, CT USA; [Nielsen, Kaare M.] Univ Tromso, Dept Pharm, Tromso, Norway; [Nielsen, Kaare M.] Genok Ctr Biosafety, Tromso, Norway; [Townsend, Jeffrey P.] Yale Univ, Grad Program Microbiol, New Haven, CT USA; [Meyers, Lauren A.] Univ Texas Austin, Sect Integrat Biol, Austin, TX 78712 USA; [Meyers, Lauren A.] Santa Fe Inst, Santa Fe, NM 87501 USA; [Tekle, Yonas I.] Spelman Coll, Dept Biol, Atlanta, GA 30314 USA	Yale University; Yale University; UiT The Arctic University of Tromso; Yale University; University of Texas System; University of Texas Austin; The Santa Fe Institute; Spelman College	Tekle, YI (corresponding author), Yale Univ, Sch Med, Dept Epidemiol & Publ Hlth, New Haven, CT 06510 USA.	ytekle@spelman.edu	Liu, J/C-5620-2013; Townsend, Jeffrey/H-2747-2019; Nielsen, Kaare Magne/G-8107-2018	Townsend, Jeffrey/0000-0002-9890-3907; Nielsen, Kaare Magne/0000-0002-7217-2114; Meyers, Lauren/0000-0002-5828-8874; Pettigrew, Melinda/0000-0001-8145-7536	NIH MIDAS [U01 GM087719-01]; ASPIRE; NSF [HRD-0714553]; Faculty of Health Science, University of Tromso; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [U01GM087719] Funding Source: NIH RePORTER	NIH MIDAS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); ASPIRE; NSF(National Science Foundation (NSF)); Faculty of Health Science, University of Tromso; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	The authors gratefully acknowledge support of NIH MIDAS grant U01 GM087719-01. YIT acknowledge financial support from ASPIRE, NSF grant HRD-0714553. KMN acknowledge financial support from The Faculty of Health Science, University of Tromso. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bagnoli F, 2012, FRONTIERS CELLULAR I; Bagnoli F, 2011, OMICS, V15, P545, DOI 10.1089/omi.2010.0127; Bahl J, 2009, VIROLOGY, V390, P289, DOI 10.1016/j.virol.2009.05.002; Bancroft EA, 2007, JAMA-J AM MED ASSOC, V298, P1803, DOI 10.1001/jama.298.15.1803; Boyce JM, 1998, JAMA-J AM MED ASSOC, V279, P623, DOI 10.1001/jama.279.8.623; Catalano G, 2003, SOUTH MED J, V96, P141, DOI 10.1097/01.SMJ.0000050683.36014.2E; Cespedes C, 2005, J INFECT DIS, V191, P444, DOI 10.1086/427240; Chambers HF, 2001, EMERG INFECT DIS, V7, P178, DOI 10.3201/eid0702.010204; COLLEY EW, 1965, LANCET, V1, P595; D'Agata EMC, 2010, MATH MODEL NAT PHENO, V5, P76, DOI 10.1051/mmnp/20105306; D'Agata EMC, 2009, CLIN INFECT DIS, V48, P274, DOI 10.1086/595844; Dall'Antonia M, 2005, J HOSP INFECT, V61, P62, DOI 10.1016/j.jhin.2005.01.008; Enright MC, 2002, P NATL ACAD SCI USA, V99, P7687, DOI 10.1073/pnas.122108599; Eskola J, 2001, NEW ENGL J MED, V344, P403, DOI 10.1056/NEJM200102083440602; Feikin DR, 2002, CLIN INFECT DIS, V35, P547, DOI 10.1086/341896; Feng ZL, 1997, J MATH BIOL, V35, P523, DOI 10.1007/s002850050064; Fey PD, 2003, ANTIMICROB AGENTS CH, V47, P196, DOI 10.1128/AAC.47.1.196-203.2003; Gonzalez BE, 2006, PEDIATR INFECT DIS J, V25, P301, DOI 10.1097/01.inf.0000207484.52850.38; Grundmann H, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000215; Hallander HO, 2005, J CLIN MICROBIOL, V43, P2856, DOI 10.1128/JCM.43.6.2856-2865.2005; Iannelli M, 2005, MATH BIOSCI, V195, P23, DOI 10.1016/j.mbs.2005.01.004; Kajita E, 2007, NAT REV MICROBIOL, V5, P700, DOI 10.1038/nrmicro1660; Khatib R, 2003, J CLIN MICROBIOL, V41, P1717, DOI 10.1128/JCM.41.4.1717-1719.2003; Klein E, 2007, EMERG INFECT DIS, V13, P1840, DOI 10.3201/eid1312.070629; Lipsitch M, 1999, EMERG INFECT DIS, V5, P336, DOI 10.3201/eid0503.990304; Lipsitch M, 2001, AM J EPIDEMIOL, V154, P85, DOI 10.1093/aje/154.1.85; Lowy FD, 1998, NEW ENGL J MED, V339, P520, DOI 10.1056/NEJM199808203390806; McCarthy NL, 2010, AM J INFECT CONTROL, V38, P600, DOI 10.1016/j.ajic.2010.01.006; McEllistrem MC, 2003, J INFECT DIS, V188, P1679, DOI 10.1086/379665; Naimi TS, 2003, JAMA-J AM MED ASSOC, V290, P2976, DOI 10.1001/jama.290.22.2976; Okuma K, 2002, J CLIN MICROBIOL, V40, P4289, DOI 10.1128/JCM.40.11.4289-4294.2002; Perez-Trallero E, 2002, LANCET, V360, P953, DOI 10.1016/S0140-6736(02)11061-0; Ribeiro GS, 2003, J INFECT DIS, V187, P109, DOI 10.1086/345863; ROBBINS JB, 1983, J INFECT DIS, V148, P1136, DOI 10.1093/infdis/148.6.1136; Robinson DA, 2003, ANTIMICROB AGENTS CH, V47, P3926, DOI 10.1128/AAC.47.12.3926-3934.2003; SARAVOLATZ LD, 1982, ANN INTERN MED, V96, P11, DOI 10.7326/0003-4819-96-1-11; Schaffer AC, 2009, INFECT DIS CLIN N AM, V23, P153, DOI 10.1016/j.idc.2008.10.005; Scott JAG, 1996, CLIN INFECT DIS, V22, P973, DOI 10.1093/clinids/22.6.973; Shinefield HR, 2000, PEDIATR INFECT DIS J, V19, P394, DOI 10.1097/00006454-200004000-00036; Spellberg B, 2011, SEMIN IMMUNOPATHOL; Spratt BG, 2000, LANCET, V356, P1210, DOI 10.1016/S0140-6736(00)02779-3; Stelfox HT, 2003, JAMA-J AM MED ASSOC, V290, P1899, DOI 10.1001/jama.290.14.1899; Tarzi S, 2001, J HOSP INFECT, V49, P250, DOI 10.1053/jhin.2001.1098; Urwin G, 1996, CLIN INFECT DIS, V22, P1069, DOI 10.1093/clinids/22.6.1069; Varrone John J, 2011, Bonekey Osteovision, V8, P187; Webb GF, 2009, J BIOL DYNAM, V48, P271; Willems RJL, 2011, FEMS MICROBIOL REV, V35, P872, DOI 10.1111/j.1574-6976.2011.00284.x	47	20	20	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 5	2012	7	12							e50688	10.1371/journal.pone.0050688	http://dx.doi.org/10.1371/journal.pone.0050688			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	057TZ	23227198	Green Submitted, gold, Green Published			2022-12-27	WOS:000312588200057
J	Zanlungo, F; Ikeda, T; Kanda, T				Zanlungo, Francesco; Ikeda, Tetsushi; Kanda, Takayuki			A Microscopic "Social Norm'' Model to Obtain Realistic Macroscopic Velocity and Density Pedestrian Distributions	PLOS ONE			English	Article							FORCE MODEL	We propose a way to introduce in microscopic pedestrian models a "social norm'' in collision avoiding and overtaking, i.e. the tendency, shared by pedestrians belonging to the same culture, to avoid collisions and perform overtaking in a preferred direction. The "social norm'' is implemented, regardless of the specific collision avoiding model, as a rotation in the perceived velocity vector of the opponent at the moment of computation of the collision avoiding strategy, and justified as an expectation that the opponent will follow the same "social norm'' (for example a tendency to avoid on the left and overtake on the right, as proposed in this work for Japanese pedestrians). By comparing with real world data, we show that the introduction of this norm allows for a better reproduction of macroscopic pedestrian density and velocity patterns.	[Zanlungo, Francesco; Ikeda, Tetsushi; Kanda, Takayuki] ATR, Intelligent Robot & Commun Labs, Kyoto, Japan; [Zanlungo, Francesco; Ikeda, Tetsushi; Kanda, Takayuki] Japan Sci & Technol Agcy, CREST, Tokyo, Japan	Japan Science & Technology Agency (JST)	Zanlungo, F (corresponding author), ATR, Intelligent Robot & Commun Labs, Kyoto, Japan.	zanlungo@atr.jp	Kanda, Takayuki/I-5843-2016	Kanda, Takayuki/0000-0002-9546-5825	Japan Science and Technology Agency, CREST	Japan Science and Technology Agency, CREST(Japan Science & Technology Agency (JST)Core Research for Evolutional Science and Technology (CREST))	This research has been funded by the Japan Science and Technology Agency, CREST (http://www.jst.go.jp/kisoken/crest/en/index.html). The research area is "Creation of Human-Harmonized Information Technology for Convivial Society'' (http://www.jst.go.jp/kisoken/crest/en/research_area/ongoing/areah21-1.html) and the project is "Enabling a mobile social robot to adapt to a public space in a city'' (project leader TK) (http://www.jst.go.jp/kisoken/crest/en/areah21/1-11.html). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AVENI AF, 1977, SOCIOMETRY, V40, P96, DOI 10.2307/3033551; COLEMAN JS, 1961, SOCIOMETRY, V24, P36, DOI 10.2307/2785927; Glas DF, 2009, ADV ROBOTICS, V23, P405, DOI 10.1163/156855309X408754; Guy SJ, 2012, PHYS REV E, V85, DOI 10.1103/PhysRevE.85.016110; HELBING D, 1995, PHYS REV E, V51, P4282, DOI 10.1103/PhysRevE.51.4282; Helbing D, 2001, ENVIRON PLANN B, V28, P361, DOI 10.1068/b2697; Helbing D, 2002, PEDESTRIAN EVACUATIO, V21; Helbing D, 2010, ENCY COMPLEXITY SYST, P6476, DOI DOI 10.1007/978-0-387-30440-3_382; Hoogendoorn S, 2005, TRAFFIC AND GRANULAR FLOW '03, P373, DOI 10.1007/3-540-28091-X_36; James John, 1953, AM SOCIOLOGICAL REV; Johansson Anders, 2007, PEDESTRIAN EVACUATIO, P267, DOI DOI 10.1007/978-3-540-47064-9; Johanssons A, 2007, ADV COMPLEX SYST, p[10, 271], DOI DOI 10.1142/S0219525907001355; Kretz T, 2006, J STAT MECH-THEORY E, DOI 10.1088/1742-5468/2006/10/P10001; Moussaid M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010047; Moussaid M, 2009, P ROY SOC B-BIOL SCI, V276, P2755, DOI 10.1098/rspb.2009.0405; Nolfi S., 2000, EVOLUTIONARY ROBOTIC; Ondrej J, 2010, ACM T GRAPHIC, V29, DOI 10.1145/1778765.1778860; Reynolds CW., 1999, GAM DEV C, P763; Rudloff C, 2012, PED EV DYN IN PRESS, V2012; Shukla PK, 2010, LECT NOTES COMPUT SC, V6024, P21, DOI 10.1007/978-3-642-12239-2_3; Zanlungo F, 2011, EPL-EUROPHYS LETT, V93, DOI 10.1209/0295-5075/93/68005; Zanlungo F, 2012, PEDESTRIAN IN PRESS	22	25	25	2	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 5	2012	7	12							e50720	10.1371/journal.pone.0050720	http://dx.doi.org/10.1371/journal.pone.0050720			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	057TZ	23227202	Green Published, Green Submitted, gold			2022-12-27	WOS:000312588200061
J	Ara, MN; Hyodo, M; Ohga, N; Hida, K; Harashima, H				Ara, Mst. Naznin; Hyodo, Mamoru; Ohga, Noritaka; Hida, Kyoko; Harashima, Hideyoshi			Development of a Novel DNA Aptamer Ligand Targeting to Primary Cultured Tumor Endothelial Cells by a Cell-Based SELEX Method	PLOS ONE			English	Article							MOLECULAR RECOGNITION; SYSTEMATIC EVOLUTION; RNA APTAMERS; LIVE CELLS; ANGIOGENESIS; SELECTION; PROBES; CHAIN	The present study used a spontaneous cell-based SELEX method (Systemic Evolution of Ligands by EXponential Enrichment) to produce DNA aptamers that specifically bind to cell surface proteins or biomarkers produced by primary cultured mouse tumor endothelial cells (mTECs). In solid tumors, new blood vessels are formed through an angiogenesis process, and this plays a critical role in cancer development as well as metastasis. To combat angiogenesis, an appropriate diagnosis and a molecular-level understanding of the different cancer types are now a high priority. The novel DNA aptamer AraHH001, developed in this study, binds specifically to mTECs with high affinity in the nano-molar range, but does not bind to normal skin endothelial cells (skin-ECs). The selected DNA aptamer was also found to bind to cultured human tumor endothelial cells (hTECs), isolated from a clinical patient with a renal carcinoma. The aptamer AraHH001 showed significant anti-angiogenesis activity by inhibiting tube formation by mTECs on matrigel. Interestingly, a confocal laser scanning microscopy examination of in vitro cellular uptake revealed that AraHH001 was assimilated by mTECs, and became co-localized in acidic compartments, as detected by labeling with Lysotracker Red. Therefore, the development of a specific DNA aptamer that binds to mTECs, as reported here for the first time, holds great promise not only as a therapeutic aptamer but also as a targeted molecular probe that appears to play a major role in angiogenesis, and for the development of a targeted new drug delivery system. Citation: Ara MN, Hyodo M, Ohga N, Hida K, Harashima H (2012) Development of a Novel DNA Aptamer Ligand Targeting to Primary Cultured Tumor Endothelial Cells by a Cell-Based SELEX Method. PLoS ONE 7(12): e50174. doi:10.1371/journal.pone.0050174	[Ara, Mst. Naznin; Hyodo, Mamoru; Harashima, Hideyoshi] Hokkaido Univ, Fac Pharmaceut Sci, Lab Innovat Nanomed, Sapporo, Hokkaido 060, Japan; [Ohga, Noritaka; Hida, Kyoko] Hokkaido Univ, Div Vasc Biol, Grad Sch Dent Med, Sapporo, Hokkaido, Japan	Hokkaido University; Hokkaido University	Hyodo, M (corresponding author), Hokkaido Univ, Fac Pharmaceut Sci, Lab Innovat Nanomed, Kita 12, Sapporo, Hokkaido 060, Japan.	hyodo_mam@pharm.hokudai.ac.jp	Hida, Kyoko/AAE-3183-2020; Hida, Kyoko/A-8444-2012; Hyodo, Mamoru/D-5496-2012	Hida, Kyoko/0000-0002-7968-6062; Hyodo, Mamoru/0000-0002-1766-3949	Special Education and Research Expenses of the Ministry of Education, Culture, Sports, Science and Technology of Japan; Ministry of Education, Culture, Sports, Science and Technology of Japan [11018330]; Grants-in-Aid for Scientific Research [23700552] Funding Source: KAKEN	Special Education and Research Expenses of the Ministry of Education, Culture, Sports, Science and Technology of Japan; Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This study was supported by grants from the Special Education and Research Expenses of the Ministry of Education, Culture, Sports, Science and Technology of Japan. This study was also supported by Grant-In-Aid for Young Scientists (B, 11018330) from the Ministry of Education, Culture, Sports, Science and Technology of Japan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akino T, 2009, AM J PATHOL, V175, P2657, DOI 10.2353/ajpath.2009.090202; Arnaoutova I, 2010, NAT PROTOC, V5, P628, DOI 10.1038/nprot.2010.6; Arnaoutova I, 2009, ANGIOGENESIS, V12, P267, DOI 10.1007/s10456-009-9146-4; BEAUCAGE SL, 1992, TETRAHEDRON, V48, P2223, DOI 10.1016/S0040-4020(01)88752-4; Berzovski MV, 2008, J AM CHEM SOC, V130, P971; Bunka DHJ, 2006, NAT REV MICROBIOL, V4, P588, DOI 10.1038/nrmicro1458; Cibiel A, 2011, PHARMACEUTICALS-BASE, V4, P1216, DOI 10.3390/ph4091216; Colas P, 1996, NATURE, V380, P548, DOI 10.1038/380548a0; Daniels DA, 2003, P NATL ACAD SCI USA, V100, P15416, DOI 10.1073/pnas.2136683100; ELLINGTON AD, 1990, NATURE, V346, P818, DOI 10.1038/346818a0; Ferrara N, 2005, NATURE, V438, P967, DOI 10.1038/nature04483; Ferreira CSM, 2009, NUCLEIC ACIDS RES, V37, P866, DOI 10.1093/nar/gkn967; FOLKMAN J, 1971, NEW ENGL J MED, V285, P1182; Folkman J, 2007, NAT REV DRUG DISCOV, V6, P273, DOI 10.1038/nrd2115; GYLLENSTEN UB, 1988, P NATL ACAD SCI USA, V85, P7652, DOI 10.1073/pnas.85.20.7652; Hicke BJ, 2006, J NUCL MED, V47, P668; Hida K, 2005, CANCER RES, V65, P2507, DOI 10.1158/0008-5472.CAN-05-0002; Hida K, 2004, CANCER RES, V64, P8249, DOI 10.1158/0008-5472.CAN-04-1567; Hida K, 2008, CANCER SCI, V99, P459, DOI 10.1111/j.1349-7006.2007.00704.x; Homann M, 2001, BIOORGAN MED CHEM, V9, P2571, DOI 10.1016/S0968-0896(01)00032-3; Ishii K, 2009, NAT MED, V15, P259, DOI 10.1038/nm.1910; Kandimalla KK, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004627; Keefe AD, 2010, NAT REV DRUG DISCOV, V9, P537, DOI 10.1038/nrd3141; Khati M, 2010, J CLIN PATHOL, V63, P480, DOI 10.1136/jcp.2008.062786; KINOUCHI T, 1985, IN VITRO CELL DEV B, V21, P195, DOI 10.1007/BF02620929; Kurosu T, 2011, BRIT J CANCER, V104, P819, DOI 10.1038/bjc.2011.20; Mallikaratchy P, 2007, MOL CELL PROTEOMICS, V6, P2230, DOI 10.1074/mcp.M700026-MCP200; Matsuda K, 2010, BIOCHEM BIOPH RES CO, V394, P947, DOI 10.1016/j.bbrc.2010.03.089; Meng L, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014018; Morris KN, 1998, P NATL ACAD SCI USA, V95, P2902, DOI 10.1073/pnas.95.6.2902; Ohga N, 2012, AM J PATHOL, V180, P1294, DOI 10.1016/j.ajpath.2011.11.035; Ray P, 2010, PHARMACEUTICALS, V3, P1761, DOI 10.3390/ph3061761; Reyes-Reyes EM, 2010, CANCER RES, V70, P8617, DOI 10.1158/0008-5472.CAN-10-0920; Sefah K, 2009, LEUKEMIA, V23, P235, DOI 10.1038/leu.2008.335; Sefah K, 2010, NAT PROTOC, V5, P1169, DOI 10.1038/nprot.2010.66; Sefah K, 2009, ANALYST, V134, P1765, DOI 10.1039/b905609m; Shangguan D, 2008, J PROTEOME RES, V7, P2133, DOI 10.1021/pr700894d; Shangguan D, 2006, P NATL ACAD SCI USA, V103, P11838, DOI 10.1073/pnas.0602615103; Shi H, 2010, CHEM-ASIAN J, V5, P2209, DOI 10.1002/asia.201000242; Srisawat C, 2010, NUCLEIC ACIDS RES, V38, P8306, DOI 10.1093/nar/gkq696; Tang ZW, 2007, ANAL CHEM, V79, P4900, DOI 10.1021/ac070189y; Tang ZW, 2009, CLIN CHEM, V55, P813, DOI 10.1373/clinchem.2008.113514; TUERK C, 1990, SCIENCE, V249, P505, DOI 10.1126/science.2200121; Xiao ZY, 2008, CHEM-EUR J, V14, P1769, DOI 10.1002/chem.200701330; Zhang KJ, 2012, CHEMMEDCHEM, V7, P79, DOI 10.1002/cmdc.201100457; Zhao ZL, 2009, ANALYST, V134, P1808, DOI 10.1039/b904476k	46	30	33	1	77	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 4	2012	7	12							e50174	10.1371/journal.pone.0050174	http://dx.doi.org/10.1371/journal.pone.0050174			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	051EQ	23226512	Green Published, Green Submitted, gold			2022-12-27	WOS:000312108500011
J	Bulk, E; Yu, J; Hascher, A; Koschmieder, S; Wiewrodt, R; Krug, U; Timmermann, B; Marra, A; Hillejan, L; Wiebe, K; Berdel, WE; Schwab, A; Muller-Tidow, C				Bulk, Etmar; Yu, Jun; Hascher, Antje; Koschmieder, Steffen; Wiewrodt, Rainer; Krug, Utz; Timmermann, Bernd; Marra, Alessandro; Hillejan, Ludger; Wiebe, Karsten; Berdel, Wolfgang E.; Schwab, Albrecht; Mueller-Tidow, Carsten			Mutations of the EPHB6 Receptor Tyrosine Kinase Induce a Pro-Metastatic Phenotype in Non-Small Cell Lung Cancer	PLOS ONE			English	Article							BREAST-CARCINOMA CELLS; SOMATIC MUTATIONS; GENE-EXPRESSION; INVASIVENESS; PROMOTER; EPHRINS; EFNB2; STAGE; TRKA	Alterations of Eph receptor tyrosine kinases are frequent events in human cancers. Genetic variations of EPHB6 have been described but the functional outcome of these alterations is unknown. The current study was conducted to screen for the occurrence and to identify functional consequences of EPHB6 mutations in non-small cell lung cancer. Here, we sequenced the entire coding region of EPHB6 in 80 non-small cell lung cancer patients and 3 tumor cell lines. Three potentially relevant mutations were identified in primary patient samples of NSCLC patients (3.8%). Two point mutations led to instable proteins. An in frame deletion mutation (del915-917) showed enhanced migration and accelerated wound healing in vitro. Furthermore, the del915-917 mutation increased the metastatic capability of NSCLC cells in an in vivo mouse model. Our results suggest that EPHB6 mutations promote metastasis in a subset of patients with non-small cell lung cancer.	[Bulk, Etmar; Yu, Jun; Hascher, Antje; Koschmieder, Steffen; Wiewrodt, Rainer; Krug, Utz; Berdel, Wolfgang E.; Mueller-Tidow, Carsten] Univ Munster, Dept Med Hematol A, Munster, Germany; [Bulk, Etmar; Schwab, Albrecht] Univ Munster, Inst Physiol 2, Munster, Germany; [Yu, Jun] Fourth Mil Med Univ, Sch Basic Med Sci, Ctr Teaching Expt, Xian 710032, Shaanxi, Peoples R China; [Timmermann, Bernd] Max Planck Inst Mol Genet, D-14195 Berlin, Germany; [Marra, Alessandro; Hillejan, Ludger] Niels Stensen Hosp Ostercappeln, Dept Thorac Surg, Ostercappeln, Germany; [Wiebe, Karsten] Univ Munster, Dept Thorac Surg, Munster, Germany	University of Munster; University of Munster; Air Force Military Medical University; Max Planck Society; University of Munster	Muller-Tidow, C (corresponding author), Univ Munster, Dept Med Hematol A, Munster, Germany.	muellerc@uni-muenster.de	Müller-Tidow, Carsten CMT/B-5257-2014; Müller-Tidow, Carsten/O-7207-2018	Müller-Tidow, Carsten/0000-0002-7166-5232; Koschmieder, Steffen/0000-0002-1011-8171	Deutsche Krebshilfe; Wilhelm-Sander Stiftung; DFG Schw [407/9-3]	Deutsche Krebshilfe(Deutsche Krebshilfe); Wilhelm-Sander Stiftung; DFG Schw(German Research Foundation (DFG))	NSCLC research in our laboratory is funded by the Deutsche Krebshilfe and the Wilhelm-Sander Stiftung. A.S. was funded by DFG Schw 407/9-3. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 1997, Cell, V90, P403; Ansari J, 2009, ANTI-CANCER AGENT ME, V9, P569, DOI 10.2174/187152009788451879; Balakrishnan A, 2007, CANCER RES, V67, P3545, DOI 10.1158/0008-5472.CAN-07-0065; Campbell TN, 2008, CURR ISSUES MOL BIOL, V10, P61; Castano J, 2008, HISTOL HISTOPATHOL, V23, P1011, DOI 10.14670/HH-23.1011; Ding L, 2008, NATURE, V455, P1069, DOI 10.1038/nature07423; Fox BP, 2009, ONCOGENE, V28, P1706, DOI 10.1038/onc.2009.18; Fox BP, 2006, BIOCHEM BIOPH RES CO, V340, P268, DOI 10.1016/j.bbrc.2005.11.174; Fox BP, 2004, BIOCHEM BIOPH RES CO, V318, P882, DOI 10.1016/j.bbrc.2004.04.102; Greenman C, 2007, NATURE, V446, P153, DOI 10.1038/nature05610; Gylfe AE, 2010, INT J CANCER, V127, P2974, DOI 10.1002/ijc.25529; Hafner C, 2004, CLIN CHEM, V50, P490, DOI 10.1373/clinchem.2003.026849; Hafner C, 2003, INT J ONCOL, V23, P1553; Heist RS, 2009, PHARMACOGENOMICS, V10, P59, DOI 10.2217/14622416.10.1.59; Jemal A, 2011, CA-CANCER J CLIN, V61, P133, DOI [10.3322/caac.20105, 10.3322/caac.20073]; Matsuoka H, 2005, J BIOL CHEM, V280, P29355, DOI 10.1074/jbc.M500010200; Menzel P, 2001, DEV BIOL, V230, P74, DOI 10.1006/dbio.2000.0109; Muller-Tidow C, 2005, CANCER RES, V65, P1778, DOI 10.1158/0008-5472.CAN-04-3388; Nechyporuk-Zloy V, 2008, AM J PHYSIOL-CELL PH, V294, pC1096, DOI 10.1152/ajpcell.00252.2007; Pasquale EB, 2010, NAT REV CANCER, V10, P165, DOI 10.1038/nrc2806; Ralser M, 2006, BIOCHEM BIOPH RES CO, V347, P747, DOI 10.1016/j.bbrc.2006.06.151; Santos ES, 2009, CLIN LUNG CANCER, V10, P168, DOI 10.3816/CLC.2009.n.023; Schwable J, 2005, BLOOD, V105, P2107, DOI 10.1182/blood-2004-03-0940; Tang XX, 1999, CLIN CANCER RES, V5, P1491; Tang XX, 2001, MED PEDIATR ONCOL, V36, P80, DOI 10.1002/1096-911X(20010101)36:1<80::AID-MPO1019>3.0.CO;2-N; Tang XX, 2000, MED PEDIATR ONCOL, V35, P656, DOI 10.1002/1096-911X(20001201)35:6<656::AID-MPO37>3.0.CO;2-A; Truitt L, 2010, CANCER RES, V70, P1141, DOI 10.1158/0008-5472.CAN-09-1710; VANZANDWIJK N, 1995, LUNG CANCER-J IASLC, V12, pS27, DOI 10.1016/0169-5002(95)00418-Z; Yu J, 2010, CLIN CANCER RES, V16, P2275, DOI 10.1158/1078-0432.CCR-09-2000	29	18	18	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 4	2012	7	12							e44591	10.1371/journal.pone.0044591	http://dx.doi.org/10.1371/journal.pone.0044591			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	051EQ	23226491	Green Published, Green Submitted, gold			2022-12-27	WOS:000312108500001
J	Gallagher, RM; Mason, JR; Bird, KA; Kirkham, JJ; Peak, M; Williamson, PR; Nunn, AJ; Turner, MA; Pirmohamed, M; Smyth, RL				Gallagher, Ruairi M.; Mason, Jennifer R.; Bird, Kim A.; Kirkham, Jamie J.; Peak, Matthew; Williamson, Paula R.; Nunn, Anthony J.; Turner, Mark A.; Pirmohamed, Munir; Smyth, Rosalind L.			Adverse Drug Reactions Causing Admission to a Paediatric Hospital	PLOS ONE			English	Article							CHILDREN; METAANALYSIS; PREVENTABILITY; DEXAMETHASONE; TONSILLECTOMY; DEFINITIONS; MANAGEMENT; FREQUENCY; MIDAZOLAM; SEIZURES	Objective(s): To obtain reliable information about the incidence of adverse drug reactions, and identify potential areas where intervention may reduce the burden of ill-health. Design: Prospective observational study. Setting: A large tertiary children's hospital providing general and specialty care in the UK. Participants: All acute paediatric admissions over a one year period. Main Exposure: Any medication taken in the two weeks prior to admission. Outcome Measures: Occurrence of adverse drug reaction. Results: 240/8345 admissions in 178/6821 patients admitted acutely to a paediatric hospital were thought to be related to an adverse drug reaction, giving an estimated incidence of 2.9% (95% CI 2.5, 3.3), with the reaction directly causing, or contributing to the cause, of admission in 97.1% of cases. No deaths were attributable to an adverse drug reaction. 22.1% (95% CI 17%, 28%) of the reactions were either definitely or possibly avoidable. Prescriptions originating in the community accounted for 44/249 (17.7%) of adverse drug reactions, the remainder originating from hospital. 120/249 (48.2%) reactions resulted from treatment for malignancies. The drugs most commonly implicated in causing admissions were cytotoxic agents, corticosteroids, non-steroidal anti-inflammatory drugs, vaccines and immunosuppressants. The most common reactions were neutropenia, immunosuppression and thrombocytopenia. Conclusions: Adverse drug reactions in children are an important public health problem. Most of those serious enough to require hospital admission are due to hospital-based prescribing, of which just over a fifth may be avoidable. Strategies to reduce the burden of ill-health from adverse drug reactions causing admission are needed. Citation: Gallagher RM, Mason JR, Bird KA, Kirkham JJ, Peak M, et al. (2012) Adverse Drug Reactions Causing Admission to a Paediatric Hospital. PLoS ONE 7(12): e50127. doi: 10.1371/journal.pone.0050127	[Gallagher, Ruairi M.; Turner, Mark A.; Smyth, Rosalind L.] Univ Liverpool, Dept Womens & Childrens Hlth, Liverpool L69 3BX, Merseyside, England; [Mason, Jennifer R.; Bird, Kim A.; Peak, Matthew] Alder Hey Childrens Hosp NHS Fdn Trust, Liverpool, Merseyside, England; [Kirkham, Jamie J.; Williamson, Paula R.] Univ Liverpool, Dept Biostat, Liverpool L69 3BX, Merseyside, England; [Nunn, Anthony J.] Univ Liverpool, Natl Inst Hlth Res Med Children Res Network, Alder Hey Hosp, Liverpool L69 3BX, Merseyside, England; [Nunn, Anthony J.] Alder Hey Childrens NHS Fdn Trust, Dept Pharm, Liverpool, Merseyside, England; [Pirmohamed, Munir] Univ Liverpool, Dept Pharmacol, Liverpool L69 3BX, Merseyside, England	University of Liverpool; Alder Hey Children's NHS Foundation Trust; University of Liverpool; Alder Hey Children's NHS Foundation Trust; Alder Hey Children's Hospital; University of Liverpool; Alder Hey Children's NHS Foundation Trust; University of Liverpool	Gallagher, RM (corresponding author), Univ Liverpool, Dept Womens & Childrens Hlth, Liverpool L69 3BX, Merseyside, England.	ruairi.gallagher@nhs.net	Kirkham, Jamie/AAD-4490-2019; Williamson, Paula R/B-6425-2016; Pirmohamed, Munir/H-6004-2011	Kirkham, Jamie/0000-0003-2579-9325; Williamson, Paula R/0000-0001-9802-6636; Pirmohamed, Munir/0000-0002-7534-7266; Peak, Matthew/0000-0003-1909-3211; Mason, Jennifer/0000-0002-1576-7234; Turner, Mark/0000-0002-5299-8656	National Institute for Health Research (NIHR [RP-PG-0606-1170]; Department of Health (England); National Institute for Health Research [RP-PG-0606-1170] Funding Source: researchfish	National Institute for Health Research (NIHR(National Institute for Health Research (NIHR)); Department of Health (England); National Institute for Health Research(National Institute for Health Research (NIHR))	This paper presents independent research commissioned by the National Institute for Health Research (NIHR) under its Programme Grants for Applied Research scheme (RP-PG-0606-1170). The views expressed are those of the author(s) and not necessarily those of the National Health Service, the NIHR or the Department of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors have declared that no competing interests exist. Munir Pirmohamed is NHS Chair of Pharmacogenetics (funded by Department of Health (England)). Rosalind Smyth and Munir Pirmohamed are members of the Commission on Human Medicines. Munir Pirmohamed Chairs the Pharmacovigilance Expert Advisory Group, while Rosalind Smyth Chairs the Paediatric Medicines Expert Advisory Group.	[Anonymous], 2008, BRIT NATL FORMULARY; Appleton R, 2008, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001905.pub2; Cardwell M, 2005, ANESTH ANALG, V101, P1558; Clavenna A, 2009, ARCH DIS CHILD, V94, P724, DOI 10.1136/adc.2008.154377; Czarnetzki C, 2008, JAMA-J AM MED ASSOC, V300, P2621, DOI 10.1001/jama.2008.794; Easton KL, 2004, BRIT J CLIN PHARMACO, V57, P611, DOI 10.1111/j.1365-2125.2003.02052.x; Edwards IR, 2000, LANCET, V356, P1255, DOI 10.1016/S0140-6736(00)02799-9; Ferner RE, 2010, DRUG SAFETY, V33, P985, DOI 10.2165/11538270-000000000-00000; Gallagher RM, 2011, J CLIN PHARM THER, V36, P194, DOI 10.1111/j.1365-2710.2010.01194.x; Gallagher RM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028096; Goldman AC, 2000, OTOLARYNG HEAD NECK, V123, P682, DOI 10.1067/mhn.2000.111354; HALLAS J, 1990, J INTERN MED, V228, P83, DOI 10.1111/j.1365-2796.1990.tb00199.x; HARTWIG SC, 1992, AM J HOSP PHARM, V49, P2229, DOI 10.1093/ajhp/49.9.2229; Hazell L, 2006, DRUG SAFETY, V29, P385, DOI 10.2165/00002018-200629050-00003; HospitalEpisodeStatistics, 2010, HOSPITALEPISODESTATI; Impicciatore P, 2001, BRIT J CLIN PHARMACO, V52, P77, DOI 10.1046/j.0306-5251.2001.01407.x; Jonville-Bera AP, 2002, BRIT J CLIN PHARMACO, V53, P207, DOI 10.1046/j.0306-5251.2001.01535.x; Kelly ME, 2010, ARCH DERMATOL, V146, P767, DOI 10.1001/archdermatol.2010.90; Lau PM, 2004, SUPPORT CARE CANCER, V12, P626, DOI 10.1007/s00520-004-0622-5; Le J, 2006, PEDIATRICS, V118, P555, DOI 10.1542/peds.2005-2429; MartinezMir I, 1996, BRIT J CLIN PHARMACO, V42, P319, DOI 10.1046/j.1365-2125.1996.04076.x; McIntyre J, 2005, LANCET, V366, P205, DOI 10.1016/S0140-6736(05)66909-7; MCKENZIE MW, 1976, J PEDIATR-US, V89, P487, DOI 10.1016/S0022-3476(76)80560-4; McMullan J, 2010, ACAD EMERG MED, V17, P575, DOI 10.1111/j.1553-2712.2010.00751.x; Medicines and Healthcare products Regulatory Agency, REP SUSP ADV DRUG RE; MITCHELL AA, 1988, PEDIATRICS, V82, P24; Rawlins MDTJ, 1977, TXB ADVERSE DRUG REA; Sasse EC, 2005, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004139.pub2; Smyth RMD, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0024061; Steward DL, 2003, COCHRANE DB SYST REV, V1; Stewart WA, 2002, ARCH DIS CHILD, V87, P225, DOI 10.1136/adc.87.3.225; Sung L, 2004, J CLIN ONCOL, V22, P3350, DOI 10.1200/JCO.2004.09.106	32	52	54	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 4	2012	7	12							e50127	10.1371/journal.pone.0050127	http://dx.doi.org/10.1371/journal.pone.0050127			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	051EQ	23226510	Green Published, Green Submitted, gold			2022-12-27	WOS:000312108500009
J	He, CQ; Meng, SL; Yan, HY; Ding, NZ; He, HB; Yan, JX; Xu, GL				He, Cheng-Qiang; Meng, Sheng-Li; Yan, Hong-Yan; Ding, Nai-Zheng; He, Hong-Bin; Yan, Jia-Xin; Xu, Ge-Lin			Isolation and Identification of a Novel Rabies Virus Lineage in China with Natural Recombinant Nucleoprotein Gene	PLOS ONE			English	Article							EVOLUTIONARY ANALYSIS; RNA RECOMBINATION; EMERGENCE; MECHANISM; GENOMES	Rabies virus (RABV) causes severe neurological disease and death. As an important mechanism for generating genetic diversity in viruses, homologous recombination can lead to the emergence of novel virus strains with increased virulence and changed host tropism. However, it is still unclear whether recombination plays a role in the evolution of RABV. In this study, we isolated and sequenced four circulating RABV strains in China. Phylogenetic analyses identified a novel lineage of hybrid origin that comprises two different strains, J and CQ92. Analyses revealed that the virus 39 untranslated region (UTR) and part of the N gene (approximate 500 nt in length) were likely derived from Chinese lineage I while the other part of the genomic sequence was homologous to Chinese lineage II. Our findings reveal that homologous recombination can occur naturally in the field and shape the genetic structure of RABV populations. Citation: He C-Q, Meng S-L, Yan H-Y, Ding N-Z, He H-B, et al. (2012) Isolation and Identification of a Novel Rabies Virus Lineage in China with Natural Recombinant Nucleoprotein Gene. PLoS ONE 7(12): e49992. doi: 10.1371/journal.pone.0049992	[He, Cheng-Qiang; Yan, Hong-Yan; Ding, Nai-Zheng] Shandong Normal Univ, Coll Life Sci, Key Lab Syst Biol Univ Shandong, Jinan, Peoples R China; [Meng, Sheng-Li; Yan, Jia-Xin; Xu, Ge-Lin] Wuhan Inst Biol Prod, Wuhan, Peoples R China; [He, Hong-Bin] Shandong Acad Agr Sci, Dairy Cattle Res Ctr, Jinan, Peoples R China	Shandong Normal University; Shandong Academy of Agricultural Sciences	He, CQ (corresponding author), Shandong Normal Univ, Coll Life Sci, Key Lab Syst Biol Univ Shandong, Jinan, Peoples R China.	hchqiang@yahoo.com.cn; hehongbin@yahoo.com			Project of Shandong Province College Teacher Visiting Scholar and Technology Program; Shandong Province Young and Middle-Aged Scientists Research Awards Fund [BS2009NY011]	Project of Shandong Province College Teacher Visiting Scholar and Technology Program; Shandong Province Young and Middle-Aged Scientists Research Awards Fund	This work was supported by a Project of Shandong Province College Teacher Visiting Scholar and Technology Program and a Shandong Province Young and Middle-Aged Scientists Research Awards Fund (BS2009NY011) to CQH. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Becher P, 2001, J VIROL, V75, P6256, DOI 10.1128/JVI.75.14.6256-6264.2001; Boni MF, 2007, GENETICS, V176, P1035, DOI 10.1534/genetics.106.068874; Boni MF, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010434; Bourhy H, 2008, J GEN VIROL, V89, P2673, DOI 10.1099/vir.0.2008/003913-0; Bruen TC, 2007, VIROLOGY, V364, P362, DOI 10.1016/j.virol.2007.03.023; Chong YL, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000872; Geue L, 2008, VACCINE, V26, P3227, DOI 10.1016/j.vaccine.2008.04.007; Gibbs MJ, 2000, BIOINFORMATICS, V16, P573, DOI 10.1093/bioinformatics/16.7.573; Han GZ, 2008, VIROLOGY, V371, P54, DOI 10.1016/j.virol.2007.09.038; He CQ, 2010, J VIROL, V84, P11487, DOI 10.1128/JVI.00889-10; Holmes E, 2003, J GEN VIROL, V84, P2691, DOI 10.1099/vir.0.19277-0; Huson DH, 2006, MOL BIOL EVOL, V23, P254, DOI 10.1093/molbev/msj030; Kew O, 2002, SCIENCE, V296, P356, DOI 10.1126/science.1068284; KIRKEGAARD K, 1986, CELL, V47, P433, DOI 10.1016/0092-8674(86)90600-8; Knobel DL, 2005, B WORLD HEALTH ORGAN, V83, P360; Krasnitz M, 2008, J VIROL, V82, P8947, DOI 10.1128/JVI.00101-08; Kuiken T, 2006, SCIENCE, V312, P394, DOI 10.1126/science.1122818; Liu W, 2011, INFECT GENET EVOL, V11, P1906, DOI 10.1016/j.meegid.2011.08.031; Lole KS, 1999, J VIROL, V73, P152, DOI 10.1128/JVI.73.1.152-160.1999; Martin D, 2000, BIOINFORMATICS, V16, P562, DOI 10.1093/bioinformatics/16.6.562; Martin DP, 2010, BIOINFORMATICS, V26, P2462, DOI 10.1093/bioinformatics/btq467; Martin DP, 2005, BIOINFORMATICS, V21, P260, DOI 10.1093/bioinformatics/bth490; Meng SL, 2007, VIRUS RES, V124, P125, DOI 10.1016/j.virusres.2006.10.011; Meng SL, 2011, VIROLOGY, V410, P403, DOI 10.1016/j.virol.2010.12.011; Meng SL, 2010, J CLIN VIROL, V49, P47, DOI 10.1016/j.jcv.2010.06.014; Ming PG, 2010, J GEN VIROL, V91, P759, DOI 10.1099/vir.0.016436-0; Padidam M, 1999, VIROLOGY, V265, P218, DOI 10.1006/viro.1999.0056; Posada D, 2001, P NATL ACAD SCI USA, V98, P13757, DOI 10.1073/pnas.241370698; Qin ZM, 2008, VIRUS RES, V131, P299, DOI 10.1016/j.virusres.2007.10.001; Rui Z, 2009, VET MICROBIOL; Schnell MJ, 2010, NAT REV MICROBIOL, V8, P51, DOI 10.1038/nrmicro2260; Si H, 2008, BMC INFECT DIS, V8, DOI 10.1186/1471-2334-8-113; SMITH JM, 1992, J MOL EVOL, V34, P126; Song QQ, 2011, J VIROL, V85, P10409, DOI 10.1128/JVI.00544-11; Spann KM, 2003, J VIROL, V77, P11201, DOI 10.1128/JVI.77.20.11201-11211.2003; Streicker DG, 2010, SCIENCE, V329, P676, DOI 10.1126/science.1188836; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; TORDO N, 1986, P NATL ACAD SCI USA, V83, P3914, DOI 10.1073/pnas.83.11.3914; Wittmann TJ, 2007, P NATL ACAD SCI USA, V104, P17123, DOI 10.1073/pnas.0704076104; Xia XH, 2003, MOL PHYLOGENET EVOL, V26, P1, DOI 10.1016/S1055-7903(02)00326-3; Zhang R, 2010, VIRUS RES, V151, P45, DOI 10.1016/j.virusres.2010.03.015	42	13	14	2	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 4	2012	7	12							e49992	10.1371/journal.pone.0049992	http://dx.doi.org/10.1371/journal.pone.0049992			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	051EQ	23226506	Green Submitted, gold, Green Published			2022-12-27	WOS:000312108500007
J	Giordano, D; Boron, I; Abbruzzetti, S; Van Leuven, W; Nicoletti, FP; Forti, F; Bruno, S; Cheng, CHC; Moens, L; di Prisco, G; Nadra, AD; Estrin, D; Smulevich, G; Dewilde, S; Viappiani, C; Verde, C				Giordano, Daniela; Boron, Ignacio; Abbruzzetti, Stefania; Van Leuven, Wendy; Nicoletti, Francesco P.; Forti, Flavio; Bruno, Stefano; Cheng, C. -H. Christina; Moens, Luc; di Prisco, Guido; Nadra, Alejandro D.; Estrin, Dario; Smulevich, Giulietta; Dewilde, Sylvia; Viappiani, Cristiano; Verde, Cinzia			Biophysical Characterisation of Neuroglobin of the Icefish, a Natural Knockout for Hemoglobin and Myoglobin. Comparison with Human Neuroglobin	PLOS ONE			English	Article							NITRIC-OXIDE; LIGAND-BINDING; MIGRATION PATHWAYS; NOTOTHENIOID FISH; SKELETAL-MUSCLE; HEME-PROTEINS; EXPRESSION; DYNAMICS; REVEALS; OXYGEN	The Antarctic icefish Chaenocephalus aceratus lacks the globins common to most vertebrates, hemoglobin and myoglobin, but has retained neuroglobin in the brain. This conserved globin has been cloned, over-expressed and purified. To highlight similarities and differences, the structural features of the neuroglobin of this colourless-blooded fish were compared with those of the well characterised human neuroglobin as well as with the neuroglobin from the retina of the red blooded, hemoglobin and myoglobin-containing, closely related Antarctic notothenioid Dissostichus mawsoni. A detailed structural and functional analysis of the two Antarctic fish neuroglobins was carried out by UV-visible and Resonance Raman spectroscopies, molecular dynamics simulations and laser-flash photolysis. Similar to the human protein, Antarctic fish neuroglobins can reversibly bind oxygen and CO in the Fe2+ form, and show six-coordination by distal His in the absence of exogenous ligands. A very large and structured internal cavity, with discrete docking sites, was identified in the modelled three-dimensional structures of the Antarctic neuroglobins. Estimate of the free-energy barriers from laser-flash photolysis and Implicit Ligand Sampling showed that the cavities are accessible from the solvent in both proteins. Comparison of structural and functional properties suggests that the two Antarctic fish neuroglobins most likely preserved and possibly improved the function recently proposed for human neuroglobin in ligand multichemistry. Despite subtle differences, the adaptation of Antarctic fish neuroglobins does not seem to parallel the dramatic adaptation of the oxygen carrying globins, hemoglobin and myoglobin, in the same organisms.	[Abbruzzetti, Stefania; Viappiani, Cristiano] Univ Parma, Dept Phys, NEST Ist Nanosci CNR, I-43100 Parma, Italy; [Giordano, Daniela; di Prisco, Guido; Verde, Cinzia] CNR, Inst Prot Biochem, I-80125 Naples, Italy; [Boron, Ignacio; Nadra, Alejandro D.; Estrin, Dario] Univ Buenos Aires, Fac Ciencias Exactas & Nat, Dept Quim Biol, Buenos Aires, DF, Argentina; [Boron, Ignacio] Univ Buenos Aires, Fac Ciencias Exactas & Nat, Dept Quim Inorgan Analit & Quim Fis INQUIMAE CONI, Buenos Aires, DF, Argentina; [Van Leuven, Wendy; Moens, Luc; Dewilde, Sylvia] Univ Antwerp, Dept Biomed Sci, PPES, Antwerp, Belgium; [Nicoletti, Francesco P.; Smulevich, Giulietta] Univ Firenze, Dipartimento Chim Ugo Schiff, Sesto Fiorentino, FI, Italy; [Forti, Flavio] Univ Barcelona, Fac Farm, Dept Fis Quim, E-08028 Barcelona, Spain; [Forti, Flavio] Univ Barcelona, Inst Biomed, Barcelona, Spain; [Bruno, Stefano] Univ Parma, Dept Biochem & Mol Biol, I-43100 Parma, Italy; [Cheng, C. -H. Christina] Univ Illinois, Dept Anim Biol, Urbana, IL 61801 USA; [Nadra, Alejandro D.] Univ Buenos Aires, Fac Ciencias Exactas & Nat, Dept Fisiol Biol Mol & Celular, Buenos Aires, DF, Argentina; [Smulevich, Giulietta] Consorzio Interuniv Ric Chim Met Sistemi Biol, Bari, Italy	Consiglio Nazionale delle Ricerche (CNR); Istituto Nanoscienze (NANO-CNR); University of Parma; Consiglio Nazionale delle Ricerche (CNR); Istituto di Biochimica delle Proteine (IBP-CNR); University of Buenos Aires; University of Buenos Aires; University of Antwerp; University of Florence; University of Barcelona; University of Barcelona; University of Parma; University of Illinois System; University of Illinois Urbana-Champaign; University of Buenos Aires	Viappiani, C (corresponding author), Univ Parma, Dept Phys, NEST Ist Nanosci CNR, I-43100 Parma, Italy.	cristiano.viappiani@fis.unipr.it; c.verde@ibp.cnr.it	abbruzzetti, stefania/M-8640-2015; Bruno, Stefano/A-4582-2011; Nadra, Alejandro/A-5668-2009; Estrin, Dario/AAY-7549-2020; Viappiani, Cristiano/AAC-7579-2019; abbruzzetti, stefania/AAE-5518-2020; Boron, Ignacio/AAE-1965-2021	abbruzzetti, stefania/0000-0001-7685-8554; Bruno, Stefano/0000-0002-7890-2472; Nadra, Alejandro/0000-0002-7860-3245; Viappiani, Cristiano/0000-0001-7470-4770; abbruzzetti, stefania/0000-0001-7685-8554; GIORDANO, DANIELA/0000-0002-8891-6245; VERDE, Cinzia/0000-0001-6185-282X; Estrin, Dario/0000-0002-5006-7225; Boron, Ignacio/0000-0003-3751-6724; Smulevich, Giulietta/0000-0003-3021-8919	Italian National Programme for Antarctic Research (PNRA) [PdR 2009/C1.03]; National Science Foundation (NSF) [OPP 0636696]; Ministero degli Affari Esteri; Direzione generale per la promozione del sistema Paese (Progetti di Grande Rilevanza, Italia-Argentina); University of Buenos Aires [20020090300117]; Agencia Nacional de Promocion Cientifica y Tecnologica [PICT 732]; CONICET [PIP 02508]; European Union; Fund for Scientific Research (FWO); CNR; Agency for Innovation by Science and Technology (IWT, Belgium)	Italian National Programme for Antarctic Research (PNRA); National Science Foundation (NSF)(National Science Foundation (NSF)); Ministero degli Affari Esteri(Ministry of Foreign Affairs and International Cooperation (Italy)); Direzione generale per la promozione del sistema Paese (Progetti di Grande Rilevanza, Italia-Argentina); University of Buenos Aires(University of Buenos Aires); Agencia Nacional de Promocion Cientifica y Tecnologica(ANPCyT); CONICET(Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET)); European Union(European Commission); Fund for Scientific Research (FWO)(FWO); CNR(Consiglio Nazionale delle Ricerche (CNR)); Agency for Innovation by Science and Technology (IWT, Belgium)(Institute for the Promotion of Innovation by Science and Technology in Flanders (IWT))	This study has been supported by the Italian National Programme for Antarctic Research (PNRA) PdR 2009/C1.03, National Science Foundation (NSF) support-OPP 0636696, Ministero degli Affari Esteri, Direzione generale per la promozione del sistema Paese (Progetti di Grande Rilevanza, Italia-Argentina 2011-2013), University of Buenos Aires (20020090300117), http://www.uba.ar/ingles/index04.php, Agencia Nacional de Promocion Cientifica y Tecnologica (PICT 732), http://www.agencia.gov.ar/, CONICET (PIP 02508), http://www.conicet.gov.ar/, European Union Project FP7-Nostress and Fund for Scientific Research (FWO). DG acknowledges CNR for a Short-Term Mobility fellowship, http://www.cnr.it/sitocnr/home.html. Research of WVL is funded by a PhD grant of the Agency for Innovation by Science and Technology (IWT, Belgium), http://www.iwt.be/english/welcome. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbruzzetti S, 2009, P NATL ACAD SCI USA, V106, P18984, DOI 10.1073/pnas.0905433106; Anselmi M, 2011, J PHYS CHEM B, V115, P2436, DOI 10.1021/jp110833v; Avivi A, 2010, P NATL ACAD SCI USA, V107, P21570, DOI 10.1073/pnas.1015379107; Beers JM, 2010, COMP BIOCHEM PHYS A, V156, P422, DOI 10.1016/j.cbpa.2010.03.027; Bidon-Chanal A, 2006, PROTEINS, V64, P457, DOI 10.1002/prot.21004; Bocahut A, 2009, J PHYS CHEM B, V113, P16257, DOI 10.1021/jp906854x; Boron I, 2011, IUBMB LIFE, V63, P206, DOI 10.1002/iub.444; Brunori M, 2005, P NATL ACAD SCI USA, V102, P8483, DOI 10.1073/pnas.0408766102; Capece L, 2009, PROTEINS, V75, P885, DOI 10.1002/prot.22297; Cheng CHC, 2009, IUBMB LIFE, V61, P184, DOI 10.1002/iub.138; Cheng CHC, 2009, GENE, V433, P100, DOI 10.1016/j.gene.2008.12.005; Cohen J, 2008, METHOD ENZYMOL, V437, P439, DOI 10.1016/S0076-6879(07)37022-5; Cohen J, 2006, BIOPHYS J, V91, P1844, DOI 10.1529/biopbysj.106.085746; Couture M, 2001, J BIOL CHEM, V276, P36377, DOI 10.1074/jbc.M103907200; Dewilde S, 2001, J BIOL CHEM, V276, P38949, DOI 10.1074/jbc.M106438200; Dewilde S, 2008, METHOD ENZYMOL, V436, P341, DOI 10.1016/S0076-6879(08)36019-4; di Prisco G, 2007, GENE, V398, P143, DOI 10.1016/j.gene.2007.02.047; Egginton S, 2002, J EXP BIOL, V205, P769; Fuchs C, 2004, J BIOL CHEM, V279, P24116, DOI 10.1074/jbc.M402011200; HAYASHI A, 1973, BIOCHIM BIOPHYS ACTA, V310, P309, DOI 10.1016/0005-2795(73)90110-4; Hendgen-Cotta UB, 2008, P NATL ACAD SCI USA, V105, P10256, DOI 10.1073/pnas.0801336105; Herold S, 2004, J BIOL CHEM, V279, P22841, DOI 10.1074/jbc.M313732200; HORI H, 1980, J AM CHEM SOC, V102, P3608, DOI 10.1021/ja00530a049; Hu SZ, 1996, J AM CHEM SOC, V118, P12638, DOI 10.1021/ja962239e; Hundahl CA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028160; Ishikawa H, 2007, P NATL ACAD SCI USA, V104, P16116, DOI 10.1073/pnas.0707718104; Jayaraman T, 2011, J BIOL CHEM, V286, P42679, DOI 10.1074/jbc.M111.271973; Johnston IA, 2003, J EXP BIOL, V206, P2595, DOI 10.1242/jeb.00474; Khan AA, 2007, P NATL ACAD SCI USA, V104, P19114, DOI 10.1073/pnas.0706167104; Kitagawa T, 1988, BIOL APPL RAMAN SPEC, V3, P97; Kriegl JM, 2002, P NATL ACAD SCI USA, V99, P7992, DOI 10.1073/pnas.082244399; Lau KS, 2000, PHYSIOL GENOMICS, V2, P21, DOI 10.1152/physiolgenomics.2000.2.1.21; Lutz S, 2009, J PHYS CHEM B, V113, P15334, DOI 10.1021/jp905673p; Marti MA, 2006, J INORG BIOCHEM, V100, P761, DOI 10.1016/j.jinorgbio.2005.12.009; Merx Marc W., 2001, FASEB Journal, V15, P1077; Milton SL, 2006, J BIOMED SCI, V13, P509, DOI 10.1007/s11373-006-9084-8; Morla M, 2003, POLAR BIOL, V26, P458, DOI 10.1007/s00300-003-0504-1; Moschetti T, 2009, BIOPHYS J, V97, P1700, DOI 10.1016/j.bpj.2009.05.059; Nadra AD, 2008, PROTEINS, V71, P695, DOI 10.1002/prot.21814; Nicoletti FP, 2010, BIOCHEMISTRY-US, V49, P1903, DOI 10.1021/bi9020567; Nienhaus K, 2004, J BIOL CHEM, V279, P22944, DOI 10.1074/jbc.M401561200; O'Brien KM, 2000, RESP PHYSIOL, V122, P71, DOI 10.1016/S0034-5687(00)00139-0; Orlowski S, 2008, BIOSYSTEMS, V94, P263, DOI 10.1016/j.biosystems.2008.04.016; PEARLMAN DA, 1995, COMPUT PHYS COMMUN, V91, P1, DOI 10.1016/0010-4655(95)00041-D; Pesce A, 2003, STRUCTURE, V11, P1087, DOI 10.1016/S0969-2126(03)00166-7; Roesner A, 2006, J EXP BIOL, V209, P2129, DOI 10.1242/jeb.02243; Ronda L, 2008, METHOD ENZYMOL, V437, P311, DOI 10.1016/S0076-6879(07)37016-X; RUUD JT, 1954, NATURE, V173, P848, DOI 10.1038/173848a0; SALI A, 1993, J MOL BIOL, V234, P779, DOI 10.1006/jmbi.1993.1626; Sawai H, 2005, BIOCHEMISTRY-US, V44, P13257, DOI 10.1021/bi050997o; Shikama K, 1998, CHEM REV, V98, P1357, DOI 10.1021/cr970042e; Shiva S, 2007, CIRC RES, V100, P654, DOI 10.1161/01.RES.0000260171.52224.6b; Sidell BD, 2006, J EXP BIOL, V209, P1791, DOI 10.1242/jeb.02091; Sidell BD, 1998, J EXP BIOL, V201, P1119; Smagghe BJ, 2006, BIOCHEMISTRY-US, V45, P9735, DOI 10.1021/bi060716s; Spiro TG, 2005, J INORG BIOCHEM, V99, P34, DOI 10.1016/j.jinorgbio.2004.09.026; Sun YJ, 2001, P NATL ACAD SCI USA, V98, P15306, DOI 10.1073/pnas.251466698; Sun YJ, 2003, P NATL ACAD SCI USA, V100, P3497, DOI 10.1073/pnas.0637726100; Tiso M, 2011, J BIOL CHEM, V286, P18277, DOI 10.1074/jbc.M110.159541; Uno T, 2004, J BIOL CHEM, V279, P5886, DOI 10.1074/jbc.M311748200; Verde C, 2004, PROTEIN SCI, V13, P2766, DOI 10.1110/ps.04861504; Vitagliano L, 2004, EUR J BIOCHEM, V271, P1651, DOI 10.1111/j.1432-1033.2004.04054.x; Vitagliano L, 2008, J AM CHEM SOC, V130, P10527, DOI 10.1021/ja803363p; Vogel KM, 1999, J AM CHEM SOC, V121, P9915, DOI 10.1021/ja990042r; Wakasugi K, 2003, J BIOL CHEM, V278, P36505, DOI 10.1074/jbc.M305519200; Watanabe S, 2008, BIOCHEMISTRY-US, V47, P5266, DOI 10.1021/bi800286m; Williams TM, 2008, P R SOC B, V275, P751, DOI 10.1098/rspb.2007.1484; Wittenberg JB, 2003, J EXP BIOL, V206, P2011, DOI 10.1242/jeb.00243	68	26	26	0	59	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 3	2012	7	12							e44508	10.1371/journal.pone.0044508	http://dx.doi.org/10.1371/journal.pone.0044508			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	051DH	23226490	Green Published, gold			2022-12-27	WOS:000312104700001
J	Hettyey, A; Vagi, B; Penn, DJ; Hoi, H; Wagner, RH				Hettyey, Attila; Vagi, Balazs; Penn, Dustin J.; Hoi, Herbert; Wagner, Richard H.			Post-Meiotic Intra-Testicular Sperm Senescence in a Wild Vertebrate	PLOS ONE			English	Article							FERTILIZATION SUCCESS; YOUNG SPERM; EVOLUTIONARY CONSEQUENCES; SOCIAL-STATUS; PARENTAL AGE; COMMON TOAD; BUFO-BUFO; MOTILITY; QUALITY; SPERMATOZOA	There is growing interest in sperm senescence, both in its underlying mechanisms and evolutionary consequences, because it can impact the evolution of numerous life history traits. Previous studies have documented various types of sperm senescence, but evidence of post-meiotic intra-testicular sperm senescence in wild animals is lacking. To assess such senescence, we studied within-season changes in sperm motility in the common toad (Bufo bufo), where males produce all sperm prior to the breeding season. We found that males exposed to experimentally induced re-hibernation at the start of the breeding season, that is to experimentally lowered metabolic rates, stored sperm of significantly higher motility than males that were kept under seminatural conditions without females throughout the breeding season. This finding indicates that re-hibernation slows normal rates of sperm ageing and constitutes the first evidence to our knowledge of post-meiotic intra-testicular sperm senescence in a wild vertebrate. We also found that in males kept in seminatural conditions, sperm motility was positively related to the number of matings a male achieved. Thus, our results suggest that post-meiotic intra-testicular sperm senescence does not have a genetically fixed rate and may be modulated by temperature and possibly by mating opportunities.	[Hettyey, Attila; Penn, Dustin J.; Hoi, Herbert; Wagner, Richard H.] Univ Vet Med, Konrad Lorenz Inst Ethol, Dept Integrat Biol & Evolut, Vienna, Austria; [Hettyey, Attila; Vagi, Balazs] Hungarian Acad Sci, Agr Res Ctr, Inst Plant Protect, Lendulet Evolutionary Ecol Grp, Budapest, Hungary; [Vagi, Balazs] Eotvos Lorand Univ, Dept Systemat Zool & Ecol, Behav Ecol Grp, Budapest, Hungary	University of Veterinary Medicine Vienna; Hungarian Academy of Sciences; Hungarian Centre for Agricultural Research; Eotvos Lorand University	Hettyey, A (corresponding author), Univ Vet Med, Konrad Lorenz Inst Ethol, Dept Integrat Biol & Evolut, Vienna, Austria.	hettyey.attila@agrar.mta.hu	Hettyey, Attila/AFJ-8104-2022	Hettyey, Attila/0000-0003-0678-0936	Hungarian Scientific Research Fund (OTKA) [F-61374]; Austrian Science Fund (FWF) [P19264]; ZHungarian Academy of Sciences (MTA) [LP2012-24/2012]	Hungarian Scientific Research Fund (OTKA)(Orszagos Tudomanyos Kutatasi Alapprogramok (OTKA)); Austrian Science Fund (FWF)(Austrian Science Fund (FWF)); ZHungarian Academy of Sciences (MTA)	Research was supported by the Hungarian Scientific Research Fund (OTKA, F-61374; www.otka.hu), the Austrian Science Fund (FWF, P19264; www.fwf.ac.at), and the "Lendulet'' programme of the ZHungarian Academy of Sciences (MTA, LP2012-24/2012; www.mta.hu). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	APHA, 1985, STAND METH EX WAT WA; Baker MA, 2004, MOL CELL ENDOCRINOL, V216, P47, DOI 10.1016/j.mce.2003.10.068; BAKER RR, 1993, ANIM BEHAV, V46, P861, DOI 10.1006/anbe.1993.1271; Bonsall MB, 2006, PHILOS T R SOC B, V361, P119, DOI 10.1098/rstb.2005.1738; BORG B, 1982, CAN J ZOOL, V60, P3377, DOI 10.1139/z82-427; Collins AM, 2004, INSECT MOL BIOL, V13, P141, DOI 10.1111/j.0962-1075.2004.00469.x; Cornwallis CK, 2007, AM NAT, V170, P758, DOI 10.1086/521955; DAVIES NB, 1979, ANIM BEHAV, V27, P1253, DOI 10.1016/0003-3472(79)90070-8; Dziminski MA, 2009, P ROY SOC B-BIOL SCI, V276, P3955, DOI 10.1098/rspb.2009.1334; Edwards DL, 2004, REPROD FERT DEVELOP, V16, P347, DOI 10.1071/RD02079; ELINSON RP, 1986, INT REV CYTOL, V101, P59, DOI 10.1016/S0074-7696(08)60246-6; Engqvist L, 2005, ANIM BEHAV, V70, P967, DOI 10.1016/j.anbehav.2005.01.016; Gage MJG, 2004, CURR BIOL, V14, P44, DOI 10.1016/j.cub.2003.12.028; GAGE MJG, 1995, P ROY SOC B-BIOL SCI, V261, P25, DOI 10.1098/rspb.1995.0112; Garcia-Berthou E, 2001, J ANIM ECOL, V70, P708, DOI 10.1046/j.1365-2656.2001.00524.x; Garcia-Gonzalez F, 2005, CURR BIOL, V15, P271, DOI 10.1016/j.cub.2005.01.032; Gasparini C, 2009, BIOL LETTERS, V5, P792, DOI 10.1098/rsbl.2009.0413; Geffen AJ, 2000, AQUACULTURE, V182, P61, DOI 10.1016/S0044-8486(99)00248-3; Goeritz F, 2003, THERIOGENOLOGY, V59, P1487, DOI 10.1016/S0093-691X(02)01201-3; Halliwell B., 2007, FREE RADICALS BIOL M; Helfenstein F, 2003, BEHAV ECOL SOCIOBIOL, V54, P370, DOI 10.1007/s00265-003-0636-x; HEMELAAR ASM, 1983, OIKOS, V40, P1, DOI 10.2307/3544193; Hettyey A, 2007, BEHAV ECOL SOCIOBIOL, V61, P1303, DOI 10.1007/s00265-007-0361-y; Hettyey A, 2012, BEHAV ECOL SOCIOBIOL, V66, P201, DOI 10.1007/s00265-011-1267-2; Hettyey A, 2009, BIOL J LINN SOC, V96, P361, DOI 10.1111/j.1095-8312.2008.01126.x; INODA T, 1987, COMP BIOCHEM PHYS A, V88, P539, DOI 10.1016/0300-9629(87)90077-6; JONES R, 1979, FERTIL STERIL, V31, P531; KIRKWOOD TBL, 1991, PHILOS T R SOC B, V332, P15, DOI 10.1098/rstb.1991.0028; KIRKWOOD TBL, 1977, NATURE, V270, P301, DOI 10.1038/270301a0; Koyama S, 1999, PHYSIOL BEHAV, V65, P665; Kumashiro M, 2003, J EXP BIOL, V206, P4507, DOI 10.1242/jeb.00697; Levitan DR, 2004, EVOLUTION, V58, P308, DOI 10.1111/j.0014-3820.2004.tb01647.x; Lewis SEM, 2005, CELL TISSUE RES, V322, P33, DOI 10.1007/s00441-005-1097-5; LOFTS B, 1974, PHYSL AMPHIBIA; LYMAN CP, 1981, SCIENCE, V212, P668, DOI 10.1126/science.7221552; Magrath MJL, 2009, CURR BIOL, V19, P792, DOI 10.1016/j.cub.2009.03.068; Medawar P., 1952, UNSOLVED PROBLEM BIO; Monroy, 1967, FERTILIZATION, P99; OLOVNIKOV AM, 1973, J THEOR BIOL, V41, P181, DOI 10.1016/0022-5193(73)90198-7; Pinder Alan W., 1992, P250; Pizzari T, 2008, TRENDS ECOL EVOL, V23, P131, DOI 10.1016/j.tree.2007.12.003; Pizzari T, 2007, P ROY SOC B-BIOL SCI, V274, P853, DOI 10.1098/rspb.2006.0080; Priest NK, 2002, EVOLUTION, V56, P927, DOI 10.1111/j.0014-3820.2002.tb01405.x; QUAY WB, 1987, GAMETE RES, V16, P83, DOI 10.1002/mrd.1120160110; Radwan J, 2003, ECOL LETT, V6, P581, DOI 10.1046/j.1461-0248.2003.00484.x; Reading CJ, 1998, OECOLOGIA, V117, P469, DOI 10.1007/s004420050682; Reinhardt K, 2005, AM NAT, V165, P718, DOI 10.1086/430010; Reinhardt K, 2007, Q REV BIOL, V82, P375, DOI 10.1086/522811; Reyer HU, 2003, BEHAV ECOL SOCIOBIOL, V54, P274, DOI 10.1007/s00265-003-0635-y; Ricklefs RE, 2010, AGING CELL, V9, P273, DOI 10.1111/j.1474-9726.2009.00542.x; RISCH N, 1987, AM J HUM GENET, V41, P218; Rome Lawrence C., 1992, P183; Rudolfsen G, 2006, P ROY SOC B-BIOL SCI, V273, P325, DOI 10.1098/rspb.2005.3305; Schulte-Hostedde AI, 2005, CAN J ZOOL, V83, P1638, DOI 10.1139/Z05-164; Shangguan B, 1999, MAR BIOL, V134, P19, DOI 10.1007/s002270050521; Sharpe RM, 2003, REPRODUCTION, V125, P769, DOI 10.1530/rep.0.1250769; Simmons LW, 2009, J EVOLUTION BIOL, V22, P225, DOI 10.1111/j.1420-9101.2008.01628.x; Siva-Jothy MT, 2000, ECOL LETT, V3, P172; SMITH AL, 1987, GAMETE RES, V16, P47, DOI 10.1002/mrd.1120160106; Snook RR, 2004, NATURE, V428, P939, DOI 10.1038/nature02455; Stearns S.C., 1992, pi; Tarin JJ, 2000, HUM REPROD UPDATE, V6, P532, DOI 10.1093/humupd/6.6.532; Turbill C, 2011, P ROY SOC B-BIOL SCI, V278, P3355, DOI 10.1098/rspb.2011.0190; Ukita M, 1999, ZOOL SCI, V16, P793, DOI 10.2108/zsj.16.793; Velando A, 2011, J EVOLUTION BIOL, V24, P693, DOI 10.1111/j.1420-9101.2010.02201.x; Vuthiphandchai V, 1999, J WORLD AQUACULT SOC, V30, P65, DOI 10.1111/j.1749-7345.1999.tb00318.x; Wagner RH, 2004, P ROY SOC B-BIOL SCI, V271, pS134, DOI 10.1098/rsbl.2003.0142; WELLS KD, 1977, ANIM BEHAV, V25, P666, DOI 10.1016/0003-3472(77)90118-X; White J, 2008, P NATL ACAD SCI USA, V105, P13947, DOI 10.1073/pnas.0803067105; Zubkova EV, 2006, HUM REPROD, V21, P2901, DOI 10.1093/humrep/del193	70	5	5	0	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 3	2012	7	12							e50820	10.1371/journal.pone.0050820	http://dx.doi.org/10.1371/journal.pone.0050820			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	051DH	23226542	Green Published, gold, Green Accepted, Green Submitted			2022-12-27	WOS:000312104700024
J	Yuan, W; Glekas, GD; Allen, GM; Walukiewicz, HE; Rao, CV; Ordal, GW				Yuan, Wei; Glekas, George D.; Allen, George M.; Walukiewicz, Hanna E.; Rao, Christopher V.; Ordal, George W.			The Importance of the Interaction of CheD with CheC and the Chemoreceptors Compared to Its Enzymatic Activity during Chemotaxis in Bacillus subtilis	PLOS ONE			English	Article							PROMOTES ADAPTATION; ESCHERICHIA-COLI; PROTEINS; METHYLATION; PURIFICATION; REPELLENTS	Bacillus subtilis use three systems for adaptation during chemotaxis. One of these systems involves two interacting proteins, CheC and CheD. CheD binds to the receptors and increases their ability to activate the CheA kinase. CheD also binds CheC, and the strength of this interaction is increased by phosphorylated CheY. CheC is believed to control the binding of CheD to the receptors in response to the levels of phosphorylated CheY. In addition to their role in adaptation, CheC and CheD also have separate enzymatic functions. CheC is a CheY phosphatase and CheD is a receptor deamidase. Previously, we demonstrated that CheC's phosphatase activity plays a minor role in chemotaxis whereas its ability to bind CheD plays a major one. In the present study, we demonstrate that CheD's deamidase activity also plays a minor role in chemotaxis whereas its ability to bind CheC plays a major one. In addition, we quantified the interaction between CheC and CheD using surface plasmon resonance. These results suggest that the most important features of CheC and CheD are not their enzymatic activities but rather their roles in adaptation.	[Rao, Christopher V.] Univ Illinois, Dept Chem & Biomol Engn, Urbana, IL 61801 USA; [Yuan, Wei; Glekas, George D.; Allen, George M.; Walukiewicz, Hanna E.; Ordal, George W.] Univ Illinois, Dept Biochem, Urbana, IL 61801 USA	University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign	Rao, CV (corresponding author), Univ Illinois, Dept Chem & Biomol Engn, Urbana, IL 61801 USA.	chris@scs.uiuc.edu; ordal@illinois.edu			National Institutes of Health [GM054365]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM054365, R56GM054365] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health Grant GM054365 to GWO 322 and CVR. CVR is an investigator with the Energy Biosciences Institute. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BERG HC, 1972, NATURE, V239, P500, DOI 10.1038/239500a0; BISCHOFF DS, 1993, BIOCHEMISTRY-US, V32, P9256, DOI 10.1021/bi00086a035; Cannistraro VJ, 2011, J BACTERIOL, V193, P3220, DOI 10.1128/JB.01255-10; Chao XJ, 2006, CELL, V124, P561, DOI 10.1016/j.cell.2005.11.046; ENGSTROM P, 1980, CELL, V20, P165, DOI 10.1016/0092-8674(80)90244-5; FREDRICK KL, 1994, J BACTERIOL, V176, P2727, DOI 10.1128/JB.176.9.2727-2735.1994; Glekas GD, 2012, MOL MICROBIOL; Hou SB, 2000, NATURE, V403, P540, DOI 10.1038/35000570; Karatan E, 2001, J BIOL CHEM, V276, P43618, DOI 10.1074/jbc.M104955200; Kirby JR, 2001, MOL MICROBIOL, V42, P573, DOI 10.1046/j.1365-2958.2001.02581.x; KIRSCH ML, 1993, J BIOL CHEM, V268, P18610; KIRSCH ML, 1993, J BIOL CHEM, V268, P25350; Kristich CJ, 2002, J BIOL CHEM, V277, P25356, DOI 10.1074/jbc.M201334200; MACNAB RM, 1972, P NATL ACAD SCI USA, V69, P2509, DOI 10.1073/pnas.69.9.2509; Muff TJ, 2007, J BIOL CHEM, V282, P34120, DOI 10.1074/jbc.M706432200; Muff TJ, 2008, MOL MICROBIOL, V70, P1054, DOI 10.1111/j.1365-2958.2008.06482.x; ORDAL GW, 1976, J MOL BIOL, V100, P103, DOI 10.1016/S0022-2836(76)80037-X; ORDAL GW, 1979, J GEN MICROBIOL, V115, P167, DOI 10.1099/00221287-115-1-167; ORDAL GW, 1977, J BACTERIOL, V129, P151, DOI 10.1128/JB.129.1.151-155.1977; Rao CV, 2008, TRENDS MICROBIOL, V16, P480, DOI 10.1016/j.tim.2008.07.003; ROSARIO MML, 1995, BIOCHEMISTRY-US, V34, P3823, DOI 10.1021/bi00011a040; ROSARIO MML, 1994, J BACTERIOL, V176, P2736, DOI 10.1128/JB.176.9.2736-2739.1994; SCHON U, 1994, GENE, V147, P91, DOI 10.1016/0378-1119(94)90044-2; Szurmant H, 2004, J BIOL CHEM, V279, P21787, DOI 10.1074/jbc.M311497200; Szurmant H, 2003, J BIOL CHEM, V278, P48611, DOI 10.1074/jbc.M306180200; Szurmant L, 2004, MICROBIOL MOL BIOL R, V68, P301, DOI 10.1128/MMBR.68.2.301-319.2004; ULLAH AHJ, 1981, J BACTERIOL, V145, P958, DOI 10.1128/JB.145.2.958-965.1981; Wu K, 2011, J BIOL CHEM, V286, P2587, DOI 10.1074/jbc.M110.188664	28	13	14	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 3	2012	7	12							e50689	10.1371/journal.pone.0050689	http://dx.doi.org/10.1371/journal.pone.0050689			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	051DH	23226535	Green Published, gold, Green Submitted			2022-12-27	WOS:000312104700021
J	Jackson, KJ; Sanjakdar, SS; Chen, XN; Damaj, MI				Jackson, Kia J.; Sanjakdar, Sarah S.; Chen, Xiangning; Damaj, M. Imad			Nicotine Reward and Affective Nicotine Withdrawal Signs Are Attenuated in Calcium/Calmodulin-Dependent Protein Kinase IV Knockout Mice	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; BEHAVIORAL-RESPONSES; CREB ACTIVITY; CALMODULIN; EXPRESSION; RECEPTOR; NEURONS; COCAINE; ACTIVATION; STRESS	The influx of Ca2+ through calcium-permeable nicotinic acetylcholine receptors (nAChRs) leads to activation of various downstream processes that may be relevant to nicotine-mediated behaviors. The calcium activated protein, calcium/calmodulin-dependent protein kinase IV (CaMKIV) phosphorylates the downstream transcription factor cyclic AMP response element binding protein (CREB), which mediates nicotine responses; however the role of CaMKIV in nicotine dependence is unknown. Given the proposed role of CaMKIV in CREB activation, we hypothesized that CaMKIV might be a crucial molecular component in the development of nicotine dependence. Using male CaMKIV genetically modified mice, we found that nicotine reward is attenuated in CaMKIV knockout (-/-) mice, but cocaine reward is enhanced in these mice. CaMKIV protein levels were also increased in the nucleus accumbens of C57Bl/6 mice after nicotine reward. In a nicotine withdrawal assessment, anxiety-related behavior, but not somatic signs or the hyperalgesia response are attenuated in CaMKIV -/- mice. To complement our animal studies, we also conducted a human genetic association analysis and found that variants in the CaMKIV gene are associated with a protective effect against nicotine dependence. Taken together, our results support an important role for CaMKIV in nicotine reward, and suggest that CaMKIV has opposing roles in nicotine and cocaine reward. Further, CaMKIV mediates affective, but not physical nicotine withdrawal signs, and has a protective effect against nicotine dependence in human genetic association studies. These findings further indicate the importance of calcium-dependent mechanisms in mediating behaviors associated with drugs of abuse.	[Sanjakdar, Sarah S.; Damaj, M. Imad] Virginia Commonwealth Univ, Dept Pharmacol & Toxicol, Richmond, VA 23284 USA; [Jackson, Kia J.; Chen, Xiangning] Virginia Commonwealth Univ, Dept Psychiat, Richmond, VA USA	Virginia Commonwealth University; Virginia Commonwealth University	Damaj, MI (corresponding author), Virginia Commonwealth Univ, Dept Pharmacol & Toxicol, Richmond, VA 23284 USA.	mdamaj@vcu.edu			National Institute of Mental Health [MH-020030, DA019498, NIDA DA-12610, R01 MH67257, R01 MH59588, R01 MH59571, R01 MH59565, R01 MH59587, R01 MH60870, R01 MH59566, R01 MH59586, R01 MH61675, R01 MH60879, R01 MH81800, U01 MH46276, U01 MH46289, U01 MH46318, U01 MH79469, U01 MH79470]; NIH Genes, Environment and Health Initiative [GEI] [U01 HG004422]; Gene Environment Association Studies (GENEVA) under GEI; NIH GEI [U01HG004438]; National Institute on Alcohol Abuse and Alcoholism; National Institute on Drug Abuse; NIH [HHSN268200782096C]; NATIONAL CANCER INSTITUTE [P01CA089392] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [U01HG004438, U01HG004446, U01HG004422] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH060879, R01MH059587, R01MH067257, R01MH060870, R01MH059586, U01MH046289, U01MH079469, R01MH059566, R01MH059588, R01MH059565, U01MH079470, U01MH046318, U01MH046276, R01MH061675, R01MH081800, R01MH059571] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [U10AA008401] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA013423] Funding Source: NIH RePORTER	National Institute of Mental Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NIH Genes, Environment and Health Initiative [GEI](United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Gene Environment Association Studies (GENEVA) under GEI; NIH GEI; National Institute on Alcohol Abuse and Alcoholism(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)); National Institute on Drug Abuse(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This work was supported by National Institute of Mental Health grant MH-020030 to KJJ, grant DA019498 to XC, and grant NIDA DA-12610 to MID. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors would like to thank Tie Shan-Han and Cindy Evans for their technical assistance with the nicotine withdrawal and nicotine CPP studies. The authors would like to thank the Genome Wide Association Study of Schizophrenia for data contribution. Funding support for the Genome-Wide Association of Schizophrenia Study was provided by the National Institute of Mental Health (R01 MH67257, R01 MH59588, R01 MH59571, R01 MH59565, R01 MH59587, R01 MH60870, R01 MH59566, R01 MH59586, R01 MH61675, R01 MH60879, R01 MH81800, U01 MH46276, U01 MH46289 U01 MH46318, U01 MH79469, and U01 MH79470) and the genotyping of samples was provided through the Genetic Association Information Network (GAIN). The datasets used for the analyses described in this manuscript were obtained from the database of Genotypes and Phenotypes (dbGaP) through dbGaP accession number phs00013 and phg00013. Samples and associated phenotype data for the Genome-Wide Association of Schizophrenia Study were provided by the Molecular Genetics of Schizophrenia Collaboration (PI: Pablo V. Gejman, Evanston Northwestern Healthcare (ENH) and Northwestern University, Evanston, IL, USA). The authors acknowledge the contribution of data from the Study of Addiction: Genetics and Environment (SAGE). Funding support for SAGE was provided through the NIH Genes, Environment and Health Initiative [GEI] (U01 HG004422). SAGE is one of the genome-wide association studies funded as part of the Gene Environment Association Studies (GENEVA) under GEI. Assistance with phenotype harmonization and genotype cleaning, as well as with general study coordination, was provided by the GENEVA Coordinating Center (U01 HG004446). Assistance with data cleaning was provided by the National Center for Biotechnology Information. Support for collection of datasets and samples was provided by the Collaborative Study on the Genetics of Alcoholism (COGA; U10 AA008401), the Collaborative Genetic Study of Nicotine Dependence (COGEND; P01 CA089392), and the Family Study of Cocaine Dependence (FSCD; R01 DA013423). Funding support for genotyping, which was performed at the Johns Hopkins University Center for Inherited Disease Research, was provided by the NIH GEI (U01HG004438), the National Institute on Alcohol Abuse and Alcoholism, the National Institute on Drug Abuse, and the NIH contract "High throughput genotyping for studying the genetic contributions to human disease" (HHSN268200782096C). The datasets used for the analyses described in this manuscript were obtained through dbGaP accession number phs000092.v1.p.	Barrot M, 2002, P NATL ACAD SCI USA, V99, P11435, DOI 10.1073/pnas.172091899; Bilbao A, 2008, P NATL ACAD SCI USA, V105, P17549, DOI 10.1073/pnas.0803959105; Brunzell DH, 2009, NEUROPSYCHOPHARMACOL, V34, P1993, DOI 10.1038/npp.2009.11; Brunzell DH, 2003, J NEUROCHEM, V84, P1431, DOI 10.1046/j.1471-4159.2003.01640.x; Carlezon WA, 1998, SCIENCE, V282, P2272, DOI 10.1126/science.282.5397.2272; Deisseroth K, 2002, NEURON, V34, P179, DOI 10.1016/S0896-6273(02)00664-5; Deisseroth K, 1998, NATURE, V392, P198, DOI 10.1038/32448; FRANGAKIS MV, 1991, J BIOL CHEM, V266, P17592; Grucza RA, 2008, BIOL PSYCHIAT, V64, P922, DOI 10.1016/j.biopsych.2008.04.018; Hook SS, 2001, ANNU REV PHARMACOL, V41, P471, DOI 10.1146/annurev.pharmtox.41.1.471; Jackson KJ, 2008, J PHARMACOL EXP THER, V325, P302, DOI 10.1124/jpet.107.132977; Jackson KJ, 2009, J PHARMACOL EXP THER, V330, P152, DOI 10.1124/jpet.109.151530; JENSEN KF, 1991, P NATL ACAD SCI USA, V88, P4050, DOI 10.1073/pnas.88.9.4050; JONES DA, 1991, FEBS LETT, V289, P105, DOI 10.1016/0014-5793(91)80919-T; Kivinummi T, 2011, NEUROSCI LETT, V491, P108, DOI 10.1016/j.neulet.2011.01.015; Ko SW, 2006, EUR J NEUROSCI, V23, P2158, DOI 10.1111/j.1460-9568.2006.04748.x; KOOB GF, 1993, CIBA F SYMP, V172, P277; Kota D, 2007, J PHARMACOL EXP THER, V322, P399, DOI 10.1124/jpet.107.121616; Lisman J, 2002, NAT REV NEUROSCI, V3, P175, DOI 10.1038/nrn753; Magi R, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-288; Markou A, 1998, NEUROPSYCHOPHARMACOL, V18, P135, DOI 10.1016/S0893-133X(97)00113-9; MULLE C, 1992, NEURON, V8, P135, DOI 10.1016/0896-6273(92)90115-T; OHMSTEDE CA, 1989, J BIOL CHEM, V264, P5866; Paxinos G., 2001, MOUSE BRAIN STEREOTA; Price AL, 2006, NAT GENET, V38, P904, DOI 10.1038/ng1847; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Scheet P, 2006, AM J HUM GENET, V78, P629, DOI 10.1086/502802; Schneider M, 2007, BMC NEUROSCI, V8, DOI 10.1186/1471-2202-8-105; Shum FWF, 2005, MOL PAIN, V1, DOI 10.1186/1744-8069-1-22; Soderling TR, 1999, TRENDS BIOCHEM SCI, V24, P232, DOI 10.1016/S0968-0004(99)01383-3; Takao K, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009460; Walters CL, 2005, NEURON, V46, P933, DOI 10.1016/j.neuron.2005.05.005; Walters CL, 2001, J NEUROSCI, V21, P9438, DOI 10.1523/JNEUROSCI.21-23-09438.2001; Wei F, 2002, NAT NEUROSCI, V5, P573, DOI 10.1038/nn0602-855	34	10	10	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 30	2012	7	11							e51154	10.1371/journal.pone.0051154	http://dx.doi.org/10.1371/journal.pone.0051154			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	054WM	23226481	gold, Green Published			2022-12-27	WOS:000312376100292
J	Karch, CM; Jeng, AT; Nowotny, P; Cady, J; Cruchaga, C; Goate, AM				Karch, Celeste M.; Jeng, Amanda T.; Nowotny, Petra; Cady, Janet; Cruchaga, Carlos; Goate, Alison M.			Expression of Novel Alzheimer's Disease Risk Genes in Control and Alzheimer's Disease Brains	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; ABC TRANSPORTERS; EPH RECEPTORS; IDENTIFIES VARIANTS; AMYLOID FORMATION; COMMON VARIANTS; CLUSTERIN; PROTEIN; ENDOCYTOSIS; CD2AP	Late onset Alzheimer's disease (LOAD) etiology is influenced by complex interactions between genetic and environmental risk factors. Large-scale genome wide association studies (GWAS) for LOAD have identified 10 novel risk genes: ABCA7, BIN1, CD2AP, CD33, CLU, CR1, EPHA1, MS4A6A, MS4A6E, and PICALM. We sought to measure the influence of GWAS single nucleotide polymorphisms (SNPs) and gene expression levels on clinical and pathological measures of AD in brain tissue from the parietal lobe of AD cases and age-matched, cognitively normal controls. We found that ABCA7, CD33, and CR1 expression levels were associated with clinical dementia rating (CDR), with higher expression being associated with more advanced cognitive decline. BIN1 expression levels were associated with disease progression, where higher expression was associated with a delayed age at onset. CD33, CLU, and CR1 expression levels were associated with disease status, where elevated expression levels were associated with AD. Additionally, MS4A6A expression levels were associated with Braak tangle and Braak plaque scores, with elevated expression levels being associated with more advanced brain pathology. We failed to detect an association between GWAS SNPs and gene expression levels in our brain series. The minor allele of rs3764650 in ABCA7 is associated with age at onset and disease duration, and the minor allele of rs670139 in MS4A6E was associated with Braak tangle and Braak plaque score. These findings suggest that expression of some GWAS genes, namely ABCA7, BIN1, CD33, CLU, CR1 and the MS4A family, are altered in AD brains.	[Goate, Alison M.] Washington Univ, Sch Med, Dept Psychiat, St Louis, MO 63110 USA; Washington Univ, Sch Med, Hope Ctr Neurol Disorders, St Louis, MO USA	Washington University (WUSTL); Washington University (WUSTL)	Goate, AM (corresponding author), Washington Univ, Sch Med, Dept Psychiat, St Louis, MO 63110 USA.	goatea@psychiatry.wustl.edu	Cruchaga, Carlos/ABF-4065-2020	Cruchaga, Carlos/0000-0002-0276-2899; Goate, Alison/0000-0002-0576-2472; Karch, Celeste/0000-0002-6854-5547	National Institutes of Health (NIH) [P50AG05681, 5R01AG035083-02]; American Health Assistance Foundation; NATIONAL INSTITUTE ON AGING [R01AG035083, P50AG005681] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Health Assistance Foundation(BrightFocus Foundation); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	Funding was provided by National Institutes of Health (NIH) P50AG05681 (John C. Morris-Knight Alzheimer's Disease Research Center); NIH 5R01AG035083-02 (Alison Goate); and the American Health Assistance Foundation (Alison Goate). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bertram L, 2008, AM J HUM GENET, V83, P623, DOI 10.1016/j.ajhg.2008.10.008; Borst P, 2002, ANNU REV BIOCHEM, V71, P537, DOI 10.1146/annurev.biochem.71.102301.093055; Borst P, 2000, BBA-MOL CELL BIOL L, V1486, P128, DOI 10.1016/S1388-1981(00)00053-6; BRAAK H, 1991, ACTA NEUROPATHOL, V82, P239, DOI 10.1007/BF00308809; Braak H, 2006, ACTA NEUROPATHOL, V112, P389, DOI 10.1007/s00401-006-0127-z; Bushlin I, 2008, J NEUROSCI, V28, P10257, DOI 10.1523/JNEUROSCI.2471-08.2008; Calero M, 2000, MICROSC RES TECHNIQ, V50, P305, DOI 10.1002/1097-0029(20000815)50:4<305::AID-JEMT10>3.0.CO;2-L; Chang MY, 2007, CANCER RES, V67, P7605, DOI 10.1158/0008-5472.CAN-07-1100; Coon KD, 2007, J CLIN PSYCHIAT, V68, P613, DOI 10.4088/JCP.v68n0419; Cormont M, 2003, TRAFFIC, V4, P97, DOI 10.1034/j.1600-0854.2003.40205.x; Crocker PR, 1997, GLYCOCONJUGATE J, V14, P601, DOI 10.1023/A:1018588526788; Dean M, 2001, J BIOENERG BIOMEMBR, V33, P475, DOI 10.1023/A:1012823120935; DeMattos RB, 2004, NEURON, V41, P193, DOI 10.1016/S0896-6273(03)00850-X; DeMattos RB, 2002, P NATL ACAD SCI USA, V99, P10843, DOI 10.1073/pnas.162228299; Dustin ML, 1998, CELL, V94, P667, DOI 10.1016/S0092-8674(00)81608-6; Harold D, 2009, NAT GENET, V41, P1088, DOI 10.1038/ng.440; Higgins CF, 2004, NAT STRUCT MOL BIOL, V11, P918, DOI 10.1038/nsmb836; Himanen JP, 2003, INT J BIOCHEM CELL B, V35, P130, DOI 10.1016/S1357-2725(02)00096-1; Hollingworth P, 2011, NAT GENET, V43, P429, DOI 10.1038/ng.803; Huber TB, 2003, MOL CELL BIOL, V23, P4917, DOI 10.1128/MCB.23.14.4917-4928.2003; Hung LW, 1998, NATURE, V396, P703, DOI 10.1038/25393; Jehle AW, 2006, J CELL BIOL, V174, P547, DOI 10.1083/jcb.200601030; JENNE DE, 1991, J BIOL CHEM, V266, P11030; Jun G, 2010, ARCH NEUROL-CHICAGO, V67, P1473, DOI 10.1001/archneurol.2010.201; Kauwe JSK, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0015918; Kim WS, 2006, NEUROREPORT, V17, P891, DOI 10.1097/01.wnr.0000221833.41340.cd; KIRSZBAUM L, 1992, FEBS LETT, V297, P70, DOI 10.1016/0014-5793(92)80330-J; Klein I, 1999, BBA-BIOMEMBRANES, V1461, P237, DOI 10.1016/S0005-2736(99)00161-3; Klein M, 2006, FEBS LETT, V580, P1112, DOI 10.1016/j.febslet.2005.11.056; Kobayashi S, 2004, FASEB J, V18, P929, DOI 10.1096/fj.03-0767fje; Kullander K, 2002, NAT REV MOL CELL BIO, V3, P475, DOI 10.1038/nrm856; Kumita JR, 2007, J MOL BIOL, V369, P157, DOI 10.1016/j.jmb.2007.02.095; Lambert JC, 2009, NAT GENET, V41, P1094, DOI 10.1038/ng.439; Leskov KS, 2003, J BIOL CHEM, V278, P11590, DOI 10.1074/jbc.M209233200; Lynch DK, 2003, J BIOL CHEM, V278, P21805, DOI 10.1074/jbc.M211407200; Morgan BP, 1998, BIOCHEM SOC T, V26, P49, DOI 10.1042/bst0260049; MORRIS JC, 1993, NEUROLOGY, V43, P2412, DOI 10.1212/WNL.43.11.2412-a; Muller AJ, 2003, MOL CELL BIOL, V23, P4295, DOI 10.1128/MCB.23.12.4295-4306.2003; Muller PY, 2002, BIOTECHNIQUES, V32, P1372; Myers AJ, 2007, NAT GENET, V39, P1494, DOI 10.1038/ng.2007.16; Naj AC, 2011, NAT GENET, V43, P436, DOI 10.1038/ng.801; Noren NK, 2004, CELL SIGNAL, V16, P655, DOI 10.1016/j.cellsig.2003.10.006; Pasquale EB, 2005, NAT REV MOL CELL BIO, V6, P462, DOI 10.1038/nrm1662; PERICAKVANCE MA, 1991, AM J HUM GENET, V48, P1034; Poliakov A, 2004, DEV CELL, V7, P465, DOI 10.1016/j.devcel.2004.09.006; Poon S, 2000, BIOCHEMISTRY-US, V39, P15953, DOI 10.1021/bi002189x; Razzaq A, 2001, GENE DEV, V15, P2967, DOI 10.1101/gad.207801; Schiffer M, 2004, J BIOL CHEM, V279, P37004, DOI 10.1074/jbc.M403534200; SCHMECHEL DE, 1993, P NATL ACAD SCI USA, V90, P9649, DOI 10.1073/pnas.90.20.9649; Seshadri S, 2010, JAMA-J AM MED ASSOC, V303, P1832, DOI 10.1001/jama.2010.574; Takahashi Kei, 2005, Medical Molecular Morphology, V38, P2, DOI 10.1007/s00795-004-0278-8; Tateno H, 2007, MOL CELL BIOL, V27, P5699, DOI 10.1128/MCB.00383-07; Wilkinson DG, 2000, INT REV CYTOL, V196, P177; Yerbury JJ, 2007, FASEB J, V21, P2312, DOI 10.1096/fj.06-7986com; Zanjani H, 2005, ALZ DIS ASSOC DIS, V19, P55, DOI 10.1097/01.wad.0000165506.60370.94; Zenkel M, 2006, INVEST OPHTH VIS SCI, V47, P1982, DOI 10.1167/iovs.05-1580; Zuccolo J, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009369	57	208	215	2	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 30	2012	7	11							e50976	10.1371/journal.pone.0050976	http://dx.doi.org/10.1371/journal.pone.0050976			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	054WM	23226438	Green Published, Green Submitted, gold			2022-12-27	WOS:000312376100249
J	Liu, Y; Cui, WJ; Xia, YY; Cui, YT; Kobayashi, M; Zhou, ZM				Liu, Yi; Cui, Wenjing; Xia, Yuanyuan; Cui, Youtian; Kobayashi, Michihiko; Zhou, Zhemin			Self-Subunit Swapping Occurs in Another Gene Type of Cobalt Nitrile Hydratase	PLOS ONE			English	Article							ACYL-COA SYNTHETASE; ESCHERICHIA-COLI; POSTTRANSLATIONAL MODIFICATION; THIOCYANATE HYDROLASE; PEPTIDE DEFORMYLASE; FUNCTIONAL EXPRESSION; CRYSTAL-STRUCTURE; LIGAND CYSTEINE; METALLOENZYME; MATURATION	Self-subunit swapping is one of the post-translational maturation of the cobalt-containing nitrile hydratase (Co-NHase) family of enzymes. All of these NHases possess a gene organization of <beta-subunit > <alpha-subunit > < activator protein >, which allows the activator protein to easily form a mediatory complex with the alpha-subunit of the NHase after translation. Here, we discovered that the incorporation of cobalt into another type of Co-NHase, with a gene organization of <alpha-subunit > <beta-subunit > < activator protein >, was also dependent on self-subunit swapping. We successfully isolated a recombinant NHase activator protein (P14K) of Pseudomonas putida NRRL-18668 by adding a Strep-tag N-terminal to the P14K gene. P14K was found to form a complex [alpha(StrepP14K)(2)] with the alpha-subunit of the NHase. The incorporation of cobalt into the NHase of P. putida was confirmed to be dependent on the alpha-subunit substitution between the cobalt-containing alpha(StrepP14K)(2) and the cobalt-free NHase. Cobalt was inserted into cobalt-free alpha(StrepP14K)(2) but not into cobalt-free NHase, suggesting that P14K functions not only as a self-subunit swapping chaperone but also as a metallochaperone. In addition, NHase from P. putida was also expressed by a mutant gene that was designed with a <beta-subunit > <alpha-subunit > < P14K > order. Our findings expand the general features of self-subunit swapping maturation. Citation: Liu Y, Cui W, Xia Y, Cui Y, Kobayashi M, et al. (2012) Self-Subunit Swapping Occurs in Another Gene Type of Cobalt Nitrile Hydratase. PLoS ONE 7(11): e50829. doi: 10.1371/journal.pone.0050829	[Kobayashi, Michihiko] Univ Tsukuba, Inst Appl Biochem, Tsukuba, Ibaraki 305, Japan; [Kobayashi, Michihiko] Univ Tsukuba, Grad Sch Life & Environm Sci, Tsukuba, Ibaraki, Japan; [Liu, Yi; Cui, Wenjing; Xia, Yuanyuan; Cui, Youtian; Zhou, Zhemin] Jiangnan Univ, Sch Biotechnol, Minist Educ, Key Lab Ind Biotechnol, Wuxi, Peoples R China	University of Tsukuba; University of Tsukuba; Jiangnan University	Kobayashi, M (corresponding author), Univ Tsukuba, Inst Appl Biochem, 1-1-1 Tennodai, Tsukuba, Ibaraki 305, Japan.	kobay@agbi.tsukuba.ac.jp; zhmzhou@jiangnan.edu.cn	Cui, Wenjing/HIR-1471-2022; Cui, Youtian/AAU-2150-2021; Cui, Youtian/ABE-1386-2020	Cui, Youtian/0000-0002-7138-2566; 	National Natural Science Foundation of China [31070711]; Doctoral Scientific Research Fund Project of Jiangnan University of China [JUDCF10011]; General University Doctor Research and Innovation Program of Jiangsu Province of China [CXZZ11_0475]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Doctoral Scientific Research Fund Project of Jiangnan University of China; General University Doctor Research and Innovation Program of Jiangsu Province of China	1. National Natural Science Foundation of China (31070711) http://159.226.244.22/portal/proj_search.asp2. Doctoral Scientific Research Fund Project of Jiangnan University of China (JUDCF10011) http://yjsb.jiangnan.edu.cn/UploadFiles/20101227135358699.doc_3. General University Doctor Research and Innovation Program of Jiangsu Province of China (CXZZ11_0475) http://www.ec.js.edu.cn/art/2011/6/30/art_4267_30675.html The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abe T, 2008, J BIOL CHEM, V283, P11312, DOI 10.1074/jbc.M709654200; Arakawa T, 2007, J MOL BIOL, V366, P1497, DOI 10.1016/j.jmb.2006.12.011; Cai JH, 2006, PROTEIN SCI, V15, P2071, DOI 10.1110/ps.062238406; Chae PS, 2005, J AM CHEM SOC, V127, P2396, DOI 10.1021/ja044043h; Deng H, 2002, BIOCHEMISTRY-US, V41, P10563, DOI 10.1021/bi026137e; Dougan DA, 2010, MOL MICROBIOL, V76, P545, DOI 10.1111/j.1365-2958.2010.07120.x; Gray HB, 2003, P NATL ACAD SCI USA, V100, P3563, DOI 10.1073/pnas.0730378100; Greene SN, 2006, INORG CHEM, V45, P17, DOI 10.1021/ic050965p; Gross R, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-449; Hashimoto Y, 2005, J BIOL CHEM, V280, P8660, DOI 10.1074/jbc.M405686200; HASHIMOTO Y, 1994, BIOSCI BIOTECH BIOCH, V58, P1859, DOI 10.1271/bbb.58.1859; Hourai S, 2003, BIOCHEM BIOPH RES CO, V312, P340, DOI 10.1016/j.bbrc.2003.10.124; Kataoka S, 2006, FEBS LETT, V580, P4667, DOI 10.1016/j.febslet.2006.07.051; Katayama Y, 2006, J AM CHEM SOC, V128, P728, DOI 10.1021/ja057010q; Kobayashi M, 1997, P NATL ACAD SCI USA, V94, P11986, DOI 10.1073/pnas.94.22.11986; Kobayashi M, 1999, EUR J BIOCHEM, V261, P1, DOI 10.1046/j.1432-1327.1999.00186.x; Kobayashi M, 1998, NAT BIOTECHNOL, V16, P733, DOI 10.1038/nbt0898-733; Lu J, 2003, FEBS LETT, V553, P391, DOI 10.1016/S0014-5793(03)01070-6; Mitra S, 2008, FEBS J, V275, P6248, DOI 10.1111/j.1742-4658.2008.06749.x; Miyanaga A, 2004, EUR J BIOCHEM, V271, P429, DOI 10.1046/j.1432-1033.2003.03943.x; Miyanaga A, 2001, BIOCHEM BIOPH RES CO, V288, P1169, DOI 10.1006/bbrc.2001.5897; Murakami T, 2000, PROTEIN SCI, V9, P1024, DOI 10.1110/ps.9.5.1024; Nagashima S, 1998, NAT STRUCT BIOL, V5, P347, DOI 10.1038/nsb0598-347; NISHIYAMA M, 1991, J BACTERIOL, V173, P2465, DOI 10.1128/jb.173.8.2465-2472.1991; Noguchi T, 2003, BIOCHEMISTRY-US, V42, P11642, DOI 10.1021/bi035260i; Nojiri M, 1999, J BIOCHEM-TOKYO, V125, P696, DOI 10.1093/oxfordjournals.jbchem.a022339; Okamoto S, 2011, METALLOMICS, V3, P963, DOI 10.1039/c1mt00056j; Okamoto S, 2010, J BIOL CHEM, V285, P25126, DOI 10.1074/jbc.M110.109223; Payne MS, 1997, BIOCHEMISTRY-US, V36, P5447, DOI 10.1021/bi962794t; Petrillo KL, 2005, APPL MICROBIOL BIOT, V67, P664, DOI 10.1007/s00253-004-1842-9; Stevens JM, 2003, J MASS SPECTROM, V38, P955, DOI 10.1002/jms.509; Wu S, 1997, APPL MICROBIOL BIOT, V48, P704, DOI 10.1007/s002530051119; Zhou ZM, 2010, BIOCHEMISTRY-US, V49, P9638, DOI 10.1021/bi100651v; Zhou ZM, 2009, J BIOL CHEM, V284, P14930, DOI 10.1074/jbc.M808464200; Zhou Z, 2008, P NATL ACAD SCI USA, V105, P14849, DOI 10.1073/pnas.0803428105	35	13	17	0	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 30	2012	7	11							e50829	10.1371/journal.pone.0050829	http://dx.doi.org/10.1371/journal.pone.0050829			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	054WM	23226397	Green Published, gold, Green Submitted			2022-12-27	WOS:000312376100208
J	Obsomer, V; Defourny, P; Coosemans, M				Obsomer, Valerie; Defourny, Pierre; Coosemans, Marc			Predicted Distribution of Major Malaria Vectors Belonging to the Anopheles dirus Complex in Asia: Ecological Niche and Environmental Influences	PLOS ONE			English	Article							SPECIES DISTRIBUTIONS; DISTRIBUTION MODELS; FOREST MALARIA; CLIMATE; TRANSMISSION; POPULATION; DIPTERA; MAPS	Methods derived from ecological niche modeling allow to define species distribution based on presence-only data. This is particularly useful to develop models from literature records such as available for the Anopheles dirus complex, a major group of malaria mosquito vectors in Asia. This research defines an innovative modeling design based on presence-only model and hierarchical framework to define the distribution of the complex and attempt to delineate sibling species distribution and environmental preferences. At coarse resolution, the potential distribution was defined using slow changing abiotic factors such as topography and climate representative for the timescale covered by literature records of the species. The distribution area was then refined in a second step using a mask of current suitable land cover. Distribution area and ecological niche were compared between species and environmental factors tested for relevance. Alternatively, extreme values at occurrence points were used to delimit environmental envelopes. The spatial distribution for the complex was broadly consistent with its known distribution and influencing factors included temperature and rainfall. If maps developed from environmental envelopes gave similar results to modeling when the number of sites was high, the results were less similar for species with low number of recorded presences. Using presence-only models and hierarchical framework this study not only predicts the distribution of a major malaria vector, but also improved ecological modeling analysis design and proposed final products better adapted to malaria control decision makers. The resulting maps can help prioritizing areas which need further investigation and help simulate distribution under changing conditions such as climate change or reforestation. The hierarchical framework results in two products one abiotic based model describes the potential maximal distribution and remains valid for decades and the other including a biotic mask easy to update with frequently available information gives current species distribution.	[Obsomer, Valerie; Coosemans, Marc] Inst Trop Med Prince Leopold, Dept Parasitol, B-2000 Antwerp, Belgium; [Obsomer, Valerie; Defourny, Pierre] Catholic Univ Louvain, Earth & Life Inst Environm Sci Dept, B-3000 Louvain, Belgium	Institute of Tropical Medicine (ITM); Universite Catholique Louvain	Obsomer, V (corresponding author), Inst Trop Med Prince Leopold, Dept Parasitol, B-2000 Antwerp, Belgium.	valerie.obsomer@uclouvain.be; mcoosemans@itg.be			Belgian Sciences Policy Office (BELSPO) through the DYNMAP project; European Union through the MALVECASIA project [IC4-CT-2002-10041, ERBIC18.CT.970211]; Institutional Collaboration between NIMPE (Vietnam); Institute of Tropical Medicine Antwerp, Belgium; Belgian Co-operation (Directorate-General for Development Co-operation)	Belgian Sciences Policy Office (BELSPO) through the DYNMAP project; European Union through the MALVECASIA project; Institutional Collaboration between NIMPE (Vietnam); Institute of Tropical Medicine Antwerp, Belgium; Belgian Co-operation (Directorate-General for Development Co-operation)	This work was funded by the Belgian Sciences Policy Office (BELSPO, http://www.belspo.be/belspo/home/port_fr.stm) through the DYNMAP project, by the European Union through the MALVECASIA project (IC4-CT-2002-10041) in the framework of the European (http://europa.eu/policies-activities/funding-grants/index_en.htm) INCODEV program (ERBIC18.CT.970211) and The Institutional Collaboration between NIMPE (Vietnam) and the Institute of Tropical Medicine Antwerp, Belgium supported by the Belgian Co-operation (Directorate-General for Development Co-operation). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], BIODIVERSITY INFORM, DOI DOI 10.1111/jbi.12227; Austin MP, 2002, ECOL MODEL, V157, P101, DOI 10.1016/S0304-3800(02)00205-3; BAIMAI V, 1984, Southeast Asian Journal of Tropical Medicine and Public Health, V15, P536; Buermann W, 2008, J BIOGEOGR, V35, P1160, DOI 10.1111/j.1365-2699.2007.01858.x; Chase J.M., 2009, ECOLOGICAL NICHES LI; Defourny P., 2009, 33 INT S REM SENS EN; Dondorp AM, 2010, NAT REV MICROBIOL, V8, P272, DOI 10.1038/nrmicro2331; Elith J, 2006, ECOGRAPHY, V29, P129, DOI 10.1111/j.2006.0906-7590.04596.x; Elton C., 1927, ANIMAL ECOLOGY; Environmental Systems Research Institute (ESRI), 2008, ARCGIS 9 3; Fang JY, 2001, SCIENCE, V292, P2320, DOI 10.1126/science.1058629; Foley DH, 2008, J MED ENTOMOL, V45, P852, DOI 10.1603/0022-2585(2008)45[852:PDOTSI]2.0.CO;2; Grinnell J., 1917, Auk Cambridge Mass, V34; Guisan A, 2000, ECOL MODEL, V135, P147, DOI 10.1016/S0304-3800(00)00354-9; HANLEY JA, 1982, RADIOLOGY, V143, P29, DOI 10.1148/radiology.143.1.7063747; Harbach RE, 2004, B ENTOMOL RES, V94, P537, DOI 10.1079/BER2004321; Hijmans RJ, 2005, INT J CLIMATOL, V25, P1965, DOI 10.1002/joc.1276; Hirzel AH, 2002, ECOLOGY, V83, P2027, DOI 10.1890/0012-9658(2002)083[2027:ENFAHT]2.0.CO;2; Hutchinson G.E., 1978, INTRO POPULATION ECO; HUTCHINSON GE, 1957, COLD SPRING HARB SYM, V22, P415, DOI 10.1101/SQB.1957.022.01.039; Kengluechal Ampornpan, 2005, Southeast Asian Journal of Tropical Medicine and Public Health, V36, P46; Legendre P, 2001, OECOLOGIA, V129, P271, DOI 10.1007/s004420100716; Linard C, 2009, ECOL MODEL, V220, P160, DOI 10.1016/j.ecolmodel.2008.09.001; Liu CR, 2005, ECOGRAPHY, V28, P385, DOI 10.1111/j.0906-7590.2005.03957.x; Lobo JM, 2008, GLOBAL ECOL BIOGEOGR, V17, P145, DOI 10.1111/j.1466-8238.2007.00358.x; MAY K, 1987, GENOME, V29, P886, DOI 10.1139/g87-151; MENDIS K N, 1983, Mosquito Systematics, V15, P318; Myo-Paing, 1989, Myanmar Health Sciences Research Journal, V1, P122; New M, 2002, CLIMATE RES, V21, P1, DOI 10.3354/cr021001; O'Loughlin SM, 2008, J EVOLUTION BIOL, V21, P1555, DOI 10.1111/j.1420-9101.2008.01606.x; Obsomer V, 2007, MALARIA J, V6, DOI 10.1186/1475-2875-6-26; Olson DM, 2001, BIOSCIENCE, V51, P933, DOI 10.1641/0006-3568(2001)051[0933:TEOTWA]2.0.CO;2; Overgaard HJ, 2003, LANDSCAPE ECOL, V18, P605, DOI 10.1023/A:1026074910038; Pearson RG, 2007, J BIOGEOGR, V34, P102, DOI 10.1111/j.1365-2699.2006.01594.x; PETRAITIS PS, 1979, ECOLOGY, V60, P703, DOI 10.2307/1936607; PEYTON E L, 1979, Mosquito Systematics, V11, P40; Phillips SJ, 2006, ECOL MODEL, V190, P231, DOI 10.1016/j.ecolmodel.2005.03.026; Phillips SJ, 2008, ECOGRAPHY, V31, P161, DOI 10.1111/j.0906-7590.2008.5203.x; Phillips SJ, 2009, ECOL APPL, V19, P181, DOI 10.1890/07-2153.1; Rascalou G, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036858; Research Systems Inc (RSI), 2007, ENV 4 4; ROSENBERG R, 1990, T ROY SOC TROP MED H, V84, P14, DOI 10.1016/0035-9203(90)90366-M; ROSENBERG R, 1982, AM J TROP MED HYG, V31, P183, DOI 10.4269/ajtmh.1982.31.183; Sallum MAM, 2005, MED VET ENTOMOL, V19, P158, DOI 10.1111/j.0269-283X.2005.00551.x; Sinka ME, 2011, PARASITE VECTOR, V4, DOI 10.1186/1756-3305-4-89; SLOBODCHIKOFF CN, 1980, ECOLOGY, V61, P1051, DOI 10.2307/1936823; Soberon J, 2007, ECOL LETT, V10, P1115, DOI 10.1111/j.1461-0248.2007.01107.x; Srivastava A, 2001, CURR SCI INDIA, V80, P1129; Stockwell D, 1999, INT J GEOGR INF SCI, V13, P143, DOI 10.1080/136588199241391; The malERA Consultative Group on Vector Control, 2011, PLOS MED, V8; Van der Vaart AW, 2000, ASYMPTOTIC STAT, V3; Vancutsem C, 2007, INT J REMOTE SENS, V28, P5123, DOI 10.1080/01431160701253212; Warren DL, 2008, EVOLUTION, V62, P2868, DOI 10.1111/j.1558-5646.2008.00482.x	53	17	19	0	47	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 30	2012	7	11							e50475	10.1371/journal.pone.0050475	http://dx.doi.org/10.1371/journal.pone.0050475			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	054WM	23226292	Green Submitted, Green Published, gold			2022-12-27	WOS:000312376100104
J	Salloto, GRB; Cardoso, AM; Coutinho, FH; Pinto, LH; Vieira, RP; Chaia, C; Lima, JL; Albano, RM; Martins, OB; Clementino, MM				Salloto, Gigliola R. B.; Cardoso, Alexander M.; Coutinho, Felipe H.; Pinto, Leonardo H.; Vieira, Ricardo P.; Chaia, Catia; Lima, Joyce L.; Albano, Rodolpho M.; Martins, Orlando B.; Clementino, Maysa M.			Pollution Impacts on Bacterioplankton Diversity in a Tropical Urban Coastal Lagoon System	PLOS ONE			English	Article							ANTIBIOTIC-RESISTANCE RESERVOIR; POLYMERASE-CHAIN-REACTION; FUNCTIONAL-CHARACTERIZATION; QUANTITATIVE PCR; WATER; BACTERIA; DNA; IDENTIFICATION; ENVIRONMENT; PATHOGENS	Despite a great number of published studies addressing estuarine, freshwater and marine bacterial diversity, few have examined urban coastal lagoons in tropical habitats. There is an increasing interest in monitoring opportunistic pathogens as well as indigenous microbial community members in these water bodies by current molecular and microbiological approaches. In this work, bacterial isolates were obtained through selective plate dilution methods to evaluate antibiotic resistances. In addition, 16S rRNA gene libraries were prepared from environmental waters and mixed cultures grown in BHI medium inoculated with Jacarepagua lagoon waters. Denaturing gradient gel electrophoresis (DGGE) analyses showed distinct community profiles between environmental communities from each studied site and their cultured counterparts. A total of 497 bacterial sequences were analyzed by MOTHUR, yielding 245 operational taxonomic units (OTUs) grouped at 97% similarity. CCA diagrams showcased how several environmental variables affect the distribution of 18 bacterial orders throughout the three distinct habitats. UniFrac metrics and Venn diagrams revealed that bacterial communities retrieved through each experimental approach were significantly different and that only one OTU, closely related to Vibrio cholerae, was shared between them. Potentially pathogenic bacteria were isolated from most sampled environments, fifty percent of which showed antibiotic resistance.	[Cardoso, Alexander M.] Inst Nacl Metrol Qualidade & Tecnol, Diretoria Programa, Rio De Janeiro, Brazil; [Salloto, Gigliola R. B.; Chaia, Catia; Clementino, Maysa M.] Fundacao Oswaldo Cruz, Lab Microrganismos Referencia, Inst Nacl Controle Qualidade Saude, Rio De Janeiro, Brazil; [Coutinho, Felipe H.; Pinto, Leonardo H.; Vieira, Ricardo P.; Lima, Joyce L.; Martins, Orlando B.] Univ Fed Rio de Janeiro, Inst Bioquim Med, Rio De Janeiro, Brazil; [Albano, Rodolpho M.] Univ Estado Rio de Janeiro, Dept Bioquim, BR-20550011 Rio De Janeiro, Brazil	Instituto Nacional de Metrologia, Qualidade e Tecnologia (INMETRO); Fundacao Oswaldo Cruz; Universidade Federal do Rio de Janeiro; Universidade do Estado do Rio de Janeiro	Cardoso, AM (corresponding author), Inst Nacl Metrol Qualidade & Tecnol, Diretoria Programa, Rio De Janeiro, Brazil.	amcardoso@bioqmed.ufrj.br	Coutinho, Felipe Hernandes/R-3714-2019; Clementino, Maysa/C-1944-2009; Cardoso, Alexander/S-6687-2017; Cardoso, Alexander/AAX-2505-2021	Coutinho, Felipe Hernandes/0000-0001-6430-7069; Cardoso, Alexander/0000-0003-2974-0232; Albano, Rodolpho/0000-0002-0643-901X	PETROBRAS; Foundation for Research Support of the State of Rio de Janeiro; Oswaldo Cruz Foundation; National Council for Scientific and Technological Development	PETROBRAS(Fundacao de Amparo a Pesquisa do Amapa (FAPEAP)Petrobras); Foundation for Research Support of the State of Rio de Janeiro; Oswaldo Cruz Foundation; National Council for Scientific and Technological Development(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	Financial support was provided by PETROBRAS, Foundation for Research Support of the State of Rio de Janeiro, Oswaldo Cruz Foundation and National Council for Scientific and Technological Development. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aiyegoro O, 2011, INT J MOL SCI, V12, P4477, DOI 10.3390/ijms12074477; Baquero F, 2008, CURR OPIN BIOTECH, V19, P260, DOI 10.1016/j.copbio.2008.05.006; Barba-Brioso C, 2010, MAR POLLUT BULL, V60, P1259, DOI 10.1016/j.marpolbul.2010.03.018; BEJ AK, 1990, APPL ENVIRON MICROB, V56, P307, DOI 10.1128/AEM.56.2.307-314.1990; BEJ AK, 1991, APPL ENVIRON MICROB, V57, P1013, DOI 10.1128/AEM.57.4.1013-1017.1991; Bhullar K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034953; Canton R, 2009, CLIN MICROBIOL INFEC, V15, P20, DOI 10.1111/j.1469-0691.2008.02679.x; Chakravorty S, 2010, J CLIN MICROBIOL, V48, P258, DOI 10.1128/JCM.01725-09; Clinical and Laboratory Standards Institute (CSLI), 2010, M100S20 CSLI; Cole JR, 2003, NUCLEIC ACIDS RES, V31, P442, DOI 10.1093/nar/gkg039; Copeland CC, 2009, J WATER HEALTH, V7, P324, DOI 10.2166/wh.2009.081; Crump BC, 1999, APPL ENVIRON MICROB, V65, P3192; Cruz OG, 1893, THESIS FACULDADE MED; D'Costa VM, 2006, SCIENCE, V311, P374, DOI 10.1126/science.1120800; Ding C, 2010, APPL MICROBIOL BIOT, V87, P925, DOI 10.1007/s00253-010-2649-5; de Oliveira AJFC, 2008, WATER RES, V42, P2242, DOI 10.1016/j.watres.2007.12.002; Fujioka RS, 2001, WATER SCI TECHNOL, V44, P181, DOI 10.2166/wst.2001.0419; Gonzalez-Fernandez D, 2010, ECOHEALTH, V7, P473, DOI 10.1007/s10393-010-0671-9; Horman A, 2004, APPL ENVIRON MICROB, V70, P87, DOI 10.1128/AEM.70.1.87-95.2004; Kumar S, 2008, BRIEF BIOINFORM, V9, P299, DOI 10.1093/bib/bbn017; Lane D.J., 1991, NUCL ACID TECH BACT, P115, DOI DOI 10.1007/S00227-012-2133-0; Lee DY, 2008, SCI TOTAL ENVIRON, V398, P203, DOI 10.1016/j.scitotenv.2008.03.004; Lee JV, 2011, J APPL MICROBIOL, V110, P1032, DOI 10.1111/j.1365-2672.2011.04957.x; Lozupone CA, 2007, P NATL ACAD SCI USA, V104, P11436, DOI 10.1073/pnas.0611525104; Malorny B, 2003, INT J FOOD MICROBIOL, V89, P241, DOI 10.1016/S0168-1605(03)00154-5; Martinez JL, 2008, SCIENCE, V321, P365, DOI 10.1126/science.1159483; Orsi RH, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-539; Riesenfeld CS, 2004, ENVIRON MICROBIOL, V6, P981, DOI 10.1111/j.1462-2920.2004.00664.x; Rupp ME, 2003, DRUGS, V63, P353, DOI 10.2165/00003495-200363040-00002; Santoro DO, 2012, INT J ENVIRON HEAL R, V22, P560, DOI 10.1080/09603123.2012.678000; Savichtcheva O, 2006, WATER RES, V40, P2463, DOI 10.1016/j.watres.2006.04.040; Schloss PD, 2009, APPL ENVIRON MICROB, V75, P7537, DOI 10.1128/AEM.01541-09; Silveira CB, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017789; Sommer MOA, 2010, VIRULENCE, V1, P299, DOI 10.4161/viru.1.4.12010; Sommer MOA, 2009, SCIENCE, V325, P1128, DOI 10.1126/science.1176950; Thompson FL, 2004, MICROBIOL MOL BIOL R, V68, P403, DOI 10.1128/MMBR.68.3.403-431.2004; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; Vieira RP, 2008, ENVIRON MICROBIOL, V10, P189, DOI 10.1111/j.1462-2920.2007.01443.x; Watanabe K, 2001, J MICROBIOL METH, V44, P253, DOI 10.1016/S0167-7012(01)00220-2; WEISBURG WG, 1991, J BACTERIOL, V173, P697, DOI 10.1128/JB.173.2.697-703.1991; Wright GD, 2010, CURR OPIN MICROBIOL, V13, P589, DOI 10.1016/j.mib.2010.08.005; Wu HC, 2010, PLOS ONE, V5; Zheng G, 2009, J APPL MICROBIOL, V106, P634, DOI 10.1111/j.1365-2672.2008.04037.x; [No title captured]	44	11	12	2	64	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 30	2012	7	11							e51175	10.1371/journal.pone.0051175	http://dx.doi.org/10.1371/journal.pone.0051175			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	054WM	23226484	Green Published, gold, Green Submitted			2022-12-27	WOS:000312376100295
J	Yue, RC; Hu, HX; Yiu, KH; Luo, T; Zhou, Z; Xu, L; Zhang, S; Li, K; Yu, ZP				Yue, Rongchuan; Hu, Houxiang; Yiu, Kai Hang; Luo, Tao; Zhou, Zhou; Xu, Lei; Zhang, Shuang; Li, Ke; Yu, Zhengping			Lycopene Protects against Hypoxia/Reoxygenation-Induced Apoptosis by Preventing Mitochondrial Dysfunction in Primary Neonatal Mouse Cardiomyocytes	PLOS ONE			English	Article							ISCHEMIA-REPERFUSION INJURY; AMERICAN-HEART-ASSOCIATION; CELL-DEATH; INDUCED ACTIVATION; INFARCT SIZE; ANEMIC RATS; PATHWAY; CAROTENOIDS; DISEASE; OXYGEN	Background: Hypoxia/reoxygenation(H/R)-induced apoptosis of cardiomyocytes plays an important role in myocardial injury. Lycopene is a potent antioxidant carotenoid that has been shown to have protective properties on cardiovascular system. The aim of the present study is to investigate the potential for lycopene to protect the cardiomyocytes exposed to H/R. Moreover, the effect on mitochondrial function upon lycopene exposure was assessed. Methods and Findings: Primary cardiomyocytes were isolated from neonatal mouse and established an in vitro model of H/R which resembles ischemia/reperfusion in vivo. The pretreatment of cardiomyocytes with 5 mu M lycopene significantly reduced the extent of apoptosis detected by TUNEL assays. To further study the mechanism underlying the benefits of lycopene, interactions between lycopene and the process of mitochondria-mediated apoptosis were examined. Lycopene pretreatment of cardiomyocytes suppressed the activation of the mitochondrial permeability transition pore ( mPTP) by reducing the intracellular reactive oxygen species (ROS) levels and inhibiting the increase of malondialdehyde (MDA) levels caused by H/R. Moreover, the loss of mitochondrial membrane potential, a decline in cellular ATP levels, a reduction in the amount of cytochrome c translocated to the cytoplasm and caspase-3 activation were observed in lycopene-treated cultures. Conclusion: The present results suggested that lycopene possesses great pharmacological potential in protecting against H/R-induced apoptosis. Importantly, the protective effects of lycopene may be attributed to its roles in improving mitochondrial function in H/R-treated cardiomyocytes. Citation: Yue R, Hu H, Yiu KH, Luo T, Zhou Z, et al. (2012) Lycopene Protects against Hypoxia/Reoxygenation-Induced Apoptosis by Preventing Mitochondrial Dysfunction in Primary Neonatal Mouse Cardiomyocytes. PLoS ONE 7(11): e50778. doi:10.1371/journal.pone.0050778	[Yue, Rongchuan; Hu, Houxiang; Luo, Tao; Xu, Lei; Zhang, Shuang; Li, Ke] Affiliated Hosp 1, N Sichuan Med Coll, Dept Cardiol, Nanchong, Sichuan, Peoples R China; [Hu, Houxiang] Affiliated Hosp 1, N Sichuan Med Coll, Med Res Ctr, Nanchong, Sichuan, Peoples R China; [Yiu, Kai Hang] Univ Hong Kong, Dept Med, Hong Kong, Hong Kong, Peoples R China; [Zhou, Zhou; Yu, Zhengping] Third Mil Med Univ, Dept Occupat Hlth, Chongqing, Peoples R China	North Sichuan Medical University; North Sichuan Medical University; University of Hong Kong; Army Medical University	Hu, HX (corresponding author), Affiliated Hosp 1, N Sichuan Med Coll, Dept Cardiol, Nanchong, Sichuan, Peoples R China.	huhouxiang326@yahoo.com.cn	Yiu, Kai Hang/AAI-2879-2021; /D-1427-2011	/0000-0003-2145-3108	Natural Science Foundation of China [NSFC 81070101]; Applied Basic Research Programs of Sichuan Provincial Science and Technology Department [2009JY0079]	Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Applied Basic Research Programs of Sichuan Provincial Science and Technology Department	This work was supported by the Natural Science Foundation of China (NSFC 81070101) and the Applied Basic Research Programs of Sichuan Provincial Science and Technology Department (2009JY0079). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Armstrong JS, 2006, MITOCHONDRION, V6, P225, DOI 10.1016/j.mito.2006.07.006; CONN PF, 1991, J PHOTOCH PHOTOBIO B, V11, P41, DOI 10.1016/1011-1344(91)80266-K; Csont T, 2010, J MOL CELL CARDIOL, V48, P649, DOI 10.1016/j.yjmcc.2010.01.013; Danz EDB, 2009, FREE RADICAL BIO MED, V46, P1589, DOI 10.1016/j.freeradbiomed.2009.03.011; Di Lisa F, 2006, CARDIOVASC RES, V70, P191, DOI 10.1016/j.cardiores.2006.01.016; Di Lisa F, 2009, BASIC RES CARDIOL, V104, P131, DOI 10.1007/s00395-009-0008-4; Diaz RJ, 1999, CIRC RES, V84, P763; Echtay KS, 2003, EMBO J, V22, P4103, DOI 10.1093/emboj/cdg412; Galluzzi L, 2009, BBA-BIOENERGETICS, V1787, P402, DOI 10.1016/j.bbabio.2008.09.006; Gerster H, 1997, J AM COLL NUTR, V16, P109; Gorbe A, 2010, BASIC RES CARDIOL, V105, P643, DOI 10.1007/s00395-010-0097-0; Hu HX, 2012, CRIT CARE MED, V40, P740, DOI 10.1097/CCM.0b013e3182376e84; Hu HX, 2009, MICROVASC RES, V78, P33, DOI 10.1016/j.mvr.2009.04.005; Klipstein-Grobusch K, 2000, ATHEROSCLEROSIS, V148, P49, DOI 10.1016/S0021-9150(99)00221-X; Kristian T, 2004, CELL CALCIUM, V36, P221, DOI 10.1016/j.ceca.2004.02.016; Kumar P, 2009, LIFE SCI, V85, P711, DOI 10.1016/j.lfs.2009.10.001; Lee YS, 2006, APOPTOSIS, V11, P1091, DOI 10.1007/s10495-006-7110-y; Li P, 1997, CELL, V91, P479, DOI 10.1016/S0092-8674(00)80434-1; Lloyd-Jones D, 2010, CIRCULATION, V121, P948, DOI 10.1161/CIRCULATIONAHA.109.192666; Lo HM, 2007, BIOCHEM PHARMACOL, V74, P54, DOI 10.1016/j.bcp.2007.03.017; Lopez N, 2007, CARDIOVASC RES, V75, P536, DOI 10.1016/j.cardiores.2007.04.025; Miller NJ, 1996, FEBS LETT, V384, P240, DOI 10.1016/0014-5793(96)00323-7; Ong SB, 2012, ANTIOXID RE IN PRESS, DOI 10.1089/ars.2012.477722793879; Papanicolaou KN, 2012, AM J PHYSIOL-HEART C, V302, pH167, DOI 10.1152/ajpheart.00833.2011; Paradies G, 2004, CIRC RES, V94, P53, DOI 10.1161/01.RES.0000109416.56608.64; Park M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019143; Petrosillo G, 2003, FASEB J, V17, P2202, DOI 10.1096/fj.03-0012com; Qu MY, 2011, NEUROCHEM INT, V59, P1095, DOI 10.1016/j.neuint.2011.10.005; Reddy L, 2006, BIOL CHEM, V387, P87, DOI 10.1515/BC.2006.012; Rosamond W, 2008, CIRCULATION, V117, pE25, DOI 10.1161/CIRCULATIONAHA.107.187998; Sarkey JP, 2011, J MOL CELL CARDIOL, V50, P1044, DOI 10.1016/j.yjmcc.2011.03.004; Sengupta A, 1999, EUR J CANCER PREV, V8, P325, DOI 10.1097/00008469-199908000-00009; Sesso HD, 2004, AM J CLIN NUTR, V79, P47; Shin E, 2009, J CELL PHYSIOL, V221, P490, DOI 10.1002/jcp.21883; Shukla SK, 2010, NAT PROD RES, V24, P873, DOI 10.1080/14786410903417378; Takatani T, 2004, BIOCHEM BIOPH RES CO, V316, P484, DOI 10.1016/j.bbrc.2004.02.066; Viswanath K, 2011, BIOMETALS, V24, P171, DOI 10.1007/s10534-010-9371-8; Wang JZ, 2010, BIOCHEM PHARMACOL, V79, P1428, DOI 10.1016/j.bcp.2010.01.021; Wang XD, 2001, GENE DEV, V15, P2922; Xenocostas A, 2010, CRIT CARE MED, V38, P2215, DOI 10.1097/CCM.0b013e3181f17d6e; Yao LL, 2010, AM J PHYSIOL-HEART C, V298, pH1310, DOI 10.1152/ajpheart.00339.2009; Zoratti M, 2005, BBA-BIOENERGETICS, V1706, P40, DOI 10.1016/j.bbabio.2004.10.006; Zweier JL, 2006, CARDIOVASC RES, V70, P181, DOI 10.1016/j.cardiores.2006.02.025	43	59	64	0	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 30	2012	7	11							e50778	10.1371/journal.pone.0050778	http://dx.doi.org/10.1371/journal.pone.0050778			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	054WM	23226382	Green Submitted, gold, Green Published			2022-12-27	WOS:000312376100193
J	Snowdon, C; van der Merwe, G				Snowdon, Chris; van der Merwe, George			Regulation of Hxt3 and Hxt7 Turnover Converges on the Vid30 Complex and Requires Inactivation of the Ras/cAMP/PKA Pathway in Saccharomyces cerevisiae	PLOS ONE			English	Article							ADENYLATE-CYCLASE PATHWAY; HEXOSE TRANSPORTER HXT7P; TOR-SIGNALING PATHWAY; PROTEIN-KINASE; GENE-EXPRESSION; INDUCED DEGRADATION; STRESS-RESPONSE; GID COMPLEX; YEAST; ENDOCYTOSIS	Eukaryotic cells adjust their intracellular protein complement as a mechanism to adapt to changing environmental signals. In Saccharomyces cerevisiae the hexose transporters Hxt3 and Hxt7 are expressed and function on the plasma membrane in high and low glucose abundance, respectively. By contrast, Hxt3 is endocytosed and degraded in the vacuole when cells are starved of glucose and Hxt7 in response to rapamycin treatment or when nitrogen is limiting. Yeast uses several signaling pathways, including the TORC1 and Ras/cAMP/Protein Kinase A (PKA) pathways, to adapt to nutrient changes in the environment. The multi-protein Vid30 complex (Vid30c), an E3 ubiquitin ligase required for the degradation of FBPase, assists in this adaptation process in a mechanism that is poorly understood. Here we show the endocytosis and the subsequent degradation of both Hxt3 and Hxt7, in response to different nutrient signals, is dependent on components of the Vid30c. Additionally, we define the signaling events required for the turnover of Hxt3 and Hxt7 by showing that Hxt3 turnover requires Ras2 and PKA inactivation, whereas Hxt7 turnover requires TORC1 and Ras2 inactivation. Further investigation led us to identify Rim15, a kinase that is inhibited by both the TORC1 and Ras/cAMP/PKA pathways, as a key downstream effector in signaling both turnover events. Finally, we show that the turnover of both Hxt3 and Hxt7 is dependent on the essential E3 ubiquitin ligase, Rsp5, indicating that the role of the Vid30c might be indirect of Hxt ubiquitylation.	[Snowdon, Chris; van der Merwe, George] Univ Guelph, Dept Mol & Cellular Biol, Guelph, ON N1G 2W1, Canada	University of Guelph	van der Merwe, G (corresponding author), Univ Guelph, Dept Mol & Cellular Biol, Guelph, ON N1G 2W1, Canada.	gvanderm@uoguelph.ca			NSERC [262276-08]; OMAFRA [SR9231]; Genome Canada/Genome British Columbia [151WIN]; Ontario Graduate Scholarship	NSERC(Natural Sciences and Engineering Research Council of Canada (NSERC)); OMAFRA; Genome Canada/Genome British Columbia(Genome Canada); Ontario Graduate Scholarship(Ontario Graduate Scholarship)	This research was funded by: NSERC (Discovery Grant #262276-08), OMAFRA (SR9231), and Genome Canada/Genome British Columbia (151WIN) grants awarded to GvdM, and an Ontario Graduate Scholarship to CS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barbet NC, 1996, MOL BIOL CELL, V7, P25, DOI 10.1091/mbc.7.1.25; Beck T, 1999, NATURE, V402, P689, DOI 10.1038/45287; Benanti JA, 2007, NAT CELL BIOL, V9, P1184, DOI 10.1038/ncb1639; Braun B, 2011, FEBS LETT, V585, P3856, DOI 10.1016/j.febslet.2011.10.038; BROEK D, 1987, CELL, V48, P789, DOI 10.1016/0092-8674(87)90076-6; CAMERON S, 1988, CELL, V53, P555, DOI 10.1016/0092-8674(88)90572-7; Cameroni E, 2004, CELL CYCLE, V3, P462; Cardenas ME, 1999, GENE DEV, V13, P3271, DOI 10.1101/gad.13.24.3271; CRECHET JB, 1990, J BIOL CHEM, V265, P1563; Cruz MC, 2001, ANTIMICROB AGENTS CH, V45, P3162, DOI 10.1128/AAC.45.11.3162-3170.2001; De Wever V, 2005, EMBO J, V24, P4115, DOI 10.1038/sj.emboj.7600871; Dennis PB, 1999, CURR OPIN GENET DEV, V9, P49, DOI 10.1016/S0959-437X(99)80007-0; Galan JM, 1996, J BIOL CHEM, V271, P10946, DOI 10.1074/jbc.271.18.10946; Griffioen G, 2002, CURR GENET, V41, P199, DOI 10.1007/s00294-002-0308-9; HANEY SA, 1994, J BIOL CHEM, V269, P16541; Hatakeyama R, 2010, MOL CELL BIOL, V30, P5598, DOI 10.1128/MCB.00464-10; Hedbacker K, 2008, FRONT BIOSCI-LANDMRK, V13, P2408, DOI 10.2741/2854; HIXSON CS, 1980, J BIOL CHEM, V255, P2137; Hoffman M, 1996, GENETICS, V143, P1555; Hung GC, 2004, J BIOL CHEM, V279, P49138, DOI 10.1074/jbc.M404544200; Petkova MI, 2010, J BIOL CHEM, V285, P19521, DOI 10.1074/jbc.M109.085282; Janke C, 2004, YEAST, V21, P947, DOI 10.1002/yea.1142; Kamada Y, 2000, J CELL BIOL, V150, P1507, DOI 10.1083/jcb.150.6.1507; Kamada Y, 2003, CURR TOP MICROBIOL, V279, P73; Krampe S, 1998, FEBS LETT, V441, P343, DOI 10.1016/S0014-5793(98)01583-X; Krampe S, 2002, FEBS LETT, V513, P193, DOI 10.1016/S0014-5793(02)02297-4; Leon S, 2009, EXP CELL RES, V315, P1574, DOI 10.1016/j.yexcr.2008.11.014; Lin CH, 2008, CELL, V135, P714, DOI 10.1016/j.cell.2008.09.025; Longtine MS, 1998, YEAST, V14, P953, DOI 10.1002/(SICI)1097-0061(199807)14:10<953::AID-YEA293>3.3.CO;2-L; MacGurn JA, 2011, CELL, V147, P1104, DOI 10.1016/j.cell.2011.09.054; Martin DE, 2004, CELL, V119, P969, DOI 10.1016/j.cell.2004.11.047; MATSUMOTO K, 1982, P NATL ACAD SCI-BIOL, V79, P2355, DOI 10.1073/pnas.79.7.2355; MBONYI K, 1988, BIOCHIM BIOPHYS ACTA, V971, P223, DOI 10.1016/S0005-2728(88)80110-5; NIKAWA J, 1987, GENE DEV, V1, P931, DOI 10.1101/gad.1.9.931; Nikko E, 2008, EMBO REP, V9, P1216, DOI 10.1038/embor.2008.199; Onodera J, 2004, J BIOL CHEM, V279, P16071, DOI 10.1074/jbc.M312706200; Pedruzzi I, 2003, MOL CELL, V12, P1607, DOI 10.1016/S1097-2765(03)00485-4; Perez-Valle J, 2007, MOL CELL BIOL, V27, P5725, DOI 10.1128/MCB.01375-06; Perez-Valle J, 2010, EUKARYOT CELL, V9, P1881, DOI 10.1128/EC.00184-10; Pitre S, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-365; Powers T, 2003, CURR TOP MICROBIOL, V279, P39; Powers T, 1999, MOL BIOL CELL, V10, P987, DOI 10.1091/mbc.10.4.987; Ramachandran V, 2011, GENETICS, V187, P441, DOI 10.1534/genetics.110.123372; Regelmann J, 2003, MOL BIOL CELL, V14, P1652, DOI 10.1091/mbc.E02-08-0456; Reinders A, 1998, GENE DEV, V12, P2943, DOI 10.1101/gad.12.18.2943; Roberts GG, 2006, MOL GENET GENOMICS, V276, P170, DOI 10.1007/s00438-006-0133-9; ROBINSON LC, 1987, SCIENCE, V235, P1218, DOI 10.1126/science.3547648; Roosen J, 2005, MOL MICROBIOL, V55, P862, DOI 10.1111/j.1365-2958.2004.04429.x; Santangelo GM, 2006, MICROBIOL MOL BIOL R, V70, P253, DOI 10.1128/MMBR.70.1.253-282.2006; Santt O, 2008, MOL BIOL CELL, V19, P3323, DOI 10.1091/mbc.E08-03-0328; Schmelzle T, 2004, MOL CELL BIOL, V24, P338, DOI 10.1128/MCB.24.1.338-351.2004; Schmelzle T, 2000, CELL, V103, P253, DOI 10.1016/S0092-8674(00)00117-3; Schmidt A, 1998, EMBO J, V17, P6924, DOI 10.1093/emboj/17.23.6924; Smith A, 1998, EMBO J, V17, P3556, DOI 10.1093/emboj/17.13.3556; Snowdon C, 2008, FEMS YEAST RES, V8, P204, DOI 10.1111/j.1567-1364.2007.00327.x; Snowdon C, 2009, FEMS YEAST RES, V9, P372, DOI 10.1111/j.1567-1364.2009.00497.x; Springael JY, 1999, BIOCHEM BIOPH RES CO, V257, P561, DOI 10.1006/bbrc.1999.0505; Springael JY, 1998, MOL BIOL CELL, V9, P1253, DOI 10.1091/mbc.9.6.1253; TANAKA K, 1991, P NATL ACAD SCI USA, V88, P468, DOI 10.1073/pnas.88.2.468; TANAKA K, 1990, CELL, V60, P803, DOI 10.1016/0092-8674(90)90094-U; TODA T, 1987, CELL, V50, P277, DOI 10.1016/0092-8674(87)90223-6; van der Merwe GK, 2001, J BIOL CHEM, V276, P28659, DOI 10.1074/jbc.M102280200; Van Driessche B, 2005, YEAST, V22, P1061, DOI 10.1002/yea.1293; Vidan S, 1997, MOL CELL BIOL, V17, P2688, DOI 10.1128/MCB.17.5.2688; WILSON RB, 1988, MOL CELL BIOL, V8, P505, DOI 10.1128/MCB.8.1.505; Zaman S, 2008, ANNU REV GENET, V42, P27, DOI 10.1146/annurev.genet.41.110306.130206	66	29	29	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 5	2012	7	12							e50458	10.1371/journal.pone.0050458	http://dx.doi.org/10.1371/journal.pone.0050458			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	057TZ	23227176	Green Published, gold, Green Submitted			2022-12-27	WOS:000312588200036
J	Radzio, J; Aung, W; Holder, A; Martin, A; Sweeney, E; Mitchell, J; Bachman, S; Pau, CP; Heneine, W; Garcia-Lerma, JG				Radzio, Jessica; Aung, Wutyi; Holder, Angela; Martin, Amy; Sweeney, Elizabeth; Mitchell, James; Bachman, Shanon; Pau, Chou-Pong; Heneine, Walid; Garcia-Lerma, J. Gerardo			Prevention of Vaginal SHIV Transmission in Macaques by a Coitally-Dependent Truvada Regimen	PLOS ONE			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; HIV PRECLINICAL INTERVENTIONS; MENSTRUAL-CYCLE; DEPO-PROVERA; NUCLEOSIDE; STRATEGY; SIV; CONTRACEPTIVES; EMTRICITABINE; PREEXPOSURE	Background: Daily pre-exposure prophylaxis (PrEP) with Truvada (a combination of emtricitabine (FTC) and tenofovir (TFV) disoproxil fumarate (TDF)) is a novel HIV prevention strategy recently found to prevent HIV transmission in men who have sex with men and heterosexual couples. We previously showed that a coitally-dependent Truvada regimen protected macaques against rectal SHIV transmission. Here we examined FTC and tenofovir TFV exposure in vaginal tissues after oral dosing and assessed if peri-coital Truvada also protects macaques against vaginal SHIV infection. Methods: The pharmacokinetic profile of emtricitabine (FTC) and tenofovir (TFV) was evaluated at first dose. FTC and TFV levels were measured in blood plasma, rectal, and vaginal secretions. Intracellular concentrations of FTC-triphosphate (FTC-TP) and TFV-diphosphate (TFV-DP) were measured in PBMCs, rectal tissues, and vaginal tissues. Efficacy of Truvada in preventing vaginal SHIV infection was assessed using a repeat-exposure vaginal SHIV transmission model consisting of weekly exposures to low doses of SHIV162p3. Six pigtail macaques with normal menstrual cycles received Truvada 24 h before and 2 h after each weekly virus exposure and six received placebo. Infection was monitored by serology and PCR amplification of SHIV RNA and DNA. Results: As in humans, the concentration of FTC was higher than the concentration of TFV in vaginal secretions. Also as in humans, TFV levels in vaginal secretions were lower than in rectal secretions. Intracellular TFV-DP concentrations were also lower in vaginal tissues than in rectal tissues. Despite the low vaginal TFV exposure, all six treated macaques were protected from infection after 18 exposures or 4 full menstrual cycles. In contrast, all 6 control animals were infected. Conclusions: We modeled a peri-coital regimen with two doses of Truvada and showed that it fully protected macaques from repeated SHIV exposures. Our results open the possibility for simplified PrEP regimens to prevent vaginal HIV transmission in women. Citation: Radzio J, Aung W, Holder A, Martin A, Sweeney E, et al. (2012) Prevention of Vaginal SHIV Transmission in Macaques by a Coitally-Dependent Truvada Regimen. PLoS ONE 7(12): e50632. doi:10.1371/journal.pone.0050632	[Radzio, Jessica; Aung, Wutyi; Holder, Angela; Martin, Amy; Sweeney, Elizabeth; Mitchell, James; Bachman, Shanon; Pau, Chou-Pong; Heneine, Walid; Garcia-Lerma, J. Gerardo] Ctr Dis Control & Prevent, Branch Lab, Div HIV AIDS Prevent, Natl Ctr HIV Hepatitis STD & Prevent, Atlanta, GA 30333 USA	Centers for Disease Control & Prevention - USA	Garcia-Lerma, JG (corresponding author), Ctr Dis Control & Prevent, Branch Lab, Div HIV AIDS Prevent, Natl Ctr HIV Hepatitis STD & Prevent, Atlanta, GA 30333 USA.	GGarcia-Lerma@cdc.gov			Disease Control and Prevention (CDC) [Y1-AI-0681-02]; National Institutes of Health	Disease Control and Prevention (CDC)(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was partially supported by Interagency Agreement Y1-AI-0681-02 between the Centers for Disease Control and Prevention (CDC) and the National Institutes of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abel K, 2004, J INFECT DIS, V190, P1697, DOI 10.1086/424600; Baeten JM, 2012, NEW ENGL J MED, V367, P399, DOI 10.1056/NEJMoa1108524; BLAKLEY GB, 1981, LAB ANIM, V15, P351, DOI 10.1258/002367781780953059; Celum C, 2012, CURR OPIN INFECT DIS, V25, P51, DOI 10.1097/QCO.0b013e32834ef5ef; dos Santos PR, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019493; Dumond JB, 2007, AIDS, V21, P1899, DOI 10.1097/QAD.0b013e328270385a; Durand-Gasselin L, 2007, ANTIMICROB AGENTS CH, V51, P2105, DOI 10.1128/AAC.00831-06; Garcia-Lerma JG, 2008, PLOS MED, V5, P291, DOI 10.1371/journal.pmed.0050028; Garcia-Lerma JG, 2011, J VIROL, V85, P6610, DOI 10.1128/JVI.00311-11; Garcia-Lerma JG, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3000391; Grant RM, 2010, NEW ENGL J MED, V363, P2587, DOI 10.1056/NEJMoa1011205; Haase AT, 2011, ANNU REV MED, V62, P127, DOI 10.1146/annurev-med-080709-124959; Hart CE, 1999, J INFECT DIS, V179, P871, DOI 10.1086/314656; Hawkins T, 2005, JAIDS-J ACQ IMM DEF, V39, P406, DOI 10.1097/01.qai.0000167155.44980.e8; Heffron R, 2012, LANCET INFECT DIS, V12, P19, DOI 10.1016/S1473-3099(11)70247-X; Hild-Petito S, 1998, AIDS RES HUM RETROV, V14, pS125; HIV Prevention Trial Network, 2012, 067 HPTN; Hu JJ, 2000, J VIROL, V74, P6087, DOI 10.1128/JVI.74.13.6087-6095.2000; Kim CN, 2006, J MED PRIMATOL, V35, P210, DOI 10.1111/j.1600-0684.2006.00169.x; Kozlowski PA, 2000, J ACQ IMMUN DEF SYND, V24, P297; Kuklenyik Z, 2009, J CHROMATOGR B, V877, P3659, DOI 10.1016/j.jchromb.2009.09.007; Kuklenyik Z, 2009, J CHROMATOGR SCI, V47, P365, DOI 10.1093/chromsci/47.5.365; Lackner AA, 2012, CSH PERSPECT MED, V2, DOI 10.1101/cshperspect.a007005; Marx PA, 1996, NAT MED, V2, P1084, DOI 10.1038/nm1096-1084; Mauck CK, 1999, CONTRACEPTION, V60, P15, DOI 10.1016/S0010-7824(99)00058-X; MORDENTI J, 1986, J PHARM SCI, V75, P1028, DOI 10.1002/jps.2600751104; Mutua G, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033103; Otten RA, 2005, J INFECT DIS, V191, P164, DOI 10.1086/426452; Parikh UM, 2009, J VIROL, V83, P10358, DOI 10.1128/JVI.01073-09; Patterson KB, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3003174; Pruvost A, 2005, ANTIMICROB AGENTS CH, V49, P1907, DOI 10.1128/AAC.49.5.1907-1914.2005; Sodora DL, 1998, AIDS RES HUM RETROV, V14, pS119; STEINER RA, 1977, LAB ANIM SCI, V27, P217; Subbarao S, 2006, J INFECT DIS, V194, P904, DOI 10.1086/507306; Thigpen MC, 2012, NEW ENGL J MED, V367, P423, DOI 10.1056/NEJMoa1110711; Van Damme L, 2012, NEW ENGL J MED, V367, P411, DOI 10.1056/NEJMoa1202614; Vishwanathan SA, 2011, JAIDS-J ACQ IMM DEF, V57, P261, DOI 10.1097/QAI.0b013e318220ebd3; Wang LH, 2004, AIDS RES HUM RETROV, V20, P1173, DOI 10.1089/aid.2004.20.1173; Wawer MJ, 2005, J INFECT DIS, V191, P1403, DOI 10.1086/429411; Wira CR, 2008, AIDS, V22, P1909, DOI 10.1097/QAD.0b013e3283060ea4	40	53	54	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 4	2012	7	12							e50632	10.1371/journal.pone.0050632	http://dx.doi.org/10.1371/journal.pone.0050632			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	051EQ	23226529	Green Published, Green Submitted, gold			2022-12-27	WOS:000312108500022
J	Yokoyama, K; Nakashima, A; Urashima, M; Suga, H; Mimura, T; Kimura, Y; Kanazawa, Y; Yokota, T; Sakamoto, M; Ishizawa, S; Nishimura, R; Kurata, H; Tanno, Y; Tojo, K; Kageyama, S; Ohkido, I; Utsunomiya, K; Hosoya, T				Yokoyama, Keitaro; Nakashima, Akio; Urashima, Mitsuyoshi; Suga, Hiroaki; Mimura, Takeshi; Kimura, Yasuo; Kanazawa, Yasushi; Yokota, Tamotsu; Sakamoto, Masaya; Ishizawa, Sho; Nishimura, Rimei; Kurata, Hideaki; Tanno, Yudo; Tojo, Katsuyoshi; Kageyama, Shigeru; Ohkido, Ichiro; Utsunomiya, Kazunori; Hosoya, Tatsuo			Interactions between Serum Vitamin D Levels and Vitamin D Receptor Gene Fok/Polymorphisms for Renal Function in Patients with Type 2 Diabetes	PLOS ONE			English	Article							RANDOMIZED CONTROLLED-TRIAL; CHRONIC KIDNEY-DISEASE; BONE-MINERAL DENSITY; 25-HYDROXYVITAMIN D; D INSUFFICIENCY; POLYMORPHISM; PREVALENCE; WOMEN	Background: We aimed to examine associations among serum 25-hydroxyvitamin D (25OHD) levels, 1,25-dihyroxyvitamin D (1,25OHD) levels, vitamin D receptor (VDR) polymorphisms, and renal function based on estimated glomerular filtration rate (eGFR) in patients with type 2 diabetes. Methods: In a cross-sectional study of 410 patients, chronic kidney disease (CKD) stage assessed by eGFR was compared with 25OHD, 1,25OHD, and VDR FokI (rs10735810) polymorphisms by an ordered logistic regression model adjusted for the following confounders: disease duration, calendar month, use of angiotensin converting enzyme inhibitors/angiotensin receptor blockers or statins, and serum calcium, phosphate, and intact parathyroid hormone levels. Results: 1,25OHD levels, rather than 25OHD levels, showed seasonal oscillations; peak levels were seen from May to October and the lowest levels were seen from December to February. These findings were evident in patients with CKD stage 3 similar to 5 but not stage 1 similar to 2. eGFR was in direct proportion to both 25OHD and 1,25OHD levels (P<0.0001), but it had stronger linearity with 1,25OHD (r = 0.73) than 25OHD (r = 0.22) levels. Using multivariate analysis, 1,25OHD levels (P<0.001), but not 25OHD levels, were negatively associated with CKD stage. Although FokI polymorphisms by themselves showed no significant associations with CKD stage, a significant interaction between 1,25OHD and FokITT was observed (P = 0.008). The positive association between 1,25OHD and eGFR was steeper in Fok/CT and CC polymorphisms (r = 0.74) than Fok/TT polymorphisms (r = 0.65). Conclusions: These results suggest that higher 1,25OHD levels may be associated with better CKD stages in patients with type 2 diabetes and that this association was modified by FokI polymorphisms.	[Nakashima, Akio; Urashima, Mitsuyoshi; Suga, Hiroaki; Mimura, Takeshi] Jikei Univ, Sch Med, Div Mol Epidemiol, Tokyo, Japan; [Yokoyama, Keitaro; Nakashima, Akio; Tanno, Yudo; Ohkido, Ichiro; Hosoya, Tatsuo] Jikei Univ, Div Kidney, Dept Internal Med, Sch Med, Tokyo, Japan; [Kimura, Yasuo] Shin Kashiwa Clin, Chiba, Japan; [Kanazawa, Yasushi; Yokota, Tamotsu; Sakamoto, Masaya; Ishizawa, Sho; Nishimura, Rimei; Kurata, Hideaki; Tojo, Katsuyoshi; Utsunomiya, Kazunori] Jikei Univ, Div Diabet Metab & Endocrinol, Dept Internal Med, Sch Med, Tokyo, Japan; [Kageyama, Shigeru] Jikei Univ, Sch Med, Div Clin Pharmacol & Therapeut, Tokyo, Japan	Jikei University; Jikei University; Jikei University; Jikei University	Urashima, M (corresponding author), Jikei Univ, Sch Med, Div Mol Epidemiol, Tokyo, Japan.	urashima@jikei.ac.jp		Nakashima, Akio/0000-0002-3730-0301	MEXT; Jikei University School of Medicine; Grants-in-Aid for Scientific Research [23591553] Funding Source: KAKEN	MEXT(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Jikei University School of Medicine(Jikei University); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This research was supported by MEXT-Supported Program for the Strategic Research Foundation at Private Universities and by the Jikei University School of Medicine. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arai H, 1997, J BONE MINER RES, V12, P915, DOI 10.1359/jbmr.1997.12.6.915; Colin EM, 2000, CLIN ENDOCRINOL, V52, P211, DOI 10.1046/j.1365-2265.2000.00909.x; de Borst MH, 2011, J AM SOC NEPHROL, V22, P1603, DOI 10.1681/ASN.2010121251; de Zeeuw D, 2010, LANCET, V376, P1543, DOI 10.1016/S0140-6736(10)61032-X; Dimitriadou M, 2011, PEDIATR HEMAT ONCOL, V28, P509, DOI 10.3109/08880018.2011.579231; Gross C, 1996, J BONE MINER RES, V11, P1850; Hama T, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0029634; Holick MF, 2007, NEW ENGL J MED, V357, P266, DOI 10.1056/NEJMra070553; Kabadi SM, 2012, DIABETES CARE, V35, P2048, DOI 10.2337/dc12-0235; Martin RJL, 2010, NEPHROL DIAL TRANSPL, V25, P497, DOI 10.1093/ndt/gfp515; Martineau AR, 2011, LANCET, V377, P242, DOI 10.1016/S0140-6736(10)61889-2; Matsuo S, 2009, AM J KIDNEY DIS, V53, P982, DOI 10.1053/j.ajkd.2008.12.034; Pocock SJ, 2002, STAT MED, V21, P2917, DOI 10.1002/sim.1296; Ravani P, 2009, KIDNEY INT, V75, P88, DOI 10.1038/ki.2008.501; Seino Y, 2010, DIABETOL INT, V1, P2, DOI 10.1007/s13340-010-0006-7; Suzuki M, 2012, MOVEMENT DISORD, V27, P264, DOI 10.1002/mds.24016; Teng M, 2005, J AM SOC NEPHROL, V16, P1115, DOI 10.1681/ASN.2004070573; Tripathi G, 2010, RENAL FAILURE, V32, P969, DOI 10.3109/0886022X.2010.501934; Uitterlinden AG, 2004, GENE, V338, P143, DOI 10.1016/j.gene.2004.05.014; Vaidya A, 2011, CLIN ENDOCRINOL, V74, P783, DOI 10.1111/j.1365-2265.2011.03991.x; van der Mei IAF, 2007, ENVIRON HEALTH PERSP, V115, P1132, DOI 10.1289/ehp.9937; Vedralova M, 2012, KIDNEY BLOOD PRESS R, V36, P1, DOI 10.1159/000339021; Vejakama P, 2012, DIABETOLOGIA, V55, P566, DOI 10.1007/s00125-011-2398-8; Wild S, 2004, DIABETES CARE, V27, P1047, DOI 10.2337/diacare.27.5.1047; Yamaji T, 2012, AM J EPIDEMIOL, V175, P236, DOI 10.1093/aje/kwr295	25	16	17	1	40	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 4	2012	7	12							e51171	10.1371/journal.pone.0051171	http://dx.doi.org/10.1371/journal.pone.0051171			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	051EQ	23226566	Green Submitted, Green Published, gold			2022-12-27	WOS:000312108500048
J	Freeman, JL; Marcus, MA; Fakra, SC; Devonshire, J; McGrath, SP; Quinn, CF; Pilon-Smits, EAH				Freeman, John L.; Marcus, Matthew A.; Fakra, Sirine C.; Devonshire, Jean; McGrath, Steve P.; Quinn, Colin F.; Pilon-Smits, Elizabeth A. H.			Selenium Hyperaccumulator Plants Stanleya pinnata and Astragalus bisulcatus Are Colonized by Se-Resistant, Se-Excluding Wasp and Beetle Seed Herbivores	PLOS ONE			English	Article							LOCATING SELENIFEROUS AREAS; WESTERN UNITED-STATES; INDICATOR PLANTS; PROTECTS PLANTS; ACCUMULATION; SPECIATION; TOLERANCE; TOXICITY; TRANSLOCATION; DETERRENCE	Selenium (Se) hyperaccumulator plants can concentrate the toxic element Se up to 1% of shoot (DW) which is known to protect hyperaccumulator plants from generalist herbivores. There is evidence for Se-resistant insect herbivores capable of feeding upon hyperaccumulators. In this study, resistance to Se was investigated in seed chalcids and seed beetles found consuming seeds inside pods of Se-hyperaccumulator species Astragalus bisulcatus and Stanleya pinnata. Selenium accumulation, localization and speciation were determined in seeds collected from hyperaccumulators in a seleniferous habitat and in seed herbivores. Astragalus bisulcatus seeds were consumed by seed beetle larvae (Acanthoscelides fraterculus Horn, Coleoptera: Bruchidae) and seed chalcid larvae (Bruchophagus mexicanus, Hymenoptera: Eurytomidae). Stanleya pinnata seeds were consumed by an unidentified seed chalcid larva. Micro X-ray absorption near-edge structure (mu XANES) and micro-X-Ray Fluorescence mapping (mu XRF) demonstrated Se was mostly organic C-Se-C forms in seeds of both hyperaccumulators, and S. pinnata seeds contained similar to 24% elemental Se. Liquid chromatography-mass spectrometry of Se-compounds in S. pinnata seeds detected the C-Se-C compound seleno-cystathionine while previous studies of A. bisulcatus seeds detected the C-Se-C compounds methyl-selenocysteine and gamma-glutamyl-methyl-selenocysteine. Micro-XRF and mu XANES revealed Se ingested from hyperaccumulator seeds redistributed throughout seed herbivore tissues, and portions of seed C-Se-C were biotransformed into selenocysteine, selenocystine, selenodiglutathione, selenate and selenite. Astragalus bisulcatus seeds contained on average 5,750 mu g Se g(-1), however adult beetles and adult chalcid wasps emerging from A. bisulcatus seed pods contained 4-6 mu g Se g(-1). Stanleya pinnata seeds contained 1,329 mu g Se g(-1) on average; however chalcid wasp larvae and adults emerging from S. pinnata seed pods contained 9 and 47 mu g Se g(-1). The results suggest Se resistant seed herbivores exclude Se, greatly reducing tissue accumulation; this explains their ability to consume high-Se seeds without suffering toxicity, allowing them to occupy the unique niche offered by Se hyperaccumulator plants. Citation: Freeman JL, Marcus MA, Fakra SC, Devonshire J, McGrath SP, et al. (2012) Selenium Hyperaccumulator Plants Stanleya pinnata and Astragalus bisulcatus Are Colonized by Se-Resistant, Se-Excluding Wasp and Beetle Seed Herbivores. PLoS ONE 7(12): e50516. doi:10.1371/journal.pone.0050516	[Freeman, John L.] Calif State Univ Fresno, Dept Biol, Fresno, CA 93740 USA; [Freeman, John L.] Intrinsyx Technol Corp, Moffett Field, CA USA; [Freeman, John L.] NASA, Ames Res Ctr, Moffett Field, CA 94035 USA; [Marcus, Matthew A.; Fakra, Sirine C.] Univ Calif Berkeley, Lawrence Berkeley Natl Lab, Adv Light Source, Berkeley, CA 94720 USA; [Devonshire, Jean; McGrath, Steve P.] Rothamsted Res, Harpenden, Herts, England; [Quinn, Colin F.; Pilon-Smits, Elizabeth A. H.] Colorado State Univ, Dept Biol, Ft Collins, CO 80523 USA	California State University System; California State University Fresno; National Aeronautics & Space Administration (NASA); NASA Ames Research Center; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley; UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Rothamsted Research; Colorado State University	Freeman, JL (corresponding author), Calif State Univ Fresno, Dept Biol, Fresno, CA 93740 USA.	John.L.Freeman@NASA.gov	marcus, matthew/P-8023-2019; McGrath, Steve P/B-5127-2008; Pilon-Smits, Elizabeth/AAN-4117-2020	McGrath, Steve P/0000-0003-0952-8947; Pilon-Smits, Elizabeth/0000-0003-1205-8798; Freeman, John/0000-0003-3403-9360	National Science Foundation [IOS-0817748]; Office of Science, Basic Energy Sciences, and Division of Materials Science of the U.S. Department of Energy [DE-AC02-05CH11231]; Biotechnology and Biological Sciences Research Council of the UK; BBSRC [BBS/E/C/00005197, BBS/E/C/00004981] Funding Source: UKRI	National Science Foundation(National Science Foundation (NSF)); Office of Science, Basic Energy Sciences, and Division of Materials Science of the U.S. Department of Energy(United States Department of Energy (DOE)); Biotechnology and Biological Sciences Research Council of the UK(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	Funding for these studies was provided by National Science Foundation grant #IOS-0817748 to EAHP. The Advanced Light Source is supported by the Office of Science, Basic Energy Sciences, and Division of Materials Science of the U.S. Department of Energy (DE-AC02-05CH11231). Rothamsted Research received grant-aided support from the Biotechnology and Biological Sciences Research Council of the UK. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Beath OA, 1939, AM J BOT, V26, P296, DOI 10.2307/2436464; Beath OA, 1939, AM J BOT, V26, P257, DOI 10.2307/2436499; Cubadda F, 2010, J AGR FOOD CHEM, V58, P2295, DOI 10.1021/jf903004a; El Mehdawi AF, 2012, PLANT BIOLOGY, V14, P1, DOI 10.1111/j.1438-8677.2011.00535.x; FASSEL VA, 1978, SCIENCE, V202, P183, DOI 10.1126/science.202.4364.183; Freeman JL, 2007, NEW PHYTOL, V175, P490, DOI 10.1111/j.1469-8137.2007.02119.x; Freeman JL, 2006, CURR BIOL, V16, P2181, DOI 10.1016/j.cub.2006.09.015; Freeman JL, 2006, PLANT PHYSIOL, V142, P124, DOI 10.1104/pp.106.081158; Freeman JL, 2010, PLANT PHYSIOL, V153, P1630, DOI [10.1104/pp.110.156570, 10.1186/1472-6785-10-19]; Freeman JL, 2009, AM J BOT, V96, P1075, DOI 10.3732/ajb.0800287; Galeas ML, 2008, NEW PHYTOL, V177, P715, DOI 10.1111/j.1469-8137.2007.02285.x; Galeas ML, 2007, NEW PHYTOL, V173, P517, DOI 10.1111/j.1469-8137.2006.01943.x; GHARIEB MM, 1995, J IND MICROBIOL, V14, P300, DOI 10.1007/BF01569943; Hanson B, 2004, NEW PHYTOL, V162, P655, DOI 10.1111/j.1469-8137.2004.01067.x; Hanson B, 2003, NEW PHYTOL, V159, P461, DOI 10.1046/j.1469-8137.2003.00786.x; Hunter WJ, 2007, CURR MICROBIOL, V55, P344, DOI 10.1007/s00284-007-0202-2; Ip C, 2000, CANCER RES, V60, P2882; Kelly SD, 2008, METHODS SOIL ANAL 5, P387, DOI DOI 10.2136/SSSABOOKSER5.5.C14; Lavigne RJ, 1989, WYOMING AGR EXPT STA, V52; Lindblom SD, 2013, ENVIRON EXP BOT, V88, P33, DOI 10.1016/j.envexpbot.2011.12.011; Marcus MA, 2004, J SYNCHROTRON RADIAT, V11, P239, DOI 10.1107/S0909049504005837; NELSON DM, 1983, J KANSAS ENTOMOL SOC, V56, P267; Neuhierl B, 1996, EUR J BIOCHEM, V239, P235, DOI 10.1111/j.1432-1033.1996.0235u.x; NIGAM SN, 1969, BIOCHIM BIOPHYS ACTA, V192, P185, DOI 10.1016/0304-4165(69)90354-7; Quinn CF, 2011, NEW PHYTOL, V192, P727, DOI 10.1111/j.1469-8137.2011.03832.x; Schofield RMS, 2002, NATURWISSENSCHAFTEN, V89, P579, DOI 10.1007/s00114-002-0381-4; SHRIFT A, 1969, ANN REV PLANT PHYSIO, V20, P475, DOI 10.1146/annurev.pp.20.060169.002355; Sors TG, 2005, PHOTOSYNTH RES, V86, P373, DOI 10.1007/s11120-005-5222-9; STADTMAN TC, 1990, ANNU REV BIOCHEM, V59, P111, DOI 10.1146/annurev.bi.59.070190.000551; Sun GX, 2010, ENVIRON SCI TECHNOL, V44, P6706, DOI 10.1021/es101843x; Trelease SF, 1937, AM J BOT, V24, P448, DOI 10.2307/2436430; WILBER CG, 1980, CLIN TOXICOL, V17, P171, DOI 10.3109/15563658008985076; ZARCINAS BA, 1987, COMMUN SOIL SCI PLAN, V18, P131, DOI 10.1080/00103628709367806	33	29	29	0	53	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 3	2012	7	12							e50516	10.1371/journal.pone.0050516	http://dx.doi.org/10.1371/journal.pone.0050516			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	051DH	23226523	gold, Green Published, Green Submitted			2022-12-27	WOS:000312104700020
J	Chabrol, E; Nurisso, A; Daina, A; Vassal-Stermann, E; Thepaut, M; Girard, E; Vives, RR; Fieschi, F				Chabrol, Eric; Nurisso, Alessandra; Daina, Antoine; Vassal-Stermann, Emilie; Thepaut, Michel; Girard, Eric; Vives, Romain R.; Fieschi, Franck			Glycosaminoglycans Are Interactants of Langerin: Comparison with gp120 Highlights an Unexpected Calcium-Independent Binding Mode	PLOS ONE			English	Article							CARBOHYDRATE-RECOGNITION DOMAIN; VIRUS-LIKE PARTICLES; RECEPTORS DC-SIGN; BIRBECK GRANULES; T-CELLS; HIV-1 TRANSMISSION; HEPARAN SULFATES; STRUCTURAL BASIS; TRANS-INFECTION; DENDRITIC CELLS	Langerin is a C-type lectin specifically expressed in Langerhans cells. As recently shown for HIV, Langerin is thought to capture pathogens and mediate their internalisation into Birbeck Granules for elimination. However, the precise functions of Langerin remain elusive, mostly because of the lack of information on its binding properties and physiological ligands. Based on recent reports that Langerin binds to sulfated sugars, we conducted here a comparative analysis of Langerin interaction with mannose-rich HIV glycoprotein gp120 and glycosaminoglycan (GAGs), a family of sulfated polysaccharides expressed at the surface of most mammalian cells. Our results first revealed that Langerin bound to these different glycans through very distinct mechanisms and led to the identification of a novel, GAG-specific binding mode within Langerin. In contrast to the canonical lectin domain, this new binding site showed no Ca2+-dependency, and could only be detected in entire, trimeric extracellular domains of Langerin. Interestingly binding to GAGs, did not simply rely on a net charge effect, but rather on more discrete saccharide features, such as 6-O-sulfation, or iduronic acid content. Using molecular modelling simulations, we proposed a model of Langerin/heparin complex, which located the GAG binding site at the interface of two of the three Carbohydrate-recognition domains of the protein, at the edge of the a-helix coiled-coil. To our knowledge, the binding properties that we have highlighted here for Langerin, have never been reported for C-type lectins before. These findings provide new insights towards the understanding of Langerin biological functions.	[Chabrol, Eric; Thepaut, Michel; Fieschi, Franck] Univ Grenoble 1, Grp Membrane & Pathogens, Inst Biol Struct, Grenoble, France; [Chabrol, Eric; Vassal-Stermann, Emilie; Thepaut, Michel; Girard, Eric; Vives, Romain R.; Fieschi, Franck] CNRS, UMR 5075, Grenoble, France; [Chabrol, Eric; Vassal-Stermann, Emilie; Thepaut, Michel; Girard, Eric; Vives, Romain R.; Fieschi, Franck] CEA, Dept Sci Vivant, Grenoble, France; [Nurisso, Alessandra; Daina, Antoine] Univ Geneva, Dept Pharmacochim, Geneva, Switzerland; [Daina, Antoine; Vives, Romain R.] Swiss Inst Bioinformat, Mol Modeling Grp, Lausanne, Switzerland; [Vassal-Stermann, Emilie] Univ Grenoble 1, Grp SAGAG, Inst Biol Struct, Grenoble, France; [Girard, Eric] Univ Grenoble 1, Grp ELMA, Inst Biol Struct, Grenoble, France; [Fieschi, Franck] Inst Univ France, Paris, France	UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); CEA; Centre National de la Recherche Scientifique (CNRS); Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); CEA; CEA; University of Geneva; Swiss Institute of Bioinformatics; UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); CEA; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); CEA; Centre National de la Recherche Scientifique (CNRS); Institut Universitaire de France	Fieschi, F (corresponding author), Univ Grenoble 1, Grp Membrane & Pathogens, Inst Biol Struct, Grenoble, France.	franck.fieschi@ibs.fr	Vives, Romain/I-9372-2012; t, m/GXF-8560-2022; T, M/GRO-7072-2022; Fieschi, Franck/W-2748-2019	FIESCHI, Franck/0000-0003-1194-8107; Stermann, Emilie/0000-0002-8486-4935; Girard, Eric/0000-0002-5758-6095	Ensemble contre le SIDA -Sidaction; French Ministry of Research and Higher Education	Ensemble contre le SIDA -Sidaction; French Ministry of Research and Higher Education	This study was supported by grants from Ensemble contre le SIDA -Sidaction. Eric Chabrol was supported by a fellowship from the French Ministry of Research and Higher Education. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andreini M, 2011, ORG BIOMOL CHEM, V9, P5778, DOI 10.1039/c1ob05573a; Balzarini J, 2007, NAT REV MICROBIOL, V5, P583, DOI 10.1038/nrmicro1707; Becer CR, 2010, J AM CHEM SOC, V132, P15130, DOI 10.1021/ja1056714; BERNFIELD M, 1992, ANNU REV CELL BIOL, V8, P365, DOI 10.1146/annurev.cb.08.110192.002053; Berzi A, 2012, AIDS, V26, P127, DOI 10.1097/QAD.0b013e32834e1567; Borrok MJ, 2007, J AM CHEM SOC, V129, P12780, DOI 10.1021/ja072944v; Bousarghin L, 2005, J GEN VIROL, V86, P1297, DOI 10.1099/vir.0.80559-0; BROOKS BR, 1983, J COMPUT CHEM, V4, P187, DOI 10.1002/jcc.540040211; Catlow KR, 2008, J BIOL CHEM, V283, P5235, DOI 10.1074/jbc.M706589200; Chatwell L, 2008, MOL IMMUNOL, V45, P1981, DOI 10.1016/j.molimm.2007.10.030; CLARK M, 1989, J COMPUT CHEM, V10, P982, DOI 10.1002/jcc.540100804; Cros S, 1997, BIOORGAN MED CHEM, V5, P1301, DOI 10.1016/S0968-0896(97)00087-4; de Witte L, 2008, TRENDS MOL MED, V14, P12, DOI 10.1016/j.molmed.2007.11.001; De Witte L, 2007, IMMUNOBIOLOGY, V212, P679, DOI 10.1016/j.imbio.2007.09.006; de Witte L, 2007, NAT MED, V13, P367, DOI 10.1038/nm1541; Esko JD, 2009, PROTEOGLYCANS SULFAT; Feinberg H, 2011, J MOL BIOL, V405, P1027, DOI 10.1016/j.jmb.2010.11.039; Feinberg H, 2010, J BIOL CHEM, V285, P13285, DOI 10.1074/jbc.M109.086058; Frese MA, 2009, J BIOL CHEM, V284, P28033, DOI 10.1074/jbc.M109.035808; Galustian C, 2004, INT IMMUNOL, V16, P853, DOI 10.1093/intimm/dxh089; Geijtenbeek TBH, 2000, CELL, V100, P587, DOI 10.1016/S0092-8674(00)80694-7; Grosdidier A, 2011, NUCLEIC ACIDS RES, V39, pW270, DOI 10.1093/nar/gkr366; Grosdidier A, 2009, J COMPUT CHEM, V30, P2021, DOI 10.1002/jcc.21202; Guo Y, 2004, NAT STRUCT MOL BIOL, V11, P591, DOI 10.1038/nsmb784; Halgren TA, 1996, J COMPUT CHEM, V17, P490, DOI [10.1002/(SICI)1096-987X(199604)17:5/6<490::AID-JCC1>3.0.CO;2-P, 10.1002/(SICI)1096-987X(199604)17:5/6<616::AID-JCC5>3.0.CO;2-X]; Hijazi K, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028307; Holla A, 2011, PROTEIN ENG DES SEL, V24, P659, DOI 10.1093/protein/gzr016; Hunger RE, 2004, J CLIN INVEST, V113, P701, DOI 10.1172/JCI200419655; IMBERTY A, 1999, PERSPECTIVES STRUCTU, P392; Jones G, 1997, J MOL BIOL, V267, P727, DOI 10.1006/jmbi.1996.0897; Kissenpfennig A, 2005, MOL CELL BIOL, V25, P88, DOI 10.1128/MCB.25.1.88-99.2005; Martinez-Avila O, 2009, CHEMBIOCHEM, V10, P1806, DOI 10.1002/cbic.200900294; Mikhailov D, 1997, BIOCHEM J, V328, P51, DOI 10.1042/bj3280051; O'Sullivan GM, 2000, EXP DERMATOL, V9, P25, DOI 10.1034/j.1600-0625.2000.009001025.x; Pye DA, 1998, J BIOL CHEM, V273, P22936, DOI 10.1074/jbc.273.36.22936; Reina JJ, 2007, CHEMMEDCHEM, V2, P1030, DOI 10.1002/cmdc.200700047; Solomon T, 2010, CELLULAR MICROBIOLOG, V12, P1553; Tabarani G, 2006, FEBS LETT, V580, P2402, DOI 10.1016/j.febslet.2006.03.061; Tabarani G, 2009, J BIOL CHEM, V284, P21229, DOI 10.1074/jbc.M109.021204; Tateno H, 2010, J BIOL CHEM, V285, P6390, DOI 10.1074/jbc.M109.041863; Thepaut M, 2008, ACTA CRYSTALLOGR F, V64, P115, DOI 10.1107/S1744309108001000; Thepaut M, 2009, BIOCHEMISTRY-US, V48, P2684, DOI 10.1021/bi802151w; Turville SG, 2002, NAT IMMUNOL, V3, P975, DOI 10.1038/ni841; Valladeau J, 2000, IMMUNITY, V12, P71, DOI 10.1016/S1074-7613(00)80160-0; Valladeau J, 2001, PATHOL BIOL, V49, P454, DOI 10.1016/S0369-8114(01)00163-8; Valladeau J, 1999, EUR J IMMUNOL, V29, P2695, DOI 10.1002/(SICI)1521-4141(199909)29:09<2695::AID-IMMU2695>3.0.CO;2-Q; Vives RR, 2002, BIOCHEMISTRY-US, V41, P14779, DOI 10.1021/bi026459i; Waldherr-Teschner M., 1992, Advances in Scientific Visualization, P58	48	33	34	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 30	2012	7	11							e50722	10.1371/journal.pone.0050722	http://dx.doi.org/10.1371/journal.pone.0050722			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	054WM	23226363	Green Submitted, gold, Green Published			2022-12-27	WOS:000312376100174
J	Garcia, PA; Rossmeisl, JH; Robertson, JL; Olson, JD; Johnson, AJ; Ellis, TL; Davalos, RV				Garcia, Paulo A.; Rossmeisl, John H., Jr.; Robertson, John L.; Olson, John D.; Johnson, Annette J.; Ellis, Thomas L.; Davalos, Rafael V.			7.0-T Magnetic Resonance Imaging Characterization of Acute Blood-Brain-Barrier Disruption Achieved with Intracranial Irreversible Electroporation	PLOS ONE			English	Article							TISSUE ABLATION; GLIOBLASTOMA; ELECTROCHEMOTHERAPY; ULTRASOUND; RADIOTHERAPY; THERAPY	The blood-brain-barrier (BBB) presents a significant obstacle to the delivery of systemically administered chemotherapeutics for the treatment of brain cancer. Irreversible electroporation (IRE) is an emerging technology that uses pulsed electric fields for the non-thermal ablation of tumors. We hypothesized that there is a minimal electric field at which BBB disruption occurs surrounding an IRE-induced zone of ablation and that this transient response can be measured using gadolinium (Gd) uptake as a surrogate marker for BBB disruption. The study was performed in a Good Laboratory Practices (GLP) compliant facility and had Institutional Animal Care and Use Committee (IACUC) approval. IRE ablations were performed in vivo in normal rat brain (n = 21) with 1-mm electrodes (0.45 mm diameter) separated by an edge-to-edge distance of 4 mm. We used an ECM830 pulse generator to deliver ninety 50-mu s pulse treatments (0, 200, 400, 600, 800, and 1000 V/cm) at 1 Hz. The effects of applied electric fields and timing of Gd administration (-5, +5, +15, and +30 min) was assessed by systematically characterizing IRE-induced regions of cell death and BBB disruption with 7.0-T magnetic resonance imaging (MRI) and histopathologic evaluations. Statistical analysis on the effect of applied electric field and Gd timing was conducted via Fit of Least Squares with alpha = 0.05 and linear regression analysis. The focal nature of IRE treatment was confirmed with 3D MRI reconstructions with linear correlations between volume of ablation and electric field. Our results also demonstrated that IRE is an ablation technique that kills brain tissue in a focal manner depicted by MRI (n = 16) and transiently disrupts the BBB adjacent to the ablated area in a voltage-dependent manner as seen with Evan's Blue (n = 5) and Gd administration.	[Garcia, Paulo A.; Davalos, Rafael V.] Virginia Tech Wake Forest Univ, Sch Biomed Engn & Sci, Bioelectromech Syst Lab, Blacksburg, VA USA; [Rossmeisl, John H., Jr.; Robertson, John L.] Virginia Polytech Inst & State Univ, Virginia Maryland Reg Coll Vet Med, Blacksburg, VA 24061 USA; [Olson, John D.] Wake Forest Univ, Bowman Gray Sch Med, Ctr Biomol Imaging, Winston Salem, NC USA; [Johnson, Annette J.] Wake Forest Univ, Bowman Gray Sch Med, Dept Radiol, Winston Salem, NC USA; [Ellis, Thomas L.] Wake Forest Univ, Bowman Gray Sch Med, Dept Neurosurg, Winston Salem, NC USA	Virginia Polytechnic Institute & State University; Virginia Polytechnic Institute & State University; Wake Forest University; Wake Forest Baptist Medical Center; Wake Forest University; Wake Forest Baptist Medical Center; Wake Forest University; Wake Forest Baptist Medical Center	Garcia, PA (corresponding author), Virginia Tech Wake Forest Univ, Sch Biomed Engn & Sci, Bioelectromech Syst Lab, Blacksburg, VA USA.	pgarcia@vt.edu; tlellis@wakehealth.edu	Rossmeisl, John H/Q-7119-2016	Rossmeisl, John H/0000-0003-1655-7076	Golfers Against Cancer; Center for Biomolecular Imaging in the Wake Forest School of Medicine; NSF CAREER Award [CBET-1055913]	Golfers Against Cancer; Center for Biomolecular Imaging in the Wake Forest School of Medicine; NSF CAREER Award(National Science Foundation (NSF)NSF - Office of the Director (OD))	This work was supported by the Golfers Against Cancer (http://www.golfersagainstcancer.org/), the Center for Biomolecular Imaging in the Wake Forest School of Medicine (http://www.wakehealth.edu/Center-for-Biomolecular-Imaging/), and NSF CAREER Award CBET-1055913 (http://www.nsf.gov/div/index.jsp?div=cbet). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agerholm-Larsen B, 2011, CANCER RES, V71, P3753, DOI 10.1158/0008-5472.CAN-11-0451; Al-Sakere B, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001135; Appelbaum L, 2012, RADIOLOGY, V262, P117, DOI 10.1148/radiol.11110475; Barajas RF, 2012, NEURO-ONCOLOGY, V14, P942, DOI 10.1093/neuonc/nos128; Ben-David E, 2012, AM J ROENTGENOL, V198, pW62, DOI 10.2214/AJR.11.6940; Cemazar M, 2001, BRIT J CANCER, V84, P565, DOI 10.1054/bjoc.2000.1625; Chopra A, 2004, MOL IMAGING CONTRAST; Davalos RV, 2008, INT J HEAT MASS TRAN, V51, P5617, DOI 10.1016/j.ijheatmasstransfer.2008.04.046; Davalos RV, 2005, ANN BIOMED ENG, V33, P223, DOI 10.1007/s10439-005-8981-8; Edd JF, 2006, IEEE T BIO-MED ENG, V53, P1409, DOI 10.1109/TBME.2006.873745; Ellis TL, 2011, J NEUROSURG, V114, P681, DOI 10.3171/2010.5.JNS091448; Frigeni V, 2001, INVEST RADIOL, V36, P561, DOI 10.1097/00004424-200110000-00001; Garcia PA, 2011, TECHNOL CANCER RES T, V10, P73, DOI 10.7785/tcrt.2012.500181; Garcia PA, 2011, BIOMED ENG ONLINE, V10, DOI 10.1186/1475-925X-10-34; Garcia PA, 2010, J MEMBRANE BIOL, V236, P127, DOI 10.1007/s00232-010-9284-z; Hirschberg H, 2009, J NEURO-ONCOL, V95, P317, DOI 10.1007/s11060-009-9930-4; Hjouj M, 2011, NEURO-ONCOLOGY, V13, P114; HOCHBERG FH, 1980, NEUROLOGY, V30, P907, DOI 10.1212/WNL.30.9.907; Howles GP, 2010, MAGN RESON MED, V64, P995, DOI 10.1002/mrm.22411; Kohrmann M, 2012, STROKE, V43, P259, DOI 10.1161/STROKEAHA.111.632356; Lee EW, 2007, TECHNOL CANCER RES T, V6, P287, DOI 10.1177/153303460700600404; Liu HL, 2010, RADIOLOGY, V255, P415, DOI 10.1148/radiol.10090699; Mahmood F, 2011, J MEMBRANE BIOL, V240, P131, DOI 10.1007/s00232-011-9351-0; Marty M, 2006, EJC SUPPL, V4, P3, DOI 10.1016/j.ejcsup.2006.08.002; Noce AL, 1999, RADIOLOGY, V34, P262; SALFORD LG, 1993, BIOCHEM BIOPH RES CO, V194, P938, DOI 10.1006/bbrc.1993.1911; Saraswathy S, 2009, J NEURO-ONCOL, V91, P69, DOI 10.1007/s11060-008-9685-3; Stupp R, 2005, NEW ENGL J MED, V352, P987, DOI 10.1056/NEJMoa043330	28	34	59	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 30	2012	7	11							e50482	10.1371/journal.pone.0050482	http://dx.doi.org/10.1371/journal.pone.0050482			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	054WM	23226293	Green Published, gold, Green Submitted			2022-12-27	WOS:000312376100105
J	Hancock, DB; Levy, JL; Gaddis, NC; Bierut, LJ; Saccone, NL; Page, GP; Johnson, EO				Hancock, Dana B.; Levy, Joshua L.; Gaddis, Nathan C.; Bierut, Laura J.; Saccone, Nancy L.; Page, Grier P.; Johnson, Eric O.			Assessment of Genotype Imputation Performance Using 1000 Genomes in African American Studies	PLOS ONE			English	Article							WIDE ASSOCIATION; HUMAN-POPULATIONS; UNTYPED MARKERS; INFERENCE; ACCURACY; METAANALYSIS; VARIANTS; COMMON; SETS; MAP	Genotype imputation, used in genome-wide association studies to expand coverage of single nucleotide polymorphisms (SNPs), has performed poorly in African Americans compared to less admixed populations. Overall, imputation has typically relied on HapMap reference haplotype panels from Africans (YRI), European Americans (CEU), and Asians (CHB/JPT). The 1000 Genomes project offers a wider range of reference populations, such as African Americans (ASW), but their imputation performance has had limited evaluation. Using 595 African Americans genotyped on Illumina's HumanHap550v3 BeadChip, we compared imputation results from four software programs (IMPUTE2, BEAGLE, MaCH, and MaCH-Admix) and three reference panels consisting of different combinations of 1000 Genomes populations (February 2012 release): (1) 3 specifically selected populations (YRI, CEU, and ASW); (2) 8 populations of diverse African (AFR) or European (AFR) descent; and (3) all 14 available populations (ALL). Based on chromosome 22, we calculated three performance metrics: (1) concordance (percentage of masked genotyped SNPs with imputed and true genotype agreement); (2) imputation quality score (IQS; concordance adjusted for chance agreement, which is particularly informative for low minor allele frequency [MAF] SNPs); and (3) average r2hat (estimated correlation between the imputed and true genotypes, for all imputed SNPs). Across the reference panels, IMPUTE2 and MaCH had the highest concordance (91%-93%), but IMPUTE2 had the highest IQS (81%-83%) and average r2hat (0.68 using YRI+ASW+CEU, 0.62 using AFR+EUR, and 0.55 using ALL). Imputation quality for most programs was reduced by the addition of more distantly related reference populations, due entirely to the introduction of low frequency SNPs (MAF <= 2%) that are monomorphic in the more closely related panels. While imputation was optimized by using IMPUTE2 with reference to the ALL panel (average r2hat = 0.86 for SNPs with MAF>2%), use of the ALL panel for African American studies requires careful interpretation of the population specificity and imputation quality of low frequency SNPs.	[Hancock, Dana B.; Johnson, Eric O.] Res Triangle Inst Int, Behav Hlth Epidemiol Program, Res Triangle Pk, NC USA; [Levy, Joshua L.; Gaddis, Nathan C.] Res Triangle Inst Int, Res Comp Div, Res Triangle Pk, NC USA; [Bierut, Laura J.] Washington Univ, Dept Psychiat, St Louis, MO USA; [Saccone, Nancy L.] Washington Univ, Dept Genet, St Louis, MO 63110 USA; [Page, Grier P.] Res Triangle Inst Int, Genom Stat Genet & Environm Res Program, Res Triangle Pk, NC USA	Research Triangle Institute; Research Triangle Institute; Washington University (WUSTL); Washington University (WUSTL); Research Triangle Institute	Hancock, DB (corresponding author), Res Triangle Inst Int, Behav Hlth Epidemiol Program, Res Triangle Pk, NC USA.	dhancock@rti.org	Gaddis, Nathan/GXG-6395-2022; Gaddis, Nathan/GXG-6447-2022; Bierut, Laura Jean/W-6806-2019	Bierut, Laura Jean/0000-0002-9952-4810; Gaddis, Nathan/0000-0001-5205-7138; Hancock, Dana/0000-0003-2240-3604; Johnson, Eric Otto/0000-0002-8870-1949; Page, Grier/0000-0003-2582-3786	National Institute of Drug Abuse [5R33DA027486, 5R01DA026141]; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA025888, R01DA026141, R33DA027486] Funding Source: NIH RePORTER	National Institute of Drug Abuse(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This work was supported by National Institute of Drug Abuse (www.drugabuse.gov) grant nos. 5R33DA027486 and 5R01DA026141. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altshuler D, 2010, NATURE, V467, P1061, DOI 10.1038/nature09534; Altshuler DM, 2010, NATURE, V467, P52, DOI 10.1038/nature09298; Beecham GW, 2010, ANN HUM GENET, V74, P189, DOI 10.1111/j.1469-1809.2010.00573.x; Browning BL, 2009, AM J HUM GENET, V84, P210, DOI 10.1016/j.ajhg.2009.01.005; Chanda P, 2012, J HUM GENET, V57, P411, DOI 10.1038/jhg.2012.43; Charles BA, 2011, BMC MED GENOMICS, V4, DOI 10.1186/1755-8794-4-17; COHEN J, 1960, EDUC PSYCHOL MEAS, V20, P37, DOI 10.1177/001316446002000104; de Bakker PIW, 2008, HUM MOL GENET, V17, pR122, DOI 10.1093/hmg/ddn288; Egyud MRL, 2009, HUM GENET, V125, P295, DOI 10.1007/s00439-009-0627-8; Frazer KA, 2007, NATURE, V449, P851, DOI 10.1038/nature06258; Genovese G, 2010, KIDNEY INT, V78, P698, DOI 10.1038/ki.2010.251; Hancock DB, 2011, 12 INT C HUM GEN 61; Hao K, 2009, BMC GENET, V10, DOI 10.1186/1471-2156-10-27; Howie B, 2011, G3-GENES GENOM GENET, V1, P457, DOI 10.1534/g3.111.001198; Huang L, 2011, GENET EPIDEMIOL, V35, P766, DOI 10.1002/gepi.20626; Huang L, 2009, AM J HUM GENET, V85, P692, DOI 10.1016/j.ajhg.2009.09.017; Huang L, 2009, AM J HUM GENET, V84, P235, DOI 10.1016/j.ajhg.2009.01.013; Jallow M, 2009, NAT GENET, V41, P657, DOI 10.1038/ng.388; Jostins L, 2011, EUR J HUM GENET, V19, P662, DOI 10.1038/ejhg.2011.10; Kang SJ, 2010, HUM MOL GENET, V19, P2725, DOI 10.1093/hmg/ddq154; Lettre G, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1001300; Li Y, 2010, GENET EPIDEMIOL, V34, P816, DOI 10.1002/gepi.20533; Lin P, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009697; Manichaikul A, 2010, BIOINFORMATICS, V26, P2867, DOI 10.1093/bioinformatics/btq559; Marchini J, 2010, NAT REV GENET, V11, P499, DOI 10.1038/nrg2796; Mathias RA, 2010, J ALLERGY CLIN IMMUN, V125, P336, DOI 10.1016/j.jaci.2009.08.031; Nho K, 2011, AMIA ANN S P, P1013; Nothnagel M, 2009, HUM GENET, V125, P163, DOI 10.1007/s00439-008-0606-5; Pasaniuc B, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1001371; Pei YF, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003551; Pemberton TJ, 2008, ANN HUM GENET, V72, P535, DOI 10.1111/j.1469-1809.2008.00457.x; Pritchard JK, 2000, GENETICS, V155, P945; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Shriner D, 2010, GENET EPIDEMIOL, V34, P258, DOI 10.1002/gepi.20457; Southam L, 2011, EUR J HUM GENET, V19, P610, DOI 10.1038/ejhg.2010.242; Sung YJ, 2012, GENET EPIDEMIOL, V36, P508, DOI 10.1002/gepi.21647; Sung YJ, 2012, HUM HERED, V73, P18, DOI 10.1159/000334084; Torgerson DG, 2011, NAT GENET, V43, P887, DOI 10.1038/ng.888; Zheng J, 2011, GENET EPIDEMIOL, V35, P102, DOI 10.1002/gepi.20552	39	32	32	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 30	2012	7	11							e50610	10.1371/journal.pone.0050610	http://dx.doi.org/10.1371/journal.pone.0050610			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	054WM	23226329	Green Submitted, gold, Green Published			2022-12-27	WOS:000312376100141
J	Kuipers, MT; Aslami, H; Vlaar, APJ; Juffermans, NP; Tuip-de Boer, AM; Hegeman, MA; Jongsma, G; Roelofs, JJTH; van der Poll, T; Schultz, MJ; Wieland, CW				Kuipers, Maria T.; Aslami, Hamid; Vlaar, Alexander P. J.; Juffermans, Nicole P.; Tuip-de Boer, Anita M.; Hegeman, Maria A.; Jongsma, Geartsje; Roelofs, Joris J. T. H.; van der Poll, Tom; Schultz, Marcus J.; Wieland, Catharina W.			Pre-Treatment with Allopurinol or Uricase Attenuates Barrier Dysfunction but Not Inflammation during Murine Ventilator-Induced Lung Injury	PLOS ONE			English	Article							XANTHINE OXIDOREDUCTASE; DANGER SIGNAL; ACID; ACTIVATION	Introduction: Uric acid released from injured tissue is considered a major endogenous danger signal and local instillation of uric acid crystals induces acute lung inflammation via activation of the NLRP3 inflammasome. Ventilator-induced lung injury (VILI) is mediated by the NLRP3 inflammasome and increased uric acid levels in lung lavage fluid are reported. We studied levels in human lung injury and the contribution of uric acid in experimental VILI. Methods: Uric acid levels in lung lavage fluid of patients with acute lung injury (ALI) were determined. In a different cohort of cardiac surgery patients, uric acid levels were correlated with pulmonary leakage index. In a mouse model of VILI the effect of allopurinol (inhibits uric acid synthesis) and uricase (degrades uric acid) pre-treatment on neutrophil influx, up-regulation of adhesion molecules, pulmonary and systemic cytokine levels, lung pathology, and regulation of receptors involved in the recognition of uric acid was studied. In addition, total protein and immunoglobulin M in lung lavage fluid and pulmonary wet/dry ratios were measured as markers of alveolar barrier dysfunction. Results: Uric acid levels increased in ALI patients. In cardiac surgery patients, elevated levels correlated significantly with the pulmonary leakage index. Allopurinol or uricase treatment did not reduce ventilator-induced inflammation, I kappa B-alpha degradation, or up-regulation of NLRP3, Toll-like receptor 2, and Toll-like receptor 4 gene expression in mice. Alveolar barrier dysfunction was attenuated which was most pronounced in mice pre-treated with allopurinol: both treatment strategies reduced wet/dry ratio, allopurinol also lowered total protein and immunoglobulin M levels. Conclusions: Local uric acid levels increase in patients with ALI. In mice, allopurinol and uricase attenuate ventilator-induced alveolar barrier dysfunction.	[Kuipers, Maria T.; Aslami, Hamid; Vlaar, Alexander P. J.; Juffermans, Nicole P.; Tuip-de Boer, Anita M.; Hegeman, Maria A.; Jongsma, Geartsje; Schultz, Marcus J.; Wieland, Catharina W.] Univ Amsterdam, Acad Med Ctr, Lab Expt Intens Care & Anesthesiol, NL-1105 AZ Amsterdam, Netherlands; [Kuipers, Maria T.; van der Poll, Tom] Univ Amsterdam, Acad Med Ctr, Ctr Expt & Mol Med, NL-1105 AZ Amsterdam, Netherlands; [van der Poll, Tom] Univ Amsterdam, Acad Med Ctr, Div Infect Dis, NL-1105 AZ Amsterdam, Netherlands; [Juffermans, Nicole P.; Schultz, Marcus J.] Univ Amsterdam, Acad Med Ctr, Dept Intens Care, NL-1105 AZ Amsterdam, Netherlands; [Roelofs, Joris J. T. H.] Univ Amsterdam, Acad Med Ctr, Dept Pathol, NL-1105 AZ Amsterdam, Netherlands	University of Amsterdam; Academic Medical Center Amsterdam; University of Amsterdam; Academic Medical Center Amsterdam; University of Amsterdam; Academic Medical Center Amsterdam; University of Amsterdam; Academic Medical Center Amsterdam; University of Amsterdam; Academic Medical Center Amsterdam; Vrije Universiteit Amsterdam	Kuipers, MT (corresponding author), Univ Amsterdam, Acad Med Ctr, Lab Expt Intens Care & Anesthesiol, Meibergdreef 9, NL-1105 AZ Amsterdam, Netherlands.	Ilse.Kuipers@amc.nl	Schultz, Marcus/AAB-6379-2021	Schultz, Marcus/0000-0003-3969-7792; Vlaar, Alexander/0000-0002-3453-7186; Roelofs, Joris/0000-0001-9595-6571	The Netherlands Organization for Scientific Research, The Hague, The Netherlands [91676096]	The Netherlands Organization for Scientific Research, The Hague, The Netherlands(Netherlands Organization for Scientific Research (NWO)Netherlands Government)	This work was supported by a grant to C. W. Wieland from The Netherlands Organization for Scientific Research, The Hague, The Netherlands, grant number 91676096. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdulnour REE, 2006, AM J PHYSIOL-LUNG C, V291, pL345, DOI 10.1152/ajplung.00453.2005; Bellani G, 2009, CRIT CARE MED, V37, P2216, DOI 10.1097/CCM.0b013e3181aab31f; Bianchi ME, 2007, J LEUKOCYTE BIOL, V81, P1, DOI 10.1189/jlb.0306164; Brower RG, 2000, NEW ENGL J MED, V342, P1301, DOI 10.1056/nejm200005043421801; CHRISTENSEN EF, 1992, CHEST, V102, P556, DOI 10.1378/chest.102.2.556; Dolinay T, 2012, AM J RESP CRIT CARE, V185, P1225, DOI 10.1164/rccm.201201-0003OC; dos Santos CC, 2006, ANNU REV PHYSIOL, V68, P585, DOI 10.1146/annurev.physiol.68.072304.113443; Gasse P, 2009, AM J RESP CRIT CARE, V179, P903, DOI 10.1164/rccm.200808-1274OC; Groeneveld ABJ, 1998, CRIT CARE MED, V26, P685, DOI 10.1097/00003246-199804000-00016; Iles Karen E, 2009, Expert Rev Respir Med, V3, P487, DOI 10.1586/ers.09.41; Jin M, 2012, FRONT BIOSCI-LANDMRK, V17, P656, DOI 10.2741/3950; Kono H, 2010, J CLIN INVEST, V120, P1939, DOI 10.1172/JCI40124; Kuipers MT, 2012, ANESTHESIOLOGY, V116, P1104, DOI 10.1097/ALN.0b013e3182518bc0; Kuipers MT, 2011, CRIT CARE, V15, DOI 10.1186/cc10437; Le A, 2008, J APPL PHYSIOL, V105, P1282, DOI 10.1152/japplphysiol.90689.2008; Li HH, 2010, ANESTHESIOLOGY, V113, P619, DOI 10.1097/ALN.0b013e3181e89ab2; Matthay MA, 2012, J CLIN INVEST, V122, P2731, DOI 10.1172/JCI60331; Ranieri VM, 2012, JAMA-J AM MED ASSOC, V307, P2526, DOI 10.1001/jama.2012.5669; Reijmers RM, 2011, BLOOD, V117, P6162, DOI 10.1182/blood-2010-12-325522; Sautin YY, 2008, NUCLEOS NUCLEOT NUCL, V27, P608, DOI 10.1080/15257770802138558; Schmidt R, 2004, EUR RESPIR J, V24, P994, DOI 10.1183/09031936.04.00120703; Schultz MJ, 2004, THORAX, V59, P130, DOI 10.1136/thorax.2003.013888; Shi Y, 2003, NATURE, V425, P516, DOI 10.1038/nature01991; Shi Y, 2010, J CLIN INVEST, V120, P1809, DOI 10.1172/JCI43132; Terragni PP, 2007, AM J RESP CRIT CARE, V175, P160, DOI 10.1164/rccm.200607-915OC; Vaneker M, 2008, ANESTHESIOLOGY, V109, P465, DOI 10.1097/ALN.0b013e318182aef1; Villar J, 2011, INTENS CARE MED, V37, P1932, DOI 10.1007/s00134-011-2380-4; Villar J, 2010, RESP RES, V11, DOI 10.1186/1465-9921-11-27; Vlaar APJ, 2012, TRANSFUSION, V52, P82, DOI 10.1111/j.1537-2995.2011.03231.x; Vlaar APJ, 2011, BLOOD, V117, P4218, DOI 10.1182/blood-2010-10-313973; Wolthuis EK, 2009, CRIT CARE, V13, DOI 10.1186/cc7688	31	18	18	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 30	2012	7	11							e50559	10.1371/journal.pone.0050559	http://dx.doi.org/10.1371/journal.pone.0050559			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	054WM	23226314	Green Published, gold, Green Submitted			2022-12-27	WOS:000312376100126
J	Lamagna, B; Greco, A; Guardascione, A; Navas, L; Ragozzino, M; Paciello, O; Brunetti, A; Meomartino, L				Lamagna, Barbara; Greco, Adelaide; Guardascione, Anna; Navas, Luigi; Ragozzino, Manuela; Paciello, Orlando; Brunetti, Arturo; Meomartino, Leonardo			Canine Lipomas Treated with Steroid Injections: Clinical Findings	PLOS ONE			English	Article							INFILTRATIVE LIPOMA; INTERMUSCULAR LIPOMAS; DOGS; LIPOSUCTION; FEATURES; REMOVAL	Lipomas are common benign tumours of fat cells. In most cases, surgical excision is curative and simple to perform; however, such a procedure requires general anaesthesia and may be associated with delayed wound healing, seroma formation and nerve injury in deep and intramuscular tumours. The objective of this study was to evaluate treatment of subcutaneous, subfascial or intermuscular lipomas using intralesional steroid injections in dogs. Fifteen dogs presenting with lipomas were selected for treatment with ultrasound-guided intralesional injection of triamcinolone acetonide at a dose of 40 mg/mL. Nine subcutaneous and subfascial tumours showed a complete regression. The other lipomas decreased in diameter, achieving, in some cases, remission of discomfort and regression of lameness. Steroid injection was a relatively safe and effective treatment for lipomas in dogs; only six dogs experienced polyuria/polydipsia for about 2 weeks posttreatment.	[Greco, Adelaide; Brunetti, Arturo] Univ Naples Federico II, Dept Biomorphol & Funct Sci, Naples, Italy; [Lamagna, Barbara; Guardascione, Anna; Navas, Luigi; Ragozzino, Manuela] Univ Naples Federico II, Dept Vet Clin Sci, Surg Unit, Naples, Italy; [Greco, Adelaide; Brunetti, Arturo] Scarl, Biotecnol Avanzate, Ceinge, Naples, Italy; [Greco, Adelaide; Brunetti, Arturo] CNR, Inst Biostruct & Bioimaging, I-80125 Naples, Italy; [Paciello, Orlando] Univ Naples Federico II, Dept Pathol & Anim Hlth, Unit Pathol, Naples, Italy; [Meomartino, Leonardo] Univ Naples Federico II, Interdept Vet Radiol Ctr, Naples, Italy	University of Naples Federico II; University of Naples Federico II; CEINGE Biotecnologie Avanzate; Consiglio Nazionale delle Ricerche (CNR); Istituto di Biostrutture e Bioimmagini (IBB-CNR); University of Naples Federico II; University of Naples Federico II	Greco, A (corresponding author), Univ Naples Federico II, Dept Biomorphol & Funct Sci, Naples, Italy.	adegreco@unina.it	Navas, Luigi/ABI-6516-2020; Greco, Adelaide/C-7679-2018; NAVAS, Luigi/AAT-2506-2021; lamagna, barbara/AAK-7148-2020; Brunetti, Arturo/AAE-5261-2019; Meomartino, Leonardo/AAC-5448-2019	Greco, Adelaide/0000-0001-6841-1963; NAVAS, Luigi/0000-0002-1851-5016; Brunetti, Arturo/0000-0001-7057-3494; Meomartino, Leonardo/0000-0002-7290-3108; Lamagna, Barbara/0000-0001-5865-3774				Ahmed I, 2006, AM J DERMATOPATH, V28, P334, DOI 10.1097/00000372-200608000-00008; ALBERS GW, 1985, J AM VET MED ASSOC, V186, P492; BERGMAN PJ, 1994, J AM VET MED ASSOC, V205, P322; Bottcher P, 2007, J SMALL ANIM PRACT, V48, P46, DOI 10.1111/j.1748-5827.2006.00287.x; Case JB, 2012, J AM ANIM HOSP ASSOC, V48, P245, DOI 10.5326/JAAHA-MS-5767; FRAZIER KS, 1993, J AM ANIM HOSP ASSOC, V29, P81; Goldman A, 2009, INT J DERMATOL, V48, P1228, DOI 10.1111/j.1365-4632.2008.04007.x; Goldman M., 2003, TUMORS DOMESTIC ANIM, P45; Herranz P, 2008, DERMATOL CLIN, V26, P569, DOI 10.1016/j.det.2008.05.004; Hisamichi K, 2002, INT J DERMATOL, V41, P176, DOI 10.1046/j.1365-4362.2002.01395.x; Hunt GB, 2011, J SMALL ANIM PRACT, V52, P418, DOI 10.1111/j.1748-5827.2011.01083.x; KRAMEK BA, 1985, J AM VET MED ASSOC, V186, P81; Mayhew PD, 2002, J SMALL ANIM PRACT, V43, P177, DOI 10.1111/j.1748-5827.2002.tb00053.x; MCCHESNEY AE, 1980, VET PATHOL, V17, P316, DOI 10.1177/030098588001700305; McEntee MC, 2000, VET RADIOL ULTRASOUN, V41, P554, DOI 10.1111/j.1740-8261.2000.tb01889.x; MCLAUGHLIN R, 1991, J AM VET MED ASSOC, V199, P1610; Miles J, 2001, J SMALL ANIM PRACT, V42, P26, DOI 10.1111/j.1748-5827.2001.tb01980.x; Morini M, 2009, J COMP PATHOL, V141, P74, DOI 10.1016/j.jcpa.2009.03.001; Nyman HT, 2006, VET RADIOL ULTRASOUN, V47, P192, DOI 10.1111/j.1740-8261.2006.00127.x; Ramirez GA, 2008, J VET DIAGN INVEST, V20, P360, DOI 10.1177/104063870802000319; Rotunda AM, 2005, J AM ACAD DERMATOL, V53, P973, DOI 10.1016/j.jaad.2005.07.068; Salam GA, 2002, AM FAM PHYSICIAN, V65, P901; Samii VF, 2002, SMALL ANIMAL DIAGNOS, P267; Szabo D, 2011, VET COMP ORTHOPAED, V24, P299, DOI 10.3415/VCOT-10-07-0107; Thomas RC, 1998, CANCER IN DOGS AND CATS: MEDICAL AND SURGICAL MANAGEMENT, P489; Thomson MJ, 1999, J AM ANIM HOSP ASSOC, V35, P165, DOI 10.5326/15473317-35-2-165; Volta A, 2006, VET RADIOL ULTRASOUN, V47, P589, DOI 10.1111/j.1740-8261.2006.00191.x; Yamamoto T, 2002, J DERMATOL, V29, P638, DOI 10.1111/j.1346-8138.2002.tb00194.x	28	8	8	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 30	2012	7	11							e50234	10.1371/journal.pone.0050234	http://dx.doi.org/10.1371/journal.pone.0050234			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	054WM	23226250	Green Published, Green Submitted, gold			2022-12-27	WOS:000312376100060
J	Pillai, D; Sheppard, E; Mitchell, P				Pillai, Dhanya; Sheppard, Elizabeth; Mitchell, Peter			Can People Guess What Happened to Others from Their Reactions?	PLOS ONE			English	Article							MIND; AUTISM; ADULTS	Are we able to infer what happened to a person from a brief sample of his/her behaviour? It has been proposed that mentalising skills can be used to retrodict as well as predict behaviour, that is, to determine what mental states of a target have already occurred. The current study aimed to develop a paradigm to explore these processes, which takes into account the intricacies of real-life situations in which reasoning about mental states, as embodied in behaviour, may be utilised. A novel task was devised which involved observing subtle and naturalistic reactions of others in order to determine the event that had previously taken place. Thirty-five participants viewed videos of real individuals reacting to the researcher behaving in one of four possible ways, and were asked to judge which of the four 'scenarios' they thought the individual was responding to. Their eye movements were recorded to establish the visual strategies used. Participants were able to deduce successfully from a small sample of behaviour which scenario had previously occurred. Surprisingly, looking at the eye region was associated with poorer identification of the scenarios, and eye movement strategy varied depending on the event experienced by the person in the video. This suggests people flexibly deploy their attention using a retrodictive mindreading process to infer events. Citation: Pillai D, Sheppard E, Mitchell P (2012) Can People Guess What Happened to Others from Their Reactions? PLoS ONE 7(11): e49859. doi:10.1371/journal.pone.0049859	[Pillai, Dhanya; Sheppard, Elizabeth; Mitchell, Peter] Univ Nottingham, Sch Psychol, Selangor, Malaysia	University of Nottingham Malaysia	Pillai, D (corresponding author), Univ Nottingham, Sch Psychol, Malaysia Campus, Selangor, Malaysia.	khpx9dkr@nottingham.edu.my	Sheppard, Elizabeth/K-3841-2017	Sheppard, Elizabeth/0000-0002-6528-0766; Mitchell, Peter/0000-0001-5215-320X				BaronCohen S, 1997, J CHILD PSYCHOL PSYC, V38, P813, DOI 10.1111/j.1469-7610.1997.tb01599.x; Cohen J.E., 1988, STAT POWER ANAL BEHA; Cunningham DW, 2004, P S APPL PERC GRAPH, P143; Ekman P., 1976, PICTURES FACIAL AFFE; Gallese V, 1998, TRENDS COGN SCI, V2, P493, DOI 10.1016/S1364-6613(98)01262-5; Gallese V., 2005, PHENOMENOLOGY COGNIT, V4, P23, DOI [10.1007/s11097-005-4737-z, DOI 10.1007/S11097-005-4737-Z]; GERGELY G, 1995, COGNITION, V56, P165, DOI 10.1016/0010-0277(95)00661-H; Goldman A, 2009, TRENDS COGN SCI, V13, P154, DOI 10.1016/j.tics.2009.01.007; Hernandez N, 2009, NEUROPSYCHOLOGIA, V47, P1004, DOI 10.1016/j.neuropsychologia.2008.10.023; Jones W, 2008, ARCH GEN PSYCHIAT, V65, P946, DOI 10.1001/archpsyc.65.8.946; Kirchner JC, 2011, J AUTISM DEV DISORD, V41, P158, DOI 10.1007/s10803-010-1032-9; Klin A, 2002, ARCH GEN PSYCHIAT, V59, P809, DOI 10.1001/archpsyc.59.9.809; Matsumoto D, 2009, J NONVERBAL BEHAV, V33, P213, DOI 10.1007/s10919-009-0071-4; Onishi KH, 2005, SCIENCE, V308, P255, DOI 10.1126/science.1107621; Perner J, 2005, SCIENCE, V308, P214, DOI 10.1126/science.1111656; ROBINSON EJ, 1995, CHILD DEV, V66, P1022, DOI 10.1111/j.1467-8624.1995.tb00920.x; SNODGRASS JG, 1988, J EXP PSYCHOL GEN, V117, P34, DOI 10.1037/0096-3445.117.1.34; WIMMER H, 1983, COGNITION, V13, P103, DOI 10.1016/0010-0277(83)90004-5	18	18	18	1	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 30	2012	7	11							e49859	10.1371/journal.pone.0049859	http://dx.doi.org/10.1371/journal.pone.0049859			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	054WM	23226227	gold, Green Published, Green Submitted			2022-12-27	WOS:000312376100035
J	Yang, SL; Chen, C; Wang, H; Rao, XQ; Wang, F; Duan, QL; Chen, FQ; Long, GW; Gong, W; Zou, MH; Wang, DW				Yang, Shenglan; Chen, Chen; Wang, Hong; Rao, Xiaoquan; Wang, Feng; Duan, Quanlu; Chen, Fuqiong; Long, Guangwen; Gong, Wei; Zou, Ming-Hui; Wang, Dao Wen			Protective Effects of Acyl-coA Thioesterase 1 on Diabetic Heart via PPAR alpha/PGC1 alpha Signaling	PLOS ONE			English	Article							FATTY-ACID-METABOLISM; SKELETAL-MUSCLE; PPAR-ALPHA; INSULIN-RESISTANCE; CONTRACTILE DYSFUNCTION; MYOCARDIAL HYPERTROPHY; SUBSTRATE METABOLISM; CARDIAC EFFICIENCY; INDUCED APOPTOSIS; OXIDATIVE STRESS	Background: Using fatty acids (FAs) exclusively for ATP generation was reported to contribute to the development of diabetic cardiomyopathy. We studied the role of substrate metabolism related genes in the heart of the diabetes to find out a novel therapeutic target for diabetic cardiomyopathy. Methods and Results: By microarray analysis of metabolic gene expression, acyl-CoA thioesterase 1 (acot1) was clearly upregulated in the myocardia of db/db mice, compared with normal control C57BL/Ks. Therefore, gain-of-function and loss-of-function approaches were employed in db/db mice to investigate the functions of ACOT1 in oxidative stress, mitochondrial dysfunction and heart function. We found that in the hearts of db/db mice which overexpressed ACOT1, H2O2 and malondialdehyde (MDA) were reduced, the activities of ATPases in mitochondria associated with mitochondrial function were promoted, the expression of uncoupling protein 3 (UCP3) contributing to oxygen wastage for noncontractile purposes was decreased, and cardiac dysfunction was attenuated, as determined by both hemodynamic and echocardiographic detections. Consistently, ACOT1 deficiency had opposite effects, which accelerated the cardiac damage induced by diabetes. Notably, by real-time PCR, we found that overexpression of ACOT1 in diabetic heart repressed the peroxisome proliferator-activated receptor alpha/PPAR gamma coactivator 1 alpha (PPAR alpha/PGC1 alpha) signaling, as shown by decreased expression of PGC1 alpha and the downstream genes involved in FAs use. Conclusion: Our results demonstrated that ACOT1 played a crucial protective role in diabetic heart via PPAR alpha/PGC1 alpha signaling.	[Yang, Shenglan; Chen, Chen; Wang, Hong; Rao, Xiaoquan; Wang, Feng; Duan, Quanlu; Chen, Fuqiong; Long, Guangwen; Gong, Wei; Wang, Dao Wen] Huazhong Univ Sci & Technol, Tongji Med Coll, Tongji Hosp, Dept Internal Med, Wuhan 430074, Peoples R China; [Yang, Shenglan; Chen, Chen; Wang, Hong; Rao, Xiaoquan; Wang, Feng; Duan, Quanlu; Chen, Fuqiong; Long, Guangwen; Gong, Wei; Wang, Dao Wen] Huazhong Univ Sci & Technol, Tongji Med Coll, Tongji Hosp, Gene Therapy Ctr, Wuhan 430074, Peoples R China; [Zou, Ming-Hui] Univ Oklahoma, Hlth Sci Ctr, Dept Med & Endocrinol, Oklahoma City, OK USA	Huazhong University of Science & Technology; Huazhong University of Science & Technology; University of Oklahoma System; University of Oklahoma Health Sciences Center	Wang, DW (corresponding author), Huazhong Univ Sci & Technol, Tongji Med Coll, Tongji Hosp, Dept Internal Med, Wuhan 430074, Peoples R China.	dwwang@tjh.tjmu.edu.cn	, Chen/R-4321-2019	Wang, Dao Wen/0000-0002-9774-3980	National Basic Research Program of China (973 Program) [2012CB518004]; National Natural Science Foundation of China [31130031, 30770882, 81070236, 31200594]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL110488, R01HL105157] Funding Source: NIH RePORTER	National Basic Research Program of China (973 Program)(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by grant from the National Basic Research Program of China (973 Program) (No. 2012CB518004) and National Natural Science Foundation of China (No. 31130031, 30770882, 81070236 and 31200594). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	An D, 2006, AM J PHYSIOL-HEART C, V291, pH1489, DOI 10.1152/ajpheart.00278.2006; Asghar O, 2009, CLIN SCI, V116, P741, DOI 10.1042/CS20080500; Barwe SP, 2009, J MOL CELL CARDIOL, V47, P552, DOI 10.1016/j.yjmcc.2009.07.018; Bertoni AG, 2003, DIABETES CARE, V26, P2791, DOI 10.2337/diacare.26.10.2791; Boudina S, 2005, CIRCULATION, V112, P2686, DOI 10.1161/CIRCULATIONAHA.105.554360; Boudina S, 2007, DIABETES, V56, P2457, DOI 10.2337/db07-0481; Boudina S, 2007, CIRCULATION, V115, P3213, DOI 10.1161/CIRCULATIONAHA.106.679597; Boudina S, 2010, REV ENDOCR METAB DIS, V11, P31, DOI 10.1007/s11154-010-9131-7; Buchanan J, 2005, ENDOCRINOLOGY, V146, P5341, DOI 10.1210/en.2005-0938; Cai L, 2002, DIABETES, V51, P1938, DOI 10.2337/diabetes.51.6.1938; Carley AN, 2005, BBA-MOL CELL BIOL L, V1734, P112, DOI 10.1016/j.bbalip.2005.03.005; Dongol B, 2007, J LIPID RES, V48, P1781, DOI 10.1194/jlr.M700119-JLR200; Durgan DJ, 2006, AM J PHYSIOL-HEART C, V290, pH2480, DOI 10.1152/ajpheart.01344.2005; Finck BN, 2003, P NATL ACAD SCI USA, V100, P1226, DOI 10.1073/pnas.0336724100; Finck BN, 2002, J CLIN INVEST, V109, P121, DOI 10.1172/JCI200214080; Forman BM, 1997, P NATL ACAD SCI USA, V94, P4312, DOI 10.1073/pnas.94.9.4312; Fujita M, 2011, BIOL PHARM BULL, V34, P87, DOI 10.1248/bpb.34.87; Giacco F, 2010, CIRC RES, V107, P1058, DOI 10.1161/CIRCRESAHA.110.223545; Hamilton KL, 2007, MED SCI SPORT EXER, V39, P1544, DOI 10.1249/mss.0b013e3180d099e8; Hostetler HA, 2005, J BIOL CHEM, V280, P18667, DOI 10.1074/jbc.M412062200; How OJ, 2006, DIABETES, V55, P466, DOI 10.2337/diabetes.55.02.06.db05-1164; Hu TP, 2006, ACTA PHARMACOL SIN, V27, P419, DOI 10.1111/j.1745-7254.2006.00300.x; Hunt MC, 2005, J LIPID RES, V46, P2029, DOI 10.1194/jlr.E500003-JLR200; Hunt MC, 2002, PROG LIPID RES, V41, P99, DOI 10.1016/S0163-7827(01)00017-0; Huss JM, 2004, CIRC RES, V95, P568, DOI 10.1161/01.RES.0000141774.29937.e3; JAGASIA D, 2003, CONGEST HEART FAIL, V9, P140; Jagasia Dinesh, 2003, Congest Heart Fail, V9, P133, DOI 10.1111/j.1527-5299.2002.00901.x; King KL, 2007, J LIPID RES, V48, P1511, DOI 10.1194/jlr.M600364-JLR200; Koves TR, 2008, CELL METAB, V7, P45, DOI 10.1016/j.cmet.2007.10.013; Lashin O, 2003, ARCH BIOCHEM BIOPHYS, V420, P298, DOI 10.1016/j.abb.2003.09.024; Li LJ, 2011, CLIN BIOCHEM, V44, P813, DOI 10.1016/j.clinbiochem.2011.04.021; Li Y, 2011, DIABETES, V60, P2985, DOI 10.2337/db10-1333; Liu ZS, 2010, CANCER-AM CANCER SOC, V116, P4753, DOI 10.1002/cncr.25323; Miyazaki M, 2010, J TOXICOL SCI, V35, P131, DOI 10.2131/jts.35.131; Momose A, 2011, BIOCHEM BIOPH RES CO, V404, P74, DOI 10.1016/j.bbrc.2010.11.066; Muoio DM, 2007, APPL PHYSIOL NUTR ME, V32, P874, DOI 10.1139/H07-083; Park SY, 2005, AM J PHYSIOL-ENDOC M, V289, pE30, DOI 10.1152/ajpendo.00251.2004; Rangan GK, 2007, NEPHROLOGY, V12, P553, DOI 10.1111/j.1440-1797.2007.00855.x; Sawyer DB, 2002, J MOL CELL CARDIOL, V34, P379, DOI 10.1006/jmcc.2002.1526; Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73; Sharma S, 2004, FASEB J, V18, P1692, DOI 10.1096/fj.04-2263com; STAMLER J, 1993, DIABETES CARE, V16, P434, DOI 10.2337/diacare.16.2.434; Stanley WC, 2005, PHYSIOL REV, V85, P1093, DOI 10.1152/physrev.00006.2004; Taegtmeyer H, 1994, Curr Probl Cardiol, V19, P59; Taegtmeyer H, 2002, CIRCULATION, V105, P1727, DOI 10.1161/01.CIR.0000012466.50373.E8; TANAKA Y, 1992, CARDIOVASC RES, V26, P409, DOI 10.1093/cvr/26.4.409; Vichai V, 2006, NAT PROTOC, V1, P1112, DOI 10.1038/nprot.2006.179; Wang HJ, 2012, METABOLISM, V61, P496, DOI 10.1016/j.metabol.2011.09.005; Wang XY, 2009, AM J PHYSIOL-CELL PH, V297, pC1490, DOI 10.1152/ajpcell.00049.2009; Wende AR, 2010, BBA-MOL CELL BIOL L, V1801, P311, DOI 10.1016/j.bbalip.2009.09.023; Wilson CR, 2007, BIOCHEM J, V406, P457, DOI 10.1042/BJ20070392; Wu JA, 2010, J ULTRAS MED, V29, P1771, DOI 10.7863/jum.2010.29.12.1771; Yamakura F, 2010, BBA-PROTEINS PROTEOM, V1804, P318, DOI 10.1016/j.bbapap.2009.10.010; Young ME, 2002, CIRCULATION, V105, P1861, DOI 10.1161/01.CIR.0000012467.61045.87; Zhou YT, 2000, P NATL ACAD SCI USA, V97, P1784, DOI 10.1073/pnas.97.4.1784; Zmijewski JW, 2005, AM J PHYSIOL-HEART C, V289, pH852, DOI 10.1152/ajpheart.00015.2005	56	9	12	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 30	2012	7	11							e50376	10.1371/journal.pone.0050376	http://dx.doi.org/10.1371/journal.pone.0050376			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	054WM	23226270	gold, Green Submitted, Green Published			2022-12-27	WOS:000312376100080
J	Zhang, AD; Chen, B; Yuan, ZZ; Li, R; Liu, C; Zhou, HB; Chen, HC; Jin, ML				Zhang, Anding; Chen, Bo; Yuan, Zhengzhi; Li, Ran; Liu, Cheng; Zhou, Hongbo; Chen, Huanchun; Jin, Meilin			HP0197 Contributes to CPS Synthesis and the Virulence of Streptococcus suis via CcpA	PLOS ONE			English	Article							TOXIC-SHOCK-SYNDROME; PROTECTIVE ANTIGEN; GENE-EXPRESSION; HUMAN PATHOGEN; REAL-TIME; IDENTIFICATION; SEROTYPE-2; PROTEIN; ADHESIN; PURIFICATION	Streptococcus suis serotype 2 (SS2), a major swine pathogen and an emerging zoonotic agent, has greatly challenged global public health. The encoding proteins with unknown functions the bacterium encodes are an obstruction to studies of the pathogenesis. A novel surface protective antigen HP0197 is one of these proteins which have no sequence homology to any known protein. In the present study, the protein was determined to be involved in bacterial virulence through an evaluation of the isogenic mutant (Delta hp0197) in both mice and pigs. The experimental infection also indicated that Delta hp0197 could be cleared easily during infection, which could be attributed to the reduced thickness of the capsular polysaccharides (CPS) and the significantly reduced phagocytotic resistance. Microarrays-based comparative transcriptome analysis suggested that the suppressed expression of the operon responsible for CPS synthesis might be reversed by CcpA activity, which controlled global regulation of carbon catabolite through the binding of the CcpA and HPr-Ser-46-P to the catabolite-responsive elements (cre) of the target operons. The hypothesis was approved by the fact that the purified FLAG-tagged HPr from WT stain exhibited a higher binding activity to cre with CcpA compared to the Delta hp0197 by the Electrophoretic Mobility Shift Assay, suggesting lower level of phosphorylation of the phosphocarrier protein HPr at residue Ser-46 (HPr-Ser-46P) in Delta hp0197. These indicated that HP0197 could enhance CcpA activity to control the expression of genes involved in carbohydrate utilization and CPS synthesis, thus contributing to the virulence of S. suis.	[Zhang, Anding; Chen, Huanchun; Jin, Meilin] Huazhong Agr Univ, Natl Key Lab Agr Microbiol, Unit Anim Infect Dis, Wuhan, Hubei, Peoples R China; [Zhang, Anding; Chen, Bo; Yuan, Zhengzhi; Li, Ran; Liu, Cheng; Zhou, Hongbo; Chen, Huanchun; Jin, Meilin] Huazhong Agr Univ, Coll Vet Med, Wuhan, Hubei, Peoples R China	Huazhong Agricultural University; Huazhong Agricultural University	Jin, ML (corresponding author), Huazhong Agr Univ, Natl Key Lab Agr Microbiol, Unit Anim Infect Dis, Wuhan, Hubei, Peoples R China.	jml8328@126.com	yuan, zonghui/A-1158-2017		National Natural Science Foundation of China [30901076]; 973 program [2012CB518805]; 863 program [2011AA10A210]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); 973 program(National Basic Research Program of China); 863 program(National High Technology Research and Development Program of China)	This work was supported by the National Natural Science Foundation of China (30901076), the 973 program (2012CB518805) and the 863 program (2011AA10A210). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baums CG, 2006, INFECT IMMUN, V74, P6154, DOI 10.1128/IAI.00359-06; Benga L, 2004, CELL MICROBIOL, V6, P867, DOI 10.1111/j.1462-5822.2004.00409.x; Benga L, 2008, VET MICROBIOL, V132, P211, DOI 10.1016/j.vetmic.2008.05.005; Bonifait L, 2011, VET MICROBIOL, V148, P333, DOI 10.1016/j.vetmic.2010.09.024; Bonifait L, 2010, BMC MICROBIOL, V10, DOI 10.1186/1471-2180-10-42; Brassard J, 2004, VET MICROBIOL, V102, P87, DOI 10.1016/j.vetmic.2004.05.008; Chabot-Roy G, 2006, MICROB PATHOGENESIS, V41, P21, DOI 10.1016/j.micpath.2006.04.001; Chen B, 2011, J PROTEOME RES, V10, P5163, DOI 10.1021/pr200758q; Chen B, 2010, FEMS MICROBIOL LETT, V307, P12, DOI 10.1111/j.1574-6968.2010.01944.x; Chen C, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000315; de Greeff A, 2002, INFECT IMMUN, V70, P1319, DOI 10.1128/IAI.70.3.1319-1325.2002; Dominguez-Punaro MC, 2007, J IMMUNOL, V179, P1842, DOI 10.4049/jimmunol.179.3.1842; Dominguez-Punaro MD, 2008, INFECT IMMUN, V76, P3901, DOI 10.1128/IAI.00350-08; Feng YJ, 2010, TRENDS MICROBIOL, V18, P124, DOI 10.1016/j.tim.2009.12.003; Feng YJ, 2009, J INFECT DIS, V200, P1583, DOI 10.1086/644602; Fittipaldi N, 2008, MOL MICROBIOL, V70, P1120, DOI 10.1111/j.1365-2958.2008.06463.x; Fittipaldi N, 2008, INFECT IMMUN, V76, P3587, DOI 10.1128/IAI.01568-07; Geng HR, 2008, J PROTEOME RES, V7, P4132, DOI 10.1021/pr800196v; Gottschalk M, 2010, FUTURE MICROBIOL, V5, P371, DOI [10.2217/fmb.10.2, 10.2217/FMB.10.2]; HAATAJA S, 1993, J BIOL CHEM, V268, P4311; HAATAJA S, 1994, J BIOL CHEM, V269, P27466; Haataja S, 1996, ADV EXP MED BIOL, V408, P25; Hellman LM, 2007, NAT PROTOC, V2, P1849, DOI 10.1038/nprot.2007.249; Hill JE, 2005, VET MICROBIOL, V107, P63, DOI 10.1016/j.vetmic.2005.01.003; Holden MTG, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006072; Hu QY, 2010, MICROB PATHOGENESIS, V48, P103, DOI 10.1016/j.micpath.2009.11.005; Jing HB, 2008, PROTEOMICS, V8, P333, DOI 10.1002/pmic.200600930; Kouki A, 2011, J BIOL CHEM, V286, P38854, DOI 10.1074/jbc.M111.260992; Lecours MP, 2011, J INFECT DIS, V204, P919, DOI 10.1093/infdis/jir415; Li M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002080; Li M, 2011, MOL MICROBIOL, V79, P1670, DOI 10.1111/j.1365-2958.2011.07553.x; Li R, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-556; Li YY, 2007, CLIN VACCINE IMMUNOL, V14, P937, DOI 10.1128/CVI.00046-07; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lun ZR, 2007, LANCET INFECT DIS, V7, P201, DOI 10.1016/S1473-3099(07)70001-4; Luo Yi, 2001, Curr Protoc Immunol, VChapter 3, DOI 10.1002/0471142735.im0320s22; Mandanici F, 2010, J PROTEOMICS, V73, P2365, DOI 10.1016/j.jprot.2010.07.009; Nghia HDT, 2008, EMERG INFECT DIS, V14, P155, DOI 10.3201/eid1401.070534; Nguyen THM, 2008, CLIN INFECT DIS, V46, P659, DOI 10.1086/527385; Pallares FJ, 2004, CAN J VET RES, V68, P236; Pan XZ, 2009, J BACTERIOL, V191, P2601, DOI 10.1128/JB.01309-08; Pian Y, 2012, INFECT IMMUN; Rodriguez-Ortega MJ, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-588; Ruggiero A, 2009, J MOL BIOL, V385, P153, DOI 10.1016/j.jmb.2008.10.042; Schmittgen TD, 2000, J BIOCHEM BIOPH METH, V46, P69, DOI 10.1016/S0165-022X(00)00129-9; Schreur PJW, 2011, J BACTERIOL, V193, P5073, DOI 10.1128/JB.05305-11; Schumacher MA, 2004, CELL, V118, P731, DOI 10.1016/j.cell.2004.08.027; Segura M, 2004, INFECT IMMUN, V72, P5322, DOI 10.1128/IAI.72.9.5322-5330.2004; Segura M, 2009, J INFECT DIS, V199, P4, DOI 10.1086/594371; Shelburne SA, 2008, P NATL ACAD SCI USA, V105, P1698, DOI 10.1073/pnas.0711767105; Smith HE, 1999, INFECT IMMUN, V67, P1750; Smith TC, 2008, EMERG INFECT DIS, V14, P1925, DOI 10.3201/eid1412.080162; Sonenshein AL, 2007, NAT REV MICROBIOL, V5, P917, DOI 10.1038/nrmicro1772; Staats JJ, 1997, VET RES COMMUN, V21, P381, DOI 10.1023/A:1005870317757; Staats JJ, 1999, VET MICROBIOL, V70, P201, DOI 10.1016/S0378-1135(99)00147-9; Takamatsu D, 2001, PLASMID, V45, P101, DOI 10.1006/plas.2000.1510; Takamatsu D, 2008, EMERG INFECT DIS, V14, P181, DOI 10.3201/eid1401.070568; Tang JQ, 2006, PLOS MED, V3, P668, DOI 10.1371/journal.pmed.0030151; Tang Y, 2012, VET MICROBIOL; Tikkanen K, 1996, INFECT IMMUN, V64, P3659, DOI 10.1128/IAI.64.9.3659-3665.1996; TIKKANEN K, 1995, J BIOL CHEM, V270, P28874, DOI 10.1074/jbc.270.48.28874; Van Calsteren MR, 2010, BIOCHEM CELL BIOL, V88, P513, DOI [10.1139/O09-170, 10.1139/o09-170]; Wertheim HFL, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005973; Wertheim HFL, 2009, CLIN INFECT DIS, V48, P617, DOI 10.1086/596763; Willenborg J, 2011, MICROBIOL-SGM, V157, P1823, DOI 10.1099/mic.0.046417-0; Ye CY, 2009, J INFECT DIS, V199, P97, DOI 10.1086/594370; Yu HJ, 2006, EMERG INFECT DIS, V12, P914, DOI 10.3201/eid1206.051194; Zhang AD, 2008, PROTEOMICS, V8, P3506, DOI 10.1002/pmic.200800007; Zhang AD, 2011, VET MICROBIOL, V148, P436, DOI 10.1016/j.vetmic.2010.09.027; Zhang AD, 2010, VET MICROBIOL, V140, P171, DOI 10.1016/j.vetmic.2009.06.034; Zhang AD, 2009, VACCINE, V27, P5209, DOI 10.1016/j.vaccine.2009.06.074; Zhang AD, 2009, VACCINE, V27, P1348, DOI 10.1016/j.vaccine.2008.12.047; Zheng X, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017987	73	23	26	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 30	2012	7	11							e50987	10.1371/journal.pone.0050987	http://dx.doi.org/10.1371/journal.pone.0050987			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	054WM	23226442	Green Published, Green Submitted, gold			2022-12-27	WOS:000312376100253
J	Aravena, P; Delevoye-Turrell, Y; Deprez, V; Cheylus, A; Paulignan, Y; Frak, V; Nazir, T				Aravena, Pia; Delevoye-Turrell, Yvonne; Deprez, Viviane; Cheylus, Anne; Paulignan, Yves; Frak, Victor; Nazir, Tatjana			Grip Force Reveals the Context Sensitivity of Language-Induced Motor Activity during "Action Words'' Processing: Evidence from Sentential Negation	PLOS ONE			English	Article							TEXT INFORMATION; MENTAL-IMAGERY; HUMAN BRAIN; REPRESENTATION; COMPREHENSION; SYSTEM; CORTEX; VERBS; MODULATION; ACTIVATION	Background: Studies demonstrating the involvement of motor brain structures in language processing typically focus on time windows beyond the latencies of lexical-semantic access. Consequently, such studies remain inconclusive regarding whether motor brain structures are recruited directly in language processing or through post-linguistic conceptual imagery. In the present study, we introduce a grip-force sensor that allows online measurements of language-induced motor activity during sentence listening. We use this tool to investigate whether language-induced motor activity remains constant or is modulated in negative, as opposed to affirmative, linguistic contexts. Methodology/Principal Findings: Participants listened to spoken action target words in either affirmative or negative sentences while holding a sensor in a precision grip. The participants were asked to count the sentences containing the name of a country to ensure attention. The grip force signal was recorded continuously. The action words elicited an automatic and significant enhancement of the grip force starting at approximately 300 ms after target word onset in affirmative sentences; however, no comparable grip force modulation was observed when these action words occurred in negative contexts. Conclusions/Significance: Our findings demonstrate that this simple experimental paradigm can be used to study the online crosstalk between language and the motor systems in an ecological and economical manner. Our data further confirm that the motor brain structures that can be called upon during action word processing are not mandatorily involved; the crosstalk is asymmetrically governed by the linguistic context and not vice versa. Citation: Aravena P, Delevoye-Turrell Y, Deprez V, Cheylus A, Paulignan Y, et al. (2012) Grip Force Reveals the Context Sensitivity of Language-Induced Motor Activity during "Action Words'' Processing: Evidence from Sentential Negation. PLoS ONE 7(12): e50287. doi:10.1371/journal.pone.0050287	[Aravena, Pia; Deprez, Viviane; Cheylus, Anne; Paulignan, Yves; Nazir, Tatjana] Univ Lyon 1, CNRS UCBL, Inst Sci Cognit L2C2, F-69365 Lyon, France; [Delevoye-Turrell, Yvonne] Univ Lille Nord France, UDL3, Lab URECA, Lille, France; [Frak, Victor] Univ Montreal, Inst Readaptat Gingras Lindsay Montreal, Ctr Rech Interdisciplinaire Readaptat Montreal Me, Quebec City, PQ, Canada	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Claude Bernard Lyon 1; Universite de Lille - ISITE; Universite de Lille; Universite de Montreal	Aravena, P (corresponding author), Univ Lyon 1, CNRS UCBL, Inst Sci Cognit L2C2, F-69365 Lyon, France.	pia.aravena@isc.cnrs.fr	Cheylus, Anne/GSD-3809-2022	Cheylus, Anne/0000-0002-4243-3686; Deprez, Viviane/0000-0002-2121-5559; Nazir, Tatjana/0000-0002-6313-9259; Paulignan, Yves/0000-0001-9474-3080; Frak, Victor/0000-0002-3311-777X	CNRS (Centre National de la Recherche Scientifique), a PhD fellowship from Becas Chile, Conicyt(Comision Nacional de Investigacion Cientifica y Tecnologica, Gobierno de Chile)	CNRS (Centre National de la Recherche Scientifique), a PhD fellowship from Becas Chile, Conicyt(Comision Nacional de Investigacion Cientifica y Tecnologica, Gobierno de Chile)	CNRS (Centre National de la Recherche Scientifique), a PhD fellowship from Becas Chile, Conicyt(Comision Nacional de Investigacion Cientifica y Tecnologica, Gobierno de Chile). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aravena P, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011751; Barsalou LW, 1999, BEHAV BRAIN SCI, V22, P577, DOI 10.1017/S0140525X99532147; Boulenger V, 2008, J PHYSIOL-PARIS, V102, P130, DOI 10.1016/j.jphysparis.2008.03.015; Boulenger V, 2009, CEREB CORTEX, V19, P1905, DOI 10.1093/cercor/bhn217; Fargier R, 2011, CORTEX; Fauconnier G., 1994, MENTAL SPACES ASPECT; Fischer MH, 2008, Q J EXP PSYCHOL, V61, P825, DOI 10.1080/17470210701623605; Frak V, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009728; Friederici AD, 2002, TRENDS COGN SCI, V6, P78, DOI 10.1016/S1364-6613(00)01839-8; Gallese V, 2005, COGN NEUROPSYCHOL, V22, P455, DOI 10.1080/02643290442000310; Gaskell MG, 1997, LANG COGNITIVE PROC, V12, P613, DOI 10.1080/016909697386646; Glenberg AM, 2002, PSYCHON B REV, V9, P558, DOI 10.3758/BF03196313; Goldfield BA, 2000, J CHILD LANG, V27, P501, DOI 10.1017/S0305000900004244; Hauk O, 2004, NEURON, V41, P301, DOI 10.1016/S0896-6273(03)00838-9; Hebb Donald O., 1949, ORG BEHAV; Hoenig K, 2008, J COGNITIVE NEUROSCI, V20, P1799, DOI 10.1162/jocn.2008.20123; Ibanez A., 2012, CORTEX; JEANNEROD M, 1995, NEUROPSYCHOLOGIA, V33, P1419, DOI 10.1016/0028-3932(95)00073-C; Jirak D, 2010, CONSCIOUS COGN, V19, P711, DOI 10.1016/j.concog.2010.06.020; Kaup B, 2001, MEM COGNITION, V29, P960, DOI 10.3758/BF03195758; Kaup B, 2007, Q J EXP PSYCHOL, V60, P976, DOI 10.1080/17470210600823512; Lakoff George., 1999, PHILOS FLESH EMBODIE; Liuzza MT, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016855; Ludtke J, 2008, J COGNITIVE NEUROSCI, V20, P1355, DOI 10.1162/jocn.2008.20093; MACDONALD MC, 1989, J EXP PSYCHOL LEARN, V15, P633, DOI 10.1037/0278-7393.15.4.633; Mahon BZ, 2008, J PHYSIOL-PARIS, V102, P59, DOI 10.1016/j.jphysparis.2008.03.004; Martin A, 2007, ANNU REV PSYCHOL, V58, P25, DOI 10.1146/annurev.psych.57.102904.190143; Meteyard L, 2010, CORTEX; New B, 2001, ANN PSYCHOL, V101, P447; OLDFIELD RC, 1971, NEUROPSYCHOLOGIA, V9, P97, DOI 10.1016/0028-3932(71)90067-4; Oliveri M, 2004, J COGNITIVE NEUROSCI, V16, P374, DOI 10.1162/089892904322926719; Papeo L, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004508; Patterson K, 2007, NAT REV NEUROSCI, V8, P976, DOI 10.1038/nrn2277; Pulvermuller F, 2006, CEREB CORTEX, V16, P1193, DOI 10.1093/cercor/bhj060; Pulvermuller F, 1999, BEHAV BRAIN SCI, V22, P253, DOI 10.1017/S0140525X9900182X; Pulvermuller F, 2005, NAT REV NEUROSCI, V6, P576, DOI 10.1038/nrn1706; Pulvermuller F, 2005, EUR J NEUROSCI, V21, P793, DOI 10.1111/j.1460-9568.2005.03900.x; Pulvermuller F, 2012, J NEUROLINGUISTICS; Pylyshyn ZW, 2002, BEHAV BRAIN SCI, V25, P157, DOI 10.1017/S0140525X02000043; Raposo A, 2009, NEUROPSYCHOLOGIA, V47, P388, DOI 10.1016/j.neuropsychologia.2008.09.017; Rossini PM, 1999, CEREB CORTEX, V9, P161, DOI 10.1093/cercor/9.2.161; Ruby P, 2001, NAT NEUROSCI, V4, P546, DOI 10.1038/87510; Tettamanti M, 2005, J COGNITIVE NEUROSCI, V17, P273, DOI 10.1162/0898929053124965; Tettamanti M, 2008, NEUROIMAGE, V43, P358, DOI 10.1016/j.neuroimage.2008.08.004; Tomasino B, 2010, NEUROSCIENCE, V169, P246, DOI 10.1016/j.neuroscience.2010.04.039; van Dam WO, 2011, HUM BRAIN MAPP; Vigliocco G, 2011, NEUROSCI BIOBEHAV R, V35, P407, DOI 10.1016/j.neubiorev.2010.04.007; Willems RM, 2011, FRONT PSYCHOL, V2, DOI 10.3389/fpsyg.2011.00116; Zwaan RA, 2006, J EXP PSYCHOL GEN, V135, P1, DOI 10.1037/0096-3445.135.1.1	49	58	59	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 5	2012	7	12							e50287	10.1371/journal.pone.0050287	http://dx.doi.org/10.1371/journal.pone.0050287			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	057TZ	23227164	gold, Green Published, Green Submitted, Green Accepted			2022-12-27	WOS:000312588200025
J	Bao, ZM; Cartinhour, S; Swingle, B				Bao, Zhongmeng; Cartinhour, Sam; Swingle, Bryan			Substrate and Target Sequence Length Influence RecTE(Psy) Recombineering Efficiency in Pseudomonas syringae	PLOS ONE			English	Article							BACTERIOPHAGE-LAMBDA; ESCHERICHIA-COLI; MEDIATED RECOMBINATION; BETA-PROTEIN; MUTAGENESIS; PATHOGEN; IDENTIFICATION; EXONUCLEASE; CHROMOSOME; REPAIR	We are developing a new recombineering system to assist experimental manipulation of the Pseudomonas syringae genome. P. syringae is a globally dispersed plant pathogen and an important model species used to study the molecular biology of bacteria-plant interactions. We previously identified orthologs of the lambda Red bet/exo and Rac recET genes in P. syringae and confirmed that they function in recombineering using ssDNA and dsDNA substrates. Here we investigate the properties of dsDNA substrates more closely to determine how they influence recombineering efficiency. We find that the length of flanking homologies and length of the sequences being inserted or deleted have a large effect on RecTE(Psy) mediated recombination efficiency. These results provide information about the design elements that should be considered when using recombineering.	[Bao, Zhongmeng; Cartinhour, Sam; Swingle, Bryan] Cornell Univ, Dept Plant Pathol & Plant Microbe Biol, Ithaca, NY 14853 USA; [Cartinhour, Sam; Swingle, Bryan] ARS, USDA, Ithaca, NY USA	Cornell University; United States Department of Agriculture (USDA)	Swingle, B (corresponding author), Cornell Univ, Dept Plant Pathol & Plant Microbe Biol, Ithaca, NY 14853 USA.	Bryan.Swingle@ars.usda.gov	Swingle, Bryan/AAX-6102-2021		U. S. Department of Agriculture, Agricultural Research Service; ARS [ARS-0423000] Funding Source: Federal RePORTER	U. S. Department of Agriculture, Agricultural Research Service(United States Department of Agriculture (USDA)USDA Agricultural Research Service); ARS(United States Department of Agriculture (USDA)USDA Agricultural Research Service)	This research was supported by the U. S. Department of Agriculture, Agricultural Research Service. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2012, BIOENGINEERED, V3, P137, DOI 10.4161/bact.18778; Bryan A, 2011, MOL MICROBIOL, V80, P231, DOI 10.1111/j.1365-2958.2011.07573.x; Buell CR, 2003, P NATL ACAD SCI USA, V100, P10181, DOI 10.1073/pnas.1731982100; CASSUTO E, 1971, NATURE-NEW BIOL, V229, P13, DOI 10.1038/newbio229013a0; Datta S, 2008, P NATL ACAD SCI USA, V105, P1626, DOI 10.1073/pnas.0709089105; Dutra BE, 2007, P NATL ACAD SCI USA, V104, P216, DOI 10.1073/pnas.0608293104; Ellis HM, 2001, P NATL ACAD SCI USA, V98, P6742, DOI 10.1073/pnas.121164898; Hirano SS, 2000, MICROBIOL MOL BIOL R, V64, P624, DOI 10.1128/MMBR.64.3.624-653.2000; Karakousis G, 1998, J MOL BIOL, V276, P721, DOI 10.1006/jmbi.1997.1573; Kaul S, 2000, NATURE, V408, P796, DOI 10.1038/35048692; KING EO, 1954, J LAB CLIN MED, V44, P301; KMIEC E, 1981, J BIOL CHEM, V256, P2636; Li XT, 2003, NUCLEIC ACIDS RES, V31, P6674, DOI 10.1093/nar/gkg844; LITTLE JW, 1967, J BIOL CHEM, V242, P679; Lovett ST, 2002, GENETICS, V160, P851; Maresca M, 2010, BMC MOL BIOL, V11, DOI 10.1186/1471-2199-11-54; Morris CE, 2008, ISME J, V2, P321, DOI 10.1038/ismej.2007.113; Mosberg JA, 2010, GENETICS, V186, P791, DOI 10.1534/genetics.110.120782; Murphy KC, 1998, J BACTERIOL, V180, P2063, DOI 10.1128/JB.180.8.2063-2071.1998; Muyrers JPP, 2000, GENE DEV, V14, P1971; O'Brien HE, 2011, ANNU REV PHYTOPATHOL, V49, P269, DOI 10.1146/annurev-phyto-072910-095242; Sato S, 2012, NATURE, V485, P635, DOI 10.1038/nature11119; Sawitzke JA, 2011, J MOL BIOL, V407, P45, DOI 10.1016/j.jmb.2011.01.030; SCHAFER A, 1994, GENE, V145, P69, DOI 10.1016/0378-1119(94)90324-7; Swingle B, 2010, APPL ENVIRON MICROB, V76, P4960, DOI 10.1128/AEM.00911-10; Swingle B, 2010, MOL MICROBIOL, V75, P138, DOI 10.1111/j.1365-2958.2009.06976.x; van Kessel JC, 2008, MOL MICROBIOL, V67, P1094, DOI 10.1111/j.1365-2958.2008.06109.x; Van Pijkeren JP, 2012, BIOENGINEERED, V3, P209, DOI 10.4161/bioe.21049; Wang HH, 2009, NATURE, V460, P894, DOI 10.1038/nature08187; WINANS SC, 1985, J BACTERIOL, V161, P1219, DOI 10.1128/JB.161.3.1219-1221.1985; Yu DG, 2000, P NATL ACAD SCI USA, V97, P5978, DOI 10.1073/pnas.100127597; Zhang Y, 2003, BMC GENOMICS, V4, DOI 10.1186/1471-2164-4-42; Zhang YM, 1998, NAT GENET, V20, P123, DOI 10.1038/2417	33	15	15	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 30	2012	7	11							e50617	10.1371/journal.pone.0050617	http://dx.doi.org/10.1371/journal.pone.0050617			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	054WM	23226333	Green Published, gold, Green Submitted			2022-12-27	WOS:000312376100144
J	Le, TT; Ziemba, A; Urasaki, Y; Brotman, S; Pizzorno, G				Le, Thuc T.; Ziemba, Amy; Urasaki, Yasuyo; Brotman, Steven; Pizzorno, Giuseppe			Label-free Evaluation of Hepatic Microvesicular Steatosis with Multimodal Coherent Anti-Stokes Raman Scattering Microscopy	PLOS ONE			English	Article							FATTY LIVER-DISEASE; MULTIPLEX-CARS MICROSCOPY; LIPID DROPLETS; CAENORHABDITIS-ELEGANS; QUANTITATIVE-ANALYSIS; MEDICAL PROGRESS; KUPFFER CELLS; EX-VIVO; FENOFIBRATE; SYSTEMS	Hepatic microvesicular steatosis is a hallmark of drug-induced hepatotoxicity and early-stage fatty liver disease. Current histopathology techniques are inadequate for the clinical evaluation of hepatic microvesicular steatosis. In this paper, we explore the use of multimodal coherent anti-Stokes Raman scattering (CARS) microscopy for the detection and characterization of hepatic microvesicular steatosis. We show that CARS microscopy is more sensitive than Oil Red O histology for the detection of microvesicular steatosis. Computer-assisted analysis of liver lipid level based on CARS signal intensity is consistent with triglyceride measurement using a standard biochemical assay. Most importantly, in a single measurement procedure on unprocessed and unstained liver tissues, multimodal CARS imaging provides a wealth of critical information including the detection of microvesicular steatosis and quantitation of liver lipid content, number and size of lipid droplets, and lipid unsaturation and packing order of lipid droplets. Such information can only be assessed by multiple different methods on processed and stained liver tissues or tissue extracts using current standard analytical techniques. Multimodal CARS microscopy also permits label-free identification of lipid-rich non-parenchymal cells. In addition, label-free and non-perturbative CARS imaging allow rapid screening of mitochondrial toxins-induced microvesicular steatosis in primary hepatocyte cultures. With its sensitivity and versatility, multimodal CARS microscopy should be a powerful tool for the clinical evaluation of hepatic microvesicular steatosis.	[Le, Thuc T.; Urasaki, Yasuyo; Pizzorno, Giuseppe] Desert Res Inst, Las Vegas, NV USA; [Le, Thuc T.; Ziemba, Amy; Urasaki, Yasuyo; Brotman, Steven; Pizzorno, Giuseppe] Nevada Canc Inst, Las Vegas, NV USA	Nevada System of Higher Education (NSHE); Desert Research Institute NSHE; University of California System; University of California San Diego	Le, TT (corresponding author), Desert Res Inst, Las Vegas, NV USA.	thuc.le@dri.edu; giuseppe.pizzorno@dri.edu			Nevada INBRE Program of the National Center for Research Resources [P20RR-016464]; American Cancer Society [IRG-08-062-04]; Vons Breast Cancer Research Award; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR016464] Funding Source: NIH RePORTER	Nevada INBRE Program of the National Center for Research Resources; American Cancer Society(American Cancer Society); Vons Breast Cancer Research Award; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	This work was supported by the Nevada INBRE Program of the National Center for Research Resources (P20RR-016464, TTL), the American Cancer Society (IRG-08-062-04, TTL), and the Vons Breast Cancer Research Award (TTL). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Angulo P, 2002, NEW ENGL J MED, V346, P1221, DOI 10.1038/nrdp.2015.80; BALFOUR JA, 1990, DRUGS, V40, P260, DOI 10.2165/00003495-199040020-00007; Begriche K, 2011, J HEPATOL, V54, P773, DOI 10.1016/j.jhep.2010.11.006; Belanger E, 2012, J BIOMED OPT, V17, DOI 10.1117/1.JBO.17.2.021107; Bissell D M, 1980, Ann N Y Acad Sci, V349, P85, DOI 10.1111/j.1749-6632.1980.tb29518.x; Bissell DM, 2001, HEPATOLOGY, V33, P1009, DOI 10.1053/jhep.2001.23505; Brackmann C, 2010, J BIOMED OPT, V15, DOI 10.1117/1.3505024; Browning JD, 2004, J CLIN INVEST, V114, P147, DOI 10.1172/JCI200422422; Brunmair B, 2004, J PHARMACOL EXP THER, V311, P109, DOI 10.1124/jpet.104.068312; Cheng JX, 2004, J PHYS CHEM B, V108, P827, DOI 10.1021/jp035693v; Cohen JC, 2011, SCIENCE, V332, P1519, DOI 10.1126/science.1204265; CROFTON RW, 1978, J EXP MED, V148, P1, DOI 10.1084/jem.148.1.1; Day CP, 1998, GASTROENTEROLOGY, V114, P842, DOI 10.1016/S0016-5085(98)70599-2; DIEHL AM, 1988, GASTROENTEROLOGY, V95, P1056, DOI 10.1016/0016-5085(88)90183-7; DUTTA PK, 1977, P NATL ACAD SCI USA, V74, P4146, DOI 10.1073/pnas.74.10.4146; El-Badry AM, 2009, ANN SURG, V250, P691, DOI 10.1097/SLA.0b013e3181bcd6dd; Evans CL, 2008, ANNU REV ANAL CHEM, V1, P883, DOI 10.1146/annurev.anchem.1.031207.112754; Evans CL, 2007, OPT EXPRESS, V15, P12076, DOI 10.1364/OE.15.012076; Fabbrini E, 2010, HEPATOLOGY, V51, P679, DOI 10.1002/hep.23280; Fu Y, 2008, OPT EXPRESS, V16, P19396, DOI 10.1364/OE.16.019396; Gottschall T, 2012, OPT EXPRESS, V20, P12004, DOI 10.1364/OE.20.012004; Hellerer T, 2007, P NATL ACAD SCI USA, V104, P14658, DOI 10.1073/pnas.0703594104; Helmchen F, 2005, NAT METHODS, V2, P932, DOI 10.1038/NMETH818; HOYUMPA AM, 1975, AM J DIG DIS, V20, P1142, DOI 10.1007/BF01070758; Huff TB, 2007, J MICROSC-OXFORD, V225, P175, DOI 10.1111/j.1365-2818.2007.01729.x; Imitola J, 2011, J BIOMED OPT, V16, DOI 10.1117/1.3533312; Kieu K, 2009, OPT LETT, V34, P2051, DOI 10.1364/OL.34.002051; Kim SH, 2010, CIRC RES, V106, P1332, DOI 10.1161/CIRCRESAHA.109.208678; Klein I, 2007, BLOOD, V110, P4077, DOI 10.1182/blood-2007-02-073841; Kleiner DE, 2005, HEPATOLOGY, V41, P1313, DOI 10.1002/hep.20701; KLOTZSCH SG, 1990, CLIN CHEM, V36, P1605; KNOWLES RG, 1994, BIOCHEM J, V298, P249, DOI 10.1042/bj2980249; Ko ACT, 2010, J BIOMED OPT, V15, DOI 10.1117/1.3353960; Krafft C, 2012, J BIOMED OPT, V17, DOI 10.1117/1.JBO.17.4.040801; Lang J, 2009, J INORG BIOCHEM, V103, P1102, DOI 10.1016/j.jinorgbio.2009.05.011; Lavine JE, 2004, CLIN LIVER DIS, V8, pviii; Lavine Joel E, 2004, Clin Liver Dis, V8, P549, DOI 10.1016/j.cld.2004.04.010; Le TT, 2007, J BIOMED OPT, V12, DOI 10.1117/1.2795437; Le TT, 2010, J LIPID RES, V51, P3091, DOI 10.1194/jlr.R008730; Le TT, 2010, J LIPID RES, V51, P672, DOI 10.1194/jlr.D000638; Le TT, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005189; LeCluyse EL, 2001, EUR J PHARM SCI, V13, P343, DOI 10.1016/S0928-0987(01)00135-X; Lee WM, 2003, NEW ENGL J MED, V349, P474, DOI 10.1056/NEJMra021844; Li L, 2005, BIOPHYS J, V89, P3480, DOI 10.1529/biophysj.105.065607; Lim RS, 2011, J LIPID RES, V52, P2177, DOI 10.1194/jlr.M018077; Lin J, 2011, J BIOMED OPT, V16, DOI 10.1117/1.3655353; Lyn RK, 2009, VIROLOGY, V394, P130, DOI 10.1016/j.virol.2009.08.022; MARKIN RS, 1993, TRANSPLANTATION, V56, P1403, DOI 10.1097/00007890-199312000-00025; Medyukhina A, 2012, J BIOPHOTONICS; Meyer T, 2012, J BIOPHOTONICS, V5, P729, DOI 10.1002/jbio.201200104; Min W, 2011, ANNU REV PHYS CHEM, V62, P507, DOI 10.1146/annurev.physchem.012809.103512; Nan XL, 2006, BIOPHYS J, V91, P728, DOI 10.1529/biophysj.105.074534; Nan XL, 2003, J LIPID RES, V44, P2202, DOI 10.1194/jlr.D300022-JLR200; Navarro VJ, 2006, NEW ENGL J MED, V354, P731, DOI 10.1056/NEJMra052270; Ohta T, 2009, TOXICOL PATHOL, V37, P521, DOI 10.1177/0192623309336152; Paar M, 2012, J BIOL CHEM, V287, P11164, DOI 10.1074/jbc.M111.316794; Pegoraro AF, 2009, OPT EXPRESS, V17, P20700, DOI 10.1364/OE.17.020700; Pezacki JP, 2011, NAT CHEM BIOL, V7, P137, DOI 10.1038/NCHEMBIO.525; Reddy JK, 2006, AM J PHYSIOL-GASTR L, V290, pG852, DOI 10.1152/ajpgi.00521.2005; Rinia HA, 2008, BIOPHYS J, V95, P4908, DOI 10.1529/biophysj.108.137737; Roth B, 1996, INTENS CARE MED, V22, P1224, DOI 10.1007/s001340050242; SCHNEIDER EL, 1990, JAMA-J AM MED ASSOC, V263, P2335, DOI 10.1001/jama.263.17.2335; Segawa H, 2012, OPT EXPRESS, V20, DOI 10.1364/OE.20.009551; Seglen P O, 1976, Methods Cell Biol, V13, P29, DOI 10.1016/S0091-679X(08)61797-5; Slipchenko MN, 2009, J PHYS CHEM B, V113, P7681, DOI 10.1021/jp902231y; Tong L, 2009, LANGMUIR, V25, P12454, DOI 10.1021/la902992w; Urasaki Y, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038418; Urena MAG, 1998, WORLD J SURG, V22, P837, DOI 10.1007/s002689900479; Vetelainen R, 2007, ANN SURG, V245, P20, DOI 10.1097/01.sla.0000225113.88433.cf; VISSER AJWG, 1983, EUR J BIOCHEM, V131, P639, DOI 10.1111/j.1432-1033.1983.tb07311.x; Wang HW, 2009, ARTERIOSCL THROM VAS, V29, P1342, DOI 10.1161/ATVBAHA.109.189316; Wang HF, 2005, BIOPHYS J, V89, P581, DOI 10.1529/biophysj.105.061911; Wang Y, 2007, EPIDEMIOL REV, V29, P6, DOI 10.1093/epirev/mxm007; Williams CD, 2011, GASTROENTEROLOGY, V140, P124, DOI 10.1053/j.gastro.2010.09.038; Wu YM, 2009, ANAL CHEM, V81, P1496, DOI 10.1021/ac8026838; Yamaguchi T, 2007, J LIPID RES, V48, P1078, DOI 10.1194/jlr.M600493-JLR200; Yen K, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012810; Zhai YH, 2011, APPL PHYS LETT, V98, DOI 10.1063/1.3589356; Zhu JB, 2009, J LIPID RES, V50, P1080, DOI 10.1194/jlr.M800555-JLR200	79	36	36	1	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 30	2012	7	11							e51092	10.1371/journal.pone.0051092	http://dx.doi.org/10.1371/journal.pone.0051092			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	054WM	23226469	Green Submitted, Green Published, gold			2022-12-27	WOS:000312376100280
J	Sykes, L; Lee, Y; Khanjani, S; MacIntyre, DA; Yap, XJ; Ponnampalam, S; Teoh, TG; Bennett, PR				Sykes, Lynne; Lee, Yun; Khanjani, Shirin; MacIntyre, David A.; Yap, Xiao J.; Ponnampalam, Sathana; Teoh, Tiong Ghee; Bennett, Phillip R.			Chemoattractant Receptor Homologous to the T Helper 2 Cell (CRTH2) Is Not Expressed in Human Amniocytes and Myocytes	PLOS ONE			English	Article							FACTOR-KAPPA-B; PROSTAGLANDIN D-2 RECEPTOR; UP-REGULATION; T-CYTOTOXIC-2 CELLS; IMPLANTATION SITES; SURFACE-MOLECULE; T-CELLS; INHIBITION; BINDING; EOSINOPHILS	Background: 15-deoxy-Delta 12,14- Prostaglandin J2 (15dPGJ2) inhibits Nuclear factor kappa B (NF-kappa B) in human myocytes and amniocytes and delays inflammation induced preterm labour in the mouse. 15dPGJ2 is a ligand for the Chemoattractant Receptor Homologous to the T helper 2 cell (CRTH2), a G protein-coupled receptor, present on a subset of T helper 2 (Th2) cells, eosinophils and basophils. It is the second receptor for Prostaglandin D2, whose activation leads to chemotaxis and the production of Th2-type interleukins. The cellular distribution of CRTH2 in non-immune cells has not been extensively researched, and its identification at the protein level has been limited by the lack of specific antibodies. In this study we explored the possibility that CRTH2 plays a role in 15dPGJ2-mediated inhibition of NF-kappa B and would therefore represent a novel small molecule therapeutic target for the prevention of inflammation induced preterm labour. Methods: The effect of a small molecule CRTH2 agonist on NF-kappa B activity in human cultured amniocytes and myocytes was assessed by detection of p65 and phospho-p65 by immunoblot. Endogenous CRTH2 expression in amniocytes, myocytes and peripheral blood mononuclear cells (PBMCs) was examined by PCR, western analysis and flow cytometry, with amniocytes and myocytes transfected with CRTH2 acting as a positive control in flow cytometry studies. Results: The CRTH2 agonist had no effect on NF-kappa B activity in amniocytes and myocytes. Although CRTH2 mRNA was detected in amniocytes and myocytes, CRTH2 was not detectable at the protein level, as demonstrated by western analysis and flow cytometry. 15dPGJ2 inhibited phospho-65 in PBMC'S, however the CRTH2 antagonist was not able to attenuate this effect. In conclusion, CRTH2 is not expressed on human amniocytes or myocytes and plays no role in the mechanism of 15dPGJ2-mediated inhibition of NF-kappa B.	[Sykes, Lynne; Lee, Yun; Khanjani, Shirin; MacIntyre, David A.; Yap, Xiao J.; Ponnampalam, Sathana; Bennett, Phillip R.] Univ London Imperial Coll Sci Technol & Med, Parturit Res Grp, Dept Surg & Canc, London, England; [Teoh, Tiong Ghee] Imperial Coll Healthcare NHS Trust, St Marys Hosp, Dept Obstet & Gynaecol, London, England	Imperial College London; Imperial College London	Sykes, L (corresponding author), Univ London Imperial Coll Sci Technol & Med, Parturit Res Grp, Dept Surg & Canc, London, England.	l.sykes@imperial.ac.uk	MacIntyre, David A/D-9267-2012	Sykes, Lynne/0000-0002-7806-5707; Bennett, Phillip/0000-0002-6253-4919; MacIntyre, David/0000-0002-4186-5567	Wellbeing of Women [148]; Imperial College NIHR Biomedical Research Centre; National Institute for Health Research [ACF-2012-21-018] Funding Source: researchfish	Wellbeing of Women(Wellbeing of Women (WoW)); Imperial College NIHR Biomedical Research Centre; National Institute for Health Research(National Institute for Health Research (NIHR))	This study was funded by a Wellbeing of Women research training fellowship, grant 148 (to LS). PRB is funded by the Imperial College NIHR Biomedical Research Centre. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allport VC, 2001, MOL HUM REPROD, V7, P581, DOI 10.1093/molehr/7.6.581; Barnes PJ, 1997, NEW ENGL J MED, V336, P1066, DOI 10.1056/NEJM199704103361506; Beck S, 2010, B WORLD HEALTH ORGAN, V88, P31, DOI 10.2471/BLT.08.062554; Bell-Parikh LC, 2003, J CLIN INVEST, V112, P945, DOI 10.1172/JCI200318012; Cernuda-Morollon E, 2001, J BIOL CHEM, V276, P35530, DOI 10.1074/jbc.M104518200; Chapman NR, 2004, J CLIN ENDOCR METAB, V89, P5683, DOI 10.1210/jc.2004-0873; Chiba T, 2006, INT ARCH ALLERGY IMM, V141, P300, DOI 10.1159/000095436; Colombe L, 2008, EXP DERMATOL, V17, P63, DOI 10.1111/j.1600-0625.2007.00639.x; Condon JC, 2006, MOL ENDOCRINOL, V20, P764, DOI 10.1210/me.2005-0242; Cosmi L, 2000, EUR J IMMUNOL, V30, P2972, DOI 10.1002/1521-4141(200010)30:10<2972::AID-IMMU2972>3.0.CO;2-#; De Fanis U, 2007, BLOOD, V109, P4343, DOI 10.1182/blood-2006-05-025940; Durand M, 2008, J BONE MINER RES, V23, P1097, DOI [10.1359/jbmr.080228, 10.1359/JBMR.080228]; El-Shazly AE, 2011, INT IMMUNOPHARMACOL, V11, P1864, DOI 10.1016/j.intimp.2011.07.017; FITZPATRICK FA, 1983, J BIOL CHEM, V258, P1713; Gallant MA, 2005, J BONE MINER RES, V20, P672, DOI 10.1359/JBMR.041211; Gervais FG, 2005, MOL PHARMACOL, V67, P1834, DOI 10.1124/mol.104.009068; Goldenberg RL, 2000, NEW ENGL J MED, V342, P1500, DOI 10.1056/NEJM200005183422007; Goldenberg RL, 2002, NUTR REV, V60, pS19, DOI 10.1301/00296640260130696; Gosset P, 2003, J IMMUNOL, V170, P4943, DOI 10.4049/jimmunol.170.10.4943; Gotsch F, 2007, CLIN OBSTET GYNECOL, V50, P652, DOI 10.1097/GRF.0b013e31811ebef6; Helliwell RJA, 2006, J CLIN ENDOCR METAB, V91, P597, DOI 10.1210/jc.2005-1982; Hirai H, 2002, J IMMUNOL, V168, P981, DOI 10.4049/jimmunol.168.3.981; Iwasaki M, 2002, J INVEST DERMATOL, V119, P609, DOI 10.1046/j.1523-1747.2002.01862.x; Lappas M, 2007, PLACENTA, V28, P543, DOI 10.1016/j.placenta.2006.05.011; Lappas M, 2009, PLACENTA, V30, pS90, DOI 10.1016/j.placenta.2008.10.005; Lim S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034707; Lindstrom TM, 2005, REPRODUCTION, V130, P569, DOI 10.1530/rep.1.00197; Lindstrom TM, 2005, J CLIN ENDOCR METAB, V90, P3534, DOI 10.1210/jc.2005-0055; Marchese A, 1999, GENOMICS, V56, P12, DOI 10.1006/geno.1998.5655; McCracken SA, 2007, EUR J IMMUNOL, V37, P1386, DOI 10.1002/eji.200636322; Michimata T, 2003, HUM REPROD, V18, P1523, DOI 10.1093/humrep/deg280; Michimata T, 2002, MOL HUM REPROD, V8, P181, DOI 10.1093/molehr/8.2.181; Monneret G, 2002, J IMMUNOL, V168, P3563, DOI 10.4049/jimmunol.168.7.3563; Monneret G, 2001, BLOOD, V98, P1942, DOI 10.1182/blood.V98.6.1942; Nagata K, 2003, J BIOL REG HOMEOS AG, V17, P334; Nagata K, 2003, PROSTAG LEUKOTR ESS, V69, P169, DOI 10.1016/S0952-3278(03)00078-4; Nagata K, 1999, FEBS LETT, V459, P195, DOI 10.1016/S0014-5793(99)01251-X; Nagata K, 1999, J IMMUNOL, V162, P1278; NARUMIYA S, 1987, J PHARMACOL EXP THER, V242, P306; Pirianov G, 2009, ENDOCRINOLOGY, V150, P699, DOI 10.1210/en.2008-1178; ROMERO R, 1994, ANN NY ACAD SCI, V734, P414, DOI 10.1111/j.1749-6632.1994.tb21771.x; Rossi A, 2000, NATURE, V403, P103, DOI 10.1038/47520; Sawyer N, 2002, BRIT J PHARMACOL, V137, P1163, DOI 10.1038/sj.bjp.0704973; Shibata T, 2002, J BIOL CHEM, V277, P10459, DOI 10.1074/jbc.M110314200; Stubbs VEL, 2002, J BIOL CHEM, V277, P26012, DOI 10.1074/jbc.M201803200; Sykes L, 2011, EUROPEAN OBSTET GYNA, V6, P100; Sykes L, 2012, MEDIAT INFLAMM, V2012, P1; Terzidou V, 2006, J CLIN ENDOCR METAB, V91, P2317, DOI 10.1210/jc.2005-2649; Tsuda H, 2001, CLIN EXP IMMUNOL, V123, P105, DOI 10.1046/j.1365-2249.2001.01422.x; Venet F, 2004, CLIN IMMUNOL, V113, P278, DOI 10.1016/j.clim.2004.07.005; Wen Shi Wu, 2004, Semin Fetal Neonatal Med, V9, P429, DOI 10.1016/j.siny.2004.04.002; Xue LZ, 2007, BIOCHEM PHARMACOL, V73, P843, DOI 10.1016/j.bcp.2006.11.021; Zayed N, 2008, ARTHRITIS RHEUM-US, V58, P3530, DOI 10.1002/art.23958	53	7	7	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 30	2012	7	11							e50734	10.1371/journal.pone.0050734	http://dx.doi.org/10.1371/journal.pone.0050734			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	054WM	23226366	gold, Green Published, Green Submitted			2022-12-27	WOS:000312376100177
J	Valdazo-Gonzalez, B; Polihronova, L; Alexandrov, T; Normann, P; Knowles, NJ; Hammond, JM; Georgiev, GK; Ozyoruk, F; Sumption, KJ; Belsham, GJ; King, DP				Valdazo-Gonzalez, Begona; Polihronova, Lilyana; Alexandrov, Tsviatko; Normann, Preben; Knowles, Nick J.; Hammond, Jef M.; Georgiev, Georgi K.; Ozyoruk, Fuat; Sumption, Keith J.; Belsham, Graham J.; King, Donald P.			Reconstruction of the Transmission History of RNA Virus Outbreaks Using Full Genome Sequences: Foot-and-Mouth Disease Virus in Bulgaria in 2011	PLOS ONE			English	Article							MOLECULAR EPIDEMIOLOGY; UNITED-KINGDOM; SEROTYPE O; PATHOGENESIS; AFGHANISTAN; DIVERSITY; PATHWAYS; DYNAMICS; PAKISTAN; SWINE	Improvements to sequencing protocols and the development of computational phylogenetics have opened up opportunities to study the rapid evolution of RNA viruses in real time. In practical terms, these results can be combined with field data in order to reconstruct spatiotemporal scenarios that describe the origin and transmission pathways of viruses during an epidemic. In the case of notifiable diseases, such as foot-and-mouth disease (FMD), these analyses provide important insights into the epidemiology of field outbreaks that can support disease control programmes. This study reconstructs the origin and transmission history of the FMD outbreaks which occurred during 2011 in Burgas Province, Bulgaria, a country that had been previously FMD-free-without-vaccination since 1996. Nineteen full genome sequences (FGS) of FMD virus (FMDV) were generated and analysed, including eight representative viruses from all of the virus-positive outbreaks of the disease in the country and 11 closely-related contemporary viruses from countries in the region where FMD is endemic (Turkey and Israel). All Bulgarian sequences shared a single putative common ancestor which was closely related to the index case identified in wild boar. The closest relative from outside of Bulgaria was a FMDV collected during 2010 in Bursa (Anatolia, Turkey). Within Bulgaria, two discrete genetic clusters were detected that corresponded to two episodes of outbreaks that occurred during January and March-April 2011. The number of nucleotide substitutions that were present between, and within, these separate clusters provided evidence that undetected FMDV infection had occurred. These conclusions are supported by laboratory data that subsequently identified three additional FMDV-infected livestock premises by serosurveillance, as well as a number of antibody positive wild boar on both sides of the border with Turkish Thrace. This study highlights how FGS analysis can be used as an effective on-the-spot tool to support and help direct epidemiological investigations of field outbreaks.	[Valdazo-Gonzalez, Begona; Knowles, Nick J.; Hammond, Jef M.; King, Donald P.] Pirbright Inst, Div Livestock Viral Dis, Surrey, England; [Polihronova, Lilyana; Georgiev, Georgi K.] Natl Diagnost & Res Vet Med Inst, Dept Exot & Emerging Dis, Sofia, Bulgaria; [Alexandrov, Tsviatko] Bulgarian Food Safety Agcy, Anim Hlth & Welf Directorate, Sofia, Bulgaria; [Normann, Preben; Belsham, Graham J.] Tech Univ Denmark, Natl Vet Inst, Lindholm, Kalvehave, Denmark; [Ozyoruk, Fuat] Foot & Mouth Dis Inst, Lab Typing & Mol Epidemiol, Ankara, Turkey; [Sumption, Keith J.] Food & Agr Org United Nations, Anim Hlth Serv, Anim Hlth Prod & Hlth Div, Rome, Italy	UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Pirbright Institute; National Veterinary Medical Institute - Bulgaria; Technical University of Denmark; Ministry of Food, Agriculture & Livestock - Turkey; Food & Agriculture Organization of the United Nations (FAO)	Valdazo-Gonzalez, B (corresponding author), Pirbright Inst, Div Livestock Viral Dis, Surrey, England.	begona.valdazo-gonzalez@pirbright.ac.uk	Belsham, Graham J./H-8589-2019; Özyörük, Fuat/AAA-5141-2020; Belsham, Graham/J-3132-2019	Belsham, Graham J./0000-0003-1187-4873; Belsham, Graham/0000-0003-1187-4873; King, Donald/0000-0002-6959-2708; Ozyoruk, Fuat/0000-0002-6965-2045	Department for Environment, Food and Rural Affairs, United Kingdom [SE2938]; International Atomic Energy Agency Fellowship [BUL/09011]; BBSRC [BBS/E/I/00001443] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BBS/E/I/00001443] Funding Source: researchfish	Department for Environment, Food and Rural Affairs, United Kingdom(Department for Environment, Food & Rural Affairs (DEFRA)); International Atomic Energy Agency Fellowship; BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This project was supported by the Department for Environment, Food and Rural Affairs, United Kingdom (Research grant no. SE2938). LP was supported by an International Atomic Energy Agency Fellowship, code No BUL/09011. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdul-Hamid NF, 2011, VIRUS GENES, V43, P41, DOI 10.1007/s11262-011-0599-3; Alexandersen S, 2003, J COMP PATHOL, V129, P268, DOI 10.1016/S0021-9975(03)00045-8; Alexandersen S, 2003, J COMP PATHOL, V129, P1, DOI 10.1016/S0021-9975(03)00041-0; Arzt J, 2011, TRANSBOUND EMERG DIS, V58, P305, DOI 10.1111/j.1865-1682.2011.01236.x; Balinda SN, 2010, VIROL J, V7, DOI 10.1186/1743-422X-7-199; Bielejec F, 2011, BIOINFORMATICS, V27, P2910, DOI 10.1093/bioinformatics/btr481; Breithaupt A, 2012, VET MICROBIOL; Carrillo C, 2005, J VIROL, V79, P6487, DOI 10.1128/JVI.79.10.6487-6504.2005; Christensen LS, 2005, J GEN VIROL, V86, P2577, DOI 10.1099/vir.0.80878-0; Clement M, 2000, MOL ECOL, V9, P1657, DOI 10.1046/j.1365-294x.2000.01020.x; CONDY JB, 1985, COMP IMMUNOL MICROB, V8, P259, DOI 10.1016/0147-9571(85)90004-9; Cottam EM, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000050; Cottam EM, 2008, P ROY SOC B-BIOL SCI, V275, P887, DOI 10.1098/rspb.2007.1442; Cottam EM, 2006, J VIROL, V80, P11274, DOI 10.1128/JVI.01236-06; Domingo E, 2003, VIRUS RES, V91, P47, DOI 10.1016/S0168-1702(02)00259-9; Drummond AJ, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-214; Hall T.A., 1999, NUCL ACIDS S SER, V41, P95; Hanada K, 2004, MOL BIOL EVOL, V21, P1074, DOI 10.1093/molbev/msh109; Jamal SM, 2011, INFECT GENET EVOL, V11, P2049, DOI 10.1016/j.meegid.2011.09.015; Jamal SM, 2011, INFECT GENET EVOL, V11, P1229, DOI 10.1016/j.meegid.2011.03.006; Knowles NJ, 2003, VIRUS RES, V91, P65, DOI 10.1016/S0168-1702(02)00260-5; Koenig GA, 2009, VET REC, V165, P410, DOI 10.1136/vr.165.14.410; Lemey P, 2010, MOL BIOL EVOL, V27, P1877, DOI 10.1093/molbev/msq067; Mohamed F, 2011, TRANSBOUND EMERG DIS, V58, P358, DOI 10.1111/j.1865-1682.2011.01213.x; Posada D, 2008, MOL BIOL EVOL, V25, P1253, DOI 10.1093/molbev/msn083; Rozas J, 2003, BIOINFORMATICS, V19, P2496, DOI 10.1093/bioinformatics/btg359; Samuel A R, 1993, Rev Sci Tech, V12, P839; Thompson D, 2002, REV SCI TECH OIE, V21, P675, DOI 10.20506/rst.21.3.1353; Valarcher JF, 2008, TRANSBOUND EMERG DIS, V55, P14, DOI 10.1111/j.1865-1682.2007.01010.x; Valdazo-Gonzalez B, 2011, VET REC, V168, P247, DOI 10.1136/vr.d1352	30	49	51	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 30	2012	7	11							e49650	10.1371/journal.pone.0049650	http://dx.doi.org/10.1371/journal.pone.0049650			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	054WM	23226216	Green Published, gold			2022-12-27	WOS:000312376100024
J	Wagener, J; Weindl, G; de Groot, PWJ; de Boer, AD; Kaesler, S; Thavaraj, S; Bader, O; Mailander-Sanchez, D; Borelli, C; Weig, M; Biedermann, T; Naglik, JR; Korting, HC; Schaller, M				Wagener, Jeanette; Weindl, Guenther; de Groot, Piet W. J.; de Boer, Albert D.; Kaesler, Susanne; Thavaraj, Selvam; Bader, Oliver; Mailaender-Sanchez, Daniela; Borelli, Claudia; Weig, Michael; Biedermann, Tilo; Naglik, Julian R.; Korting, Hans Christian; Schaller, Martin			Glycosylation of Candida albicans Cell Wall Proteins is Critical for Induction of Innate Immune Responses and Apoptosis of Epithelial Cells	PLOS ONE			English	Article							TOLL-LIKE RECEPTORS; BAD PHOSPHORYLATION; ANTIFUNGAL DEFENSE; VIRULENCE; RECOGNITION; INFECTION; CYTOKINE; YEAST; PHOSPHOLIPOMANNAN; MANNOPROTEIN	C. albicans is one of the most common fungal pathogen of humans, causing local and superficial mucosal infections in immunocompromised individuals. Given that the key structure mediating host-C. albicans interactions is the fungal cell wall, we aimed to identify features of the cell wall inducing epithelial responses and be associated with fungal pathogenesis. We demonstrate here the importance of cell wall protein glycosylation in epithelial immune activation with a predominant role for the highly branched N-glycosylation residues. Moreover, these glycan moieties induce growth arrest and apoptosis of epithelial cells. Using an in vitro model of oral candidosis we demonstrate, that apoptosis induction by C. albicans wild-type occurs in early stage of infection and strongly depends on intact cell wall protein glycosylation. These novel findings demonstrate that glycosylation of the C. albicans cell wall proteins appears essential for modulation of epithelial immunity and apoptosis induction, both of which may promote fungal pathogenesis in vivo.	[Wagener, Jeanette; Kaesler, Susanne; Mailaender-Sanchez, Daniela; Biedermann, Tilo; Schaller, Martin] Univ Tubingen, Dept Dermatol, Tubingen, Germany; [Weindl, Guenther] Free Univ Berlin, Dept Pharmacol & Toxicol, Inst Pharm, Berlin, Germany; [de Groot, Piet W. J.; de Boer, Albert D.] Univ Castilla La Mancha, Reg Ctr Biomed Res, Albacete, Spain; [de Boer, Albert D.; Bader, Oliver; Weig, Michael] Univ Med Ctr Gottingen, Dept Med Microbiol, Gottingen, Germany; [de Boer, Albert D.; Bader, Oliver; Weig, Michael] Univ Med Ctr Gottingen, Natl Reference Ctr Syst Mycoses, Gottingen, Germany; [Thavaraj, Selvam; Naglik, Julian R.] Kings Coll London, Dept Oral Immunol, Inst Dent, London WC2R 2LS, England; [Borelli, Claudia; Korting, Hans Christian] Univ Munich, Dept Dermatol, D-8000 Munich, Germany; [Wagener, Jeanette] Univ Aberdeen, Aberdeen Fungal Grp, Inst Med Sci, Aberdeen, Scotland	Eberhard Karls University of Tubingen; Eberhard Karls University Hospital; Free University of Berlin; Universidad de Castilla-La Mancha; University of Gottingen; University of Gottingen; University of London; King's College London; University of Munich; University of Aberdeen	Schaller, M (corresponding author), Univ Tubingen, Dept Dermatol, Tubingen, Germany.	Martin.Schaller@med.uni-tuebingen.de	De Groot, Piet/L-7737-2014; Thavaraj, Selvam/AAO-9113-2020; Bader, Oliver/C-7650-2015; Weindl, Günther/B-6161-2011	De Groot, Piet/0000-0002-3112-6947; Thavaraj, Selvam/0000-0001-5720-7422; Bader, Oliver/0000-0002-1534-440X; Weindl, Günther/0000-0002-4493-7597; Naglik, Julian/0000-0002-8072-7917; Wagener, Jeanette/0000-0002-7227-4348; Biedermann, Tilo/0000-0002-5352-5105	Deutsche Forschungsgemeinschaft [Sch 897/3, WE 3537/1-2, SFB773 Z2, 685, Bi 696/3-1, Bi 696/5-2, Bi 696/10-1, SFB 685 A6]; BMBF [0315409B]; NIDCR [DE017514, R01 DE017514]; MRC [MR-J008303-1]; NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [R01DE017514] Funding Source: NIH RePORTER; Medical Research Council [MR/J008303/1] Funding Source: researchfish; MRC [MR/J008303/1] Funding Source: UKRI	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); BMBF(Federal Ministry of Education & Research (BMBF)); NIDCR(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	J.W., G. W., M. W. and M. S. were supported by the Deutsche Forschungsgemeinschaft (Sch 897/3, WE 3537/1-2, SFB773 Z2, graduate college 685) and the BMBF (MedSys 0315409B); M. S. and J.N. by NIDCR (DE017514); J.N. was funded by NIDCR (R01 DE017514) and MRC (MR-J008303-1). Grants from the Deutsche Forschungsgemeinschaft supported T. B. (Bi 696/3-1; Bi 696/5-2; Bi 696/10-1) and T. B. and S. K. (SFB 685 A6). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abreu MT, 2005, J IMMUNOL, V174, P4453, DOI 10.4049/jimmunol.174.8.4453; ARAND M, 1992, ANAL BIOCHEM, V207, P73, DOI 10.1016/0003-2697(92)90502-X; Bates S, 2006, J BIOL CHEM, V281, P90, DOI 10.1074/jbc.M510360200; Bates S, 2005, J BIOL CHEM, V280, P23408, DOI 10.1074/jbc.M502162200; Brachmann CB, 1998, YEAST, V14, P115; Burrello N, 2009, REPROD BIOMED ONLINE, V18, P496, DOI 10.1016/S1472-6483(10)60125-3; Cambi A, 2008, J BIOL CHEM, V283, P20590, DOI 10.1074/jbc.M709334200; Chaffin WL, 2008, MICROBIOL MOL BIOL R, V72, P495, DOI 10.1128/MMBR.00032-07; de Boer AD, 2010, YEAST, V27, P611, DOI 10.1002/yea.1790; de Groot PWJ, 2004, EUKARYOT CELL, V3, P955, DOI 10.1128/EC.3.4.955-965.2004; Dongari-Bagtzoglou A, 2003, MICROB PATHOGENESIS, V34, P169, DOI 10.1016/S0882-4010(03)00004-4; Egusa H, 2006, INT J MED MICROBIOL, V296, P301, DOI 10.1016/j.ijmm.2005.12.017; ELLMAN GL, 1958, ARCH BIOCHEM BIOPHYS, V74, P443, DOI 10.1016/0003-9861(58)90014-6; Fukata M, 2005, AM J PHYSIOL-GASTR L, V288, pG1055, DOI 10.1152/ajpgi.00328.2004; Gantner BN, 2005, EMBO J, V24, P1277, DOI 10.1038/sj.emboj.7600594; Gasparoto TH, 2004, FEMS IMMUNOL MED MIC, V42, P219, DOI 10.1016/j.femsim.2004.05.006; GILLUM AM, 1984, MOL GEN GENET, V198, P179, DOI 10.1007/BF00328721; Goodridge HS, 2011, NATURE, V472, P471, DOI 10.1038/nature10071; Hasan UA, 2005, J BIOL CHEM, V280, P20620, DOI 10.1074/jbc.M500877200; Hornbach A, 2009, INFECT IMMUN, V77, P5216, DOI 10.1128/IAI.00723-09; Ibata-Ombetta S, 2003, J BIOL CHEM, V278, P13086, DOI 10.1074/jbc.M210680200; Ibata-Ombetta S, 2003, ANN NY ACAD SCI, V1010, P573, DOI 10.1196/annals.1299.107; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LaSala A, 1996, J BIOL REG HOMEOS AG, V10, P8; Gil ML, 2009, FRONT BIOSCI-LANDMRK, V14, P570, DOI 10.2741/3263; McKenzie CGJ, 2010, INFECT IMMUN, V78, P1650, DOI 10.1128/IAI.00001-10; Mora-Montes HM, 2010, J BIOL CHEM, V285, P12087, DOI 10.1074/jbc.M109.081513; Moyes DL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026580; Moyes DL, 2010, CELL HOST MICROBE, V8, P225, DOI 10.1016/j.chom.2010.08.002; Moyes DL, 2011, MED MICROBIOL IMMUNO; Munro CA, 2005, J BIOL CHEM, V280, P1051, DOI 10.1074/jbc.M411413200; Murciano C, 2011, INFECT IMMUN, V79, P4902, DOI 10.1128/IAI.05591-11; Nather K, 2008, FEMS MICROBIOL LETT, V285, P137, DOI 10.1111/j.1574-6968.2008.01263.x; Netea MG, 2008, NAT REV MICROBIOL, V6, P67, DOI 10.1038/nrmicro1815; Netea MG, 2006, J CLIN INVEST, V116, P1642, DOI 10.1172/JCI27114; Nisini R, 2001, INFECT IMMUN, V69, P3728, DOI 10.1128/IAI.69.6.3728-3736.2001; Pietrella D, 2006, CELL MICROBIOL, V8, P602, DOI 10.1111/j.1462-5822.2005.00651.x; Rotstein D, 2000, SHOCK, V14, P278, DOI 10.1097/00024382-200014030-00006; Rouabhia M, 2002, INFECT IMMUN, V70, P7073, DOI 10.1128/IAI.70.12.7073-7080.2002; RUPNIAK HT, 1985, J NATL CANCER I, V75, P621; Salaun B, 2007, EUR J IMMUNOL, V37, P3311, DOI 10.1002/eji.200737744; Schaller M, 2002, J INVEST DERMATOL, V118, P652, DOI 10.1046/j.1523-1747.2002.01699.x; Scheper MA, 2008, NEOPLASIA, V10, P954, DOI 10.1593/neo.08444; Siggers RH, 2011, CELL MOL LIFE SCI, V68, P3623, DOI 10.1007/s00018-011-0821-4; Steele C, 2002, INFECT IMMUN, V70, P577, DOI 10.1128/IAI.70.2.577-583.2002; van de Veerdonk FL, 2009, CELL HOST MICROBE, V5, P329, DOI 10.1016/j.chom.2009.02.006; Villar CC, 2010, MOL ORAL MICROBIOL, V25, P215, DOI 10.1111/j.2041-1014.2010.00577.x; Villar Cristina Cunha, 2008, Expert Reviews in Molecular Medicine, V10, P1, DOI 10.1017/S1462399408000835; Weindl G, 2010, J DENT RES, V89, P666, DOI 10.1177/0022034510368784; Weindl G, 2007, J CLIN INVEST, V117, P3664, DOI 10.1172/JCI28115; Wheeler RT, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000227	51	25	25	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 30	2012	7	11							e50518	10.1371/journal.pone.0050518	http://dx.doi.org/10.1371/journal.pone.0050518			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	054WM	23226301	Green Published, Green Submitted, gold			2022-12-27	WOS:000312376100113
J	de Moraes, VY; Godin, K; Tamaoki, MJS; Faloppa, F; Bhandari, M; Belloti, JC				de Moraes, Vinicius Ynoe; Godin, Katelyn; Sugawara Tamaoki, Marcel Jun; Faloppa, Flavio; Bhandari, Mohit; Belloti, Joao Carlos			Workers' Compensation Status: Does It Affect Orthopaedic Surgery Outcomes? A Meta-Analysis	PLOS ONE			English	Article							CRUCIATE LIGAMENT RECONSTRUCTION; CALCANEAL FRACTURES; SYSTEMATIC REVIEWS; LUMBAR FUSION; MANAGEMENT; CARPAL; REPAIR; RETURN; ACROMIOPLASTY; EXPECTATIONS	Introduction: Previous reviews have demonstrated that patient outcomes following orthopaedic surgery are strongly influenced by the presence of Workers' Compensation. However, the variability in the reviews' methodology may have inflated the estimated strength of this association. The main objective of this meta-analysis is to evaluate the influence of Workers' Compensation on the outcomes of orthopaedic surgical procedures. Methods: We conducted a systematic search of the literature published in this area from 1992-2012, with no language restrictions. The following databases were used MEDLINE (Ovid), Embase (Ovid), CINAHL, Google Scholar, LILACS and Pubmed. We also hand-searched the reference sections of all selected papers. We included all prospective studies evaluating the effect of compensation status on outcomes in adult patients who had undergone surgery due to orthopaedic conditions or diseases. Outcomes of interest included disease specific, region specific and/or overall quality of life scales/questionnaires and surgeons' personal judgment of the results. We used an assessment tool to appraise the quality of all included studies. We used Review Manager to create forest plots to summarize study data and funnel plots for the assessment of publication bias. Results: Twenty studies met our eligibility criteria. The overall risk ratio for experiencing an unsatisfactory result after orthopaedic surgery for patients with compensation compared to non-compensated patients is 2.08 (95% CI 1.54-2.82). A similar association was shown for continuous data extracted from the studies using assessment scales or questionnaires (Standard Mean Difference = -0.70 95% CI -0.97=-0.43). Conclusions: Among patients who undergo orthopaedic surgical procedures, those receiving Workers' Compensation experience a two-fold greater risk of a negative outcome. Our findings show a considerably lower estimate of risk compared to previous reviews that include retrospective data. Further research is warranted to determine the etiological explanation for the influence of compensation status on patient outcomes.	[de Moraes, Vinicius Ynoe; Sugawara Tamaoki, Marcel Jun; Faloppa, Flavio; Belloti, Joao Carlos] Univ Fed Sao Paulo, Dept Orthopaed & Trauma, Div Hand & Upper Limb Surg, Sao Paulo, Brazil; [Godin, Katelyn; Bhandari, Mohit] McMaster Univ, Dept Surg, Div Orthopaed Surg, Hamilton, ON L8S 4L8, Canada	Universidade Federal de Sao Paulo (UNIFESP); McMaster University	de Moraes, VY (corresponding author), Univ Fed Sao Paulo, Dept Orthopaed & Trauma, Div Hand & Upper Limb Surg, Sao Paulo, Brazil.	vymoraes@gmail.com	MORAES, VINICIUS y/P-3348-2015; Faloppa, Flavio/C-6012-2012; MORAES, VINICIUS Y/I-4057-2013; Tamaoki, Marcel Jun Sugawara/V-6047-2019; PPGCT, Ortop/ABC-3666-2021; Belloti, João Carlos/F-7164-2012; Bhandari, Mohit/AAQ-1675-2021; Tamaoki, Marcel Jun Sugawara/N-1925-2013	MORAES, VINICIUS y/0000-0002-4933-4007; Tamaoki, Marcel Jun Sugawara/0000-0002-9539-4545; Tamaoki, Marcel Jun Sugawara/0000-0002-9539-4545; Belloti, joao/0000-0002-1439-6064	Canada Research Chair; CAPES (Coordenadoria de Aperfeicoamento de Pessoal de Nivel Superior) - Sao Paulo, Brazil [11/21611-2]	Canada Research Chair(Natural Resources CanadaCanadian Forest ServiceCanada Research Chairs); CAPES (Coordenadoria de Aperfeicoamento de Pessoal de Nivel Superior) - Sao Paulo, Brazil	Dr. Bhandari is funded, in part, by a Canada Research Chair. Part of the funding for this study was provided by CAPES (Coordenadoria de Aperfeicoamento de Pessoal de Nivel Superior) - Sao Paulo, Brazil, Process number: 11/21611-2. No additional external funding received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson PA, 2009, SPINE, V34, P161, DOI 10.1097/BRS.0b013e31819286ea; Antoniou J, 2000, J BONE JOINT SURG AM, V82A, P1220, DOI 10.2106/00004623-200009000-00002; Asch HL, 2002, J NEUROSURG, V96, P34, DOI 10.3171/spi.2002.96.1.0034; Atlas SJ, 1996, SPINE, V21, P1777, DOI 10.1097/00007632-199608010-00011; Atlas SJ, 2010, SPINE, V35, P89, DOI 10.1097/BRS.0b013e3181c68047; Audige L, 2004, CLIN ORTHOP RELAT R, P249, DOI 10.1097/01.blo.0000137558.97346.fb; Balk ML, 2005, AM J ORTHOP BELLE ME, V34, p[122, 126]; Balyk R, 2008, CLIN ORTHOP RELAT R, V466, P3025, DOI 10.1007/s11999-008-0475-1; Barrett GR, 2001, ARTHROSCOPY, V17, P132, DOI 10.1053/jars.2001.21785; Bhandari M, 2009, J BONE JOINT SURG AM, V91A, P1, DOI 10.2106/JBJS.H.01747; Bhatia S, 2010, ARTHROSCOPY, V26, P1027, DOI 10.1016/j.arthro.2009.12.016; Brinker M R, 1998, Bull Hosp Jt Dis, V57, P80; Buckley R, 2002, J BONE JOINT SURG AM, V84A, P1733, DOI 10.2106/00004623-200210000-00001; Byrd JWT, 2000, ARTHROSCOPY, V16, P578, DOI 10.1053/jars.2000.7683; Cole DC, 2002, CAN MED ASSOC J, V166, P749; Cook DJ, 1997, ANN INTERN MED, V126, P376, DOI 10.7326/0003-4819-126-5-199703010-00006; Cowan J, 2012, J HAND SURG-AM, V37A, P18, DOI 10.1016/j.jhsa.2011.10.033; Day CS, 2010, J BONE JOINT SURG AM, V92A, P2294, DOI 10.2106/JBJS.I.00158; Day CS, 2010, CLIN ORTHOP RELAT R, V468, P1796, DOI 10.1007/s11999-009-1210-2; de Moraes VY, 2011, SAO PAULO MED J, V129, P94, DOI 10.1590/S1516-31802011000200007; DeBerard M Scott, 2003, Spine J, V3, P420, DOI 10.1016/S1529-9430(03)00116-5; Denard PJ, 2012, ARTHROSCOPY, V28, P451, DOI 10.1016/j.arthro.2011.09.005; DERSIMONIAN R, 1986, CONTROL CLIN TRIALS, V7, P177, DOI 10.1016/0197-2456(86)90046-2; Deutsch Harel, 2006, Neurosurg Focus, V20, pE10; Duncan SFM, 2010, J HAND SURG-ASIAN-PA, V15, P75, DOI 10.1142/S0218810410004655; DZIOBA RB, 1984, SPINE, V9, P614, DOI 10.1097/00007632-198409000-00013; Fadyl J, 2008, J OCCUP REHABIL, V18, P362, DOI 10.1007/s10926-008-9153-0; Fairbank JCT, 2000, SPINE, V25, P2940, DOI 10.1097/00007632-200011150-00017; Glowacki KA, 1997, J SHOULDER ELB SURG, V6, P89, DOI 10.1016/S1058-2746(97)90028-8; Gougoulias N, 2009, BRIT MED BULL, V92, P153, DOI 10.1093/bmb/ldp030; GREENOUGH CG, 1994, CLIN ORTHOP RELAT R, P30; Guyatt G, 2011, TOOL ASSESS RISK BIA; Harris I, 2005, JAMA-J AM MED ASSOC, V293, P1644, DOI 10.1001/jama.293.13.1644; Heckerling PS, 2006, J CLIN EPIDEMIOL, V59, P876, DOI 10.1016/j.jclinepi.2006.03.001; Henn F, 2008, J BONE JOINT SURG AM, V90A, P2105, DOI 10.2106/JBJS.F.00260; Hinkley BS, 1997, SPINE, V22, P312, DOI 10.1097/00007632-199702010-00016; Hinkley BS, 1997, SPINE, V22, P323; Hodges Scott D., 2001, Journal of the American Osteopathic Association, V101, P78; Holtby R, 2010, J SHOULDER ELB SURG, V19, P452, DOI 10.1016/j.jse.2009.06.011; Hoppe DJ, 2009, J BONE JOINT SURG AM, V91A, P2, DOI 10.2106/JBJS.H.01571; Hou WH, 2008, J REHABIL MED, V40, P440, DOI 10.2340/16501977-0194; Hudak PL, 1996, AM J IND MED, V29, P602, DOI 10.1002/(SICI)1097-0274(199606)29:6<602::AID-AJIM4>3.0.CO;2-L; Johannsen H V, 1997, Ugeskr Laeger, V159, P166; Kemp KAR, 2011, OCCUP MED-OXFORD, V61, P556, DOI 10.1093/occmed/kqr068; Koljonen P, 2009, INT ORTHOP, V33, P315, DOI 10.1007/s00264-007-0493-8; Liberati A, 2009, J CLIN EPIDEMIOL, V62, pe1; Lin SS, 2000, FOOT ANKLE INT, V21, P742, DOI 10.1177/107110070002100905; Macdonald GM, 2006, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001930.pub2; MACKAY MA, 1995, SPINE, V20, P1793, DOI 10.1097/00007632-199508150-00008; Manager(RevMan) R, 2011, COMP PROGR VERS 5 1; McKee MD, 2000, J BONE JOINT SURG AM, V82A, P970, DOI 10.2106/00004623-200007000-00009; Moraes VY, 2012, INFLUENCE PRESUMED C; NAGLE D, 1994, ARTHROSCOPY, V10, P259, DOI 10.1016/S0749-8063(05)80108-2; Nicholson GP, 2003, J BONE JOINT SURG AM, V85A, P682, DOI 10.2106/00004623-200304000-00015; Olney J R, 1999, Iowa Orthop J, V19, P111; Park MJ, 2011, ARTHROSCOPY, V27, P1335, DOI 10.1016/j.arthro.2011.06.021; Rosenberger RE, 2008, AM J SPORT MED, V36, P2336, DOI 10.1177/0363546508322888; Saleh K, 2004, J ARTHROPLASTY, V19, P310, DOI 10.1016/S0883-5403(03)00257-2; Schwartz CE, 2009, HEALTH QUAL LIFE OUT, V7, DOI 10.1186/1477-7525-7-49; Simunovic N, 2009, J BONE JOINT SURG AM, V91A, P87, DOI 10.2106/JBJS.H.01576; Spangehl MJ, 2002, J SHOULDER ELB SURG, V11, P101, DOI 10.1067/mse.2002.120915; Straub TA, 1999, ARTHROSCOPY, V15, P269, DOI 10.1016/S0749-8063(99)70033-2; Tunis SR, 2003, JAMA-J AM MED ASSOC, V290, P1624, DOI 10.1001/jama.290.12.1624; Watson EM, 2002, J SHOULDER ELB SURG, V11, P201, DOI 10.1067/mse.2002.122271; Westkaemper JG, 1998, ARTHROSCOPY, V14, P479, DOI 10.1016/S0749-8063(98)70075-1; Wexler G, 2000, ARTHROSCOPY, V16, P49, DOI 10.1016/S0749-8063(00)90127-0	66	44	45	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 5	2012	7	12							e50251	10.1371/journal.pone.0050251	http://dx.doi.org/10.1371/journal.pone.0050251			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	201YT	23227160	Green Published, gold			2022-12-27	WOS:000323179700005
J	O'Neale, DRJ; Hendy, SC				O'Neale, Dion R. J.; Hendy, Shaun C.			Power Law Distributions of Patents as Indicators of Innovation	PLOS ONE			English	Article							GROWTH; MODEL; SIZE; ZIPF	The total number of patents produced by a country (or the number of patents produced per capita) is often used as an indicator for innovation. Here we present evidence that the distribution of patents amongst applicants within many countries is well-described by power laws with exponents that vary between 1.66 (Japan) and 2.37 (Poland). We suggest that this exponent is a useful new metric for studying innovation. Using simulations based on simple preferential attachment-type rules that generate power laws, we find we can explain some of the variation in exponents between countries, with countries that have larger numbers of patents per applicant generally exhibiting smaller exponents in both the simulated and actual data. Similarly we find that the exponents for most countries are inversely correlated with other indicators of innovation, such as research and development intensity or the ubiquity of export baskets. This suggests that in more advanced economies, which tend to have smaller values of the exponent, a greater proportion of the total number of patents are filed by large companies than in less advanced countries. Citation: O'Neale DRJ, Hendy SC (2012) Power Law Distributions of Patents as Indicators of Innovation. PLoS ONE 7(12): e49501. doi:10.1371/journal.pone.0049501	[O'Neale, Dion R. J.; Hendy, Shaun C.] Ind Res Ltd, Appl Math Grp, Lower Hutt, New Zealand; [Hendy, Shaun C.] Victoria Univ Wellington, MacDiarmid Inst Adv Mat & Nanotechnol, Sch Chem & Phys Sci, Wellington, New Zealand	Callaghan Innovation; Victoria University Wellington	O'Neale, DRJ (corresponding author), Ind Res Ltd, Appl Math Grp, Lower Hutt, New Zealand.	d.oneale@irl.cri.nz	Hendy, Shaun/A-9776-2008	Hendy, Shaun/0000-0003-3468-6517; O'Neale, Dion/0000-0002-3827-3480				Acemoglu D., 2008, INTRO MODERN EC GROW; AGHION P, 1992, ECONOMETRICA, V60, P323, DOI 10.2307/2951599; Arbesman S, 2009, PHYS REV E, V79, DOI 10.1103/PhysRevE.79.016115; Axtell RL, 2001, SCIENCE, V293, P1818, DOI 10.1126/science.1062081; Bettencourt LMA, 2007, P NATL ACAD SCI USA, V104, P7301, DOI 10.1073/pnas.0610172104; Bettencourt LMA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013541; Blundell R, 1999, REV ECON STUD, V66, P529, DOI 10.1111/1467-937X.00097; Clauset A, 2009, SIAM REV, V51, P661, DOI 10.1137/070710111; Fujiwara Y, 2004, PHYSICA A, V335, P197, DOI 10.1016/j.physa.2003.12.015; Ghiglino C, 2012, J ECON THEORY, V147, P713, DOI 10.1016/j.jet.2011.02.004; GLAESER EL, 1992, J POLIT ECON, V100, P1126, DOI 10.1086/261856; Goldstein ML, 2005, PHYS REV E, V71, DOI 10.1103/PhysRevE.71.026108; Hendy SC, 2011, NZ SCI REV, V68, P1; Hidalgo CA, 2009, P NATL ACAD SCI USA, V106, P10570, DOI 10.1073/pnas.0900943106; JAFFE AB, 1993, Q J ECON, V108, P577, DOI 10.2307/2118401; Jones CI, 2005, Q J ECON, V120, P517, DOI 10.1162/0033553053970142; Lanjouw JO, 1998, J IND ECON, V46, P405, DOI 10.1111/1467-6451.00081; Luttmer EGJ, 2007, Q J ECON, V122, P1103, DOI 10.1162/qjec.122.3.1103; Luttmer EGJ, 2011, REV ECON STUD, V78, P1042, DOI 10.1093/restud/rdq028; Marshall A., 1890, PRINCIPLES EC; Mitzenmacher M., 2003, INTERNET MATH, V2, P226, DOI [10.1080/15427951.2004.10129088, DOI 10.1080/15427951.2004.10129088]; Newman MEJ, 2005, CONTEMP PHYS, V46, P323, DOI 10.1080/00107510500052444; OECD, 2006, OECD SCI TECHN IND O; Okuyama K, 1999, PHYSICA A, V269, P125, DOI 10.1016/S0378-4371(99)00086-2; ROMER PM, 1990, J POLIT ECON, V98, pS71, DOI 10.1086/261725; SCHERER FM, 1965, AM ECON REV, V55, P1097; SIMON HA, 1955, BIOMETRIKA, V42, P425; Tibshirani R.J., 1993, MONOGRAPHS STAT APPL, VVolume 57, P1; TRAJTENBERG M, 1990, RAND J ECON, V21, P172, DOI 10.2307/2555502; West GB, 1997, SCIENCE, V276, P122, DOI 10.1126/science.276.5309.122; YULE GD, 1925, PHYL T ROYAL SOC L B, P213	31	11	11	2	58	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 5	2012	7	12							e49501	10.1371/journal.pone.0049501	http://dx.doi.org/10.1371/journal.pone.0049501			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	057TZ	23227144	Green Submitted, Green Published, gold			2022-12-27	WOS:000312588200007
J	Moser, D; Roesti, M; Berner, D				Moser, Dario; Roesti, Marius; Berner, Daniel			Repeated Lake-Stream Divergence in Stickleback Life History within a Central European Lake Basin	PLOS ONE			English	Article							GASTEROSTEUS-ACULEATUS; THREESPINE STICKLEBACK; ECOLOGICAL SPECIATION; 3-SPINED STICKLEBACK; PARALLEL EVOLUTION; REPRODUCTIVE ISOLATION; GENETIC-DIVERGENCE; SEXUAL SELECTION; ALLOCHRONIC SPECIATION; LABORATORY EXPERIMENTS	Life history divergence between populations inhabiting ecologically distinct habitats might be a potent source of reproductive isolation, but has received little attention in the context of speciation. We here test for life history divergence between threespine stickleback inhabiting Lake Constance (Central Europe) and multiple tributary streams. Otolith analysis shows that lake fish generally reproduce at two years of age, while their conspecifics in all streams have shifted to a primarily annual life cycle. This divergence is paralleled by a striking and consistent reduction in body size and fecundity in stream fish relative to lake fish. Stomach content analysis suggests that life history divergence might reflect a genetic or plastic response to pelagic versus benthic foraging modes in the lake and the streams. Microsatellite and mitochondrial markers further reveal that life history shifts in the different streams have occurred independently following the colonization by Lake Constance stickleback, and indicate the presence of strong barriers to gene flow across at least some of the lake-stream habitat transitions. Given that body size is known to strongly influence stickleback mating behavior, these barriers might well be related to life history divergence. Citation: Moser D, Roesti M, Berner D (2012) Repeated Lake-Stream Divergence in Stickleback Life History within a Central European Lake Basin. PLoS ONE 7(12): e50620. doi:10.1371/journal.pone.0050620	[Moser, Dario; Roesti, Marius; Berner, Daniel] Univ Basel, Inst Zool, Basel, Switzerland	University of Basel	Berner, D (corresponding author), Univ Basel, Inst Zool, Vesalgasse 1, Basel, Switzerland.	daniel.berner@unibas.ch	Berner, Daniel/C-3461-2014		Swiss National Science Foundation (Ambizione) [PZ00P3_126391/1]; Research Fund of the University of Basel; Swiss National Science Foundation Sinergia grant [CRSII3_136293]	Swiss National Science Foundation (Ambizione)(Swiss National Science Foundation (SNSF)); Research Fund of the University of Basel; Swiss National Science Foundation Sinergia grant(Swiss National Science Foundation (SNSF))	This work was supported by grants from the Swiss National Science Foundation (Ambizione PZ00P3_126391/1) and the Research Fund of the University of Basel to DB. MR was supported by a Swiss National Science Foundation Sinergia grant (CRSII3_136293) to Walter Salzburger. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbot P, 2004, EVOLUTION, V58, P539, DOI 10.1111/j.0014-3820.2004.tb01677.x; Aguirre WE, 2009, BIOL J LINN SOC, V98, P139, DOI 10.1111/j.1095-8312.2009.01267.x; Albert AYK, 2005, EVOLUTION, V59, P927; Andersson Malte, 1994; Baggerman B., 1972, General and Comparative Endocrinology, V3, P466, DOI 10.1016/0016-6480(72)90177-3; Baker JA, 2011, J EVOLUTION BIOL, V24, P863, DOI 10.1111/j.1420-9101.2010.02217.x; Baker JA, 2005, EVOL ECOL RES, V7, P121; Baker JA, 1998, BIOL J LINN SOC, V63, P141, DOI 10.1111/j.1095-8312.1998.tb01643.x; Barluenga M, 2006, NATURE, V439, P719, DOI 10.1038/nature04325; Barrett RDH, 2009, EVOLUTION, V63, P2831, DOI 10.1111/j.1558-5646.2009.00762.x; Behrmann-Godel J, 2004, MOL ECOL, V13, P491, DOI 10.1046/j.1365-294X.2003.02082.x; Belkhir K, 2004, 5171 CNRS UMR LAB GE; Bell M.A., 1994, EVOLUTIONARY BIOL TH; BENTZEN P, 1984, CAN J ZOOL, V62, P2436, DOI 10.1139/z84-359; Bernardo J, 1996, AM ZOOL, V36, P216; BERNARDO J, 1993, TRENDS ECOL EVOL, V8, P166, DOI 10.1016/0169-5347(93)90142-C; Berner D, 2008, J EVOLUTION BIOL, V21, P1653, DOI 10.1111/j.1420-9101.2008.01583.x; Berner D, 2007, FUNCT ECOL, V21, P505, DOI 10.1111/j.1365-2435.2007.01253.x; Berner D, 2011, J EVOLUTION BIOL, V24, P1975, DOI 10.1111/j.1420-9101.2011.02330.x; Berner D, 2010, MOL ECOL, V19, P4963, DOI 10.1111/j.1365-294X.2010.04858.x; Berner D, 2010, EVOLUTION, V64, P2265, DOI 10.1111/j.1558-5646.2010.00982.x; Berner D, 2009, EVOLUTION, V63, P1740, DOI 10.1111/j.1558-5646.2009.00665.x; Bonduriansky R, 2011, AM NAT, V178, P729, DOI 10.1086/662665; Boughman JW, 2005, EVOLUTION, V59, P361; Colosimo PF, 2005, SCIENCE, V307, P1928, DOI 10.1126/science.1107239; Coombs JA, 2008, MOL ECOL RESOUR, V8, P578, DOI 10.1111/j.1471-8286.2007.02036.x; Coyne J.A., 2004, SPECIATION; Craig-Bennett A, 1931, PHILOS T R SOC LON B, V219, P197, DOI 10.1098/rstb.1931.0005; Deagle BE, 2012, P ROY SOC B-BIOL SCI, V279, P1277, DOI 10.1098/rspb.2011.1552; Dufresne F, 1990, BEHAV ECOL, V1, P140, DOI 10.1093/beheco/1.2.140; Earl DA, 2012, CONSERV GENET RESOUR, V4, P359, DOI 10.1007/s12686-011-9548-7; Endler J.A., 1977, Monographs in Population Biology, pi; Evanno G, 2005, MOL ECOL, V14, P2611, DOI 10.1111/j.1365-294X.2005.02553.x; Feder JL, 1997, P NATL ACAD SCI USA, V94, P11417, DOI 10.1073/pnas.94.21.11417; FELSENSTEIN J, 1981, J MOL EVOL, V17, P368, DOI 10.1007/BF01734359; Foster SA, 2007, NEW PHYTOL, V175, P370, DOI 10.1111/j.1469-8137.2007.02077.x; Friesen VL, 2007, P NATL ACAD SCI USA, V104, P18589, DOI 10.1073/pnas.0700446104; Gambling SJ, 2012, CAN J ZOOL, V90, P284, DOI 10.1139/Z11-133; Gavrilets S, 2000, EVOLUTION, V54, P1126; Gavrilets S, 2004, FITNESS LANDSCAPES O; Gelmond O, 2009, J FISH BIOL, V75, P2037, DOI 10.1111/j.1095-8649.2009.02417.x; Grahame JW, 2006, EVOLUTION, V60, P268; GROSS HP, 1984, COPEIA, P87; HAGEN DW, 1967, J FISH RES BOARD CAN, V24, P1637, DOI 10.1139/f67-138; HAGEN DW, 1972, EVOLUTION, V26, P32, DOI 10.1111/j.1558-5646.1972.tb00172.x; Hedrick PW, 2005, EVOLUTION, V59, P1633, DOI 10.1111/j.0014-3820.2005.tb01814.x; HELLER C, 1871, Z FERDINANDEUMS TIRO, V16, P295; Hendry AP, 2009, J FISH BIOL, V75, P2000, DOI 10.1111/j.1095-8649.2009.02419.x; Hendry AP, 2002, EVOLUTION, V56, P1199; Hendry AP, 2004, EVOL ECOL RES, V6, P1219; Hendry AP, 2004, EVOLUTION, V58, P2319; Herczeg G, 2009, EVOLUTION, V63, P3190, DOI 10.1111/j.1558-5646.2009.00781.x; Hotzl H, 1996, ENVIRON GEOL, V27, P87; HOULE D, 1992, GENETICS, V130, P195; Hubisz MJ, 2009, MOL ECOL RESOUR, V9, P1322, DOI 10.1111/j.1755-0998.2009.02591.x; Ishikawa M, 2000, BEHAVIOUR, V137, P1065, DOI 10.1163/156853900502439; JONES JW, 1950, J ANIM ECOL, V19, P59, DOI 10.2307/1571; Kaeuffer R, 2012, EVOLUTION, V66, P402, DOI 10.1111/j.1558-5646.2011.01440.x; Kalinowski ST, 2011, HEREDITY, V106, P625, DOI 10.1038/hdy.2010.95; Keller O., 2000, BERICHTE GALLISCHEN, V89, P39; Kitano J, 2009, NATURE, V461, P1079, DOI 10.1038/nature08441; LAVIN PA, 1993, CAN J ZOOL, V71, P11, DOI 10.1139/z93-003; Leinonen T, 2011, HEREDITY, V106, P218, DOI 10.1038/hdy.2010.104; Lu GQ, 1999, EVOLUTION, V53, P1491, DOI 10.1111/j.1558-5646.1999.tb05413.x; Lucek K, 2010, MOL ECOL, V19, P3995, DOI 10.1111/j.1365-294X.2010.04781.x; Maan ME, 2011, ECOL LETT, V14, P591, DOI 10.1111/j.1461-0248.2011.01606.x; Makinen HS, 2006, MOL ECOL, V15, P1519, DOI 10.1111/j.1365-294X.2006.02871.x; Manly B.F.J, 2007, RANDOMIZATION BOOTST, DOI DOI 10.1201/9780429329203; McKinnon JS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037951; McKinnon JS, 2004, NATURE, V429, P294, DOI 10.1038/nature02556; MCPHAIL JD, 1977, HEREDITY, V38, P53, DOI 10.1038/hdy.1977.7; Meirmans PG, 2006, EVOLUTION, V60, P2399, DOI 10.1111/j.0014-3820.2006.tb01874.x; MOODIE GEE, 1976, SYST ZOOL, V25, P49, DOI 10.2307/2412778; Nagel L, 1998, EVOLUTION, V52, P209, DOI 10.1111/j.1558-5646.1998.tb05154.x; Nosil P, 2005, EVOLUTION, V59, P705; Nosil P, 2007, AM NAT, V169, P151, DOI 10.1086/510634; Ogden R, 2002, P NATL ACAD SCI USA, V99, P13612, DOI 10.1073/pnas.212248499; PARKER GA, 1986, AM NAT, V128, P573, DOI 10.1086/284589; Peichel CL, 2001, NATURE, V414, P901, DOI 10.1038/414901a; Posada D, 2008, MOL BIOL EVOL, V25, P1253, DOI 10.1093/molbev/msn083; PRICE T, 1991, EVOLUTION, V45, P853, DOI 10.1111/j.1558-5646.1991.tb04354.x; Pritchard JK, 2000, GENETICS, V155, P945; Pritchard JK, 2004, DOCUMENTATION STRUCT; R Development Core Team, 2012, R LANG ENV STAT COMP; Raeymaekers JAM, 2010, J EVOLUTION BIOL, V23, P2694, DOI 10.1111/j.1420-9101.2010.02133.x; Raeymaekers JAM, 2007, MOL ECOL, V16, P891, DOI 10.1111/j.1365-294X.2006.03190.x; Ramsey J, 2003, EVOLUTION, V57, P1520, DOI 10.1111/j.0014-3820.2003.tb00360.x; REIMCHEN TE, 1992, CAN FIELD NAT, V106, P122; REIMCHEN TE, 1985, CAN J ZOOL, V63, P2944, DOI 10.1139/z85-441; Reimchen Thomas E., 1994, P240; Reusch TBH, 2001, MOL ECOL, V10, P2435, DOI 10.1046/j.0962-1083.2001.01366.x; RICE WR, 1993, EVOLUTION, V47, P1637, DOI [10.2307/2410209, 10.1111/j.1558-5646.1993.tb01257.x]; Ritchie MG, 2007, ANNU REV ECOL EVOL S, V38, P79, DOI 10.1146/annurev.ecolsys.38.091206.095733; ROBINSON BW, 1994, AM NAT, V144, P596, DOI 10.1086/285696; Roesti M, 2012, BMC EVOL BIOL, V12, DOI 10.1186/1471-2148-12-94; Roesti M, 2012, MOL ECOL, V21, P2852, DOI 10.1111/j.1365-294X.2012.05509.x; Roff Derek, 2002, pi; Rohlf F. J., 2001, TPSDIG TPSRELW TPSRE; Rosenblum EB, 2011, EVOLUTION, V65, P946, DOI 10.1111/j.1558-5646.2010.01190.x; Rundle HD, 2005, ECOL LETT, V8, P336, DOI 10.1111/j.1461-0248.2004.00715.x; Salzburger W, 2011, MOL ECOL, V20, P1952, DOI 10.1111/j.1365-294X.2011.05066.x; Santos H, 2011, J EVOLUTION BIOL, V24, P146, DOI 10.1111/j.1420-9101.2010.02147.x; SCHLUTER D, 1995, ECOLOGY, V76, P82, DOI 10.2307/1940633; Schluter D., 2000, ECOLOGY ADAPTIVE RAD; Seehausen O, 2008, NATURE, V455, P620, DOI 10.1038/nature07285; Sharpe DMT, 2008, EVOL ECOL RES, V10, P849; Shimada Y, 2011, PLOS ONE, V6; Smith TB, 1997, SCIENCE, V276, P1855, DOI 10.1126/science.276.5320.1855; SNYDER RJ, 1991, COPEIA, P526; Sobel JM, 2010, EVOLUTION, V64, P295, DOI 10.1111/j.1558-5646.2009.00877.x; Stearns S.C., 1992, pi; Swofford D.L, 1998, PAUP 4 0 PHYLOGENETI; Taylor EB, 2012, EVOLUTION, V66, P240, DOI 10.1111/j.1558-5646.2011.01439.x; Thibert-Plante X, 2011, J EVOLUTION BIOL, V24, P326, DOI 10.1111/j.1420-9101.2010.02169.x; Thibert-Plante X, 2010, MOL ECOL, V19, P2301, DOI 10.1111/j.1365-294X.2010.04641.x; Thompson CE, 1997, EVOLUTION, V51, P1955, DOI 10.1111/j.1558-5646.1997.tb05117.x; WEIR BS, 1984, EVOLUTION, V38, P1358, DOI 10.1111/j.1558-5646.1984.tb05657.x; West-Eberhard Mary Jane, 2003, pi; Wu CI, 2001, J EVOLUTION BIOL, V14, P851, DOI 10.1046/j.1420-9101.2001.00335.x	119	39	39	2	58	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 4	2012	7	12							e50620	10.1371/journal.pone.0050620	http://dx.doi.org/10.1371/journal.pone.0050620			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	051EQ	23226528	gold, Green Published, Green Accepted			2022-12-27	WOS:000312108500021
J	Parnas, A; Nisemblat, S; Weiss, C; Levy-Rimler, G; Pri-Or, A; Zor, T; Lund, PA; Bross, P; Azem, A				Parnas, Avital; Nisemblat, Shahar; Weiss, Celeste; Levy-Rimler, Galit; Pri-Or, Amir; Zor, Tsaffrir; Lund, Peter A.; Bross, Peter; Azem, Abdussalam			Identification of Elements That Dictate the Specificity of Mitochondrial Hsp60 for Its Co-Chaperonin	PLOS ONE			English	Article							HEREDITARY SPASTIC PARAPLEGIA; ESCHERICHIA-COLI; CRYSTAL-STRUCTURE; IN-VIVO; YEAST MITOCHONDRIA; ATP HYDROLYSIS; MOBILE LOOP; SINGLE-RING; HSPD1 GENE; PROTEIN	Type I chaperonins (cpn60/Hsp60) are essential proteins that mediate the folding of proteins in bacteria, chloroplast and mitochondria. Despite the high sequence homology among chaperonins, the mitochondrial chaperonin system has developed unique properties that distinguish it from the widely-studied bacterial system (GroEL and GroES). The most relevant difference to this study is that mitochondrial chaperonins are able to refold denatured proteins only with the assistance of the mitochondrial co-chaperonin. This is in contrast to the bacterial chaperonin, which is able to function with the help of co-chaperonin from any source. The goal of our work was to determine structural elements that govern the specificity between chaperonin and co-chaperonin pairs using mitochondrial Hsp60 as model system. We used a mutagenesis approach to obtain human mitochondrial Hsp60 mutants that are able to function with the bacterial co-chaperonin, GroES. We isolated two mutants, a single mutant (E321K) and a double mutant (R264K/E358K) that, together with GroES, were able to rescue an E. coli strain, in which the endogenous chaperonin system was silenced. Although the mutations are located in the apical domain of the chaperonin, where the interaction with co-chaperonin takes place, none of the residues are located in positions that are directly responsible for co-chaperonin binding. Moreover, while both mutants were able to function with GroES, they showed distinct functional and structural properties. Our results indicate that the phenotype of the E321K mutant is caused mainly by a profound increase in the binding affinity to all co-chaperonins, while the phenotype of R264K/E358K is caused by a slight increase in affinity toward co-chaperonins that is accompanied by an alteration in the allosteric signal transmitted upon nucleotide binding. The latter changes lead to a great increase in affinity for GroES, with only a minor increase in affinity toward the mammalian mitochondrial co-chaperonin. Citation: Parnas A, Nisemblat S, Weiss C, Levy-Rimler G, Pri-Or A, et al. (2012) Identification of Elements That Dictate the Specificity of Mitochondrial Hsp60 for Its Co-Chaperonin. PLoS ONE 7(12): e50318. doi:10.1371/journal.pone.0050318	[Parnas, Avital; Nisemblat, Shahar; Weiss, Celeste; Levy-Rimler, Galit; Pri-Or, Amir; Zor, Tsaffrir; Azem, Abdussalam] Tel Aviv Univ, Dept Biochem & Mol Biol, IL-69978 Tel Aviv, Israel; [Lund, Peter A.] Univ Birmingham, Sch Biosci, Birmingham, W Midlands, England; [Bross, Peter] Aarhus Univ Hosp, Res Unit Mol Med, DK-8000 Aarhus, Denmark	Tel Aviv University; University of Birmingham; Aarhus University	Azem, A (corresponding author), Tel Aviv Univ, Dept Biochem & Mol Biol, IL-69978 Tel Aviv, Israel.	azema@tauex.tau.ac.il	lund, peter a/N-9785-2018; Bross, Peter/B-7219-2013; Zor, Tsaffrir/H-1802-2013	Bross, Peter/0000-0001-9526-8525; Zor, Tsaffrir/0000-0002-7224-3939; Lund, Peter/0000-0002-6381-8526	Legacy Heritage Bio-medical Program of the Israel Science Foundation [1902/08]; Eshkol Fellowship from the Israeli Ministry of Science	Legacy Heritage Bio-medical Program of the Israel Science Foundation; Eshkol Fellowship from the Israeli Ministry of Science	This work is supported by the Legacy Heritage Bio-medical Program of the Israel Science Foundation (grant No. 1902/08) and by an Eshkol Fellowship from the Israeli Ministry of Science (to AP). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AZEM A, 1994, SCIENCE, V265, P653, DOI 10.1126/science.7913553; Azem A, 1995, P NATL ACAD SCI USA, V92, P12021, DOI 10.1073/pnas.92.26.12021; Bonshtien AL, 2007, J BIOL CHEM, V282, P4463, DOI 10.1074/jbc.M606433200; Bonshtien AL, 2009, CELL STRESS CHAPERON, V14, P509, DOI 10.1007/s12192-009-0104-2; BRAIG K, 1994, NATURE, V371, P578, DOI 10.1038/371578a0; Brocchieri L, 2000, PROTEIN SCI, V9, P476; Campanella C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042008; Cappello F, 2005, BMC CANCER, V5, DOI 10.1186/1471-2407-5-139; Cappello F, 2007, CANCER BIOL THER, V6, P487, DOI 10.4161/cbt.6.4.4087; CHANDRASEKHAR GN, 1986, J BIOL CHEM, V261, P2414; CHEN S, 1994, NATURE, V371, P261, DOI 10.1038/371261a0; CHENG MY, 1989, NATURE, V337, P620, DOI 10.1038/337620a0; Christensen JH, 2010, CELL STRESS CHAPERON, V15, P851, DOI 10.1007/s12192-010-0194-x; Chun JN, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009422; Deocaris CC, 2006, CELL STRESS CHAPERON, V11, P116, DOI 10.1379/CSC-144R.1; Dickson R, 2000, J BIOL CHEM, V275, P11829, DOI 10.1074/jbc.275.16.11829; FENTON WA, 1994, NATURE, V371, P614, DOI 10.1038/371614a0; Gevorkyan-Airapetov L, 2009, J BIOL CHEM, V284, P4865, DOI 10.1074/jbc.M807041200; Grason JP, 2008, P NATL ACAD SCI USA, V105, P17334, DOI 10.1073/pnas.0807429105; HALLBERG EM, 1993, MOL CELL BIOL, V13, P3050, DOI 10.1128/MCB.13.5.3050; Hansen J, 2007, J NEUROL, V254, P897, DOI 10.1007/s00415-006-0470-y; Hansen JJ, 2002, AM J HUM GENET, V70, P1328, DOI 10.1086/339935; Hartl FU, 2009, NAT STRUCT MOL BIOL, V16, P574, DOI 10.1038/nsmb.1591; Hartl FU, 1996, NATURE, V381, P571, DOI 10.1038/381571a0; Hayoun D, 2012, FEBS J, V279, P2083, DOI 10.1111/j.1742-4658.2012.08594.x; HOHFELD J, 1994, J CELL BIOL, V126, P305, DOI 10.1083/jcb.126.2.305; Horovitz A, 1998, CURR OPIN STRUC BIOL, V8, P93, DOI 10.1016/S0959-440X(98)80015-8; Horovitz A, 2001, J STRUCT BIOL, V135, P104, DOI 10.1006/jsbi.2001.4377; Horwich AL, 2006, CHEM REV, V106, P1917, DOI 10.1021/cr040435v; Hunt JF, 1996, NATURE, V379, P37, DOI 10.1038/379037a0; Hyeon C, 2006, P NATL ACAD SCI USA, V103, P18939, DOI 10.1073/pnas.0608759103; Johnson BJ, 2005, J BIOL CHEM, V280, P4037, DOI 10.1074/jbc.M411569200; Kass I, 2002, PROTEINS, V48, P611, DOI 10.1002/prot.10180; Klein G, 2001, GENETICS, V158, P507; Knowlton A A, 2003, Cardiovasc Toxicol, V3, P263, DOI 10.1385/CT:3:3:263; LANDRY SJ, 1993, NATURE, V364, P255, DOI 10.1038/364255a0; Landry SJ, 1996, P NATL ACAD SCI USA, V93, P11622, DOI 10.1073/pnas.93.21.11622; LANGER T, 1992, EMBO J, V11, P4757, DOI 10.1002/j.1460-2075.1992.tb05581.x; Levy-Rimler G, 2002, FEBS LETT, V529, P1, DOI 10.1016/S0014-5793(02)03178-2; Levy-Rimler G, 2001, EUR J BIOCHEM, V268, P3465, DOI 10.1046/j.1432-1327.2001.02243.x; Lorimer GH, 2001, PLANT PHYSIOL, V125, P38, DOI 10.1104/pp.125.1.38; Ma JP, 2000, J MOL BIOL, V302, P303, DOI 10.1006/jmbi.2000.4014; Magen D, 2008, AM J HUM GENET, V83, P30, DOI 10.1016/j.ajhg.2008.05.016; Mande SC, 1996, SCIENCE, V271, P203, DOI 10.1126/science.271.5246.203; Marom M, 2011, J BIOL CHEM, V286, P43809, DOI 10.1074/jbc.M111.261040; MARTIN J, 1992, SCIENCE, V258, P995, DOI 10.1126/science.1359644; McLennan N, 1998, NATURE, V392, P139, DOI 10.1038/32317; Merendino AM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009247; Nielsen KL, 1998, MOL CELL, V2, P93, DOI 10.1016/S1097-2765(00)80117-3; Nielsen KL, 1999, J BACTERIOL, V181, P5871, DOI 10.1128/JB.181.18.5871-5875.1999; Osterloh A, 2004, J BIOL CHEM, V279, P47906, DOI 10.1074/jbc.M408440200; OSTERMANN J, 1989, NATURE, V341, P125, DOI 10.1038/341125a0; Parnas A, 2009, J BIOL CHEM, V284, P28198, DOI 10.1074/jbc.M109.031997; Richardson A, 2001, J BIOL CHEM, V276, P4981, DOI 10.1074/jbc.M008628200; Rye HS, 1999, CELL, V97, P325, DOI 10.1016/S0092-8674(00)80742-4; Rye HS, 1997, NATURE, V388, P792, DOI 10.1038/42047; Saibil HR, 2002, TRENDS BIOCHEM SCI, V27, P627, DOI 10.1016/S0968-0004(02)02211-9; SCHMIDT M, 1994, SCIENCE, V265, P656, DOI 10.1126/science.7913554; Shewmaker F, 2004, PROTEIN SCI, V13, P2139, DOI 10.1110/ps.04773204; Sigler PB, 1998, ANNU REV BIOCHEM, V67, P581, DOI 10.1146/annurev.biochem.67.1.581; Sun Z, 2003, J MOL BIOL, V332, P715, DOI 10.1016/S0022-2836(03)00830-1; Tehver R, 2009, J MOL BIOL, V387, P390, DOI 10.1016/j.jmb.2008.12.032; TODD MJ, 1994, SCIENCE, V265, P659, DOI 10.1126/science.7913555; TODD MJ, 1993, BIOCHEMISTRY-US, V32, P8560, DOI 10.1021/bi00084a024; Truscott KN, 2010, BIOCHEM CELL BIOL, V88, P97, DOI [10.1139/O09-167, 10.1139/o09-167]; Viitanen PV, 1998, METHOD ENZYMOL, V290, P203, DOI 10.1016/S0076-6879(98)90020-9; VIITANEN PV, 1992, J BIOL CHEM, V267, P695; VIITANEN PV, 1995, J BIOL CHEM, V270, P18158, DOI 10.1074/jbc.270.30.18158; Vitlin A, 2011, PLANT MOL BIOL, V77, P105, DOI 10.1007/s11103-011-9797-6; Xanthoudakis S, 1999, EMBO J, V18, P2049, DOI 10.1093/emboj/18.8.2049; Xu ZH, 1997, NATURE, V388, P741, DOI 10.1038/41944	71	30	30	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 4	2012	7	12							e50318	10.1371/journal.pone.0050318	http://dx.doi.org/10.1371/journal.pone.0050318			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	051EQ	23226518	Green Published, gold			2022-12-27	WOS:000312108500015
J	Zhu, HH; Guo, JH; Chen, MB; Feng, GD; Yao, Q				Zhu, Honghui; Guo, Jianhua; Chen, Meibiao; Feng, Guangda; Yao, Qing			Burkholderia dabaoshanensis sp nov., a Heavy-Metal-Tolerant Bacteria Isolated from Dabaoshan Mining Area Soil in China	PLOS ONE			English	Article							SEQUENCE ALIGNMENT; CONTAMINATION; RESISTANCE; BRAZIL; WASTE; SITES; ORE	Heavy-metal-tolerant bacteria, GIMN1.004(T), was isolated from mine soils of Dabaoshan in South China, which were acidic (pH 2-4) and polluted with heavy metals. The isolation was Gram-negative, aerobic, non-spore-forming, and rod-shaped bacteria having a cellular width of 0.5-0.6 mu m and a length of 1.3-1.8 mu m. They showed a normal growth pattern at pH 4.0-9.0 in a temperature ranging from 5 degrees C to 40 degrees C. The organism contained ubiquinone Q-8 as the predominant isoprenoid quinine, and C-16:0, summed feature 8 (C-18:1 omega 7c and C-18:1 omega 6c), C-18:0, summed feature 3 (C-16:1 omega 7c or iso-C-15:0 2-OH), C-17:0 cyclo, C-18:1 omega 9c, C-19:0 cyclo omega 8c, C-14:0 as major fatty acid. These profiles were similar to those reported for Burkholderia species. The DNA G+C % of this strain was 61.6%. Based on the similarity to 16S rRNA gene sequence, GIMN1.004(T) was considered to be in the genus Burkholderia. The similarities of 16S rRNA gene sequence between strain GIMN1.004(T) and members of the genus Burkholderia were 96-99.4%, indicating that this novel strain was phylogenetically related to members of that genus. The novel strain showed the highest sequence similarities to Burkholderia soli DSM 18235(T) (99.4%); Levels of DNA-DNA hybridization with DSM 18235(T) was 25%. Physiological and biochemical tests including cell wall composition analysis, differentiated phenotype of this strain from that closely related Burkholderia species. The isolation had great tolerance to cadmium with MIC of 22 mmol/L, and adsorbability of 144.94 mg/g cadmium, and it was found to exhibit antibiotic resistance characteristics. The adsorptive mechanism of GIMN1.004(T) for cadmium depended on the action of the amide, carboxy and phosphate of cell surface and producing low-molecular-weight (LMW) organic acids to complex or chelated Cd2+. Therefore, the strain GIMN1.004(T) represented a new cadmium resistance species, which was tentatively named as Burkholderia dabaoshanensis sp. nov. The strain type is GIMN1.004(T) ( = CCTCC M 209109(T) = NRRL B-59553(T)). Citation: Zhu H, Guo J, Chen M, Feng G, Yao Q (2012) Burkholderia dabaoshanensis sp. nov., a Heavy-Metal-Tolerant Bacteria Isolated from Dabaoshan Mining Area Soil in China. PLoS ONE 7(12): e50225. doi:10.1371/journal.pone.0050225	[Zhu, Honghui; Guo, Jianhua; Chen, Meibiao; Feng, Guangda] Guangdong Inst Microbiol, Guangdong Prov Microbial Culture Collect & Applic, Guangdong Open Lab Appl Microbiol, State Key Lab Appl Microbiol,Minist Guangdong Pro, Guangzhou, Guangdong, Peoples R China; [Yao, Qing] S China Agr Univ, Guangzhou, Guangdong, Peoples R China	Guangdong Academy of Sciences; Institute of Microbiology, Guangdong Academy of Sciences; South China Agricultural University	Zhu, HH (corresponding author), Guangdong Inst Microbiol, Guangdong Prov Microbial Culture Collect & Applic, Guangdong Open Lab Appl Microbiol, State Key Lab Appl Microbiol,Minist Guangdong Pro, Guangzhou, Guangdong, Peoples R China.	zhuhonghui66@yahoo.com.cn	Zhu, Honghui/N-2251-2015; YAO, Qing/B-3206-2009; guo, yanbiao/G-9892-2012; Feng, Guang-Da/N-4058-2019	YAO, Qing/0000-0003-3449-6166; Feng, Guang-Da/0000-0002-2517-538X; ZHU, Honghui/0000-0001-6854-8417	Natural Science Foundation of China, People's Republic of China [31070103]; Key Project of Guangdong Natural Science Foundation [10251007002000001]	Natural Science Foundation of China, People's Republic of China(National Natural Science Foundation of China (NSFC)); Key Project of Guangdong Natural Science Foundation	This work was supported by Natural Science Foundation of China, People's Republic of China (project number 31070103) and Key Project of Guangdong Natural Science Foundation (10251007002000001). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aleem A, 2003, BIORESOURCE TECHNOL, V86, P7, DOI 10.1016/S0960-8524(02)00134-7; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Bakermans C, 2002, MICROB ECOL, V44, P107, DOI 10.1007/s00248-002-3011-y; Bramer CO, 2001, INT J SYST EVOL MICR, V51, P1709, DOI 10.1099/00207713-51-5-1709; Coenye T, 2003, ENVIRON MICROBIOL, V5, P719, DOI 10.1046/j.1462-2920.2003.00471.x; Dudka S, 1997, J ENVIRON QUAL, V26, P590, DOI 10.2134/jeq1997.00472425002600030003x; EZAKI T, 1988, J CLIN MICROBIOL, V26, P1708, DOI 10.1128/JCM.26.9.1708-1713.1988; Fujimaki H, 2000, TOXICOL LETT, V115, P99, DOI 10.1016/S0378-4274(00)00178-8; Kachenko A, 2006, WATER AIR SOIL POLL, V169, P101, DOI 10.1007/s11270-006-2027-1; Kamnev AA, 1999, J MOL STRUCT, V481, P387, DOI 10.1016/S0022-2860(98)00712-1; Kratochvil D, 1998, TRENDS BIOTECHNOL, V16, P291, DOI 10.1016/S0167-7799(98)01218-9; Kumar S, 2004, BRIEF BIOINFORM, V5, P150, DOI 10.1093/bib/5.2.150; Lane D.J., 1991, NUCL ACID TECH BACT, P115, DOI DOI 10.1007/S00227-012-2133-0; MESBAH M, 1989, INT J SYST BACTERIOL, V39, P159, DOI 10.1099/00207713-39-2-159; MOORE DD, 1995, CURRENT PROTOCOLS MO, P2; Navarro MC, 2008, J GEOCHEM EXPLOR, V96, P183, DOI 10.1016/j.gexplo.2007.04.011; O'Sullivan LA, 2005, LETT APPL MICROBIOL, V41, P8, DOI 10.1111/j.1472-765X.2005.01758.x; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; Sasser M, 1990, 101 MIDI; SILONIZ M, 2002, RES MICROBIOL, V153, P173; Smibert Robert M., 1994, P607; SUMMERS AO, 1972, J BACTERIOL, V112, P1228, DOI 10.1128/JB.112.3.1228-1236.1972; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; Valverde A, 2006, INT J SYST EVOL MICR, V56, P2421, DOI 10.1099/ijs.0.64498-0; WAYNE LG, 1987, INT J SYST BACTERIOL, V37, P463, DOI 10.1099/00207713-37-4-463; Wcislo E, 2002, CHEMOSPHERE, V47, P507, DOI 10.1016/S0045-6535(01)00301-0; Xie CH, 2003, J GEN APPL MICROBIOL, V49, P345, DOI 10.2323/jgam.49.345; YAMADA Y, 1982, J GEN APPL MICROBIOL, V28, P7, DOI 10.2323/jgam.28.7; Yang HC, 2006, INT J SYST EVOL MICR, V56, P453, DOI 10.1099/ijs.0.63968-0; Yoo SH, 2007, INT J SYST EVOL MICR, V57, P122, DOI 10.1099/ijs.0.64471-0; Zhang H, 2000, INT J SYST EVOL MICR, V50, P743, DOI 10.1099/00207713-50-2-743	31	16	17	2	56	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 4	2012	7	12							e50225	10.1371/journal.pone.0050225	http://dx.doi.org/10.1371/journal.pone.0050225			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	051EQ	23226514	gold, Green Submitted, Green Published			2022-12-27	WOS:000312108500012
J	Daneshjoo, A; Mokhtar, AH; Rahnama, N; Yusof, A				Daneshjoo, Abdolhamid; Mokhtar, Abdul Halim; Rahnama, Nader; Yusof, Ashril			The Effects of Injury Preventive Warm-Up Programs on Knee Strength Ratio in Young Male Professional Soccer Players	PLOS ONE			English	Article							ISOKINETIC STRENGTH; HAMSTRING INJURY; MUSCLE STRENGTH; QUADRICEPS; VELOCITY; PERFORMANCE; TORQUE; LEG; COACTIVATION; RELIABILITY	Purpose: We aimed to investigate the effect of FIFA 11+ (11+) and HarmoKnee injury preventive warm-up programs on conventional strength ratio (CSR), dynamic control ratio (DCR) and fast/slow speed ratio (FSR) in young male professional soccer players. These ratios are related to the risk of injury to the knee in soccer players. Methods: Thirty-six players were divided into 3 groups; FIFA 11+, HarmoKnee and control (n = 12 per group). These exercises were performed 3 times per week for 2 months (24 sessions). The CSR, DCR and FSR were measured before and after the intervention. Results: After training, the CSR and DCR of knee muscles in both groups were found to be lower than the published normal values (0.61, 0.72, and 0.78 during 60 degrees.s(-1), 180 degrees.s(-1) and 300 degrees.s(-1), respectively). The CSR (60 degrees.s(-1)) increased by 8% and FSR in the quadriceps of the non-dominant leg by 8% in the 11+. Meanwhile, the DCR in the dominant and non-dominant legs were reduced by 40% and 30% respectively in the 11+. The CSR (60 degrees.s(-1)) in the non-dominant leg showed significant differences between the 11+, HarmoKnee and control groups (p = 0.02). As for the DCR analysis between groups, there were significant differences in the non-dominant leg between both programs with the control group (p = 0.04). For FSR no significant changes were found between groups. Conclusions: It can be concluded that the 11+ improved CSR and FSR, but the HarmoKnee program did not demonstrate improvement. We suggest adding more training elements to the HarmoKnee program that aimed to enhance hamstring strength (CSR, DCR and FSR). Professional soccer players have higher predisposition of getting knee injuries because hamstring to quadriceps ratio were found to be lower than the average values. It seems that the 11+ have potentials to improve CSR and FSR as well as prevent knee injuries in soccer players. Citation: Daneshjoo A, Mokhtar AH, Rahnama N, Yusof A (2012) The Effects of Injury Preventive Warm-Up Programs on Knee Strength Ratio in Young Male Professional Soccer Players. PLoS ONE 7(12): e50979. doi: 10.1371/journal.pone.0050979	[Daneshjoo, Abdolhamid; Yusof, Ashril] Univ Malaya, Sports Ctr, Kuala Lumpur, Malaysia; [Mokhtar, Abdul Halim] Univ Malaya, Fac Med, Kuala Lumpur, Malaysia; [Rahnama, Nader] Univ Isfahan, Fac Phys Educ & Sport Sci, Esfahan, Iran	Universiti Malaya; Universiti Malaya; University of Isfahan	Daneshjoo, A (corresponding author), Univ Malaya, Sports Ctr, Kuala Lumpur, Malaysia.	daneshjoo.hamid@gmail.com	MOKHTAR, ABDUL HALIM/B-8102-2010; Daneshjoo, Abdolhamid/B-3225-2013; YUSOF, ASHRIL/B-8252-2010	MOKHTAR, ABDUL HALIM/0000-0001-8057-313X; Daneshjoo, Abdolhamid/0000-0002-6197-2300; YUSOF, ASHRIL/0000-0002-8117-6440	University of Malaya Research Grant [PV076/2011A]	University of Malaya Research Grant	This research was supported by the University of Malaya Research Grant (PV076/2011A). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aagaard P, 2000, SCAND J MED SCI SPOR, V10, P58, DOI 10.1034/j.1600-0838.2000.010002058.x; Aagaard P, 1998, AM J SPORT MED, V26, P231, DOI 10.1177/03635465980260021201; Arnason A, 2008, SCAND J MED SCI SPOR, V18, P40, DOI 10.1111/j.1600-0838.2006.00634.x; Bottinelli R, 1996, J PHYSIOL-LONDON, V495, P573, DOI 10.1113/jphysiol.1996.sp021617; Brito J, 2010, ISOKINET EXERC SCI, V18, P211, DOI 10.3233/IES-2010-0386; Cameron M, 2003, PHYS THER SPORT, V4, P159, DOI 10.1016/S1466-853X(03)00053-1; Clark R, 2005, PHYS THER SPORT, V6, P67, DOI 10.1016/j.ptsp.2005.02.003; Croisier JL, 2005, BRIT J SPORTS MED, V39; Drouin JM, 2004, EUR J APPL PHYSIOL, V91, P22, DOI 10.1007/s00421-003-0933-0; FIFA, 2006, FIFA BIG COUNT 2006; Fousekis K, 2010, J SPORT SCI MED, V9, P364; Giza E, 2005, BRIT J SPORT MED, V39, P212, DOI 10.1136/bjsm.2004.011973; Grygorowicz M, 2010, BIOL SPORT, V27, P47, DOI 10.5604/20831862.907793; Gur H, 1999, SCAND J MED SCI SPOR, V9, P81; Hardt J, 2009, J SPORT SCI, V27, P1221, DOI 10.1080/02640410903220336; Holcomb WR, 2007, J STRENGTH COND RES, V21, P41; Hole CD, 2000, ERGONOMICS, V43, P1603, DOI 10.1080/001401300750004023; Houweling TAW, 2009, ISOKINET EXERC SCI, V17, P213, DOI 10.3233/IES-2009-0356; Iga J, 2009, SCAND J MED SCI SPOR, V19, P714, DOI 10.1111/j.1600-0838.2008.00822.x; Kiani A, 2010, ARCH INTERN MED, V170, P43, DOI 10.1001/archinternmed.2009.289; Kim D, 2011, ISOKINET EXERC SCI, V19, P1, DOI 10.3233/IES-2011-0406; Kirkendall Donald T, 2010, Asian J Sports Med, V1, P81; Kofotolis ND, 2007, PHYS THER SPORT, V8, P109, DOI 10.1016/j.ptsp.2007.02.004; Machado SM, 2010, MED BIOL ENG COMPUT, V48, P573, DOI 10.1007/s11517-010-0608-z; Majewski M, 2006, KNEE, V13, P184, DOI 10.1016/j.knee.2006.01.005; Maly T, 2010, ACTA KINESIOL, V4, P17; Masuda K, 2005, J SPORT MED PHYS FIT, V45, P44; Mjolsnes R, 2004, SCAND J MED SCI SPOR, V14, P311, DOI 10.1046/j.1600-0838.2003.367.x; Morgan BE, 2001, AM J SPORT MED, V29, P426, DOI 10.1177/03635465010290040701; Ortqvist M, 2007, ARCH PHYS MED REHAB, V88, P1164, DOI 10.1016/j.apmr.2007.05.028; Pallant J., 2005, SPSS SURVIVAL MANUAL, V2; Parulyte D, 2011, SPORTS NR, V2, P38; Pieter W, 2006, J SPORT SCI MED, V5, P35; Rahnama N, 2005, ERGONOMICS, V48, P1568, DOI 10.1080/00140130500101585; Rahnama N, 2003, J SPORT SCI, V21, P933, DOI 10.1080/0264041031000140428; Sasaki K, 2005, J PHYSIOL-LONDON, V567, P1047, DOI 10.1113/jphysiol.2005.091124; Schmitt B, 2012, INT J SPORTS PHYS TH, V7, P333; Schwartz FP, 2010, J SPORT SCI MED, V9, P140; Soligard T, 2008, BRIT MED J, V337, DOI 10.1136/bmj.a2469; Steffen K, 2008, SCAND J MED SCI SPOR, V18, P596, DOI 10.1111/j.1600-0838.2007.00708.x; Tansel RB, 2008, ISOKINET EXERC SCI, V16, P81, DOI 10.3233/IES-2008-0300; Tourny-Chollet C, 2002, ISOKINET EXERC SCI, V10, P183, DOI 10.3233/IES-2002-0102; WILHITE M R, 1992, Journal of Orthopaedic and Sports Physical Therapy, V15, P175; Wright J, 2009, ISOKINET EXERC SCI, V17, P161, DOI 10.3233/IES-2009-0348; Zakas A, 2006, J SPORT MED PHYS FIT, V46, P28	45	69	71	1	57	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 3	2012	7	12							e50979	10.1371/journal.pone.0050979	http://dx.doi.org/10.1371/journal.pone.0050979			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	051DH	23226553	Green Published, Green Submitted, gold			2022-12-27	WOS:000312104700029
J	Chiang, YC; Huang, BH; Liao, PC				Chiang, Yu-Chung; Huang, Bing-Hong; Liao, Pei-Chun			Diversification, Biogeographic Pattern, and Demographic History of Taiwanese Scutellaria Species Inferred from Nuclear and Chloroplast DNA	PLOS ONE			English	Article							ADAPTIVE RADIATION; POPULATION-GROWTH; GENETIC DIVERSITY; SEQUENCE; PHYLOGEOGRAPHY; MITOCHONDRIAL; SPECIATION; DIVERGENCE; INFERENCE; PHYLOGENY	The ragged topography created by orogenesis generates diversified habitats for plants in Taiwan. In addition to colonization from nearby mainland China, high species diversity and endemism of plants is also present in Taiwan. Five of the seven Scutellaria species (Lamiaceae) in Taiwan, for example, are endemic to the island. Hypotheses of multiple sources or in situ radiation have arisen to explain the high endemism of Taiwanese species. In this study, phylogenetic analyses using both nuclear and chloroplast markers revealed the multiple sources of Taiwanese Scutellaria species and confirmed the rapid and recent speciation of endemic species, especially those of the "indica group" composed of S. indica, S. austrotaiwanensis, S. tashiroi, and S. playfairii. The common ancestors of the indica group colonized first in northern Taiwan and dispersed regionally southward and eastward. Climate changes during glacial/interglacial cycles led to gradual colonization and variance events in the ancestors of these species, resulting in the present distribution and genetic differentiation of extant populations. Population decline was also detected in S. indica, which might reflect a bottleneck effect from the glacials. In contrast, the recently speciated endemic members of the indica group have not had enough time to accumulate much genetic variation and are thus genetically insensitive to demographic fluctuations, but the extant lineages were spatially expanded in the coalescent process. This study integrated phylogenetic and population genetic analyses to illustrate the evolutionary history of Taiwanese Scutellaria of high endemism and may be indicative of the diversification mechanism of plants on continental islands.	[Huang, Bing-Hong; Liao, Pei-Chun] Natl Pingtung Univ Sci & Technol, Dept Biol Sci & Technol, Pingtung, Taiwan; [Chiang, Yu-Chung] Natl Sun Yat Sen Univ, Dept Biol Sci, Kaohsiung 80424, Taiwan	National Pingtung University Science & Technology; National Sun Yat Sen University	Liao, PC (corresponding author), Natl Pingtung Univ Sci & Technol, Dept Biol Sci & Technol, Pingtung, Taiwan.	pcliao@mail.npust.edu.tw	Chiang, Yu-Chung/E-9143-2011	Liao, Pei-Chun/0000-0003-1733-5504	Forestry Bureau, Council of Agriculture [99AS-1.1.8-FB-e1]; National Science Council, R.O.C [NSC 99-2621-B-020-001]	Forestry Bureau, Council of Agriculture; National Science Council, R.O.C(Ministry of Science and Technology, Taiwan)	Funding was provided by grants from the Forestry Bureau, Council of Agriculture (99AS-1.1.8-FB-e1) and the National Science Council, R.O.C (NSC 99-2621-B-020-001) to P-C Liao. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 1979, ACTA OCEANOGRAPHICA; Carstens BC, 2007, MOL ECOL, V16, P619, DOI 10.1111/j.1365-294X.2006.03167.x; Charami MT, 2008, PHYTOTHER RES, V22, P450, DOI 10.1002/ptr.2333; Cheng YP, 2005, MOL ECOL, V14, P2075, DOI 10.1111/j.1365-294X.2005.02567.x; Cheng YP, 2006, ANN BOT-LONDON, V98, P601, DOI 10.1093/aob/mcl135; Chiang TY, 2006, TAXON, V55, P31, DOI 10.2307/25065526; Cruzan MB, 2001, EVOLUTION, V55, P1569; Denda T., 2002, BIOL MAG OKINAWA, V40, P7; Doyle J. J., 1987, PHYTOCHEM B, P11; Drummond AJ, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-214; Esselstyn JA, 2009, EVOLUTION, V63, P2595, DOI 10.1111/j.1558-5646.2009.00743.x; Excoffier L, 2004, MOL ECOL, V13, P853, DOI 10.1046/j.1365-294X.2003.02004.x; Excoffier L, 2010, MOL ECOL RESOUR, V10, P564, DOI 10.1111/j.1755-0998.2010.02847.x; Excoffier L, 2005, EVOL BIOINFORM, V1, P47, DOI 10.1177/117693430500100003; Fulford GR, 2002, THEOR POPUL BIOL, V61, P15, DOI 10.1006/tpbi.2001.1553; GITTENBERGER E, 1991, BIOL J LINN SOC, V43, P263, DOI 10.1111/j.1095-8312.1991.tb00598.x; Givnish TJ, 2010, TAXON, V59, P1326, DOI 10.1002/tax.595003; Glor RE, 2010, ANNU REV ECOL EVOL S, V41, P251, DOI 10.1146/annurev.ecolsys.39.110707.173447; Hall TA., 1999, NUCL ACIDS S SERIES, V41, P95; HARPENDING HC, 1994, HUM BIOL, V66, P591; Hewitt G, 2000, NATURE, V405, P907, DOI 10.1038/35016000; Hosoda T, 2011, CAN J ZOOL, V89, P559, DOI 10.1139/Z11-029; Hsieh Chang-Fu, 2002, Taiwania, V47, P298; Hsieh Tsung-Hsin, 1997, Taiwania, V42, P109; Hsieh Tsung-Hsin, 1995, Taiwania, V40, P35; Huang JP, 2011, BMC EVOL BIOL, V11, DOI 10.1186/1471-2148-11-94; Huang SSF, 2002, MOL ECOL, V11, P2349, DOI 10.1046/j.1365-294X.2002.01624.x; Huang TC, 1998, FLORA TAIWAN, P432; Huang Tseng-Chieng, 2003, Taiwania, V48, P129; Huang ZY, 2003, TERR ATMOS OCEAN SCI, V14, P469, DOI 10.3319/TAO.2003.14.4.469(O); Hudson R.R., 1990, Oxford Surveys in Evolutionary Biology, V7, P1; Hwang SY, 2003, MOL ECOL, V12, P2689, DOI 10.1046/j.1365-294X.2003.01935.x; Janicsak G, 2006, BIOCHEM SYST ECOL, V34, P392, DOI 10.1016/j.bse.2005.12.004; KISHINO H, 1989, J MOL EVOL, V29, P170, DOI 10.1007/BF02100115; Koch MA, 2000, MOL BIOL EVOL, V17, P1483, DOI 10.1093/oxfordjournals.molbev.a026248; Lee YJ, 2006, J HERED, V97, P261, DOI 10.1093/jhered/esj030; Levin DA, 2005, SYST BOT, V30, P9, DOI 10.1600/0363644053661869; Li XW, 1994, SCUTELLARIA LINNAEUS, P75; Liew PM, 1998, GLOBAL PLANET CHANGE, V17, P85; Lin TP, 2001, THEOR APPL GENET, V102, P450, DOI 10.1007/s001220051666; Lukas B, 2009, J AGR FOOD CHEM, V57, P1362, DOI 10.1021/jf802963h; Martin-Bravo S, 2010, TAXON, V59, P466, DOI 10.1002/tax.592012; McGlone MS, 2001, J BIOGEOGR, V28, P199, DOI 10.1046/j.1365-2699.2001.00525.x; Middleton B, 2000, PLANT ECOL, V146, P169; MOORE BR, 2004, COMPU BIOL, V4, P487; Nakamura K, 2010, J BIOGEOGR, V37, P1907, DOI 10.1111/j.1365-2699.2010.02342.x; OLMSTEAD RG, 1990, EVOLUTION, V44, P54, DOI 10.1111/j.1558-5646.1990.tb04279.x; Paradis E, 2004, BIOINFORMATICS, V20, P289, DOI 10.1093/bioinformatics/btg412; PATON A, 1990, Kew Bulletin, V45, P399, DOI 10.2307/4110512; Pinto G, 2008, P ROY SOC B-BIOL SCI, V275, P2749, DOI 10.1098/rspb.2008.0686; Rainey PB, 1998, NATURE, V394, P69, DOI 10.1038/27900; Rambaut A, 2008, FIGTREE VER 1 3 1; Rambaut A, 2003, TRACER VER 1 4 1; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; Rozas J, 2003, BIOINFORMATICS, V19, P2496, DOI 10.1093/bioinformatics/btg359; Schluter D, 1996, AM NAT, V148, pS40, DOI 10.1086/285901; Schmiderer C, 2008, PLANT BIOLOGY, V10, P433, DOI 10.1111/j.1438-8677.2008.00053.x; Shih HT, 2007, ZOOL STUD, V46, P680; Shih HT, 2007, INVERTEBR SYST, V21, P29, DOI 10.1071/IS06007; Shimodaira H, 2001, BIOINFORMATICS, V17, P1246, DOI 10.1093/bioinformatics/17.12.1246; Shimodaira H, 1999, MOL BIOL EVOL, V16, P1114, DOI 10.1093/oxfordjournals.molbev.a026201; Shimodaira H, 2002, SYST BIOL, V51, P492, DOI 10.1080/10635150290069913; Shimodaira H, 2004, ANN STAT, V32, P2616, DOI 10.1214/009053604000000823; Simpson G. G., 1953, MAJOR FEATURES EVOLU, DOI DOI 10.7312/SIMP93764; SLATKIN M, 1977, THEOR POPUL BIOL, V12, P253, DOI 10.1016/0040-5809(77)90045-4; Sun M, 1999, MOL ECOL, V8, P1285, DOI 10.1046/j.1365-294X.1999.00691.x; TAJIMA F, 1989, GENETICS, V123, P585; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; Vidal F, 2007, EXP PARASITOL, V115, P25, DOI 10.1016/j.exppara.2006.05.001; Vilaca ST, 2010, MOL PHYLOGENET EVOL, V57, P585, DOI 10.1016/j.ympev.2010.07.010; Wagstaff SJ, 1998, PLANT SYST EVOL, V209, P265, DOI 10.1007/BF00985232; Wang CF, 2011, ZOOL J LINN SOC-LOND, V161, P613, DOI 10.1111/j.1096-3642.2010.00646.x; Wei K.-Y, 2002, W PACIFIC EARTH SCI, V2, P149; WILLIAMS PA, 1992, NEW ZEAL J ECOL, V16, P127; WOLFE KH, 1987, P NATL ACAD SCI USA, V84, P9054, DOI 10.1073/pnas.84.24.9054; Wu SH, 2006, J BIOGEOGR, V33, P936, DOI 10.1111/j.1365-2699.2006.01431.x; Yamazaki Takasi, 1992, Journal of Japanese Botany, V67, P315; Yu Y., 2011, RASP RECONSTRUCT ANC	79	21	22	0	43	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 30	2012	7	11							e50844	10.1371/journal.pone.0050844	http://dx.doi.org/10.1371/journal.pone.0050844			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	054WM	23226402	gold, Green Published, Green Submitted			2022-12-27	WOS:000312376100213
J	Eriksson, E; Zaman, F; Chrysis, D; Wehtje, H; Heino, TJ; Savendahl, L				Eriksson, Emma; Zaman, Farasat; Chrysis, Dionisios; Wehtje, Henrik; Heino, Terhi J.; Savendahl, Lars			Bortezomib Is Cytotoxic to the Human Growth Plate and Permanently Impairs Bone Growth in Young Mice	PLOS ONE			English	Article							ACUTE LYMPHOBLASTIC-LEUKEMIA; PROTEASOME INHIBITOR BORTEZOMIB; RAT METATARSAL BONES; LONG-TERM SURVIVORS; IN-VIVO; SELECTIVE INHIBITORS; APOPTOTIC PATHWAYS; PEDIATRIC-PATIENTS; SKELETAL GROWTH; RESTING ZONE	Bortezomib, a novel proteasome inhibitor approved for the treatment of cancer in adults, has recently been introduced in pediatric clinical trials. Any tissue-specific side effects on bone development have to our knowledge not yet been explored. To address this, we experimentally studied the effects of bortezomib in vivo in young mice and in vitro in organ cultures of rat metatarsal bones and human growth plate cartilage, as well as in a rat chondrocytic cell line. We found that bortezomib while efficiently blocking the ubiquitin/proteasome system (UPS) caused significant growth impairment in mice, by increasing resting/stem-like chondrocyte apoptosis. Our data support a local action of bortezomib, directly targeting growth plate chondrocytes leading to decreased bone growth since no suppression of serum levels of insulin-like growth factor-I (IGF-I) was observed. A local effect of bortezomib was confirmed in cultured rat metatarsal bones where bortezomib efficiently caused growth retardation in a dose dependent and irreversible manner, an effect linked to increased chondrocyte apoptosis, mainly of resting/stem-like chondrocytes. The cytotoxicity of bortezomib was also evaluated in a unique model of cultured human growth plate cartilage, which was found to be highly sensitive to bortezomib. Mechanistic studies of apoptotic pathways indicated that bortezomib induced activation of p53 and Bax, as well as cleavage of caspases and poly-ADP-ribose polymerase (PARP) in exposed chondrocytes. Our observations, confirmed in vivo and in vitro, suggest that bone growth could potentially be suppressed in children treated with bortezomib. We therefore propose that longitudinal bone growth should be closely monitored in ongoing clinical pediatric trials of this promising anti-cancer drug.	[Eriksson, Emma; Zaman, Farasat; Savendahl, Lars] Karolinska Inst, Pediat Endocrinol Unit, Dept Womens & Childrens Hlth, Stockholm, Sweden; [Chrysis, Dionisios] Univ Patras, Dept Pediat, Pediat Endocrinol Unit, Rion, Greece; [Wehtje, Henrik] Karolinska Inst, Pediat Orthoped Clin, Dept Womens & Childrens Hlth, Stockholm, Sweden; [Heino, Terhi J.] Univ Turku, Inst Biomed, Dept Anat, FIN-20520 Turku, Finland	Karolinska Institutet; University of Patras; Karolinska Institutet; University of Turku	Eriksson, E (corresponding author), Karolinska Inst, Pediat Endocrinol Unit, Dept Womens & Childrens Hlth, Stockholm, Sweden.	Emma.E.Eriksson@ki.se	CHRYSIS, DIONISIOS/HGB-4107-2022; Zaman, Farasat/AAE-1144-2020	Heino, Terhi/0000-0003-2274-6834; Savendahl, Lars/0000-0003-1067-4976	Swedish Research Council; Swedish Childhood Cancer Foundation; Stiftelsen Frimurare Barnhuset Stockholm; Sallskapet Barnavard	Swedish Research Council(Swedish Research CouncilEuropean Commission); Swedish Childhood Cancer Foundation(European Commission); Stiftelsen Frimurare Barnhuset Stockholm; Sallskapet Barnavard	This work was supported by the Swedish Research Council, the Swedish Childhood Cancer Foundation, Stiftelsen Frimurare Barnhuset Stockholm, and Sallskapet Barnavard. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abad V, 2002, ENDOCRINOLOGY, V143, P1851, DOI 10.1210/en.143.5.1851; Adams J, 2004, CANCER INVEST, V22, P304, DOI 10.1081/CNV-120030218; Adams J, 2004, NAT REV CANCER, V4, P349, DOI 10.1038/nrc1361; Adams J, 1998, BIOORG MED CHEM LETT, V8, P333, DOI 10.1016/S0960-894X(98)00029-8; Agarwal ML, 1998, J BIOL CHEM, V273, P1, DOI 10.1074/jbc.273.1.1; Arikoski P, 1999, ARCH DIS CHILD, V80, P143, DOI 10.1136/adc.80.2.143; AUBIN JE, 1982, J CELL BIOL, V92, P452, DOI 10.1083/jcb.92.2.452; Blaney SM, 2004, J CLIN ONCOL, V22, P4804, DOI 10.1200/JCO.2004.12.185; Brignole C, 2006, J NATL CANCER I, V98, P1142, DOI 10.1093/jnci/djj309; CARUSONICOLETTI M, 1993, EUR J PEDIATR, V152, P730, DOI 10.1007/BF01953986; Chagin AS, 2010, J ENDOCRINOL, V204, P21, DOI 10.1677/JOE-09-0307; Chagin AS, 2004, J BONE MINER RES, V19, P72, DOI 10.1359/JBMR.0301203; Chrysis D, 2005, ENDOCRINOLOGY, V146, P1391, DOI 10.1210/en.2004-1152; Demetrius L, 2005, EMBO REP, V6, pS39, DOI 10.1038/sj.embor.7400422; Fearnhead HO, 1998, P NATL ACAD SCI USA, V95, P13664, DOI 10.1073/pnas.95.23.13664; FREDIANI P, 1987, Chirurgia degli Organi di Movimento, V72, P221; Garrett IR, 2003, J CLIN INVEST, V111, P1771, DOI 10.1172/JCI200316198; Green DR, 1998, CELL, V94, P695, DOI 10.1016/S0092-8674(00)81728-6; Haddy TB, 2001, ONCOLOGIST, V6, P278, DOI 10.1634/theoncologist.6-3-278; Hakem R, 1998, CELL, V94, P339, DOI 10.1016/S0092-8674(00)81477-4; Horton TM, 2007, CLIN CANCER RES, V13, P1516, DOI 10.1158/1078-0432.CCR-06-2173; Kane RC, 2003, ONCOLOGIST, V8, P508, DOI 10.1634/theoncologist.8-6-508; Kane RC, 2007, CLIN CANCER RES, V13, P5291, DOI 10.1158/1078-0432.CCR-07-0871; KIRK JA, 1987, LANCET, V1, P190; Kisselev AF, 2001, CHEM BIOL, V8, P739, DOI 10.1016/S1074-5521(01)00056-4; Komarov PG, 1999, SCIENCE, V285, P1733, DOI 10.1126/science.285.5434.1733; LEVINE AJ, 1993, ANNU REV BIOCHEM, V62, P623, DOI 10.1146/annurev.bi.62.070193.003203; Lightcap ES, 2000, CLIN CHEM, V46, P673; Lowe SW, 2000, CARCINOGENESIS, V21, P485, DOI 10.1093/carcin/21.3.485; Martensson K, 2004, J BONE MINER RES, V19, P1805, DOI 10.1359/JBMR.040805; Martin DA, 2004, RHEUM DIS CLIN N AM, V30, P441, DOI 10.1016/j.rdc.2004.04.008; Matyskova R, 2008, PHYSIOL RES, V57, P727, DOI 10.33549/physiolres.931274; Mitsiades N, 2002, P NATL ACAD SCI USA, V99, P14374, DOI 10.1073/pnas.202445099; MOSMANN T, 1983, J IMMUNOL METHODS, V65, P55, DOI 10.1016/0022-1759(83)90303-4; Mukherjee S, 2008, J CLIN INVEST, V118, P491, DOI [10.1172/JCI33102, 10.1172/JC133102]; Muller HL, 1998, EXP CLIN ENDOCR DIAB, V106, P135; Narita M, 1998, P NATL ACAD SCI USA, V95, P14681, DOI 10.1073/pnas.95.25.14681; OGILVYSTUART AL, 1995, ACTA PAEDIATR, V84, P52, DOI 10.1111/j.1651-2227.1995.tb13864.x; OLSHAN JS, 1992, CANCER-AM CANCER SOC, V70, P2013, DOI 10.1002/1097-0142(19921001)70:7<2013::AID-CNCR2820700734>3.0.CO;2-J; Pennisi A, 2009, AM J HEMATOL, V84, P6, DOI 10.1002/ajh.21310; Rogol AD, 2000, AM J CLIN NUTR, V72, p521S, DOI 10.1093/ajcn/72.2.521S; Schrier L, 2006, J ENDOCRINOL, V189, P27, DOI 10.1677/joe.1.06489; SCHRIOCK EA, 1991, J CLIN ONCOL, V9, P400, DOI 10.1200/JCO.1991.9.3.400; Siebler T, 2002, HORM RES, V58, P80, DOI 10.1159/000064769; Spagnoli A, 2002, J BIOL CHEM, V277, P18860, DOI 10.1074/jbc.M200218200; Spagnoli A, 2001, J BIOL CHEM, V276, P5533, DOI 10.1074/jbc.M005088200; Susin SA, 1997, J EXP MED, V186, P25, DOI 10.1084/jem.186.1.25; Tang DM, 2000, J BIOL CHEM, V275, P9303, DOI 10.1074/jbc.275.13.9303; Tang DM, 1999, J BIOL CHEM, V274, P7245, DOI 10.1074/jbc.274.11.7245; THUNHOHENSTEIN L, 1992, HORM RES, V37, P91, DOI 10.1159/000182289; Tivesten A, 2004, J BONE MINER RES, V19, P1833, DOI 10.1359/JBMR.040819; Vaux DL, 1999, CELL, V96, P245, DOI 10.1016/S0092-8674(00)80564-4; Vousden KH, 2000, CELL, V103, P691, DOI 10.1016/S0092-8674(00)00171-9; Wu SF, 2006, ENDOCRINOLOGY, V147, P3761, DOI 10.1210/en.2005-1672; Yoshida H, 1998, CELL, V94, P739, DOI 10.1016/S0092-8674(00)81733-X; Zaman F, 2008, LEUKEMIA, V22, P883, DOI 10.1038/sj.leu.2404997; Zaman F, 2007, CANCER RES, V67, P10078, DOI 10.1158/0008-5472.CAN-06-3982; Zaman F, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033168	58	17	17	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 30	2012	7	11							e50523	10.1371/journal.pone.0050523	http://dx.doi.org/10.1371/journal.pone.0050523			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	054WM	23226303	Green Published, gold, Green Submitted			2022-12-27	WOS:000312376100115
J	Holley, T; Lenkiewicz, E; Evers, L; Tembe, W; Ruiz, C; Gsponer, JR; Rentsch, CA; Bubendorf, L; Stapleton, M; Amorese, D; Legendre, C; Cunliffe, HE; McCullough, AE; Pockaj, B; Craig, D; Carpten, J; Von Hoff, D; Iacobuzio-Donahue, C; Barrett, MT				Holley, Tara; Lenkiewicz, Elizabeth; Evers, Lisa; Tembe, Waibhav; Ruiz, Christian; Gsponer, Joel R.; Rentsch, Cyrill A.; Bubendorf, Lukas; Stapleton, Mark; Amorese, Doug; Legendre, Christophe; Cunliffe, Heather E.; McCullough, Ann E.; Pockaj, Barbara; Craig, David; Carpten, John; Von Hoff, Daniel; Iacobuzio-Donahue, Christine; Barrett, Michael T.			Deep Clonal Profiling of Formalin Fixed Paraffin Embedded Clinical Samples	PLOS ONE			English	Article							COMPARATIVE GENOMIC HYBRIDIZATION; COPY NUMBER; DNA; EXTRACTION; EVOLUTION; FRAMEWORK; TISSUES; FROZEN; CELLS; CGH	Formalin fixed paraffin embedded (FFPE) tissues are a vast resource of annotated clinical samples. As such, they represent highly desirable and informative materials for the application of high definition genomics for improved patient management and to advance the development of personalized therapeutics. However, a limitation of FFPE tissues is the variable quality of DNA extracted for analyses. Furthermore, admixtures of non-tumor and polyclonal neoplastic cell populations limit the number of biopsies that can be studied and make it difficult to define cancer genomes in patient samples. To exploit these valuable tissues we applied flow cytometry-based methods to isolate pure populations of tumor cell nuclei from FFPE tissues and developed a methodology compatible with oligonucleotide array CGH and whole exome sequencing analyses. These were used to profile a variety of tumors (breast, brain, bladder, ovarian and pancreas) including the genomes and exomes of matching fresh frozen and FFPE pancreatic adenocarcinoma samples.	[Holley, Tara; Lenkiewicz, Elizabeth; Evers, Lisa; Von Hoff, Daniel; Barrett, Michael T.] Translat Genom Res Inst, Clin Translat Res Div, Scottsdale, AZ USA; [Tembe, Waibhav; Legendre, Christophe] Translat Genom Res Inst, Collaborat Bioinformat Ctr, Phoenix, AZ USA; [Ruiz, Christian; Gsponer, Joel R.; Rentsch, Cyrill A.; Bubendorf, Lukas] Univ Basel, Inst Pathol, Univ Basel Hosp, Basel, Switzerland; [Rentsch, Cyrill A.] Univ Basel, Dept Urol, Univ Basel Hosp, Basel, Switzerland; [Stapleton, Mark; Amorese, Doug] NuGEN, San Carlos, CA USA; [Cunliffe, Heather E.] Translat Genom Res Inst, Computat Biol Div, Phoenix, AZ USA; [McCullough, Ann E.] Mayo Clin, Dept Lab Med, Scottsdale, AZ USA; [Pockaj, Barbara] Mayo Clin, Dept Surg, Scottsdale, AZ USA; [Craig, David] Translat Genom Res Inst, Neurogen Div, Phoenix, AZ USA; [Carpten, John] Translat Genom Res Inst, Integrated Canc Genom Div, Phoenix, AZ USA; [Von Hoff, Daniel] Scottsdale Healthcare, Virginia G Piper Canc Ctr, Scottsdale, AZ USA; [Iacobuzio-Donahue, Christine] Johns Hopkins Univ, Baltimore, MD USA	Translational Genomics Research Institute; Translational Genomics Research Institute; University of Basel; University of Basel; Translational Genomics Research Institute; Mayo Clinic; Mayo Clinic Phoenix; Mayo Clinic; Mayo Clinic Phoenix; Translational Genomics Research Institute; Translational Genomics Research Institute; Scottsdale Healthcare Osborn; Johns Hopkins University	Barrett, MT (corresponding author), Translat Genom Res Inst, Clin Translat Res Div, Scottsdale, AZ USA.	mbarrett@tgen.org	Bubendorf, Lukas/G-5299-2015; Craig, David Wesley/K-6961-2019; Bubendorfl, Lukas/H-5880-2011; Iacobuzio-Donahue, Christine/ABF-1295-2020	Bubendorf, Lukas/0000-0001-5970-1803; Craig, David Wesley/0000-0003-2040-1955; Iacobuzio-Donahue, Christine/0000-0002-4672-3023; Rentsch, Cyrill/0000-0002-8085-6006	National Institutes of Health (NIH) [1R21CA137687, 1S10RR25056-01]; AACR/SU2C Pancreatic Dream Team;  [PO1 (5P01CA109552-04)]; NATIONAL CANCER INSTITUTE [R21CA137687, P01CA109552] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR025056] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); AACR/SU2C Pancreatic Dream Team; ; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	This work was supported by National Institutes of Health (NIH) funded Innovative Technologies for Molecular Analysis of Cancer (1R21CA137687) grant entitled "High Definition Clonal Analyses of Archival Pancreatic Adenocarcinoma Samples". Additional support came from PO1 (5P01CA109552-04) "Targets to Therapeutics in Pancreatic Cancer" and the AACR/SU2C Pancreatic Dream Team (SU2C@aacr.org). The authors also thank the Network and Computing Systems division of the Translational Genomics Research Institute (TGen) for making available the data storage and computing infrastructure including the Saguaro2 supercomputing resources funded by the NIH grant 1S10RR25056-01. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Banerji S, 2012, NATURE, V486, P405, DOI 10.1038/nature11154; Bass AJ, 2011, NAT GENET, V43, P964, DOI 10.1038/ng.936; Braggio E, 2011, CLIN CANCER RES, V17, P4245, DOI 10.1158/1078-0432.CCR-11-0395; Corver WE, 2008, CANCER RES, V68, P10333, DOI 10.1158/0008-5472.CAN-08-2665; DePristo MA, 2011, NAT GENET, V43, P491, DOI 10.1038/ng.806; Ding L, 2012, NATURE, V481, P506, DOI 10.1038/nature10738; Estel R, 2011, ARCH GYNECOL OBSTET, V284, P1277, DOI 10.1007/s00404-011-1846-5; Galipeau PC, 2007, PLOS MED, V4, P342, DOI 10.1371/jourmal.pmed.0040067; Gerlinger M, 2012, NEW ENGL J MED, V366, P883, DOI 10.1056/NEJMoa1113205; Hostetter G, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkp881; Ibrahim SF, 2007, ADV BIOCHEM ENG BIOT, V106, P19, DOI 10.1007/10_2007_073; Jewell SD, 2002, AM J CLIN PATHOL, V118, P733; Jones S, 2008, SCIENCE, V321, P1801, DOI 10.1126/science.1164368; Koboldt DC, 2009, BIOINFORMATICS, V25, P2283, DOI 10.1093/bioinformatics/btp373; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Lipson D, 2006, J COMPUT BIOL, V13, P215, DOI 10.1089/cmb.2006.13.215; Liu Z, 2011, CELL DEATH DIFFER, V18, P1174, DOI 10.1038/cdd.2010.187; Loo LWM, 2004, CANCER RES, V64, P8541, DOI 10.1158/0008-5472.CAN-04-1992; Maley CC, 2006, NAT GENET, V38, P468, DOI 10.1038/ng1768; McKenna A, 2010, GENOME RES, V20, P1297, DOI 10.1101/gr.107524.110; Metzker ML, 2010, NAT REV GENET, V11, P31, DOI 10.1038/nrg2626; Paris PL, 2007, PROSTATE, V67, P1447, DOI 10.1002/pros.20632; Paris PL, 2003, AM J PATHOL, V162, P763, DOI 10.1016/S0002-9440(10)63873-4; RABINOVITCH PS, 1994, METHOD CELL BIOL, V41, P263; Ruiz C, 2011, P NATL ACAD SCI USA, V108, P12054, DOI 10.1073/pnas.1104009108; Schubert EL, 2002, AM J PATHOL, V160, P73, DOI 10.1016/S0002-9440(10)64351-9; Serth J, 2000, AM J PATHOL, V156, P1189, DOI 10.1016/S0002-9440(10)64989-9; SEYMOUR AB, 1994, CANCER RES, V54, P2761; Shendure J, 2008, NAT BIOTECHNOL, V26, P1135, DOI 10.1038/nbt1486; Shi SR, 2002, J HISTOCHEM CYTOCHEM, V50, P1005, DOI 10.1177/002215540205000802; Srinivasan M, 2002, AM J PATHOL, V161, P1961, DOI 10.1016/S0002-9440(10)64472-0; Walter MJ, 2012, NEW ENGL J MED, V366, P1090, DOI 10.1056/NEJMoa1106968; Weir BA, 2007, NATURE, V450, P893, DOI 10.1038/nature06358; Wu L, 2002, APPL IMMUNOHISTO M M, V10, P269, DOI 10.1097/00022744-200209000-00015	34	39	41	1	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 30	2012	7	11							e50586	10.1371/journal.pone.0050586	http://dx.doi.org/10.1371/journal.pone.0050586			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	054WM	23226320	Green Published, gold, Green Submitted			2022-12-27	WOS:000312376100132
J	Jiang, KC; Sun, XJ; Wang, W; Liu, L; Cai, Y; Chen, YC; Luo, N; Yu, JH; Cai, DY; Wang, AP				Jiang, Ke-chun; Sun, Xin-juan; Wang, Wei; Liu, Lan; Cai, Ying; Chen, Yin-chen; Luo, Ning; Yu, Jian-hua; Cai, Da-yong; Wang, Ai-ping			Excretions/Secretions from Bacteria-Pretreated Maggot Are More Effective against Pseudomonas aeruginosa Biofilms	PLOS ONE			English	Article							RESISTANT STAPHYLOCOCCUS-AUREUS; LUCILIA-SERICATA; IMMUNE-RESPONSE; ANTIBIOTICS; DROSOPHILA; THERAPY	Background: Sterile larvae-maggots of the green bottle blowfly Lucilia sericata are employed as a treatment tool for various types of chronic wounds. Previous studies reported that excretions/secretions (ES) of the sterile larvae could prevent and remove the biofilms of various species of bacteria. In the present study we assessed the effect of ES from the larvae pretreated with Pseudomonas aeruginosa on the bacteria biofilms. Methods and Findings: We investigated the effects of ES from the maggot pretreated with P. aeruginosa on the biofilms using microtitre plate assays and on bactericidal effect using the colony-forming unit (CFU) assay. The results showed that only 30 mu g of the ES from the pretreated maggots could prevent and degrade the biofilm of P. aeruginosa. However, the CFU count of P. aeruginosa was not decrease when compared to the ES from non pretreated maggots in this study condition. It is suggested that the ES from the pretreated maggot was more effective against biofilm of P. aeruginosa than sterile maggot ES. Conclusions: Our results showed that the maggot ES, especially the bacteria-pretreated larva ES may provide a new insight into the treatment tool of the bacterial biofilms. Citation: Jiang K-c, Sun X-j, Wang W, Liu L, Cai Y, et al. (2012) Excretions/Secretions from Bacteria-Pretreated Maggot Are More Effective against Pseudomonas aeruginosa Biofilms. PLoS ONE 7(11): e49815. doi:10.1371/journal.pone.0049815	[Jiang, Ke-chun; Sun, Xin-juan; Wang, Wei; Liu, Lan; Cai, Ying; Chen, Yin-chen; Luo, Ning; Yu, Jian-hua; Cai, Da-yong; Wang, Ai-ping] 454 Hosp PLA, Dept Endocrinol, Nanjing, Jiangsu, Peoples R China		Wang, AP (corresponding author), 454 Hosp PLA, Dept Endocrinol, Nanjing, Jiangsu, Peoples R China.	wap454hospital@163.com			Research Fund of 454 Hospital of PLA [10Z014]	Research Fund of 454 Hospital of PLA	This work was supported by Research Fund of 454 Hospital of PLA (No. 10Z014). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Basset A, 2000, P NATL ACAD SCI USA, V97, P3376, DOI 10.1073/pnas.070357597; Bexfield A, 2004, MICROBES INFECT, V6, P1297, DOI 10.1016/j.micinf.2004.08.011; Bowling FL, 2007, DIABETES CARE, V30, P370, DOI 10.2337/dc06-2348; Cazander G, 2009, J Tissue Viability, V18, P80, DOI 10.1016/j.jtv.2009.02.005; Cazander G, 2010, WOUND REPAIR REGEN, V18, P637, DOI 10.1111/j.1524-475X.2010.00625.x; Chan Dominic C. W., 2007, Hong Kong Medical Journal, V13, P382; Davis Stephen C, 2006, Curr Diab Rep, V6, P439, DOI 10.1007/s11892-006-0076-x; Edwards R, 2004, CURR OPIN INFECT DIS, V17, P91, DOI 10.1097/00001432-200404000-00004; Gjodsbol Kristine, 2006, Int Wound J, V3, P225, DOI 10.1111/j.1742-481X.2006.00159.x; Harris LG, 2009, INT J ARTIF ORGANS, V32, P555, DOI 10.1177/039139880903200904; Hoffmann JA, 2003, NATURE, V426, P33, DOI 10.1038/nature02021; Huberman L, 2007, J Wound Care, V16, P123; Kawabata T, 2010, MED VET ENTOMOL, V24, P375, DOI 10.1111/j.1365-2915.2010.00902.x; Kerridge A, 2005, MED VET ENTOMOL, V19, P333, DOI 10.1111/j.1365-2915.2005.00577.x; Sheldon Albert T Jr, 2005, Clin Lab Sci, V18, P170; Steenvoorde P, 2004, J Tissue Viability, V14, P97; Stoodley P, 2002, ANNU REV MICROBIOL, V56, P187, DOI 10.1146/annurev.micro.56.012302.160705; Thomas S, 1996, J Wound Care, V5, P60; van der Plas MJA, 2008, J ANTIMICROB CHEMOTH, V61, P117, DOI 10.1093/jac/dkm407; van der Plas MJA, 2007, MICROBES INFECT, V9, P507, DOI 10.1016/j.micinf.2007.01.008; van der Plas MJA, 2010, J ANTIMICROB CHEMOTH, V65, P917, DOI 10.1093/jac/dkq042	21	22	24	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 30	2012	7	11							e49815	10.1371/journal.pone.0049815	http://dx.doi.org/10.1371/journal.pone.0049815			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	054WM	23226221	Green Published, gold, Green Submitted			2022-12-27	WOS:000312376100029
J	Margheri, F; Schiavone, N; Papucci, L; Magnelli, L; Serrati, S; Chilla, A; Laurenzana, A; Bianchini, F; Calorini, L; Torre, E; Dotor, J; Feijoo, E; Fibbi, G; Del Rosso, M				Margheri, Francesca; Schiavone, Nicola; Papucci, Laura; Magnelli, Lucia; Serrati, Simona; Chilla, Anastasia; Laurenzana, Anna; Bianchini, Francesca; Calorini, Lido; Torre, Eugenio; Dotor, Javier; Feijoo, Esperanza; Fibbi, Gabriella; Del Rosso, Mario			GDF5 Regulates TGF beta-Dependent Angiogenesis in Breast Carcinoma MCF-7 Cells: In Vitro and In Vivo Control by Anti-TGF beta Peptides	PLOS ONE			English	Article							GROWTH-FACTOR-BETA; BONE MORPHOGENETIC PROTEIN; MICROVASCULAR ENDOTHELIAL-CELLS; TRANSFORMING GROWTH-FACTOR-BETA-1; BASIC FIBROBLAST; TUMOR-GROWTH; RECEPTOR; CANCER; TGF-BETA-1; BINDING	Background: TGF beta overproduction in cancer cells is one of the main characteristics of late tumor progression being implicated in metastasis, tumor growth, angiogenesis and immune response. We investigated the therapeutic efficacy of anti-TGF beta peptides in the control of angiogenesis elicited by conditional over-expression of TGF beta. Methods: We have inserted in human MCF7 mammary-cancer cells a mutated TGF beta gene in a tetracycline-repressible vector to obtain conditional expression of mature TGF beta upon transient transfection, evaluated the signaling pathways involved in TGF beta-dependent endothelial cells activation and the efficacy of anti-TGF beta peptides in the control of MCF7-TGF beta-dependent angiogenesis. Results: TGF beta over-expression induced in MCF7 several markers of the epithelial-to-mesenchymal transition. Conditioned-medium of TGF beta-transfected MCF7 stimulated angiogenesis in vivo and in vitro by subsequent activation of SMAD2/3 and SMAD1/5 signaling in endothelial cells, as well as SMAD4 nuclear translocation, resulting in over-expression of the pro-angiogenic growth and differentiation factor-5 (GDF5). Inhibition or silencing of GDF5 in TGF beta-stimulated EC resulted in impairment of GDF5 expression and of TGF beta-dependent urokinase-plasminogen activator receptor (uPAR) overproduction, leading to angiogenesis impairment. Two different TGF beta antagonist peptides inhibited all the angiogenesis-related properties elicited in EC by exogenous and conditionally-expressed TGF beta in vivo and in vitro, including SMAD1/5 phosphorylation, SMAD4 nuclear translocation, GDF5 and uPAR overexpression. Antagonist peptides and anti-GDF5 antibodies efficiently inhibited in vitro and in vivo angiogenesis. Conclusions: TGF beta produced by breast cancer cells induces in endothelial cells expression of GDF5, which in turn stimulates angiogenesis both in vitro and in vivo. Angiogenesis activation is rapid and the involved mechanism is totally opposed to the old and controversial dogma about the AKL5/ALK1 balance. The GDF-dependent pro-angiogenic effects of TGF beta are controlled by anti-TGF beta peptides and anti-GDF5 antibodies, providing a basis to develop targeted clinical studies.	[Margheri, Francesca; Schiavone, Nicola; Papucci, Laura; Magnelli, Lucia; Serrati, Simona; Chilla, Anastasia; Laurenzana, Anna; Bianchini, Francesca; Calorini, Lido; Torre, Eugenio; Fibbi, Gabriella; Del Rosso, Mario] Univ Florence, Dept Expt Pathol & Oncol, Florence, Italy; [Margheri, Francesca; Schiavone, Nicola; Papucci, Laura; Magnelli, Lucia; Chilla, Anastasia; Laurenzana, Anna; Bianchini, Francesca; Calorini, Lido; Fibbi, Gabriella; Del Rosso, Mario] Ist Toscano Tumori, Florence, Italy; [Serrati, Simona] Ist Tumori Giovanni Paolo II, Dept Oncohematol, Bari, Italy; [Dotor, Javier; Feijoo, Esperanza] DIGNA Biotech, Pamplona, Spain	University of Florence; ISPRO Istituto per lo studio, la prevenzione e la rete oncologica; IRCCS Istituto Tumori Bari Giovanni Paolo II	Fibbi, G (corresponding author), Univ Florence, Dept Expt Pathol & Oncol, Florence, Italy.	fibbi@unifi.it; delrosso@unifi.it	Magnelli, Lucia/J-7077-2018; Chillà, Anastasia/ABC-7402-2020; Serrati, Simona/B-2520-2013; Bianchini, Francesca/P-4355-2019	Magnelli, Lucia/0000-0003-4585-1450; Serrati, Simona/0000-0002-4015-5205; Bianchini, Francesca/0000-0002-5839-4298; Del Rosso, Mario/0000-0002-2980-2731; Papucci, Laura/0000-0002-8450-7428; Fibbi, gabriella/0000-0002-0629-851X; Schiavone, Nicola/0000-0002-1592-4244; Calorini, Lido/0000-0002-5508-4200	Istituto Toscano Tumori (ITT); DIGNA Biotech (Spain)	Istituto Toscano Tumori (ITT); DIGNA Biotech (Spain)	This work was supported by grants from Istituto Toscano Tumori (ITT) and DIGNA Biotech (Spain). The funder ITT had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. DIGNA Biotech was involved in study design in that the authors E. Feijoo and J. Dotor from DIGNA Biotech were involved in TGF-beta inhibitor design and production and the conception of the study.	Akhurst RJ, 2001, TRENDS CELL BIOL, V11, pS44, DOI 10.1016/S0962-8924(01)82259-5; Akilesh S, 2003, GENOME RES, V13, P1719, DOI 10.1101/gr.533003; Benckert C, 2003, CANCER RES, V63, P1083; Blick T, 2008, CLIN EXP METASTAS, V25, P629, DOI 10.1007/s10585-008-9170-6; Buijs JT, 2011, CANCER MICROENVIRON, V4, P261, DOI 10.1007/s12307-011-0075-6; Cunha SI, 2011, BLOOD, V117, P6999, DOI 10.1182/blood-2011-01-330142; Cunha SI, 2010, J EXP MED, V207, P85, DOI 10.1084/jem.20091309; D'Alessio S, 2004, ARTHRITIS RHEUM-US, V50, P3275, DOI 10.1002/art.20562; David L, 2007, BLOOD, V109, P1953, DOI 10.1182/blood-2006-07-034124; David L, 2009, CYTOKINE GROWTH F R, V20, P203, DOI 10.1016/j.cytogfr.2009.05.001; de Caestecker MP, 2000, JNCI-J NATL CANCER I, V92, P1388, DOI 10.1093/jnci/92.17.1388; Derynck R, 2001, NAT GENET, V29, P117, DOI 10.1038/ng1001-117; Dotor J, 2007, CYTOKINE, V39, P106, DOI 10.1016/j.cyto.2007.06.004; Drabsch Y, 2011, J MAMMARY GLAND BIOL, V16, P97, DOI 10.1007/s10911-011-9217-1; Enholm B, 1997, ONCOGENE, V14, P2475, DOI 10.1038/sj.onc.1201090; Ezquerro IJ, 2003, CYTOKINE, V22, P12, DOI 10.1016/S1043-4666(03)00101-7; Ferrari G, 2006, P NATL ACAD SCI USA, V103, P17260, DOI 10.1073/pnas.0605556103; Ferrari G, 2009, J CELL PHYSIOL, V219, P449, DOI 10.1002/jcp.21706; Fibbi G, 1999, HEPATOLOGY, V29, P868, DOI 10.1002/hep.510290343; GELBART WM, 1989, DEVELOPMENT, V107, P65; Giusti B, 2006, ARTHRITIS RES THER, V8, DOI 10.1186/ar2002; Goumans MJ, 2002, EMBO J, V21, P1743, DOI 10.1093/emboj/21.7.1743; Goumans MJ, 2003, TRENDS CARDIOVAS MED, V13, P301, DOI 10.1016/S1050-1738(03)00142-7; Hu-Lowe DD, 2011, CANCER RES, V71, P1362, DOI 10.1158/0008-5472.CAN-10-1451; KINGSLEY DM, 1994, GENE DEV, V8, P133, DOI 10.1101/gad.8.2.133; Lamouille S, 2002, BLOOD, V100, P4495, DOI 10.1182/blood.V100.13.4495; Lebrin F, 2005, CARDIOVASC RES, V65, P599, DOI 10.1016/j.cardiores.2004.10.036; Lin SJ, 2006, REPRODUCTION, V132, P179, DOI 10.1530/rep.1.01072; Luo W, 2012, INT J CANC; Margheri F, 2011, BLOOD, V118, P3743, DOI 10.1182/blood-2011-02-338681; Oshima M, 1996, DEV BIOL, V179, P297, DOI 10.1006/dbio.1996.0259; Ota T, 2002, J CELL PHYSIOL, V193, P299, DOI 10.1002/jcp.10170; Pardali E, 2010, TRENDS CELL BIOL, V20, P556, DOI 10.1016/j.tcb.2010.06.006; Pardali E, 2009, FRONT BIOSCI-LANDMRK, V14, P4848, DOI 10.2741/3573; Pepper Michael S., 1997, Cytokine and Growth Factor Reviews, V8, P21, DOI 10.1016/S1359-6101(96)00048-2; PERTOVAARA L, 1994, J BIOL CHEM, V269, P6271; Ramoshebi LN, 2000, ANAT REC, V259, P97, DOI 10.1002/(SICI)1097-0185(20000501)259:1<97::AID-AR11>3.0.CO;2-O; ROBERTS AB, 1985, CANCER SURV, V4, P683; Roberts AB, 2003, P NATL ACAD SCI USA, V100, P8621, DOI 10.1073/pnas.1633291100; Seoane J, 2006, CARCINOGENESIS, V27, P2148, DOI 10.1093/carcin/bgl068; Serrati S, 2009, BIOCHEM PHARMACOL, V77, P813, DOI 10.1016/j.bcp.2008.10.036; Stefansson S, 1996, NATURE, V383, P441, DOI 10.1038/383441a0; Stefansson S, 2001, J BIOL CHEM, V276, P8135, DOI 10.1074/jbc.M007609200; Suzuki Y, 2010, J CELL SCI, V123, P1684, DOI 10.1242/jcs.061556; Taylor MA, 2011, GENE EXPRESSION, V15, P117, DOI 10.3727/105221611X13176664479322; Tian MZ, 2011, CELL SIGNAL, V23, P951, DOI 10.1016/j.cellsig.2010.10.015; UEKI N, 1992, BIOCHIM BIOPHYS ACTA, V1137, P189; Upton PD, 2008, MOL PHARMACOL, V73, P539, DOI 10.1124/mol.107.041673; Vicent S, 2008, CANCER RES, V68, P2275, DOI 10.1158/0008-5472.CAN-07-6493; Wakefield L M, 1990, Immunol Ser, V51, P217; WALL NA, 1994, CURR OPIN GENET DEV, V4, P517, DOI 10.1016/0959-437X(94)90066-C; Yamashita H, 1997, EXP CELL RES, V235, P218, DOI 10.1006/excr.1997.3664; Zu XY, 2012, CELL TISSUE RES, V347, P73, DOI 10.1007/s00441-011-1225-3	53	23	23	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 30	2012	7	11							e50342	10.1371/journal.pone.0050342	http://dx.doi.org/10.1371/journal.pone.0050342			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	054WM	23226264	Green Published, gold, Green Submitted			2022-12-27	WOS:000312376100074
J	May, AM; Romaguera, D; Travier, N; Ekelund, U; Bergmann, MM; Kaaks, R; Teucher, B; Steffen, A; Boeing, H; Halkjaer, J; Tjonneland, A; Jakobsen, MU; Overvad, K; Dartois, L; Fagherazzi, G; Boutron-Ruault, MC; Quiros, JR; Agudo, A; Gonzalez, C; Sanchez, MJ; Amiano, P; Huerta, JM; Ardanaz, E; Wareham, NJ; Crowe, FL; Naska, A; Orfanos, P; Trichopoulou, A; Palli, D; Agnoli, C; Tumino, R; Vineis, P; Panico, S; Bueno-de-Mesquita, HB; Verschuren, M; Drake, I; Sonestedt, E; Braaten, T; Rinaldi, S; Romieu, I; Slimani, N; Norat, T; Riboli, E; Peeters, PHM				May, Anne M.; Romaguera, Dora; Travier, Noemie; Ekelund, Ulf; Bergmann, Manuela M.; Kaaks, Rudolf; Teucher, Birgit; Steffen, Annika; Boeing, Heiner; Halkjaer, Jytte; Tjonneland, Anne; Jakobsen, Marianne Uhre; Overvad, Kim; Dartois, Laureen; Fagherazzi, Guy; Boutron-Ruault, Marie-Christine; Ramon Quiros, J.; Agudo, Antonio; Gonzalez, Carlos; Sanchez, Maria-Jose; Amiano, Pilar; Huerta, Jose-Maria; Ardanaz, Eva; Wareham, Nicholas J.; Crowe, Francesca L.; Naska, Androniki; Orfanos, Philippos; Trichopoulou, Antonia; Palli, Domenico; Agnoli, Claudia; Tumino, Rosario; Vineis, Paolo; Panico, Salvatore; Bueno-de-Mesquita, H. Bas; Verschuren, Monique; Drake, Isabel; Sonestedt, Emily; Braaten, Tonje; Rinaldi, Sabina; Romieu, Isabelle; Slimani, Nadia; Norat, Teresa; Riboli, Elio; Peeters, Petra H. M.			Combined Impact of Lifestyle Factors on Prospective Change in Body Weight and Waist Circumference in Participants of the EPIC-PANACEA Study	PLOS ONE			English	Article							RANDOMIZED CONTROLLED-TRIAL; MODIFIED MEDITERRANEAN DIET; PHYSICAL-ACTIVITY; PROSPECTIVE COHORT; ABDOMINAL ADIPOSITY; ALCOHOL-CONSUMPTION; HEALTH BEHAVIORS; MASS INDEX; WOMEN; CANCER	Background: The evidence that individual dietary and lifestyle factors influence a person's weight and waist circumference is well established; however their combined impact is less well documented. Therefore, we investigated the combined effect of physical activity, nutrition and smoking status on prospective gain in body weight and waist circumference. Methods: We used data of the prospective EPIC-PANACEA study. Between 1992 and 2000, 325,537 participants (94,445 men and 231,092 women, aged between 25-70) were recruited from nine European countries. Participants were categorised into two groups (positive or negative health behaviours) for each of the following being physically active, adherent to a healthy (Mediterranean not including alcohol) diet, and never-smoking for a total score ranging from zero to three. Anthropometric measures were taken at baseline and were mainly self-reported after a medium follow-up time of 5 years. Results: Mixed-effects linear regression models adjusted for age, educational level, alcohol consumption, baseline body mass index and follow-up time showed that men and women who reported to be physically active, never-smoking and adherent to the Mediterranean diet gained over a 5-year period 537 (95% CI -706, -368) and 200 (-478, -87) gram less weight and 0.95 (-1.27, -0.639) and 0.99 (-1.29, -0.69) cm less waist circumference, respectively, compared to participants with zero healthy behaviours. Conclusion: The combination of positive health behaviours was associated with significantly lower weight and waist circumference gain.	[May, Anne M.; Verschuren, Monique; Peeters, Petra H. M.] Univ Med Ctr Utrecht, Julius Ctr Hlth Sci & Primary Care, Utrecht, Netherlands; [Bueno-de-Mesquita, H. Bas] Univ Med Ctr Utrecht, Dept Gastroenterol & Hepatol, Utrecht, Netherlands; [May, Anne M.; Bueno-de-Mesquita, H. Bas; Verschuren, Monique] Natl Inst Publ Hlth & Environm RIVM, Bilthoven, Netherlands; [Romaguera, Dora; Vineis, Paolo; Norat, Teresa; Riboli, Elio; Peeters, Petra H. M.] Univ London Imperial Coll Sci Technol & Med, Dept Epidemiol & Biostat, Sch Publ Hlth, London, England; [Travier, Noemie; Agudo, Antonio; Gonzalez, Carlos] Catalan Inst Oncol, Unit Nutr Environm & Canc, Barcelona, Spain; [Ekelund, Ulf; Wareham, Nicholas J.] Inst Metab Sci, MRC, Epidemiol Unit, Cambridge, England; [Bergmann, Manuela M.; Steffen, Annika; Boeing, Heiner] German Inst Human Nutr, Dept Epidemiol, Potsdam, Germany; [Kaaks, Rudolf; Teucher, Birgit] German Canc Res Ctr, Div Clin Epidemiol, D-6900 Heidelberg, Germany; [Halkjaer, Jytte; Tjonneland, Anne] Danish Canc Soc, Inst Canc Epidemiol, Copenhagen, Denmark; [Jakobsen, Marianne Uhre; Overvad, Kim] Aarhus Univ Hosp, Dept Clin Epidemiol, DK-8000 Aarhus, Denmark; [Overvad, Kim] Aarhus Univ Hosp, Dept Cardiol, Cardiovasc Res Ctr, Aalborg Hosp, Aalborg, Denmark; [Dartois, Laureen; Fagherazzi, Guy; Boutron-Ruault, Marie-Christine] Inst Gustave Roussy, INSERM, CESP Ctr Res Epidemiol & Populat Hlth, F-94805 Villejuif, France; [Dartois, Laureen; Fagherazzi, Guy; Boutron-Ruault, Marie-Christine] Univ Paris 11, Villejuif, France; [Ramon Quiros, J.] Publ Hlth & Participat Directorate, Asturias, Spain; [Sanchez, Maria-Jose] Andalusian Sch Publ Hlth, Granada, Spain; [Sanchez, Maria-Jose; Amiano, Pilar; Huerta, Jose-Maria; Ardanaz, Eva] CIBER Epidemiol & Publ Hlth CIBERESP, Barcelona, Spain; [Huerta, Jose-Maria] Reg Hlth Author, Dept Epidemiol, Murcia, Spain; [Ardanaz, Eva] Navarra Publ Hlth Inst, Pamplona, Spain; [Crowe, Francesca L.] Univ Oxford, Canc Epidemiol Unit, Oxford, England; [Naska, Androniki; Orfanos, Philippos; Trichopoulou, Antonia] Univ Athens, Sch Med, WHO Collaborating Ctr Food & Nutr Policies, Dept Hyg Epidemiol & Med Stat, GR-11527 Athens, Greece; [Naska, Androniki; Orfanos, Philippos; Trichopoulou, Antonia] Hellen Hlth Fdn, Athens, Greece; [Palli, Domenico] CSPO Sci Inst Tuscany, Mol & Nutr Epidemiol Unit, Florence, Italy; [Agnoli, Claudia] Natl Canc Inst, Nutr Epidemiol Unit, IRCCS Fdn, I-20133 Milan, Italy; [Tumino, Rosario] Civile M PArezzo Hosp, Canc Registry, Ragusa, Italy; [Tumino, Rosario] Civile M PArezzo Hosp, Histopathol Unit, Ragusa, Italy; [Vineis, Paolo] HuGeF Fdn, Turin, Italy; [Panico, Salvatore] Univ Naples Federico II, Dipartimento Med Clin & Sperimentale, Naples, Italy; [Romieu, Isabelle; Slimani, Nadia] Lund Univ, Dept Clin Sci Malmo, Lund, Sweden; [Braaten, Tonje] Univ Tromso, Inst Community Med, Tromso, Norway; [Rinaldi, Sabina; Romieu, Isabelle; Slimani, Nadia] Int Agcy Res Canc IARC WHO, Lyon, France	Utrecht University; Utrecht University Medical Center; Utrecht University; Utrecht University Medical Center; Netherlands National Institute for Public Health & the Environment; Imperial College London; Catalan Institute of Oncology; University of Cambridge; Deutsches Institut fur Ernahrungsforschung Potsdam-Rehbrucke (DIfE); Helmholtz Association; German Cancer Research Center (DKFZ); Danish Cancer Society; Aarhus University; Aalborg University; Aalborg University Hospital; Aarhus University; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Saclay; UNICANCER; Gustave Roussy; UDICE-French Research Universities; Universite Paris Saclay; Escuela Andaluza de Salud Publica; CIBER - Centro de Investigacion Biomedica en Red; CIBERESP; Public Health Institute of Navarra; University of Oxford; Athens Medical School; National & Kapodistrian University of Athens; World Health Organization; Fondazione IRCCS Istituto Nazionale Tumori Milan; IRCCS Ca Granda Ospedale Maggiore Policlinico; Civile M.P. Arezzo Hospital; Civile M.P. Arezzo Hospital; University of Naples Federico II; Lund University; UiT The Arctic University of Tromso; World Health Organization; International Agency for Research on Cancer (IARC)	May, AM (corresponding author), Univ Med Ctr Utrecht, Julius Ctr Hlth Sci & Primary Care, Utrecht, Netherlands.	a.m.may@umcutrecht.nl	May, Anne M/G-9183-2011; Ekelund, Ulf/AAE-8471-2019; Jakobsen, Marianne Uhre/I-8550-2018; Sonestedt, Emily/I-3814-2016; Teucher, Birgit/J-6380-2015; Steffen, Annika/E-8540-2016; Huerta, José María/N-8654-2015; Fagherazzi, Guy/P-3534-2017; Agudo, Antonio/J-1805-2016; Boutron-Ruault, Marie-Christine/H-3936-2014; Romaguera, Dora/ABE-7004-2020; Steffen, Annika/H-7709-2018; Romaguera, Dora/AAB-2852-2020; Agnoli, Claudia/K-5916-2016; Sánchez, Maria-José/D-1087-2011; Dartois, Laureen/C-4745-2013; TRICHOPOULOU, ANTONIA/ABF-8727-2021; Fagherazzi, Guy/ABB-2555-2020; Orfanos, Philippos/AAL-2606-2021	Ekelund, Ulf/0000-0003-2115-9267; Jakobsen, Marianne Uhre/0000-0001-6518-4136; Sonestedt, Emily/0000-0002-0747-4562; Steffen, Annika/0000-0003-4072-9245; Huerta, José María/0000-0002-9637-3869; Fagherazzi, Guy/0000-0001-5033-5966; Agudo, Antonio/0000-0001-9900-5677; Boutron-Ruault, Marie-Christine/0000-0002-5956-5693; Romaguera, Dora/0000-0002-5762-8558; Steffen, Annika/0000-0003-4072-9245; Agnoli, Claudia/0000-0003-4472-1179; Sánchez, Maria-José/0000-0003-4817-0757; TRICHOPOULOU, ANTONIA/0000-0002-7204-6396; Fagherazzi, Guy/0000-0001-5033-5966; Drake, Isabel/0000-0002-6500-6310; Naska, Androniki/0000-0002-1610-1813; Riboli, Elio/0000-0001-6795-6080; PALLI, Domenico/0000-0002-5558-2437; tumino, rosario/0000-0003-2666-414X; Panico, Salvatore/0000-0002-5498-8312; Overvad, Kim/0000-0001-6429-7921; Orfanos, Philippos/0000-0002-9949-3137; Travier, Noemie/0000-0001-5228-7769; Crowe, Francesca/0000-0003-4026-1726; Tjonneland, Anne/0000-0003-4385-2097	Public Health Programme of the European Union [2005328]; European Commission: Public Health and Consumer Protection Directorate; Research Directorate-General; Ligue contre le Cancer; Societe 3M; Mutuelle Generale de l'Education Nationale; Institut National de la Sante et de la Recherche Medicale (INSERM) (France); German Cancer Aid; German Cancer Research Center; Federal Ministry of Education and Research (Germany); Danish Cancer Society (Denmark); Health Research Institute Carlos III from the Spanish Ministry of Health [RETICC RD06/0020]; Cancer Research UK; Medical Research Council; Stroke Association; British Heart Foundation; Department of Health, Food Standards Agency; Wellcome Trust (United Kingdom); Hellenic Health Foundation; Stavros Niarchos Foundation; Greek Ministry of Health and Social Solidarity (Greece); Italian Association for Research on Cancer; National Research Council (Italy); Dutch Ministry of Public Health, Welfare and Sports; Dutch Ministry of Health; Dutch Prevention Funds; LK Research Funds; Dutch ZON (Zorg Onderzoek Nederland); World Cancer Research Fund (WCRF) (The Netherlands); Swedish Cancer Society; Swedish Scientific Council; Regional Government of Skane (Sweden); Norwegian Cancer Society (Norway)	Public Health Programme of the European Union; European Commission: Public Health and Consumer Protection Directorate(European CommissionEuropean Commission Joint Research Centre); Research Directorate-General; Ligue contre le Cancer(Ligue nationale contre le cancer); Societe 3M(3M); Mutuelle Generale de l'Education Nationale; Institut National de la Sante et de la Recherche Medicale (INSERM) (France)(Institut National de la Sante et de la Recherche Medicale (Inserm)); German Cancer Aid(Deutsche Krebshilfe); German Cancer Research Center; Federal Ministry of Education and Research (Germany)(Federal Ministry of Education & Research (BMBF)); Danish Cancer Society (Denmark)(Danish Cancer Society); Health Research Institute Carlos III from the Spanish Ministry of Health; Cancer Research UK(Cancer Research UK); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Stroke Association; British Heart Foundation(British Heart Foundation); Department of Health, Food Standards Agency; Wellcome Trust (United Kingdom)(Wellcome Trust); Hellenic Health Foundation; Stavros Niarchos Foundation; Greek Ministry of Health and Social Solidarity (Greece); Italian Association for Research on Cancer(Fondazione AIRC per la ricerca sul cancro); National Research Council (Italy)(Consiglio Nazionale delle Ricerche (CNR)); Dutch Ministry of Public Health, Welfare and Sports; Dutch Ministry of Health; Dutch Prevention Funds; LK Research Funds; Dutch ZON (Zorg Onderzoek Nederland)(Netherlands Organization for Scientific Research (NWO)); World Cancer Research Fund (WCRF) (The Netherlands)(Netherlands GovernmentWorld Cancer Research Fund International (WCRF)); Swedish Cancer Society(Swedish Cancer Society); Swedish Scientific Council; Regional Government of Skane (Sweden); Norwegian Cancer Society (Norway)(Norwegian Cancer Society)	The EPIC-PANACEA ((European Prospective Investigation into Cancer-Physical Activity, Nutrition, Alcohol, Cessation of Smoking, Eating out of home And obesity) project received funding from the Public Health Programme of the European Union (2005328). EPIC was financially supported by the European Commission: Public Health and Consumer Protection Directorate 1993-2004; Research Directorate-General 2005-."; Ligue contre le Cancer, Societe 3M, Mutuelle Generale de l'Education Nationale, Institut National de la Sante et de la Recherche Medicale (INSERM) (France); German Cancer Aid, German Cancer Research Center, Federal Ministry of Education and Research (Germany); Danish Cancer Society (Denmark); Health Research Institute Carlos III (RETICC RD06/0020) from the Spanish Ministry of Health, the participating regional governments and institutions (Spain); Cancer Research UK, Medical Research Council, Stroke Association, British Heart Foundation, Department of Health, Food Standards Agency, the Wellcome Trust (United Kingdom); Hellenic Health Foundation, Stavros Niarchos Foundation and Greek Ministry of Health and Social Solidarity (Greece); Italian Association for Research on Cancer, National Research Council (Italy); Dutch Ministry of Public Health, Welfare and Sports, Dutch Ministry of Health, Dutch Prevention Funds, LK Research Funds, Dutch ZON (Zorg Onderzoek Nederland), World Cancer Research Fund (WCRF) (The Netherlands); Swedish Cancer Society, Swedish Scientific Council, Regional Government of Skane (Sweden); Norwegian Cancer Society (Norway). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andrews RC, 2011, LANCET, V378, P129, DOI 10.1016/S0140-6736(11)60442-X; [Anonymous], 2011, OB EUR; Bamia C, 2004, INT J OBESITY, V28, P1091, DOI 10.1038/sj.ijo.0802697; Besson H, 2009, INT J OBESITY, V33, P497, DOI 10.1038/ijo.2009.25; Bigaard J, 2005, J NUTR, V135, P2263; Bullo M, 2011, PREV MED, V53, P155, DOI 10.1016/j.ypmed.2011.06.008; Campbell KL, 2012, J CLIN ONCOL, V30, P2314, DOI 10.1200/JCO.2011.37.9792; Chiuve SE, 2008, CIRCULATION, V118, P947, DOI 10.1161/CIRCULATIONAHA.108.781062; Ekelund U, 2011, AM J CLIN NUTR; Esposito K, 2011, METAB SYNDR RELAT D, V9, P1, DOI 10.1089/met.2010.0031; Fogelholm M, 2000, Obes Rev, V1, P95, DOI 10.1046/j.1467-789x.2000.00016.x; Ford ES, 2009, ARCH INTERN MED, V169, P1355, DOI 10.1001/archinternmed.2009.237; Gorber SC, 2007, OBES REV, V8, P307, DOI 10.1111/j.1467-789X.2007.00347.x; Haftenberger M, 2002, PUBLIC HEALTH NUTR, V5, P1147, DOI 10.1079/PHN2002396; Joosten MM, 2010, AM J CLIN NUTR, V91, P1777, DOI 10.3945/ajcn.2010.29170; Kahn HS, 1997, AM J PUBLIC HEALTH, V87, P747, DOI 10.2105/AJPH.87.5.747; Khaw KT, 2008, PLOS MED, V5, P39, DOI 10.1371/journal.pmed.0050012; Kirkegaard H, 2010, BRIT MED J, V341, DOI 10.1136/bmj.c5504; Knoops KTB, 2004, JAMA-J AM MED ASSOC, V292, P1433, DOI 10.1001/jama.292.12.1433; Koh-Banerjee P, 2003, AM J CLIN NUTR, V78, P719, DOI 10.1093/ajcn/78.4.719; Kurth T, 2006, ARCH INTERN MED, V166, P1403, DOI 10.1001/archinte.166.13.1403; May AM, 2010, AM J CLIN NUTR, V92, P491, DOI 10.3945/ajcn.2010.29404; Molenaar EA, 2009, DIABETES CARE, V32, P505, DOI 10.2337/dc08-1382; Mozaffarian D, 2011, NEW ENGL J MED, V364, P2392, DOI 10.1056/NEJMoa1014296; Mozaffarian D, 2009, ARCH INTERN MED, V169, P798, DOI 10.1001/archinternmed.2009.21; Myint PK, 2009, BRIT MED J, V338, DOI 10.1136/bmj.b349; Nechuta SJ, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000339; Pischon T, 2008, NEW ENGL J MED, V359, P2105, DOI 10.1056/NEJMoa0801891; Rankinen T, 1999, INT J OBESITY, V23, P801, DOI 10.1038/sj.ijo.0800929; Riboli E, 2002, PUBLIC HEALTH NUTR, V5, P1113, DOI 10.1079/PHN2002394; Rimm E B, 1990, Epidemiology, V1, P466, DOI 10.1097/00001648-199011000-00009; Romaguera D, 2010, AM J CLIN NUTR, V92, P912, DOI 10.3945/ajcn.2010.29482; Romaguera D, 2009, J NUTR, V139, P1728, DOI 10.3945/jn.109.108902; Ronksley PE, 2011, BMJ-BRIT MED J, V342, DOI 10.1136/bmj.d671; Room R, 2005, LANCET, V365, P519, DOI 10.1016/S0140-6736(05)70276-2; Schutze M, 2011, BMJ-BRIT MED J, V342, DOI 10.1136/bmj.d1584; Slimani N, 2002, PUBLIC HEALTH NUTR, V5, P1125, DOI 10.1079/PHN2002395; Sofi F, 2008, BMJ-BRIT MED J, V337, DOI 10.1136/bmj.a1344; Spencer EA, 2002, PUBLIC HEALTH NUTR, V5, P561, DOI 10.1079/PHN2001322; The InterAct Consortium, 2011, EUR J EPIDE IN PRESS; Travier N, 2012, PREV MED, V54, P183, DOI 10.1016/j.ypmed.2011.09.003; Travier N, 2009, PREV MED, V49, P365, DOI 10.1016/j.ypmed.2009.08.009; Trichopoulou A, 2007, EUR J EPIDEMIOL, V22, P871, DOI 10.1007/s10654-007-9190-6; Trichopoulou A, 2005, BMJ-BRIT MED J, V330, P991, DOI 10.1136/bmj.38415.644155.8F; Trichopoulou A, 2003, NEW ENGL J MED, V348, P2599, DOI 10.1056/NEJMoa025039; van Dam RM, 2008, BRIT MED J, V337, pa1440, DOI [DOI 10.1136/BMJ.A1440, 10.1136/bmj.a1440]; van den Brandt PA, 2011, AM J CLIN NUTR, V94, P913, DOI 10.3945/ajcn.110.008250; Vergnaud AC, 2010, AM J CLIN NUTR, V92, P398, DOI 10.3945/ajcn.2009.28713; Wareham NJ, 2003, PUBLIC HEALTH NUTR, V6, P407, DOI 10.1079/PHN2002439; WILLETT WC, 1995, JAMA-J AM MED ASSOC, V273, P461, DOI 10.1001/jama.273.6.461; World Cancer Research Fund and American Institute for Cancer Research, 2007, FOOD NUTR PHYS ACT P	51	18	19	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 30	2012	7	11							e50712	10.1371/journal.pone.0050712	http://dx.doi.org/10.1371/journal.pone.0050712			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	054WM	23226361	gold, Green Published, Green Submitted			2022-12-27	WOS:000312376100172
J	Mazza, V; Caramazza, A				Mazza, Veronica; Caramazza, Alfonso			Perceptual Grouping and Visual Enumeration	PLOS ONE			English	Article							SHORT-TERM-MEMORY; INDIVIDUAL-DIFFERENCES; NEURAL MEASURES; N2PC COMPONENT; ATTENTION; CAPACITY; OBJECTS; HETEROGENEITY; INFORMATION; TRACKING	We used lateralized Event-Related Potential (ERP) measures - the N2pc and CDA/SPCN components - to assess the role of grouping by target similarity during enumeration. Participants saw a variable number (0, 1, 2 or 3) of same- or differently-colored targets presented among homogeneous distracters, and performed an enumeration task. Results showed that the N2pc, but not the CDA, was larger for multiple targets of identical color relative to targets of different colors. The findings are interpreted in terms of the effects of grouping on early versus late stages of multiple object processing. Within this framework, they reveal that grouping has an effect on early individuation mechanisms, while later processing mechanisms are less prone to such an influence.	[Mazza, Veronica; Caramazza, Alfonso] Univ Trento, Ctr Mind Brain Sci CIMeC, Rovereto, Italy; [Mazza, Veronica] Univ Trento, Dept Cognit Sci & Educ, Rovereto, Italy; [Caramazza, Alfonso] Harvard Univ, Dept Psychol, Cambridge, MA 02138 USA	University of Trento; University of Trento; Harvard University	Mazza, V (corresponding author), Univ Trento, Ctr Mind Brain Sci CIMeC, Rovereto, Italy.	veronica.mazza@unitn.it		Mazza, Veronica/0000-0002-8898-4651	Fondazione Cassa di Risparmio di Trento e Rovereto (Italy)	Fondazione Cassa di Risparmio di Trento e Rovereto (Italy)	Funding was provided by Fondazione Cassa di Risparmio di Trento e Rovereto (Italy). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alvarez GA, 2004, PSYCHOL SCI, V15, P106, DOI 10.1111/j.0963-7214.2004.01502006.x; Cavanagh P, 2012, SPACE TIME NUMBER AT; Drew T, 2008, J NEUROSCI, V28, P4183, DOI 10.1523/JNEUROSCI.0556-08.2008; Driver J, 2001, COGNITION, V80, P61, DOI 10.1016/S0010-0277(00)00151-7; Eimer M, 1996, ELECTROEN CLIN NEURO, V99, P225, DOI 10.1016/0013-4694(96)95711-9; Eimer M, 2009, J EXP PSYCHOL HUMAN, V35, P1316, DOI 10.1037/a0015872; Ester EF, 2012, J NEUROSCI, V32, P7169, DOI 10.1523/JNEUROSCI.1218-12.2012; FRICK RW, 1987, PERCEPT PSYCHOPHYS, V41, P8, DOI 10.3758/BF03208207; Gao ZF, 2009, J VISION, V9, DOI 10.1167/9.7.17; He LX, 2009, PSYCHON B REV, V16, P509, DOI 10.3758/PBR.16.3.509; Hickey C, 2006, J COGNITIVE NEUROSCI, V18, P604, DOI 10.1162/jocn.2006.18.4.604; Ikkai A, 2010, J NEUROPHYSIOL, V103, P1963, DOI 10.1152/jn.00978.2009; Itti L, 2001, NAT REV NEUROSCI, V2, P194, DOI 10.1038/35058500; Jolicoeur P, 2006, PSYCHOL RES-PSYCH FO, V70, P414, DOI 10.1007/s00426-005-0008-4; KAHNEMAN D, 1992, COGNITIVE PSYCHOL, V24, P175, DOI 10.1016/0010-0285(92)90007-O; KAUFMAN EL, 1949, AM J PSYCHOL, V62, P498, DOI 10.2307/1418556; Kiss M, 2008, PSYCHOPHYSIOLOGY, V45, P240, DOI 10.1111/j.1469-8986.2007.00611.x; Lin PH, 2009, VIS COGN, V17, P356, DOI 10.1080/13506280701766313; LUCK SJ, 1994, PSYCHOPHYSIOLOGY, V31, P291, DOI 10.1111/j.1469-8986.1994.tb02218.x; Luria R, 2010, J COGNITIVE NEUROSCI, V22, P496, DOI 10.1162/jocn.2009.21214; Mazza V, 2007, EXP BRAIN RES, V181, P531, DOI 10.1007/s00221-007-1002-4; Mazza V, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017453; Mazza V, 2009, PSYCHOPHYSIOLOGY, V46, P771, DOI 10.1111/j.1469-8986.2009.00814.x; Melcher D, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0029296; Olivers CNL, 2008, VIS COGN, V16, P439, DOI 10.1080/13506280701825861; Pagano S, 2012, NEUROPSYCHOLOGIA, V50, P754, DOI 10.1016/j.neuropsychologia.2012.01.009; Palomares M, 2010, VISION RES, V50, P2000, DOI 10.1016/j.visres.2010.07.011; Pincham HL, 2012, COGNITION, V124, P107, DOI 10.1016/j.cognition.2012.05.010; Puts MJH, 1997, ACTA PSYCHOL, V97, P71, DOI 10.1016/S0001-6918(97)00024-3; Pylyshyn ZW, 2001, COGNITION, V80, P127, DOI 10.1016/S0010-0277(00)00156-6; Scholl BJ, 2001, COGNITION, V80, P1, DOI 10.1016/S0010-0277(00)00152-9; Trick LM, 2008, PERCEPT PSYCHOPHYS, V70, P743, DOI 10.3758/PP.70.5.743; TRICK LM, 1994, PSYCHOL REV, V101, P80, DOI 10.1037/0033-295X.101.1.80; Vetter P, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003269; Vogel EK, 2004, NATURE, V428, P748, DOI 10.1038/nature02447; Watson DG, 2006, PERCEPT PSYCHOPHYS, V68, P319, DOI 10.3758/BF03193679; Wauschkuhn B, 1998, J NEUROPHYSIOL, V80, P2900, DOI 10.1152/jn.1998.80.6.2900; Wolfe J. M., 1995, LINKING PSYCHOPHYSIC, P189; Woodman GF, 2009, BRAIN RES, V1297, P101, DOI 10.1016/j.brainres.2009.08.011; Xu YD, 2009, TRENDS COGN SCI, V13, P167, DOI 10.1016/j.tics.2009.01.008; Xu YD, 2009, J COGNITIVE NEUROSCI, V21, P511, DOI 10.1162/jocn.2008.21024; YANTIS S, 1992, COGNITIVE PSYCHOL, V24, P295, DOI 10.1016/0010-0285(92)90010-Y	42	14	15	2	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 30	2012	7	11							e50862	10.1371/journal.pone.0050862	http://dx.doi.org/10.1371/journal.pone.0050862			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	054WM	23226408	Green Published, gold, Green Submitted			2022-12-27	WOS:000312376100219
J	Sachdeva, R; Bhardwaj, N; Huhtaniemi, I; Aggrawal, U; Jain, SK; Zaidi, R; Singh, O; Pal, R				Sachdeva, Ruchi; Bhardwaj, Neetu; Huhtaniemi, Ilpo; Aggrawal, Usha; Jain, Swatantra Kumar; Zaidi, Rana; Singh, Om; Pal, Rahul			Transgenesis-Mediated Reproductive Dysfunction and Tumorigenesis: Effects of Immunological Neutralization	PLOS ONE			English	Article							HUMAN CHORIONIC-GONADOTROPIN; GROWTH-FACTOR VEGF; NF-KAPPA-B; BETA-SUBUNIT; LUTEINIZING-HORMONE; PITUITARY TUMORIGENESIS; UP-REGULATION; CANCER CELLS; COLORECTAL-CANCER; ENDOTHELIAL-CELLS	Human chorionic gonadotropin (hCG) was initially thought to be made only during pregnancy, but is now known to also be synthesized by a variety of cancers and is associated with poor patient prognosis. Transgenic expression of beta hCG in mice causes hyper-luteinized ovaries, a loss in estrous cyclicity and infertility, increased body weight, prolactinomas and mammary gland tumors. Strategies were devised to generate antibody responses against hCG to investigate whether reversal of the molecular processes driving tumorigenesis would follow. hCG-immunized transgenic mice did not exhibit increases in body weight or serum prolactin levels, and gross ovarian and pituitary morphology remained normal. While non-immunized transgenic animals demonstrated heightened levels of transcripts associated with pituitary tumorigenesis (HMG2A, E2F1, CCND1, PRL, GH, GAL, PTTG1, BMP4) and decreased levels of CDK inhibitors CDKN1B (p27), CDKN2A (p16) and CDKN2c (p18), immunization led to a reversal to levels found in non-transgenic animals. Serum derived from transgenic (but not non-transgenic) mice led to enhanced transcription as well as expression of VEGF, IL-8, KC (murine IL-8) and MMP-9 in tumor cells, effects not seen when sera derived from hCG-immunized transgenic mice was employed. As the definitive indication of the restoration of the reproductive axis, immunization led to the resumption of estrous cyclicity as well as fertility in transgenic mice. These results indicate that hCG may influence cancer pathogenesis and progression via several distinct mechanisms. Using a stringent in vivo system in which beta hCG acts both a "self" antigen and a tumor-promoting moiety (putatively akin to the situation in humans), the data builds a case for anti-gonadotropin vaccination strategies in the treatment of gonadotropin-dependent or secreting malignancies that frequently acquire resistance to conventional therapy.	[Sachdeva, Ruchi; Jain, Swatantra Kumar; Zaidi, Rana] Jamia Hamdard, Dept Biochem, Fac Sci, New Delhi, India; [Sachdeva, Ruchi; Bhardwaj, Neetu; Singh, Om; Pal, Rahul] Natl Inst Immunol, New Delhi 110067, India; [Huhtaniemi, Ilpo] Univ Turku, Dept Physiol, Turku, Finland; [Huhtaniemi, Ilpo] Univ London Imperial Coll Sci Technol & Med, Dept Reprod & Dev Biol, London, England; [Aggrawal, Usha] Safdarjang Hosp, Inst Pathol, New Delhi, India	Jamia Hamdard University; Department of Biotechnology (DBT) India; National Institute of Immunology (NII); University of Turku; Imperial College London; Indian Council of Medical Research (ICMR); ICMR - National Institute of Pathology (IOP); Vardhman Mahavir Medical College & Safdarjung Hospital	Zaidi, R (corresponding author), Jamia Hamdard, Dept Biochem, Fac Sci, New Delhi, India.	ranaamu@yahoo.com; omsingh@gmail.com; rahul@nii.ac.in	Bhardwaj, Neetu/GPW-9579-2022		Department of Biotechnology, Government of India	Department of Biotechnology, Government of India(Department of Biotechnology (DBT) India)	This study was funded by core and extramural grants from the Department of Biotechnology, Government of India. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acevedo HF, 1996, CANCER, V78, P2388, DOI 10.1002/(SICI)1097-0142(19961201)78:11<2388::AID-CNCR18>3.0.CO;2-X; Ahtiainen P, 2010, ENDOCR-RELAT CANCER, V17, P611, DOI 10.1677/ERC-10-0016; Ballas MS, 2011, ONCOTARGETS THER, V4, P43, DOI 10.2147/OTT.S18155; Bancroft CC, 2001, CLIN CANCER RES, V7, P435; Belotti D, 2003, CANCER RES, V63, P5224; Choi JH, 2007, ENDOCR REV, V28, P440, DOI 10.1210/er.2006-0036; Cole LA, 2006, J REPROD MED, V51, P919; Crawford RAF, 1998, J CLIN PATHOL, V51, P685, DOI 10.1136/jcp.51.9.685; Devi GR, 2002, PROSTATE, V53, P200, DOI 10.1002/pros.10151; Fedele M, 2006, CANCER CELL, V9, P459, DOI 10.1016/j.ccr.2006.04.024; Fluhr H, 2008, FERTIL STERIL, V90, P1384, DOI [10.1016/j.fertnstert.2007.07.1357, 10.1016/j.fertnstert.2007.08.023]; Franklin DS, 1998, GENE DEV, V12, P2899, DOI 10.1101/gad.12.18.2899; Freeman ME, 2000, PHYSIOL REV, V80, P1523, DOI 10.1152/physrev.2000.80.4.1523; Freemark M, 2001, ENDOCRINOLOGY, V142, P532, DOI 10.1210/en.142.2.532; Ghosh S, 2012, J BIOL CHEM, V287, P15001, DOI 10.1074/jbc.M111.284034; Gillott DJ, 1996, BRIT J CANCER, V73, P323, DOI 10.1038/bjc.1996.56; Hamada AL, 2005, J CLIN ENDOCR METAB, V90, P4873, DOI 10.1210/jc.2004-2458; Huhtaniemi I, 2005, MOL CELL ENDOCRINOL, V234, P117, DOI 10.1016/j.mce.2004.10.013; HYDE JF, 1991, ENDOCRINOLOGY, V129, P270, DOI 10.1210/endo-129-1-270; Jankowska A, 2008, MOL CANCER, V7, DOI 10.1186/1476-4598-7-26; Kirsch M, 2009, GENE CHROMOSOME CANC, V48, P143, DOI 10.1002/gcc.20621; Kosaka K, 2002, J CLIN ENDOCR METAB, V87, P5199, DOI 10.1210/jc.2002-020341; KUMAR S, 1992, J NATL CANCER I, V84, P42, DOI 10.1093/jnci/84.1.42; Kuroda H, 1998, INT J CANCER, V76, P571, DOI 10.1002/(SICI)1097-0215(19980518)76:4<571::AID-IJC21>3.3.CO;2-P; Lee TH, 2002, J BIOL CHEM, V277, P10445, DOI 10.1074/jbc.M107348200; Li AH, 2003, J IMMUNOL, V170, P3369, DOI 10.4049/jimmunol.170.6.3369; Liu G, 1999, NEW ENGL J MED, V341, P1731, DOI 10.1056/NEJM199912023412304; Luca M, 1997, AM J PATHOL, V151, P1105; Lundin M, 2000, ANTICANCER RES, V20, P4949; Martin D, 2009, J BIOL CHEM, V284, P6038, DOI 10.1074/jbc.C800207200; Masson V, 2004, FASEB J, V18, P234, DOI 10.1096/fj.04-2140fje; Mikola M, 2003, ONCOGENE, V22, P3269, DOI 10.1038/sj.onc.1206518; Moulton HM, 2002, CLIN CANCER RES, V8, P2044; Paez-Pereda M, 2003, P NATL ACAD SCI USA, V100, P1034, DOI 10.1073/pnas.0237312100; PAL R, 1990, AM J REPROD IMMUNOL, V22, P124, DOI 10.1111/j.1600-0897.1990.tb00654.x; Palmieri D, 2012, ENDOCR-RELAT CANCER, V19, P123, DOI 10.1530/ERC-11-0135; Ratner LD, 2012, ENDOCRINOLO IN PRESS, V153; RISMA KA, 1995, P NATL ACAD SCI USA, V92, P1322, DOI 10.1073/pnas.92.5.1322; Rulli SB, 2002, ENDOCRINOLOGY, V143, P4084, DOI 10.1210/en.2002-220490; Sheaff MT, 1996, J CLIN PATHOL, V49, P329, DOI 10.1136/jcp.49.4.329; SINGH O, 1989, FERTIL STERIL, V52, P739; Somiari SB, 2006, INT J CANCER, V119, P1403, DOI 10.1002/ijc.21989; Szturmowicz M, 1999, TUMOR BIOL, V20, P99, DOI 10.1159/000030052; TALWAR GP, 1994, P NATL ACAD SCI USA, V91, P8532, DOI 10.1073/pnas.91.18.8532; Torry DS, 2007, J ASSIST REPROD GEN, V24, P303, DOI 10.1007/s10815-007-9152-7; Vlotides G, 2007, ENDOCR REV, V28, P165, DOI 10.1210/er.2006-0042; Waugh DJJ, 2008, CLIN CANCER RES, V14, P6735, DOI 10.1158/1078-0432.CCR-07-4843; Yamasaki L, 1998, NAT GENET, V18, P360, DOI 10.1038/ng0498-360; Yankai Z, 2006, BIOCHEM BIOPH RES CO, V345, P1365, DOI 10.1016/j.bbrc.2006.05.022; Zhou CQ, 2009, MOL ENDOCRINOL, V23, P2000, DOI 10.1210/me.2009-0161; Zygmunt M, 2002, J CLIN ENDOCR METAB, V87, P5290, DOI 10.1210/jc.2002-020642	51	7	7	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 30	2012	7	11							e51125	10.1371/journal.pone.0051125	http://dx.doi.org/10.1371/journal.pone.0051125			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	054WM	23226476	Green Submitted, Green Published, gold			2022-12-27	WOS:000312376100287
J	Stephen, P; Cheng, KC; Lyu, PC				Stephen, Preyesh; Cheng, Kuo-Chang; Lyu, Ping-Chiang			Crystal Structure of Circular Permuted RoCBM21 (CP90): Dimerisation and Proximity of Binding Sites	PLOS ONE			English	Article							AWAMORI GLUCOAMYLASE SELECTIVITY; ASPERGILLUS-NIGER GLUCOAMYLASE; RHIZOPUS-ORYZAE GLUCOAMYLASE; TS-23 ALPHA-AMYLASE; GUANIDINE-HYDROCHLORIDE; 311-314 LOOP; STARCH; DOMAIN; DENATURATION; CYCLODEXTRIN	Glucoamylases, containing starch-binding domains (SBD), have a wide range of scientific and industrial applications. Random mutagenesis and DNA shuffling of the gene encoding a starch-binding domain have resulted in only minor improvements in the affinities of the corresponding protein to their ligands, whereas circular permutation of the RoCBM21 substantially improved its binding affinity and selectivity towards longer-chain carbohydrates. For the study reported herein, we used a standard soluble ligand (amylose EX-I) to characterize the functional and structural aspects of circularly permuted RoCBM21 (CP90). Site-directed mutagenesis and the analysis of crystal structure reveal the dimerisation and an altered binding path, which may be responsible for improved affinity and altered selectivity of this newly created starch-binding domain. The functional and structural characterization of CP90 suggests that it has significant potential in industrial applications.	[Stephen, Preyesh; Cheng, Kuo-Chang; Lyu, Ping-Chiang] Natl Tsing Hua Univ, Inst Bioinformat & Struct Biol, Hsinchu, Taiwan; [Lyu, Ping-Chiang] Natl Tsing Hua Univ, Dept Med Sci, Hsinchu, Taiwan; [Lyu, Ping-Chiang] China Med Univ, Grad Inst Mol Syst Biomed, Taichung, Taiwan	National Tsing Hua University; National Tsing Hua University; China Medical University Taiwan	Lyu, PC (corresponding author), Natl Tsing Hua Univ, Inst Bioinformat & Struct Biol, Hsinchu, Taiwan.	pclyu@mx.nthu.edu.tw	Stephen, Preyesh/L-1010-2019	Stephen, Preyesh/0000-0003-2889-2701	National Science Council of Taiwan (NSC) [100-2627-B-007-005]; National Science Council of Taiwan, ROC; National Core Facility Program for Biotechnology	National Science Council of Taiwan (NSC)(Ministry of Science and Technology, Taiwan); National Science Council of Taiwan, ROC(Ministry of Science and Technology, Taiwan); National Core Facility Program for Biotechnology	This work was supported by the National Science Council of Taiwan (NSC grant number 100-2627-B-007-005). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank Dr. Chao-Sheng Cheng for his valuable comments and Mrs. Jina Ann John for editing the manuscript. Portions of this research were carried out at the National Synchrotron Radiation Research Center, a national user facility supported by the National Science Council of Taiwan, ROC. The Synchrotron Radiation Protein Crystallography Facility is supported by the National Core Facility Program for Biotechnology.	AGASHE VR, 1995, BIOCHEMISTRY-US, V34, P3286, DOI 10.1021/bi00010a019; ASHIKARI T, 1986, AGR BIOL CHEM TOKYO, V50, P957; Bolam DN, 1998, BIOCHEM J, V331, P775, DOI 10.1042/bj3310775; Boraston AB, 2004, BIOCHEM J, V382, P769, DOI 10.1042/BJ20040892; Brown PH, 2008, COMPUT PHYS COMMUN, V178, P105, DOI 10.1016/j.cpc.2007.08.012; Buchholz K, 2008, CARBOHYD RES, V343, P1966, DOI 10.1016/j.carres.2008.02.007; BUCHWALDER A, 1992, BIOCHEMISTRY-US, V31, P1621, DOI 10.1021/bi00121a006; Buleon A, 1998, INT J BIOL MACROMOL, V23, P85, DOI 10.1016/S0141-8130(98)00040-3; Butler JS, 2009, BIOCHEMISTRY-US, V48, P3497, DOI 10.1021/bi900039e; Chou WI, 2006, BIOCHEM J, V396, P469, DOI 10.1042/BJ20051982; Coutinho PM, 1997, PROTEINS, V29, P334, DOI [10.1002/(SICI)1097-0134(199711)29:3<334::AID-PROT7>3.0.CO;2-A, 10.1002/(SICI)1097-0134(199711)29:3&lt;334::AID-PROT7&gt;3.0.CO;2-A]; Coutinho PM, 1999, MODULAR STRUCTURE CE; French, 1984, STARCH CHEM TECHNOLO; Galliard T., 1987, STARCH PROPERTIES PO; Gessler K, 1999, P NATL ACAD SCI USA, V96, P4246, DOI 10.1073/pnas.96.8.4246; Giardina T, 2001, J MOL BIOL, V313, P1149, DOI 10.1006/jmbi.2001.5097; GUZMANMALDONADO H, 1995, CRIT REV FOOD SCI, V35, P373, DOI 10.1080/10408399509527706; HADDELAND U, 1995, THROMB RES, V77, P329, DOI 10.1016/0049-3848(95)93836-O; HALL J, 1995, BIOCHEM J, V309, P749, DOI 10.1042/bj3090749; Hennecke J, 1999, J MOL BIOL, V286, P1197, DOI 10.1006/jmbi.1998.2531; Hua YW, 2004, J IND MICROBIOL BIOT, V31, P273, DOI 10.1007/s10295-004-0146-5; Huang HB, 2005, BIOPROC BIOSYST ENG, V27, P389, DOI 10.1007/s00449-005-0001-8; IMBERTY A, 1988, J MOL BIOL, V201, P365, DOI 10.1016/0022-2836(88)90144-1; Jiang TY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041131; Kahraman BYSaMV, 2011, STARCH, V63, P154; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Lin SC, 2009, PROTEIN EXPRES PURIF, V65, P261, DOI 10.1016/j.pep.2009.01.008; Liu HL, 1998, PROTEIN ENG, V11, P389, DOI 10.1093/protein/11.5.389; Liu HL, 1999, PROTEIN ENG, V12, P163, DOI 10.1093/protein/12.2.163; Liu YN, 2007, BIOCHEM J, V403, P21, DOI 10.1042/BJ20061312; Lo WC, 2009, NUCLEIC ACIDS RES, V37, pW545, DOI 10.1093/nar/gkp291; MONERA OD, 1994, PROTEIN SCI, V3, P1984, DOI 10.1002/pro.5560031110; Needham J, 1970, CHEM LIF 8 LECT HIST; Osuna J, 2002, PROTEIN ENG, V15, P463, DOI 10.1093/protein/15.6.463; Parker R, 2001, J CEREAL SCI, V34, P1, DOI 10.1006/jcrs.2000.0402; Penninga D, 1996, J BIOL CHEM, V271, P32777, DOI 10.1074/jbc.271.51.32777; Sarko AZ, 1980, DIFFRACTION METHODS, P459; SMITH AM, 1995, PLANT PHYSIOL, V107, P673, DOI 10.1104/pp.107.3.673; Sorimachi K, 1997, STRUCTURE, V5, P647, DOI 10.1016/S0969-2126(97)00220-7; Southall SM, 1999, FEBS LETT, V447, P58, DOI 10.1016/S0014-5793(99)00263-X; Stephen P, 2012, CHEM COMMUN, V48, P2612, DOI 10.1039/c2cc17376j; Synowiecki J, 2007, USE STARCH PROCESSIN; Tanaka Y, 2004, BIOCHEM BIOPH RES CO, V323, P185, DOI 10.1016/j.bbrc.2004.08.081; TANAKA Y, 1986, AGR BIOL CHEM TOKYO, V50, P965, DOI 10.1080/00021369.1986.10867492; Tung JY, 2008, BIOCHEM J, V416, P27, DOI 10.1042/BJ20080580; Vincken QJJP, 2003, PLANT MOL BIOL, V51, P789, DOI 10.1023/A:1022528705590; Wagner M, 2005, J COMPUT BIOL, V12, P355, DOI 10.1089/cmb.2005.12.355; WALLACE AC, 1995, PROTEIN ENG, V8, P127, DOI 10.1093/protein/8.2.127	48	2	2	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 30	2012	7	11							e50488	10.1371/journal.pone.0050488	http://dx.doi.org/10.1371/journal.pone.0050488			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	054WM	23226294	Green Published, Green Submitted, gold			2022-12-27	WOS:000312376100106
J	Wang, XY; Ju, SH; Li, C; Peng, XG; Chen, AF; Mao, H; Teng, GJ				Wang, Xin-Yi; Ju, Shenghong; Li, Cong; Peng, Xin-Gui; Chen, Alex F.; Mao, Hui; Teng, Gao-Jun			Non-invasive Imaging of Endothelial Progenitor Cells in Tumor Neovascularization Using a Novel Dual-modality Paramagnetic/Near-Infrared Fluorescence Probe	PLOS ONE			English	Article							UMBILICAL-CORD BLOOD; PERIPHERAL-BLOOD; VASCULAR NORMALIZATION; CYTOSINE DEAMINASE; PRECURSOR CELLS; ANGIOGENESIS; GROWTH; TRAFFICKING; RECRUITMENT; TRACKING	Objective: Bone-marrow derived endothelial progenitor cells (EPCs) play an important role in tumor neovasculature. Due to their tumor homing property, EPCs are regarded as promising targeted vectors for delivering therapeutic agents in cancer treatment. Consequently, non-invasive confirmation of targeted delivery via imaging is urgently needed. This study shows the development and application of a novel dual-modality probe for in vivo non-invasively tracking of the migration, homing and differentiation of EPCs. Methods: The paramagnetic/near-infrared fluorescence probe Conjugate 1 labeled EPCs were systemically transplanted into mice bearing human breast MDA-MB-231 tumor xenografts. Magnetic resonance imaging (MRI) and near-infrared (NIR) fluorescence optical imaging were performed at different stages of tumor development. The homing of EPCs and the tumor neovascularization were further evaluated by immunofluorescence. Results: Conjugate 1 labeled EPCs can be monitored in vivo by MRI and NIR fluorescence optical imaging without altering tumor growth for up to three weeks after the systemic transplantation. Histopathological examination confirmed that EPCs were recruited into the tumor bed and then incorporated into new vessels two weeks after the transplantation. Tumor size and microvessel density was not influenced by EPCs transplantation in the first three weeks. Conclusions: This preclinical study shows the feasibility of using a MRI and NIR fluorescence optical imaging detectable probe to non-invasively monitor transplanted EPCs and also provides strong evidence that EPCs are involved in the development of endothelial cells during the tumor neovascularization.	[Wang, Xin-Yi; Ju, Shenghong; Peng, Xin-Gui; Teng, Gao-Jun] Southeast Univ, Dept Radiol, Jiangsu Key Lab Mol & Funct Imaging, Zhongda Hosp,Med Sch, Nanjing, Jiangsu, Peoples R China; [Li, Cong] Fudan Univ, Sch Pharm, PLA, Shanghai 200433, Peoples R China; [Li, Cong] Fudan Univ, Key Lab Smart Drug Delivery, Minist Educ, Shanghai 200433, Peoples R China; [Chen, Alex F.] Univ Pittsburgh, Sch Med, Dept Surg, Pittsburgh, PA USA; [Mao, Hui] Emory Univ, Sch Med, Dept Radiol & Imaging Sci, Atlanta, GA USA	Southeast University - China; Fudan University; Fudan University; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Emory University	Ju, SH (corresponding author), Southeast Univ, Dept Radiol, Jiangsu Key Lab Mol & Funct Imaging, Zhongda Hosp,Med Sch, Nanjing, Jiangsu, Peoples R China.	jsh0836@hotmail.com			Major State Basic Research Development Program of China (973 Program) [2010CB933903]; National Nature Science Foundation of China (NSFC) [30830039, 81071125]	Major State Basic Research Development Program of China (973 Program)(National Basic Research Program of China); National Nature Science Foundation of China (NSFC)(National Natural Science Foundation of China (NSFC))	This work was supported by Major State Basic Research Development Program of China (973 Program, No. 2010CB933903) and National Nature Science Foundation of China (NSFC, No. 30830039, No. 81071125). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aoki M, 2004, STEM CELLS, V22, P994, DOI 10.1634/stemcells.22-6-994; Arbab AS, 2006, STEM CELLS, V24, P671, DOI 10.1634/stemcells.2005-0017; Asahara T, 1999, CIRC RES, V85, P221, DOI 10.1161/01.RES.85.3.221; Au P, 2008, BLOOD, V111, P1302, DOI 10.1182/blood-2007-06-094318; Bagley RG, 2005, CANCER RES, V65, P9741, DOI 10.1158/0008-5472.CAN-04-4337; Bulte JWM, 2001, NAT BIOTECHNOL, V19, P1141, DOI 10.1038/nbt1201-1141; Bulte JWM, 1999, P NATL ACAD SCI USA, V96, P15256, DOI 10.1073/pnas.96.26.15256; Dome B, 2008, CYTOM PART A, V73A, P186, DOI 10.1002/cyto.a.20480; Ferrari N, 2003, GENE THER, V10, P647, DOI 10.1038/sj.gt.3301883; FOLKMAN J, 1971, NEW ENGL J MED, V285, P1182; Fukumura D, 2007, MICROVASC RES, V74, P72, DOI 10.1016/j.mvr.2007.05.003; Gao DC, 2009, BBA-REV CANCER, V1796, P33, DOI 10.1016/j.bbcan.2009.05.001; Gioux S, 2010, MOL IMAGING, V9, P237, DOI 10.2310/7290.2010.00034; Hasegawa M, 2000, BRIT J RADIOL, V73, P1252, DOI 10.1259/bjr.73.876.11205667; Jain RK, 2007, CANCER RES, V67, P2729, DOI 10.1158/0008-5472.CAN-06-4102; Jain RK, 2005, SCIENCE, V307, P58, DOI 10.1126/science.1104819; Janic B, 2010, THESCIENTIFICWORLDJO, V10, P1088, DOI 10.1100/tsw.2010.100; Ju SH, 2011, MOL IMAGING, V10, P359, DOI 10.2310/7290.2010.00055; Koo V, 2006, CELL ONCOL, V28, P127; Li C, 2008, J MED CHEM, V51, P3572, DOI 10.1021/jm800288h; Li C, 2008, CLIN CANCER RES, V14, P515, DOI 10.1158/1078-0432.CCR-07-1837; Li C, 2006, J AM CHEM SOC, V128, P15072, DOI 10.1021/ja066199i; Liu ZF, 2010, MOL IMAGING, V9, P21, DOI 10.2310/7290.2009.00032; Lyden D, 2001, NAT MED, V7, P1194, DOI 10.1038/nm1101-1194; Mahan SD, 2004, PROTEIN ENG DES SEL, V17, P625, DOI 10.1093/protein/gzh074; Mai XL, 2009, CELL TRANSPLANT, V18, P171, DOI 10.3727/096368909788341306; Murakami J, 2009, INT J CANCER, V124, P1685, DOI 10.1002/ijc.24085; Nolan DJ, 2007, GENE DEV, V21, P1546, DOI 10.1101/gad.436307; Ntziachristos V, 2003, EUR RADIOL, V13, P195, DOI 10.1007/s00330-002-1524-x; Ogawa M, 2009, CANCER RES, V69, P1268, DOI 10.1158/0008-5472.CAN-08-3116; Pendharkar AV, 2010, STROKE, V41, P2064, DOI 10.1161/STROKEAHA.109.575993; Peters BA, 2005, NAT MED, V11, P261, DOI 10.1038/nm1200; Puppi J, 2011, CELL TRANSPLANT, V20, P963, DOI 10.3727/096368910X543367; Purhonen S, 2008, P NATL ACAD SCI USA, V105, P6620, DOI 10.1073/pnas.0710516105; Rad AM, 2009, BMC BIOTECHNOL, V9, DOI 10.1186/1472-6750-9-28; Rehman J, 2003, CIRCULATION, V107, P1164, DOI 10.1161/01.CIR.0000058702.69484.A0; Tamura M, 2004, LIFE SCI, V75, P575, DOI 10.1016/j.lfs.2003.12.025; Urbich C, 2004, CIRC RES, V95, P343, DOI 10.1161/01.RES.0000137877.89448.78; Varma NRS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030310; Winkler F, 2004, CANCER CELL, V6, P553, DOI 10.1016/S1535-6108(04)00305-8; Yao YY, 2011, MOL IMAGING BIOL, V13, P303, DOI 10.1007/s11307-010-0359-0	41	19	21	0	54	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 30	2012	7	11							e50575	10.1371/journal.pone.0050575	http://dx.doi.org/10.1371/journal.pone.0050575			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	054WM	23226317	Green Published, Green Submitted, gold			2022-12-27	WOS:000312376100129
J	Hansson, C; Shirazi, RH; Naslund, J; Vogel, H; Neuber, C; Holm, G; Anckarsater, H; Dickson, SL; Eriksson, E; Skibicka, KP				Hansson, Caroline; Shirazi, Rozita H.; Naslund, Jakob; Vogel, Heike; Neuber, Corinna; Holm, Goran; Anckarsater, Henrik; Dickson, Suzanne L.; Eriksson, Elias; Skibicka, Karolina P.			Ghrelin Influences Novelty Seeking Behavior in Rodents and Men	PLOS ONE			English	Article							EXON III POLYMORPHISM; NUCLEUS-ACCUMBENS; INDIVIDUAL-DIFFERENCES; ABDOMINAL OBESITY; RECEPTOR GENE; PREFRONTAL CORTEX; FOOD-REWARD; ALCOHOL-USE; DOPAMINE; RATS	Recent discoveries indicate an important role for ghrelin in drug and alcohol reward and an ability of ghrelin to regulate mesolimbic dopamine activity. The role of dopamine in novelty seeking, and the association between this trait and drug and alcohol abuse, led us to hypothesize that ghrelin may influence novelty seeking behavior. To test this possibility we applied several complementary rodent models of novelty seeking behavior, i.e. inescapable novelty-induced locomotor activity (NILA), novelty-induced place preference and novel object exploration, in rats subjected to acute ghrelin receptor (growth hormone secretagogue receptor; GHSR) stimulation or blockade. Furthermore we assessed the possible association between polymorphisms in the genes encoding ghrelin and GHSR and novelty seeking behavior in humans. The rodent studies indicate an important role for ghrelin in a wide range of novelty seeking behaviors. Ghrelin-injected rats exhibited a higher preference for a novel environment and increased novel object exploration. Conversely, those with GHSR blockade drastically reduced their preference for a novel environment and displayed decreased NILA. Importantly, the mesolimbic ventral tegmental area selective GHSR blockade was sufficient to reduce the NILA response indicating that the mesolimbic GHSRs might play an important role in the observed novelty responses. Moreover, in untreated animals, a striking positive correlation between NILA and sucrose reward behavior was detected. Two GHSR single nucleotide polymorphisms (SNPs), rs2948694 and rs495225, were significantly associated with the personality trait novelty seeking, as assessed using the Temperament and Character Inventory (TCI), in human subjects. This study provides the first evidence for a role of ghrelin in novelty seeking behavior in animals and humans, and also points to an association between food reward and novelty seeking in rodents. Citation: Hansson C, Shirazi RH, Naslund J, Vogel H, Neuber C, et al. (2012) Ghrelin Influences Novelty Seeking Behavior in Rodents and Men. PLoS ONE 7(12): e50409. doi:10.1371/journal.pone.0050409	[Hansson, Caroline; Shirazi, Rozita H.; Vogel, Heike; Dickson, Suzanne L.; Skibicka, Karolina P.] Univ Gothenburg, Sahlgrenska Acad, Inst Neurosci & Physiol, Dept Physiol Endocrinol, Gothenburg, Sweden; [Hansson, Caroline; Neuber, Corinna] Univ Gothenburg, Sahlgrenska Acad, Inst Med, Dept Clin & Mol Med, Gothenburg, Sweden; [Naslund, Jakob; Eriksson, Elias] Univ Gothenburg, Sahlgrenska Acad, Inst Neurosci & Physiol, Dept Pharmacol, Gothenburg, Sweden; [Holm, Goran] Univ Gothenburg, Sahlgrenska Acad, Inst Med, Dept Metab & Cardiovasc Dis, Gothenburg, Sweden; [Anckarsater, Henrik] Univ Gothenburg, Sahlgrenska Acad, Inst Neurosci & Physiol, Dept Psychiat & Neurochem, Gothenburg, Sweden	University of Gothenburg; University of Gothenburg; University of Gothenburg; University of Gothenburg; University of Gothenburg	Skibicka, KP (corresponding author), Univ Gothenburg, Sahlgrenska Acad, Inst Neurosci & Physiol, Dept Physiol Endocrinol, Gothenburg, Sweden.	karolina.skibicka@neuro.gu.se	Näslund, Jakob/I-7491-2019; Dickson, Suzanne L/U-4628-2019	Dickson, Suzanne/0000-0002-3822-5294; Naslund, Jakob/0000-0003-2782-5160	Swedish Research Council for Medicine [2011-3054, 2009-S266, 12208, 2009-2618, 2009-4746]; European Commission 7th Framework [FP7-HEALTH-2009-241592, FP7-KBBE-2009-3-245009, FP7-KBBE-2010-4-66408]; Forskning och Utvecklingsarbete/Avtal om Lakarutbildning och Forskning Goteborg [ALFGBG-138741]; NovoNordisk Foundation; Bertil Hallsten's Foundation; Brain Foundation; Soderberg's Foundation; Swedish Foundation for Strategic Research to Sahlgrenska Center for Cardiovascular and Metabolic Research [A305-188]; Novo Nordisk Fonden [NNF12OC1016479] Funding Source: researchfish	Swedish Research Council for Medicine; European Commission 7th Framework; Forskning och Utvecklingsarbete/Avtal om Lakarutbildning och Forskning Goteborg; NovoNordisk Foundation(Novo Nordisk Foundation); Bertil Hallsten's Foundation; Brain Foundation; Soderberg's Foundation; Swedish Foundation for Strategic Research to Sahlgrenska Center for Cardiovascular and Metabolic Research(Swedish Foundation for Strategic Research); Novo Nordisk Fonden(Novo Nordisk Foundation)	Swedish Research Council for Medicine (2011-3054 to K.P.S., 2009-S266 to S.L.D., 12208, 2009-2618), 2009-4746 to E.E.), European Commission 7th Framework [FP7-HEALTH-2009-241592 (EurOCHIP), FP7-KBBE-2009-3-245009 (NeuroFAST), and FP7-KBBE-2010-4-66408 (Full4Health)], Forskning och Utvecklingsarbete/Avtal om Lakarutbildning och Forskning Goteborg (ALFGBG-138741), NovoNordisk Foundation, Bertil Hallsten's Foundation, the Brain Foundation, Soderberg's Foundation, and the Swedish Foundation for Strategic Research to Sahlgrenska Center for Cardiovascular and Metabolic Research (A305-188). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abizaid A, 2006, J CLIN INVEST, V116, P3229, DOI 10.1172/JCI29867; Asakawa A, 2001, NEUROENDOCRINOLOGY, V74, P143, DOI 10.1159/000054680; Ballaz SJ, 2007, NEUROSCIENCE, V149, P192, DOI 10.1016/j.neuroscience.2007.07.043; Belin D, 2011, NEUROPSYCHOPHARMACOL, V36, P569, DOI 10.1038/npp.2010.188; Berlyne DE, 1950, B J PSYCHOL-GEN SECT, V41, P68, DOI 10.1111/j.2044-8295.1950.tb00262.x; Briggs DI, 2010, ENDOCRINOLOGY, V151, P4745, DOI 10.1210/en.2010-0556; Cain ME, 2008, NEUROPSYCHOPHARMACOL, V33, P1149, DOI 10.1038/sj.npp.1301478; Cain ME, 2005, EXP CLIN PSYCHOPHARM, V13, P367, DOI 10.1037/1064-1297.13.4.367; Chefer VI, 2003, J NEUROSCI, V23, P3076; Chuang JC, 2011, J CLIN INVEST, V121, P2684, DOI 10.1172/JCI57660; Cloninger C. R., 1994, TEMPERAMENT CHARACTE; CLONINGER CR, 1986, PSYCHIAT DEV, V4, P167; Costoli T, 2005, NEUROSCI BIOBEHAV R, V29, P113, DOI 10.1016/j.neubiorev.2004.09.016; Dellu F, 1996, NEUROPSYCHOBIOLOGY, V34, P136, DOI 10.1159/000119305; Dickson SL, 2012, J NEUROSCI, V32, P4812, DOI 10.1523/JNEUROSCI.6326-11.2012; Dulawa SC, 1999, J NEUROSCI, V19, P9550; Ebstein RP, 1996, NAT GENET, V12, P78, DOI 10.1038/ng0196-78; ERICSON E, 1991, J PHARMACOL METHOD, V25, P111, DOI 10.1016/0160-5402(91)90002-M; Finger BC, 2012, PSYCHOPHARMACOLOGY, V220, P173, DOI 10.1007/s00213-011-2468-0; Flagel SB, 2010, NEUROPSYCHOPHARMACOL, V35, P388, DOI 10.1038/npp.2009.142; Gueorguiev M, 2009, OBESITY, V17, P745, DOI 10.1038/oby.2008.589; HOOKS MS, 1992, BRAIN RES, V587, P306; HOOKS MS, 1994, J NEUROSCI, V14, P6144; HOOKS MS, 1991, SYNAPSE, V9, P121, DOI 10.1002/syn.890090206; Jerlhag E, 2007, ADDICT BIOL, V12, P6, DOI 10.1111/j.1369-1600.2006.00041.x; Jerlhag E, 2009, P NATL ACAD SCI USA, V106, P11318, DOI 10.1073/pnas.0812809106; Kabbaj M, 2000, J NEUROSCI, V20, P6983, DOI 10.1523/JNEUROSCI.20-18-06983.2000; Kern A, 2012, NEURON, V73, P317, DOI 10.1016/j.neuron.2011.10.038; Landgren S, 2008, ALCOHOL CLIN EXP RES, V32, P2054, DOI 10.1111/j.1530-0277.2008.00793.x; LeSauter J, 2009, P NATL ACAD SCI USA, V106, P13582, DOI 10.1073/pnas.0906426106; Lutter M, 2008, NAT NEUROSCI, V11, P752, DOI 10.1038/nn.2139; MISSLIN R, 1982, PSYCHONEUROENDOCRINO, V7, P217, DOI 10.1016/0306-4530(82)90015-4; Moulin A, 2007, J MED CHEM, V50, P5790, DOI 10.1021/jm0704550; Naleid AM, 2005, PEPTIDES, V26, P2274, DOI 10.1016/j.peptides.2005.04.025; Piazza P.V., 1990, Behav Pharmacol, V1, P339; PIAZZA PV, 1991, BRAIN RES, V567, P169, DOI 10.1016/0006-8993(91)91452-7; PIERCE RC, 1990, PHARMACOL BIOCHEM BE, V36, P321, DOI 10.1016/0091-3057(90)90411-A; Ray LA, 2009, ADDICT BIOL, V14, P238, DOI 10.1111/j.1369-1600.2008.00120.x; Rebec GV, 1997, BRAIN RES, V776, P61, DOI 10.1016/S0006-8993(97)01004-4; Rebec GV, 1997, NEUROSCIENCE, V76, P707, DOI 10.1016/S0306-4522(96)00382-X; RODGERS RJ, 1979, PSYCHOPHARMACOLOGY, V65, P103, DOI 10.1007/BF00491988; Rosmond R, 1998, INT J OBESITY, V22, P1184, DOI 10.1038/sj.ijo.0800745; Rosmond R, 1998, OBES RES, V6, P338, DOI 10.1002/j.1550-8528.1998.tb00361.x; Rosmond R, 1998, METABOLISM, V47, P1187, DOI 10.1016/S0026-0495(98)90321-3; Rosmond R, 1998, J CLIN ENDOCR METAB, V83, P1853, DOI 10.1210/jc.83.6.1853; Skibicka KP, 2011, NEUROSCIENCE, V180, P129, DOI 10.1016/j.neuroscience.2011.02.016; Skibicka KP, 2012, ENDOCRINOLOGY, V153, P1194, DOI 10.1210/en.2011-1606; Skibicka KP, 2011, PEPTIDES, V32, P2265, DOI 10.1016/j.peptides.2011.05.016; Skibicka KP, 2012, ADDICT BIOL, V17, P95, DOI 10.1111/j.1369-1600.2010.00294.x; Staner L, 1998, AM J MED GENET, V81, P192, DOI 10.1002/(SICI)1096-8628(19980328)81:2<192::AID-AJMG12>3.3.CO;2-I; Vanyukov MM, 1998, BEHAV GENET, V28, P75, DOI 10.1023/A:1021463722326; von Horsten S, 1998, BRAIN RES, V806, P282, DOI 10.1016/S0006-8993(98)00772-0; Wang HJ, 2004, J CLIN ENDOCR METAB, V89, P157, DOI 10.1210/jc.2003-031395; Wellman PJ, 2008, REGUL PEPTIDES, V146, P33, DOI 10.1016/j.regpep.2007.07.007; Wellman PJ, 2005, REGUL PEPTIDES, V125, P151, DOI 10.1016/j.regpep.2004.08.013; Yannielli PC, 2007, J NEUROSCI, V27, P2890, DOI 10.1523/JNEUROSCI.3913-06.2007; ZUCKERMAN M, 1990, J PERS, V58, P313, DOI 10.1111/j.1467-6494.1990.tb00918.x	57	31	31	0	40	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 5	2012	7	12							e50409	10.1371/journal.pone.0050409	http://dx.doi.org/10.1371/journal.pone.0050409			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	057TZ	23227170	gold, Green Published, Green Submitted			2022-12-27	WOS:000312588200031
J	Chia, WS; Chia, DX; Rao, F; Bar Nun, S; Shochat, SG				Chia, Wei Sheng; Chia, Diana Xueqi; Rao, Feng; Bar Nun, Shoshana; Shochat, Susana Geifman			ATP Binding to p97/VCP D1 Domain Regulates Selective Recruitment of Adaptors to Its Proximal N-Domain	PLOS ONE			English	Article							VALOSIN-CONTAINING PROTEIN; RETICULUM-ASSOCIATED DEGRADATION; INCLUSION-BODY MYOPATHY; P97 AAA ATPASE; CONFORMATIONAL-CHANGES; FRONTOTEMPORAL DEMENTIA; UBIQUITIN; P97/CDC48P; DISEASE; COMPLEX	p97/Valosin-containing protein (VCP) is a member of the AAA-ATPase family involved in many cellular processes including cell division, intracellular trafficking and extraction of misfolded proteins in endoplasmic reticulum-associated degradation (ERAD). It is a homohexamer with each subunit containing two tandem D1 and D2 ATPase domains and N- and C-terminal regions that function as adaptor protein binding domains. p97/VCP is directed to its many different functional pathways by associating with various adaptor proteins. The regulation of the recruitment of the adaptor proteins remains unclear. Two adaptor proteins, Ufd1/Npl4 and p47, which bind exclusively to the p97/VCP N-domain and direct p97/VCP to either ERAD-related processes or homotypic fusion of Golgi fragments, were studied here. Surface plasmon resonance biosensor-based assays allowed the study of binding kinetics in real time. In competition experiments, it was observed that in the presence of ATP, Ufd1/Npl4 was able to compete more effectively with p47 for binding to p97/VCP. By using non-hydrolysable ATP analogues and the hexameric truncated p97/N-D1 fragment, it was shown that binding rather than hydrolysis of ATP to the proximal D1 domain strengthened the Ufd1/Npl4 association with the N-domain, thus regulating the recruitment of either Ufd1/Npl4 or p47. This novel role of ATP and an assigned function to the D1 AAA-ATPase domain link the multiple functions of p97/VCP to the metabolic status of the cell. Citation: Chia WS, Chia DX, Rao F, Bar Nun S, Geifman Shochat S (2012) ATP Binding to p97/VCP D1 Domain Regulates Selective Recruitment of Adaptors to Its Proximal N-Domain. PLoS ONE 7(12): e50490. doi:10.1371/journal.pone.0050490	[Chia, Wei Sheng; Chia, Diana Xueqi; Rao, Feng; Shochat, Susana Geifman] Nanyang Technol Univ, Sch Biol Sci, Singapore, Singapore; [Bar Nun, Shoshana] Tel Aviv Univ, George S Wise Fac Life Sci, Dept Biochem & Mol Biol, IL-69978 Tel Aviv, Israel	Nanyang Technological University & National Institute of Education (NIE) Singapore; Nanyang Technological University; Tel Aviv University	Shochat, SG (corresponding author), Nanyang Technol Univ, Sch Biol Sci, Singapore, Singapore.	SGeifman@ntu.edu.sg	Rao, Feng/AAD-4712-2019; RAO, FENG/G-4529-2011	Rao, Feng/0000-0002-6038-6406; RAO, FENG/0000-0002-6038-6406	Ministry of Education, Singapore [RG 679/07, RG 50/10]; Chief Scientist Office of the Ministry of Health, Israel [33211]	Ministry of Education, Singapore(Ministry of Education, Singapore); Chief Scientist Office of the Ministry of Health, Israel	This work was supported by Grant RG 679/07 from Ministry of Education, Singapore; Grant RG 50/10 from Ministry of Education, Singapore; and Grant 33211 from the Chief Scientist Office of the Ministry of Health, Israel. The funders had no role in study, design, data collection and analysis, decision to publish or preparation of the manuscript.	Ando T, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002561; Ataullakhanov FI, 2002, BIOSCIENCE REP, V22, P501, DOI 10.1023/A:1022069718709; Bar-Nun S, 2005, CURR TOP MICROBIOL, V300, P95; Bays NW, 2002, CURR BIOL, V12, pR366, DOI 10.1016/S0960-9822(02)00862-X; Bebeacua C, 2012, P NATL ACAD SCI USA, V109, P1098, DOI 10.1073/pnas.1114341109; Beuron F, 2003, J MOL BIOL, V327, P619, DOI 10.1016/S0022-2836(03)00178-5; Beuron F, 2006, EMBO J, V25, P1967, DOI 10.1038/sj.emboj.7601055; Bjorkelund H, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024739; Braun S, 2002, EMBO J, V21, P615, DOI 10.1093/emboj/21.4.615; Bruderer RM, 2004, J BIOL CHEM, V279, P49609, DOI 10.1074/jbc.M408695200; Brunger AT, 2009, ACTA CRYSTALLOGR D, V65, P128, DOI 10.1107/S0907444908043795; Chang YC, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1001288; Dai RM, 1998, J BIOL CHEM, V273, P3562, DOI 10.1074/jbc.273.6.3562; Dalal S, 2004, MOL BIOL CELL, V15, P637, DOI 10.1091/mbc.E03-02-0097; Davies JM, 2008, STRUCTURE, V16, P715, DOI 10.1016/j.str.2008.02.010; Davies JM, 2005, STRUCTURE, V13, P183, DOI 10.1016/j.str.2004.11.014; DeLaBarre B, 2005, J MOL BIOL, V347, P437, DOI 10.1016/j.jmb.2005.01.060; DeLaBarre B, 2003, NAT STRUCT BIOL, V10, P856, DOI 10.1038/nsb972; DeLaBarre B, 2006, MOL CELL, V22, P451, DOI 10.1016/j.molcel.2006.03.036; Dreveny I, 2004, BIOCHEM SOC T, V32, P715, DOI 10.1042/BST0320715; Dreveny I, 2004, EMBO J, V23, P1030, DOI 10.1038/sj.emboj.7600139; Elkabetz Y, 2004, J BIOL CHEM, V279, P3980, DOI 10.1074/jbc.M309938200; Esaki M, 2010, BIOCHEM CELL BIOL, V88, P109, DOI [10.1139/o09-116, 10.1139/O09-116]; Ghislain M, 1996, EMBO J, V15, P4884, DOI 10.1002/j.1460-2075.1996.tb00869.x; Haines Dale S, 2010, Genes Cancer, V1, P753; Halawani D, 2006, MOL CELL, V22, P713, DOI 10.1016/j.molcel.2006.06.003; Hirabayashi M, 2001, CELL DEATH DIFFER, V8, P977, DOI 10.1038/sj.cdd.4400907; Huyton T, 2003, J STRUCT BIOL, V144, P337, DOI 10.1016/j.jsb.2003.10.007; Imamura H, 2009, P NATL ACAD SCI USA, V106, P15651, DOI 10.1073/pnas.0904764106; Indig FE, 2004, J STRUCT BIOL, V146, P251, DOI 10.1016/j.jsb.2003.11.009; Ishigaki S, 2004, J BIOL CHEM, V279, P51376, DOI 10.1074/jbc.M406683200; Jentsch S, 2007, TRENDS BIOCHEM SCI, V32, P6, DOI 10.1016/j.tibs.2006.11.005; Johnson JO, 2010, NEURON, V68, P857, DOI 10.1016/j.neuron.2010.11.036; Ju JS, 2010, HUM MOL GENET, V19, pR38, DOI 10.1093/hmg/ddq157; Kloppsteck P, 2011, BIOCHIM BIOPHYS ACTA, V1823, P125; Kobayashi T, 2007, GENES CELLS, V12, P889, DOI 10.1111/j.1365-2443.2007.01099.x; Kondo H, 1997, NATURE, V388, P75, DOI 10.1038/40411; Lass A, 2008, EXP CELL RES, V314, P2715, DOI 10.1016/j.yexcr.2008.06.008; Liemburg-Apers DC, 2011, PHARM RES-DORDR, V28, P2745, DOI 10.1007/s11095-011-0492-8; Madsen L, 2009, INT J BIOCHEM CELL B, V41, P2380, DOI 10.1016/j.biocel.2009.05.017; Matsumoto M, 2004, EMBO J, V23, P659, DOI 10.1038/sj.emboj.7600081; Meyer HH, 2000, EMBO J, V19, P2181, DOI 10.1093/emboj/19.10.2181; Meyer HH, 1998, FEBS LETT, V437, P255, DOI 10.1016/S0014-5793(98)01232-0; Mizuno Y, 2003, NEUROSCI LETT, V343, P77, DOI 10.1016/S0304-3940(03)00280-5; Niesen FH, 2007, NAT PROTOC, V2, P2212, DOI 10.1038/nprot.2007.321; Niwa H, 2012, J BIOL CHEM, V287, P8561, DOI 10.1074/jbc.M111.302778; Parihar MS, 2007, AM J PHYSIOL-CELL PH, V292, pC8, DOI 10.1152/ajpcell.00232.2006; PETERS JM, 1992, J MOL BIOL, V223, P557, DOI 10.1016/0022-2836(92)90670-F; Pye VE, 2006, J STRUCT BIOL, V156, P12, DOI 10.1016/j.jsb.2006.03.003; Rabinovich E, 2002, MOL CELL BIOL, V22, P626, DOI 10.1128/MCB.22.2.626-634.2002; Rape M, 2001, CELL, V107, P667, DOI 10.1016/S0092-8674(01)00595-5; Rouiller I, 2002, NAT STRUCT BIOL, V9, P950, DOI 10.1038/nsb872; Rouiller I, 2000, MOL CELL, V6, P1485, DOI 10.1016/S1097-2765(00)00144-1; Song CC, 2003, J BIOL CHEM, V278, P3648, DOI 10.1074/jbc.M208422200; Tang WK, 2010, EMBO J, V29, P2217, DOI 10.1038/emboj.2010.104; Thoms S, 2002, FEBS LETT, V520, P107, DOI 10.1016/S0014-5793(02)02777-1; Vale RD, 2000, J CELL BIOL, V150, pF13, DOI 10.1083/jcb.150.1.F13; Wallace DC, 2005, ANNU REV GENET, V39, P359, DOI 10.1146/annurev.genet.39.110304.095751; Wang Q, 2003, BIOCHEM BIOPH RES CO, V300, P253, DOI 10.1016/S0006-291X(02)02840-1; Watts GDJ, 2004, NAT GENET, V36, P377, DOI 10.1038/ng1332; Ye YH, 2001, NATURE, V414, P652, DOI 10.1038/414652a; Yeung HO, 2008, BIOCHEM SOC T, V36, P62, DOI 10.1042/BST0360062; Zhang XD, 2000, MOL CELL, V6, P1473, DOI 10.1016/S1097-2765(00)00143-X	63	21	21	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 3	2012	7	12							e50490	10.1371/journal.pone.0050490	http://dx.doi.org/10.1371/journal.pone.0050490			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	051DH	23226521	Green Published, gold			2022-12-27	WOS:000312104700018
J	Jin, W; Su, XX; Xu, M; Liu, Y; Shi, JY; Lu, L; Niu, WQ				Jin, Wei; Su, Xiuxiu; Xu, Min; Liu, Yan; Shi, Jingyi; Lu, Lin; Niu, Wenquan			Interactive Association of Five Candidate Polymorphisms in Apelin/APJ Pathway with Coronary Artery Disease among Chinese Hypertensive Patients	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; ORPHAN RECEPTOR; AGTRL1 GENE; HAN CHINESE; APJ; SYSTEM; SUSCEPTIBILITY; VALIDATION; LIGAND	Background: Via sequencing the genes of apelin/angiotensin receptor-like 1 (apelin/APJ) pathway, we have recently identified and validated four common polymorphisms (rs3761581, rs56204867, rs7119375, and rs10501367) implicated in the development of hypertension. Extending these findings, we, in Chinese hypertensive patients, sought to investigate the association of these four polymorphisms and one additional promising candidate (rs9943582) from this pathway with the risk of developing coronary artery disease (CAD). Methodology/Principal Findings: Genotypes were obtained from 994 sporadic CAD patients and 708 age-and sex-matched controls. All participants were hypertensives and angiographically-confirmed. Data were analyzed by Haplo.Stats and multifactor dimensionality reduction (MDR) softwares. Genotype distributions of five examined polymorphisms satisfied Hardy-Weinberg equilibrium in controls of both genders. Single-locus analyses exhibited no significant differences in the genotype/allele frequencies of examined polymorphisms between CAD patients and controls (P > 0.05), even after controlling traditional cardiovascular confounders. In haplotype analyses, low-penetrance haplotype G-A (in order of rs56204867 and rs3761581 from apelin gene) was significantly overrepresented in controls (1.73%) relative to in CAD patients (0.4%) in males (P = 0.047). Further interaction analyses suggested an overall best MDR model including rs3761581 in males (P = 0.0408) and including rs7119375 and rs9943582 in females (P < 0.0001), which were further substantiated in the classical logistical regression model. Conclusions: Our findings demonstrated a contributive role of low-penetrance haplotype in apelin gene on CAD in males, and more importantly, interactive effects of genetic defects in apelin/APJ pathway might confer a potential risk in Chinese hypertensive patients. Citation: Jin W, Su X, Xu M, Liu Y, Shi J, et al. (2012) Interactive Association of Five Candidate Polymorphisms in Apelin/APJ Pathway with Coronary Artery Disease among Chinese Hypertensive Patients. PLoS ONE 7(12): e51123. doi:10.1371/journal.pone.0051123	[Jin, Wei; Shi, Jingyi; Niu, Wenquan] Shanghai Jiao Tong Univ, Sch Med, Ruijin Hosp, State Key Lab Med Genom, Shanghai 200030, Peoples R China; [Jin, Wei; Su, Xiuxiu; Xu, Min; Liu, Yan; Lu, Lin] Shanghai Jiao Tong Univ, Sch Med, Ruijin Hosp, Dept Cardiol, Shanghai 200030, Peoples R China; [Niu, Wenquan] Shanghai Res Inst Hypertens, Shanghai, Peoples R China	Chinese Academy of Sciences; Shanghai Jiao Tong University; Shanghai Jiao Tong University	Niu, WQ (corresponding author), Shanghai Jiao Tong Univ, Sch Med, Ruijin Hosp, State Key Lab Med Genom, Shanghai 200030, Peoples R China.	niuwenquan@yahoo.cn		Jin, Wei/0000-0002-2905-2109	Shanghai Rising Star Program [11QA1405500]; National Natural Science Foundation of China [81070177, 30900808]	Shanghai Rising Star Program; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the Shanghai Rising Star Program (11QA1405500), and the National Natural Science Foundation of China (81070177, 30900808). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barton M, 2009, HYPERTENSION, V54, P11, DOI 10.1161/HYPERTENSIONAHA.108.120022; Cardon LR, 2001, NAT REV GENET, V2, P91, DOI 10.1038/35052543; Chen MM, 2003, CIRCULATION, V108, P1432, DOI 10.1161/01.CIR.0000091235.94914.75; Eleftherohorinou H, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008068; Falcone C, 2012, MOL MED REP, V5, P321, DOI 10.3892/mmr.2011.685; Foldes G, 2003, BIOCHEM BIOPH RES CO, V308, P480, DOI 10.1016/S0006-291X(03)01424-4; Gao LAR, 2010, CELL TRANSPLANT, V19, P949, DOI 10.3727/096368910X504450; Hahn LW, 2003, BIOINFORMATICS, V19, P376, DOI 10.1093/bioinformatics/btf869; Hardy J, 2009, NEW ENGL J MED, V360, P1759, DOI 10.1056/NEJMra0808700; Hata J, 2007, HUM MOL GENET, V16, P630, DOI 10.1093/hmg/ddm005; Hinohara K, 2009, J HUM GENET, V54, P554, DOI 10.1038/jhg.2009.78; Japp AG, 2008, J AM COLL CARDIOL, V52, P908, DOI 10.1016/j.jacc.2008.06.013; Kalea AZ, 2010, CURR OPIN INVEST DR, V11, P273; Katugampola SD, 2001, BRIT J PHARMACOL, V132, P1255, DOI 10.1038/sj.bjp.0703939; Khanna M, 1999, ONCOGENE, V18, P27, DOI 10.1038/sj.onc.1202291; Khot UN, 2003, JAMA-J AM MED ASSOC, V290, P898, DOI 10.1001/jama.290.7.898; Kuba K, 2007, CIRC RES, V101, pE32, DOI 10.1161/CIRCRESAHA.107.158659; Li WW, 2009, J HYPERTENS, V27, P1194, DOI 10.1097/HJH.0b013e32832a3eb1; McCarthy MI, 2008, NAT REV GENET, V9, P356, DOI 10.1038/nrg2344; Niu WQ, 2010, J HYPERTENS, V28, P1854, DOI 10.1097/HJH.0b013e32833b1fad; Niu WQ, 2009, J HYPERTENS, V27, P1384, DOI 10.1097/HJH.0b013e32832b7e0d; ODOWD BF, 1993, GENE, V136, P355, DOI 10.1016/0378-1119(93)90495-O; Padmanabhan S, 2008, J HYPERTENS, V26, P1275, DOI 10.1097/HJH.0b013e3282ff634f; Pattin KA, 2009, GENET EPIDEMIOL, V33, P87, DOI 10.1002/gepi.20360; Pitkin SL, 2010, BRIT J PHARMACOL, V160, P1785, DOI 10.1111/j.1476-5381.2010.00821.x; Schork NJ, 2009, CURR OPIN GENET DEV, V19, P212, DOI 10.1016/j.gde.2009.04.010; Tatemoto K, 1998, BIOCHEM BIOPH RES CO, V251, P471, DOI 10.1006/bbrc.1998.9489; WILSON PWF, 1994, AM J HYPERTENS, V7, pS7, DOI 10.1093/ajh/7.7.7S; Zintzaras E, 2008, ARCH INTERN MED, V168, P1077, DOI 10.1001/archinte.168.10.1077	29	30	30	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 3	2012	7	12							e51123	10.1371/journal.pone.0051123	http://dx.doi.org/10.1371/journal.pone.0051123			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	051DH	23226564	Green Submitted, gold, Green Published			2022-12-27	WOS:000312104700031
J	Allard, M; Tonnerre, P; Nedellec, S; Oger, R; Morice, A; Guilloux, Y; Houssaint, E; Charreau, B; Gervois, N				Allard, Mathilde; Tonnerre, Pierre; Nedellec, Steven; Oger, Romain; Morice, Alexis; Guilloux, Yannick; Houssaint, Elisabeth; Charreau, Beatrice; Gervois, Nadine			HLA-E-Restricted Cross-Recognition of Allogeneic Endothelial Cells by CMV-Associated CD8 T Cells: A Potential Risk Factor following Transplantation	PLOS ONE			English	Article							NATURAL-KILLER-CELLS; CYTOMEGALOVIRUS-INFECTION; SURFACE EXPRESSION; KIDNEY-TRANSPLANTATION; MEDIATED RECOGNITION; LYMPHOCYTES; RECEPTOR; LIGAND; IDENTIFICATION; PEPTIDE	Although association between CMV infection and allograft rejection is well admitted, the precise mechanisms involved remain uncertain. Here, we report the characterization of an alloreactive HLA-E-restricted CD8 T cell population that was detected in the PBL of a kidney transplant patient after its CMV conversion. This monoclonal CD8 T cell population represents a sizable fraction in the blood (3% of PBL) and is characterized by an effector-memory phenotype and the expression of multiple NK receptors. Interestingly, these unconventional T cells display HLA-E-dependent reactivity against peptides derived from the leader sequences of both various HCMV-UL40 and allogeneic classical HLA-I molecules. Consequently, while HLA-E-restricted CD8 T cells have potential to contribute to the control of CMV infection in vivo, they may also directly mediate graft rejection through recognition of peptides derived from allogeneic HLA-I molecules on graft cells. Therefore, as HLA-E expression in nonlymphoid organs is mainly restricted to endothelial cells, we investigated the reactivity of this HLA-E-restricted T cell population towards allogeneic endothelial cells. We clearly demonstrated that CMV-associated HLA-E-restricted T cells efficiently recognized and killed allogeneic endothelial cells in vitro. Moreover, our data indicate that this alloreactivity is tightly regulated by NK receptors, especially by inhibitory KIR2DL2 that strongly prevents TCR-induced activation through recognition of HLA-C molecules. Hence, a better evaluation of the role of CMV-associated HLA-E-restricted T cells in transplantation and of the impact of HLA-genotype, especially HLA-C, on their alloreactivity may determine whether they indeed represent a risk factor following organ transplantation.	[Allard, Mathilde; Nedellec, Steven; Oger, Romain; Morice, Alexis; Guilloux, Yannick; Houssaint, Elisabeth; Gervois, Nadine] INSERM, U892, Nantes, France; [Allard, Mathilde; Tonnerre, Pierre; Nedellec, Steven; Oger, Romain; Morice, Alexis; Guilloux, Yannick; Houssaint, Elisabeth; Charreau, Beatrice; Gervois, Nadine] Univ Nantes, Nantes, France; [Allard, Mathilde; Nedellec, Steven; Oger, Romain; Morice, Alexis; Guilloux, Yannick; Houssaint, Elisabeth; Gervois, Nadine] CNRS, UMR 6299, Nantes, France; [Tonnerre, Pierre; Charreau, Beatrice] INSERM, U1064, Nantes, France; [Charreau, Beatrice] CHU Nantes, F-44035 Nantes 01, France	Institut National de la Sante et de la Recherche Medicale (Inserm); Nantes Universite; Centre National de la Recherche Scientifique (CNRS); Ecole Nationale Veterinaire, Agroalimentaire et de l'Alimentation Nantes-Atlantique; Institut National de la Sante et de la Recherche Medicale (Inserm); Nantes Universite; CHU de Nantes	Gervois, N (corresponding author), INSERM, U892, Nantes, France.	nadine.gervois@inserm.fr	guilloux, yannick/L-4801-2015; CHARREAU, Beatrice/AAK-8186-2020; Gervois, Nadine/K-6658-2015; allard, mathilde/C-9577-2018; Tonnerre, Pierre/AAA-1631-2020; OGER, Romain/K-7423-2015	CHARREAU, Beatrice/0000-0001-5870-4615; Gervois, Nadine/0000-0002-0092-3919; allard, mathilde/0000-0002-2217-1295; Tonnerre, Pierre/0000-0002-1719-9736; guilloux, yannick/0000-0003-2352-7238; OGER, Romain/0000-0001-5012-6099	Canceropole Grand Ouest [RPH10017NNA]; Xenome; European Commission [LSHB-CT-2006-037377]; L'Agence de Biomedecine; PROVASC; la Region Pays de la Loire; Association de Recherche contre le Cancer	Canceropole Grand Ouest; Xenome; European Commission(European CommissionEuropean Commission Joint Research Centre); L'Agence de Biomedecine(French National Research Agency (ANR)); PROVASC; la Region Pays de la Loire(Region Pays de la Loire); Association de Recherche contre le Cancer(Fondation ARC pour la Recherche sur le Cancer)	This work was supported by grants awarded by the "Canceropole Grand Ouest" (RPH10017NNA), "Xenome," a European Commission-funded Integrated Project, Life Sciences, Genomics and Biotechnology for Health LSHB-CT-2006-037377, and by a grant from L'Agence de Biomedecine "Appel Recherche et Greffe 2009". PT was supported by "PROVASC" a grant from "la Region Pays de la Loire'' and Alexis Morice by the "Association de Recherche contre le Cancer." The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adler B, 2009, THROMB HAEMOSTASIS, V102, P1057, DOI 10.1160/TH09-04-0213; Al-Lamki RS, 2008, TRANSPLANTATION, V86, P1340, DOI 10.1097/TP.0b013e3181891d8b; Amir AL, 2010, BLOOD, V115, P3146, DOI 10.1182/blood-2009-07-234906; Braud VM, 1998, CURR BIOL, V8, P1, DOI 10.1016/S0960-9822(98)70014-4; Braud VM, 1998, NATURE, V391, P795, DOI 10.1038/35869; Cerboni C, 2001, EUR J IMMUNOL, V31, P2926, DOI 10.1002/1521-4141(2001010)31:10<2926::AID-IMMU2926>3.0.CO;2-2; Choi J, 2004, ANNU REV IMMUNOL, V22, P683, DOI 10.1146/annurev.immunol.22.012703.104639; Coupel S, 2004, J AM SOC NEPHROL, V15, P2429, DOI 10.1097/01.ASN.0000138237.42675.45; Coupel S, 2007, BLOOD, V109, P2806, DOI 10.1182/blood-2006-06-030213; D'Orsogna LJA, 2010, TRANSPL IMMUNOL, V23, P149, DOI 10.1016/j.trim.2010.06.008; David G, 2009, IMMUNOLOGY, V128, P172, DOI 10.1111/j.1365-2567.2009.03085.x; DePlaen E, 1997, METHODS, V12, P125, DOI 10.1006/meth.1997.0462; Fisher RA, 2009, TRANSPL INFECT DIS, V11, P195, DOI 10.1111/j.1399-3062.2009.00372.x; Gamadia LE, 2004, TRANSPLANTATION, V77, P1879, DOI 10.1097/01.tp.0000131158.81346.64; Garcia P, 2002, EUR J IMMUNOL, V32, P936, DOI 10.1002/1521-4141(200204)32:4<936::AID-IMMU936>3.3.CO;2-D; Gervois N, 2000, CLIN CANCER RES, V6, P1459; Guetta E, 2001, CARDIOVASC RES, V50, P538, DOI 10.1016/S0008-6363(01)00269-3; Hoare HL, 2006, NAT IMMUNOL, V7, P256, DOI 10.1038/ni1312; Husain S, 2009, TRANSPL IMMUNOL, V21, P1, DOI 10.1016/j.trim.2008.12.004; Jabri B, 2002, IMMUNITY, V17, P487, DOI 10.1016/S1074-7613(02)00427-2; Jiang H, 2010, J CLIN INVEST, V120, P3641, DOI 10.1172/JCI43522; Joosten SA, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000782; Klebanoff CA, 2006, IMMUNOL REV, V211, P214, DOI 10.1111/j.0105-2896.2006.00391.x; Lee N, 1998, J IMMUNOL, V160, P4951; Lee N, 1998, P NATL ACAD SCI USA, V95, P5199, DOI 10.1073/pnas.95.9.5199; Mazzarino P, 2005, EUR J IMMUNOL, V35, P3240, DOI 10.1002/eji.200535343; Moesta AK, 2008, J IMMUNOL, V180, P3969, DOI 10.4049/jimmunol.180.6.3969; Moretta L, 2003, TRENDS IMMUNOL, V24, P136, DOI 10.1016/S1471-4906(03)00031-0; Morice A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012120; Pacasova R, 1999, J IMMUNOL, V162, P5190; Pende D, 2009, BLOOD, V113, P3119, DOI 10.1182/blood-2008-06-164103; Pietra G, 2003, P NATL ACAD SCI USA, V100, P10896, DOI 10.1073/pnas.1834449100; Pietra G, 2001, EUR J IMMUNOL, V31, P3687, DOI 10.1002/1521-4141(200112)31:12<3687::AID-IMMU3687>3.0.CO;2-C; Pietra G, 2010, J BIOMED BIOTECHNOL, DOI 10.1155/2010/907092; Reddehase MJ, 2002, NAT REV IMMUNOL, V2, P831, DOI 10.1038/nri932; Romagnani C, 2002, P NATL ACAD SCI USA, V99, P11328, DOI 10.1073/pnas.172369799; Rowshani AT, 2005, TRANSPLANTATION, V79, P381, DOI 10.1097/01.TP.0000148239.00384.F0; Sacher T, 2012, EUR J CELL BIOL, V91, P70, DOI 10.1016/j.ejcb.2011.02.002; Salerno-Goncalves R, 2004, J IMMUNOL, V173, P5852, DOI 10.4049/jimmunol.173.9.5852; Saulquin X, 2000, EUR J IMMUNOL, V30, P2531, DOI 10.1002/1521-4141(200009)30:9<2531::AID-IMMU2531>3.0.CO;2-O; Schonberg K, 2011, BLOOD, V117, P98, DOI 10.1182/blood-2010-03-273656; Schulte D, 2009, J INFECT DIS, V200, P1397, DOI 10.1086/605889; Sensi M, 2009, INT IMMUNOL, V21, P257, DOI 10.1093/intimm/dxn141; Streblow DN, 2007, CURR OPIN IMMUNOL, V19, P577, DOI 10.1016/j.coi.2007.07.012; Strong RK, 2003, J BIOL CHEM, V278, P5082, DOI 10.1074/jbc.M208268200; Takemoto S, 2004, HUM IMMUNOL, V65, P1489, DOI 10.1016/j.humimm.2004.06.008; Tomasec P, 2000, SCIENCE, V287, P1031, DOI 10.1126/science.287.5455.1031; van Bergen J, 2011, AM J TRANSPLANT, V11, P1959, DOI 10.1111/j.1600-6143.2011.03621.x; Wilkinson GWG, 2008, J CLIN VIROL, V41, P206, DOI 10.1016/j.jcv.2007.10.027	53	24	24	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 30	2012	7	11							e50951	10.1371/journal.pone.0050951	http://dx.doi.org/10.1371/journal.pone.0050951			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	054WM	23226431	gold, Green Published			2022-12-27	WOS:000312376100242
J	Bao, BN; Groves, K; Zhang, J; Handy, E; Kennedy, P; Cuneo, G; Supuran, CT; Yared, W; Rajopadhye, M; Peterson, JD				Bao, Bagna; Groves, Kevin; Zhang, Jun; Handy, Emma; Kennedy, Paul; Cuneo, Garry; Supuran, Claudiu T.; Yared, Wael; Rajopadhye, Milind; Peterson, Jeffrey D.			In Vivo Imaging and Quantification of Carbonic Anhydrase IX Expression as an Endogenous Biomarker of Tumor Hypoxia	PLOS ONE			English	Article							MONOCLONAL-ANTIBODY; PH REGULATION; DIAGNOSTIC BIOMARKER; CATALYTIC DOMAIN; CANCER; METASTASIS; INHIBITORS; CARCINOMA; MARKER; GROWTH	Carbonic anhydrase IX (CA IX) is a transmembrane protein that has been shown to be greatly upregulated under conditions of hypoxia in many tumor cell lines. Tumor hypoxia is associated with impaired efficacy of cancer therapies making CA IX a valuable target for preclinical and diagnostic imaging. We have developed a quantitative in vivo optical imaging method for detection of CA IX as a marker of tumor hypoxia based on a near-infrared (NIR) fluorescent derivative of the CA IX inhibitor acetazolamide (AZ). The agent (HS680) showed single digit nanomolar inhibition of CA IX as well as selectivity over other CA isoforms and demonstrated up to 25-fold upregulation of fluorescent CA IX signal in hypoxic versus normoxic cells, which could be blocked by 60%-70% with unlabeled AZ. CA IX negative cell lines (HCT-116 and MDA-MB-231), as well as a non-binding control agent on CA IX positive cells, showed low fluorescent signal under both conditions. In vivo FMT imaging showed tumor accumulation and excellent tumor definition from 6-24 hours. In vivo selectivity was confirmed by pretreatment of the mice with unlabeled AZ resulting in >65% signal inhibition. HS680 tumor signal was further upregulated >2X in tumors by maintaining tumor-bearing mice in a low oxygen (8%) atmosphere. Importantly, intravenously injected HS680 signal was co-localized specifically with both CA IX antibody and pimonidazole (Pimo), and was located away from non-hypoxic regions indicated by a Hoechst stain. Thus, we have established a spatial correlation of fluorescence signal obtained by non-invasive, tomographic imaging of HS680 with regions of hypoxia and CA IX expression. These results illustrate the potential of HS680 and combined with FMT imaging to non-invasively quantify CA IX expression as a hypoxia biomarker, crucial to the study of the underlying biology of hypoxic tumors and the development and monitoring of novel anti-cancer therapies.	[Bao, Bagna; Groves, Kevin; Zhang, Jun; Handy, Emma; Kennedy, Paul; Cuneo, Garry; Yared, Wael; Rajopadhye, Milind; Peterson, Jeffrey D.] PerkinElmer Inc, Life Sci & Technol, Boston, MA USA; [Supuran, Claudiu T.] Univ Florence, Dept Chem, Lab Bioinorgan Chem, Florence, Italy	University of Florence	Bao, BN (corresponding author), PerkinElmer Inc, Life Sci & Technol, Boston, MA USA.	bagna.bao@perkinelmer.com	Supuran, Claudiu T/A-5151-2008		PerkinElmer, Inc., Boston	PerkinElmer, Inc., Boston	Research was supported by PerkinElmer, Inc., Boston. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The authors, including one author from the Laboratory of Bioinorganic Chemistry, Universita degli Studi di Firenze, Florence, Italy, receive no direct or indirect financial gain from publication of this research.	Ahlskog JKJ, 2009, BIOORG MED CHEM LETT, V19, P4851, DOI 10.1016/j.bmcl.2009.06.022; Akurathi V, 2010, NUCL MED BIOL, V37, P557, DOI 10.1016/j.nucmedbio.2010.02.006; Alterio V, 2009, P NATL ACAD SCI USA, V106, P16233, DOI 10.1073/pnas.0908301106; Brubaker KD, 1999, J HISTOCHEM CYTOCHEM, V47, P545, DOI 10.1177/002215549904700413; Carlin S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010857; Cecchi A, 2005, J MED CHEM, V48, P4834, DOI 10.1021/jm0501073; Chaudary N, 2007, CLIN CANCER RES, V13, P1947, DOI 10.1158/1078-0432.CCR-06-2971; Chen CL, 2010, VIRCHOWS ARCH, V457, P53, DOI 10.1007/s00428-010-0938-0; Chia SK, 2001, J CLIN ONCOL, V19, P3660, DOI 10.1200/JCO.2001.19.16.3660; Cho HJ, 2009, NEOPLASIA, V11, P247, DOI 10.1593/neo.81360; Chrastina A, 2003, NEOPLASMA, V50, P13; Chrastina A, 2003, INT J CANCER, V105, P873, DOI 10.1002/ijc.11142; DeClerck K, 2010, FRONT BIOSCI-LANDMRK, V15, P213, DOI 10.2741/3616; Dubois L, 2007, RADIOTHER ONCOL, V83, P367, DOI 10.1016/j.radonc.2007.04.018; Dubois L, 2009, RADIOTHER ONCOL, V92, P423, DOI 10.1016/j.radonc.2009.06.019; Frangioni JV, 2003, CURR OPIN CHEM BIOL, V7, P626, DOI 10.1016/j.cbpa.2003.08.007; Giatromanolaki A, 2001, CANCER RES, V61, P7992; Goel S, 2011, PHYSIOL REV, V91, P1071, DOI 10.1152/physrev.00038.2010; Groves K, 2011, BIOORG MED CHEM LETT; He FQ, 2008, CANCER RES, V68, P8597, DOI 10.1158/0008-5472.CAN-08-0677; Hohenberger P, 1998, BREAST CANCER RES TR, V48, P97, DOI 10.1023/A:1005921513083; Ivanov S, 2001, AM J PATHOL, V158, P905, DOI 10.1016/S0002-9440(10)64038-2; Koukourakis MI, 2001, CLIN CANCER RES, V7, P3399; Krohn KA, 2008, J NUCL MED, V49, p129S, DOI 10.2967/jnumed.107.045914; Lehmann S, 2011, J NUCL MED, V52, P445, DOI 10.2967/jnumed.110.082412; Li XF, 2007, CANCER RES, V67, P7646, DOI 10.1158/0008-5472.CAN-06-4353; LIAO SY, 1994, AM J PATHOL, V145, P598; Liao SY, 1997, CANCER RES, V57, P2827; Lou YM, 2011, CANCER RES, V71, P3364, DOI 10.1158/0008-5472.CAN-10-4261; Lu X, 2010, CLIN CANCER RES, V16, P5928, DOI 10.1158/1078-0432.CCR-10-1360; Luker GD, 2008, J NUCL MED, V49, P1, DOI 10.2967/jnumed.107.045799; Neri D, 2011, NAT REV DRUG DISCOV, V10, P767, DOI 10.1038/nrd3554; Ntziachristos V, 2001, OPT LETT, V26, P893, DOI 10.1364/OL.26.000893; Ntziachristos V, 2005, NAT BIOTECHNOL, V23, P313, DOI 10.1038/nbt1074; Pansare VJ, 2012, CHEM MATER, V24, P812, DOI 10.1021/cm2028367; Pastorekova S, 2008, CURR PHARM DESIGN, V14, P685, DOI 10.2174/138161208783877893; Pastorekova S, 2008, BJU INT, V101, P8, DOI 10.1111/j.1464-410X.2008.07642.x; Rami M, 2011, BIOORG MED CHEM LETT, V21, P5210, DOI 10.1016/j.bmcl.2011.07.045; Rao JH, 2007, CURR OPIN BIOTECH, V18, P17, DOI 10.1016/j.copbio.2007.01.003; Robertson N, 2004, CANCER RES, V64, P6160, DOI 10.1158/0008-5472.CAN-03-2224; Russell J, 2009, INT J RADIAT ONCOL, V73, P1177, DOI 10.1016/j.ijrobp.2008.12.004; Saarnio J, 1998, J HISTOCHEM CYTOCHEM, V46, P497, DOI 10.1177/002215549804600409; Shin KH, 2007, CANCER BIOL THER, V6, P70, DOI 10.4161/cbt.6.1.3550; Supuran CT, 2008, NAT REV DRUG DISCOV, V7, P168, DOI 10.1038/nrd2467; Svastova E, 2004, FEBS LETT, V577, P439, DOI 10.1016/j.febslet.2004.10.043; Swietach P, 2010, ONCOGENE, V29, P6509, DOI 10.1038/onc.2010.455; Tafreshi NK, 2011, CLIN CANC RES; Torigan DA, 2007, CA-CANCER J CLIN, V57, P206, DOI 10.3322/canjclin.57.4.206; VAUPEL P, 1991, CANCER RES, V51, P3316; Vaupel P, 2007, CANCER METAST REV, V26, P225, DOI 10.1007/s10555-007-9055-1; Winum JY, 2008, MED RES REV, V28, P445, DOI 10.1002/med.20112; Yeom SH, 2011, FRONT BIOSCI-LANDMRK, V16, P997, DOI 10.2741/3731; Zatovicova M, 2010, CURR PHARM DESIGN, V16, P3255, DOI 10.2174/138161210793429832	53	56	59	1	45	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 30	2012	7	11							e50860	10.1371/journal.pone.0050860	http://dx.doi.org/10.1371/journal.pone.0050860			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	054WM	23226406	Green Published, Green Submitted, gold			2022-12-27	WOS:000312376100217
J	Hepburn, AC; Veeratterapillay, R; Williamson, SC; El-Sherif, A; Sahay, N; Thomas, HD; Mantilla, A; Pickard, RS; Robson, CN; Heer, R				Hepburn, Anastasia C.; Veeratterapillay, Rajan; Williamson, Stuart C.; El-Sherif, Amira; Sahay, Neha; Thomas, Huw D.; Mantilla, Alejandra; Pickard, Robert S.; Robson, Craig N.; Heer, Rakesh			Side Population in Human Non-Muscle Invasive Bladder Cancer Enriches for Cancer Stem Cells That Are Maintained by MAPK Signalling	PLOS ONE			English	Article							RADICAL CYSTECTOMY; INITIATING CELLS; CARCINOMA; RESISTANCE; EXPRESSION; IDENTIFICATION; CISPLATIN; GENE; DIFFERENTIATION; PROGRESSION	Side population (SP) and ABC transporter expression enrich for stem cells in numerous tissues. We explored if this phenotype characterised human bladder cancer stem cells (CSCs) and attempted to identify regulatory mechanisms. Focusing on non-muscle invasive bladder cancer (NMIBC), multiple human cell lines were used to characterise SP and ABC transporter expression. In vitro and in vivo phenotypic and functional assessments of CSC behaviour were undertaken. Expression of putative CSC marker ABCG2 was assessed in clinical NMIBC samples (n = 148), and a role for MAPK signalling, a central mechanism of bladder tumourigenesis, was investigated. Results showed that the ABCG2 transporter was predominantly expressed and was up-regulated in the SP fraction by 3-fold (ABCG2(hi)) relative to the non-SP (NSP) fraction (ABCG2(low)). ABCG2(hi) SP cells displayed enrichment of stem cell markers (Nanog, Notch1 and SOX2) and a three-fold increase in colony forming efficiency (CFE) in comparison to ABCG2(low) NSP cells. In vivo, ABCG2(hi) SP cells enriched for tumour growth compared with ABCG2(low) NSP cells, consistent with CSCs. pERK was constitutively active in ABCG2(hi) SP cells and MEK inhibition also inhibited the ABCG2(hi) SP phenotype and significantly suppressed CFE. Furthermore, on examining clinical NMIBC samples, ABCG2 expression correlated with increased recurrence and decreased progression free survival. Additionally, pERK expression also correlated with decreased progression free survival, whilst a positive correlation was further demonstrated between ABCG2 and pERK expression. In conclusion, we confirm ABCG2(hi) SP enriches for CSCs in human NMIBC and MAPK/ERK pathway is a suitable therapeutic target.	[Hepburn, Anastasia C.; Williamson, Stuart C.; Sahay, Neha; Thomas, Huw D.; Mantilla, Alejandra; Robson, Craig N.; Heer, Rakesh] Newcastle Univ, No Inst Canc Res, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England; [Veeratterapillay, Rajan; Pickard, Robert S.; Heer, Rakesh] Newcastle Upon Tyne Hosp NHS Fdn Trust, Dept Urol, Freeman Hosp, Newcastle Upon Tyne, Tyne & Wear, England; [El-Sherif, Amira] Newcastle Upon Tyne Hosp NHS Fdn Trust, Dept Pathol, Royal Victoria Infirm, Newcastle Upon Tyne, Tyne & Wear, England; [Pickard, Robert S.] Newcastle Univ, Sch Med, Inst Cellular Med, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England	Newcastle University - UK; Newcastle Freeman Hospital; Newcastle Upon Tyne Hospitals NHS Foundation Trust; Newcastle University - UK; Newcastle Upon Tyne Hospitals NHS Foundation Trust; Newcastle University - UK	Heer, R (corresponding author), Newcastle Univ, No Inst Canc Res, Framlington Pl, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England.	rakesh.heer@ncl.ac.uk		Williamson, Stuart/0000-0002-5209-4796	JGW Patterson Foundation; NHS Trustees	JGW Patterson Foundation; NHS Trustees	This work was funded by JGW Patterson Foundation and NHS Trustees. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Hajj M, 2003, P NATL ACAD SCI USA, V100, P3983, DOI 10.1073/pnas.0530291100; Becker KA, 2006, J CELL PHYSIOL, V209, P883, DOI 10.1002/jcp.20776; Ben-Porath I, 2008, NAT GENET, V40, P499, DOI 10.1038/ng.127; Bentivegna A, 2010, CANCER SCI, V101, P416, DOI 10.1111/j.1349-7006.2009.01414.x; Bleau AM, 2009, CELL STEM CELL, V4, P226, DOI 10.1016/j.stem.2009.01.007; Brown MD, 2007, PROSTATE, V67, P1384, DOI 10.1002/pros.20620; Camargo FD, 2006, BLOOD, V107, P501, DOI 10.1182/blood-2005-02-0655; Chan KS, 2009, P NATL ACAD SCI USA, V106, P14016, DOI 10.1073/pnas.0906549106; Clarke Michael F, 2006, Cancer Res, V66, P9339, DOI 10.1158/0008-5472.CAN-06-3126; Clifford SC, 1996, CARCINOGENESIS, V17, P601, DOI 10.1093/carcin/17.3.601; DINNEY CPN, 1995, J UROLOGY, V154, P1532, DOI 10.1016/S0022-5347(01)66923-4; Dinney CPN, 2004, CANCER CELL, V6, P111, DOI 10.1016/j.ccr.2004.08.002; Dubrovska A, 2010, CLIN CANCER RES, V16, P5692, DOI 10.1158/1078-0432.CCR-10-1601; Falso MJS, 2012, ANTICANCER RES, V32, P733; Forster JA, 2011, BRIT J CANCER, V104, P1135, DOI 10.1038/bjc.2011.39; Golebiewska A, 2011, CELL STEM CELL, V8, P136, DOI 10.1016/j.stem.2011.01.007; Goodell MA, 1996, J EXP MED, V183, P1797, DOI 10.1084/jem.183.4.1797; Gupta PB, 2009, CELL, V138, P645, DOI 10.1016/j.cell.2009.06.034; He XB, 2009, STEM CELLS, V27, P1487, DOI 10.1002/stem.92; Ho MM, 2007, CANCER RES, V67, P4827, DOI 10.1158/0008-5472.CAN-06-3557; Imai Y, 2009, CANCER SCI, V100, P1118, DOI 10.1111/j.1349-7006.2009.01154.x; Karlou M, 2009, PATHOLOGY, V41, P327, DOI 10.1080/00313020902885011; Kassouf W, 2005, CANCER RES, V65, P10524, DOI 10.1158/0008-5472.CAN-05-1536; Kassouf W, 2008, J UROLOGY, V179, P353, DOI 10.1016/j.juro.2007.08.087; Knowles MA, 2008, INT J CLIN ONCOL, V13, P287, DOI 10.1007/s10147-008-0812-0; LAPIDOT T, 1994, NATURE, V367, P645, DOI 10.1038/367645a0; Mason MD, 2001, COCHRANE DB SYST REV; National Cancer Institute NIH DHHS, 2010, CANC TRENDS PROGR RE; Oates JE, 2009, STEM CELLS DEV, V18, P1515, DOI 10.1089/scd.2008.0302; Patrawala L, 2005, CANCER RES, V65, P6207, DOI 10.1158/0008-5472.CAN-05-0592; Ploeg M, 2009, WORLD J UROL, V27, P289, DOI 10.1007/s00345-009-0383-3; Pruthi RS, 2010, BJU INT, V106, P349, DOI 10.1111/j.1464-410X.2009.09101.x; Ricci-Vitiani L, 2007, NATURE, V445, P111, DOI 10.1038/nature05384; Schatton T, 2008, NATURE, V451, P345, DOI 10.1038/nature06489; Shah JB, 2011, CLIN CANCER RES, V17, P2608, DOI 10.1158/1078-0432.CCR-10-2770; Shariat SF, 2006, J UROLOGY, V176, P2414, DOI 10.1016/j.juro.2006.08.004; Shin K, 2011, NATURE, V472, P110, DOI 10.1038/nature09851; Sunayama J, 2010, STEM CELLS, V28, P1930, DOI 10.1002/stem.521; Sylvester RJ, 2002, J UROLOGY, V168, P1964, DOI 10.1016/S0022-5347(05)64273-5; Tabu K, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-39; Tsuchida R, 2008, ONCOGENE, V27, P3923, DOI 10.1038/onc.2008.38; van Rhijn BWG, 2001, CANCER RES, V61, P1265; Vermeulen L, 2010, NAT CELL BIOL, V12, P468, DOI 10.1038/ncb2048; Volkmer JP, 2012, P NATL ACAD SCI USA, V109, P2078, DOI 10.1073/pnas.1120605109; Wang YK, 2010, CARCINOGENESIS, V31, P1376, DOI 10.1093/carcin/bgq120; Yeh TC, 2007, CLIN CANCER RES, V13, P1576, DOI 10.1158/1078-0432.CCR-06-1150; Yilmaz OH, 2006, NATURE, V441, P475, DOI 10.1038/nature04703; Zhang X, 2009, J CELL BIOL, V184, P67, DOI 10.1083/jcb.200801009; Zhang Y, 2012, CANCER LETT, V322, P70, DOI 10.1016/j.canlet.2012.02.010; Zhou S, 2001, NAT MED, V7, P1028, DOI 10.1038/nm0901-1028	50	32	37	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 30	2012	7	11							e50690	10.1371/journal.pone.0050690	http://dx.doi.org/10.1371/journal.pone.0050690			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	054WM	23226356	Green Published, gold, Green Submitted			2022-12-27	WOS:000312376100167
J	Hill, RP; Gledhill, K; Gardner, A; Higgins, CA; Crawford, H; Lawrence, C; Hutchison, CJ; Owens, WA; Kara, B; James, SE; Jahoda, CAB				Hill, Rebecca P.; Gledhill, Karl; Gardner, Aaron; Higgins, Claire A.; Crawford, Heather; Lawrence, Clifford; Hutchison, Christopher J.; Owens, William A.; Kara, Bo; James, S. Elizabeth; Jahoda, Colin A. B.			Generation and Characterization of Multipotent Stem Cells from Established Dermal Cultures	PLOS ONE			English	Article							SKIN-DERIVED PRECURSORS; HAIR-FOLLICLES; PAPILLA CELLS; DIFFERENTIATION; EFFICIENT; FIBROBLASTS; INVITRO; INVIVO	Human multipotent skin derived precursor cells (SKPs) are traditionally sourced from dissociated dermal tissues; therefore, donor availability may become limiting. Here we demonstrate that both normal and diseased adult human dermal fibroblasts (DF) pre-cultured in conventional monolayers are capable of forming SKPs (termed m-SKPs). Moreover, we show that these m-SKPs can be passaged and that cryopreservation of original fibroblast monolayer cultures does not reduce m-SKP yield; however, extensive monolayer passaging does. Like SKPs generated from dissociated dermis, these m-SKPs expressed nestin, fibronectin and versican at the protein level. At the transcriptional level, m-SKPs derived from normal adult human DF, expressed neural crest stem cell markers such as p75NTR, embryonic stem cell markers such as Nanog and the mesenchymal stem cell marker Dermo-1. Furthermore, appropriate stimuli induced m-SKPs to differentiate down either mesenchymal or neural lineages resulting in lipid accumulation, calcification and S100 beta or beta-III tubulin expression (with multiple processes). m-SKP yield was greater from neonatal foreskin cultures compared to those from adult DF cultures; however, the former showed a greater decrease in m-SKP forming capacity after extensive monolayer passaging. m-SKP yield was greater from adult DF cultures expressing more alpha-smooth muscle actin (alpha SMA). In turn, elevated alpha SMA expression correlated with cells originating from specimens isolated from biopsies containing more terminal hair follicles; however, alpha SMA expression was lost upon m-SKP formation. Others have shown that dissociated human hair follicle dermal papilla (DP) are a highly enriched source of SKPs. However, conversely and unexpectedly, monolayer cultured human hair follicle DP cells failed to form m-SKPs whereas those from the murine vibrissae follicles did. Collectively, these findings reveal the potential for using expanded DF cultures to produce SKPs, the heterogeneity of SKP forming potential of skin from distinct anatomical locations and ages, and question the progenitor status of human hair follicle DP cells.	[Hill, Rebecca P.; Gledhill, Karl; Gardner, Aaron; Higgins, Claire A.; Crawford, Heather; Hutchison, Christopher J.; Jahoda, Colin A. B.] Univ Durham, Sch Biol & Biomed Sci, Durham, England; [Hill, Rebecca P.; Kara, Bo] Fujifilm Diosynth, Billingham, Cleveland, England; [Higgins, Claire A.] Columbia Univ, Dept Dermatol, New York, NY 10027 USA; [Owens, William A.] James Cook Univ Hosp, Dept Cardiothorac Surg, Middlesbrough, Cleveland, England; [Lawrence, Clifford] Royal Victoria Infirm, Dept Dermatol, Newcastle Upon Tyne NE1 4LP, Tyne & Wear, England; [James, S. Elizabeth] Univ Brighton, Sch Pharm & Biomol Sci, Brighton, E Sussex, England	Durham University; Fujifilm Corporation; Columbia University; James Cook University Hospital; Newcastle University - UK; University of Brighton	Jahoda, CAB (corresponding author), Univ Durham, Sch Biol & Biomed Sci, Durham, England.	colin.jahoda@durham.ac.uk	Gledhill, Karl/H-8935-2012; Owens, Andrew/K-4776-2012; Owens, W Andrew/AAG-6073-2020; Gardner, Aaron/H-1511-2012	Owens, Andrew/0000-0001-9836-9209; Owens, W Andrew/0000-0001-9836-9209; Gardner, Aaron/0000-0001-8729-9823; Jahoda, Colin/0000-0002-1762-1220; Higgins, Claire/0000-0002-9742-5149	United Kingdom DTI (TSB); Medical Research Council; DEBRA; UK government (Technology Strategy Board)	United Kingdom DTI (TSB); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); DEBRA; UK government (Technology Strategy Board)	This study was supported by United Kingdom DTI (TSB), the Medical Research Council and DEBRA. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; BK is employed by Fujifilm Diosynth. RPH was employed by Durham University whilst undertaking the work described in the manuscript; she is now employed by Fujifilm Diosynth. BK was involved as a co-investigator on a UK government (Technology Strategy Board) funded collaborative project between Durham University, and the company that is now Fujifilm Diosynth. The study was not influenced by any commercial activities or interests and study direction was under the control of CABJ at Durham University. Their employment did not raise any conflicting interests and did not alter the authors' adherence to all the PLOS ONE policies on sharing data and materials. There is no intellectual property associated with this work.	Adly MA, 2009, J AM ACAD DERMATOL, V60, P99, DOI 10.1016/j.jaad.2008.09.060; Baharvand H, 2010, NAT PROTOC, V5, P588, DOI 10.1038/nprot.2009.247; Biernaskie JA, 2006, NAT PROTOC, V1, P2803, DOI 10.1038/nprot.2006.422; Driskell RR, 2011, J CELL SCI, V124, P1179, DOI 10.1242/jcs.082446; Dyce PW, 2004, BIOCHEM BIOPH RES CO, V316, P651, DOI 10.1016/j.bbrc.2004.02.093; Fernandes KJL, 2006, EXP NEUROL, V201, P32, DOI 10.1016/j.expneurol.2006.03.018; Gago N, 2009, STEM CELLS, V27, P1164, DOI 10.1002/stem.27; Guo W, 2009, CELL PROLIFERAT, V42, P49, DOI 10.1111/j.1365-2184.2008.00573.x; Higgins CA, 2010, EXP DERMATOL, V19, P546, DOI 10.1111/j.1600-0625.2009.01007.x; Hunt DPJ, 2008, STEM CELLS, V26, P163, DOI 10.1634/stemcells.2007-0281; JAHODA CAB, 1991, J CELL SCI, V99, P627; JAHODA CAB, 1984, J EMBRYOL EXP MORPH, V79, P211; Jahoda CAB, 2003, EXP DERMATOL, V12, P849, DOI 10.1111/j.0906-6705.2003.00161.x; Jinno H, 2010, STEM CELLS, V28, P2027, DOI 10.1002/stem.525; Joannides A, 2004, LANCET, V364, P172, DOI 10.1016/S0140-6736(04)16630-0; Kawase Y, 2004, EXP CELL RES, V295, P194, DOI 10.1016/j.yexcr.2003.12.027; Lavoie JF, 2009, STEM CELLS DEV, V18, P893, DOI 10.1089/scd.2008.0260; Lorenz K, 2008, EXP DERMATOL, V17, P925, DOI 10.1111/j.1600-0625.2008.00724.x; MESSENGER AG, 1984, BRIT J DERMATOL, V110, P685, DOI 10.1111/j.1365-2133.1984.tb04705.x; Ohyama M, 2012, J CELL SCI, V125, P4114, DOI 10.1242/jcs.105700; Richards SA, 2011, HUM MOL GENET, V20, P3997, DOI 10.1093/hmg/ddr327; Steinbach SK, 2011, ARTERIOSCL THROM VAS, V31, P2938, DOI 10.1161/ATVBAHA.111.232975; Stockschlader M, 1997, BRIT J HAEMATOL, V96, P382, DOI 10.1046/j.1365-2141.1997.d01-2032.x; Toma JG, 2001, NAT CELL BIOL, V3, P778, DOI 10.1038/ncb0901-778; Toma JG, 2005, STEM CELLS, V23, P727, DOI 10.1634/stemcells.2004-0134; Wenzel V, 2012, BIOL OPEN, V1, P516, DOI 10.1242/bio.20121149	26	34	37	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 30	2012	7	11							e50742	10.1371/journal.pone.0050742	http://dx.doi.org/10.1371/journal.pone.0050742			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	054WM	23226372	Green Published, gold, Green Accepted			2022-12-27	WOS:000312376100183
J	Kremer, B; Mariman, R; van Erk, M; Lagerweij, T; Nagelkerken, L				Kremer, Bas; Mariman, Rob; van Erk, Marjan; Lagerweij, Tonny; Nagelkerken, Lex			Temporal Colonic Gene Expression Profiling in the Recurrent Colitis Model Identifies Early and Chronic Inflammatory Processes	PLOS ONE			English	Article							MAST-CELLS; BOWEL-DISEASE; PANETH CELLS; CHEMOKINE RECEPTORS; EPITHELIAL-CELLS; CROHNS-DISEASE; MOUSE MODELS; MECHANISMS; INDUCTION; FIBROSIS	The recurrent TNBS-colitis model in BALB/c mice has been proposed as a model of Inflammatory Bowel Disease with a shifting pattern of local cytokines with the expression of Th1 cytokines during the early phase, Th17 cytokines during the intermediate phase and Th2 cytokines during late fibrotic stages. In this study, we evaluated the development of pathology in time-in conjunction with genome-wide gene expression in the colons-in response to three weekly intrarectal instillations of TNBS. During this time-frame mice develop colitis with extensive cellular infiltration of (sub) mucosa and mildly to moderately affected crypt architecture. These pathological processes were sensitive to local treatment with budesonide. Gene expression profiling confirmed an acute phase response after each intrarectal TNBS-challenge. In addition, a chronic inflammatory process developed over time particularly evident from a gradual increase in expression of mast cell related genes. The changes in pathological hallmarks were consistent with a temporal expression of mRNA encoding a selection of chemokines. In conclusion, the early stages of the recurrent TNBS-colitis model reflect several aspects of inflammatory bowel disease which are sensitive to immunomodulation.	[Kremer, Bas; Mariman, Rob; Lagerweij, Tonny; Nagelkerken, Lex] TNO, Dept Metab Hlth Res, Leiden, Netherlands; [Mariman, Rob] Leiden Univ, Med Ctr, Dept Immunohematol & Bloodtransfus, Leiden, Netherlands; [Kremer, Bas; van Erk, Marjan] TNO, Dept Microbiol & Syst Biol, NL-3700 AJ Zeist, Netherlands	Netherlands Organization Applied Science Research; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Netherlands Organization Applied Science Research	Kremer, B (corresponding author), TNO, Dept Metab Hlth Res, Leiden, Netherlands.	bas.kremer@tno.nl	Lagerweij, Tonny/AAY-7128-2020	Lagerweij, Tonny/0000-0003-1043-7452; Mariman, Rob/0000-0001-6405-1091				Andoh A, 2006, ONCOL REP, V16, P103; Arijs I, 2011, AM J GASTROENTEROL, V106, P748, DOI 10.1038/ajg.2011.27; Boulton RA, 2003, WORLD J SURG, V27, P1014, DOI 10.1007/s00268-003-7054-0; Cunliffe RN, 2001, GUT, V48, P176, DOI 10.1136/gut.48.2.176; Danese S, 2006, GASTROENTEROLOGY, V130, P2060, DOI 10.1053/j.gastro.2006.03.054; Edgar R, 2002, NUCLEIC ACIDS RES, V30, P207, DOI 10.1093/nar/30.1.207; Elson CO, 2004, CURR OPIN GASTROEN, V20, P360, DOI 10.1097/00001574-200407000-00010; Engel MA, 2010, J GASTROENTEROL, V45, P571, DOI 10.1007/s00535-010-0219-3; Fahlgren A, 2003, CLIN EXP IMMUNOL, V131, P90, DOI 10.1046/j.1365-2249.2003.02035.x; Fichtner-Feigl S, 2008, MUCOSAL IMMUNOL, V1, pS24, DOI 10.1038/mi.2008.41; Fichtner-Feigl S, 2005, J CLIN INVEST, V115, P3057, DOI 10.1172/JCI24792; Fichtner-Feigl S, 2007, J IMMUNOL, V178, P5859, DOI 10.4049/jimmunol.178.9.5859; Gijsbers K, 2006, CURR DRUG TARGETS, V7, P47, DOI 10.2174/138945006775270222; Hallgren J, 2011, ADV EXP MED BIOL, V716, P14, DOI 10.1007/978-1-4419-9533-9_2; He SH, 2004, WORLD J GASTROENTERO, V10, P309; Kawada M, 2007, WORLD J GASTROENTERO, V13, P5581, DOI 10.3748/wjg.v13.i42.5581; Kozuch PL, 2008, WORLD J GASTROENTERO, V14, P354, DOI 10.3748/wjg.14.354; Lawrance IC, 2003, GASTROENTEROLOGY, V125, P1750, DOI 10.1053/j.gastro.2003.08.027; Manolakis AC, 2011, DIGEST DIS SCI, V56, P1601, DOI 10.1007/s10620-010-1494-9; Mariman R, 2012, INFLAMM BOWEL DIS, V18, P1424, DOI 10.1002/ibd.22849; Mencarelli A, 2009, BIOCHEM PHARMACOL, V78, P1214, DOI 10.1016/j.bcp.2009.06.026; Neurath M, 2000, Int Rev Immunol, V19, P51, DOI 10.3109/08830180009048389; NEURATH MF, 1995, J EXP MED, V182, P1281, DOI 10.1084/jem.182.5.1281; Noble CL, 2008, GUT, V57, P1398, DOI 10.1136/gut.2008.148395; Noble CL, 2010, INFLAMM BOWEL DIS, V16, P1717, DOI 10.1002/ibd.21263; Perminow G, 2010, AM J GASTROENTEROL, V105, P452, DOI 10.1038/ajg.2009.643; Porter BO, 2000, SEMIN IMMUNOL, V12, P465, DOI 10.1006/smim.2000.0264; Psarros M, 2005, NUCLEIC ACIDS RES, V33, pW638, DOI 10.1093/nar/gki490; RAITHEL M, 1995, INT ARCH ALLERGY IMM, V108, P127, DOI 10.1159/000237129; Paiotti APR, 2011, J MOL HISTOL, V42, P443, DOI 10.1007/s10735-011-9349-z; Rijnierse A, 2007, PHARMACOL THERAPEUT, V116, P207, DOI 10.1016/j.pharmthera.2007.06.008; Shen C, 2007, INFLAMM BOWEL DIS, V13, P308, DOI 10.1002/ibd.20005; Shulzhenko N, 2011, NAT MED, V17, P1585, DOI 10.1038/nm.2505; Smyth G.K., 2004, STAT APPL GENET MOL, V3, P3, DOI [DOI 10.2202/1544-6115.1027, 10.2202/1544-6115.1027]; SOMMERS SC, 1966, GASTROENTEROLOGY, V51, P841; Stenton GR, 1998, ANN ALLERG ASTHMA IM, V81, P1, DOI 10.1016/S1081-1206(10)63105-5; STROBEL S, 1981, J CLIN PATHOL, V34, P851, DOI 10.1136/jcp.34.8.851; Strober W, 2006, ADV EXP MED BIOL, V579, P55; Strober W, 2008, INFLAMM BOWEL DIS, V14, pS129, DOI 10.1002/ibd.20667; Theoharides TC, 2012, BBA-MOL BASIS DIS, V1822, P21, DOI 10.1016/j.bbadis.2010.12.014; Wehkamp J, 2006, CURR OPIN GASTROEN, V22, P644, DOI 10.1097/01.mog.0000245541.95408.86; Wirtz S, 2007, ADV DRUG DELIVER REV, V59, P1073, DOI 10.1016/j.addr.2007.07.003; Wirtz S, 2007, NAT PROTOC, V2, P541, DOI 10.1038/nprot.2007.41; Xavier RJ, 2007, NATURE, V448, P427, DOI 10.1038/nature06005; Zilbauer M, 2011, INFLAMM BOWEL DIS, V17, P2076, DOI 10.1002/ibd.21577; Zimmerman NP, 2008, INFLAMM BOWEL DIS, V14, P1000, DOI 10.1002/ibd.20480	46	15	17	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 30	2012	7	11							e50388	10.1371/journal.pone.0050388	http://dx.doi.org/10.1371/journal.pone.0050388			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	054WM	23226271	Green Submitted, gold, Green Published			2022-12-27	WOS:000312376100081
J	Kumari, S; Nie, J; Chen, HS; Ma, H; Stewart, R; Li, X; Lu, MZ; Taylor, WM; Wei, HR				Kumari, Sapna; Nie, Jeff; Chen, Huann-Sheng; Ma, Hao; Stewart, Ron; Li, Xiang; Lu, Meng-Zhu; Taylor, William M.; Wei, Hairong			Evaluation of Gene Association Methods for Coexpression Network Construction and Biological Knowledge Discovery	PLOS ONE			English	Article							TRANSCRIPTION FACTORS; MICROARRAY DATA; EXPRESSION; NOISE	Background: Constructing coexpression networks and performing network analysis using large-scale gene expression data sets is an effective way to uncover new biological knowledge; however, the methods used for gene association in constructing these coexpression networks have not been thoroughly evaluated. Since different methods lead to structurally different coexpression networks and provide different information, selecting the optimal gene association method is critical. Methods and Results: In this study, we compared eight gene association methods - Spearman rank correlation, Weighted Rank Correlation, Kendall, Hoeffding's D measure, Theil-Sen, Rank Theil-Sen, Distance Covariance, and Pearson - and focused on their true knowledge discovery rates in associating pathway genes and construction coordination networks of regulatory genes. We also examined the behaviors of different methods to microarray data with different properties, and whether the biological processes affect the efficiency of different methods. Conclusions: We found that the Spearman, Hoeffding and Kendall methods are effective in identifying coexpressed pathway genes, whereas the Theil-sen, Rank Theil-Sen, Spearman, and Weighted Rank methods perform well in identifying coordinated transcription factors that control the same biological processes and traits. Surprisingly, the widely used Pearson method is generally less efficient, and so is the Distance Covariance method that can find gene pairs of multiple relationships. Some analyses we did clearly show Pearson and Distance Covariance methods have distinct behaviors as compared to all other six methods. The efficiencies of different methods vary with the data properties to some degree and are largely contingent upon the biological processes, which necessitates the pre-analysis to identify the best performing method for gene association and coexpression network construction.	[Kumari, Sapna; Wei, Hairong] Michigan Technol Univ, Dept Math Sci, Houghton, MI 49931 USA; [Nie, Jeff; Stewart, Ron] Morgridge Inst Res, Madison, WI USA; [Chen, Huann-Sheng] NCI, Stat Methodol & Applicat Branch, Div Canc Control & Populat Sci, NIH, Bethesda, MD 20892 USA; [Ma, Hao] W Virginia Univ, Div Anim & Nutr Sci, Morgantown, WV 26506 USA; [Li, Xiang; Wei, Hairong] Michigan Technol Univ, Dept Comp Sci, Houghton, MI 49931 USA; [Lu, Meng-Zhu] Chinese Acad Forestry, Res Inst Forestry, State Lab Tree Genet & Breeding, Beijing, Peoples R China; [Taylor, William M.] Univ Wisconsin, Dept Comp Sci, Madison, WI 53706 USA; [Wei, Hairong] Michigan Technol Univ, Biotechnol Res Ctr, Houghton, MI 49931 USA; [Wei, Hairong] Michigan Technol Univ, Sch Forest Resources & Environm Sci, Houghton, MI 49931 USA	Michigan Technological University; University of Wisconsin System; University of Wisconsin Madison; The Morgridge Institute for Research, Inc.; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); West Virginia University; Michigan Technological University; Chinese Academy of Forestry; Research Institute of Forestry, CAF; University of Wisconsin System; University of Wisconsin Madison; Michigan Technological University; Michigan Technological University	Wei, HR (corresponding author), Michigan Technol Univ, Dept Math Sci, Houghton, MI 49931 USA.	hairong@mtu.edu	wei, hairong/GNM-7061-2022; Chen, Huann-Sheng/D-6328-2013; Lu, Meng-Zhu/AAN-9710-2020	wei, hairong/0000-0002-3551-4998; Chen, Huann-Sheng/0000-0002-5905-8050; Ma, Hao/0000-0001-9593-4102	School of Forest Resources and Environment Science, Michigan Technological University	School of Forest Resources and Environment Science, Michigan Technological University	This study was funded by the start-up fund to Dr. Wei from the School of Forest Resources and Environment Science, Michigan Technological University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aggarwal A, 2006, CANCER RES, V66, P232, DOI 10.1158/0008-5472.CAN-05-2232; Aulehla A, 2008, CURR OPIN CELL BIOL, V20, P632, DOI 10.1016/j.ceb.2008.09.002; Bennett T, 2010, PLANT CELL, V22, P640, DOI 10.1105/tpc.109.072272; Boyer LA, 2005, CELL, V122, P947, DOI 10.1016/j.cell.2005.08.020; Brezina V, 1997, P NATL ACAD SCI USA, V94, P10444, DOI 10.1073/pnas.94.19.10444; Chok N. S., 2010, PEARSONS VERSUS SPEA; Cui XQ, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-425; da Costa J. F. P., 2006, REVSTAT-STAT J, V4, P189; Da Costa JP, 2005, AUST NZ J STAT, V47, P515; DEVLIN SJ, 1975, BIOMETRIKA, V62, P531, DOI 10.2307/2335508; Fujita Andre, 2009, Journal of Bioinformatics and Computational Biology, V7, P663, DOI 10.1142/S0219720009004230; Hardin J, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-220; HOEFFDING W, 1948, ANN MATH STAT, V19, P546, DOI 10.1214/aoms/1177730150; Holloway DM, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1001069; Ingram PJ, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000192; Irizarry RA, 2003, BIOSTATISTICS, V4, P249, DOI 10.1093/biostatistics/4.2.249; Kaern M, 2005, NAT REV GENET, V6, P451, DOI 10.1038/nrg1615; Kawasaki S, 2001, PLANT CELL, V13, P889, DOI 10.1105/tpc.13.4.889; Kubo M, 2005, GENE DEV, V19, P1855, DOI 10.1101/gad.1331305; Mao LY, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-346; Minguez P, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017474; Myers JL, 2003, RES DESIGN STAT ANAL; Nelsen R.B., 2001, KENDALL TAU METRIC; Newson R, 2002, STATA J, V2, P45, DOI 10.1177/1536867X0200200103; Nie J, 2011, BMC SYST BIOL, V5, DOI 10.1186/1752-0509-5-53; Ohashi-Ito K, 2007, DEVELOPMENT, V134, P2959, DOI 10.1242/dev.006296; Peng HX, 2008, J STAT PLAN INFER, V138, P1836, DOI 10.1016/j.jspi.2007.06.036; Persson S, 2005, P NATL ACAD SCI USA, V102, P8633, DOI 10.1073/pnas.0503392102; Press W. H., 1992, ART SCI COMPUTING; Prokhorov A. V., 2001, KENDALL COEFFICIENT; Rahman N.A., 1968, COURSE THEORETICAL S; Redman JC, 2004, PLANT J, V38, P545, DOI 10.1111/j.1365-313X.2004.02061.x; RODGERS JL, 1988, AM STAT, V42, P59, DOI 10.2307/2685263; Rowicka M, 2007, P NATL ACAD SCI USA, V104, P16892, DOI 10.1073/pnas.0706022104; Spearman C, 1904, AM J PSYCHOL, V15, P201, DOI 10.2307/1412107; Stuart JM, 2003, SCIENCE, V302, P249, DOI 10.1126/science.1087447; Szekely GJ, 2007, ANN STAT, V35, P2769, DOI 10.1214/009053607000000505; Szekely GJ, 2009, ANN APPL STAT, V3, P1236, DOI 10.1214/09-AOAS312; Tu Y, 2002, P NATL ACAD SCI USA, V99, P14031, DOI 10.1073/pnas.222164199; van den Berg RA, 2010, FUNGAL GENET BIOL, V47, P539, DOI 10.1016/j.fgb.2010.03.005; Wang Z, 2011, P NATL ACAD SCI USA, V108, pE67, DOI 10.1073/pnas.1100059108; Wei HR, 2006, PLANT PHYSIOL, V142, P762, DOI 10.1104/pp.106.080358; Wilcox RR, 1998, BIOMETRICAL J, V40, P261, DOI 10.1002/(SICI)1521-4036(199807)40:3<261::AID-BIMJ261>3.0.CO;2-V; Young RA, 2011, CELL, V144, P940, DOI 10.1016/j.cell.2011.01.032; Zhang B, 2005, STAT APPL GENET MOL, V4, DOI 10.2202/1544-6115.1128; Zhong RQ, 2008, PLANT CELL, V20, P2763, DOI 10.1105/tpc.108.061325	46	77	78	1	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 30	2012	7	11							e50411	10.1371/journal.pone.0050411	http://dx.doi.org/10.1371/journal.pone.0050411			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	054WM	23226279	Green Published, Green Submitted, gold			2022-12-27	WOS:000312376100091
J	Lopez-Bellido, R; Barreto-Valer, K; Sanchez-Simon, FM; Rodriguez, RE				Lopez-Bellido, Roger; Barreto-Valer, Katherine; Macho Sanchez-Simon, Fatima; Rodriguez, Raquel E.			Cocaine Modulates the Expression of Opioid Receptors and miR-let-7d in Zebrafish Embryos	PLOS ONE			English	Article							MESSENGER-RNA LEVELS; PRENATAL COCAINE; NUCLEUS-ACCUMBENS; DANIO-RERIO; POSTTRANSCRIPTIONAL REGULATION; CELL-PROLIFERATION; MORPHINE-TOLERANCE; INDUCED ANALGESIA; MICE LACKING; CHRONIC PAIN	Prenatal exposure to cocaine, in mammals, has been shown to interfere with the expression of opioid receptors, which can have repercussions in its activity. Likewise, microRNAs, such as let-7, have been shown to regulate the expression of opioid receptors and hence their functions in mammals and in vitro experiments. In light of this, using the zebrafish embryos as a model our aim here was to evaluate the actions of cocaine in the expression of opioid receptors and let-7d miRNA during embryogenesis. In order to determine the effects produced by cocaine on the opioid receptors (zfmor, zfdor1 and zfdor2) and let-7d miRNA (dre-let-7d) and its precursors (dre-let-7d-1 and dre-let-7d-2), embryos were exposed to 1.5 mu M cocaine hydrochloride (HCl). Our results revealed that cocaine upregulated dre-let-7d and its precursors, and also increased the expression of zfmor, zfdor1 and zfdor2 during early developmental stages and decreased them in late embryonic stages. The changes observed in the expression of opioid receptors might occur through dre-let-7d, since DNA sequences and the morpholinos of opioid receptors microinjections altered the expression of dre-let-7d and its precursors. Likewise, opioid receptors and dre-let-7d showed similar distributions in the central nervous system (CNS) and at the periphery, pointing to a possible interrelationship between them. In conclusion, the silencing and overexpression of opioid receptors altered the expression of dre-let-7d, which points to the notion that cocaine via dre-let-7 can modulate the expression of opioid receptors. Our study provides new insights into the actions of cocaine during zebrafish embryogenesis, indicating a role of miRNAs, let-7d, in development and its relationship with gene expression of opioid receptors, related to pain and addiction process.	[Lopez-Bellido, Roger; Barreto-Valer, Katherine; Macho Sanchez-Simon, Fatima; Rodriguez, Raquel E.] Univ Salamanca, Dept Biochem & Mol Biol, Inst Neurosci Castilla & Leon, E-37008 Salamanca, Spain	University of Salamanca	Rodriguez, RE (corresponding author), Univ Salamanca, Dept Biochem & Mol Biol, Inst Neurosci Castilla & Leon, E-37008 Salamanca, Spain.	requelmi@usal.es		Barreto Valer, Katherine/0000-0002-7709-3896; Rodriguez Rodriguez, Raquel/0000-0003-1805-3066	Spanish Ministry of Education and Science [SAF2010-18597]; Regional Government of Castilla y Leon [B1039/SA25/10]; Spanish Ministry of Foreign Affairs; Agency for International Development Cooperation (MAEC-AECID)	Spanish Ministry of Education and Science(Spanish Government); Regional Government of Castilla y Leon; Spanish Ministry of Foreign Affairs(Spanish Government); Agency for International Development Cooperation (MAEC-AECID)	This work was supported by the Spanish Ministry of Education and Science (Grant SAF2010-18597) and the Regional Government of Castilla y Leon (Grant B1039/SA25/10). Roger Lopez-Bellido was supported by a grant from the Spanish Ministry of Foreign Affairs, and the Agency for International Development Cooperation (MAEC-AECID). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Azaryan AV, 1998, CAN J PHYSIOL PHARM, V76, P278, DOI 10.1139/cjpp-76-3-278; Ballantyne JC, 2007, PAIN, V129, P235, DOI 10.1016/j.pain.2007.03.028; Barrallo A, 1998, BIOCHEM BIOPH RES CO, V245, P544, DOI 10.1006/bbrc.1998.8496; Barrallo A, 2000, MOL BRAIN RES, V84, P1, DOI 10.1016/S0169-328X(00)00152-2; Barrallo Alejandro, 1998, Biochemical Society Transactions, V26, pS360; Chandrasekar V, 2009, MOL CELL NEUROSCI, V42, P350, DOI 10.1016/j.mcn.2009.08.009; Coolen M, 2009, CURR OPIN NEUROBIOL, V19, P461, DOI 10.1016/j.conb.2009.09.006; Cui Y, 2004, MOL CELL BIOL, V24, P8037, DOI 10.1128/MCB.24.18.8037-8047.2004; Davis-Dusenbery BN, 2010, J BIOCHEM, V148, P381, DOI 10.1093/jb/mvq096; DelaneyBlack V, 1996, PEDIATRICS, V98, P735; Dempsey D, 1999, J ANAL TOXICOL, V23, P24, DOI 10.1093/jat/23.1.24; Dey S, 2007, NEUROSCIENCE, V144, P509, DOI 10.1016/j.neuroscience.2006.09.047; Dienes-Nagy A, 1999, J CHROMATOGR A, V854, P109, DOI 10.1016/S0021-9673(99)00750-5; Eipper-Mains JE, 2011, RNA, V17, P1529, DOI 10.1261/rna.2775511; Ellett F, 2010, CURR OPIN PHARMACOL, V10, P563, DOI 10.1016/j.coph.2010.05.004; Eyler FD, 2009, DEV NEUROSCI-BASEL, V31, P121, DOI 10.1159/000207500; Feng QP, 2005, BRIT J PHARMACOL, V144, P887, DOI 10.1038/sj.bjp.0706130; Gallego MJ, 2009, STEM CELLS DEV, V18, P737, DOI 10.1089/scd.2008.0190; GERRITS MAFM, 1995, PSYCHOPHARMACOLOGY, V119, P92, DOI 10.1007/BF02246059; Gurtan AM, 2012, RNA, V18, P1116, DOI 10.1261/rna.032680.112; Haupt S, 2003, J CELL SCI, V116, P4077, DOI 10.1242/jcs.00739; HAUSER KF, 1989, J COMP NEUROL, V281, P13, DOI 10.1002/cne.902810103; He Y, 2010, J NEUROSCI, V30, P10251, DOI 10.1523/JNEUROSCI.2419-10.2010; Hojsted J, 2007, EUR J PAIN, V11, P490, DOI 10.1016/j.ejpain.2006.08.004; Hollander JA, 2010, NATURE, V466, P197, DOI 10.1038/nature09202; Hu SX, 2006, J PHARMACOL EXP THER, V318, P1280, DOI 10.1124/jpet.106.103853; Izenwasser S, 1996, EUR J PHARMACOL, V297, P187, DOI 10.1016/0014-2999(95)00828-4; Jaskiewicz L, 2008, CURR TOP MICROBIOL, V320, P77; Kim E, 2006, J BIOL CHEM, V281, P33749, DOI 10.1074/jbc.M603862200; Kosofsky Barry E., 1998, Seminars in Speech and Language, V19, P109, DOI 10.1055/s-2008-1064040; KOSTEN T, 1992, BIOL PSYCHIAT, V32, P543, DOI 10.1016/0006-3223(92)90223-M; Kuzmin AV, 1997, LIFE SCI, V60, pPL257, DOI 10.1016/S0024-3205(97)00130-6; Lee CT, 2008, PLOS MED, V5, P987, DOI 10.1371/journal.pmed.0050117; Lepsch LB, 2009, MOL BRAIN, V2, DOI 10.1186/1756-6606-2-3; Lidow MS, 2001, DEV BRAIN RES, V128, P45, DOI 10.1016/S0165-3806(01)00139-0; Loh HH, 1998, MOL BRAIN RES, V54, P321, DOI 10.1016/S0169-328X(97)00353-7; Lohi O, 2013, ACTA PAEDIATR, V102, P104, DOI 10.1111/j.1651-2227.2012.02835.x; Lopez-Patino MA, 2008, PHYSIOL BEHAV, V93, P160, DOI 10.1016/j.physbeh.2007.08.013; Ma JY, 2006, MOL PHARMACOL, V69, P1137, DOI 10.1124/mol.105.019109; Matthes HWD, 1996, NATURE, V383, P819, DOI 10.1038/383819a0; McLaughlin PJ, 1998, DEV DYNAM, V211, P153, DOI 10.1002/(SICI)1097-0177(199802)211:2<153::AID-AJA4>3.3.CO;2-O; MERINEY SD, 1991, J NEUROSCI, V11, P3705; Messiah SE, 2011, PROG PEDIATR CARDIOL, V31, P59, DOI 10.1016/j.ppedcard.2010.11.010; Narita M, 2006, J NEUROCHEM, V97, P1494, DOI 10.1111/j.1471-4159.2006.03849.x; Nasevicius A, 2000, NAT GENET, V26, P216, DOI 10.1038/79951; NESTLER EJ, 1992, J NEUROSCI, V12, P2439; Ninkovic J, 2013, AMINO ACIDS, V45, P9, DOI 10.1007/s00726-011-1163-0; Olive MF, 2001, J NEUROSCI, V21, part. no., DOI 10.1523/JNEUROSCI.21-23-j0002.2001; Orom UA, 2008, MOL CELL, V30, P460, DOI 10.1016/j.molcel.2008.05.001; Pinal-Seoane N, 2006, J MOL ENDOCRINOL, V37, P391, DOI 10.1677/jme.1.02136; Plessinger MA, 1998, OBSTET GYN CLIN N AM, V25, P99, DOI 10.1016/S0889-8545(05)70360-0; Porteros A, 1999, J COMP NEUROL, V412, P429, DOI 10.1002/(SICI)1096-9861(19990927)412:3<429::AID-CNE4>3.0.CO;2-L; Purohit V, 2012, J NEUROIMMUNE PHARM, V7, P519, DOI 10.1007/s11481-012-9356-1; Rand TA, 2005, CELL, V123, P621, DOI 10.1016/j.cell.2005.10.020; Sanchez-Simon FM, 2008, NEUROSCIENCE, V151, P129, DOI 10.1016/j.neuroscience.2007.09.086; Santoriello C, 2012, J CLIN INVEST, V122, P2337, DOI 10.1172/JCI60434; Sargeant TJ, 2007, BRAIN RES, V1175, P28, DOI 10.1016/j.brainres.2007.07.091; Schroeder JA, 2003, SYNAPSE, V47, P26, DOI 10.1002/syn.10148; Schuller AGP, 1999, NAT NEUROSCI, V2, P151, DOI 10.1038/5706; Shang EH, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000587; Ueda H, 2003, LIFE SCI, V74, P313, DOI 10.1016/j.lfs.2003.09.018; Wienholds E, 2005, SCIENCE, V309, P310, DOI 10.1126/science.1114519; Wu QF, 2008, FASEB J, V22, P4085, DOI 10.1096/fj.08-108175; Wulczyn FG, 2007, FASEB J, V21, P415, DOI 10.1096/fj.06-6130com; Yamamizu K, 2011, BLOOD, V118, P775, DOI 10.1182/blood-2010-09-306001; Yuferov V, 1999, BRAIN RES BULL, V48, P109, DOI 10.1016/S0361-9230(98)00155-5; Zhang Z, 2010, J NEUROSCI, V30, P4735, DOI 10.1523/JNEUROSCI.5968-09.2010; Zheng H, 2010, J BIOL CHEM, V285, P21994, DOI 10.1074/jbc.M110.112607; Zheng H, 2010, MOL PHARMACOL, V77, P102, DOI 10.1124/mol.109.060848; Zhu YX, 1999, NEURON, V24, P243, DOI 10.1016/S0896-6273(00)80836-3	70	17	20	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 30	2012	7	11							e50885	10.1371/journal.pone.0050885	http://dx.doi.org/10.1371/journal.pone.0050885			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	054WM	23226419	Green Published, gold, Green Submitted			2022-12-27	WOS:000312376100230
J	Papaxanthis, C; Paizis, C; White, O; Pozzo, T; Stucchi, N				Papaxanthis, Charalambos; Paizis, Christos; White, Olivier; Pozzo, Thierry; Stucchi, Natale			The Relation between Geometry and Time in Mental Actions	PLOS ONE			English	Article							MOTOR IMAGERY; POWER-LAW; REPRESENTATIONAL MOMENTUM; MOVEMENT VELOCITY; DRAWING MOVEMENTS; CURVATURE; MOTION; MEMORY; TRANSFORMATIONS; PERFORMANCE	Mental imagery is a cognitive tool that helps humans take decisions by simulating past and future events. The hypothesis has been advanced that there is a functional equivalence between actual and mental movements. Yet, we do not know whether there are any limitations to its validity even in terms of some fundamental features of actual movements, such as the relationship between space and time. Although it is impossible to directly measure the spatiotemporal features of mental actions, an indirect investigation can be conducted by taking advantage of the constraints existing in planar drawing movements and described by the two-thirds power law (2/3PL). This kinematic law describes one of the most impressive regularities observed in biological movements: movement speed decreases when curvature increases. Here, we compared the duration of identical actual and mental arm movements by changing the constraints imposed by the 2/3PL. In the first two experiments, the length of the trajectory remained constant, while its curvature (Experiment 1) or its number of inflexions (Experiment 2) was manipulated. The results showed that curvature, but not the number of inflexions, proportionally and similarly affected actual and mental movement duration, as expected from the 2/3PL. Two other control experiments confirmed that the results of Experiment 1 were not attributable to eye movements (Experiment 3) or to the perceived length of the displayed trajectory (Experiment 4). Altogether, our findings suggest that mental movement simulation is tuned to the kinematic laws characterizing actions and that kinematics of actual and mental movements is completely specified by the representation of their geometry.	[Papaxanthis, Charalambos; Paizis, Christos] Univ Bourgogne, Unite Format & Rech Sci & Tech Activites Phys & S, Ctr Expertise & Performance, F-21078 Dijon, France; [Papaxanthis, Charalambos; White, Olivier; Pozzo, Thierry] INSERM, U1093, F-21078 Dijon, France; [Pozzo, Thierry] Ist Italiano Tecnol, Dept Robot Brain & Cognit Sci, Genoa, Italy; [Stucchi, Natale] Univ Milano Bicocca, Dept Psychol, Milan, Italy; [Pozzo, Thierry] Inst Univ France, Paris, France	Universite de Bourgogne; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Bourgogne; Istituto Italiano di Tecnologia - IIT; University of Milano-Bicocca; Institut Universitaire de France	Papaxanthis, C (corresponding author), Univ Bourgogne, Unite Format & Rech Sci & Tech Activites Phys & S, Ctr Expertise & Performance, F-21078 Dijon, France.	charalambos.papaxanthis@u-bourgogne.fr	White, Olivier/AAJ-6914-2020; PAIZIS, CHRISTOS/P-1848-2019	White, Olivier/0000-0002-9119-1329; Pozzo, Thierry/0000-0002-0585-7965; Stucchi, Natale/0000-0002-7695-4068				Bakker M, 2007, EXP BRAIN RES, V179, P497, DOI 10.1007/s00221-006-0807-x; Binet A, 1893, REV PHILOS, V35, P664; Courtine G, 2004, COGNITIVE BRAIN RES, V22, P67, DOI 10.1016/j.cogbrainres.2004.07.008; Dayan E, 2007, P NATL ACAD SCI USA, V104, P20582, DOI 10.1073/pnas.0710033104; de'Sperati C, 2003, J COGNITIVE NEUROSCI, V15, P1244, DOI 10.1162/089892903322598184; DECETY J, 1991, BEHAV BRAIN RES, V42, P1, DOI 10.1016/S0166-4328(05)80033-6; Decety Jean, 1995, Behavioural Brain Research, V72, P127, DOI 10.1016/0166-4328(96)00141-6; Demougeot L, 2011, J NEUROSCI, V31, P10712, DOI 10.1523/JNEUROSCI.6032-10.2011; Demougeot L, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006769; deSperati C, 1997, J NEUROSCI, V17, P3932; Dounskaia N, 2007, BIOL CYBERN, V96, P147, DOI 10.1007/s00422-006-0109-1; Ehrsson HH, 2003, J NEUROPHYSIOL, V90, P3304, DOI 10.1152/jn.01113.2002; FINKE RA, 1986, J EXP PSYCHOL GEN, V115, P175, DOI 10.1037/0096-3445.115.2.175; FINKE RA, 1985, J EXP PSYCHOL LEARN, V11, P780, DOI 10.1037/0278-7393.11.1-4.780; Flash T, 2007, BIOL CYBERN, V96, P577, DOI 10.1007/s00422-007-0145-5; Freeman FN, 1914, PSYCHOL MONOGR, V17, P1, DOI 10.1037/h0093085; Gentili R, 2006, NEUROSCIENCE, V137, P761, DOI 10.1016/j.neuroscience.2005.10.013; Gentili R, 2010, J NEUROPHYSIOL, V104, P774, DOI 10.1152/jn.00257.2010; Gribble PL, 1996, J NEUROPHYSIOL, V76, P2853, DOI 10.1152/jn.1996.76.5.2853; Gueugneau N, 2008, BRAIN RES, V1187, P95, DOI 10.1016/j.brainres.2007.10.042; Guillot A, 2005, BRAIN RES REV, V50, P387, DOI 10.1016/j.brainresrev.2005.09.004; Hall C. R., 1997, J MENTAL IMAG, V21, P143, DOI DOI 10.1037/T07979-000; Harris CM, 1998, NATURE, V394, P780, DOI 10.1038/29528; Hubbard TL, 2005, PSYCHON B REV, V12, P822, DOI 10.3758/BF03196775; HUBBARD TL, 1995, PSYCHON B REV, V2, P322, DOI 10.3758/BF03210971; Ivanenko YP, 2002, NEUROREPORT, V13, P1171, DOI 10.1097/00001756-200207020-00020; Jeannerod M, 2001, NEUROIMAGE, V14, pS103, DOI 10.1006/nimg.2001.0832; KOSSLYN SM, 1978, J EXP PSYCHOL HUMAN, V4, P47, DOI 10.1037/0096-1523.4.1.47; LACQUANITI F, 1983, ACTA PSYCHOL, V54, P115, DOI 10.1016/0001-6918(83)90027-6; Maoz U, 2009, J NEUROPHYSIOL, V101, P1002, DOI 10.1152/jn.90702.2008; Munzert J, 2009, BRAIN RES REV, V60, P306, DOI 10.1016/j.brainresrev.2008.12.024; OLDFIELD RC, 1971, NEUROPSYCHOLOGIA, V9, P97, DOI 10.1016/0028-3932(71)90067-4; PELLIZZER G, 1992, EXP BRAIN RES, V92, P326; Pellizzer G, 2009, CORTEX, V45, P356, DOI 10.1016/j.cortex.2008.04.008; Personnier P, 2010, BEHAV BRAIN RES, V206, P184, DOI 10.1016/j.bbr.2009.09.011; Pollick FE, 2009, CORTEX, V45, P325, DOI 10.1016/j.cortex.2008.03.010; Ranganathan VK, 2004, NEUROPSYCHOLOGIA, V42, P944, DOI 10.1016/j.neuropsychologia.2003.11.018; Rodriguez M, 2009, NEUROPSYCHOLOGIA, V47, P489, DOI 10.1016/j.neuropsychologia.2008.10.009; Schaal S, 2001, EXP BRAIN RES, V136, P60, DOI 10.1007/s002210000505; Schwartz AB, 2000, EUR J NEUROSCI, V12, P1851, DOI 10.1046/j.1460-9568.2000.00097.x; Schwartz AB, 1999, J NEUROPHYSIOL, V82, P2705, DOI 10.1152/jn.1999.82.5.2705; SHEPARD RN, 1971, SCIENCE, V171, P701, DOI 10.1126/science.171.3972.701; Shepard RN, 1986, MENTAL IMAGES THEIR, Vviii, P364; Sirigu A, 1996, SCIENCE, V273, P1564, DOI 10.1126/science.273.5281.1564; Skoura X, 2008, CORTEX, V44, P1271, DOI 10.1016/j.cortex.2007.07.008; Stinear CM, 2006, EXP BRAIN RES, V168, P157, DOI 10.1007/s00221-005-0078-y; Tasko SM, 2004, J PHONETICS, V32, P65, DOI 10.1016/S0095-4470(03)00006-8; THURSTONE LL, 1994, PSYCHOL REV, V101, P266, DOI 10.1037/0033-295X.101.2.266; Thurstone LL, 1927, PSYCHOL REV, V34, P273, DOI 10.1037/h0070288; Viviani P, 1997, J EXP PSYCHOL HUMAN, V23, P1232, DOI 10.1037/0096-1523.23.4.1232; VIVIANI P, 1989, PERCEPT PSYCHOPHYS, V46, P266, DOI 10.3758/BF03208089; VIVIANI P, 1992, J EXP PSYCHOL HUMAN, V18, P603, DOI 10.1037/0096-1523.18.3.603; VIVIANI P, 1995, J EXP PSYCHOL HUMAN, V21, P32, DOI 10.1037/0096-1523.21.1.32; VIVIANI P, 1982, NEUROSCIENCE, V7, P431, DOI 10.1016/0306-4522(82)90277-9; Wolpert DM, 2001, CURR BIOL, V11, pR729, DOI 10.1016/S0960-9822(01)00432-8	55	27	27	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 30	2012	7	11							e51191	10.1371/journal.pone.0051191	http://dx.doi.org/10.1371/journal.pone.0051191			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	054WM	23226487	Green Submitted, gold, Green Published			2022-12-27	WOS:000312376100298
J	Sarma, NJ; Tiriveedhi, V; Subramanian, V; Shenoy, S; Crippin, JS; Chapman, WC; Mohanakumar, T				Sarma, Nayan J.; Tiriveedhi, Venkataswarup; Subramanian, Vijay; Shenoy, Surendra; Crippin, Jeffrey S.; Chapman, William C.; Mohanakumar, Thalachallour			Hepatitis C Virus Mediated Changes in miRNA-449a Modulates Inflammatory Biomarker YKL40 through Components of the NOTCH Signaling Pathway	PLOS ONE			English	Article							NF-KAPPA-B; HUMAN HEPATOCELLULAR-CARCINOMA; CELL-CYCLE ARREST; TRANSCRIPTION FACTORS; PROSTATE-CANCER; C/EBP-ALPHA; FIBROSIS; EXPRESSION; MICRORNAS; INFECTION	Liver disease due to hepatitis C virus (HCV) infection is an important health problem worldwide. HCV induced changes in microRNAs (miRNA) are shown to mediate inflammation leading to liver fibrosis. Gene expression analyses identified dysregulation of miRNA-449a in HCV patients but not in alcoholic and non-alcoholic liver diseases. By sequence analysis of the promoter for YKL40, an inflammatory marker upregulated in patients with chronic liver diseases with fibrosis, adjacent binding sites for nuclear factor of Kappa B/P65 and CCAAT/enhancer-binding protein alpha (CEBP alpha) were identified. P65 interacted with CEBP alpha to co-operatively activate YKL40 expression through sequence specific DNA binding. In vitro analysis demonstrated that tumor necrosis factor alpha (TNF alpha) mediated YKL40 expression is regulated by miRNA-449a and its target NOTCH1 in human hepatocytes. NOTCH1 facilitated nuclear localization of P65 in response to TNF alpha. Further, HCV patients demonstrated upregulation of NOTCH1 along with downregulation of miRNA-449a. Taken together it is demonstrated that miRNA-449a plays an important role in modulating expression of YKL40 through targeting the components of the NOTCH signaling pathway following HCV infection. Therefore, defining transcriptional regulatory mechanisms which control inflammatory responses and fibrosis will be important towards developing strategies to prevent hepatic fibrosis especially following HCV recurrence in liver transplant recipients. Citation: Sarma NJ, Tiriveedhi V, Subramanian V, Shenoy S, Crippin JS, et al. (2012) Hepatitis C Virus Mediated Changes in miRNA-449a Modulates Inflammatory Biomarker YKL40 through Components of the NOTCH Signaling Pathway. PLoS ONE 7(11): e50826. doi: 10.1371/journal.pone.0050826	[Sarma, Nayan J.; Tiriveedhi, Venkataswarup; Subramanian, Vijay; Shenoy, Surendra; Chapman, William C.; Mohanakumar, Thalachallour] Washington Univ, Sch Med, Dept Surg, St Louis, MO 63110 USA; [Mohanakumar, Thalachallour] Washington Univ, Sch Med, Dept Pathol & Immunol, St Louis, MO USA; [Crippin, Jeffrey S.] Washington Univ, Sch Med, Dept Med, St Louis, MO 63110 USA	Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL)	Mohanakumar, T (corresponding author), Washington Univ, Sch Med, Dept Surg, St Louis, MO 63110 USA.	kumart@wustl.edu			Barnes-Jewish Foundation at Barnes-Jewish Hospital, St. Louis, MO	Barnes-Jewish Foundation at Barnes-Jewish Hospital, St. Louis, MO	This work was supported by the Barnes-Jewish Foundation at Barnes-Jewish Hospital, St. Louis, MO. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alter MJ, 1999, NEW ENGL J MED, V341, P556, DOI 10.1056/NEJM199908193410802; Basha HI, 2011, AM J TRANSPLANT, V11, P775, DOI 10.1111/j.1600-6143.2011.03458.x; Bielesz B, 2010, J CLIN INVEST, V120, P4040, DOI 10.1172/JCI43025; Bihrer V, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026971; Caamano J, 2002, CLIN MICROBIOL REV, V15, P414, DOI 10.1128/CMR.15.3.414-429.2002; Cao Q, 2010, J NEUROSCI RES, V88, P2701, DOI 10.1002/jnr.22429; Cermelli S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023937; Cheng PY, 2001, J IMMUNOL, V167, P4458, DOI 10.4049/jimmunol.167.8.4458; Du R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030771; Farid WR, 2011, LIVER TRANSPL; Fullard N, 2012, INT J BIOCH CELL BIO; Girard M, 2008, J HEPATOL, V48, P648, DOI 10.1016/j.jhep.2008.01.019; Gracias DT, 2011, ADV EXP MED BIOL, V780, P15, DOI 10.1007/978-1-4419-5632-3_2; HACKER H, 2006, SCI STKE, DOI DOI 10.1126/STKE.3572006RE13; Huang Jin, 2004, Zhonghua Gan Zang Bing Za Zhi, V12, P259; Iwai A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020718; Johansen JS, 2000, J HEPATOL, V32, P911, DOI 10.1016/S0168-8278(00)80095-1; Johnson PF, 2005, J CELL SCI, V118, P2545, DOI 10.1242/jcs.02459; Kamal SM, 2006, HEPATOLOGY, V43, P771, DOI 10.1002/hep.21117; Ladner KJ, 2003, J BIOL CHEM, V278, P2294, DOI 10.1074/jbc.M207129200; Lauer GM, 2001, NEW ENGL J MED, V345, P41, DOI 10.1056/NEJM200107053450107; Lee CG, 2011, ANNU REV PHYSIOL, V73, P479, DOI 10.1146/annurev-physiol-012110-142250; Lim SO, 2011, HEPATOLOGY, V53, P1352, DOI 10.1002/hep.24208; Liu G, 2010, J EXP MED, V207, P1589, DOI 10.1084/jem.20100035; Liu Y, 2011, J VIRAL HEPATITIS, V18, pE439, DOI 10.1111/j.1365-2893.2011.01463.x; Lize M, 2010, CELL DEATH DIFFER, V17, P452, DOI 10.1038/cdd.2009.188; Lobry C, 2011, J EXP MED, V208, P1931, DOI 10.1084/jem.20111855; Lu GD, 2010, GASTROENTEROLOGY, V139, P632, DOI 10.1053/j.gastro.2010.03.051; Marquez RT, 2010, LAB INVEST, V90, P1727, DOI 10.1038/labinvest.2010.126; Matsuno Y, 2012, INT J BIOCHEM CELL B, V44, P776, DOI 10.1016/j.biocel.2012.01.021; McCoy C. E, 2012, FRONT BIOSCI, V17, P2161; McManus MT, 2003, SEMIN CANCER BIOL, V13, P253, DOI 10.1016/S1044-579X(03)00038-5; Miska EA, 2005, CURR OPIN GENET DEV, V15, P563, DOI 10.1016/j.gde.2005.08.005; Noonan EJ, 2009, ONCOGENE, V28, P1714, DOI 10.1038/onc.2009.19; Noonan EJ, 2010, ONCOTARGET, V1, P349, DOI 10.18632/oncotarget.167; Pungpopong S, 2008, LIVER TRANSPLANT, V14, P1294, DOI 10.1002/lt.21508; Saad S, 2010, INT J BIOCHEM CELL B, V42, P1115, DOI 10.1016/j.biocel.2010.03.016; Sarma NJ, 2011, J BIOL CHEM, V286, P38989, DOI 10.1074/jbc.M111.297952; Seeff LB, 2002, HEPATOLOGY, V36, pS35, DOI 10.1053/jhep.2002.36806; Shin HM, 2006, EMBO J, V25, P129, DOI 10.1038/sj.emboj.7600902; Stevens AL, 2008, ARTHRITIS RHEUM-US, V58, P489, DOI 10.1002/art.23120; Sunami Y, 2012, HEPATOLOGY; Tao LL, 2012, APOPTOSIS; Tseng HH, 2009, J CANCER RES CLIN, V135, P241, DOI 10.1007/s00432-008-0448-5; Volck B, 1998, P ASSOC AM PHYSICIAN, V110, P351; Wurmbach E, 2007, HEPATOLOGY, V45, P938, DOI 10.1002/hep.21622; Xiao XQ, 2011, HEPATOB PANCREAT DIS, V10, P605, DOI 10.1016/S1499-3872(11)60103-3; Zeng CX, 2010, HEPATOLOGY, V52, P1702, DOI 10.1002/hep.23875	48	46	49	1	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 30	2012	7	11							e50826	10.1371/journal.pone.0050826	http://dx.doi.org/10.1371/journal.pone.0050826			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	054WM	23226395	Green Published, gold			2022-12-27	WOS:000312376100206
J	Sikora, KM; Nosavanh, LM; Kantheti, P; Burmeister, M; Hortsch, M				Sikora, Kristine M.; Nosavanh, LaGina M.; Kantheti, Prameela; Burmeister, Margit; Hortsch, Michael			Expression of Caytaxin Protein in Cayman Ataxia Mouse Models Correlates with Phenotype Severity	PLOS ONE			English	Article							C-MYC PROTEINS; CARBOXYL-TERMINUS; PREDICTION; INITIATION; SEQUENCE; DOMAIN; IDENTIFICATION; TRANSLATION; MUTATIONS; DYSTONIA	Caytaxin is a highly-conserved protein, which is encoded by the Atcay/ATCAY gene. Mutations in Atcay/ATCAY have been identified as causative of cerebellar disorders such as the rare hereditary disease Cayman ataxia in humans, generalized dystonia in the dystonic (dt) rat, and marked motor defects in three ataxic mouse lines. While several lines of evidence suggest that Caytaxin plays a critical role in maintaining nervous system processes, the physiological function of Caytaxin has not been fully characterized. In the study presented here, we generated novel specific monoclonal antibodies against full-length Caytaxin to examine endogenous Caytaxin expression in wild type and Atcay mutant mouse lines. Caytaxin protein is absent from brain tissues in the two severely ataxic Atcay(jit) (jittery) and Atcay(swd) (sidewinder) mutant lines, and markedly decreased in the mildly ataxic/dystonic Atcay(ji-hes) (hesitant) line, indicating a correlation between Caytaxin expression and disease severity. As the expression of wild type human Caytaxin in mutant sidewinder and jittery mice rescues the ataxic phenotype, Caytaxin's physiological function appears to be conserved between the human and mouse orthologs. Across multiple species and in several neuronal cell lines Caytaxin is expressed as several protein isoforms, the two largest of which are caused by the usage of conserved methionine translation start sites. The work described in this manuscript presents an initial characterization of the Caytaxin protein and its expression in wild type and several mutant mouse models. Utilizing these animal models of human Cayman Ataxia will now allow an in-depth analysis to elucidate Caytaxin's role in maintaining normal neuronal function.	[Sikora, Kristine M.; Nosavanh, LaGina M.; Hortsch, Michael] Univ Michigan, Dept Cell & Dev Biol, Ann Arbor, MI 48109 USA; [Sikora, Kristine M.; Burmeister, Margit] Univ Michigan, Program Cellular & Mol Biol, Ann Arbor, MI 48109 USA; [Sikora, Kristine M.; Kantheti, Prameela; Burmeister, Margit] Univ Michigan, Mol & Behav Neurosci Inst, Ann Arbor, MI 48109 USA; [Burmeister, Margit] Univ Michigan, Dept Psychiat & Human Genet, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan	Hortsch, M (corresponding author), Univ Michigan, Dept Cell & Dev Biol, Ann Arbor, MI 48109 USA.	hortsch@umich.edu	Burmeister, Margit/A-3157-2013	Burmeister, Margit/0000-0002-1914-2434; Hortsch, Michael/0000-0002-3750-737X	Public Health grant National Institutes of Health (NIH) [NS32130]; CMB [NIH T-32-GM007315]; Rackham Graduate School of the University of Michigan; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007315] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R55NS032130, R01NS032130] Funding Source: NIH RePORTER	Public Health grant National Institutes of Health (NIH); CMB; Rackham Graduate School of the University of Michigan; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This study was in part supported by a Public Health grant National Institutes of Health (NIH) NS32130 (to MB). We also acknowledge additional support given to Kristine Sikora (previously Kristine Ito-Smith) from the CMB training grant NIH T-32-GM007315, and a Rackham Merit and a Graduate Student Research Grant from the Rackham Graduate School of the University of Michigan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding was received for this study.	Ao Li X, 2009, BDM PUB COMPUTATIONA; Aoyama T, 2009, J CELL SCI, V122, P4177, DOI 10.1242/jcs.048579; Blom N, 2004, PROTEOMICS, V4, P1633, DOI 10.1002/pmic.200300771; Bomar JM, 2003, NAT GENET, V35, P264, DOI 10.1038/ng1255; Buschdorf JP, 2006, J CELL SCI, V119, P3337, DOI 10.1242/jcs.03061; Buschdorf JP, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002686; Concepcion D, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000484; Curley JP, 2009, DEV NEUROSCI-BASEL, V31, P318, DOI 10.1159/000216543; DeOme K B., 1945, UNIV CALIFORNIA PUBL ZOOL, V53, P41; Gasteiger E, 2003, NUCLEIC ACIDS RES, V31, P3784, DOI 10.1093/nar/gkg563; Grelle G, 2006, MOL CELL PROTEOMICS, V5, P234, DOI 10.1074/mcp.M500198-MCP200; Gupta AB, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033863; HANN SR, 1995, ADV EXP MED BIOL, V375, P107; HANN SR, 1988, CELL, V52, P185, DOI 10.1016/0092-8674(88)90507-7; Hayakawa Y, 2007, BRAIN RES, V1129, P100, DOI 10.1016/j.brainres.2006.10.068; HORTSCH M, 1985, J BIOL CHEM, V260, P9137; Itoh M, 2011, NEUROCHEM RES, V36, P1304, DOI 10.1007/s11064-011-0430-5; Johansen MB, 2006, GLYCOBIOLOGY, V16, P844, DOI 10.1093/glycob/cwl009; Kapfhamer D, 1996, GENOMICS, V35, P533, DOI 10.1006/geno.1996.0394; Kho AT, 2004, GENE DEV, V18, P629, DOI 10.1101/gad.1182504; Kiemer L, 2005, BIOINFORMATICS, V21, P1269, DOI 10.1093/bioinformatics/bti130; Kozak M, 2002, GENE, V299, P1, DOI 10.1016/S0378-1119(02)01056-9; Kumar A.K, 2004, CAYM ISL COUNTR C; LORDEN JF, 1984, J NEUROSCI, V4, P1925; Low BC, 2000, J BIOL CHEM, V275, P14415, DOI 10.1074/jbc.275.19.14415; Meaney MJ, 2001, ANNU REV NEUROSCI, V24, P1161, DOI 10.1146/annurev.neuro.24.1.1161; Monigatti F, 2002, BIOINFORMATICS, V18, P769, DOI 10.1093/bioinformatics/18.5.769; Nishikawa T, 2000, BIOINFORMATICS, V16, P960, DOI 10.1093/bioinformatics/16.11.960; Nystuen A, 1996, HUM MOL GENET, V5, P525, DOI 10.1093/hmg/5.4.525; Pedersen AG, 1997, ISMB-97 - FIFTH INTERNATIONAL CONFERENCE ON INTELLIGENT SYSTEMS FOR MOLECULAR BIOLOGY, PROCEEDINGS, P226; Silver L.M., 1995, MOUSE GENETICS CONCE; Spotts GD, 1997, MOL CELL BIOL, V17, P1459, DOI 10.1128/MCB.17.3.1459; Xiao JF, 2005, MOL BRAIN RES, V141, P181, DOI 10.1016/j.molbrainres.2005.09.009; Zhou Yi Ting, 2005, Experimental Cell Research, V303, P263, DOI 10.1016/j.yexcr.2004.08.044; Zhou YT, 2002, J BIOL CHEM, V277, P7483, DOI 10.1074/jbc.M109459200	35	10	10	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 30	2012	7	11							e50570	10.1371/journal.pone.0050570	http://dx.doi.org/10.1371/journal.pone.0050570			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	054WM	23226316	Green Published, Green Submitted, gold			2022-12-27	WOS:000312376100128
J	Trubenova, B; Hager, R				Trubenova, Barbora; Hager, Reinmar			Phenotypic and Evolutionary Consequences of Social Behaviours: Interactions among Individuals Affect Direct Genetic Effects	PLOS ONE			English	Article							MULTILEVEL SELECTION; BIOLOGICAL GROUPS; MATERNAL PERFORMANCE; TRAIT; INHERITANCE; COOPERATION; RECIPROCITY; ADAPTATION; KIN	Traditional quantitative genetics assumes that an individual's phenotype is determined by both genetic and environmental factors. For many animals, part of the environment is social and provided by parents and other interacting partners. When expression of genes in social partners affects trait expression in a focal individual, indirect genetic effects occur. In this study, we explore the effects of indirect genetic effects on the magnitude and range of phenotypic values in a focal individual in a multi-member model analyzing three possible classes of interactions between individuals. We show that social interactions may not only cause indirect genetic effects but can also modify direct genetic effects. Furthermore, we demonstrate that both direct and indirect genetic effects substantially alter the range of phenotypic values, particularly when a focal trait can influence its own expression via interactions with traits in other individuals. We derive a function predicting the relative importance of direct versus indirect genetic effects. Our model reveals that both direct and indirect genetic effects can depend to a large extent on both group size and interaction strength, altering group mean phenotype and variance. This may lead to scenarios where between group variation is much higher than within group variation despite similar underlying genetic properties, potentially affecting the level of selection. Our analysis highlights key properties of indirect genetic effects with important consequences for trait evolution, the level of selection and potentially speciation.	[Trubenova, Barbora; Hager, Reinmar] Univ Manchester, Fac Life Sci, Manchester, Lancs, England	University of Manchester	Trubenova, B (corresponding author), Univ Manchester, Fac Life Sci, Manchester, Lancs, England.	barbora.trubenova@postgrad.manchester.ac.uk	Trubenova, Barbora/GQB-4224-2022; Hager, Reinmar/F-8659-2012	Trubenova, Barbora/0000-0002-6873-2967; 	Biotechnology and Biological Sciences Research Council; Faculty of Life Sciences UoM; Faculty of Engineering and Physical Sciences UoM	Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Faculty of Life Sciences UoM; Faculty of Engineering and Physical Sciences UoM	BT is a student of Doctoral Training Centre Integrative Systems Biology at the University of Manchester (http://www.mib.manchester.ac.uk/postgraduate/DTC/), which is partly supported by Biotechnology and Biological Sciences Research Council (50%), Partly by Faculty of Life Sciences UoM (25%) and partly by Faculty of Engineering and Physical Sciences UoM (25%). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agrawal AF, 2001, AM NAT, V158, P308, DOI 10.1086/321324; [Anonymous], 1988, AM ANTHROPOL; Axelrod R., 2000, ANAL KRITIK, V22, P130, DOI [10.1515/auk-2000-0107, DOI 10.1515/AUK-2000-0107]; Bijma P, 2008, J EVOLUTION BIOL, V21, P1175, DOI 10.1111/j.1420-9101.2008.01550.x; Bijma P, 2010, P R SOC B, V277, P673, DOI 10.1098/rspb.2009.1093; Bijma P, 2010, J EVOLUTION BIOL, V23, P194, DOI 10.1111/j.1420-9101.2009.01895.x; Bijma P, 2007, GENETICS, V175, P277, DOI 10.1534/genetics.106.062711; Bijma P, 2007, GENETICS, V175, P289, DOI 10.1534/genetics.106.062729; Bijma P, 2010, GENETICS, V186, P1029, DOI 10.1534/genetics.110.120485; Bijma P, 2010, GENETICS, V186, P1013, DOI 10.1534/genetics.110.120493; Boake CRB, 2002, AM NAT, V160, pS143, DOI 10.1086/342902; BRENNER FJ, 1978, ANIM BEHAV, V26, P432, DOI 10.1016/0003-3472(78)90060-X; Buttery NJ, 2010, J EVOLUTION BIOL, V23, P1664, DOI 10.1111/j.1420-9101.2010.02032.x; Cheverud James M., 1994, P67; Cheverud JM, 2003, P NATL ACAD SCI USA, V100, P4357, DOI 10.1073/pnas.0931311100; CHEVERUD JM, 1984, EVOLUTION, V38, P766, DOI 10.1111/j.1558-5646.1984.tb00349.x; Clutton-Brock T, 2009, NATURE, V462, P51, DOI 10.1038/nature08366; Crespi BJ, 2001, TRENDS ECOL EVOL, V16, P178, DOI 10.1016/S0169-5347(01)02115-2; Davies NB, 2012, INTRO BEHAV ECOLOGY; Dawkins Richard, 1976, SELFISH GENE; Gardner A, 2004, J EVOLUTION BIOL, V17, P1195, DOI 10.1111/j.1420-9101.2004.00775.x; GRIFFING B, 1969, AUST J BIOL SCI, V22, P131, DOI 10.1071/BI9690131; GRIFFING B, 1981, J THEOR BIOL, V89, P659, DOI 10.1016/0022-5193(81)90034-5; GRIFFING B, 1967, AUST J BIOL SCI, V20, P127, DOI 10.1071/BI9670127; GRIFFING B, 1976, GENETICS, V82, P703; Hadfield JD, 2007, GENETICS, V177, P667, DOI 10.1534/genetics.107.075622; Hager R, 2005, ETHOLOGY, V111, P705, DOI 10.1111/j.1439-0310.2005.01097.x; Hager R, 2008, GENETICS, V178, P1755, DOI 10.1534/genetics.107.080697; HAMILTON WD, 1964, J THEOR BIOL, V7, P1, DOI 10.1016/0022-5193(64)90039-6; Huntingford F, 1987, ANIMAL CONICT; Hurst JL, 2004, BIOESSAYS, V26, P1288, DOI 10.1002/bies.20147; Keller L, 2009, PHILOS T R SOC B, V364, P3209, DOI 10.1098/rstb.2009.0108; Kent C, 2008, CURR BIOL, V18, P1384, DOI 10.1016/j.cub.2008.07.088; Kolliker M, 2005, AM NAT, V166, P506, DOI 10.1086/491687; Laland KN, 2011, SCIENCE, V334, P1512, DOI 10.1126/science.1210879; McGlothlin JW, 2010, EVOLUTION, V64, P2558, DOI 10.1111/j.1558-5646.2010.01012.x; McGlothlin JW, 2009, EVOLUTION, V63, P1785, DOI 10.1111/j.1558-5646.2009.00676.x; Moore AJ, 1997, EVOLUTION, V51, P1352, DOI 10.1111/j.1558-5646.1997.tb01458.x; Moore AJ, 2002, AM NAT, V160, pS186, DOI 10.1086/342899; Mousseau TA, 1998, TRENDS ECOL EVOL, V13, P403, DOI 10.1016/S0169-5347(98)01472-4; Muir WM, 2005, GENETICS, V170, P1247, DOI 10.1534/genetics.104.035956; Mutic JJ, 2007, MOL ECOL, V16, P2371, DOI 10.1111/j.1365-294X.2007.03259.x; Nadell CD, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000716; NOWAK MA, 1992, NATURE, V355, P250, DOI 10.1038/355250a0; Nowak MA, 1998, NATURE, V393, P573, DOI 10.1038/31225; Nowak MA, 2006, SCIENCE, V314, P1560, DOI 10.1126/science.1133755; Peripato AC, 2002, AM NAT, V160, pS173, DOI 10.1086/342900; Peripato AC, 2002, GENETICS, V162, P1341; Reeve HK, 2000, AM NAT, V155, P365, DOI 10.1086/303322; Rowntree JK, 2011, PHILOS T R SOC B, V366, P1322, DOI 10.1098/rstb.2010.0357; Smuts B.B., 1987, P385; Sokolowski Marla B., 2010, P11; Teplitsky C, 2010, J EVOLUTION BIOL, V23, P935, DOI 10.1111/j.1420-9101.2010.01959.x; THORNHILL R, 1984, EVOLUTION, V38, P204, DOI 10.1111/j.1558-5646.1984.tb00272.x; Tibbetts EA, 2008, NATURWISSENSCHAFTEN, V95, P383, DOI 10.1007/s00114-007-0336-x; TRIVERS RL, 1974, AM ZOOL, V14, P249; Wenseleers T, 2009, SOCIAL BEHAV GENES E, P132; West SA, 2007, J EVOLUTION BIOL, V20, P415, DOI 10.1111/j.1420-9101.2006.01258.x; West SA, 2007, CURR BIOL, V17, pR661, DOI 10.1016/j.cub.2007.06.004; WILKINSON GS, 1984, NATURE, V308, P181, DOI 10.1038/308181a0; Wilson AJ, 2011, J EVOLUTION BIOL, V24, P772, DOI 10.1111/j.1420-9101.2010.02212.x; Wilson AJ, 2009, P ROY SOC B-BIOL SCI, V276, P533, DOI 10.1098/rspb.2008.1193; Wilson DS, 2007, Q REV BIOL, V82, P327, DOI 10.1086/522809; Wolf JB, 2009, PHILOS T R SOC B, V364, P1107, DOI 10.1098/rstb.2008.0238; Wolf JB, 2003, P NATL ACAD SCI USA, V100, P4655, DOI 10.1073/pnas.0635741100; Wolf JB, 1998, TRENDS ECOL EVOL, V13, P64, DOI 10.1016/S0169-5347(97)01233-0; Wolf JB., 2000, EPISTASIS EVOLUTIONA, P158; Xavier JB, 2011, MOL MICROBIOL, V79, P166, DOI 10.1111/j.1365-2958.2010.07436.x	68	8	8	0	37	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 30	2012	7	11							e46273	10.1371/journal.pone.0046273	http://dx.doi.org/10.1371/journal.pone.0046273			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	054WM	23226195	Green Published, Green Submitted, gold			2022-12-27	WOS:000312376100003
J	Wang, T; Liu, Y; Sima, L; Shi, L; Wang, ZM; Ni, CH; Zhang, ZD; Wang, ML				Wang, Ting; Liu, Yang; Sima, Li; Shi, Liang; Wang, Zhaoming; Ni, Chunhui; Zhang, Zhengdong; Wang, Meilin			Association between MLH1-93G > A Polymorphism and Risk of Colorectal Cancer	PLOS ONE			English	Article							DNA MISMATCH REPAIR; PROMOTER POLYMORPHISM; GREATER-THAN; COLON-CANCER; PREDISPOSITION; METAANALYSIS; GENE; HOMOLOG; HMLH1; SUSCEPTIBILITY	Background: The -93G>A (rs1800734) polymorphism located in the promoter of mismatch repair gene, MLH1, has been identified as a low-penetrance variant for cancer risk. Many published studies have evaluated the association between the MLH1 -93G>A polymorphism and colorectal cancer (CRC) risk. However, the results remain conflicting rather than conclusive. Objective: The aim of this study was to assess the association between the MLH1 -93G>A polymorphism and the risk of CRC. Methods: To derive a more precise estimation of the association, a meta-analysis of six studies (17,791 cases and 13,782 controls) was performed. Odds ratios (ORs) and 95% confidence intervals (CIs) were used to evaluate the strength of the association. Four of these published studies were performed on subjects of known microsatellite instability (MSI) status. An additional analysis including 742 cases and 10,895 controls was used to assess the association between the MLH1 -93G>A polymorphism and the risk of MSI-CRC. Results: The overall results indicated that the variant genotypes were associated with a significantly increased risk of CRC (AG versus GG: OR = 1.06, 95% CI = 1.01-1.11; AA/AG versus GG: OR = 1.06, 95% CI = 1.01-1.11). This increased risk was also found during stratified analysis of MSI status (AA versus GG: OR = 2.52, 95% CI = 1.94-3.28; AG versus GG: OR = 1.29, 95% CI = 1.10-1.52; AA/AG versus GG: OR = 1.45, 95% CI = 1.24-1.68; AA versus AG/GG: OR = 2.29, 95% CI = 1.78-2.96). Egger's test did not show any evidence of publication bias. Conclusion: Our results suggest that the MLH1 -93G>A polymorphism may contribute to individual susceptibility to CRC and act as a risk factor for MSI-CRC.	[Wang, Ting; Sima, Li; Shi, Liang; Zhang, Zhengdong; Wang, Meilin] Nanjing Med Univ, Ctr Canc, Jiangsu Key Lab Canc Biomarkers Prevent & Treatme, Dept Environm Genom, Nanjing, Jiangsu, Peoples R China; [Wang, Ting; Ni, Chunhui; Zhang, Zhengdong; Wang, Meilin] Nanjing Med Univ, Sch Publ Hlth, Key Lab Modern Toxicol, Dept Genet Toxicol,Minist Educ, Nanjing, Jiangsu, Peoples R China; [Liu, Yang; Wang, Zhaoming] Nanjing Med Univ, Clin Med Coll 1, Nanjing, Jiangsu, Peoples R China	Nanjing Medical University; Nanjing Medical University; Nanjing Medical University	Wang, ML (corresponding author), Nanjing Med Univ, Ctr Canc, Jiangsu Key Lab Canc Biomarkers Prevent & Treatme, Dept Environm Genom, Nanjing, Jiangsu, Peoples R China.	mwang@njmu.edu.cn	wang, tingting/AAK-2640-2020; zhang, zheng/HCH-9684-2022		National Natural Science Foundation of China [81102089]; National Natural Science Foundation of Jiangsu Province [BK2011773]; Key Program for Basic Research of Jiangsu Provincial Department of Education [11KJB330002]; Practice Innovation Training Program Projects for the Jiangsu College Students; Priority Academic Program Development of Jiangsu Higher Education Institutions (Public Health and Preventive Medicine)	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Natural Science Foundation of Jiangsu Province(Natural Science Foundation of Jiangsu Province); Key Program for Basic Research of Jiangsu Provincial Department of Education; Practice Innovation Training Program Projects for the Jiangsu College Students; Priority Academic Program Development of Jiangsu Higher Education Institutions (Public Health and Preventive Medicine)	This study was partially supported by National Natural Science Foundation of China (81102089), National Natural Science Foundation of Jiangsu Province (BK2011773), the Key Program for Basic Research of Jiangsu Provincial Department of Education (11KJB330002), the Practice Innovation Training Program Projects for the Jiangsu College Students (2011), and the Project Funded by the Priority Academic Program Development of Jiangsu Higher Education Institutions (Public Health and Preventive Medicine). The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allan JM, 2008, INT J CANCER, V123, P2456, DOI 10.1002/ijc.23770; Arita M, 2003, GENE, V306, P57, DOI 10.1016/S0378-1119(03)00385-8; BRONNER CE, 1994, NATURE, V368, P258, DOI 10.1038/368258a0; Campbell PT, 2009, GUT, V58, P661, DOI 10.1136/gut.2007.144220; Chen HP, 2007, INT J CANCER, V120, P1684, DOI 10.1002/ijc.22406; de la Chapelle A, 2004, NAT REV CANCER, V4, P769, DOI 10.1038/nrc1453; DERSIMONIAN R, 1986, CONTROL CLIN TRIALS, V7, P177, DOI 10.1016/0197-2456(86)90046-2; Egger M, 1997, BMJ-BRIT MED J, V315, P629, DOI 10.1136/bmj.315.7109.629; Garcia-Albeniz X, 2011, BEST PRACT RES CL GA, V25, P461, DOI 10.1016/j.bpg.2011.10.015; Goldsborough AS, 1996, NATURE, V381, P807, DOI 10.1038/381807a0; Handoll HH, 2006, ARCH PHYS MED REHAB, V87, P875, DOI 10.1016/j.apmr.2006.04.006; Ito E, 1999, BIOCHEM BIOPH RES CO, V256, P488, DOI 10.1006/bbrc.1999.0368; Jean M, 1999, MOL GEN GENET, V262, P633, DOI 10.1007/s004380051126; Knudson AG, 1997, ANN NY ACAD SCI, V833, P58, DOI 10.1111/j.1749-6632.1997.tb48593.x; Koessler T, 2008, GUT, V57, P1097, DOI 10.1136/gut.2007.137265; Kunkel TA, 2005, ANNU REV BIOCHEM, V74, P681, DOI 10.1146/annurev.biochem.74.082803.133243; Malekzadeh R, 2009, ARCH IRAN MED, V12, P161; MANTEL N, 1959, J NATL CANCER I, V22, P719; Mohrenweiser HW, 1998, MUTAT RES-FUND MOL M, V400, P15, DOI 10.1016/S0027-5107(98)00059-1; Pan XM, 2011, MUTAGENESIS, V26, P667, DOI 10.1093/mutage/ger032; Peltomaki P, 2004, DIS MARKERS, V20, P269, DOI 10.1155/2004/305058; Perera S, 2011, ONCOL REP, V25, P809, DOI 10.3892/or.2010.1129; Raptis S, 2007, JNCI-J NATL CANCER I, V99, P463, DOI 10.1093/jnci/djk095; Samowitz WS, 2008, GENE CHROMOSOME CANC, V47, P835, DOI 10.1002/gcc.20584; Tomlinson IPM, 2012, MUTAGENESIS, V27, P219, DOI 10.1093/mutage/ger070; Tulupova E, 2008, MUTAT RES-FUND MOL M, V648, P40, DOI 10.1016/j.mrfmmm.2008.09.005; Whiffin N, 2011, CARCINOGENESIS, V32, P1157, DOI 10.1093/carcin/bgr089; Xu JL, 2012, ASIAN PAC J CANCER P, V13, P901, DOI 10.7314/APJCP.2012.13.3.901	28	10	10	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 30	2012	7	11							e50449	10.1371/journal.pone.0050449	http://dx.doi.org/10.1371/journal.pone.0050449			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	054WM	23226285	Green Published, Green Submitted, gold			2022-12-27	WOS:000312376100097
J	Wang, YG; He, Y; Abraham, B; Rouhani, FN; Brantly, ML; Scott, DE; Reed, JL				Wang, Yonggang; He, Yong; Abraham, Bindu; Rouhani, Farshid N.; Brantly, Mark L.; Scott, Dorothy E.; Reed, Jennifer L.			Cytosolic, Autocrine Alpha-1 Proteinase Inhibitor (A1PI) Inhibits Caspase-1 and Blocks IL-1 beta Dependent Cytokine Release in Monocytes	PLOS ONE			English	Article							ENDOPLASMIC-RETICULUM STRESS; MURAMYL DIPEPTIDE; ACTIVATION; INTERLEUKIN-1-BETA; INFLAMMASOME; EXPRESSION; NECROSIS; SURVIVAL; KINASES; PATHWAY	Rationale: Activation state-dependent secretion of alpha-1 proteinase inhibitor (A1PI) by monocytes and macrophages was first reported in 1985. Since then, monocytes and tissue macrophages have emerged as key sentinels of infection and tissue damage via activation of self-assembling pattern recognition receptors (inflammasomes), which trigger inflammation and cell death in a caspase-1 dependent process. These studies examine the relationship between A1PI expression in primary monocytes and monocytic cell lines, and inflammatory cytokine expression in response to inflammasome directed stimuli. Methods: IL-1 beta expression was examined in lung macrophages expressing wild type A1PI (A1PI-M) or disease-associated Z isoform A1PI (A1PI-Z). Inflammatory cytokine release was evaluated in THP-1 monocytic cells or THP-1 cells lacking the inflammasome adaptor ASC, transfected with expression vectors encoding A1PI-M or A1PI-Z. A1PI-M was localized within monocytes by immunoprecipitation in hypotonic cell fractions. Cell-free titration of A1PI-M was performed against recombinant active caspase-1 in vitro. Results: IL-1 beta expression was elevated in lung macrophages expressing A1PI-Z. Overexpression of A1PI-M in THP-1 monocytes reduced secretion of IL-1 beta and TNF-alpha. In contrast, overexpression of A1PI-Z enhanced IL-1 beta and TNF-alpha secretion in an ASC dependent manner. A1PI-Z-enhanced cytokine release was inhibited by a small molecule caspase-1 inhibitor but not by high levels of exogenous wtA1PI. Cytosolic localization of A1PI-M in monocytes was not diminished with microtubule-inhibiting agents. A1PI-M co-localized with caspase-1 in gel-filtered cytoplasmic THP-1 preparations, and was co-immunoprecipitated with caspase 1 from nigericin-stimulated THP-1 cell lysate. Plasma-derived A1PI inhibited recombinant caspase-1 mediated conversion of a peptide substrate in a dose dependent manner. Conclusions: Our results suggest that monocyte/macrophage-expressed A1PI-M antagonizes IL-1 beta secretion possibly via caspase-1 inhibition, a function which disease-associated A1PI-Z may lack. Therapeutic approaches which limit inflammasome responses in patients with A1PI deficiency, in combination with A1PI augmentation, may provide additional respiratory tissue-sparing benefits.	[Wang, Yonggang; He, Yong; Abraham, Bindu; Scott, Dorothy E.; Reed, Jennifer L.] US FDA, Ctr Biol Evaluat & Res, Bethesda, MD USA; [Rouhani, Farshid N.; Brantly, Mark L.] Univ Florida, Dept Med, Gainesville, FL USA	US Food & Drug Administration (FDA); State University System of Florida; University of Florida	Reed, JL (corresponding author), US FDA, Ctr Biol Evaluat & Res, Bethesda, MD USA.	jennifer.reed@fda.hhs.gov	Brantly, Mark/AAH-2922-2020		US Food and Drug Administration	US Food and Drug Administration	This work was supported by US Food and Drug Administration operating funds. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AFFORD SC, 1992, BIOL CHEM H-S, V373, P219, DOI 10.1515/bchm3.1992.373.1.219; Agostini L, 2004, IMMUNITY, V20, P319, DOI 10.1016/S1074-7613(04)00046-9; Allen IC, 2009, IMMUNITY, V30, P556, DOI 10.1016/j.immuni.2009.02.005; Carroll TP, 2010, J IMMUNOL, V184, P4538, DOI 10.4049/jimmunol.0802864; Couillin I, 2009, J IMMUNOL, V183, P8195, DOI 10.4049/jimmunol.0803154; del Fresno C, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002667; Del Porto P, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019970; Doz E, 2008, J IMMUNOL, V180, P1169, DOI 10.4049/jimmunol.180.2.1169; Drecktrah D, 1999, MOL BIOL CELL, V10, P4021, DOI 10.1091/mbc.10.12.4021; Feng B, 2003, NAT CELL BIOL, V5, P781, DOI 10.1038/ncb1035; Grigg J, 1999, EUR RESPIR J, V14, P1198, DOI 10.1183/09031936.99.14511989; Harper SJ, 2001, CELL SIGNAL, V13, P299, DOI 10.1016/S0898-6568(01)00148-6; Hedl M, 2011, J BIOL CHEM, V286, P26440, DOI 10.1074/jbc.M111.237495; Hruz P, 2009, P NATL ACAD SCI USA, V106, P12873, DOI 10.1073/pnas.0904958106; Ishii Y, 2005, J IMMUNOL, V175, P6968, DOI 10.4049/jimmunol.175.10.6968; Kaneko M, 2003, BIOL PHARM BULL, V26, P931, DOI 10.1248/bpb.26.931; Komura T, 2010, DIABETES, V59, P634, DOI 10.2337/db09-0659; Lawless MW, 2004, J IMMUNOL, V172, P5722, DOI 10.4049/jimmunol.172.9.5722; Lockett AD, 2012, MOL MED, V18, P445, DOI 10.2119/molmed.2011.00207; Martinon F, 2004, CURR BIOL, V14, P1929, DOI 10.1016/j.cub.2004.10.027; Masters SL, 2011, TRENDS MOL MED, V17, P276, DOI 10.1016/j.molmed.2011.01.005; MATTER K, 1990, EMBO J, V9, P3163, DOI 10.1002/j.1460-2075.1990.tb07514.x; Mirza R, 2011, CYTOKINE, V56, P256, DOI 10.1016/j.cyto.2011.06.016; MORNEX JF, 1986, J CLIN INVEST, V77, P1952, DOI 10.1172/JCI112524; Pelegrin P, 2007, J BIOL CHEM, V282, P2386, DOI 10.1074/jbc.M610351200; PERLMUTTER DH, 1985, P NATL ACAD SCI USA, V82, P795, DOI 10.1073/pnas.82.3.795; Petrache I, 2006, AM J PATHOL, V169, P1155, DOI 10.2353/ajpath.2006.060058; RUBARTELLI A, 1990, EMBO J, V9, P1503, DOI 10.1002/j.1460-2075.1990.tb08268.x; Sandstrom CS, 2008, DIABETIC MED, V25, P1370, DOI 10.1111/j.1464-5491.2008.02584.x; Schmitz N, 2005, J VIROL, V79, P6441, DOI 10.1128/JVI.79.10.6441-6448.2005; Schroder K, 2010, CELL, V140, P821, DOI 10.1016/j.cell.2010.01.040; Schroder M, 2005, ANNU REV BIOCHEM, V74, P739, DOI 10.1146/annurev.biochem.73.011303.074134; Shi CS, 2012, NAT IMMUNOL, V13, P255, DOI 10.1038/ni.2215; Shikama Y, 2011, INNATE IMMUN-LONDON, V17, P3, DOI 10.1177/1753425909347508; Stoller JK, 2012, AM J RESP CRIT CARE, V185, P246, DOI 10.1164/rccm.201108-1428CI; SWANSON J, 1987, J CELL BIOL, V104, P1217, DOI 10.1083/jcb.104.5.1217; Taggart C, 2000, J BIOL CHEM, V275, P27258; Talmud PJ, 2003, ARTERIOSCL THROM VAS, V23, P644, DOI 10.1161/01.ATV.0000065196.61663.8D; Thompson J, 2008, J BACTERIOL, V190, P3362, DOI 10.1128/JB.02008-07; Thorp E, 2009, CELL METAB, V9, P474, DOI 10.1016/j.cmet.2009.03.003; Toldo S, 2011, J MOL CELL CARDIOL, V51, P244, DOI 10.1016/j.yjmcc.2011.05.003; Tschopp J, 2010, NAT REV IMMUNOL, V10, P210, DOI 10.1038/nri2725; TURINO GM, 1969, SCIENCE, V165, P709, DOI 10.1126/science.165.3894.709; Urano F, 2000, SCIENCE, V287, P664, DOI 10.1126/science.287.5453.664; van 't Wout EFA, 2012, AM J RESP CELL MOL, V46, P607, DOI 10.1165/rcmb.2011-0231OC; Vandanmagsar B, 2011, NAT MED, V17, P179, DOI 10.1038/nm.2279; Vassilev A, 2001, GENE DEV, V15, P1229, DOI 10.1101/gad.888601; Wilson AA, 2010, J CLIN INVEST, V120, P379, DOI 10.1172/JCI36666	48	9	10	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 30	2012	7	11							e51078	10.1371/journal.pone.0051078	http://dx.doi.org/10.1371/journal.pone.0051078			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	054WM	23226468	Green Published, Green Submitted, gold			2022-12-27	WOS:000312376100279
J	Yin, JY; Li, YK; Yin, M; Sun, JW; Liu, L; Qin, Q; Li, XR; Long, L; Nie, SF; Wei, S				Yin, Jieyun; Li, Yangkai; Yin, Ming; Sun, Jingwen; Liu, Li; Qin, Qin; Li, Xiaorong; Long, Lu; Nie, Shaofa; Wei, Sheng			TERT-CLPTM1L Polymorphism rs401681 Contributes to Cancers Risk: Evidence from a Meta-Analysis Based on 29 Publications	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; SINGLE-NUCLEOTIDE POLYMORPHISMS; MEAN TELOMERE LENGTH; LUNG-CANCER; SUSCEPTIBILITY LOCI; GENETIC-VARIATIONS; BREAST-CANCER; VARIANTS; TERT; PREDISPOSITION	Background: Some common genetic variants of TERT-CLPTM1L gene, which encode key protein subunits of telomerase, have been suggested to play a crucial role in tumorigenesis. The TERT-CLPTM1L polymorphism rs401681 was of special interest for cancers risk but with inconclusive results. Methodology/Principal Findings: We performed a comprehensive meta-analysis of 29 publications with a total of 91263 cases and 735952 controls. We assessed the strength of the association between rs401681 and overall cancers risk and performed subgroup analyses by cancer type, ethnicity, source of control, sample size and expected power. Rs401681 C allele was found to be associated with marginally increased cancers risk, with per allele OR of 1.04 (95%CI = 1.00-1.08, P-heterogeneity<0.001) and an expected power of 1.000. Following further stratified analyses, the increased cancers risk were discovered in subgroups of lung, bladder, prostate, basal cell carcinomas and Asians, while a declined risk of pancreatic cancer and melanoma were detected. Conclusions/Significance: These findings suggested that rs401681 C allele was a low-penetrance risk allele for the development of cancers of lung, bladder, prostate and basal cell carcinoma, but a potential protective allele for melanoma and pancreatic cancer.	[Yin, Jieyun; Sun, Jingwen; Liu, Li; Qin, Qin; Li, Xiaorong; Long, Lu; Nie, Shaofa; Wei, Sheng] Huazhong Univ Sci & Technol, Dept Epidemiol & Biostat, Sch Publ Hlth, Tongji Med Coll, Wuhan 430074, Peoples R China; [Yin, Jieyun; Sun, Jingwen; Liu, Li; Qin, Qin; Li, Xiaorong; Long, Lu; Nie, Shaofa; Wei, Sheng] Huazhong Univ Sci & Technol, MOE Key Lab Environm & Hlth, Sch Publ Hlth, Tongji Med Coll, Wuhan 430074, Peoples R China; [Li, Yangkai] Huazhong Univ Sci & Technol, Dept Thorac Surg, Tongji Hosp, Tongji Med Coll, Wuhan 430074, Peoples R China; [Yin, Ming] Geisinger Med Ctr, Dept Internal Med, Danville, PA 17822 USA	Huazhong University of Science & Technology; Huazhong University of Science & Technology; Huazhong University of Science & Technology; Geisinger Medical Center	Nie, SF (corresponding author), Huazhong Univ Sci & Technol, Dept Epidemiol & Biostat, Sch Publ Hlth, Tongji Med Coll, Wuhan 430074, Peoples R China.	sf_nie@mails.tjmu.edu.cn; ws2008cn@gmail.com			National Natural Science Foundation of China [NSFC 30972534, NSFC 81172752, NSFC 81172754]; Natural Science Foundation of Hubei Province [2011CDB203]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Hubei Province(Natural Science Foundation of Hubei Province)	This work was supported by the National Natural Science Foundation of China (NSFC 30972534, NSFC 81172752, and NSFC 81172754) and Natural Science Foundation of Hubei Province (2011CDB203). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Asakura T, 2005, ONCOL REP, V14, P601; Bae EY, 2012, RESPIROLOGY; Bagheri S, 2006, P NATL ACAD SCI USA, V103, P11306, DOI 10.1073/pnas.0510085103; Baird DM, 2010, EXPERT REV MOL MED, V12, DOI 10.1017/S146239941000147X; Barrett JH, 2011, NAT GENET, V43, P1108, DOI 10.1038/ng.959; Bataille V, 2007, CANCER EPIDEM BIOMAR, V16, P1499, DOI 10.1158/1055-9965.EPI-07-0152; Beesley J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024987; Bodnar AG, 1998, SCIENCE, V279, P349, DOI 10.1126/science.279.5349.349; Carpentier C, 2007, J NEURO-ONCOL, V84, P249, DOI 10.1007/s11060-007-9378-3; Chen XF, 2012, GENET MOL RES, V11, P370, DOI 10.4238/2012.February.16.2; Chudnovsky Y, 2005, NAT GENET, V37, P745, DOI 10.1038/ng1586; COLDITZ GA, 1995, AM J EPIDEMIOL, V142, P371, DOI 10.1093/oxfordjournals.aje.a117644; Colombo J, 2009, ONCOL REP, V21, P649, DOI 10.3892/or_00000268; De Vivo I, 2009, CANCER EPIDEM BIOMAR, V18, P1152, DOI 10.1158/1055-9965.EPI-08-0998; DERSIMONIAN R, 1986, CONTROL CLIN TRIALS, V7, P177, DOI 10.1016/0197-2456(86)90046-2; Egger M, 1997, BMJ-BRIT MED J, V315, P629, DOI 10.1136/bmj.315.7109.629; Gago-Dominguez M, 2011, CARCINOGENESIS, V32, P197, DOI 10.1093/carcin/bgq233; Gisselsson D, 2001, P NATL ACAD SCI USA, V98, P12683, DOI 10.1073/pnas.211357798; GREIDER CW, 1985, CELL, V43, P405, DOI 10.1016/0092-8674(85)90170-9; Gudmundsson J, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3001513; Han JL, 2009, J INVEST DERMATOL, V129, P415, DOI 10.1038/jid.2008.238; Hancock DB, 2007, CURR PROTOC HUM GENE; Harder T, 2005, AM J EPIDEMIOL, V162, P397, DOI 10.1093/aje/kwi222; Helfand BT, 2011, PROSTATE, V71, P394, DOI 10.1002/pros.21253; Higgins JPT, 2003, BRIT MED J, V327, P557, DOI 10.1136/bmj.327.7414.557; Hsu CP, 2006, EUR J CANCER, V42, P1466, DOI 10.1016/j.ejca.2006.02.014; Hu ZB, 2011, NAT GENET, V43, P792, DOI 10.1038/ng.875; Hung RJ, 2008, NATURE, V452, P633, DOI 10.1038/nature06885; Kanetsky PA, 2011, HUM MOL GENET, V20, P3109, DOI 10.1093/hmg/ddr207; Kiltie AE, 2010, CURR OPIN GENET DEV, V20, P218, DOI 10.1016/j.gde.2010.01.002; Klein RJ, 2012, EUR UROL, V61, P471, DOI 10.1016/j.eururo.2011.10.047; Kohno T, 2010, CARCINOGENESIS, V31, P834, DOI 10.1093/carcin/bgq003; Koushik A, 2004, CANCER EPIDEM BIOMAR, V13, P11, DOI 10.1158/1055-9965.EPI-083-3; Landi MT, 2009, AM J HUM GENET, V85, P679, DOI 10.1016/j.ajhg.2009.09.012; Liu PY, 2010, CANCER EPIDEM BIOMAR, V19, P517, DOI 10.1158/1055-9965.EPI-09-0791; Liu ZS, 2010, CARCINOGENESIS, V31, P1977, DOI 10.1093/carcin/bgq179; Ma Z, 2012, MOL CARCINOG; McKay JD, 2008, NAT GENET, V40, P1404, DOI 10.1038/ng.254; Miki D, 2010, NAT GENET, V42, P893, DOI 10.1038/ng.667; Mooi WJ, 2006, NEW ENGL J MED, V355, P1037, DOI 10.1056/NEJMra062285; Nan HM, 2011, HUM GENET, V129, P247, DOI 10.1007/s00439-010-0921-5; Nosrati M, 2004, CLIN CANCER RES, V10, P4983, DOI 10.1158/1078-0432.CCR-04-0134; OLOVNIKO.AM, 1971, DOKL AKAD NAUK SSSR+, V201, P1496; Palomaki GE, 2010, JAMA-J AM MED ASSOC, V303, P648, DOI 10.1001/jama.2010.118; Pande M, 2011, CARCINOGENESIS, V32, P1493, DOI 10.1093/carcin/bgr136; Petersen GM, 2010, NAT GENET, V42, P224, DOI 10.1038/ng.522; Pooley KA, 2010, CANCER EPIDEM BIOMAR, V19, P1862, DOI 10.1158/1055-9965.EPI-10-0281; Pooley KA, 2010, CANCER RES, V70, P3170, DOI 10.1158/0008-5472.CAN-09-4595; Prescott J, 2010, CANCER-AM CANCER SOC, V116, P4275, DOI 10.1002/cncr.25328; Rafnar T, 2009, NAT GENET, V41, P221, DOI 10.1038/ng.296; Rizzato C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027921; Rothman N, 2010, NAT GENET, V42, P978, DOI 10.1038/ng.687; Shete S, 2009, NAT GENET, V41, P899, DOI 10.1038/ng.407; Shimizu M, 2011, J CANC THERAPY, V2, P690; Song W, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007157; Stacey SN, 2009, NAT GENET, V41, P909, DOI 10.1038/ng.412; Szklo M, 1998, EPIDEMIOL REV, V20, P81, DOI 10.1093/oxfordjournals.epirev.a017974; Thompson SG, 1999, STAT MED, V18, P2693, DOI 10.1002/(SICI)1097-0258(19991030)18:20<2693::AID-SIM235>3.0.CO;2-V; Thompson SG, 1997, STAT MED, V16, P2741, DOI 10.1002/(SICI)1097-0258(19971215)16:23<2741::AID-SIM703>3.0.CO;2-0; Truong T, 2010, JNCI-J NATL CANCER I, V102, P959, DOI 10.1093/jnci/djq178; Turnbull C, 2010, NAT GENET, V42, P604, DOI 10.1038/ng.607; Voils CI, 2011, J EVAL CLIN PRACT, V17, P429, DOI 10.1111/j.1365-2753.2010.01444.x; Wacholder S, 2004, J NATL CANCER I, V96, P434, DOI 10.1093/jnci/djh075; Wang SW, 2007, MOL BIOL CELL, V18, P669, DOI 10.1091/mbc.E06-09-0840; Wang YF, 2008, NAT GENET, V40, P1407, DOI 10.1038/ng.273; Wick M, 1999, GENE, V232, P97, DOI 10.1016/S0378-1119(99)00108-0; Willis JA, 2012, CLIN CANCER RES, V18, P3942, DOI 10.1158/1078-0432.CCR-11-2856; Wu XF, 2003, J NATL CANCER I, V95, P1211, DOI 10.1093/jnci/djg011; Xu ZL, 2009, NUCLEIC ACIDS RES, V37, pW600, DOI 10.1093/nar/gkp290; Yamamoto K, 2001, BIOCHEM BIOPH RES CO, V280, P1148, DOI 10.1006/bbrc.2001.4250; Yoon KA, 2010, HUM MOL GENET, V19, P4948, DOI 10.1093/hmg/ddq421; Zee RYL, 2009, CANCER EPIDEM BIOMAR, V18, P2280, DOI 10.1158/1055-9965.EPI-09-0360; Zheng YL, 2012, BREAST CANCER RES TR, V132, P341, DOI 10.1007/s10549-011-1890-7; Zienolddiny S, 2009, CARCINOGENESIS, V30, P1368, DOI 10.1093/carcin/bgp131	74	17	18	2	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 30	2012	7	11							e50650	10.1371/journal.pone.0050650	http://dx.doi.org/10.1371/journal.pone.0050650			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	054WM	23226346	gold, Green Published, Green Submitted			2022-12-27	WOS:000312376100157
J	Yoon, YJ; White, SL; Ni, XL; Gokin, AP; Martin-Caraballo, M				Yoon, Yone J.; White, Sheryl L.; Ni, Xianglian; Gokin, Alexander P.; Martin-Caraballo, Miguel			Downregulation of GluA2 AMPA Receptor Subunits Reduces the Dendritic Arborization of Developing Spinal Motoneurons	PLOS ONE			English	Article							EXCITATORY AMINO-ACIDS; CALCIUM PERMEABILITY; DEPENDENT REGULATION; NMDA RECEPTOR; CHICK; CORD; EXPRESSION; GROWTH; CHANNELS; DIFFERENTIATION	AMPA receptors lacking the GluA2 subunit allow a significant influx of Ca2+ ions. Although Ca2+-permeable AMPA receptors are a familiar feature at early stages of development, the functional significance of these receptors during the maturation of the nervous system remains to be established. Chicken lumbar motoneurons express Ca2+-permeable AMPA receptors at E6 but the Ca2+ permeability of AMPA receptors decreases similar to 3-fold by E11. Considering that activity-dependent changes in intracellular Ca2+ regulates dendritic outgrowth, in this study we investigated whether downregulation of GluA2 expression during a critical period of development alters the dendritic arborization of spinal motoneurons in ovo. We use an avian replication-competent retroviral vector RCASBP (B) carrying the marker red fluorescent protein (RFP) and a GluA2 RNAi construct to downregulate GluA2 expression. Chicken embryos were infected at E2 with one of the following constructs: RCASBP(B)-RFP, RCASBP(B)-RFP-scrambled RNAi, or RCASBP(B)-RFP-GluA2 RNAi. Infection of chicken embryos at E2 resulted in widespread expression of RFP throughout the spinal cord with >= 60% of Islet1/2-positive motoneurons infected, resulting in a significant reduction in GluA2 protein expression. Downregulation of GluA2 expression had no effect on the dendritic arborization of E6 motoneurons. However, downregulation of GluA2 expression caused a significant reduction in the dendritic arborization of E11 motoneurons. Neither motoneuron survival nor maturation of network activity was affected by changes in GluA2 expression. These findings demonstrate that increased GluA2 expression and changes in the Ca2+ permeability of AMPA receptors regulate the dendritic arborization of spinal cord motoneurons during a critical period of development.	[Martin-Caraballo, Miguel] Univ Maryland Eastern Shore, Sch Pharm, Dept Pharmaceut Sci, Princess Anne, MD USA; [Yoon, Yone J.; Ni, Xianglian; Gokin, Alexander P.] Univ Vermont, Dept Biol, Burlington, VT USA; [White, Sheryl L.] Univ Vermont, Coll Med, Dept Anat & Neurobiol, Burlington, VT 05405 USA	University System of Maryland; University of Maryland Eastern Shore; University of Vermont; University of Vermont	Martin-Caraballo, M (corresponding author), Univ Maryland Eastern Shore, Sch Pharm, Dept Pharmaceut Sci, Princess Anne, MD USA.	mmartin@umes.edu		Yoon, YoneJung/0000-0002-1608-2122	National Institutes of Health from the National Center for Research Resources [P20 RR016435]; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR016435] Funding Source: NIH RePORTER	National Institutes of Health from the National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	This work was supported by National Institutes of Health grant P20 RR016435 from the National Center for Research Resources. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BURNASHEV N, 1992, NEURON, V8, P189, DOI 10.1016/0896-6273(92)90120-3; Caldero J, 1997, J COMP NEUROL, V387, P73; Casavant RH, 2004, J NEUROPHYSIOL, V92, P2644, DOI 10.1152/jn.00307.2004; Catsicas M, 2001, J NEUROBIOL, V49, P200, DOI 10.1002/neu.1075; Chub N, 1998, J NEUROSCI, V18, P294; DAHM LM, 1991, J NEUROSCI, V11, P238; Das RM, 2006, DEV BIOL, V294, P554, DOI 10.1016/j.ydbio.2006.02.020; ERICSON J, 1992, SCIENCE, V256, P1555, DOI 10.1126/science.1350865; Gomez TM, 2000, J NEUROBIOL, V44, P174, DOI 10.1002/1097-4695(200008)44:2<174::AID-NEU7>3.3.CO;2-I; Gonzalez-Islas C, 2006, NEURON, V49, P563, DOI 10.1016/j.neuron.2006.01.017; Haas K, 2006, P NATL ACAD SCI USA, V103, P12127, DOI 10.1073/pnas.0602670103; HAMBURGER V, 1992, DEV DYNAM, V195, P231, DOI 10.1002/dvdy.1001950404; HOLLYDAY M, 1977, BRAIN RES, V132, P197, DOI 10.1016/0006-8993(77)90416-4; Hughes SH, 2004, FOLIA BIOL-PRAGUE, V50, P107; Jeong GB, 2006, MOL CELL NEUROSCI, V32, P299, DOI 10.1016/j.mcn.2006.04.008; JOHNSON EM, 1992, EXP NEUROL, V115, P163, DOI 10.1016/0014-4886(92)90242-I; JONAS P, 1994, NEURON, V12, P1281, DOI 10.1016/0896-6273(94)90444-8; LANDMESSER L, 1975, J PHYSIOL-LONDON, V249, P301, DOI 10.1113/jphysiol.1975.sp011017; Lautermilch NJ, 2000, J NEUROSCI, V20, P315, DOI 10.1523/JNEUROSCI.20-01-00315.2000; LEE MT, 1988, J NEUROSCI, V8, P2530; Llado J, 1999, J NEUROSCI, V19, P10803, DOI 10.1523/JNEUROSCI.19-24-10803.1999; Lodge D, 2000, IUPHAR COMPENDIUM RE; Martin-Caraballo M, 2002, J NEUROSCI, V22, P73, DOI 10.1523/JNEUROSCI.22-01-00073.2002; MAYER ML, 1987, J PHYSIOL-LONDON, V394, P501, DOI 10.1113/jphysiol.1987.sp016883; MCCOBB DP, 1990, J NEUROSCI, V10, P2974; MCCOBB DP, 1989, NEURON, V2, P1633, DOI 10.1016/0896-6273(89)90052-4; Milner LD, 1999, J NEUROSCI, V19, P3007; Molnar E, 2002, NEUROSCIENTIST, V8, P143, DOI 10.1177/107385840200800210; Ni X, 2007, DEV NEUROBIOL, V67, P1419, DOI 10.1002/dneu.20517; Ni XL, 2010, NEUROPHARMACOLOGY, V58, P593, DOI 10.1016/j.neuropharm.2009.11.016; O'Donovan MJ, 1998, J NEUROBIOL, V37, P131, DOI 10.1002/(SICI)1097-4695(199810)37:1<131::AID-NEU10>3.0.CO;2-H; Peng YR, 2009, NEURON, V61, P71, DOI 10.1016/j.neuron.2008.11.015; PHILLIPS WD, 1987, J NEUROCYTOL, V16, P785, DOI 10.1007/BF01611986; Rajan I, 1999, J NEUROBIOL, V38, P357, DOI 10.1002/(SICI)1097-4695(19990215)38:3<357::AID-NEU5>3.0.CO;2-#; Sato N, 2002, J NEUROBIOL, V53, P381, DOI 10.1002/neu.10108; Schwartz N, 2009, NEURON, V62, P655, DOI 10.1016/j.neuron.2009.05.007; SHOLOMENKO GN, 1995, J NEUROPHYSIOL, V73, P1223, DOI 10.1152/jn.1995.73.3.1223; Sin WC, 2002, NATURE, V419, P475, DOI 10.1038/nature00987; Tripodi M, 2012, CURR OPIN NEUROBIOL, V22, P615, DOI 10.1016/j.conb.2012.02.011; TSUCHIDA T, 1994, CELL, V79, P957, DOI 10.1016/0092-8674(94)90027-2; TYMIANSKI M, 1993, J NEUROSCI, V13, P2085; Usiak MF, 1999, J NEUROSCI, V19, P7925; Vandenberghe W, 2000, J NEUROSCI, V20, P123, DOI 10.1523/JNEUROSCI.20-01-00123.2000; Wilhelm JC, 2009, P NATL ACAD SCI USA, V106, P6760, DOI 10.1073/pnas.0813058106; Wong ROL, 2002, NAT REV NEUROSCI, V3, P803, DOI 10.1038/nrn941; Yoon YJ, 2010, NEURAL DEV, V5, DOI 10.1186/1749-8104-5-11; Yoon YJ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002971; Yuan BB, 2004, NUCLEIC ACIDS RES, V32, pW130, DOI 10.1093/nar/gkh366; Zou DJ, 1999, J NEUROSCI, V19, P8909, DOI 10.1523/JNEUROSCI.19-20-08909.1999	49	6	7	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 30	2012	7	11							e49879	10.1371/journal.pone.0049879	http://dx.doi.org/10.1371/journal.pone.0049879			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	054WM	23226228	Green Submitted, Green Published, gold			2022-12-27	WOS:000312376100036
J	Dmitriew, C; Blanckenhorn, WU				Dmitriew, Caitlin; Blanckenhorn, Wolf U.			The Role of Sexual Selection and Conflict in Mediating Among-Population Variation in Mating Strategies and Sexually Dimorphic Traits in Sepsis punctum	PLOS ONE			English	Article							FEMALE MATE CHOICE; BODY-SIZE; SEAWEED FLY; EVOLUTION; SPECIATION; DIPTERA; COSTS; COEVOLUTION; ADAPTATION; ALLOMETRY	The black scavenger fly Sepsis punctum exhibits striking among-population variation in the direction and magnitude of sexual size dimorphism, modification to the male forelimb and pre-copulatory behaviour. In some populations, male-biased sexual size dimorphism is observed; in other, less dimorphic, populations males court prior to mating. Such variation in reproductive traits is of interest to evolutionary biologists because it has the potential to limit gene flow among populations, contributing to speciation. Here, we investigate whether large male body size and modified forefemur are associated with higher male mating success within populations, whether these traits are associated with higher mating success among populations, and if these traits carry viability costs that could constrain their response to sexual selection. Flies from five distinct populations were reared at high or low food, generating high and low quality males. The expression of body size, forelimb morphology and courtship rate were each greater at high food, but high food males experienced higher mating success or reduced latency to first copulation in only one of the populations. Among populations, overall mating success increased with the degree of male-bias in overall body size and forelimb modification, suggesting that these traits have evolved as a means of increasing male mating rate. The increased mating success observed in large-male populations raises the question of why variation in magnitude of dimorphism persists among populations. One reason may be that costs of producing a large size constrain the evolution of ever-larger males. We found no evidence that juvenile mortality under food stress was greater for large-male populations, but development time was considerably longer and may represent an important constraint in an ephemeral and competitive growth environment. Citation: Dmitriew C, Blanckenhorn WU (2012) The Role of Sexual Selection and Conflict in Mediating Among-Population Variation in Mating Strategies and Sexually Dimorphic Traits in Sepsis punctum. PLoS ONE 7(12): e49511. doi:10.1371/journal.pone.0049511	[Dmitriew, Caitlin] Univ Colorado, Dept Ecol & Evolutionary Biol, Boulder, CO 80309 USA; [Blanckenhorn, Wolf U.] Univ Zurich, Inst Evolutionary Biol & Environm Studies, Zurich, Switzerland	University of Colorado System; University of Colorado Boulder; University of Zurich	Dmitriew, C (corresponding author), Univ Colorado, Dept Ecol & Evolutionary Biol, Boulder, CO 80309 USA.	c.dmitriew@utoronto.ca			Swiss National Fund Grant	Swiss National Fund Grant	Swiss National Fund Grant to W.U. Blanckenhorn. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersson Malte, 1994; Arnqvist G, 2000, P NATL ACAD SCI USA, V97, P10460, DOI 10.1073/pnas.97.19.10460; Arnqvist G, 2002, EVOLUTION, V56, P936; ARNQVIST G, 1995, P ROY SOC B-BIOL SCI, V261, P123, DOI 10.1098/rspb.1995.0126; Arnqvist Goran, 2005, pUnpaginated; BATEMAN AJ, 1948, HEREDITY, V2, P349, DOI 10.1038/hdy.1948.21; Blanckenhorn WU, 2010, J INSECT SCI, V10, DOI 10.1673/031.010.1101; Blanckenhorn WU, 2002, BEHAV ECOL, V13, P353, DOI 10.1093/beheco/13.3.353; Blanckenhorn WU, 2000, Q REV BIOL, V75, P385, DOI 10.1086/393620; Blanckenhorn WU, 2002, EVOL ECOL RES, V4, P1201; Blanckenhorn WU, 2000, ETHOLOGY, V106, P577, DOI 10.1046/j.1439-0310.2000.00573.x; Chapman T, 2003, TRENDS ECOL EVOL, V18, P41, DOI 10.1016/S0169-5347(02)00004-6; Crean CS, 1998, ANIM BEHAV, V56, P1405, DOI 10.1006/anbe.1998.0932; Crean CS, 2000, ANIM BEHAV, V59, P121, DOI 10.1006/anbe.1999.1268; Dmitriew CM, 2011, BIOL REV, V86, P97, DOI 10.1111/j.1469-185X.2010.00136.x; Eberhard WG, 2001, ZOOL J LINN SOC-LOND, V133, P335, DOI [10.1006/zjls.2000.0285, 10.1111/j.1096-3642.2001.tb00630.x]; ENDLER JA, 1995, EVOLUTION, V49, P456, DOI [10.2307/2410270, 10.1111/j.1558-5646.1995.tb02278.x]; Evans JP, 2011, P ROY SOC B-BIOL SCI, V278, P2611, DOI 10.1098/rspb.2010.2453; Fairbairn DJ, 1997, ANNU REV ECOL SYST, V28, P659, DOI 10.1146/annurev.ecolsys.28.1.659; Gage MJG, 2002, P ROY SOC B-BIOL SCI, V269, P2309, DOI 10.1098/rspb.2002.2154; Gavrilets S, 2001, P ROY SOC B-BIOL SCI, V268, P531, DOI 10.1098/rspb.2000.1382; Gavrilets S, 2000, NATURE, V403, P886, DOI 10.1038/35002564; Holland B, 1998, EVOLUTION, V52, P1, DOI 10.1111/j.1558-5646.1998.tb05132.x; HONEK A, 1993, OIKOS, V66, P483, DOI 10.2307/3544943; Jann P, 2000, J EVOLUTION BIOL, V13, P927, DOI 10.1046/j.1420-9101.2000.00230.x; Kingsolver JG, 2004, EVOLUTION, V58, P1608; Kraushaar U, 2002, EVOLUTION, V56, P307, DOI 10.1111/j.0014-3820.2002.tb01341.x; MAGURRAN AE, 1994, P ROY SOC B-BIOL SCI, V255, P31, DOI 10.1098/rspb.1994.0005; Matute DR, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000341; Mayhew PJ, 2007, BIOL REV, V82, P425, DOI 10.1111/j.1469-185X.2007.00018.x; Metcalfe NB, 2001, TRENDS ECOL EVOL, V16, P254, DOI 10.1016/S0169-5347(01)02124-3; Millar NP, 2006, OIKOS, V113, P1; Muhlhauser C, 2002, BEHAV ECOL, V13, P359, DOI 10.1093/beheco/13.3.359; Ortigosa A, 2003, ANIM BEHAV, V65, P851, DOI 10.1006/anbe.2003.2112; Ortigosa A, 2002, ANIM BEHAV, V64, P369, DOI 10.1006/anbe.2002.3065; Panhuis TM, 2001, TRENDS ECOL EVOL, V16, P364, DOI 10.1016/S0169-5347(01)02160-7; Parker G.A., 1979, P123; Parker GA, 1998, PHILOS T R SOC B, V353, P261, DOI 10.1098/rstb.1998.0208; Perry JC, 2012, EVOLUTION, V66, P544, DOI 10.1111/j.1558-5646.2011.01464.x; Pont Adrian C., 2002, Fauna Entomologica Scandinavica, V37, P1; Puniamoorthy N, 2012, ONLINE EARLY VIEW, DOI [10.1111/j.1558-5646.2012.01599.x, DOI 10.1111/J.1558-5646.2012.01599.X]; Puniamoorthy N, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-155; Ritchie MG, 2007, ANNU REV ECOL EVOL S, V38, P79, DOI 10.1146/annurev.ecolsys.38.091206.095733; Ronn J, 2007, P NATL ACAD SCI USA, V104, P10921, DOI 10.1073/pnas.0701170104; ROWE L, 1994, ANIM BEHAV, V48, P1049, DOI 10.1006/anbe.1994.1338; Rowe L, 2002, EVOLUTION, V56, P754; RYAN MJ, 1993, PHILOS T ROY SOC B, V340, P187, DOI 10.1098/rstb.1993.0057; SCHULZ K, 1999, THESIS U ARIZONA TUC; Seehausen O, 1999, J EVOLUTION BIOL, V12, P514, DOI 10.1046/j.1420-9101.1999.00055.x; Servedio MR, 2004, EVOLUTION, V58, P913, DOI 10.1111/j.0014-3820.2004.tb00425.x; Stearns S.C., 1992, pi; Teder T, 2005, ECOL ENTOMOL, V30, P342, DOI 10.1111/j.0307-6946.2005.00693.x; Terai Y, 2006, PLOS BIOL, V4, P2244, DOI 10.1371/journal.pbio.0040433; Teuschl Y, 2007, J EVOLUTION BIOL, V20, P87, DOI 10.1111/j.1420-9101.2006.01225.x; Zerbe F, 1993, THESIS U WURZBURG WU	55	13	13	0	42	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 5	2012	7	12							e49511	10.1371/journal.pone.0049511	http://dx.doi.org/10.1371/journal.pone.0049511			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	057TZ	23227145	Green Published, Green Accepted, Green Submitted, gold			2022-12-27	WOS:000312588200008
J	Wong, FY; Liem, N; Xie, C; Yan, FL; Wong, WC; Wang, LZ; Yong, WP				Wong, Foong Ying; Liem, Natalia; Xie, Chen; Yan, Fui Leng; Wong, Wing Cheong; Wang, Lingzhi; Yong, Wei-Peng			Combination Therapy with Gossypol Reveals Synergism against Gemcitabine Resistance in Cancer Cells with High BCL-2 Expression	PLOS ONE			English	Article							SMALL-MOLECULE INHIBITOR; PROSTATE-CANCER; X-L; PANCREATIC-CANCER; INDUCED APOPTOSIS; CARCINOMA-CELLS; LUNG-CANCER; MEDIATED APOPTOSIS; BREAST-CANCER; IN-VITRO	Although gemcitabine is highly active in several cancer types, intrinsic and acquired drug resistance remains a major challenge. Overexpression of Bcl-2 has been associated with gemcitabine resistance. The aim of this study is to determine whether gossypol can overcome gemcitabine resistance in cell lines with high level of Bcl-2 expression in combination drug therapy. Our study demonstrated that in 10 cell lines derived from different cancers, high Bcl-2 baseline expression was observed in cell lines that were resistant to gemcitabine (GEM-R). Furthermore, synergistic effect of combination therapy was observed in gemcitabine-resistant (GEM-R) cell lines with high Bcl-2 expression, but not in a gemcitabine-sensitive (GEM-S) cell lines regardless of Bcl-2 expression. Gossypol treatment resulted in the decrease of anti-apoptotic genes such as Bcl-2 and Bcl-xl and an upregulation of the pro-apoptotic gene, Noxa. Furthermore, the addition of gossypol to gemcitabine resulted in lower expressions of anti-apoptotic genes compared to gemcitabine alone. Gene expression profiling in GEM-R and GEM-S cell lines suggest that anti-apoptotic genes such as pAkt and PI3KR2 may play important role in gemcitabine resistance, while pro-apoptotic Bcl-2 related genes (Bad, Caspase-6 and Calpain-1) may regulate synergistic interaction in combination therapy.	[Wong, Foong Ying; Liem, Natalia; Xie, Chen; Yan, Fui Leng; Yong, Wei-Peng] Natl Univ Hlth Syst, Dept Haematol Oncol, Singapore, Singapore; [Wong, Wing Cheong] Agcy Sci Technol & Res, Bioinformat Inst, Singapore, Singapore; [Wang, Lingzhi; Yong, Wei-Peng] Natl Univ Singapore, Canc Sci Inst Singapore, Singapore 117548, Singapore	National University of Singapore; Agency for Science Technology & Research (A*STAR); A*STAR - Bioinformatics Institute (BII); National University of Singapore	Wong, FY (corresponding author), Natl Univ Hlth Syst, Dept Haematol Oncol, Singapore, Singapore.	wf_ying@hotmail.com			National Medical Research Council, Singapore [NMRC/TCR/001-NUH/2007]	National Medical Research Council, Singapore(National Medical Research Council, Singapore)	This work is supported by grant NMRC/TCR/001-NUH/2007 from National Medical Research Council, Singapore. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Balakrishnan K, 2008, BLOOD, V112, P1971, DOI 10.1182/blood-2007-12-126946; Barba-Barajas M, 2009, IMMUNOPHARM IMMUNOT, V31, P320, DOI 10.1080/08923970902718049; Bauer JA, 2005, MOL CANCER THER, V4, P1096, DOI 10.1158/1535-7163.MCT-05-0081; Bergman AM, 2002, DRUG RESIST UPDATE, V5, P19, DOI 10.1016/S1368-7646(02)00002-X; Bold RJ, 1999, ANN SURG ONCOL, V6, P279, DOI 10.1007/s10434-999-0279-x; Buchholz TA, 2003, CANCER J, V9, P33, DOI 10.1097/00130404-200301000-00007; Castilla C, 2006, ENDOCRINOLOGY, V147, P4960, DOI 10.1210/en.2006-0502; Cengiz E, 2010, MOL BIOL REP, V37, P1269, DOI 10.1007/s11033-009-9501-y; Chang JS, 2004, CLIN EXP PHARMACOL P, V31, P716, DOI 10.1111/j.1440-1681.2004.04078.x; Chou TC, 1984, ADV ENZYME REGUL, V22, P22; Chua BT, 2000, J BIOL CHEM, V275, P5131, DOI 10.1074/jbc.275.7.5131; Chun EY, 2004, BIOCHEM BIOPH RES CO, V315, P771, DOI 10.1016/j.bbrc.2004.01.118; Coutinho EM, 2002, CONTRACEPTION, V65, P259, DOI 10.1016/S0010-7824(02)00294-9; Dent S, 2008, BREAST CANCER RES TR, V108, P319, DOI 10.1007/s10549-007-9610-z; Fahy BN, 2005, CANCER CHEMOTH PHARM, V56, P46, DOI 10.1007/s00280-004-0944-5; Galmarini CM, 2001, LEUKEMIA, V15, P875, DOI 10.1038/sj.leu.2402114; GILBERT NE, 1995, LIFE SCI, V57, P61, DOI 10.1016/0024-3205(95)00243-Y; GLASER R, 1989, P NATL ACAD SCI USA, V86, P9524, DOI 10.1073/pnas.86.23.9524; Han JY, 2003, MED ONCOL, V20, P355, DOI 10.1385/MO:20:4:355; Hilbig A, 2008, EXPERT REV ANTICANC, V8, P511, DOI 10.1586/14737140.8.4.511; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Humbert M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009430; Jiang JH, 2009, INT J MOL MED, V24, P69, DOI 10.3892/ijmm_00000208; Karakas T, 1998, ANN ONCOL, V9, P159, DOI 10.1023/A:1008255511404; Kitada S, 2003, J MED CHEM, V46, P4259, DOI 10.1021/jm030190z; Labi V, 2008, CELL DEATH DIFFER, V15, P977, DOI 10.1038/cdd.2008.37; Lo KW, 2001, CANCER RES, V61, P3877; Lorusso D, 2006, ANN ONCOL, V17, pV188, DOI 10.1093/annonc/mdj979; Macoska JA, 2008, PHARMACOL RES, V58, P323, DOI 10.1016/j.phrs.2008.09.005; Mandic A, 2002, MOL CELL BIOL, V22, P3003, DOI 10.1128/MCB.22.9.3003-3013.2002; Meng Y, 2008, MOL CANCER THER, V7, P2192, DOI 10.1158/1535-7163.MCT-08-0333; Mohammad RM, 2005, PANCREAS, V31, P317, DOI 10.1097/01.mpa.0000179731.46210.01; Mohammad RM, 2005, MOL CANCER THER, V4, P13; Natale R, 2005, LUNG CANCER-J IASLC, V50, pS2, DOI 10.1016/S0169-5002(05)81549-1; Oliver CL, 2005, MOL CANCER THER, V4, P23; Oliver CL, 2004, CLIN CANCER RES, V10, P7757, DOI 10.1158/1078-0432.CCR-04-0551; PLUNKETT W, 1995, SEMIN ONCOL, V22, P3; Sartorius UA, 2002, INT J CANCER, V97, P584, DOI 10.1002/ijc.10096; Scaffidi C, 1998, EMBO J, V17, P1675, DOI 10.1093/emboj/17.6.1675; Schniewind B, 2004, INT J CANCER, V109, P182, DOI 10.1002/ijc.11679; Shi X, 2002, ONCOLOGY-BASEL, V62, P354, DOI 10.1159/000065068; Shieh JJ, 2009, J INVEST DERMATOL, V129, P2497, DOI 10.1038/jid.2009.83; Slee EA, 1999, J CELL BIOL, V144, P281, DOI 10.1083/jcb.144.2.281; Tan YF, 2006, J BIOL CHEM, V281, P16016, DOI 10.1074/jbc.M601299200; Volate SR, 2010, MOL CANCER THER, V9, P461, DOI 10.1158/1535-7163.MCT-09-0507; Voutsadakis IA, 2011, WORLD J GASTRO ONCOL, V3, P153, DOI 10.4251/wjgo.v3.i11.153; Williams J, 2005, GYNECOL ONCOL, V96, P287, DOI 10.1016/j.ygyno.2004.10.026; Wong WC, 2008, BIOL DIRECT, V3, DOI 10.1186/1745-6150-3-23; Youle RJ, 2008, NAT REV MOL CELL BIO, V9, P47, DOI 10.1038/nrm2308; Yu B, 2010, J EXP CLIN CANC RES, V29, DOI 10.1186/1756-9966-29-107; Zhang MC, 2007, LIFE SCI, V80, P767, DOI 10.1016/j.lfs.2006.11.004; Zhang MC, 2003, BIOCHEM PHARMACOL, V66, P93, DOI 10.1016/S0006-2952(03)00248-X	52	26	26	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 4	2012	7	12							e50786	10.1371/journal.pone.0050786	http://dx.doi.org/10.1371/journal.pone.0050786			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	051EQ	23226540	Green Published, Green Submitted, gold			2022-12-27	WOS:000312108500031
J	Bielekova, B; Komori, M; Xu, QG; Reich, DS; Wu, TX				Bielekova, Bibiana; Komori, Mika; Xu, Quangang; Reich, Daniel S.; Wu, Tianxia			Cerebrospinal Fluid IL-12p40, CXCL13 and IL-8 as a Combinatorial Biomarker of Active Intrathecal Inflammation	PLOS ONE			English	Article							CELL-ATTRACTING CHEMOKINE-1; BIOLOGICALLY INACTIVE MOLECULE; ECTOPIC LYMPHOID FOLLICLES; MESSENGER-RNA EXPRESSION; MULTIPLE-SCLEROSIS; P40 HOMODIMER; T-CELLS; SJOGRENS-SYNDROME; GERMINAL CENTER; UP-REGULATION	Diagnosis and management of the neuroinflammatory diseases of the central nervous system (CNS) are hindered by the lack of reliable biomarkers of active intrathecal inflammation. We hypothesized that measuring several putative inflammatory biomarkers simultaneously will augment specificity and sensitivity of the biomarker to the clinically useful range. Based on our pilot experiment in which we measured 18 inflammatory biomarkers in 10-fold concentrated cerebrospinal fluid (CSF) derived from 16 untreated patients with highly active multiple sclerosis (MS) we selected a combination of three CSF biomarkers, IL-12p40, CXCL13 and IL-8, for further validation. Concentrations of IL-12p40, CXCL13 and IL-8 were determined in a blinded fashion in CSF samples from an initial cohort (n = 72) and a confirmatory cohort (n = 167) of prospectively collected, untreated subjects presenting for a diagnostic work-up of possible neuroimmunological disorder. Diagnostic conclusion was based on a thorough clinical workup, which included laboratory assessment of the blood and CSF, neuroimaging and longitudinal follow-up. Receiver operating characteristic (ROC) curve analysis in conjunction with principal component analysis (PCA), which was used to combine information from all three biomarkers, assessed the diagnostic value of measured biomarkers. Each of the three biomarkers was significantly increased in MS and other inflammatory neurological disease (OIND) in comparison to non-inflammatory neurological disorder patients (NIND) at least in one cohort. However, considering all three biomarkers together improved accuracy of predicting the presence of intrathecal inflammation to the consistently good to excellent range (area under the ROC curve = 0.868-0.924). Future clinical studies will determine if a combinatorial biomarker consisting of CSF IL-12p40, CXCL13 and IL-8 provides utility in determining the presence of active intrathecal inflammation in diagnostically uncertain cases and in therapeutic development and management.	[Bielekova, Bibiana; Komori, Mika; Xu, Quangang; Reich, Daniel S.] NINDS, Neuroimmunol Branch, NIH, Bethesda, MD 20892 USA; [Wu, Tianxia] NINDS, Clin Neurosci Program, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Neurological Disorders & Stroke (NINDS); National Institutes of Health (NIH) - USA; NIH National Institute of Neurological Disorders & Stroke (NINDS)	Bielekova, B (corresponding author), NINDS, Neuroimmunol Branch, NIH, Bldg 36,Rm 4D04, Bethesda, MD 20892 USA.	Bibi.Bielekova@nih.gov	Bielekova, Bibiana/V-1452-2017; Bielekova, Bibiana/AAA-8115-2020; Reich, Daniel S./E-5701-2010	Bielekova, Bibiana/0000-0002-0959-9430; Bielekova, Bibiana/0000-0002-0959-9430; Reich, Daniel S./0000-0002-2628-4334; Komori, Mika/0000-0003-1887-1296	Intramural Research program of the NINDS/NIH; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [ZIANS003055, ZIANS003119] Funding Source: NIH RePORTER	Intramural Research program of the NINDS/NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	The study was supported by the Intramural Research program of the NINDS/NIH. The collection of WMS cohort was supported from donor money to the Waddell Center for MS at the University of Cincinnati. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdi K, 2002, SCAND J IMMUNOL, V56, P1, DOI 10.1046/j.1365-3083.2002.01101.x; ALOISI F, 1992, J IMMUNOL, V149, P2358; Amft N, 2001, ARTHRITIS RHEUM-US, V44, P2633, DOI 10.1002/1529-0131(200111)44:11<2633::AID-ART443>3.0.CO;2-9; Androdias G, 2010, ANN NEUROL, V68, P465, DOI 10.1002/ana.22054; Asano T, 2010, SCAND J IMMUNOL, V71, P447, DOI 10.1111/j.1365-3083.2010.02391.x; Bielekova B, 2011, NEUROLOGY, V77, P1877, DOI 10.1212/WNL.0b013e318239f7ef; Brettschneider J, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011986; Carlsen HS, 2004, BLOOD, V104, P3021, DOI 10.1182/blood-2004-02-0701; Cooper AM, 2007, TRENDS IMMUNOL, V28, P33, DOI 10.1016/j.it.2006.11.002; Cross AH, 2006, J NEUROIMMUNOL, V180, P63, DOI 10.1016/j.jneuroim.2006.06.029; Dobreva ZG, 2008, CYTOKINE, V43, P76, DOI 10.1016/j.cyto.2008.04.003; Falkenhagen KM, 2005, AM J OPHTHALMOL, V140, P335, DOI 10.1016/j.ajo.2005.02.026; Frischer JM, 2009, BRAIN; GERMANN T, 1995, IMMUNOL TODAY, V16, P500, DOI 10.1016/0167-5699(95)80035-2; Grund B, 2010, CURR OPIN HIV AIDS, V5, P473, DOI 10.1097/COH.0b013e32833ed742; Holscher C, 2004, MED MICROBIOL IMMUN, V193, P1, DOI 10.1007/s00430-003-0186-x; Ishizu T, 2005, BRAIN, V128, P988, DOI 10.1093/brain/awh453; Jana M, 2009, GLIA, V57, P1553, DOI 10.1002/glia.20869; Jana M, 2009, IMMUNOLOGY, V127, P312, DOI 10.1111/j.1365-2567.2008.02985.x; Kanangat S, 1996, J IMMUNOL, V156, P1110; Katsumata Y, 2007, J RHEUMATOL, V34, P2010; Khademi M, 2010, MULT SCLER; Kichian K, 1996, J IMMUNOL, V157, P2851; Kleine TO, 2003, BRAIN RES BULL, V61, P327, DOI 10.1016/S0361-9230(03)00096-0; Klinke DJ, 2006, J THEOR BIOL, V240, P323, DOI 10.1016/j.jtbi.2005.09.022; Krumbholz M, 2006, BRAIN, V129, P200, DOI 10.1093/brain/awh680; Kushi H, 2003, ACTA NEUROCHIR SUPPL, V86, P347; Pinto VLL, 2011, BRAZ J INFECT DIS, V15, P156, DOI 10.1590/S1413-86702011000200011; LING P, 1995, J IMMUNOL, V154, P116; Luther SA, 2003, J EXP MED, V197, P1191, DOI 10.1084/jem.20021294; Magliozzi R, 2004, J NEUROIMMUNOL, V148, P11, DOI 10.1016/j.jneuroim.2003.10.056; Magliozzi R, 2007, BRAIN, V130, P1089, DOI 10.1093/brain/awm038; Manzo A, 2005, EUR J IMMUNOL, V35, P1347, DOI 10.1002/eji.200425830; Marra CM, 2010, SEX TRANSM DIS, V37, P283, DOI 10.1097/OLQ.0b013e3181d877a1; McDonald WI, 2001, ANN NEUROL, V50, P121, DOI 10.1002/ana.1032; Mellergard J, 2010, MULT SCLER J, V16, P208, DOI 10.1177/1352458509355068; Meraouna A, 2006, BLOOD, V108, P432, DOI 10.1182/blood-2005-06-2383; Ohmatsu H, 2007, J INVEST DERMATOL, V127, P2466, DOI 10.1038/sj.jid.5700873; Ortonne N, 2007, AM J SURG PATHOL, V31, P1068, DOI 10.1097/PAS.0b013e31802df4ef; Perry JSA, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3004140; Piccotti JR, 1997, J IMMUNOL, V158, P643; Pranzatelli MR, 2012, J NEUROIMMUNOL, V243, P81, DOI 10.1016/j.jneuroim.2011.12.014; Ragheb S, 2011, MULT SCLER J, V17, P819, DOI 10.1177/1352458511398887; Rudick RA, 1999, J NEUROIMMUNOL, V93, P8, DOI 10.1016/S0165-5728(98)00174-X; Rupprecht TA, 2009, J NEUROINFLAMM, V6, DOI 10.1186/1742-2094-6-42; Russell TD, 2003, J IMMUNOL, V171, P6866, DOI 10.4049/jimmunol.171.12.6866; Salomonsson S, 2002, SCAND J IMMUNOL, V55, P336, DOI 10.1046/j.1365-3083.2002.01058.x; Sato S, 2009, J CLIN NEUROSCI, V16, P1698, DOI 10.1016/j.jocn.2009.03.044; Segal BM, 2008, LANCET NEUROL, V7, P796, DOI 10.1016/S1474-4422(08)70173-X; Sellebjerg F, 2009, NEUROLOGY, V73, P2003, DOI 10.1212/WNL.0b013e3181c5b457; Shi KR, 2001, J IMMUNOL, V166, P650, DOI 10.4049/jimmunol.166.1.650; Shimozato O, 2006, IMMUNOLOGY, V117, P22, DOI 10.1111/j.1365-2567.2005.02257.x; Slight SR, 2011, CYTOKINE, V55, P372, DOI 10.1016/j.cyto.2011.05.017; Smith J, 2003, DEVELOPMENT, V130, P1, DOI 10.1242/dev.00209; Soreide K, 2011, ANN SURG, V253, P27, DOI 10.1097/SLA.0b013e318204a892; van Burgel ND, 2011, J CLIN MICROBIOL, V49, P2027, DOI 10.1128/JCM.00084-11; van de Pavert SA, 2009, NAT IMMUNOL, V10, P1193, DOI 10.1038/ni.1789; Vissers JLM, 2001, EUR J IMMUNOL, V31, P1544, DOI 10.1002/1521-4141(200105)31:5<1544::AID-IMMU1544>3.0.CO;2-I; WINDHAGEN A, 1995, J EXP MED, V182, P1985, DOI 10.1084/jem.182.6.1985; Yoshimoto T, 1998, J IMMUNOL, V160, P588; Zhong XN, 2011, J NEUROIMMUNOL, V240, P104, DOI 10.1016/j.jneuroim.2011.10.001; ZWEIG MH, 1993, CLIN CHEM, V39, P561	62	56	58	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 30	2012	7	11							e48370	10.1371/journal.pone.0048370	http://dx.doi.org/10.1371/journal.pone.0048370			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	054WM	23226202	gold, Green Published, Green Submitted			2022-12-27	WOS:000312376100011
J	Machault, V; Vignolles, C; Pages, F; Gadiaga, L; Tourre, YM; Gaye, A; Sokhna, C; Trape, JF; Lacaux, JP; Rogier, C				Machault, Vanessa; Vignolles, Cecile; Pages, Frederic; Gadiaga, Libasse; Tourre, Yves M.; Gaye, Abdoulaye; Sokhna, Cheikh; Trape, Jean-Francois; Lacaux, Jean-Pierre; Rogier, Christophe			Risk Mapping of Anopheles gambiae s.l. Densities Using Remotely-Sensed Environmental and Meteorological Data in an Urban Area: Dakar, Senegal	PLOS ONE			English	Article							MOSQUITO LARVAL HABITATS; DAR-ES-SALAAM; ENTOMOLOGICAL INOCULATION RATES; SUB-SAHARAN AFRICA; MALARIA TRANSMISSION; SPATIAL-DISTRIBUTION; SOURCE REDUCTION; BREEDING SITES; WESTERN KENYA; DETERMINANTS	Introduction: High malaria transmission heterogeneity in an urban environment is basically due to the complex distribution of Anopheles larval habitats, sources of vectors. Understanding 1) the meteorological and ecological factors associated with differential larvae spatio-temporal distribution and 2) the vectors dynamic, both may lead to improving malaria control measures with remote sensing and high resolution data as key components. In this study a robust operational methodology for entomological malaria predictive risk maps in urban settings is developed. Methods: The Tele-epidemiology approach, i.e., 1) intensive ground measurements (Anopheles larval habitats and Human Biting Rate, or HBR), 2) selection of the most appropriate satellite data (for mapping and extracting environmental and meteorological information), and 3) use of statistical models taking into account the spatio-temporal data variability has been applied in Dakar, Senegal. Results: First step was to detect all water bodies in Dakar. Secondly, environmental and meteorological conditions in the vicinity of water bodies favoring the presence of Anopheles gambiae s.l. larvae were added. Then relationship between the predicted larval production and the field measured HBR was identified, in order to generate An. gambiae s.l. HBR high resolution maps (daily, 10-m pixel in space). Discussion and Conclusion: A robust operational methodology for dynamic entomological malaria predictive risk maps in an urban setting includes spatio-temporal variability of An. gambiae s.l. larval habitats and An. gambiae s.l. HBR. The resulting risk maps are first examples of high resolution products which can be included in an operational warning and targeting system for the implementation of vector control measures.	[Machault, Vanessa; Pages, Frederic; Rogier, Christophe] IRBA, Dept Infectiol Terrain, Equipe Malad Emergentes & Moust 7, URMITE,UMR6236, Marseille, France; [Machault, Vanessa; Lacaux, Jean-Pierre] Univ Toulouse 3, Lab Aerol, OMP, F-31062 Toulouse, France; [Machault, Vanessa; Vignolles, Cecile] CNES, Direct Strategie, Toulouse, France; [Machault, Vanessa; Vignolles, Cecile] CNES, Programmes Terre Environm Climat, Toulouse, France; [Gadiaga, Libasse; Gaye, Abdoulaye; Sokhna, Cheikh; Trape, Jean-Francois] IRD, Unite Paludol Afrotropicale, Equipe Malad Emergentes & Moust 7, URMITE,UMR6236, Dakar, Senegal; [Tourre, Yves M.] METEO France, Direct Climatol, Toulouse, France; [Tourre, Yves M.] Columbia Univ, LDEO, Palisades, NY USA; [Rogier, Christophe] Inst Pasteur Madagascar, Antananarivo, Madagascar	UDICE-French Research Universities; Aix-Marseille Universite; Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); Institut de Recherche pour le Developpement (IRD); Universite de Toulouse; Universite Toulouse III - Paul Sabatier; Centre National de la Recherche Scientifique (CNRS); Institut de Recherche pour le Developpement (IRD); Meteo France; Columbia University; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Madagascar	Machault, V (corresponding author), IRBA, Dept Infectiol Terrain, Equipe Malad Emergentes & Moust 7, URMITE,UMR6236, Marseille, France.	vanessamachault@yahoo.com.br	ROGIER, Christophe/C-2550-2008		Direction Generale de l'Armement (DGA) [07CO402]; Centre National d'Etudes Spatiales (CNES)	Direction Generale de l'Armement (DGA); Centre National d'Etudes Spatiales (CNES)(Centre National D'etudes Spatiales)	This study received financial support from the Direction Generale de l'Armement (DGA - Contrat d'Objectif no 07CO402) and the Centre National d'Etudes Spatiales (CNES). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The CNES ISIS program provided access to high spatial resolution SPOT5 images.	Amek N, 2012, PARASITE VECTOR, V5, DOI 10.1186/1756-3305-5-86; [Anonymous], 1968, ANOPHELINAE AFR S SA; Awolola T. S., 2007, Journal of Vector Borne Diseases, V44, P241; Awono-Ambene HP, 1999, PARASITE, V6, P179, DOI 10.1051/parasite/1999062179; Baragatti M, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-13; Bayoh MN, 2003, B ENTOMOL RES, V93, P375, DOI 10.1079/BER2003259; Beck LR, 2000, EMERG INFECT DIS, V6, P217, DOI 10.3201/eid0603.000301; Bergquist NR, 2001, ACTA TROP, V79, P13, DOI 10.1016/S0001-706X(01)00099-7; Bob NS, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009817; Carter R, 2000, B WORLD HEALTH ORGAN, V78, P1401; Ceccato P., 2005, Parassitologia (Rome), V47, P81; CHARLWOOD JD, 1989, ANN TROP MED PARASIT, V83, P569, DOI 10.1080/00034983.1989.11812389; CHINERY WA, 1984, J TROP MED HYG, V87, P75; Dambach P, 2009, GLOB HLTH ACTION, V2; Dambach P, 2012, INT J HEALTH GEOGR, V11, DOI 10.1186/1476-072X-11-8; De Castro MC, 2004, AM J TROP MED HYG, V71, P103, DOI 10.4269/ajtmh.2004.71.103; Diabate A, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-5; Diallo A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031100; Diallo S, 2000, Sante, V10, P221; Diallo S, 1998, B SOC PATHOL EXOT, V91, P259; Eisele TP, 2003, MALARIA J, V2, DOI 10.1186/1475-2875-2-44; Ernst KC, 2009, TROP MED INT HEALTH, V14, P1258, DOI 10.1111/j.1365-3156.2009.02370.x; Fillinger U, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-20; Gadiaga L, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-312; Gillies M, 1987, ANOPHELINAE AFRICA S; Gu WD, 2005, AM J TROP MED HYG, V73, P546, DOI 10.4269/ajtmh.2005.73.546; Gu WD, 2006, P NATL ACAD SCI USA, V103, P17560, DOI 10.1073/pnas.0608452103; Guthmann JP, 2002, TROP MED INT HEALTH, V7, P518, DOI 10.1046/j.1365-3156.2002.00883.x; Hay SI, 1999, TROP MED INT HEALTH, V4, P58, DOI 10.1046/j.1365-3156.1999.00355.x; Hay SI, 2000, T ROY SOC TROP MED H, V94, P113, DOI 10.1016/S0035-9203(00)90246-3; Henry JB, 2004, THESIS U L PASTEUR S, V1; Henry M, 2006, AM J TROP MED HYG, V75, P146, DOI 10.4269/ajtmh.2006.75.146; Imbahale SS, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-81; Jacob BG, 2005, INT J REMOTE SENS, V26, P523, DOI 10.1080/01431160512331299306; Jarvis A, 2008, HOLE FILLED SEAMLESS; Keiser J, 2004, AM J TROP MED HYG, V71, P118, DOI 10.4269/ajtmh.2004.71.118; Killeen GF, 2002, LANCET INFECT DIS, V2, P618, DOI 10.1016/S1473-3099(02)00397-3; Kitron U, 2000, PARASITOL TODAY, V16, P324, DOI 10.1016/S0169-4758(00)01708-7; KITRON U, 1989, REV INFECT DIS, V11, P391; Kolaczinski K, 2007, T ROY SOC TROP MED H, V101, P852, DOI 10.1016/j.trstmh.2007.04.003; KRUSE FA, 1988, REMOTE SENS ENVIRON, V24, P31, DOI 10.1016/0034-4257(88)90004-1; Kulkarni MA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009396; Lacaux JP, 2007, REMOTE SENS ENVIRON, V106, P66, DOI 10.1016/j.rse.2006.07.012; Land Processes DAAC, 2008, MODIS REPR TOOL US M; Louis J P, 1988, Med Trop (Mars), V48, P127; Machault V, 2011, GEOSPATIAL HEALTH, V5, P151, DOI 10.4081/gh.2011.167; Machault V, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-252; Machault V, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-138; Maharaj R, 2005, SAMJ S AFR MED J, V95, P871; MANGA L, 1993, J MED ENTOMOL, V30, P936, DOI 10.1093/jmedent/30.5.936; Marechal F, 2008, GEOSPATIAL HEALTH, V3, P1; Mason SJ, 2002, Q J ROY METEOR SOC, V128, P2145, DOI 10.1256/003590002320603584; Matthys B, 2006, AM J TROP MED HYG, V75, P1223, DOI 10.4269/ajtmh.2006.75.1223; McFeeters SK, 1996, INT J REMOTE SENS, V17, P1425, DOI 10.1080/01431169608948714; Mushinzimana E, 2006, MALARIA J, V5, DOI 10.1186/1475-2875-5-13; Omlin FX, 2007, AM J TROP MED HYG, V77, P264, DOI 10.4269/ajtmh.2007.77.264; Patz JA, 2004, ENVIRON HEALTH PERSP, V112, P1092, DOI 10.1289/ehp.6877; Peterson I, 2009, AM J TROP MED HYG, V81, P944, DOI 10.4269/ajtmh.2009.08-0662; PNLP, 2010, PROGR NAT LUTT PAL R; PNLP, 2010, PROGR NAT LUTT PAL P; Raghavendra K, 2011, PARASITOL RES, V108, P757, DOI 10.1007/s00436-010-2232-0; ROBERT V, 1993, TROP MED PARASITOL, V44, P14; Robert V, 2003, AM J TROP MED HYG, V68, P169, DOI 10.4269/ajtmh.2003.68.169; Rogers DJ, 2002, NATURE, V415, P710, DOI 10.1038/415710a; Rouse Haas, 1973, MONITORING VERNAL AD, DOI DOI 10.1002/MRM.26868; Sabatinelli G., 1986, Parassitologia (Rome), V28, P33; Sattler MA, 2005, MALARIA J, V4, DOI 10.1186/1475-2875-4-4; Sogoba N, 2007, GEOSPATIAL HEALTH, V1, P213, DOI 10.4081/gh.2007.269; Sogoba N, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-205; Staedke SG, 2003, AM J TROP MED HYG, V69, P244, DOI 10.4269/ajtmh.2003.69.244; Thomson MC, 1996, ANN TROP MED PARASIT, V90, P243, DOI 10.1080/00034983.1996.11813050; Tia E, 2006, Bull Soc Pathol Exot, V99, P278; TOURE YT, 1994, GENETICA, V94, P213, DOI 10.1007/BF01443435; TRAPE JF, 1992, AM J TROP MED HYG, V47, P181, DOI 10.4269/ajtmh.1992.47.181; TRAPE JF, 1987, T ROY SOC TROP MED H, V81, P10, DOI 10.1016/0035-9203(87)90472-X; TUCKER CJ, 1979, REMOTE SENS ENVIRON, V8, P127, DOI 10.1016/0034-4257(79)90013-0; United Nations, 2003, WORD URB PROSP 2007; VERCRUYSSE J, 1985, J ANIM ECOL, V54, P343, DOI 10.2307/4482; Vignolles C, 2009, GEOSPATIAL HEALTH, V3, P211, DOI 10.4081/gh.2009.221; Wang SJ, 2005, MALARIA J, V4, DOI 10.1186/1475-2875-4-40; Watson K., 1985, P INT S REM SENS ENV; WHO, 2012, INT POS STAT ROL LAR; World Health Organization, 2012, HDB INT VECT MAN; Xu HQ, 2006, INT J REMOTE SENS, V27, P3025, DOI 10.1080/01431160600589179; Yadouleton AWM, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-103; Yohannes M, 2005, TROP MED INT HEALTH, V10, P1274, DOI 10.1111/j.1365-3156.2005.01512.x	86	30	33	0	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 30	2012	7	11							e50674	10.1371/journal.pone.0050674	http://dx.doi.org/10.1371/journal.pone.0050674			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	054WM	23226351	Green Published, gold			2022-12-27	WOS:000312376100162
J	Omori, R; Cowling, BJ; Nishiura, H				Omori, Ryosuke; Cowling, Benjamin J.; Nishiura, Hiroshi			How Is Vaccine Effectiveness Scaled by the Transmission Dynamics of Interacting Pathogen Strains with Cross-Protective Immunity?	PLOS ONE			English	Article							PNEUMOCOCCAL CONJUGATE VACCINE; STREPTOCOCCUS-PNEUMONIAE; NASOPHARYNGEAL CARRIAGE; LONGITUDINAL HOUSEHOLD; ENTEROVIRUS 71; MOUTH-DISEASE; EFFICACY; POPULATION; INFECTION; DESIGNS	Background: Many novel vaccines can cover only a fraction of all antigenic types of a pathogen. Vaccine effectiveness (VE) in the presence of interactions between vaccine strains and others is complicated by the interacting transmission dynamics among all strains. The present study investigated how the VE estimates measured in the field, based on estimated odds ratio or relative risks, are scaled by vaccination coverage and the transmission dynamics in the presence of cross-protective immunity between two strains, i.e. vaccine and non-vaccine strains. Methodology/Principal Findings: Two different types of epidemiological models, i.e. with and without re-infection by the same antigenic type, were investigated. We computed the relative risk of infection and the odds ratio of vaccination, the latter of which has been measured by indirect cohort method as applied to vaccine effectiveness study of Streptococcus pneumoniae. The VE based on the relative risk was less sensitive to epidemiological dynamics such as cross-protective immunity and vaccination coverage than the VE calculated from the odds ratio, and this was especially the case for the model without re-infection. Vaccine-induced (cross-protective) immunity against a non-vaccine strain appeared to yield the highest impact on the VE estimate calculated from the odds ratio of vaccination. Conclusion: It is essential to understand the transmission dynamics of non-vaccine strains so that epidemiological methods can appropriately measure both the direct and indirect population impact of vaccination. For pathogens with interacting antigenic types, the most valid estimates of VE, that are unlikely to be biased by the transmission dynamics, may be obtained from longitudinal prospective studies that permit estimation of the VE based on the relative risk of infection among vaccinated compared to unvaccinated individuals.	[Omori, Ryosuke; Cowling, Benjamin J.; Nishiura, Hiroshi] Univ Hong Kong, Sch Publ Hlth, Hong Kong, Hong Kong, Peoples R China; [Nishiura, Hiroshi] Japan Sci & Technol Agcy, Kawaguchi, Saitama, Japan	University of Hong Kong; Japan Science & Technology Agency (JST)	Nishiura, H (corresponding author), Univ Hong Kong, Sch Publ Hlth, Hong Kong, Hong Kong, Peoples R China.	nishiura@hku.hk	Cowling, Benjamin John/C-4263-2009	Cowling, Benjamin John/0000-0002-6297-7154; Nishiura, Hiroshi/0000-0003-0941-8537	Japan Science and Technology Agency (JST) PRESTO program; Harvard Center for Communicable Disease Dynamics from the National Institute of General Medical Sciences [U54 GM088558]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [U54GM088558] Funding Source: NIH RePORTER	Japan Science and Technology Agency (JST) PRESTO program(Japan Science & Technology Agency (JST)); Harvard Center for Communicable Disease Dynamics from the National Institute of General Medical Sciences; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	H. Nishiura received funding support from the Japan Science and Technology Agency (JST) PRESTO program. This work also received financial support from the Harvard Center for Communicable Disease Dynamics from the National Institute of General Medical Sciences (Grant no. U54 GM088558). The funding bodies were not involved in the collection, analysis, and interpretation of data, the writing of the paper or the decision to submit for publication.	Andrews N, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028435; [Anonymous], 2008, WORLD POP PROSP 2008; Barricarte A, 2007, CLIN INFECT DIS, V44, P1436, DOI 10.1086/516779; BROOME CV, 1980, NEW ENGL J MED, V303, P549, DOI 10.1056/NEJM198009043031003; Choi YH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026190; DIETZ K, 1979, J MATH BIOL, V8, P291, DOI 10.1007/BF00276314; Ejima K, 2012, INT J BIOL SCI, V8, P620, DOI 10.7150/ijbs.4329; Goldblatt D, 2005, J INFECT DIS, V192, P387, DOI 10.1086/431524; HABER M, 1991, INT J EPIDEMIOL, V20, P300, DOI 10.1093/ije/20.1.300; Halloran ME, 1997, AM J EPIDEMIOL, V146, P789; Halloran ME., 2010, DESIGN ANAL VACCINE; Hethcote H., 1996, MODELS INFECT HUMAN, V215, P238, DOI 10.1017/CBO9780511662935.030; Hussain M, 2005, EPIDEMIOL INFECT, V133, P891, DOI 10.1017/S0950268805004012; Jit M, 2010, J INFECTION, V61, P114, DOI 10.1016/j.jinf.2010.04.008; Lamb KE, 2011, J COMPUT APPL MATH, V235, P1812, DOI 10.1016/j.cam.2010.03.019; Lipsitch M, 1997, P NATL ACAD SCI USA, V94, P6571, DOI 10.1073/pnas.94.12.6571; Lipsitch M, 2012, EPIDEMIOLOGY, V23, P510, DOI 10.1097/EDE.0b013e31824f2f32; Ma E, 2011, PEDIATR INFECT DIS J, V30, P675, DOI 10.1097/INF.0b013e3182116e95; Mahon BE, 2006, VACCINE, V24, P2514, DOI 10.1016/j.vaccine.2005.12.025; MCLEAN AR, 1995, P ROY SOC B-BIOL SCI, V261, P389, DOI 10.1098/rspb.1995.0164; McMinn PC, 2012, CURR OPIN VIROL, V2, P199, DOI 10.1016/j.coviro.2012.02.009; Mercer GN, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-S1-S11; Mizuta K, 2009, VACCINE, V27, P3153, DOI 10.1016/j.vaccine.2009.03.060; Nishiura H, 2011, EMERG INFECT DIS, V17, P746, DOI [10.3201/eid1704.100525, 10.3201/eid1706.100525]; Orenstein EW, 2007, INT J EPIDEMIOL, V36, P623, DOI 10.1093/ije/dym021; Restif O, 2007, J R SOC INTERFACE, V4, P143, DOI 10.1098/rsif.2006.0167; Ruckinger S, 2010, VACCINE, V28, P5012, DOI 10.1016/j.vaccine.2010.05.021; Wang Y, 2011, EPIDEMIOLOGY, V22, P781, DOI 10.1097/EDE.0b013e318231d67a; Weinberger DM, 2011, LANCET, V378, P1962, DOI 10.1016/S0140-6736(10)62225-8	29	16	16	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 30	2012	7	11							e50751	10.1371/journal.pone.0050751	http://dx.doi.org/10.1371/journal.pone.0050751			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	054WM	23226374	Green Submitted, Green Published, gold			2022-12-27	WOS:000312376100185
J	Sueblinvong, T; Ghebre, R; Iizuka, Y; Pambuccian, SE; Vogel, RI; Skubitz, APN; Bazzaro, M				Sueblinvong, Thanasak; Ghebre, Rahel; Iizuka, Yoshie; Pambuccian, Stefan E.; Vogel, Rachel Isaksson; Skubitz, Amy P. N.; Bazzaro, Martina			Establishment, Characterization and Downstream Application of Primary Ovarian Cancer Cells Derived from Solid Tumors	PLOS ONE			English	Article							SURFACE EPITHELIAL-CELLS; PACLITAXEL; PERITONEAL; CISPLATIN; RECEPTOR; CULTURE	Ovarian cancer is the deadliest of the gynecological diseases and the fifth cause of cancer death among American women. This is mainly due to the lack of prognostic tools capable of detecting early stages of ovarian cancer and to the high rate of resistance to the current chemotherapeutic regimens. In this scenario the overall 5-year survival rate for ovarian cancer patients diagnosed at late stage is less than 25%. Abnormalities associated with the malignant phenotype and the mechanisms of tumor progression are not clearly understood. In vitro studies are necessary, yet have been hampered due to the limitations accompanied with the use of ovarian cancer cell lines and the heterogeneity of the ovarian cancer cell population derived from ascites fluids. In this study we present a simple, rapid and reproducible method for the isolation and characterization of ovarian cancer cells from solid tumor tissue and show that enzymatic digestion for 30 minutes with dispase II results in the most effective recovery of viable epithelial ovarian cancer (EOC) cells. The resulting cancer (EOC) cell preparations demonstrate a significant yield, high levels of viability and are fibroblast-free. They grow for up to six passages and retain the capacity of forming spheroids-like structures in agarose. In addition, they can be genetically manipulated and used for drug screening, thus rendering them highly suitable for downstream applications. Notably, isolation of ovarian cancer cells from solid specimens using this method has the advantage of allowing for isolation of cancer cells from early stages of ovarian cancer as well as obtaining cells from defined either primary and/or metastatic ovarian cancer sites. Thus, these cells are highly suitable for investigations aimed at understanding ovarian cancer.	[Sueblinvong, Thanasak; Ghebre, Rahel; Iizuka, Yoshie; Bazzaro, Martina] Univ Minnesota, Dept Obstet, Minneapolis, MN USA; [Sueblinvong, Thanasak; Ghebre, Rahel; Iizuka, Yoshie; Bazzaro, Martina] Univ Minnesota, Dept Gynecol, Minneapolis, MN USA; [Sueblinvong, Thanasak; Ghebre, Rahel; Iizuka, Yoshie; Bazzaro, Martina] Univ Minnesota, Dept Womens Heath, Minneapolis, MN USA; [Pambuccian, Stefan E.; Skubitz, Amy P. N.] Univ Minnesota, Dept Lab Med & Pathol, Minneapolis, MN 55455 USA; [Iizuka, Yoshie; Vogel, Rachel Isaksson; Bazzaro, Martina] Univ Minnesota, Masonic Canc Ctr, Minneapolis, MN USA	University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities	Bazzaro, M (corresponding author), Univ Minnesota, Dept Obstet, Minneapolis, MN USA.	mbazzaro@umn.edu	Cavanaugh, Amy G/E-2272-2018	Cavanaugh, Amy G/0000-0001-7049-290X; Vogel, Rachel/0000-0003-0149-8464; Skubitz, Amy/0000-0003-4672-3450	Department of Defense Ovarian Cancer Research Program (OCRP) [OC093424]; Randy Shaver Cancer Research and Community Fund	Department of Defense Ovarian Cancer Research Program (OCRP); Randy Shaver Cancer Research and Community Fund	This work was supported by the Department of Defense Ovarian Cancer Research Program (OCRP) OC093424 to MB and APNS and by the Randy Shaver Cancer Research and Community Fund to MB. The funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.	Armstrong Deborah, 2010, Clin Adv Hematol Oncol, V8, P675; Armstrong DK, 2002, ONCOLOGIST, V7, P20, DOI 10.1634/theoncologist.7-suppl_5-20; AUERSPERG N, 1994, LAB INVEST, V71, P510; Auersperg N, 2000, METH MOLEC MED, V39, P169; Auersperg N, 2001, ENDOCR REV, V22, P255, DOI 10.1210/er.22.2.255; Bast RC, 2010, NAT REV CLIN ONCOL, V7, P559, DOI 10.1038/nrclinonc.2010.152; Bazzaro M, 2008, CLIN CANCER RES, V14, P7340, DOI 10.1158/1078-0432.CCR-08-0642; Boylan KLM, 2011, INT J MOL SCI, V12, P1334, DOI 10.3390/ijms12021334; Bristow RE, 2007, GYNECOL ONCOL, V106, P476, DOI 10.1016/j.ygyno.2007.05.043; Burleson KM, 2006, J TRANSL MED, V4, DOI 10.1186/1479-5876-4-6; CANNISTRA SA, 1993, CANCER RES, V53, P3830; Casey RC, 2001, AM J PATHOL, V159, P2071, DOI 10.1016/S0002-9440(10)63058-1; Dong HP, 2008, NAT PROTOC, V3, P955, DOI 10.1038/nprot.2008.77; Dunfield Lesley D., 2002, Biol Proced Online, V4, P55; ERBA E, 1986, BRIT J CANCER, V54, P925, DOI 10.1038/bjc.1986.263; HIRTE HW, 1992, GYNECOL ONCOL, V44, P223, DOI 10.1016/0090-8258(92)90046-L; Iizuka YM, 2010, METHODS MOL BIOL, V612, P285, DOI 10.1007/978-1-60761-362-6_19; KRUK PA, 1990, LAB INVEST, V63, P132; Kurman RJ, 2011, HUM PATHOL, V42, P918, DOI 10.1016/j.humpath.2011.03.003; Masiakos PT, 1999, CLIN CANCER RES, V5, P3488; Okamoto S, 2009, ONCOL REP, V21, P1209, DOI 10.3892/or_00000343; Ordonez NG, 1998, AM J SURG PATHOL, V22, P1203, DOI 10.1097/00000478-199810000-00005; Scarberry KE, 2010, NANOMED-NANOTECHNOL, V6, P399, DOI 10.1016/j.nano.2009.11.003; Shepherd TG, 2006, NAT PROTOC, V1, P2643, DOI 10.1038/nprot.2006.328; Sherman-Baust CA, 2011, J OVARIAN RES, V4, DOI 10.1186/1757-2215-4-21; Valente MJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019337; VANNIEKERK CC, 1989, INT J CANCER, V43, P1065, DOI 10.1002/ijc.2910430619	27	16	17	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 30	2012	7	11							e50519	10.1371/journal.pone.0050519	http://dx.doi.org/10.1371/journal.pone.0050519			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	054WM	23226302	gold, Green Published, Green Submitted			2022-12-27	WOS:000312376100114
J	TeKippe, EM; Wylie, KM; Deych, E; Sodergren, E; Weinstock, G; Storch, GA				TeKippe, Erin McElvania; Wylie, Kristine M.; Deych, Elena; Sodergren, Erica; Weinstock, George; Storch, Gregory A.			Increased Prevalence of Anellovirus in Pediatric Patients with Fever	PLOS ONE			English	Article							TT VIRUS-INFECTION; HUMAN DNA VIRUS; CHICKEN-ANEMIA-VIRUS; MINI VIRUS; EARLY ACQUISITION; ENTIRE GENOMES; CORD BLOOD; CHILDREN; DISEASE; IDENTIFICATION	The Anelloviridae family consists of non-enveloped, circular, single-stranded DNA viruses. Three genera of anellovirus are known to infect humans, named TTV, TTMDV, and TTMV. Although anelloviruses were initially thought to cause non-A-G viral hepatitis, continued research has shown no definitive associations between anellovirus and human disease to date. Using high-throughput sequencing, we investigated the association between anelloviruses and fever in pediatric patients 2-36 months of age. We determined that although anelloviruses were present in a large number of specimens from both febrile and afebrile patients, they were more prevalent in the plasma and nasopharyngeal (NP) specimens of febrile patients compared to afebrile controls. Using PCR to detect each of the three species of anellovirus that infect humans, we found that anellovirus species TTV and TTMDV were more prevalent in the plasma and NP specimens of febrile patients compared to afebrile controls. This was not the case for species TTMV which was found in similar percentages of febrile and afebrile patient specimens. Analysis of patient age showed that the percentage of plasma and NP specimens containing anellovirus increased with age until patients were 19-24 months of age, after which the percentage of anellovirus positive patient specimens dropped. This trend was striking for TTV and TTMDV and very modest for TTMV in both plasma and NP specimens. Finally, as the temperature of febrile patients increased, so too did the frequency of TTV and TTMDV detection. Again, TTMV was equally present in both febrile and afebrile patient specimens. Taken together these data indicate that the human anellovirus species TTV and TTMDV are associated with fever in children, while the highly related human anellovirus TTMV has no association with fever.	[TeKippe, Erin McElvania; Storch, Gregory A.] Washington Univ, Sch Med, Dept Pediat, St Louis, MO 63110 USA; [Wylie, Kristine M.; Sodergren, Erica; Weinstock, George] Washington Univ, Sch Med, Genome Inst, St Louis, MO USA; [Deych, Elena] Washington Univ, Sch Med, Dept Med, St Louis, MO 63110 USA	Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL)	TeKippe, EM (corresponding author), Washington Univ, Sch Med, Dept Pediat, St Louis, MO 63110 USA.	emcelvania-tekippe@path.wustl.edu	Weinstock, George M/C-6314-2013	Weinstock, George M/0000-0002-2997-4592	National Human Genome Research Institute [U54 HG004968-01, 223169 54610]; National Institute of Allergy and Infectious Diseases [1UAH2AI083266-01]; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [U54HG004968] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [UH2AI083266] Funding Source: NIH RePORTER	National Human Genome Research Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	Funding for the project was from grants U54 HG004968-01 and 223169 54610 from the National Human Genome Research Institute, and grant number 1UAH2AI083266-01 from the National Institute of Allergy and Infectious Diseases. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Biagini P, 2001, J CLIN VIROL, V22, P91, DOI 10.1016/S1386-6532(01)00179-2; Biagini P, 2001, J GEN VIROL, V82, P379, DOI 10.1099/0022-1317-82-2-379; Biagini P, 2007, J GEN VIROL, V88, P2696, DOI 10.1099/vir.0.83071-0; Chung JY, 2007, EMERG INFECT DIS, V13, P791, DOI 10.3201/eid1305.061149; Colvin J, 2012, PEDIATRICS IN PRESS; Cone RW, 1996, J CLIN MICROBIOL, V34, P877, DOI 10.1128/JCM.34.4.877-881.1996; Crowther RA, 2003, J VIROL, V77, P13036, DOI 10.1128/JVI.77.24.13036-13041.2003; Deng XW, 2000, J MED VIROL, V62, P531, DOI 10.1002/1096-9071(200012)62:4&lt;531::AID-JMV20&gt;3.0.CO;2-C; Desai SM, 1999, J INFECT DIS, V179, P1242, DOI 10.1086/314735; Gallian P, 2000, J CLIN VIROL, V17, P43, DOI 10.1016/S1386-6532(00)00066-4; Gerner P, 2000, PEDIATR INFECT DIS J, V19, P1074, DOI 10.1097/00006454-200011000-00009; Gimenez-Barcons M, 1999, J HEPATOL, V30, P1028, DOI 10.1016/S0168-8278(99)80256-6; Goto K, 2000, TOHOKU J EXP MED, V191, P203, DOI 10.1620/tjem.191.203; Heim A, 2003, J MED VIROL, V70, P228, DOI 10.1002/jmv.10382; Hsieh SY, 1999, J CLIN MICROBIOL, V37, P1829, DOI 10.1128/JCM.37.6.1829-1831.1999; Ishikawa T, 1999, INFECTION, V27, P298; Ishimine P, 2006, PEDIATR CLIN N AM, V53, P167, DOI 10.1016/j.pcl.2005.09.012; Kamada K, 2006, J GEN VIROL, V87, P2227, DOI 10.1099/vir.0.81946-0; Kanda T, 1999, HEPATOLOGY, V29, P1905, DOI 10.1002/hep.510290613; Khudyakov YE, 2000, J VIROL, V74, P2990, DOI 10.1128/JVI.74.7.2990-3000.2000; King A.M.Q., 2011, VIRUS TAXONOMY, V1st ed; Lin HH, 2002, J MED VIROL, V66, P285, DOI 10.1002/jmv.2143; Maggi F, 2004, J INFECT DIS, V190, P971, DOI 10.1086/423143; Maggi F, 2003, J VIROL, V77, P9081, DOI 10.1128/JVI.77.16.9081-9083.2003; Maggi F, 2003, J VIROL, V77, P2418, DOI 10.1128/JVI.77.4.2418-2425.2003; Maggi F, 2001, J MED VIROL, V64, P190, DOI 10.1002/jmv.1035; Maggi F, 2010, REV MED VIROL, V20, P392, DOI 10.1002/rmv.668; Mariscal LF, 2002, VIROLOGY, V301, P121, DOI 10.1006/viro.2002.1545; Miyata H, 1999, J VIROL, V73, P3582, DOI 10.1128/JVI.73.5.3582-3586.1999; Mushahwar IK, 1999, P NATL ACAD SCI USA, V96, P3177, DOI 10.1073/pnas.96.6.3177; Naoumov NV, 1998, LANCET, V352, P195, DOI 10.1016/S0140-6736(98)04069-0; Ninomiya M, 2007, ARCH VIROL, V152, P1961, DOI 10.1007/s00705-007-1046-6; Ninomiya M, 2008, J CLIN MICROBIOL, V46, P507, DOI 10.1128/JCM.01703-07; Ninomiya M, 2007, J GEN VIROL, V88, P1939, DOI 10.1099/vir.0.82895-0; Nishizawa T, 1997, BIOCHEM BIOPH RES CO, V241, P92, DOI 10.1006/bbrc.1997.7765; Niska Richard, 2010, Natl Health Stat Report, P1; Okamoto H, 2000, VIROLOGY, V277, P368, DOI 10.1006/viro.2000.0588; Okamoto H, 2009, CURR TOP MICROBIOL, V331, P1, DOI 10.1007/978-3-540-70972-5_1; Okamoto H, 1998, J MED VIROL, V56, P128, DOI 10.1002/(SICI)1096-9071(199810)56:2&lt;128::AID-JMV5&gt;3.0.CO;2-A; Okamoto H, 2001, VIROLOGY, V288, P358, DOI 10.1006/viro.2001.1097; Okamoto HNT, 2004, VIRAL HEPATITIS MOL; Ott C, 2000, J GEN VIROL, V81, P2949, DOI 10.1099/0022-1317-81-12-2949; Peng YH, 2002, ARCH VIROL, V147, P21, DOI 10.1007/s705-002-8301-7; Peters MA, 2002, J BIOL CHEM, V277, P39566, DOI 10.1074/jbc.M201752200; Rocchi J, 2009, VIROLOGY, V394, P235, DOI 10.1016/j.virol.2009.08.036; Simmonds P, 1999, J INFECT DIS, V180, P1748, DOI 10.1086/315103; Simmonds P, 2002, J MED MICROBIOL, V51, P455, DOI 10.1099/0022-1317-51-6-455; Sugiyama K, 1999, J MED VIROL, V59, P204, DOI 10.1002/(SICI)1096-9071(199910)59:2&lt;204::AID-JMV13&gt;3.0.CO;2-T; Takahashi K, 2000, ARCH VIROL, V145, P979, DOI 10.1007/s007050050689; Thom K, 2003, VIROLOGY, V306, P324, DOI 10.1016/S0042-6822(02)00049-1; Toyoda H, 1999, J INFECTION, V38, P198, DOI 10.1016/S0163-4453(99)90254-2; Vasconcelos HCF, 2002, J MED VIROL, V68, P291, DOI 10.1002/jmv.10187; Wandinger KP, 2000, NEUROLOGY, V55, P178, DOI 10.1212/WNL.55.2.178; Wylie KM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0027735	54	41	43	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 30	2012	7	11							e50937	10.1371/journal.pone.0050937	http://dx.doi.org/10.1371/journal.pone.0050937			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	054WM	23226428	Green Published, Green Submitted, gold			2022-12-27	WOS:000312376100239
J	Tian, D; Li, L; Liu, YJ; Li, HP; Xu, XY; Li, JY				Tian, Di; Li, Lin; Liu, Yongjian; Li, Hanping; Xu, Xiaoyuan; Li, Jingyun			Different HCV Genotype Distributions of HIV-Infected Individuals in Henan and Guangxi, China	PLOS ONE			English	Article							HEPATITIS-C VIRUS; LIVER-ENZYME ELEVATION; INJECTION-DRUG USERS; BLOOD-DONORS; COINFECTION; MANAGEMENT; EPIDEMIOLOGY; PREVALENCE; PATIENT; YUNNAN	Background: Due to shared transmission routes, hepatitis C virus (HCV) infection is highly prevalent among people infected with human immunodeficiency virus (HIV). Highly active antiretroviral therapy (HAART) is associated with hepatotoxicity, leading to the negative effects on patients with HIV/HCV co-infection. In order to provide valuable information for HCV management in this particular population, we investigated the HCV genotypes in HIV-infected individuals from Henan and Guangxi, the two provinces with the most HIV-infected cases in China. Methods: Individuals, who acquired HIV infection through various risk routes, were recruited from Henan and Guangxi. Test of antibodies against HCV (anti-HCV) was conducted, and detection of HCV RNA was performed by PCR amplification. HCV subtypes were determined by direct sequencing of amplicons, followed by phylogenetic analysis. Results: We recruited a total of 1,112 HIV-infected people in this present study. Anti-HCV was detected from 218 (50.1%) patients from Henan and 81 (12.0%) patients from Guangxi, respectively. The highest prevalence of HIV/HCV co-infection was observed from FBDs (former blood donors) (87.2%) in Henan and IDUs (intravenous drug users) (81.8%) in Guangxi, respectively. The seroprevalence rate of HCV among people with sexual contact was significantly higher in Henan than in Guangxi (18.7% vs. 3.5%, P<0.05). The positive rate of HCV RNA in Henan and Guangxi was 30.6% (133/435) and 11.2% (76/677), respectively. Moreover, we found that 20 anti-HCV negative samples were HCV positive by PCR amplification. HCV subtype 1b (52.7%) was predominant in Henan, followed by subtype 2a (41.9%). The most frequently detected subtypes in Guangxi were 6a (35.6%) and 3b (32.9%). Conclusion: The HCV genotype distributions were different in HIV-infected people from Henan and Guangxi. HIV/HCV co-infection was not only linked to the transmission routes, but also associated with the geographic position.	[Tian, Di; Xu, Xiaoyuan] Peking Univ, Hosp 1, Dept Infect Dis, Beijing 100871, Peoples R China; [Li, Lin; Liu, Yongjian; Li, Hanping; Li, Jingyun] Beijing Inst Microbiol & Epidemiol, Dept AIDS Res, State Key Lab Pathogen & Biosecur, Beijing, Peoples R China	Peking University; Beijing Institute of Microbiology & Epidemiology	Xu, XY (corresponding author), Peking Univ, Hosp 1, Dept Infect Dis, Beijing 100871, Peoples R China.	yangpin@public3.bta.net.cn; lijy@nic.bmi.ac.cn			11th Five-Year Plan [2008ZX10001-004, 2008ZX10002-013]; Specialized Research Fund for the Doctoral Program of Higher Education (SRFDP) [20090001110081]	11th Five-Year Plan(National Key Technology R&D Program); Specialized Research Fund for the Doctoral Program of Higher Education (SRFDP)(Specialized Research Fund for the Doctoral Program of Higher Education (SRFDP))	This study was supported by the 11th Five-Year Plan (2008ZX10001-004, 2008ZX10002-013) and the Specialized Research Fund for the Doctoral Program of Higher Education (SRFDP) (20090001110081). Funders had no role in study design, data collection and analysis, decision to publish, or manuscript preparation.	Alter MJ, 2006, J HEPATOL, V44, pS6, DOI 10.1016/j.jhep.2005.11.004; Bao YP, 2010, CURR OPIN PSYCHIATR, V23, P187, DOI 10.1097/YCO.0b013e328338658b; Busch MP, 2006, TRANSFUSION, V46, P469, DOI 10.1111/j.1537-2995.2006.00745.x; Chen TY, 2009, CLIN INFECT DIS, V49, P1605, DOI 10.1086/644771; Cote P, 2007, CAN J INFECT DIS MED, V18, P293, DOI 10.1155/2007/631054; Fu YSH, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0047324, 10.1371/journal.pone.0028006]; Ghany MG, 2009, HEPATOLOGY, V49, P1335, DOI 10.1002/hep.22759; Golemba MD, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008751; Jones M, 2011, CURR OPIN HIV AIDS, V6, P546, DOI 10.1097/COH.0b013e32834bcbd9; Kaufman J, 2002, SCIENCE, V296, P2339, DOI 10.1126/science.1074479; Lu L, 2005, J MED VIROL, V75, P538, DOI 10.1002/jmv.20307; Maida I, 2006, AIDS RES HUM RETROV, V22, P139, DOI 10.1089/aid.2006.22.139; McGovern BH, 2007, JAIDS-J ACQ IMM DEF, V45, pS47, DOI 10.1097/QAI.0b013e318068d190; Murphy DG, 2007, J CLIN MICROBIOL, V45, P1102, DOI 10.1128/JCM.02366-06; Nunez M, 2010, HEPATOLOGY, V52, P1143, DOI 10.1002/hep.23716; Polis CB, 2007, CLIN INFECT DIS, V44, P1123, DOI 10.1086/512815; Qian HZ, 2006, AIDS, V20, P1429, DOI 10.1097/01.aids.0000233577.33973.fa; Reed KE, 2000, CURR TOP MICROBIOL, V242, P55; Rockstroh JK, 2005, J INFECT DIS, V192, P992, DOI 10.1086/432762; Rotman Y, 2009, J VIROL, V83, P7366, DOI 10.1128/JVI.00191-09; Schott E, 2007, J HEPATOL, V46, P372, DOI 10.1016/j.jhep.2006.09.011; Shang H, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010631; Simmonds P, 2005, HEPATOLOGY, V42, P962, DOI 10.1002/hep.20819; Simmonds P, 2001, J GEN VIROL, V82, P693, DOI 10.1099/0022-1317-82-4-693; Strasak AM, 2011, BMC INFECT DIS, V11, DOI 10.1186/1471-2334-11-15; Sy Theodore, 2006, Int J Med Sci, V3, P41; Tan Y, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003608; Tedaldi EM, 2003, CLIN INFECT DIS, V36, P1313, DOI 10.1086/374841; Thomas DL, 2011, J INT AIDS SOC, V14, DOI 10.1186/1758-2652-14-22; Torti C, 2006, JAIDS-J ACQ IMM DEF, V41, P180, DOI 10.1097/01.qai.0000192005.08153.a3; WANG Y, 1994, J HEPATOL, V21, P634, DOI 10.1016/S0168-8278(94)80112-6; WU ZY, 1995, LANCET, V346, P61, DOI 10.1016/S0140-6736(95)92698-4; Xia XS, 2008, J MED VIROL, V80, P1142, DOI 10.1002/jmv.21204; Zein NN, 2000, CLIN MICROBIOL REV, V13, P223, DOI 10.1128/CMR.13.2.223-235.2000; Zhang CY, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016817; Zhang LQ, 2004, J VIROL, V78, P13591, DOI 10.1128/JVI.78.24.13591-13599.2004; Zheng Xi-Wen, 1993, Biomedical and Environmental Sciences, V6, P348	37	19	23	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 30	2012	7	11							e50343	10.1371/journal.pone.0050343	http://dx.doi.org/10.1371/journal.pone.0050343			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	054WM	23226265	Green Published, Green Submitted, gold			2022-12-27	WOS:000312376100075
J	Tseng-Rogenski, SS; Chung, H; Wilk, MB; Zhang, S; Iwaizumi, M; Carethers, JM				Tseng-Rogenski, Stephanie S.; Chung, Heekyung; Wilk, Maike B.; Zhang, Shuai; Iwaizumi, Moriya; Carethers, John M.			Oxidative Stress Induces Nuclear-to-Cytosol Shift of hMSH3, a Potential Mechanism for EMAST in Colorectal Cancer Cells	PLOS ONE			English	Article							MICROSATELLITE INSTABILITY; TETRANUCLEOTIDE REPEATS; MUTATION-RATES; REPAIR; TUMORS; SPECIFICITY; EXPRESSION; COMPLEXES; HMLH1	Background: Elevated microsatellite alterations at selected tetranucleotide repeats (EMAST) is a genetic signature observed in 60% of sporadic colorectal cancers (CRCs). Unlike microsatellite unstable CRCs where hypermethylation of the DNA mismatch repair (MMR) gene hMLH1's promoter is causal, the precise cause of EMAST is not clearly defined but points towards hMSH3 deficiency. Aim: To examine if hMSH3 deficiency causes EMAST, and to explore mechanisms for its deficiency. Methods: We measured -4 bp framshifts at D8S321 and D20S82 loci within EGFP-containing constructs to determine EMAST formation in MMR-proficient, hMLH1(-/-), hMSH6(-/-), and hMSH3(-/-) CRC cells. We observed the subcellular location of hMSH3 with oxidative stress. Results: D8S321 mutations occurred 31-and 40-fold higher and D20S82 mutations occurred 82-and 49-fold higher in hMLH1(-/-) and hMSH3(-/-) cells, respectively, than in hMSH6(-/-) or MMR-proficient cells. hMSH3 knockdown in MMR-proficient cells caused higher D8S321 mutation rates (18.14 and 11.14x10(-4) mutations/cell/generation in two independent clones) than scrambled controls (0 and 0.26x10(-4) mutations/cell/generation; p<0.01). DNA sequencing confirmed the expected frameshift mutations with evidence for ongoing mutations of the constructs. Because EMAST-positive tumors are associated with inflammation, we subjected MMR-proficient cells to oxidative stress via H2O2 to examine its effect on hMSH3. A reversible nuclear-to-cytosol shift of hMSH3 was observed upon H2O2 treatment. Conclusion: EMAST is dependent upon the MMR background, with hMSH3(-/-) more prone to frameshift mutations than hMSH6(-/-), opposite to frameshift mutations observed for mononucleotide repeats. hMSH3(-/-) mimics complete MMR failure (hMLH1(-/-)) in inducing EMAST. Given the observed heterogeneous expression of hMSH3 in CRCs with EMAST, hMSH3-deficiency appears to be the event that commences EMAST. Oxidative stress, which causes a shift of hMSH3's subcellular location, may contribute to an hMSH3 loss-of-function phenotype by sequestering it to the cytosol.	[Tseng-Rogenski, Stephanie S.; Wilk, Maike B.; Zhang, Shuai; Iwaizumi, Moriya; Carethers, John M.] Univ Michigan, Dept Internal Med, Div Gastroenterol, Ann Arbor, MI 48109 USA; [Chung, Heekyung; Carethers, John M.] Univ Calif San Diego, Dept Med, San Diego, CA 92103 USA	University of Michigan System; University of Michigan; University of California System; University of California San Diego	Carethers, JM (corresponding author), Univ Michigan, Dept Internal Med, Div Gastroenterol, Ann Arbor, MI 48109 USA.	jcarethe@umich.edu	Iwaizumi, Moriya/AAG-3173-2019	Iwaizumi, Moriya/0000-0002-2629-0830	United States Public Health Service [DK067287, CA162147]; SDSU/UCSD Comprehensive Cancer Center Partnership [CA132379, CA132384]; NATIONAL CANCER INSTITUTE [U01CA162147, U54CA132379, U54CA132384] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK067287] Funding Source: NIH RePORTER	United States Public Health Service(United States Department of Health & Human ServicesUnited States Public Health Service); SDSU/UCSD Comprehensive Cancer Center Partnership; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by the United States Public Health Service (DK067287 and CA162147) and the SDSU/UCSD Comprehensive Cancer Center Partnership (CA132379 and CA132384). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acharya S, 1996, P NATL ACAD SCI USA, V93, P13629, DOI 10.1073/pnas.93.24.13629; Ahrendt SA, 2000, CANCER RES, V60, P2488; Boland CR, 1998, CANCER RES, V58, P5248; Burger M, 2006, J MOL MED, V84, P833, DOI 10.1007/s00109-006-0074-0; Catto JWF, 2003, ONCOGENE, V22, P8699, DOI 10.1038/sj.onc.1206964; Chang CL, 2002, AM J PHYSIOL-CELL PH, V283, pC148, DOI 10.1152/ajpcell.00422.2001; Chung H, 2010, ONCOGENE, V29, P2172, DOI 10.1038/onc.2009.508; Chung H, 2012, MUTAT RES-FUND MOL M, V729, P73, DOI 10.1016/j.mrfmmm.2011.09.009; Chung H, 2010, HUM MOL GENET, V19, P2638, DOI 10.1093/hmg/ddq151; Chung H, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003463; Clark AB, 1999, NUCLEIC ACIDS RES, V27, P736, DOI 10.1093/nar/27.3.736; Danaee H, 2002, ONCOGENE, V21, P4894, DOI 10.1038/sj.onc.1205619; Devaraj B, 2010, J GASTROINTEST SURG, V14, P1521, DOI 10.1007/s11605-010-1340-6; Garcia M, 2012, GASTROENTEROLOGY, V143, P48, DOI 10.1053/j.gastro.2012.03.034; Genschel J, 1998, J BIOL CHEM, V273, P19895, DOI 10.1074/jbc.273.31.19895; Grady WM, 2008, GASTROENTEROLOGY, V135, P1079, DOI 10.1053/j.gastro.2008.07.076; Harrington JA, 2007, MOL CELL BIOL, V27, P6546, DOI 10.1128/MCB.00855-07; Haugen AC, 2008, CANCER RES, V68, P8465, DOI 10.1158/0008-5472.CAN-08-0002; Kane MF, 1997, CANCER RES, V57, P808; Lee SY, 2010, GASTROENTEROLOGY, V139, P1519, DOI 10.1053/j.gastro.2010.08.001; Luria SE, 1943, GENETICS, V28, P491; Singer G, 2004, INT J CANCER, V112, P643, DOI 10.1002/ijc.20455; Tajima A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028117; Veigl ML, 1998, P NATL ACAD SCI USA, V95, P8698, DOI 10.1073/pnas.95.15.8698; Yamada K, 2010, ONCOL REP, V23, P551, DOI 10.3892/or_00000669	25	44	44	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 30	2012	7	11							e50616	10.1371/journal.pone.0050616	http://dx.doi.org/10.1371/journal.pone.0050616			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	054WM	23226332	Green Published, gold, Green Submitted			2022-12-27	WOS:000312376100143
J	Wan, M; Gao, B; Sun, FF; Tang, Y; Ye, L; Fan, Y; Klein, OD; Zhou, XD; Zheng, LW				Wan, Mian; Gao, Bo; Sun, Feifei; Tang, Yin; Ye, Ling; Fan, Yi; Klein, Ophir D.; Zhou, Xuedong; Zheng, Liwei			microRNA miR-34a Regulates Cytodifferentiation and Targets Multi-signaling Pathways in Human Dental Papilla Cells	PLOS ONE			English	Article							TOOTH DEVELOPMENT; SELF-RENEWAL; STEM-CELLS; CROSS-TALK; TGF-BETA; NOTCH; DIFFERENTIATION; MOUSE; MORPHOGENESIS; EXPRESSION	Odontogenesis relies on the reciprocal signaling interactions between dental epithelium and neural crest-derived mesenchyme, which is regulated by several signaling pathways. Subtle changes in the activity of these major signaling pathways can have dramatic effects on tooth development. An important regulator of such subtle changes is the fine tuning function of microRNAs (miRNAs). However, the underlying mechanism by which miRNAs regulate tooth development remains elusive. This study determined the expression of miRNAs during cytodifferentiation in the human tooth germ and studied miR-34a as a regulator of dental papilla cell differentiation. Using microarrays, miRNA expression profiles were established at selected times during development (early bell stage or late bell stage) of the human fetal tooth germ. We identified 29 differentially expressed miRNAs from early bell stage/late bell stage comparisons. Out of 6 miRNAs selected for validation by qPCR, all transcripts were confirmed to be differentially expressed. miR-34a was selected for further investigation because it has been previously reported to regulate organogenesis. miR-34a mimics and inhibitors were transfected into human fetal dental papilla cells, mRNA levels of predicted target genes were detected by quantitative real-time PCR, and levels of putative target proteins were examined by western blotting. ALP and DSPP expression were also tested by qPCR, western blotting, and immunofluorescence. Findings from these studies suggested that miR-34a may play important roles in dental papilla cell differentiation during human tooth development by targeting NOTCH and TGF-beta signaling.	[Wan, Mian; Gao, Bo; Sun, Feifei; Tang, Yin; Zhou, Xuedong; Zheng, Liwei] Sichuan Univ, State Key Lab Oral Dis, Chengdu 610064, Sichuan, Peoples R China; [Wan, Mian; Sun, Feifei; Tang, Yin; Ye, Ling; Fan, Yi; Zhou, Xuedong; Zheng, Liwei] Sichuan Univ, W China Sch Stomatol, Chengdu 610064, Sichuan, Peoples R China; [Klein, Ophir D.] Univ Calif San Francisco, Program Craniofacial & Mesenchymal Biol, San Francisco, CA 94143 USA; [Klein, Ophir D.] Univ Calif San Francisco, Dept Orofacial Sci, San Francisco, CA 94143 USA; [Klein, Ophir D.] Univ Calif San Francisco, Dept Pediat, San Francisco, CA USA	Sichuan University; Sichuan University; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco	Zhou, XD (corresponding author), Sichuan Univ, State Key Lab Oral Dis, Chengdu 610064, Sichuan, Peoples R China.	zhouxd@scu.edu.cn; zhenglw399@hotmail.com	ye, ling/AFP-0048-2022; ZHOU, XUE/F-6129-2013; tang, yin/GXZ-6989-2022; Zheng, Liwei/D-4835-2014; tang, yin/AAR-2123-2021	ye, ling/0000-0002-8417-7676; Zheng, Liwei/0000-0002-0467-1720; Klein, Ophir/0000-0002-6254-7082; Zhou, Xuedong/0000-0002-9319-7302	NSFC [30973324, JCPT2011-9, 81200760, 2011SCU11999-3]	NSFC(National Natural Science Foundation of China (NSFC))	This study was supported by NSFC grant 30973324 and JCPT2011-9 to XDZ, and NSFC grant 81200760 and 2011SCU11999-3 to LWZ. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdel-Hakeem AK, 2008, AM J OBSTET GYNECOL, V199, DOI 10.1016/j.ajog.2008.05.018; Andl T, 2006, CURR BIOL, V16, P1041, DOI 10.1016/j.cub.2006.04.005; Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Blokzijl A, 2003, J CELL BIOL, V163, P723, DOI 10.1083/jcb.200305112; Borghese L, 2010, STEM CELLS, V28, P955, DOI 10.1002/stem.408; Cao H, 2010, J DENT RES, V89, P779, DOI 10.1177/0022034510369304; Chiang HR, 2010, GENE DEV, V24, P992, DOI 10.1101/gad.1884710; de Antonellis P, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024584; Frazier-Bowers SA, 2002, CONNECT TISSUE RES, V43, P296, DOI 10.1080/03008200290000961; Griffiths-Jones S, 2008, NUCLEIC ACIDS RES, V36, pD154, DOI 10.1093/nar/gkm952; He L, 2004, NAT REV GENET, V5, P522, DOI 10.1038/nrg1379; Hotton D, 1999, J HISTOCHEM CYTOCHEM, V47, P1541, DOI 10.1177/002215549904701206; Huang ZH, 2011, CANCER RES, V71, P2582, DOI 10.1158/0008-5472.CAN-10-3032; Jarvinen E, 2006, P NATL ACAD SCI USA, V103, P18627, DOI 10.1073/pnas.0607289103; Jevnaker AM, 2008, ARCH ORAL BIOL, V53, P629, DOI 10.1016/j.archoralbio.2008.01.014; Jheon AH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024536; Karin W, 2012, PLOS ONE, V7; Klein OD, 2008, DEVELOPMENT, V135, P377, DOI 10.1242/dev.015081; Klein OD, 2006, DEV CELL, V11, P181, DOI 10.1016/j.devcel.2006.05.014; Kluppel M, 2005, BIOESSAYS, V27, P115, DOI 10.1002/bies.20187; Lesot H, 2009, ARCH ORAL BIOL, V54, pS25, DOI 10.1016/j.archoralbio.2008.05.019; Lewis BP, 2005, CELL, V120, P15, DOI 10.1016/j.cell.2004.12.035; Lin CR, 1999, NATURE, V401, P279, DOI 10.1038/45803; Liu JN, 2010, CURR TOP DEV BIOL, V92, P367, DOI [10.1016/S0070-2153(10)92012-7, 10.1016/S0070-2153(10)91012-7]; LUO G, 1995, GENE DEV, V9, P2808, DOI 10.1101/gad.9.22.2808; Martin R, 2009, MOL CELL BIOL, V29, P861, DOI 10.1128/MCB.01524-08; Michon F, 2011, BIRTH DEFECTS RES A, V91, P763, DOI 10.1002/bdra.20787; Michon F, 2010, DEV BIOL, V340, P355, DOI 10.1016/j.ydbio.2010.01.019; Miska EA, 2005, CURR OPIN GENET DEV, V15, P563, DOI 10.1016/j.gde.2005.08.005; Munne PM, 2010, EVOL DEV, V12, P383, DOI 10.1111/j.1525-142X.2010.00425.x; Munne PM, 2009, DEVELOPMENT, V136, P393, DOI 10.1242/dev.025064; Oommen S, 2012, DEV DYNAM, V241, P1465, DOI 10.1002/dvdy.23828; Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73; Sehic A, 2011, PHYSIOL GENOMICS, V43, P488, DOI 10.1152/physiolgenomics.00248.2010; Sikandar SS, 2010, CANCER RES, V70, P1469, DOI 10.1158/0008-5472.CAN-09-2557; Takizawa T, 2003, NUCLEIC ACIDS RES, V31, P5723, DOI 10.1093/nar/gkg778; Thesleff I, 2000, ACTA ODONTOL SCAND, V58, P191, DOI 10.1080/000163500750051728; Thesleff I, 2003, J CELL SCI, V116, P1647, DOI 10.1242/jcs.00410; THESLEFF I, 1995, INT J DEV BIOL, V39, P35; Tummers M, 2009, J EXP ZOOL PART B, V312B, P309, DOI 10.1002/jez.b.21280; Wang XP, 2009, DEVELOPMENT, V136, P1939, DOI 10.1242/dev.033803; Wang XP, 2004, DEV CELL, V7, P719, DOI 10.1016/j.devcel.2004.09.012; Williams MA, 2010, BIOMARK INSIGHTS, V5, P139, DOI 10.4137/BMI.S6094; Yan K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033778; Yi R, 2006, NAT GENET, V38, P356, DOI 10.1038/ng1744; Yi R, 2009, P NATL ACAD SCI USA, V106, P498, DOI 10.1073/pnas.0810766105; Zouvelou V, 2009, INT J DEV BIOL, V53, P597, DOI 10.1387/ijdb.082648vz; Zouvelou V, 2009, J EXP ZOOL PART B, V312B, P361, DOI 10.1002/jez.b.21262	49	30	37	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 30	2012	7	11							e50090	10.1371/journal.pone.0050090	http://dx.doi.org/10.1371/journal.pone.0050090			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	054WM	23226240	gold, Green Published, Green Submitted			2022-12-27	WOS:000312376100049
J	Wei, HM; Zhang, GQ; Qiu, SH; Lu, J; Sheng, JW; Manasi; Tan, G; Wong, P; Gan, SU; Shim, W				Wei, Heming; Zhang, Guangqin; Qiu, Suhua; Lu, Jun; Sheng, Jingwei; Manasi; Tan, Grace; Wong, Philip; Gan, Shu Uin; Shim, Winston			Hydrogen Sulfide Suppresses Outward Rectifier Potassium Currents in Human Pluripotent Stem Cell-Derived Cardiomyocytes	PLOS ONE			English	Article							VENTRICULAR MYOCYTES; IONIC CURRENTS; CHANNELS; INHIBITOR; MODELS	Aim: Hydrogen sulfide (H2S) is a promising cardioprotective agent and a potential modulator of cardiac ion currents. Yet its cardiac effects on humans are poorly understood due to lack of functional cardiomyocytes. This study investigates electrophysiological responses of human pluripotent stem cells (hPSCs) derived cardiomyocytes towards H2S. Methods and Results: Cardiomyocytes of ventricular, atrial and nodal subtypes differentiated from H9 embryonic stem cells (hESCs) and human induced pluripotent stem cells (hiPSCs) were electrophysiologically characterized. The effect of NaHS, a donor of H2S, on action potential (AP), outward rectifier potassium currents (I-Ks and I-Kr), L-type Ca2+ currents (I-CaL) and hyperpolarization-activated inward current (If) were determined by patch-clamp electrophysiology and confocal calcium imaging. In a concentration-dependent manner, NaHS (100 to 300 mM) consistently altered the action potential properties including prolonging action potential duration (APD) and slowing down contracting rates of ventricular-and atrial-like cardiomyocytes derived from both hESCs and hiPSCs. Moreover, inhibitions of slow and rapid I-K (I-Ks and I-Kr), I-CaL and If were found in NaHS treated cardiomyocytes and it could collectively contribute to the remodeling of AP properties. Conclusions: This is the first demonstration of effects of H2S on cardiac electrophysiology of human ventricular-like, atrial-like and nodal-like cardiomyocytes. It reaffirmed the inhibitory effect of H2S on I-CaL and revealed additional novel inhibitory effects on I-f, I-Ks and I-Kr currents in human cardiomyocytes.	[Wei, Heming; Zhang, Guangqin; Qiu, Suhua; Lu, Jun; Sheng, Jingwei; Manasi; Tan, Grace; Wong, Philip; Shim, Winston] Natl Heart Ctr Singapore, Res & Dev Unit, Singapore, Singapore; [Wei, Heming; Wong, Philip; Shim, Winston] DUKE Natl Univ Singapore, Grad Sch Med, Singapore, Singapore; [Gan, Shu Uin] Natl Univ Singapore, Yong Loo Lin Sch Med, Dept Surg, Singapore 117595, Singapore	National Heart Centre Singapore; National University of Singapore; National University of Singapore	Shim, W (corresponding author), Natl Heart Ctr Singapore, Res & Dev Unit, Singapore, Singapore.	WINSTON.SHIM.S.N@NHCS.COM.SG	Gan, Shu Uin/B-8094-2014; Gan, Shu Uin/I-6157-2019	Gan, Shu Uin/0000-0002-9672-0306	National Research Foundation, Singapore [NRF2008-CRP001-68]	National Research Foundation, Singapore(National Research Foundation, Singapore)	This study is supported by National Research Foundation, Singapore grant, NRF2008-CRP001-68. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Braam SR, 2010, STEM CELL RES, V4, P155, DOI 10.1016/j.scr.2010.04.008; Cavero I, 2000, Expert Opin Pharmacother, V1, P947, DOI 10.1517/14656566.1.5.947; Chen YH, 2005, CHEST, V128, P3205, DOI 10.1378/chest.128.5.3205; Cheng H, 1999, BIOPHYS J, V76, P606, DOI 10.1016/S0006-3495(99)77229-2; Cheng YQ, 2004, AM J PHYSIOL-HEART C, V287, pH2316, DOI 10.1152/ajpheart.00331.2004; Graichen R, 2008, DIFFERENTIATION, V76, P357, DOI 10.1111/j.1432-0436.2007.00236.x; Itzhaki I, 2011, NATURE, V471, P225, DOI 10.1038/nature09747; Kehat I, 2001, J CLIN INVEST, V108, P407, DOI 10.1172/JCI12131; Lavu M, 2011, CLIN SCI, V120, P219, DOI 10.1042/CS20100462; Li GR, 1996, CIRC RES, V78, P689, DOI 10.1161/01.RES.78.4.689; Ma JY, 2011, AM J PHYSIOL-HEART C, V301, pH2006, DOI 10.1152/ajpheart.00694.2011; MALTSEV VA, 1994, CIRC RES, V75, P233, DOI 10.1161/01.RES.75.2.233; Moretti A, 2010, NEW ENGL J MED, V363, P1397, DOI 10.1056/NEJMoa0908679; Mustafa AK, 2011, CIRC RES, V109, P1259, DOI 10.1161/CIRCRESAHA.111.240242; Mustafa AK, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2000464; REIFFENSTEIN RJ, 1992, ANNU REV PHARMACOL, V32, P109, DOI 10.1146/annurev.pa.32.040192.000545; Roden DM, 1996, ANNU REV MED, V47, P135; Roy ML, 1996, CIRCULATION, V94, P817, DOI 10.1161/01.CIR.94.4.817; Sun YG, 2008, CARDIOVASC RES, V79, P632, DOI 10.1093/cvr/cvn140; Szabo C, 2007, NAT REV DRUG DISCOV, V6, P917, DOI 10.1038/nrd2425; Tang GH, 2010, CLIN EXP PHARMACOL P, V37, P753, DOI 10.1111/j.1440-1681.2010.05351.x; Wei HM, 2012, STEM CELL RES, V9, P87, DOI 10.1016/j.scr.2012.04.003; Wu Rui, 2008, Beijing Da Xue Xue Bao Yi Xue Ban, V40, P505; Xu XQ, 2008, DIFFERENTIATION, V76, P958, DOI 10.1111/j.1432-0436.2008.00284.x; Zhang JH, 2009, CIRC RES, V104, pE30, DOI 10.1161/CIRCRESAHA.108.192237; Zhong GZ, 2010, CARDIOLOGY, V115, P120, DOI 10.1159/000260073	26	10	10	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 30	2012	7	11							e50641	10.1371/journal.pone.0050641	http://dx.doi.org/10.1371/journal.pone.0050641			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	054WM	23226343	Green Published, gold, Green Submitted			2022-12-27	WOS:000312376100154
J	Eldem, V; Akcay, UC; Ozhuner, E; Bakir, Y; Uranbey, S; Unver, T				Eldem, Vahap; Akcay, Ufuk Celikkol; Ozhuner, Esma; Bakir, Yakup; Uranbey, Serkan; Unver, Turgay			Genome-Wide Identification of miRNAs Responsive to Drought in Peach (Prunus persica) by High-Throughput Deep Sequencing	PLOS ONE			English	Article							MICROARRAY-BASED ANALYSIS; PLANT MICRORNA; SMALL RNAS; MEDICAGO-TRUNCATULA; STRESS; ARABIDOPSIS; BIOGENESIS; TARGETS; GENES; ANNOTATION	Peach (Prunus persica L.) is one of the most important worldwide fresh fruits. Since fruit growth largely depends on adequate water supply, drought stress is considered as the most important abiotic stress limiting fleshy fruit production and quality in peach. Plant responses to drought stress are regulated both at transcriptional and post-transcriptional level. As post-transcriptional gene regulators, miRNAs (miRNAs) are small (19-25 nucleotides in length), endogenous, non-coding RNAs. Recent studies indicate that miRNAs are involved in plant responses to drought. Therefore, Illumina deep sequencing technology was used for genome-wide identification of miRNAs and their expression profile in response to drought in peach. In this study, four sRNA libraries were constructed from leaf control (LC), leaf stress (LS), root control (RC) and root stress (RS) samples. We identified a total of 531, 471, 535 and 487 known mature miRNAs in LC, LS, RC and RS libraries, respectively. The expression level of 262 (104 up-regulated, 158 down-regulated) of the 453 miRNAs changed significantly in leaf tissue, whereas 368 (221 up-regulated, 147 down-regulated) of the 465 miRNAs had expression levels that changed significantly in root tissue upon drought stress. Additionally, a total of 197, 221, 238 and 265 novel miRNA precursor candidates were identified from LC, LS, RC and RS libraries, respectively. Target transcripts (137 for LC, 133 for LS, 148 for RC and 153 for RS) generated significant Gene Ontology (GO) terms related to DNA binding and catalytic activites. Genome-wide miRNA expression analysis of peach by deep sequencing approach helped to expand our understanding of miRNA function in response to drought stress in peach and Rosaceae. A set of differentially expressed miRNAs could pave the way for developing new strategies to alleviate the adverse effects of drought stress on plant growth and development. Citation: Eldem V, Celikkol Akcay U, Ozhuner E, Bakir Y, Uranbey S, et al. (2012) Genome-Wide Identification of miRNAs Responsive to Drought in Peach (Prunus persica) by High-Throughput Deep Sequencing. PLoS ONE 7(12): e50298. doi:10.1371/journal.pone.0050298	[Eldem, Vahap; Ozhuner, Esma; Uranbey, Serkan; Unver, Turgay] Cankiri Karatekin Univ, Fac Sci, Dept Biol, Cankiri, Turkey; [Eldem, Vahap] Istanbul Univ, Fac Sci, Dept Biol, Istanbul, Turkey; [Akcay, Ufuk Celikkol] Suleyman Demirel Univ, Fac Agr, Dept Agr Biotechnol, TR-32200 Isparta, Turkey; [Bakir, Yakup] Marmara Univ, Fac Arts & Sci, Dept Biol, Istanbul, Turkey	Cankiri Karatekin University; Istanbul University; Suleyman Demirel University; Marmara University	Unver, T (corresponding author), Cankiri Karatekin Univ, Fac Sci, Dept Biol, Cankiri, Turkey.	turgayunver@gmail.com	Eldem, Vahap/A-9160-2018; Celikkol Akcay, Ufuk/A-1402-2011; Unver, Turgay/B-4819-2009; Uranbey, Serkan/AAF-2939-2020	Eldem, Vahap/0000-0003-3767-5661; Unver, Turgay/0000-0001-6760-443X; Celikkol Akcay, Ufuk/0000-0003-1260-3813; OZHUNER, ESMA/0000-0002-5456-3496	State Planning Organization of Turkey [DPT2010K120720]	State Planning Organization of Turkey(Turkiye Cumhuriyeti Kalkinma Bakanligi)	The study was supported by State Planning Organization of Turkey with grant no. DPT2010K120720. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen E, 2005, CELL, V121, P207, DOI 10.1016/j.cell.2005.04.004; Ambros Victor, 2004, Methods Mol Biol, V265, P131; An FM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018937; Arenas-Huertero C, 2009, PLANT MOL BIOL, V70, P385, DOI 10.1007/s11103-009-9480-3; Axtell MJ, 2005, PLANT CELL, V17, P1658, DOI 10.1105/tpc.105.032185; BAIRD WV, 1994, J AM SOC HORTIC SCI, V119, P1312, DOI 10.21273/JASHS.119.6.1312; Barrera-Figueroa BE, 2011, BMC PLANT BIOL, V11, DOI 10.1186/1471-2229-11-127; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Buxdorf K, 2010, PLANTA, V232, P1009, DOI 10.1007/s00425-010-1231-9; Carrington JC, 2003, SCIENCE, V301, P336, DOI 10.1126/science.1085242; CHALMERS DJ, 1978, ANN BOT-LONDON, V42, P285, DOI 10.1093/oxfordjournals.aob.a085459; Chen CF, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni178; Chen XM, 2005, FEBS LETT, V579, P5923, DOI 10.1016/j.febslet.2005.07.071; Chi XY, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027530; Creighton CJ, 2009, BRIEF BIOINFORM, V10, P490, DOI 10.1093/bib/bbp019; De Paola D, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-41; Ding D, 2009, ANN BOT-LONDON, V103, P29, DOI 10.1093/aob/mcn205; Ding YF, 2011, J EXP BOT, V62, P3563, DOI 10.1093/jxb/err046; Eldem V, 2013, TURK J AGRIC FOR, V37, P1, DOI 10.3906/tar-1206-50; Fang YD, 2007, CURR BIOL, V17, P818, DOI 10.1016/j.cub.2007.04.005; Git A, 2010, RNA, V16, P991, DOI 10.1261/rna.1947110; Gonzalez-Ibeas D, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-393; Gotz S, 2008, NUCLEIC ACIDS RES, V36, P3420, DOI 10.1093/nar/gkn176; Jagadeeswaran G, 2009, PLANTA, V229, P1009, DOI 10.1007/s00425-009-0889-3; Jagadeeswaran G, 2009, NEW PHYTOL, V184, P85, DOI 10.1111/j.1469-8137.2009.02915.x; Jia XY, 2009, J PLANT PHYSIOL, V166, P2046, DOI 10.1016/j.jplph.2009.06.011; Jones-Rhoades MW, 2004, MOL CELL, V14, P787, DOI 10.1016/j.molcel.2004.05.027; Kantar M, 2011, PLANTA, V233, P471, DOI 10.1007/s00425-010-1309-4; Kantar M, 2010, FUNCT INTEGR GENOMIC, V10, P493, DOI 10.1007/s10142-010-0181-4; Kozomara A, 2011, NUCLEIC ACIDS RES, V39, pD152, DOI 10.1093/nar/gkq1027; Kurihara Y, 2004, P NATL ACAD SCI USA, V101, P12753, DOI 10.1073/pnas.0403115101; Lagos-Quintana M, 2001, SCIENCE, V294, P853, DOI 10.1126/science.1064921; Lee RC, 2001, SCIENCE, V294, P862, DOI 10.1126/science.1065329; Lee Y, 2004, EMBO J, V23, P4051, DOI 10.1038/sj.emboj.7600385; Li BS, 2011, J EXP BOT, V62, P3765, DOI 10.1093/jxb/err051; Li HY, 2011, BMC PLANT BIOL, V11, DOI 10.1186/1471-2229-11-170; Li HY, 2011, PLANTA, V233, P611, DOI 10.1007/s00425-010-1327-2; Li T, 2011, NUCLEIC ACIDS RES, V39, P2821, DOI 10.1093/nar/gkq1047; Li WX, 2008, PLANT CELL, V20, P2238, DOI 10.1105/tpc.108.059444; Lin SL, 2005, GENE, V356, P32, DOI 10.1016/j.gene.2005.04.036; Liu HH, 2008, RNA, V14, P836, DOI 10.1261/rna.895308; Lobbes D, 2006, EMBO REP, V7, P1052, DOI 10.1038/sj.embor.7400806; Lu SF, 2008, PLANT J, V55, P131, DOI 10.1111/j.1365-313X.2008.03497.x; MANTE S, 1989, PLANT CELL TISS ORG, V19, P1, DOI 10.1007/BF00037771; Miller G, 2010, PLANT CELL ENVIRON, V33, P453, DOI 10.1111/j.1365-3040.2009.02041.x; Moriya Y, 2007, NUCLEIC ACIDS RES, V35, pW182, DOI 10.1093/nar/gkm321; Nielsen Boye Schnack, 2012, Methods Mol Biol, V822, P67, DOI 10.1007/978-1-61779-427-8_5; Pantaleo V, 2010, PLANT J, V62, P960, DOI [10.1111/j.1365-313X.2010.04208.x, 10.1111/j.0960-7412.2010.04208.x]; Park W, 2002, CURR BIOL, V12, P1484, DOI 10.1016/S0960-9822(02)01017-5; Pennisi E, 2008, SCIENCE, V320, P171, DOI 10.1126/science.320.5873.171; Reinhart BJ, 2002, GENE DEV, V16, P1616, DOI 10.1101/gad.1004402; Reyes JL, 2007, PLANT J, V49, P592, DOI 10.1111/j.1365-313X.2006.02980.x; RIEGER M, 1992, TREE PHYSIOL, V11, P369, DOI 10.1093/treephys/11.4.369; Schwab R, 2005, DEV CELL, V8, P517, DOI 10.1016/j.devcel.2005.01.018; Song L, 2007, P NATL ACAD SCI USA, V104, P5437, DOI 10.1073/pnas.0701061104; Sunkar R., 2012, MICRORNAS PLANT DEV, P109, DOI [10.1007/978-3-642-27384-1_6, DOI 10.1007/978-3-642-27384-1_6]; Sunkar R, 2006, PLANT CELL, V18, P2051, DOI 10.1105/tpc.106.041673; Sunkar R, 2008, BMC PLANT BIOL, V8, DOI 10.1186/1471-2229-8-37; Sunkar R, 2012, TRENDS PLANT SCI, V17, P196, DOI 10.1016/j.tplants.2012.01.010; Sunkar R, 2010, SEMIN CELL DEV BIOL, V21, P805, DOI 10.1016/j.semcdb.2010.04.001; Takhtajan A, 1997, DIVERSITY CLASSIFICA; Tani E, 2011, PLANT PHYSIOL BIOCH, V49, P654, DOI 10.1016/j.plaphy.2011.01.020; Trindade I, 2010, PLANTA, V231, P705, DOI 10.1007/s00425-009-1078-0; Unver T, 2010, PLANT CELL REP, V29, P757, DOI 10.1007/s00299-010-0862-4; Unver T, 2010, MOL GENET GENOMICS, V283, P397, DOI 10.1007/s00438-010-0526-7; Unver T, 2009, PLANTA, V230, P659, DOI 10.1007/s00425-009-0974-7; Varallyay E, 2008, NAT PROTOC, V3, P190, DOI 10.1038/nprot.2007.528; Voinnet O, 2009, CELL, V136, P669, DOI 10.1016/j.cell.2009.01.046; Wang C, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-122; Wang TZ, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-367; Wei B, 2009, FUNCT INTEGR GENOMIC, V9, P499, DOI 10.1007/s10142-009-0128-9; Willenbrock H, 2009, RNA, V15, P2028, DOI 10.1261/rna.1699809; Yang L, 2006, PLANT J, V47, P841, DOI 10.1111/j.1365-313X.2006.02835.x; Yao YY, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-6-r96; Zhang BH, 2006, CELL MOL LIFE SCI, V63, P246, DOI 10.1007/s00018-005-5467-7; Zhang BH, 2006, DEV BIOL, V289, P3, DOI 10.1016/j.ydbio.2005.10.036; Zhang JY, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-449; Zhang LF, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000716; Zhang ZH, 2010, NUCLEIC ACIDS RES, V38, pD806, DOI 10.1093/nar/gkp818; Zhao BT, 2007, BIOCHEM BIOPH RES CO, V354, P585, DOI 10.1016/j.bbrc.2007.01.022; Zhao BT, 2009, BMC MOL BIOL, V10, DOI 10.1186/1471-2199-10-29; Zhao CZ, 2010, BMC PLANT BIOL, V10, DOI 10.1186/1471-2229-10-3; Zhebentyayeva TN, 2008, TREE GENET GENOMES, V4, P403, DOI 10.1007/s11295-007-0119-8; Zhou LG, 2010, J EXP BOT, V61, P4157, DOI 10.1093/jxb/erq237; Zhou XF, 2008, BBA-GENE REGUL MECH, V1779, P780, DOI 10.1016/j.bbagrm.2008.04.005; Zoltan H, 2010, METHODS MOL BIOL, V592, P127, DOI 10.1007/978-1-60327-005-2_9; Zuker M, 2003, NUCLEIC ACIDS RES, V31, P3406, DOI 10.1093/nar/gkg595	87	123	135	4	107	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 5	2012	7	12							e50298	10.1371/journal.pone.0050298	http://dx.doi.org/10.1371/journal.pone.0050298			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	057TZ	23227166	Green Submitted, gold, Green Published			2022-12-27	WOS:000312588200027
J	Karanth, KK; Gopalaswamy, AM; DeFries, R; Ballal, N				Karanth, Krithi K.; Gopalaswamy, Arjun M.; DeFries, Ruth; Ballal, Natasha			Assessing Patterns of Human-Wildlife Conflicts and Compensation around a Central Indian Protected Area	PLOS ONE			English	Article							LARGE CARNIVORES; NATIONAL-PARK; LIVESTOCK; CROP; RESERVE; RISK; DEPREDATION; MANAGEMENT; ELEPHANTS; FARMS	Mitigating crop and livestock loss to wildlife and improving compensation distribution are important for conservation efforts in landscapes where people and wildlife co-occur outside protected areas. The lack of rigorously collected spatial data poses a challenge to management efforts to minimize loss and mitigate conflicts. We surveyed 735 households from 347 villages in a 5154 km 2 area surrounding Kanha Tiger Reserve in India. We modeled self-reported household crop and livestock loss as a function of agricultural, demographic and environmental factors, and mitigation measures. We also modeled self-reported compensation received by households as a function of demographic factors, conflict type, reporting to authorities, and wildlife species involved. Seventy-three percent of households reported crop loss and 33% livestock loss in the previous year, but less than 8% reported human injury or death. Crop loss was associated with greater number of cropping months per year and proximity to the park. Livestock loss was associated with grazing animals inside the park and proximity to the park. Among mitigation measures only use of protective physical structures were associated with reduced livestock loss. Compensation distribution was more likely for tiger related incidents, and households reporting loss and located in the buffer. Average estimated probability of crop loss was 0.93 and livestock loss was 0.60 for surveyed households. Estimated crop and livestock loss and compensation distribution were higher for households located inside the buffer. Our approach modeled conflict data to aid managers in identifying potential conflict hotspots, influential factors, and spatially maps risk probability of crop and livestock loss. This approach could help focus allocation of conservation efforts and funds directed at conflict prevention and mitigation where high densities of people and wildlife co-occur. Citation: Karanth KK, Gopalaswamy AM, DeFries R, Ballal N (2012) Assessing Patterns of Human-Wildlife Conflicts and Compensation around a Central Indian Protected Area. PLoS ONE 7(12): e50433. doi:10.1371/journal.pone.0050433	[Karanth, Krithi K.; DeFries, Ruth] Columbia Univ, New York, NY 10027 USA; [Karanth, Krithi K.; Gopalaswamy, Arjun M.; Ballal, Natasha] Ctr Wildlife Studies, Bangalore, Karnataka, India; [Karanth, Krithi K.] Duke Univ, Nicholas Sch Environm, Durham, NC 27708 USA; [Gopalaswamy, Arjun M.] Univ Oxford, Dept Zool, Wildlife Conservat Res Unit, Tubney, England; [Gopalaswamy, Arjun M.] Wildlife Conservat Soc India Program, Bangalore, Karnataka, India	Columbia University; Duke University; University of Oxford	Karanth, KK (corresponding author), Columbia Univ, New York, NY 10027 USA.	krithi.karanth@gmail.com			National Science Foundation Grant [1029219]; Centre for Wildlife Studies; Wildlife Conservation Society-India program	National Science Foundation Grant(National Science Foundation (NSF)); Centre for Wildlife Studies; Wildlife Conservation Society-India program	National Science Foundation Grant Number 1029219 supported this research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank Centre for Wildlife Studies and Wildlife Conservation Society-India program for support. We are grateful to the Madhya Pradesh forest department especially H. S. Pabla, J. S. Chauhan, H. S. Mohanta and R. Shukla for their support. We thank S. Dasgupta, R. Jhaveri, S. Kotian and N. Patil. We thank volunteers A. Sur, A. Dhanpal, A. Joshi, A. Kerketta, N. Kumar, A. Bade, A. Kodilkar, A. Mendis, C. V. Casiker, D. Prasad, D. Dixit, I. Majhgaonkar, K. P. Kothari, Mythri. S, N. Surve, N. Shitole, P. Ghaskadbi, P. Baro, P. Thatte, P.R. Khambe, P. D. Kamble, R. Chakravarty, R. Jha, S. Sawat, Shashank K, S. Yadav, V. Kumar, Vatsaraj, V. Shinde, and Y. S. Patil. Columbia University IRB approved all survey protocols.	Akkala A., 2010, ENV PROGR SUSTAINABL, V29, P134, DOI DOI 10.1002/EP.10455; Baruch-Mordo S., 2009, Human Dimensions of Wildlife, V14, P219, DOI 10.1080/10871200902839324; Boeringa M, 2003, KRIGING INTERPOLATOR; Boitani L, 2010, WILDLIFE RES, V37, P722, DOI 10.1071/WR10029; Bulte EH, 2005, J WILDLIFE MANAGE, V69, P14, DOI 10.2193/0022-541X(2005)069&lt;0014:WCWDMB&gt;2.0.CO;2; Burnham K.P., 2002, PRACTICAL INFORM THE, V2nd ed., DOI [DOI 10.1007/B97636, 10.1007/b97636]; Campbell-Smith G, 2012, J APPL ECOL, V49, P367, DOI 10.1111/j.1365-2664.2012.02109.x; Cohen J.E., 1988, STAT POWER ANAL BEHA; Cressie NAC, 1991, STAT SPATIAL DATA, P900; DeFries R, 2010, BIOL CONSERV, V143, P2870, DOI 10.1016/j.biocon.2010.02.010; Dickman AJ, 2010, ANIM CONSERV, V13, P458, DOI 10.1111/j.1469-1795.2010.00368.x; Gehring TM, 2010, WILDLIFE RES, V37, P715, DOI 10.1071/WR10023; Gelman A, 2008, STAT MED, V27, P2865, DOI 10.1002/sim.3107; Gopalaswamy AM, 2012, ANIM CONSERV, V15, P669, DOI 10.1111/j.1469-1795.2012.00565.x; Gore ML, 2008, CONSERV LETT, V1, P136, DOI 10.1111/j.1755-263X.2008.00017.x; Graham MD, 2008, ORYX, V42, P76, DOI 10.1017/S0030605308000677; Jarynowski A., 2010, LIFE TIME CORRELATIO, V1; Karanth KK, 2012, ENVIRON MANAGE, V49, P372, DOI 10.1007/s00267-011-9778-1; Karanth KU, 2002, MAKING PARKS WORK: STRATEGIES FOR PRESERVING TROPICAL NATURE, P250; Kolowski JM, 2006, BIOL CONSERV, V128, P529, DOI 10.1016/j.biocon.2005.10.021; Linkie M, 2007, ANIM CONSERV, V10, P127, DOI 10.1111/j.1469-1795.2006.00083.x; Madden Francine, 2004, Human Dimensions of Wildlife, V9, P247, DOI 10.1080/10871200490505675; Mateo-Tomas P, 2012, J APPL ECOL, V49, P376, DOI 10.1111/j.1365-2664.2012.02119.x; McDonald-Madden E, 2008, J APPL ECOL, V45, P1630, DOI 10.1111/j.1365-2664.2008.01553.x; Mitas L., 1999, GEOGRAPHICAL INFORM, V8, P481; Naughton-Treves L, 1997, GEOGR REV, V87, P27, DOI 10.2307/215656; Naughton-Treves L, 2003, CONSERV BIOL, V17, P1500, DOI 10.1111/j.1523-1739.2003.00060.x; Peterson MN, 2010, CONSERV LETT, V3, P74, DOI 10.1111/j.1755-263X.2010.00099.x; Roskaft E, 2003, EVOL HUM BEHAV, V24, P184, DOI 10.1016/S1090-5138(03)00011-4; Sekhar NU, 1998, ENVIRON CONSERV, V25, P160, DOI 10.1017/S0376892998000204; Sitati NW, 2005, J APPL ECOL, V42, P1175, DOI 10.1111/j.1365-2664.2005.01091.x; Treves A, 2003, CONSERV BIOL, V17, P1491, DOI 10.1111/j.1523-1739.2003.00059.x; Treves A, 2005, CONSERV BIOL SER, V9, P86; Treves A, 1999, J HUM EVOL, V36, P275, DOI 10.1006/jhev.1998.0268; Treves A, 2011, BIOSCIENCE, V61, P451, DOI 10.1525/bio.2011.61.6.7; Treves A, 2009, CONSERV BIOL, V23, P1577, DOI 10.1111/j.1523-1739.2009.01242.x; Webber AD, 2007, ORYX, V41, P177, DOI 10.1017/S0030605307001792; White PCL, 2010, WILDLIFE RES, V37, P623, DOI 10.1071/WR10191; Woodroffe R., 2005, CONSERV BIOL	39	88	92	3	148	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 5	2012	7	12							e50433	10.1371/journal.pone.0050433	http://dx.doi.org/10.1371/journal.pone.0050433			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	057TZ	23227173	Green Published, gold			2022-12-27	WOS:000312588200034
J	Mason, B; Schmale, M; Gibbs, P; Miller, MW; Wang, Q; Levay, K; Shestopalov, V; Slepak, VZ				Mason, Benjamin; Schmale, Michael; Gibbs, Patrick; Miller, Margaret W.; Wang, Qiang; Levay, Konstantin; Shestopalov, Valery; Slepak, Vladlen Z.			Evidence for Multiple Phototransduction Pathways in a Reef-Building Coral	PLOS ONE			English	Article							SEQUENCE ALIGNMENT; VISUAL PIGMENTS; LIGHT; EVOLUTION; COUNTERION; RHODOPSIN; ROD; PHOTORECEPTORS; MELANOPSIN; EXPRESSION	Photosensitive behaviors and circadian rhythms are well documented in reef-building corals and their larvae, but the mechanisms responsible for photoreception have not been described in these organisms. Here we report the cloning, immunolocalization, and partial biochemical characterization of three opsins and four G proteins expressed in planulae of the Caribbean elkhorn coral, Acropora palmata. All three opsins (acropsins 1-3) possess conserved seven-pass transmembrane structure, and localize to distinct regions of coral planulae. Acropsin 1 was localized in the larval endoderm, while acropsin 2 was localized in solitary cells of the ectoderm. These rod-like cells displayed a remarkably polarized distribution, concentrated in the aboral end. We also cloned four A. palmata G protein alpha subunits. Three were homologs of vertebrate Gi, Go, and Gq. The fourth is presumably a novel G protein, which displays only 40% identity with the nearest known G protein, and we termed it Gc for "cnidarian''. We show that Gc and Gq can be activated by acropsins in a light-dependent manner in vitro. This indicates that at least acropsins 1 and 3 can form functional photoreceptors and potentially may play a role in color preference during settlement, vertical positioning and other light-guided behaviors observed in coral larvae. Citation: Mason B, Schmale M, Gibbs P, Miller MW, Wang Q, et al. (2012) Evidence for Multiple Phototransduction Pathways in a Reef-Building Coral. PLoS ONE 7(12): e50371. doi:10.1371/journal.pone.0050371	[Mason, Benjamin; Wang, Qiang; Levay, Konstantin; Slepak, Vladlen Z.] Univ Miami, Miller Sch Med, Dept Mol & Cellular Pharmacol, Miami, FL 33136 USA; [Mason, Benjamin; Schmale, Michael; Gibbs, Patrick] Univ Miami, Rosenstiel Sch Marine & Atmospher Sci, Miami, FL 33149 USA; [Miller, Margaret W.] Natl Marine Fisheries Serv, SE Fisheries Sci Ctr, Miami, FL USA; [Shestopalov, Valery] Univ Miami, Miller Sch Med, Dept Ophthalmol, Miami, FL 33136 USA	University of Miami; University of Miami; National Oceanic Atmospheric Admin (NOAA) - USA; University of Miami	Mason, B (corresponding author), James Cook Univ, ARC Ctr Excellence Coral Reef Studies, Townsville, Qld 4811, Australia.	ben.mason@jcu.edu.au; VSlepak@med.miami.edu	Shestopalov, Valery/AAE-9838-2020	Shestopalov, Valery/0000-0002-1568-6637	Florida Keys National Marine Sanctuary; National Oceanic and Atmospheric Administration (NOAA) Coral Reef Conservation Program; Henry Foundation; Ocean Foundation; University of Miami SAC award; National Institutes of Health (NIH) [RO1EY018666, RO1GM060019, EY017991, EY021517]; NIH center grant [P30 EY014801]; Research to Prevent Blindness (RPB) grant; NATIONAL EYE INSTITUTE [R21EY017991, P30EY014801, R01EY018666, R01EY021517] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM060019] Funding Source: NIH RePORTER	Florida Keys National Marine Sanctuary; National Oceanic and Atmospheric Administration (NOAA) Coral Reef Conservation Program(National Oceanic Atmospheric Admin (NOAA) - USA); Henry Foundation; Ocean Foundation; University of Miami SAC award; National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH center grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Research to Prevent Blindness (RPB) grant(Research to Prevent Blindness (RPB)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We gratefully acknowledge D. Williams, L. Johnston, and others for their assistance with fieldwork and larval culture, M. Medina for supplying larval RNA, I. Baums and N. Polato for sharing unpublished A. palmata transcriptome data, G. Gaidosh for help with confocal microscopy and imaging, R. Crouch (Medical University of South Carolina and NEI, National Institutes of Health) for providing 11-cis-retinal, D. Farrens for helpful discussions, and R. Albright for advice during preparation of this manuscript. This project was facilitated by permits FKNMS-2006-026, FKNMS-2009-022, FKNMS-2010-055, and support from the Florida Keys National Marine Sanctuary.; Funding was provided by the National Oceanic and Atmospheric Administration (NOAA) Coral Reef Conservation Program, the Henry Foundation, and the Ocean Foundation. The project was also supported by University of Miami SAC award and National Institutes of Health (NIH) grants RO1EY018666 and RO1GM060019 (VZS) and EY017991 and EY021517 (VIS), NIH center grant P30 EY014801 and an unrestricted Research to Prevent Blindness (RPB) grant to the Department of Ophthalmology. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Brady AK, 2009, CORAL REEFS, V28, P677, DOI 10.1007/s00338-009-0498-4; Dubinsky Z, 2011, CORAL REEFS: AN ECOSYSTEM IN TRANSITION, P107, DOI 10.1007/978-94-007-0114-4_8; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Gleason DF, 2006, MAR BIOL, V148, P503, DOI 10.1007/s00227-005-0098-y; Gorbunov MY, 2002, LIMNOL OCEANOGR, V47, P309, DOI 10.4319/lo.2002.47.1.0309; Harrison P.L., 1990, ECOSYSTEMS WORLD, V25, P133; Hattar S, 2003, NATURE, V424, P76, DOI 10.1038/nature01761; Jekely G, 2008, NATURE, V456, P395, DOI 10.1038/nature07590; JOKIEL PL, 1985, MAR BIOL, V88, P167, DOI 10.1007/BF00397164; Jones JC, 2010, SIGNAL COMMUN PLANTS, P1, DOI 10.1007/978-3-642-03524-1_1; Kawaguti S., 1941, Palao Tropical Biological Station Studies, V2, P319; Kojima D, 1997, J BIOL CHEM, V272, P22979, DOI 10.1074/jbc.272.37.22979; Koyanagi M, 1998, FEBS LETT, V439, P66, DOI 10.1016/S0014-5793(98)01339-8; Koyanagi M, 2002, FEBS LETT, V531, P525, DOI 10.1016/S0014-5793(02)03616-5; Koyanagi M, 2008, P NATL ACAD SCI USA, V105, P15576, DOI 10.1073/pnas.0806215105; Land MF, 2002, OXFORD ANIMAL BIOLOG; LASKER HR, 1979, BIOL BULL, V156, P196, DOI 10.2307/1541043; Levy O, 2007, SCIENCE, V318, P467, DOI 10.1126/science.1145432; Levy O, 2011, SCIENCE, V331, P175, DOI 10.1126/science.1196419; Martin VJ, 2002, CAN J ZOOL, V80, P1703, DOI 10.1139/Z02-136; Mason B, 2011, CORAL REEFS, V30, P667, DOI 10.1007/s00338-011-0739-1; Mason BM, 2012, BIOL BULL-US, V222, P88, DOI 10.1086/BBLv222n2p88; Miller Margaret W., 2006, P219; Mundy CN, 1998, J EXP MAR BIOL ECOL, V223, P235, DOI 10.1016/S0022-0981(97)00167-6; NATHANS J, 1990, BIOCHEMISTRY-US, V29, P9746, DOI 10.1021/bi00493a034; NAVON SE, 1987, J BIOL CHEM, V262, P15746; Nilsson DE, 2005, NATURE, V435, P201, DOI 10.1038/nature03484; Oldham WM, 2008, NAT REV MOL CELL BIO, V9, P60, DOI 10.1038/nrm2299; Palczewski K, 2006, ANNU REV BIOCHEM, V75, P743, DOI 10.1146/annurev.biochem.75.103004.142743; Peirson SN, 2009, PHILOS T R SOC B, V364, P2849, DOI 10.1098/rstb.2009.0050; Plachetzki DC, 2010, P ROY SOC B-BIOL SCI, V277, P1963, DOI 10.1098/rspb.2009.1797; Porter ML, 2012, P ROY SOC B-BIOL SCI, V279, P3, DOI 10.1098/rspb.2011.1819; Radu RA, 2008, J BIOL CHEM, V283, P19730, DOI 10.1074/jbc.M801288200; Rosenzweig DH, 2007, J NEUROSCI, V27, P5484, DOI 10.1523/JNEUROSCI.1421-07.2007; Rozen S, 2000, Methods Mol Biol, V132, P365; Shichida Y, 2009, PHILOS T R SOC B, V364, P2881, DOI 10.1098/rstb.2009.0051; SIMON MI, 1991, SCIENCE, V252, P802, DOI 10.1126/science.1902986; SINGLA CL, 1974, CELL TISSUE RES, V149, P413; Suga H, 2008, CURR BIOL, V18, P51, DOI 10.1016/j.cub.2007.11.059; Sweeney AM, 2011, J EXP BIOL, V214, P770, DOI 10.1242/jeb.043406; Szmant A. M., 2006, P 10 INT COR REEF S, P431; Terakita A, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-3-213; Terakita A, 2004, NAT STRUCT MOL BIOL, V11, P284, DOI 10.1038/nsmb731; Terakita A, 2000, P NATL ACAD SCI USA, V97, P14263, DOI 10.1073/pnas.260349597; Terakita A, 2008, J NEUROCHEM, V105, P883, DOI 10.1111/j.1471-4159.2007.05184.x; VANDERMEULEN JH, 1974, MAR BIOL, V27, P239, DOI 10.1007/BF00391949; Waterhouse AM, 2009, BIOINFORMATICS, V25, P1189, DOI 10.1093/bioinformatics/btp033; Westfall JA, 1998, INVERTEBR BIOL, V117, P186, DOI 10.2307/3226984; Wolken J., 1995, LIGHT DETECTORS PHOT; Yau KW, 2009, CELL, V139, P246, DOI 10.1016/j.cell.2009.09.029; YOKOYAMA S, 1995, MOL BIOL EVOL, V12, P53, DOI 10.1093/oxfordjournals.molbev.a040190	51	30	30	1	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 5	2012	7	12							e50371	10.1371/journal.pone.0050371	http://dx.doi.org/10.1371/journal.pone.0050371			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	057TZ	23227169	Green Submitted, gold, Green Published			2022-12-27	WOS:000312588200030
J	Ertelt, D; Witt, K; Reetz, K; Frank, W; Junghanns, K; Backhaus, J; Tadic, V; Pellicano, A; Born, J; Binkofski, F				Ertelt, Denis; Witt, Karsten; Reetz, Kathrin; Frank, Wolfgang; Junghanns, Klaus; Backhaus, Jutta; Tadic, Vera; Pellicano, Antonello; Born, Jan; Binkofski, Ferdinand			Skill Memory Escaping from Distraction by Sleep-Evidence from Dual-Task Performance	PLOS ONE			English	Article							MOTOR MEMORY; TIME-COURSE; SEQUENCE; CONSOLIDATION; ACQUISITION; ATTENTION	Background: Sleep facilitates off-line consolidation of memories, as shown for learning of motor skills in the absence of concomitant distractors. We often perform complex tasks focusing our attention mostly on one single part of them. However, we are equally able to skillfully perform other concurrent tasks. One may even improve performance on disregarded parts of complex tasks, which were learned implicitly. In the present study we investigated the role of sleep in the off-line consolidation of procedural skills when attention is diverted from the procedural task because of interference from a concurrent task. Methodology/Principal Findings: We used a dual-task paradigm containing (i) procedural serial reaction time task (SRTT), which was labeled as subordinate and unimportant and (ii) declarative word-pair association task (WPAT), performed concomitantly. The WPAT served as a masked distractor to SRTT and was strongly reinforced by the instructions. One experimental and three control groups were tested. The experimental group was re-tested after two nights of sleep (sleep group, SG). The first control group had sleep deprivation on the first post-learning night (nighttime-awake group, NA), the second control group was tested in the morning and then re-tested after 12-hours (daytime-awake group, DA); the third one had the same assignments as DA but with a subsequent, instead of a concomitant, WPAT (daytime-awake-subsequent-WPAT group, DAs). We found SRTT performance gains in SG but not in NA and DA groups. Furthermore, SG reached similar learning gains in SRTT as the DAs group, which gained in SRTT performance because of post-training interference from the declarative task. Conclusions/Significance: The results demonstrate that sleep allows off-line consolidation, which is resistant to deteriorating effects of a reinforced distractor on the implicit procedural learning and allowing for gains which are consistent with those produced when inhibited declarative memories of SRTT do not compete with procedural ones. Citation: Ertelt D, Witt K, Reetz K, Frank W, Junghanns K, et al. (2012) Skill Memory Escaping from Distraction by Sleep-Evidence from Dual-Task Performance. PLoS ONE 7(12): e50983. doi:10.1371/journal.pone.0050983	[Reetz, Kathrin; Binkofski, Ferdinand] Res Ctr Julich, Inst Neurosci & Med, Julich, Germany; [Ertelt, Denis; Tadic, Vera] Med Univ Lubeck, Dept Neurol, D-23538 Lubeck, Germany; [Witt, Karsten] Univ Kiel, Dept Neurol, D-2300 Kiel, Germany; [Reetz, Kathrin] Rhein Westfal TH Aachen Univ, Dept Neurol, Aachen, Germany; [Reetz, Kathrin; Binkofski, Ferdinand] Rhein Westfal TH Aachen Univ, JARA BRAIN Translat Brain Med, Aachen, Germany; [Junghanns, Klaus; Backhaus, Jutta] Med Univ Lubeck, Dept Psychiat, D-23538 Lubeck, Germany; [Born, Jan] Med Univ Lubeck, Dept Neuroendocrinol, D-23538 Lubeck, Germany; [Pellicano, Antonello; Binkofski, Ferdinand] Rhein Westfal TH Aachen, Dept Neurol, Fac Med, Div Clin & Cognit Neurosci, Aachen, Germany	Helmholtz Association; Research Center Julich; University of Lubeck; University of Kiel; RWTH Aachen University; RWTH Aachen University; University of Lubeck; University of Lubeck; RWTH Aachen University	Binkofski, F (corresponding author), Res Ctr Julich, Inst Neurosci & Med, Julich, Germany.	fbinkofski@ukaachen.de	Binkofski, Ferdinand/S-6997-2017; Born, Jan/K-2596-2016; Reetz, Kathrin/H-9510-2012; Pellicano, Antonello/C-7638-2017	Binkofski, Ferdinand/0000-0002-6750-943X; Born, Jan/0000-0002-1847-6248; Reetz, Kathrin/0000-0002-9730-9228; Pellicano, Antonello/0000-0003-1517-1323	German Research Council (Sonderforschungsbereich) [SFB 654, A2, A11]	German Research Council (Sonderforschungsbereich)(German Research Foundation (DFG))	This study was supported by the German Research Council (Sonderforschungsbereich SFB 654, Projects A2 and A11). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Born J, 2006, NEUROSCIENTIST, V12, P410, DOI 10.1177/1073858406292647; Brown RM, 2007, J NEUROSCI, V27, P10468, DOI 10.1523/JNEUROSCI.2799-07.2007; BUYSSE DJ, 1989, PSYCHIAT RES, V28, P193, DOI 10.1016/0165-1781(89)90047-4; CLEEREMANS A, 1991, J EXP PSYCHOL GEN, V120, P235, DOI 10.1037/0096-3445.120.3.235; COHEN A, 1990, J EXP PSYCHOL LEARN, V16, P17, DOI 10.1037/0278-7393.16.1.17; Ebbinghaus, 1885, GEDACHTNIS; Fenn KM, 2003, NATURE, V425, P614, DOI 10.1038/nature01951; Fischer S, 2005, J NEUROSCI, V25, P11248, DOI 10.1523/JNEUROSCI.1743-05.2005; Fischer S, 2002, P NATL ACAD SCI USA, V99, P11987, DOI 10.1073/pnas.182178199; Graves EA, 1936, J EXP PSYCHOL, V19, P316, DOI 10.1037/h0057827; Hazeltine E, 1997, BRAIN, V120, P123, DOI 10.1093/brain/120.1.123; Janke W, 2003, J EXPT PSYCHOL LEARN, V22, P948; Jenkins JG, 1924, AM J PSYCHOL, V35, P605, DOI 10.2307/1414040; KNOPMAN DS, 1987, NEUROLOGY, V37, P784, DOI 10.1212/WNL.37.5.784; Korman M, 2003, P NATL ACAD SCI USA, V100, P12492, DOI 10.1073/pnas.2035019100; Korman M, 2007, NAT NEUROSCI, V10, P1206, DOI 10.1038/nn1959; McGaugh JL, 2000, SCIENCE, V287, P248, DOI 10.1126/science.287.5451.248; Newman EB, 1939, AM J PSYCHOL, V52, P65, DOI 10.2307/1416661; NISSEN MJ, 1987, COGNITIVE PSYCHOL, V19, P1, DOI 10.1016/0010-0285(87)90002-8; OLDFIELD RC, 1971, NEUROPSYCHOLOGIA, V9, P97, DOI 10.1016/0028-3932(71)90067-4; Peigneux P, 2003, NEUROIMAGE, V20, P125, DOI 10.1016/S1053-8119(03)00278-7; Peigneux P, 2000, HUM BRAIN MAPP, V10, P179, DOI 10.1002/1097-0193(200008)10:4<179::AID-HBM30>3.0.CO;2-H; Rasch B, 2007, CURR OPIN NEUROBIOL, V17, P698, DOI 10.1016/j.conb.2007.11.007; Robertson EM, 2004, CURR BIOL, V14, P208, DOI 10.1016/j.cub.2004.01.027; Robertson EM, 2005, J NEUROSCI, V25, P6372, DOI 10.1523/JNEUROSCI.1851-05.2005; Robertson EM, 2004, NAT REV NEUROSCI, V5, P576, DOI 10.1038/nrn1426; Robertson EM, 2004, CURR BIOL, V14, pR1061, DOI 10.1016/j.cub.2004.11.048; Seidler RD, 2002, SCIENCE, V296, P2043, DOI 10.1126/science.1068524; SMITH C, 1994, J SLEEP RES, V3, P206, DOI 10.1111/j.1365-2869.1994.tb00133.x; Song SB, 2007, J NEUROSCI, V27, P12475, DOI 10.1523/JNEUROSCI.2062-07.2007; Stickgold R, 2000, J COGNITIVE NEUROSCI, V12, P246, DOI 10.1162/089892900562075; Stickgold R, 2001, SCIENCE, V294, P1052, DOI 10.1126/science.1063530; Van Ormer EB, 1933, PSYCHOL BULL, V30, P415, DOI 10.1037/h0071478; Walker MP, 2005, BEHAV BRAIN SCI, V28, P51, DOI 10.1017/S0140525X05000026; Walker MP, 2005, NEUROSCIENCE, V133, P911, DOI 10.1016/j.neuroscience.2005.04.007; Walker MP, 2003, LEARN MEMORY, V10, P275, DOI 10.1101/lm.58503; Walker MP, 2002, NEURON, V35, P205, DOI 10.1016/S0896-6273(02)00746-8; Walker MP, 2003, NATURE, V425, P616, DOI 10.1038/nature01930; WILLINGHAM DB, 1989, J EXP PSYCHOL LEARN, V15, P1047, DOI 10.1037/0278-7393.15.6.1047	39	10	10	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 4	2012	7	12							e50983	10.1371/journal.pone.0050983	http://dx.doi.org/10.1371/journal.pone.0050983			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	051EQ	23226554	Green Submitted, Green Published, gold			2022-12-27	WOS:000312108500038
J	Santos, F; Gomez-Gesteira, M; deCastro, M; Alvarez, I				Santos, Fran; Gomez-Gesteira, Moncho; deCastro, Maite; Alvarez, Ines			Variability of Coastal and Ocean Water Temperature in the Upper 700 m along the Western Iberian Peninsula from 1975 to 2006	PLOS ONE			English	Article							SEA-SURFACE-TEMPERATURE; ESTIMATING CLIMATIC TRENDS; DATA ASSIMILATION ANALYSIS; SST VARIABILITY; DECADAL CHANGES; PART II; REGIME	Temperature is observed to have different trends at coastal and ocean locations along the western Iberian Peninsula from 1975 to 2006, which corresponds to the last warming period in the area under study. The analysis was carried out by means of the Simple Ocean Data Assimilation (SODA). Reanalysis data are available at monthly scale with a horizontal resolution of 0.5 degrees x0.5 degrees and a vertical resolution of 40 levels, which allows obtaining information beneath the sea surface. Only the first 21 vertical levels (from 5.0 m to 729.35 m) were considered here, since the most important changes in heat content observed for the world ocean during the last decades, correspond to the upper 700 m. Warming was observed to be considerably higher at ocean locations than at coastal ones. Ocean warming ranged from values on the order of 0.3 degrees C dec(-1) near surface to less than 0.1 degrees C dec(-1) at 500 m, while coastal warming showed values close to 0.2 degrees C dec(-1) near surface, decreasing rapidly below 0.1 degrees C dec(-1) for depths on the order of 50 m. The heat content anomaly for the upper 700 m, showed a sharp increase from coast (0.46 Wm(-2)) to ocean (1.59 Wm(-2)). The difference between coastal and ocean values was related to the presence of coastal upwelling, which partially inhibits the warming from surface of near shore water. Citation: Santos F, Gomez-Gesteira M, deCastro M, Alvarez I (2012) Variability of Coastal and Ocean Water Temperature in the Upper 700 m along the Western Iberian Peninsula from 1975 to 2006. PLoS ONE 7(12): e50666. doi:10.1371/journal.pone.0050666	[Santos, Fran; Gomez-Gesteira, Moncho; deCastro, Maite; Alvarez, Ines] Univ Vigo, EPphysLab Environm Phys Lab, Orense, Spain; [Alvarez, Ines] Univ Aveiro, Dept Fis, CESAM, P-3800 Aveiro, Portugal	Universidade de Vigo; Universidade de Aveiro	Santos, F (corresponding author), Univ Vigo, EPphysLab Environm Phys Lab, Orense, Spain.	fsantos@uvigo.es	Gesteira, Moncho Gomez/R-9431-2019; deCastro, Maite/R-6739-2019; Alvarez, Ines/F-9482-2016	Gesteira, Moncho Gomez/0000-0002-0661-9731; deCastro, Maite/0000-0001-6443-3620; Alvarez, Ines/0000-0002-3837-1742; Santos, Fran/0000-0002-4576-3744	Xunta de Galicia [10PXIB 383169PR]; Programa de Consolidacion e Estruturacion de Unidades de Investigacion (Grupos de Referencia Competitiva); European Regional Development Fund (FEDER); Ministerio de Ciencia e Innovacion; Ramon y Cajal Program	Xunta de Galicia(Xunta de GaliciaEuropean Commission); Programa de Consolidacion e Estruturacion de Unidades de Investigacion (Grupos de Referencia Competitiva); European Regional Development Fund (FEDER)(European Commission); Ministerio de Ciencia e Innovacion(Ministry of Science and Innovation, Spain (MICINN)Instituto de Salud Carlos IIISpanish Government); Ramon y Cajal Program(Spanish Government)	This work is partially supported by Xunta de Galicia under projects 10PXIB 383169PR and Programa de Consolidacion e Estruturacion de Unidades de Investigacion (Grupos de Referencia Competitiva) funded by European Regional Development Fund (FEDER). This work is a contribution to the Spanish LOICZ (IGBP committee) supported by the Ministerio de Ciencia e Innovacion. I. Alvarez is supported by the Ramon y Cajal Program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ambar I, 2002, DEEP-SEA RES PT II, V49, P4163, DOI 10.1016/S0967-0645(02)00148-0; BAKUN A, 1990, SCIENCE, V247, P198, DOI 10.1126/science.247.4939.198; Brohan P, 2006, J GEOPHYS RES-ATMOS, V111, DOI 10.1029/2005JD006548; Carton JA, 2000, J PHYS OCEANOGR, V30, P311, DOI [10.1175/1520-0485(2000)030<0311:ASODAA>2.0.CO;2, 10.1175/1520-0485(2000)030<0294:ASODAA>2.0.CO;2]; Carton JA, 2008, MON WEATHER REV, V136, P2999, DOI 10.1175/2007MWR1978.1; Casey KS, 2001, J CLIMATE, V14, P3801, DOI 10.1175/1520-0442(2001)014<3801:GARSST>2.0.CO;2; Cole JE, 2000, SCIENCE, V287, P617, DOI 10.1126/science.287.5453.617; deCastro M, 2008, CLIM RES, V36, P169, DOI 10.3354/cr00742; deCastro M, 2009, CONT SHELF RES, V29, P1053, DOI 10.1016/j.csr.2008.11.016; Domingues CM, 2008, NATURE, V453, P1090, DOI 10.1038/nature07080; FOLLAND CK, 1984, NATURE, V310, P670, DOI 10.1038/310670a0; FOLLAND CK, 1995, Q J ROY METEOR SOC, V121, P319, DOI 10.1002/qj.49712152206; Folland CK., 1992, CLIMATE CHANGE 1992, P135; Garcia-Soto C, 2002, J GEOPHYS RES, V107, DOI DOI 10.1029/2001JC001012; Giese BS, 2011, J GEOPHYS RES-OCEANS, V116, DOI 10.1029/2010JC006695; Gill AE, 1982, ATMOSPHERIC OCEAN DY; Ginzburg AI, 2004, J MARINE SYST, V52, P33, DOI 10.1016/j.jmarsys.2004.05.002; Goikoetxea N, 2009, CONT SHELF RES, V29, P1060, DOI 10.1016/j.csr.2008.11.014; Gomez-Gesteira M, 2011, CLIM RES, V48, P109, DOI 10.3354/cr00967; Gomez-Gesteira M, 2008, J GEOPHYS RES-OCEANS, V113, DOI 10.1029/2007JC004315; Gonzalez-Pola C, 2005, J GEOPHYS RES-OCEANS, V110, DOI 10.1029/2004JC002367; Kaplan A, 1998, J GEOPHYS RES-OCEANS, V103, P18567, DOI 10.1029/97JC01734; Kara AB, 2000, J GEOPHYS RES-OCEANS, V105, P16803, DOI 10.1029/2000JC900072; Katsman CA, 2011, GEOPHYS RES LETT, V38, DOI 10.1029/2011GL048417; Kent EC, 2006, J ATMOS OCEAN TECH, V23, P464, DOI 10.1175/JTECH1843.1; Kent EC, 2006, J ATMOS OCEAN TECH, V23, P476, DOI 10.1175/JTECH1844.1; KUSHNIR Y, 1994, INTERDECADAL VARIATI, V7, P141; Lemos RT, 2004, INT J CLIMATOL, V24, P511, DOI 10.1002/joc.1009; Levitus S, 2000, SCIENCE, V287, P2225, DOI 10.1126/science.287.5461.2225; Levitus S, 2012, GEOPHYS RES LETT, V39, DOI 10.1029/2012GL051106; Levitus S, 2009, GEOPHYS RES LETT, V36, DOI 10.1029/2008GL037155; Levitus S, 2005, GEOPHYS RES LETT, V32, DOI 10.1029/2004GL021592; Lyman JM, 2010, NATURE, V465, P334, DOI 10.1038/nature09043; Michel S, 2009, CONT SHELF RES, V29, P1070, DOI 10.1016/j.csr.2008.11.019; Nerem RS, 1999, GEOPHYS RES LETT, V26, P3005, DOI 10.1029/1999GL002311; Nicholls N, 1995, CLIMATE CHANGE 1995: THE SCIENCE OF CLIMATE CHANGE, P133; OSPAR, 2000, QUAL STAT REP REG 4; PALTRIDGE G, 1981, MON WEATHER REV, V109, P2427, DOI 10.1175/1520-0493(1981)109<2427:CIGSTF>2.0.CO;2; Pardo PC, 2011, CLIM RES, V48, P231, DOI 10.3354/cr00989; PARKER DE, 1994, J GEOPHYS RES-ATMOS, V99, P14373, DOI 10.1029/94JD00548; Patti B, 2008, ESTUAR COAST SHELF S, V76, P775, DOI 10.1016/j.ecss.2007.08.005; Patti B, 2010, ESTUAR COAST SHELF S, V88, P45, DOI 10.1016/j.ecss.2010.03.004; Perez FF, 1995, DEEP-SEA RES PT I, V42, P1849, DOI 10.1016/0967-0637(95)00091-7; Perez FF, 2010, GLOBAL CHANGE BIOL, V16, P1258, DOI 10.1111/j.1365-2486.2009.02125.x; Rayner NA, 2003, J GEOPHYS RES-ATMOS, V108, DOI 10.1029/2002JD002670; Rayner NA, 2006, J CLIMATE, V19, P446, DOI 10.1175/JCLI3637.1; Santos AMP, 2005, J MAR RES, V63, P359, DOI 10.1357/0022240053693671; Santos F, 2012, CONT SHELF RES, V47, P1, DOI 10.1016/j.csr.2012.07.023; Santos F, 2011, CONT SHELF RES, V31, P2012, DOI 10.1016/j.csr.2011.10.005; Santos F, 2012, CONT SHELF RES, V34, P79, DOI 10.1016/j.csr.2011.12.004; Santos F, 2011, CLIM RES, V48, P213, DOI 10.3354/cr00972; Schwing FB, 1997, J GEOPHYS RES-OCEANS, V102, P3421, DOI 10.1029/96JC03591; Smith TM, 2008, J CLIMATE, V21, P2283, DOI 10.1175/2007JCLI2100.1; Smith TM, 2005, J CLIMATE, V18, P2021, DOI 10.1175/JCLI3362.1; Solomon S., 2007, PHYS SCI BASIS WORKI; Strong AE, 2000, GEOPHYS RES LETT, V27, P1667, DOI 10.1029/1999GL002392; Worley SJ, 2005, INT J CLIMATOL, V25, P823, DOI 10.1002/joc.1166; Zheng YX, 2010, J PHYS OCEANOGR, V40, P103, DOI 10.1175/2009JPO4213.1; Zheng YX, 2009, J GEOPHYS RES-OCEANS, V114, DOI 10.1029/2008JC005190	59	10	10	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 4	2012	7	12							e50666	10.1371/journal.pone.0050666	http://dx.doi.org/10.1371/journal.pone.0050666			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	051EQ	23226533	gold, Green Published, Green Submitted			2022-12-27	WOS:000312108500026
J	Saito, M; Stahley, SN; Caughman, CY; Mao, XM; Tucker, DK; Payne, AS; Amagai, M; Kowalczyk, AP				Saito, Masataka; Stahley, Sara N.; Caughman, Christopher Y.; Mao, Xuming; Tucker, Dana K.; Payne, Aimee S.; Amagai, Masayuki; Kowalczyk, Andrew P.			Signaling Dependent and Independent Mechanisms in Pemphigus Vulgaris Blister Formation	PLOS ONE			English	Article							TERMINAL ADHESIVE REGION; DESMOGLEIN 3; VE-CADHERIN; MONOCLONAL-ANTIBODIES; BULLOUS IMPETIGO; MOUSE MODEL; IGG CAUSES; DESMOSOMES; ACANTHOLYSIS; DISEASE	Pemphigus vulgaris (PV) is an autoimmune epidermal blistering disease caused by autoantibodies directed against the desmosomal cadherin desmoglein-3 (Dsg3). Significant advances in our understanding of pemphigus pathomechanisms have been derived from the generation of pathogenic monoclonal Dsg3 antibodies. However, conflicting models for pemphigus pathogenicity have arisen from studies using either polyclonal PV patient IgG or monoclonal Dsg3 antibodies. In the present study, the pathogenic mechanisms of polyclonal PV IgG and monoclonal Dsg3 antibodies were directly compared. Polyclonal PV IgG cause extensive clustering and endocytosis of keratinocyte cell surface Dsg3, whereas pathogenic mouse monoclonal antibodies compromise cell-cell adhesion strength without causing these alterations in Dsg3 trafficking. Furthermore, tyrosine kinase or p38 MAPK inhibition prevents loss of keratinocyte adhesion in response to polyclonal PV IgG. In contrast, disruption of adhesion by pathogenic monoclonal antibodies is not prevented by these inhibitors either in vitro or in human skin explants. Our results reveal that the pathogenic activity of polyclonal PV IgG can be attributed to p38 MAPK-dependent clustering and endocytosis of Dsg3, whereas pathogenic monoclonal Dsg3 antibodies can function independently of this pathway. These findings have important implications for understanding pemphigus pathophysiology, and for the design of pemphigus model systems and therapeutic interventions.	[Saito, Masataka; Stahley, Sara N.; Caughman, Christopher Y.; Tucker, Dana K.; Kowalczyk, Andrew P.] Emory Univ, Dept Cell Biol, Atlanta, GA 30322 USA; [Saito, Masataka; Stahley, Sara N.; Caughman, Christopher Y.; Tucker, Dana K.; Kowalczyk, Andrew P.] Emory Univ, Dept Dermatol, Atlanta, GA 30322 USA; [Saito, Masataka; Stahley, Sara N.; Caughman, Christopher Y.; Tucker, Dana K.; Kowalczyk, Andrew P.] Emory Univ, Winship Canc Inst, Atlanta, GA 30322 USA; [Mao, Xuming; Payne, Aimee S.] Univ Penn, Dept Dermatol, Philadelphia, PA 19104 USA; [Amagai, Masayuki] Keio Univ, Dept Dermatol, Tokyo, Japan	Emory University; Emory University; Emory University; University of Pennsylvania; Keio University	Kowalczyk, AP (corresponding author), Emory Univ, Dept Cell Biol, Atlanta, GA 30322 USA.	akowalc@emory.edu	Amagai, Masayuki/K-5325-2013	Amagai, Masayuki/0000-0003-3314-7052	National Institutes of Health (NIH) [R01AR048266, R01-AR057001]; NIH (University of Pennsylvania Skin Disease Research Center) [P30-AR057217]; Ministry of Education, Culture, Sports, Science and Technology of Japan; Health and Labor Sciences Research Grants for Research on Measures for Intractable Diseases from the Ministry of Health, Labor and Welfare of Japan; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR048266, P30AR057217, R01AR057001] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008367] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH (University of Pennsylvania Skin Disease Research Center); Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Health and Labor Sciences Research Grants for Research on Measures for Intractable Diseases from the Ministry of Health, Labor and Welfare of Japan; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by NIH R01AR048266 to APK, National Institutes of Health (NIH) R01-AR057001 to ASP, and NIH P30-AR057217 (University of Pennsylvania Skin Disease Research Center), Grants-in-Aid for Scientific Research from the Ministry of Education, Culture, Sports, Science and Technology of Japan, Health and Labor Sciences Research Grants for Research on Measures for Intractable Diseases from the Ministry of Health, Labor and Welfare of Japan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AMAGAI M, 1991, CELL, V67, P869, DOI 10.1016/0092-8674(91)90360-B; Amagai M, 2012, J INVEST DERMATOL, V132, P776, DOI 10.1038/jid.2011.390; Amagai M, 2010, P JPN ACAD B-PHYS, V86, P524, DOI 10.2183/pjab.86.524; Anhalt GJ, 2004, J AM ACAD DERMATOL, V51, pS20, DOI 10.1016/j.jaad.2004.01.011; Aoyama Y, 2010, BRIT J DERMATOL, V162, P1049, DOI 10.1111/j.1365-2133.2010.09672.x; Aoyama Y, 1999, J INVEST DERMATOL, V112, P67, DOI 10.1046/j.1523-1747.1999.00463.x; Berkowitz P, 2005, J BIOL CHEM, V280, P23778, DOI 10.1074/jbc.M501365200; Berkowitz P, 2006, P NATL ACAD SCI USA, V103, P12855, DOI 10.1073/pnas.0602973103; Brooke MA, 2012, J PATHOL, V226, P158, DOI 10.1002/path.3027; Caldelari R, 2001, J CELL BIOL, V153, P823, DOI 10.1083/jcb.153.4.823; Calkins CC, 2006, J BIOL CHEM, V281, P7623, DOI 10.1074/jbc.M512447200; Chernyavsky AI, 2007, J BIOL CHEM, V282, P13804, DOI 10.1074/jbc.M611365200; Chiasson CM, 2009, MOL BIOL CELL, V20, P1970, DOI 10.1091/mbc.E08-07-0735; Delva E, 2008, J BIOL CHEM, V283, P18303, DOI 10.1074/jbc.M710046200; Delva E, 2009, CSH PERSPECT BIOL, V1, DOI 10.1101/cshperspect.a002543; Getsios S, 2004, NAT REV MOL CELL BIO, V5, P271, DOI 10.1038/nrm1356; Getsios Spiro, 2010, J Invest Dermatol, V130, P1764, DOI 10.1038/jid.2010.111; Green KJ, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a000125; Heupel WM, 2008, J IMMUNOL, V181, P1825, DOI 10.4049/jimmunol.181.3.1825; Ishii K, 2005, J INVEST DERMATOL, V124, P939, DOI 10.1111/j.0022-202X.2005.23714.x; Jennings JM, 2011, J INVEST DERMATOL, V131, P706, DOI 10.1038/jid.2010.389; Jolly PS, 2010, J BIOL CHEM, V285, P8936, DOI 10.1074/jbc.M109.087999; Kawasaki H, 2006, J INVEST DERMATOL, V126, P2621, DOI 10.1038/sj.jid.5700450; LAFLAMME SE, 1994, J CELL BIOL, V126, P1287, DOI 10.1083/jcb.126.5.1287; Mahoney MG, 1999, J CLIN INVEST, V103, P461, DOI 10.1172/JCI5252; Mao XM, 2011, J BIOL CHEM, V286, P1283, DOI 10.1074/jbc.M110.172874; Mao XM, 2009, J INVEST DERMATOL, V129, P908, DOI 10.1038/jid.2008.339; Mascaro JM, 1997, CLIN IMMUNOL IMMUNOP, V85, P90, DOI 10.1006/clin.1997.4408; Muller EJ, 2008, J INVEST DERMATOL, V128, P501, DOI 10.1038/sj.jid.5701248; Oktarina DAM, 2011, BRIT J DERMATOL, V165, P552, DOI 10.1111/j.1365-2133.2011.10463.x; Payne AS, 2005, J CLIN INVEST, V115, P888, DOI 10.1172/JCI200524185; Payne AS, 2004, CURR OPIN CELL BIOL, V16, P536, DOI 10.1016/j.ceb.2004.07.006; Sanchez-Carpintero I, 2004, BRIT J DERMATOL, V151, P565, DOI 10.1111/j.1365-2133.2004.06147.x; Sato M, 2000, LAB INVEST, V80, P1583, DOI 10.1038/labinvest.3780168; Schulze K, 2012, J INVEST DERMATOL, V132, P346, DOI 10.1038/jid.2011.299; Seishima M, 1999, ARCH DERMATOL RES, V291, P606, DOI 10.1007/s004030050462; Sekiguchi M, 2001, J IMMUNOL, V167, P5439, DOI 10.4049/jimmunol.167.9.5439; Setzer SV, 2004, J INVEST DERMATOL, V123, P426, DOI 10.1111/j.0022-202X.2004.23319.x; Shapiro L, 2009, CSH PERSPECT BIOL, V1, DOI 10.1101/cshperspect.a003053; Sharma P, 2007, J DERMATOL SCI, V48, P1, DOI 10.1016/j.jdermsci.2007.05.005; Shimizu A, 2005, J INVEST DERMATOL, V124, P984, DOI 10.1111/j.0022-202X.2005.23706.x; Shimizu A, 2004, J INVEST DERMATOL, V122, P1145, DOI 10.1111/j.0022-202X.2004.22426.x; Shu E, 2007, ARCH DERMATOL RES, V299, P165, DOI 10.1007/s00403-007-0754-9; Spindler V, 2011, ANN ANAT, V193, P177, DOI 10.1016/j.aanat.2011.02.003; Stanley JR, 2006, NEW ENGL J MED, V355, P1800, DOI 10.1056/NEJMra061111; Tsunoda K, 2003, J IMMUNOL, V170, P2170, DOI 10.4049/jimmunol.170.4.2170; Wang WQ, 2009, J DERMATOL SCI, V54, P59, DOI 10.1016/j.jdermsci.2008.10.010; Waschke J, 2005, J CLIN INVEST, V115, P3157, DOI 10.1172/JCI23475; Waschke J, 2008, HISTOCHEM CELL BIOL, V130, P21, DOI 10.1007/s00418-008-0420-0; Waschke J, 2006, J CELL BIOL, V175, P721, DOI 10.1083/jcb.200605125; Williamson L, 2006, EMBO J, V25, P3298, DOI 10.1038/sj.emboj.7601224; Xiao KY, 2005, MOL BIOL CELL, V16, P5141, DOI 10.1091/mbc.E05-05-0440; Xiao KY, 2003, J BIOL CHEM, V278, P19199, DOI 10.1074/jbc.M211746200; Yamamoto Y, 2007, J BIOL CHEM, V282, P17866, DOI 10.1074/jbc.M607963200; Yin TF, 2004, SEMIN CELL DEV BIOL, V15, P665, DOI 10.1016/j.semcdb.2004.09.005; Yokouchi M, 2009, J INVEST DERMATOL, V129, P2156, DOI 10.1038/jid.2009.61	56	65	67	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 3	2012	7	12							e50696	10.1371/journal.pone.0050696	http://dx.doi.org/10.1371/journal.pone.0050696			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	051DH	23226536	gold, Green Submitted, Green Published			2022-12-27	WOS:000312104700022
J	Ahn, SK; Cuthbertson, L; Nodwell, JR				Ahn, Sang Kyun; Cuthbertson, Leslie; Nodwell, Justin R.			Genome Context as a Predictive Tool for Identifying Regulatory Targets of the TetR Family Transcriptional Regulators	PLOS ONE			English	Article							ACYL-COA DEHYDROGENASE; STREPTOMYCES-COELICOLOR; TETRACYCLINE RESISTANCE; ESCHERICHIA-COLI; EFFLUX PUMP; PSEUDOMONAS-AERUGINOSA; REPRESSOR; EXPRESSION; EXPORT; GENES	TetR family transcriptional regulators (TFRs) are found in most bacteria and archea. Most of the family members that have been investigated to date are repressors of their target genes, and the majority of these, like the well-characterized protein TetR, regulate genes that encode transmembrane efflux pumps. In many cases repression by TFR proteins is reversed through the direct binding of a small-molecule ligand. The number of TFRs in the public database has grown rapidly as a result of genome sequencing and there are now thousands of family members; however virtually nothing is known about the biology and biochemistry they regulate. Generally applicable methods for predicting their regulatory targets would assist efforts to characterize the family. Here, we investigate chromosomal context of 372 TFRs from three Streptomyces species. We find that the majority (250 TFRs) are transcribed divergently from one neighboring gene, as is the case for TetR and its target tetA. We explore predicted target gene product identity and intergenic separation to see which either correlates with a direct regulatory relationship. While intergenic separation is a critical factor in regulatory prediction the identity of the putative target gene product is not. Our data suggest that those TFRs that are,200 bp from their divergently oriented neighbors are most likely to regulate them. These target genes include membrane proteins (26% of which 22% are probable membrane-associated pumps), enzymes (60%), other proteins such as transcriptional regulators (1%), and proteins having no predictive sequence motifs (13%). In addition to establishing a solid foundation for identifying targets for TFRs of unknown function, our analysis demonstrates a much greater diversity of TFR-regulated biochemical functions.	[Ahn, Sang Kyun; Cuthbertson, Leslie; Nodwell, Justin R.] McMaster Univ, Dept Biochem & Biomed Sci, Hamilton, ON, Canada; [Ahn, Sang Kyun; Cuthbertson, Leslie; Nodwell, Justin R.] McMaster Univ, MG DeGroote Inst Infect Dis Res, Hamilton, ON, Canada	McMaster University; McMaster University	Nodwell, JR (corresponding author), McMaster Univ, Dept Biochem & Biomed Sci, Hamilton, ON, Canada.	nodwellj@mcmaster.ca			Ontario Graduate Scholarship; Natural Science and Engineering Research Council; Canadian Institutes of Health Research (MOP) [97729]	Ontario Graduate Scholarship(Ontario Graduate Scholarship); Natural Science and Engineering Research Council(Natural Sciences and Engineering Research Council of Canada (NSERC)); Canadian Institutes of Health Research (MOP)(Canadian Institutes of Health Research (CIHR))	SKA was the recipient of an Ontario Graduate Scholarship. LC was the recipient of a postdoctoral fellowship from the Natural Science and Engineering Research Council. This research was funded by a grant to JN from the Canadian Institutes of Health Research (MOP #97729). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahn SK, 2007, J BACTERIOL, V189, P6655, DOI 10.1128/JB.00717-07; Bentley SD, 2002, NATURE, V417, P141, DOI 10.1038/417141a; Chan YY, 2005, J BACTERIOL, V187, P4707, DOI 10.1128/JB.187.14.4707-4719.2005; Chattoraj P, 2011, J BACTERIOL, V193, P6605, DOI 10.1128/JB.06122-11; Christen S, 2006, J BIOL CHEM, V281, P23129, DOI 10.1074/jbc.M603486200; Craney A, 2007, NUCLEIC ACIDS RES, V35, DOI 10.1093/nar/gkm086; Croxatto A, 2002, J BACTERIOL, V184, P1617, DOI 10.1128/JB.184.6.1617-1629.2002; Dym O, 2001, PROTEIN SCI, V10, P1712, DOI 10.1110/ps.12801; Engohang-Ndong J, 2004, MOL MICROBIOL, V51, P175, DOI 10.1046/j.1365-2958.2003.03809.x; Forster-Fromme K, 2010, FEMS MICROBIOL LETT, V308, P166, DOI 10.1111/j.1574-6968.2010.02005.x; Grkovic S, 1998, J BIOL CHEM, V273, P18665, DOI 10.1074/jbc.273.29.18665; Heinzelmann E, 2005, MICROBIOL-SGM, V151, P1963, DOI 10.1099/mic.0.27844-0; HILLEN W, 1994, ANNU REV MICROBIOL, V48, P345, DOI 10.1146/annurev.mi.48.100194.002021; Hillerich B, 2008, J BACTERIOL, V190, P61, DOI 10.1128/JB.01316-07; Kieser T., 2000, PRACTICAL STREPTOMYC, V4362; Kleiger G, 2002, J MOL BIOL, V323, P69, DOI 10.1016/S0022-2836(02)00885-9; Krug A, 2005, J BIOL CHEM, V280, P585, DOI 10.1074/jbc.M408271200; Le TBK, 2009, MOL MICROBIOL, V72, P1462, DOI 10.1111/j.1365-2958.2009.06735.x; Lee LF, 2007, MICROBIOL-SGM, V153, P924, DOI 10.1099/mic.0.2006/000018-0; Ma D, 1996, MOL MICROBIOL, V19, P101, DOI 10.1046/j.1365-2958.1996.357881.x; MacEachran DP, 2008, INFECT IMMUN, V76, P3197, DOI 10.1128/IAI.00305-08; Marchler-Bauer A, 2004, NUCLEIC ACIDS RES, V32, pW327, DOI 10.1093/nar/gkh454; MCMURRY L, 1980, P NATL ACAD SCI-BIOL, V77, P3974, DOI 10.1073/pnas.77.7.3974; MEIER I, 1988, EMBO J, V7, P567, DOI 10.1002/j.1460-2075.1988.tb02846.x; Orth P, 1999, BIOCHEMISTRY-US, V38, P191, DOI 10.1021/bi9816610; Ostash I, 2008, FEMS MICROBIOL LETT, V285, P195, DOI 10.1111/j.1574-6968.2008.01225.x; Pareja E, 2006, BMC MICROBIOL, V6, DOI 10.1186/1471-2180-6-29; Park H, 2011, J BACTERIOL, V193, P6288, DOI 10.1128/JB.05649-11; Pompeani AJ, 2008, MOL MICROBIOL, V70, P76, DOI 10.1111/j.1365-2958.2008.06389.x; Poole K, 1996, MOL MICROBIOL, V21, P713, DOI 10.1046/j.1365-2958.1996.281397.x; Ramos JL, 2005, MICROBIOL MOL BIOL R, V69, P326, DOI 10.1128/MMBR.69.2.326-356.2005; ROSSMANN MG, 1976, J MOL BIOL, V105, P75, DOI 10.1016/0022-2836(76)90195-9; Sahota G, 2010, BIOINFORMATICS, V26, P2672, DOI 10.1093/bioinformatics/btq501; Sambrook J., 2002, MOL CLONING LAB MANU; Sanchez P, 2002, ANTIMICROB AGENTS CH, V46, P3386, DOI 10.1128/AAC.46.11.3386-3393.2002; Santangelo MP, 2008, BMC MICROBIOL, V8, DOI 10.1186/1471-2180-8-38; Spector MP, 1999, MICROBIOL-SGM, V145, P15, DOI 10.1099/13500872-145-1-15; Tahlan K, 2007, MOL MICROBIOL, V63, P951, DOI 10.1111/j.1365-2958.2006.05559.x; TAKAHASHI M, 1991, ANAL BIOCHEM, V199, P197, DOI 10.1016/0003-2697(91)90089-C; Uguru GC, 2005, MOL MICROBIOL, V58, P131, DOI 10.1111/j.1365-2958.2005.04817.x; Ulrich LE, 2005, TRENDS MICROBIOL, V13, P52, DOI 10.1016/j.tim.2004.12.006; Webb E. C., 1992, ENZYME NOMENCLATURE; Zhang YM, 2007, MOL MICROBIOL, V66, P622, DOI 10.1111/j.1365-2958.2007.05934.x	44	45	47	2	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 30	2012	7	11							e50562	10.1371/journal.pone.0050562	http://dx.doi.org/10.1371/journal.pone.0050562			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	054WM	23226315	Green Submitted, Green Published, gold			2022-12-27	WOS:000312376100127
J	Annunziata, K; Rak, A; Del Buono, H; DiBonaventura, M; Krishnarajah, G				Annunziata, Kathy; Rak, Aaron; Del Buono, Heather; DiBonaventura, Marco; Krishnarajah, Girishanthy			Vaccination Rates among the General Adult Population and High-Risk Groups in the United States	PLOS ONE			English	Article							HEPATITIS-B VACCINATION; INFLUENZA VACCINATION; COVERAGE; US	Background: In order to adequately assess the effectiveness of vaccination in helping to control vaccine-preventable infectious disease, it is important to identify the adherence and uptake of risk-based recommendations. Methods: The current project includes data from five consecutive datasets of the National Health and Wellness Survey (NHWS): 2007 through 2011. The NHWS is an annual, Internet-based health questionnaire, administered to a nationwide sample of adults (aged 18 or older) which included items on vaccination history as well as high-risk group status. Vaccination rates and characteristics of vaccinees were reported descriptively. Logistic regressions were conducted to predict vaccination behavior from sociodemographics and risk-related variables. Results: The influenza vaccination rate for all adults 18 years and older has increased significantly from 28.0% to 36.2% from 2007 to 2011 (ps,<05). Compared with those not at high risk (25.1%), all high-risk groups were vaccinated at a higher rate, from 36.8% (pregnant women) to 69.7% (those with renal/kidney disease); however, considerable variability among high-risk groups was observed. Vaccination rates among high-risk groups for other vaccines varied considerably though all were below 50%, with the exception of immunocompromised respondents (57.5% for the hepatitis B vaccine and 52.5% for the pneumococcal vaccine) and the elderly (50.4% for the pneumococcal). Multiple risk factors were associated with increased rate of vaccination for most vaccines. Significant racial/ethnic differences with influenza, hepatitis, and herpes zoster vaccination rates were also observed (ps,<05). Conclusions: Rates of influenza vaccination have increased over time. Rates varied by high-risk status, demographics, and vaccine. There was a pattern of modest vaccination rate increases for individuals with multiple risk factors. However, there were relatively low rates of vaccination for most risk-based recommendations and all fell below national goals.	[DiBonaventura, Marco] Kantar Hlth, Hlth Outcomes Practice, New York, NY USA; [Annunziata, Kathy] Kantar Hlth, Hlth Outcomes Practice, Princeton, NJ USA; [Rak, Aaron] GlaxoSmithKline, Vaccine Publ Policy & Advocacy, Philadelphia, PA USA; [Del Buono, Heather] GlaxoSmithKline, Global Clin Safety & Pharmacovigilance, Collegeville, PA USA; [Krishnarajah, Girishanthy] GlaxoSmithKline, US Hlth Outcomes & Epidemiol, Vaccines, Philadelphia, PA USA	GlaxoSmithKline; GlaxoSmithKline; GlaxoSmithKline	DiBonaventura, M (corresponding author), Kantar Hlth, Hlth Outcomes Practice, New York, NY USA.	marco.dibonaventura@kantarhealth.com			USAID PREDICT; GlaxoSmithKline	USAID PREDICT(United States Agency for International Development (USAID)); GlaxoSmithKline(GlaxoSmithKline)	This work was partly supported by USAID PREDICT. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors have read the journal's policy and have the following conflicts. The National Health Wellness Survey is conducted annually by Kantar Health. KA and MD are current employees of Kantar Health. GlaxoSmithKline purchased access to the NHWS data and funded the analysis and preparation of this manuscript. AR, HDB, and GK are current employees of GlaxoSmithKline. This paper includes no information on marketed products so there are no patents, products in development or marketed products to declare. This does not alter the authors' adherence to all the PLOS ONE policies on sharing data and materials.	[Anonymous], 2005, Wkly Epidemiol Rec, V80, P279; [Anonymous], SHINGL VACC WHAT YOU; Babcock HM, 2010, CLIN INFECT DIS, V50, P459, DOI 10.1086/650752; Bolge SC, 2009, QUAL LIFE RES, V18, P415, DOI 10.1007/s11136-009-9462-6; Centers for Disease Control and Prevention (CDC), 2011, MMWR Morb Mortal Wkly Rep, V60, P1; DiBonaventura Marco DaCosta, 2010, J Med Econ, V13, P709, DOI 10.3111/13696998.2010.535576; DiBonaventura MD, 2010, INT SOC PHARM OUTC R; Egede LE, 2003, AM J PUBLIC HEALTH, V93, P2074, DOI 10.2105/AJPH.93.12.2074; Finkelstein EA, 2011, J OCCUP ENVIRON MED, V53, P1025, DOI 10.1097/JOM.0b013e318229aae4; HORVITZ DG, 1952, J AM STAT ASSOC, V47, P663, DOI 10.2307/2280784; Jain N, 2004, FAM MED, V36, P480; Ligon C. B., 2008, Morbidity and Mortality Weekly Report, V57, P653; Lu PJ, 2011, VACCINE, V29, P7049, DOI 10.1016/j.vaccine.2011.07.030; Lu PJ, 2008, VACCINE, V26, P1786, DOI 10.1016/j.vaccine.2008.01.040; Lu PJ, 2005, ARCH INTERN MED, V165, P1849, DOI 10.1001/archinte.165.16.1849; Singleton JA, 2004, TEX HEART I J, V31, P22; Ware J. E. J., 2002, SCORE VERSION 2 SF 1; Weinbaum C., 2006, Morbidity and Mortality Weekly Report, V55, P509; Youngpairoj S., 2005, Morbidity and Mortality Weekly Report, V54, P1045	19	40	42	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 30	2012	7	11							e50553	10.1371/journal.pone.0050553	http://dx.doi.org/10.1371/journal.pone.0050553			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	054WM	23226312	Green Published, gold, Green Submitted			2022-12-27	WOS:000312376100124
J	Fagundes, JAD; Tomasi, CD; Giombelli, VR; Alves, SC; de Macedo, RC; Topanotti, MFL; Bristot, MDU; do Brasil, PEAA; Soares, M; Salluh, J; Dal-Pizzol, F; Ritter, C				de Oliveira Fagundes, Jorge Alberto; Tomasi, Cristiane Damiani; Giombelli, Vinicius Rene; Alves, Sarah Cascaes; de Macedo, Roberta Candal; Locks Topanotti, Maria Fernanda; Ugioni Bristot, Maria de Lourdes; Alvarenga Americano do Brasil, Pedro Emmanuel; Soares, Marcio; Salluh, Jorge; Dal-Pizzol, Felipe; Ritter, Cristiane			CAM-ICU and ICDSC Agreement in Medical and Surgical ICU Patients Is Influenced by Disease Severity	PLOS ONE			English	Article							INTENSIVE-CARE-UNIT; DELIRIUM SCREENING CHECKLIST; CONFUSION ASSESSMENT METHOD; RELIABILITY; VALIDITY; IMPACT; TOOLS	Introduction: Delirium is a prevalent condition in patients admitted to intensive care units (ICU) associated with worse outcomes. The principal aim of the present study was compare the agreement between two tools for delirium assessment in medical and surgical patients admitted to the ICU. Methods: Consecutive adult surgical and medical patients admitted to the ICU for more than 24 hours between March 2009 and September 2010 were included. Delirium was evaluated twice a day using the Intensive Care Delirium Screening Checklist (ICDSC) and Confusion Assessment Method adapted to the Intensive Care Unit (CAM-ICU). The kappa (k) and AC1 coefficients were calculated as a measure of agreement between the CAM-ICU and ICDSC. Results: A total of 595 patients were enrolled in the study. There were 69 (12%) emergency surgical, 207 (35%) elective surgical and 319 (54%) medical patients. Delirium incidence evaluated by the ICDSC, but not by the CAM-ICU, was similar among the three groups. Overall agreement between CAM-ICU and ICDSC was moderate (k = 0.5) to substantial (AC1 = 0.71). In medical patients the agreement between the two instruments was moderate (k = 0.53) to substantial (AC1 = 0.76). The agreement between the two tools in emergency surgical patients was also moderate (k = 0.53) to substantial (AC1 = 0.68). In elective surgical patients the agreement between the two instruments was low (k = 0.42) to substantial (AC1 = 0.74). Agreement rates seemed to be influenced by disease severity. The agreement rate in the general ICU population with APACHE II = <14 was k = 0.57 and AC1 = 0.81, compared to k = 0.44 and AC1 = 0.59, in patients with more severe disease. This was even more different when the need for mechanical ventilation was used as a surrogate of disease severity. Conclusions: The agreement rates between CAM-ICU and ICDSC may vary between different groups of ICU patients and seems to be affected by disease severity.	[de Oliveira Fagundes, Jorge Alberto; Tomasi, Cristiane Damiani; Giombelli, Vinicius Rene; Alves, Sarah Cascaes; de Macedo, Roberta Candal; Locks Topanotti, Maria Fernanda; Ugioni Bristot, Maria de Lourdes; Dal-Pizzol, Felipe; Ritter, Cristiane] Univ Extremo Sul Catarinense, Lab Fisiopatol Expt, Criciuma, SC, Brazil; [de Oliveira Fagundes, Jorge Alberto; Tomasi, Cristiane Damiani; Giombelli, Vinicius Rene; Alves, Sarah Cascaes; de Macedo, Roberta Candal; Locks Topanotti, Maria Fernanda; Ugioni Bristot, Maria de Lourdes; Dal-Pizzol, Felipe; Ritter, Cristiane] Univ Extremo Sul Catarinense, Inst Nacl Ciencia & Tecnol Translac Med, Programa Posgrad Ciencias Saude, Unidade Acad Ciencias Saude, Criciuma, SC, Brazil; [Tomasi, Cristiane Damiani; Giombelli, Vinicius Rene; Alves, Sarah Cascaes; de Macedo, Roberta Candal; Locks Topanotti, Maria Fernanda; Ugioni Bristot, Maria de Lourdes; Dal-Pizzol, Felipe; Ritter, Cristiane] Hosp Sao Jose, Intens Care Unit, Criciuma, SC, Brazil; [Alvarenga Americano do Brasil, Pedro Emmanuel; Soares, Marcio; Salluh, Jorge] Dor Inst Res & Educ, Rio De Janeiro, Brazil; [Alvarenga Americano do Brasil, Pedro Emmanuel] Fundacao Oswaldo Cruz, Evandro Chagas Clin Res Inst, Rio De Janeiro, Brazil; [Soares, Marcio; Salluh, Jorge] Inst Nacl Canc, Programa Posgrad Oncol, Rio De Janeiro, Brazil	Universidade do Extremo Sul Catarinense; Universidade do Extremo Sul Catarinense; Universidade Federal do Rio Grande do Sul; IDOR - Instituto D'Or de Ensino e Pesquisa; Fundacao Oswaldo Cruz; National Cancer Institute (Inca)	Dal-Pizzol, F (corresponding author), Univ Extremo Sul Catarinense, Lab Fisiopatol Expt, Criciuma, SC, Brazil.	piz@unesc.net	dantas, vicente c souza/L-2648-2013; Dal-Pizzol, Felipe/F-2756-2015; Brasil, Pedro E A A/B-4357-2008; Soares, Marcio/B-3083-2013; Salluh, Jorge IF/F-6779-2012; Salluh, Jorge/AAF-2682-2021; TOMASI, CRISTIANE/J-4792-2017	Dal-Pizzol, Felipe/0000-0003-3003-8977; Brasil, Pedro E A A/0000-0002-6700-2268; Soares, Marcio/0000-0003-2503-6088; Salluh, Jorge/0000-0002-8164-1453; TOMASI, CRISTIANE/0000-0002-1813-765X	NENASC project (PRONEX program CNPq / FAPESC); INCT-TM; FAPESC	NENASC project (PRONEX program CNPq / FAPESC)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); INCT-TM; FAPESC(Fundacao de Amparo a Pesquisa e Inovacoo Estado de Santa Catarina (FAPESC))	This research was supported by NENASC project (PRONEX program CNPq / FAPESC) and INCT-TM. CR, JQ, MS and FDP are CNPq Research Fellows. CDT is holder of a FAPESC studentship. The funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.	American Psychiatric Association, 2000, DIAGN STAT MAN MENT; Bergeron N, 2001, INTENS CARE MED, V27, P859, DOI 10.1007/s001340100909; Cole M, 2003, J AM GERIATR SOC, V51, P754, DOI 10.1046/j.1365-2389.2003.51255.x; Deiner S, 2009, Br J Anaesth, V103 Suppl 1, pi41, DOI 10.1093/bja/aep291; Ely EW, 2001, CRIT CARE MED, V29, P1370, DOI 10.1097/00003246-200107000-00012; Ely EW, 2001, INTENS CARE MED, V27, P1892, DOI 10.1007/s00134-001-1132-2; Ely EW, 2004, JAMA-J AM MED ASSOC, V291, P1753, DOI 10.1001/jama.291.14.1753; Gunther ML, 2008, CRIT CARE CLIN, V24, P45, DOI 10.1016/j.ccc.2007.10.002; Gusmao-Flores D, 2011, CLINICS, V66, P1917, DOI 10.1590/S1807-59322011001100011; Inouye SK, 2006, NEW ENGL J MED, V354, P1157, DOI 10.1056/NEJMra052321; Inouye SK, 1996, JAMA-J AM MED ASSOC, V275, P852, DOI 10.1001/jama.275.11.852; Koebrugge B, 2010, VASCULAR, V18, P279, DOI 10.2310/6670.2010.00052; Lin SM, 2004, CRIT CARE MED, V32, P2254, DOI 10.1097/01.CCM.0000145587.16421.BB; Morandi A, 2008, INTENS CARE MED, V34, P1907, DOI 10.1007/s00134-008-1177-6; Mu DL, 2010, CRIT CARE, V14, DOI 10.1186/cc9393; Olin K, 2005, BRIT J SURG, V92, P1559, DOI 10.1002/bjs.5053; Ouimet S, 2007, INTENS CARE MED, V33, P66, DOI 10.1007/s00134-006-0399-8; Plaschke K, 2008, INTENS CARE MED, V34, P431, DOI 10.1007/s00134-007-0920-8; Salluh JI, 2010, CRIT CARE, V14, DOI 10.1186/cc9333; Salluh JIF, 2009, J CRIT CARE, V24, P556, DOI 10.1016/j.jcrc.2009.04.004; Sessler CN, 2002, AM J RESP CRIT CARE, V166, P1338, DOI 10.1164/rccm.2107138; Siddiqi N, 2006, AGE AGEING, V35, P350, DOI 10.1093/ageing/afl005; Tomasi CD, 2012, J CRIT CARE, V27, P212, DOI 10.1016/j.jcrc.2011.05.015; van Eijk MMJ, 2009, CRIT CARE MED, V37, P1881, DOI 10.1097/CCM.0b013e3181a00118	24	11	14	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 30	2012	7	11							e51010	10.1371/journal.pone.0051010	http://dx.doi.org/10.1371/journal.pone.0051010			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	054WM	23226448	Green Published, Green Submitted, gold			2022-12-27	WOS:000312376100259
J	Florence, CM; Baillie, LD; Mulligan, SJ				Florence, Clare M.; Baillie, Landon D.; Mulligan, Sean J.			Dynamic Volume Changes in Astrocytes Are an Intrinsic Phenomenon Mediated by Bicarbonate Ion Flux	PLOS ONE			English	Article							INTRACELLULAR PH REGULATION; CENTRAL-NERVOUS-SYSTEM; RAT OPTIC-NERVE; GLIAL-CELLS; GLUTAMATE TRANSPORTERS; EXTRACELLULAR-SPACE; CULTURED ASTROCYTES; NEURONAL EXCITATION; K+ ACCUMULATION; WATER TRANSPORT	Astrocytes, the major type of non-neuronal cells in the brain, play an important functional role in extracellular potassium ([K+](o)) and pH homeostasis. Pathological brain states that result in [K+](o) and pH dysregulation have been shown to cause astrocyte swelling. However, whether astrocyte volume changes occur under physiological conditions is not known. In this study we used two-photon imaging to visualize real-time astrocyte volume changes in the stratum radiatum of the hippocampus CA1 region. Astrocytes were observed to swell by 19.0 +/- 0.9% in response to a small physiological increase in the concentration of [K+](o) (3 mM). Astrocyte swelling was mediated by the influx of bicarbonate (HCO3-) ions as swelling was significantly decreased when the influx of HCO3- was reduced. We found: 1) in HCO3- free extracellular solution astrocytes swelled by 5.4 +/- 0.7%, 2) when the activity of the sodium-bicarbonate cotransporter (NBC) was blocked the astrocytes swelled by 8.3 +/- 0.7%, and 3) in the presence of an extracellular carbonic anhydrase (CA) inhibitor astrocytes swelled by 11.4 +/- 0.6%. Because a significant HCO3- efflux is known to occur through the gamma-amino-butyric acid (GABA) channel, we performed a series of experiments to determine if astrocytes were capable of HCO3- mediated volume shrinkage with GABA channel activation. Astrocytes were found to shrink -7.7 +/- 0.5% of control in response to the GABA(A) channel agonist muscimol. Astrocyte shrinkage from GABA(A) channel activation was significantly decreased to -5.0 +/- 0.6% of control in the presence of the membrane-permeant CA inhibitor acetazolamide (ACTZ). These dynamic astrocyte volume changes may represent a previously unappreciated yet fundamental mechanism by which astrocytes regulate physiological brain functioning.	[Florence, Clare M.; Baillie, Landon D.; Mulligan, Sean J.] Univ Saskatchewan, Dept Physiol, Saskatoon, SK, Canada	University of Saskatchewan	Mulligan, SJ (corresponding author), Univ Saskatchewan, Dept Physiol, Saskatoon, SK, Canada.	sean.mulligan@usask.ca			Canadian Institutes of Health Research [MOP 86616]	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR))	This work was supported by the Canadian Institutes of Health Research through an operating grant awarded to S.J.M. (MOP 86616) and a Master's Scholarship awarded to C. M. F. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AGNATI LF, 1995, NEUROSCIENCE, V69, P711, DOI 10.1016/0306-4522(95)00308-6; Amiry-Moghaddam M, 2003, NAT REV NEUROSCI, V4, P991, DOI 10.1038/nrn1252; Amiry-Moghaddam M, 2003, P NATL ACAD SCI USA, V100, P13615, DOI 10.1073/pnas.2336064100; Amzica F, 1999, J NEUROPHYSIOL, V82, P2731, DOI 10.1152/jn.1999.82.5.2731; ANDREW RD, 1994, NEUROSCIENCE, V62, P371, DOI 10.1016/0306-4522(94)90372-7; Asztely F, 1997, NEURON, V18, P281, DOI 10.1016/S0896-6273(00)80268-8; Benesova J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029725; Benesova J, 2009, J NEUROSCI RES, V87, P96, DOI 10.1002/jnr.21828; Bergles DE, 1998, J NEUROSCI, V18, P7709; Bevensee MO, 1997, J GEN PHYSIOL, V110, P453, DOI 10.1085/jgp.110.4.453; Bevensee MO, 1997, J GEN PHYSIOL, V110, P467, DOI 10.1085/jgp.110.4.467; Cahoy JD, 2008, J NEUROSCI, V28, P264, DOI 10.1523/JNEUROSCI.4178-07.2008; CHAUDHRY FA, 1995, NEURON, V15, P711, DOI 10.1016/0896-6273(95)90158-2; CHEN JCT, 1992, J NEUROPHYSIOL, V67, P29, DOI 10.1152/jn.1992.67.1.29; CHESLER M, 1992, TRENDS NEUROSCI, V15, P396, DOI 10.1016/0166-2236(92)90191-A; Chvatal A, 2004, J NEUROSCI RES, V78, P668, DOI 10.1002/jnr.20284; Deitmer JW, 2010, BRAIN RES REV, V63, P113, DOI 10.1016/j.brainresrev.2009.10.006; Deitmer JW, 1996, PROG NEUROBIOL, V48, P73, DOI 10.1016/0301-0082(95)00039-9; Diamond JS, 2001, J NEUROSCI, V21, P8328, DOI 10.1523/JNEUROSCI.21-21-08328.2001; DICHTER MA, 1972, BRAIN RES, V48, P173, DOI 10.1016/0006-8993(72)90177-1; DIETZEL I, 1980, EXP BRAIN RES, V40, P432; Haj-Yasein NN, 2012, GLIA, V60, P867, DOI 10.1002/glia.22319; HEINEMANN U, 1977, BRAIN RES, V120, P231, DOI 10.1016/0006-8993(77)90903-9; Hirrlinger PG, 2008, J NEUROCHEM, V105, P1405, DOI 10.1111/j.1471-4159.2008.05243.x; Holthoff K, 1996, J NEUROSCI, V16, P2740, DOI 10.1523/jneurosci.16-08-02740.1996; JUURLINK BHJ, 1992, CAN J PHYSIOL PHARM, V70, pS344, DOI 10.1139/y92-281; KAILA K, 1987, NATURE, V330, P163, DOI 10.1038/330163a0; KAILA K, 1991, NEUROSCI LETT, V126, P9, DOI 10.1016/0304-3940(91)90358-Z; Kettenmann H, 2005, NEUROGLIA, DOI Oxford University Press; Kimelberg HK, 2006, GLIA, V54, P747, DOI 10.1002/glia.20423; Kimelberg HK, 2010, NEUROSCIENTIST, V16, P79, DOI 10.1177/1073858409342593; KIMELBERG HK, 1990, J NEUROSCI, V10, P1583; Kimelberg HK, 2000, NEUROSCIENTIST, V6, P14, DOI 10.1177/107385840000600110; Kofuji P, 2004, NEUROSCIENCE, V129, P1045, DOI 10.1016/j.neurscience.2004.06.008; LEHRE KP, 1995, J NEUROSCI, V15, P1835; Lux H D, 1986, Adv Neurol, V44, P619; Ma BF, 2012, GLIA; MACVICAR BA, 1991, J NEUROSCI, V11, P1458; Massey PV, 2004, J NEUROSCI, V24, P7821, DOI 10.1523/JNEUROSCI.1697-04.2004; Mongin AA, 2005, AM J PHYSIOL-CELL PH, V288, pC204, DOI 10.1152/ajpcell.00330.2004; Mulligan Sean J, 2006, Sci STKE, V2006, ppe42; Nagelhus EA, 2004, NEUROSCIENCE, V129, P905, DOI 10.1016/j.neuroscience.2004.08.053; Nielsen S, 1997, J NEUROSCI, V17, P171; Nimmerjahn A, 2004, NAT METHODS, V1, P31, DOI 10.1038/nmeth706; Obara M, 2008, NEUROCHEM INT, V52, P905, DOI 10.1016/j.neuint.2007.10.015; Ostby I, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000272; Panatier A, 2006, NEURON GLIA BIOL, V2, P51, DOI 10.1017/S1740925X06000019; PAPPAS CA, 1994, J NEUROPHYSIOL, V72, P2816, DOI 10.1152/jn.1994.72.6.2816; PASTERNACK M, 1993, ACTA PHYSIOL SCAND, V148, P229, DOI 10.1111/j.1748-1716.1993.tb09553.x; Payne JA, 2003, TRENDS NEUROSCI, V26, P199, DOI 10.1016/S0166-2236(03)00068-7; RANSOM BR, 1985, J NEUROSCI, V5, P532; Ransom CB, 2000, J PHYSIOL-LONDON, V522, P427, DOI 10.1111/j.1469-7793.2000.00427.x; Risher WC, 2012, GLIA, V60, P1709, DOI 10.1002/glia.22390; Risher WC, 2009, GLIA, V57, P207, DOI 10.1002/glia.20747; Smith DG, 2012, CHEM-EUR J, V18, P11604, DOI 10.1002/chem.201201738; STALEY KJ, 1995, SCIENCE, V269, P977, DOI 10.1126/science.7638623; Su G, 2002, AM J PHYSIOL-CELL PH, V282, pC1147, DOI 10.1152/ajpcell.00538.2001; Sykova E, 2005, J NEURAL TRANSM, V112, P137, DOI 10.1007/s00702-004-0120-4; Sykova E, 2003, NEUROIMAGE, V18, P214, DOI 10.1016/S1053-8119(02)00014-9; Sykova E, 1999, GLIA, V25, P56, DOI 10.1002/(SICI)1098-1136(19990101)25:1<56::AID-GLIA6>3.0.CO;2-4; Sykova E, 2000, NEUROCHEM INT, V36, P397, DOI 10.1016/S0197-0186(99)00131-X; Theodosis DT, 2008, PHYSIOL REV, V88, P983, DOI 10.1152/physrev.00036.2007; WALZ W, 1991, ANN NY ACAD SCI, V633, P589; Walz W, 2002, GLIA, V40, P1, DOI 10.1002/glia.10125; WALZ W, 1992, NEUROSCI LETT, V135, P243, DOI 10.1016/0304-3940(92)90446-E; Walz W, 2000, NEUROCHEM INT, V36, P291, DOI 10.1016/S0197-0186(99)00137-0; Wang DD, 2008, PROG NEUROBIOL, V86, P342, DOI 10.1016/j.pneurobio.2008.09.015; Wang YF, 2009, THESCIENTIFICWORLDJO, V9, P1308, DOI 10.1100/tsw.2009.148; Wong TP, 2007, P NATL ACAD SCI USA, V104, P11471, DOI 10.1073/pnas.0702308104; Zhou N, 2010, CEREB CORTEX, V20, P2614, DOI 10.1093/cercor/bhq018	70	48	49	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 30	2012	7	11							e51124	10.1371/journal.pone.0051124	http://dx.doi.org/10.1371/journal.pone.0051124			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	054WM	23226475	Green Published, gold, Green Submitted			2022-12-27	WOS:000312376100286
J	Herranz-Martin, S; Jimeno, D; Paniagua, AE; Velasco, A; Lara, JM; Aijon, J; Lillo, C				Herranz-Martin, Saul; Jimeno, David; Paniagua, Antonio E.; Velasco, Almudena; Lara, Juan M.; Aijon, Jose; Lillo, Concepcion			Immunocytochemical Evidence of the Localization of the Crumbs Homologue 3 Protein (CRB3) in the Developing and Mature Mouse Retina	PLOS ONE			English	Article							LEBER CONGENITAL AMAUROSIS; DROSOPHILA-CRUMBS; TIGHT JUNCTIONS; EXPRESSION; MPP4; PIGMENTOSA; CELLS; COMPLEX; GENE; MORPHOGENESIS	CRB3 (Crumbs homologue 3), a member of the CRB protein family (homologous to the Drosophila Crumbs), is expressed in different epithelium-derived cell types in mammals, where it seems to be involved in regulating the establishment and stability of tight junctions and in ciliogenesis. This protein has been also detected in the retina, but little is known about its localization and function in this tissue. Our goal here was to perform an in-depth study of the presence of CRB3 protein in the mouse retina and to analyze its expression during photoreceptor ciliogenesis and the establishment of the plexiform retinal layers. Double immunofluorescence experiments for CRB3 and well-known markers for the different retinal cell types were performed to study the localization of the CRB3 protein. According to our results, CRB3 is present from postnatal day 0 (P0) until adulthood in the mouse retina. It is localized in the inner segments (IS) of photoreceptor cells, especially concentrated in the area where the connecting cilium is located, in their synaptic terminals in the outer plexiform layer (OPL), and in sub-populations of amacrine and bipolar cells in the inner plexiform layer (IPL).	[Herranz-Martin, Saul; Paniagua, Antonio E.; Velasco, Almudena; Lara, Juan M.; Aijon, Jose; Lillo, Concepcion] Univ Salamanca, Inst Neurosci Castilla & Leon INCyL, Inst Biomed Res Salamanca IBSAL, E-37008 Salamanca, Spain; [Jimeno, David] Univ Salamanca, Ctr Invest Canc IBMCC CSIC USAL, E-37008 Salamanca, Spain	University of Salamanca; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro de Investigacion del Cancer (CIC); CSIC-USAL - Instituto de Biologia Molecular y Celular del Cancer de Salamanca (IBMCC); University of Salamanca	Lillo, C (corresponding author), Univ Salamanca, Inst Neurosci Castilla & Leon INCyL, Inst Biomed Res Salamanca IBSAL, E-37008 Salamanca, Spain.	conlillo@usal.es	Herranz-Martin, Saul/AFN-1028-2022; Lillo, Concepcion/A-6321-2009; Lara, Juan/L-5590-2014; Jimeno, David/D-3096-2018	Herranz-Martin, Saul/0000-0002-9239-2704; Lillo, Concepcion/0000-0001-5814-9826; Lara, Juan/0000-0001-5389-3592; Velasco, Almudena/0000-0002-7442-3255; Jimeno, David/0000-0001-7876-0083; ESCUDERO PANIAGUA, ANTONIO/0000-0002-2526-8412	Ministerio de Ciencia e Innovacion [BFU2008-04490/BFI]; Grupos de excelencia de la Junta de Castilla y Leon [GR183]; Fundacion Alicia Koplowitz; Fundacion Eugenio Rodriguez Pascual; Junta de Castilla y Leon PhD Program; Fundacion de lucha contra la ceguera (FUNDALUCE)	Ministerio de Ciencia e Innovacion(Ministry of Science and Innovation, Spain (MICINN)Instituto de Salud Carlos IIISpanish Government); Grupos de excelencia de la Junta de Castilla y Leon; Fundacion Alicia Koplowitz; Fundacion Eugenio Rodriguez Pascual; Junta de Castilla y Leon PhD Program(Junta de Castilla y Leon); Fundacion de lucha contra la ceguera (FUNDALUCE)	This study was supported by grants from the Ministerio de Ciencia e Innovacion (BFU2008-04490/BFI), Grupos de excelencia de la Junta de Castilla y Leon (GR183), Fundacion Alicia Koplowitz, Fundacion de lucha contra la ceguera (FUNDALUCE) and Fundacion Eugenio Rodriguez Pascual. S. H. M received support from the Junta de Castilla y Leon PhD Program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aartsen WM, 2006, HUM MOL GENET, V15, P1291, DOI 10.1093/hmg/ddl047; Assemat E, 2008, BBA-BIOMEMBRANES, V1778, P614, DOI 10.1016/j.bbamem.2007.08.029; Bazellieres E, 2009, FRONT BIOSCI-LANDMRK, V14, P2149, DOI 10.2741/3368; Brandstatter JH, 1996, J COMP NEUROL, V370, P1, DOI 10.1002/(SICI)1096-9861(19960617)370:1<1::AID-CNE1>3.0.CO;2-7; Brandstatter JH, 1999, EUR J NEUROSCI, V11, P3683, DOI 10.1046/j.1460-9568.1999.00793.x; Da Costa BLDA, 2003, VISUAL NEUROSCI, V20, P153, DOI 10.1017/S0952523803202066; den Hollander AI, 1999, NAT GENET, V23, P217, DOI 10.1038/13848; den Hollander AI, 2002, MECH DEVELOP, V110, P203, DOI 10.1016/S0925-4773(01)00568-8; den Hollander AI, 2001, AM J HUM GENET, V69, P198; den Hollander AI, 2008, PROG RETIN EYE RES, V27, P391, DOI 10.1016/j.preteyeres.2008.05.003; DIZHOOR AM, 1991, SCIENCE, V251, P915, DOI 10.1126/science.1672047; ERLANDER MG, 1991, NEURON, V7, P91, DOI 10.1016/0896-6273(91)90077-D; Evans RJ, 2010, HUM MOL GENET, V19, P1358, DOI 10.1093/hmg/ddq012; Fan SL, 2007, J CELL BIOL, V178, P387, DOI 10.1083/jcb.200609096; Fan SL, 2004, CURR BIOL, V14, P1451, DOI 10.1016/j.cub.2004.08.025; Fu XY, 2006, DEV BIOL, V299, P424, DOI 10.1016/j.ydbio.2006.08.015; Goda Y, 2002, NEURON, V35, P1, DOI 10.1016/S0896-6273(02)00765-1; Gosens I, 2008, EXP EYE RES, V86, P713, DOI 10.1016/j.exer.2008.02.005; Hatakeyama J, 2004, SEMIN CELL DEV BIOL, V15, P83, DOI 10.1016/j.semcdb.2003.09.005; Haverkamp S, 2009, NEUROSCIENCE, V160, P126, DOI 10.1016/j.neuroscience.2009.01.081; Haverkamp S, 2000, J COMP NEUROL, V424, P1; HECKENLIVELY JR, 1982, BRIT J OPHTHALMOL, V66, P26, DOI 10.1136/bjo.66.1.26; Izaddoost S, 2002, NATURE, V416, P178, DOI 10.1038/nature720; Johnson J, 2003, J NEUROSCI, V23, P518, DOI 10.1523/JNEUROSCI.23-02-00518.2003; Kantardzhieva A, 2005, INVEST OPHTH VIS SCI, V46, P2192, DOI 10.1167/iovs.04-1417; Lemmers C, 2004, MOL BIOL CELL, V15, P1324, DOI 10.1091/mbc.E03-04-0235; Lemmers C, 2002, J BIOL CHEM, V277, P25408, DOI 10.1074/jbc.M202196200; Liu X, 2001, EXP EYE RES, V72, P351, DOI 10.1006/exer.2000.0963; Makarova O, 2003, GENE, V302, P21, DOI 10.1016/S0378111902010843; Marquardt T, 2002, TRENDS NEUROSCI, V25, P32, DOI 10.1016/S0166-2236(00)02028-2; MCGINNIS JF, 1992, FEBS LETT, V302, P172, DOI 10.1016/0014-5793(92)80433-H; Mehalow AK, 2003, HUM MOL GENET, V12, P2179, DOI 10.1093/hmg/ddg232; Michel D, 2005, J CELL SCI, V118, P4049, DOI 10.1242/jcs.02528; NguyenLegros J, 1997, MICROSC RES TECHNIQ, V36, P26, DOI 10.1002/(SICI)1097-0029(19970101)36:1<26::AID-JEMT3>3.0.CO;2-X; OZAWA M, 1989, EMBO J, V8, P1711, DOI 10.1002/j.1460-2075.1989.tb03563.x; Pellikka M, 2002, NATURE, V416, P143, DOI 10.1038/nature721; Pignatelli V, 2004, J COMP NEUROL, V476, P254, DOI 10.1002/cne.20207; Polevoda B, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-5-reviews0006; Rich KA, 1997, J COMP NEUROL, V388, P47; Richard M, 2006, HUM MOL GENET, V15, pR235, DOI 10.1093/hmg/ddl195; Ritchey ER, 2010, NEUROSCIENCE, V169, P1376, DOI 10.1016/j.neuroscience.2010.05.081; Sedmak T, 2010, J CELL BIOL, V189, P171, DOI 10.1083/jcb.200911095; Sharma RK, 2003, DEV BRAIN RES, V145, P93, DOI 10.1016/S0165-3806(03)00217-7; Sherry DM, 2003, J COMP NEUROL, V465, P480, DOI 10.1002/cne.10838; Stohr H, 2003, INVEST OPHTH VIS SCI, V44, P5067, DOI 10.1167/iovs.03-0702; Stohr H, 2001, GENOMICS, V74, P377, DOI 10.1006/geno.2001.6559; TEPASS U, 1990, CELL, V61, P787, DOI 10.1016/0092-8674(90)90189-L; van de Pavert SA, 2004, J CELL SCI, V117, P4169, DOI 10.1242/jcs.01301; van den Hurk JAJM, 2005, MOL VIS, V11, P263; van Rossum AGSH, 2006, HUM MOL GENET, V15, P2659, DOI 10.1093/hmg/ddl194; VARDI N, 1995, J COMP NEUROL, V351, P374, DOI 10.1002/cne.903510305; Yang J, 2007, HUM MOL GENET, V16, P1017, DOI 10.1093/hmg/ddm047	52	7	7	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 30	2012	7	11							e50511	10.1371/journal.pone.0050511	http://dx.doi.org/10.1371/journal.pone.0050511			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	054WM	23226298	Green Published, gold, Green Submitted			2022-12-27	WOS:000312376100110
J	Kirby, E; Dickinson, J; Vassey, M; Dennis, M; Cornwall, M; McLeod, N; Smith, A; Marsh, PD; Walker, JT; Sutton, JM; Raven, NDH				Kirby, Elizabeth; Dickinson, Joanne; Vassey, Matthew; Dennis, Mike; Cornwall, Mark; McLeod, Neil; Smith, Andrew; Marsh, Philip D.; Walker, James T.; Sutton, J. Mark; Raven, Neil D. H.			Bioassay Studies Support the Potential for Iatrogenic Transmission of Variant Creutzfeldt Jakob Disease through Dental Procedures	PLOS ONE			English	Article							BOVINE SPONGIFORM ENCEPHALOPATHY; PRION PROTEIN; BLOOD-TRANSFUSION; TISSUE SAMPLES; SCRAPIE; PREVALENCE; VCJD; MICE; INFECTIVITY; STRAIN	Background: Evidence is required to quantify the potential risks of transmission of variant Creutzfeldt Jakob (vCJD) through dental procedures. Studies, using animal models relevant to vCJD, were performed to address two questions. Firstly, whether oral tissues could become infectious following dietary exposure to BSE? Secondly, would a vCJD-contaminated dental instrument be able to transmit disease to another patient? Methods: BSE-301V was used as a clinically relevant model for vCJD. VM-mice were challenged by injection of infected brain homogenate into the small intestine (Q1) or by five minute contact between a deliberately-contaminated dental file and the gingival margin (Q2). Ten tissues were collected from groups of challenged mice at three or four weekly intervals, respectively. Each tissue was pooled, homogenised and bioassayed in indicator mice. Findings: Challenge via the small intestine gave a transmission rate of 100% (mean incubation 157 +/- 17 days). Infectivity was found in both dental pulp and the gingival margin within 3 weeks of challenge and was observed in all tissues tested within the oral cavity before the appearance of clinical symptoms. Following exposure to deliberately contaminated dental files, 97% of mice developed clinical disease (mean incubation 234 +/- 33 days). Interpretation: Infectivity was higher than expected, in a wider range of oral tissues, than was allowed for in previous risk assessments. Disease was transmitted following transient exposure of the gingiva to a contaminated dental file. These observations provide evidence that dental procedures could be a route of cross-infection for vCJD and support the enforcement of single-use for certain dental instruments. Citation: Kirby E, Dickinson J, Vassey M, Dennis M, Cornwall M, et al. (2012) Bioassay Studies Support the Potential for Iatrogenic Transmission of Variant Creutzfeldt Jakob Disease through Dental Procedures. PLoS ONE 7(11): e49850. doi:10.1371/journal.pone.0049850	[Kirby, Elizabeth; Dickinson, Joanne; Vassey, Matthew; Dennis, Mike; Cornwall, Mark; McLeod, Neil; Marsh, Philip D.; Walker, James T.; Sutton, J. Mark; Raven, Neil D. H.] Hlth Protect Agcy Porton Down, Salisbury, Wilts, England; [Smith, Andrew] Univ Glasgow, Glasgow Dent Hosp & Sch, Coll Med Vet & Life Sci, Glasgow, Lanark, Scotland; [Marsh, Philip D.] Leeds Dent Inst, Leeds, W Yorkshire, England	University of Glasgow; University of Leeds	Sutton, JM (corresponding author), Hlth Protect Agcy Porton Down, Salisbury, Wilts, England.	mark.sutton@hpa.org.uk		Sutton, J. Mark/0000-0002-2288-0446	Department of Health (England) [007/0099]; WH Ltd; Steris Ltd; TSO3; CISA SpaA; BES Decon; BiotAK; Genencor International	Department of Health (England); WH Ltd; Steris Ltd; TSO3; CISA SpaA; BES Decon; BiotAK; Genencor International	The study was funded by the Department of Health (England), contract number 007/0099. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; AS has received lecture fees and funding for a PhD studentship from W&H Ltd, lecture fees from Steris Ltd and travel expenses for attending a meeting from Schulke and Mayr. PM identified consultancy work for Johnson and Johnson, UK and Unilever, UK. JMS identified consultancy work for Advanced Sterilisation Products and funding for research involving TSO3, CISA SpaA, BES Decon, BiotAK, and Genencor International. JMS also received travel money to attend a meeting of the British Association for the Study of Community Dentistry. This does not alter the authors' adherence to all the PLOS ONE policies on sharing data and materials.	Bishop MT, 2006, LANCET NEUROL, V5, P393, DOI 10.1016/S1474-4422(06)70413-6; BRUCE M, 1994, PHILOS T R SOC B, V343, P405, DOI 10.1098/rstb.1994.0036; Bruce ME, 2001, LANCET, V358, P208, DOI 10.1016/S0140-6736(01)05411-3; Bruce ME, 1997, NATURE, V389, P498, DOI 10.1038/39057; CARP RI, 1982, LANCET, V1, P170; Clewley JP, 2009, BRIT MED J, V338, DOI 10.1136/bmj.b1442; Collinge J, 2006, LANCET, V367, P2068, DOI 10.1016/S0140-6736(06)68930-7; Everington D, 2007, BR DENT J, V202, pE9; Farquhar CF, 1996, J GEN VIROL, V77, P1941, DOI 10.1099/0022-1317-77-8-1941; Fernie K, 2007, BIOTECHNOL APPL BIOC, V47, P175, DOI 10.1042/BA20060249; Head MW, 2007, GUT, V56, P9, DOI 10.1136/gut.2006.101964; Head MW, 2003, BRIT DENT J, V195, P339, DOI 10.1038/sj.bdj.4810536; Hewitt PE, 2006, VOX SANG, V91, P221, DOI 10.1111/j.1423-0410.2006.00833.x; Hilton DA, 2004, J PATHOL, V203, P733, DOI 10.1002/path.1580; Ingrosso L, 1999, J GEN VIROL, V80, P3043, DOI 10.1099/0022-1317-80-11-3043; Ironside JW, 2006, BRIT MED J, V332, P1186, DOI 10.1136/bmj.38804.511644.55; Joiner S, 2005, GUT, V54, P1506, DOI 10.1136/gut.2005.072447; Llewelyn CA, 2004, LANCET, V363, P417, DOI 10.1016/S0140-6736(04)15486-X; Mead S, 2007, ARCH NEUROL-CHICAGO, V64, P1780, DOI 10.1001/archneur.64.12.1780; Okada H, 2010, J COMP PATHOL, V143, P218, DOI 10.1016/j.jcpa.2010.01.015; Peden AH, 2004, LANCET, V364, P527, DOI 10.1016/S0140-6736(04)16811-6; Vassey M, 2011, BRIT DENT J, V210, DOI 10.1038/sj.bdj.2011.144; Wadsworth JDF, 2007, GUT, V56, P90, DOI 10.1136/gut.2006.091637; Wardlaw AC, 1992, PRACTICAL STAT EXPT	24	8	8	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 30	2012	7	11							e49850	10.1371/journal.pone.0049850	http://dx.doi.org/10.1371/journal.pone.0049850			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	054WM	23226225	gold, Green Published, Green Submitted, Green Accepted			2022-12-27	WOS:000312376100033
J	Liu, HT; Gomez, G; Lin, S; Lin, S; Lin, CT				Liu, Hongtao; Gomez, Gustavo; Lin, Sophia; Lin, Shuo; Lin, Chentao			Optogenetic Control of Transcription in Zebrafish	PLOS ONE			English	Article							CRYPTOCHROME 1; ARABIDOPSIS; RESISTANCE	Light inducible protein-protein interactions are powerful tools to manipulate biological processes. Genetically encoded light-gated proteins for controlling precise cellular behavior are a new and promising technology, called optogenetics. Here we exploited the blue light-induced transcription system in yeast and zebrafish, based on the blue light dependent interaction between two plant proteins, blue light photoreceptor Cryptochrome 2 (CRY2) and the bHLH transcription factor CIB1 (CRY-interacting bHLH 1). We demonstrate the utility of this system by inducing rapid transcription suppression and activation in zebrafish.	[Liu, Hongtao] Chinese Acad Sci, Inst Plant Physiol & Ecol, Shanghai Inst Biol Sci, Natl Key Lab Plant Mol Genet, Shanghai, Peoples R China; [Liu, Hongtao] Chinese Acad Sci, Inst Plant Physiol & Ecol, Shanghai Inst Biol Sci, Natl Ctr Plant Gene Res Shanghai, Shanghai, Peoples R China; [Liu, Hongtao; Gomez, Gustavo; Lin, Sophia; Lin, Shuo; Lin, Chentao] Univ Calif Los Angeles, Dept Mol Cell & Dev Biol, Los Angeles, CA USA	Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; University of California System; University of California Los Angeles	Liu, HT (corresponding author), Chinese Acad Sci, Inst Plant Physiol & Ecol, Shanghai Inst Biol Sci, Natl Key Lab Plant Mol Genet, Shanghai, Peoples R China.	htliu@sibs.ac.cn		Gomez, Gustavo/0000-0001-9294-4276	National Natural Science Foundation of China [31270285]; Institute of Plant Physiology and Ecology, Shanghai Institutes for Biological Sciences, Chinese Academy of Sciences; United States National Institutes of Health [GM56265]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM056265, R29GM056265] Funding Source: NIH RePORTER	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Institute of Plant Physiology and Ecology, Shanghai Institutes for Biological Sciences, Chinese Academy of Sciences; United States National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by grants from the National Natural Science Foundation of China (number 31270285) and the start funding from Institute of Plant Physiology and Ecology, Shanghai Institutes for Biological Sciences, Chinese Academy of Sciences, and also the United States National Institutes of Health (GM56265 to C.L.). The funders had no role in study design, data collection and manuscript.	Idevall-Hagren O, 2012, P NATL ACAD SCI USA, V109, pE2316, DOI 10.1073/pnas.1211305109; Jeong RD, 2010, P NATL ACAD SCI USA, V107, P13538, DOI 10.1073/pnas.1004529107; Keller MM, 2011, PLANT J, V67, P195, DOI 10.1111/j.1365-313X.2011.04598.x; Kennedy MJ, 2010, NAT METHODS, V7, P973, DOI 10.1038/NMETH.1524; Levskaya A, 2009, NATURE, V461, P997, DOI 10.1038/nature08446; Liu HT, 2008, SCIENCE, V322, P1535, DOI 10.1126/science.1163927; Shimizu-Sato S, 2002, NAT BIOTECHNOL, V20, P1041, DOI 10.1038/nbt734; Toettcher JE, 2011, NAT METHODS, V8, P837, DOI [10.1038/NMETH.1700, 10.1038/nmeth.1700]; Wu L, 2010, MOL PLANT, V3, P539, DOI 10.1093/mp/ssp107	9	64	67	0	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 30	2012	7	11							e50738	10.1371/journal.pone.0050738	http://dx.doi.org/10.1371/journal.pone.0050738			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	054WM	23226369	gold, Green Published, Green Submitted			2022-12-27	WOS:000312376100180
J	Rego, A; Costa, M; Chaves, SR; Matmati, N; Pereira, H; Sousa, MJ; Moradas-Ferreira, P; Hannun, YA; Costa, V; Corte-Real, M				Rego, Antonio; Costa, Margarida; Chaves, Susana Rodrigues; Matmati, Nabil; Pereira, Helena; Sousa, Maria Joao; Moradas-Ferreira, Pedro; Hannun, Yusuf A.; Costa, Vitor; Corte-Real, Manuela			Modulation of Mitochondrial Outer Membrane Permeabilization and Apoptosis by Ceramide Metabolism	PLOS ONE			English	Article							PROGRAMMED CELL-DEATH; PHOSPHOSPHINGOLIPID PHOSPHOLIPASE-C; CHRONOLOGICAL LIFE-SPAN; YEAST SACCHAROMYCES-CEREVISIAE; OXIDATIVE STRESS SENSITIVITY; ACETIC-ACID; SPHINGOLIPID METABOLISM; ADP/ATP CARRIER; DE-NOVO; PROTEINS	The yeast Saccharomyces cerevisiae undergoes a mitochondrial-dependent programmed cell death in response to different stimuli, such as acetic acid, with features similar to those of mammalian apoptosis. However, the upstream signaling events in this process, including those leading to mitochondrial membrane permeabilization, are still poorly characterized. Changes in sphingolipid metabolism have been linked to modulation of apoptosis in both yeast and mammalian cells, and ceramides have been detected in mitochondria upon apoptotic stimuli. In this study, we aimed to characterize the contribution of enzymes involved in ceramide metabolism to apoptotic cell death induced by acetic acid. We show that isc1 Delta and lag1 Delta mutants, lacking inositol phosphosphingolipid phospholipase C and ceramide synthase, respectively, exhibited a higher resistance to acetic acid that was associated with lower levels of some phytoceramide species. Consistently, these mutant cells displayed lower levels of ROS production and reduced mitochondrial alterations, such as mitochondrial fragmentation and degradation, and decreased translocation of cytochrome c into the cytosol in response to acetic acid. These results suggest that ceramide production contributes to cell death induced by acetic acid, especially through hydrolysis of complex sphingolipids catalyzed by Isc1p and de novo synthesis catalyzed by Lag1p, and provide the first in vivo indication of its involvement in mitochondrial outer membrane permeabilization in yeast.	[Rego, Antonio; Costa, Margarida; Moradas-Ferreira, Pedro; Costa, Vitor] Univ Porto, Inst Biol Mol & Celular, P-4100 Oporto, Portugal; [Rego, Antonio; Chaves, Susana Rodrigues; Pereira, Helena; Sousa, Maria Joao; Corte-Real, Manuela] Univ Minho, Dept Biol, Ctr Biol Mol & Ambiental, Braga, Portugal; [Costa, Margarida; Moradas-Ferreira, Pedro; Costa, Vitor] Univ Porto, Dept Biol Mol, Inst Ciencias Biomed Abel Salazar, P-4100 Oporto, Portugal; [Matmati, Nabil; Hannun, Yusuf A.] SUNY Stony Brook, Hlth Sci Ctr, Stony Brook Canc Ctr, Stony Brook, NY 11794 USA	Universidade do Porto; Universidade do Minho; Universidade do Porto; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook	Costa, V (corresponding author), Univ Porto, Inst Biol Mol & Celular, Rua Campo Alegre 823, P-4100 Oporto, Portugal.	vcosta@ibmc.up.pt; mcortereal@bio.uminho.pt	Chaves, Susana R/H-8786-2013; MORADAS-FERREIRA, PEDRO/E-6357-2012; Sousa, Maria/HCI-9642-2022; Rego, António/AAD-5742-2020; Corte-Real, Manuela/B-6328-2013; Costa, Vítor/A-2647-2008; Sousa, Maria João/H-8775-2013	Chaves, Susana R/0000-0002-6004-9872; MORADAS-FERREIRA, PEDRO/0000-0003-2994-0314; Rego, António/0000-0003-2849-4017; Corte-Real, Manuela/0000-0002-1423-1331; Costa, Vítor/0000-0002-7868-4663; Sousa, Maria João/0000-0001-9424-4150; Costa, Margarida/0000-0001-9147-8621; Pereira, Helena/0000-0002-0104-8714	FEDER (Fundo Europeu de Desenvolvimento Regional) through the program "Programa Operacional Factores de Competitividade-COMPETE''; FCT (Fundacao para a Ciencia e Tecnologia) [Pest-C/BIA/UI4050/2011, Pest-C/SAU/LA0002/2011, FCOMP-01-0124-FEDER-022718, FCOMP-01-0124-FEDER-007047]; Lipidomics Shared Resource; Hollings Cancer Center; Medical University of South Carolina [P30 CA138313]; Lipidomics Core in the SC Lipidomics and Pathobiology COBRE; Department Biochemistry; MUSC [P20 RR017677];  [GM 063265]; NATIONAL CANCER INSTITUTE [R01CA087584] Funding Source: NIH RePORTER	FEDER (Fundo Europeu de Desenvolvimento Regional) through the program "Programa Operacional Factores de Competitividade-COMPETE''; FCT (Fundacao para a Ciencia e Tecnologia)(Portuguese Foundation for Science and Technology); Lipidomics Shared Resource; Hollings Cancer Center; Medical University of South Carolina; Lipidomics Core in the SC Lipidomics and Pathobiology COBRE; Department Biochemistry; MUSC; ; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This project was financially supported by FEDER (Fundo Europeu de Desenvolvimento Regional) through the program "Programa Operacional Factores de Competitividade-COMPETE'' and FCT (Fundacao para a Ciencia e Tecnologia), through the projects Pest-C/BIA/UI4050/2011, Pest-C/SAU/LA0002/2011, FCOMP-01-0124-FEDER-022718 and FCOMP-01-0124-FEDER-007047. Research was supported in part by Grant GM 063265, the Lipidomics Shared Resource, Hollings Cancer Center, Medical University of South Carolina (P30 CA138313) and the Lipidomics Core in the SC Lipidomics and Pathobiology COBRE, Department Biochemistry, MUSC (P20 RR017677). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aerts AM, 2008, CELL MOL LIFE SCI, V65, P1933, DOI 10.1007/s00018-008-8129-8; Almeida T, 2008, MOL BIOL CELL, V19, P865, DOI 10.1091/mbc.E07-06-0604; Barbosa AD, 2012, MECH AGEING IN PRESS; Barbosa AD, 2012, MECH AGEING DEV, V133, P317, DOI 10.1016/j.mad.2012.03.007; Barbosa AD, 2011, MOL MICROBIOL, V81, P515, DOI 10.1111/j.1365-2958.2011.07714.x; Bartke N, 2009, J LIPID RES, V50, pS91, DOI 10.1194/jlr.R800080-JLR200; Betz C, 2002, EUR J BIOCHEM, V269, P4033, DOI 10.1046/j.1432-1033.2002.03096.x; Bielawski J, 2010, ADV EXP MED BIOL, V688, P46; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Buttner S, 2006, J CELL BIOL, V175, P521, DOI 10.1083/jcb.200608098; Burtner CR, 2009, CELL CYCLE, V8, P1256, DOI 10.4161/cc.8.8.8287; Cabiscol E, 2000, J BIOL CHEM, V275, P27393; Carmona-Gutierrez D, 2011, CELL CYCLE, V10, P3973, DOI 10.4161/cc.10.22.18212; Chipuk JE, 2012, CELL, V148, P988, DOI 10.1016/j.cell.2012.01.038; Costa WMV, 2002, FREE RADICAL BIO MED, V33, P1507, DOI 10.1016/S0891-5849(02)01086-9; Cowart LA, 2006, BIOCHEM J, V393, P733, DOI 10.1042/BJ20050643; D'Autreaux B, 2007, NAT REV MOL CELL BIO, V8, P813, DOI 10.1038/nrm2256; de Avalos SV, 2004, J BIOL CHEM, V279, P11537, DOI 10.1074/jbc.M309586200; DMELLO NP, 1994, J BIOL CHEM, V269, P15451; Fannjiang Y, 2004, GENE DEV, V18, P2785, DOI 10.1101/gad.1247904; Finkel T, 2000, NATURE, V408, P239, DOI 10.1038/35041687; Ganesan V, 2010, APOPTOSIS, V15, P553, DOI 10.1007/s10495-009-0449-0; Grant CM, 1997, FEBS LETT, V410, P219, DOI 10.1016/S0014-5793(97)00592-9; Guaragnella N, 2008, FEBS LETT, V582, P210, DOI 10.1016/j.febslet.2007.12.007; Gudz TI, 1997, J BIOL CHEM, V272, P24154, DOI 10.1074/jbc.272.39.24154; Hannun YA, 2008, NAT REV MOL CELL BIO, V9, P139, DOI 10.1038/nrm2329; Heinrich M, 1999, EMBO J, V18, P5252, DOI 10.1093/emboj/18.19.5252; HERRERO P, 1985, ARCH MICROBIOL, V143, P216, DOI 10.1007/BF00411238; Huang XH, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002493; Hwang O, 2001, MOL PHARMACOL, V59, P1249, DOI 10.1124/mol.59.5.1249; Jenkins GM, 1997, J BIOL CHEM, V272, P32566, DOI 10.1074/jbc.272.51.32566; Jiang JC, 2004, EXP GERONTOL, V39, P999, DOI 10.1016/j.exger.2004.03.026; JONES EW, 1990, METHOD ENZYMOL, V185, P372; Karbowski M, 2003, CELL DEATH DIFFER, V10, P870, DOI 10.1038/sj.cdd.4401260; Kitagaki H, 2007, BBA-BIOMEMBRANES, V1768, P2849, DOI 10.1016/j.bbamem.2007.07.019; Kitagaki H, 2009, J BIOL CHEM, V284, P10818, DOI 10.1074/jbc.M805029200; Ludovico P, 2001, MICROBIOL-SGM, V147, P3335, DOI 10.1099/00221287-147-12-3335; Ludovico P, 2002, MOL BIOL CELL, V13, P2598, DOI 10.1091/mbc.E01-12-0161; Maceyka M, 2002, BBA-MOL CELL BIOL L, V1585, P193, DOI 10.1016/S1388-1981(02)00341-4; Madeo F, 1999, J CELL BIOL, V145, P757, DOI 10.1083/jcb.145.4.757; Marques M, 2006, MICROBIOL-SGM, V152, P3595, DOI 10.1099/mic.0.29040-0; Matmati N, 2009, J BIOL CHEM, V284, P8241, DOI 10.1074/jbc.M900004200; Mollapour M, 2007, MOL CELL BIOL, V27, P6446, DOI 10.1128/MCB.02205-06; Montefusco DJ, 2012, J BIOL CHEM, V287, P9280, DOI 10.1074/jbc.M111.313445; Morales A, 2007, APOPTOSIS, V12, P923, DOI 10.1007/s10495-007-0721-0; Mullen T. D., 2011, ANTICANCER AGENTS ME; Okamoto K, 1998, J CELL BIOL, V142, P613, DOI 10.1083/jcb.142.3.613; Parra V, 2008, CARDIOVASC RES, V77, P387, DOI 10.1093/cvr/cvm029; Pereira C, 2007, MOL MICROBIOL, V66, P571, DOI 10.1111/j.1365-2958.2007.05926.x; Pereira C, 2010, MOL MICROBIOL, V76, P1398, DOI 10.1111/j.1365-2958.2010.07122.x; Perera MN, 2012, BBA-BIOMEMBRANES, V1818, P1291, DOI 10.1016/j.bbamem.2012.02.010; Perrone GG, 2008, BBA-MOL CELL RES, V1783, P1354, DOI 10.1016/j.bbamcr.2008.01.023; Sawai H, 2000, J BIOL CHEM, V275, P39793, DOI 10.1074/jbc.M007721200; Sims KJ, 2004, BIOCHEM CELL BIOL, V82, P45, DOI 10.1139/o03-086; Siskind LJ, 2008, J BIOL CHEM, V283, P6622, DOI 10.1074/jbc.M706115200; Siskind LJ, 2005, J BIOENERG BIOMEMBR, V37, P227, DOI 10.1007/s10863-005-6632-2; Siskind LJ, 2000, J BIOL CHEM, V275, P38640, DOI 10.1074/jbc.C000587200; Stiban J, 2008, J LIPID RES, V49, P625, DOI 10.1194/jlr.M700480-JLR200; Taha TA, 2006, BBA-BIOMEMBRANES, V1758, P2027, DOI 10.1016/j.bbamem.2006.10.018; Valenti D, 2008, FEMS YEAST RES, V8, P400, DOI 10.1111/j.1567-1364.2008.00348.x; Wells GB, 1998, J BIOL CHEM, V273, P7235, DOI 10.1074/jbc.273.13.7235; Wissing S, 2004, J CELL BIOL, V166, P969, DOI 10.1083/jcb.200404138	62	54	55	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 30	2012	7	11							e48571	10.1371/journal.pone.0048571	http://dx.doi.org/10.1371/journal.pone.0048571			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	054WM	23226203	Green Published, gold, Green Submitted			2022-12-27	WOS:000312376100012
J	Seifert, CL; Poppert, H; Sander, D; Feurer, R; Etgen, T; Ander, KH; Purner, K; Bronner, M; Sepp, D; Kehl, V; Forstl, H; Bickel, H				Seifert, Christian L.; Poppert, Holger; Sander, Dirk; Feurer, Regina; Etgen, Thorleif; Ander, Karl-Heinz; Puerner, Klaus; Broenner, Monika; Sepp, Dominik; Kehl, Victoria; Foerstl, Hans; Bickel, Horst			Depressive Symptoms and the Risk of Ischemic Stroke in the Elderly-Influence of Age and Sex	PLOS ONE			English	Article							CORONARY-HEART-DISEASE; INCIDENT COGNITIVE IMPAIRMENT; C-REACTIVE PROTEIN; CLINICAL DEPRESSION; ANTIDEPRESSANT USE; MAJOR DEPRESSION; SOCIAL SUPPORT; METAANALYSIS; MORTALITY; EVENTS	Although a relationship between depression and cardiovascular events has been suggested, past study results regarding the risk of stroke in relation to depression by subgroups are ambiguous. The aim of this study was to investigate the influence of depressive symptoms on risk of incident ischemic stroke in elderly according to age and sex. This prospective cohort study followed up 3852 subjects older than 55 years. Baseline depressive symptoms were defined by a score >= 5 on the Geriatric Depression Scale or antidepressant intake. The outcome measure was incident ischemic stroke within 6 years of follow-up. Multivariate Cox-proportional hazard models as well as cumulative survival analyses were computed. A total of 156 ischemic strokes occurred during the study period (24 strokes in the age-group < 65 years and 132 strokes in the age-group >= 65 years). The distribution of strokes in sex-subgroups was 4.5% in men and 3.7% in women. The multivariate analysis showed an elevated stroke risk (Hazard Ratio (HR): 2.84, 95% CI 1.11-7.29, p = 0.030) in subjects from 55 to 64 years with depressive symptoms at baseline but not in subjects older than 65 years. In the multivariate analysis according to sex the risk was increased in women (HR: 1.62, 95% CI 1.02-2.57, P = 0.043) but not in men. The Cox-regression model for interaction showed a significant interaction between age and sex (HR: 3.24, 95% CI 1.21-8.69, P = 0.020). This study corroborates that depressive symptoms pose an important risk for ischemic stroke, which is particularly remarkable in women and patients younger than 65 years.	[Seifert, Christian L.; Poppert, Holger; Feurer, Regina; Sepp, Dominik] Tech Univ Munich, Klinikum Rechts Isar, Dept Neurol, D-8000 Munich, Germany; [Etgen, Thorleif; Broenner, Monika; Foerstl, Hans; Bickel, Horst] Tech Univ Munich, Dept Psychiat & Psychotherapy, D-8000 Munich, Germany; [Etgen, Thorleif] Klinikum Traunstein, Kliniken Sudostbayern, Dept Neurol, Traunstein, Germany; [Sander, Dirk] Benedictus Hosp, Dept Neurol, Tutzing, Germany; [Kehl, Victoria] Tech Univ Munich, Inst Med Stat & Epidemiol, D-8000 Munich, Germany; [Ander, Karl-Heinz; Puerner, Klaus] INVADE Study Grp, Baldham, Germany	Technical University of Munich; Technical University of Munich; University of Munich; Technical University of Munich	Seifert, CL (corresponding author), Tech Univ Munich, Klinikum Rechts Isar, Dept Neurol, D-8000 Munich, Germany.	c.seifert@lrz.tu-muenchen.de	Etgen, Thorleif/ABB-3610-2020	Etgen, Thorleif/0000-0002-7857-6435; Forstl, Hans/0000-0002-6188-6883; Poppert, Holger/0000-0003-2189-7681	health insurance company Allgemeine Ortskrankenkasse Bayern (AOK Bayern); German Stroke Foundation; Bayer Vital GmbH; Berlin-Chemie AG; Organon Pharmaceuticals; Ratiopharm GmbH; Sanofi-Synthelabo GmbH; TEVA Pharmaceutical Industries Ltd.	health insurance company Allgemeine Ortskrankenkasse Bayern (AOK Bayern); German Stroke Foundation; Bayer Vital GmbH(Bayer AG); Berlin-Chemie AG; Organon Pharmaceuticals; Ratiopharm GmbH; Sanofi-Synthelabo GmbH; TEVA Pharmaceutical Industries Ltd.	This work was supported primarily by the health insurance company Allgemeine Ortskrankenkasse Bayern (AOK Bayern). Further support for different time periods came from German Stroke Foundation, Bayer Vital GmbH, Berlin-Chemie AG, Organon Pharmaceuticals, Ratiopharm GmbH, Sanofi-Synthelabo GmbH, and TEVA Pharmaceutical Industries Ltd. There are no relevant conflicts of interests of the authors regarding employment, consultancy, patents, products in development or marketed products. Furthermore, the authors declare that neither commercial funding nor possible conflict of interests alter the authors' adherence to all the PLOS ONE policies on sharing data and materials. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Almeida OP, 1999, INT J GERIATR PSYCH, V14, P858, DOI 10.1002/(SICI)1099-1166(199910)14:10<858::AID-GPS35>3.0.CO;2-8; Avendano M, 2006, STROKE, V37, P1368, DOI 10.1161/01.STR.0000221702.75002.66; Barth J, 2004, PSYCHOSOM MED, V66, P802, DOI 10.1097/01.psy.0000146332.53619.b2; Brooke P, 1999, INT J GERIATR PSYCH, V14, P936, DOI 10.1002/(SICI)1099-1166(199911)14:11<936::AID-GPS39>3.3.CO;2-T; Copeland WE, 2012, BIOL PSYCHIAT; Coupland C, 2011, BMJ-BRIT MED J, V343, DOI 10.1136/bmj.d4551; Dong JY, 2012, STROKE, V43, P32, DOI 10.1161/STROKEAHA.111.630871; Etgen T, 2010, ARCH INTERN MED, V170, P186, DOI 10.1001/archinternmed.2009.498; Etgen T, 2009, NEPHROL DIAL TRANSPL, V24, P3144, DOI 10.1093/ndt/gfp230; Goldstein LB, 2011, STROKE, V42, P517, DOI 10.1161/STR.0b013e3181fcb238; Hamer M, 2011, BRAIN BEHAV IMMUN, V25, P168, DOI 10.1016/j.bbi.2010.09.013; Horn CS, 2009, J NEUROL, V256, P783, DOI 10.1007/s00415-009-5017-6; Howren MB, 2009, PSYCHOSOM MED, V71, P171, DOI 10.1097/PSY.0b013e3181907c1b; Kessler RC, 2003, JAMA-J AM MED ASSOC, V289, P3095, DOI 10.1001/jama.289.23.3095; KOENIG HG, 1988, J AM GERIATR SOC, V36, P699, DOI 10.1111/j.1532-5415.1988.tb07171.x; Kwon S, 2004, STROKE, V35, P918, DOI 10.1161/01.STR.0000119385.56094.32; LaghrissiThode F, 1997, BIOL PSYCHIAT, V42, P290, DOI 10.1016/S0006-3223(96)00345-9; Lloyd-Jones D, 2010, CIRCULATION, V121, pE46, DOI 10.1161/CIRCULATIONAHA.109.192667; Luukinen H, 2003, EUR HEART J, V24, P2021, DOI 10.1016/j.ehj.2003.09.003; Mezuk B, 2008, DIABETES CARE, V31, P2383, DOI 10.2337/dc08-0985; Miller GE, 2002, AM J CARDIOL, V90, P1279, DOI 10.1016/S0002-9149(02)02863-1; Nabi H, 2010, INT J EPIDEMIOL, V39, P1016, DOI 10.1093/ije/dyq050; Nicholson A, 2006, EUR HEART J, V27, P2763, DOI 10.1093/eurheartj/ehl338; Pan A, 2011, STROKE, V42, P2770, DOI 10.1161/STROKEAHA.111.617043; Pan A, 2011, JAMA-J AM MED ASSOC, V306, P1241, DOI 10.1001/jama.2011.1282; Patten SB, 2009, PSYCHOSOM MED, V71, P273, DOI 10.1097/PSY.0b013e3181988e5f; Pizzi C, 2011, AM J CARDIOL, V107, P972, DOI 10.1016/j.amjcard.2010.11.017; Ross R, 1999, NEW ENGL J MED, V340, P115, DOI 10.1056/NEJM199901143400207; Ryan J, 2008, BRIT J PSYCHIAT, V192, P12, DOI 10.1192/bjp.bp.107.039164; Salaycik KJ, 2007, STROKE, V38, P16, DOI 10.1161/01.STR.0000251695.39877.ca; SHEIKH J I, 1986, Clinical Gerontologist, V5, P165; Silverstein B, 1999, AM J PSYCHIAT, V156, P480; Simon GE, 2003, BIOL PSYCHIAT, V54, P208, DOI 10.1016/S0006-3223(03)00420-7; Surtees PG, 2008, NEUROLOGY, V70, P788, DOI 10.1212/01.wnl.0000304109.18563.81; Whooley MA, 2008, JAMA-J AM MED ASSOC, V300, P2379, DOI 10.1001/jama.2008.711; Wu Z, 2012, J AGING HLTH; YESAVAGE JA, 1983, J PSYCHIATR RES, V17, P37, DOI 10.1016/0022-3956(82)90033-4; Zlotnick C, 1996, AM J PSYCHIAT, V153, P1021	38	20	21	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 30	2012	7	11							e50803	10.1371/journal.pone.0050803	http://dx.doi.org/10.1371/journal.pone.0050803			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	054WM	23226388	Green Published, gold, Green Submitted			2022-12-27	WOS:000312376100199
J	Zhang, RC; Lin, Y; Yue, M; Li, Q; Zhang, XF; Liu, X; Chi, H; Chai, F; Wang, M				Zhang, Rui-Chang; Lin, Yue; Yue, Ming; Li, Qian; Zhang, Xiao-Fei; Liu, Xiao; Chi, Hong; Chai, Fu; Wang, Mao			Effects of Ultraviolet-B Irradiance on Intraspecific Competition and Facilitation of Plants: Self-Thinning, Size Inequality, and Phenotypic Plasticity	PLOS ONE			English	Article							STRESS-GRADIENT HYPOTHESIS; TRITICUM-AESTIVUM L.; POSITIVE INTERACTIONS; ABIOTIC STRESS; SPRING WHEAT; RADIATION; METAANALYSIS; COMMUNITIES; POPULATIONS; HIERARCHIES	(1) The effects of facilitation on the structure and dynamics of plant populations have not been studied so widely as competition. The UV-B radiation, as a typical environmental factor causing stress, may result in direct stress and facilitation. (2) The effects of UV-B radiation on intraspecific competition and facilitation were investigated based on the following three predictions on self-thinning, size inequality, and phenotypic plasticity: i) Self-thinning is the reduction in density that results from the increase in the mean biomass of individuals in crowded populations, and is driven by competition. In this study, the mortality rate of the population is predicted to decrease from UV-B irradiance. ii) The size inequality of a population increases with competition intensity because larger individuals receive a disproportionate share of resources, thereby leaving limited resources for smaller individuals. The second hypothesis assumes that direct stress decreases the size inequality of the population. iii) Phenotypic plasticity is the ability to alter one's morphology in response to environmental changes. The third hypothesis assumes that certain morphological indices can change among the trade-offs between competition, facilitation, and stress. These predictions were tested by conducting a field pot experiment using mung beans, and were supported by the following results: (3) UV-B radiation increased the survival rate of the population at the end of self-thinning. However, this result was mainly due to direct stress rather than facilitation. (4) Just as competitor, facilitation was also asymmetric. It increased the size inequality of populations during self-thinning, whereas stress decreased the size inequality. (5) Direct stress and facilitation influence plants differently on various scales. Stress inhibited plant growth, whereas facilitation showed the opposite on an individual scale. Stress increased survival rate, whereas facilitation increased individual variability on the population scale. (6) Trade-offs between competitions, facilitation, and direct stress varied in different growing stages.	[Zhang, Rui-Chang; Yue, Ming; Li, Qian; Zhang, Xiao-Fei; Liu, Xiao; Chi, Hong; Chai, Fu; Wang, Mao] Northwest Univ, Minist Educ, Key Lab Resource Biol & Biotechnol Western China, Xian, Peoples R China; [Lin, Yue] Tech Univ Dresden, Inst Forest Growth & Comp Sci, Tharandt, Germany; [Lin, Yue] UFZ Helmholtz Ctr Environm Res, Dept Ecol Modelling, Leipzig, Germany	Northwest University Xi'an; Technische Universitat Dresden; Helmholtz Association; Helmholtz Center for Environmental Research (UFZ)	Yue, M (corresponding author), Northwest Univ, Minist Educ, Key Lab Resource Biol & Biotechnol Western China, Xian, Peoples R China.	yueming@nwu.edu.cn		Lin, Yue/0000-0002-0346-6493	National Science Foundation of China [30670366, 31070362]; Special Foundation of Key Laboratory of Resource Biology and Biotechnology in Western China, Ministry of Education [2010JS100]	National Science Foundation of China(National Natural Science Foundation of China (NSFC)); Special Foundation of Key Laboratory of Resource Biology and Biotechnology in Western China, Ministry of Education	Research was supported by grants from the National Science Foundation of China (30670366, 31070362) and Special Foundation of Key Laboratory of Resource Biology and Biotechnology in Western China, Ministry of Education (2010JS100). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barnes PW, 1988, FUNCT ECOL, V2, P319, DOI 10.2307/2389404; BARNES PW, 1990, AM J BOT, V77, P1354, DOI 10.2307/2444596; Bazzaz F.A., 1990, PERSPECTIVES PLANT C, P240; BERTNESS MD, 1994, TRENDS ECOL EVOL, V9, P191, DOI 10.1016/0169-5347(94)90088-4; BEYSCHLAG W, 1988, PHOTOSYNTHETICA, V22, P516; Brooker RW, 2008, J ECOL, V96, P18, DOI 10.1111/j.1365-2745.2007.01295.x; BURROWS FM, 1991, PHILOS T ROY SOC B, V333, P119, DOI 10.1098/rstb.1991.0064; Caldwell MM, 1998, J PHOTOCH PHOTOBIO B, V46, P40, DOI 10.1016/S1011-1344(98)00184-5; CALDWELL MM, 1989, TRENDS ECOL EVOL, V4, P363, DOI 10.1016/0169-5347(89)90100-6; CALDWELL MM, 1994, CLIMATIC CHANGE, V28, P375, DOI 10.1007/BF01104080; Caldwell MM, 1981, PHYSL PLANT ECOL, V12A, P169; Callaway R. M., 2007, POSITIVE INTERACTION; Callaway RM, 2007, NATURE, V448, P145, DOI 10.1038/448145a; Callaway RM, 1997, OECOLOGIA, V112, P143, DOI 10.1007/s004420050293; Callaway RM, 1995, BOT REV, V61, P306, DOI 10.1007/BF02912621; Callaway RM, 1997, ECOLOGY, V78, P1958, DOI 10.1890/0012-9658(1997)078[1958:CAFASA]2.0.CO;2; Callaway RM, 2002, NATURE, V417, P844, DOI 10.1038/nature00812; Choler P, 2001, ECOLOGY, V82, P3295, DOI 10.1890/0012-9658(2001)082[3295:FACOGI]2.0.CO;2; Chu CJ, 2009, J ECOL, V97, P1401, DOI 10.1111/j.1365-2745.2009.01562.x; DIXON PM, 1987, ECOLOGY, V68, P1548, DOI 10.2307/1939238; Dudley SA, 2007, BIOLOGY LETT, V3, P435, DOI 10.1098/rsbl.2007.0232; FOX FM, 1978, OECOLOGIA, V36, P173, DOI 10.1007/BF00349807; GOLD WG, 1983, PHYSIOL PLANTARUM, V58, P435, DOI 10.1111/j.1399-3054.1983.tb04205.x; Grime J. P., 2001, PLANT STRATEGIES VEG; GRIME JP, 1977, AM NAT, V111, P1169, DOI 10.1086/283244; Herman JR, 2010, J GEOPHYS RES-ATMOS, V115, DOI 10.1029/2009JD012219; JOHANSON U, 1995, AMBIO, V24, P106; KENKEL NC, 1988, ECOLOGY, V69, P1017, DOI 10.2307/1941257; Li Q, 2011, FLORA, V206, P712, DOI 10.1016/j.flora.2010.11.013; Liu J, 2006, J INTEGR PLANT BIOL, V48, P415, DOI 10.1111/j.1744-7909.2006.00240.x; Lortie CJ, 2006, J ECOL, V94, P7, DOI 10.1111/j.1365-2745.2005.01066.x; Madronich S, 1998, J PHOTOCH PHOTOBIO B, V46, P5, DOI 10.1016/S1011-1344(98)00182-1; Maestre FT, 2009, J ECOL, V97, P199, DOI 10.1111/j.1365-2745.2008.01476.x; Maestre FT, 2005, J ECOL, V93, P748, DOI 10.1111/j.1365-2745.2005.01017.x; Maestre FT, 2006, J ECOL, V94, P17, DOI 10.1111/j.1365-2745.2005.01089.x; MT L, 2001, OIKOS, V93, P8; NAGASHIMA H, 1995, ANN BOT-LONDON, V75, P173, DOI 10.1006/anbo.1995.1009; PREDIERI S, 1995, ENVIRON EXP BOT, V35, P151, DOI 10.1016/0098-8472(95)00003-2; SaileMark M, 1997, PLANT ECOL, V128, P114; Sangtarash MH, 2009, ENVIRON EXP BOT, V66, P212, DOI 10.1016/j.envexpbot.2009.03.004; SCHMID B, 1993, EVOLUTION, V47, P61, DOI 10.1111/j.1558-5646.1993.tb01199.x; TEVINI M, 1989, PHOTOCHEM PHOTOBIOL, V50, P479, DOI 10.1111/j.1751-1097.1989.tb05552.x; Tourpali K, 2009, ATMOS CHEM PHYS, V9, P1165, DOI 10.5194/acp-9-1165-2009; Weiner J, 2004, PERSPECT PLANT ECOL, V6, P207, DOI 10.1078/1433-8319-00083; WEINER J, 1985, ECOLOGY, V66, P743, DOI 10.2307/1940535; WEINER J, 1990, TRENDS ECOL EVOL, V5, P360, DOI 10.1016/0169-5347(90)90095-U; WEINER J, 1984, OECOLOGIA, V61, P334, DOI 10.1007/BF00379630; Weiner J, 2001, AM NAT, V158, P438, DOI 10.1086/321988; West GB, 1999, NATURE, V400, P664, DOI 10.1038/23251; Yuan L, 1999, ENVIRON EXP BOT, V41, P47, DOI 10.1016/S0098-8472(98)00049-5; Yue M, 1998, ENVIRON EXP BOT, V40, P187, DOI 10.1016/S0098-8472(98)00036-7; Yue M, 1999, ACTA SCI CIRCUMSTANT, V19, P526	52	46	50	0	89	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 30	2012	7	11							e50822	10.1371/journal.pone.0050822	http://dx.doi.org/10.1371/journal.pone.0050822			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	054WM	23226393	Green Published, gold, Green Submitted			2022-12-27	WOS:000312376100204
J	Mindell, JS; Leslie, D; Wardlaw, M				Mindell, Jennifer S.; Leslie, Deborah; Wardlaw, Malcolm			Exposure-Based, 'Like-for-Like' Assessment of Road Safety by Travel Mode Using Routine Health Data	PLOS ONE			English	Article							BENEFITS; INJURIES; BICYCLE; WALKING; RISKS; RATES	Background: Official reports on modal risk have not chosen appropriate numerators and denominators to enable like-for-like comparisons. We report age- and sex-specific deaths and injury rates from equivalent incidents in England by travel mode, distance travelled and time spent travelling. Methods: Hospital admissions and deaths in England 2007-2009 were obtained for relevant ICD-10 external codes for pedestrians, cyclists, and car/van drivers, by age-group and sex. Distance travelled by age- group, sex and mode in England (National Travel Survey 2007-2009 data) was converted to time spent travelling using mean trip speeds. Fatality rates were compared with age- specific Netherlands data. Results: All-age fatalities per million hours' use (f/mhu) varied over the same factor-of-three range for both sexes (0.15-0.45 f/mhu by mode for men, 0.09-0.31 f/mhu for women). Risks were similar for men aged 21-49 y for all three modes and for female pedestrians and drivers aged 21-69 y. Most at risk were: males 17-20 y (1.3 f/mhu (95% CI 1.2-1.4)) for driving; males 70+ (2.2 f/mhu(1.6-3.0)) for cycling; and females 70+ (0.95 f/mhu (0.86-1.1)) for pedestrians. In general, fatality rates were substantially higher among males than females. Risks per hour for male drivers,30 y were similar or higher than for male cyclists; for males aged 17-20 y, the risk was higher for drivers (33/Bn km (30-36), 1.3 f/mhu (1.2-1.4)) than cyclists (20/Bn km (10-37), 0.24 f/mhu (0.12-0.45)) whether using distance or time. Similar age patterns occurred for cyclists and drivers in the Netherlands. Age-sex patterns for injuries resulting in hospital admission were similar for cyclists and pedestrians but lower for drivers. Conclusions: When all relevant ICD-10 codes are used, fatalities by time spent travelling vary within similar ranges for walking, cycling and driving. Risks for drivers were highest in youth and fell with age, while for pedestrians and cyclists, risks increased with age. For the young, especially males, cycling is safer than driving. Citation: Mindell JS, Leslie D, Wardlaw M (2012) Exposure-Based, 'Like-for-Like' Assessment of Road Safety by Travel Mode Using Routine Health Data. PLoS ONE 7(12): e50606. doi: 10.1371/journal.pone.0050606	[Mindell, Jennifer S.] UCL, Res Dept Epidemiol & Publ Hlth, London, England; [Leslie, Deborah] Deakin Univ, Ctr Phys Act & Nutr Res, Burwood, Australia	University of London; University College London; Deakin University	Mindell, JS (corresponding author), UCL, Res Dept Epidemiol & Publ Hlth, London, England.	j.mindell@ucl.ac.uk	Mindell, Jennifer S/G-2241-2011	Mindell, Jennifer S/0000-0002-7604-6131				Beck LF, 2007, AM J EPIDEMIOL, V166, P212, DOI 10.1093/aje/kwm064; Bhagat A, 2008, ROAD CASUALTIES GREA; Blows Stephanie, 2005, Traffic Inj Prev, V6, P230, DOI 10.1080/15389580590969175; Byberg L, 2009, BMJ-BRIT MED J, V338, DOI 10.1136/bmj.b688; Centraal Bureau voor de Statistiek, 2010, MOB NED MOB KENM VER; Christie N, 2010, PUBLICATION DEP TRAN, V19; Christie N, 2007, INJURY PREV, V13, P125, DOI 10.1136/ip.2006.011692; Cope A, 2009, CYCLING DEMONSTRATIO; Davis A, 2011, HLTH MOVE, P2; de Hartog JJ, 2010, ENVIRON HEALTH PERSP, V118, P1109, DOI 10.1289/ehp.0901747; Department for Transport, 2009, ROAD CASUALTIES GREA; Department for Transport, 2011, NAT TRAV SURV 2010; DOBSON AJ, 1991, STAT MED, V10, P457, DOI 10.1002/sim.4780100317; Heinen E, 2010, TRANSPORT REV, V30, P59, DOI 10.1080/01441640903187001; Hillman M., 1992, CYCLING HLTH SAFETY; Jarrett J, 2012, LANCET, V379, P2198, DOI 10.1016/S0140-6736(12)60766-1; Knowles J, 2009, PPR445 TRANSP RES LA; Langford J, 2008, ACCIDENT ANAL PREV, V40, P1996, DOI 10.1016/j.aap.2008.08.027; Li GH, 2003, ACCIDENT ANAL PREV, V35, P227, DOI 10.1016/S0001-4575(01)00107-5; Morency P, 2012, AM J PUBLIC HEALTH, V102, P1112, DOI 10.2105/AJPH.2011.300528; Oja P, 2011, SCAND J MED SCI SPOR, V21, P496, DOI 10.1111/j.1600-0838.2011.01299.x; Oxley J, 2004, 218 MON U ACC RES CT; Pucher J, 2003, AM J PUBLIC HEALTH, V93, P1509, DOI 10.2105/AJPH.93.9.1509; Rabl A., 2001, TRANSPORT POLICY, V19, P121; Rissel C., 2002, AUST J PRIM HEALTH, V8, P66, DOI [DOI 10.1071/PY02029, 10.1071/PY02029]; Rojas-Rueda D, 2011, BMJ-BRIT MED J, V343, DOI 10.1136/bmj.d4521; Shafer A, 2000, REGULARITIES TRAVEL; Siman-Tov M, 2012, ACCIDENT ANAL PREV, V44, P135, DOI 10.1016/j.aap.2010.10.006; Sonkin B, 2006, J ROY SOC MED, V99, P402, DOI 10.1258/jrsm.99.8.402; Transport for London, 2008, 6 TFL; Tranter M, 2008, ROAD CASUALTIES GREA; TRL Transport Research Laboratory, 2001, COST BENEFIT ANAL ME; Wardlaw M, 2003, TRAFFIC ENG CONTROL, V43, P420; Wegman F, 2012, ACCIDENT ANAL PREV, V44, P19, DOI 10.1016/j.aap.2010.11.010	34	64	64	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 5	2012	7	12							e50606	10.1371/journal.pone.0050606	http://dx.doi.org/10.1371/journal.pone.0050606			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	057TZ	23227191	Green Published, gold, Green Submitted			2022-12-27	WOS:000312588200051
J	Swaminathan, S; Huentelman, MJ; Corneveaux, JJ; Myers, AJ; Faber, KM; Foroud, T; Mayeux, R; Shen, L; Kim, S; Turk, M; Hardy, J; Reiman, EM; Saykin, AJ				Swaminathan, Shanker; Huentelman, Matthew J.; Corneveaux, Jason J.; Myers, Amanda J.; Faber, Kelley M.; Foroud, Tatiana; Mayeux, Richard; Shen, Li; Kim, Sungeun; Turk, Mari; Hardy, John; Reiman, Eric M.; Saykin, Andrew J.		ADNI; NIA-LOAD NCRAD Family Study Grp	Analysis of Copy Number Variation in Alzheimer's Disease in a Cohort of Clinically Characterized and Neuropathologically Verified Individuals	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; LATE-ONSET; IDENTIFIES VARIANTS; PARTIAL DUPLICATION; RECEPTOR SUBUNIT; COMMON VARIANTS; RISK LOCI; GENE; BRAIN; CLU	Copy number variations (CNVs) are genomic regions that have added (duplications) or deleted (deletions) genetic material. They may overlap genes affecting their function and have been shown to be associated with disease. We previously investigated the role of CNVs in late-onset Alzheimer's disease (AD) and mild cognitive impairment using Alzheimer's Disease Neuroimaging Initiative (ADNI) and National Institute of Aging-Late Onset AD/National Cell Repository for AD (NIA-LOAD/NCRAD) Family Study participants, and identified a number of genes overlapped by CNV calls. To confirm the findings and identify other potential candidate regions, we analyzed array data from a unique cohort of 1617 Caucasian participants (1022 AD cases and 595 controls) who were clinically characterized and whose diagnosis was neuropathologically verified. All DNA samples were extracted from brain tissue. CNV calls were generated and subjected to quality control (QC). 728 cases and 438 controls who passed all QC measures were included in case/control association analyses including candidate gene and genome-wide approaches. Rates of deletions and duplications did not significantly differ between cases and controls. Case-control association identified a number of previously reported regions (CHRFAM7A, RELN and DOPEY2) as well as a new gene (HLA-DRA). Meta-analysis of CHRFAM7A indicated a significant association of the gene with AD and/ or MCI risk (P = 0.006, odds ratio = 3.986 (95% confidence interval 1.490-10.667)). A novel APP gene duplication was observed in one case sample. Further investigation of the identified genes in independent and larger samples is warranted. Citation: Swaminathan S, Huentelman MJ, Corneveaux JJ, Myers AJ, Faber KM, et al. (2012) Analysis of Copy Number Variation in Alzheimer's Disease in a Cohort of Clinically Characterized and Neuropathologically Verified Individuals. PLoS ONE 7(12): e50640. doi:10.1371/journal.pone.0050640	[Swaminathan, Shanker; Foroud, Tatiana; Shen, Li; Kim, Sungeun; Saykin, Andrew J.] Indiana Univ Sch Med, Dept Radiol & Imaging Sci, Ctr Neuroimaging, Indianapolis, IN USA; [Swaminathan, Shanker; Faber, Kelley M.; Foroud, Tatiana; Saykin, Andrew J.] Indiana Univ Sch Med, Dept Med & Mol Genet, Indianapolis, IN USA; [Huentelman, Matthew J.; Corneveaux, Jason J.; Turk, Mari; Reiman, Eric M.] Translat Genom Res Inst TGen, Neurogen Div, Phoenix, AZ USA; [Huentelman, Matthew J.; Corneveaux, Jason J.; Turk, Mari; Reiman, Eric M.] Arizona Alzheimers Consortium, Phoenix, AZ USA; [Myers, Amanda J.] Univ Miami, Miller Sch Med, Dept Psychiat & Behav Sci, Miami, FL 33136 USA; [Myers, Amanda J.] Univ Miami, Miller Sch Med, Dept Human Genet & Genom, Miami, FL 33136 USA; [Myers, Amanda J.] Johnnie B Byrd Sr Alzheimers Ctr & Res Inst, Tampa, FL USA; [Foroud, Tatiana; Shen, Li; Kim, Sungeun; Saykin, Andrew J.] Indiana Univ Sch Med, Ctr Computat Biol & Bioinformat, Indianapolis, IN USA; [Mayeux, Richard] Columbia Univ Coll Phys & Surg, Taub Inst Res Alzheimers Dis & Aging Brain, Gertrude H Sergievsky Ctr, New York, NY 10032 USA; [Mayeux, Richard] Columbia Univ Coll Phys & Surg, Dept Neurol, New York, NY 10032 USA; [Hardy, John] UCL, Inst Neurol, Dept Mol Neurosci, London, England; [Hardy, John] UCL, Inst Neurol, Reta Lila Res Labs, London, England; [Reiman, Eric M.] Banner Alzheimers Inst, Phoenix, AZ USA	Indiana University System; Indiana University Bloomington; Indiana University System; Indiana University Bloomington; Translational Genomics Research Institute; University of Miami; University of Miami; Indiana University System; Indiana University Bloomington; Columbia University; Columbia University; University of London; University College London; University of London; University College London; Banner Research; Banner Health; Banner Alzheimer's Institute	Saykin, AJ (corresponding author), Indiana Univ Sch Med, Dept Radiol & Imaging Sci, Ctr Neuroimaging, Indianapolis, IN USA.	asaykin@iupui.edu	Myers, Amanda J/B-1796-2010; Hsiung, Robin/AAT-1661-2021; Shen, Li/AAB-6870-2021; Preda, Adrian/K-8889-2013; Mayeux, Richard/E-9788-2013; Levey, Allan/F-2104-2011; Hardy, John/C-2451-2009; Saykin, Andrew/A-1318-2007	Myers, Amanda J/0000-0002-3100-9396; Hsiung, Robin/0000-0002-8017-0856; Preda, Adrian/0000-0003-3373-2438; Mayeux, Richard/0000-0001-6519-9696; Levey, Allan/0000-0002-3153-502X; Hardy, John/0000-0002-3122-0423; Saykin, Andrew/0000-0002-1376-8532; Shen, Li/0000-0002-5443-0503; DeKosky, Steven/0000-0003-3743-2758; Wijsman, Ellen/0000-0002-2725-6669	Kronos Science; National Institute of Neurological Disorders and Stroke (NINDS) [R01NS059873]; National Institute on Aging (NIA) [R01AG034504, R01AG031581, P30AG19610, Z01AG000950-06, P30AG10161, R01AG15819]; Banner Alzheimer's Foundation; Johnnie B. Byrd Sr. Alzheimer's Disease Institute; Medical Research Council; Intramural Research Program of the National Institutes of Health (NIH); State of Arizona; John Hopkins Alzheimer's Disease Research Center [NIA AG05146]; University of California, Los Angeles [NIA P50AG16570]; Kathleen Price Bryan Brain Bank, Duke University Medical Center [NIA AG05128, NINDS NS39764]; Glaxo Smith Kline [MH60451]; Massachusetts Alzheimer's Disease Research Center [P50AG005134]; University of Michigan [NIH P50-AG08671]; University of Kentucky [NIH AG05144]; Washington University, St Louis Alzheimer's Disease Research Center [NIH P50AG05681]; University of Washington, Seattle [NIH P50AG05136]; Boston University Alzheimer's Disease Research Center [NIH P30-AG13846]; Sun Health Research Institute Brain Donation Program of Sun City, Arizona [NIA P30AG19610]; Arizona Alzheimer's Disease Core Center, Arizona Department of Health Services [211002]; Arizona Alzheimer's Research Center; Arizona Biomedical Research Commission [4001, 0011, 05-901, 1001]; Rush University Medical Center, Rush Alzheimer's Disease Center [NIH AG10161]; Medical Research Council (MRC); local National Health Service (NHS) trusts; Newcastle University; Higher Education Funding Council for England (HEFCE); Alzheimer's Research Trust (ART); BRACE; North Bristol NHS Trust Research and Innovation Department; National Institute for Health Research (NIHR) Dementias and Neurodegenerative Diseases Research Network (DeNDRoN); Stichting MS Research; Brain Net Europe; Hersenstichting Nederland Breinbrekend Werk; International Parkinson Fonds; Internationale Stiching Alzheimer Onderzoek; ADNI [NIH U01AG024904, RC2AG036535]; NIA [U24AG026395, U24AG021886]; National Institute of Biomedical Imaging and Bioengineering; Canadian Institutes of Health Research; Northern California Institute for Research and Education; NIH [P30AG010129, K01AG030514, HHSN268200782096C]; Dana Foundation [U01AG032984]; Alzheimer's Disease Genetics Consortium grant [NIA R01AG1977, P30AG010133]; Indiana Economic Development Corporation (IEDC) [87884]; Foundation for the NIH for data analysis; National Institute on Aging (NIA); National Alzheimer's Coordinating Center (NACC); NATIONAL INSTITUTE OF MENTAL HEALTH [P50MH060451] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P50NS039764, R01NS059873] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG034504, P50AG005144, R01AG031581, R01AG019771, P30AG010129, U24AG026395, U01AG032984, P30AG013846, RC2AG036535, R01AG015819, R01AG041797, P30AG019610, U19AG010483, P50AG016570, P50AG005136, U01AG016976, P30AG010161, P30AG010133, P50AG005681, P50AG005134, U24AG021886, K01AG030514, Z01AG000950, U01AG024904, P50AG008671, P50AG005146] Funding Source: NIH RePORTER	Kronos Science; National Institute of Neurological Disorders and Stroke (NINDS)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); National Institute on Aging (NIA)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); Banner Alzheimer's Foundation; Johnnie B. Byrd Sr. Alzheimer's Disease Institute; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Intramural Research Program of the National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); State of Arizona; John Hopkins Alzheimer's Disease Research Center; University of California, Los Angeles(University of California System); Kathleen Price Bryan Brain Bank, Duke University Medical Center; Glaxo Smith Kline(GlaxoSmithKline); Massachusetts Alzheimer's Disease Research Center; University of Michigan(University of Michigan System); University of Kentucky; Washington University, St Louis Alzheimer's Disease Research Center; University of Washington, Seattle(University of Washington); Boston University Alzheimer's Disease Research Center; Sun Health Research Institute Brain Donation Program of Sun City, Arizona; Arizona Alzheimer's Disease Core Center, Arizona Department of Health Services; Arizona Alzheimer's Research Center; Arizona Biomedical Research Commission; Rush University Medical Center, Rush Alzheimer's Disease Center; Medical Research Council (MRC)(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); local National Health Service (NHS) trusts; Newcastle University; Higher Education Funding Council for England (HEFCE)(UK Research & Innovation (UKRI)Higher Education Funding Council for England (HEFCE)); Alzheimer's Research Trust (ART); BRACE; North Bristol NHS Trust Research and Innovation Department; National Institute for Health Research (NIHR) Dementias and Neurodegenerative Diseases Research Network (DeNDRoN); Stichting MS Research; Brain Net Europe; Hersenstichting Nederland Breinbrekend Werk; International Parkinson Fonds; Internationale Stiching Alzheimer Onderzoek; ADNI; NIA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); National Institute of Biomedical Imaging and Bioengineering(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Northern California Institute for Research and Education; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Dana Foundation; Alzheimer's Disease Genetics Consortium grant; Indiana Economic Development Corporation (IEDC); Foundation for the NIH for data analysis(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institute on Aging (NIA)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); National Alzheimer's Coordinating Center (NACC); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	Genotyping of the TGen cohort was supported by Kronos Science; the National Institute of Neurological Disorders and Stroke (NINDS) (R01NS059873); the National Institute on Aging (NIA) (R01AG034504, R01AG031581, P30AG19610, Z01AG000950-06, P30AG10161, R01AG15819); the Banner Alzheimer's Foundation; the Johnnie B. Byrd Sr. Alzheimer's Disease Institute; the Medical Research Council; the Intramural Research Program of the National Institutes of Health (NIH); and the State of Arizona. Many data and biomaterials for the TGen cohort were collected from several NIA and National Alzheimer's Coordinating Center (NACC) (U01AG016976) funded sites. These include: John Hopkins Alzheimer's Disease Research Center (NIA AG05146); University of California, Los Angeles (NIA P50AG16570); The Kathleen Price Bryan Brain Bank, Duke University Medical Center (NIA AG05128, NINDS NS39764, National Institute of Mental Health MH60451 also funded by Glaxo Smith Kline); Massachusetts Alzheimer's Disease Research Center (P50AG005134); University of Michigan (NIH P50-AG08671); University of Kentucky (NIH AG05144); Washington University, St Louis Alzheimer's Disease Research Center (NIH P50AG05681); University of Washington, Seattle (NIH P50AG05136); Boston University Alzheimer's Disease Research Center (NIH P30-AG13846); Sun Health Research Institute Brain Donation Program of Sun City, Arizona (NIA P30AG19610; Arizona Alzheimer's Disease Core Center, Arizona Department of Health Services, contract 211002, Arizona Alzheimer's Research Center; Arizona Biomedical Research Commission, contracts 4001, 0011, 05-901 and 1001 to the Arizona Parkinson's Disease Consortium; Michael J. Fox Foundation for Parkinson's Research); Rush University Medical Center, Rush Alzheimer's Disease Center (NIH AG10161). Additional tissues include samples from the following sites: Newcastle Brain Tissue Resource (funding via the Medical Research Council (MRC), local National Health Service (NHS) trusts and Newcastle University); MRC London Brain Bank for Neurodegenerative Diseases (funding via the Medical Research Council); South West Dementia Brain Bank (funding via numerous sources including the Higher Education Funding Council for England (HEFCE), Alzheimer's Research Trust (ART), BRACE as well as North Bristol NHS Trust Research and Innovation Department and the National Institute for Health Research (NIHR) Dementias and Neurodegenerative Diseases Research Network (DeNDRoN); The Netherlands Brain Bank (funding via numerous sources including Stichting MS Research, Brain Net Europe, Hersenstichting Nederland Breinbrekend Werk, International Parkinson Fonds, Internationale Stiching Alzheimer Onderzoek). Data collection and sharing for the Alzheimer's Disease Neuroimaging Initiative (ADNI) project was funded by the ADNI (NIH U01AG024904; RC2AG036535). ADNI is funded by the NIA, the National Institute of Biomedical Imaging and Bioengineering, and through generous contributions from the following: Abbott; Alzheimer's Association; Alzheimer's Drug Discovery Foundation; Amorfix Life Sciences Ltd.; AstraZeneca; Bayer HealthCare; BioClinica, Inc.; Biogen Idec Inc.; Bristol-Myers Squibb Company; Eisai Inc.; Elan Pharmaceuticals Inc.; Eli Lilly and Company; F. Hoffman-La Roche Ltd and its affiliated company Genentech, Inc.; GE Healthcare; Innogenetics, N.V.; Janssen Alzheimer Immunotherapy Research & Development, LLC.; Johnson & Johnson Pharmaceutical Research & Development LLC.; Medpace, Inc.; Merck & Co., Inc; Meso Scale Diagnostics, LLC.; Novartis Pharmaceuticals Corporation; Pfizer Inc.; ; Servier; Synarc Inc.; and Takeda Pharmaceutical Company. The Canadian Institutes of Health Research is providing funds to support ADNI clinical sites in Canada. Private sector contributions are facilitated by the Foundation for the National Institutes of Health (www.fnih.org). The grantee organization is the Northern California Institute for Research and Education, and the study is coordinated by the Alzheimer's Disease Cooperative Society at the University of California, San Diego. ADNI data are disseminated by the Laboratory of Neuro Imaging at the University of California, Los Angeles. This research was also supported by NIH grants P30AG010129, K01AG030514, the Dana Foundation, U01AG032984 Alzheimer's Disease Genetics Consortium grant, NIA R01AG19771, P30AG010133, the Indiana Economic Development Corporation (IEDC #87884), and the Foundation for the NIH for data analysis. Funding support for the National Institute of Aging-Late Onset AD/National Cell Repository for AD (NIA-LOAD/NCRAD) Family Study was provided through NIA grants U24AG026395 (NIA-LOAD Family Study), U24AG021886 (National Cell Repository for Alzheimer's Disease) and other NIA grants. Genotyping services were provided by the Center for Inherited Disease Research funded through a federal contract (HHSN268200782096C) from the NIH to the John Hopkins University. Samples from the NCRAD, which receives government support under a cooperative agreement (U24AG021886) awarded by the NIA were used in the ADNI and NIA-LOAD/NCRAD Family studies. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; Genotyping of the TGen cohort was supported by Kronos Science. This study was partly funded by Glaxo Smith Kline. Data collection and sharing for the Alzheimer's Disease Neuroimaging Initiative (ADNI) project was funded by the ADNI (NIH U01AG024904; RC2AG036535). ADNI is funded by the NIA, the National Institute of Biomedical Imaging and Bioengineering, and through generous contributions from the following: Abbott; Alzheimer's Association; Alzheimer's Drug Discovery Foundation; Amorfix Life Sciences Ltd.; AstraZeneca; Bayer HealthCare; BioClinica, Inc.; Biogen Idec Inc.; Bristol-Myers Squibb Company; Eisai Inc.; Elan Pharmaceuticals Inc.; Eli Lilly and Company; F. Hoffman-La Roche Ltd and its affiliated company Genentech, Inc.; GE Healthcare; Innogenetics, N.V.; Janssen Alzheimer Immunotherapy Research & Development, LLC.; Johnson & Johnson Pharmaceutical Research & Development LLC.; Medpace, Inc.; Merck & Co., Inc; Meso Scale Diagnostics, LLC.; Novartis Pharmaceuticals Corporation; Pfizer Inc.; Servier; Synarc Inc.; and Takeda Pharmaceutical Company. There are no patents, products in development or marketed products to declare. This does not alter the authors' adherence to all the PLOS ONE policies on sharing data and materials, as detailed online in the guide for authors.; Many data and biomaterials for the TGen cohort were collected from several National Institute on Aging (NIA) and National Alzheimer's Coordinating Center (NACC) funded sites. We thank Amanda J. Myers (University of Miami, Department of Psychiatry) and John A. Hardy (Reta Lila Weston Institute, University College London) for collecting and preparing the series. Marcelle Morrison-Bogorad, Tony Phelps, and Walter Kukull are thanked for helping to co-ordinate this collection. The directors, pathologist and technicians involved include: National Institute on Aging: Ruth Seemann; John Hopkins Alzheimer's Disease Research Center: Juan C. Troncoso, Olga Pletnikova; University of California, Los Angeles: Harry Vinters, Justine Pomakian; The Kathleen Price Bryan Brain Bank, Duke University Medical Center: Christine Hulette, John F. Ervin; Stanford University: Dikran Horoupian, Ahmad Salehi; New York Brain Bank, Taub Institute, Columbia University (NYBB): Jean Paul Vonsattel, Katerina Mancevska; Massachusetts Alzheimer's Disease Research Center: E. Tessa Hedley-Whyte, M.P. Frosch, Karlotta Fitch; University of Michigan: Roger Albin, Lisa Bain, Eszter Gombosi; University of Kentucky: William Markesbery, Sonya Anderson; Mayo Clinic, Jacksonville: Dennis W. Dickson, Natalie Thomas; University Southern California: Caroll A. Miller, Jenny Tang, Dimitri Diaz; Washington University, St Louis Alzheimer's Disease Research Center: Dan McKeel, John C. Morris, Eugene Johnson, Jr., Virginia Buckles, Deborah Carter; University of Washington, Seattle: Thomas Montine, Aimee Schantz; University of Pennsylvania School of Medicine, Alzheimer's Disease Research Center: John Q Trojanowski, Virginia M Lee, Vivianna Van Deerlin, Terry Schuck; Boston University Alzheimer's Disease Research Center: Ann C. McKee, Carol Kubilus; Sun Health Research Institute Brain Donation Program of Sun City, Arizona: Joseph Rogers, Thomas G. Beach, Lucia I. Sue; Emory University: Bruce H. Wainer, Marla Gearing; University of Texas, Southwestern Medical School: Charles L. White, III, Roger Rosenberg, Marilyn Howell, Joan Reisch; University of California, Davis: William Ellis, Mary Ann Jarvis; Rush University Medical Center, Rush Alzheimer's Disease Center: David A. Bennett, Julie A. Schneider, Karen Skish, Wayne T. Longman; University of Miami/NPF Brain Endowment Bank: Deborah C. Mash, Margaret J Basile, Mitsuko Tanaka; Oregon Health & Science University: Randy Wotljer. Additional tissues include samples from the following sites: Newcastle Brain Tissue Resource: C. M. Morris, Ian G McKeith, Robert H Perry; MRC London Brain Bank for Neurodegenerative Diseases: Simon Lovestone, Safa Al-Sarraj, Claire Troakes; South West Dementia Brain Bank: Seth Love, Patrick Kehoe, Laura Palmer; The Netherlands Brain Bank: Inge Huitinga, Marleen Rademaker, Michiel Kooreman; Institut de Neuropatologia, Servei Anatomia Patologica, Universitat de Barcelona: Isidre Ferrer Abizanda, Susana Casas Boluda.	Antonell A, 2012, J ALZHEIMERS DIS, V28, P303, DOI 10.3233/JAD-2011-110911; Araud T, 2011, BIOCHEM PHARMACOL, V82, P904, DOI 10.1016/j.bcp.2011.06.018; Bekris LM, 2010, J GERIATR PSYCH NEUR, V23, P213, DOI 10.1177/0891988710383571; Bertram L, 2007, NAT GENET, V39, P17, DOI 10.1038/ng1934; Borenstein M., 2005, COMPREHENSIVE META A; Brouwers N, 2012, MOL PSYCHIATR, V17, P223, DOI 10.1038/mp.2011.24; Chaudhury AR, 2003, J NEUROPATH EXP NEUR, V62, P42, DOI 10.1093/jnen/62.1.42; Cook EH, 2008, NATURE, V455, P919, DOI 10.1038/nature07458; Corneveaux JJ, 2010, HUM MOL GENET, V19, P3295, DOI 10.1093/hmg/ddq221; CROOK R, 1994, J NEUROSCI METH, V53, P125, DOI 10.1016/0165-0270(94)90168-6; de Lucas-Cerrillo AM, 2011, J BIOL CHEM, V286, P594, DOI 10.1074/jbc.M110.180067; Diskin SJ, 2008, NUCLEIC ACIDS RES, V36, DOI 10.1093/nar/gkn556; Feher A, 2009, DEMENT GERIATR COGN, V28, P56, DOI 10.1159/000230036; Gatz M, 2006, ARCH GEN PSYCHIAT, V63, P168, DOI 10.1001/archpsyc.63.2.168; Gault J, 1998, GENOMICS, V52, P173, DOI 10.1006/geno.1998.5363; Ghani M, 2012, G3-GENES GENOM GENET, V2, P71, DOI 10.1534/g3.111.000869; Ravetti MG, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010153; Guerini FR, 2009, INT J IMMUNOPATH PH, V22, P991, DOI 10.1177/039463200902200414; Guo Y, 2011, NEUROSCI LETT, V501, P185, DOI 10.1016/j.neulet.2011.05.245; Hafler DA, 2007, NEW ENGL J MED, V357, P851, DOI 10.1056/NEJMoa073493; Hamza TH, 2010, NAT GENET, V42, P781, DOI 10.1038/ng.642; Harold D, 2009, NAT GENET, V41, P1088, DOI 10.1038/ng.440; Hawkins JR, 2002, HUM MUTAT, V19, P543, DOI 10.1002/humu.10060; Heinzen EL, 2010, J ALZHEIMERS DIS, V19, P69, DOI 10.3233/JAD-2010-1212; Hollingworth P, 2011, NAT GENET, V43, P429, DOI 10.1038/ng.803; Hoppenbrouwers IA, 2009, J HUM GENET, V54, P676, DOI 10.1038/jhg.2009.96; Jun G, 2010, ARCH NEUROL-CHICAGO, V67, P1473, DOI 10.1001/archneurol.2010.201; Kent WJ, 2002, GENOME RES, V12, P996, DOI 10.1101/gr.229102; Kramer PL, 2011, NEUROBIOL AGING, V32, P2113, DOI 10.1016/j.neurobiolaging.2010.01.010; Lambert JC, 2009, NAT GENET, V41, P1094, DOI 10.1038/ng.439; Lehmann DJ, 2006, J NEUROINFLAMM, V3, DOI 10.1186/1742-2094-3-33; Listi F, 2006, REJUV RES, V9, P99, DOI 10.1089/rej.2006.9.99; Ma SL, 2008, DEMENT GERIATR COGN, V26, P391, DOI 10.1159/000164275; Martins-de-Souza D, 2012, J PROTEOME RES, V11, P2533, DOI 10.1021/pr2012279; McNaughton D, 2012, NEUROBIOL AGING, V33, DOI 10.1016/j.neurobiolaging.2010.10.010; Myers AJ, 2007, NAT GENET, V39, P1494, DOI 10.1038/ng.2007.16; Naj AC, 2011, NAT GENET, V43, P436, DOI 10.1038/ng.801; Naj AC, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001130; Need AC, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000373; Petersen RC, 2009, ARCH NEUROL-CHICAGO, V66, P1447, DOI 10.1001/archneurol.2009.266; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Rachidi M, 2006, CYTOGENET GENOME RES, V112, P16, DOI 10.1159/000087509; Rachidi M, 2009, INT J DEV NEUROSCI, V27, P393, DOI 10.1016/j.ijdevneu.2009.02.001; Riley B, 2002, GENOMICS, V79, P197, DOI 10.1006/geno.2002.6694; Rovelet-Lecrux A, 2006, NAT GENET, V38, P24, DOI 10.1038/ng1718; Rujescu D, 2009, HUM MOL GENET, V18, P988, DOI 10.1093/hmg/ddn351; Saykin AJ, 2010, ALZHEIMERS DEMENT, V6, P265, DOI 10.1016/j.jalz.2010.03.013; Seripa D, 2008, J ALZHEIMERS DIS, V14, P335; Seshadri S, 2010, JAMA-J AM MED ASSOC, V303, P1832, DOI 10.1001/jama.2010.574; Shaw CA, 2011, NEUROLOGY, V76, P1302, DOI 10.1212/WNL.0b013e3182166df5; Sleegers K, 2006, BRAIN, V129, P2977, DOI 10.1093/brain/awl203; Slooter AJC, 1998, ARCH NEUROL-CHICAGO, V55, P964, DOI 10.1001/archneur.55.7.964; Swaminathan S, 2011, INT J ALZHEIMERS DIS; Swaminathan S, 2012, CURR ALZHEIMER RES, V9, P801, DOI 10.2174/156720512802455331; Szatmari P, 2007, NAT GENET, V39, P319, DOI 10.1038/ng1985; Thies W, 2011, ALZHEIMERS DEMENT, V7, P175, DOI [10.1016/j.jalz.2011.02.004, 10.1016/j.jalz.2011.02.002]; Verhaaren BF, 2012, BIOL PSYCHIAT; Wallace BC, 2009, BMC MED RES METHODOL, V9, DOI 10.1186/1471-2288-9-80; Wang K, 2007, GENOME RES, V17, P1665, DOI 10.1101/gr.6861907; Webster JA, 2009, AM J HUM GENET, V84, P445, DOI 10.1016/j.ajhg.2009.03.011; Wijsman EM, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1001308; Woo RS, 2011, ANAT CELL BIOL, V44, P116, DOI 10.5115/acb.2011.44.2.116; Woo RS, 2010, ANAT CELL BIOL, V43, P332, DOI 10.5115/acb.2010.43.4.332	63	35	35	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 5	2012	7	12							e50640	10.1371/journal.pone.0050640	http://dx.doi.org/10.1371/journal.pone.0050640			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	057TZ	23227193	Green Published, gold			2022-12-27	WOS:000312588200053
J	Ple, H; Landry, P; Benham, A; Coarfa, C; Gunaratne, PH; Provost, P				Ple, Helene; Landry, Patricia; Benham, Ashley; Coarfa, Cristian; Gunaratne, Preethi H.; Provost, Patrick			The Repertoire and Features of Human Platelet microRNAs	PLOS ONE			English	Article							MESSENGER-RNA; 3' ADENYLATION; BIOGENESIS; DIFFERENTIATION; EXPRESSION; GENERATION; PROTEOMICS; DISCOVERY; PROTEINS; LET-7	Playing a central role in the maintenance of hemostasis as well as in thrombotic disorders, platelets contain a relatively diverse messenger RNA (mRNA) transcriptome as well as functional mRNA-regulatory microRNAs, suggesting that platelet mRNAs may be regulated by microRNAs. Here, we elucidated the complete repertoire and features of human platelet microRNAs by high-throughput sequencing. More than 492 different mature microRNAs were detected in human platelets, whereas the list of known human microRNAs was expanded further by the discovery of 40 novel microRNA sequences. As in nucleated cells, platelet microRNAs bear signs of post-transcriptional modifications, mainly terminal adenylation and uridylation. In vitro enzymatic assays demonstrated the ability of human platelets to uridylate microRNAs, which correlated with the presence of the uridyltransferase enzyme TUT4. We also detected numerous microRNA isoforms (isomiRs) resulting from imprecise Drosha and/or Dicer processing, in some cases more frequently than the reference microRNA sequence, including 5' shifted isomiRs with redirected mRNA targeting abilities. This study unveils the existence of a relatively diverse and complex microRNA repertoire in human platelets, and represents a mandatory step towards elucidating the intraplatelet and extraplatelet role, function and importance of platelet microRNAs. Citation: Ple H, Landry P, Benham A, Coarfa C, Gunaratne PH, et al. (2012) The Repertoire and Features of Human Platelet microRNAs. PLoS ONE 7(12): e50746. doi:10.1371/journal.pone.0050746	[Ple, Helene; Landry, Patricia; Provost, Patrick] CHU Laval, Ctr Hosp Univ Quebec Res Ctr, Quebec City, PQ G1V 4G2, Canada; [Ple, Helene; Landry, Patricia; Provost, Patrick] Univ Laval, Fac Med, Quebec City, PQ G1K 7P4, Canada; [Benham, Ashley; Coarfa, Cristian; Gunaratne, Preethi H.] Univ Houston, Dept Biol & Biochem, Houston, TX USA; [Gunaratne, Preethi H.] Baylor Coll Med, Dept Pathol, Houston, TX 77030 USA; [Gunaratne, Preethi H.] Baylor Coll Med, Human Genome Sequencing Ctr, Houston, TX 77030 USA	Laval University; Laval University; University of Houston System; University of Houston; Baylor College of Medicine; Baylor College of Medicine	Provost, P (corresponding author), CHU Laval, Ctr Hosp Univ Quebec Res Ctr, 2705 Blvd Laurier, Quebec City, PQ G1V 4G2, Canada.	patrick.provost@crchul.ulaval.ca	Provost, Patrick/G-2786-2010	Provost, Patrick/0000-0002-6099-6562	Canadian Blood Services/Canadian Institutes of Health Research Blood Utilization and Conservation Initiative [201940]	Canadian Blood Services/Canadian Institutes of Health Research Blood Utilization and Conservation Initiative(Canadian Institutes of Health Research (CIHR))	This work was supported by Grant No. 201940 from the Canadian Blood Services/Canadian Institutes of Health Research Blood Utilization and Conservation Initiative. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ambros V, 2003, RNA, V9, P277, DOI 10.1261/rna.2183803; Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002; Boilard E, 2010, SCIENCE, V327, P580, DOI 10.1126/science.1181928; BOOYSE FM, 1968, BIOCHIM BIOPHYS ACTA, V166, P689, DOI 10.1016/0005-2787(68)90376-6; Boyerinas B, 2010, ENDOCR-RELAT CANCER, V17, pF19, DOI 10.1677/ERC-09-0184; Bugert P, 2003, THROMB HAEMOSTASIS, V90, P738; Burroughs AM, 2010, GENOME RES, V20, P1398, DOI 10.1101/gr.106054.110; Chen CZ, 2004, SCIENCE, V303, P83, DOI 10.1126/science.1091903; Chi SW, 2009, NATURE, V460, P479, DOI 10.1038/nature08170; Creighton CJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009637; Creighton CJ, 2009, BRIEF BIOINFORM, V10, P490, DOI 10.1093/bib/bbp019; Edelstein LC, 2011, BLOOD, V117, P5289, DOI 10.1182/blood-2011-01-292011; Fabian MR, 2010, ANNU REV BIOCHEM, V79, P351, DOI 10.1146/annurev-biochem-060308-103103; Felli N, 2005, P NATL ACAD SCI USA, V102, P18081, DOI 10.1073/pnas.0506216102; Felli N, 2009, HAEMATOL-HEMATOL J, V94, P479, DOI 10.3324/haematol.2008.002345; Friedman RC, 2009, GENOME RES, V19, P92, DOI 10.1101/gr.082701.108; Garzon R, 2006, P NATL ACAD SCI USA, V103, P5078, DOI 10.1073/pnas.0600587103; Glass A, 2005, BIOSCI BIOTECH BIOCH, V69, P1098, DOI 10.1271/bbb.69.1098; Gnatenko DV, 2003, BLOOD, V101, P2285, DOI 10.1182/blood-2002-09-2797; Griffiths-Jones S, 2008, NUCLEIC ACIDS RES, V36, pD154, DOI 10.1093/nar/gkm952; Guo L, 2012, MOL BIOL REP, V39, P2031, DOI 10.1007/s11033-011-0950-8; Heo I, 2009, CELL, V138, P696, DOI 10.1016/j.cell.2009.08.002; Humphreys DT, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030933; John B, 2005, PLOS BIOL, V3, P1328, DOI 10.1371/journal.pbio.0030264; Jones MR, 2009, NAT CELL BIOL, V11, P1157, DOI 10.1038/ncb1931; Katoh T, 2009, GENE DEV, V23, P433, DOI 10.1101/gad.1761509; Kendziorski C, 2005, P NATL ACAD SCI USA, V102, P4252, DOI 10.1073/pnas.0500607102; Kendziorski CM, 2003, BIOSTATISTICS, V4, P465, DOI 10.1093/biostatistics/4.3.465; KIEFFER N, 1987, EUR J BIOCHEM, V164, P189, DOI 10.1111/j.1432-1033.1987.tb11010.x; Kondkar AA, 2010, J THROMB HAEMOST, V8, P369, DOI 10.1111/j.1538-7836.2009.03700.x; Kong KY, 2010, EXP HEMATOL, V38, P629, DOI 10.1016/j.exphem.2010.04.004; Krek A, 2005, NAT GENET, V37, P495, DOI 10.1038/ng1536; Krol J, 2010, NAT REV GENET, V11, P597, DOI 10.1038/nrg2843; Landry P, 2009, NAT STRUCT MOL BIOL, V16, P961, DOI 10.1038/nsmb.1651; Lee Y, 2003, NATURE, V425, P415, DOI 10.1038/nature01957; McRedmond JP, 2004, MOL CELL PROTEOMICS, V3, P133, DOI 10.1074/mcp.M300063-MCP200; Morin RD, 2008, GENOME RES, V18, P610, DOI 10.1101/gr.7179508; Nagalla S, 2011, BLOOD, V117, P5189, DOI 10.1182/blood-2010-09-299719; Newman MA, 2011, RNA, V17, P1795, DOI 10.1261/rna.2713611; Osman A, 2011, PLATELETS, V22, P433, DOI 10.3109/09537104.2011.560305; Ouellet DL, 2008, NUCLEIC ACIDS RES, V36, P2353, DOI 10.1093/nar/gkn076; Perron Marjorie P, 2007, Methods Mol Biol, V361, P311; Perron MP, 2008, FRONT BIOSCI-LANDMRK, V13, P2537, DOI 10.2741/2865; Reczko Martin, 2012, Frontiers in Genetics, V2, P103, DOI 10.3389/fgene.2011.00103; Reid JG, 2008, GENOME RES, V18, P1571, DOI 10.1101/gr.078246.108; Risitano A, 2012, BLOOD, V119, P6288, DOI 10.1182/blood-2011-12-396440; ROTH GJ, 1989, BIOCHEM BIOPH RES CO, V160, P705, DOI 10.1016/0006-291X(89)92490-X; Rowley JW, 2011, BLOOD, V118, pE101, DOI 10.1182/blood-2011-03-339705; TSAO CH, 1971, SCAND J HAEMATOL, V8, P134; Valadi H, 2007, NAT CELL BIOL, V9, P654, DOI 10.1038/ncb1596; Winter J, 2009, NAT CELL BIOL, V11, P228, DOI 10.1038/ncb0309-228; Wyman SK, 2011, GENOME RES, V21, P1450, DOI 10.1101/gr.118059.110; Xiao FF, 2009, NUCLEIC ACIDS RES, V37, pD105, DOI 10.1093/nar/gkn851; Yang GH, 2009, J CELL BIOCHEM, V107, P548, DOI 10.1002/jcb.22156	54	151	196	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 4	2012	7	12							e50746	10.1371/journal.pone.0050746	http://dx.doi.org/10.1371/journal.pone.0050746			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	051EQ	23226537	Green Published, Green Submitted, gold			2022-12-27	WOS:000312108500028
J	Richter, C; Gristwood, T; Clulow, JS; Fineran, PC				Richter, Corinna; Gristwood, Tamzin; Clulow, James S.; Fineran, Peter C.			In Vivo Protein Interactions and Complex Formation in the Pectobacterium atrosepticum Subtype I-F CRISPR/Cas System	PLOS ONE			English	Article							ANTIVIRAL DEFENSE; STRUCTURAL BASIS; IMMUNE-SYSTEM; DNA; SEQUENCE; MECHANISM; RESISTANCE; NUCLEASE; GENOME; CAS3	Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR) and their associated proteins (Cas; CRISPR associated) are a bacterial defense mechanism against extra-chromosomal elements. CRISPR/Cas systems are distinct from other known defense mechanisms insofar as they provide acquired and heritable immunity. Resistance is accomplished in multiple stages in which the Cas proteins provide the enzymatic machinery. Importantly, subtype-specific proteins have been shown to form complexes in combination with small RNAs, which enable sequence-specific targeting of foreign nucleic acids. We used Pectobacterium atrosepticum, a plant pathogen that causes soft-rot and blackleg disease in potato, to investigate protein-protein interactions and complex formation in the subtype I-F CRISPR/Cas system. The P. atrosepticum CRISPR/Cas system encodes six proteins: Cas1, Cas3, and the four subtype specific proteins Csy1, Csy2, Csy3 and Cas6f (Csy4). Using co-purification followed by mass spectrometry as well as directed co-immunoprecipitation we have demonstrated complex formation by the Csy1-3 and Cas6f proteins, and determined details about the architecture of that complex. Cas3 was also shown to co-purify all four subtype-specific proteins, consistent with its role in targeting. Furthermore, our results show that the subtype I-F Cas1 and Cas3 (a Cas2-Cas3 hybrid) proteins interact, suggesting a protein complex for adaptation and a role for subtype I-F Cas3 proteins in both the adaptation and interference steps of the CRISPR/Cas mechanism.	[Richter, Corinna; Gristwood, Tamzin; Clulow, James S.; Fineran, Peter C.] Univ Otago, Dept Microbiol & Immunol, Dunedin, New Zealand	University of Otago	Fineran, PC (corresponding author), Univ Otago, Dept Microbiol & Immunol, Dunedin, New Zealand.	peter.fineran@otago.ac.nz	Fineran, Peter C/A-5766-2012	Fineran, Peter C/0000-0002-4639-6704	University of Otago research grant; Deans Bequest Fund from the Otago School of Medical Sciences; Rutherford Discovery Fellowship from Royal Society of New Zealand; University of Otago Postgraduate Scholarship; German Academic Exchange Service (DAAD) Doktorandenstipendium	University of Otago research grant; Deans Bequest Fund from the Otago School of Medical Sciences; Rutherford Discovery Fellowship from Royal Society of New Zealand(Royal Society of New Zealand); University of Otago Postgraduate Scholarship; German Academic Exchange Service (DAAD) Doktorandenstipendium(Deutscher Akademischer Austausch Dienst (DAAD))	This work was supported by a University of Otago research grant, the Deans Bequest Fund from the Otago School of Medical Sciences and a Rutherford Discovery Fellowship to PCF from the Royal Society of New Zealand. CR was supported by a University of Otago Postgraduate Scholarship and a The German Academic Exchange Service (DAAD) Doktorandenstipendium. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Babu M, 2011, MOL MICROBIOL, V79, P484, DOI 10.1111/j.1365-2958.2010.07465.x; Barrangou R, 2007, SCIENCE, V315, P1709, DOI 10.1126/science.1138140; Bell KS, 2004, P NATL ACAD SCI USA, V101, P11105, DOI 10.1073/pnas.0402424101; Beloglazova N, 2008, J BIOL CHEM, V283, P20361, DOI 10.1074/jbc.M803225200; Beloglazova N, 2011, EMBO J, V30, P4616, DOI 10.1038/emboj.2011.377; Bolotin A, 2005, MICROBIOL-SGM, V151, P2551, DOI 10.1099/mic.0.28048-0; Brouns SJJ, 2008, SCIENCE, V321, P960, DOI 10.1126/science.1159689; Cady KC, 2011, J BACTERIOL, V193, P3433, DOI 10.1128/JB.01411-10; Carte J, 2008, GENE DEV, V22, P3489, DOI 10.1101/gad.1742908; Datsenko KA, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1937; Deveau H, 2008, J BACTERIOL, V190, P1390, DOI 10.1128/JB.01412-07; Erdmann S, 2012, MOL MICROBIOL, V85, P1044, DOI 10.1111/j.1365-2958.2012.08171.x; Grissa I, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-172; GUZMAN LM, 1995, J BACTERIOL, V177, P4121, DOI 10.1128/jb.177.14.4121-4130.1995; Haft DH, 2005, PLOS COMPUT BIOL, V1, P474, DOI 10.1371/journal.pcbi.0010060; Hale C, 2008, RNA, V14, P2572, DOI 10.1261/rna.1246808; Hale CR, 2009, CELL, V139, P945, DOI 10.1016/j.cell.2009.07.040; Hatoum-Aslan A, 2011, P NATL ACAD SCI USA, V108, P21218, DOI 10.1073/pnas.1112832108; Haurwitz RE, 2012, EMBO J, V31, P2824, DOI 10.1038/emboj.2012.107; Haurwitz RE, 2010, SCIENCE, V329, P1355, DOI 10.1126/science.1192272; Jinek M, 2012, SCIENCE, V337, P816, DOI 10.1126/science.1225829; Jore MM, 2011, NAT STRUCT MOL BIOL, V18, P529, DOI 10.1038/nsmb.2019; Kelley LA, 2009, NAT PROTOC, V4, P363, DOI 10.1038/nprot.2009.2; Labrie SJ, 2010, NAT REV MICROBIOL, V8, P317, DOI 10.1038/nrmicro2315; Lillestol Reidun K., 2006, Archaea, V2, P59, DOI 10.1155/2006/542818; Lintner NG, 2011, J BIOL CHEM, V286, P21643, DOI 10.1074/jbc.M111.238485; Makarova KS, 2006, BIOL DIRECT, V1, DOI 10.1186/1745-6150-1-7; Makarova KS, 2011, BIOL DIRECT, V6, DOI 10.1186/1745-6150-6-38; Makarova KS, 2011, NAT REV MICROBIOL, V9, P467, DOI 10.1038/nrmicro2577; Marraffini LA, 2010, NATURE, V463, P568, DOI 10.1038/nature08703; Marraffini LA, 2008, SCIENCE, V322, P1843, DOI 10.1126/science.1165771; Mcneil MB, 2012, J BIOL CHEM, V287, P18418, DOI 10.1074/jbc.M111.293803; Mojica FJM, 2009, MICROBIOL-SGM, V155, P733, DOI 10.1099/mic.0.023960-0; Mulepati S, 2011, J BIOL CHEM, V286, P31896, DOI 10.1074/jbc.M111.270017; Nam KH, 2012, J BIOL CHEM, V287, P35943, DOI 10.1074/jbc.M112.382598; Nam KH, 2012, STRUCTURE, V20, P1574, DOI 10.1016/j.str.2012.06.016; Notredame C, 2000, J MOL BIOL, V302, P205, DOI 10.1006/jmbi.2000.4042; Petty NK, 2007, TRENDS BIOTECHNOL, V25, P7, DOI 10.1016/j.tibtech.2006.11.003; Plagens A, 2012, J BACTERIOL, V194, P2491, DOI 10.1128/JB.00206-12; Platt TG, 2012, P ROY SOC B-BIOL SCI, V279, P1691, DOI 10.1098/rspb.2011.2002; Pougach K, 2010, MOL MICROBIOL, V77, P1367, DOI 10.1111/j.1365-2958.2010.07265.x; Przybilski R, 2011, RNA BIOL, V8, P517, DOI 10.4161/rna.8.3.15190; Samai P, 2010, ACTA CRYSTALLOGR F, V66, P1552, DOI 10.1107/S1744309110039801; Shevchenko A, 1996, P NATL ACAD SCI USA, V93, P14440, DOI 10.1073/pnas.93.25.14440; Sinkunas T, 2011, EMBO J, V30, P1335, DOI 10.1038/emboj.2011.41; Sternberg SH, 2012, RNA, V18, P661, DOI 10.1261/rna.030882.111; Swarts DC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035888; Westra ER, 2012, MOL CELL, V46, P595, DOI 10.1016/j.molcel.2012.03.018; Wiedenheft B, 2012, NATURE, V482, P331, DOI 10.1038/nature10886; Wiedenheft B, 2011, NATURE, V477, P486, DOI 10.1038/nature10402; Wiedenheft B, 2011, P NATL ACAD SCI USA, V108, P10092, DOI 10.1073/pnas.1102716108; Wiedenheft B, 2009, STRUCTURE, V17, P904, DOI 10.1016/j.str.2009.03.019; Yosef I, 2012, NUCLEIC ACIDS RES, V40, P5569, DOI 10.1093/nar/gks216; Zhang J, 2012, MOL CELL, V45, P303, DOI 10.1016/j.molcel.2011.12.013	54	51	58	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 3	2012	7	12							e49549	10.1371/journal.pone.0049549	http://dx.doi.org/10.1371/journal.pone.0049549			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	051DH	23226499	Green Published, gold, Green Submitted			2022-12-27	WOS:000312104700008
J	Abravanel, F; Raymond, S; Pambrun, E; Winnock, M; Bonnard, P; Sogni, P; Trimoulet, P; Dabis, F; Salmon-Ceron, D; Izopet, J				Abravanel, Florence; Raymond, Stephanie; Pambrun, Elodie; Winnock, Maria; Bonnard, Philippe; Sogni, Philippe; Trimoulet, Pascale; Dabis, Francois; Salmon-Ceron, Dominique; Izopet, Jacques		ANRS CO13 HEPAVIH Study Grp	HIV-1 Tropism and Liver Fibrosis in HIV-HCV Co-Infected Patients	PLOS ONE			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; HEPATIC STELLATE CELLS; TRANSIENT ELASTOGRAPHY; INSULIN-RESISTANCE; CORECEPTOR USE; VIRAL LOAD; ANTIRETROVIRAL THERAPY; EXPERIENCED PATIENTS; HUMAN HEPATOCYTES; TREATED PATIENTS	Background and Aims: Hepatic stellate cells, the major producers of extracellular matrix in the liver, and hepatocytes bear CXCR4 and CCR5, the two main co-receptors for entry of the human immunodeficiency virus (HIV). In vitro studies suggest that HIV-envelope proteins can modulate the replication of hepatitis C virus (HCV) and fibrogenesis. We investigated the influence of HIV tropism on liver fibrosis and the concentration of HCV RNA in HIV-HCV co-infected patients. Methods: We used a phenotypic assay to assess HIV tropism in 172 HCV-HIV co-infected patients: one group (75 patients) had mild fibrosis (score <= F2) and the other (97 patients) had severe fibrosis (score >F2). We also assessed the relationship between HIV tropism and HCV RNA concentration in all these patients. We also followed 34 of these patients for 3 years to determine the evolution of HIV tropism and liver fibrosis, estimated by liver stiffness. Results: Initially, most patients (91.8%) received a potent antiretroviral therapy. CXCR4-using viruses were found in 29% of patients. The only factor associated with a CXCR4-using virus infection in multivariate analysis was the nadir of CD4 cells: <200/mm(3) (OR: 3.94, 95% CI: 1.39-11.14). The median HCV RNA concentrations in patients infected with R5 viruses, those with dual-mixed viruses and those with X4 viruses, were all similar. The prevalence of CXCR4-using viruses in patients with mild fibrosis (<= F2) (31%) and those with severe fibrosis (F3-F4) (28%, p = 0.6) was similar. Longitudinal analyses showed that the presence of CXCR4-using viruses did not increase the likelihood of fibrosis progression, evaluated by measuring liver stiffness. Conclusions: The presence of CXCR4-using viruses in patients receiving a potent antiretroviral therapy does not influence HCV RNA concentration or liver fibrosis.	[Abravanel, Florence; Raymond, Stephanie; Izopet, Jacques] Ctr Physiopathol Toulouse Purpan, INSERM, U1043, Toulouse, France; [Abravanel, Florence; Raymond, Stephanie; Izopet, Jacques] CHU Toulouse Purpan, Virol Lab, Inst Federatif Biol Purpan, Toulouse, France; [Pambrun, Elodie; Winnock, Maria; Dabis, Francois] Univ Victor Segalen, INSERM, U897, Bordeaux, France; [Pambrun, Elodie; Winnock, Maria; Dabis, Francois] Univ Victor Segalen, ISPED, Bordeaux, France; [Bonnard, Philippe] Hop Tenon, AP HP, Serv Malad Infect & Trop, F-75970 Paris, France; [Sogni, Philippe] Hop Cochin, AP HP, Unite Hepatol, F-75674 Paris, France; [Sogni, Philippe; Salmon-Ceron, Dominique] Univ Paris 05, Paris, France; [Trimoulet, Pascale] CHU Pellegrin, Virol Lab, Bordeaux, France; [Trimoulet, Pascale] Univ Bordeaux Segalen, CNRS, UMR 5234, Bordeaux, France; [Salmon-Ceron, Dominique] Hop Cochin, AP HP, Serv Malad Infect & Trop, F-75674 Paris, France	Universite de Toulouse; Universite Toulouse III - Paul Sabatier; Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); CHU de Toulouse; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite de Bordeaux; UDICE-French Research Universities; Universite de Bordeaux; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Tenon - APHP; UDICE-French Research Universities; Sorbonne Universite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Cochin - APHP; UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite; CHU Bordeaux; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite de Bordeaux; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Cochin - APHP; UDICE-French Research Universities; Universite Paris Cite	Abravanel, F (corresponding author), Ctr Physiopathol Toulouse Purpan, INSERM, U1043, Toulouse, France.	abravanel.f@chu-toulouse.fr	Raymond, Stephanie/K-4507-2014; Abrvaanel, florence/K-3776-2014; Fourati, Slim/B-2756-2016; WINNOCK, Maria/B-5825-2011; Pambrun, Elodie/T-2756-2019; DABIS, FRANCOIS/S-9298-2019; IZOPET, Jacques/L-5756-2014; Raymond, Stephanie/L-8401-2019; Terris, Benoit/P-1497-2017; ABRAVANEL, Florence/AAC-2993-2021	DABIS, FRANCOIS/0000-0002-1614-8857; Raymond, Stephanie/0000-0002-3780-5844; ABRAVANEL, Florence/0000-0002-1753-1065; Charlotte, Frederic/0000-0003-2803-6606; Carrieri, Patrizia/0000-0002-6794-4837	Agence Nationale de Recherche contre le SIDA et les Hepatites Virales (ANRS); Abbott France; Glaxo-Smith-Kline; Roche; Schering-Plough; INSERM's "Programme cohortes TGIR"	Agence Nationale de Recherche contre le SIDA et les Hepatites Virales (ANRS)(ANRSFrench National Research Agency (ANR)); Abbott France(Abbott Laboratories); Glaxo-Smith-Kline(GlaxoSmithKline); Roche(Roche Holding); Schering-Plough(Merck & CompanySchering Plough Corporation); INSERM's "Programme cohortes TGIR"	This work was supported by the Agence Nationale de Recherche contre le SIDA et les Hepatites Virales (ANRS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The ANRS CO13 HEPAVIH cohort is sponsored by Abbott France, Glaxo-Smith-Kline, Roche and Schering-Plough, and INSERM's "Programme cohortes TGIR." This does not alter the authors' adherence to all the PLOS ONE policies on sharing data and materials.	Abbate I, 2011, CLIN MICROBIOL INFEC, V17, P725, DOI 10.1111/j.1469-0691.2010.03350.x; Ascaso Juan F, 2003, Eur J Intern Med, V14, P101, DOI 10.1016/S0953-6205(03)00022-0; Babu CK, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004623; Balagopal A, 2008, GASTROENTEROLOGY, V135, P226, DOI 10.1053/j.gastro.2008.03.022; Bedossa P, 1996, HEPATOLOGY, V24, P289, DOI 10.1002/hep.510240201; Benhamou Y, 1999, HEPATOLOGY, V30, P1054, DOI 10.1002/hep.510300409; Berger EA, 1998, NATURE, V391, P240, DOI 10.1038/34571; Berres ML, 2010, J CLIN INVEST, V120, P4129, DOI 10.1172/JCI41732; Blanco F, 2011, J VIRAL HEPATITIS, V18, P11, DOI 10.1111/j.1365-2893.2009.01261.x; Bonnard P, 2007, J VIRAL HEPATITIS, V14, P806, DOI 10.1111/j.1365-2893.2007.00874.x; Brau N, 2006, J HEPATOL, V44, P47, DOI 10.1016/j.jhep.2005.07.006; Bruno R, 2010, GUT, V59, P513, DOI 10.1136/gut.2008.163287; Canbay A, 2003, HEPATOLOGY, V38, P1188, DOI 10.1053/jhep.2003.50472; Canbay A, 2004, HEPATOLOGY, V39, P273, DOI 10.1002/hep.20051; Canbay A, 2003, LAB INVEST, V83, P655, DOI 10.1097/01.LAB.0000069036.63405.5C; Collazos J, 2011, AIDS RES HUM RETROV, V27, P383, DOI 10.1089/aid.2010.0168; de Ledinghen V, 2010, EXPERT REV MED DEVIC, V7, P811, DOI 10.1586/ERD.10.46; Fartoux L, 2005, GUT, V54, P1003, DOI 10.1136/gut.2004.050302; Graham CS, 2001, CLIN INFECT DIS, V33, P562, DOI 10.1086/321909; Gulick RM, 2008, NEW ENGL J MED, V359, P1429, DOI 10.1056/NEJMoa0803152; Halfon P, 2009, ALIMENT PHARM THER, V30, P61, DOI 10.1111/j.1365-2036.2009.03995.x; Hammer SM, 2008, JAMA-J AM MED ASSOC, V300, P555, DOI 10.1001/jama.300.5.555; Hong F, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033659; Hong F, 2009, HEPATOLOGY, V49, P2055, DOI 10.1002/hep.22890; Hunt PW, 2006, J INFECT DIS, V194, P926, DOI 10.1086/507312; Jang JY, 2011, J HEPATOL, V54, P612, DOI 10.1016/j.jhep.2010.07.042; Jiao JJ, 2009, CURR OPIN GASTROEN, V25, P223, DOI 10.1097/MOG.0b013e3283279668; Kirk GD, 2009, CLIN INFECT DIS, V48, P963, DOI 10.1086/597350; Lin W, 2008, GASTROENTEROLOGY, V134, P803, DOI 10.1053/j.gastro.2008.01.005; Lin WY, 2011, J BIOL CHEM, V286, P2665, DOI 10.1074/jbc.M110.168286; Loko MA, 2010, BMC INFECT DIS, V10, DOI 10.1186/1471-2334-10-303; Marine-Barjoana E, 2007, AIDS, V21, P1811, DOI 10.1097/QAD.0b013e3282703810; Martin-Carbonero L, 2004, CLIN INFECT DIS, V38, P128, DOI 10.1086/380130; Martinez SM, 2011, HEPATOLOGY, V53, P325, DOI 10.1002/hep.24013; Melby T, 2006, J INFECT DIS, V194, P238, DOI 10.1086/504693; Mohsen AH, 2003, GUT, V52, P1035, DOI 10.1136/gut.52.7.1035; Munshi N, 2003, J INFECT DIS, V188, P1192, DOI 10.1086/378643; Pineda JA, 2010, J VIRAL HEPATITIS, V17, P714, DOI 10.1111/j.1365-2893.2009.01229.x; Raymond S, 2012, CURR OPIN HIV AIDS; Raymond S, 2008, AIDS, V22, pF11, DOI 10.1097/QAD.0b013e32830ebcd4; Raymond S, 2010, AIDS, V24, P2305, DOI 10.1097/QAD.0b013e32833e50bb; Raymond S, 2010, J CLIN VIROL, V47, P126, DOI 10.1016/j.jcv.2009.11.018; Recordon-Pinson P, 2010, ANTIMICROB AGENTS CH, V54, P3335, DOI 10.1128/AAC.00148-10; Rotman Y, 2009, J VIROL, V83, P7366, DOI 10.1128/JVI.00191-09; Ryan P, 2009, JAIDS-J ACQ IMM DEF, V50, P109, DOI 10.1097/QAI.0b013e318186ede8; Sandrin L, 2003, ULTRASOUND MED BIOL, V29, P1705, DOI 10.1016/j.ultrasmedbio.2003.07.001; Schwabe RF, 2003, AM J PHYSIOL-GASTR L, V285, pG949, DOI 10.1152/ajpgi.00215.2003; Seki E, 2009, J CLIN INVEST, V119, P1858, DOI 10.1172/JCI37444; Soriano V, 2008, J INFECT DIS, V198, P1337, DOI 10.1086/592171; Soulie C, 2010, J ANTIMICROB CHEMOTH, V65, P749, DOI 10.1093/jac/dkq029; Thein HH, 2008, AIDS, V22, P1979, DOI 10.1097/QAD.0b013e32830e6d51; Thein HH, 2008, HEPATOLOGY, V48, P418, DOI 10.1002/hep.22375; Tuyama AC, 2010, HEPATOLOGY, V52, P612, DOI 10.1002/hep.23679; Vlahakis SR, 2003, J INFECT DIS, V188, P1455, DOI 10.1086/379738; Weber R, 2006, ARCH INTERN MED, V166, P1632, DOI 10.1001/archinte.166.15.1632; Wilkin TJ, 2007, CLIN INFECT DIS, V44, P591, DOI 10.1086/511035; Xiao P, 2008, AIDS, V22, P1749, DOI 10.1097/QAD.0b013e328308937c	57	4	4	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 30	2012	7	11							e50289	10.1371/journal.pone.0050289	http://dx.doi.org/10.1371/journal.pone.0050289			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	054WM	23226258	Green Published, Green Submitted, gold			2022-12-27	WOS:000312376100068
J	Chong, P; Guo, MS; Lin, FHY; Hsiao, KN; Weng, SY; Chou, AH; Wang, JR; Hsieh, SY; Su, IJ; Liu, CC				Chong, Pele; Guo, Meng-Shin; Lin, Fion Hsiao-Yu; Hsiao, Kuang-Nan; Weng, Shu-Yang; Chou, Ai-Hsiang; Wang, Jen-Ren; Hsieh, Shih-Yang; Su, Ih-Jen; Liu, Chia-Chyi			Immunological and Biochemical Characterization of Coxsackie Virus A16 Viral Particles	PLOS ONE			English	Article							ENTEROVIRUS 71; LETHAL ENTEROVIRUS-71; VACCINE DEVELOPMENT; PROTECTS MICE; PUBLIC-HEALTH; DISEASE VIRUS; CELL-CULTURE; INFECTION; STRAIN; IDENTIFICATION	Background: Coxsackie virus A16 (CVA16) infections have become a serious public health problem in the Asia-Pacific region. It manifests most often in childhood exanthema, commonly known as hand-foot-and-mouth disease (HFMD). There are currently no vaccine or effective medical treatments available. Principal Finding: In this study, we describe the production, purification and characterization of CVA16 virus produced from Vero cells grown on 5 g/L Cytodex 1 microcarrier beads in a five-liter serum-free bioreactor system. The viral titer was found to be >10(6) the tissue culture's infectious dose (TCID50) per mL within 7 days post-infection when a multiplicity of infection (MOI) of 10(-5) was used for initial infection. Two CVA16 virus fractions were separated and detected when the harvested CVA16 viral concentrate was purified by a sucrose gradient zonal ultracentrifugation. The viral particles detected in the 24-28% sucrose fractions had low viral infectivity and RNA content. The viral particles obtained from 35-38% sucrose fractions were found to have high viral infectivity and RNA content, and composed of four viral proteins (VP1, VP2, VP3 and VP4), as shown by SDS-PAGE analyses. These two virus fractions were formalin-inactivated and only the infectious particle fraction was found to be capable of inducing CVA16-specific neutralizing antibody responses in both mouse and rabbit immunogenicity studies. But these antisera failed to neutralize enterovirus 71. In addition, rabbit antisera did not react with any peptides derived from CVA16 capsid proteins. Mouse antisera recognized a single linear immunodominant epitope of VP3 corresponding to residues 176-190. Conclusion: These results provide important information for cell-based CVA16 vaccine development. To eliminate HFMD, a bivalent EV71/CVA16 vaccine formulation is necessary.	[Chong, Pele; Guo, Meng-Shin; Lin, Fion Hsiao-Yu; Hsiao, Kuang-Nan; Weng, Shu-Yang; Chou, Ai-Hsiang; Hsieh, Shih-Yang; Su, Ih-Jen; Liu, Chia-Chyi] Natl Hlth Res Inst, Natl Inst Infect Dis & Vaccinol, Vaccine R&D Ctr, Zhunan Town, Miaoli County, Taiwan; [Chong, Pele] China Med Univ, Grad Inst Immunol, Taichung, Taiwan; [Wang, Jen-Ren] Natl Cheng Kung Univ, Coll Med, Dept Med Lab Sci & Biotechnol, Tainan 70101, Taiwan	National Health Research Institutes - Taiwan; China Medical University Taiwan; National Cheng Kung University	Chong, P (corresponding author), Natl Hlth Res Inst, Natl Inst Infect Dis & Vaccinol, Vaccine R&D Ctr, Zhunan Town, Miaoli County, Taiwan.	pelechong@nhri.org.tw; georgeliu@nhri.org.tw	Liu, Chia-Chyi/A-8215-2012; Wang, Jen-Ren/F-5254-2011; Chong, Pele/E-3855-2010; Su, Ih-Jen/B-2655-2010	Liu, Chia-Chyi/0000-0002-6257-0389; Wang, Jen-Ren/0000-0002-4127-4046	National Science Council (NSC) of Taiwan [99A1-VCSP01-014]; NHRI [100A1-VC-PP-10-014]	National Science Council (NSC) of Taiwan(Ministry of Science and Technology, Taiwan); NHRI(National Health Research Institutes - Taiwan)	This work was supported by a grant (#99A1-VCSP01-014) from the National Science Council (NSC) of Taiwan and a grant (#100A1-VC-PP-10-014) from NHRI. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arita M, 2007, J VIROL, V81, P9386, DOI 10.1128/JVI.02856-06; Blom N, 1996, PROTEIN SCI, V5, P2203, DOI 10.1002/pro.5560051107; Brown BA, 1995, VIRUS RES, V39, P195, DOI 10.1016/0168-1702(95)00087-9; Chang GH, 2010, VIROL J, V7, DOI 10.1186/1743-422X-7-106; Chang HW, 2011, J VIROL METHODS, V173, P189, DOI 10.1016/j.jviromet.2011.02.003; Chang JY, 2012, VACCINE, V30, P703, DOI 10.1016/j.vaccine.2011.11.087; Chiu CH, 2006, MICROBES INFECT, V8, P1671, DOI 10.1016/j.micinf.2006.01.021; Chou AH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034834; Chung YC, 2008, VACCINE, V26, P1855, DOI 10.1016/j.vaccine.2008.01.058; Curry S, 1997, J VIROL, V71, P9743, DOI 10.1128/JVI.71.12.9743-9752.1997; FERGUSON M, 1990, J GEN VIROL, V71, P1271, DOI 10.1099/0022-1317-71-6-1271; Guang D, 2007, VIRUS RES, V125, P61, DOI 10.1016/j.virusres.2006.12.005; Guang DM, 2007, MICROBES INFECT, V9, P1299; Ho MT, 1999, NEW ENGL J MED, V341, P929, DOI 10.1056/NEJM199909233411301; Huang SW, 2009, J CLIN MICROBIOL, V47, P3653, DOI 10.1128/JCM.00630-09; HUMMELER K, 1962, VIROLOGY, V16, P84, DOI 10.1016/0042-6822(62)90205-2; Lee MS, 2010, EXPERT REV VACCINES, V9, P149, DOI [10.1586/erv.09.152, 10.1586/ERV.09.152]; Li YP, 2012, VACCINE, V30, P3295, DOI 10.1016/j.vaccine.2012.03.010; Lin KH, 2006, J MED VIROL, V78, P254, DOI 10.1002/jmv.20534; Lin YC, 2002, VACCINE, V20, P2485, DOI 10.1016/S0264-410X(02)00182-2; Lin YL, 2011, J IMMUNOASS IMMUNOCH, V32, P233, DOI 10.1080/15321819.2011.559297; Liu CC, 2007, VACCINE, V25, P19, DOI 10.1016/j.vaccine.2006.06.083; Liu CC, 2011, VACCINE, V29, P4362, DOI 10.1016/j.vaccine.2011.04.010; Liu CC, 2011, PLOS ONE, V6, DOI [10.1371/journal.pone.0020005, 10.1371/journal.pone.0021464]; Mao QY, 2012, ARCH VIROL, V157, P37, DOI 10.1007/s00705-011-1136-3; McMinn PC, 2002, FEMS MICROBIOL REV, V26, P91, DOI 10.1111/j.1574-6976.2002.tb00601.x; McMinn PC, 2003, NEUROL J SE ASIA, V8, P57; MINOR PD, 1980, J GEN VIROL, V51, P147, DOI 10.1099/0022-1317-51-1-147; MINOR PD, 1991, J GEN VIROL, V72, P2475, DOI 10.1099/0022-1317-72-10-2475; Nishimura Y, 2009, NAT MED, V15, P794, DOI 10.1038/nm.1961; Ong KC, 2010, J VIROL, V84, P661, DOI 10.1128/JVI.00999-09; PANEZUTTI H, 1993, INFECT IMMUN, V61, P1867, DOI 10.1128/IAI.61.5.1867-1872.1993; Plevka P, 2012, CRYSTAL STRUCTURE HU; Qiu J, 2008, LANCET NEUROL, V7, P868, DOI 10.1016/S1474-4422(08)70207-2; REED L. J., 1938, AMER JOUR HYG, V27, P493; SCHMIDT NJ, 1974, J INFECT DIS, V129, P304, DOI 10.1093/infdis/129.3.304; Sivasamugham LA, 2006, J MED VIROL, V78, P1096, DOI 10.1002/jmv.20668; Tan EL, 2008, DIAGN MICR INFEC DIS, V61, P294, DOI 10.1016/j.diagmicrobio.2008.02.009; Tung Wong Siew, 2007, Genet Vaccines Ther, V5, P6, DOI 10.1186/1479-0556-5-6; Wang XX, 2012, NAT STRUCT MOL BIOL, V19, P424, DOI 10.1038/nsmb.2255; Wu CN, 2001, VACCINE, V20, P895, DOI 10.1016/S0264-410X(01)00385-1; Wu SC, 2004, VACCINE, V22, P3858, DOI 10.1016/j.vaccine.2004.05.037; Wu TC, 2007, J VIROL, V81, P10310, DOI 10.1128/JVI.00372-07; Xu J, 2010, VACCINE, V28, P3516, DOI 10.1016/j.vaccine.2010.03.003; Yamayoshi S, 2009, NAT MED, V15, P798, DOI 10.1038/nm.1992	45	39	53	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 30	2012	7	11							e49973	10.1371/journal.pone.0049973	http://dx.doi.org/10.1371/journal.pone.0049973			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	054WM	23226233	Green Published, Green Submitted, gold			2022-12-27	WOS:000312376100041
J	Katsman, D; Stackpole, EJ; Domin, DR; Farber, DB				Katsman, Diana; Stackpole, Emma J.; Domin, Daniel R.; Farber, Debora B.			Embryonic Stem Cell-Derived Microvesicles Induce Gene Expression Changes in Muller Cells of the Retina	PLOS ONE			English	Article							NEURAL REGENERATION; HORIZONTAL TRANSFER; NEURITE OUTGROWTH; GANGLION-CELLS; MESSENGER-RNA; MICRORNAS; GLIA; PROGENITOR; MODEL; DIFFERENTIATION	Cell-derived microvesicles (MVs), recognized as important components of cell-cell communication, contain mRNAs, miRNAs, proteins and lipids and transfer their bioactive contents from parent cells to cells of other origins. We have studied the effect that MVs released from embryonic stem cells (ESMVs) have on retinal progenitor Muller cells. Cultured human Muller cells were exposed to mouse ESMVs every 48 hours for a total of 9 treatments. Morphological changes were observed by light microscopy in the treated cells, which grew as individual heterogeneous cells, compared to the uniform, spindle-like adherent cellular sheets of untreated cells. ESMVs transferred to Muller cells embryonic stem cell (ESC) mRNAs involved in the maintenance of pluripotency, including Oct4 and Sox2, and the miRNAs of the 290 cluster, important regulators of the ESC-specific cell cycle. Moreover, ESMV exposure induced up-regulation of the basal levels of endogenous human Oct4 mRNA in Muller cells. mRNA and miRNA microarrays of ESMV-treated vs. untreated Muller cells revealed the up-regulation of genes and miRNAs involved in the induction of pluripotency, cellular proliferation, early ocular genes and genes important for retinal protection and remodeling, as well as the down-regulation of inhibitory and scar-related genes and miRNAs involved in differentiation and cell cycle arrest. To further characterize the heterogeneous cell population of ESMV-treated Muller cells, their expression of retinal cell markers was compared to that in untreated control cells by immunocytochemistry. Markers for amacrine, ganglion and rod photoreceptors were present in treated but not in control Muller cells. Together, our findings indicate that ESMs induce de-differentiation and pluripotency in their target Muller cells, which may turn on an early retinogenic program of differentiation.	[Katsman, Diana; Stackpole, Emma J.; Domin, Daniel R.; Farber, Debora B.] Univ Calif Los Angeles, Jules Stein Eye Inst, Los Angeles, CA 90024 USA; [Katsman, Diana; Stackpole, Emma J.; Domin, Daniel R.; Farber, Debora B.] Univ Calif Los Angeles, Dept Ophthalmol, Los Angeles, CA USA; [Katsman, Diana; Farber, Debora B.] Univ Calif Los Angeles, Inst Mol Biol, Los Angeles, CA 90024 USA; [Farber, Debora B.] Univ Calif Los Angeles, Brain Res Inst, Los Angeles, CA 90024 USA	University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles	Farber, DB (corresponding author), Univ Calif Los Angeles, Jules Stein Eye Inst, Los Angeles, CA 90024 USA.	farber@jsei.ucla.edu		Farber, Debora/0000-0002-3207-697X	California Institute for Regenerative Medicine Training Grant [TG2-01169]; New Investigator Award from Hope for Vision; NATIONAL EYE INSTITUTE [P30EY000331] Funding Source: NIH RePORTER	California Institute for Regenerative Medicine Training Grant; New Investigator Award from Hope for Vision; NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This work was supported by California Institute for Regenerative Medicine Training Grant TG2-01169 (www.cirm.ca.gov) and a New Investigator Award from Hope for Vision (www.hopeforvision.org). The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arora A, 2010, BMC DEV BIOL, V10, DOI 10.1186/1471-213X-10-1; BerminghamMcDonogh O, 1996, DEVELOPMENT, V122, P1427; Bernardos RL, 2007, J NEUROSCI, V27, P7028, DOI 10.1523/JNEUROSCI.1624-07.2007; Bhatia B, 2010, OPEN OPHTHALMOL J, V4, P30, DOI 10.2174/1874364101004010030; Bringmann A, 2006, PROG RETIN EYE RES, V25, P397, DOI 10.1016/j.preteyeres.2006.05.003; Bruno S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033115; Camussi G, 2010, KIDNEY INT, V78, P838, DOI 10.1038/ki.2010.278; Chong DY, 2008, INVEST OPHTH VIS SCI, V49, P3193, DOI 10.1167/iovs.07-1641; Cid E, 2010, EXP EYE RES, V90, P267, DOI 10.1016/j.exer.2009.10.015; Cocucci E, 2009, TRENDS CELL BIOL, V19, P43, DOI 10.1016/j.tcb.2008.11.003; Cordes KR, 2009, NATURE, V460, P705, DOI 10.1038/nature08195; Dalkara D, 2011, MOL THER, V19, P1602, DOI 10.1038/mt.2011.62; Das AV, 2006, DEV BIOL, V299, P283, DOI 10.1016/j.ydbio.2006.07.029; Decembrini S, 2009, P NATL ACAD SCI USA, V106, P21179, DOI 10.1073/pnas.0909167106; Deregibus MC, 2007, BLOOD, V110, P2440, DOI 10.1182/blood-2007-03-078709; Deregibus MC, 2010, HISTOL HISTOPATHOL, V25, P397, DOI 10.14670/HH-25.397; Dornowicz MS, 2008, DEV BIOL, V315, P114, DOI 10.1016/j.ydbio.2007.12.014; Dorsky RI, 1997, NATURE, V385, P67, DOI 10.1038/385067a0; Duester G, 2009, CHEM-BIOL INTERACT, V178, P178, DOI 10.1016/j.cbi.2008.09.004; Dyer MA, 2000, NAT NEUROSCI, V3, P873, DOI 10.1038/78774; Fausett BV, 2008, J NEUROSCI, V28, P1109, DOI 10.1523/JNEUROSCI.4853-07.2008; Fischer AJ, 2001, NAT NEUROSCI, V4, P247, DOI 10.1038/85090; Fischer AJ, 2003, GLIA, V43, P70, DOI 10.1002/glia.10218; Giannelli SG, 2011, STEM CELLS, V29, P344, DOI 10.1002/stem.579; Gnecchi M, 2008, CIRC RES, V103, P1204, DOI 10.1161/CIRCRESAHA.108.176826; Gong J, 2008, EXP EYE RES, V86, P957, DOI 10.1016/j.exer.2008.03.014; Gotz M, 2005, NEURON, V46, P369, DOI 10.1016/j.neuron.2005.04.012; Guo L, 2011, EXP HEMATOL, V39, P608, DOI 10.1016/j.exphem.2011.01.011; Heijnen HFG, 1999, BLOOD, V94, P3791, DOI 10.1182/blood.V94.11.3791.423a22_3791_3799; Herrera MB, 2010, J CELL MOL MED, V14, P1605, DOI 10.1111/j.1582-4934.2009.00860.x; Hollborn M, 2011, MOL VIS, V17, P2738; Hufnagel RB, 2010, DEV BIOL, V340, P490, DOI 10.1016/j.ydbio.2010.02.002; Irizarry RA, 2003, BIOSTATISTICS, V4, P249, DOI 10.1093/biostatistics/4.2.249; Jadhav AP, 2009, PROG RETIN EYE RES, V28, P249, DOI 10.1016/j.preteyeres.2009.05.002; Judson RL, 2009, NAT BIOTECHNOL, V27, P459, DOI 10.1038/nbt.1535; Karl MO, 2008, P NATL ACAD SCI USA, V105, P19508, DOI 10.1073/pnas.0807453105; Kelly LE, 2007, GENE EXPR PATTERNS, V7, P233, DOI 10.1016/j.modgep.2006.10.003; Kinouchi R, 2003, NAT NEUROSCI, V6, P863, DOI 10.1038/nn1088; Klimanskaya I, 2004, CLONING STEM CELLS, V6, P217, DOI 10.1089/clo.2004.6.217; Kuffler DP, 2009, J NEUROSCI RES, V87, P2863, DOI 10.1002/jnr.22132; Lamba D, 2008, CELL STEM CELL, V2, P538, DOI 10.1016/j.stem.2008.05.002; Lau D, 2000, INVEST OPHTH VIS SCI, V41, P3622; Letzen BS, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010480; Levine EM, 1997, J COMP NEUROL, V387, P439; Li SG, 2004, NEURON, V43, P795, DOI 10.1016/j.neuron.2004.08.041; Li X, 2005, CELL, V123, P1267, DOI 10.1016/j.cell.2005.10.040; Limb GA, 2002, INVEST OPHTH VIS SCI, V43, P864; Mallanna SK, 2010, DEV BIOL, V344, P16, DOI 10.1016/j.ydbio.2010.05.014; Marquardt T, 2001, CELL, V105, P43, DOI 10.1016/S0092-8674(01)00295-1; Mathers PH, 2000, CELL MOL LIFE SCI, V57, P186, DOI 10.1007/PL00000683; Melton C, 2010, NATURE, V463, P621, DOI 10.1038/nature08725; Muranishi Y, 2012, DEV GROWTH DIFFER, V54, P341, DOI 10.1111/j.1440-169X.2012.01337.x; Nelson BR, 2008, DEV DYNAM, V237, P1565, DOI 10.1002/dvdy.21550; Nickerson PEB, 2008, BRAIN RES, V1230, P1, DOI 10.1016/j.brainres.2008.03.095; Ooto S, 2004, P NATL ACAD SCI USA, V101, P13654, DOI 10.1073/pnas.0402129101; Peter ME, 2009, CELL CYCLE, V8, P843, DOI 10.4161/cc.8.6.7907; Quesenberry PJ, 2010, EXP HEMATOL, V38, P581, DOI 10.1016/j.exphem.2010.03.021; Ratajczak J, 2006, LEUKEMIA, V20, P847, DOI 10.1038/sj.leu.2404132; Roesch K, 2008, J COMP NEUROL, V509, P225, DOI 10.1002/cne.21730; Sappington RM, 2006, INVEST OPHTH VIS SCI, V47, P2932, DOI 10.1167/iovs.05-1407; Sehgal R, 2009, DEV BIOL, V332, P429, DOI 10.1016/j.ydbio.2009.05.579; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Tetta C, 2011, ORGANOGENESIS, V7, P105, DOI 10.4161/org.7.2.15782; Tucker B, 2008, INVEST OPHTH VIS SCI, V49, P1686, DOI 10.1167/iovs.07-1058; TURNER DL, 1987, NATURE, V328, P131, DOI 10.1038/328131a0; Vergara MN, 2009, MOL VIS, V15, P1000; Wang NK, 2010, TRANSPLANTATION, V89, P911, DOI 10.1097/TP.0b013e3181d45a61; Wang YM, 2009, CANCER RES, V69, P4093, DOI 10.1158/0008-5472.CAN-09-0309; Wang Y, 2008, NAT GENET, V40, P1478, DOI 10.1038/ng.250; Ward MS, 2007, J PHARM SCI-US, V96, P558, DOI 10.1002/jps.20629; WOLF P, 1967, BRIT J HAEMATOL, V13, P269, DOI 10.1111/j.1365-2141.1967.tb08741.x; Wu DM, 2001, INVEST OPHTH VIS SCI, V42, P2115; Yu JY, 2007, SCIENCE, V318, P1917, DOI 10.1126/science.1151526; Yuan A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004722; Yurco P, 2004, INVEST OPHTH VIS SCI, V45, pU636; Zhao Y, 2007, TRENDS BIOCHEM SCI, V32, P189, DOI 10.1016/j.tibs.2007.02.006; Zovoilis A, 2010, MOL HUM REPROD, V16, P793, DOI 10.1093/molehr/gaq053	77	62	68	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 30	2012	7	11							e50417	10.1371/journal.pone.0050417	http://dx.doi.org/10.1371/journal.pone.0050417			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	054WM	23226281	Green Published, gold, Green Submitted			2022-12-27	WOS:000312376100093
J	Lindsay, TC; Jawara, M; D'Alessandro, U; Pinder, M; Lindsay, SW				Lindsay, Thomas C.; Jawara, Musa; D'Alessandro, Umberto; Pinder, Margaret; Lindsay, Steven W.			Development of Odour-Baited Flytraps for Sampling the African Latrine Fly, Chrysomya putoria, a Putative Vector of Enteric Diseases	PLOS ONE			English	Article							MUSCA-SORBENS; FLIES DIPTERA; TRAPS	African pit latrines produce prodigious numbers of the latrine fly, Chrysomya putoria, a putative vector of diarrhoeal pathogens. We set out to develop a simple, low-cost odour-baited trap for collecting C. putoria in the field. A series of field experiments was carried out in The Gambia to assess the catching-efficiency of different trap designs. The basic trap was a transparent 3L polypropylene box baited with 50 g of fish, with a white opaque lid with circular entrance holes. We tested variations of the number, diameter, position and shape of the entrance holes, the height of the trap above ground, degree of transparency of the box, its shape, volume, colour, and the attractiveness of gridded surfaces on or under the trap. Traps were rotated between positions on different sampling occasions using a Latin Square design. The optimal trapping features were incorporated into a final trap that was tested against commercially available traps. Features of the trap that increased the number of flies caught included: larger entrance holes (compared with smaller ones, p<0.001), using conical collars inside the holes (compared with without collars, p = 0.01), entrance holes on the top of the trap (compared with the side or bottom, p<0.001), traps placed on the ground (compared with above ground, p<0.001), the box having transparent sides (compared with being opaque, p<0.001), and with no wire grids nearby (compared with those with grids, p = 0.03). This trap collected similar numbers of C. putoria to other common traps for blow flies. The optimum trap design was a transparent box, with a white plastic lid on top, perforated with 10 conical entrance holes, placed on the ground. Our simple trap provides a cheap, low-maintenance and effective method of sampling C. putoria in the field.	[Lindsay, Thomas C.; Pinder, Margaret; Lindsay, Steven W.] London Sch Hyg & Trop Med, Dept Dis Control, London WC1, England; [Jawara, Musa; D'Alessandro, Umberto; Pinder, Margaret] MRC Unit, Fajara, Gambia; [D'Alessandro, Umberto] Inst Trop Med, Unit Malariol, B-2000 Antwerp, Belgium; [Lindsay, Steven W.] Univ Durham, Sch Biol & Biomed Sci, Durham, England	University of London; London School of Hygiene & Tropical Medicine; University of London; London School of Hygiene & Tropical Medicine; Institute of Tropical Medicine (ITM); Durham University	Lindsay, SW (corresponding author), London Sch Hyg & Trop Med, Dept Dis Control, London WC1, England.	S.W.Lindsay@durham.ac.uk	Pinder, Margaret/AAQ-7129-2020; D'Alessandro, Umberto/D-3457-2015	D'Alessandro, Umberto/0000-0001-6341-5009; Lindsay, Steve/0000-0002-3461-9050	Bill and Melinda Gates Foundation [OPP1034747]; Research and Policy for Infectious Disease Dynamics (RAPIDD) Program of the Science and Technology Directory; Department of Homeland Security; Fogarty International Center, National Institutes of Health; Medical Research Council, UK	Bill and Melinda Gates Foundation(Bill & Melinda Gates Foundation); Research and Policy for Infectious Disease Dynamics (RAPIDD) Program of the Science and Technology Directory; Department of Homeland Security(United States Department of Homeland Security (DHS)); Fogarty International Center, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); Medical Research Council, UK(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	The work was supported by the Bill and Melinda Gates Foundation(# OPP1034747; Grand Challenges Explorations Phase I, Round 6 Project Grant). SWL received support from the Research and Policy for Infectious Disease Dynamics (RAPIDD) Program of the Science and Technology Directory, Department of Homeland Security, and Fogarty International Center, National Institutes of Health, Medical Research Council, UK. The sponsors of the study did not have a role in the design of the study, data collection, analysis, interpretation and writing of this manuscript. SWL had full access to the data and had the final responsibility for submitting the manuscript for publication.	CURTIS CF, 1982, T ROY SOC TROP MED H, V76, P99, DOI 10.1016/0035-9203(82)90031-1; Emerson PM, 2005, TROP MED INT HEALTH, V10, P706, DOI 10.1111/j.1365-3156.2005.01432.x; Emerson PM, 2000, T ROY SOC TROP MED H, V94, P28, DOI 10.1016/S0035-9203(00)90427-9; Emerson PM, 1999, LANCET, V353, P1401, DOI 10.1016/S0140-6736(98)09158-2; Gilles J, 2007, MED VET ENTOMOL, V21, P65, DOI 10.1111/j.1365-2915.2006.00658.x; Greenberg B, 1971, FLIES AND DISEASE EC; Greenberg B, 1973, FLIES AND DISEASE BI; Gurney WB, 1926, AGR DEP NEW S WALES, V27, P4; Hecht O, 1970, B ENTOMOL SOC AM, V16, P94; Kobayashi M, 1999, AM J TROP MED HYG, V61, P625, DOI 10.4269/ajtmh.1999.61.625; LAURENCE BR, 1988, MED VET ENTOMOL, V2, P285, DOI 10.1111/j.1365-2915.1988.tb00197.x; LINDSAY DR, 1956, ANNU REV ENTOMOL, V1, P323, DOI 10.1146/annurev.en.01.010156.001543; Lindsay SW, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001895; Pickens L. G., 1995, IPM Practitioner, V17, P1; PICKENS LG, 1994, J MED ENTOMOL, V31, P828, DOI 10.1093/jmedent/31.6.828; SCUDDER HI, 1947, PUBLIC HEALTH REP, V62, P681, DOI 10.2307/4586121; UNICEF/WHO, 2009, DIARRHOEA WHY CHILDR; VALE GA, 1982, B ENTOMOL RES, V72, P71, DOI 10.1017/S000748530005029X; VALE GA, 1982, B ENTOMOL RES, V72, P95, DOI 10.1017/S0007485300050306; VOGT W G, 1974, Journal of the Australian Entomological Society, V13, P249	20	4	4	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 30	2012	7	11							e50505	10.1371/journal.pone.0050505	http://dx.doi.org/10.1371/journal.pone.0050505			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	054WM	23226296	gold, Green Accepted, Green Published			2022-12-27	WOS:000312376100108
J	Martin, LA; Horriat, NL				Martin, Loren A.; Horriat, Narges L.			The Effects of Birth Order and Birth Interval on the Phenotypic Expression of Autism Spectrum Disorder	PLOS ONE			English	Article							HIGH-FUNCTIONING AUTISM; RECEPTOR GENE OXTR; FETAL-BRAIN; DIAGNOSTIC INTERVIEW; REPETITIVE BEHAVIOR; NONVERBAL IQ; GENOME-WIDE; OXYTOCIN; ANTIBODIES; CHILDREN	A rise in the prevalence of diagnosed cases of autism spectrum disorder (ASD) has been reported in several studies in recent years. While this rise in ASD prevalence is at least partially related to increased awareness and broadened diagnostic criteria, the role of environmental factors cannot be ruled out, especially considering that the cause of most cases of ASD remains unknown. The study of families with multiple affected children can provide clues about ASD etiology. While the majority of research on ASD multiplex families has focused on identifying genetic anomalies that may underlie the disorder, the study of symptom severity across ASD birth order may provide evidence for environmental factors in ASD. We compared social and cognitive measures of behavior between over 300 first and second affected siblings within multiplex autism families obtained from the Autism Genetic Resource Exchange dataset. Measures included nonverbal IQ assessed with the Ravens Colored Progressive Matrices, verbal IQ assessed with the Peabody Picture Vocabulary Test, and autism severity assessed with the Social Responsiveness Scale (SRS), an instrument established as a quantitative measure of autism. The results indicated that females were more severely impacted by ASD than males, especially first affected siblings. When first and second affected siblings were compared, significant declines in nonverbal and verbal IQ scores were observed. In addition, SRS results demonstrated a significant increase in autism severity between first and second affected siblings consistent with an overall decline in function as indicated by the IQ data. These results remained significant after controlling for the age and sex of the siblings. Surprisingly, the SRS scores were found to only be significant when the age difference between siblings was less than 2 years. These results suggest that some cases of ASD are influenced by a dosage effect involving unknown epigenetic, environmental, and/or immunological factors.	[Martin, Loren A.] Azusa Pacific Univ, Dept Grad Psychol, Azusa, CA 91702 USA; [Horriat, Narges L.] Azusa Pacific Univ, Dept Biol & Chem, Azusa, CA USA		Martin, LA (corresponding author), Azusa Pacific Univ, Dept Grad Psychol, Azusa, CA 91702 USA.	lamartin@apu.edu			Faculty Research Council at Azusa Pacific University; National Institute of Mental Health [1U24MH081810]; NATIONAL INSTITUTE OF MENTAL HEALTH [U24MH081810] Funding Source: NIH RePORTER	Faculty Research Council at Azusa Pacific University; National Institute of Mental Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This research was funded by a grant from the Faculty Research Council at Azusa Pacific University. The Autism Genetic Resource Exchange is a program of Autism Speaks and is supported, in part, by grant 1U24MH081810 from the National Institute of Mental Health to Clara M. Lajonchere (PI). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abrahams BS, 2008, NAT REV GENET, V9, P341, DOI 10.1038/nrg2346; Altus WD, 1972, INFLUENCES HUMAN DEV, P600; Andari E, 2010, P NATL ACAD SCI USA, V107, P4389, DOI 10.1073/pnas.0910249107; Bailey A, 1996, J CHILD PSYCHOL PSYC, V37, P89, DOI 10.1111/j.1469-7610.1996.tb01381.x; BAILEY A, 1995, PSYCHOL MED, V25, P63, DOI 10.1017/S0033291700028099; Baio Jon, 2012, Morbidity and Mortality Weekly Report, V61, P1; Banach R, 2009, J AUTISM DEV DISORD, V39, P188, DOI 10.1007/s10803-008-0612-4; Bartz JA, 2008, PROG BRAIN RES, V170, P451, DOI 10.1016/S0079-6123(08)00435-4; Bishop DVM, 2004, J CHILD PSYCHOL PSYC, V45, P1431, DOI 10.1111/j.1469-7610.2004.00325.x; Bodfish JW, 2000, J AUTISM DEV DISORD, V30, P237, DOI 10.1023/A:1005596502855; Braunschweig D, 2008, NEUROTOXICOLOGY, V29, P226, DOI 10.1016/j.neuro.2007.10.010; Carone BR, 2010, CELL, V143, P1084, DOI 10.1016/j.cell.2010.12.008; Cheslack-Postava K, 2011, PEDIATRICS, V127, P246, DOI 10.1542/peds.2010-2371; Constantino JN, 2005, BIOL PSYCHIAT, V57, P655, DOI 10.1016/j.biopsych.2004.12.014; Constantino JN, 2003, J AUTISM DEV DISORD, V33, P427, DOI 10.1023/A:1025014929212; Constantino JN, 2000, AM J PSYCHIAT, V157, P2043, DOI 10.1176/appi.ajp.157.12.2043; Constantino JN, 2010, AM J PSYCHIAT, V167, P1349, DOI 10.1176/appi.ajp.2010.09101470; Croen LA, 2008, BIOL PSYCHIAT, V64, P583, DOI 10.1016/j.biopsych.2008.05.006; Dalton P, 2003, ANN NEUROL, V53, P533, DOI 10.1002/ana.10557; Dawson G, 2008, DEV PSYCHOPATHOL, V20, P775, DOI 10.1017/S0954579408000370; Dawson G, 2007, J AUTISM DEV DISORD, V37, P523, DOI 10.1007/s10803-006-0182-2; Dolinoy DC, 2007, P NATL ACAD SCI USA, V104, P13056, DOI 10.1073/pnas.0703739104; Dunn L.M., 1981, PEABODY PICTURE VOCA; El Nokali NE, 2010, CHILD DEV, V81, P988, DOI 10.1111/j.1467-8624.2010.01447.x; Filipek PA, 1999, J AUTISM DEV DISORD, V29, P439, DOI 10.1023/A:1021943802493; Fountain C, 2011, J EPIDEMIOL COMMUN H, V65, P503, DOI 10.1136/jech.2009.104588; Gillberg C, 2000, BIOL AUTISTIC SYNDRO, Vx; Goin-Kochel RP, 2008, J AUTISM DEV DISORD, V38, P1019, DOI 10.1007/s10803-007-0476-z; Goines P, 2010, CURR OPIN NEUROL, V23, P111, DOI 10.1097/WCO.0b013e3283373514; Gregory SG, 2009, BMC MED, V7, DOI 10.1186/1741-7015-7-62; Hollander E, 2003, LANCET, V362, P732, DOI 10.1016/S0140-6736(03)14236-5; Hollander E, 2007, BIOL PSYCHIAT, V61, P498, DOI 10.1016/j.biopsych.2006.05.030; Insel TR, 1999, BIOL PSYCHIAT, V45, P145, DOI 10.1016/S0006-3223(98)00142-5; Jacob S, 2007, NEUROSCI LETT, V417, P6, DOI 10.1016/j.neulet.2007.02.001; Kucharski R, 2008, SCIENCE, V319, P1827, DOI 10.1126/science.1153069; Lam KSL, 2007, J AUTISM DEV DISORD, V37, P855, DOI 10.1007/s10803-006-0213-z; Lauritsen MB, 2006, MOL PSYCHIATR, V11, P37, DOI 10.1038/sj.mp.4001754; Lerer E, 2008, MOL PSYCHIATR, V13, P980, DOI 10.1038/sj.mp.4002087; LORD C, 1992, J AUTISM DEV DISORD, V22, P663, DOI 10.1007/BF01046335; LORD C, 1985, J AUTISM DEV DISORD, V15, P185, DOI 10.1007/BF01531604; Lord C, 2000, J AUTISM DEV DISORD, V30, P205, DOI 10.1023/A:1005592401947; LORD C, 1994, J AUTISM DEV DISORD, V24, P659, DOI 10.1007/BF02172145; LOVAAS OI, 1987, J CONSULT CLIN PSYCH, V55, P3, DOI 10.1037/0022-006X.55.1.3; Martin LA, 2008, BRAIN BEHAV IMMUN, V22, P806, DOI 10.1016/j.bbi.2007.12.007; McCauley JL, 2005, BMC MED GENET, V6, DOI 10.1186/1471-2350-6-1; MCEACHIN JJ, 1993, AM J MENT RETARD, V97, P359; MODAHL C, 1992, J AUTISM DEV DISORD, V22, P449, DOI 10.1007/BF01048246; Modahl C, 1998, BIOL PSYCHIAT, V43, P270, DOI 10.1016/S0006-3223(97)00439-3; Mottron L, 2004, J AUTISM DEV DISORD, V34, P19, DOI 10.1023/B:JADD.0000018070.88380.83; Ng SF, 2010, NATURE, V467, P963, DOI 10.1038/nature09491; Parner ET, 2012, ANN EPIDEMIOL, V22, P143, DOI 10.1016/j.annepidem.2011.12.006; Raven J. C., 1995, COLORED PROGR MATRIC; Raven J.C., 1947, COLORED PROGR MATRIC; Reichenberg A, 2007, PSYCHIAT RES, V150, P199, DOI 10.1016/j.psychres.2004.09.012; Rogers SJ, 2008, J CLIN CHILD ADOLESC, V37, P8, DOI 10.1080/15374410701817808; Sandin S, 2012, J AM ACAD CHILD PSY, V51, P477, DOI 10.1016/j.jaac.2012.02.018; Singer HS, 2008, J NEUROIMMUNOL, V194, P165, DOI 10.1016/j.jneuroim.2007.11.004; Singer HS, 2009, J NEUROIMMUNOL, V211, P39, DOI 10.1016/j.jneuroim.2009.03.011; SPARROW SS, 1984, APPL RES MENT RETARD, V5, P219, DOI 10.1016/S0270-3092(84)80003-X; Spiker D, 2001, J AUTISM DEV DISORD, V31, P449, DOI 10.1023/A:1012217807469; Szatmari P, 1999, J PSYCHIATR NEUROSCI, V24, P159; Szatmari P, 1998, J AUTISM DEV DISORD, V28, P351, DOI 10.1023/A:1026096203946; Turner T, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026418; VOLKMAR FR, 1993, J AUTISM DEV DISORD, V23, P579, DOI 10.1007/BF01046103; WARREN RP, 1990, J AM ACAD CHILD PSY, V29, P873, DOI 10.1097/00004583-199011000-00005; Weaver ICG, 2004, NAT NEUROSCI, V7, P847, DOI 10.1038/nn1276; Wolff GL, 1998, FASEB J, V12, P949, DOI 10.1096/fasebj.12.11.949; Wu SP, 2005, BIOL PSYCHIAT, V58, P74, DOI 10.1016/j.biopsych.2005.03.013; Ylisaukko-oja T, 2006, ANN NEUROL, V59, P145, DOI 10.1002/ana.20722; Zimmerman AW, 2007, BRAIN BEHAV IMMUN, V21, P351, DOI 10.1016/j.bbi.2006.08.005	70	12	12	2	39	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 30	2012	7	11							e51049	10.1371/journal.pone.0051049	http://dx.doi.org/10.1371/journal.pone.0051049			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	054WM	23226454	Green Published, gold, Green Submitted			2022-12-27	WOS:000312376100265
J	Moss, TP; Rosser, BA				Moss, Timothy P.; Rosser, Benjamin A.			The Moderated Relationship of Appearance Valence on Appearance Self Consciousness: Development and Testing of New Measures of Appearance Schema Components	PLOS ONE			English	Article							MEASURE INDIVIDUAL-RESPONSES; BODY-IMAGE; DERRIFORD APPEARANCE; JAMESIAN MODEL; INVESTMENT; DISFIGUREMENT; INFORMATION; ESTEEM; SCALE	This paper describes the creation and psychometric properties of two independent measures of aspects of appearance schematicity - appearance salience and valence, assessed by the CARSAL and CARVAL, and their relation to appearance self-consciousness. Five hundred and ninety two participants provided data in a web based task. The results demonstrate the sound psychometric properties of both scales. This was demonstrated by good item total characteristics, good internal reliability of each scale, and the independence of the two scales shown through principal components analysis. Furthermore, the scales show independent and moderated relationships with valid measures of appearance related psychosocial distress. Negatively valenced appearance information was associated with increased appearance self-consciousness. More crucially, the impact of negative valence on appearance self-consciousness was exacerbated by the moderating effect increased salience of appearance.	[Moss, Timothy P.] Univ W England, Fac Hlth & Life Sci, Ctr Appearance Res, Bristol BS16 1QY, Avon, England; [Rosser, Benjamin A.] Univ Exeter, Coll Life & Environm Sci, Exeter, Devon, England	University of West England; University of Exeter	Moss, TP (corresponding author), Univ W England, Fac Hlth & Life Sci, Ctr Appearance Res, Bristol BS16 1QY, Avon, England.	tim.moss@uwe.ac.uk	Moss, Timothy/A-3501-2014	Moss, Timothy/0000-0003-0543-6228	UK academic contract; University of the West of England (Bristol), UK; University of the West of England	UK academic contract; University of the West of England (Bristol), UK; University of the West of England	For Dr. Moss, this work was carried out outside any specific funding or grant, but completed during the allowance of time for "scholarly activity" within a standard UK academic contract. Specifically, therefore, the funder is the University of the West of England (Bristol), UK. Dr. Rosser assisted with this work alongside his PhD studies, also funded by the University of the West of England, though this study was not part of his PhD. He has since collaborated on manuscript preparation and analysis as personal unfunded research during subsequent work at the University of Bath, and now at the University of Exeter (in clinical psychology training). It is therefore very true to say that the funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altabe M, 1996, COGNITIVE THER RES, V20, P171, DOI 10.1007/BF02228033; Carr T, 2005, BRIT J HEALTH PSYCH, V10, P285, DOI 10.1348/135910705X27613; Carr T, 2000, BRIT J HEALTH PSYCH, V5, P201, DOI 10.1348/135910700168865; Cash T.F., 2000, USERS MANUALS MULTID; Cash TF, 2005, CLIN PSYCHOL-SCI PR, V12, P438, DOI 10.1093/clipsy/bpi055; Cash TF, 2004, INT J EAT DISORDER, V35, P305, DOI 10.1002/eat.10264; Comfrey AL, 1992, 1 COURSE FACTOR ANAL, DOI DOI 10.4324/9781315827506; Fredrickson BL, 2011, PSYCHOL WOMEN QUART, V35, P689, DOI 10.1177/0361684311426690; Grogan S, 1998, BODY IMAGE UNDERSTAN; Hargreaves D, 2003, J YOUTH ADOLESCENCE, V32, P367, DOI 10.1023/A:1024974015581; Hayes SC, 2003, ACCEPTANCE COMMITMEN; Jose P. E., 2008, MODGRAPH I PROGRAMME; Kleve L, 2002, J EVAL CLIN PRACT, V8, P387, DOI 10.1046/j.1365-2753.2002.00348.x; MARKUS H, 1987, ANNU REV PSYCHOL, V38, P299, DOI 10.1146/annurev.ps.38.020187.001503; MARKUS H, 1987, J APPL SOC PSYCHOL, V17, P50, DOI 10.1111/j.1559-1816.1987.tb00292.x; MARKUS H, 1977, J PERS SOC PSYCHOL, V35, P63, DOI 10.1037/0022-3514.35.2.63; MARSH HW, 1995, J PERS SOC PSYCHOL, V69, P1151, DOI 10.1037/0022-3514.69.6.1151; Moss T, 2004, PSYCHOL HEALTH, V19, P737, DOI 10.1080/08870440410001722967; Moss Timothy P, 2005, Body Image, V2, P151, DOI 10.1016/j.bodyim.2005.03.004; PELHAM BW, 1995, J PERS SOC PSYCHOL, V69, P1141, DOI 10.1037/0022-3514.69.6.1141; Rumsey Nichola, 2004, Body Image, V1, P83, DOI 10.1016/S1740-1445(03)00005-6; SEDIKIDES C, 1995, J PERS SOC PSYCHOL, V69, P759, DOI 10.1037/0022-3514.69.4.759; Smith MA, 2001, CLIN PSYCHOL REV, V21, P129, DOI 10.1016/S0272-7358(99)00043-4; Streiner DL, 2015, HLTH MEASUREMENT SCA, DOI [10.1891/1521-0987.17.3.150, DOI 10.1891/1521-0987.17.3.150]; WATSON D, 1988, J PERS SOC PSYCHOL, V54, P1063, DOI 10.1037/0022-3514.54.6.1063	25	15	16	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 30	2012	7	11							e50605	10.1371/journal.pone.0050605	http://dx.doi.org/10.1371/journal.pone.0050605			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	054WM	23226326	Green Published, gold			2022-12-27	WOS:000312376100138
J	Nozaki, H; Yang, Y; Maruyama, S; Suzaki, T				Nozaki, Hisayoshi; Yang, Yi; Maruyama, Shinichiro; Suzaki, Toshinobu			A Case Study for Effects of Operational Taxonomic Units from Intracellular Endoparasites and Ciliates on the Eukaryotic Phylogeny: Phylogenetic Position of the Haptophyta in Analyses of Multiple Slowly Evolving Genes	PLOS ONE			English	Article							RED ALGAE; EVOLUTION; ORIGIN; HYPOTHESIS; SUPPORT	Recent multigene phylogenetic analyses have contributed much to our understanding of eukaryotic phylogeny. However, the phylogenetic positions of various lineages within the eukaryotes have remained unresolved or in conflict between different phylogenetic studies. These phylogenetic ambiguities might have resulted from mixtures or integration from various factors including limited taxon sampling, missing data in the alignment, saturations of rapidly evolving genes, mixed analyses of short- and long-branched operational taxonomic units (OTUs), intracellular endoparasite and ciliate OTUs with unusual substitution etc. In order to evaluate the effects from intracellular endoparasite and ciliate OTUs co-analyzed on the eukaryotic phylogeny and simplify the results, we here used two different sets of data matrices of multiple slowly evolving genes with small amounts of missing data and examined the phylogenetic position of the secondary photosynthetic chromalveolates Haptophyta, one of the most abundant groups of oceanic phytoplankton and significant primary producers. In both sets, a robust sister relationship between Haptophyta and SAR (stramenopiles, alveolates, rhizarians, or SA [stramenopiles and alveolates]) was resolved when intracellular endoparasite/ciliate OTUs were excluded, but not in their presence. Based on comparisons of character optimizations on a fixed tree (with a clade composed of haptophytes and SAR or SA), disruption of the monophyly between haptophytes and SAR (or SA) in the presence of intracellular endoparasite/ciliate OTUs can be considered to be a result of multiple evolutionary reversals of character positions that supported the synapomorphy of the haptophyte and SAR (or SA) clade in the absence of intracellular endoparasite/ciliate OTUs. Citation: Nozaki H, Yang Y, Maruyama S, Suzaki T (2012) A Case Study for Effects of Operational Taxonomic Units from Intracellular Endoparasites and Ciliates on the Eukaryotic Phylogeny: Phylogenetic Position of the Haptophyta in Analyses of Multiple Slowly Evolving Genes. PLoS ONE 7(11): e50827. doi: 10.1371/journal.pone.0050827	[Nozaki, Hisayoshi; Yang, Yi] Univ Tokyo, Grad Sch Sci, Dept Biol Sci, Tokyo 113, Japan; [Maruyama, Shinichiro] Dalhousie Univ, Dept Biochem & Mol Biol, Halifax, NS, Canada; [Suzaki, Toshinobu] Kobe Univ, Grad Sch Sci, Dept Biol, Kobe, Hyogo 657, Japan	University of Tokyo; Dalhousie University; Kobe University	Nozaki, H (corresponding author), Univ Tokyo, Grad Sch Sci, Dept Biol Sci, Tokyo 113, Japan.	nozaki@biol.s.u-tokyo.ac.jp	Maruyama, Shinichiro/AAO-4764-2021; NOZAKI, HISAYOSHI/G-4926-2014	Nozaki, Hisayoshi/0000-0002-9308-4498	MEXT/JSPS KAKENHI [24112707, 24657045, 23-528]	MEXT/JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by Grants-in-Aid for Challenging Exploratory Research (No. 24112707 to HN), Scientific Research (A) (No. 24657045 to HN) and JSPS Postdoctoral Fellowships for Research Abroad (No. 23-528 to SM) from MEXT/JSPS KAKENHI (www.jsps.go.jp/english/e-grants/index.html). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Archibald JM, 2009, CURR BIOL, V19, pR81, DOI 10.1016/j.cub.2008.11.067; Baldauf SL, 2000, SCIENCE, V290, P972, DOI 10.1126/science.290.5493.972; BRUNK CF, 1986, INT REV CYTOL, V99, P49; Burki F, 2012, P ROY SOC B-BIOL SCI, V279, P2246, DOI 10.1098/rspb.2011.2301; FELSENSTEIN J, 1983, ANNU REV ECOL SYST, V14, P313, DOI 10.1146/annurev.es.14.110183.001525; FELSENSTEIN J, 1985, EVOLUTION, V39, P783, DOI 10.1111/j.1558-5646.1985.tb00420.x; Field CB, 1998, SCIENCE, V281, P237, DOI 10.1126/science.281.5374.237; Green BR, 2011, PHOTOSYNTH RES, V107, P103, DOI 10.1007/s11120-010-9584-2; Gribaldo S, 2002, THEOR POPUL BIOL, V61, P391, DOI 10.1006/tpbi.2002.1593; Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520; Hampl V, 2009, P NATL ACAD SCI USA, V106, P3859, DOI 10.1073/pnas.0807880106; Itoh T, 2002, P NATL ACAD SCI USA, V99, P12944, DOI 10.1073/pnas.192449699; Karol KG, 2001, SCIENCE, V294, P2351, DOI 10.1126/science.1065156; Laurin-Lemay S, 2012, CURR BIOL, V22, pR593, DOI 10.1016/j.cub.2012.06.013; Lozupone CA, 2001, CURR BIOL, V11, P65, DOI 10.1016/S0960-9822(01)00028-8; Maddison D. R., 2005, MACCLADE 4 08A ANAL, DOI [DOI 10.1046/J.1420-9101.1996.9020153.X, DOI 10.1007/s13592-012-0141-1]; Madsen O, 2001, NATURE, V409, P610, DOI 10.1038/35054544; Maruyama S, 2011, BMC EVOL BIOL, V11, DOI 10.1186/1471-2148-11-105; Moreira D, 2000, NATURE, V405, P69, DOI 10.1038/35011054; Murphy WJ, 2001, NATURE, V409, P614, DOI 10.1038/35054550; Nei M, 1996, ANNU REV GENET, V30, P371, DOI 10.1146/annurev.genet.30.1.371; Nei M., 2000, MOL EVOLUTION PHYLOG; Nozaki H, 2000, MOL PHYLOGENET EVOL, V17, P256, DOI 10.1006/mpev.2000.0831; Nozaki H, 2003, J MOL EVOL, V56, P485, DOI 10.1007/s00239-002-2419-9; Nozaki H, 2007, MOL BIOL EVOL, V24, P1592, DOI 10.1093/molbev/msm091; Nozaki H, 2009, MOL PHYLOGENET EVOL, V53, P872, DOI 10.1016/j.ympev.2009.08.015; Parfrey LW, 2010, SYST BIOL, V59, P518, DOI 10.1093/sysbio/syq037; Patron NJ, 2007, CURR BIOL, V17, P887, DOI 10.1016/j.cub.2007.03.069; Philippe H, 2004, MOL BIOL EVOL, V21, P1740, DOI 10.1093/molbev/msh182; Philippe H, 1998, CURR OPIN GENET DEV, V8, P616, DOI 10.1016/S0959-437X(98)80028-2; Philippe H, 2011, BMC BIOL, V9, DOI 10.1186/1741-7007-9-91; Qiu YL, 1999, NATURE, V402, P404, DOI 10.1038/46536; Stamatakis A, 2005, BIOINFORMATICS, V21, P456, DOI 10.1093/bioinformatics/bti191; Stiller JW, 1998, P NATL ACAD SCI USA, V95, P11769, DOI 10.1073/pnas.95.20.11769; Swofford D.L, 1998, PAUP 4 0 PHYLOGENETI; Thomsen Helge A., 1994, Systematics Association Special Volume Series, V51, P187; VOSSBRINCK CR, 1987, NATURE, V326, P411, DOI 10.1038/326411a0; Whelan S, 2001, MOL BIOL EVOL, V18, P691, DOI 10.1093/oxfordjournals.molbev.a003851	38	2	2	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 30	2012	7	11							e50827	10.1371/journal.pone.0050827	http://dx.doi.org/10.1371/journal.pone.0050827			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	054WM	23226396	Green Published, Green Submitted, gold			2022-12-27	WOS:000312376100207
J	Correia, M; Neves-Petersen, MT; Jeppesen, PB; Gregersen, S; Petersen, SB				Correia, Manuel; Neves-Petersen, Maria Teresa; Jeppesen, Per Bendix; Gregersen, Soren; Petersen, Steffen B.			UV-Light Exposure of Insulin: Pharmaceutical Implications upon Covalent Insulin Dityrosine Dimerization and Disulphide Bond Photolysis	PLOS ONE			English	Article							COMPACT FLUORESCENT LAMPS; EXCITED-STATE CHEMISTRY; AROMATIC-AMINO-ACIDS; CROSS-LINKS; DECAY KINETICS; OXIDATION; TYROSINE; PROTEINS; IMMOBILIZATION; PEROXIDASE	In this work we report the effects of continuous UV-light (276 nm, similar to 2.20 W.m(-2)) excitation of human insulin on its absorption and fluorescence properties, structure and functionality. Continuous UV-excitation of the peptide hormone in solution leads to the progressive formation of tyrosine photo-product dityrosine, formed upon tyrosine radical cross-linkage. Absorbance, fluorescence emission and excitation data confirm dityrosine formation, leading to covalent insulin dimerization. Furthermore, UV-excitation of insulin induces disulphide bridge breakage. Near- and far-UV-CD spectroscopy shows that UV-excitation of insulin induces secondary and tertiary structure losses. In native insulin, the A and B chains are held together by two disulphide bridges. Disruption of either of these bonds is likely to affect insulin's structure. The UV-light induced structural changes impair its antibody binding capability and in vitro hormonal function. After 1.5 and 3.5 h of 276 nm excitation there is a 33.7% and 62.1% decrease in concentration of insulin recognized by guinea pig anti-insulin antibodies, respectively. Glucose uptake by human skeletal muscle cells decreases 61.7% when the cells are incubated with pre UV-illuminated insulin during 1.5 h. The observations presented in this work highlight the importance of protecting insulin and other drugs from UV-light exposure, which is of outmost relevance to the pharmaceutical industry. Several drug formulations containing insulin in hexameric, dimeric and monomeric forms can be exposed to natural and artificial UV-light during their production, packaging, storage or administration phases. We can estimate that direct long-term exposure of insulin to sunlight and common light sources for indoors lighting and UV-sterilization in industries can be sufficient to induce irreversible changes to human insulin structure. Routine fluorescence and absorption measurements in laboratory experiments may also induce changes in protein structure. Structural damage includes insulin dimerization via dityrosine cross-linking or disulphide bond disruption, which affects the hormone's structure and bioactivity.	[Neves-Petersen, Maria Teresa; Petersen, Steffen B.] Int Iberian Nanotechnol Lab INL, Braga, Portugal; [Correia, Manuel] Aalborg Univ, Dept Phys & Nanotechnol, Aalborg, Denmark; [Neves-Petersen, Maria Teresa] Aalborg Univ, Dept Biotechnol Chem & Environm Sci, NanoBiotechnol Grp, Aalborg, Denmark; [Jeppesen, Per Bendix; Gregersen, Soren] Aarhus Univ Hosp, Aarhus Sygehus THG, Dept Med & Endocrinol MEA, DK-8000 Aarhus C, Denmark; [Petersen, Steffen B.] Aalborg Univ, Dept Hlth Sci & Technol, NanoBiotechnol Grp, Aalborg, Denmark; [Petersen, Steffen B.] SUNY Buffalo, Inst Lasers Photon & Biophoton, Buffalo, NY 14260 USA	International Iberian Nanotechnology Laboratory; Aalborg University; Aalborg University; Aarhus University; Aalborg University; State University of New York (SUNY) System; State University of New York (SUNY) Buffalo	Neves-Petersen, MT (corresponding author), Int Iberian Nanotechnol Lab INL, Braga, Portugal.	teresa.petersen@inl.int	INL, Citations/K-3436-2015; Petersen, Steffen b/E-8727-2015	INL, Citations/0000-0002-3745-5100; Petersen, Steffen b/0000-0002-0739-2751; Correia, Manuel/0000-0001-7619-2780; Neves-Petersen, Maria Teresa/0000-0003-3178-3709; Gregersen, Soren/0000-0002-1953-8631	"Fundacao para a Ciencia e Tecnologia'' (FCT) [SFRH/BD/61012/2009]; "Programa Operacional Potencial Humano'' (POPH) in the framework of "Quadro de Referencia Estrategico Nacional'' (QREN); European Social Fund ("Fundo Social Europeu'', FSE)	"Fundacao para a Ciencia e Tecnologia'' (FCT)(Portuguese Foundation for Science and Technology); "Programa Operacional Potencial Humano'' (POPH) in the framework of "Quadro de Referencia Estrategico Nacional'' (QREN); European Social Fund ("Fundo Social Europeu'', FSE)(European Social Fund (ESF))	MC acknowledges the support from "Fundacao para a Ciencia e Tecnologia'' (FCT) for the PhD grant (SFRH/BD/61012/2009) supported by "Programa Operacional Potencial Humano'' (POPH) in the framework of "Quadro de Referencia Estrategico Nacional'' (QREN) and co-financed by the European Social Fund ("Fundo Social Europeu'', FSE). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AESCHBACH R, 1976, BIOCHIM BIOPHYS ACTA, V439, P292, DOI 10.1016/0005-2795(76)90064-7; [Anonymous], [No title captured]; Antolikova E, 2011, J BIOL CHEM, V286, P36968, DOI 10.1074/jbc.M111.265249; ASTM, 2003, ANN BOOK ASTM STAND; Attri AK, 2010, BIOPHYS CHEM, V148, P28, DOI 10.1016/j.bpc.2010.02.002; BAKER EN, 1988, PHILOS T ROY SOC B, V319, P369, DOI 10.1098/rstb.1988.0058; Balasubramanian D, 2002, MOL CELL BIOCHEM, V234, P27, DOI 10.1023/A:1015927907418; Becker RHA, 2007, DIABETES TECHNOL THE, V9, P109, DOI 10.1089/dia.2006.0035; BENT DV, 1975, J AM CHEM SOC, V97, P2599, DOI 10.1021/ja00843a002; BENT DV, 1975, J AM CHEM SOC, V97, P2612, DOI 10.1021/ja00843a004; BRANGE J, 1990, DIABETES CARE, V13, P923, DOI 10.2337/diacare.13.9.923; Brange J, 1993, Pharm Biotechnol, V5, P315; Correia M, 2012, J FLUORESC, V22, P323, DOI 10.1007/s10895-011-0963-7; CREED D, 1984, PHOTOCHEM PHOTOBIOL, V39, P563; De Meyts P, 2004, BIOESSAYS, V26, P1351, DOI 10.1002/bies.20151; De Meyts P, 2008, TRENDS BIOCHEM SCI, V33, P376, DOI 10.1016/j.tibs.2008.06.003; DEREWENDA U, 1989, BRIT MED BULL, V45, P4, DOI 10.1093/oxfordjournals.bmb.a072320; DIAZ JL, 1988, CLIN CHEM, V34, P356; Dixon JM, 2005, PHOTOCHEM PHOTOBIOL, V81, P212, DOI 10.1562/2004-11-06-TSN-361.1; Dunn MF, 2005, BIOMETALS, V18, P295, DOI 10.1007/s10534-005-3685-y; Duroux M, 2007, PROTEOMICS, V7, P3491, DOI 10.1002/pmic.200700472; FUKADA H, 1982, BIOCHEMISTRY-US, V21, P1570, DOI 10.1021/bi00536a016; GIULIVI C, 1994, METHOD ENZYMOL, V233, P363; Giulivi C, 2003, AMINO ACIDS, V25, P227, DOI 10.1007/s00726-003-0013-0; GROSS AJ, 1959, J BIOL CHEM, V234, P1611; Hawe A, 2012, J PHARM SCI-US, V101, P895, DOI 10.1002/jps.22812; HEINECKE JW, 1993, J BIOL CHEM, V268, P4069; HOFFMAN MZ, 1972, J AM CHEM SOC, V94, P7950, DOI 10.1021/ja00778a002; Kerwin BA, 2007, J PHARM SCI-US, V96, P1468, DOI 10.1002/jps.20815; Khazova M, 2008, RADIAT PROT DOSIM, V131, P521, DOI 10.1093/rpd/ncn234; Klitgaard S, 2006, J FLUORESC, V16, P595, DOI 10.1007/s10895-006-0081-0; LEHRER SS, 1967, BIOCHEMISTRY-US, V6, P757, DOI 10.1021/bi00855a017; LeRoithn D, 2003, DIABETES MELLITUS FU, P1200; Li AJ, 1998, PROTEINS, V32, P111, DOI 10.1002/(SICI)1097-0134(19980701)32:1<111::AID-PROT12>3.0.CO;2-H; Malencik DA, 2003, AMINO ACIDS, V25, P233, DOI 10.1007/s00726-003-0014-z; Malencik DA, 1996, BIOCHEMISTRY-US, V35, P4375, DOI 10.1021/bi9526037; MALENCIK DA, 1991, BIOCHEM BIOPH RES CO, V178, P60, DOI 10.1016/0006-291X(91)91779-C; MALENCIK DA, 1987, BIOCHEMISTRY-US, V26, P695, DOI 10.1021/bi00377a006; MARKUS G, 1964, J BIOL CHEM, V239, P4163; MASON HS, 1948, J BIOL CHEM, V172, P83; Mauro M, 2007, J MOL BIOL, V366, P258, DOI 10.1016/j.jmb.2006.11.008; Mayer JP, 2007, BIOPOLYMERS, V88, P687, DOI 10.1002/bip.20734; McCormick ML, 1998, J BIOL CHEM, V273, P32030, DOI 10.1074/jbc.273.48.32030; Melmed S, 2005, ENDOCRINOLOGY BASIC, V2, DOI [10.1007/978-1-59259-829-8, DOI 10.1007/978-1-59259-829-8]; Mozziconacci O, 2008, J PHYS CHEM B, V112, P15921, DOI 10.1021/jp8066519; Neves-Petersen MT, 2009, BIOPHYS J, V97, P211, DOI 10.1016/j.bpj.2009.01.065; Neves-Petersen MT, 2006, PROTEIN SCI, V15, P343, DOI 10.1110/ps.051885306; Neves-Petersen MT, 2002, PROTEIN SCI, V11, P588, DOI 10.1110/ps.06002; Nuzum-Keim AD, 2009, LUPUS, V18, P556, DOI 10.1177/0961203309103052; Olivares-Corichi IM, 2005, FRONT BIOSCI-LANDMRK, V10, P3127, DOI 10.2741/1769; Parracino A, 2011, BIOTECHNOL BIOENG, V108, P999, DOI 10.1002/bit.23015; Parracino A, 2010, PROTEIN SCI, V19, P1751, DOI 10.1002/pro.461; PEKAR AH, 1972, BIOCHEMISTRY-US, V11, P4013, DOI 10.1021/bi00772a001; Potter KN, 2000, DIABETES-METAB RES, V16, P338, DOI 10.1002/1520-7560(2000)9999:9999<::AID-DMRR145>3.0.CO;2-L; Rathore N, 2008, BIOTECHNOL PROGR, V24, P504, DOI 10.1021/bp070462h; Riener CK, 2002, ANAL BIOANAL CHEM, V373, P266, DOI 10.1007/s00216-002-1347-2; Sayre RM, 2004, PHOTOCHEM PHOTOBIOL, V80, P47, DOI 10.1562/2004-02-03-RA-074.1; Sen Lights Corporation (n.d.) Low-Pressure Mercury Lamps, LOW PRESS MERC LAMPS; Sharma P, 2009, MAPAN-J METROL SOC I, V24, P183, DOI 10.1007/s12647-009-0022-x; Sionkowska A, 2006, J PHOTOCH PHOTOBIO B, V85, P79, DOI 10.1016/j.jphotobiol.2006.05.005; Skovsen E, 2009, PROTEOMICS, V9, P3945, DOI 10.1002/pmic.200800960; STEINER DF, 1985, ANNU REV GENET, V19, P463, DOI 10.1146/annurev.ge.19.120185.002335; Terryn H, 2006, PHARM RES-DORDR, V23, P2141, DOI 10.1007/s11095-006-9053-y; TEW D, 1988, J BIOL CHEM, V263, P17880; VERWEIJ H, 1982, BIOCHIM BIOPHYS ACTA, V701, P180, DOI 10.1016/0167-4838(82)90111-X; Zhang MG, 2005, ANAL CHEM, V77, P6396, DOI 10.1021/ac0508752; Zoete V, 2004, J MOL BIOL, V342, P913, DOI 10.1016/j.jmb.2004.07.033	67	79	79	2	74	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 5	2012	7	12							e50733	10.1371/journal.pone.0050733	http://dx.doi.org/10.1371/journal.pone.0050733			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	057TZ	23227203	Green Published, Green Submitted, gold			2022-12-27	WOS:000312588200062
J	Fan, Y; Li, CM; Guo, JH; Hu, G; Wu, GY				Fan, Yi; Li, Chunman; Guo, Jianhui; Hu, Gang; Wu, Guangyu			A Single Lys Residue on the First Intracellular Loop Modulates the Endoplasmic Reticulum Export and Cell-Surface Expression of alpha(2A)-Adrenergic Receptor	PLOS ONE			English	Article							PROTEIN-COUPLED RECEPTORS; ANGIOTENSIN-II RECEPTORS; ALPHA(2)-ADRENERGIC RECEPTORS; ANTEROGRADE TRAFFICKING; ADRENERGIC-RECEPTOR; SEROTONIN RECEPTORS; OPIOID RECEPTOR; TRANSPORT; MUTANT; MOTIF	Export from the endoplasmic reticulum (ER) represents an initial step in intracellular trafficking of G protein-coupled receptors (GPCRs). However, the underlying molecular mechanisms remain poorly understood. We have previously demonstrated that a highly conserved Leu residue on the first intracellular loop (ICL1) is required for exit of several GPCRs from the ER. Here we found that, in addition to Leu64 residue in the ICL1, the neighboring positively charged residue Lys65also modulates the cell-surface transport of alpha(2A)-adrenergic receptor (alpha(2A)-AR). Mutation of Lys65 to Ala, Glu and Gln significantly attenuated, whereas mutation of Lys65 to Arg strongly augmented alpha(2A)-AR expression at the cell surface. Consistent with the effects on the cell-surface expression of alpha(2A)-AR, mutation of Lys65 to Ala and Arg produced opposing effects on alpha(2A)-AR-mediated ERK1/2 activation. Furthermore, confocal microscopy revealed that the alpha(2A)-AR mutant K65A displayed a strong intracellular expression pattern and was extensively co-localized with the ER marker DsRed2-ER, suggestive of ER accumulation. These data provide the first evidence indicating an important function for a single Lys residue on the ICL1 in the ER export and cell-surface expression of alpha(2A)-AR. These data also suggest that the ICL1 may possess multiple signals that control the cell-surface targeting of GPCRs via distinct mechanisms. Citation: Fan Y, Li C, Guo J, Hu G, Wu G (2012) A Single Lys Residue on the First Intracellular Loop Modulates the Endoplasmic Reticulum Export and Cell-Surface Expression of alpha(2A)-Adrenergic Receptor. PLoS ONE 7(12): e50416. doi:10.1371/journal.pone.0050416	[Fan, Yi; Li, Chunman; Guo, Jianhui; Wu, Guangyu] Georgia Hlth Sci Univ, Dept Pharmacol & Toxicol, Augusta, GA USA; [Hu, Gang] Nanjing Med Univ, Dept Pharmacol, Nanjing, Jiangsu, Peoples R China	University System of Georgia; Augusta University; Nanjing Medical University	Wu, GY (corresponding author), Georgia Hlth Sci Univ, Dept Pharmacol & Toxicol, Augusta, GA USA.	guwu@georgiahealth.edu	Fan, Yi/Q-9252-2018; Fan, Yi/AAQ-1874-2021; Guo, Jianhui/AAJ-6220-2020	Fan, Yi/0000-0003-1783-3220; Fan, Yi/0000-0003-1783-3220; 	National Institutes of Health grant [R01GM076167]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM076167] Funding Source: NIH RePORTER	National Institutes of Health grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by the National Institutes of Health grant R01GM076167. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bermak JC, 2001, NAT CELL BIOL, V3, P492, DOI 10.1038/35074561; Bolte S, 2006, J MICROSC-OXFORD, V224, P213, DOI 10.1111/j.1365-2818.2006.01706.x; Carrel D, 2006, J CELL SCI, V119, P4276, DOI 10.1242/jcs.03189; Chen CG, 2011, J BIOL CHEM, V286, P15106, DOI 10.1074/jbc.M111.230896; COLLEY NJ, 1991, CELL, V67, P255, DOI 10.1016/0092-8674(91)90177-Z; Conn PM, 2007, PHARMACOL REV, V59, P225, DOI 10.1124/pr.59.3.2; Daunt DA, 1997, MOL PHARMACOL, V51, P711, DOI 10.1124/mol.51.5.711; Dong CM, 2007, CELL SIGNAL, V19, P2388, DOI 10.1016/j.cellsig.2007.07.017; Dong CM, 2007, BBA-BIOMEMBRANES, V1768, P853, DOI 10.1016/j.bbamem.2006.09.008; Dong CM, 2006, J BIOL CHEM, V281, P38543, DOI 10.1074/jbc.M605734200; Dong CM, 2012, TRAFFIC, V13, P857, DOI 10.1111/j.1600-0854.2012.01351.x; Dong CM, 2011, J BIOL CHEM, V286, P43361, DOI 10.1074/jbc.M111.267286; Dong CM, 2010, J BIOL CHEM, V285, P20369, DOI 10.1074/jbc.M109.081521; Dong CM, 2010, J PHARMACOL EXP THER, V333, P174, DOI 10.1124/jpet.109.161489; Donnellan PD, 2011, BBA-BIOMEMBRANES, V1808, P1202, DOI 10.1016/j.bbamem.2011.01.003; Duvernay MT, 2011, J BIOL CHEM, V286, P14080, DOI 10.1074/jbc.M111.222323; Duvernay MT, 2009, TRAFFIC, V10, P552, DOI 10.1111/j.1600-0854.2009.00890.x; Duvernay MT, 2009, MOL PHARMACOL, V75, P751, DOI 10.1124/mol.108.051623; Duvernay MT, 2004, J BIOL CHEM, V279, P30741, DOI 10.1074/jbc.M313881200; Filipeanu CM, 2006, J BIOL CHEM, V281, P11097, DOI 10.1074/jbc.M511460200; Ge X, 2009, MOL PHARMACOL, V75, P1307, DOI 10.1124/mol.108.054064; Guo Y, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0029204; Hammad MM, 2012, BIOL CHEM, V393, P541, DOI 10.1515/hsz-2011-0284; Hanyaloglu AC, 2008, ANNU REV PHARMACOL, V48, P537, DOI 10.1146/annurev.pharmtox.48.113006.094830; Hirota N, 2010, J BIOL CHEM, V285, P5931, DOI 10.1074/jbc.M109.066282; Janovick JA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022784; Kallal L, 2000, TRENDS PHARMACOL SCI, V21, P175, DOI 10.1016/S0165-6147(00)01477-2; Kobilka BK, 2011, TRENDS PHARMACOL SCI, V32, P213, DOI 10.1016/j.tips.2011.02.005; Lan TH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017361; Lu RJ, 2009, J BIOL CHEM, V284, P13233, DOI 10.1074/jbc.M807535200; McLatchie LM, 1998, NATURE, V393, P333, DOI 10.1038/30666; Moore CAC, 2007, ANNU REV PHYSIOL, V69, P451, DOI 10.1146/annurev.physiol.69.022405.154712; Morello JP, 2001, ANNU REV PHYSIOL, V63, P607, DOI 10.1146/annurev.physiol.63.1.607; Petaja-Repo UE, 2000, J BIOL CHEM, V275, P13727, DOI 10.1074/jbc.275.18.13727; Petaja-Repo UE, 2001, J BIOL CHEM, V276, P4416, DOI 10.1074/jbc.M007151200; Pierce KL, 2002, NAT REV MOL CELL BIO, V3, P639, DOI 10.1038/nrm908; Qin K, 2011, NAT CHEM BIOL, V7, P740, DOI [10.1038/nchembio.642, 10.1038/NCHEMBIO.642]; Robert J, 2005, J BIOL CHEM, V280, P42198, DOI 10.1074/jbc.M510180200; Sanchez-Laorden BL, 2009, J CELL PHYSIOL, V220, P640, DOI 10.1002/jcp.21804; Sawyer GW, 2010, J PHARMACOL EXP THER, V332, P76, DOI 10.1124/jpet.109.160986; Schulein R, 1998, MOL PHARMACOL, V54, P525, DOI 10.1124/mol.54.3.525; Tai AW, 1999, CELL, V97, P877, DOI 10.1016/S0092-8674(00)80800-4; Ulloa-Aguirre A, 2004, TRAFFIC, V5, P821, DOI 10.1111/j.1600-0854.2004.00232.x; Wang GS, 2012, TRENDS PHARMACOL SCI, V33, P28, DOI 10.1016/j.tips.2011.09.002; Wess J, 1997, FASEB J, V11, P346, DOI 10.1096/fasebj.11.5.9141501; Wu GY, 1997, J BIOL CHEM, V272, P17836, DOI 10.1074/jbc.272.28.17836; Wu GY, 2000, J BIOL CHEM, V275, P9026, DOI 10.1074/jbc.275.12.9026; Wu GY, 2003, J BIOL CHEM, V278, P47062, DOI 10.1074/jbc.M305707200; Xia ZQ, 2003, J BIOL CHEM, V278, P21901, DOI 10.1074/jbc.M301905200; Zhang XP, 2011, J BIOL CHEM, V286, P20525, DOI 10.1074/jbc.M111.222034; Zhou FG, 2006, CELL SIGNAL, V18, P318, DOI 10.1016/j.cellsig.2005.05.014	51	6	6	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 5	2012	7	12							e50416	10.1371/journal.pone.0050416	http://dx.doi.org/10.1371/journal.pone.0050416			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	057TZ	23227171	gold, Green Published			2022-12-27	WOS:000312588200032
J	Song, Y; Xu, JL; Li, YF; Jia, CS; Ma, XW; Zhang, L; Xie, XJ; Zhang, Y; Gao, X; Zhang, YY; Zhu, DH				Song, Yao; Xu, Jialin; Li, Yanfeng; Jia, Chunshi; Ma, Xiaowei; Zhang, Lei; Xie, Xiaojie; Zhang, Yong; Gao, Xiang; Zhang, Youyi; Zhu, Dahai			Cardiac Ankyrin Repeat Protein Attenuates Cardiac Hypertrophy by Inhibition of ERK1/2 and TGF-beta Signaling Pathways	PLOS ONE			English	Article							LEFT-VENTRICULAR HYPERTROPHY; PRESSURE-OVERLOAD; DILATED CARDIOMYOPATHY; REGULATED EXPRESSION; INDUCED APOPTOSIS; GENE-EXPRESSION; HEART-FAILURE; ANKRD1; CELLS; TITIN	Aims: It has been reported that cardiac ankyrin repeat protein is associated with heart development and diseases. This study is aimed to investigate the role of CARP in heart hypertrophy in vivo. Methods and Results: We generated a cardiac-specific CARP-overexpressing transgenic mouse. Although such animals did not display any overt physiological abnormality, they developed less cardiac hypertrophy in response to pressure overload than did wildtype mice, as indicated by heart weight/body weight ratios, echocardiographic and histological analyses, and expression of hypertrophic markers. These mice also exhibited less cardiac hypertrophy after infusion of isoproterenol. To gain a molecular insight into how CARP attenuated heart hypertrophy, we examined expression of the mitogen-activated protein kinase cascade and found that the concentrations of phosphorylated ERK1/2 and MEK were markedly reduced in the hearts of transgenic mice subjected to pressure overload. In addition, the expressions of TGF-beta and phosphorylated Smad3 were significantly downregulated in the hearts of CARP Tg mice in response to pressure overload. Furthermore, addition of human TGF-beta 1 could reverse the inhibitory effect of CARP on the hypertrophic response induced by phenylephrine in cardiomyocytes. It was also evidenced that the inhibitory effect of CARP on cardiac hypertrophy was not attributed to apoptosis. Conclusion: CARP attenuates cardiac hypertrophy, in which the ERK and TGF-beta pathways may be involved. Our findings highlight the significance of CARP as an anti-hypertrophic factor in therapy of cardiac hypertrophy. Citation: Song Y, Xu J, Li Y, Jia C, Ma X, et al. (2012) Cardiac Ankyrin Repeat Protein Attenuates Cardiac Hypertrophy by Inhibition of ERK1/2 and TGF-b Signaling Pathways. PLoS ONE 7(12): e50436. doi:10.1371/journal.pone.0050436	[Xu, Jialin; Li, Yanfeng; Jia, Chunshi; Zhang, Lei; Zhang, Yong; Zhu, Dahai] Chinese Acad Med Sci, Inst Basic Med Sci, Dept Biochem & Mol Biol, Beijing 100730, Peoples R China; [Xu, Jialin; Li, Yanfeng; Jia, Chunshi; Zhang, Lei; Zhang, Yong; Zhu, Dahai] Peking Union Med Coll, Beijing 100021, Peoples R China; [Song, Yao; Ma, Xiaowei; Zhang, Youyi] Peking Univ, Hosp 3, Key Lab Cardiovasc Mol Biol & Regulatory Peptides, Inst Vasc Med,Minist Hlth, Beijing 100871, Peoples R China; [Song, Yao; Ma, Xiaowei; Zhang, Youyi] Minist Educ, Key Lab Mol Cardiovasc Sci, Beijing, Peoples R China; [Gao, Xiang] Nanjing Univ, Natl Resource Ctr Mutant Mice Model Anim Res, Nanjing, Jiangsu, Peoples R China; [Xie, Xiaojie] Zhejiang Univ, Coll Med, Affiliated Hosp 2, Dept Cardiol, Hangzhou 310003, Zhejiang, Peoples R China	Chinese Academy of Medical Sciences - Peking Union Medical College; Institute of Basic Medical Sciences - CAMS; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College; Peking University; Nanjing University; Zhejiang University	Gao, X (corresponding author), Nanjing Univ, Natl Resource Ctr Mutant Mice Model Anim Res, Nanjing, Jiangsu, Peoples R China.	gaoxiang@nju.edu.cn; zhangyy@bjmu.edu.cn; dhzhu@pumc.edu.cn	li, yan/GTI-4638-2022; xu, jia/GSD-6347-2022; Zhu, Dahai/ABA-5315-2021; Zhang, Yong/AAH-6147-2021		National Basic Research Program of China [2007CB946903, 2005CB522405, 2005CB522507, 2011CB503903]; National Natural Science Foundation of China [30721063, 30971161, 81030001]; Chinese National Programs for High Technology Research and Development [2007AA02Z109]; Project for International Cooperation [30910103902]; Project Exchanges NSFC [30910103902]	National Basic Research Program of China(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Chinese National Programs for High Technology Research and Development(National High Technology Research and Development Program of China); Project for International Cooperation; Project Exchanges NSFC	This work was supported by the National Basic Research Program of China (http://www.973.gov.cn/English/Index.aspx) (grant nos. 2007CB946903, 2005CB522405, 2005CB522507, and 2011CB503903); the National Natural Science Foundation of China (http://www.nsfc.gov.cn/e_nsfc/desktop/zn/0101.htm) (grant nos. 30721063, 30971161 and 81030001); the Chinese National Programs for High Technology Research and Development (http://www.most.gov.cn/eng/programmes1/200610/t20061009_36225.htm) (grant no. 2007AA02Z109); and the Projects for International Cooperation and Exchanges NSFC (http://www.nsfc.gov.cn/e_nsfc/desktop/zn/0110.htm) (grant no. 30910103902). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agrawal R, 2010, PHARMACOL RES, V61, P269, DOI 10.1016/j.phrs.2009.11.012; Aihara Y, 1999, BBA-GENE STRUCT EXPR, V1447, P318, DOI 10.1016/S0167-4781(99)00171-2; Arber S, 1997, CELL, V88, P393, DOI 10.1016/S0092-8674(00)81878-4; Barrick CJ, 2007, AM J PHYSIOL-HEART C, V292, pH2119, DOI 10.1152/ajpheart.00816.2006; Bueno OF, 2000, EMBO J, V19, P6341, DOI 10.1093/emboj/19.23.6341; Cinquetti R, 2008, HUM MUTAT, V29, P468, DOI 10.1002/humu.20711; DAHLOF B, 1992, AM J HYPERTENS, V5, P95, DOI 10.1093/ajh/5.2.95; Esposito G, 2001, CIRCULATION, V103, P1453, DOI 10.1161/01.CIR.103.10.1453; Frey N, 2003, ANNU REV PHYSIOL, V65, P45, DOI 10.1146/annurev.physiol.65.092101.142243; Granzier HL, 2004, CIRC RES, V94, P284, DOI 10.1161/01.RES.0000117769.88862.F8; Han XJ, 2005, J BIOL CHEM, V280, P23122, DOI 10.1074/jbc.M501095200; Hardt SE, 2004, CARDIOVASC RES, V63, P500, DOI 10.1016/j.cardiores.2004.03.015; Heineke J, 2006, NAT REV MOL CELL BIO, V7, P589, DOI 10.1038/nrm1983; Jeyaseelan R, 1997, J BIOL CHEM, V272, P22800, DOI 10.1074/jbc.272.36.22800; Kotamraju S, 2000, J BIOL CHEM, V275, P33585, DOI 10.1074/jbc.M003890200; Lim HW, 2000, CIRCULATION, V101, P2431, DOI 10.1161/01.CIR.101.20.2431; Mikhailov AT, 2008, INT J DEV BIOL, V52, P811, DOI 10.1387/ijdb.082655am; Miller MK, 2004, TRENDS CELL BIOL, V14, P119, DOI 10.1016/j.tcb.2004.01.003; Moulik M, 2009, J AM COLL CARDIOL, V54, P325, DOI 10.1016/j.jacc.2009.02.076; Nagueh SF, 2004, CIRCULATION, V110, P155, DOI 10.1161/01.CIR.0000135591.37759.AF; Nakada C, 2003, LAB INVEST, V83, P711, DOI 10.1097/01.LAB.0000067484.35298.1A; Purevjav E, 2012, HUM MOL GENET, V21, P2039, DOI 10.1093/hmg/dds022; Scurr LL, 2008, CLIN CANCER RES, V14, P6924, DOI 10.1158/1078-0432.CCR-07-5189; Shi Y, 2005, AM J PATHOL, V166, P303, DOI 10.1016/S0002-9440(10)62254-7; Takeda S, 2001, J YONAGO MED ASSOC, V52, P144; Torrado M, 2004, EUR J HEART FAIL, V6, P161, DOI 10.1016/j.ejheart.2003.11.004; Wei YJ, 2009, EUR J HEART FAIL, V11, P559, DOI 10.1093/eurjhf/hfp049; Xiao H, 2010, CARDIOVASC RES, V87, P504, DOI 10.1093/cvr/cvq066; Xu Q, 2008, ENDOCRINOLOGY, V149, P476, DOI 10.1210/en.2007-1220; Yue TL, 2000, J BIOL CHEM, V275, P37895, DOI 10.1074/jbc.M007037200; Zolk O, 2002, BIOCHEM BIOPH RES CO, V293, P1377, DOI 10.1016/S0006-291X(02)00387-X	31	21	24	0	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 5	2012	7	12							e50436	10.1371/journal.pone.0050436	http://dx.doi.org/10.1371/journal.pone.0050436			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	057TZ	23227174	Green Published, Green Submitted, gold			2022-12-27	WOS:000312588200035
J	Burte, F; Brown, BJ; Orimadegun, AE; Ajetunmobi, WA; Battaglia, F; Ely, BK; Afolabi, NK; Athanasakis, D; Akinkunmi, F; Kowobari, O; Omokhodion, S; Osinusi, K; Akinbami, FO; Shokunbi, WA; Sodeinde, O; Fernandez-Reyes, D				Burte, Florence; Brown, Biobele J.; Orimadegun, Adebola E.; Ajetunmobi, Wasiu A.; Battaglia, Francesca; Ely, Barry K.; Afolabi, Nathaniel K.; Athanasakis, Dimitrios; Akinkunmi, Francis; Kowobari, Olayinka; Omokhodion, Samuel; Osinusi, Kikelomo; Akinbami, Felix O.; Shokunbi, Wuraola A.; Sodeinde, Olugbemiro; Fernandez-Reyes, Delmiro			Severe Childhood Malaria Syndromes Defined by Plasma Proteome Profiles	PLOS ONE			English	Article							AFRICAN CHILDREN; UNCOMPLICATED MALARIA; CEREBRAL MALARIA; BURDEN	Background: Cerebral malaria (CM) and severe malarial anemia (SMA) are the most serious life-threatening clinical syndromes of Plasmodium falciparum infection in childhood. Therefore it is important to understand the pathology underlying the development of CM and SMA, as opposed to uncomplicated malaria (UM). Different host responses to infection are likely to be reflected in plasma proteome-patterns that associate with clinical status and therefore provide indicators of the pathogenesis of these syndromes. Methods and Findings: Plasma and comprehensive clinical data for discovery and validation cohorts were obtained as part of a prospective case-control study of severe childhood malaria at the main tertiary hospital of the city of Ibadan, an urban and densely populated holoendemic malaria area in Nigeria. A total of 946 children participated in this study. Plasma was subjected to high-throughput proteomic profiling. Statistical pattern-recognition methods were used to find proteome-patterns that defined disease groups. Plasma proteome-patterns accurately distinguished children with CM and with SMA from those with UM, and from healthy or severely ill malaria-negative children. Conclusions: We report that an accurate definition of the major childhood malaria syndromes can be achieved using plasma proteome-patterns. Our proteomic data can be exploited to understand the pathogenesis of the different childhood severe malaria syndromes.	[Burte, Florence; Battaglia, Francesca; Ely, Barry K.; Athanasakis, Dimitrios; Sodeinde, Olugbemiro; Fernandez-Reyes, Delmiro] Natl Inst Med Res, MRC, Div Parasitol, London NW7 1AA, England; [Brown, Biobele J.; Orimadegun, Adebola E.; Ajetunmobi, Wasiu A.; Afolabi, Nathaniel K.; Akinkunmi, Francis; Kowobari, Olayinka; Omokhodion, Samuel; Osinusi, Kikelomo; Akinbami, Felix O.; Sodeinde, Olugbemiro; Fernandez-Reyes, Delmiro] Univ Ibadan, Univ Coll Ibadan Hosp, Coll Med, Dept Paediat, Ibadan, Nigeria; [Shokunbi, Wuraola A.] Univ Ibadan, Univ Coll Ibadan Hosp, Coll Med, Dept Haematol, Ibadan, Nigeria; [Brown, Biobele J.; Omokhodion, Samuel; Osinusi, Kikelomo; Akinbami, Felix O.; Shokunbi, Wuraola A.; Sodeinde, Olugbemiro; Fernandez-Reyes, Delmiro] Univ Coll Ibadan Hosp, Childhood Malaria Res Grp, Ibadan, Nigeria	MRC National Institute for Medical Research; University of Ibadan; University of Ibadan	Fernandez-Reyes, D (corresponding author), Natl Inst Med Res, MRC, Div Parasitol, London NW7 1AA, England.	dfernan@nimr.mrc.ac.uk	Orimadegun, Adebola E/H-9330-2013; Akinkunmi, Bola Francis/CAJ-5069-2022; Burte, Florence/U-8257-2017	Orimadegun, Adebola E/0000-0001-5590-0039; Burte, Florence/0000-0001-9020-7838; Fernandez-Reyes, Delmiro/0000-0001-5070-9198; Brown, Biobele/0000-0001-6981-9872	Medical Research Council, United Kingdom [U117585869]; College of Medicine, University of Ibadan, Nigeria; MRC [MC_U117585869] Funding Source: UKRI; Medical Research Council [MC_U117585869] Funding Source: researchfish; FOGARTY INTERNATIONAL CENTER [D43TW009112] Funding Source: NIH RePORTER	Medical Research Council, United Kingdom(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); College of Medicine, University of Ibadan, Nigeria; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); FOGARTY INTERNATIONAL CENTER(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC))	This research project was supported by the Medical Research Council, United Kingdom, and the College of Medicine, University of Ibadan, Nigeria. DFR's laboratory is supported by the United Kingdom Medical Research Council funding number U117585869. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agranoff D, 2006, LANCET, V368, P1012, DOI 10.1016/S0140-6736(06)69342-2; Amzat Jimoh, 2011, World Health Popul, V12, P42; [Anonymous], 2000, T R SOC TROP MED S1, V94, pS1; Bain BJ., 2012, DACIE LEWIS PRACTICA, V11; Bryce J, 2005, LANCET, V365, P1147, DOI 10.1016/S0140-6736(05)71877-8; Ceesay SJ, 2008, LANCET, V372, P1545, DOI 10.1016/S0140-6736(08)61654-2; Conroy AL, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-295; Cristianini N, 2000, INTRO SUPPORT VECTOR; Erdman LK, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017440; Hay SI, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000290; Hay SI, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000048; Hodgetts A, 2007, FUTURE MICROBIOL, V2, P35, DOI 10.2217/17460913.2.1.35; KORENROMP E, 2005, MALARIA INCIDENCE ES; Lovegrove FE, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004912; MARSH K, 1995, NEW ENGL J MED, V332, P1399, DOI 10.1056/NEJM199505253322102; Orimadegun AE, 2007, J TROP PEDIATRICS, V53, P185, DOI 10.1093/tropej/fmm002; Pang RTK, 2006, CLIN CHEM, V52, P421, DOI 10.1373/clinchem.2005.061689; Papadopoulos MC, 2004, LANCET, V363, P1358, DOI 10.1016/S0140-6736(04)16046-7; Rojas-Galeano S, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001806; Rowe AK, 2006, INT J EPIDEMIOL, V35, P691, DOI 10.1093/ije/dyl027; Sandhu G, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038080; Snow RW, 2005, NATURE, V434, P214, DOI 10.1038/nature03342; Wu C, 2009, J GASTROEN HEPATOL, V24, P55, DOI 10.1111/j.1440-1746.2008.05580.x; Wu FX, 2009, CANCER LETT, V279, P163, DOI 10.1016/j.canlet.2009.01.034	24	17	17	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 4	2012	7	12							e49778	10.1371/journal.pone.0049778	http://dx.doi.org/10.1371/journal.pone.0049778			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	051EQ	23226502	Green Submitted, Green Published, gold, Green Accepted			2022-12-27	WOS:000312108500005
J	Takahashi, M; Tsujimura, N; Yoshino, T; Hosokawa, M; Otsuka, K; Matsunaga, T; Nakasono, S				Takahashi, Masayuki; Tsujimura, Noriyuki; Yoshino, Tomoko; Hosokawa, Masahito; Otsuka, Kensuke; Matsunaga, Tadashi; Nakasono, Satoshi			Assessment of Benzene-Induced Hematotoxicity Using a Human-Like Hematopoietic Lineage in NOD/Shi-scid/IL2-R gamma(null) Mice	PLOS ONE			English	Article							MOUSE MODEL; MICROCAVITY ARRAY; INDUCED TOXICITY; CELLS; WORKERS; METABOLISM; EXPOSURE; 2,3,7,8-TETRACHLORODIBENZO-PARA-DIOXIN; LYMPHOCYTES; DEFICIENT	Despite recent advancements, it is still difficult to evaluate in vivo responses to toxicants in humans. Development of a system that can mimic the in vivo responses of human cells will enable more accurate health risk assessments. A surrogate human hematopoietic lineage can be established in NOD/Shi-scid/IL-2R gamma(null) (NOG) mice by transplanting human hematopoietic stem/progenitor cells (Hu-NOG mice). Here, we first evaluated the toxic response of human-like hematopoietic lineage in NOG mice to a representative toxic agent, benzene. Flow cytometric analysis showed that benzene caused a significant decrease in the number of human hematopoietic stem/progenitor cells in the bone marrow and the number of human leukocytes in the peripheral blood and hematopoietic organs. Next, we established chimeric mice by transplanting C57BL/6 mouse-derived bone marrow cells into NOG mice (Mo-NOG mice). A comparison of the degree of benzene-induced hematotoxicity in donor-derived hematopoietic lineage cells within Mo-NOG mice indicated that the toxic response of Hu-NOG mice reflected interspecies differences in susceptibilities to benzene. Responses to the toxic effects of benzene were greater in lymphoid cells than in myeloid cells in Mo-NOG and Hu-NOG mice. These findings suggested that Hu-NOG mice may be a powerful in vivo tool for assessing hematotoxicity in humans, while accounting for interspecies differences. Citation: Takahashi M, Tsujimura N, Yoshino T, Hosokawa M, Otsuka K, et al. (2012) Assessment of Benzene-Induced Hematotoxicity Using a Human-Like Hematopoietic Lineage in NOD/Shi-scid/IL-2R gamma(null) Mice. PLoS ONE 7(12): e50448. doi:10.1371/journal.pone.0050448	[Takahashi, Masayuki; Nakasono, Satoshi] Cent Res Inst Elect Power Ind, Biol Environm Sect, Environm Sci Res Lab, Chiba, Japan; [Tsujimura, Noriyuki; Yoshino, Tomoko; Hosokawa, Masahito; Matsunaga, Tadashi; Nakasono, Satoshi] Tokyo Univ Agr & Technol, Dept Biotechnol, Tokyo, Japan; [Otsuka, Kensuke] Cent Res Inst Elect Power Ind, Radiat Safety Res Ctr, Tokyo 201, Japan	Central Research Institute of Electric Power Industry - Japan; Tokyo University of Agriculture & Technology; Central Research Institute of Electric Power Industry - Japan	Nakasono, S (corresponding author), Cent Res Inst Elect Power Ind, Biol Environm Sect, Environm Sci Res Lab, Chiba, Japan.	nakasono@criepi.denken.or.jp	Yoshino, Tomoko/E-9066-2013; Matsunaga, Tadashi/A-6293-2015	Yoshino, Tomoko/0000-0002-4505-2774; Matsunaga, Tadashi/0000-0002-6216-3687; Hosokawa, Masahito/0000-0002-7070-4690				Al-Hajj M, 2003, P NATL ACAD SCI USA, V100, P3983, DOI 10.1073/pnas.0530291100; Basu A, 2005, TOXICOL LETT, V159, P100, DOI 10.1016/j.toxlet.2005.05.001; Bauer AK, 2003, TOXICOL SCI, V72, P201, DOI 10.1093/toxsci/kfg024; Cai S, 2011, CLIN CANCER RES, V17, P2195, DOI 10.1158/1078-0432.CCR-10-1959; Collins JJ, 1997, J OCCUP ENVIRON MED, V39, P232, DOI 10.1097/00043764-199703000-00013; Farris GM, 1997, TOXICOLOGY, V118, P137, DOI 10.1016/S0300-483X(96)03606-2; FINE JS, 1990, J IMMUNOL, V144, P1169; Flaveny Colin A, 2009, Mol Cell Pharmacol, V1, P119; Henderson RF, 1996, ENVIRON HEALTH PERSP, V104, P1173, DOI 10.2307/3433159; HIRABAYASHI Y, 2002, ORGANOHALOGEN COMPD, V55, P359; Hirabayashi Y, 2008, ORGANOHALOGEN COMPOU, V70, P287; Hirabayashi Y, 2008, CHEMOSPHERE, V73, pS290, DOI 10.1016/j.chemosphere.2007.12.033; Hirabayashi Y, 2010, CHEM-BIOL INTERACT, V184, P252, DOI 10.1016/j.cbi.2009.12.022; Hosokawa M, 2012, BIOSENSORS IN PRESS; Hosokawa M, 2012, BIOTECHNOL BIOENG, V109, P2017, DOI 10.1002/bit.24471; Hosokawa M, 2010, ANAL CHEM, V82, P6629, DOI 10.1021/ac101222x; Ito M, 2002, BLOOD, V100, P3175, DOI 10.1182/blood-2001-12-0207; Jessen BA, 2007, J APPL TOXICOL, V27, P133, DOI 10.1002/jat.1177; KERKVLIET NI, 1990, ENVIRON RES, V52, P146, DOI 10.1016/S0013-9351(05)80249-X; Lan Q, 2004, SCIENCE, V306, P1774, DOI 10.1126/science.1102443; Li CH, 2012, TOXICOL SCI, V126, P162, DOI 10.1093/toxsci/kfr331; LONGACRE SL, 1981, TOXICOL APPL PHARM, V60, P398, DOI 10.1016/0041-008X(81)90324-0; Lutgehetmann M, 2012, HEPATOLOGY, V55, P685, DOI 10.1002/hep.24758; MIDZENSKI MA, 1992, AM J IND MED, V22, P553, DOI 10.1002/ajim.4700220410; Moriguchi T, 2003, P NATL ACAD SCI USA, V100, P5652, DOI 10.1073/pnas.1037886100; Nakamura T, 2006, BLOOD, V107, P4300, DOI 10.1182/blood-2005-11-4433; O'Brien CA, 2007, NATURE, V445, P106, DOI 10.1038/nature05372; OReilly MS, 1996, NAT MED, V2, P689, DOI 10.1038/nm0696-689; Pira E, 2010, JNCI-J NATL CANCER I, V102, P1096, DOI 10.1093/jnci/djq214; POHJANVIRTA R, 1994, PHARMACOL REV, V46, P483; Powley MW, 1999, TOXICOLOGY, V139, P207, DOI 10.1016/S0300-483X(99)00134-1; ROZEN MG, 1985, TOXICOLOGY, V37, P13, DOI 10.1016/0300-483X(85)90109-X; SABOURIN PJ, 1987, TOXICOL APPL PHARM, V87, P325, DOI 10.1016/0041-008X(87)90294-8; Schellenberger MT, 2009, TOXICOL APPL PHARM, V240, P37, DOI 10.1016/j.taap.2009.06.019; Shultz LD, 2007, NAT REV IMMUNOL, V7, P118, DOI 10.1038/nri2017; Song PZ, 2011, TOXICOL SCI, V123, P359, DOI 10.1093/toxsci/kfr177; Stehling-Sun S, 2009, NAT IMMUNOL, V10, P289, DOI 10.1038/ni.1694; Stoddart CA, 2011, VIROLOGY, V417, P154, DOI 10.1016/j.virol.2011.05.013; Suemizu H, 2008, BIOCHEM BIOPH RES CO, V377, P248, DOI 10.1016/j.bbrc.2008.09.124; Takahashi M, 2012, J BIOSCI BIOENG, V113, P529, DOI 10.1016/j.jbiosc.2011.11.011; Van den Heuvel RL, 1999, CELL BIOL TOXICOL, V15, P101, DOI 10.1023/A:1007573414306; van Waterschoot RAB, 2009, DRUG METAB DISPOS, V37, P2305, DOI 10.1124/dmd.109.029397; Wan JX, 2002, ENVIRON HEALTH PERSP, V110, P1213, DOI 10.1289/ehp.021101213; Watanabe S, 2007, BLOOD, V109, P212, DOI 10.1182/blood-2006-04-017681; Wilbur S, 2008, TOXICOL IND HEALTH, V24, P263, DOI 10.1177/0748233708090910; Yahata T, 2006, BLOOD, V108, P2446, DOI 10.1182/blood-2006-02-002204; Yoon BI, 2002, TOXICOL SCI, V70, P150, DOI 10.1093/toxsci/70.1.150	47	6	8	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 3	2012	7	12							e50448	10.1371/journal.pone.0050448	http://dx.doi.org/10.1371/journal.pone.0050448			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	051DH	23226520	Green Submitted, gold, Green Published			2022-12-27	WOS:000312104700017
J	Camps, SMT; Dutilh, BE; Arendrup, MC; Rijs, AJMM; Snelders, E; Huynen, MA; Verweij, PE; Melchers, WJG				Camps, Simone M. T.; Dutilh, Bas E.; Arendrup, Maiken C.; Rijs, Antonius J. M. M.; Snelders, Eveline; Huynen, Martijn A.; Verweij, Paul E.; Melchers, Willem J. G.			Discovery of a hapE Mutation That Causes Azole Resistance in Aspergillus fumigatus through Whole Genome Sequencing and Sexual Crossing	PLOS ONE			English	Article							ANTIFUNGAL DRUG-RESISTANCE; OF-THE-LITERATURE; CANDIDA-ALBICANS; IN-VITRO; INVASIVE ASPERGILLOSIS; MURINE MODEL; TRANSCRIPTIONAL ENHANCEMENT; SACCHAROMYCES-CEREVISIAE; ITRACONAZOLE RESISTANCE; FLUCONAZOLE RESISTANCE	Azole compounds are the primary therapy for patients with diseases caused by Aspergillus fumigatus. However, prolonged treatment may cause resistance to develop, which is associated with treatment failure. The azole target cyp51A is a hotspot for mutations that confer phenotypic resistance, but in an increasing number of resistant isolates the underlying mechanism remains unknown. Here, we report the discovery of a novel resistance mechanism, caused by a mutation in the CCAAT-binding transcription factor complex subunit HapE. From one patient, four A. fumigatus isolates were serially collected. The last two isolates developed an azole resistant phenotype during prolonged azole therapy. Because the resistant isolates contained a wild type cyp51A gene and the isolates were isogenic, the complete genomes of the last susceptible isolate and the first resistant isolate (taken 17 weeks apart) were sequenced using Illumina technology to identify the resistance conferring mutation. By comparing the genome sequences to each other as well as to two A. fumigatus reference genomes, several potential non-synonymous mutations in protein-coding regions were identified, six of which could be confirmed by PCR and Sanger sequencing. Subsequent sexual crossing experiments showed that resistant progeny always contained a P88L substitution in HapE, while the presence of the other five mutations did not correlate with resistance in the progeny. Cloning the mutated hapE gene into the azole susceptible akuB(KU80) strain showed that the HapE P88L mutation by itself could confer the resistant phenotype. This is the first time that whole genome sequencing and sexual crossing strategies have been used to find the genetic basis of a trait of interest in A. fumigatus. The discovery may help understand alternate pathways for azole resistance in A. fumigatus with implications for the molecular diagnosis of resistance and drug discovery.	[Camps, Simone M. T.; Rijs, Antonius J. M. M.; Snelders, Eveline; Verweij, Paul E.; Melchers, Willem J. G.] Radboud Univ Nijmegen, Med Ctr, Dept Med Microbiol, NL-6525 ED Nijmegen, Netherlands; [Camps, Simone M. T.; Rijs, Antonius J. M. M.; Snelders, Eveline; Verweij, Paul E.; Melchers, Willem J. G.] Nijmegen Inst Infect Inflammat & Immun N4i, Nijmegen, Netherlands; [Dutilh, Bas E.; Huynen, Martijn A.] Radboud Univ Nijmegen, Med Ctr, Nijmegen Ctr Mol Life Sci, Ctr Mol & Biomol Informat, NL-6525 ED Nijmegen, Netherlands; [Arendrup, Maiken C.] Statens Serum Inst, Dept Microbiol Surveillance & Res, Unit Mycol, DK-2300 Copenhagen, Denmark	Radboud University Nijmegen; Radboud University Nijmegen; Radboud University Nijmegen; Statens Serum Institut	Camps, SMT (corresponding author), Radboud Univ Nijmegen, Med Ctr, Dept Med Microbiol, NL-6525 ED Nijmegen, Netherlands.	S.Camps@mmb.umcn.nl	Snelders, Eveline/HHS-5284-2022; Huynen, Martijn A/A-1530-2014; Huijnen, M.A./H-8051-2014; Verweij, P.E./H-8108-2014; Dutilh, Bas E./B-9719-2011; Melchers, Willem/C-8819-2015	Huynen, Martijn A/0000-0001-6189-5491; Verweij, P.E./0000-0002-8600-9860; Dutilh, Bas E./0000-0003-2329-7890; Melchers, Willem/0000-0002-5446-2230; Snelders, Eveline/0000-0002-7868-7928; Arendrup, Maiken Cavling/0000-0002-4747-0144	Dutch Science foundation (NWO) [016.111.075]; Basilea; BioRad; Gilead; Merck; Pfizer; Schering-Plough	Dutch Science foundation (NWO)(Netherlands Organization for Scientific Research (NWO)); Basilea; BioRad; Gilead(Gilead Sciences); Merck(Merck & Company); Pfizer(Pfizer); Schering-Plough(Merck & CompanySchering Plough Corporation)	BED is supported by the Dutch Science foundation (NWO) Veni grant (016.111.075). PEV received research grants from Basilea, BioRad, Gilead, Merck, Pfizer, and Schering-Plough. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albarrag AM, 2011, ANTIMICROB AGENTS CH, V55, P5113, DOI 10.1128/AAC.00517-11; Alcazar-Fuoli L, 2006, ANTIMICROB AGENTS CH, V50, P453, DOI 10.1128/AAC.50.2.453-460.2006; Anderson JB, 2003, GENETICS, V163, P1287; Arendrup MC, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010080; Arthington-Skaggs BA, 2000, ANTIMICROB AGENTS CH, V44, P2081, DOI 10.1128/AAC.44.8.2081-2085.2000; Barker KS, 2004, J ANTIMICROB CHEMOTH, V54, P376, DOI 10.1093/jac/dkh336; Blatzer M, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002374; Blosser SJ, 2012, ANTIMICROB AGENTS CH, V56, P248, DOI 10.1128/AAC.05027-11; Bueid A, 2010, J ANTIMICROB CHEMOTH, V65, P2116, DOI 10.1093/jac/dkq279; Camps SMT, 2012, ANTIMICROB AGENTS CH, V56, P10, DOI 10.1128/AAC.05088-11; Cannon RD, 2009, CLIN MICROBIOL REV, V22, P291, DOI 10.1128/CMR.00051-08; Chamilos G, 2005, DRUG RESIST UPDATE, V8, P344, DOI 10.1016/j.drup.2006.01.001; Cornely OA, 2007, NEW ENGL J MED, V356, P348, DOI 10.1056/NEJMoa061094; Ferreira MED, 2006, CURR GENET, V50, P32, DOI 10.1007/s00294-006-0073-2; Denning DW, 2011, CLIN INFECT DIS, V52, P1123, DOI 10.1093/cid/cir179; Denning DW, 2003, CLIN INFECT DIS, V37, pS265, DOI 10.1086/376526; Denning DW, 1997, J ANTIMICROB CHEMOTH, V40, P401, DOI 10.1093/jac/40.3.401; Diaz-Guerra TM, 2003, ANTIMICROB AGENTS CH, V47, P1120, DOI 10.1128/AAC.47.3.1120-1124.2003; Dirr F, 2010, INT J MED MICROBIOL, V300, P496, DOI 10.1016/j.ijmm.2010.03.001; Dolfini D, 2012, CRIT REV BIOCHEM MOL, V47, P29, DOI 10.3109/10409238.2011.628970; Dunkel N, 2008, MOL MICROBIOL, V69, P827, DOI 10.1111/j.1365-2958.2008.06309.x; Dunkel N, 2008, EUKARYOT CELL, V7, P1180, DOI 10.1128/EC.00103-08; Fedorova ND, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000046; Ferreira MED, 2006, EUKARYOT CELL, V5, P207, DOI 10.1128/EC.5.1.207-211.2006; Ferreira MED, 2005, MED MYCOL, V43, pS313, DOI 10.1080/13693780400029114; Ferreira MED, 2004, ANTIMICROB AGENTS CH, V48, P4405, DOI [10.1128/AAC-.48.11.4405-4413.2004, 10.1128/AAC.48.11.4405-4413.2004]; Garcia-Effron G, 2005, ANTIMICROB AGENTS CH, V49, P2119, DOI 10.1128/AAC.49.5.2119-2121.2005; Gilsenan JM, 2012, NUCLEIC ACIDS RES, V40, pD660, DOI 10.1093/nar/gkr971; Herbrecht R, 2002, NEW ENGL J MED, V347, P408, DOI 10.1056/NEJMoa020191; Hodiamont CJ, 2009, MED MYCOL, V47, P217, DOI 10.1080/13693780802545600; Hoot SJ, 2011, ANTIMICROB AGENTS CH, V55, P940, DOI 10.1128/AAC.00995-10; Hortschansky P, 2007, EMBO J, V26, P3157, DOI 10.1038/sj.emboj.7601752; Howard SJ, 2010, CLIN MICROBIOL INFEC, V16, P683, DOI 10.1111/j.1469-0691.2009.02911.x; Howard SJ, 2006, INT J ANTIMICROB AG, V28, P450, DOI 10.1016/j.ijantimicag.2006.08.017; Howard SJ, 2009, EMERG INFECT DIS, V15, P1068, DOI 10.3201/eid1507.090043; Kato M, 2005, BIOSCI BIOTECH BIOCH, V69, P663, DOI 10.1271/bbb.69.663; Kuipers S, 2011, ANTIMICROB AGENTS CH, V55, P3564, DOI 10.1128/AAC.01544-10; Langfelder K, 2002, CURR GENET, V41, P268, DOI 10.1007/s00294-002-0313-z; Latge JP, 1999, CLIN MICROBIOL REV, V12, P310, DOI 10.1128/CMR.12.2.310; Li H, 2008, GENOME RES, V18, P1851, DOI 10.1101/gr.078212.108; Lockhart SR, 2011, ANTIMICROB AGENTS CH, V55, P4465, DOI 10.1128/AAC.00185-11; Lupetti A, 2002, TRENDS MOL MED, V8, P76, DOI 10.1016/S1471-4914(02)02280-3; Mabey JE, 2004, NUCLEIC ACIDS RES, V32, pD401, DOI 10.1093/nar/gkh009; Mann PA, 2003, ANTIMICROB AGENTS CH, V47, P577, DOI 10.1128/AAC.47.2.577-581.2003; Mellado E, 2007, ANTIMICROB AGENTS CH, V51, P1897, DOI 10.1128/AAC.01092-06; Mellado E, 2004, ANTIMICROB AGENTS CH, V48, P2747, DOI 10.1128/AAC.48.7.2747-2750.2004; Mellado E, 2001, J CLIN MICROBIOL, V39, P2431, DOI 10.1128/JCM.39.7.2431-2438.2001; Mogavero S, 2011, ANTIMICROB AGENTS CH, V55, P2061, DOI 10.1128/AAC.01467-10; Morio F, 2010, DIAGN MICR INFEC DIS, V66, P373, DOI 10.1016/j.diagmicrobio.2009.11.006; Nascimento AM, 2003, ANTIMICROB AGENTS CH, V47, P1719, DOI 10.1128/AAC.47.5.1719-1726.2003; Nierman WC, 2005, NATURE, V438, P1151, DOI 10.1038/nature04332; O'Gorman CM, 2009, NATURE, V457, P471, DOI 10.1038/nature07528; Odds FC, 2003, TRENDS MICROBIOL, V11, P272, DOI 10.1016/S0966-842X(03)00117-3; Paoletti M, 2005, CURR BIOL, V15, P1242, DOI 10.1016/j.cub.2005.05.045; Qiao J, 2008, CHIN J DERM VENEREO, V22, P19; Qiao JJ, 2010, MYCOPATHOLOGIA, V170, P155, DOI 10.1007/s11046-010-9309-2; Qiao Jianjun, 2008, Nihon Ishinkin Gakkai Zasshi, V49, P157, DOI 10.3314/jjmm.49.157; Rajendran R, 2011, ANTIMICROB AGENTS CH, V55, P2092, DOI 10.1128/AAC.01189-10; Revankar SG, 1998, J CLIN MICROBIOL, V36, P153, DOI 10.1128/JCM.36.1.153-156.1998; Rex JH, 1998, ANTIMICROB AGENTS CH, V42, P129, DOI 10.1128/AAC.42.1.129; Richie DL, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000258; Schrettl M, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001124; Schubert S, 2011, ANTIMICROB AGENTS CH, V55, P2212, DOI 10.1128/AAC.01343-10; Slaven JW, 2002, FUNGAL GENET BIOL, V36, P199, DOI 10.1016/S1087-1845(02)00016-6; Snelders E, 2008, PLOS MED, V5, P1629, DOI 10.1371/journal.pmed.0050219; Snelders E, 2011, FUNGAL GENET BIOL, V48, P1062, DOI 10.1016/j.fgb.2011.08.002; Snelders E, 2011, FUTURE MICROBIOL, V6, P335, DOI [10.2217/FMB.11.4, 10.2217/fmb.11.4]; Snelders E, 2009, APPL ENVIRON MICROB, V75, P4053, DOI 10.1128/AEM.00231-09; Tanoue S, 2006, BIOSCI BIOTECH BIOCH, V70, P782, DOI 10.1271/bbb.70.782; Tudela JLR, 2008, CLIN MICROBIOL INFEC, V14, P982, DOI 10.1111/j.1469-0691.2008.02086.x; Ullmann AJ, 2007, NEW ENGL J MED, V356, P335, DOI 10.1056/NEJMoa061098; van der Linden JWM, 2011, EMERG INFECT DIS, V17, P1846, DOI 10.3201/eid1710.110226; van der Linden JWM, 2009, CLIN INFECT DIS, V48, P1111, DOI 10.1086/597465; van Leer-Buter C, 2007, LANCET, V370, P102, DOI 10.1016/S0140-6736(07)61055-1; Veen M, 2005, BIOCHEM SOC T, V33, P1178, DOI 10.1042/BST0331178; Verweij PE, 2007, NEW ENGL J MED, V356, P1481, DOI 10.1056/NEJMc061720; Verweij PE, 2009, DRUG RESIST UPDATE, V12, P141, DOI 10.1016/j.drup.2009.09.002; Walsh TJ, 2008, CLIN INFECT DIS, V46, P327, DOI 10.1086/525258; Warris A, 2002, NEW ENGL J MED, V347, P2173, DOI 10.1056/NEJM200212263472618; Willger SD, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000200; Yamada E, 2010, ANTIMICROB AGENTS CH, V54, P3630, DOI 10.1128/AAC.00355-10; Zemzoumi K, 1999, J MOL BIOL, V286, P327, DOI 10.1006/jmbi.1998.2496; Znaidi S, 2007, MOL MICROBIOL, V66, P440, DOI 10.1111/j.1365-2958.2007.05931.x	83	131	148	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 30	2012	7	11							e50034	10.1371/journal.pone.0050034	http://dx.doi.org/10.1371/journal.pone.0050034			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	054WM	23226235	Green Published, gold, Green Submitted			2022-12-27	WOS:000312376100044
J	Ling, L; Shen, Y; Wang, K; Jiang, CY; Fang, CM; Ferro, A; Kang, LN; Xu, B				Ling, Lin; Shen, Yu; Wang, Kun; Jiang, Chunying; Fang, Chunmei; Ferro, Albert; Kang, Lina; Xu, Biao			Worse Clinical Outcomes in Acute Myocardial Infarction Patients with Type 2 Diabetes Mellitus: Relevance to Impaired Endothelial Progenitor Cells Mobilization	PLOS ONE			English	Article							NITRIC-OXIDE SYNTHASE; C-REACTIVE PROTEIN; BONE-MARROW; CARDIOVASCULAR-DISEASE; PRIMARY ANGIOPLASTY; NUMBER; STEM; NEOVASCULARIZATION; REPERFUSION; CONTRIBUTES	Background: Although the clinical outcome of acute myocardial infarction (AMI) in patients with type 2 diabetes mellitus (T2DM) is well established to be worse than for non-diabetic patients, the reasons for this remain unclear. We hypothesized that this may be related to impairment of bone marrow-derived endothelial progenitor cells (EPCs) mobilization. Methodology/Principal Findings: We observed short term bone marrow EPCs mobilization and long term clinical outcomes in 62 AMI patients with or without T2DM and investigated EPCs levels as well as bone marrow pathway changes in a rat model of diabetes after AMI. Patients with T2DM exhibited a delay (peak time diabetics vs. non-diabetics: day 7 vs. day 5) and a decrease in EPCs mobilization (diabetics vs. non-diabetics: 285 +/- 56/10(6) mononuclear cells (MNCs) vs. 431 +/- 88/10(6) MNCs, p < 0.05) within one month after AMI. Plasma levels of VEGF and SDF-1 alpha as well as of hsCRP were higher in T2DM patients. Over a mean of 2.26 years follow-up, T2DM patients exhibited a pronounced decrease in LVEF as well as an increase in clinical events. Glucose (HR 2.01, 95% CI 1.42-2.85, p = 0.008), first day EPC (HR 0.974, 95% CI 0.952-0.997, p = 0.02) and seven day EPCs (HR 0.966, 95% CI 0.945-0.988, p = 0.003) were independent prognostic variables for cardiovascular mortality. In a diabetic rat model of AMI, decreased circulating EPCs was accompanied by lower expression of phospho-Akt, phospho-eNOS, HIF, MMP-9 and MMP-9 activity in the bone marrow as well as impaired cardiac function, angiogenesis and increased left ventricle remodeling. Conclusions/Significance: Bone marrow EPCs mobilization is delayed and reduced in diabetes, with impaired HIF/p-Akt/p-eNOS/MMP-9 signaling. This is likely to contribute to the deterioration in cardiac function and worsened clinical outcome seen in patients with T2DM.	[Ling, Lin; Shen, Yu; Wang, Kun; Jiang, Chunying; Fang, Chunmei; Kang, Lina; Xu, Biao] Nanjing Univ, Sch Med, Affiliated Drum Tower Hosp, Dept Cardiol, Nanjing, Jiangsu, Peoples R China; [Ferro, Albert] Kings Coll London, Sch Med, Dept Clin Pharmacol, Div Cardiovasc, London WC2R 2LS, England	Nanjing University; University of London; King's College London	Xu, B (corresponding author), Nanjing Univ, Sch Med, Affiliated Drum Tower Hosp, Dept Cardiol, Nanjing, Jiangsu, Peoples R China.	xubiao@medmail.com.cn		Shen, Yu/0000-0002-5145-5182; Ferro, Albert/0000-0002-5486-9145; Jiang, Chunying/0000-0002-3505-9614	National Science Foundation of China [81070195, 81000055]	National Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the National Science Foundation of China, grant no. 81070195 and 81000055. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aicher A, 2003, NAT MED, V9, P1370, DOI 10.1038/nm948; Aronson D, 1997, ANN INTERN MED, V126, P296, DOI 10.7326/0003-4819-126-4-199702150-00006; Asahara T, 1997, SCIENCE, V275, P964, DOI 10.1126/science.275.5302.964; Asahara T, 1999, EMBO J, V18, P3964, DOI 10.1093/emboj/18.14.3964; Bouvet C, 2007, CARDIOVASC RES, V73, P504, DOI 10.1016/j.cardiores.2006.11.001; Chen L, 2010, CARDIOVASC RES, V88, P462, DOI 10.1093/cvr/cvq207; Chironi G, 2007, ATHEROSCLEROSIS, V191, P115, DOI 10.1016/j.atherosclerosis.2006.02.041; Egan CG, 2008, DIABETOLOGIA, V51, P1296, DOI 10.1007/s00125-008-0939-6; Fadini GP, 2006, DIABETOLOGIA, V49, P3075, DOI 10.1007/s00125-006-0401-6; Gallagher KA, 2007, J CLIN INVEST, V117, P1249, DOI 10.1172/JCI29710; Gill M, 2001, CIRC RES, V88, P167; Hamed S, 2009, CARDIOVASC DIABETOL, V8, DOI 10.1186/1475-2840-8-56; Harjai KJ, 2003, AM J CARDIOL, V91, P1041, DOI 10.1016/S0002-9149(03)00145-0; Heissig B, 2002, CELL, V109, P625, DOI 10.1016/S0092-8674(02)00754-7; Hill JM, 2003, NEW ENGL J MED, V348, P593, DOI 10.1056/NEJMoa022287; Huang PH, 2010, ARTERIOSCL THROM VAS, V30, P869, DOI 10.1161/ATVBAHA.109.200618; Jialal I, 2010, ATHEROSCLEROSIS, V211, P297, DOI 10.1016/j.atherosclerosis.2010.01.036; Jung C, 2010, INT J CARDIOL, V143, P368, DOI 10.1016/j.ijcard.2009.03.075; Kang LN, 2009, CLIN EXP PHARMACOL P, V36, pe47, DOI 10.1111/j.1440-1681.2009.05219.x; Kissel CK, 2007, J AM COLL CARDIOL, V49, P2341, DOI 10.1016/j.jacc.2007.01.095; Leone AM, 2005, EUR HEART J, V26, P1196, DOI 10.1093/eurheartj/ehi164; Leone AM, 2009, EUR HEART J, V30, P890, DOI 10.1093/eurheartj/ehp078; Marso SP, 2007, AM J CARDIOL, V100, P206, DOI 10.1016/j.amjcard.2007.02.080; Menegazzo L, 2012, BIOFACTORS, V38, P194, DOI 10.1002/biof.1016; Mills NL, 2009, HEART, V95, P2003, DOI 10.1136/hrt.2008.163162; Oikawa A, 2010, ARTERIOSCL THROM VAS, V30, P498, DOI 10.1161/ATVBAHA.109.200154; Prasad A, 2005, J AM COLL CARDIOL, V45, P508, DOI 10.1016/j.jacc.2004.10.054; Reed MJ, 2000, METABOLISM, V49, P1390, DOI 10.1053/meta.2000.17721; Ridker PM, 2003, CIRCULATION, V107, P363, DOI 10.1161/01.CIR.0000053730.47739.3C; Schmidt-Lucke C, 2005, CIRCULATION, V111, P2981, DOI 10.1161/CIRCULATIONAHA.104.504340; Shantsila E, 2007, J AM COLL CARDIOL, V49, P741, DOI 10.1016/j.jacc.2006.09.050; Shen C, 2010, BIOMED PHARMACOTHER, V64, P35, DOI 10.1016/j.biopha.2009.03.002; Takahashi T, 1999, NAT MED, V5, P434, DOI 10.1038/7434; Thum T, 2007, CIRC RES, V100, P434, DOI 10.1161/01.RES.0000257912.78915.af; Thum T, 2007, DIABETES, V56, P666, DOI 10.2337/db06-0699; Verma S, 2004, CIRCULATION, V109, P2058, DOI 10.1161/01.CIR.0000127577.63323.24; Werner C, 2007, DIABETES, V56, P2609, DOI 10.2337/db07-0069; Werner N, 2005, NEW ENGL J MED, V353, P999, DOI 10.1056/NEJMoa043814; Yin YG, 2010, CARDIOVASC PATHOL, V19, P218, DOI 10.1016/j.carpath.2009.04.002	39	45	48	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 30	2012	7	11							e50739	10.1371/journal.pone.0050739	http://dx.doi.org/10.1371/journal.pone.0050739			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	054WM	23226370	Green Published, gold, Green Submitted			2022-12-27	WOS:000312376100181
J	Makrantonaki, E; Brink, TC; Zampeli, V; Elewa, RM; Mlody, B; Hossini, AM; Hermes, B; Krause, U; Knolle, J; Abdallah, M; Adjaye, J; Zouboulis, CC				Makrantonaki, Evgenia; Brink, Thore C.; Zampeli, Vasiliki; Elewa, Rana Mohsen; Mlody, Barbara; Hossini, Amir M.; Hermes, Bjoern; Krause, Ulf; Knolle, Juergen; Abdallah, Marwa; Adjaye, James; Zouboulis, Christos C.			Identification of Biomarkers of Human Skin Ageing in Both Genders. Wnt Signalling - A Label of Skin Ageing?	PLOS ONE			English	Article							PROLIFERATOR-ACTIVATED RECEPTORS; HUMAN SEBOCYTES; ALZHEIMERS-DISEASE; COLORECTAL-CANCER; STEM-CELLS; EXPRESSION; GENE; METABOLISM; MUTATIONS; GENOME	The goal of our work has been to investigate the mechanisms of gender-independent human skin ageing and examine the hypothesis of skin being an adequate model of global ageing. For this purpose, whole genome gene profiling was employed in sun-protected skin obtained from European Caucasian young and elderly females (mean age 26.7+/-4 years [n1 = 7] and 70.75+/-3.3 years [n2 = 4], respectively) and males (mean age 25.8+/-5.2 years [n3 = 6] and 76+/-3.8 years [n4 = 7], respectively) using the Illumina array platform. Confirmation of gene regulation was performed by real-time RT-PCR and immunohistochemistry. 523 genes were significantly regulated in female skin and 401 genes in male skin for the chosen criteria. Of these, 183 genes exhibited increased and 340 decreased expression in females whereas 210 genes showed increased and 191 decreased expression in males with age. In total, 39 genes were common in the target lists of significant regulated genes in males and females. 35 of these genes showed increased (16) or decreased (19) expression independent of gender. Only 4 overlapping genes (OR52N2, F6FR1OP2, TUBAL3 and STK40) showed differential regulation with age. Interestingly, Wnt signalling pathway showed to be significantly downregulated in aged skin with decreased gene and protein expression for males and females, accordingly. In addition, several genes involved in central nervous system (CNS) ageing (f.i. APP, TAU) showed to be expressed in human skin and were significanlty regulated with age. In conclusion, our study provides biomarkers of endogenous human skin ageing in both genders and highlight the role of Wnt signalling in this process. Furthermore, our data give evidence that skin could be used as a good alternative to understand ageing of different tissues such as CNS.	[Makrantonaki, Evgenia; Zampeli, Vasiliki; Elewa, Rana Mohsen; Hossini, Amir M.; Zouboulis, Christos C.] Dessau Med Ctr, Dept Dermatol, Dessau, Germany; [Makrantonaki, Evgenia; Zampeli, Vasiliki; Elewa, Rana Mohsen; Hossini, Amir M.; Zouboulis, Christos C.] Dessau Med Ctr, Dept Venereol, Dessau, Germany; [Makrantonaki, Evgenia; Zampeli, Vasiliki; Elewa, Rana Mohsen; Hossini, Amir M.; Zouboulis, Christos C.] Dessau Med Ctr, Dept Allergol, Dessau, Germany; [Makrantonaki, Evgenia; Zampeli, Vasiliki; Elewa, Rana Mohsen; Hossini, Amir M.; Zouboulis, Christos C.] Dessau Med Ctr, Dept Immunol, Dessau, Germany; [Makrantonaki, Evgenia; Zampeli, Vasiliki; Hermes, Bjoern] Charite, Inst Clin Pharmacol & Toxicol, D-13353 Berlin, Germany; [Brink, Thore C.; Mlody, Barbara; Adjaye, James] Max Planck Inst Mol Genet, Dept Vertebrate Genom, D-14195 Berlin, Germany; [Elewa, Rana Mohsen; Abdallah, Marwa] Ain Shams Univ, Fac Med, Dept Dermatol Androl & Venereol, Nasr City, Cairo, Egypt; [Krause, Ulf; Knolle, Juergen] Dessau Med Ctr, Dept Pathol, Dessau, Germany; [Adjaye, James] King Saud Univ, Coll Med, Dept Anat, Stem Cell Unit, Riyadh 11461, Saudi Arabia	Dessau Medical Center; Dessau Medical Center; Dessau Medical Center; Dessau Medical Center; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Max Planck Society; Egyptian Knowledge Bank (EKB); Ain Shams University; Dessau Medical Center; King Saud University	Zouboulis, CC (corresponding author), Dessau Med Ctr, Dept Dermatol, Dessau, Germany.	christos.zouboulis@klinikum-dessau.de	Makrantonaki, Evgenia/G-1769-2010; zampeli, vasiliki/M-2724-2019; Zouboulis, Christos C./I-4493-2013; Abdallah, Marwa/AAJ-5339-2020	Makrantonaki, Evgenia/0000-0001-8522-2128; zampeli, vasiliki/0000-0002-6219-1178; Zouboulis, Christos C./0000-0003-1646-2608; Mlody, Barbara/0000-0001-5184-1772; Abdallah, Marwa/0000-0002-7791-9141	BMBF by the German Federal Ministry of Education and Research; German Federal Ministry of Education and Research (BMBF), ERASysBio+initiative under the European Union ERA-NET Plus scheme in FP7 [01GN1005, 0315717A]	BMBF by the German Federal Ministry of Education and Research; German Federal Ministry of Education and Research (BMBF), ERASysBio+initiative under the European Union ERA-NET Plus scheme in FP7	This work was supported by a BMBF research grant by the German Federal Ministry of Education and Research to CCZ, JA and EM. JA acknowledges support from the German Federal Ministry of Education and Research (BMBF) grants (01GN1005) and (0315717A), which is a partner of the ERASysBio+initiative supported under the European Union ERA-NET Plus scheme in FP7. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adjaye J, 2005, STEM CELLS, V23, P1514, DOI 10.1634/stemcells.2005-0113; ALLSOPP RC, 1992, P NATL ACAD SCI USA, V89, P10114, DOI 10.1073/pnas.89.21.10114; Azzi L, 2005, J INVEST DERMATOL, V124, P22, DOI 10.1111/j.0022-202X.2004.23545.x; Baldan A, 2006, CURR OPIN LIPIDOL, V17, P227, DOI 10.1097/01.mol.0000226113.89812.bb; Capell BC, 2009, J INVEST DERMATOL, V129, P2340, DOI 10.1038/jid.2009.103; Carlson ME, 2008, EXP CELL RES, V314, P1951, DOI 10.1016/j.yexcr.2008.03.017; Chen WC, 2003, J INVEST DERMATOL, V121, P441, DOI 10.1046/j.1523-1747.2003.12411.x; Cui YJ, 2012, NATURE, V484, P246, DOI 10.1038/nature10897; DeCarolis NA, 2008, BIOESSAYS, V30, P102, DOI 10.1002/bies.20709; Devi G, 2000, ARCH NEUROL-CHICAGO, V57, P1454, DOI 10.1001/archneur.57.10.1454; Dreesen O, 2007, STEM CELL REV, V3, P7, DOI 10.1007/s12015-007-0004-8; Gronniger E, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000971; Han C, 2008, J CELL BIOCHEM, V105, P534, DOI 10.1002/jcb.21852; Heuberger J, 2010, COLD SPRING HARB PER; Hoshii T, 2007, BIOL REPROD, V76, P303, DOI 10.1095/biolreprod.106.054619; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Kuhn K, 2004, GENOME RES, V14, P2347, DOI 10.1101/gr.2739104; Lammi L, 2004, AM J HUM GENET, V74, P1043, DOI 10.1086/386293; Lemay DG, 2006, J LIPID RES, V47, P1583, DOI 10.1194/jlr.M500504-JLR200; Lener T, 2006, EXP GERONTOL, V41, P387, DOI 10.1016/j.exger.2006.01.012; Linford NJ, 2007, AGING CELL, V6, P673, DOI 10.1111/j.1474-9726.2007.00319.x; Ly DH, 2000, SCIENCE, V287, P2486, DOI 10.1126/science.287.5462.2486; Makrantonaki E, 2007, BRIT J DERMATOL, V156, P428, DOI 10.1111/j.1365-2133.2006.07671.x; Makrantonaki E, 2007, EXP GERONTOL, V42, P879, DOI 10.1016/j.exger.2007.07.002; Makrantonaki E, 2006, AGING CELL, V5, P331, DOI 10.1111/j.1474-9726.2006.00223.x; Makrantonaki E, 2010, EXP GERONTOL, V45, P801, DOI 10.1016/j.exger.2010.08.005; Manolopoulos KN, 2010, MOL PSYCHIATR, V15, P1046, DOI 10.1038/mp.2010.17; Matsumine H, 1997, AM J HUM GENET, V60, P588; Michalik L, 2007, BBA-MOL CELL BIOL L, V1771, P991, DOI 10.1016/j.bbalip.2007.02.004; Michikawa Y, 1999, SCIENCE, V286, P774, DOI 10.1126/science.286.5440.774; Michishita E, 2008, NATURE, V452, P492, DOI 10.1038/nature06736; Miquel J, 1998, EXP GERONTOL, V33, P113, DOI 10.1016/S0531-5565(97)00060-0; Mostoslavsky R, 2006, CELL, V124, P315, DOI 10.1016/J.CEL.2005.11.044; MURRELL J, 1991, SCIENCE, V254, P97, DOI 10.1126/science.1925564; Mustata RC, 2011, EMBO REP, V12, P558, DOI 10.1038/embor.2011.52; Nijsten T, 2005, J CUTAN PATHOL, V32, P340, DOI 10.1111/j.0303-6987.2005.00345.x; Oyama K, 2011, SEX DEV, V5, P205, DOI 10.1159/000329476; Renshaw M, 2002, J IMMUNOL, V169, P4697, DOI 10.4049/jimmunol.169.9.4697; Saeed AI, 2003, BIOTECHNIQUES, V34, P374, DOI 10.2144/03342mt01; SEIDENARI S, 1994, SKIN PHARMACOL, V7, P201; Sethi JK, 2010, BIOCHEM J, V427, P1, DOI 10.1042/BJ20091866; Shin MH, 2005, J INVEST DERMATOL, V124, P315, DOI 10.1111/j.0022-202X.2004.23588.x; Simon AF, 2003, SCIENCE, V299, P1407, DOI 10.1126/science.1080539; Smith JR, 1996, SCIENCE, V273, P63, DOI 10.1126/science.273.5271.63; Song LX, 1997, J BIOL CHEM, V272, P10543; Tatar M, 2003, SCIENCE, V299, P1346, DOI 10.1126/science.1081447; van den Brink GR, 2006, GUT, V55, P912, DOI 10.1136/gut.2005.085902; Watkins PA, 2007, J LIPID RES, V48, P2736, DOI 10.1194/jlr.M700378-JLR200; Wei W, 2011, MOL CANCER, V10, DOI 10.1186/1476-4598-10-16; Wu QY, 2009, KIDNEY INT, V75, P142, DOI 10.1038/ki.2008.418; Yamazaki N, 1996, BBA-GENE STRUCT EXPR, V1307, P157, DOI 10.1016/0167-4781(96)00069-3; Yoon KA, 2004, J HUM GENET, V49, P134, DOI 10.1007/s10038-003-0122-3; Zahn JM, 2007, PLOS GENET, V3, P2326, DOI 10.1371/journal.pgen.0030201; Zhong L, 2010, TRANSCR-AUSTIN, V1, P17, DOI 10.4161/trns.1.1.12143; Zouboulis CC, 2002, P NATL ACAD SCI USA, V99, P7148, DOI 10.1073/pnas.102180999; Zouboulis CC, 2011, CLIN DERMATOL, V29, P3, DOI 10.1016/j.clindermatol.2010.07.001	56	61	63	2	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 30	2012	7	11							e50393	10.1371/journal.pone.0050393	http://dx.doi.org/10.1371/journal.pone.0050393			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	054WM	23226273	Green Submitted, Green Published, gold			2022-12-27	WOS:000312376100083
J	Milon, BC; Cheng, HB; Tselebrovsky, MV; Lavrov, SA; Nenasheva, VV; Mikhaleva, EA; Shevelyov, YY; Nurminsky, DI				Milon, Beatrice C.; Cheng, Haibo; Tselebrovsky, Mikhail V.; Lavrov, Sergei A.; Nenasheva, Valentina V.; Mikhaleva, Elena A.; Shevelyov, Yuri Y.; Nurminsky, Dmitry I.			Role of Histone Deacetylases in Gene Regulation at Nuclear Lamina	PLOS ONE			English	Article							LEM-DOMAIN PROTEINS; B-TYPE LAMIN; COEXPRESSED GENES; DROSOPHILA; CHROMATIN; GENOME; TRANSCRIPTION; COMPARTMENTALIZATION; ORGANIZATION; ACETYLATION	Theoretical models suggest that gene silencing at the nuclear periphery may involve "closing" of chromatin by transcriptional repressors, such as histone deacetylases (HDACs). Here we provide experimental evidence confirming these predictions. Histone acetylation, chromatin compactness, and gene repression in lamina-interacting multigenic chromatin domains were analyzed in Drosophila S2 cells in which B-type lamin, diverse HDACs, and lamina-associated proteins were downregulated by dsRNA. Lamin depletion resulted in decreased compactness of the repressed multigenic domain associated with its detachment from the lamina and enhanced histone acetylation. Our data reveal the major role for HDAC1 in mediating deacetylation, chromatin compaction, and gene silencing in the multigenic domain, and an auxiliary role for HDAC3 that is required for retention of the domain at the lamina. These findings demonstrate the manifold and central involvement of class I HDACs in regulation of lamina-associated genes, illuminating a mechanism by which these enzymes can orchestrate normal and pathological development.	[Milon, Beatrice C.; Cheng, Haibo; Nurminsky, Dmitry I.] Univ Maryland, Sch Med, Dept Biochem & Mol Biol, Baltimore, MD 21201 USA; [Tselebrovsky, Mikhail V.; Lavrov, Sergei A.; Mikhaleva, Elena A.; Shevelyov, Yuri Y.] RAS, Inst Mol Genet, Dept Mol Genet Cell, Moscow 117901, Russia; [Nenasheva, Valentina V.] RAS, Inst Mol Genet, Dept Viral & Cellular Mol Genet, Moscow 117901, Russia	University System of Maryland; University of Maryland Baltimore; Russian Academy of Sciences; Russian Academy of Sciences	Nurminsky, DI (corresponding author), Univ Maryland, Sch Med, Dept Biochem & Mol Biol, Baltimore, MD 21201 USA.	dnurminsky@som.umaryland.edu	Lavrov, Sergey/T-4289-2019; Mikhaleva, Elena/J-4017-2017; Lavrov, Sergey/T-2900-2018	Lavrov, Sergey/0000-0002-4767-6548; Mikhaleva, Elena/0000-0002-2665-7137; Lavrov, Sergey/0000-0002-4767-6548; Shevelyov, Yuri/0000-0002-0568-9236; Milon, Beatrice/0000-0001-9208-9134	National Science Foundation (MCB Division of Molecular and Cellular Biosciences) [0960531]; Russian Foundation for Basic Research [10-04-00669-a]; Russian Academy of Sciences	National Science Foundation (MCB Division of Molecular and Cellular Biosciences)(National Science Foundation (NSF)); Russian Foundation for Basic Research(Russian Foundation for Basic Research (RFBR)); Russian Academy of Sciences(Russian Academy of Sciences)	This study was supported by grant number 0960531 from the National Science Foundation (MCB Division of Molecular and Cellular Biosciences), http://www.nsf.gov/; Russian Foundation for Basic Research grant number 10-04-00669-a, http://www.rfbr.ru; grant for Molecular and Cellular Biology from Russian Academy of Sciences, www.ras.ru. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Boutanaev AM, 2002, NATURE, V420, P666, DOI 10.1038/nature01216; Chintapalli VR, 2007, NAT GENET, V39, P715, DOI 10.1038/ng2049; Cho YS, 2005, GENOMICS, V86, P606, DOI 10.1016/j.ygeno.2005.07.007; Cohen BA, 2000, NAT GENET, V26, P183, DOI 10.1038/79896; DAVIE JR, 1980, FEBS LETT, V110, P164, DOI 10.1016/0014-5793(80)80063-9; de Oca RM, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007050; Dialynas G, 2010, DEVELOPMENT, V137, P3067, DOI 10.1242/dev.048231; Elcock LS, 2010, BIOCHEM SOC T, V38, P263, DOI 10.1042/BST0380263; Eskeland R, 2010, COLD SH Q B, V75, P71, DOI 10.1101/sqb.2010.75.053; Filion GJ, 2010, CELL, V143, P212, DOI 10.1016/j.cell.2010.09.009; Finlan LE, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000039; Foglietti C, 2006, J BIOL CHEM, V281, P17968, DOI 10.1074/jbc.M511945200; Gemkow MJ, 1998, DEVELOPMENT, V125, P4541; Gilchrist Susan, 2004, Chromosome Res, V12, P505; Gregory PD, 2001, EXP CELL RES, V265, P195, DOI 10.1006/excr.2001.5187; Guelen L, 2008, NATURE, V453, P948, DOI 10.1038/nature06947; HANSEN JC, 1992, BIOCHEMISTRY-US, V31, P7977, DOI 10.1021/bi00149a032; Holaska JM, 2007, BIOCHEMISTRY-US, V46, P8897, DOI 10.1021/bi602636m; Hurst LD, 2004, NAT REV GENET, V5, P299, DOI 10.1038/nrg1319; Ikegami K, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-12-r120; Kalmykova AI, 2005, NUCLEIC ACIDS RES, V33, P1435, DOI 10.1093/nar/gki281; Kharchenko PV, 2011, NATURE, V471, P480, DOI 10.1038/nature09725; Lande-Diner L, 2005, NAT REV GENET, V6, P648, DOI 10.1038/nrg1639; Lee HY, 2011, J BIOL CHEM, V286, P18834, DOI 10.1074/jbc.M111.221481; Lee JM, 2003, GENOME RES, V13, P875, DOI 10.1101/gr.737703; Lucio-Eterovic AK, 2008, BMC CANCER, V8, DOI 10.1186/1471-2407-8-243; Maraldi NM, 2011, J CELL BIOCHEM, V112, P979, DOI 10.1002/jcb.22992; Pennings JLA, 2011, TOXICOLOGY, V284, P63, DOI 10.1016/j.tox.2011.03.017; Peric-Hupkes D, 2010, COLD SH Q B, V75, P517, DOI 10.1101/sqb.2010.75.014; Peric-Hupkes D, 2010, MOL CELL, V38, P603, DOI 10.1016/j.molcel.2010.03.016; Pickersgill H, 2006, NAT GENET, V38, P1005, DOI 10.1038/ng1852; Pindyurin AV, 2007, J CELL SCI, V120, P2344, DOI 10.1242/jcs.006007; Reddy KL, 2008, METHODS, V45, P242, DOI 10.1016/j.ymeth.2008.06.013; RIDSDALE JA, 1990, J BIOL CHEM, V265, P5150; Sadoni N, 1999, J CELL BIOL, V146, P1211, DOI 10.1083/jcb.146.6.1211; Schwartz YB, 2006, NAT GENET, V38, P700, DOI 10.1038/ng1817; Shevelyov YY, 2009, P NATL ACAD SCI USA, V106, P3282, DOI 10.1073/pnas.0811933106; Somech R, 2005, J CELL SCI, V118, P4017, DOI 10.1242/jcs.02521; SPERLING K, 1985, CHROMOSOMA, V93, P38, DOI 10.1007/BF01259444; Towbin BD, 2010, COLD SH Q B, V75, P555, DOI 10.1101/sqb.2010.75.041; van Bemmel JG, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015013; Wagner N, 2004, EUR J CELL BIOL, V82, P605, DOI 10.1078/0171-9335-00350; Wagner N, 2007, INT REV CYTOL, V261, P1, DOI 10.1016/S0074-7696(07)61001-8; Wang ZB, 2008, NAT GENET, V40, P897, DOI 10.1038/ng.154; Wilmington S, 2008, 49 ANN DROS RES C SA; Ye Q, 1996, J BIOL CHEM, V271, P14653, DOI 10.1074/jbc.271.25.14653; Zink D, 2004, J CELL BIOL, V166, P815, DOI 10.1083/jcb.200404107; Zullo JM, 2012, CELL, V149, P1474, DOI 10.1016/j.cell.2012.04.035	48	30	30	2	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 30	2012	7	11							e49692	10.1371/journal.pone.0049692	http://dx.doi.org/10.1371/journal.pone.0049692			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	054WM	23226217	Green Published, Green Submitted, gold			2022-12-27	WOS:000312376100025
J	Pawaria, S; Kropp, LE; Binder, RJ				Pawaria, Sudesh; Kropp, Laura E.; Binder, Robert J.			Immunotherapy of Tumors with alpha(2)-Macroglobulin-Antigen Complexes Pre-Formed In Vivo	PLOS ONE			English	Article							HEAT-SHOCK PROTEINS; PEPTIDE COMPLEXES; T-CELLS; BINDING-PROTEIN; RECEPTOR; ANTIGEN; VACCINE; CD91; INHIBITORS; CANCER	The cell surface receptor CD91/LRP-1 binds to immunogenic heat shock proteins (HSP) and alpha M-2 ligands to elicit T cell immune responses. In order to generate specific immune responses, the peptides chaperoned by HSPs or alpha M-2 are cross-presented on MHC molecules to T cells. While the immunogenic HSPs naturally chaperone peptides within cells and can be purified as an intact HSP-peptide complex, the peptides have had to be complexed artificially to alpha M-2 in previous studies. Here, we show that immunogenic alpha M-2-peptide complexes can be isolated from the blood of tumor-bearing mice without further experimental manipulation in vitro demonstrating the natural association of tumor antigens with alpha M-2. The naturally formed immunogenic alpha M-2-peptide complexes are effective in prophylaxis and therapy of cancer in mouse models. We investigate the mechanisms of cross-presentation of associated peptides and co-stimulation by APCs that interact with alpha M-2. These data have implications for vaccine design in immunotherapy of cancer and infectious disease.	[Binder, Robert J.] Univ Pittsburgh, Dept Immunol, Pittsburgh, PA 15260 USA; [Pawaria, Sudesh] Univ Pittsburgh, Dept Rheumatol, Pittsburgh, PA USA; [Kropp, Laura E.] Univ Pittsburgh, Grad Sch Publ Hlth, Pittsburgh, PA USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Binder, RJ (corresponding author), Univ Pittsburgh, Dept Immunol, Pittsburgh, PA 15260 USA.	rjb42@pitt.edu			National Institutes of Health [AI079057, CA137133, CA90440]; NATIONAL CANCER INSTITUTE [P50CA090440, K22CA137133] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI079057] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by National Institutes of Health Grant AI079057, CA137133 and CA90440 to RJB. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baker AH, 2002, J CELL SCI, V115, P3719, DOI 10.1242/jcs.00063; Basu S, 2000, INT IMMUNOL, V12, P1539, DOI 10.1093/intimm/12.11.1539; Basu S, 2001, IMMUNITY, V14, P303, DOI 10.1016/S1074-7613(01)00111-X; Berwin B, 2003, EMBO J, V22, P6127, DOI 10.1093/emboj/cdg572; Binder RJ, 2005, NAT IMMUNOL, V6, P593, DOI 10.1038/ni1201; Binder RJ, 2004, METHODS, V32, P29, DOI 10.1016/S1046-2023(03)00184-1; Binder RJ, 2000, NAT IMMUNOL, V1, P151, DOI 10.1038/77835; Binder RJ, 2001, J IMMUNOL, V166, P4968, DOI 10.4049/jimmunol.166.8.4968; Binder Robert J, 2002, Cancer Immun, V2, P16; Binder RJ, 2009, CURR OPIN MOL THER, V11, P62; Birkenmeier G., 2001, MOD ASP IMMUNOBIOL, V2, P32; Blachere NE, 1997, J EXP MED, V186, P1315, DOI 10.1084/jem.186.8.1315; BORTH W, 1992, FASEB J, V6, P3345, DOI 10.1096/fasebj.6.15.1281457; CHU CT, 1993, J IMMUNOL, V150, P48; Feige JJ, 1996, HORM RES, V45, P227, DOI 10.1159/000184793; Hekim C, 2010, PROSTATE, V70, P482, DOI 10.1002/pros.21082; Herz J, 2001, J CLIN INVEST, V108, P779, DOI 10.1172/JCI200113992; Jockheck-Clark AR, 2010, J IMMUNOL, V185, P6819, DOI 10.4049/jimmunol.1000448; Karanikas V, 2010, IMMUNOL CELL BIOL, V88, P575, DOI 10.1038/icb.2010.8; KLEIN G, 1960, CANCER RES, V20, P1561; LEGRES LG, 1995, J BIOL CHEM, V270, P8381, DOI 10.1074/jbc.270.15.8381; Misra UK, 2004, CELL SIGNAL, V16, P929, DOI 10.1016/j.cellsig.2004.01.003; MITSUDA S, 1993, BIOCHEM BIOPH RES CO, V194, P1155, DOI 10.1006/bbrc.1993.1943; Mo A, 2011, VACCINE, V29, P8530, DOI 10.1016/j.vaccine.2011.07.011; Pawaria S, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1524; Schreiber RD, 2011, SCIENCE, V331, P1565, DOI 10.1126/science.1203486; SHASTRI N, 1993, J IMMUNOL, V150, P2724; Srivastava N, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006094; Srivastava PK, 2009, EXPERT OPIN BIOL TH, V9, P179, DOI [10.1517/14712590802633918, 10.1517/14712590802633918 ]; SUTO R, 1995, SCIENCE, V269, P1585, DOI 10.1126/science.7545313; Tamura Y, 1997, SCIENCE, V278, P117, DOI 10.1126/science.278.5335.117; Testori A, 2008, J CLIN ONCOL, V26, P955, DOI 10.1200/JCO.2007.11.9941; TRAVIS J, 1983, ANNU REV BIOCHEM, V52, P655, DOI 10.1146/annurev.bi.52.070183.003255; VANLEUVEN F, 1982, BIOCHEM J, V201, P119, DOI 10.1042/bj2010119; WILLNOW TE, 1994, SCIENCE, V264, P1471, DOI 10.1126/science.7515194; Wood C, 2008, LANCET, V372, P145, DOI 10.1016/S0140-6736(08)60697-2	36	6	7	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 30	2012	7	11							e50365	10.1371/journal.pone.0050365	http://dx.doi.org/10.1371/journal.pone.0050365			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	054WM	23226267	gold, Green Submitted, Green Published			2022-12-27	WOS:000312376100077
J	Gehler, A; Tutken, T; Pack, A				Gehler, Alexander; Tuetken, Thomas; Pack, Andreas			Oxygen and Carbon Isotope Variations in a Modern Rodent Community - Implications for Palaeoenvironmental Reconstructions	PLOS ONE			English	Article							DIRECT LASER FLUORINATION; HERBIVORE TOOTH ENAMEL; STABLE-ISOTOPE; C-13/C-12 RATIOS; BONE PHOSPHATE; DIAGENETIC ALTERATION; FORAGING ECOLOGY; MAMMAL TEETH; SOUTH-AFRICA; INTRA-TOOTH	Background: The oxygen (delta O-18) and carbon (delta C-13) isotope compositions of bioapatite from skeletal remains of fossil mammals are well-established proxies for the reconstruction of palaeoenvironmental and palaeoclimatic conditions. Stable isotope studies of modern analogues are an important prerequisite for such reconstructions from fossil mammal remains. While numerous studies have investigated modern large-and medium-sized mammals, comparable studies are rare for small mammals. Due to their high abundance in terrestrial ecosystems, short life spans and small habitat size, small mammals are good recorders of local environments. Methodology/Findings: The delta O-18 and delta C-13 values of teeth and bones of seven sympatric modern rodent species collected from owl pellets at a single locality were measured, and the inter-specific, intra-specific and intra-individual variations were evaluated. Minimum sample sizes to obtain reproducible population delta O-18 means within one standard deviation were determined. These parameters are comparable to existing data from large mammals. Additionally, the fractionation between coexisting carbonate (delta O-18(CO3)) and phosphate (delta O-18(PO4)) in rodent bioapatite was determined, and delta O-18 values were compared to existing calibration equations between the delta O-18 of rodent bioapatite and local surface water (delta O-18(LW)). Specific calibration equations between delta O-18(PO4) and delta O-18(LW) may be applicable on a taxonomic level higher than the species. However, a significant bias can occur when bone-based equations are applied to tooth-data and vice versa, which is due to differences in skeletal tissue formation times. delta C-13 values reflect the rodents' diet and agree well with field observations of their nutritional behaviour. Conclusions/Significance: Rodents have a high potential for the reconstruction of palaeoenvironmental conditions by means of bioapatite delta O-18 and delta C-18 analysis. No significant disadvantages compared to larger mammals were observed. However, for refined palaeoenvironmental reconstructions a better understanding of stable isotope signatures in modern analogous communities and potential biases due to seasonality effects, population dynamics and tissue formation rates is necessary.	[Gehler, Alexander; Pack, Andreas] Univ Gottingen, Geowissensch Zentrum, Abt Isotopengeol, Gottingen, Germany; [Tuetken, Thomas] Univ Bonn, Steinmann Inst Geol Mineral & Palaontol, Emmy Noether Grp Knochengeochem, Bonn, Germany	University of Gottingen; University of Bonn	Gehler, A (corresponding author), Univ Gottingen, Geowissensch Zentrum, Abt Isotopengeol, Gottingen, Germany.	agehler@gwdg.de	Tütken, Thomas/E-4988-2010	Pack, Andreas/0000-0002-2618-2768; Tutken, Thomas/0000-0002-2590-8600	German National Science Foundation DFG grant [PA909/5-1]; DFG [TU148/2-1]	German National Science Foundation DFG grant(German Research Foundation (DFG)); DFG(German Research Foundation (DFG))	Funding was provided by the German National Science Foundation DFG grant PA909/5-1 (A.P.) and DFG grant TU148/2-1 (TT, Emmy Noether-Group "BoneGeochemistry''). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ambrose S. H., 1993, PREHISTORIC HUMAN BO, P1; Balasse M, 2003, J ARCHAEOL SCI, V30, P205, DOI 10.1006/jasc.2002.0833; Balasse M, 2002, J ARCHAEOL SCI, V29, P917, DOI 10.1006/jasc.2001.0787; BAUMLER W, 1986, ANZ SCHADLINGSKD PFL, V59, P112, DOI 10.1007/BF01903220; Becker K, 1978, HDB SAUGETIERE EUROP, P401; BENDER MM, 1971, PHYTOCHEMISTRY, V10, P1239, DOI 10.1016/S0031-9422(00)84324-1; BENDER MM, 1973, PLANT PHYSIOL, V52, P427, DOI 10.1104/pp.52.5.427; Bocherens H, 1996, PALAIOS, V11, P306, DOI 10.2307/3515241; BOWES G, 1993, ANNU REV PLANT PHYS, V44, P309, DOI 10.1146/annurev.pp.44.060193.001521; Bryant JD, 1996, GEOCHIM COSMOCHIM AC, V60, P5145; BRYANT JD, 1995, GEOCHIM COSMOCHIM AC, V59, P4523; CERLING TE, 1993, NATURE, V361, P344, DOI 10.1038/361344a0; Cerling TE, 2004, OECOLOGIA, V138, P5, DOI 10.1007/s00442-003-1375-4; Cerling TE, 1997, J HUM EVOL, V33, P635, DOI 10.1006/jhev.1997.0151; Cerling TE, 1999, OECOLOGIA, V120, P364, DOI 10.1007/s004420050869; Clementz MT, 2001, OECOLOGIA, V129, P461, DOI 10.1007/s004420100745; COPLEN TB, 1994, PURE APPL CHEM, V66, P273, DOI 10.1351/pac199466020273; DANGELA D, 1990, CHEM GEOL, V86, P75, DOI 10.1016/0168-9622(90)90007-Y; DANSGAARD W, 1964, TELLUS, V16, P436; Deines P, 1980, HDB ENV GEOCHEMISTRY, V1, P239; DENIRO MJ, 1978, GEOCHIM COSMOCHIM AC, V42, P495, DOI 10.1016/0016-7037(78)90199-0; DeSantis LG, 2011, BIOTROPICA, V43, P746, DOI 10.1111/j.1744-7429.2011.00761.x; Dettman DL, 2001, GEOLOGY, V29, P31, DOI 10.1130/0091-7613(2001)029<0031:SSIEFA>2.0.CO;2; Drucker D, 2003, PALAEOGEOGR PALAEOCL, V195, P375, DOI 10.1016/S0031-0182(03)00366-3; Drucker DG, 2008, PALAEOGEOGR PALAEOCL, V266, P69, DOI 10.1016/j.palaeo.2008.03.020; EHLERINGER JR, 1988, OECOLOGIA, V76, P562, DOI 10.1007/BF00397870; FARQUHAR GD, 1989, ANNU REV PLANT PHYS, V40, P503, DOI 10.1146/annurev.pp.40.060189.002443; Feranec RS, 2007, PALAEOGEOGR PALAEOCL, V252, P575, DOI 10.1016/j.palaeo.2007.05.012; Feranec RS, 2006, PALEOBIOLOGY, V32, P191, DOI 10.1666/05006.1; Fox-Dobbs K, 2007, CAN J ZOOL, V85, P458, DOI 10.1139/Z07-018; Freye HA, 1960, HAUSMAUS; Fricke HC, 1996, PALAEOGEOGR PALAEOCL, V126, P91, DOI 10.1016/S0031-0182(96)00072-7; Fricke HC, 1999, EARTH PLANET SC LETT, V170, P181, DOI 10.1016/S0012-821X(99)00105-3; Gehler A, 2011, PALAEOGEOGR PALAEOCL, V310, P84, DOI 10.1016/j.palaeo.2011.04.014; Grimes ST, 2005, GEOLOGY, V33, P189, DOI 10.1130/G21019.1; Grimes ST, 2004, QUATERNARY SCI REV, V23, P967, DOI 10.1016/j.quascirev.2003.06.023; Grimes ST, 2004, PALAEOGEOGR PALAEOCL, V208, P103, DOI 10.1016/j.palaeo.2004.02.031; Grimes ST, 2003, GEOCHIM COSMOCHIM AC, V67, P4033, DOI 10.1016/S0016-7037(03)00173-X; Grimes ST, 2008, PALAEOGEOGR PALAEOCL, V266, P39, DOI 10.1016/j.palaeo.2008.03.014; Harris JM, 2002, J ZOOL, V256, P45, DOI 10.1017/S0952836902000067; Heaton THE, 1999, J ARCHAEOL SCI, V26, P637, DOI 10.1006/jasc.1998.0381; Heran MA, 2010, PALAEOGEOGR PALAEOCL, V285, P331, DOI 10.1016/j.palaeo.2009.11.030; Hopley PJ, 2006, PALAEOGEOGR PALAEOCL, V233, P235, DOI 10.1016/j.palaeo.2005.09.011; Hoppe KA, 2006, EARTH PLANET SC LETT, V244, P408, DOI 10.1016/j.epsl.2006.01.062; Hoppe KA, 2005, QUATERNARY RES, V64, P138, DOI 10.1016/j.yqres.2005.05.007; Hoppe KA, 2004, PALAEOGEOGR PALAEOCL, V203, P299, DOI 10.1016/S0031-0182(03)00688-6; Hynek SA, 2012, EARTH PLANET SC LETT, V321, P177, DOI 10.1016/j.epsl.2011.12.038; Iacumin P, 1996, EARTH PLANET SC LETT, V142, P1, DOI 10.1016/0012-821X(96)00093-3; IAEA/WISER, 2011, WAT IS SYST DAT AN V; Jones AM, 1999, CHEM GEOL, V153, P241, DOI 10.1016/S0009-2541(98)00162-4; Kemp T. S., 2007, ORIGIN EVOLUTION MAM; Kirsanow K, 2011, PALAEOGEOGR PALAEOCL, V310, P9, DOI 10.1016/j.palaeo.2011.03.022; Klevezal G., 1996, RECORDING STRUCTURES; KLEVEZAL GA, 1990, ACTA THERIOL, V35, P331, DOI 10.4098/AT.arch.90-38; Koch PL, 1997, J ARCHAEOL SCI, V24, P417, DOI 10.1006/jasc.1996.0126; KOENIGSWALD WV, 1979, J MAMMAL, V60, P397, DOI 10.2307/1379813; Kohn MJ, 1996, GEOCHIM COSMOCHIM AC, V60, P3889, DOI 10.1016/0016-7037(96)00248-7; Kohn MJ, 2002, REV MINERAL GEOCHEM, V48, P455, DOI 10.2138/rmg.2002.48.12; Krapp F., 1982, P349; LAND LS, 1980, PALAEOGEOGR PALAEOCL, V32, P143, DOI 10.1016/0031-0182(80)90037-1; Levin NE, 2006, P NATL ACAD SCI USA, V103, P11201, DOI 10.1073/pnas.0604719103; Lindars ES, 2001, GEOCHIM COSMOCHIM AC, V65, P2535, DOI 10.1016/S0016-7037(01)00606-8; LONGINELLI A, 1984, GEOCHIM COSMOCHIM AC, V48, P385, DOI 10.1016/0016-7037(84)90259-X; Longinelli A, 2003, EARTH PLANET SC LETT, V214, P491, DOI 10.1016/S0012-821X(03)00395-9; LOWDON JA, 1974, CAN J EARTH SCI, V11, P79, DOI 10.1139/e74-007; LUZ B, 1985, EARTH PLANET SC LETT, V75, P29, DOI 10.1016/0012-821X(85)90047-0; LUZ B, 1984, GEOCHIM COSMOCHIM AC, V48, P1689, DOI 10.1016/0016-7037(84)90338-7; Luz B., 1999, GEOARCHAEOLOGY, V14, P1; Macfadden BJ, 1996, J VERTEBR PALEONTOL, V16, P103, DOI 10.1080/02724634.1996.10011288; MACFADDEN BJ, 1994, PALAEOGEOGR PALAEOCL, V107, P257, DOI 10.1016/0031-0182(94)90098-1; MacFadden BJ, 2004, OECOLOGIA, V140, P169, DOI 10.1007/s00442-004-1571-x; MacFadden BJ, 1999, SCIENCE, V283, P824, DOI 10.1126/science.283.5403.824; Mariotti A., 1991, Cahiers ORSTOM, Serie Pedologie, V26, P299; Martin C, 2008, PALAEOGEOGR PALAEOCL, V266, P183, DOI 10.1016/j.palaeo.2008.03.039; MEDINA E, 1980, OECOLOGIA, V45, P377, DOI 10.1007/BF00540209; Navarro N, 2004, QUATERNARY RES, V62, P172, DOI 10.1016/j.yqres.2004.06.001; Nelson SV, 2007, PALAEOGEOGR PALAEOCL, V243, P204, DOI 10.1016/j.palaeo.2006.07.017; Niethammer J., 1982, P284; Niethammer J, 1978, HDB SAUGETIERE EUROP, P337; Norrdahl K, 2002, ECOGRAPHY, V25, P428, DOI 10.1034/j.1600-0587.2002.250405.x; OLEARY MH, 1988, BIOSCIENCE, V38, P328, DOI 10.2307/1310735; Passey BH, 2005, J ARCHAEOL SCI, V32, P1459, DOI 10.1016/j.jas.2005.03.015; Pellegrini M, 2011, PALAEOGEOGR PALAEOCL, V310, P71, DOI 10.1016/j.palaeo.2011.02.023; QUADE J, 1992, CHEM GEOL, V94, P183, DOI 10.1016/0168-9622(92)90011-X; QUADE J, 1995, J HUM EVOL, V28, P373, DOI 10.1006/jhev.1995.1029; Reichstein H., 1982, P217; Reichstein H, 1978, HDB SAUGETIERE EUROP, P421; Rogers KL, 2002, QUATERNARY RES, V57, P200, DOI 10.1006/qres.2001.2309; Rozanski K, 1997, HYDROLOG SCI J, V42, P725, DOI 10.1080/02626669709492069; Rozanski K., 1993, CLIMATE CHANGE CONTI, V78, P1, DOI DOI 10.1029/GM078P0001; Ruddy Mark, 2008, Quaternary Newsletter, V116, P51; Salamolard M, 2000, ECOLOGY, V81, P2428, DOI 10.1890/0012-9658(2000)081[2428:ROAAPT]2.0.CO;2; Sayed OH, 2001, PHOTOSYNTHETICA, V39, P339, DOI 10.1023/A:1020292623960; Schonfeld M, 1977, Hercynia N.F., V14, P303; Schonfeld M., 1975, Hercynia N F, V12, P257; Still CJ, 2003, GLOBAL BIOGEOCHEM CY, V17, DOI 10.1029/2001GB001807; Stubbe M., 1982, Hercynia, V19, P110; TING IP, 1985, ANNU REV PLANT PHYS, V36, P595; Toth E, 2010, GEOL MAG, V147, P299, DOI 10.1017/S0016756809990203; Tutken T, 2006, PALAEOGEOGR PALAEOCL, V241, P457, DOI 10.1016/j.palaeo.2006.04.007; Tutken T, 2009, PALAEONTOL Z, V83, P207, DOI 10.1007/s12542-009-0011-y; VANDERMERWE NJ, 1989, GEOCHIM COSMOCHIM AC, V53, P1091, DOI 10.1016/0016-7037(89)90213-5; VANDERMERWE NJ, 1991, J ARCHAEOL SCI, V18, P249, DOI 10.1016/0305-4403(91)90064-V; Vennemann TW, 2002, CHEM GEOL, V185, P321, DOI 10.1016/S0009-2541(01)00413-2; Viro P., 1982, P109; VOGEL JC, 1978, OECOLOG PLANTAR, V13, P89; von Bulow Bernd, 1997, Natur und Heimat, V57, P37; Wang Y, 2008, PALAEOGEOGR PALAEOCL, V260, P359, DOI 10.1016/j.palaeo.2007.11.012; Yeakel JD, 2007, P ROY SOC B-BIOL SCI, V274, P1723, DOI 10.1098/rspb.2007.0330; YLONEN H, 1991, ANN ZOOL FENN, V28, P7; Zanazzi A, 2008, PALAEOGEOGR PALAEOCL, V257, P22, DOI 10.1016/j.palaeo.2007.08.007; Zazzo A, 2004, GEOCHIM COSMOCHIM AC, V68, P2245, DOI 10.1016/j.gca.2003.11.009; Zazzo A, 2001, VALIDATION METHODOLO	113	55	56	0	47	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 19	2012	7	11							e49531	10.1371/journal.pone.0049531	http://dx.doi.org/10.1371/journal.pone.0049531			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	040PB	23226212	Green Submitted, Green Published, gold			2022-12-27	WOS:000311333800031
J	Mesman, AW; de Vries, RD; McQuaid, S; Duprex, WP; de Swart, RL; Geijtenbeek, TBH				Mesman, Annelies W.; de Vries, Rory D.; McQuaid, Stephen; Duprex, W. Paul; de Swart, Rik L.; Geijtenbeek, Teunis B. H.			A Prominent Role for DC-SIGN(+) Dendritic Cells in Initiation and Dissemination of Measles Virus Infection in Non-Human Primates	PLOS ONE			English	Article							LECTIN DC-SIGN; ALVEOLAR MACROPHAGES; IMMUNE-RESPONSES; IN-VITRO; RECEPTOR; MACAQUES; PROTEIN; SLAM; IMMUNOSUPPRESSION; IMMUNIZATION	Measles virus (MV) is a highly contagious virus that is transmitted by aerosols. During systemic infection, CD150(+) T and B lymphocytes in blood and lymphoid tissues are the main cells infected by pathogenic MV. However, it is unclear which cell types are the primary targets for MV in the lungs and how the virus reaches the lymphoid tissues. In vitro studies have shown that dendritic cell (DC) C-type lectin DC-SIGN captures MV, leading to infection of DCs as well as transmission to lymphocytes. However, evidence of DC-SIGN-mediated transmission in vivo has not been established. Here we identified DC-SIGN hi DCs as first target cells in vivo and demonstrate that macaque DC-SIGN functions as an attachment receptor for MV. Notably, DC-SIGN hi cells from macaque broncho-alveolar lavage and lymph nodes transmit MV to B lymphocytes, providing in vivo support for an important role for DCs in both initiation and dissemination of MV infection. Citation: Mesman AW, de Vries RD, McQuaid S, Duprex WP, de Swart RL, et al. (2012) A Prominent Role for DC-SIGN(+) Dendritic Cells in Initiation and Dissemination of Measles Virus Infection in Non-Human Primates. PLoS ONE 7(12): e49573. doi:10.1371/journal.pone.0049573	[Mesman, Annelies W.; Geijtenbeek, Teunis B. H.] Univ Amsterdam, Acad Med Ctr, Dept Expt Immunol, NL-1105 AZ Amsterdam, Netherlands; [de Vries, Rory D.; de Swart, Rik L.] Erasmus MC, Virosci Lab, Rotterdam, Netherlands; [McQuaid, Stephen] Queens Univ Belfast, Belfast Hlth & Social Care Trust, Belfast, Antrim, North Ireland; [Duprex, W. Paul] Boston Univ, Sch Med, Dept Microbiol, Boston, MA 02118 USA	University of Amsterdam; Academic Medical Center Amsterdam; Erasmus University Rotterdam; Erasmus MC; Queens University Belfast; Boston University	Geijtenbeek, TBH (corresponding author), Univ Amsterdam, Acad Med Ctr, Dept Expt Immunol, Meibergdreef 9, NL-1105 AZ Amsterdam, Netherlands.	t.b.geijtenbeek@amc.uva.nl	de Vries, Rory D/L-2264-2015; de Swart, Rik L./E-6508-2011	de Vries, Rory D/0000-0003-2817-0127; de Swart, Rik L./0000-0003-3599-8969; Duprex, W Paul/0000-0003-1716-6376	ZonMw [9120812]; MRC [G0801001]; Medical Research Council [G0801001] Funding Source: researchfish	ZonMw(Netherlands Organization for Health Research and Development); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	These studies were funded by ZonMw (grant 9120812) and MRC (grant G0801001). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2011, Wkly Epidemiol Rec, V86, P129; Banchereau J, 1998, NATURE, V392, P245, DOI 10.1038/32588; Baron MD, 2005, J GEN VIROL, V86, P1753, DOI 10.1099/vir.0.80836-0; Bieback K, 2002, J VIROL, V76, P8729, DOI 10.1128/JVI.76.17.8729-8736.2002; Cook Donald N, 2007, Proc Am Thorac Soc, V4, P234, DOI 10.1513/pats.200701-026AW; Cutts FT, 1997, BIOLOGICALS, V25, P323, DOI 10.1006/biol.1997.0103; de Jong MAWP, 2008, J GEN VIROL, V89, P2398, DOI 10.1099/vir.0.2008/003129-0; de Swart RL, 2007, PLOS PATHOG, V3, P1771, DOI 10.1371/journal.ppat.0030178; de Swart RL, 2007, VACCINE, V25, P1183, DOI 10.1016/j.vaccine.2006.10.019; de Vries RD, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002885; de Witte L, 2006, J VIROL, V80, P3477, DOI 10.1128/JVI.80.7.3477-3486.2006; de Witte L, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000049; Ferreira CSA, 2010, J VIROL, V84, P3033, DOI 10.1128/JVI.01559-09; Galli SJ, 2011, NAT IMMUNOL, V12, P1035, DOI 10.1038/ni.2109; Geijtenbeek TBH, 2001, IMMUNOL LETT, V79, P101, DOI 10.1016/S0165-2478(01)00279-6; Geijtenbeek TBH, 2000, CELL, V100, P587, DOI 10.1016/S0092-8674(00)80694-7; Geijtenbeek TBH, 2000, CELL, V100, P575, DOI 10.1016/S0092-8674(00)80693-5; Geissmann F, 2010, SCIENCE, V327, P656, DOI 10.1126/science.1178331; GeurtsvanKessel CH, 2009, J EXP MED, V206, P2339, DOI 10.1084/jem.20090410; Griffin DE, 2010, IMMUNOL REV, V236, P176, DOI 10.1111/j.1600-065X.2010.00925.x; Gringhuis SI, 2007, IMMUNITY, V26, P605, DOI 10.1016/j.immuni.2007.03.012; Hadac EM, 2011, J VIROL METHODS, V176, P78, DOI 10.1016/j.jviromet.2011.06.005; Halle S, 2009, J EXP MED, V206, P2593, DOI 10.1084/jem.20091472; Kobune F, 1996, LAB ANIM SCI, V46, P315; Legge KL, 2003, IMMUNITY, V18, P265, DOI 10.1016/S1074-7613(03)00023-2; Lemon K, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1001263; Lin WH, 2011, P NATL ACAD SCI USA, V108, P2987, DOI 10.1073/pnas.1017334108; Masten BJ, 2006, J IMMUNOL, V177, P7784, DOI 10.4049/jimmunol.177.11.7784; McChesney MB, 1997, VIROLOGY, V233, P74, DOI 10.1006/viro.1997.8576; McGill J, 2009, J LEUKOCYTE BIOL, V86, P803, DOI 10.1189/jlb.0509368; Muhlebach MD, 2011, NATURE, V480, P530, DOI 10.1038/nature10639; Noyce RS, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002240; Randall TD, 2010, J EXP MED, V207, P451, DOI 10.1084/jem.20100059; Schneider-Schaulies S, 2009, CURR TOP MICROBIOL, V330, P243; Schnorr JJ, 1997, P NATL ACAD SCI USA, V94, P5326, DOI 10.1073/pnas.94.10.5326; Servet-Delprat C, 2000, J IMMUNOL, V164, P1753, DOI 10.4049/jimmunol.164.4.1753; Soilleux EJ, 2002, J LEUKOCYTE BIOL, V71, P445; Tailleux L, 2005, PLOS MED, V2, P1269, DOI 10.1371/journal.pmed.0020381; Tatsuo H, 2000, NATURE, V406, P893, DOI 10.1038/35022579; Ten Berge B, 2009, J IMMUNOL METHODS, V351, P13, DOI 10.1016/j.jim.2009.09.009; Valdespino-Gomez JL, 2006, CURR TOP MICROBIOL, V304, P165; VANBINNENDIJK RS, 1994, J INFECT DIS, V170, P443, DOI 10.1093/infdis/170.2.443; Zilliox MJ, 2006, P NATL ACAD SCI USA, V103, P3363, DOI 10.1073/pnas.0511345103	43	32	32	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 5	2012	7	12							e49573	10.1371/journal.pone.0049573	http://dx.doi.org/10.1371/journal.pone.0049573			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	057TZ	23227146	Green Published, gold, Green Submitted			2022-12-27	WOS:000312588200009
J	Scheper, TVO; Mansvelder, HD; van Ooyen, A				Scheper, Tjeerd V. Olde; Mansvelder, Huibert D.; van Ooyen, Arjen			Short Term Depression Unmasks the Ghost Frequency	PLOS ONE			English	Article							COCHLEAR NUCLEUS; NEURAL MECHANISM; AUDITORY-NERVE; SPIKE TRAINS; NEURONS; CELLS; MODEL; PITCH; INFORMATION; SIMULATION	Short Term Plasticity (STP) has been shown to exist extensively in synapses throughout the brain. Its function is more or less clear in the sense that it alters the probability of synaptic transmission at short time scales. However, it is still unclear what effect STP has on the dynamics of neural networks. We show, using a novel dynamic STP model, that Short Term Depression (STD) can affect the phase of frequency coded input such that small networks can perform temporal signal summation and determination with high accuracy. We show that this property of STD can readily solve the problem of the ghost frequency, the perceived pitch of a harmonic complex in absence of the base frequency. Additionally, we demonstrate that this property can explain dynamics in larger networks. By means of two models, one of chopper neurons in the Ventral Cochlear Nucleus and one of a cortical microcircuit with inhibitory Martinotti neurons, it is shown that the dynamics in these microcircuits can reliably be reproduced using STP. Our model of STP gives important insights into the potential roles of STP in self-regulation of cortical activity and long-range afferent input in neuronal microcircuits. Citation: olde Scheper TV, Mansvelder HD, van Ooyen A (2012) Short Term Depression Unmasks the Ghost Frequency. PLoS ONE 7(12): e50189. doi:10.1371/journal.pone.0050189	[Scheper, Tjeerd V. Olde; Mansvelder, Huibert D.; van Ooyen, Arjen] Vrije Univ Amsterdam, Dept Integrat Neurophysiol, Ctr Neurogenom & Cognit Res, Amsterdam, Netherlands; [Scheper, Tjeerd V. Olde] Oxford Brookes Univ, Fac Technol Design & Environm, Dept Comp & Commun Technol, Oxford OX3 0BP, England	Vrije Universiteit Amsterdam; Oxford Brookes University	Scheper, TVO (corresponding author), Vrije Univ Amsterdam, Dept Integrat Neurophysiol, Ctr Neurogenom & Cognit Res, Amsterdam, Netherlands.	tvolde-scheper@brookes.ac.uk	Scheper, Thomas/H-8143-2013; Mansvelder, Huibert/N-6138-2018	Mansvelder, Huibert/0000-0003-1365-5340; olde Scheper, Tjeerd/0000-0003-1441-1444	EU BIO-ICT Project SECO [216593]	EU BIO-ICT Project SECO	This work was supported by EU BIO-ICT Project SECO (216593). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Backoff PM, 1997, HEARING RES, V110, P155, DOI 10.1016/S0378-5955(97)00081-6; Bahmer A, 2006, BIOL CYBERN, V95, P381, DOI 10.1007/s00422-006-0091-7; Bahmer A, 2009, BIOL CYBERN, V100, P21, DOI 10.1007/s00422-008-0276-3; Balaguer-Ballester E, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000301; Balenzuela P, 2005, CHAOS, V15, DOI 10.1063/1.1871612; Bendor D, 2007, NAT NEUROSCI, V10, P763, DOI 10.1038/nn1888; Boudreau CE, 2005, J NEUROSCI, V25, P7179, DOI 10.1523/JNEUROSCI.1445-05.2005; Cao XJ, 2007, J NEUROPHYSIOL, V97, P3961, DOI 10.1152/jn.00052.2007; Chase SM, 2008, J NEUROPHYSIOL, V99, P1672, DOI 10.1152/jn.00644.2007; Chialvo DR, 2003, CHAOS, V13, P1226, DOI 10.1063/1.1617771; David SV, 2009, J NEUROSCI, V29, P3374, DOI 10.1523/JNEUROSCI.5249-08.2009; de Cheveigne A, 2005, SPR HDB AUD, V24, P169; Faisal AA, 2008, NAT REV NEUROSCI, V9, P292, DOI 10.1038/nrn2258; Ferragamo MJ, 1998, J NEUROPHYSIOL, V79, P51, DOI 10.1152/jn.1998.79.1.51; FITZHUGH R, 1961, BIOPHYS J, V1, P445, DOI 10.1016/S0006-3495(61)86902-6; Gockel HE, 2007, J ACOUST SOC AM, V121, P373, DOI 10.1121/1.2382476; HINDMARSH JL, 1984, PROC R SOC SER B-BIO, V221, P87, DOI 10.1098/rspb.1984.0024; Izhikevich EM, 2004, IEEE T NEURAL NETWOR, V15, P1063, DOI 10.1109/TNN.2004.832719; Klapuri A, 2006, SIGNAL PROCESSING ME, P229; Klyachko VA, 2006, PLOS BIOL, V4, P1187, DOI 10.1371/journal.pbio.0040207; Koch Christof, 1999, P1; Larsen E, 2008, J NEUROPHYSIOL, V100, P1301, DOI 10.1152/jn.01361.2007; MacLeod KM, 2007, J NEUROPHYSIOL, V97, P2863, DOI 10.1152/jn.01030.2006; Manjarrez E, 2007, BIOSYSTEMS, V90, P379, DOI 10.1016/j.biosystems.2006.10.002; Mino H, 2007, IEEE T BIO-MED ENG, V54, P360, DOI 10.1109/TBME.2006.890486; Pinto RD, 2000, NEURON, P26; Plack CJ, 2006, J NEUROSCI, V26, P8767, DOI 10.1523/JNEUROSCI.1134-06.2006; Planert H, 2010, J NEUROSCI, V30, P3499, DOI 10.1523/JNEUROSCI.5139-09.2010; RALL W, 1967, J NEUROPHYSIOL, V30, P1138, DOI 10.1152/jn.1967.30.5.1138; Rothman JS, 2009, NATURE, V457, P1015, DOI 10.1038/nature07604; Sayles M, 2008, J NEUROSCI, V28, P11925, DOI 10.1523/JNEUROSCI.3137-08.2008; Silberberg G, 2007, NEURON, V53, P735, DOI 10.1016/j.neuron.2007.02.012; Taschenberger H, 2000, J NEUROSCI, V20, P9162; Trussell L, 2002, CELLULAR MECH INFORM; Tsodyks M, 2000, J NEUROSCI, V20; Tsodyks M, 1998, NEURAL COMPUT, V10, P821, DOI 10.1162/089976698300017502; von Gersdorff H, 2002, NAT REV NEUROSCI, V3, P53, DOI 10.1038/nrn705	37	1	1	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 5	2012	7	12							e50189	10.1371/journal.pone.0050189	http://dx.doi.org/10.1371/journal.pone.0050189			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	057TZ	23227159	Green Published, gold, Green Submitted			2022-12-27	WOS:000312588200021
J	Wang, N; Yang, C; Xie, F; Sun, LH; Su, XL; Wang, Y; Wei, R; Zhang, R; Li, X; Yang, BF; Ai, J				Wang, Ning; Yang, Chao; Xie, Fang; Sun, Lihua; Su, Xiaolin; Wang, Ying; Wei, Ran; Zhang, Rong; Li, Xia; Yang, Baofeng; Ai, Jing			Gadd45 alpha: A Novel Diabetes-Associated Gene Potentially Linking Diabetic Cardiomyopathy and Baroreflex Dysfunction	PLOS ONE			English	Article							CIRCULATING MICRORNAS; ADENOSINE-DEAMINASE; NUCLEUS AMBIGUUS; EXPRESSION; CELLS; IDENTIFICATION; HISTONE; ALPHA; DIFFERENTIATION; HYPERTROPHY	Both diabetic cardiomyopathy (DCM) and baroreflex dysfunction independently contribute to sudden cardiac death (SCD), however the inherent connections between them under diabetic state remains unclear. As microRNAs (miRNAs) have been reported to participate in various physiological and pathological processes, we presume they may also be involved in DCM and DM-induced impairment of baroreflex sensitivity. Two sets of gene expression profiles data from streptozotocin (STZ)-induced diabetic heart and diabetic dorsal root ganglia (DDRG) were retrieved from GEO and ArrayExpress. Co-differentially-expressed genes in diabetic heart and DDRG were identified by t test and intersection analysis. Human Protein Reference Database (HPRD) was applied to find direct interacting proteins of Gadd45 alpha. Differentially-expressed miRNAs in left ventricle from 4-week STZ-induced diabetic rats were screened by miRNA microarray. Expression of miR-499 and its regulating effect on Gadd45 alpha were then verified by quantitative real-time PCR (qRT-PCR), western blot, computational predication, and dual-luciferase reporter analysis. Four co-differentially-expressed genes in DCM and DDRG were identified. Among these genes, Gadd45 alpha has 16 direct interacting proteins and 11 of them are documentedly associated with DM. Accompanied with significantly increased miR-499 expression, Gadd45 alpha expression was increased at mRNA level but decreased at protein level in both diabetic heart and nucleus ambiguous. Furthermore, miR-499 was confirmed negatively regulating Gadd45 alpha by targeting its 3'UTR. Collectively, reduced Gadd45 alpha protein expression by forced miR-499 expression indicated it's a diabetes-associated gene which might potentially be involved in both DCM and DM-induced baroreflex dysfunction.	[Wang, Ning; Yang, Chao; Xie, Fang; Sun, Lihua; Su, Xiaolin; Wang, Ying; Wei, Ran; Zhang, Rong; Yang, Baofeng; Ai, Jing] Harbin Med Univ, Dept Pharmacol, State Prov Key Lab Biomed Pharmaceut China, Harbin, Peoples R China; [Wang, Ning; Sun, Lihua; Zhang, Rong; Yang, Baofeng; Ai, Jing] Minist Educ China, Key Lab Cardiovasc Res, Harbin, Peoples R China; [Li, Xia] Harbin Med Univ, Coll Bioinformat Sci & Technol, Harbin, Peoples R China	Harbin Medical University; Ministry of Education, China; Harbin Medical University	Ai, J (corresponding author), Harbin Med Univ, Dept Pharmacol, State Prov Key Lab Biomed Pharmaceut China, Harbin, Peoples R China.	a.z.hrbmu@gmail.com	li, xia/HHZ-7468-2022		Funds for Natural Science Foundation of China [81271207, 81070882]; Creative Research Groups of the National Natural Science Foundation of China [81121003]; Outstanding Youth Foundation of Heilongjiang Province [JC200904]	Funds for Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Creative Research Groups of the National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Outstanding Youth Foundation of Heilongjiang Province	This study was supported by the Funds for Natural Science Foundation of China (81271207, 81070882), Creative Research Groups of the National Natural Science Foundation of China (81121003), the Outstanding Youth Foundation of Heilongjiang Province (JC200904). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adachi T, 2010, CLIN CHEM, V56, P1183, DOI 10.1373/clinchem.2010.144121; Al-Douahji M, 1999, KIDNEY INT, V56, P1691, DOI 10.1046/j.1523-1755.1999.00728.x; Balkau B, 1999, LANCET, V354, P1968, DOI 10.1016/S0140-6736(99)04383-4; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Brizzi MF, 2002, J CLIN INVEST, V109, P111, DOI 10.1172/JCI13617; Chang BD, 2000, P NATL ACAD SCI USA, V97, P4291, DOI 10.1073/pnas.97.8.4291; Christensen DP, 2011, MOL MED, V17, P378, DOI 10.2119/molmed.2011.00021; Corsten MF, 2010, CIRC-CARDIOVASC GENE, V3, P499, DOI 10.1161/CIRCGENETICS.110.957415; Cresci S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012584; Dhar MS, 2006, J NUTR BIOCHEM, V17, P811, DOI 10.1016/j.jnutbio.2006.01.002; Dimmeler S, 2010, EUR HEART J, V31, P2705, DOI 10.1093/eurheartj/ehq221; Doney Alex S F, 2005, Nucl Recept, V3, P4, DOI 10.1186/1478-1336-3-4; Fang ZY, 2004, ENDOCR REV, V25, P543, DOI 10.1210/er.2003-0012; Feng BA, 2010, DIABETES-METAB RES, V26, P40, DOI 10.1002/dmrr.1054; Fichtlscherer S, 2011, ARTERIOSCL THROM VAS, V31, P2383, DOI 10.1161/ATVBAHA.111.226696; Francis G, 2001, HEART, V85, P247, DOI 10.1136/heart.85.3.247; Fu JD, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027417; Garcia-Villegas R, 2009, J NEUROSCI RES, V87, P2509, DOI 10.1002/jnr.22069; Glyn-Jones S, 2007, PHYSIOL GENOMICS, V28, P284, DOI 10.1152/physiolgenomics.00204.2006; Gray ST, 2005, DIABETES-METAB RES, V21, P416, DOI 10.1002/dmrr.559; Guttula SV, 2010, INT J DIABETES DEV C, V30, P52, DOI 10.4103/0973-3930.60003; Hamada Yasuhiro, 2007, Kobe J Med Sci, V53, P53; Jenuwein T, 2001, SCIENCE, V293, P1074, DOI 10.1126/science.1063127; Kaneto H, 1999, DIABETOLOGIA, V42, P1093, DOI 10.1007/s001250051276; Kantharidis P, 2011, DIABETES, V60, P1832, DOI 10.2337/db11-0082; Katare R, 2011, CIRC RES, V108, P1238, DOI 10.1161/CIRCRESAHA.110.239111; King H, 1998, DIABETES CARE, V21, P1414, DOI 10.2337/diacare.21.9.1414; Kovacs B, 2011, INVEST OPHTH VIS SCI, V52, P4402, DOI 10.1167/iovs.10-6879; Kurabe N, 2009, J BIOL CHEM, V284, P5050, DOI 10.1074/jbc.M808598200; Lal A, 2006, CELL CYCLE, V5, P1422, DOI 10.4161/cc.5.13.2902; Lawrence IG, 1997, DIABETIC MED, V14, P82, DOI 10.1002/(SICI)1096-9136(199701)14:1<82::AID-DIA290>3.0.CO;2-3; Lee JG, 2011, DIABETES METAB J, V35, P149, DOI 10.4093/dmj.2011.35.2.149; Lefebvre P, 2006, J CLIN INVEST, V116, P571, DOI 10.1172/JCI27989; Monkemann H, 2002, AMINO ACIDS, V23, P331, DOI 10.1007/s00726-001-0146-y; Moskalev AA, 2012, AGEING RES REV, V11, P51, DOI 10.1016/j.arr.2011.09.003; Oskouie FG, 2011, J IMMUNOL, V186, P6798, DOI 10.4049/jimmunol.1004222; Poirier P, 2003, METABOLISM, V52, P1056, DOI 10.1016/S0026-0495(03)00091-X; Price SA, 2006, J NEUROPATH EXP NEUR, V65, P722, DOI 10.1097/01.jnen.0000228199.89420.90; Salama M, 1998, ARCH ANDROLOGY, V40, P95, DOI 10.3109/01485019808987932; Shi H, 2012, DIABETES TECHNOL THE, V14, P293, DOI 10.1089/dia.2011.0071; Shieh JTC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019481; Siafakas AR, 2009, INT J BIOCHEM CELL B, V41, P986, DOI 10.1016/j.biocel.2008.06.018; Sluijter JPG, 2010, ARTERIOSCL THROM VAS, V30, P859, DOI 10.1161/ATVBAHA.109.197434; Wang XH, 2009, CLIN EXP PHARMACOL P, V36, P181, DOI 10.1111/j.1440-1681.2008.05057.x; Wilson KD, 2010, CIRC-CARDIOVASC GENE, V3, P426, DOI 10.1161/CIRCGENETICS.109.934281; Yan BB, 2009, EXP NEUROL, V220, P34, DOI 10.1016/j.expneurol.2009.07.006; Yan B, 2009, AM J PHYSIOL-REG I, V296, pR299, DOI 10.1152/ajpregu.90412.2008	47	17	19	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 5	2012	7	12							e49077	10.1371/journal.pone.0049077	http://dx.doi.org/10.1371/journal.pone.0049077			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	057TZ	23227140	Green Published, gold, Green Submitted			2022-12-27	WOS:000312588200003
J	Chien, MH; Yang, JS; Chu, YH; Lin, CH; Wei, LH; Yang, SF; Lin, CW				Chien, Ming-Hsien; Yang, Jia-Sin; Chu, Yin-Hung; Lin, Chien-Huang; Wei, Lin-Hung; Yang, Shun-Fa; Lin, Chiao-Wen			Impacts of CA9 Gene Polymorphisms and Environmental Factors on Oral-Cancer Susceptibility and Clinicopathologic Characteristics in Taiwan	PLOS ONE			English	Article							CARBONIC-ANHYDRASE-IX; SQUAMOUS-CELL CARCINOMAS; CLINICAL-RELEVANCE; PREDICTIVE-VALUE; CERVICAL-CANCER; EXPRESSION; HYPOXIA; PROGNOSIS; MICROENVIRONMENT; ASSOCIATION	Background: In Taiwan, oral cancer has causally been associated with environmental carcinogens. Carbonic anhydrase 9 (CA9) is reportedly overexpressed in several types of carcinomas and is generally considered a marker of malignancy. The current study explored the combined effect of CA9 gene polymorphisms and exposure to environmental carcinogens on the susceptibility of developing oral squamous cell carcinoma (OSCC) and the clinicopathological characteristics of the tumors. Methodology and Principal Findings: Four single-nucleotide polymorphisms (SNPs) of the CA9 gene from 462 patients with oral cancer and 519 non-cancer controls were analyzed by a real-time polymerase chain reaction (PCR). While the studied SNPs (CA9 rs2071676, rs3829078, rs1048638 and +376 Del) were not associated with susceptibility to oral cancer, the GAA haplotype of 3 CA9 SNPs (rs2071676, rs3829078, and rs1048638) was related to a higher risk of oral cancer. Moreover, the four CA9 SNPs combined with betel quid chewing and/or tobacco consumption could robustly elevate susceptibility to oral cancer. Finally, patients with oral cancer who had at least one G allele of CA9 rs2071676 were at higher risk for developing lymph-node metastasis (p = 0.022), compared to those patients homozygous for AA. Conclusions: Our results suggest that the haplotype of rs2071676, rs3829078, and rs1048638 combined has potential predictive significance in oral carcinogenesis. Gene-environment interactions of CA9 polymorphisms, smoking, and betel-quid chewing might alter oral cancer susceptibility and metastasis.	[Yang, Jia-Sin; Chu, Yin-Hung; Yang, Shun-Fa] Chung Shan Med Univ, Inst Med, Taichung, Taiwan; [Chien, Ming-Hsien] Taipei Med Univ, Wan Fan Hosp, Taipei, Taiwan; [Chien, Ming-Hsien] Taipei Med Univ, Coll Med, Grad Inst Clin Med, Taipei, Taiwan; [Lin, Chien-Huang] Taipei Med Univ, Coll Med, Grad Inst Med Sci, Taipei, Taiwan; [Wei, Lin-Hung] Natl Taiwan Univ Hosp, Dept Oncol, Taipei, Taiwan; [Yang, Shun-Fa] Chung Shan Med Univ Hosp, Dept Med Res, Taichung, Taiwan; [Lin, Chiao-Wen] Chung Shan Med Univ, Inst Oral Sci, Taichung, Taiwan; [Lin, Chiao-Wen] Chung Shan Med Univ Hosp, Dept Dent, Taichung, Taiwan	Chung Shan Medical University; Taipei Medical University; Taipei Medical University; Taipei Medical University; National Taiwan University; National Taiwan University Hospital; Chung Shan Medical University; Chung Shan Medical University Hospital; Chung Shan Medical University; Chung Shan Medical University; Chung Shan Medical University Hospital	Yang, SF (corresponding author), Chung Shan Med Univ, Inst Med, Taichung, Taiwan.	ysf@csmu.edu.tw; cwlin@csmu.edu.tw	Yang, Shun-Fa/AAN-1519-2020	Yang, Shun-Fa/0000-0002-0365-7927; Lin, Chien-Huang/0000-0002-0916-8737; Wei, Lin-Hung/0000-0001-8789-0859	Taipei Medical University-Wan Fang Hospital [101swf03]	Taipei Medical University-Wan Fang Hospital	This study was supported by a grant from Taipei Medical University-Wan Fang Hospital (grant no. 101swf03 to Dr. Chien and Dr. Yang). The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Brockton NT, 2012, ORAL ONCOL, V48, P615, DOI 10.1016/j.oraloncology.2012.01.018; Bui MHT, 2003, CLIN CANCER RES, V9, P802; Bussink J, 2003, RADIOTHER ONCOL, V67, P3, DOI 10.1016/S0167-8140(03)00011-2; Chang KW, 2004, BRIT J CANCER, V91, P1551, DOI 10.1038/sj.bjc.6602186; Choi SW, 2008, HUM PATHOL, V39, P1317, DOI 10.1016/j.humpath.2007.10.026; de Martino M, 2009, J UROLOGY, V182, P728, DOI 10.1016/j.juro.2009.03.077; Gatenby RA, 2008, NAT REV CANCER, V8, P56, DOI 10.1038/nrc2255; Giatromanolaki A, 2001, CANCER RES, V61, P7992; Harris AL, 2002, NAT REV CANCER, V2, P38, DOI 10.1038/nrc704; Hedley D, 2003, CLIN CANCER RES, V9, P5666; Hoogsteen IJ, 2007, HEAD NECK-J SCI SPEC, V29, P591, DOI 10.1002/hed.20543; Huang SF, 2009, ORAL ONCOL, V45, P16, DOI 10.1016/j.oraloncology.2008.03.006; Ivanov S, 2001, AM J PATHOL, V158, P905, DOI 10.1016/S0002-9440(10)64038-2; Ivanov SV, 1998, P NATL ACAD SCI USA, V95, P12596, DOI 10.1073/pnas.95.21.12596; Jemal A, 2008, CA-CANCER J CLIN, V58, P71, DOI 10.3322/CA.2007.0010; Kim JY, 2006, J CANCER RES CLIN, V132, P302, DOI 10.1007/s00432-005-0068-2; Kim SJ, 2007, JPN J CLIN ONCOL, V37, P812, DOI 10.1093/jjco/hym121; Kondo Y, 2011, ONCOL REP, V25, P1227, DOI 10.3892/or.2011.1216; Koukourakis MI, 2001, CLIN CANCER RES, V7, P3399; Lai KC, 2006, MUTAT RES-FUND MOL M, V599, P66, DOI 10.1016/j.mrfmmm.2006.01.005; Lee S, 2007, CANCER SCI, V98, P329, DOI 10.1111/j.1349-7006.2007.00396.x; Lin CW, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035078; Lin MH, 2004, ARCH TOXICOL, V78, P167, DOI 10.1007/s00204-003-0524-1; Lin PY, 2008, J ORAL PATHOL MED, V37, P18, DOI 10.1111/j.1600-0714.2007.0057.x; Liu SY, 2005, J FORMOS MED ASSOC, V104, P113; Nagaraj NS, 2006, TOXICOL LETT, V165, P182, DOI 10.1016/j.toxlet.2006.03.008; Perez-Sayans M., 2012, J ORAL PATHOL MED; Shastry BS, 2009, METHODS MOL BIOL, V578, P3, DOI 10.1007/978-1-60327-411-1_1; Shi Q, 2001, ONCOGENE, V20, P3751, DOI 10.1038/sj.onc.1204500; Shifman S, 2002, AM J HUM GENET, V71, P1296, DOI 10.1086/344514; Sorensen BS, 2005, RADIOTHER ONCOL, V76, P187, DOI 10.1016/j.radonc.2005.06.037; Svastova E, 2003, EXP CELL RES, V290, P332, DOI 10.1016/S0014-4827(03)00351-3; Thorgeirsson SS, 2002, NAT GENET, V31, P339, DOI 10.1038/ng0802-339; TOWLE HC, 1995, J BIOL CHEM, V270, P23235, DOI 10.1074/jbc.270.40.23235; VAUPEL P, 1989, CANCER RES, V49, P6449; Weng CJ, 2011, ANN SURG ONCOL, V18, P805, DOI 10.1245/s10434-010-1432-2; Weng CJ, 2010, ORAL ONCOL, V46, P767, DOI 10.1016/j.oraloncology.2010.07.011; Yen CY, 2008, J ORAL PATHOL MED, V37, P271, DOI 10.1111/j.1600-0714.2007.00608.x; Zavras AI, 2011, ANN SURG ONCOL, V18, P1478, DOI 10.1245/s10434-010-1431-3	39	26	27	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 4	2012	7	12							e51051	10.1371/journal.pone.0051051	http://dx.doi.org/10.1371/journal.pone.0051051			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	051EQ	23226559	Green Submitted, gold, Green Published			2022-12-27	WOS:000312108500042
J	Stoebel-Richter, Y; Geue, K; Borkenhagen, A; Braehler, E; Weidner, K				Stoebel-Richter, Yve; Geue, Kristina; Borkenhagen, Ada; Braehler, Elmar; Weidner, Kerstin			What Do You Know about Reproductive Medicine? - Results of a German Representative Survey	PLOS ONE			English	Article							IN-VITRO FERTILIZATION; FERTILITY; ATTITUDES; INFERTILE; WOMEN; TECHNOLOGIES; PARENTHOOD; KNOWLEDGE; HEALTH; NEEDS	Objective: The use of reproductive medical treatments has become increasingly routine in recent years. This paper reports on a study of how different aspects of modern reproductive medicine are perceived by the German population. Design: Findings from a nationally representative sample of 2110 men and women aged 18 to 50 are presented. Participants responded to a questionnaire seeking self-report information about attitudes and knowledge regarding different aspects of reproductive medicine. Results: The majority of respondents had already heard or read something about reproductive medicine; knowledge gaps were prevalent in men and individuals with lower levels of education. The decrease in female fertility usually was underestimated, whereas both the number of involuntarily childless couples and the success rate of reproductive medical treatment were overestimated. One-third of participants would make use of reproductive medicine to have their own child. Conclusion: This study revealed inadequacies in the knowledge of the German general population regarding reproductive medicine. Despite the low interest and poor knowledge of the topic, a broad acceptance of reproductive medical methods was reported. The results illustrate the need for adequate information transfer regarding female fertility as well as success rate and risks of reproductive medical interventions. Citation: Stoebel-Richter Y, Geue K, Borkenhagen A, Braehler E, Weidner K (2012) What Do You Know about Reproductive Medicine? - Results of a German Representative Survey. PLoS ONE 7(12): e50113. doi:10.1371/journal.pone.0050113	[Stoebel-Richter, Yve; Geue, Kristina; Borkenhagen, Ada; Braehler, Elmar] Univ Leipzig, Dept Med Psychol & Med Sociol, Leipzig, Germany; [Weidner, Kerstin] Med Fac Carl Gustav Carus, Clin & Polyclin Psychotherapy & Psychosomat, Dresden, Germany	Leipzig University; Technische Universitat Dresden; Carl Gustav Carus University Hospital	Stoebel-Richter, Y (corresponding author), Univ Leipzig, Dept Med Psychol & Med Sociol, Leipzig, Germany.	yve.stoebel-richter@medizin.uni-leipzig.de	Braehler, Elmar/C-6535-2009	Braehler, Elmar/0000-0002-2648-2728	Federal Ministry of Education and Research (BMBF) [01GP0205/0255]	Federal Ministry of Education and Research (BMBF)(Federal Ministry of Education & Research (BMBF))	This research was funded by the Federal Ministry of Education and Research (BMBF), registration number: 01GP0205/0255. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbey A, 1991, FERTIL STERIL, V32, P875; Adamson GD, 2006, FERTIL STERIL, V85, P1586, DOI 10.1016/j.fertnstert.2006.01.011; Andersen AN, 2009, HUM REPROD, V24, P1267, DOI 10.1093/humrep/dep035; Baird DT, 2005, HUM REPROD UPDATE, V11, P261, DOI 10.1093/humupd/dmi006; Brahler E, 2002, REPRODUKTIONSMEDIZIN, V18, P276; Bunting L, 2008, HUM REPROD, V23, P1858, DOI 10.1093/humrep/den168; Ceballo R, 2010, FERTIL STERIL, V93, P1066, DOI 10.1016/j.fertnstert.2008.11.019; Dancet EAF, 2010, HUM REPROD UPDATE, V16, P467, DOI 10.1093/humupd/dmq004; DIR (Deutsches IVF Register), 2011, J REPROD MED ENDOCRI, V8, P253; Fisher JRW, 2010, FERTIL STERIL, V94, P574, DOI 10.1016/j.fertnstert.2009.01.165; GUNNELL DJ, 1994, J PUBLIC HEALTH MED, V16, P29, DOI 10.1093/oxfordjournals.pubmed.a042931; Heikkila K, 2004, BJOG-INT J OBSTET GY, V111, P1229, DOI 10.1111/j.1471-0528.2004.00441.x; Ittner E, 2000, FRUCHTBARKEITSSTORUN, V17, P229; Kalfoglou AL, 2005, FERTIL STERIL, V83, P1612, DOI 10.1016/j.fertnstert.2005.01.090; KENTENICH H, 2004, GYNAKOLOGE, V37, P600, DOI DOI 10.1007/s00129-004-1552-5; Kleinschmidt D, 2008, HDB BERATUNGSNETZWER; Kowalcek I, 2007, DTSCH IVF REGISTER 1, P157; Lampic C, 2006, HUM REPROD, V21, P558, DOI 10.1093/humrep/dei367; Onnen-Isemann C, 2000, FORUM QUALITATIVE SO, V1; Papaharitou S, 2007, HUM REPROD, V22, P2033, DOI 10.1093/humrep/dem086; Peronace LA, 2007, J PSYCHOSOM OBST GYN, V28, P105, DOI 10.1080/01674820701410049; Porter M, 2008, HUM REPROD, V23, P567, DOI 10.1093/humrep/dem398; Quach S, 2008, FERTIL STERIL, V90, P2099, DOI 10.1016/j.fertnstert.2007.10.024; Rauprich O, 2011, HUM REPROD, V26, P2382, DOI 10.1093/humrep/der207; Revermann C, 2011, FORTPFLANZUNGSMEDIZI; Rovei V, 2010, REPROD BIOMED ONLINE, V20, P873, DOI 10.1016/j.rbmo.2010.03.024; SCHOVER LR, 1994, HUM REPROD, V9, P176, DOI 10.1093/oxfordjournals.humrep.a138311; STEPTOE PC, 1978, LANCET, V2, P366; Stoebel-Richter Y, 2011, J REPRODUKTIONSMEDIZ, V8, P416; Stoebel-Richter Y, 2008, Z FAMILIENFORSCH, V20, P34; Stobel-Richter Y, 2009, FERTIL STERIL, V92, P124, DOI 10.1016/j.fertnstert.2008.05.015; Strauss B, 2004, UNGEWOLLTE KINDERLOS, V20; Strauss B, 2000, Z MED PSYCHOL, V9, P101; Templeton A, 1996, LANCET, V348, P1402, DOI 10.1016/S0140-6736(96)05291-9; Tough S, 2006, CAN J PUBLIC HEALTH, V97, P330, DOI 10.1007/BF03405615; Verhaak CM, 2007, HUM REPROD, V22, P305, DOI 10.1093/humrep/del355; Wischmann T, 2005, UROLOGE A, V44, P185, DOI 10.1007/s00120-004-0779-7; Zegers-Hochschild F, 2009, FERTIL STERIL, V92, P1520, DOI 10.1016/j.fertnstert.2009.09.009	38	20	21	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 3	2012	7	12							e50113	10.1371/journal.pone.0050113	http://dx.doi.org/10.1371/journal.pone.0050113			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	051DH	23226509	gold, Green Published, Green Submitted			2022-12-27	WOS:000312104700014
J	Cho, J; Hur, JH; Graniel, J; Benzer, S; Walker, DW				Cho, Jaehyoung; Hur, Jae H.; Graniel, Jacqueline; Benzer, Seymour; Walker, David W.			Expression of Yeast NDI1 Rescues a Drosophila Complex I Assembly Defect	PLOS ONE			English	Article							NADH-UBIQUINONE OXIDOREDUCTASE; ROTENONE-INSENSITIVE NADH; LIFE-SPAN; GENE; MITOCHONDRIA; INACTIVATION; MUTATIONS; GENOME; MODEL	Defects in mitochondrial electron transport chain (ETC) function have been implicated in a number of neurodegenerative disorders, cancer, and aging. Mitochondrial complex I (NADH dehydrogenase) is the largest and most complicated enzyme of the ETC with 45 subunits originating from two separate genomes. The biogenesis of complex I is an intricate process that requires multiple steps, subassemblies, and assembly factors. Here, we report the generation and characterization of a Drosophila model of complex I assembly factor deficiency. We show that CG7598 (dCIA30), the Drosophila homolog of human complex I assembly factor Ndufaf1, is necessary for proper complex I assembly. Reduced expression of dCIA30 results in the loss of the complex I holoenzyme band in blue-native polyacrylamide gel electrophoresis and loss of NADH: ubiquinone oxidoreductase activity in isolated mitochondria. The complex I assembly defect, caused by mutation or RNAi of dCIA30, has repercussions both during development and adulthood in Drosophila, including developmental arrest at the pupal stage and reduced stress resistance during adulthood. Expression of the single-subunit yeast alternative NADH dehydrogenase, Ndi1, can partially or wholly rescue phenotypes associated with the complex I assembly defect. Our work shows that CG7598/dCIA30 is a functional homolog of Ndufaf1 and adds to the accumulating evidence that transgenic NDI1 expression is a viable therapy for disorders arising from complex I deficiency.	[Cho, Jaehyoung; Hur, Jae H.; Graniel, Jacqueline; Walker, David W.] Univ Calif Los Angeles, Dept Integrat Biol & Physiol, Los Angeles, CA 90095 USA; [Cho, Jaehyoung; Benzer, Seymour] CALTECH, Div Biol, Pasadena, CA 91125 USA; [Walker, David W.] Univ Calif Los Angeles, Inst Mol Biol, Los Angeles, CA 90024 USA	University of California System; University of California Los Angeles; California Institute of Technology; University of California System; University of California Los Angeles	Walker, DW (corresponding author), Univ Calif Los Angeles, Dept Integrat Biol & Physiol, Los Angeles, CA 90095 USA.	davidwalker@ucla.edu		Cho, Jae/0000-0002-6534-116X	National Insititutes of Health/National Insititute on Aging [RO1 AG037514, R01AG040288, RO1 DK070154, RO1 AG024366]; Ellison Medical Foundation [AG-NS-0470-08]; National Institutes of Health/National Institute of General Medical Sciences [NIH MARC T34 GM008563]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK070154] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T34GM008563, R25GM086262, R25GM050067] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG040288, R01AG037514, R01AG024366] Funding Source: NIH RePORTER	National Insititutes of Health/National Insititute on Aging; Ellison Medical Foundation(Lawrence Ellison Foundation); National Institutes of Health/National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	DWW is funded by National Insititutes of Health/National Insititute on Aging (grant numbers RO1 AG037514 and R01AG040288). DWW is also an Ellison Medical Foundation New Scholar in Aging (grant number AG-NS-0470-08). SB was funded by the National Insititutes of Health/National Insititute on Aging (grant numbers RO1 DK070154 and RO1 AG024366). JG is funded by the National Institutes of Health/National Institute of General Medical Sciences (grant number NIH MARC T34 GM008563). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bahadorani S, 2010, AGING CELL, V9, P191, DOI 10.1111/j.1474-9726.2010.00546.x; Barber-Singh J, 2011, PARKINSONS DIS-US, V2011, DOI 10.4061/2011/438370; Barber-Singh J, 2009, REJUV RES, V12, P259, DOI 10.1089/rej.2009.0854; Bellen HJ, 2004, GENETICS, V167, P761, DOI 10.1534/genetics.104.026427; BRAND AH, 1993, DEVELOPMENT, V118, P401; Clason T, 2010, J STRUCT BIOL, V169, P81, DOI 10.1016/j.jsb.2009.08.017; DeCorby A, 2007, BBA-BIOENERGETICS, V1767, P1157, DOI 10.1016/j.bbabio.2007.07.003; DEVRIES S, 1988, EUR J BIOCHEM, V176, P377; DEVRIES S, 1992, EUR J BIOCHEM, V203, P587; DEZAMAROCZY M, 1986, GENE, V47, P155, DOI 10.1016/0378-1119(86)90060-0; Diaz F, 2011, SEMIN FETAL NEONAT M, V16, P197, DOI 10.1016/j.siny.2011.05.004; Dietzl G, 2007, NATURE, V448, P151, DOI 10.1038/nature05954; Dunning CJR, 2007, EMBO J, V26, P3227, DOI 10.1038/sj.emboj.7601748; Gabaldon T, 2005, J MOL BIOL, V348, P857, DOI 10.1016/j.jmb.2005.02.067; Kuffner R, 1998, J MOL BIOL, V283, P409, DOI 10.1006/jmbi.1998.2114; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Lewis E. B., 1960, DROS INFORM SERV, V34, P118; Maas MFPM, 2010, J MOL BIOL, V399, P31, DOI 10.1016/j.jmb.2010.04.015; Marella M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001433; MARRES CAM, 1991, EUR J BIOCHEM, V195, P857, DOI 10.1111/j.1432-1033.1991.tb15775.x; Mckenzie M, 2010, IUBMB LIFE, V62, P497, DOI 10.1002/iub.335; Mimaki M, 2012, BBA-BIOENERGETICS, V1817, P851, DOI 10.1016/j.bbabio.2011.08.010; Moreno-Lastres D, 2012, CELL METAB, V15, P324, DOI 10.1016/j.cmet.2012.01.015; Perry CN, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016288; Rera M, 2011, CELL METAB, V14, P623, DOI 10.1016/j.cmet.2011.09.013; Sanz A, 2010, P NATL ACAD SCI USA, V107, P9105, DOI 10.1073/pnas.0911539107; Schulte U, 2001, J BIOENERG BIOMEMBR, V33, P205, DOI 10.1023/A:1010730919074; Seo BB, 2006, J BIOL CHEM, V281, P14250, DOI 10.1074/jbc.M600922200; Vilain S, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002456; Vogel RO, 2005, FEBS J, V272, P5317, DOI 10.1111/j.1742-4658.2005.04928.x; Walker DW, 2006, P NATL ACAD SCI USA, V103, P16382, DOI 10.1073/pnas.0607918103; Wallace DC, 2005, ANNU REV GENET, V39, P359, DOI 10.1146/annurev.genet.39.110304.095751; Yagi T, 2006, BBA-BIOENERGETICS, V1757, P708, DOI 10.1016/j.bbabio.2006.01.011; Yang Y, 2011, J BIOL CHEM, V286, P9287, DOI 10.1074/jbc.M110.175547	34	29	30	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 30	2012	7	11							e50644	10.1371/journal.pone.0050644	http://dx.doi.org/10.1371/journal.pone.0050644			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	054WM	23226344	Green Published, Green Accepted, gold, Green Submitted			2022-12-27	WOS:000312376100155
J	DiCaudo, C; Riverol, M; Mundinano, IC; Ordonez, C; Hernandez, M; Marcilla, I; Luquin, MR				DiCaudo, Carla; Riverol, Mario; Mundinano, Inaki-Carril; Ordonez, Cristina; Hernandez, Maria; Marcilla, Irene; Luquin, Maria-Rosario			Chronic Levodopa Administration Followed by a Washout Period Increased Number and Induced Phenotypic Changes in Striatal Dopaminergic Cells in MPTP-Monkeys	PLOS ONE			English	Article							TYROSINE-HYDROXYLASE; IMMUNOREACTIVE NEURONS; PARKINSONIAN MONKEYS; NEOSTRIATAL NEURONS; BASAL GANGLIA; RAT STRIATUM; L-DOPA; PRIMATE; DISEASE; MECHANISMS	In addition to the medium spiny neurons the mammalian striatum contains a small population of GABAergic interneurons that are immunoreactive for tyrosine hydroxylase (TH), which dramatically increases after lesions to the nigrostriatal pathway and striatal delivery of neurotrophic factors. The regulatory effect of levodopa (L-Dopa) on the number and phenotype of these cells is less well understood. Eleven macaques (Macaca fascicularis) were included. Group I (n = 4) received 1-methyl-4-phenyl-1,2,3,6 tetrahydropyridine (MPTP) and L-Dopa; Group II (n = 4) was treated with MPTP plus vehicle and Group III (n = 3) consist of intact animals (control group). L-Dopa and vehicle were given for 1 year and animals sacrificed 6 months later. Immunohistochemistry against TH was used to identify striatal and nigral dopaminergic cells. Double and triple labeling immunofluorescence was performed to detect the neurochemical characteristics of the striatal TH-ir cells using antibodies against: TH, anti-glutamate decarboxylase (GAD(67)) anti-calretinin (CR) anti-dopa decarboxylase (DDC) and anti-dopamine and cyclic AMP-regulated phosphoprotein (DARPP-32). The greatest density of TH-ir striatal cells was detected in the striatum of the L-Dopa treated monkeys and particularly in its associative territory. None of the striatal TH-ir cell expressed DARPP-32 indicating they are interneurons. The percentages of TH-ir cells that expressed GAD67 and DDC was approximately 50%. Interestingly, we found that in the L-Dopa group the number of TH/CR expressing cells was significantly reduced. We conclude that chronic L-Dopa administration produced a long-lasting increase in the number of TH-ir cells, even after a washout period of 6 months. L-Dopa also modified the phenotype of these cells with a significant reduction of the TH/CR phenotype in favor of an increased number of TH/GAD cells that do not express CR. We suggest that the increased number of striatal TH-ir cells might be involved in the development of aberrant striatal circuits and the appearance of L-Dopa induced dyskinesias.	[Luquin, Maria-Rosario] Univ Navarra, Div Neurosci, Lab Regenerat Therapy, E-31080 Pamplona, Spain; Univ Navarra, Div Neurosci, Dept Neurol, E-31080 Pamplona, Spain	University of Navarra; University of Navarra	Luquin, MR (corresponding author), Univ Navarra, Div Neurosci, Lab Regenerat Therapy, E-31080 Pamplona, Spain.	rluquin@unav.es	Marcilla, Irene/H-3476-2017; Riverol, Mario/C-3049-2012; Luquin, M R/T-5546-2017	Marcilla, Irene/0000-0003-0536-1473; Riverol, Mario/0000-0002-4383-9127; Luquin, M R/0000-0002-5594-1794; Mundinano, Inaki-Carril/0000-0003-1063-7550	Novartis Pharmaceutique; UTE-project/Foundation for Applied Medical Research	Novartis Pharmaceutique; UTE-project/Foundation for Applied Medical Research	This work was supported by funding from Novartis Pharmaceutique and by the UTE-project/Foundation for Applied Medical Research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bartus RT, 2011, MOVEMENT DISORD, V26, P27, DOI 10.1002/mds.23442; Belujon P, 2010, MOVEMENT DISORD, V25, P1568, DOI 10.1002/mds.23245; Bernacer J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030504; Betarbet R, 1997, J NEUROSCI, V17, P6761; Bezard E, 1998, PROG NEUROBIOL, V55, P93, DOI 10.1016/S0301-0082(98)00006-9; Bink K, 2001, HISTOCHEM CELL BIOL, V115, P293; BISHOP GA, 1982, NEUROSCIENCE, V7, P179, DOI 10.1016/0306-4522(82)90159-2; Bjugstad KB, 2005, CELL TRANSPLANT, V14, P183, DOI 10.3727/000000005783983098; Brotchie J, 2009, NEUROLOGY, V72, pS32, DOI 10.1212/WNL.0b013e318198e0e9; Calabresi P, 2008, MOVEMENT DISORD, V23, pS570, DOI 10.1002/mds.22019; Cicchetti F, 2000, BRAIN RES REV, V34, P80, DOI 10.1016/S0165-0173(00)00039-4; Cossette M, 2004, EUR J NEUROSCI, V20, P2089, DOI 10.1111/j.1460-9568.2004.03661.x; Cossette M, 2005, J CHEM NEUROANAT, V29, P1, DOI 10.1016/j.jchemneu.2004.08.007; DIFIGLIA M, 1976, BRAIN RES, V114, P245, DOI 10.1016/0006-8993(76)90669-7; DUBACH M, 1987, NEUROSCI LETT, V75, P205, DOI 10.1016/0304-3940(87)90298-9; Francardo V, 2011, NEUROBIOL DIS; GRAVELAND GA, 1985, BRAIN RES, V327, P307, DOI 10.1016/0006-8993(85)91524-0; Haber SN, 2003, J CHEM NEUROANAT, V26, P317, DOI 10.1016/j.jchemneu.2003.10.003; Hou JGG, 1996, J NEUROCHEM, V66, P74; Huot P, 2008, J CHEM NEUROANAT, V35, P77, DOI 10.1016/j.jchemneu.2007.06.004; Huot P, 2007, BRAIN, V130, P222, DOI 10.1093/brain/awl332; Ibanez-Sandoval O, 2010, J NEUROSCI, V30, P6999, DOI 10.1523/JNEUROSCI.5996-09.2010; Jollivet C, 2004, NEUROSCI LETT, V362, P79, DOI 10.1016/j.neulet.2004.02.068; Kay JN, 2000, DEV NEUROSCI-BASEL, V22, P56, DOI 10.1159/000017427; Luquin MR, 2011, BRAIN RES, V1375, P120, DOI 10.1016/j.brainres.2010.12.033; Luquin MR, 1999, NEURON, V22, P743, DOI 10.1016/S0896-6273(00)80733-3; Luzzati F, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025088; Martin RF, 1996, NEUROIMAGE, V4, P119, DOI 10.1006/nimg.1996.0036; Mazloom M, 2006, J COMP NEUROL, V495, P453, DOI 10.1002/cne.20894; Meredith GE, 1999, EUR J NEUROSCI, V11, P3585, DOI 10.1046/j.1460-9568.1999.00774.x; Mura A, 1995, BRAIN RES, V704, P51, DOI 10.1016/0006-8993(95)01104-8; O'Sullivan SS, 2011, MOVEMENT DISORD, V26, P45, DOI 10.1002/mds.23340; OKAZAWA H, 1992, FEBS LETT, V313, P138, DOI 10.1016/0014-5793(92)81430-T; OUIMET CC, 1990, J NEUROCYTOL, V19, P39, DOI 10.1007/BF01188438; Palfi S, 2002, J NEUROSCI, V22, P4942, DOI 10.1523/JNEUROSCI.22-12-04942.2002; Porritt MJ, 2000, LANCET, V356, P44, DOI 10.1016/S0140-6736(00)02437-5; RIVEROL M, 2011, MOVEMENT DISORD S2, V26, pS25; San Sebastian W, 2007, BRAIN, V130, P1306, DOI 10.1093/brain/awm061; Tande D, 2006, BRAIN, V129, P1194, DOI 10.1093/brain/awl041; TASHIRO Y, 1989, NEUROSCI LETT, V97, P6, DOI 10.1016/0304-3940(89)90130-4; Weihe E, 2006, CELL MOL NEUROBIOL, V26, P659, DOI 10.1007/s10571-006-9053-9	41	10	10	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 30	2012	7	11							e50842	10.1371/journal.pone.0050842	http://dx.doi.org/10.1371/journal.pone.0050842			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	054WM	23226401	gold, Green Published, Green Submitted			2022-12-27	WOS:000312376100212
J	Dutoit, R; Brandt, N; Legrain, C; Bauvois, C				Dutoit, Raphael; Brandt, Nathalie; Legrain, Christianne; Bauvois, Cedric			Functional Characterization of Two M42 Aminopeptidases Erroneously Annotated as Cellulases	PLOS ONE			English	Article							ESCHERICHIA-COLI; TRICORN PROTEASE; CLOSTRIDIUM-THERMOCELLUM; PYROCOCCUS-HORIKOSHII; CRYSTAL-STRUCTURE; LEUCINE AMINOPEPTIDASE; ACTIVE-SITE; DEGRADATION; COMPLEX; SEQUENCE	Several aminopeptidases of the M42 family have been described as tetrahedral-shaped dodecameric (TET) aminopeptidases. A current hypothesis suggests that these enzymes are involved, along with the tricorn peptidase, in degrading peptides produced by the proteasome. Yet the M42 family remains ill defined, as some members have been annotated as cellulases because of their homology with CelM, formerly described as an endoglucanase of Clostridium thermocellum. Here we describe the catalytic functions and substrate profiles CelM and of TmPep1050, the latter having been annotated as an endoglucanase of Thermotoga maritima. Both enzymes were shown to catalyze hydrolysis of nonpolar aliphatic L-amino acid-pNA substrates, the L-leucine derivative appearing as the best substrate. No significant endoglucanase activity was measured, either for TmPep1050 or CelM. Addition of cobalt ions enhanced the activity of both enzymes significantly, while both the chelating agent EDTA and bestatin, a specific inhibitor of metalloaminopeptidases, proved inhibitory. Our results strongly suggest that one should avoid annotating members of the M42 aminopeptidase family as cellulases. In an updated assessment of the distribution of M42 aminopeptidases, we found TET aminopeptidases to be distributed widely amongst archaea and bacteria. We additionally observed that several phyla lack both TET and tricorn. This suggests that other complexes may act downstream from the proteasome.	[Dutoit, Raphael; Brandt, Nathalie; Legrain, Christianne; Bauvois, Cedric] Inst Rech Microbiol JM Wiame, Brussels, Belgium		Dutoit, R (corresponding author), Inst Rech Microbiol JM Wiame, Brussels, Belgium.	rdutoit@ulb.ac.be		Dutoit, Raphael/0000-0002-7139-8402	Commission communautaire francaise; Meurice RD asbl	Commission communautaire francaise; Meurice RD asbl	This work was supported by the Commission communautaire francaise (http://www.cocof.irisnet.be). Publication fees were supported by Meurice R&D asbl (http://www.meurice.org/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALLEN MP, 1983, BIOCHEMISTRY-US, V22, P3778, DOI 10.1021/bi00285a010; Ando S, 1999, FEBS LETT, V447, P25, DOI 10.1016/S0014-5793(99)00257-4; BEGUIN P, 1990, ANNU REV MICROBIOL, V44, P219, DOI 10.1146/annurev.mi.44.100190.001251; Borissenko L, 2005, J MOL BIOL, V346, P1207, DOI 10.1016/j.jmb.2004.12.056; Brandstetter H, 2001, NATURE, V414, P466, DOI 10.1038/35106609; CASADABAN MJ, 1980, J MOL BIOL, V138, P179, DOI 10.1016/0022-2836(80)90283-1; Chandu D, 2003, MICROBIOL-SGM, V149, P3437, DOI 10.1099/mic.0.26518-0; Cottrell MT, 2005, APPL ENVIRON MICROB, V71, P8506, DOI 10.1128/AEM.71.12.8506-8513.2005; DAHLMANN B, 1989, FEBS LETT, V251, P125, DOI 10.1016/0014-5793(89)81441-3; Dura MA, 2009, MOL MICROBIOL, V72, P26, DOI 10.1111/j.1365-2958.2009.06600.x; Dura MA, 2005, BIOCHEMISTRY-US, V44, P3477, DOI 10.1021/bi047736j; Franzetti B, 2002, EMBO J, V21, P2132, DOI 10.1093/emboj/21.9.2132; Ghose T, 1980, PURE APPL CHEM, V59, P257; Gilad R, 2003, J BACTERIOL, V185, P391, DOI 10.1128/JB.185.2.391-398.2003; Goettig P, 2002, EMBO J, V21, P5343, DOI 10.1093/emboj/cdf552; Gonzales T, 1996, FEMS MICROBIOL REV, V18, P319, DOI 10.1111/j.1574-6976.1996.tb00247.x; Groll M, 2005, CHEMBIOCHEM, V6, P222, DOI 10.1002/cbic.200400313; HALL J, 1988, GENE, V69, P29, DOI 10.1016/0378-1119(88)90375-7; Holm L, 2010, NUCLEIC ACIDS RES, V38, pW545, DOI 10.1093/nar/gkq366; IANSON KJA, 1995, MICROBIOL-UK, V141, P2873, DOI 10.1099/13500872-141-11-2873; Jain R, 2007, BIOCHEM BIOPH RES CO, V359, P486, DOI 10.1016/j.bbrc.2007.05.142; Jenal U, 2003, CURR OPIN MICROBIOL, V6, P163, DOI 10.1016/S1369-5274(03)00029-8; Jia B, 2011, BIOSCI BIOTECH BIOCH, V75, P1160, DOI 10.1271/bbb.110114; Kapoor D, 2010, ENZYME MICROB TECH, V46, P1, DOI 10.1016/j.enzmictec.2009.09.003; Kim D, 2010, BIOCHEM BIOPH RES CO, V391, P431, DOI 10.1016/j.bbrc.2009.11.075; KOBAYASHI T, 1993, J FERMENT BIOENG, V76, P251, DOI 10.1016/0922-338X(93)90189-F; Kumaki Y, 2011, J BIOSCI BIOENG, V111, P134, DOI 10.1016/j.jbiosc.2010.09.012; Kyrieleis OJP, 2005, J MOL BIOL, V349, P787, DOI 10.1016/j.jmb.2005.03.070; Lupas A, 1997, MOL BIOL REP, V24, P125, DOI 10.1023/A:1006803512761; LUPAS A, 1994, TRENDS BIOCHEM SCI, V19, P533, DOI 10.1016/0968-0004(94)90054-X; Marchler-Bauer A, 2011, NUCLEIC ACIDS RES, V39, pD225, DOI 10.1093/nar/gkq1189; Maric S, 2009, BIOCHEMISTRY-US, V48, P5435, DOI 10.1021/bi9003638; MILLER CG, 1981, J BACTERIOL, V147, P925, DOI 10.1128/JB.147.3.925-930.1981; MOORE S, 1954, J BIOL CHEM, V211, P907; Notredame C, 2000, J MOL BIOL, V302, P205, DOI 10.1006/jmbi.2000.4042; Pallen MJ, 2001, TRENDS MICROBIOL, V9, P518, DOI 10.1016/S0966-842X(01)02199-0; Park BH, 2010, GLYCOBIOLOGY, V20, P1574, DOI 10.1093/glycob/cwq106; PRESCOTT JM, 1985, BIOCHEMISTRY-US, V24, P5350, DOI 10.1021/bi00341a012; Pruteanu M, 2009, RES MICROBIOL, V160, P677, DOI 10.1016/j.resmic.2009.08.012; Rawlings ND, 2006, NUCLEIC ACIDS RES, V34, pD270, DOI 10.1093/nar/gkj089; Russo S, 2004, J BIOL CHEM, V279, P51275, DOI 10.1074/jbc.M409455200; SAKANYAN V, 1993, APPL ENVIRON MICROB, V59, P3878, DOI 10.1128/AEM.59.11.3878-3888.1993; Schoehn G, 2006, J BIOL CHEM, V281, P36327, DOI 10.1074/jbc.M604417200; Sigrist CJA, 2010, NUCLEIC ACIDS RES, V38, pD161, DOI 10.1093/nar/gkp885; Strater N, 1999, EMBO J, V18, P4513, DOI 10.1093/emboj/18.16.4513; Tamura N, 2001, BIOL CHEM, V382, P449, DOI 10.1515/BC.2001.055; Tamura T, 1996, SCIENCE, V274, P1385, DOI 10.1126/science.274.5291.1385; TAMURA T, 1995, CURR BIOL, V5, P766, DOI 10.1016/S0960-9822(95)00153-9; Tarnus C, 1996, BIOORGAN MED CHEM, V4, P1287, DOI 10.1016/0968-0896(96)00115-0; Walz J, 1997, MOL CELL, V1, P59, DOI 10.1016/S1097-2765(00)80007-6; Zheng Y, 2005, J BACTERIOL, V187, P3671, DOI 10.1128/JB.187.11.3671-3677.2005	51	12	12	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 30	2012	7	11							e50639	10.1371/journal.pone.0050639	http://dx.doi.org/10.1371/journal.pone.0050639			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	054WM	23226342	Green Published, gold, Green Submitted			2022-12-27	WOS:000312376100153
J	Gansler, J; Jaax, M; Leiting, S; Appel, B; Greinacher, A; Fischer, S; Preissner, KT				Gansler, Julia; Jaax, Miriam; Leiting, Silke; Appel, Bettina; Greinacher, Andreas; Fischer, Silvia; Preissner, Klaus T.			Structural Requirements for the Procoagulant Activity of Nucleic Acids	PLOS ONE			English	Article							MOLECULAR-WEIGHT KININOGEN; ENDOTHELIAL GROWTH-FACTOR; SYSTEMIC-LUPUS-ERYTHEMATOSUS; EXTRACELLULAR RNA; HUMAN-PLASMA; PROTEASE INHIBITORS; CONTACT SYSTEM; FACTOR-XI; PREKALLIKREIN; COAGULATION	Nucleic acids, especially extracellular RNA, are exposed following tissue- or vessel damage and have previously been shown to activate the intrinsic blood coagulation pathway in vitro and in vivo. Yet, no information on structural requirements for the procoagulant activity of nucleic acids is available. A comparison of linear and hairpin-forming RNA- and DNA-oligomers revealed that all tested oligomers forming a stable hairpin structure were protected from degradation in human plasma. In contrast to linear nucleic acids, hairpin forming compounds demonstrated highest procoagulant activities based on the analysis of clotting time in human plasma and in a prekallikrein activation assay. Moreover, the procoagulant activities of the DNA-oligomers correlated well with their binding affinity to high molecular weight kininogen, whereas the binding affinity of all tested oligomers to prekallikrein was low. Furthermore, four DNA-aptamers directed against thrombin, activated protein C, vascular endothelial growth factor and nucleolin as well as the naturally occurring small nucleolar RNA U6snRNA were identified as effective cofactors for prekallikrein auto-activation. Together, we conclude that hairpin-forming nucleic acids are most effective in promoting procoagulant activities, largely mediated by their specific binding to kininogen. Thus, in vivo application of therapeutic nucleic acids like aptamers might have undesired prothrombotic or proinflammatory side effects. Citation: Gansler J, Jaax M, Leiting S, Appel B, Greinacher A, et al. (2012) Structural Requirements for the Procoagulant Activity of Nucleic Acids. PLoS ONE 7(11): e50399. doi:10.1371/journal.pone.0050399	[Gansler, Julia; Leiting, Silke; Fischer, Silvia; Preissner, Klaus T.] Univ Giessen, Sch Med, Inst Biochem, Giessen, Germany; [Jaax, Miriam; Greinacher, Andreas] Ernst Moritz Arndt Univ Greifswald, Inst Immunol & Transfus Med, Greifswald, Germany; [Appel, Bettina] Ernst Moritz Arndt Univ Greifswald, Inst Biochem, Greifswald, Germany	Justus Liebig University Giessen; Ernst Moritz Arndt Universitat Greifswald; Ernst Moritz Arndt Universitat Greifswald	Gansler, J (corresponding author), Univ Giessen, Sch Med, Inst Biochem, Giessen, Germany.	julia.gansler@biochemie.med.uni-giessen.de; klaus.t.preissner@biochemie.med.uni-giessen.de	Fischer, Silvia/ABG-3104-2021; Appel, Bettina/D-2788-2017		Deutsche Forschungsgemeinschaft (DFG, Bonn, Germany); Excellence Cluster "Cardiopulmonary system'' (ECCPS), Priority program [SPP-1190, FI 543/2-1]; Bundesministerium fur Bildung und Forschung, Zentrum fur Innovationskompetenz ZIK HIKE [BMBF FKZ 03Z2CN12]	Deutsche Forschungsgemeinschaft (DFG, Bonn, Germany)(German Research Foundation (DFG)); Excellence Cluster "Cardiopulmonary system'' (ECCPS), Priority program; Bundesministerium fur Bildung und Forschung, Zentrum fur Innovationskompetenz ZIK HIKE	Studies were generously supported by the following grants from the Deutsche Forschungsgemeinschaft (DFG, Bonn, Germany, http://www.dfg.de), received by Klaus T. Preissner and Silvia Fischer: Excellence Cluster "Cardiopulmonary system'' (ECCPS; http://eccps.de), Priority program SPP-1190 and FI 543/2-1; and by a grant of the Bundesministerium fur Bildung und Forschung, Zentrum fur Innovationskompetenz ZIK HIKE (grant number BMBF FKZ 03Z2CN12; http://www.bmbf.de/de/2546.php). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Homood IA, 2012, ISRN RHEUMATOL, V2012; BOCK LC, 1992, NATURE, V355, P564, DOI 10.1038/355564a0; Chelliserrykattil J, 2004, NAT BIOTECHNOL, V22, P1155, DOI 10.1038/nbt1001; CHU BCF, 1992, NUCLEIC ACIDS RES, V20, P5857, DOI 10.1093/nar/20.21.5857; COCHRANE CG, 1982, ADV IMMUNOL, V33, P241, DOI 10.1016/S0065-2776(08)60837-8; Colman RW, 1997, BLOOD, V90, P3819, DOI 10.1182/blood.V90.10.3819; Fischer S, 2007, BLOOD, V110, P2457, DOI 10.1182/blood-2006-08-040691; Fischer S, 2011, THROMB HAEMOSTASIS, V105, P345, DOI 10.1160/TH10-06-0345; GREEN LS, 1995, CHEM BIOL, V2, P683, DOI 10.1016/1074-5521(95)90032-2; Hasegawa H, 2008, BIOTECHNOL LETT, V30, P829, DOI 10.1007/s10529-007-9629-6; HOJIMA Y, 1984, BLOOD, V63, P1453; Jilma-Stohlawetz P, 2012, THROMB HAEMOSTASIS, V108, P284, DOI 10.1160/TH11-12-0889; Kannemeier C, 2007, P NATL ACAD SCI USA, V104, P6388, DOI 10.1073/pnas.0608647104; Kaplan MJ, 2004, CLIN IMMUNOL, V112, P210, DOI 10.1016/j.clim.2004.04.007; Kattah NH, 2010, IMMUNOL REV, V233, P126, DOI 10.1111/j.0105-2896.2009.00863.x; KERBIRIOU DM, 1980, J BIOL CHEM, V255, P3952; LERNER MR, 1979, P NATL ACAD SCI USA, V76, P5495, DOI 10.1073/pnas.76.11.5495; Maas C, 2008, J CLIN INVEST, V118, P3208, DOI [10.1172/JC135424, 10.1172/JCI35424]; MANDLE RJ, 1976, P NATL ACAD SCI USA, V73, P4179, DOI 10.1073/pnas.73.11.4179; Muller J, 2009, CHEM BIOL, V16, P442, DOI 10.1016/j.chembiol.2009.03.007; Muller F, 2009, CELL, V139, P1143, DOI 10.1016/j.cell.2009.11.001; Nakazawa F, 2005, BIOCHEM J, V385, P831, DOI 10.1042/BJ20041021; Oehmcke S, 2009, J INNATE IMMUN, V1, P225, DOI 10.1159/000203700; Paul A, 2010, CLIN APPL THROMB-HEM, V16, P161, DOI 10.1177/1076029608329580; Ratnoff O D, 1979, Curr Top Hematol, V2, P1; REDDI KK, 1976, P NATL ACAD SCI USA, V73, P2308, DOI 10.1073/pnas.73.7.2308; Rosenberg JE, 2010, J CLIN ONCOLOGY S, V28, P4590; Russo Krauss I, 2011, NUCLEIC ACIDS RES, V39, P7858, DOI 10.1093/nar/gkr522; SCHAPIRA M, 1981, BIOCHEMISTRY-US, V20, P2738, DOI 10.1021/bi00513a006; SCOTT CF, 1982, J CLIN INVEST, V69, P844, DOI 10.1172/JCI110524; SCOTT CF, 1980, J CLIN INVEST, V65, P413, DOI 10.1172/JCI109684; Soundararajan S, 2009, MOL PHARMACOL, V76, P984, DOI 10.1124/mol.109.055947; TAIT JF, 1987, J BIOL CHEM, V262, P11651; THOMPSON RE, 1977, J CLIN INVEST, V60, P1376, DOI 10.1172/JCI108898; Tucker CE, 1999, J CHROMATOGR B, V732, P203, DOI 10.1016/S0378-4347(99)00285-6; Urban CF, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000639; Wilson C, 2006, CURR OPIN CHEM BIOL, V10, P607, DOI 10.1016/j.cbpa.2006.10.001	37	30	31	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 30	2012	7	11							e50399	10.1371/journal.pone.0050399	http://dx.doi.org/10.1371/journal.pone.0050399			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	054WM	23226277	Green Published, Green Submitted, gold			2022-12-27	WOS:000312376100087
J	Grillo-Puertas, M; Villegas, JM; Rintoul, MR; Rapisarda, VA				Grillo-Puertas, Mariana; Villegas, Josefina M.; Rintoul, Maria R.; Rapisarda, Viviana A.			Polyphosphate Degradation in Stationary Phase Triggers Biofilm Formation via LuxS Quorum Sensing System in Escherichia coli	PLOS ONE			English	Article							INORGANIC POLYPHOSPHATE; MICROBIAL BIOFILMS; PHOSPHATE CONCENTRATION; GENE-EXPRESSION; VIBRIO-CHOLERAE; KINASE; SURVIVAL; MOTILITY; SIGNAL; RESISTANCE	In most natural environments, association with a surface in a structure known as biofilm is the prevailing microbial life-style of bacteria. Polyphosphate (polyP), an ubiquitous linear polymer of hundreds of orthophosphate residues, has a crucial role in stress responses, stationary-phase survival, and it was associated to bacterial biofilm formation and production of virulence factors. In previous work, we have shown that Escherichia coli cells grown in media containing a critical phosphate concentration >37 mM maintained an unusual high polyP level in stationary phase. The aim of the present work was to analyze if fluctuations in polyP levels in stationary phase affect biofilm formation capacity in E. coli. Polymer levels were modulated by the media phosphate concentration or using mutant strains in polyP metabolism. Cells grown in media containing phosphate concentrations higher than 25 mM were defective in biofilm formation. Besides, there was a disassembly of 24 h preformed biofilm by the addition of high phosphate concentration to the medium. These phenotypes were related to the maintenance or re-synthesis of polyP in stationary phase in static conditions. No biofilm formation was observed in ppk(-)ppx(-) or ppk(-)ppx(-)/ppk(+) strains, deficient in polyP synthesis and hydrolysis, respectively. luxS and lsrK mutants, impaired in autoinducer-2 quorum sensing signal metabolism, were unable to form biofilm unless conditioned media from stationary phase wild type cells grown in low phosphate were used. We conclude that polyP degradation is required for biofilm formation in sufficient phosphate media, activating or triggering the production of autoinducer-2. According to our results, phosphate concentration of the culture media should be carefully considered in bacterial adhesion and virulence studies.	[Rapisarda, Viviana A.] Univ Nacl Tucuman, Inst Super Invest Biol, Consejo Nacl Invest Cient & Tecn, San Miguel De Tucuman, Argentina; Univ Nacl Tucuman, Inst Quim Biol Dr Bernabe Bloj, San Miguel De Tucuman, Argentina	Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); Universidad Nacional de Tucuman; Universidad Nacional de Tucuman	Rapisarda, VA (corresponding author), Univ Nacl Tucuman, Inst Super Invest Biol, Consejo Nacl Invest Cient & Tecn, San Miguel De Tucuman, Argentina.	vrapisarda@fbqf.unt.edu.ar		Rapisarda, Viviana A./0000-0002-8217-6581; Villegas, Josefina Maria/0000-0003-3081-6716	Consejo de Investigaciones de la Univeridad Nacional de Tucuman (CIUNT) [26/D329]; Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET) [PIP6399]	Consejo de Investigaciones de la Univeridad Nacional de Tucuman (CIUNT); Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET)(Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET))	This research was supported by grants 26/D329 from Consejo de Investigaciones de la Univeridad Nacional de Tucuman (CIUNT), PIP6399 from Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AHN KH, 1990, J BIOL CHEM, V265, P11734; AKIYAMA M, 1993, J BIOL CHEM, V268, P633; Aschar-Sobbi R, 2008, J FLUORESC, V18, P859, DOI 10.1007/s10895-008-0315-4; Bassler BL, 1999, CURR OPIN MICROBIOL, V2, P582, DOI 10.1016/S1369-5274(99)00025-9; Busalmen JP, 2001, J IND MICROBIOL BIOT, V26, P303, DOI 10.1038/sj.jim.7000133; CASADABAN MJ, 1979, P NATL ACAD SCI USA, V76, P4530, DOI 10.1073/pnas.76.9.4530; Castonguay MH, 2006, RES MICROBIOL, V157, P471, DOI 10.1016/j.resmic.2005.10.003; Costerton JW, 1999, SCIENCE, V284, P1318, DOI 10.1126/science.284.5418.1318; COSTERTON JW, 1995, ANNU REV MICROBIOL, V49, P711, DOI 10.1146/annurev.mi.49.100195.003431; CROOKE E, 1994, J BIOL CHEM, V269, P6290; Danese PN, 2000, J BACTERIOL, V182, P3593, DOI 10.1128/JB.182.12.3593-3596.2000; Davey ME, 2000, MICROBIOL MOL BIOL R, V64, P847, DOI 10.1128/MMBR.64.4.847-867.2000; de Kievit TR, 2000, INFECT IMMUN, V68, P4839, DOI 10.1128/IAI.68.9.4839-4849.2000; Eisenbach M, 1996, MOL MICROBIOL, V20, P903, DOI 10.1111/j.1365-2958.1996.tb02531.x; Fuqua C, 1996, ANNU REV MICROBIOL, V50, P727, DOI 10.1146/annurev.micro.50.1.727; Gomez MA, 2003, J BIOSCI BIOENG, V95, P245, DOI 10.1016/S1389-1723(03)80024-5; Jahid IK, 2006, APPL ENVIRON MICROB, V72, P7043, DOI 10.1128/AEM.00924-06; Kim HY, 1998, MOL MICROBIOL, V27, P717, DOI 10.1046/j.1365-2958.1998.00702.x; Kim KS, 2002, P NATL ACAD SCI USA, V99, P7675, DOI 10.1073/pnas.112210499; Kleerebezem M, 1997, MOL MICROBIOL, V24, P895, DOI 10.1046/j.1365-2958.1997.4251782.x; Kornberg A, 1999, ANNU REV BIOCHEM, V68, P89, DOI 10.1146/annurev.biochem.68.1.89; Kubota H, 2008, J BIOSCI BIOENG, V106, P381, DOI 10.1263/jbb.106.381; Kulaev IS, 1979, BIOCH INORGANIC POLY; Kumar CG, 1998, INT J FOOD MICROBIOL, V42, P9, DOI 10.1016/S0168-1605(98)00060-9; Lazazzera BA, 1998, TRENDS MICROBIOL, V6, P288, DOI 10.1016/S0966-842X(98)01313-4; Marques JC, 2011, J BIOL CHEM, V286, P18331, DOI 10.1074/jbc.M111.230227; Miller MB, 2001, ANNU REV MICROBIOL, V55, P165, DOI 10.1146/annurev.micro.55.1.165; O'Toole GA, 1998, MOL MICROBIOL, V28, P449, DOI 10.1046/j.1365-2958.1998.00797.x; Ogawa N, 2000, J BACTERIOL, V182, P6687, DOI 10.1128/JB.182.23.6687-6693.2000; Pratt LA, 1998, MOL MICROBIOL, V30, P285, DOI 10.1046/j.1365-2958.1998.01061.x; Price-Carter M, 2005, J BACTERIOL, V187, P3088, DOI 10.1128/JB.187.9.3088-3099.2005; Rao NN, 1996, J BACTERIOL, V178, P1394, DOI 10.1128/jb.178.5.1394-1400.1996; Rashid MH, 2000, P NATL ACAD SCI USA, V97, P4885, DOI 10.1073/pnas.060030097; Rashid MH, 2000, J BACTERIOL, V182, P225, DOI 10.1128/JB.182.1.225-227.2000; Rashid MH, 2000, P NATL ACAD SCI USA, V97, P9636, DOI 10.1073/pnas.170283397; Schurig-Briccio LA, 2008, FEMS MICROBIOL LETT, V284, P76, DOI 10.1111/j.1574-6968.2008.01188.x; Schurig-Briccio LA, 2009, J BACTERIOL, V191, P4478, DOI 10.1128/JB.00082-09; Schurig-Briccio LA, 2009, ARCH BIOCHEM BIOPHYS, V483, P106, DOI 10.1016/j.abb.2008.12.009; Shi XB, 2004, P NATL ACAD SCI USA, V101, P17061, DOI 10.1073/pnas.0407787101; Sung BH, 2006, APPL ENVIRON MICROB, V72, P3336, DOI 10.1128/AEM.72.5.3336-3342.2006; Tan SM, 2005, J BACTERIOL, V187, P7687, DOI 10.1128/JB.187.22.7687-7695.2005; Terada A, 2003, J BIOSCI BIOENG, V95, P170, DOI 10.1016/S1389-1723(03)80124-X; Han TH, 2011, RES MICROBIOL, V162, P108, DOI 10.1016/j.resmic.2010.11.005; Wang DD, 2001, J BACTERIOL, V183, P4210, DOI 10.1128/JB.183.14.4210-4216.2001; Xavier KB, 2003, CURR OPIN MICROBIOL, V6, P191, DOI 10.1016/S1369-5274(03)00028-6; YANOFSKY C, 1991, J BACTERIOL, V173, P6009, DOI 10.1128/jb.173.19.6009-6017.1991; ZOTTOLA EA, 1994, INT J FOOD MICROBIOL, V23, P125, DOI 10.1016/0168-1605(94)90047-7; Zuroff TR, 2010, BMC MICROBIOL, V10, DOI 10.1186/1471-2180-10-185	48	34	36	1	37	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 30	2012	7	11							e50368	10.1371/journal.pone.0050368	http://dx.doi.org/10.1371/journal.pone.0050368			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	054WM	23226268	Green Submitted, gold, Green Published			2022-12-27	WOS:000312376100078
J	Lin, Y; Chen, XJ; Liu, W; Gong, B; Xie, J; Xiong, JH; Cheng, J; Duan, XL; Lin, ZC; Huang, LL; Wan, HY; Liu, XQ; Song, LH; Yang, ZL				Lin, Ying; Chen, Xue-Jun; Liu, Wei; Gong, Bo; Xie, Jun; Xiong, Jun-Hao; Cheng, Jing; Duan, Xi-Ling; Lin, Zhao-Chun; Huang, Lu-Lin; Wan, Hui-Ying; Liu, Xiao-Qi; Song, Lin-Hong; Yang, Zheng-Lin			Two Novel Mutations on Exon 8 and Intron 65 of COL7A1 Gene in Two Chinese Brothers Result in Recessive Dystrophic Epidermolysis Bullosa	PLOS ONE			English	Article							VII COLLAGEN GENE; SPLICE-SITE MUTATION; PREMATURE TERMINATION CODONS; GLYCINE SUBSTITUTION MUTATIONS; COMPOUND HETEROZYGOSITY; IDENTIFICATION; PHENOTYPE; DOMINANT; PATIENT; UNDERLIE	Dystrophic epidermolysis bullosa is an inherited bullous dermatosis caused by the COL7A1 gene mutation in autosomal dominant or recessive mode. COL7A1 gene encodes type VII collagen - the main component of the anchoring fibrils at the dermal-epidermal junction. Besides the 730 mutations reported, we identified two novel COL7A1 gene mutations in a Chinese family, which caused recessive dystrophic epidermolysis bullosa (RDEB). The diagnosis was established histopathologically and ultrastructurally. After genomic DNA extraction from the peripheral blood sample of all subjects (5 pedigree members and 136 unrelated control individuals), COL7A1 gene screening was performed by polymerase chain reaction amplification and direct DNA sequencing of the whole coding exons and flanking intronic regions. Genetic analysis of the COL7A1 gene in affected individuals revealed compound heterozygotes with identical novel mutations. The maternal mutation is a 2-bp deletion at exon 8 (c.1006_1007delCA), leading to a subsequent reading frame-shift and producing a premature termination codon located 48 amino acids downstream in exon 9 (p. Q336EfsX48), consequently resulting in the truncation of 2561 amino acids downstream. This was only present in two affected brothers, but not in the other unaffected family members. The paternal mutation is a 1-bp deletion occurring at the first base of intron 65 (c. IVS5568+1delG) that deductively changes the strongly conserved GT dinucleotide at the 59 donor splice site, results in subsequent reading-through into intron 65, and creates a stop codon immediately following the amino acids encoded by exon 65 (GTAA -> TAA). This is predicted to produce a truncated protein lacking of 1089 C-terminal amino acids downstream. The latter mutation was found in all family members except one of the two unaffected sisters. Both mutations were observed concurrently only in the two affected brothers. Neither mutation was discovered in 136 unrelated Chinese control individuals. This study reveals novel disease-causing mutations in the COL7A1 gene.	[Chen, Xue-Jun; Liu, Wei; Xie, Jun; Xiong, Jun-Hao; Duan, Xi-Ling; Lin, Zhao-Chun; Wan, Hui-Ying] Sichuan Acad Med Sci, Inst Dermatol & Venereol, Chengdu, Sichuan, Peoples R China; [Lin, Ying; Gong, Bo; Cheng, Jing; Huang, Lu-Lin; Liu, Xiao-Qi; Yang, Zheng-Lin] Sichuan Acad Med Sci, Sichuan Prov Key Lab Human Dis Gene Study, Chengdu, Sichuan, Peoples R China; [Lin, Ying; Chen, Xue-Jun; Liu, Wei; Gong, Bo; Xie, Jun; Xiong, Jun-Hao; Cheng, Jing; Duan, Xi-Ling; Lin, Zhao-Chun; Huang, Lu-Lin; Wan, Hui-Ying; Liu, Xiao-Qi; Song, Lin-Hong; Yang, Zheng-Lin] Sichuan Prov Peoples Hosp, Chengdu, Sichuan, Peoples R China; [Song, Lin-Hong] Sichuan Acad Med Sci, Dept Pathol, Chengdu, Sichuan, Peoples R China	Sichuan Provincial People's Hospital; Sichuan Provincial People's Hospital; Sichuan Provincial People's Hospital; Sichuan Provincial People's Hospital	Chen, XJ (corresponding author), Sichuan Acad Med Sci, Inst Dermatol & Venereol, 32 Western 2nd Sect, Chengdu, Sichuan, Peoples R China.	xjunchen30@hotmail.com; zliny@yahoo.com			Sichuan Provincial Bureau of Health [416.001.004.051]; Sichuan Academy of Medical Sciences & Sichuan Provincial People's Hospital [303.005.002.209.051]; Department of Science and Technology of Sichuan Province, China [2011JTD0020, 2010FZ0076]	Sichuan Provincial Bureau of Health; Sichuan Academy of Medical Sciences & Sichuan Provincial People's Hospital; Department of Science and Technology of Sichuan Province, China	This study was supported by the research grants from Sichuan Provincial Bureau of Health (#416.001.004.051), Sichuan Academy of Medical Sciences & Sichuan Provincial People's Hospital (#303.005.002.209.051) (XJC); grant from the Department of Science and Technology of Sichuan Province, China (2011JTD0020, 2010FZ0076 (ZLY). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Almaani N, 2011, ACTA DERM-VENEREOL, V91, P262, DOI 10.2340/00015555-1053; Cho JW, 2009, J KOREAN MED SCI, V24, P256, DOI 10.3346/jkms.2009.24.2.256; CHRISTIANO AM, 1994, J BIOL CHEM, V269, P20256; CHRISTIANO AM, 1993, NAT GENET, V4, P62, DOI 10.1038/ng0593-62; Christiano AM, 1997, J INVEST DERMATOL, V109, P811, DOI 10.1111/1523-1747.ep12341013; CHRISTIANO AM, 1995, J CLIN INVEST, V95, P1328, DOI 10.1172/JCI117783; CHRISTIANO AM, 1994, GENOMICS, V21, P160, DOI 10.1006/geno.1994.1238; CHRISTIANO AM, 1994, GENOMICS, V21, P169, DOI 10.1006/geno.1994.1239; Christiano AM, 1997, HUM MUTAT, V10, P408, DOI 10.1002/(SICI)1098-1004(1997)10:5<408::AID-HUMU12>3.0.CO;2-3; Cserhalmi-Friedman PB, 1998, LAB INVEST, V78, P1483; CserhalmiFriedman PB, 1997, ARCH DERMATOL RES, V289, P640, DOI 10.1007/s004030050253; Cuadrado-Corrales N, 2010, BMC MED GENET, V11, DOI 10.1186/1471-2350-11-139; Dang NN, 2008, EXP DERMATOL, V17, P553, DOI 10.1111/j.1600-0625.2008.00723.x; Fassihi H, 2006, J INVEST DERMATOL, V126, P2039, DOI 10.1038/sj.jid.5700348; Fine JD, 2008, J AM ACAD DERMATOL, V58, P931, DOI 10.1016/j.jaad.2008.02.004; Galehdari H, 2010, J MOL DIAGN, V12, P377, DOI 10.2353/jmoldx.2010.090145; Gardella R, 2002, J INVEST DERMATOL, V119, P1456, DOI 10.1046/j.1523-1747.2002.19606.x; Gardella R, 2002, BRIT J DERMATOL, V147, P450, DOI 10.1046/j.1365-2133.2002.04914.x; Gardella R, 1999, HUM MUTAT, V13, P439, DOI 10.1002/(SICI)1098-1004(1999)13:6<439::AID-HUMU3>3.0.CO;2-N; Hovnanian A, 1997, AM J HUM GENET, V61, P599, DOI 10.1086/515495; Huang L, 2011, INT J DERMATOL, V50, P52, DOI 10.1111/j.1365-4632.2010.04642.x; Ishiko A, 2004, EXP DERMATOL, V13, P229, DOI 10.1111/j.0906-6705.2004.00167.x; Jiang W, 2005, BRIT J DERMATOL, V152, P1357, DOI 10.1111/j.1365-2133.2005.06638.x; Kraemer L, 2006, EUR J DERMATOL, V16, P615, DOI 10.1684/ejd.2006.0007; Leverkus M, 2011, BRIT J DERMATOL, V164, P1104, DOI 10.1111/j.1365-2133.2011.10230.x; Lin GT, 2000, J FORMOS MED ASSOC, V99, P693; Mallipeddi R, 2003, BRIT J DERMATOL, V149, P810, DOI 10.1046/j.1365-2133.2003.05315.x; Masse M, 2005, CLIN EXP DERMATOL, V30, P289, DOI 10.1111/j.1365-2230.2005.01763.x; Mellerio JE, 1999, EXP DERMATOL, V8, P22, DOI 10.1111/j.1600-0625.1999.tb00344.x; Ryoo YW, 2001, J DERMATOL SCI, V26, P125, DOI 10.1016/S0923-1811(00)00168-7; Shimizu H, 1999, J INVEST DERMATOL, V113, P419, DOI 10.1046/j.1523-1747.1999.00713.x; Titeux Matthias, 2006, Hum Mutat, V27, P291, DOI 10.1002/humu.9406; Uitto Jouni, 2011, Acta Derm Venereol, V91, P259, DOI 10.2340/00015555-1131; Varki R, 2007, J MED GENET, V44, P181, DOI 10.1136/jmg.2006.045302; Wertheim-Tysarowska K, 2012, HUM MUTAT, V33, P327, DOI 10.1002/humu.21651; Woodley DT, 2008, J BIOL CHEM, V283, P17838, DOI 10.1074/jbc.M709452200; Yonei N, 2006, J DERMATOL, V33, P802, DOI 10.1111/j.1346-8138.2006.00182.x	37	4	4	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 30	2012	7	11							e50579	10.1371/journal.pone.0050579	http://dx.doi.org/10.1371/journal.pone.0050579			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	054WM	23226319	Green Published, Green Submitted, gold			2022-12-27	WOS:000312376100131
J	Martin, EC; Bratton, MR; Zhu, Y; Rhodes, LV; Tilghman, SL; Collins-Burow, BM; Burow, ME				Martin, Elizabeth C.; Bratton, Melyssa R.; Zhu, Yun; Rhodes, Lyndsay V.; Tilghman, Syreeta L.; Collins-Burow, Bridgette M.; Burow, Matthew E.			Insulin-Like Growth Factor-1 Signaling Regulates miRNA Expression in MCF-7 Breast Cancer Cell Line	PLOS ONE			English	Article							CARCINOMA CELLS; GASTRIC-CANCER; TARGETING BCL2; MICRORNA; SUPPRESSES; LET-7; METASTASIS; MECHANISMS; RESISTANCE; PATHWAYS	In breast carcinomas, increased levels of insulin-like growth factor 1 (IGF-1) can act as a mitogen to augment tumorigenesis through the regulation of MAPK and AKT signaling pathways. Signaling through these two pathways allows IGF-1 to employ mechanisms that favor proliferation and cellular survival. Here we demonstrate a subset of previously described tumor suppressor and oncogenic microRNAs (miRNAs) that are under the direct regulation of IGF-1 signaling. Additionally, we show that the selective inhibition of either the MAPK or AKT pathways prior to IGF-1 stimulation prevents the expression of previously described tumor suppressor miRNAs that are family and cluster specific. Here we have defined, for the first time, specific miRNAs under the direct regulation of IGF-1 signaling in the estrogen receptor positive MCF-7 breast cancer cell line and demonstrate kinase signaling as a modulator of expression for a small subset of microRNAs. Taken together, these data give new insights into mechanisms governing IGF-1 signaling in breast cancer.	[Martin, Elizabeth C.; Zhu, Yun; Rhodes, Lyndsay V.; Collins-Burow, Bridgette M.; Burow, Matthew E.] Tulane Univ, Dept Med, Sect Hematol & Med Oncol, New Orleans, LA 70118 USA; [Bratton, Melyssa R.; Burow, Matthew E.] Tulane Univ, Dept Pharmacol, New Orleans, LA 70118 USA; [Tilghman, Syreeta L.] Xavier Univ Louisiana, Coll Pharm, New Orleans, LA USA	Tulane University; Tulane University; Xavier University of Louisiana	Burow, ME (corresponding author), Tulane Univ, Dept Med, Sect Hematol & Med Oncol, New Orleans, LA 70118 USA.	mburow@tulane.edu	Rhodes, Lyndsay/AAC-4989-2020; Burow, Matthew/D-6351-2013; Tilghman, Syreeta/GXH-9699-2022; Bratton, Melyssa/G-9431-2019	Rhodes, Lyndsay/0000-0001-7672-2059; Burow, Matthew/0000-0002-0642-6630; Tilghman, Syreeta/0000-0003-3215-1252; Bratton, Melyssa/0000-0001-9063-2025	National Institutes of Health [DK059389]; National Center for Research Resources [P20RR020152]; Office of Naval Research [N00014-16-1-1136]; NATIONAL CANCER INSTITUTE [R01CA125806] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR020152] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK059389] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); Office of Naval Research(Office of Naval Research); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This research was supported by: The National Institutes of Health: DK059389 (to MEB), National Center for Research Resources P20RR020152 (to BMC); The Office of Naval Research N00014-16-1-1136 (to MEB). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bhat-Nakshatri P, 2009, NUCLEIC ACIDS RES, V37, P4850, DOI 10.1093/nar/gkp500; Bolstad BM, 2003, BIOINFORMATICS, V19, P185, DOI 10.1093/bioinformatics/19.2.185; Bushati N, 2007, ANNU REV CELL DEV BI, V23, P175, DOI 10.1146/annurev.cellbio.23.090506.123406; Carlo C, 2009, NATURE REV GENETICS, V10, P704; Cimmino A, 2005, P NATL ACAD SCI USA, V102, P13944, DOI 10.1073/pnas.0506654102; Cittelly DM, 2010, CARCINOGENESIS, V31, P2049, DOI 10.1093/carcin/bgq192; Dangi-Garimella S, 2009, EMBO J, V28, P347, DOI 10.1038/emboj.2008.294; Davis BN, 2009, CELL COMMUN SIGNAL, V7, DOI 10.1186/1478-811X-7-18; Elyakim E, 2010, CANCER RES, V70, P8077, DOI 10.1158/0008-5472.CAN-10-1313; Fang L, 2011, ONCOGENE, V30, P806, DOI 10.1038/onc.2010.465; Gao XL, 2004, BIOPOLYMERS, V73, P579, DOI 10.1002/bip.20005; Gooch JL, 1999, BREAST CANCER RES TR, V56, P1, DOI 10.1023/A:1006208721167; Grimberg A, 2003, CANCER BIOL THER, V2, P630; Hua Z, 2006, PLOS ONE, V1, DOI 10.1371/journal.pone.0000116; Iliopoulos D, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2000356; Kurmasheva RT, 2006, BBA-REV CANCER, V1766, P1, DOI 10.1016/j.bbcan.2006.05.003; Li XH, 2011, J CELL MOL MED, V15, P1887, DOI 10.1111/j.1582-4934.2010.01194.x; Linsley PS, 2007, MOL CELL BIOL, V27, P2240, DOI 10.1128/MCB.02005-06; Ricarte JCM, 2009, TRANSL ONCOL, V2, P236, DOI 10.1593/tlo.09151; O'Day E, 2010, BREAST CANCER RES, V12, DOI 10.1186/bcr2484; Rhodes LV, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-295; Roush S, 2008, TRENDS CELL BIOL, V18, P505, DOI 10.1016/j.tcb.2008.07.007; Sachdev D, 2001, ENDOCR-RELAT CANCER, V8, P197, DOI 10.1677/erc.0.0080197; Vincent AM, 2002, GROWTH HORM IGF RES, V12, P193, DOI 10.1016/S1096-6374(02)00017-5; Visone R, 2009, AM J PATHOL, V174, P1131, DOI 10.2353/ajpath.2009.080794; Wickramasinghe NS, 2009, NUCLEIC ACIDS RES, V37, P2584, DOI 10.1093/nar/gkp117; Xia L, 2008, INT J CANCER, V123, P372, DOI 10.1002/ijc.23501; Xu T, 2009, HEPATOLOGY, V50, P113, DOI 10.1002/hep.22919; Zhang BH, 2007, DEV BIOL, V302, P1, DOI 10.1016/j.ydbio.2006.08.028; Zhu Qi, 2007, V382, P287, DOI 10.1007/978-1-59745-304-2_19	30	25	26	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 30	2012	7	11							e49067	10.1371/journal.pone.0049067	http://dx.doi.org/10.1371/journal.pone.0049067			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	054WM	23226206	Green Submitted, Green Published, gold			2022-12-27	WOS:000312376100015
J	Park, KW; Nozell, SE; Benveniste, EN				Park, Keun W.; Nozell, Susan E.; Benveniste, Etty N.			Protective Role of STAT3 in NMDA and Glutamate-Induced Neuronal Death: Negative Regulatory Effect of SOCS3	PLOS ONE			English	Article							LEUKEMIA INHIBITORY FACTOR; CYTOKINE SIGNALING-3; IN-VIVO; GENE-EXPRESSION; ONCOSTATIN-M; HIPPOCAMPAL-NEURONS; NEUROTROPHIC FACTOR; AXON REGENERATION; NERVOUS-SYSTEM; GROWTH-FACTOR	The present study investigates the involvement of the IL-6 family of cytokines, activation of the transcription factor Signal Transducer and Activator of Transcription-3 (STAT3), and the role of Suppressor Of Cytokine Signaling-3 (SOCS3) in regulating excitotoxic neuronal death in vitro. Biochemical evidence demonstrates that in primary cortical neurons and SH-SY5Y neuroblastoma cells, IL-6 cytokine family members, OSM and IL-6 plus the soluble IL-6R (IL-6/R), prevent NMDA and glutamate-induced neuronal toxicity. As well, OSM and IL-6/R induce tyrosine and serine phosphorylation of STAT3 in primary cortical neurons and SH-SY5Y cells. Studies using Pyridine 6 (P6), a pan-JAK inhibitor, demonstrate that the protective effect of OSM and IL-6/R on neuronal death is mediated by the JAK/STAT3 signaling pathway. In parallel to STAT3 phosphorylation, OSM and IL-6/R induce SOCS3 expression at the mRNA and protein level. P6 treatment inhibits SOCS3 expression, indicating that STAT3 is required for OSM and IL-6/R-induced SOCS3 expression. Lentiviral delivery of SOCS3, an inhibitor of STAT3 signaling, into primary neurons and SH-SY5Y cells inhibits OSM and IL-6/R-induced phosphorylation of STAT3, and also reverses the protective effect of OSM and IL-6/R on NMDA and glutamate-induced neurotoxicity in primary cortical neurons. In addition, treatment with IL-6 cytokines increases expression of the anti-apoptotic protein Bcl-xL and induces activation of the Akt signaling pathway, which are also negatively regulated by SOCS3 expression. Thus, IL-6/R and OSM-induced SOCS3 expression may be an important factor limiting the neuroprotective effects of activated STAT3 against NMDA and glutamate-induced neurotoxicity.	[Park, Keun W.; Nozell, Susan E.; Benveniste, Etty N.] Univ Alabama Birmingham, Dept Cell Dev & Integrat Biol, Birmingham, AL 35294 USA	University of Alabama System; University of Alabama Birmingham	Benveniste, EN (corresponding author), Univ Alabama Birmingham, Dept Cell Dev & Integrat Biol, Birmingham, AL 35294 USA.	tika@uab.edu			National Institutes of Health [NS45290, CA138517]; National Multiple Sclerosis Society Collaborative Research Center [CA 1059-A-13]; NATIONAL CANCER INSTITUTE [R01CA138517] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS045290] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Multiple Sclerosis Society Collaborative Research Center(National Multiple Sclerosis Society); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was funded in part by National Institutes of Health Grants NS45290 (ENB), CA138517 (SEN), and a National Multiple Sclerosis Society Collaborative Research Center Grant (CA 1059-A-13) (ENB)]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding was received for this study.	Babon JJ, 2012, IMMUNITY, V36, P239, DOI 10.1016/j.immuni.2011.12.015; Baker BJ, 2010, GLIA, V58, P1082, DOI 10.1002/glia.20989; Baker BJ, 2009, TRENDS IMMUNOL, V30, P392, DOI 10.1016/j.it.2009.07.001; Bareyre FM, 2011, P NATL ACAD SCI USA, V108, P6282, DOI 10.1073/pnas.1015239108; Billen LP, 2008, PLOS BIOL, V6, P1268, DOI 10.1371/journal.pbio.0060147; Butzkueven H, 2002, NAT MED, V8, P613, DOI 10.1038/nm0602-613; Chen YB, 2011, J CELL BIOL, V195, P263, DOI 10.1083/jcb.201108059; Croker BA, 2003, NAT IMMUNOL, V4, P540, DOI 10.1038/ni931; D'Arcangelo G, 2000, EUR J NEUROSCI, V12, P1241, DOI 10.1046/j.1460-9568.2000.00011.x; Deverman BE, 2009, NEURON, V64, P61, DOI 10.1016/j.neuron.2009.09.002; Dominguez E, 2010, J NEUROSCI, V30, P5754, DOI 10.1523/JNEUROSCI.5007-09.2010; Dziennis S, 2007, J NEUROSCI, V27, P7268, DOI 10.1523/JNEUROSCI.1558-07.2007; Dziennis S, 2008, REV NEUROSCIENCE, V19, P341; Emery B, 2006, P NATL ACAD SCI USA, V103, P7859, DOI 10.1073/pnas.0602574103; Encinas M, 2000, J NEUROCHEM, V75, P991, DOI 10.1046/j.1471-4159.2000.0750991.x; Ernst MB, 2009, J NEUROSCI, V29, P11582, DOI 10.1523/JNEUROSCI.5712-08.2009; Goldshmit Y, 2004, EUR J NEUROSCI, V20, P2260, DOI 10.1111/j.1460-9568.2004.03698.x; Guo ZH, 2008, J BIOL CHEM, V283, P1754, DOI 10.1074/jbc.M703753200; Hatta T, 2002, J NEUROSCI, V22, P5516; Heinrich PC, 2003, BIOCHEM J, V374, P1, DOI 10.1042/BJ20030407; Hellstrom M, 2011, MOL CELL NEUROSCI, V46, P507, DOI 10.1016/j.mcn.2010.12.003; Jones SA, 2011, J CLIN INVEST, V121, P3375, DOI 10.1172/JCI57158; Jung JE, 2010, MOL NEUROBIOL, V41, P172, DOI 10.1007/s12035-010-8102-z; Kuo ML, 2001, ONCOGENE, V20, P677, DOI 10.1038/sj.onc.1204140; Lang R, 2003, NAT IMMUNOL, V4, P546, DOI 10.1038/ni932; Li YH, 2006, J IMMUNOL, V177, P1679, DOI 10.4049/jimmunol.177.3.1679; Linker RA, 2002, NAT MED, V8, P620, DOI 10.1038/nm0602-620; Ma XY, 2010, J IMMUNOL, V184, P4898, DOI 10.4049/jimmunol.1000142; MAYER M, 1994, DEVELOPMENT, V120, P143; Metlakunta AS, 2011, AM J PHYSIOL-REG I, V300, pR1185, DOI 10.1152/ajpregu.00794.2010; Miao TZ, 2008, MOL CELL NEUROSCI, V37, P367, DOI 10.1016/j.mcn.2007.10.010; Miao T, 2006, J NEUROSCI, V26, P9512, DOI 10.1523/JNEUROSCI.2160-06.2006; Moidunny S, 2010, J NEUROCHEM, V114, P1667, DOI 10.1111/j.1471-4159.2010.06881.x; Mori H, 2004, NAT MED, V10, P739, DOI 10.1038/nm1071; Nicholson SE, 2000, P NATL ACAD SCI USA, V97, P6493, DOI 10.1073/pnas.100135197; Pedranzini L, 2006, CANCER RES, V66, P9714, DOI 10.1158/0008-5472.CAN-05-4280; Polizzotto MN, 2000, J COMP NEUROL, V423, P348; Qin HW, 2008, J IMMUNOL, V181, P3167, DOI 10.4049/jimmunol.181.5.3167; Qin H, 2007, J IMMUNOL, V179, P5966, DOI 10.4049/jimmunol.179.9.5966; Qin HW, 2006, J IMMUNOL, V177, P7761, DOI 10.4049/jimmunol.177.11.7761; Qin HW, 2012, P NATL ACAD SCI USA, V109, P5004, DOI 10.1073/pnas.1117218109; Repovic P, 2002, J NEUROSCI, V22, P5334; Roberts AW, 2001, P NATL ACAD SCI USA, V98, P9324, DOI 10.1073/pnas.161271798; Scheller J, 2006, SCAND J IMMUNOL, V63, P321, DOI 10.1111/j.1365-3083.2006.01750.x; Schmitz J, 2000, J BIOL CHEM, V275, P12848, DOI 10.1074/jbc.275.17.12848; Smith PD, 2009, NEURON, V64, P617, DOI 10.1016/j.neuron.2009.11.021; Sun F, 2011, NATURE, V480, P372, DOI 10.1038/nature10594; Sun F, 2010, CURR OPIN NEUROBIOL, V20, P510, DOI 10.1016/j.conb.2010.03.013; Sun Y, 2002, BIOCHEM BIOPH RES CO, V295, P532, DOI 10.1016/S0006-291X(02)00706-4; TOULMOND S, 1992, NEUROSCI LETT, V144, P49, DOI 10.1016/0304-3940(92)90713-H; Van Wagoner NJ, 1999, J NEUROSCI, V19, P5236; Van Wagoner NJ, 1999, J NEUROIMMUNOL, V100, P124, DOI 10.1016/S0165-5728(99)00187-3; Wang XQ, 2009, NEUROSCI LETT, V450, P122, DOI 10.1016/j.neulet.2008.11.051; Weiss TW, 2006, FASEB J, V20, P2369, DOI 10.1096/fj.06-5850fje; Wormald S, 2004, J BIOL CHEM, V279, P821, DOI 10.1074/jbc.R300030200; Yadav A, 2005, J BIOL CHEM, V280, P31830, DOI 10.1074/jbc.M501316200; Yamashita T, 2005, J NEUROCHEM, V94, P459, DOI 10.1111/j.1471-4159.2005.03227.x; Yoshimura A, 2007, NAT REV IMMUNOL, V7, P454, DOI 10.1038/nri2093; Zhao L, 2004, J BIOL CHEM, V279, P44093, DOI 10.1074/jbc.M313131200; Zigmond RE, 2012, FRONT MOL NEUROSCI, V4, DOI 10.3389/fnmol.2011.00062	60	27	27	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 30	2012	7	11							e50874	10.1371/journal.pone.0050874	http://dx.doi.org/10.1371/journal.pone.0050874			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	054WM	23226414	Green Published, Green Submitted, gold			2022-12-27	WOS:000312376100225
J	Smith, SM; Cai, L				Smith, Shannon M.; Cai, Li			Cell Specific CD44 Expression in Breast Cancer Requires the Interaction of AP-1 and NF kappa B with a Novel cis-Element	PLOS ONE			English	Article							GENE-EXPRESSION; SEQUENCE; CD44(+)/CD24(-); METASTASIS; ALIGNMENT; MOLECULE; TARGET; GROWTH; FRA-1	Breast cancers contain a heterogeneous population of cells with a small percentage that possess properties similar to those found in stem cells. One of the widely accepted markers of breast cancer stem cells (BCSCs) is the cell surface marker CD44. As a glycoprotein, CD44 is involved in many cellular processes including cell adhesion, migration and proliferation, making it pro-oncogenic by nature. CD44 expression is highly up-regulated in BCSCs, and has been implicated in tumorigenesis and metastasis. However, the genetic mechanism that leads to a high level of CD44 expression in breast cancer cells and BCSCs is not well understood. Here, we identify a novel cis-element of the CD44 directs gene expression in breast cancer cells in a cell type specific manner. We have further identified key trans-acting factor binding sites and nuclear factors AP-1 and NF kappa B that are involved in the regulation of cell-specific CD44 expression. These findings provide new insight into the complex regulatory mechanism of CD44 expression, which may help identify more effective therapeutic targets against the breast cancer stem cells and metastatic tumors.	[Smith, Shannon M.; Cai, Li] Rutgers State Univ, Dept Cell & Dev Biol, Piscataway, NJ 08854 USA; [Cai, Li] Rutgers State Univ, Dept Biomed Engn, Piscataway, NJ USA	Rutgers State University New Brunswick; Rutgers State University New Brunswick	Cai, L (corresponding author), Rutgers State Univ, Dept Cell & Dev Biol, Piscataway, NJ 08854 USA.	lcai@rutgers.edu		Cai, Li/0000-0003-3344-337X	National Institutes of Health [CA133675]; Busch Biomedical Research Awards; National Science Foundation - IGERT [DGE 0801620]	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Busch Biomedical Research Awards; National Science Foundation - IGERT(National Science Foundation (NSF))	This work was supported in part by the grant CA133675 from the National Institutes of Health and the Busch Biomedical Research Awards. SMS was a fellow of the National Science Foundation - IGERT grant (DGE 0801620). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Hajj M, 2003, P NATL ACAD SCI USA, V100, P3983, DOI 10.1073/pnas.0530291100; Ameyar M, 2003, BIOCHIMIE, V85, P747, DOI 10.1016/j.biochi.2003.09.006; Arvey A, 2012, GENOME RES, V22, P1723, DOI 10.1101/gr.127712.111; Brudno M, 2003, GENOME RES, V13, P721, DOI 10.1101/gr.926603; Cartharius K, 2005, BIOINFORMATICS, V21, P2933, DOI 10.1093/bioinformatics/bti473; Charafe-Jauffret E, 2009, CANCER RES, V69, P1302, DOI 10.1158/0008-5472.CAN-08-2741; Cheng C, 2012, GENOME RES, V22, P1658, DOI 10.1101/gr.136838.111; Damm S, 2010, J INVEST DERMATOL, V130, P1893, DOI 10.1038/jid.2010.45; Dave B, 2009, J MAMMARY GLAND BIOL, V14, P79, DOI 10.1007/s10911-009-9117-9; Doh ST, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-94; Dupont VN, 2007, INT J CANCER, V121, P1036, DOI 10.1002/ijc.22775; Eferl R, 2003, NAT REV CANCER, V3, P859, DOI 10.1038/nrc1209; Ferlay J, 2010, INT J CANCER, V127, P2893, DOI 10.1002/ijc.25516; Fillmore C, 2007, BREAST CANCER RES, V9, DOI 10.1186/bcr1673; Fillmore CM, 2008, BREAST CANCER RES, V10, DOI 10.1186/bcr1982; Foster LC, 2000, FASEB J, V14, P368, DOI 10.1096/fasebj.14.2.368; Han Y., 2010, CURR PROTOC MOL BIOL, V89, P21151, DOI [10.1002/0471142727.mb2115s89, DOI 10.1002/0471142727.MB2115S89, 10.1002/0471142727.MB2115S89]; Hebbard L, 2000, J CELL SCI, V113, P2619; Heintzman ND, 2009, CURR OPIN GENET DEV, V19, P541, DOI 10.1016/j.gde.2009.09.006; Heintzman ND, 2009, NATURE, V459, P108, DOI 10.1038/nature07829; Herrlich P, 2000, ANN NY ACAD SCI, V910, P106; HOFMANN M, 1993, CANCER RES, V53, P1516; Jin LQ, 2006, NAT MED, V12, P1167, DOI 10.1038/nm1483; Lamb RF, 1997, MOL CELL BIOL, V17, P963, DOI 10.1128/MCB.17.2.963; Liu C, 2011, NAT MED, V17, P211, DOI 10.1038/nm.2284; Mandal CC, 2011, J BIOL CHEM, V286, P11314, DOI 10.1074/jbc.M110.193714; Mao X, 2008, J CUTAN PATHOL, V35, P899, DOI 10.1111/j.1600-0560.2007.00924.x; McGarvey KM, 2006, CANCER RES, V66, P3541, DOI 10.1158/0008-5472.CAN-05-2481; Mlarotta LLC, 2009, CURR OPIN GENET DEV, V19, P44, DOI 10.1016/j.gde.2008.12.003; Naor D, 2008, SEMIN CANCER BIOL, V18, P260, DOI 10.1016/j.semcancer.2008.03.015; Nohr Jane, 2003, Methods Mol Biol, V232, P127; Orian-Rousseau V, 2010, EUR J CANCER, V46, P1271, DOI 10.1016/j.ejca.2010.02.024; Orom UA, 2011, TRENDS GENET, V27, P433, DOI 10.1016/j.tig.2011.06.009; Ponta H, 2003, NAT REV MOL CELL BIO, V4, P33, DOI 10.1038/nrm1004; Ramos-Nino ME, 2007, MOL CANCER, V6, DOI 10.1186/1476-4598-6-81; Risse-Hackl G, 1998, ONCOGENE, V16, P3057, DOI 10.1038/sj.onc.1201845; Schaub MA, 2012, GENOME RES, V22, P1748, DOI 10.1101/gr.136127.111; Sheridan C, 2006, BREAST CANCER RES, V8, DOI 10.1186/bcr1610; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Vernot B, 2012, GENOME RES, V22, P1689, DOI 10.1101/gr.134890.111; Visel A, 2008, NAT GENET, V40, P158, DOI 10.1038/ng.2007.55; Visel A, 2007, NUCLEIC ACIDS RES, V35, pD88, DOI 10.1093/nar/gkl822; Wallach-Dayan SB, 2008, MOL CANCER THER, V7, P1615, DOI 10.1158/1535-7163.MCT-07-2383; Wang J, 2012, GENOME RES, V22, P1798, DOI 10.1101/gr.139105.112; Wright MH, 2008, BREAST CANCER RES, V10, DOI 10.1186/bcr1855; Young MR, 2006, GENE, V379, P1, DOI 10.1016/j.gene.2006.05.001; Zoller M, 2011, NAT REV CANCER, V11, P254, DOI 10.1038/nrc3023	47	23	24	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 30	2012	7	11							e50867	10.1371/journal.pone.0050867	http://dx.doi.org/10.1371/journal.pone.0050867			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	054WM	23226410	gold, Green Published, Green Submitted			2022-12-27	WOS:000312376100221
J	Speller, CF; Hauser, L; Lepofsky, D; Moore, J; Rodrigues, AT; Moss, ML; McKechnie, I; Yang, DY				Speller, Camilla F.; Hauser, Lorenz; Lepofsky, Dana; Moore, Jason; Rodrigues, Antonia T.; Moss, Madonna L.; McKechnie, Iain; Yang, Dongya Y.			High Potential for Using DNA from Ancient Herring Bones to Inform Modern Fisheries Management and Conservation	PLOS ONE			English	Article							EFFECTIVE POPULATION-SIZE; CLUPEA-HARENGUS-PALLASI; PACIFIC-NORTHWEST COAST; MICROSATELLITE LOCI; MISCODING LESIONS; BRITISH-COLUMBIA; SPECIES IDENTIFICATION; GENOTYPING ERRORS; GENETIC-STRUCTURE; MARINE FISH	Pacific herring (Clupea pallasi) are an abundant and important component of the coastal ecosystems for the west coast of North America. Current Canadian federal herring management assumes five regional herring populations in British Columbia with a high degree of exchange between units, and few distinct local populations within them. Indigenous traditional knowledge and historic sources, however, suggest that locally adapted, distinct regional herring populations may have been more prevalent in the past. Within the last century, the combined effects of commercial fishing and other anthropogenic factors have resulted in severe declines of herring populations, with contemporary populations potentially reflecting only the remnants of a previously more abundant and genetically diverse metapopulation. Through the analysis of 85 archaeological herring bones, this study attempted to reconstruct the genetic diversity and population structure of ancient herring populations using three different marker systems (mitochondrial DNA (mtDNA), microsatellites and SNPs). A high success rate (91%) of DNA recovery was obtained from the extremely small herring bone samples (often < 10 mg). The ancient herring mtDNA revealed high haplotype diversity comparable to modern populations, although population discrimination was not possible due to the limited power of the mtDNA marker. Ancient microsatellite diversity was also similar to modern samples, but the data quality was compromised by large allele drop-out and stuttering. In contrast, SNPs were found to have low error rates with no evidence for deviations from Hardy-Weinberg equilibrium, and simulations indicated high power to detect genetic differentiation if loci under selection are used. This study demonstrates that SNPs may be the most effective and feasible approach to survey genetic population structure in ancient remains, and further efforts should be made to screen for high differentiation markers. This study provides the much needed foundation for wider scale studies on temporal genetic variation in herring, with important implications for herring fisheries management, Aboriginal title rights and herring conservation.	[Speller, Camilla F.; Moore, Jason; Rodrigues, Antonia T.; Yang, Dongya Y.] Simon Fraser Univ, Dept Archaeol, Ancient DNA Lab, Burnaby, BC V5A 1S6, Canada; [Speller, Camilla F.] Univ York, Dept Archaeol, York YO10 5DD, N Yorkshire, England; [Hauser, Lorenz] Univ Washington, Sch Aquat & Fishery Sci, Seattle, WA 98195 USA; [Moss, Madonna L.] Univ Oregon, Dept Anthropol, Eugene, OR 97403 USA; [McKechnie, Iain] Univ British Columbia, Dept Anthropol, Vancouver, BC V5Z 1M9, Canada	Simon Fraser University; University of York - UK; University of Washington; University of Washington Seattle; University of Oregon; University of British Columbia	Speller, CF (corresponding author), Simon Fraser Univ, Dept Archaeol, Ancient DNA Lab, Burnaby, BC V5A 1S6, Canada.	cfspelle@sfu.ca; donyang@sfu.ca	McKechnie, Iain/N-8411-2019; Speller, Camilla/GLV-4769-2022; Speller, Camilla/D-2830-2014; McKechnie, Iain/O-2542-2013; Hauser, Lorenz/E-4365-2010	McKechnie, Iain/0000-0002-4989-2711; Speller, Camilla/0000-0001-7128-9903; McKechnie, Iain/0000-0002-4989-2711; 	National Geographic Society; SSHRC; Hakai Network for Coastal Peoples and Ecosystems; National Science Foundation [SBR-9705014]	National Geographic Society(National Geographic Society); SSHRC(Social Sciences and Humanities Research Council of Canada (SSHRC)); Hakai Network for Coastal Peoples and Ecosystems; National Science Foundation(National Science Foundation (NSF))	This research was supported in part by a National Geographic Society Discovery grant (awarded to DYY and DL), a SSHRC Partnership grant (awarded to DL), and the Hakai Network for Coastal Peoples and Ecosystems. Excavation of the Coffman Cove sites was supported by the U.S. Forest Service, Alaska Department of Transportation and Public Facilities, and Northern Land Use Research, Inc. Excavations at Cape Addington Rockshelter were supported by the U.S. Forest Service, National Science Foundation Grant SBR-9705014 (to MM) and the University of Oregon. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allentoft ME, P ROYAL SOC B; Allentoft ME, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016670; Allentoft ME, 2009, BIOTECHNIQUES, V46, P195, DOI 10.2144/000113086; Alonso A, 2004, FORENSIC SCI INT, V139, P141, DOI 10.1016/j.forsciint.2003.10.008; Anderson CNK, 2005, BIOINFORMATICS, V21, P1733, DOI 10.1093/bioinformatics/bti154; Arndt A, 2003, J ARCHAEOL SCI, V30, P1095, DOI 10.1016/S0305-4403(02)00204-2; Bandelt HJ, 1999, MOL BIOL EVOL, V16, P37, DOI 10.1093/oxfordjournals.molbev.a026036; Barnes I, 2002, SCIENCE, V295, P2267, DOI 10.1126/science.1067814; Barta J. L, 2006, THESIS; Beacham TD, 2008, T AM FISH SOC, V137, P1795, DOI 10.1577/T08-033.1; Brotherton P, 2007, NUCLEIC ACIDS RES, V35, P5717, DOI 10.1093/nar/gkm588; Cannon A, 2006, AM ANTIQUITY, V71, P123, DOI 10.2307/40035324; Carruthers WA, 1941, BRIT COLUMBIA FISHER; Chan YL, 2005, BIOL LETT-UK, V1, P423, DOI 10.1098/rsbl.2005.0354; Cooper A, 2000, SCIENCE, V289, P1139; de Bruyn M, 2011, TRENDS ECOL EVOL, V26, P405, DOI 10.1016/j.tree.2011.03.021; Drew JA, 2005, CONSERV BIOL, V19, P1286, DOI 10.1111/j.1523-1739.2005.00158.x; Drummond AJ, 2005, MOL BIOL EVOL, V22, P1185, DOI [10.1093/molbev/msi103, 10.1093/molbev/mss075]; Ewonus PA, 2011, J ARCHAEOL SCI, V38, P2536, DOI 10.1016/j.jas.2011.04.005; Excoffier L, 2010, MOL ECOL RESOUR, V10, P564, DOI 10.1111/j.1755-0998.2010.02847.x; Foley MM, 2010, MAR POLICY, V34, P955, DOI 10.1016/j.marpol.2010.02.001; Foster DR, 2002, J BIOGEOGR, V29, P1269, DOI 10.1046/j.1365-2699.2002.00791.x; Foster DR, 2000, J BIOGEOGR, V27, P27, DOI 10.1046/j.1365-2699.2000.00376.x; Funk F, 2010, HERRING SYNTHE UNPUB; Gao YW, 2001, CAN J FISH AQUAT SCI, V58, P2113, DOI 10.1139/cjfas-58-11-2113; Gilbert MTP, 2007, NUCLEIC ACIDS RES, V35, P1, DOI 10.1093/nar/gkl483; Gilbert MTP, 2003, AM J HUM GENET, V72, P48, DOI 10.1086/345379; Gobalet KW, 2004, T AM FISH SOC, V133, P801, DOI 10.1577/T02-084.1; Gorbachev VV, 2011, RUSS J MAR BIOL+, V37, P489, DOI 10.1134/S106307401106006X; Grant WS, 2012, MOL PHYLOGENET EVOL, V65, P203, DOI 10.1016/j.ympev.2012.06.006; Grier C, J ARCHAEOLOGICAL SCI; Gustafson RG, 2007, CONSERV BIOL, V21, P1009, DOI 10.1111/j.1523-1739.2007.00693.x; HAEGELE CW, 1985, CAN J FISH AQUAT SCI, V42, P39, DOI 10.1139/f85-261; Haile J, 2009, P NATL ACAD SCI USA, V106, P22352, DOI 10.1073/pnas.0912510106; Hauser L, 2001, HEREDITY, V87, P621, DOI 10.1046/j.1365-2540.2001.00956.x; Hauser L, 2002, P NATL ACAD SCI USA, V99, P11742, DOI 10.1073/pnas.172242899; Hauser L, 1998, NATO ADV SCI I A-LIF, V306, P191; Hauser L, 2008, FISH FISH, V9, P473, DOI 10.1111/j.1467-2979.2008.00306.x; HAY DE, 1999, 99176 CAN STOCK ASS; Heath DD, 2002, MOL ECOL, V11, P197, DOI 10.1046/j.1365-294X.2002.01434.x; Hilborn R, 2003, P NATL ACAD SCI USA, V100, P6564, DOI 10.1073/pnas.1037274100; Hughes J.B., 1997, SCIENCE, V278, P689, DOI DOI 10.1126/science.278.5338.689; Jackson JBC, 2001, SCIENCE, V293, P629, DOI 10.1126/science.1059199; Larsson LC, 2007, MOL ECOL, V16, P1135, DOI 10.1111/j.1365-294X.2006.03217.x; Lepofsky D., 2007, CAN J ARCHAEOL, V31, P190; Librado P, 2009, BIOINFORMATICS, V25, P1451, DOI 10.1093/bioinformatics/btp187; Limborg MT, 2012, MOL ECOL, V21, P3686, DOI 10.1111/j.1365-294X.2012.05639.x; Liu JX, 2011, MOL ECOL, V20, P3879, DOI 10.1111/j.1365-294X.2011.05213.x; Ludwig A, 2002, NATURE, V419, P447, DOI 10.1038/419447a; Ludwig A, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-221; Lyman R. Lee, 2004, ZOOARCHAEOLOGY CONSE; McKechnie I, 2012, HUU7II HOUSEHOLD ARC, P154; Miller KM, 2001, MOL ECOL NOTES, V1, P131, DOI 10.1046/j.1471-8278.2001.00048.x; Mitchell D, 2008, MOL ECOL RESOUR, V8, P50, DOI 10.1111/j.1471-8286.2007.01840.x; Mitchell Douglas, 2006, THESIS; Moss M. L., 2006, J ISL COAST ARCHAEOL, V1, P165, DOI DOI 10.1080/15564890600934129; Moss ML, 2011, ARCHAEOLOGY OF NORTH PACIFIC FISHERIES, P281; Nei M., 1987, MOL EVOLUTIONARY GEN; Nielsen EE, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1845; NORUSIS M, 2000, SPSS 10 0 GUIDE DATA; Nylander J. A. A., 2004, MRMODELTEST V2; Nystrom V, 2010, P ROY SOC B-BIOL SCI, V277, P2331, DOI 10.1098/rspb.2010.0301; O'Connell M, 1998, J FISH BIOL, V53, P150; O'Connell M, 1998, MOL ECOL, V7, P358; Olsen JB, 2002, MOL ECOL NOTES, V2, P101, DOI 10.1046/j.1471-8286.2002.00160.x; Paabo S, 2004, ANNU REV GENET, V38, P645, DOI 10.1146/annurev.genet.37.110801.143214; PAULY D, 1995, TRENDS ECOL EVOL, V10, P430, DOI 10.1016/S0169-5347(00)89171-5; Poinar HN, 2003, INT CONGR SER, V1239, P575, DOI 10.1016/S0531-5131(02)00624-6; Pompanon F, 2005, NAT REV GENET, V6, P847, DOI 10.1038/nrg1707; Roberts SB, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030908; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; Rousset F, 2008, MOL ECOL RESOUR, V8, P103, DOI 10.1111/j.1471-8286.2007.01931.x; Ryman N, 2006, MOL ECOL, V15, P2031, DOI 10.1111/j.1365-294X.2006.02839.x; Ryman N, 2006, MOL ECOL NOTES, V6, P600, DOI 10.1111/j.1471-8286.2006.01378.x; Schweigert JF, 2010, ICES J MAR SCI, V67, P1903, DOI 10.1093/icesjms/fsq134; Seeb JE, 2009, METHODS MOL BIOL, V578, P277, DOI 10.1007/978-1-60327-411-1_18; Shapiro B, 2004, SCIENCE, V306, P1561, DOI 10.1126/science.1101074; Small MP, 2005, T AM FISH SOC, V134, P1329, DOI 10.1577/T05-050.1; Stiller M, 2010, MOL BIOL EVOL, V27, P975, DOI 10.1093/molbev/msq083; Taberlet P, 1996, NUCLEIC ACIDS RES, V24, P3189, DOI 10.1093/nar/24.16.3189; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Thornton T. F., 2010, J ECOLOGICAL ANTHR, V14, P81, DOI DOI 10.5038/2162-4593.14.1.7; Thornton TF, 2010, HERRING SYNTHE UNPUB; Turner NJ, 2008, ECOL SOC, V13; Van Oosterhout C, 2004, MOL ECOL NOTES, V4, P535, DOI 10.1111/j.1471-8286.2004.00684.x; WARE DM, 1985, CAN J FISH AQUAT SCI, V42, P127, DOI 10.1139/f85-268; WEIR BS, 1984, EVOLUTION, V38, P1358, DOI 10.1111/j.1558-5646.1984.tb05657.x; Willerslev E, 2005, P ROY SOC B-BIOL SCI, V272, P3, DOI 10.1098/rspb.2004.2813; Yang DY, 2008, J ARCHAEOL SCI, V35, P2778, DOI 10.1016/j.jas.2008.05.010; Yang DY, 2005, J ARCHAEOL SCI, V32, P331, DOI 10.1016/j.jas.2004.09.008; Yang DY, 1998, AM J PHYS ANTHROPOL, V105, P539, DOI 10.1002/(SICI)1096-8644(199804)105:4<539::AID-AJPA10>3.3.CO;2-2; Yang DYY, 2004, J ARCHAEOL SCI, V31, P619, DOI 10.1016/j.jas.2003.10.008	92	40	40	0	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 30	2012	7	11							e51122	10.1371/journal.pone.0051122	http://dx.doi.org/10.1371/journal.pone.0051122			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	054WM	23226474	gold, Green Published, Green Submitted			2022-12-27	WOS:000312376100285
J	Tao, JN; Koster, MI; Harrison, W; Moran, JL; Beier, DR; Roop, DR; Overbeek, PA				Tao, Jianning; Koster, Maranke I.; Harrison, Wilbur; Moran, Jennifer L.; Beier, David R.; Roop, Dennis R.; Overbeek, Paul A.			A Spontaneous Fatp4/Scl27a4 Splice Site Mutation in a New Murine Model for Congenital Ichthyosis	PLOS ONE			English	Article							FATTY-ACID TRANSPORT; PROTEIN 4 GENE; RESTRICTIVE DERMOPATHY; WRINKLE-FREE; EXPRESSION; SKIN; DIFFERENTIATION; FEATURES; CELLS; MICE	Congenital ichthyoses are life-threatening conditions in humans. We describe here the identification and molecular characterization of a novel recessive mutation in mice that results in newborn lethality with severe congenital lamellar ichthyosis. Mutant newborns have a taut, shiny, non-expandable epidermis that resembles cornified manifestations of autosomal-recessive congenital ichthyosis in humans. The skin is stretched so tightly that the newborn mice are immobilized. The genetic defect was mapped to a region near the proximal end of chromosome 2 by SNP analysis, suggesting Fatp4/Slc27a4 as a candidate gene. FATP4 mutations in humans cause ichthyosis prematurity syndrome (IPS), and mutations of Fatp4 in mice have previously been found to cause a phenotype that resembles human congenital ichthyoses. Characterization of the Fatp4 cDNA revealed a fusion of exon 8 to exon 10, with deletion of exon 9. Genomic sequencing identified an A to T mutation in the splice donor sequence at the 39-end of exon 9. Loss of exon 9 results in a frame shift mutation upstream from the conserved very long-chain acyl-CoA synthase (VLACS) domain. Histological studies revealed that the mutant mice have defects in keratinocyte differentiation, along with hyperproliferation of the stratum basale of the epidermis, a hyperkeratotic stratum corneum, and reduced numbers of secondary hair follicles. Since Fatp4 protein is present primarily at the stratum granulosum and the stratum spinosum, the hyperproliferation and the alterations in hair follicle induction suggest that very long chain fatty acids, in addition to being required for normal cornification, may influence signals from the stratum corneum to the basal cells that help to orchestrate normal skin differentiation.	[Tao, Jianning; Harrison, Wilbur; Roop, Dennis R.; Overbeek, Paul A.] Baylor Coll Med, Dept Mol & Cellular Biol, Houston, TX 77030 USA; [Tao, Jianning; Overbeek, Paul A.] Baylor Coll Med, Dept Mol & Human Genet, Houston, TX 77030 USA; [Koster, Maranke I.; Roop, Dennis R.] Univ Colorado, Dept Dermatol, Aurora, CO USA; [Koster, Maranke I.; Roop, Dennis R.] Univ Colorado, Charles C Gates Ctr Regenerat Med & Stem Cell Bio, Aurora, CO USA; [Moran, Jennifer L.; Beier, David R.] Harvard Univ, Brigham & Womens Hosp, Div Genet, Sch Med,Dept Med, Boston, MA 02115 USA	Baylor College of Medicine; Baylor College of Medicine; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado System; University of Colorado Anschutz Medical Campus; Harvard University; Brigham & Women's Hospital; Harvard Medical School	Tao, JN (corresponding author), Baylor Coll Med, Dept Mol & Cellular Biol, Houston, TX 77030 USA.	tao@bcm.edu; overbeek@bcm.edu	; Tao, Jianning/U-5213-2017	Koster, Maranke/0000-0003-4448-8119; Overbeek, Paul/0000-0001-9784-2084; Tao, Jianning/0000-0001-5678-9272; Moran, Jennifer/0000-0002-5664-4716	NIAMS NIH HHS [R03AR061565, R03 AR061565] Funding Source: Medline; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R03AR061565] Funding Source: NIH RePORTER	NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))		Armbrust S, 2005, ARCH DERMATOL, V141, P611, DOI 10.1001/archderm.141.5.611; Bhasi A, 2007, BIOINFORMATICS, V23, P1815, DOI 10.1093/bioinformatics/btm084; BYRNE C, 1994, DEVELOPMENT, V120, P2369; Chen Q, 2008, MOL VIS, V14, P602; DAVIDSON P, 1952, J ANAT, V86, P342; Dirusso CC, 2008, BBA-MOL CELL BIOL L, V1781, P135, DOI 10.1016/j.bbalip.2008.01.002; Elias PM, 2008, J LIPID RES, V49, P697, DOI 10.1194/jlr.R800002-JLR200; Gimeno RE, 2003, J BIOL CHEM, V278, P49512, DOI 10.1074/jbc.M309759200; Gimeno RE, 2007, CURR OPIN LIPIDOL, V18, P271, DOI 10.1097/MOL.0b013e3281338558; Herrmann T, 2005, J INVEST DERMATOL, V125, P1228, DOI 10.1111/j.0022-202X.2005.23972.x; Herrmann T, 2003, J CELL BIOL, V161, P1105, DOI 10.1083/jcb.200207080; Hopkin AS, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002829; HUBER M, 1995, SCIENCE, V267, P525, DOI 10.1126/science.7824952; Inhoff O, 2011, ARCH DERMATOL, V147, P750, DOI 10.1001/archdermatol.2011.139; Jia ZZ, 2007, J BIOL CHEM, V282, P20573, DOI 10.1074/jbc.M700568200; Khnykin D, 2012, J AM ACAD DERMATOL, V66, P606, DOI 10.1016/j.jaad.2011.04.014; Khnykin D, 2011, DERM-ENDOCRINOL, V3, P53, DOI 10.4161/derm.3.2.14816; Klar J, 2009, AM J HUM GENET, V85, P248, DOI 10.1016/j.ajhg.2009.06.021; Koster MI, 2004, GENE DEV, V18, P126, DOI 10.1101/gad.1165104; Kulessa H, 2000, EMBO J, V19, P6664, DOI 10.1093/emboj/19.24.6664; Lawson KA, 1999, GENE DEV, V13, P424, DOI 10.1101/gad.13.4.424; Mills AA, 1999, NATURE, V398, P708, DOI 10.1038/19531; Moran JL, 2006, GENOME RES, V16, P436, DOI 10.1101/gr.4563306; Morice-Picard F, 2010, AM J MED GENET A, V152A, P2664, DOI 10.1002/ajmg.a.33648; Moulson CL, 2007, J BIOL CHEM, V282, P15912, DOI 10.1074/jbc.M701779200; Moulson CL, 2003, P NATL ACAD SCI USA, V100, P5274, DOI 10.1073/pnas.0431186100; Navarro CL, 2004, HUM MOL GENET, V13, P2493, DOI 10.1093/hmg/ddh265; Oji V, 2010, J AM ACAD DERMATOL, V63, P607, DOI 10.1016/j.jaad.2009.11.020; Paus R, 1999, NEW ENGL J MED, V341, P491, DOI 10.1056/NEJM199908123410706; Pouillot Anne, 2008, J Cosmet Dermatol, V7, P143, DOI 10.1111/j.1473-2165.2008.00379.x; Proksch E, 2008, EXP DERMATOL; Rendl M, 2008, GENE DEV, V22, P543, DOI 10.1101/gad.1614408; Reneker LW, 2004, INVEST OPHTH VIS SCI, V45, P4083, DOI 10.1167/iovs.03-1270; Richard G., 2001, GENEREVIEWS; Roca X, 2008, GENOME RES, V18, P77, DOI 10.1101/gr.6859308; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; SHAPIRO MB, 1987, NUCLEIC ACIDS RES, V15, P7155, DOI 10.1093/nar/15.17.7155; Sobol Maria, 2011, BMC Res Notes, V4, P90, DOI 10.1186/1756-0500-4-90; Ting Stephen B, 2005, Organogenesis, V2, P33; Umemoto H, 2011, J DERMATOL SCI, V61, P136, DOI 10.1016/j.jdermsci.2010.11.010; Vielkind U, 1996, ACTA ANAT, V157, P183; Watkins PA, 2008, J BIOL CHEM, V283, P1773, DOI 10.1074/jbc.R700037200; Yanagi T, 2008, HUM MOL GENET, V17, P3075, DOI 10.1093/hmg/ddn204; Yusa K, 2011, NATURE, V478, P391, DOI 10.1038/nature10424; YUSPA SH, 1989, J CELL BIOL, V109, P1207, DOI 10.1083/jcb.109.3.1207; Zou ZY, 2002, J BIOL CHEM, V277, P31062, DOI 10.1074/jbc.M205034200	46	10	11	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 30	2012	7	11							e50634	10.1371/journal.pone.0050634	http://dx.doi.org/10.1371/journal.pone.0050634			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	054WM	23226340	Green Published, Green Submitted, gold			2022-12-27	WOS:000312376100151
J	Wang, D; Li, WB; Wei, XE; Li, YH; Dai, YM				Wang, Dan; Li, Wen-Bin; Wei, Xiao-Er; Li, Yue-Hua; Dai, Yong-Ming			An Investigation of Age-Related Iron Deposition Using Susceptibility Weighted Imaging	PLOS ONE			English	Article							DEEP GRAY-MATTER; BRAIN IRON; COGNITIVE IMPAIRMENT; MR; PHASE; SEQUENCE; DISEASE; RAT	Aim: To quantify age-dependent iron deposition changes in healthy subjects using Susceptibility Weighted Imaging (SWI). Materials and Methods: In total, 143 healthy volunteers were enrolled. All underwent conventional MR and SWI sequences. Subjects were divided into eight groups according to age. Using phase images to quantify iron deposition in the head of the caudate nucleus and the lenticular nucleus, the angle radian value was calculated and compared between groups. ANOVA/Pearson correlation coefficient linear regression analysis and polynomial fitting were performed to analyze the relationship between iron deposition in the head of the caudate nucleus and lenticular nucleus with age. Results: Iron deposition in the lenticular nucleus increased in individuals aged up to 40 years, but did not change in those aged over 40 years once a peak had been reached. In the head of the caudate nucleus, iron deposition peaked at 60 years (p < 0.05). The correlation coefficients for iron deposition in the L-head of the caudate nucleus, R-head of the caudate nucleus, L-lenticular nucleus and R-lenticular nucleus with age were 0.67691, 0.48585, 0.5228 and 0.5228 (p < 0.001, respectively). Linear regression analyses showed a significant correlation between iron deposition levels in with age groups. Conclusions: Iron deposition in the lenticular nucleus was found to increase with age, reaching a plateau at 40 years. Iron deposition in the head of the caudate nucleus also increased with age, reaching a plateau at 60 years.	[Wang, Dan; Li, Wen-Bin; Wei, Xiao-Er; Li, Yue-Hua] Shanghai Jiao Tong Univ, Inst Diagnost & Intervent Radiol, Affiliated Peoples Hosp 6, Shanghai 200030, Peoples R China; [Dai, Yong-Ming] German Siemens Healthcare MR Clin Applicat, Siemens MRI Tech Support Dept, Shanghai, Peoples R China	Shanghai Jiao Tong University; Siemens AG	Li, YH (corresponding author), Shanghai Jiao Tong Univ, Inst Diagnost & Intervent Radiol, Affiliated Peoples Hosp 6, Shanghai 200030, Peoples R China.	liyuehuaxp@gmail.com	LI, Yue/GRS-8071-2022					Akhlaghpoor S, 2011, CLIN NEURORADIOL; AOKI S, 1989, RADIOLOGY, V172, P381, DOI 10.1148/radiology.172.2.2748819; Aquino D, 2009, RADIOLOGY, V252, P165, DOI 10.1148/radiol.2522081399; BROOKS DJ, 1989, J NEUROL NEUROSUR PS, V52, P108, DOI 10.1136/jnnp.52.1.108; Castelnau PA, 1998, J NEUROPATH EXP NEUR, V57, P268, DOI 10.1097/00005072-199803000-00008; Chua ACG, 1996, BIOL TRACE ELEM RES, V55, P39, DOI 10.1007/BF02784167; de Rochefort L, 2010, MAGN RESON MED, V63, P194, DOI 10.1002/mrm.22187; Frackowiak J, 2004, BRAIN RES, V1002, P67, DOI 10.1016/j.brainres.2003.12.015; Gelman N, 1999, RADIOLOGY, V210, P759, DOI 10.1148/radiology.210.3.r99fe41759; Haacke EM, 2007, J MAGN RESON IMAGING, V26, P256, DOI 10.1002/jmri.22987; Haacke EM, 2010, J MAGN RESON IMAGING, V32, P561, DOI 10.1002/jmri.22293; Haller S, 2010, RADIOLOGY, V257, P764, DOI 10.1148/radiol.10100612; KONDO Y, 1995, J CEREBR BLOOD F MET, V15, P216, DOI 10.1038/jcbfm.1995.27; Miszkziel KA, 1997, MAGN RESON IMAGING, V15, P1113, DOI 10.1016/S0730-725X(97)00089-1; Pfefferbaum A, 2009, NEUROIMAGE, V47, P493, DOI 10.1016/j.neuroimage.2009.05.006; Qin YY, 2011, J HUAZHONG U SCI-MED, V31, P578, DOI 10.1007/s11596-011-0493-1; Rossi M, 2010, INVEST RADIOL, V45, P795, DOI 10.1097/RLI.0b013e3181ec9c96; Schipper HM, 2004, AGEING RES REV, V3, P265, DOI 10.1016/j.arr.2004.02.001; Shen W C, 1991, Zhonghua Yi Xue Za Zhi (Taipei), V48, P369; Siegelman ES, 1996, RADIOLOGY, V199, P13, DOI 10.1148/radiology.199.1.8633135; Sullivan EV, 2009, BRAIN IMAGING BEHAV, V3, P167, DOI 10.1007/s11682-008-9059-7; Wang Y, 2011, AJNR AM J NEURORADIO; Xu X, 2008, NEUROIMAGE, V40, P35, DOI 10.1016/j.neuroimage.2007.11.017; Zhang JQ, 2010, BRAIN RES, V1330, P124, DOI 10.1016/j.brainres.2010.03.036; Zivadinov R, 2010, INT ANGIOL, V29, P158	25	22	23	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 30	2012	7	11							e50706	10.1371/journal.pone.0050706	http://dx.doi.org/10.1371/journal.pone.0050706			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	054WM	23226360	Green Submitted, Green Published, gold			2022-12-27	WOS:000312376100171
J	Rodenburg, G; Kremers, SPJ; Oenema, A; van de Mheen, D				Rodenburg, Gerda; Kremers, Stef P. J.; Oenema, Anke; van de Mheen, Dike			Associations of Children's Appetitive Traits with Weight and Dietary Behaviours in the Context of General Parenting	PLOS ONE			English	Article							EATING BEHAVIOR; SOFT DRINKS; CHILDHOOD OVERWEIGHT; FRUIT; OBESITY; STYLE; QUESTIONNAIRE; VALIDITY; SUSCEPTIBILITY; REPRODUCIBILITY	Background: Individual variations in child weight can be explained by genetic and behavioural susceptibility to obesity. Behavioural susceptibility can be expressed in appetite-related traits, e.g. food responsiveness. Research into such behavioural factors is important, as it can provide starting points for (preventive) interventions. Objectives: To examine associations of children's appetitive traits with weight and with fruit, snack and sugar-sweetened beverage intake, and to examine whether parenting style interacts with appetite in determining child weight/intake. Methods: Data were used from 1275 children participating in the INPACT study in 2009-2010, with a mean age of 9 years in 2009. Their height and weight were measured to calculate body mass index (BMI). Parents completed a questionnaire to measure children's appetitive traits, children's dietary intake and parenting style. Child BMI z-scores, fruit, snack and sugar-sweetened beverage intake were regressed on appetitive traits. Moderation by parenting style was tested by adding interaction terms to the regression analyses. Results: Food-approaching appetitive traits were positively, and food-avoidant appetitive traits were negatively related to child BMI z-scores and to child fruit intake. There were no or less consistent associations for snack and sugar-sweetened beverage intake. Authoritative parenting voided the negative association between food fussiness and fruit intake, while neglecting parenting strengthened the positive association between food-approaching appetitive traits and weight. Conclusions: Early assessment of appetitive traits could be used to identify children at risk for overweight. As parenting style can moderate the associations between appetitive traits and weight/intake in a favourable way, parents are a promising target group for preventive interventions aimed at influencing the effect of appetitive traits on children. Citation: Rodenburg G, Kremers SPJ, Oenema A, van de Mheen D (2012) Associations of Children's Appetitive Traits with Weight and Dietary Behaviours in the Context of General Parenting. PLoS ONE 7(12): e50642. doi:10.1371/journal.pone.0050642	[Rodenburg, Gerda; van de Mheen, Dike] IVO Addict Res Inst, Rotterdam, Netherlands; [Rodenburg, Gerda; van de Mheen, Dike] Erasmus MC, Rotterdam, Netherlands; [Kremers, Stef P. J.; Oenema, Anke] Maastricht Univ, Dept Hlth Promot, Maastricht, Netherlands	Erasmus University Rotterdam; Erasmus MC; Maastricht University	Rodenburg, G (corresponding author), IVO Addict Res Inst, Rotterdam, Netherlands.	rodenburg@ivo.nl	Oenema, Anke/D-7709-2017	Oenema, Anke/0000-0002-4350-5821	ZonMw, The Netherlands Organisation for Health Research and Development [121010011]	ZonMw, The Netherlands Organisation for Health Research and Development(Netherlands Organization for Health Research and Development)	Financial support for the INPACT study was provided by ZonMw, The Netherlands Organisation for Health Research and Development (grant ID no. 121010011; www.zonmw.nl/en/). ZonMw had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alinia S, 2009, OBES REV, V10, P639, DOI 10.1111/j.1467-789X.2009.00582.x; [Anonymous], 2003, DIET NUTR PREV CHRON; ARCHER LA, 1991, J PEDIATR PSYCHOL, V16, P629, DOI 10.1093/jpepsy/16.5.629; Ashcroft J, 2008, EUR J CLIN NUTR, V62, P985, DOI 10.1038/sj.ejcn.1602855; Baranowski T, 1997, J AM DIET ASSOC, V97, P66, DOI 10.1016/S0002-8223(97)00022-9; Beyers W, 1999, J ADOLESCENCE, V22, P753, DOI 10.1006/jado.1999.0268; Bogers RP, 2004, AM J EPIDEMIOL, V159, P900, DOI 10.1093/aje/kwh123; Braet C, 2008, J HEALTH PSYCHOL, V13, P733, DOI 10.1177/1359105308093850; Bronfenbrenner U, 1979, ECOLOGY HUMAN DEV EX; Brug J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034742; Carnell S, 2011, APPETITE, V57, P665, DOI 10.1016/j.appet.2011.08.009; Carnell S, 2008, AM J CLIN NUTR, V88, P22, DOI 10.1093/ajcn/88.1.22; Carnell S, 2007, APPETITE, V48, P104, DOI 10.1016/j.appet.2006.07.075; Carnell S, 2009, APPETITE, V53, P260, DOI 10.1016/j.appet.2009.07.014; Cole TJ, 2000, BMJ-BRIT MED J, V320, P1240, DOI 10.1136/bmj.320.7244.1240; Cooke LJ, 2004, PUBLIC HEALTH NUTR, V7, P295, DOI 10.1079/PHN2003527; Croker H, 2011, APPETITE, V57, P525, DOI 10.1016/j.appet.2011.05.320; DARLING N, 1993, PSYCHOL BULL, V113, P487, DOI 10.1037/0033-2909.113.3.487; Elfhag K, 2007, PHYSIOL BEHAV, V91, P191, DOI 10.1016/j.physbeh.2007.02.005; Elfhag Kristina, 2008, Eat Behav, V9, P285, DOI 10.1016/j.eatbeh.2007.10.003; Elfhag K, 2008, PUBLIC HEALTH NUTR, V11, P914, DOI 10.1017/S1368980008002371; Fredriks AM, 2000, ARCH DIS CHILD, V82, P107, DOI 10.1136/adc.82.2.107; Goossens L, 1999, 9 EUR C DEV PSYCH IS; Haraldsdottir J, 2005, ANN NUTR METAB, V49, P221, DOI 10.1159/000087276; Huver RME, 2007, PSYCHOL HEALTH, V22, P575, DOI 10.1080/14768320600976182; Huver RME, 2007, DRUG ALCOHOL DEPEN, V89, P116, DOI 10.1016/j.drugalcdep.2006.12.005; Keij I., 2000, INDEX, V10, P24; Kral TVE, 2010, PHYSIOL BEHAV, V100, P567, DOI 10.1016/j.physbeh.2010.04.031; Kremers SP, 2003, APPETITE, V41, P43, DOI 10.1016/S0195-6663(03)00038-2; LAMBORN SD, 1991, CHILD DEV, V62, P1049, DOI 10.2307/1131151; Pearson N, 2010, PUBLIC HEALTH NUTR, V13, P1245, DOI 10.1017/S1368980009992217; Pinard CA, 2011, PUBLIC HEALTH NUTR, V7, P1; Powers SW, 2006, OBESITY, V14, P2026, DOI 10.1038/oby.2006.237; Rennie KL, 2005, BEST PRACT RES CL EN, V19, P343, DOI 10.1016/j.beem.2005.04.003; Santos JL, 2011, NUTR J, V10, DOI 10.1186/1475-2891-10-108; Sleddens EFC, 2011, INT J PEDIATR OBES, V6, pE12, DOI 10.3109/17477166.2011.566339; Sleddens EFC, 2008, INT J BEHAV NUTR PHY, V5, DOI 10.1186/1479-5868-5-49; Speakman JR, 2004, J NUTR, V134, p2090S, DOI 10.1093/jn/134.8.2090S; Spence JC, 2011, INT J PEDIATR OBES, V6, pE501, DOI 10.3109/17477166.2010.512087; STEINBERG L, 1989, CHILD DEV, V60, P1424, DOI 10.1111/j.1467-8624.1989.tb04014.x; Sweetman C, 2008, INT J BEHAV NUTR PHY, V5, DOI 10.1186/1479-5868-5-60; Van Assema Patricia, 2002, Nutrition and Health (Bicester), V16, P85; van Jaarsveld CHM, 2011, AM J CLIN NUTR, V94, P1562, DOI 10.3945/ajcn.111.015818; van Strien T, 2008, INT J EAT DISORDER, V41, P72, DOI 10.1002/eat.20424; Ventura AK, 2008, INT J BEHAV NUTR PHY, V5, DOI 10.1186/1479-5868-5-15; Viana V, 2008, BRIT J NUTR, V100, P445, DOI 10.1017/S0007114508894391; Wang Y, 2006, INT J PEDIATR OBES, V1, P11, DOI 10.1080/17477160600586747; Wardle J, 2001, J CHILD PSYCHOL PSYC, V42, P963, DOI 10.1111/1469-7610.00792; Wardle J, 2001, INT J OBESITY, V25, P971, DOI 10.1038/sj.ijo.0801661; Wardle J, 2008, AM J CLIN NUTR, V87, P398, DOI 10.1093/ajcn/87.2.398; Wardle J, 2009, ANN BEHAV MED, V38, pS25, DOI 10.1007/s12160-009-9116-5; Webber L, 2009, INT J OBESITY, V33, P21, DOI 10.1038/ijo.2008.219; Webber L, 2010, J AM DIET ASSOC, V110, P1718, DOI 10.1016/j.jada.2010.08.007; WHO, 2002, WORLD HLTH REP RED R; Wudy SA, 2005, PEDIATRICS, V116, pE52, DOI 10.1542/peds.2004-1684	55	40	41	0	50	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 5	2012	7	12							e50642	10.1371/journal.pone.0050642	http://dx.doi.org/10.1371/journal.pone.0050642			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	057TZ	23227194	Green Published, gold, Green Submitted			2022-12-27	WOS:000312588200054
J	Tsuji, PA; Carlson, BA; Naranjo-Suarez, S; Yoo, MH; Xu, XM; Fomenko, DE; Gladyshev, VN; Hatfield, DL; Davis, CD				Tsuji, Petra A.; Carlson, Bradley A.; Naranjo-Suarez, Salvador; Yoo, Min-Hyuk; Xu, Xue-Ming; Fomenko, Dmitri E.; Gladyshev, Vadim N.; Hatfield, Dolph L.; Davis, Cindy D.			Knockout of the 15 kDa Selenoprotein Protects against Chemically-Induced Aberrant Crypt Formation in Mice	PLOS ONE			English	Article							GUANYLATE-BINDING PROTEIN-1; INFLAMMATORY CYTOKINES; CANCER RISK; SELENIUM; EXPRESSION; SEP15; COLON; INHIBITION; ACTIVATION; INDUCTION	Evidence suggests that selenium has cancer preventive properties that are largely mediated through selenoproteins. Our previous observations demonstrated that targeted down-regulation of the 15 kDa selenoprotein (Sep15) in murine colon cancer cells resulted in the reversal of the cancer phenotype. The present study investigated the effect of Sep15 knockout in mice using a chemically-induced colon cancer model. Homozygous Sep15 knockout mice, and wild type littermate controls were given four weekly subcutaneous injections of azoxymethane (10 mg/kg). Sep15 knockout mice developed significantly (p<0.001) fewer aberrant crypt foci than controls demonstrating that loss of Sep15 protects against aberrant crypt foci formation. Dietary selenium above adequate levels did not significantly affect aberrant crypt foci formation in Sep15 knockout mice. To investigate molecular targets affected by loss of Sep15, gene expression patterns in colonic mucosal cells of knockout and wild type mice were examined using microarray analysis. Subsequent analyses verified that guanylate binding protein-1 (GBP-1) mRNA and protein expression were strongly upregulated in Sep15 knockout mice. GBP-1, which is expressed in response to interferon-c, is considered to be an activation marker during inflammatory diseases, and upregulation of GBP-1 in humans has been associated with a highly significant, increased five-year survival rate in colorectal cancer patients. In agreement with these studies, we observed a higher level of interferon-c in plasma of Sep15 knockout mice. Overall, our results demonstrate for the first time, that Sep15 knockout mice are protected against chemically-induced aberrant crypt foci formation and that Sep15 appears to have oncogenic properties in colon carcinogenesis in vivo. Citation: Tsuji PA, Carlson BA, Naranjo-Suarez S, Yoo M-H, Xu X-M, et al. (2012) Knockout of the 15 kDa Selenoprotein Protects against Chemically-Induced Aberrant Crypt Formation in Mice. PLoS ONE 7(12): e50574. doi:10.1371/journal.pone.0050574	[Tsuji, Petra A.] Towson Univ, Dept Biol Sci, Towson, MD USA; [Tsuji, Petra A.; Carlson, Bradley A.; Naranjo-Suarez, Salvador; Yoo, Min-Hyuk; Xu, Xue-Ming; Hatfield, Dolph L.] NIH, Mol Biol Selenium Sect, Lab Canc Prevent, Bethesda, MD 20892 USA; [Davis, Cindy D.] NIH, Off Dietary Supplements, Bethesda, MD 20892 USA; [Fomenko, Dmitri E.] Univ Nebraska, Dept Biochem, Lincoln, NE 68583 USA; [Gladyshev, Vadim N.] Harvard Univ, Brigham & Womens Hosp, Sch Med, Boston, MA 02115 USA	University System of Maryland; Towson University; National Institutes of Health (NIH) - USA; National Institutes of Health (NIH) - USA; University of Nebraska System; University of Nebraska Lincoln; Harvard University; Brigham & Women's Hospital; Harvard Medical School	Tsuji, PA (corresponding author), Towson Univ, Dept Biol Sci, Towson, MD USA.	ptsuji@towson.edu	Suarez, Salvador Naranjo/K-8450-2017; Gladyshev, Vadim N/A-9894-2013; Gladyshev, Vadim N/J-6187-2013	Suarez, Salvador Naranjo/0000-0002-7038-0753; Gladyshev, Vadim/0000-0002-0372-7016	National Cancer Institute (NCI) Intramural; Cancer Prevention Fellowship Program; Division of Cancer Prevention, National Institutes of Health (NIH) [CA080946]; Towson University; NATIONAL CANCER INSTITUTE [ZIABC005317, R01CA080946] Funding Source: NIH RePORTER	National Cancer Institute (NCI) Intramural; Cancer Prevention Fellowship Program; Division of Cancer Prevention, National Institutes of Health (NIH); Towson University; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was funded by National Cancer Institute (NCI) Intramural support, the Cancer Prevention Fellowship Program, the Division of Cancer Prevention, National Institutes of Health (NIH) CA080946, and Towson University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	American Cancer Society, 2012, CANC FACTS FIG 2012; Apostolou S, 2004, ONCOGENE, V23, P5032, DOI 10.1038/sj.onc.1207683; Baines AT, 2000, CANCER LETT, V160, P193, DOI 10.1016/S0304-3835(00)00585-1; Capaldo CT, 2012, MUCOSAL IMM IN PRESS; Caruso A, 2006, J NEUROCHEM, V98, P364, DOI 10.1111/j.1471-4159.2006.03867.x; Clark LC, 1996, JAMA-J AM MED ASSOC, V276, P1957, DOI 10.1001/jama.276.24.1957; Davis CD, 2003, J NUTR, V133, P2907, DOI 10.1093/jn/133.9.2907; Feng Y, 1999, TOXICOL APPL PHARM, V157, P36, DOI 10.1006/taap.1999.8623; Gladyshev VN, 1998, J BIOL CHEM, V273, P8910, DOI 10.1074/jbc.273.15.8910; Guenzi E, 2001, EMBO J, V20, P5568, DOI 10.1093/emboj/20.20.5568; Hatfield DL, 2002, MOL CELL BIOL, V22, P3565, DOI 10.1128/MCB.22.11.3565-3576.2002; Hatfield DL, 2009, MOL INTERV, V9, P18, DOI 10.1124/mi.9.1.6; Irons R, 2006, J NUTR, V136, P1311, DOI 10.1093/jn/136.5.1311; Irons R, 2010, CANCER PREV RES, V3, P630, DOI 10.1158/1940-6207.CAPR-10-0003; Jablonska E, 2008, EUR J NUTR, V47, P47, DOI 10.1007/s00394-008-0696-9; Kasaikina MV, 2011, J BIOL CHEM, V286, P33203, DOI 10.1074/jbc.M111.259218; Khare Sharad, 2009, V472, P373, DOI 10.1007/978-1-60327-492-0_17; Kipp A, 2009, MOL NUTR FOOD RES, V53, P1561, DOI 10.1002/mnfr.200900105; Kipp AP, 2012, BBA-GEN SUBJECTS, V1820, P1588, DOI 10.1016/j.bbagen.2012.05.016; Korotkov KV, 2002, MOL CELL BIOL, V22, P1402, DOI 10.1128/MCB.22.5.1402-1411.2002; Kryukov GV, 2003, SCIENCE, V300, P1439, DOI 10.1126/science.1083516; Kumaraswamy E, 2000, J BIOL CHEM, V275, P35540, DOI 10.1074/jbc.M004014200; Labunskyy VM, 2007, IUBMB LIFE, V59, P1, DOI 10.1080/15216540601126694; Lipnik K, 2010, MOL MED, V16, P177, DOI 10.2119/molmed.2009.00172; Lubeseder-Martellato C, 2002, AM J PATHOL, V161, P1749, DOI 10.1016/S0002-9440(10)64452-5; Mirpuri J, 2010, J IMMUNOL, V184, P7186, DOI 10.4049/jimmunol.0903116; Naschberger E, 2004, BIOCHEM J, V379, P409, DOI 10.1042/BJ20031873; Naschberger E, 2008, INT J CANCER, V123, P2120, DOI 10.1002/ijc.23764; Nasr M.A., 2004, CANC THER, V1, P293; Pagmantidis V, 2005, FEBS LETT, V579, P792, DOI 10.1016/j.febslet.2004.12.042; Peters U, 2006, CANCER EPIDEM BIOMAR, V15, P315, DOI 10.1158/1055-9965.EPI-05-0471; PRETLOW TP, 1992, J CELL BIOCHEM, P55; Subcommittee on Laboratory Animal Nutrition Committee on Animal Nutrition Board on Agriculture Council NR, 1995, NUTR REQ LAB AN; Sutherland A, 2010, GENES NUTR, V5, P215, DOI 10.1007/s12263-010-0176-8; Tachibana M, 2003, ANTICANCER RES, V23, P4161; Takayama T, 1998, NEW ENGL J MED, V339, P1277, DOI 10.1056/NEJM199810293391803; Tsuji PA, 2011, NUTRIENTS, V3, P805, DOI 10.3390/nu3090805; Vowinkel T, 2004, J CLIN INVEST, V114, P260, DOI 10.1172/JCI200421233	38	28	29	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 4	2012	7	12							e50574	10.1371/journal.pone.0050574	http://dx.doi.org/10.1371/journal.pone.0050574			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	051EQ	23226526	Green Submitted, Green Published, gold			2022-12-27	WOS:000312108500019
J	Barnes, JM; Nauseef, JT; Henry, MD				Barnes, J. Matthew; Nauseef, Jones T.; Henry, Michael D.			Resistance to Fluid Shear Stress Is a Conserved Biophysical Property of Malignant Cells	PLOS ONE			English	Article							TUMOR-CELLS; CANCER-CELLS; EXTRACELLULAR-MATRIX; METASTASIS; FLOW; CYTOSKELETON; ADHESION; MICROCIRCULATION; EXTRAVASATION; HEMOLYSIS	During metastasis, cancer cells enter the circulation in order to gain access to distant tissues, but how this fluid microenvironment influences cancer cell biology is poorly understood. A longstanding view is that circulating cancer cells derived from solid tissues may be susceptible to damage from hemodynamic shear forces, contributing to metastatic inefficiency. Here we report that compared to non-transformed epithelial cells, transformed cells are remarkably resistant to fluid shear stress (FSS) in a microfluidic protocol, exhibiting a biphasic decrease in viability when subjected to a series of millisecond pulses of high FSS. We show that magnitude of FSS resistance is influenced by several oncogenes, is an adaptive and transient response triggered by plasma membrane damage and requires extracellular calcium and actin cytoskeletal dynamics. This novel property of malignant cancer cells may facilitate hematogenous metastasis and indicates, contrary to expectations, that cancer cells are quite resistant to destruction by hemodynamic shear forces. Citation: Barnes JM, Nauseef JT, Henry MD (2012) Resistance to Fluid Shear Stress Is a Conserved Biophysical Property of Malignant Cells. PLoS ONE 7(12): e50973. doi: 10.1371/journal.pone.0050973	[Barnes, J. Matthew; Nauseef, Jones T.; Henry, Michael D.] Univ Iowa, Dept Mol Physiol & Biophys, Roy J & Lucille A Carver Coll Med, Iowa City, IA 52242 USA; [Nauseef, Jones T.; Henry, Michael D.] Univ Iowa, Med Scientist Training Program, Roy J & Lucille A Carver Coll Med, Iowa City, IA USA; [Henry, Michael D.] Univ Iowa, Dept Pathol, Roy J & Lucille A Carver Coll Med, Iowa City, IA 52242 USA; [Barnes, J. Matthew; Nauseef, Jones T.; Henry, Michael D.] Univ Iowa, Holden Comprehens Canc Ctr, Iowa City, IA USA	University of Iowa; University of Iowa; University of Iowa; University of Iowa	Henry, MD (corresponding author), Univ Iowa, Dept Mol Physiol & Biophys, Roy J & Lucille A Carver Coll Med, Iowa City, IA 52242 USA.	michael-henry@uiowa.edu		Henry, Michael/0000-0002-7871-245X	Department of Defense [W81XWH-10-1-0313, W81XWH-12-1-0163]; Holden Comprehensive Cancer Center [P30 CA086862]; NATIONAL CANCER INSTITUTE [P30CA086862] Funding Source: NIH RePORTER	Department of Defense(United States Department of Defense); Holden Comprehensive Cancer Center; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	Department of Defense pre-doctoral fellowship, W81XWH-10-1-0313 to JMB, pilot funding from the Holden Comprehensive Cancer Center P30 CA086862 and Department of Defense award W81XWH-12-1-0163 to MDH. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Armstrong AJ, 2011, CIRCULATING TUMOR CE; Avvisato CL, 2007, J CELL SCI, V120, P2672, DOI 10.1242/jcs.03476; Berger R, 2004, CANCER RES, V64, P8867, DOI 10.1158/0008-5472.CAN-04-2938; BROOKS DE, 1984, BIORHEOLOGY, V21, P85; Chandran KB, 2001, DYNAMIC BEHAV MECH H; Chin L, 1999, NATURE, V400, P468, DOI 10.1038/22788; Chiu JJ, 2011, PHYSIOL REV, V91, P327, DOI 10.1152/physrev.00047.2009; Choquet D, 1997, CELL, V88, P39, DOI 10.1016/S0092-8674(00)81856-5; CLARKE MSF, 1992, J CELL SCI, V102, P533; Cross SE, 2007, NAT NANOTECHNOL, V2, P780, DOI 10.1038/nnano.2007.388; De Giorgi V, 2010, ARCH DERMATOL, V146, P1120, DOI 10.1001/archdermatol.2010.264; Drake JM, 2005, CLIN EXP METASTAS, V22, P674, DOI 10.1007/s10585-006-9011-4; Du GS, 2011, BIOMED MICRODEVICES, V13, P29, DOI 10.1007/s10544-010-9468-4; FIDLER IJ, 1970, JNCI-J NATL CANCER I, V45, P773; Gay LJ, 2011, NAT REV CANCER, V11, P123, DOI 10.1038/nrc3004; GOLDSMITH H, 1961, NATURE, V190, P1095, DOI 10.1038/1901095a0; Guilluy C, 2011, NAT CELL BIOL, V13, P722, DOI 10.1038/ncb2254; Haier J, 1999, CLIN EXP METASTAS, V17, P377, DOI 10.1023/A:1006658414040; Hur SC, 2011, LAB CHIP, V11, P912, DOI [10.1039/c0lc00595a, 10.1039/c01c00595a]; KOOP S, 1995, CANCER RES, V55, P2520; Korb T, 2004, EXP CELL RES, V299, P236, DOI 10.1016/j.yexcr.2004.06.001; Luzzi KJ, 1998, AM J PATHOL, V153, P865, DOI 10.1016/S0002-9440(10)65628-3; Malek AM, 1999, JAMA-J AM MED ASSOC, V282, P2035, DOI 10.1001/jama.282.21.2035; Miles FL, 2008, CLIN EXP METASTAS, V25, P305, DOI 10.1007/s10585-007-9098-2; Miyake K, 2001, J CELL SCI, V114, P3487; OCHALEK T, 1988, CANCER RES, V48, P5124; Okuyama M, 1996, J CELL BIOCHEM, V63, P432; Pantel K, 2008, NAT REV CANCER, V8, P329, DOI 10.1038/nrc2375; Podsypanina K, 2008, SCIENCE, V321, P1841, DOI 10.1126/science.1161621; Reneman RS, 2008, MED BIOL ENG COMPUT, V46, P499, DOI 10.1007/s11517-008-0330-2; ROONEY JA, 1970, SCIENCE, V169, P869, DOI 10.1126/science.169.3948.869; Stott SL, 2010, P NATL ACAD SCI USA, V107, P18392, DOI 10.1073/pnas.1012539107; STRONY J, 1993, AM J PHYSIOL, V265, pH1787; Suresh S, 2007, ACTA BIOMATER, V3, P413, DOI 10.1016/j.actbio.2007.04.002; Swaminathan V, 2011, CANCER RES, V71, P5075, DOI 10.1158/0008-5472.CAN-11-0247; Terasaki M, 1997, J CELL BIOL, V139, P63, DOI 10.1083/jcb.139.1.63; Thamilselvan V, 2004, J CELL BIOCHEM, V92, P361, DOI 10.1002/jcb.20072; Truskey GA, 2009, BIOL SYSTEMS; Turgeon M.L., 2005, CLIN HEMATOLOGY THEO; WANG N, 1993, SCIENCE, V260, P1124, DOI 10.1126/science.7684161; WEISS L, 1992, INT J CANCER, V50, P103, DOI 10.1002/ijc.2910500121; WILLIAMS AR, 1970, SCIENCE, V169, P871, DOI 10.1126/science.169.3948.871; Wirtz D, 2011, NAT REV CANCER, V11, P512, DOI 10.1038/nrc3080; Yu M, 2011, J CELL BIOL, V192, P373, DOI 10.1083/jcb.201010021; ZEIDMAN I, 1950, CANCER RES, V10, P357	45	106	109	2	41	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 3	2012	7	12							e50973	10.1371/journal.pone.0050973	http://dx.doi.org/10.1371/journal.pone.0050973			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	051DH	23226552	Green Submitted, gold, Green Published			2022-12-27	WOS:000312104700028
J	Cheng, C; Wakefield, MJ; Yang, J; Tauschek, M; Robins-Browne, RM				Cheng, Catherine; Wakefield, Matthew J.; Yang, Ji; Tauschek, Marija; Robins-Browne, Roy M.			Genome-Wide Analysis of the Pho Regulon in a pstCA Mutant of Citrobacter rodentium	PLOS ONE			English	Article							ENTEROPATHOGENIC ESCHERICHIA-COLI; PHOSPHATE STARVATION RESPONSE; GENERAL STRESS-RESPONSE; ACTINOBACILLUS-ACTINOMYCETEMCOMITANS; ACID TOLERANCE; TRANSCRIPTIONAL RESPONSE; SINORHIZOBIUM-MELILOTI; NONSPECIFIC ADHERENCE; REGULATORY NETWORK; RPOS TRANSLATION	The phosphate-specific transport operon, pstSCAB-phoU, of Gram-negative bacteria is an essential part of the Pho regulon. Its key roles are to encode a high-affinity inorganic phosphate transport system and to prevent activation of PhoB in phosphate-rich environments. In general, mutations in pstSCAB-phoU lead to the constitutive expression of the Pho regulon. Previously, we constructed a pstCA deletion mutant of Citrobacter rodentium and found it to be attenuated for virulence in mice, its natural host. This attenuation was dependent on PhoB or PhoB-regulated gene(s) because a phoB mutation restored virulence for mice to the pstCA mutant. To investigate how downstream genes may contribute to the virulence of C. rodentium, we used microarray analysis to investigate global gene expression of C. rodentium strain ICC169 and its isogenic pstCA mutant when grown in phosphate-rich medium. Overall 323 genes of the pstCA mutant were differentially expressed by at least 1.5-fold compared to the wild-type C. rodentium. Of these 145 were up-regulated and 178 were down-regulated. Differentially expressed genes included some involved in phosphate homoeostasis, cellular metabolism and protein metabolism. A large number of genes involved in stress responses and of unknown function were also differentially expressed, as were some virulence-associated genes. Up-regulated virulence-associated genes in the pstCA mutant included that for DegP, a serine protease, which appeared to be directly regulated by PhoB. Down-regulated genes included those for the production of the urease, flagella, NleG8 (a type III-secreted protein) and the tad focus (which encodes type IVb pili in Yersinia enterocolitica). Infection studies using C57/BL6 mice showed that DegP and NleG8 play a role in bacterial virulence. Overall, our study provides evidence that Pho is a global regulator of gene expression in C. rodentium and indicates the presence of at least two previously unrecognized virulence determinants of C. rodentium, namely, DegP and NleG8.	[Cheng, Catherine; Yang, Ji; Tauschek, Marija; Robins-Browne, Roy M.] Univ Melbourne, Dept Microbiol & Immunol, Parkville, Vic 3052, Australia; [Wakefield, Matthew J.] Royal Melbourne Hosp, Walter & Eliza Hall Inst Med Res, Bioinformat Div, Parkville, Vic 3050, Australia; [Wakefield, Matthew J.] Univ Melbourne, Dept Genet, Parkville, Vic 3052, Australia; [Robins-Browne, Roy M.] Royal Childrens Hosp, Murdoch Childrens Res Inst, Parkville, Vic 3052, Australia	University of Melbourne; Royal Melbourne Hospital; Walter & Eliza Hall Institute; University of Melbourne; Murdoch Children's Research Institute; Royal Children's Hospital Melbourne	Robins-Browne, RM (corresponding author), Univ Melbourne, Dept Microbiol & Immunol, Parkville, Vic 3052, Australia.	r.browne@unimelb.edu.au	Robinsbrowne, Roy/ABF-8434-2020; Wakefield, Matthew/X-7593-2019; Wakefield, Matthew J/A-7795-2008	Robinsbrowne, Roy/0000-0001-9179-7884; Wakefield, Matthew/0000-0001-6624-4698; Wakefield, Matthew J/0000-0001-6624-4698	Australian National Health & Medical Research Council (NHMRC); NHMRC Independent Research Institutes Infrastructure Support Scheme; Victorian State Government Operational Infrastructure Support Program; Australian Postgraduate Award	Australian National Health & Medical Research Council (NHMRC)(National Health and Medical Research Council (NHMRC) of Australia); NHMRC Independent Research Institutes Infrastructure Support Scheme(National Health and Medical Research Council (NHMRC) of Australia); Victorian State Government Operational Infrastructure Support Program; Australian Postgraduate Award(Australian Government)	This work was supported by grants from the Australian National Health & Medical Research Council (NHMRC), the NHMRC Independent Research Institutes Infrastructure Support Scheme, and the Victorian State Government Operational Infrastructure Support Program to the Murdoch Childrens Research Institute. CC was the recipient of an Australian Postgraduate Award (www.innovation.gov.au). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Apel D, 2008, BBA-BIOMEMBRANES, V1778, P1851, DOI 10.1016/j.bbamem.2007.07.005; Ausubel FM, 2003, CURRENT PROTOCOLS MO; Baek JH, 2007, J MICROBIOL BIOTECHN, V17, P244; Baek JH, 2006, FEMS MICROBIOL LETT, V264, P104, DOI 10.1111/j.1574-6968.2006.00440.x; Bergholz TM, 2007, BMC MICROBIOL, V7, DOI 10.1186/1471-2180-7-97; Bhattacharjee MK, 2001, J BACTERIOL, V183, P5927, DOI 10.1128/JB.183.20.5927-5936.2001; Billips BK, 2008, INFECT IMMUN, V76, P3891, DOI 10.1128/IAI.00069-08; Bougdour A, 2006, GENE DEV, V20, P884, DOI 10.1101/gad.1400306; Castanie-Cornet MP, 1999, J BACTERIOL, V181, P3525, DOI 10.1128/JB.181.11.3525-3535.1999; Cheng C, 2009, INFECT IMMUN, V77, P1936, DOI 10.1128/IAI.01246-08; Cheng HY, 2002, J FOOD PROTECT, V65, P260, DOI 10.4315/0362-028X-65.2.260; Clausen T, 2002, MOL CELL, V10, P443, DOI 10.1016/S1097-2765(02)00658-5; Corvey C, 2003, BIOCHEM BIOPH RES CO, V304, P48, DOI 10.1016/S0006-291X(03)00529-1; Costanzo A, 2006, J BACTERIOL, V188, P4627, DOI 10.1128/JB.01981-05; DANESE PN, 1995, GENE DEV, V9, P387, DOI 10.1101/gad.9.4.387; Dartigalongue C, 2001, J BIOL CHEM, V276, P20866, DOI 10.1074/jbc.M100464200; Datsenko KA, 2000, P NATL ACAD SCI USA, V97, P6640, DOI 10.1073/pnas.120163297; DATTANANDA CS, 1989, J BACTERIOL, V171, P1915, DOI 10.1128/jb.171.4.1915-1922.1989; DEKONINGWARD TF, 1995, INFECT IMMUN, V63, P3790, DOI 10.1128/IAI.63.10.3790-3795.1995; Deng WY, 2005, INFECT IMMUN, V73, P2135, DOI 10.1128/IAI.73.4.2135-2146.2005; Deng WY, 2004, P NATL ACAD SCI USA, V101, P3597, DOI 10.1073/pnas.0400326101; DEVOS WM, 1995, MOL MICROBIOL, V17, P427, DOI 10.1111/j.1365-2958.1995.mmi_17030427.x; Elliott SJ, 1998, MOL MICROBIOL, V28, P1, DOI 10.1046/j.1365-2958.1998.00783.x; Ferenci T, 1999, CURR OPIN MICROBIOL, V2, P208, DOI 10.1016/S1369-5274(99)80036-8; Froelich JM, 2006, J BACTERIOL, V188, P1180, DOI 10.1128/JB.188.3.1180-1183.2006; Galan JE, 2006, NATURE, V444, P567, DOI 10.1038/nature05272; Garmendia J, 2005, INFECT IMMUN, V73, P2573, DOI 10.1128/IAI.73.5.2573-2585.2005; GORDEN J, 1993, INFECT IMMUN, V61, P364, DOI 10.1128/IAI.61.1.364-367.1993; Gruenheid S, 2004, MOL MICROBIOL, V51, P1233, DOI 10.1046/j.1365-2958.2003.03911.x; Hart E, 2008, INFECT IMMUN, V76, P5247, DOI 10.1128/IAI.00770-08; Hengge-Aronis R, 1999, CURR OPIN MICROBIOL, V2, P148, DOI 10.1016/S1369-5274(99)80026-5; Hsieh YJ, 2010, CURR OPIN MICROBIOL, V13, P198, DOI 10.1016/j.mib.2010.01.014; Hueck CJ, 1998, MICROBIOL MOL BIOL R, V62, P379, DOI 10.1128/MMBR.62.2.379-433.1998; Humphreys S, 1999, INFECT IMMUN, V67, P1560; Humphries RM, 2010, MOL MICROBIOL, V76, P1111, DOI 10.1111/j.1365-2958.2010.07192.x; Ideker T, 2001, SCIENCE, V292, P929, DOI 10.1126/science.292.5518.929; Inoue T, 2000, MICROBIOL IMMUNOL, V44, P715, DOI 10.1111/j.1348-0421.2000.tb02554.x; Inoue T, 1998, MICROBIOL IMMUNOL, V42, P253, DOI 10.1111/j.1348-0421.1998.tb02280.x; Ishige T, 2003, J BACTERIOL, V185, P4519, DOI 10.1128/JB.185.15.4519-4529.2003; Iwanowicz LR, 2006, DIS AQUAT ORGAN, V70, P219, DOI 10.3354/dao070219; JENSEN PR, 1992, J BACTERIOL, V174, P7635, DOI 10.1128/JB.174.23.7635-7641.1992; Jones CH, 2002, J BACTERIOL, V184, P5762, DOI 10.1128/JB.184.20.5762-5771.2002; Jones CH, 2001, INFECT IMMUN, V69, P5538, DOI 10.1128/IAI.69.9.5538-5545.2001; JONES CJ, 1990, J MOL BIOL, V212, P377, DOI 10.1016/0022-2836(90)90132-6; Kachlany SC, 2000, J BACTERIOL, V182, P6169, DOI 10.1128/JB.182.21.6169-6176.2000; KHAN AU, 1992, P NATL ACAD SCI USA, V89, P11426, DOI 10.1073/pnas.89.23.11426; Krol E, 2004, MOL GENET GENOMICS, V272, P1, DOI 10.1007/s00438-004-1030-8; Kurihara S, 2005, J BIOL CHEM, V280, P4602, DOI 10.1074/jbc.M411114200; Lamarche MG, 2008, FEMS MICROBIOL REV, V32, P461, DOI 10.1111/j.1574-6976.2008.00101.x; Lamarche MG, 2005, INFECT IMMUN, V73, P4138, DOI 10.1128/IAI.73.7.4138-4145.2005; Lee J, 2010, J APPL MICROBIOL, V108, P2088, DOI 10.1111/j.1365-2672.2009.04611.x; Lee LJ, 2005, J BACTERIOL, V187, P1124, DOI 10.1128/JB.187.3.1124-1134.2005; Li M, 2006, MICROBES INFECT, V8, P2890, DOI 10.1016/j.micinf.2006.09.006; MacRitchie DM, 2012, INFECT IMMUN, V80, P1766, DOI 10.1128/IAI.05679-11; Mates AK, 2007, J BACTERIOL, V189, P2759, DOI 10.1128/JB.01490-06; Merrell DS, 2002, MOL MICROBIOL, V43, P1471, DOI 10.1046/j.1365-2958.2002.02857.x; Merrell DS, 2001, J BACTERIOL, V183, P2746, DOI 10.1128/JB.183.9.2746-2754.2001; MILLER IR, 1972, ANAL BIOCHEM, V50, P84, DOI 10.1016/0003-2697(72)90488-5; MILLER SI, 1990, J BACTERIOL, V172, P2485, DOI 10.1128/jb.172.5.2485-2490.1990; MOBLEY HLT, 1995, MICROBIOL REV, V59, P451, DOI 10.1128/MMBR.59.3.451-480.1995; Moore MM, 2002, DIS AQUAT ORGAN, V52, P93, DOI 10.3354/dao052093; Mundy R, 2004, INFECT IMMUN, V72, P2288, DOI 10.1128/IAI.72.4.2288-2302.2004; Mundy R, 2003, INFECT IMMUN, V74, P2328; NEIDHARDT FC, 1974, J BACTERIOL, V119, P736, DOI 10.1128/JB.119.3.736-747.1974; Nestorovich EM, 2002, P NATL ACAD SCI USA, V99, P9789, DOI 10.1073/pnas.152206799; Nishino K, 2005, J BACTERIOL, V187, P1763, DOI 10.1128/JB.187.5.1763-1772.2005; Noriega CE, 2010, MOL MICROBIOL, V75, P394, DOI 10.1111/j.1365-2958.2009.06987.x; Osorio CG, 2004, J BACTERIOL, V186, P5167, DOI [10.1128/JB.186.15.5167-5171.2004, 10.1128/jb.186.15.5167-5171.2004]; Pages JM, 2008, NAT REV MICROBIOL, V6, P893, DOI 10.1038/nrmicro1994; Perez BA, 2006, J BACTERIOL, V188, P6361, DOI 10.1128/JB.00496-06; Peterson JD, 2001, NUCLEIC ACIDS RES, V29, P123, DOI 10.1093/nar/29.1.123; Petty NK, 2010, J BACTERIOL, V192, P525, DOI 10.1128/JB.01144-09; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Planet PJ, 2003, NAT GENET, V34, P193, DOI 10.1038/ng1154; PRASZKIER J, 1992, J BACTERIOL, V174, P2376, DOI 10.1128/JB.174.7.2376-2383.1992; Provenzano D, 2000, P NATL ACAD SCI USA, V97, P10220, DOI 10.1073/pnas.170219997; Provenzano D, 2001, J BACTERIOL, V183, P3652, DOI 10.1128/JB.183.12.3652-3662.2001; Raivio TL, 2005, MOL MICROBIOL, V56, P1119, DOI 10.1111/j.1365-2958.2005.04625.x; Ritchie ME, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-261; Ruiz N, 2003, J BACTERIOL, V185, P5984, DOI 10.1128/JB.185.20.5984-5992.2003; Salgado H, 2006, NUCLEIC ACIDS RES, V34, pD394, DOI 10.1093/nar/gkj156; Sambrook J, 1998, MOL CLONING LAB MANU, V2nd; Schembri MA, 2003, MOL MICROBIOL, V48, P253, DOI 10.1046/j.1365-2958.2003.03432.x; Schreiner HC, 2003, P NATL ACAD SCI USA, V100, P7295, DOI 10.1073/pnas.1237223100; Schurdell MS, 2007, J BACTERIOL, V189, P1150, DOI 10.1128/JB.01482-06; SLOMA A, 1991, J BACTERIOL, V173, P6889, DOI 10.1128/jb.173.21.6889-6895.1991; Smyth G.K., 2004, STAT APPL GENET MOL, V3, P3, DOI [DOI 10.2202/1544-6115.1027, 10.2202/1544-6115.1027]; SPERANDIO V, 1995, INFECT IMMUN, V63, P4433, DOI 10.1128/IAI.63.11.4433-4438.1995; Spiess C, 1999, CELL, V97, P339, DOI 10.1016/S0092-8674(00)80743-6; STRAUCH KL, 1989, J BACTERIOL, V171, P2689, DOI 10.1128/jb.171.5.2689-2696.1989; Suziedeliene E, 1999, J BACTERIOL, V181, P2084; Tennant SM, 2008, INFECT IMMUN, V76, P639, DOI 10.1128/IAI.01138-07; Tobe T, 2006, P NATL ACAD SCI USA, V103, P14941, DOI 10.1073/pnas.0604891103; Tomich M, 2007, NAT REV MICROBIOL, V5, P363, DOI 10.1038/nrmicro1636; Turner AK, 1998, INFECT IMMUN, V66, P2099, DOI 10.1128/IAI.66.5.2099-2106.1998; Valentin-Hansen P, 2007, CURR OPIN MICROBIOL, V10, P152, DOI 10.1016/j.mib.2007.03.001; Vogt SL, 2010, MOL MICROBIOL, V76, P1095, DOI 10.1111/j.1365-2958.2010.07145.x; Wagner AFV, 2001, BIOCHEM BIOPH RES CO, V285, P456, DOI 10.1006/bbrc.2001.5186; WANNER BL, 1979, J BACTERIOL, V140, P229, DOI 10.1128/JB.140.1.229-239.1979; WANNER BL, 1992, J BACTERIOL, V174, P2053, DOI 10.1128/JB.174.7.2053-2058.1992; Wanner BL, 1996, ESCHERICHIA COLI SAL, P1357, DOI DOI 10.1007/978-3-642-75969-7_16; Weber H, 2005, J BACTERIOL, V187, P1591, DOI 10.1128/JB.187.5.1591-1603.2005; Wilson RL, 2006, INFECT IMMUN, V74, P765, DOI 10.1128/IAI.74.1.765-768.2006; Yu BJ, 2006, FEMS MICROBIOL LETT, V254, P245, DOI 10.1111/j.1574-6968.2005.00026.x; Yuan ZC, 2006, NUCLEIC ACIDS RES, V34, P2686, DOI 10.1093/nar/gkl365; Zheng M, 2001, J BACTERIOL, V183, P4562, DOI 10.1128/JB.183.15.4562-4570.2001; Zhou L, 2005, J INTEGR BIOINFORM, V2, P11, DOI DOI 10.2390/BIEC0LL-JIB-2005-11.AVAILABLE; Zhu JF, 2007, BIOTECHNOL BIOENG, V97, P138, DOI 10.1002/bit.21219	108	9	10	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 30	2012	7	11							e50682	10.1371/journal.pone.0050682	http://dx.doi.org/10.1371/journal.pone.0050682			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	054WM	23226353	Green Published, gold			2022-12-27	WOS:000312376100164
J	Fan, XJ; Liu, XQ; Hao, SY; Wang, BL; Robinson, ML; Monnier, VM				Fan, Xingjun; Liu, Xiaoqin; Hao, Shuyu; Wang, Benlian; Robinson, Michael L.; Monnier, Vincent M.			The LEGSKO Mouse: A Mouse Model of Age-Related Nuclear Cataract Based on Genetic Suppression of Lens Glutathione Synthesis	PLOS ONE			English	Article							BUTHIONINE SULFOXIMINE; ADVANCED GLYCATION; TRANSGENIC MICE; PROTEIN; OXIDATION; CRYSTALLINS; DISULFIDE; CYSTEINE; DAMAGE; PIGMENTATION	Age-related nuclear cataracts are associated with progressive post-synthetic modifications of crystallins from various physical chemical and metabolic insults, of which oxidative stress is a major factor. The latter is normally suppressed by high concentrations of glutathione (GSH), which however are very low in the nucleus of the old lens. Here we generated a mouse model of oxidant stress by knocking out glutathione synthesis in the mouse in the hope of recapitulating some of the changes observed in human age-related nuclear cataract (ARNC). A floxed Gclc mouse was generated and crossed with a transgenic mouse expressing Cre in the lens to generate the LEGSKO mouse in which de novo GSH synthesis was completely abolished in the lens. Lens GSH levels were reduced up to 60% in homozygous LEGSKO mice, and a decreasing GSH gradient was noticed from cortical to nuclear region at 4 months of age. Oxidation of crystallin methionine and sulfhydryls into sulfoxides was dramatically increased, but methylglyoxal hydroimidazolones levels that are GSH/glyoxalase dependent were surprisingly normal. Homozygous LEGSKO mice developed nuclear opacities starting at 4 months that progressed into severe nuclear cataract by 9 months. We conclude that the LEGSKO mouse lens mimics several features of human ARNC and is thus expected to be a useful model for the development of anti-cataract agents. Citation: Fan X, Liu X, Hao S, Wang B, Robinson ML, et al. (2012) The LEGSKO Mouse: A Mouse Model of Age-Related Nuclear Cataract Based on Genetic Suppression of Lens Glutathione Synthesis. PLoS ONE 7(11): e50832. doi:10.1371/journal.pone.0050832	[Fan, Xingjun; Liu, Xiaoqin; Hao, Shuyu; Monnier, Vincent M.] Case Western Reserve Univ, Dept Pathol, Cleveland, OH 44106 USA; [Wang, Benlian] Case Western Reserve Univ, Case Ctr Prote & Mass Spectrometry, Cleveland, OH 44106 USA; [Robinson, Michael L.] Miami Univ, Dept Zool, Oxford, OH 45056 USA; [Monnier, Vincent M.] Case Western Reserve Univ, Dept Biochem, Cleveland, OH 44106 USA	Case Western Reserve University; Case Western Reserve University; University System of Ohio; Miami University; Case Western Reserve University	Fan, XJ (corresponding author), Case Western Reserve Univ, Dept Pathol, Cleveland, OH 44106 USA.	xxf3@cwru.edu; vmm3@case.edu			Vilma and Robert R. Kohn Biology of Aging Research Fund;  [EY-07099];  [P30EY-11373]; NATIONAL EYE INSTITUTE [P30EY011373, R01EY007099] Funding Source: NIH RePORTER	Vilma and Robert R. Kohn Biology of Aging Research Fund; ; ; NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This work was supported by grants EY-07099 to VMM, the Vilma and Robert R. Kohn Biology of Aging Research Fund, and grant P30EY-11373 to the Visual Sciences Research Center at Case Western Reserve University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmed N, 2003, INVEST OPHTH VIS SCI, V44, P5287, DOI 10.1167/iovs.03-0573; Ahmed N, 2003, BIOCHEM SOC T, V31, P1417; BHAT KS, 1991, EXP EYE RES, V52, P715, DOI 10.1016/0014-4835(91)90023-8; Bustin SA, 2009, CLIN CHEM, V55, P611, DOI 10.1373/clinchem.2008.112797; CALVIN HI, 1986, SCIENCE, V233, P553, DOI 10.1126/science.3726547; Cheng RZ, 2004, J BIOL CHEM, V279, P45441, DOI 10.1074/jbc.M405664200; Chevez-Barrios P, 2000, EXP EYE RES, V71, P575, DOI 10.1006/exer.2000.0913; Clemons TE, 2004, ARCH OPHTHALMOL-CHIC, V122, P716; Dalton TP, 2000, BIOCHEM BIOPH RES CO, V279, P324, DOI 10.1006/bbrc.2000.3930; DUNN JA, 1990, BIOCHEMISTRY-US, V29, P10964, DOI 10.1021/bi00501a014; Fan X., 2009, J BIOL CHEM; Fan XJ, 2006, P NATL ACAD SCI USA, V103, P16912, DOI 10.1073/pnas.0605101103; Fan XJ, 2010, FREE RADICAL BIO MED, V49, P847, DOI 10.1016/j.freeradbiomed.2010.06.003; Fu SL, 1998, J BIOL CHEM, V273, P28603, DOI 10.1074/jbc.273.44.28603; GARNER MH, 1980, P NATL ACAD SCI-BIOL, V77, P1274, DOI 10.1073/pnas.77.3.1274; GIBLIN FJ, 1987, EXP EYE RES, V45, P77, DOI 10.1016/S0014-4835(87)80080-5; Giblin FJ, 2000, J OCUL PHARMACOL TH, V16, P121, DOI 10.1089/jop.2000.16.121; Gosselin ME, 2007, EXP EYE RES, V84, P493, DOI 10.1016/j.exer.2006.11.002; Hains PG, 2008, BBA-PROTEINS PROTEOM, V1784, P1959, DOI 10.1016/j.bbapap.2008.07.016; Hanson SRA, 2000, EXP EYE RES, V71, P195, DOI 10.1006/exer.2000.0868; Heys KR, 2007, AGING CELL, V6, P807, DOI 10.1111/j.1474-9726.2007.00342.x; Javitt JC, 1996, ANNU REV PUBL HEALTH, V17, P159; KANNAN R, 1995, INVEST OPHTH VIS SCI, V36, P1785; Kavanagh TJ, 2001, CURRENT PROTOCOLS TO; Klein BEK, 2008, OPHTHALMOLOGY, V115, P477, DOI 10.1016/j.ophtha.2007.11.024; KODAMA T, 1988, INVEST OPHTH VIS SCI, V29, P145; MARTENSSON J, 1989, P NATL ACAD SCI USA, V86, P8727, DOI 10.1073/pnas.86.22.8727; NAGARAJ RH, 1990, EXP EYE RES, V51, P411, DOI 10.1016/0014-4835(90)90153-L; NAGARAJ RH, 1991, P NATL ACAD SCI USA, V88, P10257, DOI 10.1073/pnas.88.22.10257; Ortwerth BJ, 2009, INVEST OPHTH VIS SCI, V50, P3311, DOI 10.1167/iovs.08-2927; Panel C, 1983, NIH PUBL, P83; Pendergrass W, 2005, INVEST OPHTH VIS SCI, V46, P4661, DOI 10.1167/iovs.05-0808; Rahman I, 2006, NAT PROTOC, V1, P3159, DOI 10.1038/nprot.2006.378; RATHBUN WB, 1984, CURR EYE RES, V3, P101, DOI 10.3109/02713688408997190; Reddy VN, 1997, OPHTHALMOLOGICA, V211, P192, DOI 10.1159/000310788; Reddy VN, 2001, INVEST OPHTH VIS SCI, V42, P3247; Sharma KK, 2009, BBA-GEN SUBJECTS, V1790, P1095, DOI 10.1016/j.bbagen.2009.05.008; Spector A, 1997, EXP EYE RES, V64, P477, DOI 10.1006/exer.1996.0250; Sweeney MHJ, 1998, EXP EYE RES, V67, P587, DOI 10.1006/exer.1998.0549; Truscott RJW, 2011, AGE, V33, P543, DOI 10.1007/s11357-010-9198-9; Wu H, 2011, FREE RADIC BIOL MED; Zhao HT, 2004, INVEST OPHTH VIS SCI, V45, P1930, DOI 10.1167/iovs.03-0856	42	24	25	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 30	2012	7	11							e50832	10.1371/journal.pone.0050832	http://dx.doi.org/10.1371/journal.pone.0050832			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	054WM	23226398	gold, Green Published, Green Submitted			2022-12-27	WOS:000312376100209
J	Gao, B; Zhou, J; Ge, JP; Zhang, YP; Chen, F; Lau, WB; Wan, Y; Zhang, NY; Xing, Y; Wang, L; Fu, JF; Li, XM; Jia, HX; Zhao, X; Ji, QH				Gao, Bin; Zhou, Jie; Ge, Jiapu; Zhang, Yaping; Chen, Fei; Lau, Wayne B.; Wan, Yi; Zhang, Nanyan; Xing, Ying; Wang, Li; Fu, Jianfang; Li, Xiaomiao; Jia, Hongxia; Zhao, Xin; Ji, Qiuhe			Association of Maximum Weight with Hyperuricemia Risk: A Retrospective Study of 21,414 Chinese People	PLOS ONE			English	Article							SERUM URIC-ACID; METABOLIC SYNDROME; BODY-WEIGHT; HEIGHT LOSS; MEN; PREVALENCE; MORTALITY; GOUT; ADULTS; HEALTH	Background: Obesity has been demonstrated to be associated with increased serum uric acid (SUA); however, little is known regarding the relationship between maximum weight, or maximum weight fluctuation, and uric acid concentration. Through retrospective means, we determined the association of maximum weight with SUA risk. Methods: Data of 21,414 participants (8,630 males and 12,784 females) from the 2007-8 China National Diabetes and Metabolic Disorders Study were analyzed for parameters including lifestyle habits, biochemical blood analysis and self-reported maximum weight. Results: Elevated SUA subjects shared a cluster of demographic features. After adjustment for age, gender, education, smoking, drinking, physical activity, WHR, height, eGFR(evaluate glomerular filtration rate), and diuretic usage, multivariate logistic regression models demonstrated maximum weight was associated with increased risk of elevated SUA level (P<0.001). Duration of maximum weight was related with decreased risk of elevated SUA level (P<0.001). There was a significant correlation between time of weight loss and risk of increased SUA level reduction (P<0.001). Furthermore, our data indicated that the degree of weight loss from maximum weight was another important factor for the risk of increased SUA level reduction (P<0.001). Finally, ROC curve analysis revealed area under the curve was 0.661 (95% CI, 0.647-0.674), statistically significant for maximum weight association with hyperuricemia (P<0.001). Conclusions: Maximum weight is a strong risk factor for increased uric acid level in the Chinese population, which might serve as a novel clinical indicator suggesting hyperuricemia. Controlling maximum weight, keeping weight to the appropriate range, and maintaining the stable weight may be conducive for decreasing risk of hyperuricemia.	[Gao, Bin; Zhou, Jie; Chen, Fei; Zhang, Nanyan; Xing, Ying; Wang, Li; Fu, Jianfang; Li, Xiaomiao; Jia, Hongxia; Zhao, Xin; Ji, Qiuhe] Fourth Mil Med Univ, Affiliated Hosp 1, Dept Endocrinol, Xian 710032, Shaanxi, Peoples R China; [Ge, Jiapu] Xinjiang Uger Autonamy Peoples Hosp, Dept Endocrinol, Urumqi, Xinjiang, Peoples R China; [Zhang, Yaping] Second Mil Med Univ, Affiliated Hosp 1, Dept Endocrinol, Shanghai, Peoples R China; [Lau, Wayne B.] Thomas Jefferson Univ, Dept Emergency Med, Philadelphia, PA 19107 USA; [Wan, Yi] Fourth Mil Med Univ, Dept Hlth Stat, Xian 710032, Shaanxi, Peoples R China	Air Force Military Medical University; Naval Medical University; Jefferson University; Air Force Military Medical University	Ji, QH (corresponding author), Fourth Mil Med Univ, Affiliated Hosp 1, Dept Endocrinol, Xian 710032, Shaanxi, Peoples R China.	jqiuhe@fmmu.edu.cn	Wan, Yi/G-3173-2010	Wan, Yi/0000-0002-4125-8396; Lau, Wayne Bond/0000-0002-8064-8290	Chinese Medical Association Foundation; Chinese Diabetes Society	Chinese Medical Association Foundation; Chinese Diabetes Society	Our study was Supported by grants from the Chinese Medical Association Foundation and Chinese Diabetes Society. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABBOTT RD, 1988, J CLIN EPIDEMIOL, V41, P237, DOI 10.1016/0895-4356(88)90127-8; Andersson C, 2009, NUTR METAB, V6, DOI 10.1186/1743-7075-6-42; Apfelbaum M, 1999, AM J MED, V106, P179, DOI 10.1016/S0002-9343(98)00411-2; Auyeung TW, 2010, AGE AGEING, V39, P699, DOI 10.1093/ageing/afq101; Choi HK, 2008, RHEUMATOLOGY, V47, P1567, DOI 10.1093/rheumatology/ken305; Choi HK, 2005, ARCH INTERN MED, V165, P742, DOI 10.1001/archinte.165.7.742; Chuang SY, 2012, INT J CARDIOL, V154, P316, DOI 10.1016/j.ijcard.2011.06.055; Ezequiel Danielle Guedes Andrade, 2012, Braz. J. Nephrol., V34, P36; Grayson PC, 2011, ARTHRIT CARE RES, V63, P102, DOI 10.1002/acr.20344; Ishizaka N, 2010, J RHEUMATOL, V37, P410, DOI 10.3899/jrheum.090736; Lee JS, 2010, J GERONTOL A-BIOL, V65, P78, DOI 10.1093/gerona/glp042; Levey Andrew S., 2000, Journal of the American Society of Nephrology, V11, p155A; Lippi Giuseppe, 2010, Clin Cardiol, V33, pE76, DOI 10.1002/clc.20511; Lohsoonthorn V, 2006, ARCH MED RES, V37, P883, DOI 10.1016/j.arcmed.2006.03.008; Masuo K, 2003, HYPERTENSION, V42, P474, DOI 10.1161/01.HYP.0000091371.53502.D3; Nagahama K, 2004, HYPERTENS RES, V27, P227, DOI 10.1291/hypres.27.227; PAMUK ER, 1992, AM J EPIDEMIOL, V136, P686, DOI 10.1093/oxfordjournals.aje.a116548; Pan XR, 1997, DIABETES CARE, V20, P1664, DOI 10.2337/diacare.20.11.1664; PISUNYER FX, 1993, ANN INTERN MED, V119, P722, DOI 10.7326/0003-4819-119-7_Part_2-199310011-00019; Rzehak P, 2007, EUR J EPIDEMIOL, V22, P665, DOI 10.1007/s10654-007-9167-5; See LC, 2009, J RHEUMATOL, V36, P1691, DOI 10.3899/jrheum.081199; STEVENS J, 1990, AM J EPIDEMIOL, V132, P1156, DOI 10.1093/oxfordjournals.aje.a115758; STUNKARD AJ, 1981, AM J CLIN NUTR, V34, P1593, DOI 10.1093/ajcn/34.8.1593; Thomas TR, 2010, J APPL PHYSIOL, V109, P3, DOI 10.1152/japplphysiol.01361.2009; Wallace KL, 2004, J RHEUMATOL, V31, P1582; Wannamethee SG, 2006, ARCH INTERN MED, V166, P2546, DOI 10.1001/archinte.166.22.2546; Wannamethee SG, 1999, DIABETES CARE, V22, P1266, DOI 10.2337/diacare.22.8.1266; Yang WY, 2010, NEW ENGL J MED, V362, P1090, DOI 10.1056/NEJMoa0908292; Zhang HM, 2005, CIRC J, V69, P13, DOI 10.1253/circj.69.13; Zhang Q, 2011, CLIN RHEUMATOL, V30, P777, DOI 10.1007/s10067-010-1660-7	30	10	11	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 30	2012	7	11							e51186	10.1371/journal.pone.0051186	http://dx.doi.org/10.1371/journal.pone.0051186			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	054WM	23226486	Green Submitted, Green Published, gold			2022-12-27	WOS:000312376100297
J	Goto-Koshino, Y; Fukuchi, Y; Shibata, F; Abe, D; Kuroda, K; Okamoto, S; Kitamura, T; Nakajima, H				Goto-Koshino, Yuko; Fukuchi, Yumi; Shibata, Fumi; Abe, Daichi; Kuroda, Kana; Okamoto, Shinichiro; Kitamura, Toshio; Nakajima, Hideaki			Robo4 Plays a Role in Bone Marrow Homing and Mobilization, but Is Not Essential in the Long-Term Repopulating Capacity of Hematopoietic Stem Cells	PLOS ONE			English	Article							SLIT PROTEINS; NICHE; ANGIOGENESIS; RECEPTORS; GUIDANCE	Roundabout (Robo) family proteins are immunoglobulin-type surface receptors critical for cellular migration and pathway finding of neuronal axons. We have previously shown that Robo4 was specifically expressed in hematopoietic stem and progenitor cells and its high expression correlated with long-term repopulating (LTR) capacity. To reveal the physiological role of Robo4 in hematopoiesis, we examined the effects of Robo4 disruption on the function of hematopoietic stem cells (HSCs) and progenitors. In Robo4-deficient mice, basic hematological parameters including complete blood cell count and differentiation profile were not affected. In contrast to the previous report, HSC/hematopoietic progenitor (HPC) frequencies in the bone marrow (BM) were perfectly normal in Robo4(-/-) mice. Moreover, Robo4(-/-) HSCs were equally competitive as wild-type HSCs in transplantation assays and had normal long-term repopulating (LTR) capacity. Of note, the initial engraftment at 4-weeks after transplantation was slightly impaired by Robo4 ablation, suggesting a marginal defect in BM homing of Robo4(-/-) HSCs. In fact, homing efficiencies of HSCs/HPCs to the BM was significantly impaired in Robo4-deficient mice. On the other hand, granulocyte-colony stimulating factor-induced peripheral mobilization of HSCs was also impaired by Robo4 disruption. Lastly, marrow recovery from myelosuppressive stress was equally efficient in WT- and Robo4-mutant mice. These results clearly indicate that Robo4 plays a role in HSC trafficking such as BM homing and peripheral mobilization, but is not essential in the LTR and self-renewal capacity of HSCs.	[Fukuchi, Yumi; Abe, Daichi; Kuroda, Kana; Okamoto, Shinichiro; Nakajima, Hideaki] Keio Univ, Sch Med, Dept Internal Med, Div Hematol, Tokyo, Japan; [Goto-Koshino, Yuko; Shibata, Fumi; Kitamura, Toshio] Univ Tokyo, Inst Med Sci, Div Cellular Therapy, Adv Clin Res Ctr, Tokyo, Japan	Keio University; University of Tokyo	Nakajima, H (corresponding author), Keio Univ, Sch Med, Dept Internal Med, Div Hematol, Tokyo, Japan.	hnakajim@z2.keio.jp	Kitamura, Toshio/AAA-2071-2021	Goto-Koshino, Yuko/0000-0002-5228-7125	Ministry of Education, Culture, Sports, Science and Technology of Japan [18659278]	Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported in part by a grant from the Ministry of Education, Culture, Sports, Science and Technology of Japan (# 18659278). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arai F, 2004, CELL, V118, P149, DOI 10.1016/j.cell.2004.07.004; Brose K, 1999, CELL, V96, P795, DOI 10.1016/S0092-8674(00)80590-5; Calvi LM, 2003, NATURE, V425, P841, DOI 10.1038/nature02040; Ema H, 2006, NAT PROTOC, V1, P2979, DOI 10.1038/nprot.2006.447; Goodell MA, 1997, NAT MED, V3, P1337, DOI 10.1038/nm1297-1337; Goodell MA, 1996, J EXP MED, V183, P1797, DOI 10.1084/jem.183.4.1797; Jones CA, 2008, NAT MED, V14, P448, DOI 10.1038/nm1742; Jones CA, 2009, NAT CELL BIOL, V11, P1325, DOI 10.1038/ncb1976; Nakajima H, 2006, BIOCHEM BIOPH RES CO, V340, P35, DOI 10.1016/j.bbrc.2005.11.146; Nakajima H, 2010, BLOOD, V116, P4474, DOI 10.1182/blood-2010-01-266528; Rajagopalan S, 2000, NEURON, V28, P767, DOI 10.1016/S0896-6273(00)00152-5; Rhee J, 2002, NAT CELL BIOL, V4, P798, DOI 10.1038/ncb858; Shibata F, 2009, STEM CELLS, V27, P183, DOI 10.1634/stemcells.2008-0292; Smith-Berdan S, 2011, CELL STEM CELL, V8, P72, DOI 10.1016/j.stem.2010.11.030; Wang B, 2003, CANCER CELL, V4, P19, DOI 10.1016/S1535-6108(03)00164-8; Wong K, 2002, CURR OPIN GENET DEV, V12, P583, DOI 10.1016/S0959-437X(02)00343-X; Wu JY, 2001, NATURE, V410, P948, DOI 10.1038/35073616; Zhang JW, 2003, NATURE, V425, P836, DOI 10.1038/nature02041	18	11	12	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 30	2012	7	11							e50849	10.1371/journal.pone.0050849	http://dx.doi.org/10.1371/journal.pone.0050849			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	054WM	23226403	Green Submitted, Green Published, gold			2022-12-27	WOS:000312376100214
J	Laillou, A; Berger, J; Le, BM; Pham, VT; Le, TH; Nguyen, CK; Panagides, D; Rohner, F; Wieringa, F; Moench-Pfanner, R				Laillou, Arnaud; Berger, Jacques; Bach Mai Le; Van Thuy Pham; Thi Hop Le; Cong Khan Nguyen; Panagides, Dora; Rohner, Fabian; Wieringa, Frank; Moench-Pfanner, Regina			Improvement of the Vietnamese Diet for Women of Reproductive Age by Micronutrient Fortification of Staples Foods and Condiments	PLOS ONE			English	Article							FOLIC-ACID FORTIFICATION; FORTIFIED FISH SAUCE; NEURAL-TUBE DEFECTS; IRON-DEFICIENCY; DOUBLE-BLIND; PREGNANCY; ANEMIA; PREVALENCE; CHILDREN; FOLATE	Background: A micronutrient survey carried out in 2010 among randomly selected Vietnamese women in reproductive age indicated that anemia and micronutrient deficiencies are still prevalent. The objective of this study was thus to analyze the dietary micronutrient intakes of these women, to select the food vehicles to be fortified and to calculate their contributions to meet the recommended nutrient intake (RNI) for iron, zinc, vitamin A and folic acid. Main Findings: Consumption data showed that the median intake was 38.4% of the RNI for iron, 61.1% for vitamin A and 91.8% for zinc. However, more than 50% of the women had daily zinc consumption below the RNI. Rice and vegetable oil were consumed daily in significant amounts (median: 320.4 g/capita/day and 8.6 g/capita/day respectively) by over 90% of the women, making them suitable vehicles for fortification. Based on consumption data, fortified vegetable oil could contribute to an additional vitamin A intake of 27.1% of the RNI and fortified rice could increase the intake of iron by 41.4% of the RNI, zinc by 15.5% and folate by 34.1%. Other food vehicles, such as fish and soy sauces and flavoring powders, consumed respectively by 63% and 90% of the population could contribute to increase micronutrient intakes if they are properly fortified and promoted. Wheat flower was consumed by 39% of the women and by less than 20% women from the lowest socioeconomic strata. Conclusion: The fortification of edible vegetable oils with vitamin A and of rice with iron, zinc and folic acid are the most promising fortification strategies to increase micronutrient intakes of women in reproductive age in Vietnam. While rice fortification will be implemented, fortification of fish and soy sauces with iron, that has been proven to be effective, has to be supported and fortification of flavouring powders with micronutrients investigated.	[Laillou, Arnaud; Panagides, Dora; Rohner, Fabian; Moench-Pfanner, Regina] GAIN, Geneva, Switzerland; [Bach Mai Le; Van Thuy Pham; Thi Hop Le] Natl Inst Nutr, Hanoi, Vietnam; [Cong Khan Nguyen] VFA, Hanoi, Vietnam; [Berger, Jacques; Wieringa, Frank] UMR Nutripass IRD UM2 UM1, IRD, Montpellier, France	Institut de Recherche pour le Developpement (IRD); Universite de Montpellier	Laillou, A (corresponding author), GAIN, Geneva, Switzerland.	alaillou@gainhealth.org	Rohner, Fabian/I-5088-2019; Wieringa, Frank Tammo/K-7565-2017	Rohner, Fabian/0000-0003-0579-6952; Wieringa, Frank Tammo/0000-0002-6010-355X	Bill and Melinda Gates Foundation (BMGF); Department For International Development (DFID)	Bill and Melinda Gates Foundation (BMGF)(Bill & Melinda Gates Foundation); Department For International Development (DFID)	The work was funded by Bill and Melinda Gates Foundation (BMGF) and the Department For International Development (DFID). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen L, 2006, GUIDELINES ON FOOD F; Allen LH, 2005, AM J CLIN NUTR, V81, p1206S; Angeles-Agdeppa I, 2011, FOOD NUTR BULL, V32, P3, DOI 10.1177/156482651103200101; Bagni UV, 2009, CAD SAUDE PUBLICA, V25, P291, DOI 10.1590/S0102-311X2009000200007; Bagriansky J., 1998, VITAMIN A FORTIFICAT; Beinner MA, 2010, J NUTR, V140, P49, DOI 10.3945/jn.109.112623; Bothwell TH, 2000, AM J CLIN NUTR, V72, p257S, DOI 10.1093/ajcn/72.1.257S; Brown KH, 2010, FOOD NUTR BULL, V31, pS62, DOI 10.1177/15648265100311S106; Casanueva E, 2003, ANN NUTR METAB, V47, P60, DOI 10.1159/000069276; Central Intelligence Agency, 2012, WORLD FACT BOOK; Chavasit Visith, 2003, Food and Nutrition Bulletin, V24, P200; Chen K, 2011, NUTRITION, V27, P428, DOI 10.1016/j.nut.2010.04.004; Dop MC, 2000, FOURTH INTERNATIONAL; Ecker O, 2011, USAID SPECIAL REPORT; Fogel RW, 2004, ECON DEV CULT CHANGE, V52, P643, DOI 10.1086/383450; Food Security Statistic, 2010, DATABASE OF THE FOOD; General Statistic Office, 2008, SUMMARY RESULTS OF T; Global alliance For Improved Nutrition, 2010, CONDIMENT REPORT; Heltberg R, 2009, HEALTH ECON, V18, pS77, DOI 10.1002/hec.1462; Holick MF, 2008, AM J CLIN NUTR, V87, p1080S; Horton S, 2008, HUNGER AND MALNUTRIT; Houghton LA, 2011, AM J CLIN NUTR, V94, P136, DOI 10.3945/ajcn.110.004549; Hung Le Q., 2005, Southeast Asian Journal of Tropical Medicine and Public Health, V36, P816; Hurrell RF, 2011, ANN NUTR METAB, V59, P64, DOI 10.1159/000332140; Khan NC, 2007, ASIA PAC J CLIN NUTR, V16, P274; Khoi H, 2000, GENERAL NUTRITION SU; Kyritsi A, 2011, LWT-FOOD SCI TECHNOL, V44, P312, DOI 10.1016/j.lwt.2010.06.001; Laillou A, 2012, CALCIUM AND VITAMIN; Laillou A, 2012, NUTRIENTS, V4, P1151, DOI 10.3390/nu4091151; Laillou A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034906; Li YO, 2011, INT J FOOD SCI TECH, V46, P379, DOI 10.1111/j.1365-2621.2010.02494.x; MACPHAIL AP, 1994, AM J CLIN NUTR, V59, P644, DOI 10.1093/ajcn/59.3.644; Ministry of Public Health and National Institute of Nutrition, 2000, NUTRITIVE COMPOSITIO; Moretti D, 2006, AM J CLIN NUTR, V84, P822, DOI 10.1093/ajcn/84.4.822; Mosley BS, 2009, AM J EPIDEMIOL, V169, P9, DOI 10.1093/aje/kwn331; National Institute of Nutrition, 2010, PREVALENCE OF UNDERN; Khan NC, 2008, ASIA PAC J CLIN NUTR, V17, P409; Okebe JU, 2011, COCHRANE DATABASE SY; Prom-u-thai C, 2009, J SCI FOOD AGR, V89, P2565, DOI 10.1002/jsfa.3753; Radhika MS, 2011, AM J CLIN NUTR, V94, P1202, DOI 10.3945/ajcn.110.007179; Rustein SO, 2004, DHS COMPERATIVE REPO; Rutstein S, 2008, THE DHS WEALTH INDEX; Sayed AR, 2008, BIRTH DEFECTS RES A, V82, P211, DOI 10.1002/bdra.20442; Thuy PV, 2003, AM J CLIN NUTR, V78, P284, DOI 10.1093/ajcn/78.2.284; Torlesse H, 2003, J NUTR, V133, P1320; Van Thuy P, 2005, J NUTR, V135, P2596, DOI 10.1093/jn/135.11.2596; Viteri FE, 2005, NUTR REV, V63, pS65, DOI 10.1301/nr.2005.dec.S65-S76; Vu TTH, 2009, PUBLIC HEALTH NUTR, V12, P941, DOI 10.1017/S1368980008003479; West KP, 2010, J NUTR, V140, p201S, DOI 10.3945/jn.109.112730; WHO, 2011, GUIDELINE VITAMIN A; Williamson CS, 2005, NUTR BULL, V30, P323, DOI 10.1111/j.1467-3010.2005.00525.x; Winichagoon P, 2006, J NUTR, V136, P1617, DOI 10.1093/jn/136.6.1617; World Bank, 2006, REPOSITIONING NUTRIT; World Development Indicators, 2010, DATABASE OF WORLD BA; World Health Organisation, 2009, RECOMMENDATIONS ON W; Yoo J, 2011, INT J FOOD PROPERTIE	56	14	14	0	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 30	2012	7	11							e50538	10.1371/journal.pone.0050538	http://dx.doi.org/10.1371/journal.pone.0050538			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	054WM	23226308	Green Submitted, Green Published, gold			2022-12-27	WOS:000312376100120
J	Marie, H; Barrere, A; Schoenstein, F; Chavanne, MH; Grosgogeat, B; Mora, L				Marie, Helene; Barrere, Amelie; Schoenstein, Frederic; Chavanne, Marie-Helene; Grosgogeat, Brigitte; Mora, Laurence			PEM Anchorage on Titanium Using Catechol Grafting	PLOS ONE			English	Article							POLYELECTROLYTE MULTILAYER FILMS; BIOMEDICAL APPLICATIONS; SURFACE MODIFICATION; PROTEIN RESISTANCE; CHITOSAN; LAYER; ADHESION; STABILITY; NANOPARTICLES; IMPROVEMENT	Background: This study deals with the anchorage of polyelectrolyte films onto titanium surfaces via a cathecol-based linker for biomedical applications. Methodology: The following study uses a molecule functionalized with a catechol and a carboxylic acid: 3-(3,4-dihydroxyphenyl)propanoic acid. This molecule is anchored to the TiO2 substrate via the catechol while the carboxylic acid reacts with polymers bearing amine groups. By providing a film anchorage of chemisorption type, it makes possible to deposit polyelectrolytes on the surface of titanium. Principal Findings: Infrared spectroscopy (ATR-FTIR), X-ray photoelectron spectroscopy (XPS), contact angle and atomic force microscopy (AFM) measurements show that the different steps of grafting have been successfully performed. Conclusions: This method based on catechol anchorage of polyelectrolytes open a window towards large possibilities of clinical applications.	[Marie, Helene; Barrere, Amelie; Mora, Laurence] Univ Paris 13, BPC, F-93430 Villetaneuse, France; [Marie, Helene; Barrere, Amelie; Mora, Laurence] Univ Paris Diderot, Paris, France; [Marie, Helene; Barrere, Amelie; Mora, Laurence] INSERM, U698, Paris, France; [Schoenstein, Frederic; Chavanne, Marie-Helene] Univ Paris 13, CNRS, UPR 3407, Lab Sci Proc & Mat, F-93430 Villetaneuse, France; [Grosgogeat, Brigitte] Univ Lyon 1, Hosp Civils Lyon, Lab Multimat & Interfaces, UFR Odontol,Lyon SCTD,CNRS,UMR 5615, F-69365 Lyon, France	Universite Paris 13; UDICE-French Research Universities; Universite Paris Cite; Institut National de la Sante et de la Recherche Medicale (Inserm); Centre National de la Recherche Scientifique (CNRS); CNRS - Institute for Engineering & Systems Sciences (INSIS); Universite Paris 13; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Chemistry (INC); CHU Lyon; UDICE-French Research Universities; Universite Claude Bernard Lyon 1	Mora, L (corresponding author), Univ Paris 13, BPC, F-93430 Villetaneuse, France.	Laurence.mora@univ-paris13.fr	GROSGOGEAT, Brigitte/AAE-2810-2019; Schoenstein, Frédéric/N-2750-2019	GROSGOGEAT, Brigitte/0000-0003-2194-7300; Schoenstein, Frédéric/0000-0001-7959-1058	 [PEPS-ST2I 2009]		Funding: PEPS-ST2I 2009. Projets exploratoires : Collaboration avec Mme Berangere TOURY du Laboratoire des Multimateriaux et Interfaces (LMI) de Villeurbanne, UMR 5615 CNRS. "Revetements de fonctionnalisation antiseptique pour dispositifs medicaux odontologiques. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bhattarai N, 2005, J CONTROL RELEASE, V103, P609, DOI 10.1016/j.jconrel.2004.12.019; Blattler TM, 2006, LANGMUIR, V22, P5760, DOI 10.1021/la0602766; Boudou T, 2010, ADV MATER, V22, P441, DOI 10.1002/adma.200901327; Brunot C, 2008, DENT MATER, V24, P1025, DOI 10.1016/j.dental.2007.11.022; Brunot C, 2007, BIOMATERIALS, V28, P632, DOI 10.1016/j.biomaterials.2006.09.026; Cai KY, 2005, BIOMATERIALS, V26, P5960, DOI 10.1016/j.biomaterials.2005.03.020; Chua PH, 2008, BIOMATERIALS, V29, P1412, DOI 10.1016/j.biomaterials.2007.12.019; Dalsin JL, 2005, LANGMUIR, V21, P640, DOI 10.1021/la048626g; Dalsin JL, 2003, J AM CHEM SOC, V125, P4253, DOI 10.1021/ja0284963; Decher G, 1997, SCIENCE, V277, P1232, DOI 10.1126/science.277.5330.1232; Diebold U, 2003, SURF SCI REP, V48, P53, DOI 10.1016/S0167-5729(02)00100-0; Fan XW, 2005, J AM CHEM SOC, V127, P15843, DOI 10.1021/ja0532638; Foster LJR, 2010, BIOMACROMOLECULES, V11, P3563, DOI 10.1021/bm101028g; Hamilton V, 2006, J MATER SCI-MATER M, V17, P1373, DOI 10.1007/s10856-006-0613-9; Helmy R, 2002, LANGMUIR, V18, P8924, DOI 10.1021/la0262506; Hoogeveen NG, 1996, LANGMUIR, V12, P3675, DOI 10.1021/la951574y; Kolhe P, 2003, BIOMACROMOLECULES, V4, P173, DOI 10.1021/bm025689+; Ladam G, 2000, LANGMUIR, V16, P1249, DOI 10.1021/la990650k; Lee H, 2008, ADV MATER, V20, P1619, DOI 10.1002/adma.200702378; Li SC, 2009, J AM CHEM SOC, V131, P980, DOI 10.1021/ja803595u; Mhamdi L, 2006, MAT SCI ENG C-BIO S, V26, P273, DOI 10.1016/j.msec.2005.10.049; Muzzarelli RAA, 1999, EXS, V87, P251; Persson P, 2000, J PHYS CHEM B, V104, P10348, DOI 10.1021/jp002550p; Puckett SD, 2010, BIOMATERIALS, V31, P706, DOI 10.1016/j.biomaterials.2009.09.081; Redfern PC, 2003, J PHYS CHEM B, V107, P11419, DOI 10.1021/jp0303669; Renoud P, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039367; Richert L, 2004, LANGMUIR, V20, P448, DOI 10.1021/la035415n; Richert L, 2004, BIOMACROMOLECULES, V5, P284, DOI 10.1021/bm0342281; Riedel NA, 2012, MAT SCI ENG C-MATER, V32, P1196, DOI 10.1016/j.msec.2012.03.008; Saxer S, 2010, MACROMOLECULES, V43, P1050, DOI 10.1021/ma9020664; Scranton AB, 1995, ADV POLYM SCI, V122, P1; Tirrell M, 2002, SURF SCI, V500, P61, DOI 10.1016/S0039-6028(01)01548-5; Tsyganov I, 2004, APPL SURF SCI, V235, P156, DOI 10.1016/j.apsusc.2004.05.134; Yu DG, 2007, COLLOID SURFACE B, V54, P222, DOI 10.1016/j.colsurfb.2006.10.026	34	5	6	1	42	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 30	2012	7	11							e50326	10.1371/journal.pone.0050326	http://dx.doi.org/10.1371/journal.pone.0050326			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	054WM	23226262	Green Published, Green Submitted, gold			2022-12-27	WOS:000312376100072
J	Martinez-Rubio, L; Morais, S; Evensen, O; Wadsworth, S; Ruohonen, K; Vecino, JLG; Bell, JG; Tocher, DR				Martinez-Rubio, Laura; Morais, Sofia; Evensen, Oystein; Wadsworth, Simon; Ruohonen, Kari; Vecino, Jose L. G.; Bell, J. Gordon; Tocher, Douglas R.			Functional Feeds Reduce Heart Inflammation and Pathology in Atlantic Salmon (Salmo salar L.) following Experimental Challenge with Atlantic Salmon Reovirus (ASRV)	PLOS ONE			English	Article							SKELETAL-MUSCLE INFLAMMATION; POLYUNSATURATED FATTY-ACIDS; SEABREAM SPARUS-AURATA; EICOSANOID PRODUCTION; IMMUNE-RESPONSES; FISH-OIL; TRANSCRIPTOMIC ANALYSIS; RHEUMATOID-ARTHRITIS; PANCREAS DISEASE; INNATE IMMUNITY	Heart and Skeletal Muscle Inflammation (HSMI), recently associated with a novel Atlantic salmon reovirus (ASRV), is currently one of the most prevalent inflammatory diseases in commercial Atlantic salmon farms in Norway. Mortality varies from low to 20%, but morbidity can be very high, reducing growth performance and causing considerable financial impact. Clinical symptoms, including myocarditis, myocardial and red skeletal muscle necrosis, correlate with the intensity of the inflammatory response. In the present study, the effects of two functional feeds (FF1 and FF2) were compared to a standard commercial reference feed (ST) in Atlantic salmon subjected to an ASRV challenge. The functional feeds had reduced levels of total lipid and digestible energy, and different levels and proportions of long-chain polyunsaturated fatty acids (LC-PUFA). The objective was to determine whether these feeds could provide effective protection by decreasing the inflammatory response associated with HSMI. Histopathology, viral load, fatty acid composition and gene expression of heart tissue were assessed over a period of 16 weeks post-infection with ASRV. The viral load and histopathology scores in heart tissue in response to ASRV infection were reduced in fish fed both functional feeds, with FF1 showing the greatest effect. Microarray hierarchical cluster analysis showed that the functional feeds greatly affected expression of inflammation/immune related genes over the course of the ASRV infection. Viral load correlated with up-regulation of pro-inflammatory genes at the early-mid stages of infection in fish fed the ST diet. Expression of inflammatory genes 16-weeks after ASRV challenge reflected the difference in efficacy between the functional feeds, with fish fed FF1 showing lower expression. Thus, severity of the lesions in heart tissue correlated with the intensity of the innate immune response and was associated with tissue fatty acid compositions. The present study demonstrated that dietary modulation through clinical nutrition had major influences on the development and severity of the response to ASRV infection in salmon. Thus, HSMI was reduced in fish fed the functional feeds, particularly FF1. The modulation of gene expression between fish fed the different feeds provided further insight into the molecular mechanisms and progression of the inflammatory and immune responses to ASRV infection in salmon.	[Martinez-Rubio, Laura; Morais, Sofia; Bell, J. Gordon; Tocher, Douglas R.] Univ Stirling, Sch Nat Sci, Inst Aquaculture, Stirling FK9 4LA, Scotland; [Evensen, Oystein] Norwegian Sch Vet Sci, Oslo, Norway; [Wadsworth, Simon; Ruohonen, Kari; Vecino, Jose L. G.] EWOS Innovat AS, Dirdal, Norway	University of Stirling; Norwegian University of Life Sciences	Martinez-Rubio, L (corresponding author), Univ Stirling, Sch Nat Sci, Inst Aquaculture, Stirling FK9 4LA, Scotland.	laura.martinez@stir.ac.uk	Morais, Sofia/D-8921-2011; Tocher, Douglas R/C-5652-2011; Evensen, Øystein/O-3011-2015	Tocher, Douglas R/0000-0002-8603-9410; Evensen, Øystein/0000-0002-4856-3043				Alne H, 2009, J FISH DIS, V32, P953, DOI 10.1111/j.1365-2761.2009.01078.x; Balfry S.K., 2001, NUTR FISH HLTH, P213; Bell JG, 1996, PROSTAG LEUKOTR ESS, V54, P173, DOI 10.1016/S0952-3278(96)90013-7; BELL JG, 1993, PROSTAG LEUKOTR ESS, V49, P665, DOI 10.1016/0952-3278(93)90075-8; BELL JG, 1992, COMP BIOCHEM PHYS A, V103, P337, DOI 10.1016/0300-9629(92)90591-D; Bellisle R, 1980, BR J NUTR S, V80, pS3; Borre R, 2006, FISH SHELLFISH IMMUN, V20, P172; Calder PC, 2009, BRIT J NUTR, V101, pS1, DOI 10.1017/S0007114509377867; Calder PC, 2005, BIOCHEM SOC T, V33, P423, DOI 10.1042/BST0330423; Calder PC, 2007, PROSTAG LEUKOTR ESS, V77, P327, DOI 10.1016/j.plefa.2007.10.015; Calder PC, 2009, BIOFACTORS, V35, P266, DOI 10.1002/biof.42; CHANG KJ, 1991, J LEUKOCYTE BIOL, V50, P273, DOI 10.1002/jlb.50.3.273; Christie W.W., 2003, LIPID ANAL ISOLATION, V3rd ed., P205; Dimitroglou A, 2010, AQUACULTURE, V300, P182, DOI 10.1016/j.aquaculture.2010.01.015; Dixon B, 2001, DEV COMP IMMUNOL, V25, P683, DOI 10.1016/S0145-305X(01)00030-1; Erkkila A, 2008, PROG LIPID RES, V47, P172, DOI 10.1016/j.plipres.2008.01.004; FAO (Food and Agriculture Organization of the United Nations), 2010, STAT WORLD FISH AQ 2; Ferguson HW, 2005, J FISH DIS, V28, P119, DOI 10.1111/j.1365-2761.2004.00602.x; FOLCH J, 1957, J BIOL CHEM, V226, P497; Ganga R, 2005, COMP BIOCHEM PHYS B, V142, P410, DOI 10.1016/j.cbpb.2005.09.010; Gelman A., 1992, STAT SCI, V7, P457, DOI [10.1214/ss/1177011136, DOI 10.1214/SS/1177011136]; Gjoen T, 2007, COMP BIOCHEM PHYS B, V148, P103, DOI 10.1016/j.cbpb.2007.04.021; Hara Y, 2003, IMMUNOL LETT, V86, P139, DOI 10.1016/S0165-2478(03)00007-5; Ierna M, 2010, BMC MUSCULOSKEL DIS, V11, DOI 10.1186/1471-2474-11-136; Jorgensen SM, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-179; Jorgensen SM, 2007, FISH SHELLFISH IMMUN, V23, P576, DOI 10.1016/j.fsi.2007.01.005; Jorgensen SM, 2006, MAR BIOTECHNOL, V8, P398, DOI 10.1007/s10126-005-5164-4; Kawada J, 2006, J GEN VIROL, V87, P1677, DOI 10.1099/vir.0.81670-0; Kongtorp RT, 2004, DIS AQUAT ORGAN, V59, P217, DOI 10.3354/dao059217; Kongtorp RT, 2004, J FISH DIS, V27, P351, DOI 10.1111/j.1365-2761.2004.00549.x; Krasnov A, 2011, MOL IMMUNOL, V49, P163, DOI 10.1016/j.molimm.2011.08.007; Lee CG, 2008, CURR OPIN IMMUNOL, V20, P684, DOI 10.1016/j.coi.2008.10.002; Lin KS, 2009, EXPERT SYST APPL, V36, P3327, DOI 10.1016/j.eswa.2008.01.068; Lunn DJ, 2000, STAT COMPUT, V10, P325, DOI 10.1023/A:1008929526011; Magnadottir B, 2006, FISH SHELLFISH IMMUN, V20, P137, DOI 10.1016/j.fsi.2004.09.006; MCCOY MA, 1994, COMP BIOCHEM PHYS A, V109, P905, DOI 10.1016/0300-9629(94)90238-0; Mikalsen AB, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037269; Miller K, 2007, AQUACULTURE, V272, pS217, DOI 10.1016/j.aquaculture.2007.08.041; Montero D, 2008, FISH SHELLFISH IMMUN, V24, P147, DOI 10.1016/j.fsi.2007.08.002; Montero D, 2003, AQUACULTURE, V225, P353, DOI 10.1016/S0044-8486(03)00301-6; Morais S, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-255; Palacios G, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011487; Park K, 2010, J LEUKOCYTE BIOL, V88, P1081, DOI 10.1189/jlb.0610318; Pfaffl MW, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.9.e36; Plummer M, 2009, JAGS VERSION 1 03 MA; R Development Core Team R, 2009, R LANG ENV STAT COMP; RAYNARD RS, 1991, COMP BIOCHEM PHYS A, V98, P125, DOI 10.1016/0300-9629(91)90589-5; REEVES PG, 1993, J NUTR, V123, P1939, DOI 10.1093/jn/123.11.1939; Schiotz BL, 2008, VIRUS RES, V136, P65, DOI 10.1016/j.virusres.2008.04.019; Skjesol A, 2011, VIROL J, V8, DOI 10.1186/1743-422X-8-396; Sommerset I, 2005, EXPERT REV VACCINES, V4, P89, DOI 10.1586/14760584.4.1.89; Stamp LK, 2005, SEMIN ARTHRITIS RHEU, V35, P77, DOI 10.1016/j.semarthrit.2005.05.001; STOREBAKKEN T, 1988, AQUACULTURE, V70, P193, DOI 10.1016/0044-8486(88)90096-8; Tacchi L, 2011, FISH SHELLFISH IMMUN, V31, P704, DOI 10.1016/j.fsi.2011.02.023; Tacon AGJ, 2008, AQUACULTURE, V285, P146, DOI 10.1016/j.aquaculture.2008.08.015; Thompson KD, 1996, AQUACULT NUTR, V2, P21, DOI 10.1111/j.1365-2095.1996.tb00004.x; Timmerhaus G, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-459; Workenhe ST, 2009, MOL IMMUNOL, V46, P2955, DOI 10.1016/j.molimm.2009.06.015; Zhu W, 2010, VACCINE, V28, P2865, DOI 10.1016/j.vaccine.2010.01.060	59	46	48	0	58	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 30	2012	7	11							e40266	10.1371/journal.pone.0040266	http://dx.doi.org/10.1371/journal.pone.0040266			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	054WM	23226193	Green Published, Green Submitted, gold			2022-12-27	WOS:000312376100001
J	Rosenstrom, T; Jokela, M; Puttonen, S; Hintsanen, M; Pulkki-Raback, L; Viikari, JS; Raitakari, OT; Keltikangas-Jarvinen, L				Rosenstrom, Tom; Jokela, Markus; Puttonen, Sampsa; Hintsanen, Mirka; Pulkki-Raback, Laura; Viikari, Jorma S.; Raitakari, Olli T.; Keltikangas-Jarvinen, Liisa			Pairwise Measures of Causal Direction in the Epidemiology of Sleep Problems and Depression	PLOS ONE			English	Article							CARDIOVASCULAR RISK; MAJOR DEPRESSION; INSOMNIA; DISTURBANCES; DISORDERS; SYMPTOM; RECURRENCE; DISABILITY; PREDICTOR; MORTALITY	Depressive mood is often preceded by sleep problems, suggesting that they increase the risk of depression. Sleep problems can also reflect prodromal symptom of depression, thus temporal precedence alone is insufficient to confirm causality. The authors applied recently introduced statistical causal-discovery algorithms that can estimate causality from cross-sectional samples in order to infer the direction of causality between the two sets of symptoms from a novel perspective. Two common-population samples were used; one from the Young Finns study (690 men and 997 women, average age 37.7 years, range 30-45), and another from the Wisconsin Longitudinal study (3101 men and 3539 women, average age 53.1 years, range 52-55). These included three depression questionnaires (two in Young Finns data) and two sleep problem questionnaires. Three different causality estimates were constructed for each data set, tested in a benchmark data with a (practically) known causality, and tested for assumption violations using simulated data. Causality algorithms performed well in the benchmark data and simulations, and a prediction was drawn for future empirical studies to confirm: for minor depression/dysphoria, sleep problems cause significantly more dysphoria than dysphoria causes sleep problems. The situation may change as depression becomes more severe, or more severe levels of symptoms are evaluated; also, artefacts due to severe depression being less well presented in the population data than minor depression may intervene the estimation for depression scales that emphasize severe symptoms. The findings are consistent with other emerging epidemiological and biological evidence.	[Rosenstrom, Tom; Jokela, Markus; Puttonen, Sampsa; Hintsanen, Mirka; Pulkki-Raback, Laura; Keltikangas-Jarvinen, Liisa] Univ Helsinki, IBS, Unit Personal Work & Hlth Psychol, Helsinki, Finland; [Puttonen, Sampsa] Finnish Inst Occupat Hlth, Ctr Expertise Human Factors Work, Helsinki, Finland; [Hintsanen, Mirka] Univ Helsinki, Helsinki Collegium Adv Studies, Helsinki, Finland; [Raitakari, Olli T.] Univ Turku, Res Ctr Appl & Prevent Cardiovasc Med, Turku, Finland; [Viikari, Jorma S.] Turku Univ Hosp, Dept Med, FIN-20520 Turku, Finland; [Raitakari, Olli T.] Turku Univ Hosp, Dept Clin Physiol, FIN-20520 Turku, Finland	University of Helsinki; Finnish Institute of Occupational Health; University of Helsinki; University of Turku; University of Turku; University of Turku	Rosenstrom, T (corresponding author), Univ Helsinki, IBS, Unit Personal Work & Hlth Psychol, Helsinki, Finland.	tom.rosenstrom@helsinki.fi	Hintsanen, Mirka/B-6012-2008; Raitakari, Olli/AAQ-7389-2021; Jokela, Markus/A-4669-2009	Hintsanen, Mirka/0000-0003-2673-0901; Jokela, Markus/0000-0003-0117-0012; Rosenstrom, Tom/0000-0001-8277-3776	Academy of Finland [258711, 123621, 126925, 121584, 124282]; Social Insurance Institution of Finland, Kuopio, Tampere; Turku University Hospital Medical Funds; Juho Vainio Foundation; Paavo Nurmi FoundationFinnish Foundation of Cardiovascular Research; Finnish Cultural Foundation; Emil Aaltonen Foundation; Signe and Ane Gyllenberg Foundation; Alfred Kordelin Foundation; Research Foundation of the University of Helsinki; National Institute on Aging [AG-9775, AG-21079]; Vilas Estate Trust; National Science Foundation; Spencer Foundation; Graduate School of the University of Wisconsin-Madison; NATIONAL INSTITUTE ON AGING [R01AG009775, P01AG021079] Funding Source: NIH RePORTER	Academy of Finland(Academy of Finland); Social Insurance Institution of Finland, Kuopio, Tampere; Turku University Hospital Medical Funds; Juho Vainio Foundation; Paavo Nurmi FoundationFinnish Foundation of Cardiovascular Research; Finnish Cultural Foundation(Finnish Cultural FoundationFinnish IT center for science); Emil Aaltonen Foundation; Signe and Ane Gyllenberg Foundation; Alfred Kordelin Foundation; Research Foundation of the University of Helsinki; National Institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); Vilas Estate Trust; National Science Foundation(National Science Foundation (NSF)); Spencer Foundation; Graduate School of the University of Wisconsin-Madison; NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This study was financially supported by the Academy of Finland (grant no. 258711 (LKJ), 123621 (LPR), 126925, 121584, and 124282), the Social Insurance Institution of Finland, Kuopio, Tampere and Turku University Hospital Medical Funds, Juho Vainio Foundation, Paavo Nurmi Foundation, Finnish Foundation of Cardiovascular Research, Finnish Cultural Foundation, Emil Aaltonen Foundation (MH), Signe and Ane Gyllenberg Foundation (MH), Alfred Kordelin Foundation (TR), and Research Foundation of the University of Helsinki (TR). This research also uses data from the Wisconsin Longitudinal Study (WLS) of the University of Wisconsin-Madison. Since 1991, the WLS has been supported principally by the National Institute on Aging (AG-9775 and AG-21079), with additional support from the Vilas Estate Trust, the National Science Foundation, the Spencer Foundation, and the Graduate School of the University of Wisconsin-Madison. A public use file of data from the Wisconsin Longitudinal Study is available from the Wisconsin Longitudinal Study, University of Wisconsin-Madison, 1180 Observatory Drive, Madison, Wisconsin 53706 and at http://www.ssc.wisc.edu/wls/data/. The opinions expressed herein are those of the authors. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akerstedt T, 2002, J SLEEP RES, V11, P69, DOI 10.1046/j.1365-2869.2002.00287.x; Andersen SL, 2008, TRENDS NEUROSCI, V31, P183, DOI 10.1016/j.tins.2008.01.004; Bach FR, 2003, J MACH LEARN RES, V3, P1, DOI 10.1162/153244303768966085; Beck A, 1993, MANUAL BECK DEPRESSI; Beck A.T., 1996, PSYCHOL ASSESS, V10, DOI [10.1037/t00742-000, DOI 10.1037/T00742-000]; Beck AT, 1996, J PERS ASSESS, V67, P588, DOI 10.1207/s15327752jpa6703_13; Cramer AOJ, 2012, PSYCHOL MED, V42, P957, DOI 10.1017/S003329171100211X; Daley M, 2009, SLEEP MED, V10, P427, DOI 10.1016/j.sleep.2008.04.005; Efron Bradley, 1993, INTRO BOOTSTRAP, V57; Ejaz Shakir M, 2011, Innov Clin Neurosci, V8, P17; Elovainio M, 2006, PSYCHOL MED, V36, P797, DOI 10.1017/S0033291706007574; Fernandez-Mendoza J, 2010, SLEEP, V33, P459, DOI 10.1093/sleep/33.4.459; FORD DE, 1989, JAMA-J AM MED ASSOC, V262, P1479, DOI 10.1001/jama.262.11.1479; Harvey AG, 2001, CLIN PSYCHOL REV, V21, P1037, DOI 10.1016/S0272-7358(00)00083-0; HOEFFDING W, 1948, ANN MATH STAT, V19, P546, DOI 10.1214/aoms/1177730150; Hubert PJ, 2009, ROBUST STAT; Hyde JS, 2008, PSYCHOL REV, V115, P291, DOI 10.1037/0033-295X.115.2.291; Hyvarinen A, 2001, INDEPENDENT COMPONENT ANALYSIS: PRINCIPLES AND PRACTICE, P71; Hyvarinen A, 2010, JMLR WORKSH C P 2 AS; Irwin MR, 2008, BRAIN BEHAV IMMUN, V22, P129, DOI 10.1016/j.bbi.2007.07.013; Irwin MR, 2007, BRAIN BEHAV IMMUN, V21, P374, DOI 10.1016/j.bbi.2007.01.010; Jan JE, 2010, EUR J PAEDIATR NEURO, V14, P380, DOI 10.1016/j.ejpn.2010.05.001; Jansson-Frojmark M, 2008, J PSYCHOSOM RES, V64, P443, DOI 10.1016/j.jpsychores.2007.10.016; JENKINS CD, 1988, J CLIN EPIDEMIOL, V41, P313, DOI 10.1016/0895-4356(88)90138-2; Johnson EO, 2006, J PSYCHIATR RES, V40, P700, DOI 10.1016/j.jpsychires.2006.07.008; Katainen S, 1999, J YOUTH ADOLESCENCE, V28, P139, DOI 10.1023/A:1021645213549; Kessler RC, 2003, JAMA-J AM MED ASSOC, V289, P3095, DOI 10.1001/jama.289.23.3095; Kleinman A, 2012, LANCET, V379, P608, DOI 10.1016/S0140-6736(12)60258-X; Lacerda G, 2008, P 24 C UNC ART INT U; Lallukka T, 2011, AM J EPIDEMIOL, V173, P871, DOI 10.1093/aje/kwq462; Leger D, 2000, J SLEEP RES, V9, P35, DOI 10.1046/j.1365-2869.2000.00178.x; LILLIEFORS HW, 1967, J AM STAT ASSOC, V62, P399, DOI 10.2307/2283970; Mathers CD, 2006, PLOS MED, V3, DOI 10.1371/journal.pmed.0030442; McLahlan G., 2000, FINITE MIXTURE MODEL; Monroe SM, 2005, PSYCHOL REV, V112, P417, DOI 10.1037/0033-295X.112.2.417; Motivala SJ, 2005, PSYCHOSOM MED, V67, P187, DOI 10.1097/01.psy.0000149259.72488.09; Mueller TI, 1999, AM J PSYCHIAT, V156, P1000; Ohayon MM, 2002, SLEEP MED REV, V6, P97, DOI 10.1053/smrv.2002.0186; Olino TM, 2012, INT J METH PSYCH RES, V21, P76, DOI 10.1002/mpr.1348; Paunio T, 2009, AM J EPIDEMIOL, V169, P206, DOI 10.1093/aje/kwn305; Perlis ML, 1997, J AFFECT DISORDERS, V42, P209, DOI 10.1016/S0165-0327(96)01411-5; RADLOFF L S, 1977, Applied Psychological Measurement, V1, P385, DOI 10.1177/014662167700100306; Raitakari OT, 2008, INT J EPIDEMIOL, V37, P1220, DOI 10.1093/ije/dym225; Rapaport MH, 2002, AM J PSYCHIAT, V159, P637, DOI 10.1176/appi.ajp.159.4.637; Riemann D, 2003, J AFFECT DISORDERS, V76, P255, DOI 10.1016/S0165-0327(02)00072-1; Riemann D, 2007, SLEEP MED, V8, pS15, DOI 10.1016/S1389-9457(08)70004-2; Rizopoulos D, 2006, J STAT SOFTW, V17; Rosenstrom T, 2012, J PSYCHOSOM RES, V72, P336, DOI 10.1016/j.jpsychores.2012.02.003; Salminen S, 2010, J SLEEP RES, V19, P207, DOI 10.1111/j.1365-2869.2009.00780.x; Salo P, 2010, SLEEP, V33, P1323, DOI 10.1093/sleep/33.10.1323; Samejima F., 1997, HDB MODERN ITEM RESP; Shafer AB, 2006, J CLIN PSYCHOL, V62, P123, DOI 10.1002/jclp.20213; Shimizu S, 2006, J MACH LEARN RES, V7, P2003; Shimizu S, 2011, J MACH LEARN RES, V12, P1225; Sriperumbudur BK, 2010, J MACH LEARN RES, V11, P1517; Sullivan PF, 2000, AM J PSYCHIAT, V157, P1552, DOI 10.1176/appi.ajp.157.10.1552; Tsuno N, 2005, J CLIN PSYCHIAT, V66, P1254, DOI 10.4088/JCP.v66n1008; Uher R, 2008, PSYCHOL MED, V38, P289, DOI 10.1017/S0033291707001730; Vgontzas AN, 2010, SLEEP, V33, P1159, DOI 10.1093/sleep/33.9.1159; Weissman MM, 1996, JAMA-J AM MED ASSOC, V276, P293, DOI 10.1001/jama.276.4.293; Wu MJ, 2011, PSYCHIAT RES-NEUROIM, V194, P39, DOI 10.1016/j.pscychresns.2011.04.003	62	46	48	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 30	2012	7	11							e50841	10.1371/journal.pone.0050841	http://dx.doi.org/10.1371/journal.pone.0050841			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	054WM	23226400	Green Published, Green Submitted, gold			2022-12-27	WOS:000312376100211
J	Tsang, PWK; Bandara, HMHN; Fong, WP				Tsang, Paul Wai-Kei; Bandara, H. M. H. N.; Fong, Wing-Ping			Purpurin Suppresses Candida albicans Biofilm Formation and Hyphal Development	PLOS ONE			English	Article							YEAST; MORPHOGENESIS; INFECTIONS; PATHOGENESIS; TRANSITION; MECHANISMS; RESISTANCE; INHIBITORS	A striking and clinically relevant virulence trait of the human fungal pathogen Candida albicans is its ability to grow and switch reversibly among different morphological forms. Inhibition of yeast-to-hypha transition in C. albicans represents a new paradigm for antifungal intervention. We have previously demonstrated the novel antifungal activity of purpurin against Candida fungi. In this study, we extended our investigation by examining the in vitro effect of purpurin on C. albicans morphogenesis and biofilms. The susceptibility of C. albicans biofilms to purpurin was examined quantitatively by 2,3-bis(2-methoxy-4-nitro-5-sulfo-phenyl)-2H-tetrazolium-5-carboxanilide reduction assay. Hyphal formation and biofilm ultrastructure were examined qualitatively by scanning electron microscopy (SEM). Quantitative reverse transcription-PCR (qRT-PCR) was used to evaluate the expression of hypha-specific genes and hyphal regulator in purpurin-treated fungal cells. The results showed that, at sub-lethal concentration (3 mu g/ml), purpurin blocked the yeast-to-hypha transition under hypha-inducing conditions. Purpurin also inhibited C. albicans biofilm formation and reduced the metabolic activity of mature biofilms in a concentration-dependent manner. SEM images showed that purpurin-treated C. albicans biofilms were scanty and exclusively consisted of aggregates of blastospores. qRT-PCR analyses indicated that purpurin downregulated the expression of hypha-specific genes (ALS3, ECE1, HWP1, HYR1) and the hyphal regulator RAS1. The data strongly suggested that purpurin suppressed C. albicans morphogenesis and caused distorted biofilm formation. By virtue of the ability to block these two virulence traits in C. albicans, purpurin may represent a potential candidate that deserves further investigations in the development of antifungal strategies against this notorious human fungal pathogen in vivo.	[Tsang, Paul Wai-Kei] Univ Hong Kong, Fac Dent, Hong Kong, Hong Kong, Peoples R China; [Bandara, H. M. H. N.] Univ Texas Austin, Coll Pharm, Div Pharmaceut, Austin, TX 78712 USA; [Fong, Wing-Ping] Chinese Univ Hong Kong, Sch Life Sci, Hong Kong, Hong Kong, Peoples R China	University of Hong Kong; University of Texas System; University of Texas Austin; Chinese University of Hong Kong	Tsang, PWK (corresponding author), Univ Hong Kong, Fac Dent, Hong Kong, Hong Kong, Peoples R China.	pwktsang@hku.hk	Bandara, Nihal/O-7287-2014	Bandara, Nihal/0000-0001-7652-2030; TSANG, Paul Wai-Kei/0000-0001-9163-4217	University of Hong Kong [201003159008]; Research Fund for the Control of Infectious Diseases, the Food and Health Bureau of the Government of the HKSAR [RFCID 11100992, 11101122]	University of Hong Kong(University of Hong Kong); Research Fund for the Control of Infectious Diseases, the Food and Health Bureau of the Government of the HKSAR	This work was partially supported by the Seeding Funding Programme for Basic Research from The University of Hong Kong (Project No. 201003159008 to PWKT), by the Research Fund for the Control of Infectious Diseases, the Food and Health Bureau of the Government of the HKSAR (RFCID 11100992 & 11101122 to PWKT). No additional external funding received for this study.	Arimoto-Kobayashi S, 2005, MUTAGENESIS, V20, P229, DOI 10.1093/mutage/gei030; Bailey DA, 1996, J BACTERIOL, V178, P5353, DOI 10.1128/jb.178.18.5353-5360.1996; Bandara HMHN, 2010, J MED MICROBIOL, V59, P1225, DOI 10.1099/jmm.0.021832-0; Biswas S, 2007, MICROBIOL MOL BIOL R, V71, P348, DOI 10.1128/MMBR.00009-06; Bustamante CI, 2005, CURR OPIN INFECT DIS, V18, P490, DOI 10.1097/01.qco.0000191516.43792.61; Chandra J, 2008, NAT PROTOC, V3, P1909, DOI 10.1038/nprot.2008.192; Corner BE, 1997, CURR BIOL, V7, pR691, DOI 10.1016/S0960-9822(06)00357-5; Cottier F, 2009, FEMS MICROBIOL LETT, V295, P1, DOI 10.1111/j.1574-6968.2009.01564.x; Di Santo R, 2010, NAT PROD REP, V27, P1084, DOI 10.1039/b914961a; Dongari-Bagtzoglou A, 2008, EXPERT REV ANTI-INFE, V6, P201, DOI 10.1586/14787210.6.2.201; Finkel JS, 2011, NAT REV MICROBIOL, V9, P109, DOI 10.1038/nrmicro2475; Gauwerky K, 2009, DRUG DISCOV TODAY, V14, P214, DOI 10.1016/j.drudis.2008.11.013; Ghannoum MA, 1999, CLIN MICROBIOL REV, V12, P501, DOI 10.1128/CMR.12.4.501; Han TL, 2011, FUNGAL GENET BIOL, V48, P747, DOI 10.1016/j.fgb.2011.04.002; Kang K, 2010, MED MYCOL, V48, P904, DOI 10.3109/13693781003739351; Kojic EM, 2004, CLIN MICROBIOL REV, V17, P255, DOI 10.1128/CMR.17.2.255-267.2004; Kumamoto CA, 2005, CELL MICROBIOL, V7, P1546, DOI 10.1111/j.1462-5822.2005.00616.x; LIU HP, 1994, SCIENCE, V266, P1723, DOI 10.1126/science.7992058; Lo HJ, 1997, CELL, V90, P939, DOI 10.1016/S0092-8674(00)80358-X; Lorenz MC, 2004, EUKARYOT CELL, V3, P1076, DOI 10.1128/EC.3.5.1076-1087.2004; Luo GPS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025909; Luo G, 2010, J INFECT DIS, V201, P1718, DOI 10.1086/652407; Miceli MH, 2011, LANCET INFECT DIS, V11, P142, DOI 10.1016/S1473-3099(10)70218-8; Morschhauser J, 2010, FUNGAL GENET BIOL, V47, P94, DOI 10.1016/j.fgb.2009.08.002; Nobile CJ, 2008, CURR BIOL, V18, P1017, DOI 10.1016/j.cub.2008.06.034; Nobile CJ, 2006, EUKARYOT CELL, V5, P1604, DOI 10.1128/EC.00194-06; Nobile CJ, 2006, PLOS PATHOG, V2, P636, DOI 10.1371/journal.ppat.0020063; Rios JL, 2005, J ETHNOPHARMACOL, V100, P80, DOI 10.1016/j.jep.2005.04.025; Saville SP, 2003, EUKARYOT CELL, V2, P1053, DOI 10.1128/EC.2.5.1053-1060.2003; Schaller M, 1998, MOL MICROBIOL, V29, P605, DOI 10.1046/j.1365-2958.1998.00957.x; Shareck J, 2011, EUKARYOT CELL, V10, P1004, DOI 10.1128/EC.05030-11; Shareck J, 2011, EUKARYOT CELL, V10, P565, DOI 10.1128/EC.00305-10; Taff HT, 2012, MED MYCOL, V50, P214, DOI 10.3109/13693786.2011.580016; ten Cate JM, 2009, J DENT RES, V88, P105, DOI 10.1177/0022034508329273; Toenjes KA, 2005, ANTIMICROB AGENTS CH, V49, P963, DOI 10.1128/AAC.49.3.963-972.2005; Toenjes KA, 2009, J MED MICROBIOL, V58, P779, DOI 10.1099/jmm.0.006841-0; Tournu H, 2005, CURR DRUG TARGETS, V6, P909, DOI 10.2174/138945005774912690; Uppuluri P, 2009, MYCOPATHOLOGIA, V168, P101, DOI 10.1007/s11046-009-9205-9; Wenzel RP, 2005, CLIN INFECT DIS, V41, pS389, DOI 10.1086/430923; Whiteway M, 2007, ANNU REV MICROBIOL, V61, P529, DOI 10.1146/annurev.micro.61.080706.093341; Xie ZH, 2011, BMC MICROBIOL, V11, DOI 10.1186/1471-2180-11-93	41	80	84	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 30	2012	7	11							e50866	10.1371/journal.pone.0050866	http://dx.doi.org/10.1371/journal.pone.0050866			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	054WM	23226409	gold, Green Submitted, Green Published			2022-12-27	WOS:000312376100220
J	Vecchietti, D; Di Silvestre, D; Miriani, M; Bonomi, F; Marengo, M; Bragonzi, A; Cova, L; Franceschi, E; Mauri, P; Bertoni, G				Vecchietti, Davide; Di Silvestre, Dario; Miriani, Matteo; Bonomi, Francesco; Marengo, Mauro; Bragonzi, Alessandra; Cova, Lara; Franceschi, Eleonora; Mauri, Pierluigi; Bertoni, Giovanni			Analysis of Pseudomonas aeruginosa Cell Envelope Proteome by Capture of Surface-Exposed Proteins on Activated Magnetic Nanoparticles	PLOS ONE			English	Article							IDENTIFICATION; ANTIGENS; PHASE; RNA	We report on specific magneto-capturing followed by Multidimensional Protein Identification Technology (MudPIT) for the analysis of surface-exposed proteins of intact cells of the bacterial opportunistic pathogen Pseudomonas aeruginosa. The magneto-separation of cell envelope fragments from the soluble cytoplasmic fraction allowed the MudPIT identification of the captured and neighboring proteins. Remarkably, we identified 63 proteins captured directly by nanoparticles and 67 proteins embedded in the cell envelope fragments. For a high number of proteins, our analysis strongly indicates either surface exposure or localization in an envelope district. The localization of most identified proteins was only predicted or totally unknown. This novel approach greatly improves the sensitivity and specificity of the previous methods, such as surface shaving with proteases that was also tested on P. aeruginosa. The magneto-capture procedure is simple, safe, and rapid, and appears to be well-suited for envelope studies in highly pathogenic bacteria.	[Vecchietti, Davide; Cova, Lara; Bertoni, Giovanni] Univ Milan, Dept Life Sci, Milan, Italy; [Di Silvestre, Dario; Franceschi, Eleonora; Mauri, Pierluigi] CNR, ITB, I-20133 Milan, Italy; [Miriani, Matteo; Bonomi, Francesco; Marengo, Mauro] Univ Milan, DISMA, Milan, Italy; [Bragonzi, Alessandra] Ist Sci San Raffaele, Infect & Cyst Fibrosis Unit, Div Immunol Transplantat & Infect Dis, I-20132 Milan, Italy	University of Milan; Consiglio Nazionale delle Ricerche (CNR); Istituto di Tecnologie Biomediche (ITB-CNR); University of Milan; Vita-Salute San Raffaele University; IRCCS Ospedale San Raffaele	Bertoni, G (corresponding author), Univ Milan, Dept Life Sci, Milan, Italy.	giovanni.bertoni@unimi.it	di silvestre, dario/AAB-5037-2022; BERTONI, GIOVANNI/J-3437-2012; Bragonzi, Alessandra/AAC-6751-2022; Mauri, Pietro Luigi/AAC-3095-2019	di silvestre, dario/0000-0002-7143-6229; BERTONI, GIOVANNI/0000-0001-5761-9494; Mauri, Pietro Luigi/0000-0003-4364-0393; Bragonzi, Alessandra/0000-0002-5808-7669; Marengo, Mauro/0000-0002-5389-3979; Vecchietti, Davide/0000-0002-3140-584X; Bonomi, Francesco/0000-0003-4556-2640	Italian Cystic Fibrosis Research Foundation [8/2006]; European Commission [223670]; Fondazione Cariplo [2007.5725]	Italian Cystic Fibrosis Research Foundation(Ministry of Health, ItalyItalian Cystic Fibrosis Research Foundation); European Commission(European CommissionEuropean Commission Joint Research Centre); Fondazione Cariplo(Fondazione Cariplo)	This work was funded by the Italian Cystic Fibrosis Research Foundation (grant FFC#8/2006, with the contribution of "Antonio Guadagnin & Figlio Srl, Montebelluna - TV", "Braccialini - Vivienne Westwood e Testate Italiane di Moda" and "Martinelli Giovanni Pietro - Villa d'Alme - BG"), the European Commission (grant NABATIVI, EU-FP7-HEALTH-2007-B contract number 223670) and Fondazione Cariplo (grant 2007.5725). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Carr S, 2004, MOL CELL PROTEOMICS, V3, P531, DOI 10.1074/mcp.T400006-MCP200; Cordwell SJ, 2006, CURR OPIN MICROBIOL, V9, P320, DOI 10.1016/j.mib.2006.04.008; Ducret A, 1998, PROTEIN SCI, V7, P706, DOI 10.1002/pro.5560070320; Fischer B, 2005, J PHYS-CONDENS MAT, V17, P7875, DOI 10.1088/0953-8984/17/50/008; Grandi G, 2010, F1000 BIOL REP 2, V2; Hawe A, 2008, PHARM RES-DORDR, V25, P1487, DOI 10.1007/s11095-007-9516-9; Imperi F, 2009, PROTEOMICS, V9, P1901, DOI 10.1002/pmic.200800618; Koebnik R, 2000, MOL MICROBIOL, V37, P239, DOI 10.1046/j.1365-2958.2000.01983.x; Krogh A, 2001, J MOL BIOL, V305, P567, DOI 10.1006/jmbi.2000.4315; Lim TP, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028177; Magiorakos AP, 2012, CLIN MICROBIOL INFEC, V18, P268, DOI 10.1111/j.1469-0691.2011.03570.x; Marengo M, 2011, MOL NUTR FOOD RES, V55, P1708, DOI 10.1002/mnfr.201100386; Mauri P, 2008, METHOD ENZYMOL, V447, P99, DOI 10.1016/S0076-6879(08)02206-4; Peng XX, 2005, J PROTEOME RES, V4, P2257, DOI 10.1021/pr050159g; Remans K, 2010, MICROBIOL-SGM, V156, P2597, DOI 10.1099/mic.0.040659-0; Rodriguez-Ortega MJ, 2006, NAT BIOTECHNOL, V24, P191, DOI 10.1038/nbt1179; Senapati S, 2005, SMALL, V1, P517, DOI 10.1002/smll.200400053; Sevo M, 2004, J BACTERIOL, V186, P4903, DOI 10.1128/JB.186.15.4903-4909.2004; Silhavy TJ, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a000414; Sokal RR, 1994, THE PRINCIPLES AND P; Solis N, 2010, PROTEOMICS, V10, P2037, DOI 10.1002/pmic.200900564; Stover CK, 2000, NATURE, V406, P959, DOI 10.1038/35023079; Tjalsma H, 2008, PROTEOMICS, V8, P1415, DOI 10.1002/pmic.200700550; Tjalsma H, 2007, PROTEOM CLIN APPL, V1, P429, DOI 10.1002/prca.200601018; Tjalsma H, 2006, INT J CANCER, V119, P2127, DOI 10.1002/ijc.22116; Wagner Victoria E., 2008, P129; Wang G, 2009, ANAL CHEM, V81, P146, DOI 10.1021/ac801664q; Winsor GL, 2011, NUCLEIC ACIDS RES, V39, pD596, DOI 10.1093/nar/gkq869; Yoshida M, 2001, NAT REV MOL CELL BIO, V2, P669, DOI 10.1038/35089509; Yu NY, 2010, BIOINFORMATICS, V26, P1608, DOI 10.1093/bioinformatics/btq249; Zhang B, 2006, J PROTEOME RES, V5, P2909, DOI 10.1021/pr0600273	31	12	12	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 30	2012	7	11							e51062	10.1371/journal.pone.0051062	http://dx.doi.org/10.1371/journal.pone.0051062			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	054WM	23226459	Green Published, gold, Green Submitted			2022-12-27	WOS:000312376100270
J	Xiao, L; Ornatowska, M; Zhao, GQ; Cao, HM; Yu, R; Deng, J; Li, YC; Zhao, Q; Sadikot, RT; Christman, JW				Xiao, Lei; Ornatowska, Magdalena; Zhao, Guiqing; Cao, Hongmei; Yu, Rui; Deng, Jing; Li, Yongchao; Zhao, Qiong; Sadikot, Ruxana T.; Christman, John W.			Lipopolysaccharide-Induced Expression of Microsomal Prostaglandin E Synthase-1 Mediates Late-Phase PGE(2) Production in Bone Marrow Derived Macrophages	PLOS ONE			English	Article							LUNG INFLAMMATION; E-2 SYNTHASE; RECEPTORS; CYCLOOXYGENASE-1; IDENTIFICATION; PURIFICATION; MODULATION; INHIBITION; ENDOTOXIN; CLONING	Cyclooxygenase (COX)-2 expression and release of prostaglandins (PGs) by macrophages are consistent features of lipopolysaccharide (LPS)-induced macrophage inflammation. The two major PGs, PGE(2) and PGD(2), are synthesized by the prostanoid isomerases, PGE synthases (PGES) and PGD synthases (PGDS), respectively. Since the expression profile and the individual role of these prostanoid isomerases-mediated inflammation in macrophages has not been defined, we examined the LPS-stimulated PGs production pattern and the expression profile of their synthases in the primary cultured mouse bone marrow derived macrophages (BMDM). Our data show that LPS induced both PGE(2) and PGD(2) production, which was evident by similar to 8 hrs and remained at a similar ratio (similar to 1:1) in the early phase (<= 12 hrs) of LPS treatment. However, PGE(2) production continued increase further in the late phase (16-24 hrs); whereas the production of PGD2 remained at a stable level from 12 to 24 hrs post-treatment. In response to LPS-treatment, the expression of both COX-2 and inducible nitric oxide synthase (iNOS) was detected within 2 to 4 hrs; whereas the increased expression of microsomal PGES (mPGES)-1 and a myeloid cell transcription factor PU.1 did not appear until later phase (>= 12 hrs). In contrast, the expression of COX-1, hematopoietic-PGDS (H-PGDS), cytosolic-PGES (c-PGES), or mPGES-2 in BMDM was not affected by LPS treatment. Selective inhibition of mPGES-1 with either siRNA or isoform-selective inhibitor CAY10526, but not mPGES-2, c-PGES or PU.1, attenuated LPS-induced burst of PGE(2) production indicating that mPGES-1 mediates LPS-induced PGE(2) production in BMDM. Interestingly, selective inhibition of mPGES-1 was also associated with a decrease in LPS-induced iNOS expression. In summary, our data show that mPGES-1, but not mPGES-2 or c-PGES isomerase, mediates LPS-induced late-phase burst of PGE(2) generation, and regulates LPS-induced iNOS expression in BMDM.	[Xiao, Lei; Ornatowska, Magdalena; Zhao, Guiqing; Deng, Jing; Christman, John W.] Univ Illinois, Dept Med, Chicago, IL 60607 USA; [Cao, Hongmei; Yu, Rui; Li, Yongchao] Univ Illinois, Dept Med Chem & Pharmacognosy, Chicago, IL USA; [Xiao, Lei; Zhao, Guiqing] Univ Illinois, Cardiovasc Res Ctr, Chicago, IL USA; [Zhao, Qiong] Northwestern Univ, Dept Med, Chicago, IL 60611 USA; [Sadikot, Ruxana T.] Univ Florida, Dept Med, Gainesville, FL USA; [Sadikot, Ruxana T.] Dept Vet Affairs, Gainesville, FL USA; [Xiao, Lei; Christman, John W.] Jesse Brown Vet Affairs Med Ctr, Chicago, IL USA	University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; Northwestern University; State University System of Florida; University of Florida; US Department of Veterans Affairs; Veterans Health Administration (VHA); Jesse Brown VA Medical Center	Xiao, L (corresponding author), Univ Illinois, Dept Med, Chicago, IL 60607 USA.	leixiao@uic.edu	Yu, Rui/J-3366-2013; Yu, Rui/I-5793-2013		National Institutes of Health (NIH) [1R01 HL083218, 3R01 HL083218-01A2S1, 5R01 HL075557]; Jesse Brown VA Medical Center [1I01BX000108]; Campus Research Board [S06-118]; University of Illinois at Chicago; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL083218, R01HL103643, R01HL075557] Funding Source: NIH RePORTER; Veterans Affairs [I01BX001786] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Jesse Brown VA Medical Center; Campus Research Board; University of Illinois at Chicago; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); Veterans Affairs(US Department of Veterans Affairs)	Supported in part by National Institutes of Health (NIH, http://www.nih.gov/) grants 1R01 HL083218 (LX), 3R01 HL083218-01A2S1 (LX), and 5R01 HL075557 (JWC); Merit Review Grant 1I01BX000108 (JWC) from Jesse Brown VA Medical Center (http://www.va.gov/); Campus Research Board Grant S06-118 (LX) and Faculty Scholarship Support Grants (LX) from the University of Illinois at Chicago(http://www.uic.edu/uic/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Badawi AF, 2004, CANCER RES, V64, P1181, DOI 10.1158/0008-5472.CAN-03-2556; BARNETT J, 1994, BBA-PROTEIN STRUCT M, V1209, P130, DOI 10.1016/0167-4838(94)90148-1; Breyer RM, 2001, ANNU REV PHARMACOL, V41, P661, DOI 10.1146/annurev.pharmtox.41.1.661; Burleigh ME, 2002, CIRCULATION, V105, P1816, DOI 10.1161/01.CIR.0000014927.74465.7F; Cao H, 2008, ANAL BIOCHEM, V372, P41, DOI 10.1016/j.ab.2007.08.041; Cao HM, 2011, J PHARMACEUT BIOMED, V54, P230, DOI 10.1016/j.jpba.2010.08.001; Dahl R, 2003, BLOOD CELL MOL DIS, V31, P229, DOI 10.1016/S1079-9796(03)00152-9; Deng J, 2012, J IMMUNOL, V188, P5734, DOI 10.4049/jimmunol.1101323; Funk CD, 2001, SCIENCE, V294, P1871, DOI 10.1126/science.294.5548.1871; FUTAKI N, 1993, GEN PHARMACOL, V24, P105, DOI 10.1016/0306-3623(93)90018-S; Goulet JL, 2004, J IMMUNOL, V173, P1321, DOI 10.4049/jimmunol.173.2.1321; Guerrero MD, 2007, J MED CHEM, V50, P2176, DOI 10.1021/jm0700823; Hata AN, 2004, PHARMACOL THERAPEUT, V103, P147, DOI 10.1016/j.pharmthera.2004.06.003; Herlong JL, 2006, IMMUNOL LETT, V102, P121, DOI 10.1016/j.imlet.2005.10.004; HUME DA, 1987, LYMPHOKINE RES, V6, P127; Jakobsson PJ, 1999, P NATL ACAD SCI USA, V96, P7220, DOI 10.1073/pnas.96.13.7220; JORENS PG, 1995, MEDIAT INFLAMM, V4, P75, DOI 10.1155/S0962935195000135; Kanaoka Y, 1997, CELL, V90, P1085, DOI 10.1016/S0092-8674(00)80374-8; Karpurapu M, 2011, BLOOD, V118, P5255, DOI 10.1182/blood-2011-03-341123; Li XF, 2005, J RHEUMATOL, V32, P887; Mancini JA, 2001, J BIOL CHEM, V276, P4469, DOI 10.1074/jbc.M006865200; Marnett LJ, 1999, J BIOL CHEM, V274, P22903, DOI 10.1074/jbc.274.33.22903; Medeiros AI, 2009, J EXP MED, V206, P61, DOI 10.1084/jem.20082058; Montuschi P, 1998, AM J RESP CRIT CARE, V158, P1524, DOI 10.1164/ajrccm.158.5.9803102; Murakami M, 2003, J BIOL CHEM, V278, P37937, DOI 10.1074/jbc.M305108200; Murakami M, 2000, J BIOL CHEM, V275, P32783, DOI 10.1074/jbc.M003505200; Ornatowska M, 2007, AM J PHYSIOL-LUNG C, V293, pL1377, DOI 10.1152/ajplung.00140.2007; Peebles RS, 2002, AM J RESP CRIT CARE, V165, P1154, DOI 10.1164/rccm.2106025; Raetz CRH, 2006, J LIPID RES, V47, P1097, DOI 10.1194/jlr.M600027-JLR200; Sales KJ, 2002, CANCER RES, V62, P424; Samuelsson B, 2007, PHARMACOL REV, V59, P207, DOI 10.1124/pr.59.3.1; Sastre B, 2008, ALLERGY, V63, P58, DOI 10.1111/j.1398-9995.2007.01515.x; Scher JU, 2009, J INVEST MED, V57, P703, DOI 10.2310/JIM.0b013e31819aaa76; Simmons DL, 2004, PHARMACOL REV, V56, P387, DOI 10.1124/pr.56.3.3; Takayama K, 2006, CIRC RES, V98, P499, DOI 10.1161/01.RES.0000204451.88147.96; Tanikawa N, 2002, BIOCHEM BIOPH RES CO, V291, P884, DOI 10.1006/bbrc.2002.6531; Tanioka T, 2000, J BIOL CHEM, V275, P32775, DOI 10.1074/jbc.M003504200; Thomas S, 2011, AM J RESP CRIT CARE, V183, pA1076; Thoren S, 2003, J BIOL CHEM, V278, P22199, DOI 10.1074/jbc.M303227200; URADE Y, 1985, J BIOL CHEM, V260, P2410; WENZEL SE, 1989, AM REV RESPIR DIS, V139, P450, DOI 10.1164/ajrccm/139.2.450; Xiao L, 2002, AM J PHYSIOL-CELL PH, V282, pC926, DOI 10.1152/ajpcell.00254.2001; Xiao L, 2001, J MOL CELL CARDIOL, V33, P779, DOI 10.1006/jmcc.2001.1348; Xiao L, 2007, BIOCHEMISTRY-US, V46, P7054, DOI 10.1021/bi700467k; Yoshimura Tsuyoshi, 2008, Allergol Int, V57, P429, DOI 10.2332 allergolint.O-08-545; Yu R, 2011, J PHARMACOL EXP THER, V339, P716, DOI 10.1124/jpet.111.185405	46	15	17	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 30	2012	7	11							e50244	10.1371/journal.pone.0050244	http://dx.doi.org/10.1371/journal.pone.0050244			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	054WM	23226252	Green Published, gold, Green Submitted			2022-12-27	WOS:000312376100062
J	Guo, HH; Bao, ZM; Li, JQ; Lian, SS; Wang, S; He, Y; Fu, XT; Zhang, LL; Hu, XL				Guo, Huihui; Bao, Zhenmin; Li, Jiqin; Lian, Shanshan; Wang, Shi; He, Yan; Fu, Xiaoteng; Zhang, Lingling; Hu, Xiaoli			Molecular Characterization of TGF-beta Type I Receptor Gene (Tgfbr1) in Chlamys farreri, and the Association of Allelic Variants with Growth Traits	PLOS ONE			English	Article							CRASSOSTREA-GIGAS; COLORECTAL-CANCER; ARGOPECTEN-IRRADIANS; SIGNAL-TRANSDUCTION; PINCTADA-FUCATA; SKELETAL-MUSCLE; MYOSTATIN GENE; PRESTON 1904; BAY SCALLOP; EXPRESSION	Background: Scallops are an economically important aquaculture species in Asian countries, and growth-rate improvement is one of the main focuses of scallop breeding. Investigating the genetic regulation of scallop growth could benefit scallop breeding, as such research is currently limited. The transforming growth factor beta (TGF-beta) signaling through type I and type II receptors, plays critical roles in regulating cell proliferation and growth, and is thus a plausible candidate growth regulator in scallops. Results: We cloned and characterized the TGF-beta type I receptor (Tgfbr1) gene from Zhikong scallops (Chlamys farreri). The deduced amino acid sequence contains characteristic residues and exhibits the conserved structure of Tgfbr1 proteins. A high expression level of scallop Tgfbr1 was detected during early embryonic stages, whereas Tgfbr1 expression was enriched in the gonad and striated muscle in adults. A single nucleotide polymorphism (SNP, c. 1815C>T) in the 3' UTR was identified. Scallops with genotype TT had higher growth traits values than those with genotype CC or CT in a full-sib family, and significant differences were found between genotypes CC and TT for shell length, shell height, and striated muscle weight. An expression analysis detected significantly more Tgfbr1 transcripts in the striated muscle of scallops with genotype CC compared to those with genotype TT or CT. Further evaluation in a population also revealed higher striated muscle weight in scallops with genotype TT than those with the other two genotypes. The inverse correlation between striated muscle mass and Tgfbr1 expression is consistent with TGF-beta signaling having a negative effect on cell growth. Conclusion: The scallop Tgfbr1 gene was cloned and characterized, and an SNP potentially associated with both scallop growth and Tgfbr1 expression was identified. Our results suggest the negative regulation of Tgfbr1 in scallop growth and provide a candidate marker for Zhikong scallop breeding. Guo H, Bao Z, Li J, Lian S, Wang S, et al. (2012) Molecular Characterization of TGF-beta Type I Receptor Gene (Tgfbr1) in Chlamys farreri, and the Association of Allelic Variants with Growth Traits. PLoS ONE 7(11): e51005. doi:10.1371/journal.pone.0051005	[Guo, Huihui; Bao, Zhenmin; Li, Jiqin; Lian, Shanshan; Wang, Shi; He, Yan; Fu, Xiaoteng; Zhang, Lingling; Hu, Xiaoli] Ocean Univ China, Coll Marine Life Sci, Minist Educ, Key Lab Marine Genet & Breeding, Qingdao, Peoples R China	Ocean University of China	Hu, XL (corresponding author), Ocean Univ China, Coll Marine Life Sci, Minist Educ, Key Lab Marine Genet & Breeding, Qingdao, Peoples R China.	hxl707@ouc.edu.cn	guo, huihui/GYQ-8331-2022; Lian, Shanshan/GXV-4833-2022; zhang, lingling/HDM-2189-2022	lian, shanshan/0000-0002-0088-8826	National Natural Science Foundation of China [30972239, 31130054]; National Basic Research Program of China (973 Program) [2010CB126406, 2010CB126402]; National High-Tech R&D Program (863 Program) [SS2012AA100816, SS2012AA091704, SS2012AA100819]; National Key Technology R&D Program of China [2011BAD13B06, 2011BAD13B05]; Earmarked Fund for Modern Agro-industry Technology Research System; Taishan Scholar Program of Shandong Province; Program for New Century Excellent Talents in University [NCET-10-0716]; Natural Science Foundation of Shandong Province [ZR2009DM019]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Basic Research Program of China (973 Program)(National Basic Research Program of China); National High-Tech R&D Program (863 Program)(National High Technology Research and Development Program of China); National Key Technology R&D Program of China(National Key Technology R&D Program); Earmarked Fund for Modern Agro-industry Technology Research System; Taishan Scholar Program of Shandong Province; Program for New Century Excellent Talents in University(Program for New Century Excellent Talents in University (NCET)); Natural Science Foundation of Shandong Province(Natural Science Foundation of Shandong Province)	This work was supported by the National Natural Science Foundation of China (30972239 and 31130054, http://www.nsfc.gov.cn/Portal0/default152.htm), the National Basic Research Program of China (973 Program, 2010CB126406 and 2010CB126402, http://www.most.gov.cn/), the National High-Tech R&D Program (863 Program, SS2012AA100816, SS2012AA091704 and SS2012AA100819, http://www.most.gov.cn/), the National Key Technology R&D Program of China (2011BAD13B06 and 2011BAD13B05, http://www.most.gov.cn/), the Earmarked Fund for Modern Agro-industry Technology Research System (http://www.moa.gov.cn/), the Taishan Scholar Program of Shandong Province (http://www.shandong.gov.cn/), the Program for New Century Excellent Talents in University (NCET-10-0716, http://www.moe.edu.cn/), and the Natural Science Foundation of Shandong Province (ZR2009DM019, http://www.sdnsf.gov.cn/portal/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aoki TO, 2002, DEVELOPMENT, V129, P275; Castillejo A, 2009, BMC CANCER, V9, DOI 10.1186/1471-2407-9-406; Chen K, 2006, GENE, V384, P62, DOI 10.1016/j.gene.2006.07.009; Chen KF, 2012, ANIM BIOTECHNOL, V23, P43, DOI 10.1080/10495398.2011.630897; Chen X, 2008, CHINA AGR STAT REP 2; Chen YG, 1998, GENE DEV, V12, P2144, DOI 10.1101/gad.12.14.2144; Corporeau C, 2011, MAR BIOTECHNOL, V13, P971, DOI 10.1007/s10126-010-9361-4; Guo L, 2011, ANIM GENET, V42, P339, DOI 10.1111/j.1365-2052.2011.02172.x; Herpin A, 2005, FEBS J, V272, P3424, DOI 10.1111/j.1742-4658.2005.04761.x; Herpin A, 2005, MECH DEVELOP, V122, P695, DOI 10.1016/j.mod.2004.12.004; Herpin A, 2002, GENE, V301, P21, DOI 10.1016/S0378-1119(02)01082-X; Herpin A, 2004, DEV COMP IMMUNOL, V28, P461, DOI 10.1016/j.dci.2003.09.007; Hu XL, 2006, AQUAC RES, V37, P1187, DOI 10.1111/j.1365-2109.2006.01546.x; Hu XL, 2010, GENES GENET SYST, V85, P207, DOI 10.1266/ggs.85.207; Hu ZL, 2005, MAMM GENOME, V16, P792, DOI 10.1007/s00335-005-0060-9; Huse M, 1999, CELL, V96, P425, DOI 10.1016/S0092-8674(00)80555-3; Juengel JL, 2005, HUM REPROD UPDATE, V11, P144, DOI 10.1093/humupd/dmh061; Kaklamani Virginia G, 2004, Expert Rev Anticancer Ther, V4, P649, DOI 10.1586/14737140.4.4.649; Kim HW, 2004, BBA-GENE STRUCT EXPR, V1679, P174, DOI 10.1016/j.bbaexp.2004.06.005; KINGSLEY DM, 1994, GENE DEV, V8, P133, DOI 10.1101/gad.8.2.133; Koishi K, 2000, BBA-GENE STRUCT EXPR, V1492, P311, DOI 10.1016/S0304-419X(00)00012-3; Kollias HD, 2008, J APPL PHYSIOL, V104, P579, DOI 10.1152/japplphysiol.01091.2007; Kopecny M, 2004, ANIM GENET, V35, P253, DOI 10.1111/j.1365-2052.2004.01130.x; LAFYATIS R, 1991, MOL CELL BIOL, V11, P3795, DOI 10.1128/MCB.11.7.3795; Le Quere H, 2009, GENE, V436, P101, DOI 10.1016/j.gene.2009.01.010; Li QL, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002320; Lin J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026906; Liu D, 2001, GENE DEV, V15, P2950, DOI 10.1101/gad.925901; Liu Xiao-Lin, 2002, Oceanologia et Limnologia Sinica, V33, P673; Loeys BL, 2005, NAT GENET, V37, P275, DOI 10.1038/ng1511; Maehr T, 2011, DEV COMP IM IN PRESS; Massague J, 2000, EMBO J, V19, P1745, DOI 10.1093/emboj/19.8.1745; Massague J, 1998, ANNU REV BIOCHEM, V67, P753, DOI 10.1146/annurev.biochem.67.1.753; Massague J, 2000, GENE DEV, V14, P627; Massague J, 2000, CELL, V103, P295, DOI 10.1016/S0092-8674(00)00121-5; Massague J, 1996, CELL, V85, P947, DOI 10.1016/S0092-8674(00)81296-9; Miyashita T, 2008, BIOSCI BIOTECH BIOCH, V72, P37, DOI 10.1271/bbb.70302; Pasche B, 2010, J EXP CLIN CANC RES, V29, DOI 10.1186/1756-9966-29-57; Polley S, 2010, TROP ANIM HEALTH PRO, V42, P985, DOI 10.1007/s11250-009-9518-1; Rodgers BD, 2008, ENDOCR REV, V29, P513, DOI 10.1210/er.2008-0003; Roelen BAJ, 1998, DIFFERENTIATION, V64, P19, DOI 10.1046/j.1432-0436.1998.6410019.x; Roelen BAJ, 1998, MOL REPROD DEV, V49, P1, DOI 10.1002/(SICI)1098-2795(199801)49:1&lt;1::AID-MRD1&gt;3.0.CO;2-U; Sambrook J, 2001, MOL CLONING LAB MANN; Schabort EJ, 2009, EXP CELL RES, V315, P373, DOI 10.1016/j.yexcr.2008.10.037; SHARP PA, 1981, CELL, V23, P643, DOI 10.1016/0092-8674(81)90425-6; Shi YG, 2003, CELL, V113, P685, DOI 10.1016/S0092-8674(03)00432-X; Shimanuki S, 2005, BIOCHEM GENET, V43, P491, DOI 10.1007/s10528-005-8165-0; Shumway S.E., 2006, SCALLOPS BIOL ECOLOG; tenDijke P, 1996, CURR OPIN CELL BIOL, V8, P139; TOMODA T, 1994, BIOCHEM BIOPH RES CO, V198, P1054, DOI 10.1006/bbrc.1994.1150; Valle L, 2008, SCIENCE, V321, P1361, DOI 10.1126/science.1159397; Vellucci VF, 1997, GENOMICS, V46, P278, DOI 10.1006/geno.1997.5023; Wang S, 2008, GENETICA, V133, P37, DOI 10.1007/s10709-007-9180-3; Wang S, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-11-r126; Wang XL, 2010, COMP BIOCHEM PHYS B, V155, P327, DOI 10.1016/j.cbpb.2009.12.001; WRANA JL, 1994, NATURE, V370, P341, DOI 10.1038/370341a0; WRANA JL, 1994, MOL CELL BIOL, V14, P944, DOI 10.1128/MCB.14.2.944; Yang JL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017089; Zhao S, 2005, J COMPUT BIOL, V12, P1047, DOI 10.1089/cmb.2005.12.1047; Zhou YJ, 2008, ACTA BIOCH BIOPH SIN, V40, P244, DOI 10.1111/j.1745-7270.2008.00399.x; Zhou YJ, 2010, COMP BIOCHEM PHYS B, V156, P158, DOI 10.1016/j.cbpb.2010.02.012; Zhou Z, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018596	62	22	25	1	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 29	2012	7	11							e51005	10.1371/journal.pone.0051005	http://dx.doi.org/10.1371/journal.pone.0051005			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	051DI	23209843	gold, Green Published, Green Submitted			2022-12-27	WOS:000312104900094
J	Birn-Jeffery, AV; Miller, CE; Naish, D; Rayfield, EJ; Hone, DWE				Birn-Jeffery, Aleksandra V.; Miller, Charlotte E.; Naish, Darren; Rayfield, Emily J.; Hone, David W. E.			Pedal Claw Curvature in Birds, Lizards and Mesozoic Dinosaurs - Complicated Categories and Compensating for Mass-Specific and Phylogenetic Control	PLOS ONE			English	Article							KILLING BEHAVIOR; HABITAT USE; MORPHOLOGY; EVOLUTION; PREY; ACCIPITRIDAE; ORIGIN; FLIGHT	Pedal claw geometry can be used to predict behaviour in extant tetrapods and has frequently been used as an indicator of lifestyle and ecology in Mesozoic birds and other fossil reptiles, sometimes without acknowledgement of the caveat that data from other aspects of morphology and proportions also need to be considered. Variation in styles of measurement (both inner and outer claw curvature angles) has made it difficult to compare results across studies, as have over-simplified ecological categories. We sought to increase sample size in a new analysis devised to test claw geometry against ecological niche. We found that taxa from different behavioural categories overlapped extensively in claw geometry. Whilst most taxa plotted as predicted, some fossil taxa were recovered in unexpected positions. Inner and outer claw curvatures were statistically correlated, and both correlated with relative claw robusticity (mid-point claw height). We corrected for mass and phylogeny, as both likely influence claw morphology. We conclude that there is no strong mass-specific effect on claw curvature; furthermore, correlations between claw geometry and behaviour are consistent across disparate clades. By using independent contrasts to correct for phylogeny, we found little significant relationship between claw geometry and behaviour. 'Ground-dweller' claws are less curved and relatively dorsoventrally deep relative to those of other behavioural categories; beyond this it is difficult to assign an explicit category to a claw based purely on geometry.	[Hone, David W. E.] Queen Mary Univ London, Sch Biol & Chem Sci, London, England; [Birn-Jeffery, Aleksandra V.] Royal Vet Coll, Struct & Mot Lab, Hatfield, Herts, England; [Birn-Jeffery, Aleksandra V.; Rayfield, Emily J.] Univ Bristol, Sch Earth Sci, Bristol, Avon, England; [Miller, Charlotte E.] Duke Univ, Durham, NC USA; [Naish, Darren] Univ Southampton, Natl Oceanog Ctr, Southampton, Hants, England; [Hone, David W. E.] Univ Coll Dublin, Sch Biol & Environm Sci, Dublin 2, Ireland	University of London; Queen Mary University London; University of London; University of London Royal Veterinary College; University of Bristol; Duke University; NERC National Oceanography Centre; University of Southampton; University College Dublin	Hone, DWE (corresponding author), Queen Mary Univ London, Sch Biol & Chem Sci, London, England.	dwe_hone@yahoo.com	Rayfield, Emily/F-5038-2010; Benton, Michael J/A-5639-2008; Miller, Charlotte/ABH-5780-2020	Rayfield, Emily/0000-0002-2618-750X; Benton, Michael J/0000-0002-4323-1824; Miller, Charlotte E/0000-0002-8428-8392				Abramoff M.D., 2004, BIOPHOT INT, V11, P36, DOI DOI 10.1117/1.3589100; Ackerly DD, 2000, EVOLUTION, V54, P1480, DOI 10.1111/j.0014-3820.2000.tb00694.x; Alibardi L, 2008, ACTA ZOOL-STOCKHOLM, V89, P169, DOI 10.1111/j.1463-6395.2007.00312.x; BADEN HP, 1970, J INVEST DERMATOL, V55, P115, DOI 10.1111/1523-1747.ep12291628; Bearhop S, 2003, FUNCT ECOL, V17, P270, DOI 10.1046/j.1365-2435.2003.00725.x; Bonser RHC, 1996, J AVIAN BIOL, V27, P175, DOI 10.2307/3677149; Bonser RHC, 2000, J MATER SCI LETT, V19, P1039, DOI 10.1023/A:1006786919376; Chatterjee S, 2003, NATURWISSENSCHAFTEN, V90, P27, DOI 10.1007/s00114-002-0385-0; Chiappe Luis M., 1997, Archaeopteryx, V15, P109; Csermely D, 2012, ITAL J ZOOL, V79, P410, DOI 10.1080/11250003.2012.663003; Csermely D, 2006, ITAL J ZOOL, V73, P43, DOI 10.1080/11250000500502368; Dececchi TA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022292; Del Hoyo J., 2006, HDB BIRDS WORLD; del Hoyo J., 2005, HDB BIRDS WORLD, V10; Dial KP, 2008, NATURE, V451, P985, DOI 10.1038/nature06517; Dunning J.B., 2007, CRC HDB AVIAN BODY M, V2nd ed., DOI [10.1201/9781420064452, DOI 10.1201/9781420064452]; Elstrott J, 2004, BIOL J LINN SOC, V83, P389, DOI 10.1111/j.1095-8312.2004.00402.x; Elzanowski Andrzej, 2001, Asociacion Paleontologica Argentina Publicacion Especial, V7, P91; Ericson PGP, 2006, BIOL LETTERS, V2, P543, DOI 10.1098/rsbl.2006.0523; Ethier DM, 2010, CAN J ZOOL, V88, P1043, DOI 10.1139/Z10-073; FEDUCCIA A, 1993, SCIENCE, V259, P790, DOI 10.1126/science.259.5096.790; FELSENSTEIN J, 1985, AM NAT, V125, P1, DOI 10.1086/284325; Fowler DW, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028964; Fowler DW, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007999; Franck A, 2006, BIOSYST ENG, V93, P459, DOI 10.1016/j.biosystemseng.2006.01.007; Fraser R.D.B., 1980, Symposia of the Society for Experimental Biology, P211; GARLAND T, 1992, SYST BIOL, V41, P18, DOI 10.2307/2992503; Glen CL, 2007, CURR BIOL, V17, pR911, DOI 10.1016/j.cub.2007.09.026; Hackett SJ, 2008, SCIENCE, V320, P1763, DOI 10.1126/science.1157704; Hammer Oyvind, 2001, Palaeontologia Electronica, V4, pUnpaginated; Hopson JA, 2001, NEW PERSPECTIVES ON THE ORIGIN AND EARLY EVOLUTION OF BIRDS, P211; Hoyo J., 1997, HDB BIRDS WORLD, V4; Hoyo J, 2007, HDB BIRDS WORLD, V12; Hoyo J., 1996, HDB BIRDS WORLD, V3; Hoyo J., 1999, HDB BIRDS WORLD, V5; Hoyo J, 1992, HDB BIRDS WORLD, V1; Hoyo J.D., 1994, HDB BIRDS WORLD, V2; Hoyo Jd, 2001, HDB BIRDS WORLD, V6; Hoyo Jd, 2008, HDB BIRDS WORLD; Hoyo Jd, 2003, HDB BIRDS WORLD, V8; Hoyo Jd, 2004, HDB BIRDS WORLD, V9; Hoyo Jd, 2002, HDB BIRDS WORLD, V7; LAUDER GV, 1995, FUNCTIONAL MORPHOLOGY IN VERTEBRATE PALEONTOLOGY, P1; Livezey BC, 2007, ZOOL J LINN SOC-LOND, V149, P1, DOI 10.1111/j.1096-3642.2006.00293.x; Manning PL, 2006, BIOL LETTERS, V2, P110, DOI 10.1098/rsbl.2005.0395; Manning PL, 2009, ANAT REC, V292, P1397, DOI 10.1002/ar.20986; Meyers MA, 2008, PROG MATER SCI, V53, P1, DOI 10.1016/j.pmatsci.2007.05.002; Naish D, 2000, ARCHAEOPTERYX, V18; Ostrom J.H., 1985, P161; OSTROM JH, 1974, Q REV BIOL, V49, P27, DOI 10.1086/407902; Peters Dieter Stefan, 1992, Natural History Museum of Los Angeles County Science Series, V36, P29; Pike AVL, 2004, J ZOOL, V262, P73, DOI 10.1017/S0952836903004382; PURVIS A, 1995, COMPUT APPL BIOSCI, V11, P247; Renesto Silvio, 1995, Neues Jahrbuch fuer Geologie und Palaeontologie Abhandlungen, V197, P87; Seki Y, 2010, ACTA BIOMATER, V6, P331, DOI 10.1016/j.actbio.2009.08.026; Spielmann JA, 2005, RIV ITAL PALEONTOL S, V111, P395, DOI 10.13130/2039-4942/6328; Sustaita D, 2008, J MORPHOL, V269, P283, DOI 10.1002/jmor.10577; Sustaita D, 2010, J EXP BIOL, V213, P2617, DOI 10.1242/jeb.041731; Team R. D. C, 2011, R LANG ENV STAT COMP; Tulli MJ, 2009, ZOOLOGY, V112, P379, DOI 10.1016/j.zool.2009.02.001; Turner A. K., 1994, HDB SWALLOWS MARTINS; Van Valkenburgh B, 1987, J VERT PALEONTOL, V7, P162, DOI DOI 10.1080/02724634.1987.10011651; WITMER LM, 1995, FUNCTIONAL MORPHOLOGY IN VERTEBRATE PALEONTOLOGY, P19; Xu X, 2000, NATURE, V408, P705, DOI 10.1038/35047056; Xu X, 2009, CHINESE SCI BULL, V54, P430, DOI 10.1007/s11434-009-0009-6; Yalden D .W., 1985, P91; Zani PA, 2000, J EVOLUTION BIOL, V13, P316, DOI 10.1046/j.1420-9101.2000.00166.x; Zhou ZH, 2005, NATURE, V438, pE4, DOI 10.1038/nature04356; Zhou ZH, 2007, FRONTIERS BIOL CHINA, V2, P1, DOI [DOI 10.1007/S11515-007-0001-Y, 10.1007/s11515-007-0001-y]; [No title captured]	70	43	43	2	43	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 5	2012	7	12							e50555	10.1371/journal.pone.0050555	http://dx.doi.org/10.1371/journal.pone.0050555			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	057TZ	23227184	Green Published, Green Submitted, gold			2022-12-27	WOS:000312588200044
J	Ribeiro, DA; Cota, J; Alvarez, TM; Bruchli, F; Bragato, J; Pereira, BMP; Pauletti, BA; Jackson, G; Pimenta, MTB; Murakami, MT; Camassola, M; Ruller, R; Dillon, AJP; Pradella, JGC; Leme, AFP; Squina, FM				Ribeiro, Daniela A.; Cota, Junio; Alvarez, Thabata M.; Bruechli, Fernanda; Bragato, Juliano; Pereira, Beatriz M. P.; Pauletti, Bianca A.; Jackson, George; Pimenta, Maria T. B.; Murakami, Mario T.; Camassola, Marli; Ruller, Roberto; Dillon, Aldo J. P.; Pradella, Jose G. C.; Paes Leme, Adriana F.; Squina, Fabio M.			The Penicillium echinulatum Secretome on Sugar Cane Bagasse	PLOS ONE			English	Article							TRICHODERMA-REESEI; PHANEROCHAETE-CHRYSOSPORIUM; PROTEOMIC ANALYSIS; LIGNOCELLULOSIC BIOMASS; EXTRACELLULAR PROTEINS; ASPERGILLUS-ORYZAE; CELLULASES; ENZYMES; FERMENTATION; EXPRESSION	Plant feedstocks are at the leading front of the biofuel industry based on the potential to promote economical, social and environmental development worldwide through sustainable scenarios related to energy production. Penicillium echinulatum is a promising strain for the bioethanol industry based on its capacity to produce large amounts of cellulases at low cost. The secretome profile of P. echinulatum after grown on integral sugarcane bagasse, microcrystalline cellulose and three types of pretreated sugarcane bagasse was evaluated using shotgun proteomics. The comprehensive chemical characterization of the biomass used as the source of fungal nutrition, as well as biochemical activity assays using a collection of natural polysaccharides, were also performed. Our study revealed that the enzymatic repertoire of P. echinulatum is geared mainly toward producing enzymes from the cellulose complex (endogluganases, cellobiohydrolases and beta-glucosidases). Glycoside hydrolase (GH) family members, important to biomass-to-biofuels conversion strategies, were identified, including endoglucanases GH5, 7, 6, 12, 17 and 61, beta-glycosidase GH3, xylanases GH10 and GH11, as well as debranching hemicellulases from GH43, GH62 and CE2 and pectinanes from GH28. Collectively, the approach conducted in this study gave new insights on the better comprehension of the composition and degradation capability of an industrial cellulolytic strain, from which a number of applied technologies, such as biofuel production, can be generated.	[Ribeiro, Daniela A.; Cota, Junio; Alvarez, Thabata M.; Bruechli, Fernanda; Bragato, Juliano; Pereira, Beatriz M. P.; Pauletti, Bianca A.; Jackson, George; Pimenta, Maria T. B.; Ruller, Roberto; Pradella, Jose G. C.; Paes Leme, Adriana F.; Squina, Fabio M.] CNPEM, Lab Nacl Ciencia & Tecnol Bioetanol CTBE, Campinas, SP, Brazil; [Murakami, Mario T.] CNPEM, Lab Espectrometria Massas, Lab Nacl Biociencias LNBio, Campinas, SP, Brazil; [Camassola, Marli; Dillon, Aldo J. P.] Univ Caxias do Sul UCS, Inst Biotecnol, Caxias Do Sul, RS, Brazil	Universidade de Caxias do Sul	Squina, FM (corresponding author), CNPEM, Lab Nacl Ciencia & Tecnol Bioetanol CTBE, Campinas, SP, Brazil.	fabio.squina@bioetanol.org.br	Squina, Fabio/J-8130-2012; Dillon, Aldo José Pinheiro/J-4653-2012; Cota, Junio/J-7475-2012; Murakami, Mario T/F-5640-2016; Murakami, Mario T/C-2087-2012; DA CRUZ PRADELLA, JOSE GERALDO/AAA-7022-2019; Leme, Adriana F Paes/C-9679-2012; Büchli, Fernanda/M-8633-2018; Alvarez, Thabata/G-4117-2014; Ruller, ROBERTO/D-1260-2014	Squina, Fabio/0000-0002-8154-7459; Cota, Junio/0000-0002-1547-4087; Murakami, Mario T/0000-0002-0405-8010; DA CRUZ PRADELLA, JOSE GERALDO/0000-0002-2902-0983; Leme, Adriana F Paes/0000-0001-7959-147X; Ruller, ROBERTO/0000-0002-5087-9493; Ruller, Roberto/0000-0001-7501-5176	FAPESP [2008/58037-9, 2010/11499-1]; CNPq [475022/2011-4 e 310177/2011-1]	FAPESP(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	This research was supported by grants from FAPESP (2008/58037-9) and CNPq (475022/2011-4 e 310177/2011-1). TMA received a fellowship from FAPESP (2010/11499-1). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adav SS, 2012, MOL CELL PROTEOMICS, V11, DOI 10.1074/mcp.M111.012419; Adav SS, 2012, J PROTEOMICS, V75, P1493, DOI 10.1016/j.jprot.2011.11.020; Aragao AZB, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043521; Bendtsen JD, 2004, PROTEIN ENG DES SEL, V17, P349, DOI 10.1093/protein/gzh037; Bendtsen JD, 2004, J MOL BIOL, V340, P783, DOI 10.1016/j.jmb.2004.05.028; Berlin A, 2005, APPL BIOCHEM BIOTECH, V121, P163, DOI 10.1385/ABAB:121:1-3:0163; Beukes N, 2010, BIORESOURCE TECHNOL, V101, P4472, DOI 10.1016/j.biortech.2010.01.081; Camassola M, 2007, J APPL MICROBIOL, V103, P2196, DOI 10.1111/j.1365-2672.2007.03458.x; Camassola M, 2004, BIOCATAL BIOTRANSFOR, V22, P391, DOI 10.1080/10242420400024532; Camassola M, 2010, APPL BIOCHEM BIOTECH, V162, P1889, DOI 10.1007/s12010-010-8967-3; Cantarel BL, 2009, NUCLEIC ACIDS RES, V37, pD233, DOI 10.1093/nar/gkn663; Cota J, 2011, BIOCHEM BIOPH RES CO, V406, P590, DOI 10.1016/j.bbrc.2011.02.098; de Oliveira JMPF, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020865; DILLON AJP, 1992, REV BRAS GENET, V15, P491; Dillon AJP, 2006, APPL MICROBIOL BIOT, V70, P740, DOI 10.1007/s00253-005-0122-7; Farrell AE, 2006, SCIENCE, V311, P506, DOI 10.1126/science.1121416; Cairo JPLF, 2011, BIOTECHNOL BIOFUELS, V4, DOI 10.1186/1754-6834-4-50; Gouveia ER, 2009, QUIM NOVA, V32, P1500, DOI 10.1590/S0100-40422009000600026; Grethlein H. E., 1985, NAT BIOTECHNOL, V3, P155, DOI [10.1038/nbt0285-155, DOI 10.1038/NBT0285-155]; Guais O, 2008, J IND MICROBIOL BIOT, V35, P1659, DOI 10.1007/s10295-008-0430-x; Harris PV, 2010, BIOCHEMISTRY-US, V49, P3305, DOI 10.1021/bi100009p; Herpoel-Gimbert I, 2008, BIOTECHNOL BIOFUELS, V1, DOI 10.1186/1754-6834-1-18; Jami MS, 2010, MOL CELL PROTEOMICS, V9, P2729, DOI 10.1074/mcp.M110.001412; Juhasz T, 2005, PROCESS BIOCHEM, V40, P3519, DOI 10.1016/j.procbio.2005.03.057; Jun H, 2011, MICROB CELL FACT, V10, DOI 10.1186/1475-2859-10-68; Karlsson J, 2002, J BIOTECHNOL, V99, P63, DOI 10.1016/S0168-1656(02)00156-6; Kim KH, 2007, J PROTEOME RES, V6, P4749, DOI 10.1021/pr070355i; Krogh KBR, 2004, APPL BIOCHEM BIOTECH, V113, P389; Mahajan S, 2010, APPL MICROBIOL BIOT, V86, P1903, DOI 10.1007/s00253-010-2516-4; MANDELS M, 1957, J BACTERIOL, V73, P269, DOI 10.1128/JB.73.2.269-278.1957; Martins LF, 2008, BIORESOURCE TECHNOL, V99, P1417, DOI 10.1016/j.biortech.2007.01.060; MILLER GL, 1959, ANAL CHEM, V31, P426, DOI 10.1021/ac60147a030; Moi GP, 2012, CARIES RES, V46, P339, DOI 10.1159/000338246; Neilson KA, 2011, PROTEOMICS, V11, P535, DOI 10.1002/pmic.201000553; Oda K, 2006, APPL ENVIRON MICROB, V72, P3448, DOI 10.1128/AEM.72.5.3448-3457.2006; Otero JM, 2010, BIOTECHNOL BIOENG, V105, P439, DOI 10.1002/bit.22592; Quinlan RJ, 2011, P NATL ACAD SCI USA, V108, P15079, DOI 10.1073/pnas.1105776108; Ragauskas AJ, 2006, SCIENCE, V311, P484, DOI 10.1126/science.1114736; Rashid MH, 2008, BIOTECHNOL LETT, V30, P2165, DOI 10.1007/s10529-008-9804-4; Ravalason H, 2008, APPL MICROBIOL BIOT, V80, P719, DOI 10.1007/s00253-008-1596-x; Ravalason H, 2012, BIORESOURCE TECHNOL, V114, P589, DOI 10.1016/j.biortech.2012.03.009; Rubini MR, 2010, J APPL MICROBIOL, V108, P1187, DOI 10.1111/j.1365-2672.2009.04528.x; Sato S, 2007, MICROBIOL-SGM, V153, P3023, DOI 10.1099/mic.0.2006/000513-0; Saykhedkar S, 2012, BIOTECHNOL BIOFUELS, V5, DOI 10.1186/1754-6834-5-52; Schuster A, 2010, APPL MICROBIOL BIOT, V87, P787, DOI 10.1007/s00253-010-2632-1; Seidl V, 2010, BIOFUELS-UK, V1, P343, DOI 10.4155/BFS.10.1; SMITH DC, 1991, BIOTECHNOL BIOENG, V38, P883, DOI 10.1002/bit.260380810; Somerville C, 2010, SCIENCE, V329, P790, DOI 10.1126/science.1189268; Tambor JH, 2012, APPL MICROBIOL BIOT, V93, P203, DOI 10.1007/s00253-011-3419-8; Vaaje-Kolstad G, 2010, SCIENCE, V330, P219, DOI 10.1126/science.1192231; Whitney SEC, 2000, PLANT J, V22, P327, DOI 10.1046/j.1365-313x.2000.00742.x; Wingren A, 2003, BIOTECHNOL PROGR, V19, P1109, DOI 10.1021/bp0340180	52	51	52	1	64	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 5	2012	7	12							e50571	10.1371/journal.pone.0050571	http://dx.doi.org/10.1371/journal.pone.0050571			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	057TZ	23227186	Green Published, gold, Green Submitted			2022-12-27	WOS:000312588200046
J	Seow, WJ; Pesatori, AC; Dimont, E; Farmer, PB; Albetti, B; Ettinger, AS; Bollati, V; Bolognesi, C; Roggieri, P; Panev, TI; Georgieva, T; Merlo, DF; Bertazzi, PA; Baccarelli, AA				Seow, Wei Jie; Pesatori, Angela Cecilia; Dimont, Emmanuel; Farmer, Peter B.; Albetti, Benedetta; Ettinger, Adrienne S.; Bollati, Valentina; Bolognesi, Claudia; Roggieri, Paola; Panev, Teodor I.; Georgieva, Tzveta; Merlo, Domenico Franco; Bertazzi, Pier Alberto; Baccarelli, Andrea A.			Urinary Benzene Biomarkers and DNA Methylation in Bulgarian Petrochemical Workers: Study Findings and Comparison of Linear and Beta Regression Models	PLOS ONE			English	Article							S-PHENYLMERCAPTURIC ACID; ACUTE MYELOID-LEUKEMIA; GENETIC POLYMORPHISMS; LYMPHOCYTIC-LEUKEMIA; HYPOMETHYLATION; EXPOSURE; EXPRESSION; PATTERNS; CANCER; HYPERMETHYLATION	Chronic occupational exposure to benzene is associated with an increased risk of hematological malignancies such as acute myeloid leukemia (AML), but the underlying mechanisms are still unclear. The main objective of this study was to investigate the association between benzene exposure and DNA methylation, both in repeated elements and candidate genes, in a population of 158 Bulgarian petrochemical workers and 50 unexposed office workers. Exposure assessment included personal monitoring of airborne benzene at work and urinary biomarkers of benzene metabolism (S-phenylmercapturic acid [SPMA] and trans, trans-muconic acid [t,t-MA]) at the end of the work-shift. The median levels of airborne benzene, SPMA and t, t-MA in workers were 0.46 ppm, 15.5 mu g/L and 711 mu g/L respectively, and exposure levels were significantly lower in the controls. Repeated-element DNA methylation was measured in Alu and LINE-1, and gene-specific methylation in MAGE and p15. DNA methylation levels were not significantly different between exposed workers and controls (P>0.05). Both ordinary least squares (OLS) and beta-regression models were used to estimate benzene-methylation associations. Beta-regression showed better model specification, as reflected in improved coefficient of determination (pseudo R-2) and Akaike's information criterion (AIC). In beta-regression, we found statistically significant reductions in LINE-1 (-0.15%, P<0.01) and p15 (-0.096%, P<0.01) mean methylation levels with each interquartile range (IQR) increase in SPMA. This study showed statistically significant but weak associations of LINE-1 and p15 hypomethylation with SPMA in Bulgarian petrochemical workers. We showed that beta-regression is more appropriate than OLS regression for fitting methylation data.	[Seow, Wei Jie; Baccarelli, Andrea A.] Harvard Univ, Sch Publ Hlth, Dept Environm Hlth, Boston, MA 02115 USA; [Pesatori, Angela Cecilia; Albetti, Benedetta; Bollati, Valentina; Bertazzi, Pier Alberto] Univ Milan, Dept Clin Sci & Community Hlth, Milan, Italy; [Pesatori, Angela Cecilia; Albetti, Benedetta; Bollati, Valentina; Bertazzi, Pier Alberto] Fdn Ca Granda Maggiore Policlin Hosp, Ist Ricovero & Cura Carattere Sci, Milan, Italy; [Dimont, Emmanuel] Harvard Univ, Sch Publ Hlth, Dept Biostat, Boston, MA 02115 USA; [Farmer, Peter B.] Univ Leicester, Dept Canc Studies & Mol Med, Leicester, Leics, England; [Ettinger, Adrienne S.] Yale Univ, Sch Publ Hlth, Dept Chron Dis Epidemiol, New Haven, CT USA; [Bolognesi, Claudia; Roggieri, Paola] IST Natl Canc Res Inst, Ist Ricovero & Cura Carattere Sci AOU San Martino, Environm Carcinogenesis Unit, Genoa, Italy; [Panev, Teodor I.] Natl Ctr Publ Hlth & Anal, Dept Chem Anal, Sofia, Bulgaria; [Georgieva, Tzveta] Natl Ctr Publ Hlth & Anal, Dept Publ Hlth & Risk Assessment, Sofia, Bulgaria	Harvard University; Harvard T.H. Chan School of Public Health; University of Milan; IRCCS Ca Granda Ospedale Maggiore Policlinico; Harvard University; Harvard T.H. Chan School of Public Health; University of Leicester; Yale University	Seow, WJ (corresponding author), Harvard Univ, Sch Publ Hlth, Dept Environm Hlth, Boston, MA 02115 USA.	wes480@mail.harvard.edu	bertazzi, pietro alberto/D-5039-2017; Georgieva, Tzveta/L-8690-2016; Merlo, Domenico Franco/ABI-1345-2020; Ettinger, Adrienne S./ABF-6655-2020; pesatori, angela/K-5742-2016	bertazzi, pietro alberto/0000-0003-3475-2449; Merlo, Domenico Franco/0000-0002-1832-4754; pesatori, angela/0000-0002-0261-3252; Baccarelli, Andrea/0000-0002-3436-0640; Ettinger, Adrienne S./0000-0002-0200-8677; Bollati, Valentina/0000-0002-0370-9598	National Institute of Environmental Health Sciences [P30ES000002, R21ES020010, R21ES021895, R01ES021733, R01ES020268]; European Commission [BMH4-CT98-3785, IC20-CT98-0201]; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P30ES000002, R01ES021733, R01ES020268, R21ES021895, R21ES020010] Funding Source: NIH RePORTER	National Institute of Environmental Health Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); European Commission(European CommissionEuropean Commission Joint Research Centre); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	The present study was supported by National Institute of Environmental Health Sciences grant numbers P30ES000002, R21ES020010, R21ES021895, R01ES021733, and R01ES020268, as well as European Commission contracts BMH4-CT98-3785 and IC20-CT98-0201 (D.F. Merlo). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aston JP, 2002, BIOMARKERS, V7, P103, DOI 10.1080/13547500110099663; Bollati V, 2010, HEREDITY, V105, P105, DOI 10.1038/hdy.2010.2; Bollati V, 2007, CANCER RES, V67, P876, DOI 10.1158/0008-5472.CAN-06-2995; Boogaard PJ, 1996, ENVIRON HEALTH PERSP, V104, P1151, DOI 10.2307/3433156; Brooks C, 2008, INTRO ECONOMETRICS F, Vxxiv; Buratti M, 1996, J CHROMATOGR B, V677, P257, DOI 10.1016/0378-4347(95)00466-1; Carrieri M, 2010, TOXICOL LETT, V192, P17, DOI 10.1016/j.toxlet.2009.07.015; Chen H, 2004, CARCINOGENESIS, V25, P1779, DOI 10.1093/carcin/bgh161; Farmer PB, 2005, CHEM-BIOL INTERACT, V153, P97, DOI 10.1016/j.cbi.2005.03.013; FEINBERG AP, 1983, NATURE, V301, P89, DOI 10.1038/301089a0; Ferrari SLP, 2004, J APPL STAT, V31, P799, DOI 10.1080/0266476042000214501; Fustinoni S, 2005, CHEM-BIOL INTERACT, V153, P253, DOI 10.1016/j.cbi.2005.03.031; Fustinoni S, 2005, CANCER EPIDEM BIOMAR, V14, P2237, DOI 10.1158/1055-9965.EPI-04-0798; Greiner J, 2000, EXP HEMATOL, V28, P1413, DOI 10.1016/S0301-472X(00)00550-6; Guo SX, 2000, LEUKEMIA RES, V24, P39, DOI 10.1016/S0145-2126(99)00158-7; Herman JG, 1997, CANCER RES, V57, P837; Hon GC, 2012, GENOME RES, V22, P246, DOI 10.1101/gr.125872.111; Ji Z, 2010, LEUKEMIA, V24, P986, DOI 10.1038/leu.2010.43; Johnson N., 1994, CONTINUOUS UNIVARIAT, V2; Khalade A, 2010, ENVIRON HEALTH-GLOB, V9, DOI 10.1186/1476-069X-9-31; Kieschnick R, 2003, STAT MODEL, V3, P193, DOI 10.1191/1471082X03st053oa; Kim S, 2006, CARCINOGENESIS, V27, P772, DOI 10.1093/carcin/bgi297; Kuang SQ, 2008, LEUKEMIA, V22, P1529, DOI 10.1038/leu.2008.130; Lan Q, 2004, SCIENCE, V306, P1774, DOI 10.1126/science.1102443; Lim SO, 2008, GASTROENTEROLOGY, V135, P2128, DOI 10.1053/j.gastro.2008.07.027; Lin CH, 2001, CANCER RES, V61, P4238; Lovreglio P, 2010, INT ARCH OCC ENV HEA, V83, P341, DOI 10.1007/s00420-009-0469-7; Melki JR, 1999, CANCER RES, V59, P3730; PAOLINO P, 2001, POLIT ANAL, V0009; Pesatori AC, 2009, MED LAV, V100, P83; Pufulete M, 2005, GUT, V54, P648, DOI 10.1136/gut.2004.054718; Qu QS, 2000, AM J IND MED, V37, P522, DOI 10.1002/(SICI)1097-0274(200005)37:5<522::AID-AJIM8>3.0.CO;2-G; Rogers H.J., 2005, ENCY STAT BEHAV SCI, P485; Rusiecki JA, 2008, ENVIRON HEALTH PERSP, V116, P1547, DOI 10.1289/ehp.11338; Schnatter AR, 2005, CHEM-BIOL INTERACT, V153, P9, DOI 10.1016/j.cbi.2005.03.039; Smith MT, 2010, ANNU REV PUBL HEALTH, V31, P133, DOI 10.1146/annurev.publhealth.012809.103646; Sorensen M, 2003, SCI TOTAL ENVIRON, V309, P69, DOI 10.1016/S0048-9697(03)00054-8; Spanos A, 1999, PROBABILITY THEORY S, Vxxvii; Steinmaus C, 2008, OCCUP ENVIRON MED, V65, P371, DOI 10.1136/oem.2007.036913; Suter CM, 2004, INT J COLORECTAL DIS, V19, P95, DOI 10.1007/s00384-003-0539-3; Takiguchi M, 2003, EXP CELL RES, V286, P355, DOI 10.1016/S0014-4827(03)00062-4; TRAVERSARI C, 1992, J EXP MED, V176, P1453, DOI 10.1084/jem.176.5.1453; van Baren N, 1999, BLOOD, V94, P1156; WAHLFORS J, 1992, BLOOD, V80, P2074; Wang XF, 2012, BIOMETRICAL J, V54, P264, DOI 10.1002/bimj.201100041; WHO International Agency for Research on Cancer, 1987, IARC MON EV CARC S7, V7, P120; Yin SN, 1996, AM J IND MED, V29, P227, DOI 10.1002/(SICI)1097-0274(199603)29:3&lt;227::AID-AJIM2&gt;3.0.CO;2-N; Zhao CQ, 1997, P NATL ACAD SCI USA, V94, P10907, DOI 10.1073/pnas.94.20.10907; Zhu ZZ, 2012, INT J EPIDEMIOL, V41, P126, DOI 10.1093/ije/dyq154	49	43	45	0	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 5	2012	7	12							e50471	10.1371/journal.pone.0050471	http://dx.doi.org/10.1371/journal.pone.0050471			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	057TZ	23227177	Green Published, gold			2022-12-27	WOS:000312588200037
J	Torrens, C; Ethirajan, P; Bruce, KD; Cagampang, FRA; Siow, RCM; Hanson, MA; Byrne, CD; Mann, GE; Clough, GF				Torrens, Christopher; Ethirajan, Priya; Bruce, Kimberley D.; Cagampang, Felino R. A.; Siow, Richard C. M.; Hanson, Mark A.; Byrne, Christopher D.; Mann, Giovanni E.; Clough, Geraldine F.			Interaction between Maternal and Offspring Diet to Impair Vascular Function and Oxidative Balance in High Fat Fed Male Mice	PLOS ONE			English	Article							NITRIC-OXIDE BIOAVAILABILITY; ENDOTHELIAL DYSFUNCTION; INSULIN-RESISTANCE; ANIMAL-MODELS; OBESITY; HYPERTENSION; RESPONSES; STRESS; EDHF; PREGNANCY	Aims: To determine the impact of maternal and post-weaning consumption of a high fat diet on endothelium-dependent vasorelaxation and redox regulation in adult male mouse offspring. Methods: Female C57BL6J mice were fed an obesogenic high fat diet (HF, 45% kcal fat) or standard chow (C, 21% kcal fat) pre-conception and throughout pregnancy and lactation. Post-weaning, male offspring were continued on the same diet as their mothers or placed on the alternative diet to give 4 dietary groups (C/C, HF/C, C/HF and HF/HF) which were studied at 15 or 30 weeks of age. Results: There were significant effects of maternal diet on offspring body weight (p<0.004), systolic blood pressure (p = 0.026) and endothelium-dependent relaxation to ACh (p = 0.004) and NO production (p = 0.005) measured in the femoral artery. With control for maternal diet there was also an effect of offspring post-weaning dietary fat to increase systolic blood pressure (p<0.0001) and reduce endothelium-dependent relaxation (p = 0.022) and ACh-mediated NO production (p = 0.007). There was also a significant impact of age (p, 0.005). Redox balance was perturbed, with altered regulation of vascular enzymes involved in ROS/NO signalling. Conclusions: Maternal consumption of a HF diet is associated with changes in vascular function and oxidative balance in the offspring of similar magnitude to those seen with consumption of a high fat diet post-weaning. Further, this disadvantageous vascular phenotype is exacerbated by age to influence the risk of developing obesity, raised blood pressure and endothelial dysfunction in adult life.	[Torrens, Christopher; Ethirajan, Priya; Bruce, Kimberley D.; Cagampang, Felino R. A.; Hanson, Mark A.; Clough, Geraldine F.] Univ Southampton, Fac Med, Southampton SO9 5NH, Hants, England; [Byrne, Christopher D.] Univ Southampton, Southampton, Hants, England; [Byrne, Christopher D.] Southampton Gen Hosp, Southampton Natl Inst Hlth Res, Biomed Res Ctr, Southampton SO9 4XY, Hants, England; [Siow, Richard C. M.; Mann, Giovanni E.] Kings Coll London, BHF Ctr Res Excellence, Sch Med, Div Cardiovasc, London, England	University of Southampton; University of Southampton; University of Southampton; University of London; King's College London	Clough, GF (corresponding author), Univ Southampton, Fac Med, Southampton SO9 5NH, Hants, England.	g.f.clough@southampton.ac.uk	Hanson, Mark/AAE-8236-2019; Cagampang, Felino/AAG-5141-2019; Torrens, Christopher/A-8117-2013	Hanson, Mark/0000-0002-6907-613X; Cagampang, Felino/0000-0003-4404-9853; Torrens, Christopher/0000-0003-4377-0112; Byrne, Christopher D/0000-0001-6322-7753; Mann, Giovanni/0000-0001-7311-2044	Biotechnology and Biological Sciences Research Council [BB/D006133/1]; British Heart Foundation [PG/07/006/22212]; Heart Research United Kingdom [TRP27/09]; RCMS; European Union Cooperation in Science and Technology ACTION [B35]; British Heart Foundation [PG/12/18/29453] Funding Source: researchfish	Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); British Heart Foundation(British Heart Foundation); Heart Research United Kingdom; RCMS; European Union Cooperation in Science and Technology ACTION; British Heart Foundation(British Heart Foundation)	This work was supported by Biotechnology and Biological Sciences Research Council (BB/D006133/1); British Heart Foundation (PG/07/006/22212); Heart Research United Kingdom (TRP27/09) to GEM, RCMS; and European Union Cooperation in Science and Technology ACTION B35 to GEM. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Afzal-Ahmed I, 2007, FREE RADICAL BIO MED, V42, P1781, DOI 10.1016/j.freeradbiomed.2007.02.032; Ainge H, 2011, INT J OBESITY, V35, P325, DOI 10.1038/ijo.2010.149; Amanso Angelica M, 2012, Front Biosci (Schol Ed), V4, P1044; Ashraf MZ, 2007, INDIAN J EXP BIOL, V45, P505; Bouanane S, 2009, CLIN SCI, V116, P669, DOI 10.1042/CS20080413; Brandes RP, 2010, FREE RADICAL BIO MED, V49, P687, DOI 10.1016/j.freeradbiomed.2010.04.030; Brandes RP, 2010, HYPERTENSION, V56, P17, DOI 10.1161/HYPERTENSIONAHA.108.120295; Bruce KD, 2009, HEPATOLOGY, V50, P1796, DOI 10.1002/hep.23205; Catalano PM, 2010, REPRODUCTION, V140, P365, DOI 10.1530/REP-10-0088; Chadha PS, 2010, J PHARMACOL EXP THER, V335, P284, DOI 10.1124/jpet.110.167593; Cheng XH, 2011, ANTIOXID REDOX SIGN, V14, P469, DOI 10.1089/ars.2010.3283; Collins AR, 2009, CIRC RES, V104, pe42, DOI 10.1161/CIRCRESAHA.108.188771; De Boer MP, 2012, MICROCIRCULATION, V19, P5, DOI 10.1111/j.1549-8719.2011.00130.x; Donato AJ, 2007, J PHYSIOL-LONDON, V579, P115, DOI 10.1113/jphysiol.2006.120055; Elahi MM, 2009, BRIT J NUTR, V102, P514, DOI 10.1017/S000711450820749X; Feher A, 2010, CARDIOVASC RES, V87, P732, DOI 10.1093/cvr/cvq088; Franco MD, 2002, J CARDIOVASC PHARM, V40, P501, DOI 10.1097/00005344-200210000-00002; Franco MDP, 2004, J PHYSIOL-LONDON, V558, P239, DOI 10.1113/jphysiol.2004.064055; Frisbee JC, 2005, AM J PHYSIOL-REG I, V289, pR307, DOI 10.1152/ajpregu.00114.2005; Georgiou CD, 2008, NAT PROTOC, V3, P1679, DOI 10.1038/nprot.2008.155; Granger DN, 2010, MICROCIRCULATION, V17, P192, DOI 10.1111/j.1549-8719.2009.00015.x; Haddock RE, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016423; He M, 2011, NUTR METAB CARDIOVAS, V21, P277, DOI 10.1016/j.numecd.2009.12.008; Howie GJ, 2009, J PHYSIOL-LONDON, V587, P905, DOI 10.1113/jphysiol.2008.163477; Igosheva N, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010074; Judkins CP, 2010, AM J PHYSIOL-HEART C, V298, pH24, DOI 10.1152/ajpheart.00799.2009; Jung O, 2004, CIRCULATION, V109, P1795, DOI 10.1161/01.CIR.0000124223.00113.A4; Khan I, 2004, CIRCULATION, V110, P1097, DOI 10.1161/01.CIR.0000139843.05436.A0; Kim YM, 2011, ANTIOXID REDOX SIGN, V14, P137, DOI 10.1089/ars.2010.3153; Leo CH, 2011, BRIT J PHARMACOL, V162, P365, DOI 10.1111/j.1476-5381.2010.01023.x; Li M, 2011, EXP DIABETES RES, DOI [10.1155/2011/592408, 10.4061/2011/179819]; Liang C, 2009, BIRTH DEFECTS RES B, V86, P377, DOI 10.1002/bdrb.20206; Mamun AA, 2009, CIRCULATION, V119, P1720, DOI 10.1161/CIRCULATIONAHA.108.813436; Marchesi C, 2009, HYPERTENSION, V54, P1384, DOI 10.1161/HYPERTENSIONAHA.109.138305; McCurdy CE, 2009, J CLIN INVEST, V119, P323, DOI 10.1172/JCI32661; Miller AA, 2010, STROKE, V41, P784, DOI 10.1161/STROKEAHA.109.575365; Morton JS, 2010, AM J PHYSIOL-REG I, V298, pR930, DOI 10.1152/ajpregu.00641.2009; Muller-Delp JM, 2012, MICROCIRCULATION, V19, P19, DOI 10.1111/j.1549-8719.2011.00139.x; Oben JA, 2010, J HEPATOL, V52, P913, DOI 10.1016/j.jhep.2009.12.042; Oken E, 2009, OBSTET GYN CLIN N AM, V36, P361, DOI 10.1016/j.ogc.2009.03.007; Ozkor MA, 2011, CARDIOL RES PRACT, V2011, DOI 10.4061/2011/156146; Pacher P, 2007, PHYSIOL REV, V87, P315, DOI 10.1152/physrev.00029.2006; Poston L, 2011, MICROCIRCULATION, V18, P256, DOI 10.1111/j.1549-8719.2011.00086.x; Poston L, 2011, PEDIATR RES, V69, P175, DOI 10.1203/PDR.0b013e3182055ede; Reilly JJ, 2011, INT J OBESITY, V35, P891, DOI 10.1038/ijo.2010.222; Rodford JL, 2008, J PHYSIOL-LONDON, V586, P4709, DOI 10.1113/jphysiol.2008.156976; Rowlands DJ, 2011, HYPERTENSION, V57, P833, DOI 10.1161/HYPERTENSIONAHA.110.162198; Saker M, 2008, EUR J OBSTET GYN R B, V141, P95, DOI 10.1016/j.ejogrb.2008.07.013; Samuelsson AM, 2008, HYPERTENSION, V51, P383, DOI 10.1161/HYPERTENSIONAHA.107.101477; Shankar K, 2010, ENDOCRINOLOGY, V151, P2577, DOI 10.1210/en.2010-0017; Stamatakis E, 2010, J EPIDEMIOL COMMUN H, V64, P167, DOI 10.1136/jech.2009.098723; Strakovsky RS, 2012, ANTIOXID REDOX SIGN, V17, P237, DOI 10.1089/ars.2011.4372; Taylor PD, 2004, J PHYSIOL-LONDON, V558, P943, DOI 10.1113/jphysiol.2002.018879; Torrens C, 2009, BRIT J NUTR, V101, P27, DOI 10.1017/S0007114508988760; Trott DW, 2011, J APPL PHYSIOL, V110, P1171, DOI 10.1152/japplphysiol.01037.2010; Watkins AJ, 2008, J PHYSIOL-LONDON, V586, P2231, DOI 10.1113/jphysiol.2007.149229; Wolfle SE, 2009, CARDIOVASC RES, V82, P476, DOI 10.1093/cvr/cvp060; Zhang LN, 2011, EUR J PHARMACOL, V654, P68, DOI 10.1016/j.ejphar.2010.12.016; Zhang XY, 2011, J NUTR, V141, P1254, DOI 10.3945/jn.111.139576; Zhu JX, 2007, J VASC RES, V44, P382, DOI 10.1159/000102955	60	45	46	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 5	2012	7	12							e50671	10.1371/journal.pone.0050671	http://dx.doi.org/10.1371/journal.pone.0050671			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	201YT	23227196	Green Published, gold, Green Accepted, Green Submitted			2022-12-27	WOS:000323179700003
J	Ahrens, CW; Auer, CA				Ahrens, Collin W.; Auer, Carol A.			Annual Glyphosate Treatments Alter Growth of Unaffected Bentgrass (Agrostis) Weeds and Plant Community Composition	PLOS ONE			English	Article							RESISTANT CREEPING BENTGRASS; ECOLOGICAL RISK-ASSESSMENT; GENE FLOW; HERBICIDE; ESTABLISHMENT; STOLONIFERA; DIVERSITY; TRANSGENES; GRASSES; DENSITY	Herbicide resistance is becoming more common in weed ecotypes and crop species including turfgrasses, but current gaps in knowledge limit predictive ecological risk assessments and risk management plans. This project examined the effect of annual glyphosate applications on the vegetative growth and reproductive potential of two weedy bentgrasses, creeping bentgrass (CB) and redtop (RT), where the glyphosate resistance (GR) trait was mimicked by covering the bentgrass plants during glyphosate application. Five field plots were studied in habitats commonly inhabited by weedy bentgrasses including an agricultural hayfield, natural meadow, and wasteland. Results showed that annual glyphosate treatment improved bentgrass survivorship, vegetative growth, and reproductive potential compared with bentgrass in unsprayed subplots. In the second year of growth, RT plants had an 86-fold increase in flower number in glyphosate-treated subplots versus controls, while CB plants had a 20-fold increase. At the end of the three year study, plant community composition had changed in glyphosate-treated subplots in hayfield and meadow plots compared to controls. Soils in subplots receiving glyphosate had higher nitrate concentrations than controls. This is the first study to mimic the GR trait in bentgrass plants with the goal of quantifying bentgrass response to glyphosate selection pressure and understanding the impacts on surrounding plant communities. Citation: Ahrens CW, Auer CA (2012) Annual Glyphosate Treatments Alter Growth of Unaffected Bentgrass (Agrostis) Weeds and Plant Community Composition. PLoS ONE 7(12): e50643. doi:10.1371/journal.pone.0050643	[Ahrens, Collin W.; Auer, Carol A.] Univ Connecticut, Dept Plant Sci, Agr Biotechnol Lab, Storrs, CT 06269 USA	University of Connecticut	Auer, CA (corresponding author), Univ Connecticut, Dept Plant Sci, Agr Biotechnol Lab, Storrs, CT 06269 USA.	carol.auer@uconn.edu		Ahrens, Collin/0000-0002-0614-9928	USDA National Institute of Food and Agriculture [2008-39211-19566]; Storrs Agricultural Experiment Station; University of Connecticut	USDA National Institute of Food and Agriculture(United States Department of Agriculture (USDA)); Storrs Agricultural Experiment Station; University of Connecticut	This project was supported by the Biotechnology Risk Assessment Program Competitive Grant no. 2008-39211-19566 from the USDA National Institute of Food and Agriculture (http://www.csrees.usda.gov/fo/biotechnologyriskassessment.cfm) to CAA. Funds were also provided by the Storrs Agricultural Experiment Station and the University of Connecticut. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahrens C, 2011, WEED SCI, V59, P145, DOI 10.1614/WS-D-10-00094.1; Ahrens C, 2011, PLANT ECOL, V212, P1629, DOI 10.1007/s11258-011-9936-9; Baerson SR, 2002, PLANT PHYSIOL, V129, P1265, DOI 10.1104/pp.001560; Baucom RS, 2008, EVOLUTION, V62, P2842, DOI 10.1111/j.1558-5646.2008.00514.x; Beard JB., 2002, TURF MANAGEMENT GOLF, V2nd, P137; BEHRENDT S, 1979, GRASS WEEDS WORLD AG, P73; Belanger FC, 2003, CROP SCI, V43, P240, DOI 10.2135/cropsci2003.0240; Benson EJ, 2006, PLANT ECOL, V187, P163, DOI 10.1007/s11258-005-0975-y; Bliss CI, 1934, SCIENCE, V79, P38, DOI 10.1126/science.79.2037.38; Boyd Robert S., 1995, New Forests, V10, P17; Bushoven JT, 2000, J ENVIRON QUAL, V29, P1657, DOI 10.2134/jeq2000.00472425002900050037x; Cerdeira AL, 2006, J ENVIRON QUAL, V35, P1633, DOI 10.2134/jeq2005.0378; Chang FC, 2011, ENVIRON TOXICOL CHEM, V30, P548, DOI 10.1002/etc.431; Charles D, 2011, SCIENCE, V332, P168, DOI 10.1126/science.332.6026.168; Coupe RH, 2012, PEST MANAG SCI, V68, P16, DOI 10.1002/ps.2212; Duke SO, 2008, PEST MANAG SCI, V64, P319, DOI 10.1002/ps.1518; Fei S, 2004, IN VITRO CELL DEV-PL, V40, P266, DOI 10.1079/IVP2003522; Flanders AA, 2006, AUK, V123, P171, DOI 10.1642/0004-8038(2006)123[0171:EOIEGO]2.0.CO;2; FREEDMAN B, 1993, CAN J FOREST RES, V23, P2300, DOI 10.1139/x93-284; Gaines TA, 2011, J AGR FOOD CHEM, V59, P5886, DOI 10.1021/jf104719k; Gardner DS, 2006, HORTTECHNOLOGY, V16, P590, DOI 10.21273/HORTTECH.16.4.0590; Ge X, 2010, PEST MANAG SCI, V66, P345, DOI 10.1002/ps.1911; GUREVITCH J, 2006, ECOLOGY PLANTS; Hart SE, 2009, CROP SCI, V49, P2275, DOI 10.2135/cropsci2008.07.0431; Heap I., 2021, INT SURVEY HERBICIDE, DOI DOI 10.1002/ps.3790; Heard MS, 2003, PHILOS T ROY SOC B, V358, P1819, DOI 10.1098/rstb.2003.1402; KIK C, 1990, J ECOL, V78, P962, DOI 10.2307/2260946; Krueger-Mangold J, 2002, WEED TECHNOL, V16, P457, DOI 10.1614/0890-037X(2002)016[0457:MPCDIA]2.0.CO;2; KUYKENDALL KL, 1992, AM J PHYS ANTHROPOL, V89, P379, DOI 10.1002/ajpa.1330890310; Ledford H, 2011, NATURE, V475, P274, DOI 10.1038/475274a; LIKENS GE, 1970, ECOL MONOGR, V40, P23, DOI 10.2307/1942440; Londo JP, 2010, ANN BOT-LONDON, V106, P957, DOI 10.1093/aob/mcq190; Lortie CJ, 2004, OIKOS, V107, P433, DOI 10.1111/j.0030-1299.2004.13250.x; MACBRYDE B, 2006, WHITE PAPER PERSPECT; Magee DW, 2007, FLORA NE MANUAL VASC; Marvier M, 2005, FRONT ECOL ENVIRON, V3, P99, DOI 10.2307/3868516; Oksanen J, 2009, ORDINATION ANAL DISS; Powles SB, 2008, PEST MANAG SCI, V64, P360, DOI 10.1002/ps.1525; Puricelli E, 2005, CROP PROT, V24, P533, DOI 10.1016/j.cropro.2004.10.005; READER RJ, 1991, CAN J BOT, V69, P773, DOI 10.1139/b91-100; Rice PM, 1997, J APPL ECOL, V34, P1397, DOI 10.2307/2405257; Schimel JP, 2004, ECOLOGY, V85, P591, DOI 10.1890/03-8002; Service RF, 2007, SCIENCE, V316, P1114, DOI 10.1126/science.316.5828.1114; Shaner DL, 2012, PEST MANAG SCI, V68, P3, DOI 10.1002/ps.2261; Sullivan Thomas P., 2003, Environmental Reviews, V11, P37, DOI 10.1139/a03-005; Tozer KN, 2008, J APPL ECOL, V45, P1152, DOI 10.1111/j.1365-2664.2008.01500.x; VITOUSEK PM, 1985, ECOLOGY, V66, P1360, DOI 10.2307/1939189; VITOUSEK PM, 1992, FOREST ECOL MANAG, V49, P277, DOI 10.1016/0378-1127(92)90141-U; Warwick SI, 2008, MOL ECOL, V17, P1387, DOI 10.1111/j.1365-294X.2007.03567.x; Warwick SI, 2009, ANN NY ACAD SCI, V1168, P72, DOI 10.1111/j.1749-6632.2009.04576.x; Watrud LS, 2011, ECOL APPL, V21, P525, DOI 10.1890/09-2366.1; Watrud LS, 2004, P NATL ACAD SCI USA, V101, P14533, DOI 10.1073/pnas.0405154101; WEDIN DA, 1990, OECOLOGIA, V84, P433, DOI 10.1007/BF00328157; Wipff J. K., 2000, Diversity, V16, P36; Zapiola ML, 2008, J APPL ECOL, V45, P486, DOI 10.1111/j.1365-2664.2007.01430.x	55	1	2	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 4	2012	7	12							e50643	10.1371/journal.pone.0050643	http://dx.doi.org/10.1371/journal.pone.0050643			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	051EQ	23226530	Green Published, gold			2022-12-27	WOS:000312108500023
J	Vila, L; Roglans, N; Baena, M; Barroso, E; Alegret, M; Merlos, M; Laguna, JC				Vila, Laia; Roglans, Nuria; Baena, Miguel; Barroso, Emma; Alegret, Marta; Merlos, Manuel; Laguna, Juan C.			Metabolic Alterations and Increased Liver mTOR Expression Precede the Development of Autoimmune Disease in a Murine Model of Lupus Erythematosus	PLOS ONE			English	Article							LEPTIN; ATHEROSCLEROSIS; MECHANISMS; STRATEGIES; FRUCTOSE; PATHWAY; OBESITY; IMMUNE	Although metabolic syndrome (MS) and systemic lupus erythematosus (SLE) are often associated, a common link has not been identified. Using the BWF1 mouse, which develops MS and SLE, we sought a molecular connection to explain the prevalence of these two diseases in the same individuals. We determined SLE-markers (plasma anti-ds-DNA antibodies, splenic regulatory T cells (Tregs) and cytokines, proteinuria and renal histology) and MS-markers (plasma glucose, non-esterified fatty acids, triglycerides, insulin and leptin, liver triglycerides, visceral adipose tissue, liver and adipose tissue expression of 86 insulin signaling-related genes) in 8-, 16-, 24-, and 36-week old BWF1 and control New-Zealand-White female mice. Up to week 16, BWF1 mice showed MS-markers (hyperleptinemia, hyperinsulinemia, fatty liver and visceral adipose tissue) that disappeared at week 36, when plasma anti-dsDNA antibodies, lupus nephritis and a pro-autoimmune cytokine profile were detected. BWF1 mice had hyperleptinemia and high splenic Tregs till week 16, thereby pointing to leptin resistance, as confirmed by the lack of increased liver P-Tyr-STAT-3. Hyperinsulinemia was associated with a down-regulation of insulin related-genes only in adipose tissue, whereas expression of liver mammalian target of rapamicyn (mTOR) was increased. Although leptin resistance presented early in BWF1 mice can slow-down the progression of autoimmunity, our results suggest that sustained insulin stimulation of organs, such as liver and probably kidneys, facilitates the over-expression and activity of mTOR and the development of SLE.	[Roglans, Nuria; Alegret, Marta; Merlos, Manuel; Laguna, Juan C.] Univ Barcelona, Inst Biomed, Barcelona, Spain; [Roglans, Nuria; Alegret, Marta; Merlos, Manuel; Laguna, Juan C.] CIBER Ctr Invest Biomed Red Physiopathol Obes & N, Barcelona, Spain; [Vila, Laia; Baena, Miguel; Barroso, Emma] Univ Barcelona, Sch Pharm, Dept Pharmacol & Therapeut Chem, Barcelona, Spain	University of Barcelona; CIBER - Centro de Investigacion Biomedica en Red; CIBEROBN; University of Barcelona	Laguna, JC (corresponding author), Univ Barcelona, Inst Biomed, Barcelona, Spain.	jclagunae@ub.edu	Baena, Miguel/L-2263-2017; Laguna, JCLaguna - Juan C./C-5481-2017; Merlos, Manuel/AAC-3064-2021; Alegret, Marta/C-5086-2017; Roglans, Núria/ABH-1242-2020; Fernandez, Emma Barroso/G-9305-2018; Vilà, Laia/ABG-8595-2020	Laguna, JCLaguna - Juan C./0000-0002-7082-0704; Merlos, Manuel/0000-0002-8423-3033; Alegret, Marta/0000-0002-5652-8651; Fernandez, Emma Barroso/0000-0003-4551-4825; Roglans, Nuria/0000-0002-5018-021X; Baena, Miguel/0000-0003-2078-5258; Vila, Laia/0000-0001-7232-2250	Fundacio Privada Catalana de Nutricio i Lipids; Spanish Society of Atherosclerosis; Research and Teaching Grants from the University of Barcelona	Fundacio Privada Catalana de Nutricio i Lipids(Instituto de Salud Carlos III); Spanish Society of Atherosclerosis; Research and Teaching Grants from the University of Barcelona	This study was supported by grants from the Fundacio Privada Catalana de Nutricio i Lipids, project CENIT-GENIUSPHARMA, and the Spanish Society of Atherosclerosis. Laia Vila and Miguel Baena were supported by Research and Teaching Grants from the University of Barcelona. We have been nominated as a Consolidated Research Group by the Autonomous Government of Catalonia (SGR09-00413). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alperovich G, 2007, LUPUS, V16, P18, DOI 10.1177/0961203306073136; Bonelli M, 2010, ANN RHEUM DIS, V69, P65, DOI 10.1136/ard.2009.117135; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Chiuve SE, 2007, NAT CLIN PRACT CARD, V4, P610, DOI 10.1038/ncpcardio1009; De Rosa V, 2007, IMMUNITY, V26, P241, DOI 10.1016/j.immuni.2007.01.011; Feng PH, 2007, ANN NY ACAD SCI, V1108, P114, DOI 10.1196/annals.1422.013; Furukawa F, 2005, AUTOIMMUN REV, V4, P345, DOI 10.1016/j.autrev.2005.01.006; Gutcher I, 2007, J CLIN INVEST, V117, P1119, DOI 10.1172/JCI31720; Haque S, 2005, NAT CLIN PRACT CARD, V2, P423, DOI 10.1038/ncpcardio0270; Hersoug LG, 2007, ALLERGY, V62, P1205, DOI 10.1111/j.1398-9995.2007.01506.x; Jalving M, 2010, EUR J CANCER, V46, P2369, DOI 10.1016/j.ejca.2010.06.012; Lazarow P B, 1981, Methods Enzymol, V72, P315; Low YL, 2007, MUTAT RES-FUND MOL M, V622, P7, DOI 10.1016/j.mrfmmm.2007.01.015; Manjarrez-Orduno N, 2009, J INVEST DERMATOL, V129, P278, DOI 10.1038/jid.2008.240; Manzi S, 2009, CLEV CLIN J MED, V76, P137, DOI 10.3949/ccjm.76a.gr005; Matarese G, 2005, P NATL ACAD SCI USA, V102, P5150, DOI 10.1073/pnas.0408995102; Matarese G, 2008, J LEUKOCYTE BIOL, V84, P893, DOI 10.1189/jlb.0108022; Mok CC, 2006, SCAND J RHEUMATOL, V35, P85, DOI 10.1080/03009740600601526; Myers MG, 2008, ANNU REV PHYSIOL, V70, P537, DOI 10.1146/annurev.physiol.70.113006.100707; Ordovas J, 2007, NUTR REV, V65, pS203, DOI [10.1111/j.1753-4887.2007.tb00363.x, 10.1301/nr.2007.dec.S203-S207]; Peter S, 2007, W INDIAN MED J, V56, P264; Rahman A, 2008, NEW ENGL J MED, V358, P929, DOI 10.1056/NEJMra071297; Rana JS, 2007, DIABETES OBES METAB, V9, P218, DOI 10.1111/j.1463-1326.2006.00594.x; Reddy PS, 2008, ARTHRITIS RES THER, V10, DOI 10.1186/ar2541; Roglans N, 2007, HEPATOLOGY, V45, P778, DOI 10.1002/hep.21499; Ryan MJ, 2006, HYPERTENSION, V48, P988, DOI 10.1161/01.HYP.0000243612.02929.df; Sherer Y, 2010, AUTOIMMUNITY, V43, P98, DOI 10.3109/08916930903374527; Sigal LH, 2004, JCR-J CLIN RHEUMATOL, V10, P353, DOI 10.1097/01.rhu.0000147138.11053.e4; Stylianou K, 2011, NEPHROL DIAL TRANSPL, V26, P498, DOI 10.1093/ndt/gfq496; Taguchi A, 2008, ANNU REV PHYSIOL, V70, P191, DOI 10.1146/annurev.physiol.70.113006.100533; Vila L, 2008, HEPATOLOGY, V48, P1506, DOI 10.1002/hep.22523; Westerweel PE, 2007, ARTHRITIS RHEUM-US, V56, P1384, DOI 10.1002/art.22568; Yap TA, 2008, CURR OPIN PHARMACOL, V8, P393, DOI 10.1016/j.coph.2008.08.004; Zhu JF, 2010, CELL RES, V20, P4, DOI 10.1038/cr.2009.138	34	9	10	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 4	2012	7	12							e51118	10.1371/journal.pone.0051118	http://dx.doi.org/10.1371/journal.pone.0051118			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	051EQ	23226562	Green Published, Green Submitted, gold			2022-12-27	WOS:000312108500045
J	Ji, LL; Zhan, YX; Hua, FL; Li, F; Zou, SH; Wang, WG; Song, DL; Min, ZH; Chen, H; Cheng, YF				Ji, Lili; Zhan, Yanxia; Hua, Fanli; Li, Feng; Zou, Shanhua; Wang, Weiguang; Song, Dongli; Min, Zhihui; Chen, Hao; Cheng, Yunfeng			The Ratio of Treg/Th17 Cells Correlates with the Disease Activity of Primary Immune Thrombocytopenia	PLOS ONE			English	Article							REGULATORY T-CELLS; ROR-GAMMA-T; ADULT PATIENTS; TH17 CELLS; IN-VITRO; PURPURA; DIFFERENTIATION; LINEAGE; T(H)17; AUTOANTIBODIES	Background: Primary immune thrombocytopenia (ITP) is an autoimmune heterogeneous disorder that is characterized by decreased platelet count. Regulatory T (Treg) cells and T helper type 17 (Th17) cells are two subtypes of CD4(+) T helper (Th) cells. They play opposite roles in immune tolerance and autoimmune diseases, while they share a common differentiation pathway. The imbalance of Treg/Th17 has been demonstrated in several autoimmune diseases. In this study, we aimed to investigate the ratio of the number of Treg cells to the number of Th17 cells in ITP patients and evaluate the clinical implications of the alterations in this ratio. Methods: Thirty adult patients with newly diagnosed ITP enrolled in this study. Twelve patients had been clinically followed up for 12 months. The percentages of CD4(+)CD25(hi)Foxp3(+) Treg cells and CD3(+)CD4(+)IL-17-producing Th17 cells in these patients and healthy controls (n = 17) were longitudinally analyzed by flow cytometry. Results: The percentage of Treg cells in ITP patients was significantly lower than that of healthy controls, and the percentage of Th17 cells increased significantly at disease onset. The ratio of Treg/Th17 correlated with the disease activity. Conclusion: The ratio of Treg/Th17 might be relevant to the clinical diversity of ITP patients, and this Treg/Th17 ratio might have prognostic role in ITP patients. Citation: Ji L, Zhan Y, Hua F, Li F, Zou S, et al. (2012) The Ratio of Treg/Th17 Cells Correlates with the Disease Activity of Primary Immune Thrombocytopenia. PLoS ONE 7(12): e50909. doi: 10.1371/journal.pone.0050909	[Ji, Lili; Zhan, Yanxia; Hua, Fanli; Li, Feng; Zou, Shanhua; Wang, Weiguang; Cheng, Yunfeng] Fudan Univ, Zhongshan Hosp, Dept Hematol, Shanghai 200433, Peoples R China; [Song, Dongli; Min, Zhihui; Cheng, Yunfeng] Fudan Univ, Zhongshan Hosp, Biomed Res Ctr, Shanghai 200433, Peoples R China; [Chen, Hao] Fudan Univ, Huadong Hosp, Dept Surg, Shanghai 200433, Peoples R China; [Hua, Fanli] Fudan Univ, Jinshan Hosp, Dept Hematol, Shanghai 200433, Peoples R China	Fudan University; Fudan University; Fudan University; Fudan University	Cheng, YF (corresponding author), Fudan Univ, Zhongshan Hosp, Dept Hematol, Shanghai 200433, Peoples R China.	yfcheng@fudan.edu.cn			National Natural Science Foundation of China [30972737, 81170473]; Shanghai Health Bureau Funding [20114313]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Shanghai Health Bureau Funding	This work was supported by grants from the National Natural Science Foundation of China (30972737 and 81170473) (http://www.nsfc.gov.cn/Portal0/default152.htm) and Shanghai Health Bureau Funding (20114313) (http://wsj.sh.gov.cn/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ayyoub M, 2009, P NATL ACAD SCI USA, V106, P8635, DOI 10.1073/pnas.0900621106; Baba N, 2010, INT IMMUNOL, V22, P237, DOI 10.1093/intimm/dxp130; Bettelli E, 2006, NATURE, V441, P235, DOI 10.1038/nature04753; Rocha AMC, 2011, HAEMATOL-HEMATOL J, V96, P1560, DOI 10.3324/haematol.2011.046417; Chang M, 2003, BLOOD, V102, P887, DOI 10.1182/blood-2002-05-1475; Guo ZX, 2009, EUR J HAEMATOL, V82, P488, DOI 10.1111/j.1600-0609.2009.01229.x; Harrington LE, 2005, NAT IMMUNOL, V6, P1123, DOI 10.1038/ni1254; Hu Y, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026522; Koenen HJPM, 2008, BLOOD, V112, P2340, DOI 10.1182/blood-2008-01-133967; Kuwana M, 2005, INT J HEMATOL, V81, P106, DOI 10.1532/IJH97.04176; Kuwana M, 1998, J CLIN INVEST, V102, P1393, DOI 10.1172/JCI4238; Liu B, 2007, EUR J HAEMATOL, V78, P139, DOI 10.1111/j.1600-0609.2006.00780.x; Manel N, 2008, NAT IMMUNOL, V9, P641, DOI 10.1038/ni.1610; McMillan R, 2004, BLOOD, V103, P1364, DOI 10.1182/blood-2003-08-2672; Neunert C, 2011, BLOOD, V117, P4190, DOI 10.1182/blood-2010-08-302984; Nistala K, 2008, ARTHRITIS RHEUM-US, V58, P875, DOI 10.1002/art.23291; Nistala K, 2009, RHEUMATOLOGY, V48, P602, DOI 10.1093/rheumatology/kep028; Olsson B, 2003, NAT MED, V9, P1123, DOI 10.1038/nm921; Park H, 2005, NAT IMMUNOL, V6, P1133, DOI 10.1038/ni1261; Pene J, 2008, J IMMUNOL, V180, P7423, DOI 10.4049/jimmunol.180.11.7423; Provan D, 2010, BLOOD, V115, P168, DOI 10.1182/blood-2009-06-225565; Rodeghiero F, 2009, BLOOD, V113, P2386, DOI 10.1182/blood-2008-07-162503; SEMPLE JW, 1991, BLOOD, V78, P2619; Sollazzo D, 2011, HAEMATOL-HEMATOL J, V96, P632, DOI 10.3324/haematol.2010.038638; Voo KS, 2009, P NATL ACAD SCI USA, V106, P4793, DOI 10.1073/pnas.0900408106; Yang J, 2009, ARTHRITIS RHEUM-US, V60, P1472, DOI 10.1002/art.24499; Zhang JB, 2009, HAEMATOL-HEMATOL J, V94, P1326, DOI 10.3324/haematol.2009.007823; Zhou L, 2008, NATURE, V453, P236, DOI 10.1038/nature06878; Zhou L, 2009, IMMUNITY, V30, P646, DOI 10.1016/j.immuni.2009.05.001; Zhu XJ, 2010, J CLIN IMMUNOL, V30, P253, DOI 10.1007/s10875-009-9353-1	30	69	86	1	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 3	2012	7	12							e50909	10.1371/journal.pone.0050909	http://dx.doi.org/10.1371/journal.pone.0050909			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	051DH	23226546	Green Submitted, Green Published, gold			2022-12-27	WOS:000312104700026
J	Abel, LA; Bowman, EA; Velakoulis, D; Fahey, MC; Desmond, P; Macfarlane, MD; Looi, JCL; Adamson, CL; Walterfang, M				Abel, Larry A.; Bowman, Elizabeth A.; Velakoulis, Dennis; Fahey, Michael C.; Desmond, Patricia; Macfarlane, Matthew D.; Looi, Jeffrey Chee Leong; Adamson, Christopher L.; Walterfang, Mark			Saccadic Eye Movement Characteristics in Adult Niemann-Pick Type C Disease: Relationships with Disease Severity and Brain Structural Measures	PLOS ONE			English	Article							DORSOLATERAL PREFRONTAL CORTEX; DISORDERS; SPECTRUM; VERMIS; STEM	Niemann-Pick Type C disease (NPC) is a rare genetic disorder of lipid metabolism. A parameter related to horizontal saccadic peak velocity was one of the primary outcome measures in the clinical trial assessing miglustat as a treatment for NPC. Neuropathology is widespread in NPC, however, and could be expected to affect other saccadic parameters. We compared horizontal saccadic velocity, latency, gain, antisaccade error percentage and self-paced saccade generation in 9 adult NPC patients to data from 10 age-matched controls. These saccadic measures were correlated with appropriate MRI-derived brain structural measures (e.g., dorsolateral prefrontal cortex, frontal eye fields, supplemental eye fields, parietal eye fields, pons, midbrain and cerebellar vermis) and with measures of disease severity and duration. The best discriminators between groups were reflexive saccade gain and the two volitional saccade measures. Gain was also the strongest correlate with disease severity and duration. Most of the saccadic measures showed strongly significant correlations with neurophysiologically appropriate brain regions. While our patient sample is small, the apparent specificity of these relationships suggests that as new diagnostic methods and treatments become available for NPC, a broader range of saccadic measures may be useful tools for the assessment of disease progression and treatment efficacy.	[Abel, Larry A.; Bowman, Elizabeth A.] Univ Melbourne, Dept Optometry & Vis Sci, Melbourne, Vic, Australia; [Bowman, Elizabeth A.; Velakoulis, Dennis; Walterfang, Mark] Univ Melbourne, Melbourne Neuropsychiat Ctr, Melbourne, Vic, Australia; [Velakoulis, Dennis; Walterfang, Mark] Royal Melbourne Hosp, Neuropsychiat Unit, Melbourne, Vic, Australia; [Macfarlane, Matthew D.; Looi, Jeffrey Chee Leong] Australian Natl Univ, Sch Med, Acad Unit Psychol Med, Res Ctr Neurosci Ageing, Canberra, ACT, Australia; [Fahey, Michael C.] Monash Univ, Dept Paediat, Melbourne, Vic 3004, Australia; [Desmond, Patricia] Royal Melbourne Hosp, Dept Radiol, Melbourne, Vic, Australia; [Desmond, Patricia] Univ Melbourne, Dept Radiol, Melbourne, Vic, Australia; [Adamson, Christopher L.] Murdoch Childrens Res Inst, Parkville, Vic, Australia; [Bowman, Elizabeth A.] Univ Melbourne, Royal Melbourne Hosp, Melbourne Brain Ctr, Dept Med, Melbourne, Vic 3050, Australia	University of Melbourne; University of Melbourne; Royal Melbourne Hospital; Australian National University; Monash University; Royal Melbourne Hospital; University of Melbourne; Murdoch Children's Research Institute; Royal Melbourne Hospital; University of Melbourne	Abel, LA (corresponding author), Univ Melbourne, Dept Optometry & Vis Sci, Melbourne, Vic, Australia.	label@unimelb.edu.au	Velakoulis, Dennis/A-4778-2008; Walterfang, Mark/H-4930-2011; Desmond, Patricia/D-1966-2014; Fahey, Michael C/B-2668-2014; Bowman, Elizabeth/C-8672-2016	Velakoulis, Dennis/0000-0002-8842-8479; Walterfang, Mark/0000-0002-1389-3691; Desmond, Patricia/0000-0002-4803-6323; Fahey, Michael C/0000-0003-0811-4785; Bowman, Elizabeth/0000-0002-6876-6446; Looi, Jeffrey/0000-0003-3351-6911; Abel, Larry/0000-0002-2393-0644	Actelion Pharmaceuticals Ltd.; NHMRC; NIH [1R03HD058625-01]; NHMRC; Cancer Australia; National Health Foundation; Royal Melbourne Hospital Neuroscience Foundation; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R03HD058625] Funding Source: NIH RePORTER	Actelion Pharmaceuticals Ltd.; NHMRC(National Health and Medical Research Council (NHMRC) of Australia); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NHMRC(National Health and Medical Research Council (NHMRC) of Australia); Cancer Australia; National Health Foundation; Royal Melbourne Hospital Neuroscience Foundation; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	The authors have read the journal's policy and have the following conflicts. Competing interests are as follows: Dr. Abel has served on a scientific advisory board and as a consultant for and received funding for equipment from Actelion Pharmaceuticals Ltd. Ms. Bowman reports no competing interests. Dr. Velakoulis conceived the study, assisted with neuroimaging analysis, contributed to study design and edited the manuscript. He has received royalties from the publication of Kaplan and Sadock's Comprehensive Textbook of Psychiatry (Lippincott Williams & Wilkins, 2009) and receives research support from NH&MRC. Dr. Fahey has served on a scientific advisory board and as a consultant for and received funding for travel from Actelion Pharmaceuticals Ltd; has received speaker honoraria from the Australian Podiatry Association; receives research support from NH&MRC and the NIH (1R03HD058625-01, CI); has held/holds stock in Sigma Pharmaceuticals, Ltd and Peplin, Inc.; and has given expert testimony on behalf of the Therapeutic Goods Administration. Dr. Desmond serves on the editorial board of the Journal of Clinical Neuroscience and as an Associate Editor of the Journal of Medical Imaging and Radiation Oncology; and receives research support from NHMRC, Cancer Australia, the National Health Foundation, and The Royal Melbourne Hospital Neuroscience Foundation. Dr. Macfarlane, Dr. Looi and Dr. Adamson report no competing interests. Dr. Walterfang has served on a scientific advisory board and as a consultant for and received funding for travel from Actelion Pharmaceuticals Ltd; and received royalties from the publication of Kaplan and Sadock's Comprehensive Textbook of Psychiatry (Lippincott Williams & Wilkins, 2009). This does not alter the authors' adherence to all the PLOS ONE policies on sharing data and materials.	Abel LA, 2009, NEUROLOGY, V72, P1083, DOI 10.1212/01.wnl.0000345040.01917.9d; Abel LA, 2002, DEMENT GERIATR COGN, V13, P235, DOI 10.1159/000057702; BISCALI M, 1994, PERCEPTION, V23, P45, DOI 10.1068/p230045; CURRIE J, 1991, ARCH NEUROL-CHICAGO, V48, P644, DOI 10.1001/archneur.1991.00530180102024; Diedrichsen J, 2009, NEUROIMAGE, V46, P39, DOI 10.1016/j.neuroimage.2009.01.045; Ettinger U, 2002, NEUROSCI LETT, V328, P225, DOI 10.1016/S0304-3940(02)00517-7; FUKUSHIMA J, 1988, BIOL PSYCHIAT, V23, P670, DOI 10.1016/0006-3223(88)90050-9; Garbutt S, 2008, BRAIN, V131, P1268, DOI 10.1093/brain/awn047; Gaymard B, 1998, EXP BRAIN RES, V123, P159, DOI 10.1007/s002210050557; HOLM S, 1979, SCAND J STAT, V6, P65; INCHINGOLO P, 1985, IEEE T BIO-MED ENG, V32, P683, DOI 10.1109/TBME.1985.325586; Iturriaga C, 2006, J NEUROL SCI, V249, P1, DOI 10.1016/j.jns.2006.05.054; Leigh RJ, 1997, ANN NY ACAD SCI, V835, P353, DOI 10.1111/j.1749-6632.1997.tb48641.x; LeVasseur AL, 2001, BRAIN, V124, P2045, DOI 10.1093/brain/124.10.2045; Levy Deborah L, 2004, World Psychiatry, V3, P32; Luna B, 2004, CHILD DEV, V75, P1357, DOI 10.1111/j.1467-8624.2004.00745.x; Patterson MC, 2007, LANCET NEUROL, V6, P765, DOI 10.1016/S1474-4422(07)70194-1; Pierrot-Deseilligny C, 2003, BRAIN, V126, P1460, DOI 10.1093/brain/awg148; Pierrot-Deseilligny C, 2005, ANN NY ACAD SCI, V1039, P239, DOI 10.1196/annals.1325.023; Pierrot-Deseilligny C, 2004, CURR OPIN NEUROL, V17, P17, DOI 10.1097/00019052-200402000-00005; Porter FD, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3001417; RAJKOWSKA G, 1995, CEREB CORTEX, V5, P323, DOI 10.1093/cercor/5.4.323; Ramat S, 2007, BRAIN, V130, P10, DOI 10.1093/brain/awl309; Rottach KG, 1997, VISION RES, V37, P3627, DOI 10.1016/S0042-6989(96)00066-1; Scheel M, 2010, MOL GENET METAB, V99, P291, DOI 10.1016/j.ymgme.2009.10.180; Sevin M, 2007, BRAIN, V130, P120, DOI 10.1093/brain/awl260; Solomon D, 2005, ANN NY ACAD SCI, V1039, P436, DOI 10.1196/annals.1325.041; Takagi M, 1998, J NEUROPHYSIOL, V80, P1911, DOI 10.1152/jn.1998.80.4.1911; VAHEDI K, 1995, J NEUROL NEUROSUR PS, V58, P91, DOI 10.1136/jnnp.58.1.91; Vanier MT, 2010, ORPHANET J RARE DIS, V5, DOI 10.1186/1750-1172-5-16; VANIER MT, 1991, BIOCHIM BIOPHYS ACTA, V1096, P328, DOI 10.1016/0925-4439(91)90069-L; Walterfang M, 2012, EUR J NEUROL, V19, P462, DOI 10.1111/j.1468-1331.2011.03545.x; Walterfang M, 2006, J NEUROPSYCH CLIN N, V18, P158, DOI 10.1176/appi.neuropsych.18.2.158; Walterfang M, 2006, AUST NZ J PSYCHIAT, V40, P995, DOI 10.1111/j.1440-1614.2006.01923.x; Williams IM, 1997, J CLIN NEUROSCI, V4, P186, DOI 10.1016/S0967-5868(97)90072-2	35	20	21	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 30	2012	7	11							e50947	10.1371/journal.pone.0050947	http://dx.doi.org/10.1371/journal.pone.0050947			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	054WM	23226429	Green Published, Green Submitted, gold			2022-12-27	WOS:000312376100240
J	Bidder, OR; Qasem, LA; Wilson, RP				Bidder, Owen R.; Qasem, Lama A.; Wilson, Rory P.			On Higher Ground: How Well Can Dynamic Body Acceleration Determine Speed in Variable Terrain?	PLOS ONE			English	Article							DIEL VERTICAL MIGRATION; ENERGY-EXPENDITURE; MOVEMENT ECOLOGY; MARINE MAMMALS; SWIM SPEED; TRACKING; TELEMETRY; BEHAVIOR; PENGUINS; HABITAT	Introduction: Animal travel speed is an ecologically significant parameter, with implications for the study of energetics and animal behaviour. It is also necessary for the calculation of animal paths by dead-reckoning. Dead-reckoning uses heading and speed to calculate an animal's path through its environment on a fine scale. It is often used in aquatic environments, where transmission telemetry is difficult. However, its adoption for tracking terrestrial animals is limited by our ability to measure speed accurately on a fine scale. Recently, tri-axial accelerometers have shown promise for estimating speed, but their accuracy appears affected by changes in substrate and surface gradients. The purpose of the present study was to evaluate four metrics of acceleration; Overall dynamic body acceleration (ODBA), vectorial dynamic body acceleration (VDBA), acceleration peak frequency and acceleration peak amplitude, as proxies for speed over hard, soft and inclined surfaces, using humans as a model species. Results: A general linear model (GLM) showed a significant difference in the relationships between the metrics and speed depending on substrate or surface gradient. When the data from all surface types were considered together, VeDBA had the highest coefficient of determination. Conclusions: All of the metrics showed some variation in their relationship with speed according to the surface type. This indicates that changes in the substrate or surface gradient during locomotion by animals would produce errors in speed estimates, and also in dead-reckoned tracks if they were calculated from speeds based entirely on a priori calibrations. However, we describe a method by which the relationship between acceleration metrics and speed can be corrected ad hoc, until tracks accord with periodic ground truthed positions, obtained via a secondary means (e. g. VHF or GPS telemetry). In this way, dead-reckoning provides a means to obtain fine scale movement data for terrestrial animals, without the need for additional data on substrate or gradient.	[Bidder, Owen R.; Qasem, Lama A.; Wilson, Rory P.] Swansea Univ, Coll Sci, Swansea, W Glam, Wales	Swansea University	Bidder, OR (corresponding author), Swansea Univ, Coll Sci, Swansea, W Glam, Wales.	367097@swansea.ac.uk			European Social Fund (ESF) through the European Union's Convergence programme; Royal Society for the Prevention of Cruelty to Animals	European Social Fund (ESF) through the European Union's Convergence programme; Royal Society for the Prevention of Cruelty to Animals	Owen R. Bidder is partly funded by the European Social Fund (ESF) through the European Union's Convergence programme administered by the Welsh Government and by the Royal Society for the Prevention of Cruelty to Animals. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	de Melo LFB, 2007, J ZOOL, V271, P27, DOI 10.1111/j.1469-7998.2006.00176.x; Bartumeus F, 2008, J THEOR BIOL, V252, P43, DOI 10.1016/j.jtbi.2008.01.009; Bartumeus F, 2008, P NATL ACAD SCI USA, V105, P19072, DOI 10.1073/pnas.0801926105; BATCHELOR TA, 1980, J WILDLIFE MANAGE, V44, P497, DOI 10.2307/3807987; Benhamou S, 2006, ECOLOGY, V87, P518, DOI 10.1890/05-0495; Benhamou S, 2004, J THEOR BIOL, V229, P209, DOI 10.1016/j.jtbi.2004.03.016; Bidder OR, 2012, ZOOLOGY, V115, P58, DOI 10.1016/j.zool.2011.09.003; Block BA, 2001, SCIENCE, V293, P1310, DOI 10.1126/science.1061197; BOONSTRA R, 1986, CAN J ZOOL, V64, P1034, DOI 10.1139/z86-153; BOUTEN CV, 1994, MED SCI SPORT EXER, V26, P1516; Bouten CVC, 1997, MED BIOL ENG COMPUT, V35, P50, DOI 10.1007/BF02510392; Bradshaw CJA, 2004, ANIM BEHAV, V68, P1349, DOI 10.1016/j.anbehav.2003.12.013; BRAMANTI M, 1988, J EXP BIOL, V134, P467; Brill RW, 1999, MAR BIOL, V133, P395, DOI 10.1007/s002270050478; BRODY AJ, 1989, WILDLIFE SOC B, V17, P5; BROWN WS, 1976, COPEIA, P225, DOI 10.2307/1443941; BUCHLER ER, 1976, J MAMMAL, V57, P173, DOI 10.2307/1379522; Campbell KL, 2002, MED SCI SPORT EXER, V34, P1667, DOI 10.1097/00005768-200210000-00020; Cooke SJ, 2004, TRENDS ECOL EVOL, V19, P334, DOI 10.1016/j.tree.2004.04.003; Davis LS, 1996, POLAR BIOL, V16, P221, DOI 10.1007/BF02329210; Delciellos AC, 2007, ACTA THERIOL, V52, P101, DOI 10.1007/BF03194205; Di Orio AP, 2003, WILDLIFE SOC B, V31, P372; Dussault C, 1999, WILDLIFE SOC B, V27, P965; Eckert SA, 2002, J EXP BIOL, V205, P3689; FARLEY CT, 1993, J EXP BIOL, V185, P71; GARNER DL, 1995, ENVIRON MANAGE, V19, P233, DOI 10.1007/BF02471993; Gleiss AC, 2009, MULTICHANNEL DATA LO; Gleiss AC, 2011, METHODS ECOL EVOL, V2, P23, DOI 10.1111/j.2041-210X.2010.00057.x; GRIEVE DW, 1966, ERGONOMICS, V9, P379, DOI 10.1080/00140136608964399; Halsey LG, 2009, COMP BIOCHEM PHYS A, V152, P197, DOI 10.1016/j.cbpa.2008.09.021; Halsey LG, 2008, ZOOLOGY, V111, P231, DOI 10.1016/j.zool.2007.07.011; Halsey LG, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010170; Halsey LG, 2012, J HUMAN EVOLUTION; Hassrick JL, 2007, DEEP-SEA RES PT II, V54, P369, DOI 10.1016/j.dsr2.2006.12.001; Havens KJ, 1998, WILDLIFE SOC B, V26, P17; Hays GC, 2001, ANIM BEHAV, V61, P1035, DOI 10.1006/anbe.2001.1685; HEGLUND NC, 1974, SCIENCE, V186, P1112, DOI 10.1126/science.186.4169.1112; Herren R, 1999, MED SCI SPORT EXER, V31, P1053, DOI 10.1097/00005768-199907000-00020; HESTBECK JB, 1991, ECOLOGY, V72, P523, DOI 10.2307/2937193; Johnson MP, 2003, IEEE J OCEANIC ENG, V28, P3, DOI 10.1109/JOE.2002.808212; Kato A, 2006, MAR ECOL PROG SER, V308, P293, DOI 10.3354/meps308293; Kerdok AE, 2002, J APPL PHYSIOL, V92, P469, DOI 10.1152/japplphysiol.01164.2000; Knapik JJ, 2004, MIL MED, V169, P45, DOI 10.7205/MILMED.169.1.45; Kramer DL, 2001, AM ZOOL, V41, P137, DOI 10.1668/0003-1569(2001)041[0137:TBEOIL]2.0.CO;2; Lejeune TM, 1998, J EXP BIOL, V201, P2071; Linnell JDC, 2007, WILDLIFE BIOL, V13, P456, DOI 10.2981/0909-6396(2007)13[456:AEOSSS]2.0.CO;2; Mitani Y, 2003, POLAR BIOL, V26, P311, DOI 10.1007/s00300-003-0487-y; NAITO Y, 1990, CONDOR, V92, P582, DOI 10.2307/1368676; Nathan R, 2008, P NATL ACAD SCI USA, V105, P19052, DOI 10.1073/pnas.0800375105; Osborne PE, 2001, J APPL ECOL, V38, P458, DOI 10.1046/j.1365-2664.2001.00604.x; PANDOLF KB, 1976, ERGONOMICS, V19, P683, DOI 10.1080/00140137608931583; PONGANIS PJ, 1990, CAN J ZOOL, V68, P2105, DOI 10.1139/z90-293; Pope KL, 2001, COPEIA, P787; Qasem L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031187; Roper TJ, 2001, BEHAVIOUR, V138, P173, DOI 10.1163/15685390151074366; Ropert-Coudert Y, 2006, MAR BIOL, V149, P415, DOI 10.1007/s00227-005-0242-8; Sato K, 2003, J EXP BIOL, V206, P1461, DOI 10.1242/jeb.00265; Shanahan DF, 2007, NEW ZEAL J ECOL, V31, P160; Shepard ELC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027375; Shepard ELC, 2009, P ROY SOC B-BIOL SCI, V276, P3149, DOI 10.1098/rspb.2009.0683; Shepard Emily L. C., 2010, Endangered Species Research, V10, P47, DOI 10.3354/esr00084; Shepard Emily L. C., 2008, Endangered Species Research, V4, P157, DOI 10.3354/esr00052; Sims DW, 2005, J ANIM ECOL, V74, P755, DOI 10.1111/j.1365-2656.2005.00971.x; Steinwald MC, 2006, SOUTHWEST NAT, V51, P71, DOI 10.1894/0038-4909(2006)51[71:EOSTOS]2.0.CO;2; Sun J, 1996, ERGONOMICS, V39, P677, DOI 10.1080/00140139608964489; Tsuda Y, 2006, ECOL FRESHW FISH, V15, P264, DOI 10.1111/j.1600-0633.2006.00147.x; Ware C, 2011, MAR MAMMAL SCI, V27, P587, DOI 10.1111/j.1748-7692.2010.00427.x; Watanabe S, 2005, APPL ANIM BEHAV SCI, V94, P117, DOI 10.1016/j.applanim.2005.01.010; Wilson Rory P., 2008, Endangered Species Research, V4, P123, DOI 10.3354/esr00064; Wilson RP, 2007, DEEP-SEA RES PT II, V54, P193, DOI 10.1016/j.dsr2.2006.11.017; Wilson RP, 2006, J ANIM ECOL, V75, P1081, DOI 10.1111/j.1365-2656.2006.01127.x; WILSON RP, 1993, MAR ECOL PROG SER, V94, P101; Wilson RP, 2002, MAR ECOL PROG SER, V228, P241, DOI 10.3354/meps228241; WILSON RP, 1988, MEERESFORSCHUNG, V32, P155; WOLCOTT TG, 1977, J WILDLIFE MANAGE, V41, P309, DOI 10.2307/3800610; Yoda K, 1999, J EXP BIOL, V202, P3121; Yoda K, 2001, J EXP BIOL, V204, P685	77	27	27	1	43	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 30	2012	7	11							e50556	10.1371/journal.pone.0050556	http://dx.doi.org/10.1371/journal.pone.0050556			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	054WM	23226313	Green Published, gold			2022-12-27	WOS:000312376100125
J	Chiavacci, E; Dolfi, L; Verduci, L; Meghini, F; Gestri, G; Evangelista, AMM; Wilson, SW; Cremisi, F; Pitto, L				Chiavacci, Elena; Dolfi, Luca; Verduci, Lorena; Meghini, Francesco; Gestri, Gaia; Evangelista, Alberto Mercatanti Monica; Wilson, Stephen W.; Cremisi, Federico; Pitto, Letizia			MicroRNA 218 Mediates the Effects of Tbx5a Over-Expression on Zebrafish Heart Development	PLOS ONE			English	Article							HOLT-ORAM-SYNDROME; CHROMATIN REMODELING COMPLEX; DEVELOPING MOUSE HEART; EMBRYONIC ZEBRAFISH; SLIT; CELLS; DIFFERENTIATION; CARDIOGENESIS; MALFORMATION; INVOLVEMENT	tbx5, a member of the T-box gene family, encodes one of the key transcription factors mediating vertebrate heart development. Tbx5 function in heart development appears to be exquisitely sensitive to gene dosage, since both haploinsufficiency and gene duplication generate the cardiac abnormalities associated with Holt-Oram syndrome (HOS), a highly penetrant autosomal dominant disease characterized by congenital heart defects of varying severity and upper limb malformation. It is suggested that tight integration of microRNAs and transcription factors into the cardiac genetic circuitry provides a rich and robust array of regulatory interactions to control cardiac gene expression. Based on these considerations, we performed an in silico screening to identify microRNAs embedded in genes highly sensitive to Tbx5 dosage. Among the identified microRNAs, we focused our attention on miR-218-1 that, together with its host gene, slit2, is involved in heart development. We found correlated expression of tbx5 and miR-218 during cardiomyocyte differentiation of mouse P19CL6 cells. In zebrafish embryos, we show that both Tbx5 and miR-218 dysregulation have a severe impact on heart development, affecting early heart morphogenesis. Interestingly, down-regulation of miR-218 is able to rescue the heart defects generated by tbx5 over-expression supporting the notion that miR-218 is a crucial mediator of Tbx5 in heart development and suggesting its possible involvement in the onset of heart malformations. tbx5	[Chiavacci, Elena; Dolfi, Luca; Verduci, Lorena; Meghini, Francesco; Evangelista, Alberto Mercatanti Monica; Pitto, Letizia] CNR, Inst Clin Physiol, I-56100 Pisa, Italy; [Gestri, Gaia; Wilson, Stephen W.] UCL, Dept Cell & Dev Biol, London, England; [Cremisi, Federico] Scuola Normale Super Pisa, Pisa, Italy	Consiglio Nazionale delle Ricerche (CNR); Istituto di Fisiologia Clinica (IFC-CNR); University of London; University College London; Scuola Normale Superiore di Pisa	Pitto, L (corresponding author), CNR, Inst Clin Physiol, Via Savi 8, I-56100 Pisa, Italy.	l.pitto@ifc.cnr.it	Zebrafish, UCL/A-3125-2009; Chiavacci, Elena/B-5689-2014; Chiavacci, Elena/ABC-9088-2020; Wilson, Stephen W/B-9404-2008; Pitto, Letizia/A-3070-2014; cremisi, federico/AAI-2183-2020	Chiavacci, Elena/0000-0003-3924-3635; Chiavacci, Elena/0000-0003-3924-3635; Wilson, Stephen W/0000-0002-8557-5940; Pitto, Letizia/0000-0002-8660-9516; EVANGELISTA, MONICA/0000-0002-5674-8523; Cremisi, Federico/0000-0003-4925-2703; Mercatanti, Alberto/0000-0001-5110-9688; Gestri, Gaia/0000-0001-8854-1546	Tuscany Region [n.4177]; Medical Research Council	Tuscany Region(Regione Toscana); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This research project was funded by Tuscany Region (n.4177) and the Medical Research Council (to GG and SW). All the funders gave the financial support and they had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahn DG, 2002, NATURE, V417, P754, DOI 10.1038/nature00814; Alajez NM, 2011, CANCER RES, V71, P2381, DOI 10.1158/0008-5472.CAN-10-2754; Albalat R, 2010, GENE EXPR PATTERNS, V10, P24, DOI 10.1016/j.gep.2009.11.003; Basson CT, 1997, NAT GENET, V15, P30, DOI 10.1038/ng0197-30; Begemann G, 2000, MECH DEVELOP, V90, P299, DOI 10.1016/S0925-4773(99)00246-4; Beis D, 2005, DEVELOPMENT, V132, P4193, DOI 10.1242/dev.01970; Bruneau BG, 1999, DEV BIOL, V211, P100, DOI 10.1006/dbio.1999.9298; Bruneau BG, 2001, CELL, V106, P709, DOI 10.1016/S0092-8674(01)00493-7; Camarata T, 2010, DEV BIOL, V337, P233, DOI 10.1016/j.ydbio.2009.10.039; Chedotal A, 2011, CURR OPIN NEUROBIOL, V21, P68, DOI 10.1016/j.conb.2010.07.008; Cordes KR, 2009, CIRC RES, V104, P724, DOI 10.1161/CIRCRESAHA.108.192872; Eroglu B, 2006, DEV DYNAM, V235, P2722, DOI 10.1002/dvdy.20911; Fish JE, 2011, DEVELOPMENT, V138, P1409, DOI 10.1242/dev.060046; Garrity DM, 2002, DEVELOPMENT, V129, P4635; Gjini E, 2011, DIS MODEL MECH, V4, P57, DOI 10.1242/dmm.005033; Goetz SC, 2006, DEVELOPMENT, V133, P2575, DOI 10.1242/dev.02420; Gruenauer-Kloevekorn Claudia, 2005, Ophthalmic Genet, V26, P1, DOI 10.1080/13816810590918073; HabaraOhkubo A, 1996, CELL STRUCT FUNCT, V21, P101, DOI 10.1247/csf.21.101; Harvey RP, 2002, NAT REV GENET, V3, P544, DOI 10.1038/nrg843; Hatcher CJ, 2004, PHYSIOL GENOMICS, V18, P129, DOI 10.1152/physiolgenomics.00060.2004; Hatcher CJ, 2001, NAT MED, V7, P1185, DOI 10.1038/nm1101-1185; Horb ME, 1999, DEVELOPMENT, V126, P1739; Jin SW, 2007, DEV BIOL, V307, P29, DOI 10.1016/j.ydbio.2007.03.526; Kapsimali M, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-8-r173; Kastenhuber E, 2009, J NEUROSCI, V29, P8914, DOI 10.1523/JNEUROSCI.0568-09.2009; King T, 2002, DEV DYNAM, V225, P212, DOI 10.1002/dvdy.10142; Koshiba-Takeuchi K, 2000, SCIENCE, V287, P134, DOI 10.1126/science.287.5450.134; Li QY, 1997, NAT GENET, V15, P21; Liberatore CM, 2000, DEV BIOL, V223, P169, DOI 10.1006/dbio.2000.9748; Liu JD, 2010, CIRC RES, V106, P1818, DOI 10.1161/CIRCRESAHA.110.217950; MCCORQUODALE MM, 1986, J MENT DEFIC RES, V30, P389; MCCORQUODALE MM, 1986, AM J MED GENET, V24, P613, DOI 10.1002/ajmg.1320240405; McMahon C, 2009, DEV BIOL, V332, P287, DOI 10.1016/j.ydbio.2009.05.577; Medioni C, 2010, DEV DYNAM, V239, P3303, DOI 10.1002/dvdy.22449; MELNYK AR, 1981, AM J MED GENET, V10, P357, DOI 10.1002/ajmg.1320100408; Mercatanti A, 2002, J COMPUT BIOL, V9, P641, DOI 10.1089/106652702760277363; Mori AD, 2006, DEV BIOL, V297, P566, DOI 10.1016/j.ydbio.2006.05.023; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Pierpont ME, 2007, CIRCULATION, V115, P3015, DOI 10.1161/CIRCULATIONAHA.106.183056; Plageman TF, 2006, DEV DYNAM, V235, P2868, DOI 10.1002/dvdy.20923; Postma AV, 2008, CIRC RES, V102, P1433, DOI 10.1161/CIRCRESAHA.107.168294; Rallis C, 2003, DEVELOPMENT, V130, P2741, DOI 10.1242/dev.00473; Small EM, 2010, CIRC RES, V107, P1336, DOI 10.1161/CIRCRESAHA.110.227926; Smemo S, 2012, HUM MOL GENET, V21, P3255, DOI 10.1093/hmg/dds165; Snyder M, 2010, J BIOL CHEM, V285, P23639, DOI 10.1074/jbc.M110.101063; Stainier DYR, 2002, COLD SPRING HARB SYM, V67, P49, DOI 10.1101/sqb.2002.67.49; Takeuchi JK, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1187; Thatcher EJ, 2007, DEV DYNAM, V236, P2172, DOI 10.1002/dvdy.21211; Tie J, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000879; van Rooij E, 2006, P NATL ACAD SCI USA, V103, P18255, DOI 10.1073/pnas.0608791103; Wienholds E, 2005, SCIENCE, V309, P310, DOI 10.1126/science.1114519; Yeo SY, 2004, MECH DEVELOP, V121, P315, DOI 10.1016/j.mod.2004.03.006; Yeo SY, 2001, DEV BIOL, V230, P1, DOI 10.1006/dbio.2000.0105; Yu XP, 2008, NUCLEIC ACIDS RES, V36, P6494, DOI 10.1093/nar/gkn712	54	51	55	0	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 30	2012	7	11							e50536	10.1371/journal.pone.0050536	http://dx.doi.org/10.1371/journal.pone.0050536			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	054WM	23226307	Green Published, Green Submitted, gold			2022-12-27	WOS:000312376100119
J	Figuerola, ELM; Guerrero, LD; Rosa, SM; Simonetti, L; Duval, ME; Galantini, JA; Bedano, JC; Wall, LG; Erijman, L				Figuerola, Eva L. M.; Guerrero, Leandro D.; Rosa, Silvina M.; Simonetti, Leandro; Duval, Matias E.; Galantini, Juan A.; Bedano, Jose C.; Wall, Luis G.; Erijman, Leonardo			Bacterial Indicator of Agricultural Management for Soil under No-Till Crop Production	PLOS ONE			English	Article							MINIMUM DATA SET; PHYLUM ACIDOBACTERIA; MICROBIAL DIVERSITY; COMMUNITY STRUCTURE; QUALITY INDICATORS; RHIZOSPHERE SOIL; SYSTEMS; MICROORGANISMS; MEMBERS; SAMPLE	The rise in the world demand for food poses a challenge to our ability to sustain soil fertility and sustainability. The increasing use of no-till agriculture, adopted in many areas of the world as an alternative to conventional farming, may contribute to reduce the erosion of soils and the increase in the soil carbon pool. However, the advantages of no-till agriculture are jeopardized when its use is linked to the expansion of crop monoculture. The aim of this study was to survey bacterial communities to find indicators of soil quality related to contrasting agriculture management in soils under no-till farming. Four sites in production agriculture, with different soil properties, situated across a west-east transect in the most productive region in the Argentinean pampas, were taken as the basis for replication. Working definitions of Good no-till Agricultural Practices (GAP) and Poor no-till Agricultural Practices (PAP) were adopted for two distinct scenarios in terms of crop rotation, fertilization, agrochemicals use and pest control. Non-cultivated soils nearby the agricultural sites were taken as additional control treatments. Tag-encoded pyrosequencing was used to deeply sample the 16S rRNA gene from bacteria residing in soils corresponding to the three treatments at the four locations. Although bacterial communities as a whole appeared to be structured chiefly by a marked biogeographic provincialism, the distribution of a few taxa was shaped as well by environmental conditions related to agricultural management practices. A statistically supported approach was used to define candidates for management-indicator organisms, subsequently validated using quantitative PCR. We suggest that the ratio between the normalized abundance of a selected group of bacteria within the GP1 group of the phylum Acidobacteria and the genus Rubellimicrobium of the Alphaproteobacteria may serve as a potential management-indicator to discriminate between sustainable vs. non-sustainable agricultural practices in the Pampa region.	[Figuerola, Eva L. M.; Guerrero, Leandro D.; Rosa, Silvina M.; Simonetti, Leandro; Erijman, Leonardo] Inst Invest Ingn Genet & Biol mol INGEBI CONICET, Buenos Aires, DF, Argentina; [Duval, Matias E.; Galantini, Juan A.] Univ Nacl Sur, CERZOS CONICET Dept Agron, RA-8000 Bahia Blanca, Buenos Aires, Argentina; [Bedano, Jose C.] Univ Nacl Rio Cuarto, Dept Geol, Cordoba, Argentina; [Wall, Luis G.] Univ Nacl Quilmes, Dept Ciencia & Tecnol, Bernal, Argentina; [Erijman, Leonardo] Univ Buenos Aires, Fac Ciencias Exactas & Nat, Buenos Aires, DF, Argentina	Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); National University of the South; Universidad Nacional Rio Cuarto; University of Buenos Aires	Erijman, L (corresponding author), Inst Invest Ingn Genet & Biol mol INGEBI CONICET, Vuelta Obligado 2490, Buenos Aires, DF, Argentina.	erijman@dna.uba.ar	Erijman, Leonardo/AAI-1359-2020	Erijman, Leonardo/0000-0001-7525-2112; Simonetti, Leandro/0000-0003-1283-9770; Galantini, Juan/0000-0002-4536-8605; Bedano, Jose Camilo/0000-0001-6968-9908; Figuerola, Eva Lucia Margarita/0000-0002-7784-1452; Duval, Matias/0000-0002-8731-9107	ANPCyT, Argentina	ANPCyT, Argentina(ANPCyT)	The authors are members of the BIOSPAS consortium (http://www.biospas.org/en). ELMF, JCB, LGW and LE are members of Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET), Argentina. JAG is member of Comision de Investigaciones Cientificas of Buenos Aires Province, Argentina (CIC). MD and SR received fellowships from ANPCyT, Argentina. LDG and LS were fellows of CONICET. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abid M, 2009, SOIL TILL RES, V103, P364, DOI 10.1016/j.still.2008.11.004; Acosta-Martinez V, 2008, SOIL BIOL BIOCHEM, V40, P2762, DOI 10.1016/j.soilbio.2008.07.022; Ashelford KE, 2002, NUCLEIC ACIDS RES, V30, P3481, DOI 10.1093/nar/gkf450; Bending GD, 2004, SOIL BIOL BIOCHEM, V36, P1785, DOI 10.1016/j.soilbio.2004.04.035; Bockstaller C, 2008, AGRON SUSTAIN DEV, V28, P139, DOI 10.1051/agro:2007052; Bronick CJ, 2005, GEODERMA, V124, P3, DOI 10.1016/j.geoderma.2004.03.005; Cao YR, 2010, ANTON LEEUW INT J G, V98, P389, DOI 10.1007/s10482-010-9452-2; Carignan V, 2002, ENVIRON MONIT ASSESS, V78, P45, DOI 10.1023/A:1016136723584; Chenu C, 2001, BIOL FERT SOILS, V34, P349, DOI 10.1007/s003740100419; Cook RJ, 2006, P NATL ACAD SCI USA, V103, P18389, DOI 10.1073/pnas.0605946103; Dale Virginia H., 2001, Ecological Indicators, V1, P3, DOI 10.1016/S1470-160X(01)00003-6; Dastager SG, 2008, INT J SYST EVOL MICR, V58, P1797, DOI 10.1099/ijs.0.65590-0; Davis KER, 2011, ENVIRON MICROBIOL, V13, P798, DOI 10.1111/j.1462-2920.2010.02384.x; de Lima ACR, 2008, J ENVIRON QUAL, V37, P623, DOI 10.2134/jeq2006.0280; Denner EBM, 2006, INT J SYST EVOL MICR, V56, P1355, DOI 10.1099/ijs.0.63751-0; Derpsch Rolf, 2010, International Journal of Agricultural and Biological Engineering, V3, P1, DOI 10.3965/j.issn.1934-6344.2010.01.001-025; Dufrene M, 1997, ECOL MONOGR, V67, P345, DOI 10.1890/0012-9615(1997)067[0345:SAAIST]2.0.CO;2; Fierer N, 2007, ECOLOGY, V88, P1354, DOI 10.1890/05-1839; Ganzert L, 2011, FEMS MICROBIOL ECOL, V76, P476, DOI 10.1111/j.1574-6941.2011.01068.x; Garbisu C, 2011, APPL SOIL ECOL, V49, P1, DOI 10.1016/j.apsoil.2011.04.018; Ge Y, 2008, ISME J, V2, P254, DOI 10.1038/ismej.2008.2; Girvan MS, 2003, APPL ENVIRON MICROB, V69, P1800, DOI 10.1128/AEM.69.3.1800-1809.2003; Govaerts B, 2006, SOIL TILL RES, V87, P163, DOI 10.1016/j.still.2005.03.005; Grayston SJ, 1998, SOIL BIOL BIOCHEM, V30, P369, DOI 10.1016/S0038-0717(97)00124-7; Hartmann M, 2006, FEMS MICROBIOL ECOL, V57, P378, DOI 10.1111/j.1574-6941.2006.00132.x; Hobbs PR, 2008, PHILOS T R SOC B, V363, P543, DOI 10.1098/rstb.2007.2169; Huse SM, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-7-r143; Imaz MJ, 2010, SOIL TILL RES, V107, P17, DOI 10.1016/j.still.2010.02.003; Koberl M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024452; Kuramae E, 2011, FEMS MICROBIOL ECOL, V77, P285, DOI 10.1111/j.1574-6941.2011.01110.x; Lagomarsino A, 2009, ECOL INDIC, V9, P518, DOI 10.1016/j.ecolind.2008.07.003; Laudicina VA, 2011, BIOL FERT SOILS, V47, P63, DOI 10.1007/s00374-010-0502-8; Lee SH, 2008, FEMS MICROBIOL LETT, V285, P263, DOI 10.1111/j.1574-6968.2008.01232.x; Liles MR, 2010, SOIL BIOL BIOCHEM, V42, P739, DOI 10.1016/j.soilbio.2010.01.007; Lupwayi NZ, 1998, SOIL BIOL BIOCHEM, V30, P1733, DOI 10.1016/S0038-0717(98)00025-X; Marschner P, 2004, PLANT SOIL, V261, P199, DOI 10.1023/B:PLSO.0000035569.80747.c5; Martiny JBH, 2006, NAT REV MICROBIOL, V4, P102, DOI 10.1038/nrmicro1341; Montgomery DR, 2007, P NATL ACAD SCI USA, V104, P13268, DOI 10.1073/pnas.0611508104; Mummey D, 2006, MICROB ECOL, V51, P404, DOI 10.1007/s00248-006-9020-5; Nacke H, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017000; Parameswaran P, 2007, NUCLEIC ACIDS RES, V35, DOI 10.1093/nar/gkm760; Philippot L, 2010, NAT REV MICROBIOL, V8, P523, DOI 10.1038/nrmicro2367; Pruesse E, 2007, NUCLEIC ACIDS RES, V35, P7188, DOI 10.1093/nar/gkm864; Romaniuk R, 2011, ECOL INDIC, V11, P1345, DOI 10.1016/j.ecolind.2011.02.008; Sait M, 2006, APPL ENVIRON MICROB, V72, P1852, DOI 10.1128/AEM.72.3.1852-1857.2006; Schloss PD, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027310; Schloss PD, 2009, APPL ENVIRON MICROB, V75, P7537, DOI 10.1128/AEM.01541-09; Schloter M, 2003, AGR ECOSYST ENVIRON, V98, P255, DOI 10.1016/S0167-8809(03)00085-9; Shukla MK, 2006, SOIL TILL RES, V87, P194, DOI 10.1016/j.still.2005.03.011; Smalla K, 2001, APPL ENVIRON MICROB, V67, P4742, DOI 10.1128/AEM.67.10.4742-4751.2001; Storey JD, 2003, P NATL ACAD SCI USA, V100, P9440, DOI 10.1073/pnas.1530509100; Viglizzo EF, 2011, GLOBAL CHANGE BIOL, V17, P959, DOI 10.1111/j.1365-2486.2010.02293.x; Wall LG, 2011, HDB MOL MICROBIAL EC; Ward NL, 2009, APPL ENVIRON MICROB, V75, P2046, DOI 10.1128/AEM.02294-08; Weon HY, 2009, INT J SYST EVOL MICR, V59, P406, DOI 10.1099/ijs.0.65856-0; Wu T, 2008, MICROB ECOL, V55, P293, DOI 10.1007/s00248-007-9276-4; Yemefack M, 2006, SOIL TILL RES, V86, P84, DOI 10.1016/j.still.2005.02.017; Yin CT, 2010, SOIL BIOL BIOCHEM, V42, P2111, DOI 10.1016/j.soilbio.2010.08.006; Zelles L, 1999, BIOL FERT SOILS, V29, P111, DOI 10.1007/s003740050533	59	74	80	2	89	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 30	2012	7	11							e51075	10.1371/journal.pone.0051075	http://dx.doi.org/10.1371/journal.pone.0051075			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	054WM	23226466	Green Published, gold			2022-12-27	WOS:000312376100277
J	Hanrahan, CF; Dorman, SE; Erasmus, L; Koornhof, H; Coetzee, G; Golub, JE				Hanrahan, Colleen F.; Dorman, Susan E.; Erasmus, Linda; Koornhof, Hendrik; Coetzee, Gerrit; Golub, Jonathan E.			The Impact of Expanded Testing for Multidrug Resistant Tuberculosis Using Geontype MTBDRplus in South Africa: An Observational Cohort Study	PLOS ONE			English	Article							DIAGNOSIS; RIFAMPIN; MTB/RIF	Introduction: Globally, multidrug resistant tuberculosis (MDR-TB) remains underdiagnosed. The Genotype MTBDRplus (R), a rapid drug susceptibility testing (DST) assay used to detect resistance to isoniazid and rifampicin in the diagnosis of MDR-TB, has good diagnostic accuracy, but its impact on patient outcomes in routine practice is unproven. We assessed the clinical impact of routine DST using MTBDRplus in a single health district in South Africa. Methods: Data were collected on all adult pulmonary TB patients registered at 25 public health clinics in the periods before and after introduction of an expanded DST algorithm using MTBDRplus version 1.0. Results: We collected data on 1176 TB patients before implementation and 1177 patients afterwards. In the before period, measured MDR-TB prevalence among new cases was 0.7% (95% CI1.4-3.1%), and among retreatment cases 6.2% (95% CI:3.5-8.8%), versus 3.7% (95% CI:2.4-5.0, p<0.01) and 6.6% (95% CI:3.8-9.4%, p = 0.83) respectively after MTBDRplus introduction. The median times from sputum collection to MDR treatment in the before and after periods were 78 days (IQR:52-93) and 62 days (IQR:32-86, p = 0.05), respectively. Among MDR-TB cases, 27% (95% CI:10-44) in the before period converted sputum cultures to negative by 8 months following treatment initiation, while 52% (95% CI:38-66) converted in the intervention period (p = 0.04). Conclusions: The expanded use of MTBDRplus DST resulted in a substantial increase in the proportion of new cases identified as MDR-TB; though time to MDR treatment was reduced, it was still over two months. Culture conversion for MDR-TB patients improved after introduction of MTBDRplus. This work illustrates the mixture of successes and challenges resulting from increased access to rapid DST in a setting with a high TB burden.	[Hanrahan, Colleen F.] Johns Hopkins Bloomberg Sch Publ Hlth, Dept Epidemiol, Baltimore, MD USA; [Hanrahan, Colleen F.; Golub, Jonathan E.] UNC Gilling Sch Global Publ Hlth, Dept Epidemiol, Chapel Hill, NC USA; [Dorman, Susan E.; Golub, Jonathan E.] Johns Hopkins Sch Med, Dept Med, Baltimore, MD USA; [Erasmus, Linda; Koornhof, Hendrik; Coetzee, Gerrit] Natl Hlth Lab Serv, Natl TB Reference Lab, Johannesburg, South Africa	Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Johns Hopkins University; Johns Hopkins Medicine; National Health Laboratory Service	Hanrahan, CF (corresponding author), Johns Hopkins Bloomberg Sch Publ Hlth, Dept Epidemiol, Baltimore, MD USA.	colleen_hanrahan@unc.edu		Hanrahan, Colleen/0000-0002-4544-4591	President's Emergency Plan for AIDS Relief, Center for Disease Control, "TB Strengthening in South Africa'' [U2G/PS001328-01]	President's Emergency Plan for AIDS Relief, Center for Disease Control, "TB Strengthening in South Africa''	This study was funded by the President's Emergency Plan for AIDS Relief, Center for Disease Control, "TB Strengthening in South Africa'', U2G/PS001328-01. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2008, GUID PROGR MAN DRUG; [Anonymous], 2010, MULTIDRUG EXTENSIVEL; [Anonymous], 2011, GLOB TUB CONTR; Barnard M, 2008, AM J RESP CRIT CARE, V177, P787, DOI 10.1164/rccm.200709-1436OC; Becton Dickinson, 2010, BBL MGIT MYC GROWTH, P1; Becton Dickinson, 2002, BACTEC MGIT 960 SIRE; Boehme CC, 2011, LANCET, V377, P1495, DOI 10.1016/S0140-6736(11)60438-8; Boehme CC, 2010, NEW ENGL J MED, V363, P1005, DOI 10.1056/NEJMoa0907847; Crudu V, 2012, J CLIN MICROBIOL, V50, P1264, DOI 10.1128/JCM.05903-11; Department of Health, 2009, S AFR NAT TUB MAN GU; Dowdy DW, 2008, P NATL ACAD SCI USA, V105, P11293, DOI 10.1073/pnas.0800965105; Enarson D.A., 2000, MANAGEMENT TUBERCULO; Grandjean L, 2008, CURR OPIN INFECT DIS, V21, P454, DOI 10.1097/QCO.0b013e32830ce783; Hain LifeScience GMBH, 2009, GENOTYPE MTBDRPLUS P; Lawn SD, 2012, INT J TUBERC LUNG D, V16, P701, DOI 10.5588/ijtld.12.0131; Ling DI, 2008, EUR RESPIR J, V32, P1165, DOI 10.1183/09031936.00061808; Meyer-Rath G, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036966; SANS 5999, 2004, TIN DET TIMB; WHO, 2011, POL STAT AUT REAL TI; World Health Organization, 2008, MOL LIN PROB ASS RAP	20	27	27	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 30	2012	7	11							e49898	10.1371/journal.pone.0049898	http://dx.doi.org/10.1371/journal.pone.0049898			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	054WM	23226229	gold, Green Submitted, Green Published			2022-12-27	WOS:000312376100037
J	Kassardjian, A; Rizkallah, R; Riman, S; Renfro, SH; Alexander, KE; Hurt, MM				Kassardjian, Ari; Rizkallah, Raed; Riman, Sarah; Renfro, Samuel H.; Alexander, Karen E.; Hurt, Myra M.			The Transcription Factor YY1 Is a Novel Substrate for Aurora B Kinase at G2/M Transition of the Cell Cycle	PLOS ONE			English	Article							HISTONE H3 PHOSPHORYLATION; NF-KAPPA-B; BINDING-PROTEIN; C-MYC; MITOTIC PHOSPHORYLATION; RETINOBLASTOMA PROTEIN; SKELETAL MYOGENESIS; CLEAVAGE FURROW; ADENOVIRUS E1A; YIN YANG-1	Yin Yang 1 (YY1) is a ubiquitously expressed and highly conserved multifunctional transcription factor that is involved in a variety of cellular processes. Many YY1-regulated genes have crucial roles in cell proliferation, differentiation, apoptosis, and cell cycle regulation. Numerous mechanisms have been shown to regulate the function of YY1, such as DNA binding affinity, subcellular localization, and posttranslational modification including phosphorylation. Polo-like kinase 1(Plk1) and Casein kinase 2 alpha (CK2 alpha) were the first two kinases identified to phosphorylate YY1. In this study, we identify a third kinase. We report that YY1 is a novel substrate of the Aurora B kinase both in vitro and in vivo. Serine 184 phosphorylation of YY1 by Aurora B is cell cycle regulated and peaks at G2/M and is rapidly dephosphorylated, likely by protein phosphatase 1 (PP1) as the cells enter G1. Aurora A and Aurora C can also phosphorylate YY1 in vitro, but at serine/threonine residues other than serine 184. We present evidence that phosphorylation of YY1 in the central glycine/alanine (G/A)-rich region is important for DNA binding activity, with a potential phosphorylation/acetylation interplay regulating YY1 function. Given their importance in mitosis and overexpression in human cancers, Aurora kinases have been identified as promising therapeutic targets. Increasing our understanding of Aurora substrates will add to the understanding of their signaling pathways.	[Kassardjian, Ari; Rizkallah, Raed; Riman, Sarah; Renfro, Samuel H.; Alexander, Karen E.; Hurt, Myra M.] Florida State Univ, Dept Biomed Sci, Tallahassee, FL 32306 USA; [Kassardjian, Ari] Florida State Univ, Inst Mol Biophys, Tallahassee, FL 32306 USA; [Riman, Sarah] Univ Minnesota, Dept Biochem Mol Biol & Biophys, Minneapolis, MN USA	State University System of Florida; Florida State University; State University System of Florida; Florida State University; University of Minnesota System; University of Minnesota Twin Cities	Hurt, MM (corresponding author), Florida State Univ, Dept Biomed Sci, Tallahassee, FL 32306 USA.	myra.hurt@med.fsu.edu		Rizkallah, Raed/0000-0001-8114-4935	FSU College of Medicine	FSU College of Medicine	This work was funded by FSU College of Medicine. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Affar E, 2006, MOL CELL BIOL, V26, P3565, DOI 10.1128/MCB.26.9.3565-3581.2006; Austen M, 1997, J BIOL CHEM, V272, P1709, DOI 10.1074/jbc.272.3.1709; Baritaki S, 2007, J IMMUNOL, V179, P5441, DOI 10.4049/jimmunol.179.8.5441; Belkina NV, 2009, P NATL ACAD SCI USA, V106, P4707, DOI 10.1073/pnas.0805963106; Bischoff JR, 1998, EMBO J, V17, P3052, DOI 10.1093/emboj/17.11.3052; Brown JL, 1998, MOL CELL, V1, P1057, DOI 10.1016/S1097-2765(00)80106-9; Carpinelli P, 2008, ADV EXP MED BIOL, V610, P54, DOI 10.1007/978-0-387-73898-7_5; Crosio C, 2002, MOL CELL BIOL, V22, P874, DOI 10.1128/MCB.22.3.874-885.2002; Cui Y, 2004, CANCER RES, V64, P9199, DOI 10.1158/0008-5472.CAN-04-2126; Delehouzee S, 2005, GENES CELLS, V10, P717, DOI 10.1111/j.1365-2443.2005.00873.x; DeManno DA, 1999, MOL ENDOCRINOL, V13, P91, DOI 10.1210/me.13.1.91; Deng ZY, 2007, MOL CELL BIOL, V27, P3780, DOI 10.1128/MCB.01761-06; Donohoe ME, 1999, MOL CELL BIOL, V19, P7237; Eliassen KA, 1998, MOL CELL BIOL, V18, P7106, DOI 10.1128/MCB.18.12.7106; FLANAGAN JR, 1995, CELL GROWTH DIFFER, V6, P185; Giet R, 1999, J CELL SCI, V112, P3591; GLOVER DM, 1995, CELL, V81, P95, DOI 10.1016/0092-8674(95)90374-7; Gordon S, 2006, ONCOGENE, V25, P1125, DOI 10.1038/sj.onc.1209080; Goto H, 2003, J BIOL CHEM, V278, P8526, DOI 10.1074/jbc.M210892200; Gully CP, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-42; Hayama S, 2007, CANCER RES, V67, P4113, DOI 10.1158/0008-5472.CAN-06-4705; Hergeth SP, 2011, J CELL SCI, V124, P1623, DOI 10.1242/jcs.084947; Hiromura M, 2003, J BIOL CHEM, V278, P14046, DOI 10.1074/jbc.M300789200; Hirota T, 2005, NATURE, V438, P1176, DOI 10.1038/nature04254; Honda R, 2003, MOL BIOL CELL, V14, P3325, DOI 10.1091/mbc.E02-11-0769; Hongo F, 2005, BIOCHEM BIOPH RES CO, V336, P692, DOI 10.1016/j.bbrc.2005.08.150; Huerta-Yepez S, 2006, CLIN IMMUNOL, V120, P297, DOI 10.1016/j.clim.2006.03.015; Katayama Hiroshi, 2003, Cancer and Metastasis Reviews, V22, P451, DOI 10.1023/A:1023789416385; Kawajiri A, 2003, MOL BIOL CELL, V14, P1489, DOI 10.1091/mbc.E02-09-0612; Kettenbach AN, 2011, SCI SIGNAL, V4, DOI 10.1126/scisignal.2001497; Klein UR, 2006, MOL BIOL CELL, V17, P2547, DOI 10.1091/mbc.E05-12-1133; LEE JS, 1995, GENE DEV, V9, P1188, DOI 10.1101/gad.9.10.1188; Liu D, 2010, J CELL BIOL, V188, P809, DOI 10.1083/jcb.201001006; Lo WS, 2000, MOL CELL, V5, P917, DOI 10.1016/S1097-2765(00)80257-9; Maldonado E, 1996, NATURE, V381, P86, DOI 10.1038/381086a0; Mohan RD, 2010, NUCLEIC ACIDS RES, V38, P1135, DOI 10.1093/nar/gkp1097; Molina H, 2007, P NATL ACAD SCI USA, V104, P2199, DOI 10.1073/pnas.0611217104; Murnion ME, 2001, J BIOL CHEM, V276, P26656, DOI 10.1074/jbc.M102288200; Nair JS, 2009, MOL BIOL CELL, V20, P2218, DOI 10.1091/mbc.E08-08-0885; Nigg EA, 2001, NAT REV MOL CELL BIO, V2, P21, DOI 10.1038/35048096; Oei S L, 1997, Rev Physiol Biochem Pharmacol, V131, P127; Oei SL, 1998, J BIOL CHEM, V273, P31644, DOI 10.1074/jbc.273.48.31644; Oh HJ, 2010, CURR BIOL, V20, P416, DOI 10.1016/j.cub.2009.12.054; Palko L, 2004, J CELL SCI, V117, P465, DOI 10.1242/jcs.00870; Pascreau G, 2008, DEV BIOL, V317, P523, DOI 10.1016/j.ydbio.2008.02.053; Perrera C, 2010, J BIOL CHEM, V285, P11775, DOI 10.1074/jbc.M109.068312; Petkova V, 2001, J BIOL CHEM, V276, P7932, DOI 10.1074/jbc.M007411200; Petronczki M, 2008, DEV CELL, V14, P646, DOI 10.1016/j.devcel.2008.04.014; Prigent C, 2003, J CELL SCI, V116, P3677, DOI 10.1242/jcs.00735; Ren GL, 2009, INT J BIOCHEM CELL B, V41, P1094, DOI 10.1016/j.biocel.2008.10.015; RIGGS KJ, 1993, MOL CELL BIOL, V13, P7487, DOI 10.1128/MCB.13.12.7487; Riman S, 2012, MOL CELL BIOL, V32, P797, DOI 10.1128/MCB.06466-11; Rizkallah R, 2011, CELL CYCLE, V10, P3327, DOI 10.4161/cc.10.19.17619; Rizkallah R, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0015928; Rizkallah R, 2009, MOL BIOL CELL, V20, P4766, DOI 10.1091/mbc.E09-04-0264; Sakita-Suto S, 2007, MOL BIOL CELL, V18, P1107, DOI 10.1091/mbc.E06-11-1021; Santiago FS, 2001, J BIOL CHEM, V276, P41143, DOI 10.1074/jbc.M104913200; Schmitt A, 2002, FEBS LETT, V518, P23, DOI 10.1016/S0014-5793(02)02630-3; Shi Y, 1997, BBA-REV CANCER, V1332, pF49, DOI 10.1016/S0304-419X(96)00044-3; SHI Y, 1991, CELL, V67, P377, DOI 10.1016/0092-8674(91)90189-6; Shrivastava A, 1996, P NATL ACAD SCI USA, V93, P10638, DOI 10.1073/pnas.93.20.10638; SHRIVASTAVA A, 1993, SCIENCE, V262, P1889, DOI 10.1126/science.8266081; Stewart S, 2005, CANCER RES, V65, P8730, DOI 10.1158/0008-5472.CAN-05-1500; Sugiyama K, 2002, ONCOGENE, V21, P3103, DOI 10.1038/sj.onc.1205432; Sui GC, 2004, CELL, V117, P859, DOI 10.1016/j.cell.2004.06.004; Sullivan M, 2007, NAT REV MOL CELL BIO, V8, P894, DOI 10.1038/nrm2276; Takasaki N, 2007, EMBO J, V26, P1649, DOI 10.1038/sj.emboj.7601619; Taylor S, 2008, CURR OPIN CELL BIOL, V20, P77, DOI 10.1016/j.ceb.2007.11.008; Terada Y, 1998, EMBO J, V17, P667, DOI 10.1093/emboj/17.3.667; USHEVA A, 1994, CELL, V76, P1115, DOI 10.1016/0092-8674(94)90387-5; Vader G, 2008, BBA-REV CANCER, V1786, P60, DOI 10.1016/j.bbcan.2008.07.003; Vadlamudi RK, 2000, J BIOL CHEM, V275, P36238, DOI 10.1074/jbc.M002138200; Wang H, 2008, CANCER CELL, V14, P369, DOI 10.1016/j.ccr.2008.10.006; Wang HT, 2007, MOL CELL BIOL, V27, P4374, DOI 10.1128/MCB.02020-06; Wang XL, 2008, BBA-MOL CELL RES, V1783, P1876, DOI 10.1016/j.bbamcr.2008.05.015; Whitfield ML, 2000, MOL CELL BIOL, V20, P4188, DOI 10.1128/MCB.20.12.4188-4198.2000; Wu LM, 2011, J BIOL CHEM, V286, P2236, DOI 10.1074/jbc.M110.174755; Wurzenberger C, 2011, NAT REV MOL CELL BIO, V12, P469, DOI 10.1038/nrm3149; Yang CY, 2011, MOL CELL, V44, P597, DOI 10.1016/j.molcel.2011.09.016; Yang H, 2004, CANCER RES, V64, P463, DOI 10.1158/0008-5472.CAN-03-2907; Yang WM, 1996, P NATL ACAD SCI USA, V93, P12845, DOI 10.1073/pnas.93.23.12845; Yao YL, 2001, MOL CELL BIOL, V21, P5979, DOI 10.1128/MCB.21.17.5979-5991.2001; Yasui Y, 2004, J BIOL CHEM, V279, P12997, DOI 10.1074/jbc.M311128200; Zaravinos A, 2010, CELL CYCLE, V9, P512, DOI 10.4161/cc.9.3.10588; Zaravinos A, 2009, CELL CYCLE, V8, P1402, DOI 10.4161/cc.8.9.8308	85	23	24	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 30	2012	7	11							e50645	10.1371/journal.pone.0050645	http://dx.doi.org/10.1371/journal.pone.0050645			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	054WM	23226345	Green Published, Green Submitted, gold			2022-12-27	WOS:000312376100156
J	Madureira, PA; Hill, R; Lee, PWK; Waisman, DM				Madureira, Patricia A.; Hill, Richard; Lee, Patrick W. K.; Waisman, David M.			Genotoxic Agents Promote the Nuclear Accumulation of Annexin A2: Role of Annexin A2 in Mitigating DNA Damage	PLOS ONE			English	Article							OXIDATIVE STRESS; TYROSINE KINASE; II TETRAMER; CA2+-BINDING SITES; CELLULAR-RESPONSE; CRYSTAL-STRUCTURE; PROTEIN-KINASES; EXPORT SIGNAL; HISTONE H2AX; CALPACTIN-I	Annexin A2 is an abundant cellular protein that is mainly localized in the cytoplasm and plasma membrane, however a small population has been found in the nucleus, suggesting a nuclear function for the protein. Annexin A2 possesses a nuclear export sequence (NES) and inhibition of the NES is sufficient to cause nuclear accumulation. Here we show that annexin A2 accumulates in the nucleus in response to genotoxic agents including gamma-radiation, UV radiation, etoposide and chromium VI and that this event is mediated by the nuclear export sequence of annexin A2. Nuclear accumulation of annexin A2 is blocked by the antioxidant agent N-acetyl cysteine (NAC) and stimulated by hydrogen peroxide (H2O2), suggesting that this is a reactive oxygen species dependent event. In response to genotoxic agents, cells depleted of annexin A2 show enhanced phospho-histone H2AX and p53 levels, increased numbers of p53-binding protein 1 nuclear foci and increased levels of nuclear 8-oxo-2'-deoxyguanine, suggesting that annexin A2 plays a role in protecting DNA from damage. This is the first report showing the nuclear translocation of annexin A2 in response to genotoxic agents and its role in mitigating DNA damage.	[Madureira, Patricia A.; Waisman, David M.] Dalhousie Univ, Dept Biochem & Mol Biol, Halifax, NS, Canada; [Madureira, Patricia A.; Waisman, David M.] Dalhousie Univ, Dept Pathol, Halifax, NS, Canada; [Hill, Richard; Lee, Patrick W. K.] Dalhousie Univ, Dept Microbiol & Immunol, Halifax, NS, Canada; [Madureira, Patricia A.] Univ Algarve, Ctr Mol & Struct Biomed, Faro, Portugal	Dalhousie University; Dalhousie University; Dalhousie University; Universidade do Algarve	Waisman, DM (corresponding author), Dalhousie Univ, Dept Biochem & Mol Biol, Halifax, NS, Canada.	david.waisman@dal.ca	Madureira, Patricia/F-4656-2012; Madureira, Patricia A/C-9666-2013	Madureira, Patricia/0000-0002-4856-3908; Madureira, Patricia A/0000-0002-4856-3908; Hill, Richard/0000-0003-0394-6048; Waisman, David/0000-0002-5097-9662	Natural Sciences and Engineering Research Council of Canada (NSERC); European Union [PCOFUND-GA-2009-246542]; Foundation for Science and Technology of Portugal; Beatrice Hunter Cancer Research Institute; Terry Fox Foundation	Natural Sciences and Engineering Research Council of Canada (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC)); European Union(European Commission); Foundation for Science and Technology of Portugal(Portuguese Foundation for Science and Technology); Beatrice Hunter Cancer Research Institute; Terry Fox Foundation	This work was supported by a grant from the Natural Sciences and Engineering Research Council of Canada (NSERC) to DMW. The research performed by Patricia A. Madureira leading to these results has received funding from the European Union Seventh Framework Programme (FP7/2007-2013) under grant agreement no PCOFUND-GA-2009-246542 and from the Foundation for Science and Technology of Portugal. Patricia A. Madureira was supported by a trainee award from The Beatrice Hunter Cancer Research Institute with funds provided by The Terry Fox Foundation Strategic Health Research Training Program in Cancer Research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ARRIGO AP, 1983, EMBO J, V2, P309, DOI 10.1002/j.1460-2075.1983.tb01424.x; BAGCHI D, 1995, COMP BIOCHEM PHYS C, V110, P177, DOI 10.1016/0742-8413(94)00093-P; BECKER T, 1990, EMBO J, V9, P4207, DOI 10.1002/j.1460-2075.1990.tb07868.x; Caplan JF, 2004, J BIOL CHEM, V279, P7740, DOI 10.1074/jbc.M313049200; Choi KS, 2001, J BIOL CHEM, V276, P25212, DOI 10.1074/jbc.M101426200; Clark GB, 1998, PLANT PHYSIOL BIOCH, V36, P621, DOI 10.1016/S0981-9428(98)80010-7; COURTNEIDGE S, 1983, MOL CELL BIOL, V3, P340, DOI 10.1128/MCB.3.3.340; Crampton N, 2009, MOL BIOL CELL, V20, P5106, DOI 10.1091/mbc.E09-05-0397; Deora AB, 2004, J BIOL CHEM, V279, P43411, DOI 10.1074/jbc.M408078200; Eberhard DA, 2001, J CELL SCI, V114, P3155; Fernandez-Capetillo O, 2002, NAT CELL BIOL, V4, P993, DOI 10.1038/ncb884; Filipenko NR, 2000, J BIOL CHEM, V275, P38877, DOI 10.1074/jbc.M004125200; Filipenko NR, 2004, J BIOL CHEM, V279, P8723, DOI 10.1074/jbc.M311951200; Filipenko NR, 2001, J BIOL CHEM, V276, P5310, DOI 10.1074/jbc.M009710200; Gama-Carvalho M, 2001, FEBS LETT, V498, P157, DOI 10.1016/S0014-5793(01)02487-5; GERKE V, 1985, EMBO J, V4, P2917, DOI 10.1002/j.1460-2075.1985.tb04023.x; Gerke V, 2005, NAT REV MOL CELL BIO, V6, P449, DOI 10.1038/nrm1661; Gorecka KM, 2005, BIOCHEM BIOPH RES CO, V336, P868, DOI 10.1016/j.bbrc.2005.08.181; Gorlich D, 1996, SCIENCE, V271, P1513, DOI 10.1126/science.271.5255.1513; GOULD KL, 1986, MOL CELL BIOL, V6, P2738, DOI 10.1128/MCB.6.7.2738; Henderson BR, 2000, EXP CELL RES, V256, P213, DOI 10.1006/excr.2000.4825; Hill R, 2008, CELL CYCLE, V7, P2535; Hofmann A, 2003, EUR J BIOCHEM, V270, P2557, DOI 10.1046/j.1432-1033.2003.03612.x; JINDAL HK, 1991, J BIOL CHEM, V266, P5169; Johnson C, 1999, EMBO J, V18, P6682, DOI 10.1093/emboj/18.23.6682; JOHNSSON N, 1988, EMBO J, V7, P2435, DOI 10.1002/j.1460-2075.1988.tb03089.x; JOST M, 1992, EUR J BIOCHEM, V207, P923, DOI 10.1111/j.1432-1033.1992.tb17125.x; JOST M, 1994, BIOCHEM J, V298, P553, DOI 10.1042/bj2980553; Kassam G, 1997, J BIOL CHEM, V272, P15093, DOI 10.1074/jbc.272.24.15093; KASTAN MB, 1991, CANCER RES, V51, P6304; Konopka-Postupolska D, 2009, PLANT PHYSIOL, V150, P1394, DOI 10.1104/pp.109.135228; Kovacs I, 1998, PLANT J, V15, P185, DOI 10.1046/j.1365-313X.1998.00194.x; KUERBITZ SJ, 1992, P NATL ACAD SCI USA, V89, P7491, DOI 10.1073/pnas.89.16.7491; Liu Jie, 2003, BMC Biochem, V4, P10, DOI 10.1186/1471-2091-4-10; Luo W, 2008, MOL CARCINOGEN, V47, P934, DOI 10.1002/mc.20445; Madureira PA, 2011, ONCOTARGET, V2, P1075, DOI 10.18632/oncotarget.375; Mah LJ, 2010, LEUKEMIA, V24, P679, DOI 10.1038/leu.2010.6; Matsuda D, 2006, EXP CELL RES, V312, P1205, DOI 10.1016/j.yexcr.2006.02.003; Michael WM, 2000, TRENDS CELL BIOL, V10, P46, DOI 10.1016/S0962-8924(99)01695-5; Morel E, 2009, J BIOL CHEM, V284, P1604, DOI 10.1074/jbc.M806499200; Moss SE, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-4-219; Rappold I, 2001, J CELL BIOL, V153, P613, DOI 10.1083/jcb.153.3.613; Rety S, 1999, NAT STRUCT BIOL, V6, P89; Rezvanpour A, 2009, GEN PHYSIOL BIOPHYS, V28, pF39; Rhee NJ, 2000, EUR J BIOCHEM, V267, P3220, DOI 10.1046/j.1432-1327.2000.01345.x; Rogakou EP, 1998, J BIOL CHEM, V273, P5858, DOI 10.1074/jbc.273.10.5858; Sacre SM, 2002, EXP CELL RES, V274, P254, DOI 10.1006/excr.2002.5469; Schultz LB, 2000, J CELL BIOL, V151, P1381, DOI 10.1083/jcb.151.7.1381; van Loon B, 2010, DNA REPAIR, V9, P604, DOI 10.1016/j.dnarep.2010.03.004; Venetsanakos E, 2002, EXP CELL RES, V273, P21, DOI 10.1006/excr.2001.5424; VISHWANATHA JK, 1992, J CELL SCI, V101, P25; WAISMAN DM, 1995, MOL CELL BIOCHEM, V149, P301, DOI 10.1007/BF01076592; WOLFF B, 1988, EXP CELL RES, V178, P318, DOI 10.1016/0014-4827(88)90402-8; YONEDA Y, 1987, EXP CELL RES, V173, P586, DOI 10.1016/0014-4827(87)90297-7; ZOKAS L, 1987, J CELL BIOL, V105, P2111, DOI 10.1083/jcb.105.5.2111	55	27	32	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 30	2012	7	11							e50591	10.1371/journal.pone.0050591	http://dx.doi.org/10.1371/journal.pone.0050591			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	054WM	23226323	Green Published, gold			2022-12-27	WOS:000312376100135
J	Popiel, HA; Takeuchi, T; Fujita, H; Yamamoto, K; Ito, C; Yamane, H; Muramatsu, S; Toda, T; Wada, K; Nagai, Y				Popiel, H. Akiko; Takeuchi, Toshihide; Fujita, Hiromi; Yamamoto, Kazuhiro; Ito, Chiyomi; Yamane, Hiroshi; Muramatsu, Shin-ichi; Toda, Tatsushi; Wada, Keiji; Nagai, Yoshitaka			Hsp40 Gene Therapy Exerts Therapeutic Effects on Polyglutamine Disease Mice via a Non-Cell Autonomous Mechanism	PLOS ONE			English	Article							HUNTINGTONS-DISEASE; PROTEIN AGGREGATION; MOUSE MODEL; NEURODEGENERATION; SUPPRESSION; HEAT-SHOCK-PROTEIN-70; OVEREXPRESSION; PATHOGENESIS; CHAPERONES; TOXICITY	The polyglutamine (polyQ) diseases such as Huntington's disease (HD), are neurodegenerative diseases caused by proteins with an expanded polyQ stretch, which misfold and aggregate, and eventually accumulate as inclusion bodies within neurons. Molecules that inhibit polyQ protein misfolding/aggregation, such as Polyglutamine Binding Peptide 1 (QBP1) and molecular chaperones, have been shown to exert therapeutic effects in vivo by crossing of transgenic animals. Towards developing a therapy using these aggregation inhibitors, we here investigated the effect of viral vector-mediated gene therapy using QBP1 and molecular chaperones on polyQ disease model mice. We found that injection of adeno-associated virus type 5 (AAV5) expressing QBP1 or Hsp40 into the striatum both dramatically suppresses inclusion body formation in the HD mouse R6/2. AAV5-Hsp40 injection also ameliorated the motor impairment and extended the lifespan of R6/2 mice. Unexpectedly, we found even in virus non-infected cells that AAV5-Hsp40 appreciably suppresses inclusion body formation, suggesting a non-cell autonomous therapeutic effect. We further show that Hsp40 inhibits secretion of the polyQ protein from cultured cells, implying that it inhibits the recently suggested cell-cell transmission of the polyQ protein. Our results demonstrate for the first time the therapeutic effect of Hsp40 gene therapy on the neurological phenotypes of polyQ disease mice.	[Popiel, H. Akiko; Takeuchi, Toshihide; Fujita, Hiromi; Yamane, Hiroshi; Wada, Keiji; Nagai, Yoshitaka] Natl Ctr Neurol & Psychiat, Natl Inst Neurosci, Dept Degenerat Neurol Dis, Kodaira, Tokyo 187, Japan; [Yamamoto, Kazuhiro] Natl Ctr Neurol & Psychiat, Natl Inst Neurosci, Div Lab Anim Resources, Kodaira, Tokyo 187, Japan; [Ito, Chiyomi; Toda, Tatsushi] Kobe Univ, Grad Sch Med, Div Neurol Mol Brain Sci, Kobe, Hyogo 657, Japan; [Muramatsu, Shin-ichi] Jichi Med Univ, Dept Med, Div Neurol, Shimotsuke, Tochigi, Japan; [Nagai, Yoshitaka] Japan Sci & Technol Agcy, CREST, Kawaguchi, Saitama, Japan	National Center for Neurology & Psychiatry - Japan; National Center for Neurology & Psychiatry - Japan; Kobe University; Jichi Medical University; Japan Science & Technology Agency (JST)	Nagai, Y (corresponding author), Natl Ctr Neurol & Psychiat, Natl Inst Neurosci, Dept Degenerat Neurol Dis, Kodaira, Tokyo 187, Japan.	nagai@ncnp.go.jp	Muramatsu, Shinichi/ABC-6093-2021; Muramatsu, Shin-ichi/K-9420-2013	Muramatsu, Shinichi/0000-0002-3185-7790; Muramatsu, Shin-ichi/0000-0002-3185-7790	Ministry of Education, Culture, Sports, Science, and Technology, Japan; Japan Society for the Promotion of Science, Japan; Ministry of Health, Labor and Welfare, Japan; Grants-in-Aid for Scientific Research [23390237, 21200072] Funding Source: KAKEN	Ministry of Education, Culture, Sports, Science, and Technology, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japan Society for the Promotion of Science, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Ministry of Health, Labor and Welfare, Japan(Ministry of Health, Labour and Welfare, Japan); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported in part by Grants-in-Aid for Scientific Research on Priority Areas (Research on Pathomechanisms of Brain Disorders and Protein Community to Y.N.), and on Innovative Areas (Synapse and Neurocircuit Pathology to Y.N. and S.M.) and by a Comprehensive Brain Science Network Award for Young Scientists to H.A.P., from the Ministry of Education, Culture, Sports, Science, and Technology, Japan; by Grants-in-Aid for Scientific Research (B) to Y.N., for Young Scientists (B) to H.A.P., from the Japan Society for the Promotion of Science, Japan; by a Grant-in-Aid for the Research Committee for Ataxic Diseases to Y.N. and a Grant-in-Aid for the Research Committee of CNS Degenerative Diseases to S.M. from the Ministry of Health, Labor and Welfare, Japan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adachi H, 2003, J NEUROSCI, V23, P2203; Aguzzi A, 2009, NEURON, V64, P783, DOI 10.1016/j.neuron.2009.12.016; Bates G, 2003, LANCET, V361, P1642, DOI 10.1016/S0140-6736(03)13304-1; Bauer PO, 2010, NAT BIOTECHNOL, V28, P256, DOI 10.1038/nbt.1608; Bauer PO, 2009, J NEUROCHEM, V110, P1737, DOI 10.1111/j.1471-4159.2009.06302.x; BOBO RH, 1994, P NATL ACAD SCI USA, V91, P2076, DOI 10.1073/pnas.91.6.2076; Brundin P, 2010, NAT REV MOL CELL BIO, V11, P301, DOI 10.1038/nrm2873; Calderwood SK, 2007, FEBS LETT, V581, P3689, DOI 10.1016/j.febslet.2007.04.044; Chan HYE, 2000, HUM MOL GENET, V9, P2811, DOI 10.1093/hmg/9.19.2811; Cummings CJ, 2001, HUM MOL GENET, V10, P1511, DOI 10.1093/hmg/10.14.1511; Davidson BL, 2003, NAT REV NEUROSCI, V4, P353, DOI 10.1038/nrn1104; Fernandez-Funez P, 2000, NATURE, V408, P101, DOI 10.1038/35040584; Frost B, 2010, NAT REV NEUROSCI, V11, P155, DOI 10.1038/nrn2786; Goodenough DA, 2009, CSH PERSPECT BIOL, V1, DOI 10.1101/cshperspect.a002576; Gusella JF, 2000, NAT REV NEUROSCI, V1, P109, DOI 10.1038/35039051; Hageman J, 2010, MOL CELL, V37, P355, DOI 10.1016/j.molcel.2010.01.001; Hansson O, 2003, BRAIN RES, V970, P47, DOI 10.1016/S0006-8993(02)04275-0; Hartl FU, 2011, NATURE, V475, P324, DOI 10.1038/nature10317; Hay DG, 2004, HUM MOL GENET, V13, P1389, DOI 10.1093/hmg/ddh144; Herbst M, 2006, CURR PHARM DESIGN, V12, P2543, DOI 10.2174/138161206777698828; Herrera F, 2011, PLOS CURR, V11, P3; Howarth JL, 2007, MOL THER, V15, P1100, DOI 10.1038/sj.mt.6300163; Kampinga HH, 2010, NAT REV MOL CELL BIO, V11, P579, DOI 10.1038/nrm2941; Kazemi-Esfarjani P, 2000, SCIENCE, V287, P1837, DOI 10.1126/science.287.5459.1837; Labbadia J, 2012, BRAIN; Lee SJ, 2010, NAT REV NEUROL, V6, P702, DOI 10.1038/nrneurol.2010.145; Liberek K, 2008, EMBO J, V27, P328, DOI 10.1038/sj.emboj.7601970; Mangiarini L, 1996, CELL, V87, P493, DOI 10.1016/S0092-8674(00)81369-0; Michalik A, 2003, HUM MOL GENET, V12, pR173, DOI 10.1093/hmg/ddg295; Muramatsu S, 2010, MOL THER, V18, P1731, DOI 10.1038/mt.2010.135; Nagai Y, 2003, HUM MOL GENET, V12, P1253, DOI 10.1093/hmg/ddg144; Nagai Y, 2000, J BIOL CHEM, V275, P10437, DOI 10.1074/jbc.275.14.10437; Nagai Y, 2007, NAT STRUCT MOL BIOL, V14, P332, DOI 10.1038/nsmb1215; Nagai Y, 2008, CURR PHARM DESIGN, V14, P3267, DOI 10.2174/138161208786404164; OHTSUKA K, 1993, BIOCHEM BIOPH RES CO, V197, P235, DOI 10.1006/bbrc.1993.2466; Okada T, 2002, METHODS, V28, P237, DOI 10.1016/S1046-2023(02)00228-1; Orr HT, 2007, ANNU REV NEUROSCI, V30, P575, DOI 10.1146/annurev.neuro.29.051605.113042; Popiel HA, 2011, J AMINO ACIDS, V2011; Ren PH, 2009, NAT CELL BIOL, V11, P219, DOI 10.1038/ncb1830; Ross CA, 2005, NAT REV MOL CELL BIO, V6, P891, DOI 10.1038/nrm1742; Satyal SH, 2000, P NATL ACAD SCI USA, V97, P5750, DOI 10.1073/pnas.100107297; Shao J, 2007, HUM MOL GENET, V16, pR115, DOI 10.1093/hmg/ddm213; Warrick JM, 1999, NAT GENET, V23, P425, DOI 10.1038/70532; Williams AJ, 2008, TRENDS NEUROSCI, V31, P521, DOI 10.1016/j.tins.2008.07.004	44	31	31	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 30	2012	7	11							e51069	10.1371/journal.pone.0051069	http://dx.doi.org/10.1371/journal.pone.0051069			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	054WM	23226463	Green Published, Green Submitted, gold			2022-12-27	WOS:000312376100274
J	Roux, FE; Durand, JB; Jucla, M; Rehault, E; Reddy, M; Demonet, JF				Roux, Franck-Emmanuel; Durand, Jean-Baptiste; Jucla, Melanie; Rehault, Emilie; Reddy, Marion; Demonet, Jean-Francois			Segregation of Lexical and Sub-Lexical Reading Processes in the Left Perisylvian Cortex	PLOS ONE			English	Article							SUPERIOR TEMPORAL GYRUS; CORTICAL AREAS; BRAIN MECHANISMS; WORD; CONNECTIVITY; STIMULATION; LANGUAGE; ANATOMY; MODEL	A fundamental issue in cognitive neuroscience is the existence of two major, sub-lexical and lexical, reading processes and their possible segregation in the left posterior perisylvian cortex. Using cortical electrostimulation mapping, we identified the cortical areas involved on reading either orthographically irregular words (lexical, "direct" process) or pronounceable pseudowords (sublexical, "indirect" process) in 14 right-handed neurosurgical patients while video-recording behavioral effects. Intraoperative neuronavigation system and Montreal Neurological Institute (MNI) stereotactic coordinates were used to identify the localization of stimulation sites. Fifty-one reading interference areas were found that affected either words (14 areas), or pseudo-words (11 areas), or both (26 areas). Forty-one (80%) corresponded to the impairment of the phonological level of reading processes. Reading processes involved discrete, highly localized perisylvian cortical areas with individual variability. MNI coordinates throughout the group exhibited a clear segregation according to the tested reading route; specific pseudo-word reading interferences were concentrated in a restricted inferior and anterior subpart of the left supramarginal gyrus (barycentre x = -68.1; y = -25.9; z = 30.2; Brodmann's area 40) while specific word reading areas were located almost exclusively alongside the left superior temporal gyrus. Although half of the reading interferences found were nonspecific, the finding of specific lexical or sublexical interferences is new evidence that lexical and sublexical processes of reading could be partially supported by distinct cortical sub-regions despite their anatomical proximity. These data are in line with many brain activation studies that showed that left superior temporal and inferior parietal regions had a crucial role respectively in word and pseudoword reading and were core regions for dyslexia.	[Roux, Franck-Emmanuel; Jucla, Melanie; Rehault, Emilie; Demonet, Jean-Francois] IFR 96, UMR Unite 825, Fac Paul Sabatier, Toulouse, France; [Roux, Franck-Emmanuel; Reddy, Marion; Demonet, Jean-Francois] Ctr Hosp Univ, Toulouse, France; [Durand, Jean-Baptiste] Ctr Rech Cerveau & Cognit, Toulouse, France; [Jucla, Melanie] Univ Toulouse 2, URI Octogone Lordat 4156, Toulouse, France	Universite de Toulouse; Universite Toulouse III - Paul Sabatier; CHU de Toulouse; Universite de Toulouse; Universite Toulouse III - Paul Sabatier; Centre National de la Recherche Scientifique (CNRS); Universite de Toulouse; Universite de Toulouse - Jean Jaures	Roux, FE (corresponding author), IFR 96, UMR Unite 825, Fac Paul Sabatier, Toulouse, France.	franck_emmanuel.roux@yahoo.fr	DURAND, Jean-Baptiste/E-9252-2011; Durand, Jean-Baptiste/ABE-9090-2020	DURAND, Jean-Baptiste/0000-0003-4780-8691; Demonet, Jean-Francois/0000-0003-0100-6175				BEAUVOIS MF, 1979, J NEUROL NEUROSUR PS, V42, P1115, DOI 10.1136/jnnp.42.12.1115; Binder JR, 2005, NEUROIMAGE, V27, P677, DOI 10.1016/j.neuroimage.2005.04.029; Caspers S, 2006, NEUROIMAGE, V33, P430, DOI 10.1016/j.neuroimage.2006.06.054; Cattinelli I, J NEUROLING IN PRESS; Coltheart M, 2001, PSYCHOL REV, V108, P204, DOI 10.1037//0033-295X.108.1.204; Coltheart M, 1980, DEEP DYSLEXIA; Deloche G, 1997, TEST DENOMINATION OR; DEMONET JF, 1992, BRAIN, V115, P1753, DOI 10.1093/brain/115.6.1753; Fiez JA, 2006, CORTEX, V42, P624, DOI 10.1016/S0010-9452(08)70399-X; FUNNELL E, 1983, BRIT J PSYCHOL, V74, P159, DOI 10.1111/j.2044-8295.1983.tb01851.x; Graves WW, 2008, J COGNITIVE NEUROSCI, V20, P1698, DOI 10.1162/jocn.2008.20113; Graves WW, 2010, CEREB CORTEX, V20, P1799, DOI 10.1093/cercor/bhp245; HAGLUND MM, 1993, J NEUROSURG, V78, P785, DOI 10.3171/jns.1993.78.5.0785; HILLIS AE, 1995, COGNITIVE NEUROPSYCH, V12, P187, DOI 10.1080/02643299508251996; Hodges JR, 2007, LANCET NEUROL, V6, P1004, DOI 10.1016/S1474-4422(07)70266-1; Horwitz B, 1998, P NATL ACAD SCI USA, V95, P8939, DOI 10.1073/pnas.95.15.8939; Jobard G, 2003, NEUROIMAGE, V20, P693, DOI 10.1016/S1053-8119(03)00343-4; Joubert S, 2004, BRAIN LANG, V89, P9, DOI 10.1016/S0093-934X(03)00403-6; Levy J, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006675; Levy J, 2008, NEUROIMAGE, V43, P581, DOI 10.1016/j.neuroimage.2008.08.008; Mandonnet E, 2007, BRAIN, V130, P623, DOI 10.1093/brain/awl361; MARSHALL JC, 1973, J PSYCHOLINGUIST RES, V2, P175, DOI 10.1007/BF01067101; McIntyre CC, 2002, J NEUROPHYSIOL, V87, P995, DOI 10.1152/jn.00353.2001; Mechelli A, 2003, J COGNITIVE NEUROSCI, V15, P260, DOI 10.1162/089892903321208196; Morton J., 1980, DEEP DYSLEXIA; NATHAN SS, 1993, ELECTROEN CLIN NEURO, V86, P183, DOI 10.1016/0013-4694(93)90006-H; Nespoulous J.-L., 1992, PROTOCOLE MONTREAL T, V2nd; Nosarti C, 2010, CEREB CORTEX, V20, P315, DOI 10.1093/cercor/bhp101; Ojemann G, 1989, BRAIN MECH COGNITION; OLDFIELD RC, 1971, NEUROPSYCHOLOGIA, V9, P97, DOI 10.1016/0028-3932(71)90067-4; PATTERSON K, 1992, NEUROPSYCHOLOGIA, V30, P1025, DOI 10.1016/0028-3932(92)90096-5; PAULESU E, 1993, NATURE, V362, P342, DOI 10.1038/362342a0; Penfield W., 1959, SPEECH BRAIN MECH; PETERSEN SE, 1990, SCIENCE, V249, P1041, DOI 10.1126/science.2396097; Peterson RL, 2012, LANCET, V379, P1997, DOI 10.1016/S0140-6736(12)60198-6; Price CJ, 2003, BRAIN LANG, V86, P272, DOI 10.1016/S0093-934X(02)00544-8; Price CJ, 1998, TRENDS COGN SCI, V2, P281, DOI 10.1016/S1364-6613(98)01201-7; Rapcsak SZ, 2009, CORTEX, V45, P575, DOI 10.1016/j.cortex.2008.04.006; Richlan F, HUM BRAIN M IN PRESS; Roux FE, 2008, NEUROLOGY, V70, P210, DOI 10.1212/01.wnl.0000297194.14452.a0; Roux FE, 2004, BRAIN, V127, P1796, DOI 10.1093/brain/awh204; Roux FE, 2007, J NEUROSURG, V106, P1017, DOI 10.3171/jns.2007.106.6.1017; Simos PG, 2002, CEREB CORTEX, V12, P297, DOI 10.1093/cercor/12.3.297; Simos PG, 2000, NEUROREPORT, V11, P2443, DOI 10.1097/00001756-200008030-00021; Wilson TW, 2007, EXP BRAIN RES, V180, P247, DOI 10.1007/s00221-007-0852-0; Woollams AM, 2011, J COGNITIVE NEUROSCI, V23, P992, DOI 10.1162/jocn.2010.21502; Xu B, 2001, CEREB CORTEX, V11, P267, DOI 10.1093/cercor/11.3.267	47	30	30	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 30	2012	7	11							e50665	10.1371/journal.pone.0050665	http://dx.doi.org/10.1371/journal.pone.0050665			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	054WM	23226349	gold, Green Published, Green Submitted			2022-12-27	WOS:000312376100160
J	Feliciano, L; Li, JR; Lee, J; Pascall, MA				Feliciano, Lizanel; Li, Jianrong; Lee, Jaesung; Pascall, Melvin A.			Efficacies of Sodium Hypochlorite and Quaternary Ammonium Sanitizers for Reduction of Norovirus and Selected Bacteria during Ware-Washing Operations	PLOS ONE			English	Article							STAINLESS-STEEL; FOODBORNE PATHOGENS; FELINE CALICIVIRUS; MURINE NOROVIRUS; INACTIVATION; SURFACE; FOOD; SURROGATES; OUTBREAK; SURVIVAL	Cross-contamination of ready-to-eat (RTE) foods with pathogens on contaminated tableware and food preparation utensils is an important factor associated with foodborne illnesses. To prevent this, restaurants and food service establishments are required to achieve a minimum microbial reduction of 5 logs from these surfaces. This study evaluated the sanitization efficacies of ware-washing protocols (manual and mechanical) used in restaurants to clean tableware items. Ceramic plates, drinking glasses and stainless steel forks were used as the food contact surfaces. These were contaminated with cream cheese and reduced-fat milk inoculated with murine norovirus (MNV-1), Escherichia coli K-12 and Listeria innocua. The sanitizing solutions tested were sodium hypochlorite (chlorine), quaternary ammonium (QAC) and tap water (control). During the study, the survivability and response to the experimental conditions of the bacterial species was compared with that of MNV-1. The results showed that current ware-washing protocols used to remove bacteria from tableware items were not sufficient to achieve a 5 log reduction in MNV-1 titer. After washing, a maximum of 3 log reduction in the virus were obtained. It was concluded that MNV-1 appeared to be more resistant to both the washing process and the sanitizers when compared with E. coli K-12 and L. innocua. Citation: Feliciano L, Li J, Lee J, Pascall MA (2012) Efficacies of Sodium Hypochlorite and Quaternary Ammonium Sanitizers for Reduction of Norovirus and Selected Bacteria during Ware-Washing Operations. PLoS ONE 7(12): e50273. doi:10.1371/journal.pone.0050273	[Feliciano, Lizanel; Li, Jianrong; Lee, Jaesung; Pascall, Melvin A.] Ohio State Univ, Dept Food Sci & Technol, Columbus, OH 43210 USA	University System of Ohio; Ohio State University	Li, JR (corresponding author), Ohio State Univ, Dept Food Sci & Technol, Columbus, OH 43210 USA.	li.926@osu.edu; pascall.1@osu.edu		Pascall, Melvin/0000-0002-3601-4012	National Center for Research Resources [UL1RR025755]; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR025755] Funding Source: NIH RePORTER	National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	The project described was supported by award number UL1RR025755 from the National Center for Research Resources. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bean Nancy H., 1996, Morbidity and Mortality Weekly Report, V45, P1; Cannon JL, 2006, J FOOD PROTECT, V69, P2761, DOI 10.4315/0362-028X-69.11.2761; Cords BR, 2005, FOOD SCI, V143, P507; D'Souza DH, 2006, INT J FOOD MICROBIOL, V108, P84, DOI 10.1016/j.ijfoodmicro.2005.10.024; Estes MK, 2006, CURR OPIN INFECT DIS, V19, P467, DOI 10.1097/01.qco.0000244053.69253.3d; FDA, 2012, SAFE PRACTICE FOR FO; Food and Agriculture Organization of the United Nations/World Health Organization (FAO/WHO), 2008, MICROBIOLOGICAL RISK, V13; Food and Drug Administration (FDA), 2009, REPORT ON THE OCCURR; Gibson KE, 2011, FOOD ENVIRON VIROL, V3, P74, DOI 10.1007/s12560-011-9059-4; Goodgame Richard, 2007, Curr Infect Dis Rep, V9, P102, DOI 10.1007/s11908-007-0004-5; Hall Aron J., 2011, Morbidity and Mortality Weekly Report, V60, P1; Handojo A, 2009, J FOOD PROTECT, V72, P1315, DOI 10.4315/0362-028X-72.6.1315; Hedberg CW, 2006, J FOOD PROTECT, V69, P2697, DOI 10.4315/0362-028X-69.11.2697; Ioannou CJ, 2007, ANTIMICROB AGENTS CH, V51, P296, DOI 10.1128/AAC.00375-06; Koopmans M, 2004, INT J FOOD MICROBIOL, V90, P23, DOI 10.1016/S0168-1605(03)00169-7; Kreske AC, 2006, J FOOD PROTECT, V69, P1892, DOI 10.4315/0362-028X-69.8.1892; Kuda T, 2008, LWT-FOOD SCI TECHNOL, V41, P988, DOI 10.1016/j.lwt.2007.06.016; Kusumaningrum HD, 2003, INT J FOOD MICROBIOL, V85, P227, DOI 10.1016/S0168-1605(02)00540-8; Kusumaningrum HD, 2002, J FOOD PROTECT, V65, P61, DOI 10.4315/0362-028X-65.1.61; Lee J, 2007, J FOOD ENG, V80, P885, DOI 10.1016/j.jfoodeng.2006.08.003; LINE JE, 1991, J FOOD PROTECT, V54, P762, DOI 10.4315/0362-028X-54.10.762; Lou FF, 2011, APPL ENVIRON MICROB, V77, P1862, DOI 10.1128/AEM.01918-10; Malik YS, 2006, INT J FOOD MICROBIOL, V109, P160, DOI 10.1016/j.ijfoodmicro.2005.08.033; Moe Christine L, 2009, Clin Infect Dis, V48, P38, DOI 10.1086/594119; Nowak P, 2011, J VIROL METHODS, V174, P7, DOI 10.1016/j.jviromet.2011.03.004; Sanglay GC, 2011, J FOOD PROTECT, V74, P1155, DOI 10.4315/0362-028X.JFP-10-405; Takahashi H, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021951; Teunis PFM, 2008, J MED VIROL, V80, P1468, DOI 10.1002/jmv.21237; Trudy CP, 1996, APPL MICROBIOLOGY, V14, P769; Verhoef LPB, 2009, EMERG INFECT DIS, V15, P31, DOI 10.3201/eid1501.080673; Virto R, 2005, APPL ENVIRON MICROB, V71, P5022, DOI 10.1128/AEM.71.9.5022-5028.2005; Whitehead K, 2010, AM J INFECT CONTROL, V38, P26, DOI 10.1016/j.ajic.2009.03.015; Wobus CE, 2006, J VIROL, V80, P5104, DOI 10.1128/JVI.02346-05	33	24	24	0	40	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 5	2012	7	12							e50273	10.1371/journal.pone.0050273	http://dx.doi.org/10.1371/journal.pone.0050273			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	057TZ	23227163	gold, Green Published, Green Submitted			2022-12-27	WOS:000312588200024
J	Schomaker, J; Meeter, M				Schomaker, Judith; Meeter, Martijn			Novelty Enhances Visual Perception	PLOS ONE			English	Article							AUDITORY BRAIN-STEM; INVOLUNTARY ATTENTION; ELECTROPHYSIOLOGICAL EVIDENCE; CONTRAST SENSITIVITY; TRANSIENT ATTENTION; SPATIAL-RESOLUTION; NEURAL MECHANISMS; HUMAN AMYGDALA; MODULATION; EMOTION	The effects of novelty on low-level visual perception were investigated in two experiments using a two-alternative forced-choice tilt detection task. A target, consisting of a Gabor patch, was preceded by a cue that was either a novel or a familiar fractal image. Participants had to indicate whether the Gabor stimulus was vertically oriented or slightly tilted. In the first experiment tilt angle was manipulated; in the second contrast of the Gabor patch was varied. In the first, we found that sensitivity was enhanced after a novel compared to a familiar cue, and in the second we found sensitivity to be enhanced for novel cues in later experimental blocks when participants became more and more familiarized with the familiar cue. These effects were not caused by a shift in the response criterion. This shows for the first time that novel stimuli affect low-level characteristics of perception. We suggest that novelty can elicit a transient attentional response, thereby enhancing perception.	[Schomaker, Judith; Meeter, Martijn] Vrije Univ Amsterdam, Dept Cognit Psychol, Weesp, Noord Holland, Netherlands	Vrije Universiteit Amsterdam	Schomaker, J (corresponding author), Vrije Univ Amsterdam, Dept Cognit Psychol, Weesp, Noord Holland, Netherlands.	j.schomaker@vu.nl	Schomaker, Judith/C-1042-2009; Meeter, Martijn/A-2926-2009; Schomaker, Judith/AAA-2240-2022	Schomaker, Judith/0000-0002-8615-497X; Meeter, Martijn/0000-0002-5112-6717; Schomaker, Judith/0000-0002-8615-497X	Vidi Grant [452-09-007]	Vidi Grant	This research was supported by the Vidi Grant 452-09-007 to M. Meeter. See http://www.nwo.nl/nwohome.nsf/pages/nwop_5vtgqw_eng. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BASHINSKI HS, 1980, PERCEPT PSYCHOPHYS, V28, P241, DOI 10.3758/BF03204380; Berti S, 2003, EUR J NEUROSCI, V17, P1119, DOI 10.1046/j.1460-9568.2003.02527.x; Blackford JU, 2010, NEUROIMAGE, V50, P1188, DOI 10.1016/j.neuroimage.2009.12.083; Bocanegra BR, 2009, PSYCHOL SCI, V20, P707, DOI 10.1111/j.1467-9280.2009.02354.x; Bradley MM, 2009, PSYCHOPHYSIOLOGY, V46, P1, DOI 10.1111/j.1469-8986.2008.00702.x; BRAVO MJ, 1992, PERCEPT PSYCHOPHYS, V51, P465, DOI 10.3758/BF03211642; Brefczynski JA, 1999, NAT NEUROSCI, V2, P370, DOI 10.1038/7280; Cameron EL, 2002, VISION RES, V42, P949, DOI 10.1016/S0042-6989(02)00039-1; Carrasco M, 2000, VISION RES, V40, P1203, DOI 10.1016/S0042-6989(00)00024-9; Carrasco M, 2004, NAT NEUROSCI, V7, P308, DOI 10.1038/nn1194; Carrasco M, 2008, PERCEPT PSYCHOPHYS, V70, P1151, DOI 10.3758/PP.70.7.1151; Carrasco M, 2006, VISION RES, V46, P2028, DOI 10.1016/j.visres.2005.12.015; Carrasco M, 2009, PROG BRAIN RES, V176, P65, DOI 10.1016/S0079-6123(09)17605-7; Carrasco Marisa, 2002, J Vis, V2, P467, DOI 10.1167/2.6.4; Chong H, 2008, J COGNITIVE NEUROSCI, V20, P120, DOI 10.1162/jocn.2008.20003; COURCHESNE E, 1975, ELECTROEN CLIN NEURO, V39, P131, DOI 10.1016/0013-4694(75)90003-6; Escera C, 1998, J COGNITIVE NEUROSCI, V10, P590, DOI 10.1162/089892998562997; Escera C, 2002, COGNITIVE BRAIN RES, V14, P325, DOI 10.1016/S0926-6410(02)00135-0; Escera C, 2001, EUR J NEUROSCI, V14, P877, DOI 10.1046/j.0953-816x.2001.01707.x; FOLEY JM, 1981, VISION RES, V21, P1041, DOI 10.1016/0042-6989(81)90009-2; Grimm S, 2011, PSYCHOPHYSIOLOGY, V48, P377, DOI 10.1111/j.1469-8986.2010.01073.x; Itti L, 2000, J OPT SOC AM A, V17, P1899, DOI 10.1364/JOSAA.17.001899; Kiehl KA, 2005, NEUROIMAGE, V25, P899, DOI 10.1016/j.neuroimage.2004.12.035; Knight RT, 1996, NATURE, V383, P256, DOI 10.1038/383256a0; Krebs RM, 2009, NEUROPSYCHOLOGIA, V47, P2272, DOI 10.1016/j.neuropsychologia.2009.01.015; Lisman JE, 2005, NEURON, V46, P703, DOI 10.1016/j.neuron.2005.05.002; Liu TS, 2005, NEURON, V45, P469, DOI 10.1016/j.neuron.2004.12.039; LUCK SJ, 1994, J EXP PSYCHOL HUMAN, V20, P887, DOI 10.1037/0096-1523.20.4.887; NAATANEN R, 1992, NEUROREPORT, V3, P493; NAKAYAMA K, 1989, VISION RES, V29, P1631, DOI 10.1016/0042-6989(89)90144-2; Olivers CNL, 2008, PSYCHOL REV, V115, P836, DOI 10.1037/a0013395; Phelps EA, 2006, PSYCHOL SCI, V17, P292, DOI 10.1111/j.1467-9280.2006.01701.x; POSNER MI, 1980, J EXP PSYCHOL GEN, V109, P160, DOI 10.1037/0096-3445.109.2.160; Reynolds JH, 2004, ANNU REV NEUROSCI, V27, P611, DOI 10.1146/annurev.neuro.26.041002.131039; SanMiguel I, 2010, BIOL PSYCHOL, V83, P143, DOI 10.1016/j.biopsycho.2009.11.012; Schneider KA, 2011, J VISION, V11, DOI 10.1167/11.13.7; Schwartz CE, 2003, BIOL PSYCHIAT, V53, P854, DOI 10.1016/S0006-3223(02)01906-6; Slabu L, 2012, J NEUROSCI, V32, P1447, DOI 10.1523/JNEUROSCI.2557-11.2012; Slabu L, 2010, EUR J NEUROSCI, V32, P859, DOI 10.1111/j.1460-9568.2010.07324.x; Sokolov E.N., 1963, PERCEPTION CONDITION; SOKOLOV EN, 1963, ANNU REV PHYSIOL, V25, P545, DOI 10.1146/annurev.ph.25.030163.002553; Stoppel CM, 2009, HUM BRAIN MAPP, V30, P3759, DOI 10.1002/hbm.20804; Treue S, 2004, TRENDS COGN SCI, V8, P435, DOI 10.1016/j.tics.2004.08.001; von Restorff H, 1933, PSYCHOL FORSCH, V18, P299, DOI 10.1007/BF02409636; Vuilleumier P, 2005, TRENDS COGN SCI, V9, P585, DOI 10.1016/j.tics.2005.10.011; WEICHSELGARTNER E, 1987, SCIENCE, V238, P778, DOI 10.1126/science.3672124; Wendt J, 2011, BIOL PSYCHOL, V86, P203, DOI 10.1016/j.biopsycho.2010.11.009; Wright CI, 2003, NEUROIMAGE, V18, P660, DOI 10.1016/S1053-8119(02)00037-X; Yeshurun Y, 1999, VISION RES, V39, P293, DOI 10.1016/S0042-6989(98)00114-X; Zald DH, 2003, BRAIN RES REV, V41, P88, DOI 10.1016/S0165-0173(02)00248-5; Zeelenberg R, 2010, COGNITION, V115, P202, DOI 10.1016/j.cognition.2009.12.004	51	27	27	2	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 5	2012	7	12							e50599	10.1371/journal.pone.0050599	http://dx.doi.org/10.1371/journal.pone.0050599			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	057TZ	23227190	Green Submitted, Green Published, gold			2022-12-27	WOS:000312588200050
J	Griffin, H; Wu, ZL; Marnane, R; Dewar, V; Molijn, A; Quint, W; Van Hoof, C; Struyf, F; Colau, B; Jenkins, D; Doorbar, J				Griffin, Heather; Wu, Zhonglin; Marnane, Rebecca; Dewar, Vincent; Molijn, Anco; Quint, Wim; Van Hoof, Christine; Struyf, Frank; Colau, Brigitte; Jenkins, David; Doorbar, John			E4 Antibodies Facilitate Detection and Type-Assignment of Active HPV Infection in Cervical Disease	PLOS ONE			English	Article							HUMAN-PAPILLOMAVIRUS TYPE-16; PARTICLE VACCINE; BROAD-SPECTRUM; YOUNG-WOMEN; G(2) ARREST; LIFE-CYCLE; IN-VIVO; IDENTIFICATION; EFFICACY; CANCER	High-risk human papillomavirus (HPV) infections are the cause of nearly all cases of cervical cancer. Although the detection of HPV DNA has proved useful in cervical diagnosis, it does not necessarily predict disease presence or severity, and cannot conclusively identify the causative type when multiple HPVs are present. Such limitations may be addressed using complementary approaches such as cytology, laser capture microscopy, and/or the use of infection biomarkers. One such infection biomarker is the HPV E4 protein, which is expressed at high level in cells that are supporting (or have supported) viral genome amplification. Its distribution in lesions has suggested a role in disease staging. Here we have examined whether type-specific E4 antibodies may also allow the identification and/or confirmation of causal HPV-type. To do this, type-specific polyclonal and monoclonal antibodies against three E4 proteins (HPV-16, -18, and -58) were generated and validated by ELISA and western blotting, and by immunohistochemistry (IHC) staining of epithelial rafts containing these individual HPV types. Type-specific detection of HPV and its associated disease was subsequently examined using formalin-fixed paraffin-embedded cervical intra-epithelial neoplasias (CIN, (n = 247)) and normal controls (n = 28). All koilocytotic CIN1 lesions showed type-specific E4 expression of their respective HPV types. Differences were noted amongst E4 expression patterns in CIN3. HPV-18 E4 was not detected in any of the 6 HPV-18 DNA-positive CIN3 lesions examined, whereas in HPV-16 and -58 CIN3, 28/37 (76%) and 5/9 (55.6%) expressed E4 respectively, usually in regions of epithelial differentiation. Our results demonstrate that type-specific E4 antibodies can be used to help establish causality, as may be required when multiple HPV types are detected. The unique characteristics of the E4 biomarker suggest a role in diagnosis and patient management particularly when used in combination. Citation: Griffin H, Wu Z, Marnane R, Dewar V, Molijn A, et al. (2012) E4 Antibodies Facilitate Detection and Type-Assignment of Active HPV Infection in Cervical Disease. PLoS ONE 7(12): e49974. doi:10.1371/journal.pone.0049974	[Griffin, Heather; Wu, Zhonglin; Marnane, Rebecca; Doorbar, John] Natl Inst Med Res, London NW7 1AA, England; [Dewar, Vincent; Struyf, Frank; Colau, Brigitte; Jenkins, David] GlaxoSmithKline Biol, Rixensart, Belgium; [Van Hoof, Christine] XpePharma & Sci, Wavre, Belgium; [Molijn, Anco; Quint, Wim; Jenkins, David] DDL Diagnost Lab, Voorburg, Netherlands	MRC National Institute for Medical Research; GlaxoSmithKline; DDL Diagnostic Laboratory	Doorbar, J (corresponding author), Natl Inst Med Res, Mill Hill, London NW7 1AA, England.	jdoorba@nimr.mrc.ac.uk		Struyf, Frank/0000-0001-9988-0260; Marnane, Rebecca/0000-0002-3657-7237	Medical Research Council [MC_U117584278] Funding Source: Medline; MRC [MC_U117584278] Funding Source: UKRI	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		Bravo IG, 2010, TRENDS MICROBIOL, V18, P432, DOI 10.1016/j.tim.2010.07.008; Clifford GM, 2003, BRIT J CANCER, V89, P101, DOI 10.1038/sj.bjc.6601024; Cuschieri KS, 2004, J CLIN PATHOL, V57, P68, DOI 10.1136/jcp.57.1.68; Dallenbach-Hellweg G, 2005, COLOR ATLAS HISTOPAT; Davy CE, 2005, J VIROL, V79, P3998, DOI 10.1128/JVI.79.7.3998-4011.2005; Davy CE, 2002, J VIROL, V76, P9806, DOI 10.1128/JVI.76.19.9806-9818.2002; de Sanjose S, 2010, LANCET ONCOL, V11, P1048, DOI 10.1016/S1470-2045(10)70230-8; Dillner J, 2010, BRIT MED J, V341, DOI 10.1136/bmj.c3493; Doorbar J, 2005, J CLIN VIROL, V32, pS7, DOI 10.1016/j.jcv.2004.12.006; Doorbar J, 1997, VIROLOGY, V238, P40, DOI 10.1006/viro.1997.8768; Garcon N, 2007, EXPERT REV VACCINES, V6, P723, DOI 10.1586/14760584.6.5.723; Harper DM, 2006, LANCET, V367, P1247, DOI 10.1016/S0140-6736(06)68439-0; Iaconis L, 2007, ARCH PATHOL LAB MED, V131, P1343; Jenkins D, 2007, DIS MARKERS, V23, P199, DOI 10.1155/2007/874795; Klaes R, 2002, AM J SURG PATHOL, V26, P1389, DOI 10.1097/00000478-200211000-00001; Kleter B, 1998, AM J PATHOL, V153, P1731, DOI 10.1016/S0002-9440(10)65688-X; Kleter B, 1999, J CLIN MICROBIOL, V37, P2508, DOI 10.1128/JCM.37.8.2508-2517.1999; Lambert PF, 2005, METH MOLEC MED, V119, P141; McIntosh PB, 2010, J CELL SCI, V123, P2810, DOI 10.1242/jcs.061978; Middleton K, 2003, J VIROL, V77, P10186, DOI 10.1128/JVI.77.19.10186-10201.2003; Nakahara T, 2002, J VIROL, V76, P10914, DOI 10.1128/JVI.76.21.10914-10920.2002; Paavonen J, 2007, LANCET, V369, P2161, DOI 10.1016/S0140-6736(07)60946-5; Paovonen J, 2009, LANCET, V374, P301, DOI 10.1016/S0140-6736(09)61248-4; Peh WL, 2002, J VIROL, V76, P10401, DOI 10.1128/JVI.76.20.10401-10416.2002; Quint W, 2012, J PATHOL, V227, P62, DOI 10.1002/path.3970; Tjalma WA, 2012, INT J CANC; van Doorn LJ, 2006, J CLIN MICROBIOL, V44, P3292, DOI 10.1128/JCM.00539-06; Walboomers JMM, 1999, J PATHOL, V189, P12, DOI 10.1002/(SICI)1096-9896(199909)189:1&lt;12::AID-PATH431&gt;3.0.CO;2-F; Wang Q, 2004, J VIROL, V78, P821, DOI 10.1128/JVI.78.2.821-833.2004; Wentzensen N, 2007, DIS MARKERS, V23, P315, DOI 10.1155/2007/678793; Wentzensen N, 2006, CANCER-AM CANCER SOC, V107, P2307, DOI 10.1002/cncr.22247; Williams GH, 1998, P NATL ACAD SCI USA, V95, P14932, DOI 10.1073/pnas.95.25.14932; Woodman CBJ, 2007, NAT REV CANCER, V7, P11, DOI 10.1038/nrc2050	33	28	29	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 3	2012	7	12							e49974	10.1371/journal.pone.0049974	http://dx.doi.org/10.1371/journal.pone.0049974			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	051DH	23226504	Green Published, gold, Green Submitted			2022-12-27	WOS:000312104700011
J	Moise, MM; Benjamin, LM; Etienne, M; Thierry, G; Dalida, KN; Doris, TM; Samy, WM				Moise, Mvitu-Muaka; Benjamin, Longo-Mbenza; Etienne, Mokondjimobe; Thierry, Gombet; Dalida, Kibokela Ndembe; Doris, Tulomba Mona; Samy, Wayiza Masamba			Intake of Gnetum Africanum and Dacryodes Edulis, Imbalance of Oxidant/Antioxidant Status and Prevalence of Diabetic Retinopathy in Central Africans	PLOS ONE			English	Article							OXIDATIVE STRESS; ANTIOXIDANT VITAMINS; COMPLICATIONS; DISEASE; SEVERITY; INSULIN; RISK; EYE	Objective: To estimate the prevalence of DR and to correlate cardiometabolic, sociodemographic, and oxidant/antioxidant imbalance data to the prevalence of DR. Design: This case-control study included type 2 DM (T2 DM) patients with DR (n = 66), T2 DM patients without DR (N = 84), and healthy controls (n = 45) without DR, in Kinshasa town. Diet, albuminemia, serum vitamins, and 8-isoprostane were examined. Results: No intake of safou (OR = 2.7 95% CI 1.2-5.8; P = 0.014), low serum albumin < 4.5 g/dL (OR-2.9 95% CI 1.4-5.9; P = 0.003), no intake of fumbwa (OR = 2.8 95% CI 1.2-6.5; P = 0.014), high 8-isoprostane (OR = 14.3 95% CI 4.5-46; P < 0.0001), DM duration >= 5 years (OR = 3.8 95% CI 1.6-9.1; P = 0.003), and low serum vitamin C (OR = 4.5 95% CI 1.3-15.5; P = 0.016) were identified as the significant independent determinants of DR. Conclusion: The important role of oxidant/antioxidant status imbalance and diet is demonstrated in DR.	[Benjamin, Longo-Mbenza] Walter Sisulu Univ, Fac Hlth Sci, Mthatha, South Africa; [Moise, Mvitu-Muaka] Univ Kinshasa, Dept Ophthalmol, Kinshasa, DEM REP CONGO; [Etienne, Mokondjimobe; Thierry, Gombet] Univ Marien Ngouabi, Fac Hlth Sci, Brazzaville, DEM REP CONGO; [Dalida, Kibokela Ndembe] Univ Kinshasa, Dept Neuropsychiat, Kinshasa, DEM REP CONGO; [Doris, Tulomba Mona] Lomo Med Ctr, Biostat Unit, Kinshasa, DEM REP CONGO; [Doris, Tulomba Mona] Heart Africa Ctr Cardiol, Kinshasa, DEM REP CONGO; [Samy, Wayiza Masamba] Walter Sisulu Univ, Dept Chem & Chem Technol, Mthatha, South Africa	Walter Sisulu University; Universite de Kinshasa; Universite de Kinshasa; Walter Sisulu University	Benjamin, LM (corresponding author), Walter Sisulu Univ, Fac Hlth Sci, Mthatha, South Africa.	longombenza@gmail.com			Lomo Medical Center, Kinshasa Limete, Democratic Republic of the Congo	Lomo Medical Center, Kinshasa Limete, Democratic Republic of the Congo	The study was financed by intramural funds of Lomo Medical Center, Kinshasa Limete, Democratic Republic of the Congo. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agbor Gabriel A, 2007, Pak J Biol Sci, V10, P537, DOI 10.3923/pjbs.2007.537.544; Ajibesin K. K., 2011, Research Journal of Medicinal Plant, V5, P32, DOI 10.3923/rjmp.2011.32.41; Aldebasi Y., 2011, British Journal of Medicine and Medical Research, V1, P371; Alemu S., 2004, DIABETES VOICE, V49, P8; Ali F, 2011, J MED FOOD, V14, P1289, DOI 10.1089/jmf.2010.0327; Anan F, 2009, HYPERTENS RES, V32, P299, DOI 10.1038/hr.2009.8; ARMSTRONG D, 1994, ADV EXP MED BIOL, V366, P43; BAYNES JW, 1991, DIABETES, V40, P405, DOI 10.2337/diabetes.40.4.405; Cao CH, 2010, AM J PHYSIOL-RENAL, V299, pF1056, DOI 10.1152/ajprenal.00070.2010; Ceriello A, 2003, DIABETES CARE, V26, P1589, DOI 10.2337/diacare.26.5.1589; da Silva SB, 2010, J DIABETES METAB, V1, DOI 10.4172/2155-6156.1000111; DAVIE SJ, 1992, DIABETES, V41, P167, DOI 10.2337/diabetes.41.2.167; Democratic Republic of Congo, 2001, KINSHASA, V2, P40; ERIKSSON J, 1995, ANN NUTR METAB, V39, P217, DOI 10.1159/000177865; Ernst DJ, 2008, H3 A6 PROCEDURES COL, V27; FRIEDEWALD WT, 1972, CLIN CHEM, V18, P499; Gavin JR, 1999, DIABETES CARE, V22, pS5; Gill G, 2008, QJM-INT J MED, V101, P793, DOI 10.1093/qjmed/hcn096; Gupta Madhur M, 2005, Indian J Physiol Pharmacol, V49, P187; Hartnett ME, 2000, DIABETES CARE, V23, P234, DOI 10.2337/diacare.23.2.234; Isong EU, 1999, FOOD CHEM, V64, P489, DOI 10.1016/S0308-8146(98)00139-3; Iwasaki T, 2008, ENDOCR J, V55, P311, DOI 10.1507/endocrj.K07-086; Johns T., 2001, P S MAN BIOD AGR EC, P1; Kaimbo D K, 1995, Bull Soc Belge Ophtalmol, V255, P107; Kan H, 2007, AM J CLIN NUTR, V86, P1626; Kasiam Lasi On'kin JB, 2008, INT J DIABETES METAB, V16, P50; Kempen JH, 2004, ARCH OPHTHALMOL-CHIC, V122, P552; Koudou J., 2008, Journal of Applied Sciences, V8, P3532; LEUDEU BVT, 2006, J FOOD TECHNOL, V4, P275; Lohman TG, 1998, ANTHROPOMETRIC STAND, p[3, 39]; Longo-Mbenza B, 2012, MOL VIS, V18, P1619; Longo-Mbenza B, 2010, DIABETES VASC DIS RE, V7, P28, DOI 10.1177/1479164109346362; Longo-Mbenza B., 2008, Annales de Cardiologie et d'Angeiologie, V57, P37, DOI 10.1016/j.ancard.2007.08.013; Longo-Mbenza B, 2008, INT J DIABETES METAB, V16, P69; Longo-Mbenza B, 2008, INT J DIABETES METAB, V16, P17; Longo-Mbenza B, 2010, INT J NUTR METAB, V2, P1; Mancino R, 2011, MOL VIS, V17, P1298; Marchioli R, 2001, LIPIDS, V36, pS53, DOI 10.1007/s11745-001-0683-y; MATTHEWS DR, 1985, DIABETOLOGIA, V28, P412, DOI 10.1007/BF00280883; Mayer-Davis EJ, 1998, OPHTHALMOLOGY, V105, P2264, DOI 10.1016/S0161-6420(98)91227-1; Mbanya JC, 2003, J CARDIOVASC RISK, V10, P97, DOI [10.1097/00043798-200304000-00004, 10.1097/01.hjr.0000060842.48106.78]; Millen AE, 2003, AM J EPIDEMIOL, V158, P225, DOI 10.1093/aje/kwg116; Moise MM, 2012, INT J OPHTHALMOL-CHI, V5, P231, DOI 10.3980/j.issn.2222-3959.2012.02.23; Muaka MM, 2010, DIABETES METAB SYND, V4, P132, DOI 10.1016/j.dsx.2010.07.003; Mvitu Muaka M, 2009, MALI MED, V24, P22; Mvitu Muaka M, 2012, INT J GEN M IN PRESS; Ngondo A, 1984, CEDAS, V1, P31; Nkondi Mbadi ANsunguJ, 2009, MALI MED, V24, P17; Ogunlesi M, 2010, INT J ELECTROCHEM SC, V5, P105; Onocha P. A., 2011, Advances in Environmental Biology, V5, P2913; Plotnick GD, 1997, JAMA-J AM MED ASSOC, V278, P1682, DOI 10.1001/jama.278.20.1682; Rema M, 2005, INVEST OPHTH VIS SCI, V46, P2328, DOI 10.1167/iovs.05-0019; ROLFE M, 1988, DIABETOLOGIA, V31, P88, DOI 10.1007/BF00395553; Sidibe EH, 2000, DIABETES METAB, V26, P322; Sivaprasad S, 2012, SURV OPHTHALMOL, V57, P347, DOI 10.1016/j.survophthal.2012.01.004; Stump CS, 2006, MAYO CLIN PROC, V81, P796, DOI 10.4065/81.6.796; Takebayashi K, 2007, J CLIN ENDOCR METAB, V92, P2712, DOI 10.1210/jc.2006-1249; Wang J, 2003, AM J CLIN NUTR, V77, P379, DOI 10.1093/ajcn/77.2.379; Winkler B. S., 2007, MOL VIS, V5, P32; Wong TY, 2006, AM J OPHTHALMOL, V141, P446, DOI 10.1016/j.ajo.2005.08.063; Yudkin JS, 2000, LANCET, V355, P919, DOI 10.1016/S0140-6736(99)09225-9; Zghal-Mokni Imen, 2008, Tunis Med, V86, P1004	62	10	10	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 3	2012	7	12							e49411	10.1371/journal.pone.0049411	http://dx.doi.org/10.1371/journal.pone.0049411			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	051DH	23226496	Green Submitted, gold, Green Published			2022-12-27	WOS:000312104700005
J	Abdul-Sater, Z; Yehya, A; Beresian, J; Salem, E; Kamar, A; Baydoun, S; Shibbani, K; Soubra, A; Bitar, F; Nemer, G				Abdul-Sater, Zahi; Yehya, Amin; Beresian, Jean; Salem, Elie; Kamar, Amina; Baydoun, Serine; Shibbani, Kamel; Soubra, Ayman; Bitar, Fadi; Nemer, Georges			Two Heterozygous Mutations in NFATC1 in a Patient with Tricuspid Atresia	PLOS ONE			English	Article							CONGENITAL HEART-DISEASE; DEPENDENT TRANSCRIPTIONAL PATHWAY; VALVE DEVELOPMENT; NF-ATC; OSTEOCLAST DIFFERENTIATION; NUCLEAR TRANSLOCATION; CALCINEURIN; GENE; FAMILY; CELLS	Tricuspid Atresia (TA) is a rare form of congenital heart disease (CHD) with usually poor prognosis in humans. It presents as a complete absence of the right atrio-ventricular connection secured normally by the tricuspid valve. Defects in the tricuspid valve are so far not associated with any genetic locus, although mutations in numerous genes were linked to multiple forms of congenital heart disease. In the last decade, Knock-out mice have offered models for cardiologists and geneticists to study the causes of congenital disease. One such model was the Nfatc1(-/-) mice embryos which die at mid-gestation stage due to a complete absence of the valves. NFATC1 belongs to the Rel family of transcription factors members of which were shown to be implicated in gene activation, cell differentiation, and organogenesis. We have previously shown that a tandem repeat in the intronic region of NFATC1 is associated with ventricular septal defects. In this report, we unravel for the first time a potential link between a mutation in NFATC1 and TA. Two heterozygous missense mutations were found in the NFATC1 gene in one indexed-case out of 19 patients with TA. The two amino-acids changes were not found neither in other patients with CHDs, nor in the control healthy population. Moreover, we showed that these mutations alter dramatically the normal function of the protein at the cellular localization, DNA binding and transcriptional levels suggesting they are disease-causing.	[Bitar, Fadi] Amer Univ Beirut, Dept Pediat & Adolescent Med, Beirut, Lebanon; [Abdul-Sater, Zahi; Yehya, Amin; Beresian, Jean; Salem, Elie; Kamar, Amina; Baydoun, Serine; Shibbani, Kamel; Soubra, Ayman; Nemer, Georges] Amer Univ Beirut, Dept Biochem & Mol Genet, Beirut, Lebanon	American University of Beirut; American University of Beirut	Bitar, F (corresponding author), Amer Univ Beirut, Dept Pediat & Adolescent Med, Beirut, Lebanon.	fadi.bitar@aub.edu.lb; gn08@aub.edu.lb	Nemer, Georges/ABB-5117-2020; Nemer, Georges/H-7801-2014; Abdul-sater, Zahi/AAM-6794-2020; abdul-sater, Zahi/AAK-8547-2020; Abdul-sater, Zahi/AAM-6543-2020; Yehya, Amin/ABG-1976-2021	Nemer, Georges/0000-0003-2157-5279; Abdul-sater, Zahi/0000-0002-0340-1657; abdul-sater, Zahi/0000-0002-0340-1657; Abdul-sater, Zahi/0000-0002-0340-1657; Shibbani, Kamel/0000-0002-2644-5425; KAMAR, AMINA/0000-0002-9045-6452; Soubra, Ayman/0000-0002-5424-7530; Yehya, Amin/0000-0001-5947-4778	Lebanese National Council for Scientific Research (LNCSR) [114170 522296]; Lebanese National Council for Research (LNCSR)	Lebanese National Council for Scientific Research (LNCSR); Lebanese National Council for Research (LNCSR)	This work was supported by a grant from the Lebanese National Council for Scientific Research (LNCSR Grant# 114170 522296). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors would like to thank Mr. Nehme El-Hachem and Miss Theresa Farhat for the Bioinformatics and Biostatistics help, and Mrs Inaam El-Rassy from the Molecular Core Facility at AUB for DNA sequencing. This work was supported by a grant from the Lebanese National Council for Research (LNCSR).	Akcaboy MI, 2008, PEDIATR CARDIOL, V29, P126, DOI 10.1007/s00246-007-9058-2; Armstrong EJ, 2004, CIRC RES, V95, P459, DOI 10.1161/01.RES.0000141146.95728.da; Asagiri M, 2005, J EXP MED, V202, P1261, DOI 10.1084/jem.20051150; Beis D, 2005, DEVELOPMENT, V132, P4193, DOI 10.1242/dev.01970; Bruneau BG, 2001, CELL, V106, P709, DOI 10.1016/S0092-8674(01)00493-7; Chakraborty S, 2010, PEDIATR CARDIOL, V31, P414, DOI 10.1007/s00246-009-9616-x; Chang CP, 2004, CELL, V118, P649, DOI 10.1016/j.cell.2004.08.010; Chin ER, 1998, GENE DEV, V12, P2499, DOI 10.1101/gad.12.16.2499; Crabtree GR, 1999, CELL, V96, P611, DOI 10.1016/S0092-8674(00)80571-1; Crabtree GR, 2002, CELL, V109, pS67, DOI 10.1016/S0092-8674(02)00699-2; de la Pompa JL, 1998, NATURE, V392, P182, DOI 10.1038/32419; Elliott DA, 2003, J AM COLL CARDIOL, V41, P2072, DOI 10.1016/S0735-1097(03)00420-0; Hernandez-Ochoa EO, 2007, CELL CALCIUM, V41, P559, DOI 10.1016/j.ceca.2006.10.006; Hoffman JIE, 2002, J AM COLL CARDIOL, V39, P1890, DOI 10.1016/S0735-1097(02)01886-7; Horsley V, 2002, J CELL BIOL, V156, P771, DOI 10.1083/jcb.200111073; Ikeda F, 2004, J CLIN INVEST, V114, P475, DOI 10.1172/JCI200419657; Jain R, 2011, J CLIN INVEST, V121, P422, DOI 10.1172/JCI44244; Johnson EN, 2003, J BIOL CHEM, V278, P1686, DOI 10.1074/jbc.M210250200; Karpurapu M, 2010, J BIOL CHEM, V285, P3510, DOI 10.1074/jbc.M109.063727; Kulkarni RM, 2009, MECH DEVELOP, V126, P350, DOI 10.1016/j.mod.2009.02.003; Laforest B, 2011, J CLIN INVEST, V121, P2876, DOI 10.1172/JCI44555; Martinez-Martinez S, 2004, CURR MED CHEM, V11, P997, DOI 10.2174/0929867043455576; Masuda ES, 1997, MOL CELL BIOL, V17, P2066, DOI 10.1128/MCB.17.4.2066; Molkentin JD, 1998, CELL, V93, P215, DOI 10.1016/S0092-8674(00)81573-1; Mori AD, 2004, CURR OPIN CARDIOL, V19, P211, DOI 10.1097/00001573-200405000-00004; Musaro A, 1999, NATURE, V400, P581, DOI 10.1038/23060; Nabulsi MM, 2003, AM J MED GENET A, V116A, P342, DOI 10.1002/ajmg.a.10020; Nayak A, 2009, J BIOL CHEM, V284, P10935, DOI 10.1074/jbc.M900465200; Neal JW, 2003, J BIOL CHEM, V278, P17246, DOI 10.1074/jbc.M300528200; Negishi-Koga T, 2009, IMMUNOL REV, V231, P241, DOI 10.1111/j.1600-065X.2009.00821.x; Nemer G, 2002, DEVELOPMENT, V129, P4045; Nemer Georges, 2006, Hum Mutat, V27, P293, DOI 10.1002/humu.9410; NORTHROP JP, 1994, NATURE, V369, P497, DOI 10.1038/369497a0; Olson EN, 2000, BIOESSAYS, V22, P510, DOI 10.1002/(SICI)1521-1878(200006)22:6<510::AID-BIES4>3.3.CO;2-T; Olson EN, 2006, SCIENCE, V313, P1922, DOI 10.1126/science.1132292; Park JC, 1996, J BIOL CHEM, V271, P20914, DOI 10.1074/jbc.271.34.20914; Pehlivan T, 1999, AM J MED GENET, V83, P201, DOI 10.1002/(SICI)1096-8628(19990319)83:3<201::AID-AJMG11>3.0.CO;2-V; Ranger AM, 1998, NATURE, V392, P186, DOI 10.1038/32426; Rao A, 1997, ANNU REV IMMUNOL, V15, P707, DOI 10.1146/annurev.immunol.15.1.707; Reamon-Buettner Stella Marie, 2004, Hum Mutat, V24, P104, DOI 10.1002/humu.9255; Rodriguez A, 2009, MOL CELL, V33, P616, DOI 10.1016/j.molcel.2009.01.030; Schott JJ, 1998, SCIENCE, V281, P108, DOI 10.1126/science.281.5373.108; Schulz RA, 2004, DEV BIOL, V266, P1, DOI 10.1016/j.ydbio.2003.10.008; Wada H, 2002, J CELL BIOL, V156, P983, DOI 10.1083/jcb.200106057; Wirrig EE, 2011, CARDIOVASC PATHOL, V20, P162, DOI 10.1016/j.carpath.2010.06.010; Wisniewska M, 2004, CELL BIOL INT, V28, P773, DOI 10.1016/j.cellbi.2004.07.008; Yamak AA, 2007, CLIN GENET, V72, P59, DOI 10.1111/j.1399-0004.2007.00814.x; Yehya A, 2006, GENOME, V49, P1092, DOI 10.1139/G06-072	48	25	25	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 30	2012	7	11							e49532	10.1371/journal.pone.0049532	http://dx.doi.org/10.1371/journal.pone.0049532			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	054WM	23226213	Green Submitted, gold, Green Published			2022-12-27	WOS:000312376100021
J	Akhoundi, M; Bakhtiari, R; Guillard, T; Baghaei, A; Tolouei, R; Sereno, D; Toubas, D; Depaquit, J; Abyaneh, MR				Akhoundi, Mohammad; Bakhtiari, Rounak; Guillard, Thomas; Baghaei, Ahmad; Tolouei, Reza; Sereno, Denis; Toubas, Dominique; Depaquit, Jerome; Abyaneh, Mehdi Razzaghi			Diversity of the Bacterial and Fungal Microflora from the Midgut and Cuticle of Phlebotomine Sand Flies Collected in North-Western Iran	PLOS ONE			English	Article							PERFILIEWI-TRANSCAUCASICUS; VISCERAL LEISHMANIASIS; SPOROGONIC DEVELOPMENT; PLASMODIUM-FALCIPARUM; ANOPHELES-STEPHENSI; DIPTERA PSYCHODIDAE; MOLECULAR-DETECTION; PAPATASI DIPTERA; GUT BACTERIA; INFECTIONS	Background: Phlebotomine sand flies are the vectors of the leishmaniases, parasitic diseases caused by Leishmania spp. Little is known about the prevalence and diversity of sand fly microflora colonizing the midgut or the cuticle. Particularly, there is little information on the fungal diversity. This information is important for development of vector control strategies. Methodology/Principal Findings: Five sand fly species: Phlebotomus papatasi, P. sergenti, P. kandelakii, P. perfiliewi and P. halepensis were caught in Bileh Savar and Kaleybar in North-Western Iran that are located in endemic foci of visceral leishmaniasis. A total of 35 specimens were processed. Bacterial and fungal strains were identified by routine microbiological methods. We characterized 39 fungal isolates from the cuticle and/or the midgut. They belong to six different genera including Penicillium (17 isolates), Aspergillus (14), Acremonium (5), Fusarium (1), Geotrichum (1) and Candida (1). We identified 33 Gram-negative bacteria: Serratia marcescens (9 isolates), Enterobacter cloacae (6), Pseudomonas fluorescens (6), Klebsiella ozaenae (4), Acinetobacter sp. (3), Escherichia coli (3), Asaia sp. (1) and Pantoea sp. (1) as well as Gram-positive bacteria Bacillus subtilis (5) and Micrococcus luteus (5) in 10 isolates. Conclusion/Significance: Our study provides new data on the microbiotic diversity of field-collected sand flies and for the first time, evidence of the presence of Asaia sp. in sand flies. We have also found a link between physiological stages (unfed, fresh fed, semi gravid and gravid) of sand flies and number of bacteria that they carry. Interestingly Pantoea sp. and Klebsiella ozaenae have been isolated in Old World sand fly species. The presence of latter species on sand fly cuticle and in the female midgut suggests a role for this arthropod in dissemination of these pathogenic bacteria in endemic areas. Further experiments are required to clearly delineate the vectorial role (passive or active) of sand flies.	[Akhoundi, Mohammad; Depaquit, Jerome] Univ Reims, Fac Pharm, Transmiss Vectorielle & Epidemiosurveillance Mala, USC,ANSES,EA4688, Reims, France; [Akhoundi, Mohammad; Baghaei, Ahmad; Tolouei, Reza; Abyaneh, Mehdi Razzaghi] Pasteur Inst Iran, Mycol & Parasitol Dept, Tehran, Iran; [Bakhtiari, Rounak] Univ Tehran Med Sci, Sch Publ Hlth, Dept Microbiol, Tehran, Iran; [Bakhtiari, Rounak] Univ Tehran Med Sci, Inst Hlth Res, Tehran, Iran; [Guillard, Thomas] Univ Reims, UFR Med, SFR CAP Sante FED 4231, Reims, France; [Sereno, Denis] UMR IRD 224 CNRS 5290 UM1 UM2, MIVEGEC, Montpellier, France; [Toubas, Dominique] Univ Reims, CNRS, Unite MEDyC, URCA,FRE 3481, Reims, France; [Guillard, Thomas] Hop Robert Debre, CHU Reims, Bacteriol Lab, Reims, France; [Toubas, Dominique] Hop Maison Blanche, CHU Reims, Lab Parasitol Mycol, Reims, France	Agence Nationale de Securite Sanitaire de l'Alimentation, de l'Environnement du Travail (ANSES); Universite de Reims Champagne-Ardenne; Le Reseau International des Instituts Pasteur (RIIP); Pasteur Institute of Iran; Tehran University of Medical Sciences; Tehran University of Medical Sciences; Universite de Reims Champagne-Ardenne; Centre National de la Recherche Scientifique (CNRS); Institut de Recherche pour le Developpement (IRD); Universite de Montpellier; Centre National de la Recherche Scientifique (CNRS); Universite de Reims Champagne-Ardenne; CHU de Reims; CHU de Reims; Universite de Reims Champagne-Ardenne	Depaquit, J (corresponding author), Univ Reims, Fac Pharm, Transmiss Vectorielle & Epidemiosurveillance Mala, USC,ANSES,EA4688, Reims, France.	jerome.depaquit@univ-reims.fr	Guillard, Thomas/G-4065-2013; denis, Sereno/I-7242-2019; Bakhtiari, Ronak/AAQ-3414-2021; Razzaghi-Abyaneh, Mehdi/B-4447-2014; Depaquit, Jérôme/AAT-7586-2021	Guillard, Thomas/0000-0002-3795-0398; denis, Sereno/0000-0002-0034-9291; Bakhtiari, Ronak/0000-0002-3778-5732; Razzaghi-Abyaneh, Mehdi/0000-0001-8217-399X; Depaquit, Jérôme/0000-0001-6995-0088				ADDIS CJ, 1945, J PARASITOL, V31, P319, DOI 10.2307/3273087; ADLER S., 1929, ANN TROP MED & PARASITOL, V23, P1; Aguilar R, 2005, INSECT BIOCHEM MOLEC, V35, P709, DOI 10.1016/j.ibmb.2005.02.019; BEIER MS, 1994, J MED ENTOMOL, V31, P561, DOI 10.1093/jmedent/31.4.561; Benlarbi M, 2003, B ENTOMOL RES, V93, P383, DOI 10.1079/BER2003251; de Oliveira Sandra Maria Pereira, 2000, Revista da Sociedade Brasileira de Medicina Tropical, V33, P319, DOI 10.1590/S0037-86822000000300012; Dehkordi AS, 2011, IRAN J ARTHROPOD-BOR, V5, P20; DeMaio J, 1996, AM J TROP MED HYG, V54, P219, DOI 10.4269/ajtmh.1996.54.219; Dillon RJ, 2004, ANNU REV ENTOMOL, V49, P71, DOI 10.1146/annurev.ento.49.061802.123416; Dillon RJ, 1996, ANN TROP MED PARASIT, V90, P669, DOI 10.1080/00034983.1996.11813102; Ferro C, 1997, J MED ENTOMOL, V34, P719, DOI 10.1093/jmedent/34.6.719; Gonzalez-Ceron L, 2003, J MED ENTOMOL, V40, P371, DOI 10.1603/0022-2585-40.3.371; Gouveia C, 2008, NEOTROP ENTOMOL, V37, P597, DOI 10.1590/S1519-566X2008000500016; Guernaoui S, 2011, J VECTOR ECOL, V36, pS144, DOI 10.1111/j.1948-7134.2011.00124.x; Hillesland H, 2008, AM J TROP MED HYG, V79, P881, DOI 10.4269/ajtmh.2008.79.881; Ireri L. N., 2011, Journal of Entomology, V8, P581, DOI 10.3923/je.2011.581.587; JADIN J, 1966, Bulletin de la Societe de Pathologie Exotique, V59, P514; Kaya HK., 1993, INSECT PATHOL, V6, P12; Kiewegova A, 1999, THESIS CHARLES U PRA; KILLICKKENDRICK R, 1986, T ROY SOC TROP MED H, V80, P138, DOI 10.1016/0035-9203(86)90213-0; Leger RJS, 2000, APPL ENVIRON MICROB, V66, P320, DOI 10.1128/AEM.66.1.320-324.2000; McCarthy CB, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001304; MERRITT RW, 1992, ANNU REV ENTOMOL, V37, P349, DOI 10.1146/annurev.en.37.010192.002025; Oliveira SMP, 1998, REV SOC BRAS MED TRO, V33, P319; Ono M, 2001, J MED ENTOMOL, V38, P237, DOI 10.1603/0022-2585-38.2.237; Oshaghi MA, 2009, EXP PARASITOL, V123, P218, DOI 10.1016/j.exppara.2009.07.004; Parvizi P, 2008, T ROY SOC TROP MED H, V102, P891, DOI 10.1016/j.trstmh.2008.04.026; Pavlovich SG, 2000, GREAT LAKES ENTOMOL, V33, P141; PUMPUNI CB, 1993, EXP PARASITOL, V77, P195, DOI 10.1006/expr.1993.1076; Rajendran P, 1982, Indian J Public Health, V26, P49; Rassi Y., 2005, Pakistan Journal of Biological Sciences, V8, P1802, DOI 10.3923/pjbs.2005.1802.1806; Rassi Y, 2011, VECTOR-BORNE ZOONOT, V11, P145, DOI 10.1089/vbz.2009.0167; SAMIE M, 1990, COMP BIOCHEM PHYS B, V96, P577, DOI 10.1016/0305-0491(90)90059-3; SCHLEIN Y, 1986, J MED ENTOMOL, V23, P11, DOI 10.1093/jmedent/23.1.11; SCHLEIN Y, 1986, Parasitology Today, V2, P175, DOI 10.1016/0169-4758(86)90150-X; SCHLEIN Y, 1985, PARASITOLOGY, V90, P57, DOI 10.1017/S0031182000049015; Schlein Y, 2001, AM J TROP MED HYG, V65, P300, DOI 10.4269/ajtmh.2001.65.300; SEITZ HM, 1987, ZBL BAKT-INT J MED M, V266, P155; Soares RPP, 2003, AN ACAD BRAS CIENC, V75, P301, DOI 10.1590/S0001-37652003000300005; Strelkova MV, 2001, ANN TROP MED PARASIT, V95, P811, DOI 10.1080/00034980120111154; Volf P, 2002, FOLIA PARASIT, V49, P73, DOI 10.14411/fp.2002.014; WERREN JH, 1995, P ROY SOC B-BIOL SCI, V262, P197, DOI 10.1098/rspb.1995.0196	42	31	32	0	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 30	2012	7	11							e50259	10.1371/journal.pone.0050259	http://dx.doi.org/10.1371/journal.pone.0050259			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	054WM	23226255	gold, Green Published, Green Submitted			2022-12-27	WOS:000312376100065
J	Cevik, SI; Keskin, N; Belkaya, S; Ozlu, MI; Deniz, E; Tazebay, UH; Erman, B				Cevik, Safak Isil; Keskin, Nazli; Belkaya, Serkan; Ozlu, Meral Ilcim; Deniz, Emre; Tazebay, Uygar Halis; Erman, Batu			Cd81 Interacts with the T Cell Receptor to Suppress Signaling	PLOS ONE			English	Article							ALPHA-BETA; THYMOCYTE DEVELOPMENT; POSITIVE SELECTION; IN-VITRO; LINEAGE; LYMPHOCYTES; ANTIGEN; MICE; CD4; ASSOCIATION	CD81 (TAPA-1) is a ubiquitously expressed tetraspanin protein identified as a component of the B lymphocyte receptor (BCR) and as a receptor for the Hepatitis C Virus. In an effort to identify trans-membrane proteins that interact with the T-cell antigen receptor (TCR), we performed a membrane yeast two hybrid screen and identified CD81 as an interactor of the CD3delta subunit of the TCR. We found that in the absence of CD81, in thymocytes from knockout mice, TCR engagement resulted in stronger signals. These results were recapitulated in T cell lines that express low levels of CD81 through shRNA mediated silencing. Increased signaling did not result from alterations in the levels of TCR on the surface of T lymphocytes. Although CD81 is not essential for normal T lymphocyte development, it plays an important role in regulating TCR and possibly pre-TCR signal transduction by controlling the strength of signaling. CD81 dependent alterations in thymocyte signaling are evident in increased CD5 expression on CD81 deficient double positive (DP) thymocytes. We conclude that CD81 interacts with the T cell receptor to suppress signaling.	[Cevik, Safak Isil; Keskin, Nazli; Belkaya, Serkan; Ozlu, Meral Ilcim; Deniz, Emre; Erman, Batu] Sabanci Univ, Fac Engn & Nat Sci, Biol Sci & Bioengn Program, Istanbul, Turkey; [Cevik, Safak Isil; Tazebay, Uygar Halis] Bilkent Univ, Dept Mol Biol & Genet, Ankara, Turkey; [Keskin, Nazli; Deniz, Emre; Erman, Batu] Sabanci Univ, Nanotechnol Res & Applicat Ctr, SUNUM, Istanbul, Turkey	Sabanci University; Ihsan Dogramaci Bilkent University; Sabanci University	Erman, B (corresponding author), Sabanci Univ, Fac Engn & Nat Sci, Biol Sci & Bioengn Program, Istanbul, Turkey.	batu@sabanciuniv.edu	erman, batu/AAE-1963-2020; Belkaya, Serkan/ABD-4504-2020	Belkaya, Serkan/0000-0003-4214-382X; Thestrup, Meral Ilcim/0000-0003-3379-521X; Keskin Toklu, Nazli/0000-0002-3046-2172; TAZEBAY, UYGAR HALIS/0000-0003-1999-8213; DENIZ, EMRE/0000-0002-9635-983X	NIH [5R01TW007270]; TUBITAK [104T237]; TUBITAK BIDEP [2211]; FOGARTY INTERNATIONAL CENTER [R01TW007270] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); TUBITAK(Turkiye Bilimsel ve Teknolojik Arastirma Kurumu (TUBITAK)); TUBITAK BIDEP(Turkiye Bilimsel ve Teknolojik Arastirma Kurumu (TUBITAK)); FOGARTY INTERNATIONAL CENTER(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC))	This research was supported by grants from the NIH, 5R01TW007270 and TUBITAK, 104T237 and TUBITAK BIDEP 2211. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Azzam HS, 1998, J EXP MED, V188, P2301, DOI 10.1084/jem.188.12.2301; Boismenu R, 1996, SCIENCE, V271, P198, DOI 10.1126/science.271.5246.198; Bosselut R, 2001, IMMUNITY, V14, P483, DOI 10.1016/S1074-7613(01)00128-5; Call ME, 2002, CELL, V111, P967, DOI 10.1016/S0092-8674(02)01194-7; Cibotti R, 1997, IMMUNITY, V6, P245, DOI 10.1016/S1074-7613(00)80327-1; Dave VP, 2009, IMMUNOL REV, V232, P22, DOI 10.1111/j.1600-065X.2009.00835.x; Dave VP, 1997, EMBO J, V16, P1360, DOI 10.1093/emboj/16.6.1360; Deng J, 2002, INT IMMUNOL, V14, P513, DOI 10.1093/intimm/14.5.513; Doucey MA, 2003, J BIOL CHEM, V278, P3257, DOI 10.1074/jbc.M208119200; DUTZ JP, 1995, J IMMUNOL, V154, P2588; Erman B, 2006, J IMMUNOL, V177, P6613, DOI 10.4049/jimmunol.177.10.6613; GROVES T, 1995, J IMMUNOL, V154, P5011; Haks MC, 1998, EMBO J, V17, P1871, DOI 10.1093/emboj/17.7.1871; Holst J, 2008, NAT IMMUNOL, V9, P658, DOI 10.1038/ni.1611; IMAI T, 1995, J IMMUNOL, V155, P1229; KEARSE KP, 1995, IMMUNITY, V2, P391; Kim ST, 2010, J IMMUNOL, V185, P2951, DOI 10.4049/jimmunol.1000732; Levy S, 1998, ANNU REV IMMUNOL, V16, P89, DOI 10.1146/annurev.immunol.16.1.89; Maecker HT, 1997, J EXP MED, V185, P505; MALISSEN M, 1995, EMBO J, V14, P4641, DOI 10.1002/j.1460-2075.1995.tb00146.x; Mallaun M, 2008, J IMMUNOL, V180, P8211, DOI 10.4049/jimmunol.180.12.8211; MATSUMOTO AK, 1993, J EXP MED, V178, P1407, DOI 10.1084/jem.178.4.1407; Mittelbrunn M, 2002, J IMMUNOL, V169, P6691, DOI 10.4049/jimmunol.169.12.6691; Miyado K, 2000, SCIENCE, V287, P321, DOI 10.1126/science.287.5451.321; Miyazaki T, 1997, EMBO J, V16, P4217, DOI 10.1093/emboj/16.14.4217; OREN R, 1990, MOL CELL BIOL, V10, P4007, DOI 10.1128/MCB.10.8.4007; Pileri P, 1998, SCIENCE, V282, P938, DOI 10.1126/science.282.5390.938; Sagi Y, 2012, P NATL ACAD SCI USA, V109, P1613, DOI 10.1073/pnas.1121307109; Tsitsikov EN, 1997, P NATL ACAD SCI USA, V94, P10844, DOI 10.1073/pnas.94.20.10844; Van Laethem F, 2007, IMMUNITY, V27, P735, DOI 10.1016/j.immuni.2007.10.007	30	7	7	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 30	2012	7	11							e50396	10.1371/journal.pone.0050396	http://dx.doi.org/10.1371/journal.pone.0050396			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	054WM	23226274	gold, Green Published, Green Submitted			2022-12-27	WOS:000312376100084
J	Jarrasse, N; Charalambous, T; Burdet, E				Jarrasse, Nathanael; Charalambous, Themistoklis; Burdet, Etienne			A Framework to Describe, Analyze and Generate Interactive Motor Behaviors	PLOS ONE			English	Article							ROBOT; COLLABORATION; REHABILITATION; EVOLUTION; DYNAMICS; SYSTEM; ARM	While motor interaction between a robot and a human, or between humans, has important implications for society as well as promising applications, little research has been devoted to its investigation. In particular, it is important to understand the different ways two agents can interact and generate suitable interactive behaviors. Towards this end, this paper introduces a framework for the description and implementation of interactive behaviors of two agents performing a joint motor task. A taxonomy of interactive behaviors is introduced, which can classify tasks and cost functions that represent the way each agent interacts. The role of an agent interacting during a motor task can be directly explained from the cost function this agent is minimizing and the task constraints. The novel framework is used to interpret and classify previous works on human-robot motor interaction. Its implementation power is demonstrated by simulating representative interactions of two humans. It also enables us to interpret and explain the role distribution and switching between roles when performing joint motor tasks.	[Jarrasse, Nathanael; Burdet, Etienne] Univ London Imperial Coll Sci Technol & Med, Dept Bioengn, London, England; [Jarrasse, Nathanael] Univ Paris 06, CNRS, Inst Intelligent Syst & Robot, UMR 7222, Paris, France; [Charalambous, Themistoklis] Royal Inst Technol KTH, Dept Elect Engn, Automat Control Lab, Stockholm, Sweden; [Charalambous, Themistoklis] Royal Inst Technol KTH, ACCESS Linnaeus Ctr, Stockholm, Sweden	Imperial College London; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Sorbonne Universite; Royal Institute of Technology; Royal Institute of Technology	Jarrasse, N (corresponding author), Univ London Imperial Coll Sci Technol & Med, Dept Bioengn, London, England.	n.jarrasse@imperial.ac.uk; eburdet@imperial.ac.uk	Jarrasse, Nathanael/D-4881-2011; Charalambous, Themistoklis/ABD-9544-2021; Charalambous, Themistoklis/L-7469-2015	Jarrasse, Nathanael/0000-0002-5680-1566; Charalambous, Themistoklis/0000-0003-4800-6738; Burdet, Etienne/0000-0002-2123-0185	EU [FP7-231724 HUMOUR]	EU(European Commission)	This study was supported by the EU FP7-231724 HUMOUR grant. No additional external funding received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akella P, 1999, ICRA '99: IEEE INTERNATIONAL CONFERENCE ON ROBOTICS AND AUTOMATION, VOLS 1-4, PROCEEDINGS, P728, DOI 10.1109/ROBOT.1999.770061; Allport FH, 1920, PSYCHOL BULL, V17, P85, DOI 10.1037/h0063748; [Anonymous], 2007, J APPL PHILOS, V24, P62, DOI DOI 10.1111/J.1468-5930.2007.00346.X; Arkin R. C., 2008, P 3 ACM IEEE INT C H, P121; Asimov I., 1950, RUNAROUND; AXELROD R, 1981, SCIENCE, V211, P1390, DOI 10.1126/science.7466396; Balasubramanian S, 2010, CURR OPIN NEUROL, V23, P661, DOI 10.1097/WCO.0b013e32833e99a4; Basar T., 1998, DYNAMIC NONCOOPERATI, V2nd, DOI DOI 10.1137/1.9781611971132; Beaumarchais P, 1778, MARIAGE FIGARO; BRATMAN ME, 1992, PHILOS REV, V101, P327, DOI 10.2307/2185537; Braun DA, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000468; Burdet E, 2001, NATURE, V414, P446, DOI 10.1038/35106566; Burdet E., 2010, P INT S EXP ROB; Burghart C, 2002, INTELLIGENT AUTONOMOUS SYSTEMS 7, P38; Calinon S., 2007, 2007 2nd Annual Conference on Human-Robot Interaction (HRI), P255; Calinon S., 2009, P INT C ADV ROB ICAR, P1; Capek K., 1920, RUR ROSSUMS UNIVERSA; Chartrand TL, 1999, J PERS SOC PSYCHOL, V76, P893, DOI 10.1037/0022-3514.76.6.893; Clark H, 1996, USING LANGUAGE, V23; Cobb J, 2006, J BONE JOINT SURG BR, V88B, P188, DOI 10.1302/0301-620X.88B2.17220; Colgate J. E., 1996, Proceedings of the ASME Dynamic Systems and Control Division, P433; Colgate JE, 2003, IROS 2003: PROCEEDINGS OF THE 2003 IEEE/RSJ INTERNATIONAL CONFERENCE ON INTELLIGENT ROBOTS AND SYSTEMS, VOLS 1-4, P2516; Crawford M.P., 1937, COOPERATIVE SOLVING; Crocher V, 2012, IEEE T NEUR SYS REH, V20, P247, DOI 10.1109/TNSRE.2012.2190522; Dillenbourg P., 1996, LEARNING HUMANS MACH, P189, DOI DOI 10.1007/978-1-4020-9827-7_1; Dollar AM, 2008, IEEE T ROBOT, V24, P144, DOI 10.1109/TRO.2008.915453; Drea CM, 2009, ANIM BEHAV, V78, P967, DOI 10.1016/j.anbehav.2009.06.030; Emken J, 2007, J NEUROPHYSIOLOGY; Emken JL, 2007, J NEUROENG REHABIL, V4, DOI 10.1186/1743-0003-4-8; Evrard P, 2009, WORLD HAPTICS 2009: THIRD JOINT EUROHAPTICS CONFERENCE AND SYMPOSIUM ON HAPTIC INTERFACES FOR VIRTUAL ENVIRONMENT AND TELEOPERATOR SYSTEMS, PROCEEDINGS, P45, DOI 10.1109/WHC.2009.4810879; Franklin DW, 2008, J NEUROSCI, V28, P11165, DOI 10.1523/JNEUROSCI.3099-08.2008; Ganesh Gowrishankar, 2010, 2010 IEEE International Conference on Robotics and Automation (ICRA 2010), P2705, DOI 10.1109/ROBOT.2010.5509994; Ganesh G, 2012, PRACTICE TOGET UNPUB; Gillespie R. B., 1998, Proceedings of the ASME Dynamic Systems and Control Division-1998, P171; Hogan N, 2006, J REHABIL RES DEV, V43, P605, DOI 10.1682/JRRD.2005.06.0103; Ikemoto Shuhei, 2009, RO-MAN 2009 - The 18th IEEE International Symposium on Robot and Human Interactive Communication, P504, DOI 10.1109/ROMAN.2009.5326164; Jarrasse N, 2012, ROBOTS WILL NO UNPUB; Kadiallah A, 2012, J NEUROPHYSIOL, P2737; Kahn LE, 2006, J REHABIL RES DEV, V43, P619, DOI 10.1682/JRRD.2005.03.0056; Kamohara S, 1997, IEEE SYS MAN CYBERN, P4227, DOI 10.1109/ICSMC.1997.637363; KAZEROONI H, 1990, IEEE T SYST MAN CYB, V20, P450, DOI 10.1109/21.52555; Kitano H., 1997, Proceedings of the First International Conference on Autonomous Agents, P340, DOI 10.1145/267658.267738; Kosuge K, 2004, IEEE ROBIO 2004: PROCEEDINGS OF THE IEEE INTERNATIONAL CONFERENCE ON ROBOTICS AND BIOMIMETICS, P8; KOSUGE K, 1994, IEEE IND ELEC, P713, DOI 10.1109/IECON.1994.397872; Lum PS, 2002, ARCH PHYS MED REHAB, V83, P952, DOI 10.1053/apmr.2001.33101; Maeda Y, 2001, IROS 2001: PROCEEDINGS OF THE 2001 IEEE/RJS INTERNATIONAL CONFERENCE ON INTELLIGENT ROBOTS AND SYSTEMS, VOLS 1-4, P2240, DOI 10.1109/IROS.2001.976403; Marey Etienne-Jules, 1894, LE MOUVEMENT; Medina JR, 2012, IEEE INT CONF ROBOT, P1025, DOI 10.1109/ICRA.2012.6225085; Melendez-Calderon A., 2011, THESIS IMPERIAL COLL; Mrtl A, 2012, INT J ROBOTICS RES; MUSSAIVALDI FA, 1985, J NEUROSCI, V5, P2732; NASH J, 1951, ANN MATH, V54, P286, DOI 10.2307/1969529; NASH JF, 1950, P NATL ACAD SCI USA, V36, P48, DOI 10.1073/pnas.36.1.48; Newborn M., 1997, KASPAROV VS DEEP BLU; Nudehi SS, 2005, IEEE T CONTR SYST T, V13, P588, DOI 10.1109/TCST.2004.843131; O'Sullivan I, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000345; Oguz S. Ozgur, 2010, 2010 IEEE Haptics Symposium (Formerly known as Symposium on Haptic Interfaces for Virtual Environment and Teleoperator Systems), P371, DOI 10.1109/HAPTIC.2010.5444628; Pastor P., 2011, 2011 IEEE International Conference on Robotics and Automation (ICRA 2011), P3828, DOI 10.1109/ICRA.2011.5980200; Paynter H.M., 1961, ANAL DESIGN ENG SYST; Peshkin MA, 2001, IEEE T ROBOTIC AUTOM, V17, P377, DOI 10.1109/70.954751; Plotnik JM, 2011, P NATL ACAD SCI USA, V108, P5116, DOI 10.1073/pnas.1101765108; Polenske KR, 2004, REG STUD, V38, P1029, DOI 10.1080/0034340042000292629; RAIBERT MH, 1981, J DYN SYST-T ASME, V103, P126, DOI 10.1115/1.3139652; Reed KB, 2006, 2006 IEEE/RSJ INTERNATIONAL CONFERENCE ON INTELLIGENT ROBOTS AND SYSTEMS, VOLS 1-12, P2109, DOI 10.1109/IROS.2006.282489; Reed KB, 2008, IEEE T HAPTICS, V1, P108, DOI [10.1109/TOH.2008.13, 10.1109/ToH.2008.13]; Rigoux L, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002716; ROSENBERG LB, 1993, IEEE VIRTUAL REALITY ANNUAL INTERNATIONAL SYMPOSIUM, P76, DOI 10.1109/VRAIS.1993.380795; Rotkowitz M, 2005, IEEE T AUTOMAT CONTR, V50, P1984, DOI 10.1109/TAC.2005.860365; Sebanz N, 2006, TRENDS COGN SCI, V10, P70, DOI 10.1016/j.tics.2005.12.009; Sebanz N, 2007, UNDERSTANDING HUMAN; SHADMEHR R, 1994, J NEUROSCI, V14, P3208; Sheridan TB, 1992, TELEROBOTICS AUTOMAT; Stefanov N, 2010, IEEE INT CONF ROBOT, P5334, DOI 10.1109/ROBOT.2010.5509432; Stefanov N, 2009, WORLD HAPTICS 2009: THIRD JOINT EUROHAPTICS CONFERENCE AND SYMPOSIUM ON HAPTIC INTERFACES FOR VIRTUAL ENVIRONMENT AND TELEOPERATOR SYSTEMS, PROCEEDINGS, P51, DOI 10.1109/WHC.2009.4810846; Teasley S., 1994, NATO ASI SERIES F, V128, P69; Tee KP, 2010, BIOL CYBERN, V102, P31, DOI 10.1007/s00422-009-0348-z; Todorov E, 2002, NAT NEUROSCI, V5, P30; TRIVERS RL, 1971, Q REV BIOL, V46, P35, DOI 10.1086/406755; Vesper C, 2010, NEURAL NETWORKS, V23, P998, DOI 10.1016/j.neunet.2010.06.002; Wang Z, 2009, WORLD HAPTICS 2009: THIRD JOINT EUROHAPTICS CONFERENCE AND SYMPOSIUM ON HAPTIC INTERFACES FOR VIRTUAL ENVIRONMENT AND TELEOPERATOR SYSTEMS, PROCEEDINGS, P374, DOI 10.1109/WHC.2009.4810835; Weiner T., 2005, NY TIMES; Winter D., 1990, BIOMECHANICS MOTOR C, V2nd; Wojtara T, 2009, AUTOMATICA, V45, P333, DOI 10.1016/j.automatica.2008.08.021; Woodworth RS, 1899, PSYCHOL REV-MONOGR S, V3, P1; Yanco H. A., 2002, P AAAI FALL S HUM RO, P111; Yang C., 2011, IEEE T ROBOTICS, V27, P1; Zeng Q, 2009, NEUROREHAB NEURAL RE, V23, P494, DOI 10.1177/1545968308323692	89	99	99	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 30	2012	7	11							e49945	10.1371/journal.pone.0049945	http://dx.doi.org/10.1371/journal.pone.0049945			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	054WM	23226231	Green Published, gold			2022-12-27	WOS:000312376100039
J	Johnson, BJ; Melde, BJ; Dinderman, MA; Lin, BC				Johnson, Brandy J.; Melde, Brian J.; Dinderman, Michael A.; Lin, Baochuan			Stabilization of RNA through Absorption by Functionalized Mesoporous Silicate Nanospheres	PLOS ONE			English	Article							NANOPARTICLES; DELIVERY; IMMOBILIZATION; STABILITY; TREHALOSE; LIPOSOMES; RELEASE; SIRNA	The potential for encapsulating RNA within tunable, semi-permeable structures for storage and transportation purposes offers an interesting approach to the reduction of stringent storage requirements that often hamper the field application of genetic analysis methods. In this study, we assessed the potential for application of functionalized, porous silicate sorbents in maintaining nucleic acid integrity. Mesoporous silica nanoparticles (MSNs) with and without incorporated stabilizing reagents were used to encapsulate triosephosphate isomerase mRNA of Arabidopsis thaliana. The absorption, elution, and the long-term stability of the RNA were monitored by using quantitative real-time RT-PCR. The results indicate that adsorbed RNA can be eluted from the sorbents using simple buffers and employed directly for downstream molecular diagnostic assays without any further processing. RNA integrity can be maintained for extended time periods under refrigeration temperatures in the presence of covalently immobilized stabilizing compounds. This study provides initial evidence of the potential for application of MSNs in transportation and storage. They may also have utility in sample collection and processing in restrictive environments.	[Johnson, Brandy J.; Melde, Brian J.; Dinderman, Michael A.; Lin, Baochuan] USN, Res Lab, Ctr Bio Mol Sci & Engn, Washington, DC USA	United States Department of Defense; United States Navy; Naval Research Laboratory	Lin, BC (corresponding author), USN, Res Lab, Ctr Bio Mol Sci & Engn, Washington, DC USA.	baochuan.lin@nrl.navy.mil	Melde, Brian/K-4551-2017; Johnson, Brandy J/B-3462-2008; Lin, Baochuan/A-8390-2009	Melde, Brian/0000-0001-5072-6369; Johnson, Brandy J/0000-0002-3637-0631; Lin, Baochuan/0000-0002-9484-0785	Office of Naval Research [NRL 6.1]	Office of Naval Research(Office of Naval Research)	The funding for this project is provided by the Office of Naval Research (NRL 6.1). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anchordoquy TJ, 2005, J PHARM SCI-US, V94, P1226, DOI 10.1002/jps.20353; Blow JA, 2008, J VIROL METHODS, V150, P41, DOI 10.1016/j.jviromet.2008.02.003; COLACO C, 1992, BIO-TECHNOL, V10, P1007, DOI 10.1038/nbt0992-1007; Elbein AD, 2003, GLYCOBIOLOGY, V13, p17R, DOI 10.1093/glycob/cwg047; Foged C, 2007, J LIPOSOME RES, V17, P191, DOI 10.1080/08982100701530373; Foged C, 2007, INT J PHARMACEUT, V331, P160, DOI 10.1016/j.ijpharm.2006.11.010; Fuertes AB, 2010, J COLLOID INTERF SCI, V349, P173, DOI 10.1016/j.jcis.2010.05.041; Gao F, 2009, J PHYS CHEM B, V113, P1796, DOI 10.1021/jp807956r; Hartmann M, 2005, CHEM MATER, V17, P4577, DOI 10.1021/cm0485658; Johnson BJ, 2012, CHEM ENG SCI, V68, P376, DOI 10.1016/j.ces.2011.09.048; Johnson BJ, 2010, TALANTA, V81, P1454, DOI 10.1016/j.talanta.2010.02.050; Kasahara Toshihiko, 2006, Journal of Toxicological Sciences, V31, P509, DOI 10.2131/jts.31.509; Kataoka Kazunori, 2005, Nucleic Acids Symp Ser (Oxf), P17, DOI 10.1093/nass/49.1.17; Kim HJ, 2005, ANAL CHEM, V77, P93, DOI 10.1021/ac0401218; Miyamoto T, 2009, BIOTECHNOL PROGR, V25, P1678, DOI 10.1002/btpr.267; Oishi M, 2005, J AM CHEM SOC, V127, P1624, DOI 10.1021/ja044941d; Roder B, 2010, J CLIN MICROBIOL, V48, P4260, DOI 10.1128/JCM.01230-10; Rosenholm J, 2010, J MATER CHEM, V20, P2707, DOI 10.1039/b920076b; Rosenholm JM, 2010, NANOSCALE, V2, P1870, DOI 10.1039/c0nr00156b; Slowing II, 2007, J AM CHEM SOC, V129, P8845, DOI 10.1021/ja0719780; Slowing II, 2007, ADV FUNCT MATER, V17, P1225, DOI 10.1002/adfm.200601191; Slowing II, 2007, ABSTR PAP AM CHEM S, V233, P186; Sun JM, 2006, CHEM COMMUN, P1322, DOI 10.1039/b516930e; Trewyn BG, 2007, ACCOUNTS CHEM RES, V40, P846, DOI 10.1021/ar600032u; Umpleby RJ, 2001, ANAL CHIM ACTA, V435, P35, DOI 10.1016/S0003-2670(00)01211-3; Wang F, 2010, BIORESOURCE TECHNOL, V101, P8931, DOI 10.1016/j.biortech.2010.06.115; Workman H, 2009, J AM CHEM SOC, V131, P3806, DOI 10.1021/ja8084753	27	5	5	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 30	2012	7	11							e50356	10.1371/journal.pone.0050356	http://dx.doi.org/10.1371/journal.pone.0050356			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	054WM	23226266	gold, Green Published, Green Submitted			2022-12-27	WOS:000312376100076
J	Kim, YS; Jung, DH; Sohn, E; Kim, J; Kim, JS				Kim, Young Sook; Jung, Dong Ho; Sohn, Eunjin; Kim, Junghyun; Kim, Jin Sook			Glycoxidised LDL Induced the Upregulation of Axl Receptor Tyrosine Kinase and Its Ligand in Mouse Mesangial Cells	PLOS ONE			English	Article							ARREST-SPECIFIC GENE-6; DIABETIC-NEPHROPATHY; PROLIFERATION; ACTIVATION; EXPRESSION; GLUCOSE; MICE; COMPLICATIONS; HYPERTROPHY; INHIBITION	Aim/Hypothesis: Low-density lipoprotein (LDL) is subjected to glycoxidation in diabetes, and a novel signalling mechanism by which glycoxidised LDL functions in glomerular mesangial cells remains to be ascertained. Methods: We performed gene expression analysis in mouse glomerular mesangial cells treated with LDL modified by glycation and oxidation (GO-LDL, 100 mu g/ml) for 48 h by using DNA microarray analysis and quantitative real-time PCR. We examined the GO-LDL-specific changes in gene and protein expression in mesangial cells and glomeruli of type 2 diabetic Zucker diabetic fatty (ZDF) rats. Results: By microarray profiling, we noted that GO-LDL treatment increased Axl receptor tyrosine kinase (Axl) mRNA expression (similar to 2.5-fold, p < 0.05) compared with normal LDL (N-LDL) treatment in mesangial cells. Treatment with GO-LDL also increased the protein levels of Axl and its ligand Gas6 as measured by Western blotting. These increases were inhibited by neutralising Axl receptor-specific antibody. Silencing Gas6 by siRNA inhibited GO-LDL-induced Axl expression in mesangial cells. Axl and Gas6 protein were also increased in cells cultured in high glucose (30 mM) or methylglyoxal (200 mu M). Gas6 treatment increased the expression and secretion of TGF-beta 1 protein, a key regulator of extracellular matrix expression in the glomeruli of diabetic kidneys. Immunohistochemical analyses of glomeruli from 20-week-old ZDF rats exhibited increased Axl protein expression. Rottlerin, a selective PKC-delta inhibitor, completely blocked Gas6-induced TGF-beta 1 expression. Conclusions/Interpretation: These data suggest that LDL modified by glycoxidation may mediate Axl/Gas6 pathway activation, and this mechanism may play a significant role in the pathogenesis of diabetic nephropathy.	[Kim, Young Sook; Jung, Dong Ho; Sohn, Eunjin; Kim, Junghyun; Kim, Jin Sook] KIOM, Herbal Med Res Div, Korean Med Based Herbal Drug Res Grp, Taejon, South Korea	Korea Institute of Oriental Medicine (KIOM)	Kim, JS (corresponding author), KIOM, Herbal Med Res Div, Korean Med Based Herbal Drug Res Grp, Taejon, South Korea.	jskim@kiom.re.kr		jeong, dongho/0000-0002-6250-5720	Korea Institute of Oriental Medicine [K11040, K12040]	Korea Institute of Oriental Medicine	This study was supported by K11040 and K12040 grants from the Korea Institute of Oriental Medicine. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arai H, 2008, VITAM HORM, V78, P375, DOI 10.1016/S0083-6729(07)00015-5; BROWN MS, 1986, SCIENCE, V232, P34, DOI 10.1126/science.3513311; Cavet ME, 2008, ARTERIOSCL THROM VAS, V28, P886, DOI 10.1161/ATVBAHA.108.162693; Chen S, 2003, SEMIN NEPHROL, V23, P532, DOI 10.1053/S0270-9295(03)00132-3; D'Arcangelo D, 2006, CARDIOVASC RES, V71, P754, DOI 10.1016/j.cardiores.2006.06.002; DUELL PB, 1990, DIABETES, V39, P1257, DOI 10.2337/diabetes.39.10.1257; Fourcot A, 2011, AM J PHYSIOL-GASTR L, V300, pG1043, DOI 10.1152/ajpgi.00311.2010; Geraldes P, 2010, CIRC RES, V106, P1319, DOI 10.1161/CIRCRESAHA.110.217117; HABEEB AFS, 1966, ANAL BIOCHEM, V14, P328, DOI 10.1016/0003-2697(66)90275-2; Kim YS, 2007, EUR J PHARMACOL, V562, P12, DOI 10.1016/j.ejphar.2007.01.048; Knott HM, 2003, EUR J BIOCHEM, V270, P3572, DOI 10.1046/j.1432-1033.2003.03742.x; Krolewski M, 1996, KIDNEY INT, V50, P2041, DOI 10.1038/ki.1996.527; Lee HS, 1996, KIDNEY INT, V50, P1582, DOI 10.1038/ki.1996.474; LEE TS, 1989, P NATL ACAD SCI USA, V86, P5141, DOI 10.1073/pnas.86.13.5141; Linger RM, 2010, EXPERT OPIN THER TAR, V14, P1073, DOI 10.1517/14728222.2010.515980; Lockhart DJ, 1996, NAT BIOTECHNOL, V14, P1675, DOI 10.1038/nbt1296-1675; LYONS TJ, 1993, AM J CARDIOL, V71, pB26, DOI 10.1016/0002-9149(93)90142-Y; Maquoi E, 2005, ARTERIOSCL THROM VAS, V25, P1002, DOI 10.1161/01.ATV.0000160611.68791.c6; Menne J, 2004, DIABETES, V53, P2101, DOI 10.2337/diabetes.53.8.2101; Menne J, 2009, NEPHROL DIAL TRANSPL, V24, P2021, DOI 10.1093/ndt/gfp150; Nagai K, 2005, KIDNEY INT, V68, P552, DOI 10.1111/j.1523-1755.2005.00433.x; Nagai K, 2003, J BIOL CHEM, V278, P18229, DOI 10.1074/jbc.M213266200; Rankin EB, 2010, CANCER RES, V70, P7570, DOI 10.1158/0008-5472.CAN-10-1267; Sataranatarajan K, 2008, CELL SIGNAL, V20, P969, DOI 10.1016/j.cellsig.2008.01.016; Sreekumar R, 2002, DIABETES, V51, P1913, DOI 10.2337/diabetes.51.6.1913; Yanagita M, 2001, AM J PATHOL, V158, P1423, DOI 10.1016/S0002-9440(10)64093-X; Yanagita M, 2001, J BIOL CHEM, V276, P42364, DOI 10.1074/jbc.M107488200; Yanagita M, 1999, J AM SOC NEPHROL, V10, P2503	28	6	8	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 30	2012	7	11							e50297	10.1371/journal.pone.0050297	http://dx.doi.org/10.1371/journal.pone.0050297			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	054WM	23226259	gold, Green Submitted, Green Published			2022-12-27	WOS:000312376100069
J	Li, SS; Eloyan, A; Joel, S; Mostofsky, S; Pekar, J; Bassett, SS; Caffo, B				Li, Shanshan; Eloyan, Ani; Joel, Suresh; Mostofsky, Stewart; Pekar, James; Bassett, Susan Spear; Caffo, Brian			Analysis of Group ICA-Based Connectivity Measures from fMRI: Application to Alzheimer's Disease	PLOS ONE			English	Article							INDEPENDENT COMPONENT ANALYSIS; FUNCTIONAL MRI DATA	Functional magnetic resonance imaging (fMRI) is a powerful tool for the in vivo study of the pathophysiology of brain disorders and disease. In this manuscript, we propose an analysis stream for fMRI functional connectivity data and apply it to a novel study of Alzheimer's disease. In the first stage, spatial independent component analysis is applied to group fMRI data to obtain common brain networks (spatial maps) and subject-specific mixing matrices (time courses). In the second stage, functional principal component analysis is utilized to decompose the mixing matrices into population-level eigenvectors and subject-specific loadings. Inference is performed using permutation-based exact logistic regression for matched pairs data. The method is applied to a novel fMRI study of Alzheimer's disease risk under a verbal paired associates task. We found empirical evidence of alternative ICA-based metrics of connectivity when comparing subjects evidencing mild cognitive impairment relative to carefully matched controls.	[Li, Shanshan; Eloyan, Ani; Caffo, Brian] Johns Hopkins Univ, Dept Biostat, Baltimore, MD 21205 USA; [Joel, Suresh; Pekar, James] Johns Hopkins Univ, Dept Radiol, Baltimore, MD USA; [Joel, Suresh; Mostofsky, Stewart; Pekar, James] Kennedy Krieger Inst, Baltimore, MD USA; [Mostofsky, Stewart] Johns Hopkins Univ, Dept Neurol, Baltimore, MD 21218 USA; [Bassett, Susan Spear] Johns Hopkins Univ, Dept Psychiat & Behav Sci, Baltimore, MD USA	Johns Hopkins University; Johns Hopkins University; Kennedy Krieger Institute; Johns Hopkins University; Johns Hopkins University	Li, SS (corresponding author), Johns Hopkins Univ, Dept Biostat, Baltimore, MD 21205 USA.	shli@jhsph.edu		Pekar, James/0000-0002-9830-0655	National Institutes of Health from the National Institute of Biomedical Imaging and Bioengineering [R01 EB012547, P41 EB015909]; National Institutes of Health from National Institute of Neurological Disorders and Stroke [R01NS060910, RO1 AG 016324]; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [R01EB012547, P41EB015909] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS060910] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG016324] Funding Source: NIH RePORTER	National Institutes of Health from the National Institute of Biomedical Imaging and Bioengineering; National Institutes of Health from National Institute of Neurological Disorders and Stroke; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	The authors are grateful for support provided by National Institutes of Health grants: R01 EB012547 and P41 EB015909 from the National Institute of Biomedical Imaging and Bioengineering, R01NS060910 from the National Institute of Neurological Disorders and Stroke, RO1 AG 016324. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agresti A., 2013, CATEGORICAL DATA ANA, V3rd ed.; Allen G, 2007, ARCH NEUROL-CHICAGO, V64, P1482, DOI 10.1001/archneur.64.10.1482; Bassett SS, 2006, BRAIN, V129, P1229, DOI 10.1093/brain/awl089; Bassett SS, 2002, AM J MED GENET, V114, P679, DOI 10.1002/ajmg.10648; Beckmann CF, 2005, NEUROIMAGE, V25, P294, DOI 10.1016/j.neuroimage.2004.10.043; Beckmann CF, 2004, IEEE T MED IMAGING, V23, P137, DOI 10.1109/TMI.2003.822821; Brandt J., 1988, NEUROPSY NEUROPSY BE, V1, P111; BRESLOW NE, 1988, BIOMETRIKA, V75, P11; Buckner RL, 2005, J NEUROSCI, V25, P7709, DOI 10.1523/JNEUROSCI.2177-05.2005; Caffo BS, 2010, NEUROIMAGE, V51, P1140, DOI 10.1016/j.neuroimage.2010.02.081; Calhoun VD, 2001, HUM BRAIN MAPP, V14, P140, DOI 10.1002/hbm.1048; Calhoun VD, 2009, NEUROIMAGE, V45, pS163, DOI 10.1016/j.neuroimage.2008.10.057; Crainiceanu CM, 2009, J AM STAT ASSOC, V104, P1550, DOI 10.1198/jasa.2009.tm08564; Crainiceanu CM, 2009, J AM STAT ASSOC, V104, P541, DOI 10.1198/jasa.2009.0020; Di CZ, 2009, ANN APPL STAT, V3, P458, DOI 10.1214/08-AOAS206; FRISTON KJ, 1993, J CEREBR BLOOD F MET, V13, P5, DOI 10.1038/jcbfm.1993.4; Goldsmith J, 2010, J COMPUTATIONAL GRAP; Grady CL, 2001, BRAIN, V124, P739, DOI 10.1093/brain/124.4.739; Greven S, 2010, ELECTRON J STAT, V4, P1022, DOI 10.1214/10-EJS575; Guo Y, 2008, NEUROIMAGE, V42, P1078, DOI 10.1016/j.neuroimage.2008.05.008; Hall P, 2006, J R STAT SOC B, V68, P109, DOI 10.1111/j.1467-9868.2005.00535.x; Indritz J., 1963, METHODS ANAL; Joel S, 2011, MAGN RESON MED, V65; Karhunen K., 1947, LINEARE METHODEN WAH; Loeve M., 1945, CR HEBD ACAD SCI, V220, P469; McKeown MJ, 1998, P NATL ACAD SCI USA, V95, P803, DOI 10.1073/pnas.95.3.803; McKeown MJ, 1998, HUM BRAIN MAPP, V6, P160, DOI 10.1002/(SICI)1097-0193(1998)6:3<160::AID-HBM5>3.0.CO;2-1; Mesholam RI, 1998, ARCH NEUROL-CHICAGO, V55, P84, DOI 10.1001/archneur.55.1.84; PRENTICE RL, 1979, BIOMETRIKA, V66, P403, DOI 10.1093/biomet/66.3.403; Ramsay J., 2005, FUNCTIONAL DATA ANAL, DOI 10.1007/b98888; Swihart BJ, 2010, EPIDEMIOLOGY, V21, P621, DOI 10.1097/EDE.0b013e3181e5b06a; Tzourio-Mazoyer N, 2002, NEUROIMAGE, V15, P273, DOI 10.1006/nimg.2001.0978; Wang K, 2007, HUM BRAIN MAPP, V28, P967, DOI 10.1002/hbm.20324; Wang L, 2006, NEUROIMAGE, V31, P496, DOI 10.1016/j.neuroimage.2005.12.033; Zhu HT, 2011, NEUROIMAGE, V56, P1412, DOI 10.1016/j.neuroimage.2011.01.075	35	10	12	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 30	2012	7	11							e49340	10.1371/journal.pone.0049340	http://dx.doi.org/10.1371/journal.pone.0049340			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	054WM	23226208	Green Submitted, Green Published, gold			2022-12-27	WOS:000312376100017
J	Li, ZG; Zhang, RH; Wang, XJ; Chen, F; Tian, CY				Li, Zhi-guo; Zhang, Run-hua; Wang, Xiu-jun; Chen, Fang; Tian, Chang-yan			Growing Season Carbon Dioxide Exchange in Flooded Non-Mulching and Non-Flooded Mulching Cotton	PLOS ONE			English	Article							AGRICULTURAL SOILS; LOESS PLATEAU; NITROUS-OXIDE; CROP YIELD; CO2; WHEAT; SEQUESTRATION; TEMPERATURE; MANAGEMENT; ECOSYSTEM	There is much interest in the role that agricultural practices might play in sequestering carbon to help offset rising atmospheric CO2 concentrations. However, limited information exists regarding the potential for increased carbon sequestration of different management strategies. The objective of this study was to quantify and contrast carbon dioxide exchange in traditional non-mulching with flooding irrigation (TF) and plastic film mulching with drip irrigation (PM) cotton (Gossypium hirsutum L.) fields in northwest China. Net primary productivity (NPP), soil heterotrophic respiration (R-h) and net ecosystem productivity (NEP) were measured during the growing seasons in 2009 and 2010. As compared with TF, PM significantly increased the aboveground and belowground biomass and the NPP (340 g C m(-2) season(-1)) of cotton, and decreased the R-h (89 g C m(-2) season(-1)) (p < 0.05). In a growing season, PM had a higher carbon sequestration in terms of NEP of similar to 429 g C m(-2) season(-1) than the TF. These results demonstrate that conversion of this type of land use to mulching practices is an effective way to increase carbon sequestration in the short term in cotton systems of arid areas.	[Li, Zhi-guo; Wang, Xiu-jun; Tian, Chang-yan] Chinese Acad Sci, Xinjiang Inst Ecol & Geog, State Key Lab Desert & Oasis Ecol, Urumqi, Peoples R China; [Li, Zhi-guo; Chen, Fang] Chinese Acad Sci, Key Lab Aquat Bot & Watershed Ecol, Wuhan Bot Garden, Wuhan, Peoples R China; [Zhang, Run-hua] Wuhan Vegetable Res Inst, Wuhan, Peoples R China	Chinese Academy of Sciences; Xinjiang Institute of Ecology & Geography, CAS; Chinese Academy of Sciences; Wuhan Botanical Garden, CAS	Tian, CY (corresponding author), Chinese Acad Sci, Xinjiang Inst Ecol & Geog, State Key Lab Desert & Oasis Ecol, Urumqi, Peoples R China.	tianchy@ms.xjb.ac.cn	Wang, Xiujun/F-2641-2010	Wang, Xiujun/0000-0002-2859-8011	National Natural Science Foundation of China [40971048]; Chinese Academy of Sciences [0972021001]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Chinese Academy of Sciences(Chinese Academy of Sciences)	This study was financially supported by the project of National Natural Science Foundation of China (40971048) and the program for 100 Distinguished Young Scientists of the Chinese Academy of Sciences (0972021001). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmed ZI, 2007, PAK J BOT, V39, P1189; Bekku YS, 2009, ECOL RES, V24, P865, DOI 10.1007/s11284-008-0560-7; Bellassen V, 2011, GLOBAL CHANGE BIOL, V17, P3274, DOI 10.1111/j.1365-2486.2011.02476.x; Bernacchi CJ, 2005, GLOBAL CHANGE BIOL, V11, P1867, DOI 10.1111/j.1365-2486.01050.x; Billings SA, 2008, GLOBAL CHANGE BIOL, V14, P1025, DOI 10.1111/j.1365-2486.2008.01562.x; Chakraboyty D, 2008, AGR WATER MANAGE, V95, P1323, DOI 10.1016/j.agwat.2008.06.001; Chen XiShi, 1998, Chinese Journal of Applied Ecology, V9, P435; Desjardins RL, 2005, CLIMATIC CHANGE, V70, P283, DOI 10.1007/s10584-005-5951-y; Dong HZ, 2009, FIELD CROP RES, V111, P269, DOI 10.1016/j.fcr.2009.01.001; Flanagan LB, 2002, GLOBAL CHANGE BIOL, V8, P599, DOI 10.1046/j.1365-2486.2002.00491.x; Gao YJ, 2009, NUTR CYCL AGROECOSYS, V85, P109, DOI 10.1007/s10705-009-9252-0; [何文清 HE Wen-qing], 2009, [农业环境科学学报, Journal of Agro-Environment Science], V28, P533; Heaton E, 2004, BIOMASS BIOENERG, V27, P21, DOI 10.1016/j.biombioe.2003.10.005; Hollinger DY, 2004, GLOBAL CHANGE BIOL, V10, P1961; Ibarra-Jimenez L, 2008, AGROCHIMICA, V52, P263; Jia Y, 2006, FIELD CROP RES, V95, P64, DOI 10.1016/j.fcr.2005.02.002; Johnson JMF, 2007, ENVIRON POLLUT, V150, P107, DOI 10.1016/j.envpol.2007.06.030; Ju WM, 2010, INT J REMOTE SENS, V31, P1573, DOI 10.1080/01431160903475357; Kessavalou A, 1998, J ENVIRON QUAL, V27, P1094, DOI 10.2134/jeq1998.00472425002700050015x; Li CF, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0034642, 10.1371/journal.pone.0030026, 10.1371/journal.pone.0047442]; Li FM, 2004, SOIL TILL RES, V78, P9, DOI 10.1016/j.still.2003.12.009; Li SQ, 2001, ACTA ECOLOGICA SINIC, V21, P1519; Liu CA, 2009, EUR J AGRON, V31, P241, DOI 10.1016/j.eja.2009.08.004; Liu WH, 2005, ENVIRON INT, V31, P805, DOI 10.1016/j.envint.2005.05.042; Liu XJ, 2003, FIELD CROP RES, V83, P297, DOI 10.1016/S0378-4290(03)00079-0; Lohila A, 2003, PLANT SOIL, V251, P303, DOI 10.1023/A:1023004205844; McMichael BL, 2010, PHYSIOLOGY OF COTTON, P57, DOI 10.1007/978-90-481-3195-2_6; Mi N, 2008, GLOBAL CHANGE BIOL, V14, P2380, DOI 10.1111/j.1365-2486.2008.01642.x; Moreno MM, 2008, SCI HORTIC-AMSTERDAM, V116, P256, DOI 10.1016/j.scienta.2008.01.007; Mosier AR, 1997, CHEMOSPHERE, V35, P2059, DOI 10.1016/S0045-6535(97)00231-2; Okuda H, 2007, J JPN SOC HORTIC SCI, V76, P279, DOI 10.2503/jjshs.76.279; Paustian K, 2000, BIOGEOCHEMISTRY, V48, P147, DOI 10.1023/A:1006271331703; Reicosky DC, 2008, SOIL TILL RES, V99, P221, DOI 10.1016/j.still.2008.02.006; Reth S, 2005, THEOR APPL CLIMATOL, V80, P105, DOI 10.1007/s00704-004-0094-z; Saito M, 2009, GLOBAL CHANGE BIOL, V15, P221, DOI 10.1111/j.1365-2486.2008.01713.x; Saroa GS, 2003, LAND DEGRAD DEV, V14, P481, DOI 10.1002/ldr.569; Sombrero A, 2010, SOIL TILL RES, V107, P64, DOI 10.1016/j.still.2010.02.009; Sperow M, 2003, CLIMATIC CHANGE, V57, P319, DOI 10.1023/A:1022888832630; Teklemariam T, 2009, AGR FOREST METEOROL, V149, P2040, DOI 10.1016/j.agrformet.2009.07.011; Tum M, 2011, BIOMASS BIOENERG, V35, P4665, DOI 10.1016/j.biombioe.2011.09.015; Verma SB, 2005, AGR FOREST METEOROL, V131, P77, DOI 10.1016/j.agrformet.2005.05.003; Vleeshouwers LM, 2002, GLOBAL CHANGE BIOL, V8, P519, DOI 10.1046/j.1365-2486.2002.00485.x; Wang YG, 2008, ENVIRON MONIT ASSESS, V140, P291, DOI 10.1007/s10661-007-9867-z; Xie JX, 2009, ENVIRON GEOL, V56, P953, DOI 10.1007/s00254-008-1197-0; Xu LK, 2004, AGR FOREST METEOROL, V123, P79, DOI 10.1016/j.agrformet.2003.10.004; Yan HM, 2007, AGR ECOSYST ENVIRON, V121, P325, DOI 10.1016/j.agee.2006.11.008; Zhang GS, 2008, SOIL TILL RES, V98, P113, DOI 10.1016/j.still.2007.09.001; Zhang SL, 2009, SOIL TILL RES, V102, P78, DOI 10.1016/j.still.2008.07.019; Zhang ZC, 2008, FIELD CROP RES, V108, P71, DOI 10.1016/j.fcr.2008.03.004	49	15	16	2	65	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 30	2012	7	11							e50760	10.1371/journal.pone.0050760	http://dx.doi.org/10.1371/journal.pone.0050760			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	054WM	23226376	Green Published, Green Submitted, gold			2022-12-27	WOS:000312376100187
J	Penel-Sotirakis, K; Simonazzi, E; Peguet-Navarro, J; Rozieres, A				Penel-Sotirakis, Karine; Simonazzi, Elise; Peguet-Navarro, Josette; Rozieres, Aurore			Differential Capacity of Human Skin Dendritic Cells to Polarize CD4(+)T Cells into IL-17, IL-21 and IL-22 Producing Cells	PLOS ONE			English	Article							HUMAN LANGERHANS CELLS; T-CELLS; TH17 POLARIZATION; INTERLEUKIN 22; B7 FAMILY; BETA; DISTINCT; SUBSETS; T-H-17	Accumulating evidence suggests a contribution of T cell-derived IL-17, IL-21 and IL-22 cytokines in skin immune homeostasis as well as inflammatory disorders. Here, we analyzed whether the cytokine-producing T lymphocytes could be induced by the different subsets of human skin dendritic cells (DCs), i.e., epidermal Langerhans cells (LCs), dermal CD1c(+)CD14(-) and CD14(+) DCs (DDCs). DCs were purified following a 2-day migration from separated epidermal and dermal sheets and co-cultured with allogeneic T cells before cytokine secretion was explored. Results showed that no skin DCs could induce substantial IL-17 production by naive CD4(+) or CD8(+)T lymphocytes whereas all of them could induce IL-17 production by memory T cells. In contrast, LCs and CD1c(+)CD14(-) DDCs were able to differentiate naive CD4(+)T lymphocytes into IL-22 and IL-21-secreting cells, LCs being the most efficient in this process. Intracellular cytokine staining showed that the majority of IL-21 or IL-22 secreting CD4(+) T lymphocytes did not co-synthesized IFN-gamma, IL-4 or IL-17. IL-21 and IL-22 production were dependent on the B7/CD28 co-stimulatory pathway and ICOS-L expression on skin LCs significantly reduced IL-21 level. Finally, we found that TGF-beta strongly down-regulates both IL-21 and IL-22 secretion by allogeneic CD4(+)T cells. These results add new knowledge on the functional specialization of human skin DCs and might suggest new targets in the treatment of inflammatory skin disorders.	[Penel-Sotirakis, Karine; Simonazzi, Elise; Peguet-Navarro, Josette; Rozieres, Aurore] Univ Lyon, Hop Edouard Herriot, Lyon, France	CHU Lyon	Rozieres, A (corresponding author), Univ Lyon, Hop Edouard Herriot, Lyon, France.	aurore.rozieres@inserm.fr	ROZIERES, Aurore/M-4447-2014	ROZIERES, Aurore/0000-0003-0293-4002	Universite de Lyon	Universite de Lyon	This work was supported by the Universite de Lyon. The funders had no role in study design, data collection and analysis, decision to publish preparation of the manuscript.	Aliahmadi E, 2009, EUR J IMMUNOL, V39, P1221, DOI 10.1002/eji.200838742; Banchereau J, 2000, ANNU REV IMMUNOL, V18, P767, DOI 10.1146/annurev.immunol.18.1.767; Bouguermouh S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005087; Carreno BM, 2002, ANNU REV IMMUNOL, V20, P29, DOI 10.1146/annurev.immunol.20.091101.091806; Caruso R, 2009, NAT MED, V15, P1013, DOI 10.1038/nm.1995; Clark RA, 2010, J INVEST DERMATOL, V130, P362, DOI 10.1038/jid.2009.247; de Jong A, 2010, NAT IMMUNOL, V11, P1102, DOI 10.1038/ni.1956; Duhen T, 2009, NAT IMMUNOL, V10, P857, DOI 10.1038/ni.1767; Duraisingham SS, 2009, J IMMUNOL, V183, P2242, DOI 10.4049/jimmunol.0900474; Fife BT, 2008, IMMUNOL REV, V224, P166, DOI 10.1111/j.1600-065X.2008.00662.x; Fujita H, 2009, P NATL ACAD SCI USA, V106, P21795, DOI 10.1073/pnas.0911472106; Furio L, 2010, J INVEST DERMATOL, V130, P1345, DOI 10.1038/jid.2009.424; Greenwald RJ, 2005, ANNU REV IMMUNOL, V23, P515, DOI 10.1146/annurev.immunol.23.021704.115611; Haniff M, 2009, J EXP MED, V206, P371, DOI 10.1084/jem.20081633; King C, 2008, ANNU REV IMMUNOL, V26, P741, DOI 10.1146/annurev.immunol.26.021607.090344; Klechevsky E, 2008, IMMUNITY, V29, P497, DOI 10.1016/j.immuni.2008.07.013; Kolls JK, 2004, IMMUNITY, V21, P467, DOI 10.1016/j.immuni.2004.08.018; Korn T, 2009, ANNU REV IMMUNOL, V27, P485, DOI 10.1146/annurev.immunol.021908.132710; Liang SC, 2006, J EXP MED, V203, P2271, DOI 10.1084/jem.20061308; Manel N, 2008, NAT IMMUNOL, V9, P641, DOI 10.1038/ni.1610; Mathers AR, 2009, J IMMUNOL, V182, P921, DOI 10.4049/jimmunol.182.2.921; Nograles KE, 2008, BRIT J DERMATOL, V159, P1092, DOI 10.1111/j.1365-2133.2008.08769.x; Res PCM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014108; Sallusto F, 2009, MICROBES INFECT, V11, P620, DOI 10.1016/j.micinf.2009.04.004; STEINMAN RM, 1991, ANNU REV IMMUNOL, V9, P271, DOI 10.1146/annurev.iy.09.040191.001415; Trifari S, 2009, NAT IMMUNOL, V10, P864, DOI 10.1038/ni.1770; Ueno H, 2007, IMMUNOL REV, V219, P118, DOI 10.1111/j.1600-065X.2007.00551.x; Valladeau J, 2005, SEMIN IMMUNOL, V17, P273, DOI 10.1016/j.smim.2005.05.009; Volpe E, 2009, BLOOD, V114, P3610, DOI 10.1182/blood-2009-05-223768; Zheng Y, 2008, NAT MED, V14, P282, DOI 10.1038/nm1720; Zheng Y, 2007, NATURE, V445, P648, DOI 10.1038/nature05505	31	25	25	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 30	2012	7	11							e45680	10.1371/journal.pone.0045680	http://dx.doi.org/10.1371/journal.pone.0045680			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	054WM	23226194	Green Submitted, Green Published, gold			2022-12-27	WOS:000312376100002
J	Takashima, M; Sugita, T; Van, BH; Nakamura, M; Endoh, R; Ohkuma, M				Takashima, Masako; Sugita, Takashi; Bui Hong Van; Nakamura, Megumi; Endoh, Rikiya; Ohkuma, Moriya			Taxonomic Richness of Yeasts in Japan within Subtropical and Cool Temperate Areas	PLOS ONE			English	Article							BASIDIOMYCETOUS YEASTS; ASCOMYCETOUS YEASTS; RIBOSOMAL-RNA; FUNGAL; PHYLOGENY; IDENTIFICATION; PROPOSAL	Background: An understanding of the role of yeasts in the environment has been uncertain because estimates of population size and diversity have often been based on species identifications that were determined from a limited number of phenotypic characteristics. DNA-based species identification has now become widely used, allowing an accurate assessment of species in different habitats. However, there are still problems in classification because some genera are polyphyletic. Consequently, the identification of yeasts and measurement of their diversity at the genus level remains difficult, as does assignment of genera to higher taxonomic ranks. Methodology/Principal Findings: A total of 1021 yeast strains was isolated from soil samples and plant materials collected from Japan's subtropical Iriomote Island and the cool temperate Rishiri Island. Based on sequence analyses of the D1/D2 domain of the LSU rRNA gene, these 1021 strains were tentatively classified into 183 species, with apparent new species accounting for approximately half of the total species isolated (60 and 46, Iriomote and Rishiri, respectively). The yeast species composition was statistically different between the two sites with only 15 species in common. Rarefaction curves of respective sources/areas gave distinctive patterns when the threshold of sequence identity became broader, indicating that the yeast diversity was distinct at the different taxonomic levels compared. Conclusions/Significance: Our isolation study of yeasts in Japan has enabled us to expand the inventory of species diversity because a large number of new species was observed in the sampling areas. Further, we propose use of a particular diversity threshold as an "indicator" to recognize species, genera and higher taxonomic ranks. Citation: Takashima M, Sugita T, Van BH, Nakamura M, Endoh R, et al. (2012) Taxonomic Richness of Yeasts in Japan within Subtropical and Cool Temperate Areas. PLoS ONE 7(11): e50784. doi:10.1371/journal.pone.0050784	[Takashima, Masako; Bui Hong Van; Nakamura, Megumi; Endoh, Rikiya; Ohkuma, Moriya] RIKEN BioResource Ctr, Microbe Div Japan Collect Microorganisms, Saitama, Japan; [Sugita, Takashi] Meiji Pharmaceut Univ, Dept Microbiol, Tokyo, Japan	RIKEN; Meiji Pharmaceutical University	Takashima, M (corresponding author), RIKEN BioResource Ctr, Microbe Div Japan Collect Microorganisms, Saitama, Japan.	masako@jcm.riken.jp	Takashima, Masako/N-7959-2015; Ohkuma, Moriya/A-8100-2011		Institute of Fermentation, Osaka; Grants-in-Aid for Scientific Research [24880034] Funding Source: KAKEN	Institute of Fermentation, Osaka; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This study was supported by a grant from the Institute of Fermentation, Osaka (http://www.ifo.or.jp/index.html). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Boekhout T, 2011, YEASTS: A TAXONOMIC STUDY, VOLS 1-3, 5TH EDITION, P1339, DOI 10.1016/B978-0-444-52149-1.00100-2; Botha A, 2006, BIODIVERSITY AND ECOPHYSIOLOGY OF YEASTS, P221, DOI 10.1007/3-540-30985-3_11; FELSENSTEIN J, 1985, EVOLUTION, V39, P783, DOI 10.1111/j.1558-5646.1985.tb00420.x; Fonseca A, 2006, BIODIVERSITY AND ECOPHYSIOLOGY OF YEASTS, P263, DOI 10.1007/3-540-30985-3_13; Fonseca A, 2011, YEASTS: A TAXONOMIC STUDY, VOLS 1-3, 5TH EDITION, P1661, DOI 10.1016/B978-0-444-52149-1.00138-5; Hayakawa M, 2010, IFO RES COMMUN, V24, P169; Jones MDM, 2011, MYCOTA, V14, P37; Kageyama K, 2010, IFO RES COMMUN, V24, P117; KIMURA M, 1980, J MOL EVOL, V16, P111, DOI 10.1007/BF01731581; Kurtzman C.P., 1998, YEASTS TAXONOMIC STU; Kurtzman CP, 1997, J CLIN MICROBIOL, V35, P1216, DOI 10.1128/JCM.35.5.1216-1223.1997; Kurtzman CP, 2011, YEASTS: A TAXONOMIC STUDY, VOLS 1-3, 5TH EDITION, P1; Kurtzman CP, 2003, FEMS YEAST RES, V4, P233, DOI 10.1016/S1567-1356(03)00175-2; Kurtzman CP, 1998, ANTON LEEUW INT J G, V73, P331, DOI 10.1023/A:1001761008817; Ludwig W, 1998, ELECTROPHORESIS, V19, P554, DOI 10.1002/elps.1150190416; Mohamed DJ, 2011, ISME J, V5, P379, DOI 10.1038/ismej.2010.137; Nakase T, 1993, RIKEN REV, V3, P33; Rousk J, 2009, APPL ENVIRON MICROB, V75, P1589, DOI 10.1128/AEM.02775-08; Schloss PD, 2009, APPL ENVIRON MICROB, V75, P7537, DOI 10.1128/AEM.01541-09; Scorzetti G, 2002, FEMS YEAST RES, V2, P495, DOI 10.1111/j.1567-1364.2002.tb00117.x; Seki T, 2010, IFO RES COMMUN, V24, P111; Starmer WT, 2011, YEASTS: A TAXONOMIC STUDY, VOLS 1-3, 5TH EDITION, P65, DOI 10.1016/B978-0-444-52149-1.00006-9; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Valinsky L, 2002, APPL ENVIRON MICROB, V68, P5999, DOI 10.1128/AEM.68.12.5999-6004.2002; Vishniac HS, 2006, MICROB ECOL, V52, P90, DOI 10.1007/s00248-006-9066-4; VISHNIAC HS, 1983, CAN J MICROBIOL, V29, P90, DOI 10.1139/m83-014; Wang QM, 2008, FEMS YEAST RES, V8, P799, DOI 10.1111/j.1567-1364.2008.00403.x	27	21	21	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 30	2012	7	11							e50784	10.1371/journal.pone.0050784	http://dx.doi.org/10.1371/journal.pone.0050784			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	054WM	23226383	Green Submitted, Green Published, gold			2022-12-27	WOS:000312376100194
J	Thomas, CJ; Shankar, S; Casquilho-Gray, HE; York, J; Sprang, SR; Nunberg, JH				Thomas, Celestine J.; Shankar, Sundaresh; Casquilho-Gray, Hedi E.; York, Joanne; Sprang, Stephen R.; Nunberg, Jack H.			Biochemical Reconstitution of Hemorrhagic-Fever Arenavirus Envelope Glycoprotein-Mediated Membrane Fusion	PLOS ONE			English	Article							STABLE SIGNAL PEPTIDE; LYMPHOCYTIC CHORIOMENINGITIS VIRUS; PH-INDUCED ACTIVATION; INFLUENZA HEMAGGLUTININ; TERMINAL REGION; CLEAVAGE SITE; GP-C; IDENTIFICATION; RECEPTOR; ENTRY	The membrane-anchored proteins of enveloped viruses form labile spikes on the virion surface, primed to undergo large-scale conformational changes culminating in virus-cell membrane fusion and viral entry. The prefusion form of these envelope glycoproteins thus represents an important molecular target for antiviral intervention. A critical roadblock to this endeavor has been our inability to produce the prefusion envelope glycoprotein trimer for biochemical and structural analysis. Through our studies of the GPC envelope glycoprotein of the hemorrhagic fever arenaviruses, we have shown that GPC is unique among class I viral fusion proteins in that the mature complex retains a stable signal peptide (SSP) in addition to the conventional receptor-binding and transmembrane fusion subunits. In this report we show that the recombinant GPC precursor can be produced as a discrete native-like trimer and that its proteolytic cleavage generates the mature glycoprotein. Proteoliposomes containing the cleaved GPC mediate pH-dependent membrane fusion, a characteristic feature of arenavirus entry. This reaction is inhibited by arenavirus-specific monoclonal antibodies and small-molecule fusion inhibitors. The in vitro reconstitution of GPC-mediated membrane-fusion activity offers unprecedented opportunities for biochemical and structural studies of arenavirus entry and its inhibition. To our knowledge, this report is the first to demonstrate functional reconstitution of membrane fusion by a viral envelope glycoprotein.	[Shankar, Sundaresh; Casquilho-Gray, Hedi E.; York, Joanne; Nunberg, Jack H.] Univ Montana, Montana Biotechnol Ctr, Missoula, MT 59812 USA; [Thomas, Celestine J.; Sprang, Stephen R.] Univ Montana, Ctr Biomol Struct & Dynam, Missoula, MT 59812 USA; [Thomas, Celestine J.; Shankar, Sundaresh; Sprang, Stephen R.] Univ Montana, Div Biol Sci, Missoula, MT 59812 USA	University of Montana System; University of Montana; University of Montana System; University of Montana; University of Montana System; University of Montana	Nunberg, JH (corresponding author), Univ Montana, Montana Biotechnol Ctr, Missoula, MT 59812 USA.	jack.nunberg@umontana.edu	Shankar, Sundaresh/AAJ-5875-2021	Shankar, Sundaresh/0000-0001-9340-9945	NIH [R01 AI074818, U54 AI065357, P20 GM103546]; Rocky Mountain Center of Excellence for Biodefense and Emerging Infectious Diseases Research (RMRCE); CoBRE pilot project award; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U54AI065357, R01AI074818] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P20GM103546] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Rocky Mountain Center of Excellence for Biodefense and Emerging Infectious Diseases Research (RMRCE); CoBRE pilot project award; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by the following NIH grants to JHN: R01 AI074818 and a subaward from the Rocky Mountain Center of Excellence for Biodefense and Emerging Infectious Diseases Research (RMRCE), which is funded through NIH grant U54 AI065357 to John Belisle at Colorado State University. The CoBRE Center for Biomolecular Structure and Dynamics is supported by NIH grant P20 GM103546 to SRS. Additional funding to CJT was provided by a CoBRE pilot project award. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agnihothram SS, 2007, J VIROL, V81, P4331, DOI 10.1128/JVI.02779-06; Agnihothram SS, 2006, J VIROL, V80, P5189, DOI 10.1128/JVI.00208-06; Albarino CG, 2011, J VIROL, V85, P10404, DOI 10.1128/JVI.00856-11; Albarino CG, 2009, J VIROL, V83, P5606, DOI 10.1128/JVI.00276-09; Armstrong RT, 2000, J CELL BIOL, V151, P425, DOI 10.1083/jcb.151.2.425; Beyer WR, 2003, J VIROL, V77, P2866, DOI 10.1128/JVI.77.5.2866-2872.2003; Binley JM, 2000, J VIROL, V76, P2606; Bolken TC, 2006, ANTIVIR RES, V69, P86, DOI 10.1016/j.antiviral.2005.10.008; BRAVO DA, 1994, J BIOL CHEM, V269, P25830; Briknarova K, 2011, J BIOL CHEM, V286, P1528, DOI 10.1074/jbc.M110.166025; BULLOUGH PA, 1994, NATURE, V371, P37, DOI 10.1038/371037a0; Burton DR, 2004, NAT IMMUNOL, V5, P233, DOI 10.1038/ni0304-233; Buzon V, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000880; Cano-Monreal GL, 2010, J INSECT SCI, V10, DOI 10.1673/031.010.2901; Cao W, 1998, SCIENCE, V282, P2079, DOI 10.1126/science.282.5396.2079; Carr CM, 1997, P NATL ACAD SCI USA, V94, P14306, DOI 10.1073/pnas.94.26.14306; Chen J, 1998, CELL, V95, P409, DOI 10.1016/S0092-8674(00)81771-7; Delgado S, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000047; DISIMONE C, 1994, VIROLOGY, V198, P455, DOI 10.1006/viro.1994.1057; Droniou-Bonzom ME, 2011, J VIROL, V85, P13457, DOI 10.1128/JVI.05616-11; EARL PL, 1990, P NATL ACAD SCI USA, V87, P648, DOI 10.1073/pnas.87.2.648; Eichler R, 2003, EMBO REP, V4, P1084, DOI 10.1038/sj.embor.7400002; Eschli B, 2006, J VIROL, V80, P5897, DOI 10.1128/JVI.00008-06; FUERST TR, 1986, P NATL ACAD SCI USA, V83, P8122, DOI 10.1073/pnas.83.21.8122; Gawlik K, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005031; Harrison SC, 2008, NAT STRUCT MOL BIOL, V15, P690, DOI 10.1038/nsmb.1456; Health and Human Services, 2007, IMPL PLAN CHEM BIOL; Hernandez JM, 2012, SCIENCE, V336, P1581, DOI 10.1126/science.1221976; HOEKSTRA D, 1984, BIOCHEMISTRY-US, V23, P5675, DOI 10.1021/bi00319a002; Igonet S, 2011, P NATL ACAD SCI USA, V108, P19967, DOI 10.1073/pnas.1108910108; Jiang JY, 2007, J VIROL, V81, P9999, DOI 10.1128/JVI.00592-07; KEMBLE GW, 1994, CELL, V76, P383, DOI 10.1016/0092-8674(94)90344-1; Kunz S, 2003, VIROLOGY, V314, P168, DOI 10.1016/S0042-6822(03)00421-5; Larson RA, 2008, J VIROL, V82, P10768, DOI 10.1128/JVI.00941-08; Lee AM, 2008, J BIOL CHEM, V283, P18734, DOI 10.1074/jbc.M802089200; Lenz O, 2001, P NATL ACAD SCI USA, V98, P12701, DOI 10.1073/pnas.221447598; MCCORMICK JB, 1987, J INFECT DIS, V155, P437, DOI 10.1093/infdis/155.3.437; MELIKYAN GB, 1995, J CELL BIOL, V131, P679, DOI 10.1083/jcb.131.3.679; Messina EL, 2012, J VIROL, V86, P6138, DOI 10.1128/JVI.07241-11; MOORE JP, 1990, SCIENCE, V250, P1139, DOI 10.1126/science.2251501; NIAID, 2009, NIAID CAT A B C PRIO; Pantophlet R, 2006, ANNU REV IMMUNOL, V24, P739, DOI 10.1146/annurev.immunol.24.021605.090557; Peters CJ, 2002, CURR TOP MICROBIOL, V262, P65; Radoshitzky SR, 2007, NATURE, V446, P92, DOI 10.1038/nature05539; Rawson RB, 2003, NAT REV MOL CELL BIO, V4, P631, DOI 10.1038/nrm1174; Rojek JM, 2010, J VIROL, V84, P573, DOI 10.1128/JVI.01697-09; SANCHEZ A, 1989, J GEN VIROL, V70, P1125, DOI 10.1099/0022-1317-70-5-1125; Scherer EM, 2010, P NATL ACAD SCI USA, V107, P1529, DOI 10.1073/pnas.0909680107; Skehel JJ, 2000, ANNU REV BIOCHEM, V69, P531, DOI 10.1146/annurev.biochem.69.1.531; Stenlund P, 2003, ANAL BIOCHEM, V316, P243, DOI 10.1016/S0003-2697(03)00046-0; Thomas CJ, 2011, J BIOL CHEM, V286, P6192, DOI 10.1074/jbc.M110.196428; Toure BB, 2000, J BIOL CHEM, V275, P2349, DOI 10.1074/jbc.275.4.2349; WEISS CD, 1993, J VIROL, V67, P7060, DOI 10.1128/JVI.67.12.7060-7066.1993; White JM, 2008, CRIT REV BIOCHEM MOL, V43, P189, DOI [10.1080/10409230802058320, 10.1080/10409230802058320 ]; WILSON IA, 1981, NATURE, V289, P366, DOI 10.1038/289366a0; Yin HS, 2006, NATURE, V439, P38, DOI 10.1038/nature04322; Yin HS, 2005, P NATL ACAD SCI USA, V102, P9288, DOI 10.1073/pnas.0503989102; York J, 2004, J VIROL, V78, P10783, DOI 10.1128/JVI.78.19.10783-10792.2004; York J, 2008, J VIROL, V82, P10932, DOI 10.1128/JVI.01140-08; York J, 2007, J VIROL, V81, P13385, DOI 10.1128/JVI.01785-07; York J, 2006, J VIROL, V80, P7775, DOI 10.1128/JVI.00642-06; York J, 2010, J VIROL, V84, P6119, DOI 10.1128/JVI.02700-09; York J, 2009, J VIROL, V83, P4121, DOI 10.1128/JVI.02410-08; Zokarkar A, 2012, J VIROL, V86, P2600, DOI 10.1128/JVI.06546-11	64	8	8	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 30	2012	7	11							e51114	10.1371/journal.pone.0051114	http://dx.doi.org/10.1371/journal.pone.0051114			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	054WM	23226473	Green Submitted, Green Published, gold			2022-12-27	WOS:000312376100284
J	Bacchi, E; Negri, C; Trombetta, M; Zanolin, ME; Lanza, M; Bonora, E; Moghetti, P				Bacchi, Elisabetta; Negri, Carlo; Trombetta, Maddalena; Zanolin, Maria Elisabetta; Lanza, Massimo; Bonora, Enzo; Moghetti, Paolo			Differences in the Acute Effects of Aerobic and Resistance Exercise in Subjects with Type 2 Diabetes: Results from the RAED2 Randomized Trial	PLOS ONE			English	Article							GLUCOSE-HOMEOSTASIS; BLOOD-GLUCOSE; INSULIN SENSITIVITY; SEVERE HYPOGLYCEMIA; HYPERGLYCEMIA; ASSOCIATION; ADULTS	Objective: Both aerobic (AER) and resistance (RES) training, if maintained over a period of several months, reduce HbA1c levels in type 2 diabetes subjects. However, it is still unknown whether the short-term effects of these types of exercise on blood glucose are similar. Our objective was to assess whether there may be a difference in acute blood glucose changes after a single bout of AER or RES exercise. Study Design: Twenty-five patients participating in the RAED2 Study, a RCT comparing AER and RES training in diabetic subjects, were submitted to continuous glucose monitoring during a 60-min exercise session and over the following 47 h. These measurements were performed after 10.9+0.4 weeks of training. Glucose concentration areas under the curve (AUC) during exercise, the subsequent night, and the 24-h period following exercise, as well as the corresponding periods of the non-exercise day, were assessed. Moreover, the low (LBGI) and high (HBGI) blood glucose indices, which summarize the duration and extent of hypoglycaemia or hyperglycaemia, respectively, were measured. Results: AER and RES training similarly reduced HbA1c. Forty-eight hour glucose AUC was similar in both groups. However, a comparison of glucose AUC during the 60-min exercise period and the corresponding period of the non-exercise day showed that glucose levels were lower during exercise in the AER but not in the RES group (time-by-group interaction p = 0.04). Similar differences were observed in the nocturnal periods (time-by-group interaction p = 0.02). Accordingly, nocturnal LBGI was higher in the exercise day than in the non-exercise day in the AER (p = 0.012) but not in the RES group (p = 0.62). Conclusions: Although AER and RES training have similar long-term metabolic effects in diabetic subjects, the acute effects of single bouts of these exercise types differ, with a potential increase in late-onset hypoglycaemia risk after AER exercise.	[Bacchi, Elisabetta; Negri, Carlo; Trombetta, Maddalena; Bonora, Enzo; Moghetti, Paolo] Univ Verona, Sect Endocrinol Diabet & Metab, Dept Med, I-37100 Verona, Italy; [Bacchi, Elisabetta; Negri, Carlo; Trombetta, Maddalena; Bonora, Enzo; Moghetti, Paolo] Azienda Osped Univ Integrata Verona, Verona, Italy; [Zanolin, Maria Elisabetta] Univ Verona, Dept Publ Hlth & Community Med, Sect Epidemiol & Med Stat, I-37100 Verona, Italy; [Lanza, Massimo] Univ Verona, Dept Neurol Neuropsychol Morphol & Movement Sci, Sect Motor Sci, I-37100 Verona, Italy	University of Verona; University of Verona; Azienda Ospedaliera Universitaria Integrata Verona; University of Verona; University of Verona	Moghetti, P (corresponding author), Univ Verona, Sect Endocrinol Diabet & Metab, Dept Med, I-37100 Verona, Italy.	paolo.moghetti@univr.it	Trombetta, Maddalena/AAA-9257-2022; Bonora, Enzo/AAA-5300-2022; Moghetti, Paolo/K-1138-2016; Lanza, Massimo/AAJ-2160-2020	Trombetta, Maddalena/0000-0002-0825-1117; Moghetti, Paolo/0000-0003-3951-0297; BONORA, Enzo/0000-0003-1074-5164	University of Verona; Azienda Ospedaliera Universitaria Integrata Verona, Verona, Italy	University of Verona; Azienda Ospedaliera Universitaria Integrata Verona, Verona, Italy	This study was supported in part by grants to P. Moghetti from the University of Verona and from the Azienda Ospedaliera Universitaria Integrata Verona, Verona, Italy. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amiel SA, 2008, DIABETIC MED, V25, P245, DOI 10.1111/j.1464-5491.2007.02341.x; Bacchi E, 2012, DIABETES CARE, V35, P676, DOI 10.2337/dc11-1655; Boland E, 2001, DIABETES CARE, V24, P1858, DOI 10.2337/diacare.24.11.1858; Boule NG, 2005, DIABETES CARE, V28, P108, DOI 10.2337/diacare.28.1.108; Cheyne E, 2002, DIABETES-METAB RES, V18, pS43, DOI 10.1002/dmrr.209; Childs BP, 2005, DIABETES CARE, V28, P1245; Church TS, 2010, JAMA-J AM MED ASSOC, V304, P2253, DOI 10.1001/jama.2010.1710; Garber CE, 2011, MED SCI SPORT EXER, V43, P1334, DOI 10.1249/MSS.0b013e318213fefb; Gerstein HC, 2008, NEW ENGL J MED, V358, P2545, DOI 10.1056/NEJMoa0802743; Goto K, 2005, EUR J APPL PHYSIOL, V94, P333, DOI 10.1007/s00421-004-1296-x; Koopman R, 2005, EUR J APPL PHYSIOL, V94, P180, DOI 10.1007/s00421-004-1307-y; Kovatchev Boris P, 2005, Diabetes Technol Ther, V7, P849, DOI 10.1089/dia.2005.7.849; Kovatchev BP, 1998, DIABETES CARE, V21, P1870, DOI 10.2337/diacare.21.11.1870; Larsen JJ, 1999, DIABETES CARE, V22, P1647, DOI 10.2337/diacare.22.10.1647; Malin SK, 2012, DIABETES CARE, V35, P131, DOI 10.2337/dc11-0925; Manders RJF, 2010, MED SCI SPORT EXER, V42, P219, DOI 10.1249/MSS.0b013e3181b3b16d; MINUK HL, 1981, AM J PHYSIOL, V240, pE458, DOI 10.1152/ajpendo.1981.240.5.E458; Praet SF, 2006, MED SCI SPORT EXER, V38, P2037, DOI 10.1249/01.mss.0000235352.09061.1d; Sigal RJ, 2010, DIABETES CARE, V33, P147, DOI DOI 10.2337/DC10-9990; Sigal RJ, 2007, ANN INTERN MED, V147, P357, DOI 10.7326/0003-4819-147-6-200709180-00005; Suh SH, 2007, MOL CELLS, V23, P272; Tavris Dale R, 2004, Diabetes Technol Ther, V6, P518, DOI 10.1089/1520915041705956; Umpierre D, 2011, JAMA-J AM MED ASSOC, V305, P1790, DOI 10.1001/jama.2011.576; van Dijk JW, 2012, DIABETOLOGIA, V55, P1273, DOI 10.1007/s00125-011-2380-5; Yardley JE, 2012, DIABETES CARE, V35, P669, DOI 10.2337/dc11-1844; Yardley JE, 2010, APPL PHYSIOL NUTR ME, V35, pS112; Zoungas S, 2010, NEW ENGL J MED, V363, P1410, DOI 10.1056/NEJMoa1003795	27	36	38	3	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 5	2012	7	12							e49937	10.1371/journal.pone.0049937	http://dx.doi.org/10.1371/journal.pone.0049937			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	057TZ	23227155	Green Published, gold, Green Submitted			2022-12-27	WOS:000312588200017
J	Bennett, VA; Doerr, VAJ; Doerr, ED; Manning, AD; Lindenmayer, DB; Yoon, HJ				Bennett, Victoria A.; Doerr, Veronica A. J.; Doerr, Erik D.; Manning, Adrian D.; Lindenmayer, David B.; Yoon, Hwan-Jin			Habitat Selection and Post-Release Movement of Reintroduced Brown Treecreeper Individuals in Restored Temperate Woodland	PLOS ONE			English	Article							HOME-RANGE SIZE; REPRODUCTIVE SUCCESS; NATAL DISPERSAL; MULLIGANS FLAT; SURVIVAL; TRANSLOCATION; BIRDS; ESTABLISHMENT; CONSERVATION; RESTORATION	It is essential to choose suitable habitat when reintroducing a species into its former range. Habitat quality may influence an individual's dispersal decisions and also ultimately where they choose to settle. We examined whether variation in habitat quality (quantified by the level of ground vegetation cover and the installation of nest boxes) influenced the movement, habitat choice and survival of a reintroduced bird species. We experimentally reintroduced seven social groups (43 individuals) of the brown treecreeper (Climacteris picumnus) into two nature reserves in south-eastern Australia. We radio-tracked 18 brown treecreepers from release in November 2009 until February 2010. We observed extensive movements by individuals irrespective of the release environment or an individual's gender. This indicated that individuals were capable of dispersing and actively selecting optimum habitat. This may alleviate pressure on wildlife planners to accurately select the most optimum release sites, so long as the species' requirements are met. There was significant variation in movement between social groups, suggesting that social factors may be a more important influence on movement than habitat characteristics. We found a significant effect of ground vegetation cover on the likelihood of settlement by social groups, with high rates of settlement and survival in dry forests, rather than woodland (where the species typically resides), which has implications for the success of woodland restoration. However, overall the effects of variation in habitat quality were not as strong as we had expected, and resulted in some unpredicted effects such as low survival and settlement in woodland areas with medium levels of ground vegetation cover. The extensive movement by individuals and unforeseen effects of habitat characteristics make it difficult to predict the outcome of reintroductions, the movement behaviour and habitat selection of reintroduced individuals, particularly when based on current knowledge of a species' ecology. Citation: Bennett VA, Doerr VAJ, Doerr ED, Manning AD, Lindenmayer DB, et al. (2012) Habitat Selection and Post-Release Movement of Reintroduced Brown Treecreeper Individuals in Restored Temperate Woodland. PLoS ONE 7(12): e50612. doi:10.1371/journal.pone. 0050612	[Bennett, Victoria A.; Manning, Adrian D.; Lindenmayer, David B.] Australian Natl Univ, Fenner Sch Environm & Soc, Canberra, ACT, Australia; [Doerr, Veronica A. J.; Doerr, Erik D.] Commonwealth Sci & Ind Res Org, Ecosyst Sci, Canberra, ACT, Australia; [Doerr, Veronica A. J.; Doerr, Erik D.] Australian Natl Univ, Res Sch Biol, Div Evolut Ecol & Genet, Canberra, ACT, Australia; [Yoon, Hwan-Jin] Australian Natl Univ, Sch Math Sci, Stat Consulting Unit, Canberra, ACT, Australia	Australian National University; Commonwealth Scientific & Industrial Research Organisation (CSIRO); Australian National University; Australian National University	Bennett, VA (corresponding author), Australian Natl Univ, Fenner Sch Environm & Soc, Canberra, ACT, Australia.	victoria.bennett325@gmail.com	Lindenmayer, David B/P-7183-2017; Doerr, Erik/A-9797-2011; Manning, Adrian/AAG-2949-2019; Doerr, Veronica/A-2150-2011; Manning, Adrian/AAX-7288-2021	Lindenmayer, David B/0000-0002-4766-4088; Doerr, Erik/0000-0003-4511-9972; Doerr, Veronica/0000-0003-4330-4576; Manning, Adrian/0000-0003-0989-9203; Yoon, Hwan-Jin/0000-0003-1772-7911	Birding NSW; Birdlife Australia - Stuart Leslie Bird Research Award; Canberra Ornithologists Group; Canberra Birds Conservation Fund; Conservation and Landscape Ecology Group within the Fenner School of Environment and Society at The Australian National University; Fenner School of Environment and Society at The Australian National University; Foundation for National Parks and Wildlife; Gould League of NSW Centenary Year Cayley Memorial Scholarship; Mulligans Flat-Goorooyarroo Woodland Experiment (ARC Linkage Project) [LP0561817]; Norman Wettenhall Foundation [20108002]; Conservation and Landscape Ecology Group; Mulligans Flat-Goorooyarroo Woodland Experiment; Mulligans Flat Woodland Sanctuary Species Management Panel; Mulligans Flat-Goorooyarroo Research Committee; Hume Livestock Health and Pest Authority	Birding NSW; Birdlife Australia - Stuart Leslie Bird Research Award; Canberra Ornithologists Group; Canberra Birds Conservation Fund; Conservation and Landscape Ecology Group within the Fenner School of Environment and Society at The Australian National University; Fenner School of Environment and Society at The Australian National University; Foundation for National Parks and Wildlife; Gould League of NSW Centenary Year Cayley Memorial Scholarship; Mulligans Flat-Goorooyarroo Woodland Experiment (ARC Linkage Project)(Australian Research Council); Norman Wettenhall Foundation; Conservation and Landscape Ecology Group; Mulligans Flat-Goorooyarroo Woodland Experiment; Mulligans Flat Woodland Sanctuary Species Management Panel; Mulligans Flat-Goorooyarroo Research Committee; Hume Livestock Health and Pest Authority	The project has been made possible by funding from: Birding NSW (www.birdingnsw.org.au), Birdlife Australia - Stuart Leslie Bird Research Award (www.birdlife.org.au), Canberra Ornithologists Group, Canberra Birds Conservation Fund (www.canberrabirds.org.au), The Conservation and Landscape Ecology Group within the Fenner School of Environment and Society at The Australian National University (http://fennerschool-research.anu.edu.au/cle/), The Fenner School of Environment and Society at The Australian National University (http://fennerschool.anu.edu.au/), The Foundation for National Parks and Wildlife (www.fnpw.org.au), Gould League of NSW 2010 Centenary Year Cayley Memorial Scholarship (www.gould.edu.au), The Mulligans Flat-Goorooyarroo Woodland Experiment (ARC Linkage Project LP0561817) (http://www.mfgowoodlandexperiment.org.au/), The Norman Wettenhall Foundation (reference 20108002) (www.nwf.org.au), In-kind contribution was greatly appreciated from CSIRO Ecosystem Sciences (http://www.csiro.au/Organisation-Structure/Divisions/EcosystemSciences.aspx) and The Parks and Conservation Service within the Australian Capital Territory Government Department of Territory and Municipal Services (http://www.tams.act.gov.au/play/pcl). One field assistant was employed (Jenny Newport) using funds from Conservation and Landscape Ecology Group and the Mulligans Flat-Goorooyarroo Woodland Experiment to assist in collecting data obtained through radio-tracking reintroduced brown treecreepers. Otherwise, individuals that were employed or contracted by the funders (other than the named authors) did not play any role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We are grateful for the invaluable help and support of the Mulligans Flat Woodland Sanctuary Species Management Panel, the Mulligans Flat-Goorooyarroo Research Committee, Sanctuary rangers Peter Mills and Grant Woodbridge, the Hume Livestock Health and Pest Authority, research assistant Jenny Newport, volunteers and the landowners in Wagga Wagga.	Antos MJ, 2006, EMU, V106, P29, DOI 10.1071/MU05039; Armstrong DP, 2008, TRENDS ECOL EVOL, V23, P20, DOI 10.1016/j.tree.2007.10.003; Armstrong DP, 1999, BIOL CONSERV, V89, P329, DOI 10.1016/S0006-3207(99)00012-9; ARMSTRONG DP, 1995, BIOL CONSERV, V71, P281, DOI 10.1016/0006-3207(94)00038-R; Bajomi B, 2010, ORYX, V44, P358, DOI 10.1017/S0030605310000281; Baker MB, 2004, ECOLOGY, V85, P1039, DOI 10.1890/02-0507; Banks PB, 2002, BIOL CONSERV, V103, P133, DOI 10.1016/S0006-3207(01)00110-0; Bennett VA, 2012, EMU, V112, P298, DOI 10.1071/MU11048; Bolker BM, 2009, TRENDS ECOL EVOL, V24, P127, DOI 10.1016/j.tree.2008.10.008; Borger L, 2006, J ANIM ECOL, V75, P1393, DOI 10.1111/j.1365-2656.2006.01164.x; BRIGHT PW, 1994, J APPL ECOL, V31, P699, DOI 10.2307/2404160; Clarke MF, 1997, BIOL CONSERV, V80, P161, DOI 10.1016/S0006-3207(96)00075-4; Clarke Rohan H., 2003, Pacific Conservation Biology, V8, P223; Cooper CB, 2002, BIOL CONSERV, V105, P1, DOI 10.1016/S0006-3207(01)00172-0; Cooper CB, 2002, CONSERV BIOL, V16, P471, DOI 10.1046/j.1523-1739.2002.00346.x; De Solla SR, 1999, J ANIM ECOL, V68, P221, DOI 10.1046/j.1365-2656.1999.00279.x; Dickens MJ, 2010, BIOL CONSERV, V143, P1329, DOI 10.1016/j.biocon.2010.02.032; Doerr ED, 2005, OECOLOGIA, V142, P1, DOI 10.1007/s00442-004-1707-z; Doerr ED, 2007, J ANIM ECOL, V76, P966, DOI 10.1111/j.1365-2656.2007.01280.x; Doerr ED, 2006, ANIM BEHAV, V72, P147, DOI 10.1016/j.anbehav.2005.10.017; Doerr VAJ, 2006, EMU, V106, P93, DOI 10.1071/MU05020; Doerr VAJ, 2004, ECOLOGY, V85, P1428, DOI 10.1890/03-0015; Doerr VAJ, 2003, ALTERNATIVE DISPERSA; Doerr VAJ, 2011, EMU, V111, P71, DOI 10.1071/MU09118; Enfjall K, 2009, OIKOS, V118, P291, DOI 10.1111/j.1600-0706.2008.16863.x; Ewen JG, 2007, ECOSCIENCE, V14, P401, DOI 10.2980/1195-6860(2007)14[401:SMORIE]2.0.CO;2; Fischer J, 2000, BIOL CONSERV, V96, P1, DOI 10.1016/S0006-3207(00)00048-3; Ford HA, 2011, EMU, V111, P1, DOI 10.1071/MU09115; Ford HA, 2009, BIOL CONSERV, V142, P3182, DOI 10.1016/j.biocon.2009.08.022; FRETWELL S D, 1969, Acta Biotheoretica, V19, P16, DOI 10.1007/BF01601953; Germano JM, 2009, CONSERV BIOL, V23, P7, DOI 10.1111/j.1523-1739.2008.01123.x; GREENWOOD PJ, 1980, ANIM BEHAV, V28, P1140, DOI 10.1016/S0003-3472(80)80103-5; Haughland DL, 2004, J ANIM ECOL, V73, P1024, DOI 10.1111/j.0021-8790.2004.00884.x; Hayward MW, 2011, BIODIVERS CONSERV, V20, P2563, DOI 10.1007/s10531-011-0091-3; Heidinger IMM, 2009, BEHAV PROCESS, V82, P12, DOI 10.1016/j.beproc.2009.03.001; Hester JM, 2008, J WILDLIFE MANAGE, V72, P772, DOI 10.2193/2007-049; Higgins P.J., 2001, HDB AUSTR NZ ANTARCT; Ims Rolf A., 2001, P203; IUCN, 1998, IUCN GUID REINTR; Le Gouar P, 2008, ECOL APPL, V18, P859, DOI 10.1890/07-0854.1; Lewis F, 2011, METHODS ECOL EVOL, V2, P155, DOI 10.1111/j.2041-210X.2010.00063.x; Lin YK, 2006, J MAMMAL, V87, P446, DOI 10.1644/05-MAMM-A-201R1.1; Lindsay EA, 2009, FOREST ECOL MANAG, V258, P178, DOI 10.1016/j.foreco.2009.04.005; Luck GW, 2003, BIOL CONSERV, V109, P1, DOI 10.1016/S0006-3207(02)00085-X; Lurz PWW, 2000, J ZOOL, V251, P167, DOI 10.1111/j.1469-7998.2000.tb00601.x; Manning A.D., 2011, Australian Zoologist, V35, P633; Maron M, 2005, BIOL CONSERV, V124, P439, DOI 10.1016/j.biocon.2005.02.002; Martin CA, 2008, J ANIM ECOL, V77, P326, DOI 10.1111/j.1365-2656.2007.01349.x; McCullagh P, 1989, GEN LINEAR MODELS; McCulloch C. E., 2001, GEN LINEAR MIXED MOD; McIntyre S., 2010, Cunninghamia, V11, P319; Meek WR, 2003, BIOL CONSERV, V109, P271, DOI 10.1016/S0006-3207(02)00155-6; Moehrenschlager A, 2003, ANIM CONSERV, V6, P199, DOI 10.1017/S1367943003251; Moorhouse TP, 2009, BIOL CONSERV, V142, P53, DOI 10.1016/j.biocon.2008.09.023; MUSIL DD, 1993, J WILDLIFE MANAGE, V57, P85, DOI 10.2307/3809004; Noske R. A., 1982, AUSTR NATURAL HIST, V20, P419; NOSKE RA, 1991, EMU, V91, P73, DOI 10.1071/MU9910073; NOSKE RA, 1979, EMU, V79, P120, DOI 10.1071/MU9790120; Noske RA, 1982, COMP BEHAV ECOLOGY S; Pinheiro J, 2001, MIXED EFFECTS MODELS; Raudenbush SW, 2002, HIERARCHICAL LINEAR; Remy A, 2011, J ANIM ECOL, V80, P929, DOI 10.1111/j.1365-2656.2011.01849.x; Rittenhouse CD, 2007, J HERPETOL, V41, P115, DOI 10.1670/0022-1511(2007)41[115:MOTART]2.0.CO;2; Sakai HF, 1997, J WILDLIFE MANAGE, V61, P343, DOI 10.2307/3802590; SCANLAN JC, 1990, AUST J ECOL, V15, P191, DOI 10.1111/j.1442-9993.1990.tb01527.x; Schradin C, 2010, ANIM BEHAV, V79, P195, DOI 10.1016/j.anbehav.2009.10.027; Seddon PJ, 2007, CONSERV BIOL, V21, P303, DOI 10.1111/j.1523-1739.2006.00627.x; Sheean VA, 2012, AUSTRAL ECOL, V37, P204, DOI 10.1111/j.1442-9993.2011.02264.x; Shorthouse David J., 2012, Ecological Management & Restoration, V13, P112, DOI 10.1111/j.1442-8903.2012.00654.x; Stamps JA, 2007, APPL ANIM BEHAV SCI, V102, P392, DOI 10.1016/j.applanim.2006.05.038; Stamps JA, 2006, ANIM BEHAV, V72, P1279, DOI 10.1016/j.anbehav.2006.03.010; SWIHART RK, 1988, ECOLOGY, V69, P393, DOI 10.2307/1940437; Tweed EJ, 2003, BIOL CONSERV, V111, P1, DOI 10.1016/S0006-3207(02)00175-1; van Heezik Y, 2009, ORYX, V43, P639, DOI 10.1017/S0030605309990081; Van Zant JL, 2003, BIOL CONSERV, V112, P405, DOI 10.1016/S0006-3207(02)00338-5; Vandenberghe C, 2009, BASIC APPL ECOL, V10, P662, DOI 10.1016/j.baae.2009.03.009; VEITCH CR, 1995, REINTRODUCTION BIOLOGY OF AUSTRALIAN AND NEW ZEALAND FAUNA, P97; WALKER J, 1986, AUST J ECOL, V11, P135, DOI 10.1111/j.1442-9993.1986.tb01384.x; Walters JR, 1999, BIOL CONSERV, V90, P13, DOI 10.1016/S0006-3207(99)00016-6; Watson DM, 2011, EMU, V111, P10, DOI 10.1071/MU09109; Wiens John A., 2001, P96; Wolf CM, 1998, BIOL CONSERV, V86, P243; Yoder JM, 2004, BEHAV ECOL, V15, P469, DOI 10.1093/beheco/arh037; Zollner PA, 2005, OIKOS, V108, P219, DOI 10.1111/j.0030-1299.2005.13711.x	84	20	20	0	99	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 5	2012	7	12							e50612	10.1371/journal.pone.0050612	http://dx.doi.org/10.1371/journal.pone.0050612			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	057TZ	23227192	Green Published, gold, Green Submitted			2022-12-27	WOS:000312588200052
J	Ploemen, IHJ; Croes, HJ; van Gemert, GJJ; Wijers-Rouw, M; Hermsen, CC; Sauerwein, RW				Ploemen, Ivo H. J.; Croes, Huib J.; van Gemert, Geert-Jan J.; Wijers-Rouw, Mietske; Hermsen, Cornelus C.; Sauerwein, Robert W.			Plasmodium berghei Delta p52&p36 Parasites Develop Independent of a Parasitophorous Vacuole Membrane in Huh-7 Liver Cells	PLOS ONE			English	Article							VACCINE CANDIDATES; SPOROZOITES; INFECTION; APOPTOSIS; IMMUNITY; STAGE	The proteins P52 and P36 are expressed in the sporozoite stage of the murine malaria parasite Plasmodium berghei. Delta p52&p36 sporozoites lacking expression of both proteins are severely compromised in their capability to develop into liver stage parasites and abort development soon after invasion; presumably due to the absence of a parasitophorous vacuole membrane (PVM). However, a small proportion of P. berghei Delta p52&p36 parasites is capable to fully mature in hepatocytes causing breakthrough blood stage infections. We have studied the maturation of replicating Delta p52&p36 parasites in cultured Huh-7 hepatocytes. Approximately 50% of Delta p52&p36 parasites developed inside the nucleus of the hepatocyte but did not complete maturation and failed to produce merosomes. In contrast cytosolic Delta p52&p36 parasites were able to fully mature and produced infectious merozoites. These Delta p52&p36 parasites developed into mature schizonts in the absence of an apparent parasitophorous vacuole membrane as shown by immunofluorescence and electron microscopy. Merozoites derived from these maturing Delta p52&p36 liver stages were infectious for C57BL/6 mice.	[Ploemen, Ivo H. J.; van Gemert, Geert-Jan J.; Hermsen, Cornelus C.; Sauerwein, Robert W.] Radboud Univ Nijmegen, Med Ctr, Dept Med Microbiol, NL-6525 ED Nijmegen, Netherlands; [Croes, Huib J.; Wijers-Rouw, Mietske] Radboud Univ Nijmegen, Med Ctr, Dept Cell Biol, NL-6525 ED Nijmegen, Netherlands	Radboud University Nijmegen; Radboud University Nijmegen	Sauerwein, RW (corresponding author), Radboud Univ Nijmegen, Med Ctr, Dept Med Microbiol, NL-6525 ED Nijmegen, Netherlands.	R.Sauerwein@mmb.umcn.nl	Croes, Huib JE/G-4012-2016; Wijers-Rouw, Mietske/G-4456-2016; Sauerwein, Robert/C-8519-2013; Hermsen, C.C./L-4368-2015					Annoura T, 2012, VACCINE, V30, P2662, DOI 10.1016/j.vaccine.2012.02.010; Ishino T, 2005, MOL MICROBIOL, V58, P1264, DOI 10.1111/j.1365-2958.2005.04801.x; Ishino T, 2009, CELL MICROBIOL, V11, P1329, DOI 10.1111/j.1462-5822.2009.01333.x; Labaied M, 2007, INFECT IMMUN, V75, P3758, DOI 10.1128/IAI.00225-07; MEIS JFGM, 1984, CELL BIOL INT REP, V8, P1016, DOI 10.1016/0309-1651(84)90088-2; Mueller AK, 2005, P NATL ACAD SCI USA, V102, P3022, DOI 10.1073/pnas.0408442102; Prudencio M, 2008, CELL MICROBIOL, V10, P218, DOI 10.1111/j.1462-5822.2007.01032.x; Rennenberg A, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000825; Silvie O, 2004, TRENDS MOL MED, V10, P97, DOI 10.1016/j.molmed.2004.01.004; Silvie O, 2006, CELL MICROBIOL, V8, P1134, DOI 10.1111/j.1462-5822.2006.00697.x; van de Sand C, 2005, MOL MICROBIOL, V58, P731, DOI 10.1111/j.1365-2958.2005.04888.x; van Dijk MR, 2005, P NATL ACAD SCI USA, V102, P12194, DOI 10.1073/pnas.0500925102; VanBuskirk KM, 2009, P NATL ACAD SCI USA, V106, P13004, DOI 10.1073/pnas.0906387106; Vera IM, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002197	14	16	19	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 5	2012	7	12							e50772	10.1371/journal.pone.0050772	http://dx.doi.org/10.1371/journal.pone.0050772			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	057TZ	23227206	Green Published, Green Submitted, gold			2022-12-27	WOS:000312588200065
J	Ribot, RFH; Buchanan, KL; Endler, JA; Joseph, L; Bennett, ATD; Berg, ML				Ribot, Raoul F. H.; Buchanan, Katherine L.; Endler, John A.; Joseph, Leo; Bennett, Andrew T. D.; Berg, Mathew L.			Learned Vocal Variation Is Associated with Abrupt Cryptic Genetic Change in a Parrot Species Complex	PLOS ONE			English	Article							WHITE-CROWNED SPARROWS; RETINAL OIL DROPLETS; SEX-BIASED DISPERSAL; POPULATION-STRUCTURE; SONG VARIATION; CONTACT CALL; EVOLUTION; DIALECTS; SPECIATION; BUDGERIGARS	Contact zones between subspecies or closely related species offer valuable insights into speciation processes. A typical feature of such zones is the presence of clinal variation in multiple traits. The nature of these traits and the concordance among clines are expected to influence whether and how quickly speciation will proceed. Learned signals, such as vocalizations in species having vocal learning (e.g. humans, many birds, bats and cetaceans), can exhibit rapid change and may accelerate reproductive isolation between populations. Therefore, particularly strong concordance among clines in learned signals and population genetic structure may be expected, even among continuous populations in the early stages of speciation. However, empirical evidence for this pattern is often limited because differences in vocalisations between populations are driven by habitat differences or have evolved in allopatry. We tested for this pattern in a unique system where we may be able to separate effects of habitat and evolutionary history. We studied geographic variation in the vocalizations of the crimson rosella (Platycercus elegans) parrot species complex. Parrots are well known for their life-long vocal learning and cognitive abilities. We analysed contact calls across a ca 1300 km transect encompassing populations that differed in neutral genetic markers and plumage colour. We found steep clinal changes in two acoustic variables (fundamental frequency and peak frequency position). The positions of the two clines in vocal traits were concordant with a steep cline in microsatellite-based genetic variation, but were discordant with the steep clines in mtDNA, plumage and habitat. Our study provides new evidence that vocal variation, in a species with vocal learning, can coincide with areas of restricted gene flow across geographically continuous populations. Our results suggest that traits that evolve culturally can be strongly associated with reduced gene flow between populations, and therefore may promote speciation, even in the absence of other barriers.	[Ribot, Raoul F. H.; Buchanan, Katherine L.; Endler, John A.; Bennett, Andrew T. D.; Berg, Mathew L.] Deakin Univ, Sch Life & Environm Sci, Ctr Integrat Ecol, Geelong, Vic 3217, Australia; [Ribot, Raoul F. H.; Bennett, Andrew T. D.; Berg, Mathew L.] Univ Bristol, Sch Biol Sci, Ctr Behav Biol, Bristol, Avon, England; [Joseph, Leo] Commonwealth Sci & Ind Res Org Ecosyst Sci, Australian Natl Wildlife Collect, Canberra, ACT, Australia; [Bennett, Andrew T. D.] Univ Adelaide, Sch Earth & Environm Sci, Adelaide, SA, Australia	Deakin University; University of Bristol; Commonwealth Scientific & Industrial Research Organisation (CSIRO); University of Adelaide	Berg, ML (corresponding author), Deakin Univ, Sch Life & Environm Sci, Ctr Integrat Ecol, Geelong, Vic 3217, Australia.	mathew.berg@deakin.edu.au	Buchanan, Kate/A-8178-2012; Endler, John A/B-6659-2009; Bennett, Andrew T.D. T.D./P-2670-2016	Buchanan, Kate/0000-0002-6648-5819; Endler, John A/0000-0002-7557-7627; Bennett, Andrew T.D. T.D./0000-0001-8512-2805	Biotechnology and Biological Sciences Research Council [B01568]; Leverhulme Fellowship; Lady Emily Smyth Agricultural Research Station; University of Bristol postgraduate scholarship; Deakin University	Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Leverhulme Fellowship(Leverhulme Trust); Lady Emily Smyth Agricultural Research Station; University of Bristol postgraduate scholarship; Deakin University	This work was funded by the Biotechnology and Biological Sciences Research Council (grant B01568 to ATDB, KLB and MLB), a Leverhulme Fellowship (ATDB), the Lady Emily Smyth Agricultural Research Station (RFHR and ATDB), a University of Bristol postgraduate scholarship (RFHR), and Deakin University. All work conformed to the laws of Australia and the United Kingdom. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Avise J, 2004, MOL MARKERS NATURAL; BAKER MC, 1975, EVOLUTION, V29, P226, DOI 10.1111/j.1558-5646.1975.tb00203.x; BALABAN E, 1988, BEHAVIOUR, V105, P250, DOI 10.1163/156853988X00043; Balsby TJS, 2011, ANIM BEHAV, V81, P983, DOI 10.1016/j.anbehav.2011.01.034; BARBUJANI G, 1990, P NATL ACAD SCI USA, V87, P1816, DOI 10.1073/pnas.87.5.1816; BARTON NH, 1985, ANNU REV ECOL SYST, V16, P113, DOI 10.1146/annurev.es.16.110185.000553; Barton NH, 1979, HEREDITY, V43, P1; Behr O, 2004, BEHAV ECOL SOCIOBIOL, V56, P106, DOI 10.1007/s00265-004-0768-7; Berg KS, 2012, P ROY SOC B-BIOL SCI, V279, P585, DOI 10.1098/rspb.2011.0932; Berg KS, 2011, ANIM BEHAV, V81, P241, DOI 10.1016/j.anbehav.2010.10.012; Berg ML, 2010, EMU, V110, P10, DOI 10.1071/MU09076; Bohonak AJ, 2002, J HERED, V93, P153, DOI 10.1093/jhered/93.2.153; Bradbury JW, 2003, ANIMAL SOCIAL COMPLEXITY, P293; Brumfield RT, 2001, EVOLUTION, V55, P2070; Catchpole CK, 2008, BIRD SONG: BIOLOGICAL THEMES AND VARIATIONS, 2ND EDITION, P1, DOI 10.1017/CBO9780511754791; CavalliSforza LL, 1997, P NATL ACAD SCI USA, V94, P7719, DOI 10.1073/pnas.94.15.7719; Coyne J.A., 2004, SPECIATION; Derryberry EP, 2009, AM NAT, V174, P24, DOI 10.1086/599298; Eda-Fujiwara H, 2011, ANIM BEHAV, V82, P971, DOI 10.1016/j.anbehav.2011.07.030; Edwards SV, 2005, P NATL ACAD SCI USA, V102, P6550, DOI 10.1073/pnas.0501846102; Endler J.A., 1977, Monographs in Population Biology, pi; Forshaw JM, 2002, AUSTR PARROTS; Gay L, 2008, EVOLUTION, V62, P2789, DOI 10.1111/j.1558-5646.2008.00491.x; Higgins PJ, 1999, HDB AUSTR NZ ANTARTI, V4; Hile AG, 2000, ANIM BEHAV, V59, P1209, DOI 10.1006/anbe.1999.1438; Holland J, 1996, J AVIAN BIOL, V27, P47, DOI 10.2307/3676960; Hunley K, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000239; Irwin DE, 2008, J EVOLUTION BIOL, V21, P435, DOI 10.1111/j.1420-9101.2007.01499.x; Irwin DE, 2001, GENETICA, V112, P223, DOI 10.1023/A:1013319217703; Irwin DE, 2001, NATURE, V409, P333, DOI 10.1038/35053059; Janik Vincent M., 1999, Symposia of the Zoological Society of London, V72, P308; Joseph L, 2008, P ROY SOC B-BIOL SCI, V275, P2431, DOI 10.1098/rspb.2008.0765; Knott B, 2012, J COMP PHYSIOL A, V198, P43, DOI 10.1007/s00359-011-0684-z; Knott B, 2010, P ROY SOC B-BIOL SCI, V277, P953, DOI 10.1098/rspb.2009.1805; LOUGHEED SC, 1992, EVOLUTION, V46, P1443, DOI 10.1111/j.1558-5646.1992.tb01135.x; MacDougall-Shackleton EA, 2001, EVOLUTION, V55, P2568, DOI 10.1111/j.0014-3820.2001.tb00769.x; Marler P., 2004, NATURES MUSIC SCI BI; McCracken KG, 1997, P NATL ACAD SCI USA, V94, P3833, DOI 10.1073/pnas.94.8.3833; Moravec ML, 2006, ETHOLOGY, V112, P1108, DOI 10.1111/j.1439-0310.2006.01267.x; Moravec ML, 2010, ETHOLOGY, V116, P961, DOI 10.1111/j.1439-0310.2010.01809.x; MORTON ES, 1975, AM NAT, V109, P17, DOI 10.1086/282971; Nicholls JA, 2006, EVOLUTION, V60, P1279; Patten MA, 2004, EVOLUTION, V58, P2144; Podos J, 2001, NATURE, V409, P185, DOI 10.1038/35051570; Price T, 2008, SPECIATION BIRDS; Pritchard JK, 2000, GENETICS, V155, P945; Prugnolle F, 2002, HEREDITY, V88, P161, DOI 10.1038/sj.hdy.6800060; Rheindt FE, 2011, AUK, V128, P620, DOI 10.1525/auk.2011.128.4.620; Ribot RFH, 2011, EMU, V111, P360, DOI 10.1071/MU10080; Ribot RFH, 2009, ANIM BEHAV, V77, P581, DOI 10.1016/j.anbehav.2008.10.029; SAUNDERS DA, 1983, AUST WILDLIFE RES, V10, P527, DOI 10.1071/WR9830527; Slabbekoorn H, 2002, PHILOS T R SOC B, V357, P493, DOI 10.1098/rstb.2001.1056; Soha JA, 2004, BEHAV ECOL, V15, P636, DOI 10.1093/beheco/arh055; Tchernichovski O, 2000, ANIM BEHAV, V59, P1167, DOI 10.1006/anbe.1999.1416; Wang S, 2007, PLOS GENET, V3, P2049, DOI 10.1371/journal.pgen.0030185; Wanker R, 2005, ANIM BEHAV, V70, P111, DOI 10.1016/j.anbehav.2004.09.022; WILEY RH, 1978, BEHAV ECOL SOCIOBIOL, V3, P69, DOI 10.1007/BF00300047; Wright TF, 2005, MOL ECOL, V14, P1197, DOI 10.1111/j.1365-294X.2005.02466.x; Wright TF, 1996, P ROY SOC B-BIOL SCI, V263, P867, DOI 10.1098/rspb.1996.0128; Wright TF, 2001, P ROY SOC B-BIOL SCI, V268, P609, DOI 10.1098/rspb.2000.1403	60	25	25	0	84	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 5	2012	7	12							e50484	10.1371/journal.pone.0050484	http://dx.doi.org/10.1371/journal.pone.0050484			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	057TZ	23227179	Green Published, gold			2022-12-27	WOS:000312588200039
J	Roy, S; Javed, S; Jain, SK; Majumdar, SS; Mukhopadhyay, A				Roy, Sushmita; Javed, Saleem; Jain, Swatantra K.; Majumdar, Subeer S.; Mukhopadhyay, Asok			Donor Hematopoietic Stem Cells Confer Long-Term Marrow Reconstitution by Self-Renewal Divisions Exceeding to That of Host Cells	PLOS ONE			English	Article							COLONY-STIMULATING FACTOR; BONE-MARROW; PROGENITOR CELLS; DNA-REPLICATION; RICH SOURCE; CYCLIN-A; EX-VIVO; PROLIFERATION; MICE; ENGRAFTMENT	Dormant hematopoietic stem cells (HSCs) are activated by microenvironmental cues of the niche in response to the injury of bone marrow (BM). It is not clearly understood how engrafted cells respond to these cues and are involved in marrow regeneration. The purpose of this study was to decipher this cellular response in competitive environment. BM cells of CD45.2 mice were transplanted in sub-lethally irradiated CD45.1 mice. The status of the donor and recipient stem cells (LSK: Lin(-)Sca-1(+)c-Kit(+)) were determined by flowcytometry using CD45 alleles specific antibodies. The presence of long-term engraftable stem cells was confirmed by marrow repopulation assay in secondary hosts, and cell cycle status was determined by staining with Ho33342 and pyronin Y, and BrdU retention assay. The expressions of different hematopoietic growth factor genes in stromal compartment (CD45(-) cells) were assessed by real-time reverse transcriptase-polymerase chain reaction (RT-PCR). The presence of donor cells initially stimulated the proliferation of host LSK cells compared with control mice without transplantation. This was expected due to pro-mitotic and anti-apoptotic factors secreted by the donor hematopoietic cells. Upon transplantation, a majority of the donor LSK cells entered into cell cycle, and later they maintained cell cycle status similar to that in the normal mouse. Donor-derived LSK cells showed 1000-fold expansion within 15 days of transplantation. Donor-derived cells not only regenerated BM in the primary irradiated host for long-term, they were also found to be significantly involved in marrow regeneration after the second cycle of irradiation. The proliferation of LSK cells was associated with the onset of colossal expression of different hematopoietic growth factor genes in non-hematopoietic cellular compartment. Activation of donor LSK cells was found to be dynamically controlled by BM cellularity. Long-term study showed that a high level of hematopoietic reconstitution could be possible by donor cells in a sub-lethally irradiated host.	[Roy, Sushmita; Majumdar, Subeer S.; Mukhopadhyay, Asok] Natl Inst Immunol, New Delhi 110067, India; [Roy, Sushmita; Javed, Saleem] Jamia Hamdard, Dept Biochem, New Delhi, India; [Jain, Swatantra K.] Jamia Hamdard, Dept Biotechnol, New Delhi, India	Department of Biotechnology (DBT) India; National Institute of Immunology (NII); Jamia Hamdard University; Jamia Hamdard University	Mukhopadhyay, A (corresponding author), Natl Inst Immunol, New Delhi 110067, India.	ashok@nii.ac.in	Javed, Saleem/ABA-3845-2020	Majumdar, Subeer/0000-0003-1724-7483	Department of Science and Technology, Government of India	Department of Science and Technology, Government of India(Department of Science & Technology (India))	The last author is thankful to the Director, National Institute of Immunology for providing infrastructural support to conduct this work. A part of the research fund has been provided by Department of Science and Technology, Government of India, for which the last author is indebted. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arai F, 2004, CELL, V118, P149, DOI 10.1016/j.cell.2004.07.004; Arai F, 2007, ANN NY ACAD SCI, V1176, P36; Bodine DM, 1996, BLOOD, V88, P89; BRANDT J, 1992, BLOOD, V79, P634; Chen TC, 2007, EXP HEMATOL, V35, P203, DOI 10.1016/j.exphem.2006.10.002; Cheng T, 2000, SCIENCE, V287, P1804, DOI 10.1126/science.287.5459.1804; Cheshier SP, 1999, P NATL ACAD SCI USA, V96, P3120, DOI 10.1073/pnas.96.6.3120; Cui JS, 1999, BRIT J HAEMATOL, V107, P895, DOI 10.1046/j.1365-2141.1999.01779.x; DEAN PN, 1984, CELL TISSUE KINET, V17, P427, DOI 10.1111/j.1365-2184.1984.tb00601.x; FLEMING WH, 1993, J CELL BIOL, V122, P897, DOI 10.1083/jcb.122.4.897; GIRARD F, 1991, CELL, V67, P1169, DOI 10.1016/0092-8674(91)90293-8; GONG JK, 1978, SCIENCE, V199, P1443, DOI 10.1126/science.75570; Gothot A, 1998, BLOOD, V92, P2641, DOI 10.1182/blood.V92.8.2641.420k36_2641_2649; Habibian HK, 1998, J EXP MED, V188, P393, DOI 10.1084/jem.188.2.393; HARRISON DE, 1993, EXP HEMATOL, V21, P206; Hiraoka A, 2001, Hematol J, V2, P307, DOI 10.1038/sj.thj.6200118; Kiel MJ, 2005, CELL, V121, P1109, DOI 10.1016/j.cell.2005.05.026; Kobayashi M, 1996, BLOOD, V88, P429, DOI 10.1182/blood.V88.2.429.bloodjournal882429; Korf-Klingebiel M, 2008, EUR HEART J, V29, P2851, DOI 10.1093/eurheartj/ehn456; LEMOLI RM, 1993, EXP HEMATOL, V21, P1668; Liu LS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031300; Madhusudhan T, 2004, STEM CELLS DEV, V13, P173, DOI 10.1089/154732804323046774; Mio H, 1998, BIOCHEM BIOPH RES CO, V249, P124, DOI 10.1006/bbrc.1998.9073; MISHELL BB, 1980, SELECTED METHODS CEL, P3; Moore MAS, 1997, STEM CELLS, V15, P239, DOI 10.1002/stem.5530150832; Morrison SJ, 1997, P NATL ACAD SCI USA, V94, P1908, DOI 10.1073/pnas.94.5.1908; Mukhopadhyay A, 2004, ADV BIOCHEM ENG BIOT, V86, P215; Nilsson SK, 2001, BLOOD, V97, P2293, DOI 10.1182/blood.V97.8.2293; QUESENBERRY PJ, 1994, BLOOD CELLS, V20, P348; Shah AJ, 1996, BLOOD, V87, P3563, DOI 10.1182/blood.V87.9.3563.bloodjournal8793563; SHAPIRO HM, 1981, CYTOMETRY, V2, P143, DOI 10.1002/cyto.990020302; SHIROTA T, 1992, BLOOD CELLS, V18, P197; Stewart FM, 1998, BLOOD, V91, P3681; Suda T, 2005, TRENDS IMMUNOL, V26, P426, DOI 10.1016/j.it.2005.06.006; Trumpp A, 2010, NAT REV IMMUNOL, V10, P201, DOI 10.1038/nri2726; Veiby P, 1996, J IMMUNOL, V157, P2953; WALKER DH, 1991, NATURE, V354, P314, DOI 10.1038/354314a0; Wilson A, 2006, NAT REV IMMUNOL, V6, P93, DOI 10.1038/nri1779; Wilson A, 2008, CELL, V135, P1118, DOI 10.1016/j.cell.2008.10.048; Wright DE, 2001, BLOOD, V97, P2278, DOI 10.1182/blood.V97.8.2278; Zhang JW, 2003, NATURE, V425, P836, DOI 10.1038/nature02041; Zhang RL, 2004, J NEUROSCI, V24, P5810, DOI 10.1523/JNEUROSCI.1109-04.2004	42	8	9	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 5	2012	7	12							e50693	10.1371/journal.pone.0050693	http://dx.doi.org/10.1371/journal.pone.0050693			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	057TZ	23227199	Green Published, Green Submitted, gold			2022-12-27	WOS:000312588200058
J	Fu, LP; Li, HM; Wang, H; Xu, BX; Fan, Y; Tian, JH				Fu, Liping; Li, Hongming; Wang, Hui; Xu, Baixuan; Fan, Yong; Tian, Jiahe			SUVmax/THKmax as a Biomarker for Distinguishing Advanced Gastric Carcinoma from Primary Gastric Lymphoma	PLOS ONE			English	Article							POSITRON-EMISSION-TOMOGRAPHY; FOLLOW-UP; FDG-PET; F-18-FDG-PET; MALIGNANCY; PROGNOSIS; STOMACH	Background: Gastric carcinoma and primary gastric lymphoma (PGL) are the two most common malignancies in stomach. The purpose of this study was to screen and validate a biomarker of F-18-fluorodeoxyglucose positron emission tomography/computed tomography (F-18-FDG PET/CT) for distinguishing advanced gastric carcinoma (AGC) from PGL for clinical applications. Methodology/Principal Findings: We reviewed PET/CT scans collected from January 2008 to April 2012 of 69 AGC and 38 PGL (14 low-grade mucosa-associated lymphoid tissue [MALT], 24 non-MALT aggressive non-Hodgkin lymphoma [ANHL]) with a focus on FDG intensity (maximum standardized uptake value [SUVmax]) of primary lesions and its CT-detected abnormalities, including maximal gastrointestinal wall thickness (THKmax) and mucosal ulcerations. Gastric FDG uptake was found in 69 (100%) patients with AGC and 36 (95%, 12 MALT vs. 24 ANHL) with PGL. The presence of CT-detected abnormalities of AGC and PGL were 97% (67/69) and 89% (12 MALT vs. 22 ANHL), respectively. After controlling for THKmax, SUVmax was higher with ANHL than AGC (17.10 +/- 8.08 vs. 9.65 +/- 5.24, p<0.05) and MALT (6.20 +/- 3.60, p<0.05). THKmax did not differ among MALT, ANHL and AGC. Mucosal ulceration was more common with AGC (n = 9) than PGL (n = 2), but the difference was not statistically significant (p>0.05). Cross-validation analysis showed that for distinguishing ANHL from AGC, the classifier with SUVmax as a feature achieved a correct classification rate of 81% with thresholds 13.40 +/- 1.12 and the classifier with SUVmax/THKmax as a feature achieved a correct classification rate of 83% with thresholds 7.51 +/- 0.63. Conclusions/Significance: SUVmax/THKmax may be as a promising biomarker of FDG-PET/CT for distinguishing ANHL from AGC. Structural CT abnormalities alone may not be reliable but can help with PET assessment of gastric malignancies. F-18-FDG PET/CT have potential for distinguishing AGC from PGL at the individual level.	[Fu, Liping; Wang, Hui; Xu, Baixuan; Tian, Jiahe] Chinese Peoples Liberat Army & Mil Med Postgrad C, Gen Hosp, Dept Nucl Med, Beijing, Peoples R China; [Li, Hongming; Fan, Yong] Chinese Acad Sci, Inst Automat, Natl Lab Pattern Recognit, Beijing, Peoples R China	Chinese Academy of Sciences; Institute of Automation, CAS	Tian, JH (corresponding author), Chinese Peoples Liberat Army & Mil Med Postgrad C, Gen Hosp, Dept Nucl Med, Beijing, Peoples R China.	tianjh@vip.sina.com	Fan, Yong/O-4412-2014	Fan, Yong/0000-0001-9869-4685	China Postdoctoral Science Foundation [20090461433]; Special Fund China Postdoctoral Foundation [200902679]; National Natural Science Foundation of China [30900352, 30970770]; Hundred Talents Program of the Chinese Academy of Sciences	China Postdoctoral Science Foundation(China Postdoctoral Science Foundation); Special Fund China Postdoctoral Foundation; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Hundred Talents Program of the Chinese Academy of Sciences(Chinese Academy of Sciences)	This study was supported by the China Postdoctoral Science Foundation, No. 20090461433; the Special Fund China Postdoctoral Foundation, No. 200902679; the National Natural Science Foundation of China, No. 30900352 and 30970770; and the Hundred Talents Program of the Chinese Academy of Sciences. The authors state that the funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ambrosini V, 2006, NUCL MED REV, V9, P37; Brands F, 1997, EUR J SURG, V163, P803; BREAUX JR, 1990, WORLD J SURG, V14, P580, DOI 10.1007/BF01658794; Dassen AE, 2009, EJSO-EUR J SURG ONC, V35, P449, DOI 10.1016/j.ejso.2008.11.010; Duda R.O., 2006, PATTERN CLASSIFICATI; Duin R, 2007, PRTOOLS4 1 MATLAB TO; Enomoto K, 2008, ANN NUCL MED, V22, P261, DOI 10.1007/s12149-007-0125-9; Fan Wei-Jun, 2008, Ai Zheng, V27, P539; Good P, 1994, PERMUTATION TESTS PR; Hahn Jee Sook, 1997, Yonsei Medical Journal, V38, P270; Halme L, 1997, ACTA ONCOL, V36, P69, DOI 10.3109/02841869709100736; Hoffmann M, 2003, ONCOLOGY-BASEL, V64, P336, DOI 10.1159/000070290; Hundahl SA, 2000, CANCER-AM CANCER SOC, V88, P921, DOI 10.1002/(SICI)1097-0142(20000215)88:4<921::AID-CNCR24>3.3.CO;2-J; Jadvar H, 2003, CLIN RADIOL, V58, P215, DOI 10.1016/S0009-9260(02)00477-4; Karam M, 2006, CANCER-AM CANCER SOC, V107, P175, DOI 10.1002/cncr.21967; Kawamura T, 2001, CANCER-AM CANCER SOC, V92, P634, DOI 10.1002/1097-0142(20010801)92:3<634::AID-CNCR1364>3.0.CO;2-X; Kelessis NG, 2002, ANTICANCER RES, V22, P3457; Maes B, 2002, HISTOPATHOLOGY, V40, P117, DOI 10.1046/j.1365-2559.2002.01360.x; Mochiki E, 2004, WORLD J SURG, V28, P247, DOI 10.1007/s00268-003-7191-5; Mukai Kota, 2006, Gastric Cancer, V9, P192, DOI 10.1007/s10120-006-0374-7; Phongkitkarun S, 2005, WORLD J GASTROENTERO, V11, P7284, DOI 10.3748/wjg.v11.i46.7284; Raudys S, 1998, PATTERN RECOGN LETT, V19, P385, DOI 10.1016/S0167-8655(98)00016-6; Shoda H, 2007, BRIT J CANCER, V97, P1493, DOI 10.1038/sj.bjc.6604062; Stahl A, 2003, EUR J NUCL MED MOL I, V30, P288, DOI 10.1007/s00259-002-1029-5; Taal BG, 1996, GUT, V39, P556, DOI 10.1136/gut.39.4.556; Webb A. R., 2003, STAT PATTERN RECOGNI; Yoshioka T, 2003, J NUCL MED, V44, P690; Zhao BY., 2007, CHIN J CLIN ONCOL RE, V14, P446, DOI [10.2169/naika.100.1885, DOI 10.2169/NAIKA.100.1885]	28	14	16	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 4	2012	7	12							e50914	10.1371/journal.pone.0050914	http://dx.doi.org/10.1371/journal.pone.0050914			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	051EQ	23226547	Green Published, Green Submitted, gold			2022-12-27	WOS:000312108500034
J	Thomas, LK; Tolle, L; Ziegenhagen, B; Leyer, I				Thomas, Lisa K.; Toelle, Lena; Ziegenhagen, Birgit; Leyer, Ilona			Are Vegetative Reproduction Capacities the Cause of Widespread Invasion of Eurasian Salicaceae in Patagonian River Landscapes?	PLOS ONE			English	Article							WILLOWS SALIX SPP.; RIPARIAN WILLOW; NEW-ZEALAND; EVOLUTION; FRAGILIS; SPREAD; TREES	In recent decades, invasive willows and poplars (Salicaceae) have built dense floodplain forests along most of the rivers in Patagonia, Argentina. These invasion processes may affect Salix humboldtiana as the only native floodplain tree species in this region. It is assumed, that the property to reproduce vegetatively can play an important role in the establishment of invasive species in their new range. Thus, in order to contribute to a better understanding of willow and poplar invasions in riparian systems and to assess the potential impacts on S. humboldtiana the vegetative reproduction capacities of native and invasive Salicaceae were analysed. In a greenhouse experiment, we studied cutting survival and growth performance of the three most dominant invasive Salicaceae of the Patagonian Rio Negro region (two Salix hybrids and Populus spec.), as well as S. humboldtiana, taking into account three different moisture and two different soil conditions. In a subsequent experiment, the shoot and root biomass of cuttings from the former experiment were removed and the bare cuttings were replanted to test their ability to re-sprout. The two invasive willow hybrids performed much better than S. humboldtiana and Populus spec. under all treatment combinations and tended to re-sprout more successfully after repeated biomass loss. Taking into account the ecology of vegetative and generative recruits of floodplain willows, the results indicate that the more vigorous vegetative reproduction capacity can be a crucial property for the success of invasive willow hybrids in Patagonia being a potential threat for S. humboldtiana. Citation: Thomas LK, Tolle L, Ziegenhagen B, Leyer I (2012) Are Vegetative Reproduction Capacities the Cause of Widespread Invasion of Eurasian Salicaceae in Patagonian River Landscapes? PLoS ONE 7(12): e50652. doi:10.1371/journal.pone.0050652	[Thomas, Lisa K.; Toelle, Lena; Ziegenhagen, Birgit; Leyer, Ilona] Univ Marburg, Dept Conservat Biol, Fac Biol, Marburg, Germany; [Leyer, Ilona] Univ Appl Sci, Dept Geisenheim Plant Ecol & Nat Conservat, Hsch RheinMain, Geisenheim, Germany	Philipps University Marburg	Thomas, LK (corresponding author), Univ Marburg, Dept Conservat Biol, Fac Biol, Marburg, Germany.	lisa.thomas@gmx.de		Leyer, Ilona/0000-0003-4302-0936	German Research Foundation (DFG) [LE 1364/4-1]	German Research Foundation (DFG)(German Research Foundation (DFG))	The study was carried out within the project "Predicting effects of invasion processes of Eurasian floodplain willows in Patagonia" funded by the German Research Foundation (DFG grant LE 1364/4-1). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adair R, 2006, AUST J ENTOMOL, V45, P259, DOI 10.1111/j.1440-6055.2006.00548.x; Asaeda T, 2011, RIVER RES APPL, V27, P976, DOI 10.1002/rra.1372; Barker JHA, 2003, MOL ECOL NOTES, V3, P4, DOI 10.1046/j.1471-8286.2003.00332.x; Barrett SCH, 2008, MOL ECOL, V17, P373, DOI 10.1111/j.1365-294X.2007.03503.x; Barsoum N, 2001, EVOL ECOL, V15, P255, DOI 10.1023/A:1016028730129; Beismann H, 2000, J EXP BOT, V51, P617, DOI 10.1093/jexbot/51.344.617; Borodowski ED, 2004, SAGPYA FORESTAL, V32, P5; Brown RL, 2003, ECOLOGY, V84, P32, DOI 10.1890/0012-9658(2003)084[0032:DAIOSA]2.0.CO;2; Budde KB, 2011, BIOL INVASIONS, V13, P45, DOI 10.1007/s10530-010-9785-9; Correa M.N., 1998, FLORA PATAGONICA; Crawley M.J., 2007, R BOOK; Cremer Kurt W., 2003, Biodiversity (Ottawa), V4, P17; GLOVA GJ, 1994, NEW ZEAL J MAR FRESH, V28, P255, DOI 10.1080/00288330.1994.9516613; Gut, 2008, TREES PATAGONIA; HENDERSON L, 1991, South African Forestry Journal, P91; Holland-Clift S, 2011, AUSTRAL ECOL, V36, P511, DOI 10.1111/j.1442-9993.2010.02178.x; Hothorn T, 2008, BIOMETRICAL J, V50, P346, DOI 10.1002/bimj.200810425; Hughes FMR, 2001, REGUL RIVER, V17, P325, DOI 10.1002/rrr.656; Hunziker JH, 1992, SILVAE GENET, V11, P151; Karrenberg S, 2002, FRESHWATER BIOL, V47, P733, DOI 10.1046/j.1365-2427.2002.00894.x; Kennedy SA, 2003, MAR FRESHWATER RES, V54, P825, DOI 10.1071/MF03035; King RA, 2010, TREE GENET GENOMES, V6, P247, DOI 10.1007/s11295-009-0245-6; Kolar CS, 2001, TRENDS ECOL EVOL, V16, P199, DOI 10.1016/S0169-5347(01)02101-2; LESTER PJ, 1994, NEW ZEAL J MAR FRESH, V28, P267, DOI 10.1080/00288330.1994.9516614; Li SW, 2005, ACTA OECOL, V28, P173, DOI 10.1016/j.actao.2005.03.009; Lin J, 2009, AM J BOT, V96, P771, DOI 10.3732/ajb.0800321; Liotta J, 2001, INTERCIENCIA, V26, P397; Mack RN, 2000, ECOL APPL, V10, P689, DOI 10.1890/1051-0761(2000)010[0689:BICEGC]2.0.CO;2; Moggridge HL, 2009, AQUAT SCI, V71, P305, DOI 10.1007/s00027-009-9193-3; Naumann M, 1996, THESIS U MARBURG; Parolin P, 2002, FOLIA GEOBOT, V37, P225, DOI 10.1007/BF02804233; Radtke A, 2012, PLANT BIOLOGY, V14, P257, DOI 10.1111/j.1438-8677.2011.00509.x; Renofalt BM, 2005, LANDSCAPE ECOL, V20, P165, DOI 10.1007/s10980-004-2262-z; Richardson David M., 2000, Diversity and Distributions, V6, P93, DOI 10.1046/j.1472-4642.2000.00083.x; Sagarin RD, 2002, ECOL LETT, V5, P137, DOI 10.1046/j.1461-0248.2002.00297.x; SCHIER G A, 1976, Canadian Journal of Forest Research, V6, P253, DOI 10.1139/x76-035; Sexton JP, 2009, ANNU REV ECOL EVOL S, V40, P415, DOI 10.1146/annurev.ecolsys.110308.120317; SHAFROTH PB, 1994, AM MIDL NAT, V132, P159, DOI 10.2307/2426210; Stohlgren TJ, 1999, ECOL MONOGR, V69, P25, DOI 10.1890/0012-9615(1999)069[0025:EPSIHS]2.0.CO;2; Tabacchi E, 2005, RIVER RES APPL, V21, P299, DOI 10.1002/rra.848; Zalba S. M., 2002, Biological Invasions, V4, P55, DOI 10.1023/A:1020532609792; Ziegenhagen B, 2008, CONSERV GENET, V9, P373, DOI 10.1007/s10592-007-9349-4	42	13	13	1	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 4	2012	7	12							e50652	10.1371/journal.pone.0050652	http://dx.doi.org/10.1371/journal.pone.0050652			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	051EQ	23226531	gold, Green Published, Green Submitted			2022-12-27	WOS:000312108500024
J	Wang, MH; Zhou, WB; Zhao, YC; Xia, TS; Zha, XM; Ding, Q; Liu, XA; Zhao, Y; Ling, LJ; Chen, L; Wang, S				Wang, Minghai; Zhou, Wenbin; Zhao, Yingchun; Xia, Tiansong; Zha, Xiaoming; Ding, Qiang; Liu, Xiaoan; Zhao, Yi; Ling, Lijun; Chen, Lin; Wang, Shui			A Novel Finding of Sentinel Lymphatic Channels in Early Stage Breast Cancer Patients: Which May Influence Detection Rate and False-Negative Rate of Sentinel Lymph Node Biopsy	PLOS ONE			English	Article							SUBAREOLAR INJECTION; BLUE-DYE; DISSECTION; ANATOMY; TRIAL; MULTICENTER; SURGERY	Background: The exact lymphatic drainage pattern of the breast hasn't been explained clearly. The aim of this study was to investigate the sentinel lymphatic channels (SLCs) in the cancerous breast. Whether the type of SLCs influenced the detection rate and false-negative rate of SLNB was also assessed. Methodology and Principal Findings: Mimic SLNB was performed in 110 early-stage breast cancer patients with subareolar injection of blue methylene dye intraoperatively. Postoperatively, 110 specimens of modified radical mastectomy were examined for all blue SLCs after additional injection of methylene dye in peritumoral parenchyma. Interestingly, three types of SLCs, including superficial sentinel lymphatic channel (SSLC), deep sentinel lymphatic channel (DSLC), and penetrating sentinel lymphatic channel (PSLC) were found in 107 patients. Six lymphatic drainage patterns based on the three types of SLCs were observed in these 107 patients. The proportions of the drainage pattern SSLC, DSLC, PSLC, SSLC+DSLC, SSLC+PSLC, and DSLC+PSLC in the breast were 43%, 0.9%, 15.9%, 33.6%, 3.7% and 2.8%, respectively. The lymphatic drainage pattern in the breast was a significant risk factor for unsuccessful identification of sentinel lymph nodes (P<0.001) and false-negatives in SLNB (P = 0.034) with the subareolar injection technique. Conclusions: Three kinds of SLCs are the basis of six lymphatic drainage patterns from the breast to the axilla. The type of SLCs is the factor influencing the detection rate and false-negative rate of SLNB. These findings suggest the optimal injection technique of the combination of superficial and deep injection in SLNB procedures. Future clinical studies are needed to confirm our novel findings.	[Wang, Minghai; Zhou, Wenbin; Zhao, Yingchun; Xia, Tiansong; Zha, Xiaoming; Ding, Qiang; Liu, Xiaoan; Zhao, Yi; Ling, Lijun; Chen, Lin; Wang, Shui] Nanjing Med Univ, Affiliated Hosp 1, Dept Breast Surg, Nanjing, Jiangsu, Peoples R China; [Wang, Minghai] Wannan Med Coll, Affiliated Yijishan Hosp 1, Dept Gen Surg, Wuhu, Anhui, Peoples R China	Nanjing Medical University; Wannan Medical College	Wang, S (corresponding author), Nanjing Med Univ, Affiliated Hosp 1, Dept Breast Surg, Nanjing, Jiangsu, Peoples R China.	ws0801@hotmail.com			National Natural Science Foundation of China [81071753, 81172502]; Science and Education for Health Foundation of Jiangsu Province [RC2007054]; Natural Science Foundation of Jiangsu Province [BK2009438, BK2010581, BK2011853, BK2011855]; Program for Development of Innovative Research Team in the First Affiliated Hospital of NJMU [IRT-008]; Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD)	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Science and Education for Health Foundation of Jiangsu Province; Natural Science Foundation of Jiangsu Province(Natural Science Foundation of Jiangsu Province); Program for Development of Innovative Research Team in the First Affiliated Hospital of NJMU; Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD)	This work was supported in part by the National Natural Science Foundation of China (81071753 and 81172502), the Science and Education for Health Foundation of Jiangsu Province (RC2007054), the Natural Science Foundation of Jiangsu Province (BK2009438, BK2010581, BK2011853 and BK2011855), the Program for Development of Innovative Research Team in the First Affiliated Hospital of NJMU (IRT-008), and a project funded by the Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bajen MT, 2006, EUR J NUCL MED MOL I, V33, P338, DOI 10.1007/s00259-005-1931-8; Bezu C, 2011, SURG ONCOL, V20, pE55, DOI 10.1016/j.suronc.2010.10.002; Cheng G, 2011, EUR J NUCL MED MOL I, V38, P562, DOI 10.1007/s00259-010-1577-z; Goyal A, 2006, BREAST CANCER RES TR, V99, P203, DOI 10.1007/s10549-006-9192-1; Kaklamanos IG, 2011, J SURG ONCOL, V104, P37, DOI 10.1002/jso.21897; Kargozaran H, 2007, J SURG RES, V143, P126, DOI 10.1016/j.jss.2007.02.054; Kern KA, 1999, J AM COLL SURGEONS, V189, P539, DOI 10.1016/S1072-7515(99)00200-8; Kern KA, 2000, J AM COLL SURGEONS, V191, P479, DOI 10.1016/S1072-7515(00)00720-1; Kern KA, 2001, J AM COLL SURGEONS, V193, P601, DOI 10.1016/S1072-7515(01)01068-7; Krag DN, 2007, LANCET ONCOL, V8, P881, DOI 10.1016/S1470-2045(07)70278-4; Langer I, 2007, ANN SURG, V245, P452, DOI 10.1097/01.sla.0000245472.47748.ec; Lyman GH, 2005, J CLIN ONCOL, V23, P7703, DOI 10.1200/JCO.2005.08.001; Mansel RE, 2006, J NATL CANCER I, V98, P599, DOI 10.1093/jnci/djj158; Mudun A, 2008, CLIN NUCL MED, V33, P262, DOI 10.1097/RLU.0b013e3181662fc7; Noguchi M, 2009, J SURG ONCOL, V100, P100, DOI 10.1002/jso.21308; Purushotham AD, 2005, EJSO-EUR J SURG ONC, V31, P929, DOI 10.1016/j.ejso.2005.07.008; Sappey MPC, 1874, ANATOMIE PHYSL PATHO; Straver ME, 2010, ANN SURG ONCOL, V17, P1854, DOI 10.1245/s10434-010-0945-z; Suami H, 2008, ANN SURG ONCOL, V15, P863, DOI 10.1245/s10434-007-9709-9; Tanis PJ, 2001, J AM COLL SURGEONS, V192, P399, DOI 10.1016/S1072-7515(00)00776-6; TURNERWARWICK RT, 1959, BRIT J SURG, V46, P574, DOI 10.1002/bjs.18004620004; Veronesi U, 1997, LANCET, V349, P1864, DOI 10.1016/S0140-6736(97)01004-0; Zavagno G, 2008, EJSO-EUR J SURG ONC, V34, P620, DOI 10.1016/j.ejso.2007.07.003; Zavagno G, 2008, ANN SURG, V247, P207, DOI 10.1097/SLA.0b013e31812e6a73	24	20	22	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 4	2012	7	12							e51226	10.1371/journal.pone.0051226	http://dx.doi.org/10.1371/journal.pone.0051226			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	051EQ	23226569	Green Submitted, Green Published, gold			2022-12-27	WOS:000312108500052
J	Fernandes, N; Steinberg, P; Rusch, D; Kjelleberg, S; Thomas, T				Fernandes, Neil; Steinberg, Peter; Rusch, Doug; Kjelleberg, Staffan; Thomas, Torsten			Community Structure and Functional Gene Profile of Bacteria on Healthy and Diseased Thalli of the Red Seaweed Delisea pulchra	PLOS ONE			English	Article							SECONDARY METABOLITES; SP-NOV.; HALOGENATED FURANONES; PHYLOGENETIC ANALYSIS; VIRULENCE; ALGA; MARINE; BIOSYNTHESIS; BIODIVERSITY; RESILIENCE	Disease is increasingly viewed as a major factor in the ecology of marine communities and its impact appears to be increasing with environmental change, such as global warming. The temperate macroalga Delisea pulchra bleaches in Southeast Australia during warm summer periods, a phenomenon which previous studies have indicated is caused by a temperature induced bacterial disease. In order to better understand the ecology of this disease, the bacterial communities associated with threes type of samples was investigated using 16S rRNA gene and environmental shotgun sequencing: 1) unbleached (healthy) D. pulchra 2) bleached parts of D. pulchra and 3) apparently healthy tissue adjacent to bleached regions. Phylogenetic differences between healthy and bleached communities mainly reflected relative changes in the taxa Colwelliaceae, Rhodobacteraceae, Thalassomonas and Parvularcula. Comparative metagenomics showed clear difference in the communities of healthy and diseased D. pulchra as reflected by changes in functions associated with transcriptional regulation, cation/multidrug efflux and non-ribosomal peptide synthesis. Importantly, the phylogenetic and functional composition of apparently healthy tissue adjacent to bleached sections of the thalli indicated that changes in the microbial communities already occur in the absence of visible tissue damage. This shift in unbleached sections might be due to the decrease in furanones, algal metabolites which are antagonists of bacterial quorum sensing. This study reveals the complex shift in the community composition associated with bleaching of Delisea pulchra and together with previous studies is consistent with a model in which elevated temperatures reduce levels of chemical defenses in stressed thalli, leading to colonization or proliferation by opportunistic pathogens or scavengers.	[Fernandes, Neil; Steinberg, Peter; Kjelleberg, Staffan; Thomas, Torsten] Univ New S Wales, Ctr Marine Bioinnovat, Sydney, NSW, Australia; [Fernandes, Neil; Kjelleberg, Staffan; Thomas, Torsten] Univ New S Wales, Sch Biotechnol & Biomol Sci, Sydney, NSW, Australia; [Steinberg, Peter] Univ New S Wales, Sch Biol Earth & Environm Sci, Sydney, NSW, Australia; [Steinberg, Peter] Nanyang Technol Univ, Adv Environm Biotechnol Ctr, Singapore, Singapore; [Rusch, Doug] J Craig Venter Inst, Rockville, MD USA; [Kjelleberg, Staffan] Nanyang Technol Univ, Singapore Ctr Environm Life Sci Engn, Singapore, Singapore	University of New South Wales Sydney; University of New South Wales Sydney; University of New South Wales Sydney; Nanyang Technological University & National Institute of Education (NIE) Singapore; Nanyang Technological University; J. Craig Venter Institute; Nanyang Technological University & National Institute of Education (NIE) Singapore; Nanyang Technological University	Thomas, T (corresponding author), Univ New S Wales, Ctr Marine Bioinnovat, Sydney, NSW, Australia.	t.thomas@unsw.edu.au	Kjelleberg, Staffan/C-9229-2015; Kjelleberg, Staffan/AAB-4641-2020	Kjelleberg, Staffan/0000-0003-4271-6413; Kjelleberg, Staffan/0000-0003-4271-6413; Thomas, Torsten/0000-0001-9557-3001; Steinberg, Peter/0000-0002-1781-0726	Australian Research Council; Gordon and Betty Moore Foundation; United States Department of Energy (DOE), Office of Science, Office of Biological and Environmental Research [DE-FG02-02ER63453]; Centre for Marine Bio-Innovation; J. Craig Venter Institute, United States of America	Australian Research Council(Australian Research Council); Gordon and Betty Moore Foundation(Gordon and Betty Moore Foundation); United States Department of Energy (DOE), Office of Science, Office of Biological and Environmental Research(United States Department of Energy (DOE)); Centre for Marine Bio-Innovation; J. Craig Venter Institute, United States of America	This work was funded by the Australian Research Council, the Gordon and Betty Moore Foundation, the United States Department of Energy (DOE), Office of Science, Office of Biological and Environmental Research (DE-FG02-02ER63453), the Centre for Marine Bio-Innovation and the J. Craig Venter Institute, United States of America. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Arrebola E, 2007, MOL PLANT MICROBE IN, V20, P500, DOI 10.1094/MPMI-20-5-0500; Ashelford KE, 2006, APPL ENVIRON MICROB, V72, P5734, DOI 10.1128/AEM.00556-06; Beier D, 2006, CURR OPIN MICROBIOL, V9, P143, DOI 10.1016/j.mib.2006.01.005; Bowman JP, 2000, INT J SYST EVOL MICR, V50, P1861, DOI 10.1099/00207713-50-5-1861; Burke C, 2011, ISME J, V5, P590, DOI 10.1038/ismej.2010.164; Burke C, 2009, APPL ENVIRON MICROB, V75, P252, DOI 10.1128/AEM.01630-08; Burse A, 2004, APPL ENVIRON MICROB, V70, P693, DOI 10.1128/AEM.70.2.693-703.2004; Calva E, 2006, MICROB ECOL, V51, P166, DOI 10.1007/s00248-005-0087-1; Campbell AH, 2011, THESIS U NEW S WALES; Campbell AH, 2011, GLOBAL CHANGE BIOL, V17, P2958, DOI 10.1111/j.1365-2486.2011.02456.x; Case RJ, 2011, ENVIRON MICROBIOL, V13, P529, DOI 10.1111/j.1462-2920.2010.02356.x; Challis GL, 2000, CHEM BIOL, V7, P211, DOI 10.1016/S1074-5521(00)00091-0; CLARKE KR, 1993, AUST J ECOL, V18, P117, DOI 10.1111/j.1442-9993.1993.tb00438.x; Cole JR, 2009, NUCLEIC ACIDS RES, V37, pD141, DOI 10.1093/nar/gkn879; de Nys R, 2006, MAR MOL BIOTECHNOL, V42, P55; DENYS R, 1995, BIOFOULING, V8, P259, DOI 10.1080/08927019509378279; Fernandes N, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027387; Finking R, 2004, ANNU REV MICROBIOL, V58, P453, DOI 10.1146/annurev.micro.58.030603.123615; Vescovi EG, 2010, CURR OPIN MICROBIOL, V13, P210, DOI 10.1016/j.mib.2009.12.012; Garren M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007319; Gorley C.K., 2006, GETTING STARTED PRIM; Gram L, 1996, APPL ENVIRON MICROB, V62, P4284, DOI 10.1128/AEM.62.11.4284-4287.1996; Groll M, 2008, NATURE, V452, P755, DOI 10.1038/nature06782; Harvell CD, 2002, SCIENCE, V296, P2158, DOI 10.1126/science.1063699; Hentzer M, 2003, EMBO J, V22, P3803, DOI 10.1093/emboj/cdg366; Hentzer M, 2002, MICROBIOL-SGM, V148, P87, DOI 10.1099/00221287-148-1-87; Hosoya S, 2006, INT J SYST EVOL MICR, V56, P2931, DOI 10.1099/ijs.0.64504-0; Kelly KM, 2001, FEMS MICROBIOL ECOL, V35, P85, DOI 10.1016/S0168-6496(00)00115-X; Kerswell AP, 2006, ECOLOGY, V87, P2479, DOI 10.1890/0012-9658(2006)87[2479:GBPOBM]2.0.CO;2; Lafferty KD, 2004, ANNU REV ECOL EVOL S, V35, P31, DOI 10.1146/annurev.ecolsys.35.021103.105704; Lane D, 1991, NUCL TECHNIQUES BACT; Llama-Palacios A, 2002, APPL ENVIRON MICROB, V68, P1624, DOI 10.1128/AEM.68.4.1624-1630.2002; Longford SR, 2007, AQUAT MICROB ECOL, V48, P217, DOI 10.3354/ame048217; Manefield M, 2001, FEMS MICROBIOL LETT, V205, P131, DOI 10.1111/j.1574-6968.2001.tb10936.x; Martinez JL, 2009, FEMS MICROBIOL REV, V33, P430, DOI 10.1111/j.1574-6976.2008.00157.x; Maximilien R, 1998, AQUAT MICROB ECOL, V15, P233, DOI 10.3354/ame015233; Mayali X, 2004, J EUKARYOT MICROBIOL, V51, P139, DOI 10.1111/j.1550-7408.2004.tb00538.x; Mole BM, 2007, TRENDS MICROBIOL, V15, P363, DOI 10.1016/j.tim.2007.06.005; Montagne C, 1844, ANN SCI NAT BOT 3, V1, P151; Muyzer G, 1998, ANTON LEEUW INT J G, V73, P127, DOI 10.1023/A:1000669317571; Nylund GM, 2010, FEMS MICROBIOL ECOL, V71, P84, DOI 10.1111/j.1574-6941.2009.00791.x; Oh HM, 2011, J BACTERIOL, V193, P305, DOI 10.1128/JB.01205-10; Papenfuss G, 1964, BIBLIO ANTARCTIC SEA; Pruesse E, 2007, NUCLEIC ACIDS RES, V35, P7188, DOI 10.1093/nar/gkm864; Raina JB, 2010, TRENDS MICROBIOL, V18, P101, DOI 10.1016/j.tim.2009.12.002; Raina JB, 2009, APPL ENVIRON MICROB, V75, P3492, DOI 10.1128/AEM.02567-08; Reshef L, 2006, ENVIRON MICROBIOL, V8, P2068, DOI 10.1111/j.1462-2920.2006.01148.x; Rogers CN, 2000, J CHEM ECOL, V26, P721, DOI 10.1023/A:1005484306931; Rosenberg E, 2007, NAT REV MICROBIOL, V5, P355, DOI 10.1038/nrmicro1635; Rusch DB, 2007, PLOS BIOL, V5, P398, DOI 10.1371/journal.pbio.0050077; Schloss PD, 2009, APPL ENVIRON MICROB, V75, P7537, DOI 10.1128/AEM.01541-09; Shaw AK, 2008, ENVIRON MICROBIOL, V10, P2200, DOI 10.1111/j.1462-2920.2008.01626.x; Sorokin DY, 2005, INT J SYST EVOL MICR, V55, P1069, DOI 10.1099/ijs.0.63415-0; Staufenberger T, 2008, FEMS MICROBIOL ECOL, V64, P65, DOI 10.1111/j.1574-6941.2008.00445.x; Steneck RS, 2002, ENVIRON CONSERV, V29, P436, DOI 10.1017/S0376892902000322; Sunagawa S, 2009, ISME J, V3, P512, DOI 10.1038/ismej.2008.131; Tatusov RL, 2003, BMC BIOINFORMATICS, V4, DOI 10.1186/1471-2105-4-41; Tegos G, 2002, ANTIMICROB AGENTS CH, V46, P3133, DOI 10.1128/AAC.46.10.3133-3141.2002; Thomas T, 2010, ISME J, V4, P1557, DOI 10.1038/ismej.2010.74; Thompson FL, 2006, INT J SYST EVOL MICR, V56, P365, DOI 10.1099/ijs.0.63800-0; VINING LC, 1990, ANNU REV MICROBIOL, V44, P395, DOI 10.1146/annurev.mi.44.100190.002143; Wagner-Dobler I, 2006, ANNU REV MICROBIOL, V60, P255, DOI 10.1146/annurev.micro.60.080805.142115; Weil E, 2006, DIS AQUAT ORGAN, V69, P1, DOI 10.3354/dao069001; Wright JT, 2000, MAR ECOL PROG SER, V207, P227, DOI 10.3354/meps207227; Wyatt MA, 2010, SCIENCE, V329, P294, DOI 10.1126/science.1188888; Xia Y, 2008, APPL ENVIRON MICROB, V74, P2229, DOI 10.1128/AEM.02502-07	67	53	56	3	99	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 3	2012	7	12							e50854	10.1371/journal.pone.0050854	http://dx.doi.org/10.1371/journal.pone.0050854			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	051DH	23226544	gold, Green Published, Green Accepted			2022-12-27	WOS:000312104700025
J	Campbell, SJ; Hoey, AS; Maynard, J; Kartawijaya, T; Cinner, J; Graham, NAJ; Baird, AH				Campbell, Stuart J.; Hoey, Andrew S.; Maynard, Jeffrey; Kartawijaya, Tasrif; Cinner, Joshua; Graham, Nicholas A. J.; Baird, Andrew H.			Weak Compliance Undermines the Success of No-Take Zones in a Large Government-Controlled Marine Protected Area	PLOS ONE			English	Article							GREAT-BARRIER-REEF; FISHERIES MANAGEMENT; CUSTOMARY MANAGEMENT; RESERVE NETWORKS; CLIMATE-CHANGE; FISH; CONSERVATION; BIOMASS; RESILIENCE; VARIABLES	The effectiveness of marine protected areas depends largely on whether people comply with the rules. We quantified temporal changes in benthic composition, reef fish biomass, and fishing effort among marine park zones (including no-take areas) to assess levels of compliance following the 2005 rezoning of the government-controlled Karimunjawa National Park (KNP), Indonesia. Four years after the rezoning awareness of fishing regulations was high amongst local fishers, ranging from 79.5 +/- 7.9 (SE) % for spatial restrictions to 97.7 +/- 1.2% for bans on the use of poisons. Despite this high awareness and strong compliance with gear restrictions, compliance with spatial restrictions was weak. In the four years following the rezoning reef fish biomass declined across all zones within KNP, with >50% reduction within the no-take Core and Protection Zones. These declines were primarily driven by decreases in the biomass of groups targeted by local fishers; planktivores, herbivores, piscivores, and invertivores. These declines in fish biomass were not driven by changes in habitat quality; coral cover increased in all zones, possibly as a result of a shift in fishing gears from those which can damage reefs (i.e., nets) to those which cause little direct damage (i.e., handlines and spears). Direct observations of fishing activities in 2009 revealed there was limited variation in fishing effort between zones in which fishing was allowed or prohibited. The apparent willingness of the KNP communities to comply with gear restrictions, but not spatial restrictions is difficult to explain and highlights the complexities of the social and economic dynamics that influence the ecological success of marine protected areas. Clearly the increased and high awareness of fishery restrictions following the rezoning is a positive step. The challenge now is to understand and foster the conditions that may facilitate compliance with spatial restrictions within KNP and marine parks worldwide.	[Hoey, Andrew S.; Cinner, Joshua; Graham, Nicholas A. J.; Baird, Andrew H.] James Cook Univ, ARC Ctr Excellence Coral Reef Studies, Townsville, Qld 4811, Australia; [Campbell, Stuart J.; Kartawijaya, Tasrif] Wildlife Conservat Soc, Marine Program, Bogor, West Java, Indonesia; [Hoey, Andrew S.] King Abdullah Univ Sci & Technol, Red Sea Res Ctr, Thuwal, Saudi Arabia; [Maynard, Jeffrey] Ecole Prat Hautes Etud, Ctr Rech Insulaires, Moorea, France; [Maynard, Jeffrey] Ecole Prat Hautes Etud, Observ Environm, Moorea, France	James Cook University; Wildlife Conservation Society - Indonesia; King Abdullah University of Science & Technology	Hoey, AS (corresponding author), James Cook Univ, ARC Ctr Excellence Coral Reef Studies, Townsville, Qld 4811, Australia.	andrew.hoey1@jcu.edu.au	Graham, Nicholas AJ/C-8360-2014; Baird, Andrew Hamilton/C-8449-2009; Cinner, Joshua/AAA-6823-2021; Cinner, Joshua e/E-8966-2011; Hoey, Andrew S/B-5457-2015	Graham, Nicholas AJ/0000-0002-0304-7467; Baird, Andrew Hamilton/0000-0001-8504-4077; Cinner, Joshua e/0000-0003-2675-9317; Hoey, Andrew/0000-0002-4261-5594; Campbell, Stuart/0000-0002-1158-3200; Maynard, Dr Jeffrey/0000-0002-6444-6373	David and Lucile Packard Foundation; Tiffany Foundation	David and Lucile Packard Foundation(The David & Lucile Packard Foundation); Tiffany Foundation	This work was made possible by a grant from the David and Lucile Packard Foundation and The Tiffany Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ardiwijawa RL, 2008, P 11 INT COR REEF S, V1, P1064; Aswani S, 2010, CONSERV BIOL, V24, P520, DOI 10.1111/j.1523-1739.2009.01377.x; Badruddin M, 1996, 9 FAO; Baird AH, 2005, CURR BIOL, V15, P1926, DOI 10.1016/j.cub.2005.09.036; Balmford A, 2004, P NATL ACAD SCI USA, V101, P9694, DOI 10.1073/pnas.0403239101; Bellwood DR, 2012, P ROY SOC B-BIOL SCI, V279, P1621, DOI 10.1098/rspb.2011.1906; Bellwood DR, 2004, NATURE, V429, P827, DOI 10.1038/nature02691; Berkes F, 2006, SCIENCE, V311, P1557, DOI 10.1126/science.1122804; Brewer TD, 2012, GLOBAL ENVIRON CHANG, V22, P399, DOI 10.1016/j.gloenvcha.2012.01.006; Campbell SJ, 2006, FISH RES, V79, P75, DOI 10.1016/j.fishres.2005.12.015; Campbell SJ, 2012, ORYX, V46, P486, DOI 10.1017/S0030605312000348; Cinner JE, 2006, ENVIRON CONSERV, V33, P73, DOI 10.1017/S0376892906002748; Cinner JE, 2007, BIOL CONSERV, V140, P201, DOI 10.1016/j.biocon.2007.08.008; Cinner JE, 2009, J APPL ECOL, V46, P724, DOI 10.1111/j.1365-2664.2009.01648.x; Cinner JE, 2009, CURR BIOL, V19, P206, DOI 10.1016/j.cub.2008.11.055; Clifton J, 2003, MAR POLICY, V27, P389, DOI 10.1016/S0308-597X(03)00026-5; Crawford BR, 2004, COAST MANAGE, V32, P39, DOI 10.1080/08920750490247481; Cvitanovic C, 2010, MAR FRESHWATER RES, V61, P999, DOI 10.1071/MF09168; Daw TM, 2011, COAST MANAGE, V39, P412, DOI 10.1080/08920753.2011.589224; Fernandes L, 2005, CONSERV BIOL, V19, P1733, DOI 10.1111/j.1523-1739.2005.00302.x; Froese R., 2012, FISHBASE; Gaines SD, 2010, P NATL ACAD SCI USA, V107, P18251, DOI 10.1073/pnas.1002098107; Glaser M, 2010, MAR POLICY, V34, P1215, DOI 10.1016/j.marpol.2010.04.006; Graham NAJ, 2006, P NATL ACAD SCI USA, V103, P8425, DOI 10.1073/pnas.0600693103; Graham NAJ, 2011, OCEANOGR MAR BIOL, V49, P105; Halpern BS, 2002, ECOL LETT, V5, P361, DOI 10.1046/j.1461-0248.2002.00326.x; Hauck M, 2008, MAR POLICY, V32, P635, DOI 10.1016/j.marpol.2007.11.004; Henry G.T., 1990, PRACTICAL SAMPLING, V21; Hicks CC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036022; Hoey AS, 2011, ECOL LETT, V14, P267, DOI 10.1111/j.1461-0248.2010.01581.x; Hoey AS, 2009, ECOSYSTEMS, V12, P1316, DOI 10.1007/s10021-009-9291-z; Hughes TP, 2010, TRENDS ECOL EVOL, V25, P633, DOI 10.1016/j.tree.2010.07.011; Hughes TP, 2005, TRENDS ECOL EVOL, V20, P380, DOI 10.1016/j.tree.2005.03.022; Hughes TP, 2003, SCIENCE, V301, P929, DOI 10.1126/science.1085046; Jackson JBC, 2001, SCIENCE, V293, P629, DOI 10.1126/science.1059199; Jennings S, 1996, J APPL ECOL, V33, P400, DOI 10.2307/2404761; LUCKHURST BE, 1978, MAR BIOL, V49, P317, DOI 10.1007/BF00455026; Mangubhai S., 2011, J MAR BIOL, P1, DOI DOI 10.1155/2011/501465; MARNANE MJ, 2004, CORAL REEF SURVEYS 2; McClanahan T, 2005, ENVIRON CONSERV, V32, P42, DOI 10.1017/S0376892904001791; McClanahan TR, 2008, CONSERV LETT, V1, P53, DOI 10.1111/j.1755-263X.2008.00008_1.x; McClanahan TR, 2007, ECOL APPL, V17, P1055, DOI 10.1890/06-1450; McClanahan TR, 2009, MAR ECOL PROG SER, V396, P99, DOI 10.3354/meps08279; McClanahan TR, 2006, CURR BIOL, V16, P1408, DOI 10.1016/j.cub.2006.05.062; McClanahan TR, 2006, AQUAT CONSERV, V16, P147, DOI 10.1002/aqc.715; MCCLANAHAN TR, 1994, CORAL REEFS, V13, P231, DOI 10.1007/BF00303637; Mumby PJ, 2008, TRENDS ECOL EVOL, V23, P555, DOI 10.1016/j.tree.2008.06.011; Murray SN, 1999, FISHERIES, V24, P11, DOI 10.1577/1548-8446(1999)024&lt;0011:NRN&gt;2.0.CO;2; Patlis JM, 2005, OCEAN COAST MANAGE, V48, P450, DOI 10.1016/j.ocecoaman.2005.04.005; Pet-Soede C, 1999, ENVIRON CONSERV, V26, P83, DOI 10.1017/S0376892999000132; Pet-Soede L., 1998, SPC LIVE REEF FISH I, V4, P28; Pollnac R, 2010, P NATL ACAD SCI USA, V107, P18262, DOI 10.1073/pnas.0908266107; RANDALL JE, 1965, ECOLOGY, V46, P255, DOI 10.2307/1936328; Russ GR, 2008, CURR BIOL, V18, pR514, DOI 10.1016/j.cub.2008.04.016; Syakur A, 2012, ORYX, V46, P516, DOI 10.1017/S0030605312000166; Weeks R, 2010, CONSERV BIOL, V24, P531, DOI 10.1111/j.1523-1739.2009.01340.x; Wilkinson C, 2008, STATUS CORAL REEFS W; Wilson C, 2012, ORYX, V46, P495, DOI 10.1017/S0030605312000191; Wismer S, 2009, MAR ECOL PROG SER, V376, P45, DOI 10.3354/meps07790; Wood LJ, 2008, ORYX, V42, P340, DOI 10.1017/S003060530800046X; Worm B, 2009, SCIENCE, V325, P578, DOI 10.1126/science.1173146	61	56	57	1	101	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 30	2012	7	11							e50074	10.1371/journal.pone.0050074	http://dx.doi.org/10.1371/journal.pone.0050074			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	054WM	23226237	Green Published, Green Accepted, Green Submitted, gold			2022-12-27	WOS:000312376100046
J	Garrison, AK; Shanmugam, M; Leung, HC; Xia, CH; Wang, Z; Ma, L				Garrison, Amy K.; Shanmugam, Mahalakshmi; Leung, Haiwen Connie; Xia, Caihong; Wang, Zheng; Ma, Le			Visualization and Analysis of Microtubule Dynamics Using Dual Color-Coded Display of Plus-End Labels	PLOS ONE			English	Article							LIVING CELLS; POLYMERIZATION DYNAMICS; FLUORESCENT PROTEIN; GROWTH; QUANTIFICATION; TRACKING; CYCLE	Investigating spatial and temporal control of microtubule dynamics in live cells is critical to understanding cell morphogenesis in development and disease. Tracking fluorescently labeled plus-end-tracking proteins over time has become a widely used method to study microtubule assembly. Here, we report a complementary approach that uses only two images of these labels to visualize and analyze microtubule dynamics at any given time. Using a simple color-coding scheme, labeled plus-ends from two sequential images are pseudocolored with different colors and then merged to display color-coded ends. Based on object recognition algorithms, these colored ends can be identified and segregated into dynamic groups corresponding to four events, including growth, rescue, catastrophe, and pause. Further analysis yields not only their spatial distribution throughout the cell but also provides measurements such as growth rate and direction for each labeled end. We have validated the method by comparing our results with ground-truth data derived from manual analysis as well as with data obtained using the tracking method. In addition, we have confirmed color-coded representation of different dynamic events by analyzing their history and fate. Finally, we have demonstrated the use of the method to investigate microtubule assembly in cells and provided guidance in selecting optimal image acquisition conditions. Thus, this simple computer vision method offers a unique and quantitative approach to study spatial regulation of microtubule dynamics in cells.	[Garrison, Amy K.; Shanmugam, Mahalakshmi; Leung, Haiwen Connie; Xia, Caihong; Wang, Zheng; Ma, Le] Univ So Calif, Keck Sch Med, Zilkha Neurogenet Inst, Los Angeles, CA 90033 USA; [Garrison, Amy K.; Ma, Le] Univ So Calif, Keck Sch Med, Program Genet Mol & Cellular Biol, Los Angeles, CA 90033 USA; [Ma, Le] Univ So Calif, Keck Sch Med, Dept Cell & Neurobiol, Los Angeles, CA 90033 USA	University of Southern California; University of Southern California; University of Southern California	Ma, L (corresponding author), Univ So Calif, Keck Sch Med, Zilkha Neurogenet Inst, Los Angeles, CA 90033 USA.	le.ma@usc.edu	Ma, Le/A-3733-2013	Paterson, Amy/0000-0002-5213-0638; Ma, Le/0000-0003-2769-9416; Wang, Zheng/0000-0001-7678-0072	National Institutes of Health [R01NS062047]; Whitehall Foundation [2007-08-104]; James H. Zumberge Research and Innovation Fund from University of Southern California; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS062047] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Whitehall Foundation; James H. Zumberge Research and Innovation Fund from University of Southern California; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by grants from the National Institutes of Health (http://www.ninds.nih.gov/; R01NS062047), the Whitehall Foundation (http://www.whitehall.org/; #2007-08-104), and the James H. Zumberge Research and Innovation Fund from University of Southern California (http://research.usc.edu/for-investigators/funding/usc/zumberge/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akhmanova A, 2008, NAT REV MOL CELL BIO, V9, P309, DOI 10.1038/nrm2369; Applegate KT, 2011, J STRUCT BIOL, V176, P168, DOI 10.1016/j.jsb.2011.07.009; Dent EW, 2010, COLD SPRING HARBOR P, V3; Desai A, 1997, ANNU REV CELL DEV BI, V13, P83, DOI 10.1146/annurev.cellbio.13.1.83; Efimov A, 2008, J CELL SCI, V121, P196, DOI 10.1242/jcs.012666; Galjart N, 2010, CURR BIOL, V20, pR528, DOI 10.1016/j.cub.2010.05.022; Gierke S, 2010, METHOD CELL BIOL, V97, P15, DOI 10.1016/S0091-679X(10)97002-7; Grabham PW, 2007, J NEUROSCI, V27, P5823, DOI 10.1523/JNEUROSCI.1135-07.2007; Hoogenraad CC, 2002, NAT GENET, V32, P331, DOI 10.1038/ng1002-331c; Howard J, 2003, NATURE, V422, P753, DOI 10.1038/nature01600; Kaverina I, 2011, SEMIN CELL DEV BIOL, V22, P968, DOI 10.1016/j.semcdb.2011.09.017; Komarova YA, 2002, J CELL SCI, V115, P3527; Matov A, 2010, NAT METHODS, V7, P761, DOI 10.1038/nmeth.1493; Mimori-Kiyosue Y, 2005, J CELL BIOL, V168, P141, DOI 10.1083/jcb.200405094; MITCHISON TJ, 1988, ANNU REV CELL BIOL, V4, P527, DOI 10.1146/annurev.cellbio.4.1.527; Neukirchen D, 2011, J NEUROSCI, V31, P1528, DOI 10.1523/JNEUROSCI.3983-10.2011; Rusan NM, 2001, MOL BIOL CELL, V12, P971, DOI 10.1091/mbc.12.4.971; Salaycik KJ, 2005, J CELL SCI, V118, P4113, DOI 10.1242/jcs.02531; SAMMAK PJ, 1988, NATURE, V332, P724, DOI 10.1038/332724a0; SCHULZE E, 1988, NATURE, V334, P356, DOI 10.1038/334356a0; SHELDEN E, 1993, J CELL BIOL, V120, P935, DOI 10.1083/jcb.120.4.935; Small JV, 2003, CURR OPIN CELL BIOL, V15, P40, DOI 10.1016/S0955-0674(02)00008-X; Stepanova T, 2003, J NEUROSCI, V23, P2655; Straube A, 2011, METHODS MOL BIOL, V777, P1, DOI 10.1007/978-1-61779-252-6_1; Waterman-Storer CM, 1998, CURR BIOL, V8, P1227, DOI 10.1016/S0960-9822(07)00515-5	25	9	10	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 30	2012	7	11							e50421	10.1371/journal.pone.0050421	http://dx.doi.org/10.1371/journal.pone.0050421			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	054WM	23226282	Green Published, gold, Green Submitted			2022-12-27	WOS:000312376100094
J	Hernandez, JM; Siegel, EM; Riggs, B; Eschrich, S; Elahi, A; Qu, XT; Ajidahun, A; Berglund, A; Coppola, D; Grady, WM; Giuliano, AR; Shibata, D				Hernandez, Jonathan M.; Siegel, Erin M.; Riggs, Bridget; Eschrich, Steven; Elahi, Abul; Qu, Xiaotao; Ajidahun, Abidemi; Berglund, Anders; Coppola, Domenico; Grady, William M.; Giuliano, Anna R.; Shibata, David			DNA Methylation Profiling across the Spectrum of HPV-Associated Anal Squamous Neoplasia	PLOS ONE			English	Article							PAPILLOMAVIRUS TYPE-16 E6; TUMOR-SUPPRESSOR GENES; RECEPTOR GENES; CELL CARCINOMA; PROMOTER HYPERMETHYLATION; REGULATES EXPRESSION; CERVICAL CARCINOMAS; MEDIATED APOPTOSIS; VIRAL INTEGRATION; E7 PROTEINS	Background: Changes in host tumor genome DNA methylation patterns are among the molecular alterations associated with HPV-related carcinogenesis. However, there is little known about the epigenetic changes associated specifically with the development of anal squamous cell cancer (SCC). We sought to characterize broad methylation profiles across the spectrum of anal squamous neoplasia. Methodology/ Principal Findings: Twenty-nine formalin-fixed paraffin embedded samples from 24 patients were evaluated and included adjacent histologically normal anal mucosa (NM; n = 3), SCC-in situ (SCC-IS; n = 11) and invasive SCC (n = 15). Thirteen women and 11 men with a median age of 44 years (range 26-81) were included in the study. Using the SFP10 LiPA HPV-typing system, HPV was detected in at least one tissue from all patients with 93% (27/29) being positive for high-risk HPV types and 14 (93%) of 15 invasive SCC tissues testing positive for HPV 16. Bisulfite-modified DNA was interrogated for methylation at 1,505 CpG loci representing 807 genes using the Illumina GoldenGate Methylation Array. When comparing the progression from normal anal mucosa and SCC-IS to invasive SCC, 22 CpG loci representing 20 genes demonstrated significant differential methylation (p<0.01). The majority of differentially methylated gene targets occurred at or close to specific chromosomal locations such as previously described HPV methylation "hotspots" and viral integration sites. Conclusions: We have identified a panel of differentially methlylated CpG loci across the spectrum of HPV-associated squamous neoplasia of the anus. To our knowledge, this is the first reported application of large-scale high throughput methylation analysis for the study of anal neoplasia. Our findings support further investigations into the role of host-genome methylation in HPV-associated anal carcinogenesis with implications towards enhanced diagnosis and screening strategies.	[Hernandez, Jonathan M.; Elahi, Abul; Ajidahun, Abidemi; Shibata, David] Univ S Florida, Coll Med, H Lee Moffitt Canc Ctr & Res Inst, Dept Gastrointestinal Oncol, Tampa, FL 33612 USA; [Siegel, Erin M.; Riggs, Bridget; Giuliano, Anna R.] Univ S Florida, Coll Med, H Lee Moffitt Canc Ctr & Res Inst, Dept Canc Epidemiol, Tampa, FL 33612 USA; [Eschrich, Steven; Qu, Xiaotao; Berglund, Anders] Univ S Florida, Coll Med, H Lee Moffitt Canc Ctr & Res Inst, Dept Biomed Informat, Tampa, FL 33612 USA; [Coppola, Domenico] Univ S Florida, Coll Med, H Lee Moffitt Canc Ctr & Res Inst, Dept Anat Pathol, Tampa, FL 33612 USA; [Grady, William M.] Univ Washington, Div Gastroenterol, Seattle, WA 98195 USA; [Grady, William M.] Fred Hutchinson Canc Res Ctr, Div Clin Res, Seattle, WA 98104 USA	H Lee Moffitt Cancer Center & Research Institute; State University System of Florida; University of South Florida; H Lee Moffitt Cancer Center & Research Institute; State University System of Florida; University of South Florida; H Lee Moffitt Cancer Center & Research Institute; State University System of Florida; University of South Florida; H Lee Moffitt Cancer Center & Research Institute; State University System of Florida; University of South Florida; University of Washington; University of Washington Seattle; Fred Hutchinson Cancer Center	Shibata, D (corresponding author), Univ S Florida, Coll Med, H Lee Moffitt Canc Ctr & Res Inst, Dept Gastrointestinal Oncol, Tampa, FL 33612 USA.	david.shibata@moffitt.org	Eschrich, Steven/K-6848-2013	Eschrich, Steven/0000-0002-9833-2788; Berglund, Anders/0000-0002-0393-3530	NCI NIH HHS [P30 CA015704, P30 CA076292] Funding Source: Medline; NATIONAL CANCER INSTITUTE [P30CA015704, P30CA076292] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		American Cancer Society, 2012, CANCER FACTS FIGURES; Archey WB, 1999, CANCER RES, V59, P2292; Avvakumov N, 2003, ONCOGENE, V22, P3833, DOI 10.1038/sj.onc.1206562; Badaracco G, 2002, J MED VIROL, V67, P574, DOI 10.1002/jmv.10141; Bibikova M, 2006, GENOME RES, V16, P383, DOI 10.1101/gr.4410706; Brauer PM, 2009, CELL CYCLE, V8, P2728, DOI 10.4161/cc.8.17.9389; Bryan JT, 2000, VIROLOGY, V277, P262, DOI 10.1006/viro.2000.0599; Burgers WA, 2007, ONCOGENE, V26, P1650, DOI 10.1038/sj.onc.1209950; CANCE WG, 1994, CELL GROWTH DIFFER, V5, P1347; Chen LM, 2009, BMC CANCER, V9, DOI 10.1186/1471-2407-9-377; Chung KP, 2010, BMC HEALTH SERV RES, V10, DOI 10.1186/1472-6963-10-27; Cillo C, 2001, J CELL PHYSIOL, V188, P161, DOI 10.1002/jcp.1115; COCCHI F, 1995, SCIENCE, V270, P1811, DOI 10.1126/science.270.5243.1811; COOK DN, 1995, SCIENCE, V269, P1583, DOI 10.1126/science.7667639; CRAVEN RJ, 1995, CANCER RES, V55, P3969; Darragh TM, 2011, CANCER CYTOPATHOL, V119, P5, DOI 10.1002/cncy.20126; De Bruyne E, 2008, CLIN CANCER RES, V14, P2918, DOI 10.1158/1078-0432.CCR-07-4489; Duenas-Gonzalez A, 2005, MOL CANCER, V4, DOI 10.1186/1476-4598-4-38; Elder JT, 2002, EXP DERMATOL, V11, P406, DOI 10.1034/j.1600-0625.2002.110503.x; Eng C, 2006, CANCER INVEST, V24, P535, DOI 10.1080/07357900600815208; Farrell AW, 2010, BBA-GEN SUBJECTS, V1800, P1173, DOI 10.1016/j.bbagen.2010.07.001; Feng QH, 2005, JNCI-J NATL CANCER I, V97, P273, DOI 10.1093/jnci/dji041; Fenger C, 2000, VIRCHOWS ARCH, V436, P229, DOI 10.1007/s004280050035; Fernandez-Fernandez MR, 2008, PROTEIN SCI, V17, P1663, DOI 10.1110/ps.035527.108; Flatley JE, 2009, CANCER EPIDEM BIOMAR, V18, P2782, DOI 10.1158/1055-9965.EPI-09-0493; Gervaz P, 2004, J GASTROINTEST SURG, V8, P1024, DOI 10.1016/j.gassur.2004.08.013; Gordon-Alonso M, 2006, J IMMUNOL, V177, P5129, DOI 10.4049/jimmunol.177.8.5129; Gorodeski GI, 2009, EXPERT OPIN THER TAR, V13, P1313, DOI 10.1517/14728220903277249; Grulich AE, 2010, SEX HEALTH, V7, P244, DOI 10.1071/SH10020; Healey MA, 2010, EPIGENETICS-US, V5, P410, DOI 10.4161/epi.5.5.11929; Hernandez A, 2005, THYROID, V15, P865, DOI 10.1089/thy.2005.15.865; Hogart A, 2007, HUM MOL GENET, V16, P691, DOI 10.1093/hmg/ddm014; Howlader N, 2012, SEER CANCER STATISTI; Huang MP, 2011, THYROID, V21, P1263, DOI 10.1089/thy.2011.0105; Iliopoulos D, 2009, ONCOL REP, V22, P199, DOI 10.3892/or_00000425; Illingworth RS, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001134; Inter-Agency Standing Commitee (IASC), 2007, IASC GUID MENT HLTH, DOI [10.1037/e518422011-002, DOI 10.1037/E518422011-002]; Jones PA, 2002, NAT REV GENET, V3, P415, DOI 10.1038/nrg816; Kathpalia VP, 2006, J DERMATOL, V33, P309, DOI 10.1111/j.1346-8138.2006.00075.x; Kim DS, 2009, MOL CARCINOGEN, V48, P1109, DOI 10.1002/mc.20561; Kim J, 2012, EPIGENETICS-US, V7, P191, DOI 10.4161/epi.7.2.18973; Kim JH, 2010, GYNECOL ONCOL, V116, P99, DOI 10.1016/j.ygyno.2009.09.032; Kraus I, 2008, CANCER RES, V68, P2514, DOI 10.1158/0008-5472.CAN-07-2776; Kurita S, 2010, CANCER SCI, V101, P1431, DOI 10.1111/j.1349-7006.2010.01565.x; Kuzmin I, 2003, CANCER RES, V63, P1888; Lai HC, 2007, GYNECOL ONCOL, V104, P629, DOI 10.1016/j.ygyno.2006.10.003; Laurson J, 2010, CARCINOGENESIS, V31, P918, DOI 10.1093/carcin/bgq027; Leonard SM, 2012, CARCINOGENESIS, V33, P1286, DOI 10.1093/carcin/bgs157; Leung KT, 2011, BLOOD, V117, P1840, DOI 10.1182/blood-2010-04-281329; Leyvraz C, 2005, J CELL BIOL, V170, P487, DOI 10.1083/jcb.200501038; Li JK, 2011, INT J GYNECOL CANCER, V21, P1276, DOI 10.1097/IGC.0b013e31821f7452; Li LC, 2002, BIOINFORMATICS, V18, P1427, DOI 10.1093/bioinformatics/18.11.1427; Li PX, 2008, MOL CELL BIOL, V28, P4745, DOI 10.1128/MCB.01747-07; Lin TS, 2005, CANCER LETT, V226, P77, DOI 10.1016/j.canlet.2004.12.031; Liu GY, 2006, APOPTOSIS, V11, P183, DOI 10.1007/s10495-006-3715-4; Martin-Subero JI, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006986; Matovina M, 2009, GYNECOL ONCOL, V113, P120, DOI 10.1016/j.ygyno.2008.12.004; McIntosh PB, 2010, J CELL SCI, V123, P2810, DOI 10.1242/jcs.061978; McRonald FE, 2009, MOL CANCER, V8, DOI 10.1186/1476-4598-8-31; Milani L, 2010, BLOOD, V115, P1214, DOI 10.1182/blood-2009-04-214668; MULLINK H, 1991, AM J DERMATOPATH, V13, P530, DOI 10.1097/00000372-199113060-00002; Murvai M, 2004, ARCH VIROL, V149, P2379, DOI 10.1007/s00705-004-0376-x; Nair PN, 2007, CANCER GENET CYTOGEN, V174, P100, DOI 10.1016/j.cancergencyto.2006.11.017; Narayan Gopeshwar, 2003, Mol Cancer, V2, P24, DOI 10.1186/1476-4598-2-24; Nees M, 2000, CANCER RES, V60, P4289; NOFFSINGER A, 1992, CANCER-AM CANCER SOC, V70, P1276, DOI 10.1002/1097-0142(19920901)70:3+<1276::AID-CNCR2820701514>3.0.CO;2-B; Ohlschlager P, 2009, INT J CANCER, V125, P189, DOI 10.1002/ijc.24333; Orellano EA, 2010, MOL CELL BIOCHEM, V337, P83, DOI 10.1007/s11010-009-0288-x; Peter M, 2006, ONCOGENE, V25, P5985, DOI 10.1038/sj.onc.1209625; Philibert RA, 2012, J LEUKOCYTE BIOL, V92, P621, DOI 10.1189/jlb.1211632; Pratt ZL, 2012, J VIROL, V86, P4380, DOI 10.1128/JVI.06966-11; Quentmeier H, 2012, BMC CANCER, V12, DOI 10.1186/1471-2407-12-19; Raman V, 2000, NATURE, V405, P974, DOI 10.1038/35016125; Raman V, 2000, J BIOL CHEM, V275, P26551, DOI 10.1074/jbc.C000324200; Raveh T, 2001, NAT CELL BIOL, V3, P1, DOI 10.1038/35050500; Rayess H, 2012, INT J CANCER, V130, P1715, DOI 10.1002/ijc.27316; Rehman I, 2005, PROSTATE, V65, P322, DOI 10.1002/pros.20302; Schiffman Mark, 2009, Infect Agent Cancer, V4, P8, DOI 10.1186/1750-9378-4-8; Scholefield JH, 2011, COLORECTAL DIS, V13, P3, DOI 10.1111/j.1463-1318.2010.02494.x; Schulze-Lohoff E, 1998, AM J PHYSIOL-RENAL, V275, pF962, DOI 10.1152/ajprenal.1998.275.6.F962; Sharma PL, 2012, VIRAL IMMUNOL, V25, P12, DOI 10.1089/vim.2011.0057; Shivapurkar N, 2004, INT J CANCER, V109, P786, DOI 10.1002/ijc.20041; Sobhani I, 2004, AIDS, V18, P1561, DOI 10.1097/01.aids.0000131335.15301.dd; Strathdee G, 2007, CLIN CANCER RES, V13, P5048, DOI 10.1158/1078-0432.CCR-07-0919; Tan S, 2012, MOL PHARMACOL, V81, P701, DOI 10.1124/mol.111.076539; Tanikawa C, 2009, CANCER RES, V69, P8761, DOI 10.1158/0008-5472.CAN-09-2280; Tseng CW, 2008, VACCINE, V26, P4314, DOI 10.1016/j.vaccine.2008.06.049; Turan T, 2006, VIROLOGY, V349, P175, DOI 10.1016/j.virol.2005.12.033; Vogler M, 2012, CELL DEATH DIFFER, V19, P67, DOI 10.1038/cdd.2011.158; Walker J, 2011, VIROLOGY, V410, P283, DOI 10.1016/j.virol.2010.11.010; Wang W, 2011, APOPTOSIS, V16, P55, DOI 10.1007/s10495-010-0543-3; Wentzensen N, 2004, CANCER RES, V64, P3878, DOI 10.1158/0008-5472.CAN-04-0009; Whiteside MA, 2008, CANCER-AM CANCER SOC, V113, P2981, DOI 10.1002/cncr.23750; Wong AK, 2010, MODERN PATHOL, V23, P144, DOI 10.1038/modpathol.2009.143; Wong M, 1998, J BIOL CHEM, V273, P309, DOI 10.1074/jbc.273.1.309; Yang N, 2010, CELL ONCOL, V32, P131, DOI 10.3233/CLO-2009-0510; Yasmeen A, 2007, CELL CYCLE, V6, P2038, DOI 10.4161/cc.6.16.4555; Yu TX, 2005, CANCER GENET CYTOGEN, V158, P27, DOI 10.1016/j.cancergencyto.2004.08.021; Yu WP, 2008, CELL PROLIFERAT, V41, P86, DOI 10.1111/j.1365-2184.2007.00499.x; Zhang J, 2005, CLIN CANCER RES, V11, P6544, DOI 10.1158/1078-0432.CCR-05-0374; Zhang P, 2010, J BIOL CHEM, V285, P8953, DOI 10.1074/jbc.M109.070680; Zhang S, 2012, HEPATOLOGY; Zhong S, 2007, ONCOGENE, V26, P2621, DOI 10.1038/sj.onc.1210041; Zucchini C, 2007, INT J BIOL MARKER, V22, P39, DOI 10.1177/172460080702200106	104	16	16	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 30	2012	7	11							e50533	10.1371/journal.pone.0050533	http://dx.doi.org/10.1371/journal.pone.0050533			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	054WM	23226306	Green Published, Green Submitted, gold			2022-12-27	WOS:000312376100118
J	Korbes, AP; Machado, RD; Guzman, F; Almerao, MP; de Oliveira, LFV; Loss-Morais, G; Turchetto-Zolet, AC; Cagliari, A; Maraschin, FD; Margis-Pinheiro, M; Margis, R				Koerbes, Ana Paula; Machado, Ronei Dorneles; Guzman, Frank; Almerao, Mauricio Pereira; Valter de Oliveira, Luiz Felipe; Loss-Morais, Guilherme; Turchetto-Zolet, Andreia Carina; Cagliari, Alexandro; Maraschin, Felipe dos Santos; Margis-Pinheiro, Marcia; Margis, Rogerio			Identifying Conserved and Novel MicroRNAs in Developing Seeds of Brassica napus Using Deep Sequencing	PLOS ONE			English	Article							DIFFERENTIAL EXPRESSION ANALYSIS; SMALL RNAS; GENE-EXPRESSION; COMPUTATIONAL IDENTIFICATION; ARABIDOPSIS; BIOGENESIS; TARGETS; MIRNAS; STRESS; DEFICIENCY	MicroRNAs (miRNAs) are important post-transcriptional regulators of plant development and seed formation. In Brassica napus, an important edible oil crop, valuable lipids are synthesized and stored in specific seed tissues during embryogenesis. The miRNA transcriptome of B. napus is currently poorly characterized, especially at different seed developmental stages. This work aims to describe the miRNAome of developing seeds of B. napus by identifying plant-conserved and novel miRNAs and comparing miRNA abundance in mature versus developing seeds. Members of 59 miRNA families were detected through a computational analysis of a large number of reads obtained from deep sequencing two small RNA and two RNA-seq libraries of (i) pooled immature developing stages and (ii) mature B. napus seeds. Among these miRNA families, 17 families are currently known to exist in B. napus; additionally 29 families not reported in B. napus but conserved in other plant species were identified by alignment with known plant mature miRNAs. Assembled mRNA-seq contigs allowed for a search of putative new precursors and led to the identification of 13 novel miRNA families. Analysis of miRNA population between libraries reveals that several miRNAs and isomiRNAs have different abundance in developing stages compared to mature seeds. The predicted miRNA target genes encode a broad range of proteins related to seed development and energy storage. This work presents a comparative study of the miRNA transcriptome of mature and developing B. napus seeds and provides a basis for future research on individual miRNAs and their functions in embryogenesis, seed maturation and lipid accumulation in B. napus.	[Koerbes, Ana Paula; Guzman, Frank; Valter de Oliveira, Luiz Felipe; Turchetto-Zolet, Andreia Carina; Cagliari, Alexandro; Maraschin, Felipe dos Santos; Margis-Pinheiro, Marcia; Margis, Rogerio] Univ Fed Rio Grande do Sul, PPGGBM, Dept Genet, Porto Alegre, RS, Brazil; [Koerbes, Ana Paula; Machado, Ronei Dorneles; Almerao, Mauricio Pereira; Loss-Morais, Guilherme; Turchetto-Zolet, Andreia Carina; Margis-Pinheiro, Marcia; Margis, Rogerio] Univ Fed Rio Grande do Sul, PPGBCM, Ctr Biotecnol, Porto Alegre, RS, Brazil; [Maraschin, Felipe dos Santos] Univ Fed Rio Grande do Sul, Dept Bot, Porto Alegre, RS, Brazil; [Margis, Rogerio] Univ Fed Rio Grande do Sul, Dept Biofis, Porto Alegre, RS, Brazil	Universidade Federal do Rio Grande do Sul; Universidade Federal do Rio Grande do Sul; Universidade Federal do Rio Grande do Sul; Universidade Federal do Rio Grande do Sul	Margis, R (corresponding author), Univ Fed Rio Grande do Sul, PPGGBM, Dept Genet, Porto Alegre, RS, Brazil.	rogerio.margis@ufrgs.br	Almerão, Mauricio/AAF-7961-2019; Guzman, Fanny fg/K-5592-2013; de Oliveira, Luiz Felipe Valter/C-6850-2008; Almerão, Mauricio P/I-3312-2012; Guzman, Frank L/H-1271-2014; Margis, Rogerio/A-7230-2008; Cagliari, Alexandro/B-6060-2015; Margis-Pinheiro, Marcia/K-3064-2013; Morais, Guilherme/M-9853-2013; Cagliari, Alexandro/S-7353-2019; Zolet, Andreia Carina Turchetto/G-6288-2012; Maraschin, Felipe/K-9680-2015	Guzman, Fanny fg/0000-0003-1537-0904; de Oliveira, Luiz Felipe Valter/0000-0003-4535-0621; Guzman, Frank L/0000-0002-5048-4213; Margis, Rogerio/0000-0002-2871-4473; Cagliari, Alexandro/0000-0001-6549-8477; Margis-Pinheiro, Marcia/0000-0001-5356-3497; Maraschin, Felipe/0000-0003-1138-2473; Turchetto Zolet, Andreia Carina/0000-0002-7365-1360	CAPES; CNPq; CNPq-Universal [472575/2011-2]; Genoprot-CNPq-MCT [559636/2009-1]; Agroestruturante-FAPERGS-FINEP	CAPES(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); CNPq-Universal(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Genoprot-CNPq-MCT; Agroestruturante-FAPERGS-FINEP	This work was supported by CAPES, CNPq, CNPq-Universal 472575/2011-2, Genoprot-CNPq-MCT 559636/2009-1, Agroestruturante-FAPERGS-FINEP. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Appelqvist L.-A., 1972, Rapeseed: cultivation, composition, processing and utilization., P123; Audic S, 1997, GENOME RES, V7, P986, DOI 10.1101/gr.7.10.986; Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Buhtz A, 2008, PLANT J, V53, P739, DOI 10.1111/j.1365-313X.2007.03368.x; Buhtz A, 2010, BMC PLANT BIOL, V10, DOI 10.1186/1471-2229-10-64; Chen XM, 2004, SCIENCE, V303, P2022, DOI 10.1126/science.1088060; Conesa Ana, 2008, Int J Plant Genomics, V2008, P619832, DOI 10.1155/2008/619832; Dai XB, 2011, NUCLEIC ACIDS RES, V39, pW155, DOI 10.1093/nar/gkr319; De Paola D, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-41; Debernardi JM, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002419; Fahlgren N, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000219; Fahlgren N, 2010, PLANT CELL, V22, P1074, DOI 10.1105/tpc.110.073999; Filipowicz W, 2008, NAT REV GENET, V9, P102, DOI 10.1038/nrg2290; Griffiths-Jones S, 2008, NUCLEIC ACIDS RES, V36, pD154, DOI 10.1093/nar/gkm952; He L, 2004, NAT REV GENET, V5, P522, DOI 10.1038/nrg1379; He SM, 2008, NUCLEIC ACIDS RES, V36, pD170, DOI 10.1093/nar/gkm1011; He YQ, 2009, J INTEGR PLANT BIOL, V51, P792, DOI 10.1111/j.1744-7909.2009.00851.x; Hsieh LC, 2009, PLANT PHYSIOL, V151, P2120, DOI 10.1104/pp.109.147280; Huang SQ, 2010, PLANT BIOTECHNOL J, V8, P887, DOI 10.1111/j.1467-7652.2010.00517.x; Huijser P, 2011, DEVELOPMENT, V138, P4117, DOI 10.1242/dev.063511; Huntzinger E, 2011, NAT REV GENET, V12, P99, DOI 10.1038/nrg2936; Jones-Rhoades MW, 2006, ANNU REV PLANT BIOL, V57, P19, DOI 10.1146/annurev.arplant.57.032905.105218; Jones-Rhoades MW, 2004, MOL CELL, V14, P787, DOI 10.1016/j.molcel.2004.05.027; Juhling F, 2009, NUCLEIC ACIDS RES, V37, pD159, DOI 10.1093/nar/gkn772; Kulcheski FR, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-307; Kurihara Y, 2004, P NATL ACAD SCI USA, V101, P12753, DOI 10.1073/pnas.0403115101; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Lauter N, 2005, P NATL ACAD SCI USA, V102, P9412, DOI 10.1073/pnas.0503927102; Lee Y, 2004, EMBO J, V23, P4051, DOI 10.1038/sj.emboj.7600385; Lelandais-Briere C, 2009, PLANT CELL, V21, P2780, DOI 10.1105/tpc.109.068130; Lenz Dorina, 2011, BMC Res Notes, V4, P483, DOI 10.1186/1756-0500-4-483; Li RQ, 2009, BIOINFORMATICS, V25, P1966, DOI 10.1093/bioinformatics/btp336; Li Y, 2010, PLANT PHYSIOL, V152, P2222, DOI 10.1104/pp.109.151803; Linsen SEV, 2009, NAT METHODS, V6, P474, DOI 10.1038/nmeth0709-474; Llave C, 2002, SCIENCE, V297, P2053, DOI 10.1126/science.1076311; Mallory AC, 2004, CURR BIOL, V14, P1035, DOI 10.1016/j.cub.2004.06.022; Mallory AC, 2005, PLANT CELL, V17, P1360, DOI 10.1105/tpc.105.031716; Mallory AC, 2006, NAT GENET, V38, pS31, DOI 10.1038/ng1791; McCormick Kevin P, 2011, Silence, V2, P2, DOI 10.1186/1758-907X-2-2; Mizoi J, 2006, PLANT CELL, V18, P3370, DOI 10.1105/tpc.106.040840; Morin RD, 2008, GENOME RES, V18, P610, DOI 10.1101/gr.7179508; Moxon S, 2008, GENOME RES, V18, P1602, DOI 10.1101/gr.080127.108; Moxon S, 2008, BIOINFORMATICS, V24, P2252, DOI 10.1093/bioinformatics/btn428; Nodine MD, 2010, GENE DEV, V24, P2678, DOI 10.1101/gad.1986710; NORTON G, 1983, PHYTOCHEMISTRY, V22, P2703, DOI 10.1016/S0031-9422(00)97676-3; Pant BD, 2009, PLANT PHYSIOL, V150, P1541, DOI 10.1104/pp.109.139139; Poethig RS, 2009, CURR OPIN GENET DEV, V19, P374, DOI 10.1016/j.gde.2009.06.001; Pruesse E, 2007, NUCLEIC ACIDS RES, V35, P7188, DOI 10.1093/nar/gkm864; Reinhart BJ, 2002, GENE DEV, V16, P1616, DOI 10.1101/gad.1004402; Robinson MD, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-3-r25; Robinson MD, 2010, BIOINFORMATICS, V26, P139, DOI 10.1093/bioinformatics/btp616; Rubio-Somoza I, 2011, TRENDS PLANT SCI, V16, P258, DOI 10.1016/j.tplants.2011.03.001; Schmieder R, 2011, BIOINFORMATICS, V27, P863, DOI 10.1093/bioinformatics/btr026; Schreiber AW, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-129; Subramanian S, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-160; Troncoso-Ponce MA, 2011, PLANT J, V68, P1014, DOI 10.1111/j.1365-313X.2011.04751.x; Voinnet O, 2009, CELL, V136, P669, DOI 10.1016/j.cell.2009.01.046; Wang L, 2007, FEBS LETT, V581, P3848, DOI 10.1016/j.febslet.2007.07.010; Willmann MR, 2011, PLANT PHYSIOL, V155, P1871, DOI 10.1104/pp.110.171355; Xie FL, 2007, FEBS LETT, V581, P1464, DOI 10.1016/j.febslet.2007.02.074; Yu X, 2012, J EXP BOT, V63, P1025, DOI 10.1093/jxb/err337; Zhang BH, 2006, CELL MOL LIFE SCI, V63, P246, DOI 10.1007/s00018-005-5467-7; Zhang ZL, 2011, P NATL ACAD SCI USA, V108, P2160, DOI 10.1073/pnas.1012232108; Zhao YT, 2012, PLANT PHYSIOL, V158, P813, DOI 10.1104/pp.111.187666; Zhu QH, 2008, GENOME RES, V18, P1456, DOI 10.1101/gr.075572.107	66	55	57	0	37	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 30	2012	7	11							e50663	10.1371/journal.pone.0050663	http://dx.doi.org/10.1371/journal.pone.0050663			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	054WM	23226347	gold, Green Published, Green Submitted			2022-12-27	WOS:000312376100158
J	Ng, IC; Wen, TH; Wang, JY; Fang, CT				Ng, In-Chan; Wen, Tzai-Hung; Wang, Jann-Yuan; Fang, Chi-Tai			Spatial Dependency of Tuberculosis Incidence in Taiwan	PLOS ONE			English	Article							MYCOBACTERIUM-TUBERCULOSIS; MOLECULAR EPIDEMIOLOGY; RECENT TRANSMISSION; RISK-FACTORS; HIV; REACTIVATION; NATIONWIDE; INFECTION; DISTRICT	Tuberculosis (TB) disease can be caused by either recent transmission from infectious patients or reactivation of remote latent infection. Spatial dependency (correlation between nearby geographic areas) in tuberculosis incidence is a signature for chains of recent transmission with geographic diffusion. To understand the contribution of recent transmission in the TB endemic in Taiwan, where reactivation has been assumed to be the predominant mode of pathogenesis, we used spatial regression analysis to examine whether there was spatial dependency between the TB incidence in each township and in its neighbors. A total of 90,661 TB cases from 349 townships in 2003-2008 were included in this analysis. After adjusting for the effects of confounding socioeconomic variables, including the percentages of aboriginals and average household income, the results show that the spatial lag parameter remains positively significant (0.43, p < 0.001), which indicates that the TB incidences of neighboring townships had an effect on the TB incidence in each township. Townships with substantial spatial spillover effects were mainly located in the northern, western and eastern parts of Taiwan. Spatial dependency implies that recent transmission plays a significant role in the pathogenesis of TB in Taiwan. Therefore, in addition to the current focus on improving the cure rate under directly observed therapy programs, more resource need to be allocated to active case finding in order to break the chain of transmission.	[Wen, Tzai-Hung] Natl Taiwan Univ, Coll Sci, Dept Geog, Taipei 10764, Taiwan; [Ng, In-Chan; Fang, Chi-Tai] Natl Taiwan Univ, Coll Publ Hlth, Inst Epidemiol & Prevent Med, Taipei 10764, Taiwan; [Wang, Jann-Yuan; Fang, Chi-Tai] Natl Taiwan Univ Hosp, Dept Internal Med, Taipei 100, Taiwan	National Taiwan University; National Taiwan University; National Taiwan University; National Taiwan University Hospital	Wen, TH (corresponding author), Natl Taiwan Univ, Coll Sci, Dept Geog, Taipei 10764, Taiwan.	wenthung@ntu.edu.tw; fangct@ntu.edu.tw	Wen, Tzai-Hung/H-2635-2018; Fang, Chi-Tai/P-2908-2016	Wen, Tzai-Hung/0000-0002-9151-8336; Fang, Chi-Tai/0000-0002-7380-1699; WANG, JANN-YUAN/0000-0003-3406-366X	National Taiwan University; Infectious Diseases Research and Education Center, Department of Health	National Taiwan University(National Taiwan University); Infectious Diseases Research and Education Center, Department of Health	The authors acknowledge the financial support provided by the Infectious Diseases Research and Education Center, Department of Health and the National Taiwan University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALLAND D, 1994, NEW ENGL J MED, V330, P1710, DOI 10.1056/NEJM199406163302403; Allen R. G., 1998, FAO Irrigation and Drainage Paper; Anselin L, 2003, INT REGIONAL SCI REV, V26, P153, DOI 10.1177/0160017602250972; Anselin L, GEODA 0 9 5 I GEODA; Bauer J, 1998, J CLIN MICROBIOL, V36, P305, DOI 10.1128/JCM.36.1.305-308.1998; Bishai WR, 1998, JAMA-J AM MED ASSOC, V280, P1679, DOI 10.1001/jama.280.19.1679; Chen TC, 2010, JPN J INFECT DIS, V63, P199; Corbett EL, 2003, ARCH INTERN MED, V163, P1009, DOI 10.1001/archinte.163.9.1009; Dou HY, 2008, BMC INFECT DIS, V8, DOI 10.1186/1471-2334-8-170; Figueroa-Munoz JI, 2008, B WORLD HEALTH ORGAN, V86, P733, DOI 10.2471/BLT.06.038737; Glynn JR, 2005, J INFECT DIS, V192, P480, DOI 10.1086/431517; Godfrey-Faussett P, 2000, LANCET, V356, P1066, DOI 10.1016/S0140-6736(00)02730-6; Horsburgh CR, 2010, AM J RESP CRIT CARE, V182, P420, DOI 10.1164/rccm.200909-1355OC; Horsburgh CR, 2004, NEW ENGL J MED, V350, P2060, DOI 10.1056/NEJMsa031667; Houben RMGJ, 2009, T ROY SOC TROP MED H, V103, P1187, DOI 10.1016/j.trstmh.2009.03.013; Hsu AH, 2010, INT J TUBERC LUNG D, V14, P924; Huang WL, 2007, J FORMOS MED ASSOC, V106, P520, DOI 10.1016/S0929-6646(07)60002-3; JOHNSON IL, 1985, CAN MED ASSOC J, V133, P1221; Ko Ying-Chin, 1994, Kaohsiung Journal of Medical Sciences, V10, P352; Ko Ying-Chin, 1994, Kaohsiung Journal of Medical Sciences, V10, P337; Moonan PK, 2012, EMERG INFECT DIS, V18, P458, DOI 10.3201/eid1803.111107; MORAN PAP, 1950, BIOMETRIKA, V37, P17, DOI 10.1093/biomet/37.1-2.17; Nava-Aguilera E, 2009, INT J TUBERC LUNG D, V13, P17; SMALL PM, 1994, NEW ENGL J MED, V330, P1703, DOI 10.1056/NEJM199406163302402; van Soolingen D, 1999, J INFECT DIS, V180, P726, DOI 10.1086/314930; Verver S, 2004, INT J EPIDEMIOL, V33, P351, DOI 10.1093/ije/dyh021; Waaler HT, 2002, INT J TUBERC LUNG D, V6, P745; Wang JY, 2007, J INFECT DIS, V196, P281, DOI 10.1086/518898; Ward M.D., 2008, SPATIAL REGRESSION M; Yang CY, 2007, J FORMOS MED ASSOC, V106, P808, DOI 10.1016/S0929-6646(08)60045-5; Yu MC, 2006, J FORMOS MED ASSOC, V105, P25, DOI 10.1016/S0929-6646(09)60105-4; Yu MC, 2004, J FORMOS MED ASSOC, V103, P817; Yung-Ming Chang, 2006, Southeast Asian J Trop Med Public Health, V37 Suppl 3, P161	33	13	13	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 30	2012	7	11							e50740	10.1371/journal.pone.0050740	http://dx.doi.org/10.1371/journal.pone.0050740			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	054WM	23226371	Green Submitted, gold, Green Published			2022-12-27	WOS:000312376100182
J	Toscanini, U; Garcia-Magarinos, M; Berardi, G; Egeland, T; Raimondi, E; Salas, A				Toscanini, Ulises; Garcia-Magarinos, Manuel; Berardi, Gabriela; Egeland, Thore; Raimondi, Eduardo; Salas, Antonio			Evaluating Methods to Correct for Population Stratification when Estimating Paternity Indexes	PLOS ONE			English	Article							GENETIC-STRUCTURE; LOCI; SUBSTRUCTURE; DATABASE; FINNISH	The statistical interpretation of the forensic genetic evidence requires the use of allelic frequency estimates in the reference population for the studied markers. Differences in the genetic make up of the populations can be reflected in statistically different allelic frequency distributions. One can easily figure out that collecting such information for any given population is not always possible. Therefore, alternative approaches are needed in these cases in order to compensate for the lack of information. A number of statistics have been proposed to control for population stratification in paternity testing and forensic casework, Fst correction being the only one recommended by the forensic community. In this study we aimed to evaluate the performance of Fst to correct for population stratification in forensics. By way of simulations, we first tested the dependence of Fst on the relative sizes of the sub-populations, and second, we measured the effect of the Fst corrections on the Paternity Index (PI) values compared to the ones obtained when using the local reference database. The results provide clear-cut evidence that (i) Fst values are strongly dependent on the sampling scheme, and therefore, for most situations it would be almost impossible to estimate real values of Fst; and (ii) Fst corrections might unfairly correct PI values for stratification, suggesting the use of local databases whenever possible to estimate the frequencies of genetic profiles and PI values. Citation: Toscanini U, Garcia-Magarinos M, Berardi G, Egeland T, Raimondi E, et al. (2012) Evaluating Methods to Correct for Population Stratification when Estimating Paternity Indexes. PLoS ONE 7(11): e49832. doi:10.1371/journal.pone.0049832	[Toscanini, Ulises; Berardi, Gabriela; Raimondi, Eduardo] Pricai Fdn Favaloro, Buenos Aires, DF, Argentina; [Garcia-Magarinos, Manuel; Salas, Antonio] Univ Santiago de Compostela, Fac Med, Inst Med Legal, Unidade Xenet, Galicia, Spain; [Egeland, Thore] Norwegian Univ Life Sci, IKBM, As, Norway	Universidade de Santiago de Compostela; Norwegian University of Life Sciences	Toscanini, U (corresponding author), Pricai Fdn Favaloro, Buenos Aires, DF, Argentina.	utoscanini@pricai.com.ar; antonio.salas@usc.es	Garcia-Magariños, Manuel/K-2252-2014; Salas, Antonio/E-3977-2012; Salas, Antonio/U-2029-2019	Garcia-Magariños, Manuel/0000-0001-8257-8719; Salas, Antonio/0000-0002-2336-702X; Salas, Antonio/0000-0002-2336-702X	Ministerio de Ciencia e Innovacion [SAF2011-26983]	Ministerio de Ciencia e Innovacion(Ministry of Science and Innovation, Spain (MICINN)Instituto de Salud Carlos IIISpanish Government)	This work was funded by a grant from Ministerio de Ciencia e Innovacion (SAF2011-26983) given to AS. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Balding DJ, 1996, INT J LEGAL MED, V108, P300, DOI 10.1007/BF02432124; BALDING DJ, 1994, FORENSIC SCI INT, V64, P125, DOI 10.1016/0379-0738(94)90222-4; BALDING DJ, 1995, GENETICA, V96, P3, DOI 10.1007/BF01441146; Buckleton JS, 2006, FORENSIC SCI INT, V157, P144, DOI 10.1016/j.forsciint.2005.04.004; Buckleton JS, 2004, DNA EV; BUDOWLE B, 1994, AM J HUM GENET, V55, P533; CHAKRABORTY R, 1991, SCIENCE, V254, P1735, DOI 10.1126/science.1763323; Curran JM, 2003, FORENSIC SCI INT, V135, P1, DOI 10.1016/S0379-0738(03)00171-3; Egeland T, 2006, CHANCE, V19, P27; EVETT IW, 1998, INTERPRETING DNA EVI; Gjertson DW, 2007, FORENSIC SCI INT-GEN, V1, P223, DOI 10.1016/j.fsigen.2007.06.006; Han K, 2010, IEEE INT C BIO BIO W, P347, DOI 10.1109/BIBMW.2010.5703826; Holsinger KE, 2009, NAT REV GENET, V10, P639, DOI 10.1038/nrg2611; Karlsson AO, 2007, FORENSIC SCI INT, V172, P144, DOI 10.1016/j.forsciint.2006.12.015; KRANE DE, 1992, P NATL ACAD SCI USA, V89, P10583, DOI 10.1073/pnas.89.22.10583; Leberg PL, 2002, MOL ECOL, V11, P2445, DOI 10.1046/j.1365-294X.2002.01612.x; Marchini J, 2004, NAT GENET, V36, P512, DOI 10.1038/ng1337; Marino M, 2008, FORENS SCI INT-GEN S, V1, P350, DOI 10.1016/j.fsigss.2007.10.135; McKusick VA, 1992, DNA TECHN FOR SCI; Meirmans PG, 2011, MOL ECOL RESOUR, V11, P5, DOI 10.1111/j.1755-0998.2010.02927.x; Montgomery D., 2001, DESIGN ANAL EXPT, V5th; MORTON NE, 1992, P NATL ACAD SCI USA, V89, P2556, DOI 10.1073/pnas.89.7.2556; Overall ADJ, 2001, MOL BIOL EVOL, V18, P2048, DOI 10.1093/oxfordjournals.molbev.a003746; Toscanini U, 2008, FORENS SCI INT-GEN S, V1, P662, DOI 10.1016/j.fsigss.2007.10.070; Toscanini U, 2007, FORENSIC SCI INT, V165, P35, DOI 10.1016/j.forsciint.2006.02.042; Toscanini U, 2010, INT J LEGAL MED, V124, P63, DOI 10.1007/s00414-009-0359-2; Wright S, 1931, GENETICS, V16, P0097; Wright S, 1943, GENETICS, V28, P114; Xu Hongyan, 2009, BMC Res Notes, V2, P21, DOI 10.1186/1756-0500-2-21	29	11	11	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 30	2012	7	11							e49832	10.1371/journal.pone.0049832	http://dx.doi.org/10.1371/journal.pone.0049832			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	054WM	23226224	Green Published, gold			2022-12-27	WOS:000312376100032
J	Watanabe, K; Wada, K; Ohashi, T; Okubo, S; Takekuma, K; Hashizume, R; Hayashi, JI; Serikawa, T; Kuramoto, T; Kikkawa, Y				Watanabe, Kei; Wada, Kenta; Ohashi, Tomoko; Okubo, Saki; Takekuma, Kensuke; Hashizume, Ryoichi; Hayashi, Jun-Ichi; Serikawa, Tadao; Kuramoto, Takashi; Kikkawa, Yoshiaki			A 5-bp Insertion in Mip Causes Recessive Congenital Cataract in KFRS4/Kyo Rats	PLOS ONE			English	Article							MAJOR INTRINSIC PROTEIN; AUTOSOMAL-DOMINANT CATARACT; CHINESE FAMILY; NUCLEAR CATARACT; FIBER CELLS; LENS; MUTATION; GENE; MICE; EXPRESSION	We discovered a new cataract mutation, kfrs4, in the Kyoto Fancy Rat Stock (KFRS) background. Within 1 month of birth, all kfrs4/kfrs4 homozygotes developed cataracts, with severe opacity in the nuclei of the lens. In contrast, no opacity was observed in the kfrs4/+ heterozygotes. We continued to observe these rats until they reached 1 year of age and found that cataractogenesis did not occur in kfrs4/+ rats. To define the histological defects in the lenses of kfrs4 rats, sections of the eyes of these rats were prepared. Although the lenses of kfrs4/kfrs4 homozygotes showed severely disorganised fibres and vacuolation, the lenses of kfrs4/+ heterozygotes appeared normal and similar to those of wild-type rats. We used positional cloning to identify the kfrs4 mutation. The mutation was mapped to an approximately 9.7-Mb region on chromosome 7, which contains the Mip gene. This gene is responsible for a dominant form of cataract in humans and mice. Sequence analysis of the mutant-derived Mip gene identified a 5-bp insertion. This insertion is predicted to inactivate the MIP protein, as it produces a frameshift that results in the synthesis of 6 novel amino acid residues and a truncated protein that lacks 136 amino acids in the C-terminal region, and no MIP immunoreactivity was observed in the lens fibre cells of kfrs4/kfrs4 homozygous rats using an antibody that recognises the C- and N-terminus of MIP. In addition, the kfrs4/+ heterozygotes showed reduced expression of Mip mRNA and MIP protein and the kfrs4/kfrs4 homozygotes showed no expression in the lens. These results indicate that the kfrs4 mutation conveys a loss-of-function, which leads to functional inactivation though the degradation of Mip mRNA by an mRNA decay mechanism. Therefore, the kfrs4 rat represents the first characterised rat model with a recessive mutation in the Mip gene.	[Watanabe, Kei; Wada, Kenta; Kikkawa, Yoshiaki] Tokyo Metropolitan Inst Med Sci, Mammalian Genet Project, Tokyo 113, Japan; [Watanabe, Kei; Hayashi, Jun-Ichi] Univ Tsukuba, Grad Sch Life & Environm Sci, Tsukuba, Ibaraki, Japan; [Wada, Kenta; Ohashi, Tomoko; Okubo, Saki; Takekuma, Kensuke; Hashizume, Ryoichi] Tokyo Univ Agr, Dept Bioprod, Abashiri, Japan; [Serikawa, Tadao; Kuramoto, Takashi] Kyoto Univ, Grad Sch Med, Inst Lab Anim, Kyoto, Japan	Tokyo Metropolitan Institute of Medical Science; University of Tsukuba; Tokyo University of Agriculture; Kyoto University	Kikkawa, Y (corresponding author), Tokyo Metropolitan Inst Med Sci, Mammalian Genet Project, Bunkyo Ku, Tokyo 113, Japan.	kikkawa-ys@igakuken.or.jp	Kikkawa, Yoshiaki/AAI-7229-2020	Kikkawa, Yoshiaki/0000-0001-8859-4998	Japan Society for the Promotion of Science [24650243]; Tokyo Metropolitan Institute of Medical Science; University of Tsukuba; Tokyo University of Agriculture	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Tokyo Metropolitan Institute of Medical Science; University of Tsukuba; Tokyo University of Agriculture	This work was supported by a Grant-in-Aid of Scientific Research (Challenging Exploratory Research, no. 24650243) from the Japan Society for the Promotion of Science. This study was also supported by Tokyo Metropolitan Institute of Medical Science, University of Tsukuba, and Tokyo University of Agriculture. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Ghoul KJ, 2003, ANAT REC PART A, V273A, P714, DOI 10.1002/ar.a.10080; Baker H.J., 1979, LAB RAT; Berry V, 2000, NAT GENET, V25, P15, DOI 10.1038/75538; BLOEMENDAL H, 1972, Cell Differentiation, V1, P91, DOI 10.1016/0045-6039(72)90032-2; Cain S, 2008, DEV BIOL, V321, P420, DOI 10.1016/j.ydbio.2008.07.002; Cheng C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028147; Chepelinsky Ana B, 2009, Handb Exp Pharmacol, P265, DOI 10.1007/978-3-540-79885-9_14; Cooper MA, 2008, P NATL ACAD SCI USA, V105, P16620, DOI 10.1073/pnas.0808987105; Francis P, 2000, HUM MOL GENET, V9, P2329, DOI 10.1093/oxfordjournals.hmg.a018925; Geyer DD, 2006, AM J OPHTHALMOL, V141, P761, DOI 10.1016/j.ajo.2005.11.008; Golestaneh N, 2004, J BIOL CHEM, V279, P31813, DOI 10.1074/jbc.M403473200; GORIN MB, 1984, CELL, V39, P49, DOI 10.1016/0092-8674(84)90190-9; Gu F, 2007, MOL VIS, V13, P1651; Kuramoto T, 2010, EXP ANIM TOKYO, V59, P147, DOI 10.1538/expanim.59.147; Lin H, 2007, MOL VIS, V13, P1822; Manly KF, 2001, MAMM GENOME, V12, P930, DOI 10.1007/s00335-001-1016-3; MUGGLETONHARRIS AL, 1987, DEVELOPMENT, V99, P473; Okamura T, 2003, GENOMICS, V81, P361, DOI 10.1016/S0888-7543(03)00029-6; Shiels A, 1996, NAT GENET, V12, P212, DOI 10.1038/ng0296-212; Shiels A, 2001, PHYSIOL GENOMICS, V7, P179, DOI 10.1152/physiolgenomics.00078.2001; Sidjanin DJ, 2001, GENOMICS, V74, P313, DOI 10.1006/geno.2001.6509; Varadaraj K, 2008, EXP EYE RES, V87, P9, DOI 10.1016/j.exer.2008.04.001; Varadaraj K, 2010, EXP EYE RES, V91, P393, DOI 10.1016/j.exer.2010.06.013; Varadaraj K, 2007, DEV DYNAM, V236, P1319, DOI 10.1002/dvdy.21125; Wada K, 2011, MAMM GENOME, V22, P693, DOI 10.1007/s00335-011-9358-y; Wang KJ, 2011, MOL VIS, V17, P70; Wang W, 2010, MOL VIS, V16, P534; Xu L, 2002, EXP EYE RES, V74, P753, DOI 10.1006/exer.2002.1175; Yang GX, 2011, MOL VIS, V17, P1320; Yu XS, 2005, J BIOL CHEM, V280, P22081, DOI 10.1074/jbc.M414377200	30	15	15	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 30	2012	7	11							e50737	10.1371/journal.pone.0050737	http://dx.doi.org/10.1371/journal.pone.0050737			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	054WM	23226368	Green Published, Green Submitted, gold			2022-12-27	WOS:000312376100179
J	Guiller, A; Martin, MC; Hiraux, C; Madec, L				Guiller, Annie; Martin, Marie-Claire; Hiraux, Celine; Madec, Luc			Tracing the Invasion of the Mediterranean Land Snail Cornu aspersum aspersum Becoming an Agricultural and Garden Pest in Areas Recently Introduced	PLOS ONE			English	Article							ADDITIVE GENETIC VARIANCE; HELIX-ASPERSA; MITOCHONDRIAL-DNA; LIFE-HISTORY; POPULATION BOTTLENECKS; BIOLOGICAL INVASION; ADAPTIVE EVOLUTION; NORTH-AFRICA; MOLLUSCA; DIFFERENTIATION	This study is the first on the genetics of invasive populations of one of the most widely spread land mollusc species known in the world, the "Brown Snail'' Cornu aspersum aspersum. Deliberately or accidentally imported, the species has become recently a notorious pest outside its native Mediterranean range. We compared the spatial structure and genetic variability of invasive (America, Oceania, South Africa) versus native populations using five microsatellite loci and mitochondrial (Cyt b and 16S rRNA) genes as a first step towards (i) the detection of potential source populations, and (ii) a better understanding of mechanisms governing evolutionary changes involved in the invasion process. Results based on multivariate analysis (Discriminant Analysis of Principal Components), Bayesian statistical inference (Clustering, Approximate Bayesian Computation) and demographic tests allowed a construction of the introduction pathways of the species over recent centuries. While emigrants originated from only one of the two native lineages, the West one, the most likely scenario involved several introduction events and "source switching'' comprising (i) an early stage (around 1660) of simultaneous introductions from Europe (France, Spain) towards Oceania (New Zealand) and California, (ii) from the early 18 th century, a second colonization wave from bridgehead populations successfully established in California, (iii) genetic admixture in invasive areas where highly divergent populations came into contact as in New Zealand. Although these man-made pathways are consistent with historical data, introduction time estimates suggest that the two putative waves of invasion would have occurred long before the first field observations recorded, both in America and in Oceania. A prolonged lag period as the use of an incorrect generation time could explain such 100-150 years discrepancy. Lastly, the contrasting patterns of neutral genetic signal left in invasive populations are discussed in light of possible ways of facing novel environments (standing genetic variation versus new mutation).	[Guiller, Annie; Martin, Marie-Claire; Hiraux, Celine; Madec, Luc] Univ Rennes, CNRS, UMR 6553, Rennes, France	Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); Universite de Rennes	Guiller, A (corresponding author), Univ Rennes, CNRS, UMR 6553, Rennes, France.	annie.guiller@univ-rennes1.fr		Guiller, Annie/0000-0002-9047-9777	Centre national de la recherche scientifique	Centre national de la recherche scientifique(Centre National de la Recherche Scientifique (CNRS))	This research was funded by the Centre national de la recherche scientifique. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allendorf FW, 2003, CONSERV BIOL, V17, P24, DOI 10.1046/j.1523-1739.2003.02365.x; Ansart A., 2009, CABI INVASIVE SPECIE; Bandelt HJ, 1999, MOL BIOL EVOL, V16, P37, DOI 10.1093/oxfordjournals.molbev.a026036; Barker G. M., 2002, MOLLUSCS CROP PESTS; Barker GM, 1999, FAUNA NZ, V38; Barrett RDH, 2008, TRENDS ECOL EVOL, V23, P38, DOI 10.1016/j.tree.2007.09.008; Basinger AJ, 1931, AGRIC EXP STA BERKEL, V515, P1; Bohn T, 2004, OIKOS, V106, P138, DOI 10.1111/j.0030-1299.2004.13022.x; Bossdorf O, 2005, OECOLOGIA, V144, P1, DOI 10.1007/s00442-005-0070-z; Brook FJ, 2000, J ROY SOC NEW ZEAL, V30, P209, DOI 10.1080/03014223.2000.9517618; Burton OJ, 2010, ECOL LETT, V13, P1210, DOI 10.1111/j.1461-0248.2010.01505.x; Clobert J, 2009, ECOL LETT, V12, P197, DOI 10.1111/j.1461-0248.2008.01267.x; Cornuet JM, 2008, BIOINFORMATICS, V24, P2713, DOI 10.1093/bioinformatics/btn514; Cowie Robert H., 1997, Bishop Museum Occasional Papers, V0, P1; Davis M. A., 2009, INVASION BIOL; Dlugosch KM, 2008, MOL ECOL, V17, P431, DOI 10.1111/j.1365-294X.2007.03538.x; Downie DA, 2002, MOL ECOL, V11, P2013, DOI 10.1046/j.1365-294X.2002.01584.x; Ellstrand NC, 2000, P NATL ACAD SCI USA, V97, P7043, DOI 10.1073/pnas.97.13.7043; Evanno G, 2005, MOL ECOL, V14, P2611, DOI 10.1111/j.1365-294X.2005.02553.x; Excoffier L, 2005, EVOL BIOINFORM, V1, P47, DOI 10.1177/117693430500100003; Facon B, 2008, CURR BIOL, V18, P363, DOI 10.1016/j.cub.2008.01.063; Fearnley R, 1993, THESIS U MANCHESTER; Frankham R, 2005, HEREDITY, V94, P385, DOI 10.1038/sj.hdy.6800634; Fu YX, 1997, GENETICS, V147, P915; Gargominy O, 1996, REV ECOL-TERRE VIE, V51, P375; Goudet J, 1995, J HERED, V86, P485, DOI 10.1093/oxfordjournals.jhered.a111627; Guillemaud T, 2011, CR BIOL, V334, P237, DOI 10.1016/j.crvi.2010.12.008; Guiller A, 2001, MOL ECOL, V10, P81, DOI 10.1046/j.1365-294X.2001.01145.x; Guiller A, 1998, SYST BIOL, V47, P208, DOI 10.1080/106351598260888; Guiller A, 2000, MOL ECOL, V9, P1191, DOI 10.1046/j.1365-294x.2000.00954-13.x; GUILLER A, 1994, J MOLLUS STUD, V60, P205, DOI 10.1093/mollus/60.3.205; GUILLER A, 1994, THESIS U RENNES FRAN; Guiller A, 2006, GENET RES, V88, P27, DOI 10.1017/S0016672306008305; Guiller A, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-18; Guindon S, 2005, NUCLEIC ACIDS RES, V33, pW557, DOI 10.1093/nar/gki352; GUTELL RR, 1988, NUCLEIC ACIDS RES, V16, pR175, DOI 10.1093/nar/16.suppl.r175; Hanfling B, 2002, MAR ECOL PROG SER, V238, P307, DOI 10.3354/meps238307; HASEGAWA M, 1985, J MOL EVOL, V22, P160, DOI 10.1007/BF02101694; Hermisson J, 2005, GENETICS, V169, P2335, DOI 10.1534/genetics.104.036947; Hierro JL, 2005, J ECOL, V93, P5, DOI 10.1111/j.0022-0477.2004.00953.x; Jakobsson M, 2007, BIOINFORMATICS, V23, P1801, DOI 10.1093/bioinformatics/btm233; Jenkins C, 2011, BIOL INVASIONS, V13, P1471, DOI 10.1007/s10530-010-9907-4; Jombart T, 2010, BMC GENET, V11, DOI [DOI 10.1186/1471-2156-11-94, 10.1186/1471-2156-11-94]; Jombart T, 2008, BIOINFORMATICS, V24, P1403, DOI 10.1093/bioinformatics/btn129; Knopp T, 2007, CONSERV GENET, V8, P45, DOI 10.1007/s10592-006-9147-4; Kolbe JJ, 2008, BIOL LETTERS, V4, P434, DOI 10.1098/rsbl.2008.0205; Kolbe JJ, 2004, NATURE, V431, P177, DOI 10.1038/nature02807; KOWARIK I, 1995, PLANT INVASIONS, P15; Le Roux JJ, 2011, DIVERS DISTRIB, V17, P861, DOI 10.1111/j.1472-4642.2011.00784.x; Lee CE, 2002, TRENDS ECOL EVOL, V17, P386, DOI 10.1016/S0169-5347(02)02554-5; Lockwood JL, 2005, TRENDS ECOL EVOL, V20, P223, DOI 10.1016/j.tree.2005.02.004; Lombaert E, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009743; Lopez DP, 2011, THESIS FLORIDA INT U; Mack RN, 2000, ECOL APPL, V10, P689, DOI 10.1890/1051-0761(2000)010[0689:BICEGC]2.0.CO;2; MADEC L, 1994, J ZOOL, V233, P215, DOI 10.1111/j.1469-7998.1994.tb08585.x; Madec L, 2003, HEREDITY, V91, P224, DOI 10.1038/sj.hdy.6800301; Madec L, 2000, BIOL J LINN SOC, V69, P25, DOI 10.1111/j.1095-8312.2000.tb01667.x; Madec L, 1996, CR ACAD SCI III-VIE, V319, P225; Marsico TD, 2010, EVOL APPL, V3, P203, DOI 10.1111/j.1752-4571.2009.00101.x; Meimberg H, 2006, BIOL INVASIONS, V8, P1355, DOI 10.1007/s10530-005-2463-7; Miller N, 2005, SCIENCE, V310, P992, DOI 10.1126/science.1115871; Muller J, 2001, ZOOL-ANAL COMPLEX SY, V104, P346, DOI 10.1078/0944-2006-00040; Naciri-Graven Y, 2003, EVOLUTION, V57, P706, DOI 10.1111/j.0014-3820.2003.tb00284.x; Neiman M, 2006, HEREDITY, V96, P111, DOI 10.1038/sj.hdy.6800772; NOVAK SJ, 1993, HEREDITY, V71, P167, DOI 10.1038/hdy.1993.121; NYLANDER J.A.A., 2004, MRAIC PL PROGRAM DIS; Oliver MK, 2012, MOL BIOL EVOL, V29, P1713, DOI 10.1093/molbev/mss063; Oosterhoff LM, 1976, NETH J ZOOL, V27, P1; Phillips BL, 2009, BIOL LETTERS, V5, P802, DOI 10.1098/rsbl.2009.0367; Phillips BL, 2010, ECOLOGY, V91, P1617, DOI 10.1890/09-0910.1; Prentis PJ, 2008, TRENDS PLANT SCI, V13, P288, DOI 10.1016/j.tplants.2008.03.004; Pritchard JK, 2000, GENETICS, V155, P945; Ramos-Onsins SE, 2002, MOL BIOL EVOL, V19, P2092, DOI 10.1093/oxfordjournals.molbev.a004034; RAYMOND M, 1995, J HERED, V86, P248, DOI 10.1093/oxfordjournals.jhered.a111573; Ricciardi A, 2011, FIFTY YEARS OF INVASION ECOLOGY: THE LEGACY OF CHARLES ELTON, P225; ROGERS AR, 1992, MOL BIOL EVOL, V9, P552; Roman J, 2007, TRENDS ECOL EVOL, V22, P454, DOI 10.1016/j.tree.2007.07.002; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; Rosenberg NA, 2004, MOL ECOL NOTES, V4, P137, DOI 10.1046/j.1471-8286.2003.00566.x; Rozas J, 2003, BIOINFORMATICS, V19, P2496, DOI 10.1093/bioinformatics/btg359; Sanders NJ, 2011, FIFTY YEARS OF INVASION ECOLOGY: THE LEGACY OF CHARLES ELTON, P239; Simon A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018560; Slade RW, 1998, P ROY SOC B-BIOL SCI, V265, P769, DOI 10.1098/rspb.1998.0359; SLATKIN M, 1991, GENETICS, V129, P555; Stearns R. E. C., 1900, Science, Vxi, P655, DOI 10.1126/science.11.278.655; Taylor J. W., 1913, MONOGRAPH LAND FRESH, P236; Thomaz D, 1996, P ROY SOC B-BIOL SCI, V263, P363, DOI 10.1098/rspb.1996.0056; Turelli M, 2006, EVOLUTION, V60, P1763; van Heerwaarden B, 2008, GENETICS, V179, P2135, DOI 10.1534/genetics.107.082768	89	38	39	0	66	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 5	2012	7	12							e49674	10.1371/journal.pone.0049674	http://dx.doi.org/10.1371/journal.pone.0049674			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	201YT	23227148	Green Published, gold			2022-12-27	WOS:000323179700006
J	Simioni, S; Schluep, M; Bault, N; Coricelli, G; Kleeberg, J; Du Pasquier, RA; Gschwind, M; Vuilleumier, P; Annoni, JM				Simioni, Samanta; Schluep, Myriam; Bault, Nadege; Coricelli, Giorgio; Kleeberg, Joerg; Du Pasquier, Renaud A.; Gschwind, Markus; Vuilleumier, Patrik; Annoni, Jean-Marie			Multiple Sclerosis Decreases Explicit Counterfactual Processing and Risk Taking in Decision Making	PLOS ONE			English	Article							PREFRONTAL CORTEX; EMOTIONAL REACTIVITY; DIAGNOSTIC-CRITERIA; COGNITIVE DEFICITS; LESION LOAD; ALEXITHYMIA; DEPRESSION; ANXIETY; IMPAIRMENT; REGRET	Introduction: Deficits in decision making (DM) are commonly associated with prefrontal cortical damage, but may occur with multiple sclerosis (MS). There are no data concerning the impact of MS on tasks evaluating DM under explicit risk, where different emotional and cognitive components can be distinguished. Methods: We assessed 72 relapsing-remitting MS (RRMS) patients with mild to moderate disease and 38 healthy controls in two DM tasks involving risk with explicit rules: (1) The Wheel of Fortune (WOF), which probes the anticipated affects of decisions outcomes on future choices; and (2) The Cambridge Gamble Task (CGT) which measures risk taking. Participants also underwent a neuropsychological and emotional assessment, and skin conductance responses (SCRs) were recorded. Results: In the WOF, RRMS patients showed deficits in integrating positive counterfactual information (p < 0.005) and greater risk aversion (p < 0.001). They reported less negative affect than controls (disappointment: p = 0.007; regret: p = 0.01), although their implicit emotional reactions as measured by post-choice SCRs did not differ. In the CGT, RRMS patients differed from controls in quality of DM (p = 0.01) and deliberation time (p = 0.0002), the latter difference being correlated with attention scores. Such changes did not result in overall decreases in performance (total gains). Conclusions: The quality of DM under risk was modified by MS in both tasks. The reduction in the expression of disappointment coexisted with an increased risk aversion in the WOF and alexithymia features. These concomitant emotional alterations may have implications for better understanding the components of explicit DM and for the clinical support of MS patients.	[Simioni, Samanta; Schluep, Myriam; Kleeberg, Joerg; Du Pasquier, Renaud A.; Annoni, Jean-Marie] Univ Lausanne Hosp, Dept Clin Neurosci, Lausanne, Switzerland; [Simioni, Samanta; Schluep, Myriam; Kleeberg, Joerg; Du Pasquier, Renaud A.; Annoni, Jean-Marie] Univ Lausanne, Lausanne, Switzerland; [Bault, Nadege; Coricelli, Giorgio] CNRS, Inst Cognit Sci, Ctr Neurosci Cognit, Bron, France; [Gschwind, Markus; Vuilleumier, Patrik; Annoni, Jean-Marie] Univ Geneva, Univ Med Ctr CMU, Dept Neurosci, Geneva, Switzerland; [Annoni, Jean-Marie] Univ Fribourg, Dept Med, CH-1700 Fribourg, Switzerland	University of Lausanne; Centre Hospitalier Universitaire Vaudois (CHUV); University of Lausanne; Centre National de la Recherche Scientifique (CNRS); University of Geneva; University of Fribourg	Annoni, JM (corresponding author), Univ Lausanne Hosp, Dept Clin Neurosci, Lausanne, Switzerland.	jean-marie.annoni@unifr.ch	Bault, Nadège/L-9907-2019; Du Pasquier, Renaud/O-8588-2016; Gschwind, Markus/N-7215-2015; Vuilleumier, Patrik/AAJ-1839-2021	Bault, Nadège/0000-0001-8244-6062; Du Pasquier, Renaud/0000-0002-2786-3434; Gschwind, Markus/0000-0002-5623-1313; Vuilleumier, Patrik/0000-0002-8198-9214	Swiss MS Society; Swiss National Science Foundation [3200BO-118206]; Societe Academique de Geneve	Swiss MS Society; Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Societe Academique de Geneve	This work was supported by the Swiss MS Society (Forname Fund to Myriam Schluep), the Swiss National Science Foundation (Grant 3200BO-118206) and the Societe Academique de Geneve (Foremane Fund to Patrik Vuilleumier). The grants were used for the salaries of SS and MG and for the reimbursments of patients' travel and controls' time. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ARNETT PA, 1994, NEUROLOGY, V44, P420, DOI 10.1212/WNL.44.3_Part_1.420; Bar-On R, 2003, BRAIN, V126, P1790, DOI 10.1093/brain/awg177; BECHARA A, 1994, COGNITION, V50, P7, DOI 10.1016/0010-0277(94)90018-3; Bodini B, 2008, ACTA NEUROL SCAND, V118, P18, DOI 10.1111/j.1600-0404.2007.00969.x; Boringa JB, 2001, MULT SCLER, V7, P263, DOI 10.1177/135245850100700409; Brand M, 2006, NEURAL NETWORKS, V19, P1266, DOI 10.1016/j.neunet.2006.03.001; Burnett S, 2010, COGNITIVE DEV, V25, P183, DOI 10.1016/j.cogdev.2009.11.003; Calabrese M, 2009, ARCH NEUROL-CHICAGO, V66, P1144, DOI 10.1001/archneurol.2009.174; Camille N, 2004, SCIENCE, V304, P1167, DOI 10.1126/science.1094550; Camille N, 2010, COGN AFFECT BEHAV NE, V10, P460, DOI 10.3758/CABN.10.4.460; Chahraoui K, 2008, REV NEUROL-FRANCE, V164, P242, DOI 10.1016/j.neurol.2007.09.006; Clark L, 2008, BRAIN, V131, P1311, DOI 10.1093/brain/awn066; Clark L, 2004, NEUROCASE, V10, P398, DOI 10.1080/13554790490882799; Clark L, 2003, NEUROPSYCHOLOGIA, V41, P1474, DOI 10.1016/S0028-3932(03)00081-2; Coricelli G, 2005, NAT NEUROSCI, V8, P1255, DOI 10.1038/nn1514; Costa A, 2006, EUR J NEUROL, V13, P836, DOI 10.1111/j.1468-1331.2006.01216.x; Damasio A.R., 2005, DESCARTES ERROR EMOT; DeLuca J, 2004, J CLIN EXP NEUROPSYC, V26, P550, DOI 10.1080/13803390490496641; Di Bitonto L, 2011, REV NEUROL-FRANCE, V167, P820, DOI 10.1016/j.neurol.2011.01.024; Fulton JC, 1999, AM J NEURORADIOL, V20, P1951; Garcia-Molina A, 2009, NEUROLOGIA, V24, P94; Giorgetta C, 2012, EMOTION; He Y, 2009, BRAIN, V132, P3366, DOI 10.1093/brain/awp089; Heilman RM, 2010, EMOTION, V10, P257, DOI 10.1037/a0018489; Heinzel A, 2010, PSYCHOTHER PSYCHOSOM, V79, P363, DOI 10.1159/000320121; Kincses ZT, 2011, MULT SCLER J, V17, P681, DOI 10.1177/1352458510391342; Kleeberg J, 2004, ANN NEUROL, V56, P787, DOI 10.1002/ana.20277; Korostil M, 2007, MULT SCLER, V13, P67, DOI 10.1177/1352458506071161; KURTZKE JF, 1983, NEUROLOGY, V33, P1444, DOI 10.1212/WNL.33.11.1444; Lima FS, 2007, BEHAV NEUROL, V18, P81, DOI 10.1155/2007/674075; Manes F, 2002, BRAIN, V125, P624, DOI 10.1093/brain/awf049; Mavaddat N, 2000, BRAIN, V123, P2109, DOI 10.1093/brain/123.10.2109; McDonald WI, 2001, ANN NEUROL, V50, P121, DOI 10.1002/ana.1032; Mellers BA, 1997, PSYCHOL SCI, V8, P423, DOI 10.1111/j.1467-9280.1997.tb00455.x; Nagy H, 2006, J INT NEUROPSYCH SOC, V12, P559, DOI 10.1017/S1355617706060644; Passamonti L, 2009, BRAIN, V132, P3380, DOI 10.1093/brain/awp095; Polman CH, 2005, ANN NEUROL, V58, P840, DOI 10.1002/ana.20703; Pouga L, 2010, HUM BRAIN MAPP, V31, P1469, DOI 10.1002/hbm.20953; Preuschoff K, 2008, J NEUROSCI, V28, P2745, DOI 10.1523/JNEUROSCI.4286-07.2008; Prochnow D, 2011, J NEUROL, V258, P1683, DOI 10.1007/s00415-011-6002-4; Ptak R, 2001, BEHAV NEUROSCI, V115, P993, DOI 10.1037//0735-7044.115.5.993; Rahman S, 1999, BRAIN, V122, P1469, DOI 10.1093/brain/122.8.1469; Rao S, 1990, MANUAL BRIEF REPEATA; RAO SM, 1991, NEUROLOGY, V41, P685, DOI 10.1212/WNL.41.5.685; Roca M, 2008, MULT SCLER, V14, P364, DOI 10.1177/1352458507084270; Rogers RD, 1999, J NEUROSCI, V19, P9029, DOI 10.1523/JNEUROSCI.19-20-09029.1999; SAHAKIAN BJ, 1992, J ROY SOC MED, V85, P399; SIFNEOS PE, 1973, PSYCHOTHER PSYCHOSOM, V22, P255, DOI 10.1159/000286529; Simioni S, 2009, J INT NEUROPSYCH SOC, V15, P291, DOI 10.1017/S1355617709090262; Simioni S, 2008, J NEUROL, V255, P1762, DOI 10.1007/s00415-008-0025-5; Spalletta G, 2001, PSYCHOSOM MED, V63, P944, DOI 10.1097/00006842-200111000-00013; Wilson B.A., 1996, BEHAV ASSESSMENT DYS; WISE TN, 1994, HEADACHE, V34, P362, DOI 10.1111/j.1526-4610.1994.hed3406362.x; ZIGMOND AS, 1983, ACTA PSYCHIAT SCAND, V67, P361, DOI 10.1111/j.1600-0447.1983.tb09716.x; Zorzon M, 2001, J NEUROL, V248, P416, DOI 10.1007/s004150170184	55	17	17	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 5	2012	7	12							e50718	10.1371/journal.pone.0050718	http://dx.doi.org/10.1371/journal.pone.0050718			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	057TZ	23227201	Green Published, gold, Green Submitted			2022-12-27	WOS:000312588200060
J	Wu, JX; Du, J; Liu, LG; Li, Q; Rong, WQ; Wang, LM; Wang, Y; Zang, MY; Wu, ZY; Zhang, YW; Qu, CF				Wu, Jianxiong; Du, Jun; Liu, Liguo; Li, Qian; Rong, Weiqi; Wang, Liming; Wang, Ying; Zang, Mengya; Wu, Zhiyuan; Zhang, Yawei; Qu, Chunfeng			Elevated Pretherapy Serum IL17 in Primary Hepatocellular Carcinoma Patients Correlate to Increased Risk of Early Recurrence after Curative Hepatectomy	PLOS ONE			English	Article							HEPATITIS-B VIRUS; HELPER 17 CELLS; GENE-EXPRESSION; TUMOR-DEVELOPMENT; T-CELLS; SURVIVAL; MICROENVIRONMENT; DIFFERENTIATION; PREDICTION; SIGNATURE	Background and Aims: Primary hepatocellular carcinoma (HCC) is usually presented in inflamed fibrotic/cirrhotic liver with extensive lymphocyte infiltration. We examined the associations between the HCC early recurrence and alterations in serum levels of inflammatory cytokines. Methods: A cohort of 105 HCC patients with chronic hepatitis B virus infection were included. Pre-therapy, we quantified their serum concentrations of Th1-, Th2-, Th17-, Treg-related, and other cytokines that have been reported to be associated with poor prognosis in human cancers. IL17-producing T-cells were generated in vitro from HCC patients and co-cultured with HCC cell lines separated by a 0.4 mu M transwell. Results: All the 105 cases of HCC patients had liver cirrhosis. The patients who suffered from HCC early recurrence had higher pre-therapy serum levels of IL17 and lower levels of IL10 than those who did not suffer from recurrence after curative hepatectomy. After adjustment for general tumor clinicopathological factors, elevated serum levels of IL17 (>= 0.9 pg/ml) was found to be an independent risk factor for HCC early recurrence with a hazard ratio of 2.46 (95%CI 1.34-4.51). Patients with bigger tumors (>5 cm in diameter) and elevated serum levels of IL17 had the highest risk of early recurrence as compared to those with only one of these factors (P = 0.009) or without any (P<0.001). These factors showed similar effects on the HCC patient overall survival. Intrahepatic infiltrated T-cells in HCC patients were identified as the major IL17-producing cells. Proliferation of HCC cells, QGY-7703, was augmented QGY-7703, was augmented in the presence of IL17-producing T-cells. This effect diminished after neutralizing antibody against human IL17A or TNF alpha was included. Conclusion: Both tumors and IL17 from liver infiltrated T-cells contributed to HCC early recurrence and progression after curative resection. Pre-therapy serum IL17 levels may serve as an additional indicator for predicting high-risk patients.	[Du, Jun; Liu, Liguo; Wang, Ying; Zang, Mengya; Wu, Zhiyuan; Qu, Chunfeng] Chinese Acad Med Sci, State Key Lab Mol Oncol, Canc Inst Hosp, Beijing 100730, Peoples R China; [Wu, Jianxiong; Liu, Liguo; Rong, Weiqi; Wang, Liming] Chinese Acad Med Sci, Canc Inst Hosp, Dept Surg, Beijing 100730, Peoples R China; [Li, Qian] Chinese Acad Med Sci, Canc Inst Hosp, Natl Off Canc Prevent & Control, Beijing 100730, Peoples R China; [Li, Qian; Zhang, Yawei] Yale Univ, Sch Publ Hlth, Environm Hlth Sci Div, New Haven, CT USA	Chinese Academy of Medical Sciences - Peking Union Medical College; Cancer Institute & Hospital - CAMS; Chinese Academy of Medical Sciences - Peking Union Medical College; Cancer Institute & Hospital - CAMS; Chinese Academy of Medical Sciences - Peking Union Medical College; Cancer Institute & Hospital - CAMS; Yale University	Qu, CF (corresponding author), Chinese Acad Med Sci, State Key Lab Mol Oncol, Canc Inst Hosp, Beijing 100730, Peoples R China.	quchf@cicams.ac.cn	Wang, Liming/AAD-7697-2020		Natural Science Foundation of China [30973387]; "973'' project [2011CB504205]	Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); "973'' project(National Basic Research Program of China)	This work was supported by the Natural Science Foundation of China (#30973387) and "973'' project: 2011CB504205. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Boniface K, 2008, IMMUNOL REV, V226, P132, DOI 10.1111/j.1600-065X.2008.00714.x; Budhu A, 2006, CANCER CELL, V10, P99, DOI 10.1016/j.ccr.2006.06.016; Charles KA, 2009, J CLIN INVEST, V119, P3011, DOI 10.1172/JCI39065; Chew V, 2010, J HEPATOL, V52, P370, DOI 10.1016/j.jhep.2009.07.013; Chisari FV, 2010, PATHOL BIOL, V58, P258, DOI 10.1016/j.patbio.2009.11.001; Dahiya D, 2010, SURGERY, V147, P676, DOI 10.1016/j.surg.2009.10.043; Enewold L, 2009, CANCER EPIDEM BIOMAR, V18, P215, DOI 10.1158/1055-9965.EPI-08-0705; Guidotti LG, 2006, ANNU REV PATHOL-MECH, V1, P23, DOI 10.1146/annurev.pathol.1.110304.100230; He DG, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032126; He DG, 2010, J IMMUNOL, V184, P2281, DOI 10.4049/jimmunol.0902574; Hoshida Y, 2008, NEW ENGL J MED, V359, P1995, DOI 10.1056/NEJMoa0804525; Huang RM, 2003, CANCER RES, V63, P3775; Imamura H, 2003, J HEPATOL, V38, P200, DOI 10.1016/S0168-8278(02)00360-4; Kirshberg S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024856; Kryczek I, 2009, BLOOD, V114, P1141, DOI 10.1182/blood-2009-03-208249; Kuang DM, 2010, HEPATOLOGY, V51, P154, DOI 10.1002/hep.23291; Lee JS, 2004, GASTROENTEROLOGY, V127, pS51, DOI 10.1053/j.gastro.2004.09.015; Li J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021816; Llovet JM, 2005, J GASTROENTEROL, V40, P225, DOI 10.1007/s00535-005-1566-3; Marin-Hargreaves G, 2003, CRIT REV ONCOL HEMAT, V47, P13, DOI 10.1016/S1040-8428(02)00213-5; MING L, 2002, HEPATOLOGY, V36, P1214, DOI DOI 10.1053/jhep.2002.36366; Omata M, 2010, HEPATOL INT, V4, P439, DOI 10.1007/s12072-010-9165-7; Pandey D, 2007, ANN SURG ONCOL, V14, P2817, DOI 10.1245/s10434-007-9518-1; Poon D, 2009, LANCET ONCOL, V10, P1111, DOI 10.1016/S1470-2045(09)70241-4; Qu CF, 2003, J IMMUNOL, V170, P1010, DOI 10.4049/jimmunol.170.2.1010; Seike M, 2007, JNCI-J NATL CANCER I, V99, P1257, DOI 10.1093/jnci/djm083; Wang L, 2010, CANCER RES, V70, P10112, DOI 10.1158/0008-5472.CAN-10-0775; Wilson NJ, 2007, NAT IMMUNOL, V8, P950, DOI 10.1038/ni1497; Wu M, 2010, LIVER CANCER, P327; Yan J, 2004, ONCOGENE, V23, P1939, DOI 10.1038/sj.onc.1207306; Ye QH, 2003, NAT MED, V9, P416, DOI 10.1038/nm843; Zhang JY, 2010, HEPATOLOGY, V51, P81, DOI 10.1002/hep.23273; Zhang JP, 2009, J HEPATOL, V50, P980, DOI 10.1016/j.jhep.2008.12.033; Zhu JF, 2010, ANNU REV IMMUNOL, V28, P445, DOI 10.1146/annurev-immunol-030409-101212	34	31	34	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 5	2012	7	12							e50035	10.1371/journal.pone.0050035	http://dx.doi.org/10.1371/journal.pone.0050035			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	057TZ	23227158	gold, Green Submitted, Green Published			2022-12-27	WOS:000312588200020
J	Wynde, FJH; Port, GR				Wynde, Fiona J. H.; Port, Gordon R.			The Use of Olfactory and Visual Cues in Host Choice by the Capsid Bugs Lygus rugulipennis Poppius and Liocoris tripustulatus Fabricius	PLOS ONE			English	Article							TARNISHED PLANT BUG; POPULATION-DYNAMICS; MIRIDAE; HETEROPTERA; HEMIPTERA; VOLATILES; RESPONSES; HET	Lygus rugulipennis Poppius and Liocoris tripustulatus Fabricius (Heteroptera: Miridae) are pests of glasshouse cucumber and sweet pepper crops respectively. L. rugulipennis has a wide range of foodplants, but L. tripustulatus is specialised with very few food plants. We report behavioural assessments to investigate whether either species exhibits a preference for salad over wild hosts, and whether the role of olfaction and vision in response to cues from host plants can be distinguished. Olfactory responses to leaves were tested in choice chambers. L. rugulipennis was presented nettle (wild host) and a salad leaf of cucumber or sweet pepper, where the salad leaves had higher nitrogen content. L. tripustulatus was tested with nettle and sweet pepper of two different nitrogen contents. Female L. rugulipennis spent more time on the cucumber salad host, and chose it first most often, but males showed no preference. Neither sex discriminated between sweet pepper or nettle leaves, but males made more first contacts with sweet pepper. Neither sex of L. tripustulatus discriminated between sweet pepper and nettle leaves when the sweet pepper had higher nitrogen. When the plant species contained equivalent nitrogen both sexes spent more time on nettle. There was no difference in first choice made by either sex. When visual stimuli were available, and leaves had equivalent nitrogen, L. rugulipennis showed no preference and L. tripustulatus preferred nettle leaves. We conclude that the generalist L. rugulipennis has the ability to use remote olfactory cues for host choice whereas the specialist L. tripustulatus relies mainly on contact chemosensory and gustatory cues.	[Wynde, Fiona J. H.; Port, Gordon R.] Univ Newcastle, Sch Biol, Newcastle Upon Tyne, Tyne & Wear, England	Newcastle University - UK	Wynde, FJH (corresponding author), Royal Soc Protect Birds, Sandy SG19 2DL, Beds, England.	fiona.hunter@rspb.org.uk			BBSRC; Horticultural Development Council [PC 123]	BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Horticultural Development Council	This work was supported by a studentship from the BBSRC (www.bbsrc.ac.uk/) and a grant from the Horticultural Development Council (PC 123) (www.hdc.org.uk/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen AA, 1959, ENTOMOLOGISTS MONTHL, V95, P268; [Anonymous], 1992, PLANT PHYSIOL; Bernays EA, 2001, ANNU REV ENTOMOL, V46, P703, DOI 10.1146/annurev.ento.46.1.703; Bernays EA, 1994, HOST PLANT SELECTION, P219; Bruce TJA, 2005, TRENDS PLANT SCI, V10, P269, DOI 10.1016/j.tplants.2005.04.003; CHARNOV EL, 1976, THEOR POPUL BIOL, V9, P129, DOI 10.1016/0040-5809(76)90040-X; Chen Zhan-Ce, 2010, Acta Entomologica Sinica, V53, P47; CHINTA S, 1994, J CHEM ECOL, V20, P3251, DOI 10.1007/BF02033724; Davis NT, 1955, THESIS IOWA STATE U; DRAGLAND S, 1991, Norsk Landbruksforsking, V5, P67; ERDELYI C, 1994, J APPL ENTOMOL, V117, P195, DOI 10.1111/j.1439-0418.1994.tb00725.x; Frati F, 2009, J CHEM ECOL, V35, P201, DOI 10.1007/s10886-008-9572-6; Gillespie DR, 2000, P LYG WORK GROUP M S; Hardie Jim, 2001, Symposia of the Royal Entomological Society of London, V20, P87, DOI 10.1079/9780851994567.0087; HARRIS MO, 1990, ENVIRON ENTOMOL, V19, P303, DOI 10.1093/ee/19.2.303; Holopainen JK, 1995, NEW PHYTOL, V131, P521, DOI 10.1111/j.1469-8137.1995.tb03088.x; HOLOPAINEN JK, 1991, J APPL ENTOMOL, V111, P484, DOI 10.1111/j.1439-0418.1991.tb00351.x; Jacobson R. J., 1999, Mededelingen Faculteit Landbouwkundige en Toegepaste Biologische Wetenschappen Universiteit Gent, V64, P67; Johnson CB, 2004, PHYTOCHEM ANALYSIS, V15, P286, DOI 10.1002/pca.780; MCNEILL S, 1973, J ANIM ECOL, V42, P495, DOI 10.2307/3119; McNeill S, 1978, BIOCH ASPECTS PLANT, P78; NOTTINGHAM SF, 1993, PHYSIOL ENTOMOL, V18, P389, DOI 10.1111/j.1365-3032.1993.tb00612.x; PROKOPY RJ, 1979, ENVIRON ENTOMOL, V8, P202, DOI 10.1093/ee/8.2.202; PROKOPY RJ, 1978, ENTOMOL EXP APPL, V24, P609, DOI 10.1007/BF02385116; RACZ V, 1993, J APPL ENTOMOL, V115, P511, DOI 10.1111/j.1439-0418.1993.tb00421.x; Rancati Manuela, 1996, Redia, V79, P143; Sedivy J, 1999, ROST VYROBA, V45, P255; Simonse MP, 1985, TUINDERJI, V65, P55; SOUTHWOOD T.R.E., 1959, LAND WATER BUGS BRIT; Southwood TRE, 1984, ORIGINS DEV ADAPTATI; STEWART RK, 1969, T ROY ENT SOC LONDON, V120, P437; ULENBERG S A, 1986, Entomologische Berichten (Amsterdam), V46, P163; VARIS A-L, 1972, Annales Agriculturae Fenniae, V11, P1; Varis A-L, 1972, ANN ENTOMOLOGIA FENN, V44, P72; VARIS AL, 1991, J ECON ENTOMOL, V84, P1037, DOI 10.1093/jee/84.3.1037; VARIS AL, 1995, J ECON ENTOMOL, V88, P855, DOI 10.1093/jee/88.4.855; VISSER JH, 1978, ENTOMOL EXP APPL, V24, P738, DOI 10.1007/BF02385130; Williams L, 2010, J CHEM ECOL, V36, P467, DOI 10.1007/s10886-010-9778-2; Woets J., 1976, Bulletin SROP, V1976, P34	39	5	6	4	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 3	2012	7	12							e46448	10.1371/journal.pone.0046448	http://dx.doi.org/10.1371/journal.pone.0046448			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	051DH	23226493	Green Published, gold, Green Submitted			2022-12-27	WOS:000312104700003
J	Bastiat, B; Sauviac, L; Picheraux, C; Rossignol, M; Bruand, C				Bastiat, Benedicte; Sauviac, Laurent; Picheraux, Carole; Rossignol, Michel; Bruand, Claude			Sinorhizobium meliloti Sigma Factors RpoE1 and RpoE4 Are Activated in Stationary Phase in Response to Sulfite	PLOS ONE			English	Article							MOLECULAR-BIOLOGY; GENE-EXPRESSION; STRESS-RESPONSE; NITROGEN; SYMBIOSIS; REGULON; IDENTIFICATION; METABOLISM; PROTEIN; GROWTH	Rhizobia are soil bacteria able to establish a nitrogen-fixing symbiosis with legume plants. Both in soil and in planta, rhizobia spend non-growing periods resembling the stationary phase of in vitro-cultured bacteria. The primary objective of this work was to better characterize gene regulation in this biologically relevant growth stage in Sinorhizobium meliloti. By a tap-tag/mass spectrometry approach, we identified five sigma factors co-purifying with the RNA polymerase in stationary phase: the general stress response regulator RpoE2, the heat shock sigma factor RpoH2, and three extra-cytoplasmic function sigma factors (RpoE1, RpoE3 and RpoE4) belonging to the poorly characterized ECF26 subgroup. We then showed that RpoE1 and RpoE4 i) are activated upon metabolism of sulfite-generating compounds (thiosulfate and taurine), ii) display overlapping regulatory activities, iii) govern a dedicated sulfite response by controlling expression of the sulfite dehydrogenase SorT, iv) are activated in stationary phase, likely as a result of endogenous sulfite generation during bacterial growth. We showed that SorT is required for optimal growth of S. meliloti in the presence of sulfite, suggesting that the response governed by RpoE1 and RpoE4 may be advantageous for bacteria in stationary phase either by providing a sulfite detoxification function or by contributing to energy production through sulfite respiration. This paper therefore reports the first characterization of ECF26 sigma factors, the first description of sigma factors involved in control of sulphur metabolism, and the first indication that endogenous sulfite may act as a signal for regulation of gene expression upon entry of bacteria in stationary phase.	[Bastiat, Benedicte; Sauviac, Laurent; Bruand, Claude] INRA, Lab Interact Plantes Microorganismes, UMR441, F-31326 Castanet Tolosan, France; [Bastiat, Benedicte; Sauviac, Laurent; Bruand, Claude] CNRS, Lab Interact Plantes Microorganismes, UMR2594, Castanet Tolosan, France; [Picheraux, Carole; Rossignol, Michel] CNRS, Inst Pharmacol & Biol Struct, Toulouse, France; [Picheraux, Carole; Rossignol, Michel] Univ Toulouse, Univ Toulouse 3, Toulouse, France	INRAE; Universite de Toulouse; Universite Federale Toulouse Midi-Pyrenees (ComUE); Universite Toulouse III - Paul Sabatier; Institut National des Sciences Appliquees de Toulouse; Centre National de la Recherche Scientifique (CNRS); Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Universite de Toulouse; Universite Federale Toulouse Midi-Pyrenees (ComUE); Universite Toulouse III - Paul Sabatier; Institut National des Sciences Appliquees de Toulouse; Universite de Toulouse; Universite Toulouse III - Paul Sabatier; Centre National de la Recherche Scientifique (CNRS); Universite de Toulouse; Universite Toulouse III - Paul Sabatier	Bruand, C (corresponding author), INRA, Lab Interact Plantes Microorganismes, UMR441, F-31326 Castanet Tolosan, France.	Claude.Bruand@toulouse.inra.fr	Bruand, Claude/AAF-7695-2020	Bruand, Claude/0000-0002-2367-0782	Departement Sante des Plantes et Environnement of INRA; Fondation pour la Recherche Medicale; Genopole Toulouse Midi-Pyrenees (program Biologie-Sante); Region Midi-Pyrenees; Ministere de la Recherche et de l'Enseignement Superieur	Departement Sante des Plantes et Environnement of INRA; Fondation pour la Recherche Medicale(Fondation pour la Recherche Medicale); Genopole Toulouse Midi-Pyrenees (program Biologie-Sante)(Region Occitanie); Region Midi-Pyrenees(Region Provence-Alpes-Cote d'AzurRegion Occitanie); Ministere de la Recherche et de l'Enseignement Superieur	This work was supported in part by the Departement Sante des Plantes et Environnement of INRA. The mass spectrometry analyses were supported, in part, by grants from the Fondation pour la Recherche Medicale (contrat Grands Equipements), the Genopole Toulouse Midi-Pyrenees (program Biologie-Sante) and the Region Midi-Pyrenees. This research was done in the Laboratoire des Interactions Plantes-Microorganismes, part of the Laboratoire d'Excellence (LABEX) entitled TULIP (ANR-10-LABX-41). BB was recipient of a French doctoral fellowship (Ministere de la Recherche et de l'Enseignement Superieur). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ampe F, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-2-r15; Barnett MJ, 2012, J BACTERIOL, V194, P4983, DOI 10.1128/JB.00449-12; Barra-Bily L, 2010, J BACTERIOL, V192, P1719, DOI 10.1128/JB.01429-09; Bastiat B, 2010, J BACTERIOL, V192, P2255, DOI 10.1128/JB.01666-09; Batisson I, 2003, INFECT IMMUN, V71, P4516, DOI 10.1128/IAI.71.8.4516-4525.2003; Battesti A, 2011, ANNU REV MICROBIOL, V65, P189, DOI 10.1146/annurev-micro-090110-102946; BERTELSEN F, 1988, ENVIRON GEOCHEM HLTH, V10, P26, DOI 10.1007/BF01675626; Bittner AN, 2006, J BACTERIOL, V188, P3507, DOI 10.1128/JB.188.10.3507-3515.2006; Bruggeman C, 2004, MICROBIOL-SGM, V150, P805, DOI 10.1099/mic.0.26795-0; Capela D, 2006, MOL PLANT MICROBE IN, V19, P363, DOI 10.1094/MPMI-19-0363; Chen HC, 2003, J BACTERIOL, V185, P5029, DOI 10.1128/JB.185.17.5029-5036.2003; Costanzo A, 2006, J BACTERIOL, V188, P4627, DOI 10.1128/JB.01981-05; Cowie A, 2006, APPL ENVIRON MICROB, V72, P7156, DOI 10.1128/AEM.01397-06; de Lucena DKC, 2010, BMC MICROBIOL, V10, DOI 10.1186/1471-2180-10-265; De-La-Pena C, 2008, J BIOL CHEM, V283, P25247, DOI 10.1074/jbc.M801967200; Denger K, 2006, MICROBIOL-SGM, V152, P3197, DOI 10.1099/mic.0.29195-0; DeRisi JL, 1997, SCIENCE, V278, P680, DOI 10.1126/science.278.5338.680; Djordjevic MA, 2004, PROTEOMICS, V4, P1859, DOI 10.1002/pmic.200300802; Dombrecht B, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-12-research0076; FIGURSKI DH, 1979, P NATL ACAD SCI USA, V76, P1648, DOI 10.1073/pnas.76.4.1648; Flechard M, 2009, FEMS MICROBIOL LETT, V290, P25, DOI 10.1111/j.1574-6968.2008.01401.x; Flechard M, 2010, MICROBIOL-SGM, V156, P1708, DOI 10.1099/mic.0.034850-0; Fredriksson A, 2005, J BACTERIOL, V187, P4207, DOI 10.1128/JB.187.12.4207-4213.2005; Friedrich CG, 2001, APPL ENVIRON MICROB, V67, P2873, DOI 10.1128/AEM.67.7.2873-2882.2001; Gage DJ, 2004, MICROBIOL MOL BIOL R, V68, P280, DOI 10.1128/MMBR.68.2.280-300.2004; Gage DJ, 2002, J BACTERIOL, V184, P7042, DOI 10.1128/JB.184.24.7042-7046.2002; Galibert F, 2001, SCIENCE, V293, P668, DOI 10.1126/science.1060966; Glazebrook BJ, 1991, METHOD ENZYMOL, V204, P398; GRIFFITH OW, 1987, METHOD ENZYMOL, V143, P366; Hauser F, 2007, MOL GENET GENOMICS, V278, P255, DOI 10.1007/s00438-007-0246-9; Helmann JD, 2002, ADV MICROB PHYSIOL, V46, P47; Hengge R, 2011, BACTERIAL STRESS RESPONSES, 2ND EDITION, P251; Humann JL, 2009, APPL ENVIRON MICROB, V75, P446, DOI 10.1128/AEM.02207-08; Jamet A, 2003, MOL PLANT MICROBE IN, V16, P217, DOI 10.1094/MPMI.2003.16.3.217; Jones KM, 2007, NAT REV MICROBIOL, V5, P619, DOI 10.1038/nrmicro1705; Kappler U, 2000, J BIOL CHEM, V275, P13202, DOI 10.1074/jbc.275.18.13202; Kappler U, 2001, FEMS MICROBIOL LETT, V203, P1, DOI 10.1016/S0378-1097(01)00304-4; Kappler U, 2011, BBA-BIOENERGETICS, V1807, P1, DOI 10.1016/j.bbabio.2010.09.004; Kredich N.M., 1996, ESCHERICHIA COLI SAL, P514; Krol E, 2004, MOL GENET GENOMICS, V272, P1, DOI 10.1007/s00438-004-1030-8; Krol E, 2011, MOL MICROBIOL; KUO MS, 1986, CARBOHYD RES, V156, P173, DOI 10.1016/S0008-6215(00)90109-5; Lefebre MD, 2002, APPL ENVIRON MICROB, V68, P5956, DOI 10.1128/AEM.68.12.5956-5964.2002; LEINWEBER FJ, 1987, METHOD ENZYMOL, V143, P15; Linton D, 2002, MOL MICROBIOL, V43, P497, DOI 10.1046/j.1365-2958.2002.02762.x; Low L, 2011, FRONT MICROBIOL, V2, DOI 10.3389/fmicb.2011.00058; Luo Y, 2010, J BACTERIOL, V192, P5736, DOI 10.1128/JB.00826-10; Mascher T, 2007, J BACTERIOL, V189, P6919, DOI 10.1128/JB.00904-07; MEADE HM, 1982, J BACTERIOL, V149, P114, DOI 10.1128/JB.149.1.114-122.1982; Meilhoc E, 2010, MOL PLANT MICROBE IN, V23, P748, DOI 10.1094/MPMI-23-6-0748; Mitsuhashi H, 1998, J LEUKOCYTE BIOL, V64, P595, DOI 10.1002/jlb.64.5.595; Mitsui H, 2004, MOL GENET GENOMICS, V271, P416, DOI 10.1007/s00438-004-0992-x; Myers JD, 2005, MICROBIOL-SGM, V151, P233, DOI 10.1099/mic.0.27573-0; Llorens JMN, 2010, FEMS MICROBIOL REV, V34, P476, DOI 10.1111/j.1574-6976.2010.00213.x; Nystrom T, 2004, ANNU REV MICROBIOL, V58, P161, DOI 10.1146/annurev.micro.58.030603.123818; Oke V, 2001, MICROBIOL-SGM, V147, P2399, DOI 10.1099/00221287-147-9-2399; Ono Y, 2001, MOL GEN GENET, V264, P902, DOI 10.1007/s004380000380; PETERSON KM, 1988, INFECT IMMUN, V56, P2822, DOI 10.1128/IAI.56.11.2822-2829.1988; Pobigaylo N, 2006, APPL ENVIRON MICROB, V72, P4329, DOI 10.1128/AEM.03072-05; QUANDT J, 1993, GENE, V127, P15, DOI 10.1016/0378-1119(93)90611-6; Salazar E, 2010, APPL ENVIRON MICROB, V76, P4510, DOI 10.1128/AEM.02007-09; Sauviac L, 2007, J BACTERIOL, V189, P4204, DOI 10.1128/JB.00175-07; Schluter JP, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-245; Staron A, 2009, MOL MICROBIOL, V74, P557, DOI 10.1111/j.1365-2958.2009.06870.x; van der Ploeg JR, 2001, ARCH MICROBIOL, V176, P1, DOI 10.1007/s002030100298; van Overbeek LS, 1997, MODERN SOIL MICROBIO; VASSE J, 1990, J BACTERIOL, V172, P4295, DOI 10.1128/jb.172.8.4295-4306.1990; Wagner MA, 2009, J BACTERIOL, V191, P1695, DOI 10.1128/JB.01536-08; Wilson JJ, 2009, BBA-BIOENERGETICS, V1787, P1516, DOI 10.1016/j.bbabio.2009.07.005; Zahran HH, 1999, MICROBIOL MOL BIOL R, V63, P968, DOI 10.1128/MMBR.63.4.968-989.1999	70	12	12	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 30	2012	7	11							e50768	10.1371/journal.pone.0050768	http://dx.doi.org/10.1371/journal.pone.0050768			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	054WM	23226379	Green Published, gold			2022-12-27	WOS:000312376100190
J	Bhatia, S; Moon, J; Margolin, KA; Weber, JS; Lao, CD; Othus, M; Aparicio, AM; Ribas, A; Sondak, VK				Bhatia, Shailender; Moon, James; Margolin, Kim A.; Weber, Jeffrey S.; Lao, Christopher D.; Othus, Megan; Aparicio, Ana M.; Ribas, Antoni; Sondak, Vernon K.			Phase II Trial of Sorafenib in Combination with Carboplatin and Paclitaxel in Patients with Metastatic Uveal Melanoma: SWOG S0512	PLOS ONE			English	Article							EX-VIVO CHEMOSENSITIVITY; RAF/MEK/ERK PATHWAY; CHOROIDAL MELANOMA; PROGRESSION-FREE; SURVIVAL; MUTATIONS; BRAF; GEMCITABINE; BAY-43-9006; ACTIVATION	Background: Sorafenib, a multikinase inhibitor of cell proliferation and angiogenesis, inhibits the mitogen-activated protein kinase pathway that is activated in most uveal melanoma tumors. This phase II study was conducted by the SWOG cooperative group to evaluate the efficacy of sorafenib in combination with carboplatin and paclitaxel (CP) in metastatic uveal melanoma. Methods: Twenty-five patients with stage IV uveal melanoma who had received 0-1 prior systemic therapy were enrolled. Treatment included up to 6 cycles of carboplatin (AUC = 6) and paclitaxel (225 mg/m(2)) administered IV on day 1 plus sorafenib (400 mg PO twice daily), followed by sorafenib monotherapy until disease progression. The primary endpoint was objective response rate (ORR); a two-stage design was used with the study to be terminated if no confirmed responses were observed in the first 20 evaluable patients. Secondary efficacy endpoints included progression-free survival (PFS) and overall survival (OS). Results: No confirmed objective responses occurred among the 24 evaluable patients (ORR = 0% [95% CI: 0-14%]) and the study was terminated at the first stage. Minor responses (tumor regression less than 30%) were seen in eleven of 24 (45%) patients. The median PFS was 4 months [95% CI: 1-6 months] and the 6-month PFS was 29% [95% CI: 13%-48%]. The median OS was 11 months [95% CI: 7-14 months]. Conclusion: In this study, the overall efficacy of CP plus sorafenib in metastatic uveal melanoma did not warrant further clinical testing when assessed by ORR, although minor tumor responses and stable disease were observed in some patients.	[Bhatia, Shailender; Margolin, Kim A.] Univ Washington, Seattle, WA 98195 USA; [Moon, James; Othus, Megan] SWOG Stat Ctr, Seattle, WA USA; [Weber, Jeffrey S.; Sondak, Vernon K.] Univ S Florida, H Lee Moffitt Canc Ctr, Tampa, FL 33682 USA; [Lao, Christopher D.] Univ Michigan, Ann Arbor, MI 48109 USA; [Aparicio, Ana M.] Univ Texas MD Anderson Canc Ctr, Houston, TX 77030 USA; [Ribas, Antoni] Univ Calif Los Angeles, Med Ctr, Los Angeles, CA 90024 USA	University of Washington; University of Washington Seattle; Southwest Oncology Group; H Lee Moffitt Cancer Center & Research Institute; State University System of Florida; University of South Florida; University of Michigan System; University of Michigan; University of Texas System; UTMD Anderson Cancer Center; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center	Bhatia, S (corresponding author), Univ Washington, Seattle, WA 98195 USA.	sbhatia@uw.edu		Margolin, Kim/0000-0002-5248-4356	National Cancer Institute, National Institutes of Health, Department of Health and Human Services [CA32102, CA38926, CA27057, CA42777, CA35178, CA20319, CA58861, CA04919, CA76429]; NATIONAL CANCER INSTITUTE [U10CA035178, U10CA076429, U10CA038926, U10CA027057, U10CA058861, U10CA020319, U10CA032102, U10CA042777, P30CA015704, U10CA004919] Funding Source: NIH RePORTER	National Cancer Institute, National Institutes of Health, Department of Health and Human Services(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This investigation was supported in part by the following PHS Cooperative Agreement grant numbers awarded by the National Cancer Institute, National Institutes of Health, Department of Health and Human Services: CA32102, CA38926, CA27057, CA42777, CA35178, CA20319, CA58861, CA04919, and CA76429. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding was received for this study.	Amaravadi RK, 2009, CLIN CANCER RES, V15, P7711, DOI 10.1158/1078-0432.CCR-09-2074; Augsburger JJ, 2009, AM J OPHTHALMOL, V148, P119, DOI 10.1016/j.ajo.2009.01.023; Bedikian Agop Y., 2006, International Ophthalmology Clinics, V46, P151, DOI 10.1097/01.iio.0000195852.08453.de; BROOKMEYER R, 1982, BIOMETRICS, V38, P29, DOI 10.2307/2530286; Carter CA, 2007, CANCER CHEMOTH PHARM, V59, P183, DOI 10.1007/s00280-006-0257-y; Chang AE, 1998, CANCER, V83, P1664, DOI 10.1002/(SICI)1097-0142(19981015)83:8<1664::AID-CNCR23>3.0.CO;2-G; COCKCROFT DW, 1976, NEPHRON, V16, P31, DOI 10.1159/000180580; Diener-West M, 2005, ARCH OPHTHALMOL-CHIC, V123, P1639; EINHORN LH, 1974, CANCER, V34, P1001, DOI 10.1002/1097-0142(197410)34:4<1001::AID-CNCR2820340406>3.0.CO;2-Z; Escudier B, 2007, NEW ENGL J MED, V356, P125, DOI 10.1056/NEJMoa060655; Flaherty KT, 2010, NEW ENGL J MED, V363, P809, DOI 10.1056/NEJMoa1002011; Flaherty KT, 2006, ANN ONCOL, V17, P33; GREEN SJ, 1992, STAT MED, V11, P853, DOI 10.1002/sim.4780110703; Guenterberg KD, 2011, AM J CLIN ONCOL-CANC, V34, P87, DOI 10.1097/COC.0b013e3181d2ed67; Hauschild A, 2009, J CLIN ONCOL, V27, P2823, DOI 10.1200/JCO.2007.15.7636; Heim M., 2003, International Journal of Clinical Pharmacology and Therapeutics, V41, P616; KAPLAN EL, 1958, J AM STAT ASSOC, V53, P457, DOI 10.2307/2281868; Korn EL, 2008, J CLIN ONCOL, V26, P527, DOI 10.1200/JCO.2007.12.7837; Kujala E, 2003, INVEST OPHTH VIS SCI, V44, P4651, DOI 10.1167/iovs.03-0538; Kupsch Petra, 2005, Clin Colorectal Cancer, V5, P188, DOI 10.3816/CCC.2005.n.030; McLaughlin CC, 2005, CANCER-AM CANCER SOC, V103, P1000, DOI 10.1002/cncr.20866; Missotten GSO, 2006, ARCH OPHTHALMOL-CHIC, V124, P1428, DOI 10.1001/archopht.124.10.1428; Myatt N, 1997, ANTI-CANCER DRUG, V8, P756, DOI 10.1097/00001813-199709000-00004; Neale MH, 1999, BRIT J CANCER, V79, P1487, DOI 10.1038/sj.bjc.6690237; Neale MH, 2001, MELANOMA RES, V11, P601, DOI 10.1097/00008390-200112000-00006; Patel M, 2011, CLIN CANCER RES, V17, P2087, DOI 10.1158/1078-0432.CCR-10-3169; Peyssonnaux C, 2001, BIOL CELL, V93, P53, DOI 10.1016/S0248-4900(01)01125-X; Pingpank JF, 2010, J CLIN ONCOL, V28, DOI 10.1200/jco.2010.28.18_suppl.lba8512; Poulikakos PI, 2010, NATURE, V464, P427, DOI 10.1038/nature08902; RAJPAL S, 1983, CANCER, V52, P334, DOI 10.1002/1097-0142(19830715)52:2<334::AID-CNCR2820520225>3.0.CO;2-E; Richly H, 2006, ANN ONCOL, V17, P866, DOI 10.1093/annonc/mdl017; Richly H, 2004, Int J Clin Pharmacol Ther, V42, P650; Sato T, 2010, SEMIN ONCOL, V37, P127, DOI 10.1053/j.seminoncol.2010.03.014; Singh AD, 2011, OPHTHALMOLOGY, V118, P1881, DOI 10.1016/j.ophtha.2011.01.040; Siu LL, 2006, CLIN CANCER RES, V12, P144, DOI 10.1158/1078-0432.CCR-05-1571; Stitt AW, 1998, J PATHOL, V186, P306, DOI 10.1002/(SICI)1096-9896(1998110)186:3<306::AID-PATH183>3.0.CO;2-B; Therasse P, 2000, J NATL CANCER I, V92, P205, DOI 10.1093/jnci/92.3.205; Van Raamsdonk CD, 2010, NEW ENGL J MED, V363, P2191, DOI 10.1056/NEJMoa1000584; Van Raamsdonk CD, 2009, NATURE, V457, P599, DOI 10.1038/nature07586; Weber A, 2003, LAB INVEST, V83, P1771, DOI 10.1097/01.LAB.0000101732.89463.29; Wilhelm SM, 2004, CANCER RES, V64, P7099, DOI 10.1158/0008-5472.CAN-04-1443; Yang H, 2010, INVEST OPHTH VIS SCI, V51, P2835, DOI 10.1167/iovs.09-4755; Zuidervaart W, 2005, BRIT J CANCER, V92, P2032, DOI 10.1038/sj.bjc.6602598	43	50	51	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 30	2012	7	11							e48787	10.1371/journal.pone.0048787	http://dx.doi.org/10.1371/journal.pone.0048787			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	054WM	23226204	Green Published, Green Submitted, gold			2022-12-27	WOS:000312376100013
J	Kannan, M; Lee, SJ; Schwedhelm-Domeyer, N; Nakazawa, T; Stegmuller, J				Kannan, Madhuvanthi; Lee, Shih-Ju; Schwedhelm-Domeyer, Nicola; Nakazawa, Takanobu; Stegmueller, Judith			p250GAP Is a Novel Player in the Cdh1-APC/Smurf1 Pathway of Axon Growth Regulation	PLOS ONE			English	Article							ANAPHASE-PROMOTING COMPLEX; GTPASE-ACTIVATING-PROTEIN; E3 LIGASE SMURF1; UBIQUITIN LIGASE; RHO-GTPASES; CELL-CYCLE; DEGRADATION; RECEPTOR; MORPHOGENESIS; CONE	Axon growth is an essential process during brain development. The E3 ubiquitin ligase Cdh1-APC has emerged as a critical regulator of intrinsic axon growth control. Here, we identified the RhoGAP p250GAP as a novel interactor of the E3 ubiquitin ligase Cdh1-APC and found that p250GAP promotes axon growth downstream of Cdh1-APC. We also report that p250GAP undergoes non-proteolytic ubiquitination and associates with the Cdh1 substrate Smurf1 to synergistically regulate axon growth. Finally, we found that in vivo knockdown of p250GAP in the developing cerebellar cortex results in impaired migration and axonal growth. Taken together, our data indicate that Cdh1-APC together with the RhoA regulators p250GAP and Smurf1 controls axon growth in the mammalian brain.	[Kannan, Madhuvanthi; Lee, Shih-Ju; Schwedhelm-Domeyer, Nicola; Stegmueller, Judith] Max Planck Inst Expt Med, D-3400 Gottingen, Germany; [Nakazawa, Takanobu] Univ Tokyo, Sch Med, Dept Neurophysiol, Tokyo 113, Japan	Max Planck Society; University of Tokyo	Stegmuller, J (corresponding author), Max Planck Inst Expt Med, Hermann Rein Str 3, D-3400 Gottingen, Germany.	stegmueller@em.mpg.de	Nakazawa, Takanobu/E-1012-2014	Nakazawa, Takanobu/0000-0002-5049-9140; Kannan, Madhuvanthi/0000-0003-0664-7377; NAKAZAWA, Takanobu/0000-0003-4863-1277	Max Planck Society; German Research Foundation (Deutsche Forschungsgemeinschaft); Gottingen Graduate School for Neurosciences, Biophysics, and Molecular Biosciences (GGNB) Excellence Stipend of the University of Gottingen	Max Planck Society(Max Planck Society); German Research Foundation (Deutsche Forschungsgemeinschaft)(German Research Foundation (DFG)); Gottingen Graduate School for Neurosciences, Biophysics, and Molecular Biosciences (GGNB) Excellence Stipend of the University of Gottingen	This study was supported by the Max Planck Society (J.S.), the German Research Foundation (Deutsche Forschungsgemeinschaft) (J.S.), and the Gottingen Graduate School for Neurosciences, Biophysics, and Molecular Biosciences (GGNB) Excellence Stipend of the University of Gottingen (S.J.L.). The funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.	Bhat KP, 2011, BBA-GENE REGUL MECH, V1809, P150, DOI 10.1016/j.bbagrm.2010.11.006; Cheng PL, 2011, NEURON, V69, P231, DOI 10.1016/j.neuron.2010.12.021; Cui Y, 2011, EMBO J, V30, P2675, DOI 10.1038/emboj.2011.155; D'Arca D, 2010, P NATL ACAD SCI USA, V107, P5875, DOI 10.1073/pnas.0912874107; Dent EW, 2003, NEURON, V40, P209, DOI 10.1016/S0896-6273(03)00633-0; Dickson BJ, 2001, CURR OPIN NEUROBIOL, V11, P103, DOI 10.1016/S0959-4388(00)00180-X; Govek EE, 2005, GENE DEV, V19, P1, DOI 10.1101/gad.1256405; Greer PL, 2010, CELL, V140, P704, DOI 10.1016/j.cell.2010.01.026; Huber AB, 2003, ANNU REV NEUROSCI, V26, P509, DOI 10.1146/annurev.neuro.26.010302.081139; Huynh MA, 2011, NEURON, V69, P930, DOI 10.1016/j.neuron.2011.02.008; Huynh MA, 2009, J NEUROSCI, V29, P4322, DOI 10.1523/JNEUROSCI.5329-08.2009; Ikeuchi Y, 2009, J NEUROSCI, V29, P4312, DOI 10.1523/JNEUROSCI.0126-09.2009; JOHNSON ES, 1995, J BIOL CHEM, V270, P17442, DOI 10.1074/jbc.270.29.17442; Kannan M, 2012, DEVELOPMENT, V139, P3600, DOI 10.1242/dev.081786; Kawabe H, 2011, NAT REV NEUROSCI, V12, P251, DOI 10.1038/nrn3009; Kawabe H, 2010, CELL CYCLE, V9, P2477, DOI 10.4161/cc.9.13.12236; Kawabe H, 2010, NEURON, V65, P358, DOI 10.1016/j.neuron.2010.01.007; Kholmanskikh SS, 2006, NAT NEUROSCI, V9, P50, DOI 10.1038/nn1619; Konishi Y, 2004, SCIENCE, V303, P1026, DOI 10.1126/science.1093712; Konishi Y, 2002, MOL CELL, V9, P1005, DOI 10.1016/S1097-2765(02)00524-5; Konno D, 2005, J BIOL CHEM, V280, P5082, DOI 10.1074/jbc.M408251200; Kuczera T, 2011, LEARN MEMORY, V18, P49, DOI 10.1101/lm.1998411; Lasorella A, 2006, NATURE, V442, P471, DOI 10.1038/nature04895; Lewcock JW, 2007, NEURON, V56, P604, DOI 10.1016/j.neuron.2007.09.009; Li M, 2008, NAT CELL BIOL, V10, P1083, DOI 10.1038/ncb1768; Litterman N, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1001060; Luo LQ, 2000, NAT REV NEUROSCI, V1, P173, DOI 10.1038/35044547; McGee AW, 2003, TRENDS NEUROSCI, V26, P193, DOI 10.1016/S0166-2236(03)00062-6; Nakamura T, 2002, MOL CELL BIOL, V22, P8721, DOI 10.1128/MCB.22.24.8721-8734.2002; Nakazawa T, 2003, MOL BIOL CELL, V14, P2921, DOI 10.1091/mbc.e02-09-0623; Nakazawa T, 2008, J NEUROCHEM, V105, P1384, DOI 10.1111/j.1471-4159.2008.05335.x; Nasu-Nishimura Y, 2006, GENES CELLS, V11, P607, DOI 10.1111/j.1365-2443.2006.00966.x; Qian SB, 2002, J BIOL CHEM, V277, P38818, DOI 10.1074/jbc.M205547200; Schwab ME, 2004, CURR OPIN NEUROBIOL, V14, P118, DOI 10.1016/j.conb.2004.01.004; Solecki DJ, 2004, NAT NEUROSCI, V7, P1195, DOI 10.1038/nn1332; Stegmuller J, 2008, J NEUROSCI, V28, P1961, DOI 10.1523/JNEUROSCI.3061-07.2008; Stegmuller J, 2006, NEURON, V50, P389, DOI 10.1016/j.neuron.2006.03.034; Stroschein SL, 2001, GENE DEV, V15, P2822; Tuoc TC, 2008, GENE DEV, V22, P1972, DOI 10.1101/gad.471708; Wang HR, 2006, METHOD ENZYMOL, V406, P437, DOI 10.1016/S0076-6879(06)06032-0; Wang HR, 2003, SCIENCE, V302, P1775, DOI 10.1126/science.1090772; Westbrook TF, 2008, NATURE, V452, P370, DOI 10.1038/nature06780; Yi JJ, 2007, PHARMACOL REV, V59, P14, DOI 10.1124/pr.59.1.4	43	20	20	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 30	2012	7	11							e50735	10.1371/journal.pone.0050735	http://dx.doi.org/10.1371/journal.pone.0050735			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	054WM	23226367	Green Published, Green Submitted, gold			2022-12-27	WOS:000312376100178
J	Merikanto, I; Laakso, J; Kaitala, V				Merikanto, Ilona; Laakso, Jouni; Kaitala, Veijo			Outside-Host Growth of Pathogens Attenuates Epidemiological Outbreaks	PLOS ONE			English	Article							PARASITE POPULATION INTERACTIONS; CATFISH ICTALURUS-PUNCTATUS; TROUT ONCORHYNCHUS-MYKISS; FLAVOBACTERIUM-COLUMNARE; CHANNEL CATFISH; RAINBOW-TROUT; VIRULENCE; EVOLUTION; DYNAMICS; SURVIVAL	Opportunist saprotrophic pathogens differ from obligatory pathogens due to their capability in host-independent growth in environmental reservoirs. Thus, the outside-host environment potentially influences host-pathogen dynamics. Despite the socio-economical importance of these pathogens, theory on their dynamics is practically missing. We analyzed a novel epidemiological model that couples outside-host density-dependent growth to host-pathogen dynamics. Parameterization was based on columnaris disease, a major hazard in fresh water fish farms caused by saprotrophic Flavobacterium columnare. Stability analysis and numerical simulations revealed that the outside-host growth maintains high proportion of infected individuals, and under some conditions can drive host extinct. The model can show stable or cyclic dynamics, and the outside-host growth regulates the frequency and intensity of outbreaks. This result emerges because the density-dependence stabilizes dynamics. Our analysis demonstrates that coupling of outside-host growth and traditional host-pathogen dynamics has profound influence on disease prevalence and dynamics. This also has implications on the control of these diseases.	[Merikanto, Ilona; Laakso, Jouni; Kaitala, Veijo] Univ Helsinki, Dept Biosci, Helsinki, Finland; [Merikanto, Ilona] Natl Inst Hlth & Welf, Dept Mental Hlth & Subst Abuse Serv, Helsinki, Finland; [Laakso, Jouni] Univ Jyvaskyla, Dept Biol & Environm Sci, Ctr Excellence Biol Interact, Jyvaskyla, Finland	University of Helsinki; Finland National Institute for Health & Welfare; University of Jyvaskyla	Merikanto, I (corresponding author), Univ Helsinki, Dept Biosci, Helsinki, Finland.	ilona.merikanto@helsinki.fi	merikanto, ilona/AAF-2395-2021; Laakso, Jouni/I-7794-2013	Laakso, Jouni/0000-0001-8245-9912; Merikanto, Ilona/0000-0002-1222-6678	Finnish Academy [1130724, 125572]; Research Foundation of the University of Helsinki	Finnish Academy(Academy of Finland); Research Foundation of the University of Helsinki	This study was funded by the Finnish Academy projects 1130724 and 125572 for Jouni Laakso and a personal grant for IM from the Research Foundation of the University of Helsinki. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abrams PA, 1996, ECOLOGY, V77, P610, DOI 10.2307/2265634; Abrams PA, 1997, EVOLUTION, V51, P1742, DOI 10.1111/j.1558-5646.1997.tb05098.x; Abrams PA, 2000, ANNU REV ECOL SYST, V31, P79, DOI 10.1146/annurev.ecolsys.31.1.79; ANDERSON RM, 1978, J ANIM ECOL, V47, P219, DOI 10.2307/3933; ANDERSON RM, 1981, PHILOS T R SOC B, V291, P451, DOI 10.1098/rstb.1981.0005; Arslan Murat, 2007, Turkish Journal of Zoology, V31, P185; Atse CB, 2002, AQUAC RES, V33, P299, DOI 10.1046/j.1355-557x.2002.00674.x; Balmer O, 2009, ECOLOGY, V90, P3367, DOI 10.1890/08-2291.1; Bell AS, 2006, EVOLUTION, V60, P1358, DOI 10.1111/j.0014-3820.2006.tb01215.x; Boldin B, 2011, ECOL LETT, V14, P569; Casadevall A, 2008, ANNU REV MICROBIOL, V62, P19, DOI 10.1146/annurev.micro.61.080706.093305; Chang MX, 2008, VET IMMUNOL IMMUNOP, V124, P295, DOI 10.1016/j.vetimm.2008.04.003; Danie DS, 1984, FWSOBS821122 US ARM; Edelstein-Keshet L., 1988, MATH MODELS BIOL; FLYG C, 1980, J GEN MICROBIOL, V120, P173; Frank SA, 1996, Q REV BIOL, V71, P37, DOI 10.1086/419267; Freitag NE, 2009, NAT REV MICROBIOL, V7, P623, DOI 10.1038/nrmicro2171; Friedman Herman, 2002, Semin Pediatr Infect Dis, V13, P273, DOI 10.1053/spid.2002.127206; Gillet C, 1991, AQUAT LIVING RESOUR, V4, P109, DOI 10.1051/alr:1991010; Gioacchini G, 2010, REPRODUCTION, V140, P953, DOI 10.1530/REP-10-0145; Godfray HCJ, 1999, P ROY SOC B-BIOL SCI, V266, P233, DOI 10.1098/rspb.1999.0627; GOWEN JW, 1946, AM NAT, V80, P149, DOI 10.1086/281373; GRIMONT PAD, 1978, ANNU REV MICROBIOL, V32, P221, DOI 10.1146/annurev.mi.32.100178.001253; Hall-Stoodley L, 2005, TRENDS MICROBIOL, V13, P7, DOI 10.1016/j.tim.2004.11.004; Halpern M, 2007, ENVIRON MICROBIOL, V9, P584, DOI 10.1111/j.1462-2920.2006.01174.x; HARSHBARGER TJ, 1979, PROG FISH CULT, V41, P206, DOI 10.1577/1548-8659(1979)41[206:SOBTE]2.0.CO;2; Hiltunen T, 2012, ACTA OECOL, V38, P77, DOI 10.1016/j.actao.2011.09.010; HOLT RD, 1977, THEOR POPUL BIOL, V12, P197, DOI 10.1016/0040-5809(77)90042-9; Hudson P., 2002, ECOLOGY WILDLIFE DIS; Joh RI, 2009, B MATH BIOL, V71, P845, DOI 10.1007/s11538-008-9384-4; Kaltz O, 2002, J EVOLUTION BIOL, V15, P850, DOI 10.1046/j.1420-9101.2002.00433.x; Kunttu HMT, 2009, EPIDEMICS-NETH, V1, P96, DOI 10.1016/j.epidem.2009.04.003; Kunttu HM, 2012, ENV MICROBI IN PRESS; Lafforgue G, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017917; Leclerc H, 2002, CRIT REV MICROBIOL, V28, P371, DOI 10.1080/1040-840291046768; Levin BR, 1996, EMERG INFECT DIS, V2, P93, DOI 10.3201/eid0202.960203; Lipsitch M, 1997, TRENDS MICROBIOL, V5, P31, DOI 10.1016/S0966-842X(97)81772-6; Madetoja J, 2000, DIS AQUAT ORGAN, V43, P27, DOI 10.3354/dao043027; Mahlen SD, 2011, CLIN MICROBIOL REV, V24, P755, DOI 10.1128/CMR.00017-11; Mandal S, 2011, ASIAN PAC J TROP MED, V4, P573, DOI 10.1016/S1995-7645(11)60149-1; MAY RM, 1978, J ANIM ECOL, V47, P249, DOI 10.2307/3934; Montarry J, 2006, J EVOLUTION BIOL, V19, P522, DOI 10.1111/j.1420-9101.2005.01005.x; MURDOCH WW, 1973, J APPL ECOL, V10, P335; Murugaiah C, 2011, CRIT REV MICROBIOL, V37, P337, DOI 10.3109/1040841X.2011.603288; Parker D, 2011, AM J RESP CELL MOL, V45, P189, DOI 10.1165/rcmb.2011-0011RT; Pulkkinen K, 2010, P ROY SOC B-BIOL SCI, V277, P593, DOI 10.1098/rspb.2009.1659; QUINN TP, 1992, NEW ZEAL J MAR FRESH, V26, P429, DOI 10.1080/00288330.1992.9516536; Rahman MH, 2008, DNA CELL BIOL, V27, P347, DOI 10.1089/dna.2008.0737; Read Andrew F., 1994, Trends in Microbiology, V2, P73, DOI 10.1016/0966-842X(94)90537-1; Roche B, 2011, ECOL LETT, V14, P569, DOI 10.1111/j.1461-0248.2011.01619.x; SERVAIS P, 1985, APPL ENVIRON MICROB, V49, P1448, DOI 10.1128/AEM.49.6.1448-1454.1985; Sink TD, 2008, AQUACULTURE, V283, P68, DOI 10.1016/j.aquaculture.2008.07.024; Soto E, 2008, J APPL MICROBIOL, V104, P1302, DOI 10.1111/j.1365-2672.2007.03632.x; Suomalainen LR, 2006, DIS AQUAT ORGAN, V70, P55, DOI 10.3354/dao070055; Suomalainen LR, 2006, J FISH DIS, V29, P757, DOI 10.1111/j.1365-2761.2006.00771.x; Suomalainen LR, 2005, DIS AQUAT ORGAN, V63, P61, DOI 10.3354/dao063061; Tirri R, 2003, BIOL SANAKIRJA; TYLER CR, 1990, BIOL REPROD, V43, P202, DOI 10.1095/biolreprod43.2.202; Veneault-Fourrey C, 2011, CURR OPIN PLANT BIOL, V14, P444, DOI 10.1016/j.pbi.2011.03.022; Wagner BA, 2002, J AQUAT ANIM HEALTH, V14, P263, DOI 10.1577/1548-8667(2002)014&lt;0263:TEOBDI&gt;2.0.CO;2; Walther BA, 2004, BIOL REV, V79, P849, DOI 10.1017/S1464793104006475; Wang IN, 2006, GENETICS, V172, P17, DOI 10.1534/genetics.105.045922; Winckler-Sosinski L., 2005, ACTA LIMNOL BRAS, V17, P465	64	15	15	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 30	2012	7	11							e50158	10.1371/journal.pone.0050158	http://dx.doi.org/10.1371/journal.pone.0050158			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	054WM	23226245	Green Submitted, Green Published, gold			2022-12-27	WOS:000312376100054
J	Messiaen, P; De Spiegelaere, W; Alcami, J; Vervisch, K; Van Acker, P; Verhasselt, B; Meuwissen, P; Calonge, E; Gonzalez, N; Gutierrez-Rodero, F; Rodriguez-Martin, C; Sermijn, E; Poppe, B; Vogelaers, D; Verhofstede, C; Vandekerckhove, L				Messiaen, Peter; De Spiegelaere, Ward; Alcami, Jose; Vervisch, Karen; Van Acker, Petra; Verhasselt, Bruno; Meuwissen, Pieter; Calonge, Esther; Gonzalez, Nuria; Gutierrez-Rodero, Felix; Rodriguez-Martin, Carmen; Sermijn, Erica; Poppe, Bruce; Vogelaers, Dirk; Verhofstede, Chris; Vandekerckhove, Linos			Characterization of LEDGF/p75 Genetic Variants and Association with HIV-1 Disease Progression	PLOS ONE			English	Article							INTEGRASE; INFECTION; PROTEIN; STRESS; SUSCEPTIBILITY; IDENTIFICATION; CCR5-DELTA-32; ACTIVATION; MUTATIONS; INTERACTS	Background: As Lens epithelium-derived growth factor (LEDGF/p75) is an important co-factor involved in HIV-1 integration, the LEDGF/p75-IN interaction is a promising target for the new class of allosteric HIV integrase inhibitors (LEDGINs). Few data are available on the genetic variability of LEDGF/p75 and the influence on HIV disease in vivo. This study evaluated the relation between LEDGF/p75 genetic variation, mRNA expression and HIV-1 disease progression in order to guide future clinical use of LEDGINs. Methods: Samples were derived from a therapy-naive cohort at Ghent University Hospital and a Spanish long-term-non-progressor cohort. High-resolution melting curve analysis and Sanger sequencing were used to identify all single nucleotide polymorphisms (SNPs) in the coding region, flanking intronic regions and full 3'UTR of LEDGF/p75. In addition, two intronic tagSNPs were screened based on previous indication of influencing HIV disease. LEDGF/p75 mRNA was quantified in patient peripheral blood mononuclear cells (PBMC) using RT-qPCR. Results: 325 samples were investigated from patients of Caucasian (n = 291) and African (n = 34) origin, including Elite (n = 49) and Viremic controllers (n = 62). 21 SNPs were identified, comprising five in the coding region and 16 in the non-coding regions and 3'UTR. The variants in the coding region were infrequent and had no major impact on protein structure according to SIFT and PolyPhen score. One intronic SNP (rs2737828) was significantly under-represented in Caucasian patients (P<0.0001) compared to healthy controls (HapMap). Two SNPs showed a non-significant trend towards association with slower disease progression but not with LEDGF/p75 expression. The observed variation in LEDGF/p75 expression was not correlated with disease progression. Conclusions: LEDGF/p75 is a highly conserved protein. Two non-coding polymorphisms were identified indicating a correlation with disease outcome, but further research is needed to clarify phenotypic impact. The conserved coding region and the observed variation in LEDGF/p75 expression are important characteristics for clinical use of LEDGINs.	[Messiaen, Peter; De Spiegelaere, Ward; Vervisch, Karen; Sermijn, Erica; Vogelaers, Dirk; Vandekerckhove, Linos] Ghent Univ Hosp, Dept Gen Internal Med & Infect Dis, HIV Translat Res Unit, Ghent, Belgium; [Alcami, Jose; Calonge, Esther; Gonzalez, Nuria] Inst Salud Carlos III, Ctr Nacl Microbiol, Unidad Inmunopatol SIDA, Madrid, Spain; [Van Acker, Petra; Poppe, Bruce] Univ Ghent, Ctr Med Genet, B-9000 Ghent, Belgium; [Verhasselt, Bruno; Meuwissen, Pieter; Verhofstede, Chris; Vandekerckhove, Linos] Univ Ghent, Dept Clin Chem Microbiol & Immunol, B-9000 Ghent, Belgium; [Gutierrez-Rodero, Felix] Hosp Gen Elx, Alicante, Spain; [Rodriguez-Martin, Carmen] Ctr Sanitario Sandoval, Madrid, Spain	Ghent University; Ghent University Hospital; Instituto de Salud Carlos III; Centro Nacional de Microbiologa (CNM); Ghent University; Ghent University	Vandekerckhove, L (corresponding author), Ghent Univ Hosp, Dept Gen Internal Med & Infect Dis, HIV Translat Res Unit, Ghent, Belgium.	Linos.Vandekerckhove@ugent.be	Vandekerckhove, Linos/J-6420-2013; Alcami, Pepe/T-2242-2018; De Spiegelaere, Ward/C-6245-2008	Vandekerckhove, Linos/0000-0002-8600-1631; Alcami, Pepe/0000-0003-0023-7377; De Spiegelaere, Ward/0000-0003-2097-8439; Calonge, Esther/0000-0003-2175-5237; Gonzalez, Nuria/0000-0002-0087-5144; Verhasselt, Bruno/0000-0002-4645-1144	Flemish Agency for Innovation by Science and Technology (CellCoVir - IWT) [60813]; National Fund for Scientific Research - Belgium; Instituto de Salud Carlos III [RD06/0006/0035]; Fundacion para la Investigacion y Prevencion del SIDA en Espana (FIPSE)	Flemish Agency for Innovation by Science and Technology (CellCoVir - IWT)(Institute for the Promotion of Innovation by Science and Technology in Flanders (IWT)); National Fund for Scientific Research - Belgium(Fonds de la Recherche Scientifique - FNRS); Instituto de Salud Carlos III(Instituto de Salud Carlos IIIEuropean Commission); Fundacion para la Investigacion y Prevencion del SIDA en Espana (FIPSE)	This work was partly supported by the Flemish Agency for Innovation by Science and Technology (CellCoVir - IWT file nr 60813). Linos Vandekerckhove is supported by the National Fund for Scientific Research - Belgium as Principal Investigator. The Spanish RIS cohort and HIV BioBank are integrated in the Spanish AIDS Research Network supported by Instituto de Salud Carlos III (Grant RD06/0006/0035) and Fundacion para la Investigacion y Prevencion del SIDA en Espana (FIPSE). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adzhubei IA, 2010, NAT METHODS, V7, P248, DOI 10.1038/nmeth0410-248; Agrawal L, 2004, J VIROL, V78, P2277, DOI 10.1128/JVI.78.5.2277-2287.2004; Arts EJ, 2012, CSH PERSPECT MED, V2, DOI 10.1101/cshperspect.a007161; Ballana E, 2012, AIDS, V26, P527, DOI 10.1097/QAD.0b013e32834fa194; Brown-Bryan TA, 2008, MOL CANCER RES, V6, P1293, DOI 10.1158/1541-7786.MCR-08-0125; Bushman FD, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000437; Busschots K, 2007, J MOL BIOL, V365, P1480, DOI 10.1016/j.jmb.2006.10.094; Bustin SA, 2009, CLIN CHEM, V55, P611, DOI 10.1373/clinchem.2008.112797; Casado C, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011079; Cherepanov P, 2003, J BIOL CHEM, V278, P372, DOI 10.1074/jbc.M209278200; Cherepanov P, 2007, NUCLEIC ACIDS RES, V35, P113, DOI 10.1093/nar/gkl885; Christ F, 2010, NAT CHEM BIOL, V6, P442, DOI 10.1038/nchembio.370; Ciuffi A, 2005, NAT MED, V11, P1287, DOI 10.1038/nm1329; Cohen B, 2009, NEOPLASIA, V11, P921, DOI 10.1593/neo.09636; De Leeneer K, 2008, CLIN CHEM, V54, P982, DOI 10.1373/clinchem.2007.098764; De Rijck J, 2006, J VIROL, V80, P11498, DOI 10.1128/JVI.00801-06; Dietz F, 2002, BIOCHEM J, V366, P491, DOI 10.1042/BJ20011811; Emiliani S, 2005, J BIOL CHEM, V280, P25517, DOI 10.1074/jbc.M501378200; Eng L, 2004, HUM MUTAT, V23, P67, DOI 10.1002/humu.10295; Engelman A, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000046; Fellay J, 2007, SCIENCE, V317, P944, DOI 10.1126/science.1143767; Fellay J, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000791; Fellay J, 2009, ANTIVIR THER, V14, P731, DOI 10.3851/IMP1253; Friedrich BM, 2011, VIRUS RES, V161, P101, DOI 10.1016/j.virusres.2011.08.001; Garcia-Merino I, 2009, RETROVIROLOGY, V6, DOI 10.1186/1742-4690-6-27; Gijsbers R, 2010, MOL THER, V18, P552, DOI 10.1038/mt.2010.36; Grabar S, 2009, AIDS, V23, P1163, DOI 10.1097/QAD.0b013e32832b44c8; Hellemans J, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-2-r19; Hogg R, 2008, LANCET, V372, P293, DOI 10.1016/S0140-6736(08)61113-7; Hombrouck A, 2007, PLOS PATHOG, V3, DOI 10.1371/journal.ppat.0030047; Huang TS, 2007, MOL CANCER, V6, DOI 10.1186/1476-4598-6-31; Hunt PW, 2009, J INFECT DIS, V200, P1636, DOI 10.1086/646610; Joint United Nations Programme on HIV/AIDS, 2010, GLOB REP UNAIDS REP; Kumar P, 2009, NAT PROTOC, V4, P1073, DOI 10.1038/nprot.2009.86; Leoh LS, 2012, MOL CANCER RES, V10, P378, DOI 10.1158/1541-7786.MCR-11-0314; Llano M, 2004, J BIOL CHEM, V279, P55570, DOI 10.1074/jbc.M408508200; Llano M, 2006, J MOL BIOL, V360, P760, DOI 10.1016/j.jmb.2006.04.073; Madlala P, 2011, AIDS, V25, P1711, DOI 10.1097/QAD.0b013e328349c693; Maertens G, 2003, J BIOL CHEM, V278, P33528, DOI 10.1074/jbc.M303594200; McLaren W, 2010, BIOINFORMATICS, V26, P2069, DOI 10.1093/bioinformatics/btq330; Mediavilla-Varela M, 2009, MOL CANCER, V8, DOI 10.1186/1476-4598-8-68; Okulicz JF, 2009, J INFECT DIS, V200, P1714, DOI 10.1086/646609; Pereyra F, 2008, J INFECT DIS, V197, P563, DOI 10.1086/526786; Reese MG, 1997, J COMPUT BIOL, V4, P311, DOI 10.1089/cmb.1997.4.311; Schrijvers R, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002558; Sharma P, 2000, BIOCHEM BIOPH RES CO, V276, P1320, DOI 10.1006/bbrc.2000.3606; Shinohara T, 2002, PROG RETIN EYE RES, V21, P341, DOI 10.1016/S1350-9462(02)00007-1; Telenti A, 2006, J INFECT DIS, V193, P4, DOI 10.1086/498535; Tozzi V, 2010, ANTIVIR RES, V85, P190, DOI 10.1016/j.antiviral.2009.09.001; Vandegraaff N, 2006, VIROLOGY, V346, P415, DOI 10.1016/j.virol.2005.11.022; Vandekerckhove L, 2006, J VIROL, V80, P1886, DOI 10.1128/JVI.80.4.1886-1896.2006; Vandekerckhove L, 2009, J ANTIMICROB CHEMOTH, V63, P1087, DOI 10.1093/jac/dkp113; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; Veloso S, 2010, BMC MED GENET, V11, DOI 10.1186/1471-2350-11-63; Wittwer CT, 2003, CLIN CHEM, V49, P853, DOI 10.1373/49.6.853	55	10	11	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 30	2012	7	11							e50204	10.1371/journal.pone.0050204	http://dx.doi.org/10.1371/journal.pone.0050204			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	054WM	23226247	Green Published, gold			2022-12-27	WOS:000312376100056
J	Peters, J; Miedl, SF; Buchel, C				Peters, Jan; Miedl, Stephan Franz; Buechel, Christian			Formal Comparison of Dual-Parameter Temporal Discounting Models in Controls and Pathological Gamblers	PLOS ONE			English	Article							DELAYED REWARDS; INTERTEMPORAL CHOICE; DECISION-MAKING; NEURAL SYSTEMS; PREFRONTAL CORTEX; SUBJECTIVE VALUE; TIME PERCEPTION; SELF-CONTROL; IMPULSIVITY; STABILITY	Temporal or delay discounting refers to the phenomenon that the value of a reward is discounted as a function of time to delivery. A range of models have been proposed that approximate the shape of the discount curve describing the relationship between subjective value and time. Recent evidence suggests that more than one free parameter may be required to accurately model human temporal discounting data. Nonetheless, many temporal discounting studies in psychiatry, psychology and neuroeconomics still apply single-parameter models, despite their oftentimes poor fit to single-subject data. Previous comparisons of temporal discounting models have either not taken model complexity into account, or have overlooked particular models. Here we apply model comparison techniques in a large sample of temporal discounting datasets using several discounting models employed in the past. Among the models examined, an exponential-power model from behavioural economics (CS model, Ebert & Prelec 2007) provided the best fit to human laboratory discounting data. Inter-parameter correlations for the winning model were moderate, whereas they were substantial for other dual-parameter models examined. Analyses of previous group and context effects on temporal discounting with the winning model provided additional theoretical insights. The CS model may be a useful tool in future psychiatry, psychology and neuroscience work on inter-temporal choice.	[Peters, Jan; Miedl, Stephan Franz; Buechel, Christian] Univ Med Ctr Hamburg Eppendorf, Dept Syst Neurosci, NeuroimageNord, Hamburg, Germany	University of Hamburg; University Medical Center Hamburg-Eppendorf	Peters, J (corresponding author), Univ Med Ctr Hamburg Eppendorf, Dept Syst Neurosci, NeuroimageNord, Hamburg, Germany.	j.peters@uke.uni-hamburg.de	Peters, Jan/V-2910-2019; Peters, Jan/GWC-6713-2022	Peters, Jan/0000-0002-0195-5357; Peters, Jan/0000-0002-0195-5357; Miedl, Stephan/0000-0002-1977-5637	DFG Deutsche Forschungsgegmeinschaft [SFB TRR 58, PE 1627/3-1]; BMBF Bundesministerium fur Bildung und Forschung [01GQ0912]	DFG Deutsche Forschungsgegmeinschaft(German Research Foundation (DFG)); BMBF Bundesministerium fur Bildung und Forschung(Federal Ministry of Education & Research (BMBF))	CB is supported by the DFG Deutsche Forschungsgegmeinschaft (SFB TRR 58) and BMBF Bundesministerium fur Bildung und Forschung (01GQ0912). JP is supported by the DFG (PE 1627/3-1). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AKAIKE H, 1974, IEEE T AUTOMAT CONTR, VAC19, P716, DOI 10.1109/TAC.1974.1100705; Alessi SM, 2003, BEHAV PROCESS, V64, P345, DOI 10.1016/S0376-6357(03)00150-5; Bach DR, 2011, J NEUROSCI, V31, P4811, DOI 10.1523/JNEUROSCI.1452-10.2011; Ballard K, 2009, NEUROIMAGE, V45, P143, DOI 10.1016/j.neuroimage.2008.11.004; Berns GS, 2007, TRENDS COGN SCI, V11, P482, DOI 10.1016/j.tics.2007.08.011; Bickel WK, 2007, DRUG ALCOHOL DEPEN, V90, pS85, DOI 10.1016/j.drugalcdep.2006.09.016; Bickel WK, 2012, PHARMACOL THERAPEUT, V134, P287, DOI 10.1016/j.pharmthera.2012.02.004; Bickel WK, 1999, PSYCHOPHARMACOLOGY, V146, P447, DOI 10.1007/PL00005490; Bjork JM, 2009, BIOL PSYCHIAT, V65, P710, DOI 10.1016/j.biopsych.2008.11.023; Bleichrodt H, 2009, GAME ECON BEHAV, V66, P27, DOI 10.1016/j.geb.2008.05.007; Daw N, 2011, TRIAL TRIAL DATA ANA; Dixon MR, 2003, J APPL BEHAV ANAL, V36, P449, DOI 10.1901/jaba.2003.36-449; Doyle JR, 2011, JUDGM DECIS MAK, V6, P759; Ebert JEJ, 2007, MANAGE SCI, V53, P1423, DOI 10.1287/mnsc.1060.0671; Figner B, 2010, NAT NEUROSCI, V13, P538, DOI 10.1038/nn.2516; Frederick S, 2002, J ECON LIT, V40, P351, DOI 10.1257/002205102320161311; Gill J, 2004, SOCIOL METHOD RES, V33, P54, DOI 10.1177/0049124103262681; Glascher J, 2009, CEREB CORTEX, V19, P483, DOI 10.1093/cercor/bhn098; Grace RC, 1999, J EXP ANAL BEHAV, V71, P27, DOI 10.1901/jeab.1999.71-27; Green L, 2005, J EXP PSYCHOL LEARN, V31, P1121, DOI 10.1037/0278-7393.31.5.1121; GREEN L, 1994, PSYCHOL SCI, V5, P33, DOI 10.1111/j.1467-9280.1994.tb00610.x; Green L, 2004, PSYCHOL BULL, V130, P769, DOI 10.1037/0033-2909.130.5.769; Huber DE, 2006, BEHAV RES METHODS, V38, P557, DOI 10.3758/BF03193885; Jimura K, 2011, BEHAV PROCESS, V87, P253, DOI 10.1016/j.beproc.2011.04.006; Johnson MW, 2008, EXP CLIN PSYCHOPHARM, V16, P264, DOI 10.1037/1064-1297.16.3.264; Kable JW, 2007, NAT NEUROSCI, V10, P1625, DOI 10.1038/nn2007; Kable JW, 2010, J NEUROPHYSIOL, V103, P2513, DOI 10.1152/jn.00177.2009; Kalenscher T, 2005, CURR BIOL, V15, P594, DOI 10.1016/j.cub.2005.02.052; Killeen PR, 2009, PSYCHOL REV, V116, P602, DOI 10.1037/a0016414; Kim BK., 2009, J NEUROSCI PSYCHOL E, V2, P91, DOI [DOI 10.1037/A0017686, 10.1037/a0017686]; Kim S, 2008, NEURON, V59, P161, DOI 10.1016/j.neuron.2008.05.010; Kirby KN, 2009, PSYCHON B REV, V16, P457, DOI 10.3758/PBR.16.3.457; Kurth-Nelson Z, 2012, EUR J NEUROSCI, V35, P1052, DOI 10.1111/j.1460-9568.2012.08058.x; Laibson D, 1997, Q J ECON, V112, P443, DOI 10.1162/003355397555253; Lewandowsky S., 2011, COMPUTATIONAL MODELI; LOEWENSTEIN G, 1992, Q J ECON, V107, P573, DOI 10.2307/2118482; Madden GJ, 1999, EXP CLIN PSYCHOPHARM, V7, P284, DOI 10.1037/1064-1297.7.3.284; Mazur J.E., 1987, QUANTITATIVE ANAL BE, P55; McClure SM, 2007, J NEUROSCI, V27, P5796, DOI 10.1523/JNEUROSCI.4246-06.2007; McClure SM, 2004, SCIENCE, V306, P503, DOI 10.1126/science.1100907; McKerchar TL, 2010, BEHAV PROCESS, V84, P440, DOI 10.1016/j.beproc.2010.01.003; McKerchar TL, 2009, BEHAV PROCESS, V81, P256, DOI 10.1016/j.beproc.2008.12.017; Miedl SF, 2012, ARCH GEN PSYCHIAT, V69, P177, DOI 10.1001/archgenpsychiatry.2011.1552; Monterosso J, 1999, PSYCHOPHARMACOLOGY, V146, P339, DOI 10.1007/PL00005480; Morgan BJT, 2009, CH CRC TEXT STAT SCI, P1; MYERSON J, 1995, J EXP ANAL BEHAV, V64, P263, DOI 10.1901/jeab.1995.64-263; Nakahara H, 2010, NEURAL COMPUT, V22, P3062, DOI 10.1162/NECO_a_00049; Odum AL, 2011, BEHAV PROCESS, V87, P1, DOI 10.1016/j.beproc.2011.02.007; Ohmura Y, 2006, EXP CLIN PSYCHOPHARM, V14, P318, DOI 10.1037/1064-1297.14.3.318; Pessiglione M, 2006, NATURE, V442, P1042, DOI 10.1038/nature05051; Peters J, 2011, TRENDS COGN SCI, V15, P227, DOI 10.1016/j.tics.2011.03.002; Peters J, 2011, AM J PSYCHIAT, V168, P540, DOI 10.1176/appi.ajp.2010.10071024; Peters J, 2010, NEURON, V66, P138, DOI 10.1016/j.neuron.2010.03.026; Peters J, 2009, J NEUROSCI, V29, P15727, DOI 10.1523/JNEUROSCI.3489-09.2009; Petry NM, 1999, DRUG ALCOHOL DEPEN, V56, P25, DOI 10.1016/S0376-8716(99)00010-1; Petry NM, 2001, J ABNORM PSYCHOL, V110, P482, DOI 10.1037/0021-843X.110.3.482; Pine A, 2010, J NEUROSCI, V30, P8888, DOI 10.1523/JNEUROSCI.6028-09.2010; Pine A, 2009, J NEUROSCI, V29, P9575, DOI 10.1523/JNEUROSCI.1126-09.2009; Pitt MA, 2002, TRENDS COGN SCI, V6, P421, DOI 10.1016/S1364-6613(02)01964-2; Prevost C, 2010, J NEUROSCI, V30, P14080, DOI 10.1523/JNEUROSCI.2752-10.2010; Rachlin H, 2006, J EXP ANAL BEHAV, V85, P425, DOI 10.1901/jeab.2006.85-05; Radu PT, 2011, J EXP ANAL BEHAV, V96, P363, DOI 10.1901/jeab.2011.96-363; Ray D, 2011, FRONT NEUROSCI-SWITZ, V5, DOI 10.3389/fnins.2011.00002; Read D, 2001, J RISK UNCERTAINTY, V23, P5, DOI 10.1023/A:1011198414683; Samuelson PA, 1936, REV ECON STUD, V4, P155; Scholten M, 2006, MANAGE SCI, V52, P1424, DOI 10.1287/mnsc.1060.0534; Scholten M, 2010, PSYCHOL REV, V117, P925, DOI 10.1037/a0019619; SCHWARZ G, 1978, ANN STAT, V6, P461, DOI 10.1214/aos/1176344136; Sellitto M, 2011, REV NEUROSCIENCE, V22, P565, DOI 10.1515/RNS.2011.046; Simpson CA, 2000, PSYCHOL REC, V50, P3, DOI 10.1007/BF03395339; Stephan KE, 2009, NEUROIMAGE, V46, P1004, DOI 10.1016/j.neuroimage.2009.03.025; STEVENS SS, 1957, PSYCHOL REV, V64, P153, DOI 10.1037/h0046162; Stewart N, 2006, COGNITIVE PSYCHOL, V53, P1, DOI 10.1016/j.cogpsych.2005.10.003; Takahashi T, 2008, PHYSICA A, V387, P2066, DOI 10.1016/j.physa.2007.11.047; THALER R, 1981, ECON LETT, V8, P201, DOI 10.1016/0165-1765(81)90067-7; Ungemach C, 2011, PSYCHOL SCI, V22, P253, DOI 10.1177/0956797610396225; van der Pol M, 2010, HEALTH ECON, V20, P770; Wagenmakers EJ, 2004, PSYCHON B REV, V11, P192, DOI 10.3758/BF03206482; Wittmann M, 2008, TRENDS COGN SCI, V12, P7, DOI 10.1016/j.tics.2007.10.004; Yi Richard, 2009, J Neurosci Psychol Econ, V2, P102; Zauberman G, 2009, J MARKETING RES, V46, P543, DOI 10.1509/jmkr.46.4.543	81	32	32	0	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 30	2012	7	11							e47225	10.1371/journal.pone.0047225	http://dx.doi.org/10.1371/journal.pone.0047225			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	054WM	23226198	Green Submitted, gold, Green Published			2022-12-27	WOS:000312376100006
J	Togtema, M; Pichardo, S; Jackson, R; Lambert, PF; Curiel, L; Zehbe, I				Togtema, Melissa; Pichardo, Samuel; Jackson, Robert; Lambert, Paul F.; Curiel, Laura; Zehbe, Ingeborg			Sonoporation Delivery of Monoclonal Antibodies against Human Papillomavirus 16 E6 Restores p53 Expression in Transformed Cervical Keratinocytes	PLOS ONE			English	Article							SMALL INTERFERING RNA; FOCUSED ULTRASOUND; CARCINOMA CELLS; IN-VITRO; INTRACELLULAR DELIVERY; GENE-PRODUCT; CANCER-CELLS; APOPTOSIS; PROTEIN; TYPE-16	High-risk types of human papillomavirus (HPV), such as HPV16, have been found in nearly all cases of cervical cancer. Therapies targeted at blocking the HPV16 E6 protein and its deleterious effects on the tumour suppressor pathways of the cell can reverse the malignant phenotype of affected keratinocytes while sparing uninfected cells. Through a strong interdisciplinary collaboration between engineering and biology, a novel, non-invasive intracellular delivery method for the HPV16 E6 antibody, F127-6G6, was developed. The method employs high intensity focused ultrasound (HIFU) in combination with microbubbles, in a process known as sonoporation. In this proof of principle study, it was first demonstrated that sonoporation antibody delivery into the HPV16 positive cervical carcinoma derived cell lines CaSki and SiHa was possible, using chemical transfection as a baseline for comparison. Delivery of the E6 antibody using sonoporation significantly restored p53 expression in these cells, indicating the antibody is able to enter the cells and remains active. This delivery method is targeted, non-cytotoxic, and non-invasive, making it more easily translatable for in vivo experiments than other transfection methods.	[Togtema, Melissa; Pichardo, Samuel; Jackson, Robert; Curiel, Laura; Zehbe, Ingeborg] Thunder Bay Reg Res Inst, Thunder Bay, ON, Canada; [Togtema, Melissa; Jackson, Robert] Lakehead Univ, Dept Biol, Thunder Bay, ON P7B 5E1, Canada; [Lambert, Paul F.] Univ Wisconsin, McArdle Lab Canc Res, Madison, WI 53706 USA	Northern Ontario School of Medicine; Lakehead University; University of Wisconsin System; University of Wisconsin Madison	Zehbe, I (corresponding author), Thunder Bay Reg Res Inst, Thunder Bay, ON, Canada.	zehbei@tbh.net	Jackson, Robert/AAP-7870-2021	Jackson, Robert/0000-0001-9898-5546	Natural Sciences and Engineering Research Council of Canada (NSERC) [355858-2008]; Philips Medical Healthcare	Natural Sciences and Engineering Research Council of Canada (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC)); Philips Medical Healthcare	This work was mainly funded by a Natural Sciences and Engineering Research Council of Canada (NSERC) grant to IZ (#355858-2008) and partially funded by Philips Medical Healthcare. E6 antibodies were kindly provided by Arbor Vita Corporation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmed HU, 2011, J UROLOGY, V185, P1246, DOI 10.1016/j.juro.2010.11.079; Allen-Hoffmann BL, 2000, J INVEST DERMATOL, V114, P444, DOI 10.1046/j.1523-1747.2000.00869.x; ANDROPHY EJ, 1985, SCIENCE, V230, P442, DOI 10.1126/science.2996134; Antinore MJ, 1996, EMBO J, V15, P1950, DOI 10.1002/j.1460-2075.1996.tb00546.x; Baleja JD, 2006, ANTIVIR RES, V72, P49, DOI 10.1016/j.antiviral.2006.03.014; Bao SP, 1997, ULTRASOUND MED BIOL, V23, P953, DOI 10.1016/S0301-5629(97)00025-2; Beerheide W, 1999, J NATL CANCER I, V91, P1211, DOI 10.1093/jnci/91.14.1211; Butz K, 2003, ONCOGENE, V22, P5938, DOI 10.1038/sj.onc.1206894; Carpenter AE, 2007, NAT METHODS, V4, P120, DOI 10.1038/nmeth0207-120; Carpenter AE, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-10-r100; Choi JJ, 2007, ULTRASOUND MED BIOL, V33, P95, DOI 10.1016/j.ultrasmedbio.2006.07.018; Courtete J, 2007, MOL CANCER THER, V6, P1728, DOI 10.1158/1535-7163.MCT-06-0808; Crawford L, 1997, CLIN DERMATOL, V15, P207, DOI 10.1016/S0738-081X(96)00163-0; Curiel L, 2009, AIP C P, V1215, P119; Daling JR, 2004, CANCER-AM CANCER SOC, V101, P270, DOI 10.1002/cncr.20365; DeFilippis RA, 2003, J VIROL, V77, P1551, DOI 10.1128/JVI.77.2.1551-1563.2003; Endo-Takahashi Y, 2012, INT J PHARMACEUT, V422, P504, DOI 10.1016/j.ijpharm.2011.11.023; Forbes MM, 2008, ULTRASOUND MED BIOL, V34, P2009, DOI 10.1016/j.ultrasmedbio.2008.05.003; FRIEDL F, 1970, P SOC EXP BIOL MED, V135, P543; Hamilton N, 2009, TRAFFIC, V10, P951, DOI 10.1111/j.1600-0854.2009.00938.x; Horner SM, 2004, J VIROL, V78, P4063, DOI 10.1128/JVI.78.8.4063-4073.2004; Jackson R, 2012, VIROLOGY IN PRESS; Jiang M, 2002, ONCOGENE, V21, P6041, DOI 10.1038/sj.onc.1205878; Karshafian R, 2010, ULTRASONICS, V50, P691, DOI 10.1016/j.ultras.2010.01.009; Kinoshita M, 2005, BIOCHEM BIOPH RES CO, V335, P393, DOI 10.1016/j.bbrc.2005.07.101; Kinoshita M, 2005, PHARM RES-DORDR, V22, P716, DOI 10.1007/s11095-005-2586-7; Kinoshita M, 2007, BIOCHEM BIOPH RES CO, V359, P860, DOI 10.1016/j.bbrc.2007.05.153; Klingelhutz AJ, 1996, NATURE, V380, P79, DOI 10.1038/380079a0; Kudo N, 2009, BIOPHYS J, V96, P4866, DOI 10.1016/j.bpj.2009.02.072; Lagrange M, 2005, J GEN VIROL, V86, P1001, DOI 10.1099/vir.0.80607-0; Liu YQ, 2004, BIOCHEMISTRY-US, V43, P7421, DOI 10.1021/bi049552a; Mantovani F, 2001, ONCOGENE, V20, P7874, DOI 10.1038/sj.onc.1204869; Maxwell AD, 2011, J VASC INTERV RADIOL, V22, P369, DOI 10.1016/j.jvir.2010.10.007; Mehier-Humbert S, 2005, J CONTROL RELEASE, V104, P213, DOI 10.1016/j.jconrel.2005.01.007; Meijering BDM, 2009, CIRC RES, V104, P679, DOI 10.1161/CIRCRESAHA.108.183806; Newman CMH, 2007, GENE THER, V14, P465, DOI 10.1038/sj.gt.3302925; Nygren PA, 2008, FEBS J, V275, P2668, DOI 10.1111/j.1742-4658.2008.06438.x; PATTILLO R A, 1977, Science (Washington D C), V196, P1456, DOI 10.1126/science.867042; Richard C, 2010, ONCOGENE, V29, P3435, DOI 10.1038/onc.2010.93; Rui M, 2002, LIFE SCI, V71, P1771, DOI 10.1016/S0024-3205(02)01943-4; SCHEFFNER M, 1993, CELL, V75, P495, DOI 10.1016/0092-8674(93)90384-3; Sezgin M, 2004, J ELECTRON IMAGING, V13, P146, DOI 10.1117/1.1631315; Siddiqui K, 2010, UROLOGY, V76, P1506, DOI 10.1016/j.urology.2010.04.046; Staruch R, 2011, IEEE PULSE, V2, P39, DOI 10.1109/MPUL.2011.942604; Staruch R, 2011, INT J HYPERTHER, V27, P156, DOI 10.3109/02656736.2010.518198; Strebhardt K, 2008, NAT REV CANCER, V8, P473, DOI 10.1038/nrc2394; Tran MA, 2008, CANCER RES, V68, P7638, DOI 10.1158/0008-5472.CAN-07-6614; Tran TA, 2008, IEEE T ULTRASON FERR, V55, P44, DOI 10.1109/TUFFC.2008.615; Walker CL, 2005, SCIENCE, V308, P1589, DOI 10.1126/science.1112063; WHO/ICO Information Centre on HPV and Cervical Cancer (HPV Information Centre), 2010, HUM PAP REL CANC WOR; Wu J, 2006, ULTRASONICS, V44, pE21, DOI 10.1016/j.ultras.2006.06.033; YAMAIZUMI M, 1979, CELL, V18, P1009, DOI 10.1016/0092-8674(79)90213-7; Yamato K, 2008, CANCER GENE THER, V15, P140, DOI 10.1038/sj.cgt.7701118; Yang FY, 2011, IEEE T ULTRASON FERR, V58, P964, DOI 10.1109/TUFFC.2011.1897; Yudina A, 2011, MOL IMAGING BIOL, V13, P239, DOI 10.1007/s11307-010-0346-5; Zehbe I, 2009, VIROLOGY, V383, P69, DOI 10.1016/j.virol.2008.09.036; Zhao Y, 2003, APOPTOSIS, V8, P631, DOI 10.1023/A:1026139627930; Zhao YZ, 2008, J DRUG TARGET, V16, P18, DOI [10.1080/10611860701637792, 10.1080/10611860701637792 ]; Zheng YF, 2004, CANCER BIOL THER, V3, P1129, DOI 10.4161/cbt.3.11.1215; Zhou Y, 2009, ULTRASOUND MED BIOL, V35, P1756, DOI 10.1016/j.ultrasmedbio.2009.05.012; Zhou ZY, 2012, BMC CANCER, V12, DOI 10.1186/1471-2407-12-159; zur Hausen H, 2002, NAT REV CANCER, V2, P342, DOI 10.1038/nrc798; zurHausen H, 1996, BBA-REV CANCER, V1288, pF55	63	27	29	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 30	2012	7	11							e50730	10.1371/journal.pone.0050730	http://dx.doi.org/10.1371/journal.pone.0050730			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	054WM	23226365	Green Published, gold, Green Submitted			2022-12-27	WOS:000312376100176
J	Wu, JC; Tzanakakis, ES				Wu, Jincheng; Tzanakakis, Emmanuel S.			Contribution of Stochastic Partitioning at Human Embryonic Stem Cell Division to NANOG Heterogeneity	PLOS ONE			English	Article							POPULATION BALANCE MODELS; SELF-RENEWAL; NUMERICAL-SOLUTION; GENE-EXPRESSION; GROUND-STATE; DIFFERENTIATION; PLURIPOTENCY; REVEALS; G1; IDENTIFICATION	Heterogeneity is an often unappreciated characteristic of stem cell populations yet its importance in fate determination is becoming increasingly evident. Although gene expression noise has received greater attention as a source of non-genetic heterogeneity, the effects of stochastic partitioning of cellular material during mitosis on population variability have not been researched to date. We examined self-renewing human embryonic stem cells (hESCs), which typically exhibit a dispersed distribution of the pluripotency marker NANOG. In conjunction with our experiments, a multiscale cell population balance equation (PBE) model was constructed accounting for transcriptional noise and stochastic partitioning at division as sources of population heterogeneity. Cultured hESCs maintained time-invariant profiles of size and NANOG expression and the data were utilized for parameter estimation. Contributions from both sources considered in this study were significant on the NANOG profile, although elimination of the gene expression noise resulted in greater changes in the dispersion of the NANOG distribution. Moreover, blocking of division by treating hESCs with nocodazole or colcemid led to a 39% increase in the average NANOG content and over 68% of the cells had higher NANOG level than the mean NANOG expression of untreated cells. Model predictions, which were in excellent agreement with these findings, revealed that stochastic partitioning accounted for 17% of the total noise in the NANOG profile of self-renewing hESCs. The computational framework developed in this study will aid in gaining a deeper understanding of how pluripotent stem/progenitor cells orchestrate processes such as gene expression and proliferation for maintaining their pluripotency or differentiating along particular lineages. Such models will be essential in designing and optimizing efficient differentiation strategies and bioprocesses for the production of therapeutically suitable stem cell progeny.	[Wu, Jincheng; Tzanakakis, Emmanuel S.] SUNY Buffalo, Dept Chem & Biol Engn, Buffalo, NY 14260 USA; [Tzanakakis, Emmanuel S.] SUNY Buffalo, Dept Biomed Engn, Buffalo, NY 14260 USA; [Tzanakakis, Emmanuel S.] SUNY Buffalo, New York State Ctr Excellence Bioinformat & Life, Buffalo, NY 14260 USA; [Tzanakakis, Emmanuel S.] SUNY Buffalo, Western New York Stem Cell Culture & Anal Ctr, Buffalo, NY 14260 USA	State University of New York (SUNY) System; State University of New York (SUNY) Buffalo; State University of New York (SUNY) System; State University of New York (SUNY) Buffalo; State University of New York (SUNY) System; State University of New York (SUNY) Buffalo; State University of New York (SUNY) System; State University of New York (SUNY) Buffalo	Tzanakakis, ES (corresponding author), SUNY Buffalo, Dept Chem & Biol Engn, Buffalo, NY 14260 USA.	emtzan@buffalo.edu	Tzanakakis, Emmanuel S/F-6868-2015; Tzanakakis, Emmanuel/S-7617-2019	Tzanakakis, Emmanuel S/0000-0002-6677-352X; Tzanakakis, Emmanuel/0000-0002-6677-352X	New York State Stem Cell Science agency [C024355]; National Institutes of Health [R01HL103709]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL103709] Funding Source: NIH RePORTER	New York State Stem Cell Science agency; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	The work in this article has been supported by research grants to E.S.T. from the New York State Stem Cell Science agency (contract # C024355) and the National Institutes of Health (R01HL103709). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANDERSON EC, 1970, BIOPHYS J, V10, P630, DOI 10.1016/S0006-3495(70)86325-1; Arias AM, 2006, NAT REV GENET, V7, P34, DOI 10.1038/nrg1750; Barker N, 2007, NATURE, V449, P1003, DOI 10.1038/nature06196; Becker KA, 2010, J CELL PHYSIOL, V222, P103, DOI 10.1002/jcp.21925; Becker KA, 2006, J CELL PHYSIOL, V209, P883, DOI 10.1002/jcp.20776; Cai L, 2006, NATURE, V440, P358, DOI 10.1038/nature04599; Chambers I, 2007, NATURE, V450, P1230, DOI 10.1038/nature06403; Chang HH, 2008, NATURE, V453, P544, DOI 10.1038/nature06965; Chazaud C, 2006, DEV CELL, V10, P615, DOI 10.1016/j.devcel.2006.02.020; Diamandis P, 2007, NAT CHEM BIOL, V3, P268, DOI 10.1038/nchembio873; DOMACH MM, 1984, BIOTECHNOL BIOENG, V26, P877, DOI 10.1002/bit.260260810; Dykstra B, 2007, CELL STEM CELL, V1, P218, DOI 10.1016/j.stem.2007.05.015; Eakman AGF, 1966, CHEM ENG PROG S SERI, V62, P37; Eden E, 2011, SCIENCE, V331, P764, DOI 10.1126/science.1199784; Elowitz MB, 2002, SCIENCE, V297, P1183, DOI 10.1126/science.1070919; Enver T, 2005, HUM MOL GENET, V14, P3129, DOI 10.1093/hmg/ddi345; Enver T, 2009, CELL STEM CELL, V4, P387, DOI 10.1016/j.stem.2009.04.011; Ezzet F, 1998, BRIT J CLIN PHARMACO, V46, P553, DOI 10.1046/j.1365-2125.1998.00830.x; Filipczyk AA, 2007, STEM CELL RES, V1, P45, DOI 10.1016/j.scr.2007.09.002; Fischer Y, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012533; FREDERICKSON A. G., 1967, MATH BIO SCL, V1, P327, DOI 10.1016/0025-5564(67)90008-9; Ghule PN, 2007, J CELL PHYSIOL, V213, P9, DOI 10.1002/jcp.21119; GILLESPIE DT, 1976, J COMPUT PHYS, V22, P403, DOI 10.1016/0021-9991(76)90041-3; GILLESPIE DT, 1975, J ATMOS SCI, V32, P1977, DOI 10.1175/1520-0469(1975)032<1977:AEMFNS>2.0.CO;2; Glauche I, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011238; Hanna J, 2009, NATURE, V462, P595, DOI 10.1038/nature08592; Hayashi K, 2008, CELL STEM CELL, V3, P391, DOI 10.1016/j.stem.2008.07.027; Henson MA, 2005, COMPUT CHEM ENG, V29, P645, DOI 10.1016/j.compchemeng.2004.08.018; Hoffmann M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002922; Hough SR, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007708; Huh D, 2011, NAT GENET, V43, P95, DOI 10.1038/ng.729; Hyslop L, 2005, STEM CELLS, V23, P1035, DOI 10.1634/stemcells.2005-0080; Ivanova N, 2006, NATURE, V442, P533, DOI 10.1038/nature04915; Kaern M, 2005, NAT REV GENET, V6, P451, DOI 10.1038/nrg1615; Kallas A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019114; Kalmar T, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000149; Kloeden P.E., 1999, NUMERICAL SOLUTION S; Lin YL, 2002, CHEM ENG SCI, V57, P2241, DOI 10.1016/S0009-2509(02)00114-8; Loh YH, 2006, NAT GENET, V38, P431, DOI 10.1038/ng1760; LOKEN MR, 1984, J CELL PHYSIOL, V118, P22, DOI 10.1002/jcp.1041180106; Losick R, 2008, SCIENCE, V320, P65, DOI 10.1126/science.1147888; MacArthur BD, 2009, NAT REV MOL CELL BIO, V10, P672, DOI 10.1038/nrm2766; Mantzaris NV, 2004, J PROCESS CONTR, V14, P775, DOI 10.1016/j.jprocont.2003.12.001; Mantzaris NV, 1999, J BIOTECHNOL, V71, P157, DOI 10.1016/S0168-1656(99)00020-6; Mantzaris NV, 2001, COMPUT CHEM ENG, V25, P1411, DOI 10.1016/S0098-1354(01)00709-8; Mantzaris NV, 2001, COMPUT CHEM ENG, V25, P1463, DOI 10.1016/S0098-1354(01)00711-6; Mittag A, 2009, J BIOPHOTONICS, V2, P470, DOI 10.1002/jbio.200910033; Miyanari Y, 2012, NATURE, V483, P470, DOI 10.1038/nature10807; MULLANEY PF, 1970, BIOPHYS J, V10, P764, DOI 10.1016/S0006-3495(70)86334-2; Narsinh KH, 2011, J CLIN INVEST, V121, P1217, DOI 10.1172/JCI44635; Neganova I, 2009, ONCOGENE, V28, P20, DOI 10.1038/onc.2008.358; NELDER JA, 1965, COMPUT J, V7, P308, DOI 10.1093/comjnl/7.4.308; Niwa H, 2000, NAT GENET, V24, P372, DOI 10.1038/74199; Orford KW, 2008, NAT REV GENET, V9, P115, DOI 10.1038/nrg2269; Osorno R, 2011, PHILOS T R SOC B, V366, P2230, DOI 10.1098/rstb.2011.0043; Pinto MA, 2007, COMPUT CHEM ENG, V31, P1242, DOI 10.1016/j.compchemeng.2006.10.016; Pisu M, 2007, J BIOTECHNOL, V130, P171, DOI 10.1016/j.jbiotec.2007.02.028; Raj A, 2008, CELL, V135, P216, DOI 10.1016/j.cell.2008.09.050; Ramkrishna D., 2000, POPULATION BALANCES; Rao CV, 2002, NATURE, V420, P231, DOI 10.1038/nature01258; Raser JM, 2004, SCIENCE, V304, P1811, DOI 10.1126/science.1098641; Rodda DJ, 2005, J BIOL CHEM, V280, P24731, DOI 10.1074/jbc.M502573200; Sangiorgi E, 2008, NAT GENET, V40, P915, DOI 10.1038/ng.165; SHAH BH, 1976, MATH BIOSCI, V31, P1, DOI 10.1016/0025-5564(76)90037-7; Singh AM, 2007, STEM CELLS, V25, P2534, DOI 10.1634/stemcells.2007-0126; Srienc F, 1999, J BIOTECHNOL, V71, P233, DOI 10.1016/S0168-1656(99)00026-7; Stewart MH, 2006, NAT METHODS, V3, P807, DOI 10.1038/nmeth939; Swain PS, 2002, P NATL ACAD SCI USA, V99, P12795, DOI 10.1073/pnas.162041399; Theunissen TW, 2011, PHILOS T R SOC B, V366, P2222, DOI 10.1098/rstb.2011.0003; TOMER A, 1988, BLOOD, V71, P1244; Toyooka Y, 2008, DEVELOPMENT, V135, P909, DOI 10.1242/dev.017400; Trott J, 2012, MOL BIOSYST, V8, P744, DOI 10.1039/c1mb05398a; Tzur A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016053; Tzur A, 2009, SCIENCE, V325, P167, DOI 10.1126/science.1174294; Wang RX, 2012, EXP CELL RES, V318, P2094, DOI 10.1016/j.yexcr.2012.05.017; Werbowetski-Ogilvie TE, 2009, NAT BIOTECHNOL, V27, P91, DOI 10.1038/nbt.1516; Wilkinson DJ, 2009, NAT REV GENET, V10, P122, DOI 10.1038/nrg2509; Zhang X, 2009, J CELL BIOL, V184, P67, DOI 10.1083/jcb.200801009	78	25	25	1	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 30	2012	7	11							e50715	10.1371/journal.pone.0050715	http://dx.doi.org/10.1371/journal.pone.0050715			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	054WM	23226362	Green Published, Green Submitted, gold			2022-12-27	WOS:000312376100173
J	Piaggio, AJ; Shriner, SA; VanDalen, KK; Franklin, AB; Anderson, TD; Kolokotronis, SO				Piaggio, Antoinette J.; Shriner, Susan A.; VanDalen, Kaci K.; Franklin, Alan B.; Anderson, Theodore D.; Kolokotronis, Sergios-Orestis			Molecular Surveillance of Low Pathogenic Avian Influenza Viruses in Wild Birds across the United States: Inferences from the Hemagglutinin Gene	PLOS ONE			English	Article							A VIRUSES; PHYLOGENETIC ANALYSES; SEQUENCE-ANALYSIS; NORTH-AMERICA; TRANSMISSION; ORIGIN; NEUTRALITY; EMERGENCE; ECOLOGY; SITES	A United States interagency avian influenza surveillance plan was initiated in 2006 for early detection of highly pathogenic avian influenza viruses (HPAIV) in wild birds. The plan included a variety of wild bird sampling strategies including the testing of fecal samples from aquatic areas throughout the United States from April 2006 through December 2007. Although HPAIV was not detected through this surveillance effort we were able to obtain 759 fecal samples that were positive for low pathogenic avian influenza virus (LPAIV). We used 136 DNA sequences obtained from these samples along with samples from a public influenza sequence database for a phylogenetic assessment of hemagglutinin (HA) diversity in the United States. We analyzed sequences from all HA subtypes except H5, H7, H14 and H15 to examine genetic variation, exchange between Eurasia and North America, and geographic distribution of LPAIV in wild birds in the United States. This study confirms intercontinental exchange of some HA subtypes (including a newly documented H9 exchange event), as well as identifies subtypes that do not regularly experience intercontinental gene flow but have been circulating and evolving in North America for at least the past 20 years. These HA subtypes have high levels of genetic diversity with many lineages co-circulating within the wild birds of North America. The surveillance effort that provided these samples demonstrates that such efforts, albeit labor-intensive, provide important information about the ecology of LPAIV circulating in North America.	[Piaggio, Antoinette J.; Shriner, Susan A.; VanDalen, Kaci K.; Franklin, Alan B.; Anderson, Theodore D.] Wildlife Serv, Natl Wildlife Res Ctr, USDA, Ft Collins, CO USA; [Kolokotronis, Sergios-Orestis] Amer Museum Nat Hist, Sackler Inst Comparat Genom, New York, NY 10024 USA; [Kolokotronis, Sergios-Orestis] Fordham Univ, Dept Biol Sci, Bronx, NY 10458 USA	United States Department of Agriculture (USDA); American Museum of Natural History (AMNH); Fordham University	Piaggio, AJ (corresponding author), Wildlife Serv, Natl Wildlife Res Ctr, USDA, Ft Collins, CO USA.	toni.j.piaggio@aphis.usda.gov	Kolokotronis, Sergios-Orestis/GWM-5773-2022; Kolokotronis, Sergios-Orestis/A-1910-2009	Kolokotronis, Sergios-Orestis/0000-0003-3309-8465; Kolokotronis, Sergios-Orestis/0000-0003-3309-8465; Shriner, Susan/0000-0003-0349-7182; Franklin, Alan/0000-0001-9491-795X; Piaggio, Antoinette/0000-0002-4701-0746	United States Department of Agriculture; U.S. Defense Advanced Research Projects Agency (DARPA)	United States Department of Agriculture(United States Department of Agriculture (USDA)); U.S. Defense Advanced Research Projects Agency (DARPA)(United States Department of DefenseDefense Advanced Research Projects Agency (DARPA))	This study was primarily funded by the United States Department of Agriculture. SOK was funded by the U.S. Defense Advanced Research Projects Agency (DARPA). DARPA had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexander DJ, 2000, VET MICROBIOL, V74, P3, DOI 10.1016/S0378-1135(00)00160-7; Bahl J, 2009, VIROLOGY, V390, P289, DOI 10.1016/j.virol.2009.05.002; Bi YH, 2011, VIROL J, V8, DOI 10.1186/1743-422X-8-505; Chen HL, 2006, J VIROL, V80, P5976, DOI 10.1128/JVI.00110-06; Chen R, 2009, VIROLOGY, V383, P156, DOI 10.1016/j.virol.2008.10.015; DeLiberto TJ, 2009, INTEGR ZOOL, V4, P426, DOI 10.1111/j.1749-4877.2009.00180.x; Deliberto TJ, 2011, PANDEMIC INFLUENZA V, P156; Dohna HZ, 2009, EMERG INFECT DIS, V15, P1040, DOI 10.3201/eid1507.090245; Duan L, 2007, J VIROL, V81, P7529, DOI 10.1128/JVI.00327-07; Dugan VG, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000076; Escorcia Magdalena, 2012, BMC Res Notes, V5, P62, DOI 10.1186/1756-0500-5-62; Farnsworth ML, 2011, PANDEMIC INFLUENZA V; FELSENSTEIN J, 1985, EVOLUTION, V39, P783, DOI 10.1111/j.1558-5646.1985.tb00420.x; Fouchier RAM, 2005, J VIROL, V79, P2814, DOI 10.1128/JVI.79.5.2814-2822.2005; Fu YX, 1997, GENETICS, V147, P915; Gilbert M, 2006, EMERG INFECT DIS, V12, P1650, DOI 10.3201/eid1211.060223; Glaser L, 2006, GLYCOCONJUGATE J, V23, P93, DOI 10.1007/s10719-006-5441-0; HORIMOTO T, 1995, VIROLOGY, V213, P223, DOI 10.1006/viro.1995.1562; HUDSON RR, 1992, MOL BIOL EVOL, V9, P138; HUDSON RR, 1990, OXFORD SURVEYS EVOLU; Koehler AV, 2008, MOL ECOL, V17, P4754, DOI 10.1111/j.1365-294X.2008.03953.x; Krauss S, 2007, PLOS PATHOG, V3, P1684, DOI 10.1371/journal.ppat.0030167; LANAVE C, 1984, J MOL EVOL, V20, P86, DOI 10.1007/BF02101990; Lee DH, 2011, INFECT GENET EVOL, V11, P232, DOI 10.1016/j.meegid.2010.09.012; Librado P, 2009, BIOINFORMATICS, V25, P1451, DOI 10.1093/bioinformatics/btp187; Liu JH, 2004, VIRUS GENES, V29, P81, DOI 10.1023/B:VIRU.0000032791.26573.f1; Liu S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005022; Makarova NA, 1999, J GEN VIROL, V80, P3167, DOI 10.1099/0022-1317-80-12-3167; McLean RG, 2007, 12 WILDL DAM MAN C; Munster VJ, 2007, PLOS PATHOG, V3, P630, DOI 10.1371/journal.ppat.0030061; Nei M., 1987, MOL EVOLUTIONARY GEN; Obenauer JC, 2006, SCIENCE, V311, P1576, DOI 10.1126/science.1121586; Olsen B, 2006, SCIENCE, V312, P384, DOI 10.1126/science.1122438; Paul A.E., 2008, CAN J INFECT DIS MED, V20, pe35; Ramos-Onsins SE, 2002, MOL BIOL EVOL, V19, P2092, DOI 10.1093/oxfordjournals.molbev.a004034; Rohani P, 2009, P NATL ACAD SCI USA, V106, P10365, DOI 10.1073/pnas.0809026106; SCHAFER JR, 1993, VIROLOGY, V194, P781, DOI 10.1006/viro.1993.1319; Shi WF, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014454; Spackman E, 2002, J CLIN MICROBIOL, V40, P3256, DOI 10.1128/JCM.40.9.3256-3260.2002; Spackman E, 2005, VIRUS RES, V114, P89, DOI 10.1016/j.virusres.2005.05.013; Stailknecht DE, 2007, J WILDLIFE DIS, V43, pS15; STALLKNECHT DE, 1988, VET RES COMMUN, V12, P125, DOI 10.1007/BF00362792; Stamatakis A, 2008, LECT N BIOINFORMAT, V5265, P424, DOI 10.1007/978-3-540-88436-1_36; Stamatakis A, 2006, BIOINFORMATICS, V22, P2688, DOI 10.1093/bioinformatics/btl446; Stohr K, 2003, VACCINE, V21, P1744, DOI 10.1016/S0264-410X(03)00065-3; Suarez DL, 1998, J VIROL, V72, P6678, DOI 10.1128/JVI.72.8.6678-6688.1998; Szretter K J., 2006, CURRENT PROTOCOLS MI; U.S. Interagency Working Group, 2006, EARL DET SYST HIGHL; VanDalen KK, 2008, ARCH VIROL, V153, P1981, DOI 10.1007/s00705-008-0213-8; VanDalen KK, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012851; Wallensten A, 2005, ARCH VIROL, V150, P1685, DOI 10.1007/s00705-005-0543-8; WATTERSON GA, 1975, THEOR POPUL BIOL, V7, P256, DOI 10.1016/0040-5809(75)90020-9; WEBSTER RG, 1992, MICROBIOL REV, V56, P152, DOI 10.1128/MMBR.56.1.152-179.1992; Wessa P, 2011, FREE STAT SOFTWARE V; Widjaja L, 2004, J VIROL, V78, P8771, DOI 10.1128/JVI.78.16.8771-8779.2004; Wille M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020664; Wille M, 2011, ARCH VIROL, V156, P107, DOI 10.1007/s00705-010-0839-1; YANG ZH, 1994, J MOL EVOL, V39, P306, DOI 10.1007/BF00160154	58	24	25	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 4	2012	7	12							e50834	10.1371/journal.pone.0050834	http://dx.doi.org/10.1371/journal.pone.0050834			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	051EQ	23226543	Green Published, gold, Green Submitted			2022-12-27	WOS:000312108500032
J	Zheng, M; Wu, JN; Huang, YX; Liu, GX; Zhou, Y; Zhou, CG				Zheng, Ming; Wu, Jia-nan; Huang, Yan-xin; Liu, Gui-xia; Zhou, You; Zhou, Chun-guang			Inferring Gene Regulatory Networks by Singular Value Decomposition and Gravitation Field Algorithm	PLOS ONE			English	Article								Reconstruction of gene regulatory networks (GRNs) is of utmost interest and has become a challenge computational problem in system biology. However, every existing inference algorithm from gene expression profiles has its own advantages and disadvantages. In particular, the effectiveness and efficiency of every previous algorithm is not high enough. In this work, we proposed a novel inference algorithm from gene expression data based on differential equation model. In this algorithm, two methods were included for inferring GRNs. Before reconstructing GRNs, singular value decomposition method was used to decompose gene expression data, determine the algorithm solution space, and get all candidate solutions of GRNs. In these generated family of candidate solutions, gravitation field algorithm was modified to infer GRNs, used to optimize the criteria of differential equation model, and search the best network structure result. The proposed algorithm is validated on both the simulated scale-free network and real benchmark gene regulatory network in networks database. Both the Bayesian method and the traditional differential equation model were also used to infer GRNs, and the results were used to compare with the proposed algorithm in our work. And genetic algorithm and simulated annealing were also used to evaluate gravitation field algorithm. The cross-validation results confirmed the effectiveness of our algorithm, which outperforms significantly other previous algorithms.	[Zheng, Ming; Wu, Jia-nan; Huang, Yan-xin; Liu, Gui-xia; Zhou, You; Zhou, Chun-guang] Jilin Univ, Coll Comp Sci & Technol, Changchun 130023, Peoples R China; [Wu, Jia-nan] Changchun Univ, Coll Comp Sci & Technol, Changchun, Peoples R China; [Huang, Yan-xin] NE Normal Univ, Natl Engn Lab Druggable Gene & Prot Screening, Changchun, Peoples R China	Jilin University; Changchun University; Northeast Normal University - China	Zhou, Y (corresponding author), Jilin Univ, Coll Comp Sci & Technol, Changchun 130023, Peoples R China.	zyou@jlu.edu.cn			National Natural Science Foundation of China [60873146, 60973092, 60903097, 61172183]; Hi-Tech Research and Development Program of China [2009AA02Z307]; Project of Science and Technology Innovation Platform of Computing and Software Science [985]; Key Laboratory for Symbol Computation and Knowledge Engineering of the National Education Ministry of China; Science-Technology Development Research Project from Jilin Province of China [20101589, 201201139, 20101503]; Graduate Innovation Fund of Jilin University [20121109]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Hi-Tech Research and Development Program of China(National High Technology Research and Development Program of China); Project of Science and Technology Innovation Platform of Computing and Software Science; Key Laboratory for Symbol Computation and Knowledge Engineering of the National Education Ministry of China; Science-Technology Development Research Project from Jilin Province of China; Graduate Innovation Fund of Jilin University(Jilin University)	This work was supported by grants from The National Natural Science Foundation of China (60873146,60973092, 60903097, 61172183), Hi-Tech Research and Development Program of China (2009AA02Z307), Project of Science and Technology Innovation Platform of Computing and Software Science (985 En-gineering), the Key Laboratory for Symbol Computation and Knowledge Engineering of the National Education Ministry of China, Graduate Innovation Fund of Jilin University (20121109). The Science-Technology Development Research Project from Jilin Province of China (20101589,201201139, 20101503). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bank M, 2012, ADV ENG SOFTW, V47, P1, DOI 10.1016/j.advengsoft.2011.12.001; Barrett T, 2008, NAT METHODS, V5, P117, DOI 10.1038/nmeth0208-117b; Bowden J, 2009, T AM MATH SOC, V361, P5457, DOI 10.1090/S0002-9947-09-04721-7; Chuang LY, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021036; Darabos C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025110; Kanehisa M, 2012, NUCLEIC ACIDS RES, V40, pD109, DOI 10.1093/nar/gkr988; Katsikis VN, 2011, ELECTRON J LINEAR AL, V22, P1156; Kuwahara H, 2012, J R SOC INTERFACE, V9, P1589, DOI 10.1098/rsif.2011.0757; Liu GX, 2011, J BIONIC ENG, V8, P98, DOI 10.1016/S1672-6529(11)60008-5; Ou RQ, 2012, PHYSICA A, V391, P887, DOI 10.1016/j.physa.2011.08.056; Ponnapalli SP, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028072; Safronov V., 1972, EVOLUTION PROTOPLANE; Spellman PT, 1998, MOL BIOL CELL, V9, P3273, DOI 10.1091/mbc.9.12.3273; Vignes M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0029165; Whelan C, 2012, BIOINFORMATICS, V28, P290, DOI 10.1093/bioinformatics/btr637; Zaki N, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021821; Zheng M, 2012, PROG BIOCHEM BIOPHYS, V39, P581, DOI 10.3724/SP.J.1206.2011.00311; Zheng M, 2010, ALGORITHM MOL BIOL, V5, DOI 10.1186/1748-7188-5-32; Zhu HT, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052393	19	3	4	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 4	2012	7	12							e51141	10.1371/journal.pone.0051141	http://dx.doi.org/10.1371/journal.pone.0051141			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	051EQ	23226565	Green Published, gold, Green Submitted			2022-12-27	WOS:000312108500047
J	Iida, Y; Xu, BH; Schultz, GM; Chow, V; White, JJ; Sulaimon, S; Hezi-Yamit, A; Peterson, SR; Dalman, RL				Iida, Yasunori; Xu, Baohui; Schultz, Geoffrey M.; Chow, Vinca; White, Julie J.; Sulaimon, Shola; Hezi-Yamit, Ayala; Peterson, Susan Rea; Dalman, Ronald L.			Efficacy and Mechanism of Angiotensin II Receptor Blocker Treatment in Experimental Abdominal Aortic Aneurysms	PLOS ONE			English	Article							MONOCYTE CHEMOATTRACTANT PROTEIN-1; ENDOTHELIAL GROWTH-FACTOR; CONVERTING ENZYME-INHIBITORS; INDUCED ATHEROSCLEROSIS; RAT MODEL; SIMVASTATIN SUPPRESSES; TYPE-1 RECEPTOR; MOUSE MODEL; ANGIOGENESIS; EXPRESSION	Background: Despite the importance of the renin-angiotensin (Ang) system in abdominal aortic aneurysm (AAA) pathogenesis, strategies targeting this system to prevent clinical aneurysm progression remain controversial and unproven. We compared the relative efficacy of two Ang II type 1 receptor blockers, telmisartan and irbesartan, in limiting experimental AAAs in distinct mouse models of aneurysm disease. Methodology/Principal Findings: AAAs were induced using either 1) Ang II subcutaneous infusion (1000 ng/kg/min) for 28 days in male ApoE(-/-) mice, or 2) transient intra-aortic porcine pancreatic elastase infusion in male C57BL/6 mice. One week prior to AAA creation, mice started to daily receive irbesartan (50 mg/kg), telmisartan (10 mg/kg), fluvastatin (40 mg/kg), bosentan (100 mg/kg), doxycycline (100 mg/kg) or vehicle alone. Efficacy was determined via serial in vivo aortic diameter measurements, histopathology and gene expression analysis at sacrifice. Aortic aneurysms developed in 67% of Ang II-infused ApoE(-/-) mice fed with standard chow and water alone (n = 15), and 40% died of rupture. Strikingly, no telmisartan-treated mouse developed an AAA (n = 14). Both telmisartan and irbesartan limited aneurysm enlargement, medial elastolysis, smooth muscle attenuation, macrophage infiltration, adventitial neocapillary formation, and the expression of proteinases and proinflammatory mediators. Doxycycline, fluvastatin and bosentan did not influence aneurysm progression. Telmisartan was also highly effective in intra-aortic porcine pancreatic elastase infusion-induced AAAs, a second AAA model that did not require exogenous Ang II infusion. Conclusion/Significance: Telmisartan suppresses experimental aneurysms in a model-independent manner and may prove valuable in limiting clinical disease progression.	[Iida, Yasunori; Xu, Baohui; Schultz, Geoffrey M.; Chow, Vinca; White, Julie J.; Dalman, Ronald L.] Stanford Univ, Sch Med, Dept Surg, Div Vasc Surg, Stanford, CA 94305 USA; [Sulaimon, Shola; Hezi-Yamit, Ayala; Peterson, Susan Rea] Medtron Vasc Inc, Santa Rosa, CA USA	Stanford University	Dalman, RL (corresponding author), Stanford Univ, Sch Med, Dept Surg, Div Vasc Surg, Stanford, CA 94305 USA.	rld@stanford.edu	Iida, Yasunori/AAS-2213-2020	Iida, Yasunori/0000-0002-2182-3060; Xu, Baohui/0000-0002-2857-7464	National Heart, Lung and Blood Institute [1R21HL112122-01, 1R21HL109750-01]; Medtronic Inc.; Medtronic; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R21HL109750, R21HL112122] Funding Source: NIH RePORTER	National Heart, Lung and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); Medtronic Inc.(Medtronic); Medtronic(Medtronic); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This study was supported in part by grants from the National Heart, Lung and Blood Institute (1R21HL112122-01 and 1R21HL109750-01) and a research contract with Medtronic Inc. Drs. Peterson and Sulaimon, full time employees of Medtronic, reviewed and approved the research contract after the study design was finalized presented for research funding. Dr. Peterson did participate in finalizing the selection of compounds used in the experiments (e.g. statins, doxycycline, ARBs) and the study groups to be used for comparisons. Both Drs. Peterson and Suliamon contributed data included in the manuscript as coinvestigators, including RT-PCR and HPLC, and are included as co-authors for that purpose. Prior to beginning the research, Stanford University approved the contract with Medtronic stipulating that the funder (Medtronic) would have no undo influence on data analysis, conclusions, or the decision to publish. Consistent with that agreement, neither Drs. Peterson or Suliamon, or their employer, Medtronic Inc, made any stipulations regarding study design, data analysis, decision to publish, or manuscript preparation beyond describing the methods used in their procedures for the data elements contributed by their respective research groups.	Abisi S, 2007, J VASC SURG, V46, P1260, DOI 10.1016/j.jvs.2007.08.015; Ahluwalia N, 2007, J IMMUNOL, V179, P691, DOI 10.4049/jimmunol.179.1.691; Baxter BT, 2008, CIRCULATION, V117, P1883, DOI 10.1161/CIRCULATIONAHA.107.735274; Bien S, 2007, CANCER RES, V67, P10428, DOI 10.1158/0008-5472.CAN-07-1344; Blanchard JF, 2000, AM J EPIDEMIOL, V151, P575; Bruemmer D, 2003, J CLIN INVEST, V112, P1318, DOI 10.1172/JCI200318141; Burnier M, 2009, J INT MED RES, V37, P1662, DOI 10.1177/147323000903700602; Carbajo-Lozoya J, 2012, CELL SIGNAL, V24, P1261, DOI 10.1016/j.cellsig.2012.02.005; Cassis LA, 2007, ARTERIOSCL THROM VAS, V27, P380, DOI 10.1161/01.ATV.0000254680.71485.92; Chaikof EL, 2009, J VASC SURG, V50, p2S, DOI 10.1016/j.jvs.2009.07.002; Choke E, 2006, ANN NY ACAD SCI, V1085, P315, DOI 10.1196/annals.1383.007; Choke E, 2010, J VASC SURG, V52, P159, DOI 10.1016/j.jvs.2010.02.015; Colonnello JS, 2003, J VASC SURG, V38, P138, DOI 10.1016/S0741-5214(03)00125-3; Daugherty A, 1999, ANN NY ACAD SCI, V892, P108, DOI 10.1111/j.1749-6632.1999.tb07789.x; Daugherty A, 2000, J CLIN INVEST, V105, P1605, DOI 10.1172/JCI7818; Daugherty A, 2001, BRIT J PHARMACOL, V134, P865, DOI 10.1038/sj.bjp.0704331; Daugherty A, 2010, CLIN SCI, V118, P681, DOI 10.1042/CS20090372; Dodd BR, 2011, CURR VASC PHARM; Egami K, 2003, J CLIN INVEST, V112, P67, DOI 10.1172/JCI200316645; Erbe DV, 2006, VASC PHARMACOL, V45, P154, DOI 10.1016/j.vph.2006.05.002; Frutkin AD, 2009, ARTERIOSCL THROM VAS, V29, P1251, DOI 10.1161/ATVBAHA.109.186593; Fujiwara Y, 2008, INT J MOL MED, V22, P703, DOI 10.3892/ijmm_00000075; Goergen CJ, 2010, J MAGN RESON IMAGING, V32, P847, DOI 10.1002/jmri.22331; Golledge J, 2010, CARDIOVASC DRUGS THE; Golledge J, 2010, ATHEROSCLEROSIS, V210, P51, DOI 10.1016/j.atherosclerosis.2009.10.027; Gordon S, 2010, IMMUNITY, V32, P593, DOI 10.1016/j.immuni.2010.05.007; Habashi JP, 2011, SCIENCE, V332, P361, DOI 10.1126/science.1192152; Habashi JP, 2006, SCIENCE, V312, P117, DOI 10.1126/science.1124287; Hackam DG, 2006, LANCET, V368, P659, DOI 10.1016/S0140-6736(06)69250-7; Hamblin M, 2010, J VASC SURG, V52, P984, DOI 10.1016/j.jvs.2010.05.089; HernandezPresa M, 1997, CIRCULATION, V95, P1532; Hordijk PL, 2006, CIRC RES, V98, P453, DOI 10.1161/01.RES.0000204727.46710.5e; Huffman MD, 2000, SURGERY, V128, P429, DOI 10.1067/msy.2000.107379; Ishibashi M, 2004, ARTERIOSCL THROM VAS, V24, pE174, DOI 10.1161/01.ATV.0000143384.69170.2d; Jones A, 2009, CIRCULATION, V119, P3125, DOI 10.1161/CIRCULATIONAHA.109.852467; Kalyanasundaram A, 2006, J VASC SURG, V43, P117, DOI 10.1016/j.jvs.2005.08.007; Kaneko H, 2011, CARDIOVASC RES, V91, P358, DOI 10.1093/cvr/cvr080; Kanematsu Y, 2010, HYPERTENSION, V55, P1267, DOI 10.1161/HYPERTENSIONAHA.109.140558; Kaschina E, 2009, ATHEROSCLEROSIS, V205, P396, DOI 10.1016/j.atherosclerosis.2009.01.003; Kaschina E, 2008, J HYPERTENS, V26, P2361, DOI 10.1097/HJH.0b013e328313e547; Kintscher U, 2001, HYPERTENSION, V37, P587, DOI 10.1161/01.HYP.37.2.587; Kobayashi M, 2002, J SURG RES, V106, P239, DOI 10.1006/jsre.2002.6468; KOCH AE, 1993, AM J PATHOL, V142, P1423; Koullias GJ, 2004, ANN THORAC SURG, V78, P2106, DOI 10.1016/j.athoracsur.2004.05.088; Lenk GM, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-237; Liao SX, 2001, J VASC SURG, V33, P1057, DOI 10.1067/mva.2001.112810; Lindeman JHN, 2009, CIRCULATION, V119, P2209, DOI 10.1161/CIRCULATIONAHA.108.806505; Longo GM, 2002, J CLIN INVEST, V110, P625, DOI 10.1172/JCI200215334; Lu H, 2008, CURR HYPERTENS REP, V10, P99, DOI 10.1007/s11906-008-0020-3; Maki JM, 2002, CIRCULATION, V106, P2503, DOI 10.1161/01.CIR.0000038109.84500.1E; Manning MW, 2003, ARTERIOSCL THROM VAS, V23, P483, DOI 10.1161/01.ATV.0000058404.92759.32; McCormick ML, 2007, ARTERIOSCL THROM VAS, V27, P461, DOI 10.1161/01.ATV.0000257552.94483.14; Miskinyte S, 2011, AM J HUM GENET, V88, P718, DOI 10.1016/j.ajhg.2011.04.017; Miwa K, 2005, GENE THER, V12, P1109, DOI 10.1038/sj.gt.3302496; Moehle CW, 2011, J THORAC CARDIOV SUR, V142, P1567, DOI 10.1016/j.jtcvs.2011.07.053; Nackman GB, 1997, SURGERY, V122, P39, DOI 10.1016/S0039-6060(97)90262-2; Nagy N, 2010, BASIC RES CARDIOL, V105, P29, DOI 10.1007/s00395-009-0051-1; Nakahashi TK, 2002, ARTERIOSCL THROM VAS, V22, P2017, DOI 10.1161/01.ATV.0000042082.38014.EA; Nishibe T, 2010, INT ANGIOL, V29, P260; Nordon IM, 2009, VASCULAR, V17, P253, DOI 10.2310/6670.2009.00046; Onoda M, 2010, ATHEROSCLEROSIS, V208, P366, DOI 10.1016/j.atherosclerosis.2009.07.036; Paik DC, 2004, EXP MOL MED, V36, P524, DOI 10.1038/emm.2004.67; Petrinec D, 1996, J VASC SURG, V23, P336, DOI 10.1016/S0741-5214(96)70279-3; Pyo R, 2000, J CLIN INVEST, V105, P1641, DOI 10.1172/JCI8931; Rateri DL, 2011, CIRC RES, V108, P574, DOI 10.1161/CIRCRESAHA.110.222844; Sasaki K, 2002, J CLIN INVEST, V109, P603, DOI 10.1172/JCI200213055; Satta J, 1998, ANN CHIR GYNAECOL FE, V87, P40; Schouten O, 2006, EUR J VASC ENDOVASC, V32, P21, DOI 10.1016/j.ejvs.2005.12.024; Shiraya S, 2009, ATHEROSCLEROSIS, V202, P34, DOI 10.1016/j.atherosclerosis.2008.03.020; Sho E, 2004, J VASC SURG, V39, P1312, DOI 10.1016/j.jvs.2004.01.036; Sho E, 2004, ARTERIOSCL THROM VAS, V24, P1916, DOI 10.1161/01.ATV.0000142805.20398.74; Stalenhoef AFH, 2009, J VASC SURG, V49, P260, DOI 10.1016/j.jvs.2008.11.070; Stegbauer J, 2009, P NATL ACAD SCI USA, V106, P14942, DOI 10.1073/pnas.0903602106; Steinmetz EF, 2005, ANN SURG, V241, P92, DOI 10.1097/01.sla.0000150258.36236.e0; Suen RS, 2011, AM J PATHOL, V179, P1549, DOI 10.1016/j.ajpath.2011.05.014; Sukhija R, 2006, AM J CARDIOL, V97, P279, DOI 10.1016/j.amjcard.2005.08.033; Sweeting MJ, 2010, J VASC SURG, V52, P1, DOI 10.1016/j.jvs.2010.02.264; Swirski FK, 2009, SCIENCE, V325, P612, DOI 10.1126/science.1175202; Takagi H, 2010, J VASC SURG, V52, P1675, DOI 10.1016/j.jvs.2010.04.082; Tedesco MM, 2009, ARTERIOSCL THROM VAS, V29, P1452, DOI 10.1161/ATVBAHA.109.187757; Thompson A, 2010, J VASC SURG, V52, P55, DOI 10.1016/j.jvs.2010.02.012; Tieu BC, 2009, J CLIN INVEST, V119, P3637, DOI 10.1172/JCI38308; Trollope A, 2011, CARDIOVASC PATHOL, V20, P114, DOI 10.1016/j.carpath.2010.01.001; Tsubakimoto Y, 2009, ARTERIOSCL THROM VAS, V29, P1529, DOI 10.1161/ATVBAHA.109.187732; Turner GH, 2008, CIRC-CARDIOVASC IMAG, V1, P220, DOI 10.1161/CIRCIMAGING.108.787358; Twine CP, BR J SURG, V98, P346; Van Kuijk JP, 2009, J CARDIOVASC SURG, V50, P599; Vinh A, 2008, J VASC RES, V45, P143, DOI 10.1159/000110041; Wang JA, 2011, ATHEROSCLEROSIS, V217, P90, DOI 10.1016/j.atherosclerosis.2011.03.005; Wang Y, 2010, J CLIN INVEST, V120, P422, DOI 10.1172/JCI38136; Wassmann S, 2004, CIRCULATION, V110, P3062, DOI 10.1161/01.CIR.0000137970.47771.AF; Wiernicki I, 2010, ATHEROSCLEROSIS, V212, P161, DOI 10.1016/j.atherosclerosis.2010.04.033; Xiong WF, 2009, J IMMUNOL, V183, P2741, DOI 10.4049/jimmunol.0803164; Yamamoto S, 2011, ARTERIOSCL THROM VAS, V31, P2856, DOI 10.1161/ATVBAHA.111.237198; Zhang YL, 2009, ARTERIOSCL THROM VAS, V29, P1764, DOI 10.1161/ATVBAHA.109.192609; Zhao L, 2004, NAT MED, V10, P966, DOI 10.1038/nm1099	96	57	57	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 3	2012	7	12							e49642	10.1371/journal.pone.0049642	http://dx.doi.org/10.1371/journal.pone.0049642			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	051DH	23226500	Green Published, gold, Green Submitted			2022-12-27	WOS:000312104700009
J	Bilet, A; Bauer, CK				Bilet, Arne; Bauer, Christiane K.			Effects of the Small Molecule HERG Activator NS1643 on Kv11.3 Channels	PLOS ONE			English	Article							DELAYED-RECTIFIER CURRENT; ERG K+ CHANNELS; EXPRESSION PATTERN; POTASSIUM CHANNELS; FUNCTIONAL-ROLE; NERVOUS-SYSTEM; BINDING-SITES; MECHANISM; MODULATION; BLOCKADE	NS1643 is one of the small molecule HERG (Kv11.1) channel activators and has also been found to increase erg2 (Kv11.2) currents. We now investigated whether NS1643 is also able to act as an activator of Kv11.3 (erg3) channels expressed in CHO cells. Activation of rat Kv11.3 current occurred in a dose-dependent manner and maximal current increasing effects were obtained with 10 mu M NS1643. At this concentration, steady-state outward current increased by about 80% and the current increase was associated with a significant shift in the voltage dependence of activation to more negative potentials by about 15 mV. In addition, activation kinetics were accelerated, whereas deactivation was slowed. There was no significant effect on the kinetics of inactivation and recovery from inactivation. The strong current-activating agonistic effect of NS1643 did not result from a shift in the voltage dependence of Kv11.3 channel inactivation and was independent from external Na+ or Ca2+. At the higher concentration of 20 mu M, NS1643 induced clearly less current increase. The left shift in the voltage dependence of activation reversed and the voltage sensitivity of activation dramatically decreased along with a slowing of Kv11.3 channel activation. These data show that, in comparison to other Kv11 family members, NS1643 exerts distinct effects on Kv11.3 channels with especially pronounced partial antagonistic effects at higher concentration.	[Bilet, Arne; Bauer, Christiane K.] Univ Med Ctr Hamburg Eppendorf UKE, Inst Cellular & Integrat Physiol, Hamburg, Germany	University of Hamburg; University Medical Center Hamburg-Eppendorf	Bauer, CK (corresponding author), Univ Med Ctr Hamburg Eppendorf UKE, Inst Cellular & Integrat Physiol, Hamburg, Germany.	c.bauer@uke.uni-hamburg.de		Bauer, Christiane K./0000-0002-2078-3503				Barros F, 1996, PFLUG ARCH EUR J PHY, V431, P443, DOI 10.1007/BF02207284; Bauer CK, 1999, MOL CELL ENDOCRINOL, V148, P37, DOI 10.1016/S0303-7207(98)00241-X; Bett GCL, 2011, BIOPHYS J, V101, P631, DOI 10.1016/j.bpj.2011.06.050; Casis O, 2006, MOL PHARMACOL, V69, P658, DOI 10.1124/mol.105.019943; Chiesa N, 1997, J PHYSIOL-LONDON, V501, P313, DOI 10.1111/j.1469-7793.1997.313bn.x; Diness TG, 2008, CARDIOVASC RES, V79, P61, DOI 10.1093/cvr/cvn075; Durdagi S, 2012, J PHARMACOL EXP THER, V342, P441, DOI 10.1124/jpet.111.189159; Einarsen K, 2009, PFLUG ARCH EUR J PHY, V458, P689, DOI 10.1007/s00424-009-0651-5; Elmedyb P, 2007, NEUROPHARMACOLOGY, V53, P283, DOI 10.1016/j.neuropharm.2007.05.009; Fernandez D, 2008, MOL PHARMACOL, V73, P1159, DOI 10.1124/mol.107.043505; Grunnet M, 2011, MOL PHARMACOL, V79, P1, DOI 10.1124/mol.110.067728; Guasti L, 2005, J COMP NEUROL, V491, P157, DOI 10.1002/cne.20721; Hansen RS, 2006, MOL PHARMACOL, V69, P266, DOI 10.1124/mol.105.015859; Hirdes W, 2009, PFLUG ARCH EUR J PHY, V459, P55, DOI 10.1007/s00424-009-0709-4; Ho WK, 1998, J PHYSIOL-LONDON, V507, P631, DOI 10.1111/j.1469-7793.1998.631bs.x; Johnson JP, 1999, J GEN PHYSIOL, V113, P565, DOI 10.1085/jgp.113.4.565; Johnson JP, 2001, J NEUROSCI, V21, P4143, DOI 10.1523/JNEUROSCI.21-12-04143.2001; Kang JS, 2005, MOL PHARMACOL, V67, P827, DOI 10.1124/mol.104.006577; Larsen AP, 2010, BRIT J PHARMACOL, V161, P614, DOI 10.1111/j.1476-5381.2010.00897.x; Li GR, 2010, ADV PHARMACOL, V59, P93, DOI 10.1016/S1054-3589(10)59004-5; Liu GX, 2004, J PHYSIOL-LONDON, V556, P401, DOI 10.1113/jphysiol.2003.059303; Mewe M, 2008, AM J PHYSIOL-REG I, V294, pR895, DOI 10.1152/ajpregu.00521.2007; Mullins FM, 2002, J GEN PHYSIOL, V120, P517, DOI 10.1085/jgp.20028589; Numaguchi H, 2000, NAT NEUROSCI, V3, P429, DOI 10.1038/74793; Papa M, 2003, J COMP NEUROL, V466, P119, DOI 10.1002/cne.10886; Perry M, 2008, MOL PHARMACOL, V73, P1044, DOI 10.1124/mol.107.043018; Saganich MJ, 2001, J NEUROSCI, V21, P4609, DOI 10.1523/JNEUROSCI.21-13-04609.2001; Schledermann W, 2001, J PHYSIOL-LONDON, V532, P143, DOI 10.1111/j.1469-7793.2001.0143g.x; Schonherr R, 1999, EUR J NEUROSCI, V11, P753, DOI 10.1046/j.1460-9568.1999.00493.x; Schuster AM, 2011, MOL PHARMACOL, V80, P930, DOI 10.1124/mol.111.071621; Schwarz JR, 1999, NEWS PHYSIOL SCI, V14, P135; Schwarz JR, 2004, J CELL MOL MED, V8, P22, DOI 10.1111/j.1582-4934.2004.tb00256.x; Shi WM, 1997, J NEUROSCI, V17, P9423; Smith PL, 1996, NATURE, V379, P833, DOI 10.1038/379833a0; Sturm P, 2005, J PHYSIOL-LONDON, V564, P329, DOI 10.1113/jphysiol.2004.078840; Vandenberg JI, 2012, PHYSIOL REV, V92, P1393, DOI 10.1152/physrev.00036.2011; Wang SM, 1997, J PHYSIOL-LONDON, V502, P45, DOI 10.1111/j.1469-7793.1997.045bl.x; Wimmers S, 2002, PFLUG ARCH EUR J PHY, V445, P423, DOI 10.1007/s00424-002-0936-4; Wimmers S, 2001, PFLUG ARCH EUR J PHY, V441, P450, DOI 10.1007/s004240000467; Xu XL, 2008, MOL PHARMACOL, V73, P1709, DOI 10.1124/mol.108.045591; Zeng HY, 2006, J PHARMACOL EXP THER, V319, P957, DOI 10.1124/jpet.106.110593	41	13	14	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 30	2012	7	11							e50886	10.1371/journal.pone.0050886	http://dx.doi.org/10.1371/journal.pone.0050886			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	054WM	23226420	Green Published, Green Submitted, gold			2022-12-27	WOS:000312376100231
J	Chavoya, A; Lopez-Martin, C; Andalon-Garcia, IR; Meda-Campana, ME				Chavoya, Arturo; Lopez-Martin, Cuauhtemoc; Andalon-Garcia, Irma R.; Meda-Campana, M. E.			Genetic Programming as Alternative for Predicting Development Effort of Individual Software Projects	PLOS ONE			English	Article							COST ESTIMATION	Statistical and genetic programming techniques have been used to predict the software development effort of large software projects. In this paper, a genetic programming model was used for predicting the effort required in individually developed projects. Accuracy obtained from a genetic programming model was compared against one generated from the application of a statistical regression model. A sample of 219 projects developed by 71 practitioners was used for generating the two models, whereas another sample of 130 projects developed by 38 practitioners was used for validating them. The models used two kinds of lines of code as well as programming language experience as independent variables. Accuracy results from the model obtained with genetic programming suggest that it could be used to predict the software development effort of individual projects when these projects have been developed in a disciplined manner within a development-controlled environment.	[Chavoya, Arturo; Lopez-Martin, Cuauhtemoc; Andalon-Garcia, Irma R.; Meda-Campana, M. E.] Univ Guadalajara, Dept Informat Syst, CUCEA, Zapopan, Jalisco, Mexico	Universidad de Guadalajara	Chavoya, A (corresponding author), Univ Guadalajara, Dept Informat Syst, CUCEA, Zapopan, Jalisco, Mexico.	achavoya@cucea.udg.mx	Lopez-Martin, Cuauhtemoc/AAL-4768-2021	Meda, Maria Elena/0000-0001-8684-8296	Consejo Nacional de Ciencia y Tecnologia (CONACYT); Programa para el Mejoramiento del Profesorado (PROMEP)	Consejo Nacional de Ciencia y Tecnologia (CONACYT)(Consejo Nacional de Ciencia y Tecnologia (CONACyT)); Programa para el Mejoramiento del Profesorado (PROMEP)	Funds were provided by Consejo Nacional de Ciencia y Tecnologia (CONACYT) (http://www.conacyt.mx) and Programa para el Mejoramiento del Profesorado (PROMEP) (http://promep.sep.gob.mx). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Afzal W, 2011, EXPERT SYST APPL, V38, P11984, DOI 10.1016/j.eswa.2011.03.041; Bagert DJ, 1999, CMUSEI99TR032; Boehm B, 2000, ANN SOFTW ENG, V10, P177, DOI 10.1023/A:1018991717352; Burgess CJ, 2001, INFORM SOFTWARE TECH, V43, P863, DOI 10.1016/S0950-5849(01)00192-6; Conte S. D., 1986, SOFTWARE ENG METRICS; Dolado JJ, 1998, P INT C SOFTW PROC I, P157; Ferrucci Filomena, 2010, 2010 Proceedings of Second International Symposium on Search Based Software Engineering (SSBSE), P89, DOI 10.1109/SSBSE.2010.20; Foss T, 2003, IEEE T SOFTWARE ENG, V29, P985, DOI 10.1109/TSE.2003.1245300; Hsu CJ, 2011, SOFTWARE QUAL J, V19, P165, DOI 10.1007/s11219-010-9110-y; Humphrey WS, 2002, ANN SOFTW ENG, V14, P39, DOI 10.1023/A:1020593305601; Humphrey WS, 1995, DISCIPLINE SOFTWARE, V1st; Jorgensen M., 2007, 1 INT WORKSH SOFTW P, P15; Jorgensen M, 2007, INT J FORECASTING, V23, P449, DOI 10.1016/j.ijforecast.2007.05.008; Kitchenham BA, 2007, IEEE T SOFTWARE ENG, V33, P316, DOI [10.1109/TSE.2007.1001, 10.1109/TSE.2007.1101]; Koza JR, 1992, GENETIC PROGRAMMING; Lefley M, 2003, LECT NOTES COMPUT SC, V2724, P2477; Lopez-Martin C, 2011, APPL SOFT COMPUT, V11, P724, DOI 10.1016/j.asoc.2009.12.034; Montgomery D.C., 2012, INTRO LINEAR REGRESS, Vfifith; Park R, 1992, SOFTWARE SIZE MEASUR; Rombach D, 2008, J SYST SOFTWARE, V81, P747, DOI 10.1016/j.jss.2007.06.004; Shan Y, 2002, 2002 INTERNATIONAL CONFERENCE ON COMMUNICATIONS, CIRCUITS AND SYSTEMS AND WEST SINO EXPOSITION PROCEEDINGS, VOLS 1-4, P1108, DOI 10.1109/ICCCAS.2002.1178979; Sheetz SD, 2009, J SYST SOFTWARE, V82, P1540, DOI 10.1016/j.jss.2009.04.038; Wen JF, 2012, INFORM SOFTWARE TECH, V54, P41, DOI 10.1016/j.infsof.2011.09.002	23	6	6	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 30	2012	7	11							e50531	10.1371/journal.pone.0050531	http://dx.doi.org/10.1371/journal.pone.0050531			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	054WM	23226305	Green Submitted, Green Published, gold			2022-12-27	WOS:000312376100117
J	Donaldson, NS; Pierre, CC; Anstey, MI; Robinson, SC; Weerawardane, SM; Daniel, JM				Donaldson, Nickett S.; Pierre, Christina C.; Anstey, Michelle I.; Robinson, Shaiya C.; Weerawardane, Sonali M.; Daniel, Juliet M.			Kaiso Represses the Cell Cycle Gene cyclin D1 via Sequence-Specific and Methyl-CpG-Dependent Mechanisms	PLOS ONE			English	Article							ZINC-FINGER PROTEINS; DNA METHYLATION; TRANSCRIPTIONAL REPRESSOR; BINDING-PROTEIN; PARTNER KAISO; CANCER; COMPLEXES; DOMAIN; POZ	Kaiso is the first member of the POZ family of zinc finger transcription factors reported to bind DNA with dual-specificity in both a sequence- and methyl-CpG-specific manner. Here, we report that Kaiso associates with and regulates the cyclin D1 promoter via the consensus Kaiso binding site (KBS), and also via methylated CpG-dinucleotides. The methyl-CpG sites appear critical for Kaiso binding to the cyclin D1 promoter, while a core KBS in close proximity to the methyl-CpGs appears to stabilize Kaiso DNA binding. Kaiso's binding to both sites was demonstrated in vitro using electrophoretic mobility shift assays (EMSA) and in vivo using Chromatin immunoprecipitation (ChIP). To elucidate the functional relevance of Kaiso's binding to the cyclin D1 promoter, we assessed Kaiso overexpression effects on a minimal cyclin D1 promoter-reporter that contains both KBS and CpG sites. Kaiso repressed this minimal cyclin D1 promoter-reporter in a dose-dependent manner and transcriptional repression occurred in a KBS-specific and methyl-CpG-dependent manner. Collectively our data validates cyclin D1 as a Kaiso target gene and demonstrates a mechanism for Kaiso binding and regulation of the cyclin D1 promoter. Our data also provides a mechanistic basis for how Kaiso may regulate other target genes whose promoters possess both KBS and methyl-CpG sites. Citation: Donaldson NS, Pierre CC, Anstey MI, Robinson SC, Weerawardane SM, et al. (2012) Kaiso Represses the Cell Cycle Gene cyclin D1 via Sequence-Specific and Methyl-CpG-Dependent Mechanisms. PLoS ONE 7(11): e50398. doi:10.1371/journal.pone.0050398	[Donaldson, Nickett S.; Pierre, Christina C.; Anstey, Michelle I.; Robinson, Shaiya C.; Weerawardane, Sonali M.; Daniel, Juliet M.] McMaster Univ, Dept Biol, Hamilton, ON, Canada	McMaster University	Daniel, JM (corresponding author), McMaster Univ, Dept Biol, Hamilton, ON, Canada.	danielj@mcmaster.ca		Robinson, Shaiya/0000-0001-5317-677X	Canadian Institutes of Health Research (CIHR) Grant [MOP-84320]; Ontario Graduate Fellowship; Ontario Graduate Scholarship in Science and Technology; Ontario Graduate Scholarship; DOD Breast Cancer Predoctoral Scholarship	Canadian Institutes of Health Research (CIHR) Grant(Canadian Institutes of Health Research (CIHR)); Ontario Graduate Fellowship; Ontario Graduate Scholarship in Science and Technology; Ontario Graduate Scholarship(Ontario Graduate Scholarship); DOD Breast Cancer Predoctoral Scholarship	This work was funded by Canadian Institutes of Health Research (CIHR) Grant # MOP-84320 to Dr. Juliet Daniel. Dr. Nickett S. Donaldson was a recipient of an Ontario Graduate Fellowship, an Ontario Graduate Scholarship in Science and Technology and an Ontario Graduate Scholarship. Michelle Anstey was the recipient of a DOD Breast Cancer Predoctoral Scholarship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BARDWELL VJ, 1994, GENE DEV, V8, P1664, DOI 10.1101/gad.8.14.1664; Daniel JM, 2002, NUCLEIC ACIDS RES, V30, P2911, DOI 10.1093/nar/gkf398; Daniel JM, 1999, MOL CELL BIOL, V19, P3614; Daniel JM, 2001, HYBRIDOMA, V20, P159, DOI 10.1089/027245701750293484; Filion GJP, 2006, MOL CELL BIOL, V26, P169, DOI 10.1128/MCB.26.1.169-181.2006; Jiang GY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030303; Kelly KF, 2006, TRENDS CELL BIOL, V16, P578, DOI 10.1016/j.tcb.2006.09.003; Kikuchi A, 2009, TRENDS CELL BIOL, V19, P119, DOI 10.1016/j.tcb.2009.01.003; Kim SW, 2004, NAT CELL BIOL, V6, P1212, DOI 10.1038/ncb1191; Lan J, 2010, ACTA BIOCH BIOPH SIN, V42, P243, DOI 10.1093/abbs/gmq015; Lopes EC, 2008, CANCER RES, V68, P7258, DOI 10.1158/0008-5472.CAN-08-0344; Ndlovu MN, 2011, TRENDS BIOCHEM SCI, V36, P381, DOI 10.1016/j.tibs.2011.03.002; Ogoshi K, 2011, GENOMICS, V98, P280, DOI 10.1016/j.ygeno.2011.07.003; Park JI, 2005, DEV CELL, V8, P843, DOI 10.1016/j.devcel.2005.04.010; Prokhortchouk A, 2001, GENE DEV, V15, P1613, DOI 10.1101/gad.198501; Robertson KD, 2005, NAT REV GENET, V6, P597, DOI 10.1038/nrg1655; Ruzov A, 2004, DEVELOPMENT, V131, P6185, DOI 10.1242/dev.01549; Sasai N, 2010, NUCLEIC ACIDS RES, V38, P5015, DOI 10.1093/nar/gkq280; Sasai N, 2009, INT J DEV BIOL, V53, P323, DOI 10.1387/ijdb.082652ns; Spring CM, 2005, EXP CELL RES, V305, P253, DOI 10.1016/j.yexcr.2005.01.007; van Roy FM, 2005, NAT REV CANCER, V5, P956, DOI 10.1038/nrc1752; Willert K, 2006, GENE DEV, V20, P1394, DOI 10.1101/gad.1424006; Yoon HG, 2003, MOL CELL, V12, P723, DOI 10.1016/j.molcel.2003.08.008	23	32	33	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 30	2012	7	11							e50398	10.1371/journal.pone.0050398	http://dx.doi.org/10.1371/journal.pone.0050398			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	054WM	23226276	gold, Green Published, Green Submitted			2022-12-27	WOS:000312376100086
J	Felonato, M; Pina, A; de Araujo, EF; Loures, FV; Bazan, SB; Feriotti, C; Calich, VLG				Felonato, Maira; Pina, Adriana; de Araujo, Eliseu Frank; Loures, Flavio V.; Bazan, Silvia B.; Feriotti, Claudia; Calich, Vera L. G.			Anti-CD25 Treatment Depletes Treg Cells and Decreases Disease Severity in Susceptible and Resistant Mice Infected with Paracoccidioides brasiliensis	PLOS ONE			English	Article							REGULATORY T-CELLS; INDOLEAMINE 2,3-DIOXYGENASE; IMMUNOLOGICAL-TOLERANCE; IMMUNE-RESPONSES; FUNGAL-INFECTION; PULMONARY MODEL; TGF-BETA; IN-VIVO; CD4(+); INFLAMMATION	Regulatory T (Treg) cells are fundamental in the control of immunity and excessive tissue pathology. In paracoccidioidomycosis, an endemic mycosis of Latin America, the immunoregulatory mechanisms that control the progressive and regressive forms of this infection are poorly known. Due to its modulatory activity on Treg cells, we investigated the effects of anti-CD25 treatment over the course of pulmonary infection in resistant (A/J) and susceptible (B10.A) mice infected with Paracoccidioides brasiliensis. We verified that the resistant A/J mice developed higher numbers and more potent Treg cells than susceptible B10.A mice. Compared to B10.A cells, the CD4(+)CD25(+)Foxp3(+) Treg cells of A/J mice expressed higher levels of CD25, CTLA4, GITR, Foxp3, LAP and intracellular IL-10 and TGF-beta. In both resistant and susceptible mice, anti-CD25 treatment decreased the CD4(+)CD25(+)Foxp3(+) Treg cell number, impaired indoleamine 2,3-dioxygenase expression and resulted in decreased fungal loads in the lungs, liver and spleen. In A/J mice, anti-CD25 treatment led to an early increase in T cell immunity, demonstrated by the augmented influx of activated CD4(+) and CD8(+) T cells, macrophages and dendritic cells to the lungs. At a later phase, the mild infection was associated with decreased inflammatory reactions and increased Th1/Th2/Th17 cytokine production. In B10.A mice, anti-CD25 treatment did not alter the inflammatory reactions but increased the fungicidal mechanisms and late secretion of Th1/Th2/Th17 cytokines. Importantly, in both mouse strains, the early depletion of CD25(+) cells resulted in less severe tissue pathology and abolished the enhanced mortality observed in susceptible mice. In conclusion, this study is the first to demonstrate that anti-CD25 treatment is beneficial to the progressive and regressive forms of paracoccidioidomycosis, potentially due to the anti-CD25-mediated reduction of Treg cells, as these cells have suppressive effects on the early T cell response in resistant mice and the clearance mechanisms of fungal cells in susceptible mice.	[Felonato, Maira; Pina, Adriana; de Araujo, Eliseu Frank; Loures, Flavio V.; Bazan, Silvia B.; Feriotti, Claudia; Calich, Vera L. G.] Univ Sao Paulo, Inst Ciencias Biomed, Dept Imunol, BR-05508 Sao Paulo, Brazil	Universidade de Sao Paulo	Calich, VLG (corresponding author), Univ Sao Paulo, Inst Ciencias Biomed, Dept Imunol, BR-05508 Sao Paulo, Brazil.	vlcalich@icb.usp.br	Calich, Vera/G-8367-2011; Loures, Flávio Vieira/B-6913-2012; Felonato, Maíra/T-4805-2017; Feriotti, Claudia/AGG-1092-2022	Calich, Vera/0000-0002-2170-5099; Loures, Flávio Vieira/0000-0001-7711-4063; Felonato, Maíra/0000-0003-2166-2831; Feriotti, Claudia/0000-0002-5184-5359	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP); Conselho Nacional de Pesquisas (CNPq)	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); Conselho Nacional de Pesquisas (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	This work was supported by Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP) and Conselho Nacional de Pesquisas (CNPq). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baban B, 2009, J IMMUNOL, V183, P2475, DOI 10.4049/jimmunol.0900986; Belkaid Y, 2005, NAT IMMUNOL, V6, P353, DOI 10.1038/ni1181; Belkaid Y, 2002, NATURE, V420, P502, DOI 10.1038/nature01152; Belkaid Y, 2009, ANNU REV IMMUNOL, V27, P551, DOI 10.1146/annurev.immunol.021908.132723; Benard G, 2001, CYTOKINE, V13, P248, DOI 10.1006/cyto.2000.0824; Bettelli E, 2006, NATURE, V441, P235, DOI 10.1038/nature04753; Bonifazi P, 2009, MUCOSAL IMMUNOL, V2, P362, DOI 10.1038/mi.2009.17; Brummer E, 1994, PARACOCCIDIOIDOMYCOS, P213; CALICH VLG, 1985, BRIT J EXP PATHOL, V66, P585; Calich VLG, 2005, FUNGAL IMMUNOLOGY: FROM AN ORGAN PERSPECTIVE, P201, DOI 10.1007/0-387-25445-5_10; Cano LE, 1998, INFECT IMMUN, V66, P800, DOI 10.1128/IAI.66.2.800-806.1998; Cano LE, 2000, INFECT IMMUN, V68, P352, DOI 10.1128/IAI.68.1.352-359.2000; CANO LE, 1995, INFECT IMMUN, V63, P1777, DOI 10.1128/IAI.63.5.1777-1783.1995; Cavassani KA, 2006, J IMMUNOL, V177, P5811, DOI 10.4049/jimmunol.177.9.5811; Chen WJ, 2003, J EXP MED, V198, P1875, DOI 10.1084/jem.20030152; Chen X, 2005, J LEUKOCYTE BIOL, V78, P114, DOI 10.1189/jlb.0604341; Chiarella AP, 2007, MICROBES INFECT, V9, P1078, DOI 10.1016/j.micinf.2007.04.016; Couper KN, 2007, J IMMUNOL, V178, P4136, DOI 10.4049/jimmunol.178.7.4136; De Luca A, 2007, J IMMUNOL, V179, P5999, DOI 10.4049/jimmunol.179.9.5999; de Luca A, 2010, CELL MOL IMMUNOL, V7, P459, DOI 10.1038/cmi.2010.43; Deaglio S, 2007, J EXP MED, V204, P1257, DOI 10.1084/jem.20062512; Fallarino F, 2012, EUR J IMMUNOL, V42, P1932, DOI 10.1002/eji.201242572; Fava Netto C, 1969, REV INST MED TROP SP, V11, P177; Felonato M, 2010, INFECT IMMUN, V78, P4922, DOI 10.1128/IAI.00297-10; Ferreira MC, 2010, INFECT IMMUN, V78, P4392, DOI 10.1128/IAI.00487-10; Fontenot JD, 2005, J EXP MED, V202, P901, DOI 10.1084/jem.20050784; Fontenot JD, 2003, NAT IMMUNOL, V4, P330, DOI 10.1038/ni904; Franco M, 1987, REV SOC BRAS MED TRO, V20, P129; Calich VLG, 2008, MYCOPATHOLOGIA, V165, P223, DOI 10.1007/s11046-007-9048-1; Hori S, 2002, EUR J IMMUNOL, V32, P1282, DOI 10.1002/1521-4141(200205)32:5<1282::AID-IMMU1282>3.0.CO;2-#; Hori S, 2003, SCIENCE, V299, P1057, DOI 10.1126/science.1079490; Johanns TM, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001043; Jonuleit H, 2003, J IMMUNOL, V171, P6323, DOI 10.4049/jimmunol.171.12.6323; KASHINO SS, 1990, MYCOPATHOLOGIA, V111, P173, DOI 10.1007/BF02282801; Kroetz DN, 2010, J IMMUNOL, V184, P5224, DOI 10.4049/jimmunol.1000032; Loures FV, 2011, INFECT IMMUN, V79, P2470, DOI 10.1128/IAI.00375-10; Loures FV, 2010, INFECT IMMUN, V78, P1078, DOI 10.1128/IAI.01198-09; Loures FV, 2009, J IMMUNOL, V183, P1279, DOI 10.4049/jimmunol.0801599; Mamomi RL, 2005, CYTOKINE, V32, P20, DOI 10.1016/j.cyto.2005.07.006; McGeachy MJ, 2007, NAT IMMUNOL, V8, P1390, DOI 10.1038/ni1539; McHugh RS, 2002, J ALLERGY CLIN IMMUN, V110, P693, DOI 10.1067/mai.2002.129339; McKinley L, 2006, J IMMUNOL, V177, P6215, DOI 10.4049/jimmunol.177.9.6215; Miyara M, 2007, TRENDS MOL MED, V13, P108, DOI 10.1016/j.molmed.2007.01.003; Montagnoli C, 2006, J IMMUNOL, V176, P1712, DOI 10.4049/jimmunol.176.3.1712; Montagnoli C, 2002, J IMMUNOL, V169, P6298, DOI 10.4049/jimmunol.169.11.6298; Moreira AP, 2008, J IMMUNOL, V180, P3049, DOI 10.4049/jimmunol.180.5.3049; Nascimento FRF, 2002, J IMMUNOL, V168, P4593, DOI 10.4049/jimmunol.168.9.4593; Neill DR, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002660; Ohkura N, 2011, NAT IMMUNOL, V12, P283, DOI 10.1038/ni0411-283; Pallotta MT, 2011, NAT IMMUNOL, V12, P870, DOI 10.1038/ni.2077; Pina A, 2008, J LEUKOCYTE BIOL, V83, P1088, DOI 10.1189/jlb.1107738; Romani Luigina, 2004, Nat Rev Immunol, V4, P1, DOI 10.1038/nri2939; Rowe JH, 2012, IMMUNOLOGY, V136, P1, DOI 10.1111/j.1365-2567.2011.03551.x; Rudensky AY, 2011, IMMUNOL REV, V241, P260, DOI 10.1111/j.1600-065X.2011.01018.x; Sakaguchi S, 2003, J CLIN INVEST, V112, P1310, DOI 10.1172/JCI200320274; Sakaguchi S, 2005, NAT IMMUNOL, V6, P345, DOI 10.1038/ni1178; Sakaguchi S, 2001, IMMUNOL REV, V182, P18, DOI 10.1034/j.1600-065X.2001.1820102.x; Shevach EM, 2006, NAT REV IMMUNOL, V6, P613, DOI 10.1038/nri1867; SINGERVERMES LM, 1992, J MED VET MYCOL, V30, P261; Wing K, 2008, SCIENCE, V322, P271, DOI 10.1126/science.1160062; Yamaguchi T, 2007, IMMUNITY, V27, P145, DOI 10.1016/j.immuni.2007.04.017; Zelenay S, 2006, J IMMUNOL, V177, P2036, DOI 10.4049/jimmunol.177.4.2036-a	62	40	41	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 30	2012	7	11							e51071	10.1371/journal.pone.0051071	http://dx.doi.org/10.1371/journal.pone.0051071			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	054WM	23226464	Green Published, Green Submitted, gold			2022-12-27	WOS:000312376100275
J	Hesker, PR; Nguyen, M; Kovarova, M; Ting, JPY; Koller, BH				Hesker, Pamela R.; MyTrang Nguyen; Kovarova, Martina; Ting, Jenny P. -Y.; Koller, Beverly H.			Genetic Loss of Murine Pyrin, the Familial Mediterranean Fever Protein, Increases Interleukin-1 beta Levels	PLOS ONE			English	Article							NF-KAPPA-B; INFLAMMASOME COMPONENTS; NALP3 INFLAMMASOME; ASC; CASPASE-1; IL-1-BETA; MACROPHAGE; ACTIVATE; DOMAIN; EXPRESSION	Familial Mediterranean Fever (FMF) is an inherited autoinflammatory disorder characterized by unprovoked episodes of fever and inflammation. The associated gene, MEFV (Mediterranean Fever), is expressed primarily by cells of myeloid lineage and encodes the protein pyrin/TRIM20/Marenostrin. The mechanism by which mutations in pyrin alter protein function to cause episodic inflammation is controversial. To address this question, we have generated a mouse line lacking the Mefv gene by removing a 21 kb fragment containing the entire Mefv locus. While the development of immune cell populations appears normal in these animals, we show enhanced interleukin (IL) 1 beta release by Mefv(-/-) macrophages in response to a spectrum of inflammatory stimuli, including stimuli dependent on IL-1 beta processing by the NLRP1b, NLRP3 and NLRC4 inflammasomes. Caspase-1 activity, however, did not change under identical conditions. These results are consistent with a model in which pyrin acts to limit the release of IL-1b generated by activation and assembly of inflammasomes in response to subclinical immune challenges.	[Hesker, Pamela R.; Ting, Jenny P. -Y.; Koller, Beverly H.] Univ N Carolina, Curriculum Genet & Mol Biol, Chapel Hill, NC 27599 USA; [MyTrang Nguyen; Koller, Beverly H.] Univ N Carolina, Dept Genet, Chapel Hill, NC USA; [Kovarova, Martina; Koller, Beverly H.] Univ N Carolina, Dept Med, Chapel Hill, NC USA; [Ting, Jenny P. -Y.] Univ N Carolina, Dept Microbiol & Immunol, Chapel Hill, NC USA; [Ting, Jenny P. -Y.] Univ N Carolina, Lineberger Comprehens Canc Ctr, Chapel Hill, NC 27599 USA	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill	Koller, BH (corresponding author), Univ N Carolina, Curriculum Genet & Mol Biol, Chapel Hill, NC 27599 USA.	Treawouns@aol.com		Kovarova, Martina/0000-0001-7152-1709	National Institutes of Health [NIH/AI U19-A1077437, U54-AI 057157]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U54AI057157] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by National Institutes of Health Grant NIH/AI U19-A1077437 (to B. H. K. and J.P.-Y.T.) and U54-AI 057157 (to J.P.-Y.T.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aksentijevich I, 1997, CELL, V90, P797; Andrei C, 1999, MOL BIOL CELL, V10, P1463, DOI 10.1091/mbc.10.5.1463; Badour K, 2003, IMMUNITY, V18, P141, DOI 10.1016/S1074-7613(02)00516-2; Ben-Zvi I, 2011, NAT REV RHEUMATOL, V7, P105, DOI 10.1038/nrrheum.2010.181; Bernot A, 1997, NAT GENET, V17, P25; Booth DR, 2000, QJM-INT J MED, V93, P217, DOI 10.1093/qjmed/93.4.217; Bruey JM, 2004, J BIOL CHEM, V279, P51897, DOI 10.1074/jbc.M406741200; Centola M, 2000, BLOOD, V95, P3223, DOI 10.1182/blood.V95.10.3223; Chae JJ, 2008, BLOOD, V112, P1794, DOI 10.1182/blood-2008-01-134932; Chae JJ, 2006, P NATL ACAD SCI USA, V103, P9982, DOI 10.1073/pnas.0602081103; Chae JJ, 2003, MOL CELL, V11, P591, DOI 10.1016/S1097-2765(03)00056-X; Chae JJ, 2011, IMMUNITY; Chen GY, 2011, J IMMUNOL, V186, P7187, DOI 10.4049/jimmunol.1100412; Davis BK, 2011, ANNU REV IMMUNOL, V29, P707, DOI 10.1146/annurev-immunol-031210-101405; Dowds TA, 2003, BIOCHEM BIOPH RES CO, V302, P575, DOI 10.1016/S0006-291X(03)00221-3; Dundar M, 2010, MOL BIOL REP; Elinav E, 2011, CELL, V145, P745, DOI 10.1016/j.cell.2011.04.022; Gardella S, 2002, EMBO REP, V3, P995, DOI 10.1093/embo-reports/kvf198; Gavrilin MA, 2009, J IMMUNOL, V182, P7982, DOI 10.4049/jimmunol.0803073; Grandemange S, 2011, GENES IMMUN, V12, P497, DOI 10.1038/gene.2011.53; Gyorgy B, 2011, CELL MOL LIFE SCI, V68, P2667, DOI 10.1007/s00018-011-0689-3; Harris J, 2011, J BIOL CHEM, V286, P9587, DOI 10.1074/jbc.M110.202911; HERZYK DJ, 1992, J IMMUNOL, V149, P3052; HOLT PF, 1970, BRIT J PHARMACOL, V38, P192, DOI 10.1111/j.1476-5381.1970.tb10347.x; Hornung V, 2008, NAT IMMUNOL, V9, P847, DOI 10.1038/ni.1631; Kovarova M, 2012, J IMMUNOL; Mansfield E, 2001, BLOOD, V98, P851, DOI 10.1182/blood.V98.3.851; Mariathasan S, 2007, MICROBES INFECT, V9, P664, DOI 10.1016/j.micinf.2007.01.017; Martinon F, 2006, NATURE, V440, P237, DOI 10.1038/nature04516; Meinzer U, 2011, SEMIN ARTHRITIS RHEU; Mitroulis I, 2011, HUM IMMUNOL, V72, P135, DOI 10.1016/j.humimm.2010.11.006; Normand S, 2011, P NATL ACAD SCI USA, V108, P9601, DOI 10.1073/pnas.1100981108; Papin S, 2007, CELL DEATH DIFFER, V14, P1457, DOI 10.1038/sj.cdd.4402142; Rathinam VAK, 2010, NAT IMMUNOL, V11, P395, DOI 10.1038/ni.1864; Richards N, 2001, J BIOL CHEM, V276, P39320, DOI 10.1074/jbc.M104730200; Schroder K, 2010, CELL, V140, P821, DOI 10.1016/j.cell.2010.01.040; Schuh M, 2011, NAT CELL BIOL; Seshadri S, 2007, J IMMUNOL, V179, P1274, DOI 10.4049/jimmunol.179.2.1274; Shoham NG, 2003, P NATL ACAD SCI USA, V100, P13501, DOI 10.1073/pnas.2135380100; Stanley AC, 2010, PHYSIOLOGY, V25, P218, DOI 10.1152/physiol.00017.2010; Stehlik C, 2007, J IMMUNOL, V179, P7993, DOI 10.4049/jimmunol.179.12.7993; von Moltke J, 2012, NATURE, V490, P107, DOI 10.1038/nature11351; Waite AL, 2009, EXP BIOL MED, V234, P40, DOI 10.3181/0806-RM-184; Willingham SB, 2007, CELL HOST MICROBE, V2, P147, DOI 10.1016/j.chom.2007.07.009; Yazdi AS, 2010, P NATL ACAD SCI USA, V107, P19449, DOI 10.1073/pnas.1008155107; Yu JW, 2007, MOL CELL, V28, P214, DOI 10.1016/j.molcel.2007.08.029; Yu JW, 2006, CELL DEATH DIFFER, V13, P236, DOI 10.1038/sj.cdd.4401734	47	43	45	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 30	2012	7	11							e51105	10.1371/journal.pone.0051105	http://dx.doi.org/10.1371/journal.pone.0051105			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	054WM	23226472	Green Published, Green Submitted, gold			2022-12-27	WOS:000312376100283
J	Jensen, MM; Erichsen, KD; Bjorkling, F; Madsen, J; Jensen, PB; Sehested, M; Hojgaard, L; Kjaer, A				Jensen, Mette Munk; Erichsen, Kamille Dumong; Bjorkling, Fredrik; Madsen, Jacob; Jensen, Peter Buhl; Sehested, Maxwell; Hojgaard, Liselotte; Kjaer, Andreas			[18F]FLT PET for Non-Invasive Assessment of Tumor Sensitivity to Chemotherapy: Studies with Experimental Chemotherapy TP202377 in Human Cancer Xenografts in Mice	PLOS ONE			English	Article							HUMAN THYMIDINE KINASE; IN-VIVO; MTOR INHIBITION; F-18-FLT UPTAKE; THERAPY; PROLIFERATION; CARCINOMA; CISPLATIN; RESPONSES; MARKER	Aim: 3'-deoxy-3'-[F-18]fluorothymidine ([18F]FLT) is a tracer used to assess cell proliferation in vivo. The aim of the study was to use [18F]FLT positron emission tomography (PET) to study non-invasively early anti-proliferative effects of the experimental chemotherapeutic agent TP202377 in both sensitive and resistant tumors. Methods: Xenografts in mice from 3 human cancer cell lines were used: the TP202377 sensitive A2780 ovary cancer cell line (n = 8-16 tumors/group), the induced resistant A2780/Top216 cell line (n = 8-12 tumors/group) and the natural resistant SW620 colon cancer cell line (n = 10 tumors/group). In vivo uptake of [18F]FLT was studied at baseline and repeated 6 hours, Day 1, and Day 6 after TP202377 treatment (40 mg/kg i.v.) was initiated. Tracer uptake was quantified using small animal PET/CT. Results: TP202377 (40 mg/kg at 0 hours) caused growth inhibition at Day 6 in the sensitive A2780 tumor model compared to the control group (P<0.001). In the A2780 tumor model TP202377 treatment caused significant decrease in uptake of [18F]FLT at 6 hours (-46%; P<0.001) and Day 1 (-44%; P<0.001) after treatment start compared to baseline uptake. At Day 6 uptake was comparable to baseline. Treatment with TP202377 did not influence tumor growth or [18F]FLT uptake in the resistant A2780/Top216 and SW620 tumor models. In all control groups uptake of [18F]FLT did not change. Ki67 gene expression paralleled [18F]FLT uptake. Conclusion: Treatment of A2780 xenografts in mice with TP202377 (single dose i.v.) caused a significant decrease in cell proliferation assessed by [18F]FLT PET after 6 hours. Inhibition persisted at Day 1; however, cell proliferation had returned to baseline at Day 6. In the resistant A2780/Top216 and SW620 tumor models uptake of [18F]FLT did not change after treatment. With [18F]FLT PET it was possible to distinguish non-invasively between sensitive and resistant tumors already 6 hours after treatment initiation.	[Jensen, Mette Munk; Hojgaard, Liselotte; Kjaer, Andreas] Univ Copenhagen, Fac Hlth & Med Sci, Copenhagen, Denmark; [Jensen, Mette Munk; Madsen, Jacob; Hojgaard, Liselotte; Kjaer, Andreas] Rigshosp, Dept Clin Physiol Nucl Med & PET, Copenhagen, Denmark; [Erichsen, Kamille Dumong; Bjorkling, Fredrik; Jensen, Peter Buhl; Sehested, Maxwell] TopoTarget AS, Symb Sci Pk, Copenhagen, Denmark	University of Copenhagen; Rigshospitalet; University of Copenhagen	Jensen, MM (corresponding author), Univ Copenhagen, Fac Hlth & Med Sci, Copenhagen, Denmark.	mettemj@sund.ku.dk	Højgaard, Liselotte/AAK-8329-2020; Kjaer, Andreas/E-8932-2015	Bjorkling, Fredrik/0000-0001-7018-8334; Kjaer, Andreas/0000-0002-2706-5547	National Advanced Technology Foundation; Danish Medical Research Council; Rigshospitalets Research Foundation; Svend Andersen Foundation; AP Moller Foundation; Novo Nordisk Foundation; Lundbeck Foundation; Danish Cancer Society	National Advanced Technology Foundation; Danish Medical Research Council(Danish Medical Research CouncilUK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Rigshospitalets Research Foundation; Svend Andersen Foundation; AP Moller Foundation; Novo Nordisk Foundation(Novo Nordisk FoundationNovocure Limited); Lundbeck Foundation(Lundbeckfonden); Danish Cancer Society(Danish Cancer Society)	This study was funded by the National Advanced Technology Foundation, Danish Medical Research Council, Rigshospitalets Research Foundation, Svend Andersen Foundation, AP Moller Foundation, Novo Nordisk Foundation, Lundbeck Foundation and Danish Cancer Society. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aide N, 2010, J NUCL MED, V51, P1559, DOI 10.2967/jnumed.109.073288; Apisarnthanarax S, 2006, CLIN CANCER RES, V12, P4590, DOI 10.1158/1078-0432.CCR-05-2720; ARNER ESJ, 1995, PHARMACOL THERAPEUT, V67, P155, DOI 10.1016/0163-7258(95)00015-9; Barthel H, 2005, EUR J NUCL MED MOL I, V32, P257, DOI 10.1007/s00259-004-1611-0; Barthel H, 2003, CANCER RES, V63, P3791; Brepoels L, 2009, J NUCL MED, V50, P1102, DOI 10.2967/jnumed.109.062208; CHANG ZF, 1994, J BIOL CHEM, V269, P21249; Christensen MK, 2010, J MED CHEM, V53, P7140, DOI 10.1021/jm100763j; EVA A, 1982, NATURE, V295, P116, DOI 10.1038/295116a0; Hellemans J, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-2-r19; ISOLA J, 1990, HISTOCHEM J, V22, P498, DOI 10.1007/BF01007235; Jensen Mette Munk, 2008, BMC Med Imaging, V8, P16, DOI 10.1186/1471-2342-8-16; Jensen MA, 2010, PLOS ONE, V5, DOI [10.1371/journal.pone.0011024, 10.1371/journal.pone.0012965]; Kameyama R, 2011, NUCL MED COMMUN, V32, P460, DOI 10.1097/MNM.0b013e32834209b5; KONG XB, 1992, ANTIMICROB AGENTS CH, V36, P808, DOI 10.1128/AAC.36.4.808; Leyton J, 2005, CANCER RES, V65, P4202, DOI 10.1158/0008-5472.CAN-04-4008; Leyton J, 2006, CANCER RES, V66, P7621, DOI 10.1158/0008-5472.CAN-05-3962; Manning HC, 2008, CLIN CANCER RES, V14, P7413, DOI 10.1158/1078-0432.CCR-08-0239; Molthoff CFM, 2007, MOL IMAGING BIOL, V9, P340, DOI 10.1007/s11307-007-0104-5; Moroz MA, 2011, CLIN CANCER RES, V17, P1099, DOI 10.1158/1078-0432.CCR-10-1430; MUNCHPETERSEN B, 1995, ADV ENZYME REGUL, V35, P69, DOI 10.1016/0065-2571(94)00014-T; Oyama N, 2004, J NUCL MED, V45, P519; Rasey JS, 2002, J NUCL MED, V43, P1210; Shah C, 2009, CLIN CANCER RES, V15, P4712, DOI 10.1158/1078-0432.CCR-08-2635; SHERLEY JL, 1988, J BIOL CHEM, V263, P8350; Shields AF, 1998, NAT MED, V4, P1334, DOI 10.1038/3337; Soloviev D, 2012, EUR J CANCER, V48, P416, DOI 10.1016/j.ejca.2011.11.035; Trojel-Hansen C, 2011, CANCER CHEMOTH PHARM, V68, P127, DOI 10.1007/s00280-010-1453-3; Waldherr C, 2005, J NUCL MED, V46, P114; Yang YJ, 2006, EUR J NUCL MED MOL I, V33, P412, DOI 10.1007/s00259-005-0011-4; Yerushalmi R, 2010, LANCET ONCOL, V11, P174, DOI 10.1016/S1470-2045(09)70262-1; Zhang CC, 2012, CLIN CANCER RES, V18, P1303, DOI 10.1158/1078-0432.CCR-11-1433	32	8	8	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 30	2012	7	11							e50618	10.1371/journal.pone.0050618	http://dx.doi.org/10.1371/journal.pone.0050618			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	054WM	23226334	Green Submitted, Green Published, gold			2022-12-27	WOS:000312376100145
J	Lee, YE; Kim, JW; Lee, EM; Ahn, YB; Song, KH; Yoon, KH; Kim, HW; Park, CW; Li, GL; Liu, ZQ; Ko, SH				Lee, Young-Eun; Kim, Ji-Won; Lee, Eun-Mi; Ahn, Yu-Bae; Song, Ki-Ho; Yoon, Kun-Ho; Kim, Hyung-Wook; Park, Cheol-Whee; Li, Guolian; Liu, Zhenqi; Ko, Seung-Hyun			Chronic Resveratrol Treatment Protects Pancreatic Islets against Oxidative Stress in db/db Mice	PLOS ONE			English	Article							BETA-CELL DYSFUNCTION; INDUCED DIABETIC-RATS; GLUCOSE TOXICITY; INSULIN-SECRETION; ANTIOXIDANT; RESISTANCE; MODEL; WINE; HYPERGLYCEMIA; MECHANISMS	Resveratrol (RSV) has anti-inflammatory and anti-oxidant actions which may contribute to its cardiovascular protective effects. We examined whether RSV has any beneficial effects on pancreatic islets in db/db mice, an animal model of type 2 diabetes. The db/db and db/dm mice (non-diabetic control) were treated with (db-RSV) or without RSV (db-control) (20 mg/kg daily) for 12 weeks. After performing an intraperitoneal glucose tolerance test and insulin tolerance test, mice were sacrificed, the pancreas was weighed, pancreatic beta-cell mass was quantified by point count method, and the amount of islet fibrosis was determined. 8-Hydroxydeoxyguanosine (8-OHdG), an oxidative stress marker, was determined in 24 h urine and pancreatic islets. RSV treatment significantly improved glucose tolerance at 2 hrs in db/db mice (P = 0.036), but not in db/dm mice (P = 0.623). This was associated with a significant increase in both pancreas weight (P = 0.011) and beta-cell mass (P = 0.016). Islet fibrosis was much less in RSV-treated mice (P = 0.048). RSV treatment also decreased urinary 8-OHdG levels (P = 0.03) and the percentage of islet nuclei that were positive for 8-OHdG immunostaining (P = 0.019). We conclude that RSV treatment improves glucose tolerance, attenuates beta-cell loss, and reduces oxidative stress in type 2 diabetes. These findings suggest that RSV may have a therapeutic implication in the prevention and management of diabetes.	[Lee, Young-Eun; Kim, Ji-Won; Lee, Eun-Mi; Ahn, Yu-Bae; Song, Ki-Ho; Yoon, Kun-Ho; Ko, Seung-Hyun] Catholic Univ Korea, Dept Internal Med, Div Endocrinol & Metab, Seoul, South Korea; [Kim, Hyung-Wook; Park, Cheol-Whee] Catholic Univ Korea, Dept Internal Med, Div Nephrol, Seoul, South Korea; [Li, Guolian; Liu, Zhenqi] Univ Virginia Hlth Syst, Div Endocrinol & Metab, Dept Med, Charlottesville, VA USA	Catholic University of Korea; Catholic University of Korea; University of Virginia	Ko, SH (corresponding author), Catholic Univ Korea, Dept Internal Med, Div Endocrinol & Metab, Seoul, South Korea.	kosh@catholic.ac.kr			Catholic Medical Center Research Foundation; National Research Foundation of Korea	Catholic Medical Center Research Foundation; National Research Foundation of Korea(National Research Foundation of Korea)	This was supported by a grant from the Catholic Medical Center Research Foundation and the National Research Foundation of Korea. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	de la Lastral CA, 2007, BIOCHEM SOC T, V35, P1156, DOI 10.1042/BST0351156; Baur JA, 2006, NATURE, V444, P337, DOI 10.1038/nature05354; Baur JA, 2006, NAT REV DRUG DISCOV, V5, P493, DOI 10.1038/nrd2060; Bonner-Weir S, 2001, DIABETES, V50, pS20, DOI 10.2337/diabetes.50.2007.S20; Broedbaek K, 2011, FREE RADICAL BIO MED, V51, P1473, DOI 10.1016/j.freeradbiomed.2011.07.007; Cavallaro A, 2003, PHYSIOL RES, V52, P555; Chen H, 1996, CELL, V84, P491, DOI 10.1016/S0092-8674(00)81294-5; Chow SE, 2007, J APPL PHYSIOL, V102, P1520, DOI 10.1152/japplphysiol.00881.2006; Clark A, 2001, DIABETES, V50, pS169, DOI 10.2337/diabetes.50.2007.S169; Cucciolla V, 2007, CELL CYCLE, V6, P2495, DOI 10.4161/cc.6.20.4815; Dandona P, 1996, LANCET, V347, P444, DOI 10.1016/S0140-6736(96)90013-6; Das DK, 2006, MOL INTERV, V6, P36, DOI 10.1124/mi.6.1.7; Delmas D, 2005, MOL NUTR FOOD RES, V49, P377, DOI 10.1002/mnfr.200400098; Di Castelnuovo A, 2002, CIRCULATION, V105, P2836, DOI 10.1161/01.CIR.0000018653.19696.01; Drews G, 2010, PFLUG ARCH EUR J PHY, V460, P703, DOI 10.1007/s00424-010-0862-9; Evans JL, 2002, ENDOCR REV, V23, P599, DOI 10.1210/er.2001-0039; Fremont L, 2000, LIFE SCI, V66, P663, DOI 10.1016/S0024-3205(99)00410-5; Henriksen EJ, 2011, FREE RADICAL BIO MED, V51, P993, DOI 10.1016/j.freeradbiomed.2010.12.005; Huang A, 2012, AM J PHYSIOL-REG I, V302, pR674, DOI 10.1152/ajpregu.00699.2011; Kaneto H, 1999, DIABETES, V48, P2398, DOI 10.2337/diabetes.48.12.2398; Kaneto H, 2005, J MOL MED, V83, P429, DOI 10.1007/s00109-005-0640-x; Kitada M, 2011, DIABETES, V60, P634, DOI 10.2337/db10-0386; Lagouge M, 2006, CELL, V127, P1109, DOI 10.1016/j.cell.2006.11.013; LEAHY JL, 1992, DIABETES CARE, V15, P442, DOI 10.2337/diacare.15.3.442; Lee E, 2011, BIOCHEM BIOPH RES CO, V414, P397, DOI 10.1016/j.bbrc.2011.09.087; Lee EM, 2011, DIABETES METAB J, V35, P469, DOI 10.4093/dmj.2011.35.5.469; Leonard SS, 2003, BIOCHEM BIOPH RES CO, V309, P1017, DOI 10.1016/j.bbrc.2003.08.105; Minakawa M, 2011, J CLIN BIOCHEM NUTR, V48, P237, DOI 10.3164/jcbn.10-119; Palsamy P, 2010, J CELL PHYSIOL, V224, P423, DOI 10.1002/jcp.22138; Poitout V, 2008, ENDOCR REV, V29, P351, DOI 10.1210/er.2007-0023; Rahman I, 2006, BIOCHEM PHARMACOL, V72, P1439, DOI 10.1016/j.bcp.2006.07.004; Rains JL, 2011, FREE RADICAL BIO MED, V50, P567, DOI 10.1016/j.freeradbiomed.2010.12.006; RENAUD S, 1992, LANCET, V339, P1523, DOI 10.1016/0140-6736(92)91277-F; Rivera L, 2009, BIOCHEM PHARMACOL, V77, P1053, DOI 10.1016/j.bcp.2008.11.027; Robertson RP, 2006, FREE RADICAL BIO MED, V41, P177, DOI 10.1016/j.freeradbiomed.2005.04.030; Robertson RP, 2004, J BIOL CHEM, V279, P42351, DOI 10.1074/jbc.R400019200; Sakuraba H, 2002, DIABETOLOGIA, V45, P85, DOI 10.1007/s125-002-8248-z; Sallam N, 2011, N-S ARCH PHARMACOL, V383, P483, DOI 10.1007/s00210-011-0614-1; Shakibaei M, 2009, MOL NUTR FOOD RES, V53, P115, DOI 10.1002/mnfr.200800148; Sharma S, 2011, PHYTOTHER RES, V25, P67, DOI 10.1002/ptr.3221; Shulman GI, 2000, J CLIN INVEST, V106, P171, DOI 10.1172/JCI10583; Su HC, 2006, AM J PHYSIOL-ENDOC M, V290, pE1339, DOI 10.1152/ajpendo.00487.2005; Szkudelski T, 2007, AM J PHYSIOL-ENDOC M, V293, pE901, DOI 10.1152/ajpendo.00564.2006; Szkudelski T, 2011, ANN NY ACAD SCI, V1215, P34, DOI 10.1111/j.1749-6632.2010.05844.x; Tanaka Y, 1999, P NATL ACAD SCI USA, V96, P10857, DOI 10.1073/pnas.96.19.10857; Um JH, 2010, DIABETES, V59, P554, DOI 10.2337/db09-0482; Ungvari Z, 2007, AM J PHYSIOL-HEART C, V292, pH2417, DOI 10.1152/ajpheart.01258.2006; Vetterli L, 2011, J BIOL CHEM, V286, P6049, DOI 10.1074/jbc.M110.176842; Weibel ER, 1978, PRACTICAL METHODS BI, V1; Wenzel E, 2005, MOL NUTR FOOD RES, V49, P472, DOI 10.1002/mnfr.200500010; Weyer C, 1999, J CLIN INVEST, V104, P787, DOI 10.1172/JCI7231; Zhang HR, 2009, ARTERIOSCL THROM VAS, V29, P1164, DOI 10.1161/ATVBAHA.109.187146	52	38	38	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 30	2012	7	11							e50412	10.1371/journal.pone.0050412	http://dx.doi.org/10.1371/journal.pone.0050412			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	054WM	23226280	Green Published, gold, Green Submitted			2022-12-27	WOS:000312376100092
J	Lopert, P; Day, BJ; Patel, M				Lopert, Pamela; Day, Brian J.; Patel, Manisha			Thioredoxin Reductase Deficiency Potentiates Oxidative Stress, Mitochondrial Dysfunction and Cell Death in Dopaminergic Cells	PLOS ONE			English	Article							HUMAN SUBSTANTIA-NIGRA; PARKINSONS-DISEASE; HYDROGEN-PEROXIDE; ANIMAL-MODELS; 6-HYDROXYDOPAMINE; SUPEROXIDE; ANTIOXIDANT; INHIBITION; APOPTOSIS; METALLOPORPHYRINS	Mitochondria are considered major generators of cellular reactive oxygen species (ROS) which are implicated in the pathogenesis of neurodegenerative diseases such as Parkinson's disease (PD). We have recently shown that isolated mitochondria consume hydrogen peroxide (H2O2) in a substrate-and respiration-dependent manner predominantly via the thioredoxin/peroxiredoxin (Trx/Prx) system. The goal of this study was to determine the role of Trx/Prx system in dopaminergic cell death. We asked if pharmacological and lentiviral inhibition of the Trx/Prx system sensitized dopaminergic cells to mitochondrial dysfunction, increased steady-state H2O2 levels and death in response to toxicants implicated in PD. Incubation of N27 dopaminergic cells or primary rat mesencephalic cultures with the Trx reductase (TrxR) inhibitor auranofin in the presence of sub-toxic concentrations of parkinsonian toxicants paraquat; PQ or 6-hydroxydopamine; 6OHDA (for N27 cells) resulted in a synergistic increase in H2O2 levels and subsequent cell death. shRNA targeting the mitochondrial thioredoxin reductase (TrxR2) in N27 cells confirmed the effects of pharmacological inhibition. A synergistic decrease in maximal and reserve respiratory capacity was observed in auranofin treated cells and TrxR2 deficient cells following incubation with PQ or 6OHDA. Additionally, TrxR2 deficient cells showed decreased basal mitochondrial oxygen consumption rates. These data demonstrate that inhibition of the mitochondrial Trx/Prx system sensitizes dopaminergic cells to mitochondrial dysfunction, increased steady-state H2O2, and cell death. Therefore, in addition to their role in the production of cellular H2O2 the mitochondrial Trx/Prx system serve as a major sink for cellular H2O2 and its disruption may contribute to dopaminergic pathology associated with PD.	[Lopert, Pamela; Patel, Manisha] Univ Colorado, Neurosci Program, Aurora, CO 80045 USA; [Patel, Manisha] Univ Colorado, Dept Pharmaceut Sci, Aurora, CO USA; [Day, Brian J.] Natl Jewish Hlth, Dept Med, Denver, CO USA	University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado System; University of Colorado Anschutz Medical Campus; National Jewish Health	Patel, M (corresponding author), Univ Colorado, Neurosci Program, Anschutz Med Campus, Aurora, CO 80045 USA.	Manisha.Patel@ucdenver.edu		Lopert, Pamela/0000-0002-6625-7832	National institutes of Health [RO1NS04748]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [T32HD041697] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS086423, R01NS045748] Funding Source: NIH RePORTER	National institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by by the National institutes of Health grant RO1NS04748 (MP). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arner E S, 2001, Curr Protoc Toxicol, VChapter 7, DOI 10.1002/0471140856.tx0704s05; Basso M, 2004, PROTEOMICS, V4, P3943, DOI 10.1002/pmic.200400848; BERGMEYER HU, 1983, METHOD ENZYMAT AN, V3, P118; Betarbet R, 2002, BIOESSAYS, V24, P308, DOI 10.1002/bies.10067; Callio J, 2005, J BIOL CHEM, V280, P18536, DOI 10.1074/jbc.M413224200; Cantu D, 2011, J NEUROCHEM, V118, P79, DOI 10.1111/j.1471-4159.2011.07290.x; Cantu D, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007095; Castello PR, 2008, J PHARMACOL EXP THER, V324, P970, DOI 10.1124/jpet.107.132134; Castello PR, 2007, J BIOL CHEM, V282, P14186, DOI 10.1074/jbc.M700827200; Chen Y, 2002, J BIOL CHEM, V277, P33242, DOI 10.1074/jbc.M202026200; COHEN G, 1974, J BIOL CHEM, V249, P2447; Conrad M, 2004, MOL CELL BIOL, V24, P9414, DOI 10.1128/MCB.24.21.9414-9423.2004; Damdimopoulos AE, 2002, J BIOL CHEM, V277, P33249, DOI 10.1074/jbc.M203036200; Day BJ, 1995, J PHARMACOL EXP THER, V275, P1227; Dinis-Oliveira RJ, 2006, NEUROTOXICOLOGY, V27, P1110, DOI 10.1016/j.neuro.2006.05.012; Drechsel DA, 2010, J BIOL CHEM, V285, P27850, DOI 10.1074/jbc.M110.101196; Drechsel DA, 2009, METHOD ENZYMOL, V456, P381, DOI 10.1016/S0076-6879(08)04421-2; Finkel T, 2005, NAT REV MOL CELL BIO, V6, P971, DOI 10.1038/nrm1763; FLAGG EW, 1993, BRIT J NUTR, V70, P797, DOI 10.1079/BJN19930175; GLINKA YY, 1995, EUR J PHARM-ENVIRON, V292, P329, DOI 10.1016/0926-6917(95)90040-3; Gould NS, 2011, RESP RES, V12, DOI 10.1186/1465-9921-12-133; Gromer S, 1998, J BIOL CHEM, V273, P20096, DOI 10.1074/jbc.273.32.20096; HEIKKILA RE, 1973, SCIENCE, V181, P456, DOI 10.1126/science.181.4098.456; Jenner P, 1996, NEUROLOGY, V47, pS161, DOI 10.1212/WNL.47.6_Suppl_3.161S; Jenner P, 1998, ANN NEUROL, V44, pS72, DOI 10.1002/ana.410440712; Kachadourian R, 2004, BIOCHEM PHARMACOL, V67, P77, DOI 10.1016/j.bcp.2003.08.036; Kamata H, 1999, CELL SIGNAL, V11, P1, DOI 10.1016/S0898-6568(98)00037-0; Kulich SM, 2007, FREE RADICAL BIO MED, V43, P372, DOI 10.1016/j.freeradbiomed.2007.04.028; Mackensen GB, 2001, J NEUROSCI, V21, P4582, DOI 10.1523/JNEUROSCI.21-13-04582.2001; Murphy MP, 2009, BIOCHEM J, V417, P1, DOI 10.1042/BJ20081386; Nonn L, 2003, MOL CELL BIOL, V23, P916, DOI 10.1128/MCB.23.3.916-922.2003; Patel M, 1996, NEURON, V16, P345, DOI 10.1016/S0896-6273(00)80052-5; Patel M, 1999, TRENDS PHARMACOL SCI, V20, P359, DOI 10.1016/S0165-6147(99)01336-X; Patel MN, 2003, AGING CELL, V2, P219, DOI 10.1046/j.1474-9728.2003.00055.x; Perez VI, 2008, FREE RADICAL BIO MED, V44, P882, DOI 10.1016/j.freeradbiomed.2007.11.018; PRASAD KN, 1994, IN VITRO CELL DEV-AN, V30A, P596; Rohrbach S, 2006, AM J PHYSIOL-REG I, V291, pR927, DOI 10.1152/ajpregu.00890.2005; Saitoh M, 1998, EMBO J, V17, P2596, DOI 10.1093/emboj/17.9.2596; Schober A, 2004, CELL TISSUE RES, V318, P215, DOI 10.1007/s00441-004-0938-y; Stanley BA, 2011, J BIOL CHEM, V286, P33669, DOI 10.1074/jbc.M111.284612; Sugiyama T, 2010, AM J PHYSIOL-HEART C, V298, pH194, DOI 10.1152/ajpheart.00767.2009; Veal EA, 2007, MOL CELL, V26, P1, DOI 10.1016/j.molcel.2007.03.016; Venkateshappa C, 2012, NEUROCHEM RES, V37, P1601, DOI 10.1007/s11064-012-0755-8; Venkateshappa C, 2012, NEUROCHEM RES, V37, P358, DOI 10.1007/s11064-011-0619-7; Watson WH, 2004, TOXICOL SCI, V78, P3, DOI 10.1093/toxsci/kfh050	45	77	77	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 30	2012	7	11							e50683	10.1371/journal.pone.0050683	http://dx.doi.org/10.1371/journal.pone.0050683			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	054WM	23226354	Green Submitted, Green Published, gold			2022-12-27	WOS:000312376100165
J	Mishra, S; Steen, R; Gerbase, A; Lo, YR; Boily, MC				Mishra, Sharmistha; Steen, Richard; Gerbase, Antonio; Lo, Ying-Ru; Boily, Marie-Claude			Impact of High-Risk Sex and Focused Interventions in Heterosexual HIV Epidemics: A Systematic Review of Mathematical Models	PLOS ONE			English	Article							POTENTIAL IMPACT; INDIA; TRANSMISSION; HIV/AIDS; WORKERS; AFRICA; PROJECTIONS; PREVALENCE; DYNAMICS; VACCINES	Background: The core-group theory of sexually transmitted infections suggests that targeting prevention to high-risk groups (HRG) could be very effective. We aimed to quantify the contribution of heterosexual HRGs and the potential impact of focused interventions to HIV transmission in the wider community. Methods: We systematically identified studies published between 1980 and 2011. Studies were included if they used dynamical models of heterosexual HIV transmission, incorporated behavioural heterogeneity in risk, and provided at least one of the following primary estimates in the wider community (a) the population attributable fraction (PAF) of HIV infections due to HRGs, or (b) the number per capita or fraction of HIV infections averted, or change in HIV prevalence/incidence due to focused interventions. Findings: Of 267 selected articles, 22 were included. Four studies measured the PAF, and 20 studies measured intervention impact across 265 scenarios. In low-prevalence epidemics (<= 5% HIV prevalence), the estimated impact of sex-worker interventions in the absence of risk compensation included: 6-100% infections averted; 0.9-6.2 HIV infections averted per 100,000 adults; 11-94% and 4-47% relative reduction in prevalence and incidence respectively. In high-prevalence epidemics (> 5% HIV prevalence), sex-worker interventions were estimated to avert 6.8-40% of HIV infections and up to 564 HIV infections per 100,000 adults, and reduce HIV prevalence and incidence by 13-27% and 2-14% respectively. In both types of epidemics, greater heterogeneity in HIV risk was associated with a larger impact on the fraction of HIV infections averted and relative reduction in HIV incidence. Conclusion: Focused interventions, as estimated by mathematical models, have the potential to reduce HIV transmission in the wider community across low-and high-prevalence regions. However, considerable variability exists in estimated impact, suggesting that a targeted approach to HIV prevention should be tailored to local epidemiological context.	[Mishra, Sharmistha; Boily, Marie-Claude] Univ London Imperial Coll Sci Technol & Med, Dept Infect Dis Epidemiol, London, England; [Mishra, Sharmistha] Univ Toronto, St Michaels Hosp, Toronto, ON M5B 1W8, Canada; [Steen, Richard] Erasmus MC, Dept Publ Hlth, Rotterdam, Netherlands; [Gerbase, Antonio; Lo, Ying-Ru] World Hlth Org, Geneva, Switzerland	Imperial College London; University of Toronto; University Toronto Affiliates; Saint Michaels Hospital Toronto; Erasmus University Rotterdam; Erasmus MC; World Health Organization	Mishra, S (corresponding author), Univ London Imperial Coll Sci Technol & Med, Dept Infect Dis Epidemiol, London, England.	sharmistha.mishra08@imperial.ac.uk		Boily, Marie-Claude/0000-0003-3919-006X; Mishra, Sharmistha/0000-0001-8492-5470	World Health Organization	World Health Organization(World Health Organization)	This work was funded by the World Health Organization. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbas UL, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000875; Alary M, 2004, AIDS, V18, P945, DOI 10.1097/00002030-200404090-00013; ANDERSON R M, 1991; ANDERSON RM, 1995, P ROY SOC B-BIOL SCI, V261, P147, DOI 10.1098/rspb.1995.0129; Baral S, 2012, LANCET INFECT DIS, V12, P538, DOI 10.1016/S1473-3099(12)70066-X; Behrman J, 2011, SEXUAL TRANSMISSION; Boily MC, 2008, AIDS, V22, pS149, DOI 10.1097/01.aids.0000343773.59776.5b; Boily MC, 1997, CAN J PUBLIC HEALTH, V88, P255, DOI 10.1007/BF03404793; Boily MC, 2002, SEX TRANSM INFECT, V78, pI78, DOI 10.1136/sti.78.suppl_1.i78; Chen SX, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000147; Deering KN, 2008, AIDS, V22, pS165, DOI 10.1097/01.aids.0000343774.59776.95; Garnett GP, 2011, LANCET, V378, P515, DOI 10.1016/S0140-6736(10)61505-X; Government of Uganda, 2010, BUDG MON REP; Hallett TB, 2008, INT J EPIDEMIOL, V37, P77, DOI 10.1093/ije/dym232; Helleringer S, 2007, AIDS, V21, P2560, DOI 10.1097/QAD.0b013e3282f112bd; HETHCOTE HW, 1982, MATH BIOSCI, V58, P93, DOI 10.1016/0025-5564(82)90053-0; Hontelez JAC, 2011, VACCINE, V29, P6100, DOI 10.1016/j.vaccine.2011.06.059; http://www.who.int/hiv/pub/surveillance/en/cds_edc_2000_5.pdf, 2000, GUID 2 GEN HIV SURV; Johnson LF, 2007, VACCINE, V25, P7502, DOI 10.1016/j.vaccine.2007.08.047; Johnson LF, 2011, SEX TRANSM INFECT, V87, P629, DOI 10.1136/sti.2010.045500; Kakehashi M, 1998, IMA J MATH APPL MED, V15, P299; KAULT DA, 1995, INT J EPIDEMIOL, V24, P188, DOI 10.1093/ije/24.1.188; Kimani J, 2008, AIDS, V22, P131, DOI 10.1097/QAD.0b013e3282f27035; Lopman BA, 2009, SEX TRANSM INFECT, V85, pI41, DOI 10.1136/sti.2008.033043; Luchters SMF, 2010, BMC INFECT DIS, V10, DOI 10.1186/1471-2334-10-18; Lurie MN, 2003, SEX TRANSM DIS, V30, P149, DOI 10.1097/00007435-200302000-00011; Moher D, 2009, PLOS MED, V6, DOI [10.1136/bmj.b4037, 10.1371/journal.pmed.1000097]; Moses SA, 2006, AIDS S ASIA UNDERSTA; Nagelkerke NJD, 2011, VACCINE, V29, P6079, DOI 10.1016/j.vaccine.2011.06.048; Nagelkerke NJD, 2002, B WORLD HEALTH ORGAN, V80, P89; National AIDS Control Council, 2010, UNGASS COUNTR PROGR; National AIDS Control Organization, 2010, UNGASS COUNTR PROGR; Pettifor A, 2011, SEX TRANSM DIS, V38, P324, DOI 10.1097/OLQ.0b013e31820a8b56; Punyacharoensin N, 2011, EUR J EPIDEMIOL, V26, P695, DOI 10.1007/s10654-011-9614-1; Rao ASRS, 2009, MATH BIOSCI ENG, V6, P779, DOI 10.3934/mbe.2009.6.779; Saggurti N, 2009, AIDS BEHAV, V13, P921, DOI 10.1007/s10461-009-9564-8; Vandepitte J, 2006, SEX TRANSM INFECT, V82, pIII18, DOI 10.1136/sti.2006.020081; Vandepitte J, 2011, SEX TRANSM DIS, V38, P316, DOI 10.1097/OLQ.0b013e3182099545; Vickerman P, 2006, SEX TRANSM DIS, V33, pS122, DOI 10.1097/01.olq.0000221351.55097.36; Vickerman P, 2006, SEX TRANSM DIS, V33, P397, DOI 10.1097/01.olq.0000218974.77208.cc; Vickerman P, 2010, AIDS, V24, P2554, DOI 10.1097/QAD.0b013e32833e8663; Vissers DCJ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002077; Wasserheit JN, 1996, J INFECT DIS, V174, pS201, DOI 10.1093/infdis/174.Supplement_2.S201; Watts C, 2010, SEX TRANSM INFECT, V86, P85, DOI 10.1136/sti.2010.044602; Watts CH, 2010, SEX TRANSM INFECT, V86, P93, DOI 10.1136/sti.2010.044610; Williams JR, 2006, SEX TRANSM INFECT, V82, P372, DOI 10.1136/sti.2006.020875; Wilson D, 2008, LANCET, V372, P423, DOI 10.1016/S0140-6736(08)60883-1; Xiridou M, 2010, AIDS, V24, P2081, DOI 10.1097/QAD.0b013e32833a6071; YORKE JA, 1978, SEX TRANSM DIS, V5, P51, DOI 10.1097/00007435-197804000-00003	49	28	28	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 30	2012	7	11							e50691	10.1371/journal.pone.0050691	http://dx.doi.org/10.1371/journal.pone.0050691			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	054WM	23226357	Green Submitted, Green Published, gold			2022-12-27	WOS:000312376100168
J	Pjetri, E; de Haas, R; de Jong, S; Gelegen, C; Oppelaar, H; Verhagen, LAW; Eijkemans, MJC; Adan, RA; Olivier, B; Kas, MJ				Pjetri, Eneda; de Haas, Ria; de Jong, Simone; Gelegen, Cigdem; Oppelaar, Hugo; Verhagen, Linda A. W.; Eijkemans, Marinus J. C.; Adan, Roger A.; Olivier, Berend; Kas, Martien J.			Identifying Predictors of Activity Based Anorexia Susceptibility in Diverse Genetic Rodent Populations	PLOS ONE			English	Article							RESTRICTED FEEDING SCHEDULE; INBRED MOUSE STRAINS; EATING-DISORDERS; PHYSICAL-ACTIVITY; RISK-FACTORS; ACTIVITY LEVEL; SELF-STARVATION; BODY-WEIGHT; NERVOSA; EXERCISE	Animal studies are very useful in detection of early disease indicators and in unravelling the pathophysiological processes underlying core psychiatric disorder phenotypes. Early indicators are critical for preventive and efficient treatment of progressive psychiatric disorders like anorexia nervosa. Comparable to physical hyperactivity observed in anorexia nervosa patients, in the activity-based anorexia rodent model, mice and rats express paradoxical high voluntary wheel running activity levels when food restricted. Eleven inbred mouse strains and outbred Wistar WU rats were exposed to the activity-based anorexia model in search of identifying susceptibility predictors. Body weight, food intake and wheel running activity levels of each individual mouse and rat were measured. Mouse strains and rats with high wheel running activity levels during food restriction exhibited accelerated body weight loss. Linear mixed models for repeated measures analysis showed that baseline wheel running activity levels preceding the scheduled food restriction phase strongly predicted activity-based anorexia susceptibility (mice: Beta = -0.0158 (+/- 0.003 SE), P<0.0001; rats: Beta = -0.0242 (+/- 0.004 SE), P<0.0001) compared to other baseline parameters. These results suggest that physical activity levels play an important role in activity-based anorexia susceptibility in different rodent species with genetically diverse background. These findings support previous retrospective studies on physical activity levels in anorexia nervosa patients and indicate that pre-morbid physical activity levels could reflect an early indicator for disease severity.	[Pjetri, Eneda; de Haas, Ria; de Jong, Simone; Gelegen, Cigdem; Oppelaar, Hugo; Verhagen, Linda A. W.; Adan, Roger A.; Olivier, Berend; Kas, Martien J.] Univ Med Ctr Utrecht, Dept Neurosci & Pharmacol, Rudolf Magnus Inst Neurosci, Utrecht, Netherlands; [de Jong, Simone] Univ Calif Los Angeles, Ctr Neurobehav Genet, Los Angeles, CA USA; [Gelegen, Cigdem] Univ London Imperial Coll Sci Technol & Med, Dept Biophys, London, England; [Verhagen, Linda A. W.] Univ Cologne, Inst Genet, Dept Mouse Genet & Metab, Cologne, Germany; [Eijkemans, Marinus J. C.] Univ Med Ctr Utrecht, Julius Ctr Hlth Sci & Primary Care, Utrecht, Netherlands; [Olivier, Berend] Univ Utrecht, Utrecht Inst Pharmaceut Sci, Div Pharmacol, Fac Sci, Utrecht, Netherlands; [Olivier, Berend] Yale Univ, Sch Med, Dept Psychiat, New Haven, CT USA	Utrecht University; Utrecht University Medical Center; University of California System; University of California Los Angeles; Imperial College London; University of Cologne; Utrecht University; Utrecht University Medical Center; Utrecht University; Yale University	Kas, MJ (corresponding author), Univ Med Ctr Utrecht, Dept Neurosci & Pharmacol, Rudolf Magnus Inst Neurosci, Utrecht, Netherlands.	m.j.h.kas@umcutrecht.nl	Kas, Martien J./G-8269-2018; de Haas, Ria/G-6047-2016	Kas, Martien J./0000-0002-4471-8618; de Jong, Simone/0000-0002-8002-7195; Pjetri, Eneda/0000-0003-1973-0284	ZonMW VIDI Grant from The Netherlands Organization for Scientific Research (NWO) [91786327]	ZonMW VIDI Grant from The Netherlands Organization for Scientific Research (NWO)	This research was supported by a ZonMW VIDI Grant (91786327) from The Netherlands Organization for Scientific Research (NWO) to Dr. Martien Kas. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	APA, 1994, DIAGN STAT MAN MENT; Arcelus J, 2011, ARCH GEN PSYCHIAT, V68, P724, DOI 10.1001/archgenpsychiatry.2011.74; Bouten CV, 1996, MED SCI SPORT EXER, V28, P967, DOI 10.1097/00005768-199608000-00005; Bratland-Sanda S, 2010, INT J EAT DISORDER, V43, P266, DOI 10.1002/eat.20769; Bulik CM, 2010, BIOL PSYCHIAT, V67, P71, DOI 10.1016/j.biopsych.2009.08.010; Casper RC, 1998, INT J EAT DISORDER, V24, P381, DOI 10.1002/(SICI)1098-108X(199812)24:4<381::AID-EAT5>3.0.CO;2-Q; CASPER RC, 1991, AM J CLIN NUTR, V53, P1143, DOI 10.1093/ajcn/53.5.1143; Coners H, 1999, INT J EAT DISORDER, V26, P171, DOI 10.1002/(SICI)1098-108X(199909)26:2&lt;171::AID-EAT6&gt;3.0.CO;2-P; Dalle Grave R, 2008, COMPR PSYCHIAT, V49, P346, DOI 10.1016/j.comppsych.2007.12.007; Davis C, 1998, PSYCHOSOM MED, V60, P192, DOI 10.1097/00006842-199803000-00015; Davis C, 2005, PSYCHOL MED, V35, P377, DOI 10.1017/S0033291704003447; Davis C, 1997, COMPR PSYCHIAT, V38, P321, DOI 10.1016/S0010-440X(97)90927-5; DAVIS C, 1994, PSYCHOL MED, V24, P957, DOI 10.1017/S0033291700029044; Eriksson M, 2006, BEHAV GENET, V36, P238, DOI 10.1007/s10519-005-9018-7; FESTING MFW, 1977, LAB ANIM, V11, P257, DOI 10.1258/002367777780936530; Gelegen C, 2008, GENES BRAIN BEHAV, V7, P552, DOI 10.1111/j.1601-183X.2008.00394.x; Gelegen C, 2010, EUR NEUROPSYCHOPHARM, V20, P317, DOI 10.1016/j.euroneuro.2009.10.001; HALL JF, 1953, J COMP PHYSIOL PSYCH, V46, P429, DOI 10.1037/h0062565; Herzog DB, 2009, J AM ACAD CHILD PSY, V48, P782, DOI 10.1097/CHI.0b013e3181aa03d7; Hoek HW, 2006, CURR OPIN PSYCHIATR, V19, P389, DOI 10.1097/01.yco.0000228759.95237.78; Hofstetter JR, 2003, J BIOL RHYTHM, V18, P450, DOI 10.1177/0748730403259468; Holtkamp K, 2004, INT J EAT DISORDER, V36, P163, DOI 10.1002/eat.20035; Hudson JI, 2007, BIOL PSYCHIAT, V61, P348, DOI 10.1016/j.biopsych.2006.03.040; Jacobi C, 2004, PSYCHOL BULL, V130, P19, DOI 10.1037/0033-2909.130.1.19; Joosen AMCP, 2005, AM J CLIN NUTR, V82, P1253, DOI 10.1093/ajcn/82.6.1253; Kas MJH, 2009, GENES BRAIN BEHAV, V8, P13, DOI 10.1111/j.1601-183X.2008.00435.x; Kas MJH, 2003, MOL PSYCHIATR, V8, P235, DOI 10.1038/sj.mp.4001206; KAYE WH, 1988, AM J CLIN NUTR, V47, P989, DOI 10.1093/ajcn/47.6.989; Kelly SA, 2010, PHYSIOL GENOMICS, V42, P190, DOI 10.1152/physiolgenomics.00028.2010; Klein DA, 2007, PSYCHONEUROENDOCRINO, V32, P539, DOI 10.1016/j.psyneuen.2007.03.007; KRON L, 1978, COMPR PSYCHIAT, V19, P433, DOI 10.1016/0010-440X(78)90072-X; Lightfoot JT, 2010, J APPL PHYSIOL, V109, P623, DOI 10.1152/japplphysiol.00525.2010; Lightfoot JT, 2004, PHYSIOL GENOMICS, V19, P270, DOI 10.1152/physiolgenomics.00125.2004; Mazzeo SE, 2009, CHILD ADOL PSYCH CL, V18, P67, DOI 10.1016/j.chc.2008.07.003; Nicholls DE, 2009, J AM ACAD CHILD PSY, V48, P791, DOI 10.1097/CHI.0b013e3181ab8b75; Pike KM, 2008, PSYCHOL MED, V38, P1443, DOI 10.1017/S0033291707002310; Pjetri E, 2012, GENES BRAIN BEHAV, V11, P105, DOI 10.1111/j.1601-183X.2011.00732.x; Reed DR, 2007, PHYSIOL BEHAV, V91, P593, DOI 10.1016/j.physbeh.2007.03.026; ROUTTENBERG A, 1967, J COMP PHYSIOL PSYCH, V64, P414, DOI 10.1037/h0025205; Solenberger S E, 2001, Eat Behav, V2, P151, DOI 10.1016/S1471-0153(01)00026-5; Steinhausen HC, 2009, INT J EAT DISORDER, V42, P19, DOI 10.1002/eat.20577; Stice E, 2002, PSYCHOL BULL, V128, P825, DOI 10.1037//0033-2909.128.5.825; Svenson KL, 2007, J APPL PHYSIOL, V102, P2369, DOI 10.1152/japplphysiol.01077.2006; Swallow JG, 1998, J APPL PHYSIOL, V84, P69, DOI 10.1152/jappl.1998.84.1.69	44	24	24	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 30	2012	7	11							e50453	10.1371/journal.pone.0050453	http://dx.doi.org/10.1371/journal.pone.0050453			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	054WM	23226287	Green Submitted, Green Published, gold			2022-12-27	WOS:000312376100099
J	Smithwick, EAH; Naithani, KJ; Balser, TC; Romme, WH; Turner, MG				Smithwick, Erica A. H.; Naithani, Kusum J.; Balser, Teri C.; Romme, William H.; Turner, Monica G.			Post-Fire Spatial Patterns of Soil Nitrogen Mineralization and Microbial Abundance	PLOS ONE			English	Article							YELLOWSTONE-NATIONAL-PARK; COMMUNITY STRUCTURE; GEOSTATISTICAL ANALYSIS; TERRESTRIAL ECOSYSTEMS; LANDSCAPE DYNAMICS; NET NITRIFICATION; BRITISH-COLUMBIA; CARBON STORAGE; BOREAL FORESTS; DRIVEN CHANGES	Stand-replacing fires influence soil nitrogen availability and microbial community composition, which may in turn mediate post-fire successional dynamics and nutrient cycling. However, fires create patchiness at both local and landscape scales and do not result in consistent patterns of ecological dynamics. The objectives of this study were to (1) quantify the spatial structure of microbial communities in forest stands recently affected by stand-replacing fire and (2) determine whether microbial variables aid predictions of in situ net nitrogen mineralization rates in recently burned stands. The study was conducted in lodgepole pine (Pinus contorta var. latifolia) and Engelmann spruce/subalpine fir (Picea engelmannii/Abies lasiocarpa) forest stands that burned during summer 2000 in Greater Yellowstone (Wyoming, USA). Using a fully probabilistic spatial process model and Bayesian kriging, the spatial structure of microbial lipid abundance and fungi-to-bacteria ratios were found to be spatially structured within plots two years following fire (for most plots, autocorrelation range varied from 1.5 to 10.5 m). Congruence of spatial patterns among microbial variables, in situ net N mineralization, and cover variables was evident. Stepwise regression resulted in significant models of in situ net N mineralization and included variables describing fungal and bacterial abundance, although explained variance was low (R-2<,0.29). Unraveling complex spatial patterns of nutrient cycling and the biotic factors that regulate it remains challenging but is critical for explaining post-fire ecosystem function, especially in Greater Yellowstone, which is projected to experience increased fire frequencies by mid 21st Century.	[Smithwick, Erica A. H.; Naithani, Kusum J.] Penn State Univ, Dept Geog, University Pk, PA 16802 USA; [Smithwick, Erica A. H.; Naithani, Kusum J.] Penn State Univ, Intercoll Grad Degree Program Ecol, University Pk, PA 16802 USA; [Balser, Teri C.] Univ Florida, Dept Soil & Water Sci, Coll Agr & Life Sci, Gainesville, FL USA; [Romme, William H.] Colorado State Univ, Grad Degree Program Ecol, Ft Collins, CO 80523 USA; [Turner, Monica G.] Univ Wisconsin, Dept Zool, Madison, WI 53706 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; State University System of Florida; University of Florida; Colorado State University; University of Wisconsin System; University of Wisconsin Madison	Smithwick, EAH (corresponding author), Penn State Univ, Dept Geog, University Pk, PA 16802 USA.	smithwick@psu.edu	Romme, William H./C-7317-2016; Turner, Monica G/B-2099-2010; Naithani, Kusum/A-5441-2009	Turner, Monica G/0000-0003-1903-2822; Naithani, Kusum/0000-0003-2503-113X; Smithwick, Erica/0000-0003-3497-2011	Andrew W. Mellon Foundation	Andrew W. Mellon Foundation	The work was funded by the Conservation and Environment Program of the Andrew W. Mellon Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2010, R LANG ENV STAT COMP; Ayres E, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005964; Baath E, 2003, SOIL BIOL BIOCHEM, V35, P955, DOI 10.1016/S0038-0717(03)00154-8; Balser TC, 2001, MONOGRAPHS POPULATIO, P265; Balshi MS, 2009, GLOBAL CHANGE BIOL, V15, P1491, DOI 10.1111/j.1365-2486.2009.01877.x; Bengtson P, 2007, SOIL BIOL BIOCHEM, V39, P2429, DOI 10.1016/j.soilbio.2007.04.010; Berch SM, 2006, CAN J FOREST RES, V36, P1415, DOI 10.1139/X06-037; Binkley D., 1989, Advances in Soil Science, V10, P57; Booth MS, 2005, ECOL MONOGR, V75, P139, DOI 10.1890/04-0988; Bruckner A, 1999, GEODERMA, V93, P207, DOI 10.1016/S0016-7061(99)00059-2; DAVIDSON EA, 1991, J SOIL SCI, V42, P335, DOI 10.1111/j.1365-2389.1991.tb00413.x; Decaens T, 2010, GLOBAL ECOL BIOGEOGR, V19, P287, DOI 10.1111/j.1466-8238.2009.00517.x; DeLuca TH, 2006, SOIL SCI SOC AM J, V70, P448, DOI 10.2136/sssaj2005.0096; DeLuca TH, 2008, FRONT ECOL ENVIRON, V6, P18, DOI 10.1890/070070; Diggle P.J., 2002, GEOGR ENV MODEL, V6, P129, DOI [DOI 10.1080/1361593022000029467, 10.1080/1361593022000029467]; Diggle PJ, 1998, J R STAT SOC C-APPL, V47, P299, DOI 10.1111/1467-9876.00113; Dooley SR, 2012, BIOGEOCHEMISTRY, V109, P49, DOI 10.1007/s10533-011-9633-8; Drenovsky RE, 2010, GLOBAL ECOL BIOGEOGR, V19, P27, DOI 10.1111/j.1466-8238.2009.00486.x; Ekschmitt K, 2005, GEODERMA, V128, P167, DOI 10.1016/j.geoderma.2004.12.024; Ettema CH, 2000, OECOLOGIA, V125, P444, DOI 10.1007/s004420000468; Ettema CH, 2002, TRENDS ECOL EVOL, V17, P177, DOI 10.1016/S0169-5347(02)02496-5; FAHEY TJ, 1985, BIOGEOCHEMISTRY, V1, P257, DOI 10.1007/BF02187202; Fitter AH, 2005, J ECOL, V93, P231, DOI 10.1111/j.0022-0477.2005.00990.x; Fraterrigo JM, 2008, ECOL LETT, V11, P756, DOI 10.1111/j.1461-0248.2008.01191.x; Fraterrigo JM, 2006, ECOLOGY, V87, P570, DOI 10.1890/05-0638; Gomoryova E, 2007, POL J ECOL, V55, P457; GONZALEZ OJ, 1994, PLANT SOIL, V163, P45, DOI 10.1007/BF00033939; Groffman PM, 2009, BIOGEOCHEMISTRY, V93, P49, DOI 10.1007/s10533-008-9277-5; Grundmann GL, 2000, FEMS MICROBIOL ECOL, V34, P57, DOI 10.1111/j.1574-6941.2000.tb00754.x; Gutnecht JLM, 2010, PEDOBIOLOGIA, V53, P283; Hamman ST, 2007, SOIL BIOL BIOCHEM, V39, P1703, DOI 10.1016/j.soilbio.2007.01.018; HART SC, 1994, ECOLOGY, V75, P880, DOI 10.2307/1939413; Hart SC, 2005, FOREST ECOL MANAG, V220, P166, DOI 10.1016/j.foreco.2005.08.012; Johnstone JF, 2004, CAN J FOREST RES, V34, P267, DOI [10.1139/x03-183, 10.1139/X03-183]; Kennedy N, 2010, FOREST ECOL MANAG, V260, P787, DOI 10.1016/j.foreco.2010.05.037; Krawchuk MA, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005102; Laughlin DC, 2010, PLANT SOIL, V330, P435, DOI 10.1007/s11104-009-0217-5; LOOPE L L, 1973, Quaternary Research (Orlando), V3, P425, DOI 10.1016/0033-5894(73)90007-0; Luizao RCC, 2004, GLOBAL CHANGE BIOL, V10, P592, DOI 10.1111/j.1529-8817.2003.00757.x; Martiny JBH, 2006, NAT REV MICROBIOL, V4, P102, DOI 10.1038/nrmicro1341; Matias JM, 2006, STOCH ENV RES RISK A, V20, P243, DOI 10.1007/s00477-005-0019-0; Meigs GW, 2011, ECOSYSTEMS, V14, P758, DOI 10.1007/s10021-011-9444-8; Newman DK, 2002, SCIENCE, V296, P1071, DOI 10.1126/science.1010716; Nunan N, 2002, MICROBIAL ECOL, V44, P296, DOI 10.1007/s00248-002-2021-0; O'Neill KP, 2006, BIOGEOCHEMISTRY, V80, P1, DOI 10.1007/s10533-005-5964-7; PARKIN TB, 1993, J ENVIRON QUAL, V22, P409, DOI 10.2134/jeq1993.00472425002200030004x; PETERSEN SO, 1994, APPL ENVIRON MICROB, V60, P2421, DOI 10.1128/AEM.60.7.2421-2430.1994; Pietikainen J, 2000, SOIL BIOL BIOCHEM, V32, P277, DOI 10.1016/S0038-0717(99)00164-9; Porazinska DL, 2003, ECOL MONOGR, V73, P377, DOI 10.1890/0012-9615(2003)073[0377:RATAIP]2.0.CO;2; Remsburg AJ, 2006, CAN J FOREST RES, V36, P2112, DOI 10.1139/X06-079; Ritz K, 2004, FEMS MICROBIOL ECOL, V49, P191, DOI 10.1016/j.femsec.2004.03.005; Romero-Ruiz M, 2010, GLOBAL CHANGE BIOL, V16, P2013, DOI 10.1111/j.1365-2486.2009.02081.x; Saetre P, 1999, ECOGRAPHY, V22, P183, DOI 10.1111/j.1600-0587.1999.tb00467.x; Schoennagel T, 2008, INT J WILDLAND FIRE, V17, P742, DOI 10.1071/WF07146; Smithwick EAH, 2005, BIOGEOCHEMISTRY, V76, P517, DOI 10.1007/s10533-005-0031-y; Smithwick EAH, 2005, SOIL BIOL BIOCHEM, V37, P1546, DOI 10.1016/j.soilbio.2005.01.016; Smithwick EAH, 2005, ECOSYSTEMS, V8, P163, DOI 10.1007/s10021-004-0097-8; Smithwick EAH, 2006, PLANT SOIL, V289, P1, DOI 10.1007/s11104-006-9084-5; Smithwick EAH, 2009, ECOSYSTEMS, V12, P792, DOI 10.1007/s10021-009-9257-1; Ste-Marie C, 1999, SOIL BIOL BIOCHEM, V31, P1579, DOI 10.1016/S0038-0717(99)00086-3; Steinberger Y, 1999, BIOL FERT SOILS, V28, P292, DOI 10.1007/s003740050496; Stenrod M, 2006, SOIL BIOL BIOCHEM, V38, P962, DOI 10.1016/j.soilbio.2005.08.014; Stoyan H, 2000, PLANT SOIL, V222, P203, DOI 10.1023/A:1004757405147; Sturtevant BR, 2009, ECOSYSTEMS, V12, P445, DOI 10.1007/s10021-009-9234-8; TURNER MG, 1994, LANDSCAPE ECOL, V9, P59, DOI 10.1007/BF00135079; Turner MG, 2007, P NATL ACAD SCI USA, V104, P4782, DOI 10.1073/pnas.0700180104; Turner MG, 2011, ECOSYSTEMS, V14, P1081, DOI 10.1007/s10021-011-9465-3; Turner MG, 2010, ECOLOGY, V91, P2833, DOI 10.1890/10-0097.1; Venables WN., 2002, MODERN APPL STAT S 4; Wan SQ, 2001, ECOL APPL, V11, P1349, DOI 10.1890/1051-0761(2001)011[1349:FEONPA]2.0.CO;2; Westerling AL, 2011, P NATL ACAD SCI USA, V108, P13165, DOI 10.1073/pnas.1110199108; White David C., 1998, P255; WHITE RE, 1987, FERT RES, V11, P193, DOI 10.1007/BF01063317; Wiedinmyer Christine, 2007, Carbon Balance Manag, V2, P10, DOI 10.1186/1750-0680-2-10; Wilkinson SC, 2001, MICROBIAL ECOL, V42, P248, DOI 10.1007/s00248-001-0006-z; Wimberly MC, 2007, REMOTE SENS ENVIRON, V108, P189, DOI 10.1016/j.rse.2006.03.019; Wu YT, 2012, ECOSYSTEMS, V15, P624, DOI 10.1007/s10021-012-9533-3	77	22	22	1	141	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 30	2012	7	11							e50597	10.1371/journal.pone.0050597	http://dx.doi.org/10.1371/journal.pone.0050597			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	054WM	23226324	Green Published, Green Submitted, gold			2022-12-27	WOS:000312376100136
J	Audouard, E; Schakman, O; Rene, F; Huettl, RE; Huber, AB; Loeffler, JP; Gailly, P; Clotman, F				Audouard, Emilie; Schakman, Olivier; Rene, Frederique; Huettl, Rosa-Eva; Huber, Andrea B.; Loeffler, Jean-Philippe; Gailly, Philippe; Clotman, Frederic			The Onecut Transcription Factor HNF-6 Regulates in Motor Neurons the Formation of the Neuromuscular Junctions	PLOS ONE			English	Article							HEPATOCYTE NUCLEAR FACTOR-6; PROTEIN-KINASE-C; SCHWANN-CELLS; TGF-BETA; ACETYLCHOLINE-RECEPTORS; MAMMALIAN MEMBER; NERVOUS-SYSTEM; GAIT ANALYSIS; MUTANT MICE; IN-VITRO	The neuromuscular junctions are the specialized synapses whereby spinal motor neurons control the contraction of skeletal muscles. The formation of the neuromuscular junctions is controlled by a complex interplay of multiple mechanisms coordinately activated in motor nerve terminals and in their target myotubes. However, the transcriptional regulators that control in motor neurons the genetic programs involved in neuromuscular junction development remain unknown. Here, we provide evidence that the Onecut transcription factor HNF-6 regulates in motor neurons the formation of the neuromuscular junctions. Indeed, adult Hnf6 mutant mice exhibit hindlimb muscle weakness and abnormal locomotion. This results from defects of hindlimb neuromuscular junctions characterized by an abnormal morphology and defective localization of the synaptic vesicle protein synaptophysin at the motor nerve terminals. These defects are consequences of altered and delayed formation of the neuromuscular junctions in newborn mutant animals. Furthermore, we show that the expression level of numerous regulators of neuromuscular junction formation, namely agrin, neuregulin-2 and TGF-beta receptor II, is downregulated in the spinal motor neurons of Hnf6 mutant newborn animals. Finally, altered formation of neuromuscular junction-like structures in a co-culture model of wildtype myotubes with mutant embryonic spinal cord slices is rescued by recombinant agrin and neuregulin, indicating that depletion in these factors contributes to defective neuromuscular junction development in the absence of HNF-6. Thus, HNF-6 controls in spinal motor neurons a genetic program that coordinates the formation of hindlimb neuromuscular junctions.	[Audouard, Emilie; Clotman, Frederic] Catholic Univ Louvain, Inst Neurosci, Lab Neural Differentiat, B-1200 Brussels, Belgium; [Schakman, Olivier; Gailly, Philippe] Catholic Univ Louvain, Inst Neurosci, Lab Cell Physiol, B-1200 Brussels, Belgium; [Rene, Frederique; Loeffler, Jean-Philippe] Univ Strasbourg, Fac Med, INSERM, U692,Lab Signalisat Mol & Neurodegenerescence, Strasbourg, France; [Huettl, Rosa-Eva; Huber, Andrea B.] German Res Ctr Environm Hlth, Helmholtz Zentrum Munchen, Inst Dev Genet, Neuherberg, Germany	Universite Catholique Louvain; Universite Catholique Louvain; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health	Clotman, F (corresponding author), Catholic Univ Louvain, Inst Neurosci, Lab Neural Differentiat, B-1200 Brussels, Belgium.	frederic.clotman@uclouvain.be	LOEFFLER, Jean-Philippe/AAS-4401-2020		"Fonds speciaux de recherche'' (FSR) of the Universite catholique de Louvain; Fonds de la Recherche Scientifique [1.5.085.10.F]; Fund for Scientific Medical Research [3.4.538.10.F]; Actions de Recherche Concertees grant [10/15-026]; Association Belge contre les Maladies neuro-Musculaires (ABMM asbl); Walloon Region's Marshall Programme of Excellence (DIANE convention); Association pour la recherche sur la SLA et les autres maladies du motoneurone (ARSIa); Association pour la recherche et le developpment des moyens de lutte contre les maladies neurodegeneratives (AREMANE); F.R.I.A. (Belgium)	"Fonds speciaux de recherche'' (FSR) of the Universite catholique de Louvain; Fonds de la Recherche Scientifique(Fonds de la Recherche Scientifique - FNRS); Fund for Scientific Medical Research; Actions de Recherche Concertees grant; Association Belge contre les Maladies neuro-Musculaires (ABMM asbl); Walloon Region's Marshall Programme of Excellence (DIANE convention); Association pour la recherche sur la SLA et les autres maladies du motoneurone (ARSIa); Association pour la recherche et le developpment des moyens de lutte contre les maladies neurodegeneratives (AREMANE); F.R.I.A. (Belgium)(Fonds de la Recherche Scientifique - FNRS)	This work was supported by the "Fonds speciaux de recherche'' (FSR) of the Universite catholique de Louvain, by the Fonds de la Recherche Scientifique (F.R.S.-FNRS) including a Credit au chercheur #1.5.085.10.F and a grant from the Fund for Scientific Medical Research #3.4.538.10.F (Belgium), by the Actions de Recherche Concertees grant #10/15-026 (Communaute francaise de Belgique and Academie Louvain) and by the Association Belge contre les Maladies neuro-Musculaires (ABMM asbl) (F.C.), by the Walloon Region's Marshall Programme of Excellence (DIANE convention) (P.G.), and by the Association pour la recherche sur la SLA et les autres maladies du motoneurone (ARSIa) and the Association pour la recherche et le developpment des moyens de lutte contre les maladies neurodegeneratives (AREMANE) (F.R., J.P.L.). E.A. holds a specialization grant from the F.R.I.A. (Belgium). F.C. is a Research Associate of the F.R.S.-FNRS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Antoniou A, 2009, GASTROENTEROLOGY, V136, P2325, DOI 10.1053/j.gastro.2009.02.051; Arber S, 2000, CELL, V101, P485, DOI 10.1016/S0092-8674(00)80859-4; Baudet C, 2008, J NEUROSCI, V28, P963, DOI 10.1523/JNEUROSCI.4489-07.2008; Becher A, 1999, EUR J CELL BIOL, V78, P650, DOI 10.1016/S0171-9335(99)80050-8; Besalduch N, 2010, J COMP NEUROL, V518, P211, DOI 10.1002/cne.22220; Bezakova G, 2003, NAT REV MOL CELL BIO, V4, P295, DOI 10.1038/nrm1074; Bonanomi D, 2007, BIOCHEM J, V404, P525, DOI 10.1042/BJ20061907; Britto JM, 2004, MOL CELL BIOL, V24, P8221, DOI 10.1128/MCB.24.18.8221-8226.2004; Burau K, 2004, EUR J NEUROSCI, V20, P353, DOI 10.1111/j.1460-9568.2004.03500.x; Carraway KL, 1997, NATURE, V387, P512, DOI 10.1038/387512a0; Clotman F, 2005, GENE DEV, V19, P1849, DOI 10.1101/gad.340305; Clotman F, 2002, DEVELOPMENT, V129, P1819; Court FA, 2008, J CELL SCI, V121, P3901, DOI 10.1242/jcs.031047; Dasen JS, 2005, CELL, V123, P477, DOI 10.1016/j.cell.2005.09.009; Dupuis L, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005390; Ellis JE, 2010, DEV BIOL, V342, P121, DOI 10.1016/j.ydbio.2010.03.012; ESHKIND LG, 1995, CELL TISSUE RES, V282, P423, DOI 10.1007/s004410050493; Espana A, 2012, MOL CELL NEUROSCI, V50, P93, DOI 10.1016/j.mcn.2012.04.002; Espana A, 2012, J COMP NEUROL, V520, P1424, DOI 10.1002/cne.22803; Feng Z, 2008, J NEUROSCI, V28, P9599, DOI 10.1523/JNEUROSCI.2589-08.2008; Feng Z, 2008, ANN NY ACAD SCI, V1132, P19, DOI 10.1196/annals.1405.016; Fox MA, 2007, CELL, V129, P179, DOI 10.1016/j.cell.2007.02.035; Francius C, 2010, NEUROSCIENCE, V165, P116, DOI 10.1016/j.neuroscience.2009.09.076; Gautam M, 1996, CELL, V85, P525, DOI 10.1016/S0092-8674(00)81253-2; Hamers FPT, 2006, J NEUROTRAUM, V23, P537, DOI 10.1089/neu.2006.23.537; Hamers FPT, 2001, J NEUROTRAUM, V18, P187, DOI 10.1089/08977150150502613; Henriquez JP, 2012, ACTA PHYSIOL, V204, P128, DOI 10.1111/j.1748-1716.2011.02295.x; Hodge LK, 2007, NEURON, V55, P572, DOI 10.1016/j.neuron.2007.07.010; Jacquemin P, 2000, MOL CELL BIOL, V20, P4445, DOI 10.1128/MCB.20.12.4445-4454.2000; Jacquemin P, 2003, DEV BIOL, V258, P105, DOI 10.1016/S0012-1606(03)00115-5; Jacquemin P, 1999, J BIOL CHEM, V274, P2665, DOI 10.1074/jbc.274.5.2665; Jevsek M, 2004, EUR J NEUROSCI, V20, P2865, DOI 10.1111/j.1460-9568.2004.03752.x; Kummer TT, 2006, CURR OPIN NEUROBIOL, V16, P74, DOI 10.1016/j.conb.2005.12.003; Kummer TT, 2004, J CELL BIOL, V164, P1077, DOI 10.1083/jcb.200401115; Landry C, 1997, DEV BIOL, V192, P247, DOI 10.1006/dbio.1997.8757; Lannoy VJ, 1998, J BIOL CHEM, V273, P13552, DOI 10.1074/jbc.273.22.13552; Lanuza MA, 2000, J NEUROSCI RES, V61, P616, DOI 10.1002/1097-4547(20000915)61:6<616::AID-JNR5>3.0.CO;2-N; Lanuza MA, 2002, J NEUROSCI RES, V67, P607, DOI 10.1002/jnr.10122; Lemaigre FP, 1996, P NATL ACAD SCI USA, V93, P9460, DOI 10.1073/pnas.93.18.9460; Lenzlinger PM, 2004, RESTOR NEUROL NEUROS, V22, P73; LEONG SK, 1990, J NEUROSCI METH, V32, P15, DOI 10.1016/0165-0270(90)90067-P; Livet J, 2002, NEURON, V35, P877, DOI 10.1016/S0896-6273(02)00863-2; Margagliotti S, 2007, DEV BIOL, V311, P579, DOI 10.1016/j.ydbio.2007.09.013; Marques G, 2005, J NEUROBIOL, V64, P417, DOI 10.1002/neu.20165; McCabe BD, 2004, NEURON, V41, P891, DOI 10.1016/S0896-6273(04)00073-X; McMahon HT, 1996, P NATL ACAD SCI USA, V93, P4760, DOI 10.1073/pnas.93.10.4760; Mignion L., 2012, MAGN RESON MED; Misgeld T, 2005, P NATL ACAD SCI USA, V102, P11088, DOI 10.1073/pnas.0504806102; Pierreux CE, 2006, GASTROENTEROLOGY, V130, P532, DOI 10.1053/j.gastro.2005.12.005; Plumb-Rudewiez N, 2004, HEPATOLOGY, V40, P1266, DOI 10.1002/hep.20459; Ravassard P, 1997, J NEUROSCI RES, V48, P146, DOI 10.1002/(SICI)1097-4547(19970415)48:2<146::AID-JNR7>3.0.CO;2-C; Rawson JM, 2003, J NEUROBIOL, V55, P134, DOI 10.1002/neu.10189; Rimer M, 2004, MOL CELL NEUROSCI, V26, P271, DOI 10.1016/j.mcn.2004.02.002; Roy A, 2012, DEVELOPMENT, V139, P3109, DOI 10.1242/dev.078501; Sandrock AW, 1997, SCIENCE, V276, P599, DOI 10.1126/science.276.5312.599; Schafer S, 2011, BEHAV BRAIN RES; Schmidt N, 2011, J CELL BIOL, V195, P1171, DOI 10.1083/jcb.201107083; Schmitt U, 2009, NEUROSCIENCE, V162, P234, DOI 10.1016/j.neuroscience.2009.04.046; Stam FJ, 2012, DEVELOPMENT, V139, P179, DOI 10.1242/dev.071134; Sugiura Y, 2011, BIOSCIENCE REP, V31, P295, DOI 10.1042/BSR20100107; Todd KJ, 2010, J NEUROSCI, V30, P11870, DOI 10.1523/JNEUROSCI.3165-10.2010; Vanhorenbeeck V, 2002, BIOCHEM BIOPH RES CO, V292, P848, DOI 10.1006/bbrc.2002.6760; Witzemann V, 2006, CELL TISSUE RES, V326, P263, DOI 10.1007/s00441-006-0237-x; Wu HT, 2012, NEURON, V75, P94, DOI 10.1016/j.neuron.2012.04.033; Wu HT, 2010, DEVELOPMENT, V137, P1017, DOI 10.1242/dev.038711; Yang JF, 2001, J NEUROSCI, V21, P9572, DOI 10.1523/JNEUROSCI.21-24-09572.2001	66	20	22	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 5	2012	7	12							e50509	10.1371/journal.pone.0050509	http://dx.doi.org/10.1371/journal.pone.0050509			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	057TZ	23227180	Green Published, Green Submitted, gold			2022-12-27	WOS:000312588200040
J	Horvath, G; Farkas, E; Boncz, I; Blaho, M; Kriska, G				Horvath, Gabor; Farkas, Etelka; Boncz, Ildiko; Blaho, Miklos; Kriska, Gyorgy			Cavemen Were Better at Depicting Quadruped Walking than Modern Artists: Erroneous Walking Illustrations in the Fine Arts from Prehistory to Today	PLOS ONE			English	Article							SYMMETRICAL GAITS; LOCOMOTION; HORSES; DOGS	The experts of animal locomotion well know the characteristics of quadruped walking since the pioneering work of Eadweard Muybridge in the 1880s. Most of the quadrupeds advance their legs in the same lateral sequence when walking, and only the timing of their supporting feet differ more or less. How did this scientific knowledge influence the correctness of quadruped walking depictions in the fine arts? Did the proportion of erroneous quadruped walking illustrations relative to their total number (i.e. error rate) decrease after Muybridge? How correctly have cavemen (upper palaeolithic Homo sapiens) illustrated the walking of their quadruped prey in prehistoric times? The aim of this work is to answer these questions. We have analyzed 1000 prehistoric and modern artistic quadruped walking depictions and determined whether they are correct or not in respect of the limb attitudes presented, assuming that the other aspects of depictions used to determine the animals gait are illustrated correctly. The error rate of modern pre-Muybridgean quadruped walking illustrations was 83.5%, much more than the error rate of 73.3% of mere chance. It decreased to 57.9% after 1887, that is in the post-Muybridgean period. Most surprisingly, the prehistoric quadruped walking depictions had the lowest error rate of 46.2%. All these differences were statistically significant. Thus, cavemen were more keenly aware of the slower motion of their prey animals and illustrated quadruped walking more precisely than later artists.	[Horvath, Gabor; Farkas, Etelka; Boncz, Ildiko; Blaho, Miklos] Eotvos Lorand Univ, Inst Phys, Dept Biol Phys, Budapest, Hungary; [Boncz, Ildiko] Inst Math & Phys, Dept Phys, Szombathely, Hungary; [Kriska, Gyorgy] Eotvos Univ Budapest, Inst Biol, Grp Methodol Biol Teaching, Budapest, Hungary	Eotvos Lorand University; Eotvos Lorand University	Horvath, G (corresponding author), Eotvos Lorand Univ, Inst Phys, Dept Biol Phys, Budapest, Hungary.	gh@arago.elte.hu	Kriska, György/B-5723-2019; Szendreiné Boncz, Ildikó/H-3509-2017	Szendreiné Boncz, Ildikó/0000-0002-2245-3188; Kriska, Gyorgy/0000-0003-4271-3167				Alexander RM, 1989, DYNAMICS OF DINOSAUR; Brown Lewis, 1968, CURATOR, V11, P7; Farkas E, 2012, FIZIKAI SZEMLE, V62, P12; Gambaryan PP, 1972, THE RUNNING OF MAMMA; Gambaryan PP, 1974, HOW MAMMALS RUN ANAT; HILDEBRA.M, 1965, SCIENCE, V150, P701, DOI 10.1126/science.150.3697.701; HILDEBRAND M, 1967, AM J PHYS ANTHROPOL, V26, P119, DOI 10.1002/ajpa.1330260203; HILDEBRAND M, 1977, J MAMMAL, V58, P131, DOI 10.2307/1379571; HILDEBRAND M, 1962, AM ZOOL, V2, P151; HILDEBRAND M, 1968, J MORPHOL, V124, P353, DOI 10.1002/jmor.1051240308; HILDEBRAND M, 1989, BIOSCIENCE, V39, P766, DOI 10.2307/1311182; HILDEBRAND M, 1980, AM ZOOL, V20, P255; Horvath G, 2008, BIOLOGICAL APPLICATI; Horvath G, 2009, CURR BIOL, V19, pR61, DOI 10.1016/j.cub.2008.12.011; HOYT DF, 1981, NATURE, V292, P239, DOI 10.1038/292239a0; Hutchinson JR, 2003, NATURE, V422, P493, DOI 10.1038/422493a; JAYES AS, 1978, J ZOOL, V185, P289, DOI 10.1111/j.1469-7998.1978.tb03334.x; Muybridge E., 1887, ANIMAL LOCOMOTION; Muybridge E, 1899, ANIMALS MOTION; Muybridge E, 1881, ATTITUDES OF ANIMALS; RATZLAFF MH, 1989, AM ZOOL, V29, P267; SPOOR CF, 1986, BIJDR DIERKD, V56, P24, DOI 10.1163/26660644-05601002; Zimmermann A, 1919, TERMESZETTUDOMANYI K, V51, P305	23	6	6	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 5	2012	7	12							e49786	10.1371/journal.pone.0049786	http://dx.doi.org/10.1371/journal.pone.0049786			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	057TZ	23227149	Green Published, Green Submitted, gold			2022-12-27	WOS:000312588200011
J	Kozlitina, J; Garcia, CK				Kozlitina, Julia; Garcia, Christine Kim			Red Blood Cell Size Is Inversely Associated with Leukocyte Telomere Length in a Large Multi-Ethnic Population	PLOS ONE			English	Article							MEAN CORPUSCULAR VOLUME; PULMONARY-FIBROSIS; MYELODYSPLASTIC SYNDROME; DYSKERATOSIS-CONGENITA; TRANSFERASE-ACTIVITY; ALCOHOL-CONSUMPTION; AFRICAN-AMERICANS; APLASTIC-ANEMIA; HUMAN OBESITY; MACROCYTOSIS	Although mutations in the genes encoding either the protein or RNA component of telomerase have been found in patients with various blood disorders, the impact of telomere length on hematopoiesis is less well understood for subjects from the general population. Here we have measured telomere lengths of genomic DNA isolated from circulating leukocytes of 3157 subjects, ranging from 18 to 85 years of age, enrolled in a large multiethnic population based study, the Dallas Heart Study 2. Shorter telomere lengths are marginally associated with lower red blood cell counts in this cohort, but are significantly associated with larger mean red blood cell size (as measured by the MCV), increased red blood cell distribution width (RDW), higher hemoglobin levels and lower platelet counts, even after correction for age, gender and ethnicity (p-values of <0.0001, <0.0001, 0.0009 and 0.0016, respectively). In a multiple regression model we find that telomere length is a significant covariate of MCV (p = 7.6x10(-8)), independent of age, ethnicity, BMI, current smoking, alcohol consumption, iron or homocysteine levels. The effect of telomere length on MCV variation is comparable to the effect of smoking or alcohol consumption and is more significant in older individuals (p = 9.2x10(-7) for >50 years vs. p = 0.0006 for <50 years of age). To our knowledge, this is the first report of an association between telomere length and red cell size in a large urban US population and suggests a biologic mechanism for macrocytosis of aging.	[Kozlitina, Julia; Garcia, Christine Kim] Univ Texas SW Med Ctr Dallas, Eugene McDermott Ctr Human Growth & Dev, Dallas, TX 75390 USA; [Garcia, Christine Kim] Univ Texas SW Med Ctr Dallas, Dept Internal Med, Div Pulm & Crit Care Med, Dallas, TX 75390 USA	University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas	Garcia, CK (corresponding author), Univ Texas SW Med Ctr Dallas, Eugene McDermott Ctr Human Growth & Dev, Dallas, TX 75390 USA.	christine.garcia@utsouthwestern.edu		Kozlitina, Julia/0000-0001-7720-2290	National Institutes of Health [R01 HL093096]; Doris Duke Charitable Foundation; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL093096] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Doris Duke Charitable Foundation(Doris Duke Charitable Foundation (DDCF)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by the National Institutes of Health (R01 HL093096) and the Doris Duke Charitable Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Armanios MY, 2007, NEW ENGL J MED, V356, P1317, DOI 10.1056/NEJMoa066157; Aviv A, 2011, NUCLEIC ACIDS RES, V39, DOI 10.1093/nar/gkr634; BEGUINOT F, 1985, J CLIN ENDOCR METAB, V60, P1226, DOI 10.1210/jcem-60-6-1226; Beutler E, 2005, BLOOD, V106, P740, DOI 10.1182/blood-2005-02-0713; Bodnar AG, 1998, SCIENCE, V279, P349, DOI 10.1126/science.279.5349.349; Calado RT, 2011, HEPATOLOGY, V53, P1600, DOI 10.1002/hep.24173; Calado RT, 2009, NEW ENGL J MED, V361, P2353, DOI 10.1056/NEJMra0903373; Calado RT, 2009, P NATL ACAD SCI USA, V106, P1187, DOI 10.1073/pnas.0807057106; Cawthon RM, 2003, LANCET, V361, P393, DOI 10.1016/S0140-6736(03)12384-7; CHALMERS DM, 1979, BRIT J HAEMATOL, V43, P631, DOI 10.1111/j.1365-2141.1979.tb03796.x; Codd V, 2010, NAT GENET, V42, P197, DOI 10.1038/ng.532; Cronkhite JT, 2008, AM J RESP CRIT CARE, V178, P729, DOI 10.1164/rccm.200804-550OC; DAVIDSON RJL, 1978, J CLIN PATHOL, V31, P493, DOI 10.1136/jcp.31.5.493; de Leon AD, 2011, CHEST, V140, P753, DOI 10.1378/chest.10-2865; de Leon AD, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010680; De Meyer T, 2008, AGING CELL, V7, P700, DOI 10.1111/j.1474-9726.2008.00419.x; Den Elzen WPJ, 2011, AGE AGEING, V40, P494, DOI 10.1093/ageing/afr048; Dokal I, 2000, BRIT J HAEMATOL, V110, P768, DOI 10.1046/j.1365-2141.2000.02109.x; Ehrlenbach S, 2009, INT J EPIDEMIOL, V38, P1725, DOI 10.1093/ije/dyp273; ESCHWEGE E, 1978, J CLIN PATHOL, V31, P654, DOI 10.1136/jcp.31.7.654; Farzaneh-Far R, 2008, ARTERIOSCL THROM VAS, V28, P1379, DOI 10.1161/ATVBAHA.108.167049; Ganesh SK, 2009, NAT GENET, V41, P1191, DOI 10.1038/ng.466; GREIDER CW, 1985, CELL, V43, P405, DOI 10.1016/0092-8674(85)90170-9; Hartmann D, 2011, HEPATOLOGY, V53, P1608, DOI 10.1002/hep.24217; HASTIE ND, 1990, NATURE, V346, P866, DOI 10.1038/346866a0; Hemann MT, 2001, CELL, V107, P67, DOI 10.1016/S0092-8674(01)00504-9; Holm TM, 2002, BLOOD, V99, P1817, DOI 10.1182/blood.V99.5.1817; Hunt SC, 2008, AGING CELL, V7, P451, DOI 10.1111/j.1474-9726.2008.00397.x; Kimura M, 2008, AM J EPIDEMIOL, V167, P799, DOI 10.1093/aje/kwm380; KLIPPEL JH, 1974, JAMA-J AM MED ASSOC, V229, P180, DOI 10.1001/jama.229.2.180; Lee M, 2011, AM J HUM BIOL, V23, P100, DOI 10.1002/ajhb.21109; Liangpunsakul S, 2010, J STUD ALCOHOL DRUGS, V71, P249, DOI 10.15288/jsad.2010.71.249; Mahmoud MY, 1996, AGE AGEING, V25, P310, DOI 10.1093/ageing/25.4.310; MARSH JCW, 1992, BLOOD, V79, P3138; McClintock B, 1941, GENETICS, V26, P234; MCGRATH BP, 1975, Q J MED, V44, P57; Mollica L, 2009, J GERONTOL A-BIOL, V64, P965, DOI 10.1093/gerona/glp065; Myojo M, 2012, ATHEROSCLEROSIS, V221, P148, DOI 10.1016/j.atherosclerosis.2011.11.044; Njajou OT, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013048; Njajou OT, 2009, J GERONTOL A-BIOL, V64, P860, DOI 10.1093/gerona/glp061; Nordfjall K, 2008, OBESITY, V16, P2682, DOI 10.1038/oby.2008.413; O'Donovan A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019687; OKUNO T, 1972, BRIT MED J, V1, P569, DOI 10.1136/bmj.1.5799.569-c; PAPOZ L, 1981, Journal of the American Medical Association, V245, P1748, DOI 10.1001/jama.245.17.1748; Rauw J, 2011, LEUKEMIA RES, V35, P1335, DOI 10.1016/j.leukres.2011.05.001; RILLAERTS E, 1989, INT J OBESITY, V13, P739; Roux AVD, 2009, AGING CELL, V8, P251, DOI 10.1111/j.1474-9726.2009.00470.x; SAVAGE DG, 1994, AM J MED, V96, P239, DOI 10.1016/0002-9343(94)90149-X; Schuller CE, 2007, LEUKEMIA, V21, P983, DOI 10.1038/sj.leu.2404631; Schweiger C, 2010, OBES SURG, V20, P193, DOI 10.1007/s11695-009-0008-3; SLAGBOOM PE, 1994, AM J HUM GENET, V55, P876; Svenson U, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021485; Tsakiri KD, 2007, P NATL ACAD SCI USA, V104, P7552, DOI 10.1073/pnas.0701009104; Valdes AM, 2005, LANCET, V366, P662, DOI 10.1016/S0140-6736(05)66630-5; VALDES AM, 2007, OSTEOPOROS INT; Vasa-Nicotera M, 2005, AM J HUM GENET, V76, P147, DOI 10.1086/426734; VAZIRI H, 1994, P NATL ACAD SCI USA, V91, P9857, DOI 10.1073/pnas.91.21.9857; Willeit P, 2010, JAMA-J AM MED ASSOC, V304, P69, DOI 10.1001/jama.2010.897; Wright WE, 1996, DEV GENET, V18, P173; Yamaguchi H, 2005, NEW ENGL J MED, V352, P1413, DOI 10.1056/NEJMoa042980; Yamaguchi H, 2003, BLOOD, V102, P916, DOI 10.1182/blood-2003-01-0335	61	36	39	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 4	2012	7	12							e51046	10.1371/journal.pone.0051046	http://dx.doi.org/10.1371/journal.pone.0051046			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	051EQ	23226558	Green Submitted, gold, Green Published			2022-12-27	WOS:000312108500041
J	Sejvar, J; Lutterloh, E; Naiene, J; Likaka, A; Manda, R; Nygren, B; Monroe, S; Khaila, T; Lowther, SA; Capewell, L; Date, K; Townes, D; Redwood, Y; Schier, J; Barr, BT; Demby, A; Mallewa, M; Kampondeni, S; Blount, B; Humphrys, M; Talkington, D; Armstrong, GL; Mintz, E				Sejvar, James; Lutterloh, Emily; Naiene, Jeremias; Likaka, Andrew; Manda, Robert; Nygren, Benjamin; Monroe, Stephan; Khaila, Tadala; Lowther, Sara A.; Capewell, Linda; Date, Kashmira; Townes, David; Redwood, Yanique; Schier, Joshua; Barr, Beth Tippett; Demby, Austin; Mallewa, Macpherson; Kampondeni, Sam; Blount, Ben; Humphrys, Michael; Talkington, Deborah; Armstrong, Gregory L.; Mintz, Eric			Neurologic Manifestations Associated with an Outbreak of Typhoid Fever, Malawi - Mozambique, 2009: An Epidemiologic Investigation	PLOS ONE			English	Article							VIRUS-ASSOCIATED ENCEPHALOPATHY; TROPICAL ATAXIC NEUROPATHY; ENTERIC FEVER; NEUROPSYCHIATRIC MANIFESTATIONS; PYRIDOXAL 5'-PHOSPHATE; VITAMIN-B12 DEFICIENCY; CEREBELLAR-ATAXIA; COMPLICATIONS; APHASIA; SERUM	Background: The bacterium Salmonella enterica serovar Typhi causes typhoid fever, which is typically associated with fever and abdominal pain. An outbreak of typhoid fever in Malawi-Mozambique in 2009 was notable for a high proportion of neurologic illness. Objective: Describe neurologic features complicating typhoid fever during an outbreak in Malawi-Mozambique Methods: Persons meeting a clinical case definition were identified through surveillance, with laboratory confirmation of typhoid by antibody testing or blood/stool culture. We gathered demographic and clinical information, examined patients, and evaluated a subset of patients 11 months after onset. A sample of persons with and without neurologic signs was tested for vitamin B6 and B12 levels and urinary thiocyanate. Results: Between March - November 2009, 303 cases of typhoid fever were identified. Forty (13%) persons had objective neurologic findings, including 14 confirmed by culture/serology; 27 (68%) were hospitalized, and 5 (13%) died. Seventeen (43%) had a constellation of upper motor neuron findings, including hyperreflexia, spasticity, or sustained ankle clonus. Other neurologic features included ataxia (22, 55%), parkinsonism (8, 20%), and tremors (4, 10%). Brain MRI of 3 (ages 5, 7, and 18 years) demonstrated cerebral atrophy but no other abnormalities. Of 13 patients re-evaluated 11 months later, 11 recovered completely, and 2 had persistent hyperreflexia and ataxia. Vitamin B6 levels were markedly low in typhoid fever patients both with and without neurologic signs. Conclusions: Neurologic signs may complicate typhoid fever, and the diagnosis should be considered in persons with acute febrile neurologic illness in endemic areas.	[Sejvar, James; Monroe, Stephan] Ctr Dis Control & Prevent CDC, Div High Consequence Pathogens & Pathol, Natl Ctr Emerging & Zoonot Infect Dis NCEZID, Atlanta, GA 30333 USA; [Lutterloh, Emily; Lowther, Sara A.; Capewell, Linda; Date, Kashmira; Townes, David; Redwood, Yanique] CDC, Sci Educ & Profess Dev Program Off, Epidem Intelligence Serv, Atlanta, GA 30333 USA; [Naiene, Jeremias] Minist Hlth, Maputo, Mozambique; [Likaka, Andrew; Manda, Robert; Khaila, Tadala] Minist Hlth, Lilongwe, Malawi; [Nygren, Benjamin; Humphrys, Michael; Talkington, Deborah; Mintz, Eric] CDC, Div Foodborne Waterborne & Environm Infect Dis, NCEZID, Atlanta, GA 30333 USA; [Schier, Joshua; Blount, Ben] CDC, Div Environm Hazards & Hlth Effects, Natl Ctr Environm Hlth NCEH, Atlanta, GA 30333 USA; [Barr, Beth Tippett; Demby, Austin] CDC, Global AIDS Program, Lilongwe, Malawi; [Mallewa, Macpherson; Kampondeni, Sam] Coll Med, Malawi Liverpool Wellcome Trust, Blantyre, Malawi; [Armstrong, Gregory L.] CDC, Div Viral Dis, Natl Ctr Immunizat & Resp Dis, Atlanta, GA 30333 USA	Centers for Disease Control & Prevention - USA; Centers for Disease Control & Prevention - USA; Centers for Disease Control & Prevention - USA; Centers for Disease Control & Prevention - USA; University of Malawi; Centers for Disease Control & Prevention - USA	Sejvar, J (corresponding author), Ctr Dis Control & Prevent CDC, Div High Consequence Pathogens & Pathol, Natl Ctr Emerging & Zoonot Infect Dis NCEZID, Atlanta, GA 30333 USA.	zea3@cdc.gov	Tippett Barr, Beth A./GLU-1101-2022; Barr, Beth Tippett/L-5008-2019	Barr, Beth Tippett/0000-0001-5877-2968; Naiene, Jeremias/0000-0003-1594-0786; Monroe, Stephan/0000-0002-5424-716X	U.S. government; Centers for Disease Control and Prevention	U.S. government; Centers for Disease Control and Prevention(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA)	U.S. government funding, Centers for Disease Control and Prevention. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adehossi E, 2003, J TRAVEL MED, V10, P192, DOI 10.2310/7060.2003.35773; Ali G, 1997, TROP MED INT HEALTH, V2, P314; [Anonymous], 1973, BMJ-BRIT MED J, V2, P436; Bansal AS, 1995, J TROP MED HYG, V98, P392; Barceloux DG, 2009, DM-DIS MON, V55, P318, DOI [10.1016/j.disamonth.2009.03.006, 10.1016/j.disamonth.2009.03.005, 10.1016/j.disamonth.2009.03.010, 10.1016/j.disamonth.2009.03.007, 10.1016/j.disamonth.2009.03.011, 10.1016/j.disamonth.2009.03.002, 10.1016/j.disamonth.2009.03.004, 10.1016/j.disamonth.2009.03.003, 10.1016/j.disamonth.2009.03.008]; Blount BC, 2006, ENVIRON HEALTH PERSP, V114, P1865, DOI 10.1289/ehp.9466; Bradbury JH, 2011, FOOD CHEM TOXICOL, V49, P537, DOI 10.1016/j.fct.2010.11.001; Chand G, 1988, J Assoc Physicians India, V36, P741; Cheong B M K, 2008, Med J Malaysia, V63, P77; CHIKANZA IC, 1986, CENT AFR J MED, V32, P31; Cliff J, 1999, J TROP PEDIATRICS, V45, P139, DOI 10.1093/tropej/45.3.139; Cliff J, 1997, T ROY SOC TROP MED H, V91, P447, DOI 10.1016/S0035-9203(97)90279-0; Cliff J, 2010, FOOD CHEM TOXICOL; Crum Nancy F, 2003, Curr Gastroenterol Rep, V5, P279, DOI 10.1007/s11894-003-0064-0; DAVID CB, 1978, J PEDIATR-US, V93, P533, DOI 10.1016/S0022-3476(78)81192-5; Dewan P, 2009, ANN TROP PAEDIATR, V29, P217, DOI 10.1179/027249309X12467994693978; Gdynia HJ, 2008, NEUROMUSCULAR DISORD, V18, P156, DOI 10.1016/j.nmd.2007.09.009; Ghosh J. B., 1995, Indian Journal of Pediatrics, V62, P627, DOI 10.1007/BF02761897; Henkel JS, 2010, EXPERIENTIA SUPPL, V100, P1; Ichiyama T, 2004, CYTOKINE, V27, P31, DOI 10.1016/j.cyto.2004.03.012; Ichiyama T, 2003, SCAND J INFECT DIS, V35, P59, DOI 10.1080/0036554021000026986; Incecik F, 2010, TURKISH J PEDIATR, V52, P17; Kalita J, 2010, NEUROSCI LETT, V473, P48, DOI 10.1016/j.neulet.2010.02.017; KAMALA C S, 1991, Indian Pediatrics, V28, P1213; KANWAR K, 1962, Indian J Child Health, V11, P525; KHOSLA SN, 1977, J TROP MED HYG, V80, P95; Lutterloh E, 2012, CLIN INFECT DIS, V54, P1100, DOI 10.1093/cid/cis012; Madhusudanan M, 2008, EUR NEUROL, V60, P21, DOI 10.1159/000127975; Maheshwari V D, 2001, J Assoc Physicians India, V49, P1035; Mankad K, 2010, AM J MED, V123, pE1, DOI 10.1016/j.amjmed.2009.12.024; Misra G C, 1985, J Indian Med Assoc, V83, P352; Morris MS, 2008, AM J CLIN NUTR, V87, P1446, DOI 10.1093/ajcn/87.5.1446; NAHATA MC, 1961, J INDIAN MED ASSOC, V37, P134; NJOH J, 1990, TROP GEOGR MED, V42, P92; OSUNTOKUN BO, 1974, BRAIN, V97, P385, DOI 10.1093/brain/97.1.385; OSUNTOKUN BO, 1972, ARCH NEUROL-CHICAGO, V27, P7, DOI 10.1001/archneur.1972.00490130009002; OZEN H, 1993, TURKISH J PEDIATR, V35, P141; Parry CM, 2002, NEW ENGL J MED, V347, P1770, DOI 10.1056/NEJMra020201; Rajeshwari K, 1995, Indian Pediatr, V32, P1305; Rybak ME, 2004, ANAL BIOCHEM, V333, P336, DOI 10.1016/j.ab.2004.06.036; Sachdev H S, 1982, Indian Pediatr, V19, P639; SAWHNEY IMS, 1986, T ROY SOC TROP MED H, V80, P85, DOI 10.1016/0035-9203(86)90202-6; Senol MG, 2008, SINGAP MED J, V49, pE330; Singh Subhash, 1993, Indian Journal of Pediatrics, V60, P147, DOI 10.1007/BF02860525; Suri S, 1992, Indian Pediatr, V29, P901; Thorpe SJ, 2007, CLIN CHEM LAB MED, V45, P380, DOI 10.1515/CCLM.2007.072; TYLLESKAR T, 1993, J NEUROL NEUROSUR PS, V56, P638, DOI 10.1136/jnnp.56.6.638; Valentin-Blasini L, 2007, J CHROMATOGR A, V1155, P40, DOI 10.1016/j.chroma.2007.04.014; VENKATESH S, 1989, W INDIAN MED J, V38, P137; von Rhein C, 2006, INFECT IMMUN, V74, P6505, DOI 10.1128/IAI.00779-06; von Rhein C, 2009, INT J MED MICROBIOL, V299, P21, DOI 10.1016/j.ijmm.2008.06.004	51	22	22	2	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 3	2012	7	12							e46099	10.1371/journal.pone.0046099	http://dx.doi.org/10.1371/journal.pone.0046099			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	051DH	23226492	Green Published, Green Submitted, gold			2022-12-27	WOS:000312104700002
J	Wang, D; Wise, ML; Li, F; Dey, M				Wang, Dan; Wise, Mitchell L.; Li, Feng; Dey, Moul			Phytochemicals Attenuating Aberrant Activation of beta-Catenin in Cancer Cells	PLOS ONE			English	Article							OXIDATIVE STRESS; WNT/BETA-CATENIN; SIGNALING PATHWAY; LITHIUM-CHLORIDE; IN-VITRO; AVENANTHRAMIDES; WNT; TRIPTOLIDE; OATS; PROLIFERATION	Phytochemicals are a rich source of chemoprevention agents but their effects on modulating the Wnt/beta-catenin signaling pathway have remained largely uninvestigated. Aberrantly activated Wnt signaling can result in the abnormal stabilization of beta-catenin, a key causative step in a broad spectrum of cancers. Here we report the modulation of lithium chloride-activated canonical Wnt/beta-catenin signaling by phytochemicals that have antioxidant, anti-inflammatory or chemopreventive properties. The compounds were first screened with a cervical cancer-derived stable Wnt signaling reporter HeLa cell line. Positive hits were subsequently evaluated for beta-catenin degradation, suppression of beta-catenin nuclear localization and down-regulation of downstream oncogenic targets of Wnt/beta-catenin pathway. Our study shows a novel degradation path of beta-catenin protein in HeLa cells by Avenanthramide 2p (a polyphenol) and Triptolide (a diterpene triepoxide), respectively from oats and a Chinese medicinal plant. The findings present Avenanthramide 2p as a potential chemopreventive dietary compound that merits further study using in vivo models of cancers; they also provide a new perspective on the mechanism of action of Triptolide. Citation: Wang D, Wise ML, Li F, Dey M (2012) Phytochemicals Attenuating Aberrant Activation of beta-Catenin in Cancer Cells. PLoS ONE 7(12): e50508. doi:10.1371/journal.pone.0050508	[Wang, Dan; Dey, Moul] S Dakota State Univ, Dept Hlth & Nutr Sci, Brookings, SD 57007 USA; [Wise, Mitchell L.] USDA, Madison, WI USA; [Li, Feng] S Dakota State Univ, Dept Biol & Microbiol, Brookings, SD 57007 USA; [Li, Feng] S Dakota State Univ, Dept Vet & Biomed Sci, Brookings, SD 57007 USA	South Dakota State University; United States Department of Agriculture (USDA); South Dakota State University; South Dakota State University	Dey, M (corresponding author), S Dakota State Univ, Dept Hlth & Nutr Sci, Brookings, SD 57007 USA.	moul.dey@sdstate.edu		Li, Feng/0000-0002-8904-2893; DEY, MOUL/0000-0002-6423-9593; Wang, Dan/0000-0002-7263-8420	National Institutes of Health [R00AT4245]; USDA/SD-AES grant [328100/318000]; SDSU AES Fund [3AH203]; NIH grant [AI076125]; NATIONAL CENTER FOR COMPLEMENTARY & ALTERNATIVE MEDICINE [R00AT004245] Funding Source: NIH RePORTER; NATIONAL CENTER FOR COMPLEMENTARY &ALTERNATIVE MEDICINE [K99AT004245] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [K02AI076125] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); USDA/SD-AES grant; SDSU AES Fund; NIH grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR COMPLEMENTARY & ALTERNATIVE MEDICINE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Complementary & Alternative Medicine); NATIONAL CENTER FOR COMPLEMENTARY &ALTERNATIVE MEDICINE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Complementary & Alternative Medicine); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	The work is supported by the National Institutes of Health grant R00AT4245 (to MD), USDA/SD-AES grant 328100/318000 (to MD), SDSU AES Fund 3AH203 (to FL) and NIH grant AI076125 (to FL). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 1996, J Cell Biochem Suppl, V26, P149; Antonoff MB, 2009, SURGERY, V146, P282, DOI 10.1016/j.surg.2009.04.023; Arcidiacono B, 2012, EXP DIABETES RES, DOI 10.1155/2012/789174; Bulut G, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027243; Cairo S, 2008, CANCER CELL, V14, P471, DOI 10.1016/j.ccr.2008.11.002; Chen CYO, 2007, J NUTR, V137, P1375, DOI 10.1093/jn/137.6.1375; Chen CY, 2004, J NUTR, V134, P1459, DOI 10.1093/jn/134.6.1459; Clement-Lacroix P, 2005, P NATL ACAD SCI USA, V102, P17406, DOI 10.1073/pnas.0505259102; Clevers H, 2006, CELL, V127, P469, DOI 10.1016/j.cell.2006.10.018; Dang CV, 2009, CLIN CANCER RES, V15, P6479, DOI 10.1158/1078-0432.CCR-09-0889; Dey M, 2006, J PHARMACOL EXP THER, V317, P326, DOI 10.1124/jpet.105.096511; Essers MAG, 2005, SCIENCE, V308, P1181, DOI 10.1126/science.1109083; Fuerer C, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009370; Gao XF, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000708; Gregory CA, 2005, J BIOL CHEM, V280, P2309, DOI 10.1074/jbc.M406275200; Guo WM, 2010, NUTR CANCER, V62, P1007, DOI 10.1080/01635581.2010.492090; Guo W, 2008, FREE RADICAL BIO MED, V44, P415, DOI 10.1016/j.freeradbiomed.2007.10.036; Handeli S, 2008, MOL CANCER THER, V7, P521, DOI 10.1158/1535-7163.MCT-07-2063; He MF, 2009, J ETHNOPHARMACOL, V121, P61, DOI 10.1016/j.jep.2008.09.033; Hiyama A, 2011, J CELL BIOCHEM, V112, P2974, DOI 10.1002/jcb.23217; Jin TR, 2008, CELL SIGNAL, V20, P1697, DOI 10.1016/j.cellsig.2008.04.014; Katoh M, 2007, CLIN CANCER RES, V13, P4042, DOI 10.1158/1078-0432.CCR-06-2316; Kim JH, 2005, NATURE, V434, P921, DOI 10.1038/nature03452; Kim MJ, 2010, INT J ONCOL, V37, P1177, DOI 10.3892/ijo_00000769; Kitzen JJEM, 2009, EUR J CANCER, V45, P1764, DOI 10.1016/j.ejca.2009.01.026; Klein PS, 1996, P NATL ACAD SCI USA, V93, P8455, DOI 10.1073/pnas.93.16.8455; Koenig RT, 2011, J AGR FOOD CHEM, V59, P6438, DOI 10.1021/jf2002427; Krejci P, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035826; Liu QY, 2011, INT IMMUNOPHARMACOL, V11, P377, DOI 10.1016/j.intimp.2011.01.012; Ma J, 2007, PHYTOCHEMISTRY, V68, P1172, DOI 10.1016/j.phytochem.2007.02.021; Macville M, 1999, CANCER RES, V59, P141; Meydani M, 2009, NUTR REV, V67, P731, DOI 10.1111/j.1753-4887.2009.00256.x; Nie L, 2006, ATHEROSCLEROSIS, V186, P260, DOI 10.1016/j.atherosclerosis.2005.07.027; Nishikawa A, 2004, CURR CANCER DRUG TAR, V4, P373, DOI 10.2174/1568009043332970; Okazaki Y, 2004, PLANT J, V39, P560, DOI 10.1111/j.1365-313X.2004.02163.x; Peterson CW, 2011, FRONT BIOSCI-LANDMRK, V16, P2206, DOI 10.2741/3848; Polk WW, 2012, INT J TOXICOL; Premkumar Vummidigiridhar, 2010, BMC Chemical Biology, V10, P3, DOI 10.1186/1472-6769-10-3; Rahmani M, 2005, J BIOL CHEM, V280, P13019, DOI 10.1074/jbc.M411766200; Ren Y, 2011, J AGR FOOD CHEM, V59, P206, DOI 10.1021/jf103938e; Shao F, 2007, BIOL PHARM BULL, V30, P702, DOI 10.1248/bpb.30.702; Sokol SY, 2011, CELL RES, V21, P1002, DOI 10.1038/cr.2011.86; Stewart SA, 2003, RNA, V9, P493, DOI 10.1261/rna.2192803; Sur R, 2008, ARCH DERMATOL RES, V300, P569, DOI 10.1007/s00403-008-0858-x; Tarapore RS, 2012, CARCINOGENESIS, V33, P483, DOI 10.1093/carcin/bgr305; Wang D, 2010, J VIROL, V84, P4673, DOI 10.1128/JVI.02306-09; Wise ML, 2011, J AGR FOOD CHEM, V59, P7028, DOI 10.1021/jf2008869; Wu XA, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-269	49	26	27	1	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 3	2012	7	12							e50508	10.1371/journal.pone.0050508	http://dx.doi.org/10.1371/journal.pone.0050508			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	051DH	23226522	Green Submitted, Green Published, gold			2022-12-27	WOS:000312104700019
J	Covell, DG; Wallqvist, A; Kenney, S; Vistica, DT				Covell, David G.; Wallqvist, Anders; Kenney, Susan; Vistica, David T.			Bioinformatic Analysis of Patient-Derived ASPS Gene Expressions and ASPL-TFE3 Fusion Transcript Levels Identify Potential Therapeutic Targets	PLOS ONE			English	Article							SOFT-PART SARCOMA; GROWTH-FACTOR; AUTOCRINE GROWTH; CONNECTIVITY MAP; CHEMOKINE; TUMORS; RHABDOMYOSARCOMA; INHIBITION; SIGNATURES; CANCER	Gene expression data, collected from ASPS tumors of seven different patients and from one immortalized ASPS cell line (ASPS-1), was analyzed jointly with patient ASPL-TFE3 (t(X;17)(p11;q25)) fusion transcript data to identify disease-specific pathways and their component genes. Data analysis of the pooled patient and ASPS-1 gene expression data, using conventional clustering methods, revealed a relatively small set of pathways and genes characterizing the biology of ASPS. These results could be largely recapitulated using only the gene expression data collected from patient tumor samples. The concordance between expression measures derived from ASPS-1 and both pooled and individual patient tumor data provided a rationale for extending the analysis to include patient ASPL-TFE3 fusion transcript data. A novel linear model was exploited to link gene expressions to fusion transcript data and used to identify a small set of ASPS-specific pathways and their gene expression. Cellular pathways that appear aberrantly regulated in response to the t(X; 17)(p11; q25) translocation include the cell cycle and cell adhesion. The identification of pathways and gene subsets characteristic of ASPS support current therapeutic strategies that target the FLT1 and MET, while also proposing additional targeting of genes found in pathways involved in the cell cycle (CHK1), cell adhesion (ARHGD1A), cell division (CDC6), control of meiosis (RAD51L3) and mitosis (BIRC5), and chemokine-related protein tyrosine kinase activity (CCL4).	[Covell, David G.; Kenney, Susan; Vistica, David T.] NCI, Dev Therapeut Program, Frederick Natl Lab Canc Res, Frederick, MD 21701 USA; [Wallqvist, Anders] USA, Med Res & Mat Command, Dept Def Biotechnol,Telemed & Adv Technol Res Ctr, High Performance Comp Software Applicat Inst, Ft Detrick, MD USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Covell, DG (corresponding author), NCI, Dev Therapeut Program, Frederick Natl Lab Canc Res, Frederick, MD 21701 USA.	covelld@mail.nih.gov	wallqvist, anders/W-2584-2019	wallqvist, anders/0000-0002-9775-7469				Agulnik M, 2013, ANN ONCOL, V24, P257, DOI 10.1093/annonc/mds237; Anderson J, 1999, GENE CHROMOSOME CANC, V26, P275, DOI 10.1002/(SICI)1098-2264(199912)26:4<275::AID-GCC1>3.0.CO;2-3; Balkwill F, 2004, NAT REV CANCER, V4, P540, DOI 10.1038/nrc1388; Cambien B, 2009, BRIT J CANCER, V100, P1755, DOI 10.1038/sj.bjc.6605078; Cambien B, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028842; Cheung R, 2009, J LEUKOCYTE BIOL, V86, P833, DOI 10.1189/jlb.0908551; Chiaverini C, 2008, J BIOL CHEM, V283, P12635, DOI 10.1074/jbc.M800130200; CHRISTOPHERSON WM, 1952, CANCER, V5, P100, DOI 10.1002/1097-0142(195201)5:1<100::AID-CNCR2820050112>3.0.CO;2-K; Coelho LFL, 2005, P NATL ACAD SCI USA, V102, P11917, DOI 10.1073/pnas.0502188102; Cronshaw DG, 2004, J IMMUNOL, V172, P7761, DOI 10.4049/jimmunol.172.12.7761; Davicioni E, 2008, MOL DIAGN THER, V12, P359, DOI 10.2165/1250444-200812060-00003; ELBADRY OM, 1990, CELL GROWTH DIFFER, V1, P325; Erreni M, 2009, METHOD ENZYMOL, V460, P105, DOI 10.1016/S0076-6879(09)05205-7; Goley EM, 2004, BMC CANCER, V4, DOI 10.1186/1471-2407-4-20; Heimann P, 1998, GENE CHROMOSOME CANC, V23, P194, DOI 10.1002/(SICI)1098-2264(199810)23:2<194::AID-GCC14>3.3.CO;2-O; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Judson I, 2010, ANN ONCOL, V21, P277, DOI 10.1093/annonc/mdq288; Judson Ian, 2010, Clin Adv Hematol Oncol, V8, P244; Kenney S, 2011, J PEDIAT HEMATOL ONC, V33, P360, DOI 10.1097/MPH.0b013e3182002f9f; Kohonen T., 1997, SPRINGER SERIES INFO; Koskimaki JE, 2009, NEOPLASIA, V11, P1285, DOI 10.1593/neo.09620; Kuriyama K, 2001, MED PEDIATR ONCOL, V37, P482, DOI 10.1002/mpo.1237; Ladanyi M, 2001, ONCOGENE, V20, P48, DOI 10.1038/sj.onc.1204074; Lamb J, 2007, NAT REV CANCER, V7, P54, DOI 10.1038/nrc2044; Lamb J, 2006, SCIENCE, V313, P1929, DOI 10.1126/science.1132939; Liberzon A, 2011, BIOINFORMATICS, V27, P1739, DOI 10.1093/bioinformatics/btr260; Lindner Daniel J, 2002, Curr Oncol Rep, V4, P510, DOI 10.1007/s11912-002-0065-4; Ma CX, 2011, TRENDS MOL MED, V17, P88, DOI 10.1016/j.molmed.2010.10.009; Mootha VK, 2003, NAT GENET, V34, P267, DOI 10.1038/ng1180; Naran S, 2009, EXPERT OPIN THER TAR, V13, P569, DOI [10.1517/14728220902853917, 10.1517/14728220902853917 ]; Portera CA, 2001, CANCER, V91, P585, DOI 10.1002/1097-0142(20010201)91:3<585::AID-CNCR1038>3.0.CO;2-0; Pradelli E, 2009, INT J CANCER, V125, P2586, DOI 10.1002/ijc.24665; Prieur A, 2004, MOL CELL BIOL, V24, P7275, DOI 10.1128/MCB.24.16.7275-7283.2004; Reed D, 2011, CANCER CONTROL, V18, P188, DOI 10.1177/107327481101800306; Reichardt P, 2003, EUR J CANCER, V39, P1511, DOI 10.1016/S0959-8049(03)00264-8; Sandberg AA, 2002, CANCER GENET CYTOGEN, V132, P1, DOI 10.1016/S0165-4608(01)00528-3; Sirota M, 2011, SCI TRANSL MED, V3; Stacchiotti S, 2009, CLIN CANCER RES, V15, P1096, DOI 10.1158/1078-0432.CCR-08-2050; Stockwin LH, 2009, BMC CANCER, V9, DOI 10.1186/1471-2407-9-22; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Symmans WF, 2003, CANCER, V97, P2960, DOI 10.1002/cncr.11435; Taylor BS, 2011, NAT REV CANCER, V11, P541, DOI 10.1038/nrc3087; Tsuda M, 2007, CANCER RES, V67, P919, DOI 10.1158/0008-5472.CAN-06-2855; Vistica DT, 2009, J PEDIAT HEMATOL ONC, V31, P561, DOI 10.1097/MPH.0b013e3181a6e043; Wagner AJ, 2012, CANCER-AM CANCER SOC, V118, P5894, DOI 10.1002/cncr.27582; YEE D, 1990, J CLIN INVEST, V86, P1806, DOI 10.1172/JCI114910; ZHAN SL, 1994, J CLIN INVEST, V94, P445, DOI 10.1172/JCI117344; Zhang YW, 2009, MOL CELL, V35, P442, DOI 10.1016/j.molcel.2009.06.030	48	16	18	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 30	2012	7	11							e48023	10.1371/journal.pone.0048023	http://dx.doi.org/10.1371/journal.pone.0048023			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	054WM	23226201	Green Submitted, gold, Green Published			2022-12-27	WOS:000312376100010
J	Heo, J; Oh, J; Kim, J; Lee, M; Lee, JS; Kwon, S; Subramanian, SV; Kawachi, I				Heo, Jongho; Oh, Juwhan; Kim, Jukyung; Lee, Manwoo; Lee, Jin-seok; Kwon, Soonman; Subramanian, S. V.; Kawachi, Ichiro			Poverty in the Midst of Plenty: Unmet Needs and Distribution of Health Care Resources in South Korea	PLOS ONE			English	Article							COMPETITION; MORTALITY; ACCESS; COST; PAYMENT; SYSTEM; REFORM	Background: The unmet needs for health care have been used as an alternative measurement to monitor equity in health services. We sought to examine contextual influences on unmet needs for health care whereas precedent studies have been focused on individual characteristics on them. Methods and Findings: The current study conducted multilevel logistic regression analysis to assess the effects of individual-and contextual-level predictors in meeting individual health care needs in South Korea. We sampled 7,200 individuals over the age of 19 in the Fourth Korea National Health and Nutrition Examination Survey in 2009. Included in the regression model were individual predictors such as demographic variables, socio-economic status, and self-rated health; the density of beds and physicians in public and private sectors within different regions were used as contextual-level predictors. This study showed the inverse association between unmet needs and regional resources in private sectors after controlling for the effects of individual-level predictors. Conclusion: Our findings suggest that increasing regional resources in private sectors might produce inefficiency in the health care system and inequity in access to health services, particularly where the competition in private health care sectors was highly stimulated under the fee-for-service reimbursement scheme. Policies for the reallocation of health care resources and for reduction of individual health care costs are needed in Korea.	[Heo, Jongho] Univ Calif San Diego, Publ Hlth Joint Doctoral Program, San Diego, CA 92103 USA; [Heo, Jongho] San Diego State Univ, San Diego, CA 92182 USA; [Oh, Juwhan; Lee, Jin-seok] Seoul Natl Univ, Med Res Ctr, Inst Hlth Policy & Management, Seoul, South Korea; [Kim, Jukyung; Lee, Manwoo] Natl Assembly Res Serv, Hlth Welf Family & Gender Equ Team, Seoul, South Korea; [Kwon, Soonman] Seoul Natl Univ, Sch Publ Hlth, Seoul, South Korea; [Subramanian, S. V.; Kawachi, Ichiro] Harvard Univ, Sch Publ Hlth, Dept Soc Human Dev & Hlth, Boston, MA 02115 USA	University of California System; University of California San Diego; California State University System; San Diego State University; Seoul National University (SNU); Seoul National University (SNU); Harvard University; Harvard T.H. Chan School of Public Health	Heo, J (corresponding author), Univ Calif San Diego, Publ Hlth Joint Doctoral Program, San Diego, CA 92103 USA.	jjongho77@gmail.com		Oh, Juhwan/0000-0003-0983-4872; Heo, Jongho/0000-0002-6405-3860				Ahn SH, 2001, J KOREAN ACAD FAM ME, V22, P483; Allin S, 2010, SOC SCI MED, V70, P465, DOI 10.1016/j.socscimed.2009.10.027; Armour BS, 2001, ARCH INTERN MED, V161, P1261, DOI 10.1001/archinte.161.10.1261; Ayanian JZ, 2000, JAMA-J AM MED ASSOC, V284, P2061, DOI 10.1001/jama.284.16.2061; Baker LC, 1994, DOES COMPETITION HMO; Balsa AI, 2001, J HEALTH ECON, V20, P881, DOI 10.1016/S0167-6296(01)00101-1; BRONFENBRENNER U, 1994, PSYCHOL REV, V101, P568, DOI 10.1037/0033-295X.101.4.568; CARR W, 1976, INT J HEALTH SERV, V6, P417, DOI 10.2190/MCG0-UH8D-0AG8-VFNU; Chen Jiajian, 2002, Health Rep, V13, P23; Clemenceau A, 2006, EU SILC COMMUNITY ST; Cunningham P, 1998, UNINSURED GETTING CA, V1; Franco LM, 2002, SOC SCI MED, V54, P1255, DOI 10.1016/S0277-9536(01)00094-6; Han D, 2004, KOREAN J HLTH POLICY, V14, P20; Hur S, 2009, POLICY OPTIONS TACKL; Idler EL, 1997, J HEALTH SOC BEHAV, V38, P21, DOI 10.2307/2955359; Institute of Medicine, 2001, CROSSING QUALITY CHA; Jones RS, 2010, WORKING PAPERS OECD, P9; Kim Han-Hae, 2006, J Prev Med Public Health, V39, P141; Kirby JB, 2005, J HEALTH SOC BEHAV, V46, P15, DOI 10.1177/002214650504600103; Kwon S, 2003, HEALTH POLICY PLANN, V18, P84, DOI 10.1093/heapol/18.1.84; Kwon S, 2002, GLOBAL SOCIAL POLICY, V2, P279; Law M, 2005, HEALTH PLACE, V11, P367, DOI 10.1016/j.healthplace.2004.05.004; Litaker D, 2005, HEALTH POLICY, V73, P183, DOI 10.1016/j.healthpol.2004.11.010; Newacheck PW, 2000, PEDIATRICS, V105, P760, DOI 10.1542/peds.105.4.760; NOETHER M, 1988, J HEALTH ECON, V7, P259, DOI 10.1016/0167-6296(88)90028-8; OECD, 2009, OECD HLTH DAT 2009; Park H, 2005, EFFECTS HOSP COMETIT; Peterson LE, 2010, J RURAL HEALTH, V26, P373, DOI 10.1111/j.1748-0361.2010.00309.x; ROBINSON JC, 1985, J HEALTH ECON, V4, P333, DOI 10.1016/0167-6296(85)90012-8; ROBINSON JC, 1987, JAMA-J AM MED ASSOC, V257, P3241, DOI 10.1001/jama.257.23.3241; Sanmartin Claudia, 2002, Health Rep, V13, P15; Shin Y, 2009, COOPERATIVE SYSTEM U; Soonim Hur，, 2007, [The Korean Journal of Health Economics and Policy, 보건경제와 정책연구], V13, P1; Stevens A, 1998, BRIT MED J, V316, P1448, DOI 10.1136/bmj.316.7142.1448; U.S. Department of Health and Human Services, 2000, HLTH PEOPL 2010 UND; Veugelers PJ, 2001, AM J EPIDEMIOL, V154, P725, DOI 10.1093/aje/154.8.725; WENNBERG JE, 1987, MED CARE, V25, P354, DOI 10.1097/00005650-198704000-00008; WENNBERG JE, 1989, NEW ENGL J MED, V321, P1168, DOI 10.1056/NEJM198910263211706; Wu Z, 2005, REV CANADIENNE SANTE, V96; Xirasagar S, 2004, HEALTH SERV RES, V39, P2101, DOI 10.1111/j.1475-6773.2004.00334.x; Zuvekas SH, 2003, HEALTH AFFAIR, V22, P139, DOI 10.1377/hlthaff.22.2.139; 이용재, 2006, [Social Welfare Policy, 사회복지정책], V24, P173	42	13	13	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 30	2012	7	11							e51004	10.1371/journal.pone.0051004	http://dx.doi.org/10.1371/journal.pone.0051004			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	054WM	23226447	Green Published, gold, Green Submitted			2022-12-27	WOS:000312376100258
J	Lok, SM; Costin, JM; Hrobowski, Y; Hoffmann, AR; Rowe, DK; Kukkaro, P; Holdaway, H; Chipman, P; Fontaine, KA; Holbrook, MR; Garry, RF; Kostyuchenko, V; Wimley, WC; Isern, S; Rossmann, MG; Michael, SF				Lok, Shee-Mei; Costin, Joshua M.; Hrobowski, YanceyM.; Hoffmann, Andrew R.; Rowe, Dawne K.; Kukkaro, Petra; Holdaway, Heather; Chipman, Paul; Fontaine, Krystal A.; Holbrook, Michael R.; Garry, Robert F.; Kostyuchenko, Victor; Wimley, William C.; Isern, Sharon; Rossmann, Michael G.; Michael, Scott F.			Release of Dengue Virus Genome Induced by a Peptide Inhibitor	PLOS ONE			English	Article							BORNE ENCEPHALITIS-VIRUS; ENVELOPE GLYCOPROTEIN; MEMBRANE-FUSION; LOW-PH; PROTEIN; BINDING; ENTRY; MAGAININ-2; RESOLUTION; INFECTION	Dengue virus infects approximately 100 million people annually, but there is no available therapeutic treatment. The mimetic peptide, DN59, consists of residues corresponding to the membrane interacting, amphipathic stem region of the dengue virus envelope (E) glycoprotein. This peptide is inhibitory to all four serotypes of dengue virus, as well as other flaviviruses. Cryo-electron microscopy image reconstruction of dengue virus particles incubated with DN59 showed that the virus particles were largely empty, concurrent with the formation of holes at the five-fold vertices. The release of RNA from the viral particle following incubation with DN59 was confirmed by increased sensitivity of the RNA genome to exogenous RNase and separation of the genome from the E protein in a tartrate density gradient. DN59 interacted strongly with synthetic lipid vesicles and caused membrane disruptions, but was found to be non-toxic to mammalian and insect cells. Thus DN59 inhibits flavivirus infectivity by interacting directly with virus particles resulting in release of the genomic RNA.	[Costin, Joshua M.; Hrobowski, YanceyM.; Rowe, Dawne K.; Fontaine, Krystal A.; Isern, Sharon; Michael, Scott F.] Florida Gulf Coast Univ, Dept Biol Sci, Ft Myers, FL 33965 USA; [Lok, Shee-Mei; Holdaway, Heather; Chipman, Paul; Rossmann, Michael G.] Purdue Univ, Dept Biol Sci, W Lafayette, IN 47907 USA; [Hrobowski, YanceyM.; Garry, Robert F.] Tulane Univ, Dept Microbiol & Immunol, Hlth Sci Ctr, New Orleans, LA 70118 USA; [Hrobowski, YanceyM.; Garry, Robert F.] Tulane Univ, Grad Program Cellular & Mol Biol, Hlth Sci Ctr, New Orleans, LA 70118 USA; [Hoffmann, Andrew R.; Wimley, William C.] Tulane Univ, Dept Biochem, Hlth Sci Ctr, New Orleans, LA 70118 USA; [Holbrook, Michael R.] Univ Texas Med Branch, Dept Pathol, Galveston, TX USA; [Lok, Shee-Mei; Kukkaro, Petra; Kostyuchenko, Victor] Natl Univ Singapore, Dept Biol Sci, Duke NUS, Singapore 117548, Singapore	State University System of Florida; Florida Gulf Coast University; Purdue University System; Purdue University; Purdue University West Lafayette Campus; Tulane University; Tulane University; Tulane University; University of Texas System; University of Texas Medical Branch Galveston; National University of Singapore	Michael, SF (corresponding author), Florida Gulf Coast Univ, Dept Biol Sci, Ft Myers, FL 33965 USA.	smichael@fgcu.edu	Holbrook, Michael/AAT-6865-2020	Holbrook, Michael/0000-0002-0824-2667; Chipman, Paul/0000-0003-3652-4087; Garry, Robert/0000-0002-5683-3250; Lok, Shee-Mei/0000-0003-4631-8041; Kostyuchenko, Victor/0000-0001-9751-307X	Defense Threat Reduction Agency [HDTRA1-08-1-0003, HDTRA1-09-1-0004, HDTRA1-10-1-0009]; National Institutes of Health [R01 AI76331, AI64617, GM60000]; NRF [R-913301-015-281]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI076331, R01AI104621, R56AI064617] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM060000] Funding Source: NIH RePORTER	Defense Threat Reduction Agency(United States Department of DefenseDefense Threat Reduction Agency); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NRF; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	The work was supported by Defense Threat Reduction Agency awards HDTRA1-08-1-0003, HDTRA1-09-1-0004, and HDTRA1-10-1-0009 to SI and SFM, by National Institutes of Health Grants R01 AI76331 to MGR, AI64617 to RFG and SFM, GM60000 to WCW, and by NRF fellowship award R-913301-015-281 to SML. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bothner B, 1998, J BIOL CHEM, V273, P673, DOI 10.1074/jbc.273.2.673; Bressanelli S, 2004, EMBO J, V23, P728, DOI 10.1038/sj.emboj.7600064; Champagne K, 2009, J BIOL CHEM, V284, P3619, DOI 10.1074/jbc.M809269200; Chutinimitkul S, 2005, J VIROL METHODS, V129, P8, DOI 10.1016/j.jviromet.2005.05.006; Costin JM, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000721; CRUCIANI RA, 1992, EUR J PHARM-MOLEC PH, V226, P287, DOI 10.1016/0922-4106(92)90045-W; Hrobowski YM, 2005, VIROL J, V2, DOI 10.1186/1743-422X-2-49; Johnson JE, 2003, ADV PROTEIN CHEM, V64, P197; Kuhn RJ, 2002, CELL, V108, P717, DOI 10.1016/S0092-8674(02)00660-8; Lalezari JP, 2003, NEW ENGL J MED, V348, P2175, DOI 10.1056/NEJMoa035026; Lewis JK, 1998, P NATL ACAD SCI USA, V95, P6774, DOI 10.1073/pnas.95.12.6774; Liao MF, 2005, J CELL BIOL, V171, P111, DOI 10.1083/jcb.200507075; Lok SM, 2008, NAT STRUCT MOL BIOL, V15, P312, DOI 10.1038/nsmb.1382; Ludtke SJ, 1999, J STRUCT BIOL, V128, P82, DOI 10.1006/jsbi.1999.4174; MATSUZAKI K, 1995, BIOCHEMISTRY-US, V34, P6521, DOI 10.1021/bi00019a033; Modis Y, 2003, P NATL ACAD SCI USA, V100, P6986, DOI 10.1073/pnas.0832193100; Modis Y, 2005, J VIROL, V79, P1223, DOI 10.1128/JVI.79.2.1223-1231.2005; Modis Y, 2004, NATURE, V427, P313, DOI 10.1038/nature02165; Nemesio H, 2011, BBA-BIOMEMBRANES, V1808, P2390, DOI 10.1016/j.bbamem.2011.06.019; Nicholson CO, 2011, ANTIVIR RES, V89, P71, DOI 10.1016/j.antiviral.2010.11.008; Pokidysheva E, 2006, CELL, V124, P485, DOI 10.1016/j.cell.2005.11.042; REY FA, 1995, NATURE, V375, P291, DOI 10.1038/375291a0; Schmidt AG, 2010, J VIROL, V84, P12549, DOI 10.1128/JVI.01440-10; Schmidt AG, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000851; Schott DH, 2005, P NATL ACAD SCI USA, V102, P18420, DOI 10.1073/pnas.0507123102; Shaikh TR, 2008, NAT PROTOC, V3, P1941, DOI 10.1038/nprot.2008.156; Stiasny K, 2002, J VIROL, V76, P3784, DOI 10.1128/JVI.76.8.3784-3790.2002; Thaisomboonsuk BK, 2005, AM J TROP MED HYG, V72, P375, DOI 10.4269/ajtmh.2005.72.375; Tigabu B, 2009, J MED VIROL, V81, P1261, DOI 10.1002/jmv.21524; van der Schaar HM, 2007, J VIROL, V81, P12019, DOI 10.1128/JVI.00300-07; van Heel M, 2005, J STRUCT BIOL, V151, P250, DOI 10.1016/j.jsb.2005.05.009; White SH, 1998, METHOD ENZYMOL, V295, P62; Zaitseva E, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001131; Zhang W, 2003, NAT STRUCT BIOL, V10, P907, DOI 10.1038/nsb990; Zhang Y, 2004, STRUCTURE, V12, P1607, DOI 10.1016/j.str.2004.06.019	35	53	54	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 30	2012	7	11							e50995	10.1371/journal.pone.0050995	http://dx.doi.org/10.1371/journal.pone.0050995			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	054WM	23226444	Green Published, Green Submitted, gold			2022-12-27	WOS:000312376100255
J	Oue, M; Handa, H; Matsuzaki, Y; Suzue, K; Murakami, H; Hirai, H				Oue, Miho; Handa, Hiroshi; Matsuzaki, Yasunori; Suzue, Kazutomo; Murakami, Hirokazu; Hirai, Hirokazu			The Murine Stem Cell Virus Promoter Drives Correlated Transgene Expression in the Leukocytes and Cerebellar Purkinje Cells of Transgenic Mice	PLOS ONE			English	Article							LENTIVIRAL VECTORS; GENE-EXPRESSION; RETROVIRAL VECTORS; TRANSDUCTION; METHYLATION	The murine stem cell virus (MSCV) promoter exhibits activity in mouse hematopoietic cells and embryonic stem cells. We generated transgenic mice that expressed enhanced green fluorescent protein (GFP) under the control of the MSCV promoter. We obtained 12 transgenic founder mice through 2 independent experiments and found that the bodies of 9 of the founder neonates emitted different levels of GFP fluorescence. Flow cytometric analysis of circulating leukocytes revealed that the frequency of GFP-labeled leukocytes among white blood cells ranged from 1.6% to 47.5% across the 12 transgenic mice. The bodies of 9 founder transgenic mice showed various levels of GFP expression. GFP fluorescence was consistently observed in the cerebellum, with faint or almost no fluorescence in other brain regions. In the cerebellum, 10 founders exhibited GFP expression in Purkinje cells at frequencies of 3% to 76%. Of these, 4 mice showed Purkinje cell-specific expression, while 4 and 2 mice expressed GFP in the Bergmann glia and endothelial cells, respectively. The intensity of the GFP fluorescence in the body was relative to the proportion of GFP-positive leukocytes. Moreover, the frequency of the GFP-expressing leukocytes was significantly correlated with the frequency of GFP-expressing Purkinje cells. These results suggest that the MSCV promoter is useful for preferentially expressing a transgene in Purkinje cells. In addition, the proportion of transduced leukocytes in the peripheral circulation reflects the expression level of the transgene in Purkinje cells, which can be used as a way to monitor transgene expression properties in the cerebellum without invasive techniques.	[Oue, Miho; Matsuzaki, Yasunori; Hirai, Hirokazu] Gunma Univ, Grad Sch Med, Dept Neurophysiol, Maebashi, Gunma 371, Japan; [Handa, Hiroshi] Gunma Univ, Grad Sch Med, Dept Med & Clin Sci, Maebashi, Gunma 371, Japan; [Suzue, Kazutomo] Gunma Univ, Grad Sch Med, Dept Parasitol, Maebashi, Gunma 371, Japan; [Murakami, Hirokazu] Gunma Univ, Grad Sch Med, Dept Lab Sci, Maebashi, Gunma 371, Japan	Gunma University; Gunma University; Gunma University; Gunma University	Hirai, H (corresponding author), Gunma Univ, Grad Sch Med, Dept Neurophysiol, Maebashi, Gunma 371, Japan.	hiraih@med.gunma-u.ac.jp	Hirai, Hirokazu/ABP-1143-2022	Hirai, Hirokazu/0000-0002-0721-4293; Suzue, Kazutomo/0000-0002-8959-5746	Funding Program for Next Generation World-leading Researchers [LS021]; Research on Measures for Intractable Diseases (Ataxic Diseases and Neurodegenerative Diseases) from the Ministry of Health, Labour and Welfare;  [19670003]	Funding Program for Next Generation World-leading Researchers(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Research on Measures for Intractable Diseases (Ataxic Diseases and Neurodegenerative Diseases) from the Ministry of Health, Labour and Welfare; 	Funding was provided by Grants-in-Aid Scientific Research (19670003), http://www.jsps.go.jp/english/index.html; The Funding Program for Next Generation World-leading Researchers (LS021), http://www.jsps.go.jp/j-jisedai/index.html; Research on Measures for Intractable Diseases (Ataxic Diseases and Neurodegenerative Diseases) from the Ministry of Health, Labour and Welfare, http://www.mhlw.go.jp/english/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Brown T, 2001, CURR PROTOC IMMUNOL, DOI [DOI 10.1002/0471142735.IM1006AS06, 10.1002/0471142735.im1006as06]; Choi JK, 2001, STEM CELLS, V19, P236, DOI 10.1634/stemcells.19-3-236; FEUER G, 1989, J VIROL, V63, P2317, DOI 10.1128/JVI.63.5.2317-2324.1989; Gatlin J, 2001, J VIROL, V75, P9995, DOI 10.1128/JVI.75.20.9995-9999.2001; GAUTSCH JW, 1983, NATURE, V301, P32, DOI 10.1038/301032a0; Goenawan H, 2012, J NEUROVIROL; GREZ M, 1990, P NATL ACAD SCI USA, V87, P9202, DOI 10.1073/pnas.87.23.9202; Hanawa H, 2004, BLOOD, V103, P4062, DOI 10.1182/blood-2004-01-0045; Hanawa H, 2002, MOL THER, V5, P242, DOI 10.1006/mthe.2002.0549; HAWLEY RG, 1994, ANN NY ACAD SCI, V716, P327, DOI 10.1111/j.1749-6632.1994.tb21724.x; Hirai H, 2000, J NEUROSCI, V20, P5217, DOI 10.1523/JNEUROSCI.20-14-05217.2000; Jones S, 2009, HUM GENE THER, V20, P630, DOI 10.1089/hum.2008.048; LOH TP, 1987, MOL CELL BIOL, V7, P3775, DOI 10.1128/MCB.7.10.3775; MILLER AD, 1992, CURR TOP MICROBIOL, V158, P1; MILLER AD, 1989, BIOTECHNIQUES, V7, P980; OBERDICK J, 1990, SCIENCE, V248, P223, DOI 10.1126/science.2109351; Osborne CS, 1999, J VIROL, V73, P5490, DOI 10.1128/JVI.73.7.5490-5496.1999; Ramezani A, 2000, MOL THER, V2, P458, DOI 10.1006/mthe.2000.0190; Sawada Y, 2010, CEREBELLUM, V9, P291, DOI 10.1007/s12311-010-0161-1; STEWART CL, 1982, P NATL ACAD SCI-BIOL, V79, P4098, DOI 10.1073/pnas.79.13.4098; Swindle CS, 2004, J BIOL CHEM, V279, P34, DOI 10.1074/jbc.M309128200; Takayama K, 2008, NEUROSCI LETT, V443, P7, DOI 10.1016/j.neulet.2008.07.058; Torashima T, 2006, BRAIN RES, V1082, P11, DOI 10.1016/j.brainres.2006.01.104; Torashima T, 2006, EUR J NEUROSCI, V24, P371, DOI 10.1111/j.1460-9568.2006.04927.x; Torashima T, 2009, EUR J NEUROSCI, V30, P355, DOI 10.1111/j.1460-9568.2009.06841.x; WEIHER H, 1987, J VIROL, V61, P2742, DOI 10.1128/JVI.61.9.2742-2746.1987	26	6	7	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 30	2012	7	11							e51015	10.1371/journal.pone.0051015	http://dx.doi.org/10.1371/journal.pone.0051015			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	054WM	23226450	Green Published, Green Submitted, gold			2022-12-27	WOS:000312376100261
J	Paganini, J; Campan-Fournier, A; Da Rocha, M; Gouret, P; Pontarotti, P; Wajnberg, E; Abad, P; Danchin, EGJ				Paganini, Julien; Campan-Fournier, Amandine; Da Rocha, Martine; Gouret, Philippe; Pontarotti, Pierre; Wajnberg, Eric; Abad, Pierre; Danchin, Etienne G. J.			Contribution of Lateral Gene Transfers to the Genome Composition and Parasitic Ability of Root-Knot Nematodes	PLOS ONE			English	Article							MELOIDOGYNE-INCOGNITA; HORIZONTAL TRANSFER; PECTATE LYASE; PROTEIN; BETA-1,4-ENDOGLUCANASE; EXPRESSION; SEQUENCE; ELEMENTS; CLONING; ORIGIN	Lateral gene transfers (LGT), species to species transmission of genes by means other than direct inheritance from a common ancestor, have played significant role in shaping prokaryotic genomes and are involved in gain or transfer of important biological processes. Whether LGT significantly contributed to the composition of an animal genome is currently unclear. In nematodes, multiple LGT are suspected to have favored emergence of plant-parasitism. With the availability of whole genome sequences it is now possible to assess whether LGT have significantly contributed to the composition of an animal genome and to establish a comprehensive list of these events. We generated clusters of homologous genes and automated phylogenetic inference, to detect LGT in the genomes of root-knot nematodes and found that up to 3.34% of the genes originate from LGT of non-metazoan origin. After their acquisition, the majority of genes underwent series of duplications. Compared to the rest of the genes in these species, several predicted functional categories showed a skewed distribution in the set of genes acquired via LGT. Interestingly, functions related to metabolism, degradation or modification of carbohydrates or proteins were substantially more frequent. This suggests that genes involved in these processes, related to a parasitic lifestyle, have been more frequently fixed in these parasites after their acquisition. Genes from soil bacteria, including plant-pathogens were the most frequent closest relatives, suggesting donors were preferentially bacteria from the rhizosphere. Several of these bacterial genes are plasmid-borne, pointing to a possible role of these mobile genetic elements in the transfer mechanism. Our analysis provides the first comprehensive description of the ensemble of genes of non-metazoan origin in an animal genome. Besides being involved in important processes regarding plant-parasitism, genes acquired via LGT now constitute a substantial proportion of protein-coding genes in these nematode genomes.	[Campan-Fournier, Amandine; Da Rocha, Martine; Wajnberg, Eric; Abad, Pierre; Danchin, Etienne G. J.] Inst Sophia Agrobiotech, Inst Natl Rech Agron, UMR ISA 1355, INRA, Sophia Antipolis, France; [Paganini, Julien; Gouret, Philippe; Pontarotti, Pierre] Aix Marseille Univ, Ctr Natl Rech Sci, LATP, UMR 7353, Marseille, France; [Campan-Fournier, Amandine; Da Rocha, Martine; Wajnberg, Eric; Abad, Pierre; Danchin, Etienne G. J.] CNRS, UMR ISA 7254, Inst Sophia Agrobiotech, Sophia Antipolis, France; [Campan-Fournier, Amandine; Da Rocha, Martine; Wajnberg, Eric; Abad, Pierre; Danchin, Etienne G. J.] Univ Nice Sophia Antipolis, Inst Sophia Agrobiotech, Sophia Antipolis, France	INRAE; UDICE-French Research Universities; Universite Cote d'Azur; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Aix-Marseille Universite; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Cote d'Azur; UDICE-French Research Universities; Universite Cote d'Azur	Danchin, EGJ (corresponding author), Inst Sophia Agrobiotech, Inst Natl Rech Agron, UMR ISA 1355, INRA, Sophia Antipolis, France.	etienne.danchin@sophia.inra.fr	, pontarotti/ABB-1753-2021; Danchin, Etienne G.J./A-6648-2008; Wajnberg, Eric/A-4862-2009; Danchin, Etienne GJ/X-6969-2019	Danchin, Etienne G.J./0000-0003-4146-5608; Wajnberg, Eric/0000-0002-6700-7114; Danchin, Etienne GJ/0000-0003-4146-5608; DA ROCHA, MARTINE/0000-0003-0959-2295; Pierre, Pontarotti/0000-0001-7202-3648	CNRS; ANR	CNRS(Centre National de la Recherche Scientifique (CNRS)); ANR(French National Research Agency (ANR))	This project received funding from the CNRS multidisciplinary program 'Maladies Infectieuses Emergentes'. JP's salary was funded by the CNRS multidisciplinary program 'Maladies Infectieuses Emergentes'. AC-F's salary was funded by the ANR program plant-genomics NEMATARGETS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abad P, 2008, NAT BIOTECHNOL, V26, P909, DOI 10.1038/nbt.1482; Agrios GN, 1997, PLANT PATHOLOGY PLAN, pxvi; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Bera-Maillet C, 2000, EUR J BIOCHEM, V267, P3255, DOI 10.1046/j.1432-1327.2000.01356.x; Bird DM, 2009, ANNU REV PHYTOPATHOL, V47, P333, DOI 10.1146/annurev-phyto-080508-081839; Blaxter M, 2007, CELL HOST MICROBE, V2, P211, DOI 10.1016/j.chom.2007.09.008; Brunet FG, 2006, MOL BIOL EVOL, V23, P1808, DOI 10.1093/molbev/msl049; Cantarel BL, 2009, NUCLEIC ACIDS RES, V37, pD233, DOI 10.1093/nar/gkn663; Danchin EGJ, 2011, MOBILE GENET ELEM, V1, P1; Danchin EGJ, 2012, FRONT CELL INFECT MI, V2, DOI 10.3389/fcimb.2012.00027; Danchin EGJ, 2010, P NATL ACAD SCI USA, V107, P17651, DOI 10.1073/pnas.1008486107; Doyle EA, 2002, MOL PLANT MICROBE IN, V15, P549, DOI 10.1094/MPMI.2002.15.6.549; Dunning Hotopp JC, 2011, TRENDS GENET; Finn RD, 2008, NUCLEIC ACIDS RES, V36, pD281, DOI 10.1093/nar/gkm960; Flutre T, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016526; Francino MP, 2005, NAT GENET, V37, P573, DOI 10.1038/ng1579; Gladyshev EA, 2008, SCIENCE, V320, P1210, DOI 10.1126/science.1156407; Gouret P, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-198; Gouret P, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-298; Haegeman A, 2011, MOL PLANT MICROBE IN, V24, P879, DOI 10.1094/MPMI-03-11-0055; Haegeman A, 2010, J MOL EVOL, V70, P441, DOI 10.1007/s00239-010-9343-1; Huang GZ, 2005, INT J PARASITOL, V35, P685, DOI 10.1016/j.ijpara.2005.01.006; Jaubert S, 2002, FEBS LETT, V522, P109, DOI 10.1016/S0014-5793(02)02906-X; Kikuchi T, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002219; Lambert KN, 1999, MOL PLANT MICROBE IN, V12, P328, DOI 10.1094/MPMI.1999.12.4.328; Ledger TN, 2006, GENE, V382, P121, DOI 10.1016/j.gene.2006.06.023; Leplae R, 2010, NUCLEIC ACIDS RES, V38, pD57, DOI 10.1093/nar/gkp938; Levasseur A, 2012, EVOL BIOINFORM, V8, P437, DOI 10.4137/EBO.S9186; Li L, 2003, GENOME RES, V13, P2178, DOI 10.1101/gr.1224503; Li WZ, 2006, BIOINFORMATICS, V22, P1658, DOI 10.1093/bioinformatics/btl158; Lipinski KJ, 2011, CURR BIOL, V21, P306, DOI 10.1016/j.cub.2011.01.026; Lynch M, 2000, SCIENCE, V290, P1151, DOI 10.1126/science.290.5494.1151; Mayer WE, 2011, BMC EVOL BIOL, V11, DOI 10.1186/1471-2148-11-13; Mitreva-Dautova M, 2006, MOL PLANT MICROBE IN, V19, P521, DOI 10.1094/MPMI-19-0521; Moran NA, 2010, SCIENCE, V328, P624, DOI 10.1126/science.1187113; Opperman CH, 2008, P NATL ACAD SCI USA, V105, P14802, DOI 10.1073/pnas.0805946105; Pace JK, 2008, P NATL ACAD SCI USA, V105, P17023, DOI 10.1073/pnas.0806548105; Paganini J, 2012, EVOL BIOINFORM, V8, P417, DOI 10.4137/EBO.S9179; Pierce SK, 2011, MOL BIOL EVOL; Rice P, 2000, TRENDS GENET, V16, P276, DOI 10.1016/S0168-9525(00)02024-2; Rodelsperger C, 2011, BMC EVOL BIOL, V11, DOI 10.1186/1471-2148-11-239; Rosso MN, 1999, MOL PLANT MICROBE IN, V12, P585, DOI 10.1094/MPMI.1999.12.7.585; Rosso MN, 2012, EFFECTORS PLANT MICR; Rumpho ME, 2008, P NATL ACAD SCI USA, V105, P17867, DOI 10.1073/pnas.0804968105; Schaack S, 2010, TRENDS ECOL EVOL, V25, P537, DOI 10.1016/j.tree.2010.06.001; Scholl EH, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-6-r39	46	45	47	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 30	2012	7	11							e50875	10.1371/journal.pone.0050875	http://dx.doi.org/10.1371/journal.pone.0050875			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	054WM	23226415	Green Published, gold, Green Submitted			2022-12-27	WOS:000312376100226
J	Ramstead, AG; Schepetkin, IA; Quinn, MT; Jutila, MA				Ramstead, Andrew G.; Schepetkin, Igor A.; Quinn, Mark T.; Jutila, Mark A.			Oenothein B, a Cyclic Dimeric Ellagitannin Isolated from Epilobium angustifolium, Enhances IFN gamma Production by Lymphocytes	PLOS ONE			English	Article							DELTA-T-CELLS; INTERFERON-GAMMA; IMMUNOTHERAPY; POLYPHENOLS; RECEPTOR; EXTRACT; TANNINS; TUBERCULOSIS; STIMULATION; ACTIVATION	Oenothein B is a polyphenol isolated from Epilobium angustifolium and other plant sources, which has been reported to exhibit immunomodulatory properties. Oenothein B is known to activate myeloid cells and induce the production of IL-1 and other cytokines. However, its effects on lymphocytes are unknown. In this report, we show that oenothein B stimulated innate lymphocytes, including bovine and human gamma delta T cells and NK cells, resulting in either increased CD25 and/or CD69 expression. We also demonstrate that oenothein B enhanced the production of interferon-gamma (IFN gamma) by bovine and human NK cells alone and in combination with interleukin-18 (IL-18), a response not observed with other commonly studied polyphenols. Furthermore, we demonstrate that oenothein B enhanced the production of IFN gamma by human T cells. Since IFN gamma contributes to antitumor, antibacterial, and antiviral cell responses, these data suggest an additional mechanism that could account, at least in part, for the immune enhancing properties of oenothein B.	[Ramstead, Andrew G.; Schepetkin, Igor A.; Quinn, Mark T.; Jutila, Mark A.] Montana State Univ, Dept Immunol & Infect Dis, Bozeman, MT 59717 USA	Montana State University System; Montana State University Bozeman	Jutila, MA (corresponding author), Montana State Univ, Dept Immunol & Infect Dis, Bozeman, MT 59717 USA.	uvsmj@montana.edu		Quinn, Mark/0000-0001-8114-5073	National Institutes of Health (NIH) [NCCAM AT0004986-01]; NIH COBRE [P20 RR020185, GM103500]; M.J. Murdock Charitable Trust; Montana State University Agricultural Experiment Station; NATIONAL CENTER FOR COMPLEMENTARY & ALTERNATIVE MEDICINE [P01AT004986] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR020185] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P20GM103500] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH COBRE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); M.J. Murdock Charitable Trust; Montana State University Agricultural Experiment Station; NATIONAL CENTER FOR COMPLEMENTARY & ALTERNATIVE MEDICINE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Complementary & Alternative Medicine); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This research was funded with grants from the National Institutes of Health (NIH) (NCCAM AT0004986-01), NIH COBRE (P20 RR020185 and GM103500), the M.J. Murdock Charitable Trust (www.murdock-trust.org), and The Montana State University Agricultural Experiment Station (http://ag.montana.edu/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akiyama H, 2005, FEBS LETT, V579, P4485, DOI 10.1016/j.febslet.2005.07.019; Allen AJ, 2011, VET IMMUNOL IMMUNOP, V141, P258, DOI 10.1016/j.vetimm.2011.03.014; BANCROFT GJ, 1991, IMMUNOL REV, V124, P5, DOI 10.1111/j.1600-065X.1991.tb00613.x; Bonneville M, 2006, CURR OPIN IMMUNOL, V18, P539, DOI 10.1016/j.coi.2006.07.002; Chipeta J, 1998, CELL IMMUNOL, V183, P149, DOI 10.1006/cimm.1998.1244; Costa LF, 2012, RES VET SCI, V93, P1, DOI 10.1016/j.rvsc.2012.03.002; Daughenbaugh KF, 2011, GENES IMMUN, V12, P378, DOI 10.1038/gene.2011.7; FUKUCHI K, 1989, ANTIVIR RES, V11, P285, DOI 10.1016/0166-3542(89)90038-7; Gao YF, 2003, J EXP MED, V198, P433, DOI 10.1084/jem.20030584; Gomes AQ, 2010, CANCER RES, V70, P10024, DOI 10.1158/0008-5472.CAN-10-3236; Graff JC, 2007, J LEUKOCYTE BIOL, V82, P603, DOI 10.1189/jlb.0207125; Graff JC, 2009, INT IMMUNOPHARMACOL, V9, P1313, DOI 10.1016/j.intimp.2009.07.015; Holderness J, 2007, J IMMUNOL, V179, P6468, DOI 10.4049/jimmunol.179.10.6468; Holderness J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017301; Holderness J, 2008, CRIT REV IMMUNOL, V28, P377, DOI 10.1615/CritRevImmunol.v28.i5.20; Hushmendy S, 2009, NUTR RES, V29, P568, DOI 10.1016/j.nutres.2009.08.003; Johnson WC, 2008, DEV COMP IMMUNOL, V32, P1002, DOI 10.1016/j.dci.2008.01.011; Kenna T, 2004, CLIN IMMUNOL, V113, P56, DOI 10.1016/j.clim.2004.05.003; Kiss A, 2006, PHYTOMEDICINE, V13, P284, DOI 10.1016/j.phymed.2004.08.002; Kiss AK, 2011, PHYTOMEDICINE, V18, P557, DOI 10.1016/j.phymed.2010.10.016; Korbel DS, 2005, J IMMUNOL, V175, P7466, DOI 10.4049/jimmunol.175.11.7466; Lambert JD, 2007, CHEM RES TOXICOL, V20, P583, DOI 10.1021/tx7000515; Lion E, 2009, J IMMUNOL METHODS, V350, P89, DOI 10.1016/j.jim.2009.08.014; Lockhart E, 2006, J IMMUNOL, V177, P4662, DOI 10.4049/jimmunol.177.7.4662; Levy EM, 2011, J BIOMED BIOTECHNOL, DOI 10.1155/2011/676198; MIYAMOTO K, 1993, JPN J CANCER RES, V84, P99, DOI 10.1111/j.1349-7006.1993.tb02790.x; Oliveira RA, 2010, J DAIRY SCI, V93, P4280, DOI 10.3168/jds.2010-3314; Percival SS, 2008, J NUTR, V138, P1; Robinson D, 1997, IMMUNITY, V7, P571, DOI 10.1016/S1074-7613(00)80378-7; Sakagami H, 2000, PHYTOMEDICINE, V7, P39, DOI 10.1016/S0944-7113(00)80020-3; Schepetkin IA, 2009, J IMMUNOL, V183, P6754, DOI 10.4049/jimmunol.0901827; Schmid D, 2012, J NAT PROD, V75, P870, DOI 10.1021/np200756f; Skyberg JA, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002587; Srivastava S, 2010, CURR MED CHEM, V17, P3353, DOI 10.2174/092986710793176348; Tannenbaum CS, 2000, SEMIN CANCER BIOL, V10, P113, DOI 10.1006/scbi.2000.0314; Thompson K, 2006, BLOOD, V107, P651, DOI 10.1182/blood-2005-03-1025; Van Rhijn I, 2008, MICROBES INFECT, V10, P711, DOI 10.1016/j.micinf.2008.04.005; Vesosky B, 2004, INFECT IMMUN, V72, P4612, DOI 10.1128/IAI.72.8.4612-4618.2004; VIRELIZIER JL, 1985, MED BIOL, V63, P149; Wen W, 2008, CANCER PREV RES, V1, P554, DOI 10.1158/1940-6207.CAPR-08-0040; WHEELOCK EF, 1965, SCIENCE, V149, P310, DOI 10.1126/science.149.3681.310; Wilson E, 1998, IMMUNOL LETT, V64, P39, DOI 10.1016/S0165-2478(98)00077-7; Wu SL, 2006, TRANSPL P, V38, P3052, DOI 10.1016/j.transproceed.2006.08.150; Yamanaka D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036025; Yoshida T, 2000, BIOFACTORS, V13, P121, DOI 10.1002/biof.5520130120	45	25	27	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 30	2012	7	11							e50546	10.1371/journal.pone.0050546	http://dx.doi.org/10.1371/journal.pone.0050546			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	054WM	23226309	Green Published, Green Submitted, gold			2022-12-27	WOS:000312376100121
J	Shi, Y; Tang, B; Yu, PW; Tang, B; Hao, YX; Lei, X; Luo, HX; Zeng, DZ				Shi, Yan; Tang, Bin; Yu, Pei-Wu; Tang, Bo; Hao, Ying-Xue; Lei, Xiao; Luo, Hua-Xing; Zeng, Dong-Zhu			Autophagy Protects against Oxaliplatin-Induced Cell Death via ER Stress and ROS in Caco-2 Cells	PLOS ONE			English	Article							COLORECTAL-CANCER; GENERATION; RESISTANCE; MECHANISMS; SURVIVAL; PATHWAYS; THERAPY	Oxaliplatin is included in a number of effective combination regimens used as first and subsequent lines of therapy for metastatic colorectal cancer. Accumulating evidence indicates that autophagy plays a significant role in response to cancer therapy. However, the role of autophagy in oxaliplatin-induced cell death remains to be clarified. In this study, we showed that oxaliplatin induced cell death and autophagy in Caco-2 colorectal cancer cells. The suppression of autophagy using either pharmacologic inhibitors (3-methyladenine, bafilomycin A1) or RNA interference in essential autophagy genes (ATG5 or Beclin1) enhanced the cell death and reactive oxygen species (ROS) production induced by oxaliplatin in Caco-2 cells. Blocking oxaliplatin-induced ROS production by using ROS scavengers (NAC or Tiron) decreased autophagy. Furthermore, numerous dilated endoplasmic reticula (ER) were present in oxaliplatin-treated Caco-2 cells, and blocking ER stress by RNA interference against candidate of metastasis-1 (P8) and C/EBP-homologous protein (CHOP) decreased autophagy and ROS production. Taken together, these data indicate that oxaliplatin activates autophagy as a cytoprotective response via ER stress and ROS in human colorectal cancer cells.	[Shi, Yan; Yu, Pei-Wu; Tang, Bo; Hao, Ying-Xue; Lei, Xiao; Luo, Hua-Xing; Zeng, Dong-Zhu] Third Mil Med Univ, Southwest Hosp, Dept Gen Surg, Chongqing, Peoples R China; [Shi, Yan; Yu, Pei-Wu; Tang, Bo; Hao, Ying-Xue; Lei, Xiao; Luo, Hua-Xing; Zeng, Dong-Zhu] Third Mil Med Univ, Southwest Hosp, Ctr Minimal Invas Gastrointestinal Surg, Chongqing, Peoples R China; [Tang, Bin] Third Mil Med Univ, Coll Med Lab Sci, Dept Clin Microbiol & Immunol, Chongqing, Peoples R China	Army Medical University; Army Medical University; Army Medical University	Yu, PW (corresponding author), Third Mil Med Univ, Southwest Hosp, Dept Gen Surg, Chongqing, Peoples R China.	yupeiwu01@vip.sina.com; zdz1140@yahoo.com.cn		Multhoff, Gabriele/0000-0002-2616-3137				Arango D, 2004, BRIT J CANCER, V91, P1931, DOI 10.1038/sj.bjc.6602215; Azad MB, 2009, ANTIOXID REDOX SIGN, V11, P777, DOI [10.1089/ars.2008.2270, 10.1089/ARS.2008.2270]; Bae YS, 2011, MOL CELLS, V32, P491, DOI 10.1007/s10059-011-0276-3; Cabello CM, 2007, CURR OPIN INVEST DR, V8, P1022; Chen N, 2011, CANCER BIOL THER, V11, P157, DOI 10.4161/cbt.11.2.14622; Chen YQ, 2010, CAN J PHYSIOL PHARM, V88, P285, DOI 10.1139/Y10-010; Ding ZB, 2011, CLIN CANCER RES, V17, P6229, DOI 10.1158/1078-0432.CCR-11-0816; Grothey A, 2010, ONCOLOGY-BASEL, V79, P389, DOI 10.1159/000323491; He CC, 2009, ANNU REV GENET, V43, P67, DOI 10.1146/annurev-genet-102808-114910; Hersey P, 2008, PIGM CELL MELANOMA R, V21, P358, DOI 10.1111/j.1755-148X.2008.00467.x; Hisamuddin Irfan M, 2004, MedGenMed, V6, P13; Hu C, 2012, TOXICOL LETT, V210, P78, DOI 10.1016/j.toxlet.2012.01.019; Huang J, 2011, ANTIOXID REDOX SIGN, V14, P2215, DOI 10.1089/ars.2010.3554; Klionsky DJ, 2008, AUTOPHAGY, V4, P151, DOI 10.4161/auto.5338; Kroemer G, 2007, PHYSIOL REV, V87, P99, DOI 10.1152/physrev.00013.2006; Kung CP, 2011, CRIT REV EUKAR GENE, V21, P71, DOI 10.1615/CritRevEukarGeneExpr.v21.i1.50; Lee J, 2012, BIOCHEM J, V441, P523, DOI 10.1042/BJ20111451; Levine B, 2008, CELL, V132, P27, DOI 10.1016/j.cell.2007.12.018; Li ZY, 2011, BIOCHEM BIOPH RES CO, V414, P5, DOI 10.1016/j.bbrc.2011.09.046; Mahoney E, 2012, BLOOD, V120, P1262, DOI 10.1182/blood-2011-12-400184; Marchetti P, 2004, ANTICANCER RES, V24, P219; Martins I, 2011, ONCOGENE, V30, P1147, DOI 10.1038/onc.2010.500; Mathew R, 2009, CELL, V137, P1062, DOI 10.1016/j.cell.2009.03.048; O'Connell JB, 2004, JNCI-J NATL CANCER I, V96, P1420, DOI 10.1093/jnci/djh275; Pardini B, 2012, MUTAGENESIS, V27, P161, DOI 10.1093/mutage/ger057; Santos CXC, 2009, ANTIOXID REDOX SIGN, V11, P2409, DOI 10.1089/ARS.2009.2625; Trachootham D, 2008, ANTIOXID REDOX SIGN, V10, P1343, DOI 10.1089/ars.2007.1957; White E, 2010, CURR OPIN CELL BIOL, V22, P212, DOI 10.1016/j.ceb.2009.12.008; Yokoyama T, 2008, GENE THER, V15, P1233, DOI 10.1038/gt.2008.98; Zhou S, 2012, CANC LETT	30	59	61	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 30	2012	7	11							e51076	10.1371/journal.pone.0051076	http://dx.doi.org/10.1371/journal.pone.0051076			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	054WM	23226467	Green Published, gold, Green Submitted			2022-12-27	WOS:000312376100278
J	Srivastava, K; Srivastava, A				Srivastava, Kshitij; Srivastava, Anvesha			Comprehensive Review of Genetic Association Studies and Meta-Analyses on miRNA Polymorphisms and Cancer Risk	PLOS ONE			English	Article							SQUAMOUS-CELL CARCINOMA; NORTH INDIAN POPULATION; MICRORNA-RELATED GENES; HEPATOCELLULAR-CARCINOMA; BREAST-CANCER; FUNCTIONAL POLYMORPHISM; CHINESE POPULATION; PRE-MICRORNAS; PROSTATE-CANCER; LUNG-CANCER	Background: MicroRNAs (miRNAs) are small RNA molecules that regulate the expression of corresponding messenger RNAs (mRNAs). Variations in the level of expression of distinct miRNAs have been observed in the genesis, progression and prognosis of multiple human malignancies. The present study was aimed to investigate the association between four highly studied miRNA polymorphisms (mir-146a rs2910164, mir-196a2 rs11614913, mir-149 rs2292832 and mir-499 rs3746444) and cancer risk by using a two-sided meta-analytic approach. Methods: An updated meta-analysis based on 53 independent case-control studies consisting of 27573 cancer cases and 34791 controls was performed. Odds ratio (OR) and 95% confidence interval (95% CI) were used to investigate the strength of the association. Results: Overall, the pooled analysis showed that mir-196a2 rs11614913 was associated with a decreased cancer risk (OR = 0.846, P = 0.004, TT vs. CC) while other miRNA SNPs showed no association with overall cancer risk. Subgroup analyses based on type of cancer and ethnicity were also performed, and results indicated that there was a strong association between miR-146a rs2910164 and overall cancer risk in Caucasian population under recessive model (OR = 1.274, 95% CI = 1.096-1.481, P = 0.002). Stratified analysis by cancer type also associated mir-196a2 rs11614913 with lung and colorectal cancer at allelic and genotypic level. Conclusions: The present meta-analysis suggests an important role of mir-196a2 rs11614913 polymorphism with overall cancer risk especially in Asian population. Further studies with large sample size are needed to evaluate and confirm this association.	[Srivastava, Kshitij] NHGRI, Med Genet Branch, NIH, Bethesda, MD 20892 USA; [Srivastava, Anvesha] Univ Dist Columbia, Dept Biol, Canc Res Lab, Washington, DC USA	National Institutes of Health (NIH) - USA; NIH National Human Genome Research Institute (NHGRI); University of the District of Columbia	Srivastava, K (corresponding author), NHGRI, Med Genet Branch, NIH, Bethesda, MD 20892 USA.	srivastavak@mail.nih.gov	Srivastava, Kshitij/AAB-4468-2021	Srivastava, Kshitij/0000-0002-3658-0815	National Human Genome Research Institute, National Institutes of Health (USA)	National Human Genome Research Institute, National Institutes of Health (USA)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))	This research was supported (in part) by the Intramural Research Program of the National Human Genome Research Institute, National Institutes of Health (USA). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding was received for this study.	Akkiz H, 2011, J VIRAL HEPATITIS, V18, pE399, DOI 10.1111/j.1365-2893.2010.01414.x; Akkiz H, 2011, GENE, V486, P104, DOI 10.1016/j.gene.2011.07.006; Ambros V, 2004, NATURE, V431, P350, DOI 10.1038/nature02871; Bae JS, 2012, DIGESTIVE LIVER DIS; Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Bhaumik D, 2008, ONCOGENE, V27, P5643, DOI 10.1038/onc.2008.171; Catucci I, 2010, HUM MUTAT, V31, pE1052, DOI 10.1002/humu.21141; Chen H, 2011, INTERN MED J; Christensen BC, 2010, CLIN CANCER RES, V16, P3713, DOI 10.1158/1078-0432.CCR-10-0657; Chu HY, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018108; Chu YH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039777; COCHRAN WG, 1954, BIOMETRICS, V10, P101, DOI 10.2307/3001666; DERSIMONIAN R, 1986, CONTROL CLIN TRIALS, V7, P177, DOI 10.1016/0197-2456(86)90046-2; Dou TH, 2010, J CANCER RES CLIN, V136, P1853, DOI 10.1007/s00432-010-0844-5; Esquela-Kerscher A, 2006, NAT REV CANCER, V6, P259, DOI 10.1038/nrc1840; Gao LB, 2011, BREAST CANCER RES TR, V125, P571, DOI 10.1007/s10549-010-0993-x; Garzon R, 2011, SEMIN ONCOL, V38, P721, DOI 10.1053/j.seminoncol.2011.08.008; Garzon R, 2010, NAT REV DRUG DISCOV, V9, P775, DOI 10.1038/nrd3179; George GP, 2011, MOL BIOL REP, V38, P1609, DOI 10.1007/s11033-010-0270-4; Greenland, 1998, MODERN EPIDEMIOLOGY, P47; Guo H, 2010, FAM CANCER, V9, P599, DOI 10.1007/s10689-010-9370-5; Guo J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030585; Hishida A, 2011, DIGEST DIS SCI, V56, P1131, DOI 10.1007/s10620-010-1376-1; Hoffman AE, 2009, CANCER RES, V69, P5970, DOI 10.1158/0008-5472.CAN-09-0236; Hong Young-Seoub, 2011, J Prev Med Public Health, V44, P125, DOI 10.3961/jpmph.2011.44.3.125; Horikawa Y, 2008, CLIN CANCER RES, V14, P7956, DOI 10.1158/1078-0432.CCR-08-1199; Hu ZB, 2008, J CLIN INVEST, V118, P2600, DOI 10.1172/JCI34934; Hu ZB, 2009, HUM MUTAT, V30, P79, DOI 10.1002/humu.20837; Hurst DR, 2009, CANCER RES, V69, P1279, DOI 10.1158/0008-5472.CAN-08-3559; Jazdzewski K, 2008, P NATL ACAD SCI USA, V105, P7269, DOI 10.1073/pnas.0802682105; Jedlinski DJ, 2011, TWIN RES HUM GENET, V14, P417, DOI 10.1375/twin.14.5.417; Jia Y, 2012, ONCOL REP; Kim MJ, 2010, LUNG CANCER, V69, P127, DOI 10.1016/j.lungcan.2010.04.015; Kim WH, 2012, GENE, V504, P92, DOI 10.1016/j.gene.2012.05.014; Lagos-Quintana M, 2002, CURR BIOL, V12, P735, DOI 10.1016/S0960-9822(02)00809-6; Li L, 2010, SCAND J IMMUNOL, V71, P227, DOI 10.1111/j.1365-3083.2010.02383.x; Li XD, 2010, PATHOLOGY, V42, P669, DOI 10.3109/00313025.2010.522175; Lian H, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031615; Lin SL, 2008, RNA, V14, P417, DOI 10.1261/rna.874808; Liu ZS, 2010, CANCER-AM CANCER SOC, V116, P4753, DOI 10.1002/cncr.25323; Lu J, 2005, NATURE, V435, P834, DOI 10.1038/nature03702; Lung R. W., 2012, MOL CARCINOGENESIS; MANTEL N, 1959, J NATL CANCER I, V22, P719; Mittal RD, 2011, DNA CELL BIOL, V30, P401, DOI 10.1089/dna.2010.1159; Okubo M, 2010, HELICOBACTER, V15, P524, DOI 10.1111/j.1523-5378.2010.00806.x; Pastrello C, 2010, CARCINOGENESIS, V31, P2124, DOI 10.1093/carcin/bgq184; Peng S, 2010, DIGEST DIS SCI, V55, P2288, DOI 10.1007/s10620-009-1007-x; Permuth-Wey J, 2011, J NEURO-ONCOL, V105, P639, DOI 10.1007/s11060-011-0634-1; Peters JL, 2006, JAMA-J AM MED ASSOC, V295, P676, DOI 10.1001/jama.295.6.676; Qi P, 2010, HUM IMMUNOL, V71, P621, DOI 10.1016/j.humimm.2010.02.017; Qiu LX, 2011, CYTOKINE, V56, P695, DOI 10.1016/j.cyto.2011.09.001; Qiu LX, 2011, CYTOKINE, V56, P589, DOI 10.1016/j.cyto.2011.08.019; Schuetz JM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031560; Smith RA, 2012, CANCER GENOM PROTEOM, V9, P115; Srivastava K, 2010, J HUM GENET, V55, P495, DOI 10.1038/jhg.2010.54; Sun QM, 2010, CANCER SCI, V101, P2241, DOI 10.1111/j.1349-7006.2010.01667.x; Thakkinstian A, 2005, STAT MED, V24, P1291, DOI 10.1002/sim.2010; Tian T, 2010, INT J MOL EPIDEMIOL, V1, P358; Tian T, 2009, CANCER EPIDEM BIOMAR, V18, P1183, DOI 10.1158/1055-9965.EPI-08-0814; Trikalinos TA, 2006, AM J EPIDEMIOL, V163, P300, DOI 10.1093/aje/kwj046; Vinci S, 2011, CLIN CHEM LAB MED; Vinci S, 2011, CLIN CHEM LAB MED, V49, P2073, DOI 10.1515/CCLM.2011.708; Volinia S, 2006, P NATL ACAD SCI USA, V103, P2257, DOI 10.1073/pnas.0510565103; Wang F, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039623; Wang F, 2012, MOL BIOL REP, V39, P269, DOI 10.1007/s11033-011-0735-0; Wang J, 2012, MOL BIOL REP, V39, P4571, DOI 10.1007/s11033-011-1247-7; Wang K, 2010, BIOMARKERS, V15, P614, DOI 10.3109/1354750X.2010.505299; Wiemer EAC, 2007, EUR J CANCER, V43, P1529, DOI 10.1016/j.ejca.2007.04.002; WOOLF B, 1955, ANN HUM GENET, V19, P251, DOI 10.1111/j.1469-1809.1955.tb01348.x; Xiang Y, 2012, MOL BIOL REP; Xu B, 2010, PROSTATE, V70, P467, DOI 10.1002/pros.21080; Xu T, 2008, CARCINOGENESIS, V29, P2126, DOI 10.1093/carcin/bgn195; Xu W, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020471; Xu Y, 2011, INT J CANCER, V128, P412, DOI 10.1002/ijc.25342; Yang HS, 2008, CANCER RES, V68, P2530, DOI 10.1158/0008-5472.CAN-07-5991; Yang RX, 2011, BREAST CANCER RES TR, V127, P549, DOI 10.1007/s10549-010-1244-x; Yang RX, 2010, BREAST CANCER RES TR, V121, P693, DOI 10.1007/s10549-009-0633-5; Ye YQ, 2008, CANCER PREV RES, V1, P460, DOI 10.1158/1940-6207.CAPR-08-0135; Yue C, 2011, GYNECOL ONCOL, V122, P33, DOI 10.1016/j.ygyno.2011.03.032; Zeng Y, 2010, WORLD J GASTROENTERO, V16, P3578, DOI 10.3748/wjg.v16.i28.3578; Zhan JF, 2011, ARCH MED RES, V42, P144, DOI 10.1016/j.arcmed.2011.04.001; Zhang Huan, 2012, Cancer Biology Medicine, V9, P63, DOI 10.3969/j.issn.2095-3941.2012.01.012; Zhang LS, 2011, DNA CELL BIOL; Zhang M, 2012, EUR J CANCER CARE, V21, P274, DOI 10.1111/j.1365-2354.2011.01308.x; Zhou B, 2011, MOL CARCINOGEN, V50, P499, DOI 10.1002/mc.20740; Zhou F, 2012, DNA CELL BIOL; Zhou J, 2011, DNA CELL BIOL; Zhou XY, 2010, GYNECOL ONCOL, V117, P287, DOI 10.1016/j.ygyno.2010.01.020; Zhu L, 2011, DNA CELL BIOL	90	97	99	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 30	2012	7	11							e50966	10.1371/journal.pone.0050966	http://dx.doi.org/10.1371/journal.pone.0050966			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	054WM	23226435	Green Submitted, Green Published, gold			2022-12-27	WOS:000312376100246
J	Tu, J; Lu, L; Cai, WS; Ballard, HJ				Tu, Jie; Lu, Lin; Cai, Weisong; Ballard, Heather J.			cAMP/Protein Kinase A Activates Cystic Fibrosis Transmembrane Conductance Regulator for ATP Release from Rat Skeletal Muscle during Low pH or Contractions	PLOS ONE			English	Article							INTERSTITIAL ATP; INTRACELLULAR PH; NOREPINEPHRINE CONCENTRATIONS; ADENYLYL CYCLASES; EXCHANGE ACTIVITY; SYSTEMIC HYPOXIA; GRACILIS MUSCLE; ADENOSINE; CFTR; EXERCISE	We have shown that cystic fibrosis transmembrane conductance regulator (CFTR) is involved in ATP release from skeletal muscle at low pH. These experiments investigate the signal transduction mechanism linking pH depression to CFTR activation and ATP release, and evaluate whether CFTR is involved in ATP release from contracting muscle. Lactic acid treatment elevated interstitial ATP of buffer-perfused muscle and extracellular ATP of L6 myocytes: this ATP release was abolished by the non-specific CFTR inhibitor, glibenclamide, or the specific CFTR inhibitor, CFTRinh-172, suggesting that CFTR was involved, and by inhibition of lactic acid entry to cells, indicating that intracellular pH depression was required. Muscle contractions significantly elevated interstitial ATP, but CFTRinh-172 abolished the increase. The cAMP/PKA pathway was involved in the signal transduction pathway for CFTR-regulated ATP release from muscle: forskolin increased CFTR phosphorylation and stimulated ATP release from muscle or myocytes; lactic acid increased intracellular cAMP, pCREB and PKA activity, whereas IBMX enhanced ATP release from myocytes. Inhibition of PKA with KT5720 abolished lactic-acid-or contraction-induced ATP release from muscle. Inhibition of either the Na+/H+-exchanger (NHE) with amiloride or the Na+/Ca2+-exchanger (NCX) with SN6 or KB-R7943 abolished lactic-acid-or contraction-induced release of ATP from muscle, suggesting that these exchange proteins may be involved in the activation of CFTR. Our data suggest that CFTR-regulated release contributes to ATP release from contracting muscle in vivo, and that cAMP and PKA are involved in the activation of CFTR during muscle contractions or acidosis; NHE and NCX may be involved in the signal transduction pathway.	[Tu, Jie; Lu, Lin; Cai, Weisong; Ballard, Heather J.] Univ Hong Kong, Dept Physiol, Pokfulam, Hong Kong, Peoples R China; [Tu, Jie] Chinese Acad Sci, Shenzhen Inst Adv Technol, Shenzhen Key Lab Neuropsychiat Modulat, Shenzhen, Guangdong, Peoples R China; [Lu, Lin; Cai, Weisong; Ballard, Heather J.] Univ Hong Kong, Inst Cardiovasc Sci & Med, Pokfulam, Hong Kong, Peoples R China	University of Hong Kong; Chinese Academy of Sciences; Shenzhen Institute of Advanced Technology, CAS; University of Hong Kong	Ballard, HJ (corresponding author), Univ Hong Kong, Dept Physiol, Pokfulam, Hong Kong, Peoples R China.	ballard@hkucc.hku.hk	Ballard, Heather Janet/C-4196-2009	Ballard, Heather Janet/0000-0002-5818-8443	Hong Kong Research Grants Council [10207994-14464-21400-323-01, 10400678-14464-21400-323-01, 10401287-14464-21400-323-01]; Li Ka Shing Foundation [2046-14464-21400-N01-01]; University of Hong Kong [21372567-14464-21400-N01-01]	Hong Kong Research Grants Council(Hong Kong Research Grants Council); Li Ka Shing Foundation; University of Hong Kong(University of Hong Kong)	This work was supported by the Hong Kong Research Grants Council Direct Allocation grant numbers 10207994-14464-21400-323-01, 10400678-14464-21400-323-01 and 10401287-14464-21400-323-01, the Li Ka Shing Foundation, grant number 2046-14464-21400-N01-01, and the University of Hong Kong, grant number 21372567-14464-21400-N01-01. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABRAHAM EH, 1993, P NATL ACAD SCI USA, V90, P312, DOI 10.1073/pnas.90.1.312; ACHIKE FI, 1993, J PHYSIOL-LONDON, V463, P107, DOI 10.1113/jphysiol.1993.sp019586; AICKIN CC, 1977, J PHYSIOL-LONDON, V273, P295, DOI 10.1113/jphysiol.1977.sp012095; ARONSON PS, 1982, NATURE, V299, P161, DOI 10.1038/299161a0; BALLARD HJ, 1987, J PHYSIOL-LONDON, V387, P401, DOI 10.1113/jphysiol.1987.sp016580; Braunstein GM, 2001, J BIOL CHEM, V276, P6621, DOI 10.1074/jbc.M005893200; Burnstock G, 2009, BRAZ J MED BIOL RES, V42, P3, DOI 10.1590/S0100-879X2008005000037; Cantiello HF, 1998, AM J PHYSIOL-CELL PH, V274, pC799, DOI 10.1152/ajpcell.1998.274.3.C799; CHALLISS RAJ, 1989, AM J PHYSIOL, V256, pE129, DOI 10.1152/ajpendo.1989.256.1.E129; CHANG XB, 1993, J BIOL CHEM, V268, P11304; Chen JH, 2009, J BIOL CHEM, V284, P35495, DOI 10.1074/jbc.M109.072678; Cheng B, 2000, J PHYSIOL-LONDON, V522, P467, DOI 10.1111/j.1469-7793.2000.t01-1-00467.x; Cifuentes F, 2000, AM J PHYSIOL-CELL PH, V279, pC89, DOI 10.1152/ajpcell.2000.279.1.C89; COOPER DMF, 1995, NATURE, V374, P421, DOI 10.1038/374421a0; Costa F, 2000, HYPERTENSION, V35, P1124, DOI 10.1161/01.HYP.35.5.1124; Deval E, 2002, CELL CALCIUM, V31, P37, DOI 10.1054/ceca.2001.0254; Ferreira JCB, 2010, EXP BIOL MED, V235, P497, DOI 10.1258/ebm.2009.009165; Fraysse B, 2001, AM J PHYSIOL-CELL PH, V280, pC146, DOI 10.1152/ajpcell.2001.280.1.C146; FRELIN C, 1984, J BIOL CHEM, V259, P8880; Germinario E, 2008, EUR J APPL PHYSIOL, V104, P445, DOI 10.1007/s00421-008-0796-5; GOSHIMA K, 1981, J MOL CELL CARDIOL, V13, P489, DOI 10.1016/0022-2828(81)90265-0; Hanoune J, 2001, ANNU REV PHARMACOL, V41, P145, DOI 10.1146/annurev.pharmtox.41.1.145; Hellsten Y, 1998, CIRCULATION, V98, P6, DOI 10.1161/01.CIR.98.1.6; Houslay MD, 2005, DRUG DISCOV TODAY, V10, P1503, DOI 10.1016/S1359-6446(05)03622-6; IMAI S, 1964, CIRC RES, V15, P443, DOI 10.1161/01.RES.15.5.443; Iwata Y, 2007, AM J PATHOL, V171, P1576, DOI 10.2353/ajpath.2007.070452; JUEL C, 1986, PFLUG ARCH EUR J PHY, V406, P458, DOI 10.1007/BF00583367; Karmazyn M, 1999, CIRC RES, V85, P777, DOI 10.1161/01.RES.85.9.777; KILLE JM, 1984, AM J PHYSIOL, V246, pH274, DOI 10.1152/ajpheart.1984.246.2.H274; Lader AS, 2000, AM J PHYSIOL-CELL PH, V279, pC173, DOI 10.1152/ajpcell.2000.279.1.C173; Lader AS, 2000, AM J PHYSIOL-CELL PH, V278, pC436, DOI 10.1152/ajpcell.2000.278.2.C436; Li JH, 2005, CIRCULATION, V111, P2748, DOI 10.1161/CIRCULATIONAHA.104.510669; Li JH, 2003, J APPL PHYSIOL, V95, P577, DOI 10.1152/japplphysiol.00185.2003; Li JH, 2002, AM J PHYSIOL-HEART C, V283, pH2636, DOI 10.1152/ajpheart.00395.2002; Lo SM, 2001, EXP PHYSIOL, V86, P593, DOI 10.1113/eph8602226; Lynge J, 2001, J PHYSIOL-LONDON, V537, P597, DOI 10.1111/j.1469-7793.2001.00597.x; Marcaida G, 1997, BRAIN RES PROTOC, V1, P75, DOI 10.1016/S1385-299X(96)00009-8; Melani A, 2005, NEUROCHEM INT, V47, P442, DOI 10.1016/j.neuint.2005.05.014; Mo FM, 2001, J PHYSIOL-LONDON, V536, P593, DOI 10.1111/j.1469-7793.2001.0593c.xd; Mo FM, 2000, LIFE SCI, V67, P227, DOI 10.1016/S0024-3205(00)00624-X; Mortensen SP, 2009, J APPL PHYSIOL, V107, P1757, DOI 10.1152/japplphysiol.00638.2009; Nishiyama A, 2000, CIRC RES, V86, P656, DOI 10.1161/01.RES.86.6.656; PITTMAN N, 1995, J BIOL CHEM, V270, P28848, DOI 10.1074/jbc.270.48.28848; PITTNER R, 1995, BBA-MOL CELL RES, V1267, P75, DOI 10.1016/0167-4889(95)00033-O; POUCHER SM, 1990, J PHYSIOL-LONDON, V427, P19, DOI 10.1113/jphysiol.1990.sp018158; Prat AG, 1996, AM J PHYSIOL-CELL PH, V270, pC538, DOI 10.1152/ajpcell.1996.270.2.C538; PROCTOR KG, 1984, AM J PHYSIOL, V247, pH195, DOI 10.1152/ajpheart.1984.247.2.H195; Reddy MM, 1996, SCIENCE, V271, P1876, DOI 10.1126/science.271.5257.1876; REISIN IL, 1994, J BIOL CHEM, V269, P20584; Riordan JR, 2008, ANNU REV BIOCHEM, V77, P701, DOI 10.1146/annurev.biochem.75.103004.142532; Rosenmeier JB, 2004, J PHYSIOL-LONDON, V558, P351, DOI 10.1113/jphysiol.2004.063107; Schwiebert EM, 1999, AM J PHYSIOL-CELL PH, V276, pC1, DOI 10.1152/ajpcell.1999.276.1.C1; SHOUBRIDGE EA, 1984, BIOCHIM BIOPHYS ACTA, V805, P72, DOI 10.1016/0167-4889(84)90038-7; Sprague RS, 1998, AM J PHYSIOL-HEART C, V275, pH1726, DOI 10.1152/ajpheart.1998.275.5.H1726; Sugita M, 1998, EMBO J, V17, P898, DOI 10.1093/emboj/17.4.898; Sunahara Roger K, 2002, Mol Interv, V2, P168, DOI 10.1124/mi.2.3.168; Takata S, 2001, ARCH PHYS MED REHAB, V82, P666, DOI 10.1053/apmr.2001.21942; Taylor AL, 1998, AM J PHYSIOL-CELL PH, V275, pC1391, DOI 10.1152/ajpcell.1998.275.5.C1391; Tresguerres M, 2011, KIDNEY INT, V79, P1277, DOI 10.1038/ki.2011.95; Tu J, 2010, J PHYSIOL-LONDON, V588, P4563, DOI 10.1113/jphysiol.2010.195255; Vuillaumier S, 1997, BIOCHEM J, V327, P651, DOI 10.1042/bj3270651; WESTERBLAD H, 1988, ACTA PHYSIOL SCAND, V133, P83, DOI 10.1111/j.1748-1716.1988.tb08383.x; Willoughby D, 2007, PHYSIOL REV, V87, P965, DOI 10.1152/physrev.00049.2006	63	12	17	2	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 30	2012	7	11							e50157	10.1371/journal.pone.0050157	http://dx.doi.org/10.1371/journal.pone.0050157			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	054WM	23226244	gold, Green Published, Green Submitted			2022-12-27	WOS:000312376100053
J	Setterbo, JJ; Chau, A; Fyhrie, PB; Hubbard, M; Upadhyaya, SK; Symons, JE; Stover, SM				Setterbo, Jacob J.; Chau, Anh; Fyhrie, Patricia B.; Hubbard, Mont; Upadhyaya, Shrini K.; Symons, Jennifer E.; Stover, Susan M.			Validation of a Laboratory Method for Evaluating Dynamic Properties of Reconstructed Equine Racetrack Surfaces	PLOS ONE			English	Article							WEATHER WAXED TRACK; CRUSHED SAND TRACK; HIGH-SPEED TROT; GALLOPING HORSES; HOOF; ACCELERATION; FORCES; DIRT	Background: Racetrack surface is a risk factor for racehorse injuries and fatalities. Current research indicates that race surface mechanical properties may be influenced by material composition, moisture content, temperature, and maintenance. Race surface mechanical testing in a controlled laboratory setting would allow for objective evaluation of dynamic properties of surface and factors that affect surface behavior. Objective: To develop a method for reconstruction of race surfaces in the laboratory and validate the method by comparison with racetrack measurements of dynamic surface properties. Methods: Track-testing device (TTD) impact tests were conducted to simulate equine hoof impact on dirt and synthetic race surfaces; tests were performed both in situ (racetrack) and using laboratory reconstructions of harvested surface materials. Clegg Hammer in situ measurements were used to guide surface reconstruction in the laboratory. Dynamic surface properties were compared between in situ and laboratory settings. Relationships between racetrack TTD and Clegg Hammer measurements were analyzed using stepwise multiple linear regression. Results: Most dynamic surface property setting differences (racetrack-laboratory) were small relative to surface material type differences (dirt-synthetic). Clegg Hammer measurements were more strongly correlated with TTD measurements on the synthetic surface than the dirt surface. On the dirt surface, Clegg Hammer decelerations were negatively correlated with TTD forces. Conclusions: Laboratory reconstruction of racetrack surfaces guided by Clegg Hammer measurements yielded TTD impact measurements similar to in situ values. The negative correlation between TTD and Clegg Hammer measurements confirms the importance of instrument mass when drawing conclusions from testing results. Lighter impact devices may be less appropriate for assessing dynamic surface properties compared to testing equipment designed to simulate hoof impact (TTD). Potential Relevance: Dynamic impact properties of race surfaces can be evaluated in a laboratory setting, allowing for further study of factors affecting surface behavior under controlled conditions.	[Chau, Anh; Stover, Susan M.] Univ Calif Davis, JD Wheat Vet Orthoped Res Lab, Davis, CA 95616 USA; [Setterbo, Jacob J.; Symons, Jennifer E.] Univ Calif Davis, Biomed Engn Grad Grp, Davis, CA 95616 USA; [Fyhrie, Patricia B.; Hubbard, Mont] Univ Calif Davis, Dept Mech & Aerosp Engn, Davis, CA 95616 USA; [Upadhyaya, Shrini K.] Univ Calif Davis, Dept Biol & Agr Engn, Davis, CA 95616 USA	University of California System; University of California Davis; University of California System; University of California Davis; University of California System; University of California Davis; University of California System; University of California Davis	Stover, SM (corresponding author), Univ Calif Davis, JD Wheat Vet Orthoped Res Lab, Davis, CA 95616 USA.	smstover@ucdavis.edu	, Mont/AAE-6718-2020	, Mont/0000-0001-8321-6576	University of California, Davis Dissertation Year Fellowship; Grayson-Jockey Club Research Foundation; Southern California Equine Foundation; Center for Equine Health; State of California pari-mutuel fund	University of California, Davis Dissertation Year Fellowship; Grayson-Jockey Club Research Foundation; Southern California Equine Foundation; Center for Equine Health; State of California pari-mutuel fund	Supported by a University of California, Davis Dissertation Year Fellowship and grants from the Grayson-Jockey Club Research Foundation (http://www.grayson-jockeyclub.org/), the Southern California Equine Foundation (http://www.scef-inc.com/), and the Center for Equine Health (http://www.vetmed.ucdavis.edu/ceh/) with funds provided by the State of California pari-mutuel fund and contributions by private donors. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2005, ASTM ANN BOOK STAND, P235; [Anonymous], 2007, ASTM ANN BOOK STAND, P1706; Arthur RM, 2010, AM ASS EQUINE PRACTI, P405; Bridge JW, 2010, THERMOCHIM ACTA, V498, P106, DOI 10.1016/j.tca.2009.10.009; Chateau H, 2009, EQUINE VET J, V41, P247, DOI 10.2746/042516409X394463; CHENEY JA, 1973, AM J VET RES, V34, P1285; Crevier-Denoix N, 2009, EQUINE VET J, V41, P257, DOI 10.2746/042516409X394445; Dimock AN, 2012, EQUINE VET J; Henwood K, 1969, THESIS U CALIFORNIA; Neylan J, 1997, REV DEVICES CURRENTL; NIGG BM, 1990, MED SCI SPORT EXER, V22, P131; Peterson ML, 2008, EQUINE VET J, V40, P602, DOI 10.2746/042516408X330347; Peterson ML, 2010, EQUINE VET J, V42, P351, DOI 10.1111/j.2042-3306.2010.00072.x; Ratzlaff MH, 2005, AM J VET RES, V66, P589, DOI 10.2460/ajvr.2005.66.589; Ratzlaff MH, 1997, J EQUINE VET SCI, V17, P35, DOI 10.1016/S0737-0806(97)80456-X; Robin D, 2009, EQUINE VET J, V41, P253, DOI 10.2746/042516409X397965; Setterbo JJ, 2011, SPORTS ENG, V14, P119, DOI 10.1007/s12283-011-0073-4; Setterbo JJ, 2009, AM J VET RES, V70, P1220, DOI 10.2460/ajvr.70.10.1220; Setterbo JJ, 2012, EQUINE VET J; Stover SM, 2003, CLIN TECH EQUINE PRA, V2, P312, DOI DOI 10.1053/J.CTEP.2004.04.003; Thomason JJ, 2008, VET CLIN N AM-EQUINE, V24, P53, DOI 10.1016/j.cveq.2007.11.007; Wong JY., 2001, THEORY GROUND VEHICL	22	5	5	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 5	2012	7	12							e50534	10.1371/journal.pone.0050534	http://dx.doi.org/10.1371/journal.pone.0050534			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	057TZ	23227183	Green Published, gold, Green Submitted			2022-12-27	WOS:000312588200043
J	Vyazovskiy, VV; Tobler, I				Vyazovskiy, Vladyslav V.; Tobler, Irene			The Temporal Structure of Behaviour and Sleep Homeostasis	PLOS ONE			English	Article							REM-SLEEP; BIOCHEMICAL REGULATION; ULTRADIAN RHYTHMS; TIME-COURSE; RAT; EEG; DEPRIVATION; WAKING; MICE; WAKEFULNESS	The amount and architecture of vigilance states are governed by two distinct processes, which occur at different time scales. The first, a slow one, is related to a wake/sleep dependent homeostatic Process S, which occurs on a time scale of hours, and is reflected in the dynamics of NREM sleep EEG slow-wave activity. The second, a fast one, is manifested in a regular alternation of two sleep states - NREM and REM sleep, which occur, in rodents, on a time scale of similar to 5-10 minutes. Neither the mechanisms underlying the time constants of these two processes - the slow one and the fast one, nor their functional significance are understood. Notably, both processes are primarily apparent during sleep, while their potential manifestation during wakefulness is obscured by ongoing behaviour. Here, we find, in mice provided with running wheels, that the two sleep processes become clearly apparent also during waking at the level of behavior and brain activity. Specifically, the slow process was manifested in the total duration of waking periods starting from dark onset, while the fast process was apparent in a regular occurrence of running bouts during the waking periods. The dynamics of both processes were stable within individual animals, but showed large interindividual variability. Importantly, the two processes were not independent: the periodic structure of waking behaviour (fast process) appeared to be a strong predictor of the capacity to sustain continuous wakefulness (slow process). The data indicate that the temporal organization of vigilance states on both the fast and the slow time scales may arise from a common neurophysiologic mechanism.	[Vyazovskiy, Vladyslav V.; Tobler, Irene] Univ Zurich, Inst Pharmacol & Toxicol, Zurich, Switzerland; [Vyazovskiy, Vladyslav V.] Univ Surrey, Dept Biochem & Physiol, Guildford GU2 5XH, Surrey, England	University of Zurich; University of Surrey	Vyazovskiy, VV (corresponding author), Univ Zurich, Inst Pharmacol & Toxicol, Zurich, Switzerland.	vyazovskiy@gmail.com		Vyazovskiy, Vladyslav/0000-0002-4336-6681	Swiss National Science Foundation [3100-053005.97, 3100A0-100567]	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission)	The study was supported by the Swiss National Science Foundation grants 3100-053005.97 and 3100A0-100567. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Achermann P, 2003, FRONT BIOSCI-LANDMRK, V8, pS683, DOI 10.2741/1064; Aeschbach D, 1996, AM J PHYSIOL-REG I, V270, pR41, DOI 10.1152/ajpregu.1996.270.1.R41; [Anonymous], 2005, PRINCIPLES PRACTICE; Bassi A, 2009, SLEEP, V32, P655, DOI 10.1093/sleep/32.5.655; BENINGTON JH, 1994, AM J PHYSIOL, V266, pR1992, DOI 10.1152/ajpregu.1994.266.6.R1992; Borbely A. A., 2005, PRINCIPLES PRACTICE, P405; Cirelli C, 2008, PLOS BIOL, V6, P1605, DOI 10.1371/journal.pbio.0060216; Clinton JM, 2011, J CLIN SLEEP MED, V7, pS38, DOI 10.5664/JCSM.1360; CONTE S, 1994, PHYSIOL BEHAV, V55, P287, DOI 10.1016/0031-9384(94)90135-X; Endo T, 1998, AM J PHYSIOL-REG I, V274, pR1186, DOI 10.1152/ajpregu.1998.274.4.R1186; Endo T, 1997, PSYCHIAT RES, V66, P97, DOI 10.1016/S0165-1781(96)03029-6; Franken P, 2002, J SLEEP RES, V11, P17, DOI 10.1046/j.1365-2869.2002.00275.x; FRANKEN P, 1991, AM J PHYSIOL, V261, pR198, DOI 10.1152/ajpregu.1991.261.1.R198; FRANKEN P, 1991, NEUROSCI LETT, V130, P141, DOI 10.1016/0304-3940(91)90382-4; Franken P, 2001, J NEUROSCI, V21, P2610, DOI 10.1523/JNEUROSCI.21-08-02610.2001; HOBSON JA, 1975, SCIENCE, V189, P55, DOI 10.1126/science.1094539; Huber R, 2000, BRAIN RES, V857, P8, DOI 10.1016/S0006-8993(99)02248-9; Huber R, 2007, SLEEP, V30, P129, DOI 10.1093/sleep/30.2.129; Jones BE, 2005, TRENDS PHARMACOL SCI, V26, P578, DOI 10.1016/j.tips.2005.09.009; Krueger JM, 2008, NAT REV NEUROSCI, V9, P910, DOI 10.1038/nrn2521; Leemburg S, 2010, P NATL ACAD SCI USA, V107, P15939, DOI 10.1073/pnas.1002570107; Lo CC, 2004, P NATL ACAD SCI USA, V101, P17545, DOI 10.1073/pnas.0408242101; MAZZUCCHELLI A, 1995, BEHAV BRAIN RES, V67, P81, DOI 10.1016/0166-4328(94)00107-Q; MCCORMICK DA, 1992, J CLIN NEUROPHYSIOL, V9, P212, DOI 10.1097/00004691-199204010-00004; Mignot E, 2008, PLOS BIOL, V6, P661, DOI 10.1371/journal.pbio.0060106; Obal F, 2003, FRONT BIOSCI-LANDMRK, V8, pD520, DOI 10.2741/1033; OTHMER E, 1969, SCIENCE, V164, P447, DOI 10.1126/science.164.3878.447; Paxinos G., 2001, MOUSE BRAIN STEREOTA; Petit JM, 2002, EUR J NEUROSCI, V16, P1163, DOI 10.1046/j.1460-9568.2002.02145.x; Porkka-Heiskanen T, 1997, SCIENCE, V276, P1265, DOI 10.1126/science.276.5316.1265; Rusterholz T, 2010, SLEEP, V33, P491, DOI 10.1093/sleep/33.4.491; Saper CB, 2010, NEURON, V68, P1023, DOI 10.1016/j.neuron.2010.11.032; TOBLER I, 1986, ELECTROEN CLIN NEURO, V64, P74, DOI 10.1016/0013-4694(86)90044-1; Tononi G, 2006, SLEEP MED REV, V10, P49, DOI 10.1016/j.smrv.2005.05.002; TRACHSEL L, 1991, PHYSIOL BEHAV, V49, P575, DOI 10.1016/0031-9384(91)90283-T; Van Dongen HPA, 2005, SLEEP, V28, P479, DOI 10.1093/sleep/28.4.479; Vyazovskiy V, 2000, J SLEEP RES, V9, P367, DOI 10.1046/j.1365-2869.2000.00230.x; Vyazovskiy V, 2007, BRAIN RES BULL, V74, P37, DOI 10.1016/j.brainresbull.2007.05.001; Vyazovskiy VV, 2006, J NEUROENDOCRINOL, V18, P567, DOI 10.1111/j.1365-2826.2006.01452.x; Vyazovskiy VV, 2011, PROG BRAIN RES, V193, P17, DOI 10.1016/B978-0-444-53839-0.00002-8; Vyazovskiy VV, 2011, NATURE, V472, P443, DOI 10.1038/nature10009; Vyazovskiy VV, 2006, CEREB CORTEX, V16, P328, DOI 10.1093/cercorbhi110; Vyazovskiy VV, 2005, BRAIN RES, V1050, P64, DOI 10.1016/j.brainres.2005.05.022	43	21	22	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 5	2012	7	12							e50677	10.1371/journal.pone.0050677	http://dx.doi.org/10.1371/journal.pone.0050677			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	057TZ	23227197	Green Submitted, gold, Green Published			2022-12-27	WOS:000312588200056
J	Walsh, BH; Broadhurst, DI; Mandal, R; Wishart, DS; Boylan, GB; Kenny, LC; Murray, DM				Walsh, Brian H.; Broadhurst, David I.; Mandal, Rupasri; Wishart, David S.; Boylan, Geraldine B.; Kenny, Louise C.; Murray, Deirdre M.			The Metabolomic Profile of Umbilical Cord Blood in Neonatal Hypoxic Ischaemic Encephalopathy	PLOS ONE			English	Article							CEREBRAL FUNCTION MONITOR; PERINATAL ASPHYXIA; CARNITINE LEVELS; PROGNOSTIC VALUE; NEWBORN-INFANTS; BRAIN-INJURY; EEG; SERUM; SPECTROSCOPY; PROTEIN	Background: Hypoxic ischaemic encephalopathy (HIE) in newborns can cause significant long-term neurological disability. The insult is a complex injury characterised by energy failure and disruption of cellular homeostasis, leading to mitochondrial damage. The importance of individual metabolic pathways, and their interaction in the disease process is not fully understood. The aim of this study was to describe and quantify the metabolomic profile of umbilical cord blood samples in a carefully defined population of full-term infants with HIE. Methods and Findings: The injury severity was defined using both the modified Sarnat score and continuous multichannel electroencephalogram. Using these classification systems, our population was divided into those with confirmed HIE (n = 31), asphyxiated infants without encephalopathy (n = 40) and matched controls (n = 71). All had umbilical cord blood drawn and biobanked at -80 degrees C within 3 hours of delivery. A combined direct injection and LC-MS/MS assay (AbsolutIDQ p180 kit, Biocrates Life Sciences AG, Innsbruck, Austria) was used for the metabolomic analyses of the samples. Targeted metabolomic analysis showed a significant alteration between study groups in 29 metabolites from 3 distinct classes (Amino Acids, Acylcarnitines, and Glycerophospholipids). 9 of these metabolites were only significantly altered between neonates with Hypoxic ischaemic encephalopathy and matched controls, while 14 were significantly altered in both study groups. Multivariate Discriminant Analysis models developed showed clear multifactorial metabolite associations with both asphyxia and HIE. A logistic regression model using 5 metabolites clearly delineates severity of asphyxia and classifies HIE infants with AUC = 0.92. These data describe wide-spread disruption to not only energy pathways, but also nitrogen and lipid metabolism in both asphyxia and HIE. Conclusion: This study shows that a multi-platform targeted approach to metabolomic analyses using accurately phenotyped and meticulously biobanked samples provides insight into the pathogenesis of perinatal asphyxia. It highlights the potential for metabolomic technology to develop a diagnostic test for HIE.	[Walsh, Brian H.; Boylan, Geraldine B.; Murray, Deirdre M.] Cork Univ, Matern Hosp, Dept Paediat & Child Hlth, Neonatal Brain Res Grp, Cork, Ireland; [Broadhurst, David I.] Univ Alberta, Dept Med, Edmonton, AB, Canada; [Mandal, Rupasri; Wishart, David S.] Univ Alberta, Dept Biol, Edmonton, AB, Canada; [Mandal, Rupasri; Wishart, David S.] Univ Alberta, Dept Comp Sci, Edmonton, AB, Canada; [Kenny, Louise C.] Natl Univ Ireland Univ Coll Cork, Dept Obstet & Gynaecol, Cork, Ireland	University College Cork; University of Alberta; University of Alberta; University of Alberta; University College Cork	Walsh, BH (corresponding author), Cork Univ, Matern Hosp, Dept Paediat & Child Hlth, Neonatal Brain Res Grp, Cork, Ireland.	Bh.walsh@ucc.ie	Walsh, Brian/AAA-6421-2020; Kenny, Louise/X-6329-2019; Walsh, Brian/HGA-7649-2022; Kenny, Louise C/G-1112-2011; Wishart, David Scott/ABI-3181-2020	Kenny, Louise/0000-0002-9011-759X; Walsh, Brian/0000-0003-4665-6884; Kenny, Louise C/0000-0002-9011-759X; Murray, Deirdre/0000-0002-2201-9912; Boylan, Geraldine/0000-0003-0920-5291; Wishart, David S/0000-0002-3207-2434; Broadhurst, David/0000-0003-0775-9581	Molecular Medicine Ireland [PRTLI cycle 4 of the Higher Education Authority of Ireland]; National Children's Research Centre, Dublin, Ireland [NCT01498965]; Wellcome Trust [085249/Z/08/Z]; Health Research Board [CSA/2007/2]; Science Foundation Ireland [08/IN.1/B2083]	Molecular Medicine Ireland [PRTLI cycle 4 of the Higher Education Authority of Ireland]; National Children's Research Centre, Dublin, Ireland; Wellcome Trust(Wellcome TrustEuropean Commission); Health Research Board; Science Foundation Ireland(Science Foundation IrelandEuropean Commission)	This work was supported by Molecular Medicine Ireland [PRTLI cycle 4 of the Higher Education Authority of Ireland to BW]; the National Children's Research Centre, Dublin, Ireland [www.baselinestudy.net, www.clinicaltrials.gov NCT01498965: DM, and LK]; the Wellcome Trust [grant number 085249/Z/08/Z to GB]; Health Research Board [grant number CSA/2007/2 to LK]; Science Foundation Ireland [grant number 08/IN.1/B2083 to LK]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amiel-Tison C, 2002, PEDIATR NEUROL, V27, P196, DOI 10.1016/S0887-8994(02)00436-8; Atzori L, 2010, J MATERN-FETAL NEO M, V23, P134, DOI 10.3109/14767058.2010.517033; Azzopardi DV, 2009, NEW ENGL J MED, V361, P1349, DOI 10.1056/NEJMoa0900854; Barkovich AJ, 2006, AM J NEURORADIOL, V27, P533; Bayes R, 2001, EARLY HUM DEV, V65, pS103, DOI 10.1016/S0378-3782(01)00212-2; Beckstrom AC, 2011, J CHROMATOGR A, V1218, P1899, DOI 10.1016/j.chroma.2011.01.086; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Berg JM, 2002, BIOCHEMISTRY-US, V5th; Boylan GB, 2010, ACTA PAEDIATR, V99, P1150, DOI 10.1111/j.1651-2227.2010.01809.x; Cam H, 2005, J TROP PEDIATRICS, V51, P106, DOI 10.1093/tropej/fmh089; Chong IG, 2005, CHEMOMETR INTELL LAB, V78, P103, DOI 10.1016/j.chemolab.2004.12.011; Chu CY, 2006, CLIN BIOCHEM, V39, P203, DOI 10.1016/j.clinbiochem.2006.01.006; Dunn WB, 2011, CHEM SOC REV, V40, P387, DOI 10.1039/b906712b; ED Deigner H, 2010, ESPACENENT; El-Ayouty M, 2007, AM J PERINAT, V24, P467, DOI 10.1055/s-2007-986686; Engidawork E, 1997, EXP NEUROL, V145, P390, DOI 10.1006/exnr.1997.6482; Eriksson L., 2001, MULTI MEGAVARIATE DA; Ezgu FS, 2004, NUTR NEUROSCI, V7, P351, DOI 10.1080/10284150400017280; Fatemi A, 2009, CLIN PERINATOL, V36, P835, DOI 10.1016/j.clp.2009.07.011; Helton E, 2000, PEDIATRICS, V105, P1260; HOLMES G, 1982, ELECTROEN CLIN NEURO, V53, P60, DOI 10.1016/0013-4694(82)90106-7; Hosmer DW, 2000, APPL LOGISTIC REGRES, DOI 10.1002/0471722146; Huang CC, 1999, NEW ENGL J MED, V341, P328, DOI 10.1056/NEJM199907293410504; Kaukola T, 2004, ANN NEUROL, V55, P186, DOI 10.1002/ana.10809; Krzanowski W. J., 1988, PRINCIPLES MULTIVARI; Kumar A, 2008, PEDIATRICS, V122, pE722, DOI 10.1542/peds.2008-0269; Laforgia N, 2001, ACTA PAEDIATR, V90, P351, DOI 10.1080/080352501300067811; Lawn JE, 2005, LANCET, V365, P891, DOI 10.1016/S0140-6736(05)71048-5; LEMONS JA, 1976, J CLIN INVEST, V58, P1428, DOI 10.1172/JCI108598; LEVENE MI, 1986, LANCET, V1, P67, DOI 10.1016/S0140-6736(86)90718-X; Liu J, 2011, J CEREBR BLOOD F MET, V31, P547, DOI 10.1038/jcbfm.2010.125; LOREK A, 1994, PEDIATR RES, V36, P699, DOI 10.1203/00006450-199412000-00003; MartinAncel A, 1997, PEDIATRICS, V100, P789, DOI 10.1542/peds.100.5.789; Meyburg J, 2001, PEDIATR RES, V49, P125, DOI 10.1203/00006450-200101000-00024; Murray DM, 2008, ARCH DIS CHILD-FETAL, V93, pF183, DOI 10.1136/adc.2006.100800; Murray DM, 2006, PEDIATRICS, V118, P41, DOI 10.1542/peds.2005-1524; Murray DM, 2009, PEDIATRICS, V124, pE459, DOI 10.1542/peds.2008-2190; Nagdyman N, 2003, PEDIATR RES, V54, P270, DOI 10.1203/01.PDR.0000072518.98189.A0; Pepe MS, 2004, STAT EVALUATION MED; Perlman JM, 2004, SEMIN PERINATOL, V28, P415, DOI 10.1053/j.semperi.2004.10.003; Pressler RM, 2001, CLIN NEUROPHYSIOL, V112, P31, DOI 10.1016/S1388-2457(00)00517-4; Rennie JM, 2004, ARCH DIS CHILD-FETAL, V89, pF37, DOI 10.1136/fn.89.1.F37; ROBERTSON CMT, 1993, CLIN PERINATOL, V20, P483, DOI 10.1016/S0095-5108(18)30405-6; Roth SC, 1997, DEV MED CHILD NEUROL, V39, P718; SARNAT HB, 1976, ARCH NEUROL-CHICAGO, V33, P696, DOI 10.1001/archneur.1976.00500100030012; Signorini C, 2008, PEDIATR RES, V63, P287, DOI 10.1203/PDR.0b013e318163a1fd; Solberg R, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009606; SOLTESZ G, 1978, PEDIATRICS, V61, P77; Speed TP, 2003, STAT ANAL GENE EXPRE, Vxiii; Sunagawa S, 2009, BRAIN DEV-JPN, V31, P588, DOI 10.1016/j.braindev.2008.09.001; Tekgul H, 2004, PEDIATR NEUROL, V31, P326, DOI 10.1016/j.pediatrneurol.2004.05.004; THORNBERG E, 1995, ARCH DIS CHILD-FETAL, V72, pF39, DOI 10.1136/fn.72.1.F39; Thorngren-Jerneck K, 2004, PEDIATR RES, V55, P406, DOI 10.1203/01.PDR.0000106806.75086.D3; Trollmann R, 2002, EUR J ENDOCRINOL, V147, P711, DOI 10.1530/eje.0.1470711; van den Berg RA, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-142; van Walsum AMV, 2001, PEDIATR RES, V49, P698; VANLIESHOUT HBM, 1995, ACTA NEUROL SCAND, V91, P203; Volpe JJ., 2001, NEUROLOGY NEWBORN, V4; Wainwright MS, 2006, STROKE, V37, P524, DOI 10.1161/01.STR.0000198892.15269.f7; Wainwright MS, 2003, PEDIATR RES, V54, P688, DOI 10.1203/01.PDR.0000085036.07561.9C; Westerhuis JA, 2008, METABOLOMICS, V4, P81, DOI 10.1007/s11306-007-0099-6; White CR, 2012, J MATERN FETAL NEONA; WHITMER JT, 1978, J BIOL CHEM, V253, P4305; Wold S, 2001, CHEMOMETR INTELL LAB, V58, P131, DOI 10.1016/S0169-7439(01)00156-3	65	72	73	1	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 5	2012	7	12							e50520	10.1371/journal.pone.0050520	http://dx.doi.org/10.1371/journal.pone.0050520			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	057TZ	23227182	Green Published, Green Submitted, gold			2022-12-27	WOS:000312588200042
J	He, JQ; Chan-Yeung, M; Carlsten, C				He, Jian-Qing; Chan-Yeung, Moira; Carlsten, Chris			Airway Hyperresponsiveness and Quality of Life in Western Red Cedar Asthmatics Removed from Exposure	PLOS ONE			English	Article							BRONCHIAL HYPERRESPONSIVENESS; OCCUPATIONAL ASTHMA; PC20 EXTRAPOLATION; THUJA-PLICATA; HEALTH SURVEY; REACTIVITY; SF-36; AGE; HISTAMINE; SEVERITY	Objectives: Most western red cedar asthmatics (WRCA) continue to have symptoms even after removal from exposure. Consequently, health-related quality of life (HRQL) is often impaired. The objective of this study was to evaluate the relationship between two measures of AHR and HRQL scores in those with WRCA. Methods: HRQL was determined by the short form 36 (SF-36) in 46 male, non-smoking individuals with WRCA removed from exposure to western red cedar, on average, 15 years earlier. The relationships between the SF-36 total score and its eight domains with 2 indices from methacholine-stimulated airway hyperresponsiveness (the provocative concentration of methacholine causing a 20% fall in FEV1 [PC20] and bronchial reactivity index [BRI]) were analyzed by the Pearson correlation and multiple linear regression. Results: PC20 was significantly correlated with the SF-36 total score and its two domains of bodily pain and general health (r = 0.34, 0.40, 0.40, p = 0.023, 0.006, 0.006, respectively). BRI was significantly correlated with bodily pain and general health (r = -0.35, -0.42, p = 0.017, 0.004, respectively); correlations remain significant after adjusting for age, ethnicity, years since diagnosis, years since last exposure and use of inhaled corticosteroid. BRI and other measures of airway responsiveness were not associated with inhaled corticosteroids use. Conclusions: In Western red cedar asthmatics removed from exposure, measures of airway responsiveness are associated with HRQL. Citation: He J-Q, Chan-Yeung M, Carlsten C (2012) Airway Hyperresponsiveness and Quality of Life in Western Red Cedar Asthmatics Removed from Exposure. PLoS ONE 7(12): e50774. doi:10.1371/journal.pone.0050774	[He, Jian-Qing] Sichuan Univ, Dept Resp Med, W China Hosp, W China Med Sch, Chengdu 610064, Peoples R China; [He, Jian-Qing; Chan-Yeung, Moira; Carlsten, Chris] Univ British Columbia, Dept Med, Div Resp, Vancouver, BC, Canada; [He, Jian-Qing; Chan-Yeung, Moira; Carlsten, Chris] Vancouver Gen Hosp, Ctr Lung Hlth, Vancouver, BC, Canada	Sichuan University; University of British Columbia; University of British Columbia	He, JQ (corresponding author), Sichuan Univ, Dept Resp Med, W China Hosp, W China Med Sch, Chengdu 610064, Peoples R China.	jianqing.he@hli.ubc.ca; carlsten@mail.ubc.ca	He, Jian-Qing/AAA-6269-2021	He, Jian-Qing/0000-0002-0966-1302	WorkSafeBC (Workers' Compensation Board of British Columbia)	WorkSafeBC (Workers' Compensation Board of British Columbia)	This research is supported with funds from WorkSafeBC (Workers' Compensation Board of British Columbia, http://www.worksafebc.com/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; Jian-Qing He and Moira Chan-Yeung have declared that no competing interests exist. This research is supported with funds from WorkSafeBC (Workers' Compensation Board of British Columbia) granted to Dr. Carlsten as Principal Investigator. This does not alter the authors' adherence to all the PLOS ONE policies on sharing data and materials.	Blanc PD, 1999, AM J MED, V107, P580, DOI 10.1016/S0002-9343(99)00307-1; BOUSQUET J, 1994, AM J RESP CRIT CARE, V149, P371, DOI 10.1164/ajrccm.149.2.8306032; BURROWS B, 1995, AM J RESP CRIT CARE, V152, P1302, DOI 10.1164/ajrccm.152.4.7551386; Busse WW, 2010, CHEST, V138, p4S, DOI 10.1378/chest.10-0100; Chan-Yeung M, 1999, AM J RESP CRIT CARE, V159, P1434, DOI 10.1164/ajrccm.159.5.9807007; CHANYEUNG M, 1993, AM REV RESPIR DIS, V147, P1056; CHANYEUNG M, 1982, AM J MED, V72, P411, DOI 10.1016/0002-9343(82)90497-1; CHANYEUNG M, 1994, AM J IND MED, V25, P13, DOI 10.1002/ajim.4700250106; Cisneros C, 2010, THORAX, V65, P795, DOI 10.1136/thx.2010.137844; COCKCROFT DW, 1977, CLIN ALLERGY, V7, P235, DOI 10.1111/j.1365-2222.1977.tb01448.x; Davis BE, 2000, CHEST, V117, P881, DOI 10.1378/chest.117.3.881; Dimich-Ward H, 2007, J OCCUP ENVIRON MED, V49, P1040, DOI 10.1097/JOM.0b013e31814b2e5c; Eckert B, 2000, CHEST, V117, P294, DOI 10.1378/chest.117.1.294-a; Frew A, 1998, J ALLERGY CLIN IMMUN, V101, P841, DOI 10.1016/S0091-6749(98)70313-6; Global Initiative for Asthma, 2010, GLOB STRAT ASTHM MAN; Hagman C, 2011, RESP MED; Hardaker KM, 2011, CHEST; He J, 2011, AM J RESP CRIT CARE, V183; Hopman WM, 2000, CAN MED ASSOC J, V163, P265; Hsu PC, 2009, LIVER INT, V29, P449, DOI 10.1111/j.1478-3231.2008.01865.x; Jokic R, 1998, CHEST, V114, P1796, DOI 10.1378/chest.114.6.1796-a; Juniper EF, 2004, EUR RESPIR J, V23, P287, DOI 10.1183/09031936.04.00064204; Juniper EF, 2003, CURR OPIN PULM MED, V9, pS8, DOI 10.1097/00063198-200304001-00003; Koh YY, 1998, J ALLERGY CLIN IMMUN, V102, P921, DOI 10.1016/S0091-6749(98)70329-X; Koh YY, 2002, AM J RESP CRIT CARE, V166, P340, DOI 10.1164/rccm.2101158; Kynyk JA, 2011, CURR OPIN PULM MED, V17, P6, DOI 10.1097/MCP.0b013e3283410038; Larsson U, 2007, RESP MED, V101, P1291, DOI 10.1016/j.rmed.2006.10.014; Leidy NK, 1998, AM J RESP CRIT CARE, V158, P1082, DOI 10.1164/ajrccm.158.4.9708130; Leynaert B, 1997, AM J RESP CRIT CARE, V156, P1413, DOI 10.1164/ajrccm.156.5.9701060; MALO JL, 1993, J ALLERGY CLIN IMMUN, V91, P1121, DOI 10.1016/0091-6749(93)90313-5; Osborne ML, 1998, AM J RESP CRIT CARE, V157, P123, DOI 10.1164/ajrccm.157.1.9612063; Porsbjerg C, 2007, ANN ALLERG ASTHMA IM, V98, P44, DOI 10.1016/S1081-1206(10)60858-7; Riccioni G, 2003, RESPIRATION, V70, P496, DOI 10.1159/000074206; RICHARDS JM, 1994, AM J RESP CRIT CARE, V149, pS31, DOI 10.1164/ajrccm/149.2_Pt_2.S31; Salome CM, 2011, THORAX, V66, P265, DOI 10.1136/thx.2010.151639; Siroux V, 2008, ALLERGY, V63, P547, DOI 10.1111/j.1398-9995.2008.01638.x; TRIGG CJ, 1990, THORAX, V45, P866, DOI 10.1136/thx.45.11.866; WARE JE, 1992, MED CARE, V30, P473, DOI 10.1097/00005650-199206000-00002; YEUNG M, 1985, THORAX, V40, P241, DOI 10.1136/thx.40.4.241	39	1	1	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 4	2012	7	12							e50774	10.1371/journal.pone.0050774	http://dx.doi.org/10.1371/journal.pone.0050774			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	051EQ	23226539	gold, Green Submitted, Green Published			2022-12-27	WOS:000312108500030
J	Kuhring, M; Renard, BY				Kuhring, Mathias; Renard, Bernhard Y.			iPiG: Integrating Peptide Spectrum Matches into Genome Browser Visualizations	PLOS ONE			English	Article							SOFTWARE; IDENTIFICATION; DATABASE	Proteogenomic approaches have gained increasing popularity, however it is still difficult to integrate mass spectrometry identifications with genomic data due to differing data formats. To address this difficulty, we introduce iPiG as a tool for the integration of peptide identifications from mass spectrometry experiments into existing genome browser visualizations. Thereby, the concurrent analysis of proteomic and genomic data is simplified and proteomic results can directly be compared to genomic data. iPiG is freely available from https://sourceforge.net/projects/ipig/. It is implemented in Java and can be run as a stand-alone tool with a graphical user-interface or integrated into existing workflows. Supplementary data are available at PLOS ONE online. Citation: Kuhring M, Renard BY (2012) iPiG: Integrating Peptide Spectrum Matches into Genome Browser Visualizations. PLoS ONE 7(12): e50246. doi:10.1371/journal.pone.0050246	[Kuhring, Mathias; Renard, Bernhard Y.] Robert Koch Inst, Res Grp Bioinformat NG4, Berlin, Germany	Robert Koch Institute	Renard, BY (corresponding author), Robert Koch Inst, Res Grp Bioinformat NG4, Berlin, Germany.	RenardB@rki.de		Kuhring, Mathias/0000-0002-3287-0313; Renard, Bernhard/0000-0003-4589-9809	Robert Koch-Institute	Robert Koch-Institute	Funded by the Robert Koch-Institute. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bradshaw RA, 2006, MOL CELL PROTEOMICS, V5, P787, DOI 10.1074/mcp.E600005-MCP200; Castellana N, 2010, J PROTEOMICS, V73, P2124, DOI 10.1016/j.jprot.2010.06.007; Deutsch EW, 2012, MOL CELL PROTEOMICS, V11, P1612, DOI 10.1074/mcp.R112.019695; Dowell RD, 2001, BMC BIOINFORMATICS, V2, DOI 10.1186/1471-2105-2-7; Hubbard T, 2002, NUCLEIC ACIDS RES, V30, P38, DOI 10.1093/nar/30.1.38; Kalume DE, 2005, BMC GENOMICS, V6, DOI 10.1186/1471-2164-6-128; Kearse M, 2012, BIOINFORMATICS, V28, P1647, DOI 10.1093/bioinformatics/bts199; Kent WJ, 2002, GENOME RES, V12, P996, DOI 10.1101/gr.229102; Kessner D, 2008, BIOINFORMATICS, V24, P2534, DOI 10.1093/bioinformatics/btn323; Nicol JW, 2009, BIOINFORMATICS, V25, P2730, DOI 10.1093/bioinformatics/btp472; Renard BY, 2010, ANAL CHEM, V82, P4314, DOI 10.1021/ac902892j; Renard BY, 2009, PROTEOMICS, V9, P4978, DOI 10.1002/pmic.200900326; Renuse S, 2011, PROTEOMICS, V11, P620, DOI 10.1002/pmic.201000615; Robinson JT, 2011, NAT BIOTECHNOL, V29, P24, DOI 10.1038/nbt.1754; Sanders WS, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-115; Stein LD, 2002, GENOME RES, V12, P1599, DOI 10.1101/gr.403602; Wu S., 1994, TR9417 U AR DEP COMP	17	19	19	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 4	2012	7	12							e50246	10.1371/journal.pone.0050246	http://dx.doi.org/10.1371/journal.pone.0050246			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	051EQ	23226516	Green Submitted, Green Published, gold			2022-12-27	WOS:000312108500014
J	Miyazaki, K; Maruyama, T; Masuda, H; Yamasaki, A; Uchida, S; Oda, H; Uchida, H; Yoshimura, Y				Miyazaki, Kaoru; Maruyama, Tetsuo; Masuda, Hirotaka; Yamasaki, Akiko; Uchida, Sayaka; Oda, Hideyuki; Uchida, Hiroshi; Yoshimura, Yasunori			Stem Cell-Like Differentiation Potentials of Endometrial Side Population Cells as Revealed by a Newly Developed In Vivo Endometrial Stem Cell Assay	PLOS ONE			English	Article							STROMAL CELLS; PROGENITOR CELLS; IDENTIFICATION; MARKERS; MOUSE	Background: Endometrial stem/progenitor cells contribute to the cyclical regeneration of human endometrium throughout a woman's reproductive life. Although the candidate cell populations have been extensively studied, no consensus exists regarding which endometrial population represents the stem/progenitor cell fraction in terms of in vivo stem cell activity. We have previously reported that human endometrial side population cells (ESP), but not endometrial main population cells (EMP), exhibit stem cell-like properties, including in vivo reconstitution of endometrium-like tissues when xenotransplanted into immunodeficient mice. The reconstitution efficiency, however, was low presumably because ESP cells alone could not provide a sufficient microenvironment (niche) to support their stem cell activity. The objective of this study was to establish a novel in vivo endometrial stem cell assay employing cell tracking and tissue reconstitution systems and to examine the stem cell properties of ESP through use of this assay. Methodology/Principal Findings: ESP and EMP cells isolated from whole endometrial cells were infected with lentivirus to express tandem Tomato (TdTom), a red fluorescent protein. They were mixed with unlabeled whole endometrial cells and then transplanted under the kidney capsule of ovariectomized immunodeficient mice. These mice were treated with estradiol and progesterone for eight weeks and nephrectomized. All of the grafts reconstituted endometrium-like tissues under the kidney capsules. Immunofluorescence revealed that TdTom-positive cells were significantly more abundant in the glandular, stromal, and endothelial cells of the reconstituted endometrium in mice transplanted with TdTom-labeled ESP cells than those with TdTom-labeled EMP cells. Conclusions/Significance: We have established a novel in vivo endometrial stem cell assay in which multi-potential differentiation can be identified through cell tracking during in vivo endometrial tissue reconstitution. Using this assay, we demonstrated that ESP cells differentiated into multiple endometrial lineages in the niche provided by whole endometrial cells, indicating that ESP cells are genuine endometrial stem/progenitor cells. Citation: Miyazaki K, Maruyama T, Masuda H, Yamasaki A, Uchida S, et al. (2012) Stem Cell-Like Differentiation Potentials of Endometrial Side Population Cells as Revealed by a Newly Developed In Vivo Endometrial Stem Cell Assay. PLoS ONE 7(12): e50749. doi:10.1371/journal.pone.0050749	[Miyazaki, Kaoru; Maruyama, Tetsuo; Masuda, Hirotaka; Yamasaki, Akiko; Uchida, Sayaka; Oda, Hideyuki; Uchida, Hiroshi; Yoshimura, Yasunori] Keio Univ, Sch Med, Dept Obstet & Gynecol, Tokyo 160, Japan	Keio University	Maruyama, T (corresponding author), Keio Univ, Sch Med, Dept Obstet & Gynecol, Tokyo 160, Japan.	tetsuo@a5.keio.jp	UCHIDA, HIROSHI/AAB-2296-2019	UCHIDA, HIROSHI/0000-0001-6148-7658	Japan Society for the Promotion of Science; Keio University Sakaguchi-Memorial Medical Science Fund; Japan Medical Association; Uehara Memorial Foundation	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Keio University Sakaguchi-Memorial Medical Science Fund; Japan Medical Association; Uehara Memorial Foundation(Uehara Memorial Foundation)	This work was partly supported by grant-in-aids from the Japan Society for the Promotion of Science (to T.M and Y.Y., http://www.jsps.go.jp/english/e-grants/index.html), grant-in-aid from Keio University Sakaguchi-Memorial Medical Science Fund (to T.M., http://www.ms-fund.keio.ac.jp/index.htm); grant-in-aid from the Japan Medical Association (to T.M., http://www.med.or.jp/english/); and grant-in-aid from the Uehara Memorial Foundation (to T.M., http://www.ueharazaidan.or.jp). There is no additional external funding received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Cervello I, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010964; Challen GA, 2006, STEM CELLS, V24, P3, DOI 10.1634/stemcells.2005-0116; Chan RWS, 2004, BIOL REPROD, V70, P1738, DOI 10.1095/biolreprod.103.024109; Dimitrov R, 2008, REPRODUCTION, V135, P551, DOI 10.1530/REP-07-0428; Gargett CE, 2008, MOL CELL ENDOCRINOL, V288, P22, DOI 10.1016/j.mce.2008.02.026; Gargett CE, 2010, MOL HUM REPROD, V16, P818, DOI 10.1093/molehr/gaq061; Gargett CE, 2009, BIOL REPROD, V80, P1136, DOI 10.1095/biolreprod.108.075226; Goodell MA, 1996, J EXP MED, V183, P1797, DOI 10.1084/jem.183.4.1797; IMAI K, 1992, BIOL REPROD, V46, P328, DOI 10.1095/biolreprod46.3.328; Ito M, 2002, BLOOD, V100, P3175, DOI 10.1182/blood-2001-12-0207; Kato K, 2007, HUM REPROD, V22, P1214, DOI 10.1093/humrep/del514; LORD BI, 1986, LYMPHOKINE RES, V5, P59; Maruyama T, 2008, ENDOCR J, V55, P795, DOI 10.1507/endocrj.K08E-067; Maruyama Tetsuo, 2012, Front Biosci (Elite Ed), V4, P2754; Maruyama T, 2010, REPRODUCTION, V140, P11, DOI 10.1530/REP-09-0438; Masuda H, 2012, CELL TRANSP IN PRESS; Masuda H, 2007, P NATL ACAD SCI USA, V104, P1925, DOI 10.1073/pnas.0604310104; Masuda H, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010387; Matsuzaki Y, 2004, IMMUNITY, V20, P87, DOI 10.1016/S1074-7613(03)00354-6; Memarzadeh S, 2010, P NATL ACAD SCI USA, V107, P17298, DOI 10.1073/pnas.1012548107; MULLERSIEBURG CE, 1988, J EXP MED, V167, P1825, DOI 10.1084/jem.167.6.1825; Padykula HA, 1991, ANN N Y ACAD SCI, V622, P47, DOI 10.1111/j.1749-6632.1991.tb37849.x; Schwab KE, 2008, HUM REPROD, V23, P934, DOI 10.1093/humrep/den051; Schwab KE, 2007, HUM REPROD, V22, P2903, DOI 10.1093/humrep/dem265; Schwab KE, 2005, FERTIL STERIL, V84, P1124, DOI 10.1016/j.fertnstert.2005.02.056; Seitz G, 2008, CELL PROLIFERAT, V41, P365, DOI 10.1111/j.1365-2184.2008.00520.x; Tanaka M, 2003, AM J PATHOL, V163, P295, DOI 10.1016/S0002-9440(10)63653-X; Timmermans F, 2009, J CELL MOL MED, V13, P87, DOI 10.1111/j.1582-4934.2008.00598.x; Trzpis M, 2007, AM J PATHOL, V171, P386, DOI 10.2353/ajpath.2007.070152; Tsuji S, 2008, FERTIL STERIL, V90, P1528, DOI 10.1016/j.fertnstert.2007.08.005; Waldner C, 2009, BMC DEV BIOL, V9, DOI 10.1186/1471-213X-9-37; Weissman IL, 2008, BLOOD, V112, P3543, DOI 10.1182/blood-2008-08-078220	32	58	61	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 4	2012	7	12							e50749	10.1371/journal.pone.0050749	http://dx.doi.org/10.1371/journal.pone.0050749			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	051EQ	23226538	Green Published, gold, Green Submitted			2022-12-27	WOS:000312108500029
J	Zhang, Q; Rahim, MMA; Allan, DSJ; Tu, MM; Belanger, S; Abou-Samra, E; Ma, J; Sekhon, HS; Fairhead, T; Zein, HS; Carlyle, JR; Anderson, SK; Makrigiannis, AP				Zhang, Qiang; Rahim, Mir Munir A.; Allan, David S. J.; Tu, Megan M.; Belanger, Simon; Abou-Samra, Elias; Ma, Jaehun; Sekhon, Harman S.; Fairhead, Todd; Zein, Haggag S.; Carlyle, James R.; Anderson, Stephen K.; Makrigiannis, Andrew P.			Mouse Nkrp1-Clr Gene Cluster Sequence and Expression Analyses Reveal Conservation of Tissue-Specific MHC-Independent Immunosurveillance	PLOS ONE			English	Article							C-TYPE LECTIN; KILLER NK CELLS; LY49 CLUSTER; ENDOGENOUS RETROVIRUSES; DENDRITIC CELLS; NK1.1 ANTIGEN; HUMAN NKR-P1A; CUTTING EDGE; CLASS-I; RECEPTORS	The Nkrp1 (Klrb1)-Clr (Clec2) genes encode a receptor-ligand system utilized by NK cells as an MHC-independent immunosurveillance strategy for innate immune responses. The related Ly49 family of MHC-I receptors displays extreme allelic polymorphism and haplotype plasticity. In contrast, previous BAC-mapping and aCGH studies in the mouse suggest the neighboring and related Nkrp1-Clr cluster is evolutionarily stable. To definitively compare the relative evolutionary rate of Nkrp1-Clr vs. Ly49 gene clusters, the Nkrp1-Clr gene clusters from two Ly49 haplotype-disparate inbred mouse strains, BALB/c and 129S6, were sequenced. Both Nkrp1-Clr gene cluster sequences are highly similar to the C57BL/6 reference sequence, displaying the same gene numbers and order, complete pseudogenes, and gene fragments. The Nkrp1-Clr clusters contain a strikingly dissimilar proportion of repetitive elements compared to the Ly49 clusters, suggesting that certain elements may be partly responsible for the highly disparate Ly49 vs. Nkrp1 evolutionary rate. Focused allelic polymorphisms were found within the Nkrp1b/d (Klrb1b), Nkrp1c (Klrb1c), and Clr-c (Clec2f) genes, suggestive of possible immune selection. Cell-type specific transcription of Nkrp1-Clr genes in a large panel of tissues/organs was determined. Clrb (Clec2d) and Clr-g (Clec2i) showed wide expression, while other Clr genes showed more tissue-specific expression patterns. In situ hybridization revealed specific expression of various members of the Clr family in leukocytes/hematopoietic cells of immune organs, various tissue-restricted epithelial cells (including intestinal, kidney tubular, lung, and corneal progenitor epithelial cells), as well as myocytes. In summary, the Nkrp1-Clr gene cluster appears to evolve more slowly relative to the related Ly49 cluster, and likely regulates innate immunosurveillance in a tissue-specific manner. Citation: Zhang Q, Rahim MMA, Allan DSJ, Tu MM, Belanger S, et al. (2012) Mouse Nkrp1-Clr Gene Cluster Sequence and Expression Analyses Reveal Conservation of Tissue-Specific MHC-Independent Immunosurveillance. PLoS ONE 7(12): e50561. doi:10.1371/journal.pone.0050561	[Allan, David S. J.; Ma, Jaehun; Carlyle, James R.] Univ Toronto, Dept Immunol, Sunnybrook Res Inst, Toronto, ON, Canada; [Zhang, Qiang; Rahim, Mir Munir A.; Tu, Megan M.; Belanger, Simon; Abou-Samra, Elias; Zein, Haggag S.; Makrigiannis, Andrew P.] Univ Ottawa, Dept Biochem Microbiol & Immunol, Ottawa, ON, Canada; [Sekhon, Harman S.] Ottawa Hosp, Dept Pathol & Lab Med, Ottawa, ON, Canada; [Fairhead, Todd] Ottawa Hosp, Kidney Res Ctr, Res Inst, Ottawa, ON, Canada; [Zein, Haggag S.] Cairo Univ, Dept Genet, Giza, Egypt; [Anderson, Stephen K.] SAIC Frederick Inc, Basic Sci Program, Expt Immunol Lab, Frederick Natl Lab Canc Res, Frederick, MD USA	University of Toronto; Sunnybrook Research Institute; University Toronto Affiliates; Sunnybrook Health Science Center; University of Ottawa; University of Ottawa; Ottawa Hospital Research Institute; University of Ottawa; Ottawa Hospital Research Institute; Egyptian Knowledge Bank (EKB); Cairo University; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Science Applications International Corporation (SAIC); SAIC-Frederick	Carlyle, JR (corresponding author), Univ Toronto, Dept Immunol, Sunnybrook Res Inst, Toronto, ON, Canada.	james.carlyle@utoronto.ca; andersonst@mail.nih.gov; amakrigi@uottawa.ca	Carlyle, James R/A-1224-2008; Anderson, Stephen K/B-1727-2012	Anderson, Stephen K/0000-0002-7856-4266; Carlyle, James/0000-0002-3579-0300; Makrigiannis, Andrew/0000-0002-7258-9411; Zein, Sharif/0000-0002-8863-1450	Canadian Institutes of Health Research [CIHR 86630]; Early Researcher Award from the Ontario Ministry of Research and Innovation; Intramural Research Program of National Institutes of Health (NIH); Frederick National Lab, Center for Cancer Research; Frederick National Laboratory for Cancer Research, NIH [HHSN261200800001E]; NATIONAL CANCER INSTITUTE [ZIABC010013] Funding Source: NIH RePORTER	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Early Researcher Award from the Ontario Ministry of Research and Innovation; Intramural Research Program of National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Frederick National Lab, Center for Cancer Research; Frederick National Laboratory for Cancer Research, NIH; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by an operating grant from the Canadian Institutes of Health Research (CIHR 86630; to A.P.M. & J.R.C), and an Early Researcher Award from the Ontario Ministry of Research and Innovation (to J.R.C). A.P.M. holds a Canada Research Chair in Innate Pathogen Resistance. J.R.C. holds a CIHR New Investigator Award and an Investigator in the Pathogenesis of Infectious Disease Award from the Burroughs Wellcome Fund, United States of America. This research was supported in part by the Intramural Research Program of National Institutes of Health (NIH), Frederick National Lab, Center for Cancer Research. This project has been funded in part with federal funds from the Frederick National Laboratory for Cancer Research, NIH, under contract HHSN261200800001E. The content of this publication does not necessarily reflect the views or policies of the Department of Health and Human Services, nor does mention of trade names, commercial products, or organizations imply endorsement by the United States government. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aldemir H, 2005, J IMMUNOL, V175, P7791, DOI 10.4049/jimmunol.175.12.7791; Arase H, 1996, J EXP MED, V183, P2391, DOI 10.1084/jem.183.5.2391; Arase N, 1997, J EXP MED, V186, P1957, DOI 10.1084/jem.186.12.1957; Aust JG, 2009, J IMMUNOL, V183, P106, DOI 10.4049/jimmunol.0804281; Balada E, 2010, INT REV IMMUNOL, V29, P351, DOI 10.3109/08830185.2010.485333; Belanger S, 2008, GENES IMMUN, V9, P509, DOI 10.1038/gene.2008.43; Blasius AL, 2007, J EXP MED, V204, P2561, DOI 10.1084/jem.20070991; Brodin P, 2009, BLOOD, V113, P2434, DOI 10.1182/blood-2008-05-156836; Carlyle JR, 2008, SEMIN IMMUNOL, V20, P321, DOI 10.1016/j.smim.2008.05.004; Carlyle JR, 2006, J IMMUNOL, V176, P7511, DOI 10.4049/jimmunol.176.12.7511; Carlyle JR, 2004, P NATL ACAD SCI USA, V101, P3527, DOI 10.1073/pnas.0308304101; Carlyle JR, 1999, J IMMUNOL, V162, P5917; Chen P, 2011, IMMUNOGENETICS, V63, P627, DOI 10.1007/s00251-011-0542-8; de Haij S, 2005, KIDNEY INT, V68, P2091, DOI 10.1111/j.1523-1755.2005.00665.x; Fine JH, 2010, CANCER RES, V70, P7102, DOI 10.1158/0008-5472.CAN-10-1316; Flornes LM, 2010, IMMUNOGENETICS, V62, P521, DOI 10.1007/s00251-010-0455-y; Gasser S, 2005, NATURE, V436, P1186, DOI 10.1038/nature03884; Germain C, 2011, J BIOL CHEM, V286, P37964, DOI 10.1074/jbc.M111.285312; Gregorieff A, 2010, CURR PROTOC STEM CEL; Hao L, 2006, P NATL ACAD SCI USA, V103, P3192, DOI 10.1073/pnas.0511280103; Heng TSP, 2008, NAT IMMUNOL, V9, P1091, DOI 10.1038/ni1008-1091; Higuchi DA, 2010, GENES IMMUN, V11, P637, DOI 10.1038/gene.2010.48; Iizuka K, 2003, NAT IMMUNOL, V4, P801, DOI 10.1038/ni954; Joncker NT, 2009, J IMMUNOL, V182, P4572, DOI 10.4049/jimmunol.0803900; Kveberg L, 2011, IMMUNOGENETICS, V63, P429, DOI 10.1007/s00251-011-0520-1; Kveberg L, 2009, EUR J IMMUNOL, V39, P541, DOI 10.1002/eji.200838891; Lanier LL, 2005, ANNU REV IMMUNOL, V23, P225, DOI 10.1146/annurev.immunol.23.021704.115526; Lattin Jane E, 2008, Immunome Res, V4, P5, DOI 10.1186/1745-7580-4-5; Ljutic B, 2005, J IMMUNOL, V174, P4789, DOI 10.4049/jimmunol.174.8.4789; Makrigiannis AP, 2005, GENES IMMUN, V6, P71, DOI 10.1038/sj.gene.6364154; Plougastel B, 2001, IMMUNOGENETICS, V53, P592, DOI 10.1007/s002510100367; Plougastel B, 2001, IMMUNOGENETICS, V53, P209, DOI 10.1007/s002510100319; Proteau MF, 2004, GENOMICS, V84, P669, DOI 10.1016/j.ygeno.2004.05.004; Rosen DB, 2008, J IMMUNOL, V180, P6508, DOI 10.4049/jimmunol.180.10.6508; Rosen DB, 2005, J IMMUNOL, V175, P7796, DOI 10.4049/jimmunol.175.12.7796; RYAN JC, 1992, J IMMUNOL, V149, P1631; Ryan JC, 1997, IMMUNOL REV, V155, P79, DOI 10.1111/j.1600-065X.1997.tb00941.x; Stoye JP, 2012, NAT REV MICROBIOL, V10, P395, DOI 10.1038/nrmicro2783; Tian WZ, 2005, CELL IMMUNOL, V234, P39, DOI 10.1016/j.cellimm.2005.04.021; Vogler I, 2011, J INNATE IMMUN, V3, P227, DOI 10.1159/000324112; Voigt S, 2007, IMMUNITY, V26, P617, DOI 10.1016/j.immuni.2007.03.013; Vosshenrich CAJ, 2007, J EXP MED, V204, P2569, DOI 10.1084/jem.20071451; Wilhelm BT, 2002, GENOMICS, V80, P646, DOI 10.1006/geno.2002.7004; Williams KJN, 2012, J IMMUNOL, V188, P4980, DOI 10.4049/jimmunol.1103425; Wu C, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-11-r130; YOKOYAMA WM, 1991, J IMMUNOL, V147, P3229; Zhou H, 2001, J BIOL CHEM, V276, P14916, DOI 10.1074/jbc.M011554200; Zohar O, 2008, J IMMUNOL, V180, P6447, DOI 10.4049/jimmunol.180.10.6447	48	23	23	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 4	2012	7	12							e50561	10.1371/journal.pone.0050561	http://dx.doi.org/10.1371/journal.pone.0050561			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	051EQ	23226525	Green Submitted, Green Published, gold			2022-12-27	WOS:000312108500018
J	Ben Mosbah, I; Mouchel, Y; Pajaud, J; Ribault, C; Lucas, C; Laurent, A; Boudjema, K; Morel, F; Corlu, A; Compagnon, P				Ben Mosbah, Ismail; Mouchel, Yann; Pajaud, Julie; Ribault, Catherine; Lucas, Catherine; Laurent, Alexis; Boudjema, Karim; Morel, Fabrice; Corlu, Anne; Compagnon, Philippe			Pretreatment with Mangafodipir Improves Liver Graft Tolerance to Ischemia/Reperfusion Injury in Rat	PLOS ONE			English	Article							ISCHEMIA-REPERFUSION INJURY; MANGANESE DIPYRIDOXYL-DIPHOSPHATE; SUPEROXIDE-DISMUTASE DERIVATIVES; SINUSOIDAL ENDOTHELIAL-CELLS; HEME OXYGENASE-1; CONTRAST AGENT; HEPATOCELLULAR INJURY; HEPATIC PRESERVATION; WISCONSIN SOLUTION; COLD PRESERVATION	Ischemia/reperfusion injury occurring during liver transplantation is mainly due to the generation of reactive oxygen species (ROS) upon revascularization. Thus, delivery of antioxidant enzymes might reduce the deleterious effects of ROS and improve liver graft initial function. Mangafodipir trisodium (MnDPDP), a contrast agent currently used in magnetic resonance imaging of the liver, has been shown to be endowed with powerful antioxidant properties. We hypothesized that MnDPDP could have a protective effect against liver ischemia reperfusion injury when administrated to the donor prior to harvesting. Livers from Sprague Dawley rats pretreated or not with MnDPDP were harvested and subsequently preserved for 24 h in Celsior(R) solution at 4 degrees C. Organs were then perfused ex vivo for 120 min at 37 degrees C with Krebs Henseleit solution. In MnDPDP (5 mu mol/kg) group, we observed that ATP content was significantly higher at the end of the cold preservation period relative to untreated group. After reperfusion, livers from MnDPDP-treated rats showed better tissue integrity, less hepatocellular and endothelial cell injury. This was accompanied by larger amounts of bile production and higher ATP recovery as compared to untreated livers. The protective effect of MnDPDP was associated with a significant decrease of lipid peroxidation, mitochondrial damage, and apoptosis. Interestingly, MnDPDP-pretreated livers exhibited activation of Nfr2 and HIF-1 alpha pathways resulting in a higher catalase and HO-1 activities. MnDPDP also increased total nitric oxide (NO) production which derived from higher expression of constitutive NO synthase and lower expression of inducible NO synthase. In conclusion, our results show that donor pretreatment with MnDPDP protects the rat liver graft from cold ischemia/reperfusion injury and demonstrate for the first time the potential interest of this molecule in the field of organ preservation. Since MnDPDP is safely used in liver imaging, this preservation strategy holds great promise for translation to clinical liver transplantation.	[Ben Mosbah, Ismail; Mouchel, Yann; Pajaud, Julie; Ribault, Catherine; Boudjema, Karim; Morel, Fabrice; Corlu, Anne; Compagnon, Philippe] CHU Pontchaillou, INSERM, UMR991, Rennes, France; [Ben Mosbah, Ismail; Mouchel, Yann; Pajaud, Julie; Ribault, Catherine; Boudjema, Karim; Morel, Fabrice; Corlu, Anne] Univ Rennes 1, Rennes, France; [Lucas, Catherine] CHU Pontchaillou, Lab Biochim Gen & Enzymol, Rennes, France; [Laurent, Alexis] CHU Henri Mondor, AP HP, Serv Chirurg Digest & Hepatobiliaire Transplantat, F-94010 Creteil, France; [Laurent, Alexis] Univ Paris Est, IMRB, INSERM, UMR955, Creteil, France; [Boudjema, Karim; Compagnon, Philippe] Hop Pontchaillou, Serv Chirurg Hepatobiliaire & Digest, Rennes, France	CHU Rennes; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Rennes; CHU Rennes; Assistance Publique Hopitaux Paris (APHP); Universite Paris-Est-Creteil-Val-de-Marne (UPEC); Hopital Universitaire Henri-Mondor - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite Paris-Est-Creteil-Val-de-Marne (UPEC); CHU Rennes	Compagnon, P (corresponding author), Hop Henri Mondor, AP HP, Serv Chirurg Digest & Hepatobiliaire Transplantat, F-94010 Creteil, France.	philippe.compagnon@hmn.aphp.fr	Corlu, Anne/U-8030-2018; Laurent, Alexis/O-3657-2016	Corlu, Anne/0000-0002-7370-0564; Boudjema, Karim/0000-0002-3894-8767; Laurent, Alexis/0000-0003-1372-0843	Institut National de la Sante et de la Recherche Medicale; Centre National de la Recherche Scientifique; FEDER (Fonds europeen de developpement regional); "Contrat plan etat region" (axe biotherapie); Fondation pour la Recherche Medicale; Conseil Regional; Ligue Contre le Cancer-Comite d'Ille-et-Vilaine	Institut National de la Sante et de la Recherche Medicale(Institut National de la Sante et de la Recherche Medicale (Inserm)); Centre National de la Recherche Scientifique(Centre National de la Recherche Scientifique (CNRS)); FEDER (Fonds europeen de developpement regional)(European Commission); "Contrat plan etat region" (axe biotherapie); Fondation pour la Recherche Medicale(Fondation pour la Recherche Medicale); Conseil Regional; Ligue Contre le Cancer-Comite d'Ille-et-Vilaine	This work was supported by the Institut National de la Sante et de la Recherche Medicale, the Centre National de la Recherche Scientifique, the FEDER (Fonds europeen de developpement regional) and the "Contrat plan etat region" (axe biotherapie). Ismail Ben Mosbah was funded by the "Contrat plan etat region" (axe biotherapie) and the Fondation pour la Recherche Medicale. Julie Pajaud was funded by the Conseil Regional and the Ligue Contre le Cancer-Comite d'Ille-et-Vilaine. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexandre J, 2006, J NATL CANCER I, V98, P236, DOI 10.1093/jnci/djj049; Amersi F, 1999, J CLIN INVEST, V104, P1631, DOI 10.1172/JCI7903; ASPLUND A, 1994, J PHARMACOL EXP THER, V271, P609; Bedda S, 2003, J HEPATOL, V39, P765, DOI 10.1016/S0168-8278(03)00325-8; Mosbah I, 2010, CELL DEATH DIS, V1, DOI 10.1038/cddis.2010.29; Ben Mosbah I, 2007, LIVER TRANSPLANT, V13, P410, DOI 10.1002/lt.21059; Ben Mosbah I, 2010, LIVER TRANSPLANT, V16, P163, DOI 10.1002/lt.21968; Bessems M, 2006, LAB ANIM-UK, V40, P236, DOI 10.1258/002367706777611460; Brurok H, 1999, BIOCHEM BIOPH RES CO, V254, P768, DOI 10.1006/bbrc.1998.0131; Busuttil RW, 2005, ANN SURG, V241, P905, DOI 10.1097/01.sla.0000164077.77912.98; Busuttil RW, 2003, LIVER TRANSPLANT, V9, P651, DOI 10.1053/jlts.2003.50105; Casillas-Ramirez A, 2006, LIFE SCI, V79, P1881, DOI 10.1016/j.lfs.2006.06.024; Chen CG, 2006, TRANSPLANTATION, V82, P931, DOI 10.1097/01.tp.0000232674.52951.ff; Chen H, 2007, HEPATOB PANCREAT DIS, V6, P141; CLAVIEN PA, 1992, TRANSPLANTATION, V53, P957, DOI 10.1097/00007890-199205000-00001; Clavien PA, 1998, HEPATOLOGY, V28, P281, DOI 10.1002/hep.510280201; Compagnon P, 2001, TRANSPLANTATION, V72, P606, DOI 10.1097/00007890-200108270-00008; Coriat R, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027005; Deschenes M, 1998, TRANSPLANTATION, V66, P302, DOI 10.1097/00007890-199808150-00005; DICKSON RC, 1992, GASTROENTEROLOGY, V102, P2098, DOI 10.1016/0016-5085(92)90338-Y; Duranski MR, 2006, AM J PHYSIOL-HEART C, V291, pH2980, DOI 10.1152/ajpheart.01173.2005; ELIZONDO G, 1991, RADIOLOGY, V178, P73, DOI 10.1148/radiology.178.1.1898538; Enari M, 1998, NATURE, V391, P43, DOI 10.1038/34112; Gao WS, 1998, HEPATOLOGY, V27, P1652, DOI 10.1002/hep.510270626; Glantzounis GK, 2005, LIVER TRANSPLANT, V11, P1031, DOI 10.1002/lt.20504; GONZALEZ FX, 1994, HEPATOLOGY, V20, P565, DOI 10.1002/hep.1840200304; GORES GJ, 1990, HEPATOLOGY, V11, P690, DOI 10.1002/hep.1840110425; Ikeda A, 2009, LIVER TRANSPLANT, V15, P1458, DOI 10.1002/lt.21918; Jaeschke H, 2004, LIVER INT, V24, P85, DOI 10.1111/j.1478-3231.2004.0906.x; Jaeschke H, 2003, AM J PHYSIOL-GASTR L, V284, pG15, DOI 10.1152/ajpgi.00342.2002; Jaeschke H, 1996, J HEPATOL, V25, P774, DOI 10.1016/S0168-8278(96)80253-4; Jaeschke H, 2000, J GASTROEN HEPATOL, V15, P718, DOI 10.1046/j.1440-1746.2000.02207.x; Jaeschke H, 2011, J GASTROEN HEPATOL, V26, P173, DOI 10.1111/j.1440-1746.2010.06592.x; JAMIESON NV, 1988, CRYOBIOLOGY, V25, P300, DOI 10.1016/0011-2240(88)90038-7; Jynge P, 1997, ACTA RADIOL, V38, P740, DOI 10.1080/02841859709172407; KAMIIKE W, 1985, TRANSPLANTATION, V39, P50, DOI 10.1097/00007890-198501000-00005; Karlsson JOG, 2001, ACTA RADIOL, V42, P540, DOI 10.1080/028418501127347340; Laskar A, 2010, EUR J PHARMACOL, V640, P124, DOI 10.1016/j.ejphar.2010.04.046; Lee SM, 2000, SHOCK, V13, P279, DOI 10.1097/00024382-200004000-00005; Leonard MO, 2006, FASEB J, V20, P2624, DOI 10.1096/fj.06-5097fje; Liu XS, 1996, CELL, V86, P147, DOI 10.1016/S0092-8674(00)80085-9; MacMillan-Crow LA, 2001, FREE RADICAL RES, V34, P325, DOI 10.1080/10715760100300281; Maeda T, 1998, TRANSPLANTATION, V66, P844, DOI 10.1097/00007890-199810150-00006; Markmann JF, 1997, ANN SURG, V226, P408, DOI 10.1097/00000658-199710000-00002; Minor T, 2000, J HEPATOL, V32, P105, DOI 10.1016/S0168-8278(00)80196-8; Mizoe A, 1997, J SURG RES, V73, P160, DOI 10.1006/jsre.1997.5215; Motterlini R, 1998, CIRC RES, V83, P568, DOI 10.1161/01.RES.83.5.568; Nakagami M, 1996, J SURG RES, V62, P118, DOI 10.1006/jsre.1996.0183; NAKANO H, 1995, AM J SURG, V170, P64, DOI 10.1016/S0002-9610(99)80255-4; NATHANSON MH, 1991, HEPATOLOGY, V14, P551, DOI 10.1002/hep.1840140324; ORII T, 1992, TRANSPLANTATION, V53, P730, DOI 10.1097/00007890-199204000-00004; PREMKUMAR DRD, 1995, J NEUROCHEM, V65, P1399; Redaelli CA, 2002, HEPATOLOGY, V35, P1082, DOI 10.1053/jhep.2002.33067; Skjold A, 2007, J MAGN RESON IMAGING, V26, P720, DOI 10.1002/jmri.21065; Steib A, 1998, LIVER TRANSPLANT SUR, V4, P152, DOI 10.1002/lt.500040204; 't Hart NA, 2004, AM J TRANSPLANT, V4, P1836, DOI 10.1111/j.1600-6143.2004.00580.x; Thomas DD, 2008, FREE RADICAL BIO MED, V45, P18, DOI 10.1016/j.freeradbiomed.2008.03.020; Todo S, 1996, TRANSPLANTATION, V61, P189, DOI 10.1097/00007890-199601270-00004; Vairetti M, 2005, BBA-MOL BASIS DIS, V1740, P367, DOI 10.1016/j.bbadis.2004.11.022; Yabe Y, 1999, J PHARMACOL EXP THER, V289, P1176	60	24	24	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 30	2012	7	11							e50235	10.1371/journal.pone.0050235	http://dx.doi.org/10.1371/journal.pone.0050235			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	054WM	23226251	Green Published, gold, Green Submitted			2022-12-27	WOS:000312376100061
J	Dufton, M; Hall, BK; Franz-Odendaal, TA				Dufton, Megan; Hall, Brian K.; Franz-Odendaal, Tamara A.			Early Lens Ablation Causes Dramatic Long-Term Effects on the Shape of Bones in the Craniofacial Skeleton of Astyanax mexicanus	PLOS ONE			English	Article							PHENOTYPIC PLASTICITY; REGRESSIVE EVOLUTION; EYE DEGENERATION; CAVEFISH; EXPRESSION; MODULARITY; TELEOSTEI; DENTITION; PATTERNS; TETRA	The Mexican tetra, Astyanax mexicanus, exists as two morphs of a single species, a sighted surface morph and a blind cavefish. In addition to eye regression, cavefish have an increased number of taste buds, maxillary teeth and have an altered craniofacial skeleton compared to the sighted morph. We investigated the effect the lens has on the development of the surrounding skeleton, by ablating the lens at different time points during ontogeny. This unique long-term study sheds light on how early embryonic manipulations on the eye can affect the shape of the adult skull more than a year later, and the developmental window during which time these effects occur. The effects of lens ablation were analyzed by whole-mount bone staining, immunohistochemisty and landmark based morphometric analyzes. Our results indicate that lens ablation has the greatest impact on the skeleton when it is ablated at one day post fertilisation (dpf) compared to at four dpf. Morphometric analyzes indicate that there is a statistically significant difference in the shape of the supraorbital bone and suborbital bones four through six. These bones expand into the eye orbit exhibiting plasticity in their shape. Interestingly, the number of caudal teeth on the lower jaw is also affected by lens ablation. In contrast, the shape of the calvariae, the length of the mandible, and the number of mandibular taste buds are unaltered by lens removal. We demonstrate the plasticity of some craniofacial elements and the stability of others in the skull. Furthermore, this study highlights interactions present between sensory systems during early development and sheds light on the cavefish phenotype.	[Dufton, Megan; Franz-Odendaal, Tamara A.] Mt St Vincent Univ, Dept Biol, Halifax, NS B3M 2J6, Canada; [Dufton, Megan; Hall, Brian K.] Dalhousie Univ, Dept Biol, Halifax, NS, Canada	Mount Saint Vincent University; Dalhousie University	Franz-Odendaal, TA (corresponding author), Mt St Vincent Univ, Dept Biol, Halifax, NS B3M 2J6, Canada.	Tamara.Franz-Odendaal@msvu.ca		Franz-Odendaal, Tamara/0000-0003-4883-2677	Natural Sciences and Engineering Research Council (Canada)	Natural Sciences and Engineering Research Council (Canada)(Natural Sciences and Engineering Research Council of Canada (NSERC))	This research was funded by the Natural Sciences and Engineering Research Council (Canada) in the form of Discovery Grants to TFO and BKH and a postgraduate fellowship to MD. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Cloutier R, 2010, INT J ZOOL, V2010, P1; Cooper JW, 2010, ANN REV EVOL SYST, V31, P163; De Schepper N, 2004, ZOOL J LINN SOC-LOND, V140, P437, DOI 10.1111/j.1096-3642.2003.00098.x; Fiaz AW, 2010, J APPL ICHTHYOL, V26, P289, DOI 10.1111/j.1439-0426.2010.01423.x; Franz-Odendaal TA, 2006, EVOL DEV, V8, P94, DOI 10.1111/j.1525-142X.2006.05078.x; Franz-Odendaal TA, 2008, ANAT REC, V291, P161, DOI 10.1002/ar.20639; Franz-Odendaal TA, 2007, J EXP ZOOL PART B, V308B, P709, DOI 10.1002/jez.b.21185; Gallagher M, 2012, DEVELOPMENT IN PRESS; Gallo ND, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041443; Hausdorf B, 2011, MOL PHYLOGENET EVOL, V60, P89, DOI 10.1016/j.ympev.2011.03.009; HUYSSEUNE A, 1995, ARCH ORAL BIOL, V40, P1005, DOI 10.1016/0003-9969(95)00074-Y; Jeffery WR, 2008, EVOL DEV, V10, P265, DOI 10.1111/j.1525-142X.2008.00235.x; Jeffery WR, 2005, J HERED, V96, P185, DOI 10.1093/jhered/esi028; Jeffery WR, 2001, DEV BIOL, V231, P1, DOI 10.1006/dbio.2000.0121; KAUFMAN MH, 1995, J ANAT, V186, P607; Kavanagh KD, 2007, NATURE, V449, P427, DOI 10.1038/nature06153; KIMMEL CB, 1995, DEV DYNAM, V203, P253, DOI 10.1002/aja.1002030302; Kish PE, 2011, GENESIS, V49, P222, DOI 10.1002/dvg.20716; Langenberg T, 2008, DEV DYNAM, V237, P1645, DOI 10.1002/dvdy.21577; Mitchell R.W., 1977, MEXICAN EYELESS CHAR; Parsons KJ, 2012, AM NAT, V179, P64, DOI 10.1086/663200; Parsons KJ, 2011, INT J EVOL BIOL, V2011, P1; Protas M, 2007, CURR BIOL, V17, P452, DOI 10.1016/j.cub.2007.01.051; SCHEMMEL CHRISTIAN, 1967, Z MORPHOL TIERE, V61, P255, DOI 10.1007/BF00400988; Schilling TF, 1997, DEVELOPMENT, V124, P2945; Schwarz M, 2000, DEVELOPMENT, V127, P4325; SCHWEIGERER L, 1988, EXP EYE RES, V46, P71, DOI 10.1016/S0014-4835(88)80094-0; Strickler AG, 2001, DEV GENES EVOL, V211, P138, DOI 10.1007/s004270000123; Take-uchi M, 2003, DEVELOPMENT, V130, P955, DOI 10.1242/dev.00305; Thompson H, 2010, DEV BIOL, V347, P40, DOI 10.1016/j.ydbio.2010.08.006; Trapani J, 2005, ZOOL J LINN SOC-LOND, V145, P523, DOI 10.1111/j.1096-3642.2005.00193.x; Varatharasan N, 2009, DEV DYNAM, V238, P3056, DOI 10.1002/dvdy.22144; Wilkens H, 2010, HEREDITY, V105, P413, DOI 10.1038/hdy.2009.184; Wilkens H, 2007, BIOL J LINN SOC, V92, P287, DOI 10.1111/j.1095-8312.2007.00840.x; Yamamoto Y, 2003, EVOL DEV, V5, P435, DOI 10.1046/j.1525-142X.2003.03050.x; Yamamoto Y, 2002, METHODS, V28, P420, DOI 10.1016/S1046-2023(02)00261-X; Yamamoto Y, 2000, SCIENCE, V289, P631, DOI 10.1126/science.289.5479.631; Yamamoto Y, 2009, DEV BIOL, V330, P200, DOI 10.1016/j.ydbio.2009.03.003; Yoshizawa M, 2012, EVOLUTION, V66, P2975, DOI 10.1111/j.1558-5646.2012.01651.x; Yoshizawa Masato, 2011, Communicative & Integrative Biology, V4, P89, DOI 10.4161/cib.4.1.14118	40	28	28	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 30	2012	7	11							e50308	10.1371/journal.pone.0050308	http://dx.doi.org/10.1371/journal.pone.0050308			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	054WM	23226260	Green Submitted, Green Published, gold			2022-12-27	WOS:000312376100070
J	Fernandes, AP; Wallenberg, M; Gandin, V; Misra, S; Tisato, F; Marzano, C; Rigobello, MP; Kumar, S; Bjornstedt, M				Fernandes, Aristi P.; Wallenberg, Marita; Gandin, Valentina; Misra, Sougat; Tisato, Francesco; Marzano, Cristina; Rigobello, Maria Pia; Kumar, Sushil; Bjornstedt, Mikael			Methylselenol Formed by Spontaneous Methylation of Selenide Is a Superior Selenium Substrate to the Thioredoxin and Glutaredoxin Systems	PLOS ONE			English	Article							PROSTATE-CANCER CELLS; S-ADENOSYLMETHIONINE SYNTHESIS; SODIUM SELENITE; DIMETHYL SELENIDE; OXIDATIVE STRESS; B16F10 MELANOMA; RAT-LIVER; REDUCTASE; APOPTOSIS; SELENOMETHIONINE	Naturally occurring selenium compounds like selenite and selenodiglutathione are metabolized to selenide in plants and animals. This highly reactive form of selenium can undergo methylation and form monomethylated and multimethylated species. These redox active selenium metabolites are of particular biological and pharmacological interest since they are potent inducers of apoptosis in cancer cells. The mammalian thioredoxin and glutaredoxin systems efficiently reduce selenite and selenodiglutathione to selenide. The reactions are non-stoichiometric aerobically due to redox cycling of selenide with oxygen and thiols. Using LDI-MS, we identified that the addition of S-adenosylmethionine (SAM) to the reactions formed methylselenol. This metabolite was a superior substrate to both the thioredoxin and glutaredoxin systems increasing the velocities of the nonstoichiometric redox cycles three-fold. In vitro cell experiments demonstrated that the presence of SAM increased the cytotoxicity of selenite and selenodiglutathione, which could neither be explained by altered selenium uptake nor impaired extra-cellular redox environment, previously shown to be highly important to selenite uptake and cytotoxicity. Our data suggest that selenide and SAM react spontaneously forming methylselenol, a highly nucleophilic and cytotoxic agent, with important physiological and pharmacological implications for the highly interesting anticancer effects of selenium.	[Fernandes, Aristi P.; Wallenberg, Marita; Misra, Sougat; Bjornstedt, Mikael] Karolinska Univ, Div Pathol F46, Dept Lab Med, Karolinska Inst,Hosp Huddinge, Stockholm, Sweden; [Gandin, Valentina; Marzano, Cristina] Univ Padua, Dept Pharmaceut Sci, Padua, Italy; [Rigobello, Maria Pia] Univ Padua, Dept Biol Chem, Padua, Italy; [Tisato, Francesco] ICIS CNR, Corso Stati Uniti, Padua, Italy; [Kumar, Sushil] CSIR Indian Inst Toxicol Res, Div Environm Carcinogenesis, Lucknow, Uttar Pradesh, India	Karolinska Institutet; Karolinska University Hospital; University of Padua; University of Padua; Consiglio Nazionale delle Ricerche (CNR); Istituto di Chimica Inorganica e Delle Superfici (ICIS-CNR); Council of Scientific & Industrial Research (CSIR) - India; CSIR - Indian Institute of Toxicology Research (IITR)	Fernandes, AP (corresponding author), Karolinska Univ, Div Pathol F46, Dept Lab Med, Karolinska Inst,Hosp Huddinge, Stockholm, Sweden.	aristi.fernandes@ki.se	Misra, Sougat/AAO-9474-2021; Fernandes, Aristi/D-2507-2015	GANDIN, VALENTINA/0000-0003-0442-0670; Fernandes, Aristi/0000-0002-4145-0222; Misra, Sougat/0000-0003-1660-9438	Cancerfonden (The Swedish Cancer Society); Cancer och Allergifonden (The Swedish Cancer and Allergy Foundation); ALF (Stockholm County Council); Radiumhemmets forskningsfonder; Magnus Bergvalls stiftelse; Ake Wibergs stiftelse; Svenska Lakaresallskapet (Swedish Medical Association)	Cancerfonden (The Swedish Cancer Society)(Swedish Cancer Society); Cancer och Allergifonden (The Swedish Cancer and Allergy Foundation); ALF (Stockholm County Council)(Stockholm County Council); Radiumhemmets forskningsfonder; Magnus Bergvalls stiftelse; Ake Wibergs stiftelse; Svenska Lakaresallskapet (Swedish Medical Association)	This investigation was supported by grants from Cancerfonden (The Swedish Cancer Society), Cancer och Allergifonden (The Swedish Cancer and Allergy Foundation), ALF (Stockholm County Council), Radiumhemmets forskningsfonder, Magnus Bergvalls stiftelse, Ake Wibergs stiftelse and Svenska Lakaresallskapet (Swedish Medical Association). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BEHNE D, 1990, BIOCHEM BIOPH RES CO, V173, P1143, DOI 10.1016/S0006-291X(05)80905-2; BERRY JP, 1995, J SUBMICR CYTOL PATH, V27, P21; Bhabak KP, 2010, ACCOUNTS CHEM RES, V43, P1408, DOI 10.1021/ar100059g; BJORNSTEDT M, 1995, J BIOL CHEM, V270, P11761, DOI 10.1074/jbc.270.20.11761; BJORNSTEDT M, 1992, J BIOL CHEM, V267, P8030; BJORNSTEDT M, 1995, METHOD ENZYMOL, V252, P209; Bjornstedt M, 1997, BIOMED ENVIRON SCI, V10, P271; Bjornstedt M, 2010, EPMA J, V1, P389, DOI 10.1007/s13167-010-0033-2; Bockhorn J, 2008, P NATL ACAD SCI USA, V105, P17682, DOI 10.1073/pnas.0805642105; Bottiglieri T, 2002, AM J CLIN NUTR, V76, p1151S, DOI 10.1093/ajcn/76.5.1151S; Brigelius-Flohe R, 2008, CHEM BIODIVERS, V5, P389, DOI 10.1002/cbdv.200890039; Darvesh AS, 2010, ANTI-CANCER AGENT ME, V10, P338; Flohe L, 1988, Basic Life Sci, V49, P663; GANTHER HE, 1966, BIOCHEMISTRY-US, V5, P1089, DOI 10.1021/bi00867a039; GANTHER HE, 1971, BIOCHEMISTRY-US, V10, P4089, DOI 10.1021/bi00798a013; GANTHER HE, 1968, BIOCHEMISTRY-US, V7, P2898, DOI 10.1021/bi00848a029; Gierer P, 2010, J TRAUMA, V68, P853, DOI 10.1097/TA.0b013e3181b28a18; Gromer S, 2002, J BIOL CHEM, V277, P9701, DOI 10.1074/jbc.M109234200; Hassan W, 2010, PATHOL RES PRACT, V206, P357, DOI 10.1016/j.prp.2009.12.009; HOLMGREN A, 1995, METHOD ENZYMOL, V252, P199; HOLMGREN A, 1995, METHOD ENZYMOL, V252, P283; HSIEH HS, 1977, BIOCHIM BIOPHYS ACTA, V497, P205; Husbeck B, 2006, MOL CANCER THER, V5, P2078, DOI 10.1158/1535-7163.MCT-06-0056; Ip C, 1998, ANTICANCER RES, V18, P4019; Ip C, 1998, ANTICANCER RES, V18, P9; Jiang C, 2002, MOL CANCER THER, V1, P1059; Jiang C, 2001, CANCER RES, V61, P3062; Kim A, 2008, ONCOL REP, V20, P557, DOI 10.3892/or_00000042; Kim A, 2007, J CELL PHYSIOL, V212, P386, DOI 10.1002/jcp.21038; Kumar BS, 2010, J TRACE ELEM MED BIO, V24, P263, DOI 10.1016/j.jtemb.2010.04.003; KUMAR S, 1992, EUR J BIOCHEM, V207, P435, DOI 10.1111/j.1432-1033.1992.tb17068.x; LANFEAR J, 1994, CARCINOGENESIS, V15, P1387, DOI 10.1093/carcin/15.7.1387; Li GX, 2007, INT J CANCER, V120, P2034, DOI 10.1002/ijc.22480; Lin TT, 2009, HEPATOL RES, V39, P1125, DOI 10.1111/j.1872-034X.2009.00545.x; Luo J, 2010, INT J BIOL SCI, V6, P784; Malkowski MG, 2007, P NATL ACAD SCI USA, V104, P6678, DOI 10.1073/pnas.0610337104; Mato JM, 1997, PHARMACOL THERAPEUT, V73, P265, DOI 10.1016/S0163-7258(96)00197-0; Ohta Y, 2008, TOXICOL APPL PHARM, V226, P169, DOI 10.1016/j.taap.2007.09.011; Olm E, 2009, P NATL ACAD SCI USA, V106, P11400, DOI 10.1073/pnas.0902204106; Pakiari AH, 2008, J PHYS CHEM A, V112, P7969, DOI 10.1021/jp804033w; Palace VP, 2004, ECOTOX ENVIRON SAFE, V58, P17, DOI 10.1016/j.ecoenv.2003.08.019; Pinto JT, 2011, AMINO ACIDS, V41, P29, DOI 10.1007/s00726-010-0578-3; Sedgwick B, 2007, DNA REPAIR, V6, P429, DOI 10.1016/j.dnarep.2006.10.005; SEDLAK J, 1968, ANAL BIOCHEM, V25, P192, DOI 10.1016/0003-2697(68)90092-4; Selenius M, 2010, ANTIOXID REDOX SIGN, V12, P867, DOI 10.1089/ars.2009.2884; Stadtman TC, 1996, ANNU REV BIOCHEM, V65, P83, DOI 10.1146/annurev.bi.65.070196.000503; Stewart MS, 1999, FREE RADICAL BIO MED, V26, P42, DOI 10.1016/S0891-5849(98)00147-6; Suzuki KT, 2007, BBA-GEN SUBJECTS, V1770, P1053, DOI 10.1016/j.bbagen.2007.03.007; Tamura T, 1996, P NATL ACAD SCI USA, V93, P1006, DOI 10.1073/pnas.93.3.1006; VADHANAVIKIT S, 1993, XENOBIOTICA, V23, P731, DOI 10.3109/00498259309166780; Papp LV, 2007, ANTIOXID REDOX SIGN, V9, P775, DOI 10.1089/ars.2007.1528; Wallenberg M, 2010, BIOCHEM J, V429, P85, DOI 10.1042/BJ20100368; Wang L, 2009, CANCER PREV RES, V2, P484, DOI 10.1158/1940-6207.CAPR-08-0173; Yu SC, 2010, ORG BIOMOL CHEM, V8, P828, DOI 10.1039/b918778b; Zeng HW, 2009, J NUTR, V139, P1613, DOI 10.3945/jn.109.110320	55	28	29	4	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 30	2012	7	11							e50727	10.1371/journal.pone.0050727	http://dx.doi.org/10.1371/journal.pone.0050727			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	054WM	23226364	Green Published, Green Submitted, gold			2022-12-27	WOS:000312376100175
J	Hennenberg, M; Strittmatter, F; Beckmann, C; Rutz, B; Fullhase, C; Waidelich, R; Montorsi, F; Hedlund, P; Andersson, KE; Stief, CG; Gratzke, C				Hennenberg, Martin; Strittmatter, Frank; Beckmann, Christer; Rutz, Beata; Fuellhase, Claudius; Waidelich, Raphaela; Montorsi, Francesco; Hedlund, Petter; Andersson, Karl-Erik; Stief, Christian G.; Gratzke, Christian			Silodosin Inhibits Noradrenaline-Activated Transcription Factors Elk1 and SRF in Human Prostate Smooth Muscle	PLOS ONE			English	Article							LOWER URINARY-TRACT; ALPHA(1)-ADRENOCEPTOR ANTAGONISTS; CELL-PROLIFERATION; CANCER CELLS; HYPERPLASIA; APOPTOSIS; INDUCTION; FINASTERIDE; TERAZOSIN; DOXAZOSIN	Background: The transcription factors Elk1 and serum response factor (SRF) are central regulators of cell cycle and phenotype in various cell types. Elk1 is activated by phosphorylation (serine-383), while activation of SRF requires its cofactor, myocardin. Activation of Elk1 and SRF results in binding to specific DNA sequences in promoter regions, and may be induced by adrenergic receptor activation in different organs. Objective: To examine the effects of adrenergic stimulation on Elk1 and SRF in the human prostate and the ability of the highly selective alpha 1A-adrenoceptor antagonist, silodosin, on transcription factor activation. Methods: Prostate tissue was obtained from patients undergoing radical prostatectomy. Expression of Elk1, SRF, and myocardin was estimated by Western blot and immunohistochemistry. Colocalizations were studied by double immunofluorescence staining. Noradrenaline- (NA-) and phenylephrine- (PE-) induced phosphorylation of Elk1 was assessed by Western blot analysis using a phospho-specific antibody. NA- induced activation of Elk1 and SRF was investigated by electrophoretic mobility shift assay (EMSA). Results: Immunoreactivity for Elk1, SRF, and myocardin was observed in stromal cells of tissues from each patient. In fluorescence stainings, SRF colocalized with myocardin and alpha-smooth muscle actin (alpha SMA). Stimulation of prostate tissues with PE (10 mu M) or NA (30 mu M) increased the phosphorylation of Elk1 at serine-383. NA- induced Elk1 activation was confirmed by EMSA, where a NA- induced binding of Elk1 to the DNA sequence TTTGCAAAATGCAGGAATTGTTTTCACAGT was observed. Similarly, NA caused SRF binding to the SRF-specific DNA sequence CCATATTAGGCCATATTAGG. Application of silodosin (3 mu M) to prostate tissues reduced the activity of Elk1 and SRF in NA- stimulated tissues. Conclusions: Silodosin blocks the activation of the two transcription factors, Elk1 and SRF, which is induced by noradrenaline in the human prostate. A role of alpha 1-adrenoceptors beyond smooth muscle contraction may be considered, which includes a function in transcriptional regulation.	[Hennenberg, Martin; Strittmatter, Frank; Beckmann, Christer; Rutz, Beata; Fuellhase, Claudius; Waidelich, Raphaela; Stief, Christian G.; Gratzke, Christian] Univ Munich, Dept Urol, Munich, Germany; [Montorsi, Francesco; Hedlund, Petter] Univ San Raffaele, Urol Res Inst, Milan, Italy; [Andersson, Karl-Erik] Wake Forest Univ, Sch Med, Wake Forest Inst Regenerat Med, Winston Salem, NC 27109 USA	University of Munich; Vita-Salute San Raffaele University; Wake Forest University	Gratzke, C (corresponding author), Univ Munich, Dept Urol, Munich, Germany.	christian.gratzke@med.uni-muenchen.de	Hennenberg, Martin/M-3474-2016; Montorsi, Francesco/AAN-2473-2020		Recordati Pharma (Milan, Italy)	Recordati Pharma (Milan, Italy)	This study was supported by an unrestricted grant of Recordati Pharma (Milan, Italy). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersson KE, 2007, NEUROUROL URODYNAM, V26, P934, DOI 10.1002/nau.20500; Andersson KE, 2007, NAT CLIN PRACT UROL, V4, P368, DOI 10.1038/ncpuro0836; Andersson KE, 1997, PROSTATE, V30, P202; Anglin IE, 2002, PROSTATE CANCER P D, V5, P88, DOI 10.1038/sj.pcan.4500561; Barlow CA, 2006, J PHYSIOL-LONDON, V570, P59, DOI 10.1113/jphysiol.2005.098426; Bauer RM, 2011, UROL INT, P86; Buchwalter G, 2004, GENE, V324, P1, DOI 10.1016/j.gene.2003.09.028; Chon JK, 1999, J UROLOGY, V161, P2002, DOI 10.1016/S0022-5347(05)68873-8; Cohen-Armon M, 2007, TRENDS PHARMACOL SCI, V28, P556, DOI 10.1016/j.tips.2007.08.005; Erdogru T, 2002, UROL INT, V69, P287, DOI 10.1159/000066120; Glassman DT, 2001, PROSTATE, V46, P45, DOI 10.1002/1097-0045(200101)46:1<45::AID-PROS1007>3.0.CO;2-U; Golomb E, 1998, PROSTATE, V34, P214; Kanagawa K, 2003, PROSTATE, V56, P313, DOI 10.1002/pros.10267; Kawai-Kowase K, 2007, AM J PHYSIOL-CELL PH, V292, pC59, DOI 10.1152/ajpcell.00394.2006; Kyprianou N, 1998, J UROLOGY, V159, P1810, DOI 10.1016/S0022-5347(01)63162-8; Lepor H, CURR OPIN UROL, V22, P7; Marinese D, 2003, PROSTATE, V54, P230, DOI 10.1002/pros.10170; McConnell JD, 2003, NEW ENGL J MED, V349, P2387, DOI 10.1056/NEJMoa030656; Michel MC, 2006, BRIT J PHARMACOL, V147, pS88, DOI 10.1038/sj.bjp.0706619; Paick JS, 2008, J KOREAN MED SCI, V23, P509, DOI 10.3346/jkms.2008.23.3.509; Peterziel H, 1999, ONCOGENE, V18, P6322, DOI 10.1038/sj.onc.1203032; Pradidarcheep Wisuit, 2011, Handb Exp Pharmacol, P117, DOI 10.1007/978-3-642-16499-6_7; Roehrborn CG, 2006, PROSTATE CANCER P D, V9, P121, DOI 10.1038/sj.pcan.4500849; Roehrborn CG, 2004, J UROLOGY, V171, P1029, DOI 10.1097/01.ju.0000097026.43866.cc; Roehrborn CG, EUR UROL, V57, P123; Shaikhibrahim Z, 2012, MOL MED REP, V5, P313, DOI 10.3892/mmr.2011.647; Shaw PE, 2003, INT J BIOCHEM CELL B, V35, P1210, DOI 10.1016/S1357-2725(03)00031-1; Strittmatter F, 2012, BR J PHARM IN PRESS; Strittmatter F, 2012, BRIT J PHARMACOL; Turkeri L N, 2001, Arch Esp Urol, V54, P191; Tyagi A, 2003, ONCOGENE, V22, P1302, DOI 10.1038/sj.onc.1206265; Tyagi A, 2008, PHARM RES-DORDR, V25, P2143, DOI 10.1007/s11095-008-9545-z; Wamhoff BR, 2006, CIRC RES, V98, P868, DOI 10.1161/01.RES.0000216596.73005.3c; Xiao DM, 2002, REGUL PEPTIDES, V109, P141, DOI 10.1016/S0167-0115(02)00197-0	34	9	9	2	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 30	2012	7	11							e50904	10.1371/journal.pone.0050904	http://dx.doi.org/10.1371/journal.pone.0050904			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	054WM	23226423	Green Submitted, Green Published, gold			2022-12-27	WOS:000312376100234
J	Holveck, MJ; Gregoire, A; Staszewski, V; Guerreiro, R; Perret, P; Boulinier, T; Doutrelant, C				Holveck, Marie-Jeanne; Gregoire, Arnaud; Staszewski, Vincent; Guerreiro, Romain; Perret, Philippe; Boulinier, Thierry; Doutrelant, Claire			Eggshell Spottiness Reflects Maternally Transferred Antibodies in Blue Tits	PLOS ONE			English	Article							GENETIC-VARIATION; EGG QUALITY; FICEDULA-ALBICOLLIS; SEXUAL SELECTION; PARENTAL QUALITY; FEMALE CONDITION; GREAT TIT; COLORATION; CAROTENOIDS; PIGMENTATION	Blue-green and brown-spotted eggshells in birds have been proposed as sexual signals of female physiological condition and egg quality, reflecting maternal investment in the egg. Testing this hypothesis requires linking eggshell coloration to egg content, which is lacking for brown protoporphyrin-based pigmentation. As protoporphyrins can induce oxidative stress, and a large amount in eggshells should indicate either high female and egg quality if it reflects the female's high oxidative tolerance, or conversely poor quality if it reflects female physiological stress. Different studies supported either predictions but are difficult to compare given the methodological differences in eggshell-spottiness measurements. Using the blue tit Cyanistes caeruleus as a model species, we aimed at disentangling both predictions in testing if brown-spotted eggshell could reflect the quality of maternal investment in antibodies and carotenoids in the egg, and at improving between-study comparisons in correlating several common measurements of eggshell coloration (spectral and digital measures, spotted surface, pigmentation indices). We found that these color variables were weakly correlated highlighting the need for comparable quantitative measurements between studies and for multivariate regressions incorporating several eggshell-color characteristics. When evaluating the potential signaling function of brown-spotted eggshells, we thus searched for the brown eggshell-color variables that best predicted the maternal transfer of antibodies and carotenoids to egg yolks. We also tested the effects of several parental traits and breeding parameters potentially affecting this transfer. While eggshell coloration did not relate to yolk carotenoids, the eggs with larger and less evenly-distributed spots had higher antibody concentrations, suggesting that both the quantity and distribution of brown pigments reflected the transfer of maternal immune compounds in egg yolks. As yolk antibody concentrations were also positively related to key proxies of maternal quality (egg volume, number, yellow feather brightness, tarsus length), eggshells with larger spots concentrated at their broad pole may indicate higher-quality eggs.	[Holveck, Marie-Jeanne; Gregoire, Arnaud; Staszewski, Vincent; Guerreiro, Romain; Perret, Philippe; Boulinier, Thierry; Doutrelant, Claire] CNRS, CEFE, Montpellier, France	UDICE-French Research Universities; PSL Research University Paris; Ecole Pratique des Hautes Etudes (EPHE); Institut Agro; Montpellier SupAgro; CIRAD; Centre National de la Recherche Scientifique (CNRS); Institut de Recherche pour le Developpement (IRD); Universite Paul-Valery; Universite de Montpellier	Holveck, MJ (corresponding author), UCL, Biodivers Res Ctr, Louvain, Belgium.	marie-jeanne.holveck@uclouvain.be	Gregoire, Arnaud/B-6321-2008; Holveck, Marie-Jeanne/D-4004-2016	Gregoire, Arnaud/0000-0001-6103-355X; BOULINIER, Thierry/0000-0002-5898-7667; Holveck, Marie-Jeanne/0000-0002-6229-6367	French National Agency for Research [ANR-JC05-43762, ANR-09-JCJC-0050-01]; University of Montpellier II; Association for the Study of Animal Behaviour ASAB	French National Agency for Research(French National Research Agency (ANR)); University of Montpellier II; Association for the Study of Animal Behaviour ASAB	This research was funded by grants of the French National Agency for Research, ANR-JC05-43762 to TB and ANR-09-JCJC-0050-01 to CD, and grants of the University of Montpellier II and the Association for the Study of Animal Behaviour ASAB to MJH. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Afonso S, 1999, FREE RADICAL RES, V31, P161, DOI 10.1080/10715769900300711; BAIRD T, 1975, BRIT POULTRY SCI, V16, P201, DOI 10.1080/00071667508416177; Becker W. A, 1984, MANUAL QUANTITATIVE; Blondel J, 2006, BIOSCIENCE, V56, P661, DOI 10.1641/0006-3568(2006)56[661:ATSOPA]2.0.CO;2; Blount JD, 2002, P ROY SOC B-BIOL SCI, V269, P29, DOI 10.1098/rspb.2001.1840; Boulinier T, 2008, TRENDS ECOL EVOL, V23, P282, DOI 10.1016/j.tree.2007.12.006; Bulla M, 2012, AUK, V129, P26, DOI 10.1525/auk.2012.11090; Cassey P, 2008, NATURWISSENSCHAFTEN, V95, P713, DOI 10.1007/s00114-008-0376-x; Cherry MI, 2010, BIOL J LINN SOC, V100, P753, DOI 10.1111/j.1095-8312.2010.01457.x; Christians JK, 2002, BIOL REV, V77, P1, DOI 10.1017/S1464793101005784; Costantini D, 2008, FUNCT ECOL, V22, P367, DOI 10.1111/j.1365-2435.2007.01366.x; Costantini D, 2010, J COMP PHYSIOL B, V180, P731, DOI 10.1007/s00360-010-0456-z; De Coster G, 2012, OECOLOGIA, V170, P297, DOI 10.1007/s00442-012-2304-1; Doutrelant C, 2008, J EVOLUTION BIOL, V21, P226, DOI 10.1111/j.1420-9101.2007.01451.x; Faivre B, 2003, SCIENCE, V300, P103, DOI 10.1126/science.1081802; Forstmeier W, 2011, BEHAV ECOL SOCIOBIOL, V65, P47, DOI 10.1007/s00265-010-1038-5; Garcia-Navas V, 2011, J ORNITHOL, V152, P71, DOI 10.1007/s10336-010-0551-7; Gasparini J, 2001, P ROY SOC B-BIOL SCI, V268, P647, DOI 10.1098/rspb.2000.1411; Gomez D., 2006, AVICOL PROGRAM ANAL; Gosler AG, 2005, ECOL LETT, V8, P1105, DOI 10.1111/j.1461-0248.2005.00816.x; Gosler AG, 2000, P ROY SOC B-BIOL SCI, V267, P2469, DOI 10.1098/rspb.2000.1307; Gosler AG, 2011, AVIAN BIOL RES, V4, P214, DOI 10.3184/175815511X13207833399666; Graham AL, 2010, SCIENCE, V330, P662, DOI 10.1126/science.1194878; Groothuis TGG, 2006, J EVOLUTION BIOL, V19, P1304, DOI 10.1111/j.1420-9101.2005.01072.x; Hargitai R, 2006, FUNCT ECOL, V20, P829, DOI 10.1111/j.1365-2435.2006.01171.x; Hargitai R, 2008, J AVIAN BIOL, V39, P413, DOI 10.1111/j.2008.0908-8857.04337.x; Holveck MJ, 2010, BIOL LETTERS, V6, P453, DOI 10.1098/rsbl.2009.1044; HOYT DF, 1979, AUK, V96, P73; Sanz JJ, 2009, J ANIM ECOL, V78, P31, DOI 10.1111/j.1365-2656.2008.01465.x; Kadish KM, 2000, PROPHYRIN HDB; KENNEDY GY, 1976, COMP BIOCHEM PHYS B, V55, P117, DOI 10.1016/0305-0491(76)90183-8; Laucht S, 2010, BEHAV ECOL SOCIOBIOL, V64, P1461, DOI 10.1007/s00265-010-0961-9; LESSELLS CM, 1987, AUK, V104, P116, DOI 10.2307/4087240; Magi M, 2012, J ORNITHOL, V153, P645, DOI 10.1007/s10336-011-0782-2; Martinez-de la Puente J, 2007, J AVIAN BIOL, V38, P377, DOI 10.1111/j.0908-8857.2007.03877.x; McGraw JK, 2006, BIRD COLORATION, V1; McGraw KJ, 2005, ANIM BEHAV, V69, P757, DOI 10.1016/j.anbehav.2004.06.022; McGraw KJ, 2003, AM NAT, V162, P704, DOI 10.1086/378904; Merila J, 1998, GENETICS, V148, P1233; Montgomerie Robert, 2006, P90; Morales J, 2008, BEHAV ECOL SOCIOBIOL, V63, P227, DOI 10.1007/s00265-008-0653-x; Morales J, 2006, BIOL LETTERS, V2, P334, DOI 10.1098/rsbl.2006.0471; Moreno J, 2003, ECOL LETT, V6, P803, DOI 10.1046/j.1461-0248.2003.00505.x; Pahl R, 1997, P ROY SOC B-BIOL SCI, V264, P239, DOI 10.1098/rspb.1997.0034; Postma E, 2005, ECOLOGY, V86, P2344, DOI 10.1890/04-0348; R Development Core Team, 2012, R LANG ENV STAT COMP; Rasband Wayne, 2010, IMAGEJ; Reynolds SJ, 2009, ANIM BEHAV, V78, P209, DOI 10.1016/j.anbehav.2009.03.003; Saino N, 2002, P ROY SOC B-BIOL SCI, V269, P1729, DOI 10.1098/rspb.2002.2088; Senar JC, 2002, P ROY SOC B-BIOL SCI, V269, P257, DOI 10.1098/rspb.2001.1882; Sheldon BC, 2000, TRENDS ECOL EVOL, V15, P397, DOI 10.1016/S0169-5347(00)01953-4; Soler JJ, 2008, AM NAT, V171, P183, DOI 10.1086/524958; Stevens M, 2007, BIOL J LINN SOC, V90, P211, DOI 10.1111/j.1095-8312.2007.00725.x; Stevens M, 2011, AVIAN BIOL RES, V4, P168, DOI 10.3184/175815511X13207790177958; Stevens M, 2009, INT J PRIMATOL, V30, P893, DOI 10.1007/s10764-009-9356-z; Stoddard MC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040211; Surai P. F., 2001, Japanese Poultry Science, V38, P117; Szigeti B, 2007, J AVIAN BIOL, V38, P105, DOI 10.1111/j.2007.0908-8857.03769.x; Torok J, 2007, BEHAV ECOL SOCIOBIOL, V61, P541, DOI 10.1007/s00265-006-0282-1; von Schantz T, 1999, P ROY SOC B-BIOL SCI, V266, P1, DOI 10.1098/rspb.1999.0597; Westmoreland D, 1996, BIOL J LINN SOC, V58, P159, DOI 10.1111/j.1095-8312.1996.tb01429.x	61	22	22	1	65	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 30	2012	7	11							e50389	10.1371/journal.pone.0050389	http://dx.doi.org/10.1371/journal.pone.0050389			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	054WM	23226272	gold, Green Published, Green Submitted			2022-12-27	WOS:000312376100082
J	Li, JY; Newberg, JY; Uhlen, M; Lundberg, E; Murphy, RF				Li, Jieyue; Newberg, Justin Y.; Uhlen, Mathias; Lundberg, Emma; Murphy, Robert F.			Automated Analysis and Reannotation of Subcellular Locations in Confocal Images from the Human Protein Atlas	PLOS ONE			English	Article							FLUORESCENCE MICROSCOPE IMAGES; PATTERNS; LOCALIZATION; PROBES	The Human Protein Atlas contains immunofluorescence images showing subcellular locations for thousands of proteins. These are currently annotated by visual inspection. In this paper, we describe automated approaches to analyze the images and their use to improve annotation. We began by training classifiers to recognize the annotated patterns. By ranking proteins according to the confidence of the classifier, we generated a list of proteins that were strong candidates for reexamination. In parallel, we applied hierarchical clustering to group proteins and identified proteins whose annotations were inconsistent with the remainder of the proteins in their cluster. These proteins were reexamined by the original annotators, and a significant fraction had their annotations changed. The results demonstrate that automated approaches can provide an important complement to visual annotation.	[Li, Jieyue; Newberg, Justin Y.; Murphy, Robert F.] Carnegie Mellon Univ, Ctr Bioimage Informat, Pittsburgh, PA 15213 USA; [Li, Jieyue; Newberg, Justin Y.; Murphy, Robert F.] Carnegie Mellon Univ, Dept Biomed Engn, Pittsburgh, PA 15213 USA; [Uhlen, Mathias] Royal Inst Technol, AlbaNova Univ Ctr, Dept Biotechnol, Stockholm, Sweden; [Uhlen, Mathias; Lundberg, Emma] Royal Inst Technol, Sci Life Lab, Solna, Sweden; [Murphy, Robert F.] Carnegie Mellon Univ, Lane Ctr Computat Biol, Pittsburgh, PA 15213 USA; [Murphy, Robert F.] Carnegie Mellon Univ, Dept Machine Learning, Pittsburgh, PA 15213 USA; [Murphy, Robert F.] Carnegie Mellon Univ, Dept Biol Sci, Pittsburgh, PA 15213 USA; [Murphy, Robert F.] Univ Freiburg, Fac Biol, D-79106 Freiburg, Germany; [Murphy, Robert F.] Univ Freiburg, Freiburg Inst Adv Studies, D-79106 Freiburg, Germany	Carnegie Mellon University; Carnegie Mellon University; Royal Institute of Technology; Royal Institute of Technology; Carnegie Mellon University; Carnegie Mellon University; Carnegie Mellon University; University of Freiburg; University of Freiburg	Murphy, RF (corresponding author), Carnegie Mellon Univ, Ctr Bioimage Informat, Pittsburgh, PA 15213 USA.	murphy@cmu.edu	Uhlen, Mathias/B-3262-2016; Lundberg, Emma S K/F-3891-2010; Uhlen, Mathias/AAV-8746-2021	Uhlen, Mathias/0000-0002-4858-8056; Kaller Lundberg, Emma/0000-0001-7034-0850	National Institutes of Health (NIH) [GM075205]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM075205] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported in part by National Institutes of Health (NIH) grant GM075205. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding was received for this study.	Barbe L, 2008, MOL CELL PROTEOMICS, V7, P499, DOI 10.1074/mcp.M700325-MCP200; Berglund L, 2008, MOL CELL PROTEOMICS, V7, P2019, DOI 10.1074/mcp.R800013-MCP200; Boland MV, 2001, BIOINFORMATICS, V17, P1213, DOI 10.1093/bioinformatics/17.12.1213; Breiman L., 2001, Machine Learning, V45, P5, DOI 10.1023/A:1010933404324; Chang CC, 2011, ACM T INTEL SYST TEC, V2, DOI 10.1145/1961189.1961199; Chen SC, 2007, BIOINFORMATICS, V23, pI66, DOI 10.1093/bioinformatics/btm206; Chen X, 2006, CYTOM PART A, V69A, P631, DOI 10.1002/cyto.a.20280; Coelho LP, 2010, BIOINFORMATICS, V26, pi7, DOI 10.1093/bioinformatics/btq220; Glory E, 2007, DEV CELL, V12, P7, DOI 10.1016/j.devcel.2006.12.007; Hamilton NA, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-110; Hamilton NA, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-81; Huang K, 2003, PROC SPIE, V4962, P307, DOI 10.1117/12.477903; Lin YS, 2009, I S BIOMED IMAGING, P414, DOI 10.1109/ISBI.2009.5193072; Lowe D., 1999, P INT C COMP VIS, V2, P1150, DOI DOI 10.1109/ICCV.1999.790410; Newberg J, 2008, J PROTEOME RES, V7, P2300, DOI 10.1021/pr7007626; Newberg JY, 2009, I S BIOMED IMAGING, P1023, DOI 10.1109/ISBI.2009.5193229; Peng T, 2010, P NATL ACAD SCI USA, V107, P2944, DOI 10.1073/pnas.0912090107; Uhlen M, 2005, MOL CELL PROTEOMICS, V4, P1920, DOI 10.1074/mcp.M500279-MCP200	19	21	21	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 30	2012	7	11							e50514	10.1371/journal.pone.0050514	http://dx.doi.org/10.1371/journal.pone.0050514			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	054WM	23226299	Green Submitted, Green Published, gold			2022-12-27	WOS:000312376100111
J	Luo, XJ; Li, M; Huang, L; Nho, K; Deng, M; Chen, Q; Weinberger, DR; Vasquez, AA; Rijpkema, M; Mattay, VS; Saykin, AJ; Shen, L; Fernandez, G; Franke, B; Chen, JC; Chen, XN; Wang, JK; Xiao, X; Qi, XB; Xiang, K; Peng, YM; Cao, XY; Li, Y; Shi, XD; Gan, L; Su, B				Luo, Xiong-jian; Li, Ming; Huang, Liang; Nho, Kwangsik; Deng, Min; Chen, Qiang; Weinberger, Daniel R.; Vasquez, Alejandro Arias; Rijpkema, Mark; Mattay, Venkata S.; Saykin, Andrew J.; Shen, Li; Fernandez, Guillen; Franke, Barbara; Chen, Jing-chun; Chen, Xiang-ning; Wang, Jin-kai; Xiao, Xiao; Qi, Xue-bin; Xiang, Kun; Peng, Ying-Mei; Cao, Xiang-yu; Li, Yi; Shi, Xiao-dong; Gan, Lin; Su, Bing		Alzheimers Dis Neuroimaging	The Interleukin 3 Gene (IL3) Contributes to Human Brain Volume Variation by Regulating Proliferation and Survival of Neural Progenitors	PLOS ONE			English	Article							COMMON VARIANTS; 1ST-EPISODE SCHIZOPHRENIA; ESTROGEN-RECEPTOR; CRANIAL VOLUME; NEURONAL DEATH; IN-VITRO; ASSOCIATION; SUSCEPTIBILITY; METAANALYSIS; LOCUS	One of the most significant evolutionary changes underlying the highly developed cognitive abilities of humans is the greatly enlarged brain volume. In addition to being far greater than in most other species, the volume of the human brain exhibits extensive variation and distinct sexual dimorphism in the general population. However, little is known about the genetic mechanisms underlying normal variation as well as the observed sex difference in human brain volume. Here we show that interleukin-3 (IL3) is strongly associated with brain volume variation in four genetically divergent populations. We identified a sequence polymorphism (rs31480) in the IL3 promoter which alters the expression of IL3 by affecting the binding affinity of transcription factor SP1. Further analysis indicated that IL3 and its receptors are continuously expressed in the developing mouse brain, reaching highest levels at postnatal day 1-4. Furthermore, we found IL3 receptor alpha (IL3RA) was mainly expressed in neural progenitors and neurons, and IL3 could promote proliferation and survival of the neural progenitors. The expression level of IL3 thus played pivotal roles in the expansion and maintenance of the neural progenitor pool and the number of surviving neurons. Moreover, we found that IL3 activated both estrogen receptors, but estrogen didn't directly regulate the expression of IL3. Our results demonstrate that genetic variation in the IL3 promoter regulates human brain volume and reveals novel roles of IL3 in regulating brain development.	[Luo, Xiong-jian; Huang, Liang; Deng, Min; Gan, Lin] Univ Rochester, Flaum Eye Inst, Rochester, NY 14627 USA; [Luo, Xiong-jian; Li, Ming; Wang, Jin-kai; Xiao, Xiao; Qi, Xue-bin; Xiang, Kun; Peng, Ying-Mei; Cao, Xiang-yu; Su, Bing] Chinese Acad Sci, Kunming Inst Zool, State Key Lab Genet Resources & Evolut, Kunming, Yunnan, Peoples R China; [Nho, Kwangsik; Saykin, Andrew J.; Shen, Li] Indiana Univ Sch Med, Dept Radiol & Imaging Sci, Ctr Neuroimaging, Indianapolis, IN USA; [Huang, Liang] Gannan Med Univ, Ganzhou, Jiangxi, Peoples R China; [Nho, Kwangsik] Indiana Univ Sch Med, Ctr Computat Biol & Bioinformat, Indianapolis, IN USA; [Nho, Kwangsik; Saykin, Andrew J.; Shen, Li] Regenstrief Inst Hlth Care, Indianapolis, IN USA; [Nho, Kwangsik; Saykin, Andrew J.; Shen, Li] Indiana Univ Sch Med, Dept Med & Mol Genet, Indianapolis, IN USA; [Chen, Qiang; Weinberger, Daniel R.; Mattay, Venkata S.] NIMH, Genes Cognit & Psychosis Program, NIH, Bethesda, MD 20892 USA; [Vasquez, Alejandro Arias; Franke, Barbara] Radboud Univ Nijmegen, Dept Genet, Med Ctr, NL-6525 ED Nijmegen, Netherlands; [Vasquez, Alejandro Arias; Franke, Barbara] Radboud Univ Nijmegen, Med Ctr, Donders Inst Brain Cognit & Behav, Dept Psychiat, NL-6525 ED Nijmegen, Netherlands; [Rijpkema, Mark; Fernandez, Guillen] Radboud Univ Nijmegen, Donders Inst Brain Cognit & Behav, Donders Ctr Cognit Neuroimaging, NL-6525 ED Nijmegen, Netherlands; [Fernandez, Guillen] Radboud Univ Nijmegen, Donders Inst Brain Cognit & Behav, Dept Cognit Neurosci, Med Ctr, NL-6525 ED Nijmegen, Netherlands; [Chen, Jing-chun; Chen, Xiang-ning] Virginia Commonwealth Univ, Virginia Inst Psychiat & Behav Genet, Richmond, VA USA; [Chen, Jing-chun; Chen, Xiang-ning] Virginia Commonwealth Univ, Dept Psychiat, Richmond, VA USA; [Li, Yi; Shi, Xiao-dong] Qujing Normal Univ, Biol Resources & Environm Sci Coll, Qujing, Yunnan, Peoples R China; [Gan, Lin] Hangzhou Normal Univ, Coll Life & Environm Sci, Hangzhou, Zhejiang, Peoples R China	University of Rochester; Chinese Academy of Sciences; Kunming Institute of Zoology; Indiana University System; Indiana University Bloomington; Gannan Medical University; Indiana University System; Indiana University Bloomington; Indiana University System; Indiana University-Purdue University Indianapolis; Regenstrief Institute Inc; Indiana University System; Indiana University Bloomington; National Institutes of Health (NIH) - USA; NIH National Institute of Mental Health (NIMH); Radboud University Nijmegen; Radboud University Nijmegen; Radboud University Nijmegen; Radboud University Nijmegen; Virginia Commonwealth University; Virginia Commonwealth University; Hangzhou Normal University	Gan, L (corresponding author), Univ Rochester, Flaum Eye Inst, Rochester, NY 14627 USA.	Lin_Gan@urmc.rochester.edu; sub@mail.kiz.ac.cn	Vasquez, Alejandro Arias/E-4762-2012; Franke, Barbara/D-4836-2009; Rijpkema, Mark/D-1974-2010; Fernandez, Guillen/B-3771-2009; chen, qiang/GWZ-7308-2022; Wang, Jinkai/H-1750-2015; Shen, Li/AAB-6870-2021; chen, qiang/HGU-5418-2022; Huang, Liang/AAH-1887-2021; Saykin, Andrew/A-1318-2007	Vasquez, Alejandro Arias/0000-0002-4786-0169; Franke, Barbara/0000-0003-4375-6572; Rijpkema, Mark/0000-0002-8495-4703; Fernandez, Guillen/0000-0002-5522-0604; Huang, Liang/0000-0002-8615-2595; Shen, Li/0000-0002-5443-0503; Chen, Jingchun/0000-0001-9408-0117; Wang, Jinkai/0000-0002-2577-7575; Saykin, Andrew/0000-0002-1376-8532	National 973 project of China [2011CBA00401]; National Natural Science Foundation of China [31130051, 31071101]; United States National Institute of Health [EY013426]; Hersenstichting Nederland; Biobanking and Biomolecular Resources Research Infrastructure; NATIONAL EYE INSTITUTE [R01EY013426] Funding Source: NIH RePORTER; NATIONAL LIBRARY OF MEDICINE [K99LM011384] Funding Source: NIH RePORTER	National 973 project of China(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); United States National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Hersenstichting Nederland; Biobanking and Biomolecular Resources Research Infrastructure; NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL LIBRARY OF MEDICINE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Library of Medicine (NLM))	This study was supported by grants from the National 973 project of China (2011CBA00401), the National Natural Science Foundation of China (31130051 and 31071101), and the United States National Institute of Health (EY013426 to L. G.). The Brain Imaging Genetics study is supported by the Hersenstichting Nederland and the Biobanking and Biomolecular Resources Research Infrastructure. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	APPEL K, 1995, J NEUROSCI, V15, P5800; Ashburner J, 2000, NEUROIMAGE, V11, P805, DOI 10.1006/nimg.2000.0582; Bajic VB, 2003, NUCLEIC ACIDS RES, V31, P3605, DOI 10.1093/nar/gkg517; Barrett JC, 2005, BIOINFORMATICS, V21, P263, DOI 10.1093/bioinformatics/bth457; BASSETT AS, 1988, LANCET, V1, P799; Bralten J, 2011, AM J PSYCHIAT, V168, P1083, DOI 10.1176/appi.ajp.2011.10101509; Buckner RL, 2004, NEUROIMAGE, V23, P724, DOI 10.1016/j.neuroimage.2004.06.018; Cahn W, 2002, ARCH GEN PSYCHIAT, V59, P1002, DOI 10.1001/archpsyc.59.11.1002; Camp NJ, 2001, AM J HUM GENET, V69, P1278, DOI 10.1086/324590; Campbell RA, 2001, J BIOL CHEM, V276, P9817, DOI 10.1074/jbc.M010840200; Cattaneo E, 1996, J BIOL CHEM, V271, P23374, DOI 10.1074/jbc.271.38.23374; Chen Q, 2008, MOL PSYCHIATR, V13, P930, DOI 10.1038/sj.mp.4002051; Chen X, 2007, MOL PSYCHIATR, V12, P273, DOI 10.1038/sj.mp.4001932; Chen XN, 2008, AM J PSYCHIAT, V165, P13, DOI 10.1176/appi.ajp.2007.07121868; Chen XN, 2006, HUM MOL GENET, V15, P3329, DOI 10.1093/hmg/ddl409; COCKAYNE DA, 1994, BLOOD, V84, P2699; Cuadra MB, 2005, IEEE T MED IMAGING, V24, P1548, DOI 10.1109/TMI.2005.857652; Dean B, 2009, AUST NZ J PSYCHIAT, V43, P13, DOI 10.1080/00048670802534416; Duan X, 2007, CELL, V130, P1146, DOI 10.1016/j.cell.2007.07.010; Edwards TL, 2008, SCHIZOPHR RES, V106, P208, DOI 10.1016/j.schres.2008.07.022; Fatemi SH, 2009, SCHIZOPHRENIA BULL, V35, P528, DOI 10.1093/schbul/sbn187; Franke B, 2010, BIOL PSYCHIAT, V68, P586, DOI 10.1016/j.biopsych.2010.05.037; FREI K, 1986, J IMMUNOL, V137, P3521; FREI K, 1985, J IMMUNOL, V135, P4044; Fujita PA, 2011, NUCLEIC ACIDS RES, V39, pD876, DOI 10.1093/nar/gkq963; Goldman AL, 2008, BIOL PSYCHIAT, V63, P475, DOI 10.1016/j.biopsych.2007.06.006; Goldman AL, 2009, ARCH GEN PSYCHIAT, V66, P467, DOI 10.1001/archgenpsychiatry.2009.24; Good CD, 2001, NEUROIMAGE, V14, P21, DOI 10.1006/nimg.2001.0786; Honea R, 2005, AM J PSYCHIAT, V162, P2233, DOI 10.1176/appi.ajp.162.12.2233; Ikram MA, 2012, NAT GENET, V44, P539, DOI 10.1038/ng.2245; Jack CR, 2008, J MAGN RESON IMAGING, V27, P685, DOI 10.1002/jmri.21049; JORGENSEN J, 1961, AM J PHYS ANTHROPOL, V19, P317, DOI 10.1002/ajpa.1330190402; KAMEGAI M, 1990, NEURON, V4, P429, DOI 10.1016/0896-6273(90)90055-K; KATO S, 1995, SCIENCE, V270, P1491, DOI 10.1126/science.270.5241.1491; Kumar A, 2002, J BIOSCIENCES, V27, P629, DOI 10.1007/BF02708369; Lencz T, 2007, MOL PSYCHIATR, V12, P572, DOI 10.1038/sj.mp.4001983; Lewis CM, 2003, AM J HUM GENET, V73, P34, DOI 10.1086/376549; Lewis DA, 2002, ANNU REV NEUROSCI, V25, P409, DOI 10.1146/annurev.neuro.25.112701.142754; Luo XJ, 2008, J MED GENET, V45, P818, DOI 10.1136/jmg.2008.060657; Manjunath K.Y., 2002, J ANAT SOC INDIA, V51, P85; Mao YW, 2009, CELL, V136, P1017, DOI 10.1016/j.cell.2008.12.044; McCarthy SE, 2009, NAT GENET, V41, P1223, DOI 10.1038/ng.474; MORONI SC, 1995, INT J DEV NEUROSCI, V13, P41, DOI 10.1016/0736-5748(94)00059-C; O'Donovan MC, 2008, NAT GENET, V40, P1053, DOI 10.1038/ng.201; Paunio T, 2001, HUM MOL GENET, V10, P3037, DOI 10.1093/hmg/10.26.3037; Pimm J, 2005, AM J HUM GENET, V76, P902, DOI 10.1086/430095; Posthuma D, 2003, TWIN RES, V6, P131, DOI 10.1375/twin.6.2.131; Posthuma D, 2002, NAT NEUROSCI, V5, P83, DOI 10.1038/nn0202-83; Potvin S, 2008, BIOL PSYCHIAT, V63, P801, DOI 10.1016/j.biopsych.2007.09.024; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Purcell SM, 2009, NATURE, V460, P748, DOI 10.1038/nature08185; Reddy EP, 2000, ONCOGENE, V19, P2532, DOI 10.1038/sj.onc.1203594; Ricard AS, 2010, SURG RADIOL ANAT, V32, P989, DOI 10.1007/s00276-010-0650-4; Rimol LM, 2010, P NATL ACAD SCI USA, V107, P384, DOI 10.1073/pnas.0908454107; Risacher SL, 2009, CURR ALZHEIMER RES, V6, P347, DOI 10.2174/156720509788929273; ROUSSET F, 1995, GENETICS, V140, P1413; RUSHTON JP, 1992, INTELLIGENCE, V16, P401, DOI 10.1016/0160-2896(92)90017-L; Saykin AJ, 2010, ALZHEIMERS DEMENT, V6, P265, DOI 10.1016/j.jalz.2010.03.013; Schaid DJ, 2002, AM J HUM GENET, V70, P425, DOI 10.1086/338688; Schneider A, 2005, J CLIN INVEST, V115, P2083, DOI 10.1172/JCI23559; Schwab SG, 1997, MOL PSYCHIATR, V2, P156, DOI 10.1038/sj.mp.4000263; SHERRINGTON R, 1988, NATURE, V336, P164, DOI 10.1038/336164a0; Shi JX, 2009, NATURE, V460, P753, DOI 10.1038/nature08192; Steen RG, 2006, BRIT J PSYCHIAT, V188, P510, DOI 10.1192/bjp.188.6.510; Stefansson H, 2009, NATURE, V460, P744, DOI 10.1038/nature08186; Stein JL, 2012, NAT GENET, V44, P552, DOI 10.1038/ng.2250; Stephens M, 2001, AM J HUM GENET, V68, P978, DOI 10.1086/319501; Straub RE, 1997, MOL PSYCHIATR, V2, P148, DOI 10.1038/sj.mp.4000258; Sun SL, 2008, NEUROSCI LETT, V440, P35, DOI 10.1016/j.neulet.2008.05.029; Taal HR, 2012, NAT GENET, V44, P532, DOI 10.1038/ng.2238; Tabira T, 1998, ANN NY ACAD SCI, V840, P107, DOI 10.1111/j.1749-6632.1998.tb09554.x; Thompson PM, 2001, NAT NEUROSCI, V4, P1253, DOI 10.1038/nn758; Valera EM, 2007, BIOL PSYCHIAT, V61, P1361, DOI 10.1016/j.biopsych.2006.06.011; Wang JK, 2008, HUM MOL GENET, V17, P1329, DOI 10.1093/hmg/ddn021; Wen TC, 1998, J EXP MED, V188, P635, DOI 10.1084/jem.188.4.635; Woods CG, 2005, AM J HUM GENET, V76, P717, DOI 10.1086/429930; Xiu MH, 2008, SCHIZOPHR RES, V106, P369, DOI 10.1016/j.schres.2008.09.001; Xu B, 2008, NAT GENET, V40, P880, DOI 10.1038/ng.162; Zambrano A, 2007, BMC NEUROSCI, V8, DOI 10.1186/1471-2202-8-82; Zhang JY, 2005, NEUROIMAGE, V26, P1042, DOI 10.1016/j.neuroimage.2005.03.009	80	26	27	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 30	2012	7	11							e50375	10.1371/journal.pone.0050375	http://dx.doi.org/10.1371/journal.pone.0050375			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	054WM	23226269	Green Submitted, Green Published, gold			2022-12-27	WOS:000312376100079
J	Nishimura, O; Brillada, C; Yazawa, S; Maffei, ME; Arimura, G				Nishimura, Osamu; Brillada, Carla; Yazawa, Shigenobu; Maffei, Massimo E.; Arimura, Gen-ichiro			Transcriptome Pyrosequencing of the Parasitoid Wasp Cotesia vestalis: Genes Involved in the Antennal Odorant-Sensory System	PLOS ONE			English	Article							MOSQUITO AEDES-AEGYPTI; BINDING PROTEINS; INSECT; RECEPTORS; PHEROMONE; EVOLUTION; FAMILIES; ORIGIN	Cotesia vestalis is an endoparasitic wasp that attacks larvae of the diamondback moth (Plutella xylostella), a herbivore of cruciferous plants. Females of C. vestalis use herbivore-induced plant odorants released from plants infested by P. xylostella as a host-searching cue. Transcriptome pyrosequencing was used to identify genes in the antennae of C. vestalis adult females coding for odorant receptors (ORs) and odorant binding proteins (OBPs) involved in insect olfactory perception. Quantitative gene expression analyses showed that a few OR and OBP genes were expressed exclusively in the antenna of C. vestalis adult females whereas most other classes of genes were expressed in the antennae of both males and females, indicating their diversity in importance for the olfactory sensory system. Together, transcriptome profiling of C. vestalis genes involved in the antennal odorant-sensory system helps in detecting genes involved in host-and food-search behaviors through infochemically-mediated interactions.	[Nishimura, Osamu; Yazawa, Shigenobu; Arimura, Gen-ichiro] Kyoto Univ, Global COE Program Evolut & Biodivers, Grad Sch Sci, Kyoto, Japan; [Brillada, Carla; Maffei, Massimo E.] Univ Turin, Dept Life Sci & Syst Biol, Plant Physiol Unit, Innovat Ctr, Turin, Italy; [Brillada, Carla; Arimura, Gen-ichiro] Kyoto Univ, Ctr Ecol Res, Otsu, Shiga, Japan	Kyoto University; University of Turin; Kyoto University	Arimura, G (corresponding author), Kyoto Univ, Global COE Program Evolut & Biodivers, Grad Sch Sci, Kyoto, Japan.	garimura@ecology.kyoto-u.ac.jp	Yazawa, Shigenobu/E-6395-2014; Nishimura, Osamu/AAC-1236-2020; Maffei, Massimo E/K-9593-2015	Yazawa, Shigenobu/0000-0003-4539-3875; Nishimura, Osamu/0000-0003-1969-2580; Maffei, Massimo E/0000-0001-6814-2353	Global COE Program A06 of Kyoto University; Core-to-Core Program from the Japan Society for the Promotion of Science (JSPS) [20004]; JSPS [24770019]	Global COE Program A06 of Kyoto University; Core-to-Core Program from the Japan Society for the Promotion of Science (JSPS); JSPS(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This work was financially supported in part by Global COE Program A06 of Kyoto University; the Core-to-Core Program from the Japan Society for the Promotion of Science (JSPS) (No.20004); and a Grant-in-Aid for Scientific Research from JSPS (No.24770019) to GA. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Arimura G, 2009, PLANT CELL PHYSIOL, V50, P911, DOI 10.1093/pcp/pcp030; Benton R, 2006, PLOS BIOL, V4, P240, DOI 10.1371/journal.pbio.0040020; Benton R, 2006, CELL MOL LIFE SCI, V63, P1579, DOI 10.1007/s00018-006-6130-7; Bohbot J, 2005, INSECT BIOCHEM MOLEC, V35, P961, DOI 10.1016/j.ibmb.2005.03.010; Carey AF, 2010, NATURE, V464, P66, DOI 10.1038/nature08834; Durand N, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015026; Foret S, 2006, GENOME RES, V16, P1404, DOI 10.1101/gr.5075706; Hallem EA, 2006, CELL, V125, P143, DOI 10.1016/j.cell.2006.01.050; Hansson BS, 2011, NEURON, V72, P698, DOI 10.1016/j.neuron.2011.11.003; Ishida Y, 2008, P NATL ACAD SCI USA, V105, P9076, DOI 10.1073/pnas.0802610105; Jones PL, 2011, P NATL ACAD SCI USA, V108, P8821, DOI 10.1073/pnas.1102425108; KELLOGG FE, 1970, J INSECT PHYSIOL, V16, P99, DOI 10.1016/0022-1910(70)90117-4; Kessler A, 2001, SCIENCE, V291, P2141, DOI 10.1126/science.291.5511.2141; Larsson MC, 2004, NEURON, V43, P703, DOI 10.1016/j.neuron.2004.08.019; Laughlin JD, 2008, CELL, V133, P1255, DOI 10.1016/j.cell.2008.04.046; MCIVER S, 1971, CAN J ZOOLOG, V49, P235, DOI 10.1139/z71-033; Nichols AS, 2011, CHEM SENSES, V36, P781, DOI 10.1093/chemse/bjr053; Pask GM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028774; Pelosi P, 2006, CELL MOL LIFE SCI, V63, P1658, DOI 10.1007/s00018-005-5607-0; PELOSI P, 1990, CHEM SENSES, V15, P205, DOI 10.1093/chemse/15.2.205; Pertea G, 2003, BIOINFORMATICS, V19, P651, DOI 10.1093/bioinformatics/btg034; Robertson HM, 2010, INSECT MOL BIOL, V19, P121, DOI 10.1111/j.1365-2583.2009.00979.x; Sanchez-Gracia A, 2009, HEREDITY, V103, P208, DOI 10.1038/hdy.2009.55; Sato K, 2008, NATURE, V452, P1002, DOI 10.1038/nature06850; Shiojiri K, 2000, APPL ENTOMOL ZOOL, V35, P87, DOI 10.1303/aez.2000.87; Shiojiri K, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012161; Su CY, 2009, CELL, V139, P45, DOI 10.1016/j.cell.2009.09.015; Swarup S, 2011, GENES BRAIN BEHAV, V10, P648, DOI 10.1111/j.1601-183X.2011.00704.x; Syed Z, 2006, P NATL ACAD SCI USA, V103, P16538, DOI 10.1073/pnas.0607874103; Vieira FG, 2011, GENOME BIOL EVOL, V3, P476, DOI 10.1093/gbe/evr033; Vosshall LB, 2011, CHEM SENSES, V36, P497, DOI 10.1093/chemse/bjr022; Werren JH, 2010, SCIENCE, V327, P343, DOI 10.1126/science.1178028; Wicher D, 2008, NATURE, V452, P1007, DOI 10.1038/nature06861; Zhang SA, 2011, J CHEM ECOL, V37, P189, DOI 10.1007/s10886-010-9902-3; Zhou JJ, 2008, INSECT MOL BIOL, V17, P147, DOI 10.1111/j.1365-2583.2007.00789.x; Zhou JJ, 2010, VITAM HORM, V83, P241, DOI 10.1016/S0083-6729(10)83010-9	37	33	39	3	71	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 30	2012	7	11							e50664	10.1371/journal.pone.0050664	http://dx.doi.org/10.1371/journal.pone.0050664			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	054WM	23226348	Green Submitted, Green Published, gold			2022-12-27	WOS:000312376100159
J	Postema, SG; van der Sluis, CK; Waldenlov, K; Hermansson, LMN				Postema, Sietke G.; van der Sluis, Corry K.; Waldenlov, Kristina; Hermansson, Liselotte M. Norling			Body Structures and Physical Complaints in Upper Limb Reduction Deficiency: A 24-Year Follow-Up Study	PLOS ONE			English	Article							SWEDISH CHILDREN; BRIEF PAIN; RELIABILITY; VALIDITY; SCOLIOMETER; SCOLIOSIS; HAND; ARM; SHOULDER; QUESTIONNAIRE	Objective: To describe upper body structures associated with upper limb reduction deficiency and the development of these structures over time, to examine the presence of physical complaints in this population, and to compare body structures and complaints between groups based on prosthesis use. Design: Prospective cohort study with a follow-up period of 24 years, with matched able-bodied controls. Subjects: Twenty-eight patients with unilateral below-elbow reduction deficiency fitted with myoelectric prostheses, aged 8-18 years at inclusion. Method: Measurements of upper arm, trunk and spine were performed and study-specific questionnaires were answered at baseline and follow-up; the Brief Pain Inventory and the Quick Disability of Arm, Shoulder, and Hand questionnaires were answered at follow-up. Results: Both at baseline and follow-up, within-subjects differences in structures of the arm and trunk were shown in patients but not in controls. Spinal deviations, although small, were greater in patients compared to controls. Self-reported disability was higher in patients compared to controls. Differences in back pain and effect of prostheses use could not be shown. Conclusions: Patients with unilateral below-elbow reduction deficiency have consistent differences in upper body structures. Deviations of the spine, probably of functional origin, do not progress to clinically relevant scoliosis. Citation: Postema SG, van der Sluis CK, Waldenlov K, Norling Hermansson LM (2012) Body Structures and Physical Complaints in Upper Limb Reduction Deficiency: A 24-Year Follow-Up Study. PLoS ONE 7(11): e49727. doi:10.1371/journal.pone.0049727	[Postema, Sietke G.; Hermansson, Liselotte M. Norling] Orebro Cty Council, Rehabil Res Ctr, Orebro, Sweden; [Postema, Sietke G.; van der Sluis, Corry K.] Univ Groningen, Univ Med Ctr Groningen, Dept Rehabil Med, Groningen, Netherlands; [Waldenlov, Kristina] Orebro Univ Hosp, Dept Paediat, Limb Deficiency & Arm Prosthesis Ctr, Orebro, Sweden; [Hermansson, Liselotte M. Norling] Orebro Cty Council, Dept Prosthet & Orthot, Orebro, Sweden; [Hermansson, Liselotte M. Norling] Univ Orebro, Sch Hlth & Med Sci, Orebro, Sweden	University of Groningen; Orebro University; Orebro University	Hermansson, LMN (corresponding author), Orebro Cty Council, Rehabil Res Ctr, Orebro, Sweden.	Liselotte.Hermansson@orebroll.se	Hermansson, Liselotte/W-8579-2019	Hermansson, Liselotte/0000-0003-4247-2236	Norrbacka-Eugenia foundation	Norrbacka-Eugenia foundation	This study was financially supported by the Norrbacka-Eugenia foundation, http://www.norrbacka-eugenia.se. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AMENDT LE, 1990, PHYS THER, V70, P108, DOI 10.1093/ptj/70.2.108; Atroshi I, 2000, ACTA ORTHOP SCAND, V71, P613, DOI 10.1080/000164700317362262; Bonagamba GH, 2010, BRAZ J PHYS THER, V14, P432, DOI 10.1590/S1413-35552010005000025; BUNNELL WP, 1984, J BONE JOINT SURG AM, V66A, P1381, DOI 10.2106/00004623-198466090-00010; Cleeland CS., 2009, BRIEF PAIN INVENTORY; Cote P, 1998, SPINE, V23, P796, DOI 10.1097/00007632-199804010-00011; Datta D, 2004, CLIN REHABIL, V18, P172, DOI 10.1191/0269215504cr716oa; Deltombe T, 2007, LYMPHOLOGY, V40, P26; Egermann M, 2009, INT ORTHOP, V33, P1101, DOI 10.1007/s00264-008-0615-y; Eriks-Hoogland IE, 2011, J REHABIL MED, V43, P210, DOI 10.2340/16501977-0655; Gambrell CR, 2008, J PROSTHET ORTHOT, V20, P126, DOI DOI 10.1097/JP0.0B013E31817ECB16; Greitemann B, 1996, Z ORTHOP GRENZGEB, V134, P498, DOI 10.1055/s-2008-1037445; Gummesson C, 2006, BMC MUSCULOSKEL DIS, V7, DOI 10.1186/1471-2474-7-44; Hermansson L, 2005, ACTA PAEDIATR, V94, P479, DOI 10.1080/08035250410022512; International Organisation for Standardization, 1989, 857811989E ISO; Jones LE, 1999, PROSTHET ORTHOT INT, V23, P55; Keller S, 2004, CLIN J PAIN, V20, P309, DOI 10.1097/00002508-200409000-00005; Korovessis PG, 1996, SPINE, V21, P1661, DOI 10.1097/00007632-199607150-00010; Kuyper MA, 2001, PROSTHET ORTHOT INT, V25, P228, DOI 10.1080/03093640108726606; McBeth J, 2007, BEST PRACT RES CL RH, V21, P403, DOI 10.1016/j.berh.2007.03.003; PEARSALL DJ, 1992, PHYS THER, V72, P648, DOI 10.1093/ptj/72.9.648; POWERS TA, 1983, J PEDIATR ORTHOPED, V3, P471, DOI 10.1097/01241398-198309000-00010; Pruijs J E, 1995, Eur Spine J, V4, P176, DOI 10.1007/BF00298242; Samuelsson L, 1997, J PEDIATR ORTHOPED, V17, P769, DOI 10.1097/00004694-199711000-00013; Shaperman J., 2003, JPO J PROSTHETICS OR, V15, P11, DOI [10.1097/00008526-200301000-00004, DOI 10.1097/00008526-200301000-00004]; Tan G, 2004, J PAIN, V5, P133, DOI 10.1016/j.jpain.2003.12.005; Taylor R, 2006, PHYS THER, V86, P205, DOI 10.1093/ptj/86.2.205; van Stuivenberg-Vrielink C, 2010, PROSTHET ORTHOT INT, V34, P20, DOI 10.3109/03093640902929285; VANALLEN MI, 1981, PEDIATR ANN, V10, P219; VARNI JW, 1989, J PEDIATR PSYCHOL, V14, P515, DOI 10.1093/jpepsy/14.4.515; WILLNER S, 1979, ACTA ORTHOP SCAND, V50, P295, DOI 10.3109/17453677908989770; Ylimainen K, 2010, ACTA PAEDIATR, V99, P1550, DOI 10.1111/j.1651-2227.2010.01855.x	32	10	10	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 30	2012	7	11							e49727	10.1371/journal.pone.0049727	http://dx.doi.org/10.1371/journal.pone.0049727			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	054WM	23226218	Green Submitted, Green Published, gold			2022-12-27	WOS:000312376100026
J	Reis, MIR; do Vale, A; Pereira, PJB; Azevedo, JE; dos Santos, NMS				Reis, Marta I. R.; do Vale, Ana; Pereira, Pedro J. B.; Azevedo, Jorge E.; dos Santos, Nuno M. S.			Caspase-1 and IL-1 beta Processing in a Teleost Fish	PLOS ONE			English	Article							INTERLEUKIN-1-BETA CONVERTING-ENZYME; AMINO-ACID-SEQUENCE; MOLECULAR-CLONING; EXPRESSION ANALYSIS; RAINBOW-TROUT; SUBSTRATE-SPECIFICITY; NUCLEOTIDE-SEQUENCE; CHANNEL CATFISH; CDNA CLONING; MACROPHAGES	Interleukine-1 beta (IL-1 beta) is the most studied pro-inflammatory cytokine, playing a central role in the generation of systemic and local responses to infection, injury, and immunological challenges. In mammals, IL-1 beta is synthesized as an inactive 31 kDa precursor that is cleaved by caspase-1 generating a 17.5 kDa secreted active mature form. The caspase-1 cleavage site strictly conserved in all mammalian IL-1 beta sequences is absent in IL-1 beta sequences reported for non-mammalian vertebrates. Recently, fish caspase-1 orthologues have been identified in sea bass (Dicentrarchus labrax) and sea bream (Sparus aurata) but very little is known regarding their processing and activity. In this work it is shown that sea bass caspase-1 auto-processing is similar to that of the human enzyme, resulting in active p24/p10 and p20/p10 heterodimers. Moreover, the presence of alternatively spliced variants of caspase-1 in sea bass is reported. The existence of caspase-1 isoforms in fish and in mammals suggests that they have been evolutionarily maintained and therefore are likely to play a regulatory role in the inflammatory response, as shown for other caspases. Finally, it is shown that sea bass and avian IL-1 beta are specifically cleaved by caspase-1 at different but phylogenetically conserved aspartates, distinct from the cleavage site of mammalian IL-1 beta.	[Reis, Marta I. R.; do Vale, Ana; Pereira, Pedro J. B.; Azevedo, Jorge E.; dos Santos, Nuno M. S.] Univ Porto, IBMC, P-4100 Oporto, Portugal; [Reis, Marta I. R.; Azevedo, Jorge E.] Univ Porto, ICBAS, P-4100 Oporto, Portugal	Universidade do Porto; Universidade do Porto	dos Santos, NMS (corresponding author), Univ Porto, IBMC, Rua Campo Alegre 823, P-4100 Oporto, Portugal.	nsantos@ibmc.up.pt	do Vale, Ana/J-9380-2013; Santos, Nuno MS dos/J-8558-2013; Azevedo, Jorge E/A-4113-2008; Pereira, Pedro/F-8972-2011; Reis, Marta/J-7459-2013	do Vale, Ana/0000-0002-4044-6328; Santos, Nuno MS dos/0000-0002-5960-0647; Azevedo, Jorge E/0000-0001-7714-5302; Pereira, Pedro/0000-0003-0969-5438; Reis, Marta/0000-0002-2536-3284	Portuguese Science and Technology Foundation (FCT) [PTDC/CVT/69086/2006, FCOMP-01-0124-FEDER-007173]; FCT [SFRH/BD/37717/2007]; Programa Ciencia; Programa Operacional Potencial Humano POPH - QREN - Tipologia 4.2 - Promocao do Emprego Cientifico; Fundo Social Europeu; Ministry of Science, Technology and Higher Education (MCTES)	Portuguese Science and Technology Foundation (FCT)(Portuguese Foundation for Science and Technology); FCT(Portuguese Foundation for Science and TechnologyEuropean Commission); Programa Ciencia(Spanish Government); Programa Operacional Potencial Humano POPH - QREN - Tipologia 4.2 - Promocao do Emprego Cientifico; Fundo Social Europeu; Ministry of Science, Technology and Higher Education (MCTES)	This work was supported by a grant (PTDC/CVT/69086/2006; FCOMP-01-0124-FEDER-007173) from the Portuguese Science and Technology Foundation (FCT). MIRR was the recipient of FCT fellowship SFRH/BD/37717/2007. AdV was supported by Programa Ciencia - financed by Programa Operacional Potencial Humano POPH - QREN - Tipologia 4.2 - Promocao do Emprego Cientifico, co-funded by Fundo Social Europeu and National funding from Ministry of Science, Technology and Higher Education (MCTES). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Afonso A, 1997, FISH SHELLFISH IMMUN, V7, P335, DOI 10.1006/fsim.1997.0089; ALNEMRI ES, 1995, J BIOL CHEM, V270, P4312, DOI 10.1074/jbc.270.9.4312; Angelastro JM, 2001, J BIOL CHEM, V276, P12190, DOI 10.1074/jbc.M009523200; AURON PE, 1984, P NATL ACAD SCI-BIOL, V81, P7907, DOI 10.1073/pnas.81.24.7907; Ausubel F., 1999, CURRENT PROTOCOLS MO; AYALA JM, 1994, J IMMUNOL, V153, P2592; Bergsbaken T, 2009, NAT REV MICROBIOL, V7, P99, DOI 10.1038/nrmicro2070; Bird S, 2002, CYTOKINE GROWTH F R, V13, P483, DOI 10.1016/S1359-6101(02)00028-X; Bird S, 2002, J IMMUNOL, V168, P3329, DOI 10.4049/jimmunol.168.7.3329; BLACK RA, 1989, FEBS LETT, V247, P386, DOI 10.1016/0014-5793(89)81376-6; Brennan MA, 2000, MOL MICROBIOL, V38, P31, DOI 10.1046/j.1365-2958.2000.02103.x; Buonocore F, 2004, MAR BIOTECHNOL, V6, P53, DOI 10.1007/s10126-003-0011-y; Burns K, 2003, CURR OPIN IMMUNOL, V15, P26, DOI 10.1016/S0952-7915(02)00017-1; CAMERON P, 1985, J EXP MED, V162, P790, DOI 10.1084/jem.162.3.790; CASANO FJ, 1994, GENOMICS, V20, P474, DOI 10.1006/geno.1994.1203; CERRETTI DP, 1994, GENOMICS, V20, P468, DOI 10.1006/geno.1994.1202; CERRETTI DP, 1992, SCIENCE, V256, P97, DOI 10.1126/science.1373520; Chen M, 2009, NAT REV MOL CELL BIO, V10, P741, DOI 10.1038/nrm2777; Cheng CS, 2011, MOL IMMUNOL, V48, P947, DOI 10.1016/j.molimm.2011.01.002; Corripio-Miyar Y, 2007, MOL IMMUNOL, V44, P1361, DOI 10.1016/j.molimm.2006.05.010; Davis BK, 2011, ANNU REV IMMUNOL, V29, P707, DOI 10.1146/annurev-immunol-031210-101405; Dinarello CA, 1998, ANN NY ACAD SCI, V856, P1, DOI 10.1111/j.1749-6632.1998.tb08307.x; Dinarello CA, 2009, ANNU REV IMMUNOL, V27, P519, DOI 10.1146/annurev.immunol.021908.132612; do Vale A, 2005, MOL MICROBIOL, V58, P1025, DOI 10.1111/j.1365-2958.2005.04893.x; do Vale A, 2002, FISH SHELLFISH IMMUN, V13, P183, DOI 10.1006/fsim.2001.0394; Eder C, 2009, IMMUNOBIOLOGY, V214, P543, DOI 10.1016/j.imbio.2008.11.007; ELLSAESSER CF, 1994, CYTOKINE, V6, P10, DOI 10.1016/1043-4666(94)90002-7; Fantuzzi G, 1997, J IMMUNOL, V158, P1818; Franchi L, 2009, NAT IMMUNOL, V10, P241, DOI 10.1038/ni.1703; Guarda G, 2010, IMMUNOLOGY, V130, P329, DOI 10.1111/j.1365-2567.2010.03283.x; HOGQUIST KA, 1991, P NATL ACAD SCI USA, V88, P8485, DOI 10.1073/pnas.88.19.8485; Hong S, 2001, VET IMMUNOL IMMUNOP, V81, P1, DOI 10.1016/S0165-2427(01)00328-2; Hong SH, 2004, FISH SHELLFISH IMMUN, V16, P453, DOI 10.1016/j.fsi.2003.08.002; HOWARD AD, 1991, J IMMUNOL, V147, P2964; Jiang SG, 2008, FISH SHELLFISH IMMUN, V24, P323, DOI 10.1016/j.fsi.2007.11.020; Keren H, 2010, NAT REV GENET, V11, P345, DOI 10.1038/nrg2776; KOSTURA MJ, 1989, P NATL ACAD SCI USA, V86, P5227, DOI 10.1073/pnas.86.14.5227; Kumar S, 2004, BRIEF BIOINFORM, V5, P150, DOI 10.1093/bib/5.2.150; Lamkanfi M, 2009, IMMUNOL REV, V227, P95, DOI 10.1111/j.1600-065X.2008.00730.x; Latz E, 2010, CURR OPIN IMMUNOL, V22, P28, DOI 10.1016/j.coi.2009.12.004; Lee DS, 2006, COMP BIOCHEM PHYS A, V143, P307, DOI 10.1016/j.cbpa.2005.12.014; LIMJUCO G, 1986, P NATL ACAD SCI USA, V83, P3972, DOI 10.1073/pnas.83.11.3972; Lopez-Castejon G, 2008, MOL IMMUNOL, V45, P49, DOI 10.1016/j.molimm.2007.05.015; Lu DQ, 2008, MOL IMMUNOL, V45, P857, DOI 10.1016/j.molimm.2007.08.009; MARCH CJ, 1985, NATURE, V315, P641, DOI 10.1038/315641a0; Martinez FO, 2009, ANNU REV IMMUNOL, V27, P451, DOI 10.1146/annurev.immunol.021908.132532; Masumoto J, 2003, J BIOL CHEM, V278, P4268, DOI 10.1074/jbc.M203944200; Mathew JA, 2002, FISH SHELLFISH IMMUN, V13, P85, DOI 10.1006/fsim.2001.0383; McIntire CR, 2009, APOPTOSIS, V14, P522, DOI 10.1007/s10495-009-0312-3; Miao EA, 2011, IMMUNOL REV, V243, P206, DOI 10.1111/j.1600-065X.2011.01044.x; MILLER DK, 1993, J BIOL CHEM, V268, P18062; MOLINEAUX SM, 1993, P NATL ACAD SCI USA, V90, P1809, DOI 10.1073/pnas.90.5.1809; NEEDLEMAN SB, 1970, J MOL BIOL, V48, P443, DOI 10.1016/0022-2836(70)90057-4; Netea MG, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000661; NETT MA, 1992, J IMMUNOL, V149, P3254; O'Neill LAJ, 2008, IMMUNOL REV, V226, P10, DOI 10.1111/j.1600-065X.2008.00701.x; Pedra JHF, 2009, CURR OPIN IMMUNOL, V21, P10, DOI 10.1016/j.coi.2009.01.006; Pelegrin P, 2004, DEV COMP IMMUNOL, V28, P229, DOI 10.1016/j.dci.2003.08.002; Pelegrin P, 2001, CYTOKINE, V16, P67, DOI 10.1006/cyto.2001.0949; RAMAGE P, 1995, J BIOL CHEM, V270, P9378, DOI 10.1074/jbc.270.16.9378; Sakamaki K, 2009, J FISH BIOL, V74, P727, DOI 10.1111/j.1095-8649.2009.02184.x; Scapigliati G, 2001, FISH SHELLFISH IMMUN, V11, P711, DOI 10.1006/fsim.2001.0347; Scott AM, 2007, CELL DEATH DIFFER, V14, P23, DOI 10.1038/sj.cdd.4402026; Secombes CJ, 2011, DEV COMP IMMUNOL, V35, P1336, DOI 10.1016/j.dci.2011.05.001; Seol DW, 1999, J BIOL CHEM, V274, P2072, DOI 10.1074/jbc.274.4.2072; Seppola M, 2008, MOL IMMUNOL, V45, P887, DOI 10.1016/j.molimm.2007.08.003; Sims JE, 2010, NAT REV IMMUNOL, V10, P89, DOI 10.1038/nri2691; SLEATH PR, 1990, J BIOL CHEM, V265, P14526; Snipas SJ, 2008, CELL DEATH DIFFER, V15, P938, DOI 10.1038/cdd.2008.23; Srinivasula SM, 1999, CANCER RES, V59, P999; STET RJM, 1993, DEV COMP IMMUNOL, V17, P141, DOI 10.1016/0145-305X(93)90024-K; Strowig T, 2012, NATURE, V481, P278, DOI 10.1038/nature10759; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; THORNBERRY NA, 1992, NATURE, V356, P768, DOI 10.1038/356768a0; Vegran F, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0029058; VERBURGVANKEMENADE BM, 1995, DEV COMP IMMUNOL, V19, P59, DOI 10.1016/0145-305X(94)00047-J; Wang DL, 2010, NAT IMMUNOL, V11, P905, DOI 10.1038/ni.1925; Wang YP, 2006, MOL IMMUNOL, V43, P1653, DOI 10.1016/j.molimm.2005.09.024; Weining KC, 1998, EUR J BIOCHEM, V258, P994, DOI 10.1046/j.1432-1327.1998.2580994.x; Wu YF, 2007, VET IMMUNOL IMMUNOP, V116, P37, DOI 10.1016/j.vetimm.2006.12.010; Yamin TT, 1996, J BIOL CHEM, V271, P13273, DOI 10.1074/jbc.271.22.13273; Zou J, 1999, CYTOKINE, V11, P552, DOI 10.1006/cyto.1998.0470	83	60	63	1	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 30	2012	7	11							e50450	10.1371/journal.pone.0050450	http://dx.doi.org/10.1371/journal.pone.0050450			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	054WM	23226286	Green Submitted, gold, Green Published			2022-12-27	WOS:000312376100098
J	Runyon, RS; Cachola, LM; Rajeshuni, N; Hunter, T; Garcia, M; Ahn, R; Lurmann, F; Krasnow, R; Jack, LM; Miller, RL; Swan, GE; Kohli, A; Jacobson, AC; Nadeau, KC				Runyon, R. Scott; Cachola, Leslie M.; Rajeshuni, Nitya; Hunter, Tessa; Garcia, Marco; Ahn, Regina; Lurmann, Fred; Krasnow, Ruth; Jack, Lisa M.; Miller, Rachel L.; Swan, Gary E.; Kohli, Arunima; Jacobson, Amanda C.; Nadeau, Kari C.			Asthma Discordance in Twins Is Linked to Epigenetic Modifications of T Cells	PLOS ONE			English	Article							ENVIRONMENTAL TOBACCO-SMOKE; DNA METHYLATION; FOXP3; DISEASES; TRANSCRIPTION; POPULATION; CHILDHOOD; GENOTYPE; EXPOSURE; MICE	T cells mediate the inflammatory responses observed in asthma among genetically susceptible individuals and have been suspected to be prone to epigenetic regulation. However, these relationships are not well established from past clinical studies that have had limited capacity to control for the effects of variable genetic predisposition and early environmental exposures. Relying on a cohort of monozygotic twins discordant for asthma we sought to determine if epigenetic modifications in T cells were associated with current asthma and explored whether such modifications were associated with second hand smoke exposures. Our study was conducted in a monozygotic twin cohort of adult twin pairs (n = 21) all discordant for asthma. Regulatory T cell (Treg) and effector T cell (Teff) subsets were assessed for levels of cellular function, protein expression, gene expression and CpG methylation within Forkhead box P3 (FOXP3) and interferon gamma-gamma (IFN gamma) loci. Comparisons by asthma and current report of exposure to second hand smoke were made. Treg from asthmatic discordant twins demonstrated decreased FOXP3 protein expression and impaired Treg function that was associated with increased levels of CpG methylation within the FOXP3 locus when compared to their non-asthmatic twin partner. In parallel, Teff from discordant asthmatic twins demonstrated increased methylation of the IFN gamma locus, decreased IFN gamma expression and reduced Teff function when compared to Teff from the non-asthmatic twin. Finally, report of current exposure to second hand smoke was associated with modifications in both Treg and Teff at the transcriptional level among asthmatics. The results of the current study provide evidence for differential function of T cell subsets in monozygotic twins discordant for asthma that are regulated by changes in DNA methylation. Our preliminary data suggest exposure to second hand smoke may augment the modified T cell responses associated with asthma.	[Runyon, R. Scott; Cachola, Leslie M.; Rajeshuni, Nitya; Hunter, Tessa; Garcia, Marco; Ahn, Regina; Kohli, Arunima; Jacobson, Amanda C.; Nadeau, Kari C.] Stanford Univ, Dept Pediat, Sch Med, Stanford, CA 94305 USA; [Lurmann, Fred] Sonoma Technol Inc, Petaluma, CA USA; [Krasnow, Ruth; Jack, Lisa M.; Swan, Gary E.] SRI Int, Ctr Hlth Sci, Menlo Pk, CA 94025 USA; [Miller, Rachel L.] Columbia Univ Coll Phys & Surg, Div Pulm Allergy & Crit Care Med, New York, NY 10032 USA	Stanford University; SRI International; Columbia University	Nadeau, KC (corresponding author), Stanford Univ, Dept Pediat, Sch Med, Stanford, CA 94305 USA.	knadeau@stanford.edu		Jack, Lisa/0000-0003-0340-6578	Stanford University School of Medicine Institute of Immunity, Transplantation, and Infectious Disease; Lucile Packard Foundation; SRI's Center for Health Sciences; National Institutes of Health [DA011170, DA023063, AI057229, AI090019]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U19AI090019, U19AI057229] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA011170, R01DA023063] Funding Source: NIH RePORTER	Stanford University School of Medicine Institute of Immunity, Transplantation, and Infectious Disease; Lucile Packard Foundation(The David & Lucile Packard Foundation); SRI's Center for Health Sciences; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	Funding was provided by Stanford University School of Medicine Institute of Immunity, Transplantation, and Infectious Disease, the Lucile Packard Foundation, SRI's Center for Health Sciences, and through various grants from the National Institutes of Health including: DA011170, DA023063, AI057229, and AI090019. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Benowitz NL, 2009, AM J EPIDEMIOL, V170, P885, DOI 10.1093/aje/kwp215; Bjorksten B, 1996, TOXICOL LETT, V86, P93, DOI 10.1016/0378-4274(96)03679-X; Bjorksten B, 1999, ALLERGY, V54, P17, DOI 10.1111/j.1398-9995.1999.tb04383.x; Bocklandt S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014821; Boks MP, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006767; Breton CV, 2009, AM J RESP CRIT CARE, V180, P462, DOI 10.1164/rccm.200901-0135OC; Comhair SAA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018574; Eisner MD, 2002, ENVIRON HEALTH PERSP, V110, P765, DOI 10.1289/ehp.02110765; Fontenot JD, 2003, NAT IMMUNOL, V4, P330, DOI 10.1038/ni904; Fraga MF, 2005, P NATL ACAD SCI USA, V102, P10604, DOI 10.1073/pnas.0500398102; Fyhrquist N, 2012, J INVEST DERMATOL, V132, P1672, DOI 10.1038/jid.2012.40; Guerrero-Preston R, 2010, EPIGENETICS-US, V5, DOI 10.4161/epi.5.6.12378; Hawkins SS, 2011, J ADOLESCENT HEALTH, V48, P647, DOI 10.1016/j.jadohealth.2010.09.017; Hori S, 2003, SCIENCE, V299, P1057, DOI 10.1126/science.1079490; Hunter DJ, 2005, NAT REV GENET, V6, P287, DOI 10.1038/nrg1578; Jaakkola MS, 2003, AM J PUBLIC HEALTH, V93, P2055, DOI 10.2105/AJPH.93.12.2055; Jones B, 2006, EMBO J, V25, P2443, DOI 10.1038/sj.emboj.7601148; Lal G, 2009, BLOOD, V114, P3727, DOI 10.1182/blood-2009-05-219584; Lal G, 2009, J IMMUNOL, V182, P259, DOI 10.4049/jimmunol.182.1.259; Lin W, 2005, J ALLERGY CLIN IMMUN, V116, P1106, DOI 10.1016/j.jaci.2005.08.046; Liu X, 2009, CLIN EXP ALLERGY, V39, P991, DOI 10.1111/j.1365-2222.2009.03228.x; Lloyd CM, 2009, IMMUNITY, V31, P438, DOI 10.1016/j.immuni.2009.08.007; Meiler F, 2008, ALLERGY, V63, P1455, DOI 10.1111/j.1398-9995.2008.01774.x; Miller RL, 2008, AM J RESP CRIT CARE, V177, P567, DOI 10.1164/rccm.200710-1511PP; Moraes-Vasconcelos D, 2008, J CLIN IMMUNOL, V28, pS11, DOI 10.1007/s10875-008-9176-5; Morales E, 2012, AM J RESP CRIT CARE, V185, P937, DOI 10.1164/rccm.201105-0870OC; Nadeau K, 2010, J ALLERGY CLIN IMMUN, V126, P845, DOI 10.1016/j.jaci.2010.08.008; Nguyen KD, 2008, J IMMUNOL, V181, P5386, DOI 10.4049/jimmunol.181.8.5386; Nguyen KD, 2009, AM J RESP CRIT CARE, V180, P823, DOI 10.1164/rccm.200905-0761OC; Palomares O, 2010, EUR J IMMUNOL, V40, P1232, DOI 10.1002/eji.200940045; Swan GE, 2004, TWIN RES, V7, P435, DOI 10.1375/twin.7.5.435; Swan GE, 2005, PHARMACOGENOMICS J, V5, P21, DOI 10.1038/sj.tpj.6500281; Thomsen SF, 2010, CLIN EXP ALLERGY, V40, P1054, DOI 10.1111/j.1365-2222.2010.03525.x; Thomson NC, 2007, CURR ALLERGY ASTHM R, V7, P303, DOI 10.1007/s11882-007-0045-8; Wilhelm-Benartzi CS, 2011, CANCER CAUSE CONTROL, V22, P1205, DOI 10.1007/s10552-011-9788-6; Ziegler SF, 2006, ANNU REV IMMUNOL, V24, P209, DOI 10.1146/annurev.immunol.24.021605.090547	37	74	79	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 30	2012	7	11							e48796	10.1371/journal.pone.0048796	http://dx.doi.org/10.1371/journal.pone.0048796			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	054WM	23226205	Green Published, gold, Green Submitted			2022-12-27	WOS:000312376100014
J	Shen, X; Xia, Z; Li, XQ; Wu, J; Wang, LL; Li, J; Jiang, Y; Guo, JT; Chen, J; Hong, JJ; Yuan, Z; Pan, QC; DeRiemer, K; Sun, GM; Gao, Q; Mei, J				Shen, Xin; Xia, Zhen; Li, Xiangqun; Wu, Jie; Wang, Lili; Li, Jing; Jiang, Yuan; Guo, Juntao; Chen, Jing; Hong, Jianjun; Yuan, Zheng'an; Pan, Qichao; DeRiemer, Kathryn; Sun, Guomei; Gao, Qian; Mei, Jian			Tuberculosis in an Urban Area in China: Differences between Urban Migrants and Local Residents	PLOS ONE			English	Article							LOW-INCIDENCE COUNTRY; SHANGHAI; EPIDEMIOLOGY; IMMIGRANTS; RISK; TB	Background: The increase in urban migrants is one of major challenges for tuberculosis control in China. The different characteristics of tuberculosis cases between urban migrants and local residents in China have not been investigated before. Methodology/Principal Findings: We performed a retrospective study of all pulmonary tuberculosis patients reported in Songjiang district, Shanghai, to determine the demographic, clinical and microbiological characteristics of tuberculosis cases between urban migrants and local residents. We calculated the odds ratios (OR) and performed multivariate logistic regression to identify the characteristics that were independently associated with tuberculosis among urban migrants. A total of 1,348 pulmonary tuberculosis cases were reported during 2006-2008, among whom 440 (32.6%) were local residents and 908 (67.4%) were urban migrants. Urban migrant (38.9/100,000 population) had higher tuberculosis rates than local residents (27.8/100,000 population), and the rates among persons younger than age 35 years were 3 times higher among urban migrants than among local residents. Younger age (adjusted OR per additional year at risk = 0.92, 95% CI: 0.91-0.94, p<0.001), poor treatment outcome (adjusted OR = 4.12, 95% CI: 2.65-5.72, p<0.001), and lower frequency of any comorbidity at diagnosis (adjusted OR = 0.20, 95% CI: 0.13-0.26, p = 0.013) were significantly associated with tuberculosis patients among urban migrants. There were poor treatment outcomes among urban migrants, mainly from transfers to another jurisdiction (19.3% of all tuberculosis patients among urban migrants). Conclusions/Significance: A considerable proportion of tuberculosis cases in Songjiang district, China, during 2006-2008 occurred among urban migrants. Our findings highlight the need to develop and implement specific tuberculosis control strategies for urban migrants, such as more exhaustive case finding, improved case management and follow-up, and use of directly observed therapy (DOT).	[Shen, Xin; Sun, Guomei; Gao, Qian] Fudan Univ, Shanghai Med Coll, Key Lab Med Mol Virol, Shanghai 200433, Peoples R China; [Shen, Xin; Xia, Zhen; Li, Xiangqun; Wu, Jie; Wang, Lili; Li, Jing; Jiang, Yuan; Guo, Juntao; Chen, Jing; Yuan, Zheng'an; Pan, Qichao; Mei, Jian] Shanghai Municipal Ctr Dis Control & Prevent, Dept TB Control, Shanghai, Peoples R China; [Hong, Jianjun] Songjiang Dist Ctr Dis Control & Prevent, Dept TB Control, Shanghai, Peoples R China; [DeRiemer, Kathryn] Univ Calif Davis, Sch Med, Davis, CA 95616 USA	Fudan University; Shanghai Center for Disease Control & Prevention; Shanghai Center for Disease Control & Prevention; University of California System; University of California Davis	Gao, Q (corresponding author), Fudan Univ, Shanghai Med Coll, Key Lab Med Mol Virol, Shanghai 200433, Peoples R China.	qgao99@yahoo.com; meijiansh@yahoo.com.cn		DeRiemer, Kathryn/0000-0002-8375-7505	Science and Technology Commission of Shanghai Municipality [10JC1413700, 11ZR1430900]; Shanghai Municipal Health Bureau [XYQ2011051]; National Institutes of Health, United States of America [D43TW007887]; FOGARTY INTERNATIONAL CENTER [D43TW007887] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [DP2OD006452] Funding Source: NIH RePORTER	Science and Technology Commission of Shanghai Municipality(Science & Technology Commission of Shanghai Municipality (STCSM)); Shanghai Municipal Health Bureau; National Institutes of Health, United States of America(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); FOGARTY INTERNATIONAL CENTER(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This study was supported by the Science and Technology Commission of Shanghai Municipality (grants 10JC1413700 and 11ZR1430900), Shanghai Municipal Health Bureau (grant XYQ2011051), and the National Institutes of Health, United States of America (grant D43TW007887). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baker MA, BMC MED, V9, P81; Borgdorff MW, 2005, EMERG INFECT DIS, V11, P597, DOI 10.3201/eid1104.041103; Cain KP, 2008, JAMA-J AM MED ASSOC, V300, P405, DOI 10.1001/jama.300.4.405; Chen J, 2010, IMPROVING TB CONTROL; Chen XY, 2004, LANCET, V364, P417; Dooley KE, 2009, LANCET INFECT DIS, V9, P737, DOI 10.1016/S1473-3099(09)70282-8; Feng W, 2002, INT MIGR REV, V36, P520, DOI 10.1111/j.1747-7379.2002.tb00091.x; Garcia-Garcia JM, PLOS ONE, V6; Jia Z, J EVID BASED MED; Jia ZW, 2008, EMERG INFECT DIS, V14, P1413, DOI [10.3201/1409.071543, 10.3201/eid1409.071543]; Laifer G, 2007, AM J MED, V120, P350, DOI 10.1016/j.amjmed.2006.10.025; Li J, 2012, CHINESE J ANTITUBERC, V34, P310; Lillebaek T, 2002, EMERG INFECT DIS, V8, P679, DOI 10.3201/eid0807.010482; Ministry of Health, DIAGN CRIT PULM TUB; Odone A, BMC PUBLIC HLTH, V11, P376; Peng XZ, 2011, SCIENCE, V333, P581, DOI 10.1126/science.1209396; Roberts KD, 2000, RURAL LABOR FLOWS CH; Saukkonen JJ, 2006, AM J RESP CRIT CARE, V174, P935, DOI 10.1164/rccm.200510-1666ST; Shang PH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021836; Shen J., 2003, ASIA PAC VIEWP, V44, P51, DOI [10.1111/1467-8373.t01-1-00183, DOI 10.1111/1467-8373.T01-1-00183]; Shen X, 2009, INT J TUBERC LUNG D, V13, P253; Shen X, 2009, BMC INFECT DIS, V9, DOI 10.1186/1471-2334-9-95; Tan S, 2000, RURAL LABOR FLOWS CH; Tanaka M, 2011, J EPIDEMIOL, V21, P401, DOI 10.2188/jea.JE20100190; Wang LD, 2007, LANCET, V369, P691, DOI 10.1016/S0140-6736(07)60316-X; Wang W, 2011, EUR J CLIN MICROBIOL, V30, P581, DOI 10.1007/s10096-010-1125-6; Wang YP, 2000, INT J URBAN REGIONAL, V24, P397, DOI 10.1111/1468-2427.00254; Wei XL, 2009, TROP MED INT HEALTH, V14, P754, DOI 10.1111/j.1365-3156.2009.02286.x; WHO, 2011, WHO GLOBAL TUBERCULO; Wong DFK, 2007, INT J SOC WELF, V16, P32, DOI 10.1111/j.1468-2397.2007.00475.x; World Bank, 2011, HLTH HARMONIOUS LIFE; World Health Organization (WHO), 2009, WHOHTMTB2009420; Zhang LX, 2006, INT J TUBERC LUNG D, V10, P959	33	16	17	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 30	2012	7	11							e51133	10.1371/journal.pone.0051133	http://dx.doi.org/10.1371/journal.pone.0051133			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	054WM	23226479	gold, Green Submitted, Green Published			2022-12-27	WOS:000312376100290
J	Tang, X; Wen, Q; Kuhlenschmidt, TB; Kuhlenschmidt, MS; Janmey, PA; Saif, TA				Tang, Xin; Wen, Qi; Kuhlenschmidt, Theresa B.; Kuhlenschmidt, Mark S.; Janmey, Paul A.; Saif, Taher A.			Attenuation of Cell Mechanosensitivity in Colon Cancer Cells during In Vitro Metastasis	PLOS ONE			English	Article							E-CADHERIN; ADHESION; FORCE; EXPRESSION; MECHANICS; SUBSTRATE; STIFFNESS; MECHANOTRANSDUCTION; PHENOTYPE; COLLAGEN	Human colon carcinoma (HCT-8) cells show a stable transition from low to high metastatic state when cultured on appropriately soft substrates (21 kPa). Initially epithelial (E) in nature, the HCT-8 cells become rounded (R) after seven days of culture on soft substrate. R cells show a number of metastatic hallmarks [1]. Here, we use gradient stiffness substrates, a bio-MEMS force sensor, and Coulter counter assays to study mechanosensitivity and adhesion of E and R cells. We find that HCT-8 cells lose mechanosensitivity as they undergo E-to-R transition. HCT-8 R cells' stiffness, spread area, proliferation and migration become insensitive to substrate stiffness in contrast to their epithelial counterpart. They are softer, proliferative and migratory on all substrates. R cells show negligible cell-cell homotypic adhesion, as well as non-specific cell-substrate adhesion. Consequently they show the same spread area on all substrates in contrast to E cells. Taken together, these results indicate that R cells acquire autonomy and anchorage independence, and are thus potentially more invasive than E cells. To the best of our knowledge, this is the first report of quantitative data relating changes in cancer cell adhesion and stiffness during the expression of an in vitro metastasis-like phenotype.	[Wen, Qi; Janmey, Paul A.] Univ Penn, Inst Med & Engn, Dept Physiol, Philadelphia, PA 19104 USA; [Wen, Qi; Janmey, Paul A.] Univ Penn, Dept Phys, Inst Med & Engn, Philadelphia, PA 19104 USA; [Wen, Qi; Janmey, Paul A.] Univ Penn, Dept Bioengn, Inst Med & Engn, Philadelphia, PA 19104 USA; [Tang, Xin; Saif, Taher A.] Univ Illinois, Dept Mech Sci & Engn, Coll Engn, Urbana, IL USA; [Kuhlenschmidt, Theresa B.; Kuhlenschmidt, Mark S.] Univ Illinois, Coll Vet Med, Dept Pathobiol, Urbana, IL USA; [Saif, Taher A.] Univ Illinois, Micro & Nanotechnol Lab MNTL, Urbana, IL USA	University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; Pennsylvania Medicine; University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign	Janmey, PA (corresponding author), Univ Penn, Inst Med & Engn, Dept Physiol, Philadelphia, PA 19104 USA.	janmey@mail.med.upenn.edu; saif@uiuc.edu	Wen, Qi/E-3864-2015	Kuhlenschmidt, Mark/0000-0003-1196-0763	National Science Foundation (NSF) [ECCS 07-25831, 10-02165, 0965918 IGERT]; NIH [RO1 083272-03]; Div Of Electrical, Commun & Cyber Sys [1002165] Funding Source: National Science Foundation	National Science Foundation (NSF)(National Science Foundation (NSF)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Div Of Electrical, Commun & Cyber Sys(National Science Foundation (NSF)NSF - Directorate for Engineering (ENG))	The work is financially supported by National Science Foundation (NSF) grants No. ECCS 07-25831, 10-02165 and NIH RO1 083272-03. XT was funded by NSF Grant 0965918 IGERT: Training the Next Generation of Researchers in Cellular and Molecular Mechanics and BioNanotechnology. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bacac M, 2008, ANNU REV PATHOL-MECH, V3, P221, DOI 10.1146/annurev.pathmechdis.3.121806.151523; Bajaj P, 2010, J BIOMED MATER RES A, V95A, P1261, DOI 10.1002/jbm.a.32951; Bao G, 2003, NAT MATER, V2, P715, DOI 10.1038/nmat1001; BIRCHMEIER W, 1994, BBA-REV CANCER, V1198, P11, DOI 10.1016/0304-419X(94)90003-5; Bissell MJ, 2001, NAT REV CANCER, V1, P46, DOI 10.1038/35094059; Boal D. H., 2002, MECH CELL; Bosco D, 2007, J ENDOCRINOL, V194, P21, DOI 10.1677/JOE-06-0169; Butler JP, 1996, METHOD SYSTEM MEASUR, P1; Byfield FJ, 2009, BIOPHYS J, V96, P5095, DOI 10.1016/j.bpj.2009.03.046; Cassino TR, 2012, TISSUE ENG PT A, V18, P1101, DOI [10.1089/ten.tea.2011.0285, 10.1089/ten.TEA.2011.0285]; Cavallaro U, 2004, NAT REV CANCER, V4, P118, DOI 10.1038/nrc1276; Cha C, 2011, BIOCONJUGATE CHEM, V22, P2377, DOI 10.1021/bc200339s; Chambers AF, 2002, NAT REV CANCER, V2, P563, DOI 10.1038/nrc865; Chen DTN, 2010, ANNU REV CONDEN MA P, V1, P301, DOI 10.1146/annurev-conmatphys-070909-104120; Chowdhury F, 2010, NAT MATER, V9, P82, DOI [10.1038/NMAT2563, 10.1038/nmat2563]; Cress A. E., 2006, CELL ADHESION CYTOSK; Cross SE, 2007, NAT NANOTECHNOL, V2, P780, DOI 10.1038/nnano.2007.388; Didier JE, 2012, EUROPEAN J INORGANIC; Discher DE, 2005, SCIENCE, V310, P1139, DOI 10.1126/science.1116995; Dong R, 2007, LANGMUIR, V23, P1483, DOI 10.1021/la062738l; Engler AJ, 2007, METHOD CELL BIOL, V83, P521, DOI 10.1016/S0091-679X(07)83022-6; FRIXEN UH, 1991, J CELL BIOL, V113, P173, DOI 10.1083/jcb.113.1.173; Geiger B, 2009, NAT REV MOL CELL BIO, V10, P21, DOI 10.1038/nrm2593; Guck J, 2005, BIOPHYS J, V88, P3689, DOI 10.1529/biophysj.104.045476; Guo XY, 2009, P NATL ACAD SCI USA, V106, P20149, DOI 10.1073/pnas.0907390106; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Hu H, 2012, NANOTECHNOLOGY, V23, DOI 10.1088/0957-4484/23/17/175303; Ingber DE, 2008, SEMIN CANCER BIOL, V18, P356, DOI 10.1016/j.semcancer.2008.03.016; Isenberg BC, 2009, BIOPHYS J, V97, P1313, DOI 10.1016/j.bpj.2009.06.021; Janmey PA, 2011, J CELL SCI, V124, P9, DOI 10.1242/jcs.071001; Janmey PA, 2009, CELL MOTIL CYTOSKEL, V66, P597, DOI 10.1002/cm.20382; KUHLENSCHMIDT MS, 1982, J BIOL CHEM, V257, P3157; Kumar S, 2009, EXP MECH, V49, P11, DOI 10.1007/s11340-007-9063-7; Kumar S, 2009, CANCER METAST REV, V28, P113, DOI 10.1007/s10555-008-9173-4; LeDuc PR, 2011, ANNU REV BIOMED ENG, V13, P369, DOI 10.1146/annurev-bioeng-071910-124651; Lee H, 2010, SOFT MATTER, V6, P4342, DOI 10.1039/c0sm00092b; Li D, 2011, REGEN MED, V6, P229, DOI 10.2217/RME.11.2; Li D, 2010, J CELL BIOL, V191, P631, DOI 10.1083/jcb.201006094; Li HA, 2010, J MECH PHYS SOLIDS, V58, P2033, DOI 10.1016/j.jmps.2010.09.011; Lidstone EA, 2011, ANALYST, V136, P3608, DOI 10.1039/c1an15171a; Liu J, 2012, NATURE MAT; Lodish H., 2007, MOL CELL BIOL; Minary-Jolandan M, 2009, ACS NANO, V3, P1859, DOI 10.1021/nn900472n; Ni Y, 2007, SOFT MATTER, V3, P1285, DOI 10.1039/b703376a; Nishitani WS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026181; Paszek MJ, 2005, CANCER CELL, V8, P241, DOI 10.1016/j.ccr.2005.08.010; Pathak A, 2011, INTEGR BIOL-UK, V3, P267, DOI 10.1039/c0ib00095g; Poh YC, 2010, BIOPHYS J, V99, pL19, DOI 10.1016/j.bpj.2010.04.057; Rhee WJ, 2010, P NATL ACAD SCI USA, V107, P6858, DOI 10.1073/pnas.1000444107; Ruder WC, 2012, P NATL ACAD SCI, V109; Sackmann E, 2010, NAT PHYS, V6, P407, DOI 10.1038/nphys1677; Sastry SK, 2000, EXP CELL RES, V261, P25, DOI 10.1006/excr.2000.5043; Shi JY, 2011, J ADHESION, V87, P579, DOI 10.1080/00218464.2011.583587; Steward RL, 2010, CELL BIOCHEM BIOPHYS, V56, P115, DOI 10.1007/s12013-009-9075-2; Suresh S, 2005, ACTA BIOMATER, V1, P15, DOI 10.1016/j.actbio.2004.09.001; Tang VW, 2012, J CELL BIOL, V196, P115, DOI 10.1083/jcb.201103116; Tang X, 2011, SPECIFIC NONSPECIFIC; Tang X, 2012, GENE EXPRESSIO UNPUB; Tang X, 2007, CELL MECHANOSENSITIV; Tang X, 2012, SOFT MATTER, V8, P7197, DOI 10.1039/c2sm25533b; Tang X, 2011, SOFT MATTER, V7, P6151, DOI 10.1039/c0sm01453b; Tang X, 2010, BIOPHYS J, V99, P2460, DOI 10.1016/j.bpj.2010.08.034; Vogel V, 2006, NAT REV MOL CELL BIO, V7, P265, DOI 10.1038/nrm1890; Wang F, 1998, P NATL ACAD SCI USA, V95, P14821, DOI 10.1073/pnas.95.25.14821; Wang N, 2009, NAT REV MOL CELL BIO, V10, P75, DOI 10.1038/nrm2594; Wang X, 2010, APPL PHYS LETT, V97, P1; Wang YL, 1998, METHOD ENZYMOL, V298, P489, DOI 10.1016/S0076-6879(98)98041-7; Weinberg RA, 2007, BIOL CANC; Wozniak MA, 2009, NAT REV MOL CELL BIO, V10, P34, DOI 10.1038/nrm2592; Yang S, 2007, ACTA BIOMATER, V3, P77, DOI 10.1016/j.actbio.2006.07.005; Yum K, 2009, NANO LETT, V9, P2193, DOI 10.1021/nl901047u; Zaidel-Bar R, 2004, BIOCHEM SOC T, V32, P416, DOI 10.1042/BST0320416; Zhu C, 2000, ANNU REV BIOMED ENG, V2, P189, DOI 10.1146/annurev.bioeng.2.1.189	73	20	20	0	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 30	2012	7	11							e50443	10.1371/journal.pone.0050443	http://dx.doi.org/10.1371/journal.pone.0050443			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	054WM	23226284	Green Submitted, gold, Green Published			2022-12-27	WOS:000312376100096
J	Wang, FF; Ma, XJ; Hao, YP; Yang, R; Ni, J; Xiao, YF; Tang, JL; Bao, YQ; Jia, WP				Wang, Feifei; Ma, Xiaojing; Hao, Yaping; Yang, Rong; Ni, Jie; Xiao, Yunfeng; Tang, Junling; Bao, Yuqian; Jia, Weiping			Serum Glycated Albumin Is Inversely Influenced by Fat Mass and Visceral Adipose Tissue in Chinese with Normal Glucose Tolerance	PLOS ONE			English	Article							INSULIN-RESISTANCE; SEX-DIFFERENCES; HEMOGLOBIN; INFLAMMATION; DISEASE; OBESITY; INDEX; ACCUMULATION; ASSOCIATIONS; DENSITY	Recent studies have revealed that body mass index (BMI) inversely influenced serum glycated albumin (GA), which may cause an underestimation of GA-monitored short-term hyperglycemic control. Objective: This study was to investigate the association between anthropometric variables (BMI and waist circumference (W)) and accurate adiposity variables (percentage of body fat (%fat), fat mass, free fat mass (FFM), subcutaneous fat area (SFA), and visceral fat area (VFA)) with serum GA. Design: A total of 2563 subjects (1037 men, 593 premenopausal women, and 933 postmenopausal women) with normal glucose tolerance underwent bioelectrical impedance body fat content measurement and magnetic resonance imaging. Serum GA and absolute value of GA (aGA) were measured by enzymatic assay. Results: Compared to the BMI <25.0 kg/m(2) group, the BMI >= 25.0 kg/m(2) group had significantly higher fasting plasma glucose, glycated hemoglobin A1c, and body fat parameters including W, %fat, fat mass, FFM, SFA, and VFA, but significantly lower aGA, and GA in all the three sex- and menopause-stratified groups (all P<0.05). GA decreased with the increment of fat mass for all three groups (all P for trend >= 0.001). In the same BMI category, men and postmenopausal women with elevated %fat (men, >= 25%; women, >= 35%) still had significantly lower GA than those with normal %fat (men, >= 25%; women, >= 35%) (all P<0.05). Multiple stepwise regression showed that %fat, fat mass, and VFA were independently associated with GA. Conclusions: Serum GA was inversely influenced by fat mass and visceral adipose tissue in Chinese with normal glucose tolerance. Citation: Wang F, Ma X, Hao Y, Yang R, Ni J, et al. (2012) Serum Glycated Albumin Is Inversely Influenced by Fat Mass and Visceral Adipose Tissue in Chinese with Normal Glucose Tolerance. PLoS ONE 7(11): e51098. doi:10.1371/journal.pone.0051098	[Wang, Feifei; Ma, Xiaojing; Hao, Yaping; Yang, Rong; Ni, Jie; Tang, Junling; Bao, Yuqian; Jia, Weiping] Shanghai Jiao Tong Univ, Affiliated Peoples Hosp 6, Shanghai Clin Ctr Diabet,Dept Endocrinol & Metab, Shanghai Diabet Inst,Shanghai Key Lab Diabet Mell, Shanghai 200030, Peoples R China; [Xiao, Yunfeng] Shanghai Jiao Tong Univ, Affiliated Peoples Hosp 6, Dept Radiol, Shanghai 200030, Peoples R China	Shanghai Jiao Tong University; Shanghai Jiao Tong University	Bao, YQ (corresponding author), Shanghai Jiao Tong Univ, Affiliated Peoples Hosp 6, Shanghai Clin Ctr Diabet,Dept Endocrinol & Metab, Shanghai Diabet Inst,Shanghai Key Lab Diabet Mell, Shanghai 200030, Peoples R China.	byq522@163.com	Jia, Weiping/B-7483-2012		973 Program of China [2012CB524906]; Project of National Natural Science Foundation of China [81170788, 81100563]; National Key Technology R&D Program of China [2009BAI80B01]; Shanghai Municipal Health Bureau Youth Projects [2009BAI80B01]; Shanghai United Developing Technology Projects of Municipal Hospitals [SHDC12010115]	973 Program of China(National Basic Research Program of China); Project of National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Key Technology R&D Program of China(National Key Technology R&D Program); Shanghai Municipal Health Bureau Youth Projects; Shanghai United Developing Technology Projects of Municipal Hospitals	This work was funded by 973 Program of China (2012CB524906), Project of National Natural Science Foundation of China (81170788 and 81100563), National Key Technology R&D Program of China (2009BAI80B01), the Shanghai Municipal Health Bureau Youth Projects (2010Y032), and Shanghai United Developing Technology Projects of Municipal Hospitals (SHDC12010115). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alberti KGMM, 2006, DIABETIC MED, V23, P469, DOI 10.1111/j.1464-5491.2006.01858.x; Anonymous, 2007, Zhonghua Xinxueguanbing Zazhi, V35, P390; AUSTIN GE, 1987, CLIN CHEM, V33, P2220; Cai ZJ, 1999, WHO TECH REP SER, V887, P1; Cartier A, 2009, AM J CLIN NUTR, V89, P1307, DOI 10.3945/ajcn.2008.27030; Chujo K, 2006, J MED INVESTIG, V53, P223, DOI 10.2152/jmi.53.223; Don BR, 2004, SEMIN DIALYSIS, V17, P432, DOI 10.1111/j.0894-0959.2004.17603.x; Frankenfield DC, 2001, NUTRITION, V17, P26, DOI 10.1016/S0899-9007(00)00471-8; Fu X, 2011, OSTEOPOROSIS INT, V22, P113, DOI 10.1007/s00198-010-1210-9; Furusyo N, 2011, DIABETOLOGIA, V54, P3028, DOI 10.1007/s00125-011-2310-6; GUTHROW CE, 1979, P NATL ACAD SCI USA, V76, P4258, DOI 10.1073/pnas.76.9.4258; Kim JA, 2006, J KOREAN MED SCI, V21, P1048, DOI 10.3346/jkms.2006.21.6.1048; Kim K, 2008, METABOLISM, V57, P1181, DOI 10.1016/j.metabol.2008.04.009; Kobayashi H, 2001, JPN CIRC J, V65, P193, DOI 10.1253/jcj.65.193; Koga M, 2007, CLIN CHIM ACTA, V378, P48, DOI 10.1016/j.cca.2006.10.013; Koga M, 2006, ENDOCR J, V53, P387, DOI 10.1507/endocrj.K05-137; Koga M, 2010, ACTA DIABETOL, V47, P173, DOI 10.1007/s00592-009-0168-6; Koga M, 2009, ACTA DIABETOL, V46, P141, DOI 10.1007/s00592-008-0072-5; Kouzuma T, 2004, CLIN CHIM ACTA, V346, P135, DOI 10.1016/j.cccn.2004.02.019; Kouzuma T, 2002, CLIN CHIM ACTA, V324, P61, DOI 10.1016/S0009-8981(02)00207-3; Lee EY, 2011, ACTA DIABETOL, V48, P167, DOI 10.1007/s00592-010-0242-0; LEMIEUX S, 1993, AM J CLIN NUTR, V58, P463, DOI 10.1093/ajcn/58.4.463; LEY CJ, 1992, AM J CLIN NUTR, V55, P950, DOI 10.1093/ajcn/55.5.950; Ma XJ, 2010, CLIN EXP PHARMACOL P, V37, P974, DOI 10.1111/j.1440-1681.2010.05417.x; Miyashita Y, 2007, DIABETES RES CLIN PR, V78, P51, DOI 10.1016/j.diabres.2007.02.021; Nishimura R, 2006, DIABETES RES CLIN PR, V71, P334, DOI 10.1016/j.diabres.2005.07.008; ROUBENOFF R, 1995, AM J PUBLIC HEALTH, V85, P726, DOI 10.2105/AJPH.85.5.726; Salas-Salvado J, 2006, INT J OBESITY, V30, P1714, DOI 10.1038/sj.ijo.0803348; SEGAL KR, 1987, J CLIN INVEST, V80, P1050, DOI 10.1172/JCI113159; Shultze HE, 1966, MOL BIOL HUMAN PROTE, P450; SMALLEY KJ, 1990, AM J CLIN NUTR, V52, P405, DOI 10.1093/ajcn/52.3.405; Takahashi S, 2007, ENDOCR J, V54, P139, DOI 10.1507/endocrj.K06-103; Takei I, 2004, LAB CLIN PRACT, V21, P80; Wang Y, 2011, INT J OBES IN PRESS, DOI [10.1038/ijo.2011.222, DOI 10.1038/IJO.2011.222.IN]; World Health Organization, 1999, DIAGN CLASS DIAB M 1	35	33	39	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 29	2012	7	11							e51098	10.1371/journal.pone.0051098	http://dx.doi.org/10.1371/journal.pone.0051098			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	051DI	23209844	gold, Green Published, Green Submitted			2022-12-27	WOS:000312104900095
J	Ciuti, S; Northrup, JM; Muhly, TB; Simi, S; Musiani, M; Pitt, JA; Boyce, MS				Ciuti, Simone; Northrup, Joseph M.; Muhly, Tyler B.; Simi, Silvia; Musiani, Marco; Pitt, Justin A.; Boyce, Mark S.			Effects of Humans on Behaviour of Wildlife Exceed Those of Natural Predators in a Landscape of Fear	PLOS ONE			English	Article							WINTER HABITAT SELECTION; NORTH-AMERICAN ELK; MULE DEER; MODEL SELECTION; ANTIPREDATOR RESPONSE; MULTIMODEL INFERENCE; VIGILANCE BEHAVIOR; HUMAN DISTURBANCE; TROPHIC CASCADES; RISK	Background: Human disturbance can influence wildlife behaviour, which can have implications for wildlife populations. For example, wildlife may be more vigilant near human disturbance, resulting in decreased forage intake and reduced reproductive success. We measured the effects of human activities compared to predator and other environmental factors on the behaviour of elk (Cervus elaphus Linnaeus 1758) in a human-dominated landscape in Alberta, Canada. Methodology/Principal Findings: We collected year-round behavioural data of elk across a range of human disturbances. We estimated linear mixed models of elk behaviour and found that human factors (land-use type, traffic and distance from roads) and elk herd size accounted for more than 80% of variability in elk vigilance. Elk decreased their feeding time when closer to roads, and road traffic volumes of at least 1 vehicle every 2 hours induced elk to switch into a more vigilant behavioural mode with a subsequent loss in feeding time. Other environmental factors, thought crucial in shaping vigilance behaviour in elk (natural predators, reproductive status of females), were not important. The highest levels of vigilance were recorded on public lands where hunting and motorized recreational activities were cumulative compared to the national park during summer, which had the lowest levels of vigilance. Conclusions/Significance: In a human-dominated landscape, effects of human disturbance on elk behaviour exceed those of habitat and natural predators. Humans trigger increased vigilance and decreased foraging in elk. However, it is not just the number of people but also the type of human activity that influences elk behaviour (e.g. hiking vs. hunting). Quantifying the actual fitness costs of human disturbance remains a challenge in field studies but should be a primary focus for future researches. Some species are much more likely to be disturbed by humans than by non-human predators: for these species, quantifying human disturbance may be the highest priority for conservation.	[Ciuti, Simone; Simi, Silvia; Pitt, Justin A.; Boyce, Mark S.] Univ Alberta, Dept Biol Sci, Edmonton, AB, Canada; [Northrup, Joseph M.] Colorado State Univ, Dept Fish Wildlife & Conservat Biol, Ft Collins, CO 80523 USA; [Muhly, Tyler B.] Alberta Innovates, Technol Futures, Vegreville, AB, Canada; [Musiani, Marco] Univ Calgary, Fac Environm Design, Calgary, AB T2N 1N4, Canada	University of Alberta; Colorado State University; Alberta Innovates; University of Calgary	Ciuti, S (corresponding author), Univ Alberta, Dept Biol Sci, Edmonton, AB, Canada.	ciuti@ualberta.ca	Northrup, Joseph/G-5427-2012; Boyce, Mark S/A-2620-2014; Moreira, Nei/AAK-1357-2020; Northrup, Joseph/AAM-2874-2020; Musiani, Marco/ABB-9387-2021; Ciuti, Simone/D-7283-2013	Northrup, Joseph/0000-0001-6319-4138; Boyce, Mark S/0000-0001-5811-325X; Moreira, Nei/0000-0002-9236-667X; Northrup, Joseph/0000-0001-6319-4138; Musiani, Marco/0000-0002-6097-5841; Ciuti, Simone/0000-0003-1052-9509	Alberta Conservation Association (ACA - Grant Eligible Conservation Fund); Natural Sciences and Engineering Research Council of Canada (NSERC-CRD); Shell Canada limited	Alberta Conservation Association (ACA - Grant Eligible Conservation Fund); Natural Sciences and Engineering Research Council of Canada (NSERC-CRD)(Natural Sciences and Engineering Research Council of Canada (NSERC)); Shell Canada limited	Alberta Conservation Association (ACA - Grant Eligible Conservation Fund), the Natural Sciences and Engineering Research Council of Canada (NSERC-CRD), and Shell Canada limited. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALBERT DM, 1991, WILDLIFE SOC B, V19, P339; Barua M, 2011, BIODIVERS CONSERV, V20, P1427, DOI 10.1007/s10531-011-0035-y; Bechet A, 2004, J APPL ECOL, V41, P689, DOI 10.1111/j.0021-8901.2004.00928.x; Bekessy SA, 2009, BIOL CONSERV, V142, P2438, DOI 10.1016/j.biocon.2009.05.010; BELANGER L, 1989, J WILDLIFE MANAGE, V53, P713, DOI 10.2307/3809202; Benhaiem S, 2008, ANIM BEHAV, V76, P611, DOI 10.1016/j.anbehav.2008.03.012; Berger J, 2007, BIOL LETTERS, V3, P620, DOI 10.1098/rsbl.2007.0415; Blumstein DT, 2005, J APPL ECOL, V42, P943, DOI 10.1111/j.1365-2664.2005.01071.x; Bolker BM, 2009, TRENDS ECOL EVOL, V24, P127, DOI 10.1016/j.tree.2008.10.008; Borkowski JJ, 2006, ECOL APPL, V16, P1911, DOI 10.1890/1051-0761(2006)016[1911:BROBAE]2.0.CO;2; Bowyer RT, 1999, J MAMMAL, V80, P1070, DOI 10.2307/1383161; Boyce MS, 2002, ECOL MODEL, V157, P281, DOI 10.1016/S0304-3800(02)00200-4; Brown JS, 1999, EVOL ECOL RES, V1, P49; Burnham KP, 2011, BEHAV ECOL SOCIOBIOL, V65, P23, DOI 10.1007/s00265-010-1029-6; Caro T., 2005, ANTIPREDATOR DEFENSE; Childress MJ, 2003, ANIM BEHAV, V66, P389, DOI 10.1006/anbe.2003.2217; Christianson D, 2008, BEHAV ECOL, V19, P1258, DOI 10.1093/beheco/arn079; Christianson D, 2010, ECOLOGY, V91, P1184, DOI 10.1890/09-0221.1; Ciuti S, 2004, BEHAV ECOL SOCIOBIOL, V56, P552, DOI 10.1007/s00265-004-0819-0; Clair CCS, 2009, BEHAVIOUR, V146, P393, DOI 10.1163/156853909X410973; Cowlishaw G, 2004, P ROY SOC B-BIOL SCI, V271, P27, DOI 10.1098/rspb.2003.2522; Creel S, 2005, ECOLOGY, V86, P3387, DOI 10.1890/05-0032; Creel S, 2008, ANIM BEHAV, V76, P1139, DOI 10.1016/j.anbehav.2008.07.006; Creel S, 2008, TRENDS ECOL EVOL, V23, P194, DOI 10.1016/j.tree.2007.12.004; Creel S, 2007, SCIENCE, V315, P960, DOI 10.1126/science.1135918; Creel S, 2011, ECOL APPL, V21, P2847, DOI 10.1890/11-0768.1; Creel S, 2009, P NATL ACAD SCI USA, V106, P12388, DOI 10.1073/pnas.0902235106; Diniz JAF, 2008, GLOBAL ECOL BIOGEOGR, V17, P479, DOI 10.1111/j.1466-8238.2008.00395.x; Fahrig L, 2009, ECOL SOC, V14, P1, DOI DOI 10.5751/ES-02815-; Fieberg J, 2010, PHILOS T R SOC B, V365, P2233, DOI 10.1098/rstb.2010.0079; Forman RTT, 1998, ANNU REV ECOL SYST, V29, P207, DOI 10.1146/annurev.ecolsys.29.1.207; Forman RTT, 2003, ROAD ECOLOGY SCI SOL; Fortin D, 2004, OIKOS, V107, P172, DOI 10.1111/j.0030-1299.2004.12976.x; Frair JL, 2008, J APPL ECOL, V45, P1504, DOI 10.1111/j.1365-2664.2008.01526.x; Gelman A., 2007, DATA ANAL USING REGR; Greven S, 2010, BIOMETRIKA, V97, P773, DOI 10.1093/biomet/asq042; Grignolio S, 2011, BIOL CONSERV, V144, P641, DOI 10.1016/j.biocon.2010.10.022; Groffman P, 2006, ECOSYSTEMS, V9, P1, DOI 10.1007/s10021-003-0142-z; HARRINGTON FH, 1992, ARCTIC, V45, P213; Hollen LI, 2011, ANIM BEHAV, V82, P1435, DOI 10.1016/j.anbehav.2011.09.028; Houston AI, 2012, OIKOS, V121, P597, DOI 10.1111/j.1600-0706.2011.19594.x; ILLIUS AW, 1994, ANIM BEHAV, V47, P481, DOI 10.1006/anbe.1994.1067; Jayakody S, 2008, WILDLIFE BIOL, V14, P81, DOI 10.2981/0909-6396(2008)14[81:RDCEVB]2.0.CO;2; Johnson CJ, 2006, J WILDLIFE MANAGE, V70, P347, DOI 10.2193/0022-541X(2006)70[347:RSFBOU]2.0.CO;2; Kauffman MJ, 2007, ECOL LETT, V10, P690, DOI 10.1111/j.1461-0248.2007.01059.x; Kloppers EL, 2005, ECOL SOC, V10; Laundre JW, 2001, CAN J ZOOL, V79, P1401, DOI 10.1139/cjz-79-8-1401; Laurian C, 2008, J WILDLIFE MANAGE, V72, P1550, DOI 10.2193/2008-063; Legendre P., 2012, NUMERICAL ECOLOGY; Lele SR, 2009, J WILDLIFE MANAGE, V73, P122, DOI 10.2193/2007-535; Lian XM, 2011, WILDLIFE RES, V38, P141, DOI 10.1071/WR10158; Liley S, 2008, BEHAV ECOL, V19, P245, DOI 10.1093/beheco/arm116; LIMA SL, 1988, J THEOR BIOL, V132, P127, DOI 10.1016/S0022-5193(88)80152-8; Lung MA, 2007, BEHAV ECOL, V18, P12, DOI [10.1093/beheco/ar1066, 10.1093/beheco/arl066]; Madsen J, 1998, J APPL ECOL, V35, P398, DOI 10.1046/j.1365-2664.1998.00315.x; Manly B.F.J., 2002, RESOURCE SELECTION A; Marino A, 2008, ETHOLOGY, V114, P413, DOI 10.1111/j.1439-0310.2008.01485_1.x; Martin P., 1993, MEASURING BEHAV, V2nd, DOI [10.1017/CBO9781139168342, DOI 10.1017/CBO9781139168342]; McLoughlin PD, 2010, J ANIM ECOL, V79, P4, DOI 10.1111/j.1365-2656.2009.01613.x; MOORING MS, 1995, ANIM BEHAV, V49, P1414, DOI 10.1006/anbe.1995.0175; Morrison EB, 2011, BEHAVIOUR, V148, P1067, DOI 10.1163/000579511X589316; Muhly TB, 2010, THESIS U CALGARY CAL; Muhly TB, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017050; NAGELKERKE NJD, 1991, BIOMETRIKA, V78, P691, DOI 10.1093/biomet/78.3.691; Naylor LM, 2009, J WILDLIFE MANAGE, V73, P328, DOI 10.2193/2008-102; Northrup JM, 2012, J APPL ECOL, V49, P1159, DOI 10.1111/j.1365-2664.2012.02180.x; Pangle KL, 2007, ECOLOGY, V88, P402, DOI 10.1890/06-0768; Pays O, 2012, ETHOLOGY, V118, P1, DOI 10.1111/j.1439-0310.2011.01974.x; Peckarsky BL, 2008, ECOLOGY, V89, P2416, DOI 10.1890/07-1131.1; PECKARSKY BL, 1993, ECOLOGY, V74, P1836, DOI 10.2307/1939941; Phillips GE, 2000, J WILDLIFE MANAGE, V64, P521, DOI 10.2307/3803250; Pinheiro J, 2001, MIXED EFFECTS MODELS; Polfus JL, 2011, BIOL CONSERV, V144, P2637, DOI 10.1016/j.biocon.2011.07.023; Preisler HK, 2006, J APPL ECOL, V43, P164, DOI 10.1111/j.1365-2664.2005.01123.x; Proaktor G, 2007, J ANIM ECOL, V76, P669, DOI 10.1111/j.1365-2656.2007.01244.x; Proctor MF, 2011, WILDLIFE MONOGR, V180, P1; R DEVELOPMENT CORE TEAM, 2011, R LANG ENV STAT COMP; Riley S.J., 1999, INTERMOUNTAIN J SCI, V5, P23, DOI DOI 10.1016/j.geomorph.2010.11.003; Sawyer H, 2006, J WILDLIFE MANAGE, V70, P396, DOI 10.2193/0022-541X(2006)70[396:WHSOMD]2.0.CO;2; Sawyer H, 2009, J WILDLIFE MANAGE, V73, P1052, DOI 10.2193/2008-478; Schmitz OJ, 1997, ECOLOGY, V78, P1388, DOI 10.1890/0012-9658(1997)078[1388:BMTCEO]2.0.CO;2; Schmitz OJ, 2004, ECOL LETT, V7, P153, DOI 10.1111/j.1461-0248.2003.00560.x; Schmitz OJ, 2008, ECOLOGY, V89, P2436, DOI 10.1890/07-1030.1; Schummer ML, 2003, J WILDLIFE MANAGE, V67, P789, DOI 10.2307/3802686; Seaman DE, 1996, ECOLOGY, V77, P2075, DOI 10.2307/2265701; Shively KJ, 2005, J WILDLIFE MANAGE, V69, P1073, DOI 10.2193/0022-541X(2005)069[1073:ERRTRO]2.0.CO;2; Stankowich T, 2008, BIOL CONSERV, V141, P2159, DOI 10.1016/j.biocon.2008.06.026; Stewart KM, 2010, AM MIDL NAT, V163, P400, DOI 10.1674/0003-0031-163.2.400; Stewart KM, 2002, J MAMMAL, V83, P229, DOI 10.1644/1545-1542(2002)083&lt;0229:TDOEMD&gt;2.0.CO;2; Symonds MRE, 2011, BEHAV ECOL SOCIOBIOL, V65, P13, DOI 10.1007/s00265-010-1037-6; Trombulak SC, 2000, CONSERV BIOL, V14, P18, DOI 10.1046/j.1523-1739.2000.99084.x; Underhill J.E., 2000, ENVIRON REV, V8, P21, DOI [DOI 10.1139/A00-003, 10.1139/a00-003]; Valitzski SA, 2009, J WILDLIFE MANAGE, V73, P1072, DOI 10.2193/2007-581; Wang Z, 2011, BIOL CONSERV, V144, P101, DOI 10.1016/j.biocon.2010.06.025; Winnie J, 2007, ANIM BEHAV, V73, P215, DOI 10.1016/j.anbehav.2006.07.007; Wolff JO, 2003, CAN J ZOOL, V81, P266, DOI 10.1139/Z03-011; Woodroffe R., 2005, CONSERV BIOL; YARMOLOY C, 1988, CAN FIELD NAT, V102, P425; [No title captured]; [No title captured]	100	236	239	8	314	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 28	2012	7	11							e50611	10.1371/journal.pone.0050611	http://dx.doi.org/10.1371/journal.pone.0050611			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	057YW	23226330	Green Submitted, Green Published, gold			2022-12-27	WOS:000312601700083
J	Hanaoka, M; Droma, Y; Basnyat, B; Ito, M; Kobayashi, N; Katsuyama, Y; Kubo, K; Ota, M				Hanaoka, Masayuki; Droma, Yunden; Basnyat, Buddha; Ito, Michiko; Kobayashi, Nobumitsu; Katsuyama, Yoshihiko; Kubo, Keishi; Ota, Masao			Genetic Variants in EPAS1 Contribute to Adaptation to High-Altitude Hypoxia in Sherpas	PLOS ONE			English	Article							OXIDE SYNTHASE GENE; HEMOGLOBIN CONCENTRATION; TIBETAN; POLYMORPHISMS; ASSOCIATION; POPULATION; METABOLISM; SELECTION; GLUCOSE; ROLES	Sherpas comprise a population of Tibetan ancestry in the Himalayan region that is renowned for its mountaineering prowess. The very small amount of available genetic information for Sherpas is insufficient to explain their physiological ability to adapt to high-altitude hypoxia. Recent genetic evidence has indicated that natural selection on the endothelial PAS domain protein 1 (EPAS1) gene was occurred in the Tibetan population during their occupation in the Tibetan Plateau for millennia. Tibetan-specific variations in EPAS1 may regulate the physiological responses to high-altitude hypoxia via a hypoxia-inducible transcription factor pathway. We examined three significant tag single-nucleotide polymorphisms (SNPs, rs13419896, rs4953354, and rs4953388) in the EPAS1 gene in Sherpas, and compared these variants with Tibetan highlanders on the Tibetan Plateau as well as with non-Sherpa lowlanders. We found that Sherpas and Tibetans on the Tibetan Plateau exhibit similar patterns in three EPAS1 significant tag SNPs, but these patterns are the reverse of those in non-Sherpa lowlanders. The three SNPs were in strong linkage in Sherpas, but in weak linkage in non-Sherpas. Importantly, the haplotype structured by the Sherpa-dominant alleles was present in Sherpas but rarely present in non-Sherpas. Surprisingly, the average level of serum erythropoietin in Sherpas at 3440 m was equal to that in non-Sherpas at 1300 m, indicating a resistant response of erythropoietin to high-altitude hypoxia in Sherpas. These observations strongly suggest that EPAS1 is under selection for adaptation to the high-altitude life of Tibetan populations, including Sherpas. Understanding of the mechanism of hypoxia tolerance in Tibetans is expected to provide lights to the therapeutic solutions of some hypoxia-related human diseases, such as cardiovascular disease and cancer.	[Ota, Masao] Shinshu Univ, Sch Med, Dept Legal Med, Matsumoto, Nagano 390, Japan; [Hanaoka, Masayuki; Droma, Yunden; Ito, Michiko; Kobayashi, Nobumitsu; Kubo, Keishi] Shinshu Univ, Sch Med, Dept Med 1, Matsumoto, Nagano 390, Japan; [Basnyat, Buddha] Nepal Int Clin, Kathmandu, Nepal; [Katsuyama, Yoshihiko] Shinshu Univ Hosp, Dept Pharm, Matsumoto, Nagano, Japan	Shinshu University; Shinshu University; Shinshu University	Ota, M (corresponding author), Shinshu Univ, Sch Med, Dept Legal Med, Matsumoto, Nagano 390, Japan.	otamasao@shinshu-u.ac.jp		Ota, Masao/0000-0002-6400-5658	Japan Society for the Promotion of Science [22590853]	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This study was supported in part by a Grant-in-Aid for Scientific Research (C), No. 22590853, from the Japan Society for the Promotion of Science. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding was received for this study.	[Anonymous], SHERP HIST; Barrett JC, 2005, BIOINFORMATICS, V21, P263, DOI 10.1093/bioinformatics/bth457; Beall CM, 1997, HUM BIOL, V69, P597; Beall CM, 1998, AM J PHYS ANTHROPOL, V106, P385, DOI 10.1002/(SICI)1096-8644(199807)106:3<385::AID-AJPA10>3.3.CO;2-6; Beall CM, 2000, ADV EXP MED BIOL, V475, P63; Beall CM, 2010, P NATL ACAD SCI USA, V107, P11459, DOI 10.1073/pnas.1002443107; Bigham Abigail W., 2009, Human Genomics, V4, P79; Droma Y, 2002, CIRCULATION, V106, P826, DOI 10.1161/01.CIR.0000024409.30143.70; Droma Y, 2008, WILD ENVIRON MED, V19, P22, DOI 10.1580/06-WEME-OR-073.1; Droma Y, 2006, HIGH ALT MED BIOL, V7, P209, DOI 10.1089/ham.2006.7.209; Gabriel SB, 2002, SCIENCE, V296, P2225, DOI 10.1126/science.1069424; Garruto RM, 2003, AM J PHYS ANTHROPOL, V122, P171, DOI 10.1002/ajpa.10283; HACKETT PH, 1980, J APPL PHYSIOL, V49, P374, DOI 10.1152/jappl.1980.49.3.374; Henderson J, 2005, HUM GENET, V118, P416, DOI 10.1007/s00439-005-0066-0; Hochachka PW, 1996, J APPL PHYSIOL, V81, P1355, DOI 10.1152/jappl.1996.81.3.1355; HOLDEN JE, 1995, J APPL PHYSIOL, V79, P222, DOI 10.1152/jappl.1995.79.1.222; Hotta J, 2004, CHEST, V126, P825, DOI 10.1378/chest.126.3.825; Hu CJ, 2003, MOL CELL BIOL, V23, P9361, DOI 10.1128/MCB.23.24.9361-9374.2003; Jensen FB, 2009, J EXP BIOL, V212, P3387, DOI 10.1242/jeb.023697; Luo YJ, 2012, RESPIRATION, V84, P155, DOI 10.1159/000336625; MORPURGO G, 1972, EXPERIENTIA, V28, P1280, DOI 10.1007/BF01965295; MORPURGO G, 1976, P NATL ACAD SCI USA, V73, P747, DOI 10.1073/pnas.73.3.747; Ohneda O, 2007, METHOD ENZYMOL, V435, P199, DOI 10.1016/S0076-6879(07)35011-8; Ou LC, 1998, J APPL PHYSIOL, V84, P1242, DOI 10.1152/jappl.1998.84.4.1242; Peng J, 2000, P NATL ACAD SCI USA, V97, P8386, DOI 10.1073/pnas.140087397; Peng Y, 2011, MOL BIOL EVOL, V28, P1075, DOI 10.1093/molbev/msq290; Percy MJ, 2008, NEW ENGL J MED, V358, P162, DOI 10.1056/NEJMoa073123; SAMAJA M, 1979, J APPL PHYSIOL, V47, P337, DOI 10.1152/jappl.1979.47.2.337; SANTACHIARABENERECETTI AS, 1976, HUM HERED, V26, P351, DOI 10.1159/000152827; Sherpa LN, 2008, SHERPA WINDOW ILLUST; Simonson TS, 2010, SCIENCE, V329, P72, DOI 10.1126/science.1189406; SLOAN AW, 1978, ANN HUM BIOL, V5, P453, DOI 10.1080/03014467800003101; Tian H, 1997, GENE DEV, V11, P72, DOI 10.1101/gad.11.1.72; TORRONI A, 1994, AM J PHYS ANTHROPOL, V93, P189, DOI 10.1002/ajpa.1330930204; Wang BB, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017002; WEIR BS, 1984, EVOLUTION, V38, P1358, DOI 10.1111/j.1558-5646.1984.tb05657.x; World Medical Association General Assembly, 2004, J Int Bioethique, V15, P124; Xu SH, 2011, MOL BIOL EVOL, V28, P1003, DOI 10.1093/molbev/msq277; Yi X, 2010, SCIENCE, V329, P75, DOI 10.1126/science.1190371; Zhao M, 2009, P NATL ACAD SCI USA, V106, P21230, DOI 10.1073/pnas.0907844106	40	49	51	2	39	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 5	2012	7	12							e50566	10.1371/journal.pone.0050566	http://dx.doi.org/10.1371/journal.pone.0050566			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	057TZ	23227185	gold, Green Published, Green Submitted			2022-12-27	WOS:000312588200045
J	Bakker, PR; Al Hadithy, AFY; Amin, N; van Duijn, CM; van Os, J; van Harten, PN				Bakker, P. Roberto; Al Hadithy, Asmar F. Y.; Amin, Najaf; van Duijn, Cornelia M.; van Os, Jim; van Harten, Peter N.			Antipsychotic-Induced Movement Disorders in Long-Stay Psychiatric Patients and 45 Tag SNPs in 7 Candidate Genes: A Prospective Study	PLOS ONE			English	Article							CURACAO EXTRAPYRAMIDAL SYNDROMES; DOPAMINE D3 RECEPTOR; SINGLE-NUCLEOTIDE POLYMORPHISMS; ABNORMAL INVOLUNTARY MOVEMENTS; INDUCED TARDIVE-DYSKINESIA; GENOME-WIDE ASSOCIATION; CHRONIC-SCHIZOPHRENIA; SEROTONIN 2C; SER9GLY POLYMORPHISM; DRD3	Objective: Four types of antipsychotic-induced movement disorders: tardive dyskinesia (TD), parkinsonism, akathisia and tardive dystonia, subtypes of TD (orofacial and limb truncal dyskinesia), subtypes of parkinsonism (rest tremor, rigidity, and bradykinesia), as well as a principal-factor of the movement disorders and their subtypes, were examined for association with variation in 7 candidate genes (GRIN2B, GRIN2A, HSPG2, DRD3, DRD4, HTR2C, and NQO1). Methods: Naturalistic study of 168 white long-stay patients with chronic mental illness requiring long-term antipsychotic treatment, examined by the same rater at least two times over a 4-year period, with a mean follow-up time of 1.1 years, with validated scales for TD, parkinsonism, akathisia, and tardive dystonia. The authors genotyped 45 tag SNPs in 7 candidate genes, associated with movement disorders or schizophrenia in previous studies. Genotype and allele frequency comparisons were performed with multiple regression methods for continuous movement disorders. Results: Various tag SNPs reached nominal significance; TD with rs1345423, rs7192557, rs1650420, as well as rs11644461; orofacial dyskinesia with rs7192557, rs1650420, as well as rs4911871; limb truncal dyskinesia with rs1345423, rs7192557, rs1650420, as well as rs11866328; bradykinesia with rs2192970; akathisia with rs324035; and the principal-factor with rs10772715. After controlling for multiple testing, no significant results remained. Conclusions: The findings suggest that selected tag SNPs are not associated with a susceptibility to movement disorders. However, as the sample size was small and previous studies show inconsistent results, definite conclusions cannot be made. Replication is needed in larger study samples, preferably in longitudinal studies which take the fluctuating course of movement disorders and gene-environment interactions into account. Citation: Bakker PR, Al Hadithy AFY, Amin N, van Duijn CM, van Os J, et al. (2012) Antipsychotic-Induced Movement Disorders in Long-Stay Psychiatric Patients and 45 Tag SNPs in 7 Candidate Genes: A Prospective Study. PLoS ONE 7(12): e50970. doi:10.1371/journal.pone.0050970	[Bakker, P. Roberto; van Harten, Peter N.] Psychiat Ctr GGZ Centraal, Amersfoort, Netherlands; [Al Hadithy, Asmar F. Y.] Erasmus MC, Hosp Pharm, Rotterdam, Netherlands; [Amin, Najaf; van Duijn, Cornelia M.] Erasmus MC, Dept Epidemiol, Rotterdam, Netherlands; [van Os, Jim; van Harten, Peter N.] Maastricht Univ, Med Ctr, Dept Psychiat & Psychol, S Limburg Mental Hlth Res & Teaching Network,EURO, Maastricht, Netherlands; [van Os, Jim] Kings Coll London, Dept Psychosis Studies, Inst Psychiat, Kings Hlth Partners, London WC2R 2LS, England	Erasmus University Rotterdam; Erasmus MC; Erasmus University Rotterdam; Erasmus MC; Maastricht University; University of London; King's College London	Bakker, PR (corresponding author), Psychiat Ctr GGZ Centraal, Amersfoort, Netherlands.	robertobakker@gmail.com	van Os, Jim/V-8884-2019; Vasconcelos, Ana Carolina Souza de/GXW-3453-2022; van Os, Jim/C-2113-2014	van Os, Jim/0000-0002-7245-1586; Amin, Najaf/0000-0002-8944-1771; Bakker, P. Roberto/0000-0002-9964-9939; Van Duijn, Cornelia/0000-0002-2374-9204	Foundation 'the Open Ankh', the Netherlands [SG 21.02]; Eli Lilly; BMS; Lundbeck; Organon; Janssen-Cilag; GSK; AstraZeneca; Pfizer; Servier	Foundation 'the Open Ankh', the Netherlands; Eli Lilly(Eli Lilly); BMS(Bristol-Myers Squibb); Lundbeck(Lundbeck Corporation); Organon; Janssen-Cilag(Johnson & JohnsonJohnson & Johnson USAJanssen Biotech Inc); GSK(GlaxoSmithKline); AstraZeneca(AstraZeneca); Pfizer(Pfizer); Servier(Servier)	This work was supported by grant from the Foundation 'the Open Ankh', the Netherlands (grant number SG 21.02). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; P. Roberto Bakker, Asmar F.Y. Al Hadithy, Najaf Amin and Cornelia M. van Duijn have declared that no competing interests exist. The authors have read the journal's policy and have the following conflicts: Jim van Os is/has been an unrestricted research grant holder with, or has received financial compensation as an independent symposium speaker from Eli Lilly, BMS, Lundbeck, Organon, Janssen-Cilag, GSK, AstraZeneca, Pfizer and Servier, companies that have an interest in the treatment of psychosis. Peter N. van Harten has received financial compensation as an independent symposium speaker from Eli Lilly, BMS, Janssen-Cilag, GSK, and AstraZeneca, companies that have an interest in the treatment of psychosis. This does not alter the authors' adherence to all the PLOS ONE policies on sharing data and materials.	Aberg K, 2010, BIOL PSYCHIAT, V67, P279, DOI 10.1016/j.biopsych.2009.08.036; Al Hadithy AFY, 2009, PROG NEURO-PSYCHOPH, V33, P475, DOI 10.1016/j.pnpbp.2009.01.010; Al Hadithy AF, 2009, HUM PSYCHOPHARM CLIN, V24, P123, DOI 10.1002/hup.997; Al Hadithy AF, 2008, AM J MED GENET B, V147B, P890, DOI 10.1002/ajmg.b.30746; Alkelai A, 2009, PSYCHOPHARMACOLOGY; [Anonymous], 2009, STAT REL 11 STAT SOF; Bakker PR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036561; Bakker PR, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025588; Bakker PR, 2006, SCHIZOPHR RES, V83, P185, DOI 10.1016/j.schres.2006.01.010; Basile VS, 2002, HUM MOL GENET, V11, P2517, DOI 10.1093/hmg/11.20.2517; Benjamini Y., 2004, RECENT DEV MULTIPLE; Braff DL, 2007, SCHIZOPHRENIA BULL, V33, P21, DOI 10.1093/schbul/sbl049; Burton PR, 2007, NATURE, V447, P661, DOI 10.1038/nature05911; Carlson CS, 2004, AM J HUM GENET, V74, P106, DOI 10.1086/381000; Casey DE, 2006, CNS SPECTRUMS, V11, P25, DOI 10.1017/S1092852900026651; Chalise P, 2012, OMICS, V16, P363, DOI 10.1089/omi.2011.0126; CSIKSZENTMIHALYI M, 1987, J NERV MENT DIS, V175, P526, DOI 10.1097/00005053-198709000-00004; Eichhammer P, 2000, AM J MED GENET, V96, P187, DOI 10.1002/(SICI)1096-8628(20000403)96:2<187::AID-AJMG13>3.0.CO;2-8; Factor SA., 2005, DRUG INDUCED MOVEMEN, V2nd; Fahn S., 1987, RECENT DEV PARKINSON, V2, P153; Faraone SV, 1999, GENETIC MENTAL DISOR; Fenton WS, 2000, J CLIN PSYCHIAT, V61, P10; Greenbaum L, 2012, PHARMACOGENOMICS J, V12, P513, DOI 10.1038/tpj.2011.32; Greenbaum L, 2010, MOVEMENT DISORD, V25, P2809, DOI 10.1002/mds.23377; Gunther T, 2011, OMICS, V15, P507, DOI 10.1089/omi.2010.0154; Gunes A, 2008, EUR J CLIN PHARMACOL, V64, P477, DOI 10.1007/s00228-007-0450-x; Guy W, 1975, ECDEU ASSESSMENT MAN, P534; Guy W, 1976, ECDEU ASSESSMENT MAN, DOI DOI 10.1037/E591322011-001; Halliday J, 2002, BRIT J PSYCHIAT, V181, P422, DOI 10.1192/bjp.181.5.422; Hemminki K, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002504; Howes OD, 2009, SCHIZOPHRENIA BULL, V35, P549, DOI 10.1093/schbul/sbp006; Inada T, 2008, PHARMACOGENET GENOM, V18, P317, DOI 10.1097/FPC.0b013e3282f70492; Ioannidis JPA, 2006, NAT GENET, V38, P3, DOI 10.1038/ng0106-3; Kendler KS, 2010, BRIT J PSYCHIAT, V197, P170, DOI 10.1192/bjp.bp.110.081331; Koning J. P., 2010, Journal of Medical Engineering & Technology, V34, P71, DOI 10.3109/03091900903402105; Koning JP, 2012, PSYCHOPHARMACOLOGY, V219, P727, DOI 10.1007/s00213-011-2394-1; Koning JPF, 2010, SCHIZOPHRENIA BULL, V36, P723, DOI 10.1093/schbul/sbn146; Lambert M, 2004, EUR PSYCHIAT, V19, P415, DOI 10.1016/j.eurpsy.2004.06.031; Lattuada E, 2004, INT J NEUROPSYCHOPH, V7, P489, DOI 10.1017/S1461145704004614; Lencer R, 2004, BRIT J PSYCHIAT, V185, P465, DOI 10.1192/bjp.185.6.465; Lerer B, 2005, INT J NEUROPSYCHOPH, V8, P411, DOI 10.1017/S1461145705005389; Lerer B, 2002, NEUROPSYCHOPHARMACOL, V27, P105, DOI 10.1016/S0893-133X(02)00293-2; Lerer B., 2002, PHARMACOGENETICS PSY; McCreadie RG, 2003, BRIT J PSYCHIAT, V183, P45, DOI 10.1192/bjp.183.1.45; Molenaar PCM, 2009, CURR DIR PSYCHOL SCI, V18, P112, DOI 10.1111/j.1467-8721.2009.01619.x; Muller DJ, 2001, ACTA PSYCHIAT SCAND, V104, P375, DOI 10.1034/j.1600-0447.2001.00401.x; Myin-Germeys I, 2009, PSYCHOL MED, V39, P1533, DOI 10.1017/S0033291708004947; Myin-Germeys I, 2011, SCHIZOPHRENIA BULL, V37, P244, DOI 10.1093/schbul/sbq164; OWENS DC, 1999, GUIDE EXTRAPYRAMIDAL; Pae CU, 2004, INT J NEUROPSYCHOPH, V7, P495, DOI 10.1017/S1461145704004419; Rabe-Hesketh S., 2008, MULTILEVEL LONGITUDI; Reich DE, 2001, TRENDS GENET, V17, P502, DOI 10.1016/S0168-9525(01)02410-6; Rizos EN, 2009, PSYCHIAT GENET, V19, P106, DOI 10.1097/YPG.0b013e32832080ad; Robinson DG, 2002, SCHIZOPHR RES, V57, P209, DOI 10.1016/S0920-9964(01)00312-7; Rothman KJ., 2008, MODERN EPIDEMIOLOGY, V3rd ed; Sachdev PS, 2005, PSYCHIAT CLIN N AM, V28, P255, DOI 10.1016/j.psc.2004.10.004; SCHOOLER NR, 1982, ARCH GEN PSYCHIAT, V39, P486; Segman RH, 2000, PSYCHOPHARMACOLOGY, V152, P408, DOI 10.1007/s002130000521; Segman RH, 2002, MOL PSYCHIATR, V7, P137, DOI 10.1038/sj.mp.4000960; Segman RH, 2002, BIOL PSYCHIAT, V51, P261, DOI 10.1016/S0006-3223(01)01302-6; Smith A, 2011, OMICS, V15, P209, DOI 10.1089/omi.2011.0006; Srivastava V, 2006, PHARMACOGENET GENOM, V16, P111, DOI 10.1097/01.fpc.0000184957.98150.0f; Steyerberg E., 2009, CLIN PREDICTION MODE; Syu A, 2010, NEUROPSYCHOPHARMACOL, V35, P1155, DOI 10.1038/npp.2009.220; Szklo M., 2007, EPIDEMIOLOGY BASICS; Tanaka S, 2013, PHARMACOGENOMICS J, V13, P27, DOI 10.1038/tpj.2011.36; Van Harten P. N., 1996, Schizophrenia Research, V19, P195; van Os J, 2010, NATURE, V468, P203, DOI 10.1038/nature09563; Wang WYS, 2005, NAT REV GENET, V6, P109, DOI 10.1038/nrg1522; Wilffert B, 2009, J PSYCHOPHARMACOL, V23, P652, DOI 10.1177/0269881108091594; Xu ZL, 2009, NUCLEIC ACIDS RES, V37, pW600, DOI 10.1093/nar/gkp290; Zai CC, 2009, PHARMACOGENOMICS J, V9, P168, DOI 10.1038/tpj.2009.2; Zai CC, 2009, EUR NEUROPSYCHOPHARM, V19, P317, DOI 10.1016/j.euroneuro.2009.01.001; Zammit S, 2010, BRIT J PSYCHIAT, V197, P207, DOI 10.1192/bjp.bp.109.070904; Zammit S, 2010, EVID-BASED MENT HEAL, V13, P65, DOI 10.1136/ebmh.13.3.65; Zhang ZJ, 2003, PSYCHIAT GENET, V13, P187, DOI 10.1097/00041444-200309000-00010; Zhang ZJ, 2002, MOL PSYCHIATR, V7, P670, DOI 10.1038/sj.mp.4001052; Ziegler A, 2006, STAT APPROACH GENETI	78	18	19	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 4	2012	7	12							e50970	10.1371/journal.pone.0050970	http://dx.doi.org/10.1371/journal.pone.0050970			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	051EQ	23226551	Green Published, Green Submitted, gold			2022-12-27	WOS:000312108500037
J	Chan, JM; Zervantonakis, IK; Rimchala, T; Polacheck, WJ; Whisler, J; Kamm, RD				Chan, Juliana M.; Zervantonakis, Ioannis K.; Rimchala, Tharathorn; Polacheck, William J.; Whisler, Jordan; Kamm, Roger D.			Engineering of In Vitro 3D Capillary Beds by Self-Directed Angiogenic Sprouting	PLOS ONE			English	Article							MICROFLUIDIC PLATFORM; TUMOR ANGIOGENESIS; ENDOTHELIAL-CELLS; GROWTH-FACTORS; TISSUE; ANGIOPOIETIN-1; SCAFFOLDS; CULTURE; MIGRATION; NETWORK	In recent years, microfluidic systems have been used to study fundamental aspects of angiogenesis through the patterning of single-layered, linear or geometric vascular channels. In vivo, however, capillaries exist in complex, three-dimensional (3D) networks, and angiogenic sprouting occurs with a degree of unpredictability in all x,y,z planes. The ability to generate capillary beds in vitro that can support thick, biological tissues remains a key challenge to the regeneration of vital organs. Here, we report the engineering of 3D capillary beds in an in vitro microfluidic platform that is comprised of a biocompatible collagen I gel supported by a mechanical framework of alginate beads. The engineered vessels have patent lumens, form robust similar to 1.5 mm capillary networks across the devices, and support the perfusion of 1 mu m fluorescent beads through them. In addition, the alginate beads offer a modular method to encapsulate and co-culture cells that either promote angiogenesis or require perfusion for cell viability in engineered tissue constructs. This laboratory-constructed vascular supply may be clinically significant for the engineering of capillary beds and higher order biological tissues in a scalable and modular manner. Citation: Chan JM, Zervantonakis IK, Rimchala T, Polacheck WJ, Whisler J, et al. (2012) Engineering of In Vitro 3D Capillary Beds by Self-Directed Angiogenic Sprouting. PLoS ONE 7(12): e50582. doi:10.1371/journal.pone.0050582	[Chan, Juliana M.; Rimchala, Tharathorn; Kamm, Roger D.] MIT, Dept Biol Engn, Cambridge, MA 02139 USA; [Chan, Juliana M.] Agcy Sci Technol & Res, Mol Engn Lab, Singapore, Singapore; [Zervantonakis, Ioannis K.; Polacheck, William J.; Whisler, Jordan; Kamm, Roger D.] MIT, Dept Mech Engn, Cambridge, MA 02139 USA	Massachusetts Institute of Technology (MIT); Agency for Science Technology & Research (A*STAR); Massachusetts Institute of Technology (MIT)	Kamm, RD (corresponding author), MIT, Dept Biol Engn, 77 Massachusetts Ave, Cambridge, MA 02139 USA.	rdkamm@mit.edu	Zervantonakis, Ioannis/ADS-2519-2022; Chan, Juliana/E-8646-2014; Kamm, Roger D/I-7630-2012; Zervantonakis, Ioannis/N-9717-2019; Zervantonakis, Ioannis/C-2890-2011	Zervantonakis, Ioannis/0000-0003-2386-9553; Chan, Juliana/0000-0002-7489-3716; Zervantonakis, Ioannis/0000-0003-2386-9553; Zervantonakis, Ioannis/0000-0003-2386-9553; Polacheck, William/0000-0003-2728-0746; /0000-0002-7232-304X	NSF Science and Technology Center (EBICS); Singapore-MIT Alliance (SMART); Singapore Agency for Science, Technology and Research (A*STAR) National Science Scholarship; L'Oreal-UNESCO For Women In Science Fellowship	NSF Science and Technology Center (EBICS); Singapore-MIT Alliance (SMART); Singapore Agency for Science, Technology and Research (A*STAR) National Science Scholarship; L'Oreal-UNESCO For Women In Science Fellowship	This study was supported in part by a NSF Science and Technology Center (EBICS) grant and the Singapore-MIT Alliance (SMART). JMC acknowledges financial support from the Singapore Agency for Science, Technology and Research (A*STAR) National Science Scholarship, and the 2011 L'Oreal-UNESCO For Women In Science Fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BAR T, 1984, CELL TISSUE RES, V235, P99; Bettinger CJ, 2006, ADV MATER, V18, P165, DOI 10.1002/adma.200500438; Blow N, 2009, NAT METHODS, V6, P619, DOI 10.1038/nmeth0809-619; Borenstein JT, 2007, TISSUE ENG, V13, P1837, DOI 10.1089/ten.2006.0156; Brindle NPJ, 2006, CIRC RES, V98, P1014, DOI 10.1161/01.RES.0000218275.54089.12; Cabodi M, 2005, J AM CHEM SOC, V127, P13788, DOI 10.1021/ja054820t; Carmeliet P, 2000, NATURE, V407, P249, DOI 10.1038/35025220; Chung S, 2010, ANN BIOMED ENG, V38, P1164, DOI 10.1007/s10439-010-9899-3; Chung S, 2009, LAB CHIP, V9, P269, DOI 10.1039/b807585a; Darland DC, 2001, CURR TOP DEV BIOL, V52, P107, DOI 10.1016/S0070-2153(01)52010-4; FOLKMAN J, 1980, NATURE, V288, P551, DOI 10.1038/288551a0; FOLKMAN J, 1985, ADV CANCER RES, V43, P175, DOI 10.1016/S0065-230X(08)60946-X; Folkman J, 2007, NAT REV DRUG DISCOV, V6, P273, DOI 10.1038/nrd2115; Garcia JGN, 2001, J CLIN INVEST, V108, P689, DOI 10.1172/JCI12450; Glowacki J, 2008, BIOPOLYMERS, V89, P338, DOI 10.1002/bip.20871; Griffith CK, 2005, TISSUE ENG, V11, P257, DOI 10.1089/ten.2005.11.257; Huh D, 2010, SCIENCE, V328, P1662, DOI 10.1126/science.1188302; Johnson PC, 2007, TISSUE ENG, V13, P2827, DOI 10.1089/ten.2007.0335; Keshaw H, 2005, BIOMATERIALS, V26, P4171, DOI 10.1016/j.biomaterials.2004.10.021; Khademhosseini A, 2006, P NATL ACAD SCI USA, V103, P2480, DOI 10.1073/pnas.0507681102; King KR, 2004, ADV MATER, V16, P2007, DOI 10.1002/adma.200306522; McGuigan AP, 2006, P NATL ACAD SCI USA, V103, P11461, DOI 10.1073/pnas.0602740103; Miller J.S., 2012, NATURE MAT; MOENNER M, 1994, EUR J BIOCHEM, V226, P483, DOI 10.1111/j.1432-1033.1994.tb20073.x; Nakatsu MN, 2003, MICROVASC RES, V66, P102, DOI 10.1016/S0026-2862(03)00045-1; Papapetropoulos A, 1999, LAB INVEST, V79, P213; Polacheck WJ, 2011, P NATL ACAD SCI USA, V108, P11115, DOI 10.1073/pnas.1103581108; Schomber T, 2007, CANCER RES, V67, P10840, DOI 10.1158/0008-5472.CAN-07-1034; Song JW, 2011, P NATL ACAD SCI USA, V108, P15342, DOI 10.1073/pnas.1105316108; Taylor AM, 2005, NAT METHODS, V2, P599, DOI 10.1038/NMETH777; Uemura A, 2002, J CLIN INVEST, V110, P1619, DOI 10.1172/JCI200215621; Vickerman V, 2008, LAB CHIP, V8, P1468, DOI 10.1039/b802395f; Xia YN, 1999, CHEM REV, V99, P1823, DOI 10.1021/cr980002q; Yeon JH, 2012, LAB CHIP, V12, P2815, DOI [10.1039/c2lc40131b, 10.1039/C2LC40131B]; Zervantonakis IK, 2010, INT J MICRONANOSCALE, V1, P27, DOI DOI 10.1260/1759-3093.1.1.27; Zheng Y, 2012, P NATL ACAD SCI USA, V109, P9342, DOI 10.1073/pnas.1201240109	36	65	66	0	85	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 4	2012	7	12							e50582	10.1371/journal.pone.0050582	http://dx.doi.org/10.1371/journal.pone.0050582			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	051EQ	23226527	Green Published, Green Submitted, gold			2022-12-27	WOS:000312108500020
J	Andrieu, NA; Motino, O; Mayoral, R; Izquierdo, CL; Fernandez-Alvarez, A; Bosca, L; Casado, M; Martin-Sanz, P				Agra Andrieu, Noelia; Motino, Omar; Mayoral, Rafael; Llorente Izquierdo, Cristina; Fernandez-Alvarez, Ana; Bosca, Lisardo; Casado, Marta; Martin-Sanz, Paloma			Cyclooxygenase-2 Is a Target of MicroRNA-16 in Human Hepatoma Cells	PLOS ONE			English	Article							MESSENGER-RNA STABILITY; HUMAN HEPATOCELLULAR-CARCINOMA; MICE EXPRESSING CYCLOOXYGENASE-2; COLON-CANCER CELLS; LIVER-REGENERATION; BINDING PROTEIN; DOWN-REGULATION; HUR; COX-2; GENE	Cyclooxygenase-2 (COX-2) expression has been detected in human hepatoma cell lines and in human hepatocellular carcinoma (HCC); however, the contribution of COX-2 to the development of HCC remains controversial. COX-2 expression is higher in the non-tumoral tissue and inversely correlates with the differentiation grade of the tumor. COX-2 expression depends on the interplay between different cellular pathways involving both transcriptional and post-transcriptional regulation. The aim of this work was to assess whether COX-2 could be regulated by microRNAs in human hepatoma cell lines and in human HCC specimens since these molecules contribute to the regulation of genes implicated in cell growth and differentiation. Our results show that miR-16 silences COX-2 expression in hepatoma cells by two mechanisms: a) by binding directly to the microRNA response element (MRE) in the COX-2 3'-UTR promoting translational suppression of COX-2 mRNA; b) by decreasing the levels of the RNA-binding protein Human Antigen R (HuR). Furthermore, ectopic expression of miR-16 inhibits cell proliferation, promotes cell apoptosis and suppresses the ability of hepatoma cells to develop tumors in nude mice, partially through targeting COX-2. Moreover a reduced miR-16 expression tends to correlate to high levels of COX-2 protein in liver from patients affected by HCC. Our data show an important role for miR-16 as a post-transcriptional regulator of COX-2 in HCC and suggest the potential therapeutic application of miR-16 in those HCC with a high COX-2 expression.	[Agra Andrieu, Noelia; Motino, Omar; Mayoral, Rafael; Llorente Izquierdo, Cristina; Bosca, Lisardo; Martin-Sanz, Paloma] Univ Autonoma Madrid, CSIC UAM, Ctr Mixto Consejo Super Invest Cient, Inst Invest Biomed Alberto Sols, Madrid, Spain; [Mayoral, Rafael; Bosca, Lisardo; Casado, Marta; Martin-Sanz, Paloma] Ctr Invest Biomed Red Enfermedades Hepat & Digest, Barcelona, Spain; [Fernandez-Alvarez, Ana; Casado, Marta] IBV CSIC, Valencia, Spain	Autonomous University of Madrid; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Investigaciones Biomedicas Alberto Sols (IIBM); CIBER - Centro de Investigacion Biomedica en Red; CIBEREHD; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Biomedicina de Valencia (IBV)	Martin-Sanz, P (corresponding author), Univ Autonoma Madrid, CSIC UAM, Ctr Mixto Consejo Super Invest Cient, Inst Invest Biomed Alberto Sols, Madrid, Spain.	pmartins@iib.uam.es	Mayoral Monibas, Rafael/B-3563-2013; Martín-Sanz, Paloma/K-1303-2014; Llorente, Cristina/AAV-2623-2021; Casado, Marta/L-2078-2014; Bosca, Lisardo/A-2059-2008	Mayoral Monibas, Rafael/0000-0002-6645-7172; Llorente, Cristina/0000-0001-8135-9186; Casado, Marta/0000-0001-6457-4650; Bosca, Lisardo/0000-0002-0253-5469; Motino Garcia-Miguel, Omar/0000-0002-3858-0966; Fernandez-Alvarez, Ana/0000-0002-5296-5678	Ministry of Science and Innovation [SAF2010-16037, SAF2009-12602, BFU2011-24760]; Comunidad de Madrid [P2010/BMD-2378]	Ministry of Science and Innovation(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); Comunidad de Madrid(Comunidad de Madrid)	This work was supported by Ministry of Science and Innovation [SAF2010-16037, SAF2009-12602 and BFU2011-24760] and by Comunidad de Madrid [P2010/BMD-2378]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguda BD, 2008, P NATL ACAD SCI USA, V105, P19678, DOI 10.1073/pnas.0811166106; Bhattacharyya SN, 2006, CELL, V125, P1111, DOI 10.1016/j.cell.2006.04.031; Brennan CM, 2001, CELL MOL LIFE SCI, V58, P266, DOI 10.1007/PL00000854; Casado M, 2001, FASEB J, V15, P2016, DOI 10.1096/fj.01-0158fje; Casado M, 2007, HEPATOLOGY, V45, P631, DOI 10.1002/hep.21556; Cha YI, 2007, ANNU REV MED, V58, P239, DOI 10.1146/annurev.med.57.121304.131253; Chakrabarty A, 2007, P NATL ACAD SCI USA, V104, P15144, DOI 10.1073/pnas.0705917104; Chen XM, 2007, J BIOL CHEM, V282, P28929, DOI 10.1074/jbc.M702633200; Chen XM, 2009, WORLD J GASTROENTERO, V15, P1665, DOI 10.3748/wjg.15.1665; Cheng ASL, 2008, BIOCHEM BIOPH RES CO, V374, P175, DOI 10.1016/j.bbrc.2008.06.098; Cusimano A, 2009, ANN NY ACAD SCI, V1155, P300, DOI 10.1111/j.1749-6632.2009.03701.x; Daikoku T, 2008, CANCER RES, V68, P5619, DOI 10.1158/0008-5472.CAN-08-1274; de La Coste A, 1998, P NATL ACAD SCI USA, V95, P8847; Dixon DA, 2001, J CLIN INVEST, V108, P1657, DOI 10.1172/JCI200112973; Erkinheimo TL, 2003, CANCER RES, V63, P7591; Garzon R, 2010, NAT REV DRUG DISCOV, V9, P775, DOI 10.1038/nrd3179; Gramantieri L, 2007, CANCER RES, V67, P6092, DOI 10.1158/0008-5472.CAN-06-4607; Harper KA, 2008, BIOCHEM SOC T, V36, P543, DOI 10.1042/BST0360543; Hoshida Y, 2009, CANCER RES, V69, P7385, DOI 10.1158/0008-5472.CAN-09-1089; Hu Z, 2005, LUNG CANCER, V48, P11, DOI 10.1016/j.lungcan.2004.09.004; Huang J, 2007, J BIOL CHEM, V282, DOI 10.1074/jbc.M705116200; Ji JF, 2009, NEW ENGL J MED, V361, P1437, DOI 10.1056/NEJMoa0901282; Jing Q, 2005, CELL, V120, P623, DOI 10.1016/j.cell.2004.12.038; Kang YJ, 2007, PROG LIPID RES, V46, P108, DOI 10.1016/j.plipres.2007.01.001; Kern MA, 2004, CARCINOGENESIS, V25, P1193, DOI 10.1093/carcin/bgh110; Kern MA, 2002, HEPATOLOGY, V36, P885, DOI 10.1053/jhep.2002.36125; Kern MA, 2006, CANCER RES, V66, P7059, DOI 10.1158/0008-5472.CAN-06-0325; Kutay H, 2006, J CELL BIOCHEM, V99, P671, DOI 10.1002/jcb.20982; Ledwith BJ, 1997, J BIOL CHEM, V272, P3707, DOI 10.1074/jbc.272.6.3707; Lee JS, 2004, NAT GENET, V36, P1306, DOI 10.1038/ng1481; Izquierdo CL, 2011, AM J PATHOL, V178, P1361, DOI 10.1016/j.ajpath.2010.11.074; Llovet JM, 2008, HEPATOLOGY, V48, P1312, DOI 10.1002/hep.22506; Martin-Sanz P, 1998, BRIT J PHARMACOL, V125, P1313, DOI 10.1038/sj.bjp.0702196; Mayoral R, 2005, CARCINOGENESIS, V26, P753, DOI 10.1093/carcin/bgi022; Mayr C, 2009, CELL, V138, P673, DOI 10.1016/j.cell.2009.06.016; Meng FY, 2007, GASTROENTEROLOGY, V133, P647, DOI 10.1053/j.gastro.2007.05.022; Mukhopadhyay D, 2003, MOL CELL, V11, P113, DOI 10.1016/S1097-2765(03)00012-1; Murakami Y, 2006, ONCOGENE, V25, P2537, DOI 10.1038/sj.onc.1209283; Nicoloso MS, 2009, NAT REV CANCER, V9, P293, DOI 10.1038/nrc2619; Nunez O, 2004, GUT, V53, P1665, DOI 10.1136/gut.2003.038364; Rehmsmeier M, 2004, RNA, V10, P1507, DOI 10.1261/rna.5248604; Rudnick DA, 2001, P NATL ACAD SCI USA, V98, P8885, DOI 10.1073/pnas.151217998; Sawaoka H, 2003, J BIOL CHEM, V278, P13928, DOI 10.1074/jbc.M300016200; Simmons DL, 2004, PHARMACOL REV, V56, P387, DOI 10.1124/pr.56.3.3; Strillacci A, 2009, EXP CELL RES, V315, P1439, DOI 10.1016/j.yexcr.2008.12.010; Sureban SM, 2007, GASTROENTEROLOGY, V132, P1055, DOI 10.1053/j.gastro.2006.12.031; Tanaka T, 2009, DIFFERENTIATION, V77, P181, DOI 10.1016/j.diff.2008.10.001; Viswanathan SR, 2009, NAT GENET, V41, P843, DOI 10.1038/ng.392; Xu CW, 2010, EUR J CANCER, V46, P2828, DOI 10.1016/j.ejca.2010.06.127; Xu F, 2010, J CELL BIOCHEM, V111, P727, DOI 10.1002/jcb.22762; Yamamoto H, 2003, GASTROENTEROLOGY, V125, P556, DOI 10.1016/S0016-5085(03)00904-1; Yang XL, 2004, J BIOL CHEM, V279, P49298, DOI 10.1074/jbc.M407535200; Young LE, 2012, MOL CANCER RES, V10, P167, DOI 10.1158/1541-7786.MCR-11-0337; Young LE, 2010, CURR COLORECT CANC R, V6, P60, DOI 10.1007/s11888-010-0044-3; Young LE, 2009, GASTROENTEROLOGY, V136, P1669, DOI 10.1053/j.gastro.2009.01.010; Zhang J, 2008, MOL CARCINOGEN, V47, P974, DOI 10.1002/mc.20450; Zhao Y, 2007, CELL, V129, P303, DOI 10.1016/j.cell.2007.03.030	57	30	32	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 30	2012	7	11							e50935	10.1371/journal.pone.0050935	http://dx.doi.org/10.1371/journal.pone.0050935			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	054WM	23226427	gold, Green Submitted, Green Published			2022-12-27	WOS:000312376100238
J	Berry, CT; Sceniak, MP; Zhou, L; Sabo, SL				Berry, Corbett T.; Sceniak, Michael P.; Zhou, Louie; Sabo, Shasta L.			Developmental Up-Regulation of Vesicular Glutamate Transporter-1 Promotes Neocortical Presynaptic Terminal Development	PLOS ONE			English	Article							POSTNATAL-DEVELOPMENT; INCREASED EXPRESSION; SYNAPSE FORMATION; VGLUT1; ANTIDEPRESSANT; RELEASE; DEPRESSION; RECEPTORS; COLOCALIZATION; MECHANISMS	Presynaptic terminal formation is a complex process that requires assembly of proteins responsible for synaptic transmission at sites of axo-dendritic contact. Accumulation of presynaptic proteins at developing terminals is facilitated by glutamate receptor activation. Glutamate is loaded into synaptic vesicles for release via the vesicular glutamate transporters VGLUT1 and VGLUT2. During postnatal development there is a switch from predominantly VGLUT2 expression to high VGLUT1 and low VGLUT2, raising the question of whether the developmental increase in VGLUT1 is important for presynaptic development. Here, we addressed this question using confocal microscopy and quantitative immunocytochemistry in primary cultures of rat neocortical neurons. First, in order to understand the extent to which the developmental switch from VGLUT2 to VGLUT1 occurs through an increase in VGLUT1 at individual presynaptic terminals or through addition of VGLUT1-positive presynaptic terminals, we examined the spatio-temporal dynamics of VGLUT1 and VGLUT2 expression. Between 5 and 12 days in culture, the percentage of presynaptic terminals that expressed VGLUT1 increased during synapse formation, as did expression of VGLUT1 at individual terminals. A subset of VGLUT1-positive terminals also expressed VGLUT2, which decreased at these terminals. At individual terminals, the increase in VGLUT1 correlated with greater accumulation of other synaptic vesicle proteins, such as synapsin and synaptophysin. When the developmental increase in VGLUT1 was prevented using VGLUT1-shRNA, the density of presynaptic terminals and accumulation of synapsin and synaptophysin at terminals were decreased. Since VGLUT1 knock-down was limited to a small number of neurons, the observed effects were cell-autonomous and independent of changes in overall network activity. These results demonstrate that up-regulation of VGLUT1 is important for development of presynaptic terminals in the cortex.	[Sabo, Shasta L.] Case Western Reserve Univ, Sch Med, Dept Pharmacol, Cleveland, OH 44106 USA; Case Western Reserve Univ, Sch Med, Dept Neurosci, Cleveland, OH 44106 USA	Case Western Reserve University; Case Western Reserve University	Sabo, SL (corresponding author), Case Western Reserve Univ, Sch Med, Dept Pharmacol, Cleveland, OH 44106 USA.	shasta.sabo@case.edu		Sabo, Shasta/0000-0001-6386-7443; Sceniak, Michael/0000-0003-2415-5800; Berry, Corbett/0000-0001-9348-2034	PhRMA Foundation; Case Western Reserve University	PhRMA Foundation; Case Western Reserve University	The work was funded by a Research Starter grant from the PhRMA Foundation (SS) and start-up funds from Case Western Reserve University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmari SE, 2000, NAT NEUROSCI, V3, P445, DOI 10.1038/74814; Alvarez VA, 2007, J NEUROSCI, V27, P7365, DOI 10.1523/JNEUROSCI.0956-07.2007; Bleckert A, 2011, BIOESSAYS, V33, P61, DOI 10.1002/bies.201000095; Boulland JL, 2004, J COMP NEUROL, V480, P264, DOI 10.1002/cne.20354; Bragina L, 2007, NEUROSCIENCE, V146, P1829, DOI 10.1016/j.neuroscience.2007.02.060; BRESLAU N, 1995, PSYCHIAT RES, V58, P1, DOI 10.1016/0165-1781(95)02765-O; Bury LAD, 2011, NEURAL DEV, V6, DOI 10.1186/1749-8104-6-24; Bury LAD, 2010, MOL INTERV, V10, P282, DOI 10.1124/mi.10.5.5; Chang S, 2001, NAT NEUROSCI, V4, P787, DOI 10.1038/90489; Cline H, 2008, J PHYSIOL-LONDON, V586, P1509, DOI 10.1113/jphysiol.2007.150029; Daniels RW, 2006, NEURON, V49, P11, DOI 10.1016/j.neuron.2005.11.032; Daniels RW, 2004, J NEUROSCI, V24, P10466, DOI 10.1523/JNEUROSCI.3001-04.2004; De Gois S, 2005, J NEUROSCI, V25, P7121, DOI 10.1523/JNEUROSCI.5221-04.2005; Demarque M, 2002, NEURON, V36, P1051, DOI 10.1016/S0896-6273(02)01053-X; Elizalde N, 2010, J NEUROCHEM, V114, P1302, DOI 10.1111/j.1471-4159.2010.06854.x; Fremeau RT, 2001, NEURON, V31, P247, DOI 10.1016/S0896-6273(01)00344-0; Fremeau RT, 2004, SCIENCE, V304, P1815, DOI 10.1126/science.1097468; Gomes RA, 2006, J NEUROSCI, V26, P11487, DOI 10.1523/JNEUROSCI.2364-06.2006; Gross C, 2004, NAT REV NEUROSCI, V5, P545, DOI 10.1038/nrn1429; Herzog E, 2001, J NEUROSCI, V21, part. no., DOI 10.1523/JNEUROSCI.21-22-j0001.2001; Herzog E, 2006, J NEUROCHEM, V99, P1011, DOI 10.1111/j.1471-4159.2006.04144.x; Hua JYY, 2004, NAT NEUROSCI, V7, P327, DOI 10.1038/nn1218; Huberman AD, 2008, ANNU REV NEUROSCI, V31, P479, DOI 10.1146/annurev.neuro.31.060407.125533; Inan M, 2007, NEUROSCIENTIST, V13, P49, DOI 10.1177/1073858406296257; Jin Y, 2008, ANNU REV CELL DEV BI, V24, P237, DOI 10.1146/annurev.cellbio.23.090506.123417; Kay L, 2011, NAT NEUROSCI, V14, P688, DOI 10.1038/nn.2826; Leonardo ED, 2008, NEUROPSYCHOPHARMACOL, V33, P134, DOI 10.1038/sj.npp.1301569; Li NX, 2010, SCIENCE, V329, P959, DOI 10.1126/science.1190287; Melom JE, 2011, CURR OPIN GENET DEV, V21, P256, DOI 10.1016/j.gde.2011.01.002; Minelli A, 2003, DEV BRAIN RES, V140, P309, DOI 10.1016/S0165-3806(02)00617-X; Moutsimilli L, 2005, NEUROPHARMACOLOGY, V49, P890, DOI 10.1016/j.neuropharm.2005.06.017; Murrough JW, 2012, CLIN PHARMACOL THER, V91, P303, DOI 10.1038/clpt.2011.244; Nakamura K, 2005, J COMP NEUROL, V492, P263, DOI 10.1002/cne.20705; Parker G, 1999, J AFFECT DISORDERS, V52, P11, DOI 10.1016/S0165-0327(98)00084-6; Ripley B, 2011, P NATL ACAD SCI USA, V108, P367, DOI 10.1073/pnas.1015163108; Sabo SL, 2006, J NEUROSCI, V26, P10813, DOI 10.1523/JNEUROSCI.2052-06.2006; Sabo SL, 2003, NAT NEUROSCI, V6, P1264, DOI 10.1038/nn1149; Sceniak MP, 2012, NEURAL DEV, V7, DOI 10.1186/1749-8104-7-8; Takamori S, 2006, NEUROSCI RES, V55, P343, DOI 10.1016/j.neures.2006.04.016; Tashiro A, 2003, NEURON, V38, P773, DOI 10.1016/S0896-6273(03)00299-X; Tordera RM, 2005, J NEUROCHEM, V94, P875, DOI 10.1111/j.1471-4159.2005.03192.x; Varoqui H, 2002, J NEUROSCI, V22, P142, DOI 10.1523/JNEUROSCI.22-01-00142.2002; Weissman MM, 2005, ARCH GEN PSYCHIAT, V62, P29, DOI 10.1001/archpsyc.62.1.29; White LE, 2007, NEURON, V56, P327, DOI 10.1016/j.neuron.2007.10.011; Wilson NR, 2005, J NEUROSCI, V25, P6221, DOI 10.1523/JNEUROSCI.3003-04.2005; Wojcik SM, 2004, P NATL ACAD SCI USA, V101, P7158, DOI 10.1073/pnas.0401764101; Xia ZG, 1996, J NEUROSCI, V16, P5425	47	13	13	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 30	2012	7	11							e50911	10.1371/journal.pone.0050911	http://dx.doi.org/10.1371/journal.pone.0050911			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	054WM	23226425	Green Published, gold, Green Submitted			2022-12-27	WOS:000312376100236
J	Han, X; Cheng, ZH; Meng, HW				Han, Xu; Cheng, Zhihui; Meng, Huanwen			Soil Properties, Nutrient Dynamics, and Soil Enzyme Activities Associated with Garlic Stalk Decomposition under Various Conditions	PLOS ONE			English	Article							LEAF-LITTER DECOMPOSITION; COMMUNITY COMPOSITION; RESIDUE MANAGEMENT; ORGANIC-MATTER; ARCTIC TUNDRA; PLANT TRAITS; COVER CROP; NITROGEN; QUALITY; CARBON	The garlic stalk is a byproduct of garlic production and normally abandoned or burned, both of which cause environmental pollution. It is therefore appropriate to determine the conditions of efficient decomposition, and equally appropriate to determine the impact of this decomposition on soil properties. In this study, the soil properties, enzyme activities and nutrient dynamics associated with the decomposition of garlic stalk at different temperatures, concentrations and durations were investigated. Stalk decomposition significantly increased the values of soil pH and electrical conductivity. In addition, total nitrogen and organic carbon concentration were significantly increased by decomposing stalks at 40 degrees C, with a 5:100 ratio and for 10 or 60 days. The highest activities of sucrase, urease and alkaline phosphatase in soil were detected when stalk decomposition was performed at the lowest temperature (10 degrees C), highest concentration (5:100), and shortest duration (10 or 20 days). The evidence presented here suggests that garlic stalk decomposition improves the quality of soil by altering the value of soil pH and electrical conductivity and by changing nutrient dynamics and soil enzyme activity, compared to the soil decomposition without garlic stalks.	[Han, Xu; Cheng, Zhihui; Meng, Huanwen] NW A&F Univ, State Key Lab Crop Stress Biol Arid Areas, Yangling, Shaanxi, Peoples R China; [Han, Xu; Cheng, Zhihui; Meng, Huanwen] NW A&F Univ, Coll Hort, Yangling, Shaanxi, Peoples R China	Northwest A&F University - China; Northwest A&F University - China	Cheng, ZH (corresponding author), NW A&F Univ, State Key Lab Crop Stress Biol Arid Areas, Yangling, Shaanxi, Peoples R China.; Cheng, ZH (corresponding author), NW A&F Univ, Coll Hort, Yangling, Shaanxi, Peoples R China.	chengzh@nwsuaf.edu.cn			State Commonwealth (Agriculture) Scientific Research project [200903018]; State Natural Science Foundation [31171949]	State Commonwealth (Agriculture) Scientific Research project; State Natural Science Foundation	This research was supported by a State Commonwealth (Agriculture) Scientific Research project (No.200903018) and a State Natural Science Foundation project (No.31171949). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aerts R, 2000, ADV ECOL RES, V30, P1, DOI 10.1016/S0065-2504(08)60016-1; Jacobson TKB, 2011, ENVIRON POLLUT, V159, P2236, DOI 10.1016/j.envpol.2010.10.019; Bao S.D, 2000, SOIL AGRO CHEM ANAL, P49; Belyea LR, 1996, OIKOS, V77, P529, DOI 10.2307/3545942; Bhupinderpal-Singh, 2009, BIOL FERT SOILS, V45, P423, DOI 10.1007/s00374-008-0351-x; Cheng L, 2010, ECOL LETT, V13, P284, DOI 10.1111/j.1461-0248.2009.01421.x; Cheng Zhi-hui, 2008, Xibei Zhiwu Xuebao, V28, P324; Dilly O, 2001, BIOL FERT SOILS, V34, P64, DOI 10.1007/s003740100375; Dilly O, 2007, J PLANT NUTR SOIL SC, V170, P197, DOI 10.1002/jpln.200622044; DuPont ST, 2009, APPL SOIL ECOL, V41, P157, DOI 10.1016/j.apsoil.2008.10.004; Eskelinen A, 2008, J ECOL, V96, P155, DOI 10.1111/j.1365-2745.2007.01322.x; Eskelinen A, 2009, OECOLOGIA, V161, P113, DOI 10.1007/s00442-009-1362-5; Garnier E, 2007, ANN BOT-LONDON, V99, P967, DOI 10.1093/aob/mcl215; Gough L, 2000, J ECOL, V88, P54, DOI 10.1046/j.1365-2745.2000.00426.x; Guo RY, 2008, PLANT SOIL, V313, P55, DOI 10.1007/s11104-008-9679-0; Hodge A, 1998, NEW PHYTOL, V139, P479, DOI 10.1046/j.1469-8137.1998.00216.x; Holmgren Milena, 1997, Ecology (Washington D C), V78, P1966, DOI 10.1890/0012-9658(1997)078[1966:TIOFAC]2.0.CO;2; Ibewiro B, 2000, NUTR CYCL AGROECOSYS, V57, P131, DOI 10.1023/A:1009846203062; Icoz I, 2008, SOIL BIOL BIOCHEM, V40, P559, DOI 10.1016/j.soilbio.2007.11.002; Ilieva-Makulec K, 2006, EUR J SOIL BIOL, V42, pS244, DOI 10.1016/j.ejsobi.2006.07.030; JORDAN TE, 1989, ECOLOGY, V70, P1906, DOI 10.2307/1938121; Kang H, 2009, COMMUN SOIL SCI PLAN, V40, P3323, DOI 10.1080/00103620903325935; Kang HZ, 2010, ANN FOREST SCI, V67, DOI 10.1051/forest/2010047; Kuo S, 2002, AGRON J, V94, P501; Lagomarsino A, 2011, BIOL FERT SOILS, V47, P283, DOI 10.1007/s00374-010-0530-4; Laiho R, 2006, SOIL BIOL BIOCHEM, V38, P2011, DOI 10.1016/j.soilbio.2006.02.017; Laker M. C., 2004, South African Journal of Plant and Soil, V21, P345; Larcher W, 2003, PHYSL PLANT ECOLOGY; Lavorel S, 2002, FUNCT ECOL, V16, P545, DOI 10.1046/j.1365-2435.2002.00664.x; MACDONALD NW, 1995, SOIL SCI SOC AM J, V59, P233, DOI 10.2136/sssaj1995.03615995005900010036x; Maisto G, 2011, SOIL BIOL BIOCHEM, V43, P520, DOI 10.1016/j.soilbio.2010.11.017; Marschner H., 1995, MINERAL NUTR HIGHER, V2nd ed.; MCSORLEY R, 1994, J NEMATOL, V26, P669; Meier CL, 2009, J ECOL, V97, P941, DOI 10.1111/j.1365-2745.2009.01537.x; Miguez FE, 2005, CROP SCI, V45, P2318, DOI 10.2135/cropsci2005.0014; Mills A. J., 2004, South African Journal of Plant and Soil, V21, P388; Muthukaruppan G, 2005, J SOIL SEDIMENT, V5, P82, DOI 10.1065/jss2004.09.111; Prescott CE, 2010, BIOGEOCHEMISTRY, V101, P133, DOI 10.1007/s10533-010-9439-0; PUTNAM AR, 1994, MANAGING AGR RESIDUE, P285; Rombke J., 2005, Umweltwissenschaften und Schadstoff-Forschung, V17, P85, DOI 10.1065/uswf2004.12.088.2; Ruffo ML, 2003, AGRON J, V95, P900, DOI 10.2134/agronj2003.0900; Sarrantonio M., 2003, Journal of Crop Production, V8, P53, DOI 10.1300/J144v08n01_04; Saura-Mas S, 2012, ENVIRON EXP BOT, V77, P274, DOI 10.1016/j.envexpbot.2011.11.014; Shaver GR, 2006, J ECOL, V94, P740, DOI 10.1111/j.1365-2745.2006.01139.x; Shen GQ., 1984, ACTA PEDOLOGICA SINI, V21, P368; Strakova P, 2012, GLOBAL CHANGE BIOL, V18, P322, DOI 10.1111/j.1365-2486.2011.02503.x; Suding KN, 2008, GLOBAL CHANGE BIOL, V14, P1125, DOI 10.1111/j.1365-2486.2008.01557.x; Tian YQ, 2010, NUTR CYCL AGROECOSYS, V88, P429, DOI 10.1007/s10705-010-9367-3; VITOUSEK PM, 1986, ANNU REV ECOL SYST, V17, P137, DOI 10.1146/annurev.es.17.110186.001033; Wang ChunHui, 2009, Journal of Northwest A & F University - Natural Science Edition, V37, P103; Wei Ling, 2008, Journal of Northwest A & F University - Natural Science Edition, V36, P139; Williams SM, 2004, SOIL SCI SOC AM J, V68, P1403, DOI 10.2136/sssaj2004.1403; Yadvinder-Singh, 2010, NUTR CYCL AGROECOSYS, V88, P471, DOI 10.1007/s10705-010-9370-8; Yao HY, 2006, PLANT SOIL, V284, P195, DOI 10.1007/s11104-006-0023-2; Zak DR, 2006, ECOLOGY, V87, P1659, DOI 10.1890/0012-9658(2006)87[1659:MCCAFA]2.0.CO;2; Zibilske LM, 2005, SOIL SCI SOC AM J, V69, P378, DOI 10.2136/sssaj2005.0378	56	21	26	1	54	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 30	2012	7	11							e50868	10.1371/journal.pone.0050868	http://dx.doi.org/10.1371/journal.pone.0050868			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	054WM	23226411	Green Submitted, Green Published, gold			2022-12-27	WOS:000312376100222
J	Lee, H; Kim, JS; Kim, E				Lee, Hyunkyoung; Kim, Jong-Shu; Kim, Euikyung			Fucoidan from Seaweed Fucus vesiculosus Inhibits Migration and Invasion of Human Lung Cancer Cell via PI3K-Akt-mTOR Pathways	PLOS ONE			English	Article							NF-KAPPA-B; ACTIVATION; INVOLVEMENT; GROWTH; MTOR; PHOSPHORYLATION; METASTASIS; EXPRESSION; MAPK; ERK	Background: Recently there has been an increased interest in the pharmacologically active natural products associated with remedies of various kinds of diseases, including cancer. Fucoidan is a polysaccharide derived from brown seaweeds and has long been used as an ingredient in some dietary supplement products. Although fucoidan has been known to have anticancer activity, the anti-metastatic effects and its detailed mechanism of actions have been poorly understood. Therefore, the aims of this study were to demonstrate the anti-metastatic functions of fucoidan and its mechanism of action using A549, a highly metastatic human lung cancer cell line. Methods and Principal Findings: Fucoidan inhibits the growth of A549 cells at the concentration of 400 mg/ml. Fucoidan treatment of non-toxic dose (0-200 mu g/ml) exhibits a concentration-dependent inhibitory effect on the invasion and migration of the cancer cell via decreasing its MMP-2 activity. To know the mechanism of these inhibitory effects, Western blotting was performed. Fucoidan treatment down-regulates extracellular signal-related kinase 1 and 2 (ERK1/2) and phosphoinositide 3-kinase (PI3K)-Akt-mammalian target of rapamycin (PI3K-Akt-mTOR) pathways. Furthermore, fucoidan decreases the cytosolic and nuclear levels of Nuclear Factor-kappa B (p65). Conclusions/Significance: The present study suggests that fucoidan exhibits anti-metastatic effect on A549 lung cancer cells via the down-regulation of ERK1/2 and Akt-mTOR as well as NF-kB signaling pathways. Hence, fucoidan can be considered as a potential therapeutic reagent against the metastasis of invasive human lung cancer cells.	[Lee, Hyunkyoung; Kim, Jong-Shu; Kim, Euikyung] Gyeongsang Natl Univ, Dept Pharmacol & Toxicol, Coll Vet Med, Jinju, South Korea; [Kim, Euikyung] Gyeongsang Natl Univ, Life Sci Res Inst, Jinju, South Korea	Gyeongsang National University; Gyeongsang National University	Kim, E (corresponding author), Gyeongsang Natl Univ, Dept Pharmacol & Toxicol, Coll Vet Med, Jinju, South Korea.	ekim@gnu.ac.kr						Aisa Y, 2005, AM J HEMATOL, V78, P7, DOI 10.1002/ajh.20182; Alekseyenko TV, 2007, B EXP BIOL MED+, V143, P730, DOI 10.1007/s10517-007-0226-4; Beevers CS, 2006, INT J CANCER, V119, P757, DOI 10.1002/ijc.21932; Bhat-Nakshatri P, 2002, ONCOGENE, V21, P2066, DOI 10.1038/sj.onc.1205243; Busch S, 2009, EXP CELL RES, V315, P1724, DOI 10.1016/j.yexcr.2009.01.026; Chambers AF, 2002, NAT REV CANCER, V2, P563, DOI 10.1038/nrc865; Chen JS, 2009, HEPATOL RES, V39, P177, DOI 10.1111/j.1872-034X.2008.00449.x; Cheng JCH, 2006, ONCOGENE, V25, P7009, DOI 10.1038/sj.onc.1209706; Choi JI, 2010, CHEM-BIOL INTERACT, V183, P249, DOI 10.1016/j.cbi.2009.09.015; Chu SC, 2004, MOL CARCINOGEN, V40, P143, DOI 10.1002/mc.20018; Durig J, 1997, THROMB RES, V85, P479, DOI 10.1016/S0049-3848(97)00037-6; Easton JB, 2006, ONCOGENE, V25, P6436, DOI 10.1038/sj.onc.1209886; Engelman JA, 2006, NAT REV GENET, V7, P606, DOI 10.1038/nrg1879; Faivre S, 2006, NAT REV DRUG DISCOV, V5, P671, DOI 10.1038/nrd2062; Folgueras AR, 2004, INT J DEV BIOL, V48, P411, DOI 10.1387/ijdb.041811af; Garbisa S, 2001, CANCER-AM CANCER SOC, V91, P822, DOI 10.1002/1097-0142(20010215)91:4<822::AID-CNCR1070>3.0.CO;2-G; Hay N, 2004, GENE DEV, V18, P1926, DOI 10.1101/gad.1212704; Hennessy BT, 2005, NAT REV DRUG DISCOV, V4, P988, DOI 10.1038/nrd1902; Jemal A, 2008, CA-CANCER J CLIN, V58, P71, DOI 10.3322/CA.2007.0010; Johnson LL, 1998, CURR OPIN CHEM BIOL, V2, P466, DOI 10.1016/S1367-5931(98)80122-1; Kajanne R, 2007, J CELL PHYSIOL, V212, P489, DOI 10.1002/jcp.21041; Kang C, 2010, FOOD CHEM TOXICOL, V48, P2366, DOI 10.1016/j.fct.2010.05.073; Lee KJ, 2006, FOOD CHEM TOXICOL, V44, P1890, DOI 10.1016/j.fct.2006.06.009; Liao Dong-Wei, 2006, Ai Zheng, V25, P1238; Meng Q, 2006, CELL SIGNAL, V18, P2262, DOI 10.1016/j.cellsig.2006.05.019; Park EJ, 2002, CANCER METAST REV, V21, P231, DOI 10.1023/A:1021254725842; Smalley KSM, 2003, INT J CANCER, V104, P527, DOI 10.1002/ijc.10978; Smit AJ, 2004, J APPL PHYCOL, V16, P245, DOI 10.1023/B:JAPH.0000047783.36600.ef; Srikantan V, 2002, CANCER RES, V62, P6812; Summers J. B., 1998, ANNU REP MED CHEM, V33, P131; Suthiphongchai T, 2003, ONCOL RES, V13, P253, DOI 10.3727/096504003108748302; Viatour P, 2005, TRENDS BIOCHEM SCI, V30, P43, DOI 10.1016/j.tibs.2004.11.009; Wang J, 2009, INT J BIOL MACROMOL, V44, P170, DOI 10.1016/j.ijbiomac.2008.11.010; Westermarck J, 1999, FASEB J, V13, P781, DOI 10.1096/fasebj.13.8.781; Whitmarsh AJ, 2007, ONCOGENE, V26, P3172, DOI 10.1038/sj.onc.1210410; Wijesekara I, 2011, CARBOHYD POLYM, V84, P14, DOI 10.1016/j.carbpol.2010.10.062; Wu WS, 2008, CANCER METAST REV, V27, P303, DOI 10.1007/s10555-008-9112-4; Yamasaki-Miyamoto Y, 2009, J AGR FOOD CHEM, V57, P8677, DOI 10.1021/jf9010406; Ye J, 2005, CYTOTECHNOLOGY, V47, P117, DOI 10.1007/s10616-005-3761-8; Ye M, 2008, INVEST OPHTH VIS SCI, V49, P497, DOI 10.1167/iovs.07-0975; Zapopozhets T S, 1995, Antibiot Khimioter, V40, P9	41	106	110	5	47	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 30	2012	7	11							e50624	10.1371/journal.pone.0050624	http://dx.doi.org/10.1371/journal.pone.0050624			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	054WM	23226337	gold, Green Published, Green Submitted			2022-12-27	WOS:000312376100148
J	Ree, AH; Kristensen, AT; Saelen, MG; de Wijn, R; Edvardsen, H; Jovanovic, J; Abrahamsen, TW; Dueland, S; Flatmark, K				Ree, Anne Hansen; Kristensen, Annette Torgunrud; Saelen, Marie Gron; de Wijn, Rik; Edvardsen, Hege; Jovanovic, Jovana; Abrahamsen, Torveig Weum; Dueland, Svein; Flatmark, Kjersti			Tumor Phosphatidylinositol-3-Kinase Signaling and Development of Metastatic Disease in Locally Advanced Rectal Cancer	PLOS ONE			English	Article							COLORECTAL-CANCER; ACQUIRED-RESISTANCE; PROGNOSTIC ROLE; KINASE-ACTIVITY; KRAS MUTATION; COLON-CANCER; BIOMARKERS; CETUXIMAB; BRAF; IDENTIFICATION	Background: Recognizing EGFR as key orchestrator of the metastatic process in colorectal cancer, but also the substantial heterogeneity of responses to anti-EGFR therapy, we examined the pattern of composite tumor kinase activities governed by EGFR-mediated signaling that might be implicated in development of metastatic disease. Patients and Methods: Point mutations in KRAS, BRAF, and PIK3CA and ERBB2 amplification were determined in primary tumors from 63 patients with locally advanced rectal cancer scheduled for radical treatment. Using peptide arrays with tyrosine kinase substrates, ex vivo phosphopeptide profiles were generated from the same baseline tumor samples and correlated to metastasis-free survival. Results: Unsupervised clustering analysis of the resulting phosphorylation of 102 array substrates defined two tumor classes, both consisting of cases with and without KRAS/BRAF mutations. The smaller cluster group of patients, with tumors generating high ex vivo phosphorylation of phosphatidylinositol-3-kinase-related substrates, had a particularly aggressive disease course, with almost a half of patients developing metastatic disease within one year of follow-up. Conclusion: High phosphatidylinositol-3-kinase-mediated signaling activity of the primary tumor, rather than KRAS/BRAF mutation status, was identified as a hallmark of poor metastasis-free survival in patients with locally advanced rectal cancer undergoing radical treatment of the pelvic cavity.	[Ree, Anne Hansen] Akershus Univ Hosp, Dept Oncol, Lorenskog, Norway; [Ree, Anne Hansen; Saelen, Marie Gron; Jovanovic, Jovana] Univ Oslo, Inst Clin Med, Oslo, Norway; [Kristensen, Annette Torgunrud; Saelen, Marie Gron; Abrahamsen, Torveig Weum; Flatmark, Kjersti] Norwegian Radium Hosp, Oslo Univ Hosp, Dept Tumor Biol, Oslo, Norway; [de Wijn, Rik] PamGene Int BV, Shertogenbosch, Netherlands; [Edvardsen, Hege] Norwegian Radium Hosp, Oslo Univ Hosp, Dept Genet, Oslo, Norway; [Jovanovic, Jovana] Akershus Univ Hosp, Dept Clin Mol Biol, Lorenskog, Norway; [Dueland, Svein] Oslo Univ Hosp, Dept Oncol, Oslo, Norway; [Flatmark, Kjersti] Norwegian Radium Hosp, Oslo Univ Hosp, Dept Surg Gastroenterol, Oslo, Norway	University of Oslo; University of Oslo; University of Oslo; PamGene International BV; University of Oslo; University of Oslo; University of Oslo; University of Oslo	Ree, AH (corresponding author), Akershus Univ Hosp, Dept Oncol, Lorenskog, Norway.	a.h.ree@medisin.uio.no		Ree, Anne H./0000-0002-8264-3223	Akershus University Hospital Grant; European Union [222741-METOXIA]; Norwegian Cancer Society	Akershus University Hospital Grant; European Union(European Commission); Norwegian Cancer Society(Norwegian Cancer Society)	This work was supported by Akershus University Hospital Grant 2010-003 (to AHR), the European Union 7th Framework Programme Grant 222741-METOXIA (to AHR and KF), the Norwegian Cancer Society (to KF), and a generous patient donation (approximately 10,000 USD) in support of this specific research activity (to AHR). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alberts SR, 2012, JAMA-J AM MED ASSOC, V307, P1383, DOI 10.1001/jama.2012.385; Bengala C, 2010, BRIT J CANCER, V103, P1019, DOI 10.1038/sj.bjc.6605853; Bertotti A, 2011, CANCER DISCOV, V1, P508, DOI 10.1158/2159-8290.CD-11-0109; Bouzourene H, 2002, CANCER-AM CANCER SOC, V94, P1121, DOI 10.1002/cncr.10327; Bunney TD, 2010, NAT REV CANCER, V10, P342, DOI 10.1038/nrc2842; Dasari A, 2010, CLIN CANCER RES, V16, P3811, DOI 10.1158/1078-0432.CCR-09-2283; Davies JM, 2011, RADIAT ONCOL, V6, DOI 10.1186/1748-717X-6-114; De Roock W, 2010, JAMA-J AM MED ASSOC, V304, P1812, DOI 10.1001/jama.2010.1535; De Roock W, 2010, LANCET ONCOL, V11, P753, DOI 10.1016/S1470-2045(10)70130-3; Diaz LA, 2012, NATURE, V486, P537, DOI 10.1038/nature11219; Erben P, 2011, INT J RADIAT ONCOL, V81, P1032, DOI 10.1016/j.ijrobp.2010.06.043; Folkvord S, 2010, INT J RADIAT ONCOL, V78, P555, DOI 10.1016/j.ijrobp.2010.04.036; Folprecht G, 2010, LANCET ONCOL, V11, P38, DOI 10.1016/S1470-2045(09)70330-4; Gaedcke J, 2010, RADIOTHER ONCOL, V94, P76, DOI 10.1016/j.radonc.2009.10.001; Grimminger PP, 2011, CLIN CANCER RES, V17, P3469, DOI 10.1158/1078-0432.CCR-10-2273; Hilhorst R, 2009, ANAL BIOCHEM, V387, P150, DOI 10.1016/j.ab.2009.01.022; Hinselwood DC, 2005, ELECTROPHORESIS, V26, P2553, DOI 10.1002/elps.200410427; Hunter T, 2000, CELL, V100, P113, DOI 10.1016/S0092-8674(00)81688-8; Jinnin M, 2008, NAT MED, V14, P1236, DOI 10.1038/nm.1877; Kim SY, 2013, INT J RADIAT ONCOL, V85, P201, DOI 10.1016/j.ijrobp.2012.03.048; Kim SY, 2011, INT J RADIAT ONCOL, V81, P677, DOI 10.1016/j.ijrobp.2010.06.035; Kristensen AT, 2008, BMC CANCER, V8, DOI 10.1186/1471-2407-8-213; Martini M, 2012, NAT REV CLIN ONCOL, V9, P87, DOI 10.1038/nrclinonc.2011.164; Misale S, 2012, NATURE, V486, P532, DOI 10.1038/nature11156; Montagut C, 2012, NAT MED, V18, P221, DOI 10.1038/nm.2609; Nigro JM, 2001, AM J PATHOL, V158, P1253, DOI 10.1016/S0002-9440(10)64076-X; Petersen SH, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004078.pub2; Rizzo S, 2010, CANCER TREAT REV, V36, pS56, DOI 10.1016/S0305-7372(10)70021-9; Roth AD, 2010, J CLIN ONCOL, V28, P466, DOI 10.1200/JCO.2009.23.3452; Saelen MG, 2011, ANGIOGENESIS, V14, P481, DOI 10.1007/s10456-011-9231-3; Sikkema AH, 2012, CRIT REV ONCOL HEMAT, V82, P171, DOI 10.1016/j.critrevonc.2011.05.002; Sikkema AH, 2009, CANCER RES, V69, P5987, DOI 10.1158/0008-5472.CAN-08-3660; Tejpar S, 2012, J CLIN ONCOL, V30, P3570, DOI 10.1200/JCO.2012.42.2592; Ter Elst A, 2011, LEUKEMIA LYMPHOMA, V52, P122, DOI 10.3109/10428194.2010.535181; Thiele A, 2011, MOL BIOTECHNOL, V49, P283, DOI 10.1007/s12033-011-9402-x; Vatentini V, 2008, RADIOTHER ONCOL, V87, P449, DOI 10.1016/j.radonc.2008.05.022; Vogelstein B, 2004, NAT MED, V10, P789, DOI 10.1038/nm1087; Yonesaka K, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3002442	38	6	6	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 30	2012	7	11							e50806	10.1371/journal.pone.0050806	http://dx.doi.org/10.1371/journal.pone.0050806			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	054WM	23226389	Green Published, Green Submitted, gold			2022-12-27	WOS:000312376100200
J	Chen, RL; Song, YQ; Hu, Z; Brunner, EJ				Chen, Ruoling; Song, Yiqing; Hu, Zhi; Brunner, Eric John			Predictors of Diabetes in Older People in Urban China	PLOS ONE			English	Article							GMS-AGECAT PREVALENCE; RISK-FACTORS; MRC-ALPHA; DEPRESSION; HEALTH; COMMUNITY; MELLITUS; WOMEN; MEN; POPULATION	Background: China has the largest number of people with diabetes in the world. Over the last 30 years China has experienced rapid economic growth and a growing income gap between rich and poor. The population is ageing, however diabetes in older people has not been well studied to date. In this study we determined incidence and predictors of diabetes in older Chinese people. Methods: During 2001, using a standard interview method, we examined 1,317 adults aged >= 65 years who did not have diabetes in the city of Hefei, and characterized baseline risk factors. Over 7.5 years of follow up, we documented incident diabetes using self-reported doctor diagnosis and the cause of death in the whole cohort, and HbA(1C) >= 48 mmol/mol in a nested case-control sample. A multivariate Cox regression model was employed to investigate risk of diabetes in relation to baseline risk factors. Results: During follow up, 119 persons had newly diagnosed diabetes. World age-standardised incidence of diabetes was 24.5 (95% CI 19.5-29.5) per 1,000 person-years. Risk of diabetes was significantly and positively associated with income, waist circumference and body mass index, smoking and uncontrolled hypertension, but negatively associated with having a hobby of walking and frequency of visiting children/other relatives and contacting neighbours/friends. Higher income was significantly associated with increased diabetes risk regardless of cardiovascular and psychosocial risk factors. Compared to those with middle income and no psychosocial risk factors, the hazard ratio for incident diabetes among participants with high income and psychosocial risk was 2.13 (95% CI 1.02-4.45). Conclusions: Increasing incidence of diabetes in relation to high income has become an important public health issue in China. Maintaining social networks and gentle physical activities and reducing psychosocial factors may be integrated into current multi-faceted preventive strategies for curbing the epidemic of diabetes in the older population.	[Chen, Ruoling; Hu, Zhi] Anhui Med Univ, Sch Hlth Adm, Hefei, Anhui, Peoples R China; [Song, Yiqing] Peking Univ, Hosp 3, Inst Vasc Med, Beijing 100871, Peoples R China; [Brunner, Eric John] UCL, Sch Med, Dept Epidemiol & Publ Hlth, London W1N 8AA, England; [Chen, Ruoling] Kings Coll London, Sch Med, Dept Primary Care & Publ Hlth Sci, London, England	Anhui Medical University; Peking University; University of London; University College London; UCL Medical School; University of London; King's College London	Chen, RL (corresponding author), Anhui Med Univ, Sch Hlth Adm, Hefei, Anhui, Peoples R China.	ruoling.chen@ucl.ac.uk	Brunner, Eric/H-2114-2011	Brunner, Eric/0000-0002-0595-4474; Chen, Ruoling/0000-0002-3033-8753	BUPA Foundation, UK [45NOV06, TBF-M09-50]; British Heart Foundation	BUPA Foundation, UK; British Heart Foundation(British Heart Foundation)	The cohort follow-up data collection work was funded by two research grants from the BUPA Foundation, UK (number of grants: 45NOV06 and TBF-M09-50). Eric Brunner is supported by the British Heart Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Blanchard JF, 1996, DIABETES CARE, V19, P807, DOI 10.2337/diacare.19.8.807; Bonora E, 2004, DIABETES, V53, P1782, DOI 10.2337/diabetes.53.7.1782; Brown AF, 2004, EPIDEMIOL REV, V26, P63, DOI 10.1093/epirev/mxh002; Chen R, 2003, J HUM HYPERTENS, V17, P751, DOI 10.1038/sj.jhh.1001612; Chen R, 2009, PSYCHOL MED, V39, P425, DOI 10.1017/S0033291708003735; Chen RL, 2005, ARCH INTERN MED, V165, P2019, DOI 10.1001/archinte.165.17.2019; Chen RL, 2004, INT J GERIATR PSYCH, V19, P407, DOI 10.1002/gps.1103; Chen RL, 2005, EUR J EPIDEMIOL, V20, P141, DOI 10.1007/s10654-004-4498-y; Chen RL, 2008, BRIT J PSYCHIAT, V193, P373, DOI 10.1192/bjp.bp.107.044974; Chen RL, 2012, INT J GERIATR PSYCH, V27, P692, DOI 10.1002/gps.2767; Chen RL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024817; COPELAND JRM, 1988, PSYCHOL MED, V18, P219, DOI 10.1017/S003329170000204X; Copeland JRM, 1999, BRIT J PSYCHIAT, V175, P340, DOI 10.1192/bjp.175.4.340; Cugati S, 2007, MED J AUSTRALIA, V186, P131, DOI 10.5694/j.1326-5377.2007.tb00836.x; de JP, 2006, DIABETOLOGIA, V49, P2797; Eriksson AK, 2008, DIABETIC MED, V25, P834, DOI 10.1111/j.1464-5491.2008.02463.x; Eriksson JG, 2006, DIABETOLOGIA, V49, P2853, DOI 10.1007/s00125-006-0459-1; Guize L, 2008, B ACAD NAT MED PARIS, V192, P1707, DOI 10.1016/S0001-4079(19)32638-X; Heraclides AM, 2012, OBESITY, V20, P428, DOI 10.1038/oby.2011.95; Hesketh T, 1997, BRIT MED J, V314, P1543, DOI 10.1136/bmj.314.7093.1543; Knol MJ, 2006, DIABETOLOGIA, V49, P837, DOI 10.1007/s00125-006-0159-x; Liu Meina, 2007, Prim Care Diabetes, V1, P123, DOI 10.1016/j.pcd.2007.05.001; Gonzalez ELM, 2009, J EPIDEMIOL COMMUN H, V63, P332, DOI 10.1136/jech.2008.080382; Nathan DM, 2009, DIABETES CARE, V32, P1327, DOI 10.2337/dc09-9033; Peng LN, 2010, AGE AGEING, V39, P125, DOI 10.1093/ageing/afp193; Rockwood K, 2000, CAN MED ASSOC J, V162, P769; Shaw JE, 2010, DIABETES RES CLIN PR, V87, P4, DOI 10.1016/j.diabres.2009.10.007; Whiting DR, 2011, DIABETES RES CLIN PR, V94, P311, DOI 10.1016/j.diabres.2011.10.029; Woo J, 2002, INT J EPIDEMIOL, V31, P772, DOI 10.1093/ije/31.4.772; Yang WY, 2010, NEW ENGL J MED, V362, P1090, DOI 10.1056/NEJMoa0908292; Zhang P, 2010, DIABETES RES CLIN PR, V87, P293, DOI 10.1016/j.diabres.2010.01.026	31	91	99	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 30	2012	7	11							e50957	10.1371/journal.pone.0050957	http://dx.doi.org/10.1371/journal.pone.0050957			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	054WM	23226432	Green Published, gold, Green Submitted			2022-12-27	WOS:000312376100243
J	Liu, HB; Liu, SB; Li, Y; Wang, XH; Xue, WJ; Ge, GQ; Luo, XH				Liu, Hongbao; Liu, Shuibing; Li, Yang; Wang, Xiaohong; Xue, Wujun; Ge, Guanqun; Luo, Xiaohui			The Role of SDF-1-CXCR4/CXCR7 Axis in the Therapeutic Effects of Hypoxia-Preconditioned Mesenchymal Stem Cells for Renal Ischemia/Reperfusion Injury	PLOS ONE			English	Article							MARROW STROMAL CELLS; ACUTE KIDNEY INJURY; BONE-MARROW; CXCR4; MIGRATION; EXPRESSION; REPAIR; DIFFERENTIATION; MOBILIZATION; CONTRIBUTES	In vitro hypoxic preconditioning (HP) of mesenchymal stem cells (MSCs) could ameliorate their viability and tissue repair capabilities after transplantation into the injured tissue through yet undefined mechanisms. There is also experimental evidence that HP enhances the expression of both stromal-derived factor-1 (SDF-1) receptors, CXCR4 and CXCR7, which are involved in migration and survival of MSCs in vitro, but little is known about their role in the in vivo therapeutic effectiveness of MSCs in renal ischemia/reperfusion (I/R) injury. Here, we evaluated the role of SDF-1-CXCR4/CXCR7 pathway in regulating chemotaxis, viability and paracrine actions of HP-MSCs in vitro and in vivo. Compared with normoxic preconditioning (NP), HP not only improved MSC chemotaxis and viability but also stimulated secretion of proangiogenic and mitogenic factors. Importantly, both CXCR4 and CXCR7 were required for the production of paracrine factors by HP-MSCs though the former was only responsible for chemotaxis while the latter was for viability. SDF-1 alpha expression was upregulated in postischemic kidneys. After 24 h systemical administration following I/R, HP-MSCs but not NP-MSCs were selectively recruited to ischemic kidneys and this improved recruitment was abolished by neutralization of CXCR4, but not CXCR7. Furthermore, the increased recruitment of HP-MSCs was associated with enhanced functional recovery, accelerated mitogenic response, and reduced apoptotic cell death. In addition, neutralization of either CXCR4 or CXCR7 impaired the improved therapeutic potential of HP-MSCs. These results advance our knowledge about SDF-1-CXCR4/CXCR7 axis as an attractive target pathway for improving the beneficial effects of MSC-based therapies for renal I/R.	[Liu, Hongbao] Fourth Mil Med Univ, Xijing Hosp, Dept Nephrol, Xian 710032, Peoples R China; [Liu, Shuibing] Fourth Mil Med Univ, Sch Pharm, Dept Pharmacol, Xian 710032, Peoples R China; [Li, Yang; Wang, Xiaohong; Xue, Wujun; Ge, Guanqun; Luo, Xiaohui] Xi An Jiao Tong Univ, Affiliated Hosp 1, Dept Renal Transplant, Xian 710049, Peoples R China	Air Force Military Medical University; Air Force Military Medical University; Xi'an Jiaotong University	Liu, HB (corresponding author), Fourth Mil Med Univ, Xijing Hosp, Dept Nephrol, Xian 710032, Peoples R China.	xjsnlhb@yahoo.com.cn; xjsnxwj@126.com	Li, Yuan/GXV-1310-2022; Li, Yang/GWM-7879-2022; li, yong/HDN-3885-2022	Liu, Hui/0000-0002-4548-2002; Liu, Hongbao/0000-0002-1283-4956	National Nature Science Foundation of China [81000309, 30900277]; Natural Science Basis Research Plan in Shaanxi Province of China [2009K12-02]; Major Scientific and Technological Special Projects of Shaanxi Province of China [2007ZDKG-67]; Youth Foundation of First Affiliated Hospital, Medical College, Xi'an Jiaotong University [2011YK.20]	National Nature Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Basis Research Plan in Shaanxi Province of China; Major Scientific and Technological Special Projects of Shaanxi Province of China; Youth Foundation of First Affiliated Hospital, Medical College, Xi'an Jiaotong University	This work was supported by grants from National Nature Science Foundation of China (Nos. 81000309 and 30900277), Natural Science Basis Research Plan in Shaanxi Province of China (No: 2009K12-02), Major Scientific and Technological Special Projects of Shaanxi Province of China (No. 2007ZDKG-67) and Youth Foundation of the First Affiliated Hospital, Medical College, Xi'an Jiaotong University (No. 2011YK.20). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmed SB, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019029; Ali T, 2007, J AM SOC NEPHROL, V18, P1292, DOI 10.1681/ASN.2006070756; Askari AT, 2003, LANCET, V362, P697, DOI 10.1016/S0140-6736(03)14232-8; Bi B, 2007, J AM SOC NEPHROL, V18, P2486, DOI 10.1681/ASN.2007020140; Bussolati B, 2012, AM J PHYSIOL-RENAL, V302, pF116, DOI 10.1152/ajprenal.00184.2011; Ceradini DJ, 2004, NAT MED, V10, P858, DOI 10.1038/nm1075; Chacko SM, 2009, AM J PHYSIOL-HEART C, V296, pH1263, DOI 10.1152/ajpheart.01311.2008; Chen YT, 2011, J TRANSL MED, V9, DOI 10.1186/1479-5876-9-51; Cheng ZK, 2008, MOL THER, V16, P571, DOI 10.1038/sj.mt.6300374; Das R, 2010, TISSUE ENG PART B-RE, V16, P159, DOI 10.1089/ten.TEB.2009.0296; De Falco E, 2004, BLOOD, V104, P3472, DOI 10.1182/blood-2003-12-4423; Gao H, 2009, STEM CELLS, V27, P857, DOI 10.1002/stem.23; Gao JZ, 2001, CELLS TISSUES ORGANS, V169, P12, DOI 10.1159/000047856; Grayson WL, 2006, J CELL PHYSIOL, V207, P331, DOI 10.1002/jcp.20571; Grenz A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014812; Guo JK, 2010, ANNU REV PHYSIOL, V72, P357, DOI 10.1146/annurev.physiol.010908.163245; Gupta S, 2010, AM J PHYSIOL-RENAL, V298, pF209, DOI 10.1152/ajprenal.00451.2009; Honczarenko M, 2006, STEM CELLS, V24, P1030, DOI 10.1634/stemcells.2005-0319; Hu XF, 2007, CIRCULATION, V116, P654, DOI 10.1161/CIRCULATIONAHA.106.672451; Hu XY, 2008, J THORAC CARDIOV SUR, V135, P799, DOI 10.1016/j.jtcvs.2007.07.071; Humphreys BD, 2008, ANNU REV MED, V59, P311, DOI 10.1146/annurev.med.59.061506.154239; Hung SC, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000416; Jayakumar C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026776; Jin DK, 2006, NAT MED, V12, P557, DOI 10.1038/nm1400; Kanazawa H, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019195; Kentrup D, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026419; Kubo M, 2009, J CELL PHYSIOL, V220, P508, DOI 10.1002/jcp.21803; Lameire N, 2006, NAT CLIN PRACT NEPHR, V2, P364, DOI 10.1038/ncpneph0218; Li B, 2010, CIRCULATION, V121, P2211, DOI 10.1161/CIRCULATIONAHA.109.928796; Li KH, 2010, STEM CELLS DEV, V19, P1267, DOI 10.1089/scd.2009.0196; Liu HB, 2010, BIOCHEM BIOPH RES CO, V401, P509, DOI 10.1016/j.bbrc.2010.09.076; Mazzinghi B, 2008, J EXP MED, V205, P479, DOI 10.1084/jem.20071903; Mias C, 2008, STEM CELLS, V26, P1749, DOI 10.1634/stemcells.2007-1000; Mitra AK, 2009, J CELL MOL MED, V13, P177, DOI 10.1111/j.1582-4934.2008.00311.x; Morishita Y, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023267; Petit I, 2007, TRENDS IMMUNOL, V28, P299, DOI 10.1016/j.it.2007.05.007; Rosova I, 2008, STEM CELLS, V26, P2173, DOI 10.1634/stemcells.2007-1104; Sachse A, 2007, J AM SOC NEPHROL, V18, P2439, DOI 10.1681/ASN.2007020149; Schietke RE, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031034; Schley G, 2011, J AM SOC NEPHROL, V22, P2004, DOI 10.1681/ASN.2010121249; Shi MX, 2007, HAEMATOLOGICA, V92, P897, DOI 10.3324/haematol.10669; Shi RZ, 2008, BIOCHEM BIOPH RES CO, V376, P247, DOI 10.1016/j.bbrc.2008.09.004; Singh P, 2012, J AM SOC NEPHROL; Son BR, 2006, STEM CELLS, V24, P1254, DOI 10.1634/stemcells.2005-0271; Stokman G, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014386; Tang JM, 2011, CARDIOVASC RES, V91, P402, DOI 10.1093/cvr/cvr053; Tang YL, 2009, CIRC RES, V104, P1209, DOI 10.1161/CIRCRESAHA.109.197723; Togel F, 2005, AM J PHYSIOL-RENAL, V289, pF31, DOI 10.1152/ajprenal.00007.2005; Togel F, 2005, KIDNEY INT, V67, P1772, DOI 10.1111/j.1523-1755.2005.00275.x; Togel F, 2007, AM J PHYSIOL-RENAL, V292, pF1626, DOI 10.1152/ajprenal.00339.2006; Wang JA, 2008, ACTA PHARMACOL SIN, V29, P74, DOI 10.1111/j.1745-7254.2008.00716.x; Wang Y, 2008, BRAIN RES, V1195, P104, DOI 10.1016/j.brainres.2007.11.068; Wu HL, 2010, J AM SOC NEPHROL, V21, P1878, DOI 10.1681/ASN.2009101048; Wu J, 2010, AM J PATHOL, V176, P2163, DOI 10.2353/ajpath.2010.090386; Wu Y, 2011, STEM CELL REV; Wynn RF, 2004, BLOOD, V104, P2643, DOI 10.1182/blood-2004-02-0526; Zhang S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029876	57	178	199	0	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 12	2012	7	4							e34608	10.1371/journal.pone.0034608	http://dx.doi.org/10.1371/journal.pone.0034608			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TZ	22511954	Green Published, gold, Green Submitted			2022-12-27	WOS:000305338600040
J	Sharaf, MR; Aldawood, AS				Sharaf, Mostafa R.; Aldawood, Abdulrahman S.			Ants of the Genus Solenopsis Westwood 1840 (Hymenoptera: Formicidae) in the Arabian Peninsula with Description of a New Species, Solenopsis elhawagryi	PLOS ONE			English	Article								Ants of the genus Solenopsis Westwood in the Arabian Peninsula are revised. Six species are treated: Solenopsis elhawagryi Sharaf & Aldawood sp. n., S. geminata (Fabricius, 1804), S. omana Collingwood & Agosti, 1996, S. saudiensis Sharaf & Aldawood, 2011, S. sumara Collingwood & Agosti, 1996, and S. zingibara Collingwood & Agosti, 1996. Solenopsis elhawagryi is described from Beljorashi Governorate, Al Baha Province, Saudi Arabia, based on worker castes and the queen with notes on this species biology and ecology. Solenopsis sumara workers are redescribed and illustrated for the first time and a lectotype is designated. An identification key to the Arabian and Egyptian species is provided with scanning electron micrographs to facilitate species recognition.	[Sharaf, Mostafa R.; Aldawood, Abdulrahman S.] King Saud Univ, Coll Food & Agr Sci, Dept Plant Protect, Riyadh, Saudi Arabia	King Saud University	Sharaf, MR (corresponding author), King Saud Univ, Coll Food & Agr Sci, Dept Plant Protect, Riyadh, Saudi Arabia.	antsharaf@gmail.com	Aldawood, Abdulrahman Saad/M-3657-2019	Aldawood, Abdulrahman Saad/0000-0003-0721-6632	NPST program (King Saud University) [11-BIO1974-02]	NPST program (King Saud University)(King Saud University)	Funding for the research was provided by NPST program (King Saud University) Project No. 11-BIO1974-02. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bolton B., 1987, Bulletin of the British Museum (Natural History) Entomology, V54, P263; Bolton B., 1994, Identification guide to the ant genera of the world.; BOLTON B., 2007, BOLTONS CATALOGUE AN; Brown William L. Jr, 2000, P45; Collingwood CA, 1997, J ARID ENVIRON, V37, P505, DOI 10.1006/jare.1997.0309; Collingwood Cedric A., 1996, Fauna of Saudi Arabia, V15, P300; CREIGHTON W. S., 1950, BULL MUS COMP ZOOL HARVARD UNIV, V104, P1; Creighton WS, 1930, P AM ACAD ARTS SCI, V66, P39, DOI 10.2307/20026320; ETTERSHANK G., 1966, AUSTRALIAN J ZOOL, V14, P73, DOI 10.1071/ZO9660073; Holway DA, 2002, ANNU REV ECOL SYST, V33, P181, DOI 10.1146/annurev.ecolsys.33.010802.150444; Mayr G., 1863, VERHANDLUNGEN KAISER, V13, P385; McGlynn TP, 1999, J BIOGEOGR, V26, P535, DOI 10.1046/j.1365-2699.1999.00310.x; Pacheco JA, 2006, THESIS U TEXAS EL PA, P543; Sharaf MR, 2011, ANN SOC ENTOMOL FR, V47, P474, DOI 10.1080/00379271.2011.10697738; Sharaf MR, 2011, T AM ENTOMOL SOC, V137, P203, DOI 10.3157/061.137.0113; Sharaf MR, 2009, ZOOTAXA, P49, DOI 10.11646/zootaxa.2004.1.4; TRAGER JC, 1991, J NEW YORK ENTOMOL S, V99, P141; West-Wood J. O., 1840, ANN MAGAZINE NATURAL, V6, P81, DOI [10.1080/03745484009443610, DOI 10.1080/03745484009443610]; Wetterer JK, 2011, MYRMECOL NEWS, V14, P21	19	27	27	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 30	2012	7	11							e49485	10.1371/journal.pone.0049485	http://dx.doi.org/10.1371/journal.pone.0049485			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	054WM	23226211	Green Published, Green Submitted, gold			2022-12-27	WOS:000312376100020
J	Sharaf, MR; Aldawood, AS; Taylor, B				Sharaf, Mostafa R.; Aldawood, Abdulrahman S.; Taylor, Brian			A New Ant Species of the Genus Tetramorium Mayr, 1855 (Hymenoptera: Formicidae) from Saudi Arabia, with a Revised Key to the Arabian Species	PLOS ONE			English	Article							COMPLEX HYMENOPTERA; REGION; FOREST; FAUNA; USSR	Tetramorium amalae sp. n. is described and illustrated from Saudi Arabia based on two worker caste specimens collected in Al Bahah region. The new species belongs to the T. shilohense group and appears to be closely related to T. dysderke Bolton from Nigeria. T. amalae is distinguished by having well-developed frontal carinae, smaller eyes, greater head length and width, greater pronotal width, and the petiole node is longer than broad. Tetramorium latinode Collingwood & Agosti is recorded for the first time from Saudi Arabia and for only the second time since the original description. The worker caste of T. latinode is redescribed and illustrated using scanning electron micrographs to facilitate recognition and the gyne is described for the first time with observations given on species relationships, biology and habitat. A revised key to the nineteen Tetramorium species recorded from Arabian Peninsula based on worker castes is provided. Tetramorium bicarinatum (Nylander) is recorded for the first time from Saudi Arabia. It is suggested that T. amalae and T. latinode are endemic to the Arabian Peninsula.	[Sharaf, Mostafa R.; Aldawood, Abdulrahman S.] King Saud Univ, Dept Plant Protect, Coll Food & Agr Sci, Riyadh, Saudi Arabia	King Saud University	Sharaf, MR (corresponding author), King Saud Univ, Dept Plant Protect, Coll Food & Agr Sci, Riyadh, Saudi Arabia.	antsharaf@yahoo.com; aldawood88@yahoo.com	Aldawood, Abdulrahman Saad/M-3657-2019	Aldawood, Abdulrahman Saad/0000-0003-0721-6632	King Saud University, Deanship of Scientific Research, College of Food and Agricultural Sciences, Research Center	King Saud University, Deanship of Scientific Research, College of Food and Agricultural Sciences, Research Center	This project was supported by King Saud University, Deanship of Scientific Research, College of Food and Agricultural Sciences, Research Center. The authors express their debt and gratitude to Mr. Barry Bolton and Dr. Brian Fisher for useful and valuable comments, which much improved the manuscript. Actually, without their continuous help this study could not have been completed. Special thanks are due to Prof. Boris Kondratieff for critical reading of the manuscript. We are indebted to Dr. Stephen Judd, Director of the World Museum Liverpool and Mr. Guy Knight, Head of Zoology and Curator of Invertebrates, for allowing the senior author to examine Tetramorium material. Thanks go to Dr. Richard Pyle for providing the first Formicidae LSID for the new species. We are grateful for two anonymous reviewers for their comments which greatly improved the manuscript. We also thank Mr. Hassan Badri for technical assistance and Dr. Omer Hamed for taking SEM images. Special thanks go to Prof. Magdi Elhawagry and Mr. Mohammed Metwally for help in expedition to Baha region and Mr. Mohammed Sallam for helping with the photography of T. latinode. The senior author expresses his gratitude to his wife Amal El Saadany, for her joyful assistance and appreciated help with specimens mounting, to Mr. Cedric Collingwood, for his continuous encouragements and wonderful hospitality, and to Tony van Harten, Mr. Salah Montaser (the Egyptian Journalist, Al Ahram Newspaper), Prof. Hoda Farid (Ain Shams University), Dr. Mahmoud Eldera'a and Mr. Ismail Fareed for their encouragement.	Arnold G., 1926, Annals of the South African Museum, V23, P191; Bodenheimer FS, 1937, P LINN SOC LONDON, V148, P47; BOLTON B, 1995, J NAT HIST, V29, P1037, DOI 10.1080/00222939500770411; Bolton B., 1979, Bulletin of the British Museum (Natural History) Entomology, V38, P129; BOLTON B, 1985, J NAT HIST, V19, P243, DOI 10.1080/00222938500770191; Bolton B., 1977, Bulletin Br Mus nat Hist (Ent), V36, P67; Bolton B., 1976, Bulletin of the British Museum (Natural History), Entomology, V34, P281; Bolton B., 1980, Bulletin of the British Museum (Natural History) Entomology, V40, P193; Bolton B., 1994, IDENTIFICATION GUIDE; Brown WL, 2000, BIOL DIVERSITY HDB S; Collingwood C.A., 1985, Fauna of Saudi Arabia, V7, P230; Collingwood CA, 1997, J ARID ENVIRON, V37, P505, DOI 10.1006/jare.1997.0309; Collingwood Cedric A., 2005, Zoology in the Middle East, V35, P73; Collingwood Cedric A., 1996, Fauna of Saudi Arabia, V15, P300; Collingwood Cedric A., 2004, V20, P473; Csosz S, 2007, ZOOTAXA, P1; Csosz S, 2010, ZOOTAXA, P1; Garcia FH, 2010, ZOOTAXA, P1; Garcia FH, 2011, ZOOTAXA, P1; Garcia Francisco Hita, 2010, Bonn Zoological Bulletin, V57, P359; Garcia FH, 2010, MYRMECOL NEWS, V13, P141; Nayman J, 1972, ATLAS WILDLIFE; RADCHENKO AG, 1992, ZOOL ZH, V71, P39; RADCHENKO AG, 1992, ZOOL ZH, V71, P50; Taylor B., 1980, COCOA RES I NIGERIA, V7, P1; Yamane Seiki, 2011, Insecta Matsumurana, V67, P61	26	27	27	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 28	2012	7	2							e30811	10.1371/journal.pone.0030811	http://dx.doi.org/10.1371/journal.pone.0030811			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	928RC	23226211	Green Published, gold			2022-12-27	WOS:000302999600004
J	Chen, SS; Luetje, CW				Chen, Sisi; Luetje, Charles W.			Identification of New Agonists and Antagonists of the Insect Odorant Receptor Co-Receptor Subunit	PLOS ONE			English	Article							MOLECULAR-BASIS; SYSTEM; TASTE	Background: Insects detect attractive and aversive chemicals using several families of chemosensory receptors, including the OR family of olfactory receptors, making these receptors appealing targets for the control of insects. Insect ORs are odorant-gated ion channels, comprised of at least one common subunit (the odorant receptor co-receptor subunit, Orco) and at least one variable odorant specificity subunit. Each of the many ORs of an insect species is activated or inhibited by an unique set of odorants that interact with the variable odorant specificity subunits, making the development of OR directed insect control agents complex and laborious. However, several N-,2-substituted triazolothioacetamide compounds (VUAA1, VU0450667 and VU0183254) were recently shown to act directly on the highly conserved Orco subunit, suggesting that broadly active compounds can be developed. We have explored the chemical space around the VUAA1 structure in order to identify new Orco ligands. Principal Findings: We screened ORs from several insect species, using heterologous expression in Xenopus oocytes and an electrophysiological assay, with a panel of 22 compounds structurally related to VUAA1. By varying the nitrogen position in the pyridine ring and altering the moieties decorating the phenyl ring, we identified two new agonists and a series of competitive antagonists. Screening smaller compounds, similar to portions of the VUAA1 structure, also yielded competitive antagonists. Importantly, we show that Orco antagonists inhibit odorant activation of ORs from several insect species. Detailed examination of one antagonist demonstrated inhibition to be through a non-competitive mechanism. Conclusions: A similar pattern of agonist and antagonist sensitivity displayed by Orco subunits from different species suggests a highly conserved binding site structure. The susceptibility to inhibition of odorant activation by Orco antagonism is conserved across disparate insect species, suggesing the ligand binding site on Orco as a promising target for the development of novel, broadly active insect repellants.	[Chen, Sisi; Luetje, Charles W.] Univ Miami, Miller Sch Med, Dept Mol & Cellular Pharmacol, Miami, FL 33136 USA	University of Miami	Chen, SS (corresponding author), Univ Miami, Miller Sch Med, Dept Mol & Cellular Pharmacol, Miami, FL 33136 USA.	cluetje@med.miami.edu	CHEN, SI/GZL-4800-2022; WU, CHUN-HU/P-3958-2018	WU, CHUN-HU/0000-0001-6851-7936; Hung, Tai-Ho/0000-0003-2354-7060; Chen, Shaohua/0000-0001-8306-2626	National Institutes of Health [RO1 DC011091]; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC011091] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	This work was supported by the National Institutes of Health [RO1 DC011091 to CWL]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Benton R, 2006, PLOS BIOL, V4, P240, DOI 10.1371/journal.pbio.0040020; Benton R, 2009, CELL, V136, P149, DOI 10.1016/j.cell.2008.12.001; Bohbot JD, 2012, NEUROPHARMACOLOGY, V62, P2086, DOI 10.1016/j.neuropharm.2012.01.004; Carey AF, 2010, NATURE, V464, P66, DOI 10.1038/nature08834; Hallem EA, 2006, CELL, V125, P143, DOI 10.1016/j.cell.2006.01.050; Hallem EA, 2006, ANNU REV ENTOMOL, V51, P113, DOI 10.1146/annurev.ento.51.051705.113646; Hallem EA, 2004, CELL, V117, P965, DOI 10.1016/j.cell.2004.05.012; Hughes DT, 2010, J CHEM ECOL, V36, P797, DOI 10.1007/s10886-010-9828-9; Jones PL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030304; Jones PL, 2011, P NATL ACAD SCI USA, V108, P8821, DOI 10.1073/pnas.1102425108; Jones WD, 2005, CURR BIOL, V15, pR119, DOI 10.1016/j.cub.2005.02.007; Krieger J, 2003, J COMP PHYSIOL A, V189, P519, DOI 10.1007/s00359-003-0427-x; Larsson MC, 2004, NEURON, V43, P703, DOI 10.1016/j.neuron.2004.08.019; LIMAN ER, 1992, NEURON, V9, P861, DOI 10.1016/0896-6273(92)90239-A; Martin JP, 2011, PROG NEUROBIOL, V95, P427, DOI 10.1016/j.pneurobio.2011.09.007; Nakagawa T, 2005, SCIENCE, V307, P1638, DOI 10.1126/science.1106267; Nakagawa T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032372; Neuhaus EM, 2005, NAT NEUROSCI, V8, P15, DOI 10.1038/nn1371; Nichols AS, 2011, CHEM SENSES, V36, P781, DOI 10.1093/chemse/bjr053; Nichols AS, 2010, J BIOL CHEM, V285, P11854, DOI 10.1074/jbc.M109.058321; Pask GM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028774; Pellegrino M, 2011, NATURE, V478, P511, DOI 10.1038/nature10438; Pelletier J, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010090; Pitts RJ, 2004, P NATL ACAD SCI USA, V101, P5058, DOI 10.1073/pnas.0308146101; Sato K, 2008, NATURE, V452, P1002, DOI 10.1038/nature06850; Smart R, 2008, INSECT BIOCHEM MOLEC, V38, P770, DOI 10.1016/j.ibmb.2008.05.002; Vosshall LB, 2007, ANNU REV NEUROSCI, V30, P505, DOI 10.1146/annurev.neuro.30.051606.094306; Vosshall LB, 2011, CHEM SENSES, V36, P497, DOI 10.1093/chemse/bjr022; Wang GR, 2010, P NATL ACAD SCI USA, V107, P4418, DOI 10.1073/pnas.0913392107; Wanner KW, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008685; Wetzel CH, 2001, P NATL ACAD SCI USA, V98, P9377, DOI 10.1073/pnas.151103998; Wicher D, 2008, NATURE, V452, P1007, DOI 10.1038/nature06861; Xia YF, 2008, P NATL ACAD SCI USA, V105, P6433, DOI 10.1073/pnas.0801007105	33	338	351	8	60	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 8	2012	7	5							e36784	10.1371/journal.pone.0036784	http://dx.doi.org/10.1371/journal.pone.0036784			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TF	23226289	gold, Green Published, Green Submitted			2022-12-27	WOS:000305335500028
